PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"28736063","Bladder cancer: Present and future","Martinez Rodriguez RH, Buisan Rueda O, Ibarz L.","Med Clin (Barc). 2017 Nov 22;149(10):449-455. doi: 10.1016/j.medcli.2017.06.009. Epub 2017 Jul 21.","Martinez Rodriguez RH","Med Clin (Barc)","2017","2017/07/25","","","10.1016/j.medcli.2017.06.009"
"30414013","Bladder Cancer Survivorship","Bhanvadia SK.","Curr Urol Rep. 2018 Nov 9;19(12):111. doi: 10.1007/s11934-018-0860-6.","Bhanvadia SK","Curr Urol Rep","2018","2018/11/11","","","10.1007/s11934-018-0860-6"
"29117156","Bladder cancer","Grayson M.","Nature. 2017 Nov 8;551(7679):S33. doi: 10.1038/551S33a.","Grayson M","Nature","2017","2017/11/09","","","10.1038/551S33a"
"26177642","Immunotherapy in Bladder Cancer","Vasekar M, Degraff D, Joshi M.","Curr Mol Pharmacol. 2016;9(3):242-251. doi: 10.2174/1874467208666150716120945.","Vasekar M","Curr Mol Pharmacol","2016","2015/07/17","","","10.2174/1874467208666150716120945"
"16399414","Bladder cancer: epidemiology, staging and grading, and diagnosis","Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM, Sesterhenn IA, Tachibana M, Weider J.","Urology. 2005 Dec;66(6 Suppl 1):4-34. doi: 10.1016/j.urology.2005.07.062.","Kirkali Z","Urology","2005","2006/01/10","","","10.1016/j.urology.2005.07.062"
"26346676","Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes","Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, Shariat SF, Zlotta AR, Boorjian SA.","Eur Urol. 2016 Feb;69(2):300-10. doi: 10.1016/j.eururo.2015.08.037. Epub 2015 Sep 4.","Dobruch J","Eur Urol","2016","2015/09/09","","","10.1016/j.eururo.2015.08.037"
"29168333","Bladder cancer: diagnosis and management of bladder cancer: © NICE (2015) Bladder cancer: diagnosis and management of bladder cancer","","BJU Int. 2017 Dec;120(6):755-765. doi: 10.1111/bju.14045.","","BJU Int","2017","2017/11/24","","","10.1111/bju.14045"
"28169964","Bladder cancer: Risk factors, diagnosis, and management","Farling KB.","Nurse Pract. 2017 Mar 7;42(3):26-33. doi: 10.1097/01.NPR.0000512251.61454.5c.","Farling KB","Nurse Pract","2017","2017/02/08","","","10.1097/01.NPR.0000512251.61454.5c"
"29117159","Unlocking bladder cancer","Berdik C.","Nature. 2017 Nov 8;551(7679):S34-S35. doi: 10.1038/551S34a.","Berdik C","Nature","2017","2017/11/09","","","10.1038/551S34a"
"24492433","The mechanism of action of BCG therapy for bladder cancer--a current perspective","Redelman-Sidi G, Glickman MS, Bochner BH.","Nat Rev Urol. 2014 Mar;11(3):153-62. doi: 10.1038/nrurol.2014.15. Epub 2014 Feb 4.","Redelman-Sidi G","Nat Rev Urol","2014","2014/02/05","","","10.1038/nrurol.2014.15"
"28990272","Impact of bladder cancer on health-related quality of life","Smith AB, Jaeger B, Pinheiro LC, Edwards LJ, Tan HJ, Nielsen ME, Reeve BB.","BJU Int. 2018 Apr;121(4):549-557. doi: 10.1111/bju.14047. Epub 2017 Nov 1.","Smith AB","BJU Int","2018","2017/10/10","","","10.1111/bju.14047"
"29368051","Role of immunotherapy in bladder cancer: past, present and future","Butt SU, Malik L.","Cancer Chemother Pharmacol. 2018 Apr;81(4):629-645. doi: 10.1007/s00280-018-3518-7. Epub 2018 Jan 24.","Butt SU","Cancer Chemother Pharmacol","2018","2018/01/26","","","10.1007/s00280-018-3518-7"
"30471107","Cancer stem cells as a therapeutic target in bladder cancer","Aghaalikhani N, Rashtchizadeh N, Shadpour P, Allameh A, Mahmoodi M.","J Cell Physiol. 2019 Apr;234(4):3197-3206. doi: 10.1002/jcp.26916. Epub 2018 Nov 23.","Aghaalikhani N","J Cell Physiol","2019","2018/11/25","","","10.1002/jcp.26916"
"25836942","Bladder cancer","Bellmunt J.","Hematol Oncol Clin North Am. 2015 Apr;29(2):xiii-xiv. doi: 10.1016/j.hoc.2014.12.001. Epub 2015 Jan 9.","Bellmunt J","Hematol Oncol Clin North Am","2015","2015/04/04","","","10.1016/j.hoc.2014.12.001"
"30584034","Mental health implications in bladder cancer patients: A review","Pham H, Torres H, Sharma P.","Urol Oncol. 2019 Feb;37(2):97-107. doi: 10.1016/j.urolonc.2018.12.006. Epub 2018 Dec 21.","Pham H","Urol Oncol","2019","2018/12/26","","","10.1016/j.urolonc.2018.12.006"
"30467596","Diagnostic biomarkers in non-muscle invasive bladder cancer","Faiena I, Rosser CJ, Chamie K, Furuya H.","World J Urol. 2019 Oct;37(10):2009-2016. doi: 10.1007/s00345-018-2567-1. Epub 2018 Nov 22.","Faiena I","World J Urol","2019","2018/11/24","","","10.1007/s00345-018-2567-1"
"30855374","Trimodality therapy for bladder cancer: modern management and future directions","Pham A, Ballas LK.","Curr Opin Urol. 2019 May;29(3):210-215. doi: 10.1097/MOU.0000000000000601.","Pham A","Curr Opin Urol","2019","2019/03/12","PMC7440298","NIHMS1618690","10.1097/MOU.0000000000000601"
"29158137","Recent developments in the management of bladder cancer: Introduction","Smith AB.","Urol Oncol. 2018 Mar;36(3):95-96. doi: 10.1016/j.urolonc.2017.10.026. Epub 2017 Nov 20.","Smith AB","Urol Oncol","2018","2017/11/22","","","10.1016/j.urolonc.2017.10.026"
"30281356","Bladder cancer: overview and management. Part 2: muscle-invasive and metastatic bladder cancer","Anderson B.","Br J Nurs. 2018 Oct 4;27(18):S8-S20. doi: 10.12968/bjon.2018.27.18.S8.","Anderson B","Br J Nurs","2018","2018/10/04","","","10.12968/bjon.2018.27.18.S8"
"29520382","Unmasking molecular profiles of bladder cancer","Piao XM, Byun YJ, Kim WJ, Kim J.","Investig Clin Urol. 2018 Mar;59(2):72-82. doi: 10.4111/icu.2018.59.2.72. Epub 2018 Feb 1.","Piao XM","Investig Clin Urol","2018","2018/03/10","PMC5840121","","10.4111/icu.2018.59.2.72"
"30231340","Multidisciplinary Management of Muscle-Invasive Bladder Cancer: Current Challenges and Future Directions","Aragon-Ching JB, Werntz RP, Zietman AL, Steinberg GD.","Am Soc Clin Oncol Educ Book. 2018 May 23;38:307-318. doi: 10.1200/EDBK_201227.","Aragon-Ching JB","Am Soc Clin Oncol Educ Book","2018","2018/09/21","","","10.1200/EDBK_201227"
"27097528","Hyperthermia and radiotherapy in bladder cancer","Snider JW 3rd, Datta NR, Vujaskovic Z.","Int J Hyperthermia. 2016 Jun;32(4):398-406. doi: 10.3109/02656736.2016.1150524. Epub 2016 Apr 20.","Snider JW 3rd","Int J Hyperthermia","2016","2016/04/22","","","10.3109/02656736.2016.1150524"
"29362301","[Genitourinary Tumor Four Questions about Bladder Cancer]","Akaza H.","Gan To Kagaku Ryoho. 2018 Jan;45(1):25.","Akaza H","Gan To Kagaku Ryoho","2018","2018/01/25","","",""
"21311329","Bladder cancer","Morgan TM, Keegan KA, Clark PE.","Curr Opin Oncol. 2011 May;23(3):275-82. doi: 10.1097/CCO.0b013e3283446a11.","Morgan TM","Curr Opin Oncol","2011","2011/02/12","","","10.1097/CCO.0b013e3283446a11"
"22235187","Bladder cancer","Kader AK.","ScientificWorldJournal. 2011;11:2565-6. doi: 10.1100/2011/251920. Epub 2011 Dec 29.","Kader AK","ScientificWorldJournal","2011","2012/01/12","PMC3253580","","10.1100/2011/251920"
"32286874","Overview of VI-RADS in Bladder Cancer","Pecoraro M, Takeuchi M, Vargas HA, Muglia VF, Cipollari S, Catalano C, Panebianco V.","AJR Am J Roentgenol. 2020 Jun;214(6):1259-1268. doi: 10.2214/AJR.20.22763. Epub 2020 Apr 14.","Pecoraro M","AJR Am J Roentgenol","2020","2020/04/15","","","10.2214/AJR.20.22763"
"31311657","Treatment Options and Outcomes in Nonmetastatic Muscle Invasive Bladder Cancer","Ghandour R, Singla N, Lotan Y.","Trends Cancer. 2019 Jul;5(7):426-439. doi: 10.1016/j.trecan.2019.05.011. Epub 2019 Jun 22.","Ghandour R","Trends Cancer","2019","2019/07/18","","","10.1016/j.trecan.2019.05.011"
"28183191","Bladder cancer immunotherapy: swinging for the fences","Aoun F, El Rassy E, Peltier A.","Future Oncol. 2017 Apr;13(9):773-775. doi: 10.2217/fon-2017-0013. Epub 2017 Feb 10.","Aoun F","Future Oncol","2017","2017/02/11","","","10.2217/fon-2017-0013"
"15818174","Bladder cancer","Borden LS Jr, Clark PE, Hall MC.","Curr Opin Oncol. 2005 May;17(3):275-80. doi: 10.1097/01.cco.0000156985.47984.9e.","Borden LS Jr","Curr Opin Oncol","2005","2005/04/09","","","10.1097/01.cco.0000156985.47984.9e"
"15069323","Bladder cancer","Borden LS Jr, Clark PE, Hall MC.","Curr Opin Oncol. 2004 May;16(3):257-62. doi: 10.1097/00001622-200405000-00012.","Borden LS Jr","Curr Opin Oncol","2004","2004/04/08","","","10.1097/00001622-200405000-00012"
"18391631","Bladder cancer","Barocas DA, Clark PE.","Curr Opin Oncol. 2008 May;20(3):307-14. doi: 10.1097/CCO.0b013e3282f8b03e.","Barocas DA","Curr Opin Oncol","2008","2008/04/09","","","10.1097/CCO.0b013e3282f8b03e"
"30977669","Targeted therapies in urothelial bladder cancer: a disappointing past preceding a bright future?","Hindy JR, Souaid T, Kourie HR, Kattan J.","Future Oncol. 2019 May;15(13):1505-1524. doi: 10.2217/fon-2018-0459. Epub 2019 Apr 12.","Hindy JR","Future Oncol","2019","2019/04/13","","","10.2217/fon-2018-0459"
"30689891","Lectins as possible tools for improved urinary bladder cancer management","Višnjar T, Romih R, Zupančič D.","Glycobiology. 2019 May 1;29(5):355-365. doi: 10.1093/glycob/cwz001.","Višnjar T","Glycobiology","2019","2019/01/29","","","10.1093/glycob/cwz001"
"29342470","""Nested Type"" Bladder Cancer: Myth or Reality?","Zucchi A, Costantini E.","Urol Int. 2018;100(4):491-492. doi: 10.1159/000486533. Epub 2018 Jan 17.","Zucchi A","Urol Int","2018","2018/01/18","","","10.1159/000486533"
"30542860","[Management of muscle invasive cancer of the urinary bladder]","Karl A.","MMW Fortschr Med. 2018 Dec;160(21-22):46-50. doi: 10.1007/s15006-018-1235-0.","Karl A","MMW Fortschr Med","2018","2018/12/14","","","10.1007/s15006-018-1235-0"
"30666399","SIU-ICUD consultation on bladder cancer 2018","Black P, Gontero P.","World J Urol. 2019 Jan;37(1):1-2. doi: 10.1007/s00345-018-2601-3.","Black P","World J Urol","2019","2019/01/23","","","10.1007/s00345-018-2601-3"
"11796234","Bladder cancer","de Braud F, Maffezzini M, Vitale V, Bruzzi P, Gatta G, Hendry WF, Sternberg CN.","Crit Rev Oncol Hematol. 2002 Jan;41(1):89-106. doi: 10.1016/s1040-8428(01)00128-7.","de Braud F","Crit Rev Oncol Hematol","2002","2002/02/14","","","10.1016/s1040-8428(01)00128-7"
"28631741","Bladder cancer: oligometastases and imaging","Mertens LS, Horenblas S.","Nat Rev Urol. 2017 Sep;14(9):513-514. doi: 10.1038/nrurol.2017.96. Epub 2017 Jun 20.","Mertens LS","Nat Rev Urol","2017","2017/06/21","","","10.1038/nrurol.2017.96"
"29703514","Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer","Kwan ML, Garren B, Nielsen ME, Tang L.","Urol Oncol. 2019 Jun;37(6):380-386. doi: 10.1016/j.urolonc.2018.03.019. Epub 2018 Apr 25.","Kwan ML","Urol Oncol","2019","2018/04/29","PMC6200660","NIHMS959764","10.1016/j.urolonc.2018.03.019"
"29145591","Asia Consensus Statement on NCCN Clinical Practice Guideline for bladder cancer","Nishiyama H.","Jpn J Clin Oncol. 2018 Jan 1;48(1):3-6. doi: 10.1093/jjco/hyx130.","Nishiyama H","Jpn J Clin Oncol","2018","2017/11/18","","","10.1093/jjco/hyx130"
"28537820","Photodynamic Diagnosis and Narrow-Band Imaging in the Management of Bladder Cancer: A Review","Kutwin P, Konecki T, Cichocki M, Falkowski P, Jabłonowski Z.","Photomed Laser Surg. 2017 Sep;35(9):459-464. doi: 10.1089/pho.2016.4217. Epub 2017 May 22.","Kutwin P","Photomed Laser Surg","2017","2017/05/25","","","10.1089/pho.2016.4217"
"9015464","Bladder cancer","Leung HY, Griffiths TR, Neal DE.","Postgrad Med J. 1996 Dec;72(854):719-24. doi: 10.1136/pgmj.72.854.719.","Leung HY","Postgrad Med J","1996","1996/12/01","PMC2398659","","10.1136/pgmj.72.854.719"
"25674841","Bladder cancer: a disease ripe for major advances","Park JC, Hahn NM.","Clin Adv Hematol Oncol. 2014 Dec;12(12):838-45.","Park JC","Clin Adv Hematol Oncol","2014","2015/02/13","","",""
"24745663","Bladder cancer: a portal into men's health","Skeldon SC, Larry Goldenberg S.","Urol Oncol. 2015 Jan;33(1):40-44. doi: 10.1016/j.urolonc.2013.12.005. Epub 2014 Apr 16.","Skeldon SC","Urol Oncol","2015","2014/04/22","","","10.1016/j.urolonc.2013.12.005"
"23159285","Bladder cancer and schistosomiasis","Zaghloul MS.","J Egypt Natl Canc Inst. 2012 Dec;24(4):151-9. doi: 10.1016/j.jnci.2012.08.002. Epub 2012 Sep 20.","Zaghloul MS","J Egypt Natl Canc Inst","2012","2012/11/20","","","10.1016/j.jnci.2012.08.002"
"21597531","Bladder cancer--current management","Arianayagam R, Arianayagam M, Rashid P.","Aust Fam Physician. 2011 Apr;40(4):209-13.","Arianayagam R","Aust Fam Physician","2011","2011/05/21","","",""
"19035882","Bladder cancer today","Sternberg CN, Lerner SP, Fitzpatrick JM.","BJU Int. 2008 Nov;102(9 Pt B):1203. doi: 10.1111/j.1464-410X.2008.08159.x.","Sternberg CN","BJU Int","2008","2008/11/28","","","10.1111/j.1464-410X.2008.08159.x"
"27402371","Systemic therapy for bladder cancer finally comes into a new age","Zibelman M, Plimack ER.","Future Oncol. 2016 Oct;12(19):2227-42. doi: 10.2217/fon-2016-0135. Epub 2016 Jul 12.","Zibelman M","Future Oncol","2016","2016/07/13","PMC5066115","","10.2217/fon-2016-0135"
"9571320","Bladder cancer","Maffezzini M, Audisio R, Pavone-Macaluso M, Hall RR.","Crit Rev Oncol Hematol. 1998 Feb;27(2):151-3. doi: 10.1016/s1040-8428(97)10026-9.","Maffezzini M","Crit Rev Oncol Hematol","1998","1998/05/08","","","10.1016/s1040-8428(97)10026-9"
"28867449","Advances in intravesical drug delivery systems to treat bladder cancer","Kolawole OM, Lau WM, Mostafid H, Khutoryanskiy VV.","Int J Pharm. 2017 Oct 30;532(1):105-117. doi: 10.1016/j.ijpharm.2017.08.120. Epub 2017 Sep 1.","Kolawole OM","Int J Pharm","2017","2017/09/05","","","10.1016/j.ijpharm.2017.08.120"
"23773101","Improving bladder cancer patient care: a pharmacoeconomic perspective","Gore JL, Gilbert SM.","Expert Rev Anticancer Ther. 2013 Jun;13(6):661-8. doi: 10.1586/era.13.58.","Gore JL","Expert Rev Anticancer Ther","2013","2013/06/19","","","10.1586/era.13.58"
"27326402","Changing landscape of diagnosis and treatment of bladder cancer","Kim WJ.","Investig Clin Urol. 2016 Jun;57 Suppl 1(Suppl 1):S1-3. doi: 10.4111/icu.2016.57.S1.S1. Epub 2016 Jun 10.","Kim WJ","Investig Clin Urol","2016","2016/06/22","PMC4910766","","10.4111/icu.2016.57.S1.S1"
"31313715","Gender differences in oncologic and functional outcomes in patients with bladder cancer undergoing radical cystectomy with urinary diversion","Sadighian M, Porten S.","Curr Opin Urol. 2019 Sep;29(5):542-547. doi: 10.1097/MOU.0000000000000660.","Sadighian M","Curr Opin Urol","2019","2019/07/18","","","10.1097/MOU.0000000000000660"
"28980455","Clinical Proteomics for Precision Medicine: The Bladder Cancer Case","Latosinska A, Frantzi M, Vlahou A, Merseburger AS, Mischak H.","Proteomics Clin Appl. 2018 Mar;12(2). doi: 10.1002/prca.201700074. Epub 2017 Oct 25.","Latosinska A","Proteomics Clin Appl","2018","2017/10/06","","","10.1002/prca.201700074"
"12370626","Urinary bladder cancer","Wai CY, Miller DS.","Clin Obstet Gynecol. 2002 Sep;45(3):844-54. doi: 10.1097/00003081-200209000-00031.","Wai CY","Clin Obstet Gynecol","2002","2002/10/09","","","10.1097/00003081-200209000-00031"
"11959532","Bladder cancer","","Harv Mens Health Watch. 2002 Apr;6(9):3-6.","","Harv Mens Health Watch","2002","2002/04/18","","",""
"30085482","IMMUNOTHERAPY OF BLADDER CANCER. BCG VACCINE: PRINCIPLES OF ACTION, EFFICACY AND SAFETY","Glybochko PV, Fisenko VP.","Eksp Klin Farmakol. 2016;79(10):34-43.","Glybochko PV","Eksp Klin Farmakol","2016","2018/08/08","","",""
"23979659","The future of bladder cancer care in the USA","Kaplan AL, Litwin MS, Chamie K.","Nat Rev Urol. 2014 Jan;11(1):59-62. doi: 10.1038/nrurol.2013.180. Epub 2013 Aug 27.","Kaplan AL","Nat Rev Urol","2014","2013/08/28","","","10.1038/nrurol.2013.180"
"30678415","[Expert consensus on treatment of intravesical therapy in non-muscle invasive bladder cancer]","Chinese Urological Oncology Group.","Zhonghua Zhong Liu Za Zhi. 2019 Jan 23;41(1):42-45. doi: 10.3760/cma.j.issn.0253-3766.2019.01.007.","Chinese Urological Oncology Group","Zhonghua Zhong Liu Za Zhi","2019","2019/01/26","","","10.3760/cma.j.issn.0253-3766.2019.01.007"
"24818724","The role of inflammation in bladder cancer","Gakis G.","Adv Exp Med Biol. 2014;816:183-96. doi: 10.1007/978-3-0348-0837-8_8.","Gakis G","Adv Exp Med Biol","2014","2014/05/14","","","10.1007/978-3-0348-0837-8_8"
"25836932","Nonurothelial bladder cancer and rare variant histologies","Willis D, Kamat AM.","Hematol Oncol Clin North Am. 2015 Apr;29(2):237-52, viii. doi: 10.1016/j.hoc.2014.10.011. Epub 2015 Jan 9.","Willis D","Hematol Oncol Clin North Am","2015","2015/04/04","","","10.1016/j.hoc.2014.10.011"
"18090497","Bladder cancer: can imaging change patient management?","Beyersdorff D, Zhang J, Schöder H, Bochner B, Hricak H.","Curr Opin Urol. 2008 Jan;18(1):98-104. doi: 10.1097/MOU.0b013e3282f13aac.","Beyersdorff D","Curr Opin Urol","2008","2007/12/20","","","10.1097/MOU.0b013e3282f13aac"
"31117036","NCCN Guidelines Updates: Management of Muscle-Invasive Bladder Cancer","Flaig TW.","J Natl Compr Canc Netw. 2019 May 1;17(5.5):591-593. doi: 10.6004/jnccn.2019.5017.","Flaig TW","J Natl Compr Canc Netw","2019","2019/05/23","","","10.6004/jnccn.2019.5017"
"27784990","Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer","Smolensky D, Rathore K, Cekanova M.","Drug Des Devel Ther. 2016 Oct 5;10:3305-3322. doi: 10.2147/DDDT.S112113. eCollection 2016.","Smolensky D","Drug Des Devel Ther","2016","2016/10/28","PMC5063594","","10.2147/DDDT.S112113"
"19265855","Bladder cancer in the elderly: clinical outcomes, basic mechanisms, and future research direction","Taylor JA 3rd, Kuchel GA.","Nat Clin Pract Urol. 2009 Mar;6(3):135-44. doi: 10.1038/ncpuro1315.","Taylor JA 3rd","Nat Clin Pract Urol","2009","2009/03/07","PMC2957872","NIHMS243732","10.1038/ncpuro1315"
"20592613","Female bladder cancer: incidence, treatment, and outcome","Scosyrev E, Trivedi D, Messing E.","Curr Opin Urol. 2010 Sep;20(5):404-8. doi: 10.1097/MOU.0b013e32833c7a9b.","Scosyrev E","Curr Opin Urol","2010","2010/07/02","","","10.1097/MOU.0b013e32833c7a9b"
"27663304","[Update on molecular classifications and new histological classification of bladder cancer]","Varinot J, Furudoï A, Roupret M, Compérat E.","Prog Urol. 2016 Sep-Oct;26(11-12):600-607. doi: 10.1016/j.purol.2016.08.020. Epub 2016 Sep 20.","Varinot J","Prog Urol","2016","2016/09/25","","","10.1016/j.purol.2016.08.020"
"27930639","New treatments for bladder cancer","Hahn NM.","Clin Adv Hematol Oncol. 2016 Nov;14(11):884-887.","Hahn NM","Clin Adv Hematol Oncol","2016","2016/12/09","","",""
"17157629","Imaging of bladder cancer","Zhang J, Gerst S, Lefkowitz RA, Bach A.","Radiol Clin North Am. 2007 Jan;45(1):183-205. doi: 10.1016/j.rcl.2006.10.005.","Zhang J","Radiol Clin North Am","2007","2006/12/13","","","10.1016/j.rcl.2006.10.005"
"25056838","The health economics of bladder cancer: an updated review of the published literature","Yeung C, Dinh T, Lee J.","Pharmacoeconomics. 2014 Nov;32(11):1093-104. doi: 10.1007/s40273-014-0194-2.","Yeung C","Pharmacoeconomics","2014","2014/07/25","","","10.1007/s40273-014-0194-2"
"7030761","Bladder cancer epidemiology","Matanoski GM, Elliott EA.","Epidemiol Rev. 1981;3:203-29. doi: 10.1093/oxfordjournals.epirev.a036234.","Matanoski GM","Epidemiol Rev","1981","1981/01/01","","","10.1093/oxfordjournals.epirev.a036234"
"16192913","Occupational bladder cancer: from cohort study to biologic molecular marker","Matsumoto K, Irie A, Satoh T, Kuruma H, Arakawa T, Baba S.","Med Sci Monit. 2005 Oct;11(10):RA311-5. doi: 10.12659/msm.430336. Epub 2005 Sep 26.","Matsumoto K","Med Sci Monit","2005","2005/09/30","","","10.12659/msm.430336"
"27902481","Association of smoking status with prognosis in bladder cancer: A meta-analysis","Hou L, Hong X, Dai M, Chen P, Zhao H, Wei Q, Li F, Tan W.","Oncotarget. 2017 Jan 3;8(1):1278-1289. doi: 10.18632/oncotarget.13606.","Hou L","Oncotarget","2017","2016/12/01","PMC5352054","","10.18632/oncotarget.13606"
"22359289","Epigenetics of bladder cancer","Kim WJ, Kim YJ.","Methods Mol Biol. 2012;863:111-8. doi: 10.1007/978-1-61779-612-8_6.","Kim WJ","Methods Mol Biol","2012","2012/02/24","","","10.1007/978-1-61779-612-8_6"
"11301380","Bladder cancer in Africa: update","el-Mawla NG, el-Bolkainy MN, Khaled HM.","Semin Oncol. 2001 Apr;28(2):174-8. doi: 10.1053/sonc.2001.21961.","el-Mawla NG","Semin Oncol","2001","2001/04/13","","","10.1053/sonc.2001.21961"
"25450291","Research progress on bladder cancer molecular genetics","Kang Z, Li Y, Yu Y, Guo Z.","J Cancer Res Ther. 2014 Nov;10 Suppl:C89-94. doi: 10.4103/0973-1482.145792.","Kang Z","J Cancer Res Ther","2014","2014/12/03","","","10.4103/0973-1482.145792"
"24980189","Landmarks in non-muscle-invasive bladder cancer","Mertens LS, Neuzillet Y, Horenblas S, van Rhijn BW.","Nat Rev Urol. 2014 Aug;11(8):476-80. doi: 10.1038/nrurol.2014.130. Epub 2014 Jul 1.","Mertens LS","Nat Rev Urol","2014","2014/07/02","","","10.1038/nrurol.2014.130"
"9742894","Bladder cancer: state-of-the-art care","Droller MJ.","CA Cancer J Clin. 1998 Sep-Oct;48(5):269-84. doi: 10.3322/canjclin.48.5.269.","Droller MJ","CA Cancer J Clin","1998","1998/09/22","","","10.3322/canjclin.48.5.269"
"25882567","Management of high grade bladder cancer: a multidisciplinary approach","Taneja SS.","Urol Clin North Am. 2015 May;42(2):xi-xii. doi: 10.1016/j.ucl.2015.03.002.","Taneja SS","Urol Clin North Am","2015","2015/04/18","","","10.1016/j.ucl.2015.03.002"
"20657289","Radiotherapy in localized bladder cancer: what is the evidence?","Kotwal S, Munro N.","Curr Opin Urol. 2010 Sep;20(5):426-31. doi: 10.1097/MOU.0b013e32833cadb0.","Kotwal S","Curr Opin Urol","2010","2010/07/27","","","10.1097/MOU.0b013e32833cadb0"
"20534386","[Chemoradiation in bladder cancer]","Housset M, Durdux C, Thariat J, Dufour B.","Bull Cancer. 2010;97 Suppl Cancer de la vessie:19-25. doi: 10.1684/bdc.2010.1099.","Housset M","Bull Cancer","2010","2010/06/11","","","10.1684/bdc.2010.1099"
"25494295","Noninvasive approaches for detecting and monitoring bladder cancer","Talukdar S, Emdad L, Das SK, Sarkar D, Fisher PB.","Expert Rev Anticancer Ther. 2015 Mar;15(3):283-94. doi: 10.1586/14737140.2015.989838. Epub 2014 Dec 10.","Talukdar S","Expert Rev Anticancer Ther","2015","2014/12/11","","","10.1586/14737140.2015.989838"
"20620393","Cadherin switching and bladder cancer","Bryan RT, Tselepis C.","J Urol. 2010 Aug;184(2):423-31. doi: 10.1016/j.juro.2010.04.016. Epub 2010 Jun 17.","Bryan RT","J Urol","2010","2010/07/13","","","10.1016/j.juro.2010.04.016"
"8893866","Bladder cancer epidemiology and pathogenesis","Ross RK, Jones PA, Yu MC.","Semin Oncol. 1996 Oct;23(5):536-45.","Ross RK","Semin Oncol","1996","1996/10/01","","",""
"25716337","Recent Advances in the Diagnosis and Management of Bladder Cancer","Zhang X, Han C, He J.","Cell Biochem Biophys. 2015 Sep;73(1):11-5. doi: 10.1007/s12013-015-0632-6.","Zhang X","Cell Biochem Biophys","2015","2015/02/27","","","10.1007/s12013-015-0632-6"
"19609162","Current trends in the management of bladder cancer","Patel AR, Campbell SC.","J Wound Ostomy Continence Nurs. 2009 Jul-Aug;36(4):413-21; quiz 422-3. doi: 10.1097/WON.0b013e3181aaf1e7.","Patel AR","J Wound Ostomy Continence Nurs","2009","2009/07/18","","","10.1097/WON.0b013e3181aaf1e7"
"17414643","Bladder cancer","Clark PE.","Curr Opin Oncol. 2007 May;19(3):241-7. doi: 10.1097/CCO.0b013e3280ad43ac.","Clark PE","Curr Opin Oncol","2007","2007/04/07","","","10.1097/CCO.0b013e3280ad43ac"
"31757293","Immuno-Oncology Approaches to Salvage Treatment for Non-muscle invasive Bladder Cancer","Sathianathen NJ, Regmi S, Gupta S, Konety BR.","Urol Clin North Am. 2020 Feb;47(1):103-110. doi: 10.1016/j.ucl.2019.09.012.","Sathianathen NJ","Urol Clin North Am","2020","2019/11/24","","","10.1016/j.ucl.2019.09.012"
"16724708","[Diet and bladder cancer]","García Mediero JM, Romero Cajigal I, Angulo Cuesta J, Ferruelo Alonso A, Berenguer Sánchez A.","Arch Esp Urol. 2006 Apr;59(3):239-46. doi: 10.4321/s0004-06142006000300004.","García Mediero JM","Arch Esp Urol","2006","2006/05/27","","","10.4321/s0004-06142006000300004"
"16508726","Early bladder cancer: concept, diagnosis, and management","Kitamura H, Tsukamoto T.","Int J Clin Oncol. 2006 Feb;11(1):28-37. doi: 10.1007/s10147-006-0552-y.","Kitamura H","Int J Clin Oncol","2006","2006/03/02","","","10.1007/s10147-006-0552-y"
"30042171","Knockdown of long non-coding RNA linc00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/β-catenin signaling pathway","Li J, Li Y, Meng F, Fu L, Kong C.","Biosci Rep. 2018 Aug 29;38(4):BSR20171701. doi: 10.1042/BSR20171701. Print 2018 Aug 31.","Li J","Biosci Rep","2018","2018/07/26","PMC6131201","","10.1042/BSR20171701"
"18379965","[Radiochemotherapeutic options for bladder cancer]","Weiss C, Sauer R, Rödel C.","Aktuelle Urol. 2008 Mar;39(2):123-9. doi: 10.1055/s-2008-1038150.","Weiss C","Aktuelle Urol","2008","2008/04/02","","","10.1055/s-2008-1038150"
"14686700","Surgical management of bladder cancer in 2003","Wade M, Seigne JD.","Expert Rev Anticancer Ther. 2003 Dec;3(6):781-92. doi: 10.1586/14737140.3.6.781.","Wade M","Expert Rev Anticancer Ther","2003","2003/12/23","","","10.1586/14737140.3.6.781"
"23030221","Bladder conservation for muscle-invasive bladder cancer","Hoskin P, Dubash S.","Expert Rev Anticancer Ther. 2012 Aug;12(8):1015-20. doi: 10.1586/era.12.79.","Hoskin P","Expert Rev Anticancer Ther","2012","2012/10/04","","","10.1586/era.12.79"
"18560383","Bladder-sparing therapy for muscle-infiltrating bladder cancer","Pansadoro V, Emiliozzi P.","Nat Clin Pract Urol. 2008 Jul;5(7):368-75. doi: 10.1038/ncpuro1145. Epub 2008 Jun 17.","Pansadoro V","Nat Clin Pract Urol","2008","2008/06/19","","","10.1038/ncpuro1145"
"31567439","Updates on intravesical therapy","Pisano F, Vila Reyes H, Breda A, Palou J.","Curr Opin Urol. 2019 Nov;29(6):649-655. doi: 10.1097/MOU.0000000000000679.","Pisano F","Curr Opin Urol","2019","2019/10/01","","","10.1097/MOU.0000000000000679"
"16396753","[Chemoradiation in bladder cancer]","Durdux C.","Bull Cancer. 2005 Dec;92(12):1073-7.","Durdux C","Bull Cancer","2005","2006/01/07","","",""
"3135080","Bladder cancer: an overview","Whitmore WF Jr.","CA Cancer J Clin. 1988 Jul-Aug;38(4):213-23. doi: 10.3322/canjclin.38.4.213.","Whitmore WF Jr","CA Cancer J Clin","1988","1988/07/01","","","10.3322/canjclin.38.4.213"
"18090481","Molecular markers in bladder cancer","Shariat SF, Karam JA, Lerner SP.","Curr Opin Urol. 2008 Jan;18(1):1-8. doi: 10.1097/MOU.0b013e3282f1c5c1.","Shariat SF","Curr Opin Urol","2008","2007/12/20","","","10.1097/MOU.0b013e3282f1c5c1"
"22593639","The role of the androgen receptor in the development and progression of bladder cancer","Li Y, Izumi K, Miyamoto H.","Jpn J Clin Oncol. 2012 Jul;42(7):569-77. doi: 10.1093/jjco/hys072. Epub 2012 May 15.","Li Y","Jpn J Clin Oncol","2012","2012/05/18","","","10.1093/jjco/hys072"
"29362303","[II .Problems of Treatment for Non-Muscle Invasive Bladder Cancer]","Ozono S, Furuse H.","Gan To Kagaku Ryoho. 2018 Jan;45(1):30-32.","Ozono S","Gan To Kagaku Ryoho","2018","2018/01/25","","",""
"25836931","High-risk nonmuscle invasive bladder cancer","Orsola A, Palou J, Solsona E.","Hematol Oncol Clin North Am. 2015 Apr;29(2):227-36, viii. doi: 10.1016/j.hoc.2014.10.009. Epub 2014 Dec 19.","Orsola A","Hematol Oncol Clin North Am","2015","2015/04/04","","","10.1016/j.hoc.2014.10.009"
"16918124","Molecular genetics of bladder cancer: targets for diagnosis and therapy","Baffa R, Letko J, McClung C, LeNoir J, Vecchione A, Gomella LG.","J Exp Clin Cancer Res. 2006 Jun;25(2):145-60.","Baffa R","J Exp Clin Cancer Res","2006","2006/08/22","","",""
"8115786","Staging of bladder cancer","Gospodarowicz MK.","Semin Surg Oncol. 1994 Jan-Feb;10(1):51-9. doi: 10.1002/ssu.2980100109.","Gospodarowicz MK","Semin Surg Oncol","1994","1994/01/01","","","10.1002/ssu.2980100109"
"16530070","Chemoprevention of bladder cancer","Grossman HB.","Urology. 2006 Mar;67(3 Suppl 1):19-22; discussion 23-4. doi: 10.1016/j.urology.2006.01.015.","Grossman HB","Urology","2006","2006/03/15","","","10.1016/j.urology.2006.01.015"
"17627458","Current state of screening for bladder cancer","Madeb R, Golijanin D, Knopf J, Messing EM.","Expert Rev Anticancer Ther. 2007 Jul;7(7):981-7. doi: 10.1586/14737140.7.7.981.","Madeb R","Expert Rev Anticancer Ther","2007","2007/07/14","","","10.1586/14737140.7.7.981"
"25524242","Expression and Function of LPA1 in Bladder Cancer","Kataoka M, Ishibashi K, Kumagai S, Yanagida T, Aikawa K, Chiba H, Kojima Y.","J Urol. 2015 Jul;194(1):238-44. doi: 10.1016/j.juro.2014.12.028. Epub 2014 Dec 15.","Kataoka M","J Urol","2015","2014/12/20","","","10.1016/j.juro.2014.12.028"
"12270783","Chemoprevention of superficial bladder cancer","Gee J, Sabichi AL, Grossman HB.","Crit Rev Oncol Hematol. 2002 Sep;43(3):277-86. doi: 10.1016/s1040-8428(01)00190-1.","Gee J","Crit Rev Oncol Hematol","2002","2002/09/25","","","10.1016/s1040-8428(01)00190-1"
"24841166","Bladder cancer: bladder preservation--learning what we don't know","Hussain M, Theodorescu D.","Nat Rev Urol. 2014 Jun;11(6):310-2. doi: 10.1038/nrurol.2014.102. Epub 2014 May 20.","Hussain M","Nat Rev Urol","2014","2014/05/21","","","10.1038/nrurol.2014.102"
"26486930","Expectant Management of Low-Risk Bladder Cancer","Smith ZL, Soloway MS.","Curr Urol Rep. 2015 Dec;16(12):82. doi: 10.1007/s11934-015-0555-1.","Smith ZL","Curr Urol Rep","2015","2015/10/22","","","10.1007/s11934-015-0555-1"
"21360040","Variant forms of bladder cancer: basic considerations on treatment approaches","Pons F, Orsola A, Morote J, Bellmunt J.","Curr Oncol Rep. 2011 Jun;13(3):216-21. doi: 10.1007/s11912-011-0161-4.","Pons F","Curr Oncol Rep","2011","2011/03/02","","","10.1007/s11912-011-0161-4"
"16760884","Review of metastatic bladder cancer","Pagliaro LC, Sharma P.","Minerva Urol Nefrol. 2006 Mar;58(1):53-71.","Pagliaro LC","Minerva Urol Nefrol","2006","2006/06/09","","",""
"25836936","Perioperative therapy for muscle invasive bladder cancer","Leow JJ, Fay AP, Mullane SA, Bellmunt J.","Hematol Oncol Clin North Am. 2015 Apr;29(2):301-18, ix. doi: 10.1016/j.hoc.2014.11.002.","Leow JJ","Hematol Oncol Clin North Am","2015","2015/04/04","","","10.1016/j.hoc.2014.11.002"
"28953854","Expression of N-Myc Downstream-Regulated Gene 2 in Bladder Cancer and Its Potential Utility as a Urinary Diagnostic Biomarker","Zhang M, Ren B, Li Z, Niu W, Wang Y.","Med Sci Monit. 2017 Sep 27;23:4644-4649. doi: 10.12659/msm.901610.","Zhang M","Med Sci Monit","2017","2017/09/28","PMC5627538","","10.12659/msm.901610"
"14516177","Quality of life aspects of bladder cancer: a review of the literature","Botteman MF, Pashos CL, Hauser RS, Laskin BL, Redaelli A.","Qual Life Res. 2003 Sep;12(6):675-88. doi: 10.1023/a:1025144617752.","Botteman MF","Qual Life Res","2003","2003/10/01","","","10.1023/a:1025144617752"
"8801507","An overview of bladder cancer: treatment and nursing implications","Kelly LP, Miaskowski C.","Oncol Nurs Forum. 1996 Apr;23(3):459-68.","Kelly LP","Oncol Nurs Forum","1996","1996/04/01","","",""
"20553212","Latest developments in imaging of bladder cancer","Battista G, Sassi C, Corcioni B, Bazzocchi A, Golfieri R, Canini R.","Expert Rev Anticancer Ther. 2010 Jun;10(6):881-94. doi: 10.1586/era.10.56.","Battista G","Expert Rev Anticancer Ther","2010","2010/06/18","","","10.1586/era.10.56"
"26529173","JAMA PATIENT PAGE. Bladder Cancer","Razmaria AA.","JAMA. 2015 Nov 3;314(17):1886. doi: 10.1001/jama.2015.13738.","Razmaria AA","JAMA","2015","2015/11/04","","","10.1001/jama.2015.13738"
"10895128","Bladder-sparing treatment of invasive bladder cancer","Rivera I, Wajsman Z.","Cancer Control. 2000 Jul-Aug;7(4):340-6. doi: 10.1177/107327480000700403.","Rivera I","Cancer Control","2000","2000/07/15","","","10.1177/107327480000700403"
"20625299","Tumour node metastasis staging of bladder cancer: prognosis versus pitfalls","Gaisa NT, Henkel C, Knüchel R.","Curr Opin Urol. 2010 Sep;20(5):398-403. doi: 10.1097/MOU.0b013e32833c9649.","Gaisa NT","Curr Opin Urol","2010","2010/07/14","","","10.1097/MOU.0b013e32833c9649"
"23040252","Management of non-muscle-invasive (superficial) bladder cancer","Nargund VH, Tanabalan CK, Kabir MN.","Semin Oncol. 2012 Oct;39(5):559-72. doi: 10.1053/j.seminoncol.2012.08.001.","Nargund VH","Semin Oncol","2012","2012/10/09","","","10.1053/j.seminoncol.2012.08.001"
"16703728","[Tumor marker tests in bladder cancer]","Feil G, Stenzl A.","Actas Urol Esp. 2006 Jan;30(1):38-45. doi: 10.1016/s0210-4806(06)73394-0.","Feil G","Actas Urol Esp","2006","2006/05/18","","","10.1016/s0210-4806(06)73394-0"
"17158537","Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments","Parekh DJ, Bochner BH, Dalbagni G.","J Clin Oncol. 2006 Dec 10;24(35):5519-27. doi: 10.1200/JCO.2006.08.5431.","Parekh DJ","J Clin Oncol","2006","2006/12/13","","","10.1200/JCO.2006.08.5431"
"22500557","Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques","Green DA, Durand M, Gumpeni N, Rink M, Cha EK, Karakiewicz PI, Scherr DS, Shariat SF.","BJU Int. 2012 Nov;110(10):1463-70. doi: 10.1111/j.1464-410X.2012.11129.x. Epub 2012 Apr 13.","Green DA","BJU Int","2012","2012/04/17","","","10.1111/j.1464-410X.2012.11129.x"
"25572474","Could PD-L1 prove to be an effective therapeutic target for bladder cancer?","Hafez N, Petrylak DP.","Immunotherapy. 2015;7(1):1-2. doi: 10.2217/imt.14.110.","Hafez N","Immunotherapy","2015","2015/01/10","","","10.2217/imt.14.110"
"19652558","Bladder cancer: work in progress","Stenzl A.","Curr Opin Urol. 2009 Sep;19(5):486-7. doi: 10.1097/MOU.0b013e32832f0635.","Stenzl A","Curr Opin Urol","2009","2009/08/05","","","10.1097/MOU.0b013e32832f0635"
"27326411","Autophagy and urothelial carcinoma of the bladder: A review","Chandrasekar T, Evans CP.","Investig Clin Urol. 2016 Jun;57 Suppl 1(Suppl 1):S89-97. doi: 10.4111/icu.2016.57.S1.S89. Epub 2016 Jun 10.","Chandrasekar T","Investig Clin Urol","2016","2016/06/22","PMC4910764","","10.4111/icu.2016.57.S1.S89"
"18670272","Can we still afford bladder cancer?","Stenzl A, Hennenlotter J, Schilling D.","Curr Opin Urol. 2008 Sep;18(5):488-92. doi: 10.1097/MOU.0b013e32830b8925.","Stenzl A","Curr Opin Urol","2008","2008/08/02","","","10.1097/MOU.0b013e32830b8925"
"15907722","Quality of life in patients with bladder cancer","Gerharz EW, Månsson A, Månsson W.","Urol Oncol. 2005 May-Jun;23(3):201-7. doi: 10.1016/j.urolonc.2005.03.005.","Gerharz EW","Urol Oncol","2005","2005/05/24","","","10.1016/j.urolonc.2005.03.005"
"10696240","The natural history of bladder cancer. Implications for therapy","Lee R, Droller MJ.","Urol Clin North Am. 2000 Feb;27(1):1-13, vii. doi: 10.1016/s0094-0143(05)70229-9.","Lee R","Urol Clin North Am","2000","2000/03/04","","","10.1016/s0094-0143(05)70229-9"
"24681411","Current management practice for bladder cancer in Hong Kong: a hospital-based cross-sectional survey","Chan ES, Yee CH, Hou SM, Ng CF.","Hong Kong Med J. 2014 Jun;20(3):229-33. doi: 10.12809/hkmj134064. Epub 2014 Mar 28.","Chan ES","Hong Kong Med J","2014","2014/04/01","","","10.12809/hkmj134064"
"19834988","Patient information. Bladder cancer","","Am Fam Physician. 2009 Oct 1;80(7):717-s1.","","Am Fam Physician","2009","2009/10/17","","",""
"11464050","The early detection and diagnosis of bladder cancer: a critical review of the options","Saad A, Hanbury DC, McNicholas TA, Boustead GB, Woodman AC.","Eur Urol. 2001 Jun;39(6):619-33. doi: 10.1159/000052519.","Saad A","Eur Urol","2001","2001/07/21","","","10.1159/000052519"
"29362305","[IV .The Role of Immune Checkpoint Blockade in the Treatment of Bladder Cancer]","Kimura G.","Gan To Kagaku Ryoho. 2018 Jan;45(1):38-43.","Kimura G","Gan To Kagaku Ryoho","2018","2018/01/25","","",""
"23256895","Investigational cell cycle inhibitors in clinical trials for bladder cancer","Yun SJ, Moon SK, Kim WJ.","Expert Opin Investig Drugs. 2013 Mar;22(3):369-77. doi: 10.1517/13543784.2013.751097. Epub 2012 Dec 21.","Yun SJ","Expert Opin Investig Drugs","2013","2012/12/22","","","10.1517/13543784.2013.751097"
"24822309","[Conservative treatments for infiltrating bladder cancer]","Werenne X, Coucke P.","Rev Med Liege. 2014;69 Suppl 1:69-74.","Werenne X","Rev Med Liege","2014","2014/05/15","","",""
"17077975","Use of nomograms as predictive tools in bladder cancer","Shabsigh A, Bochner BH.","World J Urol. 2006 Nov;24(5):489-98. doi: 10.1007/s00345-006-0122-y.","Shabsigh A","World J Urol","2006","2006/11/02","","","10.1007/s00345-006-0122-y"
"17149381","Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging","Sugano K, Kakizoe T.","Nat Clin Pract Urol. 2006 Dec;3(12):642-52. doi: 10.1038/ncpuro0649.","Sugano K","Nat Clin Pract Urol","2006","2006/12/07","","","10.1038/ncpuro0649"
"16142998","The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence","Gu J, Grossman HB, Dinney CP, Wu X.","Pharmacogenomics. 2005 Sep;6(6):575-84. doi: 10.2217/14622416.6.6.575.","Gu J","Pharmacogenomics","2005","2005/09/07","","","10.2217/14622416.6.6.575"
"24569916","Adjuvant chemotherapy for bladder cancer-why does level 1 evidence not support it?","Raghavan D, Bawtinhimer A, Mahoney J, Eckrich S, Riggs S.","Ann Oncol. 2014 Oct;25(10):1930-1934. doi: 10.1093/annonc/mdu092. Epub 2014 Feb 25.","Raghavan D","Ann Oncol","2014","2014/02/27","","","10.1093/annonc/mdu092"
"26285248","Role of Repeat Resection in Non-Muscle-Invasive Bladder Cancer","Herr HW.","J Natl Compr Canc Netw. 2015 Aug;13(8):1041-6. doi: 10.6004/jnccn.2015.0123.","Herr HW","J Natl Compr Canc Netw","2015","2015/08/19","","","10.6004/jnccn.2015.0123"
"12917515","Future strategies in the diagnosis, staging and treatment of bladder cancer","van der Heijden AG, Witjes JA.","Curr Opin Urol. 2003 Sep;13(5):389-95. doi: 10.1097/00042307-200309000-00006.","van der Heijden AG","Curr Opin Urol","2003","2003/08/15","","","10.1097/00042307-200309000-00006"
"26125505","Sex difference in presentation and outcomes of bladder cancer: biological reality or statistical fluke?","Wolff I, Brookman-May S, May M.","Curr Opin Urol. 2015 Sep;25(5):418-26. doi: 10.1097/MOU.0000000000000198.","Wolff I","Curr Opin Urol","2015","2015/07/01","","","10.1097/MOU.0000000000000198"
"24772782","[Modern hypotheses of development of bladder cancer]","Prianichnikova MB.","Urologiia. 2014 Jan-Feb;(1):88-91.","Prianichnikova MB","Urologiia","2014","2014/04/30","","",""
"6770987","Treatment of superficial bladder cancer","Morales A.","Can Med Assoc J. 1980 May 24;122(10):1133-8.","Morales A","Can Med Assoc J","1980","1980/05/24","PMC1801981","",""
"27599968","Simple and Efficient Stratification of Invasive Bladder Cancer Patients","Zoidakis J.","EBioMedicine. 2016 Oct;12:6-7. doi: 10.1016/j.ebiom.2016.08.041. Epub 2016 Aug 28.","Zoidakis J","EBioMedicine","2016","2016/09/08","PMC5078578","","10.1016/j.ebiom.2016.08.041"
"24182970","Office-based management of nonmuscle invasive bladder cancer","Meeks JJ, Herr HW.","Urol Clin North Am. 2013 Nov;40(4):473-9. doi: 10.1016/j.ucl.2013.07.004. Epub 2013 Aug 6.","Meeks JJ","Urol Clin North Am","2013","2013/11/05","","","10.1016/j.ucl.2013.07.004"
"26977514","[Diagnosis and therapy of bladder cancer]","Jokisch JF, Ganswindt U, Hentrich M, Stief C, Karl A.","MMW Fortschr Med. 2015 Nov 19;157(20):42-5. doi: 10.1007/s15006-015-7539-4.","Jokisch JF","MMW Fortschr Med","2015","2016/03/16","","","10.1007/s15006-015-7539-4"
"2225921","Bladder cancer","Kantoff PW.","Curr Probl Cancer. 1990 Sep-Oct;14(5):233-92. doi: 10.1016/0147-0272(90)90016-j.","Kantoff PW","Curr Probl Cancer","1990","1990/09/01","","","10.1016/0147-0272(90)90016-j"
"15082003","Gender, racial and age differences in bladder cancer incidence and mortality","Madeb R, Messing EM.","Urol Oncol. 2004 Mar-Apr;22(2):86-92. doi: 10.1016/S1078-1439(03)00139-X.","Madeb R","Urol Oncol","2004","2004/04/15","","","10.1016/S1078-1439(03)00139-X"
"26955666","[III. Diagnosis and treatment for bladder cancer--recent topics]","Nishiyama H.","Gan To Kagaku Ryoho. 2016 Jan;43(1):54-8.","Nishiyama H","Gan To Kagaku Ryoho","2016","2016/03/10","","",""
"27686634","[Strategies for diagnosis and treatment of bladder cancer in precise times]","Huang J, Chen X, Lin TX.","Zhonghua Wai Ke Za Zhi. 2016 Oct 1;54(10):734-737. doi: 10.3760/cma.j.issn.0529-5815.2016.10.002.","Huang J","Zhonghua Wai Ke Za Zhi","2016","2016/10/01","","","10.3760/cma.j.issn.0529-5815.2016.10.002"
"18340023","Bladder cancer imaging","Legg JS.","Radiol Technol. 2008 Mar-Apr;79(4):333-46; quiz 347-9.","Legg JS","Radiol Technol","2008","2008/03/15","","",""
"12503210","Organ preservation strategies in bladder cancer","Hussain SA, James ND.","Expert Rev Anticancer Ther. 2002 Dec;2(6):641-51. doi: 10.1586/14737140.2.6.641.","Hussain SA","Expert Rev Anticancer Ther","2002","2002/12/31","","","10.1586/14737140.2.6.641"
"16530066","The diagnosis and staging of bladder cancer: from RBCs to TURs","Carmack AJ, Soloway MS.","Urology. 2006 Mar;67(3 Suppl 1):3-8; discussion 8-10. doi: 10.1016/j.urology.2006.01.026.","Carmack AJ","Urology","2006","2006/03/15","","","10.1016/j.urology.2006.01.026"
"11263594","Epidemiology and prevention of bladder cancer","Negri E, La Vecchia C.","Eur J Cancer Prev. 2001 Feb;10(1):7-14. doi: 10.1097/00008469-200102000-00002.","Negri E","Eur J Cancer Prev","2001","2001/03/27","","","10.1097/00008469-200102000-00002"
"12477647","Superficial bladder tumors","Chopin DK, Gattegno B.","Eur Urol. 2002 Dec;42(6):533-41. doi: 10.1016/s0302-2838(02)00466-9.","Chopin DK","Eur Urol","2002","2002/12/13","","","10.1016/s0302-2838(02)00466-9"
"27863388","Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer","Wang H, Niu L, Jiang S, Zhai J, Wang P, Kong F, Jin X.","Oncotarget. 2016 Dec 27;7(52):86174-86185. doi: 10.18632/oncotarget.13363.","Wang H","Oncotarget","2016","2016/11/19","PMC5349905","","10.18632/oncotarget.13363"
"21139639","Bladder cancer: Restaging TUR reduces recurrence and progression risk","Dalbagni G.","Nat Rev Urol. 2010 Dec;7(12):649-50. doi: 10.1038/nrurol.2010.189.","Dalbagni G","Nat Rev Urol","2010","2010/12/09","","","10.1038/nrurol.2010.189"
"16604997","Superficial bladder cancer epidemiology, diagnosis and management","Bulbul MA, Husseini N, Houjaij A.","J Med Liban. 2005 Apr-Jun;53(2):107-13.","Bulbul MA","J Med Liban","2005","2006/04/12","","",""
"6113360","Bladder cancer","","Lancet. 1981 Jun 27;1(8235):1404-5.","","Lancet","1981","1981/06/27","","",""
"22901576","Surgical and chemotherapeutic management of regional lymph nodes in bladder cancer","Morgan TM, Kaffenberger SD, Cookson MS.","J Urol. 2012 Oct;188(4):1081-8. doi: 10.1016/j.juro.2012.06.008. Epub 2012 Aug 15.","Morgan TM","J Urol","2012","2012/08/21","","","10.1016/j.juro.2012.06.008"
"26027772","Primary Sarcomatoid Tumor of the Bladder: A Different Entity but the Same Approach?","Molina-Cerrillo J, Martínez-Sáez O, Alonso-Gordoa T, Tirado-Zambrano P, Delgado-Vargas B, Earl J, Grande E.","Clin Genitourin Cancer. 2015 Dec;13(6):493-8. doi: 10.1016/j.clgc.2015.05.001. Epub 2015 May 13.","Molina-Cerrillo J","Clin Genitourin Cancer","2015","2015/06/02","","","10.1016/j.clgc.2015.05.001"
"12113083","Therapeutic options and treatment of muscle invasive bladder cancer","O'Connor RC, Alsikafi NF, Steinberg GD.","Expert Rev Anticancer Ther. 2001 Dec;1(4):511-22. doi: 10.1586/14737140.1.4.511.","O'Connor RC","Expert Rev Anticancer Ther","2001","2002/07/13","","","10.1586/14737140.1.4.511"
"23540783","The costs of non-muscle invasive bladder cancer","James AC, Gore JL.","Urol Clin North Am. 2013 May;40(2):261-9. doi: 10.1016/j.ucl.2013.01.004. Epub 2013 Feb 13.","James AC","Urol Clin North Am","2013","2013/04/02","","","10.1016/j.ucl.2013.01.004"
"17762630","Current strategies for first and second line intravesical therapy for nonmuscle invasive bladder cancer","Hendricksen K, Witjes JA.","Curr Opin Urol. 2007 Sep;17(5):352-7. doi: 10.1097/MOU.0b013e3281c55f2b.","Hendricksen K","Curr Opin Urol","2007","2007/09/01","","","10.1097/MOU.0b013e3281c55f2b"
"16445379","Radical radiotherapy for urinary bladder cancer: treatment outcomes","Fokdal L, Høyer M, von der Maase H.","Expert Rev Anticancer Ther. 2006 Feb;6(2):269-79. doi: 10.1586/14737140.6.2.269.","Fokdal L","Expert Rev Anticancer Ther","2006","2006/02/01","","","10.1586/14737140.6.2.269"
"17174022","Prognostic markers for bladder cancer--are we there yet?","Thalmann GN.","Eur Urol. 2007 Mar;51(3):591-2. doi: 10.1016/j.eururo.2006.12.002. Epub 2006 Dec 8.","Thalmann GN","Eur Urol","2007","2006/12/19","","","10.1016/j.eururo.2006.12.002"
"18815923","Bladder cancer: pathogenesis","Montironi R, Malmstrom PU.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):93-4. doi: 10.1080/03008880802291899.","Montironi R","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802291899"
"1101401","The current status of bladder cancer","Murphy GP.","Surg Annu. 1975;7:175-218.","Murphy GP","Surg Annu","1975","1975/01/01","","",""
"23826845","Tools to investigate biomarker expression in bladder cancer progression","Galustian C.","BJU Int. 2013 Aug;112(3):404-6. doi: 10.1111/j.1464-410X.2013.11792.x.","Galustian C","BJU Int","2013","2013/07/06","","","10.1111/j.1464-410X.2013.11792.x"
"25644153","Bladder cancer: Quality of life in patients with non-muscle-invasive bladder cancer","Sanchez A, Wszolek MF.","Nat Rev Urol. 2015 Apr;12(4):186-8. doi: 10.1038/nrurol.2015.12. Epub 2015 Feb 3.","Sanchez A","Nat Rev Urol","2015","2015/02/04","","","10.1038/nrurol.2015.12"
"23165404","Bladder cancer: Lack of progress in bladder cancer--what are the obstacles?","Soloway MS.","Nat Rev Urol. 2013 Jan;10(1):5-6. doi: 10.1038/nrurol.2012.219. Epub 2012 Nov 20.","Soloway MS","Nat Rev Urol","2013","2012/11/21","","","10.1038/nrurol.2012.219"
"22533676","Detection of mitochondrial DNA mutations in nonmuscle invasive bladder cancer","Guney AI, Ergec DS, Tavukcu HH, Koc G, Kirac D, Ulucan K, Javadova D, Turkeri L.","Genet Test Mol Biomarkers. 2012 Jul;16(7):672-8. doi: 10.1089/gtmb.2011.0227. Epub 2012 Apr 25.","Guney AI","Genet Test Mol Biomarkers","2012","2012/04/27","","","10.1089/gtmb.2011.0227"
"7016460","Bladder cancer","Droller MJ.","Curr Probl Surg. 1981 Apr;18(4):205-79. doi: 10.1016/s0011-3840(81)80002-0.","Droller MJ","Curr Probl Surg","1981","1981/04/01","","","10.1016/s0011-3840(81)80002-0"
"24526596","The role of radiotherapy in bladder cancer","Pinnarò P, Giordano C, Giovinazzo G, Saracino B.","Urologia. 2013 Jul-Sep;80(3):202-6. doi: 10.5301/RU.2013.11554.","Pinnarò P","Urologia","2013","2014/02/15","","","10.5301/RU.2013.11554"
"24717055","Circulating tumor cells in early bladder cancer: insight into micrometastatic disease","Raimondi C, Gradilone A, Gazzaniga P.","Expert Rev Mol Diagn. 2014 May;14(4):407-9. doi: 10.1586/14737159.2014.908119. Epub 2014 Apr 10.","Raimondi C","Expert Rev Mol Diagn","2014","2014/04/11","","","10.1586/14737159.2014.908119"
"25418899","Update on urinary bladder pathology","Compérat E.","Cesk Patol. 2014;50(4):129-36.","Compérat E","Cesk Patol","2014","2014/11/25","","",""
"25836930","Management of low-risk and intermediate-risk non-muscle-invasive bladder carcinoma","Weijers Y, Arentsen HC, Arends TJ, Witjes JA.","Hematol Oncol Clin North Am. 2015 Apr;29(2):219-25, vii. doi: 10.1016/j.hoc.2014.11.001.","Weijers Y","Hematol Oncol Clin North Am","2015","2015/04/04","","","10.1016/j.hoc.2014.11.001"
"11208514","Bladder cancer--genetic overview","Halachmi S, Madeb R, Kravtsov A, Moskovitz B, Halachmi N, Nativ O.","Med Sci Monit. 2001 Jan-Feb;7(1):164-8.","Halachmi S","Med Sci Monit","2001","2001/02/24","","",""
"17631349","Patients with spina bifida and bladder cancer: atypical presentation, advanced stage and poor survival","Austin JC, Elliott S, Cooper CS.","J Urol. 2007 Sep;178(3 Pt 1):798-801. doi: 10.1016/j.juro.2007.05.055. Epub 2007 Jul 16.","Austin JC","J Urol","2007","2007/07/17","","","10.1016/j.juro.2007.05.055"
"24496869","Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation","Cohn JA, Vekhter B, Lyttle C, Steinberg GD, Large MC.","Cancer. 2014 Feb 15;120(4):555-61. doi: 10.1002/cncr.28416. Epub 2013 Nov 13.","Cohn JA","Cancer","2014","2014/02/06","PMC3916781","NIHMS529597","10.1002/cncr.28416"
"19749657","Understanding the role of smoking in the aetiology of bladder cancer","Anderson B.","Br J Community Nurs. 2009 Sep;14(9):385-92. doi: 10.12968/bjcn.2009.14.9.43805.","Anderson B","Br J Community Nurs","2009","2009/09/15","","","10.12968/bjcn.2009.14.9.43805"
"17986288","Pathological variants of invasive bladder cancer according to their suggested clinical significance","Lopez-Beltran A, Requena MJ, Cheng L, Montironi R.","BJU Int. 2008 Feb;101(3):275-81. doi: 10.1111/j.1464-410X.2007.07271.x. Epub 2007 Nov 6.","Lopez-Beltran A","BJU Int","2008","2007/11/08","","","10.1111/j.1464-410X.2007.07271.x"
"15630352","[Update on treatment of bladder cancer]","Visockiene R, Inciūra A, Juozaityte E.","Medicina (Kaunas). 2004;40(12):1239-48.","Visockiene R","Medicina (Kaunas)","2004","2005/01/05","","",""
"18604392","[Bladder cancer - staging and treatment I]","Sociedade Brasileira de Urologia e Sociedade Brasileira de Patologia.","Rev Assoc Med Bras (1992). 2008 May-Jun;54(3):196-8. doi: 10.1590/s0104-42302008000300007.","Sociedade Brasileira de Urologia e Sociedade Brasileira de Patologia","Rev Assoc Med Bras (1992)","2008","2008/07/08","","","10.1590/s0104-42302008000300007"
"8734732","Staging and prognosis of T3b bladder cancer","Levy DA, Grossman HB.","Semin Urol Oncol. 1996 May;14(2):56-61.","Levy DA","Semin Urol Oncol","1996","1996/05/01","","",""
"21908503","Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","Bellmunt J, Orsola A, Wiegel T, Guix M, De Santis M, Kataja V; ESMO Guidelines Working Group.","Ann Oncol. 2011 Sep;22 Suppl 6:vi45-9. doi: 10.1093/annonc/mdr376.","Bellmunt J","Ann Oncol","2011","2011/09/13","","","10.1093/annonc/mdr376"
"28247638","[The role of viruses in the etiology of bladder cancer]","Kosova IV.","Urologiia. 2016 Aug;(3):100-103.","Kosova IV","Urologiia","2016","2017/03/02","","",""
"19362865","Updated results of bladder-sparing trimodality approach for invasive bladder cancer","Zapatero A, Martin de Vidales C, Arellano R, Bocardo G, Pérez M, Ríos P.","Urol Oncol. 2010 Jul-Aug;28(4):368-74. doi: 10.1016/j.urolonc.2009.01.031. Epub 2009 Apr 11.","Zapatero A","Urol Oncol","2010","2009/04/14","","","10.1016/j.urolonc.2009.01.031"
"23543444","The PPI network and cluster ONE analysis to explain the mechanism of bladder cancer","Wan FC, Cui YP, Wu JT, Wang JM, -Z Liu Q, Gao ZL.","Eur Rev Med Pharmacol Sci. 2013 Mar;17(5):618-23.","Wan FC","Eur Rev Med Pharmacol Sci","2013","2013/04/02","","",""
"14582243","[Bladder cancer and occupational activity]","Porru S, Scotto di Carlo A, Carta A, Placidi D.","G Ital Med Lav Ergon. 2003 Jul-Sep;25(3):298-300.","Porru S","G Ital Med Lav Ergon","2003","2003/10/30","","",""
"16336093","Recent advances in the treatment of bladder cancer","Gwynn ES, Clark PE, Hall MC.","Expert Rev Anticancer Ther. 2005 Dec;5(6):1023-30. doi: 10.1586/14737140.5.6.1023.","Gwynn ES","Expert Rev Anticancer Ther","2005","2005/12/13","","","10.1586/14737140.5.6.1023"
"7411718","Bladder cancer--Part III","Soloway MS.","J Urol. 1980 Jul;124(1):47. doi: 10.1016/s0022-5347(17)55286-6.","Soloway MS","J Urol","1980","1980/07/01","","","10.1016/s0022-5347(17)55286-6"
"117974","Management of bladder cancer","Whitmore WF Jr.","Curr Probl Cancer. 1979 Jul;4(1):1-48. doi: 10.1016/s0147-0272(79)80023-9.","Whitmore WF Jr","Curr Probl Cancer","1979","1979/07/01","","","10.1016/s0147-0272(79)80023-9"
"22588915","[Expression of OCT4 protein in bladder cancer and its clinicopathological implications]","Zhao P, Liu C, Xu K, Zheng S, Li H, Xu Y, Xu A, Li B, Huang P.","Nan Fang Yi Ke Da Xue Xue Bao. 2012 May;32(5):643-6.","Zhao P","Nan Fang Yi Ke Da Xue Xue Bao","2012","2012/05/17","","",""
"25296412","[FRancilian Oncogeriatric Group (FROG)'s focus on management of elderly patients with bladder cancer]","Ghebriou D, Avenin D, Caillet P, Mongiat-Artus P, Durdux C, Massard C, Culine S.","Bull Cancer. 2014 Sep;101(9):841-55. doi: 10.1684/bdc.2014.1939.","Ghebriou D","Bull Cancer","2014","2014/10/09","","","10.1684/bdc.2014.1939"
"28592002","[Research progress in molecular classification of muscle invasive bladder cancer]","Wang M, Teng XD.","Zhonghua Bing Li Xue Za Zhi. 2017 Jun 8;46(6):439-442. doi: 10.3760/cma.j.issn.0529-5807.2017.06.022.","Wang M","Zhonghua Bing Li Xue Za Zhi","2017","2017/06/09","","","10.3760/cma.j.issn.0529-5807.2017.06.022"
"12881096","Bladder cancer in pregnancy","Mitra S, Williamson JG, Bullock KN, Arends M.","J Obstet Gynaecol. 2003 Jul;23(4):440-2. doi: 10.1080/0144361031000122660.","Mitra S","J Obstet Gynaecol","2003","2003/07/26","","","10.1080/0144361031000122660"
"20568662","[Bladder cancer. Editorial]","Massard C, Ravaud A.","Bull Cancer. 2010;97 Suppl Cancer de la vessie:S3.","Massard C","Bull Cancer","2010","2010/06/24","","",""
"18006177","Similarity classifier in diagnosis of bladder cancer","Luukka P.","Comput Methods Programs Biomed. 2008 Jan;89(1):43-9. doi: 10.1016/j.cmpb.2007.10.001. Epub 2007 Nov 14.","Luukka P","Comput Methods Programs Biomed","2008","2007/11/17","","","10.1016/j.cmpb.2007.10.001"
"22868670","ICUD-EAU International Consultation on Bladder Cancer 2012: Recommendations on bladder cancer-progress in a cancer that lacks the limelight","Soloway MS.","Eur Urol. 2013 Jan;63(1):1-3. doi: 10.1016/j.eururo.2012.07.045. Epub 2012 Jul 31.","Soloway MS","Eur Urol","2013","2012/08/08","","","10.1016/j.eururo.2012.07.045"
"18456766","Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up","Bellmunt J, Albiol S, Kataja V; ESMO Guidelines Working Group.","Ann Oncol. 2008 May;19 Suppl 2:ii47-8. doi: 10.1093/annonc/mdn085.","Bellmunt J","Ann Oncol","2008","2008/05/09","","","10.1093/annonc/mdn085"
"24796021","[II. Urothelial carcinoma-current topics and treatment for non-muscle invasive bladder cancer-]","Kikuchi E, Oya M.","Gan To Kagaku Ryoho. 2014 Jan;41(1):42-6.","Kikuchi E","Gan To Kagaku Ryoho","2014","2014/05/07","","",""
"15300148","Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters?)","Duggan B, Williamson K.","Curr Opin Urol. 2004 Sep;14(5):277-86. doi: 10.1097/00042307-200409000-00006.","Duggan B","Curr Opin Urol","2004","2004/08/10","","","10.1097/00042307-200409000-00006"
"18092171","Considerations on the use of diagnostic markers in management of patients with bladder cancer","Agarwal PK, Black PC, Kamat AM.","World J Urol. 2008 Feb;26(1):39-44. doi: 10.1007/s00345-007-0232-1. Epub 2007 Dec 19.","Agarwal PK","World J Urol","2008","2007/12/20","","","10.1007/s00345-007-0232-1"
"8164729","Hubert Humphrey's bladder cancer","Culliton BJ.","Nature. 1994 May 5;369(6475):13. doi: 10.1038/369013a0.","Culliton BJ","Nature","1994","1994/05/05","","","10.1038/369013a0"
"21518416","Bladder tumours: time for a paradigm shift?","Malmström PU.","BJU Int. 2011 May;107(10):1543-5. doi: 10.1111/j.1464-410X.2011.10235.x.","Malmström PU","BJU Int","2011","2011/04/27","","","10.1111/j.1464-410X.2011.10235.x"
"19043336","Bladder cancer and smoking. Part 3: influence of perceptions and beliefs","Anderson B, Naish W.","Br J Nurs. 2008 Nov 13-26;17(20):1292-7. doi: 10.12968/bjon.2008.17.20.31649.","Anderson B","Br J Nurs","2008","2008/12/02","","","10.12968/bjon.2008.17.20.31649"
"14619780","Bladder cancer. Treatments improving","","Mayo Clin Health Lett. 2003 Oct;21(10):1-3.","","Mayo Clin Health Lett","2003","2003/11/19","","",""
"8515633","[Screening of bladder cancer by a combination of transabdominal ultrasonography and urine cytology]","Yamashita T, Okada N, Ogawa A.","Nihon Hinyokika Gakkai Zasshi. 1993 Mar;84(3):469-72. doi: 10.5980/jpnjurol1989.84.469.","Yamashita T","Nihon Hinyokika Gakkai Zasshi","1993","1993/03/01","","","10.5980/jpnjurol1989.84.469"
"17491039","Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up","ESMO Guidelines Working Group, Bellmont J, Albiol S.","Ann Oncol. 2007 Apr;18 Suppl 2:ii38-9. doi: 10.1093/annonc/mdm029.","ESMO Guidelines Working Group","Ann Oncol","2007","2007/05/11","","","10.1093/annonc/mdm029"
"19517712","Nursing care and treatment of patients with bladder cancer","Turner B.","Nurs Stand. 2009 May 20-26;23(37):47-56; quiz 58. doi: 10.7748/ns2009.05.23.37.47.c6973.","Turner B","Nurs Stand","2009","2009/06/13","","","10.7748/ns2009.05.23.37.47.c6973"
"23712201","Bladder cancer: Outpatient laser ablation is an option for localized bladder cancer treatment","Fenner A.","Nat Rev Urol. 2013 Jul;10(7):368. doi: 10.1038/nrurol.2013.120. Epub 2013 May 28.","Fenner A","Nat Rev Urol","2013","2013/05/29","","","10.1038/nrurol.2013.120"
"7654445","Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989","Kiemeney LA, Coebergh JW, Koper NP, van der Heijden LH, Pauwels RP, Schapers RF, Verbeek AL.","Eur J Cancer. 1994;30A(8):1134-7. doi: 10.1016/0959-8049(94)90472-3.","Kiemeney LA","Eur J Cancer","1994","1994/01/01","","","10.1016/0959-8049(94)90472-3"
"1462098","Experimental models of histogenesis and tumor cell heterogeneity in bladder cancer","Raghavan D, Russell PJ, Brown JL.","Semin Surg Oncol. 1992 Sep-Oct;8(5):279-84. doi: 10.1002/ssu.2980080506.","Raghavan D","Semin Surg Oncol","1992","1992/09/01","","","10.1002/ssu.2980080506"
"14510183","Classification of bladder cancer by microarray expression profiling: towards a general clinical use of microarrays in cancer diagnostics","Dyrskjøt L.","Expert Rev Mol Diagn. 2003 Sep;3(5):635-47. doi: 10.1586/14737159.3.5.635.","Dyrskjøt L","Expert Rev Mol Diagn","2003","2003/09/27","","","10.1586/14737159.3.5.635"
"20564128","Understanding the variation in treatment intensity among patients with early stage bladder cancer","Hollingsworth JM, Zhang Y, Krein SL, Ye Z, Hollenbeck BK.","Cancer. 2010 Aug 1;116(15):3587-94. doi: 10.1002/cncr.25221.","Hollingsworth JM","Cancer","2010","2010/06/22","","","10.1002/cncr.25221"
"18704626","Current topics and perspectives in bladder cancer research","Ogawa O.","Int J Clin Oncol. 2008 Aug;13(4):281. doi: 10.1007/s10147-008-0816-9. Epub 2008 Aug 15.","Ogawa O","Int J Clin Oncol","2008","2008/08/16","","","10.1007/s10147-008-0816-9"
"12084315","The role of a second transurethral resection for high-grade bladder cancer","Langenstroer P, See W.","Curr Urol Rep. 2000 Oct;1(3):204-7. doi: 10.1007/s11934-000-0020-6.","Langenstroer P","Curr Urol Rep","2000","2002/06/27","","","10.1007/s11934-000-0020-6"
"6850516","Bladder cancer in Spain. Mortality trends (1955-1975)","Lopez-Abente G.","Cancer. 1983 Jun 15;51(12):2367-70. doi: 10.1002/1097-0142(19830615)51:12<2367::aid-cncr2820511234>3.0.co;2-b.","Lopez-Abente G","Cancer","1983","1983/06/15","","","10.1002/1097-0142(19830615)51:12<2367::aid-cncr2820511234>3.0.co;2-b"
"12503211","Managing locally advanced bladder cancer","Lehmann J, Retz M, Siemer S, Kamradt J, Wullich B, Stöckle M.","Expert Rev Anticancer Ther. 2002 Dec;2(6):656-66. doi: 10.1586/14737140.2.6.656.","Lehmann J","Expert Rev Anticancer Ther","2002","2002/12/31","","","10.1586/14737140.2.6.656"
"18353743","[Urinary bladder cancer]","Riesz P, Mavrogenis S, Szucs M, Romics I.","Orv Hetil. 2008 Mar 30;149(13):613-5. doi: 10.1556/OH.2008.28340.","Riesz P","Orv Hetil","2008","2008/03/21","","","10.1556/OH.2008.28340"
"15828550","Organ preservation in muscle-invasive bladder cancer","Fernando SA, Sandler HM.","Oncology (Williston Park). 2005 Mar;19(3):334-9; discussion 339-40, 345, 349, 350-3.","Fernando SA","Oncology (Williston Park)","2005","2005/04/15","","",""
"15191001","Conservative treatment of bladder cancer","Horwich A, Huddart R.","Clin Oncol (R Coll Radiol). 2004 May;16(3):163-5. doi: 10.1016/j.clon.2003.11.011.","Horwich A","Clin Oncol (R Coll Radiol)","2004","2004/06/12","","","10.1016/j.clon.2003.11.011"
"17158538","Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancer","Black PC, Brown GA, Dinney CP.","J Clin Oncol. 2006 Dec 10;24(35):5528-35. doi: 10.1200/JCO.2006.08.0895.","Black PC","J Clin Oncol","2006","2006/12/13","","","10.1200/JCO.2006.08.0895"
"1305680","A prospective clinical trial of difluoromethylornithine (DFMO) in patients with resected superficial bladder cancer","Loprinzi CL, Messing EM.","J Cell Biochem Suppl. 1992;16I:153-5. doi: 10.1002/jcb.240501329.","Loprinzi CL","J Cell Biochem Suppl","1992","1992/01/01","","","10.1002/jcb.240501329"
"20505645","Bladder cancer: advances in treatment and research","Galsky MD.","Clin Adv Hematol Oncol. 2010 Apr;8(4):234-6.","Galsky MD","Clin Adv Hematol Oncol","2010","2010/05/28","","",""
"6390914","Status of integrated irradiation and cystectomy for bladder cancer","Whitmore WF Jr, Batata M.","Urol Clin North Am. 1984 Nov;11(4):681-91.","Whitmore WF Jr","Urol Clin North Am","1984","1984/11/01","","",""
"16812999","[Diet in bladder cancer ethiopathogenesis]","Radosavljević V, Ilić M, Janković S, Djokić M.","Acta Chir Iugosl. 2005;52(3):77-82. doi: 10.2298/aci0503077r.","Radosavljević V","Acta Chir Iugosl","2005","2006/07/04","","","10.2298/aci0503077r"
"23218073","12th Annual meeting of the Society of Urologic Oncology (SUO) bladder cancer sessions I and II summary report","Chang SS, Dinney CP, Donat SM, Dahm P, Gore JL, Lotan Y, Parekh DJ, Solit DB, O'Donnell PH, Feng FY, Hansel D, Milowsky MI.","Urol Oncol. 2012 Nov-Dec;30(6):944-7. doi: 10.1016/j.urolonc.2012.07.006.","Chang SS","Urol Oncol","2012","2012/12/11","","","10.1016/j.urolonc.2012.07.006"
"18322472","Why should we increase public awareness of bladder cancer, and how can we do it?","Messing EM.","Nat Clin Pract Urol. 2008 Mar;5(3):117. doi: 10.1038/ncpuro1061.","Messing EM","Nat Clin Pract Urol","2008","2008/03/07","","","10.1038/ncpuro1061"
"25665316","[Medical and economic cost of bladder cancer in France]","Legrand G, Guy L.","Rev Prat. 2014 Dec;64(10):1381.","Legrand G","Rev Prat","2014","2015/02/11","","",""
"19890622","[Symposium of the German Bladder Cancer Association]","Retz M, Nawroth R, Olbert P, Hartmann A, Stöhr R, Merseburger AS, Schulz W.","Urologe A. 2009 Dec;48(12):1517-22. doi: 10.1007/s00120-009-2132-z.","Retz M","Urologe A","2009","2009/11/06","","","10.1007/s00120-009-2132-z"
"20377834","Evidence-based clinical practice guidelines for bladder cancer (summary - JUA 2009 Edition)","Committee for Establishment of the Clinical Practice Guidelines for the Management of Bladder Cancer and the Japanese Urological Association.","Int J Urol. 2010 Feb;17(2):102-24. doi: 10.1111/j.1442-2042.2010.02486.x.","Committee for Establishment of the Clinical Practice Guidelines for the Management of Bladder Cancer and the Japanese Urological Association","Int J Urol","2010","2010/04/10","","","10.1111/j.1442-2042.2010.02486.x"
"27311842","COUNTERPOINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?","Herr HW.","Oncology (Williston Park). 2016 Jun;30(6):541, 543-4.","Herr HW","Oncology (Williston Park)","2016","2016/06/18","","",""
"27311841","POINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?","Feldman AS.","Oncology (Williston Park). 2016 Jun;30(6):541-2, 545.","Feldman AS","Oncology (Williston Park)","2016","2016/06/18","","",""
"10484839","[Bladder cancer: general and epidemiological aspects, histopathological diagnosis, clinico-pathological classification, diagnosis of metastasis and risk groups]","Vera Donoso CD, Jiménez Cruz JF.","Arch Esp Urol. 1999 Jul-Aug;52(6):553-63.","Vera Donoso CD","Arch Esp Urol","1999","1999/09/15","","",""
"9036614","[The prognostic factors in bladder cancer patients]","al-Shukri SKh, Korneev IA.","Urol Nefrol (Mosk). 1996 Nov-Dec;(6):49-53.","al-Shukri SKh","Urol Nefrol (Mosk)","1996","1996/11/01","","",""
"8863549","Bladder cancer","Pontes JE.","J Urol. 1996 Nov;156(5):1609-10. doi: 10.1016/s0022-5347(01)65460-0.","Pontes JE","J Urol","1996","1996/11/01","","","10.1016/s0022-5347(01)65460-0"
"2204904","Bladder cancer. What's new in diagnosis and treatment?","Badalament RA, Drago JR.","Postgrad Med. 1990 Sep 15;88(4):63-4, 67-70. doi: 10.1080/00325481.1990.11704753.","Badalament RA","Postgrad Med","1990","1990/09/15","","","10.1080/00325481.1990.11704753"
"15779258","[Chemotherapy as a supplement to radical treatment of patients with locally advanced bladder cancer]","Sengeløv L, von der Maase H.","Ugeskr Laeger. 2005 Feb 14;167(7):749-51.","Sengeløv L","Ugeskr Laeger","2005","2005/03/23","","",""
"1512826","A community study of bladder cancer screening by the detection of occult urinary bleeding","Britton JP, Dowell AC, Whelan P, Harris CM.","J Urol. 1992 Sep;148(3):788-90. doi: 10.1016/s0022-5347(17)36720-4.","Britton JP","J Urol","1992","1992/09/01","","","10.1016/s0022-5347(17)36720-4"
"15984821","Urothelial carcinoma of the urinary bladder in young adults--clinical experience at Taipei Veterans General Hospital","Wen YC, Kuo JY, Chen KK, Lin AT, Chang YH, Hsu YS, Chang LS.","J Chin Med Assoc. 2005 Jun;68(6):272-5. doi: 10.1016/S1726-4901(09)70149-2.","Wen YC","J Chin Med Assoc","2005","2005/06/30","","","10.1016/S1726-4901(09)70149-2"
"16954667","Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancer","Junker K, Fritsch T, Hartmann A, Schulze W, Schubert J.","Cytogenet Genome Res. 2006;114(3-4):279-83. doi: 10.1159/000094214.","Junker K","Cytogenet Genome Res","2006","2006/09/07","","","10.1159/000094214"
"26563635","Metabonomic diagnosis of bladder cancer: what are the advantages and considerations?","Hong Y, Esuvaranathan K, Pasikanti KK, Yong Chan EC.","Bioanalysis. 2015 Nov;7(21):2727-9. doi: 10.4155/bio.15.192. Epub 2015 Nov 13.","Hong Y","Bioanalysis","2015","2015/11/14","","","10.4155/bio.15.192"
"17714018","Where are we with the treatment of metastatic bladder cancer?","Papatsoris AG, Kachrilas S, Gekas A.","Expert Opin Investig Drugs. 2007 Sep;16(9):1311-4. doi: 10.1517/13543784.16.9.1311.","Papatsoris AG","Expert Opin Investig Drugs","2007","2007/08/24","","","10.1517/13543784.16.9.1311"
"16697875","Re: treatment delay and prognosis in invasive bladder cancer","Masood S, Pietrzak P, Kourief C, Vieira I, Mufti GR.","J Urol. 2006 Jun;175(6):2364. doi: 10.1016/S0022-5347(06)00332-6.","Masood S","J Urol","2006","2006/05/16","","","10.1016/S0022-5347(06)00332-6"
"2701413","Bladder cancer: deciding on appropriate surgery","Wood DP Jr, Montie JE.","Oncology (Williston Park). 1989 Mar;3(3):55-61; discussion 65-6 68.","Wood DP Jr","Oncology (Williston Park)","1989","1989/03/01","","",""
"9396186","Molecular biology in uro-oncology: clinical application. Prognostic factors in bladder cancer","Fontana D, Bellina M, Scoffone C, Cagnazzi E, Guercio S.","Arch Ital Urol Androl. 1997 Sep;69(4):253-6.","Fontana D","Arch Ital Urol Androl","1997","1997/12/13","","",""
"11101096","Multimodality therapy for the treatment of muscle-invasive bladder cancer","Thurman SA, DeWeese TL.","Semin Urol Oncol. 2000 Nov;18(4):313-22.","Thurman SA","Semin Urol Oncol","2000","2000/12/02","","",""
"1626202","Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer","Fosså SD, Ous S, Espetveit S, Langmark F.","Scand J Urol Nephrol. 1992;26(2):131-8. doi: 10.1080/00365599.1992.11690444.","Fosså SD","Scand J Urol Nephrol","1992","1992/01/01","","","10.1080/00365599.1992.11690444"
"4196530","Rx of bladder cancer: complex and controversial","Bagshaw M, Caldwell WL, Grabstald H, Wizenberg M.","CA Cancer J Clin. 1973 Mar-Apr;23(2):81-90. doi: 10.3322/canjclin.23.2.81.","Bagshaw M","CA Cancer J Clin","1973","1973/03/01","","","10.3322/canjclin.23.2.81"
"10918966","Current concepts in assessment and treatment of bladder cancer","Hassen W, Droller MJ.","Curr Opin Urol. 2000 Jul;10(4):291-9. doi: 10.1097/00042307-200007000-00002.","Hassen W","Curr Opin Urol","2000","2000/08/05","","","10.1097/00042307-200007000-00002"
"11779696","Tumor markers for the early detection of bladder cancer","Han KR, Pantuck AJ, Belldegrun AS, Rao JY.","Front Biosci. 2002 Jan 1;7:e19-26.","Han KR","Front Biosci","2002","2002/01/10","","",""
"2672232","Neoadjuvant chemotherapy for invasive bladder cancer","Herr HW.","Semin Surg Oncol. 1989;5(4):266-71. doi: 10.1002/ssu.2980050409.","Herr HW","Semin Surg Oncol","1989","1989/01/01","","","10.1002/ssu.2980050409"
"11779705","Angiogenic factors and bladder cancer","Shao ZM, Nguyen M.","Front Biosci. 2002 Jan 1;7:e33-5. doi: 10.2741/ming.","Shao ZM","Front Biosci","2002","2002/01/10","","","10.2741/ming"
"2699070","Rationals for optimizing bladder cancer treatment and control","Wolf H.","Scand J Urol Nephrol Suppl. 1989;125:103-6.","Wolf H","Scand J Urol Nephrol Suppl","1989","1989/01/01","","",""
"7299915","Regional lymph node metastasis from bladder cancer","Smith JA Jr, Whitmore WF Jr.","J Urol. 1981 Nov;126(5):591-3. doi: 10.1016/s0022-5347(17)54638-8.","Smith JA Jr","J Urol","1981","1981/11/01","","","10.1016/s0022-5347(17)54638-8"
"22674507","[Aspects of bladder cancer]","Jocham D, Stöckle M, Sommerauer M.","Urologe A. 2012 Jun;51(6):783. doi: 10.1007/s00120-012-2895-5.","Jocham D","Urologe A","2012","2012/06/08","","","10.1007/s00120-012-2895-5"
"11561985","Neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer","Dreicer R.","Semin Urol Oncol. 2001 Aug;19(3):180-5.","Dreicer R","Semin Urol Oncol","2001","2001/09/20","","",""
"9467667","The current role of radiotherapy in the treatment of invasive bladder cancer","Benda RK, Porter AT.","Crit Rev Oncog. 1996;7(5-6):457-64. doi: 10.1615/critrevoncog.v7.i5-6.40.","Benda RK","Crit Rev Oncog","1996","1996/01/01","","","10.1615/critrevoncog.v7.i5-6.40"
"24080906","Bladder cancer: mutation found in >70% of tumours","Payton S.","Nat Rev Urol. 2013 Nov;10(11):616. doi: 10.1038/nrurol.2013.222. Epub 2013 Oct 1.","Payton S","Nat Rev Urol","2013","2013/10/02","","","10.1038/nrurol.2013.222"
"5818159","Cancer of the urogenital tract: bladder cancer. Combined radiotherapy and surgical treatment","Whitmore WF Jr.","JAMA. 1969 Jan 13;207(2):349-50. doi: 10.1001/jama.207.2.349.","Whitmore WF Jr","JAMA","1969","1969/01/13","","","10.1001/jama.207.2.349"
"10532195","A critical review of the management of bladder cancer","Sternberg CN.","Crit Rev Oncol Hematol. 1999 Aug;31(3):193-207. doi: 10.1016/s1040-8428(99)00031-1.","Sternberg CN","Crit Rev Oncol Hematol","1999","1999/10/26","","","10.1016/s1040-8428(99)00031-1"
"9224312","A worldwide view of bladder cancer","Schellhammer PF.","J Urol. 1997 Aug;158(2):406-7. doi: 10.1016/s0022-5347(01)64489-6.","Schellhammer PF","J Urol","1997","1997/08/01","","","10.1016/s0022-5347(01)64489-6"
"19152439","Reducing bladder cancer deaths: the preemptive cystectomy approach","Konety BR.","Cancer. 2009 Mar 1;115(5):914-7. doi: 10.1002/cncr.24137.","Konety BR","Cancer","2009","2009/01/20","","","10.1002/cncr.24137"
"25179501","Decade in review-bladder cancer: international progress: from cytology to genomics","Costello JC, Theodorescu D.","Nat Rev Urol. 2014 Nov;11(11):609-10. doi: 10.1038/nrurol.2014.236. Epub 2014 Sep 2.","Costello JC","Nat Rev Urol","2014","2014/09/03","","","10.1038/nrurol.2014.236"
"8944067","Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer","Colvett KT, Althausen AF, Bassil B, Heney NM, McGovern FV, Young HH 2nd, Kaufman DS, Zietman AL, Shipley WU.","J Surg Oncol. 1996 Nov;63(3):201-8. doi: 10.1002/(SICI)1096-9098(199611)63:3<201::AID-JSO13>3.0.CO;2-7.","Colvett KT","J Surg Oncol","1996","1996/11/01","","","10.1002/(SICI)1096-9098(199611)63:3<201::AID-JSO13>3.0.CO;2-7"
"19069500","[Present-day diagnosis and treatment of urinary bladder cancer]","Zhuravlev VN, Borzunov IV, Bazhenov IV.","Urologiia. 2008 Sep-Oct;(5):59-63.","Zhuravlev VN","Urologiia","2008","2008/12/17","","",""
"21246347","[Bladder cancer update: what was new at the 2010 annual congress of the German Association of Urology in Düsseldorf?]","Nawroth R, Hartmann A, Olbert PJ, Merseburger AS, Stöhr R, Knüchel R, Retz M, Füssel S.","Urologe A. 2011 Feb;50(2):221-6. doi: 10.1007/s00120-010-2486-2.","Nawroth R","Urologe A","2011","2011/01/20","","","10.1007/s00120-010-2486-2"
"24795026","Study increases molecular understanding of bladder cancer","","Cancer Discov. 2014 May;4(5):OF3. doi: 10.1158/2159-8290.CD-NB2014-029. Epub 2014 Mar 6.","","Cancer Discov","2014","2014/05/06","","","10.1158/2159-8290.CD-NB2014-029"
"16194710","Biological considerations in the assessment of urothelial cancer: a retrospective","Droller MJ.","Urology. 2005 Nov;66(5 Suppl):66-75. doi: 10.1016/j.urology.2005.06.128.","Droller MJ","Urology","2005","2005/10/01","","","10.1016/j.urology.2005.06.128"
"19673123","[Cancer of the urinary bladder: prognosis of the outcome]","Zimichev AA, Prianichnikova MB, Maklakov VN.","Urologiia. 2009 May-Jun;(3):52-3.","Zimichev AA","Urologiia","2009","2009/08/13","","",""
"8411411","Invasive bladder cancer and uremia: dilemma in management","Srinivas V, Nagapurkar N, Choudary R, Kulkarni S, Kundargi P, Phadke AG.","J Urol. 1993 Nov;150(5 Pt 1):1409-11. doi: 10.1016/s0022-5347(17)35792-0.","Srinivas V","J Urol","1993","1993/11/01","","","10.1016/s0022-5347(17)35792-0"
"15000325","[Treatments in invasive bladder cancer]","Bouchot O, Zerbib M.","Prog Urol. 2003 Dec;13(6):1415-27.","Bouchot O","Prog Urol","2003","2004/03/06","","",""
"20299061","Are we making significant progress in the diagnosis and management of bladder cancer?","DeCastro GJ, Steinberg GD.","J Urol. 2010 May;183(5):1667-8. doi: 10.1016/j.juro.2010.02.2376. Epub 2010 Mar 17.","DeCastro GJ","J Urol","2010","2010/03/20","","","10.1016/j.juro.2010.02.2376"
"8734739","The management of locally recurrent invasive bladder cancer following radical cystectomy","Pisters LL, Westney L.","Semin Urol Oncol. 1996 May;14(2):112-9.","Pisters LL","Semin Urol Oncol","1996","1996/05/01","","",""
"2074502","Bladder cancer screening: lessons from a biologically based model of bladder cancer progression and therapeutic intervention","Ellwein LB.","J Occup Med. 1990 Sep;32(9):806-11. doi: 10.1097/00043764-199009000-00010.","Ellwein LB","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00010"
"3053593","Invasive bladder cancer. Strategies for cure and bladder preservation","Boileau MA, Russell KJ.","Hematol Oncol Clin North Am. 1988 Sep;2(3):447-55.","Boileau MA","Hematol Oncol Clin North Am","1988","1988/09/01","","",""
"12783582","Neoadjuvant chemotherapy for bladder cancer: current status","Dreicer R.","Expert Opin Pharmacother. 2003 Jun;4(6):853-8. doi: 10.1517/14656566.4.6.853.","Dreicer R","Expert Opin Pharmacother","2003","2003/06/05","","","10.1517/14656566.4.6.853"
"20665888","Examining the association between delay in diagnosis and decreased survival in bladder cancer","Porter MP.","Cancer. 2010 Nov 15;116(22):5122-5. doi: 10.1002/cncr.25290.","Porter MP","Cancer","2010","2010/07/29","","","10.1002/cncr.25290"
"6783224","Bladder cancer","","Br Med J (Clin Res Ed). 1981 Mar 28;282(6269):1012-3.","","Br Med J (Clin Res Ed)","1981","1981/03/28","PMC1504853","",""
"7109091","Bladder cancer","Prout GR Jr.","J Urol. 1982 Aug;128(2):284. doi: 10.1016/s0022-5347(17)52887-6.","Prout GR Jr","J Urol","1982","1982/08/01","","","10.1016/s0022-5347(17)52887-6"
"12853338","ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of invasive bladder cancer","Sengeløv L; ESMO Guidelines Task Force.","Ann Oncol. 2003 Jul;14(7):1008-9. doi: 10.1093/annonc/mdg296.","Sengeløv L","Ann Oncol","2003","2003/07/11","","","10.1093/annonc/mdg296"
"15281323","Future directions: bladder cancer","Coptcoat MJ, Oliver RT.","Cancer Surv. 1998;31:161-3.","Coptcoat MJ","Cancer Surv","1998","2004/07/30","","",""
"22353625","We abandoned 'superficial bladder cancer': we accepted 'non-muscle-invasive bladder cancer', but ... - on occasion of the 10th anniversary of the first EAU Guidelines on bladder cancer","Reljić A, Trnski D.","Urol Int. 2012;88(4):486-7. doi: 10.1159/000336514. Epub 2012 Feb 21.","Reljić A","Urol Int","2012","2012/02/23","","","10.1159/000336514"
"19320394","[Non-invasive molecular detection of bladder cancer]","Hatachmi S.","Harefuah. 2009 Jan;148(1):66-9, 86.","Hatachmi S","Harefuah","2009","2009/03/27","","",""
"2074499","Screening for bladder cancer in high-risk groups: delineation of the problem","Schulte PA.","J Occup Med. 1990 Sep;32(9):789-92. doi: 10.1097/00043764-199009000-00007.","Schulte PA","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00007"
"19880811","StatBite: A look at bladder cancer in the United States","","J Natl Cancer Inst. 2009 Nov 18;101(22):1533. doi: 10.1093/jnci/djp411. Epub 2009 Oct 30.","","J Natl Cancer Inst","2009","2009/11/03","","","10.1093/jnci/djp411"
"2205825","[Results of BCG immunotherapy in the management of bladder tumors]","Samodai L, Kiss L, Kolozsy Z, Dauda G, Drinóczy M, Mohácsi L.","Orv Hetil. 1990 Aug 5;131(31):1697-702.","Samodai L","Orv Hetil","1990","1990/08/05","","",""
"28248056","[Experience with radical surgery for muscle-invasive bladder cancer in patients with end-stage chronic kidney disease]","Pavlov VN, Pushkaryev AM, Safiullin RI, Kazikhinurov AA, Kondratenko YV, Alexeyev AV.","Urologiia. 2016 Dec;(6):124-127.","Pavlov VN","Urologiia","2016","2017/03/02","","",""
"21844533","Summaries for patients: screening for bladder cancer: recommendations from the U.S. Preventive Services Task Force","","Ann Intern Med. 2011 Aug 16;155(4):I-36. doi: 10.7326/0003-4819-155-4-201108160-00002.","","Ann Intern Med","2011","2011/08/17","","","10.7326/0003-4819-155-4-201108160-00002"
"17195410","Occupational and nonoccupational causes of bladder cancer","Golka K.","South Med J. 2006 Nov;99(11):1203. doi: 10.1097/01.smj.0000248811.29310.5e.","Golka K","South Med J","2006","2007/01/02","","","10.1097/01.smj.0000248811.29310.5e"
"3469457","Drinking, micturition habits, and urine concentration as potential risk factors in urinary bladder cancer","Braver DJ, Modan M, Chêtrit A, Lusky A, Braf Z.","J Natl Cancer Inst. 1987 Mar;78(3):437-40.","Braver DJ","J Natl Cancer Inst","1987","1987/03/01","","",""
"6409002","[Bladder cancer]","Sakatoku J, Yamamoto N.","Gan To Kagaku Ryoho. 1983 May;10(5):1225-34.","Sakatoku J","Gan To Kagaku Ryoho","1983","1983/05/01","","",""
"7546823","Bladder preservation--a prospect for patients with urinary bladder cancer","Sternberg CN.","Acta Oncol. 1995;34(5):589-97; discusion 588. doi: 10.3109/02841869509094033.","Sternberg CN","Acta Oncol","1995","1995/01/01","","","10.3109/02841869509094033"
"5099312","Bladder cancer due to exposure to para-aminobiphenyl: a 17-year followup","Melick WF, Naryka JJ, Kelly RE.","J Urol. 1971 Aug;106(2):220-6. doi: 10.1016/s0022-5347(17)61263-1.","Melick WF","J Urol","1971","1971/08/01","","","10.1016/s0022-5347(17)61263-1"
"1308687","Current trends in the management of invasive bladder cancer","Sibley GN, Kabala J.","West Engl Med J. 1992 Dec;107(3):67-9.","Sibley GN","West Engl Med J","1992","1992/12/01","PMC5115003","",""
"4596638","[Combined therapy of bladder cancer]","Albert L.","Z Urol Nephrol. 1973 Oct;66(10):785-8.","Albert L","Z Urol Nephrol","1973","1973/10/01","","",""
"8700819","Bladder cancer. Current diagnostic methods and treatment options","Badalament RA, Schervish EW.","Postgrad Med. 1996 Aug;100(2):217-9, 223-4, 230. doi: 10.3810/pgm.1996.08.60.","Badalament RA","Postgrad Med","1996","1996/08/01","","","10.3810/pgm.1996.08.60"
"20120722","[EORTC risk tables--a new diagnostic tool in urology]","Bobiński J, Lipiński M.","Pol Merkur Lekarski. 2009 Dec;27(162):524-8.","Bobiński J","Pol Merkur Lekarski","2009","2010/02/04","","",""
"7005781","[Epidemiology and pathogenesis of bladder cancer]","Adolphs HD, Thiele J, Vahlensieck W.","Onkologie. 1980 Oct;3(5):214-24. doi: 10.1159/000214798.","Adolphs HD","Onkologie","1980","1980/10/01","","","10.1159/000214798"
"12536941","[EAU Recommendations 2001. ""Guidelines on bladder cancer""]","Oosterlinck W, Lobel B, Jackse G, Malmström PU, Stöckle M, Strenberg C; European Association of Urology.","Prog Urol. 2002 Nov;12(5):1161-3.","Oosterlinck W","Prog Urol","2002","2003/01/23","","",""
"3278483","Toward the rational management of bladder cancer: an overview","Whitmore WF Jr.","Urology. 1988 Feb;31(2 Suppl):5-8.","Whitmore WF Jr","Urology","1988","1988/02/01","","",""
"22684459","Chemotherapy and radiotherapy improve bladder cancer outcomes","","Cancer Discov. 2012 Jun;2(6):OF10. doi: 10.1158/2159-8290.CD-RW2012-056. Epub 2012 Apr 26.","","Cancer Discov","2012","2012/06/12","","","10.1158/2159-8290.CD-RW2012-056"
"12082860","[Urinary bladder cancer]","von der Maase H, Steven K.","Ugeskr Laeger. 2002 Jun 3;164(23):3052-6.","von der Maase H","Ugeskr Laeger","2002","2002/06/27","","",""
"9749078","[Surgical treatment of cancer of the bladder]","Barrette LR.","Cancer Radiother. 1998 Apr;2 Suppl 1:43s-48s.","Barrette LR","Cancer Radiother","1998","1998/09/28","","",""
"4181399","[Bladder cancer]","van der Werf-Messing B.","Ned Tijdschr Geneeskd. 1969 May 24;113(21):936-42.","van der Werf-Messing B","Ned Tijdschr Geneeskd","1969","1969/05/24","","",""
"7921502","Radiology in the staging of bladder cancer","MacVicar D, Husband JE.","Br J Hosp Med. 1994 May 4-17;51(9):454-8.","MacVicar D","Br J Hosp Med","1994","1994/05/04","","",""
"10799217","Re: bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 AND TIS)","Lamm DL.","J Urol. 2000 Jun;163(6):1890-1.","Lamm DL","J Urol","2000","2000/05/08","","",""
"1924442","Organ conservation and reconstruction in advanced bladder cancer","Sternberg CN.","Prog Clin Biol Res. 1991;370:131-42.","Sternberg CN","Prog Clin Biol Res","1991","1991/01/01","","",""
"8424407","Intraoperative and external preoperative radiotherapy in invasive bladder cancer: effect of neoadjuvant chemotherapy in tumor downstaging","Calvo FA, Aristu JJ, Abuchaibe O, Rebollo J, Fernandez Hidalgo O, Zudaire J, Berian JM, Azinovic I.","Am J Clin Oncol. 1993 Feb;16(1):61-6. doi: 10.1097/00000421-199302000-00016.","Calvo FA","Am J Clin Oncol","1993","1993/02/01","","","10.1097/00000421-199302000-00016"
"21364255","[Non-muscle invasive bladder cancer]","Asociación Americana de Urología (AUA).","Arch Esp Urol. 2011 Jan-Feb;64(1):3 p preceding 3.","Asociación Americana de Urología (AUA)","Arch Esp Urol","2011","2011/03/03","","",""
"28844592","Adjuvant radiotherapy after radical cystectomy and ileal orthotopic neobladder","Zaghloul MS, Zaghloul TM.","J Egypt Natl Canc Inst. 2017 Sep;29(3):121-122. doi: 10.1016/j.jnci.2017.08.002. Epub 2017 Aug 23.","Zaghloul MS","J Egypt Natl Canc Inst","2017","2017/08/29","","","10.1016/j.jnci.2017.08.002"
"1043078","[Bladder cancer]","Teyssier P, Jablonski JP.","Rev Infirm. 1975 Dec;25(10):873-8.","Teyssier P","Rev Infirm","1975","1975/12/01","","",""
"644731","Current concepts in the study of bladder cancer","Weissman RM, Coffey DS, Jewett HJ.","Urol Surv. 1978 Feb;28(1):1-5.","Weissman RM","Urol Surv","1978","1978/02/01","","",""
"23773102","Is photodynamic diagnosis ready for introduction in urological clinical practice?","Cordeiro ER, Anastasiadis A, Bus MT, Alivizatos G, de la Rosette JJ, de Reijke TM.","Expert Rev Anticancer Ther. 2013 Jun;13(6):669-80. doi: 10.1586/era.13.60.","Cordeiro ER","Expert Rev Anticancer Ther","2013","2013/06/19","","","10.1586/era.13.60"
"7156011","Bladder cancer","Glashan RW.","Practitioner. 1982 Nov;226(1373):1891-8.","Glashan RW","Practitioner","1982","1982/11/01","","",""
"8926827","[It is possible to cure early discovered bladder cancer]","Holmäng S, Hedelin H.","Lakartidningen. 1996 Oct 2;93(40):3466-8, 3470.","Holmäng S","Lakartidningen","1996","1996/10/02","","",""
"1301571","Upfront chemotherapy in invasive bladder cancer","Splinter TA, Kok TC.","Prog Clin Biol Res. 1992;378:111-6.","Splinter TA","Prog Clin Biol Res","1992","1992/01/01","","",""
"9239476","Current therapy for invasive bladder cancer","Montie JE.","Cancer Treat Res. 1996;88:121-8. doi: 10.1007/978-1-4615-6343-3_7.","Montie JE","Cancer Treat Res","1996","1996/01/01","","","10.1007/978-1-4615-6343-3_7"
"22331092","Bladder cancer: validity of the 2004 system for grading Ta bladder cancer","Burger M, Goebell PJ.","Nat Rev Urol. 2012 Feb 14;9(3):126-7. doi: 10.1038/nrurol.2012.8.","Burger M","Nat Rev Urol","2012","2012/02/15","","","10.1038/nrurol.2012.8"
"6343631","The controversial role of radiation therapy as adjunctive treatment of bladder cancer","Droller MJ.","J Urol. 1983 May;129(5):897-903. doi: 10.1016/s0022-5347(17)52449-0.","Droller MJ","J Urol","1983","1983/05/01","","","10.1016/s0022-5347(17)52449-0"
"3538608","Invasive bladder cancer--possible future treatment considerations","Gardiner RA.","Urol Res. 1986;14(4):191-4. doi: 10.1007/BF00441112.","Gardiner RA","Urol Res","1986","1986/01/01","","","10.1007/BF00441112"
"2022226","Local BCG failures in superficial bladder cancer. A multivariate analysis of risk factors influencing survival","Herr HW, Klein EA, Rogatko A.","Eur Urol. 1991;19(2):97-100. doi: 10.1159/000473593.","Herr HW","Eur Urol","1991","1991/01/01","","","10.1159/000473593"
"8461941","The use of monoclonal antibodies for the diagnosis and therapy of bladder cancer","Russell PJ, Plomley J, Raghavan D.","Br J Urol. 1993 Feb;71(2):121-9. doi: 10.1111/j.1464-410x.1993.tb15903.x.","Russell PJ","Br J Urol","1993","1993/02/01","","","10.1111/j.1464-410x.1993.tb15903.x"
"875217","Radical cystectomy with or without prior irradiation in the treatment of bladder cancer","Whitmore WF Jr, Batata MA, Ghoneim MA, Grabstald H, Unal A.","J Urol. 1977 Jul;118(1 Pt 2):184-7. doi: 10.1016/s0022-5347(17)57942-2.","Whitmore WF Jr","J Urol","1977","1977/07/01","","","10.1016/s0022-5347(17)57942-2"
"8459618","[Clinical statistical studies of bladder cancer in Japan]","Miyanaga N, Ohtani M, Akaza H, Koiso K.","Nihon Rinsho. 1993 Jan;51 Suppl:823-9.","Miyanaga N","Nihon Rinsho","1993","1993/01/01","","",""
"9742893","Bladder cancer: twenty years of progress and the challenges that remain","Lamm DL.","CA Cancer J Clin. 1998 Sep-Oct;48(5):263-8. doi: 10.3322/canjclin.48.5.263.","Lamm DL","CA Cancer J Clin","1998","1998/09/22","","","10.3322/canjclin.48.5.263"
"2074504","Urine cytology in the detection of bladder cancer: a critical approach","Farrow GM.","J Occup Med. 1990 Sep;32(9):817-21. doi: 10.1097/00043764-199009000-00012.","Farrow GM","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00012"
"7445779","[Bladder cancer and old age. Study of the occurrence and status of diagnosis in the GDR with respect to old age]","Berndt H, Berndt R, Brunz KH, Gemperle A, Gemperle I, Hansche G, Hansche R, Hünerbein C, Weber HG, Weber S, Witt K.","Z Urol Nephrol. 1980 Feb;73(2):123-36.","Berndt H","Z Urol Nephrol","1980","1980/02/01","","",""
"5754826","Cancer of the urogenital tract: bladder cancer. Introduction: problems in definition, classification and etiology","Rubin P.","JAMA. 1968 Nov 18;206(8):1762-3 passim. doi: 10.1001/jama.206.8.1762.","Rubin P","JAMA","1968","1968/11/18","","","10.1001/jama.206.8.1762"
"9817069","[Urothelial tumors of the bladder]","André F, Soria JC, Beuzeboc P, Housset M.","Bull Cancer. 1998 Sep;(1 Suppl):16-25.","André F","Bull Cancer","1998","1998/11/17","","",""
"19496705","Should photodynamic diagnosis be standard practice for bladder cancer?","Stenzl A, Kruck S.","Expert Rev Anticancer Ther. 2009 Jun;9(6):697-9. doi: 10.1586/era.09.46.","Stenzl A","Expert Rev Anticancer Ther","2009","2009/06/06","","","10.1586/era.09.46"
"7052940","Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy","Goodman GB, Hislop TG, Elwood JM, Balfour J.","Int J Radiat Oncol Biol Phys. 1981 May;7(5):569-73. doi: 10.1016/0360-3016(81)90367-9.","Goodman GB","Int J Radiat Oncol Biol Phys","1981","1981/05/01","","","10.1016/0360-3016(81)90367-9"
"402205","Bladder cancer: superiority of preoperative irradiation and cystectomy in clinical stages B2 and C","Miller LS.","Cancer. 1977 Feb;39(2 Suppl):973-80. doi: 10.1002/1097-0142(197702)39:2+<973::aid-cncr2820390737>3.0.co;2-o.","Miller LS","Cancer","1977","1977/02/01","","","10.1002/1097-0142(197702)39:2+<973::aid-cncr2820390737>3.0.co;2-o"
"3079577","The Copenhagen bladder cancer project I","Sørensen BL, Barlebo H, Bay-Nielsen H, Gammelgaard PA, Hvidt V, Walbom-Jørgensen S.","Dan Med Bull. 1986 Jun;33(3):151-4.","Sørensen BL","Dan Med Bull","1986","1986/06/01","","",""
"7173929","N-acetylation phenotype in bladder cancer","Woodhouse KW, Adams PC, Clothier A, Mucklow JC, Rawlins MD.","Hum Toxicol. 1982 Oct;1(4):443-5. doi: 10.1177/096032718200100411.","Woodhouse KW","Hum Toxicol","1982","1982/10/01","","","10.1177/096032718200100411"
"2217418","Evaluation of tumor response and prognostic factors in patients with bladder cancer undergoing combined radiotherapy and chemotherapy","Jakse G, Feichtinger J, zur Nedden D, Hellweg G, Frommhold H.","Prog Clin Biol Res. 1990;353:187-93.","Jakse G","Prog Clin Biol Res","1990","1990/01/01","","",""
"402987","Parasites in the etiology of cancer--bilharziasis and bladder cancer","Elsebai I.","CA Cancer J Clin. 1977 Mar-Apr;27(2):100-6. doi: 10.3322/canjclin.27.2.100.","Elsebai I","CA Cancer J Clin","1977","1977/03/01","","","10.3322/canjclin.27.2.100"
"15713779","JAMA patient page. Bladder cancer","Torpy JM, Lynm C, Glass RM.","JAMA. 2005 Feb 16;293(7):890. doi: 10.1001/jama.293.7.890.","Torpy JM","JAMA","2005","2005/02/17","","","10.1001/jama.293.7.890"
"12785212","[Combined therapy for patients with invasive bladder cancer]","Startsev VIu, Karelin MI.","Vopr Onkol. 2003;49(2):235-8.","Startsev VIu","Vopr Onkol","2003","2003/06/06","","",""
"2217429","The NCI-Canada trial of concurrent cisplatin and radiotherapy for muscle invasive bladder cancer","Coppin C, Gospodarowicz M.","Prog Clin Biol Res. 1990;353:75-83.","Coppin C","Prog Clin Biol Res","1990","1990/01/01","","",""
"9854501","Combined chemoradiotherapy for invasive bladder cancer: a feasibility approach in a non selected population","de Pree C, Aapro MS, Mermillod B, Miralbell R, Graber P, Achille E, Alberto P.","Anticancer Res. 1998 Sep-Oct;18(5B):3807-12.","de Pree C","Anticancer Res","1998","1998/12/17","","",""
"5818160","Cancer of the urogenital tract: bladder cancer. Comment: the accuracy of staging for combined therapies","Rubin P.","JAMA. 1969 Jan 13;207(2):351-2.","Rubin P","JAMA","1969","1969/01/13","","",""
"21340598","[Use of marker systems in the treatment of bladder cancer]","Burger M, Vom Dorp F.","Urologe A. 2011 Mar;50(3):303-8. doi: 10.1007/s00120-010-2412-7.","Burger M","Urologe A","2011","2011/02/23","","","10.1007/s00120-010-2412-7"
"1557839","Current perspectives on diagnosis and treatment of superficial bladder cancer","Lamm DL, Griffith G, Pettit LL, Nseyo UO.","Urology. 1992 Apr;39(4):301-8. doi: 10.1016/0090-4295(92)90202-8.","Lamm DL","Urology","1992","1992/04/01","","","10.1016/0090-4295(92)90202-8"
"24689111","Bladder cancer. Spot it early, follow it closely","","Mayo Clin Health Lett. 2013 Mar;31(3):1-3.","","Mayo Clin Health Lett","2013","2014/04/03","","",""
"3641344","Bladder cancer: etiology and pathophysiology","Watt RC.","Semin Oncol Nurs. 1986 Nov;2(4):256-9. doi: 10.1016/0749-2081(86)90114-2.","Watt RC","Semin Oncol Nurs","1986","1986/11/01","","","10.1016/0749-2081(86)90114-2"
"6483904","Bladder cancer. Part A: Pathology, diagnosis, and surgery. Proceedings of the First International Symposium on Tumors of the Urinary Bladder. Paris, France, July 4-6, 1983","","Prog Clin Biol Res. 1984;162A:1-453.","","Prog Clin Biol Res","1984","1984/01/01","","",""
"482956","Urinary bladder cancer","","Semin Oncol. 1979 Jun;6(2):145-272.","","Semin Oncol","1979","1979/06/01","","",""
"15888749","ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of invasive bladder cancer","Kataja VV, Pavlidis N; ESMO Guidelines Task Force.","Ann Oncol. 2005;16 Suppl 1:i43-4. doi: 10.1093/annonc/mdi815.","Kataja VV","Ann Oncol","2005","2005/05/13","","","10.1093/annonc/mdi815"
"6385026","Operative ultrasonography in bladder cancer (three year experience of 60 cases)","Lardennois B, Lomina D, Khansa A, Brandt B.","Prog Clin Biol Res. 1984;162A:245-53.","Lardennois B","Prog Clin Biol Res","1984","1984/01/01","","",""
"5127549","[Bladder cancer cases]","Thybo E, Brons M, Kirby B.","Nord Med. 1971 Sep 23;86(38):1104.","Thybo E","Nord Med","1971","1971/09/23","","",""
"6677099","[Value of cytological examination for postoperative bladder cancer]","Kawachi Y.","Hinyokika Kiyo. 1983 Nov;29(11):1469-74.","Kawachi Y","Hinyokika Kiyo","1983","1983/11/01","","",""
"15044117","Bladder cancer in women: no time to wait","","Harv Womens Health Watch. 2004 Mar;11(7):3-5.","","Harv Womens Health Watch","2004","2004/03/27","","",""
"10037370","Bladder cancer in the next millennium","Andriole GL.","J Urol. 1999 Jan;161(1):66. doi: 10.1016/s0022-5347(01)62064-0.","Andriole GL","J Urol","1999","1999/02/26","","","10.1016/s0022-5347(01)62064-0"
"20949810","Getting ready for certification: bladder cancer","Matthews PA.","Urol Nurs. 2010 Jul-Aug;30(4):246, 245.","Matthews PA","Urol Nurs","2010","2010/10/19","","",""
"19824384","[Cancer of the urinary bladder: prognosis of the course]","Zimichev AA, Prianichnikov MB, Maklakov VN.","Urologiia. 2009 Jul-Aug;(4):48-51.","Zimichev AA","Urologiia","2009","2009/10/15","","",""
"18677811","Bibliography. Current world literature. Bladder cancer","","Curr Opin Urol. 2008 Sep;18(5):545-54.","","Curr Opin Urol","2008","2008/08/06","","",""
"19632766","Editorial comment on: Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer","Witjes JA.","Eur Urol. 2009 Dec;56(6):910. doi: 10.1016/j.eururo.2009.07.006. Epub 2009 Jul 17.","Witjes JA","Eur Urol","2009","2009/07/28","","","10.1016/j.eururo.2009.07.006"
"3766339","[Clinical analysis of high grade bladder cancer]","Miura T, Kubota Y, Ishibashi Y, Sakuramoto T, Noguchi S, Shuin T, Moriyama M, Hosaka M, Satomi Y, Fukushima S.","Hinyokika Kiyo. 1986 Jun;32(6):803-7.","Miura T","Hinyokika Kiyo","1986","1986/06/01","","",""
"19004107","Bladder cancer. Early discovery, vigilance are key","","Mayo Clin Health Lett. 2008 Oct;26(10):1-3.","","Mayo Clin Health Lett","2008","2008/11/13","","",""
"16838441","Benefits of bladder-cancer screening at home","Susman E.","Lancet Oncol. 2006 Jul;7(7):540. doi: 10.1016/s1470-2045(06)70751-3.","Susman E","Lancet Oncol","2006","2006/07/15","","","10.1016/s1470-2045(06)70751-3"
"15300151","Bibliography. Current world literature. Bladder cancer","","Curr Opin Urol. 2004 Sep;14(5):301-6.","","Curr Opin Urol","2004","2004/08/10","","",""
"2228496","Combined cisplatin and radiation therapy in patients with invasive bladder cancer","Mori Y, Ihara H, Shima H, Shimada K, Arima M, Ikoma F.","Int Urol Nephrol. 1990;22(4):337-44. doi: 10.1007/BF02549793.","Mori Y","Int Urol Nephrol","1990","1990/01/01","","","10.1007/BF02549793"
"3292046","Histological changes caused by intralesional injection of a streptococcal preparation into bladder cancer","Fujita K.","Cancer Detect Prev. 1988;11(3-6):397-403.","Fujita K","Cancer Detect Prev","1988","1988/01/01","","",""
"8015114","A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer","Scher HI.","J Urol. 1994 Aug;152(2 Pt 1):574-5.","Scher HI","J Urol","1994","1994/08/01","","",""
"8635951","Translational research in bladder cancer","Shipley WU.","Int J Radiat Oncol Biol Phys. 1996 May 1;35(2):411-2. doi: 10.1016/0360-3016(96)00141-1.","Shipley WU","Int J Radiat Oncol Biol Phys","1996","1996/05/01","","","10.1016/0360-3016(96)00141-1"
"741544","Further study of fibrinogen degradation products in bladder cancer detection","Wajsman Z, Williams PD, Greco J, Murphy GP.","Urology. 1978 Dec;12(6):659-61. doi: 10.1016/0090-4295(78)90427-2.","Wajsman Z","Urology","1978","1978/12/01","","","10.1016/0090-4295(78)90427-2"
"6864920","Bladder cancer: Part VI","Koontz WW Jr.","J Urol. 1983 Jul;130(1):83. doi: 10.1016/s0022-5347(17)50967-2.","Koontz WW Jr","J Urol","1983","1983/07/01","","","10.1016/s0022-5347(17)50967-2"
"3851013","[Pre and postoperative nursing of patients with bladder cancer. Social rehabilitation and problems in daily lives of patients with ileal conduits]","Masuda E, Kitamura I, Yamamoto T.","Kango Gijutsu. 1985 Aug;31(11):1454-9.","Masuda E","Kango Gijutsu","1985","1985/08/01","","",""
"3851010","[Pre and postoperative nursing of patients with bladder cancer. Management of patients undergoing urinary diversion for social rehabilitation]","Kawai T.","Kango Gijutsu. 1985 Aug;31(11):1432-6.","Kawai T","Kango Gijutsu","1985","1985/08/01","","",""
"6402768","Bladder cancer. Management of an increasingly common tumor","Soloway MS.","Postgrad Med. 1983 Mar;73(3):139-51. doi: 10.1080/00325481.1983.11697800.","Soloway MS","Postgrad Med","1983","1983/03/01","","","10.1080/00325481.1983.11697800"
"2750671","Bladder cancer: detection, prevention, and therapeutics","Burnham N.","Am Pharm. 1989 Jun;NS29(6):33-8. doi: 10.1016/s0160-3450(15)31761-x.","Burnham N","Am Pharm","1989","1989/06/01","","","10.1016/s0160-3450(15)31761-x"
"105442","A comprehensive protocol for management of cancer of the bilharzial bladder","Sherif M.","Urol Res. 1978;6(4):237-9. doi: 10.1007/BF00262626.","Sherif M","Urol Res","1978","1978/01/01","","","10.1007/BF00262626"
"5796387","Epidemiology and etiology of human bladder cancer: occupational bladder cancer in the British rubber industry","Parkes HG.","J Natl Cancer Inst. 1969 Jul;43(1):249-52.","Parkes HG","J Natl Cancer Inst","1969","1969/07/01","","",""
"3851014","[Pre and postoperative nursing of patients with bladder cancer. Assistance to patients with ileal conduits for eventual self care]","Takahashi M.","Kango Gijutsu. 1985 Aug;31(11):1460-4.","Takahashi M","Kango Gijutsu","1985","1985/08/01","","",""
"17220148","Urothelial changes induced by therapeutic procedures for bladder cancer","Lopez-Beltran A.","Anal Quant Cytol Histol. 2006 Dec;28(6):339.","Lopez-Beltran A","Anal Quant Cytol Histol","2006","2007/01/16","","",""
"14711986","Non-invasive management of invasive bladder cancer: lectures by professor William U. Shipley","Ikeda H.","Jpn J Clin Oncol. 2003 Nov;33(11):592-4. doi: 10.1093/jjco/hyg103.","Ikeda H","Jpn J Clin Oncol","2003","2004/01/09","","","10.1093/jjco/hyg103"
"7078197","Cystotomy and peroperative irradiation for bladder cancer: long-term results","Appelqvist P, Salmo M.","J Surg Oncol. 1982 Jun;20(2):75-9. doi: 10.1002/jso.2930200203.","Appelqvist P","J Surg Oncol","1982","1982/06/01","","","10.1002/jso.2930200203"
"8558642","Superficial bladder cancer--incremental insight","Malkowicz SB.","J Urol. 1996 Feb;155(2):488-9. doi: 10.1016/s0022-5347(01)66428-0.","Malkowicz SB","J Urol","1996","1996/02/01","","","10.1016/s0022-5347(01)66428-0"
"6632202","[Problems in urinary bladder cancer in the aged]","Yokokawa M, Fukui I, Sekine H.","Gan No Rinsho. 1983 Aug;29(10):1151-4.","Yokokawa M","Gan No Rinsho","1983","1983/08/01","","",""
"577477","Overview of the National Bladder Cancer Project and conference objectives","Friedell GH, Greenfield RE, Hilgar AG, Ellwein LB.","Cancer Res. 1977 Aug;37(8 Pt 2):2745-51.","Friedell GH","Cancer Res","1977","1977/08/01","","",""
"24323128","From genomics to imaging-advances along the care continuum","Haddad A, Lotan Y.","Nat Rev Urol. 2014 Feb;11(2):71-3. doi: 10.1038/nrurol.2013.286. Epub 2013 Dec 10.","Haddad A","Nat Rev Urol","2014","2013/12/11","","","10.1038/nrurol.2013.286"
"5052248","Tumors of the bladder. The Ad-Hoc Bladder Cancer Committee of the CCIRC","","J Urol. 1972 Sep;108(3):414-8.","","J Urol","1972","1972/09/01","","",""
"8015080","Uncertainty, stage and outcome of invasive bladder cancer","Herr HW.","J Urol. 1994 Aug;152(2 Pt 1):401-2. doi: 10.1016/s0022-5347(17)32748-9.","Herr HW","J Urol","1994","1994/08/01","","","10.1016/s0022-5347(17)32748-9"
"8175277","Transurethral resection for muscle-invasive bladder cancer","Kondás J, Váczi L, Szecsó L, Kondér G.","Int Urol Nephrol. 1993;25(6):557-63.","Kondás J","Int Urol Nephrol","1993","1993/01/01","","",""
"326396","Development of a strategy for a longitudinal study of patients with bladder cancer. National Bladder Cancer Collaborative Group A (NBCCGA)","","Cancer Res. 1977 Aug;37(8 Pt 2):2898-906.","","Cancer Res","1977","1977/08/01","","",""
"480490","Bladder cancer: pebbles to reach the water","Droller MJ.","J Urol. 1979 Oct;122(4):476-7. doi: 10.1016/s0022-5347(17)56472-1.","Droller MJ","J Urol","1979","1979/10/01","","","10.1016/s0022-5347(17)56472-1"
"23559136","[Urine cytology and new markers. Are there any advantages in terms of cost-effectiveness?]","Campodonico F.","Urologia. 2013;80 Suppl 21:7-10. doi: 10.5301/RU.2013.10856. Epub 2013 Mar 22.","Campodonico F","Urologia","2013","2013/04/06","","","10.5301/RU.2013.10856"
"3361916","Bladder cancer: pelvic lymphadenectomy revisited","Herr HW.","J Surg Oncol. 1988 Apr;37(4):242-5. doi: 10.1002/jso.2930370407.","Herr HW","J Surg Oncol","1988","1988/04/01","","","10.1002/jso.2930370407"
"4763515","Lymphocytes and bladder cancer","Amin M, Lich R Jr.","Trans Am Assoc Genitourin Surg. 1973;65:77-83.","Amin M","Trans Am Assoc Genitourin Surg","1973","1973/01/01","","",""
"3374712","Bacterial infection of urine in patients with bladder cancer","Vodvárka P, Jancová J.","Neoplasma. 1988;35(2):243-50.","Vodvárka P","Neoplasma","1988","1988/01/01","","",""
"2191568","[A trial of digitization and digital analysis of analog clinical images of bladder cancer]","Mikata N, Imao S, Horiuchi D.","Hinyokika Kiyo. 1990 Mar;36(3):265-9.","Mikata N","Hinyokika Kiyo","1990","1990/03/01","","",""
"14682138","[Preliminary results of selective combined therapy for patients with urinary bladder cancer]","Zharinov GM, Agafonova MV, Tarazov PG, Suvorova IuV, Kozlov AA.","Vopr Onkol. 2003;49(5):636-8.","Zharinov GM","Vopr Onkol","2003","2003/12/20","","",""
"12661578","[Treatment of infiltrating bladder cancer. Report of the 2002 Congress of the French Association of Urology]","","Prog Urol. 2002 Nov;12(5):763-1178.","","Prog Urol","2002","2003/03/29","","",""
"3640875","[Progress in cancer therapy. 11. Progress in the treatment of bladder cancer]","Tashiro K, Oishi Y.","Kango Gijutsu. 1986 Nov;32(15):1962-5.","Tashiro K","Kango Gijutsu","1986","1986/11/01","","",""
"3664203","The role of partial cystectomy in the treatment of recurrent invasive bladder cancer following radiotherapy","Matthews PN, Minton MJ, Haw M, Philip PF.","Br J Urol. 1987 Aug;60(2):132-5. doi: 10.1111/j.1464-410x.1987.tb04949.x.","Matthews PN","Br J Urol","1987","1987/08/01","","","10.1111/j.1464-410x.1987.tb04949.x"
"6014877","[The treatment of bladder cancer]","May F.","Munch Med Wochenschr. 1966 Sep 2;108(35):1697-9.","May F","Munch Med Wochenschr","1966","1966/09/02","","",""
"5965791","[Cytodiagnosis of bladder cancer]","Braxs A, Braxs J.","Rev Fac Cienc Med Cordoba. 1966 Apr-Jun;24(2):147-50.","Braxs A","Rev Fac Cienc Med Cordoba","1966","1966/04/01","","",""
"5776040","Bladder cancer: a 26-year review","Cox CE, Cass AS, Boyce WH.","J Urol. 1969 Apr;101(4):550-8. doi: 10.1016/s0022-5347(17)62379-6.","Cox CE","J Urol","1969","1969/04/01","","","10.1016/s0022-5347(17)62379-6"
"7928511","Organ-sparing treatment for bladder cancer: time to beat the drum","Zietman AL, Shipley WU.","Int J Radiat Oncol Biol Phys. 1994 Oct 15;30(3):741-2. doi: 10.1016/0360-3016(92)90966-l.","Zietman AL","Int J Radiat Oncol Biol Phys","1994","1994/10/15","","","10.1016/0360-3016(92)90966-l"
"3543940","EORTC Genitourinary Group Monograph 3: Developments in bladder cancer. Proceedings of the First International Consensus Development Conference on Guidelines for Clinical Research in Bladder Cancer. Antwerp, Belgium, June 20-22, 1985","","Prog Clin Biol Res. 1986;221:1-328.","","Prog Clin Biol Res","1986","1986/01/01","","",""
"4757916","Proceedings: Assessment of bladder cancer","Cooper EH, Anderson CK, Steele L, O'Boyle P.","Cancer. 1973 Nov;32(5):1263-6. doi: 10.1002/1097-0142(197311)32:5<1263::aid-cncr2820320535>3.0.co;2-l.","Cooper EH","Cancer","1973","1973/11/01","","","10.1002/1097-0142(197311)32:5<1263::aid-cncr2820320535>3.0.co;2-l"
"633478","Radical cystectomy for bladder cancer","Pearse HD, Reed RR, Hodges CV.","J Urol. 1978 Feb;119(2):216-8. doi: 10.1016/s0022-5347(17)57437-6.","Pearse HD","J Urol","1978","1978/02/01","","","10.1016/s0022-5347(17)57437-6"
"3661256","[Radiotherapy and infiltrating bladder cancer]","Serrallach Milà N.","Actas Urol Esp. 1987 May-Jun;11(3):241-4.","Serrallach Milà N","Actas Urol Esp","1987","1987/05/01","","",""
"4103333","[Therapeutic indications in bladder cancer]","Wincqz PJ.","Acta Urol Belg. 1971 Jan;39(1):72-8.","Wincqz PJ","Acta Urol Belg","1971","1971/01/01","","",""
"6677788","[Combination therapy of transurethral resection (TUR) and radiotherapy in advanced bladder cancer]","Tashiro K.","Nihon Hinyokika Gakkai Zasshi. 1983 Dec;74(12):2043-53. doi: 10.5980/jpnjurol1928.74.12_2043.","Tashiro K","Nihon Hinyokika Gakkai Zasshi","1983","1983/12/01","","","10.5980/jpnjurol1928.74.12_2043"
"7702914","[Surgical treatment of bladder cancer]","Jardin A.","Bull Cancer Radiother. 1994;81(4):299-302.","Jardin A","Bull Cancer Radiother","1994","1994/01/01","","",""
"7131409","[Lymphography as an investigation method for bladder cancer in adults]","Juimo AG, Masselot J, Markovits P, Amar MH, Rebibo-Lorimy G, Sassoon C, Budet C.","J Radiol. 1982 Jun-Jul;63(6-7):415-21.","Juimo AG","J Radiol","1982","1982/06/01","","",""
"5036004","Cytology of bladder cancer","Straffon WG.","Br J Urol. 1972 Feb;44(1):120-1.","Straffon WG","Br J Urol","1972","1972/02/01","","",""
"3641345","Treatment modalities for bladder cancer","Gray M.","Semin Oncol Nurs. 1986 Nov;2(4):260-4. doi: 10.1016/0749-2081(86)90115-4.","Gray M","Semin Oncol Nurs","1986","1986/11/01","","","10.1016/0749-2081(86)90115-4"
"4109157","[Transurethral management of bladder cancer]","Bibus B, Zeitlhofer J.","Wien Med Wochenschr. 1971 Dec 24;121(51):936-7.","Bibus B","Wien Med Wochenschr","1971","1971/12/24","","",""
"5581471","[Therapeutic indications in bladder cancer]","Lafrance L.","Acta Urol Belg. 1971 Jan;39(1):5-7.","Lafrance L","Acta Urol Belg","1971","1971/01/01","","",""
"4753378","[Radiotherapy of advanced bladder cancer]","Paunier JP.","Helv Chir Acta. 1973 Sep;40(4):417-20.","Paunier JP","Helv Chir Acta","1973","1973/09/01","","",""
"5127548","[Surgical treatment of bladder cancer]","Jakobsen BE, Genster H, Olesen S.","Nord Med. 1971 Sep 23;86(38):1103.","Jakobsen BE","Nord Med","1971","1971/09/23","","",""
"552498","Treatment of infiltrating bladder cancer","Bloom HJ.","J R Soc Med. 1979 Mar;72(3):203-10. doi: 10.1177/014107687907200312.","Bloom HJ","J R Soc Med","1979","1979/03/01","PMC1436858","","10.1177/014107687907200312"
"5499831","The role of lymphoid reaction in bladder cancer","Sarma KP.","J Urol. 1970 Dec;104(6):843-9. doi: 10.1016/s0022-5347(17)61849-4.","Sarma KP","J Urol","1970","1970/12/01","","","10.1016/s0022-5347(17)61849-4"
"1877114","Molecular and immunologic approaches in the management of bladder cancer","Fradet Y.","Urol Clin North Am. 1991 Aug;18(3):515-24.","Fradet Y","Urol Clin North Am","1991","1991/08/01","","",""
"10393710","Prevention study turns spotlight on bladder cancer","Reynolds T.","J Natl Cancer Inst. 1999 Jul 7;91(13):1102-3. doi: 10.1093/jnci/91.13.1102.","Reynolds T","J Natl Cancer Inst","1999","1999/07/07","","","10.1093/jnci/91.13.1102"
"8996378","Re: Initial evaluation of the bladder tumor antigen test in superficial bladder cancer","Kirollos MM.","J Urol. 1997 Feb;157(2):627. doi: 10.1016/s0022-5347(01)65226-1.","Kirollos MM","J Urol","1997","1997/02/01","","","10.1016/s0022-5347(01)65226-1"
"5469305","[New experience in therapy of urinary bladder cancer]","Edsmyr P, Esposti L, Giertz G, Moberger G.","Nord Med. 1970 Sep 24;84(39):1244-6.","Edsmyr P","Nord Med","1970","1970/09/24","","",""
"9516372","Bladder cancer. Early detection is critical","","Mayo Clin Health Lett. 1998 Mar;16(3):6.","","Mayo Clin Health Lett","1998","1998/03/27","","",""
"6504890","Bladder cancer. Part B: Radiation, local and systemic chemotherapy, and new treatment modalities. Proceedings of the First International Symposium on Tumors of the Urinary Bladder. Paris, July 4-6, 1983","","Prog Clin Biol Res. 1984;162B:1-453.","","Prog Clin Biol Res","1984","1984/01/01","","",""
"4107449","[Surgical treatment of bladder cancer]","Jakobsen BE, Genster HG, Olesen S.","Nord Med. 1971 Nov 8;86(44):1270-4.","Jakobsen BE","Nord Med","1971","1971/11/08","","",""
"5083949","Recent progress in bladder cancer","Clayson DB, Cooper EH.","Eur J Cancer. 1972 Apr;8(2):221-3. doi: 10.1016/0014-2964(72)90047-3.","Clayson DB","Eur J Cancer","1972","1972/04/01","","","10.1016/0014-2964(72)90047-3"
"9934798","Bladder cancer in a patient on long-term haemodialysis","Hadatsuki H, Sasagawa I, Suzuki H, Yaguchi H, Mutoh A, Kubota Y, Nakada T.","Int Urol Nephrol. 1998;30(5):565-8. doi: 10.1007/BF02550546.","Hadatsuki H","Int Urol Nephrol","1998","1999/02/06","","","10.1007/BF02550546"
"617902","Radical cystectomy with or without prior irradiation in the treatment of bladder cancer","Whitmore WF Jr, Batata MA, Ghoneim MA, Grabstald H, Unal A.","Trans Am Assoc Genitourin Surg. 1977;69:100-3.","Whitmore WF Jr","Trans Am Assoc Genitourin Surg","1977","1977/01/01","","",""
"3851017","[Pre and postoperative nursing of patients with bladder cancer. Nursing of a patient with bladder cancer complicated with hypertension and sequelae of stroke]","Sonehara K, Goshima C, Nakabayashi K.","Kango Gijutsu. 1985 Aug;31(11):1475-9.","Sonehara K","Kango Gijutsu","1985","1985/08/01","","",""
"5746140","Bladder cancer: a 26-year review","Cox CE, Cass AS, Boyce WH.","Trans Am Assoc Genitourin Surg. 1968;60:22-30.","Cox CE","Trans Am Assoc Genitourin Surg","1968","1968/01/01","","",""
"3960518","[Classification and treatment of bladder cancer]","","Orv Hetil. 1986 Mar 16;127(11):651.","","Orv Hetil","1986","1986/03/16","","",""
"11458100","Re: Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy","Thompson IM.","J Urol. 2001 Aug;166(2):630.","Thompson IM","J Urol","2001","2001/07/18","","",""
"5851340","[On the diagnosis and treatment of bladder cancer]","Pytel' A.","Bratisl Lek Listy. 1965 Nov 30;45(10):619-26.","Pytel' A","Bratisl Lek Listy","1965","1965/11/30","","",""
"3852956","[Postoperative care and rehabilitation of patients with bladder cancer]","Aoki T, Inose M, Otsuka T, Kanai K, Yajima C.","Kango Gijutsu. 1985 Oct;31(14):1913-6.","Aoki T","Kango Gijutsu","1985","1985/10/01","","",""
"8113125","Radiation as adjunctive therapy to cystectomy for bladder cancer: is there a difference for bilharzial association?","Zaghloul MS.","Int J Radiat Oncol Biol Phys. 1994 Feb 1;28(3):783. doi: 10.1016/0360-3016(94)90209-7.","Zaghloul MS","Int J Radiat Oncol Biol Phys","1994","1994/02/01","","","10.1016/0360-3016(94)90209-7"
"5127547","[Urinary bladder cancer in Sonderjylland 1955-67]","Schroeder E, Christensen TB, Jacobsen F.","Nord Med. 1971 Sep 23;86(38):1103.","Schroeder E","Nord Med","1971","1971/09/23","","",""
"5754886","Cancer of the urogenital tract: bladder cancer. Group 1, Stages 0, A, and B, grades I and II: superficial, low-grade carcinomas","Rubin P.","JAMA. 1968 Dec 16;206(12):2719.","Rubin P","JAMA","1968","1968/12/16","","",""
"10947451","Bladder cancer markers. Current availability and the future standard of care","Sawczuk IS, Burchardt T, Shabsigh A, de la Taille A, Burchardt M.","MLO Med Lab Obs. 2000 Mar;32(3):30-3, 36, 38 passim; quiz 42-4.","Sawczuk IS","MLO Med Lab Obs","2000","2000/08/18","","",""
"3851020","[Pre and postoperative nursing of patients with bladder cancer. Nursing of a patient in the terminal stage of bladder cancer with poor prognosis]","Aihara R, Sato K, Sasaki K, Hosaka Y, Narita T.","Kango Gijutsu. 1985 Aug;31(11):1492-7.","Aihara R","Kango Gijutsu","1985","1985/08/01","","",""
"6800628","Preoperative irradiation and cystectomy for bladder cancer","Smith JA Jr, Batata M, Grabstald H, Sogani PC, Herr H, Whitmore WF Jr.","Cancer. 1982 Mar 1;49(5):869-73. doi: 10.1002/1097-0142(19820301)49:5<869::aid-cncr2820490508>3.0.co;2-2.","Smith JA Jr","Cancer","1982","1982/03/01","","","10.1002/1097-0142(19820301)49:5<869::aid-cncr2820490508>3.0.co;2-2"
"5581473","[Therapeutic indications in bladder cancer]","Mombaerts J.","Acta Urol Belg. 1971 Jan;39(1):79-80.","Mombaerts J","Acta Urol Belg","1971","1971/01/01","","",""
"8260382","A plea for better coding rules for bladder cancer","Schouten LJ, Kiemeney LA.","Br J Cancer. 1993 Dec;68(6):1254-5. doi: 10.1038/bjc.1993.514.","Schouten LJ","Br J Cancer","1993","1993/12/01","PMC1968668","","10.1038/bjc.1993.514"
"1570471","Current options in bladder cancer management","Tootla J, Easterling AD.","RN. 1992 Apr;55(4):42-8.","Tootla J","RN","1992","1992/04/01","","",""
"3901475","Blood group isoantigens and bladder cancer. An overview","Srinivas V, Khan SA.","Urol Int. 1985;40(4):233-4. doi: 10.1159/000281088.","Srinivas V","Urol Int","1985","1985/01/01","","","10.1159/000281088"
"1877117","Neoadjuvant therapy in invasive bladder cancer. Problems and pitfalls","Fair WR.","Urol Clin North Am. 1991 Aug;18(3):539-42.","Fair WR","Urol Clin North Am","1991","1991/08/01","","",""
"5100518","[Bladder cancer and vesicoureteral reflux]","Fujieda J, Omuro H, Katsume M.","Iryo. 1971 Jan;25(1):17-20.","Fujieda J","Iryo","1971","1971/01/01","","",""
"6473403","Preoperative irradiation with cystectomy for bladder cancer","Whitmore WF Jr.","Prog Clin Biol Res. 1984;153:343-57.","Whitmore WF Jr","Prog Clin Biol Res","1984","1984/01/01","","",""
"6950632","Benefits of cytologic screening for bladder cancer","Davies JM, Parkes HG.","Acta Cytol. 1982 Jan-Feb;26(1):98.","Davies JM","Acta Cytol","1982","1982/01/01","","",""
"9114522","[Indications and results of treatments of bladder tumors]","Le Duc A.","Rev Prat. 1997 Feb 15;47(4):379-81.","Le Duc A","Rev Prat","1997","1997/02/15","","",""
"462614","[Cystectomy in urinary bladder cancer]","Kjaergaard J, Thybo E.","Ugeskr Laeger. 1979 Jun 11;141(24):1647-51.","Kjaergaard J","Ugeskr Laeger","1979","1979/06/11","","",""
"6858797","[Value of urinary cytology and cytology of bladder lavage in the diagnosis and observation of bladder cancer]","Denis L, Nowé P, Reiss S, Declercq G.","Acta Urol Belg. 1983;51(1):38-42.","Denis L","Acta Urol Belg","1983","1983/01/01","","",""
"4753383","[Our experience with preoperative radiotherapy of bladder cancer from the prognostic viewpoint]","Tuchschmid D, Weyeneth R, Thiébaud M.","Helv Chir Acta. 1973 Sep;40(4):467-71.","Tuchschmid D","Helv Chir Acta","1973","1973/09/01","","",""
"2194292","Quantitative fluorescence image analysis--a bladder cancer diagnosis alternative","Roy J.","Urol Nurs. 1990 Jun;10(2):21-2.","Roy J","Urol Nurs","1990","1990/06/01","","",""
"762454","Bladder cancer: the role of radiation therapy","Mansfield CM, Reddy EK, Hartman GV.","J Kans Med Soc. 1979 Feb;80(2):54-5, 59.","Mansfield CM","J Kans Med Soc","1979","1979/02/01","","",""
"8317005","[Gene mutation in bladder cancer. Towards molecular pathology]","Olsen S.","Ugeskr Laeger. 1993 May 24;155(21):1648-9.","Olsen S","Ugeskr Laeger","1993","1993/05/24","","",""
"420581","Bladder Cancer: current status of diagnosis & treatment","Stanisic TH.","Ariz Med. 1979 Jan;36(1):34-7.","Stanisic TH","Ariz Med","1979","1979/01/01","","",""
"69354","[Treatment of cancer of the bladder (author's transl)]","Rummelhardt J.","Urologe A. 1977 May;16(3):183-4.","Rummelhardt J","Urologe A","1977","1977/05/01","","",""
"10786601","Bladder cancer: its diagnosis and treatment","Baxter A.","Nurs Times. 1999 Oct 13-19;95(41):42-4.","Baxter A","Nurs Times","1999","2000/04/29","","",""
"3851021","[Pre and postoperative nursing of patients with bladder cancer. A study of the apprehension of the patient having an ileal conduit and associated nursing interventions]","Ishibashi A, Matsubara H, Yoshitsugu M, Nakamura H, Haraguchi M.","Kango Gijutsu. 1985 Aug;31(11):1498-503.","Ishibashi A","Kango Gijutsu","1985","1985/08/01","","",""
"3130703","The role of partial cystectomy in the management of transitional bladder cancer","Torelli T, Leidi GL, Corrada P, Bacchioni AM, Ordesi G, Zanitzer L, Campo B.","Tumori. 1988 Apr 30;74(2):233-6.","Torelli T","Tumori","1988","1988/04/30","","",""
"3071122","[Clinical application of MRI for urological malignancy. 2: Usefulness of various imaging modalities for local staging of bladder cancer; a comparison between MRI, CT and transurethral ultrasonography]","Nishimura K, Horii Y, Matsuda T, Okada Y, Takeuchi H, Yoshida O, Nishimura K, Nakano Y, Kaku S, Nishibuchi S.","Hinyokika Kiyo. 1988 Dec;34(12):2091-6.","Nishimura K","Hinyokika Kiyo","1988","1988/12/01","","",""
"7426945","Integrated irradiation and cystectomy for bladder cancer","Whitmore WF.","Br J Urol. 1980 Feb;52(1):1-9. doi: 10.1111/j.1464-410x.1980.tb02910.x.","Whitmore WF","Br J Urol","1980","1980/02/01","","","10.1111/j.1464-410x.1980.tb02910.x"
"7005784","[Significance of biological markers for the diagnosis of urinary bladder cancer]","Oehr P, Adolphs HD.","Onkologie. 1980 Oct;3(5):238-46. doi: 10.1159/000214801.","Oehr P","Onkologie","1980","1980/10/01","","","10.1159/000214801"
"8701807","Neo-adjuvant and adjuvant chemotherapy in locally advanced bladder cancer","Sternberg CN.","Acta Urol Belg. 1996 May;64(2):33-4.","Sternberg CN","Acta Urol Belg","1996","1996/05/01","","",""
"7129901","[Radical--supraradical surgical procedures in bladder cancer: sense and nonsense]","Schoenenberger A.","Helv Chir Acta. 1982 Aug;49(3-4):361-8.","Schoenenberger A","Helv Chir Acta","1982","1982/08/01","","",""
"4966437","Preoperative irradiation with cystectomy in the management of bladder cancer","Whitmore WF Jr, Grabstald H, Mackenzie AR, Iswariah J, Phillips R.","Am J Roentgenol Radium Ther Nucl Med. 1968 Mar;102(3):570-6. doi: 10.2214/ajr.102.3.570.","Whitmore WF Jr","Am J Roentgenol Radium Ther Nucl Med","1968","1968/03/01","","","10.2214/ajr.102.3.570"
"5232362","Bladder cancer. Importance of pretreatment assessment","Newall J.","N Y State J Med. 1967 May 15;67(10):1284-6.","Newall J","N Y State J Med","1967","1967/05/15","","",""
"2664274","[Detection and diagnosis of bladder cancer in the early stage]","Koiso K, Kano K, Nemoto R, Ishikawa H, Ohtani M, Sato T, Iwasaki A.","Nihon Rinsho. 1989 May;47(5):1172-7.","Koiso K","Nihon Rinsho","1989","1989/05/01","","",""
"473444","Experimental carcinogenesis: achievements and objectives in relation to human bladder cancer","Hicks RM.","Urol Res. 1979 Jun 22;7(2):69-70. doi: 10.1007/BF00254683.","Hicks RM","Urol Res","1979","1979/06/22","","","10.1007/BF00254683"
"6785453","Salvage cystectomy for bladder cancer after failure of definitive irradiation","Smith JA Jr, Whitmore WF Jr.","J Urol. 1981 May;125(5):643-5. doi: 10.1016/s0022-5347(17)55148-4.","Smith JA Jr","J Urol","1981","1981/05/01","","","10.1016/s0022-5347(17)55148-4"
"490773","[Infiltrating bladder cancer: is sequential radio-surgical treatment justified?]","Boccon-Gibod L, Olier C, Debré B, Eschwege F, Steg A.","J Urol Nephrol (Paris). 1979 Jun;85(6):421-4.","Boccon-Gibod L","J Urol Nephrol (Paris)","1979","1979/06/01","","",""
"5104749","[Irradiation of bladder cancer through the surgical opening]","Mikuriya S.","Gan No Rinsho. 1971 May;17(5):371-3.","Mikuriya S","Gan No Rinsho","1971","1971/05/01","","",""
"4729141","Early and late results of the radiation and combined treatment of urinary bladder cancer","Balmukhanov SB, Minakova LR, Shibanova AI, Katz MS.","Neoplasma. 1973;20(4):457-63.","Balmukhanov SB","Neoplasma","1973","1973/01/01","","",""
"3573737","A review of the effectiveness of urinary cytology as a screening technique for occupational bladder cancer","Jacobs R.","J Soc Occup Med. 1987 Spring;37(1):24-6. doi: 10.1093/occmed/37.1.24.","Jacobs R","J Soc Occup Med","1987","1987/01/01","","","10.1093/occmed/37.1.24"
"872105","Recognition of ""early"" bladder cancer and premalignant epithelial changes","Friedell GH.","Cancer Res. 1977 Aug;37(8 Pt 2):2792-3.","Friedell GH","Cancer Res","1977","1977/08/01","","",""
"7254311","Epidemiology of urinary bladder cancer: international variation in mortality","Ohno Y, Aoki K.","Nagoya J Med Sci. 1980 Nov;43(1-2):41-64.","Ohno Y","Nagoya J Med Sci","1980","1980/11/01","","",""
"9123690","Does current chemotherapy improve survival of patients with invasive bladder cancer?","Herr HW.","Urology. 1997 Mar;49(3):309-12. doi: 10.1016/S0090-4295(96)00628-0.","Herr HW","Urology","1997","1997/03/01","","","10.1016/S0090-4295(96)00628-0"
"841821","Point of view: paracystectomy irradiation--proposal for better local control of bladder cancer","Belgrad R.","Urology. 1977 Mar;9(3):364-6. doi: 10.1016/0090-4295(77)90369-7.","Belgrad R","Urology","1977","1977/03/01","","","10.1016/0090-4295(77)90369-7"
"7132598","[Role of pelvic arteriography in evaluating the efficacy of radiation and combination therapy of bladder cancer]","Drozdovskiĭ BIa, Grishin GN, Mardynskiĭ IuS, Dunchik VN.","Med Radiol (Mosk). 1982 Aug;27(8):19-24.","Drozdovskiĭ BIa","Med Radiol (Mosk)","1982","1982/08/01","","",""
"7129897","[Infiltrating bladder cancer: can tomodensitometry improve the determination of its spread?]","Boccon Gibod L, Le Portz B, Parienty R, Ducellier J.","Helv Chir Acta. 1982 Aug;49(3-4):325-27.","Boccon Gibod L","Helv Chir Acta","1982","1982/08/01","","",""
"5796386","Industrial bladder cancer: a progress report and some unanswered questions","Ferber KH.","J Natl Cancer Inst. 1969 Jul;43(1):245-8.","Ferber KH","J Natl Cancer Inst","1969","1969/07/01","","",""
"6395180","[Computed tomography in a pretherapeutic complex program for bladder cancer]","Schmidt S, Lüning M, Schilling H, Kunz B, Vogler H, Grossmann J.","Radiol Diagn (Berl). 1984;25(6):689-99.","Schmidt S","Radiol Diagn (Berl)","1984","1984/01/01","","",""
"7129894","[Diagnostic value of transurethral biopsies in bladder cancer]","Habegger R, Horica CA.","Helv Chir Acta. 1982 Aug;49(3-4):313-5.","Habegger R","Helv Chir Acta","1982","1982/08/01","","",""
"5856178","Preoperative irradiation combined with cystectomy in the treatment of bladder cancer","Whitmore WF Jr.","Proc Natl Cancer Conf. 1964;5:481-4.","Whitmore WF Jr","Proc Natl Cancer Conf","1964","1964/01/01","","",""
"1185867","Evaluation of lymphangiography for clinical staging of bladder tumors","Wajsman Z, Baumgartner G, Murphy GP, Merrin C.","J Urol. 1975 Nov;114(5):712-4. doi: 10.1016/s0022-5347(17)67125-8.","Wajsman Z","J Urol","1975","1975/11/01","","","10.1016/s0022-5347(17)67125-8"
"7861530","Re: Does a stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer?","Ansong K.","J Urol. 1995 Mar;153(3 Pt 1):751.","Ansong K","J Urol","1995","1995/03/01","","",""
"7370938","T3 bladder cancer: the case for higher radiation dosage","Miller LS.","Cancer. 1980 Apr 15;45(7 Suppl):1875-8.","Miller LS","Cancer","1980","1980/04/15","","",""
"406038","The role of irradiation in the management of clinical stage B1 (grades II and III) and stages B2 and C bladder cancer","Caldwell WL.","Cancer Res. 1977 Aug;37(8 Pt 2):2759-63.","Caldwell WL","Cancer Res","1977","1977/08/01","","",""
"3809178","Guidelines for radiation therapy in clinical research on bladder cancer","Shipley WU, Van der Schueren E, Kitagawa T, Gospodarowicz MK, Frommhold H, Magno L, Mochizuki S, Van den Bogaert W, Van der Werf-Messing B.","Prog Clin Biol Res. 1986;221:109-21.","Shipley WU","Prog Clin Biol Res","1986","1986/01/01","","",""
"7303101","[Bladder cancer of the stage T3 results of pure, preoperative and postoperative radiation treatment]","Magdeburg W, Aberle HG, Horst W.","Strahlentherapie Sonderb. 1981;76:212-4.","Magdeburg W","Strahlentherapie Sonderb","1981","1981/01/01","","",""
"7129892","[Computerized tomography--an aid in the preoperative staging of bladder cancer]","Rost A, Hantelmann W, Wegener OH, Hasselmann J.","Helv Chir Acta. 1982 Aug;49(3-4):301-5.","Rost A","Helv Chir Acta","1982","1982/08/01","","",""
"81537","[Comfort and treatment of bladder cancer (author's transl)]","von Niederhäusern W.","Ther Umsch. 1978 Oct;35(10):826-9.","von Niederhäusern W","Ther Umsch","1978","1978/10/01","","",""
"4167488","Treatment of bladder cancer in Egypt. I. General principles and methods of treatment","Fam A.","Int Surg. 1967 Oct;48(4):391-401.","Fam A","Int Surg","1967","1967/10/01","","",""
"6503117","[Urinary tissue polypeptide antigen (TPA) in bladder cancer]","Fujinaga T, Kitamura S, Yoshida M.","Nihon Hinyokika Gakkai Zasshi. 1984 Jun;75(6):959-66. doi: 10.5980/jpnjurol1928.75.6_959.","Fujinaga T","Nihon Hinyokika Gakkai Zasshi","1984","1984/06/01","","","10.5980/jpnjurol1928.75.6_959"
"3226003","[Clinicopathological studies on totally cystectomized bladder cancer]","Yagi S, Shirahama T, Goto T, Fai CY, Kakinoki T, Otoshi K, Kawahara M, Shimoinaba T, Sakamoto N, Ohi Y.","Nihon Hinyokika Gakkai Zasshi. 1988 Feb;79(2):274-82. doi: 10.5980/jpnjurol1928.79.2_274.","Yagi S","Nihon Hinyokika Gakkai Zasshi","1988","1988/02/01","","","10.5980/jpnjurol1928.79.2_274"
"3236592","[Multidisciplinary therapy of advanced bladder cancer--results of therapy in partial cystectomy cases]","Hara M, Saegusa M, Ochi J, Akagi T, Obama T, Yoshimoto J, Matumura Y, Ohmori H.","Nihon Hinyokika Gakkai Zasshi. 1988 May;79(5):772-9. doi: 10.5980/jpnjurol1928.79.5_772.","Hara M","Nihon Hinyokika Gakkai Zasshi","1988","1988/05/01","","","10.5980/jpnjurol1928.79.5_772"
"7129904","[Downstaging in the preoperative radiotherapeutic approach--cystectomy of bladder cancer: myth or reality?]","Haefliger JM, Chatelanat F, Graber P.","Helv Chir Acta. 1982 Aug;49(3-4):381-3.","Haefliger JM","Helv Chir Acta","1982","1982/08/01","","",""
"7456028","[Treatment of muscle-infiltrating bladder cancer by preoperative irradiation and total cystectomy]","Fosså SD, Høst H.","Tidsskr Nor Laegeforen. 1980 Oct 30;100(30):1773-5.","Fosså SD","Tidsskr Nor Laegeforen","1980","1980/10/30","","",""
"4684250","Lymphocytic infiltration in bladder cancer: a preliminary report","Leigh RA, Van Blerk PJ, Horn BK.","S Afr Med J. 1973 Feb 3;47(5):192-4.","Leigh RA","S Afr Med J","1973","1973/02/03","","",""
"3851018","[Pre and postoperative nursing of patients with bladder cancer. Nursing of a patient with transcutaneous urostomy--a reflection on nursing actions and family cooperation for rehabilitation of a 79-year-old woman who had never been ill]","Miyoshi A, Numanami S, Watanabe Y, Miura M.","Kango Gijutsu. 1985 Aug;31(11):1480-6.","Miyoshi A","Kango Gijutsu","1985","1985/08/01","","",""
"8114852","Bladder preservation after treatment of invasive bladder cancer","Berman DJ.","N Engl J Med. 1994 Mar 24;330(12):867; author reply 867-8. doi: 10.1056/NEJM199403243301217.","Berman DJ","N Engl J Med","1994","1994/03/24","","","10.1056/NEJM199403243301217"
"3323101","Therapy of bladder cancer","Bichler KH, Halim S.","Int Urol Nephrol. 1987;19(4):399-413. doi: 10.1007/BF02550357.","Bichler KH","Int Urol Nephrol","1987","1987/01/01","","","10.1007/BF02550357"
"9468036","Bladder cancer in Sweden","Hellsten S, Steineck G.","Med Oncol. 1997 Sep-Dec;14(3-4):141-3. doi: 10.1007/BF02989641.","Hellsten S","Med Oncol","1997","1998/02/19","","","10.1007/BF02989641"
"11136841","Detecting bladder cancer in the Chinese by microsatellite analysis: ethnic and etiologic considerations","Zhang J, Fan Z, Gao Y, Xiao Z, Li C, An Q, Cheng S.","J Natl Cancer Inst. 2001 Jan 3;93(1):45-50. doi: 10.1093/jnci/93.1.45.","Zhang J","J Natl Cancer Inst","2001","2001/01/04","","","10.1093/jnci/93.1.45"
"25869257","A New Dawn for Bladder Cancer? Recommendations from the National Institute for Health and Care Excellence (NICE) on Managing Bladder Cancer","Huddart RA, Jones R, Choudhury A.","Clin Oncol (R Coll Radiol). 2015 Jul;27(7):380-1. doi: 10.1016/j.clon.2015.03.008. Epub 2015 Apr 11.","Huddart RA","Clin Oncol (R Coll Radiol)","2015","2015/04/15","","","10.1016/j.clon.2015.03.008"
"18615663","Advanced bladder cancer: so many drugs, so little progress : what's wrong with this picture?","Dreicer R.","Cancer. 2008 Sep 15;113(6):1275-7. doi: 10.1002/cncr.23690.","Dreicer R","Cancer","2008","2008/07/11","","","10.1002/cncr.23690"
"25654736","Bladder cancer: molecular determinants of personalized therapy","Lopez-Beltran A, Santoni M, Massari F, Ciccarese C, Tortora G, Cheng L, Moch H, Scarpelli M, Reymundo C, Montironi R.","Curr Drug Targets. 2015;16(2):115-24. doi: 10.2174/1389450116666150204115756.","Lopez-Beltran A","Curr Drug Targets","2015","2015/02/06","","","10.2174/1389450116666150204115756"
"3354067","Bladder cancer prognostic indices: analysis of 286 patients treated with radical radiation therapy","Micheletti E, Morrica B, Bonanno I, Buffoli A.","Tumori. 1988 Feb 29;74(1):85-92.","Micheletti E","Tumori","1988","1988/02/29","","",""
"23852929","[Innovative treatments of non muscle invasive bladder cancer]","Racioppi M, D'Agostino D, Pugliese D, Ragonese M, Di Gianfrancesco L, Bassi P.","Urologia. 2013 Apr-Jun;80(2):120-6. doi: 10.5301/RU.2013.11302. Epub 2013 Jul 5.","Racioppi M","Urologia","2013","2013/07/16","","","10.5301/RU.2013.11302"
"12180056","[Results of organ-preserving therapy for invasive bladder cancer]","Matveev BP, Figurin KM, Toktomushev AT.","Urologiia. 2002 May-Jun;(3):3-5.","Matveev BP","Urologiia","2002","2002/08/16","","",""
"11176520","Molecular targets for the therapeutic manipulation of apoptosis in bladder cancer","Duggan BJ, Kelly JD, Keane PF, Johnston SR; Belfast Uro-oncology Research Group.","J Urol. 2001 Mar;165(3):946-54.","Duggan BJ","J Urol","2001","2001/02/15","","",""
"15041100","T1G3 bladder cancer: conservative management or cystectomy?","Gattegno B.","Eur Urol. 2004 Apr;45(4):399-400. doi: 10.1016/j.eururo.2003.11.027.","Gattegno B","Eur Urol","2004","2004/03/26","","","10.1016/j.eururo.2003.11.027"
"19271220","Economic aspects of bladder cancer: what are the benefits and costs?","Sievert KD, Amend B, Nagele U, Schilling D, Bedke J, Horstmann M, Hennenlotter J, Kruck S, Stenzl A.","World J Urol. 2009 Jun;27(3):295-300. doi: 10.1007/s00345-009-0395-z. Epub 2009 Mar 7.","Sievert KD","World J Urol","2009","2009/03/10","PMC2694315","","10.1007/s00345-009-0395-z"
"26612221","Diagnosis of Bladder Carcinoma: A Clinician's Perspective","Harshman LC, Preston MA, Bellmunt J, Beard C.","Surg Pathol Clin. 2015 Dec;8(4):677-85. doi: 10.1016/j.path.2015.07.004.","Harshman LC","Surg Pathol Clin","2015","2015/11/28","","","10.1016/j.path.2015.07.004"
"26614029","Emerging Bladder Cancer Biomarkers and Targets of Therapy","Netto GJ, Tafe LJ.","Urol Clin North Am. 2016 Feb;43(1):63-76. doi: 10.1016/j.ucl.2015.08.006.","Netto GJ","Urol Clin North Am","2016","2015/11/29","","","10.1016/j.ucl.2015.08.006"
"12478116","Contemporary concepts of radical cystectomy and the treatment of bladder cancer","Stein JP.","J Urol. 2003 Jan;169(1):116-7. doi: 10.1097/01.ju.0000042054.84500.10.","Stein JP","J Urol","2003","2002/12/13","","","10.1097/01.ju.0000042054.84500.10"
"24761840","Bladder cancer biomarkers: review and update","Ghafouri-Fard S, Nekoohesh L, Motevaseli E.","Asian Pac J Cancer Prev. 2014;15(6):2395-403. doi: 10.7314/apjcp.2014.15.6.2395.","Ghafouri-Fard S","Asian Pac J Cancer Prev","2014","2014/04/26","","","10.7314/apjcp.2014.15.6.2395"
"17962138","Bacillus Calmette-Guerin and bladder cancer","Razack AH.","Asian J Surg. 2007 Oct;30(4):302-9. doi: 10.1016/S1015-9584(08)60045-7.","Razack AH","Asian J Surg","2007","2007/10/27","","","10.1016/S1015-9584(08)60045-7"
"17382794","Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard","Raj GV, Bochner BH.","Semin Oncol. 2007 Apr;34(2):110-21. doi: 10.1053/j.seminoncol.2006.12.011.","Raj GV","Semin Oncol","2007","2007/03/27","","","10.1053/j.seminoncol.2006.12.011"
"16430078","Adjuvant radiation therapy for muscle-invasive bladder cancer","Zaghloul MS.","Tunis Med. 2005 Dec;83 Suppl 12:92-3.","Zaghloul MS","Tunis Med","2005","2006/01/25","","",""
"18304401","Bladder cancer in Africa","Heyns CF, van der Merwe A.","Can J Urol. 2008 Feb;15(1):3899-908.","Heyns CF","Can J Urol","2008","2008/02/29","","",""
"28187437","Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure","Dong F, Xu T, Shen Y, Zhong S, Chen S, Ding Q, Shen Z.","Oncotarget. 2017 Apr 18;8(16):27547-27568. doi: 10.18632/oncotarget.15173.","Dong F","Oncotarget","2017","2017/02/11","PMC5432357","","10.18632/oncotarget.15173"
"18702779","T1 G3 bladder cancer","Fitzpatrick JM.","BJU Int. 2008 Aug;102(3):i. doi: 10.1111/j.1464-410X.2008.07833.x.","Fitzpatrick JM","BJU Int","2008","2008/08/16","","","10.1111/j.1464-410X.2008.07833.x"
"6677965","[Radiotherapy of bladder cancer in an advanced stage]","Gardani G, Volterrani F.","Radiol Med. 1983 Nov;69(11):876-7.","Gardani G","Radiol Med","1983","1983/11/01","","",""
"21308672","[Diagnosis and treatment of octogenarian neoplastic patients: bladder cancers]","Destefanis P, Bisconti A, Lasaponara F, Fontana D.","Urologia. 2010 Oct-Dec;77 Suppl 17:32-7.","Destefanis P","Urologia","2010","2011/02/11","","",""
"19198028","Bladder cancer-from pathogenesis to prevention, 2008. Proceedings of an international consultation organized by the WHO Collaborating Center for Urologic Tumors. April 24-25, 2008. Stockholm, Sweden","","Scand J Urol Nephrol Suppl. 2008 Sep;(218):5-233.","","Scand J Urol Nephrol Suppl","2008","2009/02/07","","",""
"16892552","[Multiprobe FISH for enhanced prediction of recurrent bladder cancer]","Zellweger T, Benz G, Herzog M, Grilli B, Mihatsch MJ, Gasser TC, Bubendorf L.","Verh Dtsch Ges Pathol. 2004;88:194-8.","Zellweger T","Verh Dtsch Ges Pathol","2004","2006/08/09","","",""
"9134600","Summary of preoperative irradiation and cystectomy for bladder cancer (by Joseph A. Smith, Jr, MD, Mostafa Batata, MD, Harry Grabstald, MD, Pramod C. Sogani, MD, Harry Herr, MD, and Willet F. Whitmore, Jr, MD). 1982","Smith JA Jr, Fowler JE Jr, Ghoneim MA.","Semin Urol Oncol. 1997 May;15(2):86-93.","Smith JA Jr","Semin Urol Oncol","1997","1997/05/11","","",""
"7317747","The correlation of T1 bladder tumour history with prognosis and follow-up requirements","England HR, Paris AM, Blandy JP.","Br J Urol. 1981 Dec;53(6):593-7. doi: 10.1111/j.1464-410x.1981.tb03268.x.","England HR","Br J Urol","1981","1981/12/01","","","10.1111/j.1464-410x.1981.tb03268.x"
"2618183","[Studies of tryptophan metabolism in cancer of the urinary bladder]","Wich H, Grimm U, Knapp A.","Z Urol Nephrol. 1989 Nov;82(11):593-6.","Wich H","Z Urol Nephrol","1989","1989/11/01","","",""
"11069396","Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy","Duggan B, Kelly J, Keane PF, Williamson K, Johnston SR.","BJU Int. 2000 Oct;86(6):757. doi: 10.1046/j.1464-410x.2000.00895-6.x.","Duggan B","BJU Int","2000","2000/11/09","","","10.1046/j.1464-410x.2000.00895-6.x"
"3809183","Prognostic factors in superficial bladder cancer","Aso Y, Anderson L, Soloway M, Bouffioux C, Chisholm G, Debruyne F, Kawai T, Kurth KH, Maru A, Straffon WG.","Prog Clin Biol Res. 1986;221:257-69.","Aso Y","Prog Clin Biol Res","1986","1986/01/01","","",""
"104306","Multi-modal treatment of deep infiltrating (T3) bladder cancer","Bloom HJ.","Prog Clin Biol Res. 1978;25:117-34.","Bloom HJ","Prog Clin Biol Res","1978","1978/01/01","","",""
"31781871","Imaging in Localized Bladder Cancer: Can Current Diagnostic Modalities Provide Accurate Local Tumor Staging?","Gurram S, Muthigi A, Egan J, Stamatakis L.","Curr Urol Rep. 2019 Nov 28;20(12):82. doi: 10.1007/s11934-019-0948-7.","Gurram S","Curr Urol Rep","2019","2019/11/30","","","10.1007/s11934-019-0948-7"
"11342938","Tripe palms and malignant acanthosis nigricans: cutaneous signs of imminent metastasis in bladder cancer?","Möhrenschlager M, Vocks E, Wessner DB, Nährig J, Ring J.","J Urol. 2001 May;165(5):1629-30. doi: 10.1016/s0022-5347(05)66369-0.","Möhrenschlager M","J Urol","2001","2001/05/09","","","10.1016/s0022-5347(05)66369-0"
"21989305","Urothelial carcinoma of the bladder: definition, treatment and future efforts","Prasad SM, Decastro GJ, Steinberg GD; Medscape.","Nat Rev Urol. 2011 Oct 11;8(11):631-42. doi: 10.1038/nrurol.2011.144.","Prasad SM","Nat Rev Urol","2011","2011/10/13","","","10.1038/nrurol.2011.144"
"3971103","Invasive bladder cancer treated by radical external radiotherapy","Corcoran MO, Thomas DM, Lim A, Berry RJ, Milroy EJ.","Br J Urol. 1985 Feb;57(1):40-2. doi: 10.1111/j.1464-410x.1985.tb08981.x.","Corcoran MO","Br J Urol","1985","1985/02/01","","","10.1111/j.1464-410x.1985.tb08981.x"
"21929755","The association of fish consumption with bladder cancer risk: a meta-analysis","Li Z, Yu J, Miao Q, Sun S, Sun L, Yang H, Hou L.","World J Surg Oncol. 2011 Sep 19;9:107. doi: 10.1186/1477-7819-9-107.","Li Z","World J Surg Oncol","2011","2011/09/21","PMC3182909","","10.1186/1477-7819-9-107"
"26938350","Prognosis of node-positive bladder cancer in 2016","VAN Bruwaene S, Costello AJ, VAN Poppel H.","Minerva Urol Nefrol. 2016 Apr;68(2):125-37. Epub 2016 Mar 3.","VAN Bruwaene S","Minerva Urol Nefrol","2016","2016/03/04","","",""
"1611116","Diagnosis and treatment of bladder cancer","Lamm DL.","Anticancer Drugs. 1992 May;3 Suppl 1:39-47. doi: 10.1097/00001813-199205000-00009.","Lamm DL","Anticancer Drugs","1992","1992/05/01","","","10.1097/00001813-199205000-00009"
"26977846","Natural biology and management of nonmuscle invasive bladder cancer","Scarpato KR, Tyson MD, Clark PE.","Curr Opin Oncol. 2016 May;28(3):210-5. doi: 10.1097/CCO.0000000000000278.","Scarpato KR","Curr Opin Oncol","2016","2016/03/16","PMC5390683","NIHMS854356","10.1097/CCO.0000000000000278"
"3518238","[Possibility of evaluating the degree of dissemination of malignant tumors of the bladder using ultrasonic tomography]","Bal'ter SA, Matveev BP, Shipilov VI, Toktomushev AT, Mironova GT.","Vopr Onkol. 1986;32(4):46-52.","Bal'ter SA","Vopr Onkol","1986","1986/01/01","","",""
"16100784","[Three-dimentional echography in diagnosis and staging of urinary bladder cancer]","Mazo EB, Gazhonova VE, Chepurov DA.","Urologiia. 2005 May-Jun;(3):6-12.","Mazo EB","Urologiia","2005","2005/08/16","","",""
"8518224","The management of bladder cancer--a case history","Lydon AP, Harland SJ, Duchesne GM.","Ann Oncol. 1993 Apr;4(4):325-9. doi: 10.1093/oxfordjournals.annonc.a058493.","Lydon AP","Ann Oncol","1993","1993/04/01","","","10.1093/oxfordjournals.annonc.a058493"
"4810757","Immune response in bladder cancer","Merrin C, Han T.","J Urol. 1974 Feb;111(2):170-2. doi: 10.1016/s0022-5347(17)59918-8.","Merrin C","J Urol","1974","1974/02/01","","","10.1016/s0022-5347(17)59918-8"
"8173377","Superficial bladder cancer","Hall RR.","BMJ. 1994 Apr 2;308(6933):910-3. doi: 10.1136/bmj.308.6933.910.","Hall RR","BMJ","1994","1994/04/02","PMC2539828","","10.1136/bmj.308.6933.910"
"28535714","Non-muscle-invasive bladder cancer: a vision for the future","Malmström PU, Agrawal S, Bläckberg M, Boström PJ, Malavaud B, Zaak D, Hermann GG.","Scand J Urol. 2017 Apr;51(2):87-94. doi: 10.1080/21681805.2017.1283359. Epub 2017 Feb 7.","Malmström PU","Scand J Urol","2017","2017/05/25","","","10.1080/21681805.2017.1283359"
"16238136","A second look at the pT1 G3 bladder tumour","Harland SJ.","Clin Oncol (R Coll Radiol). 2005 Oct;17(7):498-502. doi: 10.1016/j.clon.2005.07.005.","Harland SJ","Clin Oncol (R Coll Radiol)","2005","2005/10/22","","","10.1016/j.clon.2005.07.005"
"6677964","[Postoperative radiotherapy in the management of bladder cancer]","Cosentino D.","Radiol Med. 1983 Nov;69(11):876.","Cosentino D","Radiol Med","1983","1983/11/01","","",""
"8632486","DNA test for bladder cancer hits a high mark","McNeil C.","J Natl Cancer Inst. 1996 Feb 21;88(3-4):146-7. doi: 10.1093/jnci/88.3-4.146.","McNeil C","J Natl Cancer Inst","1996","1996/02/21","","","10.1093/jnci/88.3-4.146"
"2683311","Transabdominal ultrasound surveillance for bladder cancer","Malone PR.","Urol Clin North Am. 1989 Nov;16(4):823-7.","Malone PR","Urol Clin North Am","1989","1989/11/01","","",""
"25895759","Re: Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link","Chang SS.","J Urol. 2015 May;193(5):1517. doi: 10.1016/j.juro.2015.02.027. Epub 2015 Feb 10.","Chang SS","J Urol","2015","2015/04/22","","","10.1016/j.juro.2015.02.027"
"18231740","Expression and significance of Oct4 in bladder cancer","Xu K, Zhu Z, Zeng F.","J Huazhong Univ Sci Technolog Med Sci. 2007 Dec;27(6):675-7. doi: 10.1007/s11596-007-0614-z.","Xu K","J Huazhong Univ Sci Technolog Med Sci","2007","2008/01/31","","","10.1007/s11596-007-0614-z"
"28328186","Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: Yes","Monteiro LL, Kassouf W.","Int Braz J Urol. 2017 Mar-Apr;43(2):184-187. doi: 10.1590/S1677-5538.IBJU.2017.02.03.","Monteiro LL","Int Braz J Urol","2017","2017/03/23","PMC5433354","","10.1590/S1677-5538.IBJU.2017.02.03"
"4102118","[Role of radiotherapy in treatment of bladder cancer]","Madore PR.","Laval Med. 1970 Jan;41(1):46-9.","Madore PR","Laval Med","1970","1970/01/01","","",""
"27326407","How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?","Yun SJ, Kim SK, Kim WJ.","Investig Clin Urol. 2016 Jun;57 Suppl 1(Suppl 1):S44-51. doi: 10.4111/icu.2016.57.S1.S44. Epub 2016 Jun 10.","Yun SJ","Investig Clin Urol","2016","2016/06/22","PMC4910762","","10.4111/icu.2016.57.S1.S44"
"19012504","Novel therapeutics in metastatic bladder cancer","Lekas A, Papathomas TG, Papatsoris AG, Deliveliotis C, Lazaris AC.","Expert Opin Investig Drugs. 2008 Dec;17(12):1889-99. doi: 10.1517/13543780802514195.","Lekas A","Expert Opin Investig Drugs","2008","2008/11/18","","","10.1517/13543780802514195"
"22164416","[The fluorescent hybridization in situ as applied in diagnostics of urinary bladder cancer]","Savostikova MV, Volchenko NN, Rusakov IG, Borisova OV, Golovashchenko MP.","Klin Lab Diagn. 2011 Aug;(8):38-40.","Savostikova MV","Klin Lab Diagn","2011","2011/12/15","","",""
"194686","Cause and prevention of bladder cancer","Rapp F.","Cancer Res. 1977 Aug;37(8 Pt 2):2937-8.","Rapp F","Cancer Res","1977","1977/08/01","","",""
"1498153","Bladder cancer","Ozen H.","Curr Opin Oncol. 1992 Jun;4(3):435-41. doi: 10.1097/00001622-199206000-00003.","Ozen H","Curr Opin Oncol","1992","1992/06/01","","","10.1097/00001622-199206000-00003"
"30128829","Molecular Subtypes of Bladder Cancer","McConkey DJ, Choi W.","Curr Oncol Rep. 2018 Aug 20;20(10):77. doi: 10.1007/s11912-018-0727-5.","McConkey DJ","Curr Oncol Rep","2018","2018/08/22","","","10.1007/s11912-018-0727-5"
"4943402","[Surgical treatment possibilities in bladder cancer]","Staehler W.","Wien Med Wochenschr. 1971 Nov 20;121(47):841-3.","Staehler W","Wien Med Wochenschr","1971","1971/11/20","","",""
"18005208","Why has the survival of patients with bladder cancer not improved?","Malmström PU.","BJU Int. 2008 Feb;101(3):267-9. doi: 10.1111/j.1464-410X.2007.07308.x. Epub 2007 Nov 13.","Malmström PU","BJU Int","2008","2007/11/17","","","10.1111/j.1464-410X.2007.07308.x"
"19467124","Local recurrence of bladder cancer occurring eight years after radical cystectomy","Kato S, Honma I, Tsukamoto T.","Int J Urol. 2009 May;16(5):532. doi: 10.1111/j.1442-2042.2009.02290.x.","Kato S","Int J Urol","2009","2009/05/27","","","10.1111/j.1442-2042.2009.02290.x"
"9812938","Bladder cancer","van der Meijden AP.","BMJ. 1998 Nov 14;317(7169):1366-9. doi: 10.1136/bmj.317.7169.1366.","van der Meijden AP","BMJ","1998","1998/11/13","PMC1114251","","10.1136/bmj.317.7169.1366"
"28982750","Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology","Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, Downs TM, Efstathiou JA, Flaig TW, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Sonpavde G, Tward J, Wile G, Dwyer MA, Gurski LA.","J Natl Compr Canc Netw. 2017 Oct;15(10):1240-1267. doi: 10.6004/jnccn.2017.0156.","Spiess PE","J Natl Compr Canc Netw","2017","2017/10/07","","","10.6004/jnccn.2017.0156"
"18206545","Does Schistosoma-associated bladder cancer differ from urothelial cancer? Proof from the laboratory and clinic","Zaghloul MS.","Cancer Genet Cytogenet. 2008 Jan 15;180(2):160-2. doi: 10.1016/j.cancergencyto.2007.10.014.","Zaghloul MS","Cancer Genet Cytogenet","2008","2008/01/22","","","10.1016/j.cancergencyto.2007.10.014"
"17208141","A rationale for developing benchmarks for the treatment of muscle-invasive bladder cancer","Lee CT.","Urol Oncol. 2007 Jan-Feb;25(1):57-65. doi: 10.1016/j.urolonc.2006.05.009.","Lee CT","Urol Oncol","2007","2007/01/09","","","10.1016/j.urolonc.2006.05.009"
"7057695","[Treatment of locally spread forms of bladder cancer]","Berezhnov IP, Nechiporenko NA, Kopaev AM.","Med Radiol (Mosk). 1982 Jan;27(1):53-5.","Berezhnov IP","Med Radiol (Mosk)","1982","1982/01/01","","",""
"18977070","Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer","Calabrò F, Sternberg CN.","Eur Urol. 2009 Feb;55(2):348-58. doi: 10.1016/j.eururo.2008.10.016. Epub 2008 Oct 16.","Calabrò F","Eur Urol","2009","2008/11/04","","","10.1016/j.eururo.2008.10.016"
"28328187","Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: No","Mitin T.","Int Braz J Urol. 2017 Mar-Apr;43(2):188-191. doi: 10.1590/S1677-5538.IBJU.2017.02.04.","Mitin T","Int Braz J Urol","2017","2017/03/23","PMC5433355","","10.1590/S1677-5538.IBJU.2017.02.04"
"9772870","Bladder preservation in muscle-invasive bladder cancer","Stackl W, Baierlein M, Albrecht W.","Br J Urol. 1998 Sep;82(3):357-60. doi: 10.1046/j.1464-410x.1998.00750.x.","Stackl W","Br J Urol","1998","1998/10/17","","","10.1046/j.1464-410x.1998.00750.x"
"877114","Two aspects of the epidemiology of bladder cancer in England and Wales","Davies JM.","Proc R Soc Med. 1977 Jun;70(6):411-3.","Davies JM","Proc R Soc Med","1977","1977/06/01","PMC1543169","",""
"6128635","Acetylator phenotype in bladder cancer","Miller ME.","Lancet. 1982 Dec 11;2(8311):1348. doi: 10.1016/s0140-6736(82)91554-9.","Miller ME","Lancet","1982","1982/12/11","","","10.1016/s0140-6736(82)91554-9"
"5014249","Bladder cancer and smoking","","Br Med J. 1972 Mar 25;1(5803):763.","","Br Med J","1972","1972/03/25","PMC1787707","",""
"30168122","Molecular Prognostication in Bladder Cancer","Mitra AP, Daneshmand S.","Cancer Treat Res. 2018;175:165-191. doi: 10.1007/978-3-319-93339-9_8.","Mitra AP","Cancer Treat Res","2018","2018/09/01","","","10.1007/978-3-319-93339-9_8"
"23479428","Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests","Goodison S, Rosser CJ, Urquidi V.","Mol Diagn Ther. 2013 Apr;17(2):71-84. doi: 10.1007/s40291-013-0023-x.","Goodison S","Mol Diagn Ther","2013","2013/03/13","PMC3627848","","10.1007/s40291-013-0023-x"
"9749079","[Role of radiotherapy in cancer of the bladder in Saguenay-Lac Saint-Jean]","Brochet F, Barrette LR.","Cancer Radiother. 1998 Apr;2 Suppl 1:49s-53s.","Brochet F","Cancer Radiother","1998","1998/09/28","","",""
"14693275","Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder","Raghavan D.","Urol Oncol. 2003 Nov-Dec;21(6):468-74. doi: 10.1016/s1078-1439(03)00145-5.","Raghavan D","Urol Oncol","2003","2003/12/25","","","10.1016/s1078-1439(03)00145-5"
"21930087","Metabolomics and bladder cancer","Hyndman ME, Mullins JK, Bivalacqua TJ.","Urol Oncol. 2011 Sep-Oct;29(5):558-61. doi: 10.1016/j.urolonc.2011.05.014.","Hyndman ME","Urol Oncol","2011","2011/09/21","","","10.1016/j.urolonc.2011.05.014"
"25388527","Metabonomic profiling of bladder cancer","Chan EC, Pasikanti KK, Hong Y, Ho PC, Mahendran R, Raman Nee Mani L, Chiong E, Esuvaranathan K.","J Proteome Res. 2015 Feb 6;14(2):587-602. doi: 10.1021/pr500966h. Epub 2014 Nov 26.","Chan EC","J Proteome Res","2015","2014/11/13","","","10.1021/pr500966h"
"32366441","Whole-bladder Radiation Therapy for Lymph Node-negative Bladder Cancer With Muscle Invasion in Elderly Patients","Adachi A, Kawamura H, Yoshida D, Kawahara M, Kudo S, Ebara T, Nakano T.","Anticancer Res. 2020 May;40(5):2905-2909. doi: 10.21873/anticanres.14267.","Adachi A","Anticancer Res","2020","2020/05/06","","","10.21873/anticanres.14267"
"3851012","[Pre- and postoperative nursing of patients with bladder cancer. Site marking for urostomy]","Omura Y.","Kango Gijutsu. 1985 Aug;31(11):1448-53.","Omura Y","Kango Gijutsu","1985","1985/08/01","","",""
"23033286","Elective bladder preservation with multimodality treatment for bladder cancer","Mayadagli A, Kocak M, Demir O, Karabulut Gul S, Ozkan A, Parlak C, Yaprak G, Gumus M.","J BUON. 2012 Jul-Sep;17(3):483-9.","Mayadagli A","J BUON","2012","2012/10/04","","",""
"15185969","Incidence of bladder cancer discovered by urethrocystoscopy at prostate biopsy: extraordinary high incidence of tiny bladder cancer in elderly males","Okazaki H, Suzuki K, Suzuki T, Kurokawa K, Ito K, Suzuki K, Yamanaka H.","Tohoku J Exp Med. 2004 May;203(1):31-6. doi: 10.1620/tjem.203.31.","Okazaki H","Tohoku J Exp Med","2004","2004/06/10","","","10.1620/tjem.203.31"
"4049625","Importance of urinary cytology and future role of flow cytometry","Dean PJ, Murphy WM.","Urology. 1985 Oct;26(4 Suppl):11-5.","Dean PJ","Urology","1985","1985/10/01","","",""
"22466574","Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer","Jobu K, Sun C, Yoshioka S, Yokota J, Onogawa M, Kawada C, Inoue K, Shuin T, Sendo T, Miyamura M.","Biol Pharm Bull. 2012;35(4):639-42. doi: 10.1248/bpb.35.639.","Jobu K","Biol Pharm Bull","2012","2012/04/03","","","10.1248/bpb.35.639"
"19235178","Lymph node assessment and lymphadenectomy in bladder cancer","Sharir S, Fleshner NE.","J Surg Oncol. 2009 Mar 15;99(4):225-31. doi: 10.1002/jso.21253.","Sharir S","J Surg Oncol","2009","2009/02/24","","","10.1002/jso.21253"
"17225686","[Bladder cancer: understanding the disease and future implications for assessment and therapy]","Droller M.","Rev Med Suisse. 2006 Dec 6;2(90):2776-8, 2781-2, 2784.","Droller M","Rev Med Suisse","2006","2007/01/18","","",""
"11832772","p53 and microvessel density in primary resection specimens of superficial bladder cancer","Reiher F, Ozer O, Pins M, Jovanovic BD, Eggener S, Campbell SC.","J Urol. 2002 Mar;167(3):1469-74.","Reiher F","J Urol","2002","2002/02/08","","",""
"30806832","Clinical and Genomic Considerations for Variant Histology in Bladder Cancer","Matulay JT, Narayan VM, Kamat AM.","Curr Oncol Rep. 2019 Feb 26;21(3):23. doi: 10.1007/s11912-019-0772-8.","Matulay JT","Curr Oncol Rep","2019","2019/02/27","","","10.1007/s11912-019-0772-8"
"1016831","The value of lymphography in the management of bladder cancer","Turner AG, Hendrg WF, MacDonald JS, Wallace DM.","Br J Urol. 1976;48(7):579-86. doi: 10.1111/j.1464-410x.1976.tb06704.x.","Turner AG","Br J Urol","1976","1976/01/01","","","10.1111/j.1464-410x.1976.tb06704.x"
"6506374","Intraoperative radiation therapy for bladder cancer","Martinez A, Gunderson LL.","Urol Clin North Am. 1984 Nov;11(4):693-8.","Martinez A","Urol Clin North Am","1984","1984/11/01","","",""
"1306098","Epidemiological models of carcinogenesis: the example of bladder cancer","Vineis P.","Cancer Epidemiol Biomarkers Prev. 1992 Jan-Feb;1(2):149-53.","Vineis P","Cancer Epidemiol Biomarkers Prev","1992","1992/01/01","","",""
"19107438","Molecular epidemiology of DNA repair genes in bladder cancer","Kiltie AE.","Methods Mol Biol. 2009;472:281-306. doi: 10.1007/978-1-60327-492-0_12.","Kiltie AE","Methods Mol Biol","2009","2008/12/25","","","10.1007/978-1-60327-492-0_12"
"21932129","BCG response prediction with cytokine gene variants and bladder cancer: where we are?","Ahirwar DK, Manchanda PK, Mittal RD, Bid HK.","J Cancer Res Clin Oncol. 2011 Dec;137(12):1729-38. doi: 10.1007/s00432-011-1056-3. Epub 2011 Sep 20.","Ahirwar DK","J Cancer Res Clin Oncol","2011","2011/09/21","","","10.1007/s00432-011-1056-3"
"12536942","[Bladder cancer. Clinical cases]","Zerbib M, Bouchot O.","Prog Urol. 2002 Nov;12(5):1167-78.","Zerbib M","Prog Urol","2002","2003/01/23","","",""
"18300553","[Modern diagnosis of bladder cancer]","Denzinger S, Wieland WF, Otto W.","MMW Fortschr Med. 2008 Jan 31;150(5):36-9; quiz 41. doi: 10.1007/BF03365318.","Denzinger S","MMW Fortschr Med","2008","2008/02/28","","","10.1007/BF03365318"
"617918","Eight years of experience with preoperative angiographic and lymphographic staging of bladder cancer","Winterberger AR, Wajsman Z, Merrin C, Murphy GP.","Trans Am Assoc Genitourin Surg. 1977;69:92-6.","Winterberger AR","Trans Am Assoc Genitourin Surg","1977","1977/01/01","","",""
"10411098","Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of radiation therapy oncology group 89-03","","J Urol. 1999 Aug;162(2):623-4. doi: 10.1016/s0022-5347(05)68645-4.","","J Urol","1999","1999/07/20","","","10.1016/s0022-5347(05)68645-4"
"30281357","Bladder cancer: an overview of treatments","Jose S.","Br J Nurs. 2018 Oct 4;27(18):S28-S30. doi: 10.12968/bjon.2018.27.18.S28.","Jose S","Br J Nurs","2018","2018/10/04","","","10.12968/bjon.2018.27.18.S28"
"9112496","Is there a role for radiation therapy in the treatment of invasive bladder cancer?","Wajsman Z.","J Urol. 1997 May;157(5):1647-8. doi: 10.1016/s0022-5347(01)64820-1.","Wajsman Z","J Urol","1997","1997/05/01","","","10.1016/s0022-5347(01)64820-1"
"1157033","Carcinoma of the bladder T3NxMo treated by preoperative irradiation followed by cystectomy","van der Werf-Messing BH.","Cancer. 1975 Aug;36(2):718-22. doi: 10.1002/1097-0142(197508)36:2+<718::aid-cncr2820360816>3.0.co;2-n.","van der Werf-Messing BH","Cancer","1975","1975/08/01","","","10.1002/1097-0142(197508)36:2+<718::aid-cncr2820360816>3.0.co;2-n"
"27542252","A greater number of dissected lymph nodes is associated with more favorable outcomes in bladder cancer treated by radical cystectomy: a meta-analysis","Li F, Hong X, Hou L, Lin F, Chen P, Pang S, Du Y, Huang H, Tan W.","Oncotarget. 2016 Sep 20;7(38):61284-61294. doi: 10.18632/oncotarget.11343.","Li F","Oncotarget","2016","2016/08/20","PMC5308651","","10.18632/oncotarget.11343"
"621812","Evaluation of bladder washing cytology for bladder cancer surveillance","Flanagan MJ, Miller A 3rd.","J Urol. 1978 Jan;119(1):42-3. doi: 10.1016/s0022-5347(17)57376-0.","Flanagan MJ","J Urol","1978","1978/01/01","","","10.1016/s0022-5347(17)57376-0"
"1301569","The natural history and the prognosis of treated superficial bladder cancer. EORTC GU Group","Kurth K, Denis L, Sylvester R, de Pauw M.","Prog Clin Biol Res. 1992;378:1-7.","Kurth K","Prog Clin Biol Res","1992","1992/01/01","","",""
"4966065","A followup study of supervoltage irradiation followed by cystectomy for bladder cancer","Galleher EP Jr, Young JD Jr, Mowad JJ, Wizenberg MJ, Bloedorn FG.","J Urol. 1968 Jan;99(1):59-64. doi: 10.1016/s0022-5347(17)62642-9.","Galleher EP Jr","J Urol","1968","1968/01/01","","","10.1016/s0022-5347(17)62642-9"
"21257257","Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy","Feifer AH, Taylor JM, Tarin TV, Herr HW.","Eur Urol. 2011 Jun;59(6):978-84. doi: 10.1016/j.eururo.2011.01.014. Epub 2011 Jan 18.","Feifer AH","Eur Urol","2011","2011/01/25","PMC3137649","NIHMS297489","10.1016/j.eururo.2011.01.014"
"21627749","Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer","Schneider AC, Heukamp LC, Rogenhofer S, Fechner G, Bastian PJ, von Ruecker A, Müller SC, Ellinger J.","BJU Int. 2011 Oct;108(8 Pt 2):E290-6. doi: 10.1111/j.1464-410X.2011.10203.x. Epub 2011 May 31.","Schneider AC","BJU Int","2011","2011/06/02","","","10.1111/j.1464-410X.2011.10203.x"
"3809180","Surgical techniques in invasive bladder cancer","Sonoda T, Debruyne FM, Prout GR Jr, Matsuda M, Blandy JP, Hohenfellner R, Keuppens F, Matsumoto K, Ogata J, Whitmore WF Jr.","Prog Clin Biol Res. 1986;221:133-48.","Sonoda T","Prog Clin Biol Res","1986","1986/01/01","","",""
"17127293","Genetic polymorphism in bladder cancer","Wu X, Lin X, Dinney CP, Gu J, Grossman HB.","Front Biosci. 2007 Jan 1;12:192-213. doi: 10.2741/2058.","Wu X","Front Biosci","2007","2006/11/28","","","10.2741/2058"
"22329192","Challenges in the modern treatment of muscle-invasive bladder cancer","Skinner EC.","Oncology (Williston Park). 2011 Dec;25(14):1405-6.","Skinner EC","Oncology (Williston Park)","2011","2012/02/15","","",""
"17382715","Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer","Weizer AZ, Joshi D, Daignault S, Kinnaman M, Hussain M, Montie JE, Zhang Y, Lee CT.","J Urol. 2007 Apr;177(4):1287-93. doi: 10.1016/j.juro.2006.11.060.","Weizer AZ","J Urol","2007","2007/03/27","","","10.1016/j.juro.2006.11.060"
"1991684","Keynote address: a critical assessment of trials of neoadjuvant (preemptive) chemotherapy for bladder cancer: lesson for future studies of combined modality treatment","Raghavan D.","Int J Radiat Oncol Biol Phys. 1991 Feb;20(2):233-7. doi: 10.1016/0360-3016(91)90096-m.","Raghavan D","Int J Radiat Oncol Biol Phys","1991","1991/02/01","","","10.1016/0360-3016(91)90096-m"
"9749069","[Prognostic factors of infiltrating tumors of the bladder]","Maulard-Durdux C, Housset M.","Cancer Radiother. 1998 Apr;2 Suppl 1:5s-11s.","Maulard-Durdux C","Cancer Radiother","1998","1998/09/28","","",""
"9263833","Report on radiotherapy for bladder cancer during surgery","Mao Y.","Front Radiat Ther Oncol. 1997;31:247-9. doi: 10.1159/000061126.","Mao Y","Front Radiat Ther Oncol","1997","1997/01/01","","","10.1159/000061126"
"6746353","Computed tomography in the management of bladder carcinoma","Giri PG, Walsh JW, Hazra TA.","Int J Radiat Oncol Biol Phys. 1984 Jul;10(7):1121-5. doi: 10.1016/0360-3016(84)90186-x.","Giri PG","Int J Radiat Oncol Biol Phys","1984","1984/07/01","","","10.1016/0360-3016(84)90186-x"
"12887464","Surgical factors in bladder cancer: more (nodes) + more (pathology) = less (mortality)","Herr HW.","BJU Int. 2003 Aug;92(3):187-8. doi: 10.1046/j.1464-410x.2003.04334.x.","Herr HW","BJU Int","2003","2003/07/31","","","10.1046/j.1464-410x.2003.04334.x"
"5788245","Bladder cancer: an evaluation of diagnosis and treatment of 93 patients","Brown HM, Elliot JS.","J Urol. 1969 Jul;102(1):63-6. doi: 10.1016/s0022-5347(17)62074-3.","Brown HM","J Urol","1969","1969/07/01","","","10.1016/s0022-5347(17)62074-3"
"22329193","Bladder cancer treatment: optimize, don't compromise","Bochner BH, Laudone VP.","Oncology (Williston Park). 2011 Dec;25(14):1412-3.","Bochner BH","Oncology (Williston Park)","2011","2012/02/15","","",""
"1395418","Staging bladder cancer","Husband JE.","Clin Radiol. 1992 Sep;46(3):153-9. doi: 10.1016/s0009-9260(05)80436-2.","Husband JE","Clin Radiol","1992","1992/09/01","","","10.1016/s0009-9260(05)80436-2"
"1921013","[A study of BBN induced bladder cancer in mice. The time differences in changes of histopathology and nuclear DNA content]","Saito B.","Nihon Hinyokika Gakkai Zasshi. 1991 Aug;82(8):1206-10. doi: 10.5980/jpnjurol1989.82.1206.","Saito B","Nihon Hinyokika Gakkai Zasshi","1991","1991/08/01","","","10.5980/jpnjurol1989.82.1206"
"5397618","Urinary lactic dehydrogenase activity as a diagnostic test for detection of bilharzial bladder cancer","Wassef SA, Abdel Sayed W, Mohran Y, Bassily S, Abdel Ghaffar Y.","J Egypt Med Assoc. 1969 Apr;52(4):274-83.","Wassef SA","J Egypt Med Assoc","1969","1969/04/01","","",""
"1556054","The role of flow cytometry in the management of bladder cancer","Walther PJ.","Hematol Oncol Clin North Am. 1992 Feb;6(1):81-98.","Walther PJ","Hematol Oncol Clin North Am","1992","1992/02/01","","",""
"31071350","Preventable Cancer Deaths Associated with Bladder Preservation for Muscle Invasive Bladder Cancer","Herr H.","Urology. 2019 Aug;130:20-21. doi: 10.1016/j.urology.2019.04.032. Epub 2019 May 7.","Herr H","Urology","2019","2019/05/10","","","10.1016/j.urology.2019.04.032"
"31372723","Non-muscle invasive bladder cancer (NMIBC): boiling arena and promissory future","Reis LO.","World J Urol. 2019 Oct;37(10):1999-2000. doi: 10.1007/s00345-019-02894-5.","Reis LO","World J Urol","2019","2019/08/03","","","10.1007/s00345-019-02894-5"
"19454472","Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up","Bellmunt J, Albiol S, Kataja V; ESMO Guidelines Working Group.","Ann Oncol. 2009 May;20 Suppl 4:79-80. doi: 10.1093/annonc/mdp136.","Bellmunt J","Ann Oncol","2009","2009/05/21","","","10.1093/annonc/mdp136"
"24887047","The burden of bladder cancer care: direct and indirect costs","Mossanen M, Gore JL.","Curr Opin Urol. 2014 Sep;24(5):487-91. doi: 10.1097/MOU.0000000000000078.","Mossanen M","Curr Opin Urol","2014","2014/06/03","","","10.1097/MOU.0000000000000078"
"30446799","Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories","Mossanen M, Wang Y, Szymaniak J, Tan WS, Huynh MJ, Preston MA, Trinh QD, Sonpavde G, Kibel AS, Chang SL.","World J Urol. 2019 Oct;37(10):2059-2065. doi: 10.1007/s00345-018-2550-x. Epub 2018 Nov 16.","Mossanen M","World J Urol","2019","2018/11/18","","","10.1007/s00345-018-2550-x"
"7370564","Prognostic importance of specific immunoreactivity in occupational bladder cancer","Kumar S, Taylor G, Wilson P, Hurst W.","Br Med J. 1980 Feb 23;280(6213):512-3. doi: 10.1136/bmj.280.6213.512.","Kumar S","Br Med J","1980","1980/02/23","PMC1601406","","10.1136/bmj.280.6213.512"
"18828023","Immunoscreening of urinary bladder cancer cDNA library and identification of potential tumor antigen","Chen L, Chen W, Zhao L, Yu HZ, Li X.","World J Urol. 2009 Feb;27(1):107-12. doi: 10.1007/s00345-008-0326-4. Epub 2008 Oct 1.","Chen L","World J Urol","2009","2008/10/02","","","10.1007/s00345-008-0326-4"
"6155618","[Bladder cancer; staging and treatment]","Essed E, Boon ME, Donker PJ.","Ned Tijdschr Geneeskd. 1980 May 17;124(20):786-92.","Essed E","Ned Tijdschr Geneeskd","1980","1980/05/17","","",""
"741295","Management of urinary bladder cancer","Fichardt T, Sandison AG.","S Afr Med J. 1978 Oct 28;54(18):731-40.","Fichardt T","S Afr Med J","1978","1978/10/28","","",""
"7992067","Platinum-based chemotherapy for bladder cancer","Waxman J, Wasan H.","Semin Oncol. 1994 Oct;21(5 Suppl 12):54-60.","Waxman J","Semin Oncol","1994","1994/10/01","","",""
"25836928","Molecular biology of bladder cancer","Martin-Doyle W, Kwiatkowski DJ.","Hematol Oncol Clin North Am. 2015 Apr;29(2):191-203, vii. doi: 10.1016/j.hoc.2014.10.002. Epub 2015 Jan 31.","Martin-Doyle W","Hematol Oncol Clin North Am","2015","2015/04/04","PMC4385194","NIHMS636692","10.1016/j.hoc.2014.10.002"
"22329191","Contemporary management of locally invasive bladder cancer","Dickstein RJ, Kamat AM.","Oncology (Williston Park). 2011 Dec;25(14):1396-405.","Dickstein RJ","Oncology (Williston Park)","2011","2012/02/15","","",""
"1637910","Options in the surgical treatment of bladder cancer","Klein EA.","J ET Nurs. 1992 Jul-Aug;19(4):122-5. doi: 10.1097/00152192-199207000-00006.","Klein EA","J ET Nurs","1992","1992/07/01","","","10.1097/00152192-199207000-00006"
"19819528","Evidence-based principles of bladder cancer and diet","Silberstein JL, Parsons JK.","Urology. 2010 Feb;75(2):340-6. doi: 10.1016/j.urology.2009.07.1260. Epub 2009 Oct 12.","Silberstein JL","Urology","2010","2009/10/13","","","10.1016/j.urology.2009.07.1260"
"12196896","Advanced bladder cancer...where are we now and where are we going?","Sarosdy MF, Machtens S.","World J Urol. 2002 Aug;20(3):143. doi: 10.1007/s00345-002-0274-3. Epub 2002 Jun 7.","Sarosdy MF","World J Urol","2002","2002/08/28","","","10.1007/s00345-002-0274-3"
"7427512","Bladder cancer as a prescribed industrial disease","Rushworth GE.","Br Med J. 1980 Oct 4;281(6245):942. doi: 10.1136/bmj.281.6245.942.","Rushworth GE","Br Med J","1980","1980/10/04","PMC1714193","","10.1136/bmj.281.6245.942"
"5383570","Progress in the treatment of bladder cancer with special reference to chemotherapy","Kaufman JJ.","Br J Urol. 1969 Oct;41(5):605.","Kaufman JJ","Br J Urol","1969","1969/10/01","","",""
"2217426","Pathology of bladder cancer: assessment of the primary lesion and response to therapy","Reuter VE.","Prog Clin Biol Res. 1990;353:45-56.","Reuter VE","Prog Clin Biol Res","1990","1990/01/01","","",""
"20085009","[Detection of bladder cancer in voided urine samples]","Thomas A, Renard I, Waltregny D.","Rev Med Liege. 2009;64 Spec No:9-14.","Thomas A","Rev Med Liege","2009","2010/01/21","","",""
"26329530","Disease map-based biomarker selection and pre-validation for bladder cancer diagnostic","De Paoli M, Perco P, Mühlberger I, Lukas A, Pandha H, Morgan R, Feng GJ, Marquette C.","Biomarkers. 2015;20(5):328-37. doi: 10.3109/1354750X.2015.1068867. Epub 2015 Jul 31.","De Paoli M","Biomarkers","2015","2015/09/03","","","10.3109/1354750X.2015.1068867"
"7005782","[Clinical diagnosis of bladder cancer]","Rübben H, Dahm HH, Lutzeyer W.","Onkologie. 1980 Oct;3(5):225-32. doi: 10.1159/000214799.","Rübben H","Onkologie","1980","1980/10/01","","","10.1159/000214799"
"11594211","[Radiotherapy of urothelial carcinomas of the urinary bladder]","Vacha P, Büttner H, Böhle A, Feyerabend T.","Urologe A. 2001 Sep;40(5):376-9. doi: 10.1007/s001200170023.","Vacha P","Urologe A","2001","2001/10/12","","","10.1007/s001200170023"
"20096175","Comprehensive surgical and chemotherapy treatment for invasive bladder cancer","Sánchez-Salas R, Duque Ruiz GI, Watson J, Rocha E, Barret E, Cathelineau X, Rozet F, Galiano M, Vallancien G.","Actas Urol Esp. 2009 Nov;33(10):1062-8. doi: 10.1016/s0210-4806(09)73182-1.","Sánchez-Salas R","Actas Urol Esp","2009","2010/01/26","","","10.1016/s0210-4806(09)73182-1"
"21061098","Metabolic profiling for the detection of bladder cancer","Van QN, Veenstra TD, Issaq HJ.","Curr Urol Rep. 2011 Feb;12(1):34-40. doi: 10.1007/s11934-010-0151-3.","Van QN","Curr Urol Rep","2011","2010/11/10","","","10.1007/s11934-010-0151-3"
"3191360","Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer","Jenkins BJ, Caulfield MJ, Fowler CG, Badenoch DF, Tiptaft RC, Paris AM, Hope-Stone HF, Oliver RT, Blandy JP.","Br J Urol. 1988 Oct;62(4):343-6. doi: 10.1111/j.1464-410x.1988.tb04362.x.","Jenkins BJ","Br J Urol","1988","1988/10/01","","","10.1111/j.1464-410x.1988.tb04362.x"
"25168459","Radical trimodality therapy for patients with locally advanced bladder cancer: The British Columbia Cancer Agency experience","Baxter E, Dennis K, Kollmannsberger C, Black P, Attwell A, Morris WJ, Tyldesley S.","Urol Oncol. 2015 Feb;33(2):66.e13-9. doi: 10.1016/j.urolonc.2014.07.009. Epub 2014 Aug 29.","Baxter E","Urol Oncol","2015","2014/08/30","","","10.1016/j.urolonc.2014.07.009"
"6237498","[Retroperitoneoscopy in diagnosis of lymphogenic metastases of bladder cancer]","Matveev BP, Shipilov VI, Ali-Zade AM.","Vopr Onkol. 1984;30(8):87-90.","Matveev BP","Vopr Onkol","1984","1984/01/01","","",""
"2096783","Selection of treatment for muscle infiltrating transitional cell bladder cancer","Whitmore WF.","Arch Esp Urol. 1990;43 Suppl 2:219-22.","Whitmore WF","Arch Esp Urol","1990","1990/01/01","","",""
"2218563","Staging of bladder cancer: is the tumor, node, metastasis system adequate?","Hall RR, Prout GR.","Semin Oncol. 1990 Oct;17(5):517-23.","Hall RR","Semin Oncol","1990","1990/10/01","","",""
"8879700","Management of invasive bladder cancer","Parker CC, Huddart RA.","Br J Hosp Med. 1996 Sep 4-17;56(5):213-8.","Parker CC","Br J Hosp Med","1996","1996/09/04","","",""
"3072748","Comparison of magnetic resonance imaging with computed tomography and intravesical ultrasound in staging bladder cancer","Salo JO, Kivisaari L, Lehtonen T.","Urol Radiol. 1988;10(4):167-72. doi: 10.1007/BF02926562.","Salo JO","Urol Radiol","1988","1988/01/01","","","10.1007/BF02926562"
"27896485","Biomarkers for precision medicine in bladder cancer","Kojima T, Kawai K, Miyazaki J, Nishiyama H.","Int J Clin Oncol. 2017 Apr;22(2):207-213. doi: 10.1007/s10147-016-1068-8. Epub 2016 Nov 29.","Kojima T","Int J Clin Oncol","2017","2016/11/30","","","10.1007/s10147-016-1068-8"
"18577983","Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties","Choueiri TK, Raghavan D.","Nat Clin Pract Oncol. 2008 Aug;5(8):444-54. doi: 10.1038/ncponc1159. Epub 2008 Jun 24.","Choueiri TK","Nat Clin Pract Oncol","2008","2008/06/26","","","10.1038/ncponc1159"
"7871625","[The intraoperative ultrasonic control of the radicalness of transurethral resection in bladder cancer]","Stepanov VN, Perel'man VM, Frank GA, Seregin AV.","Urol Nefrol (Mosk). 1994 Sep-Oct;(5):47-50.","Stepanov VN","Urol Nefrol (Mosk)","1994","1994/09/01","","",""
"3950777","Optimal management of asymptomatic workers at high risk of bladder cancer","Schulte PA, Ringen K, Hemstreet GP.","J Occup Med. 1986 Jan;28(1):13-7. doi: 10.1097/00043764-198601000-00006.","Schulte PA","J Occup Med","1986","1986/01/01","","","10.1097/00043764-198601000-00006"
"7005783","[Urinary cytology as a screening test for diagnosis of urinary bladder cancer]","de Voogt HJ.","Onkologie. 1980 Oct;3(5):233-7. doi: 10.1159/000214800.","de Voogt HJ","Onkologie","1980","1980/10/01","","","10.1159/000214800"
"28476846","Simplified Comorbidity Score and Eastern Cooperative Oncology Group Performance Score Predicts Survival in Patients Receiving Organ-preserving Treatment for Bladder Cancer","Manig L, Käsmann L, Janssen S, Schild SE, Rades D.","Anticancer Res. 2017 May;37(5):2693-2696. doi: 10.21873/anticanres.11618.","Manig L","Anticancer Res","2017","2017/05/07","","","10.21873/anticanres.11618"
"406040","The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A","","Cancer Res. 1977 Aug;37(8 Pt 2):2916-7.","","Cancer Res","1977","1977/08/01","","",""
"27712914","[Intravesical instillations in non-muscle-invasive bladder cancer (NMIBC). Prospects for thermochemotherapy]","Irani J.","Prog Urol. 2016 Nov;26(14):860-864. doi: 10.1016/j.purol.2016.09.057. Epub 2016 Oct 3.","Irani J","Prog Urol","2016","2016/10/08","","","10.1016/j.purol.2016.09.057"
"875216","Pre-cystectomy radiation for carcinoma of the bladder: 17-year experience","Galleher EP Jr, Young JD Jr, Campbell EW Jr, Wizenberg MJ, Jacobs JA, Millstein DI.","J Urol. 1977 Jul;118(1 Pt 2):179-83. doi: 10.1016/s0022-5347(17)57941-0.","Galleher EP Jr","J Urol","1977","1977/07/01","","","10.1016/s0022-5347(17)57941-0"
"30670040","Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature","Taarnhøj GA, Johansen C, Pappot H.","Health Qual Life Outcomes. 2019 Jan 22;17(1):20. doi: 10.1186/s12955-018-1077-6.","Taarnhøj GA","Health Qual Life Outcomes","2019","2019/01/24","PMC6341712","","10.1186/s12955-018-1077-6"
"11772325","Developing therapies for advanced bladder cancer","Akaza H.","Expert Opin Investig Drugs. 2002 Jan;11(1):109-15. doi: 10.1517/13543784.11.1.109.","Akaza H","Expert Opin Investig Drugs","2002","2002/01/05","","","10.1517/13543784.11.1.109"
"3700164","Factors influencing the prognosis in bladder cancer","Wijnmaalen A, van der Werf-Messing BH.","Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):559-65. doi: 10.1016/0360-3016(86)90063-5.","Wijnmaalen A","Int J Radiat Oncol Biol Phys","1986","1986/04/01","","","10.1016/0360-3016(86)90063-5"
"24432708","Urology and nephrology update: bladder and kidney cancer","Fiore DC, Fox CL.","FP Essent. 2014 Jan;416:26-9.","Fiore DC","FP Essent","2014","2014/01/18","","",""
"1877119","Interval report of a phase I-II study utilizing multiple modalities in the treatment of invasive bladder cancer. A bladder-sparing trial","Prout GR Jr, Shipley WU, Kaufman DS, Griffin PP, Heney NM.","Urol Clin North Am. 1991 Aug;18(3):547-54.","Prout GR Jr","Urol Clin North Am","1991","1991/08/11","","",""
"12731438","[Quality control plan for a primary bladder neoplastic process]","Marchal Escalona C, Padilla León M, García Penit J, Caballero Alcántara J.","Arch Esp Urol. 2003 Mar;56(2):125-31.","Marchal Escalona C","Arch Esp Urol","2003","2003/05/07","","",""
"11779714","Interphase fluorescence in-situ hybridization in the diagnosis of bladder cancer","Skacel M, Liou LS, Pettay JD, Tubbs RR.","Front Biosci. 2002 Jan 1;7:e27-32.","Skacel M","Front Biosci","2002","2002/01/10","","",""
"6504891","Preoperative irradiation with cystectomy for bladder cancer","Whitmore WF Jr.","Prog Clin Biol Res. 1984;162B:1-6.","Whitmore WF Jr","Prog Clin Biol Res","1984","1984/01/01","","",""
"7369877","New approaches to bladder cancer: individualized patient chemotherapy","Stanisic TH.","Ariz Med. 1980 Feb;37(2):89-90.","Stanisic TH","Ariz Med","1980","1980/02/01","","",""
"2675014","Bladder cancer with lymph node invasion: cystectomy or no cystectomy?","Richard F.","Prog Clin Biol Res. 1989;303:597-602.","Richard F","Prog Clin Biol Res","1989","1989/01/01","","",""
"20439033","BCAN Think Tank session 2: Molecular detection of bladder cancer: the path to progress","Robinson VL, Porter M, Messing E, Fradet Y, Kamat AM, Lotan Y.","Urol Oncol. 2010 May-Jun;28(3):334-7. doi: 10.1016/j.urolonc.2009.07.026.","Robinson VL","Urol Oncol","2010","2010/05/05","","","10.1016/j.urolonc.2009.07.026"
"10614978","Bladder cancer in women","Baniel J.","Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(6):399-404. doi: 10.1007/s001920050068.","Baniel J","Int Urogynecol J Pelvic Floor Dysfunct","1999","1999/12/30","","","10.1007/s001920050068"
"22331708","Molecular mechanisms in urinary bladder carcinogenesis","Volanis D, Papadopoulos G, Doumas K, Gkialas I, Delakas D.","J BUON. 2011 Oct-Dec;16(4):589-601.","Volanis D","J BUON","2011","2012/02/15","","",""
"31158107","Clinical implications of molecular subtyping in bladder cancer","Satyal U, Sikder RK, McConkey D, Plimack ER, Abbosh PH.","Curr Opin Urol. 2019 Jul;29(4):350-356. doi: 10.1097/MOU.0000000000000641.","Satyal U","Curr Opin Urol","2019","2019/06/04","PMC6681908","NIHMS1534089","10.1097/MOU.0000000000000641"
"8607627","[Prognostic factors in bladder cancer]","Kuroda M, Kotake T.","Gan To Kagaku Ryoho. 1995 Dec;22(14):2123-8.","Kuroda M","Gan To Kagaku Ryoho","1995","1995/12/01","","",""
"11173945","Evaluation of the BTA tests for the detection of bilharzial related bladder cancer: the Cairo experience","Khaled HM, Abdel-Salam I, Abdel-Gawad M, Metwally A, El-Demerdash S, El-Didi M, Morsi A, Ishak L.","Eur Urol. 2001 Jan;39(1):91-4. doi: 10.1159/000052418.","Khaled HM","Eur Urol","2001","2001/02/15","","","10.1159/000052418"
"28039717","TFPI-2 expression is decreased in bladder cancer and is related to apoptosis","Feng C, Ho Y, Sun C, Xia G, Ding Q, Gu B.","J BUON. 2016 Nov-Dec;21(6):1518-1523.","Feng C","J BUON","2016","2017/01/01","","",""
"19235431","Combined treatment with local thermo-chemotherapy for non muscle invasive bladder cancer. The present role in the light of acquired data and preliminary cumulative clinical experiences","Colombo R.","Arch Ital Urol Androl. 2008 Dec;80(4):149-56.","Colombo R","Arch Ital Urol Androl","2008","2009/02/25","","",""
"28247712","[Point somatic mutations in bladder cancer: key carcinogenesis events, diagnostic markers and therapeutic targets]","Mikhailenko DS, Nemtsova MV.","Urologiia. 2016 Feb;(1):100-105.","Mikhailenko DS","Urologiia","2016","2017/03/02","","",""
"16778475","Survivin: role in diagnosis, prognosis, and treatment of bladder cancer","Akhtar M, Gallagher L, Rohan S.","Adv Anat Pathol. 2006 May;13(3):122-6. doi: 10.1097/00125480-200605000-00003.","Akhtar M","Adv Anat Pathol","2006","2006/06/17","","","10.1097/00125480-200605000-00003"
"17492412","[Systemic oncological treatment of bladder cancer]","Meran JG, Kudlacek S, Beke D.","Wien Med Wochenschr. 2007;157(7-8):157-61. doi: 10.1007/s10354-007-0400-3.","Meran JG","Wien Med Wochenschr","2007","2007/05/12","","","10.1007/s10354-007-0400-3"
"30421072","Genomic classification and risk stratification of bladder cancer","Fantini D, Meeks JJ.","World J Urol. 2019 Sep;37(9):1751-1757. doi: 10.1007/s00345-018-2558-2. Epub 2018 Nov 12.","Fantini D","World J Urol","2019","2018/11/14","","","10.1007/s00345-018-2558-2"
"18724101","Bladder cancer detection using FISH (UroVysion assay)","Halling KC, Kipp BR.","Adv Anat Pathol. 2008 Sep;15(5):279-86. doi: 10.1097/PAP.0b013e3181832320.","Halling KC","Adv Anat Pathol","2008","2008/08/30","","","10.1097/PAP.0b013e3181832320"
"31448424","Toll-like receptors: The role in bladder cancer development, progression and immunotherapy","Ohadian Moghadam S, Nowroozi MR.","Scand J Immunol. 2019 Dec;90(6):e12818. doi: 10.1111/sji.12818. Epub 2019 Oct 3.","Ohadian Moghadam S","Scand J Immunol","2019","2019/08/27","","","10.1111/sji.12818"
"7846305","Bladder cancer mortality in the United States, 1951-1989: increased environmental carcinogenesis in men","Riggs JE.","Regul Toxicol Pharmacol. 1994 Oct;20(2):187-97. doi: 10.1006/rtph.1994.1069.","Riggs JE","Regul Toxicol Pharmacol","1994","1994/10/01","","","10.1006/rtph.1994.1069"
"18813273","Survival from bladder cancer in England and Wales up to 2001","Whelan P.","Br J Cancer. 2008 Sep 23;99 Suppl 1(Suppl 1):S90-2. doi: 10.1038/sj.bjc.6604600. Epub 2008 Sep 23.","Whelan P","Br J Cancer","2008","2008/10/01","PMC2557518","","10.1038/sj.bjc.6604600"
"17069531","Chemotherapy practices and perspectives in invasive bladder cancer","Flechon A, Droz JP.","Expert Rev Anticancer Ther. 2006 Oct;6(10):1473-82. doi: 10.1586/14737140.6.10.1473.","Flechon A","Expert Rev Anticancer Ther","2006","2006/10/31","","","10.1586/14737140.6.10.1473"
"16445380","Combining surgery and chemotherapy for invasive bladder cancer: current and future directions","Amiel GE, Lerner SP.","Expert Rev Anticancer Ther. 2006 Feb;6(2):281-91. doi: 10.1586/14737140.6.2.281.","Amiel GE","Expert Rev Anticancer Ther","2006","2006/02/01","","","10.1586/14737140.6.2.281"
"3334256","[Bladder cancer--basic and clinical studies of its occurrence, invasion and metastasis]","Koiso K.","Nihon Hinyokika Gakkai Zasshi. 1987 Dec;78(13):2243-53.","Koiso K","Nihon Hinyokika Gakkai Zasshi","1987","1987/12/01","","",""
"7332905","Evidence of a multiplicative effect between cigarette smoking and occupational exposures in the aetiology of bladder cancer","Vineis P, Segnan N, Costa G, Terracini B.","Cancer Lett. 1981 Dec;14(3):285-90. doi: 10.1016/0304-3835(81)90156-7.","Vineis P","Cancer Lett","1981","1981/12/01","","","10.1016/0304-3835(81)90156-7"
"27050781","Rationale of hyperthermia for radio(chemo)therapy and immune responses in patients with bladder cancer: Biological concepts, clinical data, interdisciplinary treatment decisions and biological tumour imaging","Multhoff G, Habl G, Combs SE.","Int J Hyperthermia. 2016 Jun;32(4):455-63. doi: 10.3109/02656736.2016.1152632. Epub 2016 Apr 6.","Multhoff G","Int J Hyperthermia","2016","2016/04/07","","","10.3109/02656736.2016.1152632"
"22490892","[Attach importance to the chemotherapy of muscle invasive bladder cancer]","Tian Y.","Zhonghua Yi Xue Za Zhi. 2012 Feb 14;92(6):363-5.","Tian Y","Zhonghua Yi Xue Za Zhi","2012","2012/04/12","","",""
"26525026","SERS measurement of the bladder cancer cells with the nanoparticles","Jin D, Chen H, Cao M, Yang G, Xue W, Huang Y.","Pak J Pharm Sci. 2015 Sep;28(5 Suppl):1853-6.","Jin D","Pak J Pharm Sci","2015","2015/11/04","","",""
"17494114","The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer","Whelan P.","Eur Urol. 2007 May;51(5):1436-7; discussion 1437-8.","Whelan P","Eur Urol","2007","2007/05/12","","",""
"3682510","[Studies on vascular invasion of tumor cells in bladder cancer]","Naito S, Kimiya K, Ueda T, Kumazawa J.","Nihon Hinyokika Gakkai Zasshi. 1987 Jul;78(7):1199-204. doi: 10.5980/jpnjurol1928.78.7_1199.","Naito S","Nihon Hinyokika Gakkai Zasshi","1987","1987/07/01","","","10.5980/jpnjurol1928.78.7_1199"
"3831079","[Cancers of the bladder: new therapeutic orientations]","Amiel JL, Cukier J, Droz JP.","J Urol (Paris). 1985;91(8):519-22.","Amiel JL","J Urol (Paris)","1985","1985/01/01","","",""
"8734733","Characteristics of invasive bladder cancers: histological and molecular markers","Liebert M, Seigne J.","Semin Urol Oncol. 1996 May;14(2):62-72.","Liebert M","Semin Urol Oncol","1996","1996/05/01","","",""
"25882564","Novel biomarkers to predict response and prognosis in localized bladder cancer","Lucca I, de Martino M, Klatte T, Shariat SF.","Urol Clin North Am. 2015 May;42(2):225-33, ix. doi: 10.1016/j.ucl.2015.01.004. Epub 2015 Mar 6.","Lucca I","Urol Clin North Am","2015","2015/04/18","","","10.1016/j.ucl.2015.01.004"
"7129902","[Partial resection of the bladder as a therapy in bladder cancer]","Lindenberg K, von Hochstetter AR, Mayor G.","Helv Chir Acta. 1982 Aug;49(3-4):369-74.","Lindenberg K","Helv Chir Acta","1982","1982/08/01","","",""
"7390890","Patterns of recurrence in bladder cancer treated by irradiation and/or cystectomy","Batata MA, Whitmore WF Jr, Chu FC, Hilaris BS, Unal A, Chung S.","Int J Radiat Oncol Biol Phys. 1980 Feb;6(2):155-9. doi: 10.1016/0360-3016(80)90031-0.","Batata MA","Int J Radiat Oncol Biol Phys","1980","1980/02/01","","","10.1016/0360-3016(80)90031-0"
"15199088","Does the who and how of surgery in bladder cancer matter?","Lange PH, Lin DW.","J Clin Oncol. 2004 Jul 15;22(14):2762-4. doi: 10.1200/JCO.2004.03.936. Epub 2004 Jun 15.","Lange PH","J Clin Oncol","2004","2004/06/17","","","10.1200/JCO.2004.03.936"
"19482151","Editorial comment. With many other neoplasms, bladder cancer is heterogeneous","Soloway MS.","Urology. 2009 Jun;73(6):1311. doi: 10.1016/j.urology.2009.01.030.","Soloway MS","Urology","2009","2009/06/02","","","10.1016/j.urology.2009.01.030"
"23670183","The role of heat shock proteins in bladder cancer","Ischia J, So AI.","Nat Rev Urol. 2013 Jul;10(7):386-95. doi: 10.1038/nrurol.2013.108. Epub 2013 May 14.","Ischia J","Nat Rev Urol","2013","2013/05/15","","","10.1038/nrurol.2013.108"
"22196746","Bladder cancer: a window of opportunity to understand carcinogenesis","Loughlin KR.","Urol Oncol. 2013 Oct;31(7):966-7. doi: 10.1016/j.urolonc.2011.11.029. Epub 2011 Dec 22.","Loughlin KR","Urol Oncol","2013","2011/12/27","","","10.1016/j.urolonc.2011.11.029"
"2090282","Biochemical epidemiology of bladder cancer","Vineis P, Terracini B.","Epidemiology. 1990 Nov;1(6):448-52. doi: 10.1097/00001648-199011000-00006.","Vineis P","Epidemiology","1990","1990/11/01","","","10.1097/00001648-199011000-00006"
"28675174","Landmarks in the treatment of muscle-invasive bladder cancer","Lobo N, Mount C, Omar K, Nair R, Thurairaja R, Khan MS.","Nat Rev Urol. 2017 Sep;14(9):565-574. doi: 10.1038/nrurol.2017.82. Epub 2017 Jul 4.","Lobo N","Nat Rev Urol","2017","2017/07/05","","","10.1038/nrurol.2017.82"
"25443119","Implementing hexaminolevulinate HCl blue light cystoscopy: a nursing perspective","Calvaresi AE, Trabulsi EJ, Sonzogni M, Gomella LG, Lallas CD, Wachsmuth KS.","AORN J. 2014 Nov;100(5):489-96; quiz 497-9. doi: 10.1016/j.aorn.2013.12.013. Epub 2014 Oct 25.","Calvaresi AE","AORN J","2014","2014/12/03","","","10.1016/j.aorn.2013.12.013"
"17128643","Bladder cancer update. Current evaluation methods and standard of care","Sonpavde G.","Postgrad Med. 2006 Sep-Oct;119(3):30-7. doi: 10.1080/00325481.2006.11446048.","Sonpavde G","Postgrad Med","2006","2006/11/30","","","10.1080/00325481.2006.11446048"
"7415197","Bladder cancer-new approaches","Buchanan-Davidson DJ.","Wis Med J. 1980 Aug;79(8):15-6.","Buchanan-Davidson DJ","Wis Med J","1980","1980/08/01","","",""
"3283765","Lymphadenectomy in the management of bladder cancer","Hall RR.","Prog Clin Biol Res. 1988;260:321-7.","Hall RR","Prog Clin Biol Res","1988","1988/01/01","","",""
"31494662","Diagnostic Utility of Serum Golgi Phosphoprotein 3 in Bladder Cancer Patients","Lu J, Zhong F, Sun B, Wang C.","Med Sci Monit. 2019 Sep 8;25:6736-6741. doi: 10.12659/MSM.915950.","Lu J","Med Sci Monit","2019","2019/09/09","PMC6752096","","10.12659/MSM.915950"
"7018036","Helminths in the induction of cancer II. Schistosoma haematobium and bladder cancer","Schwartz DA.","Trop Geogr Med. 1981 Mar;33(1):1-7.","Schwartz DA","Trop Geogr Med","1981","1981/03/01","","",""
"11394456","Radical transurethral resection in the management of muscle-invasive bladder cancer","Grob BM, Macchia RJ.","J Endourol. 2001 May;15(4):419-23; discussion 425-6. doi: 10.1089/089277901300189475.","Grob BM","J Endourol","2001","2001/06/08","","","10.1089/089277901300189475"
"8716817","[Treatment of bladder cancer. New methods, new management]","Moore S, Newton M, Grant E, Keetch DW.","Servir. 1996 Mar-Apr;44(2):90-8.","Moore S","Servir","1996","1996/03/01","","",""
"31289379","Molecular and histopathology directed therapy for advanced bladder cancer","Alifrangis C, McGovern U, Freeman A, Powles T, Linch M.","Nat Rev Urol. 2019 Aug;16(8):465-483. doi: 10.1038/s41585-019-0208-0. Epub 2019 Jul 9.","Alifrangis C","Nat Rev Urol","2019","2019/07/11","","","10.1038/s41585-019-0208-0"
"8638301","[Results of radiotherapy of ureteral obstruction in invasive bladder cancer]","Holm M, Miskowiak J, Rolff H.","Ugeskr Laeger. 1996 Jan 22;158(4):420-1.","Holm M","Ugeskr Laeger","1996","1996/01/22","","",""
"18786198","Clinical outcome of chemoradiotherapy for T1G3 bladder cancer","Inoue M, Ishioka J, Fukuda H, Kageyama Y, Saito Y, Higashi Y.","Int J Urol. 2008 Aug;15(8):747-50. doi: 10.1111/j.1442-2042.2008.02077.x.","Inoue M","Int J Urol","2008","2008/09/13","","","10.1111/j.1442-2042.2008.02077.x"
"2218564","Pathology of bladder cancer: assessment of prognostic variables and response to therapy","Reuter VE.","Semin Oncol. 1990 Oct;17(5):524-32.","Reuter VE","Semin Oncol","1990","1990/10/01","","",""
"25792474","Proteometabolomics of bladder cancer: current and future prospects","Bansal N, Gupta A, Sankhwar SN.","Cancer Biomark. 2015;15(4):339-48. doi: 10.3233/CBM-150479.","Bansal N","Cancer Biomark","2015","2015/03/21","","","10.3233/CBM-150479"
"23975266","Alterations of DNA methylome in human bladder cancer","Besaratinia A, Cockburn M, Tommasi S.","Epigenetics. 2013 Oct;8(10):1013-22. doi: 10.4161/epi.25927. Epub 2013 Aug 6.","Besaratinia A","Epigenetics","2013","2013/08/27","PMC3891681","","10.4161/epi.25927"
"6769927","1978 Gordon Richards memorial lecture. Assessment and management of bladder cancer","Duncan W.","J Can Assoc Radiol. 1980 Jun;31(2):83-91.","Duncan W","J Can Assoc Radiol","1980","1980/06/01","","",""
"7456166","Preoperative irradiation as an adjuvant in the surgical management of patients with invasive bladder cancer","Heney NM, Prout GR Jr.","Urol Clin North Am. 1980 Oct;7(3):543-9.","Heney NM","Urol Clin North Am","1980","1980/10/01","","",""
"17382791","Molecular alterations associated with bladder cancer progression","Sánchez-Carbayo M, Cordon-Cardó C.","Semin Oncol. 2007 Apr;34(2):75-84. doi: 10.1053/j.seminoncol.2006.12.013.","Sánchez-Carbayo M","Semin Oncol","2007","2007/03/27","","","10.1053/j.seminoncol.2006.12.013"
"2414495","[Pre and postoperative nursing of patients with bladder cancer. Management of patients before and immediately after total excision of the bladder]","Matsumoto K.","Kango Gijutsu. 1985 Aug;31(11):1428-31.","Matsumoto K","Kango Gijutsu","1985","1985/08/01","","",""
"2096782","Chemotherapy in advanced bladder cancer: a review with emphasis on future studies","Splinter TA.","Arch Esp Urol. 1990;43 Suppl 2:215-7.","Splinter TA","Arch Esp Urol","1990","1990/01/01","","",""
"12852163","[Epidemiology and risk factors for the onset of urinary bladder cancer]","Radosavljević V, Ilić M, Janković S.","Vojnosanit Pregl. 2003 Mar-Apr;60(2):195-201. doi: 10.2298/vsp0302195r.","Radosavljević V","Vojnosanit Pregl","2003","2003/07/11","","","10.2298/vsp0302195r"
"17382790","The evolution of bladder cancer treatment: improvements in clinical management, enhanced clinical outcomes, and targeting newly identified molecular alterations","Bajorin DF.","Semin Oncol. 2007 Apr;34(2):73-4. doi: 10.1053/j.seminoncol.2006.12.003.","Bajorin DF","Semin Oncol","2007","2007/03/27","","","10.1053/j.seminoncol.2006.12.003"
"2096781","Chemotherapy for invasive bladder cancer: facts and fallacies","Raghavan D, Pearson BS, Coorey GJ, Boulas J, Rosen IM, Mameghan H, Learoyd HM, Duval P.","Arch Esp Urol. 1990;43 Suppl 2:209-14.","Raghavan D","Arch Esp Urol","1990","1990/01/01","","",""
"21421240","Evidence of abnormal tyrosine phosphorylated proteins in the urine of patients with bladder cancer: the road toward a new diagnostic tool?","Khadjavi A, Barbero G, Destefanis P, Mandili G, Giribaldi G, Mannu F, Pantaleo A, Ceruti C, Bosio A, Rolle L, Turrini F, Fontana D.","J Urol. 2011 May;185(5):1922-9. doi: 10.1016/j.juro.2010.12.029. Epub 2011 Mar 21.","Khadjavi A","J Urol","2011","2011/03/23","","","10.1016/j.juro.2010.12.029"
"88112","[Cystectomy as ""ultima ratio"" after failure of radiotherapy in bladder cancer (author's transl)]","Klippel KF, Altwein JE.","Urologe A. 1979 May;18(3):118-21.","Klippel KF","Urologe A","1979","1979/05/01","","",""
"4034588","The analysis of results in prophylactic superficial bladder cancer studies","Sylvester R.","Prog Clin Biol Res. 1985;185B:3-11.","Sylvester R","Prog Clin Biol Res","1985","1985/01/01","","",""
"21656173","Impact of gender on bladder cancer incidence, staging, and prognosis","Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, Breinl E, Merseburger AS, Shariat SF.","World J Urol. 2011 Aug;29(4):457-63. doi: 10.1007/s00345-011-0709-9. Epub 2011 Jun 9.","Fajkovic H","World J Urol","2011","2011/06/10","","","10.1007/s00345-011-0709-9"
"21129663","[Bladder cancer]","Pointreau Y, Klotz S, Denis F, Durdux C.","Cancer Radiother. 2010 Nov;14 Suppl 1:S189-97. doi: 10.1016/S1278-3218(10)70023-8.","Pointreau Y","Cancer Radiother","2010","2010/12/07","","","10.1016/S1278-3218(10)70023-8"
"19829026","Prognostic significance of hydronephrosis in bladder cancer treated by radical cystectomy","Resorlu B, Baltaci S, Resorlu M, Ergun G, Abdulmajeed M, Haliloglu AH, Gogus C, Beduk Y.","Urol Int. 2009;83(3):285-8. doi: 10.1159/000241668. Epub 2009 Oct 13.","Resorlu B","Urol Int","2009","2009/10/16","","","10.1159/000241668"
"29573965","The evolution of bladder cancer genomics: What have we learned and how can we use it?","Audenet F, Attalla K, Sfakianos JP.","Urol Oncol. 2018 Jul;36(7):313-320. doi: 10.1016/j.urolonc.2018.02.017. Epub 2018 Mar 21.","Audenet F","Urol Oncol","2018","2018/03/26","","","10.1016/j.urolonc.2018.02.017"
"23724625","Quantitative changes in p53, Bcl-2 and apoptosis in blood and urine of bladder cancer patients","El-Gamal EM, Gouida MS.","Clin Lab. 2013;59(3-4):349-58. doi: 10.7754/clin.lab.2012.111224.","El-Gamal EM","Clin Lab","2013","2013/06/04","","","10.7754/clin.lab.2012.111224"
"15000300","[Management of bladder cancer associated with prostate cancer]","Bonnal JL, Irani J, Maidenberg M, Théodore C, Mauroy B.","Prog Urol. 2003 Dec;13(6):1286-9.","Bonnal JL","Prog Urol","2003","2004/03/06","","",""
"6700456","Cytotoxics first for invasive bladder cancer","Sandeman TF.","Med J Aust. 1984 Mar 3;140(5):253-4.","Sandeman TF","Med J Aust","1984","1984/03/03","","",""
"28213769","The patients' experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence","Edmondson AJ, Birtwistle JC, Catto JWF, Twiddy M.","J Cancer Surviv. 2017 Aug;11(4):453-461. doi: 10.1007/s11764-017-0603-6. Epub 2017 Feb 17.","Edmondson AJ","J Cancer Surviv","2017","2017/02/19","PMC5500680","","10.1007/s11764-017-0603-6"
"3851011","[Pre and postoperative nursing of patients with bladder cancer: a nursing standard for patients having ileal conduits]","Mizoguchi T, Isobe M.","Kango Gijutsu. 1985 Aug;31(11):1437-43.","Mizoguchi T","Kango Gijutsu","1985","1985/08/01","","",""
"16905987","Bibliography. Current world literature. Bladder cancer","","Curr Opin Urol. 2006 Sep;16(5):386-9. doi: 10.1097/01.mou.0000240314.93453.d4.","","Curr Opin Urol","2006","2006/08/15","","","10.1097/01.mou.0000240314.93453.d4"
"15250328","[Bladder cancer and prostate cancer in hemodialysis patients]","Hatori M, Suzuki K, Yamanaka H.","Nihon Rinsho. 2004 Jun;62 Suppl 6:374-7.","Hatori M","Nihon Rinsho","2004","2004/07/15","","",""
"7317748","Radiotherapy and cystectomy for T3 bladder carcinoma","Hall RR, Heath AB.","Br J Urol. 1981 Dec;53(6):598-601. doi: 10.1111/j.1464-410x.1981.tb03269.x.","Hall RR","Br J Urol","1981","1981/12/01","","","10.1111/j.1464-410x.1981.tb03269.x"
"12892574","Trends in the incidence of bladder cancer in Nova Scotia: a twenty-year perspective","McLellan RA, French CG, Bell DG.","Can J Urol. 2003 Jun;10(3):1880-4.","McLellan RA","Can J Urol","2003","2003/08/02","","",""
"8576024","Computer tomography and magnetic resonance imaging in the evaluation of bladder cancer","Husband JE.","J Belge Radiol. 1995 Dec;78(6):350-5.","Husband JE","J Belge Radiol","1995","1995/12/01","","",""
"15100585","Fluid balance, diet and bladder cancer occurrence","Radosavljevic V.","Eur J Cancer Prev. 2004 Apr;13(2):151. doi: 10.1097/00008469-200404000-00012.","Radosavljevic V","Eur J Cancer Prev","2004","2004/04/22","","","10.1097/00008469-200404000-00012"
"16526987","Update on clinical and radiological staging and surveillance of bladder cancer","Sharir S.","Can J Urol. 2006 Feb;13 Suppl 1:71-6.","Sharir S","Can J Urol","2006","2006/03/11","","",""
"5771738","[Various aspects of bladder cancer in Lebanon]","Gédéon EM.","J Med Liban. 1969;22(1):10-8.","Gédéon EM","J Med Liban","1969","1969/01/01","","",""
"8178925","Expression of the VLA beta 1 integrin family in bladder cancer","Liebert M, Washington R, Stein J, Wedemeyer G, Grossman HB.","Am J Pathol. 1994 May;144(5):1016-22.","Liebert M","Am J Pathol","1994","1994/05/01","PMC1887346","",""
"22300756","Summary of the 6th Annual Bladder Cancer Think Tank: new directions in urologic research","Svatek RS, Rosenberg JE, Galsky MD, Lee CT, Latini DM, Bochner BH, Weizer AZ, Apolo AB, Sridhar SS, Kamat AM, Hansel D, Flaig TW, Smith ND, Lotan Y.","Urol Oncol. 2013 Oct;31(7):968-73. doi: 10.1016/j.urolonc.2011.12.017. Epub 2012 Jan 31.","Svatek RS","Urol Oncol","2013","2012/02/04","PMC6777555","NIHMS1038404","10.1016/j.urolonc.2011.12.017"
"26215606","On Molecular Classification of Bladder Cancer: Out of One, Many","Aine M, Eriksson P, Liedberg F, Höglund M, Sjödahl G.","Eur Urol. 2015 Dec;68(6):921-3. doi: 10.1016/j.eururo.2015.07.021. Epub 2015 Jul 26.","Aine M","Eur Urol","2015","2015/07/29","","","10.1016/j.eururo.2015.07.021"
"4034589","The need for long-term follow-up studies after treatment of superficial bladder cancer (Tis/Ta/T1), especially after intravesical chemotherapy","Fossa SD.","Prog Clin Biol Res. 1985;185B:31-7.","Fossa SD","Prog Clin Biol Res","1985","1985/01/01","","",""
"3121200","Bladder cancer: approaches to prevention and control","Koroltchouk V, Stanley K, Stjernswärd J, Mott K.","Bull World Health Organ. 1987;65(4):513-20.","Koroltchouk V","Bull World Health Organ","1987","1987/01/01","PMC2491038","",""
"10214068","[Bladder cancer in patients over 80 years old]","Tashiro K, Furuta A, Ohishi Y, Kishimoto K, Wada T, Hasegawa N.","Nihon Ronen Igakkai Zasshi. 1998 Dec;35(12):905-9. doi: 10.3143/geriatrics.35.905.","Tashiro K","Nihon Ronen Igakkai Zasshi","1998","1999/04/24","","","10.3143/geriatrics.35.905"
"10691820","Surveillance for bladder cancer: the management of 4.8 million people. South-west Urologists","Wright MP, Jones DJ.","BJU Int. 2000 Mar;85(4):431-3. doi: 10.1046/j.1464-410x.2000.00467.x.","Wright MP","BJU Int","2000","2000/02/26","","","10.1046/j.1464-410x.2000.00467.x"
"25836929","Diagnosis and staging of bladder cancer","Sun M, Trinh QD.","Hematol Oncol Clin North Am. 2015 Apr;29(2):205-18, vii. doi: 10.1016/j.hoc.2014.10.013. Epub 2014 Nov 6.","Sun M","Hematol Oncol Clin North Am","2015","2015/04/04","","","10.1016/j.hoc.2014.10.013"
"22112475","Molecular pathology and biomarkers of bladder cancer","Czerniak B.","Cancer Biomark. 2010;9(1-6):159-76. doi: 10.3233/CBM-2011-0175.","Czerniak B","Cancer Biomark","2010","2011/11/25","","","10.3233/CBM-2011-0175"
"20346041","New Italian guidelines on bladder cancer, based on the World Health Organization 2004 classification","Puppo P, Conti G, Francesca F, Mandressi A, Naselli A; AURO.it guideline committee.","BJU Int. 2010 Jul;106(2):168-79. doi: 10.1111/j.1464-410X.2010.09324.x. Epub 2010 Mar 23.","Puppo P","BJU Int","2010","2010/03/30","","","10.1111/j.1464-410X.2010.09324.x"
"22779319","You're the flight surgeon: renal stones and bladder cancer","Reaume J.","Aviat Space Environ Med. 2012 Jul;83(7):719-21. doi: 10.3357/asem.3240.2012.","Reaume J","Aviat Space Environ Med","2012","2012/07/12","","","10.3357/asem.3240.2012"
"27149103","Rethinking Radical Cystectomy as the Best Choice for Most Patients With Muscle-Invasive Bladder Cancer","Mitin T.","JAMA Oncol. 2016 Jul 1;2(7):856-8. doi: 10.1001/jamaoncol.2016.0152.","Mitin T","JAMA Oncol","2016","2016/05/06","","","10.1001/jamaoncol.2016.0152"
"21053072","Using urine microscopy and cytology for early detection of bladder cancer in male patients with lower urinary tract symptoms","Chan ES, Ng CF, Hou SM, Yip SK.","Int Urol Nephrol. 2011 Jun;43(2):289-94. doi: 10.1007/s11255-010-9856-y. Epub 2010 Nov 4.","Chan ES","Int Urol Nephrol","2011","2010/11/06","","","10.1007/s11255-010-9856-y"
"23463895","[Treatment of muscular layer invasiveness bladder cancer]","Miyazaki J, Nishiyama H.","Gan To Kagaku Ryoho. 2013 Jan;40(1):41-6.","Miyazaki J","Gan To Kagaku Ryoho","2013","2013/03/08","","",""
"8416874","Radiation as adjunctive therapy to cystectomy for bladder cancer","Shipley WU.","Int J Radiat Oncol Biol Phys. 1993 Jan;25(1):153-4. doi: 10.1016/0360-3016(93)90161-n.","Shipley WU","Int J Radiat Oncol Biol Phys","1993","1993/01/01","","","10.1016/0360-3016(93)90161-n"
"30636472","Progress towards a Nordic standard for the investigation of hematuria: 2019","Malmström PU, Skaaheim Haug E, Boström PJ, Gudjónsson S, Bjerggaard Jensen J.","Scand J Urol. 2019 Feb;53(1):1-6. doi: 10.1080/21681805.2018.1555187. Epub 2019 Jan 14.","Malmström PU","Scand J Urol","2019","2019/01/15","","","10.1080/21681805.2018.1555187"
"1140915","Tryptophan urinary bladder absorption and bladder cancer","Flanagan MJ, Ekbal S, Coogan PS, Kalin G, Hass GM.","Invest Urol. 1975 Jul;13(1):17-9.","Flanagan MJ","Invest Urol","1975","1975/07/01","","",""
"8928463","[Diagnosis and treatment of locally advanced cancer of the urinary bladder]","Nechiporenko NA, STrotskiĭ AV.","Vopr Onkol. 1996;42(4):66-8.","Nechiporenko NA","Vopr Onkol","1996","1996/01/01","","",""
"16530078","Therapy of invasive bladder cancer","Dinney CP.","Urology. 2006 Mar;67(3 Suppl 1):56-9; discussion 60-1. doi: 10.1016/j.urology.2006.01.043.","Dinney CP","Urology","2006","2006/03/15","","","10.1016/j.urology.2006.01.043"
"18605000","[Clinical-pathology relationship in bladder cancer]","Navarro Medina P, Blanco Diez A, Artiles Hernández JL, Chesa Ponce N.","Actas Urol Esp. 2008 May;32(5):502-6. doi: 10.1016/s0210-4806(08)73874-9.","Navarro Medina P","Actas Urol Esp","2008","2008/07/09","","","10.1016/s0210-4806(08)73874-9"
"24013072","Recent advances in diagnosis and treatment of transitional cell carcinoma of the bladder","Martyn-Hemphill C, Mak D, Khan MS, Challacombe BJ, Bishop CV.","Int J Surg. 2013;11(9):749-52. doi: 10.1016/j.ijsu.2013.08.018. Epub 2013 Sep 5.","Martyn-Hemphill C","Int J Surg","2013","2013/09/10","","","10.1016/j.ijsu.2013.08.018"
"22782963","Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer","Onozawa M, Miyanaga N, Hinotsu S, Miyazaki J, Oikawa T, Kimura T, Takaoka E, Kawai K, Shimazui T, Sakurai H, Nishiyama H, Akaza H.","Jpn J Clin Oncol. 2012 Sep;42(9):825-30. doi: 10.1093/jjco/hys105. Epub 2012 Jul 10.","Onozawa M","Jpn J Clin Oncol","2012","2012/07/12","","","10.1093/jjco/hys105"
"17181486","Superficial bladder cancer: part 1. Update on etiology, classification and natural history","Josephson DY, Pasin E, Stein JP.","Expert Rev Anticancer Ther. 2006 Dec;6(12):1723-34. doi: 10.1586/14737140.6.12.1723.","Josephson DY","Expert Rev Anticancer Ther","2006","2006/12/22","","","10.1586/14737140.6.12.1723"
"6506375","Role of lymphadenectomy in the treatment of bladder cancer","Lieskovsky G, Skinner DG.","Urol Clin North Am. 1984 Nov;11(4):709-16.","Lieskovsky G","Urol Clin North Am","1984","1984/11/01","","",""
"10914702","Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4","Konety BR, Nguyen TS, Dhir R, Day RS, Becich MJ, Stadler WM, Getzenberg RH.","Clin Cancer Res. 2000 Jul;6(7):2618-25.","Konety BR","Clin Cancer Res","2000","2000/07/29","","",""
"7553301","Basic research","Debruyne F, Yoshida O, Olsson C, Bauer J, Höltl W, Kakehi Y, Schalken JA, Borkowsky A.","Int J Urol. 1995 Jun;2 Suppl 2:117-21. doi: 10.1111/j.1442-2042.1995.tb00485.x.","Debruyne F","Int J Urol","1995","1995/06/01","","","10.1111/j.1442-2042.1995.tb00485.x"
"8456184","Superficial bladder cancer: primary treatment with TUR with or without laser-coagulation","Jocham D.","Recent Results Cancer Res. 1993;126:135-42. doi: 10.1007/978-3-642-84583-3_13.","Jocham D","Recent Results Cancer Res","1993","1993/01/01","","","10.1007/978-3-642-84583-3_13"
"15281314","Risk factors in clonal development from superficial to invasive bladder cancer","Landman J, Droller MJ.","Cancer Surv. 1998;31:5-15.","Landman J","Cancer Surv","1998","2004/07/30","","",""
"17565856","[Progress and puzzle in the field of basic research on bladder cancer]","Zhang YF.","Zhonghua Yi Xue Za Zhi. 2007 Mar 27;87(12):795-7.","Zhang YF","Zhonghua Yi Xue Za Zhi","2007","2007/06/15","","",""
"7941142","[The formation of an artificial bladder from the intestines]","Sitdykov EN, Sitdykova ME, Zubkov AIu, Rumiantsev IuV.","Urol Nefrol (Mosk). 1993 Mar-Apr;(2):31-4.","Sitdykov EN","Urol Nefrol (Mosk)","1993","1993/03/01","","",""
"15759278","Genetic and epigenetic aspects of bladder cancer","Kim WJ, Quan C.","J Cell Biochem. 2005 May 1;95(1):24-33. doi: 10.1002/jcb.20412.","Kim WJ","J Cell Biochem","2005","2005/03/11","","","10.1002/jcb.20412"
"16440640","Accumulation of genetic changes during the development and progression of bladder cancer","Cianciulli AM, Merola R, Vico E, Orlandi G, Sentinelli S, Gallucci M.","Pathologica. 2005 Aug;97(4):177-8.","Cianciulli AM","Pathologica","2005","2006/01/31","","",""
"23559128","[Epidemiology of disease conditions in Italy. Has anything changed? Environment, professional exposure, and lifestyle. Is time for screening?]","Serretta V, Colombo R.","Urologia. 2013;80 Suppl 21:3-6. doi: 10.5301/RU.2013.10855. Epub 2013 Mar 22.","Serretta V","Urologia","2013","2013/04/06","","","10.5301/RU.2013.10855"
"9120916","Bladder cancer","Droller MJ.","J Urol. 1997 Apr;157(4):1266-7. doi: 10.1016/s0022-5347(01)64946-2.","Droller MJ","J Urol","1997","1997/04/01","","","10.1016/s0022-5347(01)64946-2"
"473446","Post-irradiation total cystectomy for bladder cancer","Genster HG, Mommsen S, Højsgaard A.","Urol Res. 1979 Jun 22;7(2):79-82. doi: 10.1007/BF00254685.","Genster HG","Urol Res","1979","1979/06/22","","","10.1007/BF00254685"
"2021033","Increasing incidence, but stable mortality, of bladder cancer in Ontario. Analysis of a population sample","Jewett MA, Pereira G, Nijmeh P, Herschorn S, Honey RJ, Struthers NW, Bruce AW, Barkin M.","Urology. 1991;37(5 Suppl):4-7. doi: 10.1016/0090-4295(91)80126-r.","Jewett MA","Urology","1991","1991/01/01","","","10.1016/0090-4295(91)80126-r"
"17950275","Adverse genetic prognostic profiles define a poor outcome for cystectomy in bladder cancer","Gallucci M, Vico E, Merola R, Leonardo C, Sperduti I, Felici A, Sentinelli S, Cantiani R, Orlandi G, Cianciulli A.","Exp Mol Pathol. 2007 Dec;83(3):385-91. doi: 10.1016/j.yexmp.2007.08.017. Epub 2007 Sep 18.","Gallucci M","Exp Mol Pathol","2007","2007/10/24","","","10.1016/j.yexmp.2007.08.017"
"15780568","The role of urinary cytology for detection of bladder cancer","Planz B, Jochims E, Deix T, Caspers HP, Jakse G, Boecking A.","Eur J Surg Oncol. 2005 Apr;31(3):304-8. doi: 10.1016/j.ejso.2004.12.008.","Planz B","Eur J Surg Oncol","2005","2005/03/23","","","10.1016/j.ejso.2004.12.008"
"16858861","Bladder cancer surgery better sooner, not later. Studies show lower survival rate if treatment is delayed more than three months","","Health News. 2006 Jul;12(7):14-5.","","Health News","2006","2006/07/25","","",""
"1182356","Bladder cancer mortality in diabetics in relation to saccharin consumption and smoking habits","Armstrong B, Doll R.","Br J Prev Soc Med. 1975 Jun;29(2):73-81. doi: 10.1136/jech.29.2.73.","Armstrong B","Br J Prev Soc Med","1975","1975/06/01","PMC478894","","10.1136/jech.29.2.73"
"17619742","Best approach for low-risk superficial bladder cancer","Solsona E.","ScientificWorldJournal. 2006 Oct 23;6:2638-45. doi: 10.1100/tsw.2006.407.","Solsona E","ScientificWorldJournal","2006","2007/07/11","PMC5917345","","10.1100/tsw.2006.407"
"15493783","Cancers of the bladder","Sengupta N, Siddiqui E, Mumtaz FH.","J R Soc Promot Health. 2004 Sep;124(5):228-9. doi: 10.1177/146642400412400520.","Sengupta N","J R Soc Promot Health","2004","2004/10/21","","","10.1177/146642400412400520"
"8153080","[Comments on the contribution by S. Presse et al. Morphology of bladder cancer based on cystectomy specimen]","Mikuz G.","Pathologe. 1994 Feb;15(1):63-4.","Mikuz G","Pathologe","1994","1994/02/01","","",""
"12572335","Bladder cancer: a current update","Masood S, Wazait HD, Arya M, Patel HR.","Hosp Med. 2003 Jan;64(1):40-2. doi: 10.12968/hosp.2003.64.1.1844.","Masood S","Hosp Med","2003","2003/02/08","","","10.12968/hosp.2003.64.1.1844"
"25823569","Chemotherapeutic effects on circulating tumor cells in bladder cancer","Winters B, James A, Lee J, Kho J, Morrissey C, Wright J.","Int J Urol. 2015 Jun;22(6):612-3. doi: 10.1111/iju.12758. Epub 2015 Mar 31.","Winters B","Int J Urol","2015","2015/04/01","","","10.1111/iju.12758"
"5131941","[Experience with surgical and-or radiological treatment of bladder cancer at the Regional Hospital in Orebro]","Brekkan E, Fritjofsson A, Odelberg-Johnson O, Persson JE.","Nord Med. 1971 Oct 7;86(40):1158-9.","Brekkan E","Nord Med","1971","1971/10/07","","",""
"11953681","New diagnostic and prognostic tools in bladder cancer","Tiguert R, Fradet Y.","Curr Opin Urol. 2002 May;12(3):239-43. doi: 10.1097/00042307-200205000-00011.","Tiguert R","Curr Opin Urol","2002","2002/04/16","","","10.1097/00042307-200205000-00011"
"23040258","Small cell bladder cancer: biology and management","Fahed E, Hansel DE, Raghavan D, Quinn DI, Dorff TB.","Semin Oncol. 2012 Oct;39(5):615-8. doi: 10.1053/j.seminoncol.2012.08.009.","Fahed E","Semin Oncol","2012","2012/10/09","","","10.1053/j.seminoncol.2012.08.009"
"3454805","Immunotherapy of bladder cancer with intralesional injection with BCG","Calsini P, Scapicchi G, Gazzarini O, Melone F, Aulisi A, Pellegrini G, Fabris N, Provinciali M.","J Exp Pathol. 1987 Summer;3(4):579-86.","Calsini P","J Exp Pathol","1987","1987/01/01","","",""
"3765207","[Comments and proposals on the International Classification of Bladder Cancer by the TNM system]","Tsyb AF, Dunchik VN, Kulikov VA, Tlepshukov GK.","Urol Nefrol (Mosk). 1986 Jul-Aug;(4):34-5.","Tsyb AF","Urol Nefrol (Mosk)","1986","1986/07/01","","",""
"17195646","[Results of therapy in different groups of risk for superficial bladder cancer]","Startsev VIu, Gorelov SI, Pulin IL, Merkur'eva RD, Ogava I.","Vopr Onkol. 2006;52(2):187-91.","Startsev VIu","Vopr Onkol","2006","2007/01/02","","",""
"22641360","Urological cancer: Chemoradiation superior in muscle-invasive bladder cancer","Weiss C, Rödel C.","Nat Rev Clin Oncol. 2012 May 29;9(7):374-5. doi: 10.1038/nrclinonc.2012.92.","Weiss C","Nat Rev Clin Oncol","2012","2012/05/30","","","10.1038/nrclinonc.2012.92"
"21739913","Familial aggregation of bladder cancer","Ilić M, Stojadinović M, Milosavljević Z.","Vojnosanit Pregl. 2011 May;68(5):447-51. doi: 10.2298/vsp1105447i.","Ilić M","Vojnosanit Pregl","2011","2011/07/12","","","10.2298/vsp1105447i"
"12407698","Cytogenetics and molecular genetics of bladder cancer: a personal view","Sandberg AA.","Am J Med Genet. 2002 Oct 30;115(3):173-82. doi: 10.1002/ajmg.10693.","Sandberg AA","Am J Med Genet","2002","2002/10/31","","","10.1002/ajmg.10693"
"20610275","The International Bladder Cancer Network","Grossman HB, Dinney CP, Schmitz-Dräger BJ, Goebell PJ.","Urol Oncol. 2010 Jul-Aug;28(4):375-6. doi: 10.1016/j.urolonc.2009.04.014.","Grossman HB","Urol Oncol","2010","2010/07/09","","","10.1016/j.urolonc.2009.04.014"
"19408879","[Infiltrating bladder cancer: clinical case]","Castel-Kremer E, Droz JP.","Rev Prat. 2009 Mar 20;59(3):359-60.","Castel-Kremer E","Rev Prat","2009","2009/05/05","","",""
"28652451","A New Prognostic Tool for Patients Undergoing Radiotherapy plus Upfront Transurethral Resection for Bladder Cancer","Manig L, Janssen S, Schild SE, Rades D.","In Vivo. 2017 Jul-Aug;31(4):745-748. doi: 10.21873/invivo.11125.","Manig L","In Vivo","2017","2017/06/28","PMC5566934","","10.21873/invivo.11125"
"3631363","Occupation, smoking, and alcohol in the epidemiology of bladder cancer","Brownson RC, Chang JC, Davis JR.","Am J Public Health. 1987 Oct;77(10):1298-300. doi: 10.2105/ajph.77.10.1298.","Brownson RC","Am J Public Health","1987","1987/10/01","PMC1647136","","10.2105/ajph.77.10.1298"
"22716492","Schistosomiasis and bladder cancer: similarities and differences from urothelial cancer","Zaghloul MS, Gouda I.","Expert Rev Anticancer Ther. 2012 Jun;12(6):753-63. doi: 10.1586/era.12.49.","Zaghloul MS","Expert Rev Anticancer Ther","2012","2012/06/22","","","10.1586/era.12.49"
"3736387","[Computerized x-ray tomographic evaluation of the local dissemination of bladder cancer]","Toktomushev AT, Matveev BP, Gabuniia RI, Molchanov GV.","Med Radiol (Mosk). 1986 Jul;31(7):58-61.","Toktomushev AT","Med Radiol (Mosk)","1986","1986/07/01","","",""
"23851382","Recent advances and the emerging role for chemoradiation in nonmuscle invasive bladder cancer","Gray PJ, Shipley WU, Efstathiou JA, Zietman AL.","Curr Opin Urol. 2013 Sep;23(5):429-34. doi: 10.1097/MOU.0b013e328363de04.","Gray PJ","Curr Opin Urol","2013","2013/07/16","","","10.1097/MOU.0b013e328363de04"
"3825830","[Results of the multidisciplinary treatment of invasive bladder cancer]","Miyakawa M, Oishi K, Okada Y, Takeuchi H, Okada K, Yoshida O.","Hinyokika Kiyo. 1986 Dec;32(12):1931-9.","Miyakawa M","Hinyokika Kiyo","1986","1986/12/01","","",""
"15862613","Surgical factors in the treatment of superficial and invasive bladder cancer","Herr HW.","Urol Clin North Am. 2005 May;32(2):157-64. doi: 10.1016/j.ucl.2005.02.003.","Herr HW","Urol Clin North Am","2005","2005/05/03","","","10.1016/j.ucl.2005.02.003"
"17523080","The S100 proteins for screening and prognostic grading of bladder cancer","Yao R, Davidson DD, Lopez-Beltran A, MacLennan GT, Montironi R, Cheng L.","Histol Histopathol. 2007 Sep;22(9):1025-32. doi: 10.14670/HH-22.1025.","Yao R","Histol Histopathol","2007","2007/05/25","","","10.14670/HH-22.1025"
"2378276","[Cancer of the urothelium: background and characteristics of the care process related to the prognosis in a series of clinical cases]","Villalbí JR, Gelabert-Mas A, Comín E, Coronado-García J.","Actas Urol Esp. 1990 Mar-Apr;14(2):89-91.","Villalbí JR","Actas Urol Esp","1990","1990/03/01","","",""
"21750504","Chemotherapy: Standardizing the care of invasive bladder cancer","Bochner BH.","Nat Rev Clin Oncol. 2011 Jul 12;8(8):454-5. doi: 10.1038/nrclinonc.2011.109.","Bochner BH","Nat Rev Clin Oncol","2011","2011/07/14","","","10.1038/nrclinonc.2011.109"
"11792943","Re: pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy","Neulander EZ.","J Urol. 2002 Feb;167(2 Pt 1):651.","Neulander EZ","J Urol","2002","2002/01/17","","",""
"1942300","Re: The role of radical cystectomy in the management of high grade superficial bladder cancer (Pa, P1, PIS and P2)","Schellhammer PF, Eure GR.","J Urol. 1991 Nov;146(5):1378-9. doi: 10.1016/s0022-5347(17)38107-7.","Schellhammer PF","J Urol","1991","1991/11/01","","","10.1016/s0022-5347(17)38107-7"
"1023694","Urinary bladder tumours in Zambia","Curruthers RH.","Med J Zambia. 1976 Aug-Sep;10(4):105-9.","Curruthers RH","Med J Zambia","1976","1976/08/01","","",""
"31533945","Processed Meat Intake and Bladder Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cohort","Xu X.","Cancer Epidemiol Biomarkers Prev. 2019 Dec;28(12):1993-1997. doi: 10.1158/1055-9965.EPI-19-0604. Epub 2019 Sep 18.","Xu X","Cancer Epidemiol Biomarkers Prev","2019","2019/09/20","","","10.1158/1055-9965.EPI-19-0604"
"15254717","Mitochondrial DNA mutations in chemical carcinogen-induced rat bladder and human bladder cancer","Chen GF, Chan FL, Hong BF, Chan LW, Chan PS.","Oncol Rep. 2004 Aug;12(2):463-72.","Chen GF","Oncol Rep","2004","2004/07/16","","",""
"4010114","[Flow cytometry in urinary tract malignancies. III. Quantitative analysis of DNA histogram and application to bladder cancer detection, evaluation of the treatment and follow-up examination]","Matsuura T, Tsujihashi H, Kanda H, Akiyama T, Kurita T.","Nihon Hinyokika Gakkai Zasshi. 1985 Jan;76(1):89-95.","Matsuura T","Nihon Hinyokika Gakkai Zasshi","1985","1985/01/01","","",""
"19954289","Role and rationale of gene therapy and other novel therapies in the management of NMIBC","Lojo Rial C, Wilby D, Sooriakumaran P.","Expert Rev Anticancer Ther. 2009 Dec;9(12):1777-82. doi: 10.1586/era.09.106.","Lojo Rial C","Expert Rev Anticancer Ther","2009","2009/12/04","","","10.1586/era.09.106"
"9537688","Automated image analysis for bladder cancer","van der Poel HG, Witjes JA, Schalken JA, Debruyne FM.","Urol Res. 1998;26(1):1-5. doi: 10.1007/s002400050014.","van der Poel HG","Urol Res","1998","1998/04/16","","","10.1007/s002400050014"
"21919693","The enlightenment of bladder cancer treatment: origin and progress of photodynamic diagnosis","Otto W, Burger M, Fritsche HM, Rössler W, Wieland WF, Denzinger S.","Future Oncol. 2011 Sep;7(9):1057-66. doi: 10.2217/fon.11.91.","Otto W","Future Oncol","2011","2011/09/17","","","10.2217/fon.11.91"
"3967204","Combined preoperative and postoperative radiation for bladder cancer. Results of RTOG/Jefferson Study","Mohiuddin M, Kramer S, Newall J, Parsons J, Wiley A, Strong G, Mulholland SG.","Cancer. 1985 Mar 1;55(5):963-6. doi: 10.1002/1097-0142(19850301)55:5<963::aid-cncr2820550508>3.0.co;2-#.","Mohiuddin M","Cancer","1985","1985/03/01","","","10.1002/1097-0142(19850301)55:5<963::aid-cncr2820550508>3.0.co;2-#"
"8470879","[Results of the treatment of bladder tumors infiltrating the muscle]","Chopin DK, Hoznek A, Ravery V, Antiphon P, Popov Z, Abbou CC.","Ann Urol (Paris). 1993;27(1):42-4.","Chopin DK","Ann Urol (Paris)","1993","1993/01/01","","",""
"15300145","New molecular markers for bladder cancer detection","Quek ML, Sanderson K, Daneshmand S, Stein JP.","Curr Opin Urol. 2004 Sep;14(5):259-64. doi: 10.1097/00042307-200409000-00003.","Quek ML","Curr Opin Urol","2004","2004/08/10","","","10.1097/00042307-200409000-00003"
"2211234","Chemo-radiation therapy of bladder cancer","Lange CS, Rotman M.","Int J Radiat Oncol Biol Phys. 1990 Sep;19(3):817-9. doi: 10.1016/0360-3016(90)90520-t.","Lange CS","Int J Radiat Oncol Biol Phys","1990","1990/09/01","","","10.1016/0360-3016(90)90520-t"
"15300149","Novel therapeutics in the treatment of bladder cancer","Shah JB, McKiernan JM.","Curr Opin Urol. 2004 Sep;14(5):287-93. doi: 10.1097/00042307-200409000-00007.","Shah JB","Curr Opin Urol","2004","2004/08/10","","","10.1097/00042307-200409000-00007"
"25914165","Poor survival of females with bladder cancer is limited to those aged 70 years or over: a population-wide linkage study, New South Wales, Australia","Patel MI, Bang A, Gillett D, Cheluvappa R, Smith DP.","Cancer Med. 2015 Aug;4(8):1145-52. doi: 10.1002/cam4.452. Epub 2015 Apr 27.","Patel MI","Cancer Med","2015","2015/04/28","PMC4559025","","10.1002/cam4.452"
"10861610","Detubularized rectosigmoid neobladder in women after cystectomy for bladder cancer","Mearini E, Mearini L, Zucchi A, Costantini E, Goracci G, Porena M.","J Surg Oncol. 2000 May;74(1):49-52. doi: 10.1002/1096-9098(200005)74:1<49::aid-jso12>3.0.co;2-d.","Mearini E","J Surg Oncol","2000","2000/06/22","","","10.1002/1096-9098(200005)74:1<49::aid-jso12>3.0.co;2-d"
"18974695","Bladder cancer and smoking. Part 2: diagnosis and management","Anderson B, Naish W.","Br J Nurs. 2008 Oct 23-Nov 12;17(19):1240-5. doi: 10.12968/bjon.2008.17.19.31466.","Anderson B","Br J Nurs","2008","2008/11/01","","","10.12968/bjon.2008.17.19.31466"
"27843143","Bladder cancer: Assessing the conundrum of microscopic haematuria","Steinberg GD.","Nat Rev Urol. 2016 Dec;13(12):700-701. doi: 10.1038/nrurol.2016.229. Epub 2016 Nov 15.","Steinberg GD","Nat Rev Urol","2016","2016/11/16","","","10.1038/nrurol.2016.229"
"5047415","Bladder cancer in California 1942-1969: the California tumor registry experience","Krain LS.","J Urol. 1972 Aug;108(2):268-70. doi: 10.1016/s0022-5347(17)60707-9.","Krain LS","J Urol","1972","1972/08/01","","","10.1016/s0022-5347(17)60707-9"
"24893789","Diuretic ¹⁸F-FDG PET/CT for therapy monitoring in urothelial bladder cancer","Coquan E, Lasnon C, Joly F, Lefort JM, Aide N.","Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1818-9. doi: 10.1007/s00259-014-2800-0. Epub 2014 Jun 4.","Coquan E","Eur J Nucl Med Mol Imaging","2014","2014/06/05","","","10.1007/s00259-014-2800-0"
"29548621","Editorial: Managing locally advanced bladder cancer. Third International Bladder Cancer Network seminars series","Black PC, Goebell PJ, Kamat AM, Nawroth R, Schmitz-Dräger BJ.","Urol Oncol. 2018 Sep;36(9):403-404. doi: 10.1016/j.urolonc.2017.11.006. Epub 2018 Mar 13.","Black PC","Urol Oncol","2018","2018/03/18","","","10.1016/j.urolonc.2017.11.006"
"16618384","New treatments for superficial bladder cancer","Shah JB, Badalato GM, McKiernan JM.","Curr Oncol Rep. 2006 May;8(3):201-5. doi: 10.1007/s11912-006-0020-x.","Shah JB","Curr Oncol Rep","2006","2006/04/19","","","10.1007/s11912-006-0020-x"
"11981270","Bladder cancer","Patton SE, Hall MC, Ozen H.","Curr Opin Oncol. 2002 May;14(3):265-72. doi: 10.1097/00001622-200205000-00003.","Patton SE","Curr Opin Oncol","2002","2002/05/01","","","10.1097/00001622-200205000-00003"
"4810756","Lymphocytes and bladder cancer","Amin M, Lich R Jr.","J Urol. 1974 Feb;111(2):165-9. doi: 10.1016/s0022-5347(17)59917-6.","Amin M","J Urol","1974","1974/02/01","","","10.1016/s0022-5347(17)59917-6"
"15662601","Molecular markers in bladder cancer","Hussain SA, James ND.","Semin Radiat Oncol. 2005 Jan;15(1):3-9. doi: 10.1016/j.semradonc.2004.07.007.","Hussain SA","Semin Radiat Oncol","2005","2005/01/22","","","10.1016/j.semradonc.2004.07.007"
"9672249","Prospects for optimized clinical management of bladder cancer by application of phenotypic markers","Millikan RE, Logothetis CJ.","J Natl Cancer Inst. 1998 Jul 15;90(14):1028-9. doi: 10.1093/jnci/90.14.1028.","Millikan RE","J Natl Cancer Inst","1998","1998/07/22","","","10.1093/jnci/90.14.1028"
"3690539","Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma","Havsteen H, von der Maase H, Strøyer I, Rasmussen F.","Cancer Treat Rep. 1987 Dec;71(12):1285-7.","Havsteen H","Cancer Treat Rep","1987","1987/12/01","","",""
"22409269","Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review","Koga F, Kihara K.","Int J Urol. 2012 May;19(5):388-401. doi: 10.1111/j.1442-2042.2012.02974.x. Epub 2012 Mar 12.","Koga F","Int J Urol","2012","2012/03/14","","","10.1111/j.1442-2042.2012.02974.x"
"21334665","Re: preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. C. J. Stimson, M. S. Cookson, D. A. Barocas, P. E. Clark, J. E. Humphrey, S. G. Patel, J. A. Smith, Jr. and S. S. Chang. J Urol 2010; 183: 1732-1737","Neulander EZ, Katz T, Yusim I, Kaneti J.","J Urol. 2011 Apr;185(4):1536-7. doi: 10.1016/j.juro.2010.11.057. Epub 2011 Feb 19.","Neulander EZ","J Urol","2011","2011/02/22","","","10.1016/j.juro.2010.11.057"
"4032086","Notification and risk assessment for bladder cancer of a cohort exposed to aromatic amines. III. Mortality among workers exposed to aromatic amines in the last beta-naphthylamine manufacturing facility in the United States","Stern FB, Murthy LI, Beaumont JJ, Schulte PA, Halperin WE.","J Occup Med. 1985 Jul;27(7):495-500.","Stern FB","J Occup Med","1985","1985/07/01","","",""
"26918087","[Leiomyosarcoma of the bladder in a 64 year old patient]","Elkabous M, Boukir A, Lakhdissi A, Ettahiri H, Kohen F, Afif M, Jabbour Y, Drissy A, Boutayeb S, Errihani H.","Pan Afr Med J. 2015 Oct 26;22:192. doi: 10.11604/pamj.2015.22.192.7681. eCollection 2015.","Elkabous M","Pan Afr Med J","2015","2016/02/27","PMC4752847","","10.11604/pamj.2015.22.192.7681"
"28889377","Molecular Subtype Profiling of Urothelial Carcinoma Using a Subtype-Specific Immunohistochemistry Panel","Sjödahl G.","Methods Mol Biol. 2018;1655:53-64. doi: 10.1007/978-1-4939-7234-0_5.","Sjödahl G","Methods Mol Biol","2018","2017/09/11","","","10.1007/978-1-4939-7234-0_5"
"19719844","HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management","Gaughan EM, Dezube BJ, Bower M, Aboulafia DM, Bohac G, Cooley TP, Pantanowitz L.","BMC Urol. 2009 Aug 31;9:10. doi: 10.1186/1471-2490-9-10.","Gaughan EM","BMC Urol","2009","2009/09/02","PMC2746230","","10.1186/1471-2490-9-10"
"25993148","New and promising strategies in the management of bladder cancer","Apolo AB, Vogelzang NJ, Theodorescu D.","Am Soc Clin Oncol Educ Book. 2015:105-12. doi: 10.14694/EdBook_AM.2015.35.105.","Apolo AB","Am Soc Clin Oncol Educ Book","2015","2015/05/21","PMC6777550","NIHMS1038498","10.14694/EdBook_AM.2015.35.105"
"2923827","Occupational bladder cancer and the hospital clinician","Baxter PJ.","Br J Ind Med. 1989 Feb;46(2):73. doi: 10.1136/oem.46.2.73.","Baxter PJ","Br J Ind Med","1989","1989/02/01","PMC1009730","","10.1136/oem.46.2.73"
"7336390","[The value of computer tomography in assessing operability in advanced bladder cancer]","Aspestrand F, Tofte AJ, Igesund A.","Tidsskr Nor Laegeforen. 1981 Sep 20;101(26):1445-7.","Aspestrand F","Tidsskr Nor Laegeforen","1981","1981/09/20","","",""
"1552606","Re: The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2)","Sandeman TF.","J Urol. 1992 Apr;147(4):1118. doi: 10.1016/s0022-5347(17)37498-0.","Sandeman TF","J Urol","1992","1992/04/01","","","10.1016/s0022-5347(17)37498-0"
"20657286","Follow-up of patients after curative bladder cancer treatment: guidelines vs. practice","Vrooman OP, Witjes JA.","Curr Opin Urol. 2010 Sep;20(5):437-42. doi: 10.1097/MOU.0b013e32833cf10e.","Vrooman OP","Curr Opin Urol","2010","2010/07/27","","","10.1097/MOU.0b013e32833cf10e"
"21623942","Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy","Ozcan MF, Dizdar O, Canda AE, Balbay MD.","BJU Int. 2011 Jun;107(12):2002-3; author reply 2003-4. doi: 10.1111/j.1464-410X.2011.10379_3.x.","Ozcan MF","BJU Int","2011","2011/06/01","","","10.1111/j.1464-410X.2011.10379_3.x"
"4804400","[Value of lymphography in the exploration of bladder cancer]","Camey M, Le Duc A, Khoury S.","J Urol Nephrol (Paris). 1973 Dec;79(12 Pt 2):370-2.","Camey M","J Urol Nephrol (Paris)","1973","1973/12/01","","",""
"32620639","Non-invasive Detection of Bladder Cancer by UBC Rapid Test, Ultrasonography and Cytology","Barak V, Itzkovich D, Einarsson R, Gofrit O, Pode D.","Anticancer Res. 2020 Jul;40(7):3967-3972. doi: 10.21873/anticanres.14389.","Barak V","Anticancer Res","2020","2020/07/05","","","10.21873/anticanres.14389"
"15862620","Neoadjuvant chemotherapy in patients with invasive bladder cancer","Vaughn DJ, Malkowicz SB.","Urol Clin North Am. 2005 May;32(2):231-7. doi: 10.1016/j.ucl.2005.03.001.","Vaughn DJ","Urol Clin North Am","2005","2005/05/03","","","10.1016/j.ucl.2005.03.001"
"69161","Bladder cancer: Possible new high-risk occupation","Wigle DT.","Lancet. 1977 Jul 9;2(8028):83-4. doi: 10.1016/s0140-6736(77)90079-4.","Wigle DT","Lancet","1977","1977/07/09","","","10.1016/s0140-6736(77)90079-4"
"18721202","Epigenetic markers as promising prognosticators for bladder cancer","Kim YK, Kim WJ.","Int J Urol. 2009 Jan;16(1):17-22. doi: 10.1111/j.1442-2042.2008.02143.x. Epub 2008 Aug 20.","Kim YK","Int J Urol","2009","2008/08/30","","","10.1111/j.1442-2042.2008.02143.x"
"20336786","Patterns of questionable quality care in nonmuscle invasive bladder cancer","Gore JL, Porter MP.","Cancer. 2010 Jun 1;116(11):2508-10. doi: 10.1002/cncr.25020.","Gore JL","Cancer","2010","2010/03/26","","","10.1002/cncr.25020"
"7987404","Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer","Fleming CM, Persad R, Kaisary A, Smith P, Adedoyin A, Porter J, Wilkinson GR, Branch RA.","Pharmacogenetics. 1994 Aug;4(4):199-207. doi: 10.1097/00008571-199408000-00004.","Fleming CM","Pharmacogenetics","1994","1994/08/01","","","10.1097/00008571-199408000-00004"
"3903420","[Ultrasonic scanning in determining the local spread of bladder cancer]","Tsyb AF, Slesarev VI, Grishin GN, Kariakin OB, Dunchik VN.","Med Radiol (Mosk). 1985 Oct;30(10):39-44.","Tsyb AF","Med Radiol (Mosk)","1985","1985/10/01","","",""
"3278482","Infection in patients with advanced bladder cancer","Childs SJ.","Urology. 1988 Feb;31(2 Suppl):22-8.","Childs SJ","Urology","1988","1988/02/01","","",""
"23793767","Biomarkers for assessing therapeutic response in bladder cancer","Mertens LS, Neuzillet Y, Horenblas S, van Rhijn BW.","Arch Esp Urol. 2013 Jun;66(5):495-504.","Mertens LS","Arch Esp Urol","2013","2013/06/25","","",""
"12917514","Indications and outcome of radiotherapy for invasive bladder cancer: review of developments during 2002","Moonen L.","Curr Opin Urol. 2003 Sep;13(5):385-7. doi: 10.1097/00042307-200309000-00005.","Moonen L","Curr Opin Urol","2003","2003/08/15","","","10.1097/00042307-200309000-00005"
"22814882","Monitoring high-risk bladder cancer","Schwentner C, Stenzl A, Gakis G.","Curr Opin Urol. 2012 Sep;22(5):421-6. doi: 10.1097/MOU.0b013e3283555d04.","Schwentner C","Curr Opin Urol","2012","2012/07/21","","","10.1097/MOU.0b013e3283555d04"
"18207314","Nomograms for bladder cancer","Shariat SF, Margulis V, Lotan Y, Montorsi F, Karakiewicz PI.","Eur Urol. 2008 Jul;54(1):41-53. doi: 10.1016/j.eururo.2008.01.004. Epub 2008 Jan 15.","Shariat SF","Eur Urol","2008","2008/01/22","","","10.1016/j.eururo.2008.01.004"
"8893869","Bladder cancer screening","Kryger JV, Messing E.","Semin Oncol. 1996 Oct;23(5):585-97.","Kryger JV","Semin Oncol","1996","1996/10/01","","",""
"3181238","16 years experience in the management of patients with deeply invasive bladder cancer","Skinner DG, Lieskovsky G.","Eur Urol. 1988;14 Suppl 1:30-1. doi: 10.1159/000473037.","Skinner DG","Eur Urol","1988","1988/01/01","","","10.1159/000473037"
"23518309","Active surveillance for low-risk bladder cancer","Tiu A, Jenkins LC, Soloway MS.","Urol Oncol. 2014 Jan;32(1):33.e7-10. doi: 10.1016/j.urolonc.2012.12.003. Epub 2013 Mar 19.","Tiu A","Urol Oncol","2014","2013/03/23","","","10.1016/j.urolonc.2012.12.003"
"3202683","[Significance of the stromal reaction in bladder cancer]","Goertchen R, Kluge R, Stosiek P.","Arch Geschwulstforsch. 1988;58(5):327-32.","Goertchen R","Arch Geschwulstforsch","1988","1988/01/01","","",""
"27249728","Treatment of Muscle-Invasive Bladder Cancer in Older Patients","Skinner EC.","Am Soc Clin Oncol Educ Book. 2016;35:e228-33. doi: 10.1200/EDBK_158974.","Skinner EC","Am Soc Clin Oncol Educ Book","2016","2016/06/02","","","10.1200/EDBK_158974"
"23097579","A candidate molecular biomarker panel for the detection of bladder cancer","Urquidi V, Goodison S, Cai Y, Sun Y, Rosser CJ.","Cancer Epidemiol Biomarkers Prev. 2012 Dec;21(12):2149-58. doi: 10.1158/1055-9965.EPI-12-0428. Epub 2012 Oct 24.","Urquidi V","Cancer Epidemiol Biomarkers Prev","2012","2012/10/26","PMC3537330","NIHMS415409","10.1158/1055-9965.EPI-12-0428"
"2956765","[Bladder cancer morbidity in individual territories of the RSFSR]","Prianichnikova MB, Kashafova RS.","Vopr Onkol. 1987;33(6):29-34.","Prianichnikova MB","Vopr Onkol","1987","1987/01/01","","",""
"6209725","Radiotherapy for bladder cancer","Van den Bogaert W.","Prog Clin Biol Res. 1984;162B:55-62.","Van den Bogaert W","Prog Clin Biol Res","1984","1984/01/01","","",""
"5751987","[Epidemiological problems of bladder cancer]","Yoshida O, Miyakawa M, Harada T, Okada K.","Nihon Rinsho. 1968 Aug;26(8):1850-4.","Yoshida O","Nihon Rinsho","1968","1968/08/01","","",""
"532391","[DNFB reaction in bladder cancer, an immunological study]","Hudemann B, Günther M, Seyfarth M.","Z Urol Nephrol. 1979 Oct;72(10):729-32.","Hudemann B","Z Urol Nephrol","1979","1979/10/01","","",""
"21141697","Hyperthermia as a treatment for bladder cancer","Rampersaud EN, Vujaskovic Z, Inman BA.","Oncology (Williston Park). 2010 Nov 15;24(12):1149-55.","Rampersaud EN","Oncology (Williston Park)","2010","2010/12/15","","",""
"18088231","Biological markers in the diagnosis of recurrent bladder cancer: an overview","Mohammed A, Khan Z, Zamora I, Bhatti A.","Expert Rev Mol Diagn. 2008 Jan;8(1):63-72. doi: 10.1586/14737159.8.1.63.","Mohammed A","Expert Rev Mol Diagn","2008","2007/12/20","","","10.1586/14737159.8.1.63"
"11760346","[Prognostic factors in urothelial carcinoma]","Vögeli TA, Ackermann R.","Urologe A. 2001 Nov;40(6):442-6. doi: 10.1007/s001200170002.","Vögeli TA","Urologe A","2001","2002/01/05","","","10.1007/s001200170002"
"29247553","Prediction models for progression of non-muscle-invasive bladder cancer: A review","Fujii Y.","Int J Urol. 2018 Mar;25(3):212-218. doi: 10.1111/iju.13509. Epub 2017 Dec 16.","Fujii Y","Int J Urol","2018","2017/12/17","","","10.1111/iju.13509"
"30143439","Epithelioid Angiosarcoma of the Bladder: A Case Report and Review of the Literature","Nizam A, Paquette EL, Wang BG, Aragon-Ching JB.","Clin Genitourin Cancer. 2018 Dec;16(6):e1091-e1095. doi: 10.1016/j.clgc.2018.07.010. Epub 2018 Jul 23.","Nizam A","Clin Genitourin Cancer","2018","2018/08/26","","","10.1016/j.clgc.2018.07.010"
"18082825","Re: Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer s. P. Lerner, C. M. Tangen, H. Sucharew, D. Wood and E. D. Crawford J Urol 2007; 177: 1727-1731","Lamm DL.","J Urol. 2008 Feb;179(2):788. doi: 10.1016/j.juro.2007.09.102. Epub 2007 Dec 20.","Lamm DL","J Urol","2008","2007/12/18","","","10.1016/j.juro.2007.09.102"
"27824057","Bladder cancer in individuals with spinal cord injuries: a meta-analysis","Gui-Zhong L, Li-Bo M.","Spinal Cord. 2017 Apr;55(4):341-345. doi: 10.1038/sc.2016.151. Epub 2016 Nov 8.","Gui-Zhong L","Spinal Cord","2017","2016/11/09","","","10.1038/sc.2016.151"
"24490328","[Clinical guidelines for diagnosing, treatment and monitoring patients with bladder cancer--Croatian Oncology Society and Croatian Urology Society, Croatian Medical Association]","Gamulin M, Ruzić IP, Grgić M, Jazvić M, Solarić M, Zahirović D, Zorica R, Omrcen T, Petković M, Matić M, Fuckar Z, Ruzić B, Pasini J, Situm M, Dordević G, Miletić D, Tadić T, Kastelan Z, Librenjak D, Gilja I, Vilović K, Kruslin B, Kuvezdić H; Croatian Medical Association.","Lijec Vjesn. 2013 Nov-Dec;135(11-12):292-7.","Gamulin M","Lijec Vjesn","2013","2014/02/05","","",""
"16625650","Adjuvant chemotherapy for invasive bladder cancer (individual patient data)","Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.","Cochrane Database Syst Rev. 2006 Apr 19;(2):CD006018. doi: 10.1002/14651858.CD006018.","Advanced Bladder Cancer (ABC) Meta-analysis Collaboration","Cochrane Database Syst Rev","2006","2006/04/21","","","10.1002/14651858.CD006018"
"20676116","Significance of age and comorbidity as prognostic indicators for patients with bladder cancer","Ha MS, Chang IH.","Asian J Androl. 2010 Sep;12(5):766-74. doi: 10.1038/aja.2010.29. Epub 2010 Aug 2.","Ha MS","Asian J Androl","2010","2010/08/03","PMC3739310","","10.1038/aja.2010.29"
"11808144","[Bladder cancer]","Miyanaga N, Akaza H.","Nihon Rinsho. 2001 Nov;59 Suppl 7:379-85.","Miyanaga N","Nihon Rinsho","2001","2002/01/26","","",""
"23657098","[Bladder-conserving treatment for bladder cancer: potential of and developments in radiotherapy]","Hulshof MC, Pieters BR, Koning CC.","Ned Tijdschr Geneeskd. 2013;157(19):A5556.","Hulshof MC","Ned Tijdschr Geneeskd","2013","2013/05/10","","",""
"11785092","[Diagnosis of recurrences of bladder cancer]","Startsev VIu.","Vopr Onkol. 2001;47(5):536-43.","Startsev VIu","Vopr Onkol","2001","2002/01/12","","",""
"6504905","Definitive radiation therapy and bladder cancer: do results reflect intrinsic tumor character?","Droller MJ.","Prog Clin Biol Res. 1984;162B:43-53.","Droller MJ","Prog Clin Biol Res","1984","1984/01/01","","",""
"24832198","Does quantification of smoking history correlate with initial bladder tumor grade and stage?","Pietzak EJ, Malkowicz SB.","Curr Urol Rep. 2014 Jul;15(7):416. doi: 10.1007/s11934-014-0416-3.","Pietzak EJ","Curr Urol Rep","2014","2014/05/17","","","10.1007/s11934-014-0416-3"
"741537","Radical cystectomy with or without planned preoperative irradiation in the treatment of bladder cancer","Barzell W, Whitmore WF Jr.","Urol Res. 1978;6(4):249-51. doi: 10.1007/BF00262628.","Barzell W","Urol Res","1978","1978/01/01","","","10.1007/BF00262628"
"31352566","Hope, hype and biology: the current biomarker landscape in bladder cancer","Black PC.","World J Urol. 2019 Sep;37(9):1739-1740. doi: 10.1007/s00345-019-02885-6. Epub 2019 Jul 27.","Black PC","World J Urol","2019","2019/07/29","","","10.1007/s00345-019-02885-6"
"15281315","Squamous change in bladder cancer and its relevance to understanding clonal evolution in development of bladder cancer","Baithun S, Daruwala P, Oliver RT.","Cancer Surv. 1998;31:17-27.","Baithun S","Cancer Surv","1998","2004/07/30","","",""
"3673836","[Uroepithelial tumors of the upper urinary tract following bladder cancer]","Shinka T, Morimoto S, Uekado Y, Yoshida T, Kumeda K, Hirano A, Komura T, Watanabe T, Ohkawa T.","Hinyokika Kiyo. 1987 Jun;33(6):844-51.","Shinka T","Hinyokika Kiyo","1987","1987/06/01","","",""
"3910733","[Adjuvant chemotherapy of infiltrating bladder cancer. A feasibility trial]","Droz JP, Cukier J, Beurton D, Terdjman S, Théodore C, Amiel JL.","J Urol (Paris). 1985;91(7):435-40.","Droz JP","J Urol (Paris)","1985","1985/01/01","","",""
"14594688","Diagnostic delay and prognosis in invasive bladder cancer","Liedberg F, Anderson H, Månsson A, Månsson W.","Scand J Urol Nephrol. 2003;37(5):396-400. doi: 10.1080/00365590310006246.","Liedberg F","Scand J Urol Nephrol","2003","2003/11/05","","","10.1080/00365590310006246"
"25479371","Identification of γ-synuclein as a stage-specific marker in bladder cancer by immunohistochemistry","Zhao J, Xing N.","Med Sci Monit. 2014 Dec 5;20:2550-5. doi: 10.12659/MSM.892927.","Zhao J","Med Sci Monit","2014","2014/12/06","PMC4266204","","10.12659/MSM.892927"
"3594389","Urinary bladder cancer. Selecting initial therapy","Friedell GH.","Cancer. 1987 Aug 1;60(3 Suppl):496-501. doi: 10.1002/1097-0142(19870801)60:3+<496::aid-cncr2820601511>3.0.co;2-h.","Friedell GH","Cancer","1987","1987/08/01","","","10.1002/1097-0142(19870801)60:3+<496::aid-cncr2820601511>3.0.co;2-h"
"27689332","Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent copy number variation in IPO11 and prognostic significance of importin-11 overexpression on poor survival","Zhao J, Xu W, He M, Zhang Z, Zeng S, Ma C, Sun Y, Xu C.","Oncotarget. 2016 Nov 15;7(46):75648-75658. doi: 10.18632/oncotarget.12315.","Zhao J","Oncotarget","2016","2016/10/01","PMC5342767","","10.18632/oncotarget.12315"
"27046754","[Put focus on bladder cancer]","Liedberg F, Höglund M.","Lakartidningen. 2016 Jan 6;113:DUEE.","Liedberg F","Lakartidningen","2016","2016/04/06","","",""
"7195433","Transurethral real-time scanner","Nakamura S, Niijima T.","J Urol. 1981 Jun;125(6):781-3. doi: 10.1016/s0022-5347(17)55201-5.","Nakamura S","J Urol","1981","1981/06/01","","","10.1016/s0022-5347(17)55201-5"
"17576529","[The latest news on bladder cancer]","Retz M, Lehmann J, Nawroth R, Gschwend JE.","Urologe A. 2007 Jul;46(7):727-8, 730-2. doi: 10.1007/s00120-007-1370-1.","Retz M","Urologe A","2007","2007/06/20","","","10.1007/s00120-007-1370-1"
"389480","Chemotherapy in the management of invasive bladder cancer. A review","Bush H, Thatcher N, Barnard R.","Cancer Chemother Pharmacol. 1979;3(2):87-96. doi: 10.1007/BF00254978.","Bush H","Cancer Chemother Pharmacol","1979","1979/01/01","","","10.1007/BF00254978"
"26507359","Toward improved effectiveness of bladder cancer immunotherapy","Kalinski P, Gingrich JR.","Immunotherapy. 2015;7(10):1039-42. doi: 10.2217/imt.15.71. Epub 2015 Oct 28.","Kalinski P","Immunotherapy","2015","2015/10/29","","","10.2217/imt.15.71"
"31471266","[Epidemiological, pathological and prognostic characteristics of bladder cancer in elderly patients]","Neuzillet Y, Geiss R, Caillet P, Paillaud E, Mongiat-Artus P.","Prog Urol. 2019 Nov;29(14):840-848. doi: 10.1016/j.purol.2019.08.268. Epub 2019 Aug 27.","Neuzillet Y","Prog Urol","2019","2019/09/01","","","10.1016/j.purol.2019.08.268"
"25337195","Correlation of ANXA1 expression with drug resistance and relapse in bladder cancer","Yu S, Meng Q, Hu H, Zhang M.","Int J Clin Exp Pathol. 2014 Aug 15;7(9):5538-48. eCollection 2014.","Yu S","Int J Clin Exp Pathol","2014","2014/10/23","PMC4203166","",""
"24912786","Urinary bladder cancer risk variants: recent findings and new challenges of GWAS and confirmatory studies","Selinski S.","Arch Toxicol. 2014 Jul;88(7):1469-75. doi: 10.1007/s00204-014-1297-4.","Selinski S","Arch Toxicol","2014","2014/06/11","","","10.1007/s00204-014-1297-4"
"21684071","Urine markers for detection and surveillance of non-muscle-invasive bladder cancer","Tilki D, Burger M, Dalbagni G, Grossman HB, Hakenberg OW, Palou J, Reich O, Rouprêt M, Shariat SF, Zlotta AR.","Eur Urol. 2011 Sep;60(3):484-92. doi: 10.1016/j.eururo.2011.05.053. Epub 2011 Jun 12.","Tilki D","Eur Urol","2011","2011/06/21","","","10.1016/j.eururo.2011.05.053"
"3678300","Treatment of invasive grade 3 transitional cell bladder cancer. A retrospective study of 10 years' experience with external irradiation, and preoperative irradiation and cystectomy","Wijkström H, Edsmyr F, Nilsson B.","Eur Urol. 1987;13(5):300-4. doi: 10.1159/000472805.","Wijkström H","Eur Urol","1987","1987/01/01","","","10.1159/000472805"
"7129905","[Evaluation of postoperative high-voltage irradiation after transurethral resection in bladder cancer]","Studler G, Schramek P, Hohenberg G, Susani M.","Helv Chir Acta. 1982 Aug;49(3-4):385-90.","Studler G","Helv Chir Acta","1982","1982/08/01","","",""
"18062742","Molecular therapeutic targets for bladder cancer","Zacharakis E, Monem M, Joseph JV, Patel HR.","Expert Rev Anticancer Ther. 2007 Dec;7(12):1691-3. doi: 10.1586/14737140.7.12.1691.","Zacharakis E","Expert Rev Anticancer Ther","2007","2007/12/08","","","10.1586/14737140.7.12.1691"
"1524003","[Clinicopathological analysis on invasion and metastasis in superficial bladder cancer]","Kakehi Y, Nishio Y, Hashimura T, Takeuchi H, Yoshida O.","Hinyokika Kiyo. 1992 Jul;38(7):783-8.","Kakehi Y","Hinyokika Kiyo","1992","1992/07/01","","",""
"19717884","[Bladder leiomyosarcoma. Partial cystectomy and adjuvant treatment]","Cumplido JD, Toral Peña JC.","Arch Esp Urol. 2009 May;62(4):320-2.","Cumplido JD","Arch Esp Urol","2009","2009/09/01","","",""
"12900004","Current bladder cancer tests: unnecessary or beneficial?","Simon MA, Lokeshwar VB, Soloway MS.","Crit Rev Oncol Hematol. 2003 Aug;47(2):91-107. doi: 10.1016/s1040-8428(03)00074-x.","Simon MA","Crit Rev Oncol Hematol","2003","2003/08/06","","","10.1016/s1040-8428(03)00074-x"
"311893","Immune function determination in patients with bladder cancer","Brosman SA, Fahey JL.","Natl Cancer Inst Monogr. 1978 Dec;(49):321-3.","Brosman SA","Natl Cancer Inst Monogr","1978","1978/12/01","","",""
"27609194","Vesigenurtacel-L (HS-410) in the management of high-grade nonmuscle invasive bladder cancer","Keehn A, Gartrell B, Schoenberg MP.","Future Oncol. 2016 Dec;12(23):2673-2682. doi: 10.2217/fon-2016-0284. Epub 2016 Sep 9.","Keehn A","Future Oncol","2016","2016/09/10","","","10.2217/fon-2016-0284"
"24575409","Characterization of uptake and internalization of exosomes by bladder cancer cells","Franzen CA, Simms PE, Van Huis AF, Foreman KE, Kuo PC, Gupta GN.","Biomed Res Int. 2014;2014:619829. doi: 10.1155/2014/619829. Epub 2014 Jan 19.","Franzen CA","Biomed Res Int","2014","2014/02/28","PMC3915764","","10.1155/2014/619829"
"2467716","Invasive bladder cancer. Prognostic factors and results of radiotherapy with and without cystectomy","Mameghan H, Fisher R.","Br J Urol. 1989 Mar;63(3):251-8. doi: 10.1111/j.1464-410x.1989.tb05185.x.","Mameghan H","Br J Urol","1989","1989/03/01","","","10.1111/j.1464-410x.1989.tb05185.x"
"23540788","Urologic Clinics of North America. Diagnosis, evaluation, and treatment of non-muscle invasive bladder cancer. Foreword","Taneja SS.","Urol Clin North Am. 2013 May;40(2):xi. doi: 10.1016/j.ucl.2013.01.016. Epub 2013 Feb 4.","Taneja SS","Urol Clin North Am","2013","2013/04/02","","","10.1016/j.ucl.2013.01.016"
"18813272","Survival from bladder cancer in England and Wales up to 2001","Shah A, Rachet B, Mitry E, Cooper N, Brown CM, Coleman MP.","Br J Cancer. 2008 Sep 23;99 Suppl 1(Suppl 1):S86-9. doi: 10.1038/sj.bjc.6604599.","Shah A","Br J Cancer","2008","2008/10/01","PMC2557536","","10.1038/sj.bjc.6604599"
"6440368","[Transurethral electroresection with postoperative betatron irradiation in bladder cancer: indication and results]","Haschek H, Kärcher KH, Studler G.","Wien Klin Wochenschr. 1984 Sep 14;96(17):642-6.","Haschek H","Wien Klin Wochenschr","1984","1984/09/14","","",""
"21666988","Bladder cancer and cancer stem cells: basic science and implications for therapy","Bryan RT.","ScientificWorldJournal. 2011 Jun 9;11:1187-94. doi: 10.1100/tsw.2011.117.","Bryan RT","ScientificWorldJournal","2011","2011/06/14","PMC5595271","","10.1100/tsw.2011.117"
"2271841","Detecting bladder cancer","Schattner A.","BMJ. 1990 Dec 1;301(6763):1278-9. doi: 10.1136/bmj.301.6763.1278-d.","Schattner A","BMJ","1990","1990/12/01","PMC1664427","","10.1136/bmj.301.6763.1278-d"
"29236572","Radical Treatment of the Primary Tumor in Metastatic Bladder Cancer: Potentially Dangerous Findings From Observational Data","Booth CM, Karim S, Peng Y, Siemens DR, Brennan K, Mackillop WJ.","J Clin Oncol. 2018 Feb 20;36(6):533-535. doi: 10.1200/JCO.2017.76.1759. Epub 2017 Dec 13.","Booth CM","J Clin Oncol","2018","2017/12/14","","","10.1200/JCO.2017.76.1759"
"15257435","[Radical cystectomy and urinary diversion in elderly patients with increased comorbidity]","Gschwend JE, Hautmann RE, Volkmer BG.","Urologe A. 2004 Aug;43(8):930-4. doi: 10.1007/s00120-004-0638-y.","Gschwend JE","Urologe A","2004","2004/07/17","","","10.1007/s00120-004-0638-y"
"3543942","Experimental models of bladder cancer: a critical review","Raghavan D, Debruyne F, Herr H, Jocham D, Kakizoe T, Okajima E, Sandberg A, Tannock I.","Prog Clin Biol Res. 1986;221:171-208.","Raghavan D","Prog Clin Biol Res","1986","1986/01/01","","",""
"10470205","NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer","Zippe C, Pandrangi L, Potts JM, Kursh E, Novick A, Agarwal A.","Anticancer Res. 1999 Jul-Aug;19(4A):2621-3.","Zippe C","Anticancer Res","1999","1999/09/02","","",""
"3362890","Lymphadenectomy during radical cystectomy for bladder cancer","Giuliani L, Giberti C, Martorana G, Pizzorno R.","Prog Clin Biol Res. 1988;260:329-39.","Giuliani L","Prog Clin Biol Res","1988","1988/01/01","","",""
"25788340","Coffee consumption and bladder cancer are linked, analysis shows","Gruber K.","BMJ. 2015 Mar 18;350:h1477. doi: 10.1136/bmj.h1477.","Gruber K","BMJ","2015","2015/03/20","","","10.1136/bmj.h1477"
"7871623","[Prognostic factors in bladder cancer]","Matveev BP, Bogatyrev VN, Ermilova VD, Figurin KM, Mustia AI, Iurasova IV, Ataev AA.","Urol Nefrol (Mosk). 1994 Sep-Oct;(5):43-5.","Matveev BP","Urol Nefrol (Mosk)","1994","1994/09/01","","",""
"29392479","Assessment of content validity for patient-reported outcome measures used in patients with non-muscle invasive bladder cancer: a systematic review","Rutherford C, Patel MI, Tait MA, Smith DP, Costa DSJ, King MT.","Support Care Cancer. 2018 Apr;26(4):1061-1076. doi: 10.1007/s00520-018-4058-8. Epub 2018 Feb 1.","Rutherford C","Support Care Cancer","2018","2018/02/03","","","10.1007/s00520-018-4058-8"
"12476536","Indications and technique of the orthotopic neobladder in women","Stein JP, Ginsberg DA, Skinner DG.","Urol Clin North Am. 2002 Aug;29(3):725-34, xi. doi: 10.1016/s0094-0143(02)00070-8.","Stein JP","Urol Clin North Am","2002","2002/12/13","","","10.1016/s0094-0143(02)00070-8"
"23085297","The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy","Abd El-Latif A, Watts KE, Elson P, Fergany A, Hansel DE.","J Urol. 2013 Apr;189(4):1263-7. doi: 10.1016/j.juro.2012.10.054. Epub 2012 Oct 17.","Abd El-Latif A","J Urol","2013","2012/10/23","","","10.1016/j.juro.2012.10.054"
"6539999","Intravesical CDDP therapy compared with combined CDDP and external radiation in noninvasive bladder cancer. Monitored with quantitative fluorescence cytology","Hemstreet GP 3rd, West SS, Weems WL, McFarland S, Echols CK.","Urology. 1984 Jul;24(1):59-63. doi: 10.1016/0090-4295(84)90389-3.","Hemstreet GP 3rd","Urology","1984","1984/07/01","","","10.1016/0090-4295(84)90389-3"
"24731996","Bladder cancer: genetic variants modify risks of recurrence and survival","Payton S.","Nat Rev Urol. 2014 May;11(5):247. doi: 10.1038/nrurol.2014.86. Epub 2014 Apr 15.","Payton S","Nat Rev Urol","2014","2014/04/16","","","10.1038/nrurol.2014.86"
"4199051","[Radiotherapy schedules for classified bladder cancer]","Mau S, Fürst G.","Radiobiol Radiother (Berl). 1973;14(2):111-6.","Mau S","Radiobiol Radiother (Berl)","1973","1973/01/01","","",""
"23218068","Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: summary of session at the Society of Urologic Oncology annual meeting","Apolo AB, Grossman HB, Bajorin D, Steinberg G, Kamat AM.","Urol Oncol. 2012 Nov-Dec;30(6):772-80. doi: 10.1016/j.urolonc.2012.01.012.","Apolo AB","Urol Oncol","2012","2012/12/11","PMC3524835","NIHMS420145","10.1016/j.urolonc.2012.01.012"
"20864362","Advanced bladder cancer: new agents and new approaches. A review","Volpe A, Racioppi M, D'Agostino D, D'Addessi A, Marangi F, Totaro A, Pinto F, Sacco E, Battaglia S, Chiloiro G, Bassi PF.","Urol Oncol. 2013 Jan;31(1):9-16. doi: 10.1016/j.urolonc.2010.03.022. Epub 2010 Sep 22.","Volpe A","Urol Oncol","2013","2010/09/25","","","10.1016/j.urolonc.2010.03.022"
"15078196","Isothiocyanates in the chemoprevention of bladder cancer","Tang L, Zhang Y.","Curr Drug Metab. 2004 Apr;5(2):193-201. doi: 10.2174/1389200043489027.","Tang L","Curr Drug Metab","2004","2004/04/14","","","10.2174/1389200043489027"
"24637420","Bladder cancer: high precystectomy NLR, increased risk","Payton S.","Nat Rev Urol. 2014 Apr;11(4):188. doi: 10.1038/nrurol.2014.68. Epub 2014 Mar 18.","Payton S","Nat Rev Urol","2014","2014/03/19","","","10.1038/nrurol.2014.68"
"1556055","Superficial bladder cancer","Itoku KA, Stein BS.","Hematol Oncol Clin North Am. 1992 Feb;6(1):99-116.","Itoku KA","Hematol Oncol Clin North Am","1992","1992/02/01","","",""
"4802829","[Geographic distribution and epidemiology of urinary bladder cancer]","Petkovic S, Petronic V, Markovic V.","Srp Arh Celok Lek. 1973 Oct;101(10):729-37.","Petkovic S","Srp Arh Celok Lek","1973","1973/10/01","","",""
"29362302","[I .Recent Trends in Bladder Cancer Mortality in Japan]","Onozawa M.","Gan To Kagaku Ryoho. 2018 Jan;45(1):26-29.","Onozawa M","Gan To Kagaku Ryoho","2018","2018/01/25","","",""
"28061845","Parity and bladder cancer risk: a dose-response meta-analysis","Bai Y, Wang X, Yang Y, Tang Y, Wang J, Han P.","BMC Cancer. 2017 Jan 6;17(1):31. doi: 10.1186/s12885-016-3023-5.","Bai Y","BMC Cancer","2017","2017/01/08","PMC5219774","","10.1186/s12885-016-3023-5"
"16285227","Management of patients with muscle-invasive and metastatic bladder cancer","Henry NL, MacVicar G, Hussain M.","Oncology (Williston Park). 2005 Sep;19(10):1333-42; discussion 1342, 1347, 1350 passim.","Henry NL","Oncology (Williston Park)","2005","2005/11/16","","",""
"22825461","Pathological possibilities and pitfalls in detecting aggressive bladder cancer","Mitra AP, Jordà M, Cote RJ.","Curr Opin Urol. 2012 Sep;22(5):397-404. doi: 10.1097/MOU.0b013e328356ade6.","Mitra AP","Curr Opin Urol","2012","2012/07/25","","","10.1097/MOU.0b013e328356ade6"
"3362883","Magnetic resonance imaging (MRI) in bladder cancer","Javadpour N, Lalehzarian M.","Prog Clin Biol Res. 1988;260:265-70.","Javadpour N","Prog Clin Biol Res","1988","1988/01/01","","",""
"11942979","Superficial bladder cancer T1G3: the choice of treatment","Borkowski A.","BJU Int. 2002 Apr;89(6):623-7. doi: 10.1046/j.1464-410x.2002.02696.x.","Borkowski A","BJU Int","2002","2002/04/12","","","10.1046/j.1464-410x.2002.02696.x"
"4140628","[Significance and necessity of metaphylactic studies in bladder cancer]","Albert L, Arndt J, Hienzsch E, Kriester A.","Z Arztl Fortbild (Jena). 1974 Aug 15;68(16):836-40.","Albert L","Z Arztl Fortbild (Jena)","1974","1974/08/15","","",""
"24699942","Invadopodia are essential in transurothelial invasion during the muscle invasion of bladder cancer cells","Imanishi K, Yoneyama MS, Hatakeyama S, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S.","Mol Med Rep. 2014 Jun;9(6):2159-65. doi: 10.3892/mmr.2014.2113. Epub 2014 Apr 3.","Imanishi K","Mol Med Rep","2014","2014/04/05","","","10.3892/mmr.2014.2113"
"9267831","Re: Platz CE, Cohen MB, Jones MP, Olson DB, Lynch CF. Is microstaging of early invasive bladder cancer of the urinary bladder possible or useful? Mod Pathol 1996;9:1035-9","Angulo JC, Lopez JI.","Mod Pathol. 1997 Aug;10(8):854.","Angulo JC","Mod Pathol","1997","1997/08/01","","",""
"26785526","[New approaches for the treatment of superficial bladder cancer]","Sager CC, Benamran DA, Wirth G, Iselin CE.","Rev Med Suisse. 2015 Dec 2;11(497):2281-4.","Sager CC","Rev Med Suisse","2015","2016/01/21","","",""
"29735397","Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With Chemotherapy","Flannery K, Cao X, He J, Zhong Y, Shah AY, Kamat AM.","Clin Genitourin Cancer. 2018 Aug;16(4):e909-e917. doi: 10.1016/j.clgc.2018.03.002. Epub 2018 Mar 27.","Flannery K","Clin Genitourin Cancer","2018","2018/05/09","","","10.1016/j.clgc.2018.03.002"
"23276138","Deregulation of HOX B13 expression in urinary bladder cancer progression","Marra L, Cantile M, Scognamiglio G, Perdonà S, La Mantia E, Cerrone M, Gigantino V, Cillo C, Caraglia M, Pignata S, Facchini G, Botti G, Chieffi S, Chieffi P, Franco R.","Curr Med Chem. 2013 Feb 1;20(6):833-9.","Marra L","Curr Med Chem","2013","2013/01/02","","",""
"23540786","Restaging transurethral resection for non-muscle invasive bladder cancer: who, why, when, and how?","Ritch CR, Clark PE, Morgan TM.","Urol Clin North Am. 2013 May;40(2):295-304. doi: 10.1016/j.ucl.2013.01.009. Epub 2013 Feb 16.","Ritch CR","Urol Clin North Am","2013","2013/04/02","","","10.1016/j.ucl.2013.01.009"
"25773220","Intravesical therapy for bladder cancer","Patel SG, Cohen A, Weiner AB, Steinberg GD.","Expert Opin Pharmacother. 2015 Apr;16(6):889-901. doi: 10.1517/14656566.2015.1024656. Epub 2015 Mar 14.","Patel SG","Expert Opin Pharmacother","2015","2015/03/17","","","10.1517/14656566.2015.1024656"
"27326406","Active surveillance for nonmuscle invasive bladder cancer","Miyake M, Fujimoto K, Hirao Y.","Investig Clin Urol. 2016 Jun;57 Suppl 1(Suppl 1):S4-S13. doi: 10.4111/icu.2016.57.S1.S4. Epub 2016 May 27.","Miyake M","Investig Clin Urol","2016","2016/06/22","PMC4910757","","10.4111/icu.2016.57.S1.S4"
"19369683","Earlier use of aggressive therapy could prevent one-third of bladder cancer deaths","Pinkowish MD.","CA Cancer J Clin. 2009 May-Jun;59(3):142-4. doi: 10.3322/caac.20020. Epub 2009 Apr 15.","Pinkowish MD","CA Cancer J Clin","2009","2009/04/17","","","10.3322/caac.20020"
"5515120","[Biochemical factors as causes of bladder cancer]","Bédard G.","Laval Med. 1970 Jan;41(1):27-31.","Bédard G","Laval Med","1970","1970/01/01","","",""
"30855376","Perioperative systemic therapy for bladder cancer","Eulitt PJ, Bjurlin MA, Milowsky MI.","Curr Opin Urol. 2019 May;29(3):220-226. doi: 10.1097/MOU.0000000000000600.","Eulitt PJ","Curr Opin Urol","2019","2019/03/12","","","10.1097/MOU.0000000000000600"
"12394684","Newly diagnosed bladder cancer: the relationship of initial symptoms, degree of microhematuria and tumor marker status","Boman H, Hedelin H, Jacobsson S, Holmäng S.","J Urol. 2002 Nov;168(5):1955-9. doi: 10.1097/01.ju.0000034403.18207.66.","Boman H","J Urol","2002","2002/10/24","","","10.1097/01.ju.0000034403.18207.66"
"24638080","Developments and controversies in the management of noninvasive bladder cancer","Bassett JC, Eifler JB, Resnick MJ, Clark PE.","Curr Opin Oncol. 2014 May;26(3):299-304. doi: 10.1097/CCO.0000000000000067.","Bassett JC","Curr Opin Oncol","2014","2014/03/19","","","10.1097/CCO.0000000000000067"
"4087233","[Value of x-ray computed tomography in the evaluation of the extensiveness and the therapeutic strategy for bladder cancer]","Bellin MF, Mathieu D, Larde D, Vasile N, Abbou C.","J Radiol. 1985 Nov;66(11):678.","Bellin MF","J Radiol","1985","1985/11/01","","",""
"20346489","UPK3A: a promising novel urinary marker for the detection of bladder cancer","Lai Y, Ye J, Chen J, Zhang L, Wasi L, He Z, Zhou L, Li H, Yan Q, Gui Y, Cai Z, Wang X, Guan Z.","Urology. 2010 Aug;76(2):514.e6-11. doi: 10.1016/j.urology.2009.11.045. Epub 2010 Mar 25.","Lai Y","Urology","2010","2010/03/30","","","10.1016/j.urology.2009.11.045"
"18670280","Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors","Noyes K, Singer EA, Messing EM.","Curr Opin Urol. 2008 Sep;18(5):533-9. doi: 10.1097/MOU.0b013e32830b8910.","Noyes K","Curr Opin Urol","2008","2008/08/02","PMC3980665","NIHMS471653","10.1097/MOU.0b013e32830b8910"
"21730856","High magnification cystoscopy in the primary diagnosis of bladder tumors","Jichlinski P, Lovisa B.","Curr Opin Urol. 2011 Sep;21(5):398-402. doi: 10.1097/MOU.0b013e32834956ad.","Jichlinski P","Curr Opin Urol","2011","2011/07/07","","","10.1097/MOU.0b013e32834956ad"
"14663870","Chemotherapy for bladder cancer","Sonpavde G, Rawat A, Naveed F.","N Engl J Med. 2003 Dec 4;349(23):2272-3; author reply 2272-3.","Sonpavde G","N Engl J Med","2003","2003/12/10","","",""
"11193308","[Staging urinary bladder cancer with dynamic MR imaging]","Tsuda K, Narumi Y, Nakamura H, Nonomura I, Okuyama A.","Hinyokika Kiyo. 2000 Nov;46(11):835-9.","Tsuda K","Hinyokika Kiyo","2000","2001/02/24","","",""
"27326410","Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?","Kim YJ, Kim WJ.","Investig Clin Urol. 2016 Jun;57 Suppl 1(Suppl 1):S77-88. doi: 10.4111/icu.2016.57.S1.S77. Epub 2016 May 25.","Kim YJ","Investig Clin Urol","2016","2016/06/22","PMC4910760","","10.4111/icu.2016.57.S1.S77"
"4455341","Bladder cancer mortality in England and Wales in relation to cigarette smoking and saccharin consumption","Armstrong B, Doll R.","Br J Prev Soc Med. 1974 Nov;28(4):233-40. doi: 10.1136/jech.28.4.233.","Armstrong B","Br J Prev Soc Med","1974","1974/11/01","PMC478868","","10.1136/jech.28.4.233"
"27032147","Family focus on bladder cancer research","Heyes SM, Harrington A, Belan I, Bond MJ.","Aust Nurs Midwifery J. 2016 Feb;23(7):41.","Heyes SM","Aust Nurs Midwifery J","2016","2016/04/02","","",""
"30323201","T1 bladder cancer: current considerations for diagnosis and management","Jordan B, Meeks JJ.","Nat Rev Urol. 2019 Jan;16(1):23-34. doi: 10.1038/s41585-018-0105-y.","Jordan B","Nat Rev Urol","2019","2018/10/17","","","10.1038/s41585-018-0105-y"
"15281321","The role of surgery in the multimodality treatment of bladder cancer","Coptcoat MJ, Oliver RT.","Cancer Surv. 1998;31:129-47.","Coptcoat MJ","Cancer Surv","1998","2004/07/30","","",""
"7452780","Feulgen-deoxyribonucleic acid values in the cytology of bladder cancer","Hoshi S, Orikasa S, Imai Y, Agatsuma Y.","J Urol. 1980 Nov;124(5):601-4. doi: 10.1016/s0022-5347(17)55574-3.","Hoshi S","J Urol","1980","1980/11/01","","","10.1016/s0022-5347(17)55574-3"
"18182674","Pleural metastasis in a patient with bladder cancer","Bonnin N, El Karak F, Droz JP, Flechon A.","J Clin Oncol. 2008 Jan 10;26(2):329-30. doi: 10.1200/JCO.2007.13.9865.","Bonnin N","J Clin Oncol","2008","2008/01/10","","","10.1200/JCO.2007.13.9865"
"28544294","Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review","Ngo B, Perera M, Papa N, Bolton D, Sengupta S.","BJU Int. 2017 May;119 Suppl 5:10-18. doi: 10.1111/bju.13821.","Ngo B","BJU Int","2017","2017/05/26","","","10.1111/bju.13821"
"1696738","Intraarterial chemotherapy for bladder cancer","Jacobs SC, Menashe DS.","Prog Clin Biol Res. 1990;350:101-6.","Jacobs SC","Prog Clin Biol Res","1990","1990/01/01","","",""
"23073555","Association of p53 Arg72Pro polymorphism with bladder cancer: a meta-analysis","Yang Z, Nie S, Zhu H, Wu X, Jia S, Luo Y, Tang W.","Gene. 2013 Jan 10;512(2):408-13. doi: 10.1016/j.gene.2012.09.085. Epub 2012 Oct 13.","Yang Z","Gene","2013","2012/10/18","","","10.1016/j.gene.2012.09.085"
"10383142","Optimizing syngeneic orthotopic murine bladder cancer (MB49)","Günther JH, Jurczok A, Wulf T, Brandau S, Deinert I, Jocham D, Böhle A.","Cancer Res. 1999 Jun 15;59(12):2834-7.","Günther JH","Cancer Res","1999","1999/06/26","","",""
"31355910","Overall survival is the primary endpoint in a trial of neoadjuvant chemotherapy for bladder cancer?","Takahashi T.","Cancer. 2019 Nov 15;125(22):4105-4106. doi: 10.1002/cncr.32415. Epub 2019 Jul 29.","Takahashi T","Cancer","2019","2019/07/30","","","10.1002/cncr.32415"
"23871799","Technologic developments in the field of photonics for the detection of urinary bladder cancer","Palmer S, Sokolovski SG, Rafailov E, Nabi G.","Clin Genitourin Cancer. 2013 Dec;11(4):390-6. doi: 10.1016/j.clgc.2013.04.016. Epub 2013 Jul 18.","Palmer S","Clin Genitourin Cancer","2013","2013/07/23","","","10.1016/j.clgc.2013.04.016"
"2051694","[Prognosis of the patients with high grade bladder carcinoma]","Matsuoka K, Ueda S, Hayashi K, Inada S, Noda S, Eto K.","Nihon Hinyokika Gakkai Zasshi. 1991 Apr;82(4):579-87. doi: 10.5980/jpnjurol1989.82.579.","Matsuoka K","Nihon Hinyokika Gakkai Zasshi","1991","1991/04/01","","","10.5980/jpnjurol1989.82.579"
"27149036","Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer","Chedgy EC, Black PC.","JAMA Oncol. 2016 Jul 1;2(7):855-6. doi: 10.1001/jamaoncol.2016.0149.","Chedgy EC","JAMA Oncol","2016","2016/05/06","","","10.1001/jamaoncol.2016.0149"
"32106776","Diagnostic Value of Combination of MicroRNA-192 in Urinary Sediment and B-Ultrasound for Bladder Cancer","Jiang F, Li C, Han J, Wang L.","Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033819894573. doi: 10.1177/1533033819894573.","Jiang F","Technol Cancer Res Treat","2020","2020/02/29","PMC7052445","","10.1177/1533033819894573"
"22343735","[Assessments of progression in non-muscle-invasive bladder cancer]","Suzuki K, Nohda H, Funahashi M, Chiba K, Shinagawa T, Mizuno N, Fujikawa N, Murakami T, Ikeda I, Kono N.","Hinyokika Kiyo. 2012 Jan;58(1):1-5.","Suzuki K","Hinyokika Kiyo","2012","2012/02/21","","",""
"2405994","Bladder cancer. Advances in laboratory innovations and clinical management, with emphasis on innovations allowing bladder-sparing approaches for patients with invasive tumors","Shipley WU, Prout GR Jr, Kaufman DS.","Cancer. 1990 Feb 1;65(3 Suppl):675-83. doi: 10.1002/1097-0142(19900201)65:3+<675::aid-cncr2820651310>3.0.co;2-6.","Shipley WU","Cancer","1990","1990/02/01","","","10.1002/1097-0142(19900201)65:3+<675::aid-cncr2820651310>3.0.co;2-6"
"28222088","Gender Differences in Bladder Cancer Treatment Decision Making","Pozzar RA, Berry DL.","Oncol Nurs Forum. 2017 Mar 1;44(2):204-209. doi: 10.1188/17.ONF.204-209.","Pozzar RA","Oncol Nurs Forum","2017","2017/02/22","","","10.1188/17.ONF.204-209"
"4977034","Treatment of infiltrating bladder cancer by cobalt 60 radiation: recurrence of tumor in bladder after initial disappearance","Engel RM, Urtasun RC, Jewett HJ, Lott SJ.","J Urol. 1969 Jun;101(6):859-62. doi: 10.1016/s0022-5347(17)62442-x.","Engel RM","J Urol","1969","1969/06/01","","","10.1016/s0022-5347(17)62442-x"
"7394954","The Makari skin test and immunocompetence in bladder cancer","Masters JR, Rigby CC, Munson KW, Tee DE.","Urol Res. 1980;8(2):95-100. doi: 10.1007/BF00271435.","Masters JR","Urol Res","1980","1980/01/01","","","10.1007/BF00271435"
"31399420","Scented Candles as an Unrecognized Factor that Increases the Risk of Bladder Cancer; Is There Enough Evidence to Raise a Red Flag?","Adamowicz J, Juszczak K, Poletajew S, Van Breda SV, Pokrywczynska M, Drewa T.","Cancer Prev Res (Phila). 2019 Oct;12(10):645-652. doi: 10.1158/1940-6207.CAPR-19-0093. Epub 2019 Aug 9.","Adamowicz J","Cancer Prev Res (Phila)","2019","2019/08/11","","","10.1158/1940-6207.CAPR-19-0093"
"25339141","Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link","Chamie K, Ballon-Landa E, Bassett JC, Daskivich TJ, Leventhal M, Deapen D, Litwin MS.","Cancer. 2015 Feb 1;121(3):379-85. doi: 10.1002/cncr.29071. Epub 2014 Oct 22.","Chamie K","Cancer","2015","2014/10/24","PMC6209593","NIHMS989725","10.1002/cncr.29071"
"8504942","Conservation treatment of muscle-invasive bladder cancer using radiotherapy","Parsons JT.","Front Radiat Ther Oncol. 1993;27:143-65. doi: 10.1159/000422089.","Parsons JT","Front Radiat Ther Oncol","1993","1993/01/01","","","10.1159/000422089"
"7459580","T3 bladder cancer--the case for salvage cystectomy","Blandy JP, England HR, Evans SJ, Hope-Stone HF, Mair GM, Mantell BS, Oliver RT, Paris AM, Risdon RA.","Br J Urol. 1980 Dec;52(6):506-10. doi: 10.1111/j.1464-410x.1980.tb03101.x.","Blandy JP","Br J Urol","1980","1980/12/01","","","10.1111/j.1464-410x.1980.tb03101.x"
"7067329","Radiation therapy before cystectomy in the management of patients with bladder cancer","Batata MA, Chu FC, Hilaris BS, Kim Y, Lee M, Chang B, Whitmore WF.","Clin Radiol. 1982 Jan;33(1):109-14. doi: 10.1016/s0009-9260(82)80372-3.","Batata MA","Clin Radiol","1982","1982/01/01","","","10.1016/s0009-9260(82)80372-3"
"15947579","Use of the novel marker BLCA-1 for the detection of bladder cancer","Myers-Irvin JM, Landsittel D, Getzenberg RH.","J Urol. 2005 Jul;174(1):64-8. doi: 10.1097/01.ju.0000162022.36772.a4.","Myers-Irvin JM","J Urol","2005","2005/06/11","","","10.1097/01.ju.0000162022.36772.a4"
"10736496","Urinary tissue polypeptide-specific antigen for the diagnosis of bladder cancer","Sánchez-Carbayo M, Urrutia M, Silva JM, Romaní R, García J, Alférez F, González deBuitrago JM, Navajo JA.","Urology. 2000 Apr;55(4):526-32. doi: 10.1016/s0090-4295(99)00557-9.","Sánchez-Carbayo M","Urology","2000","2000/03/29","","","10.1016/s0090-4295(99)00557-9"
"9114520","[Epidemiology and diagnosis of bladder tumors]","Coulange C, Rossi D.","Rev Prat. 1997 Feb 15;47(4):369-73.","Coulange C","Rev Prat","1997","1997/02/15","","",""
"6762743","[Bladder cancer in Denmark in 1943-1977. Cancer statistics 4]","Jensen OM, Larsen A.","Ugeskr Laeger. 1982 Nov 15;144(46):3458-60.","Jensen OM","Ugeskr Laeger","1982","1982/11/15","","",""
"24998186","Molecular classification of non-muscle-invasive bladder cancer (pTa low-grade, pT1 low-grade, and pT1 high-grade subgroups) using methylation of tumor-suppressor genes","Sacristan R, Gonzalez C, Fernández-Gómez JM, Fresno F, Escaf S, Sánchez-Carbayo M.","J Mol Diagn. 2014 Sep;16(5):564-572. doi: 10.1016/j.jmoldx.2014.04.007. Epub 2014 Jul 3.","Sacristan R","J Mol Diagn","2014","2014/07/08","","","10.1016/j.jmoldx.2014.04.007"
"27586262","microRNA expression profiles as decision-making biomarkers in the management of bladder cancer","Amir S, Mabjeesh NJ.","Histol Histopathol. 2017 Feb;32(2):107-119. doi: 10.14670/HH-11-814. Epub 2016 Sep 2.","Amir S","Histol Histopathol","2017","2016/09/03","","","10.14670/HH-11-814"
"28487492","Sequencing of cancer cell subpopulations identifies micrometastases in a bladder cancer patient","Prado K, Zhang KX, Pellegrini M, Chin AI.","Oncotarget. 2017 Jul 11;8(28):45619-45625. doi: 10.18632/oncotarget.17312.","Prado K","Oncotarget","2017","2017/05/11","PMC5542213","","10.18632/oncotarget.17312"
"28870862","Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer","Sanchez A, Wszolek MF, Niemierko A, Clayman RH, Drumm M, Rodríguez D, Feldman AS, Dahl DM, Heney NM, Shipley WU, Zietman AL, Efstathiou JA.","J Urol. 2018 Feb;199(2):407-415. doi: 10.1016/j.juro.2017.08.106. Epub 2017 Sep 1.","Sanchez A","J Urol","2018","2017/09/06","","","10.1016/j.juro.2017.08.106"
"20844851","[Oncological pelvic surgery under urological aspects: bladder carcinoma]","Kübler H, Gschwend JE.","Chirurg. 2010 Oct;81(10):883-8. doi: 10.1007/s00104-010-1943-1.","Kübler H","Chirurg","2010","2010/09/17","","","10.1007/s00104-010-1943-1"
"5581468","[Bladder cancer: therapeutic results with combined surgery and telecobalt]","Feremans W, Segers G.","Acta Urol Belg. 1971 Jan;39(1):36-43.","Feremans W","Acta Urol Belg","1971","1971/01/01","","",""
"25123040","miRNA panels as biomarkers for bladder cancer","Tölle A, Ratert N, Jung K.","Biomark Med. 2014;8(5):733-46. doi: 10.2217/bmm.14.26.","Tölle A","Biomark Med","2014","2014/08/16","","","10.2217/bmm.14.26"
"2699072","Quality of life in patients with advanced bladder cancer. A randomized study comparing cystectomy and irradiation--the Danish Bladder Cancer Study Group (DAVECA protocol 8201)","Mommsen S, Jakobsen A, Sell A.","Scand J Urol Nephrol Suppl. 1989;125:115-20.","Mommsen S","Scand J Urol Nephrol Suppl","1989","1989/01/01","","",""
"20657288","Cancer stem cells in bladder cancer: a revisited and evolving concept","Chan KS, Volkmer JP, Weissman I.","Curr Opin Urol. 2010 Sep;20(5):393-7. doi: 10.1097/MOU.0b013e32833cc9df.","Chan KS","Curr Opin Urol","2010","2010/07/27","PMC2997612","NIHMS244165","10.1097/MOU.0b013e32833cc9df"
"1877115","Transurethral resection and intravesical therapy of superficial bladder tumors","Herr HW.","Urol Clin North Am. 1991 Aug;18(3):525-8.","Herr HW","Urol Clin North Am","1991","1991/08/01","","",""
"6009673","[Studies on carcinoma of the urinary bladder. II. Clinical observations on 244 cases of bladder cancer]","Yoshida O.","Hinyokika Kiyo. 1966 Nov;12(11):1261-80.","Yoshida O","Hinyokika Kiyo","1966","1966/11/01","","",""
"7153097","Carcinoma of the urinary bladder T3NxMo treated by preoperative irradiation followed by simple cystectomy","van der Werf-Messing BH, Friedell GH, Menon RS, Hop WC, Wassif SB.","Int J Radiat Oncol Biol Phys. 1982 Nov;8(11):1849-55. doi: 10.1016/0360-3016(82)90441-2.","van der Werf-Messing BH","Int J Radiat Oncol Biol Phys","1982","1982/11/01","","","10.1016/0360-3016(82)90441-2"
"27098923","Effects of hyperthermia in neutralising mechanisms of drug resistance in non-muscle-invasive bladder cancer","van der Heijden AG, Dewhirst MW.","Int J Hyperthermia. 2016 Jun;32(4):434-45. doi: 10.3109/02656736.2016.1155761. Epub 2016 Apr 20.","van der Heijden AG","Int J Hyperthermia","2016","2016/04/22","","","10.3109/02656736.2016.1155761"
"2467028","[Manual for pre- and postoperative patient care. Bladder cancer]","Tsuchimoto K, Watanabe N, Anzai C.","Kango Gijutsu. 1989 Jan;35(2):202-5.","Tsuchimoto K","Kango Gijutsu","1989","1989/01/01","","",""
"8766082","[Is there a role for partial cystectomy in the treatment of infiltrating bladder cancer? (2nd part)]","Escudero Barrilero A, Lovaco Castellanos F, García Cuerpo E, Navio Niño S, Allona Almagro A, Crespo Martinez L, Gómez V, Carrera C.","Arch Esp Urol. 1996 Jun;49(5):453-64.","Escudero Barrilero A","Arch Esp Urol","1996","1996/06/01","","",""
"19764530","[Prognosis of local recurrence after radical cystectomy for bladder cancer]","Fukuta F, Honma I, Muto M, Masumori N, Tsukamoto T.","Hinyokika Kiyo. 2009 Aug;55(8):469-73.","Fukuta F","Hinyokika Kiyo","2009","2009/09/22","","",""
"23712207","Aberrant expression of microRNAs in bladder cancer","Yoshino H, Seki N, Itesako T, Chiyomaru T, Nakagawa M, Enokida H.","Nat Rev Urol. 2013 Jul;10(7):396-404. doi: 10.1038/nrurol.2013.113. Epub 2013 May 28.","Yoshino H","Nat Rev Urol","2013","2013/05/29","","","10.1038/nrurol.2013.113"
"4140685","[Telecobalt in the treatment of bladder cancer. Results after 5 years and postradiotherapy sequelae]","Feremans W, Dewelde-Turpin J, Segers G.","Acta Urol Belg. 1974 Jul;42(3):298-306.","Feremans W","Acta Urol Belg","1974","1974/07/01","","",""
"1649927","High energy underwater shock wave treatment on implanted urinary bladder cancer in rabbits","Hoshi S, Orikasa S, Kuwahara M, Suzuki K, Yoshikawa K, Saitoh S, Ohyama C, Satoh M, Kawamura S, Nose M.","J Urol. 1991 Aug;146(2):439-43. doi: 10.1016/s0022-5347(17)37820-5.","Hoshi S","J Urol","1991","1991/08/01","","","10.1016/s0022-5347(17)37820-5"
"26684181","Utility of lymphadenectomy following cystectomy for non-urothelial bladder cancer: a systematic review","Crozier J, Demkiw S, Lawrentschuk N.","Minerva Urol Nefrol. 2016 Apr;68(2):185-91. Epub 2015 Dec 18.","Crozier J","Minerva Urol Nefrol","2016","2015/12/20","","",""
"16474441","Early cystectomy for clinical stage T1 bladder cancer","Hollenbeck BK, Montie JE.","Nat Clin Pract Urol. 2004 Nov;1(1):4-5. doi: 10.1038/ncpuro0008.","Hollenbeck BK","Nat Clin Pract Urol","2004","2006/02/14","","","10.1038/ncpuro0008"
"21498726","15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment","Krause FS, Walter B, Ott OJ, Häberle L, Weiss C, Rödel C, Wullich B, Sauer R.","Anticancer Res. 2011 Mar;31(3):985-90.","Krause FS","Anticancer Res","2011","2011/04/19","","",""
"24872993","Bladder cancer: gender disparities may delay diagnosis in women","","Johns Hopkins Med Lett Health After 50. 2014 Apr;26(2):5.","","Johns Hopkins Med Lett Health After 50","2014","2014/05/31","","",""
"7415196","Bladder cancer--early detection and diagnosis","Buchanan-Davidson DJ.","Wis Med J. 1980 Jul;79(7):39-40.","Buchanan-Davidson DJ","Wis Med J","1980","1980/07/01","","",""
"4178239","[Clinical and pathological studies on partial cystectomy for urinary bladder cancer. 3. Studies on intermdiary tissue response at the site of and around the tumor]","Onodera Y.","Nihon Hinyokika Gakkai Zasshi. 1968 Jul;59(7):605-19. doi: 10.5980/jpnjurol1928.59.7_605.","Onodera Y","Nihon Hinyokika Gakkai Zasshi","1968","1968/07/01","","","10.5980/jpnjurol1928.59.7_605"
"25668830","[Epidemiology of and risk factors for bladder cancer and for urothelial tumors]","Guillaume L, Guy L.","Rev Prat. 2014 Dec;64(10):1372-4, 1378-80.","Guillaume L","Rev Prat","2014","2015/02/12","","",""
"18095885","Bladder cancer following upper tract urothelial carcinoma","Kauffman EC, Raman JD.","Expert Rev Anticancer Ther. 2008 Jan;8(1):75-85. doi: 10.1586/14737140.8.1.75.","Kauffman EC","Expert Rev Anticancer Ther","2008","2007/12/22","","","10.1586/14737140.8.1.75"
"3133024","Delays in diagnosing and treating bladder cancer","Stower MJ.","Br Med J (Clin Res Ed). 1988 Apr 30;296(6631):1228-9. doi: 10.1136/bmj.296.6631.1228.","Stower MJ","Br Med J (Clin Res Ed)","1988","1988/04/30","PMC2545705","","10.1136/bmj.296.6631.1228"
"17158539","Trimodality treatment and selective organ preservation for bladder cancer","Rödel C, Weiss C, Sauer R.","J Clin Oncol. 2006 Dec 10;24(35):5536-44. doi: 10.1200/JCO.2006.07.6729.","Rödel C","J Clin Oncol","2006","2006/12/13","","","10.1200/JCO.2006.07.6729"
"16818185","Bladder cancer: toward state of the art multidisciplinary molecular medicine","Rashid HH, Koeneman KS.","Urol Oncol. 2006 Jul-Aug;24(4):322-3. doi: 10.1016/j.urolonc.2005.11.029.","Rashid HH","Urol Oncol","2006","2006/07/05","","","10.1016/j.urolonc.2005.11.029"
"23083902","ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers","Kamat AM, Hegarty PK, Gee JR, Clark PE, Svatek RS, Hegarty N, Shariat SF, Xylinas E, Schmitz-Dräger BJ, Lotan Y, Jenkins LC, Droller M, van Rhijn BW, Karakiewicz PI; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012.","Eur Urol. 2013 Jan;63(1):4-15. doi: 10.1016/j.eururo.2012.09.057. Epub 2012 Oct 4.","Kamat AM","Eur Urol","2013","2012/10/23","","","10.1016/j.eururo.2012.09.057"
"23773097","Contemplating bladder cancer care: can we cut costs and improve quality of care?","Aarsæther E, Patel HR.","Expert Rev Anticancer Ther. 2013 Jun;13(6):639-40. doi: 10.1586/era.13.29.","Aarsæther E","Expert Rev Anticancer Ther","2013","2013/06/19","","","10.1586/era.13.29"
"11286015","Matrix metalloproteinases and bladder cancer","Kanayama H.","J Med Invest. 2001 Feb;48(1-2):31-43.","Kanayama H","J Med Invest","2001","2001/04/05","","",""
"2224432","Initial evaluation and response criteria for patients with superficial bladder cancer. Report of a workshop","Soloway MS, Murphy WM, Johnson DE, Farrow GM, Paulson DF, Garnick MB.","Br J Urol. 1990 Oct;66(4):380-5. doi: 10.1111/j.1464-410x.1990.tb14958.x.","Soloway MS","Br J Urol","1990","1990/10/01","","","10.1111/j.1464-410x.1990.tb14958.x"
"26481720","NBI: results review","Racioppi M, D'Agostino D, Ragonese M, Gianfrancesco LD, Bassi PF.","Urologia. 2015 Oct;82 Suppl 2:S9-11. doi: 10.5301/uro.5000155. Epub 2015 Oct 9.","Racioppi M","Urologia","2015","2015/10/21","","","10.5301/uro.5000155"
"3851016","[Pre and postoperative nursing of patients with bladder cancer. Need for continued nursing of patients with urostomy--a clinical case with a complex family background]","Noguchi N, Torii S, Sugiura M.","Kango Gijutsu. 1985 Aug;31(11):1471-4.","Noguchi N","Kango Gijutsu","1985","1985/08/01","","",""
"18815920","Infection: is it a cause of bladder cancer?","Abol-Enein H.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):79-84. doi: 10.1080/03008880802325309.","Abol-Enein H","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802325309"
"6822032","Radiation treatment planning for bladder cancer: a comparison of cystogram localisation with computed tomography","Rothwell RI, Ash DV, Jones WG.","Clin Radiol. 1983 Jan;34(1):103-11. doi: 10.1016/s0009-9260(83)80400-0.","Rothwell RI","Clin Radiol","1983","1983/01/01","","","10.1016/s0009-9260(83)80400-0"
"18683571","Effective bladder preservation strategy with low-dose radiation therapy and concurrent intraarterial chemotherapy for muscle-invasive bladder cancer","Ikushima H, Iwamoto S, Osaki K, Furutani S, Yamashita K, Kawanaka T, Kubo A, Takegawa Y, Kudoh T, Kanayama H, Nishitani H.","Radiat Med. 2008 Apr;26(3):156-63. doi: 10.1007/s11604-007-0211-x.","Ikushima H","Radiat Med","2008","2008/08/08","","","10.1007/s11604-007-0211-x"
"4084728","The role of endoscopic treatment after radical radiotherapy for invasive bladder cancer","Smith G, Quilty PM, Duncan W, Chisholm GD, Newsam JE, Hargreave TB.","Br J Urol. 1985 Dec;57(6):694-9. doi: 10.1111/j.1464-410x.1985.tb07034.x.","Smith G","Br J Urol","1985","1985/12/01","","","10.1111/j.1464-410x.1985.tb07034.x"
"2406685","[Histopathologic characteristics and clinical behavior of superficial bladder tumors]","Kolozsy Z, Samodai L, Mohácsi L, Dauda G, Endresz KF.","Orv Hetil. 1990 Feb 11;131(6):283-4, 287-9.","Kolozsy Z","Orv Hetil","1990","1990/02/11","","",""
"12109354","Potential lifestyle and dietary supplement options for the prevention and postdiagnosis of bladder cancer","Moyad MA.","Urol Clin North Am. 2002 Feb;29(1):31-48, viii. doi: 10.1016/s0094-0143(02)00013-7.","Moyad MA","Urol Clin North Am","2002","2002/07/12","","","10.1016/s0094-0143(02)00013-7"
"2513863","Evaluation of a model to predict recurrence after radical cystectomy in bilharzial bladder cancer patients","Rafla M, Ibrahim AS, Valleron AJ, Mary JY.","Br J Cancer. 1989 Dec;60(6):925-7. doi: 10.1038/bjc.1989.391.","Rafla M","Br J Cancer","1989","1989/12/01","PMC2247275","","10.1038/bjc.1989.391"
"19069481","[Frequency and stage of relapse after organ-saving combined treatment for urinary bladder cancer]","Nabruzov SN, Vakhabov OU.","Vopr Onkol. 2008;54(5):636-8.","Nabruzov SN","Vopr Onkol","2008","2008/12/17","","",""
"23790610","Elective bladder-sparing treatment for muscle invasive bladder cancer","Lendínez-Cano G, Rico-López J, Moreno S, Fernández Parra E, González-Almeida C, Camacho Martínez E.","Actas Urol Esp. 2014 Jan-Feb;38(1):7-13. doi: 10.1016/j.acuro.2013.03.004. Epub 2013 Jun 20.","Lendínez-Cano G","Actas Urol Esp","2014","2013/06/25","","","10.1016/j.acuro.2013.03.004"
"18455771","Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis","Koga F, Yoshida S, Kawakami S, Kageyama Y, Yokoyama M, Saito K, Fujii Y, Kobayashi T, Kihara K.","Urology. 2008 Aug;72(2):384-8. doi: 10.1016/j.urology.2008.03.017. Epub 2008 May 2.","Koga F","Urology","2008","2008/05/06","","","10.1016/j.urology.2008.03.017"
"8105131","[Immunohistochemical investigation of proliferating cell nuclear antigen in bladder cancer]","Sumiyoshi Y, Inoue Y, Akiyama M.","Nihon Hinyokika Gakkai Zasshi. 1993 Sep;84(9):1643-8. doi: 10.5980/jpnjurol1989.84.1643.","Sumiyoshi Y","Nihon Hinyokika Gakkai Zasshi","1993","1993/09/01","","","10.5980/jpnjurol1989.84.1643"
"20383183","Bladder cancer: nomogram aids clinical decision making after radical cystectomy","Shariat SF, Tilki D.","Nat Rev Urol. 2010 Apr;7(4):182-4. doi: 10.1038/nrurol.2010.42.","Shariat SF","Nat Rev Urol","2010","2010/04/13","","","10.1038/nrurol.2010.42"
"11149341","[Surgical treatment of urinary bladder cancer]","Lopatkin NA, Martov AG, Darenkov SP, Kamalov AA, Kudriavtsev IuV.","Urol Nefrol (Mosk). 1999 Jan-Feb;(1):26-31.","Lopatkin NA","Urol Nefrol (Mosk)","1999","2001/01/10","","",""
"2230190","[Urothelial bladder tumors in stage pTa. I.--What is the risk for the patient?]","Bittard H.","J Urol (Paris). 1990;96(5):263-5.","Bittard H","J Urol (Paris)","1990","1990/01/01","","",""
"557691","[A study of 200 cases of bladder cancer: relation of pathological characteristics to prognosis (author's transl)]","Matsumura Y, Niijima T.","Nihon Hinyokika Gakkai Zasshi. 1977 Jan;68(1):1-10. doi: 10.5980/jpnjurol1928.68.1_1.","Matsumura Y","Nihon Hinyokika Gakkai Zasshi","1977","1977/01/01","","","10.5980/jpnjurol1928.68.1_1"
"11780425","Transurethral microwave needle ablation for bladder cancer","Sun Y, Xu C, Qian S, Qu C, Zhao J, Ma Y.","Chin Med J (Engl). 2001 May;114(5):546-7.","Sun Y","Chin Med J (Engl)","2001","2002/01/10","","",""
"6506320","[Occupational bladder cancer]","Hansen KS, Jensen AA.","Ugeskr Laeger. 1984 Oct 29;146(44):3393-8.","Hansen KS","Ugeskr Laeger","1984","1984/10/29","","",""
"15283883","The International Bladder Cancer Bank: proposal for a new study concept","Goebell PJ, Groshen S, Schmitz-Dräger BJ, Sylvester R, Kogevinas M, Malats N, Sauter G, Barton Grossman H, Waldman F, Cote RJ.","Urol Oncol. 2004 Jul-Aug;22(4):277-84. doi: 10.1016/S1078-1439(03)00175-3.","Goebell PJ","Urol Oncol","2004","2004/07/31","","","10.1016/S1078-1439(03)00175-3"
"22010395","Bladder cancer: imperatives for personalized medicine","Kamat AM, Mathew P.","Oncology (Williston Park). 2011 Sep;25(10):951-8, 960.","Kamat AM","Oncology (Williston Park)","2011","2011/10/21","","",""
"11872337","Current perspectives in muscle invasive bladder cancer","Sternberg CN.","Eur J Cancer. 2002 Mar;38(4):460-7. doi: 10.1016/s0959-8049(01)00393-8.","Sternberg CN","Eur J Cancer","2002","2002/03/02","","","10.1016/s0959-8049(01)00393-8"
"31556547","Environment and urinary bladder cancer. A historical perspective","Nesi G, Galli IC, Amorosi A, Santi R.","Pol J Pathol. 2019;70(1):21-25. doi: 10.5114/pjp.2019.84458.","Nesi G","Pol J Pathol","2019","2019/09/27","","","10.5114/pjp.2019.84458"
"18723977","Localized amyloidosis of the urinary bladder, clinically masquerading as bladder cancer","DeSouza MA, Rekhi B, Thyavihally YB, Tongaonkar HB, Desai SB.","Indian J Pathol Microbiol. 2008 Jul-Sep;51(3):415-7. doi: 10.4103/0377-4929.42547.","DeSouza MA","Indian J Pathol Microbiol","2008","2008/08/30","","","10.4103/0377-4929.42547"
"22872227","An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment","Kang MR, Yang G, Charisse K, Epstein-Barash H, Manoharan M, Li LC.","J Vis Exp. 2012 Jul 28;(65):4207. doi: 10.3791/4207.","Kang MR","J Vis Exp","2012","2012/08/09","PMC3476411","","10.3791/4207"
"2181313","Biology and management of bladder cancer","Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP.","N Engl J Med. 1990 Apr 19;322(16):1129-38. doi: 10.1056/NEJM199004193221607.","Raghavan D","N Engl J Med","1990","1990/04/19","","","10.1056/NEJM199004193221607"
"23818355","Relationship of TP53 and Ki67 expression in bladder cancer under WHO 2004 classification","Wang L, Feng C, Ding G, Zhou Z, Jiang H, Wu Z.","J BUON. 2013 Apr-Jun;18(2):420-4.","Wang L","J BUON","2013","2013/07/03","","",""
"19388981","Mouse orthotopic models for bladder cancer research","Chan E, Patel A, Heston W, Larchian W.","BJU Int. 2009 Nov;104(9):1286-91. doi: 10.1111/j.1464-410X.2009.08577.x. Epub 2009 Apr 16.","Chan E","BJU Int","2009","2009/04/25","","","10.1111/j.1464-410X.2009.08577.x"
"326397","Development and application of basic research techniques in bladder cancer research","Paulson DF, Stone KR, Mickey DD, Bonar RA, Wunderli H.","Cancer Res. 1977 Aug;37(8 Pt 2):2969-73.","Paulson DF","Cancer Res","1977","1977/08/01","","",""
"3918371","Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy","Herr HW.","Urology. 1985 Feb;25(2):127-34. doi: 10.1016/0090-4295(85)90527-8.","Herr HW","Urology","1985","1985/02/01","","","10.1016/0090-4295(85)90527-8"
"28415699","The prognostic value of histological subtype in patients with metastatic bladder cancer","Chen C, Hu L, Chen Y, Hou J.","Oncotarget. 2017 Apr 25;8(17):28408-28417. doi: 10.18632/oncotarget.16083.","Chen C","Oncotarget","2017","2017/04/19","PMC5438659","","10.18632/oncotarget.16083"
"4872277","[Cryotherapy of bladder cancer]","Sigel A, Schrott KM.","Urologe. 1967 May-Jun;6(3):190-6.","Sigel A","Urologe","1967","1967/05/01","","",""
"26327355","Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria","van Kessel KE, Van Neste L, Lurkin I, Zwarthoff EC, Van Criekinge W.","J Urol. 2016 Mar;195(3):601-7. doi: 10.1016/j.juro.2015.08.085. Epub 2015 Aug 29.","van Kessel KE","J Urol","2016","2015/09/02","","","10.1016/j.juro.2015.08.085"
"4968247","Combined therapy: radiation and surgery in the treatment of bladder cancer","Laskowski TZ, Scott R Jr, Hudgins PT.","J Urol. 1968 Jun;99(6):733-9. doi: 10.1016/s0022-5347(17)62781-2.","Laskowski TZ","J Urol","1968","1968/06/01","","","10.1016/s0022-5347(17)62781-2"
"2485846","[Sequential changes in superficial bladder cancer]","Matsuda M.","Nihon Hinyokika Gakkai Zasshi. 1989;80(13 Suppl):1881-2. doi: 10.5980/jpnjurol.80.1881.","Matsuda M","Nihon Hinyokika Gakkai Zasshi","1989","1989/01/01","","","10.5980/jpnjurol.80.1881"
"30390141","Molecular Characterization of Bladder Cancer","Chandrasekar T, Erlich A, Zlotta AR.","Curr Urol Rep. 2018 Nov 3;19(12):107. doi: 10.1007/s11934-018-0853-5.","Chandrasekar T","Curr Urol Rep","2018","2018/11/04","","","10.1007/s11934-018-0853-5"
"26662386","Prognostic role of microRNA-100 in patients with bladder cancer","Cao YH, Zhang HH, Xu HF, Duan YJ, Li Q, Huang B.","Genet Mol Res. 2015 Dec 7;14(4):15948-54. doi: 10.4238/2015.December.7.6.","Cao YH","Genet Mol Res","2015","2015/12/15","","","10.4238/2015.December.7.6"
"23342256","CIP2A protein expression in high-grade, high-stage bladder cancer","Huang LP, Savoly D, Sidi AA, Adelson ME, Mordechai E, Trama JP.","Cancer Med. 2012 Aug;1(1):76-81. doi: 10.1002/cam4.15. Epub 2012 Jul 15.","Huang LP","Cancer Med","2012","2013/01/24","PMC3544439","","10.1002/cam4.15"
"5091525","A possible role of urinary metabolites of tryptophan in the heterotopic recurrence of bladder cancer in man","Yoshida O, Brown RR, Bryan GT.","Am J Clin Nutr. 1971 Jul;24(7):848-51. doi: 10.1093/ajcn/24.7.848.","Yoshida O","Am J Clin Nutr","1971","1971/07/01","","","10.1093/ajcn/24.7.848"
"17112450","Importance of node dissection in relation to neoadjuvant and adjuvant therapy","Huang WC, Bochner BH.","J Natl Compr Canc Netw. 2006 Nov;4(10):1019-26. doi: 10.6004/jnccn.2006.0085.","Huang WC","J Natl Compr Canc Netw","2006","2006/11/23","","","10.6004/jnccn.2006.0085"
"18588454","Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancer","Bruins HM, Stein JP.","Expert Rev Anticancer Ther. 2008 Jul;8(7):1091-101. doi: 10.1586/14737140.8.7.1091.","Bruins HM","Expert Rev Anticancer Ther","2008","2008/07/01","","","10.1586/14737140.8.7.1091"
"28248032","[The risk of bladder cancer in patients with prostatic hyperplasia and strategies to manage this combination]","Alyaev YG, Pshikhachev AM, Perekalina AN.","Urologiia. 2016 Nov;(5):115-118.","Alyaev YG","Urologiia","2016","2017/03/02","","",""
"1693120","Diesel exhaust exposure and bladder cancer risk","Iyer V, Harris RE, Wynder EL.","Eur J Epidemiol. 1990 Mar;6(1):49-54. doi: 10.1007/BF00155549.","Iyer V","Eur J Epidemiol","1990","1990/03/01","","","10.1007/BF00155549"
"28889375","A Versatile Assay for Detection of Aberrant DNA Methylation in Bladder Cancer","Tommasi S, Besaratinia A.","Methods Mol Biol. 2018;1655:29-41. doi: 10.1007/978-1-4939-7234-0_3.","Tommasi S","Methods Mol Biol","2018","2017/09/11","PMC6340640","NIHMS1006444","10.1007/978-1-4939-7234-0_3"
"10490387","Fluid intake and bladder cancer","Goldstein MR.","N Engl J Med. 1999 Sep 9;341(11):847-8. doi: 10.1056/NEJM199909093411113.","Goldstein MR","N Engl J Med","1999","1999/09/18","","","10.1056/NEJM199909093411113"
"19031931","Morphological and molecular profiles and pathways in bladder neoplasms","Lopez-Beltran A, Cheng L, Mazzucchelli R, Bianconi M, Blanca A, Scarpelli M, Montironi R.","Anticancer Res. 2008 Sep-Oct;28(5B):2893-900.","Lopez-Beltran A","Anticancer Res","2008","2008/11/27","","",""
"2092768","Bladder cancer","Mead GM.","Curr Opin Oncol. 1990 Jun;2(3):514-9.","Mead GM","Curr Opin Oncol","1990","1990/06/01","","",""
"23040255","Neoadjuvant and adjuvant chemotherapy approaches for invasive bladder cancer","Raghavan D, Burgess E, Gaston KE, Haake MR, Riggs SB.","Semin Oncol. 2012 Oct;39(5):588-97. doi: 10.1053/j.seminoncol.2012.08.003.","Raghavan D","Semin Oncol","2012","2012/10/09","","","10.1053/j.seminoncol.2012.08.003"
"9880476","Relationship between schistosomiasis and bladder cancer","Mostafa MH, Sheweita SA, O'Connor PJ.","Clin Microbiol Rev. 1999 Jan;12(1):97-111.","Mostafa MH","Clin Microbiol Rev","1999","1999/01/09","PMC88908","",""
"6473404","Salvage cystectomy in the treatment of invasive bladder cancer","Blandy JP, Hope-Stone HF, Oliver RT, England HR.","Prog Clin Biol Res. 1984;153:359-63.","Blandy JP","Prog Clin Biol Res","1984","1984/01/01","","",""
"25747698","Management of transitional cell carcinoma of the urinary bladder in dogs: a review","Fulkerson CM, Knapp DW.","Vet J. 2015 Aug;205(2):217-25. doi: 10.1016/j.tvjl.2015.01.017. Epub 2015 Jan 26.","Fulkerson CM","Vet J","2015","2015/03/10","","","10.1016/j.tvjl.2015.01.017"
"27370177","Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends","Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F.","Eur Urol. 2017 Jan;71(1):96-108. doi: 10.1016/j.eururo.2016.06.010. Epub 2016 Jun 28.","Antoni S","Eur Urol","2017","2016/07/03","","","10.1016/j.eururo.2016.06.010"
"10910229","Prognostic value of tumor-associated macrophage count in human bladder cancer","Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N, Nomura Y.","Int J Urol. 2000 Jul;7(7):263-9. doi: 10.1046/j.1442-2042.2000.00190.x.","Hanada T","Int J Urol","2000","2000/07/26","","","10.1046/j.1442-2042.2000.00190.x"
"11345027","New biochemical mechanisms of the anticancer effect of Ukrain in the treatment of cancer of the urinary bladder","Nefyodov LI, Uglyanitsa KN, Nechiporenko NA, Smirnov VY, Brzosko W, Karavay NL.","Drugs Exp Clin Res. 2000;26(5-6):195-9.","Nefyodov LI","Drugs Exp Clin Res","2000","2001/05/10","","",""
"25836927","Epidemiology of bladder cancer","Malats N, Real FX.","Hematol Oncol Clin North Am. 2015 Apr;29(2):177-89, vii. doi: 10.1016/j.hoc.2014.10.001.","Malats N","Hematol Oncol Clin North Am","2015","2015/04/04","","","10.1016/j.hoc.2014.10.001"
"26656514","Toward Personalized Guidelines in Bladder Cancer","Clark PE.","J Natl Compr Canc Netw. 2015 Dec;13(12):1458-60. doi: 10.6004/jnccn.2015.0173.","Clark PE","J Natl Compr Canc Netw","2015","2015/12/15","","","10.6004/jnccn.2015.0173"
"15914744","Detection of bladder cancer using a proteomic assay","Ciatto S.","JAMA. 2005 May 25;293(20):2467; author reply 2467. doi: 10.1001/jama.293.20.2467-a.","Ciatto S","JAMA","2005","2005/05/26","","","10.1001/jama.293.20.2467-a"
"2722605","Radiotherapy and cisplatin for invasive bladder cancer: criteria of ""complete response""","Sauer R.","Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1653. doi: 10.1016/0360-3016(89)90978-4.","Sauer R","Int J Radiat Oncol Biol Phys","1989","1989/06/01","","","10.1016/0360-3016(89)90978-4"
"5036016","Pre-operative irradiation combined with cystectomy in the management of bladder cancer","Whitmore WF Jr.","Br J Urol. 1972 Feb;44(1):127.","Whitmore WF Jr","Br J Urol","1972","1972/02/01","","",""
"21837494","[Urothelial carcinoma]","Rübben H, Vom Dorp F.","Urologe A. 2011 Sep;50 Suppl 1:176-8. doi: 10.1007/s00120-011-2669-5.","Rübben H","Urologe A","2011","2011/08/13","","","10.1007/s00120-011-2669-5"
"9825452","[Supravesical urinary diversion--a palliative treatment method for patients with inoperable bladder cancer]","Prokhozhev AIu, Komiakov BK.","Vestn Khir Im I I Grek. 1998;157(4):101-2.","Prokhozhev AIu","Vestn Khir Im I I Grek","1998","1998/11/24","","",""
"20818136","Efficacy of transurethral resection of the bladder tumor (TUR-BT) for huge bladder cancer","Hamasaki T, Suzuki Y, Tomita Y, Kimura G, Kondo Y.","J Nippon Med Sch. 2010 Aug;77(4):190-4. doi: 10.1272/jnms.77.190.","Hamasaki T","J Nippon Med Sch","2010","2010/09/07","","","10.1272/jnms.77.190"
"6789529","Bladder cancer in men and women treated by radiation therapy and/or radical cystectomy","Batata MA, Chu FC, Hilaris BS, Whitmore WF, Kim YS, Lee MZ.","Urology. 1981 Jul;18(1):15-20. doi: 10.1016/0090-4295(81)90488-x.","Batata MA","Urology","1981","1981/07/01","","","10.1016/0090-4295(81)90488-x"
"2766267","Effect of psychoeducational intervention on anxiety among Egyptian bladder cancer patients","Ali NS, Khalil HZ.","Cancer Nurs. 1989 Aug;12(4):236-42.","Ali NS","Cancer Nurs","1989","1989/08/01","","",""
"17382796","Multimodality bladder preservation therapy for muscle-invasive bladder tumors","Fernando SA, Sandler HM.","Semin Oncol. 2007 Apr;34(2):129-34. doi: 10.1053/j.seminoncol.2006.12.009.","Fernando SA","Semin Oncol","2007","2007/03/27","","","10.1053/j.seminoncol.2006.12.009"
"28245143","DWI as an Imaging Biomarker for Bladder Cancer","Yoshida S, Takahara T, Kwee TC, Waseda Y, Kobayashi S, Fujii Y.","AJR Am J Roentgenol. 2017 Jun;208(6):1218-1228. doi: 10.2214/AJR.17.17798. Epub 2017 Feb 28.","Yoshida S","AJR Am J Roentgenol","2017","2017/03/01","","","10.2214/AJR.17.17798"
"19093177","Contemporary management of muscle-invasive bladder cancer","Yafi FA, Steinberg JR, Kassouf W.","Int J Clin Oncol. 2008 Dec;13(6):504-9. doi: 10.1007/s10147-008-0788-9. Epub 2008 Dec 18.","Yafi FA","Int J Clin Oncol","2008","2008/12/19","","","10.1007/s10147-008-0788-9"
"29291665","An updated review on primary signet-ring cell carcinoma of the urinary bladder and report of a case","Lendorf ME, Dohn LH, Á Dunga B, Loya AC, Pappot H.","Scand J Urol. 2018 Apr;52(2):87-93. doi: 10.1080/21681805.2017.1418020. Epub 2018 Jan 1.","Lendorf ME","Scand J Urol","2018","2018/01/03","","","10.1080/21681805.2017.1418020"
"698919","Clinical bladder cancer in sponge matrix tissue culture: procedures for collection, cultivation, and assessment of viability","Abaza NA, Leighton J, Zajac BA.","Cancer. 1978 Sep;42(3):1364-74. doi: 10.1002/1097-0142(197809)42:3<1364::aid-cncr2820420347>3.0.co;2-b.","Abaza NA","Cancer","1978","1978/09/01","","","10.1002/1097-0142(197809)42:3<1364::aid-cncr2820420347>3.0.co;2-b"
"11708492","A possible noninvasive method for the detection of bladder cancer in patients: microsatellite analysis of free DNA in urine and blood","Utting M, Werner W, Müller G, Schubert J, Junker K.","Ann N Y Acad Sci. 2001 Sep;945:31-5. doi: 10.1111/j.1749-6632.2001.tb03861.x.","Utting M","Ann N Y Acad Sci","2001","2001/11/16","","","10.1111/j.1749-6632.2001.tb03861.x"
"25668833","[Bladder cancer: interpretation of international recommendations]","Rivière A, Ploussard G, Desgrandchamps F.","Rev Prat. 2014 Dec;64(10):1415-9.","Rivière A","Rev Prat","2014","2015/02/12","","",""
"2618897","[Occupational bladder cancer in Japan and the world]","Ohno Y.","Hinyokika Kiyo. 1989 Dec;35(12):1997-2002.","Ohno Y","Hinyokika Kiyo","1989","1989/12/01","","",""
"20299056","Development and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer","Gilbert SM, Dunn RL, Hollenbeck BK, Montie JE, Lee CT, Wood DP, Wei JT.","J Urol. 2010 May;183(5):1764-9. doi: 10.1016/j.juro.2010.01.013. Epub 2010 Mar 17.","Gilbert SM","J Urol","2010","2010/03/20","","","10.1016/j.juro.2010.01.013"
"6632204","[Ultrasonographic assessment of bladder tumors: clinical staging]","Niijima T.","Gan No Rinsho. 1983 Aug;29(10):1175-80.","Niijima T","Gan No Rinsho","1983","1983/08/01","","",""
"7880599","A classification after radical cystectomy of patients with bladder cancer associated with schistosomiasis","Rafla M, Ibrahim AS, Valleron AJ, Mary JY.","Eur J Cancer. 1994;30A(12):1751-6. doi: 10.1016/0959-8049(94)e0163-x.","Rafla M","Eur J Cancer","1994","1994/01/01","","","10.1016/0959-8049(94)e0163-x"
"5754829","Cancer of the urogenital tract: bladder cancer. Carcinogens and chemical causes","McDonald DF.","JAMA. 1968 Nov 18;206(8):1774 passim. doi: 10.1001/jama.206.8.1774.","McDonald DF","JAMA","1968","1968/11/18","","","10.1001/jama.206.8.1774"
"7299917","Bladder cancer-1981","Radwin HM.","J Urol. 1981 Nov;126(5):604. doi: 10.1016/s0022-5347(17)54646-7.","Radwin HM","J Urol","1981","1981/11/01","","","10.1016/s0022-5347(17)54646-7"
"23341375","Value of fluorescence cystoscopy in high risk non-muscle invasive bladder cancer","Mayr R, Burger M.","Curr Urol Rep. 2013 Apr;14(2):90-3. doi: 10.1007/s11934-013-0306-0.","Mayr R","Curr Urol Rep","2013","2013/01/24","","","10.1007/s11934-013-0306-0"
"10430016","Bladder cancer in women","van der Poel HG, Mungan NA, Witjes JA.","Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(3):207-12. doi: 10.1007/s001920050046.","van der Poel HG","Int Urogynecol J Pelvic Floor Dysfunct","1999","1999/08/03","","","10.1007/s001920050046"
"7058603","Combined pre- and postoperative adjuvant radiotherapy for bladder cancer","Mohiuddin M, Strong GH, Mulholland SG.","Urology. 1982 Feb;19(2):135-8. doi: 10.1016/0090-4295(82)90566-0.","Mohiuddin M","Urology","1982","1982/02/01","","","10.1016/0090-4295(82)90566-0"
"27711726","Highly stable selenadiazole derivatives induce bladder cancer cell apoptosis and inhibit cell migration and invasion through the activation of ROS-mediated signaling pathways","Yang Y, Deng S, Zeng Q, Hu W, Chen T.","Dalton Trans. 2016 Nov 22;45(46):18465-18475. doi: 10.1039/c6dt02045c.","Yang Y","Dalton Trans","2016","2016/10/07","","","10.1039/c6dt02045c"
"18995950","Neoadjuvant chemotherapy: a new treatment paradigm for muscle-invasive bladder cancer","Herr HW.","Eur Urol. 2009 Feb;55(2):303-5; discussion 305-6. doi: 10.1016/j.eururo.2008.10.033. Epub 2008 Nov 4.","Herr HW","Eur Urol","2009","2008/11/11","","","10.1016/j.eururo.2008.10.033"
"8544669","Cigarette smoking and bladder cancer in Washington County, Maryland: ammunition for health educators","McCarthy PV, Bhatia AJ, Saw SM, Mosley JD, Vega-Quiñones A.","Md Med J. 1995 Dec;44(12):1039-42.","McCarthy PV","Md Med J","1995","1995/12/01","","",""
"12449781","Characterisation of a bladder cancer cohort in a urological unit","Perera ND.","Ceylon Med J. 2002 Sep;47(3):102. doi: 10.4038/cmj.v47i3.3443.","Perera ND","Ceylon Med J","2002","2002/11/27","","","10.4038/cmj.v47i3.3443"
"3775958","[Bladder cancer in a limited region]","Jørgensen F, Lynge E.","Ugeskr Laeger. 1986 Sep 29;148(40):2571-2.","Jørgensen F","Ugeskr Laeger","1986","1986/09/29","","",""
"4414205","Letter: Effects of hyperthermia on bladder cancer","Har-Kedar I.","Br Med J. 1974 Aug 3;3(5926):345-6. doi: 10.1136/bmj.3.5926.345-d.","Har-Kedar I","Br Med J","1974","1974/08/03","PMC1611712","","10.1136/bmj.3.5926.345-d"
"12868149","[BTA tests in the diagnosis and follow-up of superficial bladder cancer]","Bassi PF, Mostaccio G, Pappagallo GL, Longo F, Bertoloni R, Ingrassia A, Gottardo F, Iafrate M, Tavolini IM.","Arch Ital Urol Androl. 2003 Jun;75(2):105-9.","Bassi PF","Arch Ital Urol Androl","2003","2003/07/19","","",""
"7018050","Preoperative radiotherapy for bladder cancer. A perspective","Mohiuddin M, Kramer S.","Urology. 1981 Jun;17(6):515-20. doi: 10.1016/0090-4295(81)90066-2.","Mohiuddin M","Urology","1981","1981/06/01","","","10.1016/0090-4295(81)90066-2"
"22716491","Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential","Calistri D, Casadio V, Bravaccini S, Zoli W, Amadori D.","Expert Rev Anticancer Ther. 2012 Jun;12(6):743-52. doi: 10.1586/era.12.50.","Calistri D","Expert Rev Anticancer Ther","2012","2012/06/22","","","10.1586/era.12.50"
"22454984","[Biomarker for bladder cancer]","Miyazaki J, Nishiyama H.","Gan To Kagaku Ryoho. 2012 Jan;39(1):48-53.","Miyazaki J","Gan To Kagaku Ryoho","2012","2012/03/30","","",""
"17674603","Getting ready for certification: bladder cancer","Matthews PA.","Urol Nurs. 2007 Jun;27(3):249-50.","Matthews PA","Urol Nurs","2007","2007/08/07","","",""
"31469632","Viral Therapy for Bladder Cancer: Everything Old is New Again","Gomella LG.","Can J Urol. 2019 Aug;26(4):9802.","Gomella LG","Can J Urol","2019","2019/08/31","","",""
"7374632","Immunology of bladder cancer","Mariani AJ, Ritts RE Jr, Rife CC.","Minn Med. 1980 Mar;63(3):173-4.","Mariani AJ","Minn Med","1980","1980/03/01","","",""
"395442","Cancer of the urinary bladder in the Pacific Basin","Nomura A.","Natl Cancer Inst Monogr. 1979 Nov;(53):143-8.","Nomura A","Natl Cancer Inst Monogr","1979","1979/11/01","","",""
"14690564","[Relationship between early enhanced helical CT and tumor angiogenesis in bladder cancer]","Xie Q, Zhang J, Jiang XQ, Chen SL, Wang QL, Xu J, Gu JH, Zheng YJ.","Zhonghua Zhong Liu Za Zhi. 2003 Nov;25(6):569-72.","Xie Q","Zhonghua Zhong Liu Za Zhi","2003","2003/12/24","","",""
"29620192","Tumor-suppressing effects of microRNA-612 in bladder cancer cells by targeting malic enzyme 1 expression","Liu M, Chen Y, Huang B, Mao S, Cai K, Wang L, Yao X.","Int J Oncol. 2018 Jun;52(6):1923-1933. doi: 10.3892/ijo.2018.4342. Epub 2018 Mar 29.","Liu M","Int J Oncol","2018","2018/04/06","PMC5919718","","10.3892/ijo.2018.4342"
"6474624","[Results of the combined treatment of bladder cancer patients]","Aslamazov EG, Doldurov GS, Sarkisian IuKh, Agafonova GB.","Urol Nefrol (Mosk). 1984 Jul-Aug;(4):27-30.","Aslamazov EG","Urol Nefrol (Mosk)","1984","1984/07/01","","",""
"8220992","Urinary fibronectin in diagnosis and follow-up of patients with urinary bladder cancer","Malmström PU, Larsson A, Johansson S.","Br J Urol. 1993 Sep;72(3):307-10. doi: 10.1111/j.1464-410x.1993.tb00723.x.","Malmström PU","Br J Urol","1993","1993/09/01","","","10.1111/j.1464-410x.1993.tb00723.x"
"6482017","Survival of patients with superficial bladder cancer after treatment: a 10-year retrospective follow-up study","Uchida K, Shimazui T, Nemoto R, Kano S, Koiso K.","Jpn J Clin Oncol. 1984 Sep;14(3):369-77.","Uchida K","Jpn J Clin Oncol","1984","1984/09/01","","",""
"23425709","Management of superficial and muscle-invasive urothelial cancers of the bladder","Resnick MJ, Bassett JC, Clark PE.","Curr Opin Oncol. 2013 May;25(3):281-8. doi: 10.1097/CCO.0b013e32835eb583.","Resnick MJ","Curr Opin Oncol","2013","2013/02/22","","","10.1097/CCO.0b013e32835eb583"
"22117153","Current treatment of metastatic bladder cancer and future directions","Lei AQ, Cheng L, Pan CX.","Expert Rev Anticancer Ther. 2011 Dec;11(12):1851-62. doi: 10.1586/era.11.181.","Lei AQ","Expert Rev Anticancer Ther","2011","2011/11/26","","","10.1586/era.11.181"
"12885826","Alternatives to cystectomy in muscle-invasive bladder cancer","Goel S.","J Clin Oncol. 2003 Aug 1;21(15):3003; author reply 3003-4. doi: 10.1200/JCO.2003.99.015.","Goel S","J Clin Oncol","2003","2003/07/30","","","10.1200/JCO.2003.99.015"
"2690524","[Status of surgical treatment of urinary bladder cancer]","Hautmann R.","Verh Dtsch Ges Inn Med. 1989;95:537-44.","Hautmann R","Verh Dtsch Ges Inn Med","1989","1989/01/01","","",""
"7129895","[Early diagnosis of (recurring) bladder cancer by cytology]","Studer UE, Antonelli M, Kraft R.","Helv Chir Acta. 1982 Aug;49(3-4):317-20.","Studer UE","Helv Chir Acta","1982","1982/08/01","","",""
"1244080","Studies on tryptophan metabolism in Danish bladder cancer patients","Wolf H, Brown RR, Nyholm K.","Acta Vitaminol Enzymol. 1975;29(1-6):117-22.","Wolf H","Acta Vitaminol Enzymol","1975","1975/01/01","","",""
"18041361","The cost of treatment and follow-up of bladder cancer in Italy","Racioppi M, Volpe A, Falabella R, Pinto F, Sacco E, Gulino G, D'Agostino D, Bassi PF.","Arch Ital Urol Androl. 2007 Sep;79(3):111-7.","Racioppi M","Arch Ital Urol Androl","2007","2007/11/29","","",""
"7037151","Concepts in causality: chemically induced human urinary bladder cancer","Lower GM Jr.","Cancer. 1982 Mar 1;49(5):1056-66. doi: 10.1002/1097-0142(19820301)49:5<1056::aid-cncr2820490535>3.0.co;2-i.","Lower GM Jr","Cancer","1982","1982/03/01","","","10.1002/1097-0142(19820301)49:5<1056::aid-cncr2820490535>3.0.co;2-i"
"3735532","Pattern of urinary symptoms in patients with metastatic bladder cancer","Cohen JM, Persky L, Resnick MI.","J Urol. 1986 Sep;136(3):586-8. doi: 10.1016/s0022-5347(17)44981-0.","Cohen JM","J Urol","1986","1986/09/01","","","10.1016/s0022-5347(17)44981-0"
"4642784","Immunological characteristics of bladder cancer","","Br Med J. 1972 Dec 2;4(5839):502-3. doi: 10.1136/bmj.4.5839.502.","","Br Med J","1972","1972/12/02","PMC1788713","","10.1136/bmj.4.5839.502"
"8943997","New tumor markers in bladder cancer: high promise for lower risk patients?","McNeil C.","J Natl Cancer Inst. 1996 Dec 4;88(23):1704-5. doi: 10.1093/jnci/88.23.1704.","McNeil C","J Natl Cancer Inst","1996","1996/12/04","","","10.1093/jnci/88.23.1704"
"28357911","Advances in urothelial bladder cancer immunotherapy, dawn of a new age of treatment","Aoun F, Rassy EE, Assi T, Albisinni S, Katan J.","Immunotherapy. 2017 Mar;9(5):451-460. doi: 10.2217/imt-2017-0007.","Aoun F","Immunotherapy","2017","2017/03/31","","","10.2217/imt-2017-0007"
"19728855","Level of selenoprotein transcripts in peripheral leukocytes of patients with bladder cancer and healthy individuals","Reszka E, Gromadzinska J, Jablonska E, Wasowicz W, Jablonowski Z, Sosnowski M.","Clin Chem Lab Med. 2009;47(9):1125-32. doi: 10.1515/CCLM.2009.261.","Reszka E","Clin Chem Lab Med","2009","2009/09/05","","","10.1515/CCLM.2009.261"
"23628807","DNA methylation-based biomarkers in bladder cancer","Kandimalla R, van Tilborg AA, Zwarthoff EC.","Nat Rev Urol. 2013 Jun;10(6):327-35. doi: 10.1038/nrurol.2013.89. Epub 2013 Apr 30.","Kandimalla R","Nat Rev Urol","2013","2013/05/01","","","10.1038/nrurol.2013.89"
"2722603","Cisplatin and external beam radiation in patients with invasive bladder cancer","Shipley WU.","Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1649-50. doi: 10.1016/0360-3016(89)90976-0.","Shipley WU","Int J Radiat Oncol Biol Phys","1989","1989/06/01","","","10.1016/0360-3016(89)90976-0"
"9874845","Predicting prognosis in patients with superficial bladder cancer","de Vere White RW, Stapp E.","Oncology (Williston Park). 1998 Dec;12(12):1717-23; discussion 1724-6.","de Vere White RW","Oncology (Williston Park)","1998","1999/01/06","","",""
"25882562","Potential role for targeted therapy in muscle-invasive bladder cancer: lessons from the cancer genome atlas and beyond","Mitra AP, Lerner SP.","Urol Clin North Am. 2015 May;42(2):201-15, viii. doi: 10.1016/j.ucl.2015.01.003. Epub 2015 Mar 6.","Mitra AP","Urol Clin North Am","2015","2015/04/18","","","10.1016/j.ucl.2015.01.003"
"17762631","The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery","Merseburger AS, Kuczyk MA.","Curr Opin Urol. 2007 Sep;17(5):358-62. doi: 10.1097/MOU.0b013e3282c4afa0.","Merseburger AS","Curr Opin Urol","2007","2007/09/01","","","10.1097/MOU.0b013e3282c4afa0"
"21844905","Bladder cancer: validating the EORTC risk tables in BCG-treated patients","Buethe DD, Sexton WJ.","Nat Rev Urol. 2011 Aug 16;8(9):480-1. doi: 10.1038/nrurol.2011.118.","Buethe DD","Nat Rev Urol","2011","2011/08/17","","","10.1038/nrurol.2011.118"
"21996986","Controversies in the management of T1 urothelial bladder cancer","Azzouz H, Cauberg EC, De Reijke TM.","Minerva Urol Nefrol. 2011 Dec;63(4):309-15.","Azzouz H","Minerva Urol Nefrol","2011","2011/10/15","","",""
"7401015","[Computer tomography for the detection of bladder tumors (author's transl)]","Bruneton JN, Dilhuydy MH, Elie G, Calabet A, Le Treut A.","J Radiol. 1980 May;61(5):343-5.","Bruneton JN","J Radiol","1980","1980/05/01","","",""
"5810324","Evolution of bladder cancer in man","Cooper EH, Levi PE, Anderson CK, Williams RE.","Proc R Soc Med. 1969 Aug;62(8):865-6.","Cooper EH","Proc R Soc Med","1969","1969/08/01","PMC1811131","",""
"8490491","Improving the management of superficial bladder cancer","Kirk D.","BMJ. 1993 Apr 17;306(6884):1014-5. doi: 10.1136/bmj.306.6884.1014.","Kirk D","BMJ","1993","1993/04/17","PMC1677003","","10.1136/bmj.306.6884.1014"
"11340577","Adenovirus-mediated gene therapy for bladder cancer in an orthotopic model using a dominant negative H-ras mutant","Watanabe T, Shinohara N, Sazawa A, Takimoto M, Hashimoto A, Koyanagi T, Kuzumaki N.","Int J Cancer. 2001 Jun 1;92(5):712-7. doi: 10.1002/1097-0215(20010601)92:5<712::aid-ijc1242>3.0.co;2-z.","Watanabe T","Int J Cancer","2001","2001/05/08","","","10.1002/1097-0215(20010601)92:5<712::aid-ijc1242>3.0.co;2-z"
"12632842","[Bladder carcinoma--a current review]","Engeler DS, Schmid HP.","Praxis (Bern 1994). 2003 Jan 22;92(4):117-26. doi: 10.1024/0369-8394.92.4.117.","Engeler DS","Praxis (Bern 1994)","2003","2003/03/14","","","10.1024/0369-8394.92.4.117"
"17889428","Bladder cancer--contemporary dilemmas in its management","Whelan P.","Eur Urol. 2008 Jan;53(1):24-6. doi: 10.1016/j.eururo.2007.08.056. Epub 2007 Sep 7.","Whelan P","Eur Urol","2008","2007/09/25","","","10.1016/j.eururo.2007.08.056"
"9291429","Diagnosis of bladder cancer by analysis of the allelic loss of the p53 gene in urine samples using blunt-end single-strand conformation polymorphism","Sugano K, Tsutsumi M, Nakashima Y, Yamaguchi K, Ohkura H, Kakizoe T, Sekiya T.","Int J Cancer. 1997 Aug 22;74(4):403-6. doi: 10.1002/(sici)1097-0215(19970822)74:4<403::aid-ijc7>3.0.co;2-z.","Sugano K","Int J Cancer","1997","1997/08/22","","","10.1002/(sici)1097-0215(19970822)74:4<403::aid-ijc7>3.0.co;2-z"
"29663062","[Follow-up of bladder cancer : The right examinations at the right time]","Olbert P, Goebell PJ, Hegele A.","Urologe A. 2018 Jun;57(6):693-701. doi: 10.1007/s00120-018-0641-3.","Olbert P","Urologe A","2018","2018/04/18","","","10.1007/s00120-018-0641-3"
"27358136","BLCA-4 and UBC combined detection for early diagnosis of bladder cancer","Cui L, Sun MM, Zhao ZH, Yang JP, Zheng YP, He LL, Chen KS, Fan QX.","J Biol Regul Homeost Agents. 2016 Apr-Jun;30(2):485-90.","Cui L","J Biol Regul Homeost Agents","2016","2016/07/01","","",""
"22901111","Research progress in potential urinary markers for the early detection, diagnosis and follow-up of human bladder cancer","Wang HF, Wang JS.","Asian Pac J Cancer Prev. 2012;13(5):1723-6. doi: 10.7314/apjcp.2012.13.5.1723.","Wang HF","Asian Pac J Cancer Prev","2012","2012/08/21","","","10.7314/apjcp.2012.13.5.1723"
"25823547","Bladder Tumor Heterogeneity: The Impact on Clinical Treatment","Chen C, Qi XJ, Cao YW, Wang YH, Yang XC, Shao SX, Niu HT.","Urol Int. 2015;95(1):1-8. doi: 10.1159/000370165. Epub 2015 Mar 21.","Chen C","Urol Int","2015","2015/04/01","","","10.1159/000370165"
"22111835","Nuclear hormone receptor signals as new therapeutic targets for urothelial carcinoma","Miyamoto H, Zheng Y, Izumi K.","Curr Cancer Drug Targets. 2012 Jan;12(1):14-22. doi: 10.2174/156800912798888965.","Miyamoto H","Curr Cancer Drug Targets","2012","2011/11/25","","","10.2174/156800912798888965"
"8571131","Molecular detection of primary bladder cancer by microsatellite analysis","Mao L, Schoenberg MP, Scicchitano M, Erozan YS, Merlo A, Schwab D, Sidransky D.","Science. 1996 Feb 2;271(5249):659-62. doi: 10.1126/science.271.5249.659.","Mao L","Science","1996","1996/02/02","","","10.1126/science.271.5249.659"
"22349600","Selenoproteins in bladder cancer","Reszka E.","Clin Chim Acta. 2012 May 18;413(9-10):847-54. doi: 10.1016/j.cca.2012.01.041. Epub 2012 Feb 12.","Reszka E","Clin Chim Acta","2012","2012/02/22","","","10.1016/j.cca.2012.01.041"
"11101088","Biological pathways to bladder carcinogenesis","Gonzalgo ML, Schoenberg MP, Rodriguez R.","Semin Urol Oncol. 2000 Nov;18(4):256-63.","Gonzalgo ML","Semin Urol Oncol","2000","2000/12/02","","",""
"3674788","[Infiltrating cancer of the bladder with lymph node invasion: is total cystectomy justified?]","Zerbib M, Boccon-Gibod L, Steg A.","Ann Urol (Paris). 1987;21(4):271-4.","Zerbib M","Ann Urol (Paris)","1987","1987/01/01","","",""
"22711262","Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a Chinese population","Ma Z, Hu Q, Chen Z, Tao S, Macnamara L, Kim ST, Tian L, Xu K, Ding Q, Zheng SL, Sun J, Xia G, Xu J.","Mol Carcinog. 2013 Nov;52(11):916-21. doi: 10.1002/mc.21932. Epub 2012 Jun 18.","Ma Z","Mol Carcinog","2013","2012/06/20","","","10.1002/mc.21932"
"18706153","Orthotopic neobladder for bladder cancer and neurogenic bladder dysfunction","Maurice MJ, Meeks JJ, Smith ND.","Can J Urol. 2008 Aug;15(4):4194-5.","Maurice MJ","Can J Urol","2008","2008/08/19","","",""
"12801735","Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis","Advanced Bladder Cancer Meta-analysis Collaboration.","Lancet. 2003 Jun 7;361(9373):1927-34. doi: 10.1016/s0140-6736(03)13580-5.","Advanced Bladder Cancer Meta-analysis Collaboration","Lancet","2003","2003/06/13","","","10.1016/s0140-6736(03)13580-5"
"31496500","Clinical Use Cases for a Tool to Assess Risk in Superficial Bladder Cancer","McMullen CK, Rosetti MO, Weinmann S, Leo MC, Nielsen ME.","Perm J. 2019;23:18-276. doi: 10.7812/TPP/18.276. Epub 2019 Aug 19.","McMullen CK","Perm J","2019","2019/09/10","PMC6730961","","10.7812/TPP/18.276"
"9915423","Do we have a prostate specific antigen for bladder cancer?","Soloway MS.","J Urol. 1999 Feb;161(2):447-8. doi: 10.1016/s0022-5347(01)61920-7.","Soloway MS","J Urol","1999","1999/01/23","","","10.1016/s0022-5347(01)61920-7"
"16916767","Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001","Gårdmark T, Bladström A, Hellsten S, Malmström PU; Members Of The Swedish National Bladder Cancer Registry.","Scand J Urol Nephrol. 2006;40(4):276-82. doi: 10.1080/00365590600744238.","Gårdmark T","Scand J Urol Nephrol","2006","2006/08/19","","","10.1080/00365590600744238"
"30116985","Enhanced Endoscopy in Bladder Cancer","Pearce S, Daneshmand S.","Curr Urol Rep. 2018 Aug 17;19(10):84. doi: 10.1007/s11934-018-0833-9.","Pearce S","Curr Urol Rep","2018","2018/08/18","","","10.1007/s11934-018-0833-9"
"20566675","Bladder cancer in 2010: how far have we come?","Jacobs BL, Lee CT, Montie JE.","CA Cancer J Clin. 2010 Jul-Aug;60(4):244-72. doi: 10.3322/caac.20077. Epub 2010 Jun 21.","Jacobs BL","CA Cancer J Clin","2010","2010/06/23","","","10.3322/caac.20077"
"6748245","[Problems of the preservation treatment of vesical function of bladder cancer]","Matsumoto K.","Gan No Rinsho. 1984 May;30(6 Suppl):680-7.","Matsumoto K","Gan No Rinsho","1984","1984/05/01","","",""
"6725047","Effective treatment of patients with T1 grade III bladder cancer by external beam irradiation","Abratt RP, Tucker RD, Barnes DR.","Int J Radiat Oncol Biol Phys. 1984 Apr;10(4):578-9. doi: 10.1016/0360-3016(84)90042-7.","Abratt RP","Int J Radiat Oncol Biol Phys","1984","1984/04/01","","","10.1016/0360-3016(84)90042-7"
"1613879","Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma: a possible predictor for successful bladder preservation following transurethral surgery and chemotherapy-radiotherapy","Hug EB, Donnelly SM, Shipley WU, Heney NM, Kaufman DS, Preffer FI, Schwartz SM, Colvin RB, Althausen AF.","J Urol. 1992 Jul;148(1):47-51. doi: 10.1016/s0022-5347(17)36505-9.","Hug EB","J Urol","1992","1992/07/01","","","10.1016/s0022-5347(17)36505-9"
"15126839","Re: tumor markers in the diagnosis of primary bladder cancer. A systematic review","Casella R.","J Urol. 2004 Jun;171(6 Pt 1):2383-4. doi: 10.1097/01.ju.0000124332.57014.29.","Casella R","J Urol","2004","2004/05/06","","","10.1097/01.ju.0000124332.57014.29"
"9229153","Bladder cancer","Ozen H.","Curr Opin Oncol. 1997 May;9(3):295-300.","Ozen H","Curr Opin Oncol","1997","1997/05/01","","",""
"20609511","Invasive bladder cancer and the role of follow-up: should we consider the match over at radical cystectomy or should we play for extra time?","Colombo R.","Eur Urol. 2010 Oct;58(4):495-7. doi: 10.1016/j.eururo.2010.06.026. Epub 2010 Jun 23.","Colombo R","Eur Urol","2010","2010/07/09","","","10.1016/j.eururo.2010.06.026"
"12074395","Guidelines on bladder cancer","Oosterlinck W, Lobel B, Jakse G, Malmström PU, Stöckle M, Sternberg C; European Association of Urology (EAU) Working Group on Oncological Urology.","Eur Urol. 2002 Feb;41(2):105-12. doi: 10.1016/s0302-2838(01)00026-4.","Oosterlinck W","Eur Urol","2002","2002/06/21","","","10.1016/s0302-2838(01)00026-4"
"25377503","Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement","Clin B; ""RecoCancerProf"" Working Group, Pairon JC.","BMC Public Health. 2014 Nov 6;14:1155. doi: 10.1186/1471-2458-14-1155.","Clin B","BMC Public Health","2014","2014/11/08","PMC4230399","","10.1186/1471-2458-14-1155"
"22176770","Probiotics, dendritic cells and bladder cancer","Feyisetan O, Tracey C, Hellawell GO.","BJU Int. 2012 Jun;109(11):1594-7. doi: 10.1111/j.1464-410X.2011.10749.x. Epub 2011 Dec 16.","Feyisetan O","BJU Int","2012","2011/12/20","","","10.1111/j.1464-410X.2011.10749.x"
"6644762","The association of the slow acetylator phenotype with bladder cancer","Evans DA, Eze LC, Whibley EJ.","J Med Genet. 1983 Oct;20(5):330-3. doi: 10.1136/jmg.20.5.330.","Evans DA","J Med Genet","1983","1983/10/01","PMC1049143","","10.1136/jmg.20.5.330"
"6883284","A comparison of short-course, low-dose and long-course, high-dose preoperative radiation for carcinoma of the bladder","Scanlon PW, Scott M, Segura JW.","Cancer. 1983 Oct 1;52(7):1153-9. doi: 10.1002/1097-0142(19831001)52:7<1153::aid-cncr2820520705>3.0.co;2-b.","Scanlon PW","Cancer","1983","1983/10/01","","","10.1002/1097-0142(19831001)52:7<1153::aid-cncr2820520705>3.0.co;2-b"
"2206939","Chemotherapy for advanced bladder cancer: 'Midsummer Night's Dream' or 'Much Ado About Nothing'?","Raghavan D.","Br J Cancer. 1990 Sep;62(3):337-40. doi: 10.1038/bjc.1990.293.","Raghavan D","Br J Cancer","1990","1990/09/01","PMC1971441","","10.1038/bjc.1990.293"
"27461645","A clinicoepidemiological study of young age bladder tumors: An eastern Indian scenario","Singh JP, Priyadarshi V, Pal DK.","J Cancer Res Ther. 2016 Apr-Jun;12(2):751-4. doi: 10.4103/0973-1482.154028.","Singh JP","J Cancer Res Ther","2016","2016/07/28","","","10.4103/0973-1482.154028"
"21520632","[Bladder preservation using chemoradiation therapy for locally invasive bladder cancer]","Abe T, Yoshioka T, Sato M, Mori N, Sekii K, Itatani H.","Nihon Hinyokika Gakkai Zasshi. 2011 Jan;102(1):14-22. doi: 10.5980/jpnjurol.102.14.","Abe T","Nihon Hinyokika Gakkai Zasshi","2011","2011/04/28","","","10.5980/jpnjurol.102.14"
"10524909","Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association","Smith JA Jr, Labasky RF, Cockett AT, Fracchia JA, Montie JE, Rowland RG.","J Urol. 1999 Nov;162(5):1697-701.","Smith JA Jr","J Urol","1999","1999/10/19","","",""
"17507038","Re: can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? H. W. Herr, S. M. Donat and G. Dalbagni J Urol 2007; 177: 75-79","Nieder AM, Soloway MS, Jewett MA.","J Urol. 2007 Jul;178(1):352. doi: 10.1016/j.juro.2007.03.050. Epub 2007 May 15.","Nieder AM","J Urol","2007","2007/05/18","","","10.1016/j.juro.2007.03.050"
"1113721","Bladder cancer in man. An update","Kolosseus RC, Fraley EE, Blackard CE.","Minn Med. 1975 Mar;58(3):232-5.","Kolosseus RC","Minn Med","1975","1975/03/01","","",""
"31175538","Frailty as a prognostic indicator in the radical cystectomy population: a review","Parikh N, Sharma P.","Int Urol Nephrol. 2019 Aug;51(8):1281-1290. doi: 10.1007/s11255-019-02189-z. Epub 2019 Jun 7.","Parikh N","Int Urol Nephrol","2019","2019/06/09","","","10.1007/s11255-019-02189-z"
"30737158","Sex steroid hormone receptors in bladder cancer: Usefulness in differential diagnosis and implications in histogenesis of bladder cancer","Imai Y, Noda S, Matsuyama C, Shimizu A, Kamai T.","Urol Oncol. 2019 Jun;37(6):353.e9-353.e15. doi: 10.1016/j.urolonc.2019.01.023. Epub 2019 Feb 6.","Imai Y","Urol Oncol","2019","2019/02/10","","","10.1016/j.urolonc.2019.01.023"
"5754828","Cancer of the urogenital tract: bladder cancer. The accuracy of clinical vs. surgical staging","Baker R.","JAMA. 1968 Nov 18;206(8):1770-3 passim.","Baker R","JAMA","1968","1968/11/18","","",""
"29678595","Trimodalities for bladder cancer in elderly: Transurethral resection, hypofractionated radiotherapy and gemcitabine","Mohamed HAH, Salem MA, Elnaggar MS, Gabr A, Abdelrheem AM.","Cancer Radiother. 2018 May;22(3):236-240. doi: 10.1016/j.canrad.2017.09.013. Epub 2018 Apr 17.","Mohamed HAH","Cancer Radiother","2018","2018/04/22","","","10.1016/j.canrad.2017.09.013"
"15298479","[Difficulties of the new classification system for bladder cancer]","Ghorra C, Nemr E, Vieillefond A.","J Med Liban. 2002 Jul-Aug;50(4):180-3.","Ghorra C","J Med Liban","2002","2004/08/10","","",""
"20686360","Translational research in bladder cancer: from molecular pathogenesis to useful tissue biomarkers","Bolenz C, Lotan Y.","Cancer Biol Ther. 2010 Sep 1;10(5):407-15. doi: 10.4161/cbt.10.5.13022. Epub 2010 Sep 14.","Bolenz C","Cancer Biol Ther","2010","2010/08/06","","","10.4161/cbt.10.5.13022"
"2444082","[Bladder cancer. Epidemiological, clinical and histological aspects in the Republic of Niger]","Docquier J, Sourabie B.","Acta Urol Belg. 1987;55(3):373-9.","Docquier J","Acta Urol Belg","1987","1987/01/01","","",""
"3895790","Intravesical ultrasonography as an aid to study the size of bladder cancers","Rózsahegyi J, Magasi P, Kiss F, Szebeni A, Bohár L.","Acta Chir Hung. 1985;26(2):77-84.","Rózsahegyi J","Acta Chir Hung","1985","1985/01/01","","",""
"30855378","The impact of gender on oncologic outcomes of bladder cancer","Mun DH, Kimura S, Shariat SF, Abufaraj M.","Curr Opin Urol. 2019 May;29(3):279-285. doi: 10.1097/MOU.0000000000000606.","Mun DH","Curr Opin Urol","2019","2019/03/12","","","10.1097/MOU.0000000000000606"
"1871920","[The dispensary care and work disability expertise of bladder cancer patients following cystectomy]","Nechiporenko NA, Strotskiĭ AV.","Urol Nefrol (Mosk). 1991 May-Jun;(3):28-33.","Nechiporenko NA","Urol Nefrol (Mosk)","1991","1991/05/01","","",""
"32852900","Immunotherapy for urothelial carcinoma: Metastatic disease and beyond","Poon DM.","Asia Pac J Clin Oncol. 2020 Sep;16 Suppl 3:18-23. doi: 10.1111/ajco.13312.","Poon DM","Asia Pac J Clin Oncol","2020","2020/08/28","","","10.1111/ajco.13312"
"21105261","Time to change our approach to high-risk nonmuscle-invasive bladder cancer management in the United Kingdom? Observations from the British Association of Urological Surgeons Cancer Registry","Yates DR, Catto JW.","BJU Int. 2010 Sep;106(5):593-4. doi: 10.1111/j.1464-410x.2010.09536.x.","Yates DR","BJU Int","2010","2010/11/25","","","10.1111/j.1464-410x.2010.09536.x"
"2142803","[Neoadjuvant chemotherapy in locally advanced bladder cancer. Proceedings of the 36th meeting of Lombard Urologists. Milan, 25 November 1989]","","Arch Ital Urol Nefrol Androl. 1990 Jun;62(2):215-74.","","Arch Ital Urol Nefrol Androl","1990","1990/06/01","","",""
"2218561","Chemotherapy for invasive bladder cancer: introduction","Scher HI, Splinter TA.","Semin Oncol. 1990 Oct;17(5):515-6.","Scher HI","Semin Oncol","1990","1990/10/01","","",""
"26790764","[A Case of Muscle Invasive Bladder Cancer in a Patient with Systemic Lupus Erythematosus]","Iida K, Tomioka A, Maruyama Y, Otani T, Fujimoto K.","Hinyokika Kiyo. 2015 Dec;61(12):499-503.","Iida K","Hinyokika Kiyo","2015","2016/01/22","","",""
"16474574","Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies","Garcia JA, Dreicer R.","Nat Clin Pract Urol. 2005 Jan;2(1):32-7. doi: 10.1038/ncpuro0068.","Garcia JA","Nat Clin Pract Urol","2005","2006/02/14","","","10.1038/ncpuro0068"
"19538035","Strategies to improve drug delivery in bladder cancer therapy","Wirth M, Plattner VE, Gabor F.","Expert Opin Drug Deliv. 2009 Jul;6(7):727-44. doi: 10.1517/17425240903022758.","Wirth M","Expert Opin Drug Deliv","2009","2009/06/23","","","10.1517/17425240903022758"
"5043669","The biology of bladder cancer","Cooper EH.","Ann R Coll Surg Engl. 1972 Jul;51(1):1-16.","Cooper EH","Ann R Coll Surg Engl","1972","1972/07/01","PMC2388010","",""
"18815930","Molecular alterations associated with bladder cancer initiation and progression","Cordon-Cardo C.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):154-65. doi: 10.1080/03008880802291915.","Cordon-Cardo C","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802291915"
"2414496","[Pre and postoperative nursing of patients with bladder cancer. Nursing following TUR-bt (transurethral resection of bladder tumor)]","Orikasa U, Izumi K, Kobayashi Y, Wakamatsu N, Usami R.","Kango Gijutsu. 1985 Aug;31(11):1444-7.","Orikasa U","Kango Gijutsu","1985","1985/08/01","","",""
"21123306","Accuracy of contrast-enhanced ultrasound in the detection of bladder cancer","Nicolau C, Bunesch L, Peri L, Salvador R, Corral JM, Mallofre C, Sebastia C.","Br J Radiol. 2011 Dec;84(1008):1091-9. doi: 10.1259/bjr/43400531. Epub 2010 Dec 1.","Nicolau C","Br J Radiol","2011","2010/12/03","PMC3473820","","10.1259/bjr/43400531"
"29129693","FOXJ1 promotes bladder cancer cell growth and regulates Warburg effect","Xian S, Shang D, Kong G, Tian Y.","Biochem Biophys Res Commun. 2018 Jan 1;495(1):988-994. doi: 10.1016/j.bbrc.2017.11.063. Epub 2017 Nov 10.","Xian S","Biochem Biophys Res Commun","2018","2017/11/14","","","10.1016/j.bbrc.2017.11.063"
"20394976","Regional differences in early stage bladder cancer care and outcomes","Skolarus TA, Ye Z, Zhang S, Hollenbeck BK.","Urology. 2010 Aug;76(2):391-6. doi: 10.1016/j.urology.2009.12.079. Epub 2010 Apr 14.","Skolarus TA","Urology","2010","2010/04/17","","","10.1016/j.urology.2009.12.079"
"28283914","Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies","Zainfeld D, Daneshmand S.","Curr Urol Rep. 2017 May;18(5):34. doi: 10.1007/s11934-017-0680-0.","Zainfeld D","Curr Urol Rep","2017","2017/03/12","","","10.1007/s11934-017-0680-0"
"18822262","[Bladder cancer: news in 2008]","Irani J, Descazeaud A.","Prog Urol. 2008 Sep;18 Suppl 6:S125-9. doi: 10.1016/S1166-7087(08)73937-X.","Irani J","Prog Urol","2008","2008/11/26","","","10.1016/S1166-7087(08)73937-X"
"2672017","BCG in the treatment of bladder cancer: state of the art","Morales A.","Prog Clin Biol Res. 1989;310:3-10.","Morales A","Prog Clin Biol Res","1989","1989/01/01","","",""
"6504902","Loco-regional immunotherapy for bladder cancer","Kuss R, Haertig A.","Prog Clin Biol Res. 1984;162B:321-33.","Kuss R","Prog Clin Biol Res","1984","1984/01/01","","",""
"30369228","[A Case of PT1 Plasmacytoid Variant Bladder Cancer Treated by Bladder Conserving Therapy]","Kimura H, Uemura Y, Megumi Y, Fukuzawa S.","Hinyokika Kiyo. 2018 Sep;64(9):369-372. doi: 10.14989/ActaUrolJap_64_9_369.","Kimura H","Hinyokika Kiyo","2018","2018/10/30","","","10.14989/ActaUrolJap_64_9_369"
"17357998","Long-term outcome of hematuria home screening for bladder cancer in men","Cai T, Bartoletti R.","Cancer. 2007 May 1;109(9):1923-4; author reply 1924. doi: 10.1002/cncr.22590.","Cai T","Cancer","2007","2007/03/16","","","10.1002/cncr.22590"
"7407467","Bladder cancer as a prescribed industrial disease","Veys C.","Br Med J. 1980 Apr 12;280(6220):1053. doi: 10.1136/bmj.280.6220.1053.","Veys C","Br Med J","1980","1980/04/12","PMC1600655","","10.1136/bmj.280.6220.1053"
"8290820","Carcinoma of the bladder","Hossan E, Striegel A.","Semin Oncol Nurs. 1993 Nov;9(4):252-66. doi: 10.1016/s0749-2081(05)80053-1.","Hossan E","Semin Oncol Nurs","1993","1993/11/01","","","10.1016/s0749-2081(05)80053-1"
"28543959","Epidemiology of urothelial carcinoma","Miyazaki J, Nishiyama H.","Int J Urol. 2017 Oct;24(10):730-734. doi: 10.1111/iju.13376. Epub 2017 May 21.","Miyazaki J","Int J Urol","2017","2017/05/26","","","10.1111/iju.13376"
"29528758","Update on early instillation of chemotherapy after transurethral resection of non-muscle-invasive bladder cancer","Oosterlinck W, Decaestecker K.","Expert Rev Anticancer Ther. 2018 May;18(5):437-443. doi: 10.1080/14737140.2018.1451748. Epub 2018 Mar 15.","Oosterlinck W","Expert Rev Anticancer Ther","2018","2018/03/13","","","10.1080/14737140.2018.1451748"
"17070211","Chemoprevention for bladder cancer","Busby JE, Kamat AM.","J Urol. 2006 Nov;176(5):1914-20. doi: 10.1016/j.juro.2006.07.004.","Busby JE","J Urol","2006","2006/10/31","","","10.1016/j.juro.2006.07.004"
"19477582","Editorial comment on: FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer","Sherif A.","Eur Urol. 2010 Apr;57(4):647. doi: 10.1016/j.eururo.2009.05.021. Epub 2009 May 18.","Sherif A","Eur Urol","2010","2009/05/30","","","10.1016/j.eururo.2009.05.021"
"19878561","High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression","Egerod FL, Bartels A, Fristrup N, Borre M, Ørntoft TF, Oleksiewicz MB, Brünner N, Dyrskjøt L.","BMC Cancer. 2009 Oct 30;9:385. doi: 10.1186/1471-2407-9-385.","Egerod FL","BMC Cancer","2009","2009/11/03","PMC2774864","","10.1186/1471-2407-9-385"
"22098276","Quality of bladder cancer care in the USA","Chamie K, Litwin MS.","Expert Rev Pharmacoecon Outcomes Res. 2011 Dec;11(6):619-21. doi: 10.1586/erp.11.81.","Chamie K","Expert Rev Pharmacoecon Outcomes Res","2011","2011/11/22","","","10.1586/erp.11.81"
"31501796","Improving the diagnosis of high grade and stage bladder cancer by detecting increased urinary calprotectin expression in tumor tissue and tumor-associated inflammatory response","Sahin Y, Yucetas U, Ates HA, Erkan E, Yucetas E, Temiz MZ, Toktas MG, Kadihasanoglu M, Topkaya BC.","Investig Clin Urol. 2019 Sep;60(5):343-350. doi: 10.4111/icu.2019.60.5.343. Epub 2019 Aug 19.","Sahin Y","Investig Clin Urol","2019","2019/09/11","PMC6722403","","10.4111/icu.2019.60.5.343"
"24496864","Disparity in bladder cancer outcomes: what's sex got to do with it?","Ristau BT, Davies BJ.","Cancer. 2014 Feb 15;120(4):461-3. doi: 10.1002/cncr.28420. Epub 2013 Nov 13.","Ristau BT","Cancer","2014","2014/02/06","","","10.1002/cncr.28420"
"30158406","[Navigation Surgery for Bladder Cancer by ALA-PDD]","Fukuhara H, Inoue K.","Gan To Kagaku Ryoho. 2018 Aug;45(8):1144-1146.","Fukuhara H","Gan To Kagaku Ryoho","2018","2018/08/31","","",""
"17430693","The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer","Stein JP.","Curr Oncol Rep. 2007 May;9(3):213-21. doi: 10.1007/s11912-007-0024-1.","Stein JP","Curr Oncol Rep","2007","2007/04/14","","","10.1007/s11912-007-0024-1"
"28050015","Bladder cancer in 2016: News in diagnosis, treatment, and risk group assessment","Zigeuner R.","Nat Rev Urol. 2017 Feb;14(2):74-76. doi: 10.1038/nrurol.2016.264. Epub 2017 Jan 4.","Zigeuner R","Nat Rev Urol","2017","2017/01/05","","","10.1038/nrurol.2016.264"
"23609843","Bladder cancer: biomarker panel predicts recurrence after radical cystectomy","Payton S.","Nat Rev Urol. 2013 Jun;10(6):309. doi: 10.1038/nrurol.2013.95. Epub 2013 Apr 23.","Payton S","Nat Rev Urol","2013","2013/04/24","","","10.1038/nrurol.2013.95"
"17824561","Managing bladder cancer: today & tomorrow","McGee L.","ONS Connect. 2007;22(8 Suppl):45-6.","McGee L","ONS Connect","2007","2007/09/11","","",""
"17009051","Improving outcomes with radical cystectomy for high-grade invasive bladder cancer","Stein JP.","World J Urol. 2006 Nov;24(5):509-16. doi: 10.1007/s00345-006-0111-1.","Stein JP","World J Urol","2006","2006/09/30","","","10.1007/s00345-006-0111-1"
"19345471","Editorial comment on: HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer","Colombo R.","Eur Urol. 2010 Jan;57(1):93-4. doi: 10.1016/j.eururo.2009.03.058. Epub 2009 Mar 31.","Colombo R","Eur Urol","2010","2009/04/07","","","10.1016/j.eururo.2009.03.058"
"20861813","Bladder cancer: a review of non-muscle invasive disease","Sexton WJ, Wiegand LR, Correa JJ, Politis C, Dickinson SI, Kang LC.","Cancer Control. 2010 Oct;17(4):256-68. doi: 10.1177/107327481001700406.","Sexton WJ","Cancer Control","2010","2010/09/24","","","10.1177/107327481001700406"
"15088905","Tumor suppressor genes of bladder cancer and potential for gene therapy","Tanaka M, Grossman HB.","Adv Exp Med Biol. 2003;539(Pt A):185-91. doi: 10.1007/978-1-4419-8889-8_14.","Tanaka M","Adv Exp Med Biol","2003","2004/04/20","","","10.1007/978-1-4419-8889-8_14"
"3941467","The value of excretory urography in staging bladder cancer","Hatch TR, Barry JM.","J Urol. 1986 Jan;135(1):49. doi: 10.1016/s0022-5347(17)45511-x.","Hatch TR","J Urol","1986","1986/01/01","","","10.1016/s0022-5347(17)45511-x"
"30218307","The role of biomarkers in bladder preservation management of muscle-invasive bladder cancer","Mitin T, Choudhury A.","World J Urol. 2019 Sep;37(9):1767-1772. doi: 10.1007/s00345-018-2480-7. Epub 2018 Sep 14.","Mitin T","World J Urol","2019","2018/09/16","","","10.1007/s00345-018-2480-7"
"2218565","Biological markers of prognosis in invasive bladder cancer","Fradet Y.","Semin Oncol. 1990 Oct;17(5):533-43.","Fradet Y","Semin Oncol","1990","1990/10/01","","",""
"19811634","ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines","Videira PA, Correia M, Malagolini N, Crespo HJ, Ligeiro D, Calais FM, Trindade H, Dall'Olio F.","BMC Cancer. 2009 Oct 7;9:357. doi: 10.1186/1471-2407-9-357.","Videira PA","BMC Cancer","2009","2009/10/09","PMC2763879","","10.1186/1471-2407-9-357"
"3694809","[Intra-operative radiotherapy with excision of urinary bladder carcinoma]","Tari K, Satake I, Kogima S, Tsugii T, Sakura M.","Gan No Rinsho. 1987 Nov;33(14):1805-9.","Tari K","Gan No Rinsho","1987","1987/11/01","","",""
"10570409","Bladder cancer redefined","Murphy WM.","Cancer. 1999 Nov 15;86(10):1890-2. doi: 10.1002/(sici)1097-0142(19991115)86:10<1890::aid-cncr2>3.0.co;2-j.","Murphy WM","Cancer","1999","1999/11/26","","","10.1002/(sici)1097-0142(19991115)86:10<1890::aid-cncr2>3.0.co;2-j"
"21068759","Bladder cancer: Photodynamic diagnosis can improve surgical outcome","O'Brien T, Thomas K.","Nat Rev Urol. 2010 Nov;7(11):598-9. doi: 10.1038/nrurol.2010.183.","O'Brien T","Nat Rev Urol","2010","2010/11/12","","","10.1038/nrurol.2010.183"
"30868894","APC promoter methylation is correlated with development and progression of bladder cancer, but not linked to overall survival: a meta-analysis","Bai ZJ, Liu Q, Wang XS, Liu WY.","Neoplasma. 2019 May 23;66(3):470-480. doi: 10.4149/neo_2018_181009N753. Epub 2019 Mar 7.","Bai ZJ","Neoplasma","2019","2019/03/15","","","10.4149/neo_2018_181009N753"
"21784673","The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database","Anderson JK, Alanee S, Lindgren B, Slaton J.","Urol Oncol. 2013 Aug;31(6):862-5. doi: 10.1016/j.urolonc.2011.06.005. Epub 2011 Jul 23.","Anderson JK","Urol Oncol","2013","2011/07/26","","","10.1016/j.urolonc.2011.06.005"
"11125419","Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 tumor suppressor genes","Sourvinos G, Kazanis I, Delakas D, Cranidis A, Spandidos DA.","J Urol. 2001 Jan;165(1):249-52. doi: 10.1097/00005392-200101000-00073.","Sourvinos G","J Urol","2001","2000/12/23","","","10.1097/00005392-200101000-00073"
"31368627","Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancer","Hirotsu Y, Yokoyama H, Amemiya K, Hagimoto T, Daimon H, Hosaka K, Oyama T, Mochizuki H, Omata M.","Cancer Sci. 2019 Oct;110(10):3235-3243. doi: 10.1111/cas.14155. Epub 2019 Aug 10.","Hirotsu Y","Cancer Sci","2019","2019/08/02","PMC6778642","","10.1111/cas.14155"
"16526248","[Current diagnostic and therapeutic approaches to invasive bladder cancer]","Dozić J, Bogdanović J.","Med Pregl. 2005 Sep-Oct;58(9-10):465-71. doi: 10.2298/mpns0510465d.","Dozić J","Med Pregl","2005","2006/03/11","","","10.2298/mpns0510465d"
"1942699","[The anticancer effects of high energy shock waves on rat bladder cancer induced by BBN]","Umekawa T, Ishikawa Y, Kodama M, Katayama Y, Takamura C, Takada M, Kataoka K, Kohri K, Iguchi M, Kurita T.","Nihon Hinyokika Gakkai Zasshi. 1991 Sep;82(9):1391-8. doi: 10.5980/jpnjurol1989.82.1391.","Umekawa T","Nihon Hinyokika Gakkai Zasshi","1991","1991/09/01","","","10.5980/jpnjurol1989.82.1391"
"14734196","Urinary markers of bladder carcinoma","Dey P.","Clin Chim Acta. 2004 Feb;340(1-2):57-65. doi: 10.1016/j.cccn.2003.11.008.","Dey P","Clin Chim Acta","2004","2004/01/22","","","10.1016/j.cccn.2003.11.008"
"19858384","Bladder cancer: narrowing the gap between evidence and practice","Hussain MH, Wood DP, Bajorin DF, Bochner BH, Dreicer R, Lamm DL, O'Donnell MA, Siefker-Radtke AO, Theodorescu D, Dinney CP.","J Clin Oncol. 2009 Dec 1;27(34):5680-4. doi: 10.1200/JCO.2009.23.6901. Epub 2009 Oct 26.","Hussain MH","J Clin Oncol","2009","2009/10/28","PMC4659855","","10.1200/JCO.2009.23.6901"
"23971365","[The history and the present conditions of the occupational bladder cancer in our country]","Matsushima M, Kuwabara T.","Nihon Hinyokika Gakkai Zasshi. 2013 Jul;104(4):569-78. doi: 10.5980/jpnjurol.104.569.","Matsushima M","Nihon Hinyokika Gakkai Zasshi","2013","2013/08/27","","","10.5980/jpnjurol.104.569"
"4027515","Chemotherapy before radiotherapy for T3 bladder cancer. A pilot study","Kaye SB, MacFarlane JR, McHattie I, Hart AJ.","Br J Urol. 1985 Aug;57(4):434-7. doi: 10.1111/j.1464-410x.1985.tb06304.x.","Kaye SB","Br J Urol","1985","1985/08/01","","","10.1111/j.1464-410x.1985.tb06304.x"
"26725219","Surgical bladder-preserving techniques in the management of muscle-invasive bladder cancer","Lyons MD, Smith AB.","Urol Oncol. 2016 Jun;34(6):262-70. doi: 10.1016/j.urolonc.2015.11.023. Epub 2015 Dec 24.","Lyons MD","Urol Oncol","2016","2016/01/04","","","10.1016/j.urolonc.2015.11.023"
"17969413","[Use of flow cytometry in diagnosis of urinary bladder cancer]","Bozhenko VK, Kaprin AD, Kostin AA, Kulinich TM, Kudinova EA, Chazova NL, Mel'nikova NV, Nesterov PV.","Vopr Onkol. 2007;53(4):468-72.","Bozhenko VK","Vopr Onkol","2007","2007/11/01","","",""
"17455864","Risk factors for bladder cancer","Janković S, Radosavljević V.","Tumori. 2007 Jan-Feb;93(1):4-12.","Janković S","Tumori","2007","2007/04/26","","",""
"30243478","Precision medicine and bladder cancer heterogeneity","Ma G, Yang X, Liang Y, Wang L, Li D, Chen Y, Liang Z, Wang Y, Niu H.","Bull Cancer. 2018 Oct;105(10):925-931. doi: 10.1016/j.bulcan.2018.07.015. Epub 2018 Sep 20.","Ma G","Bull Cancer","2018","2018/09/24","","","10.1016/j.bulcan.2018.07.015"
"7601372","[Treatment of urinary bladder cancer--a retrospective analysis]","Kuten A, Cohen Y, Rubinov R, Baz M, Dale J, Haim N, Robinson E.","Harefuah. 1995 May 15;128(10):606-10, 672.","Kuten A","Harefuah","1995","1995/05/15","","",""
"31532234","Evaluation of platelet distribution width as a diagnostic and prognostic biomarker in bladder neoplasm","Liu L, Zhao Y, Cui J, Chen S, Shi B.","Future Oncol. 2019 Nov;15(33):3797-3807. doi: 10.2217/fon-2019-0441. Epub 2019 Sep 18.","Liu L","Future Oncol","2019","2019/09/19","","","10.2217/fon-2019-0441"
"16568690","[The influence of ""differentiated trandurethral resection"" in the recurrence and progression of superficial bladder cancer]","Angbein S, Guzmán S, Haecker A, Weib C, Michel MS, Alken P, Siegsmund M.","Arch Esp Urol. 2006 Jan-Feb;59(1):25-30.","Angbein S","Arch Esp Urol","2006","2006/03/30","","",""
"11306420","Noninvasive detection and prediction of bladder cancer by fluorescence in situ hybridization analysis of exfoliated urothelial cells in voided urine","Ishiwata S, Takahashi S, Homma Y, Tanaka Y, Kameyama S, Hosaka Y, Kitamura T.","Urology. 2001 Apr;57(4):811-5. doi: 10.1016/s0090-4295(00)01074-8.","Ishiwata S","Urology","2001","2001/04/18","","","10.1016/s0090-4295(00)01074-8"
"23540787","Optimal risk-adapted surveillance strategies for NMIBC, including upper tract imaging","Large MC, Cohn JA, Steinberg GD.","Urol Clin North Am. 2013 May;40(2):305-15. doi: 10.1016/j.ucl.2013.01.013. Epub 2013 Feb 19.","Large MC","Urol Clin North Am","2013","2013/04/02","","","10.1016/j.ucl.2013.01.013"
"9873256","Solitary cutaneous metastasis of superficial bladder cancer","Saito S.","Urol Int. 1998;61(2):126-7. doi: 10.1159/000030304.","Saito S","Urol Int","1998","1999/01/05","","","10.1159/000030304"
"19670726","[Ductal cytometry of urinary sediment in the diagnosis of bladder cancer]","Bozhenko BK, Kaprin AD, Kulinich TM, Nesterov PV.","Vopr Onkol. 2009;55(3):278-84.","Bozhenko BK","Vopr Onkol","2009","2009/08/13","","",""
"27734426","The Rate of Neoadjuvant Chemotherapy Use in Muscle Invasive Bladder Cancer and The Approach of Urologists in Turkey","Üçer O, Albaz AC, Atag E, Karaoglu A, Muezzinoglu T.","Urol J. 2016 Oct 10;13(5):2841-2844.","Üçer O","Urol J","2016","2016/10/14","","",""
"31692303","Epidemiology and unmet needs of bladder cancer in Italy: a critical review","De Nunzio C, Giannatempo P, Passalacqua R, Fiorini E, Luccarini I, Brigido A.","Minerva Urol Nefrol. 2020 Feb;72(1):1-12. doi: 10.23736/S0393-2249.19.03498-2. Epub 2019 Nov 4.","De Nunzio C","Minerva Urol Nefrol","2020","2019/11/07","","","10.23736/S0393-2249.19.03498-2"
"16018944","Bladder cancer clinical trials","Lerner SP.","Urol Oncol. 2005 Jul-Aug;23(4):275-9. doi: 10.1016/j.urolonc.2005.05.005.","Lerner SP","Urol Oncol","2005","2005/07/16","","","10.1016/j.urolonc.2005.05.005"
"22354060","Value of current chemotherapy and surgery in advanced and metastatic bladder cancer","Racioppi M, D'Agostino D, Totaro A, Pinto F, Sacco E, D'Addessi A, Marangi F, Palermo G, Bassi PF.","Urol Int. 2012;88(3):249-58. doi: 10.1159/000335556. Epub 2012 Feb 17.","Racioppi M","Urol Int","2012","2012/02/23","","","10.1159/000335556"
"17280910","Radiotherapy for bladder cancer","Milosevic M, Gospodarowicz M, Zietman A, Abbas F, Haustermans K, Moonen L, Rödel C, Schoenberg M, Shipley W.","Urology. 2007 Jan;69(1 Suppl):80-92. doi: 10.1016/j.urology.2006.05.060.","Milosevic M","Urology","2007","2007/02/07","","","10.1016/j.urology.2006.05.060"
"6467507","Genetically determined debrisoquine oxidation capacity in bladder cancer","Cartwright RA, Philip PA, Rogers HJ, Glashan RW.","Carcinogenesis. 1984 Sep;5(9):1191-2. doi: 10.1093/carcin/5.9.1191.","Cartwright RA","Carcinogenesis","1984","1984/09/01","","","10.1093/carcin/5.9.1191"
"2018387","Nucleolar organiser regions (NORs) in bladder cancer; relation to histological grade, clinical stage and prognosis","Lipponen PK, Eskelinen MJ.","Anticancer Res. 1991 Jan-Feb;11(1):75-80.","Lipponen PK","Anticancer Res","1991","1991/01/01","","",""
"6613925","Anatomic considerations in radiotherapeutic management of bladder cancer","Emami B, Pilepich MV.","Am J Clin Oncol. 1983 Oct;6(5):593-7.","Emami B","Am J Clin Oncol","1983","1983/10/01","","",""
"1319578","Bladder cancer, 1992","Rath GD.","Postgrad Med. 1992 Jul;92(1):105-12, 115-6, 121-4. doi: 10.1080/00325481.1992.11701394.","Rath GD","Postgrad Med","1992","1992/07/01","","","10.1080/00325481.1992.11701394"
"4806174","Some morphological and physiological problems of bladder cancer","Hicks RM.","Cancro. 1973;26(3):193-200.","Hicks RM","Cancro","1973","1973/01/01","","",""
"21623943","Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment","Birnie A, Blick C, Fawcett D.","BJU Int. 2011 Jun;107(12):2002; author reply 2002. doi: 10.1111/j.1464-410X.2011.10379_1.x.","Birnie A","BJU Int","2011","2011/06/01","","","10.1111/j.1464-410X.2011.10379_1.x"
"7200929","Update on Dx and management of bladder cancer","Trump DL.","Geriatrics. 1982 Jul;37(7):87-91.","Trump DL","Geriatrics","1982","1982/07/01","","",""
"11307770","[Current treatment of bladder cancer: from epidemiology to surgical treatment]","Rischmann P.","Anticancer Drugs. 2000 Oct;11 Suppl 1:S3-8.","Rischmann P","Anticancer Drugs","2000","2001/04/20","","",""
"6726903","Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer","Skinner DG, Lieskovsky G.","J Urol. 1984 Jun;131(6):1069-72. doi: 10.1016/s0022-5347(17)50809-5.","Skinner DG","J Urol","1984","1984/06/01","","","10.1016/s0022-5347(17)50809-5"
"8664918","[Partial cystectomy versus TUR in T1G3 tumors]","Manca GP, Martina G, Piras P, D'Alpaos M, Scuzarella S, Andreassi F.","Arch Ital Urol Androl. 1996 Feb;68(1):33-4.","Manca GP","Arch Ital Urol Androl","1996","1996/02/01","","",""
"31631042","Transgelin in bladder cancer: A potential biomarker and therapeutic target","Li WM, Wu WJ.","EBioMedicine. 2019 Oct;48:16-17. doi: 10.1016/j.ebiom.2019.09.011. Epub 2019 Oct 17.","Li WM","EBioMedicine","2019","2019/10/22","PMC6838370","","10.1016/j.ebiom.2019.09.011"
"22830472","Radiotherapy plus chemotherapy in muscle-invasive bladder cancer","Cathcart P, Sylvester R, Catto J.","N Engl J Med. 2012 Jul 26;367(4):379-80; author reply 380-1. doi: 10.1056/NEJMc1206002.","Cathcart P","N Engl J Med","2012","2012/07/27","","","10.1056/NEJMc1206002"
"22512487","Old drugs, new purpose--bladder cancer turning a corner","Shipley WU, Zietman AL.","N Engl J Med. 2012 Apr 19;366(16):1540-1. doi: 10.1056/NEJMe1201531.","Shipley WU","N Engl J Med","2012","2012/04/20","","","10.1056/NEJMe1201531"
"23994371","Bladder cancer in Spain 2011: population based study","Miñana B, Cózar JM, Palou J, Unda Urzaiz M, Medina-Lopez RA, Subirá Ríos J, de la Rosa-Kehrmann F, Chantada-Abal V, Lozano F, Ribal MJ, Rodríguez Fernández E, Castiñeiras Fernández J, Concepción Masip T, Requena-Tapia MJ, Moreno-Sierra J, Hevia M, Gómez Rodríguez A, Martínez-Ballesteros C, Ramos M, Amón Sesmero JH, Pizá Reus P, Bohorquez Barrientos A, Rioja Sanz C, Gomez-Pascual JA, Hidalgo Zabala E, Parra Escobar JL, Serrano O.","J Urol. 2014 Feb;191(2):323-8. doi: 10.1016/j.juro.2013.08.049. Epub 2013 Aug 28.","Miñana B","J Urol","2014","2013/09/03","","","10.1016/j.juro.2013.08.049"
"6009442","[Clinical and pathological studies on partial cystectomy for urinary bladder cancer. II. Examination on the reasonable extension of vesical wall resection with pathological procedure]","Miura T.","Nihon Hinyokika Gakkai Zasshi. 1966 Oct;57(10):1122-37. doi: 10.5980/jpnjurol1928.57.10_1122.","Miura T","Nihon Hinyokika Gakkai Zasshi","1966","1966/10/01","","","10.5980/jpnjurol1928.57.10_1122"
"28859894","The Prevalence and Impact of Urinary Marker Testing in Patients with Bladder Cancer","Narayan VM, Adejoro O, Schwartz I, Ziegelmann M, Elliott S, Konety BR.","J Urol. 2018 Jan;199(1):74-80. doi: 10.1016/j.juro.2017.08.097. Epub 2017 Aug 30.","Narayan VM","J Urol","2018","2017/09/02","","","10.1016/j.juro.2017.08.097"
"23899731","Detecting and treating bladder cancer","Anderson B.","Br J Nurs. 2013 Jun 13-26;22(11):628. doi: 10.12968/bjon.2013.22.11.628.","Anderson B","Br J Nurs","2013","2013/08/01","","","10.12968/bjon.2013.22.11.628"
"25689651","Bladder cancer: a focus on sexuality","Weinstein Dunn M.","Clin J Oncol Nurs. 2015 Feb;19(1):68-73. doi: 10.1188/15.CJON.68-73.","Weinstein Dunn M","Clin J Oncol Nurs","2015","2015/02/18","","","10.1188/15.CJON.68-73"
"23163857","The association between milk consumption and bladder cancer risk: appraisal of a recent meta-analysis","Zhang ZH, Yang LS, Sun YH.","Nutr Cancer. 2012;64(8):1288-9. doi: 10.1080/01635581.2012.718403.","Zhang ZH","Nutr Cancer","2012","2012/11/21","","","10.1080/01635581.2012.718403"
"7370937","Current perspectives in the management of high-grade invasive bladder cancer","Skinner DG.","Cancer. 1980 Apr 15;45(7 Suppl):1866-74.","Skinner DG","Cancer","1980","1980/04/15","","",""
"20439032","BCAN Think Tank session 1: Overview of risks for and causes of bladder cancer","Zlotta AR, Cohen SM, Dinney C, Droller M, van der Kwast TH, van Rhijn BW, Bochner B, Ameil G, Jewett MA.","Urol Oncol. 2010 May-Jun;28(3):329-33. doi: 10.1016/j.urolonc.2009.10.011.","Zlotta AR","Urol Oncol","2010","2010/05/05","","","10.1016/j.urolonc.2009.10.011"
"418856","Bladder cancer","Whitmore WF.","CA Cancer J Clin. 1978 May-Jun;28(3):170-7. doi: 10.3322/canjclin.28.3.170.","Whitmore WF","CA Cancer J Clin","1978","1978/05/01","","","10.3322/canjclin.28.3.170"
"26197237","Downregulation of SKA1 Gene Expression Inhibits Cell Growth in Human Bladder Cancer","Tian F, Xing X, Xu F, Cheng W, Zhang Z, Gao J, Ge J, Xie H.","Cancer Biother Radiopharm. 2015 Sep;30(7):271-7. doi: 10.1089/cbr.2014.1715. Epub 2015 Jul 21.","Tian F","Cancer Biother Radiopharm","2015","2015/07/22","","","10.1089/cbr.2014.1715"
"25210143","Patterns of practice in the radiation therapy for bladder cancer: survey of the Japanese Radiation Oncology Study Group (JROSG)","Maebayashi T, Ishikawa H, Yorozu A, Yoshida D, Katoh H, Nemoto K, Ishihara S, Takemoto S, Ishibashi N, Tokumaru S, Akimoto T; Working Subgroup of Urological Cancers in Japanese Radiation Oncology Study Group.","Jpn J Clin Oncol. 2014 Nov;44(11):1109-15. doi: 10.1093/jjco/hyu129. Epub 2014 Sep 10.","Maebayashi T","Jpn J Clin Oncol","2014","2014/09/12","","","10.1093/jjco/hyu129"
"10711576","Organ-conserving approaches to muscle-invasive bladder cancer: future alternatives to radical cystectomy","Zietman AL, Shipley WU, Kaufman DS.","Ann Med. 2000 Feb;32(1):34-42. doi: 10.3109/07853890008995908.","Zietman AL","Ann Med","2000","2000/03/11","","","10.3109/07853890008995908"
"5359495","The evolution of tumour cell populations in human bladder cancer","Cooper EH, Levi PE, Anderson CK, Williams RE.","Br J Urol. 1969 Dec;41(6):714-7. doi: 10.1111/j.1464-410x.1969.tb09983.x.","Cooper EH","Br J Urol","1969","1969/12/01","","","10.1111/j.1464-410x.1969.tb09983.x"
"22677572","A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer","Meeks JJ, Bellmunt J, Bochner BH, Clarke NW, Daneshmand S, Galsky MD, Hahn NM, Lerner SP, Mason M, Powles T, Sternberg CN, Sonpavde G.","Eur Urol. 2012 Sep;62(3):523-33. doi: 10.1016/j.eururo.2012.05.048. Epub 2012 Jun 1.","Meeks JJ","Eur Urol","2012","2012/06/09","","","10.1016/j.eururo.2012.05.048"
"25879349","Survival trends in metastatic bladder cancer in the United States: a population based study","Shah BK, Mandal R.","J Cancer Res Ther. 2015 Jan-Mar;11(1):124-8. doi: 10.4103/0973-1482.140982.","Shah BK","J Cancer Res Ther","2015","2015/04/17","","","10.4103/0973-1482.140982"
"16807436","Challenges in the treatment of bladder cancer","Kaufman DS.","Ann Oncol. 2006 May;17 Suppl 5:v106-12. doi: 10.1093/annonc/mdj963.","Kaufman DS","Ann Oncol","2006","2006/06/30","","","10.1093/annonc/mdj963"
"11690548","p53 Mutation in bladder cancer patients in Japan and inhibition of growth by in vitro adenovirus-mediated wild-type p53 transduction in bladder cancer cells","Irie A, Uchida T, Ishida H, Matsumoto K, Iwamura M, Baba S.","Mol Urol. 2001 Summer;5(2):53-8. doi: 10.1089/109153601300177556.","Irie A","Mol Urol","2001","2001/11/03","","","10.1089/109153601300177556"
"24978392","Sex steroids and gender differences in nonmuscle invasive bladder cancer","Lucca I, Fajkovic H, Klatte T.","Curr Opin Urol. 2014 Sep;24(5):500-5. doi: 10.1097/MOU.0000000000000092.","Lucca I","Curr Opin Urol","2014","2014/07/01","","","10.1097/MOU.0000000000000092"
"23659445","Egg consumption and risk of bladder cancer: a meta-analysis","Li F, Zhou Y, Hu RT, Hou LN, Du YJ, Zhang XJ, Olkkonen VM, Tan WL.","Nutr Cancer. 2013;65(4):538-46. doi: 10.1080/01635581.2013.770041.","Li F","Nutr Cancer","2013","2013/05/11","","","10.1080/01635581.2013.770041"
"30272657","3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer","Wang Y, Day ML, Simeone DM, Palmbos PL.","J Vis Exp. 2018 Sep 13;(139):58345. doi: 10.3791/58345.","Wang Y","J Vis Exp","2018","2018/10/02","PMC6235181","","10.3791/58345"
"3362882","Staging of bladder cancer","Freiha FS.","Prog Clin Biol Res. 1988;260:245-9.","Freiha FS","Prog Clin Biol Res","1988","1988/01/01","","",""
"30109022","Advances in risk stratification of bladder cancer to guide personalized medicine","Matulay JT, Kamat AM.","F1000Res. 2018 Jul 25;7:F1000 Faculty Rev-1137. doi: 10.12688/f1000research.14903.1. eCollection 2018.","Matulay JT","F1000Res","2018","2018/08/16","PMC6069735","","10.12688/f1000research.14903.1"
"776446","Recent advances in the immunobiology of human bladder cancer","Herr HW.","Clin Bull. 1975;5(4):149-53.","Herr HW","Clin Bull","1975","1975/01/01","","",""
"20625298","Imaging bladder cancer","Cowan NC, Crew JP.","Curr Opin Urol. 2010 Sep;20(5):409-13. doi: 10.1097/MOU.0b013e32833cbcb9.","Cowan NC","Curr Opin Urol","2010","2010/07/14","","","10.1097/MOU.0b013e32833cbcb9"
"2074520","Current therapy of bladder cancer","Whitmore WF Jr.","J Occup Med. 1990 Sep;32(9):921-5. doi: 10.1097/00043764-199009000-00034.","Whitmore WF Jr","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00034"
"24992244","Bladder cancer: the curious case of a not so rare disease","Shariat SF.","Curr Opin Urol. 2014 Sep;24(5):483-6. doi: 10.1097/MOU.0000000000000098.","Shariat SF","Curr Opin Urol","2014","2014/07/04","","","10.1097/MOU.0000000000000098"
"25929573","Nanotechnology in bladder cancer: current state of development and clinical practice","Tomlinson B, Lin TY, Dall'Era M, Pan CX.","Nanomedicine (Lond). 2015;10(7):1189-201. doi: 10.2217/nnm.14.212.","Tomlinson B","Nanomedicine (Lond)","2015","2015/05/02","PMC4562431","NIHMS718866","10.2217/nnm.14.212"
"28544293","Bladder cancer- time for a higher profile in our region","Lawrentschuk N.","BJU Int. 2017 May;119 Suppl 5:5. doi: 10.1111/bju.13877.","Lawrentschuk N","BJU Int","2017","2017/05/26","","","10.1111/bju.13877"
"28895563","Characteristics and clinical significance of histological variants of bladder cancer","Moschini M, D'Andrea D, Korn S, Irmak Y, Soria F, Compérat E, Shariat SF.","Nat Rev Urol. 2017 Nov;14(11):651-668. doi: 10.1038/nrurol.2017.125. Epub 2017 Sep 12.","Moschini M","Nat Rev Urol","2017","2017/09/13","","","10.1038/nrurol.2017.125"
"1305686","Pathology of carcinoma in situ of the urinary bladder and related lesions","Farrow GM.","J Cell Biochem Suppl. 1992;16I:39-43. doi: 10.1002/jcb.240501308.","Farrow GM","J Cell Biochem Suppl","1992","1992/01/01","","","10.1002/jcb.240501308"
"25533675","Modelling bladder cancer in mice: opportunities and challenges","Kobayashi T, Owczarek TB, McKiernan JM, Abate-Shen C.","Nat Rev Cancer. 2015 Jan;15(1):42-54. doi: 10.1038/nrc3858.","Kobayashi T","Nat Rev Cancer","2015","2014/12/24","PMC4386904","NIHMS675911","10.1038/nrc3858"
"12645373","[Neoplastic pathology of the urothelium]","Rodríguez-Rubio Vidal F, Garrido Insua S, Rodríguez-Rubio Cortadellas FI, Nogueira March JL.","Actas Urol Esp. 2002 Nov-Dec;26(10):763-70. doi: 10.1016/s0210-4806(02)72855-6.","Rodríguez-Rubio Vidal F","Actas Urol Esp","2002","2003/03/21","","","10.1016/s0210-4806(02)72855-6"
"14750899","The health economics of bladder cancer: a comprehensive review of the published literature","Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R.","Pharmacoeconomics. 2003;21(18):1315-30. doi: 10.1007/BF03262330.","Botteman MF","Pharmacoeconomics","2003","2004/01/31","","","10.1007/BF03262330"
"31237444","Bladder cancer mortality after a diagnosis of nonmuscle-invasive bladder carcinoma","Abdel-Rahman O.","Future Oncol. 2019 Jul;15(19):2267-2275. doi: 10.2217/fon-2018-0861. Epub 2019 Jun 25.","Abdel-Rahman O","Future Oncol","2019","2019/06/26","","","10.2217/fon-2018-0861"
"28527621","Physical activity patterns and associations with health-related quality of life in bladder cancer survivors","Gopalakrishna A, Longo TA, Fantony JJ, Harrison MR, Inman BA.","Urol Oncol. 2017 Sep;35(9):540.e1-540.e6. doi: 10.1016/j.urolonc.2017.04.016. Epub 2017 May 17.","Gopalakrishna A","Urol Oncol","2017","2017/05/22","PMC5573654","NIHMS871485","10.1016/j.urolonc.2017.04.016"
"12389114","Ras signal transduction in carcinogenesis and progression of bladder cancer: molecular target for treatment?","Shinohara N, Koyanagi T.","Urol Res. 2002 Oct;30(5):273-81. doi: 10.1007/s00240-002-0275-0. Epub 2002 Sep 7.","Shinohara N","Urol Res","2002","2002/10/22","","","10.1007/s00240-002-0275-0"
"2039913","Lasers in the treatment of bladder cancer","Ruston MA, Fowler CG.","Br J Urol. 1991 May;67(5):449-55. doi: 10.1111/j.1464-410x.1991.tb15185.x.","Ruston MA","Br J Urol","1991","1991/05/01","","","10.1111/j.1464-410x.1991.tb15185.x"
"7431715","[Pathological study of growth pattern of bladder cancer from view point of mapping (author's transl)]","Murase T, Fujita J, Kakizoe T, Matsumoto K, Kishi K.","Nihon Hinyokika Gakkai Zasshi. 1980 Aug;71(8):829-39. doi: 10.5980/jpnjurol1928.71.8_829.","Murase T","Nihon Hinyokika Gakkai Zasshi","1980","1980/08/01","","","10.5980/jpnjurol1928.71.8_829"
"19496719","Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer","Clark PE.","Expert Rev Anticancer Ther. 2009 Jun;9(6):821-30. doi: 10.1586/era.09.36.","Clark PE","Expert Rev Anticancer Ther","2009","2009/06/06","","","10.1586/era.09.36"
"12780826","Where are the 'poster boys' for bladder cancer?","Soloway MS.","BJU Int. 2003 Jun;91(9):769-70. doi: 10.1046/j.1464-410x.2003.04251.x.","Soloway MS","BJU Int","2003","2003/06/05","","","10.1046/j.1464-410x.2003.04251.x"
"15234237","Recent advances in bladder cancer diagnostics","Sanchez-Carbayo M.","Clin Biochem. 2004 Jul;37(7):562-71. doi: 10.1016/j.clinbiochem.2004.05.014.","Sanchez-Carbayo M","Clin Biochem","2004","2004/07/06","","","10.1016/j.clinbiochem.2004.05.014"
"26508308","Economic Burden of Bladder Cancer Across the European Union","Leal J, Luengo-Fernandez R, Sullivan R, Witjes JA.","Eur Urol. 2016 Mar;69(3):438-47. doi: 10.1016/j.eururo.2015.10.024. Epub 2015 Oct 25.","Leal J","Eur Urol","2016","2015/10/29","","","10.1016/j.eururo.2015.10.024"
"1999849","Cancer registry problems in classifying invasive bladder cancer","Lynch CF, Platz CE, Jones MP, Gazzaniga JM.","J Natl Cancer Inst. 1991 Mar 20;83(6):429-33. doi: 10.1093/jnci/83.6.429.","Lynch CF","J Natl Cancer Inst","1991","1991/03/20","","","10.1093/jnci/83.6.429"
"16625287","Synchronous primary carcinomas of the bladder and prostate","Lee SH, Chang PL, Chen SM, Sun GH, Chen CL, Shen BY, Wu YS, Tsui KH.","Asian J Androl. 2006 May;8(3):357-9. doi: 10.1111/j.1745-7262.2006.00129.x.","Lee SH","Asian J Androl","2006","2006/04/21","","","10.1111/j.1745-7262.2006.00129.x"
"22296361","MTHFR gene polymorphisms and bladder cancer susceptibility: a meta-analysis including race, smoking status and tumour stage","Kouidhi S, Rouissi K, Khedhiri S, Ouerhani S, Cherif M, Benammar-Elgaaied A.","Asian Pac J Cancer Prev. 2011;12(9):2227-32.","Kouidhi S","Asian Pac J Cancer Prev","2011","2012/02/03","","",""
"5169347","[Interstitial irradiation with radon-seed in bladder cancer with special reference to the follow-up results]","Yokokawa M.","Gan No Rinsho. 1971 Dec;17(12):860-6.","Yokokawa M","Gan No Rinsho","1971","1971/12/01","","",""
"29893311","The epidemiological and histological trend of bladder cancer in Iran","Rafiemanesh H, Lotfi Z, Bakhtazad S, Ghoncheh M, Salehiniya H.","J Cancer Res Ther. 2018 Apr-Jun;14(3):532-536. doi: 10.4103/0973-1482.172134.","Rafiemanesh H","J Cancer Res Ther","2018","2018/06/13","","","10.4103/0973-1482.172134"
"24300483","Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogate","Lavery HJ, Stensland KD, Niegisch G, Albers P, Droller MJ.","J Urol. 2014 Apr;191(4):898-906. doi: 10.1016/j.juro.2013.10.142. Epub 2013 Dec 1.","Lavery HJ","J Urol","2014","2013/12/05","","","10.1016/j.juro.2013.10.142"
"808828","Bladder cancer: results of radiation therapy in 384 patients","Goffinet DR, Schneider MJ, Glatstein EJ, Ludwig H, Ray GR, Dunnick NR, Bagshaw MA.","Radiology. 1975 Oct;117(1):149-53. doi: 10.1148/117.1.149.","Goffinet DR","Radiology","1975","1975/10/01","","","10.1148/117.1.149"
"26075567","Management of muscle-invasive bladder cancer in the elderly","Rose TL, Milowsky MI.","Curr Opin Urol. 2015 Sep;25(5):459-67. doi: 10.1097/MOU.0000000000000190.","Rose TL","Curr Opin Urol","2015","2015/06/16","","","10.1097/MOU.0000000000000190"
"1618888","Chemical carcinogenesis of the urinary bladder--a status report","Jones RF, Debiec-Rychter M, Wang CY.","J Cancer Res Clin Oncol. 1992;118(6):411-9. doi: 10.1007/BF01629423.","Jones RF","J Cancer Res Clin Oncol","1992","1992/01/01","","","10.1007/BF01629423"
"17334088","[Management of occupational bladder cancer in Japan (Vol. 1)]","Ishizu S, Hashida C.","Nihon Eiseigaku Zasshi. 2007 Jan;62(1):9-17. doi: 10.1265/jjh.62.9.","Ishizu S","Nihon Eiseigaku Zasshi","2007","2007/03/06","","","10.1265/jjh.62.9"
"15049983","Bladder cancer in patients with spinal cord injuries","Subramonian K, Cartwright RA, Harnden P, Harrison SC.","BJU Int. 2004 Apr;93(6):739-43. doi: 10.1111/j.1464-410X.2003.04718.x.","Subramonian K","BJU Int","2004","2004/03/31","","","10.1111/j.1464-410X.2003.04718.x"
"2782911","[Cis-radiation therapy of locally advanced bladder cancer]","Itatani H, Utsunomiya M.","Gan To Kagaku Ryoho. 1989 Sep;16(9):3129-35.","Itatani H","Gan To Kagaku Ryoho","1989","1989/09/01","","",""
"20150808","Bladder cancer","Morgan TM, Clark PE.","Curr Opin Oncol. 2010 May;22(3):242-9. doi: 10.1097/CCO.0b013e3283378c6b.","Morgan TM","Curr Opin Oncol","2010","2010/02/13","","","10.1097/CCO.0b013e3283378c6b"
"10732697","Chromosomal numerical aberrations of exfoliated cells in the urine detected by fluorescence in situ hybridization: clinical implication for the detection of bladder cancer","Inoue T, Nasu Y, Tsushima T, Miyaji Y, Murakami T, Kumon H.","Urol Res. 2000 Jan;28(1):57-61. doi: 10.1007/s002400050011.","Inoue T","Urol Res","2000","2000/03/25","","","10.1007/s002400050011"
"31006743","[OUTCOME OF BLADDER PRESERVATION USING LOW DOSE CHEMORADIATION THERAPY IN PATIENTS WITH LOCALLY INVASIVE BLADDER CANCER]","Matsushita M, Kitakaze H, Okada K, Minato N, Mori N, Yoshioka T.","Nihon Hinyokika Gakkai Zasshi. 2018;109(2):59-67. doi: 10.5980/jpnjurol.109.59.","Matsushita M","Nihon Hinyokika Gakkai Zasshi","2018","2019/04/23","","","10.5980/jpnjurol.109.59"
"16515958","Entrez into the immunogenetics of superficial bladder cancer response to bacillus Calmette-Guerin","O'Donnell M.","J Urol. 2006 Apr;175(4):1197-8. doi: 10.1016/S0022-5347(06)00054-1.","O'Donnell M","J Urol","2006","2006/03/07","","","10.1016/S0022-5347(06)00054-1"
"9273765","[Urinary bladder tumors. Report of the Danish Bladder-cancer Committee 1993]","","Ugeskr Laeger. 1997;159 Suppl 1:1-14.","","Ugeskr Laeger","1997","1997/01/01","","",""
"25668831","[Muscle-invasive bladder cancer]","Pashootan P, Legrand G, Ploussard G.","Rev Prat. 2014 Dec;64(10):1391-2, 1395-8.","Pashootan P","Rev Prat","2014","2015/02/12","","",""
"6620782","[Study on the thymic lymphocytes in the rats treated with bladder cancer-inducing BBN--in vitro effect of the thymus humoral factor]","Wada S.","Nihon Hinyokika Gakkai Zasshi. 1983 May;74(5):821-33. doi: 10.5980/jpnjurol1928.74.5_821.","Wada S","Nihon Hinyokika Gakkai Zasshi","1983","1983/05/01","","","10.5980/jpnjurol1928.74.5_821"
"31779626","The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice","Degoricija M, Korac-Prlic J, Vilovic K, Ivanisevic T, Haupt B, Palada V, Petkovic M, Karaman I, Terzic J.","J Transl Med. 2019 Nov 28;17(1):394. doi: 10.1186/s12967-019-02146-5.","Degoricija M","J Transl Med","2019","2019/11/30","PMC6883615","","10.1186/s12967-019-02146-5"
"16862567","Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysis","Lotan Y, Svatek RS, Sagalowsky AI.","Cancer. 2006 Sep 1;107(5):982-90. doi: 10.1002/cncr.22084.","Lotan Y","Cancer","2006","2006/07/25","","","10.1002/cncr.22084"
"23883869","Neoadjuvant paradigm for accelerated drug development: an ideal model in bladder cancer","Chism DD, Woods ME, Milowsky MI.","Oncologist. 2013;18(8):933-40. doi: 10.1634/theoncologist.2013-0023. Epub 2013 Jul 24.","Chism DD","Oncologist","2013","2013/07/26","PMC3755931","","10.1634/theoncologist.2013-0023"
"16905984","Lymphovascular invasion as a prognostic tool for advanced bladder cancer","Algaba F.","Curr Opin Urol. 2006 Sep;16(5):367-71. doi: 10.1097/01.mou.0000240311.08701.55.","Algaba F","Curr Opin Urol","2006","2006/08/15","","","10.1097/01.mou.0000240311.08701.55"
"2218571","Surgery of invasive bladder cancer: is pathologic staging necessary?","Herr HW, Scher HI.","Semin Oncol. 1990 Oct;17(5):590-7.","Herr HW","Semin Oncol","1990","1990/10/01","","",""
"17095522","HSP60 may predict good pathological response to neoadjuvant chemoradiotherapy in bladder cancer","Urushibara M, Kageyama Y, Akashi T, Otsuka Y, Takizawa T, Koike M, Kihara K.","Jpn J Clin Oncol. 2007 Jan;37(1):56-61. doi: 10.1093/jjco/hyl121. Epub 2006 Nov 9.","Urushibara M","Jpn J Clin Oncol","2007","2006/11/11","","","10.1093/jjco/hyl121"
"19914099","Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways","Wallerand H, Bernhard JC, Culine S, Ballanger P, Robert G, Reiter RE, Ferrière JM, Ravaud A.","Urol Oncol. 2011 Jan-Feb;29(1):4-11. doi: 10.1016/j.urolonc.2009.07.025. Epub 2009 Nov 13.","Wallerand H","Urol Oncol","2011","2009/11/17","","","10.1016/j.urolonc.2009.07.025"
"24936033","Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development","Knapp DW, Ramos-Vara JA, Moore GE, Dhawan D, Bonney PL, Young KE.","ILAR J. 2014;55(1):100-18. doi: 10.1093/ilar/ilu018.","Knapp DW","ILAR J","2014","2014/06/18","","","10.1093/ilar/ilu018"
"17134607","[Occupationally conditioned bladder cancer--are the patients identified?]","Thomsen M, Mikines KJ.","Ugeskr Laeger. 2006 Nov 20;168(47):4095-8.","Thomsen M","Ugeskr Laeger","2006","2006/12/01","","",""
"18722043","Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy","Herr HW.","Eur Urol. 2009 Apr;55(4):920-1. doi: 10.1016/j.eururo.2008.08.029. Epub 2008 Aug 15.","Herr HW","Eur Urol","2009","2008/08/30","","","10.1016/j.eururo.2008.08.029"
"22830473","Radiotherapy plus chemotherapy in muscle-invasive bladder cancer","Atkins CD, Wrzesinski SH.","N Engl J Med. 2012 Jul 26;367(4):380; author reply 380-1. doi: 10.1056/NEJMc1206002.","Atkins CD","N Engl J Med","2012","2012/07/27","","","10.1056/NEJMc1206002"
"18815911","Bladder cancer: from pathogenesis to prevention","Andersson L, Droller MJ.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):5-6. doi: 10.1080/03008880802283789.","Andersson L","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802283789"
"7613860","The therapeutic potential of monoclonal antibodies for bladder cancer","Kunkler RB, Kockelbergh RC.","Br J Urol. 1995 Jun;75 Suppl 1:9-17.","Kunkler RB","Br J Urol","1995","1995/06/01","","",""
"7750525","Advances in the treatment of superficial bladder cancer: optimizing BCG immunotherapy. Proceedings of a symposium. International Society of Urology, Sydney, Australia, September 18, 1994","","Eur Urol. 1995;27 Suppl 1:1-33.","","Eur Urol","1995","1995/01/01","","",""
"3543946","Response criteria for phase III studies of superficial bladder cancer","Schröder FH, Sylvester R, Gustafson H, Kawai T, Kurth KH, Matsuda M, Miyakawa M, Newling DW, Studer E.","Prog Clin Biol Res. 1986;221:311-21.","Schröder FH","Prog Clin Biol Res","1986","1986/01/01","","",""
"3735853","[Statistical study on tumors of the urinary bladder--multivariate analyses of prognostic determinants for bladder cancer]","Takashi M, Murase T, Miyake K, Mitsuya H, Ohno Y, Hamajima N.","Nihon Hinyokika Gakkai Zasshi. 1986 Feb;77(2):195-201. doi: 10.5980/jpnjurol1928.77.2_195.","Takashi M","Nihon Hinyokika Gakkai Zasshi","1986","1986/02/01","","","10.5980/jpnjurol1928.77.2_195"
"27374472","Essential content of evidence-based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update","Kubota Y, Nakaigawa N; Committee for Establishment of the Clinical Practice Guideline for the Management of Bladder Cancer and the Japanese Urological Association.","Int J Urol. 2016 Aug;23(8):640-5. doi: 10.1111/iju.13141. Epub 2016 Jul 3.","Kubota Y","Int J Urol","2016","2016/07/05","","","10.1111/iju.13141"
"1785381","[A clinical survey of advanced bladder cancer: treatment of advanced and non-resectable bladder cancer]","Naito K, Hasegawa T, Ishida T, Yamamoto H, Mihara S, Komatsu K, Ueki O, Koshida K, Hisazumi H.","Hinyokika Kiyo. 1991 Dec;37(12):1601-6.","Naito K","Hinyokika Kiyo","1991","1991/12/01","","",""
"23751372","Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy","Aziz A, Gierth M, Fritsche HM, May M, Otto W, Denzinger S, Wieland WF, Merseburger A, Riedmiller H, Kocot A, Burger M.","Urol Int. 2013;91(1):97-102. doi: 10.1159/000350232. Epub 2013 Jun 6.","Aziz A","Urol Int","2013","2013/06/12","","","10.1159/000350232"
"7129891","[Classification of bladder cancer]","Bandhauer K, Toggenburg H.","Helv Chir Acta. 1982 Aug;49(3-4):293-300.","Bandhauer K","Helv Chir Acta","1982","1982/08/01","","",""
"617698","[Special aspects of bladder cancer in the Egyptian farmer with bilharziasis]","Badr MM.","J Urol Nephrol (Paris). 1977;83 Suppl 2:370.","Badr MM","J Urol Nephrol (Paris)","1977","1977/01/01","","",""
"14621363","What do I tell my patients about drinking water and the risk of bladder cancer?","Moyad MA.","Urol Nurs. 2003 Oct;23(5):371-7.","Moyad MA","Urol Nurs","2003","2003/11/19","","",""
"929781","[Causes of bladder cancer and the possibilities for its prevention according to epidemiologic study data]","Prianichnikova MB.","Urol Nefrol (Mosk). 1977 Nov-Dec;(6):28-31.","Prianichnikova MB","Urol Nefrol (Mosk)","1977","1977/11/01","","",""
"18219107","Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis","Barboro P, Rubagotti A, Orecchia P, Spina B, Truini M, Repaci E, Carmignani G, Romagnoli A, Introini C, Boccardo F, Carnemolla B, Balbi C.","Cell Oncol. 2008;30(1):13-26. doi: 10.1155/2008/686940.","Barboro P","Cell Oncol","2008","2008/01/26","PMC4618805","","10.1155/2008/686940"
"9951121","[Transitional cell bladder carcinoma in patients younger than 40 years of age]","Madrid García FJ, Parra Muntaner L, Rivas Escudero JA, Sánchez Sánchez E, Monsalve Rodríguez M, Gómez Cisneros S, García Alonso J.","Arch Esp Urol. 1998 Dec;51(10):991-4.","Madrid García FJ","Arch Esp Urol","1998","1999/02/10","","",""
"20156116","Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006","Engholm G, Hakulinen T, Gislum M, Tryggvadóttir L, Klint A, Bray F, Storm HH.","Acta Oncol. 2010 Jun;49(5):655-64. doi: 10.3109/02841860903575299.","Engholm G","Acta Oncol","2010","2010/02/17","","","10.3109/02841860903575299"
"99408","The local, regional and systemic attack on bladder cancer","Bloom HJ.","Int J Radiat Oncol Biol Phys. 1978 May-Jun;4(5-6):533-7. doi: 10.1016/0360-3016(78)90094-9.","Bloom HJ","Int J Radiat Oncol Biol Phys","1978","1978/05/01","","","10.1016/0360-3016(78)90094-9"
"25836940","Future directions and targeted therapies in bladder cancer","Sonpavde G, Jones BS, Bellmunt J, Choueiri TK, Sternberg CN.","Hematol Oncol Clin North Am. 2015 Apr;29(2):361-76, x. doi: 10.1016/j.hoc.2014.10.008. Epub 2014 Dec 13.","Sonpavde G","Hematol Oncol Clin North Am","2015","2015/04/04","","","10.1016/j.hoc.2014.10.008"
"12196900","The role of chemotherapy and radiation in organ-preservation strategies for muscle-invasive bladder cancer","Bradley BA, Wajsman Z.","World J Urol. 2002 Aug;20(3):167-74. doi: 10.1007/s00345-002-0276-1. Epub 2002 Jul 13.","Bradley BA","World J Urol","2002","2002/08/28","","","10.1007/s00345-002-0276-1"
"26617736","The effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancer","Zhang Z, Xu Q, Huang X, Yang J, Xu Y, Zhang G.","Int J Clin Exp Pathol. 2015 Sep 1;8(9):10283-93. eCollection 2015.","Zhang Z","Int J Clin Exp Pathol","2015","2015/12/01","PMC4637551","",""
"18405739","Commentary on the etiologic relationship between prostate radiation and bladder cancer: the scourge for one is poison for the other","Konety BR.","J Urol. 2008 May;179(5 Suppl):S12-3. doi: 10.1016/j.juro.2008.03.007.","Konety BR","J Urol","2008","2008/04/25","","","10.1016/j.juro.2008.03.007"
"23969246","[Bladder cancer radiotherapy margins]","Régnier É, Nguyen TD, Beckendorf V, Lagrange JL.","Cancer Radiother. 2013 Oct;17(5-6):470-6. doi: 10.1016/j.canrad.2013.06.024. Epub 2013 Aug 19.","Régnier É","Cancer Radiother","2013","2013/08/24","","","10.1016/j.canrad.2013.06.024"
"15794449","Urothelial changes induced by therapeutic procedures for bladder cancer. A review","Mazzucchelli R, Barbisan F, Tarquini LM, Streccioni M, Galosi AB.","Anal Quant Cytol Histol. 2005 Feb;27(1):27-34.","Mazzucchelli R","Anal Quant Cytol Histol","2005","2005/03/30","","",""
"7304557","Bladder cancer in pet dogs: a sentinel for environmental cancer?","Hayes HM Jr, Hoover R, Tarone RE.","Am J Epidemiol. 1981 Aug;114(2):229-33. doi: 10.1093/oxfordjournals.aje.a113186.","Hayes HM Jr","Am J Epidemiol","1981","1981/08/01","","","10.1093/oxfordjournals.aje.a113186"
"14665946","Oligoclonality in bladder cancer: the implication for molecular therapies","Duggan BJ, Gray SB, McKnight JJ, Watson CJ, Johnston SR, Williamson KE.","J Urol. 2004 Jan;171(1):419-25. doi: 10.1097/01.ju.0000100105.27708.6c.","Duggan BJ","J Urol","2004","2003/12/11","","","10.1097/01.ju.0000100105.27708.6c"
"15914741","Detection of bladder cancer using a proteomic assay","Louria DB.","JAMA. 2005 May 25;293(20):2466-7; author reply 2467. doi: 10.1001/jama.293.20.2466-b.","Louria DB","JAMA","2005","2005/05/26","","","10.1001/jama.293.20.2466-b"
"15088904","Gene and antisense therapy of bladder cancer","Ardelt P, Kausch I, Böhle A.","Adv Exp Med Biol. 2003;539(Pt A):155-83. doi: 10.1007/978-1-4419-8889-8_13.","Ardelt P","Adv Exp Med Biol","2003","2004/04/20","","","10.1007/978-1-4419-8889-8_13"
"17008071","Cell-nuclear data reduction and prognostic model selection in bladder tumor recurrence","Tasoulis DK, Spyridonos P, Pavlidis NG, Plagianakos VP, Ravazoula P, Nikiforidis G, Vrahatis MN.","Artif Intell Med. 2006 Nov;38(3):291-303. doi: 10.1016/j.artmed.2006.07.008. Epub 2006 Sep 27.","Tasoulis DK","Artif Intell Med","2006","2006/09/30","","","10.1016/j.artmed.2006.07.008"
"29094888","Bladder Cancer: Diagnosis and Treatment","DeGeorge KC, Holt HR, Hodges SC.","Am Fam Physician. 2017 Oct 15;96(8):507-514.","DeGeorge KC","Am Fam Physician","2017","2017/11/03","","",""
"21971316","Reactive oxygen species-mediated therapeutic control of bladder cancer","Wang HC, Choudhary S.","Nat Rev Urol. 2011 Oct 4;8(11):608-16. doi: 10.1038/nrurol.2011.135.","Wang HC","Nat Rev Urol","2011","2011/10/06","","","10.1038/nrurol.2011.135"
"14667515","Cyclooxygenase-2 expression in bladder cancer: correlation with poor outcome after chemotherapy","Wülfing C, Eltze E, von Struensee D, Wülfing P, Hertle L, Piechota H.","Eur Urol. 2004 Jan;45(1):46-52. doi: 10.1016/j.eururo.2003.08.007.","Wülfing C","Eur Urol","2004","2003/12/12","","","10.1016/j.eururo.2003.08.007"
"18006010","Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer","Ellinger J, El Kassem N, Heukamp LC, Matthews S, Cubukluoz F, Kahl P, Perabo FG, Müller SC, von Ruecker A, Bastian PJ.","J Urol. 2008 Jan;179(1):346-52. doi: 10.1016/j.juro.2007.08.091. Epub 2007 Nov 19.","Ellinger J","J Urol","2008","2007/11/17","","","10.1016/j.juro.2007.08.091"
"28058776","Guideline of guidelines: non-muscle-invasive bladder cancer","Woldu SL, Bagrodia A, Lotan Y.","BJU Int. 2017 Mar;119(3):371-380. doi: 10.1111/bju.13760. Epub 2017 Jan 24.","Woldu SL","BJU Int","2017","2017/01/07","PMC5315602","NIHMS841796","10.1111/bju.13760"
"327096","Commentary on the immunobiology of bladder cancer","Catalona WJ.","J Urol. 1977 Jul;118(1 Pt 1):2-6. doi: 10.1016/s0022-5347(17)57865-9.","Catalona WJ","J Urol","1977","1977/07/01","","","10.1016/s0022-5347(17)57865-9"
"28926124","Reliability of urinary cytology and cystoscopy for the screening and diagnosis of bladder cancer in patients with neurogenic bladder: A systematic review","Alimi Q, Hascoet J, Manunta A, Kammerer-Jacquet SF, Verhoest G, Brochard C, Freton L, Kerdraon J, Senal N, Siproudhis L, Rioux-Leclercq N, Brucker B, Gamé X, Peyronnet B.","Neurourol Urodyn. 2018 Mar;37(3):916-925. doi: 10.1002/nau.23395. Epub 2017 Sep 19.","Alimi Q","Neurourol Urodyn","2018","2017/09/20","","","10.1002/nau.23395"
"30392012","A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease","Lyon TD, Frank I, Sharma V, Shah PH, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Cheville JC, Boorjian SA.","World J Urol. 2019 Aug;37(8):1605-1613. doi: 10.1007/s00345-018-2551-9. Epub 2018 Nov 3.","Lyon TD","World J Urol","2019","2018/11/05","","","10.1007/s00345-018-2551-9"
"27321156","Anti-PD-L1 inhibitor durvalumab in bladder cancer","Brower V.","Lancet Oncol. 2016 Jul;17(7):e275. doi: 10.1016/S1470-2045(16)30242-X. Epub 2016 Jun 16.","Brower V","Lancet Oncol","2016","2016/06/21","","","10.1016/S1470-2045(16)30242-X"
"18048811","p53: it has it all, but will it make it to the clinic as a marker in bladder cancer?","Real FX.","J Clin Oncol. 2007 Dec 1;25(34):5341-4. doi: 10.1200/JCO.2007.13.1904.","Real FX","J Clin Oncol","2007","2007/12/01","","","10.1200/JCO.2007.13.1904"
"4083208","[Nine cases of bladder cancer occurring in occupational dye users]","Murase T, Takashi M, Aota Y, Shimoji T, Miyake K, Mitsuya H.","Hinyokika Kiyo. 1985 Aug;31(8):1459-62.","Murase T","Hinyokika Kiyo","1985","1985/08/01","","",""
"30033069","Radiotherapy for High-grade T1 Bladder Cancer","Raby SEM, Choudhury A.","Eur Urol Focus. 2018 Jul;4(4):506-508. doi: 10.1016/j.euf.2018.07.017. Epub 2018 Jul 20.","Raby SEM","Eur Urol Focus","2018","2018/07/24","","","10.1016/j.euf.2018.07.017"
"7676518","[Disease classification--how are bladder tumors registered? A questionnaire]","Eldrup J, Borly L, Rasmussen HM, Amstrup JH.","Ugeskr Laeger. 1995 Aug 28;157(35):4816-8.","Eldrup J","Ugeskr Laeger","1995","1995/08/28","","",""
"28157695","Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer","Chen M, Li J, Zhuang C, Cai Z.","Oncotarget. 2017 Apr 25;8(17):28176-28186. doi: 10.18632/oncotarget.14945.","Chen M","Oncotarget","2017","2017/02/04","PMC5438641","","10.18632/oncotarget.14945"
"28250883","[Neoplastic Vesico-vaginal Fistula (VVF) secondary to bladder cancer: a rare entity]","Bagayogo T, Jakhal N, Slaoui A, Ziouziou I, Karmouni T, El Khader K, Koutani A, Andaloussi AB.","Pan Afr Med J. 2016 Oct 3;25:59. doi: 10.11604/pamj.2016.25.59.9969. eCollection 2016.","Bagayogo T","Pan Afr Med J","2016","2017/03/03","PMC5321150","","10.11604/pamj.2016.25.59.9969"
"18518807","Evaluation of associations between lifetime exposure to drinking water disinfection by-products and bladder cancer in dogs","Backer LC, Coss AM, Wolkin AF, Flanders WD, Reif JS.","J Am Vet Med Assoc. 2008 Jun 1;232(11):1663-8. doi: 10.2460/javma.232.11.1663.","Backer LC","J Am Vet Med Assoc","2008","2008/06/04","","","10.2460/javma.232.11.1663"
"21769109","Bladder cancer: chemohyperthermia for bladder cancer--clinically effective?","Gingrich JR.","Nat Rev Urol. 2011 Jul 19;8(8):414-6. doi: 10.1038/nrurol.2011.104.","Gingrich JR","Nat Rev Urol","2011","2011/07/20","","","10.1038/nrurol.2011.104"
"5155466","[Diastatic perforation of the cecum due to bladder cancer]","Alcala-Santaella F.","J Urol Nephrol (Paris). 1971 Dec;77:Suppl:459-60.","Alcala-Santaella F","J Urol Nephrol (Paris)","1971","1971/12/01","","",""
"26729098","Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives","Ohishi T, Koga F, Migita T.","Int J Mol Sci. 2015 Dec 29;17(1):43. doi: 10.3390/ijms17010043.","Ohishi T","Int J Mol Sci","2015","2016/01/06","PMC4730288","","10.3390/ijms17010043"
"8616767","Distant metastasis from bilharzial bladder cancer","Zaghloul MS.","Cancer. 1996 Feb 15;77(4):743-9. doi: 10.1002/(sici)1097-0142(19960215)77:4<743::aid-cncr21>3.0.co;2-#.","Zaghloul MS","Cancer","1996","1996/02/15","","","10.1002/(sici)1097-0142(19960215)77:4<743::aid-cncr21>3.0.co;2-#"
"22687923","NMR-based metabolomic analysis of human bladder cancer","Cao M, Zhao L, Chen H, Xue W, Lin D.","Anal Sci. 2012;28(5):451-6. doi: 10.2116/analsci.28.451.","Cao M","Anal Sci","2012","2012/06/13","","","10.2116/analsci.28.451"
"17669582","Organ preservation for T1G3 bladder cancer: is it feasible?","Thalmann G.","Eur Urol. 2008 Jan;53(1):27-9. doi: 10.1016/j.eururo.2007.07.023. Epub 2007 Jul 20.","Thalmann G","Eur Urol","2008","2007/08/03","","","10.1016/j.eururo.2007.07.023"
"11595129","A comparison between microsatellite analysis and cytology of urine for the detection of bladder cancer","Zhang J, Zheng S, Fan Z, Gao Y, Di X, Wang D, Xiao Z, Li C, An Q, Cheng S.","Cancer Lett. 2001 Oct 22;172(1):55-8. doi: 10.1016/s0304-3835(01)00609-7.","Zhang J","Cancer Lett","2001","2001/10/12","","","10.1016/s0304-3835(01)00609-7"
"3543944","Prognostic factors in infiltrating bladder cancer","Richards B, Aso Y, Bollack C, Fossa S, Koontz W, Matsuda M, Matsumoto K, Prout G, Van der Werf-Messing B, Wolf H.","Prog Clin Biol Res. 1986;221:271-86.","Richards B","Prog Clin Biol Res","1986","1986/01/01","","",""
"3043877","[Chemoprevention in superficial bladder cancer 1988]","Rübben H.","Urologe A. 1988 May;27(3):152-7.","Rübben H","Urologe A","1988","1988/05/01","","",""
"1924451","Organ preservation in superficial bladder cancer","Oosterhof GO, Witjes JA, Debruyne FM.","Prog Clin Biol Res. 1991;370:195-202.","Oosterhof GO","Prog Clin Biol Res","1991","1991/01/01","","",""
"11887115","Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer","Groah SL, Weitzenkamp DA, Lammertse DP, Whiteneck GG, Lezotte DC, Hamman RF.","Arch Phys Med Rehabil. 2002 Mar;83(3):346-51. doi: 10.1053/apmr.2002.29653.","Groah SL","Arch Phys Med Rehabil","2002","2002/03/12","","","10.1053/apmr.2002.29653"
"10569546","Surveillance of superficial bladder cancer--tradition and innovation","Stanisic TH.","J Urol. 1999 Dec;162(6):1957-8. doi: 10.1016/s0022-5347(05)68077-9.","Stanisic TH","J Urol","1999","1999/11/24","","","10.1016/s0022-5347(05)68077-9"
"1743223","pT1 bladder cancer","Herr H, Jakse G.","Eur Urol. 1991;20(1):1-8. doi: 10.1159/000471649.","Herr H","Eur Urol","1991","1991/01/01","","","10.1159/000471649"
"23501769","[Urachal cancers]","Peugniez C, Ghoneim T, Leroy X, Amela E, Fantoni JC, Culine S, Villers A, Adenis A.","Bull Cancer. 2013 May;100(5):509-17. doi: 10.1684/bdc.2013.1718.","Peugniez C","Bull Cancer","2013","2013/03/19","","","10.1684/bdc.2013.1718"
"27491496","Metastatic Malignant Melanoma of the Urinary Bladder in a Patient With Benign Prostatic Hyperplasia and Urethral Stricture","Krishnan A, Caravaglio JV, Jhaveri F.","Clin Genitourin Cancer. 2017 Feb;15(1):e119-e121. doi: 10.1016/j.clgc.2016.07.001. Epub 2016 Jul 9.","Krishnan A","Clin Genitourin Cancer","2017","2016/08/06","","","10.1016/j.clgc.2016.07.001"
"10351121","Diagnosis of bladder cancer: a challenge for urine cytology by tumor markers?","Ray VH.","Am Clin Lab. 1999 Jan-Feb;18(1):21.","Ray VH","Am Clin Lab","1999","1999/06/03","","",""
"24577895","Methylation of tumor suppressor genes in a novel panel predicts clinical outcome in paraffin-embedded bladder tumors","García-Baquero R, Puerta P, Beltran M, Alvarez-Mújica M, Alvarez-Ossorio JL, Sánchez-Carbayo M.","Tumour Biol. 2014 Jun;35(6):5777-86. doi: 10.1007/s13277-014-1767-6. Epub 2014 Feb 28.","García-Baquero R","Tumour Biol","2014","2014/03/01","","","10.1007/s13277-014-1767-6"
"15479490","Double primary cancers of the prostate and bladder: a literature review","Kinoshita Y, Singh A, Rovito PM Jr, Wang CY, Haas GP.","Clin Prostate Cancer. 2004 Sep;3(2):83-6. doi: 10.3816/cgc.2004.n.016.","Kinoshita Y","Clin Prostate Cancer","2004","2004/10/14","","","10.3816/cgc.2004.n.016"
"25338118","Perineural tumor spread of bladder cancer causing lumbosacral plexopathy: an anatomic explanation","Aghion DM, Capek S, Howe BM, Hepel JT, Sambandam S, Oyelese AA, Spinner RJ.","Acta Neurochir (Wien). 2014 Dec;156(12):2331-6. doi: 10.1007/s00701-014-2257-8. Epub 2014 Oct 22.","Aghion DM","Acta Neurochir (Wien)","2014","2014/10/23","","","10.1007/s00701-014-2257-8"
"25048864","Bladder cancer: Defining intermediate-risk non-muscle-invasive bladder cancer","Malkowicz SB.","Nat Rev Urol. 2014 Aug;11(8):430-2. doi: 10.1038/nrurol.2014.172. Epub 2014 Jul 22.","Malkowicz SB","Nat Rev Urol","2014","2014/07/23","","","10.1038/nrurol.2014.172"
"25323610","Thromboembolism and bleeding in bladder cancer","Fantony JJ, Inman BA.","Oncology (Williston Park). 2014 Oct;28(10):847-54.","Fantony JJ","Oncology (Williston Park)","2014","2014/10/18","","",""
"2671506","Advances in the diagnosis and management of bladder cancer: flow cytometry, intravesical bacillus Calmette-Guerin, and systemic chemotherapy","Badalament RA, Drago JR.","J Surg Oncol. 1989 Sep;42(1):33-8. doi: 10.1002/jso.2930420109.","Badalament RA","J Surg Oncol","1989","1989/09/01","","","10.1002/jso.2930420109"
"23179440","Interleukin-11, an interleukin-6-like cytokine, is a promising predictor for bladder cancer prognosis","Wu D, Tao J, Ding J, Qu P, Lu Q, Zhang W.","Mol Med Rep. 2013 Feb;7(2):684-8. doi: 10.3892/mmr.2012.1199. Epub 2012 Nov 23.","Wu D","Mol Med Rep","2013","2012/11/27","","","10.3892/mmr.2012.1199"
"17087348","[Case of multiple thin-walled cavitary pulmonary metastasis from bladder cancer]","Takagi M, Saito K, Yano H, Tai H, Akiba T.","Nihon Kokyuki Gakkai Zasshi. 2006 Oct;44(10):771-4.","Takagi M","Nihon Kokyuki Gakkai Zasshi","2006","2006/11/08","","",""
"31046476","Immunotherapy in non-metastatic urothelial cancer: back to the 'future'","Darling HS, Bellmunt J.","Expert Opin Biol Ther. 2019 Jul;19(7):685-695. doi: 10.1080/14712598.2019.1604673. Epub 2019 May 2.","Darling HS","Expert Opin Biol Ther","2019","2019/05/04","","","10.1080/14712598.2019.1604673"
"27830363","Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer","Hu H, Chen Y, Cheng S, Li G, Zhang Z.","Wien Klin Wochenschr. 2017 Jun;129(11-12):391-397. doi: 10.1007/s00508-016-1108-4. Epub 2016 Nov 9.","Hu H","Wien Klin Wochenschr","2017","2016/11/11","","","10.1007/s00508-016-1108-4"
"7158096","[Significance of infiltration of the lamina propria for the prognosis of patients with bladder tumors]","Hornák M, Ondrus D, Ondrus B.","Z Urol Nephrol. 1982 Sep;75(9):631-4.","Hornák M","Z Urol Nephrol","1982","1982/09/01","","",""
"741529","Alternative methods of diagnosis and staging of bladder cancer","Trapeznikova MF.","Urol Res. 1978;6(4):187-90. doi: 10.1007/BF00262614.","Trapeznikova MF","Urol Res","1978","1978/01/01","","","10.1007/BF00262614"
"3750594","In vitro chemosensitivity of J-82 human bladder cancer cells","Anderson KC, Simpson WG, Ballou RJ, Harty JI, Tseng MT.","Urol Res. 1986;14(3):141-4. doi: 10.1007/BF00255833.","Anderson KC","Urol Res","1986","1986/01/01","","","10.1007/BF00255833"
"26390971","Targeted therapies in bladder cancer: an overview of in vivo research","van Kessel KE, Zuiverloon TC, Alberts AR, Boormans JL, Zwarthoff EC.","Nat Rev Urol. 2015 Dec;12(12):681-94. doi: 10.1038/nrurol.2015.231. Epub 2015 Sep 22.","van Kessel KE","Nat Rev Urol","2015","2015/09/23","","","10.1038/nrurol.2015.231"
"8470874","[Pelvic lymphatic excision using laparoscopy. Its value in the staging of tumors of the bladder]","Antiphon P, Chopin DK, Bellot J, Barthélémy Y, Abbou CC.","Ann Urol (Paris). 1993;27(1):12-9.","Antiphon P","Ann Urol (Paris)","1993","1993/01/01","","",""
"7640075","Recent developments in the biology and management of advanced bladder cancer","van Oosterom AT, Schrijvers D.","Eur J Cancer. 1995;31A(5):838-9. doi: 10.1016/0959-8049(95)00111-u.","van Oosterom AT","Eur J Cancer","1995","1995/01/01","","","10.1016/0959-8049(95)00111-u"
"15118111","Bladder cancer: analysis of multi-detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging","Kim JK, Park SY, Ahn HJ, Kim CS, Cho KS.","Radiology. 2004 Jun;231(3):725-31. doi: 10.1148/radiol.2313021253. Epub 2004 Apr 29.","Kim JK","Radiology","2004","2004/05/01","","","10.1148/radiol.2313021253"
"6483916","Classification of patients with bladder cancer: clinical versus pathologic staging","Cummings KB.","Prog Clin Biol Res. 1984;162A:33-53.","Cummings KB","Prog Clin Biol Res","1984","1984/01/01","","",""
"4672397","[So-called silent bladder cancer]","Nagayama T, Kataumi S.","Nihon Hinyokika Gakkai Zasshi. 1972 Jun;63(6):427-37. doi: 10.5980/jpnjurol1928.63.6_427.","Nagayama T","Nihon Hinyokika Gakkai Zasshi","1972","1972/06/01","","","10.5980/jpnjurol1928.63.6_427"
"16818190","Lymphadenectomy in bladder cancer: how high is ""high enough""?","Stein JP.","Urol Oncol. 2006 Jul-Aug;24(4):349-55. doi: 10.1016/j.urolonc.2005.07.013.","Stein JP","Urol Oncol","2006","2006/07/05","","","10.1016/j.urolonc.2005.07.013"
"19319539","Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3)","Hautmann RE, Volkmer BG, Gust K.","World J Urol. 2009 Jun;27(3):347-51. doi: 10.1007/s00345-009-0402-4. Epub 2009 Mar 25.","Hautmann RE","World J Urol","2009","2009/03/26","","","10.1007/s00345-009-0402-4"
"2772151","[Results of combined operative-radiologic therapy of bladder cancer from the viewpoint of optimizing the physical-technical irradiation planning]","Füller J, Kob D, Kriester A.","Radiobiol Radiother (Berl). 1989;30(3):235-40.","Füller J","Radiobiol Radiother (Berl)","1989","1989/01/01","","",""
"23907505","Actionable mutations in muscle-invasive bladder cancer","Bambury RM, Rosenberg JE.","Curr Opin Urol. 2013 Sep;23(5):472-8. doi: 10.1097/MOU.0b013e328363a3cd.","Bambury RM","Curr Opin Urol","2013","2013/08/03","","","10.1097/MOU.0b013e328363a3cd"
"17102951","Toward critical evaluation of the role(s) of molecular biomarkers in the management of bladder cancer","Nielsen ME, Gonzalgo ML, Schoenberg MP, Getzenberg RH.","World J Urol. 2006 Nov;24(5):499-508. doi: 10.1007/s00345-006-0116-9.","Nielsen ME","World J Urol","2006","2006/11/15","","","10.1007/s00345-006-0116-9"
"105441","Radiation treatment of urinary bladder carcinoma","Edsmyr F, Esposti PL, Giertz G, Littbrand B.","Urol Res. 1978;6(4):229-32. doi: 10.1007/BF00262624.","Edsmyr F","Urol Res","1978","1978/01/01","","","10.1007/BF00262624"
"16925494","Controversial issues and optimal management of stage T1G3 bladder cancer","Metwalli AR, Kamat AM.","Expert Rev Anticancer Ther. 2006 Aug;6(8):1283-94. doi: 10.1586/14737140.6.8.1283.","Metwalli AR","Expert Rev Anticancer Ther","2006","2006/08/24","","","10.1586/14737140.6.8.1283"
"16526988","Perioperative chemotherapy for localized bladder cancer","Winquist E.","Can J Urol. 2006 Feb;13 Suppl 1:77-80.","Winquist E","Can J Urol","2006","2006/03/11","","",""
"29959582","Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer","Johnson SB, Yu JB.","Curr Oncol Rep. 2018 Jun 30;20(9):66. doi: 10.1007/s11912-018-0711-0.","Johnson SB","Curr Oncol Rep","2018","2018/07/01","","","10.1007/s11912-018-0711-0"
"1877165","[Dynamics of kidney function by renography findings in the connection to the results of radiotherapy of urinary bladder cancer]","Pereslegin IA, Vinogradov VA, Mufazalov FF.","Vestn Rentgenol Radiol. 1991 Mar-Apr;(2):62-5.","Pereslegin IA","Vestn Rentgenol Radiol","1991","1991/03/01","","",""
"21814055","Biomarkers for prognosis and treatment selection in advanced bladder cancer patients","Ru Y, Dancik GM, Theodorescu D.","Curr Opin Urol. 2011 Sep;21(5):420-7. doi: 10.1097/MOU.0b013e32834956d6.","Ru Y","Curr Opin Urol","2011","2011/08/05","PMC3257805","NIHMS348463","10.1097/MOU.0b013e32834956d6"
"12069123","Bladder cancer--room for improvement","Bloomfield DJ.","Clin Oncol (R Coll Radiol). 2002 Apr;14(2):139-40. doi: 10.1053/clon.2002.0062.","Bloomfield DJ","Clin Oncol (R Coll Radiol)","2002","2002/06/19","","","10.1053/clon.2002.0062"
"16971115","What is the significance of pT0 at cystectomy?","Hotston M, Patel S, Sohail M, Persad RA.","Surg Oncol. 2006 Aug;15(2):65-9. doi: 10.1016/j.suronc.2006.07.005. Epub 2006 Sep 12.","Hotston M","Surg Oncol","2006","2006/09/15","","","10.1016/j.suronc.2006.07.005"
"1416708","A departmental audit of patients with bladder cancer","Sahabudin RM, Persad RA, Mishriki F, Feneley RC.","Ann R Coll Surg Engl. 1992 Sep;74(5):351-5.","Sahabudin RM","Ann R Coll Surg Engl","1992","1992/09/01","PMC2497655","",""
"20665490","Delays in diagnosis and bladder cancer mortality","Hollenbeck BK, Dunn RL, Ye Z, Hollingsworth JM, Skolarus TA, Kim SP, Montie JE, Lee CT, Wood DP Jr, Miller DC.","Cancer. 2010 Nov 15;116(22):5235-42. doi: 10.1002/cncr.25310.","Hollenbeck BK","Cancer","2010","2010/07/29","","","10.1002/cncr.25310"
"2413744","[Effect of hyperthermic irrigation with bleomycin on prophylaxis of recurrence of bladder cancer]","Nishimura K, Ogawa O, Yoshimura N, Nakagawa T, Sasaki M.","Hinyokika Kiyo. 1985 May;31(5):769-73.","Nishimura K","Hinyokika Kiyo","1985","1985/05/01","","",""
"916096","Re-evaluation of hydrostatic pressure treatment for malignant bladder lesions","Hirose K, Seto T, Takayasu H.","J Urol. 1977 Nov;118(5):762-4. doi: 10.1016/s0022-5347(17)58185-9.","Hirose K","J Urol","1977","1977/11/01","","","10.1016/s0022-5347(17)58185-9"
"8354118","Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference","Wheeless LL, Badalament RA, de Vere White RW, Fradet Y, Tribukait B.","Cytometry. 1993;14(5):478-81. doi: 10.1002/cyto.990140504.","Wheeless LL","Cytometry","1993","1993/01/01","","","10.1002/cyto.990140504"
"7238198","[Evaluation of radiofrequency diathermy and radiation for bladder cancer: a preliminary report (author's transl)]","Zhao BD.","Zhonghua Wai Ke Za Zhi. 1980 Dec;18(6):498-9.","Zhao BD","Zhonghua Wai Ke Za Zhi","1980","1980/12/01","","",""
"23088957","Trimodality treatment in the conservative management of infiltrating bladder cancer: a critical review of the literature","Caffo O, Veccia A, Fellin G, Russo L, Mussari S, Galligioni E.","Crit Rev Oncol Hematol. 2013 May;86(2):176-90. doi: 10.1016/j.critrevonc.2012.09.011. Epub 2012 Oct 22.","Caffo O","Crit Rev Oncol Hematol","2013","2012/10/24","","","10.1016/j.critrevonc.2012.09.011"
"7479154","The bladder: cystectomy and ileal conduit to treat cancer","Dickson C.","Nurs Times. 1995 Oct 18-24;91(42):34-5.","Dickson C","Nurs Times","1995","1995/10/18","","",""
"17929456","[Bladder preservation by chemoradiotherapy in combination with radical TUR-Bt in muscle invasive bladder cancer]","Ishioka J, Kageyama Y, Ichiyanagi N, Saito Y, Nozu S, Nishida K, Fukuda H, Higashi Y.","Nihon Hinyokika Gakkai Zasshi. 2007 Sep;98(6):752-6. doi: 10.5980/jpnjurol1989.98.752.","Ishioka J","Nihon Hinyokika Gakkai Zasshi","2007","2007/10/13","","","10.5980/jpnjurol1989.98.752"
"7946582","Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients. Dutch South Eastern Bladder Cancer Study Group","Mulders PF, Hoekstra WJ, Heybroek RP, Schapers ER, Verbeek AL, Oosterhof GO, Debruyne FM.","Eur J Cancer. 1994;30A(7):914-7. doi: 10.1016/0959-8049(94)90113-9.","Mulders PF","Eur J Cancer","1994","1994/01/01","","","10.1016/0959-8049(94)90113-9"
"26681820","Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy","Miyata Y, Sakai H.","Dis Markers. 2015;2015:857416. doi: 10.1155/2015/857416. Epub 2015 Nov 23.","Miyata Y","Dis Markers","2015","2015/12/19","PMC4670878","","10.1155/2015/857416"
"23792129","Practice based collaboration to improve the use of immediate intravesical therapy after resection of nonmuscle invasive bladder cancer","Barocas DA, Liu A, Burks FN, Suh RS, Schuster TG, Bradford T, Moylan DA, Knapp PM, Murtagh DS, Morris D, Dunn RL, Montie JE, Miller DC.","J Urol. 2013 Dec;190(6):2011-6. doi: 10.1016/j.juro.2013.06.025. Epub 2013 Jun 18.","Barocas DA","J Urol","2013","2013/06/25","","","10.1016/j.juro.2013.06.025"
"31750878","International consensus for advanced bladder cancer: an opportunity between the lines","Murthy V.","Ann Oncol. 2019 Nov 1;30(11):1688-1690. doi: 10.1093/annonc/mdz405.","Murthy V","Ann Oncol","2019","2019/11/22","","","10.1093/annonc/mdz405"
"25934521","Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials","Arcangeli G, Strigari L, Arcangeli S.","Crit Rev Oncol Hematol. 2015 Sep;95(3):387-96. doi: 10.1016/j.critrevonc.2015.04.006. Epub 2015 Apr 17.","Arcangeli G","Crit Rev Oncol Hematol","2015","2015/05/03","","","10.1016/j.critrevonc.2015.04.006"
"28247690","[Importance of surgery of quick recovery program for surgical treatment of bladder tumors]","Darenkov SP, Kotov SV, Proskokov AA, Jusufov AG, Belomytcev SV, Badovskaya EV, Gubaidullin RR, Pinchuk IS.","Urologiia. 2015 Dec;(6):109-115.","Darenkov SP","Urologiia","2015","2017/03/02","","",""
"2273706","[Production of monoclonal antibodies against human bladder cancer cells and application to immunohistochemical analysis of bladder cancer]","Saiki S, Meguro N, Morita T, Tomooka Y, Maeda O, Kinouchi T, Kuroda M, Miki T, Usami M, Kotake T.","Nihon Hinyokika Gakkai Zasshi. 1990 Oct;81(10):1537-42. doi: 10.5980/jpnjurol1989.81.1537.","Saiki S","Nihon Hinyokika Gakkai Zasshi","1990","1990/10/01","","","10.5980/jpnjurol1989.81.1537"
"9146622","Perineal cystoprostatectomy and ureterosigmoidostomy for invasive bladder cancer","Nishiya M, Crawford ED.","J Urol. 1997 Jun;157(6):2227-9.","Nishiya M","J Urol","1997","1997/06/01","","",""
"872121","Cytology and histopathology of bladder cancer cases in a prospective longitudinal study. National Bladder Cancer Collaborative Group A","","Cancer Res. 1977 Aug;37(8 Pt 2):2911-5.","","Cancer Res","1977","1977/08/01","","",""
"80271","Phase II trial of bleomycin in bilharzial bladder cancer","Gad-el-Mawla N, Hamsa R, Chevlen E, Ziegler JL.","Cancer Treat Rep. 1978 Jul;62(7):1109-10.","Gad-el-Mawla N","Cancer Treat Rep","1978","1978/07/01","","",""
"3360034","Value of radical cystectomy in bladder cancer with pelvic node involvement","Zungri E, Chéchile G, Sarroca J, Algaba F.","Eur Urol. 1988;14(2):123-6. doi: 10.1159/000472918.","Zungri E","Eur Urol","1988","1988/01/01","","","10.1159/000472918"
"15661425","Re: Schrier BPh, Hollander MP, van Rhijn BWG, Kiemeney LALM, Witjes JA. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 2004;45:292-6","Soloway MS.","Eur Urol. 2005 Feb;47(2):264; author reply 264. doi: 10.1016/j.eururo.2004.08.013.","Soloway MS","Eur Urol","2005","2005/01/22","","","10.1016/j.eururo.2004.08.013"
"14621357","Lived female experience of chronic bladder cancer: a phenomenologic case study","Hilton EL, Henderson LJ.","Urol Nurs. 2003 Oct;23(5):349-54.","Hilton EL","Urol Nurs","2003","2003/11/19","","",""
"8199999","The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience","Vieweg J, Whitmore WF Jr, Herr HW, Sogani PC, Russo P, Sheinfeld J, Fair WR.","Cancer. 1994 Jun 15;73(12):3020-8. doi: 10.1002/1097-0142(19940615)73:12<3020::aid-cncr2820731221>3.0.co;2-y.","Vieweg J","Cancer","1994","1994/06/15","","","10.1002/1097-0142(19940615)73:12<3020::aid-cncr2820731221>3.0.co;2-y"
"30154296","[Comprehensive therapy of bladder preservation for muscle invasive bladder cancer]","Li B, Li Y.","Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Jan 28;43(1):82-89. doi: 10.11817/j.issn.1672-7347.2018.01.013.","Li B","Zhong Nan Da Xue Xue Bao Yi Xue Ban","2018","2018/08/30","","","10.11817/j.issn.1672-7347.2018.01.013"
"1977171","Neoadjuvant chemotherapy in invasive bladder cancer. Proceedings of an international workshop. San Francisco, May 19-20, 1989","","Prog Clin Biol Res. 1990;353:1-236.","","Prog Clin Biol Res","1990","1990/01/01","","",""
"18815934","Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease","Kakizoe T, Mucci LA, Albertsen PC, Droller MJ.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):191-212. doi: 10.1080/03008880802284936.","Kakizoe T","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802284936"
"18602604","[Can MRI be used to distinguish between superficial and invasive transitional cell bladder cancer?]","Tillou X, Grardel E, Fourmarier M, Bernasconi T, Demailly M, Hakami F, Saint F, Petit J.","Prog Urol. 2008 Jul;18(7):440-4. doi: 10.1016/j.purol.2008.04.019. Epub 2008 Jun 10.","Tillou X","Prog Urol","2008","2008/07/08","","","10.1016/j.purol.2008.04.019"
"23897501","Bladder cancer: Getting into the right (urine) headspace","Clyne M.","Nat Rev Urol. 2013 Sep;10(9):490. doi: 10.1038/nrurol.2013.165. Epub 2013 Jul 30.","Clyne M","Nat Rev Urol","2013","2013/07/31","","","10.1038/nrurol.2013.165"
"20078597","Redefining personalized medicine in the postgenomic era: developing bladder cancer therapeutics with proteomics","Blanchet KD.","BJU Int. 2010 Jan;105(2):i-iii. doi: 10.1111/j.1464-410X.2009.09168.x.","Blanchet KD","BJU Int","2010","2010/01/19","","","10.1111/j.1464-410X.2009.09168.x"
"1875565","[Experimental bladder tumor]","Okajima E, Ozono S.","Nihon Hinyokika Gakkai Zasshi. 1991 May;82(5):705-15. doi: 10.5980/jpnjurol1989.82.705.","Okajima E","Nihon Hinyokika Gakkai Zasshi","1991","1991/05/01","","","10.5980/jpnjurol1989.82.705"
"1868482","Bladder transitional cell carcinoma","Angulo JC, Lopez JI, Unda-Urzaiz M, Flores N.","Child Nephrol Urol. 1991;11(1):47-8.","Angulo JC","Child Nephrol Urol","1991","1991/01/01","","",""
"30014439","Detectability of residual invasive bladder cancer in delayed (18)F-FDG PET imaging with oral hydration using 500 mL of water and voiding-refilling","Higashiyama A, Komori T, Juri H, Inada Y, Azuma H, Narumi Y.","Ann Nucl Med. 2018 Oct;32(8):561-567. doi: 10.1007/s12149-018-1280-x. Epub 2018 Jul 16.","Higashiyama A","Ann Nucl Med","2018","2018/07/18","","","10.1007/s12149-018-1280-x"
"17208144","Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancer","Coen JJ, Zietman AL, Kaufman DS, Shipley WU.","Urol Oncol. 2007 Jan-Feb;25(1):76-84. doi: 10.1016/j.urolonc.2006.05.012.","Coen JJ","Urol Oncol","2007","2007/01/09","","","10.1016/j.urolonc.2006.05.012"
"19751235","Human leukocyte antigen class I down-regulation in muscle-invasive bladder cancer: its association with clinical characteristics and survival after cystectomy","Homma I, Kitamura H, Torigoe T, Tanaka T, Sato E, Hirohashi Y, Masumori N, Sato N, Tsukamoto T.","Cancer Sci. 2009 Dec;100(12):2331-4. doi: 10.1111/j.1349-7006.2009.01329.x. Epub 2009 Aug 27.","Homma I","Cancer Sci","2009","2009/09/16","","","10.1111/j.1349-7006.2009.01329.x"
"10696243","The utility of fibrin/fibrinogen degradation products in superficial bladder cancer","Tsihlias J, Grossman HB.","Urol Clin North Am. 2000 Feb;27(1):39-46. doi: 10.1016/s0094-0143(05)70232-9.","Tsihlias J","Urol Clin North Am","2000","2000/03/04","","","10.1016/s0094-0143(05)70232-9"
"24813931","Strategies to improve quality of life in bladder cancer patients","Roaldsen M, Aarsaether E, Knutsen T, Patel HR.","Expert Rev Pharmacoecon Outcomes Res. 2014 Aug;14(4):537-44. doi: 10.1586/14737167.2014.917967. Epub 2014 May 12.","Roaldsen M","Expert Rev Pharmacoecon Outcomes Res","2014","2014/05/13","","","10.1586/14737167.2014.917967"
"2201038","The evolution of active chemotherapy in metastatic and locally advanced bladder cancer","Newling DW.","Prog Clin Biol Res. 1990;350:115-27.","Newling DW","Prog Clin Biol Res","1990","1990/01/01","","",""
"11176475","Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer","Herr HW, Donat SM, Bajorin DF.","J Urol. 2001 Mar;165(3):811-4.","Herr HW","J Urol","2001","2001/02/15","","",""
"16515975","Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival","Lee CT, Madii R, Daignault S, Dunn RL, Zhang Y, Montie JE, Wood DP Jr.","J Urol. 2006 Apr;175(4):1262-7; discussion 1267. doi: 10.1016/S0022-5347(05)00644-0.","Lee CT","J Urol","2006","2006/03/07","","","10.1016/S0022-5347(05)00644-0"
"3851015","[Pre and postoperative nursing of patients with bladder cancer. Postoperative care of patients having ureterostomy--assistance given at our hospital toward patients' self care]","Chiba M.","Kango Gijutsu. 1985 Aug;31(11):1465-70.","Chiba M","Kango Gijutsu","1985","1985/08/01","","",""
"21228821","Contemporary management of low-risk bladder cancer","Falke J, Witjes JA.","Nat Rev Urol. 2011 Jan;8(1):42-9. doi: 10.1038/nrurol.2010.208.","Falke J","Nat Rev Urol","2011","2011/01/14","","","10.1038/nrurol.2010.208"
"16518661","Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure","Stein JP, Skinner DG.","World J Urol. 2006 Aug;24(3):296-304. doi: 10.1007/s00345-006-0061-7. Epub 2006 Mar 4.","Stein JP","World J Urol","2006","2006/03/07","","","10.1007/s00345-006-0061-7"
"2729474","Black/white differences in non-treatment of bladder cancer patients and implications for survival","Mayer WJ, McWhorter WP.","Am J Public Health. 1989 Jun;79(6):772-5. doi: 10.2105/ajph.79.6.772.","Mayer WJ","Am J Public Health","1989","1989/06/01","PMC1349641","","10.2105/ajph.79.6.772"
"29534585","Urinary fluorescence analysis in diagnosis of bladder cancer","Kollarik B, Zvarik M, Bujdak P, Weibl P, Rybar L, Sikurova L, Hunakova L.","Neoplasma. 2018;65(2):234-241. doi: 10.4149/neo_2018_170610N420.","Kollarik B","Neoplasma","2018","2018/03/15","","","10.4149/neo_2018_170610N420"
"19370808","Bladder cancer","Bischoff CJ, Clark PE.","Curr Opin Oncol. 2009 May;21(3):272-7. doi: 10.1097/cco.0b013e328329f184.","Bischoff CJ","Curr Opin Oncol","2009","2009/04/18","","","10.1097/cco.0b013e328329f184"
"671624","Cystitis cystica (cystosis) with bladder cancer","Sarma KP.","J Urol. 1978 Aug;120(2):169-71. doi: 10.1016/s0022-5347(17)57089-5.","Sarma KP","J Urol","1978","1978/08/01","","","10.1016/s0022-5347(17)57089-5"
"20089093","Is immediate postoperative intravesical chemotherapy beneficial in non-muscle- invasive bladder cancer?","Ayres BE, Crew JP; Action for Bladder Cancer.","BJU Int. 2010 Feb;105 Suppl 2:14-7. doi: 10.1111/j.1464-410X.2009.09152.x.","Ayres BE","BJU Int","2010","2010/01/22","","","10.1111/j.1464-410X.2009.09152.x"
"31042108","Emerging Immunotherapy Options for bacillus Calmette-Guérin Unresponsive Nonmuscle Invasive Bladder Cancer","Meng MV, Gschwend JE, Shore N, Grossfeld GD, Mostafid H, Black PC.","J Urol. 2019 Dec;202(6):1111-1119. doi: 10.1097/JU.0000000000000297. Epub 2019 May 1.","Meng MV","J Urol","2019","2019/05/02","","","10.1097/JU.0000000000000297"
"25051024","Noncoding RNA in bladder cancer: a specific focus upon high-risk nonmuscle invasive disease","Noon AP, Catto JW.","Curr Opin Urol. 2014 Sep;24(5):506-11. doi: 10.1097/MOU.0000000000000090.","Noon AP","Curr Opin Urol","2014","2014/07/23","","","10.1097/MOU.0000000000000090"
"28745580","Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer","Zuiverloon TC, Theodorescu D.","Pharmacogenomics. 2017 Aug;18(12):1167-1178. doi: 10.2217/pgs-2017-0055. Epub 2017 Jul 26.","Zuiverloon TC","Pharmacogenomics","2017","2017/07/27","","","10.2217/pgs-2017-0055"
"25535079","The promise of novel molecular markers in bladder cancer","Miremami J, Kyprianou N.","Int J Mol Sci. 2014 Dec 22;15(12):23897-908. doi: 10.3390/ijms151223897.","Miremami J","Int J Mol Sci","2014","2014/12/24","PMC4284796","","10.3390/ijms151223897"
"17530260","Epidemiology of urinary bladder cancer: from tumor development to patient's death","Murta-Nascimento C, Schmitz-Dräger BJ, Zeegers MP, Steineck G, Kogevinas M, Real FX, Malats N.","World J Urol. 2007 Jun;25(3):285-95. doi: 10.1007/s00345-007-0168-5.","Murta-Nascimento C","World J Urol","2007","2007/05/29","","","10.1007/s00345-007-0168-5"
"19673000","High-risk, high-grade (T1G3) bladder cancer: models versus reality","Herr HW.","Cancer. 2009 Dec 1;115(23):5366-7. doi: 10.1002/cncr.24553.","Herr HW","Cancer","2009","2009/08/13","","","10.1002/cncr.24553"
"23726455","Re: Lambert et al.: Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer (Urology 2013;81:587-592)","Campodonico F, Parodi D.","Urology. 2013 Jun;81(6):1382. doi: 10.1016/j.urology.2013.02.007.","Campodonico F","Urology","2013","2013/06/04","","","10.1016/j.urology.2013.02.007"
"19046104","Promise of antisense oligodeoxynucleotide-based therapy for bladder cancer","Miyake H, Fujisawa M.","Expert Rev Anticancer Ther. 2008 Dec;8(12):1851-4. doi: 10.1586/14737140.8.12.1851.","Miyake H","Expert Rev Anticancer Ther","2008","2008/12/03","","","10.1586/14737140.8.12.1851"
"7109064","Mode of presentation of invasive bladder cancer: reassessment of the problem","Kaye KW, Lange PH.","J Urol. 1982 Jul;128(1):31-3. doi: 10.1016/s0022-5347(17)52738-x.","Kaye KW","J Urol","1982","1982/07/01","","","10.1016/s0022-5347(17)52738-x"
"6806484","Discouraging results for high dose external beam radiation therapy in low stage (O and A) bladder cancer","Whitmore WF 3rd, Prout GR Jr.","J Urol. 1982 May;127(5):902-5. doi: 10.1016/s0022-5347(17)54123-3.","Whitmore WF 3rd","J Urol","1982","1982/05/01","","","10.1016/s0022-5347(17)54123-3"
"16582750","Bladder cancer: revealing news about a hidden threat","Campbell BD.","Nursing. 2006 Apr;36(4):54-7. doi: 10.1097/00152193-200604000-00041.","Campbell BD","Nursing","2006","2006/04/04","","","10.1097/00152193-200604000-00041"
"16265353","Gene expression profiling of noninvasive primary urothelial tumours using microarrays","Aaboe M, Marcussen N, Jensen KM, Thykjaer T, Dyrskjøt L, Orntoft TF.","Br J Cancer. 2005 Nov 14;93(10):1182-90. doi: 10.1038/sj.bjc.6602813.","Aaboe M","Br J Cancer","2005","2005/11/03","PMC2361501","","10.1038/sj.bjc.6602813"
"27799511","High-Risk of Adverse Pathologic Features in Patients With Clinical T1 High-Grade Bladder Cancer Undergoing Radical Cystectomy","Matulewicz RS, Frainey BT, Oberlin DT, Meeks JJ.","J Natl Compr Canc Netw. 2016 Nov;14(11):1403-1411. doi: 10.6004/jnccn.2016.0150. Epub 2016 Oct 31.","Matulewicz RS","J Natl Compr Canc Netw","2016","2016/11/02","","","10.6004/jnccn.2016.0150"
"11270423","Metallothionein isoform 1 and 2 gene expression in the human bladder: evidence for upregulation of MT-1X mRNA in bladder cancer","Somji S, Sens MA, Lamm DL, Garrett SH, Sens DA.","Cancer Detect Prev. 2001;25(1):62-75.","Somji S","Cancer Detect Prev","2001","2001/03/29","","",""
"24917520","Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle-invasive bladder cancer","Gurung PM, Veerakumarasivam A, Williamson M, Counsell N, Douglas J, Tan WS, Feber A, Crabb SJ, Short SC, Freeman A, Powles T, Hoskin PJ, West CM, Kelly JD.","Int J Cancer. 2015 Feb 1;136(3):709-20. doi: 10.1002/ijc.29022. Epub 2014 Jul 22.","Gurung PM","Int J Cancer","2015","2014/06/12","","","10.1002/ijc.29022"
"9239470","Epidemiology of prostate cancer and bladder cancer: an overview","Ross RK.","Cancer Treat Res. 1996;88:1-11. doi: 10.1007/978-1-4615-6343-3_1.","Ross RK","Cancer Treat Res","1996","1996/01/01","","","10.1007/978-1-4615-6343-3_1"
"7553304","The place of radiation therapy as definitive treatment of bladder cancer","Gospodarowicz MK, Quilty PM, Scalliet P, Tsujii H, Fossa SD, Horenblas S, Isaka S, Prout GR, Shipley WU, Wijnmaalen AJ, et al.","Int J Urol. 1995 Jun;2 Suppl 2:41-8. doi: 10.1111/j.1442-2042.1995.tb00478.x.","Gospodarowicz MK","Int J Urol","1995","1995/06/01","","","10.1111/j.1442-2042.1995.tb00478.x"
"22842681","High-risk nonmuscle invasive bladder cancer: definition and epidemiology","Porten SP, Cooperberg MR.","Curr Opin Urol. 2012 Sep;22(5):385-9. doi: 10.1097/MOU.0b013e328356aecf.","Porten SP","Curr Opin Urol","2012","2012/07/31","","","10.1097/MOU.0b013e328356aecf"
"32248340","Blue Light Cystoscopy: Indications and Outcomes","Pohar KS.","Curr Urol Rep. 2020 Apr 4;21(5):19. doi: 10.1007/s11934-020-0966-5.","Pohar KS","Curr Urol Rep","2020","2020/04/06","","","10.1007/s11934-020-0966-5"
"27119956","[Organ-sparing treatment of bladder cancer]","Niedworok C, Shaleva A, Rübben H, Stenzl A.","Urologe A. 2016 May;55(5):609-14. doi: 10.1007/s00120-016-0086-5.","Niedworok C","Urologe A","2016","2016/04/28","","","10.1007/s00120-016-0086-5"
"2122923","Detecting bladder cancer","Plail R.","BMJ. 1990 Sep 22;301(6752):567-8. doi: 10.1136/bmj.301.6752.567.","Plail R","BMJ","1990","1990/09/22","PMC1663715","","10.1136/bmj.301.6752.567"
"27231966","Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia","Tan WS, Rodney S, Lamb B, Feneley M, Kelly J.","Cancer Treat Rev. 2016 Jun;47:22-31. doi: 10.1016/j.ctrv.2016.05.002. Epub 2016 May 10.","Tan WS","Cancer Treat Rev","2016","2016/05/28","","","10.1016/j.ctrv.2016.05.002"
"31282342","[Clinical Features and Diagnosis of Encrusted Bladder Cancer]","Zhang WY, Wang HR, Hu H, Wang Q, Zhang XP, Xu KX.","Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019 Jun 30;41(3):430-434. doi: 10.3881/j.issn.1000-503X.10552.","Zhang WY","Zhongguo Yi Xue Ke Xue Yuan Xue Bao","2019","2019/07/09","","","10.3881/j.issn.1000-503X.10552"
"20131661","You're the flight surgeon: bladder cancer","Egerstrom K.","Aviat Space Environ Med. 2010 Feb;81(2):154-5. doi: 10.3357/asem.23009.2010.","Egerstrom K","Aviat Space Environ Med","2010","2010/02/06","","","10.3357/asem.23009.2010"
"32516554","Staging of bladder cancer with multiparametric MRI","Juri H, Narumi Y, Panebianco V, Osuga K.","Br J Radiol. 2020 Aug;93(1112):20200116. doi: 10.1259/bjr.20200116. Epub 2020 Jun 9.","Juri H","Br J Radiol","2020","2020/06/10","PMC7446004","","10.1259/bjr.20200116"
"19265853","Comment on ""Does the probiotic L. casei help prevent recurrence after transurethral resection for superficial bladder cancer?""","Naito S.","Nat Clin Pract Urol. 2009 Mar;6(3):E5. doi: 10.1038/ncpuro1323.","Naito S","Nat Clin Pract Urol","2009","2009/03/07","","","10.1038/ncpuro1323"
"21939147","[Bladder cancer--symptoms and diagnosis]","Karl A, Tritschler S, Staehler M, Schneevoigt BS, Stief C.","MMW Fortschr Med. 2011 Aug 11;153(32-34):38-41; quiz 42.","Karl A","MMW Fortschr Med","2011","2011/09/24","","",""
"1984097","Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification","Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W, Garbeglio A.","J Urol. 1991 Jan;145(1):45-50. doi: 10.1016/s0022-5347(17)38244-7.","Pagano F","J Urol","1991","1991/01/01","","","10.1016/s0022-5347(17)38244-7"
"7776563","[Evaluation of advanced bladder tumor]","Nagase Y, Moriyama N, Kurimoto S, Tanaka Y, Oshi M, Honma Y, Tajima A, Higashihara E, Aso Y.","Nihon Hinyokika Gakkai Zasshi. 1995 Apr;86(4):933-9. doi: 10.5980/jpnjurol1989.86.933.","Nagase Y","Nihon Hinyokika Gakkai Zasshi","1995","1995/04/01","","","10.5980/jpnjurol1989.86.933"
"18433783","Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry","Issaq HJ, Nativ O, Waybright T, Luke B, Veenstra TD, Issaq EJ, Kravstov A, Mullerad M.","J Urol. 2008 Jun;179(6):2422-6. doi: 10.1016/j.juro.2008.01.084. Epub 2008 Apr 23.","Issaq HJ","J Urol","2008","2008/04/25","","","10.1016/j.juro.2008.01.084"
"29749526","Human HLA‑F adjacent transcript 10 promotes the formation of cancer initiating cells and cisplatin resistance in bladder cancer","Li C, Wang Z, Feng N, Dong J, Deng X, Yue Y, Guo Y, Hou J.","Mol Med Rep. 2018 Jul;18(1):308-314. doi: 10.3892/mmr.2018.9005. Epub 2018 May 9.","Li C","Mol Med Rep","2018","2018/05/12","PMC6059684","","10.3892/mmr.2018.9005"
"10650805","Antiproliferative activity of interferon gamma in superficial bladder cancer","Stavropoulos NE, Ioachim E, Pappa L, Hastazeris K, Agnantis NJ.","Anticancer Res. 1999 Sep-Oct;19(5C):4529-33.","Stavropoulos NE","Anticancer Res","1999","2000/01/29","","",""
"26818689","Unusual presentation of bladder cancer resurgence and efficacy of radiotherapy","Galot R, Christian N, Bitar M, Seront E.","BMJ Case Rep. 2016 Jan 27;2016:bcr2015213538. doi: 10.1136/bcr-2015-213538.","Galot R","BMJ Case Rep","2016","2016/01/29","PMC4735395","","10.1136/bcr-2015-213538"
"6443168","Clinical trials in superficial and invasive bladder cancer","Smith PH.","Turk J Pediatr. 1984;26(1-4):251-63.","Smith PH","Turk J Pediatr","1984","1984/01/01","","",""
"29900509","[Bladder cancer : Current diagnosis and treatment modalities]","Retz M, Karl A.","Urologe A. 2018 Jun;57(6):655-656. doi: 10.1007/s00120-018-0651-1.","Retz M","Urologe A","2018","2018/06/15","","","10.1007/s00120-018-0651-1"
"24366195","Urine tenascin‑C is an independent risk factor for bladder cancer patients","Guan Z, Zeng J, Wang Z, Xie H, Lv C, Ma Z, Xu S, Wang X, He D, Li L.","Mol Med Rep. 2014 Mar;9(3):961-6. doi: 10.3892/mmr.2013.1873. Epub 2013 Dec 18.","Guan Z","Mol Med Rep","2014","2013/12/25","","","10.3892/mmr.2013.1873"
"19557464","[Urine-based tumour diagnostics for bladder cancer: effects of the new histopathological classification--food for thought]","Knüchel R, Lindemann-Docter K.","Urologe A. 2009 Jun;48(6):598-608. doi: 10.1007/s00120-009-1988-2.","Knüchel R","Urologe A","2009","2009/06/27","","","10.1007/s00120-009-1988-2"
"6022649","[Cancer of the urinary bladder]","Sorensen BL.","Nord Med. 1967 Apr 13;77(15):461-8.","Sorensen BL","Nord Med","1967","1967/04/13","","",""
"19829021","Methodology of superficial bladder cancer trials: objective evaluation of treatment - the need for standardization","Bassi PF, Volpe A, Racioppi M, D'Agostino D, Gardi M, Totaro A, Pinto F, Sacco E, Bongiovanni L.","Urol Int. 2009;83(3):258-63. doi: 10.1159/000241663. Epub 2009 Oct 13.","Bassi PF","Urol Int","2009","2009/10/16","","","10.1159/000241663"
"27974922","Outcome of urinary bladder cancer after combined therapies","Anghel RM, Gales LN, Trifanescu OG.","J Med Life. 2016 Jan-Mar;9(1):95-100.","Anghel RM","J Med Life","2016","2016/12/16","PMC5152610","",""
"17310775","[Only metastasis to uterine corpus from superficial bladder cancer that of no original recurrence]","Murakami T, Hoshino K, Hasumi H, Makiyama K, Miyoshi Y, Yoshida M, Nakaigawa N, Ogawa T, Uemura H, Yao M, Kubota Y.","Hinyokika Kiyo. 2007 Jan;53(1):75-7.","Murakami T","Hinyokika Kiyo","2007","2007/02/22","","",""
"11493773","Recent clinical trials in superficial bladder cancer","Oosterlinck W.","Curr Opin Urol. 2001 Sep;11(5):511-5. doi: 10.1097/00042307-200109000-00010.","Oosterlinck W","Curr Opin Urol","2001","2001/08/09","","","10.1097/00042307-200109000-00010"
"8976217","Coincidence of bladder and prostate cancer","Chun TY.","J Urol. 1997 Jan;157(1):65-7.","Chun TY","J Urol","1997","1997/01/01","","",""
"10840466","Re: Ileal neobladder and local recurrence of bladder cancer: patterns of failure and impact on function in men","Gheiler EL.","J Urol. 2000 Jul;164(1):128-9.","Gheiler EL","J Urol","2000","2000/06/07","","",""
"2618184","[The acetylator phenotype in patients with urinary bladder cancer]","Wich H, Franke G, Grimm U, Siegmund W.","Z Urol Nephrol. 1989 Nov;82(11):597-9.","Wich H","Z Urol Nephrol","1989","1989/11/01","","",""
"25987046","Pemetrexed in treating patients with metastatic bladder cancer","Li Q, Li JZ, Xu WH, Gao L.","Asian Pac J Cancer Prev. 2015;16(9):3839-41. doi: 10.7314/apjcp.2015.16.9.3839.","Li Q","Asian Pac J Cancer Prev","2015","2015/05/20","","","10.7314/apjcp.2015.16.9.3839"
"2074519","Acetylation phenotypes and bladder cancer","Hanke J, Krajewska B.","J Occup Med. 1990 Sep;32(9):917-8. doi: 10.1097/00043764-199009000-00032.","Hanke J","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00032"
"26887704","Re: Conditional Survival after Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time","Chang SS.","J Urol. 2016 Mar;195(3):610-1. doi: 10.1016/j.juro.2015.12.003. Epub 2015 Dec 10.","Chang SS","J Urol","2016","2016/02/19","","","10.1016/j.juro.2015.12.003"
"31385744","Six essential conditions for bladder-sparing strategies in bacillus Calmette-Guérin unresponsive bladder cancer","Shariat SF, Enikeev DV, Mostafaei H.","Immunotherapy. 2019 Sep;11(13):1083-1086. doi: 10.2217/imt-2019-0083. Epub 2019 Aug 6.","Shariat SF","Immunotherapy","2019","2019/08/07","","","10.2217/imt-2019-0083"
"18823917","Re: History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story: H. W. Herr and A. Morales. J Urol 2008; 179: 53-56","Koyama A.","J Urol. 2008 Nov;180(5):2255; author reply 2255. doi: 10.1016/j.juro.2008.07.081. Epub 2008 Sep 27.","Koyama A","J Urol","2008","2008/10/01","","","10.1016/j.juro.2008.07.081"
"2790741","Distribution of marker chromosomes in relation to histologic grade in bladder cancer","Milasin J, Mićić M, Mićić S, Diklić V.","Cancer Genet Cytogenet. 1989 Oct 1;42(1):135-42. doi: 10.1016/0165-4608(89)90016-2.","Milasin J","Cancer Genet Cytogenet","1989","1989/10/01","","","10.1016/0165-4608(89)90016-2"
"17127444","Recent advances in high-throughput molecular marker identification for superficial and invasive bladder cancers","Dyrskjot L, Zieger K, Orntoft TF.","Front Biosci. 2007 Jan 1;12:2063-73. doi: 10.2741/2211.","Dyrskjot L","Front Biosci","2007","2006/11/28","","","10.2741/2211"
"19792967","Clinical states model for biomarkers in bladder cancer","Apolo AB, Milowsky M, Bajorin DF.","Future Oncol. 2009 Sep;5(7):977-92. doi: 10.2217/fon.09.57.","Apolo AB","Future Oncol","2009","2009/10/02","PMC3705955","NIHMS324606","10.2217/fon.09.57"
"6369721","Clinical versus pathologic staging and the classification of bladder cancer","Cummings KB.","Urology. 1984 Apr;23(4 Suppl):55-62. doi: 10.1016/s0090-4295(84)80070-9.","Cummings KB","Urology","1984","1984/04/01","","","10.1016/s0090-4295(84)80070-9"
"6651015","The use of hierarchic classification in the image analysis of a complex cell population. Experience with the sediment of voided urine","Koss LG, Sherman AB, Adams SE.","Anal Quant Cytol. 1983 Sep;5(3):159-66.","Koss LG","Anal Quant Cytol","1983","1983/09/01","","",""
"14661419","[Standardization and its importance in rendering medical care to patients with cancer of the bladder]","Chernyshev IV, Kakorina EP, Apolikhin OI.","Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2003 Sep-Oct;(5):43-7.","Chernyshev IV","Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med","2003","2003/12/10","","",""
"25794835","Screening for bladder cancer in individuals with spinal cord injury","Elliott SP.","J Urol. 2015 Jun;193(6):1880-1. doi: 10.1016/j.juro.2015.03.069. Epub 2015 Mar 17.","Elliott SP","J Urol","2015","2015/03/22","","","10.1016/j.juro.2015.03.069"
"3809188","Statistical analysis techniques and sample size determination for clinical trials of treatments for bladder cancer","Byar D, Kaihara S, Sylvester R, Freedman L, Hannigan J, Koiso K, Oohashi Y, Tsugawa R.","Prog Clin Biol Res. 1986;221:49-64.","Byar D","Prog Clin Biol Res","1986","1986/01/01","","",""
"6569901","[A study of invasive factor in bladder cancer--elastase-like activity as a marker of bladder cancer invasiveness]","Nemoto S, Koiso K, Aoyagi K, Tojo S.","Nihon Hinyokika Gakkai Zasshi. 1984 Sep;75(9):1391-400. doi: 10.5980/jpnjurol1928.75.9_1391.","Nemoto S","Nihon Hinyokika Gakkai Zasshi","1984","1984/09/01","","","10.5980/jpnjurol1928.75.9_1391"
"26481718","Clinical pitfalls in diagnosis of nonmuscle-invasive bladder cancer","Serretta V, Scalici Gesolfo C.","Urologia. 2015 Oct;82 Suppl 2:S1-4. doi: 10.5301/uro.5000160. Epub 2015 Oct 9.","Serretta V","Urologia","2015","2015/10/21","","","10.5301/uro.5000160"
"8069498","[Occupation and bladder cancer]","Prianichnikova MB.","Med Tr Prom Ekol. 1993;(5-6):14-7.","Prianichnikova MB","Med Tr Prom Ekol","1993","1993/01/01","","",""
"28456635","Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline","Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM.","J Urol. 2017 Sep;198(3):552-559. doi: 10.1016/j.juro.2017.04.086. Epub 2017 Apr 26.","Chang SS","J Urol","2017","2017/05/01","PMC5626446","NIHMS902683","10.1016/j.juro.2017.04.086"
"11249922","Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer","Priolo G, Gontero P, Martinasso G, Mengozzi G, Formiconi A, Pelucelli G, Zitella A, Casetta G, Viberti L, Aimo G, Tizzani A.","Clin Chim Acta. 2001 Mar;305(1-2):47-53. doi: 10.1016/s0009-8981(00)00416-2.","Priolo G","Clin Chim Acta","2001","2001/03/16","","","10.1016/s0009-8981(00)00416-2"
"30082470","Phage Display-Derived Peptide-Based Dual-Modality Imaging Probe for Bladder Cancer Diagnosis and Resection Postinstillation: A Preclinical Study","Peng L, Shang W, Guo P, He K, Wang H, Han Z, Jiang H, Tian J, Wang K, Xu W.","Mol Cancer Ther. 2018 Oct;17(10):2100-2111. doi: 10.1158/1535-7163.MCT-18-0212. Epub 2018 Aug 6.","Peng L","Mol Cancer Ther","2018","2018/08/08","","","10.1158/1535-7163.MCT-18-0212"
"7385910","Bladder cancer etiology and synthetic carcinogens","Buchanan-Davidson DJ.","Wis Med J. 1980 Apr;79(4):39-40.","Buchanan-Davidson DJ","Wis Med J","1980","1980/04/01","","",""
"25675127","Genitourinary small cell malignancies: prostate and bladder","Shatagopam K, Kaimakliotis HZ, Cheng L, Koch MO.","Future Oncol. 2015;11(3):479-88. doi: 10.2217/fon.14.277.","Shatagopam K","Future Oncol","2015","2015/02/13","","","10.2217/fon.14.277"
"31597003","Update on the guideline of guidelines: non-muscle-invasive bladder cancer","Taylor J, Becher E, Steinberg GD.","BJU Int. 2020 Feb;125(2):197-205. doi: 10.1111/bju.14915. Epub 2019 Nov 1.","Taylor J","BJU Int","2020","2019/10/10","","","10.1111/bju.14915"
"6887357","Bladder cancer: results of radical cystectomy for invasive and recurrent superficial tumors","Drago JR, Rohner TJ Jr.","J Urol. 1983 Sep;130(3):460-2. doi: 10.1016/s0022-5347(17)51250-1.","Drago JR","J Urol","1983","1983/09/01","","","10.1016/s0022-5347(17)51250-1"
"10688044","The growth inhibitory effect of p21 adenovirus on human bladder cancer cells","Hall MC, Li Y, Pong RC, Ely B, Sagalowsky AI, Hsieh JT.","J Urol. 2000 Mar;163(3):1033-8.","Hall MC","J Urol","2000","2000/02/25","","",""
"24602161","The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis","Ren B, Li W, Yang Y, Wu S.","World J Surg Oncol. 2014 Mar 6;12:55. doi: 10.1186/1477-7819-12-55.","Ren B","World J Surg Oncol","2014","2014/03/08","PMC3973981","","10.1186/1477-7819-12-55"
"24354468","Snail expression and outcome in T1 high-grade and T2 bladder cancer: a retrospective immunohistochemical analysis","Nomura S, Suzuki Y, Takahashi R, Terasaki M, Kimata R, Hamasaki T, Kimura G, Shimizu A, Kondo Y.","BMC Urol. 2013 Dec 19;13:73. doi: 10.1186/1471-2490-13-73.","Nomura S","BMC Urol","2013","2013/12/21","PMC3914703","","10.1186/1471-2490-13-73"
"1749327","[The radiation therapy of bladder cancer in a regimen of nontraditional fractionation with local radiomodification by metronidazole]","Pereslegin IA, Mufazalov FF.","Med Radiol (Mosk). 1991;36(12):26-8.","Pereslegin IA","Med Radiol (Mosk)","1991","1991/01/01","","",""
"8078295","Urinary bladder cancer: mechanisms of development and progression","Kroft SH, Oyasu R.","Lab Invest. 1994 Aug;71(2):158-74.","Kroft SH","Lab Invest","1994","1994/08/01","","",""
"8303473","[Radical cystectomy in the therapy of bladder tumors]","Hornák M, Bárdos A, Ondrus D.","Rozhl Chir. 1993 Oct;72(7):293-5.","Hornák M","Rozhl Chir","1993","1993/10/01","","",""
"12507544","Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer","Puente D, Malats N, Cecchini L, Tardón A, García-Closas R, Serra C, Carrato A, Sala M, Boixeda R, Dosemeci M, Real FX, Kogevinas M; EPICURO Study Group Investigators.","Eur Urol. 2003 Jan;43(1):53-62. doi: 10.1016/s0302-2838(02)00496-7.","Puente D","Eur Urol","2003","2003/01/01","","","10.1016/s0302-2838(02)00496-7"
"26558307","[A novel biomarker for diagnosis of bladder cancer]","Koshikawa N.","Nihon Yakurigaku Zasshi. 2015 Nov;146(5):248-51. doi: 10.1254/fpj.146.248.","Koshikawa N","Nihon Yakurigaku Zasshi","2015","2015/11/13","","","10.1254/fpj.146.248"
"26922578","Serum-based protein biomarkers of bladder cancer: A pre- and post-operative evaluation","Bansal N, Gupta AK, Gupta A, Sankhwar SN, Mahdi AA.","J Pharm Biomed Anal. 2016 May 30;124:22-25. doi: 10.1016/j.jpba.2016.02.026. Epub 2016 Feb 22.","Bansal N","J Pharm Biomed Anal","2016","2016/02/29","","","10.1016/j.jpba.2016.02.026"
"8533698","[Indication of neobladder replacement in patients undergoing radical cystectomy for bladder cancer]","Sahashi M, Ono Y, Kato N, Kinukawa T, Ohshima S.","Hinyokika Kiyo. 1995 Nov;41(11):915-9.","Sahashi M","Hinyokika Kiyo","1995","1995/11/01","","",""
"25087173","Multimodal management of muscle-invasive bladder cancer","Park JC, Citrin DE, Agarwal PK, Apolo AB.","Curr Probl Cancer. 2014 May-Jun;38(3):80-108. doi: 10.1016/j.currproblcancer.2014.06.001. Epub 2014 Jun 23.","Park JC","Curr Probl Cancer","2014","2014/08/04","PMC4190161","NIHMS618516","10.1016/j.currproblcancer.2014.06.001"
"23295237","Bladder cancer in 2012: Challenging current paradigms","Noon AP, Catto JW.","Nat Rev Urol. 2013 Feb;10(2):67-8. doi: 10.1038/nrurol.2012.252. Epub 2013 Jan 8.","Noon AP","Nat Rev Urol","2013","2013/01/09","","","10.1038/nrurol.2012.252"
"19195047","Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker","Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Kawaoka K, Wong SG, Belldegrun AS, Pantuck AJ.","Cancer. 2009 Apr 1;115(7):1448-58. doi: 10.1002/cncr.24163.","Klatte T","Cancer","2009","2009/02/06","","","10.1002/cncr.24163"
"6710728","Bladder cancer: defining the clinical problem","Whitmore WF Jr.","Urology. 1984 Apr;23(4 Suppl):5-8. doi: 10.1016/s0090-4295(84)80061-8.","Whitmore WF Jr","Urology","1984","1984/04/01","","","10.1016/s0090-4295(84)80061-8"
"6726904","Adjuvant doxorubicin hydrochloride and radiation in stage D bladder cancer: a preliminary report","Schaeffer AJ, Grayhack JT, Merrill JM, Kies MS, Bulkley GJ, Shetty RM, Chmiel JS.","J Urol. 1984 Jun;131(6):1073-6. doi: 10.1016/s0022-5347(17)50810-1.","Schaeffer AJ","J Urol","1984","1984/06/01","","","10.1016/s0022-5347(17)50810-1"
"16458776","Adaptive radiotherapy for invasive bladder cancer: a feasibility study","Pos FJ, Hulshof M, Lebesque J, Lotz H, van Tienhoven G, Moonen L, Remeijer P.","Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):862-8. doi: 10.1016/j.ijrobp.2005.07.976.","Pos FJ","Int J Radiat Oncol Biol Phys","2006","2006/02/07","","","10.1016/j.ijrobp.2005.07.976"
"19573775","Candidate quality of care indicators for localized bladder cancer","Cooperberg MR, Porter MP, Konety BR.","Urol Oncol. 2009 Jul-Aug;27(4):435-42. doi: 10.1016/j.urolonc.2009.01.012.","Cooperberg MR","Urol Oncol","2009","2009/07/04","","","10.1016/j.urolonc.2009.01.012"
"22411938","Urinary bladder cancer: role of MR imaging","Verma S, Rajesh A, Prasad SR, Gaitonde K, Lall CG, Mouraviev V, Aeron G, Bracken RB, Sandrasegaran K.","Radiographics. 2012 Mar-Apr;32(2):371-87. doi: 10.1148/rg.322115125.","Verma S","Radiographics","2012","2012/03/14","","","10.1148/rg.322115125"
"8944065","Incidence of recurrent bladder cancer in patients requiring admission for abdominal pain long after cystectomy","Phillips JL, Salem RR.","J Surg Oncol. 1996 Nov;63(3):191-4. doi: 10.1002/(SICI)1096-9098(199611)63:3<191::AID-JSO11>3.0.CO;2-8.","Phillips JL","J Surg Oncol","1996","1996/11/01","","","10.1002/(SICI)1096-9098(199611)63:3<191::AID-JSO11>3.0.CO;2-8"
"29517678","The clinical significance of COL5A2 in patients with bladder cancer: A retrospective analysis of bladder cancer gene expression data","Zeng XT, Liu XP, Liu TZ, Wang XH.","Medicine (Baltimore). 2018 Mar;97(10):e0091. doi: 10.1097/MD.0000000000010091.","Zeng XT","Medicine (Baltimore)","2018","2018/03/09","PMC5882427","","10.1097/MD.0000000000010091"
"6677123","[Histological study of urinary bladder tumor: DNA of rat urinary bladder tumor caused by N-butyl-N-(4-hydroxybutyl) nitrosamine and that of human bladder tumor]","Murase T, Kobayashi O, Aota Y, Mitsuta H, Koshikawa T.","Hinyokika Kiyo. 1983 Mar;29(3):303-10.","Murase T","Hinyokika Kiyo","1983","1983/03/01","","",""
"2798874","Bladder cancer: staging with CT and MR imaging","Husband JE, Olliff JF, Williams MP, Heron CW, Cherryman GR.","Radiology. 1989 Nov;173(2):435-40. doi: 10.1148/radiology.173.2.2798874.","Husband JE","Radiology","1989","1989/11/01","","","10.1148/radiology.173.2.2798874"
"25141488","Value of urinary survivin as a diagnostic marker in bladder cancer","Abd El-Hakim TF, El-Shafie MK, Abdou AG, Azmy RM, El-Naidany SS, Badr El-Din MO.","Anal Quant Cytopathol Histpathol. 2014 Jun;36(3):121-7.","Abd El-Hakim TF","Anal Quant Cytopathol Histpathol","2014","2014/08/22","","",""
"8078544","Hubert Humphrey's bladder cancer","Homer RJ.","N Engl J Med. 1994 Sep 29;331(13):880; author reply 880-1.","Homer RJ","N Engl J Med","1994","1994/09/29","","",""
"9144896","Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients","Herr HW.","World J Urol. 1997;15(2):84-8. doi: 10.1007/BF02201977.","Herr HW","World J Urol","1997","1997/01/01","","","10.1007/BF02201977"
"20493448","[Management of muscle invasive bladder in elderly]","Bastide C, Droupy S, Ravaud A, Depuydt-Baillon MG, Guillotreau J.","Prog Urol. 2010 Mar;20 Suppl 1:S57-60. doi: 10.1016/S1166-7087(10)70029-4.","Bastide C","Prog Urol","2010","2010/05/25","","","10.1016/S1166-7087(10)70029-4"
"8453182","Chemotherapy for bladder cancer in the elderly","Raghavan D.","Drugs Aging. 1993 Jan-Feb;3(1):1-8. doi: 10.2165/00002512-199303010-00001.","Raghavan D","Drugs Aging","1993","1993/01/01","","","10.2165/00002512-199303010-00001"
"21717438","A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer","Wosnitzer MS, Hruby GW, Murphy AM, Barlow LJ, Cordon-Cardo C, Mansukhani M, Petrylak DP, Benson MC, McKiernan JM.","Cancer. 2012 Jan 15;118(2):358-64. doi: 10.1002/cncr.26278. Epub 2011 Jun 29.","Wosnitzer MS","Cancer","2012","2011/07/01","","","10.1002/cncr.26278"
"6620781","[Analysis of cases with superficial bladder cancer with follow-up for more than 5 years]","Maru A, Tsuji I, Shiba T, Ohashi N, Fujieda J, Omuro H, Kawakura K, Nishida T, Kusakai Y, Otsuka A, et al.","Nihon Hinyokika Gakkai Zasshi. 1983 May;74(5):798-807. doi: 10.5980/jpnjurol1928.74.5_798.","Maru A","Nihon Hinyokika Gakkai Zasshi","1983","1983/05/01","","","10.5980/jpnjurol1928.74.5_798"
"29396722","Increased expression of the gene encoding stearoyl-CoA desaturase 1 in human bladder cancer","Presler M, Wojtczyk-Miaskowska A, Schlichtholz B, Kaluzny A, Matuszewski M, Mika A, Sledzinski T, Swierczynski J.","Mol Cell Biochem. 2018 Oct;447(1-2):217-224. doi: 10.1007/s11010-018-3306-z. Epub 2018 Feb 2.","Presler M","Mol Cell Biochem","2018","2018/02/04","PMC6133071","","10.1007/s11010-018-3306-z"
"22179893","Evaluation of bladder microvasculature with high-resolution photoacoustic imaging","Xie Z, Roberts W, Carson P, Liu X, Tao C, Wang X.","Opt Lett. 2011 Dec 15;36(24):4815-7. doi: 10.1364/OL.36.004815.","Xie Z","Opt Lett","2011","2011/12/20","PMC3660853","NIHMS472994","10.1364/OL.36.004815"
"5115288","[Bladder cancer with fever as the first symptom]","Moulonguet A, Camplez P.","J Urol Nephrol (Paris). 1971 Jun;77(6):473-6.","Moulonguet A","J Urol Nephrol (Paris)","1971","1971/06/01","","",""
"1984090","Immunotherapy of murine bladder cancer by irradiated tumor vaccine","Lamm DL, Riggs DR, DeHaven JI, Bryner RW.","J Urol. 1991 Jan;145(1):195-8. doi: 10.1016/s0022-5347(17)38290-3.","Lamm DL","J Urol","1991","1991/01/01","","","10.1016/s0022-5347(17)38290-3"
"29727033","Patient-centered prioritization of bladder cancer research","Smith AB, Chisolm S, Deal A, Spangler A, Quale DZ, Bangs R, Jones JM, Gore JL.","Cancer. 2018 Aug 1;124(15):3136-3144. doi: 10.1002/cncr.31530. Epub 2018 May 4.","Smith AB","Cancer","2018","2018/05/05","","","10.1002/cncr.31530"
"8689102","Phase II trials in Ta, T1 bladder cancer. The marker tumour concept","van der Meijden AP, Hall RR, Kurth KH, Bouffioux C, Sylvester R.","Br J Urol. 1996 May;77(5):634-7. doi: 10.1046/j.1464-410x.1996.09002.x.","van der Meijden AP","Br J Urol","1996","1996/05/01","","","10.1046/j.1464-410x.1996.09002.x"
"27326403","Dietary factors associated with bladder cancer","Piyathilake C.","Investig Clin Urol. 2016 Jun;57 Suppl 1(Suppl 1):S14-25. doi: 10.4111/icu.2016.57.S1.S14. Epub 2016 Jun 10.","Piyathilake C","Investig Clin Urol","2016","2016/06/22","PMC4910759","","10.4111/icu.2016.57.S1.S14"
"28423688","MicroRNAs in biofluids are novel tools for bladder cancer screening","Liu X, Liu X, Wu Y, Wu Q, Wang Q, Yang Z, Li L.","Oncotarget. 2017 May 9;8(19):32370-32379. doi: 10.18632/oncotarget.16026.","Liu X","Oncotarget","2017","2017/04/21","PMC5458291","","10.18632/oncotarget.16026"
"6540880","Combined radiation and chemotherapy for locally advanced bladder cancer","Jakse G, Frommhold H.","Prog Clin Biol Res. 1984;153:365-72.","Jakse G","Prog Clin Biol Res","1984","1984/01/01","","",""
"10953112","The current status of bladder preservation in the treatment of muscle invasive bladder cancer","Kim HL, Steinberg GD.","J Urol. 2000 Sep;164(3 Pt 1):627-32. doi: 10.1097/00005392-200009010-00002.","Kim HL","J Urol","2000","2000/08/23","","","10.1097/00005392-200009010-00002"
"29534590","Clinically node-positive bladder cancer: oncological results of induction chemotherapy and consolidative surgery","Stanik M, Poprach A, Macik D, Capak I, Maluskova D, Mareckova N, Lakomy R, Jarkovsky J, Dolezel J.","Neoplasma. 2018;65(2):287-291. doi: 10.4149/neo_2018_170403N239.","Stanik M","Neoplasma","2018","2018/03/15","","","10.4149/neo_2018_170403N239"
"19914691","Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer","Yoshida S, Koga F, Kawakami S, Ishii C, Tanaka H, Numao N, Sakai Y, Saito K, Masuda H, Fujii Y, Kihara K.","Urology. 2010 Feb;75(2):387-91. doi: 10.1016/j.urology.2009.06.111. Epub 2009 Nov 14.","Yoshida S","Urology","2010","2009/11/17","","","10.1016/j.urology.2009.06.111"
"23569128","Downregulation of protocadherin-10 expression correlates with malignant behaviour and poor prognosis in human bladder cancer","Ma JG, He ZK, Ma JH, Li WP, Sun G.","J Int Med Res. 2013 Feb;41(1):38-47. doi: 10.1177/0300060513476989. Epub 2013 Jan 23.","Ma JG","J Int Med Res","2013","2013/04/10","","","10.1177/0300060513476989"
"16835604","Aggressive management of elderly patients with muscle-invasive bladder cancer","Weizer AZ, Montie JE, Lee CT.","Nat Clin Pract Urol. 2006 Jul;3(7):346-7. doi: 10.1038/ncpuro0506.","Weizer AZ","Nat Clin Pract Urol","2006","2006/07/13","","","10.1038/ncpuro0506"
"25070136","Unveiling the surgical risk associated with neoadjuvant chemotherapy in bladder cancer","Bellmunt J, Leow JJ, Martin-Doyle W.","BJU Int. 2014 Aug;114(2):163-4. doi: 10.1111/bju.12661.","Bellmunt J","BJU Int","2014","2014/07/30","","","10.1111/bju.12661"
"6390450","Current status of bladder cancer protocols in the EORTC Genito-Urinary Group","Denis L, Pavone-Macaluso M, De Pauw M.","Prog Clin Biol Res. 1984;162B:429-39.","Denis L","Prog Clin Biol Res","1984","1984/01/01","","",""
"11989905","The management of bladder cancer in the elderly","Sternberg CN, Calabrò F.","Tumori. 2002 Jan-Feb;88(1 Suppl 1):S128-9.","Sternberg CN","Tumori","2002","2002/05/07","","",""
"12586805","Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer","Roychowdhury DF, Hayden A, Liepa AM.","J Clin Oncol. 2003 Feb 15;21(4):673-8. doi: 10.1200/JCO.2003.04.166.","Roychowdhury DF","J Clin Oncol","2003","2003/02/15","","","10.1200/JCO.2003.04.166"
"4822692","Lymphocytic reaction associated with bladder cancer. Effect of chronic immunosuppression","Soloway MS, Myers GH Jr, Krueger G.","Urology. 1974 Apr;3(4):437-43. doi: 10.1016/s0090-4295(74)80157-3.","Soloway MS","Urology","1974","1974/04/01","","","10.1016/s0090-4295(74)80157-3"
"25263197","Selective organ preservation for the treatment of muscle-invasive transitional cell carcinoma of the bladder: a review of current and future perspectives","Hafeez S, Huddart R.","Expert Rev Anticancer Ther. 2014 Dec;14(12):1429-43. doi: 10.1586/14737140.2014.953938. Epub 2014 Sep 27.","Hafeez S","Expert Rev Anticancer Ther","2014","2014/09/30","","","10.1586/14737140.2014.953938"
"12861735","Intravesical Bacillus Calmette-Guerin for treating bladder cancer","Boyd LA.","Urol Nurs. 2003 Jun;23(3):189-91, 199; quiz 192.","Boyd LA","Urol Nurs","2003","2003/07/17","","",""
"25731206","Low level of the X-linked ribosomal protein S4 in human urothelial carcinomas is associated with a poor prognosis","Paquet ÉR, Hovington H, Brisson H, Lacombe C, Larue H, Têtu B, Lacombe L, Fradet Y, Lebel M.","Biomark Med. 2015;9(3):187-97. doi: 10.2217/bmm.14.115.","Paquet ÉR","Biomark Med","2015","2015/03/04","","","10.2217/bmm.14.115"
"31732739","Development and Initial Testing of a Modified UroVysion-Based Fluorescence In Situ Hybridization Score for Prediction of Progression in Bladder Cancer","Kocsmár I, Pajor G, Gyöngyösi B, Székely E, Varga M, Kocsmár É, Kenessey I, Beöthe T, Süle N, Majoros A, Szendrői A, Nyírády P, Kiss A, Riesz P, Lotz G.","Am J Clin Pathol. 2020 Jan 2;153(2):274-284. doi: 10.1093/ajcp/aqz165.","Kocsmár I","Am J Clin Pathol","2020","2019/11/17","","","10.1093/ajcp/aqz165"
"28982751","Clinical Significance of Histologic Variants of Bladder Cancer","Warrick JI.","J Natl Compr Canc Netw. 2017 Oct;15(10):1268-1274. doi: 10.6004/jnccn.2017.7027.","Warrick JI","J Natl Compr Canc Netw","2017","2017/10/07","","","10.6004/jnccn.2017.7027"
"22830471","Radiotherapy plus chemotherapy in muscle-invasive bladder cancer","Chung SD, Huang CY, Yu HJ.","N Engl J Med. 2012 Jul 26;367(4):379; author reply 380-1. doi: 10.1056/NEJMc1206002.","Chung SD","N Engl J Med","2012","2012/07/27","","","10.1056/NEJMc1206002"
"18722044","Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy","Witjes JA.","Eur Urol. 2009 Apr;55(4):919. doi: 10.1016/j.eururo.2008.08.028. Epub 2008 Aug 15.","Witjes JA","Eur Urol","2009","2008/08/30","","","10.1016/j.eururo.2008.08.028"
"20522307","Mechanisms of recurrence of Ta/T1 bladder cancer","Bryan RT, Collins SI, Daykin MC, Zeegers MP, Cheng KK, Wallace DM, Sole GM.","Ann R Coll Surg Engl. 2010 Sep;92(6):519-24. doi: 10.1308/003588410X12664192076935. Epub 2010 Jun 1.","Bryan RT","Ann R Coll Surg Engl","2010","2010/06/05","PMC3182798","","10.1308/003588410X12664192076935"
"20336780","The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer","Sandhu R, Pan CX, Wun T, Harvey D, Zhou H, White RH, Chew HK.","Cancer. 2010 Jun 1;116(11):2596-603. doi: 10.1002/cncr.25004.","Sandhu R","Cancer","2010","2010/03/26","","","10.1002/cncr.25004"
"1877116","Will Rogers and the results of radical cystectomy for invasive bladder cancer","Wishnow KI, Tenney DM.","Urol Clin North Am. 1991 Aug;18(3):529-37.","Wishnow KI","Urol Clin North Am","1991","1991/08/01","","",""
"17020462","Recent improvements in the detection and treatment of nonmuscle-invasive bladder cancer","Kausch I, Doehn C, Jocham D.","Expert Rev Anticancer Ther. 2006 Sep;6(9):1301-11. doi: 10.1586/14737140.6.9.1301.","Kausch I","Expert Rev Anticancer Ther","2006","2006/10/06","","","10.1586/14737140.6.9.1301"
"22559976","Cytogenetic profile of locally advanced and metastatic Schistosoma-related bladder cancer and response to chemotherapy","Aly MS, Khaled HM, Emara M, Hussein TD.","Cancer Genet. 2012 Apr;205(4):156-62. doi: 10.1016/j.cancergen.2012.01.011.","Aly MS","Cancer Genet","2012","2012/05/08","","","10.1016/j.cancergen.2012.01.011"
"24661883","Discovery of Apo-A1 as a potential bladder cancer biomarker by urine proteomics and analysis","Li C, Li H, Zhang T, Li J, Liu L, Chang J.","Biochem Biophys Res Commun. 2014 Apr 18;446(4):1047-52. doi: 10.1016/j.bbrc.2014.03.053. Epub 2014 Mar 21.","Li C","Biochem Biophys Res Commun","2014","2014/03/26","","","10.1016/j.bbrc.2014.03.053"
"22879988","Detection of bladder cancer using proteomic profiling of urine sediments","Majewski T, Spiess PE, Bondaruk J, Black P, Clarke C, Benedict W, Dinney CP, Grossman HB, Tang KS, Czerniak B.","PLoS One. 2012;7(8):e42452. doi: 10.1371/journal.pone.0042452. Epub 2012 Aug 3.","Majewski T","PLoS One","2012","2012/08/11","PMC3411788","","10.1371/journal.pone.0042452"
"30283995","Can urinary biomarkers replace cystoscopy?","Maas M, Bedke J, Stenzl A, Todenhöfer T.","World J Urol. 2019 Sep;37(9):1741-1749. doi: 10.1007/s00345-018-2505-2. Epub 2018 Oct 3.","Maas M","World J Urol","2019","2018/10/05","","","10.1007/s00345-018-2505-2"
"25391784","[A case of bladder cancer arising after augmentation cystoplasty using ileal patch for interstitial cystitis]","Kumagai J, Matsushima H, Murayama S, Yokoyama M, Homma Y.","Hinyokika Kiyo. 2014 Oct;60(10):513-5.","Kumagai J","Hinyokika Kiyo","2014","2014/11/14","","",""
"8680604","Attributable risks for bladder cancer in northern Italy","D'Avanzo B, La Vecchia C, Negri E, Decarli A, Benichou J.","Ann Epidemiol. 1995 Nov;5(6):427-31. doi: 10.1016/1047-2797(95)00057-7.","D'Avanzo B","Ann Epidemiol","1995","1995/11/01","","","10.1016/1047-2797(95)00057-7"
"23055195","Clinical significance of UNC5B expression in bladder cancer","Liu J, Zhang Z, Li ZH, Kong CZ.","Tumour Biol. 2013 Aug;34(4):2099-108. doi: 10.1007/s13277-012-0532-y. Epub 2012 Oct 2.","Liu J","Tumour Biol","2013","2012/10/12","","","10.1007/s13277-012-0532-y"
"23327481","Recent advances in the diagnosis and treatment of bladder cancer","Cheung G, Sahai A, Billia M, Dasgupta P, Khan MS.","BMC Med. 2013 Jan 17;11:13. doi: 10.1186/1741-7015-11-13.","Cheung G","BMC Med","2013","2013/01/19","PMC3566975","","10.1186/1741-7015-11-13"
"1069549","Discussion paper: treatment of superficial bladder cancer in man","Eidinger D, Morales A.","Ann N Y Acad Sci. 1976;277(00):239-40. doi: 10.1111/j.1749-6632.1976.tb41701.x.","Eidinger D","Ann N Y Acad Sci","1976","1976/01/01","","","10.1111/j.1749-6632.1976.tb41701.x"
"19931978","Re: Richard J. Sylvester, Willem Oosterlinck. An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed? Eur Urol 2009;56;43-5","Gudjónsson S, Månsson W, Holmäng S, Liedberg F.","Eur Urol. 2010 Mar;57(3):e28-9; author reply e30. doi: 10.1016/j.eururo.2009.11.026. Epub 2009 Nov 17.","Gudjónsson S","Eur Urol","2010","2009/11/26","","","10.1016/j.eururo.2009.11.026"
"2675273","Advances in the diagnosis and treatment of bladder cancer","Stein BS.","R I Med J. 1989 Aug;72(8):289-93.","Stein BS","R I Med J","1989","1989/08/01","","",""
"9422567","Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer","Sauer R, Birkenhake S, Kühn R, Wittekind C, Schrott KM, Martus P.","Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):121-7. doi: 10.1016/s0360-3016(97)00579-8.","Sauer R","Int J Radiat Oncol Biol Phys","1998","1998/01/09","","","10.1016/s0360-3016(97)00579-8"
"18815916","Tobacco smoking and risk of bladder cancer","Boffetta P.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):45-54. doi: 10.1080/03008880802283664.","Boffetta P","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802283664"
"2284534","The current status of adjuvant chemotherapy for bladder cancer","Tannock IF.","Semin Urol. 1990 Nov;8(4):291-7.","Tannock IF","Semin Urol","1990","1990/11/01","","",""
"20061076","Re: Guido Dalbagni, Kinjal Vora, Matthew Kaag, et al. Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. Eur Urol 2009;56:903-10","Cai T, Bartoletti R.","Eur Urol. 2010 Apr;57(4):e38. doi: 10.1016/j.eururo.2009.12.033. Epub 2010 Jan 5.","Cai T","Eur Urol","2010","2010/01/12","","","10.1016/j.eururo.2009.12.033"
"7277589","The diagnostic value of urine versus bladder washing in patients with bladder cancer","Murphy WM, Crabtree WN, Jukkola AF, Soloway MS.","J Urol. 1981 Sep;126(3):320-2. doi: 10.1016/s0022-5347(17)54505-x.","Murphy WM","J Urol","1981","1981/09/01","","","10.1016/s0022-5347(17)54505-x"
"19234856","Application of new technology in bladder cancer diagnosis and treatment","Goh AC, Lerner SP.","World J Urol. 2009 Jun;27(3):301-7. doi: 10.1007/s00345-009-0387-z. Epub 2009 Feb 22.","Goh AC","World J Urol","2009","2009/02/24","","","10.1007/s00345-009-0387-z"
"14686702","Chemoprevention of superficial bladder cancer","Kamat AM.","Expert Rev Anticancer Ther. 2003 Dec;3(6):799-808. doi: 10.1586/14737140.3.6.799.","Kamat AM","Expert Rev Anticancer Ther","2003","2003/12/23","","","10.1586/14737140.3.6.799"
"648339","[Selective transfemoral embolization of the internal iliac artery in carcinoma of the bladder (author's transl)]","Brühl P, Thelen M.","Dtsch Med Wochenschr. 1978 Apr 28;103(17):737-9, 747. doi: 10.1055/s-0028-1104794.","Brühl P","Dtsch Med Wochenschr","1978","1978/04/28","","","10.1055/s-0028-1104794"
"456044","Development of urinary bladder cancer in the rat","Kunze E.","Curr Top Pathol. 1979;67:145-232. doi: 10.1007/978-3-642-67292-7_3.","Kunze E","Curr Top Pathol","1979","1979/01/01","","","10.1007/978-3-642-67292-7_3"
"23437204","Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies","Zhu Z, Zhang X, Shen Z, Zhong S, Wang X, Lu Y, Xu C.","PLoS One. 2013;8(2):e56662. doi: 10.1371/journal.pone.0056662. Epub 2013 Feb 20.","Zhu Z","PLoS One","2013","2013/02/26","PMC3577653","","10.1371/journal.pone.0056662"
"22824081","[Acute arthritis secondary to intravesical bacillus Calmette-Guérin for bladder cancer]","Raheem OA, Kalunian K, Kellogg Parsons J.","Actas Urol Esp. 2012 Sep;36(8):461-6. doi: 10.1016/j.acuro.2012.02.006. Epub 2012 Jul 22.","Raheem OA","Actas Urol Esp","2012","2012/07/25","","","10.1016/j.acuro.2012.02.006"
"31743118","Updates on the Genomics of Bladder Cancer and Novel Molecular Taxonomy","Al-Ahmadie H, Netto GJ.","Adv Anat Pathol. 2020 Jan;27(1):36-43. doi: 10.1097/PAP.0000000000000252.","Al-Ahmadie H","Adv Anat Pathol","2020","2019/11/20","","","10.1097/PAP.0000000000000252"
"19969329","The role of actinin-4 in bladder cancer invasion","Koizumi T, Nakatsuji H, Fukawa T, Avirmed S, Fukumori T, Takahashi M, Kanayama H.","Urology. 2010 Feb;75(2):357-64. doi: 10.1016/j.urology.2009.09.037. Epub 2009 Dec 6.","Koizumi T","Urology","2010","2009/12/09","","","10.1016/j.urology.2009.09.037"
"9922778","[Concomitant chemoradiotherapy of infiltrating cancers of the bladder]","Housset M.","Cancer Radiother. 1998 Dec;2(6):713-7. doi: 10.1016/s1278-3218(99)80013-4.","Housset M","Cancer Radiother","1998","1999/01/29","","","10.1016/s1278-3218(99)80013-4"
"8092012","Recent developments in the pathophysiology of bladder cancer","Rozanski TA, Grossman HB.","AJR Am J Roentgenol. 1994 Oct;163(4):789-92. doi: 10.2214/ajr.163.4.8092012.","Rozanski TA","AJR Am J Roentgenol","1994","1994/10/01","","","10.2214/ajr.163.4.8092012"
"25895561","[Nonmuscle-invasive bladder cancer]","Vom Dorp F, Lümmen G, Rübben H.","Urologe A. 2015 Apr;54(4):479. doi: 10.1007/s00120-015-3828-x.","Vom Dorp F","Urologe A","2015","2015/04/22","","","10.1007/s00120-015-3828-x"
"11259458","Filling the void: urinary markers for bladder cancer risk and diagnosis","Gazdar AF, Czerniak B.","J Natl Cancer Inst. 2001 Mar 21;93(6):413-5. doi: 10.1093/jnci/93.6.413.","Gazdar AF","J Natl Cancer Inst","2001","2001/03/22","","","10.1093/jnci/93.6.413"
"21725243","Are we undertreating invasive bladder cancer? Optimizing outcomes in a high-risk disease","Blais N.","Curr Opin Support Palliat Care. 2011 Sep;5(3):192-8. doi: 10.1097/SPC.0b013e3283490441.","Blais N","Curr Opin Support Palliat Care","2011","2011/07/05","","","10.1097/SPC.0b013e3283490441"
"8727698","Correlation analysis between bladder cancer and cigarette smoking in various countries","Nakata S, Sato J, Yamanaka H.","Tohoku J Exp Med. 1996 Feb;178(2):169-76. doi: 10.1620/tjem.178.169.","Nakata S","Tohoku J Exp Med","1996","1996/02/01","","","10.1620/tjem.178.169"
"24102813","An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps","Compérat E, Egevad L, Lopez-Beltran A, Camparo P, Algaba F, Amin M, Epstein JI, Hamberg H, Hulsbergen-van de Kaa C, Kristiansen G, Montironi R, Pan CC, Heloir F, Treurniet K, Sykes J, Van der Kwast TH.","Histopathology. 2013 Dec;63(6):756-66. doi: 10.1111/his.12214. Epub 2013 Sep 16.","Compérat E","Histopathology","2013","2013/10/10","","","10.1111/his.12214"
"10948898","[Bladder cancer--diagnosis and therapy]","Schiefelbein F.","Krankenpfl J. 2000 Mar-Apr;38(3):64-8.","Schiefelbein F","Krankenpfl J","2000","2000/08/19","","",""
"16474497","Intravesical chemotherapy for superficial bladder cancer","Witjes JA, Debruyne FM.","Nat Clin Pract Urol. 2004 Dec;1(2):56-7. doi: 10.1038/ncpuro0009.","Witjes JA","Nat Clin Pract Urol","2004","2006/02/14","","","10.1038/ncpuro0009"
"32988916","Bladder-conserving Approach in Radical Treatment of Patients With Bladder Cancer - A Single-institution Experience","Majewski W, Nieckula J, Dworzecki T, Miszczyk L.","Anticancer Res. 2020 Oct;40(10):5861-5868. doi: 10.21873/anticanres.14605.","Majewski W","Anticancer Res","2020","2020/09/29","","","10.21873/anticanres.14605"
"15948755","Micropapillary bladder cancer","Nishizawa K, Kobayashi T, Mitsumori K, Ide Y, Watanabe J, Ogura K.","Int J Urol. 2005 May;12(5):506-8. doi: 10.1111/j.1442-2042.2005.01075.x.","Nishizawa K","Int J Urol","2005","2005/06/14","","","10.1111/j.1442-2042.2005.01075.x"
"7082929","Factors influencing salvage cystectomy results","Osborn DE, Honan RP, Palmer MK, Barnard RJ, McIntyre D, Pointon RS.","Br J Urol. 1982 Apr;54(2):122-5. doi: 10.1111/j.1464-410x.1982.tb13534.x.","Osborn DE","Br J Urol","1982","1982/04/01","","","10.1111/j.1464-410x.1982.tb13534.x"
"10791911","Proteomic strategies in bladder cancer","Celis JE, Wolf H, Ostergaard M.","IUBMB Life. 1999 Jul;48(1):19-23. doi: 10.1080/713803472.","Celis JE","IUBMB Life","1999","2000/05/03","","","10.1080/713803472"
"9738301","[Guidelines for diagnosis of bladder cancer. German Society of Urology]","","Urologe A. 1998 Jul;37(4):441-57.","","Urologe A","1998","1998/09/17","","",""
"916449","[Experimental and clinical studies on bladder cancer: clinical evaluation of partial cystectomy (author's transl)]","Mishina T, Watanabe K, Miyakoda K, Araki H, Fujiwara T.","Nihon Hinyokika Gakkai Zasshi. 1977 Jul;68(7):678-85. doi: 10.5980/jpnjurol1928.68.7_678.","Mishina T","Nihon Hinyokika Gakkai Zasshi","1977","1977/07/01","","","10.5980/jpnjurol1928.68.7_678"
"11828993","Photodynamic therapy in superficial bladder cancer: past, present and future","Jichlinski P, Leisinger HJ.","Urol Res. 2001 Dec;29(6):396-405. doi: 10.1007/s002400100215.","Jichlinski P","Urol Res","2001","2002/02/07","","","10.1007/s002400100215"
"1932313","Familial aggregation of bladder cancer stratified by smoking status","Kramer AA, Graham S, Burnett WS, Nasca P.","Epidemiology. 1991 Mar;2(2):145-8. doi: 10.1097/00001648-199103000-00010.","Kramer AA","Epidemiology","1991","1991/03/01","","","10.1097/00001648-199103000-00010"
"22386114","[Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines]","Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA; European Association of Urology.","Actas Urol Esp. 2012 Sep;36(8):449-60. doi: 10.1016/j.acuro.2011.11.001. Epub 2012 Mar 2.","Stenzl A","Actas Urol Esp","2012","2012/03/06","","","10.1016/j.acuro.2011.11.001"
"17646045","Editorial comment on: Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light","Lerner SP.","Eur Urol. 2007 Dec;52(6):1708-9. doi: 10.1016/j.eururo.2007.07.008.","Lerner SP","Eur Urol","2007","2007/07/25","","","10.1016/j.eururo.2007.07.008"
"29274202","'Very-low-risk' bladder tumours - a new entity?","Gofrit ON, Pode D, Pizov G, Duvdevani M, Landau EH, Hidas G, Yutkin V.","BJU Int. 2018 Apr;121(4):627-631. doi: 10.1111/bju.14108. Epub 2018 Jan 17.","Gofrit ON","BJU Int","2018","2017/12/24","","","10.1111/bju.14108"
"7967292","[Intra-arterial infusion chemotherapy for invasive bladder cancer: its contribution to survival of patients and preservation of the bladder]","Naito K.","Nihon Hinyokika Gakkai Zasshi. 1994 Sep;85(9):1313-21.","Naito K","Nihon Hinyokika Gakkai Zasshi","1994","1994/09/01","","",""
"18640506","Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center: in regard to Kotwal et al. (Int J Radiat Oncol Biol Phys 2008;70:456-463)","Rosario DJ, Catto JW, Cutinha PE, Anderson JB, Ferguson C, Kirkbride P, Hamdy FC.","Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1601-2; author reply 1602. doi: 10.1016/j.ijrobp.2008.03.037.","Rosario DJ","Int J Radiat Oncol Biol Phys","2008","2008/07/22","","","10.1016/j.ijrobp.2008.03.037"
"30672335","Bladder Cancer in the Genomic Era","Guo CC, Czerniak B.","Arch Pathol Lab Med. 2019 Jun;143(6):695-704. doi: 10.5858/arpa.2018-0329-RA. Epub 2019 Jan 23.","Guo CC","Arch Pathol Lab Med","2019","2019/01/24","","","10.5858/arpa.2018-0329-RA"
"2008919","Drake Chemical Workers' Health Registry Study: I. Notification and medical surveillance of a group of workers at high risk of developing bladder cancer","Marsh GM, Leviton LC, Talbott EO, Callahan C, Pavlock D, Hemstreet G, Logue JN, Fox J, Schulte P.","Am J Ind Med. 1991;19(3):291-301. doi: 10.1002/ajim.4700190304.","Marsh GM","Am J Ind Med","1991","1991/01/01","","","10.1002/ajim.4700190304"
"3362905","Neoadjuvant intravenous cisplatin for T2-4NxMo bladder cancer","Raghavan D, Pearson B, Duval P, Rogers J, Watt H, Tynan A.","Prog Clin Biol Res. 1988;260:561-70.","Raghavan D","Prog Clin Biol Res","1988","1988/01/01","","",""
"9815773","Thymidine phosphorylase activity in human bladder cancer: difference between superficial and invasive cancer","Kubota Y, Miura T, Moriyama M, Noguchi S, Matsuzaki J, Takebayashi S, Hosaka M.","Clin Cancer Res. 1997 Jun;3(6):973-6.","Kubota Y","Clin Cancer Res","1997","1997/06/01","","",""
"26292856","Re: Association between Cannabis Use and the Risk of Bladder Cancer: Results from the California Men's Health Study","Penson DF.","J Urol. 2015 Sep;194(3):667. doi: 10.1016/j.juro.2015.06.009. Epub 2015 Jun 9.","Penson DF","J Urol","2015","2015/08/22","","","10.1016/j.juro.2015.06.009"
"6833019","Carcinoma of the urinary bladder category T3NxMo treated by the combination of radium implant and external irradiation: second report","van der Werf-Messing B, Menon RS, Hop WC.","Int J Radiat Oncol Biol Phys. 1983 Feb;9(2):177-80. doi: 10.1016/0360-3016(83)90095-0.","van der Werf-Messing B","Int J Radiat Oncol Biol Phys","1983","1983/02/01","","","10.1016/0360-3016(83)90095-0"
"6495445","Possibilities for an extended classification of bladder cancer","Wahren B, Nilsson B, Esposti PL, Edsmyr F, Holmberg V.","Urol Res. 1984;12(4):195-7. doi: 10.1007/BF00256802.","Wahren B","Urol Res","1984","1984/01/01","","","10.1007/BF00256802"
"12898036","[Biochips in bladder cancer research]","Suhr J, Eisenhardt A, Schmid KW, vom Dorp F, Otto T.","Urologe A. 2003 Jul;42(7):927-32. doi: 10.1007/s00120-003-0309-4. Epub 2003 Mar 21.","Suhr J","Urologe A","2003","2003/08/05","","","10.1007/s00120-003-0309-4"
"26612220","Morphologic and Molecular Characteristics of Bladder Cancer","Solomon JP, Hansel DE.","Surg Pathol Clin. 2015 Dec;8(4):663-76. doi: 10.1016/j.path.2015.07.003.","Solomon JP","Surg Pathol Clin","2015","2015/11/28","","","10.1016/j.path.2015.07.003"
"24617100","Prompt diagnosis key in bladder cancer","DeSouza K, Chowdhury S, Hughes S.","Practitioner. 2014 Jan;258(1767):23-7, 3.","DeSouza K","Practitioner","2014","2014/03/13","","",""
"12196903","Prognostic markers in muscle invasive bladder cancer","Tiguert R, Lessard A, So A, Fradet Y.","World J Urol. 2002 Aug;20(3):190-5. doi: 10.1007/s00345-002-0279-y. Epub 2002 Jun 7.","Tiguert R","World J Urol","2002","2002/08/28","","","10.1007/s00345-002-0279-y"
"928042","[An analysis of survival data of urinary bladder cancer patients after radiotherapy (author's transl)]","Ito S, Suzaki K, Tsujii H, Fujieda J, Irie G.","Nihon Igaku Hoshasen Gakkai Zasshi. 1977 Jul;37(7):685-90.","Ito S","Nihon Igaku Hoshasen Gakkai Zasshi","1977","1977/07/01","","",""
"28650267","Robotic-assisted radical cystectomy versus open radical cystectomy for management of bladder cancer: review of literature and randomized trials","Attalla K, Kent M, Waingankar N, Mehrazin R.","Future Oncol. 2017 Jun;13(13):1195-1204. doi: 10.2217/fon-2017-0004. Epub 2017 Jun 26.","Attalla K","Future Oncol","2017","2017/06/27","","","10.2217/fon-2017-0004"
"21814053","Perioperative management of nonmuscle-invasive bladder cancer","Falke J, Witjes JA.","Curr Opin Urol. 2011 Sep;21(5):403-8. doi: 10.1097/MOU.0b013e3283490560.","Falke J","Curr Opin Urol","2011","2011/08/05","","","10.1097/MOU.0b013e3283490560"
"22235185","Emerging endoscopic and photodynamic techniques for bladder cancer detection and surveillance","Patel P, Bryan RT, Wallace DM.","ScientificWorldJournal. 2011;11:2550-8. doi: 10.1100/2011/412739. Epub 2011 Dec 29.","Patel P","ScientificWorldJournal","2011","2012/01/12","PMC3253550","","10.1100/2011/412739"
"30057091","Unmet informational and supportive care needs of patients with muscle invasive bladder cancer: A systematic review of the evidence","Paterson C, Jensen BT, Jensen JB, Nabi G.","Eur J Oncol Nurs. 2018 Aug;35:92-101. doi: 10.1016/j.ejon.2018.05.006. Epub 2018 Jun 30.","Paterson C","Eur J Oncol Nurs","2018","2018/07/31","","","10.1016/j.ejon.2018.05.006"
"28074341","Gap junction protein connexin43 deregulation contributes to bladder carcinogenesis via targeting MAPK pathway","Ai XL, Chi Q, Qiu Y, Li HY, Li DJ, Wang JX, Wang ZY.","Mol Cell Biochem. 2017 Apr;428(1-2):109-118. doi: 10.1007/s11010-016-2921-9. Epub 2017 Jan 10.","Ai XL","Mol Cell Biochem","2017","2017/01/12","","","10.1007/s11010-016-2921-9"
"2357783","High-stage bladder cancer: bladder preservation or reconstruction?","Montie JE.","Cleve Clin J Med. 1990 May;57(3):280-4. doi: 10.3949/ccjm.57.3.280.","Montie JE","Cleve Clin J Med","1990","1990/05/01","","","10.3949/ccjm.57.3.280"
"18756044","Single institutional experience of bladder-preserving trimodality treatment for muscle-invasive bladder cancer","Joung JY, Han KS, Kim TS, Seo HK, Chung J, Lee KH.","J Korean Med Sci. 2008 Aug;23(4):598-603. doi: 10.3346/jkms.2008.23.4.598.","Joung JY","J Korean Med Sci","2008","2008/08/30","PMC2526414","","10.3346/jkms.2008.23.4.598"
"28623648","Systemic chemotherapy in muscle invasive and metastatic bladder cancer: present and future","Del Bene G, Sternberg CN.","Urologia. 2017 Aug 1;84(3):130-141. doi: 10.5301/uj.5000230. Epub 2017 Jun 14.","Del Bene G","Urologia","2017","2017/06/18","","","10.5301/uj.5000230"
"30447847","Urologic Pathology: Key Parameters from a Urologist's Perspective","Borchert A, Rogers CG.","Surg Pathol Clin. 2018 Dec;11(4):893-901. doi: 10.1016/j.path.2018.07.012. Epub 2018 Oct 17.","Borchert A","Surg Pathol Clin","2018","2018/11/19","","","10.1016/j.path.2018.07.012"
"25836941","Therapeutic opportunities in the intrinsic subtypes of muscle-invasive bladder cancer","McConkey DJ, Choi W, Ochoa A, Siefker-Radtke A, Czerniak B, Dinney CP.","Hematol Oncol Clin North Am. 2015 Apr;29(2):377-94, x-xi. doi: 10.1016/j.hoc.2014.11.003.","McConkey DJ","Hematol Oncol Clin North Am","2015","2015/04/04","","","10.1016/j.hoc.2014.11.003"
"27814720","miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7","Zhou M, Wang S, Hu L, Liu F, Zhang Q, Zhang D.","BMC Urol. 2016 Nov 4;16(1):64. doi: 10.1186/s12894-016-0181-3.","Zhou M","BMC Urol","2016","2016/11/06","PMC5097416","","10.1186/s12894-016-0181-3"
"29530786","The Bladder Utility Symptom Scale: A Novel Patient Reported Outcome Instrument for Bladder Cancer","Perlis N, Krahn MD, Boehme KE, Alibhai SMH, Jamal M, Finelli A, Sridhar SS, Chung P, Gandhi R, Jones J, Tomlinson G, Bremner KE, Kulkarni G.","J Urol. 2018 Aug;200(2):283-291. doi: 10.1016/j.juro.2018.03.006. Epub 2018 Mar 9.","Perlis N","J Urol","2018","2018/03/14","","","10.1016/j.juro.2018.03.006"
"9366321","Rapid detection of bladder cancer: a comparative study of point of care tests","Johnston B, Morales A, Emerson L, Lundie M.","J Urol. 1997 Dec;158(6):2098-101. doi: 10.1016/s0022-5347(01)68166-7.","Johnston B","J Urol","1997","1997/11/20","","","10.1016/s0022-5347(01)68166-7"
"23754249","Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1","Koutros S, Baris D, Fischer A, Tang W, Garcia-Closas M, Karagas MR, Schwenn M, Johnson A, Figueroa J, Waddell R, Prokunina-Olsson L, Rothman N, Silverman DT.","Int J Cancer. 2013 Dec 15;133(12):3008-13. doi: 10.1002/ijc.28325. Epub 2013 Jul 16.","Koutros S","Int J Cancer","2013","2013/06/12","PMC3797230","NIHMS497786","10.1002/ijc.28325"
"4005498","Cystectomy for carcinoma of the bilharzial bladder. 126 patients 10 years later","Ghoneim MA, Ashamalla A, Gaballa MA, Ibrahim EI.","Br J Urol. 1985 Jun;57(3):303-5. doi: 10.1111/j.1464-410x.1985.tb06349.x.","Ghoneim MA","Br J Urol","1985","1985/06/01","","","10.1111/j.1464-410x.1985.tb06349.x"
"17483020","The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer","Gonzalgo ML, Datar RH, Schoenberg MP, Cote RJ.","Urol Oncol. 2007 May-Jun;25(3):228-35. doi: 10.1016/j.urolonc.2006.07.020.","Gonzalgo ML","Urol Oncol","2007","2007/05/08","","","10.1016/j.urolonc.2006.07.020"
"25400817","Long noncoding RNA GHET1 promotes the development of bladder cancer","Li LJ, Zhu JL, Bao WS, Chen DK, Huang WW, Weng ZL.","Int J Clin Exp Pathol. 2014 Sep 15;7(10):7196-205. eCollection 2014.","Li LJ","Int J Clin Exp Pathol","2014","2014/11/18","PMC4230137","",""
"7768113","Management of bladder cancer","Raghavan D, Huben R.","Curr Probl Cancer. 1995 Jan-Feb;19(1):1-64.","Raghavan D","Curr Probl Cancer","1995","1995/01/01","","",""
"16382717","[The therapeutic dilemma of the early invasive bladder cancer]","Caviezel A, Pelte MF, Fateri F, Iselin C.","Rev Med Suisse. 2005 Dec 7;1(44):2849-50, 2853.","Caviezel A","Rev Med Suisse","2005","2005/12/31","","",""
"27221750","A review of the Paris system for reporting urinary cytology","VandenBussche CJ.","Cytopathology. 2016 Jun;27(3):153-6. doi: 10.1111/cyt.12345.","VandenBussche CJ","Cytopathology","2016","2016/05/26","","","10.1111/cyt.12345"
"31631674","Preoperative CD4(+)CD25(+)/CD4(+) and tumor diameter predict prognosis in male patients with bladder cancer","Wang RJ, Liu W, Mu XY, Yao ZX, Wu K, Zheng Z, Jiang JT, Tan MY, Sun F, Fan J, Wang X, Zheng JH, He YY, Liu ZH.","Biomark Med. 2019 Nov;13(16):1387-1397. doi: 10.2217/bmm-2018-0481. Epub 2019 Oct 21.","Wang RJ","Biomark Med","2019","2019/10/22","","","10.2217/bmm-2018-0481"
"872123","The etiology of bladder cancer from the epidemiological viewpoint","Miller AB.","Cancer Res. 1977 Aug;37(8 Pt 2):2939-42.","Miller AB","Cancer Res","1977","1977/08/01","","",""
"16005375","Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience","Nieuwenhuijzen JA, Pos F, Moonen LM, Hart AA, Horenblas S.","Eur Urol. 2005 Aug;48(2):239-45. doi: 10.1016/j.eururo.2005.03.022. Epub 2005 Apr 13.","Nieuwenhuijzen JA","Eur Urol","2005","2005/07/12","","","10.1016/j.eururo.2005.03.022"
"5388243","Causation of urinary bladder cancer","Bryan GT.","Hinyokika Kiyo. 1969 Aug;15(8):545-6.","Bryan GT","Hinyokika Kiyo","1969","1969/08/01","","",""
"6799197","Chemotherapy of bladder cancer: a review","Smith PH.","Cancer Treat Rep. 1981;65 Suppl 1:165-73.","Smith PH","Cancer Treat Rep","1981","1981/01/01","","",""
"11825522","[A further study on potential of microsatellite analysis of urine in diagnosis of bladder cancer]","Zhang J, Zheng S, Di X.","Zhonghua Yi Xue Za Zhi. 2001 Oct 25;81(20):1224-6.","Zhang J","Zhonghua Yi Xue Za Zhi","2001","2002/02/05","","",""
"21560291","Bladder cancer: men at risk","","Harv Mens Health Watch. 2011 Apr;15(9):1-5.","","Harv Mens Health Watch","2011","2011/05/13","","",""
"28601885","Safety and Efficacy of Intravesical Bacillus Calmette-Guérin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria: A Systematic Review","Poletajew S, Zapała P, Radziszewski P.","Urol Int. 2017;99(1):1-5. doi: 10.1159/000477673. Epub 2017 Jun 10.","Poletajew S","Urol Int","2017","2017/06/12","","","10.1159/000477673"
"6275595","Signet-ring cell carcinoma involving the urinary bladder. Report of a case and review of 21 cases","Kondo A, Ogisu B, Mitsuya H.","Urol Int. 1981;36(6):373-9. doi: 10.1159/000280784.","Kondo A","Urol Int","1981","1981/01/01","","","10.1159/000280784"
"24829140","AEG-1 is associated with tumor progression in nonmuscle-invasive bladder cancer","Yang G, Zhang L, Lin S, Li L, Liu M, Chen H, Cao M, Liu D, Huang YR, Bo J.","Med Oncol. 2014 Jun;31(6):986. doi: 10.1007/s12032-014-0986-4. Epub 2014 May 15.","Yang G","Med Oncol","2014","2014/05/16","","","10.1007/s12032-014-0986-4"
"20929433","Evaluation of second-look transurethral resection in restaging of patients with nonmuscle-invasive bladder cancer","Ali MH, Ismail IY, Eltobgy A, Gobeish A.","J Endourol. 2010 Dec;24(12):2047-50. doi: 10.1089/end.2010.0319. Epub 2010 Oct 8.","Ali MH","J Endourol","2010","2010/10/09","","","10.1089/end.2010.0319"
"31350988","Urine and Serum Exosomes as Novel Biomarkers in Detection of Bladder Cancer","Elsharkawi F, Elsabah M, Shabayek M, Khaled H.","Asian Pac J Cancer Prev. 2019 Jul 1;20(7):2219-2224. doi: 10.31557/APJCP.2019.20.7.2219.","Elsharkawi F","Asian Pac J Cancer Prev","2019","2019/07/28","PMC6745236","","10.31557/APJCP.2019.20.7.2219"
"24231293","Treatment of bacillus Calmette-Guerin refractory non-muscle invasive bladder cancer","Turker P, Turkeri L.","Arch Esp Urol. 2013 Nov;66(9):833-40.","Turker P","Arch Esp Urol","2013","2013/11/16","","",""
"9552072","Role of adjuvant chemotherapy in the treatment of invasive carcinoma of the urinary bladder","Dimopoulos MA, Moulopoulos LA.","J Clin Oncol. 1998 Apr;16(4):1601-12. doi: 10.1200/JCO.1998.16.4.1601.","Dimopoulos MA","J Clin Oncol","1998","1998/04/29","","","10.1200/JCO.1998.16.4.1601"
"19157687","The updated EAU guidelines on muscle-invasive and metastatic bladder cancer","Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA.","Eur Urol. 2009 Apr;55(4):815-25. doi: 10.1016/j.eururo.2009.01.002. Epub 2009 Jan 13.","Stenzl A","Eur Urol","2009","2009/01/23","","","10.1016/j.eururo.2009.01.002"
"19077567","Alcohol, coffee, and bladder cancer risk: a review of epidemiological studies","Pelucchi C, La Vecchia C.","Eur J Cancer Prev. 2009 Feb;18(1):62-8. doi: 10.1097/CEJ.0b013e32830c8d44.","Pelucchi C","Eur J Cancer Prev","2009","2008/12/17","","","10.1097/CEJ.0b013e32830c8d44"
"20564131","The excessive cost of early stage bladder cancer care: are providers really to blame?","Hemani ML, Bennett CL.","Cancer. 2010 Aug 1;116(15):3530-2. doi: 10.1002/cncr.25227.","Hemani ML","Cancer","2010","2010/06/22","","","10.1002/cncr.25227"
"12647351","[Molecular genetics of urinary bladder cancer progression]","Sauter G, Simon R, Bubendorf L, Mihatsch M.","Verh Dtsch Ges Pathol. 2002;86:49-56.","Sauter G","Verh Dtsch Ges Pathol","2002","2003/03/22","","",""
"10494289","Bladder treatment. Immunotherapy and chemotherapy","Lopez-Beltran A.","Urol Clin North Am. 1999 Aug;26(3):535-54. doi: 10.1016/s0094-0143(05)70199-3.","Lopez-Beltran A","Urol Clin North Am","1999","1999/09/24","","","10.1016/s0094-0143(05)70199-3"
"23269072","Current preclinical models for the advancement of translational bladder cancer research","DeGraff DJ, Robinson VL, Shah JB, Brandt WD, Sonpavde G, Kang Y, Liebert M, Wu XR, Taylor JA 3rd; Translational Science Working Group of the Bladder Advocacy Network Think Tank.","Mol Cancer Ther. 2013 Feb;12(2):121-30. doi: 10.1158/1535-7163.MCT-12-0508. Epub 2012 Dec 26.","DeGraff DJ","Mol Cancer Ther","2013","2012/12/28","","","10.1158/1535-7163.MCT-12-0508"
"32549074","Bladder Cancer at the time of COVID-19 Outbreak","Esperto F, Pang KH, Albisinni S, Papalia R, Scarpa RM.","Int Braz J Urol. 2020 Jul;46(suppl.1):62-68. doi: 10.1590/S1677-5538.IBJU.2020.S107.","Esperto F","Int Braz J Urol","2020","2020/06/18","","","10.1590/S1677-5538.IBJU.2020.S107"
"22014799","A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group","Brausi M, Witjes JA, Lamm D, Persad R, Palou J, Colombel M, Buckley R, Soloway M, Akaza H, Böhle A.","J Urol. 2011 Dec;186(6):2158-67. doi: 10.1016/j.juro.2011.07.076. Epub 2011 Oct 19.","Brausi M","J Urol","2011","2011/10/22","","","10.1016/j.juro.2011.07.076"
"21620296","[The role of chemotherapy in the management of bladder cancer]","Ismaili N, Amzerin M, Elmajjaoui S, Droz JP, Flechon A, Errihani H.","Prog Urol. 2011 Jun;21(6):369-82. doi: 10.1016/j.purol.2011.02.005. Epub 2011 Mar 29.","Ismaili N","Prog Urol","2011","2011/05/31","","","10.1016/j.purol.2011.02.005"
"22264718","Urinary BLCA-4 is highly specific for detection of bladder cancer in Chinese Han population and is related to tumour invasiveness","Feng CC, Wang PH, Guan M, Jiang HW, Wen H, Ding Q, Wu Z.","Folia Biol (Praha). 2011;57(6):242-7.","Feng CC","Folia Biol (Praha)","2011","2012/01/24","","",""
"2738443","[The biological properties and drug sensitivity of rat bladder cancer implanted into the subcutis and the bladder wall of rats]","Yamashita T.","Nihon Gan Chiryo Gakkai Shi. 1989 Jan 20;24(1):78-82.","Yamashita T","Nihon Gan Chiryo Gakkai Shi","1989","1989/01/20","","",""
"2003833","The management of invasive bladder cancer: a review of selected Australasian studies in radiotherapy, chemotherapy and cystectomy","Mameghan H, Sandeman TF.","Aust N Z J Surg. 1991 Mar;61(3):173-8. doi: 10.1111/j.1445-2197.1991.tb07587.x.","Mameghan H","Aust N Z J Surg","1991","1991/03/01","","","10.1111/j.1445-2197.1991.tb07587.x"
"8624800","Bladder cancer, 1996","Lamm DL, Torti FM.","CA Cancer J Clin. 1996 Mar-Apr;46(2):93-112. doi: 10.3322/canjclin.46.2.93.","Lamm DL","CA Cancer J Clin","1996","1996/03/01","","","10.3322/canjclin.46.2.93"
"1447813","[DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer]","Hosaka Y.","Nihon Rinsho. 1992 Oct;50(10):2426-31.","Hosaka Y","Nihon Rinsho","1992","1992/10/01","","",""
"2801405","[The clinical study of 23 cases in patients with bladder cancer over 85 years old]","Owada F, Fukuda H, Saito T, Negishi T, Yamada T, Kageyama Y, Tari K, Tsujii T, Onase J, Saito H, et al.","Hinyokika Kiyo. 1989 Jul;35(7):1141-4.","Owada F","Hinyokika Kiyo","1989","1989/07/01","","",""
"27607746","Factors Related to Adaptation to Cystectomy With Urinary Diversion: An Integrative Review","Merandy K.","J Wound Ostomy Continence Nurs. 2016 Sep-Oct;43(5):499-508. doi: 10.1097/WON.0000000000000269.","Merandy K","J Wound Ostomy Continence Nurs","2016","2016/09/09","","","10.1097/WON.0000000000000269"
"20452159","Comparison of virtual cystoscopy and ultrasonography for bladder cancer detection: a meta-analysis","Qu X, Huang X, Wu L, Huang G, Ping X, Yan W.","Eur J Radiol. 2011 Nov;80(2):188-97. doi: 10.1016/j.ejrad.2010.04.003. Epub 2010 May 7.","Qu X","Eur J Radiol","2011","2010/05/11","","","10.1016/j.ejrad.2010.04.003"
"30370443","Patient-Centered Outcomes in Bladder Cancer","Gore JL.","Curr Urol Rep. 2018 Oct 29;19(12):105. doi: 10.1007/s11934-018-0858-0.","Gore JL","Curr Urol Rep","2018","2018/10/30","","","10.1007/s11934-018-0858-0"
"17222605","Defining optimal therapy for muscle invasive bladder cancer","Herr HW, Dotan Z, Donat SM, Bajorin DF.","J Urol. 2007 Feb;177(2):437-43. doi: 10.1016/j.juro.2006.09.027.","Herr HW","J Urol","2007","2007/01/16","","","10.1016/j.juro.2006.09.027"
"8806198","Molecular biology of dissemination in bladder cancer--laboratory findings and clinical significance","Schmitz-Dräger BJ, Jankevicius F, Ackermann R.","World J Urol. 1996;14(3):190-6. doi: 10.1007/BF00186899.","Schmitz-Dräger BJ","World J Urol","1996","1996/01/01","","","10.1007/BF00186899"
"10223269","A sensitive bladder: an atypical presentation of cancer in a U.S. Army pilot","Carter RM, Mansfield JT.","Aviat Space Environ Med. 1999 Apr;70(4):335-7.","Carter RM","Aviat Space Environ Med","1999","1999/05/01","","",""
"7701761","[A new method for the surgical treatment of bladder cancer and its immediate results]","Schilling A, Friesen A, Grünwald VA.","Vestn Khir Im I I Grek. 1994 Jan-Feb;152(1-2):82-90.","Schilling A","Vestn Khir Im I I Grek","1994","1994/01/01","","",""
"25034988","Re: Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancer","Griebling TL.","J Urol. 2014 Aug;192(2):372. doi: 10.1016/j.juro.2014.05.058. Epub 2014 May 14.","Griebling TL","J Urol","2014","2014/07/19","","","10.1016/j.juro.2014.05.058"
"23083873","Intravesical oncoviral therapy for bladder cancer","So A, Rennie PS, Jia W.","J Urol. 2012 Dec;188(6):2039-40. doi: 10.1016/j.juro.2012.09.044. Epub 2012 Oct 18.","So A","J Urol","2012","2012/10/23","","","10.1016/j.juro.2012.09.044"
"7728097","Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis","Badawi AF, Mostafa MH, Probert A, O'Connor PJ.","Eur J Cancer Prev. 1995 Feb;4(1):45-59. doi: 10.1097/00008469-199502000-00004.","Badawi AF","Eur J Cancer Prev","1995","1995/02/01","","","10.1097/00008469-199502000-00004"
"23122040","MR imaging of urinary bladder carcinoma and beyond","Raza SA, Jhaveri KS.","Radiol Clin North Am. 2012 Nov;50(6):1085-110. doi: 10.1016/j.rcl.2012.08.011.","Raza SA","Radiol Clin North Am","2012","2012/11/06","","","10.1016/j.rcl.2012.08.011"
"5339766","Bladder cancer","Price JM.","Proc Can Cancer Conf. 1966;6:224-43.","Price JM","Proc Can Cancer Conf","1966","1966/01/01","","",""
"12913753","Noninvasive detection of bladder cancer in an orthotopic murine model with green fluorescence protein cytology","Tanaka M, Gee JR, De La Cerda J, Rosser CJ, Zhou JH, Benedict WF, Grossman HB.","J Urol. 2003 Sep;170(3):975-8. doi: 10.1097/01.ju.0000073209.65128.c1.","Tanaka M","J Urol","2003","2003/08/13","","","10.1097/01.ju.0000073209.65128.c1"
"26443388","Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities","Richards KA, Ham S, Cohn JA, Steinberg GD.","Int J Urol. 2016 Jan;23(1):42-7. doi: 10.1111/iju.12959. Epub 2015 Oct 6.","Richards KA","Int J Urol","2016","2015/10/08","","","10.1111/iju.12959"
"3664446","Chromosomal analysis of bladder cancer. II. A practical method","Smeets W, Pauwels R, Laarakkers L, Debruyne F, Geraedts J.","Cancer Genet Cytogenet. 1987 Nov;29(1):23-7. doi: 10.1016/0165-4608(87)90027-6.","Smeets W","Cancer Genet Cytogenet","1987","1987/11/01","","","10.1016/0165-4608(87)90027-6"
"628985","Developments in preoperative staging of bladder tumors","Murphy GP.","Urology. 1978 Feb;11(2):109-15. doi: 10.1016/0090-4295(78)90086-9.","Murphy GP","Urology","1978","1978/02/01","","","10.1016/0090-4295(78)90086-9"
"24304022","Intra-arterial infusion therapy following alteration of pelvic blood flow and concurrent radiation therapy for invasive bladder cancer","Umeyama T, Mashimo T, Nakazato H, Tokunaga T, Uehara H, Shinozaki T, Kawashima M, Akimoto T.","Int J Urol. 1996 Jan;3(1 Suppl):S44-5. doi: 10.1111/j.1442-2042.1996.tb00084.x.","Umeyama T","Int J Urol","1996","2013/12/06","","","10.1111/j.1442-2042.1996.tb00084.x"
"18257375","[Use of antibodies arrays in the study of bladder cancer]","Sánchez-Carbayo M.","Actas Urol Esp. 2007 Oct;31(9):1082-8. doi: 10.1016/s0210-4806(07)73769-5.","Sánchez-Carbayo M","Actas Urol Esp","2007","2008/02/09","","","10.1016/s0210-4806(07)73769-5"
"4032909","[Studies on bladder cancer by flow cytometry. I. Evaluation of the malignant potential of bladder cancer based on flow cytometric DNA analysis]","Yoshikawa K.","Nihon Hinyokika Gakkai Zasshi. 1985 Apr;76(4):483-90. doi: 10.5980/jpnjurol1928.76.4_483.","Yoshikawa K","Nihon Hinyokika Gakkai Zasshi","1985","1985/04/01","","","10.5980/jpnjurol1928.76.4_483"
"10328596","Bladder cancer","Ozen H.","Curr Opin Oncol. 1999 May;11(3):207-12. doi: 10.1097/00001622-199905000-00013.","Ozen H","Curr Opin Oncol","1999","1999/05/18","","","10.1097/00001622-199905000-00013"
"9369144","Invasive bladder cancer: treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for bladder conservation","Shipley WU, Zietman AL, Kaufman DS, Althausen AF, Heney NM.","Int J Radiat Oncol Biol Phys. 1997 Nov 1;39(4):937-43. doi: 10.1016/s0360-3016(97)00461-6.","Shipley WU","Int J Radiat Oncol Biol Phys","1997","1997/11/22","","","10.1016/s0360-3016(97)00461-6"
"29745924","[BCG therapy in NMIBC: How much and for how long?.]","Sánchez Vázquez A, Pereira Arias JG, Gamarra Quintanilla M, Urdaneta Salegui F, Mora Christian J, Ibarluzea González G, Astobieta Odriozola A.","Arch Esp Urol. 2018 May;71(4):349-357.","Sánchez Vázquez A","Arch Esp Urol","2018","2018/05/11","","",""
"19657740","Supraphysiological thermal injury in different human bladder carcinoma cell lines","Jen CP, Huang CT, Tsai CH.","Ann Biomed Eng. 2009 Nov;37(11):2407-15. doi: 10.1007/s10439-009-9773-3. Epub 2009 Aug 6.","Jen CP","Ann Biomed Eng","2009","2009/08/07","","","10.1007/s10439-009-9773-3"
"10895001","Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies","Gschwend JE, Fair WR, Vieweg J.","Eur Urol. 2000 Aug;38(2):121-30. doi: 10.1159/000020268.","Gschwend JE","Eur Urol","2000","2000/07/15","","","10.1159/000020268"
"4086877","[Treatment aimed at a cure of a metastasized bladder cancer]","Amiel JL, Droz JP, Cukier J, Levasseur P, Théodore C, Caillaud JM, Hacker P.","J Urol (Paris). 1985;91(7):441-2.","Amiel JL","J Urol (Paris)","1985","1985/01/01","","",""
"1441023","Assessment of study design in clinical trials for bladder cancer","Tannock IF.","Urol Clin North Am. 1992 Nov;19(4):655-62.","Tannock IF","Urol Clin North Am","1992","1992/11/01","","",""
"7100861","Occupational bladder cancer and cigarette smoking in West Yorkshire","Cartwright R.","Scand J Work Environ Health. 1982;8 Suppl 1:79-82.","Cartwright R","Scand J Work Environ Health","1982","1982/01/01","","",""
"8364777","Staging of bladder cancer by transabdominal real-time ultrasound","Fang YC, Chou YH, Hsu CC, Chang T.","Zhonghua Yi Xue Za Zhi (Taipei). 1993 Jul;52(1):21-5.","Fang YC","Zhonghua Yi Xue Za Zhi (Taipei)","1993","1993/07/01","","",""
"6864917","Acetylator phenotype in human bladder cancer","Miller ME, Cosgriff JM.","J Urol. 1983 Jul;130(1):65-6. doi: 10.1016/s0022-5347(17)50956-8.","Miller ME","J Urol","1983","1983/07/01","","","10.1016/s0022-5347(17)50956-8"
"8603421","Bladder cancer-associated nuclear matrix proteins","Getzenberg RH, Konety BR, Oeler TA, Quigley MM, Hakam A, Becich MJ, Bahnson RR.","Cancer Res. 1996 Apr 1;56(7):1690-4.","Getzenberg RH","Cancer Res","1996","1996/04/01","","",""
"16299858","New role for Herceptin in treating bladder cancer","","Health News. 2005 Nov;11(11):9-10.","","Health News","2005","2005/11/22","","",""
"1609133","Treatment time in bladder cancer","Marks LB.","Radiother Oncol. 1992 Apr;23(4):269-70. doi: 10.1016/s0167-8140(92)80134-5.","Marks LB","Radiother Oncol","1992","1992/04/01","","","10.1016/s0167-8140(92)80134-5"
"4064525","An analysis of the contribution of computed tomography to the treatment outcome in bladder cancer","Rothwell RI, Ash DV, Thorogood J.","Clin Radiol. 1985 Jul;36(4):369-72. doi: 10.1016/s0009-9260(85)80303-2.","Rothwell RI","Clin Radiol","1985","1985/07/01","","","10.1016/s0009-9260(85)80303-2"
"1985746","Black tobacco, maté, and bladder cancer. A case-control study from Uruguay","De Stefani E, Correa P, Fierro L, Fontham E, Chen V, Zavala D.","Cancer. 1991 Jan 15;67(2):536-40. doi: 10.1002/1097-0142(19910115)67:2<536::aid-cncr2820670236>3.0.co;2-8.","De Stefani E","Cancer","1991","1991/01/15","","","10.1002/1097-0142(19910115)67:2<536::aid-cncr2820670236>3.0.co;2-8"
"8881944","Quality of life in patients undergoing bacille Calmette-Guérin therapy for superficial bladder cancer","Mack D, Frick J.","Br J Urol. 1996 Sep;78(3):369-71. doi: 10.1046/j.1464-410x.1996.00134.x.","Mack D","Br J Urol","1996","1996/09/01","","","10.1046/j.1464-410x.1996.00134.x"
"25709027","Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature","Kluth LA, Black PC, Bochner BH, Catto J, Lerner SP, Stenzl A, Sylvester R, Vickers AJ, Xylinas E, Shariat SF.","Eur Urol. 2015 Aug;68(2):238-53. doi: 10.1016/j.eururo.2015.01.032. Epub 2015 Feb 21.","Kluth LA","Eur Urol","2015","2015/02/25","","","10.1016/j.eururo.2015.01.032"
"29758554","Psychosocial Distress in Bladder Cancer Stratified by Gender, Age, Treatment, and Tumour Stage","Draeger DL, Sievert KD, Hakenberg OW.","Urol Int. 2018;101(1):31-37. doi: 10.1159/000489502. Epub 2018 May 14.","Draeger DL","Urol Int","2018","2018/05/15","","","10.1159/000489502"
"7548724","High bladder cancer mortality in rural New England (United States): an etiologic study","Brown LM, Zahm SH, Hoover RN, Fraumeni JF Jr.","Cancer Causes Control. 1995 Jul;6(4):361-8. doi: 10.1007/BF00051412.","Brown LM","Cancer Causes Control","1995","1995/07/01","","","10.1007/BF00051412"
"3929394","Bladder cancer after pelvic irradiation for cervical cancer","Kaplan J, Loftus L.","South Med J. 1985 Sep;78(9):1068-70. doi: 10.1097/00007611-198509000-00011.","Kaplan J","South Med J","1985","1985/09/01","","","10.1097/00007611-198509000-00011"
"16898593","[Clinical analysis of bladder cancer]","Honda M, Satoh M, Hasebe K, Tujimoto Y, Takada T, Fujioka H.","Nihon Hinyokika Gakkai Zasshi. 2006 Jul;97(5):704-11. doi: 10.5980/jpnjurol1989.97.704.","Honda M","Nihon Hinyokika Gakkai Zasshi","2006","2006/08/11","","","10.5980/jpnjurol1989.97.704"
"18020206","[Are there any differences between the characteristics and the behavior of bladder cancer according to the age of presentation? Our experience]","Serrano Frago P, Gil Martínez P, Gil Sanz MJ, Felipo F, Allué López M, Rioja Sanz LA.","Actas Urol Esp. 2007 Sep;31(8):825-30. doi: 10.1016/s0210-4806(07)73736-1.","Serrano Frago P","Actas Urol Esp","2007","2007/11/21","","","10.1016/s0210-4806(07)73736-1"
"7278942","Bladder cancer and HLA antigens","Obata K, Ohno Y, Murase T, Aoki K, Tsuji K.","Nagoya J Med Sci. 1981 Mar;43(3-4):65-70.","Obata K","Nagoya J Med Sci","1981","1981/03/01","","",""
"1462467","[Cystectomy for urinary bladder cancer. Postoperative complications and mortality]","Lund L, Lindorff-Larsen KG, Søndergaard G, Nielsen K, Krarup T.","Ugeskr Laeger. 1992 Nov 30;154(49):3501-3.","Lund L","Ugeskr Laeger","1992","1992/11/30","","",""
"8618285","Invasive bladder cancer--where do we go from here?","Waters WB.","J Urol. 1996 Jun;155(6):1910-1. doi: 10.1016/s0022-5347(01)66044-0.","Waters WB","J Urol","1996","1996/06/01","","","10.1016/s0022-5347(01)66044-0"
"20553214","Managing muscle-invasive bladder cancer in the elderly","Weizer AZ, Palella GV, Montgomery JS.","Expert Rev Anticancer Ther. 2010 Jun;10(6):903-15. doi: 10.1586/era.10.71.","Weizer AZ","Expert Rev Anticancer Ther","2010","2010/06/18","","","10.1586/era.10.71"
"25424386","Muscle invasive bladder cancer: closing the gap between practice and evidence","Tsao CK, Liaw BC, Oh WK, Galsky MD.","Minerva Urol Nefrol. 2015 Mar;67(1):65-73. Epub 2014 Nov 26.","Tsao CK","Minerva Urol Nefrol","2015","2014/11/27","","",""
"15817242","Bladder cancer--resection/ablation","Corica FA, Keane TE.","Surg Oncol Clin N Am. 2005 Apr;14(2):321-52. doi: 10.1016/j.soc.2004.11.001.","Corica FA","Surg Oncol Clin N Am","2005","2005/04/09","","","10.1016/j.soc.2004.11.001"
"22692973","Interleukin-17 gene polymorphisms are associated with bladder cancer in a Chinese Han population","Zhou B, Zhang P, Wang Y, Shi S, Zhang K, Liao H, Zhang L.","Mol Carcinog. 2013 Nov;52(11):871-8. doi: 10.1002/mc.21928. Epub 2012 Jun 12.","Zhou B","Mol Carcinog","2013","2012/06/14","","","10.1002/mc.21928"
"8478228","Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12","Tester W, Porter A, Asbell S, Coughlin C, Heaney J, Krall J, Martz K, Venner P, Hammond E.","Int J Radiat Oncol Biol Phys. 1993 Apr 2;25(5):783-90. doi: 10.1016/0360-3016(93)90306-g.","Tester W","Int J Radiat Oncol Biol Phys","1993","1993/04/02","","","10.1016/0360-3016(93)90306-g"
"23113622","Editorial comment to plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: a single center randomized controlled trial","Naselli A.","Int J Urol. 2013 Apr;20(4):404. doi: 10.1111/j.1442-2042.2012.03180.x. Epub 2012 Nov 1.","Naselli A","Int J Urol","2013","2012/11/02","","","10.1111/j.1442-2042.2012.03180.x"
"2178723","Chemotherapy for metastatic bladder cancer. Is there new hope?","Waxman J.","Br J Urol. 1990 Jan;65(1):1-5. doi: 10.1111/j.1464-410x.1990.tb14648.x.","Waxman J","Br J Urol","1990","1990/01/01","","","10.1111/j.1464-410x.1990.tb14648.x"
"633476","Eight years of experience with preoperative angiographic and lymphographic staging of bladder cancer","Winterberger AR, Wajsman Z, Merrin C, Murphy GP.","J Urol. 1978 Feb;119(2):208-12. doi: 10.1016/s0022-5347(17)57435-2.","Winterberger AR","J Urol","1978","1978/02/01","","","10.1016/s0022-5347(17)57435-2"
"7703679","Myeloperoxidase activity and whole blood chemiluminescence in bladder cancer--influence of smoking","Lafuente A, Pujol F, Carretero P, Trias M, Trush MA.","Exp Toxicol Pathol. 1994 Dec;46(6):471-6. doi: 10.1016/S0940-2993(11)80064-3.","Lafuente A","Exp Toxicol Pathol","1994","1994/12/01","","","10.1016/S0940-2993(11)80064-3"
"12487557","Muscle-invasive bladder cancer in elderly-unfit patients with concomitant illness: can a curative radiation therapy be delivered?","Santacaterina A, Settineri N, De Renzis C, Frosina P, Brancati A, Delia P, Palazzolo C, Romeo A, Sansotta G, Pergolizzi S.","Tumori. 2002 Sep-Oct;88(5):390-4.","Santacaterina A","Tumori","2002","2002/12/19","","",""
"22925709","RE: Prognostic significance of Bacillus Calmette-Guérin failure classification in non-muscle-invasive bladder cancer","Shirakawa H, Kikuchi E.","BJU Int. 2012 Sep;110(6):E164. doi: 10.1111/j.1464-410X.2012.10742_2.x.","Shirakawa H","BJU Int","2012","2012/08/29","","","10.1111/j.1464-410X.2012.10742_2.x"
"20333825","New bladder cancer removal technique reduces recurrence","","Mayo Clin Health Lett. 2010 Feb;28(2):4.","","Mayo Clin Health Lett","2010","2010/03/26","","",""
"6214821","[Preoperative irradiation with high doses, for a short period, in bladder cancer]","Ghilezan N, Milea N, Berariu T.","Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir. 1982 Mar-Apr;31(2):141-8.","Ghilezan N","Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir","1982","1982/03/01","","",""
"31077532","Health-related quality of life around the time of diagnosis in patients with bladder cancer","Yu EY, Nekeman D, Billingham LJ, James ND, Cheng KK, Bryan RT, Wesselius A, Zeegers MP.","BJU Int. 2019 Dec;124(6):984-991. doi: 10.1111/bju.14804. Epub 2019 Jun 7.","Yu EY","BJU Int","2019","2019/05/12","PMC6907410","","10.1111/bju.14804"
"2074508","Molecular and cellular biological approaches and techniques in the detection of bladder cancer and enhanced risk for bladder cancer in high-risk groups","Hurst RE, Jones PL, Rao JY, Hemstreet GP 3rd.","J Occup Med. 1990 Sep;32(9):854-62. doi: 10.1097/00043764-199009000-00018.","Hurst RE","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00018"
"12942718","[Organization of care for patients with urinary bladder cancer in the Russian Federation and approaches to its improvement based on standardization of a diagnostic and therapeutic process]","Apolikhin OI, Chernyshev IV, Kakorina EP.","Urologiia. 2003 Jul-Aug;(4):9-14.","Apolikhin OI","Urologiia","2003","2003/08/29","","",""
"3830957","Radical cystectomy in the treatment of advanced bladder cancer","Fagioli A, Ferrone G, Bonacina R, Baiocco N, Di Natale G, La Pera G.","Ital J Surg Sci. 1985;15(4):361-4.","Fagioli A","Ital J Surg Sci","1985","1985/01/01","","",""
"16280743","Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy","Herr HW.","J Urol. 2005 Dec;174(6):2134-7. doi: 10.1097/01.ju.0000181799.81119.fc.","Herr HW","J Urol","2005","2005/11/11","","","10.1097/01.ju.0000181799.81119.fc"
"3681382","Appropriate endpoints for superficial bladder cancer clinical trials","Kalish LA, Garnick MB, Richie JP.","J Clin Oncol. 1987 Dec;5(12):2004-8. doi: 10.1200/JCO.1987.5.12.2004.","Kalish LA","J Clin Oncol","1987","1987/12/01","","","10.1200/JCO.1987.5.12.2004"
"26343030","Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with Radiotherapy","Feuerstein MA, Goenka A.","Curr Urol Rep. 2015 Nov;16(11):75. doi: 10.1007/s11934-015-0547-1.","Feuerstein MA","Curr Urol Rep","2015","2015/09/07","","","10.1007/s11934-015-0547-1"
"21730850","The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer","Gakis G, Todenhöfer T, Stenzl A.","Curr Opin Urol. 2011 Sep;21(5):428-33. doi: 10.1097/MOU.0b013e32834966fa.","Gakis G","Curr Opin Urol","2011","2011/07/07","","","10.1097/MOU.0b013e32834966fa"
"29362304","[III .Current Status of Bladder Preservation Therapy for Muscle Invasive Bladder Cancer]","Miyazaki J.","Gan To Kagaku Ryoho. 2018 Jan;45(1):33-37.","Miyazaki J","Gan To Kagaku Ryoho","2018","2018/01/25","","",""
"19962553","Re: Featherstone et al.: Live cell imaging of multidrug resistance reversal in human primary bladder cancer explant cultures (Urology 2009;74:378-384)","Lwaleed BA, Birch BR, Sharpe P, Cooper AJ.","Urology. 2009 Dec;74(6):1385-6. doi: 10.1016/j.urology.2009.07.1230.","Lwaleed BA","Urology","2009","2009/12/08","","","10.1016/j.urology.2009.07.1230"
"15076285","Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report","Herr H, Lee C, Chang S, Lerner S; Bladder Cancer Collaborative Group.","J Urol. 2004 May;171(5):1823-8; discussion 1827-8. doi: 10.1097/01.ju.0000120289.78049.0e.","Herr H","J Urol","2004","2004/04/13","","","10.1097/01.ju.0000120289.78049.0e"
"28242163","Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer","Solanki AA, Martin B, Korpics M, Small C, Harkenrider MM, Mitin T.","Clin Oncol (R Coll Radiol). 2017 Jul;29(7):429-435. doi: 10.1016/j.clon.2017.02.005. Epub 2017 Feb 24.","Solanki AA","Clin Oncol (R Coll Radiol)","2017","2017/03/01","","","10.1016/j.clon.2017.02.005"
"24448324","Loss of GATA3 in bladder cancer promotes cell migration and invasion","Li Y, Ishiguro H, Kawahara T, Kashiwagi E, Izumi K, Miyamoto H.","Cancer Biol Ther. 2014 Apr;15(4):428-35. doi: 10.4161/cbt.27631. Epub 2014 Jan 21.","Li Y","Cancer Biol Ther","2014","2014/01/23","PMC3979820","","10.4161/cbt.27631"
"5077205","Epidemiology of urinary bladder cancer in Oklahoma","Asal NR, Ferguson SW.","J Okla State Med Assoc. 1972 Oct;65(10):409-17.","Asal NR","J Okla State Med Assoc","1972","1972/10/01","","",""
"17168369","[Use of novel radiation fractionation regimens in organ-sparing therapy of bladder cancer]","Gumenetskaia IuV, Gulibov IA, Kariakin OB, Popov AM.","Vopr Onkol. 2006;52(5):571-5.","Gumenetskaia IuV","Vopr Onkol","2006","2006/12/16","","",""
"20405206","The role of adjuvant chemotherapy in patients with locally advanced (pT3, pT4a) and/or lymph node-positive bladder cancer","Reşorlu B, Türkölmez K, Ergün G, Baltacı S, Göğüş C, Bedük Y.","Int Urol Nephrol. 2010 Dec;42(4):959-64. doi: 10.1007/s11255-010-9736-5. Epub 2010 Apr 20.","Reşorlu B","Int Urol Nephrol","2010","2010/04/21","","","10.1007/s11255-010-9736-5"
"26954073","MicroRNAs as noninvasive biomarkers in bladder cancer detection: a diagnostic meta-analysis based on qRT-PCR data","Xiao S, Wang J, Xiao N.","Int J Biol Markers. 2016 Jul 30;31(3):e276-85. doi: 10.5301/jbm.5000199.","Xiao S","Int J Biol Markers","2016","2016/03/09","","","10.5301/jbm.5000199"
"18308136","Re: Honma I, Masumori N, Sato E, et al: Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer-analysis of role of pelvic lymph node dissection. Urology 68: 543-548, 2006","Thomas AJ.","Urology. 2008 Feb;71(2):365; author reply 366. doi: 10.1016/j.urology.2007.07.076.","Thomas AJ","Urology","2008","2008/03/01","","","10.1016/j.urology.2007.07.076"
"20034638","Re: DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers L. Mengual, M. Burset, E. Ars, J. J. Lozano, H. Villavicencio, M. J. Ribal And A. Alcaraz J Urol 2009; 182: 741-748","Pfister C, Lamy A, Gobet F, Frebourg T.","J Urol. 2010 Feb;183(2):825-7; author reply 827-8. doi: 10.1016/j.juro.2009.10.042.","Pfister C","J Urol","2010","2009/12/26","","","10.1016/j.juro.2009.10.042"
"21996109","Patient resources available to bladder cancer patients: a pilot study of healthcare providers","Lee CT, Mei M, Ashley J, Breslow G, O'Donnell M, Gilbert S, Lemmy S, Saxton C, Sagalowsky A, Sansgiry S, Latini DM; Bladder Cancer Think Tank; Bladder Cancer Advocacy Network.","Urology. 2012 Jan;79(1):172-7. doi: 10.1016/j.urology.2011.07.1405. Epub 2011 Oct 11.","Lee CT","Urology","2012","2011/10/15","","","10.1016/j.urology.2011.07.1405"
"12900012","New drugs and new approaches in metastatic bladder cancer","Bellmunt J, de Wit R, Albiol S, Tabernero J, Albanell J, Baselga J.","Crit Rev Oncol Hematol. 2003 Aug;47(2):195-206. doi: 10.1016/s1040-8428(03)00082-9.","Bellmunt J","Crit Rev Oncol Hematol","2003","2003/08/06","","","10.1016/s1040-8428(03)00082-9"
"19351926","Does treatment intensity matter in superficial bladder cancer? Consensus, clinical practice, and confounding","Lyman GH, Kuderer NM, Freedland SJ.","J Natl Cancer Inst. 2009 Apr 15;101(8):543-5. doi: 10.1093/jnci/djp060. Epub 2009 Apr 7.","Lyman GH","J Natl Cancer Inst","2009","2009/04/09","PMC4415052","","10.1093/jnci/djp060"
"20962513","Imaging in bladder cancer: present role and future perspectives","Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini A, Bassi P.","Urol Int. 2010;85(4):373-80. doi: 10.1159/000321279. Epub 2010 Oct 21.","Totaro A","Urol Int","2010","2010/10/22","","","10.1159/000321279"
"7897922","[Bladder cancer: diagnosis and prognosis--molecularbiological approach for prognostic factors. Discussion]","","Nihon Hinyokika Gakkai Zasshi. 1995 Jan;86(1):55-65.","","Nihon Hinyokika Gakkai Zasshi","1995","1995/01/01","","",""
"2362486","[Hematuria in young people should be investigated. Bladder cancer could be the cause of symptoms]","Bergman B.","Lakartidningen. 1990 May 30;87(22):1966.","Bergman B","Lakartidningen","1990","1990/05/30","","",""
"28181054","An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer","Panebianco V, De Berardinis E, Barchetti G, Simone G, Leonardo C, Grompone MD, Del Monte M, Carano D, Gallucci M, Catto J, Catalano C.","Eur Radiol. 2017 Sep;27(9):3759-3766. doi: 10.1007/s00330-017-4758-3. Epub 2017 Feb 8.","Panebianco V","Eur Radiol","2017","2017/02/10","","","10.1007/s00330-017-4758-3"
"32242269","[Report from the 9th symposium of the German Association for Bladder Cancer Research]","Schulz WA, Hoffmann MJ, Niegisch G, Füssel S, Nawroth R.","Urologe A. 2020 Jun;59(6):731-732. doi: 10.1007/s00120-020-01181-1.","Schulz WA","Urologe A","2020","2020/04/04","","","10.1007/s00120-020-01181-1"
"10953126","The challenge of improved diagnostic and prognostic indicators of superficial bladder cancer","Lamm DL.","J Urol. 2000 Sep;164(3 Pt 1):690-1. doi: 10.1097/00005392-200009010-00017.","Lamm DL","J Urol","2000","2000/08/23","","","10.1097/00005392-200009010-00017"
"4671040","Immunological characteristics of experimental bladder cancer","Daly JJ, Prout GR Jr, Ahl CA.","Surg Forum. 1972;23(0):103-5.","Daly JJ","Surg Forum","1972","1972/01/01","","",""
"26032289","E2F4 Program Is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder Cancer","Cheng C, Varn FS, Marsit CJ.","Mol Cancer Res. 2015 Sep;13(9):1316-24. doi: 10.1158/1541-7786.MCR-15-0120. Epub 2015 Jun 1.","Cheng C","Mol Cancer Res","2015","2015/06/03","PMC4734892","NIHMS753519","10.1158/1541-7786.MCR-15-0120"
"20047789","Re: Guido Dalbagni, Kinjal Vora, Matthew Kaag, et al. Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. Eur Urol 2009;56:903-10","Banerji JS, Devasia A.","Eur Urol. 2010 Apr;57(4):e37. doi: 10.1016/j.eururo.2009.12.027. Epub 2009 Dec 30.","Banerji JS","Eur Urol","2010","2010/01/06","","","10.1016/j.eururo.2009.12.027"
"21233106","Could patient age influence tumor recurrence rate in non-muscle-invasive bladder cancer patients treated with BCG immunotherapy?","Yuge K, Kikuchi E, Matsumoto K, Takeda T, Miyajima A, Oya M.","Jpn J Clin Oncol. 2011 Apr;41(4):565-70. doi: 10.1093/jjco/hyq241. Epub 2011 Jan 13.","Yuge K","Jpn J Clin Oncol","2011","2011/01/15","","","10.1093/jjco/hyq241"
"26985818","Perineal herniation of an ileal neobladder following radical cystectomy and consecutive rectal resection for recurrent bladder carcinoma","Neumann PA, Mehdorn AS, Puehse G, Senninger N, Rijcken E.","Ann R Coll Surg Engl. 2016 Apr;98(4):e62-4. doi: 10.1308/rcsann.2016.0102.","Neumann PA","Ann R Coll Surg Engl","2016","2016/03/18","PMC5226036","","10.1308/rcsann.2016.0102"
"20191034","High-grade hydronephrosis predicts poor outcomes after radical cystectomy in patients with bladder cancer","Kim DS, Cho KS, Lee YH, Cho NH, Oh YT, Hong SJ.","J Korean Med Sci. 2010 Mar;25(3):369-73. doi: 10.3346/jkms.2010.25.3.369. Epub 2010 Feb 17.","Kim DS","J Korean Med Sci","2010","2010/03/02","PMC2826737","","10.3346/jkms.2010.25.3.369"
"6708176","An international study of smoking and bladder cancer","Morrison AS, Buring JE, Verhoek WG, Aoki K, Leck I, Ohno Y, Obata K.","J Urol. 1984 Apr;131(4):650-4. doi: 10.1016/s0022-5347(17)50559-5.","Morrison AS","J Urol","1984","1984/04/01","","","10.1016/s0022-5347(17)50559-5"
"9446951","Organ preservation with radiochemotherapy in locally advanced bladder cancer","Ausili-Cefaro G, Marmiroli L, Fiorentino G, Nardone L, Palazzoni G, Salvi G.","Rays. 1997 Jul-Sep;22(3):460-6.","Ausili-Cefaro G","Rays","1997","1997/07/01","","",""
"29496693","LINE-1 ORF1 Protein Is Up-regulated by Reactive Oxygen Species and Associated with Bladder Urothelial Carcinoma Progression","Whongsiri P, Pimratana C, Wijitsettakul U, Jindatip D, Sanpavat A, Schulz WA, Hoffmann MJ, Goering W, Boonla C.","Cancer Genomics Proteomics. 2018 Mar-Apr;15(2):143-151. doi: 10.21873/cgp.20072.","Whongsiri P","Cancer Genomics Proteomics","2018","2018/03/03","PMC5892605","","10.21873/cgp.20072"
"8967723","Bladder cancer: a selected review of the epidemiological literature","Pirastu R, Iavarone I, Comba P.","Ann Ist Super Sanita. 1996;32(1):3-20.","Pirastu R","Ann Ist Super Sanita","1996","1996/01/01","","",""
"25543121","To be an ally or an adversary in bladder cancer: the NF-κB story has not unfolded","Mukherjee N, Houston TJ, Cardenas E, Ghosh R.","Carcinogenesis. 2015 Mar;36(3):299-306. doi: 10.1093/carcin/bgu321. Epub 2014 Dec 27.","Mukherjee N","Carcinogenesis","2015","2014/12/28","PMC4425835","","10.1093/carcin/bgu321"
"11101093","Transurethral resection and partial cystectomy for invasive bladder cancer","Laufer M.","Semin Urol Oncol. 2000 Nov;18(4):296-9.","Laufer M","Semin Urol Oncol","2000","2000/12/02","","",""
"4178358","The surgical attack in invasive bladder cancer","Wallace DM.","JAMA. 1969 Jan 13;207(2):345-6.","Wallace DM","JAMA","1969","1969/01/13","","",""
"25975233","Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer","Wang J, Zhang X, Wang L, Dong Z, Du L, Yang Y, Guo Y, Wang C.","J Surg Oncol. 2015 Jun;111(8):992-9. doi: 10.1002/jso.23937. Epub 2015 May 14.","Wang J","J Surg Oncol","2015","2015/05/16","","","10.1002/jso.23937"
"3238827","Radical cystectomy in bladder cancer: mortality and morbidity. A series of 123 cases","Jacqmin D, Nardi A, Schumacker C, Bollack C.","Urol Int. 1988;43(6):327-9. doi: 10.1159/000281384.","Jacqmin D","Urol Int","1988","1988/01/01","","","10.1159/000281384"
"9507829","The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience","Serretta V, Lo Greco G, Pavone C, Pavone-Macaluso M.","J Urol. 1998 Apr;159(4):1187-91.","Serretta V","J Urol","1998","1998/03/21","","",""
"22028816","Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer model","Kim SK, Yun SJ, Kim J, Lee OJ, Bae SC, Kim WJ.","PLoS One. 2011;6(10):e26131. doi: 10.1371/journal.pone.0026131. Epub 2011 Oct 10.","Kim SK","PLoS One","2011","2011/10/27","PMC3189956","","10.1371/journal.pone.0026131"
"12938579","[The role of tumor markers in prognosing transitional bladder cancer]","Lorenzo Gómez MF, Schroeder G.","Actas Urol Esp. 2003 Jul-Aug;27(7):501-12. doi: 10.1016/s0210-4806(03)72963-5.","Lorenzo Gómez MF","Actas Urol Esp","2003","2003/08/27","","","10.1016/s0210-4806(03)72963-5"
"3278484","Neoadjuvant chemotherapy in bladder cancer","Yagoda A.","Urology. 1988 Feb;31(2 Suppl):9-12.","Yagoda A","Urology","1988","1988/02/01","","",""
"5632554","[Contribution to the study of bladder cancer in patients suffereing from bilharziasis]","Sadeler C.","Bull Soc Pathol Exot Filiales. 1967 Mar-Apr;60(2):156-65.","Sadeler C","Bull Soc Pathol Exot Filiales","1967","1967/03/01","","",""
"15610124","Urine dendritic cells: a noninvasive probe for immune activity in bladder cancer?","Beatty JD, Islam S, North ME, Knight SC, Ogden CW.","BJU Int. 2004 Dec;94(9):1377-83. doi: 10.1111/j.1464-410X.2004.05176.x.","Beatty JD","BJU Int","2004","2004/12/22","","","10.1111/j.1464-410X.2004.05176.x"
"3962044","[Adjuvant topical chemotherapy with cisplatin in superficial bladder cancer]","Flamm J, Grof F.","Urologe A. 1986 Jan;25(1):48-50.","Flamm J","Urologe A","1986","1986/01/01","","",""
"31424681","Research on correlations of MiR-203 expression with onset and prognosis of bladder cancer","Huang Z, Liu G.","J BUON. 2019 May-Jun;24(3):1210-1218.","Huang Z","J BUON","2019","2019/08/20","","",""
"20089350","Re: Guido Dalbagni, Kinjal Vora, Matthew Kaag, et al. Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. Eur Urol 2009;56:903-10","Bultitude M, O'Brien T.","Eur Urol. 2010 Apr;57(4):e39-40; author reply e41-2. doi: 10.1016/j.eururo.2010.01.001. Epub 2010 Jan 14.","Bultitude M","Eur Urol","2010","2010/01/22","","","10.1016/j.eururo.2010.01.001"
"17382792","Advances in the management of superficial bladder cancer","O'Donnell MA.","Semin Oncol. 2007 Apr;34(2):85-97. doi: 10.1053/j.seminoncol.2006.12.012.","O'Donnell MA","Semin Oncol","2007","2007/03/27","","","10.1053/j.seminoncol.2006.12.012"
"18626513","Neoadjuvant chemotherapy for the treatment of muscle-invasive bladder cancer: argument in favor","Gallagher DJ, Bajorin DF.","Nat Clin Pract Urol. 2008 Sep;5(9):484-5. doi: 10.1038/ncpuro1147. Epub 2008 Jul 15.","Gallagher DJ","Nat Clin Pract Urol","2008","2008/07/16","","","10.1038/ncpuro1147"
"16238138","Radiation therapy for muscle-invasive bladder cancer: treatment planning and delivery","Logue J, McBain CA.","Clin Oncol (R Coll Radiol). 2005 Oct;17(7):508-13. doi: 10.1016/j.clon.2005.07.004.","Logue J","Clin Oncol (R Coll Radiol)","2005","2005/10/22","","","10.1016/j.clon.2005.07.004"
"16416851","[Gene therapies for bladder cancer]","Satoh M, Wang H, Arai Y.","Nihon Rinsho. 2005 Dec;63 Suppl 12:548-51.","Satoh M","Nihon Rinsho","2005","2006/01/19","","",""
"25912492","Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer","Alva A, Friedlander T, Clark M, Huebner T, Daignault S, Hussain M, Lee C, Hafez K, Hollenbeck B, Weizer A, Premasekharan G, Tran T, Fu C, Ionescu-Zanetti C, Schwartz M, Fan A, Paris P.","J Urol. 2015 Sep;194(3):790-8. doi: 10.1016/j.juro.2015.02.2951. Epub 2015 Apr 23.","Alva A","J Urol","2015","2015/04/28","PMC5103704","NIHMS827217","10.1016/j.juro.2015.02.2951"
"22423665","Pioglitazone and bladder cancer in human studies: is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?","Tseng CH.","J Formos Med Assoc. 2012 Mar;111(3):123-31. doi: 10.1016/j.jfma.2011.10.003. Epub 2012 Feb 15.","Tseng CH","J Formos Med Assoc","2012","2012/03/20","","","10.1016/j.jfma.2011.10.003"
"11901799","Detecting recurrent bladder cancer: new methods and biomarkers","Ross JS, Cohen MB.","Expert Rev Mol Diagn. 2001 May;1(1):39-52. doi: 10.1586/14737159.1.1.39.","Ross JS","Expert Rev Mol Diagn","2001","2002/03/21","","","10.1586/14737159.1.1.39"
"11547058","Molecular followup of newly diagnosed bladder cancer using urine samples","Shigyo M, Sugano K, Tobisu K, Tsukamoto T, Sekiya T, Kakizoe T.","J Urol. 2001 Oct;166(4):1280-5.","Shigyo M","J Urol","2001","2001/09/08","","",""
"25107315","Involvement of Seladin-1 in goniothalamin-induced apoptosis in urinary bladder cancer cells","Yen HK, Fauzi AR, Din LB, McKelvey-Martin VJ, Meng CK, Inayat-Hussain SH, Rajab NF.","BMC Complement Altern Med. 2014 Aug 9;14:295. doi: 10.1186/1472-6882-14-295.","Yen HK","BMC Complement Altern Med","2014","2014/08/10","PMC4150971","","10.1186/1472-6882-14-295"
"30270097","Durvalumab: a newly approved checkpoint inhibitor for the treatment of urothelial carcinoma","Wills S, Hochmuth LK, Bauer KS Jr, Deshmukh R.","Curr Probl Cancer. 2019 Jun;43(3):181-194. doi: 10.1016/j.currproblcancer.2018.08.010. Epub 2018 Sep 18.","Wills S","Curr Probl Cancer","2019","2018/10/02","","","10.1016/j.currproblcancer.2018.08.010"
"19841100","Is T1G3 bladder cancer having a definite muscle layer in TUR specimens a highly progressive disease?","Shindo T, Masumori N, Fukuta F, Miyamoto S, Tsukamoto T.","Jpn J Clin Oncol. 2010 Feb;40(2):153-6. doi: 10.1093/jjco/hyp132. Epub 2009 Oct 19.","Shindo T","Jpn J Clin Oncol","2010","2009/10/21","","","10.1093/jjco/hyp132"
"12194805","Superficial bladder cancer","Lamm DL.","Curr Treat Options Oncol. 2002 Oct;3(5):403-11. doi: 10.1007/s11864-002-0005-4.","Lamm DL","Curr Treat Options Oncol","2002","2002/08/27","","","10.1007/s11864-002-0005-4"
"28589857","Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer","Shivakumar M, Lee Y, Bang L, Garg T, Sohn KA, Kim D.","BMC Med Genomics. 2017 May 24;10(Suppl 1):30. doi: 10.1186/s12920-017-0269-y.","Shivakumar M","BMC Med Genomics","2017","2017/06/08","PMC5461531","","10.1186/s12920-017-0269-y"
"27246180","Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses","Sankhwar M, Sankhwar SN, Bansal SK, Gupta G, Rajender S.","Sci Rep. 2016 Jun 1;6:27018. doi: 10.1038/srep27018.","Sankhwar M","Sci Rep","2016","2016/06/02","PMC4887911","","10.1038/srep27018"
"31312329","[Metastatic bladder metachrone to a kaposi sarcoma cancer at a therapeutic impasse: about a case]","Shamalirwa BB, Wembonyama O, Tidahy R, Mellas S, Ammari JEE, Tazi MF, Farih MH, Elmahi H, Sidibe IS.","Pan Afr Med J. 2019 Apr 30;32:218. doi: 10.11604/pamj.2019.32.218.16007. eCollection 2019.","Shamalirwa BB","Pan Afr Med J","2019","2019/07/18","PMC6620053","","10.11604/pamj.2019.32.218.16007"
"25454383","[Concomitant chemoradiotherapy for muscle-invasive bladder cancer: current knowledge, controversies and future directions]","Bellefqih S, Khalil J, Mezouri I, ElKacemi H, Kebdani T, Hadadi K, Benjaafar N.","Cancer Radiother. 2014 Dec;18(8):779-89. doi: 10.1016/j.canrad.2014.08.006. Epub 2014 Nov 1.","Bellefqih S","Cancer Radiother","2014","2014/12/03","","","10.1016/j.canrad.2014.08.006"
"16336090","Neoadjuvant chemotherapy in invasive bladder cancer","Bamias A, Dimopoulos MA.","Expert Rev Anticancer Ther. 2005 Dec;5(6):993-1000. doi: 10.1586/14737140.5.6.993.","Bamias A","Expert Rev Anticancer Ther","2005","2005/12/13","","","10.1586/14737140.5.6.993"
"7609102","Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer","Sarosdy MF, deVere White RW, Soloway MS, Sheinfeld J, Hudson MA, Schellhammer PF, Jarowenko MV, Adams G, Blumenstein BA.","J Urol. 1995 Aug;154(2 Pt 1):379-83; discussion 383-4. doi: 10.1097/00005392-199508000-00013.","Sarosdy MF","J Urol","1995","1995/08/01","","","10.1097/00005392-199508000-00013"
"9731738","Re: Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines","See WA.","J Natl Cancer Inst. 1998 Sep 2;90(17):1303. doi: 10.1093/jnci/90.17.1303.","See WA","J Natl Cancer Inst","1998","1998/09/10","","","10.1093/jnci/90.17.1303"
"24119219","Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy","Knoedler JJ, Boorjian SA, Tollefson MK, Cheville JC, Thapa P, Tarrell RF, Frank I.","BJU Int. 2014 Dec;114(6):832-6. doi: 10.1111/bju.12486.","Knoedler JJ","BJU Int","2014","2013/10/15","","","10.1111/bju.12486"
"15837038","The management of lymph node metastasis from bladder cancer","Simms MS, Mann G, Kockelbergh RC, Mellon JK.","Eur J Surg Oncol. 2005 May;31(4):348-56. doi: 10.1016/j.ejso.2004.11.003. Epub 2004 Dec 16.","Simms MS","Eur J Surg Oncol","2005","2005/04/20","","","10.1016/j.ejso.2004.11.003"
"25444900","MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene","Lv L, Li Y, Deng H, Zhang C, Pu Y, Qian L, Xiao J, Zhao W, Liu Q, Zhang D, Wang Y, Zhang H, He Y, Zhu J.","Cancer Lett. 2015 Feb 1;357(1):105-113. doi: 10.1016/j.canlet.2014.11.002. Epub 2014 Nov 11.","Lv L","Cancer Lett","2015","2014/12/03","","","10.1016/j.canlet.2014.11.002"
"23167631","Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies","Tseng CH, Tseng FH.","J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2012;30(4):368-402. doi: 10.1080/10590501.2012.735519.","Tseng CH","J Environ Sci Health C Environ Carcinog Ecotoxicol Rev","2012","2012/11/22","","","10.1080/10590501.2012.735519"
"9073049","Survival after curative treatment of muscle-invasive bladder cancer","Fossa SD, Aass N, Ous S, Waehre H, Ilner K, Hannisdal E.","Acta Oncol. 1996;35 Suppl 8:59-65. doi: 10.3109/02841869609098521.","Fossa SD","Acta Oncol","1996","1996/01/01","","","10.3109/02841869609098521"
"14676790","Applications of array technology: identification of molecular targets in bladder cancer","Sánchez-Carbayo M, Cordon-Cardo C.","Br J Cancer. 2003 Dec 15;89(12):2172-7. doi: 10.1038/sj.bjc.6601406.","Sánchez-Carbayo M","Br J Cancer","2003","2003/12/17","PMC2395269","","10.1038/sj.bjc.6601406"
"10892638","American Urological Association issues guidelines on the management of bladder cancer","Morey SS.","Am Fam Physician. 2000 Jun 15;61(12):3734, 3736.","Morey SS","Am Fam Physician","2000","2000/07/13","","",""
"31239237","Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?","Rouprêt M, Malmstrom PU, Black P.","Eur Urol Oncol. 2019 Nov;2(6):723-729. doi: 10.1016/j.euo.2019.06.003. Epub 2019 Jun 22.","Rouprêt M","Eur Urol Oncol","2019","2019/06/27","","","10.1016/j.euo.2019.06.003"
"2618903","[Occupation and tobacco as risk factors in urinary bladder cancer]","Nishio Y, Miyakawa M, Yoshida O.","Hinyokika Kiyo. 1989 Dec;35(12):2041-8.","Nishio Y","Hinyokika Kiyo","1989","1989/12/01","","",""
"21606973","Bladder cancer: improvements in clinical staging of muscle-invasive bladder cancer","Resnick MJ, Guzzo TJ.","Nat Rev Urol. 2011 May 24;8(7):360-1. doi: 10.1038/nrurol.2011.69.","Resnick MJ","Nat Rev Urol","2011","2011/05/25","","","10.1038/nrurol.2011.69"
"12898034","[Non-invasive urinary diagnosis of bladder cancer. What do we know?]","Kausch I, Böhle A.","Urologe A. 2003 Jul;42(7):912-21. doi: 10.1007/s00120-003-0307-6. Epub 2003 Apr 11.","Kausch I","Urologe A","2003","2003/08/05","","","10.1007/s00120-003-0307-6"
"30285760","Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer","Ansari AA, Park I, Kim I, Park S, Ahn SM, Lee JL.","BMC Med Genomics. 2018 Oct 3;11(1):88. doi: 10.1186/s12920-018-0406-2.","Ansari AA","BMC Med Genomics","2018","2018/10/05","PMC6171176","","10.1186/s12920-018-0406-2"
"30197325","Assessment of microsatellite instability for screening bladder cancer in high-risk population","Wadhwa N, Mathew BB, Tandon S, Biju VG, Tiwari A.","J Cancer Res Ther. 2018 Jul-Sep;14(5):916-920. doi: 10.4103/jcrt.JCRT_346_13.","Wadhwa N","J Cancer Res Ther","2018","2018/09/11","","","10.4103/jcrt.JCRT_346_13"
"26759009","Poly(I:C) potentiates Bacillus Calmette-Guérin immunotherapy for bladder cancer","Ayari C, Besançon M, Bergeron A, LaRue H, Bussières V, Fradet Y.","Cancer Immunol Immunother. 2016 Feb;65(2):223-34. doi: 10.1007/s00262-015-1789-y. Epub 2016 Jan 12.","Ayari C","Cancer Immunol Immunother","2016","2016/01/14","","","10.1007/s00262-015-1789-y"
"19913827","Perioperative intravesical therapy after transurethral resection for bladder cancer","Kamat AM, Lotan YR.","J Urol. 2010 Jan;183(1):19-20. doi: 10.1016/j.juro.2009.10.058.","Kamat AM","J Urol","2010","2009/11/17","","","10.1016/j.juro.2009.10.058"
"15271318","The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer","Sanderson KM, Stein JP, Skinner DG.","Urol Oncol. 2004 May-Jun;22(3):205-11; discussion 212-3. doi: 10.1016/j.urolonc.2004.04.030.","Sanderson KM","Urol Oncol","2004","2004/07/24","","","10.1016/j.urolonc.2004.04.030"
"30324833","Trimodal therapy for muscle-invasive bladder cancer","Mathes J, Rausch S, Todenhöfer T, Stenzl A.","Expert Rev Anticancer Ther. 2018 Dec;18(12):1219-1229. doi: 10.1080/14737140.2018.1535314. Epub 2018 Oct 17.","Mathes J","Expert Rev Anticancer Ther","2018","2018/10/17","","","10.1080/14737140.2018.1535314"
"20414956","Errors and difficulties in the diagnosis of bladder cancer in the 19th century: about an uncommon case reported by Professor Claude-François Lallemand (1790-1854)","Karamanou M, Tsoukalas G, Papandreou X, Androutsos G.","J BUON. 2010 Jan-Mar;15(1):196-200.","Karamanou M","J BUON","2010","2010/04/24","","",""
"23564765","In vitro and in vivo experimental models as tools to investigate the efficacy of antineoplastic drugs on urinary bladder cancer","Arantes-Rodrigues R, Colaço A, Pinto-Leite R, Oliveira PA.","Anticancer Res. 2013 Apr;33(4):1273-96.","Arantes-Rodrigues R","Anticancer Res","2013","2013/04/09","","",""
"11410772","Radical cystectomy for invasive bladder cancer in the octogenarian","Lance RS, Dinney CP, Swanson D, Babaian RJ, Pisters LL, Palmer LJ, Grossman HB.","Oncol Rep. 2001 Jul-Aug;8(4):723-6. doi: 10.3892/or.8.4.723.","Lance RS","Oncol Rep","2001","2001/06/19","","","10.3892/or.8.4.723"
"16903933","Can the levels of nitric oxide in the urine, serum and tumor tissue be putative markers for bladder cancer?","Kiliç S, Bayraktar N, Beytur A, Ergin H, Bayraktar M, Egri M.","Int J Urol. 2006 Aug;13(8):1079-85. doi: 10.1111/j.1442-2042.2006.01481.x.","Kiliç S","Int J Urol","2006","2006/08/15","","","10.1111/j.1442-2042.2006.01481.x"
"2074500","Current understanding of pathology of bladder cancer and attendant problems","Mostofi FK, Davis CJ Jr, Sesterhenn IA.","J Occup Med. 1990 Sep;32(9):793-6. doi: 10.1097/00043764-199009000-00008.","Mostofi FK","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00008"
"5622363","[Kinetic criteria on the effectiveness of treatment of bladder cancer in humans]","Emanuél' NM, Barsel' VA, Bulaevskiĭ LN, Evseenko LS.","Dokl Akad Nauk SSSR. 1967 Feb 1;172(4):988-91.","Emanuél' NM","Dokl Akad Nauk SSSR","1967","1967/02/01","","",""
"2316479","Intraoperative and external beam radiotherapy in invasive bladder cancer: pathological findings following cystectomy","Calvo FA, Henriquez I, Santos M, Abuchaibe O, Ortiz de Urbina D, Pardo J, Valerdiz S, Zudaire J, Berián JM.","Am J Clin Oncol. 1990 Apr;13(2):101-6. doi: 10.1097/00000421-199004000-00003.","Calvo FA","Am J Clin Oncol","1990","1990/04/01","","","10.1097/00000421-199004000-00003"
"16807440","Adjuvant chemotherapy of bladder cancer","Boccardo F, Palmeri L.","Ann Oncol. 2006 May;17 Suppl 5:v129-32. doi: 10.1093/annonc/mdj967.","Boccardo F","Ann Oncol","2006","2006/06/30","","","10.1093/annonc/mdj967"
"31164019","Should chemotherapy still be used to treat all muscle invasive bladder cancer in the ""era of immunotherapy""?","Duplisea JJ, Dinney CPN.","Expert Rev Anticancer Ther. 2019 Jul;19(7):543-545. doi: 10.1080/14737140.2019.1625773. Epub 2019 Jun 5.","Duplisea JJ","Expert Rev Anticancer Ther","2019","2019/06/06","","","10.1080/14737140.2019.1625773"
"8709343","Use of an anti-ras ribozyme to alter the malignant phenotype of a human bladder cancer cell line","Eastham JA, Ahlering TE.","J Urol. 1996 Sep;156(3):1186-8.","Eastham JA","J Urol","1996","1996/09/01","","",""
"7405763","Screening tests for the detection of bladder cancer","Betkerur V, Hliang V, Baumgartner G, Rao R, Ablin RJ, Guinan PD.","Allergol Immunopathol (Madr). 1980 May-Jun;8(3):169-76.","Betkerur V","Allergol Immunopathol (Madr)","1980","1980/05/01","","",""
"11225005","Chemoprevention of superficial bladder cancer","Lieberman R.","Cancer Treat Res. 2001;106:237-54. doi: 10.1007/978-1-4615-1657-6_10.","Lieberman R","Cancer Treat Res","2001","2001/02/28","","","10.1007/978-1-4615-1657-6_10"
"14733998","Surgical management of infiltrating bladder cancer in elderly patients","Peyromaure M, Guerin F, Debre B, Zerbib M.","Eur Urol. 2004 Feb;45(2):147-53; discussion 154. doi: 10.1016/j.eururo.2003.08.017.","Peyromaure M","Eur Urol","2004","2004/01/22","","","10.1016/j.eururo.2003.08.017"
"29501732","The role of STAG2 in bladder cancer","Aquila L, Ohm J, Woloszynska-Read A.","Pharmacol Res. 2018 May;131:143-149. doi: 10.1016/j.phrs.2018.02.025. Epub 2018 Mar 1.","Aquila L","Pharmacol Res","2018","2018/03/05","","","10.1016/j.phrs.2018.02.025"
"11561986","Adjuvant chemotherapy for muscle-invasive bladder cancer","Sun W, Vaughn DJ.","Semin Urol Oncol. 2001 Aug;19(3):186-93.","Sun W","Semin Urol Oncol","2001","2001/09/20","","",""
"12512976","Surgery or radiotherapy for bladder cancer?","Duchesne G.","Clin Oncol (R Coll Radiol). 2002 Dec;14(6):519-20. doi: 10.1053/clon.2002.0168.","Duchesne G","Clin Oncol (R Coll Radiol)","2002","2003/01/07","","","10.1053/clon.2002.0168"
"28528857","Rare Occurrence of Giant Metastatic Inguinal Lymph Nodes in Carcinoma Bladder","Aeron R, Kumar M, Goel S, Sokhal AK.","Urology. 2017 Aug;106:e13-e14. doi: 10.1016/j.urology.2017.05.017. Epub 2017 May 18.","Aeron R","Urology","2017","2017/05/23","","","10.1016/j.urology.2017.05.017"
"27322140","Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer","Kashiwagi E, Ide H, Inoue S, Kawahara T, Zheng Y, Reis LO, Baras AS, Miyamoto H.","Oncotarget. 2016 Aug 2;7(31):49169-49179. doi: 10.18632/oncotarget.9994.","Kashiwagi E","Oncotarget","2016","2016/06/21","PMC5226499","","10.18632/oncotarget.9994"
"20817286","Adaptive radiotherapy for bladder cancer reduces integral dose despite daily volumetric imaging","Kron T, Wong J, Rolfo A, Pham D, Cramb J, Foroudi F.","Radiother Oncol. 2010 Dec;97(3):485-7. doi: 10.1016/j.radonc.2010.07.023.","Kron T","Radiother Oncol","2010","2010/09/07","","","10.1016/j.radonc.2010.07.023"
"8233286","Prophylaxis of superficial bladder cancer with a modified intravesical epirubicin treatment schedule","Melekos MD.","Oncology. 1993 Nov-Dec;50(6):450-5. doi: 10.1159/000227228.","Melekos MD","Oncology","1993","1993/11/01","","","10.1159/000227228"
"14532772","Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program","Konety BR, Joslyn SA.","J Urol. 2003 Nov;170(5):1765-71. doi: 10.1097/01.ju.0000091620.86778.2e.","Konety BR","J Urol","2003","2003/10/09","","","10.1097/01.ju.0000091620.86778.2e"
"9751338","Predictive value of p53 and pRb immunostaining in locally advanced bladder cancer treated with cystectomy","Jahnson S, Karlsson MG.","J Urol. 1998 Oct;160(4):1291-6.","Jahnson S","J Urol","1998","1998/09/29","","",""
"15324694","Focus on bladder cancer","Dinney CP, McConkey DJ, Millikan RE, Wu X, Bar-Eli M, Adam L, Kamat AM, Siefker-Radtke AO, Tuziak T, Sabichi AL, Grossman HB, Benedict WF, Czerniak B.","Cancer Cell. 2004 Aug;6(2):111-6. doi: 10.1016/j.ccr.2004.08.002.","Dinney CP","Cancer Cell","2004","2004/08/25","","","10.1016/j.ccr.2004.08.002"
"28739768","Preoperative High Neutrophil-to-Lymphocyte Ratio Is Associated with High-grade Bladder Cancer","Tang X, Wang S, An C, Du P, Yang Y.","Anticancer Res. 2017 Aug;37(8):4659-4663. doi: 10.21873/anticanres.11869.","Tang X","Anticancer Res","2017","2017/07/26","","","10.21873/anticanres.11869"
"22502656","Apoptin induces apoptosis in human bladder cancer EJ and BIU-87 cells","Zhan H, Wang JS, Wang HF, Zuo YG, Wang CH, Ding MX.","Asian Pac J Cancer Prev. 2012;13(1):135-8. doi: 10.7314/apjcp.2012.13.1.135.","Zhan H","Asian Pac J Cancer Prev","2012","2012/04/17","","","10.7314/apjcp.2012.13.1.135"
"29896971","Circulating miRNAs in blood and urine as diagnostic and prognostic biomarkers for bladder cancer: an update in 2017","Tölle A, Blobel CC, Jung K.","Biomark Med. 2018 Jun;12(6):667-676. doi: 10.2217/bmm-2017-0392. Epub 2018 Jun 13.","Tölle A","Biomark Med","2018","2018/06/14","","","10.2217/bmm-2017-0392"
"26153639","A precision, personalized approach to the management of bladder cancer","Apolo AB, Burger M.","Curr Opin Urol. 2015 Sep;25(5):416-7. doi: 10.1097/MOU.0000000000000195.","Apolo AB","Curr Opin Urol","2015","2015/07/09","PMC6777553","NIHMS1038700","10.1097/MOU.0000000000000195"
"23584349","Quality indicators in the management of bladder cancer","Montgomery JS, Miller DC, Weizer AZ.","J Natl Compr Canc Netw. 2013 Apr 1;11(4):492-500. doi: 10.6004/jnccn.2013.0061.","Montgomery JS","J Natl Compr Canc Netw","2013","2013/04/16","","","10.6004/jnccn.2013.0061"
"15341676","Alternatives to cytology in the management of non-muscle invasive bladder cancer","Amiel GE, Shu T, Lerner SP.","Curr Treat Options Oncol. 2004 Oct;5(5):377-89. doi: 10.1007/s11864-004-0028-0.","Amiel GE","Curr Treat Options Oncol","2004","2004/09/03","","","10.1007/s11864-004-0028-0"
"25836935","Bladder preservation strategies","Jani AB, Efstathiou JA, Shipley WU.","Hematol Oncol Clin North Am. 2015 Apr;29(2):289-300, ix. doi: 10.1016/j.hoc.2014.10.004. Epub 2014 Dec 15.","Jani AB","Hematol Oncol Clin North Am","2015","2015/04/04","","","10.1016/j.hoc.2014.10.004"
"28524002","Mirna Expression in Bladder Cancer and Their Potential Role in Clinical Practice","Blanca A, Cheng L, Montironi R, Moch H, Massari F, Fiorentino M, Raspollini MR, Scarpelli M, Lopez-Beltran A.","Curr Drug Metab. 2017 Oct 16;18(8):712-722. doi: 10.2174/1389200218666170518164507.","Blanca A","Curr Drug Metab","2017","2017/05/20","","","10.2174/1389200218666170518164507"
"7459581","The management of squamous cell carcinoma of the bladder","Jones MA, Bloom HJ, Williams G, Trott PA, Wallace DM.","Br J Urol. 1980 Dec;52(6):511-4. doi: 10.1111/j.1464-410x.1980.tb03102.x.","Jones MA","Br J Urol","1980","1980/12/01","","","10.1111/j.1464-410x.1980.tb03102.x"
"17428176","Superficial bladder cancer: part 2. Management","Josephson D, Pasin E, Stein JP.","Expert Rev Anticancer Ther. 2007 Apr;7(4):567-81. doi: 10.1586/14737140.7.4.567.","Josephson D","Expert Rev Anticancer Ther","2007","2007/04/13","","","10.1586/14737140.7.4.567"
"30223570","Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer","Koga F, Takemura K, Fukushima H.","Int J Mol Sci. 2018 Sep 15;19(9):2777. doi: 10.3390/ijms19092777.","Koga F","Int J Mol Sci","2018","2018/09/19","PMC6165010","","10.3390/ijms19092777"
"25443266","The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer","Furberg H, Schoenberg M.","Urol Oncol. 2015 Jan;33(1):49. doi: 10.1016/j.urolonc.2014.09.011. Epub 2014 Nov 6.","Furberg H","Urol Oncol","2015","2014/12/03","","","10.1016/j.urolonc.2014.09.011"
"18815915","Coffee and alcohol consumption and bladder cancer","Pelucchi C, Tavani A, La Vecchia C.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):37-44. doi: 10.1080/03008880802237090.","Pelucchi C","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802237090"
"24773914","Vitamin A and risk of bladder cancer: a meta-analysis of epidemiological studies","Tang JE, Wang RJ, Zhong H, Yu B, Chen Y.","World J Surg Oncol. 2014 Apr 29;12:130. doi: 10.1186/1477-7819-12-130.","Tang JE","World J Surg Oncol","2014","2014/04/30","PMC4030017","","10.1186/1477-7819-12-130"
"20955163","Bladder cancer stem cells","Tran MN, Goodwin Jinesh G, McConkey DJ, Kamat AM.","Curr Stem Cell Res Ther. 2010 Dec;5(4):387-95. doi: 10.2174/157488810793351640.","Tran MN","Curr Stem Cell Res Ther","2010","2010/10/20","","","10.2174/157488810793351640"
"11937249","Distressful symptoms after radical radiotherapy for urinary bladder cancer","Henningsohn L, Wijkström H, Dickman PW, Bergmark K, Steineck G.","Radiother Oncol. 2002 Feb;62(2):215-25. doi: 10.1016/s0167-8140(01)00455-8.","Henningsohn L","Radiother Oncol","2002","2002/04/09","","","10.1016/s0167-8140(01)00455-8"
"16649517","[Determination of P53 in infiltrative primary bladder tumors as a prognostic factor for understaging]","Musquera Felip M, Palou Redorta J, Moscatiello P, Huguet Pérez J, Rodríguez Faba O, Ribal Caparrós MJ, Algaba Arrea F, Villavicencio Mavrich H.","Arch Esp Urol. 2006 Mar;59(2):125-31. doi: 10.4321/s0004-06142006000200002.","Musquera Felip M","Arch Esp Urol","2006","2006/05/03","","","10.4321/s0004-06142006000200002"
"6445219","Bladder cancer as a prescribed industrial disease: a guide for clinicians","Somerville SM, Davies JM, Hendry WF, Williams G.","Br Med J. 1980 Feb 23;280(6213):540-2. doi: 10.1136/bmj.280.6213.540.","Somerville SM","Br Med J","1980","1980/02/23","PMC1601438","","10.1136/bmj.280.6213.540"
"19604712","The feasibility of computational modelling technique to detect the bladder cancer","Keshtkar A, Mesbahi A, Rasta SH, Keshtkar A.","Phys Med. 2010 Jan;26(1):34-7. doi: 10.1016/j.ejmp.2009.06.001. Epub 2009 Jul 14.","Keshtkar A","Phys Med","2010","2009/07/17","","","10.1016/j.ejmp.2009.06.001"
"14680314","Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer","Bochner BH, Montie JE, Lee CT.","Urol Clin North Am. 2003 Nov;30(4):777-89. doi: 10.1016/s0094-0143(03)00061-2.","Bochner BH","Urol Clin North Am","2003","2003/12/19","","","10.1016/s0094-0143(03)00061-2"
"19068691","[Use of diffusion-weighted MRI in monitoring response of lymph node metastatic bladder cancer treated with chemotherary]","Nakayama T, Yoshida S, Fujii Y, Koga F, Saito K, Masuda H, Kobayashi T, Kawakami S, Kihara K.","Nihon Hinyokika Gakkai Zasshi. 2008 Nov;99(7):737-41. doi: 10.5980/jpnjurol1989.99.737.","Nakayama T","Nihon Hinyokika Gakkai Zasshi","2008","2008/12/17","","","10.5980/jpnjurol1989.99.737"
"2508190","Effect of misonidazole in preoperative irradiation for bladder cancer followed by total cystectomy","Ono K, Akuta K, Takahashi M, Abe M, Nishio Y, Okada K, Yoshida O.","Radiat Med. 1989 Mar-Apr;7(2):105-9.","Ono K","Radiat Med","1989","1989/03/01","","",""
"25638160","Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1","Kawahara T, Kashiwagi E, Ide H, Li Y, Zheng Y, Miyamoto Y, Netto GJ, Ishiguro H, Miyamoto H.","Oncotarget. 2015 Jan 30;6(3):1582-93. doi: 10.18632/oncotarget.2750.","Kawahara T","Oncotarget","2015","2015/02/02","PMC4359316","","10.18632/oncotarget.2750"
"6741300","[Staging of metastasized bladder cancer using parietocystotomography]","Hofmann W, Muth EP, Kluge R, Forth HJ.","Z Urol Nephrol. 1984 Apr;77(4):201-6.","Hofmann W","Z Urol Nephrol","1984","1984/04/01","","",""
"20870921","Bladder Cancer Working Group report","Kakehi Y, Hirao Y, Kim WJ, Ozono S, Masumori N, Miyanaga N, Nasu Y, Yokomizo A.","Jpn J Clin Oncol. 2010 Sep;40 Suppl 1:i57-64. doi: 10.1093/jjco/hyq128.","Kakehi Y","Jpn J Clin Oncol","2010","2010/09/28","","","10.1093/jjco/hyq128"
"22691896","Diagnosis and treatment of bladder cancer: how can we improve?","Gorin MA, Ayyathurai R, Soloway MS.","Postgrad Med. 2012 May;124(3):28-36. doi: 10.3810/pgm.2012.05.2545.","Gorin MA","Postgrad Med","2012","2012/06/14","","","10.3810/pgm.2012.05.2545"
"26907529","Origins of Bladder Cancer","Czerniak B, Dinney C, McConkey D.","Annu Rev Pathol. 2016 May 23;11:149-74. doi: 10.1146/annurev-pathol-012513-104703. Epub 2016 Feb 22.","Czerniak B","Annu Rev Pathol","2016","2016/02/25","","","10.1146/annurev-pathol-012513-104703"
"2096778","Systemic chemotherapy in the management of advanced bladder cancer","Hall RR.","Arch Esp Urol. 1990;43 Suppl 2:193-6.","Hall RR","Arch Esp Urol","1990","1990/01/01","","",""
"30197371","Nasopharyngeal carcinoma with unusual metastasis to urinary bladder","Seth N, Gandhi JS, Pasricha S, Mehta A.","J Cancer Res Ther. 2018 Jul-Sep;14(5):1160-1161. doi: 10.4103/0973-1482.204844.","Seth N","J Cancer Res Ther","2018","2018/09/11","","","10.4103/0973-1482.204844"
"21567105","Suppression of bladder cancer cell tumorigenicity in an athymic mouse model by adenoviral vector-mediated transfer of LRIG1","Li F, Ye ZQ, Guo DS, Yang WM.","Oncol Rep. 2011 Aug;26(2):439-46. doi: 10.3892/or.2011.1304. Epub 2011 May 10.","Li F","Oncol Rep","2011","2011/05/14","","","10.3892/or.2011.1304"
"18383883","DNA image cytometry in bladder cancer: state of the art","Palmeira CA, Oliveira PA, Seixas F, Pires MA, Lopes C, Santos L.","Anticancer Res. 2008 Jan-Feb;28(1B):443-50.","Palmeira CA","Anticancer Res","2008","2008/04/04","","",""
"12771703","Improving and predicting radiosensitivity in muscle invasive bladder cancer","Colquhoun AJ, Jones GD, Moneef MA, Bowman KJ, Kockelbergh RC, Symonds RP, Steward WP, Mellon JK.","J Urol. 2003 Jun;169(6):1983-92. doi: 10.1097/01.ju.0000067941.12011.40.","Colquhoun AJ","J Urol","2003","2003/05/29","","","10.1097/01.ju.0000067941.12011.40"
"2238296","Management of superficial G2 (pTa and pT1) bladder cancer","Thorpe AC, Jenkins BJ, Martin JE.","Urology. 1990 Nov;36(5):395-7. doi: 10.1016/s0090-4295(90)80282-r.","Thorpe AC","Urology","1990","1990/11/01","","","10.1016/s0090-4295(90)80282-r"
"20407954","Proteomic assays for the detection of urothelial cancer","Gaston KE, Grossman HB.","Methods Mol Biol. 2010;641:303-23. doi: 10.1007/978-1-60761-711-2_17.","Gaston KE","Methods Mol Biol","2010","2010/04/22","","","10.1007/978-1-60761-711-2_17"
"21554107","Intravesical interleukin-15 gene therapy in an orthotopic bladder cancer model","Matsumoto K, Kikuchi E, Horinaga M, Takeda T, Miyajima A, Nakagawa K, Oya M.","Hum Gene Ther. 2011 Nov;22(11):1423-32. doi: 10.1089/hum.2011.013. Epub 2011 Jul 8.","Matsumoto K","Hum Gene Ther","2011","2011/05/11","","","10.1089/hum.2011.013"
"15582259","Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer","Eisenhardt A, Frey U, Tack M, Rosskopf D, Lümmen G, Rübben H, Siffert W.","Eur Urol. 2005 Jan;47(1):111-7. doi: 10.1016/j.eururo.2004.10.001.","Eisenhardt A","Eur Urol","2005","2004/12/08","","","10.1016/j.eururo.2004.10.001"
"1441025","Treatment of regionally advanced bladder cancer. An overview","Droller MJ.","Urol Clin North Am. 1992 Nov;19(4):685-93.","Droller MJ","Urol Clin North Am","1992","1992/11/01","","",""
"21677502","[A case of marked efficacy of low-dose UFT against metastatic bladder cancer]","Satoh M, Nakano O, Kuwahara M, Ito A, Arai Y.","Gan To Kagaku Ryoho. 2011 Jun;38(6):1029-33.","Satoh M","Gan To Kagaku Ryoho","2011","2011/06/17","","",""
"12553531","Advances in gene therapy for bladder cancer","Irie A.","Curr Gene Ther. 2003 Feb;3(1):1-11. doi: 10.2174/1566523033347499.","Irie A","Curr Gene Ther","2003","2003/01/30","","","10.2174/1566523033347499"
"7200654","[Results of chemoimmune prophylaxis of superficial bladder carcinoma (author's transl)]","Adolphs HD, Helpap B.","Urologe A. 1982 Jan;21(1):29-33.","Adolphs HD","Urologe A","1982","1982/01/01","","",""
"26757905","Role of Sonic Hedgehog (Shh) Signaling in Bladder Cancer Stemness and Tumorigenesis","Syed IS, Pedram A, Farhat WA.","Curr Urol Rep. 2016 Feb;17(2):11. doi: 10.1007/s11934-015-0568-9.","Syed IS","Curr Urol Rep","2016","2016/01/14","","","10.1007/s11934-015-0568-9"
"16697865","Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer","Moussa O, Abol-Enein H, Bissada NK, Keane T, Ghoneim MA, Watson DK.","J Urol. 2006 Jun;175(6):2312-6. doi: 10.1016/S0022-5347(06)00254-0.","Moussa O","J Urol","2006","2006/05/16","","","10.1016/S0022-5347(06)00254-0"
"12029884","Management of bladder cancer: a nursing view","Roodhouse A.","Prof Nurse. 2000 Dec;16(3):987-90.","Roodhouse A","Prof Nurse","2000","2002/05/28","","",""
"534838","Cystectomy for carcinoma of the bilharzial bladder: 138 cases 5 years later","Ghoneim MA, Ashamallah AG, El-Hammady S, Gaballah MA, Soliman el-SH.","Br J Urol. 1979 Dec;51(6):541-4. doi: 10.1111/j.1464-410x.1979.tb03597.x.","Ghoneim MA","Br J Urol","1979","1979/12/01","","","10.1111/j.1464-410x.1979.tb03597.x"
"9933788","Vascular endothelial growth factor: an important angiogenic mediator in bladder cancer","Crew JP.","Eur Urol. 1999 Jan;35(1):2-8. doi: 10.1159/000019811.","Crew JP","Eur Urol","1999","1999/02/06","","","10.1159/000019811"
"17085207","Re: Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. C. T. Lee, R. Madii, S. Daignault, R. L. Dunn, Y. Zhang, J. E. Montie and D. P. Wood, Jr., J Urol, 175: 1262-1267, 2006","Horan AH.","J Urol. 2006 Dec;176(6 Pt 1):2744. doi: 10.1016/j.juro.2006.08.028.","Horan AH","J Urol","2006","2006/11/07","","","10.1016/j.juro.2006.08.028"
"28451912","A conceptual framework for patient-reported outcomes in non-muscle invasive bladder cancer","Rutherford C, Costa DSJ, King MT, Smith DP, Patel MI.","Support Care Cancer. 2017 Oct;25(10):3095-3102. doi: 10.1007/s00520-017-3717-5. Epub 2017 Apr 27.","Rutherford C","Support Care Cancer","2017","2017/04/29","","","10.1007/s00520-017-3717-5"
"15749550","Staging bladder carcinoma by three-dimensional ultrasound rendering","Wagner B, Nesslauer T, Bartsch G Jr, Hautmann RE, Gottfried HW.","Ultrasound Med Biol. 2005 Mar;31(3):301-5. doi: 10.1016/j.ultrasmedbio.2004.12.017.","Wagner B","Ultrasound Med Biol","2005","2005/03/08","","","10.1016/j.ultrasmedbio.2004.12.017"
"30157039","Diagnostic, prognostic and surveillance urinary markers in nonmuscle invasive bladder cancer: any role in clinical practice?","Soria F, D'Andrea D, Pohar K, Shariat SF, Lotan Y.","Curr Opin Urol. 2018 Nov;28(6):577-583. doi: 10.1097/MOU.0000000000000545.","Soria F","Curr Opin Urol","2018","2018/08/30","","","10.1097/MOU.0000000000000545"
"4966203","[Discussion: the results of treatment of bladder cancer]","","J Urol Nephrol (Paris). 1966 Dec;72(12):Suppl:229-348.","","J Urol Nephrol (Paris)","1966","1966/12/01","","",""
"9915424","Pelvic lymph node dissection can be curative in patients with node positive bladder cancer","Vieweg J, Gschwend JE, Herr HW, Fair WR.","J Urol. 1999 Feb;161(2):449-54.","Vieweg J","J Urol","1999","1999/01/23","","",""
"369084","Immunoperoxidase staining of carcinoembryonic antigen in urinary bladder cancer","Goldenberg DM, Wahren B.","Urol Res. 1978;6(4):211-4. doi: 10.1007/BF00262620.","Goldenberg DM","Urol Res","1978","1978/01/01","","","10.1007/BF00262620"
"9123661","[The surgical results in malignant bladder tumors using the Scalpel-1 carbon-dioxide laser]","Dmitriev BV, Nikol'skiĭ AD, Latyshev MM, Zolin VP, Sanevich RA.","Urol Nefrol (Mosk). 1997 Jan-Feb;(1):25-8.","Dmitriev BV","Urol Nefrol (Mosk)","1997","1997/01/01","","",""
"23770147","The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer","Eisenberg MS, Boorjian SA, Cheville JC, Thompson RH, Thapa P, Kaushik D, Frank I.","J Urol. 2013 Dec;190(6):2005-10. doi: 10.1016/j.juro.2013.06.022. Epub 2013 Jun 14.","Eisenberg MS","J Urol","2013","2013/06/18","","","10.1016/j.juro.2013.06.022"
"26556269","[YB-1-based virotherapy: A new therapeutic intervention for transitional cell carcinoma of the bladder?]","Holm PS, Retz M, Gschwend JE, Nawroth R.","Urologe A. 2016 Mar;55(3):356-63. doi: 10.1007/s00120-015-3811-6.","Holm PS","Urologe A","2016","2015/11/12","","","10.1007/s00120-015-3811-6"
"19090014","Sex and race in bladder cancer: what we have learned and future directions","Katz MH, Steinberg GD.","Cancer. 2009 Jan 1;115(1):10-2. doi: 10.1002/cncr.23997.","Katz MH","Cancer","2009","2008/12/18","","","10.1002/cncr.23997"
"2294257","Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder","Swanson DA, Liles A, Zagars GK.","J Urol. 1990 Jan;143(1):37-40. doi: 10.1016/s0022-5347(17)39857-9.","Swanson DA","J Urol","1990","1990/01/01","","","10.1016/s0022-5347(17)39857-9"
"6637998","Bladder cancer and alcoholic beverage consumption","Thomas DB, Uhl CN, Hartge P.","Am J Epidemiol. 1983 Nov;118(5):720-7. doi: 10.1093/oxfordjournals.aje.a113682.","Thomas DB","Am J Epidemiol","1983","1983/11/01","","","10.1093/oxfordjournals.aje.a113682"
"28500617","Post-chemotherapy PD-L1 expression correlates with clinical outcomes in Japanese bladder cancer patients treated with total cystectomy","Noro D, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Kawaguchi T, Ohyama C.","Med Oncol. 2017 Jun;34(6):117. doi: 10.1007/s12032-017-0977-3. Epub 2017 May 12.","Noro D","Med Oncol","2017","2017/05/14","","","10.1007/s12032-017-0977-3"
"30167832","Immunotherapy for bladder cancer: the fight is on","Rouprêt M.","World J Urol. 2018 Nov;36(11):1699-1701. doi: 10.1007/s00345-018-2468-3.","Rouprêt M","World J Urol","2018","2018/09/01","","","10.1007/s00345-018-2468-3"
"16568255","[Bladder cancer--what's new]","Gschwend J.","Urologe A. 2006 Apr;45(4):496-8. doi: 10.1007/s00120-006-1040-8.","Gschwend J","Urologe A","2006","2006/03/29","","","10.1007/s00120-006-1040-8"
"7510013","Experimental antiangiogenesis therapy using cortisone acetate in murine bladder cancer: independence from ""tumor volume effect""","Lee K, Iwamura M, Sluss PM.","Microvasc Res. 1993 Nov;46(3):406-11. doi: 10.1006/mvre.1993.1064.","Lee K","Microvasc Res","1993","1993/11/01","","","10.1006/mvre.1993.1064"
"12036406","Pharmacotherapy of bladder cancer--practice and prospects","Nawrocki S, Skacel T, Skoneczna I.","Expert Opin Pharmacother. 2002 Jun;3(6):671-9. doi: 10.1517/14656566.3.6.671.","Nawrocki S","Expert Opin Pharmacother","2002","2002/05/31","","","10.1517/14656566.3.6.671"
"25482022","How I treat bladder cancer in elderly patients","Galsky MD.","J Geriatr Oncol. 2015 Jan;6(1):1-7. doi: 10.1016/j.jgo.2014.11.006. Epub 2014 Dec 4.","Galsky MD","J Geriatr Oncol","2015","2014/12/09","","","10.1016/j.jgo.2014.11.006"
"7084156","The carcinogenic effect of aromatic amines: an epidemiological study on the role of o-toluidine and 4,4'-methylene bis (2-methylaniline) in inducing bladder cancer in man","Rubino GF, Scansetti G, Piolatto G, Pira E.","Environ Res. 1982 Apr;27(2):241-54. doi: 10.1016/0013-9351(82)90079-2.","Rubino GF","Environ Res","1982","1982/04/01","","","10.1016/0013-9351(82)90079-2"
"808781","Chemoprophylaxis of bladder cancer recurrence: immunological aspects","Corrado F, Lalanne G, Pizza GC.","Panminerva Med. 1975 Jul-Aug;17(7-8):253-8.","Corrado F","Panminerva Med","1975","1975/07/01","","",""
"19635641","The search for the etiology of bladder cancer: are achievements sufficient?","Babjuk M.","Eur Urol. 2009 Nov;56(5):771-2; discussion 773-4. doi: 10.1016/j.eururo.2009.07.014. Epub 2009 Jul 22.","Babjuk M","Eur Urol","2009","2009/07/29","","","10.1016/j.eururo.2009.07.014"
"7750524","Advances in the treatment of superficial bladder cancer: optimizing BCG immunotherapy. Introduction","Lamm DL.","Eur Urol. 1995;27 Suppl 1:1.","Lamm DL","Eur Urol","1995","1995/01/01","","",""
"17760744","Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes","Nagao K, Itoh Y, Fujita K, Fujime M.","Int J Urol. 2007 Sep;14(9):795-9. doi: 10.1111/j.1442-2042.2007.01840.x.","Nagao K","Int J Urol","2007","2007/09/01","","","10.1111/j.1442-2042.2007.01840.x"
"22529264","Impact of a bladder cancer diagnosis on smoking behavior","Bassett JC, Gore JL, Chi AC, Kwan L, McCarthy W, Chamie K, Saigal CS.","J Clin Oncol. 2012 May 20;30(15):1871-8. doi: 10.1200/JCO.2011.36.6518. Epub 2012 Apr 23.","Bassett JC","J Clin Oncol","2012","2012/04/25","","","10.1200/JCO.2011.36.6518"
"6542269","[Value of exfoliative cytology of the urinary bladder in occult bladder cancer and in the control of treated cancers]","Schmitz A, Meyer U, Kierfeld G, Küchemann K.","Urologe A. 1984 Sep;23(5):278-80.","Schmitz A","Urologe A","1984","1984/09/01","","",""
"24240836","Risk of bladder cancer in patients with spina bifida: case reports and review of the literature","Mirkin K, Casey JT, Mukherjee S, Kielb SJ.","J Pediatr Rehabil Med. 2013;6(3):155-62. doi: 10.3233/PRM-130254.","Mirkin K","J Pediatr Rehabil Med","2013","2013/11/19","","","10.3233/PRM-130254"
"6410347","Current topics in the pathology of bladder cancer","Murphy WM.","Pathol Annu. 1983;18 Pt 1:1-25.","Murphy WM","Pathol Annu","1983","1983/01/01","","",""
"18242381","Economic impact of tumor markers in bladder cancer surveillance","Hong YM, Loughlin KR.","Urology. 2008 Jan;71(1):131-5. doi: 10.1016/j.urology.2007.08.014.","Hong YM","Urology","2008","2008/02/05","","","10.1016/j.urology.2007.08.014"
"7471631","Bipedal lymphography in the management of bladder cancer","Rodger A, Wild SR, Duncan W.","Clin Radiol. 1980 Sep;31(5):555-8. doi: 10.1016/s0009-9260(80)80050-x.","Rodger A","Clin Radiol","1980","1980/09/01","","","10.1016/s0009-9260(80)80050-x"
"9797129","Allelic loss on chromosome 9 in bladder cancer tissues and urine samples detected by blunt-end single-strand DNA conformation polymorphism","Shigyo M, Sugano K, Fukayama N, Taniguchi T, Tobisu K, Fujimoto H, Doi N, Niwakawa M, Shimamura K, Tsukamoto T, Sekiya T, Kakizoe T.","Int J Cancer. 1998 Nov 9;78(4):425-9. doi: 10.1002/(sici)1097-0215(19981109)78:4<425::aid-ijc6>3.0.co;2-w.","Shigyo M","Int J Cancer","1998","1998/10/31","","","10.1002/(sici)1097-0215(19981109)78:4<425::aid-ijc6>3.0.co;2-w"
"3113714","Intraoperative radiation therapy in patients with bladder cancer. A review of techniques allowing improved tumor doses and providing high cure rates without loss of bladder function","Shipley WU, Kaufman SD, Prout GR Jr.","Cancer. 1987 Oct 1;60(7):1485-8. doi: 10.1002/1097-0142(19871001)60:7<1485::aid-cncr2820600714>3.0.co;2-o.","Shipley WU","Cancer","1987","1987/10/01","","","10.1002/1097-0142(19871001)60:7<1485::aid-cncr2820600714>3.0.co;2-o"
"6415298","Predeposit autologous blood transfusions in patients undergoing irradiation and radical cystectomy","Swanson DA, Lo RK, Lichtiger B.","J Urol. 1983 Nov;130(5):892-4. doi: 10.1016/s0022-5347(17)51555-4.","Swanson DA","J Urol","1983","1983/11/01","","","10.1016/s0022-5347(17)51555-4"
"28741703","Intravesical bacillus Calmette-Guérin instillation in non-muscle-invasive bladder cancer: A review","Saluja M, Gilling P.","Int J Urol. 2018 Jan;25(1):18-24. doi: 10.1111/iju.13410. Epub 2017 Jul 25.","Saluja M","Int J Urol","2018","2017/07/26","","","10.1111/iju.13410"
"1271545","Abnormal monocyte function in bladder cancer patients","Hausman MS, Brosman SA.","J Urol. 1976 May;115(5):537-41. doi: 10.1016/s0022-5347(17)59271-x.","Hausman MS","J Urol","1976","1976/05/01","","","10.1016/s0022-5347(17)59271-x"
"10599440","Interferon alpha for the treatment of superficial bladder cancer","Naitoh J, Franklin J, O'Donnell MA, Belldegrun AS.","Adv Exp Med Biol. 1999;462:371-86; discussion 387-92. doi: 10.1007/978-1-4615-4737-2_29.","Naitoh J","Adv Exp Med Biol","1999","1999/12/22","","","10.1007/978-1-4615-4737-2_29"
"20451423","T1 bladder cancer: advocating early cystectomy to improve oncologic control","Montgomery JS, Weizer AZ, Montie JE.","Urol Oncol. 2010 Sep-Oct;28(5):466-8. doi: 10.1016/j.urolonc.2010.01.003. Epub 2010 May 6.","Montgomery JS","Urol Oncol","2010","2010/05/11","","","10.1016/j.urolonc.2010.01.003"
"12801061","Surgery versus radiotherapy for muscle invasive bladder cancer?","Shelley MD, Barber J, Wilt TJ, Mason MD.","Clin Oncol (R Coll Radiol). 2003 May;15(3):167-8. doi: 10.1053/clon.2003.0227.","Shelley MD","Clin Oncol (R Coll Radiol)","2003","2003/06/13","","","10.1053/clon.2003.0227"
"8015075","Intravesical therapy for bladder cancer","Soloway MS.","J Urol. 1994 Aug;152(2 Pt 1):379-81. doi: 10.1016/s0022-5347(17)32743-x.","Soloway MS","J Urol","1994","1994/08/01","","","10.1016/s0022-5347(17)32743-x"
"11842744","T1G3 bladder cancer--the case for TUR and BCG","Miller K.","Front Radiat Ther Oncol. 2002;36:147-50. doi: 10.1159/000061336.","Miller K","Front Radiat Ther Oncol","2002","2002/02/15","","","10.1159/000061336"
"20534384","[Perioperative strategies in patients with muscle invasive bladder cancer]","Pouessel D, Thariat J, Lagrange JL, Mottet N, Culine S.","Bull Cancer. 2010;97 Suppl Cancer de la vessie:5-9. doi: 10.1684/bdc.2010.1096.","Pouessel D","Bull Cancer","2010","2010/06/11","","","10.1684/bdc.2010.1096"
"16286095","Non-muscle-invasive bladder cancer: the role of radical cystectomy","Chang SS, Cookson MS.","Urology. 2005 Nov;66(5):917-22. doi: 10.1016/j.urology.2005.05.003.","Chang SS","Urology","2005","2005/11/16","","","10.1016/j.urology.2005.05.003"
"17628306","Markers of detection","Messing E.","Urol Oncol. 2007 Jul-Aug;25(4):344-7. doi: 10.1016/j.urolonc.2007.05.012.","Messing E","Urol Oncol","2007","2007/07/14","","","10.1016/j.urolonc.2007.05.012"
"7132597","[Changes in the arteries of the pelvic region following radiation and combination therapy of bladder cancer]","Tsyb AF, Drozdovskiĭ BIa, Grishin GN.","Med Radiol (Mosk). 1982 Aug;27(8):15-9.","Tsyb AF","Med Radiol (Mosk)","1982","1982/08/01","","",""
"22825460","Predictive factors for recurrence progression and cancer specific survival in high-risk bladder cancer","Rodríguez Faba O, Palou J.","Curr Opin Urol. 2012 Sep;22(5):415-20. doi: 10.1097/MOU.0b013e328356ac20.","Rodríguez Faba O","Curr Opin Urol","2012","2012/07/25","","","10.1097/MOU.0b013e328356ac20"
"2672233","Treatment alternatives for invasive bladder cancer","Wajsman Z, Klimberg IW.","Semin Surg Oncol. 1989;5(4):272-81. doi: 10.1002/ssu.2980050410.","Wajsman Z","Semin Surg Oncol","1989","1989/01/01","","","10.1002/ssu.2980050410"
"6473405","Adjuvant chemotherapy in bladder cancer","Williams G.","Prog Clin Biol Res. 1984;153:373-80.","Williams G","Prog Clin Biol Res","1984","1984/01/01","","",""
"16552241","Bladder cancer","Gwynn ES, Clark PE.","Curr Opin Oncol. 2006 May;18(3):277-83. doi: 10.1097/01.cco.0000219258.75961.1a.","Gwynn ES","Curr Opin Oncol","2006","2006/03/23","","","10.1097/01.cco.0000219258.75961.1a"
"671606","Serial multiple-site biopsies in patients with bladder cancer","Soloway MS, Murphy W, Rao MK, Cox C.","J Urol. 1978 Jul;120(1):57-9. doi: 10.1016/s0022-5347(17)57037-8.","Soloway MS","J Urol","1978","1978/07/01","","","10.1016/s0022-5347(17)57037-8"
"20382064","Virus therapy for bladder cancer","Burke J.","Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):99-102. doi: 10.1016/j.cytogfr.2010.02.003. Epub 2010 Apr 9.","Burke J","Cytokine Growth Factor Rev","2010","2010/04/13","","","10.1016/j.cytogfr.2010.02.003"
"5439124","[Selective pelvic arteriography in bladder cancer]","Bouker.","J Urol Nephrol (Paris). 1970 Jan-Feb;76(1):69-77.","Bouker","J Urol Nephrol (Paris)","1970","1970/01/01","","",""
"11912378","Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression","Holmang S, Johansson SL.","J Urol. 2002 Apr;167(4):1634-7.","Holmang S","J Urol","2002","2002/03/26","","",""
"3375982","[Follow-up of combined radiotherapy and chemotherapy of advanced bladder cancer using magnetic resonance tomography. Initial results]","Meydam K, Sehlen S, Michel W, Voigtmann R, Beyer HK.","Strahlenther Onkol. 1988 May;164(5):284-8.","Meydam K","Strahlenther Onkol","1988","1988/05/01","","",""
"1609658","[Postoperative adjuvant M-VAC chemotherapy for invasive bladder cancer]","Yamashita S, Taniguchi K, Morimitsu H, Suzu H, Kanetake H, Saito Y, Yushita Y, Sakuragi T.","Hinyokika Kiyo. 1992 May;38(5):519-24.","Yamashita S","Hinyokika Kiyo","1992","1992/05/01","","",""
"17561295","Intravesical markers for delineation of target volume during external focal irradiation of bladder carcinomas","Hulshof MC, van Andel G, Bel A, Gangel P, van de Kamer JB.","Radiother Oncol. 2007 Jul;84(1):49-51. doi: 10.1016/j.radonc.2007.05.017. Epub 2007 Jun 11.","Hulshof MC","Radiother Oncol","2007","2007/06/15","","","10.1016/j.radonc.2007.05.017"
"26349498","The Use of Biomarkers for Bladder Cancer Diagnosis and Surveillance","Grubmüller B, Roupret M, Briganti A, Shariat SF.","Mini Rev Med Chem. 2016;16(18):1444-1449. doi: 10.2174/1389557515666150909141404.","Grubmüller B","Mini Rev Med Chem","2016","2015/09/10","","","10.2174/1389557515666150909141404"
"1710884","[Usefulness of radiotherapy in the treatment of infiltrating bladder cancer]","Escudero Barrilero A.","Arch Esp Urol. 1990;43 Suppl 2:165-84.","Escudero Barrilero A","Arch Esp Urol","1990","1990/01/01","","",""
"16619518","Is aneusomy of chromosome 9 alone a valid biomarker for urinary bladder cancer screening?","Panani AD, Kozirakis D, Anastasiou J, Babanaraki A, Malovrouvas D, Roussos C.","Anticancer Res. 2006 Mar-Apr;26(2A):1161-5.","Panani AD","Anticancer Res","2006","2006/04/20","","",""
"23044645","Smoking and survival after radical cystectomy for bladder cancer","Lee C, Kim KH, You D, Jeong IG, Hong B, Hong JH, Ahn H, Kim CS.","Urology. 2012 Dec;80(6):1307-12. doi: 10.1016/j.urology.2012.08.026. Epub 2012 Oct 5.","Lee C","Urology","2012","2012/10/10","","","10.1016/j.urology.2012.08.026"
"26485857","LYMPHOEPITHELIOMA-LIKE CARCINOMA OF THE URINARY BLADDER ASSOCIATED WITH SCHISTOSOMIASIS: A CASE REPORT AND REVIEW OF LITERATURE","Mina SN, Antonios SN.","J Egypt Soc Parasitol. 2015 Aug;45(2):385-8. doi: 10.12816/0017583.","Mina SN","J Egypt Soc Parasitol","2015","2015/10/22","","","10.12816/0017583"
"20362229","Clinical usefulness of fluorescence in situ hybridization for diagnosis and surveillance of bladder cancer","Song MJ, Lee HM, Kim SH.","Cancer Genet Cytogenet. 2010 Apr 15;198(2):144-50. doi: 10.1016/j.cancergencyto.2010.01.007.","Song MJ","Cancer Genet Cytogenet","2010","2010/04/06","","","10.1016/j.cancergencyto.2010.01.007"
"1555885","The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer","Hasui Y, Marutsuka K, Suzumiya J, Kitada S, Osada Y, Sumiyoshi A.","Int J Cancer. 1992 Apr 1;50(6):871-3. doi: 10.1002/ijc.2910500607.","Hasui Y","Int J Cancer","1992","1992/04/01","","","10.1002/ijc.2910500607"
"2239591","[Stereological estimation of mean nuclear volume in bladder cancer--measurement by point sampled intercepts]","Sasaki M, Kaneko Y.","Hinyokika Kiyo. 1990 Aug;36(8):909-12; discussion 912-3.","Sasaki M","Hinyokika Kiyo","1990","1990/08/01","","",""
"26239806","miR‑485‑5p inhibits bladder cancer metastasis by targeting HMGA2","Chen Z, Li Q, Wang S, Zhang J.","Int J Mol Med. 2015 Oct;36(4):1136-42. doi: 10.3892/ijmm.2015.2302. Epub 2015 Aug 3.","Chen Z","Int J Mol Med","2015","2015/08/05","","","10.3892/ijmm.2015.2302"
"8945824","[Infiltrating cancer of the bladder. Is concomitant radiochemotherapy an alternative to cystectomy?]","Dufour B, Housset M, Chrétien Y, Méjean A, Hallez JP, Maulard-Durdux C.","Chirurgie. 1996;121(3):187-91; discussion 191-2.","Dufour B","Chirurgie","1996","1996/01/01","","",""
"17115297","The management of hydronephrosis in patients undergoing TURBT","Thiruchelvam N, Ubhayakar G, Mostafid H.","Int Urol Nephrol. 2006;38(3-4):483-6. doi: 10.1007/s11255-005-4794-9.","Thiruchelvam N","Int Urol Nephrol","2006","2006/11/23","","","10.1007/s11255-005-4794-9"
"18175124","Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform","Schiffer E, Mischak H, Theodorescu D, Vlahou A.","World J Urol. 2008 Feb;26(1):67-74. doi: 10.1007/s00345-007-0234-z. Epub 2008 Jan 4.","Schiffer E","World J Urol","2008","2008/01/05","","","10.1007/s00345-007-0234-z"
"1912834","Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment","Gulliford MC, Petruckevitch A, Burney PG.","BMJ. 1991 Aug 24;303(6800):437-40. doi: 10.1136/bmj.303.6800.437.","Gulliford MC","BMJ","1991","1991/08/24","PMC1670565","","10.1136/bmj.303.6800.437"
"10690546","Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade","Wada T, Louhelainen J, Hemminki K, Adolfsson J, Wijkström H, Norming U, Borgström E, Hansson J, Sandstedt B, Steineck G.","Clin Cancer Res. 2000 Feb;6(2):610-5.","Wada T","Clin Cancer Res","2000","2000/02/26","","",""
"8314387","Chemotherapy, radical irradiation plus salvage cystectomy for bladder cancer--severe late small bowel morbidity","Abratt RP, Pontin AR, Barnes RD.","Eur J Surg Oncol. 1993 Jun;19(3):279-82.","Abratt RP","Eur J Surg Oncol","1993","1993/06/01","","",""
"7073841","[Recurrences of bladder cancer]","Nechiporenko NA, Savkova NV.","Vrach Delo. 1982 Feb;(2):87-9.","Nechiporenko NA","Vrach Delo","1982","1982/02/01","","",""
"24133921","The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer","Eissa S, Badr S, Barakat M, Zaghloul AS, Mohanad M.","Clin Lab. 2013;59(7-8):893-900. doi: 10.7754/clin.lab.2012.120623.","Eissa S","Clin Lab","2013","2013/10/19","","","10.7754/clin.lab.2012.120623"
"10696249","The potential role of gene therapy in the treatment of bladder cancer","Hsieh JT, Dinney CP, Chung LW.","Urol Clin North Am. 2000 Feb;27(1):103-13, ix. doi: 10.1016/s0094-0143(05)70238-x.","Hsieh JT","Urol Clin North Am","2000","2000/03/04","","","10.1016/s0094-0143(05)70238-x"
"16432078","Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays","Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C.","J Clin Oncol. 2006 Feb 10;24(5):778-89. doi: 10.1200/JCO.2005.03.2375. Epub 2006 Jan 23.","Sanchez-Carbayo M","J Clin Oncol","2006","2006/01/25","","","10.1200/JCO.2005.03.2375"
"8813912","Staging with computed tomography, transrectal ultrasonography and transurethral resection of bladder tumour: comparison with final pathological stage in invasive bladder carcinoma","Yaman O, Baltaci S, Arikan N, Yilmaz E, Gögüs O.","Br J Urol. 1996 Aug;78(2):197-200. doi: 10.1046/j.1464-410x.1996.01008.x.","Yaman O","Br J Urol","1996","1996/08/01","","","10.1046/j.1464-410x.1996.01008.x"
"29211694","Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle","Fankhauser CD, Mostafid H.","Curr Opin Urol. 2018 Jan;28(1):88-92. doi: 10.1097/MOU.0000000000000452.","Fankhauser CD","Curr Opin Urol","2018","2017/12/07","","","10.1097/MOU.0000000000000452"
"17026797","Highlights from: the third International Congress on Kidney and Bladder Cancer. Orlando, FL; August 3-6, 2006","Reddy GK, Gupta M, Tyagi P.","Clin Genitourin Cancer. 2006 Sep;5(2):104-9. doi: 10.1016/s1558-7673(11)70170-7.","Reddy GK","Clin Genitourin Cancer","2006","2006/10/10","","","10.1016/s1558-7673(11)70170-7"
"8249229","Radical cystectomy for invasive squamous cell bladder cancer in a renal transplant patient","Srinivas V, Deshmukh R, Shah B, Kapadia A.","Urol Int. 1993;51(3):167-70. doi: 10.1159/000282537.","Srinivas V","Urol Int","1993","1993/01/01","","","10.1159/000282537"
"30098938","Predicting Response to Intravesical Therapy in Non-muscle-invasive Bladder Cancer","Alameddine M, Kineish O, Ritch C.","Eur Urol Focus. 2018 Jul;4(4):494-502. doi: 10.1016/j.euf.2018.07.032. Epub 2018 Aug 8.","Alameddine M","Eur Urol Focus","2018","2018/08/13","","","10.1016/j.euf.2018.07.032"
"20734878","[A complex approach to prediction of long-term results of urinary bladder cancer treatment]","Zimichev AA, Prianichnikova MB, Maklakov VN.","Urologiia. 2010 May-Jun;(3):47-9.","Zimichev AA","Urologiia","2010","2010/08/26","","",""
"17494113","The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer","Brausi MA.","Eur Urol. 2007 May;51(5):1435-6.","Brausi MA","Eur Urol","2007","2007/05/12","","",""
"3511288","Bacillus Calmette-Guerin in the management of bladder cancer","Droller MJ.","J Urol. 1986 Feb;135(2):331-3. doi: 10.1016/s0022-5347(17)45629-1.","Droller MJ","J Urol","1986","1986/02/01","","","10.1016/s0022-5347(17)45629-1"
"2078067","[Intravesical echography. II. Staging]","Passas J, Espuela R, Leiva O, Calahorra J, de la Rosa F, Borobia V.","Arch Esp Urol. 1990;43 Suppl 1:35-47.","Passas J","Arch Esp Urol","1990","1990/01/01","","",""
"31778047","[Cisplatin-based chemotherapy in muscle-invasive bladder cancer: soon outdated ?]","Bosshard P, Roth B.","Rev Med Suisse. 2019 Nov 27;15(673):2190-2194.","Bosshard P","Rev Med Suisse","2019","2019/11/29","","",""
"18184184","Solitary brain metastasis from pT1, G3 bladder cancer","Zennami K, Yamada Y, Nakamura K, Aoki S, Taki T, Honda N.","Int J Urol. 2008 Jan;15(1):96-8. doi: 10.1111/j.1442-2042.2007.01935.x.","Zennami K","Int J Urol","2008","2008/01/11","","","10.1111/j.1442-2042.2007.01935.x"
"18602465","Targeted drug delivery: binding and uptake of plant lectins using human 5637 bladder cancer cells","Plattner VE, Wagner M, Ratzinger G, Gabor F, Wirth M.","Eur J Pharm Biopharm. 2008 Oct;70(2):572-6. doi: 10.1016/j.ejpb.2008.06.004. Epub 2008 Jun 17.","Plattner VE","Eur J Pharm Biopharm","2008","2008/07/08","","","10.1016/j.ejpb.2008.06.004"
"12175422","A study comparing various non-invasive methods of detecting bladder cancer in urine","Lane T, Oliver T.","BJU Int. 2002 Sep;90(4):477. doi: 10.1046/j.1464-410x.2002.t01-8-02967.x.","Lane T","BJU Int","2002","2002/08/15","","","10.1046/j.1464-410x.2002.t01-8-02967.x"
"31277775","Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes","Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Quevedo FJ, Cheville JC, Karnes RJ.","Eur Urol Oncol. 2019 Jul;2(4):390-396. doi: 10.1016/j.euo.2018.09.004. Epub 2018 Sep 28.","Boeri L","Eur Urol Oncol","2019","2019/07/07","","","10.1016/j.euo.2018.09.004"
"28705577","Comparative Evaluation of Bladder-specific Health-related Quality of Life Instruments for Bladder Cancer","Moncrief TJ, Balaji P, Lindgren BB, Weight CJ, Konety BR.","Urology. 2017 Oct;108:76-81. doi: 10.1016/j.urology.2017.06.032. Epub 2017 Jul 10.","Moncrief TJ","Urology","2017","2017/07/15","","","10.1016/j.urology.2017.06.032"
"7817453","[Superficial bladder cancer. Open questions]","Böhle A.","Urologe A. 1994 Nov;33(6):536-9.","Böhle A","Urologe A","1994","1994/11/01","","",""
"15058048","[Photodynamic diagnosis and therapy of bladder cancer]","Dettlaff-Pokora A, Schlichtholz B.","Przegl Lek. 2003;60(11):744-7.","Dettlaff-Pokora A","Przegl Lek","2003","2004/04/03","","",""
"29158136","It's all about the perspective: Removing bias when co-managing patients with high-grade T1 bladder cancer and localized prostate cancer-A competing risks analysis","Ferguson JE 3rd, Kamat AM.","Urol Oncol. 2018 Feb;36(2):39-42. doi: 10.1016/j.urolonc.2017.10.019. Epub 2017 Nov 20.","Ferguson JE 3rd","Urol Oncol","2018","2017/11/22","","","10.1016/j.urolonc.2017.10.019"
"29912804","Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation","Zhong J, Switchenko J, Jegadeesh NK, Cassidy RJ, Gillespie TW, Master V, Nieh P, Alemozaffar M, Kucuk O, Carthon B, Filson CP, Bilen MA, Jani AB.","Am J Clin Oncol. 2019 Jan;42(1):36-41. doi: 10.1097/COC.0000000000000471.","Zhong J","Am J Clin Oncol","2019","2018/06/19","PMC6295350","NIHMS968680","10.1097/COC.0000000000000471"
"6200623","[Application of radiofrequency hyperthermia for treating advanced urinary bladder cancer--a case report]","Kubota Y, Takebayashi S, Asakura K, Oshima H.","Gan No Rinsho. 1984 Feb;30(2):215-9.","Kubota Y","Gan No Rinsho","1984","1984/02/01","","",""
"150129","[Ways to improve the early detection of bladder cancer patients (based on Grodno Province data)]","Nechiporenko AZ, Bogdanovich FA, Nechiporenko NA.","Vopr Onkol. 1978;24(6):90-4.","Nechiporenko AZ","Vopr Onkol","1978","1978/01/01","","",""
"20844861","[Diagnostic procedure for bladder cancer. Standards and current developments]","Karl A, Tritschler S, Zaak D, Tilki D, Stief C, Burger M.","Urologe A. 2010 Oct;49(10):1303-11; quiz 1312. doi: 10.1007/s00120-010-2343-3.","Karl A","Urologe A","2010","2010/09/17","","","10.1007/s00120-010-2343-3"
"17712491","Comparisons of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China","Tsui KH, Chen SM, Wang TM, Juang HH, Chen CL, Sun GH, Chang PL.","Asian J Androl. 2007 Sep;9(5):711-5. doi: 10.1111/j.1745-7262.2007.00218.x.","Tsui KH","Asian J Androl","2007","2007/08/23","","","10.1111/j.1745-7262.2007.00218.x"
"12664613","Antitumor effects of piroxicam in spontaneous canine invasive urinary bladder cancer, a relevant model of human invasive bladder cancer","Knapp DW, Glickman NW, Mohammed SI, DeNicola DB, Widmer WR, Bonney PL, DeGortari AE.","Adv Exp Med Biol. 2002;507:377-80. doi: 10.1007/978-1-4615-0193-0_58.","Knapp DW","Adv Exp Med Biol","2002","2003/04/01","","","10.1007/978-1-4615-0193-0_58"
"480487","Immunological evaluation of a streptococcal preparation (OK-432) in treatment of bladder carcinoma","Kagawa S, Ogura K, Kurokawa K, Uyama K.","J Urol. 1979 Oct;122(4):467-70. doi: 10.1016/s0022-5347(17)56466-6.","Kagawa S","J Urol","1979","1979/10/01","","","10.1016/s0022-5347(17)56466-6"
"7911446","Genetic alterations associated with bladder cancer","Cordon-Cardo C, Dalbagni G, Sarkis AS, Reuter VE.","Important Adv Oncol. 1994:71-83.","Cordon-Cardo C","Important Adv Oncol","1994","1994/01/01","","",""
"28088793","HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways","Lv D, Wu H, Xing R, Shu F, Lei B, Lei C, Zhou X, Wan B, Yang Y, Zhong L, Mao X, Zou Y.","Oncotarget. 2017 Feb 21;8(8):13586-13599. doi: 10.18632/oncotarget.14600.","Lv D","Oncotarget","2017","2017/01/16","PMC5355122","","10.18632/oncotarget.14600"
"7044462","Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy","Bloom HJ, Hendry WF, Wallace DM, Skeet RG.","Br J Urol. 1982 Apr;54(2):136-51. doi: 10.1111/j.1464-410x.1982.tb13537.x.","Bloom HJ","Br J Urol","1982","1982/04/01","","","10.1111/j.1464-410x.1982.tb13537.x"
"17208143","Chemotherapy for muscle-invasive bladder cancer in the perioperative setting: current standards","Dreicer R.","Urol Oncol. 2007 Jan-Feb;25(1):72-5. doi: 10.1016/j.urolonc.2006.05.011.","Dreicer R","Urol Oncol","2007","2007/01/09","","","10.1016/j.urolonc.2006.05.011"
"2217428","Endpoints of clinical trials for muscle-invasive bladder cancer","Tannock IF.","Prog Clin Biol Res. 1990;353:65-74.","Tannock IF","Prog Clin Biol Res","1990","1990/01/01","","",""
"8184271","[Chemotherapy of bladder tumors]","Botto H.","Rev Prat. 1994 Feb 15;44(4):514-9.","Botto H","Rev Prat","1994","1994/02/15","","",""
"650752","The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading","Gilbert HA, Logan JL, Kagan AR, Friedman HA, Cove JK, Fox M, Muldoon TM, Lonni YW, Rowe JH, Cooper JF, Nussbaum H, Chan P, Rao A, Starr A.","J Urol. 1978 Apr;119(4):488-92. doi: 10.1016/s0022-5347(17)57526-6.","Gilbert HA","J Urol","1978","1978/04/01","","","10.1016/s0022-5347(17)57526-6"
"28895409","Long noncoding RNA ASAP1-IT1 promotes cancer stemness and predicts a poor prognosis in patients with bladder cancer","Yang L, Xue Y, Liu J, Zhuang J, Shen L, Shen B, Yan J, Guo H.","Neoplasma. 2017;64(6):847-855. doi: 10.4149/neo_2017_606.","Yang L","Neoplasma","2017","2017/09/13","","","10.4149/neo_2017_606"
"6472835","[Diagnosis, prognosis and therapeutic results in urothelial dysplasia in patients with bladder cancer]","Csapó Z, Kolozsy Z, Dauda G, Mohácsi L.","Orv Hetil. 1984 Jul 29;125(31):1875-8, 1881.","Csapó Z","Orv Hetil","1984","1984/07/29","","",""
"3435708","A model to predict the outcome of the bilharzial bladder cancer patient after radical cystectomy","Rafla M, Ibrahim AS, Sherif M, Valleron AJ.","Br J Cancer. 1987 Dec;56(6):830-3. doi: 10.1038/bjc.1987.299.","Rafla M","Br J Cancer","1987","1987/12/01","PMC2002416","","10.1038/bjc.1987.299"
"2284533","Adjuvant chemotherapy following cystectomy benefits patients with deeply invasive bladder cancer","Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, Krailo M, Groshen S.","Semin Urol. 1990 Nov;8(4):279-84.","Skinner DG","Semin Urol","1990","1990/11/01","","",""
"3232687","Bladder cancer among workers in the textile industry: results of a Spanish case-control study","Gonzales CA, Riboli E, Lopez-Abente G.","Am J Ind Med. 1988;14(6):673-80. doi: 10.1002/ajim.4700140607.","Gonzales CA","Am J Ind Med","1988","1988/01/01","","","10.1002/ajim.4700140607"
"6797993","Preoperative whole pelvis verus true pelvis irradiation and/or cystectomy for bladder cancer","Batata MA, Chu FC, Hilaris BS, Lee MZ, Varesko RW, Lee HS, Visetsiri E, Kim YS, Ong R, Whitmore WF Jr.","Int J Radiat Oncol Biol Phys. 1981 Oct;7(10):1349-55. doi: 10.1016/0360-3016(81)90030-4.","Batata MA","Int J Radiat Oncol Biol Phys","1981","1981/10/01","","","10.1016/0360-3016(81)90030-4"
"9749071","[Therapeutic approach to bladder cancer classified as T3]","Burette R.","Cancer Radiother. 1998 Apr;2 Suppl 1:16s.","Burette R","Cancer Radiother","1998","1998/09/28","","",""
"31081702","Drug strategies for bladder cancer in the elderly: is there promise for the future?","Soria F, Mosca A, Gontero P.","Expert Opin Pharmacother. 2019 Aug;20(11):1387-1396. doi: 10.1080/14656566.2019.1615055. Epub 2019 May 13.","Soria F","Expert Opin Pharmacother","2019","2019/05/14","","","10.1080/14656566.2019.1615055"
"24168049","Expert review: an update in current and developing intravesical therapies for non-muscle-invasive bladder cancer","van Lingen AV, Arends TJ, Witjes JA.","Expert Rev Anticancer Ther. 2013 Nov;13(11):1257-68. doi: 10.1586/14737140.2013.852474.","van Lingen AV","Expert Rev Anticancer Ther","2013","2013/10/31","","","10.1586/14737140.2013.852474"
"8172997","Associations between bladder cancer risk factors and tumor stage and grade at diagnosis","Sturgeon SR, Hartge P, Silverman DT, Kantor AF, Linehan WM, Lynch C, Hoover RN.","Epidemiology. 1994 Mar;5(2):218-25. doi: 10.1097/00001648-199403000-00012.","Sturgeon SR","Epidemiology","1994","1994/03/01","","","10.1097/00001648-199403000-00012"
"3315161","Prostatic and bladder cancer in the elderly","Gaddipati J, Ahmed T, Friedland M.","Clin Geriatr Med. 1987 Nov;3(4):649-67.","Gaddipati J","Clin Geriatr Med","1987","1987/11/01","","",""
"11828992","P53 codon 72 polymorphism in bladder cancer--no evidence of association with increased risk or invasiveness","Törüner GA, Uçar A, Tez M, Cetinkaya M, Ozen H, Ozçelik T.","Urol Res. 2001 Dec;29(6):393-5. doi: 10.1007/s002400100218.","Törüner GA","Urol Res","2001","2002/02/07","","","10.1007/s002400100218"
"8375926","Incidence of infiltrating cancer following superficial bladder carcinoma","Levi F, La Vecchia C, Randimbison L, Franceschi S.","Int J Cancer. 1993 Sep 30;55(3):419-21. doi: 10.1002/ijc.2910550316.","Levi F","Int J Cancer","1993","1993/09/30","","","10.1002/ijc.2910550316"
"3129737","Treatment of muscle-infiltrating bladder cancer: the Norwegian Radium Hospital's experience 1966-1982","Fosså SD, Miller A, Ous S, Poppe E, Host H, Kaalhus O.","Prog Clin Biol Res. 1988;260:525-41.","Fosså SD","Prog Clin Biol Res","1988","1988/01/01","","",""
"103371","[Clinical-experience with thiotepa in the treatment of bladder cancer]","Gallo FJ, Menéndez-Ondina L, Matallana A, Bonilla JA, Serrano E, Carballido JA, Mendoza A.","Actas Urol Esp. 1978 Sep-Oct;2(5):237-40.","Gallo FJ","Actas Urol Esp","1978","1978/09/01","","",""
"16400012","Profiling bladder cancer using targeted antibody arrays","Sanchez-Carbayo M, Socci ND, Lozano JJ, Haab BB, Cordon-Cardo C.","Am J Pathol. 2006 Jan;168(1):93-103. doi: 10.2353/ajpath.2006.050601.","Sanchez-Carbayo M","Am J Pathol","2006","2006/01/10","PMC1592677","","10.2353/ajpath.2006.050601"
"18047965","The best treatment for high-grade T1 bladder cancer is cystectomy","Skinner EC.","Urol Oncol. 2007 Nov-Dec;25(6):523-5. doi: 10.1016/j.urolonc.2007.05.023.","Skinner EC","Urol Oncol","2007","2007/12/01","","","10.1016/j.urolonc.2007.05.023"
"26598426","A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer","Park JC, Gandhi NM, Carducci MA, Eisenberger MA, Baras AS, Netto GJ, Liu JJ, Drake CG, Schoenberg MP, Bivalacqua TJ, Hahn NM.","J Urol. 2016 Apr;195(4 Pt 1):880-5. doi: 10.1016/j.juro.2015.11.024. Epub 2015 Nov 18.","Park JC","J Urol","2016","2015/11/25","","","10.1016/j.juro.2015.11.024"
"10918764","Bladder cancer: a review of diagnosis and management","Metts MC, Metts JC, Milito SJ, Thomas CR Jr.","J Natl Med Assoc. 2000 Jun;92(6):285-94.","Metts MC","J Natl Med Assoc","2000","2000/08/05","PMC2640522","",""
"1466591","Invasive bladder cancer in women","Romero JA, Alvarez-Vijande R, Gutiérrez R, Vendrell R, Gil-Vernet JM Jr, Carretero P.","Arch Esp Urol. 1992 Oct;45(8):837-9.","Romero JA","Arch Esp Urol","1992","1992/10/11","","",""
"30064166","[Distant Metastasis in Patients with Non-Muscle Invasive Bladder Cancer without Local Recurrence : Report of Two Rare Cases]","Kida K, Shimizu Y, Ogawa K, Kanamaru S, Ito N.","Hinyokika Kiyo. 2018 Jun;64(6):271-275. doi: 10.14989/ActaUrolJap_64_6_271.","Kida K","Hinyokika Kiyo","2018","2018/08/01","","","10.14989/ActaUrolJap_64_6_271"
"16176693","Do patients with frank haematuria referred under the two-week rule have a higher incidence of bladder cancer?","Thiruchelvam N, Mostafid H.","Ann R Coll Surg Engl. 2005 Sep;87(5):345-7. doi: 10.1308/003588405X60623.","Thiruchelvam N","Ann R Coll Surg Engl","2005","2005/09/24","PMC1963976","","10.1308/003588405X60623"
"17382797","Chemotherapy for metastatic or unresectable bladder cancer","Bellmunt J, Albiol S.","Semin Oncol. 2007 Apr;34(2):135-44. doi: 10.1053/j.seminoncol.2006.12.008.","Bellmunt J","Semin Oncol","2007","2007/03/27","","","10.1053/j.seminoncol.2006.12.008"
"2074514","Occupational bladder cancer in textile dyeing and printing workers: six cases and their significance for screening programs","Frumin E, Velez H, Bingham E, Gillen M, Brathwaite M, LaBarck R.","J Occup Med. 1990 Sep;32(9):887-90. doi: 10.1097/00043764-199009000-00026.","Frumin E","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00026"
"18765122","Bladder-preserving therapy for muscle-invasive bladder cancer: should it be recommended to appropriate patients?","Akaza H.","Curr Urol Rep. 2008 Jul;9(4):257-8. doi: 10.1007/s11934-008-0044-x.","Akaza H","Curr Urol Rep","2008","2008/09/04","","","10.1007/s11934-008-0044-x"
"16352616","Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?","Knowles MA.","Carcinogenesis. 2006 Mar;27(3):361-73. doi: 10.1093/carcin/bgi310. Epub 2005 Dec 13.","Knowles MA","Carcinogenesis","2006","2005/12/15","","","10.1093/carcin/bgi310"
"8967722","Molecular epidemiology of bladder cancer","Vineis P, Martone T.","Ann Ist Super Sanita. 1996;32(1):21-7.","Vineis P","Ann Ist Super Sanita","1996","1996/01/01","","",""
"28789929","Commentary on: ""Comprehensive transcriptional analysis of early-stage urothelial carcinoma."" Hedegaard J, Lamy P, Nordentoft I, Algaba F, Høyer S, Ulhøi BP, Vang S, Reinert T, Hermann GG, Mogensen K, Thomsen MB, Nielsen MM, Marquez M, Segersten U, Aine M, Höglund M, Birkenkamp-Demtröder K, Fristrup N, Borre M, Hartmann A, Stöhr R, Wach S, Keck B, Seitz AK, Nawroth R, Maurer T, Tulic C, Simic T, Junker K, Horstmann M, Harving N, Petersen AC, Calle ML, Steyerberg EW, Beukers W, van Kessel KE, Jensen JB, Pedersen JS, Malmström PU, Malats N, Real FX, Zwarthoff EC, Ørntoft TF, Dyrskjøt L. Cancer Cell. 2016 Jul 11;30(1):27-42","Lee BH.","Urol Oncol. 2017 Sep;35(9):576-577. doi: 10.1016/j.urolonc.2017.07.020. Epub 2017 Aug 5.","Lee BH","Urol Oncol","2017","2017/08/10","","","10.1016/j.urolonc.2017.07.020"
"18060549","Bladder cancer markers in patient management: the current perspective","Schmitz-Dräger BJ, Fradet Y, Grossman HB.","World J Urol. 2008 Feb;26(1):1-3. doi: 10.1007/s00345-007-0225-0. Epub 2007 Dec 4.","Schmitz-Dräger BJ","World J Urol","2008","2007/12/07","","","10.1007/s00345-007-0225-0"
"7355283","Artificial sweetener use and bladder cancer: a case-control study","Wynder EL, Stellman SD.","Science. 1980 Mar 14;207(4436):1214-6. doi: 10.1126/science.7355283.","Wynder EL","Science","1980","1980/03/14","","","10.1126/science.7355283"
"23449930","Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions","Besaratinia A, Tommasi S.","FASEB J. 2013 Jun;27(6):2090-100. doi: 10.1096/fj.12-227074. Epub 2013 Feb 28.","Besaratinia A","FASEB J","2013","2013/03/02","","","10.1096/fj.12-227074"
"1301591","New approaches to intravesical chemo-immunotherapy in superficial bladder cancer","van der Meijden AP.","Prog Clin Biol Res. 1992;378:95-101.","van der Meijden AP","Prog Clin Biol Res","1992","1992/01/01","","",""
"19576682","Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy","van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, Witjes JA, Zlotta AR.","Eur Urol. 2009 Sep;56(3):430-42. doi: 10.1016/j.eururo.2009.06.028. Epub 2009 Jun 26.","van Rhijn BW","Eur Urol","2009","2009/07/07","","","10.1016/j.eururo.2009.06.028"
"30321552","Concurrent Radiotherapy and Panitumumab after Lymph Node Dissection and Induction Chemotherapy for Invasive Bladder Cancer","Fransen van de Putte EE, Pos F, Doodeman B, van Rhijn BWG, van der Laan E, Nederlof P, van der Heijden MS, Bloos-van der Hulst J, Sanders J, Broeks A, Kerst JM, van der Noort V, Horenblas S, Bergman AM.","J Urol. 2019 Mar;201(3):478-485. doi: 10.1016/j.juro.2018.10.007.","Fransen van de Putte EE","J Urol","2019","2018/10/16","","","10.1016/j.juro.2018.10.007"
"1408061","[5-year experience with BCG immunoprophylaxis in superficial bladder cancer]","Romics I, Bach D, Rüssel C.","Orv Hetil. 1992 Sep 6;133(36):2275-6, 2279-81.","Romics I","Orv Hetil","1992","1992/09/06","","",""
"31781979","High-grade T1 Urothelial Carcinoma: Where Do We Stand?","Yip W, Ashrafi A, Daneshmand S.","Curr Urol Rep. 2019 Nov 28;20(12):79. doi: 10.1007/s11934-019-0945-x.","Yip W","Curr Urol Rep","2019","2019/11/30","","","10.1007/s11934-019-0945-x"
"20192584","Screening of N-ras gene mutations in urothelial cell carcinomas of the urinary bladder in the Kashmiri population","Pandith AA, Shah ZA, Khan NP, Bhat AY, Wani SM, Siddiqi MA.","Asian Pac J Cancer Prev. 2009;10(6):1063-6.","Pandith AA","Asian Pac J Cancer Prev","2009","2010/03/03","","",""
"24363084","Genetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group","Zhang K, Zhou B, Zhang P, Zhang Z, Chen P, Pu Y, Song Y, Zhang L.","Tumour Biol. 2014 May;35(5):4031-40. doi: 10.1007/s13277-013-1527-z. Epub 2013 Dec 22.","Zhang K","Tumour Biol","2014","2013/12/24","","","10.1007/s13277-013-1527-z"
"4911965","Further progress on bladder cancer","","Food Cosmet Toxicol. 1970 Apr;8(2):210-4.","","Food Cosmet Toxicol","1970","1970/04/01","","",""
"16215307","Incidentally detected prostate cancer in cystoprostatectomy specimens","Kouriefs C, Fazili T, Masood S, Naseem MS, Mufti GR.","Urol Int. 2005;75(3):213-6. doi: 10.1159/000087796.","Kouriefs C","Urol Int","2005","2005/10/11","","","10.1159/000087796"
"2645832","[Intravesical chemotherapy of superficial bladder tumors]","Matsumura Y.","Gan To Kagaku Ryoho. 1989 Feb;16(2):193-8.","Matsumura Y","Gan To Kagaku Ryoho","1989","1989/02/01","","",""
"19557465","[Urine-based markers of angiogenesis in bladder cancer]","Becker M, Tilki D, Szarvas T, Rübben H, Ergün S.","Urologe A. 2009 Jun;48(6):609-14. doi: 10.1007/s00120-009-1989-1.","Becker M","Urologe A","2009","2009/06/27","","","10.1007/s00120-009-1989-1"
"3990530","[Indications for lymphography in bladder cancer]","Tsyb AF, Kulikov VA, Poltorakov AM, Tlepshukov GK.","Med Radiol (Mosk). 1985 Apr;30(4):14-7.","Tsyb AF","Med Radiol (Mosk)","1985","1985/04/01","","",""
"17052994","Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer","Zhu Y, Lai M, Yang H, Lin J, Huang M, Grossman HB, Dinney CP, Wu X.","Carcinogenesis. 2007 Mar;28(3):698-703. doi: 10.1093/carcin/bgl201. Epub 2006 Oct 19.","Zhu Y","Carcinogenesis","2007","2006/10/21","","","10.1093/carcin/bgl201"
"7344612","Urine cytology: early diagnosis of induced carcinoma of the rat urinary bladder","Reznik G, Brennan LM, Creasia DA.","Anticancer Res. 1981;1(6):389-92.","Reznik G","Anticancer Res","1981","1981/01/01","","",""
"26942590","Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers","El-Taji OM, Alam S, Hussain SA.","Curr Treat Options Oncol. 2016 Mar;17(3):15. doi: 10.1007/s11864-016-0390-8.","El-Taji OM","Curr Treat Options Oncol","2016","2016/03/05","PMC4779141","","10.1007/s11864-016-0390-8"
"30419021","Novel protein signatures suggest progression to muscular invasiveness in bladder cancer","Berle M, Ghila L, Vethe H, Chaudhry A, Garberg H, Beisland C, Haaland ØA, Oveland E, Halvorsen OJ, Davidsson T, Chera S.","PLoS One. 2018 Nov 12;13(11):e0206475. doi: 10.1371/journal.pone.0206475. eCollection 2018.","Berle M","PLoS One","2018","2018/11/13","PMC6231613","","10.1371/journal.pone.0206475"
"9259085","Bladder cancer: natural history, tumor markers, and early detection strategies","Foresman WH, Messing EM.","Semin Surg Oncol. 1997 Sep-Oct;13(5):299-306. doi: 10.1002/(sici)1098-2388(199709/10)13:5<299::aid-ssu3>3.0.co;2-8.","Foresman WH","Semin Surg Oncol","1997","1997/09/01","","","10.1002/(sici)1098-2388(199709/10)13:5<299::aid-ssu3>3.0.co;2-8"
"28832261","Prospects and progress of immunotherapy for bladder cancer","Boegemann M, Aydin AM, Bagrodia A, Krabbe LM.","Expert Opin Biol Ther. 2017 Nov;17(11):1417-1431. doi: 10.1080/14712598.2017.1366445. Epub 2017 Aug 23.","Boegemann M","Expert Opin Biol Ther","2017","2017/08/24","","","10.1080/14712598.2017.1366445"
"4139781","[Treatment planning in cancer of the bladder]","Fryjordet A Jr.","Tidsskr Nor Laegeforen. 1974 Nov 10;94(31):2164-5.","Fryjordet A Jr","Tidsskr Nor Laegeforen","1974","1974/11/10","","",""
"16018940","A prognostic index (bladder prognostic index) for bilharzial-related invasive bladder cancer","Khaled H, El Hattab O, Moneim DA, Kassem HA, Morsi A, Sherif G, Darwish T, Gaafar R.","Urol Oncol. 2005 Jul-Aug;23(4):254-60. doi: 10.1016/j.urolonc.2005.04.005.","Khaled H","Urol Oncol","2005","2005/07/16","","","10.1016/j.urolonc.2005.04.005"
"8625187","Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction","Freeman JA, Esrig D, Stein JP, Simoneau AR, Skinner EC, Chen SC, Groshen S, Lieskovsky G, Boyd SD, Skinner DG.","Cancer. 1995 Sep 1;76(5):833-9. doi: 10.1002/1097-0142(19950901)76:5<833::aid-cncr2820760518>3.0.co;2-m.","Freeman JA","Cancer","1995","1995/09/01","","","10.1002/1097-0142(19950901)76:5<833::aid-cncr2820760518>3.0.co;2-m"
"29110046","[Supplementary optical techniques for the detection of nonmuscle invasive bladder cancer]","Aeishen S, Dawood Y, Papadoukakis S, Horstmann M.","Urologe A. 2018 Feb;57(2):139-147. doi: 10.1007/s00120-017-0539-5.","Aeishen S","Urologe A","2018","2017/11/08","","","10.1007/s00120-017-0539-5"
"24732047","Size-based enrichment of exfoliated tumor cells in urine increases the sensitivity for DNA-based detection of bladder cancer","Andersson E, Steven K, Guldberg P.","PLoS One. 2014 Apr 14;9(4):e94023. doi: 10.1371/journal.pone.0094023. eCollection 2014.","Andersson E","PLoS One","2014","2014/04/16","PMC3986060","","10.1371/journal.pone.0094023"
"5458095","Treatment of carcinoma of the bladder: a summary","Jewett HJ.","Proc Natl Cancer Conf. 1970;6:211-7.","Jewett HJ","Proc Natl Cancer Conf","1970","1970/01/01","","",""
"19553821","Perioperative instillation therapy in superficial bladder cancer: is it effective regarding outcome and costs?","Engel RP, Witjes JA.","Curr Opin Urol. 2009 Sep;19(5):511-5. doi: 10.1097/MOU.0b013e32832eb449.","Engel RP","Curr Opin Urol","2009","2009/06/26","","","10.1097/MOU.0b013e32832eb449"
"26812305","Association of Itraconazole, a Hedgehog Inhibitor, and Bladder Cancer","Mamtani R, Yang YX, Scott FI, Lewis JD, Boursi B.","J Urol. 2016 Aug;196(2):343-8. doi: 10.1016/j.juro.2016.01.089. Epub 2016 Jan 23.","Mamtani R","J Urol","2016","2016/01/27","PMC4958604","NIHMS754416","10.1016/j.juro.2016.01.089"
"4063735","Urethral dysplasia and bladder cancer in cystectomy specimens","Coutts AG, Grigor KM, Fowler JW.","Br J Urol. 1985 Oct;57(5):535-41. doi: 10.1111/j.1464-410x.1985.tb05862.x.","Coutts AG","Br J Urol","1985","1985/10/01","","","10.1111/j.1464-410x.1985.tb05862.x"
"16480698","Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on survivin","Schultz IJ, Witjes JA, Swinkels DW, de Kok JB.","Clin Chim Acta. 2006 Jun;368(1-2):20-32. doi: 10.1016/j.cca.2005.12.036. Epub 2006 Feb 9.","Schultz IJ","Clin Chim Acta","2006","2006/02/17","","","10.1016/j.cca.2005.12.036"
"24968946","Patterns of referral for perioperative chemotherapy among patients with muscle-invasive bladder cancer: a population-based study","Booth CM, Siemens DR, Peng Y, Mackillop WJ.","Urol Oncol. 2014 Nov;32(8):1200-8. doi: 10.1016/j.urolonc.2014.05.012. Epub 2014 Jun 23.","Booth CM","Urol Oncol","2014","2014/06/28","","","10.1016/j.urolonc.2014.05.012"
"18094410","A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer","Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, Gao B, Wang W, Gu L, Meng J, Wang J, Feng X, Li Y, Yao X, Zhu J.","Clin Cancer Res. 2007 Dec 15;13(24):7296-304. doi: 10.1158/1078-0432.CCR-07-0861.","Yu J","Clin Cancer Res","2007","2007/12/21","","","10.1158/1078-0432.CCR-07-0861"
"9677446","Planned preoperative radiation therapy in muscle invasive bladder cancer; results of a meta-analysis","Huncharek M, Muscat J, Geschwind JF.","Anticancer Res. 1998 May-Jun;18(3B):1931-4.","Huncharek M","Anticancer Res","1998","1998/07/25","","",""
"7456797","[Bladder cancer arising from interstitial cystitis]","Németh D.","Z Urol Nephrol. 1980 Oct;73(10):741-5.","Németh D","Z Urol Nephrol","1980","1980/10/01","","",""
"24488686","A comprehensive evaluation of bladder cancer epidemiology and outcomes in Australia","Cheluvappa R, Smith DP, Cerimagic S, Patel MI.","Int Urol Nephrol. 2014 Jul;46(7):1351-60. doi: 10.1007/s11255-014-0643-z. Epub 2014 Feb 1.","Cheluvappa R","Int Urol Nephrol","2014","2014/02/04","","","10.1007/s11255-014-0643-z"
"19954287","Management of patients with advanced bladder cancer following major response to systemic chemotherapy","Yafi FA, Kassouf W.","Expert Rev Anticancer Ther. 2009 Dec;9(12):1757-64. doi: 10.1586/era.09.148.","Yafi FA","Expert Rev Anticancer Ther","2009","2009/12/04","","","10.1586/era.09.148"
"872125","Chromosome markers and progression in bladder cancer","Sandberg AA.","Cancer Res. 1977 Aug;37(8 Pt 2):2950-6.","Sandberg AA","Cancer Res","1977","1977/08/01","","",""
"9446944","Organ preservation in the management of bladder and prostate cancer","Vitale V.","Rays. 1997 Jul-Sep;22(3):406-9.","Vitale V","Rays","1997","1997/07/01","","",""
"12194806","Localized and locally advanced bladder cancer","Calabrò F, Sternberg CN.","Curr Treat Options Oncol. 2002 Oct;3(5):413-28. doi: 10.1007/s11864-002-0006-3.","Calabrò F","Curr Treat Options Oncol","2002","2002/08/27","","","10.1007/s11864-002-0006-3"
"8772815","Superficial bladder cancer. A 10 year experience","Tongaonkar HB, Dalal AV, Kulkarni JN, Kamat MR.","Indian J Cancer. 1995 Sep;32(3):141-8.","Tongaonkar HB","Indian J Cancer","1995","1995/09/01","","",""
"21794064","Prognostic implications of lymph node involvement in bladder cancer: are we understaging using current methods?","Watts KL, Ristau BT, Yamase HT, Taylor JA 3rd.","BJU Int. 2011 Aug;108(4):484-92. doi: 10.1111/j.1464-410X.2011.10330.x.","Watts KL","BJU Int","2011","2011/07/29","","","10.1111/j.1464-410X.2011.10330.x"
"24423367","Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer","Suriano F, Santini D, Perrone G, Amato M, Vincenzi B, Tonini G, Muda A, Boggia S, Buscarini M, Pantano F.","J Exp Clin Cancer Res. 2013 Nov 5;32(1):87. doi: 10.1186/1756-9966-32-87.","Suriano F","J Exp Clin Cancer Res","2013","2014/01/16","PMC4029537","","10.1186/1756-9966-32-87"
"7984457","BCG in bladder cancer","Meek D.","Nurs Times. 1994 Oct 26-Nov 1;90(43):34-5.","Meek D","Nurs Times","1994","1994/10/01","","",""
"11296634","[Simultaneous chemotherapy/radiotherapy in locally advanced unresectable cancer of the bladder]","Paule B, Saint F.","Prog Urol. 2001 Feb;11(1):132-40.","Paule B","Prog Urol","2001","2001/04/12","","",""
"30292293","Targeted metabolomics in bladder cancer: From analytical methods development and validation towards application to clinical samples","Yumba Mpanga A, Siluk D, Jacyna J, Szerkus O, Wawrzyniak R, Markuszewski M, Matuszewski M, Kaliszan R, Markuszewski MJ.","Anal Chim Acta. 2018 Dec 11;1037:188-199. doi: 10.1016/j.aca.2018.01.055. Epub 2018 Feb 3.","Yumba Mpanga A","Anal Chim Acta","2018","2018/10/08","","","10.1016/j.aca.2018.01.055"
"16818188","Economic impact of screening for bladder cancer using bladder tumor markers: a decision analysis","Svatek RS, Sagalowsky AI, Lotan Y.","Urol Oncol. 2006 Jul-Aug;24(4):338-43. doi: 10.1016/j.urolonc.2005.11.025.","Svatek RS","Urol Oncol","2006","2006/07/05","","","10.1016/j.urolonc.2005.11.025"
"20944539","Bladder cancer: a review of clinical management and prognostic factors","Patel T, Pitman M, McKiernan JM.","Minerva Urol Nefrol. 2010 Dec;62(4):377-86.","Patel T","Minerva Urol Nefrol","2010","2010/10/15","","",""
"18815928","Tissue microarray studies in bladder cancer","Hartmann A.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):141-6. doi: 10.1080/03008880802291840.","Hartmann A","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802291840"
"12576819","Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base","Konety BR, Joslyn SA, O'Donnell MA.","J Urol. 2003 Mar;169(3):946-50. doi: 10.1097/01.ju.0000052721.61645.a3.","Konety BR","J Urol","2003","2003/02/11","","","10.1097/01.ju.0000052721.61645.a3"
"7917537","A cross-national investigation of diet and bladder cancer","Hebert JR, Miller DR.","Eur J Cancer. 1994;30A(6):778-84. doi: 10.1016/0959-8049(94)90292-5.","Hebert JR","Eur J Cancer","1994","1994/01/01","","","10.1016/0959-8049(94)90292-5"
"26384800","POINT: Is Cystectomy Needed for Small-Cell Bladder Cancer?","Raghavan D.","Oncology (Williston Park). 2015 Sep;29(9):645-7.","Raghavan D","Oncology (Williston Park)","2015","2015/09/20","","",""
"27098227","Risk of Alcohol Consumption in Bladder Cancer: Case-Control Study from a Nationwide Inpatient Database in Japan","Zaitsu M, Nakamura F, Toyokawa S, Tonooka A, Takeuchi T, Homma Y, Kobayashi Y.","Tohoku J Exp Med. 2016 May;239(1):9-15. doi: 10.1620/tjem.239.9.","Zaitsu M","Tohoku J Exp Med","2016","2016/04/22","","","10.1620/tjem.239.9"
"3591591","[A case of Werner's syndrome associated with bladder cancer]","Arima K, Tsukamoto K, Hori N, Sugimura Y, Tochigi H, Kawamura J, Goto M.","Hinyokika Kiyo. 1987 Feb;33(2):269-74.","Arima K","Hinyokika Kiyo","1987","1987/02/01","","",""
"2074507","Hematuria screening for bladder cancer","Messing EM, Vaillancourt A.","J Occup Med. 1990 Sep;32(9):838-45. doi: 10.1097/00043764-199009000-00016.","Messing EM","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00016"
"18436255","Re: Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer. D. Margel, R. Tal and J. Baniel. J Urol 2007; 178: 2297-2301","Suzuki K.","J Urol. 2008 Jun;179(6):2481; author reply 2481. doi: 10.1016/j.juro.2008.01.156. Epub 2008 Apr 23.","Suzuki K","J Urol","2008","2008/04/26","","","10.1016/j.juro.2008.01.156"
"22583418","Targeted therapy for advanced urothelial cancer of the bladder: where do we stand?","Zhu Z, Shen Z, Xu C.","Anticancer Agents Med Chem. 2012 Nov;12(9):1081-7. doi: 10.2174/187152012803529673.","Zhu Z","Anticancer Agents Med Chem","2012","2012/05/16","","","10.2174/187152012803529673"
"7150930","Morbidity and mortality in 100 consecutive radical cystectomies","Thomas DM, Riddle PR.","Br J Urol. 1982 Dec;54(6):716-9. doi: 10.1111/j.1464-410x.1982.tb13632.x.","Thomas DM","Br J Urol","1982","1982/12/01","","","10.1111/j.1464-410x.1982.tb13632.x"
"23958829","Bladder cancer: Gaps in staging and care identified","Razzak M.","Nat Rev Urol. 2013 Sep;10(9):493. doi: 10.1038/nrurol.2013.182. Epub 2013 Aug 20.","Razzak M","Nat Rev Urol","2013","2013/08/21","","","10.1038/nrurol.2013.182"
"17336246","Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results","Mills RD, Fleischmann A, Studer UE.","Surg Oncol Clin N Am. 2007 Jan;16(1):233-45. doi: 10.1016/j.soc.2006.10.001.","Mills RD","Surg Oncol Clin N Am","2007","2007/03/06","","","10.1016/j.soc.2006.10.001"
"2074512","Bladder cancer screening in the United Kingdom","Cartwright RA.","J Occup Med. 1990 Sep;32(9):878-80. doi: 10.1097/00043764-199009000-00024.","Cartwright RA","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00024"
"2746044","Tissue and serum TPA in subjects at risk for bladder cancer","Giovagnoli MR, Di Fraia P, Manna A, Marafini V, Valli C, Marchei P, Vecchione A.","Int J Biol Markers. 1989 Jan-Mar;4(1):13-7.","Giovagnoli MR","Int J Biol Markers","1989","1989/01/01","","",""
"6504901","Hydrostatic bladder distension for bladder cancer","Smith PH, Hetherington JW.","Prog Clin Biol Res. 1984;162B:309-19.","Smith PH","Prog Clin Biol Res","1984","1984/01/01","","",""
"12429155","Reduced thrombospondin-1 at presentation predicts disease progression in superficial bladder cancer","Goddard JC, Sutton CD, Jones JL, O'Byrne KJ, Kockelbergh RC.","Eur Urol. 2002 Nov;42(5):464-8. doi: 10.1016/s0302-2838(02)00372-x.","Goddard JC","Eur Urol","2002","2002/11/14","","","10.1016/s0302-2838(02)00372-x"
"6612234","Presenting symptoms, treatment delay and survival in bladder cancer","Mommsen S, Aagaard J, Sell A.","Scand J Urol Nephrol. 1983;17(2):163-7. doi: 10.3109/00365598309180162.","Mommsen S","Scand J Urol Nephrol","1983","1983/01/01","","","10.3109/00365598309180162"
"8477313","The incidence of bladder cancer in the black foot disease endemic area in Taiwan","Chiang HS, Guo HR, Hong CL, Lin SM, Lee EF.","Br J Urol. 1993 Mar;71(3):274-8. doi: 10.1111/j.1464-410x.1993.tb15942.x.","Chiang HS","Br J Urol","1993","1993/03/01","","","10.1111/j.1464-410x.1993.tb15942.x"
"7474605","[Benefits and adverse effects of post-operative radiation therapy after radical cystectomy for patients with advanced bladder cancer]","Yabusaki N, Komatsu H, Tanabe N, Tago K, Ueno A.","Nihon Hinyokika Gakkai Zasshi. 1995 Oct;86(10):1552-6. doi: 10.5980/jpnjurol1989.86.1552.","Yabusaki N","Nihon Hinyokika Gakkai Zasshi","1995","1995/10/01","","","10.5980/jpnjurol1989.86.1552"
"3339723","Cancer detection by quantitative fluorescence image analysis","Parry WL, Hemstreet GP 3rd.","J Urol. 1988 Feb;139(2):270-4. doi: 10.1016/s0022-5347(17)42384-6.","Parry WL","J Urol","1988","1988/02/01","","","10.1016/s0022-5347(17)42384-6"
"7483139","Establishment and characterization of a new cell line from human bladder cancer (JMSU1)","Morita T, Shinohara N, Honma M, Tokue A.","Urol Res. 1995;23(3):143-9. doi: 10.1007/BF00389565.","Morita T","Urol Res","1995","1995/01/01","","","10.1007/BF00389565"
"7563394","Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced bladder cancer overview collaboration","Scher HI.","J Urol. 1995 Nov;154(5):1970.","Scher HI","J Urol","1995","1995/11/01","","",""
"19767219","MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL","Lu Q, Lu C, Zhou GP, Zhang W, Xiao H, Wang XR.","Urol Oncol. 2010 Nov-Dec;28(6):635-41. doi: 10.1016/j.urolonc.2009.06.005. Epub 2009 Sep 19.","Lu Q","Urol Oncol","2010","2009/09/22","","","10.1016/j.urolonc.2009.06.005"
"12778082","Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1-5","Hsieh JL, Wu CL, Lai MD, Lee CH, Tsai CS, Shiau AL.","Br J Cancer. 2003 May 6;88(9):1492-9. doi: 10.1038/sj.bjc.6600908.","Hsieh JL","Br J Cancer","2003","2003/06/05","PMC2741042","","10.1038/sj.bjc.6600908"
"4829661","Ocular metastasis of bladder cancer","Gordon HL, Munro R.","South Med J. 1974 Jun;67(6):745-6. doi: 10.1097/00007611-197406000-00028.","Gordon HL","South Med J","1974","1974/06/01","","","10.1097/00007611-197406000-00028"
"21889367","Small interfering RNA targeting heat shock protein 70 enhances chemosensitivity in human bladder cancer cells","Behnsawy HM, Miyake H, Kusuda Y, Fujisawa M.","Urol Oncol. 2013 Aug;31(6):843-8. doi: 10.1016/j.urolonc.2011.07.007. Epub 2011 Sep 1.","Behnsawy HM","Urol Oncol","2013","2011/09/06","","","10.1016/j.urolonc.2011.07.007"
"9186324","The treated natural history of high risk superficial bladder cancer: 15-year outcome","Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR.","J Urol. 1997 Jul;158(1):62-7. doi: 10.1097/00005392-199707000-00017.","Cookson MS","J Urol","1997","1997/07/01","","","10.1097/00005392-199707000-00017"
"12460344","'Superficial' bladder cancer - time to uncouple pT1 tumours from pTa tumours","Bryan RT, Wallace DM.","BJU Int. 2002 Dec;90(9):846-52. doi: 10.1046/j.1464-410x.2002.03053.x.","Bryan RT","BJU Int","2002","2002/12/04","","","10.1046/j.1464-410x.2002.03053.x"
"31197260","Organ preservation in bladder cancer: an opportunity for truly personalized treatment","Song YP, McWilliam A, Hoskin PJ, Choudhury A.","Nat Rev Urol. 2019 Sep;16(9):511-522. doi: 10.1038/s41585-019-0199-x. Epub 2019 Jun 13.","Song YP","Nat Rev Urol","2019","2019/06/15","","","10.1038/s41585-019-0199-x"
"17706406","Carbonic anhydrase IX expression and outcome after radiotherapy for muscle-invasive bladder cancer","Sherwood BT, Colquhoun AJ, Richardson D, Bowman KJ, O'Byrne KJ, Kockelbergh RC, Symonds RP, Mellon JK, Jones GD.","Clin Oncol (R Coll Radiol). 2007 Dec;19(10):777-83. doi: 10.1016/j.clon.2007.06.014. Epub 2007 Aug 13.","Sherwood BT","Clin Oncol (R Coll Radiol)","2007","2007/08/21","","","10.1016/j.clon.2007.06.014"
"10616681","Bracken fern consumption and human bladder cancer","Brown LM, Zahm SH, Hoover RN, Fraumeni JF.","J Epidemiol Community Health. 1999 Oct;53(10):653. doi: 10.1136/jech.53.10.653.","Brown LM","J Epidemiol Community Health","1999","2000/01/05","PMC1756788","","10.1136/jech.53.10.653"
"25501325","Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus","Schmitz-Dräger BJ, Droller M, Lokeshwar VB, Lotan Y, Hudson MA, van Rhijn BW, Marberger MJ, Fradet Y, Hemstreet GP, Malmstrom PU, Ogawa O, Karakiewicz PI, Shariat SF.","Urol Int. 2015;94(1):1-24. doi: 10.1159/000369357. Epub 2014 Dec 10.","Schmitz-Dräger BJ","Urol Int","2015","2014/12/16","","","10.1159/000369357"
"18067829","[Early diagnosis of bladder cancer by special fluorescence spectrum: an in vitro experiment]","Zou J, He HC, Yao YB, Dai QS, Han ZD, Zhong WD.","Zhonghua Yi Xue Za Zhi. 2007 Sep 25;87(36):2544-6.","Zou J","Zhonghua Yi Xue Za Zhi","2007","2007/12/11","","",""
"16406242","Current practice in the management of superficial bladder cancer in the Netherlands and Belgian Flanders: a survey","Witjes JA, Melissen DO, Kiemeney LA.","Eur Urol. 2006 Mar;49(3):478-84. doi: 10.1016/j.eururo.2005.11.010. Epub 2005 Dec 19.","Witjes JA","Eur Urol","2006","2006/01/13","","","10.1016/j.eururo.2005.11.010"
"9719935","[Clinical studies on the quality of life in patients with ileal conduit]","Okano Y, Kamiyama Y, Iiyama T, Shimizu H, Tomomasa H, Iizumi T, Yazaki T, Umeda T.","Hinyokika Kiyo. 1998 Jun;44(6):381-5.","Okano Y","Hinyokika Kiyo","1998","1998/08/28","","",""
"18815924","Bladder cancer: clinical and pathological profile","Lopez-Beltran A.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):95-109. doi: 10.1080/03008880802325226.","Lopez-Beltran A","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802325226"
"10505859","Gelsolin gene therapy by retrovirus producer cells for human bladder cancer in nude mice","Tanaka M, Sazawa A, Shinohara N, Kobayashi Y, Fujioka Y, Koyanagi T, Kuzumaki N.","Cancer Gene Ther. 1999 Sep-Oct;6(5):482-7. doi: 10.1038/sj.cgt.7700073.","Tanaka M","Cancer Gene Ther","1999","1999/10/03","","","10.1038/sj.cgt.7700073"
"19414122","Management of the first recurrence of T1G3 bladder cancer: does intravesical chemotherapy deserve a chance?","Witjes JA.","Urol Oncol. 2009 May-Jun;27(3):322-4. doi: 10.1016/j.urolonc.2008.10.027.","Witjes JA","Urol Oncol","2009","2009/05/06","","","10.1016/j.urolonc.2008.10.027"
"24525502","Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survival","Fleischmann A, Thalmann GN, Perren A, Seiler R.","Am J Surg Pathol. 2014 Mar;38(3):325-32. doi: 10.1097/PAS.0000000000000142.","Fleischmann A","Am J Surg Pathol","2014","2014/02/15","","","10.1097/PAS.0000000000000142"
"19963252","Bladder cancer detection, treatment and outcomes: opportunities and challenges","Latini DM, Lerner SP, Wade SW, Lee DW, Quale DZ.","Urology. 2010 Feb;75(2):334-9. doi: 10.1016/j.urology.2009.09.051. Epub 2009 Dec 5.","Latini DM","Urology","2010","2009/12/08","","","10.1016/j.urology.2009.09.051"
"31961624","Bladder preservation in muscle-invasive bladder cancer: a comprehensive review","Hamad J, McCloskey H, Milowsky MI, Royce T, Smith A.","Int Braz J Urol. 2020 Mar-Apr;46(2):169-184. doi: 10.1590/S1677-5538.IBJU.2020.99.01.","Hamad J","Int Braz J Urol","2020","2020/01/22","PMC7025842","","10.1590/S1677-5538.IBJU.2020.99.01"
"19375216","An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed?","Sylvester RJ, Oosterlinck W.","Eur Urol. 2009 Jul;56(1):43-5. doi: 10.1016/j.eururo.2009.03.074. Epub 2009 Apr 3.","Sylvester RJ","Eur Urol","2009","2009/04/21","","","10.1016/j.eururo.2009.03.074"
"18410437","Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians?","Chamie K, Hu B, Devere White RW, Ellison LM.","BJU Int. 2008 Aug;102(3):284-90. doi: 10.1111/j.1464-410X.2008.07636.x. Epub 2008 Apr 11.","Chamie K","BJU Int","2008","2008/04/16","","","10.1111/j.1464-410X.2008.07636.x"
"24850094","Bladder cancer biorepositories in the ""-omics"" era: integrating quality tissue specimens with comprehensive clinical annotation","Sapre N, Hong MK, Huang JG, Pedersen J, Ryan A, Anderson P, Costello AJ, Corcoran NM, Hovens CM.","Biopreserv Biobank. 2013 Jun;11(3):166-72. doi: 10.1089/bio.2012.0062. Epub 2013 May 31.","Sapre N","Biopreserv Biobank","2013","2014/05/23","","","10.1089/bio.2012.0062"
"17272224","Molecular biology of bladder cancer","Luis NM, López-Knowles E, Real FX.","Clin Transl Oncol. 2007 Jan;9(1):5-12. doi: 10.1007/s12094-007-0003-x.","Luis NM","Clin Transl Oncol","2007","2007/02/03","","","10.1007/s12094-007-0003-x"
"19417560","Peroxisome proliferator-activated receptor gamma in bladder cancer: a promising therapeutic target","Mansure JJ, Nassim R, Kassouf W.","Cancer Biol Ther. 2009 Apr;8(7):6-15. doi: 10.4161/cbt.8.7.7853.","Mansure JJ","Cancer Biol Ther","2009","2009/05/07","","","10.4161/cbt.8.7.7853"
"29917188","Mechanism of lncRNA DUXAP8 in promoting proliferation of bladder cancer cells by regulating PTEN","Lin MG, Hong YK, Zhang Y, Lin BB, He XJ.","Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3370-3377. doi: 10.26355/eurrev_201806_15158.","Lin MG","Eur Rev Med Pharmacol Sci","2018","2018/06/20","","","10.26355/eurrev_201806_15158"
"7314335","Cystectomy for superficial bladder cancer","Bracken RB, McDonald MW, Johnson DE.","Urology. 1981 Nov;18(5):459-63. doi: 10.1016/0090-4295(81)90289-2.","Bracken RB","Urology","1981","1981/11/01","","","10.1016/0090-4295(81)90289-2"
"36278","A study on the aetiological factors of bilharzial bladder cancer in Egypt--1. Nitrosamines and their precursors in urine","El-Merzabani MM, El-Aaser AA, Zakhary NI.","Eur J Cancer. 1979 Mar;15(3):287-91. doi: 10.1016/0014-2964(79)90039-2.","El-Merzabani MM","Eur J Cancer","1979","1979/03/01","","","10.1016/0014-2964(79)90039-2"
"20205607","Intravesical therapy for bladder cancer","Williams SK, Hoenig DM, Ghavamian R, Soloway M.","Expert Opin Pharmacother. 2010 Apr;11(6):947-58. doi: 10.1517/14656561003657145.","Williams SK","Expert Opin Pharmacother","2010","2010/03/09","","","10.1517/14656561003657145"
"499168","Phenacetin abuse related to bladder cancer","Fokkens W.","Environ Res. 1979 Oct;20(1):192-8. doi: 10.1016/0013-9351(79)90097-5.","Fokkens W","Environ Res","1979","1979/10/01","","","10.1016/0013-9351(79)90097-5"
"29130146","Recent Developments in the Search for Urinary Biomarkers in Bladder Cancer","Leiblich A.","Curr Urol Rep. 2017 Nov 13;18(12):100. doi: 10.1007/s11934-017-0748-x.","Leiblich A","Curr Urol Rep","2017","2017/11/14","PMC5682315","","10.1007/s11934-017-0748-x"
"15551095","Molecular pathways in bladder cancer","Williams SG, Stein JP.","Urol Res. 2004 Dec;32(6):373-85. doi: 10.1007/s00240-003-0345-y. Epub 2004 Nov 13.","Williams SG","Urol Res","2004","2004/11/20","","","10.1007/s00240-003-0345-y"
"19817342","Diagnosis and treatment of bladder cancer","Sharma S, Ksheersagar P, Sharma P.","Am Fam Physician. 2009 Oct 1;80(7):717-23.","Sharma S","Am Fam Physician","2009","2009/10/13","","",""
"28807237","Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets","Cormio A, Sanguedolce F, Musicco C, Pesce V, Calò G, Bufo P, Carrieri G, Cormio L.","Crit Rev Oncol Hematol. 2017 Sep;117:67-72. doi: 10.1016/j.critrevonc.2017.07.001. Epub 2017 Jul 11.","Cormio A","Crit Rev Oncol Hematol","2017","2017/08/16","","","10.1016/j.critrevonc.2017.07.001"
"20566019","Tumor implantation: a rare but potentially preventable cause of death in cystectomy patients","Via KJ, Burns KM, Lamm DL.","Can J Urol. 2010 Jun;17(3):5216-8.","Via KJ","Can J Urol","2010","2010/06/23","","",""
"30706728","A two-gene methylation signature for the diagnosis of bladder cancer in urine","Bosschieter J, Nieuwenhuijzen JA, Hentschel A, van Splunter AP, Segerink LI, Vis AN, Wilting SM, Lissenberg-Witte BI, A van Moorselaar RJ, Steenbergen RD.","Epigenomics. 2019 Feb;11(3):337-347. doi: 10.2217/epi-2018-0094. Epub 2019 Feb 1.","Bosschieter J","Epigenomics","2019","2019/02/02","","","10.2217/epi-2018-0094"
"8749946","Cytotoxicity of gallium nitrate in vitro using bladder cancer cells","Aoyagi T, Bander NH.","Int J Urol. 1995 Nov;2(5):288-94.","Aoyagi T","Int J Urol","1995","1995/11/01","","",""
"28415640","Accuracy of the urine UCA1 for diagnosis of bladder cancer: a meta-analysis","Cui X, Jing X, Long C, Yi Q, Tian J, Zhu J.","Oncotarget. 2017 May 23;8(21):35222-35233. doi: 10.18632/oncotarget.16473.","Cui X","Oncotarget","2017","2017/04/19","PMC5471048","","10.18632/oncotarget.16473"
"24528060","Dickkopf-1 levels in Turkish patients with bladder cancer and its association with clinicopathological features","Kaba M, Pirincci N, Benli E, Gecit I, Gunes M, Yuksel MB, Tok A, Kemik AS.","Asian Pac J Cancer Prev. 2014;15(1):381-4. doi: 10.7314/apjcp.2014.15.1.381.","Kaba M","Asian Pac J Cancer Prev","2014","2014/02/18","","","10.7314/apjcp.2014.15.1.381"
"617699","[Total cystectomy for bilharzic bladder cancer]","Ghoneim MA, El-Bolkainy MN, Ashamallan A.","J Urol Nephrol (Paris). 1977;83 Suppl 2:371-6.","Ghoneim MA","J Urol Nephrol (Paris)","1977","1977/01/01","","",""
"17144532","[Fluorescence in situ hybridization in diagnosis of urinary bladder cancer]","Stroganova AM, Khachaturian AV.","Arkh Patol. 2006 Sep-Oct;68(5):43-6.","Stroganova AM","Arkh Patol","2006","2006/12/06","","",""
"24043006","The value of urine cytology in the diagnosis of bladder cancer. Cytopathological correlation","Abdullah LS.","Saudi Med J. 2013 Sep;34(9):937-41.","Abdullah LS","Saudi Med J","2013","2013/09/18","","",""
"26372038","Immunotherapies for bladder cancer: a new hope","Fakhrejahani F, Tomita Y, Maj-Hes A, Trepel JB, De Santis M, Apolo AB.","Curr Opin Urol. 2015 Nov;25(6):586-96. doi: 10.1097/MOU.0000000000000213.","Fakhrejahani F","Curr Opin Urol","2015","2015/09/16","PMC6777558","NIHMS1038705","10.1097/MOU.0000000000000213"
"3597148","Radical radiation and oral and intra-vesical misonidazole for bladder cancer","Abratt RP, Barnes DR, Pontin AR, Sarembock LA, Williams AM.","Int J Radiat Oncol Biol Phys. 1987 Jul;13(7):1053-5. doi: 10.1016/0360-3016(87)90044-7.","Abratt RP","Int J Radiat Oncol Biol Phys","1987","1987/07/01","","","10.1016/0360-3016(87)90044-7"
"2147716","Palmar keratoses in family members of individuals with bladder cancer","Cuzick J, Babiker A, De Stavola BL, McCance D, Cartwright R, Glashan RW.","J Clin Epidemiol. 1990;43(12):1421-6. doi: 10.1016/0895-4356(90)90111-2.","Cuzick J","J Clin Epidemiol","1990","1990/01/01","","","10.1016/0895-4356(90)90111-2"
"6872405","Arylamines and bladder cancer causality: application of conceptual and operational criteria","Lower GM Jr.","Clin Pharmacol Ther. 1983 Aug;34(2):129-35. doi: 10.1038/clpt.1983.141.","Lower GM Jr","Clin Pharmacol Ther","1983","1983/08/01","","","10.1038/clpt.1983.141"
"19539325","DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers","Mengual L, Burset M, Ars E, Lozano JJ, Villavicencio H, Ribal MJ, Alcaraz A.","J Urol. 2009 Aug;182(2):741-8. doi: 10.1016/j.juro.2009.03.084. Epub 2009 Jun 18.","Mengual L","J Urol","2009","2009/06/23","","","10.1016/j.juro.2009.03.084"
"18893799","[Cystectomy in cancer of the bladder in a woman with one kidney]","BEDRNA.","Cesk Gynekol. 1948;13(4):212.","BEDRNA","Cesk Gynekol","1948","1948/01/01","","",""
"2142802","[Neoadjuvant chemotherapy of locally advanced tumors of the bladder: introduction]","Mandressi A.","Arch Ital Urol Nefrol Androl. 1990 Jun;62(2):215-7.","Mandressi A","Arch Ital Urol Nefrol Androl","1990","1990/06/01","","",""
"6399746","[Radiological evaluation of the degree of progression and extent of the changes in bladder cancer]","Walecki J, Gomuła A, Klaczyńska E, Nurkiewicz W.","Pol Przegl Radiol. 1984 Nov-Dec;48(6):397-401.","Walecki J","Pol Przegl Radiol","1984","1984/11/01","","",""
"25794874","Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer","Begnini KR, Buss JH, Collares T, Seixas FK.","Appl Microbiol Biotechnol. 2015 May;99(9):3741-54. doi: 10.1007/s00253-015-6495-3. Epub 2015 Mar 21.","Begnini KR","Appl Microbiol Biotechnol","2015","2015/03/22","","","10.1007/s00253-015-6495-3"
"21554043","Joint genitourinary cancer symposium between Egyptian and American centers","Zaghloul MS.","Expert Rev Anticancer Ther. 2011 May;11(5):697-9. doi: 10.1586/era.11.29.","Zaghloul MS","Expert Rev Anticancer Ther","2011","2011/05/11","","","10.1586/era.11.29"
"31377169","Editorial: Bladder cancer within the focus of basic and clinical research. Sixth IBCN Seminars Series","Seiler R, Black PC, Williams SB, Goebell PJ, Kamat AM, Nawroth R, Schmitz-Dräger BJ.","Urol Oncol. 2019 Nov;37(11):815-817. doi: 10.1016/j.urolonc.2019.06.025. Epub 2019 Jul 31.","Seiler R","Urol Oncol","2019","2019/08/05","","","10.1016/j.urolonc.2019.06.025"
"30689556","Identification of biomarkers associated with progression and prognosis in bladder cancer via co-expression analysis","Shi S, Tian B.","Cancer Biomark. 2019;24(2):183-193. doi: 10.3233/CBM-181940.","Shi S","Cancer Biomark","2019","2019/01/29","","","10.3233/CBM-181940"
"2800075","[The combined treatment of bladder cancer]","Kariakin OB, Dunchik VN, Sakharova OV, Grishin GN.","Urol Nefrol (Mosk). 1989 Jul-Aug;(4):34-9.","Kariakin OB","Urol Nefrol (Mosk)","1989","1989/07/01","","",""
"31670586","Application of R2* and Apparent Diffusion Coefficient in Estimating Tumor Grade and T Category of Bladder Cancer","Wang Y, Shen Y, Hu X, Li Z, Feng C, Hu D, Kamel IR.","AJR Am J Roentgenol. 2020 Feb;214(2):383-389. doi: 10.2214/AJR.19.21668. Epub 2019 Oct 31.","Wang Y","AJR Am J Roentgenol","2020","2019/11/01","","","10.2214/AJR.19.21668"
"21707291","Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer","Daneshmand S, Bartsch G.","Expert Rev Anticancer Ther. 2011 Jun;11(6):941-8. doi: 10.1586/era.11.19.","Daneshmand S","Expert Rev Anticancer Ther","2011","2011/06/29","","","10.1586/era.11.19"
"22925707","Prognostic significance of Bacillus Calmette-Guérin failure classification in non-muscle-invasive bladder cancer","Singh BP, Dhakad U.","BJU Int. 2012 Sep;110(6):E163-4. doi: 10.1111/j.1464-410X.2012.10742.x.","Singh BP","BJU Int","2012","2012/08/29","","","10.1111/j.1464-410X.2012.10742.x"
"29234154","LncRNA-SNHG16 predicts poor prognosis and promotes tumor proliferation through epigenetically silencing p21 in bladder cancer","Cao X, Xu J, Yue D.","Cancer Gene Ther. 2018 Feb;25(1-2):10-17. doi: 10.1038/s41417-017-0006-x. Epub 2017 Dec 12.","Cao X","Cancer Gene Ther","2018","2017/12/14","","","10.1038/s41417-017-0006-x"
"23624844","Gene expression is highly correlated on the chromosome level in urinary bladder cancer","Lambrou GI, Adamaki M, Delakas D, Spandidos DA, Vlahopoulos S, Zaravinos A.","Cell Cycle. 2013 May 15;12(10):1544-59. doi: 10.4161/cc.24673. Epub 2013 May 8.","Lambrou GI","Cell Cycle","2013","2013/04/30","PMC3680534","","10.4161/cc.24673"
"20553203","Can urinary biomarkers replace cystoscopic examination in bladder cancer surveillance?","Yutkin V, Nisman B, Pode D.","Expert Rev Anticancer Ther. 2010 Jun;10(6):787-90. doi: 10.1586/era.10.75.","Yutkin V","Expert Rev Anticancer Ther","2010","2010/06/18","","","10.1586/era.10.75"
"10213331","Screening cystoscopy in chronically catheterized spinal cord injury patients","Yang CC, Clowers DE.","Spinal Cord. 1999 Mar;37(3):204-7. doi: 10.1038/sj.sc.3100767.","Yang CC","Spinal Cord","1999","1999/04/23","","","10.1038/sj.sc.3100767"
"11394455","Laser treatment for invasive and noninvasive carcinoma of the bladder","Pietrow PK, Smith JA Jr.","J Endourol. 2001 May;15(4):415-8; discussion 425-6. doi: 10.1089/089277901300189466.","Pietrow PK","J Endourol","2001","2001/06/08","","","10.1089/089277901300189466"
"15616879","Chemoradiotherapy as a bladder-preservation approach for muscle-invasive bladder cancer: current status and perspectives","Sumiyoshi Y.","Int J Clin Oncol. 2004 Dec;9(6):484-90. doi: 10.1007/s10147-004-0434-0.","Sumiyoshi Y","Int J Clin Oncol","2004","2004/12/24","","","10.1007/s10147-004-0434-0"
"24942859","Loss of periplakin expression is associated with pathological stage and cancer-specific survival in patients with urothelial carcinoma of the urinary bladder","Matsumoto K, Ikeda M, Sato Y, Kuruma H, Kamata Y, Nishimori T, Tomonaga T, Nomura F, Egawa S, Iwamura M.","Biomed Res. 2014;35(3):201-6. doi: 10.2220/biomedres.35.201.","Matsumoto K","Biomed Res","2014","2014/06/20","","","10.2220/biomedres.35.201"
"29333514","What is the fate of artificial urinary sphincters among men undergoing repetitive bladder cancer treatment?","Heiner SM, Viers BR, Rivera ME, Linder BJ, Elliott DS.","Investig Clin Urol. 2018 Jan;59(1):44-48. doi: 10.4111/icu.2018.59.1.44. Epub 2017 Dec 28.","Heiner SM","Investig Clin Urol","2018","2018/01/16","PMC5754582","","10.4111/icu.2018.59.1.44"
"22159313","Growth differentiation factor-9 expression is inversely correlated with an aggressive behaviour in human bladder cancer cells","Du P, Ye L, Li H, Ruge F, Yang Y, Jiang WG.","Int J Mol Med. 2012 Mar;29(3):428-34. doi: 10.3892/ijmm.2011.858. Epub 2011 Dec 12.","Du P","Int J Mol Med","2012","2011/12/14","","","10.3892/ijmm.2011.858"
"2475266","Immunoglobulin A and alpha 2-macroglobulin as tumor markers in bladder cancer","Khalifa A, Fathi O, Mousa MA, el Magraby H.","Chemioterapia. 1987 Jun;6(2 Suppl):736-7.","Khalifa A","Chemioterapia","1987","1987/06/01","","",""
"11842745","Radiochemotherapy for T1G3 bladder cancer","Dunst J, Rödel C, Diestelhorst A, Heynemann H, Schrott KM, Sauer R.","Front Radiat Ther Oncol. 2002;36:151-8. doi: 10.1159/000061338.","Dunst J","Front Radiat Ther Oncol","2002","2002/02/15","","","10.1159/000061338"
"5064631","[Urinary bladder cancer]","Ito N, Okajima E.","Nihon Rinsho. 1972 Jan;30(1):450-3.","Ito N","Nihon Rinsho","1972","1972/01/01","","",""
"28183696","Nivolumab Gets FDA Nod for Bladder Cancer","","Cancer Discov. 2017 Apr;7(4):OF7. doi: 10.1158/2159-8290.CD-NB2017-021. Epub 2017 Feb 9.","","Cancer Discov","2017","2017/02/11","","","10.1158/2159-8290.CD-NB2017-021"
"17986289","Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study","Denzinger S, Wieland WF, Otto W, Filbeck T, Knuechel R, Burger M.","BJU Int. 2008 Mar;101(5):566-9. doi: 10.1111/j.1464-410X.2007.07314.x. Epub 2007 Nov 5.","Denzinger S","BJU Int","2008","2007/11/08","","","10.1111/j.1464-410X.2007.07314.x"
"12406054","Bladder cancer: epidemiology, diagnosis, and management","Pashos CL, Botteman MF, Laskin BL, Redaelli A.","Cancer Pract. 2002 Nov-Dec;10(6):311-22. doi: 10.1046/j.1523-5394.2002.106011.x.","Pashos CL","Cancer Pract","2002","2002/10/31","","","10.1046/j.1523-5394.2002.106011.x"
"29146119","An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis","Davidson MB, Pan D.","Diabetes Res Clin Pract. 2018 Jan;135:102-110. doi: 10.1016/j.diabres.2017.11.002. Epub 2017 Nov 13.","Davidson MB","Diabetes Res Clin Pract","2018","2017/11/18","","","10.1016/j.diabres.2017.11.002"
"11776091","Clinical application of radioimmunoimaging with 99mTc-BDI-1 in the diagnosis of bladder cancer","Wang R, Zhang C, Yu L, Guo Y.","Chin Med J (Engl). 2000 May;113(5):396-9.","Wang R","Chin Med J (Engl)","2000","2002/01/05","","",""
"875214","Early detection but delayed appearance of a bladder tumor","Marshall VF, Seybolt JF.","J Urol. 1977 Jul;118(1 Pt 2):175-6. doi: 10.1016/s0022-5347(17)57939-2.","Marshall VF","J Urol","1977","1977/07/01","","","10.1016/s0022-5347(17)57939-2"
"10470204","BTA-TRAK--a useful diagnostic tool in urinary bladder cancer?","Mahnert B, Tauber S, Kriegmair M, Schmitt UM, Hasholzner U, Reiter W, Hofmann K, Schmeller N, Stieber P.","Anticancer Res. 1999 Jul-Aug;19(4A):2615-9.","Mahnert B","Anticancer Res","1999","1999/09/02","","",""
"23734524","[Early diagnostics of bladder cancer recurrence with fluorescence in situ hybridization method in the first 24 months after a transurethral resection of a bladder in old and elderly persons]","Pushkin AS, Ryzhak GA.","Adv Gerontol. 2012;25(4):745-8.","Pushkin AS","Adv Gerontol","2012","2013/06/06","","",""
"23485510","Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study","García-Baquero R, Puerta P, Beltran M, Alvarez M, Sacristan R, Alvarez-Ossorio JL, Sánchez-Carbayo M.","J Urol. 2013 Aug;190(2):723-30. doi: 10.1016/j.juro.2013.01.105. Epub 2013 Feb 26.","García-Baquero R","J Urol","2013","2013/03/15","","","10.1016/j.juro.2013.01.105"
"23387725","Control over structure-specific flexibility improves anatomical accuracy for point-based deformable registration in bladder cancer radiotherapy","Wognum S, Bondar L, Zolnay AG, Chai X, Hulshof MC, Hoogeman MS, Bel A.","Med Phys. 2013 Feb;40(2):021702. doi: 10.1118/1.4773040.","Wognum S","Med Phys","2013","2013/02/08","","","10.1118/1.4773040"
"9290162","Bladder cancer in Estonia, 1968-1992: incidence, mortality, prevalence and survival","Timberg G, Rahu M, Gornoi K, Aareleid T, Baburin A.","Scand J Urol Nephrol. 1997 Aug;31(4):337-42. doi: 10.3109/00365599709030616.","Timberg G","Scand J Urol Nephrol","1997","1997/08/01","","","10.3109/00365599709030616"
"18480628","Clinical value of PTEN in patients with superficial bladder cancer","Han KS, Jeong IG, Joung JY, Yang SO, Chung J, Seo HK, Kwon KS, Park WS, Lee KH.","Urol Int. 2008;80(3):264-9. doi: 10.1159/000127338. Epub 2008 May 14.","Han KS","Urol Int","2008","2008/05/16","","","10.1159/000127338"
"19351661","Bladder preservation therapy conducted by intra-arterial chemotherapy and radiotherapy for muscle invasive bladder cancer","Hashine K, Kusuhara Y, Miura N, Shirato A, Sumiyoshi Y, Kataoka M.","Jpn J Clin Oncol. 2009 Jun;39(6):381-6. doi: 10.1093/jjco/hyp023. Epub 2009 Apr 7.","Hashine K","Jpn J Clin Oncol","2009","2009/04/09","","","10.1093/jjco/hyp023"
"2340369","Prediction of response to radiotherapy in invasive bladder cancer","Jenkins BJ, Martin JE, Baithun SI, Zuk RJ, Oliver RT, Blandy JP.","Br J Urol. 1990 Apr;65(4):345-8. doi: 10.1111/j.1464-410x.1990.tb14753.x.","Jenkins BJ","Br J Urol","1990","1990/04/01","","","10.1111/j.1464-410x.1990.tb14753.x"
"19162510","Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer","Inamoto T, Shah JB, Kamat AM.","Urol Oncol. 2009 Nov-Dec;27(6):585-91. doi: 10.1016/j.urolonc.2008.11.002. Epub 2009 Jan 22.","Inamoto T","Urol Oncol","2009","2009/01/24","","","10.1016/j.urolonc.2008.11.002"
"18823035","Neoadjuvant gemcitabine and cisplatin: another step on the path toward improving the outcomes of patients with high-risk, invasive bladder cancer","Nielsen ME.","Cancer. 2008 Nov 1;113(9):2379-81. doi: 10.1002/cncr.23849.","Nielsen ME","Cancer","2008","2008/10/01","","","10.1002/cncr.23849"
"23773558","Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit?","Niegisch G, Lorch A, Droller MJ, Lavery HJ, Stensland KD, Albers P.","Eur Urol. 2013 Sep;64(3):355-7. doi: 10.1016/j.eururo.2013.06.002. Epub 2013 Jun 12.","Niegisch G","Eur Urol","2013","2013/06/19","","","10.1016/j.eururo.2013.06.002"
"4203019","Proceedings: Megavoltage irradiation for bladder cancer: alone, postoperative, or preoperative?","Miller LS, Johnson DE.","Proc Natl Cancer Conf. 1972;7:771-82.","Miller LS","Proc Natl Cancer Conf","1972","1972/01/01","","",""
"24606498","Bladder cancer: innovative approaches beyond the diagnosis","Piergentili R, Carradori S, Gulia C, De Monte C, Cristini C, Grande P, Santini E, Gentile V, Di Pierro GB.","Curr Med Chem. 2014;21(20):2219-36. doi: 10.2174/0929867321666140304110231.","Piergentili R","Curr Med Chem","2014","2014/03/11","","","10.2174/0929867321666140304110231"
"2405977","Bladder cancer in geriatric patients. Alternatives to radical cystectomy","Nitti VW, Macchia RJ.","Clin Geriatr Med. 1990 Feb;6(1):173-84.","Nitti VW","Clin Geriatr Med","1990","1990/02/01","","",""
"2449781","[The problem of urinary bladder cancer--an attempt at a therapeutic standard]","Langkopf B, Hofmann W.","Z Urol Nephrol. 1987 Nov;80(11):647-51.","Langkopf B","Z Urol Nephrol","1987","1987/11/01","","",""
"9609335","Human papillomavirus and bladder cancer","Boucher NR, Anderson JB.","Int Urogynecol J Pelvic Floor Dysfunct. 1997;8(6):354-7. doi: 10.1007/BF02765596.","Boucher NR","Int Urogynecol J Pelvic Floor Dysfunct","1997","1997/01/01","","","10.1007/BF02765596"
"23544191","Optimizing outcomes for octogenarians with invasive bladder cancer: One size does not fit all","Resnick MJ, Chang SS.","Urol Oncol. 2013 Jan;31(1):1-4. doi: 10.1016/j.urolonc.2011.12.024.","Resnick MJ","Urol Oncol","2013","2013/04/02","","","10.1016/j.urolonc.2011.12.024"
"23075724","Shorter recurrence-free survival time, higher risk of multiple recurrences: a retrospective study of non-muscle invasive bladder cancer after transurethral resection","Deng N, Chen JX, Chen LW, Qiu SP, Li XF, Wang DH.","Chin Med J (Engl). 2012 Oct;125(20):3681-6.","Deng N","Chin Med J (Engl)","2012","2012/10/19","","",""
"27900539","SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)","Lázaro M, Gallardo E, Doménech M, Pinto Á, González-del-Alba A, Del Alba AG, Puente J, Fernández O, Font A, Lainez N, Vázquez S.","Clin Transl Oncol. 2016 Dec;18(12):1197-1205. doi: 10.1007/s12094-016-1584-z. Epub 2016 Nov 29.","Lázaro M","Clin Transl Oncol","2016","2016/12/01","PMC5138255","","10.1007/s12094-016-1584-z"
"2356842","Investigation of a bladder cancer cluster in northwestern Illinois","Mallin K.","Am J Epidemiol. 1990 Jul;132(1 Suppl):S96-106. doi: 10.1093/oxfordjournals.aje.a115795.","Mallin K","Am J Epidemiol","1990","1990/07/01","","","10.1093/oxfordjournals.aje.a115795"
"16617868","[A large amount of distilled water ineffective for prevention of bladder cancer cell implantation at the time of transurethral resection]","Sakai Y, Fujii Y, Hyochi N, Masuda H, Kawakami S, Kobayashi T, Kageyama Y, Kihara K.","Hinyokika Kiyo. 2006 Mar;52(3):173-5.","Sakai Y","Hinyokika Kiyo","2006","2006/04/19","","",""
"30262197","Critical Questions To Optimize Intravesical Therapy for Non-muscle-invasive Bladder Cancer","Black P.","Eur Urol Focus. 2018 Jul;4(4):463. doi: 10.1016/j.euf.2018.09.004. Epub 2018 Sep 24.","Black P","Eur Urol Focus","2018","2018/09/29","","","10.1016/j.euf.2018.09.004"
"936369","Cytologic and histopathologic study of bladder cancer patients","Friedell GH, Soto EA, Nagy GK.","Urol Clin North Am. 1976 Feb;3(1):71-8.","Friedell GH","Urol Clin North Am","1976","1976/02/01","","",""
"7627835","A new tumor marker for bladder cancer","Koiso K, Akaza H, Ohtani M, Miyanaga N, Aoyagi K.","Int J Urol. 1994 Mar;1(1):33-6. doi: 10.1111/j.1442-2042.1994.tb00005.x.","Koiso K","Int J Urol","1994","1994/03/01","","","10.1111/j.1442-2042.1994.tb00005.x"
"30298694","Bladder cancer surveillance in patients with spinal cord injuries","Qu LG, Lawrentschuk N.","BJU Int. 2019 Mar;123(3):379-380. doi: 10.1111/bju.14582. Epub 2018 Nov 16.","Qu LG","BJU Int","2019","2018/10/10","","","10.1111/bju.14582"
"4695100","Radical cystectomy for bladder cancer: 10-year survival","Pearse HD, Pappas JT, Hodges CV.","J Urol. 1973 Apr;109(4):623-4. doi: 10.1016/s0022-5347(17)60497-x.","Pearse HD","J Urol","1973","1973/04/01","","","10.1016/s0022-5347(17)60497-x"
"24996129","Transurethral bladder tumor resection can cause seeding of cancer cells into the bloodstream","Engilbertsson H, Aaltonen KE, Björnsson S, Kristmundsson T, Patschan O, Rydén L, Gudjonsson S.","J Urol. 2015 Jan;193(1):53-7. doi: 10.1016/j.juro.2014.06.083. Epub 2014 Jul 1.","Engilbertsson H","J Urol","2015","2014/07/05","","","10.1016/j.juro.2014.06.083"
"25889321","Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer","Bi D, Ning H, Liu S, Que X, Ding K.","Comput Biol Chem. 2015 Jun;56:71-83. doi: 10.1016/j.compbiolchem.2015.04.001. Epub 2015 Apr 15.","Bi D","Comput Biol Chem","2015","2015/04/19","","","10.1016/j.compbiolchem.2015.04.001"
"21598245","Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: a multidisciplinary approach","Alva AS, Tallman CT, He C, Hussain MH, Hafez K, Montie JE, Smith DC, Weizer AZ, Wood D, Lee CT.","Cancer. 2012 Jan 1;118(1):44-53. doi: 10.1002/cncr.26240. Epub 2011 May 19.","Alva AS","Cancer","2012","2011/05/21","","","10.1002/cncr.26240"
"3605053","A case-control study of bladder cancer using city directories as a source of occupational data","Steenland K, Burnett C, Osorio AM.","Am J Epidemiol. 1987 Aug;126(2):247-57. doi: 10.1093/aje/126.2.247.","Steenland K","Am J Epidemiol","1987","1987/08/01","","","10.1093/aje/126.2.247"
"3686753","Enhanced radioinduced cytotoxicity of cultured human bladder cancer cells using 43 degrees C hyperthermia or anticancer drugs","Nakajima K, Hisazumi H.","Urol Res. 1987;15(5):255-60. doi: 10.1007/BF00258191.","Nakajima K","Urol Res","1987","1987/01/01","","","10.1007/BF00258191"
"7294542","Bladder cancer diagnosis by image analysis of cells in voided urine using a small computer","Sherman A, Koss LG, Adams S, Schreiber K, Moussouris HF, Freed SZ, Bartels PH, Wied GL.","Anal Quant Cytol. 1981 Sep;3(3):239-49.","Sherman A","Anal Quant Cytol","1981","1981/09/01","","",""
"30653591","A multi-institutional study of bladder-preserving therapy for stage II-IV bladder cancer: A Korean Radiation Oncology Group Study (KROG 14-16)","Byun SJ, Park W, Cho KH, Cho J, Chang AR, Kang KM, Kim JH, Kim JH.","PLoS One. 2019 Jan 17;14(1):e0209998. doi: 10.1371/journal.pone.0209998. eCollection 2019.","Byun SJ","PLoS One","2019","2019/01/18","PMC6336268","","10.1371/journal.pone.0209998"
"15922428","Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population","Schrag D, Mitra N, Xu F, Rabbani F, Bach PB, Herr H, Begg CB.","Urology. 2005 Jun;65(6):1118-25. doi: 10.1016/j.urology.2004.12.029.","Schrag D","Urology","2005","2005/06/01","","","10.1016/j.urology.2004.12.029"
"15049580","Primary care update on kidney and bladder cancer: a urologic perspective","Droller MJ.","Med Clin North Am. 2004 Mar;88(2):309-28, x. doi: 10.1016/S0025-7125(03)00170-6.","Droller MJ","Med Clin North Am","2004","2004/03/31","","","10.1016/S0025-7125(03)00170-6"
"872120","Surveillance, initial assessment, and subsequent progress of patients with superficial bladder cancer in a prospective longitudinal study. National Bladder Cancer Collaborative Group A (NBCCGA)","","Cancer Res. 1977 Aug;37(8 Pt 2):2907-10.","","Cancer Res","1977","1977/08/01","","",""
"26939993","Overview of bladder heating technology: matching capabilities with clinical requirements","Stauffer PR, van Rhoon GC.","Int J Hyperthermia. 2016 Jun;32(4):407-16. doi: 10.3109/02656736.2016.1141239. Epub 2016 Mar 4.","Stauffer PR","Int J Hyperthermia","2016","2016/03/05","PMC4968693","NIHMS802887","10.3109/02656736.2016.1141239"
"19138196","Unusual occurrence of neuroleptic malignant syndrome in urological surgery: a case report following radical cystectomy for invasive bladder cancer","Sejima T.","Int J Urol. 2008 Oct;15(11):1023. doi: 10.1111/j.1442-2042.2008.02159.x.","Sejima T","Int J Urol","2008","2009/01/14","","","10.1111/j.1442-2042.2008.02159.x"
"24737586","DNA damage-inducible gene, UNC5A, functions as a tumor-suppressor in bladder cancer","Zhu Y, Yu M, Chen Y, Wang Y, Wang J, Yang C, Bi J.","Tumour Biol. 2014 Jul;35(7):6887-91. doi: 10.1007/s13277-014-1930-0. Epub 2014 Apr 16.","Zhu Y","Tumour Biol","2014","2014/04/17","","","10.1007/s13277-014-1930-0"
"6676554","[Biochemical marker of malignant bladder tumors--polyamine concentration in tissues of bladder cancer]","Kiyohara H, Saiki S, Kinouchi T, Kuroda M, Kotake T, Matsuda M.","Nihon Hinyokika Gakkai Zasshi. 1983 Oct;74(10):1749-57. doi: 10.5980/jpnjurol1928.74.10_1749.","Kiyohara H","Nihon Hinyokika Gakkai Zasshi","1983","1983/10/01","","","10.5980/jpnjurol1928.74.10_1749"
"30086593","[Practice Pattern of Systemic Therapy for Urothelial Cancer in Germany - A Survey of the German Cancer Society]","Hupe MC, Merseburger AS, de Wit M, Rexer H, Gschwend JE, Krege S.","Aktuelle Urol. 2018 Aug;49(4):346-354. doi: 10.1055/a-0645-1076. Epub 2018 Aug 7.","Hupe MC","Aktuelle Urol","2018","2018/08/08","","","10.1055/a-0645-1076"
"3382235","[Studies on the clinical effectiveness of combination therapy with irradiation and chemotherapy for advanced bladder cancer]","Koiso K, Kanoh S, Rinsho K, Ishikawa S, Ohtani M, Takeshima H, Noguchi R.","Gan To Kagaku Ryoho. 1988 Apr;15(4 Pt 2-3):1646-51.","Koiso K","Gan To Kagaku Ryoho","1988","1988/04/01","","",""
"482958","Urinary bladder cancer: potentials of and problems associated with early intervention strategies","Bryan GT.","Semin Oncol. 1979 Jun;6(2):161-5.","Bryan GT","Semin Oncol","1979","1979/06/01","","",""
"31650173","LncRNA-MALAT1 mediates cisplatin resistance via miR-101-3p/VEGF-C pathway in bladder cancer","Liu P, Li X, Cui Y, Chen J, Li C, Li Q, Li H, Zhang X, Zu X.","Acta Biochim Biophys Sin (Shanghai). 2019 Nov 18;51(11):1148-1157. doi: 10.1093/abbs/gmz112.","Liu P","Acta Biochim Biophys Sin (Shanghai)","2019","2019/10/26","","","10.1093/abbs/gmz112"
"28753798","Selection Effects May Explain Smoking-related Outcome Differences After Radical Cystectomy","Froehner M, Koch R, Hübler M, Heberling U, Novotny V, Zastrow S, Baretton GB, Wirth MP.","Eur Urol Focus. 2018 Apr;4(3):395-398. doi: 10.1016/j.euf.2016.10.003. Epub 2016 Oct 26.","Froehner M","Eur Urol Focus","2018","2017/07/30","","","10.1016/j.euf.2016.10.003"
"22206799","Re: Sven van den Bosch, J. Alfred Witjes. Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review. Eur Urol 2011;60:493-500","Banerjee S, Kumar V.","Eur Urol. 2012 Mar;61(3):e13. doi: 10.1016/j.eururo.2011.12.025. Epub 2011 Dec 22.","Banerjee S","Eur Urol","2012","2011/12/31","","","10.1016/j.eururo.2011.12.025"
"27199504","Prognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-Analysis","Gan X, Lin X, He R, Lin X, Wang H, Yan L, Zhou H, Qin H, Chen G.","Dis Markers. 2016;2016:5259602. doi: 10.1155/2016/5259602. Epub 2016 Apr 20.","Gan X","Dis Markers","2016","2016/05/21","PMC4854991","","10.1155/2016/5259602"
"753011","Experience with high dose, short course preoperative radiation therapy and immediate single stage cystectomy in management of bladder cancer: a preliminary report","Skinner DG, Kaufman JJ, Tift JP.","Trans Am Assoc Genitourin Surg. 1978;70:113-8.","Skinner DG","Trans Am Assoc Genitourin Surg","1978","1978/01/01","","",""
"1305693","Chromosome changes in early bladder neoplasms","Sandberg AA.","J Cell Biochem Suppl. 1992;16I:76-9. doi: 10.1002/jcb.240501317.","Sandberg AA","J Cell Biochem Suppl","1992","1992/01/01","","","10.1002/jcb.240501317"
"2074510","Bladder cancer screening among primary aluminum production workers in Quebec","Thériault GP, Tremblay CG, Armstrong BG.","J Occup Med. 1990 Sep;32(9):869-72. doi: 10.1097/00043764-199009000-00021.","Thériault GP","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00021"
"2171057","[A new non-surgically implantable catheter port system for locoregional chemotherapy of advanced bladder cancer]","Strecker EP, Michaelis W, Claus T, Tsikuras P.","Rofo. 1990 Sep;153(3):260-5. doi: 10.1055/s-2008-1033375.","Strecker EP","Rofo","1990","1990/09/01","","","10.1055/s-2008-1033375"
"18289582","Assessing the value of reflex fluorescence in situ hybridization testing in the diagnosis of bladder cancer when routine urine cytological examination is equivocal","Kipp BR, Halling KC, Campion MB, Wendel AJ, Karnes RJ, Zhang J, Sebo TJ.","J Urol. 2008 Apr;179(4):1296-301; discussion 1301. doi: 10.1016/j.juro.2007.11.082. Epub 2008 Mar 4.","Kipp BR","J Urol","2008","2008/02/22","","","10.1016/j.juro.2007.11.082"
"7014931","Treatment of residual, non-infiltrating bladder cancer with bacillus Calmette-Guerin","Morales A, Ottenhof P, Emerson L.","J Urol. 1981 May;125(5):649-51. doi: 10.1016/s0022-5347(17)55150-2.","Morales A","J Urol","1981","1981/05/01","","","10.1016/s0022-5347(17)55150-2"
"31241937","Sulforaphane Inhibits Nonmuscle Invasive Bladder Cancer Cells Proliferation through Suppression of HIF-1α-Mediated Glycolysis in Hypoxia","Xia Y, Kang TW, Jung YD, Zhang C, Lian S.","J Agric Food Chem. 2019 Jul 17;67(28):7844-7854. doi: 10.1021/acs.jafc.9b03027. Epub 2019 Jul 9.","Xia Y","J Agric Food Chem","2019","2019/06/27","","","10.1021/acs.jafc.9b03027"
"23173870","Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer","Wang S, Xue S, Dai Y, Yang J, Chen Z, Fang X, Zhou W, Wu W, Li Q.","Diagn Pathol. 2012 Nov 22;7:159. doi: 10.1186/1746-1596-7-159.","Wang S","Diagn Pathol","2012","2012/11/24","PMC3539897","","10.1186/1746-1596-7-159"
"7268999","The diagnostic and prognostic value of urinary polyamine measurement in bladder cancer","Pastorini P, Milano G, Toubol J, Raymond G, Cambon P, Lalanne CM.","Urol Res. 1981;9(1):13-6. doi: 10.1007/BF00256832.","Pastorini P","Urol Res","1981","1981/01/01","","","10.1007/BF00256832"
"14572754","Localization of avidin in superficial bladder cancer: a potentially new approach for radionuclide therapy","Chinol M, De Cobelli O, Trifirò G, Scardino E, Bartolomei M, Verweij F, Papi S, Matei DV, Paganelli G.","Eur Urol. 2003 Nov;44(5):556-9. doi: 10.1016/s0302-2838(03)00369-5.","Chinol M","Eur Urol","2003","2003/10/24","","","10.1016/s0302-2838(03)00369-5"
"6152561","Arylsulfatase A activities in urine and tissues taken from bladder cancer patients","Mitsuhashi K, Maru A, Koyanagi T, Ishibashi T, Imai Y, Gasa S, Taniguchi N, Makita A.","Jpn J Exp Med. 1984 Oct;54(5):211-6.","Mitsuhashi K","Jpn J Exp Med","1984","1984/10/01","","",""
"18399340","Urinary bladder cancer and schistosomiasis in North-Western Nigeria","Mungadi IA, Malami SA.","West Afr J Med. 2007 Jul-Sep;26(3):226-9. doi: 10.4314/wajm.v26i3.28315.","Mungadi IA","West Afr J Med","2007","2008/04/11","","","10.4314/wajm.v26i3.28315"
"30773067","Recent advances in the metabolomic study of bladder cancer","Amara CS, Vantaku V, Lotan Y, Putluri N.","Expert Rev Proteomics. 2019 Apr;16(4):315-324. doi: 10.1080/14789450.2019.1583105. Epub 2019 Feb 26.","Amara CS","Expert Rev Proteomics","2019","2019/02/19","PMC6538267","NIHMS1522033","10.1080/14789450.2019.1583105"
"246580","[Cancer of the bladder: elements of care]","Bregetzer J.","Rev Infirm. 1978 Mar;28(3):193-201.","Bregetzer J","Rev Infirm","1978","1978/03/01","","",""
"7768969","Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer","Lipponen PK, Eskelinen MJ.","J Cancer Res Clin Oncol. 1995;121(5):303-8. doi: 10.1007/BF01209598.","Lipponen PK","J Cancer Res Clin Oncol","1995","1995/01/01","","","10.1007/BF01209598"
"31663405","Management and outcome of muscle-invasive bladder cancer with clinical lymph node metastases. A nationwide population-based study in the bladder cancer data base Sweden (BladderBaSe)","Aljabery F, Liedberg F, Häggström C, Ströck V, Hosseini A, Gårdmark T, Sherif A, Jerlström T, Malmström PU, Holmberg L, Hagberg O, Jahnson S.","Scand J Urol. 2019 Oct;53(5):332-338. doi: 10.1080/21681805.2019.1681504. Epub 2019 Oct 30.","Aljabery F","Scand J Urol","2019","2019/10/31","","","10.1080/21681805.2019.1681504"
"25724433","Preoperative imaging for staging bladder cancer","McKibben MJ, Woods ME.","Curr Urol Rep. 2015 Apr;16(4):22. doi: 10.1007/s11934-015-0496-8.","McKibben MJ","Curr Urol Rep","2015","2015/03/01","","","10.1007/s11934-015-0496-8"
"3444168","[An experimental study of attachment to collagen, utilizing an established cell line of human urinary bladder cancer (T24)]","Hirano K.","Nihon Hinyokika Gakkai Zasshi. 1987 Oct;78(10):1754-63. doi: 10.5980/jpnjurol1928.78.10_1754.","Hirano K","Nihon Hinyokika Gakkai Zasshi","1987","1987/10/01","","","10.5980/jpnjurol1928.78.10_1754"
"7683345","The effect of methylene blue-sensitized photodynamic treatment on bladder cancer cells: a further study on flow cytometric basis","Yu DS, Chang SY, Ma CP.","J Urol. 1993 May;149(5):1198-201. doi: 10.1016/s0022-5347(17)36347-4.","Yu DS","J Urol","1993","1993/05/01","","","10.1016/s0022-5347(17)36347-4"
"1538437","Management of local bacillus Calmette-Guerin failures in superficial bladder cancer","Klein EA, Rogatko A, Herr HW.","J Urol. 1992 Mar;147(3):601-5. doi: 10.1016/s0022-5347(17)37317-2.","Klein EA","J Urol","1992","1992/03/01","","","10.1016/s0022-5347(17)37317-2"
"9366325","Radical cystectomy in the octogenarian","Stroumbakis N, Herr HW, Cookson MS, Fair WR.","J Urol. 1997 Dec;158(6):2113-7. doi: 10.1016/s0022-5347(01)68171-0.","Stroumbakis N","J Urol","1997","1997/11/20","","","10.1016/s0022-5347(01)68171-0"
"27596300","Association of thymosin β4 expression with clinicopathological parameters and clinical outcomes of bladder cancer patients","Wang ZY, Zhang W, Yang JJ, Song DK, Wei JX, Gao S.","Neoplasma. 2016;63(6):991-998. doi: 10.4149/neo_2016_619.","Wang ZY","Neoplasma","2016","2016/09/07","","","10.4149/neo_2016_619"
"25132313","Novel endoscopic diagnosis for bladder cancer","Lerner SP, Goh A.","Cancer. 2015 Jan 15;121(2):169-78. doi: 10.1002/cncr.28905. Epub 2014 Aug 5.","Lerner SP","Cancer","2015","2014/08/19","","","10.1002/cncr.28905"
"3765237","Squamous cell carcinoma of bladder: an increased incidence in blacks","Schroder LE, Weiss MA, Hughes C.","Urology. 1986 Oct;28(4):288-91. doi: 10.1016/0090-4295(86)90006-3.","Schroder LE","Urology","1986","1986/10/01","","","10.1016/0090-4295(86)90006-3"
"22702358","Urine epigenomics: a promising path for bladder cancer diagnostics","Sánchez-Carbayo M.","Expert Rev Mol Diagn. 2012 Jun;12(5):429-32. doi: 10.1586/erm.12.42.","Sánchez-Carbayo M","Expert Rev Mol Diagn","2012","2012/06/19","","","10.1586/erm.12.42"
"23737352","Recurrence of high-risk bladder cancer: a population-based analysis","Chamie K, Litwin MS, Bassett JC, Daskivich TJ, Lai J, Hanley JM, Konety BR, Saigal CS; Urologic Diseases in America Project.","Cancer. 2013 Sep 1;119(17):3219-27. doi: 10.1002/cncr.28147. Epub 2013 Jun 4.","Chamie K","Cancer","2013","2013/06/06","PMC3773281","NIHMS470747","10.1002/cncr.28147"
"15985089","Sigmoidorectal (Mainz II) pouch for continent urinary diversion in bladder cancer","Triantafyllidis A, Rombis V, Papatsoris AG, Papathanasiou A, Kalaitzis C, Touloupidis S.","Int J Urol. 2005 Jun;12(6):599-602. doi: 10.1111/j.1442-2042.2005.01100.x.","Triantafyllidis A","Int J Urol","2005","2005/06/30","","","10.1111/j.1442-2042.2005.01100.x"
"31154670","Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer","Trenti E, D'Elia C, Mian C, Schwienbacher C, Hanspeter E, Pycha A, Kafka M, Degener S, Danuser H, Roth S, Pycha A.","Cancer Cytopathol. 2019 Jul;127(7):465-469. doi: 10.1002/cncy.22152. Epub 2019 Jun 2.","Trenti E","Cancer Cytopathol","2019","2019/06/03","","","10.1002/cncy.22152"
"31464892","GPR137 is a promising novel bio-marker for the prognosis of bladder cancer patients","Lu J, Zhong F, Sun B, Wang C.","Medicine (Baltimore). 2019 Aug;98(35):e16576. doi: 10.1097/MD.0000000000016576.","Lu J","Medicine (Baltimore)","2019","2019/08/30","PMC6736378","","10.1097/MD.0000000000016576"
"7069829","High dose, short course preoperative radiation therapy and immediate single stage radical cystectomy with pelvic node dissection in the management of bladder cancer","Skinner DG, Tift JP, Kaufman JJ.","J Urol. 1982 Apr;127(4):671-4. doi: 10.1016/s0022-5347(17)53986-5.","Skinner DG","J Urol","1982","1982/04/01","","","10.1016/s0022-5347(17)53986-5"
"23052262","[Assessment of clinical features in solitary minimum size (<1 cm) bladder cancer]","Suzuki K, Nohda H, Funahashi M, Chiba K, Shinagawa T, Mizuno N, Fujikawa N, Murakami T, Ikeda I, Kono N.","Hinyokika Kiyo. 2012 Aug;58(8):401-4.","Suzuki K","Hinyokika Kiyo","2012","2012/10/12","","",""
"16882077","Laparoscopic radical cystectomy and bilateral ureteric ligation for muscle-invasive bladder cancer in a patient on hemodialysis","Ishii D, Irie A, Matsumoto K, Tojo T, Taoka Y, Iwamura M, Yoshida K, Baba S.","Int J Urol. 2006 Jul;13(7):1009-11. doi: 10.1111/j.1442-2042.2006.01462.x.","Ishii D","Int J Urol","2006","2006/08/03","","","10.1111/j.1442-2042.2006.01462.x"
"7073941","High susceptibility of analbuminaemic rats to induced bladder cancer","Kakizoe T, Komatsu H, Honma Y, Niijima T, Kawachi T, Sugimura T, Nagase S.","Br J Cancer. 1982 Mar;45(3):474-6. doi: 10.1038/bjc.1982.77.","Kakizoe T","Br J Cancer","1982","1982/03/01","PMC2010921","","10.1038/bjc.1982.77"
"22576102","[Therapy selection in patients with advanced bladder cancer. Is molecular biology helpful?]","Junker K, Hartmann A, Stöckle M.","Urologe A. 2012 Jun;51(6):805-12. doi: 10.1007/s00120-012-2898-2.","Junker K","Urologe A","2012","2012/05/12","","","10.1007/s00120-012-2898-2"
"21854525","Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?","Balar AV, Milowsky MI.","BJU Int. 2011 Sep;108(5):699. doi: 10.1111/j.1464-410X.2010.10006.x. Epub 2010 Nov 24.","Balar AV","BJU Int","2011","2011/08/23","","","10.1111/j.1464-410X.2010.10006.x"
"3543945","Response criteria phase II/phase III invasive bladder cancer","Van Oosterom AT, Akaza H, Hall R, Hirao Y, Jones WG, Matsumura Y, Raghavan D, Tannock IF, Yagoda A.","Prog Clin Biol Res. 1986;221:301-10.","Van Oosterom AT","Prog Clin Biol Res","1986","1986/01/01","","",""
"31613877","A population-based cohort study examining the association of documented bladder diverticulum and bladder cancer risk in urology patients","Fang CW, Hsieh VC, Huang SK, Tsai IJ, Muo CH, Wu SC.","PLoS One. 2019 Oct 15;14(10):e0222875. doi: 10.1371/journal.pone.0222875. eCollection 2019.","Fang CW","PLoS One","2019","2019/10/16","PMC6793858","","10.1371/journal.pone.0222875"
"29707982","Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer","Maas M, Walz S, Stühler V, Aufderklamm S, Rausch S, Bedke J, Stenzl A, Todenhöfer T.","Expert Rev Mol Diagn. 2018 May;18(5):443-455. doi: 10.1080/14737159.2018.1469979.","Maas M","Expert Rev Mol Diagn","2018","2018/05/01","","","10.1080/14737159.2018.1469979"
"28165132","Nonmuscle-invasive bladder cancer: what's changing and what has changed","Manikandan R, Rodriguez O, Parada R, Palou Redorta J.","Urologia. 2017 Feb 3;84(1):1-8. doi: 10.5301/uro.5000213. Epub 2017 Feb 2.","Manikandan R","Urologia","2017","2017/02/07","","","10.5301/uro.5000213"
"6677110","[Tissue polypeptide antigen (TPA) in urological malignancies. I. S-TPA in bladder cancer patients]","Akiyama T, Tsujihashi H, Boku E, Nagai N, Matsuura T, Iguchi M, Yachiku S, Kurita T.","Hinyokika Kiyo. 1983 Dec;29(12):1635-40.","Akiyama T","Hinyokika Kiyo","1983","1983/12/01","","",""
"17525849","The rationale for radical cystectomy as primary therapy for T4 bladder cancer","Nagele U, Anastasiadis AG, Merseburger AS, Corvin S, Hennenlotter J, Adam M, Sievert KD, Stenzl A, Kuczyk MA.","World J Urol. 2007 Aug;25(4):401-5. doi: 10.1007/s00345-007-0172-9. Epub 2007 May 25.","Nagele U","World J Urol","2007","2007/05/26","","","10.1007/s00345-007-0172-9"
"3511282","Transurethral ultrasonography in bladder cancer","Resnick MI, Kursh ED.","J Urol. 1986 Feb;135(2):253-5. doi: 10.1016/s0022-5347(17)45601-1.","Resnick MI","J Urol","1986","1986/02/01","","","10.1016/s0022-5347(17)45601-1"
"12092656","Radical cystectomy versus alternative treatments for muscle-confined bladder cancer","Tekin A, Aki FT, Ozen H.","Int Urol Nephrol. 2001;33(2):357-62. doi: 10.1023/a:1015261628978.","Tekin A","Int Urol Nephrol","2001","2002/07/03","","","10.1023/a:1015261628978"
"19520422","Bladder cancer","Kaufman DS, Shipley WU, Feldman AS.","Lancet. 2009 Jul 18;374(9685):239-49. doi: 10.1016/S0140-6736(09)60491-8. Epub 2009 Jun 10.","Kaufman DS","Lancet","2009","2009/06/13","","","10.1016/S0140-6736(09)60491-8"
"24032224","[Comparative evaluation of the predictive value of UroVysion and AURKA FISH tests of urine sediment cells for the diagnosis of bladder cancer]","Vorobtsova IE, Kouzova ED, Kolesnikova IS.","Vopr Onkol. 2013;59(4):483-6.","Vorobtsova IE","Vopr Onkol","2013","2013/09/17","","",""
"22158597","Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?","Netto GJ.","Nat Rev Urol. 2011 Dec 13;9(1):41-51. doi: 10.1038/nrurol.2011.193.","Netto GJ","Nat Rev Urol","2011","2011/12/14","","","10.1038/nrurol.2011.193"
"24890633","Salvage therapy for recurrence of bladder cancer: do we need a uniform approach?","Iacovelli R.","Expert Rev Clin Pharmacol. 2014 Jul;7(4):397-9. doi: 10.1586/17512433.2014.926811. Epub 2014 Jun 3.","Iacovelli R","Expert Rev Clin Pharmacol","2014","2014/06/04","","","10.1586/17512433.2014.926811"
"25387487","Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature","Zhang G, Gomes-Giacoia E, Dai Y, Lawton A, Miyake M, Furuya H, Goodison S, Rosser CJ.","Diagn Pathol. 2014 Nov 12;9:200. doi: 10.1186/s13000-014-0200-1.","Zhang G","Diagn Pathol","2014","2014/11/13","PMC4245773","","10.1186/s13000-014-0200-1"
"15638895","The economic consequences of prostate and bladder cancer in the UK","Sangar VK, Ragavan N, Matanhelia SS, Watson MW, Blades RA.","BJU Int. 2005 Jan;95(1):59-63. doi: 10.1111/j.1464-410X.2005.05249.x.","Sangar VK","BJU Int","2005","2005/01/11","","","10.1111/j.1464-410X.2005.05249.x"
"31601522","What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review","Veskimäe E, Espinos EL, Bruins HM, Yuan Y, Sylvester R, Kamat AM, Shariat SF, Witjes JA, Compérat EM.","Eur Urol Oncol. 2019 Nov;2(6):625-642. doi: 10.1016/j.euo.2019.09.003. Epub 2019 Oct 8.","Veskimäe E","Eur Urol Oncol","2019","2019/10/12","","","10.1016/j.euo.2019.09.003"
"18107322","Extravesical radium therapy in cancer of the bladder","WARD RO.","Br J Urol. 1948 Dec;20(4):191-202. doi: 10.1111/j.1464-410x.1948.tb10737.x.","WARD RO","Br J Urol","1948","1948/12/01","","","10.1111/j.1464-410x.1948.tb10737.x"
"22927958","Selection of microsatellite markers for bladder cancer diagnosis without the need for corresponding blood","van Tilborg AA, Kompier LC, Lurkin I, Poort R, El Bouazzaoui S, van der Keur K, Zuiverloon T, Dyrskjot L, Orntoft TF, Roobol MJ, Zwarthoff EC.","PLoS One. 2012;7(8):e43345. doi: 10.1371/journal.pone.0043345. Epub 2012 Aug 22.","van Tilborg AA","PLoS One","2012","2012/08/29","PMC3425555","","10.1371/journal.pone.0043345"
"26713510","Hyperthermia for non-muscle invasive bladder cancer","Soria F, Allasia M, Oderda M, Gontero P.","Expert Rev Anticancer Ther. 2016;16(3):313-21. doi: 10.1586/14737140.2016.1135743. Epub 2016 Jan 21.","Soria F","Expert Rev Anticancer Ther","2016","2015/12/30","","","10.1586/14737140.2016.1135743"
"3430018","[The quality of life in patients with bladder cancer after radical cystectomy with ileal conduit: I. Results of questionnaire surveys]","Miyakawa M, Yoshida O.","Nihon Gan Chiryo Gakkai Shi. 1987 Aug 20;22(7):1289-95.","Miyakawa M","Nihon Gan Chiryo Gakkai Shi","1987","1987/08/20","","",""
"19879476","Bladder cancer in the elderly","Shariat SF, Milowsky M, Droller MJ.","Urol Oncol. 2009 Nov-Dec;27(6):653-67. doi: 10.1016/j.urolonc.2009.07.020.","Shariat SF","Urol Oncol","2009","2009/11/03","PMC4225777","NIHMS629695","10.1016/j.urolonc.2009.07.020"
"18815935","Bladder cancer: chemoprevention, complementary approaches and budgetary considerations","Grossman HB, Stenzl A, Moyad MA, Droller MJ.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):213-33. doi: 10.1080/03008880802284258.","Grossman HB","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802284258"
"19111802","Optimizing outcomes at every stage of bladder cancer: do we practice it?","Herr H, Konety B, Stein J, Sternberg CN, Wood DP Jr.","Urol Oncol. 2009 Jan-Feb;27(1):72-4. doi: 10.1016/j.urolonc.2008.06.005.","Herr H","Urol Oncol","2009","2008/12/30","","","10.1016/j.urolonc.2008.06.005"
"19424934","A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden","Jahnson S, Damm O, Hellsten S, Holmäng S, Liedberg F, Ljungberg B, Malmström PU, Månsson W, Strömberg F, Wijkstöm H.","Scand J Urol Nephrol. 2009;43(4):271-6. doi: 10.1080/00365590902909778.","Jahnson S","Scand J Urol Nephrol","2009","2009/05/09","","","10.1080/00365590902909778"
"28065393","Quality indicators in the management of bladder cancer: A modified Delphi study","Khare SR, Aprikian A, Black P, Blais N, Booth C, Brimo F, Chin J, Chung P, Drachenberg D, Eapen L, Fairey A, Fleshner N, Fradet Y, Gotto G, Izawa J, Jewett M, Kulkarni G, Lacombe L, Moore R, Morash C, North S, Rendon R, Saad F, Shayegan B, Siemens R, So A, Sridhar SS, Traboulsi SL, Kassouf W.","Urol Oncol. 2017 Jun;35(6):328-334. doi: 10.1016/j.urolonc.2016.12.003. Epub 2017 Jan 3.","Khare SR","Urol Oncol","2017","2017/01/10","","","10.1016/j.urolonc.2016.12.003"
"8310570","[The immunotherapy and immunoprophylaxis of bladder cancer]","Figurin KM, Tsiganu VI.","Urol Nefrol (Mosk). 1993 Jul-Aug;(4):46-9.","Figurin KM","Urol Nefrol (Mosk)","1993","1993/07/01","","",""
"3189279","Racial differences in bladder cancer risk: a case-control study","Schairer C, Hartge P, Hoover RN, Silverman DT.","Am J Epidemiol. 1988 Nov;128(5):1027-37. doi: 10.1093/oxfordjournals.aje.a115047.","Schairer C","Am J Epidemiol","1988","1988/11/01","","","10.1093/oxfordjournals.aje.a115047"
"20949805","Applicability of the FISH test for bladder cancer","Ward-Smith P, Miller B, Caughron M.","Urol Nurs. 2010 Jul-Aug;30(4):218-21, 251; quiz 222.","Ward-Smith P","Urol Nurs","2010","2010/10/19","","",""
"3929269","Mitomycin C therapy in superficial bladder cancer","Denis L, Keuppens F, Hendrickx G.","Prog Clin Biol Res. 1985;185B:113-22.","Denis L","Prog Clin Biol Res","1985","1985/01/01","","",""
"24268503","Perioperative chemotherapy in muscle-invasive bladder cancer: overview and the unmet clinical need for alternative adjuvant therapy as studied in the MAGNOLIA trial","Colombel M, Heidenreich A, Martínez-Piñeiro L, Babjuk M, Korneyev I, Surcel C, Yakovlev P, Colombo R, Radziszewski P, Witjes F, Schipper R, Mulders P, Witjes WP.","Eur Urol. 2014 Mar;65(3):509-11. doi: 10.1016/j.eururo.2013.10.056. Epub 2013 Nov 11.","Colombel M","Eur Urol","2014","2013/11/26","","","10.1016/j.eururo.2013.10.056"
"21205209","microRNA-203 suppresses bladder cancer development by repressing bcl-w expression","Bo J, Yang G, Huo K, Jiang H, Zhang L, Liu D, Huang Y.","FEBS J. 2011 Mar;278(5):786-92. doi: 10.1111/j.1742-4658.2010.07997.x. Epub 2011 Jan 25.","Bo J","FEBS J","2011","2011/01/06","","","10.1111/j.1742-4658.2010.07997.x"
"30834632","Low-risk non-muscle-invasive bladder cancer: Further prognostic stratification into the ""very-low-risk"" group based on tumor size","Lee A, Lee HJ, Huang HH, Ho H, Chen K.","Int J Urol. 2019 Apr;26(4):481-486. doi: 10.1111/iju.13913. Epub 2019 Mar 4.","Lee A","Int J Urol","2019","2019/03/06","","","10.1111/iju.13913"
"27167196","Coexistence of YWHAZ amplification predicts better prognosis in muscle-invasive bladder cancer with CDKN2A or TP53 loss","Liu S, Wu Y, Yang T, Feng C, Jiang H.","Oncotarget. 2016 Jun 7;7(23):34752-8. doi: 10.18632/oncotarget.9158.","Liu S","Oncotarget","2016","2016/05/12","PMC5085186","","10.18632/oncotarget.9158"
"29209142","Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer","Wong JPC, Wei R, Lyu P, Tong OLH, Zhang SD, Wen Q, Yuen HF, El-Tanani M, Kwok HF.","Int J Biol Sci. 2017 Nov 1;13(11):1373-1386. doi: 10.7150/ijbs.21457. eCollection 2017.","Wong JPC","Int J Biol Sci","2017","2017/12/07","PMC5715521","","10.7150/ijbs.21457"
"18707804","Open to debate. The motion: perioperative chemotherapy in muscle invasive bladder cancer improves survival","Bellmunt J, Hautmann RE.","Eur Urol. 2008 Nov;54(5):1192-7. doi: 10.1016/j.eururo.2008.07.056. Epub 2008 Aug 5.","Bellmunt J","Eur Urol","2008","2008/08/19","","","10.1016/j.eururo.2008.07.056"
"27410033","Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis","Tian Y, Ma Z, Chen Z, Li M, Wu Z, Hong M, Wang H, Svatek R, Rodriguez R, Wang Z.","PLoS One. 2016 Jul 13;11(7):e0158891. doi: 10.1371/journal.pone.0158891. eCollection 2016.","Tian Y","PLoS One","2016","2016/07/14","PMC4943634","","10.1371/journal.pone.0158891"
"26882077","The association between coffee consumption and bladder cancer incidence in a pooled analysis of the Miyagi Cohort Study and Ohsaki Cohort Study","Sugiyama K, Sugawara Y, Tomata Y, Nishino Y, Fukao A, Tsuji I.","Eur J Cancer Prev. 2017 Mar;26(2):125-130. doi: 10.1097/CEJ.0000000000000226.","Sugiyama K","Eur J Cancer Prev","2017","2016/02/17","","","10.1097/CEJ.0000000000000226"
"3989436","Treatment delay in patients with bladder tumours","MacArthur C, Pendleton LL, Smith A.","J Epidemiol Community Health. 1985 Mar;39(1):63-6. doi: 10.1136/jech.39.1.63.","MacArthur C","J Epidemiol Community Health","1985","1985/03/01","PMC1052403","","10.1136/jech.39.1.63"
"24292452","Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential","Bryan RT, Shimwell NJ, Wei W, Devall AJ, Pirrie SJ, James ND, Zeegers MP, Cheng KK, Martin A, Ward DG.","Br J Cancer. 2014 Feb 4;110(3):679-85. doi: 10.1038/bjc.2013.744. Epub 2013 Nov 28.","Bryan RT","Br J Cancer","2014","2013/12/03","PMC3915119","","10.1038/bjc.2013.744"
"27465044","A novel hedgehog inhibitor iG2 suppresses tumorigenesis by impairing self-renewal in human bladder cancer","Zhu L, Ni C, Dong B, Zhang Y, Shi Y, Niu H, Li C.","Cancer Med. 2016 Sep;5(9):2579-86. doi: 10.1002/cam4.802. Epub 2016 Jul 27.","Zhu L","Cancer Med","2016","2016/07/29","PMC5055183","","10.1002/cam4.802"
"2218577","Neoadjuvant chemotherapy for invasive bladder cancer: future directions","Scher HI, Splinter TA.","Semin Oncol. 1990 Oct;17(5):635-8.","Scher HI","Semin Oncol","1990","1990/10/01","","",""
"26503215","CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients","Zhu X, Qiao Y, Liu W, Wang W, Shen H, Lu Y, Hao G, Zheng J, Tian Y.","Tumour Biol. 2016 Apr;37(4):4569-77. doi: 10.1007/s13277-015-4275-4. Epub 2015 Oct 27.","Zhu X","Tumour Biol","2016","2015/10/28","","","10.1007/s13277-015-4275-4"
"30833139","Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer","Li R, Spiess PE, Gilbert SM, Necchi A.","Eur Urol. 2019 Jul;76(1):4-6. doi: 10.1016/j.eururo.2019.02.027. Epub 2019 Mar 2.","Li R","Eur Urol","2019","2019/03/06","","","10.1016/j.eururo.2019.02.027"
"3129738","Adjuvant chemotherapy of bladder cancer","Freiha FS, Torti FM.","Prog Clin Biol Res. 1988;260:545-9.","Freiha FS","Prog Clin Biol Res","1988","1988/01/01","","",""
"16028412","Microdissection for detecting genetic aberrations in early and advanced human urinary bladder cancer","Hartmann A, Stoehr R, Wild PJ, Dietmaier W, Knuechel R.","Methods Mol Biol. 2005;293:79-92. doi: 10.1385/1-59259-853-6:079.","Hartmann A","Methods Mol Biol","2005","2005/07/21","","","10.1385/1-59259-853-6:079"
"9366322","The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms","Murphy WM, Rivera-Ramirez I, Medina CA, Wright NJ, Wajsman Z.","J Urol. 1997 Dec;158(6):2102-6. doi: 10.1016/s0022-5347(01)68167-9.","Murphy WM","J Urol","1997","1997/11/20","","","10.1016/s0022-5347(01)68167-9"
"8727807","Pathology and its importance in evaluating outcome in patients with superficial bladder cancer","Huben RP, Gaeta J.","Semin Urol Oncol. 1996 Feb;14(1 Suppl 1):23-9.","Huben RP","Semin Urol Oncol","1996","1996/02/01","","",""
"9859583","[Usefulness of BTA Stat test (Bard) in the diagnosis of bladder cancer. Preliminary results and comparison with cytology and cystoscopy]","Gutiérrez Baños JL, Martín García B, Hernández Rodríguez R, Portillo Martín JA, Correas Gómez MA, del Valle Schaan JI, Roca Edreira A, Villanueva Peña A, Gutíerrez García R, De Diego Rodríguez E, Rado Velázquez MA.","Arch Esp Urol. 1998 Oct;51(8):778-82.","Gutiérrez Baños JL","Arch Esp Urol","1998","1998/12/22","","",""
"1827165","Adjuvant intravesicular pharmacotherapy for superficial bladder cancer","Lum BL, Torti FM.","J Natl Cancer Inst. 1991 May 15;83(10):682-94. doi: 10.1093/jnci/83.10.682.","Lum BL","J Natl Cancer Inst","1991","1991/05/15","","","10.1093/jnci/83.10.682"
"10696257","Biological markers in superficial bladder tumors and their prognostic significance","Zlotta AR, Schulman CC.","Urol Clin North Am. 2000 Feb;27(1):179-89, xi-xii. doi: 10.1016/s0094-0143(05)70246-9.","Zlotta AR","Urol Clin North Am","2000","2000/03/04","","","10.1016/s0094-0143(05)70246-9"
"23906669","Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature","Rink M, Babjuk M, Catto JW, Jichlinski P, Shariat SF, Stenzl A, Stepp H, Zaak D, Witjes JA.","Eur Urol. 2013 Oct;64(4):624-38. doi: 10.1016/j.eururo.2013.07.007. Epub 2013 Jul 19.","Rink M","Eur Urol","2013","2013/08/03","","","10.1016/j.eururo.2013.07.007"
"4084727","First-line intravenous cisplatin for deeply invasive bladder cancer: update on 70 cases","Pearson BS, Raghavan D.","Br J Urol. 1985 Dec;57(6):690-3. doi: 10.1111/j.1464-410x.1985.tb07033.x.","Pearson BS","Br J Urol","1985","1985/12/01","","","10.1111/j.1464-410x.1985.tb07033.x"
"1485797","[Epidemiology of bladder cancer]","Paneau C, Schaffer P, Bollack C.","Ann Urol (Paris). 1992;26(5):281-93.","Paneau C","Ann Urol (Paris)","1992","1992/01/01","","",""
"2304161","Unexpectedly high serum methotrexate levels in cystectomized bladder cancer patients with an ileal conduit treated with intermediate doses of the drug","Fosså SD, Heilo A, Børmer O.","J Urol. 1990 Mar;143(3):498-501. doi: 10.1016/s0022-5347(17)40001-2.","Fosså SD","J Urol","1990","1990/03/01","","","10.1016/s0022-5347(17)40001-2"
"25331368","Use of bacillus Calmette-Guérin in stage T1 bladder cancer: Long-term observation of a population-based cohort","Patschan O, Holmäng S, Hosseini A, Liedberg F, Ljungberg B, Malmström PU, Rosell J, Jahnson S.","Scand J Urol. 2015 Apr;49(2):127-32. doi: 10.3109/21681805.2014.968868. Epub 2014 Oct 21.","Patschan O","Scand J Urol","2015","2014/10/22","","","10.3109/21681805.2014.968868"
"8539637","Neoadjuvant and adjuvant chemotherapy for invasive bladder cancer","Smith MR, Kantoff PW.","Semin Oncol. 1995 Dec;22(6):625-32.","Smith MR","Semin Oncol","1995","1995/12/01","","",""
"29434365","Bladder cancer: BBN mouse model mimics human MIBC","Kelsey R.","Nat Rev Urol. 2018 Apr;15(4):202. doi: 10.1038/nrurol.2018.17. Epub 2018 Feb 13.","Kelsey R","Nat Rev Urol","2018","2018/02/14","","","10.1038/nrurol.2018.17"
"20299058","Loss of heterozygosis on IFN-alpha locus is a prognostic indicator of bacillus Calmette-Guerin response for nonmuscle invasive bladder cancer","Cai T, Nesi G, Dal Canto M, Tinacci G, Mondaini N, Piazzini M, Geppetti P, Bartoletti R.","J Urol. 2010 May;183(5):1738-43. doi: 10.1016/j.juro.2009.12.105. Epub 2010 Mar 17.","Cai T","J Urol","2010","2010/03/20","","","10.1016/j.juro.2009.12.105"
"26894268","Tumor Suppressor in Lung Cancer-1 Is a Prognostic Predictor for the Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer","Chen Y, Yang Y, Liu L, Wang S, Song H, Liu X.","Urol Int. 2016;96(2):142-7. doi: 10.1159/000438492. Epub 2015 Aug 15.","Chen Y","Urol Int","2016","2016/02/20","","","10.1159/000438492"
"22336379","Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire","Burger M, Mulders P, Witjes W.","Eur Urol. 2012 May;61(5):1070-1. doi: 10.1016/j.eururo.2012.01.039. Epub 2012 Feb 1.","Burger M","Eur Urol","2012","2012/02/17","","","10.1016/j.eururo.2012.01.039"
"22497142","[Study on bladder cancer tissues with Raman spectroscopy]","Wang L, Fan JH, Guan ZF, Liu Y, Zeng J, He DL, Huang LQ, Wang XY, Gong HL.","Guang Pu Xue Yu Guang Pu Fen Xi. 2012 Jan;32(1):123-6.","Wang L","Guang Pu Xue Yu Guang Pu Fen Xi","2012","2012/04/14","","",""
"23540775","Urinary markers/cytology: what and when should a urologist use","Tomasini JM, Konety BR.","Urol Clin North Am. 2013 May;40(2):165-73. doi: 10.1016/j.ucl.2013.01.015. Epub 2013 Mar 1.","Tomasini JM","Urol Clin North Am","2013","2013/04/02","","","10.1016/j.ucl.2013.01.015"
"24124676","[Effects of neoadjuvant chemotherapy on the prognostic mortality risk of invasive transitional bladder cancer: a meta-analysis]","Fan B, Zhang L, Li XC, Song YS, Guo EZ, Pan T, Shen L, Xin SY, Song XS, Wang JB.","Zhonghua Yi Xue Za Zhi. 2013 Jun 11;93(22):1705-10.","Fan B","Zhonghua Yi Xue Za Zhi","2013","2013/10/16","","",""
"8953583","Superficial bladder cancer: decreasing the risk of recurrence","Grossman HB.","Oncology (Williston Park). 1996 Nov;10(11):1617-24; discussion 1624, 1627-8.","Grossman HB","Oncology (Williston Park)","1996","1996/11/01","","",""
"8265124","[Immunotherapy of superficial bladder tumors in a hospital department]","Prekopp G, Rosdy E.","Orv Hetil. 1993 Dec 12;134(50):2757-60.","Prekopp G","Orv Hetil","1993","1993/12/12","","",""
"26004301","Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume Institution","Moschini M, Dell' Oglio P, Capogrosso P, Cucchiara V, Luzzago S, Gandaglia G, Zattoni F, Briganti A, Damiano R, Montorsi F, Salonia A, Colombo R.","Clin Genitourin Cancer. 2015 Dec;13(6):562-7. doi: 10.1016/j.clgc.2015.04.009. Epub 2015 May 4.","Moschini M","Clin Genitourin Cancer","2015","2015/05/26","","","10.1016/j.clgc.2015.04.009"
"7994780","Superficial bladder cancer: state of the art","Bono AV.","Cancer Chemother Pharmacol. 1994;35 Suppl:S101-9. doi: 10.1007/BF00686931.","Bono AV","Cancer Chemother Pharmacol","1994","1994/01/01","","","10.1007/BF00686931"
"29883442","Clinical Significance of Serological and Urological Levels of Bladder Cancer-Specific Antigen-1 (BLCA-1) in Bladder Cancer","Wang Z, Li H, Chi Q, Qiu Y, Li X, Xin L.","Med Sci Monit. 2018 Jun 8;24:3882-3887. doi: 10.12659/MSM.907075.","Wang Z","Med Sci Monit","2018","2018/06/09","PMC6022784","","10.12659/MSM.907075"
"3314069","Preoperative radiation therapy in the treatment of bladder cancer","Crawford ED, Das S, Smith JA Jr.","Urol Clin North Am. 1987 Nov;14(4):781-7.","Crawford ED","Urol Clin North Am","1987","1987/11/01","","",""
"28195647","Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification","Sjödahl G, Eriksson P, Liedberg F, Höglund M.","J Pathol. 2017 May;242(1):113-125. doi: 10.1002/path.4886. Epub 2017 Mar 28.","Sjödahl G","J Pathol","2017","2017/02/15","PMC5413843","","10.1002/path.4886"
"26687318","Long-term oncological outcomes of an active surveillance program in recurrent low grade Ta bladder cancer","Hernández V, Llorente C, de la Peña E, Pérez-Fernández E, Guijarro A, Sola I.","Urol Oncol. 2016 Apr;34(4):165.e19-23. doi: 10.1016/j.urolonc.2015.11.005. Epub 2015 Dec 10.","Hernández V","Urol Oncol","2016","2015/12/22","","","10.1016/j.urolonc.2015.11.005"
"16310931","p53 protein transduction therapy: successful targeting and inhibition of the growth of the bladder cancer cells","Inoue M, Tomizawa K, Matsushita M, Lu YF, Yokoyama T, Yanai H, Takashima A, Kumon H, Matsui H.","Eur Urol. 2006 Jan;49(1):161-8. doi: 10.1016/j.eururo.2005.08.019. Epub 2005 Nov 2.","Inoue M","Eur Urol","2006","2005/11/29","","","10.1016/j.eururo.2005.08.019"
"18355900","Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer","Sogni F, Brausi M, Frea B, Martinengo C, Faggiano F, Tizzani A, Gontero P.","Urology. 2008 May;71(5):919-23. doi: 10.1016/j.urology.2007.11.125. Epub 2008 Mar 20.","Sogni F","Urology","2008","2008/03/22","","","10.1016/j.urology.2007.11.125"
"19683766","Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer","Ehdaie B, Stukenborg GJ, Theodorescu D.","J Urol. 2009 Oct;182(4):1482-7. doi: 10.1016/j.juro.2009.06.043. Epub 2009 Aug 15.","Ehdaie B","J Urol","2009","2009/08/18","","","10.1016/j.juro.2009.06.043"
"23470167","Tumour expression of bladder cancer-associated urinary proteins","Lindén M, Segersten U, Runeson M, Wester K, Busch C, Pettersson U, Lind SB, Malmström PU.","BJU Int. 2013 Aug;112(3):407-15. doi: 10.1111/j.1464-410X.2012.11653.x. Epub 2013 Mar 7.","Lindén M","BJU Int","2013","2013/03/09","","","10.1111/j.1464-410X.2012.11653.x"
"30769831","Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles","Oeyen E, Hoekx L, De Wachter S, Baldewijns M, Ameye F, Mertens I.","Int J Mol Sci. 2019 Feb 14;20(4):821. doi: 10.3390/ijms20040821.","Oeyen E","Int J Mol Sci","2019","2019/02/17","PMC6412916","","10.3390/ijms20040821"
"9114524","[Surgery of infiltrating bladder tumors]","Lobel B, Guillé F.","Rev Prat. 1997 Feb 15;47(4):388-91.","Lobel B","Rev Prat","1997","1997/02/15","","",""
"25836933","New trends in the surgical management of invasive bladder cancer","Preston MA, Lerner SP, Kibel AS.","Hematol Oncol Clin North Am. 2015 Apr;29(2):253-69, viii. doi: 10.1016/j.hoc.2014.10.010.","Preston MA","Hematol Oncol Clin North Am","2015","2015/04/04","","","10.1016/j.hoc.2014.10.010"
"916105","Falsely positive urinary cytology: pathologist's error or preclinical cancer?","Murphy WM.","J Urol. 1977 Nov;118(5):811-3. doi: 10.1016/s0022-5347(17)58204-x.","Murphy WM","J Urol","1977","1977/11/01","","","10.1016/s0022-5347(17)58204-x"
"872104","The emotional problems of patients with bladder cancer","Miller RN.","Cancer Res. 1977 Aug;37(8 Pt 2):2789-91.","Miller RN","Cancer Res","1977","1977/08/01","","",""
"9719934","[A clinical study of superficial bladder cancer with grade 3 components]","Iiyama T, Hariu K, Kawai M, Kamiyama Y, Okano Y, Shimizu H, Tomomasa H, Iizumi T, Yazaki T, Umeda T.","Hinyokika Kiyo. 1998 Jun;44(6):375-9.","Iiyama T","Hinyokika Kiyo","1998","1998/08/28","","",""
"10333247","Heterogeneity of in vitro radiosensitivity in human bladder cancer cells","Barnetson AR, Banasiak D, Fisher RJ, Mameghan H, Ribeiro JC, Brown K, Brown JL, O'Mara SM, Russell PJ.","Radiat Oncol Investig. 1999;7(2):66-76. doi: 10.1002/(SICI)1520-6823(1999)7:2<66::AID-ROI2>3.0.CO;2-T.","Barnetson AR","Radiat Oncol Investig","1999","1999/05/20","","","10.1002/(SICI)1520-6823(1999)7:2<66::AID-ROI2>3.0.CO;2-T"
"18377416","Molecular biomarkers in urothelial bladder cancer","Kim WJ, Bae SC.","Cancer Sci. 2008 Apr;99(4):646-52. doi: 10.1111/j.1349-7006.2008.00735.x.","Kim WJ","Cancer Sci","2008","2008/04/02","","","10.1111/j.1349-7006.2008.00735.x"
"8210838","Computer modeling and decision making: clinical applications in bladder cancer","Albertsen PC.","Semin Urol. 1993 Aug;11(3):171-6.","Albertsen PC","Semin Urol","1993","1993/08/01","","",""
"30017900","Combination Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer","Steinberg RL, Thomas LJ, O'Donnell MA.","Eur Urol Focus. 2018 Jul;4(4):503-505. doi: 10.1016/j.euf.2018.07.005. Epub 2018 Jul 14.","Steinberg RL","Eur Urol Focus","2018","2018/07/19","","","10.1016/j.euf.2018.07.005"
"16129368","P53 as a prognostic marker for bladder cancer: a meta-analysis and review","Malats N, Bustos A, Nascimento CM, Fernandez F, Rivas M, Puente D, Kogevinas M, Real FX.","Lancet Oncol. 2005 Sep;6(9):678-86. doi: 10.1016/S1470-2045(05)70315-6.","Malats N","Lancet Oncol","2005","2005/09/01","","","10.1016/S1470-2045(05)70315-6"
"2284531","When does superficial bladder cancer resist intravesical therapy?","Vögeli T, Ackermann R.","Semin Urol. 1990 Nov;8(4):248-53.","Vögeli T","Semin Urol","1990","1990/11/01","","",""
"17892428","Treatment of muscle-invasive bladder cancer","Sherif A, Jonsson MN, Wiklund NP.","Expert Rev Anticancer Ther. 2007 Sep;7(9):1279-83. doi: 10.1586/14737140.7.9.1279.","Sherif A","Expert Rev Anticancer Ther","2007","2007/09/26","","","10.1586/14737140.7.9.1279"
"1300829","[The fate of bladder cancer patients who refused radical treatment]","Nechiporenko NA, Zaborovskiĭ GI, Bushma TV.","Vopr Onkol. 1992;38(9):1124-31.","Nechiporenko NA","Vopr Onkol","1992","1992/01/01","","",""
"3544450","[Demonstration of complications caused by implantable catheter systems in regional arterial infusion therapy of tumors of the pelvis (bladder cancer). Radiologic and nuclear medicine control possibilities]","Reichelt HG, Gellhaar G, Eickenberg HU.","Urologe A. 1986 Nov;25(6):333-7.","Reichelt HG","Urologe A","1986","1986/11/01","","",""
"18416068","[Assessment of mucosal injury in stage T1-T2NOMO bladder cancer after radiation or intravesical chemotherapy]","Kaprin AD, Panyshin GA, Garmash SV, Kostin AA, Khmelevskiĭ EV, Elagin VO.","Vopr Onkol. 2008;54(1):98-101.","Kaprin AD","Vopr Onkol","2008","2008/04/18","","",""
"2417949","Saccharin/cyclamates: epidemiological evidence","Armstrong BK.","IARC Sci Publ. 1985;(65):129-43.","Armstrong BK","IARC Sci Publ","1985","1985/01/01","","",""
"12196902","Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancer","Kuczyk M, Machtens S, Bokemeyer C, Kollmannsberger C, Hartmann J, Kondoh M, Merseburger A, Jonas U.","World J Urol. 2002 Aug;20(3):183-9. doi: 10.1007/s00345-002-0278-z. Epub 2002 Jul 12.","Kuczyk M","World J Urol","2002","2002/08/28","","","10.1007/s00345-002-0278-z"
"20671329","Relaxation training and guided imagery for an elderly man with bladder cancer: a case report","Ferreira JB.","Adv Mind Body Med. 2009 Winter;24(4):8-10.","Ferreira JB","Adv Mind Body Med","2009","2010/07/31","","",""
"590165","Bladder cancer in the Sudan. A clinicopathological study of 61 cases","Ibrahim A, Malik MO.","East Afr Med J. 1977 Jul;54(7):393-8.","Ibrahim A","East Afr Med J","1977","1977/07/01","","",""
"28554751","Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer","Wang Y, Kang XL, Zeng FC, Xu CJ, Zhou JQ, Luo DN.","Pathol Res Pract. 2017 Jul;213(7):766-772. doi: 10.1016/j.prp.2017.04.004. Epub 2017 Apr 20.","Wang Y","Pathol Res Pract","2017","2017/05/31","","","10.1016/j.prp.2017.04.004"
"17601311","[Enterocystoplasty for bladder cancer in a woman: 19 years of clinical course]","Janeiro País JM, Rodríguez Gómez I, Casas Agudo VP, López García D, Chantada Abad V, González Martín M.","Arch Esp Urol. 2007 Apr;60(3):310-1. doi: 10.4321/s0004-06142007000300017.","Janeiro País JM","Arch Esp Urol","2007","2007/07/03","","","10.4321/s0004-06142007000300017"
"15734988","Gastric and duodenal ulcer and risk of bladder cancer","Pelucchi C, Negri E, Talamini R, Franceschi S, La Vecchia C.","Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):550. doi: 10.1158/1055-9965.EPI-04-0262.","Pelucchi C","Cancer Epidemiol Biomarkers Prev","2005","2005/03/01","","","10.1158/1055-9965.EPI-04-0262"
"6017470","Early diagnosis of bladder cancer","","Br Med J. 1967 Feb 4;1(5535):253-4.","","Br Med J","1967","1967/02/04","PMC1840678","",""
"23083804","ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology","Amin MB, McKenney JK, Paner GP, Hansel DE, Grignon DJ, Montironi R, Lin O, Jorda M, Jenkins LC, Soloway M, Epstein JI, Reuter VE; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012.","Eur Urol. 2013 Jan;63(1):16-35. doi: 10.1016/j.eururo.2012.09.063. Epub 2012 Oct 5.","Amin MB","Eur Urol","2013","2012/10/23","","","10.1016/j.eururo.2012.09.063"
"5018148","The use of N-(4-(5-nitro-2-furyl)-2-thiazolyl) formamide in the study of bladder cancer","Tiltman AJ.","S Afr Med J. 1972 Mar 11;46(11):293-4.","Tiltman AJ","S Afr Med J","1972","1972/03/11","","",""
"7853575","Long-term outcome related to epidermal growth factor receptor status in bladder cancer","Mellon K, Wright C, Kelly P, Horne CH, Neal DE.","J Urol. 1995 Mar;153(3 Pt 2):919-25.","Mellon K","J Urol","1995","1995/03/01","","",""
"10484843","[Postcystectomy radiotherapy in bladder cancer]","Salina Ramos J, de las Heras González M, Serna Berna A.","Arch Esp Urol. 1999 Jul-Aug;52(6):595-7.","Salina Ramos J","Arch Esp Urol","1999","1999/09/15","","",""
"15206213","[Meta-analysis of neoadjuvant chemotherapy in locally advanced bladder cancer]","Ruggeri EM.","Suppl Tumori. 2004 Jul-Aug;3(4):S55-6.","Ruggeri EM","Suppl Tumori","2004","2004/06/23","","",""
"2841614","Association between the occurrence of antibodies to simian vacuolating virus 40 and bladder cancer in male smokers","Bravo MP, Del Rey-Calero J.","Neoplasma. 1988;35(3):285-8.","Bravo MP","Neoplasma","1988","1988/01/01","","",""
"10373991","Maintenance therapy with bacillus Calmette-Guerin in patients with superficial bladder cancer","Swibold LK.","Urol Nurs. 1999 Mar;19(1):38-41.","Swibold LK","Urol Nurs","1999","1999/06/22","","",""
"18374289","Minimally invasive radical cystectomy for bladder cancer?","Karam JA, Sagalowsky AI.","Lancet Oncol. 2008 Apr;9(4):317-8. doi: 10.1016/S1470-2045(08)70087-1.","Karam JA","Lancet Oncol","2008","2008/04/01","","","10.1016/S1470-2045(08)70087-1"
"10481963","Use of diagnostic categories in urinary cytology in comparison with the bladder tumour antigen (BTA) test in bladder cancer patients","Takashi M, Schenck U, Kissel K, Leyh H, Treiber U.","Int Urol Nephrol. 1999;31(2):189-96. doi: 10.1023/a:1007124724817.","Takashi M","Int Urol Nephrol","1999","1999/09/11","","","10.1023/a:1007124724817"
"18939452","[Cae of double cancer involving of the bladder and prostate which was treated by radical cystectomy 8 years after radical prostatectomy]","Tamura Y, Ohki K, Sasaki Y, Ohtake N, Ohnuki T, Kurokawa K.","Nihon Hinyokika Gakkai Zasshi. 2008 Sep;99(6):694-7. doi: 10.5980/jpnjurol1989.99.694.","Tamura Y","Nihon Hinyokika Gakkai Zasshi","2008","2008/10/23","","","10.5980/jpnjurol1989.99.694"
"20310051","Patterns of care for early stage bladder cancer","Strope SA, Ye Z, Hollingsworth JM, Hollenbeck BK.","Cancer. 2010 Jun 1;116(11):2604-11. doi: 10.1002/cncr.25007.","Strope SA","Cancer","2010","2010/03/24","PMC2876213","NIHMS189701","10.1002/cncr.25007"
"17382708","The concept of lymph node density--is it ready for clinical practice?","Herr HW.","J Urol. 2007 Apr;177(4):1273-5; discussion 1275-6. doi: 10.1016/j.juro.2006.11.094.","Herr HW","J Urol","2007","2007/03/27","","","10.1016/j.juro.2006.11.094"
"10197434","Molecular genetic diagnosis of de novo and recurrent bladder cancer","Steiner G, Reinschmidt G, Müller SC.","Electrophoresis. 1999 Feb;20(2):280-2. doi: 10.1002/(SICI)1522-2683(19990201)20:2<280::AID-ELPS280>3.0.CO;2-Z.","Steiner G","Electrophoresis","1999","1999/04/10","","","10.1002/(SICI)1522-2683(19990201)20:2<280::AID-ELPS280>3.0.CO;2-Z"
"12271476","Bladder cancer among chemical workers exposed to nitrogen products and other substances","Marsh GM, Gula MJ, Youk AO, Cassidy LD.","Am J Ind Med. 2002 Oct;42(4):286-95. doi: 10.1002/ajim.10116.","Marsh GM","Am J Ind Med","2002","2002/09/25","","","10.1002/ajim.10116"
"9245197","[The need of prolonged BCG treatment in superficial bladder cancer is suggested by the development of a peripheral immune response induced by BCG]","Shekarsarai H, Zlotta AR, Drowart A, Van Vooren JP, De Cock M, Pirson M, Palfliet K, Jurion F, Vanonckelen A, Simon J, Schulman CC, Huygen K.","Acta Urol Belg. 1997 Mar;65(1):1-4.","Shekarsarai H","Acta Urol Belg","1997","1997/03/01","","",""
"11223747","Comparison of cytology and nuclear matrix protein 22 for the detection and follow-up of bladder cancer","Lahme S, Bichler KH, Feil G, Krause S.","Urol Int. 2001;66(2):72-7. doi: 10.1159/000056574.","Lahme S","Urol Int","2001","2001/02/27","","","10.1159/000056574"
"14696940","Bladder cancer in Kano--a histopathological review","Ochicha O, Alhassan S, Mohammed AZ, Edino ST, Nwokedi EE.","West Afr J Med. 2003 Sep;22(3):202-4. doi: 10.4314/wajm.v22i3.27949.","Ochicha O","West Afr J Med","2003","2003/12/31","","","10.4314/wajm.v22i3.27949"
"5430817","[Cancer of the bladder]","Nakarai K, Sonoda T.","Nihon Rinsho. 1970 Mar 25;28 Suppl:1168-9.","Nakarai K","Nihon Rinsho","1970","1970/03/25","","",""
"20195678","A pretreatment nomogram predicting recurrence- and progression-free survival for nonmuscle invasive bladder cancer in Japanese patients","Yamada T, Tsuchiya K, Kato S, Kamei S, Taniguchi M, Takeuchi T, Yamamoto N, Ehara H, Deguchi T.","Int J Clin Oncol. 2010 Jun;15(3):271-9. doi: 10.1007/s10147-010-0049-6. Epub 2010 Mar 2.","Yamada T","Int J Clin Oncol","2010","2010/03/03","","","10.1007/s10147-010-0049-6"
"11780464","Apoptosis inducing effects of arsenic trioxide on human bladder cancer cell line BIU-87","Tong Q, Zeng F, Zheng L, Zhao J, Lu G.","Chin Med J (Engl). 2001 Apr;114(4):402-6.","Tong Q","Chin Med J (Engl)","2001","2002/01/10","","",""
"1737266","Vesicosigmoid fistula as an incidental finding accompanying bladder cancer","Stavropoulos NE, Kontogiannis DS, Stavridadis JS, Gossios KJ.","Br J Urol. 1992 Jan;69(1):99. doi: 10.1111/j.1464-410x.1992.tb15471.x.","Stavropoulos NE","Br J Urol","1992","1992/01/01","","","10.1111/j.1464-410x.1992.tb15471.x"
"3898141","Superficial bladder cancer--the need for long-term follow-up of clinical trials","Newling DW.","Prog Clin Biol Res. 1985;185B:19-30.","Newling DW","Prog Clin Biol Res","1985","1985/01/01","","",""
"678842","Adjuvant chemotherapy in T3 bladder cancer","Richards B, Smith P, Glashan R, Robinson MR.","Br Med J. 1978 Jul 15;2(6131):200. doi: 10.1136/bmj.2.6131.200-b.","Richards B","Br Med J","1978","1978/07/15","PMC1606292","","10.1136/bmj.2.6131.200-b"
"9394912","Superficial bladder cancer: the role of molecular markers in the treatment of high-risk superficial disease","Malkowicz SB.","Semin Urol Oncol. 1997 Aug;15(3):169-78.","Malkowicz SB","Semin Urol Oncol","1997","1997/08/01","","",""
"25615534","Bladder cancer mortality after spinal cord injury over 4 decades","Nahm LS, Chen Y, DeVivo MJ, Lloyd LK.","J Urol. 2015 Jun;193(6):1923-8. doi: 10.1016/j.juro.2015.01.070. Epub 2015 Jan 20.","Nahm LS","J Urol","2015","2015/01/24","","","10.1016/j.juro.2015.01.070"
"7189792","Cis-diamminedichloride platinum II in the treatment of advanced bladder cancer","Herr HW.","J Urol. 1980 Jun;123(6):853-5. doi: 10.1016/s0022-5347(17)56161-3.","Herr HW","J Urol","1980","1980/06/01","","","10.1016/s0022-5347(17)56161-3"
"5624084","[TNM classification--bladder cancer]","Takayasu H.","Gan No Rinsho. 1967 May;13(5):316-9.","Takayasu H","Gan No Rinsho","1967","1967/05/01","","",""
"26520428","Osteoclast-Like Giant Cell Carcinoma Hidden by a Bladder Stone in a Patient With Neurogenic Bladder","Palazzetti A, Oderda M, Falcone M, Cassenti A, Delsedime L, Frea B, Pacchioni D, Gontero P.","Clin Genitourin Cancer. 2016 Feb;14(1):e127-30. doi: 10.1016/j.clgc.2015.10.004. Epub 2015 Oct 20.","Palazzetti A","Clin Genitourin Cancer","2016","2015/11/02","","","10.1016/j.clgc.2015.10.004"
"21738037","Which patients benefit the most from neoadjuvant chemotherapy in advanced bladder cancer?","Niegisch G, Albers P.","Curr Opin Urol. 2011 Sep;21(5):434-9. doi: 10.1097/MOU.0b013e328349582e.","Niegisch G","Curr Opin Urol","2011","2011/07/09","","","10.1097/MOU.0b013e328349582e"
"27612592","Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use","Dadhania V, Zhang M, Zhang L, Bondaruk J, Majewski T, Siefker-Radtke A, Guo CC, Dinney C, Cogdell DE, Zhang S, Lee S, Lee JG, Weinstein JN, Baggerly K, McConkey D, Czerniak B.","EBioMedicine. 2016 Oct;12:105-117. doi: 10.1016/j.ebiom.2016.08.036. Epub 2016 Aug 25.","Dadhania V","EBioMedicine","2016","2016/09/11","PMC5078592","","10.1016/j.ebiom.2016.08.036"
"26874533","A Review Comparing Experience and Results with Bipolar Versus Monopolar Resection for Treatment of Bladder Tumors","Osman Y, Harraz AM.","Curr Urol Rep. 2016 Mar;17(3):21. doi: 10.1007/s11934-016-0579-1.","Osman Y","Curr Urol Rep","2016","2016/02/15","","","10.1007/s11934-016-0579-1"
"24745483","Re: recurrence of high-risk bladder cancer: a population-based analysis","Wood DP.","J Urol. 2014 May;191(5):1264. doi: 10.1016/j.juro.2014.02.083. Epub 2014 Feb 22.","Wood DP","J Urol","2014","2014/04/22","","","10.1016/j.juro.2014.02.083"
"28109084","miR-5195-3p Inhibits Proliferation and Invasion of Human Bladder Cancer Cells by Directly Targeting Oncogene KLF5","Jiang Z, Zhang Y, Cao R, Li L, Zhong K, Chen Q, Xiao J.","Oncol Res. 2017 Aug 7;25(7):1081-1087. doi: 10.3727/096504016X14831120463349. Epub 2017 Jan 20.","Jiang Z","Oncol Res","2017","2017/01/22","","","10.3727/096504016X14831120463349"
"23598909","Advances in the management of muscle-invasive bladder cancer through risk prediction, risk communication, and novel treatment approaches","Galsky MD, Domingo-Domenech J.","Clin Adv Hematol Oncol. 2013 Feb;11(2):86-92.","Galsky MD","Clin Adv Hematol Oncol","2013","2013/04/20","","",""
"6677108","[Clinical study of urinary cytology: with special reference to bladder cancer]","Nemoto S, Ishikawa S, Takeshima H, Iizumi T, Uchida K, Yazaki T, Nemoto R, Rinsho K, Kano S.","Hinyokika Kiyo. 1983 Dec;29(12):1611-5.","Nemoto S","Hinyokika Kiyo","1983","1983/12/01","","",""
"6532207","[Bladder cancer in elderly patients]","Isaka S, Igarashi T, Akimoto S, Okano T, Shimazaki J, Matsuzaki O.","Hinyokika Kiyo. 1984 Dec;30(12):1793-9.","Isaka S","Hinyokika Kiyo","1984","1984/12/01","","",""
"15770207","Occupation and bladder cancer: a cohort study in Sweden","Ji J, Granström C, Hemminki K.","Br J Cancer. 2005 Apr 11;92(7):1276-8. doi: 10.1038/sj.bjc.6602473.","Ji J","Br J Cancer","2005","2005/03/17","PMC2361966","","10.1038/sj.bjc.6602473"
"24530986","Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression","Beckham CJ, Olsen J, Yin PN, Wu CH, Ting HJ, Hagen FK, Scosyrev E, Messing EM, Lee YF.","J Urol. 2014 Aug;192(2):583-92. doi: 10.1016/j.juro.2014.02.035. Epub 2014 Feb 14.","Beckham CJ","J Urol","2014","2014/02/18","","","10.1016/j.juro.2014.02.035"
"19199274","Bladder tumor markers: a review of the literature","Volpe A, Racioppi M, D'Agostino D, Cappa E, Gardi M, Totaro A, Pinto F, Sacco E, Marangi F, Palermo G, Bassi PF.","Int J Biol Markers. 2008 Oct-Dec;23(4):249-61. doi: 10.5301/jbm.2009.4479.","Volpe A","Int J Biol Markers","2008","2009/02/10","","","10.5301/jbm.2009.4479"
"8677544","[The late results of organ-preserving operations in acute hemorrhages in patients with bladder cancer]","Dovlatian AA.","Urol Nefrol (Mosk). 1996 Mar-Apr;(2):17-21.","Dovlatian AA","Urol Nefrol (Mosk)","1996","1996/03/01","","",""
"9477357","Transitional cell carcinoma of the bladder in patients under 30 years of age","Atan A, Başar M, Başar H, Yildiz M, Akalin Z.","Int Urol Nephrol. 1997;29(6):623-5. doi: 10.1007/BF02552176.","Atan A","Int Urol Nephrol","1997","1997/01/01","","","10.1007/BF02552176"
"10765101","Brachytherapy with iridium-192 for bladder cancer","Van Poppel H, Lievens Y, Van Limbergen E, Baert L.","Eur Urol. 2000 May;37(5):605-8. doi: 10.1159/000020200.","Van Poppel H","Eur Urol","2000","2000/04/15","","","10.1159/000020200"
"24669634","Risk factors for urinary bladder cancer in Baluchistan","Ahmad MR, Pervaiz MK, Chawala JA.","J Ayub Med Coll Abbottabad. 2012 Jul-Dec;24(3-4):135-7.","Ahmad MR","J Ayub Med Coll Abbottabad","2012","2014/03/28","","",""
"3116912","[Conservative treatment of bladder epitheliomas by partial cystectomy and iridium-192 curietherapy]","Mazeron JJ, Abbou CC, Chopin D, Antiphon P, Kouri G, Lansiaux P, Pierquin B, Auvert J.","Ann Urol (Paris). 1987;21(3):175-8.","Mazeron JJ","Ann Urol (Paris)","1987","1987/01/01","","",""
"9230190","Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization","Richter J, Jiang F, Görög JP, Sartorius G, Egenter C, Gasser TC, Moch H, Mihatsch MJ, Sauter G.","Cancer Res. 1997 Jul 15;57(14):2860-4.","Richter J","Cancer Res","1997","1997/07/15","","",""
"29117158","Theatre: The bladder's tale","Worth T.","Nature. 2017 Nov 8;551(7679):S42-S43. doi: 10.1038/551S42a.","Worth T","Nature","2017","2017/11/09","","","10.1038/551S42a"
"26320810","Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010","Cole AP, Dalela D, Hanske J, Mullane SA, Choueiri TK, Meyer CP, Nguyen PL, Menon M, Kibel AS, Preston MA, Bellmunt J, Trinh QD.","Urol Oncol. 2015 Dec;33(12):504.e9-17. doi: 10.1016/j.urolonc.2015.07.015. Epub 2015 Aug 25.","Cole AP","Urol Oncol","2015","2015/09/01","","","10.1016/j.urolonc.2015.07.015"
"22088692","Re.: Practice patterns and recurrence after partial cystectomy for bladder cancer","Wood DP.","J Urol. 2011 May;185(5):1643. doi: 10.1016/S0022-5347(11)60230-9.","Wood DP","J Urol","2011","2011/11/18","","","10.1016/S0022-5347(11)60230-9"
"18815922","Chemotherapy-induced bladder cancer","Nilsson S, Ullén A.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):89-92. doi: 10.1080/03008880802291832.","Nilsson S","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802291832"
"19522865","A novel strategy based on histological protein profiling in-silico for identifying potential biomarkers in urinary bladder cancer","Segersten MU, Edlund EK, Micke P, de la Torre M, Hamberg H, Edvinsson AE, Andersson SE, Malmström PU, Wester HK.","BJU Int. 2009 Dec;104(11):1780-5. doi: 10.1111/j.1464-410X.2009.08674.x. Epub 2009 Jun 12.","Segersten MU","BJU Int","2009","2009/06/16","","","10.1111/j.1464-410X.2009.08674.x"
"1700928","Recurrence and treatment of urinary bladder cancer after failure in radiotherapy","Salminen E.","Cancer. 1990 Dec 1;66(11):2341-5. doi: 10.1002/1097-0142(19901201)66:11<2341::aid-cncr2820661115>3.0.co;2-a.","Salminen E","Cancer","1990","1990/12/01","","","10.1002/1097-0142(19901201)66:11<2341::aid-cncr2820661115>3.0.co;2-a"
"15986448","High-throughput tissue microarray analysis of CMYC amplificationin urinary bladder cancer","Zaharieva B, Simon R, Ruiz C, Oeggerli M, Mihatsch MJ, Gasser T, Sauter G, Toncheva D.","Int J Cancer. 2005 Dec 20;117(6):952-6. doi: 10.1002/ijc.21253.","Zaharieva B","Int J Cancer","2005","2005/06/30","","","10.1002/ijc.21253"
"19108811","Gender-specific differences in bladder cancer: a retrospective analysis","Horstmann M, Witthuhn R, Falk M, Stenzl A.","Gend Med. 2008 Dec;5(4):385-94. doi: 10.1016/j.genm.2008.11.002.","Horstmann M","Gend Med","2008","2008/12/26","","","10.1016/j.genm.2008.11.002"
"33571","[New aspects in the treatment of elderly people with carcinoma of the urinary bladder (author's transl)]","Haschek H, Studler G.","Aktuelle Gerontol. 1979 Feb;9(2):53-8.","Haschek H","Aktuelle Gerontol","1979","1979/02/01","","",""
"25282704","Long-term follow-up of TaG1 non-muscle-invasive bladder cancer","Olivier Bosset P, Neuzillet Y, Paoletti X, Molinie V, Botto H, Lebret T.","Urol Oncol. 2015 Jan;33(1):20.e1-20.e7. doi: 10.1016/j.urolonc.2014.09.001. Epub 2014 Oct 2.","Olivier Bosset P","Urol Oncol","2015","2014/10/06","","","10.1016/j.urolonc.2014.09.001"
"15201817","Re: extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study","Malmström PU, Sherif A, Thörn M.","J Urol. 2004 Jul;172(1):386; author reply 386. doi: 10.1097/01.ju.0000132366.20760.53.","Malmström PU","J Urol","2004","2004/06/18","","","10.1097/01.ju.0000132366.20760.53"
"18704630","Glycosylation in bladder cancer","Ohyama C.","Int J Clin Oncol. 2008 Aug;13(4):308-13. doi: 10.1007/s10147-008-0809-8. Epub 2008 Aug 15.","Ohyama C","Int J Clin Oncol","2008","2008/08/16","","","10.1007/s10147-008-0809-8"
"6539739","Coffee drinking and bladder cancer","Hopkins J.","Food Chem Toxicol. 1984 Jun;22(6):481-3. doi: 10.1016/0278-6915(84)90336-3.","Hopkins J","Food Chem Toxicol","1984","1984/06/01","","","10.1016/0278-6915(84)90336-3"
"7395005","Screening tests for detection of bladder cancer","Betkerur V, Rao R, Hlaing V, Rhee H, Baumgartner G, Guinan P.","Urology. 1980 Jul;16(1):16-9. doi: 10.1016/0090-4295(80)90323-4.","Betkerur V","Urology","1980","1980/07/01","","","10.1016/0090-4295(80)90323-4"
"24176406","[Transurethral bladder resection of non muscle invasive bladder cancer with Hexvix ®]","Seisen T, Rouprêt M.","Prog Urol. 2013 Nov;23(14):1177-80. doi: 10.1016/j.purol.2013.06.008. Epub 2013 Jul 19.","Seisen T","Prog Urol","2013","2013/11/02","","","10.1016/j.purol.2013.06.008"
"31247687","[Investigation of Clinical Outcome and Prognosis of 2nd TUR-Bt for T1 High Grade Bladder Cancer]","Kato D, Kawase M, Ishida T, Kato S, Uno M, Fujimoto Y.","Hinyokika Kiyo. 2019 Apr;65(4):105-109. doi: 10.14989/ActaUrolJap_65_4_105.","Kato D","Hinyokika Kiyo","2019","2019/06/28","","","10.14989/ActaUrolJap_65_4_105"
"8345598","Neoadjuvant cisplatin, methotrexate and vinblastine for muscle-invasive bladder cancer: long-term followup","Dreicer R, Kollmorgen TA, Smith RF, Williams RD.","J Urol. 1993 Sep;150(3):849-52. doi: 10.1016/s0022-5347(17)35630-6.","Dreicer R","J Urol","1993","1993/09/01","","","10.1016/s0022-5347(17)35630-6"
"18702915","Is there a rationale for bladder cancer screening?","Svatek RS, Lotan Y.","Curr Urol Rep. 2008 Sep;9(5):339-41. doi: 10.1007/s11934-008-0058-4.","Svatek RS","Curr Urol Rep","2008","2008/08/16","","","10.1007/s11934-008-0058-4"
"59446","Radiotherapy: definitive, integrated and palliative therapy","Caldwell WL.","Urol Clin North Am. 1976 Feb;3(1):129-48.","Caldwell WL","Urol Clin North Am","1976","1976/02/01","","",""
"9616982","[Clinical efficacy of intravesical BCG treatment for superficial bladder neoplasms with respect to the iduced immune response]","Longeri D, Iantorno R, Nicolai M, Sisto A, Bailardi L, Pizzigallo E, Tenaglia R.","Arch Ital Urol Androl. 1998 Apr;70(2):65-9.","Longeri D","Arch Ital Urol Androl","1998","1998/06/09","","",""
"20596678","Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy","Mizutani Y, Katsuoka Y, Bonavida B.","Int J Oncol. 2010 Aug;37(2):503-8. doi: 10.3892/ijo_00000699.","Mizutani Y","Int J Oncol","2010","2010/07/03","","","10.3892/ijo_00000699"
"29496649","Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis","Chen J, Zhang H, Sun G, Zhang X, Zhao J, Liu J, Shen P, Shi M, Zeng H.","Int J Surg. 2018 Apr;52:214-220. doi: 10.1016/j.ijsu.2018.02.049. Epub 2018 Feb 27.","Chen J","Int J Surg","2018","2018/03/03","","","10.1016/j.ijsu.2018.02.049"
"25583419","Treatment and management of high-grade T1 bladder cancer: what should we do after second TUR?","Kitamura H, Kakehi Y.","Jpn J Clin Oncol. 2015 Apr;45(4):315-22. doi: 10.1093/jjco/hyu219. Epub 2015 Jan 12.","Kitamura H","Jpn J Clin Oncol","2015","2015/01/14","","","10.1093/jjco/hyu219"
"24326612","An orthotopic bladder cancer model for gene delivery studies","Kasman L, Voelkel-Johnson C.","J Vis Exp. 2013 Dec 1;(82):50181. doi: 10.3791/50181.","Kasman L","J Vis Exp","2013","2013/12/12","PMC4011168","","10.3791/50181"
"2318234","Epidemiological case-control study on the etiology of bladder cancer in Turkey","Akdaş A, Kirkali Z, Bilir N.","Eur Urol. 1990;17(1):23-6. doi: 10.1159/000463993.","Akdaş A","Eur Urol","1990","1990/01/01","","","10.1159/000463993"
"22245308","Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A new and highly prognostic system to discern T1 bladder cancer substage. Eur Urol 2012;61:378-84","Burger M, Otto W, Hartmann A.","Eur Urol. 2012 Apr;61(4):e31-2; author reply e33-4. doi: 10.1016/j.eururo.2012.01.005. Epub 2012 Jan 11.","Burger M","Eur Urol","2012","2012/01/17","","","10.1016/j.eururo.2012.01.005"
"10961281","Bladder cancer staging","MacVicar AD.","BJU Int. 2000 Jul;86 Suppl 1:111-22. doi: 10.1046/j.1464-410x.2000.00589.x.","MacVicar AD","BJU Int","2000","2000/08/29","","","10.1046/j.1464-410x.2000.00589.x"
"3511291","Intravesical bacillus Calmette-Guerin therapy and associated granulomatous renal masses","Stanisic TH, Brewer ML, Graham AR.","J Urol. 1986 Feb;135(2):356-8. doi: 10.1016/s0022-5347(17)45638-2.","Stanisic TH","J Urol","1986","1986/02/01","","","10.1016/s0022-5347(17)45638-2"
"24029362","Re: Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer","Atala A.","J Urol. 2013 Oct;190(4):1437. doi: 10.1016/j.juro.2013.06.057. Epub 2013 Jun 29.","Atala A","J Urol","2013","2013/09/14","","","10.1016/j.juro.2013.06.057"
"25306182","Words of wisdom. Re: Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review","Kiltie AE.","Eur Urol. 2014 Sep;66(3):597-8. doi: 10.1016/j.eururo.2014.06.033.","Kiltie AE","Eur Urol","2014","2014/10/13","","","10.1016/j.eururo.2014.06.033"
"20812921","Combined treatment involving unilateral common iliac embolization and femoro-femoral arterial bypass for lower gastrointestinal bleeding due to recurrent bladder cancer","Honda M, Watanabe T, Miyagawa I.","Int J Urol. 2010 Oct;17(10):894-5. doi: 10.1111/j.1442-2042.2010.02611.x. Epub 2010 Aug 31.","Honda M","Int J Urol","2010","2010/09/04","","","10.1111/j.1442-2042.2010.02611.x"
"6831368","Prognostic factors in local surgical treatment of invasive bladder cancer, with special reference to the presence of urothelial dysplasia","Wolf H, Højgaard K.","Cancer. 1983 May 1;51(9):1710-5. doi: 10.1002/1097-0142(19830501)51:9<1710::aid-cncr2820510925>3.0.co;2-n.","Wolf H","Cancer","1983","1983/05/01","","","10.1002/1097-0142(19830501)51:9<1710::aid-cncr2820510925>3.0.co;2-n"
"1636230","Diagnosis and staging of bladder cancer","Cummings KB, Barone JG, Ward WS.","Urol Clin North Am. 1992 Aug;19(3):455-65.","Cummings KB","Urol Clin North Am","1992","1992/08/01","","",""
"2217423","Criteria of response to neo-adjuvant chemotherapy in the treatment of invasive bladder cancer: a critical assessment","Vogelzang NJ, Raghaven D.","Prog Clin Biol Res. 1990;353:225-36.","Vogelzang NJ","Prog Clin Biol Res","1990","1990/01/01","","",""
"18190628","C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy","Yoshida S, Saito K, Koga F, Yokoyama M, Kageyama Y, Masuda H, Kobayashi T, Kawakami S, Kihara K.","BJU Int. 2008 Apr;101(8):978-81. doi: 10.1111/j.1464-410X.2007.07408.x. Epub 2008 Jan 10.","Yoshida S","BJU Int","2008","2008/01/15","","","10.1111/j.1464-410X.2007.07408.x"
"17904301","Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center","Kotwal S, Choudhury A, Johnston C, Paul AB, Whelan P, Kiltie AE.","Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):456-63. doi: 10.1016/j.ijrobp.2007.06.030. Epub 2007 Sep 27.","Kotwal S","Int J Radiat Oncol Biol Phys","2008","2007/10/02","","","10.1016/j.ijrobp.2007.06.030"
"4216089","Detection of bladder-cancer-associated antigens in urine by micro-complement fixation","Gozzo JJ, Schlesinger RM, Monaco AP.","Surg Forum. 1974;25(0):117-9.","Gozzo JJ","Surg Forum","1974","1974/01/01","","",""
"24875752","Low- and high-grade bladder cancer appraisal via serum-based proteomics approach","Bansal N, Gupta A, Sankhwar SN, Mahdi AA.","Clin Chim Acta. 2014 Sep 25;436:97-103. doi: 10.1016/j.cca.2014.05.012. Epub 2014 May 27.","Bansal N","Clin Chim Acta","2014","2014/05/31","","","10.1016/j.cca.2014.05.012"
"26343350","External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical Cystectomy","Brooks M, Godoy G, Sun M, Shariat SF, Amiel GE, Lerner SP.","J Urol. 2016 Feb;195(2):283-9. doi: 10.1016/j.juro.2015.08.093. Epub 2015 Sep 5.","Brooks M","J Urol","2016","2015/09/08","PMC6289832","NIHMS798810","10.1016/j.juro.2015.08.093"
"30415269","IC-2 Suppresses Proliferation and Induces Apoptosis of Bladder Cancer Cells via the Wnt/β-Catenin Pathway","Wu L, He S, He Y, Wang X, Lu L.","Med Sci Monit. 2018 Nov 11;24:8074-8080. doi: 10.12659/MSM.910742.","Wu L","Med Sci Monit","2018","2018/11/12","PMC6240849","","10.12659/MSM.910742"
"422411","The value of computed tomography in the management of bladder cancer","Yu WS, Sagerman RH, King GA, Chung CT, Yu YW.","Int J Radiat Oncol Biol Phys. 1979 Jan;5(1):135-42. doi: 10.1016/0360-3016(79)90052-x.","Yu WS","Int J Radiat Oncol Biol Phys","1979","1979/01/01","","","10.1016/0360-3016(79)90052-x"
"26209498","[The role of chemotherapy in bladder cancer]","Fiard G, Pavillet J.","Prog Urol. 2015 Nov;25(14):907-11. doi: 10.1016/j.purol.2015.06.011. Epub 2015 Jul 21.","Fiard G","Prog Urol","2015","2015/07/26","","","10.1016/j.purol.2015.06.011"
"8210833","Etiology of bladder cancer","Shirai T.","Semin Urol. 1993 Aug;11(3):113-26.","Shirai T","Semin Urol","1993","1993/08/01","","",""
"23462986","Low RKIP expression associates with poor prognosis in bladder cancer patients","Afonso J, Longatto-Filho A, Martinho O, Lobo F, Amaro T, Reis RM, Santos LL.","Virchows Arch. 2013 Apr;462(4):445-53. doi: 10.1007/s00428-013-1388-2. Epub 2013 Mar 6.","Afonso J","Virchows Arch","2013","2013/03/07","","","10.1007/s00428-013-1388-2"
"22446350","Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer","Tritschler S, Mosler C, Tilki D, Buchner A, Stief C, Graser A.","Urology. 2012 Jun;79(6):1317-21. doi: 10.1016/j.urology.2012.01.040. Epub 2012 Mar 23.","Tritschler S","Urology","2012","2012/03/27","","","10.1016/j.urology.2012.01.040"
"29666128","Prognostic value of ki67 in BCG-treated non-muscle invasive bladder cancer: a meta-analysis and systematic review","He Y, Wang N, Zhou X, Wang J, Ding Z, Chen X, Deng Y.","BMJ Open. 2018 Apr 17;8(4):e019635. doi: 10.1136/bmjopen-2017-019635.","He Y","BMJ Open","2018","2018/04/19","PMC5905754","","10.1136/bmjopen-2017-019635"
"25765384","Re: Surveillance of patients with bladder cancer following cystectomy: yield of CT urography","Siegel C.","J Urol. 2015 Mar;193(3):785. doi: 10.1016/j.juro.2014.12.059. Epub 2014 Dec 18.","Siegel C","J Urol","2015","2015/03/14","","","10.1016/j.juro.2014.12.059"
"24712067","I've heard that symptoms of urinary tract infections and bladder cancer are very similar. My wife has been treated numerous times recently for urinary tract infections. Could bladder cancer be a possibility?","","Mayo Clin Health Lett. 2013 Aug;31(8):8.","","Mayo Clin Health Lett","2013","2014/04/10","","",""
"15302481","Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older","Hollenbeck BK, Miller DC, Taub D, Dunn RL, Underwood W 3rd, Montie JE, Wei JT.","Urology. 2004 Aug;64(2):292-7. doi: 10.1016/j.urology.2004.03.034.","Hollenbeck BK","Urology","2004","2004/08/11","","","10.1016/j.urology.2004.03.034"
"2074522","Advances in screening protocols for the detection of early bladder cancer","Geller AC, Brooks DR, Barber CE, Koh HK, Lew RA, Wax S, Prout MN.","J Occup Med. 1990 Sep;32(9):929-35. doi: 10.1097/00043764-199009000-00036.","Geller AC","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00036"
"30327690","Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer","Liu GM, Xu ZQ, Ma HS.","Dis Markers. 2018 Sep 19;2018:4272064. doi: 10.1155/2018/4272064. eCollection 2018.","Liu GM","Dis Markers","2018","2018/10/18","PMC6169241","","10.1155/2018/4272064"
"23392958","Current role of PET, CT, MR for invasive bladder cancer","Lawrentschuk N, Lee ST, Scott AM.","Curr Urol Rep. 2013 Apr;14(2):84-9. doi: 10.1007/s11934-013-0308-y.","Lawrentschuk N","Curr Urol Rep","2013","2013/02/09","","","10.1007/s11934-013-0308-y"
"28168933","Incidental Dose to Pelvic Nodes in Bladder-Only Radiotherapy: Is It Clinically Relevant?","Lewis S, Murthy V, Mahantshetty U, Shrivastava SK.","Technol Cancer Res Treat. 2017 Jun;16(3):382-387. doi: 10.1177/1533034617691409. Epub 2017 Feb 7.","Lewis S","Technol Cancer Res Treat","2017","2017/02/08","PMC5616055","","10.1177/1533034617691409"
"29063301","Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy","Hakozaki K, Kikuchi E, Fukumoto K, Shirotake S, Miyazaki Y, Maeda T, Kaneko G, Yoshimine S, Tanaka N, Kanai K, Oyama M, Nakajima Y, Momma T, Oya M.","Med Oncol. 2017 Oct 23;34(12):187. doi: 10.1007/s12032-017-1048-5.","Hakozaki K","Med Oncol","2017","2017/10/25","","","10.1007/s12032-017-1048-5"
"21227392","Multiplexed methylation profiles of tumor suppressor genes in bladder cancer","Cabello MJ, Grau L, Franco N, Orenes E, Alvarez M, Blanca A, Heredero O, Palacios A, Urrutia M, Fernández JM, López-Beltrán A, Sánchez-Carbayo M.","J Mol Diagn. 2011 Jan;13(1):29-40. doi: 10.1016/j.jmoldx.2010.11.008. Epub 2010 Dec 23.","Cabello MJ","J Mol Diagn","2011","2011/01/14","PMC3070573","","10.1016/j.jmoldx.2010.11.008"
"19837472","Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia","Wittlinger M, Rödel CM, Weiss C, Krause SF, Kühn R, Fietkau R, Sauer R, Ott OJ.","Radiother Oncol. 2009 Nov;93(2):358-63. doi: 10.1016/j.radonc.2009.09.018.","Wittlinger M","Radiother Oncol","2009","2009/10/20","","","10.1016/j.radonc.2009.09.018"
"710032","The role of radiology in the assessment of bladder cancer","Muir BB, Sinclair DJ, Duncan W.","Clin Radiol. 1978 Sep;29(5):479-85. doi: 10.1016/s0009-9260(78)80031-2.","Muir BB","Clin Radiol","1978","1978/09/01","","","10.1016/s0009-9260(78)80031-2"
"1785004","Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group","Sell A, Jakobsen A, Nerstrøm B, Sørensen BL, Steven K, Barlebo H.","Scand J Urol Nephrol Suppl. 1991;138:193-201.","Sell A","Scand J Urol Nephrol Suppl","1991","1991/01/01","","",""
"29284232","Chromium in urothelial carcinoma of the bladder","Golabek T, Socha K, Kudelski J, Darewicz B, Markiewicz-Zukowska R, Chlosta P, Borawska M.","Ann Agric Environ Med. 2017 Dec 23;24(4):602-605. doi: 10.5604/12321966.1232760. Epub 2017 May 11.","Golabek T","Ann Agric Environ Med","2017","2017/12/30","","","10.5604/12321966.1232760"
"16859582","Molecular biology of bladder cancer: prognostic and clinical implications","Mitra AP, Lin H, Datar RH, Cote RJ.","Clin Genitourin Cancer. 2006 Jun;5(1):67-77. doi: 10.3816/CGC.2006.n.020.","Mitra AP","Clin Genitourin Cancer","2006","2006/07/25","","","10.3816/CGC.2006.n.020"
"15981433","[Primary lymphoepithelioma-like carcinoma urinary bladder]","Abascal Junquera JM, Martos Calvo R, Salvador Lacambra C, Idiope Tomás JI, de Torres I, Morote Robles J.","Actas Urol Esp. 2005 Apr;29(4):419-22. doi: 10.1016/s0210-4806(05)73266-6.","Abascal Junquera JM","Actas Urol Esp","2005","2005/06/29","","","10.1016/s0210-4806(05)73266-6"
"20446896","Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer","Lintula S, Hotakainen K.","Expert Opin Biol Ther. 2010 Aug;10(8):1169-80. doi: 10.1517/14712598.2010.489546.","Lintula S","Expert Opin Biol Ther","2010","2010/05/08","","","10.1517/14712598.2010.489546"
"1169997","Proceedings: Combined treatment of bladder cancer with sensitized pig lymphocytes and radiotherapy","Eckert H, Symes MO.","Br J Radiol. 1975 May;48(569):414-5.","Eckert H","Br J Radiol","1975","1975/05/01","","",""
"5120539","Population trends in cigarette smoking and bladder cancer","Hoover R, Cole P.","Am J Epidemiol. 1971 Nov;94(5):409-18. doi: 10.1093/oxfordjournals.aje.a121337.","Hoover R","Am J Epidemiol","1971","1971/11/01","","","10.1093/oxfordjournals.aje.a121337"
"5805017","[On the problem of secondary chronic pyelonephritis and kidney parenchyma inflammation in patients with bladder cancer]","Nieczyporenko A, Nieczyporenko M.","Pol Przegl Chir. 1969;41(4):Suppl 4a:481+.","Nieczyporenko A","Pol Przegl Chir","1969","1969/01/01","","",""
"18688595","[EMMPRIN (CD147). A new key protein during tumor progression in bladder cancer]","Nawroth R, Stöhr R, Hartmann A, Gschwend JE, Retz M.","Urologe A. 2008 Sep;47(9):1152-6. doi: 10.1007/s00120-008-1828-9.","Nawroth R","Urologe A","2008","2008/08/09","","","10.1007/s00120-008-1828-9"
"4810754","The masquerade of bladder cancer in situ as interstitial cystitis","Utz DC, Zincke H.","J Urol. 1974 Feb;111(2):160-1. doi: 10.1016/s0022-5347(17)59915-2.","Utz DC","J Urol","1974","1974/02/01","","","10.1016/s0022-5347(17)59915-2"
"18577979","Incorporating fluorescence cystoscopy for the diagnosis of bladder cancer into clinical practice","Karl A, Zaak D, Stief CG.","Nat Clin Pract Urol. 2008 Aug;5(8):424-5. doi: 10.1038/ncpuro1150. Epub 2008 Jun 24.","Karl A","Nat Clin Pract Urol","2008","2008/06/26","","","10.1038/ncpuro1150"
"5098237","[Results of the treatment of bladder cancer with concentrated cobaltotherapy (study of 2 comparative series)]","Harvey P, Brunet M, Bachelot F, Gest J.","Ann Urol (Paris). 1971 Sep;5(3):183-8.","Harvey P","Ann Urol (Paris)","1971","1971/09/01","","",""
"22445221","Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and highly prognostic system to discern T1 bladder cancer substage. Eur Urol 2012;61:378-84","Orsola A, de Torres I, Morote J.","Eur Urol. 2012 Jun;61(6):e53-4; author reply e55-6. doi: 10.1016/j.eururo.2012.03.016. Epub 2012 Mar 21.","Orsola A","Eur Urol","2012","2012/03/27","","","10.1016/j.eururo.2012.03.016"
"1984179","Biology and management of bladder cancer","","N Engl J Med. 1991 Jan 10;324(2):125-6. doi: 10.1056/NEJM199101103240211.","","N Engl J Med","1991","1991/01/10","","","10.1056/NEJM199101103240211"
"25556372","MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1","Liang Z, Li S, Xu X, Xu X, Wang X, Wu J, Zhu Y, Hu Z, Lin Y, Mao Y, Chen H, Luo J, Liu B, Zheng X, Xie L.","Mol Cells. 2015;38(2):130-7. doi: 10.14348/molcells.2015.2146. Epub 2014 Dec 30.","Liang Z","Mol Cells","2015","2015/01/06","PMC4332027","","10.14348/molcells.2015.2146"
"29391086","B7-Homolog 4 Promotes Epithelial-Mesenchymal Transition and Invasion of Bladder Cancer Cells via Activation of Nuclear Factor-κB","Wu H, Wang X, Mo N, Zhang L, Yuan X, Lü Z.","Oncol Res. 2018 Sep 14;26(8):1267-1274. doi: 10.3727/096504018X15172227703244. Epub 2018 Feb 1.","Wu H","Oncol Res","2018","2018/02/03","","","10.3727/096504018X15172227703244"
"2276186","[1:1 pair matched case-control study on bladder cancer]","Wang L.","Zhonghua Liu Xing Bing Xue Za Zhi. 1990 Dec;11(6):352-5.","Wang L","Zhonghua Liu Xing Bing Xue Za Zhi","1990","1990/12/01","","",""
"20624129","Adjuvant and neoadjuvant radiotherapy for bladder cancer: revisited","Zaghloul MS.","Future Oncol. 2010 Jul;6(7):1177-91. doi: 10.2217/fon.10.82.","Zaghloul MS","Future Oncol","2010","2010/07/14","","","10.2217/fon.10.82"
"26191193","Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer","Tang K, Wang C, Chen Z, Xu H, Ye Z.","Int J Clin Exp Pathol. 2015 May 1;8(5):4999-5007. eCollection 2015.","Tang K","Int J Clin Exp Pathol","2015","2015/07/21","PMC4503065","",""
"10754152","Bladder cancer arising in a spina bifida patient","Game X, Villers A, Malavaud B, Sarramon J.","Urology. 1999 Nov;54(5):923. doi: 10.1016/s0090-4295(99)00309-x.","Game X","Urology","1999","2001/02/07","","","10.1016/s0090-4295(99)00309-x"
"1305674","Superficial bladder cancer: diagnosis, surveillance and treatment","Soloway MS, Perito PE.","J Cell Biochem Suppl. 1992;16I:120-7. doi: 10.1002/jcb.240501323.","Soloway MS","J Cell Biochem Suppl","1992","1992/01/01","","","10.1002/jcb.240501323"
"26077307","[Molecular Characterisation of Urothelial Bladder Cancer: Will it Improve Patient Care?]","Erben P, Hartmann A, Bolenz C.","Aktuelle Urol. 2015 May;46(3):227-35. doi: 10.1055/s-0035-1549992. Epub 2015 Jun 12.","Erben P","Aktuelle Urol","2015","2015/06/17","","","10.1055/s-0035-1549992"
"3398164","Establishment and characterization of a doxorubicin-resistant human bladder cancer cell line (MGH-U1R)","McGovern F, Kachel T, Vijan S, Schiff S, Lin CW, Prout GR Jr.","J Urol. 1988 Aug;140(2):410-4. doi: 10.1016/s0022-5347(17)41647-8.","McGovern F","J Urol","1988","1988/08/01","","","10.1016/s0022-5347(17)41647-8"
"20389046","Is pure laparoscopic radical cystectomy still an attractive solution for the treatment of muscle-invasive bladder cancer?","Chlosta P, Drewa T, Dobruch J, Antoniewicz A, Olejniczak P, Obarzanowski M, Borowka A.","Urol Int. 2010;85(3):291-5. doi: 10.1159/000310349. Epub 2010 Apr 8.","Chlosta P","Urol Int","2010","2010/04/15","","","10.1159/000310349"
"26780243","[Molecular classification of bladder cancer. Possible similarities to breast cancer]","Wirtz RM, Fritz V, Stöhr R, Hartmann A.","Pathologe. 2016 Feb;37(1):52-60. doi: 10.1007/s00292-015-0134-8.","Wirtz RM","Pathologe","2016","2016/01/19","","","10.1007/s00292-015-0134-8"
"8322631","[A case of complete response in a patient with invasive bladder cancer due to intermittent intraarterial infusion chemotherapy using the alteration of blood flow]","Minami H, Umeda M, Maekawa T, Yoshihara H, Nakatani T, Yasumoto R, Kishimoto T.","Hinyokika Kiyo. 1993 May;39(5):471-4.","Minami H","Hinyokika Kiyo","1993","1993/05/01","","",""
"26637476","Expression of Annexin A2 and Its Correlation With Drug Resistance and Recurrence of Bladder Cancer","Hu H, Zhao J, Zhang M.","Technol Cancer Res Treat. 2016 Dec;15(6):NP61-NP68. doi: 10.1177/1533034615617078. Epub 2015 Dec 4.","Hu H","Technol Cancer Res Treat","2016","2015/12/06","","","10.1177/1533034615617078"
"22040502","Reassessment of the predictive role of perivesical fat invasion in invasive bladder cancer prognosis in 151 Chinese patients","Zhang ZL, Xiong YH, Li YH, Hou GL, Liu ZW, Han H, Qin ZK, Yun JP, Zhou FJ.","Chin Med J (Engl). 2011 Sep;124(18):2915-9.","Zhang ZL","Chin Med J (Engl)","2011","2011/11/02","","",""
"25618112","Effect of different Bacillus Calmette-Guerin substrains on growth inhibition of T24 bladder cancer cells and cytokines secretion by BCG activated peripheral blood mononuclear cells of PBMCs","Janaszek-Seydlitz W, Prygiel M, Bucholc B, Wiatrzyk A, Czajka U, Górska P, Soliwoda U.","Adv Clin Exp Med. 2014 Nov-Dec;23(6):877-84. doi: 10.17219/acem/37330.","Janaszek-Seydlitz W","Adv Clin Exp Med","2014","2015/01/26","","","10.17219/acem/37330"
"18058108","Defining the role of NMP22 in bladder cancer surveillance","Nguyen CT, Jones JS.","World J Urol. 2008 Feb;26(1):51-8. doi: 10.1007/s00345-007-0226-z. Epub 2007 Dec 4.","Nguyen CT","World J Urol","2008","2007/12/07","","","10.1007/s00345-007-0226-z"
"4008097","Familial and environmental interactions in bladder cancer risk","Kantor AF, Hartge P, Hoover RN, Fraumeni JF Jr.","Int J Cancer. 1985 Jun 15;35(6):703-6. doi: 10.1002/ijc.2910350602.","Kantor AF","Int J Cancer","1985","1985/06/15","","","10.1002/ijc.2910350602"
"7553305","The status of bladder-preserving therapeutic strategies in the management of patients with muscle-invasive bladder cancer","Koiso K, Shipley W, Keuppens F, Baert L, Hall R, Hudson MA, Khoury S, Kubota Y, Kubota Y, van Poppel H.","Int J Urol. 1995 Jun;2 Suppl 2:49-57. doi: 10.1111/j.1442-2042.1995.tb00479.x.","Koiso K","Int J Urol","1995","1995/06/01","","","10.1111/j.1442-2042.1995.tb00479.x"
"8411819","[Urokinase-type plasminogen activator antigen as a prognostic factor in bladder cancer]","Hasui Y, Nishi S, Kitada S, Osada Y.","Nihon Hinyokika Gakkai Zasshi. 1993 Sep;84(9):1624-8. doi: 10.5980/jpnjurol1989.84.1624.","Hasui Y","Nihon Hinyokika Gakkai Zasshi","1993","1993/09/01","","","10.5980/jpnjurol1989.84.1624"
"9338728","Incidence of urethral involvement in female bladder cancer: an anatomic pathologic study","Maralani S, Wood DP Jr, Grignon D, Banerjee M, Sakr W, Pontes JE.","Urology. 1997 Oct;50(4):537-41. doi: 10.1016/S0090-4295(97)00263-X.","Maralani S","Urology","1997","1997/10/24","","","10.1016/S0090-4295(97)00263-X"
"12972704","Perioperative chemotherapy in advanced bladder cancer: part I. Neoadjuvant treatment","Goebell PJ, Otto T, Rübben H.","Onkologie. 2003 Aug;26(4):361-5. doi: 10.1159/000072097.","Goebell PJ","Onkologie","2003","2003/09/16","","","10.1159/000072097"
"6465848","Short-term prognosis of bladder cancer. Evaluation with urinary CEA","Holmberg V, Nilsson B.","Anticancer Res. 1984 May-Jun;4(3):121-2.","Holmberg V","Anticancer Res","1984","1984/05/01","","",""
"25052754","Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette-Guérin","Liu X, Dowell AC, Patel P, Viney RP, Foster MC, Porfiri E, James ND, Bryan RT.","Future Oncol. 2014 Jun;10(8):1443-56. doi: 10.2217/fon.14.79.","Liu X","Future Oncol","2014","2014/07/24","","","10.2217/fon.14.79"
"3720364","The Copenhagen bladder cancer project II","Sørensen BL, Barlebo H, Bay-Nielsen H, Gammelgaard PA, Hvidt V, Walbom-Jørgensen S.","Dan Med Bull. 1986 Jun;33(3):155-61.","Sørensen BL","Dan Med Bull","1986","1986/06/01","","",""
"18162285","Urinary markers in bladder cancer","Vrooman OP, Witjes JA.","Eur Urol. 2008 May;53(5):909-16. doi: 10.1016/j.eururo.2007.12.006. Epub 2007 Dec 17.","Vrooman OP","Eur Urol","2008","2007/12/29","","","10.1016/j.eururo.2007.12.006"
"23053076","Auxotrophic recombinant Mycobacterium bovis BCG overexpressing Ag85B enhances cytotoxicity on superficial bladder cancer cells in vitro","Begnini KR, Rizzi C, Campos VF, Borsuk S, Schultze E, Yurgel VC, Nedel F, Dellagostin OA, Collares T, Seixas FK.","Appl Microbiol Biotechnol. 2013 Feb;97(4):1543-52. doi: 10.1007/s00253-012-4416-2. Epub 2012 Sep 30.","Begnini KR","Appl Microbiol Biotechnol","2013","2012/10/12","","","10.1007/s00253-012-4416-2"
"24330062","Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes","Lee RK, Abol-Enein H, Artibani W, Bochner B, Dalbagni G, Daneshmand S, Fradet Y, Hautmann RE, Lee CT, Lerner SP, Pycha A, Sievert KD, Stenzl A, Thalmann G, Shariat SF.","BJU Int. 2014 Jan;113(1):11-23. doi: 10.1111/bju.12121.","Lee RK","BJU Int","2014","2013/12/17","","","10.1111/bju.12121"
"26011327","Urothelial carcinoma: Recurrence and risk factors","Milojevic B, Dzamic Z, Kajmakovic B, Milenkovic Petronic D, Sipetic Grujicic S.","J BUON. 2015 Mar-Apr;20(2):391-8.","Milojevic B","J BUON","2015","2015/05/27","","",""
"18815914","Nutrition, total fluid and bladder cancer","Brinkman M, Zeegers MP.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):25-36. doi: 10.1080/03008880802285073.","Brinkman M","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802285073"
"22760792","Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer","Eissa S, Shehata H, Mansour A, Esmat M, El-Ahmady O.","Med Oncol. 2012 Dec;29(5):3345-51. doi: 10.1007/s12032-012-0295-8. Epub 2012 Jul 4.","Eissa S","Med Oncol","2012","2012/07/05","","","10.1007/s12032-012-0295-8"
"1556043","Bladder cancer","","Hematol Oncol Clin North Am. 1992 Feb;6(1):1-203.","","Hematol Oncol Clin North Am","1992","1992/02/01","","",""
"2410250","A case-control study of diesel exhaust exposure and bladder cancer","Wynder EL, Dieck GS, Hall NE, Lahti H.","Environ Res. 1985 Aug;37(2):475-89. doi: 10.1016/0013-9351(85)90129-x.","Wynder EL","Environ Res","1985","1985/08/01","","","10.1016/0013-9351(85)90129-x"
"24954108","Presence of lymphovascular invasion in urothelial bladder cancer specimens after transurethral resections correlates with risk of upstaging and survival: a systematic review and meta-analysis","Kim HS, Kim M, Jeong CW, Kwak C, Kim HH, Ku JH.","Urol Oncol. 2014 Nov;32(8):1191-9. doi: 10.1016/j.urolonc.2014.05.008. Epub 2014 Jun 20.","Kim HS","Urol Oncol","2014","2014/06/24","","","10.1016/j.urolonc.2014.05.008"
"23773411","Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial","Eustace A, Irlam JJ, Taylor J, Denley H, Agrawal S, Choudhury A, Ryder D, Ord JJ, Harris AL, Rojas AM, Hoskin PJ, West CM.","Radiother Oncol. 2013 Jul;108(1):40-7. doi: 10.1016/j.radonc.2013.05.017. Epub 2013 Jun 14.","Eustace A","Radiother Oncol","2013","2013/06/19","PMC3885794","","10.1016/j.radonc.2013.05.017"
"21437834","[Benefits and risks of orthotopic neobladder reconstruction in female patients]","Gakis G, Jentzmik F, Schrader M, Stenzl A, Sievert KD.","Aktuelle Urol. 2011 Mar;42(2):109-14. doi: 10.1055/s-0031-1271413. Epub 2011 Mar 24.","Gakis G","Aktuelle Urol","2011","2011/03/26","","","10.1055/s-0031-1271413"
"1769787","The efficacy of intravesical BCG in the treatment of patients with high risk superficial bladder cancer","Samodai L, Kiss L, Kolozsy Z, Mohácsi L.","Int Urol Nephrol. 1991;23(6):559-67. doi: 10.1007/BF02549846.","Samodai L","Int Urol Nephrol","1991","1991/01/01","","","10.1007/BF02549846"
"25665318","[Diagnostic and prognostic markers in non-muscle invasive bladder cancer]","El Mrini M, Xylinas E.","Rev Prat. 2014 Dec;64(10):1386-7.","El Mrini M","Rev Prat","2014","2015/02/11","","",""
"12731325","[The role of tumor markers in urologic consultation for screening, diagnosis, and follow-up of bladder cancer]","Lorenzo Gómez MF.","Actas Urol Esp. 2003 Feb;27(2):110-6. doi: 10.1016/s0210-4806(03)72888-5.","Lorenzo Gómez MF","Actas Urol Esp","2003","2003/05/07","","","10.1016/s0210-4806(03)72888-5"
"22699781","Runt-related transcription factor 3 methylation as a possible prognosticator in muscle-invasive bladder cancer","Jeong P, Ha YS, Kim JS, Cho IC, Kim WT, Kim YJ, Yi Kim I, Yun SJ, Lee SC, Cha EJ, Kim WJ.","Cancer Biomark. 2011;10(5):205-11. doi: 10.3233/CBM-2012-0248.","Jeong P","Cancer Biomark","2011","2012/06/16","","","10.3233/CBM-2012-0248"
"11834389","Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer?","Schips L, Augustin H, Zigeuner RE, Gallé G, Habermann H, Trummer H, Pummer K, Hubmer G.","Urology. 2002 Feb;59(2):220-3. doi: 10.1016/s0090-4295(01)01522-9.","Schips L","Urology","2002","2002/02/09","","","10.1016/s0090-4295(01)01522-9"
"24042563","BCG immunotherapy for bladder cancer--the effects of substrain differences","Gan C, Mostafid H, Khan MS, Lewis DJ.","Nat Rev Urol. 2013 Oct;10(10):580-8. doi: 10.1038/nrurol.2013.194. Epub 2013 Sep 17.","Gan C","Nat Rev Urol","2013","2013/09/18","","","10.1038/nrurol.2013.194"
"26384801","COUNTERPOINT: Is Cystectomy Needed for Small-Cell Bladder Cancer?","Kollmeier MA.","Oncology (Williston Park). 2015 Sep;29(9):645, 648-9.","Kollmeier MA","Oncology (Williston Park)","2015","2015/09/20","","",""
"8976297","Wavelength dependent photodynamic effects on chemically induced rat bladder tumors following intravesical instillation of 5-aminolevulinic acid","Stocker S, Knüchel R, Sroka R, Kriegmair M, Steinbach P, Baumgartner R.","J Urol. 1997 Jan;157(1):357-61.","Stocker S","J Urol","1997","1997/01/01","","",""
"24810644","Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis","Pan J, Liu M, Zhou X.","Front Med. 2014 Jun;8(2):241-9. doi: 10.1007/s11684-014-0328-0. Epub 2014 May 8.","Pan J","Front Med","2014","2014/05/10","","","10.1007/s11684-014-0328-0"
"2313794","Computerized morphonuclear cell image analyses of malignant disease in bladder tissues","de Prez C, de Launoit Y, Kiss R, Petein M, Pasteels JL, Verhest A, Van Velthoven R.","J Urol. 1990 Apr;143(4):694-9. doi: 10.1016/s0022-5347(17)40063-2.","de Prez C","J Urol","1990","1990/04/01","","","10.1016/s0022-5347(17)40063-2"
"24894749","Cadmium as a possible cause of bladder cancer: a review of accumulated evidence","Feki-Tounsi M, Hamza-Chaffai A.","Environ Sci Pollut Res Int. 2014 Sep;21(18):10561-73. doi: 10.1007/s11356-014-2970-0. Epub 2014 Jun 4.","Feki-Tounsi M","Environ Sci Pollut Res Int","2014","2014/06/05","","","10.1007/s11356-014-2970-0"
"22762511","Editorial comment to role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer","Matsuyama H.","Int J Urol. 2012 Nov;19(11):994. doi: 10.1111/j.1442-2042.2012.03096.x. Epub 2012 Jul 4.","Matsuyama H","Int J Urol","2012","2012/07/06","","","10.1111/j.1442-2042.2012.03096.x"
"15105344","How are we going to discover new cancer biomarkers? A proteomic approach for bladder cancer","Diamandis EP.","Clin Chem. 2004 May;50(5):793-5. doi: 10.1373/clinchem.2004.032177.","Diamandis EP","Clin Chem","2004","2004/04/24","","","10.1373/clinchem.2004.032177"
"21091091","Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer","Kehinde EO, Al-Mulla F, Kapila K, Anim JT.","Scand J Urol Nephrol. 2011 Mar;45(2):113-21. doi: 10.3109/00365599.2010.533694. Epub 2010 Nov 22.","Kehinde EO","Scand J Urol Nephrol","2011","2010/11/25","","","10.3109/00365599.2010.533694"
"7020918","Combined pre- and postoperative adjuvant radiotherapy for bladder cancer: results of RTOG/Jefferson Study","Mohiuddin M, Kramer S, Newall J, Parsons J, Wiley A.","Cancer. 1981 Jun 15;47(12):2840-3. doi: 10.1002/1097-0142(19810615)47:12<2840::aid-cncr2820471215>3.0.co;2-n.","Mohiuddin M","Cancer","1981","1981/06/15","","","10.1002/1097-0142(19810615)47:12<2840::aid-cncr2820471215>3.0.co;2-n"
"30806823","Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma","Lattanzi M, Balar AV.","Curr Oncol Rep. 2019 Feb 26;21(3):24. doi: 10.1007/s11912-019-0775-5.","Lattanzi M","Curr Oncol Rep","2019","2019/02/27","","","10.1007/s11912-019-0775-5"
"24346015","Bladder cancer: Conditional survival after radical cystectomy","Gandaglia G, Sun M.","Nat Rev Urol. 2014 Jan;11(1):8-9. doi: 10.1038/nrurol.2013.301. Epub 2013 Dec 17.","Gandaglia G","Nat Rev Urol","2014","2013/12/19","","","10.1038/nrurol.2013.301"
"3413909","Does invasive bladder cancer differ between women and men?","Hickey D, Soloway MS.","Urology. 1988 Sep;32(3):183-5. doi: 10.1016/0090-4295(88)90380-9.","Hickey D","Urology","1988","1988/09/01","","","10.1016/0090-4295(88)90380-9"
"23389364","Clinical value of vascular endothelial growth factor and endostatin in urine for diagnosis of bladder cancer","Cheng D, Liang B, Li Y.","Tumori. 2012 Nov;98(6):762-7. doi: 10.1700/1217.13501.","Cheng D","Tumori","2012","2013/02/08","","","10.1700/1217.13501"
"9772297","Combined effect of chemopreventive agent N-(4-hydroxyphenyl) retinamide (4-HPR) and gamma-radiation on bladder cancer cell lines","Zou C, Wang L, Liebert M, Grossman HB, Lotan R, Wei Q.","Int J Oncol. 1998 Nov;13(5):1037-41. doi: 10.3892/ijo.13.5.1037.","Zou C","Int J Oncol","1998","1998/10/17","","","10.3892/ijo.13.5.1037"
"1770703","[Whole layer needle biopsy for evaluation of neoadjuvant therapy to invasive bladder cancer]","Hoshi S, Orikasa S, Yoshikawa K, Saitoh S, Ohyama C, Satoh M, Kawamura S, Suzuki K, Nakazumi H, Tochigi T, et al.","Nihon Hinyokika Gakkai Zasshi. 1991 Oct;82(10):1649-55. doi: 10.5980/jpnjurol1989.82.1649.","Hoshi S","Nihon Hinyokika Gakkai Zasshi","1991","1991/10/01","","","10.5980/jpnjurol1989.82.1649"
"10349303","[Assessment of QOL and survival for patients undergoing radical cystectomy or bladder preservation for invasive bladder cancer]","Miyanaga N, Akaza H, Shinohara N, Koyanagi T, Tsujino S, Miki M, Tobisu K, Niimi M, Hinotsu J.","Nihon Hinyokika Gakkai Zasshi. 1999 Mar;90(3):445-53. doi: 10.5980/jpnjurol1989.90.445.","Miyanaga N","Nihon Hinyokika Gakkai Zasshi","1999","1999/06/01","","","10.5980/jpnjurol1989.90.445"
"18477502","Molecular profiling of bladder cancer: involvement of the TGF-beta pathway in bladder cancer progression","Hung TT, Wang H, Kingsley EA, Risbridger GP, Russell PJ.","Cancer Lett. 2008 Jun 28;265(1):27-38. doi: 10.1016/j.canlet.2008.02.034. Epub 2008 May 13.","Hung TT","Cancer Lett","2008","2008/05/15","","","10.1016/j.canlet.2008.02.034"
"1514197","[Indications for topical therapy in superficial bladder cancer]","Krege S.","Urologe A. 1992 Jul;31(4):201-2.","Krege S","Urologe A","1992","1992/07/01","","",""
"29178899","Smoking and alcohol cessation intervention in relation to radical cystectomy: a qualitative study of cancer patients' experiences","Lauridsen SV, Thomsen T, Kaldan G, Lydom LN, Tønnesen H.","BMC Cancer. 2017 Nov 25;17(1):793. doi: 10.1186/s12885-017-3792-5.","Lauridsen SV","BMC Cancer","2017","2017/11/28","PMC5702236","","10.1186/s12885-017-3792-5"
"10755416","Non-steroidal anti-inflammatory drugs and bladder cancer prevention","Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK.","Br J Cancer. 2000 Apr;82(7):1364-9. doi: 10.1054/bjoc.1999.1106.","Castelao JE","Br J Cancer","2000","2001/02/07","PMC2374480","","10.1054/bjoc.1999.1106"
"18722046","Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy","Solsona E, Climent MA, Iborra I, Collado A, Rubio J, Ricós JV, Casanova J, Calatrava A, Monrós JL.","Eur Urol. 2009 Apr;55(4):911-9. doi: 10.1016/j.eururo.2008.08.027. Epub 2008 Aug 15.","Solsona E","Eur Urol","2009","2008/08/30","","","10.1016/j.eururo.2008.08.027"
"29022185","Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer","Nazari A, Khorramdelazad H, Hassanshahi G.","Int J Clin Oncol. 2017 Dec;22(6):991-1000. doi: 10.1007/s10147-017-1187-x. Epub 2017 Oct 11.","Nazari A","Int J Clin Oncol","2017","2017/10/13","","","10.1007/s10147-017-1187-x"
"29916265","The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer","Lichtenegger E, Koll F, Haas H, Mantwill K, Janssen KP, Laschinger M, Gschwend J, Steiger K, Black PC, Moskalev I, Nawroth R, Holm PS.","Hum Gene Ther. 2019 Jan;30(1):44-56. doi: 10.1089/hum.2018.026. Epub 2018 Aug 3.","Lichtenegger E","Hum Gene Ther","2019","2018/06/20","","","10.1089/hum.2018.026"
"8664921","[T1G3 bladder neoplasms: treatment and results]","Cosciani Cunico S, Magri V, Aulenti V, Tosana M, Botturi A.","Arch Ital Urol Androl. 1996 Feb;68(1):47-50.","Cosciani Cunico S","Arch Ital Urol Androl","1996","1996/02/01","","",""
"18494831","Invasive T1 bladder cancer: indications and rationale for radical cystectomy","Stein JP, Penson DF.","BJU Int. 2008 Aug;102(3):270-5. doi: 10.1111/j.1464-410X.2008.07743.x. Epub 2008 May 20.","Stein JP","BJU Int","2008","2008/05/23","","","10.1111/j.1464-410X.2008.07743.x"
"31199968","Survival Benefit Persists With Delayed Initiation of Adjuvant Chemotherapy Following Radical Cystectomy for Locally Advanced Bladder Cancer","Corbett CJ, Xia L, Mamtani R, Malkowicz SB, Guzzo TJ.","Urology. 2019 Oct;132:143-149. doi: 10.1016/j.urology.2019.05.038. Epub 2019 Jun 11.","Corbett CJ","Urology","2019","2019/06/15","","","10.1016/j.urology.2019.05.038"
"28259358","Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy","Muppa P, Gupta S, Frank I, Boorjian SA, Karnes RJ, Thompson RH, Thapa P, Tarrell RF, Herrera Hernandez LP, Jimenez RE, Cheville JC.","Pathology. 2017 Apr;49(3):259-266. doi: 10.1016/j.pathol.2016.12.347. Epub 2017 Mar 1.","Muppa P","Pathology","2017","2017/03/06","","","10.1016/j.pathol.2016.12.347"
"16530068","The pathology of bladder cancer","Reuter VE.","Urology. 2006 Mar;67(3 Suppl 1):11-7; discussion 17-8. doi: 10.1016/j.urology.2006.01.037.","Reuter VE","Urology","2006","2006/03/15","","","10.1016/j.urology.2006.01.037"
"6461377","Industrial bladder cancer","Glashan RW.","Br Med J (Clin Res Ed). 1982 Feb 27;284(6316):614-5. doi: 10.1136/bmj.284.6316.614.","Glashan RW","Br Med J (Clin Res Ed)","1982","1982/02/27","PMC1496205","","10.1136/bmj.284.6316.614"
"31084565","Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Nonmuscle-Invasive Bladder Cancer Treated with GreenLight Laser Vaporization","Luo F, Ma C, Wu J, Li J.","Photobiomodul Photomed Laser Surg. 2019 May;37(5):312-317. doi: 10.1089/photob.2018.4592. Epub 2019 Apr 11.","Luo F","Photobiomodul Photomed Laser Surg","2019","2019/05/16","","","10.1089/photob.2018.4592"
"29614625","Inhibition of E-cadherin expression by lnc-RNA H19 to facilitate bladder cancer metastasis","Zhu Z, Xu L, Wan Y, Zhou J, Fu D, Chao H, Bao K, Zeng T.","Cancer Biomark. 2018;22(2):275-281. doi: 10.3233/CBM-170998.","Zhu Z","Cancer Biomark","2018","2018/04/05","","","10.3233/CBM-170998"
"22759493","Bladder cancer, a review of the environmental risk factors","Letašiová S, Medve'ová A, Šovčíková A, Dušinská M, Volkovová K, Mosoiu C, Bartonová A.","Environ Health. 2012 Jun 28;11 Suppl 1(Suppl 1):S11. doi: 10.1186/1476-069X-11-S1-S11.","Letašiová S","Environ Health","2012","2012/07/05","PMC3388449","","10.1186/1476-069X-11-S1-S11"
"8494917","Advances in bladder cancer","Ozen H.","Curr Opin Oncol. 1993 May;5(3):574-80. doi: 10.1097/00001622-199305000-00020.","Ozen H","Curr Opin Oncol","1993","1993/05/01","","","10.1097/00001622-199305000-00020"
"27614395","Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia","Ieda T, Muto S, Shimizu F, Taguri M, Yanada S, Kitamura K, Terai K, Saito K, Ogishima T, Nagata M, Ide H, Okegawa T, Wakumoto Y, Sakamoto Y, Tsujimura A, Yamaguchi R, Nutahara K, Horie S.","EBioMedicine. 2016 Oct;12:98-104. doi: 10.1016/j.ebiom.2016.08.051. Epub 2016 Sep 2.","Ieda T","EBioMedicine","2016","2016/09/12","PMC5078579","","10.1016/j.ebiom.2016.08.051"
"21465747","Disinfection by-products and bladder cancer. Common genetic variants may confer increased risk","Freeman KS.","Environ Health Perspect. 2010 Nov;118(11):A491. doi: 10.1289/ehp.118-a491a.","Freeman KS","Environ Health Perspect","2010","2011/04/06","PMC2974723","","10.1289/ehp.118-a491a"
"1117519","Failure of ascorbic acid to inhibit FANFT-induced bladder cancer","Soloway MS, Cohen SM, Dekernion JB, Persky L.","J Urol. 1975 Apr;113(4):483-6. doi: 10.1016/s0022-5347(17)59506-3.","Soloway MS","J Urol","1975","1975/04/01","","","10.1016/s0022-5347(17)59506-3"
"27108225","Chemoradiation for organ preservation in the treatment of muscle-invasive bladder cancer","McHaffie DR, Kruser TJ, Gaston K, Mahoney J, Graham D, Haake M.","Urol Oncol. 2016 Jun;34(6):271-8. doi: 10.1016/j.urolonc.2016.03.011. Epub 2016 Apr 20.","McHaffie DR","Urol Oncol","2016","2016/04/25","","","10.1016/j.urolonc.2016.03.011"
"31269502","Bacillus Calmette-Guérin in Immunosuppressed Patient with High-Grade Nonmuscle Invasive Bladder Carcinoma","Aznar Martínez L, López Cubillana P, López Abad A, Vidal Crespo N, Gómez Gómez GA.","Urol Int. 2019;103(2):242-244. doi: 10.1159/000501108. Epub 2019 Jul 3.","Aznar Martínez L","Urol Int","2019","2019/07/04","","","10.1159/000501108"
"2618182","[Dynamic computerized tomography in staging of urinary bladder cancer]","Schwarzbach C, Freitag J, Müller GW, Freitag G.","Z Urol Nephrol. 1989 Nov;82(11):583-91.","Schwarzbach C","Z Urol Nephrol","1989","1989/11/01","","",""
"8727804","Diagnosis and treatment of superficial bladder cancer: an update","Crawford ED.","Semin Urol Oncol. 1996 Feb;14(1 Suppl 1):1-9.","Crawford ED","Semin Urol Oncol","1996","1996/02/01","","",""
"29224371","Electrostatic interaction of tumor-targeting adenoviruses with aminoclay acquires enhanced infectivity to tumor cells inside the bladder and has better cytotoxic activity","Kim SY, Kwon WA, Shin SP, Seo HK, Lim SJ, Jung YS, Han HK, Jeong KC, Lee SJ.","Drug Deliv. 2018 Nov;25(1):49-58. doi: 10.1080/10717544.2017.1413450.","Kim SY","Drug Deliv","2018","2017/12/12","PMC6058485","","10.1080/10717544.2017.1413450"
"3692366","[Reliability of urinary cytology for follow-up of bladder cancer]","Ginesin Y, Malberger E, Semberg S, Levin DR.","Harefuah. 1987 Sep;113(5-6):101-3.","Ginesin Y","Harefuah","1987","1987/09/01","","",""
"18070458","[Diagnosis and substaging of pT1 bladder cancer]","Cheng L, Huang WB, Zheng SQ, Zheng J.","Zhonghua Bing Li Xue Za Zhi. 2007 Sep;36(9):636-9.","Cheng L","Zhonghua Bing Li Xue Za Zhi","2007","2007/12/12","","",""
"6534487","Treatment of invasive bladder cancer by local resection and high dose methotrexate","Hall RR, Newling DW, Ramsden PD, Richards B, Robinson MR, Smith PH.","Br J Urol. 1984 Dec;56(6):668-72. doi: 10.1111/j.1464-410x.1984.tb06142.x.","Hall RR","Br J Urol","1984","1984/12/01","","","10.1111/j.1464-410x.1984.tb06142.x"
"15990329","Perioperative chemotherapy for bladder cancer","Sonpavde G, Petrylak DP.","Crit Rev Oncol Hematol. 2006 Feb;57(2):133-44. doi: 10.1016/j.critrevonc.2005.05.004. Epub 2005 Jun 28.","Sonpavde G","Crit Rev Oncol Hematol","2006","2005/07/02","","","10.1016/j.critrevonc.2005.05.004"
"30322400","P3H4 is correlated with clinicopathological features and prognosis in bladder cancer","Li W, Ye L, Chen Y, Chen P.","World J Surg Oncol. 2018 Oct 15;16(1):206. doi: 10.1186/s12957-018-1507-2.","Li W","World J Surg Oncol","2018","2018/10/17","PMC6190559","","10.1186/s12957-018-1507-2"
"1459152","Studies of temperature rise in bladder cancer and surrounding tissues during radiofrequency hyperthermia","Uchibayashi T, Nakajima K, Hisazumi H, Mihara S, Yamamoto H, Koshida K.","Eur Urol. 1992;21(4):299-303. doi: 10.1159/000474861.","Uchibayashi T","Eur Urol","1992","1992/01/01","","","10.1159/000474861"
"21545386","Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity","van Rhijn BW.","BJU Int. 2011 Oct;108(7):1123-4. doi: 10.1111/j.1464-410X.2011.10344.x. Epub 2011 May 4.","van Rhijn BW","BJU Int","2011","2011/05/07","","","10.1111/j.1464-410X.2011.10344.x"
"27468885","MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection","Pospisilova S, Pazourkova E, Horinek A, Brisuda A, Svobodova I, Soukup V, Hrbacek J, Capoun O, Hanus T, Mares J, Korabecna M, Babjuk M.","Neoplasma. 2016;63(5):799-808. doi: 10.4149/neo_2016_518.","Pospisilova S","Neoplasma","2016","2016/07/30","","","10.4149/neo_2016_518"
"10799161","Sensitivity of human complement factor H related protein (BTA stat) test and voided urine cytology in the diagnosis of bladder cancer","Raitanen MP, Marttila T, Kaasinen E, Rintala E, Aine R, Tammela TL.","J Urol. 2000 Jun;163(6):1689-92.","Raitanen MP","J Urol","2000","2000/05/08","","",""
"17162005","Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?","Herr HW, Donat SM, Dalbagni G.","J Urol. 2007 Jan;177(1):75-9; discussion 79. doi: 10.1016/j.juro.2006.08.070.","Herr HW","J Urol","2007","2006/12/13","","","10.1016/j.juro.2006.08.070"
"16844461","Chemically induced bladder cancer--a sonographic and morphologic description","Gofrit ON, Birman T, Dinaburg A, Ayesh S, Ohana P, Hochberg A.","Urology. 2006 Jul;68(1):231-5. doi: 10.1016/j.urology.2006.03.022.","Gofrit ON","Urology","2006","2006/07/18","","","10.1016/j.urology.2006.03.022"
"25542424","The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer","Deng H, Lv L, Li Y, Zhang C, Meng F, Pu Y, Xiao J, Qian L, Zhao W, Liu Q, Zhang D, Wang Y, Zhang H, He Y, Zhu J.","Biochim Biophys Acta. 2015 Mar;1852(3):520-8. doi: 10.1016/j.bbadis.2014.12.014. Epub 2014 Dec 24.","Deng H","Biochim Biophys Acta","2015","2014/12/28","","","10.1016/j.bbadis.2014.12.014"
"30600382","Duodenal obstruction induced by retroperitoneal progression of bladder cancer: a report of two cases","Tokunaga K, Furuta A, Arizono S, Teramoto Y, Negoro H, Kido A, Isoda H, Togashi K.","Abdom Radiol (NY). 2019 Apr;44(4):1223-1229. doi: 10.1007/s00261-018-1874-8.","Tokunaga K","Abdom Radiol (NY)","2019","2019/01/03","","","10.1007/s00261-018-1874-8"
"17483025","Chronic inflammation and bladder cancer","Michaud DS.","Urol Oncol. 2007 May-Jun;25(3):260-8. doi: 10.1016/j.urolonc.2006.10.002.","Michaud DS","Urol Oncol","2007","2007/05/08","","","10.1016/j.urolonc.2006.10.002"
"25665320","[Combined chemotherapy and radiotherapy in bladder cancer: an alternative to surgery?]","Hennequin C, Menard J, Quero L.","Rev Prat. 2014 Dec;64(10):1393-5.","Hennequin C","Rev Prat","2014","2015/02/11","","",""
"17982569","Five-year, disease-free survival after repeat palliative multimodality therapy in a patient with recurrent metastatic bladder cancer","Fetscher S, Schmielau J, Schulze-Seemann W.","ScientificWorldJournal. 2007 Oct 22;7:1736-42. doi: 10.1100/tsw.2007.283.","Fetscher S","ScientificWorldJournal","2007","2007/11/06","PMC5900847","","10.1100/tsw.2007.283"
"3664943","The chemotherapy of advanced bladder cancer","Newling DW, Stoter G, Sylvester R, de Pauw M.","Cancer Chemother Pharmacol. 1987;20 Suppl:S39-43. doi: 10.1007/BF00262483.","Newling DW","Cancer Chemother Pharmacol","1987","1987/01/01","","","10.1007/BF00262483"
"4810759","Prophylactic urethrectomy in male patients with bladder cancer","Stams UK, Gursel EO, Veenema RJ.","J Urol. 1974 Feb;111(2):177-9. doi: 10.1016/s0022-5347(17)59920-6.","Stams UK","J Urol","1974","1974/02/01","","","10.1016/s0022-5347(17)59920-6"
"15605580","[Occupational exposure and bladder cancer]","Conso F.","Rev Prat. 2004 Oct 15;54(15):1665-70.","Conso F","Rev Prat","2004","2004/12/21","","",""
"25781573","Immunotherapy: The development of immunotherapy in urothelial bladder cancer","Powles T.","Nat Rev Clin Oncol. 2015 Apr;12(4):193-4. doi: 10.1038/nrclinonc.2015.51. Epub 2015 Mar 17.","Powles T","Nat Rev Clin Oncol","2015","2015/03/18","","","10.1038/nrclinonc.2015.51"
"8701803","A combined analysis of EORTC/MRC randomized clinical trials for the prophylactic treatment of TaT1 bladder cancer. Eortc Genito-Urinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer","Pawinski A, Sylvester R, Bouffioux C, Kurth KH, Parmar M, Bijnens L.","Acta Urol Belg. 1996 May;64(2):27.","Pawinski A","Acta Urol Belg","1996","1996/05/01","","",""
"19414124","Optimal timing of radical cystectomy for patients with T1 bladder cancer","Bochner BH.","Urol Oncol. 2009 May-Jun;27(3):329-31. doi: 10.1016/j.urolonc.2008.10.022.","Bochner BH","Urol Oncol","2009","2009/05/06","","","10.1016/j.urolonc.2008.10.022"
"2232433","[Preoperative adjuvant therapy for urinary bladder cancer--preoperative intra-arterial anticancer drugs infusion using artificial liver, and preoperative radiotherapy]","Gohji K, Sugino M, Arakawa S, Matsumoto O, Kamidono S, Fujii A, Morishita S, Nakano Y, Oda Y, Hamami G, et al.","Nihon Hinyokika Gakkai Zasshi. 1990 Sep;81(9):1404-11. doi: 10.5980/jpnjurol1989.81.1404.","Gohji K","Nihon Hinyokika Gakkai Zasshi","1990","1990/09/01","","","10.5980/jpnjurol1989.81.1404"
"11992927","Positive expression of HIF-2alpha/EPAS1 in invasive bladder cancer","Xia G, Kageyama Y, Hayashi T, Hyochi N, Kawakami S, Kihara K.","Urology. 2002 May;59(5):774-8. doi: 10.1016/s0090-4295(01)01607-7.","Xia G","Urology","2002","2002/05/07","","","10.1016/s0090-4295(01)01607-7"
"29256186","Bladder cancer in an inguinal vesical hernia","Kandemirli SG, Dikici AS, Nurili F, Tutar O, Mujgan YO, Mihmanli I, Kantarci F.","J Med Ultrason (2001). 2018 Jul;45(3):535-537. doi: 10.1007/s10396-017-0854-x. Epub 2017 Dec 18.","Kandemirli SG","J Med Ultrason (2001)","2018","2017/12/20","","","10.1007/s10396-017-0854-x"
"23196781","[Chemotherapy for urothelial cancer of the bladder--update 2012]","Niegisch G, Lorch A, Albers P.","Aktuelle Urol. 2012 Dec;43(6):412-9. doi: 10.1055/s-0032-1327699. Epub 2012 Nov 29.","Niegisch G","Aktuelle Urol","2012","2012/12/01","","","10.1055/s-0032-1327699"
"20571236","Serum interleukin-8 and insulin like growth factor-1 in Egyptian bladder cancer patients","Mahmoud MA, Ali MH, Hassoba HM, Elhadidy GS.","Cancer Biomark. 2010;6(2):105-10. doi: 10.3233/CBM-2009-0133.","Mahmoud MA","Cancer Biomark","2010","2010/06/24","","","10.3233/CBM-2009-0133"
"24415439","New treatments for bladder cancer: when will we make progress?","Nadal R, Bellmunt J.","Curr Treat Options Oncol. 2014 Mar;15(1):99-114. doi: 10.1007/s11864-013-0271-3.","Nadal R","Curr Treat Options Oncol","2014","2014/01/14","","","10.1007/s11864-013-0271-3"
"8558643","Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup","Schoenberg MP, Walsh PC, Breazeale DR, Marshall FF, Mostwin JL, Brendler CB.","J Urol. 1996 Feb;155(2):490-4.","Schoenberg MP","J Urol","1996","1996/02/01","","",""
"6537078","Bladder cancer: treatment of carcinoma in situ","Chisholm GD.","Turk J Pediatr. 1984;26(1-4):241-2.","Chisholm GD","Turk J Pediatr","1984","1984/01/01","","",""
"17127460","Tumor suppressor loci in bladder cancer","Knowles MA.","Front Biosci. 2007 Jan 1;12:2233-51. doi: 10.2741/2226.","Knowles MA","Front Biosci","2007","2006/11/28","","","10.2741/2226"
"27941379","Can we improve transurethral resection of the bladder tumour for nonmuscle invasive bladder cancer?","Liem EI, de Reijke TM.","Curr Opin Urol. 2017 Mar;27(2):149-155. doi: 10.1097/MOU.0000000000000370.","Liem EI","Curr Opin Urol","2017","2016/12/13","","","10.1097/MOU.0000000000000370"
"23917751","Digital quantitative immunofluorescent detection of p53 protein in urinary bladder cancer tissue samples","Saidi S, Popov Z, Stavridis S, Janevska V, Panov S.","Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2013;34(1):167-74.","Saidi S","Pril (Makedon Akad Nauk Umet Odd Med Nauki)","2013","2013/08/07","","",""
"8230298","Rationale for selecting exfoliated bladder cell micronuclei as potential biomarkers for arsenic genotoxicity","Smith AH, Hopenhayn-Rich C, Warner M, Biggs ML, Moore L, Smith MT.","J Toxicol Environ Health. 1993 Oct-Nov;40(2-3):223-34. doi: 10.1080/15287399309531790.","Smith AH","J Toxicol Environ Health","1993","1993/10/01","","","10.1080/15287399309531790"
"20004052","Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies","Kausch I, Sommerauer M, Montorsi F, Stenzl A, Jacqmin D, Jichlinski P, Jocham D, Ziegler A, Vonthein R.","Eur Urol. 2010 Apr;57(4):595-606. doi: 10.1016/j.eururo.2009.11.041. Epub 2009 Dec 2.","Kausch I","Eur Urol","2010","2009/12/17","","","10.1016/j.eururo.2009.11.041"
"4764937","Proceedings: Preoperative irradiation and cystectomy for bladder carcinoma. IV. Results in a selected population","Prout GR Jr, Slack NH, Bross ID.","Proc Natl Cancer Conf. 1972;7:783-91.","Prout GR Jr","Proc Natl Cancer Conf","1972","1972/01/01","","",""
"27600610","Effect of combined treatment of radiation and tissue-specific recombinant oncolytic adenovirus on bladder cancer cells","Zhang H, Wang F, Mao C, Zhang Z, Fu S, Lu J, Zhai Z, Li R, Li S, Rodriguez R, Wang Z.","Int J Radiat Biol. 2017 Feb;93(2):174-183. doi: 10.1080/09553002.2017.1231942. Epub 2016 Oct 14.","Zhang H","Int J Radiat Biol","2017","2016/09/08","","","10.1080/09553002.2017.1231942"
"14708234","[Choice of a method of surgical treatment of urinary bladder neoplasms]","Sitdykov EN, Sitdykova ME, Zubkov AIu.","Urologiia. 2003 Nov-Dec;(6):3-6.","Sitdykov EN","Urologiia","2003","2004/01/08","","",""
"4843725","Evaluation of immunological reactivity in bladder cancer","O'Boyle PJ, Cooper EH, Williams RE.","Br J Urol. 1974 Jun;46(3):303-8. doi: 10.1111/j.1464-410x.1974.tb03831.x.","O'Boyle PJ","Br J Urol","1974","1974/06/01","","","10.1111/j.1464-410x.1974.tb03831.x"
"2433019","Superficial bladder cancer. Risk of recurrence and potential role for interferon therapy","Torti FM, Lum BL.","Cancer. 1987 Feb 1;59(3 Suppl):613-6. doi: 10.1002/1097-0142(19870201)59:3+<613::aid-cncr2820591307>3.0.co;2-3.","Torti FM","Cancer","1987","1987/02/01","","","10.1002/1097-0142(19870201)59:3+<613::aid-cncr2820591307>3.0.co;2-3"
"21110757","Developments in intravesical therapy for non-muscle-invasive bladder cancer","Lammers RJ, Witjes JA.","Expert Rev Anticancer Ther. 2010 Dec;10(12):1903-16. doi: 10.1586/era.10.155.","Lammers RJ","Expert Rev Anticancer Ther","2010","2010/11/30","","","10.1586/era.10.155"
"7317745","The clinical significance of tissue polypeptide antigen (TPA) in the urine of bladder cancer patients","Kumar S, Costello CB, Glashan RW, Björklund B.","Br J Urol. 1981 Dec;53(6):578-81. doi: 10.1111/j.1464-410x.1981.tb03264.x.","Kumar S","Br J Urol","1981","1981/12/01","","","10.1111/j.1464-410x.1981.tb03264.x"
"8437249","Management of abdominal aortic aneurysm and invasive transitional cell carcinoma of bladder","Lierz MF, Davis BE, Noble MJ, Wattenhofer SP, Thomas JH.","J Urol. 1993 Mar;149(3):476-9. doi: 10.1016/s0022-5347(17)36122-0.","Lierz MF","J Urol","1993","1993/03/01","","","10.1016/s0022-5347(17)36122-0"
"2074505","Quantitative fluorescence image analysis in bladder cancer screening","Hemstreet GP 3rd, Hurst RE, Bass RA, Rao JY.","J Occup Med. 1990 Sep;32(9):822-8. doi: 10.1097/00043764-199009000-00013.","Hemstreet GP 3rd","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00013"
"3687623","[Clinical evaluation of total cystectomy in patients with bladder cancer]","Nakano M, Iwamuro S, Fujii H, Kondo I.","Hinyokika Kiyo. 1987 Jul;33(7):1011-6.","Nakano M","Hinyokika Kiyo","1987","1987/07/01","","",""
"16142557","Diet and bladder cancer: a case-control study","Radosavljević V, Janković S, Marinković J, Dokić M.","Int Urol Nephrol. 2005;37(2):283-9. doi: 10.1007/s11255-004-4710-8.","Radosavljević V","Int Urol Nephrol","2005","2005/09/06","","","10.1007/s11255-004-4710-8"
"4964820","Combined radiotherapy, surgery and chemotherapy in carcinoma of the bladder","Veenema RJ, Guttmann R, Uson AC, Sagerman RH, Dean AL Jr, Ciardullo L.","Cancer. 1967 Nov;20(11):1879-85. doi: 10.1002/1097-0142(196711)20:11<1879::aid-cncr2820201113>3.0.co;2-n.","Veenema RJ","Cancer","1967","1967/11/01","","","10.1002/1097-0142(196711)20:11<1879::aid-cncr2820201113>3.0.co;2-n"
"31298933","LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC","Zhuang C, Ma Q, Zhuang C, Ye J, Zhang F, Gui Y.","FASEB J. 2019 Oct;33(10):11045-11059. doi: 10.1096/fj.201900078RR. Epub 2019 Jul 12.","Zhuang C","FASEB J","2019","2019/07/13","","","10.1096/fj.201900078RR"
"10940701","Long-term risk of salvage cystectomy after radiotherapy for muscle-invasive bladder cancer","Cooke PW, Dunn JA, Latief T, Bathers S, James ND, Wallace DM.","Eur Urol. 2000 Sep;38(3):279-86. doi: 10.1159/000020294.","Cooke PW","Eur Urol","2000","2000/08/15","","","10.1159/000020294"
"452184","[Results of postoperative radiotherapy of bladder cancer (author's transl)]","Hübener KH, Voss AC.","Urologe A. 1979 May;18(3):137-42.","Hübener KH","Urologe A","1979","1979/05/01","","",""
"18716846","Mathematical model of pulsed immunotherapy for superficial bladder cancer","Bunimovich-Mendrazitsky S, Byrne H, Stone L.","Bull Math Biol. 2008 Oct;70(7):2055-76. doi: 10.1007/s11538-008-9344-z. Epub 2008 Aug 21.","Bunimovich-Mendrazitsky S","Bull Math Biol","2008","2008/08/22","","","10.1007/s11538-008-9344-z"
"29517839","PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer","Dong L, Li Y, Xue D, Liu Y.","IUBMB Life. 2018 Apr;70(4):291-299. doi: 10.1002/iub.1717. Epub 2018 Mar 8.","Dong L","IUBMB Life","2018","2018/03/09","","","10.1002/iub.1717"
"7459879","N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids","Becci PJ, Thompson HJ, Strum JM, Brown CC, Sporn MB, Moon RC.","Cancer Res. 1981 Mar;41(3):927-32.","Becci PJ","Cancer Res","1981","1981/03/01","","",""
"25638546","Anti-PD-L1 antibody active in metastatic bladder cancer","Brower V.","Lancet Oncol. 2015 Jan;16(1):e11. doi: 10.1016/S1470-2045(14)71167-2. Epub 2014 Dec 5.","Brower V","Lancet Oncol","2015","2015/02/02","","","10.1016/S1470-2045(14)71167-2"
"23276589","Prognostic value of the lymphovascular invasion in high-grade stage pT1 bladder cancer","Branchereau J, Larue S, Vayleux B, Karam G, Bouchot O, Rigaud J.","Clin Genitourin Cancer. 2013 Jun;11(2):182-8. doi: 10.1016/j.clgc.2012.10.002. Epub 2012 Dec 29.","Branchereau J","Clin Genitourin Cancer","2013","2013/01/02","","","10.1016/j.clgc.2012.10.002"
"19111073","Presentation and outcome following radical cystectomy in Hispanics with bladder cancer","Manoharan M, Ayyathurai R, de Los Santos R, Nieder AM, Soloway MS.","Int Braz J Urol. 2008 Nov-Dec;34(6):691-8; discussion 698. doi: 10.1590/s1677-55382008000600003.","Manoharan M","Int Braz J Urol","2008","2008/12/30","","","10.1590/s1677-55382008000600003"
"326394","Some immunological considerations relevant to the study of human bladder cancer","Bean MA.","Cancer Res. 1977 Aug;37(8 Pt 2):2879-84.","Bean MA","Cancer Res","1977","1977/08/01","","",""
"29744470","Organoid culture of bladder cancer cells","Yoshida T, Singh AK, Bishai WR, McConkey DJ, Bivalacqua TJ.","Investig Clin Urol. 2018 May;59(3):149-151. doi: 10.4111/icu.2018.59.3.149. Epub 2018 Apr 30.","Yoshida T","Investig Clin Urol","2018","2018/05/11","PMC5934275","","10.4111/icu.2018.59.3.149"
"12924464","A case of Addison's disease as presenting feature in recurrent metastatic bladder cancer","Lee MA, Hong YS, Lee KS.","Clin Oncol (R Coll Radiol). 2003 Aug;15(5):298-9. doi: 10.1016/s0936-6555(03)00098-0.","Lee MA","Clin Oncol (R Coll Radiol)","2003","2003/08/20","","","10.1016/s0936-6555(03)00098-0"
"23033490","Contrary regulation of bladder cancer cell proliferation and invasion by dexamethasone-mediated glucocorticoid receptor signals","Zheng Y, Izumi K, Li Y, Ishiguro H, Miyamoto H.","Mol Cancer Ther. 2012 Dec;11(12):2621-32. doi: 10.1158/1535-7163.MCT-12-0621. Epub 2012 Oct 1.","Zheng Y","Mol Cancer Ther","2012","2012/10/04","","","10.1158/1535-7163.MCT-12-0621"
"3391705","Fluid intake and bladder cancer in Utah","Slattery ML, West DW, Robison LM.","Int J Cancer. 1988 Jul 15;42(1):17-22. doi: 10.1002/ijc.2910420105.","Slattery ML","Int J Cancer","1988","1988/07/15","","","10.1002/ijc.2910420105"
"9670730","[Prognostic significance of ultrastructural analysis of basal compartment disorder in recurrent transitional cell papilloma and in situ cancer of the bladder]","Gaĭyrov AG.","Klin Khir. 1998;(3):36-7.","Gaĭyrov AG","Klin Khir","1998","1998/07/22","","",""
"17250433","A case-control study on the etiology of urinary bladder cancer in Istanbul, Turkey","Yaris F, Dikici MF, Sabuncu HH, Yaris E.","Asian Pac J Cancer Prev. 2006 Oct-Dec;7(4):591-4.","Yaris F","Asian Pac J Cancer Prev","2006","2007/01/26","","",""
"30938068","Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study","Häggström C, Garmo H, de Luna X, Van Hemelrijck M, Söderkvist K, Aljabery F, Ströck V, Hosseini A, Gårdmark T, Malmström PU, Jahnson S, Liedberg F, Holmberg L.","Cancer Med. 2019 May;8(5):2196-2204. doi: 10.1002/cam4.2126. Epub 2019 Apr 1.","Häggström C","Cancer Med","2019","2019/04/03","PMC6536982","","10.1002/cam4.2126"
"26125511","Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder","Fransen van de Putte EE, Behrendt MA, Pigot GL, van der Kwast TH, van Rhijn BW.","Curr Opin Urol. 2015 Sep;25(5):427-35. doi: 10.1097/MOU.0000000000000202.","Fransen van de Putte EE","Curr Opin Urol","2015","2015/07/01","","","10.1097/MOU.0000000000000202"
"8749781","Origins and clinical implications of aneuploidy in early bladder cancer","Shackney SE, Berg G, Simon SR, Cohen J, Amina S, Pommersheim W, Yakulis R, Wang S, Uhl M, Smith CA, et al.","Cytometry. 1995 Dec 15;22(4):307-16. doi: 10.1002/cyto.990220407.","Shackney SE","Cytometry","1995","1995/12/15","","","10.1002/cyto.990220407"
"9719413","Isolation and characterization of a novel human bladder cancer cell line: BK10","Roberson KM, Yancey DR, Padilla-Nash H, Edwards DW, Nash W, Jacobs S, Padilla GM, Larchian WA, Robertson CN.","In Vitro Cell Dev Biol Anim. 1998 Jul-Aug;34(7):537-44. doi: 10.1007/s11626-998-0113-y.","Roberson KM","In Vitro Cell Dev Biol Anim","1998","1998/08/27","","","10.1007/s11626-998-0113-y"
"24200618","[Paraneoplastic cerebellar degeneration with bladder cancer confirmed the existence of an anti-neural antibody: a case report]","Kawanishi K, Morita M, Nakahara K, Tetsuka S, Kouki T, Tominaga K, Endo H, Yashiro T, Tanaka K, Nakano I.","Brain Nerve. 2013 Nov;65(11):1401-5.","Kawanishi K","Brain Nerve","2013","2013/11/09","","",""
"3613331","[Studies on bladder cancer using flow cytometry. II. Evaluation of prognosis and intravesical recurrence of bladder cancer based on flow cytometric DNA analysis]","Yoshikawa K, Tochigi T, Hoshi S, Orikasa S, Imai Y.","Nihon Hinyokika Gakkai Zasshi. 1987 Feb;78(2):227-31.","Yoshikawa K","Nihon Hinyokika Gakkai Zasshi","1987","1987/02/01","","",""
"24125689","Understanding avoidance, refusal, and abandonment of chemotherapy before and after cystectomy for bladder cancer","Rehman S, Crane A, Din R, Raza SJ, Shi Y, Wilding G, Levine EG, George S, Pili R, Trump DL, Guru KA.","Urology. 2013 Dec;82(6):1370-5. doi: 10.1016/j.urology.2013.07.055. Epub 2013 Oct 11.","Rehman S","Urology","2013","2013/10/16","","","10.1016/j.urology.2013.07.055"
"9866458","Metastatic spread and common symptoms. Part One: Introduction, bladder cancer, and brain cancer","Kemp C.","Am J Hosp Palliat Care. 1998 Nov-Dec;15(6):355-60. doi: 10.1177/104990919801500609.","Kemp C","Am J Hosp Palliat Care","1998","1998/12/29","","","10.1177/104990919801500609"
"2675002","BCG in the management of superficial bladder cancer","Guinan P, Richardson C, Hanna M, Rubenstein M.","Prog Clin Biol Res. 1989;303:447-53.","Guinan P","Prog Clin Biol Res","1989","1989/01/01","","",""
"30855372","Urinary biomarkers in bladder cancer: where do we stand?","Bhat A, Ritch CR.","Curr Opin Urol. 2019 May;29(3):203-209. doi: 10.1097/MOU.0000000000000605.","Bhat A","Curr Opin Urol","2019","2019/03/12","","","10.1097/MOU.0000000000000605"
"16892094","Systemic management of bladder cancer in Egypt: revisited","Khaled HM.","J Egypt Natl Canc Inst. 2005 Sep;17(3):127-31.","Khaled HM","J Egypt Natl Canc Inst","2005","2006/08/08","","",""
"16530080","The use of urine-based biomarkers in bladder cancer","Grossman HB, Blute ML, Dinney CP, Jones JS, Liou LS, Reuter VE, Soloway MS.","Urology. 2006 Mar;67(3 Suppl 1):62-4. doi: 10.1016/j.urology.2006.01.036.","Grossman HB","Urology","2006","2006/03/15","","","10.1016/j.urology.2006.01.036"
"21620301","[Influence of occupational exposures in nonmuscle infiltration bladder cancer: preliminary results of a prospective study from October 2005 to February 2009]","Pecoux F, Fantoni JC, Berthon N, Lepage N, Sobaszek A, Sebbane N, Devos P, Biserte J.","Prog Urol. 2011 Jun;21(6):405-11. doi: 10.1016/j.purol.2010.11.009. Epub 2011 Jan 26.","Pecoux F","Prog Urol","2011","2011/05/31","","","10.1016/j.purol.2010.11.009"
"12200095","Smoking and other risk factors for bladder cancer in women","Pelucchi C, La Vecchia C, Negri E, Dal Maso L, Franceschi S.","Prev Med. 2002 Aug;35(2):114-20. doi: 10.1006/pmed.2002.1061.","Pelucchi C","Prev Med","2002","2002/08/30","","","10.1006/pmed.2002.1061"
"22389275","Solitary skin metastasis adjacent to ureterocutaneostomy 4 years after radical cystectomy for bladder cancer","Yoshida T, Takayama H, Uemura M, Nakai Y, Nonomura N, Tsujimura A.","Jpn J Clin Oncol. 2012 Apr;42(4):331-4. doi: 10.1093/jjco/hys017. Epub 2012 Mar 2.","Yoshida T","Jpn J Clin Oncol","2012","2012/03/06","","","10.1093/jjco/hys017"
"30266310","Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants","Warrick JI, Sjödahl G, Kaag M, Raman JD, Merrill S, Shuman L, Chen G, Walter V, DeGraff DJ.","Eur Urol. 2019 Jan;75(1):18-22. doi: 10.1016/j.eururo.2018.09.003. Epub 2018 Sep 25.","Warrick JI","Eur Urol","2019","2018/09/30","","","10.1016/j.eururo.2018.09.003"
"15168998","Bladder preserving approach for muscle invasive bladder cancer--role of mycobacterium w","Chaudhuri P, Mukhopadhyay S.","J Indian Med Assoc. 2003 Sep;101(9):559-60.","Chaudhuri P","J Indian Med Assoc","2003","2004/06/01","","",""
"482959","Public health value of using epidemiologic information to identify high-risk groups for bladder cancer screening","Morrison AS.","Semin Oncol. 1979 Jun;6(2):184-8.","Morrison AS","Semin Oncol","1979","1979/06/01","","",""
"25784448","[Study on the treatment of nonmuscle invasive bladder cancer: A phase III efficacy study for intravesical instillation of mistletoe extract in superficial bladder cancer (TIM) AB 40/11 of the AUO]","Rexer H; Geschäftsstelle der AUO.","Urologe A. 2015 Mar;54(3):406-8. doi: 10.1007/s00120-015-3781-8.","Rexer H","Urologe A","2015","2015/03/19","","","10.1007/s00120-015-3781-8"
"24687312","Bladder cancer in women","Nicholson BD, McGrath JS, Hamilton W.","BMJ. 2014 Mar 31;348:g2171. doi: 10.1136/bmj.g2171.","Nicholson BD","BMJ","2014","2014/04/02","","","10.1136/bmj.g2171"
"18535931","Predictive biomarkers and signatures in urinary bladder cancer","Roos PH, Golka K, Hengstler JG.","Curr Opin Mol Ther. 2008 Jun;10(3):243-50.","Roos PH","Curr Opin Mol Ther","2008","2008/06/07","","",""
"9258086","A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer","Schmetter BS, Habicht KK, Lamm DL, Morales A, Bander NH, Grossman HB, Hanna MG Jr, Silberman SR, Butman BT.","J Urol. 1997 Sep;158(3 Pt 1):801-5. doi: 10.1097/00005392-199709000-00029.","Schmetter BS","J Urol","1997","1997/09/01","","","10.1097/00005392-199709000-00029"
"9182484","[Survival in stage T2-T3A bladder cancer treated with radical cystectomy]","Angulo Cuesta J, Sánchez Chapado M, Guil Cid M, Flores Corral N, Pontes EJ, Grignon DJ.","Arch Esp Urol. 1997 Jan-Feb;50(1):17-23; discussion 24-5.","Angulo Cuesta J","Arch Esp Urol","1997","1997/01/01","","",""
"17805506","[Is there an indication for adjuvant or neoadjuvant systemic chemotherapy in bladder cancer?]","Suttmann H, Retz M, Gschwend JE, Stöckle M.","Urologe A. 2007 Oct;46(10):1379-80, 1382-4. doi: 10.1007/s00120-007-1546-8.","Suttmann H","Urologe A","2007","2007/09/07","","","10.1007/s00120-007-1546-8"
"332323","The epidemiology of bladder cancer: a second look","Wynder EL, Goldsmith R.","Cancer. 1977 Sep;40(3):1246-68. doi: 10.1002/1097-0142(197709)40:3<1246::aid-cncr2820400340>3.0.co;2-5.","Wynder EL","Cancer","1977","1977/09/01","","","10.1002/1097-0142(197709)40:3<1246::aid-cncr2820400340>3.0.co;2-5"
"17514806","Long-term Mitomycin C is better for bladder cancer","Gould P.","Lancet Oncol. 2007 May;8(5):377. doi: 10.1016/s1470-2045(07)70124-9.","Gould P","Lancet Oncol","2007","2007/05/22","","","10.1016/s1470-2045(07)70124-9"
"9131099","[Therapy and prevention of recurrence in bladder cancer. Convincing results]","","Urologe A. 1995 Sep;34(5 Suppl):1-4.","","Urologe A","1995","1995/09/01","","",""
"20969638","Editorial Comment to Cancer death from non-muscle invasive bladder cancer: Report of the Japanese Urological Association of data from the 1999-2001 registry in Japan","Koga F.","Int J Urol. 2010 Nov;17(11):913. doi: 10.1111/j.1442-2042.2010.02640.x.","Koga F","Int J Urol","2010","2010/10/26","","","10.1111/j.1442-2042.2010.02640.x"
"19152434","Understanding bladder cancer death: tumor biology versus physician practice","Morris DS, Weizer AZ, Ye Z, Dunn RL, Montie JE, Hollenbeck BK.","Cancer. 2009 Mar 1;115(5):1011-20. doi: 10.1002/cncr.24136.","Morris DS","Cancer","2009","2009/01/20","","","10.1002/cncr.24136"
"29901311","[En-bloc laser resection of the urinary bladder tumor]","Alyaev YG, Rapoport LM, Vinarov AZ, Sorokin NI, Dymov AM, Kislyakov DA, Afanasyevskaya EV, Lekarev VY.","Urologiia. 2018 May;(2):147-153.","Alyaev YG","Urologiia","2018","2018/06/15","","",""
"9146593","The use of urine cytology for diagnosing bladder cancer in spinal cord injured patients","Stonehill WH, Goldman HB, Dmochowski RR.","J Urol. 1997 Jun;157(6):2112-4.","Stonehill WH","J Urol","1997","1997/06/01","","",""
"2629569","[Superficial bladder tumors. Results of preventive treatment of recurrence by intravesical instillation of BCG]","Charbit L, Tremeaux JC, Cukier J.","Ann Med Interne (Paris). 1989;140(8):695-7.","Charbit L","Ann Med Interne (Paris)","1989","1989/01/01","","",""
"3319007","Evaluation of bladder cancer with a miniature high frequency transurethral ultrasonography probe","Devonec M, Chapelon JY, Codas H, Dubernard JM, Revillard JP, Cathignol D.","Br J Urol. 1987 Jun;59(6):550-3. doi: 10.1111/j.1464-410x.1987.tb04875.x.","Devonec M","Br J Urol","1987","1987/06/01","","","10.1111/j.1464-410x.1987.tb04875.x"
"3576876","Radical cystectomy in presence of fused ""cake"" kidney","Vaughn W, Hickey D, Milam WH, Soloway M.","Urology. 1987 May;29(5):552-4. doi: 10.1016/0090-4295(87)90050-1.","Vaughn W","Urology","1987","1987/05/01","","","10.1016/0090-4295(87)90050-1"
"23089235","Measuring priority symptoms in advanced bladder cancer: development and initial validation of a brief symptom index","Jensen SE, Beaumont JL, Jacobsen PB, Abernethy A, Syrjala KL, Cella D.","J Support Oncol. 2013 Jun;11(2):86-93. doi: 10.1016/j.suponc.2012.07.002.","Jensen SE","J Support Oncol","2013","2012/10/24","PMC5886785","NIHMS954343","10.1016/j.suponc.2012.07.002"
"23584347","Bladder cancer","Clark PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Spiess PE, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M; National Comprehensive Cancer Network (NCCN).","J Natl Compr Canc Netw. 2013 Apr 1;11(4):446-75. doi: 10.6004/jnccn.2013.0059.","Clark PE","J Natl Compr Canc Netw","2013","2013/04/16","","","10.6004/jnccn.2013.0059"
"1300819","[Increased risk factors for the occurrence of bladder cancer]","Zaridze DG, Nekrasova LI, Basieva TKh.","Vopr Onkol. 1992;38(9):1066-73.","Zaridze DG","Vopr Onkol","1992","1992/01/01","","",""
"10696244","Utility of nuclear matrix protein (NMP22) in the detection of recurrent bladder cancer","Grocela JA, McDougal WS.","Urol Clin North Am. 2000 Feb;27(1):47-51, viii. doi: 10.1016/s0094-0143(05)70233-0.","Grocela JA","Urol Clin North Am","2000","2000/03/04","","","10.1016/s0094-0143(05)70233-0"
"10484851","[Complications of radiotherapy for invasive bladder cancer: acute and chronic effects. Method of evaluation: measurement by RTOG/EORTC, SOMA/LENT]","Esco Barón R, Baquedano Baquedano JE.","Arch Esp Urol. 1999 Jul-Aug;52(6):675-83.","Esco Barón R","Arch Esp Urol","1999","1999/09/15","","",""
"7351716","Factors influencing the recurrence rate of bladder cancer","Loening S, Narayana A, Yoder L, Slymen D, Weinstein S, Penick G, Culp D.","J Urol. 1980 Jan;123(1):29-31. doi: 10.1016/s0022-5347(17)55763-8.","Loening S","J Urol","1980","1980/01/01","","","10.1016/s0022-5347(17)55763-8"
"8179678","Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapy","Hall RR, Parmar MK, Richards AB, Smith PH.","BMJ. 1994 Jan 22;308(6923):257-60. doi: 10.1136/bmj.308.6923.257.","Hall RR","BMJ","1994","1994/01/22","PMC2539314","","10.1136/bmj.308.6923.257"
"8076366","Carcinogen-DNA adducts in bladder biopsies and urothelial cells: a risk assessment exercise","Talaska G, Schamer M, Casetta G, Tizzani A, Vineis P.","Cancer Lett. 1994 Aug 29;84(1):93-7. doi: 10.1016/0304-3835(94)90362-x.","Talaska G","Cancer Lett","1994","1994/08/29","","","10.1016/0304-3835(94)90362-x"
"10810417","The clinical value of p21WAF1/CIP1 expression in superficial bladder cancer","Chow NH, Tzai TS, Cheng HL, Liu HS, Chan SH, Tong YC.","Anticancer Res. 2000 Mar-Apr;20(2B):1173-6.","Chow NH","Anticancer Res","2000","2000/05/16","","",""
"12478112","A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival","Shahin O, Thalmann GN, Rentsch C, Mazzucchelli L, Studer UE.","J Urol. 2003 Jan;169(1):96-100; discussion 100. doi: 10.1097/01.ju.0000035543.69161.58.","Shahin O","J Urol","2003","2002/12/13","","","10.1097/01.ju.0000035543.69161.58"
"7507227","[Cystectomy in the management of bladder cancer]","Kondás J, Szentgyörgyi E, Diószeghy G, Váczi L, Kiss A.","Orv Hetil. 1994 Jan 16;135(3):119-24.","Kondás J","Orv Hetil","1994","1994/01/16","","",""
"28052524","Cross-species analysis of the canine and human bladder cancer transcriptome and exome","Ramsey SA, Xu T, Goodall C, Rhodes AC, Kashyap A, He J, Bracha S.","Genes Chromosomes Cancer. 2017 Apr;56(4):328-343. doi: 10.1002/gcc.22441. Epub 2017 Jan 25.","Ramsey SA","Genes Chromosomes Cancer","2017","2017/01/05","","","10.1002/gcc.22441"
"4714061","Carcinoma of the urinary bladder in North India","Singh SM, Singh T, Wadhwa SN, Bapna BC, Sharma SK, Sharma U.","Indian J Cancer. 1973 Mar;10(1):36-9.","Singh SM","Indian J Cancer","1973","1973/03/01","","",""
"3996113","[Leukocyte adherence inhibition assay for the diagnosis of bladder cancer]","Xu JN, Li YT, Zhang ZY.","Zhonghua Wai Ke Za Zhi. 1985 Mar;23(3):148-51, 190.","Xu JN","Zhonghua Wai Ke Za Zhi","1985","1985/03/01","","",""
"28504717","Fibulin-3 promotes muscle-invasive bladder cancer","Han AL, Veeneman BA, El-Sawy L, Day KC, Day ML, Tomlins SA, Keller ET.","Oncogene. 2017 Sep 14;36(37):5243-5251. doi: 10.1038/onc.2017.149. Epub 2017 May 15.","Han AL","Oncogene","2017","2017/05/16","","","10.1038/onc.2017.149"
"23481180","Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients","Noon AP, Albertsen PC, Thomas F, Rosario DJ, Catto JW.","Br J Cancer. 2013 Apr 16;108(7):1534-40. doi: 10.1038/bjc.2013.106. Epub 2013 Mar 12.","Noon AP","Br J Cancer","2013","2013/03/14","PMC3629420","","10.1038/bjc.2013.106"
"10895125","Bladder cancer: one enemy, many fronts","Pow-Sang JM.","Cancer Control. 2000 Jul-Aug;7(4):307. doi: 10.1177/107327480000700405.","Pow-Sang JM","Cancer Control","2000","2000/07/15","","","10.1177/107327480000700405"
"8290914","Relationship between blood groups and tumour grade, number, size, stage, recurrence and survival in patients with transitional cell carcinoma of the bladder","Raitanen MP, Tammela TL.","Scand J Urol Nephrol. 1993;27(3):343-7. doi: 10.3109/00365599309180445.","Raitanen MP","Scand J Urol Nephrol","1993","1993/01/01","","","10.3109/00365599309180445"
"30507304","Expression profile of miRNAs in urine samples of bladder cancer patients","Nekoohesh L, Modarressi MH, Mowla SJ, Sadroddiny E, Etemadian M, Afsharpad M, Zolfaghari F, Barzegari M, Saffari M, Oskooei VK, Motevaseli E, Ghafouri-Fard S.","Biomark Med. 2018 Dec;12(12):1311-1321. doi: 10.2217/bmm-2018-0190. Epub 2018 Dec 3.","Nekoohesh L","Biomark Med","2018","2018/12/04","","","10.2217/bmm-2018-0190"
"11829890","[Prevention of postoperative recurrence of bladder cancer: a clinical study]","Yang D, Li S, Wang H, Li X, Liu S, Han W, Hao J, Zhang H.","Zhonghua Wai Ke Za Zhi. 1999 Aug;37(8):464-5.","Yang D","Zhonghua Wai Ke Za Zhi","1999","2002/02/07","","",""
"9530649","Is the risk of urinary tract tumorigenesis enhanced by a marginal chronic essential fatty acid deficiency (EFAD)?","Eynard AR.","Nutrition. 1998 Feb;14(2):211-6. doi: 10.1016/s0899-9007(97)00426-7.","Eynard AR","Nutrition","1998","1998/04/08","","","10.1016/s0899-9007(97)00426-7"
"3238828","Place of cystectomy in superficial bladder cancer","Chéchile G, Sarroca J, Zungri E, Rosales E, Martinez E.","Urol Int. 1988;43(6):330-3. doi: 10.1159/000281385.","Chéchile G","Urol Int","1988","1988/01/01","","","10.1159/000281385"
"16399419","Management of stage T1 tumors of the bladder: International Consensus Panel","Nieder AM, Brausi M, Lamm D, O'Donnell M, Tomita K, Woo H, Jewett MA.","Urology. 2005 Dec;66(6 Suppl 1):108-25. doi: 10.1016/j.urology.2005.08.066.","Nieder AM","Urology","2005","2006/01/10","","","10.1016/j.urology.2005.08.066"
"9615204","Meticulous pelvic lymphadenectomy in surgical treatment of the invasive bladder cancer: an option or a must?","Turner WH, Markwalder R, Perrig S, Studer UE.","Eur Urol. 1998;33 Suppl 4:21-2. doi: 10.1159/000052258.","Turner WH","Eur Urol","1998","1998/06/06","","","10.1159/000052258"
"1399383","Superficial bladder cancer treated by total cystectomy: tumour characteristics and patient survival","Takashi M, Sakata T, Nakano Y, Murase T, Miyake K.","Int Urol Nephrol. 1992;24(3):265-71. doi: 10.1007/BF02549534.","Takashi M","Int Urol Nephrol","1992","1992/01/01","","","10.1007/BF02549534"
"20830767","Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer","Raj GV, Karavadia S, Schlomer B, Arriaga Y, Lotan Y, Sagalowsky A, Frenkel E.","Cancer. 2011 Jan 15;117(2):276-82. doi: 10.1002/cncr.25429. Epub 2010 Sep 9.","Raj GV","Cancer","2011","2010/09/11","","","10.1002/cncr.25429"
"26420594","The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer","Schubert T, Todenhöfer T, Mischinger J, Schwentner C, Renninger M, Stenzl A, Gakis G.","World J Urol. 2016 Jun;34(6):829-34. doi: 10.1007/s00345-015-1693-2. Epub 2015 Sep 29.","Schubert T","World J Urol","2016","2015/10/01","","","10.1007/s00345-015-1693-2"
"16861380","Oxaliplatin in inoperable or metastatic bladder cancer","Mir O, Alexandre J, Ropert S, Goldwasser F.","Ann Oncol. 2006 Dec;17(12):1853-4. doi: 10.1093/annonc/mdl157. Epub 2006 Jul 21.","Mir O","Ann Oncol","2006","2006/07/25","","","10.1093/annonc/mdl157"
"7167187","Association of cigarette smoking and nitrosamines with urinary bladder cancer: a review","Nomura AM.","Natl Cancer Inst Monogr. 1982;62:185-90.","Nomura AM","Natl Cancer Inst Monogr","1982","1982/01/01","","",""
"17885932","Bladder cancer in Taiwan: relationship to trihalomethane concentrations present in drinking-water supplies","Chang CC, Ho SC, Wang LY, Yang CY.","J Toxicol Environ Health A. 2007 Oct;70(20):1752-7. doi: 10.1080/15287390701459031.","Chang CC","J Toxicol Environ Health A","2007","2007/09/22","","","10.1080/15287390701459031"
"9246190","Relationship between radiation response and p53 status in human bladder cancer cells","Ribeiro JC, Barnetson AR, Fisher RJ, Mameghan H, Russell PJ.","Int J Radiat Biol. 1997 Jul;72(1):11-20. doi: 10.1080/095530097143491.","Ribeiro JC","Int J Radiat Biol","1997","1997/07/01","","","10.1080/095530097143491"
"27520487","Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer","Longo T, McGinley KF, Freedman JA, Etienne W, Wu Y, Sibley A, Owzar K, Gresham J, Moy C, Szabo S, Greshock J, Zhou H, Bai Y, Inman BA.","Eur Urol. 2016 Nov;70(5):714-717. doi: 10.1016/j.eururo.2016.07.049. Epub 2016 Aug 9.","Longo T","Eur Urol","2016","2016/08/14","","","10.1016/j.eururo.2016.07.049"
"1688603","Carcinoma of the prostate simulating primary bladder cancer","Amin M, Broghamer W, Amin EA.","J Ky Med Assoc. 1990 Jan;88(1):13-6.","Amin M","J Ky Med Assoc","1990","1990/01/01","","",""
"3368604","Bladder cancer and asbestos in Spain","Bravo MP, Del Rey-Calero J, Conde M.","Rev Epidemiol Sante Publique. 1988;36(1):10-4.","Bravo MP","Rev Epidemiol Sante Publique","1988","1988/01/01","","",""
"30888973","The interaction of gender and smoking on bladder cancer risks","Janisch F, Shariat SF, Schernhammer E, Rink M, Fajkovic H.","Curr Opin Urol. 2019 May;29(3):249-255. doi: 10.1097/MOU.0000000000000602.","Janisch F","Curr Opin Urol","2019","2019/03/20","","","10.1097/MOU.0000000000000602"
"8808849","Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy","Chauvet B, Brewer Y, Félix-Faure C, Davin JL, Choquenet C, Reboul F.","J Urol. 1996 Oct;156(4):1258-62.","Chauvet B","J Urol","1996","1996/10/01","","",""
"15540205","CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells","Retz MM, Sidhu SS, Blaveri E, Kerr SC, Dolganov GM, Lehmann J, Carroll P, Simko J, Waldman FM, Basbaum C.","Int J Cancer. 2005 Mar 20;114(2):182-9. doi: 10.1002/ijc.20729.","Retz MM","Int J Cancer","2005","2004/11/13","","","10.1002/ijc.20729"
"16617867","[Clinical evaluation of urinary NMP22 (nuclear matrix protein 22) bladder chek in the detection of patients with bladder cancer]","Kitsukawa S, Yamamoto Y, Hosoda S, Otsuru N, Matsumoto T, Matsumoto T, Aizawa T, Noda K, Ito T.","Hinyokika Kiyo. 2006 Mar;52(3):167-72.","Kitsukawa S","Hinyokika Kiyo","2006","2006/04/19","","",""
"8470875","[Natural history and prognostic factors of superficial tumors of the bladder]","Hoznek A, Bellot J, Abbou CC, Chopin DK.","Ann Urol (Paris). 1993;27(1):20-3.","Hoznek A","Ann Urol (Paris)","1993","1993/01/01","","",""
"20707791","The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer","Otto W, Denzinger S, Fritsche HM, Burger M, Wieland WF, Hofstädter F, Hartmann A, Bertz S.","BJU Int. 2011 Feb;107(3):404-8. doi: 10.1111/j.1464-410X.2010.09515.x. Epub 2010 Aug 12.","Otto W","BJU Int","2011","2010/08/17","","","10.1111/j.1464-410X.2010.09515.x"
"9179686","Recurrence of primary superficial bladder cancer treated with prophylactic intravesical Tokyo 172 bacillus Calmette-Guérin: a long-term follow-up","Shinka T, Matsumoto M, Ogura H, Hirano A, Ohkawa T.","Int J Urol. 1997 Mar;4(2):139-43. doi: 10.1111/j.1442-2042.1997.tb00160.x.","Shinka T","Int J Urol","1997","1997/03/01","","","10.1111/j.1442-2042.1997.tb00160.x"
"675925","Urinary cytology and bladder biopsy in patients with bladder cancer","Loening S, Fallon B, Narayana A, Penick GD, Hawtrey C, Culp DA, Bonney WW.","Urology. 1978 Jun;11(6):591-5. doi: 10.1016/0090-4295(78)90009-2.","Loening S","Urology","1978","1978/06/01","","","10.1016/0090-4295(78)90009-2"
"6848183","Orthotopic implantation of primary N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer in bladder submucosa: an animal model for bladder cancer study","Ibrahiem EH, Nigam VN, Brailovsky CA, Madarnas P, Elhilali M.","Cancer Res. 1983 Feb;43(2):617-22.","Ibrahiem EH","Cancer Res","1983","1983/02/01","","",""
"28192481","A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer","Xiong Y, Li J, Ma S, Ge J, Zhou L, Li D, Chen Q.","PLoS One. 2017 Feb 13;12(2):e0170819. doi: 10.1371/journal.pone.0170819. eCollection 2017.","Xiong Y","PLoS One","2017","2017/02/14","PMC5305060","","10.1371/journal.pone.0170819"
"17940349","Lymphadenectomy in bladder cancer: a review","Buscarini M, Josephson DY, Stein JP.","Urol Int. 2007;79(3):191-9. doi: 10.1159/000107949.","Buscarini M","Urol Int","2007","2007/10/18","","","10.1159/000107949"
"11744462","Risk factors for multiple intravesical recurrences of superficial bladder cancer","Hisataki T, Miyao N, Masumori N, Takahashi A, Yanase M, Itoh N, Tsukamoto T.","Urology. 2001 Dec;58(6):935-9. doi: 10.1016/s0090-4295(01)01435-2.","Hisataki T","Urology","2001","2001/12/18","","","10.1016/s0090-4295(01)01435-2"
"7661636","[Conservative treatment of muscle-infiltrating bladder tumors with TUR]","Acebal Lucía J, Paez Borda A, Llorente Abarca C, Quijano Barroso P, Herrero Payo A, Bustamante Alarma S, Montes Díaz MJ, Berenguer Sánchez A.","Arch Esp Urol. 1995 Jul-Aug;48(6):579-85.","Acebal Lucía J","Arch Esp Urol","1995","1995/07/01","","",""
"16805311","[Macrosystemic approach in cytological studies of the urothelial urinary bladder using the computerized morphometry data]","Abenova MT, Friazinova TS, Zharkov NV.","Tsitologiia. 2006;48(3):216-9.","Abenova MT","Tsitologiia","2006","2006/06/30","","",""
"10418562","Two cases of metastatic bladder cancers showing diffuse thickening of the bladder wall","Ota T, Shinohara M, Kinoshita K, Sakoma T, Kitamura M, Maeda Y.","Jpn J Clin Oncol. 1999 Jun;29(6):314-6. doi: 10.1093/jjco/29.6.314.","Ota T","Jpn J Clin Oncol","1999","1999/07/27","","","10.1093/jjco/29.6.314"
"26456281","Getting the Most Out of bacillus Calmette-Guérin for Treatment of Bladder Cancer","Lamm DL.","J Urol. 2016 Jan;195(1):7-8. doi: 10.1016/j.juro.2015.10.024. Epub 2015 Oct 9.","Lamm DL","J Urol","2016","2015/10/13","","","10.1016/j.juro.2015.10.024"
"20562792","Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer","Smaldone MC, Gingrich JR.","Minerva Urol Nefrol. 2010 Jun;62(2):129-32.","Smaldone MC","Minerva Urol Nefrol","2010","2010/06/22","","",""
"28958822","Computer-assisted cystoscopy diagnosis of bladder cancer","Gosnell ME, Polikarpov DM, Goldys EM, Zvyagin AV, Gillatt DA.","Urol Oncol. 2018 Jan;36(1):8.e9-8.e15. doi: 10.1016/j.urolonc.2017.08.026. Epub 2017 Sep 25.","Gosnell ME","Urol Oncol","2018","2017/09/30","","","10.1016/j.urolonc.2017.08.026"
"23238655","Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer","Singer S, Ziegler C, Schwalenberg T, Hinz A, Götze H, Schulte T.","Support Care Cancer. 2013 May;21(5):1383-93. doi: 10.1007/s00520-012-1680-8. Epub 2012 Dec 14.","Singer S","Support Care Cancer","2013","2012/12/15","","","10.1007/s00520-012-1680-8"
"15285760","Intracranial aspergillosis in a non-immunocompromised patient treated for muscle-invasive bladder cancer","Merseburger AS, Oelke M, Hartmann J, Stenzl A, Kuczyk MA.","Int J Urol. 2004 Aug;11(8):666-8. doi: 10.1111/j.1442-2042.2004.00850.x.","Merseburger AS","Int J Urol","2004","2004/08/03","","","10.1111/j.1442-2042.2004.00850.x"
"19556072","PDT combined with Intravesical BCG instillation would form an autovaccine for bladder cancer?","Pan H, Ma X, Chen J, Jiang H.","Med Hypotheses. 2009 Oct;73(4):559-60. doi: 10.1016/j.mehy.2009.05.037. Epub 2009 Jun 24.","Pan H","Med Hypotheses","2009","2009/06/27","","","10.1016/j.mehy.2009.05.037"
"6483909","Nuclear magnetic resonance imaging and bladder cancer","Resnick MI, Kursh ED, Bryan PD.","Prog Clin Biol Res. 1984;162A:255-65.","Resnick MI","Prog Clin Biol Res","1984","1984/01/01","","",""
"29492946","Is This Patient With Metastatic Bladder Cancer a Candidate for Second-Line Immunotherapy Treatment?","Bourlon MT, Velázquez HE, Luna-Santiago R, Vázquez-Manjarrez S, Bourlon C.","Oncology (Williston Park). 2018 Feb 15;32(2):64-8.","Bourlon MT","Oncology (Williston Park)","2018","2018/03/02","","",""
"12238168","[Treatment and follow-up of superficial bladder cancer]","Raitanen M.","Duodecim. 2002;118(9):903-9.","Raitanen M","Duodecim","2002","2002/09/20","","",""
"2053221","Evaluation of the invasive potential of superficial bladder cancer by adenosine triphosphate measurement","Koiso K, Nemoto R, Ohtani M, Uchida K, Shimazui T, Noguchi R, Hattori K, Miyanaga N, Shiraiwa H, Iwasaki A.","Urol Int. 1991;46(2):145-8. doi: 10.1159/000282120.","Koiso K","Urol Int","1991","1991/01/01","","","10.1159/000282120"
"19048932","[Case report: collecting (Bellini) duct carcinoma during the follow-up for bladder cancer]","Okuda H, Tei N, Shimizu K, Imazu T, Yoshimura K, Kiyohara H, Nakamura Y, Fujimura H.","Hinyokika Kiyo. 2008 Oct;54(10):665-8.","Okuda H","Hinyokika Kiyo","2008","2008/12/04","","",""
"21682190","Genetic and epigenetic biomarkers for early detection, therapeutic effectiveness and relapse monitoring in bladder cancer","Dumache R, David D, Kaycsa A, Minciu R, Negru S, Puiu M.","Rev Med Chir Soc Med Nat Iasi. 2011 Jan-Mar;115(1):163-7.","Dumache R","Rev Med Chir Soc Med Nat Iasi","2011","2011/06/21","","",""
"17434253","Editorial comment on: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors","Brausi M.","Eur Urol. 2007 Sep;52(3):775-6. doi: 10.1016/j.eururo.2007.03.088.","Brausi M","Eur Urol","2007","2007/04/17","","","10.1016/j.eururo.2007.03.088"
"24862180","Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients","Keck B, Wach S, Taubert H, Zeiler S, Ott OJ, Kunath F, Hartmann A, Bertz S, Weiss C, Hönscheid P, Schellenburg S, Rödel C, Baretton GB, Sauer R, Fietkau R, Wullich B, Krause FS, Datta K, Muders MH.","Int J Cancer. 2015 Jan 15;136(2):443-51. doi: 10.1002/ijc.28987. Epub 2014 Jun 12.","Keck B","Int J Cancer","2015","2014/05/28","","","10.1002/ijc.28987"
"15923437","Systemic chemotherapy for patients with advanced and metastatic bladder cancer: current status and future directions","Lorusso V, Silvestris N.","Ann Oncol. 2005 May;16 Suppl 4:iv85-89. doi: 10.1093/annonc/mdi914.","Lorusso V","Ann Oncol","2005","2005/06/01","","","10.1093/annonc/mdi914"
"2698439","[Usefulness of biological tumor markers for early detection of neoplastic changes in the bladder of persons exposed to aromatic amines]","Hanke J, Krajewska B, Lutz W.","Med Pr. 1989;40(6):376-80.","Hanke J","Med Pr","1989","1989/01/01","","",""
"24166285","The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer","Karaoglu I, van der Heijden AG, Witjes JA.","World J Urol. 2014 Jun;32(3):651-9. doi: 10.1007/s00345-013-1035-1. Epub 2013 Oct 29.","Karaoglu I","World J Urol","2014","2013/10/30","","","10.1007/s00345-013-1035-1"
"22790798","Microbubble and ultrasound radioenhancement of bladder cancer","Tran WT, Iradji S, Sofroni E, Giles A, Eddy D, Czarnota GJ.","Br J Cancer. 2012 Jul 24;107(3):469-76. doi: 10.1038/bjc.2012.279. Epub 2012 Jul 12.","Tran WT","Br J Cancer","2012","2012/07/14","PMC3405216","","10.1038/bjc.2012.279"
"26302620","[Lieutaud's triangle lesion and urodynamic disorders in bladder cancer according to magnetic resonance imaging data]","Grigor'ev EG, Frolova IG, Velichko SA.","Vestn Rentgenol Radiol. 2015 May-Jun;(3):31-6.","Grigor'ev EG","Vestn Rentgenol Radiol","2015","2015/08/26","","",""
"2941910","Photodynamic therapy of bladder carcinoma","Rosenberg SJ, Williams RD.","Urol Clin North Am. 1986 Aug;13(3):435-44.","Rosenberg SJ","Urol Clin North Am","1986","1986/08/01","","",""
"17382795","Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation","Sternberg CN.","Semin Oncol. 2007 Apr;34(2):122-8. doi: 10.1053/j.seminoncol.2006.12.006.","Sternberg CN","Semin Oncol","2007","2007/03/27","","","10.1053/j.seminoncol.2006.12.006"
"9275980","What is new in bladder cancer imaging","Barentsz JO, Witjes JA, Ruijs JH.","Urol Clin North Am. 1997 Aug;24(3):583-602. doi: 10.1016/s0094-0143(05)70403-1.","Barentsz JO","Urol Clin North Am","1997","1997/08/01","","","10.1016/s0094-0143(05)70403-1"
"19771524","Bladder cancer","Gallagher DJ, Milowsky MI.","Curr Treat Options Oncol. 2009 Aug;10(3-4):205-15. doi: 10.1007/s11864-009-0112-6.","Gallagher DJ","Curr Treat Options Oncol","2009","2009/09/23","","","10.1007/s11864-009-0112-6"
"20116164","Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations","Witjes JA, Redorta JP, Jacqmin D, Sofras F, Malmström PU, Riedl C, Jocham D, Conti G, Montorsi F, Arentsen HC, Zaak D, Mostafid AH, Babjuk M.","Eur Urol. 2010 Apr;57(4):607-14. doi: 10.1016/j.eururo.2010.01.025. Epub 2010 Jan 22.","Witjes JA","Eur Urol","2010","2010/02/02","","","10.1016/j.eururo.2010.01.025"
"23664103","Constitutional and occupational risk factors associated with bladder cancer","Ferrís J, Garcia J, Berbel O, Ortega JA.","Actas Urol Esp. 2013 Sep;37(8):513-22. doi: 10.1016/j.acuro.2013.01.001. Epub 2013 May 9.","Ferrís J","Actas Urol Esp","2013","2013/05/14","PMC5176027","NIHMS836018","10.1016/j.acuro.2013.01.001"
"9060542","Bladder preservation by combined modality therapy for invasive bladder cancer","Kachnic LA, Kaufman DS, Heney NM, Althausen AF, Griffin PP, Zietman AL, Shipley WU.","J Clin Oncol. 1997 Mar;15(3):1022-9. doi: 10.1200/JCO.1997.15.3.1022.","Kachnic LA","J Clin Oncol","1997","1997/03/01","","","10.1200/JCO.1997.15.3.1022"
"12536929","[Molecular markers of infiltrating cancer of the bladder]","Rigaud J, Tiguert R, Fradet Y.","Prog Urol. 2002 Nov;12(5):1057-83.","Rigaud J","Prog Urol","2002","2003/01/23","","",""
"18035695","[Evaluation of potential target genes of the 6p22.3-amplicon in urinary bladder cancer]","Oeggerli M, Schraml P, Novotny H, Sauter G, Simon R.","Verh Dtsch Ges Pathol. 2005;89:219-24.","Oeggerli M","Verh Dtsch Ges Pathol","2005","2007/11/27","","",""
"19830877","Screening for bladder cancer. The challenge: identifying who might benefit most from screening","","Duke Med Health News. 2009 Oct;15(10):7.","","Duke Med Health News","2009","2009/10/16","","",""
"9381579","[Patient satisfaction with the information in received after molecular oncology examination of bladder cancer]","Hein B, Wolf H.","Ugeskr Laeger. 1997 Oct 6;159(41):6068-72.","Hein B","Ugeskr Laeger","1997","1998/02/12","","",""
"31325035","MicroRNAs: Key Players in Bladder Cancer","Li Q, Wang H, Peng H, Huang Q, Huyan T, Huang Q, Yang H, Shi J.","Mol Diagn Ther. 2019 Oct;23(5):579-601. doi: 10.1007/s40291-019-00410-4.","Li Q","Mol Diagn Ther","2019","2019/07/21","","","10.1007/s40291-019-00410-4"
"7760310","Piroxicam for bladder cancer","Barsanti JA.","J Vet Intern Med. 1995 Mar-Apr;9(2):113-4. doi: 10.1111/j.1939-1676.1995.tb03282.x.","Barsanti JA","J Vet Intern Med","1995","1995/03/01","","","10.1111/j.1939-1676.1995.tb03282.x"
"6504892","The place of chemotherapy associated with active immunotherapy with levamisol in advanced bladder cancer","Giannopoulos A, Lykourinas M, Kioupkiolis G, Dimopoulos C.","Prog Clin Biol Res. 1984;162B:123-4.","Giannopoulos A","Prog Clin Biol Res","1984","1984/01/01","","",""
"18670277","Bladder preserving strategies for muscle-invasive bladder cancer","Merseburger AS, Matuschek I, Kuczyk MA.","Curr Opin Urol. 2008 Sep;18(5):513-8. doi: 10.1097/MOU.0b013e32830b86bd.","Merseburger AS","Curr Opin Urol","2008","2008/08/02","","","10.1097/MOU.0b013e32830b86bd"
"30030599","[Nonmuscle invasive bladder cancer : Efficacy of electromotive drug administration]","Miernik A.","Urologe A. 2018 Sep;57(9):1133-1136. doi: 10.1007/s00120-018-0737-9.","Miernik A","Urologe A","2018","2018/07/22","","","10.1007/s00120-018-0737-9"
"2102637","Possibilities of laser in the treatment of urinary bladder cancer","Beisland HO.","Ann Chir Gynaecol. 1990;79(4):197-9.","Beisland HO","Ann Chir Gynaecol","1990","1990/01/01","","",""
"7953274","Metastatic bladder cancer involving the testis","Watkin NA, Gallegos CR, Moisey CU, Charlton CA.","Br J Urol. 1994 Sep;74(3):380. doi: 10.1111/j.1464-410x.1994.tb16633.x.","Watkin NA","Br J Urol","1994","1994/09/01","","","10.1111/j.1464-410x.1994.tb16633.x"
"22842380","Primary amyloidosis with high grade transitional cell carcinoma of bladder: a rare case report","Gupta P, Hanamshetti S, Kulkarni JN.","J Cancer Res Ther. 2012 Apr-Jun;8(2):297-9. doi: 10.4103/0973-1482.98994.","Gupta P","J Cancer Res Ther","2012","2012/07/31","","","10.4103/0973-1482.98994"
"30676477","Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016","Ebrahimi H, Amini E, Pishgar F, Moghaddam SS, Nabavizadeh B, Rostamabadi Y, Aminorroaya A, Fitzmaurice C, Farzadfar F, Nowroozi MR, Black PC, Daneshmand S.","J Urol. 2019 May;201(5):893-901. doi: 10.1097/JU.0000000000000025.","Ebrahimi H","J Urol","2019","2019/01/25","","","10.1097/JU.0000000000000025"
"8270966","Intravesical therapy for superficial bladder cancer: is it a wash?","Kilbridge KL, Kantoff P.","J Clin Oncol. 1994 Jan;12(1):1-4. doi: 10.1200/JCO.1994.12.1.1.","Kilbridge KL","J Clin Oncol","1994","1994/01/01","","","10.1200/JCO.1994.12.1.1"
"3851008","[Current trends in the treatment of bladder cancer]","Koiso K.","Kango Gijutsu. 1985 Aug;31(11):1413-7.","Koiso K","Kango Gijutsu","1985","1985/08/01","","",""
"10592486","Tumor-adopted diagnosis of bladder cancer","Brauers A, Jung P, Jakse G.","Urol Int. 1999;63(1):22-6. doi: 10.1159/000030414.","Brauers A","Urol Int","1999","1999/12/11","","","10.1159/000030414"
"16910593","Annular rectal constriction due to infiltration by bladder cancer","Kobayashi S, Kato H, Iijima K, Kinebuchi Y, Igawa Y, Nishizawa O.","Hinyokika Kiyo. 2006 Jul;52(7):569-72.","Kobayashi S","Hinyokika Kiyo","2006","2006/08/17","","",""
"25107371","miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer","Feng Y, Liu J, Kang Y, He Y, Liang B, Yang P, Yu Z.","J Exp Clin Cancer Res. 2014 Aug 10;33(1):67. doi: 10.1186/PREACCEPT-9242556491295527.","Feng Y","J Exp Clin Cancer Res","2014","2014/08/10","PMC4237814","","10.1186/PREACCEPT-9242556491295527"
"29808294","Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial Carcinoma","Nadal R, Apolo AB.","Curr Treat Options Oncol. 2018 May 28;19(7):36. doi: 10.1007/s11864-018-0551-z.","Nadal R","Curr Treat Options Oncol","2018","2018/05/30","","","10.1007/s11864-018-0551-z"
"26810055","Chemotherapy for Muscle-Invasive Bladder Cancer","Trenta P, Calabrò F, Cerbone L, Sternberg CN.","Curr Treat Options Oncol. 2016 Jan;17(1):6. doi: 10.1007/s11864-015-0376-y.","Trenta P","Curr Treat Options Oncol","2016","2016/01/27","","","10.1007/s11864-015-0376-y"
"8401633","The evaluation and follow-up of patients with Ta, Tcis, and T1 bladder cancer","Soloway MS.","World J Urol. 1993;11(3):153-5. doi: 10.1007/BF00211410.","Soloway MS","World J Urol","1993","1993/01/01","","","10.1007/BF00211410"
"26234187","Dr. Alan Yagoda and the Development of Systemic Therapy for Advanced Bladder Cancer","Cardona-Grau D, White MD.","Urology. 2015 Oct;86(4):727-9. doi: 10.1016/j.urology.2015.06.039. Epub 2015 Jul 30.","Cardona-Grau D","Urology","2015","2015/08/04","","","10.1016/j.urology.2015.06.039"
"8619387","[Clinical evaluation of intra-operative radiotherapy combined with subtotal cystectomy for invasive bladder carcinoma]","Ozawa K, Nakagomi K, Yonese J, Kojima S, Tsuzii T, Satake I, Tari K, Sakura M, Kato S, Kazumoto T.","Hinyokika Kiyo. 1996 Mar;42(3):191-5.","Ozawa K","Hinyokika Kiyo","1996","1996/03/01","","",""
"27752150","High-grade urothelial bladder cancer in children: A case report and critical analysis of the literature","Kral M, Michalek J, Skarda J, Tichy T, Smakal O, Kodet R, Student V.","Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Dec;160(4):578-582. doi: 10.5507/bp.2016.045. Epub 2016 Oct 3.","Kral M","Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub","2016","2016/10/19","","","10.5507/bp.2016.045"
"3109725","Selecting initial therapy for bladder cancer","Soloway MS.","Cancer. 1987 Aug 1;60(3 Suppl):502-13. doi: 10.1002/1097-0142(19870801)60:3+<502::aid-cncr2820601512>3.0.co;2-w.","Soloway MS","Cancer","1987","1987/08/01","","","10.1002/1097-0142(19870801)60:3+<502::aid-cncr2820601512>3.0.co;2-w"
"28866819","Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette-Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer","Liem EIML, Baard J, Cauberg ECC, Bus MTJ, de Bruin DM, Laguna Pes MP, de la Rosette JJMCH, de Reijke TM.","Med Oncol. 2017 Sep 2;34(10):172. doi: 10.1007/s12032-017-1033-z.","Liem EIML","Med Oncol","2017","2017/09/04","PMC5581817","","10.1007/s12032-017-1033-z"
"22064641","Image-guided radiation therapy for muscle-invasive bladder cancer","Thariat J, Aluwini S, Pan Q, Caullery M, Marcy PY, Housset M, Lagrange JL.","Nat Rev Urol. 2011 Nov 8;9(1):23-9. doi: 10.1038/nrurol.2011.173.","Thariat J","Nat Rev Urol","2011","2011/11/09","","","10.1038/nrurol.2011.173"
"30268659","Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018","Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, Kiemeney L, Lotan Y, Pang K, Silverman DT, Znaor A, Catto JWF.","Eur Urol. 2018 Dec;74(6):784-795. doi: 10.1016/j.eururo.2018.09.001. Epub 2018 Sep 26.","Cumberbatch MGK","Eur Urol","2018","2018/10/01","","","10.1016/j.eururo.2018.09.001"
"17168368","[Prognosis of efficacy of organ-saving treatment of invasive bladder cancer]","Ivanov SD, Masliukova EA, Karelin MI, Iamshanov VA, Kovan'ko EG.","Vopr Onkol. 2006;52(5):565-70.","Ivanov SD","Vopr Onkol","2006","2006/12/16","","",""
"27795607","Diagnostic and Prognostic Markers in Bladder Cancer","Ku JH, Kim WJ, Lerner SP, Chun F, Kluth LA.","Dis Markers. 2016;2016:2425091. doi: 10.1155/2016/2425091. Epub 2016 Sep 29.","Ku JH","Dis Markers","2016","2016/11/01","PMC5067309","","10.1155/2016/2425091"
"21253823","Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population","Pandith AA, Khan NP, Shah ZA, Shah AM, Wani SM, Siddiqi MA.","Biochem Genet. 2011 Aug;49(7-8):417-26. doi: 10.1007/s10528-011-9418-8. Epub 2011 Jan 21.","Pandith AA","Biochem Genet","2011","2011/01/22","","","10.1007/s10528-011-9418-8"
"6504893","Comparative study of actuarial survival rates in P3 P4 (N+ Mo) transitional cell carcinoma of bladder managed by total cystectomy alone or associated with preoperative radiotherapy and pelvic lymphadenectomy","Gilloz A, Héritier P.","Prog Clin Biol Res. 1984;162B:15-9.","Gilloz A","Prog Clin Biol Res","1984","1984/01/01","","",""
"9259091","Cystectomy and urinary diversion","Turner WH, Studer UE.","Semin Surg Oncol. 1997 Sep-Oct;13(5):350-8. doi: 10.1002/(sici)1098-2388(199709/10)13:5<350::aid-ssu9>3.0.co;2-c.","Turner WH","Semin Surg Oncol","1997","1997/09/01","","","10.1002/(sici)1098-2388(199709/10)13:5<350::aid-ssu9>3.0.co;2-c"
"18432530","Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States","Schned AR, Andrew AS, Marsit CJ, Kelsey KT, Zens MS, Karagas MR.","Scand J Urol Nephrol. 2008;42(3):237-42. doi: 10.1080/00365590801948166.","Schned AR","Scand J Urol Nephrol","2008","2008/04/25","PMC2640838","NIHMS88631","10.1080/00365590801948166"
"9092275","Advertisement for the Bard BTA test for bladder cancer","Marshall KG.","Am Fam Physician. 1997 Mar;55(4):1078, 1080, 1085-6 passim.","Marshall KG","Am Fam Physician","1997","1997/03/01","","",""
"4698000","Current topics in the pathology of bladder cancer","Anderson CK.","Proc R Soc Med. 1973 Mar;66(3):283-6.","Anderson CK","Proc R Soc Med","1973","1973/03/01","PMC1644815","",""
"9026128","[Dynamics of cytotoxicity of blood mononuclear cells in patients with bladder cancer during endolymphatic immunotherapy with lymphokine- activated killer cells and recombinant interleukin-2]","Malakhova NV, Figurin KM, Fedorova NS, Kiselevskiĭ MV, Bykovskaia SN.","Biull Eksp Biol Med. 1996 Feb;121(2):188-91.","Malakhova NV","Biull Eksp Biol Med","1996","1996/02/01","","",""
"378817","The identification and control of occupational bladder cancer","Parkes HG.","IARC Sci Publ. 1979;(25):47-58.","Parkes HG","IARC Sci Publ","1979","1979/01/01","","",""
"3696304","Risk factors of bladder cancer in Spain","Bravo MP, Del Rey-Calero J, Conde M.","Neoplasma. 1987;34(5):633-7.","Bravo MP","Neoplasma","1987","1987/01/01","","",""
"23358831","[Siliconchiptechnology-based MMP-7 analysis in urine: an option for preoperative identification of lymph node metastasis in bladder cancer]","Jäger T, Tschirdewahn S, Vom Dorp F, Piechotta G, Rübben H, Szarvas T.","Urologe A. 2013 Jun;52(6):853-8. doi: 10.1007/s00120-012-3110-4.","Jäger T","Urologe A","2013","2013/01/30","","","10.1007/s00120-012-3110-4"
"17127340","Chromosomal deletions in bladder cancer: shutting down pathways","Abraham R, Pagano F, Gomella LG, Baffa R.","Front Biosci. 2007 Jan 1;12:826-38. doi: 10.2741/2105.","Abraham R","Front Biosci","2007","2006/11/28","","","10.2741/2105"
"1295123","[Study of the association of bladder cancer and phenacetin use. Problems set by a pharmaco-epidemiological study]","Berleur MP, Cordier S.","Therapie. 1992 May-Jun;47(3):231-8.","Berleur MP","Therapie","1992","1992/05/01","","",""
"3851019","[Pre and postoperative nursing of patients with bladder cancer. Prevention of pyelonephritis following transcutaneous urostomy]","Yamamoto H, Otsuka I, Hiramatsu E, Iida M.","Kango Gijutsu. 1985 Aug;31(11):1487-91.","Yamamoto H","Kango Gijutsu","1985","1985/08/01","","",""
"18440835","Adjuvant chemotherapy in lymph node positive bladder cancer","Gofrit ON, Stadler WM, Zorn KC, Lin S, Silvestre J, Shalhav AL, Zagaja GP, Steinberg GD.","Urol Oncol. 2009 Mar-Apr;27(2):160-4. doi: 10.1016/j.urolonc.2007.12.013. Epub 2008 Apr 28.","Gofrit ON","Urol Oncol","2009","2008/04/29","","","10.1016/j.urolonc.2007.12.013"
"513389","[Studies of heterotransplantation of transplantable human urogenital malignant neoplasms. Part II. Experimental treatment of human bladder cancer transplantable to nude mice, and its experimental transplantation to hamsters (author's transl)]","Nakajima H.","Nihon Hinyokika Gakkai Zasshi. 1979 Aug;70(8):849-66.","Nakajima H","Nihon Hinyokika Gakkai Zasshi","1979","1979/08/01","","",""
"21429607","Adaptive radiotherapy in muscle invasive urinary bladder cancer--an effective method to reduce the irradiated bowel volume","Tuomikoski L, Collan J, Keyriläinen J, Visapää H, Saarilahti K, Tenhunen M.","Radiother Oncol. 2011 Apr;99(1):61-6. doi: 10.1016/j.radonc.2011.02.011. Epub 2011 Mar 21.","Tuomikoski L","Radiother Oncol","2011","2011/03/25","","","10.1016/j.radonc.2011.02.011"
"6656052","[Case of bladder cancer associated with erythrocytosis: a review of the Japanese literature on tumors associated with erythrocytosis]","Yanagizawa R, Abe S, Mikata N, Kinoshita K.","Nihon Hinyokika Gakkai Zasshi. 1983 Jun;74(6):1044-50. doi: 10.5980/jpnjurol1928.74.6_1044.","Yanagizawa R","Nihon Hinyokika Gakkai Zasshi","1983","1983/06/01","","","10.5980/jpnjurol1928.74.6_1044"
"1529395","[A new adjuvant therapy modality in the treatment of superficial bladder carcinoma. Study of feasibility of postoperative radiotherapy ""flash""]","Magrini S, Melone F, Chiavacci A, Biti G, Gazzarrini O, Muraro G, Benelli R, Gavazzi M, Ponticelli P, Rimondi C, et al.","Minerva Urol Nefrol. 1992 Jan-Mar;44(1):1-8.","Magrini S","Minerva Urol Nefrol","1992","1992/01/01","","",""
"12673701","Overview of bladder cancer trials in the Cancer and Leukemia Group B","Small EJ, Halabi S, Dalbagni G, Pruthi R, Phillips G, Edelman M, Bajorin D; Cancer and Leukemia Group B.","Cancer. 2003 Apr 15;97(8 Suppl):2090-8. doi: 10.1002/cncr.11299.","Small EJ","Cancer","2003","2003/04/04","","","10.1002/cncr.11299"
"2217420","Sensitivity to short-term chemotherapy in patients with bladder cancer evaluated by computed tomography of the primary tumor","Sager EM, Fossa SD, Ous S.","Prog Clin Biol Res. 1990;353:203-12.","Sager EM","Prog Clin Biol Res","1990","1990/01/01","","",""
"3280534","Planned preoperative irradiation in the management of clinical stage B2-C (T3) bladder carcinoma","Parsons JT, Million RR.","Int J Radiat Oncol Biol Phys. 1988 Apr;14(4):797-810. doi: 10.1016/0360-3016(88)90102-2.","Parsons JT","Int J Radiat Oncol Biol Phys","1988","1988/04/01","","","10.1016/0360-3016(88)90102-2"
"12194804","Urinary diversion after radical cystectomy","Clark PE.","Curr Treat Options Oncol. 2002 Oct;3(5):389-402. doi: 10.1007/s11864-002-0004-5.","Clark PE","Curr Treat Options Oncol","2002","2002/08/27","","","10.1007/s11864-002-0004-5"
"12955365","Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type- p53 but not in p53-mutated bladder cancer cells","Hinata N, Shirakawa T, Zhang Z, Matsumoto A, Fujisawa M, Okada H, Kamidono S, Gotoh A.","Urol Res. 2003 Dec;31(6):387-96. doi: 10.1007/s00240-003-0355-9. Epub 2003 Sep 4.","Hinata N","Urol Res","2003","2003/09/05","","","10.1007/s00240-003-0355-9"
"9092286","Organ-sparing treatment of bladder cancer: an innovative approach","Kaufman DS, Shipley WU.","Am Fam Physician. 1997 Mar;55(4):1257-62.","Kaufman DS","Am Fam Physician","1997","1997/03/01","","",""
"8766684","[Good results of bladder-preserving treatment in poorly differentiated and invasive bladder carcinoma using interstitial Iridium-192 radiotherapy]","Moonen LM, Horenblas S, Pos F, Schaefer BS, Meinhardt W, Bartelink H.","Ned Tijdschr Geneeskd. 1996 Jul 6;140(27):1406-10.","Moonen LM","Ned Tijdschr Geneeskd","1996","1996/07/06","","",""
"1358617","DNA-ploidy, morphometric-stereological and P-glycoprotein study of superficial bladder carcinomas","Sanchez-Fernandez de Sevilla MC, Gil-Salmon M, Perez-Bacete M, Morell-Quadreny L, Martinez-Diaz F, Iborra-Juan I, Fenollosa-Entrena B, Llombart-Bosch A.","Eur Urol. 1992;21 Suppl 1:16-21. doi: 10.1159/000474881.","Sanchez-Fernandez de Sevilla MC","Eur Urol","1992","1992/01/01","","","10.1159/000474881"
"23178638","Comparison of surveillance strategies for low-risk bladder cancer patients","Zhang Y, Denton BT, Nielsen ME.","Med Decis Making. 2013 Feb;33(2):198-214. doi: 10.1177/0272989X12465353. Epub 2012 Nov 25.","Zhang Y","Med Decis Making","2013","2012/11/27","","","10.1177/0272989X12465353"
"21502548","Kuhn's paradigms: are those closest to treating bladder cancer the last to appreciate the paradigm shift?","Bajorin DF, Herr HW.","J Clin Oncol. 2011 Jun 1;29(16):2135-7. doi: 10.1200/JCO.2010.34.0471. Epub 2011 Apr 18.","Bajorin DF","J Clin Oncol","2011","2011/04/20","","","10.1200/JCO.2010.34.0471"
"7321350","[Studies on invasiveness and metastasis of bladder cancer. Ist report. A pathologic study of blood vessel and lymyhatics invasion (author's transl)]","Numasawa K, Sugano O, Kubota Y, Saito M, Adachi K, Kawamura S, Suzuki K.","Nihon Hinyokika Gakkai Zasshi. 1981 Aug;72(8):1035-9. doi: 10.5980/jpnjurol1928.72.8_1035.","Numasawa K","Nihon Hinyokika Gakkai Zasshi","1981","1981/08/01","","","10.5980/jpnjurol1928.72.8_1035"
"18549344","Apaziquone for non-muscle invasive bladder cancer: a critical review","Witjes JA, Kolli PS.","Expert Opin Investig Drugs. 2008 Jul;17(7):1085-96. doi: 10.1517/13543784.17.7.1085.","Witjes JA","Expert Opin Investig Drugs","2008","2008/06/14","","","10.1517/13543784.17.7.1085"
"14673937","Construction of a global score quantifying allelic imbalance among biallelic SIDP markers in bladder cancer","Panhard X, Dominique S, Gaub MP, Ravery V, Grandchamp B, Mentré F.","Stat Med. 2003 Dec 30;22(24):3771-9. doi: 10.1002/sim.1679.","Panhard X","Stat Med","2003","2003/12/16","","","10.1002/sim.1679"
"3499769","Evaluation of lymphocyte subpopulations in patients with bladder cancer: a study with monoclonal antibodies","Morita T, Yonese Y, Minato N.","Hinyokika Kiyo. 1987 Jun;33(6):838-43.","Morita T","Hinyokika Kiyo","1987","1987/06/01","","",""
"6471226","Potential overstaging of bladder cancer by computerized tomography scanning","Lome LG, Presman D.","J Urol. 1984 Oct;132(4):758-61. doi: 10.1016/s0022-5347(17)49860-0.","Lome LG","J Urol","1984","1984/10/01","","","10.1016/s0022-5347(17)49860-0"
"17982131","Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression","Sanchez-Carbayo M, Socci ND, Richstone L, Corton M, Behrendt N, Wulkfuhle J, Bochner B, Petricoin E, Cordon-Cardo C.","Am J Pathol. 2007 Nov;171(5):1650-8. doi: 10.2353/ajpath.2007.070338.","Sanchez-Carbayo M","Am J Pathol","2007","2007/11/06","PMC2043525","","10.2353/ajpath.2007.070338"
"3458939","Factors affecting recurrence rates in superficial bladder cancer","Koch M, Hill GB, McPhee MS.","J Natl Cancer Inst. 1986 Jun;76(6):1025-9.","Koch M","J Natl Cancer Inst","1986","1986/06/01","","",""
"20551305","Intake of cruciferous vegetables modifies bladder cancer survival","Tang L, Zirpoli GR, Guru K, Moysich KB, Zhang Y, Ambrosone CB, McCann SE.","Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1806-11. doi: 10.1158/1055-9965.EPI-10-0008. Epub 2010 Jun 15.","Tang L","Cancer Epidemiol Biomarkers Prev","2010","2010/06/17","PMC2901397","NIHMS201999","10.1158/1055-9965.EPI-10-0008"
"28389625","Association of body mass index with bladder cancer risk: a dose-response meta-analysis of prospective cohort studies","Zhao L, Tian X, Duan X, Ye Y, Sun M, Huang J.","Oncotarget. 2017 May 16;8(20):33990-34000. doi: 10.18632/oncotarget.16722.","Zhao L","Oncotarget","2017","2017/04/09","PMC5464928","","10.18632/oncotarget.16722"
"14713774","Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer","Shariat SF, Casella R, Khoddami SM, Hernandez G, Sulser T, Gasser TC, Lerner SP.","J Urol. 2004 Feb;171(2 Pt 1):626-30. doi: 10.1097/01.ju.0000107826.78479.90.","Shariat SF","J Urol","2004","2004/01/10","","","10.1097/01.ju.0000107826.78479.90"
"19477579","FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer","Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, Werbrouck P.","Eur Urol. 2010 Apr;57(4):641-7. doi: 10.1016/j.eururo.2009.05.014. Epub 2009 May 18.","Swinnen G","Eur Urol","2010","2009/05/30","","","10.1016/j.eururo.2009.05.014"
"8491323","Female sexual functioning after radical surgical treatment of rectal and bladder cancer","van Driel MF, Weymar Schultz WC, van de Wiel HB, Hahn DE, Mensink HJ.","Eur J Surg Oncol. 1993 Apr;19(2):183-7.","van Driel MF","Eur J Surg Oncol","1993","1993/04/01","","",""
"6503115","[Experiences of total cystectomy for superficial bladder cancer]","Matsushima H, Akaza H, Kishi H, Umeda T, Kawabe K, Isurugi K, Niijima T.","Nihon Hinyokika Gakkai Zasshi. 1984 Jun;75(6):940-4. doi: 10.5980/jpnjurol1928.75.6_940.","Matsushima H","Nihon Hinyokika Gakkai Zasshi","1984","1984/06/01","","","10.5980/jpnjurol1928.75.6_940"
"10477864","[Social class differences in bladder cancer in Catalonia]","Fortuny J, Serra C, Bonfill X, Kogevinas M, Sunyer J.","Gac Sanit. 1999 May-Jun;13(3):208-17. doi: 10.1016/s0213-9111(99)71352-x.","Fortuny J","Gac Sanit","1999","1999/09/09","","","10.1016/s0213-9111(99)71352-x"
"2217424","The role of radiotherapy in the treatment of muscle invasive bladder cancer","Porter AT.","Prog Clin Biol Res. 1990;353:23-34.","Porter AT","Prog Clin Biol Res","1990","1990/01/01","","",""
"2239573","[Treatment using CDDP and radiation therapy in treating bladder tumor]","Kase T, Kuwabara T, Kuroda K, Takanami M, Yagishita T, Sawamura Y, Tajima M, Matsushima M, Shirai M, Kaneko I, et al.","Hinyokika Kiyo. 1990 Jul;36(7):765-70.","Kase T","Hinyokika Kiyo","1990","1990/07/01","","",""
"1556046","Surgery for invasive bladder cancer","Richie JP.","Hematol Oncol Clin North Am. 1992 Feb;6(1):129-45.","Richie JP","Hematol Oncol Clin North Am","1992","1992/02/01","","",""
"27896277","Prediction of Bacillus Calmette-Guerin Response in Patients with Bladder Cancer after Transurethral Resection of Bladder Tumor by Using Genetic Variation Based on Genomic Studies","Zhang N, Jiang G, Liu X, Na R, Wang X, Xu J.","Biomed Res Int. 2016;2016:9859021. doi: 10.1155/2016/9859021. Epub 2016 Nov 8.","Zhang N","Biomed Res Int","2016","2016/11/30","PMC5118509","","10.1155/2016/9859021"
"28718164","Advances in Imaging in Prostate and Bladder Cancer","Srivastava A, Douglass LM, Chernyak V, Watts KL.","Curr Urol Rep. 2017 Sep;18(9):69. doi: 10.1007/s11934-017-0718-3.","Srivastava A","Curr Urol Rep","2017","2017/07/19","","","10.1007/s11934-017-0718-3"
"3063539","Bladder tumor staging by transurethral ultrasonic scanning","Holm HH, Juul N, Torp-Pedersen S, Fredfeldt KE, Steven K, Hald T, Larsen S, Hansen U.","Eur Urol. 1988;15(1-2):31-3. doi: 10.1159/000473389.","Holm HH","Eur Urol","1988","1988/01/01","","","10.1159/000473389"
"20534389","[Bladder cancer and new drugs]","Massard C, Albouy B, Gross-Goupil M, Ravaud A.","Bull Cancer. 2010;97 Suppl Cancer de la vessie:43-50. doi: 10.1684/bdc.2010.1100.","Massard C","Bull Cancer","2010","2010/06/11","","","10.1684/bdc.2010.1100"
"15088892","Recent developments in the treatment of bladder cancer","Lance RS, Grossman HB.","Adv Exp Med Biol. 2003;539(Pt A):3-14. doi: 10.1007/978-1-4419-8889-8_1.","Lance RS","Adv Exp Med Biol","2003","2004/04/20","","","10.1007/978-1-4419-8889-8_1"
"29374095","Bladder cancer and occupational exposure to metalworking fluid mist: a counter-matched case-control study in French steel-producing factories","Colin R, Grzebyk M, Wild P, Hédelin G, Bourgkard È.","Occup Environ Med. 2018 May;75(5):328-336. doi: 10.1136/oemed-2017-104666. Epub 2018 Jan 26.","Colin R","Occup Environ Med","2018","2018/01/28","","","10.1136/oemed-2017-104666"
"3293072","Survival and neo-adjuvant chemotherapy in invasive bladder cancer","Hall RR.","Prog Clin Biol Res. 1988;269:569-77.","Hall RR","Prog Clin Biol Res","1988","1988/01/01","","",""
"29363820","Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer","Prack Mc Cormick B, Langle Y, Belgorosky D, Vanzulli S, Balarino N, Sandes E, Eiján AM.","J Cell Biochem. 2018 Jul;119(7):5402-5412. doi: 10.1002/jcb.26693. Epub 2018 Mar 14.","Prack Mc Cormick B","J Cell Biochem","2018","2018/01/25","","","10.1002/jcb.26693"
"1096114","Occupational bladder cancer","Parkes HG.","Practitioner. 1975 Jan;214(1279):80-6.","Parkes HG","Practitioner","1975","1975/01/01","","",""
"6052408","The significance of pulmonary function for the response of lung and bladder cancer to radiotherapy","Holsti LR, Puronto M.","Ann Med Intern Fenn. 1967;56(2):73-7.","Holsti LR","Ann Med Intern Fenn","1967","1967/01/01","","",""
"22386622","Sensitivity to chemoradiation predicts development of metastasis in muscle-invasive bladder cancer patients","Koga F, Numao N, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K.","Urol Oncol. 2013 Oct;31(7):1270-5. doi: 10.1016/j.urolonc.2012.01.014. Epub 2012 Mar 2.","Koga F","Urol Oncol","2013","2012/03/06","","","10.1016/j.urolonc.2012.01.014"
"11101089","Endoscopic fluorescence diagnosis and laser treatment of transitional cell carcinoma of the bladder","Frimberger D, Zaak D, Hofstetter A.","Semin Urol Oncol. 2000 Nov;18(4):264-72.","Frimberger D","Semin Urol Oncol","2000","2000/12/02","","",""
"624303","Geographic and time trends of coffee imports and bladder cancer","Morrison AS.","Eur J Cancer. 1978 Jan;14(1):51-4. doi: 10.1016/0014-2964(78)90137-8.","Morrison AS","Eur J Cancer","1978","1978/01/01","","","10.1016/0014-2964(78)90137-8"
"27805248","Raman microscopy of bladder cancer cells expressing green fluorescent protein","Mandair GS, Han AL, Keller ET, Morris MD.","J Biomed Opt. 2016 Nov 1;21(11):115001. doi: 10.1117/1.JBO.21.11.115001.","Mandair GS","J Biomed Opt","2016","2016/11/03","","","10.1117/1.JBO.21.11.115001"
"24561487","Minimally invasive establishment of murine orthotopic bladder xenografts","Jäger W, Moskalev I, Janssen C, Hayashi T, Gust KM, Awrey S, Black PC.","J Vis Exp. 2014 Feb 11;(84):e51123. doi: 10.3791/51123.","Jäger W","J Vis Exp","2014","2014/02/25","PMC4123502","","10.3791/51123"
"21616918","Primary cT2 bladder cancer: a good candidate for radiotherapy combined with cisplatin for bladder preservation","Hara T, Nishijima J, Miyachika Y, Yamamoto Y, Sakano S, Matsuyama H.","Jpn J Clin Oncol. 2011 Jul;41(7):902-7. doi: 10.1093/jjco/hyr064. Epub 2011 May 25.","Hara T","Jpn J Clin Oncol","2011","2011/05/28","","","10.1093/jjco/hyr064"
"12778017","Bladder cancer","Borden LS Jr, Clark PE, Hall MC.","Curr Opin Oncol. 2003 May;15(3):227-33. doi: 10.1097/00001622-200305000-00009.","Borden LS Jr","Curr Opin Oncol","2003","2003/06/05","","","10.1097/00001622-200305000-00009"
"23893180","Intravesical chemo-immunotherapy in non muscle invasive bladder cancer","Leopardo D, Cecere SC, Di Napoli M, Cavaliere C, Pisano C, Striano S, Marra L, Menna L, Claudio L, Perdonà S, Setola S, Berretta M, Franco R, Tambaro R, Pignata S, Facchini G.","Eur Rev Med Pharmacol Sci. 2013 Aug;17(16):2145-58.","Leopardo D","Eur Rev Med Pharmacol Sci","2013","2013/07/30","","",""
"31364745","Upregulation of JMJD2A promotes migration and invasion in bladder cancer through regulation of SLUG","Wang F, Li Y, Shan F, Zhang Q, Wang L, Sheng B, Cheng G.","Oncol Rep. 2019 Oct;42(4):1431-1440. doi: 10.3892/or.2019.7246. Epub 2019 Jul 23.","Wang F","Oncol Rep","2019","2019/08/01","","","10.3892/or.2019.7246"
"12541268","The Drake Health Registry Study: findings from fifteen years of continuous bladder cancer screening","Marsh GM, Cassidy LD.","Am J Ind Med. 2003 Feb;43(2):142-8. doi: 10.1002/ajim.10166.","Marsh GM","Am J Ind Med","2003","2003/01/24","","","10.1002/ajim.10166"
"11488731","A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer","Shelley MD, Kynaston H, Court J, Wilt TJ, Coles B, Burgon K, Mason MD.","BJU Int. 2001 Aug;88(3):209-16. doi: 10.1046/j.1464-410x.2001.02306.x.","Shelley MD","BJU Int","2001","2001/08/08","","","10.1046/j.1464-410x.2001.02306.x"
"7050919","Artificial sweeteners in relation to the epidemiology of bladder cancer","Howe GR, Burch JD.","Nutr Cancer. 1981;2(4):213-6. doi: 10.1080/01635588109513685.","Howe GR","Nutr Cancer","1981","1981/01/01","","","10.1080/01635588109513685"
"3907198","[Results of radiotherapeutic optimization within the scope of combined operative-radiologic therapy of urinary bladder cancer]","Kob D, Kloetzer KH, Kriester A, Arndt J, Bockhorn V, Möller A, Bothor C, Pirlich W.","Z Urol Nephrol. 1985 Oct;78(10):545-50.","Kob D","Z Urol Nephrol","1985","1985/10/01","","",""
"16626308","Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer","Sandhu JS, Vickers AJ, Bochner B, Donat SM, Herr HW, Dalbagni G.","BJU Int. 2006 Jul;98(1):59-62. doi: 10.1111/j.1464-410X.2006.06182.x. Epub 2006 Apr 18.","Sandhu JS","BJU Int","2006","2006/04/22","","","10.1111/j.1464-410X.2006.06182.x"
"8839388","Ultraweak biophoton emission imaging of transplanted bladder cancer","Amano T, Kobayashi M, Devaraj B, Usa M, Inaba H.","Urol Res. 1995;23(5):315-318. doi: 10.1007/BF00300020.","Amano T","Urol Res","1995","1995/01/01","","","10.1007/BF00300020"
"8212422","[Immunotherapy of superficial bladder cancer]","Schmitz-Dräger BJ, Schattka SO, Ebert T.","Urologe A. 1993 Sep;32(5):374-81.","Schmitz-Dräger BJ","Urologe A","1993","1993/09/01","","",""
"24134387","Lymph node-positive bladder cancer: surgical, pathologic, molecular and prognostic aspects","Pedrosa JA, Koch MO, Cheng L.","Expert Rev Anticancer Ther. 2013 Nov;13(11):1281-95. doi: 10.1586/14737140.2013.850847. Epub 2013 Oct 18.","Pedrosa JA","Expert Rev Anticancer Ther","2013","2013/10/19","","","10.1586/14737140.2013.850847"
"2152750","[Prophylaxis of superficial tumors of the bladder with interferon alfa-2B]","Maffucci A, Fico A, Giannella L, Giannella R.","Arch Monaldi Mal Torace. 1990 Nov-Dec;45(6):415-8.","Maffucci A","Arch Monaldi Mal Torace","1990","1990/11/01","","",""
"18636402","Discovery of myopodin methylation in bladder cancer","Cebrian V, Alvarez M, Aleman A, Palou J, Bellmunt J, Gonzalez-Peramato P, Cordón-Cardo C, García J, Piulats JM, Sánchez-Carbayo M.","J Pathol. 2008 Sep;216(1):111-9. doi: 10.1002/path.2390.","Cebrian V","J Pathol","2008","2008/07/19","","","10.1002/path.2390"
"17627461","Clinical and therapeutic significance of aberrant differentiation patterns in bladder cancer","Black PC, Brown GA, Dinney CP.","Expert Rev Anticancer Ther. 2007 Jul;7(7):1015-26. doi: 10.1586/14737140.7.7.1015.","Black PC","Expert Rev Anticancer Ther","2007","2007/07/14","","","10.1586/14737140.7.7.1015"
"8345582","Characterization of a new human bladder cancer cell line, UCRU-BL-28","Russell PJ, Palavidis Z, Rozinova E, Philips J, Wills EJ, Lukeis R, Wass J, Raghavan D.","J Urol. 1993 Sep;150(3):1038-44. doi: 10.1016/s0022-5347(17)35682-3.","Russell PJ","J Urol","1993","1993/09/01","","","10.1016/s0022-5347(17)35682-3"
"19800703","Lipiodol injection for target volume delineation and image guidance during radiotherapy for bladder cancer","Pos F, Bex A, Dees-Ribbers HM, Betgen A, van Herk M, Remeijer P.","Radiother Oncol. 2009 Nov;93(2):364-7. doi: 10.1016/j.radonc.2009.09.003. Epub 2009 Oct 1.","Pos F","Radiother Oncol","2009","2009/10/06","","","10.1016/j.radonc.2009.09.003"
"31162712","lncRNA TUC338 is a potential diagnostic biomarker for bladder cancer","Li G, Zhang Y, Mao J, Hu P, Chen Q, Ding W, Pu R.","J Cell Biochem. 2019 Oct;120(10):18014-18019. doi: 10.1002/jcb.29104. Epub 2019 Jun 4.","Li G","J Cell Biochem","2019","2019/06/05","","","10.1002/jcb.29104"
"27312881","T.A.B.: Proposed new system for graphic standardization (and sharing) of clinical histories of bladder cancer patients","Dal Moro F, Zattoni F.","Urologia. 2016 Sep 26;83(3):149-151. doi: 10.5301/uro.5000177. Epub 2016 Jun 6.","Dal Moro F","Urologia","2016","2016/06/18","","","10.5301/uro.5000177"
"11775223","Relationship between metabolic phenotype of N-acetylation and bladder cancer","Cui X, Guo R, Xu Z, Wang B, Li C.","Chin Med J (Engl). 2000 Apr;113(4):303-5.","Cui X","Chin Med J (Engl)","2000","2002/01/05","","",""
"24373477","EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines","Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG, Sherif A; European Association of Urology.","Eur Urol. 2014 Apr;65(4):778-92. doi: 10.1016/j.eururo.2013.11.046. Epub 2013 Dec 12.","Witjes JA","Eur Urol","2014","2013/12/31","","","10.1016/j.eururo.2013.11.046"
"1556052","Clinical staging: its importance in therapeutic decisions and clinical trials","Denis LJ.","Hematol Oncol Clin North Am. 1992 Feb;6(1):41-58.","Denis LJ","Hematol Oncol Clin North Am","1992","1992/02/01","","",""
"7510039","Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients","Rosin MP, Saad el Din Zaki S, Ward AJ, Anwar WA.","Mutat Res. 1994 Mar 1;305(2):283-92. doi: 10.1016/0027-5107(94)90248-8.","Rosin MP","Mutat Res","1994","1994/03/01","","","10.1016/0027-5107(94)90248-8"
"29233549","Trimodality therapy for older patients with bladder cancer: Overtreatment or benefit?","Bonet M, Bonfill T, Nuñez M, Mur E, Arenas M.","J Geriatr Oncol. 2018 May;9(3):279-280. doi: 10.1016/j.jgo.2017.11.006. Epub 2017 Dec 8.","Bonet M","J Geriatr Oncol","2018","2017/12/14","","","10.1016/j.jgo.2017.11.006"
"9400445","Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term followup of a prospective study","Solsona E, Iborra I, Ricós JV, Monrós JL, Casanova J, Calabuig C.","J Urol. 1998 Jan;159(1):95-8; discussion 98-9. doi: 10.1016/s0022-5347(01)64022-9.","Solsona E","J Urol","1998","1997/12/24","","","10.1016/s0022-5347(01)64022-9"
"4003967","Simultaneous staining of nuclear DNA and blood group cell surface antigens on cells from bladder irrigation fluid","Devonec M, Fontaniere B, Blanc-Brunat N, Muchada E, Dubernard JM.","Anal Quant Cytol Histol. 1985 Mar;7(1):69-71.","Devonec M","Anal Quant Cytol Histol","1985","1985/03/01","","",""
"2797266","[Reconstruction of the urinary bladder following cystectomy]","Langemeyer TN, Ferwerda WH.","Ned Tijdschr Geneeskd. 1989 Aug 12;133(32):1602-5.","Langemeyer TN","Ned Tijdschr Geneeskd","1989","1989/08/12","","",""
"20123357","Role of biomarkers to predict outcomes and response to therapy","Lotan Y.","Urol Oncol. 2010 Jan-Feb;28(1):97-101. doi: 10.1016/j.urolonc.2009.03.017.","Lotan Y","Urol Oncol","2010","2010/02/04","","","10.1016/j.urolonc.2009.03.017"
"31621380","Prognostic utility of the combination of pretreatment monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NMIBC after transurethral resection","Wang Q, Huang T, Ji J, Wang H, Guo C, Sun X, Zheng K, Dong Z, Cao Y.","Biomark Med. 2019 Dec;13(18):1543-1555. doi: 10.2217/bmm-2019-0398. Epub 2019 Oct 17.","Wang Q","Biomark Med","2019","2019/10/18","","","10.2217/bmm-2019-0398"
"15368686","Prognostic significance of angiogenesis in superficial bladder cancer","Stavropoulos NE, Bouropoulos C, Ioachim IE, Michael M, Hastazeris K, Tsimaris I, Kalogeras D, Liamis Z, Stefanaki S, Agnantis NI.","Int Urol Nephrol. 2004;36(2):163-7. doi: 10.1023/b:urol.0000034676.50636.e0.","Stavropoulos NE","Int Urol Nephrol","2004","2004/09/17","","","10.1023/b:urol.0000034676.50636.e0"
"26705102","The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis","Bruins HM, Aben KK, Arends TJ, van der Heijden AG, Witjes AJ.","Urol Oncol. 2016 Apr;34(4):166.e1-6. doi: 10.1016/j.urolonc.2015.11.006. Epub 2015 Dec 15.","Bruins HM","Urol Oncol","2016","2015/12/26","","","10.1016/j.urolonc.2015.11.006"
"20051252","Environmental factors and genetic susceptibility promote urinary bladder cancer","Volanis D, Kadiyska T, Galanis A, Delakas D, Logotheti S, Zoumpourlis V.","Toxicol Lett. 2010 Mar 15;193(2):131-7. doi: 10.1016/j.toxlet.2009.12.018. Epub 2010 Jan 4.","Volanis D","Toxicol Lett","2010","2010/01/07","","","10.1016/j.toxlet.2009.12.018"
"3865013","Spontaneous urinary bladder tumors in DA/Han rats: a feasible model of human bladder cancer","Deerberg F, Rehm S, Jostmeyer HH.","J Natl Cancer Inst. 1985 Dec;75(6):1113-21.","Deerberg F","J Natl Cancer Inst","1985","1985/12/01","","",""
"26799188","Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer","Zhan Y, Liu Y, Wang C, Lin J, Chen M, Chen X, Zhuang C, Liu L, Xu W, Zhou Q, Sun X, Zhang Q, Zhao G, Huang W.","Oncotarget. 2016 Mar 29;7(13):16038-48. doi: 10.18632/oncotarget.6946.","Zhan Y","Oncotarget","2016","2016/01/23","PMC4941296","","10.18632/oncotarget.6946"
"19054170","Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association","Hinotsu S, Akaza H, Miki T, Fujimoto H, Shinohara N, Kikuchi E, Mizutani Y, Koga H, Okajima E, Okuyama A; Japanese Urological Association.","Int J Urol. 2009 Jan;16(1):64-9. doi: 10.1111/j.1442-2042.2008.02194.x. Epub 2008 Nov 27.","Hinotsu S","Int J Urol","2009","2008/12/05","","","10.1111/j.1442-2042.2008.02194.x"
"26597618","Bladder cancer: A step closer to individualized treatment for bladder cancer","Traboulsi SL, Kassouf W.","Nat Rev Urol. 2016 Mar;13(3):127-8. doi: 10.1038/nrurol.2015.265. Epub 2015 Nov 24.","Traboulsi SL","Nat Rev Urol","2016","2015/11/25","","","10.1038/nrurol.2015.265"
"5343563","[Some problems related to urinary bladder cancer in the light of statistical studies using prepunched cards. Preliminary report]","Bieniak B, Pietraszun R.","Pol Przegl Chir. 1969 Aug;41(8):Suppl 8a:1159+.","Bieniak B","Pol Przegl Chir","1969","1969/08/01","","",""
"11400479","[Usefulness of p53 in the clinical management of bladder tumors]","Bernardini S, Chabannes E, Bittard H.","Prog Urol. 2001 Apr;11(2):201-8.","Bernardini S","Prog Urol","2001","2001/06/13","","",""
"2003116","Bladder preserving combined modality therapy for invasive bladder cancer","Held J, Volpe H.","Oncol Nurs Forum. 1991 Jan-Feb;18(1):49-57.","Held J","Oncol Nurs Forum","1991","1991/01/01","","",""
"6677137","[Diagnosis of bladder cancer by transurethral ultrasonic scanning]","Sakamoto W, Nishio S, Maekawa M.","Hinyokika Kiyo. 1983 Sep;29(9):1015-8.","Sakamoto W","Hinyokika Kiyo","1983","1983/09/01","","",""
"10451439","Stat bite: U.S. urinary bladder cancer death rates","","J Natl Cancer Inst. 1999 Aug 18;91(16):1362. doi: 10.1093/jnci/91.16.1362.","","J Natl Cancer Inst","1999","1999/08/19","","","10.1093/jnci/91.16.1362"
"23831312","Validation study of a noninvasive urine test for diagnosis and prognosis assessment of bladder cancer: evidence for improved models","Mengual L, Ribal MJ, Lozano JJ, Ingelmo-Torres M, Burset M, Fernández PL, Alcaraz A.","J Urol. 2014 Jan;191(1):261-9. doi: 10.1016/j.juro.2013.06.083. Epub 2013 Jul 2.","Mengual L","J Urol","2014","2013/07/09","","","10.1016/j.juro.2013.06.083"
"24851023","Long-term oncologic outcomes after radical cystectomy for bladder cancer at a single institution","Kwon T, Jeong IG, You D, Hong B, Hong JH, Ahn H, Kim CS.","J Korean Med Sci. 2014 May;29(5):669-75. doi: 10.3346/jkms.2014.29.5.669. Epub 2014 Apr 25.","Kwon T","J Korean Med Sci","2014","2014/05/23","PMC4024950","","10.3346/jkms.2014.29.5.669"
"29749774","Bladder cancer: overview and disease management. Part 1: non-muscle-invasive bladder cancer","Anderson B.","Br J Nurs. 2018 May 10;27(9):S27-S37. doi: 10.12968/bjon.2018.27.9.S27.","Anderson B","Br J Nurs","2018","2018/05/12","","","10.12968/bjon.2018.27.9.S27"
"2834853","Antibodies to simian vacuolating virus 40 in bladder cancer patients","Bravo MP, del Rey-Calero J, Olivares I, Vizcaino MJ.","Urol Int. 1987;42(6):427-30. doi: 10.1159/000282008.","Bravo MP","Urol Int","1987","1987/01/01","","","10.1159/000282008"
"1414752","[Transitional cell carcinoma of the upper urinary tract following total cystectomy for bladder cancer]","Hayashi Y, Tawada T, Ando Y.","Hinyokika Kiyo. 1992 Sep;38(9):1015-8; discussion 1018-9.","Hayashi Y","Hinyokika Kiyo","1992","1992/09/01","","",""
"21491174","Initial results with (11)C-acetate positron emission tomography/computed tomography (PET/CT) in the staging of urinary bladder cancer","Schöder H, Ong SC, Reuter VE, Cai S, Burnazi E, Dalbagni G, Larson SM, Bochner BH.","Mol Imaging Biol. 2012 Apr;14(2):245-51. doi: 10.1007/s11307-011-0488-0.","Schöder H","Mol Imaging Biol","2012","2011/04/15","","","10.1007/s11307-011-0488-0"
"3668457","The Copenhagen case-control study of bladder cancer: role of smoking in invasive and non-invasive bladder tumours","Jensen OM, Wahrendorf J, Blettner M, Knudsen JB, Sørensen BL.","J Epidemiol Community Health. 1987 Mar;41(1):30-6. doi: 10.1136/jech.41.1.30.","Jensen OM","J Epidemiol Community Health","1987","1987/03/01","PMC1052573","","10.1136/jech.41.1.30"
"17128672","[Characteristics of a new bladder cancer classification]","Altarac S.","Lijec Vjesn. 2006 Sep-Oct;128(9-10):322.","Altarac S","Lijec Vjesn","2006","2006/11/30","","",""
"17159272","Inorganic arsenic in drinking water and bladder cancer: a meta-analysis for dose-response assessment","Chu HA, Crawford-Brown DJ.","Int J Environ Res Public Health. 2006 Dec;3(4):316-22. doi: 10.3390/ijerph2006030039.","Chu HA","Int J Environ Res Public Health","2006","2006/12/13","","","10.3390/ijerph2006030039"
"28951003","Bladder-sparing Radiotherapy for Muscle-invasive Bladder Cancer: A Qualitative Study to Identify Barriers and Enablers","Walker M, Doiron RC, French SD, Feldman-Stewart D, Siemens DR, Mackillop WJ, Booth CM.","Clin Oncol (R Coll Radiol). 2017 Dec;29(12):818-826. doi: 10.1016/j.clon.2017.09.001. Epub 2017 Sep 23.","Walker M","Clin Oncol (R Coll Radiol)","2017","2017/09/28","","","10.1016/j.clon.2017.09.001"
"7460999","Effect of hyperthermia on experimental bladder tumors","Ogura K, Kagawa S, Kurokawa K.","Eur Urol. 1981;7(2):100-4. doi: 10.1159/000473190.","Ogura K","Eur Urol","1981","1981/01/01","","","10.1159/000473190"
"26878804","Bladder cancer: Active surveillance for low-grade Ta bladder tumours","Soloway MS.","Nat Rev Urol. 2016 Jun;13(6):303-4. doi: 10.1038/nrurol.2016.35. Epub 2016 Feb 16.","Soloway MS","Nat Rev Urol","2016","2016/02/17","","","10.1038/nrurol.2016.35"
"2674845","[Significance of seemingly intact urothelium in patients with bladder cancer]","Kolozsy Z, Mohácsi L, Dauda G, Samodai L, Endresz KF, Tóth A.","Orv Hetil. 1989 Sep 3;130(36):1925-6, 1929-31.","Kolozsy Z","Orv Hetil","1989","1989/09/03","","",""
"6390912","Multiple cell markers in bladder cancer. Principles and clinical applications","Javadpour N.","Urol Clin North Am. 1984 Nov;11(4):609-16.","Javadpour N","Urol Clin North Am","1984","1984/11/01","","",""
"30519746","Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy","Milenkovic U, Akand M, Moris L, Demaegd L, Muilwijk T, Bekhuis Y, Laenen A, Van Cleynenbreugel B, Everaerts W, Van Poppel H, Dumez H, Albersen M, Joniau S.","World J Urol. 2019 Sep;37(9):1857-1866. doi: 10.1007/s00345-018-2584-0. Epub 2018 Dec 5.","Milenkovic U","World J Urol","2019","2018/12/07","","","10.1007/s00345-018-2584-0"
"1705177","Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancer","Morita T, Tokue A, Minato N.","Cancer Immunol Immunother. 1990;32(3):191-4. doi: 10.1007/BF01771456.","Morita T","Cancer Immunol Immunother","1990","1990/01/01","","","10.1007/BF01771456"
"25833466","Sex Differences of ≥ pT1 Bladder Cancer Survival in Austria: A Descriptive, Long-Term, Nation-Wide Analysis Based on 27,773 Patients","Waldhoer T, Berger I, Haidinger G, Zielonke N, Madersbacher S.","Urol Int. 2015;94(4):383-9. doi: 10.1159/000368418. Epub 2015 Mar 28.","Waldhoer T","Urol Int","2015","2015/04/03","","","10.1159/000368418"
"3215248","Prognosis of bladder cancer. III. The value of radical cystectomy in the management of invasive bladder cancer","Pagano F, Guazzieri S, Artibani W, Prayer-Galetti T, Milani C, Bassi P, Garbeglio A.","Eur Urol. 1988;15(3-4):166-70. doi: 10.1159/000473425.","Pagano F","Eur Urol","1988","1988/01/01","","","10.1159/000473425"
"1877136","Immunohistochemical staining of CA 50 antigen in human bladder cancer. Relation to histologic grade, clinical stage, and prognosis","Lipponen PK, Eskelinen MJ, Collan Y.","Urology. 1991 Aug;38(2):163-9. doi: 10.1016/s0090-4295(05)80080-9.","Lipponen PK","Urology","1991","1991/08/01","","","10.1016/s0090-4295(05)80080-9"
"3135421","A new treatment for invasive squamous cell bladder cancer: the Nigro regimen: preoperative chemotherapy and radiation therapy","Patterson JM, Ray EH Jr, Mendiondo OA, Medina WD, Gee WF.","J Urol. 1988 Aug;140(2):379-80. doi: 10.1016/s0022-5347(17)41613-2.","Patterson JM","J Urol","1988","1988/08/01","","","10.1016/s0022-5347(17)41613-2"
"369082","Current concepts of the aetiology, pathogenesis and pathology of bladder cancer","Friedell GH.","Urol Res. 1978;6(4):179-82. doi: 10.1007/BF00262611.","Friedell GH","Urol Res","1978","1978/01/01","","","10.1007/BF00262611"
"22274923","Hypermethylation in bladder cancer: biological pathways and translational applications","Sánchez-Carbayo M.","Tumour Biol. 2012 Apr;33(2):347-61. doi: 10.1007/s13277-011-0310-2. Epub 2012 Jan 25.","Sánchez-Carbayo M","Tumour Biol","2012","2012/01/26","","","10.1007/s13277-011-0310-2"
"23559135","[How to apply follow-up in relation to risk group]","Montanaro V, Di Girolamo A, Ferro M, Altieri V.","Urologia. 2013;80 Suppl 21:42-7. doi: 10.5301/RU.2013.10864. Epub 2013 Mar 22.","Montanaro V","Urologia","2013","2013/04/06","","","10.5301/RU.2013.10864"
"23852928","[Role of the combined regimen with local chemotherapy and Mw-induced hyperthermia for non-muscle invasive bladder cancer management. A systematic review]","Colombo R, Moschini M.","Urologia. 2013 Apr-Jun;80(2):112-9. doi: 10.5301/RU.2013.11296. Epub 2013 Jul 1.","Colombo R","Urologia","2013","2013/07/16","","","10.5301/RU.2013.11296"
"24122724","High morbidity and mortality found for high-risk, non-muscle-invasive bladder cancer","Barton MK.","CA Cancer J Clin. 2013 Nov-Dec;63(6):371-2. doi: 10.3322/caac.21201. Epub 2013 Oct 7.","Barton MK","CA Cancer J Clin","2013","2013/10/15","","","10.3322/caac.21201"
"30896880","MicroRNA‑663b downregulation inhibits proliferation and induces apoptosis in bladder cancer cells by targeting TUSC2","Chen J, Song B, Kong G.","Mol Med Rep. 2019 May;19(5):3896-3902. doi: 10.3892/mmr.2019.10023. Epub 2019 Mar 14.","Chen J","Mol Med Rep","2019","2019/03/22","","","10.3892/mmr.2019.10023"
"22093295","Prognosis of T1G3 bladder cancer: how well can we predict progression?","Witjes JA.","Eur Urol. 2012 Jul;62(1):126-7; discussion 128-9. doi: 10.1016/j.eururo.2011.11.001. Epub 2011 Nov 10.","Witjes JA","Eur Urol","2012","2011/11/19","","","10.1016/j.eururo.2011.11.001"
"1738381","Bladder cancer--field versus clonal origin","Harris AL, Neal DE.","N Engl J Med. 1992 Mar 12;326(11):759-61. doi: 10.1056/NEJM199203123261108.","Harris AL","N Engl J Med","1992","1992/03/12","","","10.1056/NEJM199203123261108"
"30475756","TROY expression is associated with pathological stage and poor prognosis in patients treated with radical cystectomy","Nomura M, Matsumoto K, Shimizu Y, Ikeda M, Amano N, Nishi M, Ryo A, Nagashio R, Sato Y, Iwamura M.","Cancer Biomark. 2019;24(1):91-96. doi: 10.3233/CBM-181911.","Nomura M","Cancer Biomark","2019","2018/11/27","","","10.3233/CBM-181911"
"19996544","Exposed workers and bladder cancer in Italy: an estimate starting from the ISPESL's database of enterprises","Scarselli A, Scano P, Marinaccio A.","Ind Health. 2009 Dec;47(6):673-6. doi: 10.2486/indhealth.47.673.","Scarselli A","Ind Health","2009","2009/12/10","","","10.2486/indhealth.47.673"
"15271370","MR imaging of the bladder","Mallampati GK, Siegelman ES.","Magn Reson Imaging Clin N Am. 2004 Aug;12(3):545-55, vii. doi: 10.1016/j.mric.2004.03.010.","Mallampati GK","Magn Reson Imaging Clin N Am","2004","2004/07/24","","","10.1016/j.mric.2004.03.010"
"1906848","Work-related bladder cancer risks in male Japanese workers: estimation of attributable fraction and geographical correlation analysis","Yamaguchi N, Watanabe S, Okubo T, Takahashi K.","Jpn J Cancer Res. 1991 Jun;82(6):624-31. doi: 10.1111/j.1349-7006.1991.tb01896.x.","Yamaguchi N","Jpn J Cancer Res","1991","1991/06/01","PMC5918511","","10.1111/j.1349-7006.1991.tb01896.x"
"28634245","Targeting Nectin-4 in Bladder Cancer","","Cancer Discov. 2017 Aug;7(8):OF3. doi: 10.1158/2159-8290.CD-NB2017-095. Epub 2017 Jun 20.","","Cancer Discov","2017","2017/06/22","","","10.1158/2159-8290.CD-NB2017-095"
"22000498","Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review","Zuiverloon TC, Nieuweboer AJ, Vékony H, Kirkels WJ, Bangma CH, Zwarthoff EC.","Eur Urol. 2012 Jan;61(1):128-45. doi: 10.1016/j.eururo.2011.09.026. Epub 2011 Oct 6.","Zuiverloon TC","Eur Urol","2012","2011/10/18","","","10.1016/j.eururo.2011.09.026"
"8488900","Treating bladder cancer: new methods, new management","Moore S, Newton M, Grant EG, Keetch DW.","Am J Nurs. 1993 May;93(5):32-9.","Moore S","Am J Nurs","1993","1993/05/01","","",""
"23022113","Neoadjuvant chemotherapy in muscle-invasive bladder cancer: ready for prime time?","Pouessel D, Mongiat-Artus P, Culine S.","Crit Rev Oncol Hematol. 2013 Mar;85(3):288-94. doi: 10.1016/j.critrevonc.2012.09.002. Epub 2012 Sep 27.","Pouessel D","Crit Rev Oncol Hematol","2013","2012/10/02","","","10.1016/j.critrevonc.2012.09.002"
"20843454","[Response and progression-free survival in T2 to T4 bladder tumors treated with trimodality therapy with bladder preservation]","Rincón Mayans A, Rosell Costa D, Zudaire Bergera JJ, Rioja Zuazu J, Barba Abad J, Tolosa Eizaguirre E, Romero Vargas L, Pascual Piedrola I.","Actas Urol Esp. 2010 Oct;34(9):775-80.","Rincón Mayans A","Actas Urol Esp","2010","2010/09/17","","",""
"16890657","Racial disparity in bladder cancer: trends in tumor presentation at diagnosis","Lee CT, Dunn RL, Williams C, Underwood W 3rd.","J Urol. 2006 Sep;176(3):927-33; discussion 933-4. doi: 10.1016/j.juro.2006.04.074.","Lee CT","J Urol","2006","2006/08/08","","","10.1016/j.juro.2006.04.074"
"22892257","NMP-22, urinary cytology, and cystoscopy: a 1 year comparison study","Schlake A, Crispen PL, Cap AP, Atkinson T, Davenport D, Preston DM.","Can J Urol. 2012 Aug;19(4):6345-50.","Schlake A","Can J Urol","2012","2012/08/16","","",""
"30108246","The urinary microbiome associated with bladder cancer","Bučević Popović V, Šitum M, Chow CT, Chan LS, Roje B, Terzić J.","Sci Rep. 2018 Aug 14;8(1):12157. doi: 10.1038/s41598-018-29054-w.","Bučević Popović V","Sci Rep","2018","2018/08/16","PMC6092344","","10.1038/s41598-018-29054-w"
"25869382","Efficacy and safety of late-course hypofractionated radiation therapy for muscle-invasive bladder carcinoma after bladder-conserving surgery","Song YP, Ma JB, Wang L, Chen EC, Liu P, Ma Z, Zang RK, Yu JM.","Asia Pac J Clin Oncol. 2017 Apr;13(2):e111-e116. doi: 10.1111/ajco.12351. Epub 2015 Apr 14.","Song YP","Asia Pac J Clin Oncol","2017","2015/04/15","","","10.1111/ajco.12351"
"6491356","[Is the improvement of survival in advanced bladder cancer possible?]","Gilloz A, Heritier P, Crochet J, Tostain J, Melka R, Chandrasekar D.","J Urol (Paris). 1984;90(3):201-6.","Gilloz A","J Urol (Paris)","1984","1984/01/01","","",""
"31558843","Determining superior first-line therapy in metastatic bladder cancer","Apolo AB.","Nat Rev Urol. 2019 Dec;16(12):698-699. doi: 10.1038/s41585-019-0245-8.","Apolo AB","Nat Rev Urol","2019","2019/09/28","","","10.1038/s41585-019-0245-8"
"26415356","[CLINICAL CHARACTERISTICS OF T1 HIGH GRADE BLADDER CANCER]","Tsuzuki S, Miki J, Moritake J, Kimura S, Shimomura T, Kimura T, Kishimoto K, Egawa S.","Nihon Hinyokika Gakkai Zasshi. 2015 Apr;106(2):71-8. doi: 10.5980/jpnjurol.106.71.","Tsuzuki S","Nihon Hinyokika Gakkai Zasshi","2015","2015/09/30","","","10.5980/jpnjurol.106.71"
"31154583","Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics","Ślusarczyk A, Zapała P, Zapała Ł, Piecha T, Radziszewski P.","Int Urol Nephrol. 2019 Jul;51(7):1089-1099. doi: 10.1007/s11255-019-02183-5. Epub 2019 Jun 1.","Ślusarczyk A","Int Urol Nephrol","2019","2019/06/03","","","10.1007/s11255-019-02183-5"
"25670479","The nested variant of bladder transitional cell carcinoma: Review of 12 cases and review of the literature","Carrion-Ballardo CJ, Gala-Solana L, Portillo-Martin JA, Azueta-Etxebarria A, Truan-Cacho D, Campos-Juanatey F.","Actas Urol Esp. 2015 Jul-Aug;39(6):387-91. doi: 10.1016/j.acuro.2014.12.003. Epub 2015 Feb 7.","Carrion-Ballardo CJ","Actas Urol Esp","2015","2015/02/12","","","10.1016/j.acuro.2014.12.003"
"22742566","The bladder cancer genome; chromosomal changes as prognostic makers, opportunities, and obstacles","Höglund M.","Urol Oncol. 2012 Jul-Aug;30(4):533-40. doi: 10.1016/j.urolonc.2012.04.001.","Höglund M","Urol Oncol","2012","2012/06/30","","","10.1016/j.urolonc.2012.04.001"
"10772442","Management of complications of bacillus Calmette-Guérin immunotherapy in the treatment of bladder cancer","Huang TC.","Ann Pharmacother. 2000 Apr;34(4):529-32. doi: 10.1345/aph.19145.","Huang TC","Ann Pharmacother","2000","2000/04/20","","","10.1345/aph.19145"
"18585634","[Management of Ta, T1, and in situ bladder carcinoma: what is new?]","Irani J.","Prog Urol. 2008 May;18 Suppl 5:S94-8. doi: 10.1016/S1166-7087(08)72484-9.","Irani J","Prog Urol","2008","2008/07/01","","","10.1016/S1166-7087(08)72484-9"
"18719781","[Bladder cancer - treatment of invasive and metastatic carcinoma]","Pompeo AC, Carrerette FB, Glina S, Ortiz V, Ferreira U, Fonseca CE; Sociedade Brasileira de Urologia; Sociedade Brasileira de Patologia.","Rev Assoc Med Bras (1992). 2008 Jul-Aug;54(4):290-2; quiz 297. doi: 10.1590/s0104-42302008000400008.","Pompeo AC","Rev Assoc Med Bras (1992)","2008","2008/08/23","","","10.1590/s0104-42302008000400008"
"22340743","Bilateral ureteral complete obstruction with huge spontaneous urinoma formation in a patient with advanced bladder cancer","Jou YC, Shen CH, Cheng MC, Lin CT, Chen PC.","J Chin Med Assoc. 2012 Feb;75(2):84-6. doi: 10.1016/j.jcma.2011.12.005. Epub 2012 Jan 9.","Jou YC","J Chin Med Assoc","2012","2012/02/21","","","10.1016/j.jcma.2011.12.005"
"12356924","Risk of bladder cancer in foundry workers: a meta-analysis","Gaertner RR, Thériault GP.","Occup Environ Med. 2002 Oct;59(10):655-63. doi: 10.1136/oem.59.10.655.","Gaertner RR","Occup Environ Med","2002","2002/10/03","PMC1740225","","10.1136/oem.59.10.655"
"26975197","Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden","Dansk V, Malmström PU, Bläckberg M, Malmenäs M.","Future Oncol. 2016;12(8):1025-38. doi: 10.2217/fon-2015-0021. Epub 2016 Mar 15.","Dansk V","Future Oncol","2016","2016/03/16","","","10.2217/fon-2015-0021"
"26334084","Bladder cancer: Patient-derived murine xenografts","Fenner A.","Nat Rev Urol. 2015 Oct;12(10):536. doi: 10.1038/nrurol.2015.222. Epub 2015 Sep 1.","Fenner A","Nat Rev Urol","2015","2015/09/04","","","10.1038/nrurol.2015.222"
"23097023","Upregulation of tissue and urinary nicotinamide N-methyltransferase in bladder cancer: potential for the development of a urine-based diagnostic test","Sartini D, Muzzonigro G, Milanese G, Pozzi V, Vici A, Morganti S, Rossi V, Mazzucchelli R, Montironi R, Emanuelli M.","Cell Biochem Biophys. 2013 Apr;65(3):473-83. doi: 10.1007/s12013-012-9451-1.","Sartini D","Cell Biochem Biophys","2013","2012/10/26","","","10.1007/s12013-012-9451-1"
"26053693","Molecular markers in bladder cancer: Novel research frontiers","Sanguedolce F, Cormio A, Bufo P, Carrieri G, Cormio L.","Crit Rev Clin Lab Sci. 2015;52(5):242-55. doi: 10.3109/10408363.2015.1033610. Epub 2015 Jun 8.","Sanguedolce F","Crit Rev Clin Lab Sci","2015","2015/06/09","","","10.3109/10408363.2015.1033610"
"31064722","Long noncoding RNAs in bladder cancer prognosis: A meta-analysis","Zhu W, Liu H, Wang X, Lu J, Yang W.","Pathol Res Pract. 2019 Jun;215(6):152429. doi: 10.1016/j.prp.2019.04.021. Epub 2019 Apr 29.","Zhu W","Pathol Res Pract","2019","2019/05/09","","","10.1016/j.prp.2019.04.021"
"19383312","High throughput molecular diagnostics in bladder cancer - on the brink of clinical utility","Zieger K.","Mol Oncol. 2008 Apr;1(4):384-94. doi: 10.1016/j.molonc.2007.11.002. Epub 2007 Dec 8.","Zieger K","Mol Oncol","2008","2009/04/23","PMC5543843","","10.1016/j.molonc.2007.11.002"
"19271527","[Superficial bladder cancer detection using diffuse reflectance spectral ratio R540/R575 of oxygenated hemoglobin bands]","Wei HJ, Xing D, Wu GY, Lu JJ, Wu RH, Gu HM, He BH, Chen XM.","Guang Pu Xue Yu Guang Pu Fen Xi. 2008 Nov;28(11):2721-5.","Wei HJ","Guang Pu Xue Yu Guang Pu Fen Xi","2008","2009/03/11","","",""
"21883835","Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases","Papalia R, Simone G, Grasso R, Augelli R, Faiella E, Guaglianone S, Cazzato R, Del Vescovo R, Ferriero M, Zobel B, Gallucci M.","BJU Int. 2012 Apr;109(7):1031-6. doi: 10.1111/j.1464-410X.2011.10446.x. Epub 2011 Aug 25.","Papalia R","BJU Int","2012","2011/09/03","","","10.1111/j.1464-410X.2011.10446.x"
"30515595","Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC)","Werntz RP, Adamic B, Steinberg GD.","World J Urol. 2019 Oct;37(10):2031-2040. doi: 10.1007/s00345-018-2592-0. Epub 2018 Dec 4.","Werntz RP","World J Urol","2019","2018/12/06","","","10.1007/s00345-018-2592-0"
"8274374","Magnetic resonance imaging of urinary bladder cancer: an overview and new developments","Barentsz JO, Ruijs SH, van Erning LJ.","Magn Reson Q. 1993 Dec;9(4):235-58.","Barentsz JO","Magn Reson Q","1993","1993/12/01","","",""
"12228754","Surgical management of bladder carcinoma","Carrion R, Seigne J.","Cancer Control. 2002 Jul-Aug;9(4):284-92. doi: 10.1177/107327480200900403.","Carrion R","Cancer Control","2002","2002/09/14","","","10.1177/107327480200900403"
"24085356","Genetic polymorphisms of XRCC3 Thr241Met (C18067T, rs861539) and bladder cancer risk: a meta-analysis of 18 research studies","Ma Q, Zhao Y, Wang S, Zhang X, Zhang J, Du M, Li L, Zhang Y.","Tumour Biol. 2014 Feb;35(2):1473-80. doi: 10.1007/s13277-013-1203-3. Epub 2013 Oct 2.","Ma Q","Tumour Biol","2014","2013/10/03","","","10.1007/s13277-013-1203-3"
"27787959","Cytologic persistence of malignant cells after transurethral resection of bladder tumors: Implications for concomitant manipulation of the urinary tract at the time of endoscopic resection","Macleod LC, Pham KN, Agoff SN, Dahl KL, Pritchett TR, Corman JM.","Cancer Cytopathol. 2017 Feb;125(2):114-119. doi: 10.1002/cncy.21785. Epub 2016 Oct 27.","Macleod LC","Cancer Cytopathol","2017","2016/10/28","","","10.1002/cncy.21785"
"3464851","[Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma]","Cicigoi A, Rocca Rossetti S, Piantino P, Cerchier A.","Minerva Med. 1986 Nov 10;77(42-43):1983-7.","Cicigoi A","Minerva Med","1986","1986/11/10","","",""
"17434255","Editorial comment on: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors","Colombo R.","Eur Urol. 2007 Sep;52(3):774-5. doi: 10.1016/j.eururo.2007.03.087.","Colombo R","Eur Urol","2007","2007/04/17","","","10.1016/j.eururo.2007.03.087"
"11792917","False-positive results of the NMP22 test due to hematuria","Atsü N, Ekici S, Oge O O, Ergen A, Hasçelik G, Ozen H.","J Urol. 2002 Feb;167(2 Pt 1):555-8.","Atsü N","J Urol","2002","2002/01/17","","",""
"30102624","Current concept of transurethral resection of bladder cancer: from re-transurethral resection of bladder cancer to en-bloc resection","Schraml J, Silva JDC, Babjuk M.","Curr Opin Urol. 2018 Nov;28(6):591-597. doi: 10.1097/MOU.0000000000000542.","Schraml J","Curr Opin Urol","2018","2018/08/14","","","10.1097/MOU.0000000000000542"
"14605467","Perioperative Chemotherapy in Advanced Bladder Cancer - Part II: Adjuvant Treatment","Otto T, Goebell PJ, Rübben H.","Onkologie. 2003 Oct;26(5):484-8. doi: 10.1159/000072983.","Otto T","Onkologie","2003","2003/11/08","","","10.1159/000072983"
"10629639","Prognostic relevance of micro-vessel density in cancer of the urinary bladder","Chaudhary R, Bromley M, Clarke NW, Betts CD, Barnard RJ, Ryder WD, Kumar S.","Anticancer Res. 1999 Jul-Aug;19(4C):3479-84.","Chaudhary R","Anticancer Res","1999","2000/01/12","","",""
"7752327","The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years","Holmäng S, Hedelin H, Anderström C, Johansson SL.","J Urol. 1995 Jun;153(6):1823-6; discussion 1826-7.","Holmäng S","J Urol","1995","1995/06/01","","",""
"7569009","Intraarterial infusion of cisplatin with and without preoperative concurrent radiation for urinary bladder cancer: a preliminary report","Monzen Y, Mori H, Matsumoto S, Takaki H, Yoshida S, Wakisaka M, Ueda S, Mizoguchi H, Ogata J, Kato Y.","Radiat Med. 1995 May-Jun;13(3):149-52.","Monzen Y","Radiat Med","1995","1995/05/01","","",""
"19671025","Hexyl aminolevulinate fluorescence cystoscopy in bladder cancer","Sievert KD, Kruck S.","Expert Rev Anticancer Ther. 2009 Aug;9(8):1055-63. doi: 10.1586/era.09.73.","Sievert KD","Expert Rev Anticancer Ther","2009","2009/08/13","","","10.1586/era.09.73"
"26469956","Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer","Sun X, Du P, Yuan W, Du Z, Yu M, Yu X, Hu T.","Cell Death Dis. 2015 Oct 15;6(10):e1907. doi: 10.1038/cddis.2015.269.","Sun X","Cell Death Dis","2015","2015/10/16","PMC4632298","","10.1038/cddis.2015.269"
"30266376","Long-term Outcomes and Patterns of Failure Following Trimodality Treatment With Bladder Preservation for Invasive Bladder Cancer","Büchser D, Zapatero A, Rogado J, Talaya M, Martín de Vidales C, Arellano R, Bocardo G, Cruz Conde A, Pérez L, Murillo MT.","Urology. 2019 Feb;124:183-190. doi: 10.1016/j.urology.2018.07.058. Epub 2018 Sep 25.","Büchser D","Urology","2019","2018/09/30","","","10.1016/j.urology.2018.07.058"
"22082917","Re: effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer","Montie JE.","J Urol. 2011 Jan;185(1):103. doi: 10.1016/S0022-5347(11)60093-1.","Montie JE","J Urol","2011","2011/11/16","","","10.1016/S0022-5347(11)60093-1"
"9649299","Improved detection of recurrent bladder cancer using the bard BTA stat test","Droller MJ.","J Urol. 1998 Feb;159(2):601-2. doi: 10.1016/s0022-5347(01)63878-3.","Droller MJ","J Urol","1998","1998/07/02","","","10.1016/s0022-5347(01)63878-3"
"3437647","[Diagnosis of bladder cancer by cytogenetic method]","Mitsuhashi H, Maru A, Koyanagi T.","Nihon Hinyokika Gakkai Zasshi. 1987 Aug;78(8):1409-16. doi: 10.5980/jpnjurol1928.78.8_1409.","Mitsuhashi H","Nihon Hinyokika Gakkai Zasshi","1987","1987/08/01","","","10.5980/jpnjurol1928.78.8_1409"
"7273315","The epidemiology of bladder cancer in West Yorkshire. A preliminary report on non-occupational aetiologies","Cartwright RA, Adib R, Glashan R, Gray BK.","Carcinogenesis. 1981;2(4):343-7. doi: 10.1093/carcin/2.4.343.","Cartwright RA","Carcinogenesis","1981","1981/01/01","","","10.1093/carcin/2.4.343"
"27146766","Radiation therapy outcomes in muscle invasive urinary bladder cancer: A single institution experience","Tiwana MS, Ni LH, Saini S, Verma SK, Doddamani D, Jain N, Biswas M, Gupta M, Gupta M, Saini M, Chauhan N.","Indian J Cancer. 2016 Jan-Mar;53(1):143-6. doi: 10.4103/0019-509X.180842.","Tiwana MS","Indian J Cancer","2016","2016/05/06","","","10.4103/0019-509X.180842"
"24746580","The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART","Foroudi F, Pham D, Rolfo A, Bressel M, Tang CI, Tan A, Turner S, Hruby G, Williams S, Hayne D, Lehman M, Skala M, Jose CC, Gogna K, Kron T.","Radiother Oncol. 2014 May;111(2):316-20. doi: 10.1016/j.radonc.2014.02.015. Epub 2014 Apr 17.","Foroudi F","Radiother Oncol","2014","2014/04/22","","","10.1016/j.radonc.2014.02.015"
"3831948","[Evaluation of 2 years' results of the treatment of patients with bladder cancer by cystectomy following preoperative irradiation with 2000 rads]","Borkowski A, Krzeski T, Czaplicki M, Niemierko M, Borówka A, Gajl D, Walecki S.","Nowotwory. 1985 Oct-Dec;35(4):336-40.","Borkowski A","Nowotwory","1985","1985/10/01","","",""
"4634145","[Response of bladder cancer to radiotherapy from the histological viewpoint]","Arndt J, Albert L, Kriester A.","Strahlentherapie. 1973 Apr;145(4):361-8.","Arndt J","Strahlentherapie","1973","1973/04/01","","",""
"24366498","Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer","Luo ZG, Li ZG, Gui SL, Chi BJ, Ma JG.","J Int Med Res. 2014 Feb;42(1):35-41. doi: 10.1177/0300060513504705. Epub 2013 Dec 23.","Luo ZG","J Int Med Res","2014","2013/12/25","","","10.1177/0300060513504705"
"21320277","Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy","Kaag MG, Milowsky MI, Dalbagni G, Thompson RH, Katz D, Reuter VE, Herr HW, Bajorin D, Bochner BH.","BJU Int. 2011 Oct;108(8 Pt 2):E272-7. doi: 10.1111/j.1464-410X.2010.09981.x. Epub 2011 Feb 14.","Kaag MG","BJU Int","2011","2011/02/16","PMC4319321","NIHMS657802","10.1111/j.1464-410X.2010.09981.x"
"22561076","Re: Shahrokh F. Shariat, Behfar Ehdaie, Michael Rink, et al. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. Eur urol 2012;61:237-42","Studer UE, Sylvester R.","Eur Urol. 2012 Sep;62(3):e61-2. doi: 10.1016/j.eururo.2012.04.039. Epub 2012 Apr 24.","Studer UE","Eur Urol","2012","2012/05/08","","","10.1016/j.eururo.2012.04.039"
"7933177","Bladder cancer","Droller MJ.","J Urol. 1994 Nov;152(5 Pt 1):1434. doi: 10.1016/s0022-5347(17)32438-2.","Droller MJ","J Urol","1994","1994/11/01","","","10.1016/s0022-5347(17)32438-2"
"19553819","Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling","van der Kwast TH, Bapat B.","Curr Opin Urol. 2009 Sep;19(5):516-21. doi: 10.1097/MOU.0b013e32832eb45f.","van der Kwast TH","Curr Opin Urol","2009","2009/06/26","","","10.1097/MOU.0b013e32832eb45f"
"1258167","[Etiology and pathogenesis of bladder cancer]","Wolf H.","Ugeskr Laeger. 1976 Mar 8;138(11):647-53.","Wolf H","Ugeskr Laeger","1976","1976/03/08","","",""
"3743345","[Photodynamic therapy (PDT) of bladder cancer in the rat]","Fan XJ, Xie JG, Lin PZ, Cui W, Zhang JS, Shen H, Ha XW, Okada M.","Zhonghua Zhong Liu Za Zhi. 1986 May;8(3):181-3.","Fan XJ","Zhonghua Zhong Liu Za Zhi","1986","1986/05/01","","",""
"27720312","The surgical management of patients with clinical stage T4 bladder cancer: A single institution experience","Moschini M, Luzzago S, Zaffuto E, Dell'Oglio P, Gandaglia G, Mattei A, Damiano R, Soria F, Klatte T, Shariat SF, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R.","Eur J Surg Oncol. 2017 Apr;43(4):808-814. doi: 10.1016/j.ejso.2016.08.024. Epub 2016 Sep 28.","Moschini M","Eur J Surg Oncol","2017","2016/10/11","","","10.1016/j.ejso.2016.08.024"
"1775975","The evolving role of chemotherapy for muscle infiltrating bladder cancer","Seidman AD, Scher HI.","Semin Oncol. 1991 Dec;18(6):585-95.","Seidman AD","Semin Oncol","1991","1991/12/01","","",""
"11758874","Molecular markers for diagnosis, staging, and prognosis of bladder cancer","Williams SG, Buscarini M, Stein JP.","Oncology (Williston Park). 2001 Nov;15(11):1461-70, 1473-4, 1476; discussion 1476-84.","Williams SG","Oncology (Williston Park)","2001","2002/01/05","","",""
"7933174","Bladder cancer and the risk of smoking-related cancers during followup","Salminen E, Pukkala E, Teppo L.","J Urol. 1994 Nov;152(5 Pt 1):1420-3. doi: 10.1016/s0022-5347(17)32435-7.","Salminen E","J Urol","1994","1994/11/01","","","10.1016/s0022-5347(17)32435-7"
"9842100","Combined hyperfractionated radiotherapy and protracted infusion chemotherapy in bladder cancer for organ preservation","Saracino B, Arcangeli G, Mecozzi A, Tirindelli Danesi D, Cruciani E, Altavista P, Giannarelli D.","Clin Ter. 1998 May-Jun;149(3):183-9.","Saracino B","Clin Ter","1998","1998/12/08","","",""
"11773261","Treated natural history of superficial bladder cancer","Ozono S, Hinotsu S, Tabata S, Takashima K, Fujimoto K, Okajima E, Hirao Y, Ohashi Y, Akaza H, Fukushima S; Nara Uro-Oncology Research Group.","Jpn J Clin Oncol. 2001 Nov;31(11):536-40. doi: 10.1093/jjco/hye114.","Ozono S","Jpn J Clin Oncol","2001","2002/01/05","","","10.1093/jjco/hye114"
"8966694","[Hematuria]","Blöchlinger AM, Gasser TC, Stoffel F, Laschke S, Bühring C.","Ther Umsch. 1996 Sep;53(9):672-5.","Blöchlinger AM","Ther Umsch","1996","1996/09/01","","",""
"25842745","Diagnostic accuracy of ultrasound T-staging of the urinary bladder cancer in comparison with histology in elderly patients","Tadin T, Sotosek S, Rahelić D, Fuckar Z.","Coll Antropol. 2014 Dec;38(4):1123-6.","Tadin T","Coll Antropol","2014","2015/04/07","","",""
"11693557","Computer identification of neoplastic urothelial nuclei from the bladder","Dulewicz A, Pietka BD, Jaszczak P, Nechay A, Sawicki W, Pykalo R, Kozminska E, Borkowski A.","Anal Quant Cytol Histol. 2001 Oct;23(5):321-9.","Dulewicz A","Anal Quant Cytol Histol","2001","2001/11/06","","",""
"10696258","Vascular endothelial growth factor and its correlation with superficial bladder cancer recurrence rates and stage progression","Jones A, Crew J.","Urol Clin North Am. 2000 Feb;27(1):191-7. doi: 10.1016/s0094-0143(05)70247-0.","Jones A","Urol Clin North Am","2000","2000/03/04","","","10.1016/s0094-0143(05)70247-0"
"9382586","[Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study]","Zapatero A, Pinar B, Arellano R, López M, Marín A, Jiménez U, Pérez Torrubia A.","Arch Esp Urol. 1997 Jun;50(5):448-54; discussion 454-6.","Zapatero A","Arch Esp Urol","1997","1997/06/01","","",""
"27417036","A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria","Dahmcke CM, Steven KE, Larsen LK, Poulsen AL, Abdul-Al A, Dahl C, Guldberg P.","Eur Urol. 2016 Dec;70(6):916-919. doi: 10.1016/j.eururo.2016.06.035. Epub 2016 Jul 11.","Dahmcke CM","Eur Urol","2016","2016/07/16","","","10.1016/j.eururo.2016.06.035"
"3228309","[Low-pressure enterocystoplasty in bladder cancer. Preliminary results with a new technical modification]","Romero Maroto J, Perales Cabanas L, Ruiz de Zárate C, Escudero Barrilero A.","Arch Esp Urol. 1988 Nov-Dec;41(9):839-44.","Romero Maroto J","Arch Esp Urol","1988","1988/11/01","","",""
"25171275","Biomarkers in patients treated with BCG: an update","Klap J, Schmid M, Loughlin KR.","Can J Urol. 2014 Aug;21(4):7335-43.","Klap J","Can J Urol","2014","2014/08/30","","",""
"17987763","Urological implications of concurrent bladder and lung cancer","Vainrib M, Leibovitch I.","Isr Med Assoc J. 2007 Oct;9(10):732-5.","Vainrib M","Isr Med Assoc J","2007","2007/11/09","","",""
"27644620","Chronic Infections of the Urinary Tract and Bladder Cancer Risk: a Systematic Review","Anderson-Otunu O, Akhtar S.","Asian Pac J Cancer Prev. 2016;17(8):3805-7.","Anderson-Otunu O","Asian Pac J Cancer Prev","2016","2016/09/21","","",""
"7847776","The pathologist's role in multidisciplinary management of bladder cancer","Szakacs JE, Pow-Sang J.","Ann Clin Lab Sci. 1994 Nov-Dec;24(6):481-8.","Szakacs JE","Ann Clin Lab Sci","1994","1994/11/01","","",""
"25536294","Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy","Yang G, Tan Z, Lu W, Guo J, Yu H, Yu J, Sun C, Qi X, Li Z, Guan F.","J Proteome Res. 2015 Feb 6;14(2):639-53. doi: 10.1021/pr5006026. Epub 2015 Jan 8.","Yang G","J Proteome Res","2015","2014/12/24","","","10.1021/pr5006026"
"5137331","The histogenesis of experimental bladder cancer","Tiltman AJ, Friedell GH.","Invest Urol. 1971 Nov;9(3):218-26.","Tiltman AJ","Invest Urol","1971","1971/11/01","","",""
"28753799","A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study","Davis N, Shtabsky A, Lew S, Rona R, Leibovitch I, Nativ O, Cohen M, Mor Y, Lindner U, Glickman Y, Matzkin H, Tsivian A, Gofrit O, Yossepovitch O.","Eur Urol Focus. 2018 Apr;4(3):388-394. doi: 10.1016/j.euf.2016.10.004. Epub 2016 Oct 31.","Davis N","Eur Urol Focus","2018","2017/07/30","","","10.1016/j.euf.2016.10.004"
"29516933","Does preoperative neutrophil/lymphocyte rate have an effect on survival of the bladder cancer patients who received radical cystectomy?","Ün S, Türk H, Dindar AS, Zorlu F.","J Cancer Res Ther. 2018 Jan-Mar;14(2):432-436. doi: 10.4103/0973-1482.183555.","Ün S","J Cancer Res Ther","2018","2018/03/09","","","10.4103/0973-1482.183555"
"1999842","Problems in cancer surveillance: delineating in situ and invasive bladder cancer","Hankey BF, Edwards BK, Ries LA, Percy CL, Shambaugh E.","J Natl Cancer Inst. 1991 Mar 20;83(6):384-5. doi: 10.1093/jnci/83.6.384.","Hankey BF","J Natl Cancer Inst","1991","1991/03/20","","","10.1093/jnci/83.6.384"
"12477660","Assessing the use of p16(INK4a) promoter gene methylation in serum for detection of bladder cancer","Valenzuela MT, Galisteo R, Zuluaga A, Villalobos M, Núñez MI, Oliver FJ, Ruiz de Almodóvar JM.","Eur Urol. 2002 Dec;42(6):622-8; discussion 628-30. doi: 10.1016/s0302-2838(02)00468-2.","Valenzuela MT","Eur Urol","2002","2002/12/13","","","10.1016/s0302-2838(02)00468-2"
"20219549","Adaptive management of bladder cancer radiotherapy","Pos F, Remeijer P.","Semin Radiat Oncol. 2010 Apr;20(2):116-20. doi: 10.1016/j.semradonc.2009.11.005.","Pos F","Semin Radiat Oncol","2010","2010/03/12","","","10.1016/j.semradonc.2009.11.005"
"8862995","Arsenic and bladder cancer mortality","Brown KG, Beck BD.","Epidemiology. 1996 Sep;7(5):557-8. doi: 10.1097/00001648-199609000-00024.","Brown KG","Epidemiology","1996","1996/09/01","","","10.1097/00001648-199609000-00024"
"21780300","Cross-polarization optical coherence tomography for early bladder-cancer detection: statistical study","Gladkova N, Streltsova O, Zagaynova E, Kiseleva E, Gelikonov V, Gelikonov G, Karabut M, Yunusova K, Evdokimova O.","J Biophotonics. 2011 Aug;4(7-8):519-32. doi: 10.1002/jbio.201000088. Epub 2010 Nov 22.","Gladkova N","J Biophotonics","2011","2011/07/23","","","10.1002/jbio.201000088"
"27122461","[Selective bladder preservation in muscle-invasive bladder cancer by transurethral resection combined with intravesical instillation therapy: analysis of clinical effect in the elderly]","Zhou XF, Ding ZS, Fang DB, Wang JF, Chen X, Fang ZL, Liu NB.","Zhonghua Yi Xue Za Zhi. 2016 Apr 26;96(16):1278-80. doi: 10.3760/cma.j.issn.0376-2491.2016.16.011.","Zhou XF","Zhonghua Yi Xue Za Zhi","2016","2016/04/29","","","10.3760/cma.j.issn.0376-2491.2016.16.011"
"17669597","Allogeneic stem cells seeded tissue engineered bladder: a possible alternative for bladder reconstruction and treatment to bladder cancer","Yinan Z, Guomin W.","Med Hypotheses. 2008;70(2):294-7. doi: 10.1016/j.mehy.2007.05.046. Epub 2007 Jul 31.","Yinan Z","Med Hypotheses","2008","2007/08/03","","","10.1016/j.mehy.2007.05.046"
"18203523","Clinical outcome of conservative therapy with transurethral resection for patients with invasive bladder cancer who cannot tolerate cystectomy","Akamatsu S, Kanamaru S, Takenawa J, Soeda A.","Hinyokika Kiyo. 2007 Dec;53(12):863-8.","Akamatsu S","Hinyokika Kiyo","2007","2008/01/22","","",""
"31499716","BCG and IL - 2 model for bladder cancer treatment with fast and slow dynamics based on SPVF method-stability analysis","Nave O, Hareli S, Elbaz M, Iluz IH, Bunimovich-Mendrazitsky S.","Math Biosci Eng. 2019 Jun 11;16(5):5346-5379. doi: 10.3934/mbe.2019267.","Nave O","Math Biosci Eng","2019","2019/09/11","","","10.3934/mbe.2019267"
"26782465","Serum Dickkopf-1 levels as a clinical and prognostic factor in patients with bladder cancer","Sun DK, Wang L, Wang JM, Zhang P.","Genet Mol Res. 2015 Dec 28;14(4):18181-7. doi: 10.4238/2015.December.23.5.","Sun DK","Genet Mol Res","2015","2016/01/20","","","10.4238/2015.December.23.5"
"3343756","Treatment of experimental bladder cancer with hyperthermia and phase transition liposomes containing methotrexate","Bassett JB, Tacker JR, Anderson RU, Bostwick D.","J Urol. 1988 Mar;139(3):634-6. doi: 10.1016/s0022-5347(17)42548-1.","Bassett JB","J Urol","1988","1988/03/01","","","10.1016/s0022-5347(17)42548-1"
"25461441","Fruits, vegetables, and bladder cancer risk: a systematic review and meta-analysis","Vieira AR, Vingeliene S, Chan DS, Aune D, Abar L, Navarro Rosenblatt D, Greenwood DC, Norat T.","Cancer Med. 2015 Jan;4(1):136-46. doi: 10.1002/cam4.327. Epub 2014 Dec 2.","Vieira AR","Cancer Med","2015","2014/12/03","PMC4312127","","10.1002/cam4.327"
"8558639","Initial evaluation of the bladder tumor antigen test in superficial bladder cancer","D'Hallewin MA, Baert L.","J Urol. 1996 Feb;155(2):475-6.","D'Hallewin MA","J Urol","1996","1996/02/01","","",""
"22716484","Branched peptides as novel tumor-targeting agents for bladder cancer","Minervini A, Siena G, Falciani C, Carini M, Bracci L.","Expert Rev Anticancer Ther. 2012 Jun;12(6):699-701. doi: 10.1586/era.12.57.","Minervini A","Expert Rev Anticancer Ther","2012","2012/06/22","","","10.1586/era.12.57"
"26524350","Adequacy in voided urine cytology specimens: The role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma","VandenBussche CJ, Rosenthal DL, Olson MT.","Cancer Cytopathol. 2016 Mar;124(3):174-80. doi: 10.1002/cncy.21634. Epub 2015 Nov 2.","VandenBussche CJ","Cancer Cytopathol","2016","2015/11/03","","","10.1002/cncy.21634"
"2675009","Chemotherapy of advanced bladder cancer","Hall RR, Roberts JT.","Prog Clin Biol Res. 1989;303:525-31.","Hall RR","Prog Clin Biol Res","1989","1989/01/01","","",""
"2217408","Neoadjuvant chemotherapy in invasive bladder cancer. Trial design","Parmer MK.","Prog Clin Biol Res. 1990;353:115-8.","Parmer MK","Prog Clin Biol Res","1990","1990/01/01","","",""
"21699616","Use of cone-beam computed tomography to characterize daily urinary bladder variations during fractionated radiotherapy for canine bladder cancer","Nieset JR, Harmon JF, Larue SM.","Vet Radiol Ultrasound. 2011 Sep-Oct;52(5):580-8. doi: 10.1111/j.1740-8261.2011.01838.x. Epub 2011 Jun 23.","Nieset JR","Vet Radiol Ultrasound","2011","2011/06/25","","","10.1111/j.1740-8261.2011.01838.x"
"19176204","Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality","Donat SM.","J Natl Compr Canc Netw. 2009 Jan;7(1):40-7. doi: 10.6004/jnccn.2009.0003.","Donat SM","J Natl Compr Canc Netw","2009","2009/01/30","","","10.6004/jnccn.2009.0003"
"1785002","Prophylactic instillation therapy of superficial bladder cancer. A randomized study comparing mitomycin C and adriamycin with special reference to DNA ploidy","Gustafson H, Wijkström H, Nyman C, Brolin J, Borgström E, Tribukait B.","Scand J Urol Nephrol Suppl. 1991;138:187-91.","Gustafson H","Scand J Urol Nephrol Suppl","1991","1991/01/01","","",""
"9471737","[Intravesical immunotherapy with BCG vaccine in superficial carcinoma of the urinary bladder]","Pacík D, Vít V, Turjanica M.","Rozhl Chir. 1997 Oct;76(10):482-5.","Pacík D","Rozhl Chir","1997","1998/02/21","","",""
"27846935","[CCAFU french national guidelines 2016-2018 on bladder cancer]","Rouprêt M, Neuzillet Y, Masson-Lecomte A, Colin P, Compérat E, Dubosq F, Houédé N, Larré S, Pignot G, Puech P, Roumiguié M, Xylinas E, Méjean A.","Prog Urol. 2016 Nov;27 Suppl 1:S67-S91. doi: 10.1016/S1166-7087(16)30704-7.","Rouprêt M","Prog Urol","2016","2016/11/17","","","10.1016/S1166-7087(16)30704-7"
"9114525","[Radiotherapy and chemotherapy in infiltrating bladder tumors]","Durdux C, Housset M.","Rev Prat. 1997 Feb 15;47(4):392-5.","Durdux C","Rev Prat","1997","1997/02/15","","",""
"6702036","Sex-dependent variations in natural history of transitional cell carcinoma of bladder","Laor E, Schiffman Z, Reid RE, Tolia BM, Freed SZ.","Urology. 1984 Mar;23(3):237-9. doi: 10.1016/s0090-4295(84)90036-0.","Laor E","Urology","1984","1984/03/01","","","10.1016/s0090-4295(84)90036-0"
"26232112","Do amount of variant differentiation and mitotic rate in bladder cancer change with neoadjuvant chemotherapy?","Shen HM, D'Souza AM, Green IF, Pohar KS, Mortazavi A, Zynger DL.","Hum Pathol. 2015 Sep;46(9):1367-75. doi: 10.1016/j.humpath.2015.05.020. Epub 2015 Jun 4.","Shen HM","Hum Pathol","2015","2015/08/02","","","10.1016/j.humpath.2015.05.020"
"28199978","Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway","Pei Z, Du X, Song Y, Fan L, Li F, Gao Y, Wu R, Chen Y, Li W, Zhou H, Yang Y, Zeng J.","Oncotarget. 2017 Mar 14;8(11):18145-18153. doi: 10.18632/oncotarget.15210.","Pei Z","Oncotarget","2017","2017/02/16","PMC5392314","","10.18632/oncotarget.15210"
"12074795","Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue","Berger AP, Parson W, Stenzl A, Steiner H, Bartsch G, Klocker H.","Eur Urol. 2002 May;41(5):532-9. doi: 10.1016/s0302-2838(02)00073-8.","Berger AP","Eur Urol","2002","2002/06/21","","","10.1016/s0302-2838(02)00073-8"
"25533099","Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena","Bryan RT.","Philos Trans R Soc Lond B Biol Sci. 2015 Feb 5;370(1661):20140042. doi: 10.1098/rstb.2014.0042.","Bryan RT","Philos Trans R Soc Lond B Biol Sci","2015","2014/12/24","PMC4275911","","10.1098/rstb.2014.0042"
"11167630","The management of superficial bladder cancer","Oosterlinck W.","BJU Int. 2001 Jan;87(2):135-40. doi: 10.1046/j.1464-410x.2001.00948.x.","Oosterlinck W","BJU Int","2001","2001/02/13","","","10.1046/j.1464-410x.2001.00948.x"
"3898140","BCG in the management of superficial bladder cancer","Robinson MR.","Prog Clin Biol Res. 1985;185B:161-6.","Robinson MR","Prog Clin Biol Res","1985","1985/01/01","","",""
"2201046","Immune modifiers in the treatment of bladder cancer","Morales A.","Prog Clin Biol Res. 1990;350:25-33.","Morales A","Prog Clin Biol Res","1990","1990/01/01","","",""
"12628839","The role of pelvic lymph node dissection as a predictive and prognostic factor in bladder cancer","Knap MM, Lundbeck F, Overgaard J.","Eur J Cancer. 2003 Mar;39(5):604-13. doi: 10.1016/s0959-8049(02)00768-2.","Knap MM","Eur J Cancer","2003","2003/03/12","","","10.1016/s0959-8049(02)00768-2"
"9844397","[Analysis of the prognostic factor in the patients with locally invasive bladder cancer who underwent total cystectomy]","Noguchi S, Takase K, Kubota Y, Uemura H, Saitoh K, Masuda M, Yao M, Hosaka M.","Nihon Hinyokika Gakkai Zasshi. 1998 Oct;89(10):816-22. doi: 10.5980/jpnjurol1989.89.816.","Noguchi S","Nihon Hinyokika Gakkai Zasshi","1998","1998/12/09","","","10.5980/jpnjurol1989.89.816"
"30308033","Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy","Yu A, Mansure JJ, Solanki S, Siemens DR, Koti M, Dias ABT, Burnier MM, Brimo F, Kassouf W.","PLoS One. 2018 Oct 11;13(10):e0205746. doi: 10.1371/journal.pone.0205746. eCollection 2018.","Yu A","PLoS One","2018","2018/10/12","PMC6181418","","10.1371/journal.pone.0205746"
"4230274","Cancer of the bladder","Wallace D.","Am J Roentgenol Radium Ther Nucl Med. 1968 Mar;102(3):581-6. doi: 10.2214/ajr.102.3.581.","Wallace D","Am J Roentgenol Radium Ther Nucl Med","1968","1968/03/01","","","10.2214/ajr.102.3.581"
"28248058","[Robot-assisted cystprostatectomy for urinary bladder cancer (the first experience)]","Yarmoshchuk SV, Kudryavtsev AS, Zeravin AA, Drobyazgin EA, Arkhipov AN.","Urologiia. 2016 Dec;(6):132-135.","Yarmoshchuk SV","Urologiia","2016","2017/03/02","","",""
"21870644","Homozygous deletion of the FHIT gene, p21WAF1 protein expression and apoptosis in bilharzial bladder cancer","Ghaleb KI, Alkaladi A.","Pak J Biol Sci. 2011 Feb 1;14(3):212-8. doi: 10.3923/pjbs.2011.212.218.","Ghaleb KI","Pak J Biol Sci","2011","2011/08/30","","","10.3923/pjbs.2011.212.218"
"1520584","The induction of bladder cancer in portally diverted rats","Jaffe V, Alexander B, Price AB, Zanelli GD.","Br J Cancer. 1992 Sep;66(3):470-3. doi: 10.1038/bjc.1992.297.","Jaffe V","Br J Cancer","1992","1992/09/01","PMC1977933","","10.1038/bjc.1992.297"
"23911603","Muscle invasive bladder cancer: examining survivor burden and unmet needs","Mohamed NE, Chaoprang Herrera P, Hudson S, Revenson TA, Lee CT, Quale DZ, Zarcadoolas C, Hall SJ, Diefenbach MA.","J Urol. 2014 Jan;191(1):48-53. doi: 10.1016/j.juro.2013.07.062. Epub 2013 Jul 30.","Mohamed NE","J Urol","2014","2013/08/06","PMC4286331","NIHMS649588","10.1016/j.juro.2013.07.062"
"29660813","Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States","Jazzar U, Yong S, Klaassen Z, Huo J, Hughes BD, Esparza E, Mehta HB, Kim SP, Tyler DS, Freedland SJ, Kamat AM, Wolf DV, Williams SB.","Cancer. 2018 Aug 1;124(15):3127-3135. doi: 10.1002/cncr.31404. Epub 2018 Apr 16.","Jazzar U","Cancer","2018","2018/04/17","PMC6097900","NIHMS955351","10.1002/cncr.31404"
"2593109","[Comparison of MRI and CT X-ray in the evaluation of bladder cancer. Apropos of 26 cases]","Chiche JF, Dao TH, Hélénon O, Di Stéfano D, Moreau JF.","J Radiol. 1989 Oct;70(10):529-39.","Chiche JF","J Radiol","1989","1989/10/01","","",""
"23395237","Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer","Song YH, Shiota M, Yokomizo A, Uchiumi T, Kiyoshima K, Kuroiwa K, Oda Y, Naito S.","Urol Oncol. 2014 Jan;32(1):31.e1-7. doi: 10.1016/j.urolonc.2012.11.003. Epub 2013 Feb 6.","Song YH","Urol Oncol","2014","2013/02/12","","","10.1016/j.urolonc.2012.11.003"
"31500788","Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer","Bao Y, Liu X, Liu Y, Wang S, Wu B.","Surg Oncol. 2019 Sep;30:63-71. doi: 10.1016/j.suronc.2019.05.009. Epub 2019 May 20.","Bao Y","Surg Oncol","2019","2019/09/11","","","10.1016/j.suronc.2019.05.009"
"17969414","[An evaluation of damage caused by radiation and chemical drugs to urinary bladder mucosa in stage T1-T2N0V0 cancer]","Kaprin AD, Pan'shin GA, Garmash SV, Kostin AA, Khmelevskiĭ EV, Elagin VO.","Vopr Onkol. 2007;53(4):473-6.","Kaprin AD","Vopr Onkol","2007","2007/11/01","","",""
"1711089","Combination radiotherapy of urinary bladder carcinoma with chemohyperthermia","Matsui K, Takebayashi S, Watai K, Kakehi M, Kubota Y, Yao M, Shuin T.","Int J Hyperthermia. 1991 Jan-Feb;7(1):19-26. doi: 10.3109/02656739109004973.","Matsui K","Int J Hyperthermia","1991","1991/01/01","","","10.3109/02656739109004973"
"17627172","A comparison of the platinum analogues in bladder cancer cell lines","Powles T, Perry J, Shamash J, Liu W, Oliver T, Joel S.","Urol Int. 2007;79(1):67-72. doi: 10.1159/000102917.","Powles T","Urol Int","2007","2007/07/14","","","10.1159/000102917"
"24401582","[Application of apparent diffusion coefficient ratio in the diagnosis of bladder cancer grading pre-operation]","Zhou GX, Wang YB, Hao NX, Wu YW, Zhu JQ, Wang B, Wang ZQ, Tao XF.","Zhonghua Yi Xue Za Zhi. 2013 Oct 8;93(37):2953-6.","Zhou GX","Zhonghua Yi Xue Za Zhi","2013","2014/01/10","","",""
"24282982","T1 high-grade bladder cancer recurring after BCG therapy: radical cystectomy is still the best approach. Pro","Clark PE.","Oncology (Williston Park). 2013 Sep;27(9):872, 921.","Clark PE","Oncology (Williston Park)","2013","2013/11/29","","",""
"24410904","Malnourishment in bladder cancer and the role of immunonutrition at the time of cystectomy: an overview for urologists","Munbauhal G, Drouin SJ, Mozer P, Colin P, Phé V, Cussenot O, Rouprêt M.","BJU Int. 2014 Aug;114(2):177-84. doi: 10.1111/bju.12529. Epub 2014 Feb 20.","Munbauhal G","BJU Int","2014","2014/01/14","","","10.1111/bju.12529"
"6875981","Diagnosis, management and follow-up of patients with bladder cancer (1978-1979). A multidisciplinary approach","Hindmarsh JR, Theodorou C, Hargreave TB, Webb J, Busuttil A, Newsam JE, Chisholm GD.","J R Coll Surg Edinb. 1983 May;28(3):135-40.","Hindmarsh JR","J R Coll Surg Edinb","1983","1983/05/01","","",""
"83732","[Late results of the combined treatment of bladder cancer depending on the histological form of the tumor]","Goĭkhberg MI, Romanenko AM, Zaparin VK, Klimenko IA.","Vopr Onkol. 1978;24(12):73-6.","Goĭkhberg MI","Vopr Onkol","1978","1978/01/01","","",""
"27428265","Innovation in Bladder Cancer Immunotherapy","Grossman HB, Lamm DL, Kamat AM, Keefe S, Taylor JA 3rd, Ingersoll MA.","J Immunother. 2016 Oct;39(8):291-7. doi: 10.1097/CJI.0000000000000130.","Grossman HB","J Immunother","2016","2016/07/19","","","10.1097/CJI.0000000000000130"
"18248875","Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer","Herr HW.","Eur Urol. 2008 Jul;54(1):126-32. doi: 10.1016/j.eururo.2007.12.031. Epub 2007 Dec 27.","Herr HW","Eur Urol","2008","2008/02/06","","","10.1016/j.eururo.2007.12.031"
"27211289","Comparative Effectiveness of a Patient Centered Pathology Report for Bladder Cancer Care","Mossanen M, Macleod LC, Chu A, Wright JL, Dalkin B, Lin DW, True L, Gore JL.","J Urol. 2016 Nov;196(5):1383-1389. doi: 10.1016/j.juro.2016.05.083. Epub 2016 May 19.","Mossanen M","J Urol","2016","2016/05/24","","","10.1016/j.juro.2016.05.083"
"4179723","Palliative treatment of carcinoma of the urinary bladder","Silber I, Bowles WT, Cordonnier JJ.","Cancer. 1969 Mar;23(3):586-8. doi: 10.1002/1097-0142(196903)23:3<586::aid-cncr2820230309>3.0.co;2-u.","Silber I","Cancer","1969","1969/03/01","","","10.1002/1097-0142(196903)23:3<586::aid-cncr2820230309>3.0.co;2-u"
"2409650","[Parameters of incurability in urinary bladder cancer]","Egghart G, Schutz AJ, Altwein JE.","Urol Int. 1985;40(3):121-7. doi: 10.1159/000281064.","Egghart G","Urol Int","1985","1985/01/01","","","10.1159/000281064"
"20059769","Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer","Kim WJ, Kim EJ, Kim SK, Kim YJ, Ha YS, Jeong P, Kim MJ, Yun SJ, Lee KM, Moon SK, Lee SC, Cha EJ, Bae SC.","Mol Cancer. 2010 Jan 8;9:3. doi: 10.1186/1476-4598-9-3.","Kim WJ","Mol Cancer","2010","2010/01/12","PMC2821358","","10.1186/1476-4598-9-3"
"27564278","Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study","Favilla V, Castelli T, Urzì D, Reale G, Privitera S, Salici A, Russo GI, Cimino S, Morgia G.","Int Braz J Urol. 2016 Jul-Aug;42(4):685-93. doi: 10.1590/S1677-5538.IBJU.2015.0243.","Favilla V","Int Braz J Urol","2016","2016/08/27","PMC5006763","","10.1590/S1677-5538.IBJU.2015.0243"
"31251717","Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma","Kuroiwa K, Inokuchi J, Nishiyama H, Kojima T, Kakehi Y, Sugimoto M, Tanigawa T, Fujimoto H, Gotoh M, Masumori N, Ogawa O, Eto M, Ohyama C, Yokomizo A, Matsuyama H, Ichikawa T, Mizusawa J, Eba J, Naito S; JCOG UOSG.","J Urol. 2019 Dec;202(6):1127-1135. doi: 10.1097/JU.0000000000000422. Epub 2019 Jun 28.","Kuroiwa K","J Urol","2019","2019/06/29","","","10.1097/JU.0000000000000422"
"25361801","Predictors of outcome in bladder cancer","Eifler JB, Barocas DA, Resnick MJ.","J Natl Compr Canc Netw. 2014 Nov;12(11):1549-54. doi: 10.6004/jnccn.2014.0154.","Eifler JB","J Natl Compr Canc Netw","2014","2014/11/02","","","10.6004/jnccn.2014.0154"
"16566813","A re-staging transurethral resection predicts early progression of superficial bladder cancer","Herr HW, Donat SM.","BJU Int. 2006 Jun;97(6):1194-8. doi: 10.1111/j.1464-410X.2006.06145.x. Epub 2006 Mar 23.","Herr HW","BJU Int","2006","2006/03/29","","","10.1111/j.1464-410X.2006.06145.x"
"10422436","[A clinical study of bladder cancer in adolescent patients]","Kawaguchi T, Hashimoto Y, Kobayashi H, Kudoh S, Takahashi S, Yanagisawa T, Mikuni T, Kido K, Kudo T.","Nihon Hinyokika Gakkai Zasshi. 1999 Jun;90(6):614-8. doi: 10.5980/jpnjurol1989.90.614.","Kawaguchi T","Nihon Hinyokika Gakkai Zasshi","1999","1999/07/28","","","10.5980/jpnjurol1989.90.614"
"8565663","Clinical application of monoclonal antibody-drug conjugate to immunotargeting chemotherapy of bladder cancer","Li L, Zhang Y, Lin Q, Li C, He M.","Chin Med J (Engl). 1995 Oct;108(10):764-8.","Li L","Chin Med J (Engl)","1995","1995/10/01","","",""
"18384578","Health-related quality of life after bladder preservation therapy for muscle invasive bladder cancer","Hashine K, Miura N, Numata K, Shirato A, Sumiyoshi Y, Kataoka M.","Int J Urol. 2008 May;15(5):403-6. doi: 10.1111/j.1442-2042.2008.02032.x. Epub 2008 Mar 27.","Hashine K","Int J Urol","2008","2008/04/04","","","10.1111/j.1442-2042.2008.02032.x"
"9879827","Host genes affecting survival period of chemically induced bladder cancer in mice","Higashi S, Murai T, Mori S, Kamoto T, Yoshitomi M, Arakawa Y, Makino S, Fukushima S, Yoshida O, Hiai H.","J Cancer Res Clin Oncol. 1998;124(12):670-6. doi: 10.1007/s004320050230.","Higashi S","J Cancer Res Clin Oncol","1998","1999/01/08","","","10.1007/s004320050230"
"30148753","A risk-stratified approach to the management of high-grade T1 bladder cancer","Mannas MP, Lee T, Nykopp TK, Batista da Costa J, Black PC.","Curr Opin Urol. 2018 Nov;28(6):563-569. doi: 10.1097/MOU.0000000000000548.","Mannas MP","Curr Opin Urol","2018","2018/08/28","","","10.1097/MOU.0000000000000548"
"17492411","[Interdisciplinary strategies for the treatment of bladder cancer]","Bauer W, Lamche M, Schramek P.","Wien Med Wochenschr. 2007;157(7-8):153-6. doi: 10.1007/s10354-007-0399-3.","Bauer W","Wien Med Wochenschr","2007","2007/05/12","","","10.1007/s10354-007-0399-3"
"23559138","[Second-line intravesical therapy. What is the present role of device-assisted therapy?]","Racioppi M, D'Agostino D, Gianfrancesco LD, Bassi PF.","Urologia. 2013;80 Suppl 21:37-41. doi: 10.5301/RU.2013.10863. Epub 2013 Mar 22.","Racioppi M","Urologia","2013","2013/04/06","","","10.5301/RU.2013.10863"
"9308492","Bladder cancer within an inguinoscrotal bladder hernia","Darío Casas J, Mariscal A, Gallart A.","AJR Am J Roentgenol. 1997 Oct;169(4):1194-5. doi: 10.2214/ajr.169.4.9308492.","Darío Casas J","AJR Am J Roentgenol","1997","1997/10/06","","","10.2214/ajr.169.4.9308492"
"2686724","The Copenhagen case-control study of bladder cancer. V. Review of the role of urinary-tract infection","Kjaer SK, Knudsen JB, Sørensen BL, Møller Jensen O.","Acta Oncol. 1989;28(5):631-6. doi: 10.3109/02841868909092283.","Kjaer SK","Acta Oncol","1989","1989/01/01","","","10.3109/02841868909092283"
"10460403","When the bladder is gone: quality of life following different types of urinary diversion","Månsson A, Månsson W.","World J Urol. 1999 Aug;17(4):211-8. doi: 10.1007/s003450050135.","Månsson A","World J Urol","1999","1999/08/25","","","10.1007/s003450050135"
"26181353","Benefits of Adjuvant Chemotherapy for Bladder Cancer","Booth CM, Tannock IF.","JAMA Oncol. 2015 Sep;1(6):727-8. doi: 10.1001/jamaoncol.2015.1210.","Booth CM","JAMA Oncol","2015","2015/07/17","","","10.1001/jamaoncol.2015.1210"
"30401719","High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer","Garinet S, Pignot G, Vacher S, Le Goux C, Schnitzler A, Chemlali W, Sirab N, Barry Delongchamps N, Zerbib M, Sibony M, Allory Y, Damotte D, Bieche I.","Mol Cancer Res. 2019 Feb;17(2):469-475. doi: 10.1158/1541-7786.MCR-18-0363. Epub 2018 Nov 6.","Garinet S","Mol Cancer Res","2019","2018/11/08","","","10.1158/1541-7786.MCR-18-0363"
"30741647","[Usefulness of photodynamic diagnosis in high-grade Bladder Cancer and subsequent BCG failure. Bibliographic review.]","Gómez Rivas J, Eguibar Gonzalez A, Tortolero Blanco L, Aguilera Bazán A, Martínez-Piñeiro L, Sánchez-Salas R.","Arch Esp Urol. 2019 Jan;72(1):2-8.","Gómez Rivas J","Arch Esp Urol","2019","2019/02/12","","",""
"7941173","[Applications for lasers in carcinoma of the urinary bladder]","Hofstetter A.","Urologe A. 1994 Jul;33(4):288-90.","Hofstetter A","Urologe A","1994","1994/07/01","","",""
"8893867","Pathology and staging of bladder cancer","Bane BL, Rao JY, Hemstreet GP.","Semin Oncol. 1996 Oct;23(5):546-70.","Bane BL","Semin Oncol","1996","1996/10/01","","",""
"12917631","Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome","Sanchez-Carbayo M, Schwarz K, Charytonowicz E, Cordon-Cardo C, Mundel P.","Oncogene. 2003 Aug 14;22(34):5298-305. doi: 10.1038/sj.onc.1206616.","Sanchez-Carbayo M","Oncogene","2003","2003/08/15","","","10.1038/sj.onc.1206616"
"30756528","Cigarette smoking promotes bladder cancer via increased platelet-activating factor","Kispert S, Marentette J, McHowat J.","Physiol Rep. 2019 Feb;7(3):e13981. doi: 10.14814/phy2.13981.","Kispert S","Physiol Rep","2019","2019/02/14","PMC6372534","","10.14814/phy2.13981"
"18815921","Radiation-associated urinary bladder cancer","Hall P.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):85-8. doi: 10.1080/03008880802401423.","Hall P","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802401423"
"25254936","Clinical outcomes of cT1 micropapillary bladder cancer","Willis DL, Fernandez MI, Dickstein RJ, Parikh S, Shah JB, Pisters LL, Guo CC, Henderson S, Czerniak BA, Grossman HB, Dinney CP, Kamat AM.","J Urol. 2015 Apr;193(4):1129-34. doi: 10.1016/j.juro.2014.09.092. Epub 2014 Sep 22.","Willis DL","J Urol","2015","2014/09/26","PMC4687395","NIHMS740996","10.1016/j.juro.2014.09.092"
"7786818","The treatment of advanced bladder cancer","Sternberg CN.","Ann Oncol. 1995 Feb;6(2):113-26. doi: 10.1093/oxfordjournals.annonc.a059105.","Sternberg CN","Ann Oncol","1995","1995/02/01","","","10.1093/oxfordjournals.annonc.a059105"
"30268632","Bladder cancer knowledge in the Lebanese population: When ignorance could be harmful","Souaid T, Hindy JR, Eid R, Kourie HR, Kattan J.","Bull Cancer. 2018 Oct;105(10):857-861. doi: 10.1016/j.bulcan.2018.08.004. Epub 2018 Sep 26.","Souaid T","Bull Cancer","2018","2018/10/01","","","10.1016/j.bulcan.2018.08.004"
"2780661","Treatment of invasive bladder cancer (lymph node negative, metastases negative)","Chisholm GD.","Prog Clin Biol Res. 1989;303:559-61.","Chisholm GD","Prog Clin Biol Res","1989","1989/01/01","","",""
"1399731","Combined pre- and postoperative adjuvant radiation therapy for bladder cancer--a ten year experience","Reisinger SA, Mohiuddin M, Mulholland SG.","Int J Radiat Oncol Biol Phys. 1992;24(3):463-8. doi: 10.1016/0360-3016(92)91060-z.","Reisinger SA","Int J Radiat Oncol Biol Phys","1992","1992/01/01","","","10.1016/0360-3016(92)91060-z"
"23796420","miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1","Lin Y, Chen H, Hu Z, Mao Y, Xu X, Zhu Y, Xu X, Wu J, Li S, Mao Q, Zheng X, Xie L.","FEBS Lett. 2013 Aug 2;587(15):2467-73. doi: 10.1016/j.febslet.2013.06.021. Epub 2013 Jun 22.","Lin Y","FEBS Lett","2013","2013/06/26","","","10.1016/j.febslet.2013.06.021"
"28895415","Hyaluronic acid/ Hyaluronidase as biomarkers for bladder cancer: a diagnostic meta-analysis","Liang Z, Zhang Q, Wang C, Shi F, Cao H, Yu Y, Zhang M, Liu X.","Neoplasma. 2017;64(6):901-908. doi: 10.4149/neo_2017_612.","Liang Z","Neoplasma","2017","2017/09/13","","","10.4149/neo_2017_612"
"11416957","Cystitis glandularis mimics bladder cancer--three case reports and literature review","Lin HY, Wu WJ, Jang MY, Shen JT, Tsai HN, Chou YH, Huang CH.","Kaohsiung J Med Sci. 2001 Feb;17(2):102-6.","Lin HY","Kaohsiung J Med Sci","2001","2001/06/22","","",""
"2218562","Neoadjuvant treatment of invasive bladder cancer","","Semin Oncol. 1990 Oct;17(5):515-638.","","Semin Oncol","1990","1990/10/01","","",""
"22825520","Predictive value of maspin and Ki-67 expression in transurethral resection specimens in patients with T1 bladder cancer","Acikalin D, Oner U, Can C, Acikalin MF, Colak E.","Tumori. 2012 May-Jun;98(3):344-50. doi: 10.1700/1125.12403.","Acikalin D","Tumori","2012","2012/07/25","","","10.1700/1125.12403"
"28578683","Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study","Peng D, Gong YQ, Hao H, He ZS, Li XS, Zhang CJ, Zhou LQ.","BMC Cancer. 2017 Jun 2;17(1):391. doi: 10.1186/s12885-017-3372-8.","Peng D","BMC Cancer","2017","2017/06/06","PMC5455109","","10.1186/s12885-017-3372-8"
"26051783","Biological determinants of bladder cancer gene expression subtypes","Aine M, Eriksson P, Liedberg F, Sjödahl G, Höglund M.","Sci Rep. 2015 Jun 8;5:10957. doi: 10.1038/srep10957.","Aine M","Sci Rep","2015","2015/06/09","PMC4650643","","10.1038/srep10957"
"27977784","High Expression of Derlin-1 Is Associated with the Malignancy of Bladder Cancer in a Chinese Han Population","Wu Z, Wang C, Zhang Z, Liu W, Xu H, Wang H, Wang Y, Zhang W, Wang SL.","PLoS One. 2016 Dec 15;11(12):e0168351. doi: 10.1371/journal.pone.0168351. eCollection 2016.","Wu Z","PLoS One","2016","2016/12/16","PMC5158059","","10.1371/journal.pone.0168351"
"20514302","Pattern of failure in bladder cancer patients treated with radical cystectomy: rationale for adjuvant radiotherapy","Kim YB, Hong SJ, Yang SC, Cho JH, Choi YD, Kim GE, Rha KH, Han WK, Cho NH, Oh YT.","J Korean Med Sci. 2010 Jun;25(6):835-40. doi: 10.3346/jkms.2010.25.6.835. Epub 2010 May 24.","Kim YB","J Korean Med Sci","2010","2010/06/02","PMC2877228","","10.3346/jkms.2010.25.6.835"
"15947569","Update on chemotherapy for advanced bladder cancer","Rosenberg JE, Carroll PR, Small EJ.","J Urol. 2005 Jul;174(1):14-20. doi: 10.1097/01.ju.0000162039.38023.5f.","Rosenberg JE","J Urol","2005","2005/06/11","","","10.1097/01.ju.0000162039.38023.5f"
"23849998","Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis","Petrelli F, Coinu A, Cabiddu M, Ghilardi M, Vavassori I, Barni S.","Eur Urol. 2014 Feb;65(2):350-7. doi: 10.1016/j.eururo.2013.06.049. Epub 2013 Jul 3.","Petrelli F","Eur Urol","2014","2013/07/16","","","10.1016/j.eururo.2013.06.049"
"507944","[The BCG as coadjuvant in the treatment of bladder carcinoma]","Rodrigues Netto N Jr, Caserta Lemos G, de Belis N.","Arch Esp Urol. 1979 Sep-Oct;32(5):417-26.","Rodrigues Netto N Jr","Arch Esp Urol","1979","1979/09/01","","",""
"16826589","Variations in reconstruction after radical cystectomy","Gore JL, Saigal CS, Hanley JM, Schonlau M, Litwin MS; Urologic Diseases in America Project.","Cancer. 2006 Aug 15;107(4):729-37. doi: 10.1002/cncr.22058.","Gore JL","Cancer","2006","2006/07/11","PMC3242407","NIHMS341416","10.1002/cncr.22058"
"21664041","Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review","van den Bosch S, Alfred Witjes J.","Eur Urol. 2011 Sep;60(3):493-500. doi: 10.1016/j.eururo.2011.05.045. Epub 2011 Jun 1.","van den Bosch S","Eur Urol","2011","2011/06/14","","","10.1016/j.eururo.2011.05.045"
"9749077","[Survival of patients with infiltrating tumors of the bladder treated with cystectomy]","Mandron E, Desrez G, Chatelain C.","Cancer Radiother. 1998 Apr;2 Suppl 1:39s-42s.","Mandron E","Cancer Radiother","1998","1998/09/28","","",""
"21296393","Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer","Shirotake S, Miyajima A, Kosaka T, Tanaka N, Maeda T, Kikuchi E, Oya M.","Urology. 2011 Apr;77(4):1009.e19-25. doi: 10.1016/j.urology.2010.11.002. Epub 2011 Feb 5.","Shirotake S","Urology","2011","2011/02/08","","","10.1016/j.urology.2010.11.002"
"19711266","Palliative treatment of intractable hematuria in context of advanced bladder cancer: a systematic review","Ghahestani SM, Shakhssalim N.","Urol J. 2009 Summer;6(3):149-56.","Ghahestani SM","Urol J","2009","2009/08/28","","",""
"5826848","[Treatment of bladder cancer with ionizing radiations]","Gibb R.","Acta Oncol (Madr). 1964 Jul-Dec;3(2):189-99.","Gibb R","Acta Oncol (Madr)","1964","1964/07/01","","",""
"15384281","[Priapism following paraneoplastic leukemoid reaction in a patient with bladder cancer]","Rodríguez Alonso A, Romero Picos E, Suárez Pascual G, Bonelli Martín C, González Blanco A, Lorenzo Franco J, Cuerpo Pérez MA, Nieto García J.","Actas Urol Esp. 2004 Jul-Aug;28(7):539-43. doi: 10.1016/s0210-4806(04)73126-5.","Rodríguez Alonso A","Actas Urol Esp","2004","2004/09/24","","","10.1016/s0210-4806(04)73126-5"
"26452803","A non-invasive genomic diagnostic method for bladder cancer using size-based filtration and microchip electrophoresis","Deng Y, Yi L, Lin X, Lin L, Li H, Lin JM.","Talanta. 2015 Nov 1;144:136-44. doi: 10.1016/j.talanta.2015.05.065. Epub 2015 May 27.","Deng Y","Talanta","2015","2015/10/11","","","10.1016/j.talanta.2015.05.065"
"26574637","Immunohistochemistry Biomarkers in Nonmuscle Invasive Bladder Cancer","Ranzi AD, da Silva JN, Graziottin TM, Annels N, Bica CG.","Appl Immunohistochem Mol Morphol. 2017 Mar;25(3):178-183. doi: 10.1097/PAI.0000000000000280.","Ranzi AD","Appl Immunohistochem Mol Morphol","2017","2015/11/18","","","10.1097/PAI.0000000000000280"
"25284638","The effect of Glutathione-S-transferases in the susceptibility to bladder cancer","Ceylan GG, Ceylan C, Taşdemir S, Gözalan A.","Ir J Med Sci. 2015 Dec;184(4):851-4. doi: 10.1007/s11845-014-1200-6. Epub 2014 Oct 5.","Ceylan GG","Ir J Med Sci","2015","2014/10/07","","","10.1007/s11845-014-1200-6"
"5413504","Papilloma of the urinary bladder","Lerman RI, Hutter RV, Whitmore WF Jr.","Cancer. 1970 Feb;25(2):333-42. doi: 10.1002/1097-0142(197002)25:2<333::aid-cncr2820250209>3.0.co;2-e.","Lerman RI","Cancer","1970","1970/02/01","","","10.1002/1097-0142(197002)25:2<333::aid-cncr2820250209>3.0.co;2-e"
"22316374","Molecular mechanisms of cisplatin resistance in bladder cancer","Drayton RM, Catto JW.","Expert Rev Anticancer Ther. 2012 Feb;12(2):271-81. doi: 10.1586/era.11.201.","Drayton RM","Expert Rev Anticancer Ther","2012","2012/02/10","","","10.1586/era.11.201"
"10102906","Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer","Thomas L, Leyh H, Marberger M, Bombardieri E, Bassi P, Pagano F, Pansadoro V, Sternberg CN, Boccon-Gibod L, Ravery V, Le Guludec D, Meulemans A, Conort P, Ishak L.","Clin Chem. 1999 Apr;45(4):472-7.","Thomas L","Clin Chem","1999","1999/04/02","","",""
"32329060","Variables associated with survival in patients with invasive bladder cancer with and without surgery","Longdon E, Mistry H, Pratt O, Donnelly A, O'Neill S, Nachiappan M, Darwin L, Clarke N, Hartley R.","Anaesthesia. 2020 Jul;75(7):887-895. doi: 10.1111/anae.15034. Epub 2020 Apr 24.","Longdon E","Anaesthesia","2020","2020/04/25","","","10.1111/anae.15034"
"3339724","Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience","Klein FA, White FK.","J Urol. 1988 Feb;139(2):275-8. doi: 10.1016/s0022-5347(17)42385-8.","Klein FA","J Urol","1988","1988/02/01","","","10.1016/s0022-5347(17)42385-8"
"16184478","Estimated urine pH and bladder cancer risk in a cohort of male smokers (Finland)","Wright ME, Michaud DS, Pietinen P, Taylor PR, Virtamo J, Albanes D.","Cancer Causes Control. 2005 Nov;16(9):1117-23. doi: 10.1007/s10552-005-0348-9.","Wright ME","Cancer Causes Control","2005","2005/09/27","","","10.1007/s10552-005-0348-9"
"21193872","Tissue polypeptide antigen in the follow-up of patients with urinary bladder cancer compared with conventional urine cytology","Bantis A, Zissimopoulos A, Sountoulides P, Giannakopoulos S, Kalaitzis C, Athanassiadou P, Agelonidou E, Touloupidis S.","Hell J Nucl Med. 2010 Sep-Dec;13(3):213-7.","Bantis A","Hell J Nucl Med","2010","2011/01/04","","",""
"28034491","A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement","Chiang Y, Cheng JC, Huang CY, Tsai YC, Lin CC, Hsu CH, Cheng AL, Pu YS.","J Formos Med Assoc. 2017 Sep;116(9):689-696. doi: 10.1016/j.jfma.2016.10.014. Epub 2016 Dec 26.","Chiang Y","J Formos Med Assoc","2017","2016/12/31","","","10.1016/j.jfma.2016.10.014"
"5159875","Carcinoma of the bladder treated by preoperative irradiation followed by cystectomy","van der Werf-Messing B.","Eur J Cancer. 1971 Oct;7(5):467-72. doi: 10.1016/0014-2964(71)90045-4.","van der Werf-Messing B","Eur J Cancer","1971","1971/10/01","","","10.1016/0014-2964(71)90045-4"
"15564265","Olfactory detection of human bladder cancer by dogs: cause or association?","Leahy M.","BMJ. 2004 Nov 27;329(7477):1286; author reply 1286. doi: 10.1136/bmj.329.7477.1286.","Leahy M","BMJ","2004","2004/11/27","PMC534453","","10.1136/bmj.329.7477.1286"
"11112954","Tobacco consumption and bladder cancer in non-coffee drinkers","López-Abente G, Escolar A.","J Epidemiol Community Health. 2001 Jan;55(1):68-70. doi: 10.1136/jech.55.1.68.","López-Abente G","J Epidemiol Community Health","2001","2000/12/12","PMC1731763","","10.1136/jech.55.1.68"
"29371719","Awareness of risk factors and fallacies associated with urinary bladder cancer in our population: A prospective survey","Mithani MH, Khan SA, Khalid SE, Siddique R, Humayun H, Awan AS.","J Pak Med Assoc. 2018 Jan;68(1):55-58.","Mithani MH","J Pak Med Assoc","2018","2018/01/27","","",""
"6539991","[Accuracy of computer tomography in urinary bladder cancer. Study of 74 patients following radical cystectomy]","Engelmann U, Schild H, Klose K, Schweden F, Jacobi GH.","Urologe A. 1984 May;23(3):161-6.","Engelmann U","Urologe A","1984","1984/05/01","","",""
"9117215","Prognostic value of Ki-67 antigen and p53 protein in urinary bladder cancer: immunohistochemical analysis of radical cystectomy specimens","Tsuji M, Kojima K, Murakami Y, Kanayama H, Kagawa S.","Br J Urol. 1997 Mar;79(3):367-72. doi: 10.1046/j.1464-410x.1997.02710.x.","Tsuji M","Br J Urol","1997","1997/03/01","","","10.1046/j.1464-410x.1997.02710.x"
"20973141","[Epidemiology of bladder cancer in the Samara region]","Zimichev AA, Prianichnikova MB, Maklakov VN.","Urologiia. 2010 Mar-Apr;(2):44-7.","Zimichev AA","Urologiia","2010","2010/10/26","","",""
"5428205","Synthetic sweetener consumption and bladder cancer trends in the United States","Burbank F, Fraumeni JF Jr.","Nature. 1970 Jul 18;227(5255):296-7. doi: 10.1038/227296a0.","Burbank F","Nature","1970","1970/07/18","","","10.1038/227296a0"
"17997439","History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story","Herr HW, Morales A.","J Urol. 2008 Jan;179(1):53-6. doi: 10.1016/j.juro.2007.08.122. Epub 2007 Nov 13.","Herr HW","J Urol","2008","2007/11/13","","","10.1016/j.juro.2007.08.122"
"31128037","Expression of mir-143 in serum of bladder cancer patients and its correlation with clinical features and prognosis","Liu X, Zhao W, Wang X, Zhu Y, Zhou Z, Shi B.","J BUON. 2019 Mar-Apr;24(2):791-796.","Liu X","J BUON","2019","2019/05/26","","",""
"10022687","Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates","Crew JP, O'Brien T, Bicknell R, Fuggle S, Cranston D, Harris AL.","J Urol. 1999 Mar;161(3):799-804.","Crew JP","J Urol","1999","1999/02/18","","",""
"25304156","Increased miR-141 expression is associated with diagnosis and favorable prognosis of patients with bladder cancer","Wang XL, Xie HY, Zhu CD, Zhu XF, Cao GX, Chen XH, Xu HF.","Tumour Biol. 2015 Feb;36(2):877-83. doi: 10.1007/s13277-014-2656-8. Epub 2014 Oct 11.","Wang XL","Tumour Biol","2015","2014/10/12","","","10.1007/s13277-014-2656-8"
"24246329","Induction chemotherapy followed by surgery in node positive bladder cancer","Meijer RP, Mertens LS, van Rhijn BW, Bex A, van der Poel HG, Meinhardt W, Kerst JM, Bergman AM, Fioole-Bruining A, van Werkhoven E, Horenblas S.","Urology. 2014 Jan;83(1):134-9. doi: 10.1016/j.urology.2013.08.082. Epub 2013 Nov 15.","Meijer RP","Urology","2014","2013/11/20","","","10.1016/j.urology.2013.08.082"
"32350965","Integrin β8 facilitates tumor growth and drug resistance through a Y-box binding protein 1-dependent signaling pathway in bladder cancer","Liu S, Chen L, Zhao H, Li Q, Hu R, Wang H.","Cancer Sci. 2020 Jul;111(7):2423-2430. doi: 10.1111/cas.14439. Epub 2020 May 25.","Liu S","Cancer Sci","2020","2020/05/01","PMC7385385","","10.1111/cas.14439"
"6199070","Sensitivity of exfoliative cytology in bladder cancer using the divided one-urine specimen examination","Theodorou C, Goulandris N, Kotzia-Theodorou E, Nacopoulou L, Kyrkos KA, Dimopoulos C.","Br J Urol. 1984 Feb;56(1):48-9. doi: 10.1111/j.1464-410x.1984.tb07162.x.","Theodorou C","Br J Urol","1984","1984/02/01","","","10.1111/j.1464-410x.1984.tb07162.x"
"9817312","Hydronephrosis as a prognostic indicator in bladder cancer patients","Haleblian GE, Skinner EC, Dickinson MG, Lieskovsky G, Boyd SD, Skinner DG.","J Urol. 1998 Dec;160(6 Pt 1):2011-4. doi: 10.1097/00005392-199812010-00018.","Haleblian GE","J Urol","1998","1998/11/17","","","10.1097/00005392-199812010-00018"
"537446","[A modern treatment of the bladder cancer (author's transl)]","Novak R.","Lijec Vjesn. 1979 Jul;101(7):393-4.","Novak R","Lijec Vjesn","1979","1979/07/01","","",""
"24184369","The natural history of symptoms and distress in patients and families following cystectomy for treatment of muscle invasive bladder cancer","Benner C, Greenberg M, Shepard N, Meng MV, Rabow MW.","J Urol. 2014 Apr;191(4):937-42. doi: 10.1016/j.juro.2013.10.101. Epub 2013 Oct 29.","Benner C","J Urol","2014","2013/11/05","","","10.1016/j.juro.2013.10.101"
"25765211","Words of wisdom. Re: The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guerin","Babjuk M.","Eur Urol. 2015 Apr;67(4):815. doi: 10.1016/j.eururo.2014.12.050.","Babjuk M","Eur Urol","2015","2015/03/14","","","10.1016/j.eururo.2014.12.050"
"19072984","Sex and racial differences in bladder cancer presentation and mortality in the US","Scosyrev E, Noyes K, Feng C, Messing E.","Cancer. 2009 Jan 1;115(1):68-74. doi: 10.1002/cncr.23986.","Scosyrev E","Cancer","2009","2008/12/17","","","10.1002/cncr.23986"
"9817310","Urinary cytology and competitive reverse transcriptase-polymerase chain reaction analysis of a specific CD44 variant to detect and monitor bladder cancer","Miyake H, Hara I, Gohji K, Yamanaka K, Arakawa S, Kamidono S.","J Urol. 1998 Dec;160(6 Pt 1):2004-8. doi: 10.1097/00005392-199812010-00015.","Miyake H","J Urol","1998","1998/11/17","","","10.1097/00005392-199812010-00015"
"25641451","Neoadjuvant chemotherapy versus cystectomy in management of stages II, and III urinary bladder cancer","Osman MA, Gabr AM, Elkady MS.","Arch Ital Urol Androl. 2014 Dec 30;86(4):278-83. doi: 10.4081/aiua.2014.4.278.","Osman MA","Arch Ital Urol Androl","2014","2015/02/03","","","10.4081/aiua.2014.4.278"
"19287977","Fluorescence diagnosis and flat lesions of urothelium: new challenges for pathologists and urologists (Review)","Compérat E, Conort P, Roupret M, Capron F, Camparo P, Montironi R.","Oncol Rep. 2009 Apr;21(4):839-44. doi: 10.3892/or_00000292.","Compérat E","Oncol Rep","2009","2009/03/17","","","10.3892/or_00000292"
"11825447","[Apoptosis and expression of PCNA in superficial transitional cell bladder cancer as related to recurrence]","Chen L, Wang X, Mei H, Chen W.","Zhonghua Wai Ke Za Zhi. 1998 Aug;36(8):484-6.","Chen L","Zhonghua Wai Ke Za Zhi","1998","2002/02/05","","",""
"10696247","A critical analysis of the use of p53 as a marker for management of bladder cancer","Olumi AF.","Urol Clin North Am. 2000 Feb;27(1):75-82, ix. doi: 10.1016/s0094-0143(05)70236-6.","Olumi AF","Urol Clin North Am","2000","2000/03/04","","","10.1016/s0094-0143(05)70236-6"
"22811589","Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer","Zhu Z, Shen Z, Xu C.","Mediators Inflamm. 2012;2012:528690. doi: 10.1155/2012/528690. Epub 2012 Jul 2.","Zhu Z","Mediators Inflamm","2012","2012/07/20","PMC3395159","","10.1155/2012/528690"
"16758719","[Clinical significance of pelvic lymph-node dissection for the patients with locally invasive bladder cancer--correlation between the number of retrieved lymph nodes and prognosis]","Noguchi S, Takase K, Oogo Y, Muraoka K, Shioi K, Nakamura M, Onuki T, Kishi H, Satomi Y, Fukuda M.","Hinyokika Kiyo. 2006 May;52(5):327-30.","Noguchi S","Hinyokika Kiyo","2006","2006/06/09","","",""
"14767276","Treatment and outcome of invasive bladder cancer in patients after renal transplantation","Master VA, Meng MV, Grossfeld GD, Koppie TM, Hirose R, Carroll PR.","J Urol. 2004 Mar;171(3):1085-8. doi: 10.1097/01.ju.0000110612.42382.0a.","Master VA","J Urol","2004","2004/02/10","","","10.1097/01.ju.0000110612.42382.0a"
"5021088","[In-vitro studies on the etiology of bladder cancer]","Hochberg K, Röhl L, Kochen W.","Urologe A. 1972 Mar;11(2):98-102.","Hochberg K","Urologe A","1972","1972/03/01","","",""
"27072176","Diagnosis and treatment in primary bladder small cell carcinoma: Literature review","Celik O, Ekin G, Ipekci T, Budak S, Ilbey YO.","Arch Ital Urol Androl. 2016 Mar 31;88(1):52-5. doi: 10.4081/aiua.2016.1.52.","Celik O","Arch Ital Urol Androl","2016","2016/04/14","","","10.4081/aiua.2016.1.52"
"23555699","Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach","Jäger W, Moskalev I, Janssen C, Hayashi T, Awrey S, Gust KM, So AI, Zhang K, Fazli L, Li E, Thüroff JW, Lange D, Black PC.","PLoS One. 2013;8(3):e59536. doi: 10.1371/journal.pone.0059536. Epub 2013 Mar 26.","Jäger W","PLoS One","2013","2013/04/05","PMC3608695","","10.1371/journal.pone.0059536"
"23040249","Prognostic value of cell-cycle regulation biomarkers in bladder cancer","Mitra AP, Hansel DE, Cote RJ.","Semin Oncol. 2012 Oct;39(5):524-33. doi: 10.1053/j.seminoncol.2012.08.008.","Mitra AP","Semin Oncol","2012","2012/10/09","PMC3478886","NIHMS407097","10.1053/j.seminoncol.2012.08.008"
"21617853","Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer","Tada Y, Yokomizo A, Shiota M, Tsunoda T, Plass C, Naito S.","Int J Oncol. 2011 Sep;39(3):727-33. doi: 10.3892/ijo.2011.1049. Epub 2011 May 23.","Tada Y","Int J Oncol","2011","2011/05/28","","","10.3892/ijo.2011.1049"
"6692301","The Noble rat bladder cancer model. FANFT-induced tumors","Drago JR.","Cancer. 1984 Mar 1;53(5):1093-9. doi: 10.1002/1097-0142(19840301)53:5<1093::aid-cncr2820530513>3.0.co;2-8.","Drago JR","Cancer","1984","1984/03/01","","","10.1002/1097-0142(19840301)53:5<1093::aid-cncr2820530513>3.0.co;2-8"
"12885455","Concomitant boost radiotherapy for muscle invasive bladder cancer","Pos FJ, van Tienhoven G, Hulshof MC, Koedooder K, González González D.","Radiother Oncol. 2003 Jul;68(1):75-80. doi: 10.1016/s0167-8140(03)00019-7.","Pos FJ","Radiother Oncol","2003","2003/07/30","","","10.1016/s0167-8140(03)00019-7"
"7154480","[Case of bladder cancer discovered during the 15th week of pregnancy]","Saeki H, Miura K, Igarashi N, Ogawa H, Shimizu S, Wada I, Suzuki T, Harada T, Morita T, Kato T.","Nihon Hinyokika Gakkai Zasshi. 1982 Aug;73(8):1058-62. doi: 10.5980/jpnjurol1928.73.8_1058.","Saeki H","Nihon Hinyokika Gakkai Zasshi","1982","1982/08/01","","","10.5980/jpnjurol1928.73.8_1058"
"17173946","The effect of ultrasonic irradiation on doxorubicin-induced cytotoxicity in three human bladder cancer cell lines","Arthur C, Flaig T, Su LJ, Denney R, Barnes F, Glodé LM.","Ultrasonics. 2007 Mar;46(1):68-73. doi: 10.1016/j.ultras.2006.10.003. Epub 2006 Nov 27.","Arthur C","Ultrasonics","2007","2006/12/19","","","10.1016/j.ultras.2006.10.003"
"26489616","Prognostic significance of lymphovascular invasion in bladder cancer after surgical resection: A meta-analysis","Tian YF, Zhou H, Yu G, Wang J, Li H, Xia D, Xiao HB, Liu JH, Ye ZQ, Xu H, Zhuang QY.","J Huazhong Univ Sci Technolog Med Sci. 2015 Oct;35(5):646-655. doi: 10.1007/s11596-015-1484-4. Epub 2015 Oct 22.","Tian YF","J Huazhong Univ Sci Technolog Med Sci","2015","2015/10/23","","","10.1007/s11596-015-1484-4"
"19811072","Urinary proteomic profiling for diagnostic bladder cancer biomarkers","Goodison S, Rosser CJ, Urquidi V.","Expert Rev Proteomics. 2009 Oct;6(5):507-14. doi: 10.1586/epr.09.70.","Goodison S","Expert Rev Proteomics","2009","2009/10/09","PMC3422861","NIHMS396961","10.1586/epr.09.70"
"14518736","Neural network-based assessment of prognostic markers and outcome prediction in bilharziasis-associated bladder cancer","Ji W, Naguib RN, Ghoneim MA.","IEEE Trans Inf Technol Biomed. 2003 Sep;7(3):218-24. doi: 10.1109/titb.2003.813796.","Ji W","IEEE Trans Inf Technol Biomed","2003","2003/10/02","","","10.1109/titb.2003.813796"
"18639472","Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy","Dwivedi US, Kumar A, Das SK, Trivedi S, Kumar M, Sunder S, Singh PB.","Urol Oncol. 2009 Sep-Oct;27(5):514-9. doi: 10.1016/j.urolonc.2008.04.015. Epub 2008 Jul 17.","Dwivedi US","Urol Oncol","2009","2008/07/22","","","10.1016/j.urolonc.2008.04.015"
"8908592","Scrotal cystocele associated with bladder cancer diagnosed by ultrasonography","Yağci C, Aytaç S, Atasoy C.","J Ultrasound Med. 1996 Nov;15(11):793-5. doi: 10.7863/jum.1996.15.11.793.","Yağci C","J Ultrasound Med","1996","1996/11/01","","","10.7863/jum.1996.15.11.793"
"28084874","Human papillomavirus types 44, 52, 66 and 67 detected in a woman with squamous cell carcinoma of the urinary bladder","Jørgensen KR, Høyer S, Sørensen MM, Jensen JB.","Scand J Urol. 2017 Feb;51(1):85-86. doi: 10.1080/21681805.2016.1271826. Epub 2017 Jan 13.","Jørgensen KR","Scand J Urol","2017","2017/01/14","","","10.1080/21681805.2016.1271826"
"10730418","[Quantification of bladder tumor antigen (BTA trak) and its correlation with bladder cancer grade and stage]","Rodríguez Martínez JJ, Escaf Barmadah S, Allende MT, Raigoso P, Martín Benito JL, Pérez García FJ, Fernández Gómez JM.","Arch Esp Urol. 2000 Jan-Feb;53(1):1-6.","Rodríguez Martínez JJ","Arch Esp Urol","2000","2000/03/24","","",""
"7444197","Cell differentiation and its relation to promotion and prevention of bladder cancer","Hicks RM.","Results Probl Cell Differ. 1980;11:251-8. doi: 10.1007/978-3-540-38267-6_32.","Hicks RM","Results Probl Cell Differ","1980","1980/01/01","","","10.1007/978-3-540-38267-6_32"
"6483914","Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival","Kurth KH.","Prog Clin Biol Res. 1984;162A:307-18.","Kurth KH","Prog Clin Biol Res","1984","1984/01/01","","",""
"25937623","Promises and challenges of fluorescence cystoscopy","Lotan Y.","Urol Oncol. 2015 Jun;33(6):261-4. doi: 10.1016/j.urolonc.2015.03.019. Epub 2015 Apr 27.","Lotan Y","Urol Oncol","2015","2015/05/05","","","10.1016/j.urolonc.2015.03.019"
"29180330","[Role of lncRNA PTENP1 in tumorigenesis and progression of bladder cancer and the molecular mechanism]","Yu G, Ou ZY, Tao QY, Wan GY, Lu ZH, Lang B.","Nan Fang Yi Ke Da Xue Xue Bao. 2017 Nov 20;37(11):1494-1500. doi: 10.3969/j.issn.1673-4254.2017.11.11.","Yu G","Nan Fang Yi Ke Da Xue Xue Bao","2017","2017/11/29","PMC6779653","","10.3969/j.issn.1673-4254.2017.11.11"
"2149466","Preemptive (neoadjuvant) chemotherapy for invasive bladder cancer: a decade of experience","Raghavan D, Pearson B, Tynan A, Watt WH, Wines RD, Rochford M, Langdon P, Duval P.","Semin Urol. 1990 Nov;8(4):285-90.","Raghavan D","Semin Urol","1990","1990/11/01","","",""
"22126575","MTHFR gene polymorphisms in bladder cancer in the Turkish population","Izmirli M, Inandiklioglu N, Abat D, Alptekin D, Demirhan O, Tansug Z, Bayazit Y.","Asian Pac J Cancer Prev. 2011;12(7):1833-5.","Izmirli M","Asian Pac J Cancer Prev","2011","2011/12/01","","",""
"21473288","iASPP is important for bladder cancer cell proliferation","Liu T, Li L, Yang W, Jia H, Xu M, Bi J, Li Z, Liu X, Li Z, Jing H, Kong C.","Oncol Res. 2011;19(3-4):125-30. doi: 10.3727/096504011x12935427587768.","Liu T","Oncol Res","2011","2011/04/09","","","10.3727/096504011x12935427587768"
"20376453","A rat model of intravesical delivery of small interfering RNA for studying urinary carcinoma","Arum CJ, Kodama Y, Rolim N, Widerøe M, Anderssen E, Viset T, Otterlei M, Lundgren S, Chen D, Zhao CM.","World J Urol. 2010 Aug;28(4):479-85. doi: 10.1007/s00345-010-0542-6. Epub 2010 Apr 8.","Arum CJ","World J Urol","2010","2010/04/09","","","10.1007/s00345-010-0542-6"
"24133909","Hypoxia inducible factor-1alpha and microvessel density as angiogenic factors in bilharzial and non-bilharzial bladder cancer","Badr S, Salem A, Yuosif AH, Awadallah H, Awed N, Bakr A.","Clin Lab. 2013;59(7-8):805-12. doi: 10.7754/clin.lab.2012.120605.","Badr S","Clin Lab","2013","2013/10/19","","","10.7754/clin.lab.2012.120605"
"17688917","Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer","Matsumoto K, Irie A, Satoh T, Ishii J, Iwabuchi K, Iwamura M, Egawa S, Baba S.","Urology. 2007 Sep;70(3):602-7. doi: 10.1016/j.urology.2007.04.007. Epub 2007 Aug 3.","Matsumoto K","Urology","2007","2007/08/11","","","10.1016/j.urology.2007.04.007"
"7411717","Radiotherapy and bladder cancer: a critical review","Radwin HM.","J Urol. 1980 Jul;124(1):43-6. doi: 10.1016/s0022-5347(17)55283-0.","Radwin HM","J Urol","1980","1980/07/01","","","10.1016/s0022-5347(17)55283-0"
"24044914","Leukemoid reaction: a rare paraneoplastic syndrome in bladder cancer associated with a grave prognosis","Shapiro DD, Potretzke A, Downs TM.","Urology. 2014 Feb;83(2):274-7. doi: 10.1016/j.urology.2013.07.036. Epub 2013 Sep 14.","Shapiro DD","Urology","2014","2013/09/19","","","10.1016/j.urology.2013.07.036"
"7395262","Bladder cancer etiology and natural carcinogens","Buchanan-Davidson DJ.","Wis Med J. 1980 May;79(5):29-30.","Buchanan-Davidson DJ","Wis Med J","1980","1980/05/01","","",""
"5677049","Untreated bladder cancer: 31 autopsy cases","Friedell GH, Mcauley RL.","J Urol. 1968 Sep;100(3):293-6. doi: 10.1016/s0022-5347(17)62523-0.","Friedell GH","J Urol","1968","1968/09/01","","","10.1016/s0022-5347(17)62523-0"
"16632178","Focal S100A4 protein expression is an independent predictor of development of metastatic disease in cystectomized bladder cancer patients","Agerbaek M, Alsner J, Marcussen N, Lundbeck F, Von der Maase H.","Eur Urol. 2006 Oct;50(4):777-85. doi: 10.1016/j.eururo.2006.02.027. Epub 2006 Mar 9.","Agerbaek M","Eur Urol","2006","2006/04/25","","","10.1016/j.eururo.2006.02.027"
"20960505","Fluorescence cystoscopy for nonmuscle invasive bladder cancer: is the honeymoon over for the blue light special?","Shah JB, Kamat AM.","Cancer. 2011 Mar 1;117(5):882-3. doi: 10.1002/cncr.25521. Epub 2010 Oct 19.","Shah JB","Cancer","2011","2010/10/21","","","10.1002/cncr.25521"
"3283763","Transurethral ultrasonography, CT scan, nuclear magnetic resonance (NMR) imaging and pathological control in staging and follow up of invasive bladder carcinoma","Pavone C, Di Trapani D, Serretta V, Filosto L, Cacciatore M, Caramia G, Pavone-Macaluso M.","Prog Clin Biol Res. 1988;260:251-63.","Pavone C","Prog Clin Biol Res","1988","1988/01/01","","",""
"29953747","Risk factors for upper tract urothelial recurrence following local excision of bladder cancer","Lin N, Wu YP, Lin YZ, Tao X, Chen SH, Ke ZB, Wei Y, Zheng QS, Xue XY, Xu N.","Cancer Med. 2018 Aug;7(8):4098-4103. doi: 10.1002/cam4.1642. Epub 2018 Jun 28.","Lin N","Cancer Med","2018","2018/06/29","PMC6089153","","10.1002/cam4.1642"
"29739079","Hsa-miR-3658 Promotes Cell Proliferation, Migration and Invasion by Effecting LASS2 in Bladder Cancer","Luan T, Zou R, Huang L, Li N, Fu S, Huang Y, Wang H, Wang J.","Clin Lab. 2018 Apr 1;64(4):515-525. doi: 10.7754/Clin.Lab.2017.171026.","Luan T","Clin Lab","2018","2018/05/09","","","10.7754/Clin.Lab.2017.171026"
"18759990","Muscle invasive bladder cancer in Upper Egypt: the shift in risk factors and tumor characteristics","Zarzour AH, Selim M, Abd-Elsayed AA, Hameed DA, Abdelaziz MA.","BMC Cancer. 2008 Aug 29;8:250. doi: 10.1186/1471-2407-8-250.","Zarzour AH","BMC Cancer","2008","2008/09/02","PMC2533340","","10.1186/1471-2407-8-250"
"28894042","The role of the BLCA-4 nuclear matrix protein in bladder cancer","Szymańska B, Długosz A.","Postepy Hig Med Dosw (Online). 2017 Aug 13;71(1):681-689. doi: 10.5604/01.3001.0010.3847.","Szymańska B","Postepy Hig Med Dosw (Online)","2017","2017/09/13","","","10.5604/01.3001.0010.3847"
"16093959","The treatment of patients with bladder cancer: let's not forget the past!","Stein JP.","J Urol. 2005 Sep;174(3):814-5. doi: 10.1097/01.ju.0000175047.15232.f4.","Stein JP","J Urol","2005","2005/08/12","","","10.1097/01.ju.0000175047.15232.f4"
"22837145","Serum vitamin D and risk of bladder cancer in PLCO--letter","Grant WB.","Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1602; author reply 1603. doi: 10.1158/1055-9965.EPI-12-0726. Epub 2012 Jul 26.","Grant WB","Cancer Epidemiol Biomarkers Prev","2012","2012/07/28","","","10.1158/1055-9965.EPI-12-0726"
"26260808","Anti-PD-1 and PD-L1 therapy for bladder cancer: what is on the horizon?","Sundararajan S, Vogelzang NJ.","Future Oncol. 2015;11(16):2299-306. doi: 10.2217/fon.15.162.","Sundararajan S","Future Oncol","2015","2015/08/12","","","10.2217/fon.15.162"
"26204286","Treatment Response Assessment for Bladder Cancer on CT Based on Computerized Volume Analysis, World Health Organization Criteria, and RECIST","Hadjiiski L, Weizer AZ, Alva A, Caoili EM, Cohan RH, Cha K, Chan HP.","AJR Am J Roentgenol. 2015 Aug;205(2):348-52. doi: 10.2214/AJR.14.13732.","Hadjiiski L","AJR Am J Roentgenol","2015","2015/07/24","PMC4791536","NIHMS765658","10.2214/AJR.14.13732"
"12172434","High-risk metastatic urothelial cancer: chances for cure?","Calabrò F, Sternberg CN.","Curr Opin Urol. 2002 Sep;12(5):441-8. doi: 10.1097/00042307-200209000-00013.","Calabrò F","Curr Opin Urol","2002","2002/08/13","","","10.1097/00042307-200209000-00013"
"22555038","The role of radiotherapy in urinary bladder cancer: current status","Marta GN, Hanna SA, Gadia R, Correa SF, Silva JL, Carvalho Hde A.","Int Braz J Urol. 2012 Mar-Apr;38(2):144-53; discussion 153-4. doi: 10.1590/s1677-55382012000200002.","Marta GN","Int Braz J Urol","2012","2012/05/05","","","10.1590/s1677-55382012000200002"
"12900003","The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?","Epstein JI.","Crit Rev Oncol Hematol. 2003 Aug;47(2):83-9. doi: 10.1016/s1040-8428(03)00073-8.","Epstein JI","Crit Rev Oncol Hematol","2003","2003/08/06","","","10.1016/s1040-8428(03)00073-8"
"1785384","[Present status on bladder replacement--colon bladder replacement]","Yasuno H, Arakawa S, Matsumoto O, Kamidono S, Yamanaka N.","Hinyokika Kiyo. 1991 Dec;37(12):1621-5.","Yasuno H","Hinyokika Kiyo","1991","1991/12/01","","",""
"826656","Vesicoureteral reflux in recurrent carcinoma of the bladder--implications for treatment and prognosis","Schmidt JD, Jacobo EC, Weinstein SH.","J Urol. 1976 Dec;116(6):734-6. doi: 10.1016/s0022-5347(17)58990-9.","Schmidt JD","J Urol","1976","1976/12/01","","","10.1016/s0022-5347(17)58990-9"
"23090757","Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy","Keck B, Ott OJ, Häberle L, Kunath F, Weiss C, Rödel C, Sauer R, Fietkau R, Wullich B, Krause FS.","World J Urol. 2013 Oct;31(5):1023-8. doi: 10.1007/s00345-012-0971-5. Epub 2012 Oct 23.","Keck B","World J Urol","2013","2012/10/24","","","10.1007/s00345-012-0971-5"
"8683681","Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer","Donat SM, Herr HW, Bajorin DF, Fair WR, Sogani PC, Russo P, Sheinfeld J, Scher I.","J Urol. 1996 Aug;156(2 Pt 1):368-71. doi: 10.1097/00005392-199608000-00009.","Donat SM","J Urol","1996","1996/08/01","","","10.1097/00005392-199608000-00009"
"15145509","Systemic chemotherapy for patients with bladder cancer--current controversies and future directions","Chester JD, Hall GD, Forster M, Protheroe AS.","Cancer Treat Rev. 2004 Jun;30(4):343-58. doi: 10.1016/j.ctrv.2003.12.005.","Chester JD","Cancer Treat Rev","2004","2004/05/18","","","10.1016/j.ctrv.2003.12.005"
"741536","Treatment of bladder cancer at the Rotterdam Radiotherapy Institute (R.R.T.I.) with special reference to bladder radium implantation and preoperative radiotherapy followed by cystectomy","Wassif SB, van der Werf-Messing B.","Urol Res. 1978;6(4):241-7. doi: 10.1007/BF00262627.","Wassif SB","Urol Res","1978","1978/01/01","","","10.1007/BF00262627"
"29032338","An analysis of suppressing migratory effect on human urinary bladder cancer cell line by silencing of snail-1","Salehi S, Mansoori B, Mohammadi A, Davoudian S, Musavi Shenas SMH, Shajari N, Majidi J, Baradaran B.","Biomed Pharmacother. 2017 Dec;96:545-550. doi: 10.1016/j.biopha.2017.10.044. Epub 2017 Oct 13.","Salehi S","Biomed Pharmacother","2017","2017/10/17","","","10.1016/j.biopha.2017.10.044"
"31104013","E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma","Gondkar K, Patel K, Krishnappa S, Patil A, Nair B, Sundaram GM, Zea TT, Kumar P.","Cancer Biomark. 2019;25(2):223-232. doi: 10.3233/CBM-190013.","Gondkar K","Cancer Biomark","2019","2019/05/20","","","10.3233/CBM-190013"
"25604887","Pharmacokinetic and toxicity considerations in the use of neoadjuvant chemotherapy for bladder cancer","Narayan V, Vaughn D.","Expert Opin Drug Metab Toxicol. 2015 May;11(5):731-42. doi: 10.1517/17425255.2015.1005600. Epub 2015 Jan 21.","Narayan V","Expert Opin Drug Metab Toxicol","2015","2015/01/22","","","10.1517/17425255.2015.1005600"
"21707293","Potential of histone deacetylase inhibitors for bladder cancer treatment","Tanji N, Ozawa A, Kikugawa T, Miura N, Sasaki T, Azuma K, Yokoyama M.","Expert Rev Anticancer Ther. 2011 Jun;11(6):959-65. doi: 10.1586/era.10.230.","Tanji N","Expert Rev Anticancer Ther","2011","2011/06/29","","","10.1586/era.10.230"
"19379084","Epigenetic biomarkers in urothelial bladder cancer","Kim WJ, Kim YJ.","Expert Rev Mol Diagn. 2009 Apr;9(3):259-69. doi: 10.1586/erm.09.5.","Kim WJ","Expert Rev Mol Diagn","2009","2009/04/22","","","10.1586/erm.09.5"
"7201723","[Thoughts on the radical intervention of transurethral electroresection in bladder cancer]","Matz M.","Z Urol Nephrol. 1982 Apr;75(4):259-64.","Matz M","Z Urol Nephrol","1982","1982/04/01","","",""
"12074406","Prediction of muscle invasion of bladder cancer by cystoscopy","Satoh E, Miyao N, Tachiki H, Fujisawa Y.","Eur Urol. 2002 Feb;41(2):178-81. doi: 10.1016/s0302-2838(01)00035-5.","Satoh E","Eur Urol","2002","2002/06/21","","","10.1016/s0302-2838(01)00035-5"
"31053526","Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer","Krafft U, Tschirdewahn S, Hess J, Harke NN, Hadaschik B, Olah C, Krege S, Nyirády P, Szendröi A, Szücs M, Módos O, Székely E, Reis H, Szarvas T.","Urol Oncol. 2019 Nov;37(11):810.e7-810.e15. doi: 10.1016/j.urolonc.2019.04.015. Epub 2019 Apr 30.","Krafft U","Urol Oncol","2019","2019/05/05","","","10.1016/j.urolonc.2019.04.015"
"22043867","Milk consumption and bladder cancer risk: a meta-analysis of published epidemiological studies","Mao QQ, Dai Y, Lin YW, Qin J, Xie LP, Zheng XY.","Nutr Cancer. 2011 Nov;63(8):1263-71. doi: 10.1080/01635581.2011.614716. Epub 2011 Nov 1.","Mao QQ","Nutr Cancer","2011","2011/11/03","","","10.1080/01635581.2011.614716"
"8857236","Cisplatin-based neoadjuvant chemotherapy for invasive bladder cancer","Kadena H, Igawa M, Shigeta M, Nakamoto T, Usui T.","Hiroshima J Med Sci. 1995 Dec;44(4):129-32.","Kadena H","Hiroshima J Med Sci","1995","1995/12/01","","",""
"19707952","Lead concentration in the bladder tissue and blood of patients with bladder cancer","Golabek T, Darewicz B, Borawska M, Markiewicz R, Socha K, Kudelski J.","Scand J Urol Nephrol. 2009;43(6):467-70. doi: 10.3109/00365590903198991.","Golabek T","Scand J Urol Nephrol","2009","2009/08/27","","","10.3109/00365590903198991"
"17138134","Urinary bladder tumor markers","Lokeshwar VB, Selzer MG.","Urol Oncol. 2006 Nov-Dec;24(6):528-37. doi: 10.1016/j.urolonc.2006.07.003.","Lokeshwar VB","Urol Oncol","2006","2006/12/02","","","10.1016/j.urolonc.2006.07.003"
"17115289","Eosinophilic cystitis simulating invasive bladder cancer: a real diagnostic challenge","Salman M, Al-Ansari AA, Talib RA, El Malik el F, Al-Bozaom IA, Shokeir AA.","Int Urol Nephrol. 2006;38(3-4):545-8. doi: 10.1007/s11255-006-0103-5. Epub 2006 Nov 18.","Salman M","Int Urol Nephrol","2006","2006/11/23","","","10.1007/s11255-006-0103-5"
"27377160","Bladder cancer: ASCO endorses EAU muscle-invasive bladder cancer guidelines","Lerner SP.","Nat Rev Urol. 2016 Aug;13(8):440-1. doi: 10.1038/nrurol.2016.114. Epub 2016 Jul 5.","Lerner SP","Nat Rev Urol","2016","2016/07/06","","","10.1038/nrurol.2016.114"
"10536447","[Factors influencing treatment results of definitive radiotherapy following transurethral surgery for muscle-invasive bladder cancer]","Abe T, Kanehira C.","Nihon Igaku Hoshasen Gakkai Zasshi. 1999 Sep;59(11):516-20.","Abe T","Nihon Igaku Hoshasen Gakkai Zasshi","1999","1999/10/28","","",""
"3388662","Muscle-invasive bladder cancer: does it arise de novo or from pre-existing superficial disease?","Newman LH, Tannenbaum M, Droller MJ.","Urology. 1988 Jul;32(1):58-62. doi: 10.1016/0090-4295(88)90457-8.","Newman LH","Urology","1988","1988/07/01","","","10.1016/0090-4295(88)90457-8"
"29493186","Nephrogenic adenoma of the bladder: a single institution experience assessing clinical factors","Yi Y, Wu A, Cameron AP.","Int Braz J Urol. 2018 May-Jun;44(3):506-511. doi: 10.1590/S1677-5538.IBJU.2017.0155.","Yi Y","Int Braz J Urol","2018","2018/03/02","PMC5996808","","10.1590/S1677-5538.IBJU.2017.0155"
"7323554","[Hematuria and cancer of the bladder]","Mayor G.","Rev Med Suisse Romande. 1981 Oct;101(10):771-6.","Mayor G","Rev Med Suisse Romande","1981","1981/10/01","","",""
"1507729","[Clinical analysis of multiple primary cancers associated with bladder cancer]","Takahashi S, Sugimoto M, Shinohara M, Kinoshita K.","Nihon Hinyokika Gakkai Zasshi. 1992 Jul;83(7):1118-23. doi: 10.5980/jpnjurol1989.83.1118.","Takahashi S","Nihon Hinyokika Gakkai Zasshi","1992","1992/07/01","","","10.5980/jpnjurol1989.83.1118"
"8734735","The role of chemotherapy in the management of the patient with T3b bladder cancer","Millikan R, Dinney CP.","Semin Urol Oncol. 1996 May;14(2):81-5.","Millikan R","Semin Urol Oncol","1996","1996/05/01","","",""
"30630734","The clinical implication of gamma globulin levels in patients with nonmuscle-invasive bladder cancer","Niwa N, Matsumoto K, Ide H.","Urol Oncol. 2019 Apr;37(4):291.e1-291.e7. doi: 10.1016/j.urolonc.2018.12.026. Epub 2019 Jan 8.","Niwa N","Urol Oncol","2019","2019/01/12","","","10.1016/j.urolonc.2018.12.026"
"12673700","Molecular targeting and pharmacogenomics in the management of advanced bladder cancer","Raghavan D.","Cancer. 2003 Apr 15;97(8 Suppl):2083-9. doi: 10.1002/cncr.11281.","Raghavan D","Cancer","2003","2003/04/04","","","10.1002/cncr.11281"
"27432379","Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy","Hugen CM, Duddalwar V, Daneshmand S.","Curr Urol Rep. 2016 Sep;17(9):62. doi: 10.1007/s11934-016-0618-y.","Hugen CM","Curr Urol Rep","2016","2016/07/20","PMC7474952","NIHMS1623358","10.1007/s11934-016-0618-y"
"10484845","[Combination chemotherapy and radiotherapy in the conservative treatment of infiltrating bladder carcinoma]","Villà Freixa S.","Arch Esp Urol. 1999 Jul-Aug;52(6):614-24.","Villà Freixa S","Arch Esp Urol","1999","1999/09/15","","",""
"29359984","Current approaches for identifying high-risk non-muscle invasive bladder cancer","Sanli O, Lotan Y.","Expert Rev Anticancer Ther. 2018 Mar;18(3):223-235. doi: 10.1080/14737140.2018.1432358. Epub 2018 Jan 31.","Sanli O","Expert Rev Anticancer Ther","2018","2018/01/24","","","10.1080/14737140.2018.1432358"
"22228636","Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer","Riester M, Taylor JM, Feifer A, Koppie T, Rosenberg JE, Downey RJ, Bochner BH, Michor F.","Clin Cancer Res. 2012 Mar 1;18(5):1323-33. doi: 10.1158/1078-0432.CCR-11-2271. Epub 2012 Jan 6.","Riester M","Clin Cancer Res","2012","2012/01/10","PMC3569085","NIHMS347821","10.1158/1078-0432.CCR-11-2271"
"5818157","Cancer of the urogenital tract: bladder cancer","Rubin P.","JAMA. 1969 Jan 13;207(2):341.","Rubin P","JAMA","1969","1969/01/13","","",""
"29185631","[Myths and reality about immunonutrition in uro-oncology]","Cerantola Y.","Rev Med Suisse. 2017 Nov 29;13(585):2079-2082.","Cerantola Y","Rev Med Suisse","2017","2017/11/30","","",""
"18815931","Gene signatures for risk-adapted treatment of bladder cancer","Ørntoft TF, Dyrskjøt L.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):166-74. doi: 10.1080/03008880802283730.","Ørntoft TF","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802283730"
"10405804","Utility of the BTA stat test kit for bladder cancer screening","Nasuti JF, Gomella LG, Ismial M, Bibbo M.","Diagn Cytopathol. 1999 Jul;21(1):27-9. doi: 10.1002/(sici)1097-0339(199907)21:1<27::aid-dc8>3.0.co;2-8.","Nasuti JF","Diagn Cytopathol","1999","1999/07/16","","","10.1002/(sici)1097-0339(199907)21:1<27::aid-dc8>3.0.co;2-8"
"27557494","Pesticide exposure and risk of bladder cancer: A meta-analysis","Liang Z, Wang X, Xie B, Zhu Y, Wu J, Li S, Meng S, Zheng X, Ji A, Xie L.","Oncotarget. 2016 Oct 11;7(41):66959-66969. doi: 10.18632/oncotarget.11397.","Liang Z","Oncotarget","2016","2016/08/25","PMC5341850","","10.18632/oncotarget.11397"
"18792102","The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses","Hemelt M, Yamamoto H, Cheng KK, Zeegers MP.","Int J Cancer. 2009 Jan 15;124(2):412-9. doi: 10.1002/ijc.23856.","Hemelt M","Int J Cancer","2009","2008/09/16","","","10.1002/ijc.23856"
"17419368","[A case of small cell carcinoma in a diverticulum of the bladder]","Tamura K, Nakajima F, Izawa A.","Nihon Hinyokika Gakkai Zasshi. 2007 Mar;98(3):573-5. doi: 10.5980/jpnjurol1989.98.573.","Tamura K","Nihon Hinyokika Gakkai Zasshi","2007","2007/04/11","","","10.5980/jpnjurol1989.98.573"
"16397035","Evaluation for surrogacy of end points by using data from observational studies: tumor downstaging for evaluating neoadjuvant chemotherapy in invasive bladder cancer","Teramukai S, Nishiyama H, Matsui Y, Ogawa O, Fukushima M.","Clin Cancer Res. 2006 Jan 1;12(1):139-43. doi: 10.1158/1078-0432.CCR-05-1598.","Teramukai S","Clin Cancer Res","2006","2006/01/07","","","10.1158/1078-0432.CCR-05-1598"
"26759324","Treatment strategy for bladder cancer in patients on hemodialysis: a clinical review of 28 cases","Sato Y, Kondo T, Takagi T, Junpei I, Tanabe K.","Int Urol Nephrol. 2016 Apr;48(4):503-9. doi: 10.1007/s11255-015-1199-2. Epub 2016 Jan 12.","Sato Y","Int Urol Nephrol","2016","2016/01/14","","","10.1007/s11255-015-1199-2"
"22608749","Androgen receptor signaling regulates cell growth and vulnerability to doxorubicin in bladder cancer","Shiota M, Takeuchi A, Yokomizo A, Kashiwagi E, Tatsugami K, Kuroiwa K, Naito S.","J Urol. 2012 Jul;188(1):276-86. doi: 10.1016/j.juro.2012.02.2554. Epub 2012 May 16.","Shiota M","J Urol","2012","2012/05/22","","","10.1016/j.juro.2012.02.2554"
"8339222","The binding site for fucose-binding proteins of Lotus tetragonolobus is a prognostic marker for transitional cell carcinoma of the human urinary bladder","Shirahama T, Ikoma M, Muramatsu T, Kayajima T, Ohi Y, Tsushima T, Akebi N, Ohmori H, Hirao Y, Okajima E.","Cancer. 1993 Aug 15;72(4):1329-34. doi: 10.1002/1097-0142(19930815)72:4<1329::aid-cncr2820720430>3.0.co;2-6.","Shirahama T","Cancer","1993","1993/08/15","","","10.1002/1097-0142(19930815)72:4<1329::aid-cncr2820720430>3.0.co;2-6"
"3607723","The practical use of tumor marker determination in bladder washing specimens. Assessing the urothelium of patients with superficial bladder cancer","Orihuela E, Varadachay S, Herr HW, Melamed MR, Whitmore WF Jr.","Cancer. 1987 Sep 1;60(5):1009-16. doi: 10.1002/1097-0142(19870901)60:5<1009::aid-cncr2820600515>3.0.co;2-b.","Orihuela E","Cancer","1987","1987/09/01","","","10.1002/1097-0142(19870901)60:5<1009::aid-cncr2820600515>3.0.co;2-b"
"3947560","Occupation and cancer in London: an investigation into nasal and bladder cancer using the Cancer Atlas","Baxter PJ, McDowall ME.","Br J Ind Med. 1986 Jan;43(1):44-9. doi: 10.1136/oem.43.1.44.","Baxter PJ","Br J Ind Med","1986","1986/01/01","PMC1007599","","10.1136/oem.43.1.44"
"29542328","Waiting in the wings: the emerging role of molecular biomarkers in bladder cancer","Ilijazi D, Abufaraj M, Hassler MR, Ertl IE, D'Andrea D, Shariat SF.","Expert Rev Mol Diagn. 2018 Apr;18(4):347-356. doi: 10.1080/14737159.2018.1453808. Epub 2018 Mar 21.","Ilijazi D","Expert Rev Mol Diagn","2018","2018/03/16","","","10.1080/14737159.2018.1453808"
"1871936","[Animal experiment aspects of bladder cancer]","Recker F, Otto T.","Urologe A. 1991 May;30(3):172-9.","Recker F","Urologe A","1991","1991/05/01","","",""
"18158021","Laparoscopic inguinal herniorrhaphy complicating radical cystoprostatectomy","Jones JS.","Urology. 2007 Dec;70(6):1079-81. doi: 10.1016/j.urology.2007.07.041.","Jones JS","Urology","2007","2007/12/26","","","10.1016/j.urology.2007.07.041"
"1580253","Mortality and incidence of bladder cancer in benzidine-exposed workers in China","Bi W, Hayes RB, Feng P, Qi Y, You X, Zhen J, Zhang M, Qu B, Fu Z, Chen M, et al.","Am J Ind Med. 1992;21(4):481-9. doi: 10.1002/ajim.4700210404.","Bi W","Am J Ind Med","1992","1992/01/01","","","10.1002/ajim.4700210404"
"25060358","The changing reality of urothelial bladder cancer: should non-squamous variant histology be managed as a distinct clinical entity?","Monn MF, Kaimakliotis HZ, Cary KC, Bihrle R, Pedrosa JA, Masterson TA, Foster RS, Gardner TA, Cheng L, Koch MO.","BJU Int. 2015 Aug;116(2):236-40. doi: 10.1111/bju.12877. Epub 2015 Mar 6.","Monn MF","BJU Int","2015","2014/07/26","","","10.1111/bju.12877"
"27441754","Arsenic in private well water may contribute to bladder cancer risk","Printz C.","Cancer. 2016 Aug 1;122(15):2291. doi: 10.1002/cncr.30176.","Printz C","Cancer","2016","2016/07/22","","","10.1002/cncr.30176"
"16427554","Gender and geographic influence on the racial disparity in bladder cancer mortality in the US","Underwood W 3rd, Dunn RL, Williams C, Lee CT.","J Am Coll Surg. 2006 Feb;202(2):284-90. doi: 10.1016/j.jamcollsurg.2005.09.009. Epub 2005 Dec 19.","Underwood W 3rd","J Am Coll Surg","2006","2006/01/24","","","10.1016/j.jamcollsurg.2005.09.009"
"25155828","[The urinary bladder is an uncommon site of metastasis from breast cancer]","Sauvanaud C, Sergent F, Long JA, Pasquier D, Saada-Sebag G, Descotes JL, Rambeaud JJ.","Gynecol Obstet Fertil. 2014 Nov;42(11):813-5. doi: 10.1016/j.gyobfe.2014.07.015. Epub 2014 Aug 23.","Sauvanaud C","Gynecol Obstet Fertil","2014","2014/08/27","","","10.1016/j.gyobfe.2014.07.015"
"2217422","The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group","Splinter TA, Scher HI, Denis L, Bukowski R, Soloway M, Vogelzang N, Klimberg I, Dalesio O, Herr H.","Prog Clin Biol Res. 1990;353:219-24.","Splinter TA","Prog Clin Biol Res","1990","1990/01/01","","",""
"2074518","Detection of exfoliated bladder cancer cells by monoclonal antibodies to tumor-associated cell surface antigens","Lin CW, Kirley SD, Khaw AH, Zhang DS, Prout GR Jr.","J Occup Med. 1990 Sep;32(9):910-6. doi: 10.1097/00043764-199009000-00031.","Lin CW","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00031"
"16203077","Lymph node metastasis in bladder cancer","Liedberg F, Månsson W.","Eur Urol. 2006 Jan;49(1):13-21. doi: 10.1016/j.eururo.2005.08.007. Epub 2005 Sep 8.","Liedberg F","Eur Urol","2006","2005/10/06","","","10.1016/j.eururo.2005.08.007"
"27561847","Infiltrating bladder cancer: prognostic factors, follow-up and treatment of relapses","Hernández-Fernández C, Herranz-Amo F, Moralejo-Gárate M, Subirá-Ríos D, Caño-Velasco J, Barbas-Bernardos G.","Actas Urol Esp. 2017 Jul-Aug;41(6):352-358. doi: 10.1016/j.acuro.2016.07.006. Epub 2016 Aug 22.","Hernández-Fernández C","Actas Urol Esp","2017","2016/08/27","","","10.1016/j.acuro.2016.07.006"
"4953602","Supervoltage x-ray therapy of bladder cancer","Mackenzie AR, Whitmore WF Jr, Nickson JJ.","Cancer. 1965 Oct;18(10):1255-60. doi: 10.1002/1097-0142(196510)18:10<1255::aid-cncr2820181007>3.0.co;2-5.","Mackenzie AR","Cancer","1965","1965/10/01","","","10.1002/1097-0142(196510)18:10<1255::aid-cncr2820181007>3.0.co;2-5"
"20591189","Clinical impact of bladder biopsies with TUR-BT according to cytology results in patients with bladder cancer: a case control study","Matsushima M, Kikuchi E, Hasegawa M, Matsumoto K, Miyajima A, Oya M.","BMC Urol. 2010 Jun 30;10:12. doi: 10.1186/1471-2490-10-12.","Matsushima M","BMC Urol","2010","2010/07/02","PMC2912875","","10.1186/1471-2490-10-12"
"18253738","Guidelines for development of diagnostic markers in bladder cancer","Goebell PJ, Groshen SL, Schmitz-Dräger BJ.","World J Urol. 2008 Feb;26(1):5-11. doi: 10.1007/s00345-008-0240-9. Epub 2008 Feb 6.","Goebell PJ","World J Urol","2008","2008/02/07","","","10.1007/s00345-008-0240-9"
"25528636","World Urologic Oncology Federation Bladder Cancer Prevention Program: a global initiative","Klotz L, Brausi MA.","Urol Oncol. 2015 Jan;33(1):25-29. doi: 10.1016/j.urolonc.2014.07.017.","Klotz L","Urol Oncol","2015","2014/12/22","","","10.1016/j.urolonc.2014.07.017"
"2424879","Radiotherapy for squamous carcinoma of the urinary bladder","Quilty PM, Duncan W.","Int J Radiat Oncol Biol Phys. 1986 Jun;12(6):861-5. doi: 10.1016/0360-3016(86)90377-9.","Quilty PM","Int J Radiat Oncol Biol Phys","1986","1986/06/01","","","10.1016/0360-3016(86)90377-9"
"22450840","[A case of late recurrence of urothelial carcinoma in an ileal conduit after radical cystectomy and ileal conduit diversion for bladder cancer]","Yanagi M, Nishimura T, Kimura G, Kondo Y, Yamazaki K, Kojo K, Igarashi T, Hosoda K, Yamamoto Y.","Hinyokika Kiyo. 2012 Feb;58(2):109-12.","Yanagi M","Hinyokika Kiyo","2012","2012/03/28","","",""
"23427740","Narrow-band imaging (NBI) and white light (WLI) transurethral resection of the bladder in the treatment of non-muscle-invasive bladder cancer","Montanari E, de la Rosette J, Longo F, Del Nero A, Laguna P.","Arch Ital Urol Androl. 2012 Dec;84(4):179-83.","Montanari E","Arch Ital Urol Androl","2012","2013/02/23","","",""
"20299042","Marker lesion experiments in bladder cancer--what have we learned?","Gofrit ON, Zorn KC, Shikanov S, Steinberg GD.","J Urol. 2010 May;183(5):1678-84. doi: 10.1016/j.juro.2009.12.104. Epub 2010 Mar 17.","Gofrit ON","J Urol","2010","2010/03/20","","","10.1016/j.juro.2009.12.104"
"2251814","[Changes in protein metabolism and the free amino acid profile in bladder cancer]","Nechiporenko NA, Nefedov LI, Klimovich II.","Vopr Onkol. 1990;36(10):1201-5.","Nechiporenko NA","Vopr Onkol","1990","1990/01/01","","",""
"25726332","Exosomal protein interactors as emerging therapeutic targets in urothelial bladder cancer","Kumari N, Saxena S, Agrawal U.","J Egypt Natl Canc Inst. 2015 Jun;27(2):51-8. doi: 10.1016/j.jnci.2015.02.002. Epub 2015 Feb 25.","Kumari N","J Egypt Natl Canc Inst","2015","2015/03/02","","","10.1016/j.jnci.2015.02.002"
"8797968","Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT","Barentsz JO, Jager GJ, Witjes JA, Ruijs JH.","Eur Radiol. 1996;6(2):129-33. doi: 10.1007/BF00181125.","Barentsz JO","Eur Radiol","1996","1996/01/01","","","10.1007/BF00181125"
"15826749","Expression of the endothelin axis in bladder cancer: relationship to clinicopathologic parameters and long-term survival","Wülfing C, Eltze E, Yamini J, Wülfing P, Bierer S, Böcker W, Hertle L, Semjonow A, Sievert KD.","Eur Urol. 2005 May;47(5):593-600. doi: 10.1016/j.eururo.2004.12.019. Epub 2005 Jan 26.","Wülfing C","Eur Urol","2005","2005/04/14","","","10.1016/j.eururo.2004.12.019"
"19229539","Topic issue on new treatments in bladder cancer","Witjes JA.","World J Urol. 2009 Jun;27(3):285-7. doi: 10.1007/s00345-009-0390-4. Epub 2009 Feb 20.","Witjes JA","World J Urol","2009","2009/02/21","PMC2694317","","10.1007/s00345-009-0390-4"
"31284327","Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cystectomy","Toide M, Yokoyama M, Fujiwara M, Kijima T, Saito K, Fujii Y.","Int J Urol. 2019 Oct;26(10):1010-1012. doi: 10.1111/iju.14054. Epub 2019 Jul 8.","Toide M","Int J Urol","2019","2019/07/09","","","10.1111/iju.14054"
"5627452","[Exfoliated cells of bladder cancer--with special reference to cytodiagnostic specificity]","Yamada T, Inada T.","Gan No Rinsho. 1967 Oct;13(10):765-74.","Yamada T","Gan No Rinsho","1967","1967/10/01","","",""
"24325202","Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base","Smith AB, Deal AM, Woods ME, Wallen EM, Pruthi RS, Chen RC, Milowsky MI, Nielsen ME.","BJU Int. 2014 Nov;114(5):719-26. doi: 10.1111/bju.12601. Epub 2014 Apr 16.","Smith AB","BJU Int","2014","2013/12/12","","","10.1111/bju.12601"
"20940694","Tissue-based molecular markers for bladder cancer","Barbieri CE, Lotan Y, Lee RK, Sonpavde G, Karakiewicz PI, Robinson B, Scherr DS, Shariat SF.","Minerva Urol Nefrol. 2010 Sep;62(3):241-58.","Barbieri CE","Minerva Urol Nefrol","2010","2010/10/14","","",""
"3314068","Evaluation and management of patients with superficial bladder cancer","Soloway MS.","Urol Clin North Am. 1987 Nov;14(4):771-80.","Soloway MS","Urol Clin North Am","1987","1987/11/01","","",""
"16964190","The prognostic and staging value of lymph node dissection in the treatment of invasive bladder cancer","Sanderson KM, Skinner D, Stein JP.","Nat Clin Pract Urol. 2006 Sep;3(9):485-94. doi: 10.1038/ncpuro0582.","Sanderson KM","Nat Clin Pract Urol","2006","2006/09/12","","","10.1038/ncpuro0582"
"7414706","A study on the etiological factors of bilharzial bladder cancer in Egypt: 5-urinary nitrite in a rural population","El-Aaser AA, El-Merzabani MM, El-Bolkainy MN, Ibrahim AS, Zakhary NI, El-Morsi B.","Tumori. 1980 Aug 31;66(4):409-14.","El-Aaser AA","Tumori","1980","1980/08/31","","",""
"28544298","Bladder cancer - Old lessons yet to be learned","Hayne D.","BJU Int. 2017 May;119 Suppl 5:7. doi: 10.1111/bju.13869.","Hayne D","BJU Int","2017","2017/05/26","","","10.1111/bju.13869"
"25533611","Sex differences in bladder cancer pathology and survival: analysis of a population-based cancer registry","Zaitsu M, Toyokawa S, Tonooka A, Nakamura F, Takeuchi T, Homma Y, Kobayashi Y.","Cancer Med. 2015 Mar;4(3):363-70. doi: 10.1002/cam4.379. Epub 2014 Dec 23.","Zaitsu M","Cancer Med","2015","2014/12/24","PMC4380962","","10.1002/cam4.379"
"28551678","Radiotherapy of Primary or Recurrent Bladder Cancer in the Very Elderly","Janssen S, Manig L, Schild SE, Rades D.","Anticancer Res. 2017 Jun;37(6):3287-3290. doi: 10.21873/anticanres.11694.","Janssen S","Anticancer Res","2017","2017/05/29","","","10.21873/anticanres.11694"
"18769377","Management of muscle-invasive bladder cancer: an update","Ghoneim MA, Abol-Enein H.","Nat Clin Pract Urol. 2008 Sep;5(9):501-8. doi: 10.1038/ncpuro1202.","Ghoneim MA","Nat Clin Pract Urol","2008","2008/09/05","","","10.1038/ncpuro1202"
"17628305","Searching for novel therapeutics and targets: insights from clinical trials","Mitra AP, Cote RJ.","Urol Oncol. 2007 Jul-Aug;25(4):341-3. doi: 10.1016/j.urolonc.2007.05.004.","Mitra AP","Urol Oncol","2007","2007/07/14","","","10.1016/j.urolonc.2007.05.004"
"25096609","Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up","Bellmunt J, Orsola A, Leow JJ, Wiegel T, De Santis M, Horwich A; ESMO Guidelines Working Group.","Ann Oncol. 2014 Sep;25 Suppl 3:iii40-8. doi: 10.1093/annonc/mdu223. Epub 2014 Aug 5.","Bellmunt J","Ann Oncol","2014","2014/08/07","","","10.1093/annonc/mdu223"
"17728339","High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk","Chen M, Kamat AM, Huang M, Grossman HB, Dinney CP, Lerner SP, Wu X, Gu J.","Carcinogenesis. 2007 Oct;28(10):2160-5. doi: 10.1093/carcin/bgm167. Epub 2007 Aug 29.","Chen M","Carcinogenesis","2007","2007/08/31","","","10.1093/carcin/bgm167"
"19070628","Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer","Wang M, Wang M, Cheng G, Zhang Z, Fu G, Zhang Z.","Mutat Res. 2009 Feb 10;661(1-2):85-92. doi: 10.1016/j.mrfmmm.2008.11.009. Epub 2008 Nov 25.","Wang M","Mutat Res","2009","2008/12/17","","","10.1016/j.mrfmmm.2008.11.009"
"27775374","A model of thermotherapy treatment for bladder cancer","Sadee C, Kashdan E.","Math Biosci Eng. 2016 Dec 1;13(6):1169-1183. doi: 10.3934/mbe.2016037.","Sadee C","Math Biosci Eng","2016","2016/10/25","","","10.3934/mbe.2016037"
"2675010","Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group","Bono AV, Benvenuti C, Reali L, Pozzi E, Gibba A, Cosciani-Cunico S, Comuzzi U, Anselmo G.","Prog Clin Biol Res. 1989;303:533-40.","Bono AV","Prog Clin Biol Res","1989","1989/01/01","","",""
"19447328","[What's new in 2008 in the field of basic and clinical research in bladder cancer?]","Phé V, Rouprêt M, Irani J.","Prog Urol. 2009 May;19 Suppl 2:S43-50. doi: 10.1016/S1166-7087(09)73894-1.","Phé V","Prog Urol","2009","2009/05/19","","","10.1016/S1166-7087(09)73894-1"
"22218530","Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer","Mizutani Y, Katsuoka Y, Bonavida B.","Int J Oncol. 2012 Apr;40(4):1246-50. doi: 10.3892/ijo.2012.1324. Epub 2012 Jan 3.","Mizutani Y","Int J Oncol","2012","2012/01/06","PMC3584575","","10.3892/ijo.2012.1324"
"19846973","Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer","Cormio L, Tolve I, Annese P, Saracino A, Zamparese R, Sanguedolce F, Bufo P, Battaglia M, Selvaggi FP, Carrieri G.","Anticancer Res. 2009 Oct;29(10):4201-4.","Cormio L","Anticancer Res","2009","2009/10/23","","",""
"9749083","[Treatment of cancer of the bladder in elderly patients with an intra-arterial chemotherapy and radiotherapy combination: 10-year experience]","Eapen L, Stewart D, Grimard L, Crook J, Futter N, Aref I, Huan S, Rasuli P, Peterson R.","Cancer Radiother. 1998 Apr;2 Suppl 1:73s-76s.","Eapen L","Cancer Radiother","1998","1998/09/28","","",""
"9036458","[Role of computerized tomography in bladder carcinoma treated with simultaneous combined radiotherapy and chemotherapy]","Preziosi P, Orefici F, Di Renzi P, La Vecchia L, Tirindelli-Danesi D, Giacobini S, Cruciani E, Fabiano A, Orlacchio A.","Radiol Med. 1996 Nov;92(5):629-33.","Preziosi P","Radiol Med","1996","1996/11/01","","",""
"19451891","Outcomes and response to therapy in bladder cancer. Are biomarkers of any help?","Goebell PJ.","Minerva Urol Nefrol. 2009 Jun;61(2):91-107.","Goebell PJ","Minerva Urol Nefrol","2009","2009/05/20","","",""
"23559131","[When the conservative treatment in high-risk non-muscle invasive bladder cancer patients should be abandoned]","Colombo R, Maccagnano C, Rocchini L, Pellucchi F.","Urologia. 2013;80 Suppl 21:48-52. doi: 10.5301/RU.2013.10866. Epub 2013 Mar 22.","Colombo R","Urologia","2013","2013/04/06","","","10.5301/RU.2013.10866"
"3777830","Single-stage versus two-stage diversion-cystectomy in treatment of bladder cancer: a comparative study","Lindell O, Lehtonen T.","Ann Chir Gynaecol. 1986;75(4):225-8.","Lindell O","Ann Chir Gynaecol","1986","1986/01/01","","",""
"16443246","Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in Ghana","Shiff C, Veltri R, Naples J, Quartey J, Otchere J, Anyan W, Marlow C, Wiredu E, Adjei A, Brakohiapa E, Bosompem K.","Trans R Soc Trop Med Hyg. 2006 Sep;100(9):847-54. doi: 10.1016/j.trstmh.2005.10.010. Epub 2006 Jan 26.","Shiff C","Trans R Soc Trop Med Hyg","2006","2006/01/31","","","10.1016/j.trstmh.2005.10.010"
"3788302","[Value of angiography and computerized tomography for preoperative evaluation of bladder cancer]","Schwarzbach C, Freitag J, Müller GW, Freitag G.","Z Urol Nephrol. 1986 Sep;79(9):517-23.","Schwarzbach C","Z Urol Nephrol","1986","1986/09/01","","",""
"2726237","[Repeated yearly BCG treatment in superficial bladder cancer]","Somogyi L, Török A, Bors G, Drinóczy M, Horváth R.","Orv Hetil. 1989 Mar 26;130(13):671-3.","Somogyi L","Orv Hetil","1989","1989/03/26","","",""
"19282102","Editorial comment on: Serum proteomic profiling in patients with bladder cancer","Lotan Y.","Eur Urol. 2009 Dec;56(6):996-7. doi: 10.1016/j.eururo.2009.02.032. Epub 2009 Mar 6.","Lotan Y","Eur Urol","2009","2009/03/14","","","10.1016/j.eururo.2009.02.032"
"7541181","[A case of bladder cancer producing alpha-fetoprotein (AFP)]","Takayama H.","Hinyokika Kiyo. 1995 May;41(5):387-9.","Takayama H","Hinyokika Kiyo","1995","1995/05/01","","",""
"1942334","Multivariate analysis of flow cytometric deoxyribonucleic acid parameters and histological features for prognosis of bladder cancer patients","Tachibana M, Deguchi N, Baba S, Jitsukawa S, Hata M, Tazaki H.","J Urol. 1991 Dec;146(6):1530-4. doi: 10.1016/s0022-5347(17)38158-2.","Tachibana M","J Urol","1991","1991/12/01","","","10.1016/s0022-5347(17)38158-2"
"20811698","Novel bladder preservation therapy for locally invasive bladder cancer: combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation","Azuma H, Inamoto T, Ibuki N, Ubai T, Kotake Y, Takahara K, Kiyama S, Nomi H, Uehara H, Komura K, Yamamoto K, Narumi Y, Katsuoka Y.","Int J Oncol. 2010 Oct;37(4):773-85. doi: 10.3892/ijo_00000727.","Azuma H","Int J Oncol","2010","2010/09/03","","","10.3892/ijo_00000727"
"12553324","Bladder-sparing procedure as good as cystectomy for treating invasive bladder cancer","Rollins G.","Rep Med Guidel Outcomes Res. 2002 Aug 9;13(15):7-9.","Rollins G","Rep Med Guidel Outcomes Res","2002","2003/01/30","","",""
"24390799","Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710","Christodouleas JP, Baumann BC, He J, Hwang WT, Tucker KN, Bekelman JE, Tangen CM, Lerner SP, Guzzo TJ, Malkowicz SB, Herr H.","Cancer. 2014 Apr 15;120(8):1272-80. doi: 10.1002/cncr.28544. Epub 2014 Jan 3.","Christodouleas JP","Cancer","2014","2014/01/07","","","10.1002/cncr.28544"
"19740595","An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer","Kulkarni GS, Hakenberg OW, Gschwend JE, Thalmann G, Kassouf W, Kamat A, Zlotta A.","Eur Urol. 2010 Jan;57(1):60-70. doi: 10.1016/j.eururo.2009.08.024. Epub 2009 Sep 1.","Kulkarni GS","Eur Urol","2010","2009/09/11","","","10.1016/j.eururo.2009.08.024"
"6429779","[Possibilities and limitations of computed tomographic staging of bladder carcinoma]","Lorenz R, Beyer D, Allhoff E, Mödder U.","Rofo. 1984 Jun;140(6):660-5. doi: 10.1055/s-2008-1053049.","Lorenz R","Rofo","1984","1984/06/01","","","10.1055/s-2008-1053049"
"20657287","Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers?","Gakis G, Kruck S, Stenzl A.","Curr Opin Urol. 2010 Sep;20(5):388-92. doi: 10.1097/MOU.0b013e32833cc9f4.","Gakis G","Curr Opin Urol","2010","2010/07/27","","","10.1097/MOU.0b013e32833cc9f4"
"19231102","Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy","Weiss C, von Römer F, Capalbo G, Ott OJ, Wittlinger M, Krause SF, Sauer R, Rödel C, Rödel F.","Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1455-60. doi: 10.1016/j.ijrobp.2008.10.063. Epub 2009 Feb 21.","Weiss C","Int J Radiat Oncol Biol Phys","2009","2009/02/24","","","10.1016/j.ijrobp.2008.10.063"
"18171646","Case-control study of the effects of trihalomethanes on urinary bladder cancer risk","Bove GE Jr, Rogerson PA, Vena JE.","Arch Environ Occup Health. 2007 Spring;62(1):39-47. doi: 10.3200/AEOH.62.1.39-47.","Bove GE Jr","Arch Environ Occup Health","2007","2008/01/04","","","10.3200/AEOH.62.1.39-47"
"8911360","A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer","Pawinski A, Sylvester R, Kurth KH, Bouffioux C, van der Meijden A, Parmar MK, Bijnens L.","J Urol. 1996 Dec;156(6):1934-40, discussion 1940-1.","Pawinski A","J Urol","1996","1996/12/01","","",""
"16336089","Adjuvant chemotherapy for bladder cancer","Sternberg CN, Calabró F.","Expert Rev Anticancer Ther. 2005 Dec;5(6):987-92. doi: 10.1586/14737140.5.6.987.","Sternberg CN","Expert Rev Anticancer Ther","2005","2005/12/13","","","10.1586/14737140.5.6.987"
"30357590","Performance Measurement and Quality Improvement Initiatives for Bladder Cancer Care","Ristau BT, Smaldone MC.","Curr Urol Rep. 2018 Oct 24;19(12):100. doi: 10.1007/s11934-018-0856-2.","Ristau BT","Curr Urol Rep","2018","2018/10/26","","","10.1007/s11934-018-0856-2"
"25677026","Comparative effectiveness research in urologic cancers","Strope SA.","Cancer Treat Res. 2015;164:221-35. doi: 10.1007/978-3-319-12553-4_12.","Strope SA","Cancer Treat Res","2015","2015/02/14","","","10.1007/978-3-319-12553-4_12"
"3106633","Cost-effectiveness of investigations for invasive bladder cancer","Hunt MT, Woodhouse CR.","J R Soc Med. 1987 Mar;80(3):143-4.","Hunt MT","J R Soc Med","1987","1987/03/01","PMC1290718","",""
"17723968","Intravesical antineoplastic therapy following transurethral resection of bladder tumors: nursing implications from the operating room to discharge","Washburn DJ.","Clin J Oncol Nurs. 2007 Aug;11(4):553-9. doi: 10.1188/07.CJON.553-559.","Washburn DJ","Clin J Oncol Nurs","2007","2007/08/29","","","10.1188/07.CJON.553-559"
"21365347","[Exfoliative urine cytology in the treatment of bladder cancer]","Tschirdewahn S, Vom Dorp F, Rübben H, Hakenberg OW.","Urologe A. 2011 Mar;50(3):292-6. doi: 10.1007/s00120-010-2410-9.","Tschirdewahn S","Urologe A","2011","2011/03/03","","","10.1007/s00120-010-2410-9"
"9634043","The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index","Allard P, Bernard P, Fradet Y, Têtu B.","Br J Urol. 1998 May;81(5):692-8. doi: 10.1046/j.1464-410x.1998.00628.x.","Allard P","Br J Urol","1998","1998/06/20","","","10.1046/j.1464-410x.1998.00628.x"
"24187851","[First experiences of laparoscopic radical cystectomy]","Karashima T, Inoue K, Fukata S, Ashida S, Shimamoto T, Fukuhara H, Anchi T, Kamei M, Tamura K, Yamasaki I, Kamada M, Satake H, Shuin T.","Nihon Hinyokika Gakkai Zasshi. 2013 Sep;104(5):644-50. doi: 10.5980/jpnjurol.104.644.","Karashima T","Nihon Hinyokika Gakkai Zasshi","2013","2013/11/06","","","10.5980/jpnjurol.104.644"
"732065","[In vitro sensitivity of bladder cancer cells (T24) to various anticancer drugs and intravesical use of a selected drug (author's transl)]","Kato T, Kumagai I, Miura K, Nemoto R, Nishimoto T.","Nihon Hinyokika Gakkai Zasshi. 1978 Oct;69(10):1308-13. doi: 10.5980/jpnjurol1928.69.10_1308.","Kato T","Nihon Hinyokika Gakkai Zasshi","1978","1978/10/01","","","10.5980/jpnjurol1928.69.10_1308"
"29925938","Loss of Fezf2 promotes malignant progression of bladder cancer by regulating the NF-κB signaling pathway","Chen Z, Zhou L, Liu X, Wang L, Kazobinka G, Zhang X, Hou T.","Lab Invest. 2018 Sep;98(9):1225-1236. doi: 10.1038/s41374-018-0077-9. Epub 2018 Jun 20.","Chen Z","Lab Invest","2018","2018/06/22","","","10.1038/s41374-018-0077-9"
"8032829","The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer","","Br J Urol. 1994 Jun;73(6):632-8. doi: 10.1111/j.1464-410x.1994.tb07547.x.","","Br J Urol","1994","1994/06/01","","","10.1111/j.1464-410x.1994.tb07547.x"
"8918660","[Consideration of therapeutic choice for grade 3 superficial bladder cancer]","Noguchi S, Kubota Y, Takase K, Masuda M, Yao M, Hosaka M, Miura T, Kondoh I, Kawasaki C, Moriyama M.","Hinyokika Kiyo. 1996 Sep;42(9):635-8.","Noguchi S","Hinyokika Kiyo","1996","1996/09/01","","",""
"30315954","Recent advances in optical imaging technologies for the detection of bladder cancer","Raharja PAR, Hamid ARAH, Mochtar CA, Umbas R.","Photodiagnosis Photodyn Ther. 2018 Dec;24:192-197. doi: 10.1016/j.pdpdt.2018.10.009. Epub 2018 Oct 10.","Raharja PAR","Photodiagnosis Photodyn Ther","2018","2018/10/14","","","10.1016/j.pdpdt.2018.10.009"
"18190825","Tissue microarray based analysis of prognostic markers in invasive bladder cancer: much effort to no avail?","Liedberg F, Anderson H, Chebil G, Gudjonsson S, Höglund M, Lindgren D, Lundberg LM, Lövgren K, Fernö M, Månsson W.","Urol Oncol. 2008 Jan-Feb;26(1):17-24. doi: 10.1016/j.urolonc.2006.08.021. Epub 2007 Oct 22.","Liedberg F","Urol Oncol","2008","2008/01/15","","","10.1016/j.urolonc.2006.08.021"
"16155471","Corrections to: Markowitz SB, Levin K. Continued epidemic of bladder cancer in workers exposed to ortho-toluidine in a chemical factory. J Occup Environ Med. 2004;46:154-160","Markowitz SB.","J Occup Environ Med. 2005 Sep;47(9):875-7. doi: 10.1097/01.jom.0000169128.43064.8b.","Markowitz SB","J Occup Environ Med","2005","2005/09/13","","","10.1097/01.jom.0000169128.43064.8b"
"21599969","Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine","Chen PC, Tsai MH, Yip SK, Jou YC, Ng CF, Chen Y, Wang X, Huang W, Tung CL, Chen GC, Huang MM, Tong JH, Song EJ, Chang DC, Hsu CD, To KF, Shen CH, Chan MW.","BMC Med Genomics. 2011 May 20;4:45. doi: 10.1186/1755-8794-4-45.","Chen PC","BMC Med Genomics","2011","2011/05/24","PMC3127971","","10.1186/1755-8794-4-45"
"2376434","Occupation and the risk of bladder cancer","la Vecchia C, Negri E, D'Avanzo B, Franceschi S.","Int J Epidemiol. 1990 Jun;19(2):264-8. doi: 10.1093/ije/19.2.264.","la Vecchia C","Int J Epidemiol","1990","1990/06/01","","","10.1093/ije/19.2.264"
"23906232","Effect of laminin 332 on motility and invasion in bladder cancer","Kang SG, Ha YR, Ko YH, Kang SH, Joo KJ, Cho HY, Park HS, Kim CH, Kwon SY, Kim JJ, Cheon J, Lee JG.","Kaohsiung J Med Sci. 2013 Aug;29(8):422-9. doi: 10.1016/j.kjms.2012.12.003. Epub 2013 Feb 14.","Kang SG","Kaohsiung J Med Sci","2013","2013/08/03","","","10.1016/j.kjms.2012.12.003"
"8693967","[Recurrent and up-grading bladder cancer in a young female: a case report]","Ouchi H, Noguchi S, Masuda M, Yao M, Kubota Y, Hosaka M.","Hinyokika Kiyo. 1996 Apr;42(4):311-3.","Ouchi H","Hinyokika Kiyo","1996","1996/04/01","","",""
"26865049","Mycobacterium phlei cell wall-nucleic acid complex in the treatment of nonmuscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin","Morales A, Cohen Z.","Expert Opin Biol Ther. 2016;16(2):273-83. doi: 10.1517/14712598.2016.1134483.","Morales A","Expert Opin Biol Ther","2016","2016/02/12","","","10.1517/14712598.2016.1134483"
"1891991","[Immunohistochemical localization of proteoglycans in interstitial elements of human bladder cancer]","Takamura S, Miyake K, Takeuchi J.","Hinyokika Kiyo. 1991 Apr;37(4):329-34.","Takamura S","Hinyokika Kiyo","1991","1991/04/01","","",""
"20418013","Does routine second transurethral resection affect the long-term outcome of patients with T1 bladder cancer? Why a flawed randomized controlled trial cannot address the issue","Novara G, Ficarra V.","Eur Urol. 2010 Aug;58(2):193-4. doi: 10.1016/j.eururo.2010.04.012. Epub 2010 Apr 21.","Novara G","Eur Urol","2010","2010/04/27","","","10.1016/j.eururo.2010.04.012"
"30104615","Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer","Perera M, McGrath S, Sengupta S, Crozier J, Bolton D, Lawrentschuk N.","Nat Rev Urol. 2018 Nov;15(11):686-692. doi: 10.1038/s41585-018-0066-1.","Perera M","Nat Rev Urol","2018","2018/08/15","","","10.1038/s41585-018-0066-1"
"12469123","Identifying distinct classes of bladder carcinoma using microarrays","Dyrskjøt L, Thykjaer T, Kruhøffer M, Jensen JL, Marcussen N, Hamilton-Dutoit S, Wolf H, Orntoft TF.","Nat Genet. 2003 Jan;33(1):90-6. doi: 10.1038/ng1061. Epub 2002 Dec 9.","Dyrskjøt L","Nat Genet","2003","2002/12/07","","","10.1038/ng1061"
"15606330","Management of muscle-invasive bladder cancer in the elderly","Basso U, Bassi P, Sava T, Monfardini S.","Expert Rev Anticancer Ther. 2004 Dec;4(6):1017-35. doi: 10.1586/14737140.4.6.1017.","Basso U","Expert Rev Anticancer Ther","2004","2004/12/21","","","10.1586/14737140.4.6.1017"
"3986451","Ileocaeco-urethroplasty after total cystectomy for bladder cancer","Alcini E, Vincenzoni M, Destito A, D'Addessi A, Castiglioni GC.","Br J Urol. 1985 Apr;57(2):160-3. doi: 10.1111/j.1464-410x.1985.tb06412.x.","Alcini E","Br J Urol","1985","1985/04/01","","","10.1111/j.1464-410x.1985.tb06412.x"
"28247730","[The role of telomerase activity in non-invasive diagnostics of bladder cancer]","Glybochko PV, Alyaev JG, Potoldykova NV, Polyakovsky KA, Vinarov AZ, Glukhov AI, Gordeev SA.","Urologiia. 2016 Aug;(4):76-81.","Glybochko PV","Urologiia","2016","2017/03/02","","",""
"1801981","Urothelial bladder biopsy--important evolution prognosis factor of superficial bladder cancer under intravesical Bacille Calmette-Guérin therapy","Geavlete P, Taşcă C.","Rom J Morphol Embryol. 1991 Jan-Jun;37(1-2):61-8.","Geavlete P","Rom J Morphol Embryol","1991","1991/01/01","","",""
"23778020","Precise morphologic documentation with large-format histology of clinical findings in a bladder cancer patient","Galosi AB, Cheng L, Lopez-Beltran A, Montorsi F, Scarpelli M, Mazzucchelli R, Montironi R.","Eur Urol. 2013 Sep;64(3):519-21. doi: 10.1016/j.eururo.2013.06.001. Epub 2013 Jun 12.","Galosi AB","Eur Urol","2013","2013/06/20","","","10.1016/j.eururo.2013.06.001"
"32284533","Malignancies of suprapubic catheter (SPC) tracts in spinal cord injury patients: a case series and review of literature","Prattley S, New F, Davies M.","Spinal Cord Ser Cases. 2019 Apr 15;5(1):34. doi: 10.1038/s41394-019-0177-9.","Prattley S","Spinal Cord Ser Cases","2019","2020/04/15","","","10.1038/s41394-019-0177-9"
"12452614","Staging error in the bladder tumor: the correlation between stage of TUR and cystectomy","Bayraktar Z, Gurbuz G, Taşci AI, Sevin G.","Int Urol Nephrol. 2001;33(4):627-9. doi: 10.1023/a:1020553812554.","Bayraktar Z","Int Urol Nephrol","2001","2002/11/28","","","10.1023/a:1020553812554"
"8015072","Neoadjuvant intra-arterial doxorubicin chemotherapy in combination with low dose radiotherapy for the treatment of locally advanced transitional cell carcinoma of the bladder","Sumiyoshi Y, Yokota K, Akiyama M, Inoue Y, Yoneda F, Tsujimura H, Nakajima M, Yokozeki H, Maebayashi K.","J Urol. 1994 Aug;152(2 Pt 1):362-6. doi: 10.1016/s0022-5347(17)32740-4.","Sumiyoshi Y","J Urol","1994","1994/08/01","","","10.1016/s0022-5347(17)32740-4"
"22722366","Recurrence and progression in non-muscle-invasive bladder cancer using EORTC risk tables","Altieri VM, Castellucci R, Palumbo P, Verratti V, Sut M, Olivieri R, Manco R, Ricciardulli S, Nicolai M, Criniti P, Tenaglia RL.","Urol Int. 2012;89(1):61-6. doi: 10.1159/000336516. Epub 2012 Jun 19.","Altieri VM","Urol Int","2012","2012/06/23","","","10.1159/000336516"
"23266053","A clinical review of small-cell carcinoma of the urinary bladder","Thota S, Kistangari G, Daw H, Spiro T.","Clin Genitourin Cancer. 2013 Jun;11(2):73-7. doi: 10.1016/j.clgc.2012.11.002. Epub 2012 Dec 23.","Thota S","Clin Genitourin Cancer","2013","2012/12/26","","","10.1016/j.clgc.2012.11.002"
"330958","Five-year follow-up results of a collaborative study of therapies for carcinoma of the bladder","Slack NH, Bross ID, Prout GR Jr.","J Surg Oncol. 1977;9(4):393-405. doi: 10.1002/jso.2930090410.","Slack NH","J Surg Oncol","1977","1977/01/01","","","10.1002/jso.2930090410"
"24841793","Expression profiles of variation integration genes in bladder urothelial carcinoma","Wang JM, Wang YQ, Gao ZL, Wu JT, Shi BK, Yu CC.","Genet Mol Res. 2014 Apr 30;13(2):3486-94. doi: 10.4238/2014.April.30.9.","Wang JM","Genet Mol Res","2014","2014/05/21","","","10.4238/2014.April.30.9"
"7602742","Analysis of known risk factors for bladder cancer in Pakistani population","Hashmi AH, Naqvi AA, Rizvi AH.","J Pak Med Assoc. 1995 Feb;45(2):41-2.","Hashmi AH","J Pak Med Assoc","1995","1995/02/01","","",""
"12474524","p21 gene codon 31 polymorphism is associated with bladder cancer","Chen WC, Wu HC, Hsu CD, Chen HY, Tsai FJ.","Urol Oncol. 2002 Mar-Apr;7(2):63-6. doi: 10.1016/s1078-1439(01)00152-1.","Chen WC","Urol Oncol","2002","2002/12/12","","","10.1016/s1078-1439(01)00152-1"
"6180792","The role of palliative urinary diversion in the management of bladder cancer","Kirk D, Slade N, Feneley RC.","Br J Urol. 1982 Aug;54(4):363-5. doi: 10.1111/j.1464-410x.1982.tb08944.x.","Kirk D","Br J Urol","1982","1982/08/01","","","10.1111/j.1464-410x.1982.tb08944.x"
"8966844","Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in superficial bladder cancer. Finnbladder Group","Liukkonen TJ, Lipponen PK, Helle M, Haapasalo HK, Nordling S, Rajala P.","Urol Res. 1996;24(1):61-6. doi: 10.1007/BF00296736.","Liukkonen TJ","Urol Res","1996","1996/01/01","","","10.1007/BF00296736"
"6792169","Factors of prognostic and therapeutic significance in patients with bladder cancer","Batata MA, Chu FC, Hilaris BS, Kim YS, Lee MZ, Chung S, Whitmore WF.","Int J Radiat Oncol Biol Phys. 1981 May;7(5):575-9. doi: 10.1016/0360-3016(81)90368-0.","Batata MA","Int J Radiat Oncol Biol Phys","1981","1981/05/01","","","10.1016/0360-3016(81)90368-0"
"10411075","Re: NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer","Casella R, Lehmann K, Gasser TC.","J Urol. 1999 Aug;162(2):500-1. doi: 10.1016/s0022-5347(05)68609-0.","Casella R","J Urol","1999","1999/07/20","","","10.1016/s0022-5347(05)68609-0"
"26076423","[Activity and efficacy of vinflunine in metastatic carcinoma of the bladder after failure of adjuvant treatment: description of a clinical case]","Morelli F.","Recenti Prog Med. 2015 Jun;106(6):e300-5. doi: 10.1701/1884.20570.","Morelli F","Recenti Prog Med","2015","2015/06/16","","","10.1701/1884.20570"
"16846680","Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature","Fahmy NM, Mahmud S, Aprikian AG.","Eur Urol. 2006 Dec;50(6):1176-82. doi: 10.1016/j.eururo.2006.05.046. Epub 2006 Jun 13.","Fahmy NM","Eur Urol","2006","2006/07/19","","","10.1016/j.eururo.2006.05.046"
"25065704","Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward","Apolo AB, Hoffman V, Kaag MG, Latini DM, Lee CT, Rosenberg JE, Knowles M, Theodorescu D, Czerniak BA, Efstathiou JA, Albert ML, Sridhar SS, Margulis V, Matin SF, Galsky MD, Hansel D, Kamat AM, Flaig TW, Smith AB, Messing E, Zipursky Quale D, Lotan Y.","Urol Oncol. 2015 Feb;33(2):53-64. doi: 10.1016/j.urolonc.2014.06.013. Epub 2014 Jul 25.","Apolo AB","Urol Oncol","2015","2014/07/29","PMC6776416","NIHMS1038429","10.1016/j.urolonc.2014.06.013"
"8456189","Neoadjuvant versus adjuvant chemotherapy in invasive bladder cancer","Scher HI.","Recent Results Cancer Res. 1993;126:189-205. doi: 10.1007/978-3-642-84583-3_18.","Scher HI","Recent Results Cancer Res","1993","1993/01/01","","","10.1007/978-3-642-84583-3_18"
"11291129","Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy","Dunst J, Rödel C, Zietman A, Schrott KM, Sauer R, Shipley WU.","Semin Surg Oncol. 2001 Jan-Feb;20(1):24-32. doi: 10.1002/ssu.1013.","Dunst J","Semin Surg Oncol","2001","2001/04/06","","","10.1002/ssu.1013"
"11464030","Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients","Retz M, Lehmann J, Röder C, Weichert-Jacobsen K, Loch T, Romahn E, Lühl C, Kalthoff H, Stöckle M.","Eur Urol. 2001 May;39(5):507-15; discussion 516-7. doi: 10.1159/000052496.","Retz M","Eur Urol","2001","2001/07/21","","","10.1159/000052496"
"3743597","Evaluation of a double-monoclonal radioimmunoassay for the measurement of carcinoembryonic antigen in the urine of patients with bladder cancer","Hetherington JW, Ewing R, Cooper EH.","Eur Urol. 1986;12(4):270-3. doi: 10.1159/000472634.","Hetherington JW","Eur Urol","1986","1986/01/01","","","10.1159/000472634"
"28696839","Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis","Lukas C, Selinski S, Prager HM, Blaszkewicz M, Hengstler JG, Golka K.","J Toxicol Environ Health A. 2017;80(7-8):439-452. doi: 10.1080/10937404.2017.1304731. Epub 2017 Jul 11.","Lukas C","J Toxicol Environ Health A","2017","2017/07/12","","","10.1080/10937404.2017.1304731"
"19462820","[Effect of prophylactic intravesical instillation of BCG for superficial bladder cancer]","Segawa N, Inamoto T, Nomi H, Ibuki N, Azuma H, Katsuoka Y.","Hinyokika Kiyo. 2009 Apr;55(4):175-80.","Segawa N","Hinyokika Kiyo","2009","2009/05/26","","",""
"18184174","Clinical outcome of radical cystectomy for patients with pT4 bladder cancer","Furukawa J, Miyake H, Hara I, Takenaka A, Fujisawa M.","Int J Urol. 2008 Jan;15(1):58-61. doi: 10.1111/j.1442-2042.2007.01916.x.","Furukawa J","Int J Urol","2008","2008/01/11","","","10.1111/j.1442-2042.2007.01916.x"
"8073942","[Infiltrating bladder carcinoma: influence of complementary treatment on local control and survival]","Berián Polo JM, Zudaire Bergera JJ, Robles García JE, de Castro Barbosa F.","Actas Urol Esp. 1994 May;18 Suppl:520-6.","Berián Polo JM","Actas Urol Esp","1994","1994/05/01","","",""
"9495703","Should continent diversion be performed in patients with locally advanced bladder cancer?","Ward AM, Olencki T, Peerboom D, Klein EA.","Urology. 1998 Feb;51(2):232-6. doi: 10.1016/s0090-4295(97)00501-3.","Ward AM","Urology","1998","1998/03/12","","","10.1016/s0090-4295(97)00501-3"
"2214477","[The study of BBN induced bladder cancer in mice. Influence of Freund complete adjuvant and associated immunological reactions in mice]","Saito B, Ohashi T, Togashi M, Koyanagi T.","Nihon Hinyokika Gakkai Zasshi. 1990 Jul;81(7):993-6. doi: 10.5980/jpnjurol1989.81.993.","Saito B","Nihon Hinyokika Gakkai Zasshi","1990","1990/07/01","","","10.5980/jpnjurol1989.81.993"
"18475256","The origins of bladder cancer","Crawford JM.","Lab Invest. 2008 Jul;88(7):686-93. doi: 10.1038/labinvest.2008.48. Epub 2008 May 12.","Crawford JM","Lab Invest","2008","2008/05/14","","","10.1038/labinvest.2008.48"
"25792473","Clinical significance of the VEGF level in urinary bladder carcinoma","Sankhwar M, Sankhwar SN, Abhishek A, Rajender S.","Cancer Biomark. 2015;15(4):349-55. doi: 10.3233/CBM-150478.","Sankhwar M","Cancer Biomark","2015","2015/03/21","","","10.3233/CBM-150478"
"18384859","Bladder cancer in Native Americans and Alaskan Natives","Watson RA, Sidor M.","Urology. 2008 Jul;72(1):10-4. doi: 10.1016/j.urology.2007.12.087. Epub 2008 Apr 2.","Watson RA","Urology","2008","2008/04/04","","","10.1016/j.urology.2007.12.087"
"5337777","Epidemiology of urinary bladder cancer. A review of selected literature","King H, Bailar JC 3rd.","J Chronic Dis. 1966 Jul;19(7):735-72. doi: 10.1016/0021-9681(66)90074-9.","King H","J Chronic Dis","1966","1966/07/01","","","10.1016/0021-9681(66)90074-9"
"27617552","Failure of Bacillus Calmette-Guérin therapy in non-muscle-invasive bladder cancer: Definition and treatment options","Gual Frau J, Palou J, Rodríguez O, Parada R, Breda A, Villavicencio H.","Arch Esp Urol. 2016 Sep;69(7):423-33.","Gual Frau J","Arch Esp Urol","2016","2016/09/13","","",""
"8343264","The changing importance of prognostic factors in bladder cancer during a long-term follow-up","Lipponen P.","Eur J Cancer. 1993;29A(9):1261-5. doi: 10.1016/0959-8049(93)90069-r.","Lipponen P","Eur J Cancer","1993","1993/01/01","","","10.1016/0959-8049(93)90069-r"
"3303592","Epithelial membrane antigen as an immunohistochemical marker for transitional cell carcinoma of the urinary bladder","Takashi M, Murase T, Kinjo T, Mitsuya H, Nagura H.","Urol Int. 1987;42(3):170-5. doi: 10.1159/000281888.","Takashi M","Urol Int","1987","1987/01/01","","","10.1159/000281888"
"81868","[Hyperthermic treatment of the bladder cancer: combined hyperthermic treatment with bleomycin and/or radiation (author's transl)]","Kubota Y, Nishimura R, Takai S, Fukushima S.","Nihon Gan Chiryo Gakkai Shi. 1978 Aug 20;13(4):394-405.","Kubota Y","Nihon Gan Chiryo Gakkai Shi","1978","1978/08/20","","",""
"6755854","Treatment of stage D bladder cancer with adjuvant doxorubicin hydrochloride and radiation","Schaeffer AJ, Grayhack JT, Merrill JM, Bulkley GJ, Shetty RM.","Urology. 1982 Oct;20(4):393-400. doi: 10.1016/0090-4295(82)90463-0.","Schaeffer AJ","Urology","1982","1982/10/01","","","10.1016/0090-4295(82)90463-0"
"26647897","[Immunotherapy of Urothelial Carcinoma of the Bladder -  from BCG Vaccines to Targeted Therapy]","Matoušková M.","Klin Onkol. 2015;28 Suppl 4:4S95-102. doi: 10.14735/amko20154s95.","Matoušková M","Klin Onkol","2015","2015/12/10","","","10.14735/amko20154s95"
"15721893","Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan","Yang CY, Chiu HF, Chang CC, Ho SC, Wu TN.","Environ Res. 2005 May;98(1):127-32. doi: 10.1016/j.envres.2004.07.013.","Yang CY","Environ Res","2005","2005/02/22","","","10.1016/j.envres.2004.07.013"
"1305676","New opportunities for screening and early detection of bladder cancer","Mason TJ, Walsh WP, Lee K, Vogler W.","J Cell Biochem Suppl. 1992;16I:13-22. doi: 10.1002/jcb.240501304.","Mason TJ","J Cell Biochem Suppl","1992","1992/01/01","","","10.1002/jcb.240501304"
"19150582","The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer","Karl A, Carroll PR, Gschwend JE, Knüchel R, Montorsi F, Stief CG, Studer UE.","Eur Urol. 2009 Apr;55(4):826-35. doi: 10.1016/j.eururo.2009.01.004. Epub 2009 Jan 13.","Karl A","Eur Urol","2009","2009/01/20","","","10.1016/j.eururo.2009.01.004"
"18704629","Epigenetics in bladder cancer","Enokida H, Nakagawa M.","Int J Clin Oncol. 2008 Aug;13(4):298-307. doi: 10.1007/s10147-008-0811-1. Epub 2008 Aug 15.","Enokida H","Int J Clin Oncol","2008","2008/08/16","","","10.1007/s10147-008-0811-1"
"20186823","Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer","Fang AC, Ahmad AE, Whitson JM, Ferrell LD, Carroll PR, Konety BR.","Cancer. 2010 Apr 15;116(8):1901-8. doi: 10.1002/cncr.25011.","Fang AC","Cancer","2010","2010/02/27","","","10.1002/cncr.25011"
"7571218","Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up","Given RW, Parsons JT, McCarley D, Wajsman Z.","Urology. 1995 Oct;46(4):499-504; discussion 504-5. doi: 10.1016/S0090-4295(99)80262-3.","Given RW","Urology","1995","1995/10/01","","","10.1016/S0090-4295(99)80262-3"
"31808417","Metastatic non-muscle invasive bladder can-cer with cervical lymph node metastasis","Garrido-Abad P, Martin LG, Zarra KV, Menendez AD, Arjona MF.","Int Braz J Urol. 2019 Nov-Dec;45(6):1270-1274. doi: 10.1590/S1677-5538.IBJU.2018.0421.","Garrido-Abad P","Int Braz J Urol","2019","2019/12/07","PMC6909866","","10.1590/S1677-5538.IBJU.2018.0421"
"20843708","Current chemotherapeutic options for the treatment of advanced bladder cancer: a review","Pliarchopoulou K, Laschos K, Pectasides D.","Urol Oncol. 2013 Apr;31(3):294-302. doi: 10.1016/j.urolonc.2010.07.011. Epub 2010 Sep 16.","Pliarchopoulou K","Urol Oncol","2013","2010/09/17","","","10.1016/j.urolonc.2010.07.011"
"16363709","[Invasive bladder cancer recurrenced 5 years after complete response status by chemotherapy and radiotherapy: a case report]","Ito S, Yokomizo S, Imazu T, Sugao H.","Hinyokika Kiyo. 2005 Nov;51(11):755-7.","Ito S","Hinyokika Kiyo","2005","2005/12/21","","",""
"19080819","[Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985-2019: urinary bladder cancer]","Galceran J, Ameijide A, Piñol JL, Gumà J.","Med Clin (Barc). 2008 Oct;131 Suppl 1:67-71. doi: 10.1016/s0025-7753(08)76437-6.","Galceran J","Med Clin (Barc)","2008","2008/12/17","","","10.1016/s0025-7753(08)76437-6"
"23764080","Multiplex protein signature for the detection of bladder cancer in voided urine samples","Rosser CJ, Ross S, Chang M, Dai Y, Mengual L, Zhang G, Kim J, Urquidi V, Alcaraz A, Goodison S.","J Urol. 2013 Dec;190(6):2257-62. doi: 10.1016/j.juro.2013.06.011. Epub 2013 Jun 11.","Rosser CJ","J Urol","2013","2013/06/15","PMC4013793","NIHMS517454","10.1016/j.juro.2013.06.011"
"17400362","Re: Matthew E. Nielsen, Shahrokh F. Shariat, Pierre I. Karakiewicz et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur urol 2007;51:699-708","Cai T, Bartoletti R.","Eur Urol. 2007 Aug;52(2):611-2. doi: 10.1016/j.eururo.2007.03.047. Epub 2007 Mar 28.","Cai T","Eur Urol","2007","2007/04/03","","","10.1016/j.eururo.2007.03.047"
"11257833","Smoking and bladder cancer","Hogan TF, Lamm DL, Riggs DR, Ducatman AM.","W V Med J. 2001 Jan-Feb;97(1):29-31.","Hogan TF","W V Med J","2001","2001/03/22","","",""
"28064545","Androgen receptor activation: a prospective therapeutic target for bladder cancer?","Mizushima T, Tirador KA, Miyamoto H.","Expert Opin Ther Targets. 2017 Mar;21(3):249-257. doi: 10.1080/14728222.2017.1280468. Epub 2017 Jan 19.","Mizushima T","Expert Opin Ther Targets","2017","2017/01/10","","","10.1080/14728222.2017.1280468"
"31093305","KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells","Shen T, Yang L, Zhang Z, Yu J, Dai L, Gao M, Shang Z, Niu Y.","Dis Markers. 2019 Apr 9;2019:4863182. doi: 10.1155/2019/4863182. eCollection 2019.","Shen T","Dis Markers","2019","2019/05/17","PMC6481133","","10.1155/2019/4863182"
"30286596","Demographic and Survivorship Disparities in Non-muscle-invasive Bladder Cancer in the United States","Seo M, Langabeer Ii JR.","J Prev Med Public Health. 2018 Sep;51(5):242-247. doi: 10.3961/jpmph.18.092. Epub 2018 Aug 23.","Seo M","J Prev Med Public Health","2018","2018/10/06","PMC6182276","","10.3961/jpmph.18.092"
"23880740","Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer","Zehnder P, Thalmann GN.","Curr Opin Urol. 2013 Sep;23(5):423-8. doi: 10.1097/MOU.0b013e328363e46f.","Zehnder P","Curr Opin Urol","2013","2013/07/25","","","10.1097/MOU.0b013e328363e46f"
"30371744","The latest treatment options for bladder cancer","Crabb SJ, Douglas J.","Br Med Bull. 2018 Dec 1;128(1):85-95. doi: 10.1093/bmb/ldy034.","Crabb SJ","Br Med Bull","2018","2018/10/30","","","10.1093/bmb/ldy034"
"10228196","Prevention of bladder cancer","Jones PA, Ross RK.","N Engl J Med. 1999 May 6;340(18):1424-6. doi: 10.1056/NEJM199905063401810.","Jones PA","N Engl J Med","1999","1999/05/06","","","10.1056/NEJM199905063401810"
"497668","Genetic association with bladder cancer","","Br Med J. 1979 Sep 1;2(6189):514.","","Br Med J","1979","1979/09/01","PMC1596225","",""
"3534312","Prognostic significance of ABH antigenicity of mucosal biopsies in superficial bladder cancer","Das G, Buxton NJ, Stewart PA, Glashan RW.","J Urol. 1986 Dec;136(6):1194-6. doi: 10.1016/s0022-5347(17)45280-3.","Das G","J Urol","1986","1986/12/01","","","10.1016/s0022-5347(17)45280-3"
"1958395","Short-term moderate-dose pelvic radiotherapy of advanced bladder carcinoma. A questionnaire-based evaluation of its symptomatic effect","Fosså SD, Hosbach G.","Acta Oncol. 1991;30(6):735-8. doi: 10.3109/02841869109092449.","Fosså SD","Acta Oncol","1991","1991/01/01","","","10.3109/02841869109092449"
"15862612","Radical cystectomy for bladder cancer: the case for early intervention","Chang SS, Cookson MS.","Urol Clin North Am. 2005 May;32(2):147-55. doi: 10.1016/j.ucl.2005.01.001.","Chang SS","Urol Clin North Am","2005","2005/05/03","","","10.1016/j.ucl.2005.01.001"
"28112819","Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guérin","Packiam VT, Johnson SC, Steinberg GD.","Cancer. 2017 Feb 1;123(3):390-400. doi: 10.1002/cncr.30392. Epub 2016 Nov 2.","Packiam VT","Cancer","2017","2017/01/24","","","10.1002/cncr.30392"
"28705118","Curcumin inhibits bladder cancer progression via regulation of β-catenin expression","Shi J, Wang Y, Jia Z, Gao Y, Zhao C, Yao Y.","Tumour Biol. 2017 Jul;39(7):1010428317702548. doi: 10.1177/1010428317702548.","Shi J","Tumour Biol","2017","2017/07/15","","","10.1177/1010428317702548"
"7122129","Classification of premalignant urothelial abnormalities. A Delphi study of the National Bladder Cancer Collaborative Group A","Nagy GK, Frable WJ, Murphy WM.","Pathol Annu. 1982;17 (Pt 1):219-33.","Nagy GK","Pathol Annu","1982","1982/01/01","","",""
"12121579","Recent advances in the management of superficial bladder tumors","Fradet Y.","Can J Urol. 2002 Jun;9(3):1544-50.","Fradet Y","Can J Urol","2002","2002/07/18","","",""
"6544614","Cis-diamminedichloroplatinum (DDP) as initial treatment of invasive bladder cancer","Fagg SL, Dawson-Edwards P, Hughes MA, Latief TN, Rolfe EB, Fielding JW.","Br J Urol. 1984 Jun;56(3):296-300. doi: 10.1111/j.1464-410x.1984.tb05390.x.","Fagg SL","Br J Urol","1984","1984/06/01","","","10.1111/j.1464-410x.1984.tb05390.x"
"8709350","Familial transitional cell carcinoma","Kiemeney LA, Schoenberg M.","J Urol. 1996 Sep;156(3):867-72.","Kiemeney LA","J Urol","1996","1996/09/01","","",""
"26835832","Dynamic Prognostication Using Conditional Recurrence and Progression Estimates for Patients with Nonmuscle Invasive Bladder Cancer","Leitner CV, Ederer IA, de Martino M, Hofbauer SL, Lucca I, Mbeutcha A, Mathieu R, Haitel A, Susani M, Shariat SF, Klatte T.","J Urol. 2016 Jul;196(1):46-51. doi: 10.1016/j.juro.2016.01.102. Epub 2016 Feb 2.","Leitner CV","J Urol","2016","2016/02/03","","","10.1016/j.juro.2016.01.102"
"31735557","Identification of an immunotherapy-responsive molecular subtype of bladder cancer","Song BN, Kim SK, Mun JY, Choi YD, Leem SH, Chu IS.","EBioMedicine. 2019 Dec;50:238-245. doi: 10.1016/j.ebiom.2019.10.058. Epub 2019 Nov 15.","Song BN","EBioMedicine","2019","2019/11/19","PMC6921227","","10.1016/j.ebiom.2019.10.058"
"16353771","[Cell cycle and apoptosis mechanisms implicated in intravesical chemotherapy resistances in superficial bladder cancer]","Burgués Gasión JP, Pontones Moreno JL, Vera Donoso CD, Jiménez Cruz JF, Ozonas Moragues M.","Actas Urol Esp. 2005 Oct;29(9):846-59. doi: 10.1016/s0210-4806(05)73356-8.","Burgués Gasión JP","Actas Urol Esp","2005","2005/12/16","","","10.1016/s0210-4806(05)73356-8"
"12490108","Combined modality therapy following bladder conservation surgery for bladder cancers","Sun X, Hu J, Yang Q.","Chin Med J (Engl). 2002 Oct;115(10):1548-51.","Sun X","Chin Med J (Engl)","2002","2002/12/20","","",""
"8078223","[Prognostic factors for muscle-invasive bladder cancer treated with a combination of intra-arterial chemotherapy and low-dose radiotherapy]","Sumiyoshi Y, Yokota K, Akiyama M, Hashine K, Tsuzimura H, Yoneda F, Nakazima M, Yokozeki H, Maebayashi.","Nihon Hinyokika Gakkai Zasshi. 1994 Jul;85(7):1072-8. doi: 10.5980/jpnjurol1989.85.1072.","Sumiyoshi Y","Nihon Hinyokika Gakkai Zasshi","1994","1994/07/01","","","10.5980/jpnjurol1989.85.1072"
"23249204","Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers","Oliveira AI, Jerónimo C, Henrique R.","Expert Rev Mol Diagn. 2012 Nov;12(8):871-8. doi: 10.1586/erm.12.114.","Oliveira AI","Expert Rev Mol Diagn","2012","2012/12/20","","","10.1586/erm.12.114"
"3342650","Radical cystectomy for residual of recurrent tumour after definitive radiotherapy (salvage cystectomy)","Rasmussen RB, Knudsen JB, Sørensen BL, Walbom-Jørgensen S.","Dan Med Bull. 1988 Feb;35(1):98-100.","Rasmussen RB","Dan Med Bull","1988","1988/02/01","","",""
"10022689","The potential usefulness of bladder cancer markers","Elhilali MM.","J Urol. 1999 Mar;161(3):810-1. doi: 10.1016/s0022-5347(01)61777-4.","Elhilali MM","J Urol","1999","1999/02/18","","","10.1016/s0022-5347(01)61777-4"
"32166460","Genomic Subtyping in Bladder Cancer","Jalanko T, de Jong JJ, Gibb EA, Seiler R, Black PC.","Curr Urol Rep. 2020 Mar 13;21(2):9. doi: 10.1007/s11934-020-0960-y.","Jalanko T","Curr Urol Rep","2020","2020/03/14","","","10.1007/s11934-020-0960-y"
"15711244","Apoptosis and chemotherapy for bladder cancer","McKnight JJ, Gray SB, O'Kane HF, Johnston SR, Williamson KE.","J Urol. 2005 Mar;173(3):683-90. doi: 10.1097/01.ju.0000143194.79287.a9.","McKnight JJ","J Urol","2005","2005/02/16","","","10.1097/01.ju.0000143194.79287.a9"
"20362526","Green tea polyphenol suppresses tumor invasion and angiogenesis in N-butyl-(-4-hydroxybutyl) nitrosamine-induced bladder cancer","Sagara Y, Miyata Y, Nomata K, Hayashi T, Kanetake H.","Cancer Epidemiol. 2010 Jun;34(3):350-4. doi: 10.1016/j.canep.2010.03.001. Epub 2010 Apr 1.","Sagara Y","Cancer Epidemiol","2010","2010/04/06","","","10.1016/j.canep.2010.03.001"
"8664926","[T1G3 transitional bladder neoplasms: what to do?]","Marcelli G, Bottanelli A, Scattoni V, Baroni GP, Rovellini P, Sciaraffia G, Toia G.","Arch Ital Urol Androl. 1996 Feb;68(1):67-9.","Marcelli G","Arch Ital Urol Androl","1996","1996/02/01","","",""
"4034586","Superficial bladder cancer--problems with selection","Glashan RW.","Prog Clin Biol Res. 1985;185B:13-8.","Glashan RW","Prog Clin Biol Res","1985","1985/01/01","","",""
"25033957","Relationship between bladder cancer and total fluid intake: a meta-analysis of epidemiological evidence","Bai Y, Yuan H, Li J, Tang Y, Pu C, Han P.","World J Surg Oncol. 2014 Jul 17;12:223. doi: 10.1186/1477-7819-12-223.","Bai Y","World J Surg Oncol","2014","2014/07/19","PMC4127191","","10.1186/1477-7819-12-223"
"3973999","Upper urinary tract transitional cell carcinoma in patients with bladder carcinoma and associated vesicoureteral reflux","Amar AD, Das S.","J Urol. 1985 Mar;133(3):468-71. doi: 10.1016/s0022-5347(17)49028-8.","Amar AD","J Urol","1985","1985/03/01","","","10.1016/s0022-5347(17)49028-8"
"12478130","Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence","Yossepowitch O, Dalbagni G, Golijanin D, Donat SM, Bochner BH, Herr HW, Fair WR, Russo P.","J Urol. 2003 Jan;169(1):177-81. doi: 10.1097/01.ju.0000041411.03266.14.","Yossepowitch O","J Urol","2003","2002/12/13","","","10.1097/01.ju.0000041411.03266.14"
"10411054","An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy","Shipley WU, Kaufman DS, Heney NM, Althausen AF, Zietman AL.","J Urol. 1999 Aug;162(2):445-50; discussion 450-1.","Shipley WU","J Urol","1999","1999/07/20","","",""
"28013490","Is there a link between urinary microbiota and bladder cancer?","Raoult D.","Eur J Epidemiol. 2017 Mar;32(3):255. doi: 10.1007/s10654-016-0213-z. Epub 2016 Dec 24.","Raoult D","Eur J Epidemiol","2017","2016/12/26","","","10.1007/s10654-016-0213-z"
"25591934","Role of osteopontin in the regulation of human bladder cancer proliferation and migration in T24 cells","Xu ST, Guo C, Ding X, Fan WJ, Zhang FH, Xu WL, Ma YC.","Mol Med Rep. 2015 May;11(5):3701-7. doi: 10.3892/mmr.2015.3202. Epub 2015 Jan 15.","Xu ST","Mol Med Rep","2015","2015/01/17","","","10.3892/mmr.2015.3202"
"30952730","Pro-GA, a Novel Inhibitor of γ-Glutamylcyclotransferase, Suppresses Human Bladder Cancer Cell Growth","Hanada E, Kageyama S, Murai R, Kubota S, Ii H, Nakata S, Kita H, Kawauchi A, Chano T.","Anticancer Res. 2019 Apr;39(4):1893-1898. doi: 10.21873/anticanres.13297.","Hanada E","Anticancer Res","2019","2019/04/07","","","10.21873/anticanres.13297"
"28357426","Specific and relative detection of urinary microRNA signatures in bladder cancer for point-of-care diagnostics","Cheng N, Xu Y, Luo Y, Zhu L, Zhang Y, Huang K, Xu W.","Chem Commun (Camb). 2017 Apr 11;53(30):4222-4225. doi: 10.1039/c7cc01007a.","Cheng N","Chem Commun (Camb)","2017","2017/03/31","","","10.1039/c7cc01007a"
"25525927","Bladder cancer screening in aluminum smelter workers","Taiwo OA, Slade MD, Cantley LF, Tessier-Sherman B, Galusha D, Kirsche SR, Donoghue AM, Cullen MR.","J Occup Environ Med. 2015 Apr;57(4):421-7. doi: 10.1097/JOM.0000000000000377.","Taiwo OA","J Occup Environ Med","2015","2014/12/20","PMC4374722","NIHMS641897","10.1097/JOM.0000000000000377"
"24332601","Langerhans cell histiocytosis of the urinary bladder in a patient with bladder cancer previously treated with intravesical Bacillus Calmette-Guérin therapy","Numakura S, Morikawa T, Ushiku T, Toyoshima T, Fukayama M.","Pathol Res Pract. 2014 Feb;210(2):123-6. doi: 10.1016/j.prp.2013.11.005. Epub 2013 Nov 22.","Numakura S","Pathol Res Pract","2014","2013/12/17","","","10.1016/j.prp.2013.11.005"
"10226810","Neoadjuvant therapy and bladder substitute for invasive bladder cancer: 20 years experience at Tohoku University","Hoshi S, Orikasa S, Yoshikawa K, Sato K, Toyoda S, Saitoh S, Satoh M, Ohyama C, Namima T, Kawamura S, Suzuki K.","Int J Urol. 1999 Feb;6(2):68-74. doi: 10.1046/j.1442-2042.1999.06220.x.","Hoshi S","Int J Urol","1999","1999/05/05","","","10.1046/j.1442-2042.1999.06220.x"
"12895299","Ras oncogene mutations in urine sediments of patients with bladder cancer","Buyru N, Tigli H, Ozcan F, Dalay N.","J Biochem Mol Biol. 2003 Jul 31;36(4):399-402. doi: 10.5483/bmbrep.2003.36.4.399.","Buyru N","J Biochem Mol Biol","2003","2003/08/05","","","10.5483/bmbrep.2003.36.4.399"
"2056386","Simultaneous detection of fluorescent in situ hybridization and in vivo incorporated BrdU in a human bladder tumour","Van Dekken H, Schervish EW, Pizzolo JG, Fair WR, Melamed MR.","J Pathol. 1991 May;164(1):17-22. doi: 10.1002/path.1711640104.","Van Dekken H","J Pathol","1991","1991/05/01","","","10.1002/path.1711640104"
"22812186","Gene silence-induced downregulation of survivin inhibits bladder cancer cells","Gou X, Yang HA, He WY, Xioa MC, Wang M.","Oncol Res. 2011;19(12):535-41. doi: 10.3727/096504012x13340632812550.","Gou X","Oncol Res","2011","2012/07/21","","","10.3727/096504012x13340632812550"
"7946577","Aggressive superficial bladder cancer","Harland SJ.","Eur J Cancer. 1994;30A(7):899-900. doi: 10.1016/0959-8049(94)90108-2.","Harland SJ","Eur J Cancer","1994","1994/01/01","","","10.1016/0959-8049(94)90108-2"
"27768223","Study on the significance of Cofilin 1 overexpression in human bladder cancer","Wang F, Wu D, He F, Fu H, Xu J, Chen J, Zhang S, Wang W.","Tumori. 2017 Nov 23;103(6):537-542. doi: 10.5301/tj.5000569. Epub 2016 Oct 21.","Wang F","Tumori","2017","2016/10/30","","","10.5301/tj.5000569"
"10969815","Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer","Schneider A, Borgnat S, Lang H, Régine O, Lindner V, Kassem M, Saussine C, Oudet P, Jacqmin D, Gaub MP.","Cancer Res. 2000 Aug 15;60(16):4617-22.","Schneider A","Cancer Res","2000","2000/09/02","","",""
"1279876","Radical cystectomy in regionally advanced bladder cancer","Lerner SP, Skinner E, Skinner DG.","Urol Clin North Am. 1992 Nov;19(4):713-23.","Lerner SP","Urol Clin North Am","1992","1992/11/01","","",""
"11842741","Outcome of patients undergoing radical cystectomy for invasive bladder cancer","Gschwend JE.","Front Radiat Ther Oncol. 2002;36:106-17. doi: 10.1159/000061335.","Gschwend JE","Front Radiat Ther Oncol","2002","2002/02/15","","","10.1159/000061335"
"2125987","Detection of the c-myc gene product in urinary bladder cancer","Kotake T, Saiki S, Kinouchi T, Shiku H, Nakayama E.","Jpn J Cancer Res. 1990 Dec;81(12):1198-201. doi: 10.1111/j.1349-7006.1990.tb02677.x.","Kotake T","Jpn J Cancer Res","1990","1990/12/01","PMC5918014","","10.1111/j.1349-7006.1990.tb02677.x"
"998613","Canine bladder cancer: epidemiologic features","Hayes HM Jr.","Am J Epidemiol. 1976 Dec;104(6):673-7. doi: 10.1093/oxfordjournals.aje.a112346.","Hayes HM Jr","Am J Epidemiol","1976","1976/12/01","","","10.1093/oxfordjournals.aje.a112346"
"4076270","In vitro chemosensitivity testing of KK-47 bladder cancer cell line: a short-term culture technique","Bazeed MA, Schärfe T, Becht E, Schmidt J, Jacobi GH, Thüroff JW.","Eur Urol. 1985;11(5):320-3. doi: 10.1159/000472528.","Bazeed MA","Eur Urol","1985","1985/01/01","","","10.1159/000472528"
"6232995","Predictive value of excretory urography, ultrasonography, computerized tomography, and liver and bone scan in the staging of bilharzial bladder cancer in Saudi Arabia","Hanash KA, Bissada NK, Abla A, Esmail D, Dowling A.","Cancer. 1984 Jul 1;54(1):172-6. doi: 10.1002/1097-0142(19840701)54:1<172::aid-cncr2820540132>3.0.co;2-u.","Hanash KA","Cancer","1984","1984/07/01","","","10.1002/1097-0142(19840701)54:1<172::aid-cncr2820540132>3.0.co;2-u"
"7314331","Pre-operative intra-arterial chemotherapy for bladder cancer","Nakazono M, Iwata S.","Urol Res. 1981;9(6):289-95. doi: 10.1007/BF00257778.","Nakazono M","Urol Res","1981","1981/01/01","","","10.1007/BF00257778"
"27498113","The anatomical limits and oncological benefit of lymphadenectomy in muscle invasive bladder cancer","Guijarro A, Hernández V, Llorente C.","Actas Urol Esp. 2017 Jun;41(5):284-291. doi: 10.1016/j.acuro.2016.07.001. Epub 2016 Aug 3.","Guijarro A","Actas Urol Esp","2017","2016/08/08","","","10.1016/j.acuro.2016.07.001"
"31757298","Genomic and Therapeutic Landscape of Non-muscle-invasive Bladder Cancer","Cooley LF, McLaughlin KA, Meeks JJ.","Urol Clin North Am. 2020 Feb;47(1):35-46. doi: 10.1016/j.ucl.2019.09.006.","Cooley LF","Urol Clin North Am","2020","2019/11/24","","","10.1016/j.ucl.2019.09.006"
"21936670","Repeated white light transurethral resection of the bladder in nonmuscle-invasive urothelial bladder cancers: systematic review and meta-analysis","Vianello A, Costantini E, Del Zingaro M, Bini V, Herr HW, Porena M.","J Endourol. 2011 Nov;25(11):1703-12. doi: 10.1089/end.2011.0081. Epub 2011 Sep 21.","Vianello A","J Endourol","2011","2011/09/23","","","10.1089/end.2011.0081"
"15847712","Adjuvant chemotherapy for transitional cell carcinoma of the bladder: paradigms for the design of clinical trials","Boyar M, Petrylak DP.","Curr Oncol Rep. 2005 May;7(3):207-14. doi: 10.1007/s11912-005-0075-0.","Boyar M","Curr Oncol Rep","2005","2005/04/26","","","10.1007/s11912-005-0075-0"
"18373357","Isolation and identification of potential urinary microparticle biomarkers of bladder cancer","Smalley DM, Sheman NE, Nelson K, Theodorescu D.","J Proteome Res. 2008 May;7(5):2088-96. doi: 10.1021/pr700775x. Epub 2008 Mar 29.","Smalley DM","J Proteome Res","2008","2008/04/01","","","10.1021/pr700775x"
"28889386","Patient-Derived Bladder Cancer Xenografts","Bernardo C, Santos LL.","Methods Mol Biol. 2018;1655:169-175. doi: 10.1007/978-1-4939-7234-0_14.","Bernardo C","Methods Mol Biol","2018","2017/09/11","","","10.1007/978-1-4939-7234-0_14"
"4640489","Proliferative and lymphoid reactions in bladder cancer","Sarma KP.","Invest Urol. 1972 Nov;10(3):199-207.","Sarma KP","Invest Urol","1972","1972/11/01","","",""
"29909945","Current controversies on the role of lymphadenectomy for bladder cancer","Ghodoussipour S, Daneshmand S.","Urol Oncol. 2019 Mar;37(3):193-200. doi: 10.1016/j.urolonc.2018.05.005. Epub 2018 Jun 15.","Ghodoussipour S","Urol Oncol","2019","2018/06/19","","","10.1016/j.urolonc.2018.05.005"
"30509883","Neoadjuvant pembrolizumab in bladder cancer","Gourd E.","Lancet Oncol. 2018 Dec;19(12):e669. doi: 10.1016/S1470-2045(18)30814-3. Epub 2018 Oct 25.","Gourd E","Lancet Oncol","2018","2018/12/05","","","10.1016/S1470-2045(18)30814-3"
"24613684","Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review","Ploussard G, Daneshmand S, Efstathiou JA, Herr HW, James ND, Rödel CM, Shariat SF, Shipley WU, Sternberg CN, Thalmann GN, Kassouf W.","Eur Urol. 2014 Jul;66(1):120-37. doi: 10.1016/j.eururo.2014.02.038. Epub 2014 Feb 26.","Ploussard G","Eur Urol","2014","2014/03/12","","","10.1016/j.eururo.2014.02.038"
"26039120","Deceptive muscle invasive bladder cancer recurrence with benign biopsy foci after bladder sparing treatment","Xu C, Zeng S, Zhang Z, Song R, Ma C, Chen X, Sun Y.","Medicine (Baltimore). 2015 Jun;94(22):e898. doi: 10.1097/MD.0000000000000898.","Xu C","Medicine (Baltimore)","2015","2015/06/04","PMC4616362","","10.1097/MD.0000000000000898"
"23295831","Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer","Ying L, Huang Y, Chen H, Wang Y, Xia L, Chen Y, Liu Y, Qiu F.","Mol Biosyst. 2013 Mar;9(3):407-11. doi: 10.1039/c2mb25386k. Epub 2013 Jan 8.","Ying L","Mol Biosyst","2013","2013/01/09","","","10.1039/c2mb25386k"
"25895563","[Alternatives to cystectomy]","Niedworok C, Gratzke C.","Urologe A. 2015 Apr;54(4):504-9. doi: 10.1007/s00120-015-3775-6.","Niedworok C","Urologe A","2015","2015/04/22","","","10.1007/s00120-015-3775-6"
"16430619","Lymphadenectomy for invasive bladder cancer. II. technical aspects and prognostic factors","Stein JP, Quek ML, Skinner DG.","BJU Int. 2006 Feb;97(2):232-7. doi: 10.1111/j.1464-410X.2006.05901.x.","Stein JP","BJU Int","2006","2006/01/25","","","10.1111/j.1464-410X.2006.05901.x"
"24877661","New insights into subtypes of invasive bladder cancer: considerations of the clinician","McConkey DJ, Choi W, Dinney CP.","Eur Urol. 2014 Oct;66(4):609-10. doi: 10.1016/j.eururo.2014.05.006. Epub 2014 May 27.","McConkey DJ","Eur Urol","2014","2014/06/01","","","10.1016/j.eururo.2014.05.006"
"30537032","FAM83H-AS1 is associated with clinical progression and modulates cell proliferation, migration, and invasion in bladder cancer","Shan H, Yang Y, Zhu X, Han X, Zhang P, Zhang X.","J Cell Biochem. 2019 Mar;120(3):4687-4693. doi: 10.1002/jcb.27758. Epub 2018 Dec 9.","Shan H","J Cell Biochem","2019","2018/12/12","","","10.1002/jcb.27758"
"18704628","Molecular pathogenesis of bladder cancer","Knowles MA.","Int J Clin Oncol. 2008 Aug;13(4):287-97. doi: 10.1007/s10147-008-0812-0. Epub 2008 Aug 15.","Knowles MA","Int J Clin Oncol","2008","2008/08/16","","","10.1007/s10147-008-0812-0"
"4092537","[Effect of the serum blocking factor assay in the diagnosis and treatment of bladder cancer]","Xu JN, Li YT, Zhang ZY.","Zhonghua Wai Ke Za Zhi. 1985 Aug;23(8):453-6, 508.","Xu JN","Zhonghua Wai Ke Za Zhi","1985","1985/08/01","","",""
"29491061","Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells","Michalska M, Schultze-Seemann S, Kuckuck I, Katzenwadel A, Wolf P.","Anticancer Res. 2018 Mar;38(3):1369-1375. doi: 10.21873/anticanres.12360.","Michalska M","Anticancer Res","2018","2018/03/02","","","10.21873/anticanres.12360"
"7069859","Re: salvage cystectomy for bladder cancer after failure of definitive irradiation","Crawford ED, Skinner DG.","J Urol. 1982 Apr;127(4):784. doi: 10.1016/s0022-5347(17)54045-8.","Crawford ED","J Urol","1982","1982/04/01","","","10.1016/s0022-5347(17)54045-8"
"949693","Intensive radiotherapy of locally advanced bladder cancer","Birkhead BM, Conley JG, Scott RM.","Cancer. 1976 Jun;37(6):2746-8. doi: 10.1002/1097-0142(197606)37:6<2746::aid-cncr2820370626>3.0.co;2-n.","Birkhead BM","Cancer","1976","1976/06/01","","","10.1002/1097-0142(197606)37:6<2746::aid-cncr2820370626>3.0.co;2-n"
"920778","The pathogenesis of bladder cancer","Friedell GH, Jacobs JB, Nagy GK, Cohen SM.","Am J Pathol. 1977 Nov;89(2):431-42.","Friedell GH","Am J Pathol","1977","1977/11/01","PMC2032241","",""
"20383640","Treatment and outcome in muscle invasive bladder cancer: a population-based survey","Leliveld AM, Doornweerd BH, Bastiaannet E, Schaapveld M, de Jong IJ.","World J Urol. 2010 Aug;28(4):439-44. doi: 10.1007/s00345-010-0546-2. Epub 2010 Apr 10.","Leliveld AM","World J Urol","2010","2010/04/13","","","10.1007/s00345-010-0546-2"
"7666680","Genetically determined sparteine oxidation and sulfadimidine acetylation polymorphism in patients with non-occupational urinary bladder cancer","Orzechowska-Juzwenko K, Niewiński P, Pawlik J, Milejski P, Dembowski J, Swiebodzki L, Lorenz J.","Mater Med Pol. 1994 Oct-Dec;26(4):145-8.","Orzechowska-Juzwenko K","Mater Med Pol","1994","1994/10/01","","",""
"2389958","[Intra-arterial infusion chemotherapy in bladder cancer]","Sumiyoshi Y, Yano M, Yokota K, Akiyama M, Uyama T.","Gan To Kagaku Ryoho. 1990 Aug;17(8 Pt 2):1697-700.","Sumiyoshi Y","Gan To Kagaku Ryoho","1990","1990/08/01","","",""
"31626340","The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years","Fletcher SA, Cole AP, Lu C, Marchese M, Krimphove MJ, Friedlander DF, Mossanen M, Kilbridge KL, Kibel AS, Trinh QD.","Cancer. 2020 Feb 1;126(3):496-505. doi: 10.1002/cncr.32562. Epub 2019 Oct 18.","Fletcher SA","Cancer","2020","2019/10/19","","","10.1002/cncr.32562"
"5372435","[Round table conference; case finding, diagnosis and treatment of primary cancer of the bladder. Tuesday 22 June 1969]","","Rev Argent Urol Nefrol. 1969 Jun-Aug;38(6):33-56.","","Rev Argent Urol Nefrol","1969","1969/06/01","","",""
"25794588","[Treatment of bladder cancer in the elderly]","Fröhner M, Rübben H.","Urologe A. 2015 Apr;54(4):510-5. doi: 10.1007/s00120-015-3777-4.","Fröhner M","Urologe A","2015","2015/03/22","","","10.1007/s00120-015-3777-4"
"27485165","MicroRNA-101 inhibits the proliferation and invasion of bladder cancer cells via targeting c-FOS","Long Y, Wu Z, Yang X, Chen L, Han Z, Zhang Y, Liu J, Liu W, Liu X.","Mol Med Rep. 2016 Sep;14(3):2651-6. doi: 10.3892/mmr.2016.5534. Epub 2016 Jul 20.","Long Y","Mol Med Rep","2016","2016/08/04","","","10.3892/mmr.2016.5534"
"29962297","Urinary schistosomiasis presented as bladder malignancy with pulmonary metastases: a case report","Hosny K, Luk A.","Ann R Coll Surg Engl. 2018 Jul;100(6):e145-e146. doi: 10.1308/rcsann.2018.0072.","Hosny K","Ann R Coll Surg Engl","2018","2018/07/03","PMC6111915","","10.1308/rcsann.2018.0072"
"25194907","Re: David J. McConkey, Woonyoung Choi, Colin P.N. Dinney. New insights into subtypes of invasive bladder cancer: considerations of the clinician. Eur Urol 2014;66:609-10","Aine M, Liedberg F, Sjödahl G, Höglund M.","Eur Urol. 2015 Apr;67(4):e73-5. doi: 10.1016/j.eururo.2014.08.063. Epub 2014 Sep 4.","Aine M","Eur Urol","2015","2014/09/08","","","10.1016/j.eururo.2014.08.063"
"8518667","Superficial bladder cancer","Abel PD.","BMJ. 1993 May 29;306(6890):1480. doi: 10.1136/bmj.306.6890.1480-c.","Abel PD","BMJ","1993","1993/05/29","PMC1677851","","10.1136/bmj.306.6890.1480-c"
"28982487","Management of Muscle-Invasive Urothelial Cancer and the Emerging Role of Immunotherapy in Advanced Urothelial Cancer","Giridhar KV, Kohli M.","Mayo Clin Proc. 2017 Oct;92(10):1564-1582. doi: 10.1016/j.mayocp.2017.07.010.","Giridhar KV","Mayo Clin Proc","2017","2017/10/07","","","10.1016/j.mayocp.2017.07.010"
"8689108","Polymorphism and smoking in bladder carcinogenesis","Chinegwundoh FI, Kaisary AV.","Br J Urol. 1996 May;77(5):672-5. doi: 10.1046/j.1464-410x.1996.09748.x.","Chinegwundoh FI","Br J Urol","1996","1996/05/01","","","10.1046/j.1464-410x.1996.09748.x"
"4757905","Proceedings: Carcinoma of the bladder treated by preoperative irradiation followed by cystectomy. The second report","van der Werf-Messing B.","Cancer. 1973 Nov;32(5):1084-8. doi: 10.1002/1097-0142(197311)32:5<1084::aid-cncr2820320511>3.0.co;2-#.","van der Werf-Messing B","Cancer","1973","1973/11/01","","","10.1002/1097-0142(197311)32:5<1084::aid-cncr2820320511>3.0.co;2-#"
"10579080","Neo-adjuvant and adjuvant treatment of locally invasive bladder cancer","Schultz-Lampel D, Lampel A.","Curr Opin Urol. 1999 Sep;9(5):419-24. doi: 10.1097/00042307-199909000-00009.","Schultz-Lampel D","Curr Opin Urol","1999","1999/12/01","","","10.1097/00042307-199909000-00009"
"23321168","Clinical and prognostic significance of protocadherin-10 (PCDH10) promoter methylation in bladder cancer","Lin YL, Li ZG, He ZK, Guan TY, Ma JG.","J Int Med Res. 2012;40(6):2117-23. doi: 10.1177/030006051204000609.","Lin YL","J Int Med Res","2012","2013/01/17","","","10.1177/030006051204000609"
"30855375","Molecular subtyping of bladder cancer: current trends and future directions in 2019","Smelser WW, Woolbright BL, Taylor JA 3rd.","Curr Opin Urol. 2019 May;29(3):198-202. doi: 10.1097/MOU.0000000000000599.","Smelser WW","Curr Opin Urol","2019","2019/03/12","","","10.1097/MOU.0000000000000599"
"4080521","[Intraoperative radiotherapy for urinary bladder cancer]","Murakami Y, Sakurai T, Nishio M, Kagami Y, Narimatsu N, Fujieda J, Omuro H.","Nihon Igaku Hoshasen Gakkai Zasshi. 1985 Jul 25;45(7):1017-22.","Murakami Y","Nihon Igaku Hoshasen Gakkai Zasshi","1985","1985/07/25","","",""
"22035906","[The role and method of fluorescence-guided cystoscopy in 2011 for management of bladder cancer: Review of the Oncology Committee of the French Urology Association]","Wallerand H, Rouprêt M, Larré S, Houédé N, Neuzillet Y, Compérat E, Quintens H, Pignot G, Roy C, Soulié M, Pfister C; Comité de cancérologie de l’AFU.","Prog Urol. 2011 Nov;21(12):823-8. doi: 10.1016/j.purol.2011.08.027. Epub 2011 Sep 16.","Wallerand H","Prog Urol","2011","2011/11/01","","","10.1016/j.purol.2011.08.027"
"71404","Bladder cancer and saccharin","","Lancet. 1977 Sep 17;2(8038):592-3.","","Lancet","1977","1977/09/17","","",""
"21409933","Risk factors of urinary bladder cancer in Peshawar region of Khyber Pukhtoonkhawa","Ahmad MR, Pervaiz MK.","J Ayub Med Coll Abbottabad. 2010 Jan-Mar;22(1):160-3.","Ahmad MR","J Ayub Med Coll Abbottabad","2010","2011/03/18","","",""
"2042428","Cytologic detection of urothelial cancer and other abnormalities in a cohort of workers exposed to aromatic amines","Crosby JH, Allsbrook WC Jr, Koss LG, Bales CE, Witherington R, Schulte PA, Hemstreet G 3rd, Ringer K.","Acta Cytol. 1991 May-Jun;35(3):263-8.","Crosby JH","Acta Cytol","1991","1991/05/01","","",""
"24576318","Clinical utility of urinary soluble Fas in screening for bladder cancer","Srivastava AK, Singh PK, Singh D, Dalela D, Rath SK, Bhatt ML.","Asia Pac J Clin Oncol. 2016 Jun;12(2):e215-21. doi: 10.1111/ajco.12165. Epub 2014 Feb 27.","Srivastava AK","Asia Pac J Clin Oncol","2016","2014/03/01","","","10.1111/ajco.12165"
"18923362","Management of bladder cancer","Hegarty PK, Kamat AM.","Minerva Urol Nefrol. 2008 Dec;60(4):255-64.","Hegarty PK","Minerva Urol Nefrol","2008","2008/10/17","","",""
"3393556","Combined radiotherapy, chemotherapy and surgery in the management of invasive bladder cancer","Jakse G, Frommhold H.","Prog Clin Biol Res. 1988;269:591-600.","Jakse G","Prog Clin Biol Res","1988","1988/01/01","","",""
"3735871","[Adjuvant chemotherapy for high-stage and/or high-grade bladder cancer following radical cystectomy. A preliminary report]","Uekado Y, Shinka T, Kumeda K, Hirano A, Yoshida M, Yamamoto S, Watanabe T, Ohkawa T.","Nihon Hinyokika Gakkai Zasshi. 1986 Mar;77(3):466-73. doi: 10.5980/jpnjurol1928.77.3_466.","Uekado Y","Nihon Hinyokika Gakkai Zasshi","1986","1986/03/01","","","10.5980/jpnjurol1928.77.3_466"
"11519763","Cigar, pipe, and cigarette smoking and bladder cancer risk in European men","Pitard A, Brennan P, Clavel J, Greiser E, Lopez-Abente G, Chang-Claude J, Wahrendorf J, Serra C, Kogevinas M, Boffetta P.","Cancer Causes Control. 2001 Aug;12(6):551-6. doi: 10.1023/a:1011291015233.","Pitard A","Cancer Causes Control","2001","2001/08/25","","","10.1023/a:1011291015233"
"31950596","Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG)","Matulay JT, Soloway M, Witjes JA, Buckley R, Persad R, Lamm DL, Boehle A, Palou J, Colombel M, Brausi M, Kamat AM.","BJU Int. 2020 Apr;125(4):497-505. doi: 10.1111/bju.14995. Epub 2020 Feb 8.","Matulay JT","BJU Int","2020","2020/01/18","","","10.1111/bju.14995"
"5589222","[Apropos of 32 total cystectomies for cancer of the bladder]","Camey M.","J Urol Nephrol (Paris). 1967 Dec;73(12):917-20.","Camey M","J Urol Nephrol (Paris)","1967","1967/12/01","","",""
"22825458","Biomarkers for bladder cancer aggressiveness","Frantzi M, Makridakis M, Vlahou A.","Curr Opin Urol. 2012 Sep;22(5):390-6. doi: 10.1097/MOU.0b013e328356ad0e.","Frantzi M","Curr Opin Urol","2012","2012/07/25","","","10.1097/MOU.0b013e328356ad0e"
"466938","The role of computed tomography in the staging of bladder cancer","Hodson NJ, Husband JE, MacDonald JS.","Clin Radiol. 1979 Jul;30(4):389-95. doi: 10.1016/s0009-9260(79)80215-9.","Hodson NJ","Clin Radiol","1979","1979/07/01","","","10.1016/s0009-9260(79)80215-9"
"31107371","Immunogenomic Analysis of Exceptional Responder to ALT-803 (IL-15 Analogue) in BCG Unresponsive Nonmuscle Invasive Bladder Cancer: A Case Series and Review of the Literature","Huang J, Shiao SL, Furuya H, Rosser CJ.","J Immunother. 2019 Nov/Dec;42(9):354-358. doi: 10.1097/CJI.0000000000000269.","Huang J","J Immunother","2019","2019/05/21","PMC6783344","NIHMS1527263","10.1097/CJI.0000000000000269"
"12893327","Usefulness of tissue polypeptide antigen in the follow-up of bladder cancer","Menéndez López V, Galán JA, Fernández-Suárez A, López-Celada S, Alcover J, Filella X.","Urology. 2003 Aug;62(2):243-8. doi: 10.1016/s0090-4295(03)00263-2.","Menéndez López V","Urology","2003","2003/08/02","","","10.1016/s0090-4295(03)00263-2"
"3239521","[Clinical application of MRI for urological malignancy. 3: A new trial of MRI for bladder cancer and prostatic cancer; surface coil and GD-DTPA]","Nishimura K, Hida S, Nishio Y, Yoshida O, Nakano Y.","Hinyokika Kiyo. 1988 Dec;34(12):2097-100.","Nishimura K","Hinyokika Kiyo","1988","1988/12/01","","",""
"24817966","SKIP expression is correlated with clinical prognosis in patients with bladder cancer","Wang L, Zhang M, Wu Y, Cheng C, Huang Y, Shi Z, Huang H.","Int J Clin Exp Pathol. 2014 Mar 15;7(4):1695-701. eCollection 2014.","Wang L","Int J Clin Exp Pathol","2014","2014/05/13","PMC4014250","",""
"27317986","Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline","Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, Pruthi R, Quale DZ, Ritch CR, Seigne JD, Skinner EC, Smith ND, McKiernan JM.","J Urol. 2016 Oct;196(4):1021-9. doi: 10.1016/j.juro.2016.06.049. Epub 2016 Jun 16.","Chang SS","J Urol","2016","2016/06/19","","","10.1016/j.juro.2016.06.049"
"18180545","Inorganic arsenic in drinking water and bladder cancer: a meta-analysis for dose-response assessment","Chu HA, Crawford-Brown D.","Int J Environ Res Public Health. 2007 Dec;4(4):340-1. doi: 10.3390/ijerph200704040010.","Chu HA","Int J Environ Res Public Health","2007","2008/01/09","PMC3732405","","10.3390/ijerph200704040010"
"26773572","Treatment of muscle-invasive bladder cancer: A systematic review","Chou R, Selph SS, Buckley DI, Gustafson KS, Griffin JC, Grusing SE, Gore JL.","Cancer. 2016 Mar 15;122(6):842-51. doi: 10.1002/cncr.29843. Epub 2016 Jan 15.","Chou R","Cancer","2016","2016/01/17","","","10.1002/cncr.29843"
"20573844","Bladder cancer risk in painters","Vineis P.","Occup Environ Med. 2010 Aug;67(8):505-6. doi: 10.1136/oem.2009.053215. Epub 2010 Jun 23.","Vineis P","Occup Environ Med","2010","2010/06/25","","","10.1136/oem.2009.053215"
"10997813","The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why","Sylvester R, Sternberg C.","Ann Oncol. 2000 Jul;11(7):851-6. doi: 10.1023/a:1008399130226.","Sylvester R","Ann Oncol","2000","2000/09/21","","","10.1023/a:1008399130226"
"7273025","Doxorubicin hypogastric artery infusion combined with hyperthermia therapy for transitional cell carcinoma of the bladder","Jacobs SC, Maddison FE, Lawson RK.","Cancer Treat Rep. 1981 Sep-Oct;65(9-10):891-3.","Jacobs SC","Cancer Treat Rep","1981","1981/09/01","","",""
"9206878","[The results of the surgical treatment of bladder cancer patients]","Matveev BP, Figurin KM.","Urol Nefrol (Mosk). 1997 Mar-Apr;(2):25-8.","Matveev BP","Urol Nefrol (Mosk)","1997","1997/03/01","","",""
"24100147","Adaptive plan selection vs. re-optimisation in radiotherapy for bladder cancer: a dose accumulation comparison","Vestergaard A, Muren LP, Søndergaard J, Elstrøm UV, Høyer M, Petersen JB.","Radiother Oncol. 2013 Dec;109(3):457-62. doi: 10.1016/j.radonc.2013.08.045. Epub 2013 Oct 4.","Vestergaard A","Radiother Oncol","2013","2013/10/09","","","10.1016/j.radonc.2013.08.045"
"8558845","Comparison of P53 protein overexpression with P53 mutation in bladder cancer: clinical and biologic aspects","Vet JA, Bringuier PP, Schaafsma HE, Witjes JA, Debruyne FM, Schalken JA.","Lab Invest. 1995 Dec;73(6):837-43.","Vet JA","Lab Invest","1995","1995/12/01","","",""
"22088598","Selective organ preservation in muscle-invasive bladder cancer: review of the literature","Khosravi-Shahi P, Cabezón-Gutiérrez L.","Surg Oncol. 2012 Mar;21(1):e17-22. doi: 10.1016/j.suronc.2011.10.004. Epub 2011 Nov 16.","Khosravi-Shahi P","Surg Oncol","2012","2011/11/18","","","10.1016/j.suronc.2011.10.004"
"7582848","Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection","Gajda M, Tyloch F, Jóźwicki W, Tyloch J, Sujkowska R, Skok Z.","Int J Occup Med Environ Health. 1995;8(2):103-8.","Gajda M","Int J Occup Med Environ Health","1995","1995/01/01","","",""
"17565855","[Study of bladder cancer gene and relevant molecular biology should be strengthened]","Li CL, Han SJ.","Zhonghua Yi Xue Za Zhi. 2007 Mar 27;87(12):793-4.","Li CL","Zhonghua Yi Xue Za Zhi","2007","2007/06/15","","",""
"17555386","Lymph node density: surrogate marker for quality of resection in bladder cancer?","Kamat AM, Fisher MB.","Expert Rev Anticancer Ther. 2007 Jun;7(6):777-9. doi: 10.1586/14737140.7.6.777.","Kamat AM","Expert Rev Anticancer Ther","2007","2007/06/09","","","10.1586/14737140.7.6.777"
"8528714","Why are the occupational and smoking risks for bladder cancer not confounded? An epidemiologic puzzle","Sterling TD, Weinkam JJ, Rosenbaum W.","J Occup Environ Med. 1995 Sep;37(9):1072-3. doi: 10.1097/00043764-199509000-00003.","Sterling TD","J Occup Environ Med","1995","1995/09/01","","","10.1097/00043764-199509000-00003"
"1249876","Letter: Re: failure of ascorbic acid to inhibit FANFT-induced bladder cancer","Schlegel JU.","J Urol. 1976 Feb;115(2):223-4. doi: 10.1016/s0022-5347(17)59144-2.","Schlegel JU","J Urol","1976","1976/02/01","","","10.1016/s0022-5347(17)59144-2"
"20813661","[Analysis and verification of the interaction network of differentially expressed genes in invasive bladder cancer]","Shi R, Zhao Z, Gao Y, Wu QH, Song YB, Jiang L, Zheng WL, Ma WL.","Nan Fang Yi Ke Da Xue Xue Bao. 2010 Aug;30(8):1771-4.","Shi R","Nan Fang Yi Ke Da Xue Xue Bao","2010","2010/09/04","","",""
"21965727","Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer","Du P, Ye L, Ruge F, Yang Y, Jiang WG.","Anticancer Res. 2011 Oct;31(10):3205-12.","Du P","Anticancer Res","2011","2011/10/04","","",""
"12592374","Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder","Hussain SA, Ganesan R, Hiller L, Murray PG, el-Magraby MM, Young L, James ND.","Br J Cancer. 2003 Feb 24;88(4):586-92. doi: 10.1038/sj.bjc.6600765.","Hussain SA","Br J Cancer","2003","2003/02/20","PMC2377165","","10.1038/sj.bjc.6600765"
"21444130","[Positron emission tomography using 18F-fluorodeoxy-glucose in a case of bladder cancer with a solitary cutaneous metastasis]","Contreras Gutiérrez J, Frutos Esteban L, Navarro Fernández JL, Claver Valderas MA.","Rev Esp Med Nucl. 2011 Jul-Aug;30(4):254-5. doi: 10.1016/j.remn.2010.11.003. Epub 2011 Mar 27.","Contreras Gutiérrez J","Rev Esp Med Nucl","2011","2011/03/30","","","10.1016/j.remn.2010.11.003"
"4973573","Cancer of the urogenital tract: bladder cancer. The radiation attack","Cuccia CA.","JAMA. 1969 Jan 13;207(2):347-8. doi: 10.1001/jama.207.2.347.","Cuccia CA","JAMA","1969","1969/01/13","","","10.1001/jama.207.2.347"
"3430019","[The quality of life in patients with bladder cancer after radical cystectomy with ileal conduit: II. Results of questionnaire surveys to compare the impact of treatments]","Miyakawa M, Yoshida O.","Nihon Gan Chiryo Gakkai Shi. 1987 Aug 20;22(7):1296-303.","Miyakawa M","Nihon Gan Chiryo Gakkai Shi","1987","1987/08/20","","",""
"17693304","Urinary nucleosides based potential biomarker selection by support vector machine for bladder cancer recognition","Mao Y, Zhao X, Wang S, Cheng Y.","Anal Chim Acta. 2007 Aug 13;598(1):34-40. doi: 10.1016/j.aca.2007.07.038. Epub 2007 Jul 21.","Mao Y","Anal Chim Acta","2007","2007/08/19","","","10.1016/j.aca.2007.07.038"
"11280894","[A case of transitional cell carcinoma of the bladder in a juvenile patient]","Aoki S, Tanaka K, Ohori T, Nishikawa E, Yamada Y, Honda N, Fukatsu H.","Hinyokika Kiyo. 2001 Feb;47(2):99-103.","Aoki S","Hinyokika Kiyo","2001","2001/04/03","","",""
"9240180","Which patients will benefit from psychosocial intervention after cystectomy for bladder cancer?","Månsson A, Colleen S, Hermerén G, Johnson G.","Br J Urol. 1997 Jul;80(1):50-7. doi: 10.1046/j.1464-410x.1997.00210.x.","Månsson A","Br J Urol","1997","1997/07/01","","","10.1046/j.1464-410x.1997.00210.x"
"25217465","Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice","van Rhijn BW, Catto JW, Goebell PJ, Knüchel R, Shariat SF, van der Poel HG, Sanchez-Carbayo M, Thalmann GN, Schmitz-Dräger BJ, Kiemeney LA.","Urol Oncol. 2014 Oct;32(7):1078-87. doi: 10.1016/j.urolonc.2014.07.002. Epub 2014 Sep 10.","van Rhijn BW","Urol Oncol","2014","2014/09/14","","","10.1016/j.urolonc.2014.07.002"
"2729014","[Significance of isoantigen in the management of the urinary bladder tumor--a basic study of ABO isoantigen in step sections of the entire bladder]","Ogawa T, Sugimoto M, Hamami G, Kamidono S.","Hinyokika Kiyo. 1989 Jan;35(1):13-25.","Ogawa T","Hinyokika Kiyo","1989","1989/01/01","","",""
"28238343","Indication for early cystectomy in nonmuscle-invasive bladder cancer. Literature review","Cogorno Wasylkowski L, Ríos-González E, Linares Espinós E, Leibar Tamayo A, Martínez-Piñeiro Lorenzo L.","Actas Urol Esp. 2018 Jan-Feb;42(1):17-24. doi: 10.1016/j.acuro.2016.12.004. Epub 2017 Feb 21.","Cogorno Wasylkowski L","Actas Urol Esp","2018","2017/02/28","","","10.1016/j.acuro.2016.12.004"
"10710246","A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer: a prospective study","Miyanaga N, Akaza H, Okumura T, Sekido N, Kawai K, Shimazui T, Kikuchi K, Uchida K, Takeshima H, Ohara K, Akine Y, Ita Y.","Int J Urol. 2000 Feb;7(2):41-8. doi: 10.1046/j.1442-2042.2000.00137.x.","Miyanaga N","Int J Urol","2000","2000/03/10","","","10.1046/j.1442-2042.2000.00137.x"
"23944379","Complementary and alternative medicine (CAM) in prostate and bladder cancer","Philippou Y, Hadjipavlou M, Khan S, Rane A.","BJU Int. 2013 Dec;112(8):1073-9. doi: 10.1111/bju.12062.","Philippou Y","BJU Int","2013","2013/08/16","","","10.1111/bju.12062"
"24518761","The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies","Richards KA, Smith ND, Steinberg GD.","J Urol. 2014 Jun;191(6):1655-64. doi: 10.1016/j.juro.2014.01.087. Epub 2014 Feb 8.","Richards KA","J Urol","2014","2014/02/13","","","10.1016/j.juro.2014.01.087"
"15662602","The surgical management of muscle invasive bladder cancer: a contemporary review","Cookson MS.","Semin Radiat Oncol. 2005 Jan;15(1):10-8. doi: 10.1016/j.semradonc.2004.07.009.","Cookson MS","Semin Radiat Oncol","2005","2005/01/22","","","10.1016/j.semradonc.2004.07.009"
"8442300","Treatment of T3a bladder cancer with iridium implantation","Grossman HB, Sandler HM, Perez-Tamayo C.","Urology. 1993 Mar;41(3):217-20. doi: 10.1016/0090-4295(93)90559-s.","Grossman HB","Urology","1993","1993/03/01","","","10.1016/0090-4295(93)90559-s"
"27002743","Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer","Thorstenson A, Hagberg O, Ljungberg B, Liedberg F, Jancke G, Holmäng S, Malmström PU, Hosseini A, Jahnson S.","Scand J Urol. 2016 Aug;50(4):292-7. doi: 10.3109/21681805.2016.1158207. Epub 2016 Mar 22.","Thorstenson A","Scand J Urol","2016","2016/03/23","","","10.3109/21681805.2016.1158207"
"8659034","[The immunotherapy of bladder tumors and the immunoprophylaxis of disease recurrence]","Korovin AI, Savvin VT.","Urol Nefrol (Mosk). 1996 Jan-Feb;(1):19-21.","Korovin AI","Urol Nefrol (Mosk)","1996","1996/01/01","","",""
"9572628","The treatment of bladder cancer in the elderly","Phillips HA, Howard GC.","Radiother Oncol. 1998 Mar;46(3):334-5. doi: 10.1016/s0167-8140(97)00156-4.","Phillips HA","Radiother Oncol","1998","1998/05/08","","","10.1016/s0167-8140(97)00156-4"
"16939699","Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosis","Tritschler S, Scharf S, Karl A, Tilki D, Knuechel R, Hartmann A, Stief CG, Zaak D.","Eur Urol. 2007 Feb;51(2):403-7; discussion 407-8. doi: 10.1016/j.eururo.2006.08.001. Epub 2006 Aug 15.","Tritschler S","Eur Urol","2007","2006/08/31","","","10.1016/j.eururo.2006.08.001"
"7112544","Hyperthermic irrigation of urinary bladder tumor in rabbits","Nemoto R, Kato T, Mori H, Iwata K, Harada M.","Tohoku J Exp Med. 1982 Jun;137(2):199-205. doi: 10.1620/tjem.137.199.","Nemoto R","Tohoku J Exp Med","1982","1982/06/01","","","10.1620/tjem.137.199"
"25160520","Long-term survival in bone-predominant metastatic urothelial carcinoma","Ramos JD, Cheng HH, Yu EY.","Clin Genitourin Cancer. 2014 Dec;12(6):e241-4. doi: 10.1016/j.clgc.2014.07.005. Epub 2014 Jul 23.","Ramos JD","Clin Genitourin Cancer","2014","2014/08/28","PMC4252264","NIHMS616357","10.1016/j.clgc.2014.07.005"
"26044131","Successful Pregnancy and Neobladder Subsequent to Muscle Invasive Bladder Cancer and Fertility Preserving Surgery: Case Report and Review of the Literature","Hupe MC, Merseburger AS, Günter HH, Wüstemann M, von Kaisenberg CS.","Urol Int. 2016;96(4):488-91. doi: 10.1159/000430921. Epub 2015 May 30.","Hupe MC","Urol Int","2016","2015/06/06","","","10.1159/000430921"
"15662608","Quality of life after radical treatment for invasive bladder cancer","Zietman A, Skinner E.","Semin Radiat Oncol. 2005 Jan;15(1):55-9. doi: 10.1016/j.semradonc.2004.07.013.","Zietman A","Semin Radiat Oncol","2005","2005/01/22","","","10.1016/j.semradonc.2004.07.013"
"16820545","NMP22 and surveillance for recurrent bladder cancer","Eggener S, Herr H.","JAMA. 2006 Jul 5;296(1):45; author reply 45-6. doi: 10.1001/jama.296.1.45-a.","Eggener S","JAMA","2006","2006/07/06","","","10.1001/jama.296.1.45-a"
"15176322","Cystectomy causes immunosuppression in bladder cancer","Herwig R, Brinkmann OA, Sievert KD, Brodner G, Hertle L.","Adv Exp Med Biol. 2003;539(Pt B):741-8. doi: 10.1007/978-1-4419-8889-8_46.","Herwig R","Adv Exp Med Biol","2003","2004/06/05","","","10.1007/978-1-4419-8889-8_46"
"14758869","The limitations of using hospital controls in cancer etiology--one more example for Berkson's bias","Sadetzki S, Bensal D, Novikov I, Modan B.","Eur J Epidemiol. 2003;18(12):1127-31. doi: 10.1023/b:ejep.0000006634.49205.c5.","Sadetzki S","Eur J Epidemiol","2003","2004/02/05","","","10.1023/b:ejep.0000006634.49205.c5"
"19154452","Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study","Koga F, Kihara K, Fujii Y, Yoshida S, Saito K, Masuda H, Kageyama Y, Kawakami S.","BJU Int. 2009 Jul;104(2):189-94. doi: 10.1111/j.1464-410X.2008.08297.x. Epub 2008 Dec 22.","Koga F","BJU Int","2009","2009/01/22","","","10.1111/j.1464-410X.2008.08297.x"
"8886073","Bladder cancer","Soloway MS.","Urology. 1996 Oct;48(4):631. doi: 10.1016/S0090-4295(96)00328-7.","Soloway MS","Urology","1996","1996/10/01","","","10.1016/S0090-4295(96)00328-7"
"914301","Study of bladder tumours in North India","Singh SM, Gupta NP, Wadhwa SN.","Indian J Cancer. 1977 Jun;14(2):122-5.","Singh SM","Indian J Cancer","1977","1977/06/01","","",""
"31262208","Incidence, survival and mortality trends of bladder cancer in Sweden 1997-2016","Malmström PU, Gårdmark T, Sherif A, Ströck V, Hosseini-Aliabad A, Jahnson S, Aljabery F, Liedberg F.","Scand J Urol. 2019 Aug;53(4):193-199. doi: 10.1080/21681805.2019.1632380. Epub 2019 Jul 2.","Malmström PU","Scand J Urol","2019","2019/07/03","","","10.1080/21681805.2019.1632380"
"8294212","Prognostic significance of selected lifestyle factors in urinary bladder cancer","Wakai K, Ohno Y, Obata K, Aoki K.","Jpn J Cancer Res. 1993 Dec;84(12):1223-9. doi: 10.1111/j.1349-7006.1993.tb02826.x.","Wakai K","Jpn J Cancer Res","1993","1993/12/01","PMC5919112","","10.1111/j.1349-7006.1993.tb02826.x"
"24485286","[CCAFU Recommendations 2013: Bladder carcinoma]","Pfister C, Roupret M, Neuzillet Y, Larré S, Pignot G, Quintens H, Houedé N, Compérat E, Colin P, Roy C, Davin JL, Guy L, Irani J, Lebret T, Coloby P, Soulié M; Les membres du CCAFU.","Prog Urol. 2013 Nov;23 Suppl 2:S105-25. doi: 10.1016/S1166-7087(13)70049-6.","Pfister C","Prog Urol","2013","2014/02/04","","","10.1016/S1166-7087(13)70049-6"
"32381859","[Ⅲ.Topics of Bladder Cancer Treatment of New ""Reiwa"" Era]","Kimura T, Nishiyama H.","Gan To Kagaku Ryoho. 2020 Jan;47(1):30-37.","Kimura T","Gan To Kagaku Ryoho","2020","2020/05/09","","",""
"10613319","A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer","Hayter CR, Paszat LF, Groome PA, Schulze K, Math M, Mackillop WJ.","Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1239-45. doi: 10.1016/s0360-3016(99)00306-5.","Hayter CR","Int J Radiat Oncol Biol Phys","1999","1999/12/29","","","10.1016/s0360-3016(99)00306-5"
"8683895","[Random biopsy and recurrence risk in patients with bladder cancer]","Yamada Y, Hayashi Y, Kohri K, Terao E, Hirao N, HoriH, IwaiY, Kato K, Ito T, Tawada T, Asaka H, Andou H, Kawai T, Ikeuchi T, Watanabe H.","Nihon Hinyokika Gakkai Zasshi. 1996 Jan;87(1):61-6. doi: 10.5980/jpnjurol1989.87.61.","Yamada Y","Nihon Hinyokika Gakkai Zasshi","1996","1996/01/01","","","10.5980/jpnjurol1989.87.61"
"26863611","Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec","Zakaria AS, Santos F, Kassouf W, Tanguay S, Aprikian A.","Urol Int. 2016;97(1):49-53. doi: 10.1159/000444093. Epub 2016 Feb 11.","Zakaria AS","Urol Int","2016","2016/02/11","","","10.1159/000444093"
"16217397","Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians","Ratliff TL.","J Urol. 2005 Nov;174(5):2066.","Ratliff TL","J Urol","2005","2005/10/12","","",""
"25456839","Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancer","Kanatani A, Nakagawa T, Kawai T, Naito A, Sato Y, Yoshida K, Nozaki K, Nagata M, Yamada Y, Azuma T, Suzuki M, Fujimura T, Fukuhara H, Nishimatsu H, Kume H, Igawa Y, Homma Y.","Clin Genitourin Cancer. 2015 Apr;13(2):e107-12. doi: 10.1016/j.clgc.2014.09.007. Epub 2014 Nov 6.","Kanatani A","Clin Genitourin Cancer","2015","2014/12/03","","","10.1016/j.clgc.2014.09.007"
"21814052","Bladder cancer imaging: an update","Moses KA, Zhang J, Hricak H, Bochner BH.","Curr Opin Urol. 2011 Sep;21(5):393-7. doi: 10.1097/MOU.0b013e32834956c3.","Moses KA","Curr Opin Urol","2011","2011/08/05","","","10.1097/MOU.0b013e32834956c3"
"27019161","The cytomorphological features of low-grade urothelial neoplasms vary by specimen type","Zhang ML, Rosenthal DL, VandenBussche CJ.","Cancer Cytopathol. 2016 Aug;124(8):552-64. doi: 10.1002/cncy.21716. Epub 2016 Mar 28.","Zhang ML","Cancer Cytopathol","2016","2016/03/29","","","10.1002/cncy.21716"
"14680313","Evaluation and follow-up strategies for superficial bladder cancer","Donat SM.","Urol Clin North Am. 2003 Nov;30(4):765-76. doi: 10.1016/s0094-0143(03)00060-0.","Donat SM","Urol Clin North Am","2003","2003/12/19","","","10.1016/s0094-0143(03)00060-0"
"4034585","Methotrexate in superficial bladder cancer--what happens to the drug?","Hall RR, Gibb I.","Prog Clin Biol Res. 1985;185B:105-10.","Hall RR","Prog Clin Biol Res","1985","1985/01/01","","",""
"2063502","[Transabdominal and transurethral scanning in the diagnosis of the bladder cancer stage]","Stepanov VN, Perel'man VM, Abdukhakimov AF.","Urol Nefrol (Mosk). 1991 Mar-Apr;(2):33-7.","Stepanov VN","Urol Nefrol (Mosk)","1991","1991/03/01","","",""
"2264543","[A clinicopathological study on patients with bladder cancer treated with cystectomy]","Yamashita S, Taniguchi K, Suzu H, Yushita Y, Sakuragi T, Kanetake H, Shindo K, Saito Y, Hori T, Tasaki T, et al.","Hinyokika Kiyo. 1990 Oct;36(10):1149-54.","Yamashita S","Hinyokika Kiyo","1990","1990/10/01","","",""
"20803606","A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer","Lughezzani G, Sun M, Shariat SF, Budäus L, Thuret R, Jeldres C, Liberman D, Montorsi F, Perrotte P, Karakiewicz PI.","Cancer. 2011 Jan 1;117(1):103-9. doi: 10.1002/cncr.25345. Epub 2010 Aug 27.","Lughezzani G","Cancer","2011","2010/08/31","","","10.1002/cncr.25345"
"25541698","Bladder cancer biomarker discovery using global metabolomic profiling of urine","Wittmann BM, Stirdivant SM, Mitchell MW, Wulff JE, McDunn JE, Li Z, Dennis-Barrie A, Neri BP, Milburn MV, Lotan Y, Wolfert RL.","PLoS One. 2014 Dec 26;9(12):e115870. doi: 10.1371/journal.pone.0115870. eCollection 2014.","Wittmann BM","PLoS One","2014","2014/12/27","PMC4277370","","10.1371/journal.pone.0115870"
"10648997","[Protocol for the pathologic examination of cystectomy and cystoprostatectomy specimens. Proposal for a standardized form]","Lesourd A, Billerey C.","Ann Pathol. 2000 Jan;20(1):85-90.","Lesourd A","Ann Pathol","2000","2000/01/29","","",""
"9394908","High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumor","Herr HW.","Semin Urol Oncol. 1997 Aug;15(3):142-6.","Herr HW","Semin Urol Oncol","1997","1997/08/01","","",""
"26032551","Targeting glycogen metabolism in bladder cancer","Ritterson Lew C, Guin S, Theodorescu D.","Nat Rev Urol. 2015 Jul;12(7):383-91. doi: 10.1038/nrurol.2015.111. Epub 2015 May 26.","Ritterson Lew C","Nat Rev Urol","2015","2015/06/03","PMC4678000","NIHMS742245","10.1038/nrurol.2015.111"
"30105084","Stability Analysis of Delayed Immune Response BCG Infection in Bladder Cancer Treatment Model by Stochastic Perturbations","Shaikhet L, Bunimovich-Mendrazitsky S.","Comput Math Methods Med. 2018 Jul 9;2018:9653873. doi: 10.1155/2018/9653873. eCollection 2018.","Shaikhet L","Comput Math Methods Med","2018","2018/08/15","PMC6076981","","10.1155/2018/9653873"
"28366700","European Association of Urology and American Urological Association/Society of Urologic Oncology Guidelines on Risk Categories for Non-muscle-invasive Bladder Cancer May Lead to Overtreatment for Low-grade Ta Bladder Tumors","Klaassen Z, Soloway MS.","Urology. 2017 Jul;105:14-17. doi: 10.1016/j.urology.2017.03.034. Epub 2017 Mar 30.","Klaassen Z","Urology","2017","2017/04/04","","","10.1016/j.urology.2017.03.034"
"1662739","Evaluation of nonlinear optimization for scheduling of follow-up cystoscopies to detect recurrent bladder cancer. The Bladder Cancer follow-up Group","Kent DL, Nease RA, Sox HC Jr, Shortliffe LD, Shachter R.","Med Decis Making. 1991 Oct-Dec;11(4):240-8. doi: 10.1177/0272989X9101100402.","Kent DL","Med Decis Making","1991","1991/10/11","","","10.1177/0272989X9101100402"
"27034531","Network Biomarkers of Bladder Cancer Based on a Genome-Wide Genetic and Epigenetic Network Derived from Next-Generation Sequencing Data","Li CW, Chen BS.","Dis Markers. 2016;2016:4149608. doi: 10.1155/2016/4149608. Epub 2016 Feb 29.","Li CW","Dis Markers","2016","2016/04/02","PMC4789422","","10.1155/2016/4149608"
"9179671","Correlation of allelic loss of the P53 gene and tumor grade, stage, and malignant progression in bladder cancer","Tsutsumi M, Sugano K, Yamaguchi K, Kakizoe T, Akaza H.","Int J Urol. 1997 Jan;4(1):74-8. doi: 10.1111/j.1442-2042.1997.tb00144.x.","Tsutsumi M","Int J Urol","1997","1997/01/01","","","10.1111/j.1442-2042.1997.tb00144.x"
"3406757","The role of radiation therapy and chemotherapy in the treatment of invasive carcinoma of the urinary bladder","Shipley WU, Kaufman SD, Prout GR Jr.","Semin Oncol. 1988 Aug;15(4):390-5.","Shipley WU","Semin Oncol","1988","1988/08/01","","",""
"31070194","Current Status of Functional Studies on Circular RNAs in Bladder Cancer and their Potential Role as Diagnostic and Prognostic Biomarkers: A Review","Cong L, Yang Q, Hu C, Yu Q, Hao S, Li D.","Med Sci Monit. 2019 May 9;25:3425-3434. doi: 10.12659/MSM.916697.","Cong L","Med Sci Monit","2019","2019/05/10","PMC6528548","","10.12659/MSM.916697"
"8837247","Urinary glycosaminoglycan excretion in bladder carcinoma","Atahan O, Kayigil O, Hizel N, Yavuz O, Metin A.","Scand J Urol Nephrol. 1996 Jun;30(3):173-7. doi: 10.3109/00365599609181295.","Atahan O","Scand J Urol Nephrol","1996","1996/06/01","","","10.3109/00365599609181295"
"29454591","The effect of treatment at minority-serving hospitals on outcomes for bladder cancer","Fletcher SA, Gild P, Cole AP, Vetterlein MW, Kibel AS, Choueiri TK, Sonpavde GP, Preston MA, Pucheril D, Menon M, Sun M, Lipsitz SR, Trinh QD.","Urol Oncol. 2018 May;36(5):238.e7-238.e17. doi: 10.1016/j.urolonc.2018.01.010. Epub 2018 Feb 15.","Fletcher SA","Urol Oncol","2018","2018/02/19","","","10.1016/j.urolonc.2018.01.010"
"27812861","Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU)","García J, Santomé L, Anido U, Fernández-Calvo O, Afonso-Afonso J, Lázaro M, Medina A, Vázquez Estévez S.","Curr Oncol Rep. 2016 Dec;18(12):72. doi: 10.1007/s11912-016-0556-3.","García J","Curr Oncol Rep","2016","2016/11/05","","","10.1007/s11912-016-0556-3"
"30138123","Biology of nonmuscle-invasive bladder cancer: pathology, genomic implications, and immunology","Dyrskjøt L, Ingersoll MA.","Curr Opin Urol. 2018 Nov;28(6):598-603. doi: 10.1097/MOU.0000000000000543.","Dyrskjøt L","Curr Opin Urol","2018","2018/08/24","","","10.1097/MOU.0000000000000543"
"9224385","Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor","Kadhim SA, Chin JL, Batislam E, Karlik SJ, Garcia B, Skamene E.","J Urol. 1997 Aug;158(2):646-52.","Kadhim SA","J Urol","1997","1997/08/01","","",""
"7459579","TNM (1978) in bladder cancer: use and abuse","Chisholm GD, Hindmarsh JR, Howatson AG, Webb JN, Busuttil A, Hargreave TB, Newsam JE.","Br J Urol. 1980 Dec;52(6):500-5. doi: 10.1111/j.1464-410x.1980.tb03100.x.","Chisholm GD","Br J Urol","1980","1980/12/01","","","10.1111/j.1464-410x.1980.tb03100.x"
"29312460","Dynamics of Immune Checkpoints, Immune System, and BCG in the Treatment of Superficial Bladder Cancer","Saad FT, Hincal E, Kaymakamzade B.","Comput Math Methods Med. 2017;2017:3573082. doi: 10.1155/2017/3573082. Epub 2017 Oct 26.","Saad FT","Comput Math Methods Med","2017","2018/01/10","PMC5684605","","10.1155/2017/3573082"
"31171142","Patient-Friendly Summary of the ACR Appropriateness Criteria: Pretreatment Staging of Muscle-Invasive Bladder Cancer","Rybicki F Jr, Glanc P.","J Am Coll Radiol. 2019 Jun;16(6):e25. doi: 10.1016/j.jacr.2019.01.012.","Rybicki F Jr","J Am Coll Radiol","2019","2019/06/08","","","10.1016/j.jacr.2019.01.012"
"16520658","The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells","Tang L, Li G, Song L, Zhang Y.","Anticancer Drugs. 2006 Mar;17(3):297-305. doi: 10.1097/00001813-200603000-00008.","Tang L","Anticancer Drugs","2006","2006/03/08","","","10.1097/00001813-200603000-00008"
"23773402","Quantitative assessment of the association between MHTFR C677T (rs1801133, Ala222Val) polymorphism and susceptibility to bladder cancer","Xu W, Zhang H, Wang F, Wang H.","Diagn Pathol. 2013 Jun 17;8:95. doi: 10.1186/1746-1596-8-95.","Xu W","Diagn Pathol","2013","2013/06/19","PMC3751124","","10.1186/1746-1596-8-95"
"7596084","[Histochemical expression of proliferating cell nuclear antigen (PCNA) for pre and post chemotherapeutic bladder cancer]","Nagase Y, Moriyama N, Kurimoto S, Tajima A, Higashihara E, Aso Y.","Nihon Hinyokika Gakkai Zasshi. 1995 May;86(5):985-90. doi: 10.5980/jpnjurol1989.86.985.","Nagase Y","Nihon Hinyokika Gakkai Zasshi","1995","1995/05/01","","","10.5980/jpnjurol1989.86.985"
"17982617","An alternatively spliced KAI1 mRNA is expressed at low levels in human bladder cancers and bladder cancer cell lines and is not associated with invasive behaviour","Jackson P, Rowe A, Grimm MO.","Oncol Rep. 2007 Dec;18(6):1357-63.","Jackson P","Oncol Rep","2007","2007/11/06","","",""
"1836689","[Occupational hazards and bladder cancer]","Nizamova RS.","Urol Nefrol (Mosk). 1991 Sep-Oct;(5):35-8.","Nizamova RS","Urol Nefrol (Mosk)","1991","1991/09/01","","",""
"8285161","[Clinical observations on bladder cancer--difference in clinical features with age]","Noguchi S, Kubota Y, Shuin T, Masuda M, Yao M, Miura T, Moriyama M, Sakuramoto T, Ishibashi Y, Misaki H, et al.","Hinyokika Kiyo. 1993 Dec;39(12):1131-8.","Noguchi S","Hinyokika Kiyo","1993","1993/12/01","","",""
"6605891","Suppression of granulocyte-macrophage colony formation in vitro by conditioned medium derived from human bladder cancer cells","Fujita J, Oishi K, Yoshida O, Kamamoto T, Miyanomae T, Mori KJ.","Gan. 1983 Oct;74(5):671-8.","Fujita J","Gan","1983","1983/10/01","","",""
"11061882","Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer","Golijanin D, Shapiro A, Pode D.","J Urol. 2000 Dec;164(6):1922-5.","Golijanin D","J Urol","2000","2000/11/04","","",""
"3176723","[Dose uncertainties in irradiation of bladder cancer with the Nd: YAG laser beam]","Freude W, Huber RD, Matouschek E.","Z Urol Nephrol. 1988 Aug;81(8):481-5.","Freude W","Z Urol Nephrol","1988","1988/08/01","","",""
"31042695","Higher Expression of Linc00152 Promotes Bladder Cancer Proliferation and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway","Xian-Li T, Hong L, Hong Z, Yuan L, Jun-Yong D, Peng X, Yan-Ping S, Fang Y, Nan L.","Med Sci Monit. 2019 May 1;25:3221-3230. doi: 10.12659/MSM.913944.","Xian-Li T","Med Sci Monit","2019","2019/05/03","PMC6507494","","10.12659/MSM.913944"
"27224661","Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer","Rose TL, Deal AM, Nielsen ME, Smith AB, Milowsky MI.","Cancer. 2016 Jul 1;122(13):2012-20. doi: 10.1002/cncr.30029. Epub 2016 May 25.","Rose TL","Cancer","2016","2016/05/26","PMC4911298","NIHMS772704","10.1002/cncr.30029"
"29536411","MiR-192-5p suppresses the growth of bladder cancer cells via targeting Yin Yang 1","Ji D, Jiang L, Li Y.","Hum Cell. 2018 Jul;31(3):210-219. doi: 10.1007/s13577-018-0201-6. Epub 2018 Mar 13.","Ji D","Hum Cell","2018","2018/03/15","","","10.1007/s13577-018-0201-6"
"24091477","Management of muscle-invasive bladder cancer","Mueller J, Schrader AJ, Schrader M, Schnoeller T, Jentzmik F.","Minerva Urol Nefrol. 2013 Dec;65(4):235-48.","Mueller J","Minerva Urol Nefrol","2013","2013/10/05","","",""
"19324494","Differential effects of valproic acid on growth, proliferation and metastasis in HTB5 and HTB9 bladder cancer cell lines","Byun SS, Kim FJ, Khandrika L, Kumar B, Koul S, Wilson S, Koul HK.","Cancer Lett. 2009 Aug 28;281(2):196-202. doi: 10.1016/j.canlet.2009.02.045. Epub 2009 Mar 25.","Byun SS","Cancer Lett","2009","2009/03/28","","","10.1016/j.canlet.2009.02.045"
"26980488","Genetic alteration in phosphofructokinase family promotes growth of muscle-invasive bladder cancer","Sun CM, Xiong DB, Yan Y, Geng J, Liu M, Yao XD.","Int J Biol Markers. 2016 Jul 30;31(3):e286-93. doi: 10.5301/jbm.5000189.","Sun CM","Int J Biol Markers","2016","2016/03/17","","","10.5301/jbm.5000189"
"9474851","[Rudolf Virchow Prize 1997. Molecular cytogenetic analysis of superficial urothelial cancer of the bladder]","Sauter G.","Verh Dtsch Ges Pathol. 1997;81:18-27.","Sauter G","Verh Dtsch Ges Pathol","1997","1997/01/01","","",""
"12189498","The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems","Busch C, Algaba F.","Virchows Arch. 2002 Aug;441(2):105-8. doi: 10.1007/s00428-002-0633-x. Epub 2002 May 2.","Busch C","Virchows Arch","2002","2002/08/22","","","10.1007/s00428-002-0633-x"
"17324324","Metastatic cancer involving bladder: a review","Velcheti V, Govindan R.","Can J Urol. 2007 Feb;14(1):3443-8.","Velcheti V","Can J Urol","2007","2007/02/28","","",""
"9165578","Morbidity after preoperative radiotherapy and cystectomy in patients with bladder cancer","Tomic R, Granfors T, Modig H.","Scand J Urol Nephrol. 1997 Apr;31(2):149-53. doi: 10.3109/00365599709070321.","Tomic R","Scand J Urol Nephrol","1997","1997/04/01","","","10.3109/00365599709070321"
"8441827","Update on artificial sweeteners and bladder cancer","Elcock M, Morgan RW.","Regul Toxicol Pharmacol. 1993 Feb;17(1):35-43. doi: 10.1006/rtph.1993.1004.","Elcock M","Regul Toxicol Pharmacol","1993","1993/02/01","","","10.1006/rtph.1993.1004"
"28677000","Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results","Trinh TW, Glazer DI, Sadow CA, Sahni VA, Geller NL, Silverman SG.","Abdom Radiol (NY). 2018 Mar;43(3):663-671. doi: 10.1007/s00261-017-1249-6.","Trinh TW","Abdom Radiol (NY)","2018","2017/07/06","","","10.1007/s00261-017-1249-6"
"23880739","Should histologic variants alter definitive treatment of bladder cancer?","Willis DL, Porten SP, Kamat AM.","Curr Opin Urol. 2013 Sep;23(5):435-43. doi: 10.1097/MOU.0b013e328363e415.","Willis DL","Curr Opin Urol","2013","2013/07/25","","","10.1097/MOU.0b013e328363e415"
"19587505","Stage of urinary bladder cancer at first presentation","Al-Bazzaz PH.","Saudi J Kidney Dis Transpl. 2009 Jul;20(4):628-31.","Al-Bazzaz PH","Saudi J Kidney Dis Transpl","2009","2009/07/10","","",""
"8988054","Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer","O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL.","Cancer Res. 1997 Jan 1;57(1):136-40.","O'Brien T","Cancer Res","1997","1997/01/01","","",""
"16220401","Organ-sparing treatment in muscle-invasive bladder cancer","Dunst J, Diestelhorst A, Kühn R, Müller AC, Scholz HJ, Fornara P.","Strahlenther Onkol. 2005 Oct;181(10):632-7. doi: 10.1007/s00066-005-1416-5.","Dunst J","Strahlenther Onkol","2005","2005/10/13","","","10.1007/s00066-005-1416-5"
"3988562","Bladder cancer: pattern of recurrence in 142 patients","Timmer PR, Hartlief HA, Hooijkaas JA.","Int J Radiat Oncol Biol Phys. 1985 May;11(5):899-905. doi: 10.1016/0360-3016(85)90111-7.","Timmer PR","Int J Radiat Oncol Biol Phys","1985","1985/05/01","","","10.1016/0360-3016(85)90111-7"
"11852762","[Diagnosis of bladder tumors]","Rischmann P.","Rev Prat. 2002 Jan 1;52(1):32-5.","Rischmann P","Rev Prat","2002","2002/02/21","","",""
"28116879","Physical activity in the prevention and management of bladder cancer","Shephard RJ.","J Sports Med Phys Fitness. 2017 Oct;57(10):1359-1366. doi: 10.23736/S0022-4707.17.06830-X. Epub 2017 Jan 23.","Shephard RJ","J Sports Med Phys Fitness","2017","2017/01/25","","","10.23736/S0022-4707.17.06830-X"
"18627327","Neoadjuvant chemotherapy preceding cystectomy for bladder cancer","Sonpavde G, Amiel GE, Mims MP, Hayes TG, Lerner SP.","Expert Opin Pharmacother. 2008 Aug;9(11):1885-93. doi: 10.1517/14656566.9.11.1885.","Sonpavde G","Expert Opin Pharmacother","2008","2008/07/17","","","10.1517/14656566.9.11.1885"
"534837","The role of multiple mucosal biopsies in the management of patients with bladder cancer","Wallace DM, Hindmarsh JR, Webb JN, Busuttil A, Hargreave TB, Newsam JE, Chisholm GD.","Br J Urol. 1979 Dec;51(6):535-40. doi: 10.1111/j.1464-410x.1979.tb03596.x.","Wallace DM","Br J Urol","1979","1979/12/01","","","10.1111/j.1464-410x.1979.tb03596.x"
"15126880","Management of bladder cancer","Lamm DL.","J Urol. 2004 Jun;171(6 Pt 1):2482-3. doi: 10.1097/01.ju.0000127757.72243.3e.","Lamm DL","J Urol","2004","2004/05/06","","","10.1097/01.ju.0000127757.72243.3e"
"2295082","Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group","Fradet Y, Tardif M, Bourget L, Robert J.","Cancer Res. 1990 Jan 15;50(2):432-7.","Fradet Y","Cancer Res","1990","1990/01/15","","",""
"16626343","Management of muscle-invasive bladder cancer in Victoria, 1990-1995","Millar JL, Frydenberg M, Toner G, Syme R, Thursfield V, Giles GG; Urology Study Committee of the Victorian Co-operative Oncology Group.","ANZ J Surg. 2006 Mar;76(3):113-9. doi: 10.1111/j.1445-2197.2006.03665.x.","Millar JL","ANZ J Surg","2006","2006/04/22","","","10.1111/j.1445-2197.2006.03665.x"
"27492610","High-Risk Non-Muscle-Invasive Bladder Cancer-Therapy Options During Intravesical BCG Shortage","Veeratterapillay R, Heer R, Johnson MI, Persad R, Bach C.","Curr Urol Rep. 2016 Sep;17(9):68. doi: 10.1007/s11934-016-0625-z.","Veeratterapillay R","Curr Urol Rep","2016","2016/08/06","PMC4980405","","10.1007/s11934-016-0625-z"
"21415213","New strategies in muscle-invasive bladder cancer: on the road to personalized medicine","Shah JB, McConkey DJ, Dinney CP.","Clin Cancer Res. 2011 May 1;17(9):2608-12. doi: 10.1158/1078-0432.CCR-10-2770. Epub 2011 Mar 17.","Shah JB","Clin Cancer Res","2011","2011/03/19","","","10.1158/1078-0432.CCR-10-2770"
"28813037","Concomitant bladder cancer and prostate cancer: challenges and controversies","Lopez-Beltran A, Cheng L, Montorsi F, Scarpelli M, Raspollini MR, Montironi R.","Nat Rev Urol. 2017 Oct;14(10):620-629. doi: 10.1038/nrurol.2017.124. Epub 2017 Aug 16.","Lopez-Beltran A","Nat Rev Urol","2017","2017/08/17","","","10.1038/nrurol.2017.124"
"10638946","Determination of cytosolic citrulline and nitrate as indicators of nitric oxide in bladder cancer: possible association with basic fibroblast growth factor","Khalifa A, Eissa S, Aziz A.","Clin Biochem. 1999 Nov;32(8):635-8. doi: 10.1016/s0009-9120(99)00069-7.","Khalifa A","Clin Biochem","1999","2000/01/19","","","10.1016/s0009-9120(99)00069-7"
"21336453","Predictors of outcome of non-muscle-invasive and muscle-invasive bladder cancer","Youssef RF, Lotan Y.","ScientificWorldJournal. 2011 Feb 14;11:369-81. doi: 10.1100/tsw.2011.28.","Youssef RF","ScientificWorldJournal","2011","2011/02/22","PMC5733251","","10.1100/tsw.2011.28"
"10840099","Gender differences in stage-adjusted bladder cancer survival","Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, Kiemeney LA.","Urology. 2000 Jun;55(6):876-80. doi: 10.1016/s0090-4295(00)00523-9.","Mungan NA","Urology","2000","2000/06/07","","","10.1016/s0090-4295(00)00523-9"
"3809190","The role of cytology in the diagnosis, detection and follow-up of bladder cancer","Koss LG, Esposti L, Nagayama T, De Voogt H, Farsund T, Felderhof J, Friedell G, Reiss E, Tanke H, Tribukait B.","Prog Clin Biol Res. 1986;221:97-108.","Koss LG","Prog Clin Biol Res","1986","1986/01/01","","",""
"18840072","Molecular pathogenesis and diagnostics of bladder cancer","Mitra AP, Cote RJ.","Annu Rev Pathol. 2009;4:251-85. doi: 10.1146/annurev.pathol.4.110807.092230.","Mitra AP","Annu Rev Pathol","2009","2008/10/09","","","10.1146/annurev.pathol.4.110807.092230"
"16372497","Intra-arterial chemotherapy in elderly patients with invasive bladder cancer","Mambrini A, Bondavalli C, Caudana R, Amoroso V, Pacetti P, Fiorentini G, Cantore M.","Clin Oncol (R Coll Radiol). 2005 Dec;17(8):663-4. doi: 10.1016/j.clon.2005.06.008.","Mambrini A","Clin Oncol (R Coll Radiol)","2005","2005/12/24","","","10.1016/j.clon.2005.06.008"
"6427488","Superficial bladder cancer: comments on evaluation and management","Soloway MS.","J Urol. 1984 Jul;132(1):91. doi: 10.1016/s0022-5347(17)49477-8.","Soloway MS","J Urol","1984","1984/07/01","","","10.1016/s0022-5347(17)49477-8"
"25863833","Lower Urinary Tract Symptoms and Risk of Bladder Cancer in Men: Results From the Health Professionals Follow-up Study","Zhou J, Kelsey KT, Smith S, Giovannucci E, Michaud DS.","Urology. 2015 Jun;85(6):1312-8. doi: 10.1016/j.urology.2015.02.024. Epub 2015 Apr 8.","Zhou J","Urology","2015","2015/04/13","PMC4479979","NIHMS669456","10.1016/j.urology.2015.02.024"
"21709390","Bladder cancer and occupational exposure: estimating the workers potentially at risk in Italy","Scarselli A, Scanno P, Marinaccio A, Iavicoli S.","Ann Ist Super Sanita. 2011;47(2):200-6. doi: 10.4415/ANN_11_02_12.","Scarselli A","Ann Ist Super Sanita","2011","2011/06/29","","","10.4415/ANN_11_02_12"
"2549605","Diagnosis and management of superficial bladder cancer","Soloway MS.","Semin Surg Oncol. 1989;5(4):247-54. doi: 10.1002/ssu.2980050407.","Soloway MS","Semin Surg Oncol","1989","1989/01/01","","","10.1002/ssu.2980050407"
"10788718","Histopathological analysis of a bladder cancer stalk observed on MRI","Saito W, Amanuma M, Tanaka J, Heshiki A.","Magn Reson Imaging. 2000 May;18(4):411-5. doi: 10.1016/s0730-725x(00)00124-7.","Saito W","Magn Reson Imaging","2000","2000/05/02","","","10.1016/s0730-725x(00)00124-7"
"24840856","Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality","Psutka SP, Carrasco A, Schmit GD, Moynagh MR, Boorjian SA, Frank I, Stewart SB, Thapa P, Tarrell RF, Cheville JC, Tollefson MK.","Cancer. 2014 Sep 15;120(18):2910-8. doi: 10.1002/cncr.28798. Epub 2014 May 19.","Psutka SP","Cancer","2014","2014/05/21","","","10.1002/cncr.28798"
"29479839","Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer","Mayr R, Gierth M, Zeman F, Reiffen M, Seeger P, Wezel F, Pycha A, Comploj E, Bonatti M, Ritter M, van Rhijn BWG, Burger M, Bolenz C, Fritsche HM, Martini T.","J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):505-513. doi: 10.1002/jcsm.12279. Epub 2018 Feb 25.","Mayr R","J Cachexia Sarcopenia Muscle","2018","2018/02/27","PMC5989852","","10.1002/jcsm.12279"
"7944466","[Intraarterial chemotherapy for patients with invasive bladder cancer--clinical effects and preliminary results in bladder preservation]","Uekado Y, Hirano A, Inagaki T, Hiroi A.","Gan To Kagaku Ryoho. 1994 Sep;21(13):2307-10.","Uekado Y","Gan To Kagaku Ryoho","1994","1994/09/01","","",""
"27156320","Improved Noninvasive Bladder Cancer Diagnosis using Urine Sediments and Novel DNA Methylation Biomarker Panels","Wang K, Tian Y, Xu H.","Clin Lab. 2016;62(3):327-36. doi: 10.7754/clin.lab.2015.150602.","Wang K","Clin Lab","2016","2016/05/10","","","10.7754/clin.lab.2015.150602"
"25196524","Artesunate induces apoptosis of bladder cancer cells by miR-16 regulation of COX-2 expression","Zuo W, Wang ZZ, Xue J.","Int J Mol Sci. 2014 Aug 15;15(8):14298-312. doi: 10.3390/ijms150814298.","Zuo W","Int J Mol Sci","2014","2014/09/09","PMC4159851","","10.3390/ijms150814298"
"28571826","Mucinous Signet-Ring Urachal Carcinoma of the Bladder: Case Report and Review of the Literature","Aragon-Ching JB, Chung S, Paquette E, Woodward K, Wang B.","Clin Genitourin Cancer. 2017 Oct;15(5):e889-e891. doi: 10.1016/j.clgc.2017.05.015. Epub 2017 May 10.","Aragon-Ching JB","Clin Genitourin Cancer","2017","2017/06/03","","","10.1016/j.clgc.2017.05.015"
"23648149","Lymphadenectomy for bladder cancer at the time of radical cystectomy","Tilki D, Brausi M, Colombo R, Evans CP, Fradet Y, Fritsche HM, Lerner SP, Sagalowsky A, Shariat SF, Bochner BH.","Eur Urol. 2013 Aug;64(2):266-76. doi: 10.1016/j.eururo.2013.04.036. Epub 2013 Apr 29.","Tilki D","Eur Urol","2013","2013/05/08","","","10.1016/j.eururo.2013.04.036"
"23813186","Establishment of a Chinese bladder cancer cell line (T921) with high metastatic activity","Xu C, Xu W, Ren S, Wu C, Wang F, Lu J, Sun Y, Shen J, Wei M, Zhang Z, Gao X, Sun Y.","In Vitro Cell Dev Biol Anim. 2013 Oct;49(9):668-78. doi: 10.1007/s11626-013-9651-z. Epub 2013 Jun 28.","Xu C","In Vitro Cell Dev Biol Anim","2013","2013/07/02","","","10.1007/s11626-013-9651-z"
"16818011","Does prolonging the time to bladder cancer surgery affect long-term cancer control: a systematic review of the literature","Fradet Y, Aprikian A, Dranitsaris G, Siemens R, Tsihlias J, Fleshner N; Canadian surgical wait times (SWAT) initiative.","Can J Urol. 2006 Jun;13 Suppl 3:37-47.","Fradet Y","Can J Urol","2006","2006/07/05","","",""
"17151866","Dye-manufacturing workers and bladder cancer in South Korea","Kim Y, Park J, Shin YC.","Arch Toxicol. 2007 May;81(5):381-4. doi: 10.1007/s00204-006-0166-1. Epub 2006 Dec 7.","Kim Y","Arch Toxicol","2007","2006/12/08","","","10.1007/s00204-006-0166-1"
"16669821","Reducing recurrence and costs in superficial bladder cancer: preclinical evaluation of osmotic cytolysis by distilled water vs. mitomycin","Fechner G, Pocha K, Schmidt D, Müller SC.","Int J Clin Pract. 2006 Oct;60(10):1178-80. doi: 10.1111/j.1742-1241.2006.00847.x.","Fechner G","Int J Clin Pract","2006","2006/05/04","","","10.1111/j.1742-1241.2006.00847.x"
"4957072","Ultraviolet cystoscopy for the detection of bladder cancer","","CA Cancer J Clin. 1966 May-Jun;16(3):127-30. doi: 10.3322/canjclin.16.3.127.","","CA Cancer J Clin","1966","1966/05/01","","","10.3322/canjclin.16.3.127"
"16093971","Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study","Jocham D, Witjes F, Wagner S, Zeylemaker B, van Moorselaar J, Grimm MO, Muschter R, Popken G, König F, Knüchel R, Kurth KH.","J Urol. 2005 Sep;174(3):862-6; discussion 866. doi: 10.1097/01.ju.0000169257.19841.2a.","Jocham D","J Urol","2005","2005/08/12","","","10.1097/01.ju.0000169257.19841.2a"
"17416204","Prolonged cytotoxic effect of aqueous extracts from dried viscum album on bladder cancer cells","Hunziker-Basler N, Zuzak TJ, Eggenschwiler J, Rist L, Simões-Wüst AP, Viviani A.","Pharmazie. 2007 Mar;62(3):237-8.","Hunziker-Basler N","Pharmazie","2007","2007/04/10","","",""
"16197705","Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy","Loskog A, Ninalga C, Hedlund T, Alimohammadi M, Malmström PU, Tötterman TH.","Lab Anim. 2005 Oct;39(4):384-93. doi: 10.1258/002367705774286475.","Loskog A","Lab Anim","2005","2005/10/04","","","10.1258/002367705774286475"
"18062746","Molecular markers for bladder cancer: the road to a multimarker approach","Birkhahn M, Mitra AP, Cote RJ.","Expert Rev Anticancer Ther. 2007 Dec;7(12):1717-27. doi: 10.1586/14737140.7.12.1717.","Birkhahn M","Expert Rev Anticancer Ther","2007","2007/12/08","","","10.1586/14737140.7.12.1717"
"30126053","Persistent muscle-invasive bladder cancer after neoadjuvant chemotherapy: an analysis of Surveillance, Epidemiology and End Results-Medicare data","Lane G, Risk M, Fan Y, Krishna S, Konety B.","BJU Int. 2019 May;123(5):818-825. doi: 10.1111/bju.14529. Epub 2018 Sep 17.","Lane G","BJU Int","2019","2018/08/21","","","10.1111/bju.14529"
"24291546","Differential expression of SDF-1 isoforms in bladder cancer","Gosalbez M, Hupe MC, Lokeshwar SD, Yates TJ, Shields J, Veerapen MK, Merseburger AS, Rosser CJ, Soloway MS, Lokeshwar VB.","J Urol. 2014 Jun;191(6):1899-1905. doi: 10.1016/j.juro.2013.11.053. Epub 2013 Nov 26.","Gosalbez M","J Urol","2014","2013/12/03","PMC4197846","NIHMS634810","10.1016/j.juro.2013.11.053"
"25443274","Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum","Dinney CP, Hansel D, McConkey D, Shipley W, Hagan M, Dreicer R, Lerner S, Czerniak B, Waldman F, Groshen S, True LD, Petricoin E, Theodorescu D, Hruszkewycz A, Bajorin D.","Urol Oncol. 2014 Nov;32(8):1108-15. doi: 10.1016/j.urolonc.2013.10.021. Epub 2014 Oct 24.","Dinney CP","Urol Oncol","2014","2014/12/03","PMC4262150","NIHMS631150","10.1016/j.urolonc.2013.10.021"
"9805666","[Intravesical BCG therapy for superficial bladder cancer]","Segawa N, Iwamoto Y, Azuma H, Yamamoto K, Ueda H, Katsuoka Y.","Hinyokika Kiyo. 1998 Sep;44(9):627-31.","Segawa N","Hinyokika Kiyo","1998","1998/11/07","","",""
"19444499","Tumor detection and serosal invasion of bladder cancer: role of three-dimensional volumetric reconstructed US","Park HJ, Hong SS, Kim JH, Kwon SB, Kwon KH, Choi DL, Park ST, Chang YW, Hwang JH.","Abdom Imaging. 2010 Jun;35(3):265-70. doi: 10.1007/s00261-009-9529-4. Epub 2009 May 15.","Park HJ","Abdom Imaging","2010","2009/05/16","","","10.1007/s00261-009-9529-4"
"19035891","The optimal management of T1G3 bladder cancer","Emiliozzi P, Pansadoro A, Pansadoro V.","BJU Int. 2008 Nov;102(9 Pt B):1265-73. doi: 10.1111/j.1464-410X.2008.07969.x.","Emiliozzi P","BJU Int","2008","2008/11/28","","","10.1111/j.1464-410X.2008.07969.x"
"31200837","Mouse Models of Muscle-invasive Bladder Cancer: Key Considerations for Clinical Translation Based on Molecular Subtypes","Ruan JL, Hsu JW, Browning RJ, Stride E, Yildiz YO, Vojnovic B, Kiltie AE.","Eur Urol Oncol. 2019 May;2(3):239-247. doi: 10.1016/j.euo.2018.08.014. Epub 2018 Sep 13.","Ruan JL","Eur Urol Oncol","2019","2019/06/16","","","10.1016/j.euo.2018.08.014"
"2213906","Unexplained excess risk of bladder cancer in men","Hartge P, Harvey EB, Linehan WM, Silverman DT, Sullivan JW, Hoover RN, Fraumeni JF Jr.","J Natl Cancer Inst. 1990 Oct 17;82(20):1636-40. doi: 10.1093/jnci/82.20.1636.","Hartge P","J Natl Cancer Inst","1990","1990/10/17","","","10.1093/jnci/82.20.1636"
"27002077","Lifestyle factors and health-related quality of life in bladder cancer survivors: a systematic review","Gopalakrishna A, Longo TA, Fantony JJ, Van Noord M, Inman BA.","J Cancer Surviv. 2016 Oct;10(5):874-82. doi: 10.1007/s11764-016-0533-8. Epub 2016 Mar 21.","Gopalakrishna A","J Cancer Surviv","2016","2016/03/23","PMC5018420","NIHMS774452","10.1007/s11764-016-0533-8"
"29650133","Contemporary Preoperative and Intraoperative Management of the Radical Cystectomy Patient","Campbell JG, Smelser WW, Lee EK.","Urol Clin North Am. 2018 May;45(2):169-181. doi: 10.1016/j.ucl.2017.12.003.","Campbell JG","Urol Clin North Am","2018","2018/04/14","","","10.1016/j.ucl.2017.12.003"
"29661728","Overexpression of COX2 indicates poor survival in urothelial bladder cancer","Agrawal U, Kumari N, Vasudeva P, Mohanty NK, Saxena S.","Ann Diagn Pathol. 2018 Jun;34:50-55. doi: 10.1016/j.anndiagpath.2018.01.008. Epub 2018 Jan 31.","Agrawal U","Ann Diagn Pathol","2018","2018/04/18","","","10.1016/j.anndiagpath.2018.01.008"
"22623707","Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial","Mondul AM, Weinstein SJ, Horst RL, Purdue M, Albanes D.","Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1222-5. doi: 10.1158/1055-9965.EPI-12-0439. Epub 2012 May 23.","Mondul AM","Cancer Epidemiol Biomarkers Prev","2012","2012/05/25","PMC3392360","NIHMS379101","10.1158/1055-9965.EPI-12-0439"
"20062074","A novel XPF -357A>C polymorphism predicts risk and recurrence of bladder cancer","Wang M, Wang M, Yuan L, Wu D, Zhang Z, Yin C, Fu G, Wei Q, Zhang Z.","Oncogene. 2010 Apr 1;29(13):1920-8. doi: 10.1038/onc.2009.484. Epub 2010 Jan 11.","Wang M","Oncogene","2010","2010/01/12","","","10.1038/onc.2009.484"
"3962813","[Cancer of the bladder in a patient with spinal cord injury]","Irisawa C, Numasawa K, Watanabe H, Onmura Y, Kaneko H, Saito M.","Hinyokika Kiyo. 1986 Jan;32(1):99-104.","Irisawa C","Hinyokika Kiyo","1986","1986/01/01","","",""
"10484838","[Radiotherapy of invasive bladder cancer]","Petschen Verdaguer I.","Arch Esp Urol. 1999 Jul-Aug;52(6):551-2.","Petschen Verdaguer I","Arch Esp Urol","1999","1999/09/15","","",""
"28990088","Identification and bioinformatics analysis of miRNAs associated with human muscle invasive bladder cancer","Chen L, Yuan L, Wang G, Cao R, Peng J, Shu B, Qian G, Wang X, Xiao Y.","Mol Med Rep. 2017 Dec;16(6):8709-8720. doi: 10.3892/mmr.2017.7726. Epub 2017 Oct 4.","Chen L","Mol Med Rep","2017","2017/10/10","PMC5779952","","10.3892/mmr.2017.7726"
"2207559","Re: The fate of G3pT1 bladder cancer","Harland SJ.","Br J Urol. 1990 Sep;66(3):330-1. doi: 10.1111/j.1464-410x.1990.tb14946.x.","Harland SJ","Br J Urol","1990","1990/09/01","","","10.1111/j.1464-410x.1990.tb14946.x"
"12175543","N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines","Zou C, Guan Y, Zou C, Wang J, Wang LE, Liebert M, Grossman HB, Wei Q.","Cancer Lett. 2002 Jun 28;180(2):131-7. doi: 10.1016/s0304-3835(01)00864-3.","Zou C","Cancer Lett","2002","2002/08/15","","","10.1016/s0304-3835(01)00864-3"
"15942671","Tight junctions and bladder cancer (review)","Haynes MD, Martin TA, Jenkins SA, Kynaston HG, Matthews PN, Jiang WG.","Int J Mol Med. 2005 Jul;16(1):3-9.","Haynes MD","Int J Mol Med","2005","2005/06/09","","",""
"9228669","A model of orthotopic murine bladder (MBT-2) tumor implants","Jiang F, Zhou XM.","Urol Res. 1997;25(3):179-82. doi: 10.1007/BF00941979.","Jiang F","Urol Res","1997","1997/01/01","","","10.1007/BF00941979"
"22088624","Re: impact of patient age on outcome following bladder-preserving treatment for non-muscle-invasive bladder cancer","Griebling TL.","J Urol. 2011 Feb;185(2):466-7. doi: 10.1016/S0022-5347(11)60135-3.","Griebling TL","J Urol","2011","2011/11/18","","","10.1016/S0022-5347(11)60135-3"
"22944273","[Case-control study on the correlation of bladder cancer incidence and occupational factors]","He GN, Zhong WD, Bi XC, Hu ZQ, Zhong CH, Xie LP, He HC, Han ZD, Ye ZQ.","Zhonghua Yi Xue Za Zhi. 2012 Jul 24;92(28):1978-80.","He GN","Zhonghua Yi Xue Za Zhi","2012","2012/09/05","","",""
"15066235","Combined chemotherapy and external beam radiotherapy for transitional cell carcinoma of the bladder","Ennis RD.","Curr Oncol Rep. 2004 May;6(3):230-6. doi: 10.1007/s11912-004-0054-x.","Ennis RD","Curr Oncol Rep","2004","2004/04/07","","","10.1007/s11912-004-0054-x"
"11520532","Occupational exposure to carbon black and risk of bladder cancer","Puntoni R, Ceppi M, Reggiardo G, Merlo F.","Lancet. 2001 Aug 18;358(9281):562. doi: 10.1016/S0140-6736(01)05717-8.","Puntoni R","Lancet","2001","2001/08/25","","","10.1016/S0140-6736(01)05717-8"
"16019763","New agents in intravesical chemotherapy of superficial bladder cancer","Perabo FG, Müller SC.","Scand J Urol Nephrol. 2005;39(2):108-16. doi: 10.1080/00365590510007676.","Perabo FG","Scand J Urol Nephrol","2005","2005/07/16","","","10.1080/00365590510007676"
"30415921","Building on a Solid Foundation: Enhancing Bacillus Calmette-Guérin Therapy","Rentsch CA, Derré L, Dugas SG, Wetterauer C, Federer-Gsponer JR, Thalmann GN, Ingersoll MA.","Eur Urol Focus. 2018 Jul;4(4):485-493. doi: 10.1016/j.euf.2018.10.010. Epub 2018 Nov 8.","Rentsch CA","Eur Urol Focus","2018","2018/11/13","","","10.1016/j.euf.2018.10.010"
"10928863","Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation","Vineis P, Kogevinas M, Simonato L, Brennan P, Boffetta P.","Mutat Res. 2000 Jul;463(1):103-10.","Vineis P","Mutat Res","2000","2000/08/06","","",""
"27980085","The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer","Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Yamauchi A, Shimazui T, Ohtani M.","Jpn J Clin Oncol. 2017 Mar 1;47(3):252-256. doi: 10.1093/jjco/hyw191.","Koie T","Jpn J Clin Oncol","2017","2016/12/17","","","10.1093/jjco/hyw191"
"18984977","Current status of prognostic immunohistochemical markers for urothelial bladder cancer","Rosenblatt R, Jonmarker S, Lewensohn R, Egevad L, Sherif A, Kälkner KM, Nilsson S, Valdman A, Ullén A.","Tumour Biol. 2008;29(5):311-22. doi: 10.1159/000170878. Epub 2008 Nov 5.","Rosenblatt R","Tumour Biol","2008","2008/11/06","","","10.1159/000170878"
"6483911","Classification of bladder cancer","Andersson L.","Prog Clin Biol Res. 1984;162A:27-32.","Andersson L","Prog Clin Biol Res","1984","1984/01/01","","",""
"9751337","Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder","Dinney CP, Babkowski RC, Antelo M, Perrotte P, Liebert M, Zhang HZ, Palmer J, Veltri RW, Katz RL, Grossman HB.","J Urol. 1998 Oct;160(4):1285-90.","Dinney CP","J Urol","1998","1998/09/29","","",""
"10841198","Bladder cancer","Ozen H, Hall MC.","Curr Opin Oncol. 2000 May;12(3):255-9. doi: 10.1097/00001622-200005000-00012.","Ozen H","Curr Opin Oncol","2000","2000/06/07","","","10.1097/00001622-200005000-00012"
"7264531","The influence of malignant cell cytology screening on the survival of industrial bladder cancer cases","Cartwright RA, Gadian T, Garland JB, Bernard SM.","J Epidemiol Community Health. 1981 Mar;35(1):35-8. doi: 10.1136/jech.35.1.35.","Cartwright RA","J Epidemiol Community Health","1981","1981/03/01","PMC1052117","","10.1136/jech.35.1.35"
"24681333","Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer","Kamat AM, Witjes JA, Brausi M, Soloway M, Lamm D, Persad R, Buckley R, Böhle A, Colombel M, Palou J.","J Urol. 2014 Aug;192(2):305-15. doi: 10.1016/j.juro.2014.02.2573. Epub 2014 Mar 25.","Kamat AM","J Urol","2014","2014/04/01","PMC4687397","NIHMS741000","10.1016/j.juro.2014.02.2573"
"17492413","[Therapy and follow-up of bladder cancer]","Meyer D, Schmid HP, Engeler DS.","Wien Med Wochenschr. 2007;157(7-8):162-9. doi: 10.1007/s10354-007-0381-2.","Meyer D","Wien Med Wochenschr","2007","2007/05/12","","","10.1007/s10354-007-0381-2"
"26279824","New and contemporary markers of prognosis in nonmuscle invasive urothelial cancer","Ather MH, Nazim SM.","Korean J Urol. 2015 Aug;56(8):553-64. doi: 10.4111/kju.2015.56.8.553. Epub 2015 Jul 31.","Ather MH","Korean J Urol","2015","2015/08/18","PMC4534429","","10.4111/kju.2015.56.8.553"
"30805684","Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience","Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Tarrel R, Quevedo FJ, Cheville JC, Karnes RJ.","World J Urol. 2019 Nov;37(11):2409-2418. doi: 10.1007/s00345-019-02689-8. Epub 2019 Feb 25.","Boeri L","World J Urol","2019","2019/02/27","","","10.1007/s00345-019-02689-8"
"2771995","Future clinical research on the use of BCG for bladder cancer","Morales A, Nickel JC.","Prog Clin Biol Res. 1989;310:361-9.","Morales A","Prog Clin Biol Res","1989","1989/01/01","","",""
"1441028","Radiation therapy in regionally advanced bladder cancer","Wesson MF.","Urol Clin North Am. 1992 Nov;19(4):725-34.","Wesson MF","Urol Clin North Am","1992","1992/11/01","","",""
"28259975","Gene expression profiling in bladder cancer identifies potential therapeutic targets","Hussain SA, Palmer DH, Syn WK, Sacco JJ, Greensmith RM, Elmetwali T, Aachi V, Lloyd BH, Jithesh PV, Arrand J, Barton D, Ansari J, Sibson DR, James ND.","Int J Oncol. 2017 Apr;50(4):1147-1159. doi: 10.3892/ijo.2017.3893. Epub 2017 Mar 2.","Hussain SA","Int J Oncol","2017","2017/03/06","PMC5363876","","10.3892/ijo.2017.3893"
"9589874","[Long-term survival of bladder preservation therapy with radiation and chemotherapy for locally invasive bladder cancer]","Noguchi S, Takase K, Kubota Y, Masuda M, Yao M, Hosaka M.","Hinyokika Kiyo. 1998 Mar;44(3):149-53.","Noguchi S","Hinyokika Kiyo","1998","1998/05/20","","",""
"21110759","Trimodality treatment for bladder cancer: does modern radiotherapy improve the end results?","Zaghloul MS, Mousa AG.","Expert Rev Anticancer Ther. 2010 Dec;10(12):1933-44. doi: 10.1586/era.10.156.","Zaghloul MS","Expert Rev Anticancer Ther","2010","2010/11/30","","","10.1586/era.10.156"
"31201825","Impact of Neoadjuvant Chemotherapy on Concordance of PD-L1 Staining Fidelity between the Primary Tumor and Lymph Node Metastases in Bladder Cancer","Patel KR, Taylor BL, Khani F, Guzzo TJ, Scherr DS, Ravishankar R, Lal P, Malkowicz SB.","Urology. 2019 Sep;131:150-156. doi: 10.1016/j.urology.2019.05.039. Epub 2019 Jun 12.","Patel KR","Urology","2019","2019/06/16","","","10.1016/j.urology.2019.05.039"
"8911513","Clinical evaluation of soluble cytokeratin 19 fragments (CYFRA 21-1) in serum and urine of patients with bladder cancer","Senga Y, Kimura G, Hattori T, Yoshida K.","Urology. 1996 Nov;48(5):703-10. doi: 10.1016/S0090-4295(96)00253-1.","Senga Y","Urology","1996","1996/11/01","","","10.1016/S0090-4295(96)00253-1"
"31152879","Methods for bladder cancer diagnosis - The role of autofluorescence and photodynamic diagnosis","Bochenek K, Aebisher D, Międzybrodzka A, Cieślar G, Kawczyk-Krupka A.","Photodiagnosis Photodyn Ther. 2019 Sep;27:141-148. doi: 10.1016/j.pdpdt.2019.05.036. Epub 2019 May 29.","Bochenek K","Photodiagnosis Photodyn Ther","2019","2019/06/02","","","10.1016/j.pdpdt.2019.05.036"
"482865","Tryptophan metabolism in bladder cancer patients from Copenhagen","Wolf H, Brown RR.","Scand J Urol Nephrol. 1979;13(2):143-8. doi: 10.3109/00365597909181169.","Wolf H","Scand J Urol Nephrol","1979","1979/01/01","","","10.3109/00365597909181169"
"10874974","[Locoregional chemoperfusion with mitoxantrone for palliative therapy in bleeding bladder cancer compared with embolization]","Textor HJ, Wilhelm K, Strunk H, Layer G, Dölitzsch C, Schild HH.","Rofo. 2000 May;172(5):462-6. doi: 10.1055/s-2000-678.","Textor HJ","Rofo","2000","2000/06/30","","","10.1055/s-2000-678"
"1623214","Effects of intravesical Corynebacterium parvum on recurrences of superficial tumors of the urinary bladder","Raica M.","Anticancer Drugs. 1992 Feb;3(1):39-42. doi: 10.1097/00001813-199202000-00007.","Raica M","Anticancer Drugs","1992","1992/02/01","","","10.1097/00001813-199202000-00007"
"25935956","Small cell carcinoma of the urinary bladder: a case report and review of the literature","Roy C, Deb AR, Pal M, Das D, Mandal A, Mukhopadhyay S.","J Indian Med Assoc. 2014 Jan;112(1):57-9.","Roy C","J Indian Med Assoc","2014","2015/05/05","","",""
"4698001","Strategy of surgical management of bladder cancer","Wallace DM.","Proc R Soc Med. 1973 Mar;66(3):286-8.","Wallace DM","Proc R Soc Med","1973","1973/03/01","PMC1644818","",""
"4458275","[Clinical aspects of cancer of the urachus]","Noack P, Raatzsch U.","Z Arztl Fortbild (Jena). 1974 Sep 1;68(17):907-9.","Noack P","Z Arztl Fortbild (Jena)","1974","1974/09/01","","",""
"26520458","Increased risk of bladder cancer in critical areas at high pressure of pollution of the Campania region in Italy: A systematic review","Di Lorenzo G, Federico P, De Placido S, Buonerba C.","Crit Rev Oncol Hematol. 2015 Dec;96(3):534-41. doi: 10.1016/j.critrevonc.2015.07.004. Epub 2015 Jul 20.","Di Lorenzo G","Crit Rev Oncol Hematol","2015","2015/11/02","","","10.1016/j.critrevonc.2015.07.004"
"4452963","[Evaluation of the prognosis for cancer of the bladder]","Cooper EH, Anderson CK.","J Radiol Electrol Med Nucl. 1974 Nov;55(11):814-5.","Cooper EH","J Radiol Electrol Med Nucl","1974","1974/11/01","","",""
"28281310","Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis","Shimizu F, Muto S, Taguri M, Ieda T, Tsujimura A, Sakamoto Y, Fujita K, Okegawa T, Yamaguchi R, Horie S.","Int J Urol. 2017 May;24(5):367-372. doi: 10.1111/iju.13324. Epub 2017 Mar 9.","Shimizu F","Int J Urol","2017","2017/03/11","","","10.1111/iju.13324"
"8781382","Cigarette smoking and p53 mutations in lung cancer and bladder cancer","Husgafvel-Pursiainen K, Kannio A.","Environ Health Perspect. 1996 May;104 Suppl 3(Suppl 3):553-6. doi: 10.1289/ehp.96104s3553.","Husgafvel-Pursiainen K","Environ Health Perspect","1996","1996/05/01","PMC1469661","","10.1289/ehp.96104s3553"
"7209428","Bladder cancer associated with hypercalcaemia. A case report","Eddeland A, Hedelin H.","Scand J Urol Nephrol. 1980;14(2):211-3. doi: 10.3109/00365598009179563.","Eddeland A","Scand J Urol Nephrol","1980","1980/01/01","","","10.3109/00365598009179563"
"31333338","A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival","Chen Z, Liu G, Hossain A, Danilova IG, Bolkov MA, Liu G, Tuzankina IA, Tan W.","Hereditas. 2019 Jul 9;156:24. doi: 10.1186/s41065-019-0100-1. eCollection 2019.","Chen Z","Hereditas","2019","2019/07/24","PMC6617625","","10.1186/s41065-019-0100-1"
"29863247","Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy","Rajwa P, Życzkowski M, Paradysz A, Bujak K, Bryniarski P.","Eur Rev Med Pharmacol Sci. 2018 May;22(10):3027-3037. doi: 10.26355/eurrev_201805_15060.","Rajwa P","Eur Rev Med Pharmacol Sci","2018","2018/06/05","","","10.26355/eurrev_201805_15060"
"24874290","The granulocyte macrophage-colony stimulating factor surface modified MB49 bladder cancer stem cells vaccine against metastatic bladder cancer","Zhu YT, Zhao Z, Fu XY, Luo Y, Lei CY, Chen W, Li F, Pang SY, Chen SS, Tan WL.","Stem Cell Res. 2014 Jul;13(1):111-22. doi: 10.1016/j.scr.2014.04.006. Epub 2014 Apr 24.","Zhu YT","Stem Cell Res","2014","2014/05/31","","","10.1016/j.scr.2014.04.006"
"22364623","[Chemotherapy in perioperative setting for infiltrative bladder cancer]","Houédé N, Beuzeboc P, Culine S, Soulié M, Pfister C; Groupe vessie du Comité de cancérologie de l’Association française d’urologie.","Prog Urol. 2012 Mar;22(3):139-45. doi: 10.1016/j.purol.2011.09.010. Epub 2011 Oct 28.","Houédé N","Prog Urol","2012","2012/02/28","","","10.1016/j.purol.2011.09.010"
"16363702","[Clinical analysis of bladder cancer patients undergoing radical cystectomy]","Kato Y, Hasegawa Y, Wakita T, Hayashi N.","Hinyokika Kiyo. 2005 Nov;51(11):719-25.","Kato Y","Hinyokika Kiyo","2005","2005/12/21","","",""
"25198970","The effects and effectiveness of electromotive drug administration and chemohyperthermia for treating non-muscle invasive bladder cancer","Slater SE, Patel P, Viney R, Foster M, Porfiri E, James ND, Montgomery B, Bryan RT.","Ann R Coll Surg Engl. 2014 Sep;96(6):415-9. doi: 10.1308/003588414X13946184901001.","Slater SE","Ann R Coll Surg Engl","2014","2014/09/09","PMC4474190","","10.1308/003588414X13946184901001"
"9027618","Genetic alterations as clonal markers for bladder cancer detection in urine","Mao L.","J Cell Biochem Suppl. 1996;25:191-6.","Mao L","J Cell Biochem Suppl","1996","1996/01/01","","",""
"27317460","Tumor budding, a novel prognostic indicator for predicting stage progression in T1 bladder cancers","Fukumoto K, Kikuchi E, Mikami S, Ogihara K, Matsumoto K, Miyajima A, Oya M.","Cancer Sci. 2016 Sep;107(9):1338-44. doi: 10.1111/cas.12990. Epub 2016 Aug 12.","Fukumoto K","Cancer Sci","2016","2016/06/19","PMC5021027","","10.1111/cas.12990"
"9072545","Tumor-associated antigens in normal mucosa of patients with superficial transitional cell carcinoma of the bladder","Lee E, Schwaibold H, Fradet Y, Huland E, Huland H.","J Urol. 1997 Mar;157(3):1070-3.","Lee E","J Urol","1997","1997/03/01","","",""
"23210413","Neoadjuvant chemotherapy for invasive bladder cancer: an interesting case report","Abed El Rahman D, Matei VD, Musi G, Bottero D, Brescia A, Galasso G, Mazzoleni F, De Cobelli O.","Arch Ital Urol Androl. 2012 Sep;84(3):167-70.","Abed El Rahman D","Arch Ital Urol Androl","2012","2012/12/06","","",""
"1895616","[Establishment and characterization of a cis-diamminedichloro platinum-resistant human bladder cancer cell line]","Ochi J.","Nihon Hinyokika Gakkai Zasshi. 1991 Jul;82(7):1045-52. doi: 10.5980/jpnjurol1989.82.1045.","Ochi J","Nihon Hinyokika Gakkai Zasshi","1991","1991/07/01","","","10.5980/jpnjurol1989.82.1045"
"19564101","Radiochemotherapy for bladder cancer","Ott OJ, Rödel C, Weiss C, Wittlinger M, St Krause F, Dunst J, Fietkau R, Sauer R.","Clin Oncol (R Coll Radiol). 2009 Sep;21(7):557-65. doi: 10.1016/j.clon.2009.05.005. Epub 2009 Jun 28.","Ott OJ","Clin Oncol (R Coll Radiol)","2009","2009/07/01","","","10.1016/j.clon.2009.05.005"
"29665744","Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer","Jiang X, Lei T, Zhang M.","Technol Cancer Res Treat. 2018 Jan 1;17:1533034618769413. doi: 10.1177/1533034618769413.","Jiang X","Technol Cancer Res Treat","2018","2018/04/19","PMC5912276","","10.1177/1533034618769413"
"17031377","Are bladder cancer patients with pT0 disease following radical cystectomy cured of cancer?","Thalmann G.","Nat Clin Pract Urol. 2006 Oct;3(10):530-1. doi: 10.1038/ncpuro0601.","Thalmann G","Nat Clin Pract Urol","2006","2006/10/13","","","10.1038/ncpuro0601"
"12823375","Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer","Stein JP, Skinner DG.","BJU Int. 2003 Jul;92(1):12-7.","Stein JP","BJU Int","2003","2003/06/26","","",""
"27207387","Active surveillance for low-risk non-muscle-invasive bladder cancer: mid-term results from the Bladder cancer Italian Active Surveillance (BIAS) project","Hurle R, Pasini L, Lazzeri M, Colombo P, Buffi N, Lughezzani G, Casale P, Morenghi E, Peschechera R, Zandegiacomo S, Benetti A, Saita A, Cardone P, Guazzoni G.","BJU Int. 2016 Dec;118(6):935-939. doi: 10.1111/bju.13536. Epub 2016 Jun 13.","Hurle R","BJU Int","2016","2016/05/22","","","10.1111/bju.13536"
"9123660","[The surgical treatment of patients with bladder cancer in middle and old age]","Tkachuk VN, al-Shukri SKh, Issa M.","Urol Nefrol (Mosk). 1997 Jan-Feb;(1):23-5.","Tkachuk VN","Urol Nefrol (Mosk)","1997","1997/01/01","","",""
"16280732","Transurethral resection of superficial bladder cancer: technically safe, oncologically anything but perfect","Grimm MO, Ackermann R.","J Urol. 2005 Dec;174(6):2086-7. doi: 10.1097/01.ju.0000190537.95113.e4.","Grimm MO","J Urol","2005","2005/11/11","","","10.1097/01.ju.0000190537.95113.e4"
"25512206","Bladder cancer: Could MPDL3280A offer a therapeutic breakthrough in metastatic bladder cancer?","Fenner A.","Nat Rev Urol. 2015 Feb;12(2):61. doi: 10.1038/nrurol.2014.344. Epub 2014 Dec 16.","Fenner A","Nat Rev Urol","2015","2014/12/17","","","10.1038/nrurol.2014.344"
"1305692","Cytology","Melamed MR.","J Cell Biochem Suppl. 1992;16I:73-5. doi: 10.1002/jcb.240501316.","Melamed MR","J Cell Biochem Suppl","1992","1992/01/01","","","10.1002/jcb.240501316"
"6438645","Definitive and adjunctive external irradiation in bladder cancer without radical cystectomy","Pardo De Unceta E, Estecha S, Palomero I.","Prog Clin Biol Res. 1984;162B:63-9.","Pardo De Unceta E","Prog Clin Biol Res","1984","1984/01/01","","",""
"10475235","Use of monoclonal antibodies for the diagnosis and treatment of bladder cancer","Syrigos KN, Deonarian DP, Epenetos AA.","Hybridoma. 1999 Jun;18(3):219-24. doi: 10.1089/027245799315862.","Syrigos KN","Hybridoma","1999","1999/09/04","","","10.1089/027245799315862"
"15022437","[Diagnosis and treatment of bladder cancer]","Lopatkin NA, Darenkov SP, Chernyshev IV, Martov AG, Stupak NV.","Urologiia. 2004 Jan-Feb;(1):12-7.","Lopatkin NA","Urologiia","2004","2004/03/17","","",""
"25482920","[Impact of neoadjuvant chemotherapy on therapeutic management of muscle-invasive bladder cancer]","Meyer V, Flechon A, Tartas S, Fassi-Fehri H, Ruffion A, Martin X, Colombel M.","Prog Urol. 2015 Feb;25(2):83-9. doi: 10.1016/j.purol.2014.11.001. Epub 2014 Nov 7.","Meyer V","Prog Urol","2015","2014/12/09","","","10.1016/j.purol.2014.11.001"
"16287446","Is adjuvant chemotherapy for bladder cancer safer in patients with an ileal conduit than a neobladder?","Manoharan M, Reyes MA, Kava BR, Singal R, Kim SS, Soloway MS.","BJU Int. 2005 Dec;96(9):1286-9. doi: 10.1111/j.1464-410X.2005.05822.x.","Manoharan M","BJU Int","2005","2005/11/17","","","10.1111/j.1464-410X.2005.05822.x"
"30711948","Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer","Kusuhara Y, Daizumoto K, Kawai K, Hirayama K, Kowada M, Shintani T, Fukuhara Y, Dondoo TO, Ozaki K, Tsuda M, Fukawa T, Nakatsuji H, Bando Y, Uehara H, Fukumori T, Takahashi M, Kanayama HO.","Anticancer Res. 2019 Feb;39(2):703-711. doi: 10.21873/anticanres.13166.","Kusuhara Y","Anticancer Res","2019","2019/02/04","","","10.21873/anticanres.13166"
"21113783","Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer","Weizer AZ, Tallman C, Montgomery JS.","World J Urol. 2011 Feb;29(1):59-71. doi: 10.1007/s00345-010-0617-4. Epub 2010 Nov 28.","Weizer AZ","World J Urol","2011","2010/11/30","","","10.1007/s00345-010-0617-4"
"19160695","Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminology","Van der Kwast TH, Zlotta AR, Fleshner N, Jewett M, Lopez-Beltran A, Montironi R.","Anal Quant Cytol Histol. 2008 Dec;30(6):309-15.","Van der Kwast TH","Anal Quant Cytol Histol","2008","2009/01/24","","",""
"21320273","Population-based analyses of radical cystectomy and urinary diversion for bladder cancer in northern Italy","Fedeli U, Novara G, Galassi C, Ficarra V, Schievano E, Gilardetti M, Muto G, Bertetto O, Ciccone G, Spolaore P.","BJU Int. 2011 Oct;108(8 Pt 2):E266-71. doi: 10.1111/j.1464-410X.2011.10095.x. Epub 2011 Feb 14.","Fedeli U","BJU Int","2011","2011/02/16","","","10.1111/j.1464-410X.2011.10095.x"
"28065394","Characterizing intermediate-risk non-muscle-invasive bladder cancer: Implications for the definition of intermediate risk and treatment strategy","Matsumoto K, Kikuchi E, Yanai Y, Hayakawa N, Ito Y, Maeda T, Nagata H, Miyajima A, Oya M.","Urol Oncol. 2017 May;35(5):208-214. doi: 10.1016/j.urolonc.2016.11.014. Epub 2017 Jan 3.","Matsumoto K","Urol Oncol","2017","2017/01/10","","","10.1016/j.urolonc.2016.11.014"
"28644736","Asymptomatic microscopic hematuria as a predictor of neoplasia in the urinary tract","Ordell Sundelin M, Jensen JB.","Scand J Urol. 2017 Oct;51(5):373-375. doi: 10.1080/21681805.2017.1334699. Epub 2017 Jun 23.","Ordell Sundelin M","Scand J Urol","2017","2017/06/24","","","10.1080/21681805.2017.1334699"
"31953517","Competitive glucose metabolism as a target to boost bladder cancer immunotherapy","Afonso J, Santos LL, Longatto-Filho A, Baltazar F.","Nat Rev Urol. 2020 Feb;17(2):77-106. doi: 10.1038/s41585-019-0263-6. Epub 2020 Jan 17.","Afonso J","Nat Rev Urol","2020","2020/01/19","","","10.1038/s41585-019-0263-6"
"6692306","The grade and pathologic stage of bladder cancer","Kern WH.","Cancer. 1984 Mar 1;53(5):1185-9. doi: 10.1002/1097-0142(19840301)53:5<1185::aid-cncr2820530526>3.0.co;2-r.","Kern WH","Cancer","1984","1984/03/01","","","10.1002/1097-0142(19840301)53:5<1185::aid-cncr2820530526>3.0.co;2-r"
"2034098","[Radiation treatment of bladder cancer using different fractionation regimens]","Goldobenko GV, Matveev BP, Shipilov VI, Klimakov BD, Tkachev SI.","Med Radiol (Mosk). 1991;36(5):14-6.","Goldobenko GV","Med Radiol (Mosk)","1991","1991/01/01","","",""
"1636233","Recurrent or aggressive bladder cancer. Indications for adjuvant intravesical therapy","Badalament RA, Ortolano V, Burgers JK.","Urol Clin North Am. 1992 Aug;19(3):485-98.","Badalament RA","Urol Clin North Am","1992","1992/08/01","","",""
"1812570","[Systemic adjuvant chemotherapy of bladder carcinoma with 5 fluorouracil and cyclophosphamide]","Sbalzarini G, Giuberti AC, Pandolfi C, Del Boca C, Labadini A, Bolognini G.","Minerva Urol Nefrol. 1991 Oct-Dec;43(4):273-7.","Sbalzarini G","Minerva Urol Nefrol","1991","1991/10/01","","",""
"3012703","[1.5 Tesla nuclear magnetic resonance tomographic studies of bladder cancer]","Küper K, Kölbel G, Schmiedl U.","Rofo. 1986 Jun;144(6):674-80. doi: 10.1055/s-2008-1048861.","Küper K","Rofo","1986","1986/06/01","","","10.1055/s-2008-1048861"
"8497967","[Systemic chemotherapy in bladder cancer]","Sengeløv L, Kamby C, von der Maase H.","Ugeskr Laeger. 1993 May 3;155(18):1363-8.","Sengeløv L","Ugeskr Laeger","1993","1993/05/03","","",""
"20644482","Bladder cancer in patients after organ transplantation","Wallerand H, Ravaud A, Ferrière JM.","Curr Opin Urol. 2010 Sep;20(5):432-6. doi: 10.1097/MOU.0b013e32833cf1ef.","Wallerand H","Curr Opin Urol","2010","2010/07/21","","","10.1097/MOU.0b013e32833cf1ef"
"3919933","Bladder cancer. The selection of patients for treatment by full-dose irradiation","Shipley WU, Rose MA.","Cancer. 1985 May 1;55(9 Suppl):2278-84. doi: 10.1002/1097-0142(19850501)55:9+<2278::aid-cncr2820551435>3.0.co;2-#.","Shipley WU","Cancer","1985","1985/05/01","","","10.1002/1097-0142(19850501)55:9+<2278::aid-cncr2820551435>3.0.co;2-#"
"8794154","Bladder cancer","Ozen H.","Curr Opin Oncol. 1996 May;8(3):259-63.","Ozen H","Curr Opin Oncol","1996","1996/05/01","","",""
"18271417","[Bladder cancer in neurological patients: analysis of a single-centre series]","Parra J, Drouin S, Comperat E, Misraï V, Van Glabeke E, Richard F, Denys P, Chartier-Kastler E, Rouprêt M.","Prog Urol. 2007 Nov;17(7):1333-6. doi: 10.1016/s1166-7087(07)78572-x.","Parra J","Prog Urol","2007","2008/02/15","","","10.1016/s1166-7087(07)78572-x"
"29368096","Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A","Khandelwal M, Anand V, Appunni S, Seth A, Singh P, Mathur S, Sharma A.","Mol Cell Biochem. 2018 Sep;446(1-2):105-114. doi: 10.1007/s11010-018-3278-z. Epub 2018 Jan 24.","Khandelwal M","Mol Cell Biochem","2018","2018/01/26","","","10.1007/s11010-018-3278-z"
"17437776","Bladder and upper tract urothelial cancer","Konety BR, Joyce GF, Wise M.","J Urol. 2007 May;177(5):1636-45. doi: 10.1016/j.juro.2007.01.055.","Konety BR","J Urol","2007","2007/04/18","","","10.1016/j.juro.2007.01.055"
"6236595","[Tryptophan metabolic disorder--1 of the criteria for forming groups at high risk for spontaneous bladder cancer]","Prianichnikova MB.","Urol Nefrol (Mosk). 1984 Jul-Aug;(4):61-5.","Prianichnikova MB","Urol Nefrol (Mosk)","1984","1984/07/01","","",""
"15358590","Genotypic and phenotypic biomarker profiles for individual risk assessment and cancer detection (lessons from bladder cancer risk assessment in symptomatic patients and workers exposed to benzidine)","Hemstreet GP, Wang W.","Front Biosci. 2004 Sep 1;9:2671-9. doi: 10.2741/1426.","Hemstreet GP","Front Biosci","2004","2004/09/11","","","10.2741/1426"
"30256070","Association of Autophagy Gene ATG16L1 Polymorphism with Human Prostate Cancer and Bladder Cancer in Turkish Population","Budak Diler S, Aybuğa F.","Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2625-2630. doi: 10.22034/APJCP.2018.19.9.2625.","Budak Diler S","Asian Pac J Cancer Prev","2018","2018/09/27","PMC6249448","","10.22034/APJCP.2018.19.9.2625"
"2317654","Influence of retinoids on bladder cancer growth as detected by primary tissue culture","Sawczuk IS, Olsson CA, Mertz JR.","Br J Urol. 1990 Feb;65(2):186-8. doi: 10.1111/j.1464-410x.1990.tb14696.x.","Sawczuk IS","Br J Urol","1990","1990/02/01","","","10.1111/j.1464-410x.1990.tb14696.x"
"7994796","Advanced bladder cancer: options of therapy","Pontes JE.","Cancer Chemother Pharmacol. 1994;35 Suppl:S93-6. doi: 10.1007/BF00686929.","Pontes JE","Cancer Chemother Pharmacol","1994","1994/01/01","","","10.1007/BF00686929"
"3226022","[Evaluation of tumor specific antigens in bladder cancer using anti Thomsen-Friedenreich monoclonal antibody and soybean agglutinin]","Oda H, Oda T, Yokoyama M, Takeuchi M, Ohoka H, Utsumi S.","Nihon Hinyokika Gakkai Zasshi. 1988 Apr;79(4):713-8. doi: 10.5980/jpnjurol1928.79.4_713.","Oda H","Nihon Hinyokika Gakkai Zasshi","1988","1988/04/01","","","10.5980/jpnjurol1928.79.4_713"
"3543941","Quality of life assessment in bladder cancer clinical trials: conceptual, methodological and practical issues","Aaronson NK, Calais da Silva F, Yoshida O, van Dam FS, Fosså SD, Miyakawa M, Raghavan D, Riedl H, Robinson MR, Worden JW.","Prog Clin Biol Res. 1986;221:149-70.","Aaronson NK","Prog Clin Biol Res","1986","1986/01/01","","",""
"3723909","[A study on 52 patients with bladder cancer treated with radical cystectomy--pathological findings, lymph node metastasis and prognosis]","Takashi M, Murase T, Sobajima T, Shimoji T, Miyake K, Mitsuya H, Tsubone M, Kato N, Kakehi H, Ogisu B, et al.","Nihon Hinyokika Gakkai Zasshi. 1986 Jan;77(1):19-30. doi: 10.5980/jpnjurol1928.77.1_19.","Takashi M","Nihon Hinyokika Gakkai Zasshi","1986","1986/01/01","","","10.5980/jpnjurol1928.77.1_19"
"11844817","Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation","Kuball J, Wen SF, Leissner J, Atkins D, Meinhardt P, Quijano E, Engler H, Hutchins B, Maneval DC, Grace MJ, Fritz MA, Störkel S, Thüroff JW, Huber C, Schuler M.","J Clin Oncol. 2002 Feb 15;20(4):957-65. doi: 10.1200/JCO.2002.20.4.957.","Kuball J","J Clin Oncol","2002","2002/02/15","","","10.1200/JCO.2002.20.4.957"
"16763645","Mechanisms of disease: The epidemiology of bladder cancer","Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C.","Nat Clin Pract Urol. 2006 Jun;3(6):327-40. doi: 10.1038/ncpuro0510.","Pelucchi C","Nat Clin Pract Urol","2006","2006/06/10","","","10.1038/ncpuro0510"
"20736328","Prediction of stage, grade, and survival in bladder cancer using genome-wide expression data: a validation study","Lauss M, Ringnér M, Höglund M.","Clin Cancer Res. 2010 Sep 1;16(17):4421-33. doi: 10.1158/1078-0432.CCR-10-0606. Epub 2010 Aug 24.","Lauss M","Clin Cancer Res","2010","2010/08/26","","","10.1158/1078-0432.CCR-10-0606"
"1441213","[The frequency of recurrences and metastases of bladder cancer following a radical course of radiotherapy]","Pereslegin IA, Mufazalov FF.","Vestn Rentgenol Radiol. 1992 May-Jun;(3):57-8.","Pereslegin IA","Vestn Rentgenol Radiol","1992","1992/05/01","","",""
"23569127","N-acetyltransferase 1 polymorphism and bladder cancer susceptibility: a meta-analysis of epidemiological studies","Wu K, Wang X, Xie Z, Liu Z, Lu Y.","J Int Med Res. 2013 Feb;41(1):31-7. doi: 10.1177/0300060513476988. Epub 2013 Jan 24.","Wu K","J Int Med Res","2013","2013/04/10","","","10.1177/0300060513476988"
"12793013","[Development of bladder cancer chemoprevention]","Dai G, Wang X.","Wei Sheng Yan Jiu. 2003 Mar;32(2):159-62.","Dai G","Wei Sheng Yan Jiu","2003","2003/06/10","","",""
"482961","Pathologist's role in bladder cancer","Farrow GM.","Semin Oncol. 1979 Jun;6(2):198-206.","Farrow GM","Semin Oncol","1979","1979/06/01","","",""
"27350368","Comprehensive investigation of aberrant microRNA profiling in bladder cancer tissues","Wei Y, He R, Wu Y, Gan B, Wu P, Qiu X, Lan A, Chen G, Wang Q, Lin X, Chen Y, Mo Z.","Tumour Biol. 2016 Sep;37(9):12555-12569. doi: 10.1007/s13277-016-5121-z. Epub 2016 Jun 28.","Wei Y","Tumour Biol","2016","2016/06/29","","","10.1007/s13277-016-5121-z"
"12355941","[Urology]","Hinotsu S, Akaza H.","Gan To Kagaku Ryoho. 2002 Sep;29(9):1549-69.","Hinotsu S","Gan To Kagaku Ryoho","2002","2002/10/03","","",""
"30666449","Integrated analysis of (18)F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer","Girard A, Rouanne M, Taconet S, Radulescu C, Neuzillet Y, Girma A, Beaufrere A, Lebret T, Le Stanc E, Grellier JF.","Eur Radiol. 2019 Aug;29(8):4286-4293. doi: 10.1007/s00330-018-5959-0. Epub 2019 Jan 21.","Girard A","Eur Radiol","2019","2019/01/23","","","10.1007/s00330-018-5959-0"
"29650141","Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma","Achkar T, Parikh RA.","Urol Clin North Am. 2018 May;45(2):257-266. doi: 10.1016/j.ucl.2017.12.010. Epub 2018 Feb 21.","Achkar T","Urol Clin North Am","2018","2018/04/14","","","10.1016/j.ucl.2017.12.010"
"22959049","Treatment options available for bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer","Yates DR, Brausi MA, Catto JW, Dalbagni G, Rouprêt M, Shariat SF, Sylvester RJ, Witjes JA, Zlotta AR, Palou-Redorta J.","Eur Urol. 2012 Dec;62(6):1088-96. doi: 10.1016/j.eururo.2012.08.055. Epub 2012 Sep 3.","Yates DR","Eur Urol","2012","2012/09/11","","","10.1016/j.eururo.2012.08.055"
"26251520","Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer","Poyet C, Buser L, Roudnicky F, Detmar M, Hermanns T, Mannhard D, Höhn A, Rüschoff J, Zhong Q, Sulser T, Moch H, Wild PJ.","J Clin Pathol. 2015 Oct;68(10):819-24. doi: 10.1136/jclinpath-2015-202898. Epub 2015 Aug 6.","Poyet C","J Clin Pathol","2015","2015/08/08","PMC4602233","","10.1136/jclinpath-2015-202898"
"2819392","Bladder tumours in Enugu, Nigeria","Aghaji AE, Mbonu OO.","Br J Urol. 1989 Oct;64(4):399-402. doi: 10.1111/j.1464-410x.1989.tb06051.x.","Aghaji AE","Br J Urol","1989","1989/10/01","","","10.1111/j.1464-410x.1989.tb06051.x"
"23911605","Refining patient selection for neoadjuvant chemotherapy before radical cystectomy","Culp SH, Dickstein RJ, Grossman HB, Pretzsch SM, Porten S, Daneshmand S, Cai J, Groshen S, Siefker-Radtke A, Millikan RE, Czerniak B, Navai N, Wszolek MF, Kamat AM, Dinney CP.","J Urol. 2014 Jan;191(1):40-7. doi: 10.1016/j.juro.2013.07.061. Epub 2013 Jul 30.","Culp SH","J Urol","2014","2013/08/06","PMC4158919","NIHMS600511","10.1016/j.juro.2013.07.061"
"10089635","[Bilharziasis and bladder cancer. A case report]","Alvarez Kindelan J, Alameda Aragoneses V, Carmona Campos E, Anglada Curado F, Prieto Castro R, Regueiro López JC, López Rubio F, Requena Tapia MJ.","Actas Urol Esp. 1999 Jan;23(1):60-3.","Alvarez Kindelan J","Actas Urol Esp","1999","1999/03/25","","",""
"3582456","Intravesical irrigation with distilled water during and immediately after transurethral resection and later for superficial bladder cancer","Moskovitz B, Levin DR.","Eur Urol. 1987;13(1-2):7-9. doi: 10.1159/000472726.","Moskovitz B","Eur Urol","1987","1987/01/01","","","10.1159/000472726"
"26614030","Pharmacogenomics: Biomarker-Directed Therapy for Bladder Cancer","Jones RT, Felsenstein KM, Theodorescu D.","Urol Clin North Am. 2016 Feb;43(1):77-86. doi: 10.1016/j.ucl.2015.08.007. Epub 2015 Oct 31.","Jones RT","Urol Clin North Am","2016","2015/11/29","PMC4663013","NIHMS719023","10.1016/j.ucl.2015.08.007"
"30850856","Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer","Brant A, Daniels M, Chappidi MR, Joice GA, Sopko NA, Matoso A, Bivalacqua TJ, Kates M.","World J Urol. 2019 Dec;37(12):2683-2689. doi: 10.1007/s00345-019-02673-2. Epub 2019 Mar 8.","Brant A","World J Urol","2019","2019/03/10","","","10.1007/s00345-019-02673-2"
"5131262","Screening for bladder cancer","Parkes HG.","Proc R Soc Med. 1971 Dec;64(12):1207-11.","Parkes HG","Proc R Soc Med","1971","1971/12/01","PMC1813179","",""
"19954288","Organ-sparing strategies in the management of invasive bladder cancer","Yafi FA, Cury FL, Kassouf W.","Expert Rev Anticancer Ther. 2009 Dec;9(12):1765-75. doi: 10.1586/era.09.151.","Yafi FA","Expert Rev Anticancer Ther","2009","2009/12/04","","","10.1586/era.09.151"
"11186722","[Urinary bladder cancer in patients with tuberculous and post-tuberculous cystitis]","Kamyshan IS, Klimenko IA, Kirichenko SA.","Urologiia. 2000 Mar-Apr;(2):21-4.","Kamyshan IS","Urologiia","2000","2001/02/24","","",""
"10754137","Detection of adenocarcinoma by urinary microsatellite analysis after augmentation cystoplasty","Docimo SG, Chow NH, Steiner G, Silver RI, Rodriguez R, Kinsman S, Sidransky D, Schoenberg M.","Urology. 1999 Sep;54(3):561. doi: 10.1016/s0090-4295(99)00159-4.","Docimo SG","Urology","1999","2001/02/07","","","10.1016/s0090-4295(99)00159-4"
"29297169","Clinical Decision Making in Surveillance of Non-Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers","Zuiverloon TCM, de Jong FC, Theodorescu D.","Oncology (Williston Park). 2017 Dec 15;31(12):855-62.","Zuiverloon TCM","Oncology (Williston Park)","2017","2018/01/04","","",""
"27211927","The First Report of Urothelial (Clear Cell Variant) Bladder Cancer in a Child","Minkowitz SY, Wadee R, Adam A.","Urology. 2016 Nov;97:204-207. doi: 10.1016/j.urology.2016.05.010. Epub 2016 May 17.","Minkowitz SY","Urology","2016","2016/05/24","","","10.1016/j.urology.2016.05.010"
"9839578","Urine cytology, tumour markers and bladder cancer","Halachmi S, Linn JF, Amiel GE, Moskovitz B, Nativ O.","Br J Urol. 1998 Nov;82(5):647-54. doi: 10.1046/j.1464-410x.1998.00821.x.","Halachmi S","Br J Urol","1998","1998/12/05","","","10.1046/j.1464-410x.1998.00821.x"
"29551404","Unconventional Bladder Preservation: Factors Predicting Failure to Receive Definitive Surgery following Chemotherapy for Nonmetastatic Muscle Invasive Bladder Cancer in the National Cancer Database","Kapadia AA, Martinez Acevedo A, Liu JJ, Garzotto M, Conlin M, Amling C, Kopp RP.","J Urol. 2018 Sep;200(3):535-540. doi: 10.1016/j.juro.2018.03.075. Epub 2018 Mar 15.","Kapadia AA","J Urol","2018","2018/03/20","","","10.1016/j.juro.2018.03.075"
"11510521","Urine detection of survivin and diagnosis of bladder cancer","Moore M.","J Insur Med. 2001;33(2):202-3.","Moore M","J Insur Med","2001","2001/08/21","","",""
"29214354","Wide-field autofluorescence-guided TUR-B for the detection of bladder cancer: a pilot study","Kriegmair MC, Honeck P, Theuring M, Bolenz C, Ritter M.","World J Urol. 2018 May;36(5):745-751. doi: 10.1007/s00345-017-2147-9. Epub 2017 Dec 6.","Kriegmair MC","World J Urol","2018","2017/12/08","","","10.1007/s00345-017-2147-9"
"11775532","High frequency loss of heterozygosity in the region of the DBH locus in bladder cancer","Yang X, Shen P, Yao K, Mi Z, Liu S, Zhang H, Wang D, Liu C, Liu H.","Chin Med J (Engl). 2000 Feb;113(2):117-9.","Yang X","Chin Med J (Engl)","2000","2002/01/05","","",""
"23617090","Tissue fatty acid composition in human urothelial carcinoma","Miryaghoubzadeh J, Darabi M, Madaen K, Shaaker M, Mehdizadeh A, Hajihosseini R.","Br J Biomed Sci. 2013;70(1):1-5. doi: 10.1080/09674845.2013.11669921.","Miryaghoubzadeh J","Br J Biomed Sci","2013","2013/04/27","","","10.1080/09674845.2013.11669921"
"11490305","Potent antitumor effects of CD154 transduced tumor cells in experimental bladder cancer","Loskog A, Björkland A, Brown MP, Korsgren O, Malmström PU, Tötterman TH.","J Urol. 2001 Sep;166(3):1093-7.","Loskog A","J Urol","2001","2001/08/08","","",""
"28420564","Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer","D'Andrea D, Moschini M, Gust K, Abufaraj M, Özsoy M, Mathieu R, Soria F, Briganti A, Rouprêt M, Karakiewicz PI, Shariat SF.","Clin Genitourin Cancer. 2017 Oct;15(5):e755-e764. doi: 10.1016/j.clgc.2017.03.007. Epub 2017 Mar 27.","D'Andrea D","Clin Genitourin Cancer","2017","2017/04/20","","","10.1016/j.clgc.2017.03.007"
"3455662","Chromosome changes in bladder cancer: clinical and other correlations","Sandberg AA.","Cancer Genet Cytogenet. 1986 Jan 1;19(1-2):163-75. doi: 10.1016/0165-4608(86)90384-5.","Sandberg AA","Cancer Genet Cytogenet","1986","1986/01/01","","","10.1016/0165-4608(86)90384-5"
"22402109","Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence","Xylinas E, Rink M, Margulis V, Karakiewicz P, Novara G, Shariat SF; Upper Tract Urothelial Carcinoma Collaboration (UTUCC).","Eur Urol. 2012 May;61(5):1069-70. doi: 10.1016/j.eururo.2012.02.042. Epub 2012 Feb 25.","Xylinas E","Eur Urol","2012","2012/03/10","","","10.1016/j.eururo.2012.02.042"
"8187096","Decreased connexin expression and intercellular communication in human bladder cancer cells","Grossman HB, Liebert M, Lee IW, Lee SW.","Cancer Res. 1994 Jun 1;54(11):3062-5.","Grossman HB","Cancer Res","1994","1994/06/01","","",""
"30521161","Small cell bladder cancer: should we consider prophylactic cranial irradiation?","Morgan TN, Turner RM II, Baptiste J, Lyon TD, Maranchie JK, Hrebinko RL, Davies BJ, Gingrich JR, Jacobs BL.","Int Braz J Urol. 2019 Mar-Apr;45(2):299-305. doi: 10.1590/S1677-5538.IBJU.2018.0242.","Morgan TN","Int Braz J Urol","2019","2018/12/07","PMC6541124","","10.1590/S1677-5538.IBJU.2018.0242"
"21145577","Variation in use of lymph node dissection during radical cystectomy for bladder cancer","Hedgepeth RC, Zhang Y, Skolarus TA, Hollenbeck BK.","Urology. 2011 Feb;77(2):385-90. doi: 10.1016/j.urology.2010.08.050. Epub 2010 Dec 9.","Hedgepeth RC","Urology","2011","2010/12/15","","","10.1016/j.urology.2010.08.050"
"8335677","The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification","Angulo JC, Lopez JI, Flores N, Toledo JD.","J Cancer Res Clin Oncol. 1993;119(10):578-93. doi: 10.1007/BF01372721.","Angulo JC","J Cancer Res Clin Oncol","1993","1993/01/01","","","10.1007/BF01372721"
"4168150","Treatment of bladder cancer in Egypt, Part II: reconstruction technics","Fam A.","Int Surg. 1967 Nov;48(5):454-65.","Fam A","Int Surg","1967","1967/11/01","","",""
"30666451","Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor method","Wang F, Chen HG, Zhang RY, Jin D, Xu SS, Wu GY, Xu JR.","Eur Radiol. 2019 Aug;29(8):4447-4455. doi: 10.1007/s00330-018-5977-y. Epub 2019 Jan 21.","Wang F","Eur Radiol","2019","2019/01/23","","","10.1007/s00330-018-5977-y"
"7371657","Diagnostic contribution of bladder washing and multiple biopsies in bladder cancers","Denis L, Nowé P, Declercq G.","Eur Urol. 1980;6(3):137-8. doi: 10.1159/000473311.","Denis L","Eur Urol","1980","1980/01/01","","","10.1159/000473311"
"28067434","Pioglitazone and bladder cancer: FDA's assessment","Hampp C, Pippins J.","Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):117-118. doi: 10.1002/pds.4154. Epub 2017 Jan 9.","Hampp C","Pharmacoepidemiol Drug Saf","2017","2017/01/10","","","10.1002/pds.4154"
"29313114","Bladder cancer local staging: multiparametric MRI performance following transurethral resection","van der Pol CB, Shinagare AB, Tirumani SH, Preston MA, Vangel MG, Silverman SG.","Abdom Radiol (NY). 2018 Sep;43(9):2412-2423. doi: 10.1007/s00261-017-1449-0.","van der Pol CB","Abdom Radiol (NY)","2018","2018/01/10","","","10.1007/s00261-017-1449-0"
"31547991","MiRNA-217 accelerates the proliferation and migration of bladder cancer via inhibiting KMT2D","Hou G, Xu W, Jin Y, Wu J, Pan Y, Zhou F.","Biochem Biophys Res Commun. 2019 Nov 19;519(4):747-753. doi: 10.1016/j.bbrc.2019.09.029. Epub 2019 Sep 20.","Hou G","Biochem Biophys Res Commun","2019","2019/09/25","","","10.1016/j.bbrc.2019.09.029"
"2179581","A clinically applicable method to preserve urine and bladder washing cells for flow cytometric monitoring of bladder cancer patients","Deitch AD, Andreotti VA, Strand MA, Howell L, deVere White RW.","J Urol. 1990 Apr;143(4):700-5. doi: 10.1016/s0022-5347(17)40064-4.","Deitch AD","J Urol","1990","1990/04/01","","","10.1016/s0022-5347(17)40064-4"
"11005452","Outcome of radical cystectomy for invasive bladder cancer","Bassi P.","Curr Opin Urol. 2000 Sep;10(5):459-63. doi: 10.1097/00042307-200009000-00016.","Bassi P","Curr Opin Urol","2000","2000/09/27","","","10.1097/00042307-200009000-00016"
"2046684","Early indicators of bladder carcinogenesis produced by non-genotoxic agents","Anderson RL.","Mutat Res. 1991 Jun;248(2):261-70. doi: 10.1016/0027-5107(91)90061-r.","Anderson RL","Mutat Res","1991","1991/06/01","","","10.1016/0027-5107(91)90061-r"
"25234951","[Pharmaceutical treatment of advanced urinary bladder cancer: new developments in 2014]","Schmid SC, Gschwend JE, Retz M.","Urologe A. 2014 Oct;53(10):1535-42. doi: 10.1007/s00120-014-3641-y.","Schmid SC","Urologe A","2014","2014/09/20","","","10.1007/s00120-014-3641-y"
"30342063","Estimating Minimally Important Differences for the Bladder Cancer Index Using Distribution and Anchor Based Approaches","Peyton CC, Henriksen C, Reich RR, Azizi M, Gilbert SM.","J Urol. 2019 Apr;201(4):709-714. doi: 10.1016/j.juro.2018.10.008.","Peyton CC","J Urol","2019","2018/10/21","","","10.1016/j.juro.2018.10.008"
"9681394","BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines","Bevers RF, de Boer EC, Kurth KH, Schamhart DH.","Eur Cytokine Netw. 1998 Jun;9(2):181-6.","Bevers RF","Eur Cytokine Netw","1998","1998/07/29","","",""
"9394911","The case for radiotherapy with or without chemotherapy in high-risk superficial and muscle-invading bladder cancer","Zietman AL, Shipley WU, Heney NM, Althausen AF.","Semin Urol Oncol. 1997 Aug;15(3):161-8.","Zietman AL","Semin Urol Oncol","1997","1997/08/01","","",""
"2405193","Fibronectin distribution in normal and malignant urothelium","Grossman HB, Liebert M, Wedemeyer G, Wilson G, Flint A.","J Urol. 1990 Feb;143(2):418-20. doi: 10.1016/s0022-5347(17)39977-9.","Grossman HB","J Urol","1990","1990/02/01","","","10.1016/s0022-5347(17)39977-9"
"1233104","A comparison between pre- and post-operative pelvic irradiation using curative dosage and radical surgery alone for the treatment of advanced cancer of the urinary bladder","Leong CH, Yu H, Ong GB.","Bull Soc Int Chir. 1975;34(6):507-11.","Leong CH","Bull Soc Int Chir","1975","1975/01/01","","",""
"6675437","[Pathological changes associated with topical chemotherapy of adriamycin for bladder cancer]","Fujioka T, Ishii N, Chiba R.","Hinyokika Kiyo. 1983 Aug;29(8):869-73.","Fujioka T","Hinyokika Kiyo","1983","1983/08/01","","",""
"28537702","The awareness of patients with non - muscle invasive bladder cancer regarding the importance of smoking cessation and their access to smoking cessation programs","Yuruk E, Tuken M, Colakerol A, Serefoglu EC.","Int Braz J Urol. 2017 Jul-Aug;43(4):607-614. doi: 10.1590/S1677-5538.IBJU.2016.0014.","Yuruk E","Int Braz J Urol","2017","2017/05/25","PMC5557435","","10.1590/S1677-5538.IBJU.2016.0014"
"27602581","Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer","Falzone L, Candido S, Salemi R, Basile MS, Scalisi A, McCubrey JA, Torino F, Signorelli SS, Montella M, Libra M.","Oncotarget. 2016 Nov 8;7(45):72758-72766. doi: 10.18632/oncotarget.11805.","Falzone L","Oncotarget","2016","2016/09/08","PMC5341942","","10.18632/oncotarget.11805"
"3616512","Life with an ileal conduit in cystectomized bladder cancer patients: expectations and experience","Fosså SD, Reitan JB, Ous S, Kaalhus O.","Scand J Urol Nephrol. 1987;21(2):97-101. doi: 10.3109/00365598709180301.","Fosså SD","Scand J Urol Nephrol","1987","1987/01/01","","","10.3109/00365598709180301"
"25579780","Exploring the 3 A's of cystectomy access to care for muscle-invasive bladder cancer","Spencer ES, Smith AB.","Urol Oncol. 2015 Mar;33(3):105-7. doi: 10.1016/j.urolonc.2014.11.014. Epub 2015 Jan 8.","Spencer ES","Urol Oncol","2015","2015/01/13","","","10.1016/j.urolonc.2014.11.014"
"30185677","A review of bladder cancer in Sub-Saharan Africa: A different disease, with a distinct presentation, assessment, and treatment","Bowa K, Mulele C, Kachimba J, Manda E, Mapulanga V, Mukosai S.","Ann Afr Med. 2018 Jul-Sep;17(3):99-105. doi: 10.4103/aam.aam_48_17.","Bowa K","Ann Afr Med","2018","2018/09/07","PMC6126046","","10.4103/aam.aam_48_17"
"11354029","Maintenance therapy for superficial bladder cancer","Droller MJ.","Oncology (Williston Park). 2001 Feb;15(2):239-41.","Droller MJ","Oncology (Williston Park)","2001","2001/05/17","","",""
"22512972","Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer","Mark JR, Gelpi-Hammerschmidt F, Trabulsi EJ, Gomella LG.","Can J Urol. 2012 Apr;19(2):6227-31.","Mark JR","Can J Urol","2012","2012/04/20","","",""
"31865738","Palliative radiation therapy in bladder cancer: a matter of dose, techniques and patients' selection","Jereczek-Fossa BA, Marvaso G.","Ann Palliat Med. 2019 Nov;8(5):786-789. doi: 10.21037/apm.2019.11.02.","Jereczek-Fossa BA","Ann Palliat Med","2019","2019/12/24","","","10.21037/apm.2019.11.02"
"4513505","Studies on the role of tryptophan metabolites in the genesis of bladder cancer","Wolf H.","Acta Chir Scand Suppl. 1973;433:154-68.","Wolf H","Acta Chir Scand Suppl","1973","1973/01/01","","",""
"1810904","Urinary cytology in the detection of bladder carcinoma","O'Donoghue JM, Horgan PG, Corcoran M, Bredin H, McGuire M, Given HF.","Ir J Med Sci. 1991 Nov;160(11):352-3. doi: 10.1007/BF02957894.","O'Donoghue JM","Ir J Med Sci","1991","1991/11/01","","","10.1007/BF02957894"
"21286014","GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer","Ha YS, Yan C, Jeong P, Kim WT, Yun SJ, Kim IY, Moon SK, Kim WJ.","J Korean Med Sci. 2011 Feb;26(2):231-6. doi: 10.3346/jkms.2011.26.2.231. Epub 2011 Jan 24.","Ha YS","J Korean Med Sci","2011","2011/02/03","PMC3031007","","10.3346/jkms.2011.26.2.231"
"12686811","Patterns of care for the treatment of bladder cancer","Snyder C, Harlan L, Knopf K, Potosky A, Kaplan R.","J Urol. 2003 May;169(5):1697-701. doi: 10.1097/01.ju.0000056727.30546.b7.","Snyder C","J Urol","2003","2003/04/11","","","10.1097/01.ju.0000056727.30546.b7"
"28184446","Lymphovascular invasion predicts poor prognosis in high-grade pT1 bladder cancer patients who underwent transurethral resection in one piece","Ukai R, Hashimoto K, Nakayama H, Iwamoto T.","Jpn J Clin Oncol. 2017 May 1;47(5):447-452. doi: 10.1093/jjco/hyx012.","Ukai R","Jpn J Clin Oncol","2017","2017/02/11","","","10.1093/jjco/hyx012"
"14657696","Intravesical bacillus Calmette-Guèrin for the treatment of superficial bladder cancer in renal transplant patients","Palou J, Angerri O, Segarra J, Caparrós J, Guirado L, Diaz JM, Salvador-Bayarri J, Villavicencio-Mavrich H.","Transplantation. 2003 Nov 27;76(10):1514-6. doi: 10.1097/01.TP.0000090748.32764.0F.","Palou J","Transplantation","2003","2003/12/06","","","10.1097/01.TP.0000090748.32764.0F"
"17487406","Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer","Sonoda T, Sugimura K, Ikemoto S, Kawashima H, Nakatani T.","Oncol Rep. 2007 Jun;17(6):1469-74.","Sonoda T","Oncol Rep","2007","2007/05/10","","",""
"20146880","The effects of intravesical chemoimmunotherapy with gemcitabine and Bacillus Calmette-Guérin in superficial bladder cancer: a preliminary study","Cho DY, Bae JH, Moon DG, Cheon J, Lee JG, Kim JJ, Yoon DK, Park HS.","J Int Med Res. 2009 Nov-Dec;37(6):1823-30. doi: 10.1177/147323000903700618.","Cho DY","J Int Med Res","2009","2010/02/12","","","10.1177/147323000903700618"
"21943989","What are the expected developments in the medical treatment of bladder cancer","Bellmunt J.","Eur J Cancer. 2011 Sep;47 Suppl 3:S294-7. doi: 10.1016/S0959-8049(11)70177-0.","Bellmunt J","Eur J Cancer","2011","2011/09/28","","","10.1016/S0959-8049(11)70177-0"
"7394986","Intravesical instillation of adriamycin combined with low-dose irradiation for superficial bladder cancer","Uyama T, Moriwaki S, Nakamura S, Kagawa S.","Urology. 1980 Jun;15(6):584-7. doi: 10.1016/0090-4295(80)90372-6.","Uyama T","Urology","1980","1980/06/01","","","10.1016/0090-4295(80)90372-6"
"25910967","Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study","Rose A, El-Leithy T, vom Dorp F, Zakaria A, Eisenhardt A, Tschirdewahn S, Rübben H.","J Urol. 2015 Oct;194(4):939-43. doi: 10.1016/j.juro.2015.04.073. Epub 2015 Apr 22.","Rose A","J Urol","2015","2015/04/26","","","10.1016/j.juro.2015.04.073"
"31336246","The case for BK polyomavirus as a cause of bladder cancer","Starrett GJ, Buck CB.","Curr Opin Virol. 2019 Dec;39:8-15. doi: 10.1016/j.coviro.2019.06.009. Epub 2019 Jul 20.","Starrett GJ","Curr Opin Virol","2019","2019/07/24","PMC6901737","NIHMS1535343","10.1016/j.coviro.2019.06.009"
"1558369","[Neo-adjuvant (or preliminary) chemotherapy in cancer of the bladder. Evaluation]","Charrot-Chinet P.","Ann Urol (Paris). 1992;26(1):25-9.","Charrot-Chinet P","Ann Urol (Paris)","1992","1992/01/01","","",""
"23022177","High precision bladder cancer irradiation by integrating a library planning procedure of 6 prospectively generated SIB IMRT plans with image guidance using lipiodol markers","Meijer GJ, van der Toorn PP, Bal M, Schuring D, Weterings J, de Wildt M.","Radiother Oncol. 2012 Nov;105(2):174-9. doi: 10.1016/j.radonc.2012.08.011. Epub 2012 Sep 27.","Meijer GJ","Radiother Oncol","2012","2012/10/02","","","10.1016/j.radonc.2012.08.011"
"16791629","[Noninvasive and invasive bladder cancer: diagnostics and treatment]","Goebell PJ, Vom Dorp F, Rödel C, Frohneberg D, Thüroff JW, Jocham D, Stief C, Roth S, Knüchel R, Schmidt KW, Kausch I, Zaak D, Wiesner C, Miller K, Sauer R, Rübben H.","Urologe A. 2006 Jul;45(7):873-84; quiz 885. doi: 10.1007/s00120-006-1065-z.","Goebell PJ","Urologe A","2006","2006/06/23","","","10.1007/s00120-006-1065-z"
"21437971","Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancer","Naish JH, McGrath DM, Bains LJ, Passera K, Roberts C, Watson Y, Cheung S, Taylor MB, Logue JP, Buckley DL, Tessier J, Young H, Waterton JC, Parker GJ.","Magn Reson Med. 2011 Jul;66(1):219-26. doi: 10.1002/mrm.22774. Epub 2011 Mar 24.","Naish JH","Magn Reson Med","2011","2011/03/26","","","10.1002/mrm.22774"
"19035903","Bladder preservation: optimizing radiotherapy and integrated treatment strategies","Mak RH, Zietman AL, Heney NM, Kaufman DS, Shipley WU.","BJU Int. 2008 Nov;102(9 Pt B):1345-53. doi: 10.1111/j.1464-410X.2008.07981.x.","Mak RH","BJU Int","2008","2008/11/28","","","10.1111/j.1464-410X.2008.07981.x"
"20563846","The practice of the first check cystoscopy following radiotherapy for the treatment of muscle-invasive (T3N0M0) bladder cancer: a UK national survey","Mohammed A, Hameed A, Shergill I, Barua J.","Int Urol Nephrol. 2011 Jun;43(2):377-81. doi: 10.1007/s11255-010-9789-5. Epub 2010 Jun 20.","Mohammed A","Int Urol Nephrol","2011","2010/06/22","","","10.1007/s11255-010-9789-5"
"21055568","[Microsatellite markers and methylation of promoters of tumour suppressor genes in bladder cancer]","Collin-Chavagnac D, Descotes F, Billon S, Adams M, Decaussin M, Piaton E, Rodriguez-Lafrasse C, Ruffion A.","Ann Pathol. 2010 Nov;30(5 Suppl 1):119-20. doi: 10.1016/j.annpat.2010.07.022. Epub 2010 Sep 15.","Collin-Chavagnac D","Ann Pathol","2010","2010/11/09","","","10.1016/j.annpat.2010.07.022"
"6861100","The use of a tumor colony assay in predicting chemotherapeutic drug response in murine bladder cancer","Niell HB, Soloway MS, Wood CA, McCallum LW, Webster K.","Cancer. 1983 Aug 15;52(4):619-25. doi: 10.1002/1097-0142(19830815)52:4<619::aid-cncr2820520408>3.0.co;2-9.","Niell HB","Cancer","1983","1983/08/15","","","10.1002/1097-0142(19830815)52:4<619::aid-cncr2820520408>3.0.co;2-9"
"25776013","Is the inverse association between selenium and bladder cancer due to confounding by smoking?","Beane Freeman LE, Karagas MR, Baris D, Schwenn M, Johnson AT, Colt JS, Jackson B, Hosain GM, Cantor KP, Silverman DT.","Am J Epidemiol. 2015 Apr 1;181(7):488-95. doi: 10.1093/aje/kwu324. Epub 2015 Mar 15.","Beane Freeman LE","Am J Epidemiol","2015","2015/03/18","PMC4447815","","10.1093/aje/kwu324"
"23052261","[Follow-up method for patients with non-muscle-invasive bladder cancer who remained recurrence-free for a long time]","Akagashi K, Nakajima H, Nitta T, Sato Y, Tobe M, Haga K, Uchida K, Honma I, Tanda H, Kato S, Ohnishi S, Hanzawa T.","Hinyokika Kiyo. 2012 Aug;58(8):395-9.","Akagashi K","Hinyokika Kiyo","2012","2012/10/12","","",""
"11758203","[Intravesical instillation of cytotoxic T-lymphocytes induced by soluble tumor antigen in the prophylaxis of recurrence of bladder cancer]","Li X, Sun D, Gao W.","Zhonghua Wai Ke Za Zhi. 2001 Aug;39(8):619-22.","Li X","Zhonghua Wai Ke Za Zhi","2001","2002/01/05","","",""
"10494286","Bladder. Risk and prognostic factors--a pathologist's perspective","Reuter VE.","Urol Clin North Am. 1999 Aug;26(3):481-92. doi: 10.1016/s0094-0143(05)70196-8.","Reuter VE","Urol Clin North Am","1999","1999/09/24","","","10.1016/s0094-0143(05)70196-8"
"22808294","High expression level of BLCA-4 correlates with poor prognosis in human bladder cancer","Zhao Q, Shen WH, Chen ZW, Zhou ZS, Ji HX.","Int J Clin Exp Pathol. 2012;5(5):422-7. Epub 2012 May 23.","Zhao Q","Int J Clin Exp Pathol","2012","2012/07/19","PMC3396067","",""
"28415579","Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics","Shao CH, Chen CL, Lin JY, Chen CJ, Fu SH, Chen YT, Chang YS, Yu JS, Tsui KH, Juo CG, Wu KP.","Oncotarget. 2017 Jun 13;8(24):38802-38810. doi: 10.18632/oncotarget.16393.","Shao CH","Oncotarget","2017","2017/04/19","PMC5503573","","10.18632/oncotarget.16393"
"15794774","Molecular prognostic factors in bladder cancer","Buscarini M, Quek ML, Gill P, Xia G, Quinn DI, Stein JP.","BJU Int. 2005 Apr;95(6):739-42. doi: 10.1111/j.1464-410X.2005.05393.x.","Buscarini M","BJU Int","2005","2005/03/30","","","10.1111/j.1464-410X.2005.05393.x"
"19685529","Cost-effectiveness analysis of immediate radical cystectomy versus intravesical Bacillus Calmette-Guerin therapy for high-risk, high-grade (T1G3) bladder cancer","Kulkarni GS, Alibhai SM, Finelli A, Fleshner NE, Jewett MA, Lopushinsky SR, Bayoumi AM.","Cancer. 2009 Dec 1;115(23):5450-9. doi: 10.1002/cncr.24634.","Kulkarni GS","Cancer","2009","2009/08/18","","","10.1002/cncr.24634"
"10786348","[Tumor markers of bladder cancer]","Martínez E, Morote J.","Med Clin (Barc). 2000 Mar 18;114(10):378-9. doi: 10.1016/s0025-7753(00)71302-9.","Martínez E","Med Clin (Barc)","2000","2000/04/29","","","10.1016/s0025-7753(00)71302-9"
"7083117","Urinary CEA for prediction of survival time and recurrence in bladder cancer","Wahren B, Nilsson B, Zimmerman R.","Cancer. 1982 Jul 1;50(1):139-45. doi: 10.1002/1097-0142(19820701)50:1<139::aid-cncr2820500126>3.0.co;2-s.","Wahren B","Cancer","1982","1982/07/01","","","10.1002/1097-0142(19820701)50:1<139::aid-cncr2820500126>3.0.co;2-s"
"11079794","Current trends in bladder cancer treatment","Lamm DL, Allaway M.","Ann Chir Gynaecol. 2000;89(3):234-41.","Lamm DL","Ann Chir Gynaecol","2000","2000/11/18","","",""
"28376901","Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression","Jiang H, Hu X, Zhang H, Li W.","Radiat Oncol. 2017 Apr 4;12(1):65. doi: 10.1186/s13014-017-0802-3.","Jiang H","Radiat Oncol","2017","2017/04/06","PMC5381027","","10.1186/s13014-017-0802-3"
"12559278","Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy","Herr HW.","Urology. 2003 Jan;61(1):105-8. doi: 10.1016/s0090-4295(02)02116-7.","Herr HW","Urology","2003","2003/02/01","","","10.1016/s0090-4295(02)02116-7"
"2466141","[Clinical diagnosis of bladder cancer by microscopic chromocystoscopy]","Iguchi A.","Nihon Hinyokika Gakkai Zasshi. 1988 Dec;79(12):1928-36. doi: 10.5980/jpnjurol1928.79.12_1928.","Iguchi A","Nihon Hinyokika Gakkai Zasshi","1988","1988/12/01","","","10.5980/jpnjurol1928.79.12_1928"
"1700178","[Clinical significances of intraoperative radiation therapy for aged patients with bladder cancer]","Shinohara M, Yamamoto T, Sugimoto M, Kinoshita K, Tanaka Y, Matsuda T.","Nihon Hinyokika Gakkai Zasshi. 1990 Sep;81(9):1317-21. doi: 10.5980/jpnjurol1989.81.1317.","Shinohara M","Nihon Hinyokika Gakkai Zasshi","1990","1990/09/01","","","10.5980/jpnjurol1989.81.1317"
"22088333","Influence of renal excretory function on the performance of urine based markers to detect bladder cancer","Todenhöfer T, Hennenlotter J, Witstruk M, Gakis G, Aufderklamm S, Kuehs U, Stenzl A, Schwentner C.","J Urol. 2012 Jan;187(1):68-73. doi: 10.1016/j.juro.2011.09.023. Epub 2011 Nov 16.","Todenhöfer T","J Urol","2012","2011/11/18","","","10.1016/j.juro.2011.09.023"
"25975677","Hypofractionated palliative radiotherapy for bladder cancer","Dirix P, Vingerhoedt S, Joniau S, Van Cleynenbreugel B, Haustermans K.","Support Care Cancer. 2016 Jan;24(1):181-186. doi: 10.1007/s00520-015-2765-y. Epub 2015 May 16.","Dirix P","Support Care Cancer","2016","2015/05/16","","","10.1007/s00520-015-2765-y"
"29575439","Urinary cytology and the Paris system for reporting urinary cytology: Implications for urological management","Gupta M, VandenBussche CJ, Bivalacqua TJ.","Cytopathology. 2018 Aug;29(4):368-370. doi: 10.1111/cyt.12538. Epub 2018 Mar 25.","Gupta M","Cytopathology","2018","2018/03/26","","","10.1111/cyt.12538"
"11455318","[The significance of ""atypical metaplasia"" in the follow-up of patients operated for bladder cancer]","Giovagnoli MR, Rocchi M, Grillo L, Vecchione A.","Minerva Urol Nefrol. 2001 Jun;53(2):93-7.","Giovagnoli MR","Minerva Urol Nefrol","2001","2001/07/17","","",""
"7524174","Treatment of muscle invasive bladder cancer. Is there a role for neoadjuvant chemotherapy?","Kuten A, Baz M, Rubinov R, Dale J, Haim N, Robinson E, Cohen Y.","Strahlenther Onkol. 1994 Sep;170(9):524-30.","Kuten A","Strahlenther Onkol","1994","1994/09/01","","",""
"20401558","Galectin-3 expression is associated with bladder cancer progression and clinical outcome","Canesin G, Gonzalez-Peramato P, Palou J, Urrutia M, Cordón-Cardo C, Sánchez-Carbayo M.","Tumour Biol. 2010 Aug;31(4):277-85. doi: 10.1007/s13277-010-0033-9. Epub 2010 Apr 17.","Canesin G","Tumour Biol","2010","2010/04/20","","","10.1007/s13277-010-0033-9"
"11064896","[Study of survival after cystectomy for bladder cancer. Report of 504 cases]","Lebret T, Hervé JM, Yonneau L, Barré P, Lugagne PM, Butreau M, Molinié V, Botto H.","Prog Urol. 2000 Sep;10(4):553-60.","Lebret T","Prog Urol","2000","2000/11/07","","",""
"26712616","Lymph node dissection in bladder cancer: Where do we stand?","Hugen CM, Daneshmand S.","World J Urol. 2017 Apr;35(4):527-533. doi: 10.1007/s00345-015-1751-9. Epub 2015 Dec 28.","Hugen CM","World J Urol","2017","2015/12/30","","","10.1007/s00345-015-1751-9"
"26600535","Association between MYC rs9642880[T] allele and bladder cancer risk: a meta-analysis","Zhao Y, Qi JG, Yang N, Lin YL, Liang J, Zhu X.","Genet Mol Res. 2015 Nov 23;14(4):14745-51. doi: 10.4238/2015.November.18.39.","Zhao Y","Genet Mol Res","2015","2015/11/25","","","10.4238/2015.November.18.39"
"11577435","[Gadolinium-enhanced MR imaging, T2-weighted MR imaging, and transurethral ultrasonography]","Mizuno K, Sasaki T, Saito Y, Itabashi Y, Miura H, Yodono H, Abe Y, Kawaguchi T.","Nihon Igaku Hoshasen Gakkai Zasshi. 2001 Aug;61(9):496-501.","Mizuno K","Nihon Igaku Hoshasen Gakkai Zasshi","2001","2001/10/02","","",""
"3851009","[Surgical treatment of bladder cancer--indications for various surgical modalities and their clinical outcomes]","Miyagawa M, Yoshida O.","Kango Gijutsu. 1985 Aug;31(11):1418-23.","Miyagawa M","Kango Gijutsu","1985","1985/08/01","","",""
"10233445","Apoptosis and its clinical significance for bladder cancer therapy","Kelly JD, Williamson KE, Irvine AE, Hamilton PW, Weir HP, Anderson NH, Keane PF, Johnston SR.","BJU Int. 1999 Jan;83(1):1-10. doi: 10.1046/j.1464-410x.1999.00871.x.","Kelly JD","BJU Int","1999","1999/05/08","","","10.1046/j.1464-410x.1999.00871.x"
"2021831","Massive scrotal cystocele with bladder cancer","Papadimitriou SH, Chlepas MA, Kokinacos CP, Papadopoulos CB.","Br J Urol. 1991 Mar;67(3):330-1. doi: 10.1111/j.1464-410x.1991.tb15151.x.","Papadimitriou SH","Br J Urol","1991","1991/03/01","","","10.1111/j.1464-410x.1991.tb15151.x"
"29694981","CircRNA-Cdr1as Exerts Anti-Oncogenic Functions in Bladder Cancer by Sponging MicroRNA-135a","Li P, Yang X, Yuan W, Yang C, Zhang X, Han J, Wang J, Deng X, Yang H, Li P, Tao J, Lu Q, Gu M.","Cell Physiol Biochem. 2018;46(4):1606-1616. doi: 10.1159/000489208. Epub 2018 Apr 20.","Li P","Cell Physiol Biochem","2018","2018/04/26","","","10.1159/000489208"
"7370933","The pathology of human bladder cancer","Friedell GH, Parija GC, Nagy GK, Soto EA.","Cancer. 1980 Apr 15;45(7 Suppl):1823-31.","Friedell GH","Cancer","1980","1980/04/15","","",""
"31757294","Role of Indoleamine-2,3-Dioxygenase Inhibitors in Salvage Therapy for Non-Muscle Invasive Bladder Cancer","Chu CE, Porten SP, Grossfeld GD, Meng MV.","Urol Clin North Am. 2020 Feb;47(1):111-118. doi: 10.1016/j.ucl.2019.09.013.","Chu CE","Urol Clin North Am","2020","2019/11/24","","","10.1016/j.ucl.2019.09.013"
"12691100","[HER-2 and TOP2A gene amplification in urinary bladder cancer]","Simon R, Atefy R, Wagner U, Forster T, Fijan A, Bruderer J, Wilber K, Mihatsch M, Gasser T G, Sauter G.","Verh Dtsch Ges Pathol. 2002;86:176-83.","Simon R","Verh Dtsch Ges Pathol","2002","2003/04/15","","",""
"20555063","Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up","Bellmunt J, Orsola A, Maldonado X, Kataja V; ESMO Guidelines Working Group.","Ann Oncol. 2010 May;21 Suppl 5:v134-6. doi: 10.1093/annonc/mdq175.","Bellmunt J","Ann Oncol","2010","2010/06/18","","","10.1093/annonc/mdq175"
"5551015","Aetiological factors in bilharzial bladder cancer","Makhyoun NA, el-Kashlan KM, al-Ghorab MM, Mokhles AS.","J Trop Med Hyg. 1971 Mar;74(3):73-8.","Makhyoun NA","J Trop Med Hyg","1971","1971/03/01","","",""
"16979735","Clinical model of lifetime cost of treating bladder cancer and associated complications","Avritscher EB, Cooksley CD, Grossman HB, Sabichi AL, Hamblin L, Dinney CP, Elting LS.","Urology. 2006 Sep;68(3):549-53. doi: 10.1016/j.urology.2006.03.062. Epub 2006 Sep 18.","Avritscher EB","Urology","2006","2006/09/19","","","10.1016/j.urology.2006.03.062"
"19222609","Establishment and characterization of a new squamous cell carcinoma cell line, TMUU-08, derived from human bladder cancer","Ozu C, Takeuchi H, Matsushita K, Horiguchi Y, Namiki K, Yoshioka K, Nagai T, Tachibana M.","Hum Cell. 2009 Feb;22(1):25-9. doi: 10.1111/j.1749-0774.2008.00064.x.","Ozu C","Hum Cell","2009","2009/02/19","","","10.1111/j.1749-0774.2008.00064.x"
"1434266","[Adjuvant chemotherapy for invasive bladder cancer. Multicenter study]","Fukui I, Gotoh S, Kihara K, Oshima H, Okada K, Tari K, Owada F, Negishi T, Sakai K, Ishiwata D, et al.","Nihon Hinyokika Gakkai Zasshi. 1992 Oct;83(10):1633-9. doi: 10.5980/jpnjurol1989.83.1633.","Fukui I","Nihon Hinyokika Gakkai Zasshi","1992","1992/10/01","","","10.5980/jpnjurol1989.83.1633"
"21849760","Predicting the risk of high-grade bladder cancer using noninvasive data","Shapur N, Pode D, Katz R, Shapiro A, Yutkin V, Pizov G, Appelbaum L, Zorn KC, Duvdevani M, Landau EH, Gofrit ON.","Urol Int. 2011;87(3):319-24. doi: 10.1159/000328635. Epub 2011 Aug 18.","Shapur N","Urol Int","2011","2011/08/19","","","10.1159/000328635"
"4016694","Anticancer drug activity in human bladder tumor cell lines","Niell HB, Webster KC, Smith EE.","Cancer. 1985 Sep 1;56(5):1039-44. doi: 10.1002/1097-0142(19850901)56:5<1039::aid-cncr2820560512>3.0.co;2-3.","Niell HB","Cancer","1985","1985/09/01","","","10.1002/1097-0142(19850901)56:5<1039::aid-cncr2820560512>3.0.co;2-3"
"1556049","Radiotherapy and chemotherapy in invasive bladder cancer with potential bladder sparing","Kaufman DS, Shipley WU, Althausen AF.","Hematol Oncol Clin North Am. 1992 Feb;6(1):179-94.","Kaufman DS","Hematol Oncol Clin North Am","1992","1992/02/01","","",""
"21620497","Patient-specific PTV margins in radiotherapy for bladder cancer - a feasibility study using cone beam CT","Tolan S, Kong V, Rosewall T, Craig T, Bristow R, Milosevic M, Gospodarowicz M, Chung P.","Radiother Oncol. 2011 May;99(2):131-6. doi: 10.1016/j.radonc.2011.04.008. Epub 2011 May 26.","Tolan S","Radiother Oncol","2011","2011/05/31","","","10.1016/j.radonc.2011.04.008"
"2412496","[Hyperthermic treatment with peplomycin and bestatin in superficial bladder cancer]","Kitagawa M, Ushiyama T, Suzuki K, Tajima A, Aso Y.","Gan To Kagaku Ryoho. 1985 Sep;12(9):1820-6.","Kitagawa M","Gan To Kagaku Ryoho","1985","1985/09/01","","",""
"11002231","Bladder cancer: race differences in extent of disease at diagnosis","Prout GR Jr, Wesley MN, Greenberg RS, Chen VW, Brown CC, Miller AW, Weinstein RS, Robboy SJ, Haynes MA, Blacklow RS, Edwards BK.","Cancer. 2000 Sep 15;89(6):1349-58. doi: 10.1002/1097-0142(20000915)89:6<1349::aid-cncr20>3.0.co;2-d.","Prout GR Jr","Cancer","2000","2000/09/26","","","10.1002/1097-0142(20000915)89:6<1349::aid-cncr20>3.0.co;2-d"
"2058072","[Inductive chemotherapy of bladder cancer. A critical evaluation]","Debruyne FM.","Urologe A. 1991 Mar;30(2):81-4.","Debruyne FM","Urologe A","1991","1991/03/01","","",""
"10210403","Leukocytosis associated with and localized bladder cancer: resolution with radiation therapy","Georgilis K, Athanassiades P.","J Urol. 1999 May;161(5):1567.","Georgilis K","J Urol","1999","1999/04/21","","",""
"1960096","Home Bacillus Calmette-Guerin therapy for the treatment of superficial bladder cancer","Giglione L.","Home Healthc Nurse. 1991 Sep-Oct;9(5):50-2. doi: 10.1097/00004045-199109000-00012.","Giglione L","Home Healthc Nurse","1991","1991/09/01","","","10.1097/00004045-199109000-00012"
"1924443","Organ reconstruction and conservation in bladder cancer","Pavone-Macaluso M.","Prog Clin Biol Res. 1991;370:143-5.","Pavone-Macaluso M","Prog Clin Biol Res","1991","1991/01/01","","",""
"8114569","[Treatment of bladder cancer with cytostatic agents]","Steineck G, Wijkström H, Borghede G.","Lakartidningen. 1994 Feb 2;91(5):397-404.","Steineck G","Lakartidningen","1994","1994/02/02","","",""
"24033445","Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer","Ohyama C, Hatakeyama S, Yoneyama T, Koie T.","Int J Urol. 2014 Jan;21(1):3-4. doi: 10.1111/iju.12230. Epub 2013 Aug 22.","Ohyama C","Int J Urol","2014","2013/09/17","","","10.1111/iju.12230"
"7901518","Genetic alterations in bladder cancer","Harrington K, Waxman J.","Lancet. 1993 Nov 6;342(8880):1184-5.","Harrington K","Lancet","1993","1993/11/06","","",""
"21883838","Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy?","Segal R, Yafi FA, Brimo F, Tanguay S, Aprikian A, Kassouf W.","BJU Int. 2012 Apr;109(7):1026-30. doi: 10.1111/j.1464-410X.2011.10462.x. Epub 2011 Aug 24.","Segal R","BJU Int","2012","2011/09/03","","","10.1111/j.1464-410X.2011.10462.x"
"24513883","Porphyrin conjugated with serum albumins and monoclonal antibodies boosts efficiency in targeted destruction of human bladder cancer cells","Pereira PM, Carvalho JJ, Silva S, Cavaleiro JA, Schneider RJ, Fernandes R, Tomé JP.","Org Biomol Chem. 2014 Mar 21;12(11):1804-11. doi: 10.1039/c3ob42082e.","Pereira PM","Org Biomol Chem","2014","2014/02/12","","","10.1039/c3ob42082e"
"8413433","Selective bladder preservation by combination treatment of invasive bladder cancer","Kaufman DS, Shipley WU, Griffin PP, Heney NM, Althausen AF, Efird JT.","N Engl J Med. 1993 Nov 4;329(19):1377-82. doi: 10.1056/NEJM199311043291903.","Kaufman DS","N Engl J Med","1993","1993/11/04","","","10.1056/NEJM199311043291903"
"15126782","A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials","Sylvester RJ, Oosterlinck W, van der Meijden AP.","J Urol. 2004 Jun;171(6 Pt 1):2186-90, quiz 2435. doi: 10.1097/01.ju.0000125486.92260.b2.","Sylvester RJ","J Urol","2004","2004/05/06","","","10.1097/01.ju.0000125486.92260.b2"
"8731915","[The study of p53 gene mutation in human bladder cancer]","Ding Q, Zhang Y, Sun X.","Zhonghua Wai Ke Za Zhi. 1995 Nov;33(11):684-6.","Ding Q","Zhonghua Wai Ke Za Zhi","1995","1995/11/01","","",""
"2163740","[Significance and application of DNA ploidy of bladder cancer cells in studying the malignancy of tumors]","Cao S.","Zhonghua Yi Xue Za Zhi. 1990 Mar;70(3):143-5.","Cao S","Zhonghua Yi Xue Za Zhi","1990","1990/03/01","","",""
"2975863","Association of ABO (H) antigen negative transitional cell tumours with abnormal mucosal biopsies in superficial bladder cancer","Das G.","Arch Ital Urol Nefrol Androl. 1988 Sep;60(3):295-9.","Das G","Arch Ital Urol Nefrol Androl","1988","1988/09/01","","",""
"3656852","[Postoperative adjuvant chemotherapy of bladder cancer. The effects of cisplatin administration on cases with vascular invasion]","Numasawa K, Suzuki H, Kakizaki H, Hirano K, Takamizawa A, Kubota Y, Suzuki K.","Nihon Hinyokika Gakkai Zasshi. 1987 Mar;78(3):489-95.","Numasawa K","Nihon Hinyokika Gakkai Zasshi","1987","1987/03/01","","",""
"6521133","[Studies on tissue blood-group antigens of superficial bladder cancer]","Yamada T, Fukui I, Sekine H, Yokokawa M, Kamiyama R, Inada T, Ishiwata D, Hosoda K, Ariwa R.","Nihon Hinyokika Gakkai Zasshi. 1984 Sep;75(9):1430-6. doi: 10.5980/jpnjurol1928.75.9_1430.","Yamada T","Nihon Hinyokika Gakkai Zasshi","1984","1984/09/01","","","10.5980/jpnjurol1928.75.9_1430"
"3314067","Newer diagnostic techniques for bladder cancer","Carter HB, Amberson JB, Bander NH, Badalament R, Gorelick J, Vaughan ED Jr, Whitmore WF Jr.","Urol Clin North Am. 1987 Nov;14(4):763-9.","Carter HB","Urol Clin North Am","1987","1987/11/01","","",""
"17679457","Incidence of multiple primary bladder and prostate cancer in a central region of Italy. Umbria, 1994-2004","Cassetti T, Scheibel M, Stracci F, Minelli L, La Rosa F.","Tumori. 2007 May-Jun;93(3):242-3.","Cassetti T","Tumori","2007","2007/08/08","","",""
"10943597","Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder","Heicappell R, Schostak M, Müller M, Miller K.","Scand J Clin Lab Invest. 2000 Jul;60(4):275-82. doi: 10.1080/003655100750046431.","Heicappell R","Scand J Clin Lab Invest","2000","2000/08/16","","","10.1080/003655100750046431"
"3111028","The incidence of squamous and transitional cell carcinomas of the urinary bladder in northern Tanzania in areas of high and low levels of endemic Schistosoma haematobium infection","Kitinya JN, Laurèn PA, Eshleman LJ, Paljärvi L, Tanaka K.","Trans R Soc Trop Med Hyg. 1986;80(6):935-9. doi: 10.1016/0035-9203(86)90264-6.","Kitinya JN","Trans R Soc Trop Med Hyg","1986","1986/01/01","","","10.1016/0035-9203(86)90264-6"
"6471651","[A clinicopathological study on urinary bladder cancer. Relation of pathological characteristics to prognosis after total cystectomy]","Kuroda M.","Nihon Hinyokika Gakkai Zasshi. 1984 Mar;75(3):379-90. doi: 10.5980/jpnjurol1928.75.3_379.","Kuroda M","Nihon Hinyokika Gakkai Zasshi","1984","1984/03/01","","","10.5980/jpnjurol1928.75.3_379"
"24007445","Squamous cell carcinoma of the bladder in a female associated with multiple bladder stones","Cho JH, Holley JL.","BMC Res Notes. 2013 Sep 4;6:354. doi: 10.1186/1756-0500-6-354.","Cho JH","BMC Res Notes","2013","2013/09/07","PMC3848612","","10.1186/1756-0500-6-354"
"546732","External irradiation in bladder cancer","Sharma U, Rath GK, Singhal RM, Pant GS, Singh SM.","Indian J Cancer. 1979 Jun;16(2):54-8.","Sharma U","Indian J Cancer","1979","1979/06/01","","",""
"25119986","Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting","Kwon T, Jeong IG, Lee J, Lee C, You D, Hong B, Hong JH, Ahn H, Kim CS.","J Cancer Res Clin Oncol. 2015 Jan;141(1):169-76. doi: 10.1007/s00432-014-1793-1. Epub 2014 Aug 14.","Kwon T","J Cancer Res Clin Oncol","2015","2014/08/15","","","10.1007/s00432-014-1793-1"
"4179176","Cancer of the urogenital tract: bladder cancer. Group 3, stage D, grades 3 and IV: metastatic carcinomas","Rubin P.","JAMA. 1969 Feb 10;207(6):1131.","Rubin P","JAMA","1969","1969/02/10","","",""
"25535001","Bladder cancer: Stem cells repopulate tumours","Phillips R.","Nat Rev Urol. 2015 Feb;12(2):63. doi: 10.1038/nrurol.2014.352. Epub 2014 Dec 23.","Phillips R","Nat Rev Urol","2015","2014/12/24","","","10.1038/nrurol.2014.352"
"22902038","Re: Anobel Y. Odisho, Anna B. Berry, Ardalan E. Ahmad, Matthew R. Cooperberg, Peter R. Carroll, Badrinath R. Konety. Reflex immunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology. Eur urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.019","Prakash J, Goel A, Garg M.","Eur Urol. 2012 Nov;62(5):e87; author reply e88. doi: 10.1016/j.eururo.2012.07.050. Epub 2012 Aug 9.","Prakash J","Eur Urol","2012","2012/08/21","","","10.1016/j.eururo.2012.07.050"
"11834395","Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy?","Pannek J.","Urology. 2002 Feb;59(2):240-4. doi: 10.1016/s0090-4295(01)01495-9.","Pannek J","Urology","2002","2002/02/09","","","10.1016/s0090-4295(01)01495-9"
"23867826","Analyses in human urothelial cells identify methylation of miR-152, miR-200b and miR-10a genes as candidate bladder cancer biomarkers","Köhler CU, Bryk O, Meier S, Lang K, Rozynek P, Brüning T, Käfferlein HU.","Biochem Biophys Res Commun. 2013 Aug 16;438(1):48-53. doi: 10.1016/j.bbrc.2013.07.021. Epub 2013 Jul 16.","Köhler CU","Biochem Biophys Res Commun","2013","2013/07/23","","","10.1016/j.bbrc.2013.07.021"
"29089607","The anti-PD-1 era - an opportunity to enhance radiotherapy for patients with bladder cancer","Walshaw RC, Honeychurch J, Illidge TM, Choudhury A.","Nat Rev Urol. 2018 Apr;15(4):251-259. doi: 10.1038/nrurol.2017.172. Epub 2017 Oct 31.","Walshaw RC","Nat Rev Urol","2018","2017/11/02","","","10.1038/nrurol.2017.172"
"25836937","First-line treatment and prognostic factors of metastatic bladder cancer for platinum-eligible patients","Abida W, Bajorin DF, Rosenberg JE.","Hematol Oncol Clin North Am. 2015 Apr;29(2):319-28, ix-x. doi: 10.1016/j.hoc.2014.10.005. Epub 2014 Dec 15.","Abida W","Hematol Oncol Clin North Am","2015","2015/04/04","","","10.1016/j.hoc.2014.10.005"
"25541350","A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC)","Arcangeli G, Arcangeli S, Strigari L.","Crit Rev Oncol Hematol. 2015 Apr;94(1):105-15. doi: 10.1016/j.critrevonc.2014.11.007. Epub 2014 Dec 4.","Arcangeli G","Crit Rev Oncol Hematol","2015","2014/12/27","","","10.1016/j.critrevonc.2014.11.007"
"1531596","Clinical trials referral resource. Bladder cancer","Cheson BD.","Oncology (Williston Park). 1992 Jan;6(1):105-6.","Cheson BD","Oncology (Williston Park)","1992","1992/01/01","","",""
"6677960","[Introduction to the role of radiotherapy in the management of bladder cancer]","Volterrani F.","Radiol Med. 1983 Nov;69(11):870-1.","Volterrani F","Radiol Med","1983","1983/11/01","","",""
"23211155","Predicting risk of bladder cancer in the UK","Coupland C, Hippisley-Cox J.","Br J Gen Pract. 2012 Nov;62(604):570-1. doi: 10.3399/bjgp12X658160.","Coupland C","Br J Gen Pract","2012","2012/12/06","PMC3481492","","10.3399/bjgp12X658160"
"27157639","Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection","Sasaki H, Yoshiike M, Nozawa S, Usuba W, Katsuoka Y, Aida K, Kitajima K, Kudo H, Hoshikawa M, Yoshioka Y, Kosaka N, Ochiya T, Chikaraishi T.","Clin Genitourin Cancer. 2016 Oct;14(5):e493-e499. doi: 10.1016/j.clgc.2016.04.002. Epub 2016 Apr 9.","Sasaki H","Clin Genitourin Cancer","2016","2016/05/10","","","10.1016/j.clgc.2016.04.002"
"29187445","The Contrasting Role of the Mediator Subunit MED30 in the Progression of Bladder Cancer","Syring I, Weiten R, Müller T, Schmidt D, Steiner S, Kristiansen G, Müller SC, Ellinger J.","Anticancer Res. 2017 Dec;37(12):6685-6695. doi: 10.21873/anticanres.12127.","Syring I","Anticancer Res","2017","2017/12/01","","","10.21873/anticanres.12127"
"11144504","Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor","Takagi Y, Takashi M, Koshikawa T, Sakata T, Ohshima S.","Int J Urol. 2000 Oct;7(10):366-72. doi: 10.1046/j.1442-2042.2000.00212.x.","Takagi Y","Int J Urol","2000","2001/01/06","","","10.1046/j.1442-2042.2000.00212.x"
"19336562","Secondhand smoking, 4-aminobiphenyl, and bladder cancer: two meta-analyses","Van Hemelrijck MJ, Michaud DS, Connolly GN, Kabir Z.","Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1312-20. doi: 10.1158/1055-9965.EPI-08-0613. Epub 2009 Mar 31.","Van Hemelrijck MJ","Cancer Epidemiol Biomarkers Prev","2009","2009/04/02","","","10.1158/1055-9965.EPI-08-0613"
"20071311","[The diagnostic value of microsatellite LOH analysis and the prognostic relevance of angiogenic gene expression in urinary bladder cancer]","Szarvas T.","Magy Onkol. 2009 Dec;53(4):385-9. doi: 10.1556/MOnkol.53.2009.4.8.","Szarvas T","Magy Onkol","2009","2010/01/15","","","10.1556/MOnkol.53.2009.4.8"
"12828164","[Preoperative superselective intra-internal iliac arterial chemotherapy for invasive bladder cancer and curative analysis]","Deng X, Wu Y, Jiang Y, Cong P, Li S.","Zhonghua Wai Ke Za Zhi. 2000 Apr;38(4):278-9.","Deng X","Zhonghua Wai Ke Za Zhi","2000","2003/06/28","","",""
"22078012","A rare bladder cancer--small cell carcinoma: review and update","Ismaili N.","Orphanet J Rare Dis. 2011 Nov 13;6:75. doi: 10.1186/1750-1172-6-75.","Ismaili N","Orphanet J Rare Dis","2011","2011/11/15","PMC3253713","","10.1186/1750-1172-6-75"
"2672231","Role of planned preoperative irradiation in the management of clinical stage B2-C (T3) bladder carcinoma in the 1980s","Parsons JT, Million RR.","Semin Surg Oncol. 1989;5(4):255-65. doi: 10.1002/ssu.2980050408.","Parsons JT","Semin Surg Oncol","1989","1989/01/01","","","10.1002/ssu.2980050408"
"23587507","The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation","Garfield SS, Gavaghan MB, Armstrong SO, Jones JS.","Can J Urol. 2013 Apr;20(2):6682-9.","Garfield SS","Can J Urol","2013","2013/04/17","","",""
"17656209","Primary application study in early diagnosis of bladder cancer by survivin molecular beacons","Zhao J, He D, He H, Li L, Zhang LL, Wang XY.","Urology. 2007 Jul;70(1):60-4. doi: 10.1016/j.urology.2007.03.023.","Zhao J","Urology","2007","2007/07/28","","","10.1016/j.urology.2007.03.023"
"24591208","Aminopeptidase activities as prospective urinary biomarkers for bladder cancer","Taylor JM, Yaneva M, Velasco K, Philip J, Erdjument-Bromage H, Ostrovnaya I, Lilja HG, Bochner BH, Tempst P.","Proteomics Clin Appl. 2014 Jun;8(5-6):317-26. doi: 10.1002/prca.201300118. Epub 2014 Mar 31.","Taylor JM","Proteomics Clin Appl","2014","2014/03/05","PMC4059539","NIHMS584918","10.1002/prca.201300118"
"7165402","[Cancer of the bladder. Diagnosis and staging]","Smith PH, Green DF.","Arch Esp Urol. 1982 Nov-Dec;35(6):376-80.","Smith PH","Arch Esp Urol","1982","1982/11/01","","",""
"20204300","The prognostic value of cadherin switch in bladder cancer","Jäger T, Becker M, Eisenhardt A, Tilki D, Tötsch M, Schmid KW, Romics I, Rübben H, Ergün S, Szarvas T.","Oncol Rep. 2010 Apr;23(4):1125-32. doi: 10.3892/or_00000741.","Jäger T","Oncol Rep","2010","2010/03/06","","","10.3892/or_00000741"
"17445650","Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study","Denzinger S, Burger M, Walter B, Knuechel R, Roessler W, Wieland WF, Filbeck T.","Urology. 2007 Apr;69(4):675-9. doi: 10.1016/j.urology.2006.12.023.","Denzinger S","Urology","2007","2007/04/21","","","10.1016/j.urology.2006.12.023"
"27698389","Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells","Matsumoto R, Tsuda M, Yoshida K, Tanino M, Kimura T, Nishihara H, Abe T, Shinohara N, Nonomura K, Tanaka S.","Sci Rep. 2016 Oct 4;6:34625. doi: 10.1038/srep34625.","Matsumoto R","Sci Rep","2016","2016/10/05","PMC5048132","","10.1038/srep34625"
"7371658","Contribution of angiography in bladder cancer","Thiry AJ, Mathieu J, Brion JP, Struyven J.","Eur Urol. 1980;6(3):139-44. doi: 10.1159/000473312.","Thiry AJ","Eur Urol","1980","1980/01/01","","","10.1159/000473312"
"3376373","[Iatrogenic tumor cell implantation in bladder cancer]","Mack D, Rammal E, Jakse G.","Urologe A. 1988 Mar;27(2):99-104.","Mack D","Urologe A","1988","1988/03/01","","",""
"31030123","Management of metastatic bladder cancer","Nadal R, Bellmunt J.","Cancer Treat Rev. 2019 Jun;76:10-21. doi: 10.1016/j.ctrv.2019.04.002. Epub 2019 Apr 15.","Nadal R","Cancer Treat Rev","2019","2019/04/29","","","10.1016/j.ctrv.2019.04.002"
"7702916","[Conservative treatment of invasive cancers of the bladder with radiotherapy-chemotherapy combination]","Chauvet B, Davin JL, Reboul F.","Bull Cancer Radiother. 1994;81(4):312-9.","Chauvet B","Bull Cancer Radiother","1994","1994/01/01","","",""
"872117","Immunological responsiveness in patients with bladder cancer","Fahey JL, Brosman S, Dorey F.","Cancer Res. 1977 Aug;37(8 Pt 2):2875-8.","Fahey JL","Cancer Res","1977","1977/08/01","","",""
"9072571","Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study","Smith JA Jr, Crawford ED, Paradelo JC, Blumenstein B, Herschman BR, Grossman HB, Christie DW.","J Urol. 1997 Mar;157(3):805-7; discussion 807-8.","Smith JA Jr","J Urol","1997","1997/03/01","","",""
"9854500","Comparison of nuclear matrix protein 22 and bladder tumor antigen in urine of patients with bladder cancer","Abbate I, D'Introno A, Cardo G, Marano A, Addabbo L, Musci MD, Pagliarulo A, Correale M, Quaranta M.","Anticancer Res. 1998 Sep-Oct;18(5B):3803-5.","Abbate I","Anticancer Res","1998","1998/12/17","","",""
"8401632","Prognostic factors in superficial bladder cancer","Chopin DK, Popov Z, Ravery V, Bellot J, Hoznek A, Patard JJ, Abbou CC, Colombel M.","World J Urol. 1993;11(3):148-52. doi: 10.1007/BF00211409.","Chopin DK","World J Urol","1993","1993/01/01","","","10.1007/BF00211409"
"20582546","Photodynamic diagnosis in patients with T1G3 bladder cancer: influence on recurrence rate","Stanislaus P, Zaak D, Stadler T, Tritschler S, Knüchel R, Stief CG, Karl A.","World J Urol. 2010 Aug;28(4):407-11. doi: 10.1007/s00345-010-0574-y. Epub 2010 Jun 26.","Stanislaus P","World J Urol","2010","2010/06/29","","","10.1007/s00345-010-0574-y"
"2389750","Occupational risks of bladder cancer among white women in the United States","Silverman DT, Levin LI, Hoover RN.","Am J Epidemiol. 1990 Sep;132(3):453-61. doi: 10.1093/oxfordjournals.aje.a115680.","Silverman DT","Am J Epidemiol","1990","1990/09/01","","","10.1093/oxfordjournals.aje.a115680"
"9242471","Trends in urinary bladder cancer incidence in Sweden 1960-93 with special reference to histopathology, time period, birth cohort, and smoking","Thörn M, Bergström R, Johansson AM, Ramström L, Persson I, Malmström PU.","Cancer Causes Control. 1997 Jul;8(4):560-7. doi: 10.1023/a:1018486111572.","Thörn M","Cancer Causes Control","1997","1997/07/01","","","10.1023/a:1018486111572"
"3499374","Distribution of alpha-1-antitrypsin and haptoglobin phenotypes in bladder cancer patients","Benkmann HG, Hanssen HP, Ovenbeck R, Goedde HW.","Hum Hered. 1987;37(5):290-3. doi: 10.1159/000153720.","Benkmann HG","Hum Hered","1987","1987/01/01","","","10.1159/000153720"
"4833966","Effects of hyperthermia on bladder cancer","Hall RR, Schade RO, Swinney J.","Br Med J. 1974 Jun 15;2(5919):593-4. doi: 10.1136/bmj.2.5919.593.","Hall RR","Br Med J","1974","1974/06/15","PMC1610802","","10.1136/bmj.2.5919.593"
"6424299","Full-dose irradiation for invasive bladder cancer: prognostic factors and techniques","Shipley WU.","Urology. 1984 Apr;23(4 Suppl):95-100. doi: 10.1016/s0090-4295(84)80077-1.","Shipley WU","Urology","1984","1984/04/01","","","10.1016/s0090-4295(84)80077-1"
"30188332","Tissue biomarkers in nonmuscle-invasive bladder cancer: any role in clinical practice?","Bruchbacher A, Soria F, Hassler M, Shariat SF, D'Andrea D.","Curr Opin Urol. 2018 Nov;28(6):584-590. doi: 10.1097/MOU.0000000000000546.","Bruchbacher A","Curr Opin Urol","2018","2018/09/07","","","10.1097/MOU.0000000000000546"
"458975","Non-papillary carcinoma in situ of the bladder: a clinicopathologic study of 2 cases treated with radical cystoprostatourethrectomy","Kano M, Iwasaki H.","J Urol. 1979 Jul;122(1):116-20. doi: 10.1016/s0022-5347(17)56280-1.","Kano M","J Urol","1979","1979/07/01","","","10.1016/s0022-5347(17)56280-1"
"31757296","Identification of Candidates for Salvage Therapy: The Past, Present, and Future of Defining Bacillus Calmette-Guérin Failure","Becker REN, Kates MR, Bivalacqua TJ.","Urol Clin North Am. 2020 Feb;47(1):15-21. doi: 10.1016/j.ucl.2019.09.004.","Becker REN","Urol Clin North Am","2020","2019/11/24","","","10.1016/j.ucl.2019.09.004"
"18799038","[Clinical value of combined detection with urinary bladder cancer antigen, hyaluronic acid and cytokeratin 20 in diagnosis of bladder cancer]","Pu XY, Wang ZP, Chen YR, Wu YL, Wang HP, Wang XH.","Ai Zheng. 2008 Sep;27(9):970-3.","Pu XY","Ai Zheng","2008","2008/09/19","","",""
"19235432","Intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer","Di Stasi SM, Liberati E, Dutto L, Verri C.","Arch Ital Urol Androl. 2008 Dec;80(4):157-61.","Di Stasi SM","Arch Ital Urol Androl","2008","2009/02/25","","",""
"18301817","Delayed local recurrence following radiation therapy for muscle-invasive bladder cancer emphasizing the need for lifelong surveillance: a case report","Sunkara R, Ayyathurai R, Nieder A, Manoharan M.","ScientificWorldJournal. 2008 Feb 19;8:166-8. doi: 10.1100/tsw.2008.34.","Sunkara R","ScientificWorldJournal","2008","2008/02/28","PMC5848628","","10.1100/tsw.2008.34"
"23754611","[T1 bladder cancer: role of documentation for bladder tumor findings and targeted second resection]","Lazica DA, Böttcher S, Degener S, von Rundstedt FC, Brandt AS, Störkel S, Roth S.","Urologe A. 2013 Aug;52(8):1110-7. doi: 10.1007/s00120-013-3206-5.","Lazica DA","Urologe A","2013","2013/06/12","","","10.1007/s00120-013-3206-5"
"21976419","New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer","Gabriel U, Li L, Bolenz C, Steidler A, Kränzlin B, Saile M, Gretz N, Trojan L, Michel MS.","Mol Carcinog. 2012 Nov;51(11):907-15. doi: 10.1002/mc.20860. Epub 2011 Oct 4.","Gabriel U","Mol Carcinog","2012","2011/10/07","","","10.1002/mc.20860"
"30950446","Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in India","Prakash G, Pal M, Odaiyappan K, Shinde R, Mishra J, Jalde D, Rajkumar B, Prabhash K, Joshi A, Noronha V, Murthy V, Krishnatry R, Desai S, Menon S, Sable N, Popat P, Rangarajan V, Agrawal A, Bakshi G.","Indian J Cancer. 2019 Jan-Mar;56(1):54-58. doi: 10.4103/ijc.IJC_351_18.","Prakash G","Indian J Cancer","2019","2019/04/06","","","10.4103/ijc.IJC_351_18"
"9749075","[Combination of endoscopic resection and external radiotherapy in carcinoma of the bladder]","Kahlain A, Bouras N, Sahraoui S, Acharki A, Benider A, Samlali R.","Cancer Radiother. 1998 Apr;2 Suppl 1:31s-33s.","Kahlain A","Cancer Radiother","1998","1998/09/28","","",""
"23637926","IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer","Chen MF, Lin PY, Wu CF, Chen WC, Wu CT.","PLoS One. 2013 Apr 30;8(4):e61901. doi: 10.1371/journal.pone.0061901. Print 2013.","Chen MF","PLoS One","2013","2013/05/03","PMC3640078","","10.1371/journal.pone.0061901"
"27681756","Adjuvant Chemotherapy Is More Suitable Than Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer Patients Treated With Radical Chemoradiotherapy","Joseph N, Choudhury A.","Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):614-6. doi: 10.1016/j.ijrobp.2016.06.2452.","Joseph N","Int J Radiat Oncol Biol Phys","2016","2016/09/30","","","10.1016/j.ijrobp.2016.06.2452"
"6418897","Does intravesical chemotherapy prevent invasive bladder cancer?","Green DF, Robinson MR, Glashan R, Newling D, Dalesio O, Smith PH.","J Urol. 1984 Jan;131(1):33-5. doi: 10.1016/s0022-5347(17)50180-9.","Green DF","J Urol","1984","1984/01/01","","","10.1016/s0022-5347(17)50180-9"
"16417404","Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique","Langbein S, Lehmann J, Harder A, Steidler A, Michel MS, Alken P, Badawi JK.","Technol Cancer Res Treat. 2006 Feb;5(1):67-72. doi: 10.1177/153303460600500109.","Langbein S","Technol Cancer Res Treat","2006","2006/01/19","","","10.1177/153303460600500109"
"27791991","Impact of surgical margin status on the outcome of bladder cancer treated by radical cystectomy: a meta-analysis","Hong X, Li T, Ling F, Yang D, Hou L, Li F, Tan W.","Oncotarget. 2017 Mar 7;8(10):17258-17269. doi: 10.18632/oncotarget.12907.","Hong X","Oncotarget","2017","2016/10/30","PMC5370038","","10.18632/oncotarget.12907"
"22681672","PET in prostate and bladder tumors","Lee ST, Lawrentschuk N, Scott AM.","Semin Nucl Med. 2012 Jul;42(4):231-46. doi: 10.1053/j.semnuclmed.2012.03.002.","Lee ST","Semin Nucl Med","2012","2012/06/12","","","10.1053/j.semnuclmed.2012.03.002"
"2975828","Tumor markers in bladder cancer","Newling DW.","Arch Ital Urol Nefrol Androl. 1988 Mar;60(1):11-7.","Newling DW","Arch Ital Urol Nefrol Androl","1988","1988/03/01","","",""
"24007431","Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence","Christoforidou EP, Riza E, Kales SN, Hadjistavrou K, Stoltidi M, Kastania AN, Linos A.","J Environ Sci Health A Tox Hazard Subst Environ Eng. 2013;48(14):1764-75. doi: 10.1080/10934529.2013.823329.","Christoforidou EP","J Environ Sci Health A Tox Hazard Subst Environ Eng","2013","2013/09/07","","","10.1080/10934529.2013.823329"
"11974021","BCG immunotherapy for carcinoma of the urinary bladder","Cumisky S.","Nurs Stand. 2000 May 31-Jun 6;14(37):45-7. doi: 10.7748/ns2000.05.14.37.45.c2849.","Cumisky S","Nurs Stand","2000","2002/04/27","","","10.7748/ns2000.05.14.37.45.c2849"
"7926063","Neo-adjuvant chemotherapy and radical irradiation for locally advanced bladder cancer--a phase 2 study","Abratt RP, Pontin AR, Barnes RD.","Eur J Surg Oncol. 1994 Oct;20(5):576-9.","Abratt RP","Eur J Surg Oncol","1994","1994/10/01","","",""
"18778504","Systemic treatment for invasive bladder cancer: neoadjuvant chemotherapy and laparoscopic radical cystectomy","Barret E, Sanchez-Salas R, Vallancien G.","Int Braz J Urol. 2008 Jul-Aug;34(4):513-5. doi: 10.1590/s1677-55382008000400015.","Barret E","Int Braz J Urol","2008","2008/09/10","","","10.1590/s1677-55382008000400015"
"8638379","Chemotherapy for invasive bladder cancer","Malkowicz SB, Vaughn DJ.","Urology. 1996 Apr;47(4):602-14. doi: 10.1016/s0090-4295(99)80506-8.","Malkowicz SB","Urology","1996","1996/04/01","","","10.1016/s0090-4295(99)80506-8"
"7941143","[The function of an artificial bladder made from the intestines]","Galeev RKh, Gaĭnetdinov IM.","Urol Nefrol (Mosk). 1993 Mar-Apr;(2):35-7.","Galeev RKh","Urol Nefrol (Mosk)","1993","1993/03/01","","",""
"27913234","Editorial comment to: Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy for bladder cancer: A meta-analysis","Martini A, Villari D, Nicita G.","Int J Surg. 2017 Jan;37:13-14. doi: 10.1016/j.ijsu.2016.11.137. Epub 2016 Nov 30.","Martini A","Int J Surg","2017","2016/12/04","","","10.1016/j.ijsu.2016.11.137"
"9834529","[Recommendations for the diagnosis, treatment, and follow-up of cancer of the bladder]","Lobel B, Abbou CC, Brausi MA, Flanigan RC, Kameyama S, Scher HI, Caffrey JM, Tachibana M.","Prog Urol. 1998 Sep;8(4):590-2.","Lobel B","Prog Urol","1998","1998/12/03","","",""
"2096771","[Cancer of the bladder: where are we?]","Martínez-Piñeiro JA.","Arch Esp Urol. 1990;43 Suppl 2:109-12.","Martínez-Piñeiro JA","Arch Esp Urol","1990","1990/01/01","","",""
"4067684","Bladder cancer in dye manufacturing workers","Boyko RW, Cartwright RA, Glashan RW.","J Occup Med. 1985 Nov;27(11):799-803. doi: 10.1097/00043764-198511000-00010.","Boyko RW","J Occup Med","1985","1985/11/01","","","10.1097/00043764-198511000-00010"
"1606797","Contrast enhancing lymph nodes in bladder cancer: a potential pitfall on CT","Husband JE, Robinson L, Thomas G.","Clin Radiol. 1992 Jun;45(6):395-8. doi: 10.1016/s0009-9260(05)80998-5.","Husband JE","Clin Radiol","1992","1992/06/01","","","10.1016/s0009-9260(05)80998-5"
"30806186","Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?","Turker P, Segersten U, Malmström PU, Hemdan T.","Scand J Urol. 2019 Feb;53(1):45-50. doi: 10.1080/21681805.2019.1575467. Epub 2019 Feb 26.","Turker P","Scand J Urol","2019","2019/02/27","","","10.1080/21681805.2019.1575467"
"9033605","[Bladder neoplasms and cyclophosphamide. Apropos pf 3 cases amd review of the literature]","Alexandre J, Lévy V, Hunault M, Bazarbachi A, Delmer A, Rio B, Zittoun R.","Bull Cancer. 1996 Nov;83(11):945-50.","Alexandre J","Bull Cancer","1996","1996/11/01","","",""
"26719575","The Role of HMGB1 in Radioresistance of Bladder Cancer","Shrivastava S, Mansure JJ, Almajed W, Cury F, Ferbeyre G, Popovic M, Seuntjens J, Kassouf W.","Mol Cancer Ther. 2016 Mar;15(3):471-9. doi: 10.1158/1535-7163.MCT-15-0581. Epub 2015 Dec 30.","Shrivastava S","Mol Cancer Ther","2016","2016/01/01","","","10.1158/1535-7163.MCT-15-0581"
"21246348","[Plasmacytoid and micropapillary urothelial carcinoma: rare forms of urothelial carcinoma]","Keck B, Stoehr R, Wach S, Rogler A, Nolte E, Hartmann A, Wullich B.","Urologe A. 2011 Feb;50(2):217-20. doi: 10.1007/s00120-010-2484-4.","Keck B","Urologe A","2011","2011/01/20","","","10.1007/s00120-010-2484-4"
"25510376","Management of Node-Positive Bladder Cancer After Neoadjuvant Chemotherapy and Radical Cystectomy: A Survey of Current UK Practice","Tan WS, Lamb BW, Payne H, Hughes S, Green JS, Lane T, Adshead J, Boustead G, Vasdev N.","Clin Genitourin Cancer. 2015 Jun;13(3):e153-8. doi: 10.1016/j.clgc.2014.11.006. Epub 2014 Nov 20.","Tan WS","Clin Genitourin Cancer","2015","2014/12/17","","","10.1016/j.clgc.2014.11.006"
"27026309","Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy","Reddy AV, Pariser JJ, Pearce SM, Weichselbaum RR, Smith ND, Steinberg GD, Liauw SL.","Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1031-9. doi: 10.1016/j.ijrobp.2015.10.051. Epub 2015 Nov 5.","Reddy AV","Int J Radiat Oncol Biol Phys","2016","2016/03/31","","","10.1016/j.ijrobp.2015.10.051"
"8976221","Advances in diagnostic and prognostic markers of bladder cancer","Sufrin G.","J Urol. 1997 Jan;157(1):83-4. doi: 10.1016/s0022-5347(01)65290-x.","Sufrin G","J Urol","1997","1997/01/01","","","10.1016/s0022-5347(01)65290-x"
"24569446","Genetics: what do breast and bladder cancer have in common?","Hutchinson L.","Nat Rev Clin Oncol. 2014 Apr;11(4):179. doi: 10.1038/nrclinonc.2014.33. Epub 2014 Feb 25.","Hutchinson L","Nat Rev Clin Oncol","2014","2014/02/27","","","10.1038/nrclinonc.2014.33"
"597706","A toxicity study of the treatment of T3 bladder tumours with a combination of radiotherapy and chemotherapy","Glashan RW, Houghton AL, Robinson MR.","Br J Urol. 1977;49(7):669-71. doi: 10.1111/j.1464-410x.1977.tb04550.x.","Glashan RW","Br J Urol","1977","1977/01/01","","","10.1111/j.1464-410x.1977.tb04550.x"
"18602605","[Bladder cancers in Senegal: epidemiological, clinical and histological features]","Diao B, Amath T, Fall B, Fall PA, Diémé MJ, Steevy NN, Ndoye AK, Ba M, Mendes V, Diagne BA.","Prog Urol. 2008 Jul;18(7):445-8. doi: 10.1016/j.purol.2008.04.016. Epub 2008 Jun 2.","Diao B","Prog Urol","2008","2008/07/08","","","10.1016/j.purol.2008.04.016"
"1935440","[Inhibitory effect of Chinese herb medicine zhuling on urinary bladder cancer. An experimental and clinical study]","Yang DA.","Zhonghua Wai Ke Za Zhi. 1991 Jun;29(6):393-5, 399.","Yang DA","Zhonghua Wai Ke Za Zhi","1991","1991/06/01","","",""
"10192349","Apoptosis in carcinoma of the bladder: relation with radiation treatment results","Lara PC, Pérez S, Rey A, Santana C.","Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):1015-9. doi: 10.1016/s0360-3016(98)00472-6.","Lara PC","Int J Radiat Oncol Biol Phys","1999","1999/04/07","","","10.1016/s0360-3016(98)00472-6"
"17078324","Using Peplau's theory of interpersonal relations to guide the education of patients undergoing urinary diversion","Marchese K.","Urol Nurs. 2006 Oct;26(5):363-70.","Marchese K","Urol Nurs","2006","2006/11/03","","",""
"26704277","[Urinary diversion in elderly patients]","Spahn M, Boxler S.","Urologe A. 2015 Dec;54(12):1753-7. doi: 10.1007/s00120-015-4010-1.","Spahn M","Urologe A","2015","2015/12/26","","","10.1007/s00120-015-4010-1"
"26229034","The emerging role of the androgen receptor in bladder cancer","Lombard AP, Mudryj M.","Endocr Relat Cancer. 2015 Oct;22(5):R265-77. doi: 10.1530/ERC-15-0209. Epub 2015 Jul 30.","Lombard AP","Endocr Relat Cancer","2015","2015/08/01","","","10.1530/ERC-15-0209"
"29174817","[Bladder cancer in neurogenic patients: A retrospective study of management and follow-up]","Ali P, Lefevre C, Perrouin-Verbe B, Le Normand L, Rigaud J, Bouchot O, Levesque A, Perrouin-Verbe MA.","Prog Urol. 2018 Mar;28(4):215-220. doi: 10.1016/j.purol.2017.10.012. Epub 2017 Nov 23.","Ali P","Prog Urol","2018","2017/11/28","","","10.1016/j.purol.2017.10.012"
"29128420","Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future","Hermans TJN, Voskuilen CS, van der Heijden MS, Schmitz-Dräger BJ, Kassouf W, Seiler R, Kamat AM, Grivas P, Kiltie AE, Black PC, van Rhijn BWG.","Urol Oncol. 2018 Sep;36(9):413-422. doi: 10.1016/j.urolonc.2017.10.014. Epub 2017 Nov 8.","Hermans TJN","Urol Oncol","2018","2017/11/13","","","10.1016/j.urolonc.2017.10.014"
"26804478","The role of PD-L1 in the radiation response and clinical outcome for bladder cancer","Wu CT, Chen WC, Chang YH, Lin WY, Chen MF.","Sci Rep. 2016 Jan 25;6:19740. doi: 10.1038/srep19740.","Wu CT","Sci Rep","2016","2016/01/26","PMC4726250","","10.1038/srep19740"
"23442927","microRNA response elements-regulated TRAIL expression shows specific survival-suppressing activity on bladder cancer","Zhao Y, Li Y, Wang L, Yang H, Wang Q, Qi H, Li S, Zhou P, Liang P, Wang Q, Li X.","J Exp Clin Cancer Res. 2013 Feb 26;32(1):10. doi: 10.1186/1756-9966-32-10.","Zhao Y","J Exp Clin Cancer Res","2013","2013/02/28","PMC3764979","","10.1186/1756-9966-32-10"
"29758961","Exploration of genetics commonness between bladder cancer and breast cancer based on a silcio analysis on disease subtypes","Xu W, Xia H, Liu W, Zheng W, Hua L.","Technol Health Care. 2018;26(S1):361-377. doi: 10.3233/THC-174699.","Xu W","Technol Health Care","2018","2018/05/16","PMC6027900","","10.3233/THC-174699"
"11287448","Gender- and smoking-related bladder cancer risk","Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC.","J Natl Cancer Inst. 2001 Apr 4;93(7):538-45. doi: 10.1093/jnci/93.7.538.","Castelao JE","J Natl Cancer Inst","2001","2001/04/05","","","10.1093/jnci/93.7.538"
"4446471","[Treatment of neglected cancer of the bladder]","Smiltens EE.","Vopr Onkol. 1974;20(12):44-9.","Smiltens EE","Vopr Onkol","1974","1974/01/01","","",""
"9817366","Microsatellite deoxyribonucleic acid analysis to detect bladder cancer in bladder exstrophy","Baker LA, Chow NH, Docimo SG, Gearhart JP, Sidransky D, Schoenberg MP.","J Urol. 1998 Dec;160(6 Pt 1):2192-3. doi: 10.1097/00005392-199812010-00082.","Baker LA","J Urol","1998","1998/11/17","","","10.1097/00005392-199812010-00082"
"8709376","A new staging system for transitional cell carcinoma involvement of the prostate and reconfirmation studies of intravesical therapy for superficial bladder cancer","Hudson MR.","J Urol. 1996 Sep;156(3):972-4. doi: 10.1016/s0022-5347(01)65675-1.","Hudson MR","J Urol","1996","1996/09/01","","","10.1016/s0022-5347(01)65675-1"
"969076","Preoperative irradiation and cystectomy in 135 cases of bladder cancer","Reid EC, Oliver JA, Fishman IJ.","Urology. 1976 Sep;8(3):247-50. doi: 10.1016/0090-4295(76)90377-0.","Reid EC","Urology","1976","1976/09/01","","","10.1016/0090-4295(76)90377-0"
"6890050","[Systemic chemotherapy of bladder cancer]","Seematter RJ.","Helv Chir Acta. 1982 Aug;49(3-4):339-43.","Seematter RJ","Helv Chir Acta","1982","1982/08/01","","",""
"28219587","Management of Bladder Cancer After Renal Transplantation","Demirdag C, Citgez S, Talat Z, Onal B.","Transplant Proc. 2017 Mar;49(2):293-296. doi: 10.1016/j.transproceed.2016.11.039.","Demirdag C","Transplant Proc","2017","2017/02/22","","","10.1016/j.transproceed.2016.11.039"
"9330404","Combined-modality therapy for bladder cancer","McCaffrey JA, Bajorin DF, Scher HI, Bosl GJ.","Oncology (Williston Park). 1997 Sep;11(9 Suppl 9):18-26.","McCaffrey JA","Oncology (Williston Park)","1997","1997/10/23","","",""
"10081854","Transurethral resection with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study--Finnbladder III","Rajala P, Liukkonen T, Raitanen M, Rintala E, Kaasinen E, Helle M, Lukkarinen O.","J Urol. 1999 Apr;161(4):1133-5; discussion 1135-6. doi: 10.1016/s0022-5347(01)61609-4.","Rajala P","J Urol","1999","1999/03/19","","","10.1016/s0022-5347(01)61609-4"
"20860834","Prognostic value of radical cystoprostatectomy in men with bladder cancer infiltrating prostate versus co-existing prostate cancer: a research study","Bryniarski P, Fryczkowski M, Pawlaczek P, Pliszek K, Prokopowicz G, Kaletka Z, Paradysz A.","BMC Urol. 2010 Sep 22;10:16. doi: 10.1186/1471-2490-10-16.","Bryniarski P","BMC Urol","2010","2010/09/24","PMC2954913","","10.1186/1471-2490-10-16"
"25427191","Bladder cancer biomarker array to detect aberrant levels of proteins in urine","Gogalic S, Sauer U, Doppler S, Preininger C.","Analyst. 2015 Feb 7;140(3):724-35. doi: 10.1039/c4an01432d.","Gogalic S","Analyst","2015","2014/11/27","","","10.1039/c4an01432d"
"23946174","Trimodality bladder preservation therapy for muscle-invasive bladder cancer","Chen RC, Shipley WU, Efstathiou JA, Zietman AL.","J Natl Compr Canc Netw. 2013 Aug;11(8):952-60. doi: 10.6004/jnccn.2013.0116.","Chen RC","J Natl Compr Canc Netw","2013","2013/08/16","","","10.6004/jnccn.2013.0116"
"22814883","Indication and timing of cystectomy in high-risk bladder cancer","Lebret T, Neuzillet Y.","Curr Opin Urol. 2012 Sep;22(5):427-31. doi: 10.1097/MOU.0b013e328356ac0a.","Lebret T","Curr Opin Urol","2012","2012/07/21","","","10.1097/MOU.0b013e328356ac0a"
"25794589","[Superficial bladder cancer: Transurethral resection and instillation therapy]","Schenck M, Lümmen G.","Urologe A. 2015 Apr;54(4):499-503. doi: 10.1007/s00120-015-3778-3.","Schenck M","Urologe A","2015","2015/03/22","","","10.1007/s00120-015-3778-3"
"1993277","Clinical significance of the ""palpable mass"" in patients with muscle-infiltrating bladder cancer undergoing cystectomy after pre-operative radiotherapy","Fosså SD, Ous S, Berner A.","Br J Urol. 1991 Jan;67(1):54-60. doi: 10.1111/j.1464-410x.1991.tb15070.x.","Fosså SD","Br J Urol","1991","1991/01/01","","","10.1111/j.1464-410x.1991.tb15070.x"
"15709910","Antisense oligonucleotides in the treatment of bladder cancer","Glackin AJ, Gray SB, Johnston SR, Duggan BJ, Williamson KE.","Expert Opin Biol Ther. 2005 Jan;5(1):67-77. doi: 10.1517/14712598.5.1.67.","Glackin AJ","Expert Opin Biol Ther","2005","2005/02/16","","","10.1517/14712598.5.1.67"
"5465594","[Studies on the chemotherapy of urinary bladder cancer. 3. Studies on the effect of the continuous infusion of anticancer agent into the internal iliac artery on DNA content in cellular nucleus both of human bladder cancer and canine bladder epithelium]","Migita N.","Nihon Hinyokika Gakkai Zasshi. 1970 Jul;61(7):658-72.","Migita N","Nihon Hinyokika Gakkai Zasshi","1970","1970/07/01","","",""
"19557467","[Urine-based diagnostics: an update on the Kiel Tumor Bank]","Hautmann S, Lokeshwar VB, Juenemann KP.","Urologe A. 2009 Jun;48(6):619-24. doi: 10.1007/s00120-009-1991-7.","Hautmann S","Urologe A","2009","2009/06/27","","","10.1007/s00120-009-1991-7"
"10699612","Gender differences in stage distribution of bladder cancer","Mungan NA, Kiemeney LA, van Dijck JA, van der Poel HG, Witjes JA.","Urology. 2000 Mar;55(3):368-71. doi: 10.1016/s0090-4295(99)00481-1.","Mungan NA","Urology","2000","2000/03/04","","","10.1016/s0090-4295(99)00481-1"
"20862387","Mycobacterium bovis bacillus Calmette-Guérin-induced macrophage cytotoxicity against bladder cancer cells","Luo Y, Knudson MJ.","Clin Dev Immunol. 2010;2010:357591. doi: 10.1155/2010/357591. Epub 2010 Sep 1.","Luo Y","Clin Dev Immunol","2010","2010/09/24","PMC2939389","","10.1155/2010/357591"
"18274722","[Diagnosis of urothelial carcinoma]","Karl A, Zaak D, Tilki D, Hungerhuber E, Staehler M, Denzinger S, Stanislaus P, Tritschler S, Strittmatter F, Stief C, Burger M.","Urologe A. 2008 Mar;47(3):357-67. doi: 10.1007/s00120-008-1675-8.","Karl A","Urologe A","2008","2008/02/16","","","10.1007/s00120-008-1675-8"
"21397826","[New concepts in the management of MIBC in 2010]","Pignot G, Molinié V, Coloby P, Culine S, Gravis G, Rossi D, Theodore C, Zerbib M.","Prog Urol. 2011 Mar;21 Suppl 2:S38-42. doi: 10.1016/S1166-7087(11)70008-2.","Pignot G","Prog Urol","2011","2011/03/15","","","10.1016/S1166-7087(11)70008-2"
"17102950","New imaging modalities in bladder cancer","Saksena MA, Dahl DM, Harisinghani MG.","World J Urol. 2006 Nov;24(5):473-80. doi: 10.1007/s00345-006-0118-7.","Saksena MA","World J Urol","2006","2006/11/15","","","10.1007/s00345-006-0118-7"
"3094119","[Radiation therapy combined with hyperthermia in advanced cancer]","Okuma A, Terashima H, Torii Y, Nakata H, Inatomi H.","J UOEH. 1986 Sep 1;8(3):317-21. doi: 10.7888/juoeh.8.317.","Okuma A","J UOEH","1986","1986/09/01","","","10.7888/juoeh.8.317"
"32773802","[Individual control of urine volume to improve stability of bladder volume in radiotherapy of urinary tumor]","Wang H, Jiang SK, Peng R, Huang Y, Wang MQ, Wang JJ, Liu C, Zhang F, Ma LL.","Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Aug 18;52(4):688-691. doi: 10.19723/j.issn.1671-167X.2020.04.017.","Wang H","Beijing Da Xue Xue Bao Yi Xue Ban","2020","2020/08/11","PMC7433637","","10.19723/j.issn.1671-167X.2020.04.017"
"3928553","Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide","Hosaka Y, Muramatsu M, Matsushima T, Niijima T, Nagase S.","Jpn J Cancer Res. 1985 Jul;76(7):577-82.","Hosaka Y","Jpn J Cancer Res","1985","1985/07/01","","",""
"9259092","Treatment strategies using transurethral surgery, chemotherapy, and radiation therapy with selection that safely allows bladder conservation for invasive bladder cancer","Kanady KE, Shipley WU, Zietman AL, Kaufman DS, Althausen AF, Heney NM.","Semin Surg Oncol. 1997 Sep-Oct;13(5):359-64. doi: 10.1002/(sici)1098-2388(199709/10)13:5<359::aid-ssu10>3.0.co;2-i.","Kanady KE","Semin Surg Oncol","1997","1997/09/01","","","10.1002/(sici)1098-2388(199709/10)13:5<359::aid-ssu10>3.0.co;2-i"
"26432963","Epigenetics application in the diagnosis and treatment of bladder cancer","Harb-de la Rosa A, Acker M, Kumar RA, Manoharan M.","Can J Urol. 2015 Oct;22(5):7947-51.","Harb-de la Rosa A","Can J Urol","2015","2015/10/04","","",""
"327705","[Immunologic and clinical parameters in patients with bladder cancer]","Sagaster P, Flamn J, Misksche M.","Wien Med Wochenschr. 1977 May 30;127(10):315-9.","Sagaster P","Wien Med Wochenschr","1977","1977/05/30","","",""
"18008364","Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience","Perdonà S, Autorino R, Damiano R, De Sio M, Morrica B, Gallo L, Silvestro G, Farella A, De Placido S, Di Lorenzo G.","Cancer. 2008 Jan 1;112(1):75-83. doi: 10.1002/cncr.23137.","Perdonà S","Cancer","2008","2007/11/17","","","10.1002/cncr.23137"
"25039565","Obesity and prognosis in muscle-invasive bladder cancer: the continuing controversy","Kwon T, Jeong IG, You D, Han KS, Hong S, Hong B, Hong JH, Ahn H, Kim CS.","Int J Urol. 2014 Nov;21(11):1106-12. doi: 10.1111/iju.12530. Epub 2014 Jul 8.","Kwon T","Int J Urol","2014","2014/07/22","","","10.1111/iju.12530"
"18519668","Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis","Moussa O, Ashton AW, Fraig M, Garrett-Mayer E, Ghoneim MA, Halushka PV, Watson DK.","Cancer Res. 2008 Jun 1;68(11):4097-104. doi: 10.1158/0008-5472.CAN-07-6560.","Moussa O","Cancer Res","2008","2008/06/04","","","10.1158/0008-5472.CAN-07-6560"
"25752555","Adjuvant chemotherapy in locally advanced bladder cancer","Lu K.","Lancet Oncol. 2015 Mar;16(3):e103-4. doi: 10.1016/S1470-2045(15)70028-8.","Lu K","Lancet Oncol","2015","2015/03/11","","","10.1016/S1470-2045(15)70028-8"
"21818919","Prognostic value of apoptotic activity in muscle-invasive bladder cancer","Ristić A, Velicković LJ, Stokanović D.","Vojnosanit Pregl. 2011 Jun;68(6):511-4. doi: 10.2298/vsp1106510r.","Ristić A","Vojnosanit Pregl","2011","2011/08/09","","","10.2298/vsp1106510r"
"3682501","[Effect of immunotherapy on bladder cancer]","Watanabe K, Suzuki T, Takahashi N, Kawaguchi T, Kudo T, Kogawa T, Funyu T.","Nihon Hinyokika Gakkai Zasshi. 1987 Jun;78(6):1092-102. doi: 10.5980/jpnjurol1928.78.6_1092.","Watanabe K","Nihon Hinyokika Gakkai Zasshi","1987","1987/06/01","","","10.5980/jpnjurol1928.78.6_1092"
"3502649","Interleukin-2 in the treatment of infiltrating bladder cancer","Pizza G, Berton F, Casanova S, De Vinci C, Corrado F.","J Exp Pathol. 1987 Summer;3(4):525-31.","Pizza G","J Exp Pathol","1987","1987/01/01","","",""
"11455827","[Selective bladder sparing with transrectal resection of muscle-infiltrating tumors]","Páez Borda A, Luján Galán M, Romero Cajigal I, Llanes González L, Gómez de Vicente JM, Berenguer Sánchez A.","Actas Urol Esp. 2001 Apr;25(4):264-8. doi: 10.1016/s0210-4806(01)72613-7.","Páez Borda A","Actas Urol Esp","2001","2001/07/18","","","10.1016/s0210-4806(01)72613-7"
"30173222","Gender and Mortality after Radical Cystectomy: Competing Risk Analysis","Heberling U, Koch R, Hübler M, Baretton GB, Hakenberg OW, Wirth MP, Froehner M.","Urol Int. 2018;101(3):293-299. doi: 10.1159/000487445. Epub 2018 Aug 31.","Heberling U","Urol Int","2018","2018/09/03","","","10.1159/000487445"
"16686351","[Clinical analysis of double cancer involving bladder and prostate]","Yumura Y, Oogo Y, Takase K, Kato Y, Hamano A, Noguchi S, Fukuda M, Satomi Y.","Hinyokika Kiyo. 2006 Apr;52(4):255-8.","Yumura Y","Hinyokika Kiyo","2006","2006/05/12","","",""
"19924831","Urinary diversion and morbidity after radical cystectomy for bladder cancer","Gore JL, Yu HY, Setodji C, Hanley JM, Litwin MS, Saigal CS; Urologic Diseases in America Project.","Cancer. 2010 Jan 15;116(2):331-9. doi: 10.1002/cncr.24763.","Gore JL","Cancer","2010","2009/11/20","PMC3057123","NIHMS267822","10.1002/cncr.24763"
"14678183","Detection of circulating MUC7-positive cells by reverse transcription-polymerase chain reaction in bladder cancer patients","Kinjo M, Okegawa T, Horie S, Nutahara K, Higashihara E.","Int J Urol. 2004 Jan;11(1):38-43. doi: 10.1111/j.1442-2042.2004.00739.x.","Kinjo M","Int J Urol","2004","2003/12/18","","","10.1111/j.1442-2042.2004.00739.x"
"2359171","Photoinactivation of bladder tumor cells by methylene blue: study of a variety of tumor and normal cells","Yu DS, Chang SY, Ma CP.","J Urol. 1990 Jul;144(1):164-8. doi: 10.1016/s0022-5347(17)39402-8.","Yu DS","J Urol","1990","1990/07/01","","","10.1016/s0022-5347(17)39402-8"
"11333625","[Chlorination of drinking water in Spain and bladder cancer]","Villanueva CM, Kogevinas M, Grimalt JO.","Gac Sanit. 2001 Jan-Feb;15(1):48-53. doi: 10.1016/s0213-9111(01)71517-8.","Villanueva CM","Gac Sanit","2001","2001/05/03","","","10.1016/s0213-9111(01)71517-8"
"15827690","Combined-modality treatment and organ preservation in bladder cancer. Do molecular markers predict outcome?","Weiss C, Rödel F, Wolf I, Papadopoulos T, Engehausen DG, Schrott KM, Sauer R, Rödel C.","Strahlenther Onkol. 2005 Apr;181(4):213-22. doi: 10.1007/s00066-005-1417-4.","Weiss C","Strahlenther Onkol","2005","2005/04/14","","","10.1007/s00066-005-1417-4"
"3632056","[Cutaneous metastasis of bladder cancer]","Moreno E, Ojados F, Pastor FA, Trigueros M.","Arch Esp Urol. 1987 May;40(4):279-80.","Moreno E","Arch Esp Urol","1987","1987/05/01","","",""
"16217395","Urine markers for bladder cancer surveillance: a systematic review","Ratliff TL.","J Urol. 2005 Nov;174(5):2065-6. doi: 10.1016/s0022-5347(01)68890-6.","Ratliff TL","J Urol","2005","2005/10/12","","","10.1016/s0022-5347(01)68890-6"
"9615202","T1 and T2 bladder cancer: selecting optimal therapy","Soloway MS.","Eur Urol. 1998;33 Suppl 4:16-7. doi: 10.1159/000052256.","Soloway MS","Eur Urol","1998","1998/06/06","","","10.1159/000052256"
"14979091","[Skin exposure to carbon black and bladder tumors]","Traversa F, Giacchero F, Giacinti F, Vitto V.","G Ital Med Lav Ergon. 2003 Jul-Sep;25 Suppl(3):75-6.","Traversa F","G Ital Med Lav Ergon","2003","2004/02/26","","",""
"28505504","Standardization of the apparent diffusion coefficient value of bladder cancer across different centers: Applicability in predicting aggressive pathologic phenotypes","Nishizawa T, Yoshida S, Koga F, Tanaka H, Kaga M, Watanabe K, Fukushima H, Nakanishi Y, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K.","Clin Imaging. 2017 Jul-Aug;44:121-126. doi: 10.1016/j.clinimag.2017.05.004. Epub 2017 May 5.","Nishizawa T","Clin Imaging","2017","2017/05/16","","","10.1016/j.clinimag.2017.05.004"
"23124847","Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer","Cha EK, Tirsar LA, Schwentner C, Hennenlotter J, Christos PJ, Stenzl A, Mian C, Martini T, Pycha A, Shariat SF, Schmitz-Dräger BJ.","World J Urol. 2012 Dec;30(6):847-52. doi: 10.1007/s00345-012-0979-x. Epub 2012 Nov 5.","Cha EK","World J Urol","2012","2012/11/06","PMC4004026","NIHMS461667","10.1007/s00345-012-0979-x"
"30838338","Role of adjuvant cisplatin-based chemotherapy following radical cystectomy in locally advanced muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized trials","Kim DK, Lee JY, Jung JH, Hah YS, Cho KS.","Investig Clin Urol. 2019 Mar;60(2):64-74. doi: 10.4111/icu.2019.60.2.64. Epub 2019 Jan 31.","Kim DK","Investig Clin Urol","2019","2019/03/07","PMC6397926","","10.4111/icu.2019.60.2.64"
"9915485","Dominant role of E-cadherin in the progression of bladder cancer","Imao T, Koshida K, Endo Y, Uchibayashi T, Sasaki T, Namiki M.","J Urol. 1999 Feb;161(2):692-8.","Imao T","J Urol","1999","1999/01/23","","",""
"18990160","The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy","Resorlu B, Beduk Y, Baltaci S, Ergun G, Talas H.","BJU Int. 2009 Feb;103(4):480-3. doi: 10.1111/j.1464-410X.2008.08033.x. Epub 2008 Oct 16.","Resorlu B","BJU Int","2009","2008/11/08","","","10.1111/j.1464-410X.2008.08033.x"
"15662605","Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates--the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences","Shipley WU, Zietman AL, Kaufman DS, Coen JJ, Sandler HM.","Semin Radiat Oncol. 2005 Jan;15(1):36-41. doi: 10.1016/j.semradonc.2004.07.008.","Shipley WU","Semin Radiat Oncol","2005","2005/01/22","","","10.1016/j.semradonc.2004.07.008"
"19117038","Continous improvement of TNM staging system for bladder cancer","Ward JF, Margulis V.","Cancer. 2009 Feb 15;115(4):704-5. doi: 10.1002/cncr.24112.","Ward JF","Cancer","2009","2009/01/01","","","10.1002/cncr.24112"
"7893521","Carcinoma of the urinary bladder: long-term results of interstitial radiotherapy","Lybeert ML, Ribot JG, de Neve W, Goor C, Crommelin MA.","Bull Cancer Radiother. 1994;81(1):33-40.","Lybeert ML","Bull Cancer Radiother","1994","1994/01/01","","",""
"26206104","Surgical management of bladder urothelial carcinoma with squamous differentiation","Raman JD, Jafri SM.","Urol Oncol. 2015 Oct;33(10):429-33. doi: 10.1016/j.urolonc.2015.06.010. Epub 2015 Jul 21.","Raman JD","Urol Oncol","2015","2015/07/25","","","10.1016/j.urolonc.2015.06.010"
"10470689","Is neoadjuvant chemotherapy the answer for bladder cancer?","Bartelink H.","Lancet. 1999 Aug 14;354(9178):526-7. doi: 10.1016/S0140-6736(99)00210-X.","Bartelink H","Lancet","1999","1999/09/02","","","10.1016/S0140-6736(99)00210-X"
"2792314","Tobacco smoking, coffee, cocoa and tea consumption in relation to mortality from urinary bladder cancer in Italy","Pannelli F, La Rosa F, Saltalamacchia G, Vitali R, Petrinelli AM, Mastrandrea V.","Eur J Epidemiol. 1989 Sep;5(3):392-7. doi: 10.1007/BF00144843.","Pannelli F","Eur J Epidemiol","1989","1989/09/01","","","10.1007/BF00144843"
"19100600","Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy","Kaufman DS, Winter KA, Shipley WU, Heney NM, Wallace HJ 3rd, Toonkel LM, Zietman AL, Tanguay S, Sandler HM.","Urology. 2009 Apr;73(4):833-7. doi: 10.1016/j.urology.2008.09.036. Epub 2008 Dec 18.","Kaufman DS","Urology","2009","2008/12/23","","","10.1016/j.urology.2008.09.036"
"25763447","Words of wisdom. Re: prognostic factors and risk groups in T1G3 non–muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients","Lotan Y.","Eur Urol. 2014 Nov;66(5):968-9. doi: 10.1016/j.eururo.2014.08.032.","Lotan Y","Eur Urol","2014","2015/03/13","","","10.1016/j.eururo.2014.08.032"
"22237233","Squamous cell carcinoma in exstrophic unreconstructed urinary bladder in an adult","Bansal P, Gupta A, Mongha R, Kundu AK.","Saudi J Kidney Dis Transpl. 2012 Jan;23(1):122-4.","Bansal P","Saudi J Kidney Dis Transpl","2012","2012/01/13","","",""
"24362884","Gender-specific survival following radical cystectomy for pT4 bladder cancer","Kaushik D, Frank I, Eisenberg MS, Cheville JC, Tarrell R, Thapa P, Thompson RH, Boorjian SA.","World J Urol. 2014 Dec;32(6):1433-9. doi: 10.1007/s00345-013-1232-y. Epub 2013 Dec 21.","Kaushik D","World J Urol","2014","2013/12/24","","","10.1007/s00345-013-1232-y"
"22507415","Challenges in non-muscle invasive bladder cancer: lessons from a regional review","Siddins MT, Wong VV, Fitzgerald JT, Bamberg LJ.","ANZ J Surg. 2011 Dec;81(12):889-94. doi: 10.1111/j.1445-2197.2011.05894.x. Epub 2011 Nov 10.","Siddins MT","ANZ J Surg","2011","2012/04/18","","","10.1111/j.1445-2197.2011.05894.x"
"30981463","[Care of advanced or metastatic bladder cancer in second line: A specific place for vinflunine]","Houédé N, Milano G.","Bull Cancer. 2019 May;106(5):431-435. doi: 10.1016/j.bulcan.2019.02.007. Epub 2019 Apr 10.","Houédé N","Bull Cancer","2019","2019/04/15","","","10.1016/j.bulcan.2019.02.007"
"16617879","[The recurrence of urothelial carcinoma in situ at the fossa navicularis of the urethra and the glans penis arising eight years after transurethral resection of a bladder tumor to treat superficial bladder cancer]","Nishizawa S, Inagaki T, Mori T, Kohjimoto Y, Suzuki A, Uekado Y, Shinka T.","Hinyokika Kiyo. 2006 Mar;52(3):223-6.","Nishizawa S","Hinyokika Kiyo","2006","2006/04/19","","",""
"11687012","Surgery versus radiotherapy for muscle invasive bladder cancer","Shelley MD, Barber J, Mason MD.","Cochrane Database Syst Rev. 2001;(3):CD002079. doi: 10.1002/14651858.CD002079.","Shelley MD","Cochrane Database Syst Rev","2001","2001/11/01","","","10.1002/14651858.CD002079"
"10901372","Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information","Popov Z, Gil-Diez de Medina S, Lefrere-Belda MA, Hoznek A, Bastuji-Garin S, Abbou CC, Thiery JP, Radvanyi F, Chopin DK.","Br J Cancer. 2000 Jul;83(2):209-14. doi: 10.1054/bjoc.2000.1233.","Popov Z","Br J Cancer","2000","2000/07/20","PMC2363483","","10.1054/bjoc.2000.1233"
"29717908","Comparison of GreenLight Laser Photoselective Vaporization and Thulium Laser Enucleation for Nonmuscle Invasive Bladder Cancer","Lu M, Liu X.","Photomed Laser Surg. 2018 Jul;36(7):383-385. doi: 10.1089/pho.2018.4440. Epub 2018 May 2.","Lu M","Photomed Laser Surg","2018","2018/05/03","","","10.1089/pho.2018.4440"
"17430648","[Establishment and application of an orthotopic murine bladder cancer model]","Yang SM, Wen DG, Hou JQ, He J, Cen JN, Chen JH.","Ai Zheng. 2007 Apr;26(4):341-5.","Yang SM","Ai Zheng","2007","2007/04/14","","",""
"9143031","Comments regarding the American Association of Directors of Anatomic and Surgical Pathology (ADASP) recommendations for the reporting of urinary bladder specimens containing bladder neoplasms: comparison with the Japanese General Rule for Clinical and Pathological Studies on Bladder Cancer","Kishi K.","Pathol Int. 1997 May;47(5):332. doi: 10.1111/j.1440-1827.1997.tb04503.x.","Kishi K","Pathol Int","1997","1997/05/01","","","10.1111/j.1440-1827.1997.tb04503.x"
"1561948","[Neoadjuvant intra-arterial chemotherapy followed by partial cystectomy for invasive bladder cancer]","Sekine H, Mine M, Ohya K, Kaneoya F, Yokokawa M.","Hinyokika Kiyo. 1992 Feb;38(2):155-9.","Sekine H","Hinyokika Kiyo","1992","1992/02/01","","",""
"20922798","Bladder cancer and BCG response prediction: what we must know?","Cai T, Malossini G.","Cancer. 2011 Feb 15;117(4):872; author reply 872-3. doi: 10.1002/cncr.25400. Epub 2010 Oct 4.","Cai T","Cancer","2011","2010/10/06","","","10.1002/cncr.25400"
"11696721","Familial bladder cancer in the National Swedish Family Cancer Database","Plna K, Hemminki K.","J Urol. 2001 Dec;166(6):2129-33.","Plna K","J Urol","2001","2001/11/07","","",""
"12547718","Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome","Sanchez-Carbayo M, Capodieci P, Cordon-Cardo C.","Am J Pathol. 2003 Feb;162(2):609-17. doi: 10.1016/S0002-9440(10)63854-0.","Sanchez-Carbayo M","Am J Pathol","2003","2003/01/28","PMC1851149","","10.1016/S0002-9440(10)63854-0"
"872114","Development of tissue culture procedures for predicting the individual risk of recurrence in bladder cancer","Leighton J, Abaza N, Tchao R, Geisinger K, Valentich J.","Cancer Res. 1977 Aug;37(8 Pt 2):2854-9.","Leighton J","Cancer Res","1977","1977/08/01","","",""
"23906146","Hybrid discrete-continuous model of invasive bladder cancer","Kashdan E, Bunimovich-Mendrazitsky S.","Math Biosci Eng. 2013 Jun;10(3):729-42. doi: 10.3934/mbe.2013.10.729.","Kashdan E","Math Biosci Eng","2013","2013/08/03","","","10.3934/mbe.2013.10.729"
"12704444","Diabetes mellitus and bladder cancer--an epidemiological relationship?","Ng Y, Husain I, Waterfall N.","Pathol Oncol Res. 2003;9(1):30-1. doi: 10.1007/BF03033711. Epub 2003 Apr 18.","Ng Y","Pathol Oncol Res","2003","2003/04/22","","","10.1007/BF03033711"
"3362911","Assessment of quality of life in long-term survivors treated by first-line intravenous cisplatin for invasive bladder cancer","Raghavan D, Grundy R, Lancaster L.","Prog Clin Biol Res. 1988;260:625-31.","Raghavan D","Prog Clin Biol Res","1988","1988/01/01","","",""
"28586371","Opium and bladder cancer: A systematic review and meta-analysis of the odds ratios for opium use and the risk of bladder cancer","Afshari M, Janbabaei G, Bahrami MA, Moosazadeh M.","PLoS One. 2017 Jun 6;12(6):e0178527. doi: 10.1371/journal.pone.0178527. eCollection 2017.","Afshari M","PLoS One","2017","2017/06/07","PMC5460843","","10.1371/journal.pone.0178527"
"2074515","Voided urine flow cytometry in screening high-risk patients for the presence of bladder cancer","Hermansen DK, Badalament RA, Bretton PR, Kimmel M, Aswad CM, Whitmore WF Jr, Melamed MR.","J Occup Med. 1990 Sep;32(9):894-7. doi: 10.1097/00043764-199009000-00028.","Hermansen DK","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00028"
"11801625","Tobacco smoking and bladder cancer in coffee non-drinkers","Pelucchi C, Tavani A, Negri E, Franceschi S, La Vecchia C.","J Epidemiol Community Health. 2002 Jan;56(1):78-9. doi: 10.1136/jech.56.1.78.","Pelucchi C","J Epidemiol Community Health","2002","2002/01/22","PMC1732005","","10.1136/jech.56.1.78"
"7354513","Detection of urinary cancer with urinalysis sediment","Holmquist ND.","J Urol. 1980 Feb;123(2):188-9. doi: 10.1016/s0022-5347(17)55847-4.","Holmquist ND","J Urol","1980","1980/02/01","","","10.1016/s0022-5347(17)55847-4"
"7550798","Bladder cancer among French farmers: does exposure to pesticides in vineyards play a part?","Viel JF, Challier B.","Occup Environ Med. 1995 Sep;52(9):587-92. doi: 10.1136/oem.52.9.587.","Viel JF","Occup Environ Med","1995","1995/09/01","PMC1128311","","10.1136/oem.52.9.587"
"16379317","[Assessment of 8-hydroxy-2'-deoxyguanosine concentrations in bladder cancer patients treated with intravesical BCG instillation]","Kaczmarek P, Błaszczyk J, Fijałkowski P, Sierakowska-Fijałek A, Niemirowicz J, Kasprzak A, Baj Z.","Pol Merkur Lekarski. 2005 Oct;19(112):526-8.","Kaczmarek P","Pol Merkur Lekarski","2005","2005/12/29","","",""
"2920262","Concurrent adriamycin and radiotherapy in locally advanced bladder cancer","Jakse G, Fritsch E, Frommhold H.","Br J Urol. 1989 Jan;63(1):64-7. doi: 10.1111/j.1464-410x.1989.tb05125.x.","Jakse G","Br J Urol","1989","1989/01/01","","","10.1111/j.1464-410x.1989.tb05125.x"
"2473237","[Fundamental studies on intravesical instillation of interferons in the treatment of bladder cancer]","Hara M.","Nihon Hinyokika Gakkai Zasshi. 1989 Feb;80(2):158-66. doi: 10.5980/jpnjurol1989.80.158.","Hara M","Nihon Hinyokika Gakkai Zasshi","1989","1989/02/01","","","10.5980/jpnjurol1989.80.158"
"28453896","Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy","Huddart RA, Birtle A, Maynard L, Beresford M, Blazeby J, Donovan J, Kelly JD, Kirkbank T, McLaren DB, Mead G, Moynihan C, Persad R, Scrase C, Lewis R, Hall E.","BJU Int. 2017 Nov;120(5):639-650. doi: 10.1111/bju.13900. Epub 2017 May 29.","Huddart RA","BJU Int","2017","2017/04/29","PMC5655733","","10.1111/bju.13900"
"15708040","Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey","Yoshimura K, Utsunomiya N, Ichioka K, Matsui Y, Terai A, Arai Y.","Urology. 2005 Feb;65(2):290-4. doi: 10.1016/j.urology.2004.09.050.","Yoshimura K","Urology","2005","2005/02/15","","","10.1016/j.urology.2004.09.050"
"7529427","Prognosis in bladder cancer. A study of cytometric, morphometric and immunohistochemical techniques","Vaskó J.","Scand J Urol Nephrol Suppl. 1994;160:1-73.","Vaskó J","Scand J Urol Nephrol Suppl","1994","1994/01/01","","",""
"2264199","[The free amino acid content of the blood serum in bladder cancer patients]","Nechiporenko NA, Nefedov LI, Klimovich II.","Urol Nefrol (Mosk). 1990 Sep-Oct;(5):17-20.","Nechiporenko NA","Urol Nefrol (Mosk)","1990","1990/09/01","","",""
"16753451","Re: Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy","Palou J, Rodríguez O, Segarra J, Rosales A.","J Urol. 2006 Jul;176(1):407; author reply 407-8. doi: 10.1016/S0022-5347(06)00593-3.","Palou J","J Urol","2006","2006/06/07","","","10.1016/S0022-5347(06)00593-3"
"1003671","Klinefelter's syndrome and bladder cancer","Fujita K, Fujita HM.","J Urol. 1976 Dec;116(6):836-7. doi: 10.1016/s0022-5347(17)59040-0.","Fujita K","J Urol","1976","1976/12/01","","","10.1016/s0022-5347(17)59040-0"
"17921969","The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer","Witjes JA, Douglass J.","Nat Clin Pract Urol. 2007 Oct;4(10):542-9. doi: 10.1038/ncpuro0917.","Witjes JA","Nat Clin Pract Urol","2007","2007/10/09","","","10.1038/ncpuro0917"
"27898096","On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer","Yamashita H, Amponsa VO, Warrick JI, Zheng Z, Clark PE, Raman JD, Wu XR, Mendelsohn C, DeGraff DJ.","Nat Rev Urol. 2017 Feb;14(2):98-106. doi: 10.1038/nrurol.2016.239. Epub 2016 Nov 29.","Yamashita H","Nat Rev Urol","2017","2016/11/30","","","10.1038/nrurol.2016.239"
"30677457","The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic Hematuria","Gonzalez AN, Lipsky MJ, Li G, Rutman MP, Cooper KL, Weiner DM, Badalato G, Decastro GJ, Wenske S, McKiernan JM, Anderson CB.","Urology. 2019 Apr;126:34-38. doi: 10.1016/j.urology.2019.01.011. Epub 2019 Jan 22.","Gonzalez AN","Urology","2019","2019/01/25","","","10.1016/j.urology.2019.01.011"
"15939524","Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration","Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.","Eur Urol. 2005 Aug;48(2):202-5; discussion 205-6. doi: 10.1016/j.eururo.2005.04.006. Epub 2005 Apr 21.","Advanced Bladder Cancer (ABC) Meta-analysis Collaboration","Eur Urol","2005","2005/06/09","","","10.1016/j.eururo.2005.04.006"
"21176080","Does the presence of muscularis propria on transurethral resection of bladder tumour specimens affect the rate of upstaging in cT1 bladder cancer?","Badalato G, Patel T, Hruby G, McKiernan J.","BJU Int. 2011 Oct;108(8):1292-6. doi: 10.1111/j.1464-410X.2010.09893.x. Epub 2010 Dec 22.","Badalato G","BJU Int","2011","2010/12/24","","","10.1111/j.1464-410X.2010.09893.x"
"23352372","Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer","Lambert JW, Ingham M, Gibbs BB, Given RW, Lance RS, Riggs SB.","Urology. 2013 Mar;81(3):587-92. doi: 10.1016/j.urology.2012.10.055. Epub 2013 Jan 24.","Lambert JW","Urology","2013","2013/01/29","","","10.1016/j.urology.2012.10.055"
"10037372","The impact of primary stage on survival in patients with lymph node positive bladder cancer","Vieweg J, Gschwend JE, Herr HW, Fair WR.","J Urol. 1999 Jan;161(1):72-6.","Vieweg J","J Urol","1999","1999/02/26","","",""
"2274796","Nursing aspects of bacillus Calmette-Guerin immunotherapy for superficial bladder cancer","LeBouton J.","Urol Nurs. 1990 Dec;10(4):9-14.","LeBouton J","Urol Nurs","1990","1990/12/01","","",""
"30922688","Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study","Ueno Y, Takeuchi M, Tamada T, Sofue K, Takahashi S, Kamishima Y, Hinata N, Harada K, Fujisawa M, Murakami T.","Eur Urol. 2019 Jul;76(1):54-56. doi: 10.1016/j.eururo.2019.03.012. Epub 2019 Mar 26.","Ueno Y","Eur Urol","2019","2019/03/30","","","10.1016/j.eururo.2019.03.012"
"8128741","Production of tumor necrosis factor by intravesical administration of bacillus Calmette Guérin in patients with superficial bladder cancer","Kim CI, Shin JS, Kim HI, Lee JM, Kim SJ.","Yonsei Med J. 1993 Dec;34(4):356-64. doi: 10.3349/ymj.1993.34.4.356.","Kim CI","Yonsei Med J","1993","1993/12/01","","","10.3349/ymj.1993.34.4.356"
"30355276","Preadmission antidepressant use and bladder cancer: a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes","Steffensen EH, Cary C, Jensen JB, Larsson H, Weiner M, Nørgaard M.","BMC Cancer. 2018 Oct 24;18(1):1035. doi: 10.1186/s12885-018-4939-8.","Steffensen EH","BMC Cancer","2018","2018/10/26","PMC6201496","","10.1186/s12885-018-4939-8"
"2103372","DNA ploidy analysis of invasive bladder cancer by flow cytometry","Badalament RA, Smith JJ, Franklin GL, Drago JR.","In Vivo. 1990 Jul-Aug;4(4):269-72.","Badalament RA","In Vivo","1990","1990/07/01","","",""
"10212789","[Preoperative balloon occluded arterial infusion chemotherapy for locally invasive bladder cancer--accurate staging for bladder preservation]","Hayashi N, Arima K, Kawamura J, Tochigi H.","Hinyokika Kiyo. 1999 Feb;45(2):139-43.","Hayashi N","Hinyokika Kiyo","1999","1999/04/23","","",""
"309205","[Influence of T-lymphocytes in bladder cancer on appearance and infiltration of recurrences (author's transl)]","Stöber U.","Urologe A. 1978 Sep;17(5):296-302.","Stöber U","Urologe A","1978","1978/09/01","","",""
"22593481","Comparative analysis of sensitivity to blood in the urine for urine-based point-of-care assays (UBC rapid, NMP22 BladderChek and BTA-stat) in primary diagnosis of bladder carcinoma. Interference of blood on the results of urine-based POC tests","Lüdecke G, Pilatz A, Hauptmann A, Bschleipfer T, Weidner W.","Anticancer Res. 2012 May;32(5):2015-8.","Lüdecke G","Anticancer Res","2012","2012/05/18","","",""
"29125888","Circular RNA hsa_circ_0003221 (circPTK2) promotes the proliferation and migration of bladder cancer cells","Xu ZQ, Yang MG, Liu HJ, Su CQ.","J Cell Biochem. 2018 Apr;119(4):3317-3325. doi: 10.1002/jcb.26492. Epub 2017 Dec 26.","Xu ZQ","J Cell Biochem","2018","2017/11/11","","","10.1002/jcb.26492"
"18815926","Bladder cancer subtypes defined by genomic alterations","Knowles MA.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):116-30. doi: 10.1080/03008880802284605.","Knowles MA","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802284605"
"21142890","Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers","Schwamborn K, Gaisa NT, Henkel C.","Expert Rev Proteomics. 2010 Dec;7(6):897-906. doi: 10.1586/epr.10.82.","Schwamborn K","Expert Rev Proteomics","2010","2010/12/15","","","10.1586/epr.10.82"
"6655413","Cigarette smoking and bladder cancer: an epidemiological inquiry in West Yorkshire","Cartwright RA, Adib R, Appleyard I, Glashan RW, Gray B, Hamilton-Stewart PA, Robinson M, Barham-Hall D.","J Epidemiol Community Health. 1983 Dec;37(4):256-63. doi: 10.1136/jech.37.4.256.","Cartwright RA","J Epidemiol Community Health","1983","1983/12/01","PMC1052920","","10.1136/jech.37.4.256"
"28263495","Neutrophil-to-lymphocyte ratio is elevated in recurringnonmuscle invasive bladder cancer","Yürük E, Saitz TR, Gönültaş S, Şerefoğlu EC, Müslümanoğlu AY.","Turk J Med Sci. 2017 Feb 27;47(1):234-239. doi: 10.3906/sag-1509-73.","Yürük E","Turk J Med Sci","2017","2017/03/07","","","10.3906/sag-1509-73"
"9749087","[Chemotherapy of metastatic cancer of the bladder. Apropos of 50 patients treated with M-VAC]","Beuzeboc P, Dhote R, Thiounn N, Flam T, Zerbib M, Debré B, Pouillart P.","Cancer Radiother. 1998 Apr;2 Suppl 1:92s-96s.","Beuzeboc P","Cancer Radiother","1998","1998/09/28","","",""
"11776861","[Transurethral microwave tissue coagulation therapy for carcinoma of urinary bladder: an analysis of 35 patients]","Wu Z, Lu H, Luo S.","Zhonghua Zhong Liu Za Zhi. 1999 Mar;21(2):148-50.","Wu Z","Zhonghua Zhong Liu Za Zhi","1999","2002/01/05","","",""
"455288","Inhibition of N-n-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in rats by administration of disulfiram in the diet","Irving CC, Tice AJ, Murphy WM.","Cancer Res. 1979 Aug;39(8):3040-3.","Irving CC","Cancer Res","1979","1979/08/01","","",""
"29673806","The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients","Racioppi M, Di Gianfrancesco L, Ragonese M, Palermo G, Sacco E, Bassi P.","J Geriatr Oncol. 2018 Sep;9(5):507-512. doi: 10.1016/j.jgo.2018.03.020. Epub 2018 Apr 16.","Racioppi M","J Geriatr Oncol","2018","2018/04/21","","","10.1016/j.jgo.2018.03.020"
"9675952","Cytofluorimetric evaluation of DNA ploidy in the diagnosis of bladder cancer","Armone S, Voce S, dal Pozzo C, Severini G, Montanari F, Monti G, Tavolazzi L.","Arch Esp Urol. 1998 Jun;51(5):507-10.","Armone S","Arch Esp Urol","1998","1998/07/24","","",""
"11905689","Proteomics may aid bladder cancer diagnosis","Sansom C.","Lancet Oncol. 2000 Sep;1(1):5. doi: 10.1016/S1470-2045(00)00042-5.","Sansom C","Lancet Oncol","2000","2002/03/22","","","10.1016/S1470-2045(00)00042-5"
"7817480","Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer","Angulo JC, Lopez JI, Grignon DJ, Sanchez-Chapado M.","Urology. 1995 Jan;45(1):47-53. doi: 10.1016/s0090-4295(95)96490-8.","Angulo JC","Urology","1995","1995/01/01","","","10.1016/s0090-4295(95)96490-8"
"9815751","Translational studies of glutathione in bladder cancer cell lines and human specimens","Pendyala L, Velagapudi S, Toth K, Zdanowicz J, Glaves D, Slocum H, Perez R, Huben R, Creaven PJ, Raghavan D.","Clin Cancer Res. 1997 May;3(5):793-8.","Pendyala L","Clin Cancer Res","1997","1997/05/01","","",""
"27317490","Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer","Chedgy EC, Douglas J, Wright JL, Seiler R, van Rhijn BW, Boormans J, Todenhöfer T, Dinney CP, Collins CC, Van der Heijden MS, Black PC.","Urol Oncol. 2016 Oct;34(10):469-76. doi: 10.1016/j.urolonc.2016.05.012. Epub 2016 Jun 15.","Chedgy EC","Urol Oncol","2016","2016/06/19","","","10.1016/j.urolonc.2016.05.012"
"3606146","[Analysis of bladder cancer-associated antigens and their application to diagnosis]","Masuko T, Hashimoto Y.","Gan To Kagaku Ryoho. 1987 Jun;14(6 Pt 2):2191-7.","Masuko T","Gan To Kagaku Ryoho","1987","1987/06/01","","",""
"9554340","The molecular characteristics of bladder cancer in young patients","Linn JF, Sesterhenn I, Mostofi FK, Schoenberg M.","J Urol. 1998 May;159(5):1493-6. doi: 10.1097/00005392-199805000-00022.","Linn JF","J Urol","1998","1998/04/29","","","10.1097/00005392-199805000-00022"
"24815071","Inhibition of autophagy potentiates atorvastatin-induced apoptotic cell death in human bladder cancer cells in vitro","Kang M, Jeong CW, Ku JH, Kwak C, Kim HH.","Int J Mol Sci. 2014 May 8;15(5):8106-21. doi: 10.3390/ijms15058106.","Kang M","Int J Mol Sci","2014","2014/05/13","PMC4057722","","10.3390/ijms15058106"
"11690547","Gene therapy for bladder cancer using adenoviral vector","Wada Y, Gotoh A, Shirakawa T, Hamada K, Kamidono S.","Mol Urol. 2001 Summer;5(2):47-52. doi: 10.1089/109153601300177547.","Wada Y","Mol Urol","2001","2001/11/03","","","10.1089/109153601300177547"
"23645739","Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro","Zhang N, Ye L, Wu L, Deng X, Yang Y, Jiang WG.","Anticancer Res. 2013 May;33(5):1917-25.","Zhang N","Anticancer Res","2013","2013/05/07","","",""
"30382619","Circulating miRNA panels for specific and early detection in bladder cancer","Usuba W, Urabe F, Yamamoto Y, Matsuzaki J, Sasaki H, Ichikawa M, Takizawa S, Aoki Y, Niida S, Kato K, Egawa S, Chikaraishi T, Fujimoto H, Ochiya T.","Cancer Sci. 2019 Jan;110(1):408-419. doi: 10.1111/cas.13856. Epub 2018 Dec 12.","Usuba W","Cancer Sci","2019","2018/11/02","PMC6317958","","10.1111/cas.13856"
"21617220","Experimental study of the anticancer effect of gemcitabine combined with sirolimus on chemically induced urothelial lesions","Vasconcelos-Nóbrega C, Colaço A, Santos L, Vala H, Palomino LF, Lopes C, Oliveira PA.","Anticancer Res. 2011 May;31(5):1637-42.","Vasconcelos-Nóbrega C","Anticancer Res","2011","2011/05/28","","",""
"15606332","Treatment of muscle-invasive bladder cancer: progress and new challenges","Herring JC, Kamat AM.","Expert Rev Anticancer Ther. 2004 Dec;4(6):1047-56. doi: 10.1586/14737140.4.6.1047.","Herring JC","Expert Rev Anticancer Ther","2004","2004/12/21","","","10.1586/14737140.4.6.1047"
"23474117","Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer","Coen JJ, Paly JJ, Niemierko A, Kaufman DS, Heney NM, Spiegel DY, Efstathiou JA, Zietman AL, Shipley WU.","Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):311-6. doi: 10.1016/j.ijrobp.2013.01.020. Epub 2013 Mar 6.","Coen JJ","Int J Radiat Oncol Biol Phys","2013","2013/03/12","","","10.1016/j.ijrobp.2013.01.020"
"26237821","[BILATERAL NEPHROURETERECTOMY WITH CYSTOPROSTATECTOMY AD BLOC AND LYMPHADENECTOMY IN A PATIENT WITH END-STAGE RENAL FAILURE AND CANCER OF THE URINARY BLADDER T2BN0M0]","Vtorenko VI, Trushkin RN, Lubennikov AE, Podkorytova OL, Motin PI.","Urologiia. 2015 Mar-Apr;(2):126-9.","Vtorenko VI","Urologiia","2015","2015/08/05","","",""
"11248651","Preferential gene transfer to BBN-induced rat bladder tumor by simple instillation of adenoviral vector","Shimizu H, Akasaka S, Suzuki S, Akimoto M, Shimada T.","Urology. 2001 Mar;57(3):579-84. doi: 10.1016/s0090-4295(00)01008-6.","Shimizu H","Urology","2001","2001/03/15","","","10.1016/s0090-4295(00)01008-6"
"9293753","[Urethral recurrence of bladder cancer 16 years after total cystectomy. A case report]","Takayama H, Arai Y, Meguro N, Maeda O, Saiki S, Kinouchi T, Kuroda M, Usami M, Kotake T.","Nihon Hinyokika Gakkai Zasshi. 1997 Aug;88(8):762-5. doi: 10.5980/jpnjurol1989.88.762.","Takayama H","Nihon Hinyokika Gakkai Zasshi","1997","1997/08/01","","","10.5980/jpnjurol1989.88.762"
"23350856","Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies","Ferwana M, Firwana B, Hasan R, Al-Mallah MH, Kim S, Montori VM, Murad MH.","Diabet Med. 2013 Sep;30(9):1026-32. doi: 10.1111/dme.12144.","Ferwana M","Diabet Med","2013","2013/01/29","","","10.1111/dme.12144"
"30507435","Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer","Miyamoto DT, Mouw KW, Feng FY, Shipley WU, Efstathiou JA.","Lancet Oncol. 2018 Dec;19(12):e683-e695. doi: 10.1016/S1470-2045(18)30693-4.","Miyamoto DT","Lancet Oncol","2018","2018/12/04","","","10.1016/S1470-2045(18)30693-4"
"2114292","Evaluation of tumor response in patients with bladder cancer undergoing combined radiotherapy and chemotherapy","Jakse G, zur Nedden D, Hellweg G, Fritsch E, Frommhold H.","Eur Urol. 1990;17(4):286-8. doi: 10.1159/000464060.","Jakse G","Eur Urol","1990","1990/01/01","","","10.1159/000464060"
"9619365","Bladder cancer","Ozen H.","Curr Opin Oncol. 1998 May;10(3):273-8.","Ozen H","Curr Opin Oncol","1998","1998/06/10","","",""
"24524203","Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer","Miyake M, Lawton A, Dai Y, Chang M, Mengual L, Alcaraz A, Goodison S, Rosser CJ.","BMC Cancer. 2014 Feb 13;14:86. doi: 10.1186/1471-2407-14-86.","Miyake M","BMC Cancer","2014","2014/02/15","PMC3930286","","10.1186/1471-2407-14-86"
"24731526","Advances in uro-oncology ""OncoForum"": the best of 2013","Gómez-Veiga F, Alcaraz-Asensio A, Burgos-Revilla J, Cózar-Olmo J.","Actas Urol Esp. 2014 Oct;38(8):491-8. doi: 10.1016/j.acuro.2014.03.001. Epub 2014 Apr 14.","Gómez-Veiga F","Actas Urol Esp","2014","2014/04/16","","","10.1016/j.acuro.2014.03.001"
"15662604","Organ preservation by combined modality treatment in bladder cancer: the European perspective","Rödel C, Weiss C, Sauer R.","Semin Radiat Oncol. 2005 Jan;15(1):28-35. doi: 10.1016/j.semradonc.2004.07.010.","Rödel C","Semin Radiat Oncol","2005","2005/01/22","","","10.1016/j.semradonc.2004.07.010"
"7654832","Recent studies in bladder cancer","Ozen H.","Curr Opin Oncol. 1995 May;7(3):297-302. doi: 10.1097/00001622-199505000-00016.","Ozen H","Curr Opin Oncol","1995","1995/05/01","","","10.1097/00001622-199505000-00016"
"1565199","Bladder cancer after cyclophosphamide therapy for lupus nephritis","Ortiz A, Gonzalez-Parra E, Alvarez-Costa G, Egido J.","Nephron. 1992;60(3):378-9. doi: 10.1159/000186790.","Ortiz A","Nephron","1992","1992/01/01","","","10.1159/000186790"
"24821580","Does the nonurologic scientific community understand urothelial bladder cancer?","Bryan RT, Kirby R, Mostafid H.","Eur Urol. 2014 Sep;66(3):601-2. doi: 10.1016/j.eururo.2014.04.010. Epub 2014 May 10.","Bryan RT","Eur Urol","2014","2014/05/14","","","10.1016/j.eururo.2014.04.010"
"15010889","Possible distinct molecular carcinogenic pathways for bladder cancer in Ukraine, before and after the Chernobyl disaster","Morimura K, Romanenko A, Min W, Salim EI, Kinoshita A, Wanibuchi H, Vozianov A, Fukushima S.","Oncol Rep. 2004 Apr;11(4):881-6.","Morimura K","Oncol Rep","2004","2004/03/11","","",""
"20825402","Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer","Szarvas T, Singer BB, Becker M, Vom Dorp F, Jäger T, Szendroi A, Riesz P, Romics I, Rübben H, Ergün S.","BJU Int. 2011 Apr;107(7):1069-73. doi: 10.1111/j.1464-410X.2010.09625.x. Epub 2010 Sep 3.","Szarvas T","BJU Int","2011","2010/09/10","","","10.1111/j.1464-410X.2010.09625.x"
"30419836","Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model","Wang Z, Xiao H, Wei G, Zhang N, Wei M, Chen Z, Peng Z, Peng S, Qiu S, Li H, Long J.","BMC Cancer. 2018 Nov 12;18(1):1108. doi: 10.1186/s12885-018-4988-z.","Wang Z","BMC Cancer","2018","2018/11/14","PMC6233591","","10.1186/s12885-018-4988-z"
"8221572","A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer","Waehre H, Ous S, Klevmark B, Kvarstein B, Urnes T, Ogreid P, Johansen TE, Fosså SD.","Cancer. 1993 Nov 15;72(10):3044-51. doi: 10.1002/1097-0142(19931115)72:10<3044::aid-cncr2820721029>3.0.co;2-d.","Waehre H","Cancer","1993","1993/11/15","","","10.1002/1097-0142(19931115)72:10<3044::aid-cncr2820721029>3.0.co;2-d"
"8664913","[T1G3 transitional cell carcinoma of the bladder: our experience with 44 patients treated with intravesical BCG after TUR]","Hurle R, Graziotti P, Ranieri A, Losa A, Micheli E, Lembo A.","Arch Ital Urol Androl. 1996 Feb;68(1):13-6.","Hurle R","Arch Ital Urol Androl","1996","1996/02/01","","",""
"3347968","Is radical cystectomy indicated in patients with regional lymphatic metastases?","Grossman HB, Konnak JW.","Urology. 1988 Mar;31(3):214-6. doi: 10.1016/0090-4295(88)90142-2.","Grossman HB","Urology","1988","1988/03/01","","","10.1016/0090-4295(88)90142-2"
"1492770","[Ileal cystoplasty in bladder cancer]","González Martín M, Sánchez Rodríguez-Losada J, Chantada Abal V, Gómez Veiga F.","Arch Esp Urol. 1992 Nov;45(9):915-26.","González Martín M","Arch Esp Urol","1992","1992/11/01","","",""
"20233890","Gene signatures for the prediction of response to Bacillus Calmette-Guerin immunotherapy in primary pT1 bladder cancers","Kim YJ, Ha YS, Kim SK, Yoon HY, Lym MS, Kim MJ, Moon SK, Choi YH, Kim WJ.","Clin Cancer Res. 2010 Apr 1;16(7):2131-7. doi: 10.1158/1078-0432.CCR-09-3323. Epub 2010 Mar 16.","Kim YJ","Clin Cancer Res","2010","2010/03/18","","","10.1158/1078-0432.CCR-09-3323"
"9503200","[Clinical experience of ileal neobladder for bladder cancer]","Miyoshi S, Iwasaki A, Inoue H, Tsukikawa M, Oka D, Takao T, Mizutani S.","Hinyokika Kiyo. 1998 Jan;44(1):7-11.","Miyoshi S","Hinyokika Kiyo","1998","1998/03/21","","",""
"16856462","[MR tomography in diagnosis and staging of urinary bladder cancer]","Mazo E B, Belichenko OI, Shariia MA, Kontsedalov DV.","Urologiia. 2000 Jan-Feb;(1):43-5.","Mazo E B","Urologiia","2000","2006/07/22","","",""
"16820544","NMP22 and surveillance for recurrent bladder cancer","Wilson CT.","JAMA. 2006 Jul 5;296(1):44-5; author reply 45-6. doi: 10.1001/jama.296.1.44-b.","Wilson CT","JAMA","2006","2006/07/06","","","10.1001/jama.296.1.44-b"
"12118016","Radiotherapy and organ preservation in bladder cancer: are we ignoring the evidence?","Gospodarowicz M.","J Clin Oncol. 2002 Jul 15;20(14):3048-50. doi: 10.1200/JCO.2002.20.14.3048.","Gospodarowicz M","J Clin Oncol","2002","2002/07/16","","","10.1200/JCO.2002.20.14.3048"
"8701801","Superficial bladder cancer--treatment approach","Abi-Aad A, Biquet P, Penders L.","Acta Urol Belg. 1996 May;64(2):19-24.","Abi-Aad A","Acta Urol Belg","1996","1996/05/01","","",""
"6169867","[Hyperthermic therapy of the bladder cancer. III. Clinical studies (author's transl)]","Kubota Y.","Nihon Hinyokika Gakkai Zasshi. 1981 Jun;72(6):742-51. doi: 10.5980/jpnjurol1928.72.6_742.","Kubota Y","Nihon Hinyokika Gakkai Zasshi","1981","1981/06/01","","","10.5980/jpnjurol1928.72.6_742"
"5444389","Radiotherapy in the treatment of bladder cancer. A preliminary report","Stanley RJ, Francisco DS, Pilla LA.","Mo Med. 1970 Jun;67(6):363-5.","Stanley RJ","Mo Med","1970","1970/06/01","","",""
"26775720","Programmed Death-Ligand 1 Expression in Muscle-Invasive Bladder Cancer Cystectomy Specimens and Lymph Node Metastasis: A Reliable Treatment Selection Biomarker?","Mukherji D, Jabbour MN, Saroufim M, Temraz S, Nasr R, Charafeddine M, Assi R, Shamseddine A, Tawil AN.","Clin Genitourin Cancer. 2016 Apr;14(2):183-7. doi: 10.1016/j.clgc.2015.12.002. Epub 2015 Dec 17.","Mukherji D","Clin Genitourin Cancer","2016","2016/01/19","","","10.1016/j.clgc.2015.12.002"
"381090","Antigen characteristics of nitrosamine-induced urinary bladder cancer in rats","Hashimoto Y, Kitagawa HS.","Gan. 1979 Jun;70(3):305-14.","Hashimoto Y","Gan","1979","1979/06/01","","",""
"29322799","Predictors and prognostic implications of clinical decisions in patients with primary high-risk non-muscle-invasive bladder cancer - results of a cross country retrospective study","Poletajew S, Biernacki R, Buraczynski P, Chojnacki J, Czarniecki S, Gajewska D, Pohaba T, Sondka-Migdalska J, Skrzypczyk M, Suchojad T, Wojtkowiak D, Zaforemski B, Zapala L, Zemla A, Radziszewski P.","Neoplasma. 2018;65(1):147-152. doi: 10.4149/neo_2018_170217N123.","Poletajew S","Neoplasma","2018","2018/01/12","","","10.4149/neo_2018_170217N123"
"18282448","[Treatment of invasive bladder cancer]","Walter S, Krarup T.","Ugeskr Laeger. 2008 Jan 21;170(4):213.","Walter S","Ugeskr Laeger","2008","2008/02/20","","",""
"25376209","N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population","Hosen MB, Islam J, Salam MA, Islam MF, Hawlader MZ, Kabir Y.","Asia Pac J Clin Oncol. 2015 Mar;11(1):78-84. doi: 10.1111/ajco.12291. Epub 2014 Nov 6.","Hosen MB","Asia Pac J Clin Oncol","2015","2014/11/08","","","10.1111/ajco.12291"
"11125361","De novo muscle invasive bladder cancer: is there a change in trend?","Vaidya A, Soloway MS, Hawke C, Tiguert R, Civantos F.","J Urol. 2001 Jan;165(1):47-50; discussion 50. doi: 10.1097/00005392-200101000-00012.","Vaidya A","J Urol","2001","2000/12/23","","","10.1097/00005392-200101000-00012"
"8965375","[Diagnosis and treatment of bladder and prostate cancer in early stages]","Watanabe H, Nakagawa S, Kojima M.","Nihon Rinsho. 1996 May;54(5):1405-9.","Watanabe H","Nihon Rinsho","1996","1996/05/01","","",""
"29595450","[Analysis of the correlation between E2F3 expression and the number of tumor-infiltrating CD8(+)T cells in invasive bladder cancer tissues]","Wang C, Xu Z, Li W, Jiao Y, Wang J, Zhang B.","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018 Jan;34(1):1-8.","Wang C","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi","2018","2018/03/30","","",""
"31651200","Clinical utility versus futility: a tipping point for liquid biopsies in bladder cancer","Kouba E, Cheng L.","Future Oncol. 2019 Nov;15(33):3751-3753. doi: 10.2217/fon-2019-0522. Epub 2019 Oct 25.","Kouba E","Future Oncol","2019","2019/10/26","","","10.2217/fon-2019-0522"
"21074192","Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007","Fedeli U, Fedewa SA, Ward EM.","J Urol. 2011 Jan;185(1):72-8. doi: 10.1016/j.juro.2010.09.015. Epub 2010 Nov 12.","Fedeli U","J Urol","2011","2010/11/16","","","10.1016/j.juro.2010.09.015"
"31030829","Urologic Malignancies","Thuener JE.","Prim Care. 2019 Jun;46(2):275-285. doi: 10.1016/j.pop.2019.02.009. Epub 2019 Apr 1.","Thuener JE","Prim Care","2019","2019/04/30","","","10.1016/j.pop.2019.02.009"
"23188879","Low-dose risk assessment for arsenic: a meta-analysis approach","Begum M, Horowitz J, Hossain MI.","Asia Pac J Public Health. 2015 Mar;27(2):NP20-35. doi: 10.1177/1010539512466568. Epub 2012 Nov 27.","Begum M","Asia Pac J Public Health","2015","2012/11/29","","","10.1177/1010539512466568"
"5940166","[Aromatic amines and bladder cancer]","Reith JF.","Pharm Weekbl. 1966 Jun 3;101(22):498-500.","Reith JF","Pharm Weekbl","1966","1966/06/03","","",""
"31045513","Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder","Kuang S, Li H, Feng J, Xu S, Le Y.","Cancer Biomark. 2019;25(2):203-212. doi: 10.3233/CBM-182379.","Kuang S","Cancer Biomark","2019","2019/05/03","","","10.3233/CBM-182379"
"22010396","Bladder cancer: a condition worthy of clinical investigation","Sandler H.","Oncology (Williston Park). 2011 Sep;25(10):960, 962.","Sandler H","Oncology (Williston Park)","2011","2011/10/21","","",""
"2776594","Difficulties in evaluating urinary specimens after local mitomycin therapy of bladder cancer","Koshikawa T, Leyh H, Schenck U.","Diagn Cytopathol. 1989;5(2):117-21. doi: 10.1002/dc.2840050202.","Koshikawa T","Diagn Cytopathol","1989","1989/01/01","","","10.1002/dc.2840050202"
"27814275","Detection of bladder cancer in urine sediments by a hypermethylation panel of selected tumor suppressor genes","Pietrusiński M, Kȩpczyński Ƚ, Jȩdrzejczyk A, Borkowska E, Traczyk-Borszyńska M, Constantinou M, Kaƚużewski B, Borowiec M.","Cancer Biomark. 2017;18(1):47-59. doi: 10.3233/CBM-160673.","Pietrusiński M","Cancer Biomark","2017","2016/11/05","","","10.3233/CBM-160673"
"23945327","[A case of portal vein thrombosis during chemotherapy for bladder cancer]","Ueda N, Nakayama M, Matsuzaki K, Yamamoto Y, Takeda K, Nakata W, Arai Y, Kakimoto K, Nishimura K, Mukai M.","Hinyokika Kiyo. 2013 Jul;59(7):449-52.","Ueda N","Hinyokika Kiyo","2013","2013/08/16","","",""
"30850337","Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery","Moschini M, Martini A, Zamboni S, Mattei A, Baumeister P, Di Bona C, Dell'Oglio P, Zaffuto E, Burgio G, Shariat SF, Sanchez-Salas R, Cathelineau X, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R.","Clin Genitourin Cancer. 2019 Jun;17(3):e541-e548. doi: 10.1016/j.clgc.2019.02.001. Epub 2019 Feb 13.","Moschini M","Clin Genitourin Cancer","2019","2019/03/10","","","10.1016/j.clgc.2019.02.001"
"28460449","Laparoscopic versus open radical cystectomy for patients with bladder cancer over 75-year-old: a prospective randomized controlled trial","Yong C, Daihui C, Bo Z.","Oncotarget. 2017 Apr 18;8(16):26565-26572. doi: 10.18632/oncotarget.15717.","Yong C","Oncotarget","2017","2017/05/03","PMC5432279","","10.18632/oncotarget.15717"
"7992700","[Long-term results and complications of intravesical instillation of bacillus Calmette-Guerin for prophylaxis of bladder cancer recurrence]","Irie A, Lee KE, Kadowaki K, Sawamura M.","Hinyokika Kiyo. 1994 Oct;40(10):873-7.","Irie A","Hinyokika Kiyo","1994","1994/10/01","","",""
"4960807","Radiotherapy in the treatment of cancer of the bladder","Bloedorn FG, Wizenberg MJ, Seydel HG, Light JP.","South Med J. 1967 May;60(5):539-44. doi: 10.1097/00007611-196705000-00020.","Bloedorn FG","South Med J","1967","1967/05/01","","","10.1097/00007611-196705000-00020"
"4217438","Chemoprophylaxis of bladder cancer recurrence: immunological aspects","Corrado F, Lalanne G, Pizza GC.","Panminerva Med. 1974 Mar;16(3):85-91.","Corrado F","Panminerva Med","1974","1974/03/01","","",""
"30836962","The unveiling of a new risk factor associated with bladder cancer in Lebanon","Temraz S, Haibe Y, Charafeddine M, Saifi O, Mukherji D, Shamseddine A.","BMC Urol. 2019 Mar 5;19(1):16. doi: 10.1186/s12894-019-0445-9.","Temraz S","BMC Urol","2019","2019/03/07","PMC6402117","","10.1186/s12894-019-0445-9"
"9259088","Surgical management of superficial bladder cancer (stages Ta/T1/CIS)","Smith JA Jr.","Semin Surg Oncol. 1997 Sep-Oct;13(5):328-34. doi: 10.1002/(sici)1098-2388(199709/10)13:5<328::aid-ssu6>3.0.co;2-f.","Smith JA Jr","Semin Surg Oncol","1997","1997/09/01","","","10.1002/(sici)1098-2388(199709/10)13:5<328::aid-ssu6>3.0.co;2-f"
"27638828","Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells","Péchery A, Fauconnet S, Bittard H, Lascombe I.","Tumour Biol. 2016 Nov;37(11):14789-14802. doi: 10.1007/s13277-016-5305-6. Epub 2016 Sep 16.","Péchery A","Tumour Biol","2016","2016/09/18","","","10.1007/s13277-016-5305-6"
"31279815","Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?","Grossman HB, Bellmunt J, Black PC.","Eur Urol Oncol. 2019 Sep;2(5):597-602. doi: 10.1016/j.euo.2019.06.002. Epub 2019 Jul 4.","Grossman HB","Eur Urol Oncol","2019","2019/07/08","","","10.1016/j.euo.2019.06.002"
"5754887","Conservative treatment vs radical surgery for superficial cancer of the bladder","Jewett HJ.","JAMA. 1968 Dec 16;206(12):2720-1.","Jewett HJ","JAMA","1968","1968/12/16","","",""
"28879675","miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy","Ecke TH, Stier K, Weickmann S, Zhao Z, Buckendahl L, Stephan C, Kilic E, Jung K.","Cancer Med. 2017 Oct;6(10):2252-2262. doi: 10.1002/cam4.1161. Epub 2017 Sep 6.","Ecke TH","Cancer Med","2017","2017/09/08","PMC5633587","","10.1002/cam4.1161"
"24472711","The economics of bladder cancer: costs and considerations of caring for this disease","Svatek RS, Hollenbeck BK, Holmäng S, Lee R, Kim SP, Stenzl A, Lotan Y.","Eur Urol. 2014 Aug;66(2):253-62. doi: 10.1016/j.eururo.2014.01.006. Epub 2014 Jan 21.","Svatek RS","Eur Urol","2014","2014/01/30","","","10.1016/j.eururo.2014.01.006"
"18076917","Florida bladder cancer trends 1981 to 2004: minimal progress in decreasing advanced disease","Nieder AM, Mackinnon JA, Huang Y, Fleming LE, Koniaris LG, Lee DJ.","J Urol. 2008 Feb;179(2):491-5; discussion 495. doi: 10.1016/j.juro.2007.09.082.","Nieder AM","J Urol","2008","2007/12/14","","","10.1016/j.juro.2007.09.082"
"24662797","[Genetic and immunologic determinants of intravesical BCG therapy in non-muscle-invasive urothelial bladder cancer]","Krajewski W, Kołodziej A, Dembowski J, Zdrojowy R.","Postepy Hig Med Dosw (Online). 2014 Mar 20;68:291-300. doi: 10.5604/17322693.1094714.","Krajewski W","Postepy Hig Med Dosw (Online)","2014","2014/03/26","","","10.5604/17322693.1094714"
"20831494","Evaluation of adaptive radiotherapy of bladder cancer by image-based tumour control probability modelling","Wright P, Muren LP, Høyer M, Malinen E.","Acta Oncol. 2010 Oct;49(7):1045-51. doi: 10.3109/0284186X.2010.498431.","Wright P","Acta Oncol","2010","2010/09/14","","","10.3109/0284186X.2010.498431"
"179255","Herpesvirus in bladder cancer","Murphy WM.","Acta Cytol. 1976 May-Jun;20(3):207-10.","Murphy WM","Acta Cytol","1976","1976/05/01","","",""
"10101598","Biomarkers in monitoring for efficacy of immunotherapy and chemoprevention of bladder cancer with dimethylsulfoxide","Hemstreet GP 3rd, Rao J, Hurst RE, Bonner RB, Mellott JE, Rooker GM.","Cancer Detect Prev. 1999;23(2):163-71. doi: 10.1046/j.1525-1500.1999.09917.x.","Hemstreet GP 3rd","Cancer Detect Prev","1999","1999/04/02","","","10.1046/j.1525-1500.1999.09917.x"
"30550547","Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder","van den Tempel N, Naipal KAT, Raams A, van Gent DC, Franckena M, Boormans JL, Kanaar R.","PLoS One. 2018 Dec 14;13(12):e0209101. doi: 10.1371/journal.pone.0209101. eCollection 2018.","van den Tempel N","PLoS One","2018","2018/12/15","PMC6294360","","10.1371/journal.pone.0209101"
"23030228","Current strategies in the treatment of non-muscle-invasive bladder cancer","Oosterlinck W, Decaestecker K.","Expert Rev Anticancer Ther. 2012 Aug;12(8):1097-106. doi: 10.1586/era.12.87.","Oosterlinck W","Expert Rev Anticancer Ther","2012","2012/10/04","","","10.1586/era.12.87"
"16905982","Quality of life after therapy for muscle-invasive bladder cancer","Henningsohn L.","Curr Opin Urol. 2006 Sep;16(5):356-60. doi: 10.1097/01.mou.0000240309.62958.19.","Henningsohn L","Curr Opin Urol","2006","2006/08/15","","","10.1097/01.mou.0000240309.62958.19"
"15705066","Molecular pathways in bladder cancer: part 2","Bryan RT, Hussain SA, James ND, Jankowski JA, Wallace DM.","BJU Int. 2005 Mar;95(4):491-6. doi: 10.1111/j.1464-410X.2005.05326.x.","Bryan RT","BJU Int","2005","2005/02/12","","","10.1111/j.1464-410X.2005.05326.x"
"17613039","Diagnosis of bladder cancer at 465 MHz","Gervino G, Autino E, Kolomoets E, Leucci G, Balma M.","Electromagn Biol Med. 2007;26(2):119-34. doi: 10.1080/15368370701380850.","Gervino G","Electromagn Biol Med","2007","2007/07/07","","","10.1080/15368370701380850"
"27147566","JNK2 downregulation promotes tumorigenesis and chemoresistance by decreasing p53 stability in bladder cancer","Pan CW, Liu H, Zhao Y, Qian C, Wang L, Qi J.","Oncotarget. 2016 Jun 7;7(23):35119-31. doi: 10.18632/oncotarget.9046.","Pan CW","Oncotarget","2016","2016/05/06","PMC5085214","","10.18632/oncotarget.9046"
"2249199","Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder","Schapers RF, Pauwels RP, Havenith MG, Smeets AW, van den Brandt PA, Bosman FT.","Cancer. 1990 Dec 15;66(12):2583-8. doi: 10.1002/1097-0142(19901215)66:12<2583::aid-cncr2820661222>3.0.co;2-s.","Schapers RF","Cancer","1990","1990/12/15","","","10.1002/1097-0142(19901215)66:12<2583::aid-cncr2820661222>3.0.co;2-s"
"2692107","Benign and low-grade papillary lesions of the urinary bladder: a review of the papilloma-papillary carcinoma controversy, and a report of five typical papillomas","Eble JN, Young RH.","Semin Diagn Pathol. 1989 Nov;6(4):351-71.","Eble JN","Semin Diagn Pathol","1989","1989/11/01","","",""
"27095782","[Clinical significance of residual tumors at repeat transurethral resection in patients with T1 bladder cancer]","Chen JC, Li T, Ning XH, Peng SH, Wang JY, Qi NN, Cai L, Gong K.","Zhonghua Yi Xue Za Zhi. 2016 Apr 12;96(14):1124-7. doi: 10.3760/cma.j.issn.0376-2491.2016.14.013.","Chen JC","Zhonghua Yi Xue Za Zhi","2016","2016/04/21","","","10.3760/cma.j.issn.0376-2491.2016.14.013"
"15150694","[Prevention of bladder cancer]","Otto T, Rübben H.","Urologe A. 2004 May;43(5):562-4. doi: 10.1007/s00120-003-0477-2.","Otto T","Urologe A","2004","2004/05/20","","","10.1007/s00120-003-0477-2"
"16889085","[Photodynamic therapy of urinary bladder cancer using a chlorin based photosensitizer]","Iagudaev DM, Martov AG, Sorokatyĭ AE, Geĭnits AV.","Urologiia. 2006 May-Jun;(3):24-7.","Iagudaev DM","Urologiia","2006","2006/08/08","","",""
"28882404","Health Related Quality of Life Following Radical Cystectomy: Comparative Analysis from the Medicare Health Outcomes Survey","Winters BR, Wright JL, Holt SK, Dash A, Gore JL, Schade GR.","J Urol. 2018 Mar;199(3):669-675. doi: 10.1016/j.juro.2017.08.111. Epub 2017 Sep 5.","Winters BR","J Urol","2018","2017/09/09","","","10.1016/j.juro.2017.08.111"
"30306728","National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging","Lin HY, Ye H, Kernen KM, Hafron JM, Krauss DJ.","Cancer Med. 2018 Nov;7(11):5370-5381. doi: 10.1002/cam4.1684. Epub 2018 Oct 10.","Lin HY","Cancer Med","2018","2018/10/12","PMC6247074","","10.1002/cam4.1684"
"21953426","[Systemic therapy of muscle invasive bladder cancer - an update]","Niedersüss-Beke D.","Wien Med Wochenschr. 2011 Aug;161(15-16):371-3. doi: 10.1007/s10354-011-0017-4.","Niedersüss-Beke D","Wien Med Wochenschr","2011","2011/09/29","","","10.1007/s10354-011-0017-4"
"32377877","Disparities in Bladder Cancer Outcomes Based on Key Sociodemographic Characteristics","Yip W, Cacciamani G, Bhanvadia SK.","Curr Urol Rep. 2020 May 7;21(6):24. doi: 10.1007/s11934-019-0950-0.","Yip W","Curr Urol Rep","2020","2020/05/08","","","10.1007/s11934-019-0950-0"
"26547270","Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment","Kiselyov A, Bunimovich-Mendrazitsky S, Startsev V.","Int J Cancer. 2016 Jun 1;138(11):2562-9. doi: 10.1002/ijc.29918. Epub 2015 Nov 23.","Kiselyov A","Int J Cancer","2016","2015/11/09","","","10.1002/ijc.29918"
"6768441","The management of superficial bladder cancer","Soloway MS.","Cancer. 1980 Apr 15;45(7 Suppl):1856-65.","Soloway MS","Cancer","1980","1980/04/15","","",""
"26406865","Urine CXCL1 as a biomarker for tumor detection and outcome prediction in bladder cancer","Nakashima M, Matsui Y, Kobayashi T, Saito R, Hatahira S, Kawakami K, Nakamura E, Nishiyama H, Ogawa O.","Cancer Biomark. 2015;15(4):357-64. doi: 10.3233/CBM-150472.","Nakashima M","Cancer Biomark","2015","2015/09/26","","","10.3233/CBM-150472"
"9435799","[Tracking the gatekeeper gene in the stages of carcinogenesis in the bladder]","Baud E, Catilina P, Bignon YJ.","Bull Cancer. 1997 Oct;84(10):971-5.","Baud E","Bull Cancer","1997","1998/01/22","","",""
"8578986","[Epidemiological study of risk factors for bladder cancer]","Nakata S, Sato J, Ohtake N, Imai K, Yamanaka H.","Hinyokika Kiyo. 1995 Dec;41(12):969-77.","Nakata S","Hinyokika Kiyo","1995","1995/12/01","","",""
"15816385","[Epidemiology of bladder cancer]","Irani J.","Prog Urol. 2003 Nov;13(5 Suppl 2):1207-8.","Irani J","Prog Urol","2003","2005/04/09","","",""
"29730200","Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors","Mäkelä VJ, Kotsar A, Tammela TLJ, Murtola TJ.","J Urol. 2018 Oct;200(4):743-748. doi: 10.1016/j.juro.2018.04.082. Epub 2018 May 3.","Mäkelä VJ","J Urol","2018","2018/05/07","","","10.1016/j.juro.2018.04.082"
"17565857","[Identification of gene expression patterns in superficial and invasive human bladder cancers]","Zhou L, Shi BT, Wang SX, Luo Y, Yang L, Zhang LL, Wang XY, He DL.","Zhonghua Yi Xue Za Zhi. 2007 Mar 27;87(12):798-801.","Zhou L","Zhonghua Yi Xue Za Zhi","2007","2007/06/15","","",""
"32203842","The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor","Morales-Barrera R, Suárez C, González M, Valverde C, Serra E, Mateo J, Raventos C, Maldonado X, Morote J, Carles J.","Cancer Treat Rev. 2020 Jun;86:102000. doi: 10.1016/j.ctrv.2020.102000. Epub 2020 Mar 13.","Morales-Barrera R","Cancer Treat Rev","2020","2020/03/24","","","10.1016/j.ctrv.2020.102000"
"27056069","Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendations","Liem EI, Crezee H, de la Rosette JJ, de Reijke TM.","Int J Hyperthermia. 2016 Jun;32(4):363-73. doi: 10.3109/02656736.2016.1155760. Epub 2016 Apr 7.","Liem EI","Int J Hyperthermia","2016","2016/04/09","","","10.3109/02656736.2016.1155760"
"28889381","Oxidative Stress in Urothelial Carcinogenesis: Measurements of Protein Carbonylation and Intracellular Production of Reactive Oxygen Species","Whongsiri P, Phoyen S, Boonla C.","Methods Mol Biol. 2018;1655:109-117. doi: 10.1007/978-1-4939-7234-0_9.","Whongsiri P","Methods Mol Biol","2018","2017/09/11","","","10.1007/978-1-4939-7234-0_9"
"8640726","FISH studies on the Y chromosome in male urinary cells","Betz J, Meloni AM, Sandberg AA.","Cancer Genet Cytogenet. 1996 Jun;88(2):155-7. doi: 10.1016/0165-4608(95)00283-9.","Betz J","Cancer Genet Cytogenet","1996","1996/06/01","","","10.1016/0165-4608(95)00283-9"
"25695283","Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin","Yan Z, Jiang J, Li F, Yang W, Xie G, Zhou C, Xia S, Cheng Y.","Oncol Rep. 2015 Apr;33(4):1791-8. doi: 10.3892/or.2015.3807. Epub 2015 Feb 16.","Yan Z","Oncol Rep","2015","2015/02/20","","","10.3892/or.2015.3807"
"3349278","Grading in superficial bladder cancer. (2). Cytogenetic classification","Pauwels RP, Smeets AW, Schapers RF, Geraedts JP, Debruyne FM.","Br J Urol. 1988 Feb;61(2):135-9. doi: 10.1111/j.1464-410x.1988.tb05061.x.","Pauwels RP","Br J Urol","1988","1988/02/01","","","10.1111/j.1464-410x.1988.tb05061.x"
"8351756","Mean nuclear volume of bladder cancer: stereological estimation and its clinical value","Arima K, Sugimura Y, Tochigi H, Kawamura J.","Urol Int. 1993;51(2):62-6. doi: 10.1159/000282515.","Arima K","Urol Int","1993","1993/01/01","","","10.1159/000282515"
"6948130","Coffee drinking and cancer of the lower urinary tract","Morrison AS, Buring JE, Verhoek WG, Aoki K, Leck I, Ohno Y, Obata K.","J Natl Cancer Inst. 1982 Jan;68(1):91-4.","Morrison AS","J Natl Cancer Inst","1982","1982/01/01","","",""
"23714501","A multidisciplinary approach in muscle-invasive disease: novel chemotherapy combinations and targets in chemoradiation","James ND, Hussain SA.","Am Soc Clin Oncol Educ Book. 2013:200-6. doi: 10.14694/EdBook_AM.2013.33.200.","James ND","Am Soc Clin Oncol Educ Book","2013","2013/05/30","","","10.14694/EdBook_AM.2013.33.200"
"644715","[Suppression of leukocyte migration in bladder cancer with tumor antigens before and after surgery]","Borisenko ID, Novikov DK, Shein IA.","Urol Nefrol (Mosk). 1978 Mar-Apr;(2):26-9.","Borisenko ID","Urol Nefrol (Mosk)","1978","1978/03/01","","",""
"25443900","Editorial comment","Mayer E.","Urology. 2014 Nov;84(5):1056. doi: 10.1016/j.urology.2014.06.073. Epub 2014 Oct 24.","Mayer E","Urology","2014","2014/12/03","","","10.1016/j.urology.2014.06.073"
"15201740","Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy?","Thalmann GN, Markwalder R, Shahin O, Burkhard FC, Hochreiter WW, Studer UE.","J Urol. 2004 Jul;172(1):70-5. doi: 10.1097/01.ju.0000132129.87598.3b.","Thalmann GN","J Urol","2004","2004/06/18","","","10.1097/01.ju.0000132129.87598.3b"
"7942363","[A clinical study of total cystectomy for patients with bladder cancer]","Hashimoto H, Nishihara M, Fujii H, Kaneko S, Yachiku S.","Hinyokika Kiyo. 1994 Aug;40(8):669-75.","Hashimoto H","Hinyokika Kiyo","1994","1994/08/01","","",""
"27271229","Bladder cancer: working towards better outcomes","Lawrentschuk N.","Minerva Urol Nefrol. 2016 Apr;68(2):105.","Lawrentschuk N","Minerva Urol Nefrol","2016","2016/06/09","","",""
"17591812","Role of external radiation therapy in urinary cancers","Parisi S, Troiano M, Corsa P, Raguso A, Cossa S, Piazzolla EE, Munafò T, Sanpaolo G, Natuno A, Maiello E.","Ann Oncol. 2007 Jun;18 Suppl 6:vi157-61. doi: 10.1093/annonc/mdm247.","Parisi S","Ann Oncol","2007","2007/09/27","","","10.1093/annonc/mdm247"
"12447643","Two cases of acute polyarthritis secondary to intravesical BCG adjuvant therapy for superficial bladder cancer","Pardalidis NP, Papatsoris AG, Kosmaoglou EV, Georganas C.","Clin Rheumatol. 2002 Nov;21(6):536-7. doi: 10.1007/s100670200131.","Pardalidis NP","Clin Rheumatol","2002","2002/11/26","","","10.1007/s100670200131"
"1729547","The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy","Jacobsen AB, Pettersen EO, Amellem O, Berner A, Ous S, Fosså SD.","J Urol. 1992 Jan;147(1):34-7. doi: 10.1016/s0022-5347(17)37127-6.","Jacobsen AB","J Urol","1992","1992/01/01","","","10.1016/s0022-5347(17)37127-6"
"26774348","Long-Term Response After Surgery and Adjuvant Chemoradiation for T4 Mucinous Adenocarcinoma of the Bladder: A Case Report and Review of the Literature","Ball MW, Nathan R, Gerayli F.","Clin Genitourin Cancer. 2016 Apr;14(2):e225-7. doi: 10.1016/j.clgc.2015.12.025. Epub 2015 Dec 24.","Ball MW","Clin Genitourin Cancer","2016","2016/01/18","","","10.1016/j.clgc.2015.12.025"
"8337442","[An expert system for the staging and therapy of carcinoma of the bladder]","Giovagnorio F, Biggio A, Cruciani E, Cavallo V.","Radiol Med. 1993 Jun;85(6):831-5.","Giovagnorio F","Radiol Med","1993","1993/06/01","","",""
"3756409","Results of surgery following radical radiotherapy for invasive bladder cancer","Quilty PM, Duncan W, Chisholm GD, Fowler JW, Hargreave TB, Newsam JE, Tolley DA.","Br J Urol. 1986 Aug;58(4):396-405. doi: 10.1111/j.1464-410x.1986.tb09093.x.","Quilty PM","Br J Urol","1986","1986/08/01","","","10.1111/j.1464-410x.1986.tb09093.x"
"19069498","[Pilot trial of vaccines based on autologous dendritic cells loaded in vitro with tumor antigens in the treatment of cancer of the urinary bladder]","Shoua AB, Sergienco NF, Sitnikov NV, Chkadua GZ.","Urologiia. 2008 Sep-Oct;(5):54-7.","Shoua AB","Urologiia","2008","2008/12/17","","",""
"23746384","Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI","Wu LM, Chen XX, Xu JR, Zhang XF, Suo ST, Yao QY, Fan Y, Hu J.","Acad Radiol. 2013 Aug;20(8):939-46. doi: 10.1016/j.acra.2013.02.012. Epub 2013 Jun 5.","Wu LM","Acad Radiol","2013","2013/06/11","","","10.1016/j.acra.2013.02.012"
"30317334","Muscle Invasive Bladder Cancer (MIBC) - The Gold Standard Radical Cystectomy or Bladder Preserving Approach, YES or NO?","Mahmud SM.","J Pak Med Assoc. 2018 Oct;68(10):1425-1426.","Mahmud SM","J Pak Med Assoc","2018","2018/10/15","","",""
"15036656","Effects of Schistosoma haematobium infection on drug-metabolizing enzymes in human bladder cancer tissues","Sheweita SA, El-Shahat FG, Bazeed MA, Abu El-Maati MR, O'Connor PJ.","Cancer Lett. 2004 Mar 8;205(1):15-21. doi: 10.1016/j.canlet.2003.09.023.","Sheweita SA","Cancer Lett","2004","2004/03/24","","","10.1016/j.canlet.2003.09.023"
"29145273","Diabetes mellitus and the risk of bladder cancer: A PRISMA-compliant meta-analysis of cohort studies","Xu Y, Huo R, Chen X, Yu X.","Medicine (Baltimore). 2017 Nov;96(46):e8588. doi: 10.1097/MD.0000000000008588.","Xu Y","Medicine (Baltimore)","2017","2017/11/18","PMC5704818","","10.1097/MD.0000000000008588"
"5589220","[The place of total cystectomy in cancer of the bladder]","Couvelaire R.","J Urol Nephrol (Paris). 1967 Dec;73(12):909-15.","Couvelaire R","J Urol Nephrol (Paris)","1967","1967/12/01","","",""
"19025393","Results of repeated transurethral resection for a second opinion in patients referred for nonmuscle invasive bladder cancer: the referral cancer center experience and review of the literature","Han KS, Joung JY, Cho KS, Seo HK, Chung J, Park WS, Lee KH.","J Endourol. 2008 Dec;22(12):2699-704. doi: 10.1089/end.2008.0281.","Han KS","J Endourol","2008","2008/11/26","","","10.1089/end.2008.0281"
"4934541","The role of urinary tryptophan metabolites in the etiology of bladder cancer","Bryan GT.","Am J Clin Nutr. 1971 Jul;24(7):841-7. doi: 10.1093/ajcn/24.7.841.","Bryan GT","Am J Clin Nutr","1971","1971/07/01","","","10.1093/ajcn/24.7.841"
"19995789","Tumor multiplicity is an independent prognostic factor of non-muscle-invasive high-grade (T1G3) bladder cancer","Nakai Y, Nonomura N, Kawashima A, Mukai M, Nagahara A, Nakayama M, Takayama H, Nishimura K, Okuyama A.","Jpn J Clin Oncol. 2010 Mar;40(3):252-7. doi: 10.1093/jjco/hyp159. Epub 2009 Dec 7.","Nakai Y","Jpn J Clin Oncol","2010","2009/12/10","","","10.1093/jjco/hyp159"
"25882710","Immunotherapy for urothelial cancer: from BCG to checkpoint inhibitors and beyond","Wu Y, Enting D, Rudman S, Chowdhury S.","Expert Rev Anticancer Ther. 2015 May;15(5):509-23. doi: 10.1586/14737140.2015.1015419. Epub 2015 Apr 16.","Wu Y","Expert Rev Anticancer Ther","2015","2015/04/18","","","10.1586/14737140.2015.1015419"
"2735264","[Colon bladder replacement after total cystectomy]","Yamanaka N, Imai T, Miyazaki J, Umezu K, Kawabata G, Ghoji K, Yasuno H, Okada H, Kamidono S.","Hinyokika Kiyo. 1989 Apr;35(4):587-91.","Yamanaka N","Hinyokika Kiyo","1989","1989/04/01","","",""
"30719704","Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy","Heide T, Maurer A, Eipel M, Knoll K, Geelvink M, Veeck J, Knuechel R, van Essen J, Stoehr R, Hartmann A, Altmueller J, Graham TA, Gaisa NT.","J Pathol. 2019 Jun;248(2):230-242. doi: 10.1002/path.5250. Epub 2019 Mar 18.","Heide T","J Pathol","2019","2019/02/06","","","10.1002/path.5250"
"26748103","The determination of serum and urinary endocan concentrations in patients with bladder cancer","Laloglu E, Aksoy H, Aksoy Y, Ozkaya F, Akcay F.","Ann Clin Biochem. 2016 Nov;53(6):647-653. doi: 10.1177/0004563216629169. Epub 2016 Sep 28.","Laloglu E","Ann Clin Biochem","2016","2016/01/10","","","10.1177/0004563216629169"
"21844550","Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement","Moyer VA; U.S. Preventive Services Task Force.","Ann Intern Med. 2011 Aug 16;155(4):246-51. doi: 10.7326/0003-4819-155-4-201108160-00008.","Moyer VA","Ann Intern Med","2011","2011/08/17","","","10.7326/0003-4819-155-4-201108160-00008"
"16758720","[Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation]","Honda M, Satoh M, Tujimoto Y, Takada T, Matsumiya K, Fujioka H.","Hinyokika Kiyo. 2006 May;52(5):331-5.","Honda M","Hinyokika Kiyo","2006","2006/06/09","","",""
"4651993","Specific induction of bladder cancer in mice by butyl-(4-hydroxybutyl)-nitrosamine and the effects of hormonal modifications on the sex difference in response","Bertram JS, Craig AW.","Eur J Cancer. 1972 Dec;8(6):587-94. doi: 10.1016/0014-2964(72)90137-5.","Bertram JS","Eur J Cancer","1972","1972/12/01","","","10.1016/0014-2964(72)90137-5"
"28314322","Concurrent Chemotherapy Improves the Overall Survival of Patients Irradiated for Locally Recurrent Bladder Cancer","Rades D, Manig L, Janssen S, Schild SE.","Anticancer Res. 2017 Mar;37(3):1485-1488. doi: 10.21873/anticanres.11474.","Rades D","Anticancer Res","2017","2017/03/19","","","10.21873/anticanres.11474"
"15165174","Impact of proteomics on bladder cancer research","Celis JE, Gromova I, Moreira JM, Cabezon T, Gromov P.","Pharmacogenomics. 2004 Jun;5(4):381-94. doi: 10.1517/14622416.5.4.381.","Celis JE","Pharmacogenomics","2004","2004/05/29","","","10.1517/14622416.5.4.381"
"6498846","A diagnostic-prognostic test for bladder cancer using a monoclonal antibody-based enzyme-linked immunoassay for detection of urinary fibrin(ogen) degradation products","McCabe RP, Lamm DL, Haspel MV, Pomato N, Smith KO, Thompson E, Hanna MG Jr.","Cancer Res. 1984 Dec;44(12 Pt 1):5886-93.","McCabe RP","Cancer Res","1984","1984/12/01","","",""
"26271292","Small cell carcinoma of the urinary bladder without gross hematuria: a case report","Huang W, Luan Y, Jin L, Wang T, Chen R, Liu Z, Chen Z, Lan R.","Front Med. 2015 Sep;9(3):384-7. doi: 10.1007/s11684-015-0405-z. Epub 2015 Aug 13.","Huang W","Front Med","2015","2015/08/15","","","10.1007/s11684-015-0405-z"
"4757902","Proceedings: Cancer of the bladder. Diagnosis and staging","Jewett HJ.","Cancer. 1973 Nov;32(5):1072-4. doi: 10.1002/1097-0142(197311)32:5<1072::aid-cncr2820320508>3.0.co;2-n.","Jewett HJ","Cancer","1973","1973/11/01","","","10.1002/1097-0142(197311)32:5<1072::aid-cncr2820320508>3.0.co;2-n"
"9783988","Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer","Droller MJ.","J Urol. 1998 Nov;160(5):1932. doi: 10.1016/s0022-5347(01)62450-9.","Droller MJ","J Urol","1998","1998/10/23","","","10.1016/s0022-5347(01)62450-9"
"12937859","Fluid intake and bladder cancer. A case control study","Radosavljević V, Janković S, Marinković J, Djokić M.","Neoplasma. 2003;50(3):234-8.","Radosavljević V","Neoplasma","2003","2003/08/26","","",""
"6677961","[Indications and limitations of radical surgery for cancer of the bladder]","Marcelli G, Bottanelli A.","Radiol Med. 1983 Nov;69(11):871-3.","Marcelli G","Radiol Med","1983","1983/11/01","","",""
"23399020","Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression","Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J.","FEBS J. 2013 Apr;280(7):1709-16. doi: 10.1111/febs.12185. Epub 2013 Mar 6.","Luo M","FEBS J","2013","2013/02/13","","","10.1111/febs.12185"
"11522659","The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure","Okegawa T, Pong RC, Li Y, Bergelson JM, Sagalowsky AI, Hsieh JT.","Cancer Res. 2001 Sep 1;61(17):6592-600.","Okegawa T","Cancer Res","2001","2001/08/28","","",""
"30592142","Inhibition of stearoyl CoA desaturase-1 activity suppresses tumour progression and improves prognosis in human bladder cancer","Piao C, Cui X, Zhan B, Li J, Li Z, Li Z, Liu X, Bi J, Zhang Z, Kong C.","J Cell Mol Med. 2019 Mar;23(3):2064-2076. doi: 10.1111/jcmm.14114. Epub 2018 Dec 27.","Piao C","J Cell Mol Med","2019","2018/12/29","PMC6378218","","10.1111/jcmm.14114"
"15285748","Comparative study of novel endoluminal ultrasonography and conventional transurethral ultrasonography in staging of bladder cancer","Saga Y, Numata A, Tokumitsu M, Yamaguchi S, Fujii H, Hashimoto H, Kaneko S, Yachiku S.","Int J Urol. 2004 Aug;11(8):597-601. doi: 10.1111/j.1442-2042.2004.00865.x.","Saga Y","Int J Urol","2004","2004/08/03","","","10.1111/j.1442-2042.2004.00865.x"
"26804544","Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems","Rodrigues D, Jerónimo C, Henrique R, Belo L, de Lourdes Bastos M, de Pinho PG, Carvalho M.","Int J Cancer. 2016 Jul 15;139(2):256-68. doi: 10.1002/ijc.30016. Epub 2016 Feb 23.","Rodrigues D","Int J Cancer","2016","2016/01/26","","","10.1002/ijc.30016"
"20534390","[Uncommon bladder tumours]","Boyle H, Fléchon A, Droz JP.","Bull Cancer. 2010;97 Suppl Cancer de la vessie:51-7. doi: 10.1684/bdc.2010.1097.","Boyle H","Bull Cancer","2010","2010/06/11","","","10.1684/bdc.2010.1097"
"19333225","Surgery: preserving continence in muscle-invasive bladder cancer","Costello A, Goel R.","Nat Rev Clin Oncol. 2009 Apr;6(4):194-6. doi: 10.1038/nrclinonc.2009.26.","Costello A","Nat Rev Clin Oncol","2009","2009/04/01","","","10.1038/nrclinonc.2009.26"
"23721764","Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes","Ma B, Li H, Zhang C, Yang K, Qiao B, Zhang Z, Xu Y.","Eur J Surg Oncol. 2013 Oct;39(10):1150-6. doi: 10.1016/j.ejso.2013.04.006. Epub 2013 May 27.","Ma B","Eur J Surg Oncol","2013","2013/06/01","","","10.1016/j.ejso.2013.04.006"
"28120522","Sigma 2 receptor expression levels in blood and bladder from healthy and bladder cancer cattle","Russo V, Inglese C, Avallone L, Roperto F, Abate C, Zizzo N, Munday JS, Berardi F, Colabufo NA, Roperto S.","Vet Comp Oncol. 2017 Dec;15(4):1503-1512. doi: 10.1111/vco.12295. Epub 2017 Jan 25.","Russo V","Vet Comp Oncol","2017","2017/01/26","","","10.1111/vco.12295"
"7901517","Genetic alterations in bladder cancer","Knowles MA, Currie GA.","Lancet. 1993 Nov 6;342(8880):1184.","Knowles MA","Lancet","1993","1993/11/06","","",""
"9206879","[The intravesical administration of BCG vaccine in treating recurrent superficial bladder cancer]","Panteleeva ES, Neprina GS, Vatin OE, Kariakin OB, Safiullin KN.","Urol Nefrol (Mosk). 1997 Mar-Apr;(2):29-32.","Panteleeva ES","Urol Nefrol (Mosk)","1997","1997/03/01","","",""
"23765955","Gene expression profile and enrichment pathways in different stages of bladder cancer","Fang ZQ, Zang WD, Chen R, Ye BW, Wang XW, Yi SH, Chen W, He F, Ye G.","Genet Mol Res. 2013 May 6;12(2):1479-89. doi: 10.4238/2013.May.6.1.","Fang ZQ","Genet Mol Res","2013","2013/06/15","","","10.4238/2013.May.6.1"
"4703119","Studies on tryptophen metabolism in patients with bladder cancer","Gailani S, Murphy G, Kenny G, Nussbaum A, Silvernail P.","Cancer Res. 1973 May;33(5):1071-7.","Gailani S","Cancer Res","1973","1973/05/01","","",""
"19298346","Molecular markers for detection, surveillance and prognostication of bladder cancer","Vrooman OP, Witjes JA.","Int J Urol. 2009 Mar;16(3):234-43. doi: 10.1111/j.1442-2042.2008.02225.x.","Vrooman OP","Int J Urol","2009","2009/03/21","","","10.1111/j.1442-2042.2008.02225.x"
"15199091","Surgical factors influence bladder cancer outcomes: a cooperative group report","Herr HW, Faulkner JR, Grossman HB, Natale RB, deVere White R, Sarosdy MF, Crawford ED.","J Clin Oncol. 2004 Jul 15;22(14):2781-9. doi: 10.1200/JCO.2004.11.024. Epub 2004 Jun 15.","Herr HW","J Clin Oncol","2004","2004/06/17","","","10.1200/JCO.2004.11.024"
"16579943","Microscopic hematuria as a predictive factor for detecting bladder cancer at cystoscopy in women with irritative voiding symptoms","Wu JM, Williams KS, Hundley AF, Jannelli ML, Visco AG.","Am J Obstet Gynecol. 2006 May;194(5):1423-6. doi: 10.1016/j.ajog.2006.01.053. Epub 2006 Mar 30.","Wu JM","Am J Obstet Gynecol","2006","2006/04/04","","","10.1016/j.ajog.2006.01.053"
"8814837","Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder","Philp EA, Stephenson TJ, Reed MW.","Br J Urol. 1996 Mar;77(3):352-7. doi: 10.1046/j.1464-410x.1996.08475.x.","Philp EA","Br J Urol","1996","1996/03/01","","","10.1046/j.1464-410x.1996.08475.x"
"2672015","Low-dose BCG-Pasteur strain in the treatment of superficial bladder cancer: preliminary results","Pagano F, Bassi P, Milani C, Meneghini A, Tuccitto G, Garbeglio A, Guazzieri S.","Prog Clin Biol Res. 1989;310:253-61.","Pagano F","Prog Clin Biol Res","1989","1989/01/01","","",""
"29374709","Non-invasive Detection of Bladder Tumors Through Volatile Organic Compounds: A Pilot Study with an Electronic Nose","Heers H, Gut JM, Hegele A, Hofmann R, Boeselt T, Hattesohl A, Koczulla AR.","Anticancer Res. 2018 Feb;38(2):833-837. doi: 10.21873/anticanres.12291.","Heers H","Anticancer Res","2018","2018/01/29","","","10.21873/anticanres.12291"
"15628536","[Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer]","Yumura Y, Oogo Y, Takase K, Hamano A, Yamashita Y, Noguchi S, Satomi Y.","Hinyokika Kiyo. 2004 Nov;50(11):767-71.","Yumura Y","Hinyokika Kiyo","2004","2005/01/05","","",""
"15701847","Down-regulation of S100C is associated with bladder cancer progression and poor survival","Memon AA, Sorensen BS, Meldgaard P, Fokdal L, Thykjaer T, Nexo E.","Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):606-11.","Memon AA","Clin Cancer Res","2005","2005/02/11","","",""
"9076485","Application of clinical trials to the care of patients with bladder cancer","Hall RR.","Eur Urol. 1997;31 Suppl 1:42-6. doi: 10.1159/000474530.","Hall RR","Eur Urol","1997","1997/01/01","","","10.1159/000474530"
"8709330","Re: Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer","Sun WH, Chan AY, Yiu TF.","J Urol. 1996 Sep;156(3):1137-8. doi: 10.1016/s0022-5347(01)65732-x.","Sun WH","J Urol","1996","1996/09/01","","","10.1016/s0022-5347(01)65732-x"
"31212130","Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-κB signaling","Li G, Wang M, Ren L, Li H, Liu Q, Ouyang Y, He L, Li F.","Biomed Pharmacother. 2019 Sep;117:109112. doi: 10.1016/j.biopha.2019.109112. Epub 2019 Jun 15.","Li G","Biomed Pharmacother","2019","2019/06/19","","","10.1016/j.biopha.2019.109112"
"9387703","[The evaluation of clinical staging by preoperative CT examination in patients with bladder cancer]","Liu D, Chen Q, Tang A.","Zhonghua Wai Ke Za Zhi. 1996 May;34(5):283-5.","Liu D","Zhonghua Wai Ke Za Zhi","1996","1996/05/01","","",""
"7456165","Management of carcinoma in situ of the bladder: the case for surgical management","Utz DC, Farrow GM.","Urol Clin North Am. 1980 Oct;7(3):533-41.","Utz DC","Urol Clin North Am","1980","1980/10/01","","",""
"25305789","Words of wisdom. Re: Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer","Ohno Y.","Eur Urol. 2014 Aug;66(2):391. doi: 10.1016/j.eururo.2014.05.023.","Ohno Y","Eur Urol","2014","2014/10/13","","","10.1016/j.eururo.2014.05.023"
"3301365","Immunotherapy of xenografted human bladder cancer in nude mice using monoclonal antibody","Yu DS, Yeh MY, Chang SY, Ma CP, Han SH.","Eur Urol. 1987;13(3):198-202. doi: 10.1159/000472773.","Yu DS","Eur Urol","1987","1987/01/01","","","10.1159/000472773"
"26504012","Inhibition of Growth of Bladder Cancer Cells by 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one in Combination with Other Compounds Affecting Glucose Metabolism","Lea MA, Altayyar M, desBordes C.","Anticancer Res. 2015 Nov;35(11):5889-99.","Lea MA","Anticancer Res","2015","2015/10/28","","",""
"23510879","Accidental finding of bladder cancer in 99mTc methylene diphosphonate whole-body bone scan","Lin Y, Lu YY, Wang HY, Tsai SC, Lin WY.","Clin Nucl Med. 2013 Aug;38(8):643-5. doi: 10.1097/RLU.0b013e31827087af.","Lin Y","Clin Nucl Med","2013","2013/03/21","","","10.1097/RLU.0b013e31827087af"
"26767648","[Update 2016 - Immunotherapy for urothelial carcinoma]","Retz M, Gschwend JE, Schmid SC.","Urologe A. 2016 Feb;55(2):246-52. doi: 10.1007/s00120-015-0024-y.","Retz M","Urologe A","2016","2016/01/16","","","10.1007/s00120-015-0024-y"
"7609103","New efforts to stage bladder cancer","Droller MJ.","J Urol. 1995 Aug;154(2 Pt 1):385-6.","Droller MJ","J Urol","1995","1995/08/01","","",""
"7801212","[Results of radiotherapy in patients with bladder carcinoma]","Tombolini V, Banelli E, Zotti P, Osti M, Zurlo A, Guidi C, Enrici RM.","Minerva Urol Nefrol. 1994 Sep;46(3):163-6.","Tombolini V","Minerva Urol Nefrol","1994","1994/09/01","","",""
"11019375","[A case of squamous cell carcinoma arising in the urinary bladder diverticulum]","Abe T, Konari S, Obara W, Okamoto T, Fujioka T.","Hinyokika Kiyo. 2000 Aug;46(8):553-5.","Abe T","Hinyokika Kiyo","2000","2000/10/06","","",""
"7950899","DNA flow cytometry as a surrogate end-point in patients with superficial bladder cancer treated with 4-HPR","Decensi A, Curotto A, Bruno S, Costantini M, Torrisi R, Gatteschi B, Cussotto M, Pizzorno R, Quattrini S, Repetto U, et al.","Eur J Cancer Prev. 1994 Jul;3(4):377-9. doi: 10.1097/00008469-199407000-00017.","Decensi A","Eur J Cancer Prev","1994","1994/07/01","","","10.1097/00008469-199407000-00017"
"18192690","Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis","Baffa R, Fassan M, Sevignani C, Vecchione A, Ishii H, Giarnieri E, Iozzo RV, Gomella LG, Croce CM.","Carcinogenesis. 2008 Apr;29(4):846-8. doi: 10.1093/carcin/bgn006. Epub 2008 Jan 12.","Baffa R","Carcinogenesis","2008","2008/01/15","","","10.1093/carcin/bgn006"
"9474882","[Genomic changes in urinary bladder cancer]","Sauter G, Moch H, Wagner U, Bubendorf L, Gasser TC, Mihatsch MJ.","Verh Dtsch Ges Pathol. 1997;81:287-96.","Sauter G","Verh Dtsch Ges Pathol","1997","1997/01/01","","",""
"2405331","[Results obtained by intravesical instillation of BCG in superficial bladder tumors]","Romics I, Dietmar B, Christoph R.","Orv Hetil. 1990 Jan 7;131(1):25-8.","Romics I","Orv Hetil","1990","1990/01/07","","",""
"26429874","URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling","Wu M, Chen J, Wang Y, Hu J, Liu C, Feng C, Zeng X.","Oncotarget. 2015 Oct 13;6(31):30887-901. doi: 10.18632/oncotarget.5134.","Wu M","Oncotarget","2015","2015/10/03","PMC4741575","","10.18632/oncotarget.5134"
"25877676","Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection","Pastore A, Palleschi G, Fuschi A, Silvestri L, Al Salhi Y, Costantini E, Zucchi A, Petrozza V, de Nunzio C, Carbone A.","BMC Cancer. 2015 Mar 13;15:120. doi: 10.1186/s12885-015-1152-x.","Pastore A","BMC Cancer","2015","2015/04/17","PMC4369111","","10.1186/s12885-015-1152-x"
"19103472","Detection of circulating tumor cells in bladder cancer patients","Nezos A, Pissimisis N, Lembessis P, Sourla A, Dimopoulos P, Dimopoulos T, Tzelepis K, Koutsilieris M.","Cancer Treat Rev. 2009 May;35(3):272-9. doi: 10.1016/j.ctrv.2008.11.003. Epub 2008 Dec 21.","Nezos A","Cancer Treat Rev","2009","2008/12/24","","","10.1016/j.ctrv.2008.11.003"
"6876296","Re: Immunotherapy of superficial bladder cancer","Connolly JG.","J Urol. 1983 Aug;130(2):368-9. doi: 10.1016/s0022-5347(17)51159-3.","Connolly JG","J Urol","1983","1983/08/01","","","10.1016/s0022-5347(17)51159-3"
"9749082","[Concurrent radio-chemotherapy in infiltrating cancer of the bladder: a new therapeutic approach?]","Housset M, Dufour B, Durdux C, Chrétien Y, Méjean A, Baillet F.","Cancer Radiother. 1998 Apr;2 Suppl 1:67s-72s.","Housset M","Cancer Radiother","1998","1998/09/28","","",""
"8114853","Bladder preservation after treatment of invasive bladder cancer","Lytton B.","N Engl J Med. 1994 Mar 24;330(12):867; author reply 867-8.","Lytton B","N Engl J Med","1994","1994/03/24","","",""
"31215365","Nanomedicines for Intravesical Chemotherapy in Bladder Cancer","Guo H, Hou Y, Ding J.","Curr Pharm Des. 2019;25(4):371-373. doi: 10.2174/138161282504190516080607.","Guo H","Curr Pharm Des","2019","2019/06/20","","","10.2174/138161282504190516080607"
"10579077","Markers for recurrence of superficial bladder cancer: what is valid?","van der Poel HG.","Curr Opin Urol. 1999 Sep;9(5):401-6. doi: 10.1097/00042307-199909000-00006.","van der Poel HG","Curr Opin Urol","1999","1999/12/01","","","10.1097/00042307-199909000-00006"
"11272669","Orthotopic bladder replacement to the urethra following salvage radical cystoprostatectomy in men with failed radiation therapy","Abbas F, Biyabani SR, Talati J.","Tech Urol. 2001 Mar;7(1):20-6.","Abbas F","Tech Urol","2001","2001/03/29","","",""
"16110407","[Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony]","Steinbach F, Schuster F.","Aktuelle Urol. 2005 Aug;36(4):337-41. doi: 10.1055/s-2004-830188.","Steinbach F","Aktuelle Urol","2005","2005/08/20","","","10.1055/s-2004-830188"
"18468779","EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J; European Association of Urology (EAU).","Eur Urol. 2008 Aug;54(2):303-14. doi: 10.1016/j.eururo.2008.04.051. Epub 2008 Apr 30.","Babjuk M","Eur Urol","2008","2008/05/13","","","10.1016/j.eururo.2008.04.051"
"19322012","Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell","He XD, Wang ZP, Wei HY, Zhou Q, Wang DG, Tian JQ, Fu SJ, Rodriguez R.","Urol Int. 2009;82(2):209-13. doi: 10.1159/000200802. Epub 2009 Mar 19.","He XD","Urol Int","2009","2009/03/27","","","10.1159/000200802"
"20062071","Molecular screening for bladder cancer: progress and potential","Mitra AP, Cote RJ.","Nat Rev Urol. 2010 Jan;7(1):11-20. doi: 10.1038/nrurol.2009.236.","Mitra AP","Nat Rev Urol","2010","2010/01/12","","","10.1038/nrurol.2009.236"
"20958951","Variations in cone beam CT numbers as a function of patient size: in vivo demonstration in bladder cancer patients","Mullen A, Kron T, Thomas J, Foroudi F.","J Med Imaging Radiat Oncol. 2010 Oct;54(5):505-7. doi: 10.1111/j.1754-9485.2010.02203.x.","Mullen A","J Med Imaging Radiat Oncol","2010","2010/10/21","","","10.1111/j.1754-9485.2010.02203.x"
"23052791","A meta-analysis of tea consumption and the risk of bladder cancer","Wang X, Lin YW, Wang S, Wu J, Mao QQ, Zheng XY, Xie LP.","Urol Int. 2013;90(1):10-6. doi: 10.1159/000342804. Epub 2012 Oct 9.","Wang X","Urol Int","2013","2012/10/12","","","10.1159/000342804"
"18315881","Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells","Suttmann H, Retz M, Paulsen F, Harder J, Zwergel U, Kamradt J, Wullich B, Unteregger G, Stöckle M, Lehmann J.","BMC Urol. 2008 Mar 3;8:5. doi: 10.1186/1471-2490-8-5.","Suttmann H","BMC Urol","2008","2008/03/05","PMC2276511","","10.1186/1471-2490-8-5"
"10650816","Expression of vascular endothelial growth factor in primary superficial bladder cancer","Chow NH, Liu HS, Chan SH, Cheng HL, Tzai TS.","Anticancer Res. 1999 Sep-Oct;19(5C):4593-7.","Chow NH","Anticancer Res","1999","2000/01/29","","",""
"7314339","Efficacy of combination therapy with intravesical instillation of doxorubicin and low-dose radiation for bladder cancer. Comparison with Instillation of Doxorubicin alone","Kagawa S, Maebayashi K, Kurokawa K, Uyama T, Moriwaki S.","Urology. 1981 Nov;18(5):478-81. doi: 10.1016/0090-4295(81)90296-x.","Kagawa S","Urology","1981","1981/11/01","","","10.1016/0090-4295(81)90296-x"
"2388320","The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2)","Malkowicz SB, Nichols P, Lieskovsky G, Boyd SD, Huffman J, Skinner DG.","J Urol. 1990 Sep;144(3):641-5. doi: 10.1016/s0022-5347(17)39544-7.","Malkowicz SB","J Urol","1990","1990/09/01","","","10.1016/s0022-5347(17)39544-7"
"6640835","Long-term intra-arterial infusion chemotherapy with adriamycin for advanced bladder cancer","Kanoh S, Umeyama T, Nemoto S, Ishikawa S, Nemoto R, Rinsho K, Yazaki T, Koiso K, Takahashi S, Kitagawa R.","Cancer Chemother Pharmacol. 1983;11 Suppl:S51-8. doi: 10.1007/BF00256719.","Kanoh S","Cancer Chemother Pharmacol","1983","1983/01/01","","","10.1007/BF00256719"
"25800393","Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer","Kamat AM, Flaig TW, Grossman HB, Konety B, Lamm D, O'Donnell MA, Uchio E, Efstathiou JA, Taylor JA 3rd.","Nat Rev Urol. 2015 Apr;12(4):225-35. doi: 10.1038/nrurol.2015.58. Epub 2015 Mar 24.","Kamat AM","Nat Rev Urol","2015","2015/03/25","","","10.1038/nrurol.2015.58"
"3488463","[Study on rosette formation of thymus lymphocytes in the rat treated with BBN inducing urinary bladder cancer. Effect of the thymus humoral factor in vitro]","Ozaki Y.","Nihon Hinyokika Gakkai Zasshi. 1986 Mar;77(3):392-402. doi: 10.5980/jpnjurol1928.77.3_392.","Ozaki Y","Nihon Hinyokika Gakkai Zasshi","1986","1986/03/01","","","10.5980/jpnjurol1928.77.3_392"
"1462097","Critical review of the models to study the biologic progression of bladder cancer","Schalken JA, van Moorselaar RJ, Bringuier PP, Debruyne FM.","Semin Surg Oncol. 1992 Sep-Oct;8(5):274-8. doi: 10.1002/ssu.2980080505.","Schalken JA","Semin Surg Oncol","1992","1992/09/01","","","10.1002/ssu.2980080505"
"7960541","Evaluation of 88 cystectomies for bladder cancer","Kondás J, Diószeghy G, Szentgyörgyi E, Váczi L, Kiss A.","Int Urol Nephrol. 1994;26(3):307-16. doi: 10.1007/BF02768214.","Kondás J","Int Urol Nephrol","1994","1994/01/01","","","10.1007/BF02768214"
"25074594","Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinoma","Yoshida S, Koga F, Masuda H, Fujii Y, Kihara K.","Int J Urol. 2014 Dec;21(12):1190-200. doi: 10.1111/iju.12587. Epub 2014 Jul 30.","Yoshida S","Int J Urol","2014","2014/07/31","","","10.1111/iju.12587"
"17561135","Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base","David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM.","J Urol. 2007 Aug;178(2):451-4. doi: 10.1016/j.juro.2007.03.101. Epub 2007 Jun 11.","David KA","J Urol","2007","2007/06/15","","","10.1016/j.juro.2007.03.101"
"1949367","Multidisciplinary treatment of invasive bladder cancer","Kakehi Y, Nishio Y, Yoshida O.","Urol Int. 1991;47 Suppl 1:120-2. doi: 10.1159/000282269.","Kakehi Y","Urol Int","1991","1991/01/01","","","10.1159/000282269"
"11119441","Economic evaluation of NMP22 in the management of bladder cancer","Lachaine J, Valiquette L, Crott R.","Can J Urol. 2000 Apr;7(2):974-80.","Lachaine J","Can J Urol","2000","2000/12/19","","",""
"31092404","Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer","Washington SL 3rd, Neuhaus J, Meng MV, Porten SP.","Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1339-1344. doi: 10.1158/1055-9965.EPI-18-1280. Epub 2019 May 15.","Washington SL 3rd","Cancer Epidemiol Biomarkers Prev","2019","2019/05/17","PMC6679737","NIHMS1529402","10.1158/1055-9965.EPI-18-1280"
"23978839","Epithelial urinary bladder tumors from cows with enzootic hematuria: structural and cell cycle-related protein expression","Cota JB, Carvalho T, Pinto C, Peleteiro MC.","Vet Pathol. 2014 Jul;51(4):749-54. doi: 10.1177/0300985813501337. Epub 2013 Aug 26.","Cota JB","Vet Pathol","2014","2013/08/28","","","10.1177/0300985813501337"
"24006935","The complexity of bladder cancer: long noncoding RNAs are on the stage","Zhang Q, Su M, Lu G, Wang J.","Mol Cancer. 2013 Sep 5;12(1):101. doi: 10.1186/1476-4598-12-101.","Zhang Q","Mol Cancer","2013","2013/09/07","PMC3846905","","10.1186/1476-4598-12-101"
"28696895","Urinary bladder cancer risk factors in an area of former coal, iron, and steel industries in Germany","Krech E, Selinski S, Blaszkewicz M, Bürger H, Kadhum T, Hengstler JG, Truss MC, Golka K.","J Toxicol Environ Health A. 2017;80(7-8):430-438. doi: 10.1080/10937404.2017.1304719. Epub 2017 Jul 11.","Krech E","J Toxicol Environ Health A","2017","2017/07/12","","","10.1080/10937404.2017.1304719"
"361410","Further experiences with the specific red cell adherence test (SRCA) in bladder cancer. a histological and cytological study","Jakse G, Hofstädter F.","Eur Urol. 1978;4(5):356-60. doi: 10.1159/000473993.","Jakse G","Eur Urol","1978","1978/01/01","","","10.1159/000473993"
"1636227","Epidemiology and etiology of bladder cancer","Cohen SM, Johansson SL.","Urol Clin North Am. 1992 Aug;19(3):421-8.","Cohen SM","Urol Clin North Am","1992","1992/08/01","","",""
"32735882","Isoflurane promotes epithelial-to-mesenchymal transition and metastasis of bladder cancer cells through HIF-1α-β-catenin/Notch1 pathways","Lu N, Piao MH, Feng CS, Yuan Y.","Life Sci. 2020 Oct 1;258:118154. doi: 10.1016/j.lfs.2020.118154. Epub 2020 Jul 28.","Lu N","Life Sci","2020","2020/08/01","","","10.1016/j.lfs.2020.118154"
"20089114","A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results","Pruthi RS, Nielsen M, Heathcote S, Wallen EM, Rathmell WK, Godley P, Whang Y, Fielding J, Schultz H, Grigson G, Smith A, Kim W.","BJU Int. 2010 Aug;106(3):349-54. doi: 10.1111/j.1464-410X.2009.09101.x. Epub 2010 Jan 19.","Pruthi RS","BJU Int","2010","2010/01/22","","","10.1111/j.1464-410X.2009.09101.x"
"18815918","Occupational risk factors","Delclos GL, Lerner SP.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):58-63. doi: 10.1080/03008880802284423.","Delclos GL","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802284423"
"21799048","Bladder cancer determination via two urinary metabolites: a biomarker pattern approach","Huang Z, Lin L, Gao Y, Chen Y, Yan X, Xing J, Hang W.","Mol Cell Proteomics. 2011 Oct;10(10):M111.007922. doi: 10.1074/mcp.M111.007922. Epub 2011 Jul 28.","Huang Z","Mol Cell Proteomics","2011","2011/07/30","PMC3205862","","10.1074/mcp.M111.007922"
"6821840","Bladder cancer etiology. A different perspective","Weinberg DM, Ross RK, Mack TM, Paganini-Hill A, Henderson BE.","Cancer. 1983 Feb 15;51(4):675-80. doi: 10.1002/1097-0142(19830215)51:4<675::aid-cncr2820510421>3.0.co;2-9.","Weinberg DM","Cancer","1983","1983/02/15","","","10.1002/1097-0142(19830215)51:4<675::aid-cncr2820510421>3.0.co;2-9"
"23532915","Network views for personalized medicine","Vlahou A.","Proteomics Clin Appl. 2013 Jun;7(5-6):384-7. doi: 10.1002/prca.201200121. Epub 2013 May 10.","Vlahou A","Proteomics Clin Appl","2013","2013/03/28","","","10.1002/prca.201200121"
"24957100","microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer","Feng Y, Kang Y, He Y, Liu J, Liang B, Yang P, Yu Z.","BMC Urol. 2014 Jun 23;14:50. doi: 10.1186/1471-2490-14-50.","Feng Y","BMC Urol","2014","2014/06/25","PMC4083872","","10.1186/1471-2490-14-50"
"31746333","CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling","Zhang WY, Liu QH, Wang TJ, Zhao J, Cheng XH, Wang JS.","Biosci Rep. 2019 Dec 20;39(12):BSR20192779. doi: 10.1042/BSR20192779.","Zhang WY","Biosci Rep","2019","2019/11/21","PMC6893170","","10.1042/BSR20192779"
"5903863","Heterotransplantation of bladder cancer in the hamster cheek pouch: in vivo testing of cancer chemotherapeutic agents","Burt FB, Pavone-Macaluso M, Horns JW, Kaufman JJ.","J Urol. 1966 Jan;95(1):51-7. doi: 10.1016/s0022-5347(17)63406-2.","Burt FB","J Urol","1966","1966/01/01","","","10.1016/s0022-5347(17)63406-2"
"28290459","Contemporary update on neoadjuvant therapy for bladder cancer","Nguyen DP, Thalmann GN.","Nat Rev Urol. 2017 Jun;14(6):348-358. doi: 10.1038/nrurol.2017.30. Epub 2017 Mar 14.","Nguyen DP","Nat Rev Urol","2017","2017/03/15","","","10.1038/nrurol.2017.30"
"12674770","Adenovirus-mediated transfer of p53 and p16 inhibiting proliferating activity of human bladder cancer cell EJ in vitro and in vivo","Zhu Z, Xing S, Lin C, Zeng F, Lu G, Fu M, Zhang X, Liang X, Wu M.","J Huazhong Univ Sci Technolog Med Sci. 2002;22(4):324-6. doi: 10.1007/BF02896776.","Zhu Z","J Huazhong Univ Sci Technolog Med Sci","2002","2003/04/05","","","10.1007/BF02896776"
"8664914","[pT1G3 bladder carcinoma: parameters of a correct therapy]","Ruoppolo M, Dell'Orto P, Fenice O, Seveso M, Ferri P, Zaatar C, Tagliaferri A, Cogni M, Bellorofonte G, Tombolini P.","Arch Ital Urol Androl. 1996 Feb;68(1):17-20.","Ruoppolo M","Arch Ital Urol Androl","1996","1996/02/01","","",""
"6656729","[Staging of cancer of the bladder. Current status and prospects]","D'Addessi A, Giustacchini M, Destito A, Sasso F, Alcini E.","Minerva Urol. 1983 Jul-Sep;35(3):187-93.","D'Addessi A","Minerva Urol","1983","1983/07/01","","",""
"26684800","Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer","Shi Z, Li X, Wu D, Tang R, Chen R, Xue S, Sun X.","Tumour Biol. 2016 Jun;37(6):7515-23. doi: 10.1007/s13277-015-4625-2. Epub 2015 Dec 18.","Shi Z","Tumour Biol","2016","2015/12/20","","","10.1007/s13277-015-4625-2"
"18449376","Possible role of cyclooxygenase-2 in schistosomal and non-schistosomal-associated bladder cancer","Hammam OA, Aziz AA, Roshdy MS, Abdel Hadi AM.","Medscape J Med. 2008 Mar 11;10(3):60.","Hammam OA","Medscape J Med","2008","2008/05/02","PMC2329780","",""
"28013415","Prognostic impact of preoperative anemia on non-muscle-invasive bladder carcinoma treated with GreenLight laser vaporization","Luo F, Wang YS, Su YH, Zhang ZH, Sun HH, Li J.","Lasers Med Sci. 2017 Feb;32(2):397-403. doi: 10.1007/s10103-016-2133-2. Epub 2016 Dec 24.","Luo F","Lasers Med Sci","2017","2016/12/26","","","10.1007/s10103-016-2133-2"
"23083854","Detecting DNA methylation of the BCL2, CDKN2A and NID2 genes in urine using a nested methylation specific polymerase chain reaction assay to predict bladder cancer","Scher MB, Elbaum MB, Mogilevkin Y, Hilbert DW, Mydlo JH, Sidi AA, Adelson ME, Mordechai E, Trama JP.","J Urol. 2012 Dec;188(6):2101-7. doi: 10.1016/j.juro.2012.08.015. Epub 2012 Oct 18.","Scher MB","J Urol","2012","2012/10/23","","","10.1016/j.juro.2012.08.015"
"20478593","Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors","Alkhateeb SS, Van Rhijn BW, Finelli A, van der Kwast T, Evans A, Hanna S, Vajpeyi R, Fleshner NE, Jewett MA, Zlotta AR.","J Urol. 2010 Jul;184(1):81-6. doi: 10.1016/j.juro.2010.03.022. Epub 2010 May 15.","Alkhateeb SS","J Urol","2010","2010/05/19","","","10.1016/j.juro.2010.03.022"
"25109573","T1G3 bladder cancer and Bacillus Calmette-Guérin: tell me something we don't know","Yates DR.","Eur Urol. 2015 Jan;67(1):83-84. doi: 10.1016/j.eururo.2014.07.019. Epub 2014 Aug 7.","Yates DR","Eur Urol","2015","2014/08/12","","","10.1016/j.eururo.2014.07.019"
"21950136","[Peculiarities of urinary bladder cancer tumor cells apoptosis response on neoadjuvant chemotherapy]","Iatsyna AI, Stakhovskiĭ ÉA, Sheremet IaA, Spivak SI, Stakhovskiĭ AÉ, Gavriliuk ON, Vitruk IuV, Emets AI, Blium IaB.","Tsitol Genet. 2011 Jul-Aug;45(4):3-8.","Iatsyna AI","Tsitol Genet","2011","2011/09/29","","",""
"24892391","Review of a series of cystectomies in women for bladder cancer:Complications and quality of life","Fuentes J, Ramos E, Truan D, Portillo JA, Campos-Juanatey F, Gala L, Meidavilla E, Dominguez M, Gutierrez JL.","Arch Esp Urol. 2014 May;67(4):303-12.","Fuentes J","Arch Esp Urol","2014","2014/06/04","","",""
"3101140","The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy","Duncan W, Quilty PM.","Radiother Oncol. 1986 Dec;7(4):299-310. doi: 10.1016/s0167-8140(86)80059-7.","Duncan W","Radiother Oncol","1986","1986/12/01","","","10.1016/s0167-8140(86)80059-7"
"25882559","Trimodality therapy in bladder cancer: who, what, and when?","Premo C, Apolo AB, Agarwal PK, Citrin DE.","Urol Clin North Am. 2015 May;42(2):169-80, vii. doi: 10.1016/j.ucl.2015.02.002.","Premo C","Urol Clin North Am","2015","2015/04/18","PMC4465095","NIHMS668221","10.1016/j.ucl.2015.02.002"
"23707452","The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer?","Linder BJ, Boorjian SA, Cheville JC, Sukov WR, Thapa P, Tarrell RF, Frank I.","J Urol. 2013 Nov;190(5):1692-6. doi: 10.1016/j.juro.2013.05.040. Epub 2013 May 23.","Linder BJ","J Urol","2013","2013/05/28","","","10.1016/j.juro.2013.05.040"
"12074806","Molecular aspects of bladder cancer IV: gene therapy of bladder cancer","Ardelt P, Böhle A.","Eur Urol. 2002 Apr;41(4):372-80; discussion 380-1. doi: 10.1016/s0302-2838(02)00034-9.","Ardelt P","Eur Urol","2002","2002/06/21","","","10.1016/s0302-2838(02)00034-9"
"1713182","Treatment decisions in end-stage bladder cancer. Bilingual liaison rounds","Lima J, Cohen MA.","Gen Hosp Psychiatry. 1991 May;13(3):209-12. doi: 10.1016/0163-8343(91)90144-l.","Lima J","Gen Hosp Psychiatry","1991","1991/05/01","","","10.1016/0163-8343(91)90144-l"
"11101094","Management dilemmas in bladder cancer: radical TUR +/- systemic chemotherapy in the treatment of muscle-invasive bladder cancer","Feneley MR, Mellon JK.","Semin Urol Oncol. 2000 Nov;18(4):300-7.","Feneley MR","Semin Urol Oncol","2000","2000/12/02","","",""
"23887292","CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response","Seiler R, Thalmann GN, Rotzer D, Perren A, Fleischmann A.","Mod Pathol. 2014 Jan;27(1):87-95. doi: 10.1038/modpathol.2013.125. Epub 2013 Jul 26.","Seiler R","Mod Pathol","2014","2013/07/27","","","10.1038/modpathol.2013.125"
"15041703","Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel","Dulaimi E, Uzzo RG, Greenberg RE, Al-Saleem T, Cairns P.","Clin Cancer Res. 2004 Mar 15;10(6):1887-93. doi: 10.1158/1078-0432.ccr-03-0127.","Dulaimi E","Clin Cancer Res","2004","2004/03/26","","","10.1158/1078-0432.ccr-03-0127"
"9720515","Prognostic markers in bladder cancer: a contemporary review of the literature","Stein JP, Grossfeld GD, Ginsberg DA, Esrig D, Freeman JA, Figueroa AJ, Skinner DG, Cote RJ.","J Urol. 1998 Sep;160(3 Pt 1):645-59.","Stein JP","J Urol","1998","1998/08/28","","",""
"27381893","Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project","Schmitz-Dräger C, Bonberg N, Pesch B, Todenhöfer T, Sahin S, Behrens T, Brüning T, Schmitz-Dräger BJ.","Urol Oncol. 2016 Oct;34(10):452-9. doi: 10.1016/j.urolonc.2016.06.001. Epub 2016 Jul 2.","Schmitz-Dräger C","Urol Oncol","2016","2016/07/07","","","10.1016/j.urolonc.2016.06.001"
"12050495","Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial","Goebell PJ, Otto T, Suhr J, Rübben H.","J Urol. 2002 Jul;168(1):72-5.","Goebell PJ","J Urol","2002","2002/06/07","","",""
"16864852","Are nomograms better than currently available stage groupings for bladder cancer?","Sternberg CN.","J Clin Oncol. 2006 Aug 20;24(24):3819-20. doi: 10.1200/JCO.2006.07.1290. Epub 2006 Jul 24.","Sternberg CN","J Clin Oncol","2006","2006/07/26","","","10.1200/JCO.2006.07.1290"
"12701477","[Staging of infiltrating bladder cancer. Role of C.T. scan]","Blanco Díez A, Ruibal Moldes M, Suárez Pascual G, Fernández Rosado E, Gómez Veiga F, Alvarez Castelo L, Chantada Abal V, González Martín M.","Arch Esp Urol. 2003 Jan-Feb;56(1):23-9.","Blanco Díez A","Arch Esp Urol","2003","2003/04/19","","",""
"5041565","Rapid induction of bladder cancer in rats with N-methyl-N-nitrosourea. I. Histology","Hicks RM, Wakefield JS.","Chem Biol Interact. 1972 Jul;5(2):139-52. doi: 10.1016/0009-2797(72)90040-3.","Hicks RM","Chem Biol Interact","1972","1972/07/01","","","10.1016/0009-2797(72)90040-3"
"11376567","Suicide gene therapy for chemically induced rat bladder tumor entailing instillation of adenoviral vectors","Akasaka S, Suzuki S, Shimizu H, Igarashi T, Akimoto M, Shimada T.","Jpn J Cancer Res. 2001 May;92(5):568-75. doi: 10.1111/j.1349-7006.2001.tb01131.x.","Akasaka S","Jpn J Cancer Res","2001","2001/05/30","PMC5926741","","10.1111/j.1349-7006.2001.tb01131.x"
"20812047","[Diagnostic work-up and treatment of bladder cancer: current developments]","Ohlmann CH, Stöckle M.","Urologe A. 2010 Sep;49 Suppl 1:172-7. doi: 10.1007/s00120-010-2377-6.","Ohlmann CH","Urologe A","2010","2010/09/03","","","10.1007/s00120-010-2377-6"
"20271761","The treatment of bladder cancer","SHACKMAN R.","Br J Surg. 1947 Oct;35(138):140-6. doi: 10.1002/bjs.18003513806.","SHACKMAN R","Br J Surg","1947","2010/03/19","","","10.1002/bjs.18003513806"
"6640836","Intra-arterial adriamycin chemotherapy for bladder cancer. Semiselective intra-arterial chemotherapy with compression of the femoral arteries at the time of injection","Uyama T, Moriwaki S, Yonezawa M, Fujita J.","Cancer Chemother Pharmacol. 1983;11 Suppl:S59-63.","Uyama T","Cancer Chemother Pharmacol","1983","1983/01/01","","",""
"8950440","Surgery for the urinary tract cancer","Lukkarinen O.","Ann Chir Gynaecol. 1996;85(3):202-6.","Lukkarinen O","Ann Chir Gynaecol","1996","1996/01/01","","",""
"1785383","[Current status of continent urinary reservoirs for invasive bladder cancer patients undergoing total cystectomy]","Okada Y, Tomoyoshi T, Yoshida O, Oishi K, Arai Y, Okabe T, Kawakita M, Kamoto T.","Hinyokika Kiyo. 1991 Dec;37(12):1613-9.","Okada Y","Hinyokika Kiyo","1991","1991/12/01","","",""
"6864915","Bladder cancer: factors affecting survival","Narayana AS, Loening SA, Slymen DJ, Culp DA.","J Urol. 1983 Jul;130(1):56-60. doi: 10.1016/s0022-5347(17)50952-0.","Narayana AS","J Urol","1983","1983/07/01","","","10.1016/s0022-5347(17)50952-0"
"16580504","Tumor motion and deformation during external radiotherapy of bladder cancer","Lotz HT, Pos FJ, Hulshof MC, van Herk M, Lebesque JV, Duppen JC, Remeijer P.","Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1551-8. doi: 10.1016/j.ijrobp.2005.12.025.","Lotz HT","Int J Radiat Oncol Biol Phys","2006","2006/04/04","","","10.1016/j.ijrobp.2005.12.025"
"28889385","The N-butyl-N-4-hydroxybutyl Nitrosamine Mouse Urinary Bladder Cancer Model","Oliveira PA, Vasconcelos-Nóbrega C, Gil da Costa RM, Arantes-Rodrigues R.","Methods Mol Biol. 2018;1655:155-167. doi: 10.1007/978-1-4939-7234-0_13.","Oliveira PA","Methods Mol Biol","2018","2017/09/11","","","10.1007/978-1-4939-7234-0_13"
"26230496","Quantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC Method","Yang G, Xu Z, Lu W, Li X, Sun C, Guo J, Xue P, Guan F.","PLoS One. 2015 Jul 31;10(7):e0134727. doi: 10.1371/journal.pone.0134727. eCollection 2015.","Yang G","PLoS One","2015","2015/08/01","PMC4521931","","10.1371/journal.pone.0134727"
"2804562","B5 tumour marker and urine cytology in diagnosis and follow-up of transitional cell bladder cancer","Malpani K, Metcalfe SM, Hinchliffe A.","Br J Urol. 1989 Sep;64(3):257-62. doi: 10.1111/j.1464-410x.1989.tb06009.x.","Malpani K","Br J Urol","1989","1989/09/01","","","10.1111/j.1464-410x.1989.tb06009.x"
"10687970","Comparison of molecular and conventional strategies for followup of superficial bladder cancer using decision analysis","Nam RK, Redelmeier DA, Spiess PE, Sampson HA, Fradet Y, Jewett MA.","J Urol. 2000 Mar;163(3):752-7.","Nam RK","J Urol","2000","2000/02/25","","",""
"20709377","Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies","Zhang M, Tao R, Zhang C, Shen Z.","Urology. 2010 Oct;76(4):902-7. doi: 10.1016/j.urology.2010.05.007. Epub 2010 Aug 14.","Zhang M","Urology","2010","2010/08/17","","","10.1016/j.urology.2010.05.007"
"22490897","[Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer]","Zhang Z, Hao H, Zhang CJ, Yang XY, He Q, Lin J.","Zhonghua Yi Xue Za Zhi. 2012 Feb 14;92(6):384-7.","Zhang Z","Zhonghua Yi Xue Za Zhi","2012","2012/04/12","","",""
"27871055","Microfluidic device for label-free quantitation and distinction of bladder cancer cells from the blood cells using micro machined silicon based electrical approach; suitable in urinalysis assays","Hosseini SA, Zanganeh S, Akbarnejad E, Salehi F, Abdolahad M.","J Pharm Biomed Anal. 2017 Feb 5;134:36-42. doi: 10.1016/j.jpba.2016.11.026. Epub 2016 Nov 13.","Hosseini SA","J Pharm Biomed Anal","2017","2016/11/22","","","10.1016/j.jpba.2016.11.026"
"9801132","MVAC chemotherapy-induced apoptosis and p53 alterations in the rat model of bladder cancer","Zhang X, Jin L, Takenaka I.","Urology. 1998 Nov;52(5):925-31. doi: 10.1016/s0090-4295(98)00364-1.","Zhang X","Urology","1998","1998/11/04","","","10.1016/s0090-4295(98)00364-1"
"10601583","Expression of the alpha6beta4 integrin provides prognostic information in bladder cancer","Grossman HB, Lee C, Bromberg J, Liebert M.","Oncol Rep. 2000 Jan-Feb;7(1):13-6.","Grossman HB","Oncol Rep","2000","1999/12/22","","",""
"11695203","Coding criteria of bladder cancer: effects on estimating survival","Patriarca S, Gafà L, Ferretti S, Vitarelli S, Cesaraccio R, Crocetti E, Ferrante MC, Rollo P, Tagliabue G.","Epidemiol Prev. 2001;25(3 Suppl):42-7.","Patriarca S","Epidemiol Prev","2001","2001/11/07","","",""
"27363065","Diagnostic Value of Urine Cytology in Bladder Cancer. A Meta-Analysis","Xie Q, Huang Z, Zhu Z, Zheng X, Liu J, Zhang M, Zhang Y.","Anal Quant Cytopathol Histpathol. 2016 Feb;38(1):38-44.","Xie Q","Anal Quant Cytopathol Histpathol","2016","2016/07/02","","",""
"31781877","Radical Cystectomy in Female Patients - Improving Outcomes","Kalampokis N, Grivas N, Ölschläger M, Hassan FN, Gakis G.","Curr Urol Rep. 2019 Nov 28;20(12):83. doi: 10.1007/s11934-019-0951-z.","Kalampokis N","Curr Urol Rep","2019","2019/11/30","","","10.1007/s11934-019-0951-z"
"30352837","MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2","Wang S, Zhang G, Zheng W, Xue Q, Wei D, Zheng Y, Yuan J.","Biosci Rep. 2018 Dec 7;38(6):BSR20181436. doi: 10.1042/BSR20181436. Print 2018 Dec 21.","Wang S","Biosci Rep","2018","2018/10/25","PMC6435551","","10.1042/BSR20181436"
"23374291","Does phosphorylation of cofilin affect the progression of human bladder cancer?","Chung H, Kim B, Jung SH, Won KJ, Jiang X, Lee CK, Lim SD, Yang SK, Song KH, Kim HS.","BMC Cancer. 2013 Feb 1;13:45. doi: 10.1186/1471-2407-13-45.","Chung H","BMC Cancer","2013","2013/02/05","PMC3568060","","10.1186/1471-2407-13-45"
"4982980","[The radiological treatment of deeply infiltrating bladder cancer (T3-T4)]","Tholen JM.","Ned Tijdschr Geneeskd. 1969 Dec 20;113(51):2309-10.","Tholen JM","Ned Tijdschr Geneeskd","1969","1969/12/20","","",""
"26094388","[MODIFIED INTRAVESICAL CHEMOTHERAPY OF BLADDER CANCER]","Shevchenko AN, Shihjarova AI, Filatova EV, Tarnopol'skaja OV, Kurkina TA, Seleznev SG, Homutenko IA, Shvyrev DA.","Urologiia. 2015 Jan-Feb;(1):54-7.","Shevchenko AN","Urologiia","2015","2015/06/23","","",""
"30327148","Influence of the laparoscopic approach on cancer-specific mortality of patients with stage pt3-4 bladder cancer treated with cystectomy","Subirá-Ríos D, Herranz-Amo F, Moralejo-Gárate M, Caño-Velasco J, Renedo-Villar T, Barbas-Bernardos G, Bueno-Chomón G, Rodríguez-Fernández E, Hernández-Fernández C.","Actas Urol Esp. 2019 Mar;43(2):71-76. doi: 10.1016/j.acuro.2018.06.009. Epub 2018 Oct 13.","Subirá-Ríos D","Actas Urol Esp","2019","2018/10/18","","","10.1016/j.acuro.2018.06.009"
"27457483","Ct2 Bladder Cancer","Soloway MS.","Curr Urol Rep. 2016 Sep;17(9):66. doi: 10.1007/s11934-016-0624-0.","Soloway MS","Curr Urol Rep","2016","2016/07/27","","","10.1007/s11934-016-0624-0"
"7742594","Interphase cytogenetic studies of bladder cancer","Wang MR, Perissel B, Taillandier J, Malet P.","Bull Cancer. 1994 Dec;81(12):1060-6.","Wang MR","Bull Cancer","1994","1994/12/01","","",""
"8839387","Introduction of wild-type p53 gene downregulates the expression of H-ras gene and suppresses the growth of bladder cancer cells","Li M, Gu FL, Li WB, Song YS, Zhou AR, Guo YL.","Urol Res. 1995;23(5):311-314. doi: 10.1007/BF00300019.","Li M","Urol Res","1995","1995/01/01","","","10.1007/BF00300019"
"741535","Cancer of the bilharzial bladder","Elsebai I.","Urol Res. 1978;6(4):233-6. doi: 10.1007/BF00262625.","Elsebai I","Urol Res","1978","1978/01/01","","","10.1007/BF00262625"
"18727617","Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease","Guzzo TJ, Rogers CG, Deng CY, Bivalacqua TJ, Palapattu GS, Bastian PJ, Eisenberger MA, Schoenberg MP, Gonzalgo ML.","BJU Int. 2008 Dec;102(11):1539-43. doi: 10.1111/j.1464-410X.2008.07877.x. Epub 2008 Aug 22.","Guzzo TJ","BJU Int","2008","2008/08/30","","","10.1111/j.1464-410X.2008.07877.x"
"20230393","Influence of clinical information on the interpretation of urinary cytology in bladder cancer: how suggestible is a cytologist?","Tritschler S, Karl A, Sommer ML, Straub J, Strittmatter F, Tilki D, Hocaoglu Y, Stief C, Zaak D.","BJU Int. 2010 Oct;106(8):1165-8. doi: 10.1111/j.1464-410X.2010.09285.x.","Tritschler S","BJU Int","2010","2010/03/17","","","10.1111/j.1464-410X.2010.09285.x"
"22010397","Bladder cancer: time for a rethink?","Bryan RT, James ND.","Oncology (Williston Park). 2011 Sep;25(10):965, 968.","Bryan RT","Oncology (Williston Park)","2011","2011/10/21","","",""
"28753837","Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy","Kukreja JB, Porten S, Golla V, Ho PL, Noguera-Gonzalez G, Navai N, Kamat AM, Dinney CPN, Shah JB.","Eur Urol Focus. 2018 Sep;4(5):720-724. doi: 10.1016/j.euf.2016.12.005. Epub 2017 Jan 18.","Kukreja JB","Eur Urol Focus","2018","2017/07/30","","","10.1016/j.euf.2016.12.005"
"14501243","Detection of bladder tumours: role of cytology, morphology-based assays, biochemical and molecular markers","Eissa S, Kassim S, El-Ahmady O.","Curr Opin Obstet Gynecol. 2003 Oct;15(5):395-403. doi: 10.1097/00001703-200310000-00008.","Eissa S","Curr Opin Obstet Gynecol","2003","2003/09/23","","","10.1097/00001703-200310000-00008"
"16740038","Dual-track pathway of bladder carcinogenesis: practical implications","Spiess PE, Czerniak B.","Arch Pathol Lab Med. 2006 Jun;130(6):844-52. doi: 10.1043/1543-2165(2006)130[844:DPOBCP]2.0.CO;2.","Spiess PE","Arch Pathol Lab Med","2006","2006/06/03","","","10.1043/1543-2165(2006)130[844:DPOBCP]2.0.CO;2"
"8533691","[A case of leiomyosarcoma of the diverticulum of urinary bladder]","Takei K, Ito H, Masai M, Kotake T, Ishida Y, Nagao K.","Hinyokika Kiyo. 1995 Nov;41(11):883-6.","Takei K","Hinyokika Kiyo","1995","1995/11/01","","",""
"15010867","Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients","Obermann EC, Meyer S, Hellge D, Zaak D, Filbeck T, Stoehr R, Hofstaedter F, Hartmann A, Knuechel R.","Oncol Rep. 2004 Apr;11(4):745-51.","Obermann EC","Oncol Rep","2004","2004/03/11","","",""
"24856504","Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer","Zhao J, Dong D, Sun L, Zhang G, Sun L.","Int Braz J Urol. 2014 Mar-Apr;40(2):179-89. doi: 10.1590/S1677-5538.IBJU.2014.02.07.","Zhao J","Int Braz J Urol","2014","2014/05/27","","","10.1590/S1677-5538.IBJU.2014.02.07"
"31130343","Significance of CLASP2 expression in prognosis for muscle-invasive bladder cancer patients: A propensity score-based analysis","Chen L, Xiong W, Guo W, Su S, Qi L, Zhu B, Mo M, Jiang H, Li Y.","Urol Oncol. 2019 Oct;37(10):800-807. doi: 10.1016/j.urolonc.2019.05.003. Epub 2019 May 24.","Chen L","Urol Oncol","2019","2019/05/28","","","10.1016/j.urolonc.2019.05.003"
"3898647","[Diagnosis of urinary bladder cancer by transurethral sonography]","Jaeger N, Radeke HW, Vahlensieck W.","Z Urol Nephrol. 1985 Jun;78(6):323-9.","Jaeger N","Z Urol Nephrol","1985","1985/06/01","","",""
"27919999","Predicting Survival After Irradiation of Metastases from Transitional Carcinoma of the Bladder","Manig L, Käsmann L, Janssen S, Rades D.","Anticancer Res. 2016 Dec;36(12):6663-6665. doi: 10.21873/anticanres.11275.","Manig L","Anticancer Res","2016","2016/12/07","","","10.21873/anticanres.11275"
"9074842","Current recommendations for the management of bladder cancer. Drug therapy","Witjes JA.","Drugs. 1997 Mar;53(3):404-14. doi: 10.2165/00003495-199753030-00005.","Witjes JA","Drugs","1997","1997/03/01","","","10.2165/00003495-199753030-00005"
"11228536","An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies","Watanabe T, Shinohara N, Sazawa A, Harabayashi T, Ogiso Y, Koyanagi T, Takiguchi M, Hashimoto A, Kuzumaki N, Yamashita M, Tanaka M, Grossman HB, Benedict WF.","Cancer Gene Ther. 2000 Dec;7(12):1575-80. doi: 10.1038/sj.cgt.7700261.","Watanabe T","Cancer Gene Ther","2000","2001/03/03","","","10.1038/sj.cgt.7700261"
"27212042","Female, Black, and Unmarried Patients Are More Likely to Present With Metastatic Bladder Urothelial Carcinoma","Klaassen Z, DiBianco JM, Jen RP, Evans AJ, Reinstatler L, Terris MK, Madi R.","Clin Genitourin Cancer. 2016 Oct;14(5):e489-e492. doi: 10.1016/j.clgc.2016.04.006. Epub 2016 Apr 29.","Klaassen Z","Clin Genitourin Cancer","2016","2016/05/24","","","10.1016/j.clgc.2016.04.006"
"5858906","[Pathogenesis of bladder cancer]","Wolf H, Iversen HG.","Nord Med. 1965 Dec 23;74(51):1309-14.","Wolf H","Nord Med","1965","1965/12/23","","",""
"2111194","Clinical studies on cell-mediated immunity in patients with urinary bladder carcinoma: blastogenic response, interleukin-2 production and interferon-gamma production of lymphocytes","Ikemoto S, Kishimoto T, Wada S, Nishio S, Maekawa M.","Br J Urol. 1990 Apr;65(4):333-8. doi: 10.1111/j.1464-410x.1990.tb14751.x.","Ikemoto S","Br J Urol","1990","1990/04/01","","","10.1111/j.1464-410x.1990.tb14751.x"
"10427132","Subsequential telomerase activity in exfoliated urinary cells detects recurrent disease in bladder cancer after transurethral resection","Kitsukawa SI, Ohyashiki K, Yahata N, Ebihara Y, Aizawa T, Ito T, Miki M.","Int J Oncol. 1999 Sep;15(3):505-10. doi: 10.3892/ijo.15.3.505.","Kitsukawa SI","Int J Oncol","1999","1999/07/31","","","10.3892/ijo.15.3.505"
"24354110","Validation of the urostomy education scale: the European experience","Jensen BT, de Blok W, Kiesbye B, Kristensen SA.","Urol Nurs. 2013 Sep-Oct;33(5):219-29.","Jensen BT","Urol Nurs","2013","2013/12/21","","",""
"24568895","Reply from authors re: Cora N. Sternberg, Richard Sylvester. Thoughts on a systematic review and meta-analysis of adjuvant chemotherapy in muscle-invasive bladder cancer. Eur Urol 2014;66:55-6","Leow JJ, Chang SL, Bellmunt J.","Eur Urol. 2014 Jul;66(1):57-8. doi: 10.1016/j.eururo.2014.02.006. Epub 2014 Feb 14.","Leow JJ","Eur Urol","2014","2014/02/27","","","10.1016/j.eururo.2014.02.006"
"30911812","Utility of the EORTC risk tables and CUETO scoring model for predicting recurrence and progression in non-muscle-invasive bladder cancer patients treated with routine second transurethral resection","Zhang G, Steinbach D, Grimm MO, Horstmann M.","World J Urol. 2019 Dec;37(12):2699-2705. doi: 10.1007/s00345-019-02681-2. Epub 2019 Mar 25.","Zhang G","World J Urol","2019","2019/03/27","","","10.1007/s00345-019-02681-2"
"15020658","Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis","Takahashi A, Tsukamoto T, Tobisu K, Shinohara N, Sato K, Tomita Y, Komatsubara S, Nishizawa O, Igarashi T, Fujimoto H, Nakazawa H, Komatsu H, Sugimura Y, Ono Y, Kuroda M, Ogawa O, Hirao Y, Hayashi T, Tsushima T, Kakehi Y, Arai Y, Ueda S, Nakagawa M.","Jpn J Clin Oncol. 2004 Jan;34(1):14-9. doi: 10.1093/jjco/hyh005.","Takahashi A","Jpn J Clin Oncol","2004","2004/03/17","","","10.1093/jjco/hyh005"
"7472774","Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities","Matsumura Y, Sugiyama M, Matsumura S, Hayle AJ, Robinson P, Smith JC, Tarin D.","J Pathol. 1995 Sep;177(1):11-20. doi: 10.1002/path.1711770104.","Matsumura Y","J Pathol","1995","1995/09/01","","","10.1002/path.1711770104"
"5151094","[Cancer in bladder exstrophy]","Gubler JP, Chelloul N.","Ann Chir Infant. 1971 Nov-Dec;12(6):475-8.","Gubler JP","Ann Chir Infant","1971","1971/11/01","","",""
"15610858","Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis","Khaled HM, Aly MS, Mokhtar N.","Urol Oncol. 2004 Nov-Dec;22(6):443-7. doi: 10.1016/j.urolonc.2004.07.015.","Khaled HM","Urol Oncol","2004","2004/12/22","","","10.1016/j.urolonc.2004.07.015"
"29023722","Prevalence and clonality of synchronous primary carcinomas in the bladder and prostate","Jing Y, Zhang R, Ma P, Cai MC, Zhuang G, Chen H.","J Pathol. 2018 Jan;244(1):5-10. doi: 10.1002/path.4997.","Jing Y","J Pathol","2018","2017/10/13","","","10.1002/path.4997"
"2116674","Conventionally administered preoperative radiotherapy in urinary bladder cancer","Salminen E.","Strahlenther Onkol. 1990 Jul;166(7):443-5.","Salminen E","Strahlenther Onkol","1990","1990/07/01","","",""
"29633803","Conservative management of a bladder leiomyosarcoma in a 43-year-old patient","Anastasiou A, Katafigiotis I, Skoufias S, Anastasiou I, Constantinides C.","Arch Ital Urol Androl. 2018 Mar 31;90(1):70-71. doi: 10.4081/aiua.2018.1.70.","Anastasiou A","Arch Ital Urol Androl","2018","2018/04/11","","","10.4081/aiua.2018.1.70"
"23608203","[Kodamaea ohmeri: fungemia in a patient with invasive bladder cancer]","de Miguel-Martinez I, Carrillo-Quintero D, Cano-Lira JF, Ojeda-Vargas M.","Enferm Infecc Microbiol Clin. 2013 Nov;31(9):633-4. doi: 10.1016/j.eimc.2013.03.007. Epub 2013 Apr 19.","de Miguel-Martinez I","Enferm Infecc Microbiol Clin","2013","2013/04/24","","","10.1016/j.eimc.2013.03.007"
"22574784","Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34","Ajili F, Kacem M, Tounsi H, Darouiche A, Enayfer E, Chebi M, Manai M, Boubaker S.","Ultrastruct Pathol. 2012 Oct;36(5):336-42. doi: 10.3109/01913123.2012.672847. Epub 2012 May 10.","Ajili F","Ultrastruct Pathol","2012","2012/05/12","","","10.3109/01913123.2012.672847"
"1324833","Occupational exposure to asbestos and urinary bladder cancer","Molinini R, Paoletti L, Albrizio M, Pennella A, Nardulli F, Caruso G.","Environ Res. 1992 Aug;58(2):176-83. doi: 10.1016/s0013-9351(05)80213-0.","Molinini R","Environ Res","1992","1992/08/01","","","10.1016/s0013-9351(05)80213-0"
"19827894","A descriptive retrospective study of bladder cancer at a hospital in Iran (1973-2003)","Yavari P, Sadrolhefazi B, Mohagheghi MA, Mehrazin R.","Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):681-4.","Yavari P","Asian Pac J Cancer Prev","2009","2009/10/16","","",""
"6832095","Modifying factors in urinary bladder carcinogenesis","Ito N, Fukushima S, Shirai T, Nakanishi K, Hasegawa R, Imaida K.","Environ Health Perspect. 1983 Mar;49:217-22. doi: 10.1289/ehp.8349217.","Ito N","Environ Health Perspect","1983","1983/03/01","PMC1569132","","10.1289/ehp.8349217"
"20400716","Use of radical cystectomy for patients with invasive bladder cancer","Gore JL, Litwin MS, Lai J, Yano EM, Madison R, Setodji C, Adams JL, Saigal CS; Urologic Diseases in America Project.","J Natl Cancer Inst. 2010 Jun 2;102(11):802-11. doi: 10.1093/jnci/djq121. Epub 2010 Apr 16.","Gore JL","J Natl Cancer Inst","2010","2010/04/20","PMC3245689","","10.1093/jnci/djq121"
"28427222","Prognostic role of matrix metalloproteinases in bladder carcinoma: a systematic review and meta-analysis","Miao C, Liang C, Zhu J, Xu A, Zhao K, Hua Y, Zhang J, Chen W, Suo C, Zhang C, Liu Y, Su S, Wang Z.","Oncotarget. 2017 May 9;8(19):32309-32321. doi: 10.18632/oncotarget.15907.","Miao C","Oncotarget","2017","2017/04/22","PMC5458286","","10.18632/oncotarget.15907"
"24314030","Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity","Chang L, Shi R, Yang T, Li F, Li G, Guo Y, Lang B, Yang W, Zhuang Q, Xu H.","J Exp Clin Cancer Res. 2013 Dec 8;32(1):101. doi: 10.1186/1756-9966-32-101.","Chang L","J Exp Clin Cancer Res","2013","2013/12/10","PMC3880093","","10.1186/1756-9966-32-101"
"24837807","Bioactive exosomes: possibilities for diagnosis and management of bladder cancer","Street JM, Yuen PS, Star RA.","J Urol. 2014 Aug;192(2):297-8. doi: 10.1016/j.juro.2014.05.050. Epub 2014 May 15.","Street JM","J Urol","2014","2014/05/20","","","10.1016/j.juro.2014.05.050"
"30388583","The overlooked primary: bladder cancer metastases on dry bone. A study of the 20th century CAL Milano Cemetery Skeletal Collection","Biehler-Gomez L, Giordano G, Cattaneo C.","Int J Paleopathol. 2019 Mar;24:130-140. doi: 10.1016/j.ijpp.2018.10.005. Epub 2018 Oct 25.","Biehler-Gomez L","Int J Paleopathol","2019","2018/11/03","","","10.1016/j.ijpp.2018.10.005"
"28286066","Emerging Impact of Malnutrition on Surgical Patients: Literature Review and Potential Implications for Cystectomy in Bladder Cancer","Tobert CM, Hamilton-Reeves JM, Norian LA, Hung C, Brooks NA, Holzbeierlein JM, Downs TM, Robertson DP, Grossman R, Nepple KG.","J Urol. 2017 Sep;198(3):511-519. doi: 10.1016/j.juro.2017.01.087. Epub 2017 Mar 9.","Tobert CM","J Urol","2017","2017/03/14","PMC5705177","NIHMS920267","10.1016/j.juro.2017.01.087"
"8116130","Intravesical therapy in superficial bladder cancer","Witjes JA, Mulders PF, Debruyne FM.","Urology. 1994 Feb;43(2 Suppl):2-5; discussion 6. doi: 10.1016/0090-4295(94)90211-9.","Witjes JA","Urology","1994","1994/02/01","","","10.1016/0090-4295(94)90211-9"
"27602771","Single-cell analyses of transcriptional heterogeneity in squamous cell carcinoma of urinary bladder","Zhang X, Zhang M, Hou Y, Xu L, Li W, Zou Z, Liu C, Xu A, Wu S.","Oncotarget. 2016 Oct 4;7(40):66069-66076. doi: 10.18632/oncotarget.11803.","Zhang X","Oncotarget","2016","2016/09/08","PMC5323215","","10.18632/oncotarget.11803"
"6403716","Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double-blind, controlled trial","Zincke H, Utz DC, Taylor WF, Myers RP, Leary FJ.","J Urol. 1983 Mar;129(3):505-9. doi: 10.1016/s0022-5347(17)52205-3.","Zincke H","J Urol","1983","1983/03/01","","","10.1016/s0022-5347(17)52205-3"
"16303860","Systemic chemotherapy in inoperable or metastatic bladder cancer","Bamias A, Tiliakos I, Karali MD, Dimopoulos MA.","Ann Oncol. 2006 Apr;17(4):553-61. doi: 10.1093/annonc/mdj079. Epub 2005 Nov 22.","Bamias A","Ann Oncol","2006","2005/11/24","","","10.1093/annonc/mdj079"
"17467193","Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer","Weiss C, Engehausen DG, Krause FS, Papadopoulos T, Dunst J, Sauer R, Rödel C.","Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1072-80. doi: 10.1016/j.ijrobp.2007.01.054. Epub 2007 Apr 30.","Weiss C","Int J Radiat Oncol Biol Phys","2007","2007/05/01","","","10.1016/j.ijrobp.2007.01.054"
"20374999","Bladder cancer: optimal application of preclinical models to suitable translational questions","Raghavan D.","Sci Transl Med. 2010 Mar 10;2(22):22ps11. doi: 10.1126/scitranslmed.3000215.","Raghavan D","Sci Transl Med","2010","2010/04/09","","","10.1126/scitranslmed.3000215"
"21387760","[Bladder cancer biomarkers]","Dobrowolska-Glazar B, Glazar W, Dobrowolski Z, Lipczyński W.","Przegl Lek. 2010;67(7):479-83.","Dobrowolska-Glazar B","Przegl Lek","2010","2011/03/11","","",""
"15076284","Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer","Colombo R, Bertini R, Salonia A, Naspro R, Ghezzi M, Mazzoccoli B, Deho' F, Montorsi F, Rigatti P.","J Urol. 2004 May;171(5):1819-22; discussion 1822. doi: 10.1097/01.ju.0000123781.49896.fe.","Colombo R","J Urol","2004","2004/04/13","","","10.1097/01.ju.0000123781.49896.fe"
"11880083","Long-term maintenance bacille Calmette-Guérin therapy in high-grade superficial bladder cancer","Iori F, Di Seri M, De Nunzio C, Leonardo C, Franco G, Spalletta B, Laurenti C.","Urology. 2002 Mar;59(3):414-8. doi: 10.1016/s0090-4295(01)01539-4.","Iori F","Urology","2002","2002/03/07","","","10.1016/s0090-4295(01)01539-4"
"31277774","Genome-wide Association Study for Tumour Stage, Grade, Size, and Age at Diagnosis of Non-muscle-invasive Bladder Cancer","Lipunova N, Wesselius A, Cheng KK, van Schooten FJ, Bryan RT, Cazier JB, Galesloot TE, Kiemeney LALM, Zeegers MP.","Eur Urol Oncol. 2019 Jul;2(4):381-389. doi: 10.1016/j.euo.2018.08.020. Epub 2018 Sep 15.","Lipunova N","Eur Urol Oncol","2019","2019/07/07","","","10.1016/j.euo.2018.08.020"
"1569662","Dose-response of bacillus Calmette-Guerin in the treatment of superficial bladder cancer","Morales A, Nickel JC, Wilson JW.","J Urol. 1992 May;147(5):1256-8. doi: 10.1016/s0022-5347(17)37532-8.","Morales A","J Urol","1992","1992/05/01","","","10.1016/s0022-5347(17)37532-8"
"30275913","Bladder Cancer-Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection","Wang ZY, Li HY, Wang H, Chi Q, Liu Y, Li XM.","Dis Markers. 2018 Sep 10;2018:5609395. doi: 10.1155/2018/5609395. eCollection 2018.","Wang ZY","Dis Markers","2018","2018/10/03","PMC6151371","","10.1155/2018/5609395"
"8290824","Pathways of development and progression in bladder cancer: new correlations between clinical observations and molecular mechanisms","Jones PA, Droller MJ.","Semin Urol. 1993 Nov;11(4):177-92.","Jones PA","Semin Urol","1993","1993/11/01","","",""
"15281316","Malignancy associated papillomaviruses and morphology of human bladder cancer","Oliver RT, Breuer J, Nouri AM, Campo S.","Cancer Surv. 1998;31:29-47.","Oliver RT","Cancer Surv","1998","2004/07/30","","",""
"25511320","Evaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosis","Eissa S, Habib H, Ali E, Kotb Y.","Med Oncol. 2015 Jan;32(1):413. doi: 10.1007/s12032-014-0413-x. Epub 2014 Dec 16.","Eissa S","Med Oncol","2015","2014/12/17","","","10.1007/s12032-014-0413-x"
"11797946","Detection of tumorigenesis in rat bladders with optical coherence tomography","Pan Y, Lavelle JP, Bastacky SI, Meyers S, Pirtskhalaishvili G, Zeidel ML, Farkas DL.","Med Phys. 2001 Dec;28(12):2432-40. doi: 10.1118/1.1418726.","Pan Y","Med Phys","2001","2002/01/19","","","10.1118/1.1418726"
"27494900","Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis","Roth B, Jayaratna I, Sundi D, Cheng T, Melquist J, Choi W, Porten S, Nitti G, Navai N, Wszolek M, Guo C, Czerniak B, McConkey D, Dinney C.","Oncotarget. 2017 May 23;8(21):34205-34222. doi: 10.18632/oncotarget.11009.","Roth B","Oncotarget","2017","2016/08/06","PMC5470961","","10.18632/oncotarget.11009"
"24443255","Clinical significance and biological roles of CARMA3 in human bladder carcinoma","Man X, He J, Kong C, Zhu Y, Zhang Z.","Tumour Biol. 2014 May;35(5):4131-6. doi: 10.1007/s13277-013-1540-2. Epub 2014 Jan 18.","Man X","Tumour Biol","2014","2014/01/21","","","10.1007/s13277-013-1540-2"
"6506369","Symposium on advances in the management of urothelial cancer","","Urol Clin North Am. 1984 Nov;11(4):555-749.","","Urol Clin North Am","1984","1984/11/01","","",""
"30066919","Increased expression of TNFRSF14 indicates good prognosis and inhibits bladder cancer proliferation by promoting apoptosis","Zhu YD, Lu MY.","Mol Med Rep. 2018 Sep;18(3):3403-3410. doi: 10.3892/mmr.2018.9306. Epub 2018 Jul 23.","Zhu YD","Mol Med Rep","2018","2018/08/02","","","10.3892/mmr.2018.9306"
"20921545","Screening adults for bladder cancer: a review of the evidence for the U.S. preventive services task force","Chou R, Dana T.","Ann Intern Med. 2010 Oct 5;153(7):461-8. doi: 10.7326/0003-4819-153-7-201010050-00009.","Chou R","Ann Intern Med","2010","2010/10/06","","","10.7326/0003-4819-153-7-201010050-00009"
"16406877","Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer","Liedberg F, Chebil G, Davidsson T, Gudjonsson S, Månsson W.","J Urol. 2006 Jan;175(1):84-8; discussion 88-9. doi: 10.1016/S0022-5347(05)00066-2.","Liedberg F","J Urol","2006","2006/01/13","","","10.1016/S0022-5347(05)00066-2"
"15446572","[Orotate phosphoribosyl transferase in bladder cancer]","Furuse H, Hirano Y, Harada M, Mugiya S, Ushiyama T, Suzuki K, Ozono S.","Gan To Kagaku Ryoho. 2004 Sep;31(9):1431-3.","Furuse H","Gan To Kagaku Ryoho","2004","2004/09/28","","",""
"9817313","Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall","Poulsen AL, Horn T, Steven K.","J Urol. 1998 Dec;160(6 Pt 1):2015-9; discussion 2020.","Poulsen AL","J Urol","1998","1998/11/17","","",""
"28113097","The immune infiltrate in prostate, bladder and testicular tumors: An old friend for new challenges","Solinas C, Chanzá NM, Awada A, Scartozzi M.","Cancer Treat Rev. 2017 Feb;53:138-145. doi: 10.1016/j.ctrv.2016.12.004. Epub 2016 Dec 30.","Solinas C","Cancer Treat Rev","2017","2017/01/24","","","10.1016/j.ctrv.2016.12.004"
"6189575","Unresectable carcinoma of the bladder","Montie JE, Whitmore WF Jr, Grabstald HM, Yagoda A.","Cancer. 1983 Jun 15;51(12):2351-5. doi: 10.1002/1097-0142(19830615)51:12<2351::aid-cncr2820511231>3.0.co;2-2.","Montie JE","Cancer","1983","1983/06/15","","","10.1002/1097-0142(19830615)51:12<2351::aid-cncr2820511231>3.0.co;2-2"
"9166504","Combined modality treatment with selective bladder conservation for invasive bladder cancer: long-term tolerance in the female patient","Kachnic LA, Shipley WU, Griffin PP, Zietman AL, Kaufman DS, Althausen AF, Heney NM.","Cancer J Sci Am. 1996 Mar-Apr;2(2):79-84.","Kachnic LA","Cancer J Sci Am","1996","1996/03/01","","",""
"18585632","[Nonmuscle-invasive bladder cancer (NMIBC): when to perform cystectomy?]","Lebret T.","Prog Urol. 2008 May;18 Suppl 5:S111-4. doi: 10.1016/S1166-7087(08)72487-4.","Lebret T","Prog Urol","2008","2008/07/01","","","10.1016/S1166-7087(08)72487-4"
"12113085","Gene therapy for superficial bladder cancer","Rosser CJ, Benedict WF, Dinney CP.","Expert Rev Anticancer Ther. 2001 Dec;1(4):531-9. doi: 10.1586/14737140.1.4.531.","Rosser CJ","Expert Rev Anticancer Ther","2001","2002/07/13","","","10.1586/14737140.1.4.531"
"28218036","Chemopreventive effect of omega-3 polyunsaturated fatty acids and atorvastatin in rats with bladder cancer","El-Ashmawy NE, Khedr EG, El-Bahrawy HA, Al-Tantawy SM.","Tumour Biol. 2017 Feb;39(2):1010428317692254. doi: 10.1177/1010428317692254.","El-Ashmawy NE","Tumour Biol","2017","2017/02/21","","","10.1177/1010428317692254"
"28481707","Immune Checkpoint Blockade in Metastatic Urothelial Cancer","Balar AV.","J Clin Oncol. 2017 Jul 1;35(19):2109-2112. doi: 10.1200/JCO.2017.72.8444. Epub 2017 May 8.","Balar AV","J Clin Oncol","2017","2017/05/09","","","10.1200/JCO.2017.72.8444"
"11251984","Use of permanent hair dyes and bladder-cancer risk","Gago-Dominguez M, Castelao JE, Yuan JM, Yu MC, Ross RK.","Int J Cancer. 2001 Feb 15;91(4):575-9. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1092>3.0.co;2-s.","Gago-Dominguez M","Int J Cancer","2001","2001/03/17","","","10.1002/1097-0215(200002)9999:9999<::aid-ijc1092>3.0.co;2-s"
"10101597","Prognostic significance of flow cytometric deoxyribonucleic acid analysis for patients with superficial bladder cancers: a long-term follow-up study","Tachibana M, Miyakawa A, Miyakawa M, Saito S, Nakamura K, Baba S, Murai M.","Cancer Detect Prev. 1999;23(2):155-62. doi: 10.1046/j.1525-1500.1999.09910.x.","Tachibana M","Cancer Detect Prev","1999","1999/04/02","","","10.1046/j.1525-1500.1999.09910.x"
"18919205","The treatment of inoperable vesical carcinoma","WALKER K.","Med World. 1947 Nov 28;67(14):428-30.","WALKER K","Med World","1947","1947/11/28","","",""
"2148881","Prediction of superficial bladder cancer by histoquantitative methods","Lipponen PK, Eskelinen MJ, Sotarauta M.","Eur J Cancer. 1990;26(10):1060-3. doi: 10.1016/0277-5379(90)90052-u.","Lipponen PK","Eur J Cancer","1990","1990/01/01","","","10.1016/0277-5379(90)90052-u"
"25966163","CYFRA21-1 levels could be a biomarker for bladder cancer: a meta-analysis","Kuang LI, Song WJ, Qing HM, Yan S, Song FL.","Genet Mol Res. 2015 Apr 27;14(2):3921-31. doi: 10.4238/2015.April.27.6.","Kuang LI","Genet Mol Res","2015","2015/05/13","","","10.4238/2015.April.27.6"
"30654603","Bladder recurrence of primary upper tract urinary carcinoma following nephroureterectomy, and risk of upper urinary tract recurrence after ureteral stent positioning in patients with primary bladder cancer","Mistretta FA, Carrion DM, Nazzani S, Vásquez JL, Fiori C, De Cobelli O, Porpiglia F, Esperto F.","Minerva Urol Nefrol. 2019 Jun;71(3):191-200. doi: 10.23736/S0393-2249.19.03311-3. Epub 2019 Jan 17.","Mistretta FA","Minerva Urol Nefrol","2019","2019/01/19","","","10.23736/S0393-2249.19.03311-3"
"22772340","Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer","Minner S, De Silva C, Rink M, Dahlem R, Chun F, Fisch M, Höppner W, Wagner W, Bokemeyer C, Terracciano L, Simon R, Sauter G, Wilczak W.","Pathology. 2012 Aug;44(5):448-52. doi: 10.1097/PAT.0b013e32835576ee.","Minner S","Pathology","2012","2012/07/10","","","10.1097/PAT.0b013e32835576ee"
"15375606","Non-viral tumor necrosis factor-alpha gene transfer decreases the incidence of orthotopic bladder tumors","Zang Z, Mahendran R, Wu Q, Yong T, Esuvaranathan K.","Int J Mol Med. 2004 Oct;14(4):713-7.","Zang Z","Int J Mol Med","2004","2004/09/18","","",""
"9751254","The expression of platelet-derived endothelial cell growth factor in human bladder cancer","Sawase K, Nomata K, Kanetake H, Saito Y.","Cancer Lett. 1998 Aug 14;130(1-2):35-41. doi: 10.1016/s0304-3835(98)00097-4.","Sawase K","Cancer Lett","1998","1998/09/29","","","10.1016/s0304-3835(98)00097-4"
"11912367","Contemporary management of stage T1 transitional cell carcinoma of the bladder","Soloway MS, Sofer M, Vaidya A.","J Urol. 2002 Apr;167(4):1573-83.","Soloway MS","J Urol","2002","2002/03/26","","",""
"8959322","Can hematuria be a predictor as well as a symptom or sign of bladder cancer?","Friedman GD, Carroll PR, Cattolica EV, Hiatt RA.","Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):993-6.","Friedman GD","Cancer Epidemiol Biomarkers Prev","1996","1996/12/01","","",""
"16651838","Persistence, recurrence, and progression rates of superficial bladder tumours after resection using the differentiated technique","Langbein S, Badawi K, Haecker A, Weiss C, Hatzinger M, Alken P, Siegsmund M.","Med Princ Pract. 2006;15(3):215-8. doi: 10.1159/000092184.","Langbein S","Med Princ Pract","2006","2006/05/03","","","10.1159/000092184"
"23689256","Bladder cancer: Towards risk stratification in bladder cancer","Furberg H, Bochner BH.","Nat Rev Urol. 2013 Jul;10(7):374-5. doi: 10.1038/nrurol.2013.114. Epub 2013 May 21.","Furberg H","Nat Rev Urol","2013","2013/05/22","","","10.1038/nrurol.2013.114"
"17409436","Oncogenic role of MPHOSPH1, a cancer-testis antigen specific to human bladder cancer","Kanehira M, Katagiri T, Shimo A, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y.","Cancer Res. 2007 Apr 1;67(7):3276-85. doi: 10.1158/0008-5472.CAN-06-3748.","Kanehira M","Cancer Res","2007","2007/04/06","","","10.1158/0008-5472.CAN-06-3748"
"23790536","Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors","Foutadakis S, Avgeris M, Tokas T, Stravodimos K, Scorilas A.","Urol Oncol. 2014 Jan;32(1):39.e29-36. doi: 10.1016/j.urolonc.2013.04.005. Epub 2013 Jun 18.","Foutadakis S","Urol Oncol","2014","2013/06/25","","","10.1016/j.urolonc.2013.04.005"
"8703683","New chemoradiation approach for bladder cancer tested in RTOG 95-06","","Oncology (Williston Park). 1995 Nov;9(11):1144.","","Oncology (Williston Park)","1995","1995/11/01","","",""
"2051696","[Study of c-myc gene transfected T-24 human bladder cancer cells]","Kubota Y, Yao M, Noguchi S, Ishibashi Y, Shuin T.","Nihon Hinyokika Gakkai Zasshi. 1991 Apr;82(4):593-9. doi: 10.5980/jpnjurol1989.82.593.","Kubota Y","Nihon Hinyokika Gakkai Zasshi","1991","1991/04/01","","","10.5980/jpnjurol1989.82.593"
"18670275","Follow-up of nonmuscle invasive transitional cell carcinoma of the bladder: how and how often?","Schmidbauer J, Lindenau G.","Curr Opin Urol. 2008 Sep;18(5):504-7. doi: 10.1097/MOU.0b013e32830b86a9.","Schmidbauer J","Curr Opin Urol","2008","2008/08/02","","","10.1097/MOU.0b013e32830b86a9"
"7129896","[Endovesical ultrasonic diagnosis in bladder cancer]","Tomamichel G.","Helv Chir Acta. 1982 Aug;49(3-4):321-4.","Tomamichel G","Helv Chir Acta","1982","1982/08/01","","",""
"12187264","Adenovirus mediated gelsolin gene therapy for orthotopic human bladder cancer in nude mice","Sazawa A, Watanabe T, Tanaka M, Haga K, Fujita H, Harabayashi T, Shinohara N, Koyanagi T, Kuzumaki N.","J Urol. 2002 Sep;168(3):1182-7. doi: 10.1097/01.ju.0000023401.33247.e0.","Sazawa A","J Urol","2002","2002/08/21","","","10.1097/01.ju.0000023401.33247.e0"
"20039317","Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4","Nishizawa K, Nishiyama H, Oishi S, Tanahara N, Kotani H, Mikami Y, Toda Y, Evans BJ, Peiper SC, Saito R, Watanabe J, Fujii N, Ogawa O.","Int J Cancer. 2010 Sep 1;127(5):1180-7. doi: 10.1002/ijc.25145.","Nishizawa K","Int J Cancer","2010","2009/12/30","","","10.1002/ijc.25145"
"8144986","Phase I/II trial of preoperative thermoradiotherapy in the treatment of urinary bladder cancer","Masunaga SI, Hiraoka M, Akuta K, Nishimura Y, Nagata Y, Jo S, Takahashi M, Abe M, Terachi T, Oishi K, et al.","Int J Hyperthermia. 1994 Jan-Feb;10(1):31-40. doi: 10.3109/02656739409009329.","Masunaga SI","Int J Hyperthermia","1994","1994/01/01","","","10.3109/02656739409009329"
"21741685","Novel immunotherapy for metastatic bladder cancer using vaccine of human interleukin-2 surface-modified MB 49 cells","Zhang X, Shi X, Li J, Hu Z, Guo F, Huang X, Zhang Z, Sun P, Jing Y, Gao J, Tan W.","Urology. 2011 Sep;78(3):722.e1-722.e6. doi: 10.1016/j.urology.2011.04.044. Epub 2011 Jul 13.","Zhang X","Urology","2011","2011/07/12","","","10.1016/j.urology.2011.04.044"
"1975127","Biochemical epidemiology: uses in the study of human carcinogenesis","Vineis P, Faggiano F, Terracini B.","Teratog Carcinog Mutagen. 1990;10(3):231-7. doi: 10.1002/tcm.1770100306.","Vineis P","Teratog Carcinog Mutagen","1990","1990/01/01","","","10.1002/tcm.1770100306"
"30591241","The deregulation of miR-133b is associated with poor prognosis in bladder cancer","Shi Z, Kadeer A, Wang M, Wen B, Li M, Huang J, Gao Y, Liu E, Liu D, Jia D, Liang C.","Pathol Res Pract. 2019 Feb;215(2):354-357. doi: 10.1016/j.prp.2018.11.018. Epub 2018 Nov 24.","Shi Z","Pathol Res Pract","2019","2018/12/29","","","10.1016/j.prp.2018.11.018"
"9203034","Correlation of nuclear p53 over-expression with clinical and histopathological features of transitional cell bladder cancer","Sinik Z, Alkibay T, Ataoğlu O, Akyol G, Tokuçoğlu H, Bozkirli I.","Int Urol Nephrol. 1997;29(1):25-31. doi: 10.1007/BF02551413.","Sinik Z","Int Urol Nephrol","1997","1997/01/01","","","10.1007/BF02551413"
"24787300","T2 muscle-invasive bladder cancer","Tsao CK, Small A, Hall S, Oh WK, Galsky MD, Buckstein M, Stock R, Ali G, Morris GJ.","Semin Oncol. 2014 Apr;41(2):e11-8. doi: 10.1053/j.seminoncol.2014.03.005. Epub 2014 Mar 5.","Tsao CK","Semin Oncol","2014","2014/05/03","","","10.1053/j.seminoncol.2014.03.005"
"5142645","[Diagnosis and therapy of cancer of the bladder]","Andreev T.","Khirurgiia (Sofiia). 1971;24(2):184-7.","Andreev T","Khirurgiia (Sofiia)","1971","1971/01/01","","",""
"12654438","Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer","Meijer GJ, Rasch C, Remeijer P, Lebesque JV.","Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1277-87. doi: 10.1016/s0360-3016(02)04162-7.","Meijer GJ","Int J Radiat Oncol Biol Phys","2003","2003/03/26","","","10.1016/s0360-3016(02)04162-7"
"1825478","Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer","Gordon GB, Helzlsouer KJ, Comstock GW.","Cancer Res. 1991 Mar 1;51(5):1366-9.","Gordon GB","Cancer Res","1991","1991/03/01","","",""
"21403827","Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model","Sereno J, Parada B, Reis F, Cunha FX, Teixeira-Lemos E, Garrido P, Pinto R, Rocha-Pereira P, Neto P, Ruivo J, Rodrigues-Santos P, Nunes S, Mota A, Figueiredo A, Teixeira F.","Mediators Inflamm. 2010;2010:380937. doi: 10.1155/2010/380937. Epub 2011 Feb 13.","Sereno J","Mediators Inflamm","2010","2011/03/16","PMC3042634","","10.1155/2010/380937"
"5818158","Cancer of the urogenital tract: bladder cancer. Triple cystogram and selective arteriography","Lang EK.","JAMA. 1969 Jan 13;207(2):342-4. doi: 10.1001/jama.207.2.342.","Lang EK","JAMA","1969","1969/01/13","","","10.1001/jama.207.2.342"
"20489789","Autophagy is induced by adenoviral-mediated interferon alpha treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors produced","Zhang XQ, Dunner K Jr, Benedict WF.","Cancer Gene Ther. 2010 Aug;17(8):579-84. doi: 10.1038/cgt.2010.14. Epub 2010 May 21.","Zhang XQ","Cancer Gene Ther","2010","2010/05/22","PMC2906639","NIHMS167596","10.1038/cgt.2010.14"
"20089092","Is the role of intravesical bacillus Calmette-Guérin in non-muscle-invasive bladder cancer changing?","Ayres BE, Griffiths TR, Persad RA.","BJU Int. 2010 Feb;105 Suppl 2:8-13. doi: 10.1111/j.1464-410X.2009.09151.x.","Ayres BE","BJU Int","2010","2010/01/22","","","10.1111/j.1464-410X.2009.09151.x"
"10696252","Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer","Dalbagni G, Herr HW.","Urol Clin North Am. 2000 Feb;27(1):137-46,. doi: 10.1016/s0094-0143(05)70241-x.","Dalbagni G","Urol Clin North Am","2000","2000/03/04","","","10.1016/s0094-0143(05)70241-x"
"24125166","Incidence and long-term outcomes of squamous cell bladder cancer after deceased donor renal transplantation","Davis NF, McLoughlin LC, Dowling C, Power R, Mohan P, Hickey D, Smyth G, Eng M, Little DM.","Clin Transplant. 2013 Nov-Dec;27(6):E665-8. doi: 10.1111/ctr.12245. Epub 2013 Oct 11.","Davis NF","Clin Transplant","2013","2013/10/16","","","10.1111/ctr.12245"
"14685796","Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder","Lekili M, Sener E, Demir MA, Temeltaş G, Müezzinoğlu T, Büyüksu C.","Urol Res. 2004 May;32(2):124-8. doi: 10.1007/s00240-003-0394-2. Epub 2003 Dec 19.","Lekili M","Urol Res","2004","2003/12/20","","","10.1007/s00240-003-0394-2"
"7286549","Metabolic fate of N-alkyl-N-(3-hydroxypropyl and 2-hydroxy-ethyl)nitrosamines in the rat in relation to the induction of bladder cancer by N-butyl-N-(4-hydroxybutyl)nitrosamine and its homologs","Suzuki E, Iiyoshi M, Okada M.","Gan. 1981 Apr;72(2):254-8.","Suzuki E","Gan","1981","1981/04/01","","",""
"7491826","[Confounding of occupational cancer risk in epidemiological studies due to ignorance of smoking data as exemplified by bladder and lung cancer in painters]","Scherg H.","Soz Praventivmed. 1995;40(5):302-8. doi: 10.1007/BF01299198.","Scherg H","Soz Praventivmed","1995","1995/01/01","","","10.1007/BF01299198"
"26788910","Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy","Zhao MJ, Song YF, Niu HT, Tian YX, Yang XG, Xie K, Jing YH, Wang DG.","Oncotarget. 2016 Feb 23;7(8):8956-67. doi: 10.18632/oncotarget.6909.","Zhao MJ","Oncotarget","2016","2016/01/21","PMC4891017","","10.18632/oncotarget.6909"
"27053504","Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis","Yin M, Joshi M, Meijer RP, Glantz M, Holder S, Harvey HA, Kaag M, Fransen van de Putte EE, Horenblas S, Drabick JJ.","Oncologist. 2016 Jun;21(6):708-15. doi: 10.1634/theoncologist.2015-0440. Epub 2016 Apr 6.","Yin M","Oncologist","2016","2016/04/08","PMC4912364","","10.1634/theoncologist.2015-0440"
"11585741","Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer","Shiina H, Igawa M, Urakami S, Shigeno K, Yoneda T, Terashima M, Deguchi M, Ribeiro-Filho L, Dahiya R.","Cancer Res. 2001 Oct 1;61(19):7101-9.","Shiina H","Cancer Res","2001","2001/10/05","","",""
"31461726","Intravesical Treatment with Electro-Mediated Administration of Mytomicin C as Prophylaxis for Intermediate and High-Risk Nonmuscle-Invasive Bladder Cancer: A Retrospective Multicenter Study","Carando R, Zazzara M, Cotrufo S, Ludovico GM.","Urol Int. 2019;103(3):285-290. doi: 10.1159/000502663. Epub 2019 Aug 28.","Carando R","Urol Int","2019","2019/08/29","","","10.1159/000502663"
"20006858","Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer","Eissa S, Swellam M, Shehata H, El-Khouly IM, El-Zayat T, El-Ahmady O.","J Urol. 2010 Feb;183(2):493-8. doi: 10.1016/j.juro.2009.10.024. Epub 2009 Dec 14.","Eissa S","J Urol","2010","2009/12/17","","","10.1016/j.juro.2009.10.024"
"17628308","Cancer patient advocacy: new opportunities for treatment advances","Quale DZ, Droller MJ.","Urol Oncol. 2007 Jul-Aug;25(4):351-2. doi: 10.1016/j.urolonc.2007.05.001.","Quale DZ","Urol Oncol","2007","2007/07/14","","","10.1016/j.urolonc.2007.05.001"
"24484605","Thoughts on a systematic review and meta-analysis of adjuvant chemotherapy in muscle-invasive bladder cancer","Sternberg CN, Sylvester R.","Eur Urol. 2014 Jul;66(1):55-6. doi: 10.1016/j.eururo.2014.01.008. Epub 2014 Jan 23.","Sternberg CN","Eur Urol","2014","2014/02/04","","","10.1016/j.eururo.2014.01.008"
"26707614","CYP1B1 gene polymorphisms correlate with an increased risk of urinary bladder cancer in India","Sankhwar M, Sankhwar SN, Abhishek A, Gupta N, Rajender S.","Urol Oncol. 2016 Apr;34(4):167.e1-8. doi: 10.1016/j.urolonc.2015.11.010. Epub 2015 Dec 18.","Sankhwar M","Urol Oncol","2016","2015/12/29","","","10.1016/j.urolonc.2015.11.010"
"17896857","Optimal management of high-risk T1G3 bladder cancer: a decision analysis","Kulkarni GS, Finelli A, Fleshner NE, Jewett MA, Lopushinsky SR, Alibhai SM.","PLoS Med. 2007 Sep;4(9):e284. doi: 10.1371/journal.pmed.0040284.","Kulkarni GS","PLoS Med","2007","2007/09/28","PMC1989749","","10.1371/journal.pmed.0040284"
"21272294","Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand","Lin TY, Zhang H, Wang S, Xie L, Li B, Rodriguez CO Jr, de Vere White R, Pan CX.","Mol Cancer. 2011 Jan 27;10(1):9. doi: 10.1186/1476-4598-10-9.","Lin TY","Mol Cancer","2011","2011/01/29","PMC3040722","","10.1186/1476-4598-10-9"
"25882561","Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery?","Cha EK, Donahue TF, Bochner BH.","Urol Clin North Am. 2015 May;42(2):189-99, viii. doi: 10.1016/j.ucl.2015.02.003. Epub 2015 Feb 28.","Cha EK","Urol Clin North Am","2015","2015/04/18","PMC4977988","NIHMS783053","10.1016/j.ucl.2015.02.003"
"28521108","MiR-301b promotes the proliferation, mobility, and epithelial-to-mesenchymal transition of bladder cancer cells by targeting EGR1","Yan L, Wang Y, Liang J, Liu Z, Sun X, Cai K.","Biochem Cell Biol. 2017 Oct;95(5):571-577. doi: 10.1139/bcb-2016-0232. Epub 2017 May 18.","Yan L","Biochem Cell Biol","2017","2017/05/19","","","10.1139/bcb-2016-0232"
"15537566","Early evaluation of hematuria in a patient receiving anticoagulant therapy and detection of malignancy","Ripley TL, Havrda DE, Blevins S, Culkin D.","Pharmacotherapy. 2004 Nov;24(11):1638-40. doi: 10.1592/phco.24.16.1638.50949.","Ripley TL","Pharmacotherapy","2004","2004/11/13","","","10.1592/phco.24.16.1638.50949"
"15076286","Editorial: cystectomy for bladder cancer","Olsson CA.","J Urol. 2004 May;171(5):1829. doi: 10.1097/01.ju.0000121661.04866.d7.","Olsson CA","J Urol","2004","2004/04/13","","","10.1097/01.ju.0000121661.04866.d7"
"15947583","Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer","Nieuwenhuijzen JA, Bex A, Meinhardt W, Kerst JM, Schornagel JH, VAN Tinteren H, Horenblas S.","J Urol. 2005 Jul;174(1):80-5. doi: 10.1097/01.ju.0000162018.40891.ba.","Nieuwenhuijzen JA","J Urol","2005","2005/06/11","","","10.1097/01.ju.0000162018.40891.ba"
"23058006","A contemporary update on pathology reporting for urinary bladder cancer","Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Di Primio R, Montironi R.","Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):565-71. doi: 10.1177/039463201202500302.","Mazzucchelli R","Int J Immunopathol Pharmacol","2012","2012/10/13","","","10.1177/039463201202500302"
"18995951","Critical evaluation of the prostate from cystoprostatectomies for bladder cancer: insights from a complete sampling with the whole mount technique","Montironi R, Cheng L, Mazzucchelli R, Scarpelli M, Kirkali Z, Montorsi F, Lopez-Beltran A.","Eur Urol. 2009 Jun;55(6):1305-9. doi: 10.1016/j.eururo.2008.10.032. Epub 2008 Oct 28.","Montironi R","Eur Urol","2009","2008/11/11","","","10.1016/j.eururo.2008.10.032"
"10637735","[Concurrent platinum-based chemotherapy and radiotherapy for locally advanced bladder cancer]","Nakatsuji H, Yamashita Y, Hashine K, Sumiyoshi Y.","Hinyokika Kiyo. 1999 Nov;45(11):745-8.","Nakatsuji H","Hinyokika Kiyo","1999","2000/01/19","","",""
"30528834","Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?","Mazzone E, Knipper S, Mistretta FA, Tian Z, Preisser F, Gallina A, Soulieres D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Wisnivesky J, Karakiewicz PI.","Cancer Epidemiol. 2019 Feb;58:83-88. doi: 10.1016/j.canep.2018.11.007. Epub 2018 Dec 6.","Mazzone E","Cancer Epidemiol","2019","2018/12/12","","","10.1016/j.canep.2018.11.007"
"12857059","Urethral recurrence following neobladder in bladder cancer patients","Yamashita S, Hoshi S, Ohyama C, Satoh M, Soma F, Okada Y, Kato S, Shintaku I, Arai Y.","Tohoku J Exp Med. 2003 Apr;199(4):197-203. doi: 10.1620/tjem.199.197.","Yamashita S","Tohoku J Exp Med","2003","2003/07/15","","","10.1620/tjem.199.197"
"10599444","DNA methylation in development of bladder cancer","Jones PA.","Adv Exp Med Biol. 1999;462:419-23. doi: 10.1007/978-1-4615-4737-2_32.","Jones PA","Adv Exp Med Biol","1999","1999/12/22","","","10.1007/978-1-4615-4737-2_32"
"31200843","Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign","Li R, Metcalfe MJ, Tabayoyong WB, Guo CC, Nogueras González GM, Navai N, Grossman HB, Dinney CP, Kamat AM.","Eur Urol Oncol. 2019 May;2(3):286-293. doi: 10.1016/j.euo.2018.08.013. Epub 2018 Sep 10.","Li R","Eur Urol Oncol","2019","2019/06/16","","","10.1016/j.euo.2018.08.013"
"21117956","Genetic polymorphisms of glutathione S-transferase P1 and bladder cancer susceptibility in a Chinese population","Zhang R, Xu G, Chen W, Zhang W.","Genet Test Mol Biomarkers. 2011 Jan-Feb;15(1-2):85-8. doi: 10.1089/gtmb.2010.0162. Epub 2010 Nov 30.","Zhang R","Genet Test Mol Biomarkers","2011","2010/12/02","","","10.1089/gtmb.2010.0162"
"15281313","Introduction: Clonal evolution in bladder cancer: a scientific and clinical perspective","Oliver RT, Coptcoat MJ.","Cancer Surv. 1998;31:1-3.","Oliver RT","Cancer Surv","1998","2004/07/30","","",""
"26290403","Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy","Oh JJ, Kang MY, Jo JK, Lee HM, Byun SS, Lee SE, Lee S, Hong SK.","Int J Urol. 2015 Dec;22(12):1112-7. doi: 10.1111/iju.12901. Epub 2015 Aug 20.","Oh JJ","Int J Urol","2015","2015/08/21","","","10.1111/iju.12901"
"3617616","[The type of anesthesia and intravascular blood coagulation during the surgical treatment of bladder cancer patients]","Popov AI.","Vopr Onkol. 1987;33(7):90-4.","Popov AI","Vopr Onkol","1987","1987/01/01","","",""
"32385036","[Advances in Pelvic Lymph Node Dissection for Bladder Cancer]","Wang F, Qin CP, Yang WB, Liu SJ, Xu T.","Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2020 Apr 28;42(2):263-269. doi: 10.3881/j.issn.1000-503X.11226.","Wang F","Zhongguo Yi Xue Ke Xue Yuan Xue Bao","2020","2020/05/10","","","10.3881/j.issn.1000-503X.11226"
"25324947","Usefulness of urine cytology as a routine work-up in the detection of recurrence in patients with prior non-muscle-invasive bladder cancer: practicality and cost-effectiveness","Ok BG, Ji YS, Ko YH, Song PH.","Korean J Urol. 2014 Oct;55(10):650-5. doi: 10.4111/kju.2014.55.10.650. Epub 2014 Oct 10.","Ok BG","Korean J Urol","2014","2014/10/18","PMC4198763","","10.4111/kju.2014.55.10.650"
"15736329","Personal use of hair dyes and the risk of bladder cancer: results of a meta-analysis","Huncharek M, Kupelnick B.","Public Health Rep. 2005 Jan-Feb;120(1):31-8. doi: 10.1177/003335490512000107.","Huncharek M","Public Health Rep","2005","2005/03/02","PMC1497675","","10.1177/003335490512000107"
"1992935","Proportion of lung and bladder cancers in males resulting from occupation: a systematic approach","Vineis P, Simonato L.","Arch Environ Health. 1991 Jan-Feb;46(1):6-15. doi: 10.1080/00039896.1991.9937423.","Vineis P","Arch Environ Health","1991","1991/01/01","","","10.1080/00039896.1991.9937423"
"3751035","[Results of treatment by Co-60 irradiation of patients with bladder cancer]","Mazurkiewicz M, Patyra R, Peszyński J.","Wiad Lek. 1986 Apr 1;39(7):460-4.","Mazurkiewicz M","Wiad Lek","1986","1986/04/01","","",""
"31850704","A Novel Long Non-Coding RNA KMU15 Promotes Growth and Chemoresistance of Bladder Cancer","Huang Y, Luan T, Bao X, Fu S, Li N, Li H, Wang H, Li C, Wang J.","Clin Lab. 2019 Dec 1;65(12). doi: 10.7754/Clin.Lab.2019.190532.","Huang Y","Clin Lab","2019","2019/12/19","","","10.7754/Clin.Lab.2019.190532"
"3518247","[Bladder cancer as an incidental finding]","Mack D, Jakse G.","Wien Klin Wochenschr. 1986 Mar 21;98(6):175-8.","Mack D","Wien Klin Wochenschr","1986","1986/03/21","","",""
"25616696","XRCC1 polymorphisms associated with survival among Chinese bladder cancer patients receiving epirubicin and mitomycin C","Deng X, Zhang X, Cheng Y, Yang X, Zhao R, Liu X, Li X, Qin C, Lu Q, Yin C.","Tumour Biol. 2015 Jun;36(6):4591-6. doi: 10.1007/s13277-015-3104-0. Epub 2015 Jan 25.","Deng X","Tumour Biol","2015","2015/01/25","","","10.1007/s13277-015-3104-0"
"30984788","Low Expression of hsa_circ_0018069 in Human Bladder Cancer and Its Clinical Significance","Li M, Wang Y, Liu Y, Zhang X, Liu J, Wang P.","Biomed Res Int. 2019 Mar 10;2019:9681863. doi: 10.1155/2019/9681863. eCollection 2019.","Li M","Biomed Res Int","2019","2019/04/16","PMC6431508","","10.1155/2019/9681863"
"32468092","[Immunotherapy in bladder cancer-quo vadis? Update on current trials and developments]","Todenhöfer T, Boegemann M.","Urologe A. 2020 Jul;59(7):810-816. doi: 10.1007/s00120-020-01237-2.","Todenhöfer T","Urologe A","2020","2020/05/30","","","10.1007/s00120-020-01237-2"
"14767218","Continued epidemic of bladder cancer in workers exposed to ortho-toluidine in a chemical factory","Markowitz SB, Levin K.","J Occup Environ Med. 2004 Feb;46(2):154-60. doi: 10.1097/01.jom.0000111602.76443.15.","Markowitz SB","J Occup Environ Med","2004","2004/02/10","","","10.1097/01.jom.0000111602.76443.15"
"2988064","[Combined radio-/chemotherapy of invasive bladder cancer]","Fritsch E, Jakse G, Frommhold H.","Rofo. 1985 Jun;142(6):654-8. doi: 10.1055/s-2008-1052732.","Fritsch E","Rofo","1985","1985/06/01","","","10.1055/s-2008-1052732"
"10848688","Rethinking the secondary prevention of superficial bladder cancer: is there a role for retinoids?","Nutting C, Huddart RA.","BJU Int. 2000 Jun;85(9):1023-6. doi: 10.1046/j.1464-410x.2000.00655.x.","Nutting C","BJU Int","2000","2000/06/10","","","10.1046/j.1464-410x.2000.00655.x"
"7796280","Bacillus Calmette-Guérin immunotherapy for superficial bladder cancer. New prospects for an old warhorse","O'Donnell MA, DeWolf WC.","Surg Oncol Clin N Am. 1995 Apr;4(2):189-202.","O'Donnell MA","Surg Oncol Clin N Am","1995","1995/04/01","","",""
"25791481","Pirarubicin induces an autophagic cytoprotective response through suppression of the mammalian target of rapamycin signaling pathway in human bladder cancer cells","Li K, Chen X, Liu C, Gu P, Li Z, Wu S, Xu K, Lin T, Huang J.","Biochem Biophys Res Commun. 2015 May 1;460(2):380-5. doi: 10.1016/j.bbrc.2015.03.042. Epub 2015 Mar 17.","Li K","Biochem Biophys Res Commun","2015","2015/03/21","","","10.1016/j.bbrc.2015.03.042"
"25704311","Incidental prostate cancer in Asian men: high prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy","Yang X, Monn MF, Liu L, Liu Y, Su J, Lyu T, Gong Y, Wang L, Davidson DD, Cheng L.","Prostate. 2015 Jun;75(8):845-54. doi: 10.1002/pros.22966. Epub 2015 Feb 19.","Yang X","Prostate","2015","2015/02/24","","","10.1002/pros.22966"
"27318955","Computed Tomography Loopogram: A Novel Technique for Upper Tract Evaluation After Radical Cystectomy","Correa AF, Kang A, Lyon TD, Maranchie JK.","Clin Genitourin Cancer. 2016 Aug;14(4):e427-30. doi: 10.1016/j.clgc.2016.02.010. Epub 2016 May 27.","Correa AF","Clin Genitourin Cancer","2016","2016/06/20","","","10.1016/j.clgc.2016.02.010"
"23634793","The impact of age and clinical factors in non-muscle-invasive bladder cancer treated with Bacillus Calmette Guerin therapy","Ajili F, Darouiche A, Chebil M, Boubaker S.","Ultrastruct Pathol. 2013 May;37(3):191-5. doi: 10.3109/01913123.2013.770110. Epub 2013 May 1.","Ajili F","Ultrastruct Pathol","2013","2013/05/03","","","10.3109/01913123.2013.770110"
"2727280","[Results of intensive radiotherapy of bladder cancer following transurethral tumor resection]","Oehler W, Fiebig D, Lessel A, Harnisch T, Merkle K.","Radiobiol Radiother (Berl). 1989;30(1):39-46.","Oehler W","Radiobiol Radiother (Berl)","1989","1989/01/01","","",""
"26377495","Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy","Thomas C, Giesswein A, Hainz M, Stein R, Rubenwolf P, Roos FC, Neisius A, Nestler S, Hampel C, Jäger W, Wiesner C, Thüroff JW.","Int Urol Nephrol. 2015 Nov;47(11):1789-96. doi: 10.1007/s11255-015-1110-1. Epub 2015 Sep 16.","Thomas C","Int Urol Nephrol","2015","2015/09/18","","","10.1007/s11255-015-1110-1"
"19963248","Cell-penetrating D-isomer peptides of p53 C-terminus: long-term inhibitory effect on the growth of bladder cancer","Araki D, Takayama K, Inoue M, Watanabe T, Kumon H, Futaki S, Matsui H, Tomizawa K.","Urology. 2010 Apr;75(4):813-9. doi: 10.1016/j.urology.2009.10.002. Epub 2009 Dec 6.","Araki D","Urology","2010","2009/12/08","","","10.1016/j.urology.2009.10.002"
"23482744","Serum DNA hypermethylation in patients with bladder cancer: results of a prospective multicenter study","Hauser S, Kogej M, Fechner G, VON Pezold J, Vorreuther R, Lümmen G, Müller SC, Ellinger J.","Anticancer Res. 2013 Mar;33(3):779-84.","Hauser S","Anticancer Res","2013","2013/03/14","","",""
"17681680","It is time to abandon the ""superficial"" in bladder cancer","Soloway MS.","Eur Urol. 2007 Dec;52(6):1564-5. doi: 10.1016/j.eururo.2007.07.011. Epub 2007 Jul 17.","Soloway MS","Eur Urol","2007","2007/08/08","","","10.1016/j.eururo.2007.07.011"
"28661572","Delays in the diagnosis and initial treatment of bladder cancer in Western Australia","McCombie SP, Bangash HK, Kuan M, Thyer I, Lee F, Hayne D.","BJU Int. 2017 Nov;120 Suppl 3:28-34. doi: 10.1111/bju.13939. Epub 2017 Jul 28.","McCombie SP","BJU Int","2017","2017/06/30","","","10.1111/bju.13939"
"26036640","IPP51, a chalcone acting as a microtubule inhibitor with in vivo antitumor activity against bladder carcinoma","Martel-Frachet V, Keramidas M, Nurisso A, DeBonis S, Rome C, Coll JL, Boumendjel A, Skoufias DA, Ronot X.","Oncotarget. 2015 Jun 10;6(16):14669-86. doi: 10.18632/oncotarget.4144.","Martel-Frachet V","Oncotarget","2015","2015/06/04","PMC4546496","","10.18632/oncotarget.4144"
"27345655","Bladder cancer","Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmström PU, Choi W, Guo CC, Lotan Y, Kassouf W.","Lancet. 2016 Dec 3;388(10061):2796-2810. doi: 10.1016/S0140-6736(16)30512-8. Epub 2016 Jun 23.","Kamat AM","Lancet","2016","2016/06/28","","","10.1016/S0140-6736(16)30512-8"
"17628309","Adjuvant radiotherapy in bladder cancer: time to take a fresh look?","Murthy V, Zaghloul MS.","Urol Oncol. 2007 Jul-Aug;25(4):353-4. doi: 10.1016/j.urolonc.2007.02.015.","Murthy V","Urol Oncol","2007","2007/07/14","","","10.1016/j.urolonc.2007.02.015"
"5127550","[Cases of bladder cancer from a whole district during a 10-year period]","Frandsen AE.","Nord Med. 1971 Sep 23;86(38):1104.","Frandsen AE","Nord Med","1971","1971/09/23","","",""
"28286068","Efficacy of bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis","Boehm BE, Cornell JE, Wang H, Mukherjee N, Oppenheimer JS, Svatek RS.","J Urol. 2017 Sep;198(3):503-510. doi: 10.1016/j.juro.2017.01.086. Epub 2017 Mar 10.","Boehm BE","J Urol","2017","2017/03/14","PMC6464123","NIHMS1016246","10.1016/j.juro.2017.01.086"
"31568988","Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer","Yang D, Ma Y, Zhao P, Ma J, He C.","Biomed Pharmacother. 2019 Dec;120:109433. doi: 10.1016/j.biopha.2019.109433. Epub 2019 Sep 27.","Yang D","Biomed Pharmacother","2019","2019/10/01","","","10.1016/j.biopha.2019.109433"
"23553206","Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy","Sacerdote C, Guarrera S, Ricceri F, Pardini B, Polidoro S, Allione A, Critelli R, Russo A, Andrew AS, Ye Y, Wu X, Kiemeney LA, Bosio A, Casetta G, Cucchiarale G, Destefanis P, Gontero P, Rolle L, Zitella A, Fontana D, Vineis P, Matullo G.","Int J Cancer. 2013 Oct 15;133(8):2004-9. doi: 10.1002/ijc.28186. Epub 2013 Apr 25.","Sacerdote C","Int J Cancer","2013","2013/04/05","PMC3804126","NIHMS510208","10.1002/ijc.28186"
"8691711","[The long-term effect and outcome of preoperative chemotherapy combined with radiation therapy for bladder cancer]","Nasu T, Nakane H, Kamata S, Mitsui H, Hayashida S.","Nihon Hinyokika Gakkai Zasshi. 1996 May;87(5):857-64. doi: 10.5980/jpnjurol1989.87.857.","Nasu T","Nihon Hinyokika Gakkai Zasshi","1996","1996/05/01","","","10.5980/jpnjurol1989.87.857"
"25065987","The utility of an extensive postchemotherapy staging evaluation in patients receiving neoadjuvant chemotherapy for bladder cancer","Reese AC, Ball MW, Gandhi N, Gorin MA, Netto GJ, Bivalacqua TJ, Schoenberg MP.","Urology. 2014 Aug;84(2):358-63. doi: 10.1016/j.urology.2014.03.040.","Reese AC","Urology","2014","2014/07/29","PMC4332781","NIHMS662554","10.1016/j.urology.2014.03.040"
"11172603","Tree models for dependent copy number changes in bladder cancer","Schäffer AA, Simon R, Desper R, Richter J, Sauter G.","Int J Oncol. 2001 Feb;18(2):349-54.","Schäffer AA","Int J Oncol","2001","2001/02/15","","",""
"3134109","Delays in treating bladder cancer","Jones M, Cox R, Davies K, Rose M.","Br Med J (Clin Res Ed). 1988 May 28;296(6635):1539. doi: 10.1136/bmj.296.6635.1539.","Jones M","Br Med J (Clin Res Ed)","1988","1988/05/28","PMC2546058","","10.1136/bmj.296.6635.1539"
"22328190","Role and extent of lymphadenectomy during radical cystectomy for invasive bladder cancer","Svatek R, Zehnder P.","Curr Urol Rep. 2012 Apr;13(2):115-21. doi: 10.1007/s11934-012-0235-3.","Svatek R","Curr Urol Rep","2012","2012/02/14","","","10.1007/s11934-012-0235-3"
"7664248","Y chromosome loss detected by FISH in bladder cancer","Sauter G, Moch H, Wagner U, Novotna H, Gasser TC, Mattarelli G, Mihatsch MJ, Waldman FM.","Cancer Genet Cytogenet. 1995 Jul 15;82(2):163-9. doi: 10.1016/0165-4608(95)00030-s.","Sauter G","Cancer Genet Cytogenet","1995","1995/07/15","","","10.1016/0165-4608(95)00030-s"
"25706386","SATB1 overexpression regulates the development and progression in bladder cancer through EMT","Wan F, Cheng C, Wang Z, Xiao X, Zeng H, Xing S, Chen X, Wang J, Li S, Zhang Y, Xiang W, Zhu Z, Johnson C, Zhu Z.","PLoS One. 2015 Feb 23;10(2):e0117518. doi: 10.1371/journal.pone.0117518. eCollection 2015.","Wan F","PLoS One","2015","2015/02/24","PMC4338074","","10.1371/journal.pone.0117518"
"18712513","[From marker expression to individual therapy of patients with bladder cancer]","Vom Dorp F, Börgermann C, Jäger T, Becker M, Schmid KW, Rübben H.","Urologe A. 2008 Sep;47(9):1167-70. doi: 10.1007/s00120-008-1851-x.","Vom Dorp F","Urologe A","2008","2008/08/21","","","10.1007/s00120-008-1851-x"
"6873029","Effect of promoters on incidence of bladder cancer in experimental animal models","Hicks RM.","Environ Health Perspect. 1983 Apr;50:37-49. doi: 10.1289/ehp.835037.","Hicks RM","Environ Health Perspect","1983","1983/04/01","PMC1569250","","10.1289/ehp.835037"
"24978702","The prognostic value of family history among patients with urinary bladder cancer","Egbers L, Grotenhuis AJ, Aben KK, Alfred Witjes J, Kiemeney LA, Vermeulen SH.","Int J Cancer. 2015 Mar 1;136(5):1117-24. doi: 10.1002/ijc.29062. Epub 2014 Jul 9.","Egbers L","Int J Cancer","2015","2014/07/01","PMC4277320","","10.1002/ijc.29062"
"2653234","[Treatment of cancer of the bladder]","Escudero Barrilero A.","Arch Esp Urol. 1989 Jan-Feb;42(1):1-7.","Escudero Barrilero A","Arch Esp Urol","1989","1989/01/01","","",""
"24709965","Bladder cancer: better clinical outcomes with BCG Connaught than Tice","Payton S.","Nat Rev Urol. 2014 May;11(5):244. doi: 10.1038/nrurol.2014.76. Epub 2014 Apr 8.","Payton S","Nat Rev Urol","2014","2014/04/09","","","10.1038/nrurol.2014.76"
"2149465","The T1 bladder tumor","Herr HW, Jakse G, Sheinfeld J.","Semin Urol. 1990 Nov;8(4):254-61.","Herr HW","Semin Urol","1990","1990/11/01","","",""
"11762797","Extravesical cryosurgical approach for VX2 bladder tumor in rabbits","Yang WH, Liebert M, Price RE, Cromeens DM, Lin JS, Grossman HB.","Urol Res. 2001 Oct;29(5):345-9. doi: 10.1007/s002400100204.","Yang WH","Urol Res","2001","2002/01/05","","","10.1007/s002400100204"
"3129582","Re: The effect of nutritional status and support on morbidity and mortality of bladder cancer patients treated by radical cystectomy","","J Urol. 1988 May;139(5):1070-2. doi: 10.1016/s0022-5347(17)42781-9.","","J Urol","1988","1988/05/01","","","10.1016/s0022-5347(17)42781-9"
"14983818","Best treatments for beating bladder cancer","","Johns Hopkins Med Lett Health After 50. 2004 Jan;15(11):6-7.","","Johns Hopkins Med Lett Health After 50","2004","2004/02/27","","",""
"14982004","[Radical cystectomy in the treatment of invasive bladder cancer]","Shaplygin LV, Sitnikov NV, Furashov DV, Dronov VI, Deviatov AS, Sidorov VA.","Voen Med Zh. 2003 Dec;324(12):43-6.","Shaplygin LV","Voen Med Zh","2003","2004/02/26","","",""
"15337540","Clinical radiobiology of stage T2-T3 bladder cancer","Majewski W, Maciejewski B, Majewski S, Suwinski R, Miszczyk L, Tarnawski R.","Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):60-70. doi: 10.1016/j.ijrobp.2004.02.056.","Majewski W","Int J Radiat Oncol Biol Phys","2004","2004/09/01","","","10.1016/j.ijrobp.2004.02.056"
"24837013","The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer","Hayden A, Douglas J, Sommerlad M, Andrews L, Gould K, Hussain S, Thomas GJ, Packham G, Crabb SJ.","Urol Oncol. 2014 Aug;32(6):806-14. doi: 10.1016/j.urolonc.2014.02.006. Epub 2014 May 16.","Hayden A","Urol Oncol","2014","2014/05/20","","","10.1016/j.urolonc.2014.02.006"
"17285948","Isolated cerebellar metastasis in a patient with organ-confined, lymph node negative bladder cancer","Perlmutter AE, Zaitoon A, Sparks SS, Zaslau S, Zaitoon M.","W V Med J. 2006 Sep-Oct;102(5):14-5.","Perlmutter AE","W V Med J","2006","2007/02/09","","",""
"10190079","Ukrain therapy of stage T1N0M0 bladder cancer patients","Uglianitsa KN, Nechiporenko NA, Nefyodov LI, Brzosko WJ.","Drugs Exp Clin Res. 1998;24(5-6):227-30.","Uglianitsa KN","Drugs Exp Clin Res","1998","1999/04/06","","",""
"6142253","Palmar keratoses and cancers of the bladder and lung","Cuzick J, Harris R, Mortimer PS.","Lancet. 1984 Mar 10;1(8376):530-3. doi: 10.1016/s0140-6736(84)90931-0.","Cuzick J","Lancet","1984","1984/03/10","","","10.1016/s0140-6736(84)90931-0"
"29226734","Emerging first line treatment options for bladder cancer: a review of phase II and III therapies in the pipeline","Jamy O, Sonpavde G.","Expert Opin Emerg Drugs. 2017 Dec;22(4):347-355. doi: 10.1080/14728214.2017.1416092. Epub 2017 Dec 19.","Jamy O","Expert Opin Emerg Drugs","2017","2017/12/12","","","10.1080/14728214.2017.1416092"
"1305677","Chemoprevention of experimental bladder cancer","Moon RC, Detrisac CJ, Thomas CF, Kelloff GJ.","J Cell Biochem Suppl. 1992;16I:134-8. doi: 10.1002/jcb.240501326.","Moon RC","J Cell Biochem Suppl","1992","1992/01/01","","","10.1002/jcb.240501326"
"28655970","Association between the TACC3 rs798766 Polymorphism and Risk of Urinary Bladder Cancer: A Synthesis Based on Current Evidence","Meng XY, Shi MJ, Chen JF, Liao Y, Hu BW, Hireche A.","Dis Markers. 2017;2017:7850708. doi: 10.1155/2017/7850708. Epub 2017 Jun 5.","Meng XY","Dis Markers","2017","2017/06/29","PMC5474538","","10.1155/2017/7850708"
"23420564","Combined use of fluorescence cystoscopy and cross-polarization OCT for diagnosis of bladder cancer and correlation with immunohistochemical markers","Gladkova N, Kiseleva E, Streltsova O, Prodanets N, Snopova L, Karabut M, Gubarkova E, Zagaynova E.","J Biophotonics. 2013 Sep;6(9):687-98. doi: 10.1002/jbio.201200105. Epub 2013 Feb 18.","Gladkova N","J Biophotonics","2013","2013/02/20","","","10.1002/jbio.201200105"
"22622487","[Transurethral en bloc resection of non-muscle invasive bladder cancer. What is the state of the art?]","Kramer MW, Wolters M, Abdelkawi IF, Merseburger AS, Nagele U, Gross A, Bach T, Kuczyk MA, Herrmann TR.","Urologe A. 2012 Jun;51(6):798-804. doi: 10.1007/s00120-012-2876-8.","Kramer MW","Urologe A","2012","2012/05/25","","","10.1007/s00120-012-2876-8"
"8633395","Routine CT scan in cystectomy patients: does it change management?","Herr HW.","Urology. 1996 Mar;47(3):324-5. doi: 10.1016/s0090-4295(99)80446-4.","Herr HW","Urology","1996","1996/03/01","","","10.1016/s0090-4295(99)80446-4"
"30171455","The molecular limitations of biomarker research in bladder cancer","Vlachostergios PJ, Faltas BM.","World J Urol. 2019 May;37(5):837-848. doi: 10.1007/s00345-018-2462-9. Epub 2018 Aug 31.","Vlachostergios PJ","World J Urol","2019","2018/09/02","","","10.1007/s00345-018-2462-9"
"25803993","Small cell carcinoma of the bladder associated with schistosomiasis: a case report","Almeida M, Canas-Marques R, Lopez-Beltran A, Rebola J, Lúcio R, Montironi R, Cheng L, Fonseca J.","Anal Quant Cytopathol Histpathol. 2014 Dec;36(6):339-44.","Almeida M","Anal Quant Cytopathol Histpathol","2014","2015/03/26","","",""
"439244","Re: serial multiple-site biopsies in patients with bladder cancer","Soloway MS.","J Urol. 1979 Apr;121(4):545. doi: 10.1016/s0022-5347(17)56866-4.","Soloway MS","J Urol","1979","1979/04/01","","","10.1016/s0022-5347(17)56866-4"
"9535597","Clinical evaluation of random biopsy of urinary bladder in patients with superficial bladder cancer","Taguchi I, Gohji K, Hara I, Gotoh A, Yamada Y, Yamanaka K, Okada H, Arakawa S, Kamidono S.","Int J Urol. 1998 Jan;5(1):30-4. doi: 10.1111/j.1442-2042.1998.tb00229.x.","Taguchi I","Int J Urol","1998","1998/04/16","","","10.1111/j.1442-2042.1998.tb00229.x"
"17902641","Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach","Orenes-Piñero E, Cortón M, González-Peramato P, Algaba F, Casal I, Serrano A, Sánchez-Carbayo M.","J Proteome Res. 2007 Nov;6(11):4440-8. doi: 10.1021/pr070368w. Epub 2007 Sep 29.","Orenes-Piñero E","J Proteome Res","2007","2007/10/02","","","10.1021/pr070368w"
"19030177","EBAG9 is a tumor-promoting and prognostic factor for bladder cancer","Kumagai J, Urano T, Ogushi T, Takahashi S, Horie-Inoue K, Fujimura T, Azuma K, Muramatsu M, Ouchi Y, Kitamura T, Inoue S.","Int J Cancer. 2009 Feb 15;124(4):799-805. doi: 10.1002/ijc.23982.","Kumagai J","Int J Cancer","2009","2008/11/26","","","10.1002/ijc.23982"
"3136821","Pre-emptive (neo-adjuvant) chemotherapy prior to radical radiotherapy for fit septuagenarians with bladder cancer: age itself is not a contra-indication","Raghavan D, Grundy R, Greenaway TM, Pearson BS, Rogers J, Duval P, Meagher M, Mameghan H.","Br J Urol. 1988 Aug;62(2):154-9. doi: 10.1111/j.1464-410x.1988.tb04297.x.","Raghavan D","Br J Urol","1988","1988/08/01","","","10.1111/j.1464-410x.1988.tb04297.x"
"8142811","Cystoscopy in bladder cancer","Prescott S, Tolley DA.","BMJ. 1994 Mar 12;308(6930):718. doi: 10.1136/bmj.308.6930.718a.","Prescott S","BMJ","1994","1994/03/12","PMC2539356","","10.1136/bmj.308.6930.718a"
"17311310","Survivin expression is associated with bladder cancer presence, stage, progression, and mortality","Shariat SF, Ashfaq R, Karakiewicz PI, Saeedi O, Sagalowsky AI, Lotan Y.","Cancer. 2007 Mar 15;109(6):1106-13. doi: 10.1002/cncr.22521.","Shariat SF","Cancer","2007","2007/02/22","","","10.1002/cncr.22521"
"22244504","Expression of TRAIL, DR4, and DR5 in bladder cancer: correlation with response to adjuvant therapy and implications of prognosis","Li Y, Jin X, Li J, Jin X, Yu J, Sun X, Chu Y, Xu C, Li X, Wang X, Kakehi Y, Wu X.","Urology. 2012 Apr;79(4):968.e7-15. doi: 10.1016/j.urology.2011.11.011. Epub 2012 Jan 11.","Li Y","Urology","2012","2012/01/17","","","10.1016/j.urology.2011.11.011"
"20056061","The impact of the two-week wait rule on the diagnosis and management of bladder cancer in a single UK institution","Blick C, Bailey D, Haldar N, Bdesha A, Kelleher J, Muneer A.","Ann R Coll Surg Engl. 2010 Jan;92(1):46-50. doi: 10.1308/003588410X12518836440207.","Blick C","Ann R Coll Surg Engl","2010","2010/01/09","PMC3024617","","10.1308/003588410X12518836440207"
"25457532","Intradiverticular bladder cancer: CT imaging features and their association with clinical outcomes","Di Paolo PL, Vargas HA, Karlo CA, Lakhman Y, Zheng J, Moskowitz CS, Al-Ahmadie HA, Sala E, Bochner BH, Hricak H.","Clin Imaging. 2015 Jan-Feb;39(1):94-8. doi: 10.1016/j.clinimag.2014.10.004. Epub 2014 Oct 16.","Di Paolo PL","Clin Imaging","2015","2014/12/03","PMC4268062","NIHMS635647","10.1016/j.clinimag.2014.10.004"
"21203820","Dietary intake of micronutrients and the risk of developing bladder cancer: results from the Belgian case-control study on bladder cancer risk","Brinkman MT, Buntinx F, Kellen E, Dagnelie PC, Van Dongen MC, Muls E, Zeegers MP.","Cancer Causes Control. 2011 Mar;22(3):469-78. doi: 10.1007/s10552-010-9718-z. Epub 2011 Jan 4.","Brinkman MT","Cancer Causes Control","2011","2011/01/05","PMC3042097","","10.1007/s10552-010-9718-z"
"20193328","[Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer]","Li Q, Xu T, Wang XF.","Zhonghua Zhong Liu Za Zhi. 2009 Dec;31(12):904-7.","Li Q","Zhonghua Zhong Liu Za Zhi","2009","2010/03/03","","",""
"1949409","[Occupational bladder tumors among persons subjected to carcinogenic amino compound exposure: the epidemiology and prevention]","Bul'bulian MA.","Urol Nefrol (Mosk). 1991 Jul-Aug;(4):12-8.","Bul'bulian MA","Urol Nefrol (Mosk)","1991","1991/07/01","","",""
"25139163","Construction of predictive models for cancer-specific survival of patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: results from a multicenter retrospective study","Nishiyama N, Kitamura H, Hotta H, Takahashi A, Yanase M, Itoh N, Tachiki H, Miyao N, Matsukawa M, Kunishima Y, Taguchi K, Masumori N.","Jpn J Clin Oncol. 2014 Nov;44(11):1101-8. doi: 10.1093/jjco/hyu119. Epub 2014 Aug 19.","Nishiyama N","Jpn J Clin Oncol","2014","2014/08/21","","","10.1093/jjco/hyu119"
"2455442","[Instillation chemotherapy with peplomycin in superficial bladder cancer: clinical study on the effects of the direct antitumor activity and of the prophylaxis of recurrence]","Sonoda T, Osafune M, Matsuda M, Usami M.","Hinyokika Kiyo. 1988 Mar;34(3):574-81.","Sonoda T","Hinyokika Kiyo","1988","1988/03/01","","",""
"23563388","Urachal carcinoma","Abeygunasekera AM, Ranasinghe DD.","Indian J Med Res. 2013 Feb;137(2):398.","Abeygunasekera AM","Indian J Med Res","2013","2013/04/09","PMC3657868","",""
"15939530","Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration","Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.","Eur Urol. 2005 Aug;48(2):189-199; discussion 199-201. doi: 10.1016/j.eururo.2005.04.005. Epub 2005 Apr 25.","Advanced Bladder Cancer (ABC) Meta-analysis Collaboration","Eur Urol","2005","2005/06/09","","","10.1016/j.eururo.2005.04.005"
"26334934","Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study","Patel MI, Bang A, Gillatt D, Smith DP.","BJU Int. 2015 Oct;116 Suppl 3:18-25. doi: 10.1111/bju.13152. Epub 2015 Sep 2.","Patel MI","BJU Int","2015","2015/09/04","","","10.1111/bju.13152"
"7511274","[Etiology, pathogenesis and epidemiology or urothelial tumors]","Kunze E, Chang-Claude J, Frentzel-Beyme R.","Verh Dtsch Ges Pathol. 1993;77:147-56.","Kunze E","Verh Dtsch Ges Pathol","1993","1993/01/01","","",""
"621811","Lymphangiography in staging patients with carcinoma of the bladder","Farah RN, Cerny JC.","J Urol. 1978 Jan;119(1):40-1. doi: 10.1016/s0022-5347(17)57375-9.","Farah RN","J Urol","1978","1978/01/01","","","10.1016/s0022-5347(17)57375-9"
"3941468","Relationship of blood groups and bladder cancer","Srinivas V, Khan SA, Hoisington S, Varma A, Gonder MJ.","J Urol. 1986 Jan;135(1):50-2. doi: 10.1016/s0022-5347(17)45512-1.","Srinivas V","J Urol","1986","1986/01/01","","","10.1016/s0022-5347(17)45512-1"
"29363887","Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer","Juracek J, Peltanova B, Dolezel J, Fedorko M, Pacik D, Radova L, Vesela P, Svoboda M, Slaby O, Stanik M.","J Cell Mol Med. 2018 Mar;22(3):2033-2038. doi: 10.1111/jcmm.13487. Epub 2018 Jan 24.","Juracek J","J Cell Mol Med","2018","2018/01/25","PMC5824364","","10.1111/jcmm.13487"
"27687590","Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo","Wang DG, Zhao MJ, Liu YQ, Liu XW, Niu HT, Song YF, Tian YX.","Oncotarget. 2016 Nov 1;7(44):71710-71717. doi: 10.18632/oncotarget.12324.","Wang DG","Oncotarget","2016","2016/10/01","PMC5342114","","10.18632/oncotarget.12324"
"20367633","Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma","Dalbagni G, Kaag M, Cronin A, Vora K, Bochner B, Donat SM, Herr HW.","BJU Int. 2010 Nov;106(10):1502-7. doi: 10.1111/j.1464-410X.2010.09347.x.","Dalbagni G","BJU Int","2010","2010/04/07","","","10.1111/j.1464-410X.2010.09347.x"
"9868393","[Advances in surgical techniques and results of radical cystectomies for bladder cancer. 106 patients]","Zerbib M, Thirouard D, Conquy S, Thiounn N, Flam T, Debré B.","Cancer Radiother. 1998 Sep-Oct;2(5):505-11. doi: 10.1016/s1278-3218(98)80059-0.","Zerbib M","Cancer Radiother","1998","1998/12/30","","","10.1016/s1278-3218(98)80059-0"
"6375309","[Biochemistry of occupational bladder cancer]","Matsushima M, Ando K.","Hinyokika Kiyo. 1983 Nov;29(11):1383-94.","Matsushima M","Hinyokika Kiyo","1983","1983/11/01","","",""
"384516","Experimental chemotherapy of bladder cancer--systemic and intravesical","Soloway MS, Murphy WM.","Semin Oncol. 1979 Jun;6(2):166-83.","Soloway MS","Semin Oncol","1979","1979/06/01","","",""
"10879897","Cigarette smoking patterns in patients after treatment of bladder cancer","Ostroff J, Garland J, Moadel A, Fleshner N, Hay J, Cramer L, Zauber A, Trambert R, O'Sullivan ME, Russo P.","J Cancer Educ. 2000 Summer;15(2):86-90. doi: 10.1080/08858190009528663.","Ostroff J","J Cancer Educ","2000","2000/07/06","","","10.1080/08858190009528663"
"20669097","[Analysis of Clinical, Histopathological and Follow-Up Data on Transurethral Resections of the Bladder Performed during One Year at a University Centre]","Otto W, Fritsche HM, Dirmeyer M, Burger M, Straub M, Rössler W, Wieland WF, Denzinger S.","Aktuelle Urol. 2010 Sep;41(5):316-9. doi: 10.1055/s-0030-1247481. Epub 2010 Jul 28.","Otto W","Aktuelle Urol","2010","2010/07/30","","","10.1055/s-0030-1247481"
"2218573","Restaging procedures, criteria of response, and relationship between pathological response and survival","Splinter T, Denis L.","Semin Oncol. 1990 Oct;17(5):606-12.","Splinter T","Semin Oncol","1990","1990/10/01","","",""
"22226665","A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer","Hu H, Wang YL, Wang GW, Wong YC, Wang XF, Wang Y, Xu KX.","Urol Oncol. 2013 Oct;31(7):1242-53. doi: 10.1016/j.urolonc.2011.12.003. Epub 2012 Jan 5.","Hu H","Urol Oncol","2013","2012/01/10","","","10.1016/j.urolonc.2011.12.003"
"6720112","[Prevention of the recurrence of superficial bladder cancer]","Flamm J, Grof F.","Z Urol Nephrol. 1984 Mar;77(3):129-36.","Flamm J","Z Urol Nephrol","1984","1984/03/01","","",""
"28010124","Validation of a protein panel for the noninvasive detection of recurrent non-muscle invasive bladder cancer","Gogalic S, Sauer U, Doppler S, Heinzel A, Perco P, Lukas A, Simpson G, Pandha H, Horvath A, Preininger C.","Biomarkers. 2017 Nov;22(7):674-681. doi: 10.1080/1354750X.2016.1276628. Epub 2017 Jan 19.","Gogalic S","Biomarkers","2017","2016/12/25","","","10.1080/1354750X.2016.1276628"
"18794047","Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer","Kipp BR, Tyner HL, Campion MB, Voss JS, Karnes RJ, Sebo TJ, Halling KC, Zhang J.","Am J Clin Pathol. 2008 Oct;130(4):552-9. doi: 10.1309/DFJUHY3WPC9GUU2W.","Kipp BR","Am J Clin Pathol","2008","2008/09/17","","","10.1309/DFJUHY3WPC9GUU2W"
"19345470","Have we abandoned the ""superficial"" in bladder cancer?","Bryan RT, Wallace DM.","Eur Urol. 2009 Dec;56(6):1091. doi: 10.1016/j.eururo.2009.03.051. Epub 2009 Mar 31.","Bryan RT","Eur Urol","2009","2009/04/07","","","10.1016/j.eururo.2009.03.051"
"1866194","[Tumor grading in urinary cytology. A study of the cytohistological relationship with evaluation of the kappa statistic for concordance]","Andrion A, Gaglio A, Zai G, Zanin A, Boffetta P.","Pathologica. 1991 Jan-Feb;83(1083):111-7.","Andrion A","Pathologica","1991","1991/01/01","","",""
"6436510","Cisplatin and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response","Shipley WU, Coombs LJ, Einstein AB Jr, Soloway MS, Wajsman Z, Prout GR Jr.","J Urol. 1984 Nov;132(5):899-903. doi: 10.1016/s0022-5347(17)49938-1.","Shipley WU","J Urol","1984","1984/11/01","","","10.1016/s0022-5347(17)49938-1"
"18724390","Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration","Wu Y, Siadaty MS, Berens ME, Hampton GM, Theodorescu D.","Oncogene. 2008 Nov 6;27(52):6679-89. doi: 10.1038/onc.2008.264. Epub 2008 Aug 25.","Wu Y","Oncogene","2008","2008/08/30","PMC5373842","NIHMS849200","10.1038/onc.2008.264"
"3676671","Invasive bladder cancer. Should patients who respond to radiotherapy be treated by cystectomy?","Langemeyer TN, Peer PG, Janknegt RA, Leers WH.","Br J Urol. 1987 Sep;60(3):248-51. doi: 10.1111/j.1464-410x.1987.tb05492.x.","Langemeyer TN","Br J Urol","1987","1987/09/01","","","10.1111/j.1464-410x.1987.tb05492.x"
"6699986","Analysis of 90 step-sectioned cystectomized specimens of bladder cancer","Kakizoe T, Matsumoto K, Nishio Y, Kishi K.","J Urol. 1984 Mar;131(3):467-72. doi: 10.1016/s0022-5347(17)50454-1.","Kakizoe T","J Urol","1984","1984/03/01","","","10.1016/s0022-5347(17)50454-1"
"29724585","Urothelial carcinoma in children: A case series","Marinoni F, Destro F, Selvaggio GGO, Riccipetitoni G.","Bull Cancer. 2018 Jun;105(6):556-561. doi: 10.1016/j.bulcan.2018.03.002. Epub 2018 May 1.","Marinoni F","Bull Cancer","2018","2018/05/05","","","10.1016/j.bulcan.2018.03.002"
"3307646","[Immunotherapy use of keyhole-limpet hemocyanin in the treatment of bladder cancer. Preliminary study]","Jurincic CD, Engelman U, Gasch J, Klippel KF.","Arch Esp Urol. 1987 May;40(4):254-8.","Jurincic CD","Arch Esp Urol","1987","1987/05/01","","",""
"27257135","Bladder Preservation Therapy: A Review of the Literature and Future Directions","Cahn DB, Ristau BT, Ghiraldi EM, Churilla TM, Geynisman DM, Horwitz EM, Uzzo RG, Smaldone MC.","Urology. 2016 Oct;96:54-61. doi: 10.1016/j.urology.2016.05.041. Epub 2016 May 30.","Cahn DB","Urology","2016","2016/06/04","","","10.1016/j.urology.2016.05.041"
"16514843","Cytology of lleal conduit urine in bladder cancer patients: diagnostic utility and pitfalls","Ajit D, Dighe SB, Desai SB.","Acta Cytol. 2006 Jan-Feb;50(1):70-3. doi: 10.1159/000325897.","Ajit D","Acta Cytol","2006","2006/03/07","","","10.1159/000325897"
"19751260","The West Midlands Bladder Cancer Prognosis Programme: rationale and design","Zeegers MP, Bryan RT, Langford C, Billingham L, Murray P, Deshmukh NS, Hussain S, James N, Wallace DM, Cheng KK.","BJU Int. 2010 Mar;105(6):784-8. doi: 10.1111/j.1464-410X.2009.08849.x. Epub 2009 Sep 14.","Zeegers MP","BJU Int","2010","2009/09/16","","","10.1111/j.1464-410X.2009.08849.x"
"15606329","The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer","Quek ML, Sanderson KM, Daneshmand S, Stein JP.","Expert Rev Anticancer Ther. 2004 Dec;4(6):1007-16. doi: 10.1586/14737140.4.6.1007.","Quek ML","Expert Rev Anticancer Ther","2004","2004/12/21","","","10.1586/14737140.4.6.1007"
"4806170","The need for experimental research in bladder cancer","Clayson D.","Cancro. 1973;26(3):145-9.","Clayson D","Cancro","1973","1973/01/01","","",""
"16230180","Efficacy of BTA stat, cytology, and survivin in bladder cancer surveillance over 5 years in patients with spinal cord injury","Davies B, Chen JJ, McMurry T, Landsittel D, Lewis N, Brenes G, Getzenberg RH.","Urology. 2005 Oct;66(4):908-11. doi: 10.1016/j.urology.2005.05.022.","Davies B","Urology","2005","2005/10/19","","","10.1016/j.urology.2005.05.022"
"19954290","Lymph node dissection for bladder cancer: the issue of extent and feasibility in the minimally invasive era","Ghavamian R, Hakimi AA.","Expert Rev Anticancer Ther. 2009 Dec;9(12):1783-92. doi: 10.1586/era.09.147.","Ghavamian R","Expert Rev Anticancer Ther","2009","2009/12/04","","","10.1586/era.09.147"
"23269336","Eosinophilic cystitis simulating recurrence of an aggressive urothelial cancer","Quinta A, Carvalho AP, Oliveira M, Oliveira C, Ribeiro Santos A.","Arch Esp Urol. 2012 Dec;65(10):891-4.","Quinta A","Arch Esp Urol","2012","2012/12/28","","",""
"27273619","Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy","Ang WX, Zhao Y, Kwang T, Wu C, Chen C, Toh HC, Mahendran R, Esuvaranathan K, Wang S.","Sci Rep. 2016 Jun 8;6:27455. doi: 10.1038/srep27455.","Ang WX","Sci Rep","2016","2016/06/09","PMC4897700","","10.1038/srep27455"
"29865039","High expression of spindle and kinetochore- associated protein 1 predicts early recurrence and progression of non-muscle invasive bladder cancer","Jiang S, Tian F, Wang Q, Cheng W, Wang L, Wang Y, Sun W.","Cancer Biomark. 2018;22(3):543-549. doi: 10.3233/CBM-181202.","Jiang S","Cancer Biomark","2018","2018/06/06","","","10.3233/CBM-181202"
"9615206","25-year experience in the management of invasive bladder cancer by radical cystectomy","Skinner DG, Stein JP, Lieskovsky G, Skinner EC, Boyd SD, Figueroa A, Jones P, Cote R, Groshen S.","Eur Urol. 1998;33 Suppl 4:25-6. doi: 10.1159/000052260.","Skinner DG","Eur Urol","1998","1998/06/06","","","10.1159/000052260"
"12603405","Time after surgery, symptoms and well-being in survivors of urinary bladder cancer","Henningsohn L, Wijkström H, Pedersen J, Ahlstrand C, Aus G, Bergmark K, Onelöv E, Steineck G.","BJU Int. 2003 Mar;91(4):325-30; discussion 330. doi: 10.1046/j.1464-410x.2003.04101.x.","Henningsohn L","BJU Int","2003","2003/02/27","","","10.1046/j.1464-410x.2003.04101.x"
"671605","Pre-clinical cytological diagnosis of bladder cancer","Geisse LJ, Tweeddale DN.","J Urol. 1978 Jul;120(1):51-6. doi: 10.1016/s0022-5347(17)57036-6.","Geisse LJ","J Urol","1978","1978/07/01","","","10.1016/s0022-5347(17)57036-6"
"23025650","Tumor multiplicity is an independent prognostic factor of non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guerin immunotherapy","Ajili F, Manai M, Darouiche A, Chebil M, Boubaker S.","Ultrastruct Pathol. 2012 Oct;36(5):320-4. doi: 10.3109/01913123.2012.681833.","Ajili F","Ultrastruct Pathol","2012","2012/10/03","","","10.3109/01913123.2012.681833"
"30231589","Extracellular Vesicles in Bladder Cancer: Biomarkers and Beyond","Liu YR, Ortiz-Bonilla CJ, Lee YF.","Int J Mol Sci. 2018 Sep 18;19(9):2822. doi: 10.3390/ijms19092822.","Liu YR","Int J Mol Sci","2018","2018/09/21","PMC6165150","","10.3390/ijms19092822"
"11783019","[Deletion mapping of chromosome 18q and Smad proteins expression analysis in urinary bladder carcinomas]","Fan Z, Zhang J, Bai J.","Zhonghua Zhong Liu Za Zhi. 2001 Mar;23(2):135-7.","Fan Z","Zhonghua Zhong Liu Za Zhi","2001","2002/01/11","","",""
"6523891","[Peritumoral infiltration of mononuclear leukocytes and clinical course in bladder cancer]","Flamm J, Benesch A.","Wien Klin Wochenschr. 1984 Oct 12;96(19):735-9.","Flamm J","Wien Klin Wochenschr","1984","1984/10/12","","",""
"19417725","Neobladder reconstruction following radical cystoprostatectomy for invasive bladder cancer","Tunuguntla HS, Nieder AM, Manoharan M.","Minerva Urol Nefrol. 2009 Mar;61(1):41-54.","Tunuguntla HS","Minerva Urol Nefrol","2009","2009/05/07","","",""
"7511295","[Spectrum of morphologic findings in cystectomy specimens]","Savvas V, Presse S, Kuntz RM.","Verh Dtsch Ges Pathol. 1993;77:266-70.","Savvas V","Verh Dtsch Ges Pathol","1993","1993/01/01","","",""
"28212556","Urinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancer","Ingelmo-Torres M, Lozano JJ, Izquierdo L, Carrion A, Costa M, Gómez L, Ribal MJ, Alcaraz A, Mengual L.","Oncotarget. 2017 Mar 14;8(11):18238-18247. doi: 10.18632/oncotarget.15315.","Ingelmo-Torres M","Oncotarget","2017","2017/02/18","PMC5392323","","10.18632/oncotarget.15315"
"17725540","Improving the management of bladder cancer with fluorescence cystoscopy","Grossman HB.","J Environ Pathol Toxicol Oncol. 2007;26(2):143-7. doi: 10.1615/jenvironpatholtoxicoloncol.v26.i2.90.","Grossman HB","J Environ Pathol Toxicol Oncol","2007","2007/08/30","","","10.1615/jenvironpatholtoxicoloncol.v26.i2.90"
"8646593","Early disease progression after intravesical bacillus Calmette-Guérin (BCG) therapy for superficial bladder cancer","Kanamaru H, Saikawa S, Muranaka K, Mori H, Akino H, Miwa Y, Nakamura N, Fujita T, Okada K.","Int J Urol. 1996 Jan;3(1):18-22. doi: 10.1111/j.1442-2042.1996.tb00623.x.","Kanamaru H","Int J Urol","1996","1996/01/01","","","10.1111/j.1442-2042.1996.tb00623.x"
"27502337","Prediction of histological stage based on cystoscopic appearances of newly diagnosed bladder tumours","During VA, Sole GM, Jha AK, Anderson JA, Bryan RT.","Ann R Coll Surg Engl. 2016 Nov;98(8):547-551. doi: 10.1308/rcsann.2016.0246. Epub 2016 Aug 9.","During VA","Ann R Coll Surg Engl","2016","2016/08/10","PMC5392893","","10.1308/rcsann.2016.0246"
"21906968","Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis","Canter D, Egleston B, Wong YN, Smaldone MC, Simhan J, Greenberg RE, Uzzo RG, Kutikov A.","Urol Oncol. 2013 Aug;31(6):866-70. doi: 10.1016/j.urolonc.2011.07.009. Epub 2011 Sep 9.","Canter D","Urol Oncol","2013","2011/09/13","","","10.1016/j.urolonc.2011.07.009"
"30909190","Circ0001429 regulates progression of bladder cancer through binding miR-205-5p and promoting VEGFA expression","Cao W, Zhao Y, Wang L, Huang X.","Cancer Biomark. 2019;25(1):101-113. doi: 10.3233/CBM-182380.","Cao W","Cancer Biomark","2019","2019/03/26","","","10.3233/CBM-182380"
"17338244","[Immunotherapy of invasive cancer of the urinary bladder]","Kharchenko VP, Kaprin AD, Ivanov SA, Klimenko AA.","Vopr Onkol. 2006;52(6):659-62.","Kharchenko VP","Vopr Onkol","2006","2007/03/07","","",""
"18595231","Local recurrence of bladder cancer after cystectomy with orthotopic bladder substitution and ileal conduit","Pejcic T, Hadzi-Djokic J, Acimovic M, Markovic B, Maksimovic H, Milkovic B, Kajmakovic B.","Acta Chir Iugosl. 2007;54(4):63-7. doi: 10.2298/aci0704063p.","Pejcic T","Acta Chir Iugosl","2007","2008/07/04","","","10.2298/aci0704063p"
"15539134","A 'bioreactor' for bladder cancer cells","Foubister V.","Drug Discov Today. 2004 Nov 15;9(22):946-7. doi: 10.1016/S1359-6446(04)03270-2.","Foubister V","Drug Discov Today","2004","2004/11/13","","","10.1016/S1359-6446(04)03270-2"
"21330047","High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy","Jensen JB, Munksgaard PP, Sørensen CM, Fristrup N, Birkenkamp-Demtroder K, Ulhøi BP, Jensen KM, Ørntoft TF, Dyrskjøt L.","Eur Urol. 2011 May;59(5):841-8. doi: 10.1016/j.eururo.2011.01.048. Epub 2011 Feb 16.","Jensen JB","Eur Urol","2011","2011/02/19","","","10.1016/j.eururo.2011.01.048"
"11464028","Bladder cancer. I. Molecular and genetic basis of carcinogenesis","Brandau S, Böhle A.","Eur Urol. 2001 May;39(5):491-7. doi: 10.1159/000052494.","Brandau S","Eur Urol","2001","2001/07/21","","","10.1159/000052494"
"9615200","Molecular prognostic factors in bladder cancer","Schalken JA.","Eur Urol. 1998;33 Suppl 4:13-4. doi: 10.1159/000052254.","Schalken JA","Eur Urol","1998","1998/06/06","","","10.1159/000052254"
"1396943","From the 19th to the 21st centuries: BCG in the treatment of superficial bladder cancer","Morales A.","Eur Urol. 1992;21 Suppl 2:2-6. doi: 10.1159/000474913.","Morales A","Eur Urol","1992","1992/01/01","","","10.1159/000474913"
"29496372","Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network","Zuiverloon TCM, van Kessel KEM, Bivalacqua TJ, Boormans JL, Ecke TH, Grivas PD, Kiltie AE, Liedberg F, Necchi A, van Rhijn BW, Roghmann F, Sanchez-Carbayo M, Schmitz-Dräger BJ, Wezel F, Kamat AM.","Urol Oncol. 2018 Sep;36(9):423-431. doi: 10.1016/j.urolonc.2018.01.014. Epub 2018 Mar 2.","Zuiverloon TCM","Urol Oncol","2018","2018/03/03","","","10.1016/j.urolonc.2018.01.014"
"753485","Adoptive immunotherapy and radiotherapy in the treatment of urinary bladder cancer","Symes MO, Eckert H, Feneley RC, Lai T, Mitchell JP, Roberts JB, Tribe CR.","Br J Urol. 1978 Aug;50(5):328-31. doi: 10.1111/j.1464-410x.1978.tb03641.x.","Symes MO","Br J Urol","1978","1978/08/01","","","10.1111/j.1464-410x.1978.tb03641.x"
"11832716","Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer","Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF.","J Urol. 2002 Mar;167(3):1295-8.","Herr HW","J Urol","2002","2002/02/08","","",""
"6551554","[Topics in medicine: the urine of patients with bladder cancer]","Shibusawa K.","Kango. 1983 Jan;35(1):104.","Shibusawa K","Kango","1983","1983/01/01","","",""
"1564822","[Inhibitory effects of IFN on N-butyl-N-(hydroxybutyl) nitrosamine induced rats bladder tumors]","Yasumoto R, Asakawa M, Fukui J, Wada S, Kishimoto T, Maekawa M.","Nihon Hinyokika Gakkai Zasshi. 1992 Jan;83(1):16-22. doi: 10.5980/jpnjurol1989.83.16.","Yasumoto R","Nihon Hinyokika Gakkai Zasshi","1992","1992/01/01","","","10.5980/jpnjurol1989.83.16"
"17382711","Use of urinary biomarkers for bladder cancer surveillance: patient perspectives","Yossepowitch O, Herr HW, Donat SM.","J Urol. 2007 Apr;177(4):1277-82; discussion 1282. doi: 10.1016/j.juro.2006.11.066.","Yossepowitch O","J Urol","2007","2007/03/27","","","10.1016/j.juro.2006.11.066"
"2201476","BCG product released for therapy of urinary bladder cancer","","Clin Pharm. 1990 Aug;9(8):598-9.","","Clin Pharm","1990","1990/08/01","","",""
"7262162","Prognostic significance of serum proteins in invasive bladder cancer. A preliminary report of the E.O.R.T.C. Urological Group","O'Quigley J, Haworth S, Cooper EH, Haije W, van der Werf-Messing B, Richards B, Robinson MR.","Eur J Cancer. 1981 Feb;17(2):251-5. doi: 10.1016/0014-2964(81)90044-x.","O'Quigley J","Eur J Cancer","1981","1981/02/01","","","10.1016/0014-2964(81)90044-x"
"25728352","Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer","Islam SS, Mokhtari RB, Noman AS, Uddin M, Rahman MZ, Azadi MA, Zlotta A, van der Kwast T, Yeger H, Farhat WA.","Mol Carcinog. 2016 May;55(5):537-51. doi: 10.1002/mc.22300. Epub 2015 Mar 1.","Islam SS","Mol Carcinog","2016","2015/03/03","","","10.1002/mc.22300"
"12576818","Superiority of ratio based lymph node staging for bladder cancer","Herr HW.","J Urol. 2003 Mar;169(3):943-5. doi: 10.1097/01.ju.0000032474.22093.06.","Herr HW","J Urol","2003","2003/02/11","","","10.1097/01.ju.0000032474.22093.06"
"1723657","A dipstick, dot-ELISA assay for the rapid and early detection of bladder cancer","Attallah AM, Helmi H, el-Helali E, el-Mohamadi H.","Cancer Detect Prev. 1991;15(6):495-9.","Attallah AM","Cancer Detect Prev","1991","1991/01/01","","",""
"16103747","Immunostimulatory CpG oligonucleotides reduce tumor burden after intravesical administration in an orthotopic murine bladder cancer model","Hegele A, Dalpke A, Heeg K, Barth P, Varga Z, Hofmann R, Olbert P.","Tumour Biol. 2005 Sep-Oct;26(5):274-80. doi: 10.1159/000087380. Epub 2005 Aug 9.","Hegele A","Tumour Biol","2005","2005/08/17","","","10.1159/000087380"
"22849562","Statin use and the risk of bladder cancer: a population-based case-control study","Kuo CC, Chiu HF, Lee IM, Kuo HW, Lee CT, Yang CY.","Expert Opin Drug Saf. 2012 Sep;11(5):733-8. doi: 10.1517/14740338.2012.712960. Epub 2012 Jul 31.","Kuo CC","Expert Opin Drug Saf","2012","2012/08/02","","","10.1517/14740338.2012.712960"
"20598491","Variations in treatment policies and outcome for bladder cancer in the Netherlands","Goossens-Laan CA, Visser O, Wouters MW, Jansen-Landheer ML, Coebergh JW, van de Velde CJ, Hulshof MC, Kil PJ.","Eur J Surg Oncol. 2010 Sep;36 Suppl 1:S100-7. doi: 10.1016/j.ejso.2010.06.003. Epub 2010 Jul 2.","Goossens-Laan CA","Eur J Surg Oncol","2010","2010/07/06","","","10.1016/j.ejso.2010.06.003"
"7487120","[Preoperative chemotherapy in genitourinary cancer]","Kawai K, Akaza H.","Gan To Kagaku Ryoho. 1995 Nov;22(13):1912-7.","Kawai K","Gan To Kagaku Ryoho","1995","1995/11/01","","",""
"28248027","[Choosing treatment for patients with bladder cancer combined with prostatic hyperplasia]","Glybochko PV, Alyaev YG, Pshikhachev AM, Sorokin NI, Dymov AM.","Urologiia. 2016 Nov;(5):92-96.","Glybochko PV","Urologiia","2016","2017/03/02","","",""
"21110754","Prognostic value of CA 125 in transitional cell carcinoma of the bladder","Manvar AM, Wallen EM, Pruthi RS, Nielsen ME.","Expert Rev Anticancer Ther. 2010 Dec;10(12):1877-81. doi: 10.1586/era.10.186.","Manvar AM","Expert Rev Anticancer Ther","2010","2010/11/30","","","10.1586/era.10.186"
"23137019","Current perspectives in bladder cancer management","Griffiths TR; Action on Bladder Cancer.","Int J Clin Pract. 2013 May;67(5):435-48. doi: 10.1111/ijcp.12075. Epub 2012 Nov 9.","Griffiths TR","Int J Clin Pract","2013","2012/11/10","","","10.1111/ijcp.12075"
"2728145","Are frozen-section examinations of ureteral margins required for all patients undergoing radical cystectomy for bladder cancer?","Johnson DE, Wishnow KI, Tenney D.","Urology. 1989 Jun;33(6):451-4. doi: 10.1016/0090-4295(89)90127-1.","Johnson DE","Urology","1989","1989/06/01","","","10.1016/0090-4295(89)90127-1"
"28268231","MiR-1-3p Suppresses the Proliferation, Invasion and Migration of Bladder Cancer Cells by Up-Regulating SFRP1 Expression","Shang A, Yang M, Shen F, Wang J, Wei J, Wang W, Lu W, Wang C, Wang C.","Cell Physiol Biochem. 2017;41(3):1179-1188. doi: 10.1159/000464379. Epub 2017 Mar 6.","Shang A","Cell Physiol Biochem","2017","2017/03/08","","","10.1159/000464379"
"3310556","[Review of ureteral carcinoma as seen in mapping of the cystectomized bladder]","Kim CG, Hamada H, Koh E, Saiki S, Kinouchi T, Kuroda M, Miki T, Kiyohara H, Usami M, Nakamura M, et al.","Hinyokika Kiyo. 1987 May;33(5):692-6.","Kim CG","Hinyokika Kiyo","1987","1987/05/01","","",""
"28447581","Effect of cisplatin-based neoadjuvant chemotherapy on survival in patients with bladder cancer: a meta-analysis","Li G, Niu HM, Wu HT, Lei BY, Wang XH, Guo XB, Feng SL.","Clin Invest Med. 2017 Apr 26;40(2):E81-E94. doi: 10.25011/cim.v40i2.28199.","Li G","Clin Invest Med","2017","2017/04/28","","","10.25011/cim.v40i2.28199"
"24134934","Gene profiling suggests a common evolution of bladder cancer subtypes","Hansel DE, Zhang Z, Petillo D, Teh BT.","BMC Med Genomics. 2013 Oct 17;6:42. doi: 10.1186/1755-8794-6-42.","Hansel DE","BMC Med Genomics","2013","2013/10/19","PMC4015777","","10.1186/1755-8794-6-42"
"18559493","Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer","Hadaschik BA, Zhang K, So AI, Fazli L, Jia W, Bell JC, Gleave ME, Rennie PS.","Cancer Res. 2008 Jun 15;68(12):4506-10. doi: 10.1158/0008-5472.CAN-08-0238.","Hadaschik BA","Cancer Res","2008","2008/06/19","","","10.1158/0008-5472.CAN-08-0238"
"21703358","Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer","Ryk C, Wiklund NP, Nyberg T, de Verdier PJ.","Nitric Oxide. 2011 Oct 30;25(3):338-43. doi: 10.1016/j.niox.2011.06.003. Epub 2011 Jun 13.","Ryk C","Nitric Oxide","2011","2011/06/28","","","10.1016/j.niox.2011.06.003"
"25882560","Neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer: bridging the gap between evidence and practice","Sfakianos JP, Galsky MD.","Urol Clin North Am. 2015 May;42(2):181-7, viii. doi: 10.1016/j.ucl.2015.01.002. Epub 2015 Mar 5.","Sfakianos JP","Urol Clin North Am","2015","2015/04/18","","","10.1016/j.ucl.2015.01.002"
"24659585","Tetrachloroethylene exposure and bladder cancer risk: a meta-analysis of dry-cleaning-worker studies","Vlaanderen J, Straif K, Ruder A, Blair A, Hansen J, Lynge E, Charbotel B, Loomis D, Kauppinen T, Kyyronen P, Pukkala E, Weiderpass E, Guha N.","Environ Health Perspect. 2014 Jul;122(7):661-6. doi: 10.1289/ehp.1307055. Epub 2014 Mar 21.","Vlaanderen J","Environ Health Perspect","2014","2014/03/25","PMC4080536","","10.1289/ehp.1307055"
"22898175","Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression","Byler TK, Leocadio D, Shapiro O, Bratslavsky G, Stodgell CJ, Wood RW, Messing EM, Reeder JE.","BMC Urol. 2012 Aug 16;12:21. doi: 10.1186/1471-2490-12-21.","Byler TK","BMC Urol","2012","2012/08/18","PMC3487994","","10.1186/1471-2490-12-21"
"12536914","[Results of cystectomy for cancer]","Zerbib M, Bouchot O.","Prog Urol. 2002 Nov;12(5):913-22.","Zerbib M","Prog Urol","2002","2003/01/23","","",""
"2724749","[Histological effect of preoperative irradiation in bladder cancer]","Isaka S, Okano T, Shimazaki J, Morita S, Tsunemoto H, Teshima S.","Nihon Hinyokika Gakkai Zasshi. 1989 Jan;80(1):82-7. doi: 10.5980/jpnjurol1989.80.82.","Isaka S","Nihon Hinyokika Gakkai Zasshi","1989","1989/01/01","","","10.5980/jpnjurol1989.80.82"
"872110","Comments on ""Recognition of 'Early' Bladder Cancer and Premalignant Epithelial Changes""","Veenema RJ.","Cancer Res. 1977 Aug;37(8 Pt 2):2836.","Veenema RJ","Cancer Res","1977","1977/08/01","","",""
"6668646","Cell surface antigens in bladder cancer","Javadpour N.","J Urol. 1983 Feb;129(2):439. doi: 10.1016/s0022-5347(17)52135-7.","Javadpour N","J Urol","1983","1983/02/01","","","10.1016/s0022-5347(17)52135-7"
"18618249","Validation of prognostic indices using the frailty model","Legrand C, Duchateau L, Janssen P, Ducrocq V, Sylvester R.","Lifetime Data Anal. 2009 Mar;15(1):59-78. doi: 10.1007/s10985-008-9092-2. Epub 2008 Jul 11.","Legrand C","Lifetime Data Anal","2009","2008/07/12","","","10.1007/s10985-008-9092-2"
"11957752","[Radical cystectomy for superficial tumors in the BCG era]","Huguet Pérez J, Palou J, Millán Rodríguez F, Villavicencio Mavrich H, Rodríguez JV.","Arch Esp Urol. 2002 Jan-Feb;55(1):50-6.","Huguet Pérez J","Arch Esp Urol","2002","2002/04/18","","",""
"17439739","XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer","Li M, Song T, Yin ZF, Na YQ.","Chin Med J (Engl). 2007 Mar 20;120(6):469-73.","Li M","Chin Med J (Engl)","2007","2007/04/19","","",""
"26549051","Rapid bladder cancer cell detection from clinical urine samples using an ultra-thin silicone membrane","Appel JH, Ren H, Sin ML, Liao JC, Chae J.","Analyst. 2016 Jan 21;141(2):652-60. doi: 10.1039/c5an01616a.","Appel JH","Analyst","2016","2015/11/10","","","10.1039/c5an01616a"
"20223133","[Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma]","Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA; European Association of Urology.","Actas Urol Esp. 2010 Jan;34(1):51-62.","Stenzl A","Actas Urol Esp","2010","2010/03/13","","",""
"27845906","Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer","Ochoa AE, Choi W, Su X, Siefker-Radtke A, Czerniak B, Dinney C, McConkey DJ.","Oncotarget. 2016 Dec 6;7(49):80164-80174. doi: 10.18632/oncotarget.13284.","Ochoa AE","Oncotarget","2016","2016/11/16","PMC5348311","","10.18632/oncotarget.13284"
"17106329","Urinary bladder cancer risk factors in men: a Spanish case-control study","Baena AV, Allam MF, Del Castillo AS, Díaz-Molina C, Requena Tapia MJ, Abdel-Rahman AG, Navajas RF.","Eur J Cancer Prev. 2006 Dec;15(6):498-503. doi: 10.1097/01.cej.0000215618.05757.04.","Baena AV","Eur J Cancer Prev","2006","2006/11/16","","","10.1097/01.cej.0000215618.05757.04"
"25248495","Intake of fruit and vegetables and risk of bladder cancer: a dose-response meta-analysis of observational studies","Yao B, Yan Y, Ye X, Fang H, Xu H, Liu Y, Li S, Zhao Y.","Cancer Causes Control. 2014 Dec;25(12):1645-58. doi: 10.1007/s10552-014-0469-0. Epub 2014 Sep 24.","Yao B","Cancer Causes Control","2014","2014/09/25","","","10.1007/s10552-014-0469-0"
"19491893","UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer","Unoki M, Kelly JD, Neal DE, Ponder BA, Nakamura Y, Hamamoto R.","Br J Cancer. 2009 Jul 7;101(1):98-105. doi: 10.1038/sj.bjc.6605123. Epub 2009 Jun 2.","Unoki M","Br J Cancer","2009","2009/06/04","PMC2713709","","10.1038/sj.bjc.6605123"
"19282158","Ultrasound imaging to assess inter- and intra-fraction motion during bladder radiotherapy and its potential as a verification tool","McBain CA, Green MM, Stratford J, Davies J, McCarthy C, Taylor B, McHugh D, Swindell R, Khoo V, Price P.","Clin Oncol (R Coll Radiol). 2009 Jun;21(5):385-93. doi: 10.1016/j.clon.2009.01.016. Epub 2009 Mar 17.","McBain CA","Clin Oncol (R Coll Radiol)","2009","2009/03/14","","","10.1016/j.clon.2009.01.016"
"22500693","Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience","Daneshmand S.","BJU Int. 2012 Nov;110(9):1324. doi: 10.1111/j.1464-410X.2012.11158.x. Epub 2012 Apr 13.","Daneshmand S","BJU Int","2012","2012/04/17","","","10.1111/j.1464-410X.2012.11158.x"
"26781169","The safety and efficacy of gemcitabine for the treatment of bladder cancer","Schlack K, Boegemann M, Steinestel J, Schrader AJ, Krabbe LM.","Expert Rev Anticancer Ther. 2016;16(3):255-71. doi: 10.1586/14737140.2016.1143777. Epub 2016 Feb 9.","Schlack K","Expert Rev Anticancer Ther","2016","2016/01/20","","","10.1586/14737140.2016.1143777"
"20730711","Meta-analysis of epidemiological studies of association of P53 codon 72 polymorphism with bladder cancer","Li DB, Wei X, Jiang LH, Wang Y, Xu F.","Genet Mol Res. 2010 Aug 17;9(3):1599-605. doi: 10.4238/vol9-3gmr882.","Li DB","Genet Mol Res","2010","2010/08/24","","","10.4238/vol9-3gmr882"
"27510007","Risk Factors for Upper and Lower Urinary Tract Cancer Death in a Japanese Population: Findings from the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study)","Washio M, Mori M, Mikami K, Miki T, Watanabe Y, Nakao M, Kubo T, Suzuki K, Ozasa K, Wakai K, Tamakoshi A.","Asian Pac J Cancer Prev. 2016;17(7):3545-9.","Washio M","Asian Pac J Cancer Prev","2016","2016/08/12","","",""
"27630325","Radiotherapy for Muscle-invasive Bladder Cancer in Very Elderly Patients","Maebayashi T, Ishibashi N, Aizawa T, Sakaguchi M, Sato K, Matsui T, Yamaguchi K, Takahashi S.","Anticancer Res. 2016 Sep;36(9):4763-9. doi: 10.21873/anticanres.11033.","Maebayashi T","Anticancer Res","2016","2016/09/16","","","10.21873/anticanres.11033"
"28166762","CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor","Zhu B, Qi L, Liu S, Liu W, Ou Z, Chen M, Liu L, Zu X, Wang J, Li Y.","BMC Cancer. 2017 Feb 6;17(1):105. doi: 10.1186/s12885-017-3101-3.","Zhu B","BMC Cancer","2017","2017/02/08","PMC5294712","","10.1186/s12885-017-3101-3"
"26138037","Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer","de Martino M, Lucca I, Mbeutcha A, Wiener HG, Haitel A, Susani M, Shariat SF, Klatte T.","Eur Urol. 2015 Oct;68(4):552-4. doi: 10.1016/j.eururo.2015.06.015. Epub 2015 Jun 30.","de Martino M","Eur Urol","2015","2015/07/04","","","10.1016/j.eururo.2015.06.015"
"4086141","Increased risk for male bladder cancer among a cohort of male and female hairdressers from Geneva","Gubéran E, Raymond L, Sweetnam PM.","Int J Epidemiol. 1985 Dec;14(4):549-54. doi: 10.1093/ije/14.4.549.","Gubéran E","Int J Epidemiol","1985","1985/12/01","","","10.1093/ije/14.4.549"
"384517","Surgical management of low stage bladder cancer","Whitmore WF Jr.","Semin Oncol. 1979 Jun;6(2):207-16.","Whitmore WF Jr","Semin Oncol","1979","1979/06/01","","",""
"16675585","Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer","Kosugi M, Miyajima A, Kikuchi E, Horiguchi Y, Murai M.","Clin Cancer Res. 2006 May 1;12(9):2888-93. doi: 10.1158/1078-0432.CCR-05-2213.","Kosugi M","Clin Cancer Res","2006","2006/05/06","","","10.1158/1078-0432.CCR-05-2213"
"24190368","Clinical significance of definite muscle layer in TUR specimen for evaluating progression rate in T1G3 bladder cancer: multicenter retrospective study by the Sapporo Medical University Urologic Oncology Consortium (SUOC)","Shindo T, Masumori N, Kitamura H, Tanaka T, Fukuta F, Hasegawa T, Yanase M, Miyake M, Miyao N, Takahashi A, Matsukawa M, Taguchi K, Shigyo M, Kunishima Y, Tachiki H, Tsukamoto T.","World J Urol. 2014 Oct;32(5):1281-5. doi: 10.1007/s00345-013-1205-1. Epub 2013 Nov 5.","Shindo T","World J Urol","2014","2013/11/06","","","10.1007/s00345-013-1205-1"
"10958945","H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers","Przybojewska B, Jagiello A, Jalmuzna P.","Cancer Genet Cytogenet. 2000 Aug;121(1):73-7. doi: 10.1016/s0165-4608(00)00223-5.","Przybojewska B","Cancer Genet Cytogenet","2000","2000/08/26","","","10.1016/s0165-4608(00)00223-5"
"23844063","MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer","Majid S, Dar AA, Saini S, Deng G, Chang I, Greene K, Tanaka Y, Dahiya R, Yamamura S.","PLoS One. 2013 Jul 2;8(7):e67686. doi: 10.1371/journal.pone.0067686. Print 2013.","Majid S","PLoS One","2013","2013/07/12","PMC3699593","","10.1371/journal.pone.0067686"
"3362902","Retrospective analysis of 246 patients after radical cystectomy for treatment of bladder cancer without preoperative radiotherapy","Stöckle M, Alken P, Jacobi GH, Riedmiller H, Hohenfellner R.","Prog Clin Biol Res. 1988;260:461-7.","Stöckle M","Prog Clin Biol Res","1988","1988/01/01","","",""
"1836650","[Suprapubic bladder ultrasonography and urinary cytology: indications and limits in the follow-up of superficial bladder tumors]","Pegoraro C, Bondavalli C, Molani L, Capitanio A, Schiavon L, Dall'Oglio B, Luciano M, Negri S.","Arch Ital Urol Nefrol Androl. 1991 Jun;63 Suppl 2:127-9.","Pegoraro C","Arch Ital Urol Nefrol Androl","1991","1991/06/01","","",""
"16103064","Mechanistic analysis of the role of BLCA-4 in bladder cancer pathobiology","Myers-Irvin JM, Van Le TS, Getzenberg RH.","Cancer Res. 2005 Aug 15;65(16):7145-50. doi: 10.1158/0008-5472.CAN-05-1142.","Myers-Irvin JM","Cancer Res","2005","2005/08/17","","","10.1158/0008-5472.CAN-05-1142"
"31321235","Common Core Bacterial Biomarkers of Bladder Cancer Based on Multiple Datasets","Mai G, Chen L, Li R, Liu Q, Zhang H, Ma Y.","Biomed Res Int. 2019 Jun 19;2019:4824909. doi: 10.1155/2019/4824909. eCollection 2019.","Mai G","Biomed Res Int","2019","2019/07/20","PMC6607711","","10.1155/2019/4824909"
"558345","The clinical utility of plasma and urinary carcinoembryonic antigen in patients with genitourinary disease","Fleisher M, Grabstald H, Whitmore WF Jr, Pinsky CM, Oettgen HF, Schwartz MK.","J Urol. 1977 May;117(5):635-7. doi: 10.1016/s0022-5347(17)58567-5.","Fleisher M","J Urol","1977","1977/05/01","","","10.1016/s0022-5347(17)58567-5"
"31481299","Bladder cancer survival: Women only fare worse in the first two years after diagnosis","Richters A, Dickman PW, Witjes JA, Boormans JL, Kiemeney LALM, Aben KKH.","Urol Oncol. 2019 Dec;37(12):853-861. doi: 10.1016/j.urolonc.2019.08.001. Epub 2019 Aug 31.","Richters A","Urol Oncol","2019","2019/09/05","","","10.1016/j.urolonc.2019.08.001"
"31808521","m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer","Chen M, Nie ZY, Wen XH, Gao YH, Cao H, Zhang SF.","Biosci Rep. 2019 Dec 20;39(12):BSR20192892. doi: 10.1042/BSR20192892.","Chen M","Biosci Rep","2019","2019/12/07","PMC6923333","","10.1042/BSR20192892"
"23709426","Pure laparoscopic radical cystectomy with ileal conduit: a single surgeon's mid-term outcomes","Park B, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI.","Yonsei Med J. 2013 Jul;54(4):912-20. doi: 10.3349/ymj.2013.54.4.912.","Park B","Yonsei Med J","2013","2013/05/28","PMC3663232","","10.3349/ymj.2013.54.4.912"
"20845292","Genetic aberrations of the K-ras proto-oncogene in bladder cancer in Kashmiri population","Nanda MS, Sameer AS, Syeed N, Shah ZA, Murtaza I, Siddiqi MA, Ali A.","Urol J. 2010 Summer;7(3):168-73.","Nanda MS","Urol J","2010","2010/09/17","","",""
"12442004","Loss of heterozygosity on chromosome 5p13-12 predicts adverse prognosis in advanced bladder cancer independent of tumor stage and grade","Böhm M, Wieland I, Schmidt C, Rubben H, Allhoff EP.","J Urol. 2002 Dec;168(6):2655-8. doi: 10.1097/01.ju.0000036540.89492.88.","Böhm M","J Urol","2002","2002/11/21","","","10.1097/01.ju.0000036540.89492.88"
"8687163","Treatment of superficial bladder cancer with intravesical perfusion of rIL-2: a follow-up study","Ferlazzo G, Magno C, Iemmo R, Rizzo M, Lupo G, Semino C, Bruno S, Melioli G.","Anticancer Res. 1996 Mar-Apr;16(2):979-80.","Ferlazzo G","Anticancer Res","1996","1996/03/01","","",""
"8017004","[The immunomodulating action of bestatin in the combined therapy of bladder cancer patients]","Neprina GS, Panteleeva ES, Vatin OE, Kariakin OB.","Urol Nefrol (Mosk). 1994 Mar-Apr;(2):34-8.","Neprina GS","Urol Nefrol (Mosk)","1994","1994/03/01","","",""
"10549252","Can immunohistochemistry enhance the detection of micrometastases in pelvic lymph nodes from patients with high-grade urothelial carcinoma of the bladder?","Yang XJ, Lecksell K, Epstein JI.","Am J Clin Pathol. 1999 Nov;112(5):649-53. doi: 10.1093/ajcp/112.5.649.","Yang XJ","Am J Clin Pathol","1999","1999/11/05","","","10.1093/ajcp/112.5.649"
"24092576","Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis","He S, Tang YH, Zhao G, Yang X, Wang D, Zhang Y.","Tumour Biol. 2014 Mar;35(3):2095-102. doi: 10.1007/s13277-013-1278-x. Epub 2013 Oct 4.","He S","Tumour Biol","2014","2013/10/05","","","10.1007/s13277-013-1278-x"
"16549617","From the Archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation","Wong-You-Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA.","Radiographics. 2006 Mar-Apr;26(2):553-80. doi: 10.1148/rg.262055172.","Wong-You-Cheong JJ","Radiographics","2006","2006/03/22","","","10.1148/rg.262055172"
"11779712","Targeting actin remodeling profiles for the detection and management of urothelial cancers--a perspective for bladder cancer research","Rao J.","Front Biosci. 2002 Jan 1;7:e1-8.","Rao J","Front Biosci","2002","2002/01/10","","",""
"24832931","Comparison of adaptive radiotherapy techniques for external radiation therapy of canine bladder cancer","Nieset JR, Harmon JF, Johnson TE, Larue SM.","Vet Radiol Ultrasound. 2014 Nov-Dec;55(6):644-50. doi: 10.1111/vru.12163. Epub 2014 May 16.","Nieset JR","Vet Radiol Ultrasound","2014","2014/05/17","","","10.1111/vru.12163"
"27601277","Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder","Singh R, Ansari JA, Maurya N, Mandhani A, Agrawal V, Garg M.","Clin Genitourin Cancer. 2017 Apr;15(2):e187-e197. doi: 10.1016/j.clgc.2016.07.021. Epub 2016 Aug 9.","Singh R","Clin Genitourin Cancer","2017","2016/09/08","","","10.1016/j.clgc.2016.07.021"
"6610295","[T-cell bearing IgG-Fc receptor in patients with bladder cancer]","Sakai S, Kato N, Ishiyama S, Deguchi T, Fujimoto Y, Muranaka K, Matsuda S, Fujihiro S, Setsuda O, Nishiura T.","Hinyokika Kiyo. 1983 Dec;29(12):1625-9.","Sakai S","Hinyokika Kiyo","1983","1983/12/01","","",""
"18062747","Current status of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer","Rosenberg JE.","Expert Rev Anticancer Ther. 2007 Dec;7(12):1729-36. doi: 10.1586/14737140.7.12.1729.","Rosenberg JE","Expert Rev Anticancer Ther","2007","2007/12/08","","","10.1586/14737140.7.12.1729"
"26258464","Progress in bladder cancer: is there light at the end of the tunnel?","Saad F.","Curr Opin Support Palliat Care. 2015 Sep;9(3):244. doi: 10.1097/SPC.0000000000000159.","Saad F","Curr Opin Support Palliat Care","2015","2015/08/11","","","10.1097/SPC.0000000000000159"
"12111175","The role of antisense oligonucleotides in the treatment of bladder cancer","Duggan BJ, Gray S, Johnston SR, Williamson K, Miyaki H, Gleave M.","Urol Res. 2002 Jul;30(3):137-47. doi: 10.1007/s00240-002-0248-3. Epub 2002 May 23.","Duggan BJ","Urol Res","2002","2002/07/12","","","10.1007/s00240-002-0248-3"
"19356669","Flourescence cystoscopy--how to do it","Shaw GL, Bunce CJ.","Photodiagnosis Photodyn Ther. 2008 Dec;5(4):267-70. doi: 10.1016/j.pdpdt.2009.01.007. Epub 2009 Feb 24.","Shaw GL","Photodiagnosis Photodyn Ther","2008","2009/04/10","","","10.1016/j.pdpdt.2009.01.007"
"32132031","The Dual Function of Aryl Hydrocarbon Receptor in Bladder Carcinogenesis","Yu J, Lu Y, Muto S, Ide H, Horie S.","Anticancer Res. 2020 Mar;40(3):1345-1357. doi: 10.21873/anticanres.14076.","Yu J","Anticancer Res","2020","2020/03/06","","","10.21873/anticanres.14076"
"21042001","Preoperative hydronephrosis predicts advanced bladder cancer but is not an independent factor for cancer-specific survival after radical cystectomy","Hofner T, Haferkamp A, Knapp L, Pahernik S, Hadaschik B, Djakovic N, Wagener N, Hohenfellner M.","Urol Int. 2011;86(1):25-30. doi: 10.1159/000321008. Epub 2010 Nov 2.","Hofner T","Urol Int","2011","2010/11/03","","","10.1159/000321008"
"24835058","Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis","Garg T, Pinheiro LC, Atoria CL, Donat SM, Weissman JS, Herr HW, Elkin EB.","J Urol. 2014 Oct;192(4):1072-7. doi: 10.1016/j.juro.2014.04.101. Epub 2014 May 14.","Garg T","J Urol","2014","2014/05/20","PMC4260395","NIHMS639684","10.1016/j.juro.2014.04.101"
"14969797","Analgesic therapy and the prevention of bladder cancer","Blumentals WA, Foulis PR, Schwartz SW, Mason TJ.","Urol Oncol. 2004 Jan-Feb;22(1):11-5. doi: 10.1016/S1078-1439(03)00100-5.","Blumentals WA","Urol Oncol","2004","2004/02/19","","","10.1016/S1078-1439(03)00100-5"
"1467858","The quality of life after radical radiotherapy for bladder cancer","Lynch WJ, Jenkins BJ, Fowler CG, Hope-Stone HF, Blandy JP.","Br J Urol. 1992 Nov;70(5):519-21.","Lynch WJ","Br J Urol","1992","1992/11/01","","",""
"21171541","Radical cystectomy for bladder cancer: a qualitative study of patient experiences and implications for practice","Fitch MI, Miller D, Sharir S, McAndrew A.","Can Oncol Nurs J. 2010 Fall;20(4):177-87. doi: 10.5737/1181912x204177181.","Fitch MI","Can Oncol Nurs J","2010","2010/12/22","","","10.5737/1181912x204177181"
"28674853","FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy","van de Putte EEF, Vegt E, Mertens LS, Bruining A, Hendricksen K, van der Heijden MS, Horenblas S, van Rhijn BWG.","Int Urol Nephrol. 2017 Sep;49(9):1585-1591. doi: 10.1007/s11255-017-1637-4. Epub 2017 Jul 3.","van de Putte EEF","Int Urol Nephrol","2017","2017/07/05","","","10.1007/s11255-017-1637-4"
"9118412","Modification of the surgical technique in radical cystectomy","Douglas TH, McLeod DG.","Tech Urol. 1996 Summer;2(2):73-6.","Douglas TH","Tech Urol","1996","1996/07/01","","",""
"15758789","Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature","Porter MP, Penson DF.","J Urol. 2005 Apr;173(4):1318-22. doi: 10.1097/01.ju.0000149080.82697.65.","Porter MP","J Urol","2005","2005/03/11","","","10.1097/01.ju.0000149080.82697.65"
"24856979","Short-term morbidity and mortality of Indiana pouch, ileal conduit, and neobladder urinary diversion following radical cystectomy","Monn MF, Kaimakliotis HZ, Cary KC, Pedrosa JA, Flack CK, Koch MO, Bihrle R.","Urol Oncol. 2014 Nov;32(8):1151-7. doi: 10.1016/j.urolonc.2014.04.009. Epub 2014 May 23.","Monn MF","Urol Oncol","2014","2014/05/27","","","10.1016/j.urolonc.2014.04.009"
"27471992","Role of surgical consolidation in metastatic urothelial carcinoma","Abe T, Matsumoto R, Shinohara N.","Curr Opin Urol. 2016 Nov;26(6):573-80. doi: 10.1097/MOU.0000000000000329.","Abe T","Curr Opin Urol","2016","2016/07/30","PMC5051536","","10.1097/MOU.0000000000000329"
"2217430","The integration of chemotherapy, radiotherapy and transurethral surgery in bladder-sparing approaches for patients with invasive tumors","Shipley WU, Kaufman DS, Heney NM, Griffin PP, Althausen AF, Prout GR Jr.","Prog Clin Biol Res. 1990;353:85-94.","Shipley WU","Prog Clin Biol Res","1990","1990/01/01","","",""
"7005785","[Therapy, follow-up treatment and prevention of urinary bladder cancer]","Thüroff JW, Jacobi GH.","Onkologie. 1980 Oct;3(5):248-54. doi: 10.1159/000214802.","Thüroff JW","Onkologie","1980","1980/10/01","","","10.1159/000214802"
"31401220","Chemoradiation Vs Radical Cystectomy for Muscle-invasive Bladder Cancer: A Propensity Score-weighted Comparative Analysis Using the National Cancer Database","Kaushik D, Wang H, Michalek J, Liss MA, Liu Q, Jha RP, Svatek RS, Mansour AM.","Urology. 2019 Nov;133:164-174. doi: 10.1016/j.urology.2019.05.062. Epub 2019 Aug 8.","Kaushik D","Urology","2019","2019/08/12","PMC6842694","NIHMS1536887","10.1016/j.urology.2019.05.062"
"22266013","A novel therapeutic vaccine of mouse GM-CSF surface modified MB49 cells against metastatic bladder cancer","Zhang X, Shi X, Li J, Hu Z, Zhou D, Gao J, Tan W.","J Urol. 2012 Mar;187(3):1071-9. doi: 10.1016/j.juro.2011.10.126. Epub 2012 Jan 21.","Zhang X","J Urol","2012","2012/01/24","","","10.1016/j.juro.2011.10.126"
"28433471","Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study","Moschini M, Shariat SF, Freschi M, Soria F, D'Andrea D, Abufaraj M, Foerster B, Dell'Oglio P, Zaffuto E, Mattei A, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R.","Urol Oncol. 2017 Aug;35(8):528.e1-528.e5. doi: 10.1016/j.urolonc.2017.03.024. Epub 2017 Apr 19.","Moschini M","Urol Oncol","2017","2017/04/24","","","10.1016/j.urolonc.2017.03.024"
"29329898","[Prognostic of older age for patients with invasive-muscle-bladder cancer and treated by radical cystectomy]","Dehayni Y, Tetou M, Khdach Y, Janane A, Alami M, Ameur A.","Prog Urol. 2018 Mar;28(3):166-172. doi: 10.1016/j.purol.2017.12.005. Epub 2018 Jan 9.","Dehayni Y","Prog Urol","2018","2018/01/14","","","10.1016/j.purol.2017.12.005"
"19583723","The fate of an unsatisfactory urine cytology test among patients with urothelial carcinoma","Ordon M, Boerner S, Zlotta AR, Jewett MA, Fleshner N.","BJU Int. 2009 Dec;104(11):1641-5. doi: 10.1111/j.1464-410X.2009.08650.x. Epub 2009 Jul 2.","Ordon M","BJU Int","2009","2009/07/09","","","10.1111/j.1464-410X.2009.08650.x"
"17970642","Non-steroidal anti-inflammatory drugs in the treatment of genitourinary malignancies: focus on clinical data","Giannitsas K, Konstantinopoulos A, Perimenis P.","Expert Opin Investig Drugs. 2007 Nov;16(11):1841-9. doi: 10.1517/13543784.16.11.1841.","Giannitsas K","Expert Opin Investig Drugs","2007","2007/11/01","","","10.1517/13543784.16.11.1841"
"30125523","Primary carcinoid tumor of the bladder","Warncke J, White S, O'Keefe M, Kim F, da Silva RD.","Can J Urol. 2018 Aug;25(4):9421-9423.","Warncke J","Can J Urol","2018","2018/08/21","","",""
"6639395","[Mechanism of development of fatal pulmonary artery thromboembolism during the treatment of kidney and bladder cancer]","Gonchar MA, Popov AI, Fomenko VR.","Arkh Patol. 1983;45(8):56-9.","Gonchar MA","Arkh Patol","1983","1983/01/01","","",""
"21897260","Ileal neobladder in women with bladder cancer: cancer control and functional aspects","Kübler H, Gschwend JE.","Curr Opin Urol. 2011 Nov;21(6):478-82. doi: 10.1097/MOU.0b013e32834b31c4.","Kübler H","Curr Opin Urol","2011","2011/09/08","","","10.1097/MOU.0b013e32834b31c4"
"3756312","Bestatin treatment enhances the recovery of radiation induced impairments of the immunological reactivity of the blood lymphocyte population in bladder cancer patients","Blomgren H, Edsmyr F, von Stedingk LV, Wasserman J.","Biomed Pharmacother. 1986;40(2):50-4.","Blomgren H","Biomed Pharmacother","1986","1986/01/01","","",""
"32349928","Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guérin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic","Lenfant L, Seisen T, Loriot Y, Rouprêt M.","Eur Urol. 2020 Jul;78(1):1-3. doi: 10.1016/j.eururo.2020.04.039. Epub 2020 Apr 24.","Lenfant L","Eur Urol","2020","2020/05/01","PMC7180366","","10.1016/j.eururo.2020.04.039"
"19117061","Sex-specific familial risks of urinary bladder cancer and associated neoplasms in Sweden","Bermejo JL, Sundquist J, Hemminki K.","Int J Cancer. 2009 May 1;124(9):2166-71. doi: 10.1002/ijc.24178.","Bermejo JL","Int J Cancer","2009","2009/01/01","","","10.1002/ijc.24178"
"2218566","Imaging of invasive bladder cancer","Dershaw DD, Panicek DM.","Semin Oncol. 1990 Oct;17(5):544-50.","Dershaw DD","Semin Oncol","1990","1990/10/01","","",""
"20143327","The effect of changes in Medicare reimbursement on the practice of office and hospital-based endoscopic surgery for bladder cancer","Hemani ML, Makarov DV, Huang WC, Taneja SS.","Cancer. 2010 Mar 1;116(5):1264-71. doi: 10.1002/cncr.24875.","Hemani ML","Cancer","2010","2010/02/10","","","10.1002/cncr.24875"
"20859610","[Update on chemotherapy for bladder cancer. Update 2010]","Heck MM, Gschwend JE, Retz M.","Urologe A. 2010 Oct;49(10):1294-300. doi: 10.1007/s00120-010-2380-y.","Heck MM","Urologe A","2010","2010/09/23","","","10.1007/s00120-010-2380-y"
"29917187","Effects of paclitaxel combined with miR-448 on growth and proliferation of bladder cancer EJ cells","Wang Y, Li LJ, Qiu MX, Gong BS.","Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3363-3369. doi: 10.26355/eurrev_201806_15157.","Wang Y","Eur Rev Med Pharmacol Sci","2018","2018/06/20","","","10.26355/eurrev_201806_15157"
"8417213","Grading of superficial bladder cancer by quantitative mitotic frequency analysis","Lipponen PK, Eskelinen MJ, Jauhiainen K, Harju E, Terho R, Haapasalo H.","J Urol. 1993 Jan;149(1):36-41. doi: 10.1016/s0022-5347(17)35992-x.","Lipponen PK","J Urol","1993","1993/01/01","","","10.1016/s0022-5347(17)35992-x"
"1785388","[Study of the combined M-VAC therapy in invasive bladder cancer]","Asano K, Masuda F, Suzuki H, Takamizawa S, Kaneko R.","Hinyokika Kiyo. 1991 Dec;37(12):1645-50.","Asano K","Hinyokika Kiyo","1991","1991/12/01","","",""
"8509438","Acetylsalicylic acid inhibition of n-butyl-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats","Klän R, Knispel HH, Meier T.","J Cancer Res Clin Oncol. 1993;119(8):482-5. doi: 10.1007/BF01215929.","Klän R","J Cancer Res Clin Oncol","1993","1993/01/01","","","10.1007/BF01215929"
"15270419","Incidence and evolution of aortic aneurysm in patients with bladder cancer","Mearini L, Zucchi A, Pizzirusso G, Vivacqua C, Mearini E.","Arch Ital Urol Androl. 2004 Jun;76(2):80-2.","Mearini L","Arch Ital Urol Androl","2004","2004/07/24","","",""
"25363092","Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma","Tai YS, Chen CH, Huang CY, Tai HC, Wang SM, Pu YS.","Diabetes Metab Res Rev. 2015 Mar;31(3):307-14. doi: 10.1002/dmrr.2614. Epub 2014 Dec 5.","Tai YS","Diabetes Metab Res Rev","2015","2014/11/04","","","10.1002/dmrr.2614"
"9783930","Bladder preservation in patients with bladder cancer--quality versus quantity of life?","Raghavan D.","J Urol. 1998 Nov;160(5):1678-9. doi: 10.1016/s0022-5347(01)62381-4.","Raghavan D","J Urol","1998","1998/10/23","","","10.1016/s0022-5347(01)62381-4"
"24859442","Prospective external validation of a bladder cancer detection model","Lotan Y, Svatek RS, Krabbe LM, Xylinas E, Klatte T, Shariat SF.","J Urol. 2014 Nov;192(5):1343-8. doi: 10.1016/j.juro.2014.05.087. Epub 2014 May 21.","Lotan Y","J Urol","2014","2014/05/27","","","10.1016/j.juro.2014.05.087"
"12801730","Perioperative chemotherapy in locally advanced bladder cancer","Stadler WM, Lerner SP.","Lancet. 2003 Jun 7;361(9373):1922-3. doi: 10.1016/S0140-6736(03)13598-2.","Stadler WM","Lancet","2003","2003/06/13","","","10.1016/S0140-6736(03)13598-2"
"3408862","The value of the pre-clinic intravenous urogram in the earlier diagnosis of the cause of haematuria","Jones MW, Cox R, Davies KI, Rose MB.","Br J Urol. 1988 Jul;62(1):11-2. doi: 10.1111/j.1464-410x.1988.tb04256.x.","Jones MW","Br J Urol","1988","1988/07/01","","","10.1111/j.1464-410x.1988.tb04256.x"
"1915540","Ultrastructural changes of bladder cancer cells following methylene blue-sensitized photodynamic treatment","Yu DS, Chang SY, Ma CP.","Eur Urol. 1991;19(4):322-6. doi: 10.1159/000473652.","Yu DS","Eur Urol","1991","1991/01/01","","","10.1159/000473652"
"2217421","EORTC Group Study 30851: a phase II study of neoadjuvant chemotherapy in patients with invasive bladder cancer","Splinter TA, Jacqmin D, Roberts JT, Pavone-Macaluso M, de Pauw M, Sylvester R, Carpentier P.","Prog Clin Biol Res. 1990;353:213-7.","Splinter TA","Prog Clin Biol Res","1990","1990/01/01","","",""
"2582965","Detection of bladder carcinoma in females by flow cytometry and cytology","Hermansen DK, Badalament RA, Fair WR, Kimmel M, Whitmore WF Jr, Melamed MR.","Cytometry. 1989 Nov;10(6):739-42. doi: 10.1002/cyto.990100611.","Hermansen DK","Cytometry","1989","1989/11/01","","","10.1002/cyto.990100611"
"3277688","Pre-emptive (neo-adjuvant) intravenous chemotherapy for invasive bladder cancer","Raghavan D.","Br J Urol. 1988 Jan;61(1):1-8. doi: 10.1111/j.1464-410x.1988.tb09152.x.","Raghavan D","Br J Urol","1988","1988/01/01","","","10.1111/j.1464-410x.1988.tb09152.x"
"25620614","Evaluation of urinary microRNA panel in bladder cancer diagnosis: relation to bilharziasis","Eissa S, Matboli M, Hegazy MG, Kotb YM, Essawy NO.","Transl Res. 2015 Jun;165(6):731-9. doi: 10.1016/j.trsl.2014.12.008. Epub 2015 Jan 7.","Eissa S","Transl Res","2015","2015/01/27","","","10.1016/j.trsl.2014.12.008"
"12697851","Adherence to surveillance among patients with superficial bladder cancer","Schrag D, Hsieh LJ, Rabbani F, Bach PB, Herr H, Begg CB.","J Natl Cancer Inst. 2003 Apr 16;95(8):588-97. doi: 10.1093/jnci/95.8.588.","Schrag D","J Natl Cancer Inst","2003","2003/04/17","","","10.1093/jnci/95.8.588"
"18863737","CANCER of the bladder","","Tex Cancer Bull. 1948 Apr-May;1(2):44.","","Tex Cancer Bull","1948","1948/04/01","","",""
"18506312","[Cancer of bladder: diagnosis]","Sociedade Brasileira de Urologia e Sociedade Brasileira de Patologia.","Rev Assoc Med Bras (1992). 2008 Mar-Apr;54(2):100-1. doi: 10.1590/s0104-42302008000200006.","Sociedade Brasileira de Urologia e Sociedade Brasileira de Patologia","Rev Assoc Med Bras (1992)","2008","2008/05/29","","","10.1590/s0104-42302008000200006"
"19307067","Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer","Lin CC, Hsu CH, Cheng JC, Huang CY, Tsai YC, Hsu FM, Huang KH, Cheng AL, Pu YS.","Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):442-8. doi: 10.1016/j.ijrobp.2008.11.030. Epub 2009 Mar 21.","Lin CC","Int J Radiat Oncol Biol Phys","2009","2009/03/25","","","10.1016/j.ijrobp.2008.11.030"
"3617289","Coexisting adenocarcinoma of prostate in patients undergoing cystoprostatectomy for bladder cancer","Winfield HN, Reddy PK, Lange PH.","Urology. 1987 Aug;30(2):100-1. doi: 10.1016/0090-4295(87)90170-1.","Winfield HN","Urology","1987","1987/08/01","","","10.1016/0090-4295(87)90170-1"
"10092282","Review on bladder cancer. New rather than old TNM staging system should have been used","Millar J.","BMJ. 1999 Mar 27;318(7187):875-6. doi: 10.1136/bmj.318.7187.875a.","Millar J","BMJ","1999","1999/03/26","PMC1115296","","10.1136/bmj.318.7187.875a"
"25374226","Genetic variation in PSCA is associated with bladder cancer susceptibility in a Korean population","Lee JH, Song HR, Kim HN, Kweon SS, Yun YW, Choi JS, Jung SI, Kwon DD, Kim SH, Choi YD, Shin MH.","Asian Pac J Cancer Prev. 2014;15(20):8901-4. doi: 10.7314/apjcp.2014.15.20.8901.","Lee JH","Asian Pac J Cancer Prev","2014","2014/11/07","","","10.7314/apjcp.2014.15.20.8901"
"7157240","[Treatment of muscle-infiltrating bladder cancer (P2/P3) with partial cystectomy]","Fosså SD, Kaalhus O, Gjersvik T, Segadal E.","Tidsskr Nor Laegeforen. 1982 Apr 20;102(11):627-9.","Fosså SD","Tidsskr Nor Laegeforen","1982","1982/04/20","","",""
"2392743","[Blood and urine determinations of tissue polypeptide antigen in patients with bladder carcinoma]","Tizzani A, Casetta G, Cavallini A, Piana P, Piantino P.","Minerva Urol Nefrol. 1990 Apr-Jun;42(2):69-71.","Tizzani A","Minerva Urol Nefrol","1990","1990/04/01","","",""
"20097572","Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: the state of the art","Williamson SR, Montironi R, Lopez-Beltran A, MacLennan GT, Davidson DD, Cheng L.","Crit Rev Oncol Hematol. 2010 Nov;76(2):112-26. doi: 10.1016/j.critrevonc.2010.01.005. Epub 2010 Jan 25.","Williamson SR","Crit Rev Oncol Hematol","2010","2010/01/26","","","10.1016/j.critrevonc.2010.01.005"
"29338913","Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013)","Weiner AB, Keeter MK, Manjunath A, Meeks JJ.","Urol Oncol. 2018 May;36(5):237.e9-237.e17. doi: 10.1016/j.urolonc.2017.12.015. Epub 2018 Jan 12.","Weiner AB","Urol Oncol","2018","2018/01/18","","","10.1016/j.urolonc.2017.12.015"
"26427696","Contemporary role of advanced imaging for bladder cancer staging","Rais-Bahrami S, Pietryga JA, Nix JW.","Urol Oncol. 2016 Mar;34(3):124-33. doi: 10.1016/j.urolonc.2015.08.018. Epub 2015 Oct 1.","Rais-Bahrami S","Urol Oncol","2016","2015/10/03","","","10.1016/j.urolonc.2015.08.018"
"30732900","Suppression of proliferation and activation of cell death by sodium selenite involves mitochondria and lysosomes in chemoresistant bladder cancer cells","Soukupová K, Rudolf E.","J Trace Elem Med Biol. 2019 Mar;52:58-67. doi: 10.1016/j.jtemb.2018.11.009. Epub 2018 Nov 27.","Soukupová K","J Trace Elem Med Biol","2019","2019/02/09","","","10.1016/j.jtemb.2018.11.009"
"25150634","An adaptive radiotherapy planning strategy for bladder cancer using deformation vector fields","Vestergaard A, Kallehauge JF, Petersen JB, Høyer M, Søndergaard J, Muren LP.","Radiother Oncol. 2014 Sep;112(3):371-5. doi: 10.1016/j.radonc.2014.07.012. Epub 2014 Aug 20.","Vestergaard A","Radiother Oncol","2014","2014/08/25","","","10.1016/j.radonc.2014.07.012"
"6209724","External radiotherapy in invasive bladder cancer","van den Bogaert W.","Prog Clin Biol Res. 1984;162B:39-41.","van den Bogaert W","Prog Clin Biol Res","1984","1984/01/01","","",""
"15862619","The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy","Aparicio AM, Elkhouiery AB, Quinn DI.","Urol Clin North Am. 2005 May;32(2):217-30, vii. doi: 10.1016/j.ucl.2005.03.002.","Aparicio AM","Urol Clin North Am","2005","2005/05/03","","","10.1016/j.ucl.2005.03.002"
"12952139","Phenobarbital use and bladder cancer risk","Castelao JE, Gago-Dominguez M, Yuan JM, Ross RK, Yu MC.","Eur J Epidemiol. 2003;18(7):659-64. doi: 10.1023/a:1024851324274.","Castelao JE","Eur J Epidemiol","2003","2003/09/04","","","10.1023/a:1024851324274"
"1641358","[Radioimmunoscintigraphy and magnetic resonance tomography in the diagnosis of urinary bladder cancer]","Benz P, Dewes W, Hau U, Becht E, Keweloh C, Ziegler M, Kramann B.","Nuklearmedizin. 1992 Jun;31(3):74-9.","Benz P","Nuklearmedizin","1992","1992/06/01","","",""
"28885656","Bladder cancer to patients younger than 30 years: a retrospective study and review of the literature","Katafigiotis I, Sfoungaristos S, Martini A, Stravodimos K, Anastasiou I, Mykoniatis I, Duvdevani M, Constantinides C.","Urologia. 2017 Oct 25;84(4):231-235. doi: 10.5301/uj.5000264. Epub 2017 Sep 5.","Katafigiotis I","Urologia","2017","2017/09/09","","","10.5301/uj.5000264"
"25445116","Clinical significance of the reduction of UT-B expression in urothelial carcinoma of the bladder","Li C, Xue H, Lei Y, Zhu J, Yang B, Gai X.","Pathol Res Pract. 2014 Dec;210(12):799-803. doi: 10.1016/j.prp.2014.09.012. Epub 2014 Oct 7.","Li C","Pathol Res Pract","2014","2014/12/03","","","10.1016/j.prp.2014.09.012"
"7093883","Detection and follow-up of carcinoma of the urinary bladder by flow cytometry","Klein FA, Herr HW, Sogani PC, Whitmore WF Jr, Melamed MR.","Cancer. 1982 Aug 1;50(3):389-95. doi: 10.1002/1097-0142(19820801)50:3<389::aid-cncr2820500302>3.0.co;2-i.","Klein FA","Cancer","1982","1982/08/01","","","10.1002/1097-0142(19820801)50:3<389::aid-cncr2820500302>3.0.co;2-i"
"23865049","Omega-3 fatty acids inhibit tumor growth in a rat model of bladder cancer","Parada B, Reis F, Cerejo R, Garrido P, Sereno J, Xavier-Cunha M, Neto P, Mota A, Figueiredo A, Teixeira F.","Biomed Res Int. 2013;2013:368178. doi: 10.1155/2013/368178. Epub 2013 Jun 20.","Parada B","Biomed Res Int","2013","2013/07/19","PMC3705844","","10.1155/2013/368178"
"18818110","Combined modality treatment with bladder preservation for muscle invasive bladder cancer","Sabaa MA, El-Gamal OM, Abo-Elenen M, Khanam A.","Urol Oncol. 2010 Jan-Feb;28(1):14-20. doi: 10.1016/j.urolonc.2008.07.005. Epub 2008 Sep 24.","Sabaa MA","Urol Oncol","2010","2008/09/27","","","10.1016/j.urolonc.2008.07.005"
"7167188","Bracken fern, phenacetin, and cancer of the urinary tract","Aoki K, Ohno Y.","Natl Cancer Inst Monogr. 1982;62:191-5.","Aoki K","Natl Cancer Inst Monogr","1982","1982/01/01","","",""
"10725634","Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation","Rödel C, Grabenbauer GG, Rödel F, Birkenhake S, Kühn R, Martus P, Zörcher T, Fürsich D, Papadopoulos T, Dunst J, Schrott KM, Sauer R.","Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1213-21. doi: 10.1016/s0360-3016(99)00544-1.","Rödel C","Int J Radiat Oncol Biol Phys","2000","2000/03/22","","","10.1016/s0360-3016(99)00544-1"
"28291637","Is The Cancer Genome Atlas (TCGA) bladder cancer cohort representative of invasive bladder cancer?","Seiler R, Black PC, Thalmann G, Stenzl A, Todenhöfer T.","Urol Oncol. 2017 Jul;35(7):458.e1-458.e7. doi: 10.1016/j.urolonc.2017.01.024. Epub 2017 Mar 11.","Seiler R","Urol Oncol","2017","2017/03/15","","","10.1016/j.urolonc.2017.01.024"
"18028019","Potential of urinary biomarkers in early bladder cancer diagnosis","Lam T, Nabi G.","Expert Rev Anticancer Ther. 2007 Aug;7(8):1105-15. doi: 10.1586/14737140.7.8.1105.","Lam T","Expert Rev Anticancer Ther","2007","2007/11/22","","","10.1586/14737140.7.8.1105"
"6383491","Immunological and haematological monitoring in bladder cancer patients receiving adjuvant bestatin treatment following radiation therapy. A prospective randomized trial","Blomgren H, Edsmyr F, Esposti PL, Näslund I.","Biomed Pharmacother. 1984;38(3):143-9.","Blomgren H","Biomed Pharmacother","1984","1984/01/01","","",""
"26351885","Robotic-Assisted Radical Cystectomy","Luchey AM, Agarwal G, Poch MA.","Cancer Control. 2015 Jul;22(3):301-6. doi: 10.1177/107327481502200307.","Luchey AM","Cancer Control","2015","2015/09/10","","","10.1177/107327481502200307"
"23881008","Surveillance of patients with bladder cancer following cystectomy: yield of CT urography","Shinagare AB, Sadow CA, Silverman SG.","Abdom Imaging. 2013 Dec;38(6):1415-21. doi: 10.1007/s00261-013-0024-6.","Shinagare AB","Abdom Imaging","2013","2013/07/25","","","10.1007/s00261-013-0024-6"
"27467005","Induction of cell cycle arrest and apoptosis by grape seed procyanidin extract in human bladder cancer BIU87 cells","Liu J, Zhang WY, Kong ZH, Ding DG.","Eur Rev Med Pharmacol Sci. 2016 Jul;20(15):3282-91.","Liu J","Eur Rev Med Pharmacol Sci","2016","2016/07/29","","",""
"23394122","High-grade non-muscle-invasive bladder cancer: is re-resection necessary in all patients before intravesical bacillus Calmette-Guérin treatment?","Holmäng S.","Scand J Urol. 2013 Oct;47(5):363-9. doi: 10.3109/21681805.2013.769461. Epub 2013 Feb 11.","Holmäng S","Scand J Urol","2013","2013/02/12","","","10.3109/21681805.2013.769461"
"17762633","Open radical cystectomy with lymphadenectomy remains the treatment of choice for invasive bladder cancer","Huang GJ, Stein JP.","Curr Opin Urol. 2007 Sep;17(5):369-75. doi: 10.1097/MOU.0b013e3282dc95b5.","Huang GJ","Curr Opin Urol","2007","2007/09/01","","","10.1097/MOU.0b013e3282dc95b5"
"20002664","Predicting individual outcomes after radical cystectomy: an external validation of current nomograms","Zaak D, Burger M, Otto W, Bastian PJ, Denzinger S, Stief CG, Buchner H, Hartmann A, Wieland WF, Shariat SF, Fritsche HM.","BJU Int. 2010 Aug;106(3):342-8. doi: 10.1111/j.1464-410X.2009.09138.x. Epub 2009 Dec 11.","Zaak D","BJU Int","2010","2009/12/17","","","10.1111/j.1464-410X.2009.09138.x"
"2780656","Tur vs TUR plus adriamycin in patients with superficial bladder cancer--a five-year follow-up","Burk K, Schultze-Seemann W, Rodeck G.","Prog Clin Biol Res. 1989;303:417-22.","Burk K","Prog Clin Biol Res","1989","1989/01/01","","",""
"25882566","Targeted therapy in advanced bladder cancer: what have we learned?","Jordan EJ, Iyer G.","Urol Clin North Am. 2015 May;42(2):253-62, ix. doi: 10.1016/j.ucl.2015.01.006. Epub 2015 Mar 12.","Jordan EJ","Urol Clin North Am","2015","2015/04/18","PMC4939834","NIHMS783641","10.1016/j.ucl.2015.01.006"
"22335874","Urothelial carcinoma of the bladder in patients on hemodialysis: clinical characteristics and oncological outcomes","Yossepowitch O, Sagy I, Margel D, Baniel J.","J Urol. 2012 Apr;187(4):1215-9. doi: 10.1016/j.juro.2011.11.098. Epub 2012 Feb 14.","Yossepowitch O","J Urol","2012","2012/02/17","","","10.1016/j.juro.2011.11.098"
"12552981","Prognostic value of tissue-polypeptide specific antigen (TPS) in bladder cancer","Menendez V, Galan JA, Fernandez-Suarez A, Lopez S, Alcover J, Calpena R, Filella X.","Anticancer Res. 2002 Nov-Dec;22(6B):3713-6.","Menendez V","Anticancer Res","2002","2003/01/30","","",""
"15180101","Participation behavior of bladder cancer survivors in a medical follow-up survey on quality of life in France","Matsuda T, Marche H, Grosclaude P, Clement S.","Eur J Epidemiol. 2004;19(4):313-21. doi: 10.1023/b:ejep.0000024703.54660.e5.","Matsuda T","Eur J Epidemiol","2004","2004/06/08","","","10.1023/b:ejep.0000024703.54660.e5"
"20999789","[About bladder cancer and adolescent bladder cancer]","ALLEMANN R.","Schweiz Med Wochenschr. 1946 Oct 5;76(40):1009-13.","ALLEMANN R","Schweiz Med Wochenschr","1946","2010/10/29","","",""
"26382667","Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment","Jahnson S, Hosseini Aliabad A, Holmäng S, Jancke G, Liedberg F, Ljungberg B, Malmström PU, Rosell J.","Scand J Urol. 2016;50(1):14-20. doi: 10.3109/21681805.2015.1085089. Epub 2015 Sep 18.","Jahnson S","Scand J Urol","2016","2015/09/19","","","10.3109/21681805.2015.1085089"
"18303728","Quality of life in patients undergone oncopreventive intravesical treatment for superficial bladder cancer","Abbona A, Morabito F, Rossi R, Billia M, Liberale F, Ferrando U.","Arch Ital Urol Androl. 2007 Dec;79(4):143-6.","Abbona A","Arch Ital Urol Androl","2007","2008/02/29","","",""
"12684626","BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladder","Hussain SA, Ganesan R, Hiller L, Cooke PW, Murray P, Young LS, James ND.","Oncol Rep. 2003 May-Jun;10(3):571-6.","Hussain SA","Oncol Rep","2003","2003/04/10","","",""
"25078265","Increased expression of miR-222 is associated with poor prognosis in bladder cancer","Zhang DQ, Zhou CK, Jiang XW, Chen J, Shi BK.","World J Surg Oncol. 2014 Jul 31;12:241. doi: 10.1186/1477-7819-12-241.","Zhang DQ","World J Surg Oncol","2014","2014/08/01","PMC4132207","","10.1186/1477-7819-12-241"
"7057502","Pathologic effects of pre-cystectomy therapy with combination intra-arterial doxorubicin hydrochloride and local bladder hyperthermia for bladder cancer","Jacobs SC, Lawson RK.","J Urol. 1982 Jan;127(1):43-7. doi: 10.1016/s0022-5347(17)53596-x.","Jacobs SC","J Urol","1982","1982/01/01","","","10.1016/s0022-5347(17)53596-x"
"11447756","Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings","Bubendorf L, Grilli B, Sauter G, Mihatsch MJ, Gasser TC, Dalquen P.","Am J Clin Pathol. 2001 Jul;116(1):79-86. doi: 10.1309/K5P2-4Y8B-7L5A-FAA9.","Bubendorf L","Am J Clin Pathol","2001","2001/07/13","","","10.1309/K5P2-4Y8B-7L5A-FAA9"
"22952293","Watchful waiting versus intravesical BCG therapy for high-grade pT1 bladder cancer with pT0 histology after second transurethral resection: Japan Clinical Oncology Group Study JCOG1019","Kunieda F, Kitamura H, Niwakawa M, Kuroiwa K, Shinohara N, Tobisu K, Nakamura K, Shibata T, Tsuzuki T, Tsukamoto T, Kakehi Y; Urologic Oncology Study Group of the Japan Clinical Oncology Group.","Jpn J Clin Oncol. 2012 Nov;42(11):1094-8. doi: 10.1093/jjco/hys143. Epub 2012 Sep 5.","Kunieda F","Jpn J Clin Oncol","2012","2012/09/07","","","10.1093/jjco/hys143"
"24461081","Pathology of bladder cancer among diabetic patients undergoing radical cystectomy with a history of pioglitazone (Actos) use","Romero V, Peyton C, Gray I, Hemal A, Terlecki R.","BMC Urol. 2014 Jan 25;14:10. doi: 10.1186/1471-2490-14-10.","Romero V","BMC Urol","2014","2014/01/28","PMC3937152","","10.1186/1471-2490-14-10"
"2695801","[Prevention of occupational tumors: an update]","Vineis P, Merler E, Simonato L.","Med Lav. 1989 Sep-Oct;80(5):371-80.","Vineis P","Med Lav","1989","1989/09/01","","",""
"18684727","Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis","Zhang Z, Wang S, Wang M, Tong N, Fu G, Zhang Z.","Carcinogenesis. 2008 Oct;29(10):1973-8. doi: 10.1093/carcin/bgn183. Epub 2008 Aug 5.","Zhang Z","Carcinogenesis","2008","2008/08/08","","","10.1093/carcin/bgn183"
"29473226","Infiltrative lamina propria invasion pattern as an independent predictor for cancer-specific and overall survival of instillation treatment-naïve stage T1 high-grade urothelial bladder cancer","Otto W, van Rhijn BW, Breyer J, Bertz S, Eckstein M, Mayr R, Lausenmeyer EM, Denzinger S, Burger M, Hartmann A.","Int J Urol. 2018 May;25(5):442-449. doi: 10.1111/iju.13532. Epub 2018 Feb 22.","Otto W","Int J Urol","2018","2018/02/24","","","10.1111/iju.13532"
"25843691","Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer","Xu N, Shao MM, Zhang HT, Jin MS, Dong Y, Ou RJ, Wang HM, Shi AP.","Cancer Epidemiol. 2015 Jun;39(3):375-81. doi: 10.1016/j.canep.2015.03.003. Epub 2015 Apr 3.","Xu N","Cancer Epidemiol","2015","2015/04/07","","","10.1016/j.canep.2015.03.003"
"21996111","Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries","Skolarus TA, Ye Z, Montgomery JS, Weizer AZ, Hafez KS, Lee CT, Miller DC, Wood DP Jr, Montie JE, Hollenbeck BK.","Urology. 2011 Dec;78(6):1345-9. doi: 10.1016/j.urology.2011.05.071. Epub 2011 Oct 11.","Skolarus TA","Urology","2011","2011/10/15","","","10.1016/j.urology.2011.05.071"
"11712804","Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis","Curigliano G, Ferretti G, Flamini G, Goldhirsch A, de Braud F, Calabro MG, Mandaly M, Nole F, De Pas T, D'Addessi A, Cittadini A.","Anticancer Res. 2001 Jul-Aug;21(4B):3015-20.","Curigliano G","Anticancer Res","2001","2001/11/20","","",""
"10533458","Antitumour immunity of Bacillus Calmette-Guerin and interferon alpha in murine bladder cancer","Gan YH, Zhang Y, Khoo HE, Esuvaranathan K.","Eur J Cancer. 1999 Jul;35(7):1123-9. doi: 10.1016/s0959-8049(99)00057-x.","Gan YH","Eur J Cancer","1999","1999/10/26","","","10.1016/s0959-8049(99)00057-x"
"809015","Immunological detection of human bladder carcinoma","Monaco AP, Gozzo JJ, Schlesinger RM, Codish SD.","Ann Surg. 1975 Sep;182(3):325-33. doi: 10.1097/00000658-197509000-00015.","Monaco AP","Ann Surg","1975","1975/09/01","PMC1343948","","10.1097/00000658-197509000-00015"
"7427883","Assessment of serial CEA determinations in urine of patients with bladder carcinoma","Zimmerman R, Wahren B, Edsmyr F.","Cancer. 1980 Oct 15;46(8):1802-9. doi: 10.1002/1097-0142(19801015)46:8<1802::aid-cncr2820460818>3.0.co;2-5.","Zimmerman R","Cancer","1980","1980/10/15","","","10.1002/1097-0142(19801015)46:8<1802::aid-cncr2820460818>3.0.co;2-5"
"21367517","Improving the outcome for invasive bladder cancer: the debate regarding pelvic lymphadenectomy moves from if to how","Catto JW.","Eur Urol. 2011 May;59(5):719-20. doi: 10.1016/j.eururo.2011.02.007. Epub 2011 Mar 1.","Catto JW","Eur Urol","2011","2011/03/04","","","10.1016/j.eururo.2011.02.007"
"10436435","Urinary diversion following cystectomy in a patient with situs inversus totalis","Rodrigues GP, Gheiler EL, Tefilli MV, Da Silva EA, Tiguert R, Pontes JE.","Urol Int. 1999;62(1):55-6. doi: 10.1159/000030358.","Rodrigues GP","Urol Int","1999","1999/08/07","","","10.1159/000030358"
"30302904","Sulforaphane Normalizes Intestinal Flora and Enhances Gut Barrier in Mice with BBN-Induced Bladder Cancer","He C, Huang L, Lei P, Liu X, Li B, Shan Y.","Mol Nutr Food Res. 2018 Dec;62(24):e1800427. doi: 10.1002/mnfr.201800427. Epub 2018 Nov 22.","He C","Mol Nutr Food Res","2018","2018/10/11","","","10.1002/mnfr.201800427"
"22998911","Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications","Zarei S, Frank I, Boorjian SA, Thompson RH, Kim S, Weight C, Tarrell R, Thapa P, Cheville JC.","J Urol. 2012 Nov;188(5):1706-11. doi: 10.1016/j.juro.2012.07.035. Epub 2012 Sep 19.","Zarei S","J Urol","2012","2012/09/25","","","10.1016/j.juro.2012.07.035"
"18380198","[The role of low-field strength magnetic resonance imaging in bladder cancer staging]","Lutsenko PE, Bulanova TV, Chernyshev IV, Churaiants VV.","Vestn Rentgenol Radiol. 2007 Mar-Apr;(2):46-51.","Lutsenko PE","Vestn Rentgenol Radiol","2007","2008/04/03","","",""
"31273010","Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer","Annels NE, Mansfield D, Arif M, Ballesteros-Merino C, Simpson GR, Denyer M, Sandhu SS, Melcher AA, Harrington KJ, Davies B, Au G, Grose M, Bagwan I, Fox B, Vile R, Mostafid H, Shafren D, Pandha HS.","Clin Cancer Res. 2019 Oct 1;25(19):5818-5831. doi: 10.1158/1078-0432.CCR-18-4022. Epub 2019 Jul 4.","Annels NE","Clin Cancer Res","2019","2019/07/06","","","10.1158/1078-0432.CCR-18-4022"
"23540776","Office-based Bladder Tumor Fulguration and Surveillance: Indications and Techniques","O'Neil BB, Lowrance WT.","Urol Clin North Am. 2013 May;40(2):175-82. doi: 10.1016/j.ucl.2013.01.007. Epub 2013 Feb 15.","O'Neil BB","Urol Clin North Am","2013","2013/04/02","","","10.1016/j.ucl.2013.01.007"
"4985860","[Complex treatment of patients with cancer of the urinary bladder]","Lazarev IR, Enenko IuA, Rodovich VS, Dmitrenko SI.","Vrach Delo. 1968 Nov;11:137-8.","Lazarev IR","Vrach Delo","1968","1968/11/01","","",""
"8520006","Urine cytology evaluation in cases of uretero-ileal cutaneous diversion","Anagnostopoulou I, Rammou-Kinia R, Likourinas M.","Cytopathology. 1995 Aug;6(4):268-72. doi: 10.1111/j.1365-2303.1995.tb00478.x.","Anagnostopoulou I","Cytopathology","1995","1995/08/01","","","10.1111/j.1365-2303.1995.tb00478.x"
"3147281","Carcinoma of the urinary bladder associated with schistosomiasis in Egypt: the possible causal relationship","Tawfik HN.","Princess Takamatsu Symp. 1987;18:197-209.","Tawfik HN","Princess Takamatsu Symp","1987","1987/01/01","","",""
"18946612","Transitional cell carcinoma of the urinary bladder: a clinicopathological study","Matalka I, Bani-Hani K, Shotar A, Bani Hani O, Bani-Hani I.","Singapore Med J. 2008 Oct;49(10):790-4.","Matalka I","Singapore Med J","2008","2008/10/24","","",""
"86659","Immunologic features of a carcinogen-induced murine bladder cancer: in vivo and in vitro studies","Javadpour N, Hyatt CL, Soares T.","J Surg Oncol. 1979;11(2):153-9. doi: 10.1002/jso.2930110209.","Javadpour N","J Surg Oncol","1979","1979/01/01","","","10.1002/jso.2930110209"
"27495910","[Short version of the German S3 guideline for bladder cancer]","Retz M, Gschwend JE, Maisch P.","Urologe A. 2016 Sep;55(9):1173-87. doi: 10.1007/s00120-016-0195-1.","Retz M","Urologe A","2016","2016/08/07","","","10.1007/s00120-016-0195-1"
"10470203","Serum tissue polypeptide antigen (TPA): monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer","Bennink R, Van Poppel H, Billen J, Decoster M, Baert L, Mortelmans L, Blanckaert N.","Anticancer Res. 1999 Jul-Aug;19(4A):2609-13.","Bennink R","Anticancer Res","1999","1999/09/02","","",""
"1305684","Bladder cancer from a perspective of 40 years","Koss LG.","J Cell Biochem Suppl. 1992;16I:23-9. doi: 10.1002/jcb.240501305.","Koss LG","J Cell Biochem Suppl","1992","1992/01/01","","","10.1002/jcb.240501305"
"23330817","Evolution of the concept of androgen-sensitive bladder cancer","Gakis G, Stenzl A, Renninger M.","Scand J Urol. 2013 Jun;47(3):173-8. doi: 10.3109/00365599.2012.756929. Epub 2013 Jan 21.","Gakis G","Scand J Urol","2013","2013/01/22","","","10.3109/00365599.2012.756929"
"28963292","Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)","Häggström C, Liedberg F, Hagberg O, Aljabery F, Ströck V, Hosseini A, Gårdmark T, Sherif A, Malmström PU, Garmo H, Jahnson S, Holmberg L.","BMJ Open. 2017 Sep 27;7(9):e016606. doi: 10.1136/bmjopen-2017-016606.","Häggström C","BMJ Open","2017","2017/10/01","PMC5623498","","10.1136/bmjopen-2017-016606"
"17311259","Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer","Moore LE, Malats N, Rothman N, Real FX, Kogevinas M, Karami S, García-Closas R, Silverman D, Chanock S, Welch R, Tardón A, Serra C, Carrato A, Dosemeci M, García-Closas M.","Int J Cancer. 2007 Jun 1;120(11):2452-8. doi: 10.1002/ijc.22565.","Moore LE","Int J Cancer","2007","2007/02/22","","","10.1002/ijc.22565"
"19348188","[Intra-arterial chemotherapy for bladder preservation in patients with locally advanced bladder cancer]","Washino S, Hirai M, Terauchi F, Matsuzaki A, Kobayashi Y, Matsuura K.","Nihon Hinyokika Gakkai Zasshi. 2009 Mar;100(3):486-94. doi: 10.5980/jpnjurol.100.486.","Washino S","Nihon Hinyokika Gakkai Zasshi","2009","2009/04/08","","","10.5980/jpnjurol.100.486"
"7506870","[Studies of combined treatment of radiofrequency hyperthermia with anticancer agents or irradiation for invasive bladder cancer]","Uchibayashi T, Lee SW, Hisazumi H, Naito K, Endo Y, Noguchi M, Tanaka M, Sasaki T.","Hinyokika Kiyo. 1993 Dec;39(12):1209-13.","Uchibayashi T","Hinyokika Kiyo","1993","1993/12/01","","",""
"26237810","[INTRAOPERATIVE CONTROL OF THE EFFECTIVENESS OF TRANSURETHRAL RESECTION OF NON-MUSCLE-INVASIVE BLADDER CANCER]","Zubkov AJ, Sitdykov JN, Nuriev LR, Sitdykova MJ.","Urologiia. 2015 Mar-Apr;(2):65-7.","Zubkov AJ","Urologiia","2015","2015/08/05","","",""
"11760354","[Treatment of metastases of urothelial carcinoma. Results of a prospective study of metastases surgery]","Otto T, Rübben H.","Urologe A. 2001 Nov;40(6):471-4. doi: 10.1007/s001200170010.","Otto T","Urologe A","2001","2002/01/05","","","10.1007/s001200170010"
"16707208","Re: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis and Donald W.W. Newling. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-77","Maffezzini M.","Eur Urol. 2006 Sep;50(3):623-4; author reply 624-5. doi: 10.1016/j.eururo.2006.04.005. Epub 2006 May 4.","Maffezzini M","Eur Urol","2006","2006/05/19","","","10.1016/j.eururo.2006.04.005"
"17575217","Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study","Dyrskjøt L, Zieger K, Real FX, Malats N, Carrato A, Hurst C, Kotwal S, Knowles M, Malmström PU, de la Torre M, Wester K, Allory Y, Vordos D, Caillault A, Radvanyi F, Hein AM, Jensen JL, Jensen KM, Marcussen N, Orntoft TF.","Clin Cancer Res. 2007 Jun 15;13(12):3545-51. doi: 10.1158/1078-0432.CCR-06-2940.","Dyrskjøt L","Clin Cancer Res","2007","2007/06/19","","","10.1158/1078-0432.CCR-06-2940"
"31467912","Irradiated Bladder Cancer Cells Expressing both GM-CSF and IL-21 versus Either GM-CSF or IL-21 Alone as Tumor Vaccine in a Mouse Xenograft Model","Peng J, Ye L, Li T, Zhu Q, Guo J, Xiao K, Wei Y.","Biomed Res Int. 2019 Aug 5;2019:8262989. doi: 10.1155/2019/8262989. eCollection 2019.","Peng J","Biomed Res Int","2019","2019/08/31","PMC6699310","","10.1155/2019/8262989"
"29029769","Role of imaging techniques in the diagnosis and follow-up of muscle-invasive bladder carcinoma","Mesa A, Nava E, Fernández Del Valle A, Argüelles B, Menéndez-Del Llano R, Sal de Rellán S.","Actas Urol Esp. 2018 Sep;42(7):425-434. doi: 10.1016/j.acuro.2017.08.001. Epub 2017 Oct 11.","Mesa A","Actas Urol Esp","2018","2017/10/15","","","10.1016/j.acuro.2017.08.001"
"17905100","Muscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors","Türkölmez K, Tokgöz H, Reşorlu B, Köse K, Bedük Y.","Urology. 2007 Sep;70(3):477-81. doi: 10.1016/j.urology.2007.05.008.","Türkölmez K","Urology","2007","2007/10/02","","","10.1016/j.urology.2007.05.008"
"15245939","Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer","Ito M, Habuchi T, Watanabe J, Higashi S, Nishiyama H, Wang L, Tsuchiya N, Kamoto T, Ogawa O.","Urology. 2004 Jul;64(1):74-8. doi: 10.1016/j.urology.2004.03.001.","Ito M","Urology","2004","2004/07/13","","","10.1016/j.urology.2004.03.001"
"8365842","The significance of cystoscopy for the diagnosis of urothelial tumour","Hattori R, Ohshima S, Ono Y, Miyake K.","Int Urol Nephrol. 1993;25(2):135-9.","Hattori R","Int Urol Nephrol","1993","1993/01/01","","",""
"7230333","Lack of value of routine preoperative bone and liver scans in cystectomy candidates","Berger GL, Sadlowski RW, Sharpe JR, Finney RP.","J Urol. 1981 May;125(5):637-9. doi: 10.1016/s0022-5347(17)55144-7.","Berger GL","J Urol","1981","1981/05/01","","","10.1016/s0022-5347(17)55144-7"
"25472584","Toll-like receptor 4 gene polymorphism downregulates gene expression and involves in susceptibility to bladder cancer","Shen Y, Bu M, Zhang A, Liu Y, Fu B.","Tumour Biol. 2015 Apr;36(4):2779-84. doi: 10.1007/s13277-014-2902-0. Epub 2014 Dec 4.","Shen Y","Tumour Biol","2015","2014/12/05","","","10.1007/s13277-014-2902-0"
"2359215","[Pathological studies of the bladder wall after contact Nd:YAG laser irradiation in the treatment of bladder cancer]","Washida H, Watanabe H, Noguchi Y, Sasaki S, Hori T.","Nihon Hinyokika Gakkai Zasshi. 1990 Mar;81(3):380-5. doi: 10.5980/jpnjurol1989.81.380.","Washida H","Nihon Hinyokika Gakkai Zasshi","1990","1990/03/01","","","10.5980/jpnjurol1989.81.380"
"8704743","[How to treat infiltrating cancer of the bladder?]","Witjes JA, Debruyne FM.","Prog Urol. 1996 Apr;6(2 Suppl 1):31-41.","Witjes JA","Prog Urol","1996","1996/04/01","","",""
"2476317","Quality of life in patients with muscle-infiltrating bladder cancer and hormone-resistant prostatic cancer","Fosså SD, Aaronson N, Calais da Silva F, Denis L, Newling D, Hosbach G, Kaalhus O.","Eur Urol. 1989;16(5):335-9. doi: 10.1159/000471611.","Fosså SD","Eur Urol","1989","1989/01/01","","","10.1159/000471611"
"6788238","Bladder cancer","Traynor OJ, Carter AE.","Br Med J (Clin Res Ed). 1981 Jun 27;282(6282):2136-7. doi: 10.1136/bmj.282.6282.2136-c.","Traynor OJ","Br Med J (Clin Res Ed)","1981","1981/06/27","PMC1506506","","10.1136/bmj.282.6282.2136-c"
"29604919","Liquid Biopsies in the Management of Bladder Cancer: Next-Generation Biomarkers for Diagnosis, Surveillance, and Treatment-Response Prediction","Yang Y, Miller CR, Lopez-Beltran A, Montironi R, Cheng M, Zhang S, Koch MO, Kaimakliotis HZ, Cheng L.","Crit Rev Oncog. 2017;22(5-6):389-401. doi: 10.1615/CritRevOncog.2017020803.","Yang Y","Crit Rev Oncog","2017","2018/04/02","","","10.1615/CritRevOncog.2017020803"
"25882557","Advances in imaging technologies in the evaluation of high-grade bladder cancer","Zlatev DV, Altobelli E, Liao JC.","Urol Clin North Am. 2015 May;42(2):147-57, vii. doi: 10.1016/j.ucl.2015.01.001. Epub 2015 Feb 28.","Zlatev DV","Urol Clin North Am","2015","2015/04/18","PMC4402158","NIHMS668974","10.1016/j.ucl.2015.01.001"
"3411695","Tumor-specific immunotherapy of murine bladder cancer with butanol-extracted antigens and ethylchlorformate polymerized tumor protein","Rochester MG, Sarosdy MF, Pickett SH, Stogdill BJ, Lamm DL.","J Urol. 1988 Sep;140(3):647-50. doi: 10.1016/s0022-5347(17)41747-2.","Rochester MG","J Urol","1988","1988/09/01","","","10.1016/s0022-5347(17)41747-2"
"15242355","Clinical study of bladder cancer: Proteinuria as a predictor of recurrence and efficacy of intravesical bacille Calmette-Guerin therapy","Satoh A, Hanawa Y, Nakamura S.","Int J Urol. 2004 Jul;11(7):476-82. doi: 10.1111/j.1442-2042.2004.00847.x.","Satoh A","Int J Urol","2004","2004/07/10","","","10.1111/j.1442-2042.2004.00847.x"
"28460622","Intravesical Chemotherapy and Chemohyperthermia in Non-Muscle-Invasive Bladder Cancer; An Overview on Drug Administration Technologies and Pharmacokinetics","Campodonico F, Di Stasi S, Lev GM, Terrone C, Bongiovanni L, Mattioli F, Pagliarulo V, Introini C.","Curr Drug Metab. 2017;18(7):657-665. doi: 10.2174/1389200218666170427092421.","Campodonico F","Curr Drug Metab","2017","2017/05/03","","","10.2174/1389200218666170427092421"
"2577185","Laser treatment of transitional cell cancer of the bladder and upper urinary tract","Orihuela E, Smith AD.","Cancer Treat Res. 1989;46:123-42. doi: 10.1007/978-1-4613-1595-7_7.","Orihuela E","Cancer Treat Res","1989","1989/01/01","","","10.1007/978-1-4613-1595-7_7"
"1382555","How should we palliate bladder cancer?","Lydon A, Duchesne GM.","Clin Oncol (R Coll Radiol). 1992 Sep;4(5):273-4. doi: 10.1016/s0936-6555(05)81096-9.","Lydon A","Clin Oncol (R Coll Radiol)","1992","1992/09/01","","","10.1016/s0936-6555(05)81096-9"
"7427402","Bladder cancer as a prescribed industrial disease","Case RA.","Br Med J. 1980 Aug 30;281(6240):621. doi: 10.1136/bmj.281.6240.621.","Case RA","Br Med J","1980","1980/08/30","PMC1713910","","10.1136/bmj.281.6240.621"
"31059726","Advanced Bladder Cancer Rechallenged With an Immune Checkpoint Inhibitor: A Case Report","Bat T, Buck DA, Nathan R, Cinquino J, Sikorski M, Elefante A, Herbst L, Sule N, Fabiano A, George S.","Urology. 2019 Sep;131:24-26. doi: 10.1016/j.urology.2019.04.031. Epub 2019 May 3.","Bat T","Urology","2019","2019/05/07","","","10.1016/j.urology.2019.04.031"
"10576004","Update on urine-based markers for bladder cancer. How sensitive and specific are the new noninvasive tests?","Pirtskalaishvili G, Konety BR, Getzenberg RH.","Postgrad Med. 1999 Nov;106(6):85-6, 91-4. doi: 10.3810/pgm.1999.11.774.","Pirtskalaishvili G","Postgrad Med","1999","1999/11/27","","","10.3810/pgm.1999.11.774"
"3678301","Prognosis of bladder cancer. II. The fate of patients with T1b transitional cell bladder cancer","Pagano F, Pegoraro V, Prayer-Galetti T, Pizzarella M, Milani C, Garbeglio A.","Eur Urol. 1987;13(5):305-9.","Pagano F","Eur Urol","1987","1987/01/01","","",""
"16984549","Selenium is inversely associated with bladder cancer risk: a report from the Belgian case-control study on bladder cancer","Kellen E, Zeegers M, Buntinx F.","Int J Urol. 2006 Sep;13(9):1180-4. doi: 10.1111/j.1442-2042.2006.01526.x.","Kellen E","Int J Urol","2006","2006/09/21","","","10.1111/j.1442-2042.2006.01526.x"
"24821409","[Study on the therapy of nonmuscle-invasive bladder cancer: treatment of nonmuscle-invasive high-grade urothelial cancer of the bladder with the standard number and dosage of intravesical BCG instillations versus a reduced number of intravesical BCG instillations in the standard dosage: a randomized phase 3 study of the European Association of Urology Research Foundation (NIMBUS - AB 37/10 of the AUO)]","Rexer H.","Urologe A. 2014 Jun;53(6):890-2. doi: 10.1007/s00120-014-3458-8.","Rexer H","Urologe A","2014","2014/05/14","","","10.1007/s00120-014-3458-8"
"2126646","Evaluation of in-vitro effects of recombinant human alpha 2 interferon on bilharzial urinary bladder cancer cells","Khaled HM, Attia MM, Nabawi AR.","Tumori. 1990 Dec 31;76(6):582-4.","Khaled HM","Tumori","1990","1990/12/31","","",""
"11111186","p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?","Schmitz-Dräger BJ, Goebell PJ, Ebert T, Fradet Y.","Eur Urol. 2000 Dec;38(6):691-9;discussion 700. doi: 10.1159/000020364.","Schmitz-Dräger BJ","Eur Urol","2000","2000/12/09","","","10.1159/000020364"
"21680105","SOX4 expression levels in urothelial bladder carcinoma","Gunes S, Yegin Z, Sullu Y, Buyukalpelli R, Bagci H.","Pathol Res Pract. 2011 Jul 15;207(7):423-7. doi: 10.1016/j.prp.2011.05.005. Epub 2011 Jun 15.","Gunes S","Pathol Res Pract","2011","2011/06/18","","","10.1016/j.prp.2011.05.005"
"10206273","Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells","Miyake H, Hara I, Yamanaka K, Gohji K, Arakawa S, Kamidono S.","Br J Cancer. 1999 Apr;79(11-12):1651-6. doi: 10.1038/sj.bjc.6690264.","Miyake H","Br J Cancer","1999","1999/04/17","PMC2362776","","10.1038/sj.bjc.6690264"
"7091049","Blood group precursor T-antigen expression in human urinary bladder carcinoma","Coon JS, Weinstein RS, Summers JL.","Am J Clin Pathol. 1982 Jun;77(6):692-9. doi: 10.1093/ajcp/77.6.692.","Coon JS","Am J Clin Pathol","1982","1982/06/01","","","10.1093/ajcp/77.6.692"
"24529010","The role of pelvic lymphadenectomy in non-muscle invasive bladder cancer","Lin J, Deibert CM, Holder D, Benson MC, McKiernan JM.","Can J Urol. 2014 Feb;21(1):7108-13.","Lin J","Can J Urol","2014","2014/02/18","","",""
"15761870","Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis","Weikert S, Christoph F, Schrader M, Krause H, Miller K, Müller M.","Int J Cancer. 2005 Aug 10;116(1):100-4. doi: 10.1002/ijc.21000.","Weikert S","Int J Cancer","2005","2005/03/12","","","10.1002/ijc.21000"
"24764283","Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer","Lewis JD, Habel L, Quesenberry C, Mamtani R, Peng T, Bilker WB, Hedderson M, Nessel L, Vaughn DJ, Strom BL, Ferrara A.","Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):636-45. doi: 10.1002/pds.3619. Epub 2014 Apr 25.","Lewis JD","Pharmacoepidemiol Drug Saf","2014","2014/04/26","","","10.1002/pds.3619"
"30898713","miR-3622a promotes proliferation and invasion of bladder cancer cells by downregulating LASS2","Fu S, Luan T, Jiang C, Huang Y, Li N, Wang H, Wang J.","Gene. 2019 Jun 15;701:23-31. doi: 10.1016/j.gene.2019.02.083. Epub 2019 Mar 19.","Fu S","Gene","2019","2019/03/23","","","10.1016/j.gene.2019.02.083"
"26222929","Imaging muscle-invasive and metastatic urothelial carcinoma","Malayeri AA, Pattanayak P, Apolo AB.","Curr Opin Urol. 2015 Sep;25(5):441-8. doi: 10.1097/MOU.0000000000000208.","Malayeri AA","Curr Opin Urol","2015","2015/07/30","PMC6771285","NIHMS1038703","10.1097/MOU.0000000000000208"
"21380501","Genetic variants in urinary bladder cancer: collective power of the ""wimp SNPs""","Golka K, Selinski S, Lehmann ML, Blaszkewicz M, Marchan R, Ickstadt K, Schwender H, Bolt HM, Hengstler JG.","Arch Toxicol. 2011 Jun;85(6):539-54. doi: 10.1007/s00204-011-0676-3. Epub 2011 Mar 5.","Golka K","Arch Toxicol","2011","2011/03/08","","","10.1007/s00204-011-0676-3"
"26905963","Intravesical radiofrequency-induced hyperthermia combined with chemotherapy for non-muscle-invasive bladder cancer","van Valenberg H, Colombo R, Witjes F.","Int J Hyperthermia. 2016 Jun;32(4):351-62. doi: 10.3109/02656736.2016.1140232. Epub 2016 Feb 24.","van Valenberg H","Int J Hyperthermia","2016","2016/02/25","","","10.3109/02656736.2016.1140232"
"23971371","[A case of aggressively growing bladder cancer in patient with long-term cystostomy due to spinal cord injury]","Kohno M, Kishida T, Fujikawa A, Muraoka K, Ishida H, Miura T, Tanaka K.","Nihon Hinyokika Gakkai Zasshi. 2013 Jul;104(4):612-5. doi: 10.5980/jpnjurol.104.612.","Kohno M","Nihon Hinyokika Gakkai Zasshi","2013","2013/08/27","","","10.5980/jpnjurol.104.612"
"30076714","LncRNA PVT1 regulates VEGFC through inhibiting miR-128 in bladder cancer cells","Yu C, Longfei L, Long W, Feng Z, Chen J, Chao L, Peihua L, Xiongbing Z, Hequn C.","J Cell Physiol. 2019 Feb;234(2):1346-1353. doi: 10.1002/jcp.26929. Epub 2018 Aug 4.","Yu C","J Cell Physiol","2019","2018/08/05","","","10.1002/jcp.26929"
"20213913","[Narrowband fibrocystoscopy in diagnosis of bladder cancer]","Martov AG, Maksimov VA, Ergakov DV, Adronov AS.","Urologiia. 2009 Sep-Oct;(5):54-9.","Martov AG","Urologiia","2009","2010/03/10","","",""
"28373478","Second Primary Malignancy in Bladder Carcinoma - A Population-based Study","Khanal A, Budhathoki N, Singh VP, Shah BK.","Anticancer Res. 2017 Apr;37(4):2033-2036. doi: 10.21873/anticanres.11548.","Khanal A","Anticancer Res","2017","2017/04/05","","","10.21873/anticanres.11548"
"8583569","A genotype study of the c-Ha-ras-1 locus in human bladder tumors","Bittard H, Descotes F, Billerey C, Lamy B, Adessi GR.","J Urol. 1996 Mar;155(3):1083-8.","Bittard H","J Urol","1996","1996/03/01","","",""
"27510392","Impact of Glycemic Control and Metformin Use on the Recurrence and Progression of Non-Muscle Invasive Bladder Cancer in Patients with Diabetes Mellitus","Ahn JH, Jung SI, Yim SU, Kim SW, Hwang EC, Kwon DD.","J Korean Med Sci. 2016 Sep;31(9):1464-71. doi: 10.3346/jkms.2016.31.9.1464.","Ahn JH","J Korean Med Sci","2016","2016/08/12","PMC4974190","","10.3346/jkms.2016.31.9.1464"
"7776561","[Pelvic lymph node involvement in primary bladder cancer. A clinicopathological study of radical cystectomies]","Kuriki O, Ono Y, Katoh N, Sahashi M, Kinukawa T, Matsuura O, Ohshima S.","Nihon Hinyokika Gakkai Zasshi. 1995 Apr;86(4):919-26. doi: 10.5980/jpnjurol1989.86.919.","Kuriki O","Nihon Hinyokika Gakkai Zasshi","1995","1995/04/01","","","10.5980/jpnjurol1989.86.919"
"8012975","Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines","Saito S, Bannerji R, Gansbacher B, Rosenthal FM, Romanenko P, Heston WD, Fair WR, Gilboa E.","Cancer Res. 1994 Jul 1;54(13):3516-20.","Saito S","Cancer Res","1994","1994/07/01","","",""
"25828962","Molecular biology and targeted therapies for urothelial carcinoma","Seront E, Machiels JP.","Cancer Treat Rev. 2015 Apr;41(4):341-53. doi: 10.1016/j.ctrv.2015.03.004. Epub 2015 Mar 24.","Seront E","Cancer Treat Rev","2015","2015/04/02","","","10.1016/j.ctrv.2015.03.004"
"17464497","[Primary prevention of bladder cancer. What's new?]","Altwein JE.","Urologe A. 2007 Jun;46(6):616-21. doi: 10.1007/s00120-007-1348-z.","Altwein JE","Urologe A","2007","2007/04/28","","","10.1007/s00120-007-1348-z"
"19035895","Laparoscopic radical cystectomy for muscle-invasive bladder cancer: pathological and oncological outcomes","Stephenson AJ, Gill IS.","BJU Int. 2008 Nov;102(9 Pt B):1296-301. doi: 10.1111/j.1464-410X.2008.07973.x.","Stephenson AJ","BJU Int","2008","2008/11/28","","","10.1111/j.1464-410X.2008.07973.x"
"10071563","Human papillomavirus-related bladder cancer following renal transplantation","McInerney PD, Koffman CG, Mundy AR.","Br J Urol. 1993 Nov;72(5 Pt 1):663-4. doi: 10.1111/j.1464-410x.1993.tb16235.x.","McInerney PD","Br J Urol","1993","1993/11/01","","","10.1111/j.1464-410x.1993.tb16235.x"
"21615850","Clinically unconfirmed positive urinary cytology: diagnostic implications and oncological outcomes","Aharony S, Baniel J, Yossepowitch O.","BJU Int. 2011 Oct;108(8 Pt 2):E179-83. doi: 10.1111/j.1464-410X.2011.10210.x. Epub 2011 May 26.","Aharony S","BJU Int","2011","2011/05/28","","","10.1111/j.1464-410X.2011.10210.x"
"22893018","Individual risk assessment in bladder cancer patients based on a multi-marker panel","Todenhöfer T, Hennenlotter J, Aufderklamm S, Kühs U, Gakis G, Germann M, Stenzl A, Schwentner C.","J Cancer Res Clin Oncol. 2013 Jan;139(1):49-56. doi: 10.1007/s00432-012-1297-9. Epub 2012 Aug 15.","Todenhöfer T","J Cancer Res Clin Oncol","2013","2012/08/16","","","10.1007/s00432-012-1297-9"
"10645802","Lower urinary tract function after intra-arterial chemotherapy with concurrent pelvic radiotherapy for invasive bladder cancer","Sekido N, Miyanaga N, Kikuchi K, Takeshima H, Akaza H.","Jpn J Clin Oncol. 1999 Oct;29(10):479-84. doi: 10.1093/jjco/29.10.479.","Sekido N","Jpn J Clin Oncol","1999","2000/01/25","","","10.1093/jjco/29.10.479"
"15536887","Polymyositis associated with urinary bladder cancer: an autopsy case","Takeda I, Sugisaki K, Iwadate H, Kanno T, Odajima H, Kamimura K, Sakuma H, Endo H, Kasukawa R.","Fukushima J Med Sci. 2004 Jun;50(1):21-8. doi: 10.5387/fms.50.21.","Takeda I","Fukushima J Med Sci","2004","2004/11/13","","","10.5387/fms.50.21"
"29241311","A larger detrusor wall thickness increases the risk of non muscle invasive bladder cancer recurrence and progression: result from a multicenter observational study","Cicione A, Manno S, Ucciero G, Cantiello F, Damiano R, Lima E, Posti A, Balloni F, De Nunzio C.","Minerva Urol Nefrol. 2018 Jun;70(3):310-318. doi: 10.23736/S0393-2249.17.02992-7. Epub 2017 Dec 14.","Cicione A","Minerva Urol Nefrol","2018","2017/12/16","","","10.23736/S0393-2249.17.02992-7"
"20500535","Granulocyte colony-stimulating factor (G-CSF) producing bladder cancer subsequently developed from recurrent non-muscle invasive bladder cancer","Sawazaki H, Taki Y, Takeuchi H.","Int J Urol. 2010 Aug;17(8):741-2. doi: 10.1111/j.1442-2042.2010.02573.x. Epub 2010 May 25.","Sawazaki H","Int J Urol","2010","2010/05/27","","","10.1111/j.1442-2042.2010.02573.x"
"7551872","Management of superficial bladder cancer","Coptcoat MJ, Britton JP, Lynch TH, Thomas P, Hargreave TB, Bailey MJ, Rosario D, Rowsa AD.","Br J Urol. 1995 Sep;76(3):413.","Coptcoat MJ","Br J Urol","1995","1995/09/01","","",""
"3095288","Radioimmunoimaging of human bladder tumor xenografts in nude mice by using monoclonal antibodies","Sakahara H, Endo K, Koizumi M, Nakashima T, Okada K, Yoshida O, Masuko T, Hashimoto Y, Torizuka K.","Jpn J Cancer Res. 1986 Sep;77(9):916-21.","Sakahara H","Jpn J Cancer Res","1986","1986/09/01","","",""
"3626562","NB rat bladder cancer model: evaluation of the subrenal capsular assay system","Drago JR, Nesbitt JA.","J Surg Oncol. 1987 Sep;36(1):5-7. doi: 10.1002/jso.2930360103.","Drago JR","J Surg Oncol","1987","1987/09/01","","","10.1002/jso.2930360103"
"30238982","Upregulation of lncRNA DGCR5 correlates with better prognosis and inhibits bladder cancer progression via transcriptionally facilitating P21 expression","Fang C, He W, Xu T, Dai J, Xu L, Sun F.","J Cell Physiol. 2019 May;234(5):6254-6262. doi: 10.1002/jcp.27356. Epub 2018 Sep 21.","Fang C","J Cell Physiol","2019","2018/09/22","","","10.1002/jcp.27356"
"7827238","Bladder cancer: epidemiology and risk factors in Bulawayo, Zimbabwe","Vizcaino AP, Parkin DM, Boffetta P, Skinner ME.","Cancer Causes Control. 1994 Nov;5(6):517-22. doi: 10.1007/BF01831379.","Vizcaino AP","Cancer Causes Control","1994","1994/11/01","","","10.1007/BF01831379"
"24566016","Computed tomography or magnetic resonance imaging - our experiences in determining preoperative TNM staging of bladder cancer","Stojovska-Jovanovska E, Mitreska N, Stojovski M, Lazarova A, Stavridis S, Dodevski A.","Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2013;34(3):63-70.","Stojovska-Jovanovska E","Pril (Makedon Akad Nauk Umet Odd Med Nauki)","2013","2014/02/26","","",""
"17280909","Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer","Sternberg CN, Donat SM, Bellmunt J, Millikan RE, Stadler W, De Mulder P, Sherif A, von der Maase H, Tsukamoto T, Soloway MS.","Urology. 2007 Jan;69(1 Suppl):62-79. doi: 10.1016/j.urology.2006.10.041.","Sternberg CN","Urology","2007","2007/02/07","","","10.1016/j.urology.2006.10.041"
"10528591","[14th Congress European Association of Urology, Stockholm, Sweden. Therapy of advanced cancer of the bladder]","","Urologe A. 1999 Sep;38(5 Suppl):1-8.","","Urologe A","1999","1999/10/21","","",""
"12609806","[Bladder cancer: realities and perspectives]","Chrétien Y, Oudard S, Durdux C.","Bull Cancer. 2003 Jan;90(1):61-7.","Chrétien Y","Bull Cancer","2003","2003/03/01","","",""
"25056737","Optimal treatment for metastatic bladder cancer","Carballido EM, Rosenberg JE.","Curr Oncol Rep. 2014 Sep;16(9):404. doi: 10.1007/s11912-014-0404-2.","Carballido EM","Curr Oncol Rep","2014","2014/07/25","","","10.1007/s11912-014-0404-2"
"20089271","The role of pathology review of transurethral bladder tumor resection specimens in the modern era","Lee MC, Levin HS, Jones JS.","J Urol. 2010 Mar;183(3):921-7. doi: 10.1016/j.juro.2009.11.049. Epub 2010 Jan 20.","Lee MC","J Urol","2010","2010/01/22","","","10.1016/j.juro.2009.11.049"
"30012566","The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer","Bielli P, Panzeri V, Lattanzio R, Mutascio S, Pieraccioli M, Volpe E, Pagliarulo V, Piantelli M, Giannantoni A, Di Stasi SM, Sette C.","Clin Cancer Res. 2018 Nov 1;24(21):5422-5432. doi: 10.1158/1078-0432.CCR-17-3850. Epub 2018 Jul 16.","Bielli P","Clin Cancer Res","2018","2018/07/18","","","10.1158/1078-0432.CCR-17-3850"
"26435378","Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer","Ramirez D, Gupta A, Canter D, Harrow B, Dobbs RW, Kucherov V, Mueller E, Streeper N, Uhlman MA, Svatek RS, Messing EM, Lotan Y.","BJU Int. 2016 May;117(5):783-6. doi: 10.1111/bju.13345. Epub 2015 Oct 29.","Ramirez D","BJU Int","2016","2015/10/06","","","10.1111/bju.13345"
"10925118","Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model","Miyake H, Hara I, Hara S, Arakawa S, Kamidono S.","Urology. 2000 Aug 1;56(2):332-6. doi: 10.1016/s0090-4295(00)00567-7.","Miyake H","Urology","2000","2000/08/05","","","10.1016/s0090-4295(00)00567-7"
"29764095","Clinical outcomes in a cohort of patients with T1 high grade urothelial bladder cancer not receiving intravesical bacillus Calmette-Guerin: a 15 year experience","Goonewardena SAS, Jayarajah U, Kuruppu SN, Herath HMKB, Fernando DMH, Vickneswaran K.","Ceylon Med J. 2018 Mar 31;63(1):37-39. doi: 10.4038/cmj.v63i1.8626.","Goonewardena SAS","Ceylon Med J","2018","2018/05/17","","","10.4038/cmj.v63i1.8626"
"29557986","Letter to the editor regarding the article ""Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study""","Besiroglu H, Ozbek E.","World J Urol. 2018 Nov;36(11):1795-1796. doi: 10.1007/s00345-018-2271-1. Epub 2018 Mar 20.","Besiroglu H","World J Urol","2018","2018/03/21","","","10.1007/s00345-018-2271-1"
"19286209","The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer","deVere White RW, Katz MH, Steinberg GD.","J Urol. 2009 May;181(5):1994-7. doi: 10.1016/j.juro.2009.02.052. Epub 2009 Mar 14.","deVere White RW","J Urol","2009","2009/03/17","","","10.1016/j.juro.2009.02.052"
"18077878","Prof. Dr. Ramon Abascal Garcia's clear statement to fluorescence diagnosis of bladder cancer by 5- amino-levolinic acid","Hofstetter A.","Arch Esp Urol. 2007 Nov;60(9):1.147.","Hofstetter A","Arch Esp Urol","2007","2007/12/14","","",""
"18934992","[Bladder cancer]","GAMMELGAARD A.","Nord Med. 1948 Apr 30;37(18):900-2.","GAMMELGAARD A","Nord Med","1948","1948/04/30","","",""
"18380818","Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer","Muramaki M, Miyake H, Kurahashi T, Takenaka A, Inoue TA, Fujisawa M.","Int J Urol. 2008 Apr;15(4):314-8. doi: 10.1111/j.1442-2042.2008.02000.x.","Muramaki M","Int J Urol","2008","2008/04/03","","","10.1111/j.1442-2042.2008.02000.x"
"2675011","Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response","Splinter TA, Denis L, Scher HI, Schröder FH, Dalesio O.","Prog Clin Biol Res. 1989;303:541-7.","Splinter TA","Prog Clin Biol Res","1989","1989/01/01","","",""
"32469066","Prognostic significance of non-urothelial carcinoma of bladder: analysis of nationwide hospital-based cancer registry data in Japan","Nagumo Y, Kawai K, Kojima T, Shiga M, Kojo K, Tanaka K, Kandori S, Kimura T, Kawahara T, Okuyama A, Higashi T, Nishiyama H.","Jpn J Clin Oncol. 2020 Sep 5;50(9):1068-1075. doi: 10.1093/jjco/hyaa072.","Nagumo Y","Jpn J Clin Oncol","2020","2020/05/30","","","10.1093/jjco/hyaa072"
"24744216","[The value of surgical margins for clinical predictions and decisions following radical cystectomy for bladder cancer]","Colombo R, Moschini M.","Urologia. 2014 Jan-Mar;81(1):25-9. doi: 10.5301/uro.5000062. Epub 2014 Apr 14.","Colombo R","Urologia","2014","2014/04/19","","","10.5301/uro.5000062"
"31368905","The Impact of Radiotherapy Facility Volume on the Survival and Guideline Concordance of Patients With Muscle-invasive Bladder Cancer Receiving Bladder-preservation Therapy","D'Rummo KA, TenNapel MJ, Shen X.","Am J Clin Oncol. 2019 Sep;42(9):705-710. doi: 10.1097/COC.0000000000000582.","D'Rummo KA","Am J Clin Oncol","2019","2019/08/02","","","10.1097/COC.0000000000000582"
"21980733","Imaging of bladder cancer: update on current approaches for diagnosis","Turkbey B, Turkbey EB, Ravizzini G, Karcaaltincaba M.","JBR-BTR. 2011 Jul-Aug;94(4):178-84. doi: 10.5334/jbr-btr.581.","Turkbey B","JBR-BTR","2011","2011/10/11","","","10.5334/jbr-btr.581"
"10037358","Can p53 help select patients with invasive bladder cancer for bladder preservation?","Herr HW, Bajorin DF, Scher HI, Cordon-Cardo C, Reuter VE.","J Urol. 1999 Jan;161(1):20-2; discussion 22-3.","Herr HW","J Urol","1999","1999/02/26","","",""
"24091270","[Prognostic significance of the 2004 WHO classification compared with the 1973 WHO classification for organ-confined invasive bladder cancer]","Zhong MZ, Guo SJ, Jiang LJ, Yun JP, Zhou FJ.","Zhonghua Wai Ke Za Zhi. 2013 Jun 1;51(6):538-41.","Zhong MZ","Zhonghua Wai Ke Za Zhi","2013","2013/10/05","","",""
"1544689","Methylene dianiline: assessment of exposure and cancer morbidity in power generator workers","Seldén A, Berg P, Jakobsson R, de Laval J.","Int Arch Occup Environ Health. 1992;63(6):403-8. doi: 10.1007/BF00386936.","Seldén A","Int Arch Occup Environ Health","1992","1992/01/01","","","10.1007/BF00386936"
"19904035","A method to individualize adaptive planning target volumes for deformable targets","Wright P, Redpath AT, Høyer M, Muren LP.","Phys Med Biol. 2009 Dec 7;54(23):7121-33. doi: 10.1088/0031-9155/54/23/006. Epub 2009 Nov 11.","Wright P","Phys Med Biol","2009","2009/11/12","","","10.1088/0031-9155/54/23/006"
"20172551","HAMLET treatment delays bladder cancer development","Mossberg AK, Hou Y, Svensson M, Holmqvist B, Svanborg C.","J Urol. 2010 Apr;183(4):1590-7. doi: 10.1016/j.juro.2009.12.008. Epub 2010 Feb 21.","Mossberg AK","J Urol","2010","2010/02/23","","","10.1016/j.juro.2009.12.008"
"10799246","Retrovirus type C in the mouse bladder carcinoma cell line MBT-2","De Boer EC, Teppema JS, Steerenberg PA, De Jong WH.","J Urol. 2000 Jun;163(6):1999-2001. doi: 10.1097/00005392-200006000-00109.","De Boer EC","J Urol","2000","2000/05/08","","","10.1097/00005392-200006000-00109"
"25135219","The biochemical value of urinary metalloproteinases 3 and 9 in diagnosis and prognosis of bladder cancer in Egypt","El-Sharkawi F, El Sabah M, Hassan Z, Khaled H.","J Biomed Sci. 2014 Aug 19;21(1):72. doi: 10.1186/s12929-014-0072-4.","El-Sharkawi F","J Biomed Sci","2014","2014/08/20","PMC4237805","","10.1186/s12929-014-0072-4"
"4038748","Initial intravenous cis-platinum therapy: improved management for invasive high risk bladder cancer?","Raghavan D, Pearson B, Duval P, Rogers J, Meagher M, Wines R, Mameghan H, Boulas J, Green D.","J Urol. 1985 Mar;133(3):399-402. doi: 10.1016/s0022-5347(17)48995-6.","Raghavan D","J Urol","1985","1985/03/01","","","10.1016/s0022-5347(17)48995-6"
"30888482","Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression","Yajima S, Yoshida S, Takahara T, Arita Y, Tanaka H, Waseda Y, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.","Eur Radiol. 2019 Jul;29(7):3881-3888. doi: 10.1007/s00330-019-06119-6. Epub 2019 Mar 19.","Yajima S","Eur Radiol","2019","2019/03/20","","","10.1007/s00330-019-06119-6"
"25790869","Reduced ING4 Expression Is Associated with the Malignancy of Human Bladder","Wang Y, Wang T, Han Y, Wu H, Zhao W, Tong D, Wei L, Zhong Z, An R, Wang Y.","Urol Int. 2015;94(4):464-71. doi: 10.1159/000364832. Epub 2015 Mar 14.","Wang Y","Urol Int","2015","2015/03/21","","","10.1159/000364832"
"29599318","Lentiviral Vector-mediated Gene Transfer in Human Bladder Cancer Cell Lines","Matsunaga W, Ichikawa M, Nakamura A, Ishikawa T, Gotoh A.","Anticancer Res. 2018 Apr;38(4):2015-2020. doi: 10.21873/anticanres.12440.","Matsunaga W","Anticancer Res","2018","2018/03/31","","","10.21873/anticanres.12440"
"9552029","Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome","Herr HW, Bajorin DF, Scher HI.","J Clin Oncol. 1998 Apr;16(4):1298-301. doi: 10.1200/JCO.1998.16.4.1298.","Herr HW","J Clin Oncol","1998","1998/04/29","","","10.1200/JCO.1998.16.4.1298"
"25665317","[Non-muscle invasive bladder cancer]","Irani J.","Rev Prat. 2014 Dec;64(10):1382-5.","Irani J","Rev Prat","2014","2015/02/11","","",""
"29860035","Prognostic value of DNA methylation for bladder cancer","Yu Y, Cao H, Zhang M, Shi F, Wang R, Liu X.","Clin Chim Acta. 2018 Sep;484:207-212. doi: 10.1016/j.cca.2018.05.056. Epub 2018 Jun 1.","Yu Y","Clin Chim Acta","2018","2018/06/04","","","10.1016/j.cca.2018.05.056"
"10700863","Loss of Y chromosome in bilharzial bladder cancer","Khaled HM, Aly MS, Magrath IT.","Cancer Genet Cytogenet. 2000 Feb;117(1):32-6. doi: 10.1016/s0165-4608(99)00126-0.","Khaled HM","Cancer Genet Cytogenet","2000","2000/03/04","","","10.1016/s0165-4608(99)00126-0"
"26310391","MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1","Wang X, Wu Q, Xu B, Wang P, Fan W, Cai Y, Gu X, Meng F.","FEBS J. 2015 Nov;282(22):4376-88. doi: 10.1111/febs.13502. Epub 2015 Sep 19.","Wang X","FEBS J","2015","2015/08/28","","","10.1111/febs.13502"
"21153394","[Plasma E-cadherin levels in urinary bladder cancer: does it improve risk stratification?]","Szarvas T, Hoffmann F, Becker M, Schenck M, Vom Dorp F, Rübben H, Jäger T.","Urologe A. 2011 Jan;50(1):64-70. doi: 10.1007/s00120-010-2454-x.","Szarvas T","Urologe A","2011","2010/12/15","","","10.1007/s00120-010-2454-x"
"23308193","A quantitative proteomic analysis uncovers the relevance of CUL3 in bladder cancer aggressiveness","Grau L, Luque-Garcia JL, González-Peramato P, Theodorescu D, Palou J, Fernandez-Gomez JM, Sánchez-Carbayo M.","PLoS One. 2013;8(1):e53328. doi: 10.1371/journal.pone.0053328. Epub 2013 Jan 8.","Grau L","PLoS One","2013","2013/01/12","PMC3540081","","10.1371/journal.pone.0053328"
"22704101","The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma","Kim SP, Frank I, Cheville JC, Thompson RH, Weight CJ, Thapa P, Boorjian SA.","J Urol. 2012 Aug;188(2):405-9. doi: 10.1016/j.juro.2012.04.020. Epub 2012 Jun 14.","Kim SP","J Urol","2012","2012/06/19","","","10.1016/j.juro.2012.04.020"
"24563275","Accurate determination of the pathological stage with gross dissection protocol for radical cystectomy","Sükösd F, Iványi B, Pajor L.","Pathol Oncol Res. 2014 Jul;20(3):677-85. doi: 10.1007/s12253-014-9748-z. Epub 2014 Feb 23.","Sükösd F","Pathol Oncol Res","2014","2014/02/25","","","10.1007/s12253-014-9748-z"
"9465598","[The clinical study of radical cystectomy for lymph node positive bladder cancer]","Kajiwara T, Kashibuchi K, Shinohara M, Munakata A, Itakura H, Inoue S, Kinoshita K.","Nihon Hinyokika Gakkai Zasshi. 1997 Dec;88(12):992-6. doi: 10.5980/jpnjurol1989.88.992.","Kajiwara T","Nihon Hinyokika Gakkai Zasshi","1997","1998/02/18","","","10.5980/jpnjurol1989.88.992"
"24602011","Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancer","Miyake M, Nakai Y, Anai S, Tatsumi Y, Kuwada M, Onishi S, Chihara Y, Tanaka N, Hirao Y, Fujimoto K.","Cancer Sci. 2014 May;105(5):616-22. doi: 10.1111/cas.12393. Epub 2014 Apr 6.","Miyake M","Cancer Sci","2014","2014/03/08","PMC4317833","","10.1111/cas.12393"
"22845408","Recent advances in urinary bladder cancer detection","Bhatt J, Cowan N, Protheroe A, Crew J.","Expert Rev Anticancer Ther. 2012 Jul;12(7):929-39. doi: 10.1586/era.12.73.","Bhatt J","Expert Rev Anticancer Ther","2012","2012/08/01","","","10.1586/era.12.73"
"6685567","Planned preoperative cisplatin and radiation therapy for locally advanced bladder cancer","Herr HW, Yagoda A, Batata M, Sogani PC, Whitmore WF Jr.","Cancer. 1983 Dec 15;52(12):2205-8. doi: 10.1002/1097-0142(19831215)52:12<2205::aid-cncr2820521205>3.0.co;2-l.","Herr HW","Cancer","1983","1983/12/15","","","10.1002/1097-0142(19831215)52:12<2205::aid-cncr2820521205>3.0.co;2-l"
"21256082","Personalised treatment for bladder cancer","Ørntoft TF.","Lancet Oncol. 2011 Feb;12(2):111-2. doi: 10.1016/S1470-2045(11)70001-8. Epub 2011 Jan 20.","Ørntoft TF","Lancet Oncol","2011","2011/01/25","","","10.1016/S1470-2045(11)70001-8"
"28126499","Bacillus Calmette-Guerin improves local and systemic response to radiotherapy in invasive bladder cancer","Prack Mc Cormick B, Belgorosky D, Langle Y, Balarino N, Sandes E, Eiján AM.","Nitric Oxide. 2017 Apr 1;64:22-30. doi: 10.1016/j.niox.2017.01.008. Epub 2017 Jan 23.","Prack Mc Cormick B","Nitric Oxide","2017","2017/01/28","","","10.1016/j.niox.2017.01.008"
"15560278","[Infiltrative small cell carcinoma of the bladder. New case report: treatment with radical surgery and chemotherapy]","Cruz Guerra NA, Fradejas Rodríguez A, Zamora Martínez T, del Valle Manteca A, Tinajas Saldaña A, Tarroc Blanco A.","Arch Esp Urol. 2004 Oct;57(8):854-6.","Cruz Guerra NA","Arch Esp Urol","2004","2004/11/25","","",""
"26995542","Blue Light Cystoscopy Should be Used Routinely for Bladder Cancer Detection: Pro","Steinberg G.","J Urol. 2016 Jun;195(6):1652-3. doi: 10.1016/j.juro.2016.03.073. Epub 2016 Mar 16.","Steinberg G","J Urol","2016","2016/03/21","","","10.1016/j.juro.2016.03.073"
"9342752","A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer","Kraggerud SM, Jacobsen KD, Berner A, Stokke T, Holm R, Smedshammer L, Børresen-Dale AL, Fosså SD.","Pathol Res Pract. 1997;193(7):471-8. doi: 10.1016/s0344-0338(97)80099-4.","Kraggerud SM","Pathol Res Pract","1997","1997/01/01","","","10.1016/s0344-0338(97)80099-4"
"27353655","The use of hyperthermia in the treatment of bladder cancer","Crezee H, Inman BA.","Int J Hyperthermia. 2016 Jun;32(4):349-50. doi: 10.3109/02656736.2016.1163739.","Crezee H","Int J Hyperthermia","2016","2016/06/30","","","10.3109/02656736.2016.1163739"
"9366149","10-year survival rate in 92 patients with invasive bladder carcinoma treated by bladder sparing methods","Ogawa H, Nishimura T, Hori N, Abe H, Ito H, Kubota M, Kiriyama I.","Nihon Ika Daigaku Zasshi. 1997 Oct;64(5):446-54. doi: 10.1272/jnms1923.64.446.","Ogawa H","Nihon Ika Daigaku Zasshi","1997","1997/11/20","","","10.1272/jnms1923.64.446"
"10827348","[An uncommon tumor of the urinary bladder: the small cell carcinoma]","Henno S, Guiraud P, Rioux-Leclercq N, Caulet-Maugendre S, Kerbrat P, Lobel B, Ramée MP, Turlin B.","Bull Cancer. 2000 Apr;87(4):307-10.","Henno S","Bull Cancer","2000","2000/05/29","","",""
"3664945","Intra-arterial chemotherapy for bladder cancer","Kanoh S, Noguchi R, Ohtani M, Ishikawa S, Nemoto R, Koiso K, Kitagawa R.","Cancer Chemother Pharmacol. 1987;20 Suppl:S6-9. doi: 10.1007/BF00262476.","Kanoh S","Cancer Chemother Pharmacol","1987","1987/01/01","","","10.1007/BF00262476"
"1593678","Feasibility of transurethral resection for muscle-infiltrating carcinoma of the bladder: prospective study","Solsona E, Iborra I, Ricós JV, Monrós JL, Dumont R.","J Urol. 1992 Jun;147(6):1513-5. doi: 10.1016/s0022-5347(17)37612-7.","Solsona E","J Urol","1992","1992/06/01","","","10.1016/s0022-5347(17)37612-7"
"15498297","[The heat shock protein 70 antisense oligomers enhance the sensitivity of bladder cancer cell EJ to mitomycin C]","He LF, Hou SK, Yan Z, Ren L, Wang SW.","Zhonghua Wai Ke Za Zhi. 2004 Sep 22;42(18):1108-10.","He LF","Zhonghua Wai Ke Za Zhi","2004","2004/10/23","","",""
"9245952","Surveillance of nasal and bladder cancer to locate sources of exposure to occupational carcinogens","Teschke K, Morgan MS, Checkoway H, Franklin G, Spinelli JJ, van Belle G, Weiss NS.","Occup Environ Med. 1997 Jun;54(6):443-51. doi: 10.1136/oem.54.6.443.","Teschke K","Occup Environ Med","1997","1997/06/01","PMC1128806","","10.1136/oem.54.6.443"
"17374437","Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?","Sylvester RJ.","Eur Urol. 2007 Oct;52(4):951-3; discussion 953-4. doi: 10.1016/j.eururo.2007.03.028. Epub 2007 Mar 15.","Sylvester RJ","Eur Urol","2007","2007/03/22","","","10.1016/j.eururo.2007.03.028"
"6805635","Industrial bladder cancer","Pickering AH.","Br Med J (Clin Res Ed). 1982 May 29;284(6329):1632. doi: 10.1136/bmj.284.6329.1632.","Pickering AH","Br Med J (Clin Res Ed)","1982","1982/05/29","PMC1498537","","10.1136/bmj.284.6329.1632"
"27706668","Enhancement of dendritic cells with melanoma-associated antigen 3 for inducing cytotoxicity by cytotoxic T lymphocytes on bladder cancer BIU-87 cells","Li XZ, Han Y, Tian J, Ren X, Ma X, Ma M.","Genet Mol Res. 2016 Aug 30;15(3). doi: 10.4238/gmr.15039001.","Li XZ","Genet Mol Res","2016","2016/10/06","","","10.4238/gmr.15039001"
"12085284","[Significance of pelvic lymphadenectomy for the prognosis after radical cystectomy]","Leissner J, Allhoff EP, Hohenfellner R, Wolf HK.","Zentralbl Chir. 2002 Apr;127(4):315-21. doi: 10.1055/s-2002-31550.","Leissner J","Zentralbl Chir","2002","2002/06/27","","","10.1055/s-2002-31550"
"23973937","Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition","Lamm D, Persad R, Brausi M, Buckley R, Witjes JA, Palou J, Böhle A, Kamat AM, Colombel M, Soloway M.","J Urol. 2014 Jan;191(1):20-7. doi: 10.1016/j.juro.2013.07.102. Epub 2013 Aug 22.","Lamm D","J Urol","2014","2013/08/27","","","10.1016/j.juro.2013.07.102"
"8914393","[The efficacy of neoadjuvant chemotherapy and morphological classification of invasive bladder cancer according to chemoresponse]","Tsutsumi M, Tobisu K, Tomita K, Fujimoto H, Kume H, Niwakawa H, Yuen K, Kakizoe T.","Nihon Hinyokika Gakkai Zasshi. 1996 Sep;87(9):1105-13. doi: 10.5980/jpnjurol1989.87.1105.","Tsutsumi M","Nihon Hinyokika Gakkai Zasshi","1996","1996/09/01","","","10.5980/jpnjurol1989.87.1105"
"22652680","Bladder cancer documentation of causes: multilingual questionnaire, 'bladder cancer doc'","Golka K, Abreu-Villaca Y, Anbari Attar R, Angeli-Greaves M, Aslam M, Basaran N, Belik R, Butryee C, Dalpiaz O, Dzhusupov K, Ecke TH, Galambos H, Galambos H, Gerilovica H, Gerullis H, Gonzalez PC, Goossens ME, Gorgishvili-Hermes L, Heyns CF, Hodzic J, Ikoma F, Jichlinski P, Kang BH, Kiesswetter E, Krishnamurthi K, Lehmann ML, Martinova I, Mittal RD, Ravichandran B, Romics I, Roy B, Rungkat-Zakaria F, Rydzynski K, Scutaru C, Shen J, Soufi M, Toguzbaeva K, Vu Duc T, Widera A, Wishahi M, Hengstler JG.","Front Biosci (Elite Ed). 2012 Jun 1;4:2709-22. doi: 10.2741/e585.","Golka K","Front Biosci (Elite Ed)","2012","2012/06/02","","","10.2741/e585"
"19035883","Epidemiology and genetic susceptibility to bladder cancer","Wu X, Ros MM, Gu J, Kiemeney L.","BJU Int. 2008 Nov;102(9 Pt B):1207-15. doi: 10.1111/j.1464-410X.2008.07961.x.","Wu X","BJU Int","2008","2008/11/28","","","10.1111/j.1464-410X.2008.07961.x"
"21113501","Cellular expression of INK4a gene in cells of bladder cancer associated with human papilloma virus-16","Volgareva GM, Zavalishina LE, Golovina DA, Andreeva YY, Ermilova VD, Trofimova OB, Kuevda DA, Shipulina OY, Glazunova VA, Cheng S, Pavlova LS, Cheban NL, Matveev VB, Frank GA.","Bull Exp Biol Med. 2010 Aug;149(2):242-5. doi: 10.1007/s10517-010-0917-0.","Volgareva GM","Bull Exp Biol Med","2010","2010/11/30","","","10.1007/s10517-010-0917-0"
"3613023","Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery","Shipley WU, Prout GR Jr, Einstein AB, Coombs LJ, Wajsman Z, Soloway MS, Englander L, Barton BA, Hafermann MD.","JAMA. 1987 Aug 21;258(7):931-5.","Shipley WU","JAMA","1987","1987/08/21","","",""
"12196901","Management of locally advanced bladder cancer: early vs deferred chemotherapy","Syed S, Weiss GR.","World J Urol. 2002 Aug;20(3):175-82. doi: 10.1007/s00345-002-0277-0. Epub 2002 Jun 19.","Syed S","World J Urol","2002","2002/08/28","","","10.1007/s00345-002-0277-0"
"27272001","[Study for the treatment of nonmuscle invasive bladder cancer : A phase III efficacy trial for intravesical instillation of mistletoe extract in superficial bladder cancer (TIM) - AB 40/11 of the AUO]","Rexer H; Geschäftsstelle der AUO.","Urologe A. 2016 Jul;55(7):963-5. doi: 10.1007/s00120-016-0135-0.","Rexer H","Urologe A","2016","2016/06/09","","","10.1007/s00120-016-0135-0"
"16033071","Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer","Akçetin Z, Todorov J, Tüzel E, Engehausen DG, Krause FS, Sauer R, Schrott KM, Rödel C.","Anticancer Res. 2005 May-Jun;25(3A):1623-8.","Akçetin Z","Anticancer Res","2005","2005/07/22","","",""
"26489968","MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids","Matullo G, Naccarati A, Pardini B.","Int J Cancer. 2016 May 15;138(10):2334-45. doi: 10.1002/ijc.29895. Epub 2015 Nov 9.","Matullo G","Int J Cancer","2016","2015/10/23","","","10.1002/ijc.29895"
"20649827","Transurethral resection of the bladder tumour (TURBT) for non-muscle invasive bladder cancer: basic skills","Furuse H, Ozono S.","Int J Urol. 2010 Aug;17(8):698-9. doi: 10.1111/j.1442-2042.2010.02556.x.","Furuse H","Int J Urol","2010","2010/07/24","","","10.1111/j.1442-2042.2010.02556.x"
"28477210","Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer","Williams SB, Huo J, Kosarek CD, Chamie K, Rogers SO Jr, Williams MA, Giordano SH, Kim SP, Kamat AM.","Cancer Causes Control. 2017 Jul;28(7):755-766. doi: 10.1007/s10552-017-0902-2. Epub 2017 May 5.","Williams SB","Cancer Causes Control","2017","2017/05/07","PMC5497706","NIHMS874238","10.1007/s10552-017-0902-2"
"26689010","[The biochemical carcinogenesis of selected heavy metals in bladder cancer]","Rorbach-Dolata A, Marchewka Z, Piwowar A.","Postepy Biochem. 2015;61(2):176-82.","Rorbach-Dolata A","Postepy Biochem","2015","2015/12/23","","",""
"18572767","[Postradiation and postchemotherapy complications in patients with urinary bladder cancer]","Kharchenko VP, Kaprin AD, Ivanov SA, Klimenko AA, Elagin VO.","Urologiia. 2008 Mar-Apr;(2):32-5.","Kharchenko VP","Urologiia","2008","2008/06/25","","",""
"17009050","Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective?","Donat SM.","World J Urol. 2006 Nov;24(5):557-64. doi: 10.1007/s00345-006-0117-8.","Donat SM","World J Urol","2006","2006/09/30","","","10.1007/s00345-006-0117-8"
"29477716","Gender Specific Differences in Disease-Free, Cancer Specific and Overall Survival after Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis","Uhlig A, Seif Amir Hosseini A, Simon J, Lotz J, Trojan L, Schmid M, Uhlig J.","J Urol. 2018 Jul;200(1):48-60. doi: 10.1016/j.juro.2017.11.150. Epub 2018 Mar 1.","Uhlig A","J Urol","2018","2018/02/26","","","10.1016/j.juro.2017.11.150"
"30345496","Effect of Treatment Modality on Long Term Renal Functions in Patients With Muscle Invasive Bladder Cancer","Hamidi N, Suer E, Ozkidik M, Gokce MI, Ozturk E, Ozcan C, Turkolmez K, Beduk Y, Baltaci S.","Urol J. 2019 Jun 17;16(3):274-278. doi: 10.22037/uj.v0i0.4251.","Hamidi N","Urol J","2019","2018/10/23","","","10.22037/uj.v0i0.4251"
"18775029","Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy","Komai Y, Fujii Y, Okubo Y, Yamamoto S, Kawakami S, Yonese J, Fukui I.","Int J Urol. 2008 Oct;15(11):971-5. doi: 10.1111/j.1442-2042.2008.02160.x. Epub 2008 Sep 3.","Komai Y","Int J Urol","2008","2008/09/09","","","10.1111/j.1442-2042.2008.02160.x"
"6793738","Pathological changes associated with topical chemotherapy for superficial bladder cancer","Murphy WM, Soloway MS, Finebaum PJ.","J Urol. 1981 Oct;126(4):461-4. doi: 10.1016/s0022-5347(17)54576-0.","Murphy WM","J Urol","1981","1981/10/01","","","10.1016/s0022-5347(17)54576-0"
"14978958","[A case report of a young patient with invasive bladder cancer]","Nakashima M, Nishiyama H, Yagihashi Y, Yamamoto S, Kamoto T, Habuchi T, Ogawa O.","Hinyokika Kiyo. 2003 Dec;49(12):745-8.","Nakashima M","Hinyokika Kiyo","2003","2004/02/26","","",""
"26205531","A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy","Zargar-Shoshtari K, Zargar H, Lotan Y, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC.","J Urol. 2016 Jan;195(1):53-9. doi: 10.1016/j.juro.2015.07.085. Epub 2015 Jul 21.","Zargar-Shoshtari K","J Urol","2016","2015/07/25","","","10.1016/j.juro.2015.07.085"
"25665313","[Bladder cancer and urothelial tumors. New therapeutic strategies]","Desgrandchamps F, Hennequin C, Culine S.","Rev Prat. 2014 Dec;64(10):1363-4.","Desgrandchamps F","Rev Prat","2014","2015/02/11","","",""
"15262136","Prevalence of bladder tumors in women referred with postmenopausal bleeding","Abdel-Fattah M, Barrington JW, Youssef M, Mac Dermott JP.","Gynecol Oncol. 2004 Jul;94(1):167-9. doi: 10.1016/j.ygyno.2004.04.017.","Abdel-Fattah M","Gynecol Oncol","2004","2004/07/21","","","10.1016/j.ygyno.2004.04.017"
"10510924","Initial evaluation of the new urinary bladder cancer rapid test in the detection of transitional cell carcinoma of the bladder","Sánchez-Carbayo M, Herrero E, Megías J, Mira A, Soria F.","Urology. 1999 Oct;54(4):656-61. doi: 10.1016/s0090-4295(99)00195-8.","Sánchez-Carbayo M","Urology","1999","1999/10/08","","","10.1016/s0090-4295(99)00195-8"
"5615603","Substituting colosigmoid bladder and subtotal colocystoplastics with mucoclasia of remaining trigonum in the treatment of urinary bladder cancer","Puscariu V, Schileru G, Maior E.","Acta Urol Belg. 1967 Jul;35(3):443-9.","Puscariu V","Acta Urol Belg","1967","1967/07/01","","",""
"21281051","Bladder cancer co-existing with ovarian cancer coincidentally detected by transvaginal ultrasonography","Yoshino K, Ohta Y, Takezawa K, Kinouchi T, Kamiura S.","J Obstet Gynaecol. 2011;31(2):196-7. doi: 10.3109/01443615.2010.529519.","Yoshino K","J Obstet Gynaecol","2011","2011/02/02","","","10.3109/01443615.2010.529519"
"17349526","Gene expression profile in squamous cell carcinoma of the urinary bladder using complementary deoxyribonucleic acid microarray","Ewis AA, El-Samman E, Ali N, Kajimoto K, Shinohara Y, Ishikawa M, Kanayama HO, Baba Y.","Urol Oncol. 2007 Mar-Apr;25(2):120-7. doi: 10.1016/j.urolonc.2006.03.006.","Ewis AA","Urol Oncol","2007","2007/03/14","","","10.1016/j.urolonc.2006.03.006"
"32147666","Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway","Shi C, Sun L, Liu S, Zhang E, Song Y.","Med Sci Monit. 2020 Mar 9;26:e921087. doi: 10.12659/MSM.921087.","Shi C","Med Sci Monit","2020","2020/03/10","PMC7081662","","10.12659/MSM.921087"
"15762459","[Comparative research on attenuation characteristics of human bladder cancer tissue at different wavelengths of laser and their linearly polarized laser in vitro]","Wei HJ, Xing D, Wu GY, Jin Y, Gu HM.","Guang Pu Xue Yu Guang Pu Fen Xi. 2004 Nov;24(11):1296-8.","Wei HJ","Guang Pu Xue Yu Guang Pu Fen Xi","2004","2005/03/15","","",""
"29231044","A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy","Rammant E, Decaestecker K, Bultijnck R, Sundahl N, Ost P, Pauwels NS, Deforche B, Pieters R, Fonteyne V.","Clin Rehabil. 2018 May;32(5):594-606. doi: 10.1177/0269215517746472. Epub 2017 Dec 12.","Rammant E","Clin Rehabil","2018","2017/12/13","","","10.1177/0269215517746472"
"2051691","[Studies of biological malignancy in bladder cancer using two parameter DNA-RNA cytofluorometric analysis]","Yamamoto H.","Nihon Hinyokika Gakkai Zasshi. 1991 Apr;82(4):551-9. doi: 10.5980/jpnjurol1989.82.551.","Yamamoto H","Nihon Hinyokika Gakkai Zasshi","1991","1991/04/01","","","10.5980/jpnjurol1989.82.551"
"20579130","Biomarkers in bladder cancer","Proctor I, Stoeber K, Williams GH.","Histopathology. 2010 Jul;57(1):1-13. doi: 10.1111/j.1365-2559.2010.03592.x. Epub 2010 Jun 23.","Proctor I","Histopathology","2010","2010/06/29","","","10.1111/j.1365-2559.2010.03592.x"
"29643502","Unravelling disparate roles of NOTCH in bladder cancer","Goriki A, Seiler R, Wyatt AW, Contreras-Sanz A, Bhat A, Matsubara A, Hayashi T, Black PC.","Nat Rev Urol. 2018 Jun;15(6):345-357. doi: 10.1038/s41585-018-0005-1.","Goriki A","Nat Rev Urol","2018","2018/04/13","","","10.1038/s41585-018-0005-1"
"11428296","Cytometric investigations of bladder irrigation/washing and voided urine","Longatto Filho A, Santinelli A, Montironi R.","Pathologica. 2001 Apr;93(2):164-7.","Longatto Filho A","Pathologica","2001","2001/06/29","","",""
"19584734","Potential new urinary markers in the early detection of bladder cancer","Shirodkar SP, Lokeshwar VB.","Curr Opin Urol. 2009 Sep;19(5):488-93. doi: 10.1097/MOU.0b013e32832eb3a0.","Shirodkar SP","Curr Opin Urol","2009","2009/07/09","PMC2822718","NIHMS175486","10.1097/MOU.0b013e32832eb3a0"
"10668937","Prognostic significance of p53 protein accumulation in stage pT1 transitional cell carcinoma of the bladder","Toktaş G, Türkeri LN, Unlüer E, Atuğ F, Murat C, Ozveren B, Calişkan M, Akdaş A.","Int Urol Nephrol. 1999;31(4):437-41. doi: 10.1023/a:1007150825243.","Toktaş G","Int Urol Nephrol","1999","2000/02/11","","","10.1023/a:1007150825243"
"10730421","[Comparative study of BTA stat test, NMP-22, and cytology in the diagnosis of bladder cancer]","Gutiérrez Baños JL, Rebollo Rodrigo MH, Antolín Juarez F, Martín García B, Hernández Rodríguez R, Portillo Martín JA, Correas Gómez MA, del Valle Schaan JI, Roca Edreira A, de Diego Rodríguez E, Radó Velázquez MA.","Arch Esp Urol. 2000 Jan-Feb;53(1):21-7.","Gutiérrez Baños JL","Arch Esp Urol","2000","2000/03/24","","",""
"16905979","Urinary bladder cancer: hard times for evidenced-based data","Malmstrom PU.","Curr Opin Urol. 2006 Sep;16(5):342-3. doi: 10.1097/01.mou.0000240306.78205.ac.","Malmstrom PU","Curr Opin Urol","2006","2006/08/15","","","10.1097/01.mou.0000240306.78205.ac"
"695653","[Arterial embolic occlusion in tumours of kidney and bladder (author's transl)]","Rummelhardt S, Latal D.","Wien Klin Wochenschr. 1978 Sep 15;90(17):628-33.","Rummelhardt S","Wien Klin Wochenschr","1978","1978/09/15","","",""
"22019956","Specific survivin dual fluorescence resonance energy transfer molecular beacons for detection of human bladder cancer cells","Wang ZQ, Zhao J, Zeng J, Wu KJ, Chen YL, Wang XY, Chang LS, He DL.","Acta Pharmacol Sin. 2011 Dec;32(12):1522-8. doi: 10.1038/aps.2011.122. Epub 2011 Oct 24.","Wang ZQ","Acta Pharmacol Sin","2011","2011/10/25","PMC4010209","","10.1038/aps.2011.122"
"17622071","[Bladder cancer and neurogenic bladder]","Ruffion A, Comperat E, Roupret M, Chartier-Kastler E.","Prog Urol. 2007 May;17(3):431-5. doi: 10.1016/s1166-7087(07)92342-8.","Ruffion A","Prog Urol","2007","2007/07/12","","","10.1016/s1166-7087(07)92342-8"
"14751352","Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution","Peyromaure M, Slama J, Beuzeboc P, Ponvert D, Debré B, Zerbib M.","Urology. 2004 Jan;63(1):73-7. doi: 10.1016/j.urology.2003.09.018.","Peyromaure M","Urology","2004","2004/01/31","","","10.1016/j.urology.2003.09.018"
"7750530","BCG treatment of existing Ta, T1 tumours or carcinoma in situ of the bladder","Akaza H.","Eur Urol. 1995;27 Suppl 1:9-12. doi: 10.1159/000475202.","Akaza H","Eur Urol","1995","1995/01/01","","","10.1159/000475202"
"31608691","[Molecular subtype classification of urothelial bladder cancer and its clinical relevance]","Szarvas T, Oláh C, Riesz P, Géczi L, Nyirády P.","Orv Hetil. 2019 Oct;160(42):1647-1654. doi: 10.1556/650.2019.31559.","Szarvas T","Orv Hetil","2019","2019/10/15","","","10.1556/650.2019.31559"
"23458775","Guanidino anthrathiophenediones as G-quadruplex binders: uptake, intracellular localization, and anti-Harvey-Ras gene activity in bladder cancer cells","Cogoi S, Shchekotikhin AE, Membrino A, Sinkevich YB, Xodo LE.","J Med Chem. 2013 Apr 11;56(7):2764-78. doi: 10.1021/jm3019063. Epub 2013 Mar 21.","Cogoi S","J Med Chem","2013","2013/03/06","","","10.1021/jm3019063"
"19537062","[Prognostic factors for survival in patients with transitional bladder cancer treated with radical cystectomy]","Monzó Gardiner JI, Herranz Amo F, Díez Cordero JM, Cabello Benavente R, Silmi Moyano A, Hernández Fernández C.","Actas Urol Esp. 2009 Mar;33(3):249-57. doi: 10.1016/s0210-4806(09)74138-5.","Monzó Gardiner JI","Actas Urol Esp","2009","2009/06/20","","","10.1016/s0210-4806(09)74138-5"
"12057106","Locally advanced and metastatic bladder cancer","Dreicer R.","Curr Treat Options Oncol. 2001 Oct;2(5):431-6. doi: 10.1007/s11864-001-0048-y.","Dreicer R","Curr Treat Options Oncol","2001","2002/06/12","","","10.1007/s11864-001-0048-y"
"18707871","Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men","Larsson SC, Andersson SO, Johansson JE, Wolk A.","Eur J Cancer. 2008 Nov;44(17):2655-60. doi: 10.1016/j.ejca.2008.07.012. Epub 2008 Aug 15.","Larsson SC","Eur J Cancer","2008","2008/08/19","","","10.1016/j.ejca.2008.07.012"
"24176953","Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis","Yang D, Liu C, Shi J, Wang N, Du X, Yin Q, Wang Y.","Gene. 2014 Jan 15;534(1):17-23. doi: 10.1016/j.gene.2013.10.038. Epub 2013 Oct 29.","Yang D","Gene","2014","2013/11/02","","","10.1016/j.gene.2013.10.038"
"4013945","[Treatment of low grade and low stage urinary bladder cancer]","Miura T, Sakuramoto T, Noguchi S, Shuin T, Moriyama M, Kubota Y.","Hinyokika Kiyo. 1985 Feb;31(2):265-71.","Miura T","Hinyokika Kiyo","1985","1985/02/01","","",""
"30269149","Value of a Marker Lesion in Non-Muscle-Invasive Bladder Cancer Patients Treated with Interleukin-2 Instillations: A Randomized Controlled Multicentre Trial","Bosschieter J, Nieuwenhuijzen JA, Hentschel A, Vis AN, Lissenberg-Witte BI, den Otter W, van Moorselaar RJA.","Urol Int. 2019;102(1):69-76. doi: 10.1159/000493159. Epub 2018 Sep 28.","Bosschieter J","Urol Int","2019","2018/10/01","","","10.1159/000493159"
"31870696","Sex and the Diagnostic Pathway to Bladder Cancer among Veterans: No Evidence of Disparity","Lynch KE, Viernes B, Khader K, DuVall SL, Schroeck FR.","Womens Health Issues. 2020 Mar-Apr;30(2):128-135. doi: 10.1016/j.whi.2019.11.001. Epub 2019 Dec 24.","Lynch KE","Womens Health Issues","2020","2019/12/25","","","10.1016/j.whi.2019.11.001"
"24206206","A new method for detecting urinary bladder cancer by using FDG PET/CT","Chen YK, Yeh CH, Su CT, Tsui CC, Cheng RH, Hung GU, Kao CH.","Technol Cancer Res Treat. 2014 Aug;13(4):369-76. doi: 10.7785/tcrt.2012.500383. Epub 2013 Nov 4.","Chen YK","Technol Cancer Res Treat","2014","2013/11/12","","","10.7785/tcrt.2012.500383"
"12496060","Dietary soy and increased risk of bladder cancer: the Singapore Chinese Health Study","Sun CL, Yuan JM, Arakawa K, Low SH, Lee HP, Yu MC.","Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1674-7.","Sun CL","Cancer Epidemiol Biomarkers Prev","2002","2002/12/24","","",""
"16938461","Cytokine gene polymorphisms can alter the effect of Bacillus Calmette-Guérin (BCG) immunotherapy","Basturk B, Yavascaoglu I, Oral B, Göral G, Oktay B.","Cytokine. 2006 Jul;35(1-2):1-5. doi: 10.1016/j.cyto.2006.06.009. Epub 2006 Aug 30.","Basturk B","Cytokine","2006","2006/08/30","","","10.1016/j.cyto.2006.06.009"
"12442923","Cell cycle inhibitors and outcome after radiotherapy in bladder cancer patients","Røtterud R, Pettersen EO, Berner A, Holm R, Olsen DR, Fosså SD.","Acta Oncol. 2002;41(5):463-70. doi: 10.1080/028418602320405069.","Røtterud R","Acta Oncol","2002","2002/11/22","","","10.1080/028418602320405069"
"31843138","Tobacco carcinogens and the methionine metabolism in human bladder cancer","Wojtczyk-Miaskowska A, Schlichtholz B.","Mutat Res. 2019 Oct-Dec;782:108281. doi: 10.1016/j.mrrev.2019.06.001. Epub 2019 Jun 4.","Wojtczyk-Miaskowska A","Mutat Res","2019","2019/12/18","","","10.1016/j.mrrev.2019.06.001"
"25562196","Developing urinary metabolomic signatures as early bladder cancer diagnostic markers","Shen C, Sun Z, Chen D, Su X, Jiang J, Li G, Lin B, Yan J.","OMICS. 2015 Jan;19(1):1-11. doi: 10.1089/omi.2014.0116.","Shen C","OMICS","2015","2015/01/07","PMC4281851","","10.1089/omi.2014.0116"
"14642031","Laparoscopy-assisted robotic radical cystoprostatectomy with ileal conduit urinary diversion for muscle-invasive bladder cancer: initial two cases","Yohannes P, Puri V, Yi B, Khan AK, Sudan R.","J Endourol. 2003 Nov;17(9):729-32. doi: 10.1089/089277903770802254.","Yohannes P","J Endourol","2003","2003/12/04","","","10.1089/089277903770802254"
"12415631","Lymphocyte activation by granulocyte macrophage-colony stimulating factor in human bladder cancer","Theano T, Pelagia S, Konstantinos N, Petros K, Alfred B, Konstantinos D, Panagiotis G.","J Exp Ther Oncol. 2002 May-Jun;2(3):153-7. doi: 10.1046/j.1359-4117.2002.01008.x.","Theano T","J Exp Ther Oncol","2002","2002/11/06","","","10.1046/j.1359-4117.2002.01008.x"
"25597161","Urothelial carcinoma of the urinary bladder mixed with squamous differentiation or squamous cell carcinoma in areas with schistosomiasis is showing high risk of recurrence and poor survival","Wishahi M, Elganzoury H, Elhouly A, Badawi M.","J Egypt Soc Parasitol. 2014 Aug;44(2):467-73.","Wishahi M","J Egypt Soc Parasitol","2014","2015/01/20","","",""
"22781846","Catheter-assisted 18F-FDG-PET/CT imaging of primary bladder cancer: a prospective study","Mertens LS, Bruin NM, Vegt E, de Blok WM, Fioole-Bruining A, van Rhijn BW, Horenblas S, Vogel WV.","Nucl Med Commun. 2012 Nov;33(11):1195-201. doi: 10.1097/MNM.0b013e3283567473.","Mertens LS","Nucl Med Commun","2012","2012/07/12","","","10.1097/MNM.0b013e3283567473"
"23674087","Does age really matter in the choice of treatment for bladder cancer?","Dal Moro F, Rossi A, Zattoni F.","Br J Cancer. 2013 Jun 11;108(11):2415-6. doi: 10.1038/bjc.2013.239. Epub 2013 May 14.","Dal Moro F","Br J Cancer","2013","2013/05/16","PMC3681024","","10.1038/bjc.2013.239"
"30864906","Re: Outcomes of Radiosensitisation in Elderly Patients with Advanced Bladder Cancer","Griebling TL.","J Urol. 2019 Jun;201(6):1034. doi: 10.1097/01.JU.0000554634.73867.12.","Griebling TL","J Urol","2019","2019/03/14","","","10.1097/01.JU.0000554634.73867.12"
"25224447","Bladder cancer: benefits of trimodal OMC regimen","Phillips R.","Nat Rev Urol. 2014 Nov;11(11):607. doi: 10.1038/nrurol.2014.258. Epub 2014 Sep 16.","Phillips R","Nat Rev Urol","2014","2014/09/17","","","10.1038/nrurol.2014.258"
"8167481","BCG vaccine in superficial bladder cancer","Sharma N, Prescott S.","BMJ. 1994 Mar 26;308(6932):801-2. doi: 10.1136/bmj.308.6932.801.","Sharma N","BMJ","1994","1994/03/26","PMC2539986","","10.1136/bmj.308.6932.801"
"21586619","Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments","Chung W, Bondaruk J, Jelinek J, Lotan Y, Liang S, Czerniak B, Issa JP.","Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1483-91. doi: 10.1158/1055-9965.EPI-11-0067. Epub 2011 May 17.","Chung W","Cancer Epidemiol Biomarkers Prev","2011","2011/05/19","PMC3132294","NIHMS297799","10.1158/1055-9965.EPI-11-0067"
"2706136","Chemotherapy in invasive carcinoma of the bladder. A review of phase II trials in Egypt","Gad-el-Mawla N, Hamza MR, Zikri ZK, el-Serafi M, el-Khodary A, Khaled H, Abdel-Wareth A.","Acta Oncol. 1989;28(1):73-6. doi: 10.3109/02841868909111185.","Gad-el-Mawla N","Acta Oncol","1989","1989/01/01","","","10.3109/02841868909111185"
"6987189","Luminal plasma membrane alterations in bladder cancer","Caruthers JM, Bonneville MA.","Invest Urol. 1980 Mar;17(5):364-72.","Caruthers JM","Invest Urol","1980","1980/03/01","","",""
"25974985","Flow cytometric study of cell cycle and DNA ploidy in bilharzial bladder cancer","El-Gamal EM, Gouida MS.","Clin Lab. 2015;61(3-4):211-8. doi: 10.7754/clin.lab.2014.140609.","El-Gamal EM","Clin Lab","2015","2015/05/16","","","10.7754/clin.lab.2014.140609"
"16380991","Fruit consumption reduces the effect of smoking on bladder cancer risk. The Belgian case control study on bladder cancer","Kellen E, Zeegers M, Paulussen A, Van Dongen M, Buntinx F.","Int J Cancer. 2006 May 15;118(10):2572-8. doi: 10.1002/ijc.21714.","Kellen E","Int J Cancer","2006","2005/12/29","","","10.1002/ijc.21714"
"6446345","Bladder cancer as a prescribed industrial disease","Darby FJ.","Br Med J. 1980 May 17;280(6225):1229-30. doi: 10.1136/bmj.280.6225.1229-c.","Darby FJ","Br Med J","1980","1980/05/17","PMC1601492","","10.1136/bmj.280.6225.1229-c"
"16517187","Enhanced formation of nitric oxide in bladder carcinoma in situ and in BCG treated bladder cancer","Hosseini A, Koskela LR, Ehrén I, Aguilar-Santelises M, Sirsjö A, Wiklund NP.","Nitric Oxide. 2006 Dec;15(4):337-43. doi: 10.1016/j.niox.2006.01.007. Epub 2006 Mar 6.","Hosseini A","Nitric Oxide","2006","2006/03/07","","","10.1016/j.niox.2006.01.007"
"31131537","Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition","Yuan W, Zhou R, Wang J, Han J, Yang X, Yu H, Lu H, Zhang X, Li P, Tao J, Wei J, Lu Q, Yang H, Gu M.","Mol Oncol. 2019 Jul;13(7):1559-1576. doi: 10.1002/1878-0261.12523. Epub 2019 Jun 9.","Yuan W","Mol Oncol","2019","2019/05/28","PMC6599840","","10.1002/1878-0261.12523"
"10037373","The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer","Sadek S, Soloway MS, Hook S, Civantos F.","J Urol. 1999 Jan;161(1):77-9; discussion 79-80.","Sadek S","J Urol","1999","1999/02/26","","",""
"16321468","Detection of immune responses against urinary bladder cancer in sentinel lymph nodes","Marits P, Karlsson M, Sherif A, Garske U, Thörn M, Winqvist O.","Eur Urol. 2006 Jan;49(1):59-70. doi: 10.1016/j.eururo.2005.09.010. Epub 2005 Nov 14.","Marits P","Eur Urol","2006","2005/12/03","","","10.1016/j.eururo.2005.09.010"
"29168217","Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic review","Ismail S, Karsenty G, Chartier-Kastler E, Cussenot O, Compérat E, Rouprêt M, Phé V.","Neurourol Urodyn. 2018 Apr;37(4):1386-1395. doi: 10.1002/nau.23457. Epub 2017 Nov 23.","Ismail S","Neurourol Urodyn","2018","2017/11/24","","","10.1002/nau.23457"
"18119889","Cancer of the urinary bladder","LEWIS LG.","J Natl Cancer Inst. 1949 May;1(7):25-8.","LEWIS LG","J Natl Cancer Inst","1949","1949/05/01","","",""
"10619940","Quality of life after radical cystectomy and orthotopic bladder substitution: a comparison between Italian and Swedish men","Månsson A, Caruso A, Capovilla E, Colleen S, Bassi P, Pagano F, Månsson W.","BJU Int. 2000 Jan;85(1):26-31. doi: 10.1046/j.1464-410x.2000.00416.x.","Månsson A","BJU Int","2000","2000/01/05","","","10.1046/j.1464-410x.2000.00416.x"
"11520271","Conserved genetic findings in metastatic bladder cancer: a possible utility of allelic loss of chromosomes 9p21 and 17p13 in diagnosis","Cheng L, Bostwick DG, Li G, Zhang S, Vortmeyer AO, Zhuang Z.","Arch Pathol Lab Med. 2001 Sep;125(9):1197-9. doi: 10.1043/0003-9985(2001)125<1197:CGFIMB>2.0.CO;2.","Cheng L","Arch Pathol Lab Med","2001","2001/08/25","","","10.1043/0003-9985(2001)125<1197:CGFIMB>2.0.CO;2"
"1491179","Simultaneous determination of urinary CEA, ferritin and TPA in Egyptian bladder cancer patients","Halim AB, el-Ahmady O, Hamza S, Aboul-Ela M, Oehr P.","Int J Biol Markers. 1992 Oct-Dec;7(4):234-9.","Halim AB","Int J Biol Markers","1992","1992/10/01","","",""
"19783793","Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer","Moreira JM, Ohlsson G, Gromov P, Simon R, Sauter G, Celis JE, Gromova I.","Mol Cell Proteomics. 2010 Jan;9(1):161-77. doi: 10.1074/mcp.M900294-MCP200. Epub 2009 Sep 25.","Moreira JM","Mol Cell Proteomics","2010","2009/09/29","PMC2808262","","10.1074/mcp.M900294-MCP200"
"4452965","[Cancer of the bladder]","Couvelaire R.","J Radiol Electrol Med Nucl. 1974 Nov;55(11):821-2.","Couvelaire R","J Radiol Electrol Med Nucl","1974","1974/11/01","","",""
"31101578","Comparison of Different Treatment Modalities Outcomes in Clinically Node-positive Bladder Cancer: Analysis of a Population-based Cancer Registry","Staník M, Poprach A, Zapletalová M, Krejčí D, Macík D, Čapák I, Jarkovský J, Lakomý R, Doležel J.","Clin Genitourin Cancer. 2019 Aug;17(4):e759-e767. doi: 10.1016/j.clgc.2019.04.007. Epub 2019 Apr 16.","Staník M","Clin Genitourin Cancer","2019","2019/05/19","","","10.1016/j.clgc.2019.04.007"
"21693249","Association between urothelial carcinoma after renal transplantation and infection by human papillomavirus types 16 and 18","Xiao J, Zhu X, Hao GY, Zhu YC, Ma LL, Zhang YH, Tian Y.","Transplant Proc. 2011 Jun;43(5):1638-40. doi: 10.1016/j.transproceed.2011.03.053.","Xiao J","Transplant Proc","2011","2011/06/23","","","10.1016/j.transproceed.2011.03.053"
"26939677","The safety and efficacy of bladder cryoablation in a beagle model by using a novel balloon cryoprobe","Liu S, Zou L, Mao S, Zhang L, Xu H, Yang T, Jiang H, Ding Q.","Cryobiology. 2016 Apr;72(2):157-60. doi: 10.1016/j.cryobiol.2016.02.007. Epub 2016 Mar 3.","Liu S","Cryobiology","2016","2016/03/05","","","10.1016/j.cryobiol.2016.02.007"
"880952","Fluorescence urinary cytology in bladder cancer","Martinez-Piñeiro JA, Muntanola P, Martin MG, Hidalgo L.","Eur Urol. 1977;3(3):142-4. doi: 10.1159/000472079.","Martinez-Piñeiro JA","Eur Urol","1977","1977/01/01","","","10.1159/000472079"
"29342465","De Novo Bladder Urothelial Neoplasm in Renal Transplant Recipients: A Retrospective, Multicentered Study","Palazzetti A, Bosio A, Dalmasso E, Destefanis P, Fop F, Pisano F, Segoloni G, Biancone L, Volpe A, Di Domenico A, Terrone C, Iesari S, Famulari A, Todeschini P, Frea B, Gontero P.","Urol Int. 2018;100(2):185-192. doi: 10.1159/000481917. Epub 2018 Jan 17.","Palazzetti A","Urol Int","2018","2018/01/18","","","10.1159/000481917"
"30840335","Delays in radical cystectomy for muscle-invasive bladder cancer","Chu AT, Holt SK, Wright JL, Ramos JD, Grivas P, Yu EY, Gore JL.","Cancer. 2019 Jun 15;125(12):2011-2017. doi: 10.1002/cncr.32048. Epub 2019 Mar 6.","Chu AT","Cancer","2019","2019/03/07","","","10.1002/cncr.32048"
"21552038","FDG PET/CT incidental diagnosis of a synchronous bladder cancer as a fourth malignancy in a patient with head and neck cancer","Osman MM, Altinyay ME, Abdelmalik AG, Brickman TM, Varvares MA, Nguyen NC.","Clin Nucl Med. 2011 Jun;36(6):496-7. doi: 10.1097/RLU.0b013e318217393f.","Osman MM","Clin Nucl Med","2011","2011/05/10","","","10.1097/RLU.0b013e318217393f"
"24825727","Prostate cancer incidence on cystoprostatectomy specimens is directly linked to age: results from a multicentre study","Pignot G, Salomon L, Lebacle C, Neuzillet Y, Lunardi P, Rischmann P, Zerbib M, Champy C, Roupret M, Peyronnet B, Verhoest G, Murez T, Quintens H, Larré S, Houédé N, Compérat E, Soulié M, Pfister C.","BJU Int. 2015 Jan;115(1):87-93. doi: 10.1111/bju.12803. Epub 2014 Aug 11.","Pignot G","BJU Int","2015","2014/05/15","","","10.1111/bju.12803"
"30535715","Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European Organization of Research and Treatment of Cancer scoring system","Kim HS, Jeong CW, Kwak C, Kim HH, Ku JH.","World J Urol. 2019 Sep;37(9):1867-1877. doi: 10.1007/s00345-018-2581-3. Epub 2018 Dec 10.","Kim HS","World J Urol","2019","2018/12/12","","","10.1007/s00345-018-2581-3"
"21586890","[The prognostic significance of human equilibrative nucleoside transporter1 (hENT1) expression in metastatic bladder cancer patients treated with gemcitabine-cisplatin based combination chemotherapy]","Matsumura N, Hara I.","Hinyokika Kiyo. 2011 Mar;57(3):157-61.","Matsumura N","Hinyokika Kiyo","2011","2011/05/19","","",""
"28680010","Apparent diffusion coefficient on magnetic resonance imaging (MRI) in bladder cancer: relations with recurrence/progression risk","Kikuchi K, Shigihara T, Hashimoto Y, Miyajima M, Haga N, Kojima Y, Shishido F.","Fukushima J Med Sci. 2017 Aug 9;63(2):90-99. doi: 10.5387/fms.2017-05. Epub 2017 Jul 5.","Kikuchi K","Fukushima J Med Sci","2017","2017/07/07","PMC5597528","","10.5387/fms.2017-05"
"19914698","Impact of comorbidity on survival of invasive bladder cancer patients, 1996-2007: a Danish population-based cohort study","Lund L, Jacobsen J, Clark P, Borre M, Nørgaard M; Northern Danish Cancer Quality Assessment Group.","Urology. 2010 Feb;75(2):393-8. doi: 10.1016/j.urology.2009.07.1320. Epub 2009 Nov 14.","Lund L","Urology","2010","2009/11/17","","","10.1016/j.urology.2009.07.1320"
"2793238","Bladder cancer and occupational exposure to polycyclic aromatic hydrocarbons","Bonassi S, Merlo F, Pearce N, Puntoni R.","Int J Cancer. 1989 Oct 15;44(4):648-51. doi: 10.1002/ijc.2910440415.","Bonassi S","Int J Cancer","1989","1989/10/15","","","10.1002/ijc.2910440415"
"25715815","Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guérin","Baltacı S, Bozlu M, Yıldırım A, Gökçe Mİ, Tinay İ, Aslan G, Can C, Türkeri L, Kuyumcuoğlu U, Mungan A.","BJU Int. 2015 Nov;116(5):721-6. doi: 10.1111/bju.13102. Epub 2015 May 11.","Baltacı S","BJU Int","2015","2015/02/27","","","10.1111/bju.13102"
"27863434","A microRNA biomarker panel for the non-invasive detection of bladder cancer","Urquidi V, Netherton M, Gomes-Giacoia E, Serie DJ, Eckel-Passow J, Rosser CJ, Goodison S.","Oncotarget. 2016 Dec 27;7(52):86290-86299. doi: 10.18632/oncotarget.13382.","Urquidi V","Oncotarget","2016","2016/11/19","PMC5349914","","10.18632/oncotarget.13382"
"10411055","Against bladder sparing: surgery","Montie JE.","J Urol. 1999 Aug;162(2):452-5; discussion 455-7.","Montie JE","J Urol","1999","1999/07/20","","",""
"10226834","Analysis of prognostic factors related to primary superficial bladder cancer tumor recurrence in prophylactic intravesical epirubicin therapy","Kondo T, Onitsuka S, Ryoji O, Kihara T, Goto Y, Satoh T, Nakazawa H, Toma H.","Int J Urol. 1999 Apr;6(4):178-83. doi: 10.1046/j.1442-2042.1999.06441.x.","Kondo T","Int J Urol","1999","1999/05/05","","","10.1046/j.1442-2042.1999.06441.x"
"2305493","DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO)","Lipponen PK, Eskelinen MJ, Collan Y, Pesonen E, Ventilä T, Sotarauta M, Nordling S.","Urol Int. 1990;45(1):4-9. doi: 10.1159/000281649.","Lipponen PK","Urol Int","1990","1990/01/01","","","10.1159/000281649"
"19579886","[EAU guidelines on non-muscle-carcinoma of the bladder]","Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J; Asociación Europea de Urología.","Actas Urol Esp. 2009 Apr;33(4):361-71. doi: 10.1016/s0210-4806(09)74161-0.","Babjuk M","Actas Urol Esp","2009","2009/07/08","","","10.1016/s0210-4806(09)74161-0"
"16406961","Eliminate the term ""superficial"" bladder cancer","Nieder AM, Soloway MS.","J Urol. 2006 Feb;175(2):417-8. doi: 10.1016/S0022-5347(05)00290-9.","Nieder AM","J Urol","2006","2006/01/13","","","10.1016/S0022-5347(05)00290-9"
"24395618","It's in your blood: spectral biomarker candidates for urinary bladder cancer from automated FTIR spectroscopy","Ollesch J, Heinze M, Heise HM, Behrens T, Brüning T, Gerwert K.","J Biophotonics. 2014 Apr;7(3-4):210-21. doi: 10.1002/jbio.201300163. Epub 2014 Jan 7.","Ollesch J","J Biophotonics","2014","2014/01/08","","","10.1002/jbio.201300163"
"20600831","BLT2 promotes the invasion and metastasis of aggressive bladder cancer cells through a reactive oxygen species-linked pathway","Kim EY, Seo JM, Kim C, Lee JE, Lee KM, Kim JH.","Free Radic Biol Med. 2010 Sep 15;49(6):1072-81. doi: 10.1016/j.freeradbiomed.2010.06.023. Epub 2010 Jun 28.","Kim EY","Free Radic Biol Med","2010","2010/07/06","","","10.1016/j.freeradbiomed.2010.06.023"
"24119175","External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder","Al-Daghmin A, English S, Kauffman EC, Din R, Khan A, Syed JR, Sztorc J, Mehedint D, Sharif M, Shi Y, Wilding G, Guru KA.","BJU Int. 2014 Aug;114(2):253-60. doi: 10.1111/bju.12484. Epub 2014 Jan 22.","Al-Daghmin A","BJU Int","2014","2013/10/15","","","10.1111/bju.12484"
"30811419","Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score","Simon M, Bosset PO, Rouanne M, Benhamou S, Radulescu C, Molinié V, Neuzillet Y, Paoletti X, Lebret T.","PLoS One. 2019 Feb 27;14(2):e0211721. doi: 10.1371/journal.pone.0211721. eCollection 2019.","Simon M","PLoS One","2019","2019/02/28","PMC6392242","","10.1371/journal.pone.0211721"
"9231929","Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy","Hoskin PJ, Saunders MI, Phillips H, Cladd H, Powell ME, Goodchild K, Stratford MR, Rojas A.","Br J Cancer. 1997;76(2):260-3. doi: 10.1038/bjc.1997.372.","Hoskin PJ","Br J Cancer","1997","1997/01/01","PMC2223941","","10.1038/bjc.1997.372"
"20647380","Bladder cancer risk in painters: a meta-analysis","Guha N, Steenland NK, Merletti F, Altieri A, Cogliano V, Straif K.","Occup Environ Med. 2010 Aug;67(8):568-73. doi: 10.1136/oem.2009.051565.","Guha N","Occup Environ Med","2010","2010/07/22","","","10.1136/oem.2009.051565"
"24552248","Relationships between CYP1A1 genetic polymorphisms and bladder cancer risk: a meta-analysis","Wang Y, Kong CZ, Zhang Z, Yang CM, Li J.","DNA Cell Biol. 2014 Mar;33(3):171-81. doi: 10.1089/dna.2013.2298. Epub 2014 Feb 19.","Wang Y","DNA Cell Biol","2014","2014/02/21","","","10.1089/dna.2013.2298"
"30414698","A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer","Goodspeed A, Jean A, Costello JC.","Eur Urol. 2019 Feb;75(2):242-250. doi: 10.1016/j.eururo.2018.10.040. Epub 2018 Nov 7.","Goodspeed A","Eur Urol","2019","2018/11/12","PMC6339584","NIHMS1510205","10.1016/j.eururo.2018.10.040"
"994212","Abnormal tryptophan metabolism in a family with a history of bladder cancer","Leklem JE, Brown RR.","J Natl Cancer Inst. 1976 Jun;56(6):1101-4. doi: 10.1093/jnci/56.6.1101.","Leklem JE","J Natl Cancer Inst","1976","1976/06/01","","","10.1093/jnci/56.6.1101"
"28501564","Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin","Schmid SC, Sathe A, Guerth F, Seitz AK, Heck MM, Maurer T, Schwarzenböck SM, Krause BJ, Schulz WA, Stoehr R, Gschwend JE, Retz M; German Bladder Cancer Network, Nawroth R.","Urol Oncol. 2017 Sep;35(9):544.e1-544.e10. doi: 10.1016/j.urolonc.2017.04.015. Epub 2017 May 10.","Schmid SC","Urol Oncol","2017","2017/05/15","","","10.1016/j.urolonc.2017.04.015"
"7351717","Salvage cystectomy after irradiation failure","Crawford ED, Skinner DG.","J Urol. 1980 Jan;123(1):32-4. doi: 10.1016/s0022-5347(17)55765-1.","Crawford ED","J Urol","1980","1980/01/01","","","10.1016/s0022-5347(17)55765-1"
"11801538","Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer","Utting M, Werner W, Dahse R, Schubert J, Junker K.","Clin Cancer Res. 2002 Jan;8(1):35-40.","Utting M","Clin Cancer Res","2002","2002/01/22","","",""
"20007063","Cutaneous sarcoid reaction in a patient with bladder cancer","Yukawa M, Satoh T, Takayama K, Yokozeki H.","Eur J Dermatol. 2010 Mar-Apr;20(2):235. doi: 10.1684/ejd.2010.0867. Epub 2009 Dec 14.","Yukawa M","Eur J Dermatol","2010","2009/12/17","","","10.1684/ejd.2010.0867"
"21854101","Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: a Swedish population-based survey","Liedberg F, Holmberg E, Holmäng S, Ljungberg B, Malmström PU, Månsson W, Nunez L, Wessman C, Wijkström H, Jahnson S.","Scand J Urol Nephrol. 2012 Feb;46(1):14-8. doi: 10.3109/00365599.2011.609835. Epub 2011 Aug 19.","Liedberg F","Scand J Urol Nephrol","2012","2011/08/23","","","10.3109/00365599.2011.609835"
"20018352","Bladder preservation in octogenarians with invasive bladder cancer","Wehrberger C, Berger I, Marszalek M, Ponholzer A, Wehrberger M, Rauchenwald M, Madersbacher S.","Urology. 2010 Feb;75(2):370-5. doi: 10.1016/j.urology.2009.10.027.","Wehrberger C","Urology","2010","2009/12/19","","","10.1016/j.urology.2009.10.027"
"27737712","Long term disease free survival with multimodal therapy in small cell bladder cancer","Heidegger I, Tulchiner G, Schäfer G, Horninger W, Pichler R.","Eur J Med Res. 2016 Oct 13;21(1):40. doi: 10.1186/s40001-016-0234-9.","Heidegger I","Eur J Med Res","2016","2016/10/15","PMC5064780","","10.1186/s40001-016-0234-9"
"30248710","Considering Relationship of Proteins for Radiotherapy Prognosis of Bladder Cancer Cells in Small Data Set","Tsai TI, Zhang Y, Zhang Z, Chao GY, Tsai CC.","Methods Inf Med. 2018 Sep;57(4):220-229. doi: 10.3414/ME17-02-0003. Epub 2018 Sep 24.","Tsai TI","Methods Inf Med","2018","2018/09/25","","","10.3414/ME17-02-0003"
"6539997","Current status of adjuvant chemotherapy after radical cystectomy for deeply invasive bladder cancer","Skinner DG, Daniels JR, Lieskovsky G.","Urology. 1984 Jul;24(1):46-52. doi: 10.1016/0090-4295(84)90387-x.","Skinner DG","Urology","1984","1984/07/01","","","10.1016/0090-4295(84)90387-x"
"25168574","Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): a population-based study of bladder cancer","Booth CM, Siemens DR, Wei X, Peng Y, Berman DM, Mackillop WJ.","BJU Int. 2015 Sep;116(3):373-81. doi: 10.1111/bju.12913. Epub 2014 Dec 29.","Booth CM","BJU Int","2015","2014/08/30","","","10.1111/bju.12913"
"4053003","Long-term effect of 2-hydroxyethyl retinamide on urinary bladder carcinogenesis and tumor transplantation in Fischer 344 rats","Quander RV, Leary SL, Strandberg JD, Yarbrough BA, Squire RA.","Cancer Res. 1985 Nov;45(11 Pt 1):5235-9.","Quander RV","Cancer Res","1985","1985/11/01","","",""
"31043379","Smoking Cessation and the Risk of Bladder Cancer among Postmenopausal Women","Li Y, Tindle HA, Hendryx MS, Xun P, He K, Liang X, Luo J.","Cancer Prev Res (Phila). 2019 May;12(5):305-314. doi: 10.1158/1940-6207.CAPR-18-0441.","Li Y","Cancer Prev Res (Phila)","2019","2019/05/03","","","10.1158/1940-6207.CAPR-18-0441"
"28641488","UCA1 involved in the metformin-regulated bladder cancer cell proliferation and glycolysis","Li T, Sun X, Jiang X.","Tumour Biol. 2017 Jun;39(6):1010428317710823. doi: 10.1177/1010428317710823.","Li T","Tumour Biol","2017","2017/06/24","","","10.1177/1010428317710823"
"7697976","Surgery in the management of bladder cancer","Esrig D, Freeman JA, Stein JP, Skinner DG.","Compr Ther. 1995;21(1):20-4.","Esrig D","Compr Ther","1995","1995/01/01","","",""
"6169866","[Hyperthermic therapy of the bladder cancer. II. The kinetics of cell killing by hyperthermia plus bleomycin (author's transl)]","Kubota Y.","Nihon Hinyokika Gakkai Zasshi. 1981 Jun;72(6):735-41.","Kubota Y","Nihon Hinyokika Gakkai Zasshi","1981","1981/06/01","","",""
"21896987","Role of p53 gene polymorphism and bladder cancer predisposition in northern India","Srivastava P, Jaiswal PK, Singh V, Mittal RD.","Cancer Biomark. 2010-2011;8(1):21-8. doi: 10.3233/DMA-2011-0816.","Srivastava P","Cancer Biomark","2010","2011/09/08","","","10.3233/DMA-2011-0816"
"2114385","The effect of high-energy underwater shock waves on implanted urinary bladder cancer in rabbits","Hosi S, Orikasa S, Kuwahara M, Yoshikawa K, Ohyama C, Satoh M, Kawamura S, Nose M.","Jpn J Cancer Res. 1990 Apr;81(4):317-9. doi: 10.1111/j.1349-7006.1990.tb02568.x.","Hosi S","Jpn J Cancer Res","1990","1990/04/01","PMC5918054","","10.1111/j.1349-7006.1990.tb02568.x"
"6699985","Immune complexes in urine and serum of patients with bladder cancer","Babaian RJ, Watson DA, Jones JM.","J Urol. 1984 Mar;131(3):463-6. doi: 10.1016/s0022-5347(17)50452-8.","Babaian RJ","J Urol","1984","1984/03/01","","","10.1016/s0022-5347(17)50452-8"
"31757297","Predictors of Response to Intravesical Therapy","Li R, Kamat AM.","Urol Clin North Am. 2020 Feb;47(1):23-33. doi: 10.1016/j.ucl.2019.09.005.","Li R","Urol Clin North Am","2020","2019/11/24","","","10.1016/j.ucl.2019.09.005"
"30818082","The landscape of chimeric RNAs in bladder urothelial carcinoma","Zhu D, Singh S, Chen X, Zheng Z, Huang J, Lin T, Li H.","Int J Biochem Cell Biol. 2019 May;110:50-58. doi: 10.1016/j.biocel.2019.02.007. Epub 2019 Feb 25.","Zhu D","Int J Biochem Cell Biol","2019","2019/03/01","","","10.1016/j.biocel.2019.02.007"
"23773798","Short-term patient reported health-related quality of life (HRQL) outcomes after robot-assisted radical cystectomy (RARC)","Poch MA, Stegemann AP, Rehman S, Sharif MA, Hussain A, Consiglio JD, Wilding GE, Guru KA.","BJU Int. 2014 Feb;113(2):260-5. doi: 10.1111/bju.12162. Epub 2013 Jun 14.","Poch MA","BJU Int","2014","2013/06/19","","","10.1111/bju.12162"
"30922406","Three-dimensional histopathological reconstruction of bladder tumours","Jansen I, Lucas M, Savci-Heijink CD, Meijer SL, Liem EIML, de Boer OJ, van Leeuwen TG, Marquering HA, de Bruin DM.","Diagn Pathol. 2019 Mar 28;14(1):25. doi: 10.1186/s13000-019-0803-7.","Jansen I","Diagn Pathol","2019","2019/03/30","PMC6440143","","10.1186/s13000-019-0803-7"
"1591726","Antibody drug carrier for immunotherapy of superficial bladder cancer: ultrastructural studies","de Harven E, Fradet Y, Connolly JG, Hanna W, He S, Wang Y, Choi BC, McGroarty R, Bootsma G, Tilups A, et al.","Cancer Res. 1992 Jun 1;52(11):3131-7.","de Harven E","Cancer Res","1992","1992/06/01","","",""
"30954405","The impact of postoperative inflammatory biomarkers on oncologic outcomes of bladder cancer","Albisinni S, Moussa I, Aoun F, Quackels T, Assenmacher G, Peltier A, Roumeguère T.","Prog Urol. 2019 Apr;29(5):270-281. doi: 10.1016/j.purol.2019.02.008. Epub 2019 Apr 4.","Albisinni S","Prog Urol","2019","2019/04/08","","","10.1016/j.purol.2019.02.008"
"24148819","Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development","Hsu I, Chuang KL, Slavin S, Da J, Lim WX, Pang ST, O'Brien JH, Yeh S.","Carcinogenesis. 2014 Mar;35(3):651-61. doi: 10.1093/carcin/bgt348. Epub 2013 Oct 22.","Hsu I","Carcinogenesis","2014","2013/10/24","","","10.1093/carcin/bgt348"
"2508191","Split-course radiotherapy for urinary bladder cancer","Salminen E.","Radiother Oncol. 1989 Aug;15(4):327-31. doi: 10.1016/0167-8140(89)90078-9.","Salminen E","Radiother Oncol","1989","1989/08/01","","","10.1016/0167-8140(89)90078-9"
"4970862","[Total cystectomy for bladder cancer. Results of follow-up studies]","Suzuki K, Kato M, Onodera Y, Kurosawa M, Sugawara K, Miyada K.","Kangogaku Zasshi. 1968 Sep;32(9):47-50.","Suzuki K","Kangogaku Zasshi","1968","1968/09/01","","",""
"5273706","[Myeloid leukemia associated with vesical cancer. Diagnostic and therapeutic problems]","Brizard CP, Fraisse J, Preynat P, Le Petit JC, Calcat P, Gilloz A.","J Med Lyon. 1970 Jun 5;51(188):1311-2 passim.","Brizard CP","J Med Lyon","1970","1970/06/05","","",""
"23973518","The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin","Sfakianos JP, Kim PH, Hakimi AA, Herr HW.","J Urol. 2014 Feb;191(2):341-5. doi: 10.1016/j.juro.2013.08.022. Epub 2013 Aug 20.","Sfakianos JP","J Urol","2014","2013/08/27","PMC4157345","NIHMS612282","10.1016/j.juro.2013.08.022"
"10737724","Suppressive effects of dominant negative ras mutant N116Y on transformed phenotypes of human bladder cancer cells","Watanabe T, Shinohara N, Sazawa A, Kobayashi Y, Ogiso Y, Kimura T, Takiguchi M, Yasuda J, Hashimoto A, Koyanagi T, Kuzumaki N.","Cancer Lett. 2000 Feb 28;149(1-2):195-202. doi: 10.1016/s0304-3835(99)00359-6.","Watanabe T","Cancer Lett","2000","2000/03/29","","","10.1016/s0304-3835(99)00359-6"
"17141846","Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer","Tsai HK, Katz MS, Coen JJ, Zietman AL, Kaufman DS, Shipley WU.","Urology. 2006 Dec;68(6):1188-92. doi: 10.1016/j.urology.2006.08.1078. Epub 2006 Dec 4.","Tsai HK","Urology","2006","2006/12/05","","","10.1016/j.urology.2006.08.1078"
"26010047","Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer","Baack Kukreja JE, Scosyrev E, Brasacchio RA, Toy EP, Messing EM, Wu G.","BJU Int. 2014 Dec;114(6):844-51. doi: 10.1111/bju.12543. Epub 2014 Jul 17.","Baack Kukreja JE","BJU Int","2014","2015/05/27","","","10.1111/bju.12543"
"29797794","Identification and characterization of bladder cancer by low-resolution fiber-optic Raman spectroscopy","Chen H, Li X, Broderick N, Liu Y, Zhou Y, Han J, Xu W.","J Biophotonics. 2018 Sep;11(9):e201800016. doi: 10.1002/jbio.201800016. Epub 2018 Jun 19.","Chen H","J Biophotonics","2018","2018/05/26","","","10.1002/jbio.201800016"
"30984306","High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer","Yang L, Li YL, Li XQ, Zhang Z.","Dis Markers. 2019 Mar 7;2019:4586405. doi: 10.1155/2019/4586405. eCollection 2019.","Yang L","Dis Markers","2019","2019/04/16","PMC6431528","","10.1155/2019/4586405"
"18670274","The detection of genetic markers of bladder cancer in urine and serum","Lodde M, Fradet Y.","Curr Opin Urol. 2008 Sep;18(5):499-503. doi: 10.1097/MOU.0b013e32830b86d1.","Lodde M","Curr Opin Urol","2008","2008/08/02","","","10.1097/MOU.0b013e32830b86d1"
"30506756","Impact of serum sodium concentration on survival outcomes in patients with invasive bladder cancer without metastasis treated by cystectomy","Nakata W, Yamamichi G, Tsujimura G, Tsujimoto Y, Nin M, Tsujihata M.","Int J Urol. 2019 Mar;26(3):429-431. doi: 10.1111/iju.13880. Epub 2018 Dec 2.","Nakata W","Int J Urol","2019","2018/12/04","PMC7379653","","10.1111/iju.13880"
"8449645","Bladder cancer and coffee consumption in smokers and non-smokers in Spain","Escolar Pujolar A, González CA, López-Abente G, Errezola M, Izarzugaza I, Nebot M, Riboli E.","Int J Epidemiol. 1993 Feb;22(1):38-44. doi: 10.1093/ije/22.1.38.","Escolar Pujolar A","Int J Epidemiol","1993","1993/02/01","","","10.1093/ije/22.1.38"
"28525539","Prediction of Multiple Recurrent Events: A Comparison of Extended Cox Models in Bladder Cancer","Smedinga H, Steyerberg EW, Beukers W, van Klaveren D, Zwarthoff EC, Vergouwe Y.","Am J Epidemiol. 2017 Sep 1;186(5):612-623. doi: 10.1093/aje/kwx133.","Smedinga H","Am J Epidemiol","2017","2017/05/20","","","10.1093/aje/kwx133"
"19460053","Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control","Luke C, Tracey E, Stapleton A, Roder D.","Intern Med J. 2010 May;40(5):357-62. doi: 10.1111/j.1445-5994.2009.01980.x.","Luke C","Intern Med J","2010","2009/05/23","","","10.1111/j.1445-5994.2009.01980.x"
"29212084","Perioperative Outcomes and Early Survival in Octogenarians Who Underwent Radical Cystectomy for Bladder Cancer","Zattoni F, Palumbo V, Giannarini G, Crestani A, Kungulli A, Novara G, Zattoni F, Ficarra V.","Urol Int. 2018;100(1):13-17. doi: 10.1159/000478990. Epub 2017 Dec 7.","Zattoni F","Urol Int","2018","2017/12/07","","","10.1159/000478990"
"11257649","Cystectomy for bladder cancer: a contemporary series","Dalbagni G, Genega E, Hashibe M, Zhang ZF, Russo P, Herr H, Reuter V.","J Urol. 2001 Apr;165(4):1111-6.","Dalbagni G","J Urol","2001","2001/03/21","","",""
"18028024","Prostatic transitional cell carcinoma: pathologic features and clinical management","Shen SS, Lerner SP.","Expert Rev Anticancer Ther. 2007 Aug;7(8):1155-62. doi: 10.1586/14737140.7.8.1155.","Shen SS","Expert Rev Anticancer Ther","2007","2007/11/22","","","10.1586/14737140.7.8.1155"
"25982585","Hypofractionated radiation therapy for treatment of bladder carcinoma in patients aged 90 years and more: A new paradigm to be explored?","Méry B, Falk AT, Assouline A, Trone JC, Guy JB, Rivoirard R, Auberdiac P, Escure JL, Moncharmont C, Moriceau G, Almokhles H, de Laroche G, Pacaut C, Guillot A, Chargari C, Magné N.","Int Urol Nephrol. 2015 Jul;47(7):1129-34. doi: 10.1007/s11255-015-0999-8. Epub 2015 May 17.","Méry B","Int Urol Nephrol","2015","2015/05/19","","","10.1007/s11255-015-0999-8"
"11174461","Orthotopic neobladder following cystectomy: indications, management, and outcomes","Krupski T, Theodorescu D.","J Wound Ostomy Continence Nurs. 2001 Jan;28(1):37-46. doi: 10.1067/mjw.2001.112084.","Krupski T","J Wound Ostomy Continence Nurs","2001","2001/02/15","","","10.1067/mjw.2001.112084"
"8460449","Cell and tumor markers' immunohistochemistry in transitional cell carcinoma of the bladder","Lopez-Beltran A, Croghan GA, Croghan I, Gaeta JF.","Urol Int. 1993;50(2):61-4. doi: 10.1159/000282453.","Lopez-Beltran A","Urol Int","1993","1993/01/01","","","10.1159/000282453"
"15559503","[New methods of urinary bladder cancer detection at the early stage of the disease in patients of various ages]","Kheĭfets VKh.","Adv Gerontol. 2004;14:75-8.","Kheĭfets VKh","Adv Gerontol","2004","2004/11/24","","",""
"17208142","Surgical benchmarks for the treatment of invasive bladder cancer","Skinner EC, Stein JP, Skinner DG.","Urol Oncol. 2007 Jan-Feb;25(1):66-71. doi: 10.1016/j.urolonc.2006.05.010.","Skinner EC","Urol Oncol","2007","2007/01/09","","","10.1016/j.urolonc.2006.05.010"
"29094397","High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer","Tan YG, Eu EWC, Huang HH, Lau WKO.","Int J Urol. 2018 Mar;25(3):232-238. doi: 10.1111/iju.13480. Epub 2017 Nov 1.","Tan YG","Int J Urol","2018","2017/11/03","","","10.1111/iju.13480"
"28786480","Urinary bladder cancer staging in CT urography using machine learning","Garapati SS, Hadjiiski L, Cha KH, Chan HP, Caoili EM, Cohan RH, Weizer A, Alva A, Paramagul C, Wei J, Zhou C.","Med Phys. 2017 Nov;44(11):5814-5823. doi: 10.1002/mp.12510. Epub 2017 Sep 5.","Garapati SS","Med Phys","2017","2017/08/09","PMC5689080","NIHMS898063","10.1002/mp.12510"
"23579952","Connexin 26 is down-regulated by KDM5B in the progression of bladder cancer","Li X, Su Y, Pan J, Zhou Z, Song B, Xiong E, Chen Z.","Int J Mol Sci. 2013 Apr 11;14(4):7866-79. doi: 10.3390/ijms14047866.","Li X","Int J Mol Sci","2013","2013/04/13","PMC3645721","","10.3390/ijms14047866"
"10203916","The influence of gender on incidence and outcome of patients with bladder cancer in Harlem","Hoke GP, Stone BA, Klein L, Williams KN.","J Natl Med Assoc. 1999 Mar;91(3):144-8.","Hoke GP","J Natl Med Assoc","1999","1999/04/16","PMC2608460","",""
"28766915","Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer","Sahu D, Lotan Y, Wittmann B, Neri B, Hansel DE.","Cancer Med. 2017 Sep;6(9):2106-2120. doi: 10.1002/cam4.1109. Epub 2017 Aug 1.","Sahu D","Cancer Med","2017","2017/08/03","PMC5603845","","10.1002/cam4.1109"
"17963263","Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology","Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L, Freiberger A, Lew S, Leibovitch I.","Cancer. 2007 Dec 25;111(6):517-24. doi: 10.1002/cncr.23119.","Daniely M","Cancer","2007","2007/10/30","","","10.1002/cncr.23119"
"23807662","SNAI1 protein expression is an independent negative prognosticator in muscle-invasive bladder cancer","Keck B, Wach S, Goebell PJ, Kunath F, Bertz S, Lehmann J, Stöckle M, Taubert H, Wullich B, Hartmann A.","Ann Surg Oncol. 2013 Oct;20(11):3669-74. doi: 10.1245/s10434-013-3075-6. Epub 2013 Jun 27.","Keck B","Ann Surg Oncol","2013","2013/06/29","","","10.1245/s10434-013-3075-6"
"31472011","Estimating the optimal perioperative chemotherapy utilization rate for muscle-invasive bladder cancer","Karim S, Mackillop WJ, Brennan K, Peng Y, Siemens DR, Krzyzanowska MK, Booth CM.","Cancer Med. 2019 Oct;8(14):6258-6271. doi: 10.1002/cam4.2449. Epub 2019 Aug 31.","Karim S","Cancer Med","2019","2019/09/01","PMC6797575","","10.1002/cam4.2449"
"1511915","Radio-chemotherapy for invasive carcinoma of the bladder","Shipley WU, Kaufman DS, Griffin P, Althausen AF, Heney NM, Prout GR Jr.","Front Radiat Ther Oncol. 1992;26:142-52. doi: 10.1159/000421062.","Shipley WU","Front Radiat Ther Oncol","1992","1992/01/11","","","10.1159/000421062"
"19706487","SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer","Sayan AE, Griffiths TR, Pal R, Browne GJ, Ruddick A, Yagci T, Edwards R, Mayer NJ, Qazi H, Goyal S, Fernandez S, Straatman K, Jones GD, Bowman KJ, Colquhoun A, Mellon JK, Kriajevska M, Tulchinsky E.","Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14884-9. doi: 10.1073/pnas.0902042106. Epub 2009 Aug 17.","Sayan AE","Proc Natl Acad Sci U S A","2009","2009/08/27","PMC2736415","","10.1073/pnas.0902042106"
"12010230","Delay and survival in bladder cancer","Wallace DM, Bryan RT, Dunn JA, Begum G, Bathers S; West Midlands Urological Research Group.","BJU Int. 2002 Jun;89(9):868-78. doi: 10.1046/j.1464-410x.2002.02776.x.","Wallace DM","BJU Int","2002","2002/05/16","","","10.1046/j.1464-410x.2002.02776.x"
"24140246","Gene-based urinary biomarkers for bladder cancer: an unfulfilled promise?","Sapre N, Anderson PD, Costello AJ, Hovens CM, Corcoran NM.","Urol Oncol. 2014 Jan;32(1):48.e9-17. doi: 10.1016/j.urolonc.2013.07.002. Epub 2013 Oct 17.","Sapre N","Urol Oncol","2014","2013/10/22","","","10.1016/j.urolonc.2013.07.002"
"22471489","Serum trace element levels in patients with bladder cancer","Gecit I, Kavak S, Demir H, Gunes M, Pirincci N, Cetin C, Ceylan K, Benli E, Yildiz I.","Asian Pac J Cancer Prev. 2011;12(12):3409-13.","Gecit I","Asian Pac J Cancer Prev","2011","2012/04/05","","",""
"30509988","Noninvasive diagnostic imaging using machine-learning analysis of nanoresolution images of cell surfaces: Detection of bladder cancer","Sokolov I, Dokukin ME, Kalaparthi V, Miljkovic M, Wang A, Seigne JD, Grivas P, Demidenko E.","Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12920-12925. doi: 10.1073/pnas.1816459115. Epub 2018 Dec 3.","Sokolov I","Proc Natl Acad Sci U S A","2018","2018/12/05","PMC6304950","","10.1073/pnas.1816459115"
"17760743","The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy","Kashibuchi K, Tomita K, Schalken JA, Kume H, Takeuchi T, Kitamura T.","Int J Urol. 2007 Sep;14(9):789-94. doi: 10.1111/j.1442-2042.2007.01830.x.","Kashibuchi K","Int J Urol","2007","2007/09/01","","","10.1111/j.1442-2042.2007.01830.x"
"8253519","Chemoprevention by indomethacin of tumor promotion in a rat urinary bladder carcinogenesis model","Shibata MA, Hasegawa R, Shirai T, Takesada Y, Fukushima S.","Int J Cancer. 1993 Dec 2;55(6):1011-7. doi: 10.1002/ijc.2910550622.","Shibata MA","Int J Cancer","1993","1993/12/02","","","10.1002/ijc.2910550622"
"7289320","[Hyperthermic therapy of the bladder cancer. I. Effect of the hyperthermia on the cultured bladder cancer cell lines (author's transl)]","Kubota Y.","Nihon Hinyokika Gakkai Zasshi. 1981 Jun;72(6):730-4. doi: 10.5980/jpnjurol1928.72.6_730.","Kubota Y","Nihon Hinyokika Gakkai Zasshi","1981","1981/06/01","","","10.5980/jpnjurol1928.72.6_730"
"7327381","Drug sensitivity of rat bladder cancer in syngeneic hosts and athymic nude mice","Kitagawa H, Nakamura M, Kiuchi Y, Iwaguchi T.","Gan. 1981 Oct;72(5):802-5.","Kitagawa H","Gan","1981","1981/10/01","","",""
"6384666","Peroxidase antiperoxidase versus specific red cell adherence in detection of O (H) antigen in bladder cancer: a blind study","Javadpour N, Vafrier J, Worsham GF, O'Connel K.","J Surg Oncol. 1984 Oct;27(2):112-5. doi: 10.1002/jso.2930270211.","Javadpour N","J Surg Oncol","1984","1984/10/01","","","10.1002/jso.2930270211"
"24462548","Follow-up after cystectomy: regularly scheduled, risk adjusted, or symptom guided? Patterns of recurrence, relapse presentation, and survival after cystectomy","Nieuwenhuijzen JA, de Vries RR, van Tinteren H, Bex A, Van der Poel HG, Meinhardt W, Horenblas S.","Eur J Surg Oncol. 2014 Dec;40(12):1677-85. doi: 10.1016/j.ejso.2013.12.017. Epub 2014 Jan 2.","Nieuwenhuijzen JA","Eur J Surg Oncol","2014","2014/01/28","","","10.1016/j.ejso.2013.12.017"
"3761439","A comparative evaluation of lymphoscintigraphy versus lymphangiography and computerized tomography scanning in diagnosis of lymph node metastases in advanced bladder cancer","Nissenkorn I, Winkler H, Servadio C, Melloul M, Lubin E, Idelsohn AR, Hadar H.","J Urol. 1986 Oct;136(4):825-7. doi: 10.1016/s0022-5347(17)45093-2.","Nissenkorn I","J Urol","1986","1986/10/01","","","10.1016/s0022-5347(17)45093-2"
"23522296","Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist","Hansel DE, Miller JS, Cookson MS, Chang SS.","Urology. 2013 Jun;81(6):1123-30. doi: 10.1016/j.urology.2013.01.027. Epub 2013 Mar 19.","Hansel DE","Urology","2013","2013/03/26","PMC5224832","NIHMS602112","10.1016/j.urology.2013.01.027"
"15520187","Profiling the evolution of human metastatic bladder cancer","Nicholson BE, Frierson HF, Conaway MR, Seraj JM, Harding MA, Hampton GM, Theodorescu D.","Cancer Res. 2004 Nov 1;64(21):7813-21. doi: 10.1158/0008-5472.CAN-04-0826.","Nicholson BE","Cancer Res","2004","2004/11/03","","","10.1158/0008-5472.CAN-04-0826"
"24249842","The effects of a physical exercise programme after radical cystectomy for urinary bladder cancer. A pilot randomized controlled trial","Porserud A, Sherif A, Tollbäck A.","Clin Rehabil. 2014 May;28(5):451-9. doi: 10.1177/0269215513506230. Epub 2013 Nov 18.","Porserud A","Clin Rehabil","2014","2013/11/20","","","10.1177/0269215513506230"
"29240363","Symptoms Control for Patients with Superficial Bladder Cancers Before and After TURBT and Intravesical Epirubicin Instillation","Gezginci E, Yyigun E, Yalcin S, Ozgok IY.","Urol Nurs. 2017 Jan-Feb;37(1):31-5.","Gezginci E","Urol Nurs","2017","2017/12/15","","",""
"20495334","[A case report of a patient treatable by home palliative care, administered zoledronic acid used for bladder cancer with hypercalcemia]","Murakami N, Tanabe K, Murasugi K, Kadoya S, Matsumoto Y, Yoshii I, Fujikawa Y, Ohura F.","Gan To Kagaku Ryoho. 2010 May;37(5):939-42.","Murakami N","Gan To Kagaku Ryoho","2010","2010/05/25","","",""
"22313808","The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer","Daneshmand S.","BJU Int. 2012 Jul;110(2 Pt 2):E80. doi: 10.1111/j.1464-410X.2011.10919.x. Epub 2012 Feb 7.","Daneshmand S","BJU Int","2012","2012/02/09","","","10.1111/j.1464-410X.2011.10919.x"
"29146217","Bladder Herpes Infection in a Patient With Low-grade Non-Muscle-invasive Bladder Cancer","Garrido-Abad P, Díaz-Menéndez A, Fernández-Arjona M.","Urology. 2018 Feb;112:e1-e2. doi: 10.1016/j.urology.2017.10.032. Epub 2017 Nov 13.","Garrido-Abad P","Urology","2018","2017/11/18","","","10.1016/j.urology.2017.10.032"
"24998787","Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer","Stevenson SM, Danzig MR, Ghandour RA, Deibert CM, Decastro GJ, Benson MC, McKiernan JM.","Urol Oncol. 2014 Nov;32(8):1172-7. doi: 10.1016/j.urolonc.2014.05.001. Epub 2014 Jul 4.","Stevenson SM","Urol Oncol","2014","2014/07/08","","","10.1016/j.urolonc.2014.05.001"
"29755116","Health-related quality of life after treatment for bladder cancer in England","Mason SJ, Downing A, Wright P, Hounsome L, Bottomley SE, Corner J, Richards M, Catto JW, Glaser AW.","Br J Cancer. 2018 May;118(11):1518-1528. doi: 10.1038/s41416-018-0084-z. Epub 2018 May 14.","Mason SJ","Br J Cancer","2018","2018/05/15","PMC5988662","","10.1038/s41416-018-0084-z"
"12433705","Prediagnostic toenail selenium and risk of bladder cancer","Zeegers MP, Goldbohm RA, Bode P, van den Brandt PA.","Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1292-7.","Zeegers MP","Cancer Epidemiol Biomarkers Prev","2002","2002/11/16","","",""
"29651708","[En bloc resection and vaporization techniques for the treatment of bladder cancer]","Struck JP, Karl A, Schwentner C, Herrmann TRW, Kramer MW.","Urologe A. 2018 Jun;57(6):665-672. doi: 10.1007/s00120-018-0625-3.","Struck JP","Urologe A","2018","2018/04/14","","","10.1007/s00120-018-0625-3"
"2218567","Invasive bladder cancer: selection of primary treatment","Soloway MS.","Semin Oncol. 1990 Oct;17(5):551-4.","Soloway MS","Semin Oncol","1990","1990/10/01","","",""
"18667021","Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments","Horiguchi Y, Kikuchi E, Ozu C, Nishiyama T, Oyama M, Horinaga M, Yoshioka K, Tachibana M.","Hum Cell. 2008 Aug;21(3):57-63. doi: 10.1111/j.1749-0774.2008.00055.x.","Horiguchi Y","Hum Cell","2008","2008/08/01","","","10.1111/j.1749-0774.2008.00055.x"
"10792076","Predicting extravesical extension of bladder carcinoma: a novel method based on micrometer measurement of the depth of invasion in transurethral resection specimens","Cheng L, Weaver AL, Bostwick DG.","Urology. 2000 May;55(5):668-72. doi: 10.1016/s0090-4295(99)00595-6.","Cheng L","Urology","2000","2000/05/03","","","10.1016/s0090-4295(99)00595-6"
"21665358","Stage pT0 after radical cystectomy: are all patients equal?","Chromecki TF, Cha EK, Shariat SF; Bladder Cancer Research Consortium.","Eur Urol. 2011 Sep;60(3):603-4. doi: 10.1016/j.eururo.2011.05.050. Epub 2011 Jun 7.","Chromecki TF","Eur Urol","2011","2011/06/14","","","10.1016/j.eururo.2011.05.050"
"7581512","[Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature]","Punga-Maole ML, Hubert J, Mangin P.","Prog Urol. 1995 Sep;5(4):580-5.","Punga-Maole ML","Prog Urol","1995","1995/09/01","","",""
"18516580","[Fluorescence cystoscopy. Perspective in clinical practice and research]","Jichlinski P, Lovisa B, Erling C, Aymon D, van den Berg H, Wagnieres G.","Urologe A. 2008 Aug;47(8):975-7. doi: 10.1007/s00120-008-1778-2.","Jichlinski P","Urologe A","2008","2008/06/03","","","10.1007/s00120-008-1778-2"
"18314629","Artificial intelligence and bladder cancer arrays","Wild PJ, Catto JW, Abbod MF, Linkens DA, Herr A, Pilarsky C, Wissmann C, Stoehr R, Denzinger S, Knuechel R, Hamdy FC, Hartmann A.","Verh Dtsch Ges Pathol. 2007;91:308-19.","Wild PJ","Verh Dtsch Ges Pathol","2007","2008/03/05","","",""
"28430636","Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures","Bacchetti T, Sartini D, Pozzi V, Cacciamani T, Ferretti G, Emanuelli M.","Oncotarget. 2017 Apr 25;8(17):28785-28795. doi: 10.18632/oncotarget.15674.","Bacchetti T","Oncotarget","2017","2017/04/22","PMC5438691","","10.18632/oncotarget.15674"
"17465196","Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix","Hauser PJ, Han Z, Sindhwani P, Hurst RE.","Anticancer Res. 2007 Mar-Apr;27(2):737-40.","Hauser PJ","Anticancer Res","2007","2007/05/01","PMC2604907","NIHMS80403",""
"27384201","Paradox of life among survivors of bladder cancer and treatments","Lopes M, Nascimento LC, Zago MM.","Rev Esc Enferm USP. 2016 Apr;50(2):224-31. doi: 10.1590/S0080-623420160000200007.","Lopes M","Rev Esc Enferm USP","2016","2016/07/08","","","10.1590/S0080-623420160000200007"
"30916832","lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150","Luo H, Xu C, Le W, Ge B, Wang T.","J Cell Biochem. 2019 Aug;120(8):13487-13493. doi: 10.1002/jcb.28622. Epub 2019 Mar 27.","Luo H","J Cell Biochem","2019","2019/03/28","PMC6619255","","10.1002/jcb.28622"
"15846746","Neoadjuvant chemotherapy for invasive bladder cancer","Advanced Bladder Cancer Overview Collaboration.","Cochrane Database Syst Rev. 2005 Apr 18;(2):CD005246. doi: 10.1002/14651858.CD005246.","Advanced Bladder Cancer Overview Collaboration","Cochrane Database Syst Rev","2005","2005/04/23","","","10.1002/14651858.CD005246"
"11839590","Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer","Levett D, Flecknell PA, Rudland PS, Barraclough R, Neal DE, Mellon JK, Davies BR.","Am J Pathol. 2002 Feb;160(2):693-700. doi: 10.1016/S0002-9440(10)64889-4.","Levett D","Am J Pathol","2002","2002/02/13","PMC1850652","","10.1016/S0002-9440(10)64889-4"
"21339722","An orthotopic model of murine bladder cancer","Dobek GL, Godbey WT.","J Vis Exp. 2011 Feb 6;(48):2535. doi: 10.3791/2535.","Dobek GL","J Vis Exp","2011","2011/02/23","PMC3197410","","10.3791/2535"
"15859187","Population attributable risk for occupational cancer in Italy","Barone-Adesi F, Richiardi L, Merletti F.","Int J Occup Environ Health. 2005 Jan-Mar;11(1):23-31. doi: 10.1179/oeh.2005.11.1.23.","Barone-Adesi F","Int J Occup Environ Health","2005","2005/04/30","","","10.1179/oeh.2005.11.1.23"
"17997024","Prognostic impact of comorbidity in patients with bladder cancer","Megwalu II, Vlahiotis A, Radwan M, Piccirillo JF, Kibel AS.","Eur Urol. 2008 Mar;53(3):581-9. doi: 10.1016/j.eururo.2007.10.069. Epub 2007 Nov 5.","Megwalu II","Eur Urol","2008","2007/11/13","PMC2262100","NIHMS40736","10.1016/j.eururo.2007.10.069"
"29407369","Immune checkpoint inhibitors for metastatic bladder cancer","Massari F, Di Nunno V, Cubelli M, Santoni M, Fiorentino M, Montironi R, Cheng L, Lopez-Beltran A, Battelli N, Ardizzoni A.","Cancer Treat Rev. 2018 Mar;64:11-20. doi: 10.1016/j.ctrv.2017.12.007. Epub 2018 Jan 31.","Massari F","Cancer Treat Rev","2018","2018/02/07","","","10.1016/j.ctrv.2017.12.007"
"29904624","Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China","Wu P, Zhang G, Zhao J, Chen J, Chen Y, Huang W, Zhong J, Zeng J.","Front Cell Infect Microbiol. 2018 May 31;8:167. doi: 10.3389/fcimb.2018.00167. eCollection 2018.","Wu P","Front Cell Infect Microbiol","2018","2018/06/16","PMC5990618","","10.3389/fcimb.2018.00167"
"21494761","Detection of smoothelin expression in the urinary bladder is strongly dependent on pretreatment conditions: a critical analysis with possible consequences for cancer staging","Lindh C, Nilsson R, Lindstrom ML, Lundin L, Elmberger G.","Virchows Arch. 2011 Jun;458(6):665-70. doi: 10.1007/s00428-011-1076-z. Epub 2011 Apr 15.","Lindh C","Virchows Arch","2011","2011/04/16","","","10.1007/s00428-011-1076-z"
"19227212","[Case of bladder cancer following adjuvant external beam radiation for prostate cancer]","Nishikawa K, Soga N, Kato M, Masui S, Hasegawa Y, Yamada Y, Kise H, Arima K, Sugimura Y.","Hinyokika Kiyo. 2009 Jan;55(1):39-41.","Nishikawa K","Hinyokika Kiyo","2009","2009/02/21","","",""
"23201384","Combinations of urinary biomarkers for surveillance of patients with incident nonmuscle invasive bladder cancer: the European FP7 UROMOL project","Zuiverloon TC, Beukers W, van der Keur KA, Nieuweboer AJ, Reinert T, Dyrskjot L, Orntoft TF, Zwarthoff EC.","J Urol. 2013 May;189(5):1945-51. doi: 10.1016/j.juro.2012.11.115. Epub 2012 Nov 28.","Zuiverloon TC","J Urol","2013","2012/12/04","","","10.1016/j.juro.2012.11.115"
"29271836","The Economic Burden of Bladder Cancer Due to Occupational Exposure","Jung YL, Tompa E, Longo C, Kalcevich C, Kim J, Song C, Demers P.","J Occup Environ Med. 2018 Mar;60(3):217-225. doi: 10.1097/JOM.0000000000001242.","Jung YL","J Occup Environ Med","2018","2017/12/23","","","10.1097/JOM.0000000000001242"
"7751885","Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial","Herr HW, Schwalb DM, Zhang ZF, Sogani PC, Fair WR, Whitmore WF Jr, Oettgen HF.","J Clin Oncol. 1995 Jun;13(6):1404-8. doi: 10.1200/JCO.1995.13.6.1404.","Herr HW","J Clin Oncol","1995","1995/06/01","","","10.1200/JCO.1995.13.6.1404"
"10895129","Progress in the management of metastatic bladder cancer","Parimoo D, Raghavan D.","Cancer Control. 2000 Jul-Aug;7(4):347-56. doi: 10.1177/107327480000700404.","Parimoo D","Cancer Control","2000","2000/07/15","","","10.1177/107327480000700404"
"16520271","Overexpression of alpha-defensin is associated with bladder cancer invasiveness","Holterman DA, Diaz JI, Blackmore PF, Davis JW, Schellhammer PF, Corica A, Semmes OJ, Vlahou A.","Urol Oncol. 2006 Mar-Apr;24(2):97-108. doi: 10.1016/j.urolonc.2005.07.010.","Holterman DA","Urol Oncol","2006","2006/03/08","","","10.1016/j.urolonc.2005.07.010"
"31158085","Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance Project","Hurle R, Colombo P, Lazzeri M, Lughezzani G, Buffi NM, Saita A, Elefante GM, Morenghi E, Forni G, Cardone P, Lista G, Maffei D, Guazzoni G, Casale P.","Eur Urol Oncol. 2018 Oct;1(5):437-442. doi: 10.1016/j.euo.2018.05.006. Epub 2018 Jun 5.","Hurle R","Eur Urol Oncol","2018","2019/06/04","","","10.1016/j.euo.2018.05.006"
"12853794","Expectant management of small, recurrent, noninvasive papillary bladder tumors","Soloway MS, Bruck DS, Kim SS.","J Urol. 2003 Aug;170(2 Pt 1):438-41. doi: 10.1097/01.ju.0000076621.71247.6c.","Soloway MS","J Urol","2003","2003/07/11","","","10.1097/01.ju.0000076621.71247.6c"
"6820898","[Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer]","Okajima E, Hiramatsu T, Kihoin K, Ijuin M, Hirao Y, Ohara S, Babaya K, Tanaka M, Maruyama Y.","Gan To Kagaku Ryoho. 1982 Mar;9(3):473-9.","Okajima E","Gan To Kagaku Ryoho","1982","1982/03/01","","",""
"871045","Urinary amino acid excretion: comparison of normal individuals and patients with bladder cancer","McGregor RF, Crawford R, Johnson DE, Brown B, Sharon MS, Johnston D.","Urology. 1977 May;9(5):538-42. doi: 10.1016/0090-4295(77)90247-3.","McGregor RF","Urology","1977","1977/05/01","","","10.1016/0090-4295(77)90247-3"
"25208941","Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease","Joshi BH, Leland P, Lababidi S, Varrichio F, Puri RK.","Cancer Med. 2014 Dec;3(6):1615-28. doi: 10.1002/cam4.330. Epub 2014 Sep 10.","Joshi BH","Cancer Med","2014","2014/09/12","PMC4298388","","10.1002/cam4.330"
"15828265","[Two cases of second bladder cancer after radiotherapy for prostate cancer]","Numata K, Azuma K, Hashine K, Sumiyoshi Y.","Nihon Hinyokika Gakkai Zasshi. 2005 Mar;96(3):466-9. doi: 10.5980/jpnjurol1989.96.466.","Numata K","Nihon Hinyokika Gakkai Zasshi","2005","2005/04/15","","","10.5980/jpnjurol1989.96.466"
"6474625","[Pathogenesis of postradiation hemorrhage in the combined treatment of bladder cancer]","Popov AI.","Urol Nefrol (Mosk). 1984 Jul-Aug;(4):31-3.","Popov AI","Urol Nefrol (Mosk)","1984","1984/07/01","","",""
"29059781","Re: ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer","Atala A.","J Urol. 2017 Nov;198(5):985. doi: 10.1016/j.juro.2017.08.010. Epub 2017 Aug 9.","Atala A","J Urol","2017","2017/10/25","","","10.1016/j.juro.2017.08.010"
"8896140","Survival analyses of randomized clinical trials adjusted for patients who switch treatments","Law MG, Kaldor JM.","Stat Med. 1996 Oct 15;15(19):2069-76. doi: 10.1002/(SICI)1097-0258(19961015)15:19<2069::AID-SIM347>3.0.CO;2-V.","Law MG","Stat Med","1996","1996/10/15","","","10.1002/(SICI)1097-0258(19961015)15:19<2069::AID-SIM347>3.0.CO;2-V"
"22724563","[New and clinically used oncomarkers of bladder cancer]","Bilecová-Rabajdová M, Varga J, Urban P, Ostró A, Pilátová M, Mareková M.","Klin Onkol. 2012;25(3):162-5.","Bilecová-Rabajdová M","Klin Onkol","2012","2012/06/26","","",""
"11752857","Alcohol dehydrogenase type 3 (ADH3) and the risk of bladder cancer","van Dijk B, van Houwelingen KP, Witjes JA, Schalken JA, Kiemeney LA.","Eur Urol. 2001 Nov;40(5):509-14. doi: 10.1159/000049827.","van Dijk B","Eur Urol","2001","2001/12/26","","","10.1159/000049827"
"15925072","Four years experience in bladder preserving management for muscle invasive bladder cancer","Lodde M, Palermo S, Comploj E, Signorello D, Mian C, Lusuardi L, Longhi E, Zanon P, Mian M, Pycha A.","Eur Urol. 2005 Jun;47(6):773-8; discussion 778-9. doi: 10.1016/j.eururo.2005.01.017. Epub 2005 Feb 10.","Lodde M","Eur Urol","2005","2005/06/01","","","10.1016/j.eururo.2005.01.017"
"2014595","Adenocarcinoma of urinary bladder: classification and management","Burnett AL, Epstein JI, Marshall FF.","Urology. 1991 Apr;37(4):315-21. doi: 10.1016/0090-4295(91)80256-7.","Burnett AL","Urology","1991","1991/04/01","","","10.1016/0090-4295(91)80256-7"
"31541269","[Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group]","Ortiz-Brüchle N, Muders M, Toma M, Esposito I, Hartmann A, Stöhr R, Reis H, Wild P, Köllermann J, Bremmer F, Leichsenring J, Stenzinger A, Merkelbach-Bruse S, Kirfel S, Perner S, Hartmann N, Roth W, Jung A, Kirchner T, Schwamborn K, Pfarr N, Dahl E, Knüchel R, Gaisa NT.","Urologe A. 2020 Mar;59(3):318-325. doi: 10.1007/s00120-019-01046-2.","Ortiz-Brüchle N","Urologe A","2020","2019/09/22","","","10.1007/s00120-019-01046-2"
"16902498","Treatment of high-risk, non-muscle-invasive bladder cancer","Lerner SP.","Nat Clin Pract Urol. 2006 Aug;3(8):398-9. doi: 10.1038/ncpuro0517.","Lerner SP","Nat Clin Pract Urol","2006","2006/08/12","","","10.1038/ncpuro0517"
"12050493","Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome","Yossepowitch O, Dalbagni G.","J Urol. 2002 Jul;168(1):61-6.","Yossepowitch O","J Urol","2002","2002/06/07","","",""
"10484840","[Prognostic factors and radiosensitivity of bladder cancer]","de las Heras González M, Salinas Ramos J, de la Fuente I, Navarrete Montoya A.","Arch Esp Urol. 1999 Jul-Aug;52(6):565-76.","de las Heras González M","Arch Esp Urol","1999","1999/09/15","","",""
"8677546","[The complications of transurethral resection of the bladder for tumor]","Chepurov AK, Nemenova AA.","Urol Nefrol (Mosk). 1996 Mar-Apr;(2):21-3.","Chepurov AK","Urol Nefrol (Mosk)","1996","1996/03/01","","",""
"24404589","E-cadherin gene promoter hypermethylation may contribute to the risk of bladder cancer among Asian populations","Li G, Liu Y, Yin H, Zhang X, Mo X, Tang J, Chen W.","Gene. 2014 Jan 15;534(1):48-53.","Li G","Gene","2014","2014/01/10","","",""
"23958053","Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients","Zhang ZL, Dong P, Li YH, Liu ZW, Yao K, Han H, Qin ZK, Zhou FJ.","Chin J Cancer. 2014 Mar;33(3):165-71. doi: 10.5732/cjc.012.10312. Epub 2013 Aug 6.","Zhang ZL","Chin J Cancer","2014","2013/08/21","PMC3966145","","10.5732/cjc.012.10312"
"7613798","The application of a prognostic factor analysis for Ta.T1 bladder cancer in routine urological practice","Reading J, Hall RR, Parmar MK.","Br J Urol. 1995 May;75(5):604-7. doi: 10.1111/j.1464-410x.1995.tb07417.x.","Reading J","Br J Urol","1995","1995/05/01","","","10.1111/j.1464-410x.1995.tb07417.x"
"1585509","Lectins in diagnosis of bladder carcinoma","Recker F, Otto T, Rübben H.","Urol Int. 1992;48(2):149-53. doi: 10.1159/000282319.","Recker F","Urol Int","1992","1992/01/01","","","10.1159/000282319"
"31552489","MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer","Baumgart S, Meschkat P, Edelmann P, Heinzelmann J, Pryalukhin A, Bohle R, Heinzelbecker J, Stöckle M, Junker K.","J Cancer Res Clin Oncol. 2019 Nov;145(11):2725-2736. doi: 10.1007/s00432-019-03035-6. Epub 2019 Sep 24.","Baumgart S","J Cancer Res Clin Oncol","2019","2019/09/26","","","10.1007/s00432-019-03035-6"
"7571232","Invasive bladder cancer following cardiac transplantation","Baldwin DD, Ruckle HC.","Urology. 1995 Oct;46(4):570-2. doi: 10.1016/S0090-4295(99)80276-3.","Baldwin DD","Urology","1995","1995/10/01","","","10.1016/S0090-4295(99)80276-3"
"21178421","Schistosoma haematobium and bladder cancer: what lies beneath?","Botelho MC, Machado JC, da Costa JM.","Virulence. 2010 Mar-Apr;1(2):84-7. doi: 10.4161/viru.1.2.10487.","Botelho MC","Virulence","2010","2010/12/24","","","10.4161/viru.1.2.10487"
"1951278","Tobacco smoke inhalation pattern, tobacco type, and bladder cancer in Spain","López-Abente G, González CA, Errezola M, Escolar A, Izarzugaza I, Nebot M, Riboli E.","Am J Epidemiol. 1991 Oct 15;134(8):830-9. doi: 10.1093/oxfordjournals.aje.a116158.","López-Abente G","Am J Epidemiol","1991","1991/10/15","","","10.1093/oxfordjournals.aje.a116158"
"11138807","A meta-analysis of bladder cancer and diesel exhaust exposure","Boffetta P, Silverman DT.","Epidemiology. 2001 Jan;12(1):125-30. doi: 10.1097/00001648-200101000-00021.","Boffetta P","Epidemiology","2001","2001/01/04","","","10.1097/00001648-200101000-00021"
"21642839","Long-term response in advanced bladder cancer involving the use of temsirolimus and vinflunine after platin resistance","Gerullis H, Ecke TH, Janusch B, Arndt C, Heidari M, Oniani J, Otto T.","Anticancer Drugs. 2011 Oct;22(9):940-3. doi: 10.1097/CAD.0b013e328347a86a.","Gerullis H","Anticancer Drugs","2011","2011/06/07","","","10.1097/CAD.0b013e328347a86a"
"3428318","Radical cystectomy--often too late?","Stöckle M, Alken P, Engelmann U, Jacobi GH, Riedmiller H, Hohenfellner R.","Eur Urol. 1987;13(6):361-7. doi: 10.1159/000472824.","Stöckle M","Eur Urol","1987","1987/01/01","","","10.1159/000472824"
"25743828","High expression level of preoperative serum Uroplakin III is associated with biologically aggressive bladder cancer","Tsumura H, Matsumoto K, Ikeda M, Yanagita K, Hirano S, Hagiwara M, Nagashio R, Fujita T, Sato Y, Iwamura M.","Asian Pac J Cancer Prev. 2015;16(4):1539-43. doi: 10.7314/apjcp.2015.16.4.1539.","Tsumura H","Asian Pac J Cancer Prev","2015","2015/03/07","","","10.7314/apjcp.2015.16.4.1539"
"6390913","Endoscopic management of bladder cancer with hematoporphyrin derivative phototherapy","Benson RC Jr.","Urol Clin North Am. 1984 Nov;11(4):637-42.","Benson RC Jr","Urol Clin North Am","1984","1984/11/01","","",""
"20824576","[Diagnosis of and therapy for non-muscle-invasive bladder cancer - state of the art]","Kausch von Schmeling I.","Aktuelle Urol. 2010 Sep;41(5):307-15. doi: 10.1055/s-0030-1262555. Epub 2010 Sep 7.","Kausch von Schmeling I","Aktuelle Urol","2010","2010/09/09","","","10.1055/s-0030-1262555"
"18670278","Gene therapy in bladder cancer","Bochner BH.","Curr Opin Urol. 2008 Sep;18(5):519-23. doi: 10.1097/MOU.0b013e32830b86e3.","Bochner BH","Curr Opin Urol","2008","2008/08/02","","","10.1097/MOU.0b013e32830b86e3"
"30901172","Decrease in skeletal muscle index 1 year after radical cystectomy as a prognostic indicator in patients with urothelial bladder cancer","Ha YS, Kim SW, Kwon TG, Chung SK, Yoo ES.","Int Braz J Urol. 2019 Jul-Aug;45(4):686-694. doi: 10.1590/S1677-5538.IBJU.2018.0530.","Ha YS","Int Braz J Urol","2019","2019/03/23","PMC6837591","","10.1590/S1677-5538.IBJU.2018.0530"
"19717877","[Response to adjuvant chemotherapy after radical cystectomy in patients with infiltrative bladder: Analysis of 397 cases]","Monzó Gardiner JI, Herranz Amo F, Cabello Benavente R, Díez Cordero R, López Díez I, Tabares Jiménez J, Molina Escudero R, Paños Facundo E, Hernández Fernández C.","Arch Esp Urol. 2009 May;62(4):275-82. doi: 10.4321/s0004-06142009000400002.","Monzó Gardiner JI","Arch Esp Urol","2009","2009/09/01","","","10.4321/s0004-06142009000400002"
"2217405","Chemotherapy for invasive bladder tumors","Scher HI.","Prog Clin Biol Res. 1990;353:1-22.","Scher HI","Prog Clin Biol Res","1990","1990/01/01","","",""
"19692168","Genetic susceptibility to distinct bladder cancer subphenotypes","Guey LT, García-Closas M, Murta-Nascimento C, Lloreta J, Palencia L, Kogevinas M, Rothman N, Vellalta G, Calle ML, Marenne G, Tardón A, Carrato A, García-Closas R, Serra C, Silverman DT, Chanock S, Real FX, Malats N; EPICURO/Spanish Bladder Cancer Study investigators.","Eur Urol. 2010 Feb;57(2):283-92. doi: 10.1016/j.eururo.2009.08.001. Epub 2009 Aug 12.","Guey LT","Eur Urol","2010","2009/08/21","PMC3220186","NIHMS282864","10.1016/j.eururo.2009.08.001"
"9175284","Contemporary non-imaging methods in diagnosis of bladder cancer: a review","De Graeve N, D'Hallewin MA, Baert L.","Acta Urol Belg. 1997 Mar;65(1):55-8.","De Graeve N","Acta Urol Belg","1997","1997/03/01","","",""
"21385480","Invasive bladder cancer in the eighties: transurethral resection or cystectomy?","Faba OR, Palou J, Urdaneta G, Gausa L, Villavicencio H.","Int Braz J Urol. 2011 Jan-Feb;37(1):49-55;discussion 55-6. doi: 10.1590/s1677-55382011000100007.","Faba OR","Int Braz J Urol","2011","2011/03/10","","","10.1590/s1677-55382011000100007"
"61639","Role of radiation therapy in cancer of bladder","Shehata WM.","Urology. 1976 Oct;8(4):342-6. doi: 10.1016/0090-4295(76)90487-8.","Shehata WM","Urology","1976","1976/10/01","","","10.1016/0090-4295(76)90487-8"
"16501234","Prognostic value of cytology, nuclear matrix protein 22 (NMP22) test, and urinary bladder cancer II (UBC II) test in early recurrent transitional cell carcinoma of the bladder","Kibar Y, Goktas S, Kilic S, Yaman H, Onguru O, Peker AF.","Ann Clin Lab Sci. 2006 Winter;36(1):31-8.","Kibar Y","Ann Clin Lab Sci","2006","2006/02/28","","",""
"14685762","The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review","Zeegers MP, Kellen E, Buntinx F, van den Brandt PA.","World J Urol. 2004 Feb;21(6):392-401. doi: 10.1007/s00345-003-0382-8. Epub 2003 Dec 17.","Zeegers MP","World J Urol","2004","2003/12/20","","","10.1007/s00345-003-0382-8"
"25675122","Three-tiered nodal classification system for bladder cancer: a new proposal","Pedrosa JA, Koch MO, Kaimakliotis HZ, Monn MF, Masterson TA, Rice KR, Cary KC, Foster RS, Bihrle R, Cheng L.","Future Oncol. 2015;11(3):399-408. doi: 10.2217/fon.14.267.","Pedrosa JA","Future Oncol","2015","2015/02/13","","","10.2217/fon.14.267"
"20224111","Proteomics analysis of bladder cancer exosomes","Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A.","Mol Cell Proteomics. 2010 Jun;9(6):1324-38. doi: 10.1074/mcp.M000063-MCP201. Epub 2010 Mar 11.","Welton JL","Mol Cell Proteomics","2010","2010/03/13","PMC2877990","","10.1074/mcp.M000063-MCP201"
"3045345","Detection of tumor cells in bladder washings by a monoclonal antibody to human bladder tumor-associated antigen","Lin CW, Young DA, Kirley SD, Khaw AH, Prout GR Jr.","J Urol. 1988 Sep;140(3):672-7. doi: 10.1016/s0022-5347(17)41753-8.","Lin CW","J Urol","1988","1988/09/01","","","10.1016/s0022-5347(17)41753-8"
"24550651","Risk of bladder cancer among patients with diabetes treated with a 15 mg pioglitazone dose in Korea: a multi-center retrospective cohort study","Jin SM, Song SO, Jung CH, Chang JS, Suh S, Kang SM, Jung I, Park CY, Kim JH, Cho JH, Lee BW.","J Korean Med Sci. 2014 Feb;29(2):238-42. doi: 10.3346/jkms.2014.29.2.238. Epub 2014 Jan 28.","Jin SM","J Korean Med Sci","2014","2014/02/20","PMC3924003","","10.3346/jkms.2014.29.2.238"
"30392011","Forty years of cisplatin-based chemotherapy in muscle-invasive bladder cancer: are we understanding how, who and when?","Schardt J, Roth B, Seiler R.","World J Urol. 2019 Sep;37(9):1759-1765. doi: 10.1007/s00345-018-2544-8. Epub 2018 Nov 3.","Schardt J","World J Urol","2019","2018/11/05","","","10.1007/s00345-018-2544-8"
"6874452","Radical irradiation of T2 grade III and T3 bladder cancer--tumor response and prognosis","Abratt RP, Tucker RD, Barnes DR.","Int J Radiat Oncol Biol Phys. 1983 Aug;9(8):1213-5. doi: 10.1016/0360-3016(83)90183-9.","Abratt RP","Int J Radiat Oncol Biol Phys","1983","1983/08/01","","","10.1016/0360-3016(83)90183-9"
"17522068","Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer","Marsit CJ, Houseman EA, Schned AR, Karagas MR, Kelsey KT.","Carcinogenesis. 2007 Aug;28(8):1745-51. doi: 10.1093/carcin/bgm116. Epub 2007 May 23.","Marsit CJ","Carcinogenesis","2007","2007/05/25","","","10.1093/carcin/bgm116"
"23283744","Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation","He HC, Ling XH, Zhu JG, Fu X, Han ZD, Liang YX, Deng YH, Lin ZY, Chen G, Chen YF, Mo RJ, Zhong WD.","Mol Biol Rep. 2013 May;40(5):3799-805. doi: 10.1007/s11033-012-2458-2. Epub 2013 Jan 3.","He HC","Mol Biol Rep","2013","2013/01/04","","","10.1007/s11033-012-2458-2"
"25445384","Radical cystectomy vs. chemoradiation in T2-4aN0M0 bladder cancer: a case-control study","Gofrit ON, Nof R, Meirovitz A, Pode D, Frank S, Katz R, Shapiro A, Landau EH, Hidas G, Yutkin V, Duvdevani M, Wygoda M.","Urol Oncol. 2015 Jan;33(1):19.e1-19.e5. doi: 10.1016/j.urolonc.2014.09.014. Epub 2014 Nov 4.","Gofrit ON","Urol Oncol","2015","2014/12/03","","","10.1016/j.urolonc.2014.09.014"
"15869990","The effects of stage divergence on survival after radical cystectomy for urothelial cancer","Hollenbeck BK, Miller DC, Dunn RL, Montie JE, Wei JT.","Urol Oncol. 2005 Mar-Apr;23(2):77-81. doi: 10.1016/j.urolonc.2004.08.012.","Hollenbeck BK","Urol Oncol","2005","2005/05/05","","","10.1016/j.urolonc.2004.08.012"
"20707727","Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer","Tatsugami K, Kuroiwa K, Kamoto T, Nishiyama H, Watanabe J, Ishikawa S, Shinohara N, Sazawa A, Fukushima S, Naito S.","J Endourol. 2010 Nov;24(11):1807-11. doi: 10.1089/end.2010.0055. Epub 2010 Aug 14.","Tatsugami K","J Endourol","2010","2010/08/17","","","10.1089/end.2010.0055"
"29387931","Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation","Tanimoto R, Saika T, Ebara S, Kobayashi Y, Nasu R, Yamada D, Takamoto H, Miyaji Y, Nasu Y, Tsushima T, Kumon H.","World J Urol. 2018 Jun;36(6):889-895. doi: 10.1007/s00345-018-2196-8. Epub 2018 Jan 31.","Tanimoto R","World J Urol","2018","2018/02/02","","","10.1007/s00345-018-2196-8"
"22127016","Disparities in bladder cancer","Jacobs BL, Montgomery JS, Zhang Y, Skolarus TA, Weizer AZ, Hollenbeck BK.","Urol Oncol. 2012 Jan-Feb;30(1):81-8. doi: 10.1016/j.urolonc.2011.08.011. Epub 2011 Nov 27.","Jacobs BL","Urol Oncol","2012","2011/12/01","","","10.1016/j.urolonc.2011.08.011"
"24484180","Nanoscale organization of human GnRH-R on human bladder cancer cells","Zhang J, Chtcheglova LA, Zhu R, Hinterdorfer P, Zhang B, Tang J.","Anal Chem. 2014 Mar 4;86(5):2458-64. doi: 10.1021/ac403304g. Epub 2014 Feb 11.","Zhang J","Anal Chem","2014","2014/02/04","","","10.1021/ac403304g"
"12735496","Mixed discrete and continuous Cox regression model","Prentice RL, Kalbfleisch JD.","Lifetime Data Anal. 2003 Jun;9(2):195-210. doi: 10.1023/a:1022935019768.","Prentice RL","Lifetime Data Anal","2003","2003/05/09","","","10.1023/a:1022935019768"
"25023786","Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytology","Neuzillet Y, Methorst C, Schneider M, Lebret T, Rouanne M, Radulescu C, Molinie V, Dreyfus JF, Pelcat V, Botto H.","Urol Oncol. 2014 Nov;32(8):1135-40. doi: 10.1016/j.urolonc.2014.04.005. Epub 2014 Jul 9.","Neuzillet Y","Urol Oncol","2014","2014/07/16","","","10.1016/j.urolonc.2014.04.005"
"12162191","[Angiogenesis and bladder cancer: trendy prognostic factor or new therapeutic target?]","Jayet C, Deperthes D, Leisinger HJ.","Ann Urol (Paris). 2002 Jul;36(4):258-63. doi: 10.1016/s0003-4401(02)00105-5.","Jayet C","Ann Urol (Paris)","2002","2002/08/07","","","10.1016/s0003-4401(02)00105-5"
"28266813","Generation of potent cytotoxic T lymphocytes against in male patients with non-muscle invasive bladder cancer by dendritic cells loaded with dying T24 bladder cancer cells","Hwang EC, Jung SI, Lee HJ, Lee JJ, Kwon DD.","Int Braz J Urol. 2017 Jul-Aug;43(4):615-627. doi: 10.1590/S1677-5538.IBJU.2016.0274.","Hwang EC","Int Braz J Urol","2017","2017/03/08","PMC5557436","","10.1590/S1677-5538.IBJU.2016.0274"
"15726119","The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder","Hilmy M, Bartlett JM, Underwood MA, McMillan DC.","Br J Cancer. 2005 Feb 28;92(4):625-7. doi: 10.1038/sj.bjc.6602406.","Hilmy M","Br J Cancer","2005","2005/02/24","PMC2361870","","10.1038/sj.bjc.6602406"
"19455607","Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors","Madeb R, Golijanin D, Noyes K, Fisher S, Stephenson JJ, Long SR, Knopf J, Lyman GH, Messing EM.","Cancer. 2009 Jun 15;115(12):2660-70. doi: 10.1002/cncr.24311.","Madeb R","Cancer","2009","2009/05/21","PMC2769205","NIHMS140795","10.1002/cncr.24311"
"12006244","Hammerhead ribozymes as therapeutic agents for bladder cancer","Irie A, Kashani-Sabet M, Scanlon KJ, Uchida T, Baba S.","Mol Urol. 2000 Summer;4(2):61-6. doi: 10.1089/10915360050138602.","Irie A","Mol Urol","2000","2002/05/15","","","10.1089/10915360050138602"
"16835335","Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender","Samanic C, Kogevinas M, Dosemeci M, Malats N, Real FX, Garcia-Closas M, Serra C, Carrato A, García-Closas R, Sala M, Lloreta J, Tardón A, Rothman N, Silverman DT.","Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1348-54. doi: 10.1158/1055-9965.EPI-06-0021.","Samanic C","Cancer Epidemiol Biomarkers Prev","2006","2006/07/13","","","10.1158/1055-9965.EPI-06-0021"
"23040251","Radiologic imaging of patients with bladder cancer","Purysko AS, Leão Filho HM, Herts BR.","Semin Oncol. 2012 Oct;39(5):543-58. doi: 10.1053/j.seminoncol.2012.08.010.","Purysko AS","Semin Oncol","2012","2012/10/09","","","10.1053/j.seminoncol.2012.08.010"
"27377810","Ulceration in bladder cancer associates with extravesical disease, independent of cell cycle, or hypoxia pathways status: Integrating gross morphology and expression profiles in cystectomies","Schultz L, Spagnul SJT, Damm GR, da Cunha IW, Bezerra SM, da Costa WH, Guimaraes GC, Zequi SD, Soares FA.","Urol Oncol. 2016 Nov;34(11):484.e9-484.e17. doi: 10.1016/j.urolonc.2016.05.031. Epub 2016 Jul 1.","Schultz L","Urol Oncol","2016","2016/07/06","","","10.1016/j.urolonc.2016.05.031"
"23686449","Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer","Mengual L, Lozano JJ, Ingelmo-Torres M, Gazquez C, Ribal MJ, Alcaraz A.","Int J Cancer. 2013 Dec 1;133(11):2631-41. doi: 10.1002/ijc.28274. Epub 2013 Jun 14.","Mengual L","Int J Cancer","2013","2013/05/21","","","10.1002/ijc.28274"
"7147508","Long-term results following thoracotomy for metastatic bladder cancer","Cowles RS, Johnson DE, McMurtrey MJ.","Urology. 1982 Oct;20(4):390-2. doi: 10.1016/0090-4295(82)90462-9.","Cowles RS","Urology","1982","1982/10/01","","","10.1016/0090-4295(82)90462-9"
"15871006","[Lymphadenectomy for bladder cancer. Diagnostic and prognostic significance as well as therapeutic benefit]","Leissner J.","Urologe A. 2005 Jun;44(6):638-44. doi: 10.1007/s00120-005-0827-3.","Leissner J","Urologe A","2005","2005/05/05","","","10.1007/s00120-005-0827-3"
"3590816","[Therapy and follow-up using TPA in radio-oncologic after-care in bladder cancer]","Handl-Zeller L, Kärcher KH, Hohenberg G.","Wien Med Wochenschr. 1987 Feb 28;137(4):80-2.","Handl-Zeller L","Wien Med Wochenschr","1987","1987/02/28","","",""
"2074521","Bladder cancer survival statistics","Smart CR.","J Occup Med. 1990 Sep;32(9):926-8. doi: 10.1097/00043764-199009000-00035.","Smart CR","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00035"
"24445555","Contemporary lymphadenectomy templates: kidney, prostate and bladder cancer","Pagliara T, Nguyen A, Konety B.","Curr Opin Urol. 2014 Mar;24(2):148-54. doi: 10.1097/MOU.0000000000000026.","Pagliara T","Curr Opin Urol","2014","2014/01/22","","","10.1097/MOU.0000000000000026"
"17406000","Promotion of bladder cancer development and progression by androgen receptor signals","Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C.","J Natl Cancer Inst. 2007 Apr 4;99(7):558-68. doi: 10.1093/jnci/djk113.","Miyamoto H","J Natl Cancer Inst","2007","2007/04/05","","","10.1093/jnci/djk113"
"30627815","Relationship between the expression of PD-1/PD-L1 and (18)F-FDG uptake in bladder cancer","Chen R, Zhou X, Liu J, Huang G.","Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):848-854. doi: 10.1007/s00259-018-4208-8. Epub 2019 Jan 9.","Chen R","Eur J Nucl Med Mol Imaging","2019","2019/01/11","","","10.1007/s00259-018-4208-8"
"17118019","Comparison of two-port and four-port irradiation in the bladder preservation therapy for locally invasive bladder cancer","Sawada Y, Takeuchi Y, Iwasawa T, Kuroda K, Matsushima M, Nagamoto M, Wakayama M.","Int J Urol. 2006 Dec;13(12):1470-4. doi: 10.1111/j.1442-2042.2006.01680.x.","Sawada Y","Int J Urol","2006","2006/11/23","","","10.1111/j.1442-2042.2006.01680.x"
"8646235","The use of neobladders in women undergoing cystectomy for transitional-cell cancer","Stenzl A, Colleselli K, Poisel S, Feichtinger H, Bartsch G.","World J Urol. 1996;14(1):15-21. doi: 10.1007/BF01836339.","Stenzl A","World J Urol","1996","1996/01/01","","","10.1007/BF01836339"
"23436614","HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling","Kim YJ, Yoon HY, Kim JS, Kang HW, Min BD, Kim SK, Ha YS, Kim IY, Ryu KH, Lee SC, Kim WJ.","Int J Cancer. 2013 Sep 1;133(5):1135-42. doi: 10.1002/ijc.28121. Epub 2013 Mar 16.","Kim YJ","Int J Cancer","2013","2013/02/26","","","10.1002/ijc.28121"
"3303602","[Prevention of bladder cancer in relation to epidemiological data]","Prianichnikova MB.","Urol Nefrol (Mosk). 1987 May-Jun;(3):58-63.","Prianichnikova MB","Urol Nefrol (Mosk)","1987","1987/05/01","","",""
"30001845","FDG-PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients","Soubra A, Gencturk M, Froelich J, Balaji P, Gupta S, Jha G, Konety BR.","Clin Genitourin Cancer. 2018 Oct;16(5):360-364. doi: 10.1016/j.clgc.2018.05.008. Epub 2018 May 31.","Soubra A","Clin Genitourin Cancer","2018","2018/07/14","","","10.1016/j.clgc.2018.05.008"
"30044124","Urinary Bladder Pathology: World Health Organization Classification and American Joint Committee on Cancer Staging Update","Wang G, McKenney JK.","Arch Pathol Lab Med. 2019 May;143(5):571-577. doi: 10.5858/arpa.2017-0539-RA. Epub 2018 Jul 25.","Wang G","Arch Pathol Lab Med","2019","2018/07/26","","","10.5858/arpa.2017-0539-RA"
"7823292","Chlorination of drinking water and cancer incidence","Morales Suarez-Varela MM, Llopis Gonzalez A, Tejerizo Perez ML, Ferrer Caraco E.","J Environ Pathol Toxicol Oncol. 1994;13(1):39-41.","Morales Suarez-Varela MM","J Environ Pathol Toxicol Oncol","1994","1994/01/01","","",""
"26423342","A novel risk stratification model, involving preoperative lymphocyte-monocyte ratio and standard pathological factors, for overall survival in patients with bladder cancer undergoing radical cystectomy","Yoshida T, Kinoshita H, Yoshida K, Yanishi M, Inui H, Komai Y, Sugi M, Inoue T, Murota T, Matsuda T.","Jpn J Clin Oncol. 2015 Dec;45(12):1162-7. doi: 10.1093/jjco/hyv146. Epub 2015 Sep 29.","Yoshida T","Jpn J Clin Oncol","2015","2015/10/02","","","10.1093/jjco/hyv146"
"17004179","[International Consensus Panel--treatment strategies for superficial bladder cancer]","Adler S, St Niclas M.","Aktuelle Urol. 2006 Sep;37(5):320-3; discussion 322-3. doi: 10.1055/s-2006-951427.","Adler S","Aktuelle Urol","2006","2006/09/28","","","10.1055/s-2006-951427"
"9424420","[Carcinoma of the bladder: experience of the USC Los Angeles (antireflux nipple according to Ghoneim)]","Skinner DG.","Chir Ital. 1997;49(7):9-15.","Skinner DG","Chir Ital","1997","1997/01/01","","",""
"26984414","Improving Systemic Chemotherapy for Bladder Cancer","Rose TL, Milowsky MI.","Curr Oncol Rep. 2016 May;18(5):27. doi: 10.1007/s11912-016-0512-2.","Rose TL","Curr Oncol Rep","2016","2016/03/18","","","10.1007/s11912-016-0512-2"
"6203335","Inhibition of cell growth by irradiation in combination with hyperthermia or anticancer drugs","Nakajima K, Hisazumi H, Kumaki O, Ueki O.","Acta Radiol Oncol. 1983;22(6):487-92. doi: 10.3109/02841868309135975.","Nakajima K","Acta Radiol Oncol","1983","1983/01/01","","","10.3109/02841868309135975"
"28248951","BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG","Kamat AM, Colombel M, Sundi D, Lamm D, Boehle A, Brausi M, Buckley R, Persad R, Palou J, Soloway M, Witjes JA.","Nat Rev Urol. 2017 Apr;14(4):244-255. doi: 10.1038/nrurol.2017.16. Epub 2017 Feb 21.","Kamat AM","Nat Rev Urol","2017","2017/03/02","","","10.1038/nrurol.2017.16"
"8734734","Radical cystectomy for stage T3b bladder cancer","Hall CM, Dinney CP.","Semin Urol Oncol. 1996 May;14(2):73-80.","Hall CM","Semin Urol Oncol","1996","1996/05/01","","",""
"1785380","[Current status of the conservative treatment of urinary bladder for invasive bladder cancer]","Ueda K, Sakagami H, Kato F, Mogami T, Ohtaguro K.","Hinyokika Kiyo. 1991 Dec;37(12):1597-9.","Ueda K","Hinyokika Kiyo","1991","1991/12/01","","",""
"11032951","Cathepsin B levels in urine from bladder cancer patients","Eiján AM, Sandes E, Puricelli L, Bal De Kier Joffé E, Casabé AR.","Oncol Rep. 2000 Nov-Dec;7(6):1395-9. doi: 10.3892/or.7.6.1395.","Eiján AM","Oncol Rep","2000","2000/10/18","","","10.3892/or.7.6.1395"
"15378645","Gene expression in the bladder carcinoma rat model","Ariel I, Ayesh S, Gofrit O, Ayesh B, Abdul-Ghani R, Pizov G, Smith Y, Sidi AA, Birman T, Schneider T, de Groot N, Hochberg A.","Mol Carcinog. 2004 Oct;41(2):69-76. doi: 10.1002/mc.20046.","Ariel I","Mol Carcinog","2004","2004/09/21","","","10.1002/mc.20046"
"3811308","[Long-term selective infusion of cis-diamminedichloroplatinum into the internal iliac arteries in the treatment of bladder cancer]","Granov AM, Anisimov VN, Fatale EG.","Vopr Onkol. 1987;33(1):42-5.","Granov AM","Vopr Onkol","1987","1987/01/01","","",""
"17347659","Quality-of-life assessment in patients with bladder cancer","Wright JL, Porter MP.","Nat Clin Pract Urol. 2007 Mar;4(3):147-54. doi: 10.1038/ncpuro0750.","Wright JL","Nat Clin Pract Urol","2007","2007/03/10","","","10.1038/ncpuro0750"
"11760347","[Etiopathology, risk factors, environmental influences and epidemiology of bladder cancer]","Kälble T.","Urologe A. 2001 Nov;40(6):447-50. doi: 10.1007/s001200170003.","Kälble T","Urologe A","2001","2002/01/05","","","10.1007/s001200170003"
"9148473","[Bladder tumor, metastasis from breast carcinoma. A case report with literature review]","Lund JA, Lundgren S.","Tidsskr Nor Laegeforen. 1997 Mar 20;117(8):1082-3.","Lund JA","Tidsskr Nor Laegeforen","1997","1997/03/20","","",""
"8997073","[Prognostic significance of carcinoma in situ and epithelial dysplasia accompanying bladder cancers]","Wajiki M.","Nihon Hinyokika Gakkai Zasshi. 1996 Dec;87(12):1269-76. doi: 10.5980/jpnjurol1989.87.1269.","Wajiki M","Nihon Hinyokika Gakkai Zasshi","1996","1996/12/01","","","10.5980/jpnjurol1989.87.1269"
"22399109","[Lymphadenectomy for bladder cancer: current status and controversies]","Metzger T, Thalmann GN, Zehnder P.","Urologe A. 2012 Mar;51(3):310-8. doi: 10.1007/s00120-012-2833-6.","Metzger T","Urologe A","2012","2012/03/09","","","10.1007/s00120-012-2833-6"
"26260193","Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival","Schmid SC, Zahel T, Haller B, Horn T, Metzger I, Holzapfel K, Seitz AK, Gschwend JE, Retz M, Maurer T.","World J Urol. 2016 Apr;34(4):569-76. doi: 10.1007/s00345-015-1654-9. Epub 2015 Aug 11.","Schmid SC","World J Urol","2016","2015/08/12","","","10.1007/s00345-015-1654-9"
"3884754","Risk assessment of a cohort exposed to aromatic amines. Initial results","Schulte PA, Ringen K, Hemstreet GP, Altekruse EB, Gullen WH, Patton MG, Allsbrook WC Jr, Crosby JH, West SS, Witherington R, et al.","J Occup Med. 1985 Feb;27(2):115-21.","Schulte PA","J Occup Med","1985","1985/02/01","","",""
"29284318","Pembrolizumab for the treatment of bladder cancer","Sundahl N, Rottey S, De Maeseneer D, Ost P.","Expert Rev Anticancer Ther. 2018 Feb;18(2):107-114. doi: 10.1080/14737140.2018.1421461. Epub 2017 Dec 29.","Sundahl N","Expert Rev Anticancer Ther","2018","2017/12/30","","","10.1080/14737140.2018.1421461"
"18815919","A meta-analysis on the association between bladder cancer and occupation","Reulen RC, Kellen E, Buntinx F, Brinkman M, Zeegers MP.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):64-78. doi: 10.1080/03008880802325192.","Reulen RC","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802325192"
"29126568","Treatment options and predictive factors for recurrence and cancer-specific mortality in bladder cancer after renal transplantation: A multi-institutional analysis","Rodriguez Faba O, Palou J, Vila Reyes H, Guirado L, Palazzetti A, Gontero P, Vigués F, Garcia-Olaverri J, Fernández Gómez JM, Olsburg J, Terrone C, Figueiredo A, Burgos J, Lledó E, Breda A.","Actas Urol Esp. 2017 Dec;41(10):639-645. doi: 10.1016/j.acuro.2017.05.007. Epub 2017 Nov 8.","Rodriguez Faba O","Actas Urol Esp","2017","2017/11/12","","","10.1016/j.acuro.2017.05.007"
"25579522","The usefulness of diffusion-weighted magnetic resonance imaging in bladder cancer staging and functional analysis","Yamada Y, Kobayashi S, Isoshima S, Arima K, Sakuma H, Sugimura Y.","J Cancer Res Ther. 2014 Oct-Dec;10(4):878-82. doi: 10.4103/0973-1482.138225.","Yamada Y","J Cancer Res Ther","2014","2015/01/13","","","10.4103/0973-1482.138225"
"23410637","PMN and anti-tumor immunity--the case of bladder cancer immunotherapy","Brincks EL, Risk MC, Griffith TS.","Semin Cancer Biol. 2013 Jun;23(3):183-9. doi: 10.1016/j.semcancer.2013.02.002. Epub 2013 Feb 11.","Brincks EL","Semin Cancer Biol","2013","2013/02/16","","","10.1016/j.semcancer.2013.02.002"
"9312452","[Possible etiologic role of occupational exposure to arsenic anhydride in a case of bladder carcinoma]","La Paglia G, Candura SM, Maira G, Cortese G, Tagliani M.","G Ital Med Lav. 1996 Jan-May;18(1-3):97-100.","La Paglia G","G Ital Med Lav","1996","1996/01/01","","",""
"25397626","Incidental detection of increased (18)F-FDG uptake and its follow-up in patients with granulomatous prostatitis after BCG treatment for urinary bladder cancer","Kim CY, Lee SW, Yoon G, Jeong SY, Ahn BC, Lee J.","Hell J Nucl Med. 2014 Sep-Dec;17(3):204-7. doi: 10.1967/s002449910146. Epub 2014 Nov 12.","Kim CY","Hell J Nucl Med","2014","2014/11/15","","","10.1967/s002449910146"
"23472134","Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies","Xu X, Wu J, Mao Y, Zhu Y, Hu Z, Xu X, Lin Y, Chen H, Zheng X, Qin J, Xie L.","PLoS One. 2013;8(3):e58079. doi: 10.1371/journal.pone.0058079. Epub 2013 Mar 5.","Xu X","PLoS One","2013","2013/03/09","PMC3589481","","10.1371/journal.pone.0058079"
"27269939","Comparative Effectiveness of Treatment Strategies for Bladder Cancer With Clinical Evidence of Regional Lymph Node Involvement","Galsky MD, Stensland K, Sfakianos JP, Mehrazin R, Diefenbach M, Mohamed N, Tsao CK, Boffetta P, Wiklund P, Oh WK, Mazumdar M, Ferket B.","J Clin Oncol. 2016 Aug 1;34(22):2627-35. doi: 10.1200/JCO.2016.67.5033. Epub 2016 Jun 6.","Galsky MD","J Clin Oncol","2016","2016/06/09","PMC5012691","","10.1200/JCO.2016.67.5033"
"6807460","Industrial bladder cancer","Vineis P.","Br Med J (Clin Res Ed). 1982 Jul 24;285(6337):295. doi: 10.1136/bmj.285.6337.295-c.","Vineis P","Br Med J (Clin Res Ed)","1982","1982/07/24","PMC1499639","","10.1136/bmj.285.6337.295-c"
"18592382","Dietary patterns and risk of bladder cancer: a factor analysis in Uruguay","De Stefani E, Boffetta P, Ronco AL, Deneo-Pellegrini H, Acosta G, Mendilaharsu M.","Cancer Causes Control. 2008 Dec;19(10):1243-9. doi: 10.1007/s10552-008-9195-9. Epub 2008 Jul 1.","De Stefani E","Cancer Causes Control","2008","2008/07/02","","","10.1007/s10552-008-9195-9"
"22177149","Systematic review of urological followup after spinal cord injury","Cameron AP, Rodriguez GM, Schomer KG.","J Urol. 2012 Feb;187(2):391-7. doi: 10.1016/j.juro.2011.10.020. Epub 2011 Dec 15.","Cameron AP","J Urol","2012","2011/12/20","","","10.1016/j.juro.2011.10.020"
"7920731","[Tumors of the upper urinary tract in patients following bladder tumors: multicentric locations or seeding? Apropos of 14 cases]","Ferriere JM, Parienté JL, Mettetal PJ, Allard P, Chabannes E, Maire J, Mevel O, Le Guillou M.","Prog Urol. 1994 Aug-Sep;4(4):563-8.","Ferriere JM","Prog Urol","1994","1994/08/01","","",""
"30509102","Downregulation of hsa_circ_0000285 serves as a prognostic biomarker for bladder cancer and is involved in cisplatin resistance","Chi BJ, Zhao DM, Liu L, Yin XZ, Wang FF, Bi S, Gui SL, Zhou SB, Qin WB, Wu DM, Wang SQ.","Neoplasma. 2019 Mar 5;66(2):197-202. doi: 10.4149/neo_2018_180318N185. Epub 2018 Sep 16.","Chi BJ","Neoplasma","2019","2018/12/05","","","10.4149/neo_2018_180318N185"
"24139504","Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach","Alberice JV, Amaral AF, Armitage EG, Lorente JA, Algaba F, Carrilho E, Márquez M, García A, Malats N, Barbas C.","J Chromatogr A. 2013 Nov 29;1318:163-70. doi: 10.1016/j.chroma.2013.10.002. Epub 2013 Oct 4.","Alberice JV","J Chromatogr A","2013","2013/10/22","","","10.1016/j.chroma.2013.10.002"
"23839861","Higher surgeon and hospital volume improves long-term survival after radical cystectomy","Kulkarni GS, Urbach DR, Austin PC, Fleshner NE, Laupacis A.","Cancer. 2013 Oct 1;119(19):3546-54. doi: 10.1002/cncr.28235. Epub 2013 Jul 9.","Kulkarni GS","Cancer","2013","2013/07/11","","","10.1002/cncr.28235"
"28247665","[The criteria of patient selection for repeat transurethral resection of non-muscle invasive bladder cancer]","Rolevich AI.","Urologiia. 2016 Apr;(2):71-76.","Rolevich AI","Urologiia","2016","2017/03/02","","",""
"17437435","Prognostic accuracy of an artificial neural network in patients undergoing radical cystectomy for bladder cancer: a comparison with logistic regression analysis","Bassi P, Sacco E, De Marco V, Aragona M, Volpe A.","BJU Int. 2007 May;99(5):1007-12. doi: 10.1111/j.1464-410X.2007.06755.x.","Bassi P","BJU Int","2007","2007/04/18","","","10.1111/j.1464-410X.2007.06755.x"
"3168348","Five year follow-up of patients with cancer of the bladder--the Northern Alberta experience","Koch M, McPhee MS, Gaedke H, Williams Y.","Clin Invest Med. 1988 Aug;11(4):253-8.","Koch M","Clin Invest Med","1988","1988/08/01","","",""
"872101","The curability of vesical cancer: greater now or then?","Marshall VF, McCarron JP Jr.","Cancer Res. 1977 Aug;37(8 Pt 2):2753-5.","Marshall VF","Cancer Res","1977","1977/08/01","","",""
"26786930","Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer","Galsky MD, Stensland KD, Moshier E, Sfakianos JP, McBride RB, Tsao CK, Casey M, Boffetta P, Oh WK, Mazumdar M, Wisnivesky JP.","J Clin Oncol. 2016 Mar 10;34(8):825-32. doi: 10.1200/JCO.2015.64.1076. Epub 2016 Jan 19.","Galsky MD","J Clin Oncol","2016","2016/01/21","","","10.1200/JCO.2015.64.1076"
"15765292","[Endobronchial metastasis from urinary bladder cancer]","Sakar A, Gencer N, Demireli P, Müezzinoğlu T, Celik P, Yorgancioğlu A.","Tuberk Toraks. 2005;53(1):75-9.","Sakar A","Tuberk Toraks","2005","2005/03/15","","",""
"31463832","Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion","Xin F, Yao DW, Fan L, Liu JH, Liu XD.","Clin Exp Med. 2019 Nov;19(4):525-534. doi: 10.1007/s10238-019-00576-5. Epub 2019 Aug 28.","Xin F","Clin Exp Med","2019","2019/08/30","","","10.1007/s10238-019-00576-5"
"7377464","Spindle cell cancer of bladder during cyclophosphamide therapy for Wegener's granulomatosis","Chasko SB, Keuhnelian JG, Gutowski WT 3rd, Gray GF.","Am J Surg Pathol. 1980 Apr;4(2):191-6. doi: 10.1097/00000478-198004000-00011.","Chasko SB","Am J Surg Pathol","1980","1980/04/01","","","10.1097/00000478-198004000-00011"
"26733306","Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy","Chen J, Wang L, Tang Y, Gong G, Liu L, Chen M, Chen Z, Cui Y, Li C, Cheng X, Qi L, Zu X.","J Exp Clin Cancer Res. 2016 Jan 6;35:2. doi: 10.1186/s13046-015-0282-y.","Chen J","J Exp Clin Cancer Res","2016","2016/01/07","PMC4702361","","10.1186/s13046-015-0282-y"
"23430447","Association of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer risk","Jaiswal PK, Tripathi N, Shukla A, Mittal RD.","Med Oncol. 2013 Jun;30(2):509. doi: 10.1007/s12032-013-0509-8. Epub 2013 Feb 21.","Jaiswal PK","Med Oncol","2013","2013/02/23","","","10.1007/s12032-013-0509-8"
"25023787","The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer","Grotenhuis AJ, Ebben CW, Aben KK, Witjes JA, Vrieling A, Vermeulen SH, Kiemeney LA.","Urol Oncol. 2015 Feb;33(2):65.e9-17. doi: 10.1016/j.urolonc.2014.06.002. Epub 2014 Jul 9.","Grotenhuis AJ","Urol Oncol","2015","2014/07/16","","","10.1016/j.urolonc.2014.06.002"
"7850328","Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced Bladder Cancer Overview Collaboration","","Br J Urol. 1995 Feb;75(2):206-13. doi: 10.1111/j.1464-410x.1995.tb07313.x.","","Br J Urol","1995","1995/02/01","","","10.1111/j.1464-410x.1995.tb07313.x"
"12394764","Immunohistochemical expression of metallothionein in human bladder cancer: correlation with histopathological parameters and patient survival","Saga Y, Hashimoto H, Yachiku S, Tokumitsu M, Kaneko S.","J Urol. 2002 Nov;168(5):2227-31. doi: 10.1097/01.ju.0000025940.78920.8a.","Saga Y","J Urol","2002","2002/10/24","","","10.1097/01.ju.0000025940.78920.8a"
"21938565","[Bladder cancer at an early age in father and son]","Ovsiannikov D, Stöhr R, Hartmann A, Böttrich R, Hengstler JG, Golka K.","Urologe A. 2011 Dec;50(12):1614-6. doi: 10.1007/s00120-011-2704-6.","Ovsiannikov D","Urologe A","2011","2011/09/23","","","10.1007/s00120-011-2704-6"
"30357502","Epigenetic Alterations in Bladder Cancer","Porten SP.","Curr Urol Rep. 2018 Oct 24;19(12):102. doi: 10.1007/s11934-018-0861-5.","Porten SP","Curr Urol Rep","2018","2018/10/26","","","10.1007/s11934-018-0861-5"
"28889388","Quantification of MicroRNAs in Urine-Derived Specimens","Fuessel S, Lohse-Fischer A, Vu Van D, Salomo K, Erdmann K, Wirth MP.","Methods Mol Biol. 2018;1655:201-226. doi: 10.1007/978-1-4939-7234-0_16.","Fuessel S","Methods Mol Biol","2018","2017/09/11","","","10.1007/978-1-4939-7234-0_16"
"23991964","MicroRNA-16 inhibits bladder cancer proliferation by targeting Cyclin D1","Jiang QQ, Liu B, Yuan T.","Asian Pac J Cancer Prev. 2013;14(7):4127-30. doi: 10.7314/apjcp.2013.14.7.4127.","Jiang QQ","Asian Pac J Cancer Prev","2013","2013/09/03","","","10.7314/apjcp.2013.14.7.4127"
"19176205","Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis","Nese N, Gupta R, Bui MH, Amin MB.","J Natl Compr Canc Netw. 2009 Jan;7(1):48-57. doi: 10.6004/jnccn.2009.0004.","Nese N","J Natl Compr Canc Netw","2009","2009/01/30","","","10.6004/jnccn.2009.0004"
"23604451","[Cystectomy in the elderly patient]","Bartsch G, Gust K, Vallo S, Bartsch C, Tsaur I, Mani J, Haferkamp A.","Urologe A. 2013 Jun;52(6):821-6. doi: 10.1007/s00120-013-3196-3.","Bartsch G","Urologe A","2013","2013/04/23","","","10.1007/s00120-013-3196-3"
"26706119","The decrease of cyclin B2 expression inhibits invasion and metastasis of bladder cancer","Lei CY, Wang W, Zhu YT, Fang WY, Tan WL.","Urol Oncol. 2016 May;34(5):237.e1-10. doi: 10.1016/j.urolonc.2015.11.011. Epub 2015 Dec 17.","Lei CY","Urol Oncol","2016","2015/12/27","","","10.1016/j.urolonc.2015.11.011"
"11101092","Indications for early cystectomy","Stein JP.","Semin Urol Oncol. 2000 Nov;18(4):289-95.","Stein JP","Semin Urol Oncol","2000","2000/12/02","","",""
"31026378","The encouraging role of long noncoding RNA small nuclear RNA host gene 16 in epithelial-mesenchymal transition of bladder cancer via directly acting on miR-17-5p/metalloproteinases 3 axis","Peng H, Li H.","Mol Carcinog. 2019 Aug;58(8):1465-1480. doi: 10.1002/mc.23028. Epub 2019 Apr 26.","Peng H","Mol Carcinog","2019","2019/04/27","","","10.1002/mc.23028"
"1399384","Post-herniorrhaphy paravesical granuloma simulating pelvic metastasis in a patient with bladder cancer","Neulander E, Kaneti J, Lissmer L, Hertzanu Y, Smailowitz Z, Barki Y.","Int Urol Nephrol. 1992;24(3):273-6. doi: 10.1007/BF02549535.","Neulander E","Int Urol Nephrol","1992","1992/01/01","","","10.1007/BF02549535"
"21105122","Bladder cancer: current management and opportunities for a personalized approach","Galsky MD, Hall SJ.","Mt Sinai J Med. 2010 Nov-Dec;77(6):587-96. doi: 10.1002/msj.20224.","Galsky MD","Mt Sinai J Med","2010","2010/11/25","","","10.1002/msj.20224"
"28796558","Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary","Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM.","J Oncol Pract. 2017 Sep;13(9):621-625. doi: 10.1200/JOP.2017.024919. Epub 2017 Aug 10.","Chang SS","J Oncol Pract","2017","2017/08/11","","","10.1200/JOP.2017.024919"
"3102424","Urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)-nitrosamine in an analbuminemic congenic strain of rats with an ACI genetic background","Nagase S, Shumiya S, Takahashi M, Maekawa A, Hayashi Y.","Jpn J Cancer Res. 1986 Dec;77(12):1198-200.","Nagase S","Jpn J Cancer Res","1986","1986/12/01","","",""
"16094056","Quality of care: partial cystectomy for bladder cancer--a case of inappropriate use?","Hollenbeck BK, Taub DA, Dunn RL, Wei JT.","J Urol. 2005 Sep;174(3):1050-4; discussion 1054. doi: 10.1097/01.ju.0000169477.30477.3d.","Hollenbeck BK","J Urol","2005","2005/08/12","","","10.1097/01.ju.0000169477.30477.3d"
"2782901","[The long-term prognosis of intra-arterial chemotherapy in invasive bladder cancer]","Miyanaga N, Noguchi R, Ohtani M, Kanoh S, Koiso K.","Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 2):2949-52.","Miyanaga N","Gan To Kagaku Ryoho","1989","1989/08/01","","",""
"29692199","The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review","Bosschieter J, Lutz C, Segerink LI, Vis AN, Zwarthoff EC, A van Moorselaar RJ, van Rhijn BW, Heymans MW, Jansma EP, Steenbergen RD, Nieuwenhuijzen JA.","Epigenomics. 2018 May;10(5):673-687. doi: 10.2217/epi-2017-0156. Epub 2018 Apr 25.","Bosschieter J","Epigenomics","2018","2018/04/26","","","10.2217/epi-2017-0156"
"12850529","Therapeutic approaches to bladder cancer: identifying targets and mechanisms","Cote RJ, Datar RH.","Crit Rev Oncol Hematol. 2003 Jun 27;46 Suppl:S67-83. doi: 10.1016/s1040-8428(03)00066-0.","Cote RJ","Crit Rev Oncol Hematol","2003","2003/07/10","","","10.1016/s1040-8428(03)00066-0"
"29363913","Immunohistochemical differentiation between muscularis mucosae and muscularis propria for improving the staging of bladder cancer in patients undergoing transurethral resection of bladder tumours","Poletajew S, Wolińska E, Wasiutyński A, Dybowski B, Radziszewski P, Górnicka B.","Pol J Pathol. 2017;68(3):218-224. doi: 10.5114/pjp.2017.71529.","Poletajew S","Pol J Pathol","2017","2018/01/25","","","10.5114/pjp.2017.71529"
"2250346","[Clinical assessment of thermoradiotherapy of breast cancer and cancer of the urinary bladder]","Hiraoka M, Masunaga S, Nishimura Y, Nagata Y, Li YP, Koishi M, Mitsumori M, Abe M, Takahashi M, Akuta K.","Gan No Rinsho. 1990 Oct;36(13):2267-71.","Hiraoka M","Gan No Rinsho","1990","1990/10/01","","",""
"25953449","Bladder cancer diagnosis: the role of CT urography","Capalbo E, Kluzer A, Peli M, Cosentino M, Berti E, Cariati M.","Tumori. 2015 Jul-Aug;101(4):412-7. doi: 10.5301/tj.5000331. Epub 2015 Apr 30.","Capalbo E","Tumori","2015","2015/05/09","","","10.5301/tj.5000331"
"27326408","Aberrantly expressed microRNAs in the context of bladder tumorigenesis","Lee JY, Ryu DS, Kim WJ, Kim SJ.","Investig Clin Urol. 2016 Jun;57 Suppl 1(Suppl 1):S52-9. doi: 10.4111/icu.2016.57.S1.S52. Epub 2016 Jun 10.","Lee JY","Investig Clin Urol","2016","2016/06/22","PMC4910763","","10.4111/icu.2016.57.S1.S52"
"26254697","Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: a paradigm for molecular subtyping of urothelial cell carcinoma of the bladder","Adam RM, DeGraff DJ.","Urol Oncol. 2015 Oct;33(10):444-50. doi: 10.1016/j.urolonc.2015.06.006. Epub 2015 Aug 5.","Adam RM","Urol Oncol","2015","2015/08/10","","","10.1016/j.urolonc.2015.06.006"
"7750528","BCG in perspective: advances in the treatment of superficial bladder cancer","Lamm DL.","Eur Urol. 1995;27 Suppl 1:2-8. doi: 10.1159/000475201.","Lamm DL","Eur Urol","1995","1995/01/01","","","10.1159/000475201"
"19890586","Metastatic bladder cancer presenting as duodenal obstruction","Hawtin K, Kent A, Collins C, Blunt D.","Ann Acad Med Singap. 2009 Oct;38(10):914-2.","Hawtin K","Ann Acad Med Singap","2009","2009/11/06","","",""
"24957559","Normal tissue sparing in a phase II trial on daily adaptive plan selection in radiotherapy for urinary bladder cancer","Vestergaard A, Muren LP, Lindberg H, Jakobsen KL, Petersen JB, Elstrøm UV, Agerbæk M, Høyer M.","Acta Oncol. 2014 Aug;53(8):997-1004. doi: 10.3109/0284186X.2014.928419. Epub 2014 Jun 24.","Vestergaard A","Acta Oncol","2014","2014/06/25","","","10.3109/0284186X.2014.928419"
"11043394","Epidemiology and biology of human urinary bladder cancer","Brauers A, Jakse G.","J Cancer Res Clin Oncol. 2000 Oct;126(10):575-83. doi: 10.1007/pl00008467.","Brauers A","J Cancer Res Clin Oncol","2000","2000/10/24","","","10.1007/pl00008467"
"25344601","Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer","Mitra AP, Lam LL, Ghadessi M, Erho N, Vergara IA, Alshalalfa M, Buerki C, Haddad Z, Sierocinski T, Triche TJ, Skinner EC, Davicioni E, Daneshmand S, Black PC.","J Natl Cancer Inst. 2014 Oct 24;106(11):dju290. doi: 10.1093/jnci/dju290. Print 2014 Nov.","Mitra AP","J Natl Cancer Inst","2014","2014/10/26","PMC4241889","","10.1093/jnci/dju290"
"6084949","[Adjuvant chemotherapy following total cystectomy for invasive bladder cancer with bleomycin, vincristine and methotrexate]","Takeuchi S, Yamada T, Sekine H, Katoh M, Washizuka M, Fukui I, Yokokawa M.","Hinyokika Kiyo. 1984 Nov;30(11):1619-25.","Takeuchi S","Hinyokika Kiyo","1984","1984/11/01","","",""
"30367600","The surgical technique and initial outcomes of Anatolian neobladder: a novel technique of ileal neobladder after radical cystectomy","Talat Z, Onal B, Cetinel B, Demirdag C, Citgez S, Dogan C.","BMC Urol. 2018 Oct 26;18(1):94. doi: 10.1186/s12894-018-0406-8.","Talat Z","BMC Urol","2018","2018/10/28","PMC6203991","","10.1186/s12894-018-0406-8"
"6489904","[Adjuvant topical doxorubicin therapy in bladder cancer]","Vecsey D, Pánykó E.","Fortschr Med. 1984 Sep 27;102(36):909-12.","Vecsey D","Fortschr Med","1984","1984/09/27","","",""
"19809887","Bladder cancer incidence and mortality rates compared to ecologic factors among states in America","Colli JL, Kolettis PN.","Int Urol Nephrol. 2010 Sep;42(3):659-65. doi: 10.1007/s11255-009-9655-5. Epub 2009 Oct 7.","Colli JL","Int Urol Nephrol","2010","2009/10/08","","","10.1007/s11255-009-9655-5"
"1807106","[Infiltrating transitional carcinoma of the bladder (I). Comparison of 2 groups treated with preoperative radiotherapy (long-term protocol and short-term protocol) + radical cystectomy versus radical cystectomy only. Analysis of local recurrence and metastasis]","Escudero Barrilero A, Allona A, Berenguer A, Burgos J, Castañeda A, Negrin A, Tellez M.","Actas Urol Esp. 1991 Mar-Apr;15(2):124-38.","Escudero Barrilero A","Actas Urol Esp","1991","1991/03/01","","",""
"29138560","Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice","Smilowitz HM, Tarmu LJ, Sanders MM, Taylor JA 3rd, Choudhary D, Xue C, Dyment NA, Sasso D, Deng X, Hainfeld JF.","Int J Nanomedicine. 2017 Oct 27;12:7937-7946. doi: 10.2147/IJN.S140977. eCollection 2017.","Smilowitz HM","Int J Nanomedicine","2017","2017/11/16","PMC5667800","","10.2147/IJN.S140977"
"31757302","Apaziquone for Nonmuscle Invasive Bladder Cancer: Where Are We Now?","Arends TJH, Alfred Witjes J.","Urol Clin North Am. 2020 Feb;47(1):73-82. doi: 10.1016/j.ucl.2019.09.009.","Arends TJH","Urol Clin North Am","2020","2019/11/24","","","10.1016/j.ucl.2019.09.009"
"15300144","Old friends, new ways: revisiting extended lymphadenectomy and neoadjuvant chemotherapy to improve outcomes","Busby JE, Evans CP.","Curr Opin Urol. 2004 Sep;14(5):251-7. doi: 10.1097/00042307-200409000-00002.","Busby JE","Curr Opin Urol","2004","2004/08/10","","","10.1097/00042307-200409000-00002"
"15292937","Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer","Matsumoto H, Matsuyama H, Fukunaga K, Yoshihiro S, Wada T, Naito K.","Br J Cancer. 2004 Sep 13;91(6):1025-31. doi: 10.1038/sj.bjc.6602073.","Matsumoto H","Br J Cancer","2004","2004/08/05","PMC2747707","","10.1038/sj.bjc.6602073"
"20388370","[Detection of bladder cancer by FISH test: a meta-analysis]","Zeng Z, Zhou XJ.","Zhonghua Bing Li Xue Za Zhi. 2010 Feb;39(2):75-8.","Zeng Z","Zhonghua Bing Li Xue Za Zhi","2010","2010/04/15","","",""
"11246738","The Nordic experience of cooperative urinary bladder cancer trials","Malmström PU, Rintala E, Hellsten S.","Semin Urol Oncol. 2001 Feb;19(1):69-70.","Malmström PU","Semin Urol Oncol","2001","2001/03/15","","",""
"23083857","Economic and humanistic consequences of preventable bladder tumor recurrences in nonmuscle invasive bladder cancer cases","Lee CT, Barocas D, Globe DR, Oefelein MG, Colayco DC, Bruno A, O'Day K, Bramley T.","J Urol. 2012 Dec;188(6):2114-9. doi: 10.1016/j.juro.2012.08.005. Epub 2012 Oct 18.","Lee CT","J Urol","2012","2012/10/23","","","10.1016/j.juro.2012.08.005"
"15250764","Spectroscopic detection of bladder cancer using near-infrared imaging techniques","Demos SG, Gandour-Edwards R, Ramsamooj R, deVere White R.","J Biomed Opt. 2004 Jul-Aug;9(4):767-71. doi: 10.1117/1.1753587.","Demos SG","J Biomed Opt","2004","2004/07/15","","","10.1117/1.1753587"
"30810403","Synthesis and characterization of gold nanoparticles from Abies spectabilis extract and its anticancer activity on bladder cancer T24 cells","Wu T, Duan X, Hu C, Wu C, Chen X, Huang J, Liu J, Cui S.","Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):512-523. doi: 10.1080/21691401.2018.1560305.","Wu T","Artif Cells Nanomed Biotechnol","2019","2019/02/28","","","10.1080/21691401.2018.1560305"
"9419913","The influence of ostomy surgery on body image in patients with cancer","Jenks JM, Morin KH, Tomaselli N.","Appl Nurs Res. 1997 Nov;10(4):174-80. doi: 10.1016/s0897-1897(97)80548-4.","Jenks JM","Appl Nurs Res","1997","1998/01/07","","","10.1016/s0897-1897(97)80548-4"
"21688007","Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness","Kobayashi S, Koga F, Yoshida S, Masuda H, Ishii C, Tanaka H, Komai Y, Yokoyama M, Saito K, Fujii Y, Kawakami S, Kihara K.","Eur Radiol. 2011 Oct;21(10):2178-86. doi: 10.1007/s00330-011-2174-7. Epub 2011 Jun 18.","Kobayashi S","Eur Radiol","2011","2011/06/21","","","10.1007/s00330-011-2174-7"
"25017607","Rare type of bladder cancer: malign fibrous histiocytoma","Celik O, Turk H, Budak S, Ilbey YO.","Arch Ital Urol Androl. 2014 Jun 30;86(2):158-9. doi: 10.4081/aiua.2014.2.158.","Celik O","Arch Ital Urol Androl","2014","2014/07/15","","","10.4081/aiua.2014.2.158"
"8345717","[Shock wave therapy of the rabbit VX2 bladder cancer--THP-ADM concentration in the tissue after combination therapy of THP-ADM and shock wave]","Suzuki K, Orikasa S, Hoshi S, Kuwahara M, Yoshikawa K, Ohyama C, Satou M, Kawamura S.","Nihon Hinyokika Gakkai Zasshi. 1993 Jun;84(6):1007-12. doi: 10.5980/jpnjurol1989.84.1007.","Suzuki K","Nihon Hinyokika Gakkai Zasshi","1993","1993/06/01","","","10.5980/jpnjurol1989.84.1007"
"31404517","Management of Urothelial Bladder Cancer in Clinical Practice: Real-World Answers to Difficult Questions","Mar N, Dayyani F.","J Oncol Pract. 2019 Aug;15(8):421-428. doi: 10.1200/JOP.19.00215.","Mar N","J Oncol Pract","2019","2019/08/13","","","10.1200/JOP.19.00215"
"23826418","UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy","Morikawa T, Kawai T, Abe H, Kume H, Homma Y, Fukayama M.","Int J Clin Exp Pathol. 2013 Jun 15;6(7):1367-74. Print 2013.","Morikawa T","Int J Clin Exp Pathol","2013","2013/07/05","PMC3693202","",""
"30022623","CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer","Zhang XG, Zhang T, Li CY, Zhang MH, Chen FM.","Cancer Med. 2018 Aug;7(8):3763-3772. doi: 10.1002/cam4.1607. Epub 2018 Jul 18.","Zhang XG","Cancer Med","2018","2018/07/20","PMC6089154","","10.1002/cam4.1607"
"29478100","Certain BCG-reactive responses are associated with bladder cancer prognosis","Shan G, Tang T, Qian H, Xia Y.","Cancer Immunol Immunother. 2018 May;67(5):797-803. doi: 10.1007/s00262-018-2127-y. Epub 2018 Feb 24.","Shan G","Cancer Immunol Immunother","2018","2018/02/26","","","10.1007/s00262-018-2127-y"
"7824966","Theoretical and experimental evidence on the use of glycosaminoglycans in BCG-mediated immunotherapy of superficial bladder cancer","Schamhart DH, De Boer EC, Vleeming R, Kurth KH.","Semin Thromb Hemost. 1994;20(3):301-9. doi: 10.1055/s-2007-1001917.","Schamhart DH","Semin Thromb Hemost","1994","1994/01/01","","","10.1055/s-2007-1001917"
"19244059","Bladder cancer detection with CT urography","Francica G, Scarano F.","Radiology. 2009 Mar;250(3):956; author reply 956-7. doi: 10.1148/radiol.2503081803.","Francica G","Radiology","2009","2009/02/27","","","10.1148/radiol.2503081803"
"22716490","Minimally invasive cystectomy approaches in the treatment of bladder cancer","Cheung G, Dasgupta P, Guru KA, Billia M, Khan MS.","Expert Rev Anticancer Ther. 2012 Jun;12(6):733-41. doi: 10.1586/era.12.52.","Cheung G","Expert Rev Anticancer Ther","2012","2012/06/22","","","10.1586/era.12.52"
"15912780","[Prognostic factors of superficial bladder cancer recurring after initial transurethral resection]","Nakata S, Nakano K, Takahashi H, Shimizu K.","Hinyokika Kiyo. 2005 Apr;51(4):229-33.","Nakata S","Hinyokika Kiyo","2005","2005/05/26","","",""
"9868391","[Prognostic factors of infiltrating bladder tumors]","Durdux C, Housset M.","Cancer Radiother. 1998 Sep-Oct;2(5):491-8. doi: 10.1016/s1278-3218(98)80057-7.","Durdux C","Cancer Radiother","1998","1998/12/30","","","10.1016/s1278-3218(98)80057-7"
"27402302","Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer","Hensley PJ, Zetter D, Horbinski CM, Strup SE, Kyprianou N.","Hum Pathol. 2016 Nov;57:68-77. doi: 10.1016/j.humpath.2016.06.020. Epub 2016 Jul 8.","Hensley PJ","Hum Pathol","2016","2016/07/13","PMC5629972","NIHMS889427","10.1016/j.humpath.2016.06.020"
"17896086","Pretreatment proliferation and local control in bladder cancer after radiotherapy with or without concurrent chemotherapy","Weiss C, Rödel F, Ott O, Engehausen DG, Papadopoulos T, Sauer R, Rödel C.","Strahlenther Onkol. 2007 Oct;183(10):552-6. doi: 10.1007/s00066-007-1766-2.","Weiss C","Strahlenther Onkol","2007","2007/09/27","","","10.1007/s00066-007-1766-2"
"19054166","Discrepancies between cytology, cystoscopy and biopsy in bladder cancer detection after Bacille Calmette-Guerin intravesical therapy","Hara T, Takahashi M, Gondo T, Nagao K, Ohmi C, Sakano S, Naito K, Matsuyama H.","Int J Urol. 2009 Feb;16(2):192-5. doi: 10.1111/j.1442-2042.2008.02200.x. Epub 2008 Nov 27.","Hara T","Int J Urol","2009","2008/12/05","","","10.1111/j.1442-2042.2008.02200.x"
"18979549","Radical therapy for muscle-infiltrating bladder cancer (cystectomy or radiotherapy): does age affect the final therapeutic benefit for the patient?","Kalogeras D, Lampri E, Goussia A, Bai M, Capizzello A, Tassiou I, Stavropoulos NE, Tsekeris P.","J BUON. 2008 Jul-Sep;13(3):353-8.","Kalogeras D","J BUON","2008","2008/11/04","","",""
"28960560","Angiogenesis in Schistosoma haematobium-associated urinary bladder cancer","Dematei A, Fernandes R, Soares R, Alves H, Richter J, Botelho MC.","APMIS. 2017 Dec;125(12):1056-1062. doi: 10.1111/apm.12756. Epub 2017 Sep 28.","Dematei A","APMIS","2017","2017/09/30","","","10.1111/apm.12756"
"24462386","Assessment of the radiation-equivalent of chemotherapy contributions in 1-phase radio-chemotherapy treatment of muscle-invasive bladder cancer","Plataniotis GA, Dale RG.","Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):927-32. doi: 10.1016/j.ijrobp.2013.11.242. Epub 2014 Jan 22.","Plataniotis GA","Int J Radiat Oncol Biol Phys","2014","2014/01/28","","","10.1016/j.ijrobp.2013.11.242"
"23360321","Photodynamic effect of 5-aminolevulinic acid-loaded nanoparticles on bladder cancer cells: a preliminary investigation","Yan X, Al-Hayek S, Huang H, Zhu Z, Zhu W, Guo H.","Scand J Urol. 2013 Apr;47(2):145-51. doi: 10.3109/00365599.2012.713000. Epub 2013 Jan 30.","Yan X","Scand J Urol","2013","2013/01/31","","","10.3109/00365599.2012.713000"
"26975668","Bladder Cancer Chemopreventive Agents: Current Knowledge and Concepts","Khajeh NR, Khoyilar C, Wu Y, Spradling K, Zi X, Youssef RF.","Mini Rev Med Chem. 2018;18(13):1143-1150. doi: 10.2174/1389557516666160315114132.","Khajeh NR","Mini Rev Med Chem","2018","2016/03/16","","","10.2174/1389557516666160315114132"
"19396568","The effects of neoadjuvant chemotherapy and chemo-radiation therapy on MRI staging in invasive bladder cancer: comparative study based on the pathological examination of whole layer bladder wall","Nishimura K, Fujiyama C, Nakashima K, Satoh Y, Tokuda Y, Uozumi J.","Int Urol Nephrol. 2009 Dec;41(4):869-75. doi: 10.1007/s11255-009-9566-5. Epub 2009 Apr 25.","Nishimura K","Int Urol Nephrol","2009","2009/04/28","","","10.1007/s11255-009-9566-5"
"31501397","[A Case of Adenocarcinoma of the Reconstructed Bladder 45 Years after Ileocystoplasty]","Tateoka J, Wada N, Tamaki G, Kikuchi D, Abe N, Tsuchida M, Banjo H, Hori J, Kita M, Kakizaki H.","Hinyokika Kiyo. 2019 Jul;65(7):305-308. doi: 10.14989/ActaUrolJap_65_7_305.","Tateoka J","Hinyokika Kiyo","2019","2019/09/11","","","10.14989/ActaUrolJap_65_7_305"
"30890547","CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer","Kiss B, van den Berg NS, Ertsey R, McKenna K, Mach KE, Zhang CA, Volkmer JP, Weissman IL, Rosenthal EL, Liao JC.","Clin Cancer Res. 2019 Jun 15;25(12):3561-3571. doi: 10.1158/1078-0432.CCR-18-3267. Epub 2019 Mar 19.","Kiss B","Clin Cancer Res","2019","2019/03/21","PMC7039531","NIHMS1523811","10.1158/1078-0432.CCR-18-3267"
"16129842","Lymphovascular invasion as an independent predictor of recurrence and survival in node-negative bladder cancer remains to be proven","Reuter VE.","J Clin Oncol. 2005 Sep 20;23(27):6450-1. doi: 10.1200/JCO.2005.05.033. Epub 2005 Aug 29.","Reuter VE","J Clin Oncol","2005","2005/09/01","","","10.1200/JCO.2005.05.033"
"12401701","Neo-adjuvant and adjuvant chemotherapy of bladder cancer: Is there a role?","Sternberg CN.","Ann Oncol. 2002;13 Suppl 4:273-9. doi: 10.1093/annonc/mdf670.","Sternberg CN","Ann Oncol","2002","2002/10/29","","","10.1093/annonc/mdf670"
"8701809","Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?","Hall RR.","Acta Urol Belg. 1996 May;64(2):39-42.","Hall RR","Acta Urol Belg","1996","1996/05/01","","",""
"7129911","[Value of impulse cytophotometry for the diagnosis and prognosis of bladder cancer]","Blech M, Zimmermann A, Truss F.","Helv Chir Acta. 1982 Aug;49(3-4):415-8.","Blech M","Helv Chir Acta","1982","1982/08/01","","",""
"31990119","Human papillomavirus and urinary bladder cancer revisited","Jørgensen KR, Jensen JB.","APMIS. 2020 Feb;128(2):72-79. doi: 10.1111/apm.13016. Epub 2020 Jan 28.","Jørgensen KR","APMIS","2020","2020/01/29","","","10.1111/apm.13016"
"16904815","Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series","Bartsch GC, Kuefer R, Gschwend JE, de Petriconi R, Hautmann RE, Volkmer BG.","Eur Urol. 2007 Mar;51(3):690-7; discussion 697-8. doi: 10.1016/j.eururo.2006.07.009. Epub 2006 Jul 28.","Bartsch GC","Eur Urol","2007","2006/08/15","","","10.1016/j.eururo.2006.07.009"
"7557903","The prognostic significance of vascular invasion in stage T1 bladder cancer","Lopez JI, Angulo JC.","Histopathology. 1995 Jul;27(1):27-33. doi: 10.1111/j.1365-2559.1995.tb00287.x.","Lopez JI","Histopathology","1995","1995/07/01","","","10.1111/j.1365-2559.1995.tb00287.x"
"1615584","Morphological aspects of the interaction of Bacillus Calmette-Guérin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity?","Teppema JS, de Boer EC, Steerenberg PA, van der Meijden AP.","Urol Res. 1992;20(3):219-28. doi: 10.1007/BF00299721.","Teppema JS","Urol Res","1992","1992/01/01","","","10.1007/BF00299721"
"21273609","The role of pelvic lymph node dissection during radical cystectomy for bladder cancer","Brunocilla E, Pernetti R, Martorana G.","Anticancer Res. 2011 Jan;31(1):271-5.","Brunocilla E","Anticancer Res","2011","2011/01/29","","",""
"31501534","The multifaceted immune regulation of bladder cancer","Schneider AK, Chevalier MF, Derré L.","Nat Rev Urol. 2019 Oct;16(10):613-630. doi: 10.1038/s41585-019-0226-y. Epub 2019 Sep 9.","Schneider AK","Nat Rev Urol","2019","2019/09/11","","","10.1038/s41585-019-0226-y"
"22898150","Metadherin is a novel prognostic marker for bladder cancer progression and overall patient survival","Zhou J, Li J, Wang Z, Yin C, Zhang W.","Asia Pac J Clin Oncol. 2012 Sep;8(3):e42-8. doi: 10.1111/j.1743-7563.2012.01541.x. Epub 2012 May 15.","Zhou J","Asia Pac J Clin Oncol","2012","2012/08/18","","","10.1111/j.1743-7563.2012.01541.x"
"4461908","[Indications for radiotherapy of bladder cancer with disorders of the urination function of the kidneys]","Mazovka NN.","Med Radiol (Mosk). 1974 Jan;19(1):17-24.","Mazovka NN","Med Radiol (Mosk)","1974","1974/01/01","","",""
"9624552","Preliminary results of bladder preservation by concurrent intraarterial chemotherapy and radiotherapy for muscle-invasive bladder cancer","Sumiyoshi Y, Hashine K, Karashima T, Kasahara K, Inoue Y.","Int J Urol. 1998 May;5(3):225-9. doi: 10.1111/j.1442-2042.1998.tb00594.x.","Sumiyoshi Y","Int J Urol","1998","1998/06/13","","","10.1111/j.1442-2042.1998.tb00594.x"
"3339758","Photosensitization treatment in bladder cancer","Droller MJ.","J Urol. 1988 Feb;139(2):390-1. doi: 10.1016/s0022-5347(17)42440-2.","Droller MJ","J Urol","1988","1988/02/01","","","10.1016/s0022-5347(17)42440-2"
"11176474","Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?","Brauers A, Buettner R, Jakse G.","J Urol. 2001 Mar;165(3):808-10.","Brauers A","J Urol","2001","2001/02/15","","",""
"27717367","A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort","Goodison S, Ogawa O, Matsui Y, Kobayashi T, Miyake M, Ohnishi S, Fujimoto K, Dai Y, Shimizu Y, Tsukikawa K, Furuya H, Rosser CJ.","J Transl Med. 2016 Oct 7;14(1):287. doi: 10.1186/s12967-016-1043-1.","Goodison S","J Transl Med","2016","2016/10/09","PMC5055716","","10.1186/s12967-016-1043-1"
"14992333","Bladder cancer in patients with spinal cord injury","Hess MJ, Zhan EH, Foo DK, Yalla SV.","J Spinal Cord Med. 2003 Winter;26(4):335-8. doi: 10.1080/10790268.2003.11753702.","Hess MJ","J Spinal Cord Med","2003","2004/03/03","","","10.1080/10790268.2003.11753702"
"28870814","Curcumin inhibits bladder cancer stem cells by suppressing Sonic Hedgehog pathway","Wang D, Kong X, Li Y, Qian W, Ma J, Wang D, Yu D, Zhong C.","Biochem Biophys Res Commun. 2017 Nov 4;493(1):521-527. doi: 10.1016/j.bbrc.2017.08.158. Epub 2017 Sep 4.","Wang D","Biochem Biophys Res Commun","2017","2017/09/06","","","10.1016/j.bbrc.2017.08.158"
"11233839","Radiotherapy is an effective treatment for high-risk T1-bladder cancer","Rödel C, Dunst J, Grabenbauer GG, Kühn R, Papadopoulos T, Schrott KM, Sauer R.","Strahlenther Onkol. 2001 Feb;177(2):82-8; discussion 89. doi: 10.1007/pl00002387.","Rödel C","Strahlenther Onkol","2001","2001/03/10","","","10.1007/pl00002387"
"19347288","Application of phage display to discovery of tumor-specific homing peptides: developing strategies for therapy and molecular imaging of cancer","Seung-Min L, Gil-Suk Y, Eun-Sang Y, Tae-Gyun K, In-San K, Byung-Heon L.","Methods Mol Biol. 2009;512:355-63. doi: 10.1007/978-1-60327-530-9_20.","Seung-Min L","Methods Mol Biol","2009","2009/04/07","","","10.1007/978-1-60327-530-9_20"
"30203936","The pathologist's role in the detection of rare variants of bladder cancer and analysis of the impact on incidence and type detection","Mantica G, Simonato A, Du Plessis DE, Maffezzini M, De Rose AF, van der Merwe A, Terrone C.","Minerva Urol Nefrol. 2018 Dec;70(6):594-597. doi: 10.23736/S0393-2249.18.03175-2. Epub 2018 Sep 10.","Mantica G","Minerva Urol Nefrol","2018","2018/09/12","","","10.23736/S0393-2249.18.03175-2"
"12942717","[Radical treatment of invasive bladder cancer]","Lopatkin NA, Darenkov SP, Chernyshev NV, Sokolov AE, Gorilovskiĭ ML, Akmatov NA, Samsonov IuV.","Urologiia. 2003 Jul-Aug;(4):3-8.","Lopatkin NA","Urologiia","2003","2003/08/29","","",""
"29471601","[Bladder Rupture during Intravesical BCG Therapy : A Case Report]","Iemura Y, Fukui S, Matsumura Y, Kagebayashi Y, Toyoshima Y, Inoue T, Samma S.","Hinyokika Kiyo. 2018 Jan;64(1):25-28. doi: 10.14989/ActaUrolJap_64_1_25.","Iemura Y","Hinyokika Kiyo","2018","2018/02/23","","","10.14989/ActaUrolJap_64_1_25"
"26126604","An online tool for evaluating diagnostic and prognostic gene expression biomarkers in bladder cancer","Dancik GM.","BMC Urol. 2015 Jul 1;15:59. doi: 10.1186/s12894-015-0056-z.","Dancik GM","BMC Urol","2015","2015/07/02","PMC4487975","","10.1186/s12894-015-0056-z"
"4036737","[Total cystectomy for urinary bladder cancer: clinicopathological study of 95 cases]","Murase T, Takashi M, Aota Y, Shimoji T, Miyake K, Mitsuya H.","Hinyokika Kiyo. 1985 Apr;31(4):615-21.","Murase T","Hinyokika Kiyo","1985","1985/04/01","","",""
"2450642","Motor exhaust-related occupations and bladder cancer","Wynder EL, Miller S.","Cancer Res. 1988 Apr 1;48(7):1989-90.","Wynder EL","Cancer Res","1988","1988/04/01","","",""
"11196186","Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells","Simon R, Eltze E, Schäfer KL, Bürger H, Semjonow A, Hertle L, Dockhorn-Dworniczak B, Terpe HJ, Böcker W.","Cancer Res. 2001 Jan 1;61(1):355-62.","Simon R","Cancer Res","2001","2001/02/24","","",""
"18320942","[New developments in the treatment of muscle-invasive bladder cancer]","Kerst JM, Pos FJ, Visser O, Horenblas S.","Ned Tijdschr Geneeskd. 2008 Jan 26;152(4):187-92.","Kerst JM","Ned Tijdschr Geneeskd","2008","2008/03/07","","",""
"11729476","[Neoadjuvant chemotherapy for invasive bladder cancer]","Kageyama Y, Kihara K.","Gan To Kagaku Ryoho. 2001 Nov;28(12):1838-44.","Kageyama Y","Gan To Kagaku Ryoho","2001","2001/12/04","","",""
"2402614","Scanning electron microscopy of immuno-gold labeled antigens associated with bladder cancer","de Harven E, Connolly JG, Wang Y, Hanna W, Bootsma G.","Scanning Microsc. 1990 Jun;4(2):467-76; discussion 476-7.","de Harven E","Scanning Microsc","1990","1990/06/01","","",""
"10696241","Surgical management of noninvasive bladder cancer (stages Ta/T1/CIS)","Holzbeierlein JM, Smith JA Jr.","Urol Clin North Am. 2000 Feb;27(1):15-24, vii-viii. doi: 10.1016/s0094-0143(05)70230-5.","Holzbeierlein JM","Urol Clin North Am","2000","2000/03/04","","","10.1016/s0094-0143(05)70230-5"
"15474281","The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines","van der Heijden AG, Jansen CF, Verhaegh G, O'donnell MA, Schalken JA, Witjes JA.","Eur Urol. 2004 Nov;46(5):670-4. doi: 10.1016/j.eururo.2004.06.009.","van der Heijden AG","Eur Urol","2004","2004/10/12","","","10.1016/j.eururo.2004.06.009"
"22991056","[Direct health care costs of lung and bladder cancer attributable to work. Spain, 2008]","García Gómez M, Urbanos Garrido R, Castañeda López R, López Menduiña P.","Rev Esp Salud Publica. 2012 Mar-Apr;86(2):127-38. doi: 10.1590/S1135-57272012000200002.","García Gómez M","Rev Esp Salud Publica","2012","2012/09/20","","","10.1590/S1135-57272012000200002"
"11869621","Surgery versus radiotherapy for muscle invasive bladder cancer","Shelley MD, Barber J, Wilt T, Mason MD.","Cochrane Database Syst Rev. 2002;(1):CD002079. doi: 10.1002/14651858.CD002079.","Shelley MD","Cochrane Database Syst Rev","2002","2002/03/01","","","10.1002/14651858.CD002079"
"27597124","Recent progress with next-generation biomarkers in muscle-invasive bladder cancer","Contreras-Sanz A, Roberts ME, Seiler R, Black PC.","Int J Urol. 2017 Jan;24(1):7-15. doi: 10.1111/iju.13193. Epub 2016 Sep 6.","Contreras-Sanz A","Int J Urol","2017","2016/09/07","","","10.1111/iju.13193"
"25574842","NOTCH pathway inactivation promotes bladder cancer progression","Maraver A, Fernandez-Marcos PJ, Cash TP, Mendez-Pertuz M, Dueñas M, Maietta P, Martinelli P, Muñoz-Martin M, Martínez-Fernández M, Cañamero M, Roncador G, Martinez-Torrecuadrada JL, Grivas D, de la Pompa JL, Valencia A, Paramio JM, Real FX, Serrano M.","J Clin Invest. 2015 Feb;125(2):824-30. doi: 10.1172/JCI78185. Epub 2015 Jan 9.","Maraver A","J Clin Invest","2015","2015/01/10","PMC4319408","","10.1172/JCI78185"
"30145816","Activation of type 4 metabotropic glutamate receptor promotes cell apoptosis and inhibits proliferation in bladder cancer","Zhang Z, Liu Y, Wang K, Zhu K, Zheng X, Wang L, Luan Y, Wang X, Lu H, Wu K, Chen X, He D, Liu Y.","J Cell Physiol. 2019 Mar;234(3):2741-2755. doi: 10.1002/jcp.27089. Epub 2018 Aug 26.","Zhang Z","J Cell Physiol","2019","2018/08/27","","","10.1002/jcp.27089"
"2771989","BCG in superficial bladder cancer. EORTC Genitourinary Group Monograph 6. Proceedings of a meeting. Kerkrade, The Netherlands, September 7-8, 1988","","Prog Clin Biol Res. 1989;310:1-381.","","Prog Clin Biol Res","1989","1989/01/01","","",""
"621810","Comments on the staging of invasive bladder cancer two B's or not two B's: that is the question (apologies to Shakespeare, Hamlet. Act III, sc. I, 1. 56)","Jewett HJ.","J Urol. 1978 Jan;119(1):39. doi: 10.1016/s0022-5347(17)57374-7.","Jewett HJ","J Urol","1978","1978/01/01","","","10.1016/s0022-5347(17)57374-7"
"18604731","Pax-5 protein expression in bladder cancer: a preliminary study that shows no correlation to grade, stage or clinical outcome","Denzinger S, Burger M, Hammerschmied CG, Wieland WF, Hartmann A, Obermann EC, Stoehr R.","Pathology. 2008 Aug;40(5):465-9. doi: 10.1080/00313020802197871.","Denzinger S","Pathology","2008","2008/07/08","","","10.1080/00313020802197871"
"16425727","[Role of the combination of external radiotherapy--partial cystectomy--interstitial brachytherapy in pT1 G3, pT2 and pT3 bladder tumors]","Jordana F, Lagrange JL, Gérard JP, Amiel J.","Ann Urol (Paris). 2005 Nov;39 Suppl 5:S104-12.","Jordana F","Ann Urol (Paris)","2005","2006/01/24","","",""
"8900425","Homozygous deletions of p16(INK4) occur frequently in bilharziasis-associated bladder cancer","Tamimi Y, Bringuier PP, Smit F, van Bokhoven A, Abbas A, Debruyne FM, Schalken JA.","Int J Cancer. 1996 Oct 9;68(2):183-7. doi: 10.1002/(SICI)1097-0215(19961009)68:2<183::AID-IJC7>3.0.CO;2-U.","Tamimi Y","Int J Cancer","1996","1996/10/09","","","10.1002/(SICI)1097-0215(19961009)68:2<183::AID-IJC7>3.0.CO;2-U"
"17406798","Organ-sparing treatment of advanced bladder cancer: paclitaxel as a radiosensitizer","Müller AC, Diestelhorst A, Kuhnt T, Kühn R, Fornara P, Scholz HJ, Dunst J, Zietman AL.","Strahlenther Onkol. 2007 Apr;183(4):177-83. doi: 10.1007/s00066-007-1651-z.","Müller AC","Strahlenther Onkol","2007","2007/04/05","","","10.1007/s00066-007-1651-z"
"23446284","[Bladder tumor targeting by Hexvix(®) fluorescence: 4 years results after prospective monocentric evaluation]","Ferré A, Cordonnier C, Demailly M, Hakami F, Sevestre H, Saint F.","Prog Urol. 2013 Mar;23(3):195-202. doi: 10.1016/j.purol.2012.12.002. Epub 2013 Jan 9.","Ferré A","Prog Urol","2013","2013/03/01","","","10.1016/j.purol.2012.12.002"
"10088958","Polyarthritis as a complication of intravesical bacillus Calmette-Guerin immunotherapy for bladder cancer","Onur O, Celiker R.","Clin Rheumatol. 1999;18(1):74-6. doi: 10.1007/s100670050059.","Onur O","Clin Rheumatol","1999","1999/03/24","","","10.1007/s100670050059"
"23589321","Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer","Kobayashi S, Koga F, Kajino K, Yoshita S, Ishii C, Tanaka H, Saito K, Masuda H, Fujii Y, Yamada T, Kihara K.","J Magn Reson Imaging. 2014 Jan;39(1):172-8. doi: 10.1002/jmri.24148. Epub 2013 Apr 15.","Kobayashi S","J Magn Reson Imaging","2014","2013/04/17","","","10.1002/jmri.24148"
"10565741","Tea consumption: fluid intake and bladder cancer risk in Southern Taiwan","Lu CM, Lan SJ, Lee YH, Huang JK, Huang CH, Hsieh CC.","Urology. 1999 Nov;54(5):823-8. doi: 10.1016/s0090-4295(99)00281-2.","Lu CM","Urology","1999","1999/11/24","","","10.1016/s0090-4295(99)00281-2"
"27530435","Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy","Moschini M, Soria F, Klatte T, Wirth GJ, Özsoy M, Gust K, Briganti A, Roupret M, Susani M, Haitel A, Shariat SF.","Clin Genitourin Cancer. 2017 Apr;15(2):e267-e273. doi: 10.1016/j.clgc.2016.07.014. Epub 2016 Jul 22.","Moschini M","Clin Genitourin Cancer","2017","2016/08/18","","","10.1016/j.clgc.2016.07.014"
"17448680","Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers","Alexander BH, Olsen GW.","Ann Epidemiol. 2007 Jun;17(6):471-8. doi: 10.1016/j.annepidem.2007.01.036. Epub 2007 Apr 19.","Alexander BH","Ann Epidemiol","2007","2007/04/24","","","10.1016/j.annepidem.2007.01.036"
"9649247","Is the role of cystoscopy in the detection of bladder cancer really declining?","Badalament RA.","J Urol. 1998 Feb;159(2):399-400. doi: 10.1016/s0022-5347(01)63931-4.","Badalament RA","J Urol","1998","1998/07/02","","","10.1016/s0022-5347(01)63931-4"
"9275378","Long-term results of intravesical N-CWS therapy for preventing bladder cancer recurrence after operation","Chen S, Lin Z, Ye C, Xu E.","Chin Med J (Engl). 1996 Nov;109(11):890-1.","Chen S","Chin Med J (Engl)","1996","1996/11/01","","",""
"9807889","[Overcoming pitfalls: vesical substitution in women with bladder cancer]","Martínez-Sagarra JM.","Arch Esp Urol. 1998 Sep;51(7):641-3.","Martínez-Sagarra JM","Arch Esp Urol","1998","1998/11/10","","",""
"29232802","[Sarcomatoid Urothelial Carcinoma of the Bladder Including an Osteosarcoma Element]","Tanuma K, Kawai K, Tsuchiya H, Matsumoto Y, Kandori S, Kojima T, Kimura T, Joraku A, Miyazaki J, Nishiyama H, Sakata A.","Hinyokika Kiyo. 2017 Nov;63(11):487-492. doi: 10.14989/ActaUrolJap_63_11_487.","Tanuma K","Hinyokika Kiyo","2017","2017/12/13","","","10.14989/ActaUrolJap_63_11_487"
"23711293","Prognostic impact of preoperative hematological disorders and a risk stratification model in bladder cancer patients treated with radical cystectomy","Sejima T, Morizane S, Yao A, Isoyama T, Saito M, Amisaki T, Koumi T, Takenaka A.","Int J Urol. 2014 Jan;21(1):52-7. doi: 10.1111/iju.12161. Epub 2013 May 27.","Sejima T","Int J Urol","2014","2013/05/29","","","10.1111/iju.12161"
"23649653","Association between MTHFR Ala222Val (rs1801133) polymorphism and bladder cancer susceptibility: a systematic review and meta-analysis","Li K, Hu Yp, Yang Z, Sun T.","Tumour Biol. 2013 Oct;34(5):2565-72. doi: 10.1007/s13277-013-0802-3. Epub 2013 May 7.","Li K","Tumour Biol","2013","2013/05/08","","","10.1007/s13277-013-0802-3"
"24355418","Cisplatin-ineligible and chemotherapy-ineligible patients should be the focus of new drug development in patients with advanced bladder cancer","Sonpavde G, Galsky MD, Latini D, Chen GJ.","Clin Genitourin Cancer. 2014 Apr;12(2):71-3. doi: 10.1016/j.clgc.2013.11.016. Epub 2013 Nov 14.","Sonpavde G","Clin Genitourin Cancer","2014","2013/12/21","","","10.1016/j.clgc.2013.11.016"
"15736398","[Biologic characteristics of invasive bladder cancer: is there a difference between primary and progressive tumours?]","Hornák M, Bárdos A.","Rozhl Chir. 2004 Dec;83(12):648-50.","Hornák M","Rozhl Chir","2004","2005/03/02","","",""
"9839616","Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells","Lokeshwar VB, Soloway MS, Block NL.","Cancer Lett. 1998 Sep 11;131(1):21-7. doi: 10.1016/s0304-3835(98)00197-9.","Lokeshwar VB","Cancer Lett","1998","1998/12/05","","","10.1016/s0304-3835(98)00197-9"
"9508078","New methods for detection of bladder cancer","Grossman HB.","Semin Urol Oncol. 1998 Feb;16(1):17-22.","Grossman HB","Semin Urol Oncol","1998","1998/03/21","","",""
"18595224","The role of partial cystectomy in treatment of muscle invasive bladder cancer","Vukotic V, Lazic M, Savic S, Cerovic S, Kojic D.","Acta Chir Iugosl. 2007;54(4):25-7. doi: 10.2298/aci0704025v.","Vukotic V","Acta Chir Iugosl","2007","2008/07/04","","","10.2298/aci0704025v"
"26544730","Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription","Gao Y, Wu K, Chen Y, Zhou J, Du C, Shi Q, Xu S, Jia J, Tang X, Li F, Hui K, He D, Guo P.","Oncotarget. 2015 Dec 22;6(41):43791-805. doi: 10.18632/oncotarget.6101.","Gao Y","Oncotarget","2015","2015/11/07","PMC4791267","","10.18632/oncotarget.6101"
"22178231","Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis","Lin HY, Yang MC, Huang CH, Wu WJ, Yu TJ, Lung FW.","Urol Oncol. 2013 Oct;31(7):1231-41. doi: 10.1016/j.urolonc.2011.11.031. Epub 2011 Dec 16.","Lin HY","Urol Oncol","2013","2011/12/20","","","10.1016/j.urolonc.2011.11.031"
"27589936","Perioperative change in neutrophil-lymphocyte ratio predicts the overall survival of patients with bladder cancer undergoing radical cystectomy","Yoshida T, Kinoshita H, Yoshida K, Mishima T, Yanishi M, Komai Y, Sugi M, Murota T, Kawa G, Matsuda T.","Jpn J Clin Oncol. 2016 Dec;46(12):1162-1167. doi: 10.1093/jjco/hyw129. Epub 2016 Sep 2.","Yoshida T","Jpn J Clin Oncol","2016","2016/09/04","","","10.1093/jjco/hyw129"
"12705995","Centrosome hyperamplification and chromosomal instability in bladder cancer","Kawamura K, Moriyama M, Shiba N, Ozaki M, Tanaka T, Nojima T, Fujikawa-Yamamoto K, Ikeda R, Suzuki K.","Eur Urol. 2003 May;43(5):505-15. doi: 10.1016/s0302-2838(03)00056-3.","Kawamura K","Eur Urol","2003","2003/04/23","","","10.1016/s0302-2838(03)00056-3"
"16530074","DNA-based molecular cytology for bladder cancer surveillance","Jones JS.","Urology. 2006 Mar;67(3 Suppl 1):35-45; discussion 45-7. doi: 10.1016/j.urology.2006.01.039.","Jones JS","Urology","2006","2006/03/15","","","10.1016/j.urology.2006.01.039"
"23632476","Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk","Wang J, Wu X, Kamat A, Barton Grossman H, Dinney CP, Lin J.","Br J Cancer. 2013 Jun 11;108(11):2372-80. doi: 10.1038/bjc.2013.190. Epub 2013 Apr 30.","Wang J","Br J Cancer","2013","2013/05/02","PMC3681021","","10.1038/bjc.2013.190"
"25839773","BK virus as a potential oncovirus for bladder cancer in a renal transplant patient","Yin WY, Lee MC, Lai NS, Lu MC.","J Formos Med Assoc. 2015 Apr;114(4):373-4. doi: 10.1016/j.jfma.2012.02.019. Epub 2012 Jun 7.","Yin WY","J Formos Med Assoc","2015","2015/04/04","","","10.1016/j.jfma.2012.02.019"
"21849181","Presacral and retroperitoneal lymph node involvement in urothelial bladder cancer: results of a prospective mapping study","Miocinovic R, Gong MC, Ghoneim IA, Fergany AF, Hansel DE, Stephenson AJ.","J Urol. 2011 Oct;186(4):1269-73. doi: 10.1016/j.juro.2011.05.088. Epub 2011 Aug 17.","Miocinovic R","J Urol","2011","2011/08/19","","","10.1016/j.juro.2011.05.088"
"8078309","Malignancy grading in bladder cancer","Cramer SF.","Lab Invest. 1994 Aug;71(2):316-7.","Cramer SF","Lab Invest","1994","1994/08/01","","",""
"1214307","Pattern of bladder cancer in the Sudan and its relation to schistosomiasis: a study of 255 vesical carcinomas","Malik MO, Veress B, Daoud EH, El-Hassan AM.","J Trop Med Hyg. 1975 Oct-Nov;78(10-11):219-23.","Malik MO","J Trop Med Hyg","1975","1975/10/01","","",""
"7028242","Randomized trial of standard therapy with or without poly I:C in patients with superficial bladder cancer","Kemeny N, Yagoda A, Wang Y, Field K, Wrobleski H, Whitmore W.","Cancer. 1981 Nov 15;48(10):2154-7. doi: 10.1002/1097-0142(19811115)48:10<2154::aid-cncr2820481006>3.0.co;2-x.","Kemeny N","Cancer","1981","1981/11/15","","","10.1002/1097-0142(19811115)48:10<2154::aid-cncr2820481006>3.0.co;2-x"
"28923856","Genomic Activation of PPARG Reveals a Candidate Therapeutic Axis in Bladder Cancer","Goldstein JT, Berger AC, Shih J, Duke FF, Furst L, Kwiatkowski DJ, Cherniack AD, Meyerson M, Strathdee CA.","Cancer Res. 2017 Dec 15;77(24):6987-6998. doi: 10.1158/0008-5472.CAN-17-1701. Epub 2017 Sep 18.","Goldstein JT","Cancer Res","2017","2017/09/20","PMC5835321","NIHMS907696","10.1158/0008-5472.CAN-17-1701"
"29037814","Piperlongumine suppresses bladder cancer invasion via inhibiting epithelial mesenchymal transition and F-actin reorganization","Liu D, Qiu XY, Wu X, Hu DX, Li CY, Yu SB, Pan F, Chen XQ.","Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):165-172. doi: 10.1016/j.bbrc.2017.10.061. Epub 2017 Oct 14.","Liu D","Biochem Biophys Res Commun","2017","2017/10/18","","","10.1016/j.bbrc.2017.10.061"
"2305560","[Effects of forced diuresis on butylbutanolnitrosamine induction of bladder tumors in rats]","Pliss GB, Frolov AG.","Vopr Onkol. 1990;36(1):33-6.","Pliss GB","Vopr Onkol","1990","1990/01/01","","",""
"6790154","The effect of thio-TEPA on developing and established mammalian bladder tumors","Murphy WM, Soloway MS.","Cancer. 1980 Mar 1;45(5):870-5. doi: 10.1002/1097-0142(19800301)45:5<870::aid-cncr2820450508>3.0.co;2-h.","Murphy WM","Cancer","1980","1980/03/01","","","10.1002/1097-0142(19800301)45:5<870::aid-cncr2820450508>3.0.co;2-h"
"31645400","Primary clear-cell urothelial carcinoma of urinary bladder: a not-so-clear entity with review of literature","Kumar L, Narwal A, Kumar M, Kaushal S.","BMJ Case Rep. 2019 Oct 23;12(10):e231192. doi: 10.1136/bcr-2019-231192.","Kumar L","BMJ Case Rep","2019","2019/10/25","PMC6827777","","10.1136/bcr-2019-231192"
"25483834","Inter- and intra-fractional bladder motion during radiotherapy for bladder cancer: a comparison of full and empty bladders","Dees-Ribbers HM, Betgen A, Pos FJ, Witteveen T, Remeijer P, van Herk M.","Radiother Oncol. 2014 Nov;113(2):254-9. doi: 10.1016/j.radonc.2014.08.019.","Dees-Ribbers HM","Radiother Oncol","2014","2014/12/09","","","10.1016/j.radonc.2014.08.019"
"3481419","[Cytogenetic analysis of human urinary bladder cancer]","Moriyama M.","Nihon Hinyokika Gakkai Zasshi. 1987 Aug;78(8):1295-305. doi: 10.5980/jpnjurol1928.78.8_1295.","Moriyama M","Nihon Hinyokika Gakkai Zasshi","1987","1987/08/01","","","10.5980/jpnjurol1928.78.8_1295"
"31724997","En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature","Mori K, D'Andrea D, Enikeev DV, Egawa S, Shariat SF.","Curr Opin Urol. 2020 Jan;30(1):41-47. doi: 10.1097/MOU.0000000000000697.","Mori K","Curr Opin Urol","2020","2019/11/15","","","10.1097/MOU.0000000000000697"
"936365","Epidemiology of bladder cancer","Morrison AS, Cole P.","Urol Clin North Am. 1976 Feb;3(1):13-29.","Morrison AS","Urol Clin North Am","1976","1976/02/01","","",""
"18702824","DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection","Negraes PD, Favaro FP, Camargo JL, Oliveira ML, Goldberg J, Rainho CA, Salvadori DM.","BMC Cancer. 2008 Aug 14;8:238. doi: 10.1186/1471-2407-8-238.","Negraes PD","BMC Cancer","2008","2008/08/16","PMC2527332","","10.1186/1471-2407-8-238"
"8959319","Characterization of the DD23 tumor-associated antigen for bladder cancer detection and recurrence monitoring. Marker Network for Bladder Cancer","Bonner RB, Liebert M, Hurst RE, Grossman HB, Bane BL, Hemstreet GP 3rd.","Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):971-8.","Bonner RB","Cancer Epidemiol Biomarkers Prev","1996","1996/12/01","","",""
"10425290","Chemoimmunosensitization of the T24 human bladder cancer line to Fas-mediated cytotoxicity and apoptosis by cisplatin and 5-fluorouracil","Mizutani Y, Wu XX, Yoshida O, Shirasaka T, Bonavida B.","Oncol Rep. 1999 Sep-Oct;6(5):979-82. doi: 10.3892/or.6.5.979.","Mizutani Y","Oncol Rep","1999","1999/07/30","","","10.3892/or.6.5.979"
"26375441","GOLPH3 is a potential therapeutic target and a prognostic indicator of poor survival in bladder cancer treated by cystectomy","Zhang Q, Zhuang J, Deng Y, Zhao X, Tang B, Yao D, Zhao W, Chang C, Lu Q, Chen W, Zhang S, Ji C, Cao L, Guo H.","Oncotarget. 2015 Oct 13;6(31):32177-92. doi: 10.18632/oncotarget.4867.","Zhang Q","Oncotarget","2015","2015/09/17","PMC4741668","","10.18632/oncotarget.4867"
"16316941","Lack of urinary bladder carcinogenicity of sodium L-ascorbate in human c-Ha-ras proto-oncogene transgenic rats","Morimura K, Kang JS, Wei M, Wanibuchi H, Tsuda H, Fukushima S.","Toxicol Pathol. 2005;33(7):764-7. doi: 10.1080/01926230500416336.","Morimura K","Toxicol Pathol","2005","2005/12/01","","","10.1080/01926230500416336"
"11176456","Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors","Takahashi T, Kakehi Y, Mitsumori K, Akao T, Terachi T, Kato T, Ogawa O, Habuchi T.","J Urol. 2001 Feb;165(2):672-7. doi: 10.1097/00005392-200102000-00092.","Takahashi T","J Urol","2001","2001/02/15","","","10.1097/00005392-200102000-00092"
"19957332","Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death","Zhang KX, Matsui Y, Hadaschik BA, Lee C, Jia W, Bell JC, Fazli L, So AI, Rennie PS.","Int J Cancer. 2010 Aug 15;127(4):830-8. doi: 10.1002/ijc.25088.","Zhang KX","Int J Cancer","2010","2009/12/04","","","10.1002/ijc.25088"
"21176079","Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer","Hinotsu S, Akaza H, Naito S, Ozono S, Sumiyoshi Y, Noguchi S, Yamaguchi A, Nagamori S, Terai A, Nasu Y, Kume H, Tomita Y, Tanaka Y, Samma S, Uemura H, Koga H, Tsushima T.","BJU Int. 2011 Jul;108(2):187-95. doi: 10.1111/j.1464-410X.2010.09891.x. Epub 2010 Dec 22.","Hinotsu S","BJU Int","2011","2010/12/24","","","10.1111/j.1464-410X.2010.09891.x"
"28069380","microRNA-495 promotes bladder cancer cell growth and invasion by targeting phosphatase and tensin homolog","Tan M, Mu X, Liu Z, Tao L, Wang J, Ge J, Qiu J.","Biochem Biophys Res Commun. 2017 Feb 5;483(2):867-873. doi: 10.1016/j.bbrc.2017.01.019. Epub 2017 Jan 6.","Tan M","Biochem Biophys Res Commun","2017","2017/01/11","","","10.1016/j.bbrc.2017.01.019"
"1415134","Occupation and bladder cancer risk","Anton-Culver H, Lee-Feldstein A, Taylor TH.","Am J Epidemiol. 1992 Jul 1;136(1):89-94. doi: 10.1093/oxfordjournals.aje.a116424.","Anton-Culver H","Am J Epidemiol","1992","1992/07/01","","","10.1093/oxfordjournals.aje.a116424"
"19683272","Longer wait times increase overall mortality in patients with bladder cancer","Kulkarni GS, Urbach DR, Austin PC, Fleshner NE, Laupacis A.","J Urol. 2009 Oct;182(4):1318-24. doi: 10.1016/j.juro.2009.06.041. Epub 2009 Aug 14.","Kulkarni GS","J Urol","2009","2009/08/18","","","10.1016/j.juro.2009.06.041"
"11592769","Are retinol, vitamin C, vitamin E, folate and carotenoids intake associated with bladder cancer risk? Results from the Netherlands Cohort Study","Zeegers MP, Goldbohm RA, van den Brandt PA.","Br J Cancer. 2001 Sep 28;85(7):977-83. doi: 10.1054/bjoc.2001.1968.","Zeegers MP","Br J Cancer","2001","2001/10/11","PMC2375109","","10.1054/bjoc.2001.1968"
"27876505","Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis","Abdel-Rahman O.","Clin Genitourin Cancer. 2017 Jun;15(3):e463-e468. doi: 10.1016/j.clgc.2016.10.007. Epub 2016 Oct 28.","Abdel-Rahman O","Clin Genitourin Cancer","2017","2016/11/24","","","10.1016/j.clgc.2016.10.007"
"16909110","Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells","Olsson AY, Feber A, Edwards S, Te Poele R, Giddings I, Merson S, Cooper CS.","Oncogene. 2007 Feb 15;26(7):1028-37. doi: 10.1038/sj.onc.1209854. Epub 2006 Aug 14.","Olsson AY","Oncogene","2007","2006/08/16","","","10.1038/sj.onc.1209854"
"3986450","Pelvic lymphadenectomy and radical cystectomy for transitional cell carcinoma of the bladder with pelvic nodal disease","Zincke H, Patterson DE, Utz DC, Benson RC Jr.","Br J Urol. 1985 Apr;57(2):156-9. doi: 10.1111/j.1464-410x.1985.tb06411.x.","Zincke H","Br J Urol","1985","1985/04/01","","","10.1111/j.1464-410x.1985.tb06411.x"
"19466944","Outcome after radical cystectomy in patients with clinical T2 bladder cancer in whom neoadjuvant chemotherapy has failed","Manoharan M, Katkoori D, Kishore TA, Kava B, Singal R, Soloway MS.","BJU Int. 2009 Dec;104(11):1646-9. doi: 10.1111/j.1464-410X.2009.08626.x. Epub 2009 May 19.","Manoharan M","BJU Int","2009","2009/05/27","","","10.1111/j.1464-410X.2009.08626.x"
"11411867","DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH: prognostic implications","Cianciulli AM, Bovani R, Leonardo C, Iori F, Coletta AM, Marzano R, Antenucci A, Gandolfo GM, Laurenti C.","Eur J Histochem. 2001;45(1):65-71. doi: 10.4081/1615.","Cianciulli AM","Eur J Histochem","2001","2001/06/20","","","10.4081/1615"
"8481494","Are the known bladder cancer risk-factors associated with more advanced bladder cancer?","Hayes RB, Friedell GH, Zahm SH, Cole P.","Cancer Causes Control. 1993 Mar;4(2):157-62. doi: 10.1007/BF00053157.","Hayes RB","Cancer Causes Control","1993","1993/03/01","","","10.1007/BF00053157"
"24304278","The neuroendocrine component in bladder tumors","Pompas-Veganzones N, Gonzalez-Peramato P, Sanchez-Carbayo M.","Curr Med Chem. 2014;21(9):1117-28. doi: 10.2174/0929867321666131201141346.","Pompas-Veganzones N","Curr Med Chem","2014","2013/12/06","","","10.2174/0929867321666131201141346"
"6614934","[Clinical study on prophylaxis of diacetyl-glucaro-(1-4) (6-3) dilactone for recurrence of bladder cancer]","Isomatsu Y, Kaburagi Y, Jinbo S, Nashimo T, Miki M, Yamanaka H.","Gan To Kagaku Ryoho. 1983 Sep;10(9):1958-62.","Isomatsu Y","Gan To Kagaku Ryoho","1983","1983/09/01","","",""
"11349222","Increased incidence of diabetes mellitus in the patients with transitional cell carcinoma of urinary bladder","Kravchick S, Gal R, Cytron S, Peled R, Weissman Y, Mukamel E, Koren R.","Pathol Oncol Res. 2001;7(1):56-9. doi: 10.1007/BF03032606.","Kravchick S","Pathol Oncol Res","2001","2001/05/12","","","10.1007/BF03032606"
"27737963","Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancer","Takaoka EI, Miyazaki J, Ishikawa H, Kawai K, Kimura T, Ishitsuka R, Kojima T, Kanuma R, Takizawa D, Okumura T, Sakurai H, Nishiyama H.","Jpn J Clin Oncol. 2017 Jan;47(1):67-73. doi: 10.1093/jjco/hyw151. Epub 2016 Oct 13.","Takaoka EI","Jpn J Clin Oncol","2017","2016/10/15","","","10.1093/jjco/hyw151"
"9615205","Complications and results after cystectomy in male and female patients with locally invasive bladder cancer","Hautmann RE.","Eur Urol. 1998;33 Suppl 4:23-4. doi: 10.1159/000052259.","Hautmann RE","Eur Urol","1998","1998/06/06","","","10.1159/000052259"
"19663730","Bladder neck involvement as pT4 disease in prostate cancer: implications for prognosis and patient surveillance","Ploussard G, Rotondo S, Salomon L.","Future Oncol. 2009 Aug;5(6):803-10. doi: 10.2217/fon.09.59.","Ploussard G","Future Oncol","2009","2009/08/12","","","10.2217/fon.09.59"
"19665319","A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK","Munro NP, Sundaram SK, Weston PM, Fairley L, Harrison SC, Forman D, Chahal R.","Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):119-24. doi: 10.1016/j.ijrobp.2009.04.050. Epub 2009 Aug 6.","Munro NP","Int J Radiat Oncol Biol Phys","2010","2009/08/12","","","10.1016/j.ijrobp.2009.04.050"
"25854170","Diagnostic accuracy of cytokeratin-19 fragment (CYFRA 21-1) for bladder cancer: a systematic review and meta-analysis","Huang YL, Chen J, Yan W, Zang D, Qin Q, Deng AM.","Tumour Biol. 2015 May;36(5):3137-45. doi: 10.1007/s13277-015-3352-z. Epub 2015 Apr 9.","Huang YL","Tumour Biol","2015","2015/04/10","","","10.1007/s13277-015-3352-z"
"24586637","Prognostic significance of lymphovascular invasion in radical cystectomy on patients with bladder cancer: a systematic review and meta-analysis","Kim H, Kim M, Kwak C, Kim HH, Ku JH.","PLoS One. 2014 Feb 21;9(2):e89259. doi: 10.1371/journal.pone.0089259. eCollection 2014.","Kim H","PLoS One","2014","2014/03/04","PMC3931717","","10.1371/journal.pone.0089259"
"30419948","Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA","Zhan Y, Chen Z, Li Y, He A, He S, Gong Y, Li X, Zhou L.","J Exp Clin Cancer Res. 2018 Nov 12;37(1):273. doi: 10.1186/s13046-018-0921-1.","Zhan Y","J Exp Clin Cancer Res","2018","2018/11/14","PMC6233575","","10.1186/s13046-018-0921-1"
"27326409","The role of microRNAs in bladder cancer","Enokida H, Yoshino H, Matsushita R, Nakagawa M.","Investig Clin Urol. 2016 Jun;57 Suppl 1(Suppl 1):S60-76. doi: 10.4111/icu.2016.57.S1.S60. Epub 2016 Jun 7.","Enokida H","Investig Clin Urol","2016","2016/06/22","PMC4910767","","10.4111/icu.2016.57.S1.S60"
"5754830","Cancer of the urogenital tract: bladder cancer. Comment: an occupational disease","Rubin P.","JAMA. 1968 Nov 18;206(8):1775-6. doi: 10.1001/jama.206.8.1775.","Rubin P","JAMA","1968","1968/11/18","","","10.1001/jama.206.8.1775"
"15540727","Assessment of perioperative psychological distress in patients undergoing radical cystectomy for bladder cancer","Palapattu GS, Haisfield-Wolfe ME, Walker JM, BrintzenhofeSzoc K, Trock B, Zabora J, Schoenberg M.","J Urol. 2004 Nov;172(5 Pt 1):1814-7. doi: 10.1097/01.ju.0000141245.08456.1a.","Palapattu GS","J Urol","2004","2004/11/16","","","10.1097/01.ju.0000141245.08456.1a"
"3055675","[Transvaginal longitudinal ultrasonic study in the diagnosis of bladder cancer]","Komarevtsev VN, Slesarev VI.","Vopr Onkol. 1988;34(9):1111-4.","Komarevtsev VN","Vopr Onkol","1988","1988/01/01","","",""
"24820511","Haematuria: from identification to treatment","King K, Steggall M.","Br J Nurs. 2014 May 8-21;23(9):S28-32. doi: 10.12968/bjon.2014.23.Sup9.S28.","King K","Br J Nurs","2014","2014/05/14","","","10.12968/bjon.2014.23.Sup9.S28"
"29185630","[Immunotherapy : a revolution in the management of urothelial bladder cancer ?]","Adam SM, Derré L, Jichlinski P, Lucca I.","Rev Med Suisse. 2017 Nov 29;13(585):2074-2078.","Adam SM","Rev Med Suisse","2017","2017/11/30","","",""
"12900009","Transitional cell carcinoma of the ureter and renal pelvis","Kirkali Z, Tuzel E.","Crit Rev Oncol Hematol. 2003 Aug;47(2):155-69. doi: 10.1016/s1040-8428(03)00079-9.","Kirkali Z","Crit Rev Oncol Hematol","2003","2003/08/06","","","10.1016/s1040-8428(03)00079-9"
"29449555","Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer","Hu C, Liu Y, Lin Y, Liang JK, Zhong WW, Li K, Huang WT, Wang DJ, Yan GM, Zhu WB, Qiu JG, Gao X.","Cell Death Dis. 2018 Feb 15;9(3):274. doi: 10.1038/s41419-018-0325-3.","Hu C","Cell Death Dis","2018","2018/02/17","PMC5833719","","10.1038/s41419-018-0325-3"
"29166807","Secondary Malignancies of the Bladder: Avoiding the Diagnostic Pitfall","Feldman A, Borak S, Rais-Bahrami S, Gordetsky J.","Int J Surg Pathol. 2018 Apr;26(2):120-125. doi: 10.1177/1066896917741550. Epub 2017 Nov 23.","Feldman A","Int J Surg Pathol","2018","2017/11/24","","","10.1177/1066896917741550"
"10830534","Increased uptake of 99mTc-HL91 in tumor cells exposed to X-ray radiation","Kinuya S, Yokoyama K, Konishi S, Li XF, Watanabe N, Shuke N, Aburano T, Takayama T, Michigishi T, Tonami N.","Ann Nucl Med. 2000 Apr;14(2):139-41. doi: 10.1007/BF02988595.","Kinuya S","Ann Nucl Med","2000","2000/06/01","","","10.1007/BF02988595"
"32268665","[Consensus on standardized handling of specimen and pathological diagnosis of bladder cancer]","Expert Group of Genital and Urological Pathology, Chinese Society of Pathology.","Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):305-310. doi: 10.3760/cma.j.cn112151-20190620-00358.","Expert Group of Genital and Urological Pathology, Chinese Society of Pathology","Zhonghua Bing Li Xue Za Zhi","2020","2020/04/10","","","10.3760/cma.j.cn112151-20190620-00358"
"21723795","Individual learning curve reduces the clinical value of urinary cytology","Strittmatter F, Buchner A, Karl A, Sommer ML, Straub J, Tilki D, Hennenberg M, Knuechel R, Stief CG, Zaak D, Tritschler S.","Clin Genitourin Cancer. 2011 Sep;9(1):22-6. doi: 10.1016/j.clgc.2011.05.007. Epub 2011 Jul 1.","Strittmatter F","Clin Genitourin Cancer","2011","2011/07/05","","","10.1016/j.clgc.2011.05.007"
"10696253","Interleukin-12. Opportunities for the treatment of bladder cancer","Clinton SK, Canto E, O'Donnell MA.","Urol Clin North Am. 2000 Feb;27(1):147-55. doi: 10.1016/s0094-0143(05)70242-1.","Clinton SK","Urol Clin North Am","2000","2000/03/04","","","10.1016/s0094-0143(05)70242-1"
"19237606","Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk","Michiels S, Laplanche A, Boulet T, Dessen P, Guillonneau B, Méjean A, Desgrandchamps F, Lathrop M, Sarasin A, Benhamou S.","Carcinogenesis. 2009 May;30(5):763-8. doi: 10.1093/carcin/bgp046. Epub 2009 Feb 23.","Michiels S","Carcinogenesis","2009","2009/02/25","","","10.1093/carcin/bgp046"
"15809754","Enhanced radiosensitivity by inhibition of the anti-apoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model","Yamanaka K, Gleave M, Muramaki M, Hara I, Miyake H.","Oncol Rep. 2005 May;13(5):885-90.","Yamanaka K","Oncol Rep","2005","2005/04/06","","",""
"30145112","Photodynamic Therapy in the Treatment of Bladder Cancer: Past Challenges and Current Innovations","Railkar R, Agarwal PK.","Eur Urol Focus. 2018 Jul;4(4):509-511. doi: 10.1016/j.euf.2018.08.005. Epub 2018 Aug 23.","Railkar R","Eur Urol Focus","2018","2018/08/27","","","10.1016/j.euf.2018.08.005"
"27001593","Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement","Milowsky MI, Rumble RB, Booth CM, Gilligan T, Eapen LJ, Hauke RJ, Boumansour P, Lee CT.","J Clin Oncol. 2016 Jun 1;34(16):1945-52. doi: 10.1200/JCO.2015.65.9797. Epub 2016 Mar 21.","Milowsky MI","J Clin Oncol","2016","2016/03/23","","","10.1200/JCO.2015.65.9797"
"7355533","Adjuvant ""sandwich"" radiation therapy for bladder cancer","Mohiuddin M, Kramer S, Strong G.","Urology. 1980 Feb;15(2):115-8. doi: 10.1016/0090-4295(80)90399-4.","Mohiuddin M","Urology","1980","1980/02/01","","","10.1016/0090-4295(80)90399-4"
"27737647","Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014","Andreassen BK, Aagnes B, Gislefoss R, Andreassen M, Wahlqvist R.","BMC Cancer. 2016 Oct 13;16(1):799. doi: 10.1186/s12885-016-2832-x.","Andreassen BK","BMC Cancer","2016","2016/10/15","PMC5064906","","10.1186/s12885-016-2832-x"
"28326433","Application of Electronic Algorithms to Improve Diagnostic Evaluation for Bladder Cancer","Murphy DR, Meyer AN, Vaghani V, Russo E, Sittig DF, Richards KA, Wei L, Wu L, Singh H.","Appl Clin Inform. 2017 Mar 22;8(1):279-290. doi: 10.4338/ACI-2016-10-RA-0176.","Murphy DR","Appl Clin Inform","2017","2017/03/23","PMC5373770","","10.4338/ACI-2016-10-RA-0176"
"3362888","The advantages of staged cystectomy and urinary diversion in the management of invasive bladder cancer","Newling DW.","Prog Clin Biol Res. 1988;260:303-8.","Newling DW","Prog Clin Biol Res","1988","1988/01/01","","",""
"8072103","RE: Editorial: bladder cancer","Lamm DL.","J Urol. 1994 Oct;152(4):1213. doi: 10.1016/s0022-5347(17)32547-8.","Lamm DL","J Urol","1994","1994/10/01","","","10.1016/s0022-5347(17)32547-8"
"20337499","Noninvasive urinary metabonomic diagnosis of human bladder cancer","Pasikanti KK, Esuvaranathan K, Ho PC, Mahendran R, Kamaraj R, Wu QH, Chiong E, Chan EC.","J Proteome Res. 2010 Jun 4;9(6):2988-95. doi: 10.1021/pr901173v.","Pasikanti KK","J Proteome Res","2010","2010/03/27","","","10.1021/pr901173v"
"7057503","4,000 RAD preoperative irradiation followed by prompt radical cystectomy for invasive bladder carcinoma: a prospective study of patient tolerance and pathologic downstaging","Shipley WU, Cummings KB, Coombs LJ, Hawkins IR, Einstein AB, Penick G.","J Urol. 1982 Jan;127(1):48-51. doi: 10.1016/s0022-5347(17)53598-3.","Shipley WU","J Urol","1982","1982/01/01","","","10.1016/s0022-5347(17)53598-3"
"29804156","Development and external validation of a nomogram to predict high-grade papillary bladder cancer before first-time transurethral resection of the bladder tumor","Wakai K, Utsumi T, Yoneda K, Oka R, Endo T, Yano M, Fujimura M, Kamiya N, Sekita N, Mikami K, Sugano I, Hiruta N, Suzuki H.","Int J Clin Oncol. 2018 Oct;23(5):957-964. doi: 10.1007/s10147-018-1299-y. Epub 2018 May 26.","Wakai K","Int J Clin Oncol","2018","2018/05/28","","","10.1007/s10147-018-1299-y"
"23082147","The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer","Chen Z, Ding W, Xu K, Tan J, Sun C, Gou Y, Tong S, Xia G, Fang Z, Ding Q.","PLoS One. 2012;7(10):e47199. doi: 10.1371/journal.pone.0047199. Epub 2012 Oct 17.","Chen Z","PLoS One","2012","2012/10/20","PMC3474808","","10.1371/journal.pone.0047199"
"23849827","A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine","Birkhahn M, Mitra AP, Williams AJ, Barr NJ, Skinner EC, Stein JP, Skinner DG, Tai YC, Datar RH, Cote RJ.","Eur J Cancer. 2013 Oct;49(15):3159-68. doi: 10.1016/j.ejca.2013.04.033. Epub 2013 Jul 9.","Birkhahn M","Eur J Cancer","2013","2013/07/16","PMC3787946","NIHMS498765","10.1016/j.ejca.2013.04.033"
"27146943","Paraneoplastic retinopathy associated with occult bladder cancer","Nivean M, Muttuvelu DV, Afzelius P, Berman DC.","Indian J Ophthalmol. 2016 Mar;64(3):248-50. doi: 10.4103/0301-4738.181744.","Nivean M","Indian J Ophthalmol","2016","2016/05/06","PMC4869471","","10.4103/0301-4738.181744"
"8618280","Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer","Bittard H, Lamy B, Billery C.","J Urol. 1996 Jun;155(6):1887-91.","Bittard H","J Urol","1996","1996/06/01","","",""
"8664117","Urinary gonadotropin peptide (UGP) in Egyptian patients with benign and advanced malignant urological disease","el-Ahmady O, Halim AB, Mansour O, Salman T, el-Din AG, Walker RP.","Br J Cancer. 1996 Jun;73(12):1486-90. doi: 10.1038/bjc.1996.281.","el-Ahmady O","Br J Cancer","1996","1996/06/01","PMC2074546","","10.1038/bjc.1996.281"
"21373847","Urothelial cancers after renal transplantation","Cox J, Colli JL.","Int Urol Nephrol. 2011 Sep;43(3):681-6. doi: 10.1007/s11255-011-9907-z. Epub 2011 Mar 4.","Cox J","Int Urol Nephrol","2011","2011/03/05","","","10.1007/s11255-011-9907-z"
"18762781","Argument against frozen section analysis of distal ureters in transitional cell bladder cancer","Donat SM.","Nat Clin Pract Urol. 2008 Oct;5(10):538-9. doi: 10.1038/ncpuro1210. Epub 2008 Sep 2.","Donat SM","Nat Clin Pract Urol","2008","2008/09/03","","","10.1038/ncpuro1210"
"28696911","N-acetyltransferase 1*10 genotype in bladder cancer patients","Höhne S, Gerullis H, Blaszkewicz M, Selinski S, Hengstler JG, Otto T, Golka K.","J Toxicol Environ Health A. 2017;80(7-8):417-422. doi: 10.1080/10937404.2017.1304727. Epub 2017 Jul 11.","Höhne S","J Toxicol Environ Health A","2017","2017/07/12","","","10.1080/10937404.2017.1304727"
"15008751","Is this the poster boy for bladder cancer?","Hodgson D, Adeniyi A, Rimington PD.","BJU Int. 2004 Mar;93(4):637. doi: 10.1111/j.1464-410x.2004.4686_5.x.","Hodgson D","BJU Int","2004","2004/03/11","","","10.1111/j.1464-410x.2004.4686_5.x"
"10738205","World Health Organization and International Society of Urological Pathology classification and two-number grading system of bladder tumors","Oyasu R.","Cancer. 2000 Apr 1;88(7):1509-12. doi: 10.1002/(sici)1097-0142(20000401)88:7<1509::aid-cncr1>3.0.co;2-g.","Oyasu R","Cancer","2000","2000/03/30","","","10.1002/(sici)1097-0142(20000401)88:7<1509::aid-cncr1>3.0.co;2-g"
"4106848","Paraganglioma of the urinary bladder","Leestma JE, Price EB Jr.","Cancer. 1971 Oct;28(4):1063-73. doi: 10.1002/1097-0142(1971)28:4<1063::aid-cncr2820280433>3.0.co;2-r.","Leestma JE","Cancer","1971","1971/10/01","","","10.1002/1097-0142(1971)28:4<1063::aid-cncr2820280433>3.0.co;2-r"
"11668518","Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine","Seripa D, Parrella P, Gallucci M, Gravina C, Papa S, Fortunato P, Alcini A, Flammia G, Lazzari M, Fazio VM.","Int J Cancer. 2001 Nov 20;95(6):364-9. doi: 10.1002/1097-0215(20011120)95:6<364::aid-ijc1064>3.0.co;2-v.","Seripa D","Int J Cancer","2001","2001/10/23","","","10.1002/1097-0215(20011120)95:6<364::aid-ijc1064>3.0.co;2-v"
"24861327","Bladder cancer: Accelerating MVAC","Killock D.","Nat Rev Urol. 2014 Jun;11(6):307. doi: 10.1038/nrurol.2014.128. Epub 2014 May 27.","Killock D","Nat Rev Urol","2014","2014/05/28","","","10.1038/nrurol.2014.128"
"6865152","[Experimental and clinica studies on antineoplastic agent sensitivity of bladder cancer cells based on their nucleic acid metabolism]","Ishii Y.","Nihon Hinyokika Gakkai Zasshi. 1983 Jan;74(1):46-60. doi: 10.5980/jpnjurol1928.74.1_46.","Ishii Y","Nihon Hinyokika Gakkai Zasshi","1983","1983/01/01","","","10.5980/jpnjurol1928.74.1_46"
"19540057","Cone beam CT imaging analysis of interfractional variations in bladder volume and position during radiotherapy for bladder cancer","Yee D, Parliament M, Rathee S, Ghosh S, Ko L, Murray B.","Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1045-53. doi: 10.1016/j.ijrobp.2009.03.022. Epub 2009 Jun 18.","Yee D","Int J Radiat Oncol Biol Phys","2010","2009/06/23","","","10.1016/j.ijrobp.2009.03.022"
"12243077","[Bladder cancer producing granulocyte colony-stimulating factor (G-CSF): a case report]","Asano T, Morimoto S, Kitami Y, Miyauchi T, Sakai K, Takagi K.","Hinyokika Kiyo. 2002 Aug;48(8):495-8.","Asano T","Hinyokika Kiyo","2002","2002/09/24","","",""
"3431330","The contact Nd:YAG laser system in the treatment of bladder cancer: a preliminary report in 48 patients","Washida H, Watanabe H, Sakagami H, Sasaki S, Daikuzono N.","Lasers Surg Med. 1987;7(6):524-7. doi: 10.1002/lsm.1900070616.","Washida H","Lasers Surg Med","1987","1987/01/01","","","10.1002/lsm.1900070616"
"7817459","[Neoadjuvant chemotherapy of invasive bladder cancer]","Rassweiler J.","Urologe A. 1994 Nov;33(6):576-81.","Rassweiler J","Urologe A","1994","1994/11/01","","",""
"1640484","Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer","Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z, Reuter VE.","J Natl Cancer Inst. 1992 Aug 19;84(16):1251-6. doi: 10.1093/jnci/84.16.1251.","Cordon-Cardo C","J Natl Cancer Inst","1992","1992/08/19","","","10.1093/jnci/84.16.1251"
"18114140","[Bladder cancer and total cystectomy]","DIAZ MUNOZ I, LIRA VALENCIA A.","Rev Med Chil. 1949 Jan;77(1):54-7.","DIAZ MUNOZ I","Rev Med Chil","1949","1949/01/01","","",""
"9569060","Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt","Bedwani R, Renganathan E, El Kwhsky F, Braga C, Abu Seif HH, Abul Azm T, Zaki A, Franceschi S, Boffetta P, La Vecchia C.","Br J Cancer. 1998 Apr;77(7):1186-9. doi: 10.1038/bjc.1998.197.","Bedwani R","Br J Cancer","1998","1998/05/06","PMC2150141","","10.1038/bjc.1998.197"
"8254830","Bladder cancer","Droller MJ.","J Urol. 1994 Jan;151(1):47-8. doi: 10.1016/s0022-5347(17)34869-3.","Droller MJ","J Urol","1994","1994/01/01","","","10.1016/s0022-5347(17)34869-3"
"2374333","[Analysis of histopathological prognostic factors in patients who underwent radical cystectomy in cancer of the bladder]","Tachibana M, Jitsukawa S, Deguchi N, Baba S, Hata M, Tazaki H.","Nihon Hinyokika Gakkai Zasshi. 1990 Apr;81(4):601-7. doi: 10.5980/jpnjurol1989.81.601.","Tachibana M","Nihon Hinyokika Gakkai Zasshi","1990","1990/04/01","","","10.5980/jpnjurol1989.81.601"
"24863165","Bladder cancer: accelerating MVAC","Killock D.","Nat Rev Clin Oncol. 2014 Jul;11(7):378. doi: 10.1038/nrclinonc.2014.94. Epub 2014 May 27.","Killock D","Nat Rev Clin Oncol","2014","2014/05/28","","","10.1038/nrclinonc.2014.94"
"7998589","Occupational risk factors for bladder cancer: results from a case-control study in Montreal, Quebec, Canada","Siemiatycki J, Dewar R, Nadon L, Gérin M.","Am J Epidemiol. 1994 Dec 15;140(12):1061-80. doi: 10.1093/oxfordjournals.aje.a117207.","Siemiatycki J","Am J Epidemiol","1994","1994/12/15","","","10.1093/oxfordjournals.aje.a117207"
"21896649","Boxing bladder cancer with COX-2-specific inhibition","Kelly JD, Hall E.","Cancer Prev Res (Phila). 2011 Oct;4(10):1534-5. doi: 10.1158/1940-6207.CAPR-11-0409. Epub 2011 Sep 6.","Kelly JD","Cancer Prev Res (Phila)","2011","2011/09/08","","","10.1158/1940-6207.CAPR-11-0409"
"8893868","A molecular genetic model of human bladder cancer pathogenesis","Reznikoff CA, Belair CD, Yeager TR, Savelieva E, Blelloch RH, Puthenveettil JA, Cuthill S.","Semin Oncol. 1996 Oct;23(5):571-84.","Reznikoff CA","Semin Oncol","1996","1996/10/01","","",""
"17429783","Cutaneous uretero-ureterostomy: a technique of urinary diversion for high-risk patients with bladder cancer","Shafik A, Shafik IA, El Sibai O.","Surg Technol Int. 2007;16:151-5.","Shafik A","Surg Technol Int","2007","2007/04/13","","",""
"15708245","Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?","Pos F, Horenblas S, Dom P, Moonen L, Bartelink H.","Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):678-86. doi: 10.1016/j.ijrobp.2004.06.249.","Pos F","Int J Radiat Oncol Biol Phys","2005","2005/02/15","","","10.1016/j.ijrobp.2004.06.249"
"15906354","TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer","Kelsey KT, Hirao T, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Colt J, Baris D, Morris JS, Schned A, Karagas M.","Int J Cancer. 2005 Nov 10;117(3):370-5. doi: 10.1002/ijc.21195.","Kelsey KT","Int J Cancer","2005","2005/05/21","","","10.1002/ijc.21195"
"19625496","Intravesical combination treatment with antisense oligonucleotides targeting heat shock protein-27 and HTI-286 as a novel strategy for high-grade bladder cancer","Matsui Y, Hadaschik BA, Fazli L, Andersen RJ, Gleave ME, So AI.","Mol Cancer Ther. 2009 Aug;8(8):2402-11. doi: 10.1158/1535-7163.MCT-09-0148. Epub 2009 Jul 22.","Matsui Y","Mol Cancer Ther","2009","2009/07/24","","","10.1158/1535-7163.MCT-09-0148"
"23851384","The anatomic extent and completeness of pelvic lymphadenectomy is what matters","Pohar KS.","Curr Opin Urol. 2013 Sep;23(5):444-8. doi: 10.1097/MOU.0b013e328363f5f8.","Pohar KS","Curr Opin Urol","2013","2013/07/16","","","10.1097/MOU.0b013e328363f5f8"
"15778693","Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways","Kim JH, Tuziak T, Hu L, Wang Z, Bondaruk J, Kim M, Fuller G, Dinney C, Grossman HB, Baggerly K, Zhang W, Czerniak B.","Lab Invest. 2005 Apr;85(4):532-49. doi: 10.1038/labinvest.3700250.","Kim JH","Lab Invest","2005","2005/03/22","","","10.1038/labinvest.3700250"
"30578528","Human Papilloma Virus DNA in Tumor Tissue and Urine in Different Stage of Bladder Cancer","Javanmard B, Barghi MR, Amani D, Fallah Karkan M, Mazloomfard MM.","Urol J. 2019 Aug 18;16(4):352-356. doi: 10.22037/uj.v0i0.4181.","Javanmard B","Urol J","2019","2018/12/23","","","10.22037/uj.v0i0.4181"
"15232647","Multifocal pathomorphological study of bladder cancer with the use of luminescence analysis","Kunin IS, Mezentseva GA, Aidagulova SV, Nepomnyashchikh LM.","Bull Exp Biol Med. 2004 Mar;137(3):308-12. doi: 10.1023/b:bebm.0000031577.78639.90.","Kunin IS","Bull Exp Biol Med","2004","2004/07/03","","","10.1023/b:bebm.0000031577.78639.90"
"16153194","The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer","Sivalingam S, Probert JL, Schwaibold H.","BJU Int. 2005 Oct;96(6):759-62. doi: 10.1111/j.1464-410X.2005.05710.x.","Sivalingam S","BJU Int","2005","2005/09/13","","","10.1111/j.1464-410X.2005.05710.x"
"6632443","[Invasiveness and metastasis of bladder cancer. 2. Prevention of postoperative metastasis by chemotherapy]","Numasawa K, Kakizaki H, Watanabe H, Takamizawa A, Masaki T, Hirano K, Hirano J, Kubota Y, Sugano O, Saito M, et al.","Nihon Hinyokika Gakkai Zasshi. 1983 Mar;74(3):349-56. doi: 10.5980/jpnjurol1928.74.3_349.","Numasawa K","Nihon Hinyokika Gakkai Zasshi","1983","1983/03/01","","","10.5980/jpnjurol1928.74.3_349"
"17189409","Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease","Margulis V, Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y.","Clin Cancer Res. 2006 Dec 15;12(24):7369-73. doi: 10.1158/1078-0432.CCR-06-1472.","Margulis V","Clin Cancer Res","2006","2006/12/26","","","10.1158/1078-0432.CCR-06-1472"
"2293269","[Treatment of bladder neoplasm: vesical instillation of BCG vaccine in microdoses]","Rivera P, Gorena M, Hinostroza J, Pastor P, Venegas P.","Rev Med Chil. 1990 May;118(5):503-5.","Rivera P","Rev Med Chil","1990","1990/05/01","","",""
"19174821","Urinary tract infections and reduced risk of bladder cancer in Los Angeles","Jiang X, Castelao JE, Groshen S, Cortessis VK, Shibata D, Conti DV, Yuan JM, Pike MC, Gago-Dominguez M.","Br J Cancer. 2009 Mar 10;100(5):834-9. doi: 10.1038/sj.bjc.6604889. Epub 2009 Jan 27.","Jiang X","Br J Cancer","2009","2009/01/29","PMC2653778","","10.1038/sj.bjc.6604889"
"8284363","Neoplasms of the bladder, prostate, and testis","Heiken JP, Forman HP, Brown JJ.","Radiol Clin North Am. 1994 Jan;32(1):81-98.","Heiken JP","Radiol Clin North Am","1994","1994/01/01","","",""
"8313752","[Intravesical instillation of BCG for the bladder cancer: relationship between effect and immune cells in peripheral blood and bladder wall]","Chen LZ.","Zhonghua Wai Ke Za Zhi. 1993 Jun;31(6):336-8.","Chen LZ","Zhonghua Wai Ke Za Zhi","1993","1993/06/01","","",""
"8842494","Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target","Crew JP, O'Brien TS, Harris AL.","Cancer Metastasis Rev. 1996 Jun;15(2):221-30. doi: 10.1007/BF00437475.","Crew JP","Cancer Metastasis Rev","1996","1996/06/01","","","10.1007/BF00437475"
"25444981","ΔNp63 expression is a protective factor of progression in clinical high grade T1 bladder cancer","Gaya JM, López-Martínez JM, Karni-Schmidt O, Bonal DM, Algaba F, Palou J, Villavicencio H, Benson MC, Cordon-Cardo C, Castillo-Martin M.","J Urol. 2015 Apr;193(4):1144-50. doi: 10.1016/j.juro.2014.10.098. Epub 2014 Oct 28.","Gaya JM","J Urol","2015","2014/12/03","","","10.1016/j.juro.2014.10.098"
"31232464","Molecular pathology of the luminal class of urothelial tumors","Bernardo C, Eriksson P, Marzouka NA, Liedberg F, Sjödahl G, Höglund M.","J Pathol. 2019 Nov;249(3):308-318. doi: 10.1002/path.5318. Epub 2019 Aug 27.","Bernardo C","J Pathol","2019","2019/06/25","PMC6851980","","10.1002/path.5318"
"23341373","Trimodality therapy for bladder conservation in treatment of invasive bladder cancer","Mitin T, Shipley WU, Efstathiou JA, Heney NM, Kaufman DS, Lee RJ, Zietman AL.","Curr Urol Rep. 2013 Apr;14(2):109-15. doi: 10.1007/s11934-012-0301-x.","Mitin T","Curr Urol Rep","2013","2013/01/24","","","10.1007/s11934-012-0301-x"
"25891331","Prognostic significance of cystoscopy findings following neoadjuvant chemotherapy for muscle-invasive bladder cancer","Mansour AM, Soloway MS, Eldefrawy A, Singal R, Joshi S, Manoharan M.","Can J Urol. 2015 Apr;22(2):7690-7.","Mansour AM","Can J Urol","2015","2015/04/21","","",""
"27004619","Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysis","Bamias A, Tsantoulis P, Zilli T, Papatsoris A, Caparrotti F, Kyratsas C, Tzannis K, Stravodimos K, Chrisofos M, Wirth GJ, Skolarikos A, Mitropoulos D, Constantinides CA, Deliveliotis C, Iselin CE, Miralbell R, Dietrich PY, Dimopoulos MA.","Cancer Med. 2016 Jun;5(6):1098-107. doi: 10.1002/cam4.685. Epub 2016 Mar 22.","Bamias A","Cancer Med","2016","2016/03/24","PMC4924368","","10.1002/cam4.685"
"28422550","Evaluation of the diagnostic accuracy of UBC(®) Rapid in bladder cancer: a Swedish multicentre study","Styrke J, Henriksson H, Ljungberg B, Hasan M, Silfverberg I, Einarsson R, Malmström PU, Sherif A.","Scand J Urol. 2017 Aug;51(4):293-300. doi: 10.1080/21681805.2017.1313309. Epub 2017 Apr 19.","Styrke J","Scand J Urol","2017","2017/04/20","","","10.1080/21681805.2017.1313309"
"23204394","CLT1 targets bladder cancer through integrin α5β1 and CLIC3","Knowles LM, Zewe J, Malik G, Parwani AV, Gingrich JR, Pilch J.","Mol Cancer Res. 2013 Feb;11(2):194-203. doi: 10.1158/1541-7786.MCR-12-0300. Epub 2012 Nov 30.","Knowles LM","Mol Cancer Res","2013","2012/12/04","PMC3579011","NIHMS423697","10.1158/1541-7786.MCR-12-0300"
"19849694","The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy","Hellenthal NJ, Ramirez ML, Evans CP, Devere White RW.","BJU Int. 2010 Feb;105(4):485-8. doi: 10.1111/j.1464-410X.2009.08905.x. Epub 2009 Oct 22.","Hellenthal NJ","BJU Int","2010","2009/10/24","","","10.1111/j.1464-410X.2009.08905.x"
"28278504","Assessing the Feasibility of Replacing Standard-Dose Bacillus Calmette-Guérin Immunotherapy with Other Intravesical Instillation Therapies in Bladder Cancer Patients: A Network Meta-Analysis","Wu C, Zhou X, Miao C, Zhang J, Tang Q, Chang X, Ni H.","Cell Physiol Biochem. 2017;41(4):1298-1312. doi: 10.1159/000464432. Epub 2017 Mar 8.","Wu C","Cell Physiol Biochem","2017","2017/03/10","","","10.1159/000464432"
"32706981","Quantification and correction of distortion in diffusion-weighted MRI at 1.5 and 3 T in a muscle-invasive bladder cancer phantom for radiotherapy planning","Rogers J, Sherwood V, Wayte SC, Duffy JA, Manolopoulos S.","Br J Radiol. 2020 Oct 1;93(1114):20190710. doi: 10.1259/bjr.20190710. Epub 2020 Aug 5.","Rogers J","Br J Radiol","2020","2020/07/25","","","10.1259/bjr.20190710"
"3629047","Models for temporal variation in cancer rates. I: Age-period and age-cohort models","Clayton D, Schifflers E.","Stat Med. 1987 Jun;6(4):449-67. doi: 10.1002/sim.4780060405.","Clayton D","Stat Med","1987","1987/06/01","","","10.1002/sim.4780060405"
"18109865","[Orchiectomy in bladder cancer]","HEBERT A.","Union Med Can. 1949 Feb;78(2):192-5.","HEBERT A","Union Med Can","1949","1949/02/01","","",""
"19356647","The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer","Dindyal S, Nitkunan T, Bunce CJ.","Photodiagnosis Photodyn Ther. 2008 Jun;5(2):153-8. doi: 10.1016/j.pdpdt.2008.05.001. Epub 2008 Jul 7.","Dindyal S","Photodiagnosis Photodyn Ther","2008","2009/04/10","","","10.1016/j.pdpdt.2008.05.001"
"28556678","Emerging drugs for urothelial (bladder) cancer","Cumberbatch K, He T, Thorogood Z, Gartrell BA.","Expert Opin Emerg Drugs. 2017 Jun;22(2):149-164. doi: 10.1080/14728214.2017.1336536. Epub 2017 Jun 12.","Cumberbatch K","Expert Opin Emerg Drugs","2017","2017/05/31","","","10.1080/14728214.2017.1336536"
"9649245","Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors","Pode D, Golijanin D, Sherman Y, Lebensart P, Shapiro A.","J Urol. 1998 Feb;159(2):389-92; discussion 393. doi: 10.1016/s0022-5347(01)63928-4.","Pode D","J Urol","1998","1998/07/02","","","10.1016/s0022-5347(01)63928-4"
"19351919","Provider treatment intensity and outcomes for patients with early-stage bladder cancer","Hollenbeck BK, Ye Z, Dunn RL, Montie JE, Birkmeyer JD.","J Natl Cancer Inst. 2009 Apr 15;101(8):571-80. doi: 10.1093/jnci/djp039. Epub 2009 Apr 7.","Hollenbeck BK","J Natl Cancer Inst","2009","2009/04/09","PMC2669100","","10.1093/jnci/djp039"
"7129910","[Preventive oncology in bladder cancer: determination of carcinogens in urine]","Harzmann R, Gericke D, Bichler KH.","Helv Chir Acta. 1982 Aug;49(3-4):409-14.","Harzmann R","Helv Chir Acta","1982","1982/08/01","","",""
"15897575","Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II","Kurahashi T, Hara I, Oka N, Kamidono S, Eto H, Miyake H.","Clin Cancer Res. 2005 May 15;11(10):3773-7. doi: 10.1158/1078-0432.CCR-04-2297.","Kurahashi T","Clin Cancer Res","2005","2005/05/18","","","10.1158/1078-0432.CCR-04-2297"
"31757300","Salvage Therapies for Non-muscle-invasive Bladder Cancer: Who Will Respond to Bacillus Calmette-Guérin? Predictors and Nomograms","Faba ÓR, Pisano F, Krajewski W, Breda A, Palou J.","Urol Clin North Am. 2020 Feb;47(1):5-13. doi: 10.1016/j.ucl.2019.09.003.","Faba ÓR","Urol Clin North Am","2020","2019/11/24","","","10.1016/j.ucl.2019.09.003"
"73272","[Palliative interventions in advanced bladder cancer]","Frank S, Decristoforo A.","ZFA (Stuttgart). 1977 Oct 10;53(28):1657-62.","Frank S","ZFA (Stuttgart)","1977","1977/10/10","","",""
"25316812","Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent mutations of UNC5C and prognostic importance of DNA repair gene mutations on survival","Yap KL, Kiyotani K, Tamura K, Antic T, Jang M, Montoya M, Campanile A, Yew PY, Ganshert C, Fujioka T, Steinberg GD, O'Donnell PH, Nakamura Y.","Clin Cancer Res. 2014 Dec 15;20(24):6605-17. doi: 10.1158/1078-0432.CCR-14-0257. Epub 2014 Oct 14.","Yap KL","Clin Cancer Res","2014","2014/10/16","PMC4268280","NIHMS636262","10.1158/1078-0432.CCR-14-0257"
"8356221","Blood tests and prognosis in bladder carcinomas treated with definitive radiotherapy","Hannisdal E, Fosså SD, Høst H.","Radiother Oncol. 1993 May;27(2):117-22. doi: 10.1016/0167-8140(93)90131-q.","Hannisdal E","Radiother Oncol","1993","1993/05/01","","","10.1016/0167-8140(93)90131-q"
"1587750","T1 and T2 carcinoma of the urinary bladder: long term results with external, preoperative, or interstitial radiotherapy","De Neve W, Lybeert ML, Goor C, Crommelin MA, Ribot JG.","Int J Radiat Oncol Biol Phys. 1992;23(2):299-304. doi: 10.1016/0360-3016(92)90745-4.","De Neve W","Int J Radiat Oncol Biol Phys","1992","1992/01/01","","","10.1016/0360-3016(92)90745-4"
"19250539","Does the biomarker search paradigm need re-booting?","Hurst RE.","BMC Urol. 2009 Feb 27;9:1. doi: 10.1186/1471-2490-9-1.","Hurst RE","BMC Urol","2009","2009/03/03","PMC2654904","","10.1186/1471-2490-9-1"
"11125364","Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy","Herr HW, Donat SM.","J Urol. 2001 Jan;165(1):62-4; discussion 64. doi: 10.1097/00005392-200101000-00015.","Herr HW","J Urol","2001","2000/12/23","","","10.1097/00005392-200101000-00015"
"7946433","Secondary malignancies following cancer chemotherapy","Boffetta P, Kaldor JM.","Acta Oncol. 1994;33(6):591-8. doi: 10.3109/02841869409121767.","Boffetta P","Acta Oncol","1994","1994/01/01","","","10.3109/02841869409121767"
"16164272","[Treatment for locally advanced bladder cancer in elderly patients]","Nishiyama H.","Hinyokika Kiyo. 2005 Aug;51(8):553-7.","Nishiyama H","Hinyokika Kiyo","2005","2005/09/17","","",""
"29948043","Molecularly-driven precision medicine for advanced bladder cancer","Krabbe LM, Margulis V, Schrader AJ, Shariat SF, Gust KM, Boegemann M.","World J Urol. 2018 Nov;36(11):1749-1757. doi: 10.1007/s00345-018-2354-z. Epub 2018 Jun 8.","Krabbe LM","World J Urol","2018","2018/06/28","","","10.1007/s00345-018-2354-z"
"31662514","Hyperforin Induces Apoptosis Through Extrinsic/Intrinsic Pathways and Inhibits NF-ĸB-modulated Survival and Invasion Potential in Bladder Cancer","Liu YC, Lin KH, Hsieh JH, Chung JG, Tan ZL, Hsu FT, Chiang CH.","In Vivo. 2019 Nov-Dec;33(6):1865-1877. doi: 10.21873/invivo.11680.","Liu YC","In Vivo","2019","2019/10/31","PMC6899093","","10.21873/invivo.11680"
"15661064","Bladder cancer discovered by ovarian metastasis: cytokeratin expression is useful when making differential diagnosis","Ishii Y, Itoh N, Takahashi A, Masumori N, Ikeda T, Tsukamoto T.","Int J Urol. 2005 Jan;12(1):104-7. doi: 10.1111/j.1442-2042.2004.00972.x.","Ishii Y","Int J Urol","2005","2005/01/22","","","10.1111/j.1442-2042.2004.00972.x"
"7928455","Organ-sparing treatment of advanced bladder cancer: a 10-year experience","Dunst J, Sauer R, Schrott KM, Kühn R, Wittekind C, Altendorf-Hofmann A.","Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):261-6. doi: 10.1016/0360-3016(94)90003-5.","Dunst J","Int J Radiat Oncol Biol Phys","1994","1994/09/30","","","10.1016/0360-3016(94)90003-5"
"4416547","The treatment of advanced bladder cancer with sensitized pig lymphocytes","Feneley RC, Eckert H, Riddell AG, Symes MO, Tribe CR.","Br J Surg. 1974 Oct;61(10):825-7. doi: 10.1002/bjs.1800611018.","Feneley RC","Br J Surg","1974","1974/10/01","","","10.1002/bjs.1800611018"
"15069539","Carbonic anhydrase IX, a marker of hypoxia: correlation with clinical outcome in transitional cell carcinoma of the bladder","Hussain SA, Palmer DH, Ganesan R, Hiller L, Gregory J, Murray PG, Pastorek J, Young L, James ND.","Oncol Rep. 2004 May;11(5):1005-10.","Hussain SA","Oncol Rep","2004","2004/04/08","","",""
"23536017","Intravesical bacillus Calmette-Guérin instillation therapy for non-muscle-invasive bladder cancer following solid organ transplantation","Swietek N, Waldert M, Susani M, Schatzl G, Klatte T.","Wien Klin Wochenschr. 2013 Apr;125(7-8):189-95. doi: 10.1007/s00508-013-0343-1. Epub 2013 Mar 28.","Swietek N","Wien Klin Wochenschr","2013","2013/03/29","","","10.1007/s00508-013-0343-1"
"8627858","Transitional cell carcinoma of the labia minor: evidence of contact implantation of bladder cancer","Yu DS, Harn HJ, Lee WH, Ma CP.","J Urol. 1996 May;155(5):1699.","Yu DS","J Urol","1996","1996/05/01","","",""
"16848358","[Intra-arterial chemotherapy for invasive bladder cancer (T2-3N0M0)]","Maruyama T, Kondoh N, Nojima M, Yamamoto S, Mori Y, Shima H, Kamikonnya N, Hirota S, Nakao N.","Hinyokika Kiyo. 2006 Jun;52(6):445-9.","Maruyama T","Hinyokika Kiyo","2006","2006/07/20","","",""
"3820368","Incidence, extent and location of unsuspected pelvic lymph node metastasis in patients undergoing radical cystectomy for bladder cancer","Wishnow KI, Johnson DE, Ro JY, Swanson DA, Babaian RJ, von Eschenbach AC.","J Urol. 1987 Mar;137(3):408-10. doi: 10.1016/s0022-5347(17)44050-x.","Wishnow KI","J Urol","1987","1987/03/01","","","10.1016/s0022-5347(17)44050-x"
"1425834","Prediction of recurrence and progression in primary superficial bladder cancer with DNA flow cytometry","Saracino GA, Ditonno P, Disabato G, Traficante A, Battaglia M, Lucivero G, Selvaggi FP.","Eur Urol. 1992;21 Suppl 1:26-30. doi: 10.1159/000474883.","Saracino GA","Eur Urol","1992","1992/01/01","","","10.1159/000474883"
"10210380","Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort","Bassi P, Ferrante GD, Piazza N, Spinadin R, Carando R, Pappagallo G, Pagano F.","J Urol. 1999 May;161(5):1494-7.","Bassi P","J Urol","1999","1999/04/21","","",""
"18183079","Routine transurethral biopsy of the bladder is not necessary to evaluate the response to bacillus calmette-guerin therapy","Murakami T, Ebara S, Saika T, Irie S, Takeda K, Maki Y, Miyaji S, Manabe D, Kaku H, Nasu Y, Tsushima T, Kumon H.","Acta Med Okayama. 2007 Dec;61(6):341-4. doi: 10.18926/AMO/32881.","Murakami T","Acta Med Okayama","2007","2008/01/10","","","10.18926/AMO/32881"
"4757547","Leukemoid reaction, thrombocytosis and hypercalcemia associated with bladder cancer","Block NL, Whitmore WF Jr.","J Urol. 1973 Dec;110(6):660-3. doi: 10.1016/s0022-5347(17)60308-2.","Block NL","J Urol","1973","1973/12/01","","","10.1016/s0022-5347(17)60308-2"
"20251947","[Bladder cancer]","VIANNA JB.","Hospital (Rio J). 1947 May;31(5):725-34.","VIANNA JB","Hospital (Rio J)","1947","2010/03/19","","",""
"29078093","Comparison of variable selection methods for high-dimensional survival data with competing events","Gilhodes J, Zemmour C, Ajana S, Martinez A, Delord JP, Leconte E, Boher JM, Filleron T.","Comput Biol Med. 2017 Dec 1;91:159-167. doi: 10.1016/j.compbiomed.2017.10.021. Epub 2017 Oct 20.","Gilhodes J","Comput Biol Med","2017","2017/10/28","","","10.1016/j.compbiomed.2017.10.021"
"2736484","Intraarterial cisplatin infusion in the management of transitional cell carcinoma of the bladder","Jacobs SC, Menashe DS, Mewissen MW, Lipchik EO.","Cancer. 1989 Jul 15;64(2):388-91. doi: 10.1002/1097-0142(19890715)64:2<388::aid-cncr2820640208>3.0.co;2-7.","Jacobs SC","Cancer","1989","1989/07/15","","","10.1002/1097-0142(19890715)64:2<388::aid-cncr2820640208>3.0.co;2-7"
"32277695","Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer","Lin YZ, Wu YP, Ke ZB, Cai H, Chen DN, Chen SH, Li XD, Lin TT, Huang JB, Zheng QS, Xue XY, Xu N, Wei Y.","Med Sci Monit. 2020 Apr 11;26:e920504. doi: 10.12659/MSM.920504.","Lin YZ","Med Sci Monit","2020","2020/04/12","PMC7169439","","10.12659/MSM.920504"
"27888634","Targeting protein kinase CK2 suppresses bladder cancer cell survival via the glucose metabolic pathway","Zhang X, Yang X, Yang C, Li P, Yuan W, Deng X, Cheng Y, Li P, Yang H, Tao J, Lu Q.","Oncotarget. 2016 Dec 27;7(52):87361-87372. doi: 10.18632/oncotarget.13571.","Zhang X","Oncotarget","2016","2016/11/27","PMC5349994","","10.18632/oncotarget.13571"
"23797604","Risk of bladder cancer in diabetic patients treated with rosiglitazone or pioglitazone: a nested case–control study","Hsiao FY, Hsieh PH, Huang WF, Tsai YW, Gau CS.","Drug Saf. 2013 Aug;36(8):643-9. doi: 10.1007/s40264-013-0080-4.","Hsiao FY","Drug Saf","2013","2013/06/26","","","10.1007/s40264-013-0080-4"
"10980118","High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer","Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knönagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schönenberger A, Flury R, Jäger P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Kallioniemi OP, Sauter G.","Am J Pathol. 2000 Sep;157(3):787-94. doi: 10.1016/s0002-9440(10)64592-0.","Richter J","Am J Pathol","2000","2000/09/12","PMC1885698","","10.1016/s0002-9440(10)64592-0"
"11344122","Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model","Cozzi PJ, Malhotra S, McAuliffe P, Kooby DA, Federoff HJ, Huryk B, Johnson P, Scardino PT, Heston WD, Fong Y.","FASEB J. 2001 May;15(7):1306-8. doi: 10.1096/fj.00-0533fje.","Cozzi PJ","FASEB J","2001","2001/05/10","","","10.1096/fj.00-0533fje"
"10618647","Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial","Bruno S, Torrisi R, Costantini M, Baglietto L, Fontana V, Gatteschi B, Melioli G, Nicolo G, Curotto A, Malcangi B, Bruttini GP, Varaldo M, Bruzzi P, Decensi A.","J Cell Biochem. 1999 Dec;76(2):311-21. doi: 10.1002/(sici)1097-4644(20000201)76:2<311::aid-jcb14>3.0.co;2-a.","Bruno S","J Cell Biochem","1999","2000/01/05","","","10.1002/(sici)1097-4644(20000201)76:2<311::aid-jcb14>3.0.co;2-a"
"2514882","Dipstick haematuria and bladder cancer in men over 60","Jones BF.","BMJ. 1989 Dec 16;299(6714):1528. doi: 10.1136/bmj.299.6714.1528.","Jones BF","BMJ","1989","1989/12/16","PMC1838343","","10.1136/bmj.299.6714.1528"
"20646590","[Pay attention to the study of bladder cancer recurrence]","Kong CZ.","Zhonghua Yi Xue Za Zhi. 2010 May 11;90(18):1225-6.","Kong CZ","Zhonghua Yi Xue Za Zhi","2010","2010/07/22","","",""
"26772886","miR-1182 inhibits growth and mediates the chemosensitivity of bladder cancer by targeting hTERT","Zhou J, Dai W, Song J.","Biochem Biophys Res Commun. 2016 Feb 5;470(2):445-452. doi: 10.1016/j.bbrc.2016.01.014. Epub 2016 Jan 7.","Zhou J","Biochem Biophys Res Commun","2016","2016/01/17","","","10.1016/j.bbrc.2016.01.014"
"30837209","Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy","Gild P, Nguyen DD, Fletcher SA, Cole AP, Lipsitz SR, Kibel AS, Fisch M, Preston MA, Trinh QD.","Clin Genitourin Cancer. 2019 Jun;17(3):e488-e493. doi: 10.1016/j.clgc.2019.01.009. Epub 2019 Jan 29.","Gild P","Clin Genitourin Cancer","2019","2019/03/07","","","10.1016/j.clgc.2019.01.009"
"29190807","Identification of BLCAP as a novel STAT3 interaction partner in bladder cancer","Gromova I, Svensson S, Gromov P, Moreira JMA.","PLoS One. 2017 Nov 30;12(11):e0188827. doi: 10.1371/journal.pone.0188827. eCollection 2017.","Gromova I","PLoS One","2017","2017/12/01","PMC5708675","","10.1371/journal.pone.0188827"
"1254426","Urinary cytology automation. Preliminary studies with acridine orange stain and flow-through cytofluorometry","Melamed MR, Traganos F, Sharpless T, Darzynkiewicz Z.","Invest Urol. 1976 Mar;13(5):331-8.","Melamed MR","Invest Urol","1976","1976/03/01","","",""
"8664927","[pT1G3 bladder carcinoma: our experience]","Dell'Orto P, Trinchieri A, D'Addezio F, Bernardini P, Mangiarotti B, Del Nero A, Pisani E.","Arch Ital Urol Androl. 1996 Feb;68(1):9-11.","Dell'Orto P","Arch Ital Urol Androl","1996","1996/02/01","","",""
"10188054","Molecular determinants of outcome in bladder cancer","Cote RJ, Chatterjee SJ.","Cancer J Sci Am. 1999 Jan-Feb;5(1):2-15.","Cote RJ","Cancer J Sci Am","1999","1999/04/03","","",""
"10569548","Ileal neobladder and local recurrence of bladder cancer: patterns of failure and impact on function in men","Hautmann RE, Simon J.","J Urol. 1999 Dec;162(6):1963-6. doi: 10.1016/s0022-5347(05)68079-2.","Hautmann RE","J Urol","1999","1999/11/24","","","10.1016/s0022-5347(05)68079-2"
"4419440","Proceedings: Schistosoma haematobium and bladder cancer","James C, Hicks M, Webbe G, Nelson GS.","Parasitology. 1974 Oct;69(2):viii-ix.","James C","Parasitology","1974","1974/10/01","","",""
"7257633","[Results of combined surgical and radiological treatment of bladder cancer with particular reference to local tumor recurrence]","Hoffmann L, Günther M, Kittner H, Hudemann B, Ziegler PG.","Z Urol Nephrol. 1981 Jun;74(6):427-35.","Hoffmann L","Z Urol Nephrol","1981","1981/06/01","","",""
"28849140","STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells","Tsujita Y, Horiguchi A, Tasaki S, Isono M, Asano T, Ito K, Asano T, Mayumi Y, Kushibiki T.","Oncol Rep. 2017 Oct;38(4):2197-2204. doi: 10.3892/or.2017.5902. Epub 2017 Aug 11.","Tsujita Y","Oncol Rep","2017","2017/08/30","","","10.3892/or.2017.5902"
"2711834","Bladder cancers. Their process of development and its modification","Ito N, Fukushima S, Hasegawa R.","Acta Pathol Jpn. 1989 Jan;39(1):1-14. doi: 10.1111/j.1440-1827.1989.tb02397.x.","Ito N","Acta Pathol Jpn","1989","1989/01/01","","","10.1111/j.1440-1827.1989.tb02397.x"
"22088690","Re.: Mechanisms of recurrence of Ta/T1 bladder cancer","Wood DP.","J Urol. 2011 May;185(5):1642. doi: 10.1016/j.juro.2011.01.072. Epub 2011 Mar 21.","Wood DP","J Urol","2011","2011/11/18","","","10.1016/j.juro.2011.01.072"
"8032832","Immunotherapy with bacille Calmette-Guérin in patients with superficial transitional cell carcinoma of the bladder associated with bilharziasis","Wishahi MM, Ismail IM, el-Sherbini M.","Br J Urol. 1994 Jun;73(6):649-54. doi: 10.1111/j.1464-410x.1994.tb07550.x.","Wishahi MM","Br J Urol","1994","1994/06/01","","","10.1111/j.1464-410x.1994.tb07550.x"
"29061538","Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer Detection","Wallace E, Higuchi R, Satya M, McCann L, Sin MLY, Bridge JA, Wei H, Zhang J, Wong E, Hiar A, Mach KE, Scherr D, Egerdie RB, Ohta S, Sexton WJ, Meng MV, Weizer AZ, Woods M, Jansz GK, Zadra J, Lotan Y, Goldfarb B, Liao JC.","J Urol. 2018 Mar;199(3):655-662. doi: 10.1016/j.juro.2017.09.141. Epub 2017 Oct 20.","Wallace E","J Urol","2018","2017/10/25","","","10.1016/j.juro.2017.09.141"
"31381249","Health-related quality of life among non-muscle-invasive bladder cancer survivors: a population-based study","Jung A, Nielsen ME, Crandell JL, Palmer MH, Smith SK, Bryant AL, Mayer DK.","BJU Int. 2020 Jan;125(1):38-48. doi: 10.1111/bju.14888. Epub 2019 Sep 25.","Jung A","BJU Int","2020","2019/08/06","PMC7137766","NIHMS1577798","10.1111/bju.14888"
"7534842","[Molecular aspects of invasion and metastasis of bladder cancer]","Kagawa S.","Nihon Hinyokika Gakkai Zasshi. 1995 Jan;86(1):82-3.","Kagawa S","Nihon Hinyokika Gakkai Zasshi","1995","1995/01/01","","",""
"15664576","Bladder transitional cell carcinoma: correlation of contrast enhancement on computed tomography with histological grade and tumour angiogenesis","Xie Q, Zhang J, Wu PH, Jiang XQ, Chen SL, Wang QL, Xu J, Chen GD, Deng JH.","Clin Radiol. 2005 Feb;60(2):215-23. doi: 10.1016/j.crad.2004.05.009.","Xie Q","Clin Radiol","2005","2005/01/25","","","10.1016/j.crad.2004.05.009"
"26354883","Re: Clinical Outcomes of cT1 Micropapillary Bladder Cancer: D. L. Willis, M. I. Fernandez, R. J. Dickstein, S. Parikh, J. B. Shah, L. L. Pisters, C. C. Guo, S. Henderson, B. A. Czerniak, H. B. Grossman, C. P. Dinney and A. M. Kamat J Urol 2015;193:1129-1134","Banerjee I, Yadav S, Priyadarshi S, Tomar V.","J Urol. 2015 Dec;194(6):1825. doi: 10.1016/j.juro.2015.04.119. Epub 2015 Sep 4.","Banerjee I","J Urol","2015","2015/09/11","","","10.1016/j.juro.2015.04.119"
"10422122","[Robust analysis methods for multivariate survival times]","Lancar R.","Rev Epidemiol Sante Publique. 1999 Jun;47(3):287-96.","Lancar R","Rev Epidemiol Sante Publique","1999","1999/07/28","","",""
"1574199","Writing competition winner: Robert Wood Johnson pouch","Barone JG, Cummings KB.","N J Med. 1992 Mar;89(3):197-9.","Barone JG","N J Med","1992","1992/03/01","","",""
"23253215","Cause-effect? Understanding the risk factors associated with bladder cancer","Bachir BG, Kassouf W.","Expert Rev Anticancer Ther. 2012 Dec;12(12):1499-502. doi: 10.1586/era.12.140.","Bachir BG","Expert Rev Anticancer Ther","2012","2012/12/21","","","10.1586/era.12.140"
"8160775","Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization","Sauter G, Deng G, Moch H, Kerschmann R, Matsumura K, De Vries S, George T, Fuentes J, Carroll P, Mihatsch MJ, et al.","Am J Pathol. 1994 Apr;144(4):756-66.","Sauter G","Am J Pathol","1994","1994/04/01","PMC1887234","",""
"10599441","Overview of cancer of the bladder","Hayward SW.","Adv Exp Med Biol. 1999;462:395-7.","Hayward SW","Adv Exp Med Biol","1999","1999/12/22","","",""
"25155791","Bladder cancer: Normal cystoscopy, malignant cytology in NMIBC: why biopsy?","Lopez-Beltran A.","Nat Rev Urol. 2014 Oct;11(10):550-1. doi: 10.1038/nrurol.2014.225. Epub 2014 Aug 26.","Lopez-Beltran A","Nat Rev Urol","2014","2014/08/27","","","10.1038/nrurol.2014.225"
"11907736","Bladder cancer within a direct inguinal hernia: CT demonstration","Caterino M, Finocchi V, Giunta S, De Carli P, Crecco M.","Abdom Imaging. 2001 Nov-Dec;26(6):664-6. doi: 10.1007/s00261-001-0019-6.","Caterino M","Abdom Imaging","2001","2002/03/22","","","10.1007/s00261-001-0019-6"
"19819538","Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors","Burger M, Stief CG, Zaak D, Stenzl A, Wieland WF, Jocham D, Otto W, Denzinger S.","Urology. 2009 Dec;74(6):1282-6. doi: 10.1016/j.urology.2009.06.088. Epub 2009 Oct 12.","Burger M","Urology","2009","2009/10/13","","","10.1016/j.urology.2009.06.088"
"10484842","[Pre-operative radiotherapy, conventional or accelerated, for invasive bladder cancer. Objectives and radiation modalities. Results and complications]","López Torrecilla J, Tormo A, García-Miragall E, Rodríguez I, Solsona E, Petschen I.","Arch Esp Urol. 1999 Jul-Aug;52(6):586-94.","López Torrecilla J","Arch Esp Urol","1999","1999/09/15","","",""
"3994914","Bladder cancer mortality of workers exposed to aromatic amines: analysis of models of carcinogenesis","Decarli A, Peto J, Piolatto G, La Vecchia C.","Br J Cancer. 1985 May;51(5):707-12. doi: 10.1038/bjc.1985.106.","Decarli A","Br J Cancer","1985","1985/05/01","PMC1977059","","10.1038/bjc.1985.106"
"25478998","Methylation-mediated silencing of Dlg5 facilitates bladder cancer metastasis","Zhou Z, Guo Y, Liu Y, Zhang F, Wang Y, Shen B, Qin Y, Qiu J.","Exp Cell Res. 2015 Feb 15;331(2):399-407. doi: 10.1016/j.yexcr.2014.11.015. Epub 2014 Dec 3.","Zhou Z","Exp Cell Res","2015","2014/12/06","","","10.1016/j.yexcr.2014.11.015"
"15604255","Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer","Oliveira-Ferrer L, Tilki D, Ziegeler G, Hauschild J, Loges S, Irmak S, Kilic E, Huland H, Friedrich M, Ergün S.","Cancer Res. 2004 Dec 15;64(24):8932-8. doi: 10.1158/0008-5472.CAN-04-0505.","Oliveira-Ferrer L","Cancer Res","2004","2004/12/18","","","10.1158/0008-5472.CAN-04-0505"
"16464532","Management of BCG failures in superficial bladder cancer: a review","Witjes JA.","Eur Urol. 2006 May;49(5):790-7. doi: 10.1016/j.eururo.2006.01.017. Epub 2006 Jan 24.","Witjes JA","Eur Urol","2006","2006/02/09","","","10.1016/j.eururo.2006.01.017"
"6538255","Intravenous cis-platinum for invasive bladder cancer. Safety and feasibility of a new approach","Raghavan D, Pearson B, Coorey G, Woods W, Arnold D, Smith J, Donovan J, Langdon P.","Med J Aust. 1984 Mar 3;140(5):276-8.","Raghavan D","Med J Aust","1984","1984/03/03","","",""
"26238431","Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer","Plimack ER, Dunbrack RL, Brennan TA, Andrake MD, Zhou Y, Serebriiskii IG, Slifker M, Alpaugh K, Dulaimi E, Palma N, Hoffman-Censits J, Bilusic M, Wong YN, Kutikov A, Viterbo R, Greenberg RE, Chen DY, Lallas CD, Trabulsi EJ, Yelensky R, McConkey DJ, Miller VA, Golemis EA, Ross EA.","Eur Urol. 2015 Dec;68(6):959-67. doi: 10.1016/j.eururo.2015.07.009. Epub 2015 Aug 1.","Plimack ER","Eur Urol","2015","2015/08/05","PMC4764095","NIHMS760697","10.1016/j.eururo.2015.07.009"
"11831983","[Expression of VEGF and tumor angiogenesis in bladder cancer]","Wang S, Xia T, Zhang Z, Kong X, Zeng L, Mi P, Xue Z.","Zhonghua Wai Ke Za Zhi. 2000 Jan;38(1):34-6.","Wang S","Zhonghua Wai Ke Za Zhi","2000","2002/02/08","","",""
"28885787","An Inexpensive, Point-of-Care Urine Test for Bladder Cancer in Patients Undergoing Hematuria Evaluation","Acharya AP, Theisen KM, Correa A, Meyyappan T, Apfel A, Sun T, Tarin TV, Little SR.","Adv Healthc Mater. 2017 Nov;6(22). doi: 10.1002/adhm.201700808. Epub 2017 Sep 8.","Acharya AP","Adv Healthc Mater","2017","2017/09/09","","","10.1002/adhm.201700808"
"6337443","New concepts in staging and follow-up of bladder carcinoma","Nelson RP.","Urology. 1983 Feb;21(2):105-12. doi: 10.1016/0090-4295(83)90001-8.","Nelson RP","Urology","1983","1983/02/01","","","10.1016/0090-4295(83)90001-8"
"9489956","The value of DNA cytometry in transitional cell carcinoma of the urinary bladder","Nenning H, Rassler J, Minh DH, Stolzenburg JU.","Gen Diagn Pathol. 1997 Dec;143(4):231-6.","Nenning H","Gen Diagn Pathol","1997","1998/03/07","","",""
"12031868","Surgery and adjunctive chemotherapy for invasive bladder cancer","Raghavan D, Quinn D, Skinner DG, Stein JP.","Surg Oncol. 2002 Jun;11(1-2):55-63. doi: 10.1016/s0960-7404(02)00007-5.","Raghavan D","Surg Oncol","2002","2002/05/29","","","10.1016/s0960-7404(02)00007-5"
"31223123","[Prognostic factors of mortality in patients with urothelial bladder tumor treated with radical cistectomy.]","Del Pozo Jiménez G, Herranz Amo F, Díez Cordero JM, Monzó Gardiner JI, Lledó García E, Subirá Ríos D, Carballido Rodríguez J, Hernández Fernández C.","Arch Esp Urol. 2019 Jun;72(5):451-462.","Del Pozo Jiménez G","Arch Esp Urol","2019","2019/06/22","","",""
"16979737","Radical cystectomy with ultrasound-guided partial prostatectomy for bladder cancer: a complication-preventing concept","Wunderlich H, Wolf M, Reichelt O, Fröber R, Schubert J.","Urology. 2006 Sep;68(3):554-9. doi: 10.1016/j.urology.2006.03.047. Epub 2006 Sep 18.","Wunderlich H","Urology","2006","2006/09/19","","","10.1016/j.urology.2006.03.047"
"30973136","[Immunotherapy and bladder cancer]","Lenfant L, Rouprêt M.","Biol Aujourdhui. 2018;212(3-4):81-84. doi: 10.1051/jbio/2018028. Epub 2019 Apr 11.","Lenfant L","Biol Aujourdhui","2018","2019/04/12","","","10.1051/jbio/2018028"
"27432433","Accuracy of urethral frozen section during radical cystectomy for bladder cancer","Kates M, Ball MW, Chappidi MR, Baras AS, Gordetsky J, Sopko NA, Brant A, Pierorazio PM, Epstein JI, Schoenberg MP, Bivalacqua TJ.","Urol Oncol. 2016 Dec;34(12):532.e1-532.e6. doi: 10.1016/j.urolonc.2016.06.014. Epub 2016 Jul 16.","Kates M","Urol Oncol","2016","2016/07/20","","","10.1016/j.urolonc.2016.06.014"
"10792161","Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy","Cooke PW, James ND, Ganesan R, Burton A, Young LS, Wallace DM.","BJU Int. 2000 May;85(7):829-35. doi: 10.1046/j.1464-410x.2000.00612.x.","Cooke PW","BJU Int","2000","2000/05/03","","","10.1046/j.1464-410x.2000.00612.x"
"2101455","[Changes in the concentration of N-acetylneuraminic acid in the blood of patients with bladder cancer during radiotherapy]","Bellmann S, Bollmann G, Kammerer R, Röder K.","Radiobiol Radiother (Berl). 1990;31(6):509-15.","Bellmann S","Radiobiol Radiother (Berl)","1990","1990/01/01","","",""
"31775672","Detection of carcinogen-induced bladder cancer by fluorocoxib A","Bourn J, Rathore K, Donnell R, White W, Uddin MJ, Marnett L, Cekanova M.","BMC Cancer. 2019 Nov 27;19(1):1152. doi: 10.1186/s12885-019-6366-x.","Bourn J","BMC Cancer","2019","2019/11/29","PMC6882158","","10.1186/s12885-019-6366-x"
"17698132","Bladder cancer: improving care with better classification and risk stratification","Lamm D.","J Urol. 2007 Oct;178(4 Pt 1):1146-7. doi: 10.1016/j.juro.2007.07.065. Epub 2007 Aug 14.","Lamm D","J Urol","2007","2007/08/19","","","10.1016/j.juro.2007.07.065"
"31195416","[Personalised medicine in urothelial bladder cancer]","Grunewald CM, Niegisch G.","Aktuelle Urol. 2019 Sep;50(5):502-508. doi: 10.1055/a-0927-6725. Epub 2019 Jun 13.","Grunewald CM","Aktuelle Urol","2019","2019/06/14","","","10.1055/a-0927-6725"
"20399456","Histone deacetylase inhibitors and bladder cancer","Adam RM.","J Urol. 2010 Jun;183(6):2120-1. doi: 10.1016/j.juro.2010.03.047.","Adam RM","J Urol","2010","2010/04/20","","","10.1016/j.juro.2010.03.047"
"17631333","Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature","Stein JP, Penson DF, Wu SD, Skinner DG.","J Urol. 2007 Sep;178(3 Pt 1):756-60. doi: 10.1016/j.juro.2007.05.013. Epub 2007 Jul 13.","Stein JP","J Urol","2007","2007/07/17","","","10.1016/j.juro.2007.05.013"
"26707952","Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review","Bientinesi R, Ragonese M, Pinto F, Bassi PF, Sacco E.","Clin Genitourin Cancer. 2016 Apr;14(2):e199-201. doi: 10.1016/j.clgc.2015.11.010. Epub 2015 Nov 17.","Bientinesi R","Clin Genitourin Cancer","2016","2015/12/29","","","10.1016/j.clgc.2015.11.010"
"27167342","Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer","Jiang X, Du L, Duan W, Wang R, Yan K, Wang L, Li J, Zheng G, Zhang X, Yang Y, Wang C.","Oncotarget. 2016 Jun 14;7(24):36733-36742. doi: 10.18632/oncotarget.9166.","Jiang X","Oncotarget","2016","2016/05/12","PMC5095035","","10.18632/oncotarget.9166"
"761178","Restoration by levamisole of E-rosette formation and its abrogation by autochthonous serum from patients with bladder cancer","Akaza H, Yokoyama H, Umeda T, Niijima T.","Cancer. 1979 Jan;43(1):97-100. doi: 10.1002/1097-0142(197901)43:1<97::aid-cncr2820430115>3.0.co;2-6.","Akaza H","Cancer","1979","1979/01/01","","","10.1002/1097-0142(197901)43:1<97::aid-cncr2820430115>3.0.co;2-6"
"24377526","Stratifying patients with haematuria into high or low risk groups for bladder cancer: a novel clinical scoring system","Hee TG, Shah SA, Ann HS, Hemdan SN, Shen LC, Al-Fahmi Abdul Galib N, Singam P, Chee Kong CH, Hong GE, Bahadzor B, Zainuddin ZM.","Asian Pac J Cancer Prev. 2013;14(11):6327-30. doi: 10.7314/apjcp.2013.14.11.6327.","Hee TG","Asian Pac J Cancer Prev","2013","2014/01/01","","","10.7314/apjcp.2013.14.11.6327"
"17160667","[Invasive bladder cancer with lymphangiosis carcinomatosa and carcinoma in situ in a 19-year-old female. Case report with 21-year follow-up]","Klatte T, Klatte D.","Urologe A. 2007 Mar;46(3):281-3. doi: 10.1007/s00120-006-1246-9.","Klatte T","Urologe A","2007","2006/12/13","","","10.1007/s00120-006-1246-9"
"28457661","Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review","Soukup V, Čapoun O, Cohen D, Hernández V, Babjuk M, Burger M, Compérat E, Gontero P, Lam T, MacLennan S, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Yuan Y, Zigeuner R.","Eur Urol. 2017 Nov;72(5):801-813. doi: 10.1016/j.eururo.2017.04.015. Epub 2017 Apr 28.","Soukup V","Eur Urol","2017","2017/05/02","","","10.1016/j.eururo.2017.04.015"
"19534791","Micropapillary bladder cancer: a review of Léon Bérard Cancer Center experience","Heudel P, El Karak F, Ismaili N, Droz JP, Flechon A.","BMC Urol. 2009 Jun 17;9:5. doi: 10.1186/1471-2490-9-5.","Heudel P","BMC Urol","2009","2009/06/19","PMC2713271","","10.1186/1471-2490-9-5"
"23249382","Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancer","Rivas A, Burzio V, Landerer E, Borgna V, Gatica S, Ávila R, López C, Villota C, de la Fuente R, Echenique J, Burzio LO, Villegas J.","BMC Urol. 2012 Dec 18;12:37. doi: 10.1186/1471-2490-12-37.","Rivas A","BMC Urol","2012","2012/12/20","PMC3541257","","10.1186/1471-2490-12-37"
"31262890","Amentoflavone Induces Apoptosis and Reduces Expression of Anti-apoptotic and Metastasis-associated Proteins in Bladder Cancer","Chiang CH, Yeh CY, Chung JG, Chiang IT, Hsu FT.","Anticancer Res. 2019 Jul;39(7):3641-3649. doi: 10.21873/anticanres.13512.","Chiang CH","Anticancer Res","2019","2019/07/03","","","10.21873/anticanres.13512"
"24925635","Nucleophosmin1 associated with drug resistance and recurrence of bladder cancer","Hu H, Meng Q, Lei T, Zhang M.","Clin Exp Med. 2015 Aug;15(3):361-9. doi: 10.1007/s10238-014-0288-3. Epub 2014 Jun 13.","Hu H","Clin Exp Med","2015","2014/06/14","","","10.1007/s10238-014-0288-3"
"11195897","Comparison of BTA stat and NMP22 tests in the detection of bladder cancer","Oge O, Atsü N, Sahin A, Ozen H.","Scand J Urol Nephrol. 2000 Dec;34(6):349-51. doi: 10.1080/003655900455404.","Oge O","Scand J Urol Nephrol","2000","2001/02/24","","","10.1080/003655900455404"
"11235222","[A case of human chorionic gonadotropin-producing bladder cancer]","Ito M, Okumura K, Nishio Y.","Hinyokika Kiyo. 2001 Jan;47(1):47-9.","Ito M","Hinyokika Kiyo","2001","2001/03/10","","",""
"15173088","Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer","Theodorescu D, Sapinoso LM, Conaway MR, Oxford G, Hampton GM, Frierson HF Jr.","Clin Cancer Res. 2004 Jun 1;10(11):3800-6. doi: 10.1158/1078-0432.CCR-03-0653.","Theodorescu D","Clin Cancer Res","2004","2004/06/03","","","10.1158/1078-0432.CCR-03-0653"
"20346223","The diagnostic value of urine-based survivin mRNA test using reverse transcription-polymerase chain reaction for bladder cancer: a systematic review","Xia Y, Liu YL, Yang KH, Chen W.","Chin J Cancer. 2010 Apr;29(4):441-6. doi: 10.5732/cjc.009.10509.","Xia Y","Chin J Cancer","2010","2010/03/30","","","10.5732/cjc.009.10509"
"1931628","A prospective randomised trial of radiation with or without oral and intravesical misonidazole for bladder cancer","Abratt RP, Craighead P, Reddi VB, Sarembock LA.","Br J Cancer. 1991 Nov;64(5):968-70. doi: 10.1038/bjc.1991.438.","Abratt RP","Br J Cancer","1991","1991/11/01","PMC1977474","","10.1038/bjc.1991.438"
"1949449","Cyclophosphamide-associated carcinoma of urothelium: modalities for prevention","Cannon J, Linke CA, Cos LR.","Urology. 1991 Nov;38(5):413-6. doi: 10.1016/0090-4295(91)80228-y.","Cannon J","Urology","1991","1991/11/01","","","10.1016/0090-4295(91)80228-y"
"10668939","The effect of intravesical mitomycin C on the recurrence of superficial (Ta-T1) bladder cancer. A Hungarian Multicenter Study","Kondás J, Kiss L, Határ A, Kiss A, Lukács T, Szeldeli P, Törzsök F, Bodrogi I.","Int Urol Nephrol. 1999;31(4):451-6. doi: 10.1023/a:1007155026151.","Kondás J","Int Urol Nephrol","1999","2000/02/11","","","10.1023/a:1007155026151"
"28258492","SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors","Yin H, Qin C, Zhao Y, Du Y, Sheng Z, Wang Q, Song Q, Chen L, Liu C, Xu T.","Clin Transl Oncol. 2017 Aug;19(8):1035-1044. doi: 10.1007/s12094-017-1641-2. Epub 2017 Mar 3.","Yin H","Clin Transl Oncol","2017","2017/03/05","","","10.1007/s12094-017-1641-2"
"80389","Tumours of the urinary bladder accidentally diagnosed during prostatectomy","Krzeski T, Witeska A, Zachwiej J.","Int Urol Nephrol. 1978;10(3):225-7. doi: 10.1007/BF02082030.","Krzeski T","Int Urol Nephrol","1978","1978/01/01","","","10.1007/BF02082030"
"26916216","Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis","Motawi TK, Rizk SM, Ibrahim TM, Ibrahim IA.","Cell Biochem Funct. 2016 Apr;34(3):142-8. doi: 10.1002/cbf.3171. Epub 2016 Feb 24.","Motawi TK","Cell Biochem Funct","2016","2016/02/27","","","10.1002/cbf.3171"
"24204662","Prognostic role of survivin in bladder cancer: a systematic review and meta-analysis","Jeon C, Kim M, Kwak C, Kim HH, Ku JH.","PLoS One. 2013 Oct 18;8(10):e76719. doi: 10.1371/journal.pone.0076719. eCollection 2013.","Jeon C","PLoS One","2013","2013/11/09","PMC3799942","","10.1371/journal.pone.0076719"
"26195712","Depth of Invasion in High-Grade T1 Bladder Cancer: Added Value In Timely Cystectomy?","Lu K.","J Clin Oncol. 2015 Aug 20;33(24):2715-6. doi: 10.1200/JCO.2015.62.2712. Epub 2015 Jul 20.","Lu K","J Clin Oncol","2015","2015/07/22","","","10.1200/JCO.2015.62.2712"
"8254803","The content of urokinase-type plasminogen activator and tumor recurrence in superficial bladder cancer","Hasui Y, Marutsuka K, Nishi S, Kitada S, Osada Y, Sumiyoshi A.","J Urol. 1994 Jan;151(1):16-9; discussion 19-20. doi: 10.1016/s0022-5347(17)34861-9.","Hasui Y","J Urol","1994","1994/01/01","","","10.1016/s0022-5347(17)34861-9"
"15311036","Current trends in bladder cancer in England and Wales","Hayne D, Arya M, Quinn MJ, Babb PJ, Beacock CJ, Patel HR.","J Urol. 2004 Sep;172(3):1051-5. doi: 10.1097/01.ju.0000136376.11896.62.","Hayne D","J Urol","2004","2004/08/18","","","10.1097/01.ju.0000136376.11896.62"
"22196000","[Chemoradiotherapy for muscle-invasive cancer: methods, surveillance and results. An update from the cancer committee of the French National Association of Urology]","Quintens H, Roupret M, Larré S, Neuzillet Y, Pignot G, Compérat E, Wallerand H, Houédé N, Roy C, Soulié M, Pfister C; Membres du CC-AFU.","Prog Urol. 2012 Jan;22(1):13-6. doi: 10.1016/j.purol.2011.09.016. Epub 2011 Nov 9.","Quintens H","Prog Urol","2012","2011/12/27","","","10.1016/j.purol.2011.09.016"
"2739511","Photodynamic therapy of superficial bladder cancer","Javadpour N.","Md Med J. 1989 Jun;38(6):461.","Javadpour N","Md Med J","1989","1989/06/01","","",""
"5862862","[On the possibilities of improving recovery results in bladder cancer]","Karcher G.","Med Welt. 1965 Sep 18;38:2148-52.","Karcher G","Med Welt","1965","1965/09/18","","",""
"11144892","Prevention and treatment of urothelial premalignant and malignant lesions","Wijkström H, Cohen SM, Gardiner RA, Kakizoe T, Schoenberg M, Steineck G, Tobisu K.","Scand J Urol Nephrol Suppl. 2000;(205):116-35. doi: 10.1080/00365590050509878.","Wijkström H","Scand J Urol Nephrol Suppl","2000","2001/01/06","","","10.1080/00365590050509878"
"16849682","Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection","Hoque MO, Begum S, Topaloglu O, Chatterjee A, Rosenbaum E, Van Criekinge W, Westra WH, Schoenberg M, Zahurak M, Goodman SN, Sidransky D.","J Natl Cancer Inst. 2006 Jul 19;98(14):996-1004. doi: 10.1093/jnci/djj265.","Hoque MO","J Natl Cancer Inst","2006","2006/07/20","","","10.1093/jnci/djj265"
"1445747","Prediction of superficial bladder cancer by nuclear image analysis","Lipponen PK, Eskelinen MJ, Jauhiainen K, Harju E, Terho R, Haapasalo H.","Eur J Cancer. 1992;29A(1):61-5. doi: 10.1016/0959-8049(93)90577-3.","Lipponen PK","Eur J Cancer","1992","1992/01/01","","","10.1016/0959-8049(93)90577-3"
"23796199","Commentary on ""The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature."" Swietek N, Waldert M, Rom M, Schatzl G, Wiener HG, Susani M, Klatte T. Department of Urology, Medical University of Vienna, Vienna, Austria: J Urol 2012;188(3):748-53 [Epub 2012 Jul 20]","See WA.","Urol Oncol. 2013 Jul;31(5):715-6. doi: 10.1016/j.urolonc.2013.03.014.","See WA","Urol Oncol","2013","2013/06/26","","","10.1016/j.urolonc.2013.03.014"
"18946399","Bladder cancer and smoking. Part 1: addressing the associated risk factors","Anderson B, Naish W.","Br J Nurs. 2008 Oct 9-22;17(18):1182-6.","Anderson B","Br J Nurs","2008","2008/10/24","","",""
"24455982","Chemotherapeutic and targeted biological agents for metastatic bladder cancer: a comprehensive review","Sio TT, Ko J, Gudena VK, Verma N, Chaudhary UB.","Int J Urol. 2014 Jul;21(7):630-7. doi: 10.1111/iju.12407. Epub 2014 Jan 23.","Sio TT","Int J Urol","2014","2014/01/25","","","10.1111/iju.12407"
"24264314","Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies","Wang Y, Li Z, Liu N, Zhang G.","Tumour Biol. 2014 Apr;35(4):3155-65. doi: 10.1007/s13277-013-1412-9. Epub 2013 Nov 22.","Wang Y","Tumour Biol","2014","2013/11/23","","","10.1007/s13277-013-1412-9"
"1893857","[4-Chloro-o-toluidine-induced bladder cancer]","Stasik MJ.","Dtsch Med Wochenschr. 1991 Sep 20;116(38):1444-7. doi: 10.1055/s-2008-1063771.","Stasik MJ","Dtsch Med Wochenschr","1991","1991/09/20","","","10.1055/s-2008-1063771"
"3750596","Retrospective study of efficacy of intravesical BCG alone in treatment of superficial bladder cancer","Mydlo JH, Usher SM, Camacho F, Freed S.","Urology. 1986 Sep;28(3):173-5. doi: 10.1016/0090-4295(86)90036-1.","Mydlo JH","Urology","1986","1986/09/01","","","10.1016/0090-4295(86)90036-1"
"30634335","Re: Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens:","Chang SS.","J Urol. 2019 Feb;201(2):225-226. doi: 10.1097/01.JU.0000553022.59240.43.","Chang SS","J Urol","2019","2019/01/13","","","10.1097/01.JU.0000553022.59240.43"
"21691016","Incidence of bladder cancer in a one-stop clinic","Yakasai A, Allam M, Thompson AJ.","Ann Afr Med. 2011 Apr-Jun;10(2):112-4. doi: 10.4103/1596-3519.82071.","Yakasai A","Ann Afr Med","2011","2011/06/22","","","10.4103/1596-3519.82071"
"7974896","Management of the patient with bladder cancer. Urethral recurrence","Freeman JA, Esrig D, Stein JP, Skinner DG.","Urol Clin North Am. 1994 Nov;21(4):645-51.","Freeman JA","Urol Clin North Am","1994","1994/11/01","","",""
"26822497","Comparative efficacy of vitamin D status in reducing the risk of bladder cancer: A systematic review and network meta-analysis","Zhao Y, Chen C, Pan W, Gao M, He W, Mao R, Lin T, Huang J.","Nutrition. 2016 May;32(5):515-23. doi: 10.1016/j.nut.2015.10.023. Epub 2015 Dec 19.","Zhao Y","Nutrition","2016","2016/01/30","","","10.1016/j.nut.2015.10.023"
"25802103","[Non-muscle-invasive high-grade bladder cancer]","Gakis G, Stenzl A, Horn T, Gschwend JE, Otto W, Burger M.","Urologe A. 2015 Apr;54(4):491-8. doi: 10.1007/s00120-015-3774-7.","Gakis G","Urologe A","2015","2015/03/25","","","10.1007/s00120-015-3774-7"
"3297290","Chemoprevention of bladder cancer","Malone WF, Kelloff GJ, Pierson H, Greenwald P.","Cancer. 1987 Aug 1;60(3 Suppl):650-7. doi: 10.1002/1097-0142(19870801)60:3+<650::aid-cncr2820601535>3.0.co;2-j.","Malone WF","Cancer","1987","1987/08/01","","","10.1002/1097-0142(19870801)60:3+<650::aid-cncr2820601535>3.0.co;2-j"
"19224167","Expression of transcription factor Oct4 in bladder cancer cell line T24 and its effects on the biological characteristics of the cells","Zhu Z, Wen J, Zheng X, Wang D, Wang Q, Fan C.","J Huazhong Univ Sci Technolog Med Sci. 2009 Feb;29(1):73-6. doi: 10.1007/s11596-009-0115-3. Epub 2009 Feb 18.","Zhu Z","J Huazhong Univ Sci Technolog Med Sci","2009","2009/02/19","","","10.1007/s11596-009-0115-3"
"26437554","[Rapid Sequence Intubation with the McGRATH MAC Videolaryngoscope in the Sitting Position for a Patient with Restricted Mouth Opening]","Hasegawa Y, Komasawa N, Matsunami S, Kido H, Kusaka Y, Minami T.","Masui. 2015 Jun;64(6):632-4.","Hasegawa Y","Masui","2015","2015/10/07","","",""
"30549867","[Surgical treatment of bladder cancer in the geriatric patients]","Koie T, Hatakeyama S, Ohyama C.","Nihon Rinsho. 2017 Apr;75(4):611-614.","Koie T","Nihon Rinsho","2017","2018/12/15","","",""
"6832092","Pathogenesis of human urinary bladder cancer","Bryan GT.","Environ Health Perspect. 1983 Mar;49:201-7. doi: 10.1289/ehp.8349201.","Bryan GT","Environ Health Perspect","1983","1983/03/01","PMC1569116","","10.1289/ehp.8349201"
"10895126","Molecular mechanisms and pathways in bladder cancer development and progression","Jung I, Messing E.","Cancer Control. 2000 Jul-Aug;7(4):325-34. doi: 10.1177/107327480000700401.","Jung I","Cancer Control","2000","2000/07/15","","","10.1177/107327480000700401"
"1263311","Anergy and tryptophan metabolism in bladder cancer","Romas NA, Ionascu L, Ionescu G, Wechsler M, Tannenbaum M, Veenema RJ.","J Urol. 1976 Apr;115(4):387-9. doi: 10.1016/s0022-5347(17)59212-5.","Romas NA","J Urol","1976","1976/04/01","","","10.1016/s0022-5347(17)59212-5"
"16281833","[One-stage transurethral resection of the urinary bladder and the prostate in patients with superficial cancer of the urinary bladder combined with benign prostatic hyperplasia]","Karaguzhin SG, Merinov DS, Martov AG.","Urologiia. 2005 Sep-Oct;(5):17-21.","Karaguzhin SG","Urologiia","2005","2005/11/12","","",""
"519209","Genetic association with bladder cancer","Cartwright RA.","Br Med J. 1979 Sep 29;2(6193):798. doi: 10.1136/bmj.2.6193.798-b.","Cartwright RA","Br Med J","1979","1979/09/29","PMC1596415","","10.1136/bmj.2.6193.798-b"
"8497991","DNA profile of nephrogenic adenoma assessed by flow cytometry","Gaylis FD, Keer HN, Bauer KD, Kozlowski JM, Grayhack JT.","Urology. 1993 Feb;41(2):160-1. doi: 10.1016/0090-4295(93)90172-7.","Gaylis FD","Urology","1993","1993/02/01","","","10.1016/0090-4295(93)90172-7"
"23295599","Serum adenosine deaminase, catalase and carbonic anhydrase activities in patients with bladder cancer","Pirinççi N, Geçit I, Güneş M, Yüksel MB, Kaba M, Tanık S, Demir H, Aslan M.","Clinics (Sao Paulo). 2012 Dec;67(12):1443-6. doi: 10.6061/clinics/2012(12)15.","Pirinççi N","Clinics (Sao Paulo)","2012","2013/01/09","PMC3521808","","10.6061/clinics/2012(12)15"
"15862616","The role of lymphadenectomy in high-grade invasive bladder cancer","Stein JP, Skinner DG.","Urol Clin North Am. 2005 May;32(2):187-97. doi: 10.1016/j.ucl.2005.01.005.","Stein JP","Urol Clin North Am","2005","2005/05/03","","","10.1016/j.ucl.2005.01.005"
"7167367","[Diagnosis of preoperative staging of bladder cancer by CT and angiography]","Munechika H, Saito K, Tanaka O, Tomiie F, Aihara T, Ohsawa T, Tokue A, Matsumoto S.","Nihon Igaku Hoshasen Gakkai Zasshi. 1982 Oct 25;42(10):919-27.","Munechika H","Nihon Igaku Hoshasen Gakkai Zasshi","1982","1982/10/25","","",""
"6943379","Emergence of an epidermis-associated cell surface antigen in epithelial cells of the rat urinary bladder in carcinogenesis","Masuko T, Hashimoto Y.","J Natl Cancer Inst. 1981 Aug;67(2):431-6.","Masuko T","J Natl Cancer Inst","1981","1981/08/01","","",""
"15300147","Second-line intravesical therapy versus cystectomy for bacille Calmette-Guérin (BCG) failures","Joudi FN, O'Donnell MA.","Curr Opin Urol. 2004 Sep;14(5):271-5. doi: 10.1097/00042307-200409000-00005.","Joudi FN","Curr Opin Urol","2004","2004/08/10","","","10.1097/00042307-200409000-00005"
"31199049","Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target","Yamada Y, Kato M, Arai T, Sanada H, Uchida A, Misono S, Sakamoto S, Komiya A, Ichikawa T, Seki N.","Mol Oncol. 2019 Sep;13(9):1898-1912. doi: 10.1002/1878-0261.12532. Epub 2019 Jun 27.","Yamada Y","Mol Oncol","2019","2019/06/15","PMC6717764","","10.1002/1878-0261.12532"
"19787625","Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis","Zancan M, Galdi F, Di Tonno F, Mazzariol C, Orlando C, Malentacchi F, Agostini M, Maran M, Del Bianco P, Fabricio AS, Murer B, Pianon C, Gion M.","Int J Biol Markers. 2009 Jul-Sep;24(3):147-55. doi: 10.5301/jbm.2009.5054.","Zancan M","Int J Biol Markers","2009","2009/09/30","","","10.5301/jbm.2009.5054"
"23142689","FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer","Mertens LS, Fioole-Bruining A, van Rhijn BW, Kerst JM, Bergman AM, Vogel WV, Vegt E, Horenblas S.","J Urol. 2013 May;189(5):1687-91. doi: 10.1016/j.juro.2012.11.009. Epub 2012 Nov 6.","Mertens LS","J Urol","2013","2012/11/13","","","10.1016/j.juro.2012.11.009"
"31358595","Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer","Cheng S, Wang G, Wang Y, Cai L, Qian K, Ju L, Liu X, Xiao Y, Wang X.","Clin Sci (Lond). 2019 Aug 7;133(15):1745-1758. doi: 10.1042/CS20190587. Print 2019 Aug 15.","Cheng S","Clin Sci (Lond)","2019","2019/07/31","","","10.1042/CS20190587"
"24495014","Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling","Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y.","FEBS J. 2014 Apr;281(7):1750-8. doi: 10.1111/febs.12737. Epub 2014 Feb 20.","Fan Y","FEBS J","2014","2014/02/06","","","10.1111/febs.12737"
"28025079","βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancer","Hinsch A, Chaker A, Burdelski C, Koop C, Tsourlakis MC, Steurer S, Rink M, Eichenauer TS, Wilczak W, Wittmer C, Fisch M, Simon R, Sauter G, Büschek F, Clauditz T, Minner S, Jacobsen F.","Hum Pathol. 2017 Mar;61:210-220. doi: 10.1016/j.humpath.2016.11.005. Epub 2016 Dec 24.","Hinsch A","Hum Pathol","2017","2016/12/28","","","10.1016/j.humpath.2016.11.005"
"29902678","Novel urinary biomarkers for the detection of bladder cancer: A systematic review","Tan WS, Tan WP, Tan MY, Khetrapal P, Dong L, deWinter P, Feber A, Kelly JD.","Cancer Treat Rev. 2018 Sep;69:39-52. doi: 10.1016/j.ctrv.2018.05.012. Epub 2018 May 29.","Tan WS","Cancer Treat Rev","2018","2018/06/15","","","10.1016/j.ctrv.2018.05.012"
"1704277","Short-term radiotherapy as palliative treatment in patients with transitional cell bladder cancer","Wijkström H, Näslund I, Ekman P, Köhler C, Nilsson B, Norming U.","Br J Urol. 1991 Jan;67(1):74-8. doi: 10.1111/j.1464-410x.1991.tb15073.x.","Wijkström H","Br J Urol","1991","1991/01/01","","","10.1111/j.1464-410x.1991.tb15073.x"
"27181362","HIF-1α activates hypoxia-induced PFKFB4 expression in human bladder cancer cells","Zhang H, Lu C, Fang M, Yan W, Chen M, Ji Y, He S, Liu T, Chen T, Xiao J.","Biochem Biophys Res Commun. 2016 Jul 29;476(3):146-52. doi: 10.1016/j.bbrc.2016.05.026. Epub 2016 May 13.","Zhang H","Biochem Biophys Res Commun","2016","2016/05/17","","","10.1016/j.bbrc.2016.05.026"
"30458195","Loss of DUSP2 predicts a poor prognosis in patients with bladder cancer","Yin H, He W, Li Y, Xu N, Zhu X, Lin Y, Gou X.","Hum Pathol. 2019 Mar;85:152-161. doi: 10.1016/j.humpath.2018.11.007. Epub 2018 Nov 17.","Yin H","Hum Pathol","2019","2018/11/21","","","10.1016/j.humpath.2018.11.007"
"7614452","Gelsolin: a candidate for suppressor of human bladder cancer","Tanaka M, Müllauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T, Kuzumaki N.","Cancer Res. 1995 Aug 1;55(15):3228-32.","Tanaka M","Cancer Res","1995","1995/08/01","","",""
"20679745","The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer","Asadauskiene J, Aleknavicius E, Pipiriene-Zelviene T, Jankevicius F.","Medicina (Kaunas). 2010;46(5):305-14.","Asadauskiene J","Medicina (Kaunas)","2010","2010/08/04","","",""
"29186087","Three more immune checkpoint inhibitors for advanced bladder cancer","","Med Lett Drugs Ther. 2017 Dec 4;59(1535):e202-e203.","","Med Lett Drugs Ther","2017","2017/11/30","","",""
"21118662","[Introduction of integrated cancer pathway shortens diagnostic delay in bladder cancer]","Lijkendijk M, Thind P.","Ugeskr Laeger. 2010 Nov 29;172(48):3330-2.","Lijkendijk M","Ugeskr Laeger","2010","2010/12/02","","",""
"3092786","[Pathomorphosis of bladder cancer after endolymphatic polychemotherapy]","Danil'chenko SA, Shlopov VG, Serniak PS, Geev IuV.","Arkh Patol. 1986;48(7):31-5.","Danil'chenko SA","Arkh Patol","1986","1986/01/01","","",""
"30914736","Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer","Li A, Zhu X, Wang C, Yang S, Qiao Y, Qiao R, Zhang J.","Sci Rep. 2019 Mar 26;9(1):5166. doi: 10.1038/s41598-019-41660-w.","Li A","Sci Rep","2019","2019/03/28","PMC6435802","","10.1038/s41598-019-41660-w"
"4184653","[Role of microscopic study of the urine in the diagnosis of bladder cancer]","Blokh MIa, Goznyĭ AD.","Lab Delo. 1968;6:364-5.","Blokh MIa","Lab Delo","1968","1968/01/01","","",""
"31219763","Reduction of Pain during Flexible Cystoscopy: A Systematic Review and Meta-Analysis","Raskolnikov D, Brown B, Holt SK, Ball AL, Lotan Y, Strope S, Schroeck F, Ullman R, Lipman R, Smith AB, Gore JL.","J Urol. 2019 Dec;202(6):1136-1142. doi: 10.1097/JU.0000000000000399. Epub 2019 Jun 20.","Raskolnikov D","J Urol","2019","2019/06/21","","","10.1097/JU.0000000000000399"
"25471790","Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer","Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y.","Med Oncol. 2015 Jan;32(1):421. doi: 10.1007/s12032-014-0421-x. Epub 2014 Dec 4.","Koie T","Med Oncol","2015","2014/12/05","","","10.1007/s12032-014-0421-x"
"30365104","Overexpression of long non‑coding RNA n346372 in bladder cancer tissues is associated with a poor prognosis","Liu A, Zhang Z, Xu W, Qin S, Hua M, Zeng S, Xu C.","Mol Med Rep. 2018 Dec;18(6):5437-5444. doi: 10.3892/mmr.2018.9597. Epub 2018 Oct 25.","Liu A","Mol Med Rep","2018","2018/10/27","PMC6236288","","10.3892/mmr.2018.9597"
"3567865","The role of adjunctive immunotherapy in superficial bladder cancer","Fujita K.","Cancer. 1987 Jun 15;59(12):2027-30. doi: 10.1002/1097-0142(19870615)59:12<2027::aid-cncr2820591210>3.0.co;2-n.","Fujita K","Cancer","1987","1987/06/15","","","10.1002/1097-0142(19870615)59:12<2027::aid-cncr2820591210>3.0.co;2-n"
"20493447","[Management of bladder cancer in unfit patients]","Mongiat-Artus P, Pfister C, Théodore C, De Crevoisier R, Guillotreau J.","Prog Urol. 2010 Mar;20 Suppl 1:S54-6. doi: 10.1016/S1166-7087(10)70028-2.","Mongiat-Artus P","Prog Urol","2010","2010/05/25","","","10.1016/S1166-7087(10)70028-2"
"2249210","Cancer of the urinary bladder in blacks and whites. A case-control study","Harris RE, Chen-Backlund JY, Wynder EL.","Cancer. 1990 Dec 15;66(12):2673-80. doi: 10.1002/1097-0142(19901215)66:12<2673::aid-cncr2820661235>3.0.co;2-g.","Harris RE","Cancer","1990","1990/12/15","","","10.1002/1097-0142(19901215)66:12<2673::aid-cncr2820661235>3.0.co;2-g"
"31144594","A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014","Westergren DO, Gårdmark T, Lindhagen L, Chau A, Malmström PU.","J Urol. 2019 Nov;202(5):905-912. doi: 10.1097/JU.0000000000000350. Epub 2019 Oct 9.","Westergren DO","J Urol","2019","2019/05/31","","","10.1097/JU.0000000000000350"
"16184465","Bladder cancer risk in painters: a review of the epidemiological evidence, 1989-2004","Bosetti C, Pira E, La Vecchia C.","Cancer Causes Control. 2005 Nov;16(9):997-1008. doi: 10.1007/s10552-005-3636-5.","Bosetti C","Cancer Causes Control","2005","2005/09/27","","","10.1007/s10552-005-3636-5"
"21673031","Human papillomavirus infection and bladder cancer risk: a meta-analysis","Li N, Yang L, Zhang Y, Zhao P, Zheng T, Dai M.","J Infect Dis. 2011 Jul 15;204(2):217-23. doi: 10.1093/infdis/jir248.","Li N","J Infect Dis","2011","2011/06/16","PMC3114469","","10.1093/infdis/jir248"
"25688510","Dynamic expression changes between non-muscle-invasive bladder cancer and muscle-invasive bladder cancer","Zhao YG, Shi BY, Qian YY, Bai HW, Xiao L, He XY.","Tumori. 2014 Nov-Dec;100(6):e273-81. doi: 10.1700/1778.19294.","Zhao YG","Tumori","2014","2015/02/18","","","10.1700/1778.19294"
"3362886","The assessment of patients with invasive bladder cancer prior to definitive treatment to enable individual planning of the most appropriate therapy","Newling DW.","Prog Clin Biol Res. 1988;260:291-300.","Newling DW","Prog Clin Biol Res","1988","1988/01/01","","",""
"17935615","The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo","Buckley MT, Yoon J, Yee H, Chiriboga L, Liebes L, Ara G, Qian X, Bajorin DF, Sun TT, Wu XR, Osman I.","J Transl Med. 2007 Oct 12;5:49. doi: 10.1186/1479-5876-5-49.","Buckley MT","J Transl Med","2007","2007/10/16","PMC2100044","","10.1186/1479-5876-5-49"
"12893328","Tumor-associated trypsin inhibitor as a prognostic factor during follow-up of bladder cancer","Kelloniemi E, Rintala E, Finne P, Stenman UH; Finnbladder Group.","Urology. 2003 Aug;62(2):249-53. doi: 10.1016/s0090-4295(03)00329-7.","Kelloniemi E","Urology","2003","2003/08/02","","","10.1016/s0090-4295(03)00329-7"
"21631144","Use of quasi-normal form to examine stability of tumor-free equilibrium in a mathematical model of BCG treatment of bladder cancer","Bunimovich-Mendrazitsky S, Goltser Y.","Math Biosci Eng. 2011 Apr;8(2):529-47. doi: 10.3934/mbe.2011.8.529.","Bunimovich-Mendrazitsky S","Math Biosci Eng","2011","2011/06/03","","","10.3934/mbe.2011.8.529"
"3747308","[Multidisciplinary treatment of invasive bladder cancer]","Akaza H, Koseki K, Kishi H, Umeda T, Isurugi K, Niijima T.","Nihon Hinyokika Gakkai Zasshi. 1986 May;77(5):716-21. doi: 10.5980/jpnjurol1928.77.5_716.","Akaza H","Nihon Hinyokika Gakkai Zasshi","1986","1986/05/01","","","10.5980/jpnjurol1928.77.5_716"
"31287354","Re: Population-Based Assessment of Racial/Ethnic Differences in Utilization of Radical Cystectomy for Patients Diagnosed with Bladder Cancer","Chang SS.","J Urol. 2019 Oct;202(4):659. doi: 10.1097/01.JU.0000576988.05549.2c. Epub 2019 Sep 6.","Chang SS","J Urol","2019","2019/07/10","","","10.1097/01.JU.0000576988.05549.2c"
"11315586","[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]","Hautmann SH, Schroeder GL, Civantos F, Duncan RC, Gnann R, Friedrich MG, Hellstern A, Huland H, Soloway MS, Lokeshwar VB.","Urologe A. 2001 Mar;40(2):121-6. doi: 10.1007/s001200050449.","Hautmann SH","Urologe A","2001","2001/04/24","","","10.1007/s001200050449"
"6406399","Presumptive downstaging from preoperative irradiation for bladder cancer as determined by flow cytometry: preliminary report","Klein FA, Whitmore WF Jr, Wolf RM, Herr HW, Sogani PC, Staiano-Coico L, Melamed MR.","Int J Radiat Oncol Biol Phys. 1983 Apr;9(4):487-91. doi: 10.1016/0360-3016(83)90065-2.","Klein FA","Int J Radiat Oncol Biol Phys","1983","1983/04/01","","","10.1016/0360-3016(83)90065-2"
"1640485","Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer","Logothetis CJ, Xu HJ, Ro JY, Hu SX, Sahin A, Ordonez N, Benedict WF.","J Natl Cancer Inst. 1992 Aug 19;84(16):1256-61. doi: 10.1093/jnci/84.16.1256.","Logothetis CJ","J Natl Cancer Inst","1992","1992/08/19","","","10.1093/jnci/84.16.1256"
"15072489","Local recurrence in patients after radical cystectomy and orthotopic ileal neobladder: impact on function","Oberneder R, Staudte S, Waidelich R, Schmeller N, Hofstetter A.","Int Urol Nephrol. 2003;35(2):175-9. doi: 10.1023/b:urol.0000020303.37190.95.","Oberneder R","Int Urol Nephrol","2003","2004/04/10","","","10.1023/b:urol.0000020303.37190.95"
"7735802","Prognostic evaluation of morphonuclear parameters in superficial and invasive bladder cancer","Colombel M, De Launoit Y, Bellot J, Kiss R, Abbou C, Chopin D.","Br J Urol. 1995 Mar;75(3):364-9. doi: 10.1111/j.1464-410x.1995.tb07350.x.","Colombel M","Br J Urol","1995","1995/03/01","","","10.1111/j.1464-410x.1995.tb07350.x"
"16336832","Enhanced sensitivity to mitomycin C by abating heat shock protein 70 expression in human bladder cancer cell line of BIU-87","He LF, Guan KP, Yan Z, Ye HY, Xu KX, Ren L, Hou SK.","Chin Med J (Engl). 2005 Dec 5;118(23):1965-72.","He LF","Chin Med J (Engl)","2005","2005/12/13","","",""
"25882558","Novel therapeutic approaches for recurrent nonmuscle invasive bladder cancer","Boehm BE, Svatek RS.","Urol Clin North Am. 2015 May;42(2):159-68, vii. doi: 10.1016/j.ucl.2015.02.001. Epub 2015 Mar 6.","Boehm BE","Urol Clin North Am","2015","2015/04/18","","","10.1016/j.ucl.2015.02.001"
"19054893","The global burden of urinary bladder cancer","Parkin DM.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):12-20. doi: 10.1080/03008880802285032.","Parkin DM","Scand J Urol Nephrol Suppl","2008","2008/12/06","","","10.1080/03008880802285032"
"1947849","Transurethral ultrasound scanning in the evaluation of invasive bladder cancer","Schulze S, Holm-Nielsen A, Mogensen P.","Scand J Urol Nephrol. 1991;25(3):215-7. doi: 10.3109/00365599109107949.","Schulze S","Scand J Urol Nephrol","1991","1991/01/01","","","10.3109/00365599109107949"
"24859184","Analysis of results of recurrence and progression rates of high-grade Ta bladder cancer and comparison with results of high-grade T1","Kilinc MF, Sonmez NC, Dalkilic A, Arisan S, Guney S.","Urologia. 2014 Oct-Dec;81(4):237-41. doi: 10.5301/uro.5000072. Epub 2014 May 22.","Kilinc MF","Urologia","2014","2014/05/27","","","10.5301/uro.5000072"
"23712470","HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker","Lorenzi T, Lorenzi M, Altobelli E, Marzioni D, Mensà E, Quaranta A, Paolinelli F, Morroni M, Mazzucchelli R, De Luca A, Procopio AD, Baldi A, Muzzonigro G, Montironi R, Castellucci M.","Int J Cancer. 2013 Dec 1;133(11):2650-61. doi: 10.1002/ijc.28280. Epub 2013 Jul 9.","Lorenzi T","Int J Cancer","2013","2013/05/29","","","10.1002/ijc.28280"
"26578732","Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer","Joseph N, Dovedi SJ, Thompson C, Lyons J, Kennedy J, Elliott T, West CM, Choudhury A.","Ann Oncol. 2016 Feb;27(2):294-9. doi: 10.1093/annonc/mdv546. Epub 2015 Nov 16.","Joseph N","Ann Oncol","2016","2015/11/19","","","10.1093/annonc/mdv546"
"3325677","[Combined cisplatin and radiation therapy in patients with invasive bladder cancer]","Mori Y, Arima M, Shimada K, Shima H, Terakawa T, Yabumoto H, Tsujimoto S, Hosokawa S, Ogino T, Fujisue H, et al.","Nihon Hinyokika Gakkai Zasshi. 1987 Aug;78(8):1345-53. doi: 10.5980/jpnjurol1928.78.8_1345.","Mori Y","Nihon Hinyokika Gakkai Zasshi","1987","1987/08/01","","","10.5980/jpnjurol1928.78.8_1345"
"3454800","In vitro produced human antibodies in the treatment of superficial bladder cancer","Corrado F, Pizza G, Casanova S, De Vinci C, Fini M, Severini G, Menniti D, Corrado G.","J Exp Pathol. 1987 Summer;3(4):347-58.","Corrado F","J Exp Pathol","1987","1987/01/01","","",""
"14587237","[Microsatellite analysis in exfoliated cells from urinary sediment. Its utility for the detection of bladder cancer. Comparison with urinary cytology]","Molina Burgos R, Millán Salvador JM, Oltra Soler JS, Jiménez Cruz JF.","Actas Urol Esp. 2003 Sep;27(8):618-28. doi: 10.1016/s0210-4806(03)72984-2.","Molina Burgos R","Actas Urol Esp","2003","2003/11/01","","","10.1016/s0210-4806(03)72984-2"
"30168123","The Role and Importance of Timely Radical Cystectomy for High-Risk Non-muscle-Invasive Bladder Cancer","Lee DJ, Chang SS.","Cancer Treat Res. 2018;175:193-214. doi: 10.1007/978-3-319-93339-9_9.","Lee DJ","Cancer Treat Res","2018","2018/09/01","","","10.1007/978-3-319-93339-9_9"
"31894276","Identification of a 13‑mRNA signature for predicting disease progression and prognosis in patients with bladder cancer","Yin H, Zhang C, Gou X, He W, Gan D.","Oncol Rep. 2020 Feb;43(2):379-394. doi: 10.3892/or.2019.7429. Epub 2019 Dec 12.","Yin H","Oncol Rep","2020","2020/01/03","PMC6967157","","10.3892/or.2019.7429"
"6448656","Bladder cancer as a prescribed industrial disease","Darby FJ.","Br Med J. 1980 Sep 27;281(6244):870. doi: 10.1136/bmj.281.6244.870-a.","Darby FJ","Br Med J","1980","1980/09/27","PMC1714238","","10.1136/bmj.281.6244.870-a"
"1780702","Extraperitoneal perforation of the urinary bladder in association with urothelial cancer in a female","Sørensen VT, Asklin B, Brunkwall P.","Scand J Urol Nephrol. 1991;25(4):277-8. doi: 10.3109/00365599109024559.","Sørensen VT","Scand J Urol Nephrol","1991","1991/01/01","","","10.3109/00365599109024559"
"2393797","Clinical study of prognostic factors of superficial bladder cancer treated with intravesical bacillus Calmette-Guerin","Shinka T, Hirano A, Uekado Y, Ohkawa T.","Br J Urol. 1990 Jul;66(1):35-9. doi: 10.1111/j.1464-410x.1990.tb14861.x.","Shinka T","Br J Urol","1990","1990/07/01","","","10.1111/j.1464-410x.1990.tb14861.x"
"31122808","Radiotherapy Management of Muscle Invasive Bladder Cancer: Evaluation of a National Cohort","Varughese M, Treece S, Drinkwater KJ.","Clin Oncol (R Coll Radiol). 2019 Sep;31(9):637-645. doi: 10.1016/j.clon.2019.04.009. Epub 2019 May 20.","Varughese M","Clin Oncol (R Coll Radiol)","2019","2019/05/25","","","10.1016/j.clon.2019.04.009"
"11583354","Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer","Oge O, Atsü N, Kendi S, Ozen H.","Int Urol Nephrol. 2001;32(3):367-70. doi: 10.1023/a:1017509418440.","Oge O","Int Urol Nephrol","2001","2001/10/05","","","10.1023/a:1017509418440"
"3055897","Cystitis mimicking bladder cancer on sonography","Afroz S, Taher MA.","AJR Am J Roentgenol. 1988 Dec;151(6):1252-3. doi: 10.2214/ajr.151.6.1252-a.","Afroz S","AJR Am J Roentgenol","1988","1988/12/01","","","10.2214/ajr.151.6.1252-a"
"25572786","Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?","Buti S, Ciccarese C, Zanoni D, Santoni M, Modena A, Maines F, Gilli A, Bria E, Brunelli M, Rimanti A, Cascinu S, Ardizzoni A, Tortora G, Massari F.","Future Oncol. 2015;11(1):107-19. doi: 10.2217/fon.14.172.","Buti S","Future Oncol","2015","2015/01/10","","","10.2217/fon.14.172"
"31811594","The effect of multiple recruitment contacts on response rates and patterns of missing data in a survey of bladder cancer survivors 6 months after cystectomy","Bulkley JE, O'Keeffe-Rosetti M, Wendel CS, Davis JV, Danforth KN, Harrison TN, Kwan ML, Munneke J, Brooks N, Grant M, Leo MC, Banegas M, Weinmann S, McMullen CK.","Qual Life Res. 2020 Apr;29(4):879-889. doi: 10.1007/s11136-019-02379-3. Epub 2019 Dec 6.","Bulkley JE","Qual Life Res","2020","2019/12/08","","","10.1007/s11136-019-02379-3"
"25199718","Reply to Mattias Aine, Fredrik Liedberg, Gottfrid Sjödahl, and Mattias Höglund's Letter to the Editor re: David J. McConkey, Woonyoung Choi, Colin P.N. Dinney. New insights into subtypes of invasive bladder cancer: considerations of the clinician. Eur Urol 2014;66:609-10","McConkey D, Choi W, Dinney C.","Eur Urol. 2015 Apr;67(4):e76-8. doi: 10.1016/j.eururo.2014.08.064. Epub 2014 Sep 6.","McConkey D","Eur Urol","2015","2014/09/10","","","10.1016/j.eururo.2014.08.064"
"7463517","Occupational cancer of the urinary bladder","Tola S.","J Toxicol Environ Health. 1980 Sep-Nov;6(5-6):1253-60. doi: 10.1080/15287398009529944.","Tola S","J Toxicol Environ Health","1980","1980/09/01","","","10.1080/15287398009529944"
"2211216","Radiotherapy with and without cisplatin in bladder cancer","Sauer R, Dunst J, Altendorf-Hofmann A, Fischer H, Bornhof C, Schrott KM.","Int J Radiat Oncol Biol Phys. 1990 Sep;19(3):687-91. doi: 10.1016/0360-3016(90)90497-8.","Sauer R","Int J Radiat Oncol Biol Phys","1990","1990/09/01","","","10.1016/0360-3016(90)90497-8"
"11961481","Nonbilharzial bladder carcinoma complicating pregnancy: review of the literature","Wax JR, Pinette MG, Blackstone J, Cartin A, McCrann DJ.","Obstet Gynecol Surv. 2002 Apr;57(4):236-44. doi: 10.1097/00006254-200204000-00023.","Wax JR","Obstet Gynecol Surv","2002","2002/04/19","","","10.1097/00006254-200204000-00023"
"5165092","[The fibrinolytic activity of bladder cancer]","Hisazumi H.","Nihon Hinyokika Gakkai Zasshi. 1971 Jul;62(7):519-26. doi: 10.5980/jpnjurol1928.62.7_519.","Hisazumi H","Nihon Hinyokika Gakkai Zasshi","1971","1971/07/01","","","10.5980/jpnjurol1928.62.7_519"
"7889862","Epidemiology of cancer from exposure to arylamines","Vineis P.","Environ Health Perspect. 1994 Oct;102 Suppl 6(Suppl 6):7-10. doi: 10.1289/ehp.94102s67.","Vineis P","Environ Health Perspect","1994","1994/10/01","PMC1566830","","10.1289/ehp.94102s67"
"1556047","The role of radiation therapy in the management of transitional cell carcinoma of the bladder","Gospodarowicz MK, Warde P.","Hematol Oncol Clin North Am. 1992 Feb;6(1):147-68.","Gospodarowicz MK","Hematol Oncol Clin North Am","1992","1992/02/01","","",""
"17506771","Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer","Kosugi M, Miyajima A, Kikuchi E, Kosaka T, Horiguchi Y, Murai M.","Hum Cell. 2007 Feb;20(1):1-9. doi: 10.1111/j.1749-0774.2007.00025.x.","Kosugi M","Hum Cell","2007","2007/05/18","","","10.1111/j.1749-0774.2007.00025.x"
"15062066","[Study on Toll-like receptors expression and cytokine production induced by bacillus Calmette-Guerin in human bladder cancer cell]","Li X, Gong ZY, Li H, Wei Q, Shi M, Yang YR.","Zhonghua Wai Ke Za Zhi. 2004 Feb 7;42(3):177-81.","Li X","Zhonghua Wai Ke Za Zhi","2004","2004/04/06","","",""
"25142434","Molecular subtyping of bladder cancer using Kohonen self-organizing maps","Borkowska EM, Kruk A, Jedrzejczyk A, Rozniecki M, Jablonowski Z, Traczyk M, Constantinou M, Banaszkiewicz M, Pietrusinski M, Sosnowski M, Hamdy FC, Peter S, Catto JW, Kaluzewski B.","Cancer Med. 2014 Oct;3(5):1225-34. doi: 10.1002/cam4.217. Epub 2014 Aug 20.","Borkowska EM","Cancer Med","2014","2014/08/22","PMC4302672","","10.1002/cam4.217"
"9615197","DNA methylation in bladder cancer","Jones PA, Gonzalgo ML, Tsutsumi M, Bender CM.","Eur Urol. 1998;33 Suppl 4:7-8. doi: 10.1159/000052251.","Jones PA","Eur Urol","1998","1998/06/06","","","10.1159/000052251"
"24716732","Bladder metastasis from lung adenocarcinoma: a difficult differential diagnosis with primary bladder adenocarcinoma","Cormio L, Sanguedolce F, Di Fino G, Massenio P, Liuzzi G, Bufo P, Carrieri G.","World J Surg Oncol. 2014 Apr 9;12:90. doi: 10.1186/1477-7819-12-90.","Cormio L","World J Surg Oncol","2014","2014/04/11","PMC3984282","","10.1186/1477-7819-12-90"
"15331904","Urinary basic fibroblast growth factor in bladder cancer patients. Histopathological correlation and clinical potential","Gravas S, Bosinakou I, Kehayas P, Giannopoulos A.","Urol Int. 2004;73(2):173-7. doi: 10.1159/000079700.","Gravas S","Urol Int","2004","2004/08/28","","","10.1159/000079700"
"19333224","Surgery: selective bladder-preserving therapy for muscle-invasive cancer","Heney NM, Kaufman DS, Shipley WU.","Nat Rev Clin Oncol. 2009 Apr;6(4):193-4. doi: 10.1038/nrclinonc.2009.21.","Heney NM","Nat Rev Clin Oncol","2009","2009/04/01","","","10.1038/nrclinonc.2009.21"
"23485480","Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis","Abdollah F, Gandaglia G, Thuret R, Schmitges J, Tian Z, Jeldres C, Passoni NM, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI, Sun M.","Cancer Epidemiol. 2013 Jun;37(3):219-25. doi: 10.1016/j.canep.2013.02.002. Epub 2013 Feb 26.","Abdollah F","Cancer Epidemiol","2013","2013/03/15","","","10.1016/j.canep.2013.02.002"
"7817457","[Chemotherapy of bladder carcinoma. Current status and trends]","Block T.","Urologe A. 1994 Nov;33(6):557-67.","Block T","Urologe A","1994","1994/11/01","","",""
"18487721","Characterizing the dimensions of clinical practice guideline evolution","Bouaud J, Séroussi B.","Stud Health Technol Inform. 2008;136:139-44.","Bouaud J","Stud Health Technol Inform","2008","2008/05/20","","",""
"3048209","Photodynamic laser therapy. A bladder cancer protocol","Etchells JL.","AORN J. 1988 Aug;48(2):221-4, 226-9, 232-5. doi: 10.1016/s0001-2092(07)68839-5.","Etchells JL","AORN J","1988","1988/08/01","","","10.1016/s0001-2092(07)68839-5"
"2076933","Current approaches in the treatment of bladder cancer and policy in Marmara University Hospital","Ersev D, Ilker Y, Simşek F, Akdaş A.","Int Urol Nephrol. 1990;22(5):441-5. doi: 10.1007/BF02549775.","Ersev D","Int Urol Nephrol","1990","1990/01/01","","","10.1007/BF02549775"
"20607757","Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer","Hugen CM, Polcari AJ, Fitzgerald MP, Dauw C, Flanigan RC, Quek ML.","J Surg Oncol. 2010 Sep 15;102(4):334-7. doi: 10.1002/jso.21642.","Hugen CM","J Surg Oncol","2010","2010/07/08","","","10.1002/jso.21642"
"9301696","Improved detection of recurrent bladder cancer using the Bard BTA stat Test","Sarosdy MF, Hudson MA, Ellis WJ, Soloway MS, deVere White R, Sheinfeld J, Jarowenko MV, Schellhammer PF, Schervish EW, Patel JV, Chodak GW, Lamm DL, Johnson RD, Henderson M, Adams G, Blumenstein BA, Thoelke KR, Pfalzgraf RD, Murchison HA, Brunelle SL.","Urology. 1997 Sep;50(3):349-53. doi: 10.1016/s0090-4295(97)00292-6.","Sarosdy MF","Urology","1997","1997/09/25","","","10.1016/s0090-4295(97)00292-6"
"30925088","Re: Mutational Patterns in Chemotherapy Resistant Muscle-Invasive Bladder Cancer","Chang SS.","J Urol. 2019 Jul;202(1):30-31. doi: 10.1097/01.JU.0000557727.39723.cd. Epub 2019 Jun 7.","Chang SS","J Urol","2019","2019/03/30","","","10.1097/01.JU.0000557727.39723.cd"
"3564513","Early stage bladder cancer","Messing EM.","Wis Med J. 1987 Feb;86(2):14-7.","Messing EM","Wis Med J","1987","1987/02/01","","",""
"148320","Effects of systemic administration of neocarzinostatin, a new protein antibiotic, on human bladder cancer","Sakamoto S, Ogata J, Ikegami K, Maeda H.","Cancer Treat Rep. 1978 Mar;62(3):453-4.","Sakamoto S","Cancer Treat Rep","1978","1978/03/01","","",""
"9451553","Combining QUANTICYT karyometric analysis with architectural confocal-aided cytology to prognosticate superficial bladder cancer","Boon ME, Marres EM, van der Poel HG.","Diagn Cytopathol. 1998 Jan;18(1):10-7. doi: 10.1002/(sici)1097-0339(199801)18:1<10::aid-dc3>3.0.co;2-y.","Boon ME","Diagn Cytopathol","1998","1998/02/06","","","10.1002/(sici)1097-0339(199801)18:1<10::aid-dc3>3.0.co;2-y"
"11157016","Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG.","J Clin Oncol. 2001 Feb 1;19(3):666-75. doi: 10.1200/JCO.2001.19.3.666.","Stein JP","J Clin Oncol","2001","2001/02/07","","","10.1200/JCO.2001.19.3.666"
"29512774","Knockdown of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) enhances tumorigenesis both in vivo and in vitro in bladder cancer","Liu S, Jiang H, Wen H, Ding Q, Feng C.","Oncol Rep. 2018 May;39(5):2127-2135. doi: 10.3892/or.2018.6294. Epub 2018 Mar 5.","Liu S","Oncol Rep","2018","2018/03/08","PMC5928769","","10.3892/or.2018.6294"
"23296458","Diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women's Health Study","Prizment AE, Anderson KE, Yuan JM, Folsom AR.","Cancer Causes Control. 2013 Mar;24(3):603-8. doi: 10.1007/s10552-012-0143-3. Epub 2013 Jan 8.","Prizment AE","Cancer Causes Control","2013","2013/01/09","PMC3574198","NIHMS433690","10.1007/s10552-012-0143-3"
"3382886","The limited usefulness of external beam radiotherapy in the control of superficial bladder cancer","Sawczuk IS, Olsson CA, deVere White R.","Br J Urol. 1988 Apr;61(4):330-2. doi: 10.1111/j.1464-410x.1988.tb13968.x.","Sawczuk IS","Br J Urol","1988","1988/04/01","","","10.1111/j.1464-410x.1988.tb13968.x"
"11728682","Combined p21WAF1/CIP1 and p53 overexpression predict improved survival in muscle-invasive bladder cancer treated by radical radiotherapy","Qureshi KN, Griffiths TR, Robinson MC, Marsh C, Roberts JT, Lunec J, Neal DE, Mellon JK.","Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1234-40. doi: 10.1016/s0360-3016(01)01801-6.","Qureshi KN","Int J Radiat Oncol Biol Phys","2001","2001/12/01","","","10.1016/s0360-3016(01)01801-6"
"2417650","DNA/RNA ratio in bladder cancer: a factor indicating the recurrence rate?","Hadjissotiriou GG, Green DK, McIntyre MA, Hargreave TB, Chisholm GD.","Br J Urol. 1985 Dec;57(6):668-75. doi: 10.1111/j.1464-410x.1985.tb07029.x.","Hadjissotiriou GG","Br J Urol","1985","1985/12/01","","","10.1111/j.1464-410x.1985.tb07029.x"
"30315148","Expression of B7 Homolog 1 (B7H1) Is Associated with Clinicopathologic Features in Urothelial Bladder Cancer","Li Q, Li F, Che J, Zhao Y, Qiao C.","Med Sci Monit. 2018 Oct 13;24:7303-7308. doi: 10.12659/MSM.910956.","Li Q","Med Sci Monit","2018","2018/10/14","PMC6196594","","10.12659/MSM.910956"
"2404564","Prognostic factors in patients with bladder carcinoma treated with definitive irradiation","Greven KM, Solin LJ, Hanks GE.","Cancer. 1990 Feb 15;65(4):908-12. doi: 10.1002/1097-0142(19900215)65:4<908::aid-cncr2820650415>3.0.co;2-z.","Greven KM","Cancer","1990","1990/02/15","","","10.1002/1097-0142(19900215)65:4<908::aid-cncr2820650415>3.0.co;2-z"
"3772535","Screening for bladder cancer at the Du Pont Chambers Works: initial findings","Mason TJ, Prorok PC, Neeld WE Jr, Vogler WJ.","J Occup Med. 1986 Oct;28(10):1011-6. doi: 10.1097/00043764-198610000-00022.","Mason TJ","J Occup Med","1986","1986/10/01","","","10.1097/00043764-198610000-00022"
"11176843","Urine detection of survivin and diagnosis of bladder cancer","Smith SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM, Altieri DC.","JAMA. 2001 Jan 17;285(3):324-8. doi: 10.1001/jama.285.3.324.","Smith SD","JAMA","2001","2001/02/15","","","10.1001/jama.285.3.324"
"10815690","Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction","Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, Branch RA, Brockmöller J, Ishizaki T, Karakaya AE, Ladero JM, Mommsen S, Okkels H, Romkes M, Roots I, Rothman N.","Cancer Epidemiol Biomarkers Prev. 2000 May;9(5):461-7.","Marcus PM","Cancer Epidemiol Biomarkers Prev","2000","2000/05/18","","",""
"2793232","Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco","Clavel J, Cordier S, Boccon-Gibod L, Hemon D.","Int J Cancer. 1989 Oct 15;44(4):605-10. doi: 10.1002/ijc.2910440408.","Clavel J","Int J Cancer","1989","1989/10/15","","","10.1002/ijc.2910440408"
"30403383","[Hyponatremia as a presenting sign of metastatic disease in muscle invasive bladder cancer.]","Calleja P, Domínguez M, Ramos E, Carrión CJ, Velilla G, Gutiérrez JL.","Arch Esp Urol. 2018 Nov;71(9):799-804.","Calleja P","Arch Esp Urol","2018","2018/11/08","","",""
"10944129","Independent prognostic value of serum hepatocyte growth factor in bladder cancer","Gohji K, Nomi M, Niitani Y, Kitazawa S, Fujii A, Katsuoka Y, Nakajima M.","J Clin Oncol. 2000 Aug;18(16):2963-71. doi: 10.1200/JCO.2000.18.16.2963.","Gohji K","J Clin Oncol","2000","2000/08/16","","","10.1200/JCO.2000.18.16.2963"
"18631356","Could nuclear matrix protein 22 (NMP22) play a role with urine cytology in screening for bladder cancer?--experience at Kuwait University","Kapila K, Kehinde EO, Anim JT, Mojiminiyi OA, Vinsu A, George SS, Al-Maghrebi M, Al-Mulla F.","Cytopathology. 2008 Dec;19(6):369-74. doi: 10.1111/j.1365-2303.2008.00586.x. Epub 2008 Jul 9.","Kapila K","Cytopathology","2008","2008/07/18","","","10.1111/j.1365-2303.2008.00586.x"
"30322728","A urinary microRNA (miR) signature for diagnosis of bladder cancer","Hofbauer SL, de Martino M, Lucca I, Haitel A, Susani M, Shariat SF, Klatte T.","Urol Oncol. 2018 Dec;36(12):531.e1-531.e8. doi: 10.1016/j.urolonc.2018.09.006. Epub 2018 Oct 12.","Hofbauer SL","Urol Oncol","2018","2018/10/17","","","10.1016/j.urolonc.2018.09.006"
"12573771","Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapy","Pos FJ, Koedooder K, Hulshof MC, van Tienhoven G, González González D.","Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):835-41. doi: 10.1016/s0360-3016(02)04158-5.","Pos FJ","Int J Radiat Oncol Biol Phys","2003","2003/02/08","","","10.1016/s0360-3016(02)04158-5"
"21039023","Prominent bladder cancer risk factors in Iran","Shakhssalim N, Hosseini SY, Basiri A, Eshrati B, Mazaheri M, Soleimanirahbar A.","Asian Pac J Cancer Prev. 2010;11(3):601-6.","Shakhssalim N","Asian Pac J Cancer Prev","2010","2010/11/03","","",""
"17905099","Organ preservation for muscle-invasive bladder cancer by transurethral resection","Leibovici D, Kassouf W, Pisters LL, Pettaway CA, Wu X, Dinney CP, Grossman HB.","Urology. 2007 Sep;70(3):473-6. doi: 10.1016/j.urology.2007.05.007.","Leibovici D","Urology","2007","2007/10/02","","","10.1016/j.urology.2007.05.007"
"15308961","Does ozonation of drinking water reduce the risk of bladder cancer?","Chevrier C, Junod B, Cordier S.","Epidemiology. 2004 Sep;15(5):605-14. doi: 10.1097/01.ede.0000134866.61780.28.","Chevrier C","Epidemiology","2004","2004/08/17","","","10.1097/01.ede.0000134866.61780.28"
"26880382","The PD-1/PD-L1 axis in the pathogenesis of urothelial bladder cancer and evaluating its potential as a therapeutic target","Bardoli AD, Afshar M, Viney R, Foster M, Porfiri E, Zarkar A, Stevenson R, James ND, Bryan RT, Patel P.","Future Oncol. 2016 Mar;12(5):595-600. doi: 10.2217/fon.15.337. Epub 2016 Feb 1.","Bardoli AD","Future Oncol","2016","2016/02/17","","","10.2217/fon.15.337"
"17531374","What is the optimal BCG dose in non-muscle-invasive bladder cancer?","Witjes JA.","Eur Urol. 2007 Nov;52(5):1300-2. doi: 10.1016/j.eururo.2007.05.010. Epub 2007 May 22.","Witjes JA","Eur Urol","2007","2007/05/29","","","10.1016/j.eururo.2007.05.010"
"9698660","The role of neoadjuvant chemotherapy for invasive bladder cancer","Martínez-Piñeiro JA, Martínez-Piñeiro L.","Br J Urol. 1998 Jul;82(1):33-42.","Martínez-Piñeiro JA","Br J Urol","1998","1998/08/12","","",""
"30668336","Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression","Daga M, Pizzimenti S, Dianzani C, Cucci MA, Cavalli R, Grattarola M, Ferrara B, Scariot V, Trotta F, Barrera G.","Phytomedicine. 2019 Mar 15;56:156-164. doi: 10.1016/j.phymed.2018.10.034. Epub 2018 Oct 29.","Daga M","Phytomedicine","2019","2019/01/23","","","10.1016/j.phymed.2018.10.034"
"24360662","Clinical performance and utility of a DNA methylation urine test for bladder cancer","Abern MR, Owusu R, Inman BA.","Urol Oncol. 2014 Jan;32(1):51.e21-6. doi: 10.1016/j.urolonc.2013.08.003.","Abern MR","Urol Oncol","2014","2013/12/24","","","10.1016/j.urolonc.2013.08.003"
"6143877","Bladder cancer in the aluminium industry","Thériault G, Tremblay C, Cordier S, Gingras S.","Lancet. 1984 Apr 28;1(8383):947-50. doi: 10.1016/s0140-6736(84)92399-7.","Thériault G","Lancet","1984","1984/04/28","","","10.1016/s0140-6736(84)92399-7"
"10368237","Radical cystoprostatectomy combined with Mainz pouch bladder substitution to the urethra: long-term results","Leissner J, Stein R, Hohenfellner R, Köhl U, Riedmiller H, Schröder A, Lampel A, Thüroff JW.","BJU Int. 1999 Jun;83(9):964-70. doi: 10.1046/j.1464-410x.1999.00049.x.","Leissner J","BJU Int","1999","1999/06/15","","","10.1046/j.1464-410x.1999.00049.x"
"8659036","[A method for urinary diversion in cystectomy for transitional-cell bladder cancer]","Toktomushev AT, Saiakov UK, Mukambetov KM, Iiazaliev KT, Murzaliev AZh, Motuzova VT.","Urol Nefrol (Mosk). 1996 Jan-Feb;(1):21-2.","Toktomushev AT","Urol Nefrol (Mosk)","1996","1996/01/01","","",""
"23945108","miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome","Ratert N, Meyer HA, Jung M, Lioudmer P, Mollenkopf HJ, Wagner I, Miller K, Kilic E, Erbersdobler A, Weikert S, Jung K.","J Mol Diagn. 2013 Sep;15(5):695-705. doi: 10.1016/j.jmoldx.2013.05.008. Epub 2013 Aug 12.","Ratert N","J Mol Diagn","2013","2013/08/16","","","10.1016/j.jmoldx.2013.05.008"
"8170076","[Results of radical cystectomy for bladder cancer]","Komatsu H, Tanabe N, Tago K, Ueno A.","Nihon Hinyokika Gakkai Zasshi. 1994 Mar;85(3):452-9. doi: 10.5980/jpnjurol1989.85.452.","Komatsu H","Nihon Hinyokika Gakkai Zasshi","1994","1994/03/01","","","10.5980/jpnjurol1989.85.452"
"11711760","Foods and risk of bladder cancer: a case-control study in Uruguay","Balbi JC, Larrinaga MT, De Stefani E, Mendilaharsu M, Ronco AL, Boffetta P, Brennan P.","Eur J Cancer Prev. 2001 Oct;10(5):453-8. doi: 10.1097/00008469-200110000-00009.","Balbi JC","Eur J Cancer Prev","2001","2001/11/17","","","10.1097/00008469-200110000-00009"
"22314880","Neoadjuvant chemotherapy for invasive bladder cancer","Sonpavde G, Sternberg CN.","Curr Urol Rep. 2012 Apr;13(2):136-46. doi: 10.1007/s11934-012-0236-2.","Sonpavde G","Curr Urol Rep","2012","2012/02/09","","","10.1007/s11934-012-0236-2"
"14629876","Near misses in bladder cancer - an airline safety approach to urology","Singh R, Saleemi A, Walsh K, Popert R, O'Brien T.","Ann R Coll Surg Engl. 2003 Nov;85(6):378-81. doi: 10.1308/003588403322520717.","Singh R","Ann R Coll Surg Engl","2003","2003/11/25","PMC1964416","","10.1308/003588403322520717"
"17320663","Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis","Uchida A, Yonou H, Hayashi E, Iha K, Oda M, Miyazato M, Oshiro Y, Hokama S, Sugaya K, Ogawa Y.","Urology. 2007 Feb;69(2):275-9. doi: 10.1016/j.urology.2006.10.017.","Uchida A","Urology","2007","2007/02/27","","","10.1016/j.urology.2006.10.017"
"9065092","[Response of lymphocytes and cytokines in patients with superficial bladder cancer treated with 1 mg of BCG vaccine instillations]","Rivera P, Inostroza J, Orio M.","Actas Urol Esp. 1996 Oct;20(9):812-7.","Rivera P","Actas Urol Esp","1996","1996/10/01","","",""
"8727808","Intravesical chemotherapy for superficial bladder tumors category Ta/T1: who should be treated and how?","Kurth KH.","Semin Urol Oncol. 1996 Feb;14(1 Suppl 1):30-5.","Kurth KH","Semin Urol Oncol","1996","1996/02/01","","",""
"8712094","[A clinical study of renal pelvic and ureteral cancer associated with bladder cancer]","Sakaue K, Kakimoto K, Oda M, Kajikawa J, Koide T, Kobayashi Y.","Hinyokika Kiyo. 1996 Feb;42(2):91-4.","Sakaue K","Hinyokika Kiyo","1996","1996/02/01","","",""
"6506370","Advances in the etiology of urothelial cancer","Morrison AS.","Urol Clin North Am. 1984 Nov;11(4):557-66.","Morrison AS","Urol Clin North Am","1984","1984/11/01","","",""
"1807121","[Usefulness++ of total parenteral nutrition in radical surgery for bladder cancer]","Herranz Amo F, García Peris P, Jara Rascón J, Moncada Iribarren I, Basquero González B, Martín Martínez JC, Díez Cordero JM, Verdú Tartajo F.","Actas Urol Esp. 1991 Sep-Oct;15(5):429-36.","Herranz Amo F","Actas Urol Esp","1991","1991/09/01","","",""
"30433852","Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial","Coen JJ, Zhang P, Saylor PJ, Lee CT, Wu CL, Parker W, Lautenschlaeger T, Zietman AL, Efstathiou JA, Jani AB, Kucuk O, Souhami L, Rodgers JP, Sandler HM, Shipley WU.","J Clin Oncol. 2019 Jan 1;37(1):44-51. doi: 10.1200/JCO.18.00537. Epub 2018 Nov 15.","Coen JJ","J Clin Oncol","2019","2018/11/16","PMC6354769","","10.1200/JCO.18.00537"
"8285166","[Two cases of bladder cancer in patients with chronic renal failure]","Uchida T, Takekawa K, Omata T, Mukai N, Egawa S, Mashimo S, Endo T, Koshiba K.","Hinyokika Kiyo. 1993 Dec;39(12):1167-70.","Uchida T","Hinyokika Kiyo","1993","1993/12/01","","",""
"8189664","[Influence of Lactobacillus casei on rat bladder carcinogenesis]","Tomita K, Akaza H, Nomoto K, Yokokura T, Matsushima H, Homma Y, Aso Y.","Nihon Hinyokika Gakkai Zasshi. 1994 Apr;85(4):655-63. doi: 10.5980/jpnjurol1989.85.655.","Tomita K","Nihon Hinyokika Gakkai Zasshi","1994","1994/04/01","","","10.5980/jpnjurol1989.85.655"
"2074511","Bladder cancer screening at the Dupont Chambers Works: a new initiative","Mason TJ, Vogler WJ.","J Occup Med. 1990 Sep;32(9):874-7. doi: 10.1097/00043764-199009000-00023.","Mason TJ","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00023"
"7902877","P-glycoprotein expression in bladder cancer","Park J, Shinohara N, Liebert M, Noto L, Flint A, Grossman HB.","J Urol. 1994 Jan;151(1):43-6. doi: 10.1016/s0022-5347(17)34868-1.","Park J","J Urol","1994","1994/01/01","","","10.1016/s0022-5347(17)34868-1"
"26655504","Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer","Peng XC, Gong FM, Chen Y, Qiu M, Cheng K, Tang J, Ge J, Chen N, Zeng H, Liu JY.","J Proteomics. 2016 Jan 30;132:85-92. doi: 10.1016/j.jprot.2015.11.027. Epub 2015 Dec 3.","Peng XC","J Proteomics","2016","2015/12/15","","","10.1016/j.jprot.2015.11.027"
"29343838","Estimating the impact of body mass index on bladder cancer risk: Stratification by smoking status","Choi JB, Lee EJ, Han KD, Hong SH, Ha US.","Sci Rep. 2018 Jan 17;8(1):947. doi: 10.1038/s41598-018-19531-7.","Choi JB","Sci Rep","2018","2018/01/19","PMC5772621","","10.1038/s41598-018-19531-7"
"3089128","[Cancer of schistosomiasis-infected bladders. Apropos of 6 cases]","Delmas V, Dauge MC, Davody AP, Couland JP, Moulonguet A.","Ann Urol (Paris). 1986;20(3):213-7.","Delmas V","Ann Urol (Paris)","1986","1986/01/01","","",""
"8310580","[Smoking and bladder cancer (an epidemiological study)]","Nekrasova LI, Zaridze DG.","Urol Nefrol (Mosk). 1993 Sep-Oct;(5):25-7.","Nekrasova LI","Urol Nefrol (Mosk)","1993","1993/09/01","","",""
"30616479","Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer - a follow-up five years after the start of treatment","Danielsson G, Malmström PU, Jahnson S, Wijkström H, Nyberg T, Thulin H.","Scand J Urol. 2018 Oct-Dec;52(5-6):377-384. doi: 10.1080/21681805.2018.1538162. Epub 2019 Jan 8.","Danielsson G","Scand J Urol","2018","2019/01/09","","","10.1080/21681805.2018.1538162"
"12576815","T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin","Volkmer BG, Gschwend JE, Maier SH, Seidl-Schlick EM, Bach D, Romics I.","J Urol. 2003 Mar;169(3):931-4; discussion 934-5. doi: 10.1097/01.ju.0000049002.75782.39.","Volkmer BG","J Urol","2003","2003/02/11","","","10.1097/01.ju.0000049002.75782.39"
"30407690","Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer","Tian DW, Wu ZL, Jiang LM, Gao J, Wu CL, Hu HL.","Cancer Sci. 2019 Jan;110(1):458-467. doi: 10.1111/cas.13865. Epub 2018 Dec 10.","Tian DW","Cancer Sci","2019","2018/11/09","PMC6317957","","10.1111/cas.13865"
"23731241","HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease","Tripathi P, Somashekar BS, Ponnusamy M, Gursky A, Dailey S, Kunju P, Lee CT, Chinnaiyan AM, Rajendiran TM, Ramamoorthy A.","J Proteome Res. 2013 Jul 5;12(7):3519-28. doi: 10.1021/pr4004135. Epub 2013 Jun 18.","Tripathi P","J Proteome Res","2013","2013/06/05","PMC3722911","NIHMS495842","10.1021/pr4004135"
"26514538","Incidence and Mortality of Bladder Cancer and their Relationship with Development in Asia","Pakzad R, Mohammadian-Hafshejani A, Mohammadian M, Pakzad I, Safiri S, Khazaei S, Salehiniya H.","Asian Pac J Cancer Prev. 2015;16(16):7365-74. doi: 10.7314/apjcp.2015.16.16.7365.","Pakzad R","Asian Pac J Cancer Prev","2015","2015/10/31","","","10.7314/apjcp.2015.16.16.7365"
"20999740","Cancer of the bladder and urinary tract","TURLEY HK.","Memphis Med J. 1946 Sep;21:138.","TURLEY HK","Memphis Med J","1946","2010/10/29","","",""
"10037407","The quality of medical textbooks: bladder cancer diagnosis as a case study","Baker CL.","J Urol. 1999 Jan;161(1):223-9. doi: 10.1016/s0022-5347(01)62108-6.","Baker CL","J Urol","1999","1999/02/26","","","10.1016/s0022-5347(01)62108-6"
"32314705","[High expression of activated CD4(+) memory T cells and CD8(+) T cells and low expression of M0 macrophage are associated with better clinical prognosis in bladder cancer patients]","Li W, Zeng J, Luo B, Mao Y, Liang Y, Zhao W, Hu N, Chen G, Zheng X.","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020 Feb;36(2):97-103.","Li W","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi","2020","2020/04/22","","",""
"10506616","Predicting cancer progression in patients with stage T1 bladder carcinoma","Cheng L, Neumann RM, Weaver AL, Spotts BE, Bostwick DG.","J Clin Oncol. 1999 Oct;17(10):3182-7. doi: 10.1200/JCO.1999.17.10.3182.","Cheng L","J Clin Oncol","1999","1999/10/03","","","10.1200/JCO.1999.17.10.3182"
"3282403","Serial transabdominal sonography of bladder cancer","Dershaw DD, Scher HI.","AJR Am J Roentgenol. 1988 May;150(5):1055-9. doi: 10.2214/ajr.150.5.1055.","Dershaw DD","AJR Am J Roentgenol","1988","1988/05/01","","","10.2214/ajr.150.5.1055"
"8370629","Descriptive epidemiology of bladder cancer in Egypt","Bedwani R, el-Khwsky F, La Vecchia C, Boffetta P, Levi F.","Int J Cancer. 1993 Sep 9;55(2):351-2. doi: 10.1002/ijc.2910550228.","Bedwani R","Int J Cancer","1993","1993/09/09","","","10.1002/ijc.2910550228"
"25784271","[Therapy of low-grade nonmuscle-invasive bladder cancer]","Olbert PJ, Ohlmann CH, Schwentner C.","Urologe A. 2015 Apr;54(4):484-90. doi: 10.1007/s00120-015-3773-8.","Olbert PJ","Urologe A","2015","2015/03/19","","","10.1007/s00120-015-3773-8"
"23208127","External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy","Masson-Lecomte A, Vordos D, Hoznek A, Yiou R, Allory Y, Abbou CC, de la Taille A, Salomon L.","Ann Surg Oncol. 2013 Apr;20(4):1389-94. doi: 10.1245/s10434-012-2753-0. Epub 2012 Dec 4.","Masson-Lecomte A","Ann Surg Oncol","2013","2012/12/05","","","10.1245/s10434-012-2753-0"
"1933158","Carcinoma in situ as a prognostic factor for G3pT1 bladder tumours","Vicente J, Laguna MP, Duarte D, Algaba F, Chéchile G.","Br J Urol. 1991 Oct;68(4):380-2. doi: 10.1111/j.1464-410x.1991.tb15355.x.","Vicente J","Br J Urol","1991","1991/10/01","","","10.1111/j.1464-410x.1991.tb15355.x"
"3129740","TUR and chemotherapy or radiotherapy for invasive bladder cancer","Hall RR, Roberts T, Powell PH, Marsh MM.","Prog Clin Biol Res. 1988;260:605-12.","Hall RR","Prog Clin Biol Res","1988","1988/01/01","","",""
"22391706","Early dynamic PET/CT and 18F-FDG blood flow imaging in bladder cancer detection: a novel approach","Belakhlef S, Church C, Jani C, Lakhanpal S.","Clin Nucl Med. 2012 Apr;37(4):366-8. doi: 10.1097/RLU.0b013e3182443110.","Belakhlef S","Clin Nucl Med","2012","2012/03/07","","","10.1097/RLU.0b013e3182443110"
"25760254","Re: bacillus Calmette-guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy","Bid HK.","Eur Urol. 2015 Feb;67(2):351. doi: 10.1016/j.eururo.2014.11.022.","Bid HK","Eur Urol","2015","2015/03/12","","","10.1016/j.eururo.2014.11.022"
"19467794","Dose distribution in bladder and surrounding normal tissues in relation to bladder volume in conformal radiotherapy for bladder cancer","Majewski W, Wesolowska I, Urbanczyk H, Hawrylewicz L, Schwierczok B, Miszczyk L.","Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1371-8. doi: 10.1016/j.ijrobp.2009.01.005. Epub 2009 May 19.","Majewski W","Int J Radiat Oncol Biol Phys","2009","2009/05/27","","","10.1016/j.ijrobp.2009.01.005"
"27806337","Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin","Dong D, Jiang W, Lei J, Chen L, Liu X, Ge J, Che B, Xi X, Shao J.","Oncotarget. 2016 Dec 6;7(49):81463-81473. doi: 10.18632/oncotarget.12976.","Dong D","Oncotarget","2016","2016/11/03","PMC5348406","","10.18632/oncotarget.12976"
"2393550","Polymorphic oxidation of debrisoquine in bladder cancer","Benítez J, Ladero JM, Fernández-Gundín MJ, Llerena A, Cobaleda J, Martínez C, Muñoz JJ, Vargas E, Prados J, González-Rozas F, et al.","Ann Med. 1990 Jun;22(3):157-60. doi: 10.3109/07853899009147261.","Benítez J","Ann Med","1990","1990/06/01","","","10.3109/07853899009147261"
"15717966","Laparoscopic radical cystectomy","Puppo P, Naselli A.","Curr Urol Rep. 2005 Mar;6(2):106-8. doi: 10.1007/s11934-005-0076-4.","Puppo P","Curr Urol Rep","2005","2005/02/19","","","10.1007/s11934-005-0076-4"
"1415161","Ingested arsenic, keratoses, and bladder cancer","Cuzick J, Sasieni P, Evans S.","Am J Epidemiol. 1992 Aug 15;136(4):417-21. doi: 10.1093/oxfordjournals.aje.a116514.","Cuzick J","Am J Epidemiol","1992","1992/08/15","","","10.1093/oxfordjournals.aje.a116514"
"15958626","Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder","Wild PJ, Herr A, Wissmann C, Stoehr R, Rosenthal A, Zaak D, Simon R, Knuechel R, Pilarsky C, Hartmann A.","Clin Cancer Res. 2005 Jun 15;11(12):4415-29. doi: 10.1158/1078-0432.CCR-05-0259.","Wild PJ","Clin Cancer Res","2005","2005/06/17","","","10.1158/1078-0432.CCR-05-0259"
"6960193","A study of the immune response to the organ-specific neoantigen of human bladder cancer","Lajzerowicz M, Thomson DM, Reid EC.","J Urol. 1982 Nov;128(5):1122-9. doi: 10.1016/s0022-5347(17)53358-3.","Lajzerowicz M","J Urol","1982","1982/11/01","","","10.1016/s0022-5347(17)53358-3"
"8529739","p53 and Rb immunostaining in locally advanced bladder cancer: relation to prognostic variables and predictive value for the local response to radical radiotherapy","Jahnson S, Risberg B, Karlsson MG, Westman G, Bergström R, Pedersen J.","Eur Urol. 1995;28(2):135-42. doi: 10.1159/000475038.","Jahnson S","Eur Urol","1995","1995/01/01","","","10.1159/000475038"
"27311547","Time to re-evaluate and refine re-transurethral resection in bladder cancer?","Mostafid AH.","BJU Int. 2016 Jul;118(1):9-10. doi: 10.1111/bju.13385.","Mostafid AH","BJU Int","2016","2016/06/18","","","10.1111/bju.13385"
"19846948","192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer","Oztürk O, Kağnici OF, Oztürk T, Durak H, Tüzüner BM, Kisakesen HI, Cakalir C, Isbir T.","Anticancer Res. 2009 Oct;29(10):4041-6.","Oztürk O","Anticancer Res","2009","2009/10/23","","",""
"29650139","Follow-up Management of Cystectomy Patients","Reddy M, Kader K.","Urol Clin North Am. 2018 May;45(2):241-247. doi: 10.1016/j.ucl.2018.01.001.","Reddy M","Urol Clin North Am","2018","2018/04/14","","","10.1016/j.ucl.2018.01.001"
"11306381","Usefulness of the BTA STAT Test for the diagnosis of bladder cancer","Gutiérrez Baños JL, del Henar Rebollo Rodrigo M, Antolín Juárez FM, García BM.","Urology. 2001 Apr;57(4):685-9. doi: 10.1016/s0090-4295(00)01090-6.","Gutiérrez Baños JL","Urology","2001","2001/04/18","","","10.1016/s0090-4295(00)01090-6"
"27296150","The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient","Gopalakrishna A, Longo TA, Fantony JJ, Owusu R, Foo WC, Dash R, Inman BA.","BMC Urol. 2016 Jun 13;16(1):30. doi: 10.1186/s12894-016-0147-5.","Gopalakrishna A","BMC Urol","2016","2016/06/15","PMC4906712","","10.1186/s12894-016-0147-5"
"8024328","[Infiltrating transitional carcinoma of the bladder. Preoperative or neoadjuvant chemotherapy. Our experience with 38 patients with long-term follow-up]","Escudero Barrilero A, Fernández Fernández E, Crespo Maffieu C.","Arch Esp Urol. 1994 Apr;47(3):219-31.","Escudero Barrilero A","Arch Esp Urol","1994","1994/04/01","","",""
"7974879","In vitro effects of high energy shock wave alone and combined with anticancer drugs on human bladder cancer cells","Rahman M.","Urol Int. 1994;53(1):12-7. doi: 10.1159/000282624.","Rahman M","Urol Int","1994","1994/01/01","","","10.1159/000282624"
"5950230","[Cancer of the urinary bladder and tryptophan metabolism]","Koike R.","Hinyokika Kiyo. 1966 Jan;12(1):1-2.","Koike R","Hinyokika Kiyo","1966","1966/01/01","","",""
"455207","Cancer of the bladder in Alberta: a urologic audit review","Hnatko G, Hanson J, Grace M, McPhee MS.","Can Med Assoc J. 1979 Jun 23;120(12):1511-4.","Hnatko G","Can Med Assoc J","1979","1979/06/23","PMC1704205","",""
"24302759","Prospective phase II study of image-guided local boost using a real-time tumor-tracking radiotherapy (RTRT) system for locally advanced bladder cancer","Nishioka K, Shimizu S, Shinohara N, Ito YM, Abe T, Maruyama S, Kinoshita R, Harada K, Nishikawa N, Miyamoto N, Onimaru R, Shirato H.","Jpn J Clin Oncol. 2014 Jan;44(1):28-35. doi: 10.1093/jjco/hyt182. Epub 2013 Dec 2.","Nishioka K","Jpn J Clin Oncol","2014","2013/12/05","PMC3880146","","10.1093/jjco/hyt182"
"27933927","Three-Dimensionally Functionalized Reverse Phase Glycoprotein Array for Cancer Biomarker Discovery and Validation","Pan L, Aguilar HA, Wang L, Iliuk A, Tao WA.","J Am Chem Soc. 2016 Nov 30;138(47):15311-15314. doi: 10.1021/jacs.6b10239. Epub 2016 Nov 17.","Pan L","J Am Chem Soc","2016","2016/12/10","PMC5310384","NIHMS848807","10.1021/jacs.6b10239"
"19282097","Serum proteomic profiling in patients with bladder cancer","Schwamborn K, Krieg RC, Grosse J, Reulen N, Weiskirchen R, Knuechel R, Jakse G, Henkel C.","Eur Urol. 2009 Dec;56(6):989-96. doi: 10.1016/j.eururo.2009.02.031. Epub 2009 Mar 6.","Schwamborn K","Eur Urol","2009","2009/03/14","","","10.1016/j.eururo.2009.02.031"
"31266754","Metastatic plasmacytoid bladder cancer causing malignant priapism","Pereira R, Perera M, Rhee H.","BMJ Case Rep. 2019 Jul 1;12(7):e228088. doi: 10.1136/bcr-2018-228088.","Pereira R","BMJ Case Rep","2019","2019/07/04","PMC6605945","","10.1136/bcr-2018-228088"
"17997457","Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy","Bostrom PJ, Soloway MS, Manoharan M, Ayyathurai R, Samavedi S.","J Urol. 2008 Jan;179(1):91-5; discussion 95. doi: 10.1016/j.juro.2007.08.157. Epub 2007 Nov 12.","Bostrom PJ","J Urol","2008","2007/11/13","","","10.1016/j.juro.2007.08.157"
"10516449","Concomitant radiotherapy and carboplatin in locally advanced bladder cancer","Radosevic-Jelic L, Pekmezovic T, Pavlovic-Cvetkovic L, Radulovic S, Petronic V.","Eur Urol. 1999 Nov;36(5):401-5. doi: 10.1159/000020020.","Radosevic-Jelic L","Eur Urol","1999","1999/10/12","","","10.1159/000020020"
"4090102","Immunological findings in patients with superficial bladder cancer during human alpha-2-interferon treatment","Grups JW, Frohmüller HG, Ackermann R.","Urol Int. 1985;40(6):301-6. doi: 10.1159/000281117.","Grups JW","Urol Int","1985","1985/01/01","","","10.1159/000281117"
"6485957","[Histological study of cases of bladder cancer and chronic cystitis with difficulty in cystoscopic diagnosis]","Okamura K, Ito K, Suzuki Y, Shimoji T.","Hinyokika Kiyo. 1984 Apr;30(4):459-65.","Okamura K","Hinyokika Kiyo","1984","1984/04/01","","",""
"29548022","RE: Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic","Koutros S, Lenz P, Hewitt SM, Kida M, Jones M, Schned AR, Baris D, Pfeiffer R, Schwenn M, Johnson A, Karagas MR, Garcia-Closas M, Rothman N, Moore LE, Silverman DT.","J Natl Cancer Inst. 2018 Nov 1;110(11):1273-1274. doi: 10.1093/jnci/djy045.","Koutros S","J Natl Cancer Inst","2018","2018/03/17","PMC6235686","","10.1093/jnci/djy045"
"28380492","Comparison of Monopolar and Bipolar Transurethral Resection of Non-Muscle Invasive Bladder Cancer","Balci M, Tuncel A, Keten T, Guzel O, Lokman U, Koseoglu E, Aslan Y, Atan A.","Urol Int. 2018;100(1):100-104. doi: 10.1159/000467397. Epub 2017 Apr 6.","Balci M","Urol Int","2018","2017/04/06","","","10.1159/000467397"
"7992699","[Membranous and penile urethral involvement in bladder cancer patients-- review of cystoprostatourethrectomy specimens]","Shimizu T, Suzuki T, Yamanaka H, Satoh J, Suzuki K.","Hinyokika Kiyo. 1994 Oct;40(10):869-72.","Shimizu T","Hinyokika Kiyo","1994","1994/10/01","","",""
"8754189","[Advances in the treatment of infiltrating transitional cancer of the bladder]","Escudero Barrilero A.","Arch Esp Urol. 1996 May;49(4):317-23; discussion 323-35.","Escudero Barrilero A","Arch Esp Urol","1996","1996/05/01","","",""
"6864918","Hematoporphyrin derivative and laser photoradiation in the diagnosis and treatment of bladder cancer","Tsuchiya A, Obara N, Miwa M, Ohi T, Kato H, Hayata Y.","J Urol. 1983 Jul;130(1):79-82. doi: 10.1016/s0022-5347(17)50965-9.","Tsuchiya A","J Urol","1983","1983/07/01","","","10.1016/s0022-5347(17)50965-9"
"3455732","Bladder tumor incidence among workers exposed to benzidine: a thirty-year follow-up","Meigs JW, Marrett LD, Ulrich FU, Flannery JT.","J Natl Cancer Inst. 1986 Jan;76(1):1-8.","Meigs JW","J Natl Cancer Inst","1986","1986/01/01","","",""
"20430723","TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells","Szliszka E, Mazur B, Zydowicz G, Czuba ZP, Król W.","Folia Histochem Cytobiol. 2009;47(4):579-85. doi: 10.2478/v10042-009-0111-2.","Szliszka E","Folia Histochem Cytobiol","2009","2010/05/01","","","10.2478/v10042-009-0111-2"
"24411629","Bladder function preservation with brachytherapy, external beam radiation therapy, and limited surgery in bladder cancer patients: Long-term results [corrected]","Aluwini S, van Rooij PH, Kirkels WJ, Boormans JL, Kolkman-Deurloo IK, Wijnmaalen A.","Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):611-7. doi: 10.1016/j.ijrobp.2013.11.227. Epub 2014 Jan 7.","Aluwini S","Int J Radiat Oncol Biol Phys","2014","2014/01/14","","","10.1016/j.ijrobp.2013.11.227"
"7853581","The risk of urethral tumors in female bladder cancer: can the urethra be used for orthotopic reconstruction of the lower urinary tract?","Stenzl A, Draxl H, Posch B, Colleselli K, Falk M, Bartsch G.","J Urol. 1995 Mar;153(3 Pt 2):950-5.","Stenzl A","J Urol","1995","1995/03/01","","",""
"18294806","Outcomes for a large series of radical cystectomies for bladder cancer","Niu HT, Xu T, Zhang YB, Pang DQ, Zhang ZL, Wu S, Cheng B, Wang Y, Chang JW, Sun G.","Eur J Surg Oncol. 2008 Aug;34(8):911-5. doi: 10.1016/j.ejso.2008.01.010. Epub 2008 Feb 21.","Niu HT","Eur J Surg Oncol","2008","2008/02/26","","","10.1016/j.ejso.2008.01.010"
"11396630","MMP-3 mRNA and MMP-3 and MMP-1 proteins in bladder cancer: a comparison with clinicopathologic features and survival","Nakopoulou L, Gakiopoulou H, Zervas A, Giannopoulou I, Constantinides C, Lazaris AC, Liapis H, Kyriakou G, Dimopoulos C.","Appl Immunohistochem Mol Morphol. 2001 Jun;9(2):130-7. doi: 10.1097/00129039-200106000-00005.","Nakopoulou L","Appl Immunohistochem Mol Morphol","2001","2001/06/09","","","10.1097/00129039-200106000-00005"
"17632171","The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer","Divrik RT, Sahin A, Altok M, Unlü N, Zorlu F.","J Urol. 2007 Sep;178(3 Pt 1):802-6; discussion 806. doi: 10.1016/j.juro.2007.05.054. Epub 2007 Jul 16.","Divrik RT","J Urol","2007","2007/07/17","","","10.1016/j.juro.2007.05.054"
"27586866","Theophylline controllable RNAi-based genetic switches regulate expression of lncRNA TINCR and malignant phenotypes in bladder cancer cells","Chen Z, Liu Y, He A, Li J, Chen M, Zhan Y, Lin J, Zhuang C, Liu L, Zhao G, Huang W, Cai Z.","Sci Rep. 2016 Sep 2;6:30798. doi: 10.1038/srep30798.","Chen Z","Sci Rep","2016","2016/09/03","PMC5009373","","10.1038/srep30798"
"30689132","Penile Implant Considerations in the Bladder Cancer Survivor","Loh-Doyle JC.","Curr Urol Rep. 2019 Jan 28;20(2):7. doi: 10.1007/s11934-019-0873-9.","Loh-Doyle JC","Curr Urol Rep","2019","2019/01/29","","","10.1007/s11934-019-0873-9"
"30910257","Influence of laparoscopic access in cancer-specific mortality of patients with pTa-2pN0R0 bladder cancer treated with radical cistectomy","Subirá-Ríos D, Herranz-Amo F, Renedo-Villar T, Moralejo-Gárate M, Del Pozo-Jiménez G, Bueno-Chomón G, Rodríguez-Fernández E, Moncada-Iribarren I, Hernández-Fernández C.","Actas Urol Esp. 2019 Jun;43(5):241-247. doi: 10.1016/j.acuro.2019.01.001. Epub 2019 Mar 23.","Subirá-Ríos D","Actas Urol Esp","2019","2019/03/27","","","10.1016/j.acuro.2019.01.001"
"30806768","Association of body mass index with bladder cancer risk in men depends on abdominal obesity","Choi JB, Kim JH, Hong SH, Han KD, Ha US.","World J Urol. 2019 Nov;37(11):2393-2400. doi: 10.1007/s00345-019-02690-1. Epub 2019 Feb 26.","Choi JB","World J Urol","2019","2019/02/27","","","10.1007/s00345-019-02690-1"
"12665306","Application of Photofrin II as a specific radiosensitising agent in patients with bladder cancer--a report of two cases","Schaffer M, Schaffer PM, Vogesser M, Ertl-Wagner B, Rauch J, Oberneder R, Jori G, Hofstetter A, Dühmke E.","Photochem Photobiol Sci. 2002 Sep;1(9):686-9. doi: 10.1039/b203732g.","Schaffer M","Photochem Photobiol Sci","2002","2003/04/01","","","10.1039/b203732g"
"14968207","Evaluation of disability of occupational illness claims for workers' compensation","Al-Otaibi ST.","Saudi Med J. 2004 Feb;25(2):145-9.","Al-Otaibi ST","Saudi Med J","2004","2004/02/18","","",""
"28648755","High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer","Li C, Cui Y, Liu LF, Ren WB, Li QQ, Zhou X, Li YL, Li Y, Bai XY, Zu XB.","Clin Genitourin Cancer. 2017 Oct;15(5):570-576. doi: 10.1016/j.clgc.2017.05.001. Epub 2017 May 10.","Li C","Clin Genitourin Cancer","2017","2017/06/27","","","10.1016/j.clgc.2017.05.001"
"24650577","Autophagy inhibition sensitizes bladder cancer cells to the photodynamic effects of the novel photosensitizer chlorophyllin e4","Du L, Jiang N, Wang G, Chu Y, Lin W, Qian J, Zhang Y, Zheng J, Chen G.","J Photochem Photobiol B. 2014 Apr 5;133:1-10. doi: 10.1016/j.jphotobiol.2014.02.010. Epub 2014 Feb 27.","Du L","J Photochem Photobiol B","2014","2014/03/22","","","10.1016/j.jphotobiol.2014.02.010"
"12118019","Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results","Rödel C, Grabenbauer GG, Kühn R, Papadopoulos T, Dunst J, Meyer M, Schrott KM, Sauer R.","J Clin Oncol. 2002 Jul 15;20(14):3061-71. doi: 10.1200/JCO.2002.11.027.","Rödel C","J Clin Oncol","2002","2002/07/16","","","10.1200/JCO.2002.11.027"
"7563371","Re: Functional replacement of bladder and urethra after cystectomy for bladder cancer in a female patient","Zimmern PE.","J Urol. 1995 Nov;154(5):1870. doi: 10.1016/s0022-5347(01)66808-3.","Zimmern PE","J Urol","1995","1995/11/01","","","10.1016/s0022-5347(01)66808-3"
"18619223","Imaging of urinary tract tumors","Blake MA, Kalra MK.","Cancer Treat Res. 2008;143:299-317. doi: 10.1007/978-0-387-75587-8_12.","Blake MA","Cancer Treat Res","2008","2008/07/16","","","10.1007/978-0-387-75587-8_12"
"28324275","The Impact of Blue Light Cystoscopy on the Diagnosis and Treatment of Bladder Cancer","Pietzak EJ.","Curr Urol Rep. 2017 May;18(5):39. doi: 10.1007/s11934-017-0685-8.","Pietzak EJ","Curr Urol Rep","2017","2017/03/22","","","10.1007/s11934-017-0685-8"
"1441026","Transurethral resection in regionally advanced bladder cancer","Herr HW.","Urol Clin North Am. 1992 Nov;19(4):695-700.","Herr HW","Urol Clin North Am","1992","1992/11/01","","",""
"25770485","Predicting Outcomes in Bladder Cancer: Are We Any Good and Could We Do Better?","Cresswell J, Mostafid AH.","Eur Urol. 2015 Aug;68(2):254-5. doi: 10.1016/j.eururo.2015.02.033. Epub 2015 Mar 11.","Cresswell J","Eur Urol","2015","2015/03/16","","","10.1016/j.eururo.2015.02.033"
"27690238","CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer","Miyake M, Hori S, Morizawa Y, Tatsumi Y, Nakai Y, Anai S, Torimoto K, Aoki K, Tanaka N, Shimada K, Konishi N, Toritsuka M, Kishimoto T, Rosser CJ, Fujimoto K.","Neoplasia. 2016 Oct;18(10):636-646. doi: 10.1016/j.neo.2016.08.002. Epub 2016 Sep 28.","Miyake M","Neoplasia","2016","2016/10/01","PMC5043399","","10.1016/j.neo.2016.08.002"
"23164389","Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma","Patel AR, Cohn JA, Abd El Latif A, Miocinovic R, Steinberg GD, Paner GP, Hansel DE.","J Urol. 2013 Jan;189(1):53-8. doi: 10.1016/j.juro.2012.09.006. Epub 2012 Nov 16.","Patel AR","J Urol","2013","2012/11/21","","","10.1016/j.juro.2012.09.006"
"28162942","Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?","Kang M, Balpukov UJ, Jeong CW, Kwak C, Kim HH, Ku JH.","Clin Genitourin Cancer. 2017 Jun;15(3):e411-e420. doi: 10.1016/j.clgc.2016.10.015. Epub 2017 Jan 9.","Kang M","Clin Genitourin Cancer","2017","2017/02/07","","","10.1016/j.clgc.2016.10.015"
"23011762","Plasma human neutrophil proteins-1, -2, and -3 levels in patients with bladder cancer","Gunes M, Gecit I, Pirincci N, Kemik AS, Purisa S, Ceylan K, Aslan M.","J Cancer Res Clin Oncol. 2013 Feb;139(2):195-9. doi: 10.1007/s00432-012-1305-0. Epub 2012 Sep 26.","Gunes M","J Cancer Res Clin Oncol","2013","2012/09/27","","","10.1007/s00432-012-1305-0"
"19176203","Bladder cancer","Montie JE, Clark PE, Eisenberger MA, El-Galley R, Greenberg RE, Herr HW, Hudes GR, Kuban DA, Kuzel TM, Lange PH, Lele SM, Michalski J, Patterson A, Pohar KS, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Walther PJ, Wilson TG; National Comprehensive Cancer Network.","J Natl Compr Canc Netw. 2009 Jan;7(1):8-39. doi: 10.6004/jnccn.2009.0002.","Montie JE","J Natl Compr Canc Netw","2009","2009/01/30","","","10.6004/jnccn.2009.0002"
"19060816","Bladder cancer and smoking. Part 4: efficacy of health promotion","Anderson B, Naish W.","Br J Nurs. 2008 Nov 27-Dec 10;17(21):1340-4. doi: 10.12968/bjon.2008.17.21.31741.","Anderson B","Br J Nurs","2008","2008/12/09","","","10.12968/bjon.2008.17.21.31741"
"25443901","Reply: To PMID 25443899","Siemens DR, Booth CM.","Urology. 2014 Nov;84(5):1056-7. doi: 10.1016/j.urology.2014.06.074. Epub 2014 Oct 24.","Siemens DR","Urology","2014","2014/12/03","","","10.1016/j.urology.2014.06.074"
"6350964","[Elevated CEA values after cystectomy for bladder cancer and intestinal urinary diversion not evidence of tumor recurrence]","Klippel KF, Axt D, Schärfe T, Preiss J, Alves de Oliveira CR.","Onkologie. 1983 Jun;6(3):126, 127-31.","Klippel KF","Onkologie","1983","1983/06/01","","",""
"9590746","[Loss of p16 gene in bladder cancer and genitourinary carcinoma cell lines]","Guo D, Gu F, Zhou A.","Zhonghua Wai Ke Za Zhi. 1996 Nov;34(11):643-4.","Guo D","Zhonghua Wai Ke Za Zhi","1996","1996/11/01","","",""
"18099077","Cancer of the bladder","SCHOLL AJ.","Calif Med. 1948 Dec;69(6):462-7.","SCHOLL AJ","Calif Med","1948","1948/12/01","PMC1643643","",""
"17253087","Metallothionein in bladder cancer: correlation of overexpression with poor outcome after chemotherapy","Wülfing C, van Ahlen H, Eltze E, Piechota H, Hertle L, Schmid KW.","World J Urol. 2007 Apr;25(2):199-205. doi: 10.1007/s00345-006-0141-8.","Wülfing C","World J Urol","2007","2007/01/27","","","10.1007/s00345-006-0141-8"
"23328160","Prognostic factors including Ki-67 and p53 in Bacillus Calmette-Guérin-treated non-muscle-invasive bladder cancer: a prospective study","Oderda M, Ricceri F, Pisano F, Fiorito C, Gurioli A, Casetta G, Zitella A, Pacchioni D, Gontero P.","Urol Int. 2013;90(2):184-90. doi: 10.1159/000343431. Epub 2013 Jan 17.","Oderda M","Urol Int","2013","2013/01/19","","","10.1159/000343431"
"9228605","Evaluation of effect of treatment for invasive bladder cancer by ultrasonography with intra-arterial infusion of carbon dioxide microbubbles","Akimoto T, Matsumoto M, Mitsuhashi N, Mashimo T, Niibe H.","Invest Radiol. 1997 Jul;32(7):396-400. doi: 10.1097/00004424-199707000-00005.","Akimoto T","Invest Radiol","1997","1997/07/01","","","10.1097/00004424-199707000-00005"
"1690584","Diagnosis of clinically occult bladder cancer by in vivo staining with methylene blue","Mufti GR, Shah PJ, Parkinson MC, Riddle PR.","Br J Urol. 1990 Feb;65(2):173-5. doi: 10.1111/j.1464-410x.1990.tb14693.x.","Mufti GR","Br J Urol","1990","1990/02/01","","","10.1111/j.1464-410x.1990.tb14693.x"
"16164271","[Radical cystectomy for invasive bladder carcinoma in patients 75 years old or older]","Uekado Y, Inagaki T, Hagino K, Suzuki A, Shinka T.","Hinyokika Kiyo. 2005 Aug;51(8):547-51.","Uekado Y","Hinyokika Kiyo","2005","2005/09/17","","",""
"8607236","Intravesical bacille Calmette-Guérin therapy for muscle invasive bladder cancer","Rosenbaum RS, Park MC, Fleischmann J.","Urology. 1996 Feb;47(2):208-11. doi: 10.1016/S0090-4295(99)80418-X.","Rosenbaum RS","Urology","1996","1996/02/01","","","10.1016/S0090-4295(99)80418-X"
"11523222","Novel gelatin-adriamycin sustained drug release system for intravesical therapy of bladder cancer","Ye Z, Chen J, Zhang X, Li J, Zhou S, Yang W, Zhang Y.","J Tongji Med Univ. 2001;21(2):145-8. doi: 10.1007/BF02888081.","Ye Z","J Tongji Med Univ","2001","2001/08/29","","","10.1007/BF02888081"
"17373664","Improved detection of bladder carcinoma cells in voided urine by standardized microsatellite analysis","Frigerio S, Padberg BC, Strebel RT, Lenggenhager DM, Messthaler A, Abdou MT, Moch H, Zimmermann DR.","Int J Cancer. 2007 Jul 15;121(2):329-38. doi: 10.1002/ijc.22690.","Frigerio S","Int J Cancer","2007","2007/03/22","","","10.1002/ijc.22690"
"11175346","Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest","Simoneau M, LaRue H, Aboulkassim TO, Meyer F, Moore L, Fradet Y.","Oncogene. 2000 Dec 14;19(54):6317-23. doi: 10.1038/sj.onc.1204022.","Simoneau M","Oncogene","2000","2001/02/15","","","10.1038/sj.onc.1204022"
"9868392","[Conservative treatment of bladder cancers with radiotherapy and concurrent chemotherapy: results and perspectives]","Chauvet B, Davin JL, Alfonsi M, Berger C, Vincent P, Reboul F.","Cancer Radiother. 1998 Sep-Oct;2(5):499-504. doi: 10.1016/s1278-3218(98)80058-9.","Chauvet B","Cancer Radiother","1998","1998/12/30","","","10.1016/s1278-3218(98)80058-9"
"21070578","Radical cystectomy for BCG failure: has the timing improved in recent years?","Soloway MS, Hepps D, Katkoori D, Ayyathurai R, Manoharan M.","BJU Int. 2011 Jul;108(2):182-5. doi: 10.1111/j.1464-410X.2010.09830.x. Epub 2010 Nov 10.","Soloway MS","BJU Int","2011","2010/11/13","","","10.1111/j.1464-410X.2010.09830.x"
"5752259","[Effect of chromomycin A3 on urinary bladder cancer]","Suzuki K, Kato M, Onodera Y, Sugawara K, Miyata K.","Gan No Rinsho. 1968 Nov;14(11):935-8.","Suzuki K","Gan No Rinsho","1968","1968/11/01","","",""
"27105761","Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures","Seiler R, Lam LL, Erho N, Takhar M, Mitra AP, Buerki C, Davicioni E, Skinner EC, Daneshmand S, Black PC.","J Urol. 2016 Oct;196(4):1036-41. doi: 10.1016/j.juro.2016.04.061. Epub 2016 Apr 19.","Seiler R","J Urol","2016","2016/04/24","","","10.1016/j.juro.2016.04.061"
"2121361","Studies on the nucleic acid of human bladder carcinoma","Nabih I, Mantawy MM, Abdel-Hamid AZ.","Cell Mol Biol. 1990;36(3):299-308.","Nabih I","Cell Mol Biol","1990","1990/01/01","","",""
"4956353","Present stage of chemotherapy in the complex treatment of urinary bladder cancer","Puscariu V, Bunescu U, Schileru G.","Acta Urol Belg. 1966 Jan;34(1):29-32.","Puscariu V","Acta Urol Belg","1966","1966/01/01","","",""
"5338305","[Studies on urinary beta-glucuronidase in patients with bladder cancer]","Tamiya T.","Sapporo Igaku Zasshi. 1966 May-Jun;29(5):269-303.","Tamiya T","Sapporo Igaku Zasshi","1966","1966/05/01","","",""
"26410305","DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling","Wu K, Wang B, Chen Y, Zhou J, Huang J, Hui K, Zeng J, Zhu J, Zhang K, Li L, Guo P, Wang X, Hsieh JT, He D, Fan J.","Cell Signal. 2015 Dec;27(12):2515-23. doi: 10.1016/j.cellsig.2015.09.014. Epub 2015 Sep 26.","Wu K","Cell Signal","2015","2015/09/28","","","10.1016/j.cellsig.2015.09.014"
"28984720","Prevention of bladder cancer incidence and recurrence: tobacco use","Soria F, Marra G, Čapoun O, Soukup V, Gontero P.","Curr Opin Urol. 2018 Jan;28(1):80-87. doi: 10.1097/MOU.0000000000000453.","Soria F","Curr Opin Urol","2018","2017/10/07","","","10.1097/MOU.0000000000000453"
"28780419","Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells","Miao X, Gao H, Liu S, Chen M, Xu W, Ling X, Deng X, Rao C.","Int J Biol Macromol. 2018 Jan;106:234-240. doi: 10.1016/j.ijbiomac.2017.07.184. Epub 2017 Aug 2.","Miao X","Int J Biol Macromol","2018","2017/08/07","","","10.1016/j.ijbiomac.2017.07.184"
"20575692","Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer","Yuan L, Gu X, Shao J, Wang M, Wang M, Zhu Q, Zhang Z.","DNA Cell Biol. 2010 Oct;29(10):611-7. doi: 10.1089/dna.2010.1018.","Yuan L","DNA Cell Biol","2010","2010/06/26","","","10.1089/dna.2010.1018"
"23830475","Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review","Perlis N, Zlotta AR, Beyene J, Finelli A, Fleshner NE, Kulkarni GS.","Eur Urol. 2013 Sep;64(3):421-30. doi: 10.1016/j.eururo.2013.06.009. Epub 2013 Jun 19.","Perlis N","Eur Urol","2013","2013/07/09","","","10.1016/j.eururo.2013.06.009"
"23664207","Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer","Azuma T, Nagase Y, Oshi M.","Clin Genitourin Cancer. 2013 Sep;11(3):331-6. doi: 10.1016/j.clgc.2013.04.002. Epub 2013 May 9.","Azuma T","Clin Genitourin Cancer","2013","2013/05/14","","","10.1016/j.clgc.2013.04.002"
"8928358","[Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation]","Venz S, Ilg J, Ebert T, Hierholzer J, Friedrichs R, Hosten N, Felix R.","Urologe A. 1996 Jul;35(4):297-304.","Venz S","Urologe A","1996","1996/07/01","","",""
"11289120","Identification of gene expression patterns in superficial and invasive human bladder cancer","Thykjaer T, Workman C, Kruhøffer M, Demtröder K, Wolf H, Andersen LD, Frederiksen CM, Knudsen S, Orntoft TF.","Cancer Res. 2001 Mar 15;61(6):2492-9.","Thykjaer T","Cancer Res","2001","2001/04/06","","",""
"7370936","Carcinoma of the bladder: predictors","Cummings KB.","Cancer. 1980 Apr 15;45(7 Suppl):1849-55.","Cummings KB","Cancer","1980","1980/04/15","","",""
"29579342","Cost considerations for systemic therapy for patients with advanced genitourinary malignancies","Henry MA, Leung A, Filson CP.","Cancer. 2018 Jul 15;124(14):2897-2905. doi: 10.1002/cncr.31355. Epub 2018 Mar 26.","Henry MA","Cancer","2018","2018/03/27","","","10.1002/cncr.31355"
"8918486","Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group","Coppin CM, Gospodarowicz MK, James K, Tannock IF, Zee B, Carson J, Pater J, Sullivan LD.","J Clin Oncol. 1996 Nov;14(11):2901-7. doi: 10.1200/JCO.1996.14.11.2901.","Coppin CM","J Clin Oncol","1996","1996/11/01","","","10.1200/JCO.1996.14.11.2901"
"28993351","Haematuria in ADPKD: not always benign. Be aware!","Agarwal M, Sokhal AK, Kumar M, Goel S.","BMJ Case Rep. 2017 Oct 9;2017:bcr2017220638. doi: 10.1136/bcr-2017-220638.","Agarwal M","BMJ Case Rep","2017","2017/10/11","PMC5652374","","10.1136/bcr-2017-220638"
"6417870","Salvage cystectomy","Freiha FS, Faysal MH.","Urology. 1983 Nov;22(5):496-8. doi: 10.1016/0090-4295(83)90227-3.","Freiha FS","Urology","1983","1983/11/01","","","10.1016/0090-4295(83)90227-3"
"16962489","Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy","Joudi FN, Dahmoush L, Spector DM, Konety BR.","Urol Oncol. 2006 Sep-Oct;24(5):403-6. doi: 10.1016/j.urolonc.2005.12.002.","Joudi FN","Urol Oncol","2006","2006/09/12","","","10.1016/j.urolonc.2005.12.002"
"26102052","[Analysis of budgetary impact of moderate and high risk non muscle-invasive bladder cancer by means of neoadjuvant hyperthermia chemotherapy compared to the standard adjuvant treatment with BCG]","Sousa A, Piñeiro I, Aparici V, Neira P, Monserrat V, Uribarri C.","Arch Esp Urol. 2015 Jun;68(5):482-92.","Sousa A","Arch Esp Urol","2015","2015/06/24","","",""
"2310928","Neodymium-YAG laser irradiation of stage T2 muscle-invasive bladder cancer. Long-term results","Beisland HO, Sander S.","Br J Urol. 1990 Jan;65(1):24-6. doi: 10.1111/j.1464-410x.1990.tb14654.x.","Beisland HO","Br J Urol","1990","1990/01/01","","","10.1111/j.1464-410x.1990.tb14654.x"
"2413339","Superficial bladder cancer","Trybula M, King M.","Med Pediatr Oncol. 1985;13(6):384-9. doi: 10.1002/mpo.2950130617.","Trybula M","Med Pediatr Oncol","1985","1985/01/01","","","10.1002/mpo.2950130617"
"11125422","Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin","Mizutani Y, Nakao M, Ogawa O, Yoshida O, Bonavida B, Miki T.","J Urol. 2001 Jan;165(1):263-70. doi: 10.1097/00005392-200101000-00076.","Mizutani Y","J Urol","2001","2000/12/23","","","10.1097/00005392-200101000-00076"
"18393367","Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies","Bryan RT, Atherfold PA, Yeo Y, Jones LJ, Harrison RF, Wallace DM, Jankowski JA.","J Pathol. 2008 Jun;215(2):184-94. doi: 10.1002/path.2346.","Bryan RT","J Pathol","2008","2008/04/09","","","10.1002/path.2346"
"11832773","Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer","Andrews B, Shariat SF, Kim JH, Wheeler TM, Slawin KM, Lerner SP.","J Urol. 2002 Mar;167(3):1475-81.","Andrews B","J Urol","2002","2002/02/08","","",""
"19571756","How to improve the effectiveness of transurethral resection in nonmuscle invasive bladder cancer?","Cauberg EC, de la Rosette JJ, de Reijke TM.","Curr Opin Urol. 2009 Sep;19(5):504-10. doi: 10.1097/MOU.0b013e32832eb2a3.","Cauberg EC","Curr Opin Urol","2009","2009/07/03","","","10.1097/MOU.0b013e32832eb2a3"
"25135188","Mapping of the chromosomal amplification 1p21-22 in bladder cancer","Scaravilli M, Asero P, Tammela TL, Visakorpi T, Saramäki OR.","BMC Res Notes. 2014 Aug 18;7:547. doi: 10.1186/1756-0500-7-547.","Scaravilli M","BMC Res Notes","2014","2014/08/20","PMC4143550","","10.1186/1756-0500-7-547"
"10688071","Intravesical therapy for bladder cancer","Kamat AM, Lamm DL.","Urology. 2000 Feb;55(2):161-8. doi: 10.1016/s0090-4295(99)00463-x.","Kamat AM","Urology","2000","2000/02/25","","","10.1016/s0090-4295(99)00463-x"
"30609111","VEGF gene rs3025039C/T and rs833052C/A variants are associated with bladder cancer risk in Asian descendants","Zhang LF, Ren KW, Zuo L, Zou JG, Song NH, Mi YY, Wang ZJ, Zhang W.","J Cell Biochem. 2019 Jun;120(6):10402-10412. doi: 10.1002/jcb.28324. Epub 2019 Jan 4.","Zhang LF","J Cell Biochem","2019","2019/01/05","","","10.1002/jcb.28324"
"31454284","Alternative Therapies to Bacillus Calmette-Guérin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations","Wroclawski ML, Schutz FA, Cha JD, Soares A.","J Glob Oncol. 2019 Aug;5:1-9. doi: 10.1200/JGO.19.00112.","Wroclawski ML","J Glob Oncol","2019","2019/08/28","PMC6776038","","10.1200/JGO.19.00112"
"30213291","Expression profiles of proto-oncogene TWIST1 and tumor metastasis suppressor gene LASS2 in bladder cancer","Yegin Z, Aydin O, Koc H, Buyukalpelli R.","Cell Mol Biol (Noisy-le-grand). 2018 Aug 30;64(11):66-73.","Yegin Z","Cell Mol Biol (Noisy-le-grand)","2018","2018/09/15","","",""
"2867277","Outpatient treatment of superficial bladder cancer","Fowler CG, Boorman LS.","Lancet. 1986 Jan 4;1(8471):38. doi: 10.1016/s0140-6736(86)91915-x.","Fowler CG","Lancet","1986","1986/01/04","","","10.1016/s0140-6736(86)91915-x"
"14728827","[The role of cell adhesion, multidrug resistance and cell proliferation in short-term recurrent cases with T1G3 superficial bladder cancer]","Zhu YY, Kong CZ, Zeng Y, Pang GY, Yang CM, Sun ZX.","Zhonghua Wai Ke Za Zhi. 2003 Dec;41(12):893-6.","Zhu YY","Zhonghua Wai Ke Za Zhi","2003","2004/01/20","","",""
"24368268","Percutaneous cryotherapy for metastatic bladder cancer: experience with 23 patients","Liang Z, Fei Y, Lizhi N, Jianying Z, Zhikai Z, Jibing C, Jialiang L, Kecheng X.","Cryobiology. 2014 Feb;68(1):79-83. doi: 10.1016/j.cryobiol.2013.12.004. Epub 2013 Dec 22.","Liang Z","Cryobiology","2014","2013/12/26","","","10.1016/j.cryobiol.2013.12.004"
"12463120","[Prognostic factors of invasive bladder cancer with lymph node invasion]","Lacroix B, Rusch P, Cerisier A, Pages A, Armand C, Tostain J.","Prog Urol. 2002 Sep;12(4):615-20.","Lacroix B","Prog Urol","2002","2002/12/05","","",""
"21868262","Intravesical bacillus Calmette-Guerin immunotherapy after previous prostate radiotherapy for high-grade non-muscle-invasive bladder cancer","Rao MV, Ellimoottil C, Sondej T, Flanigan RC, Quek ML.","Urol Oncol. 2013 Aug;31(6):857-61. doi: 10.1016/j.urolonc.2011.07.005. Epub 2011 Aug 24.","Rao MV","Urol Oncol","2013","2011/08/27","","","10.1016/j.urolonc.2011.07.005"
"29288006","Advancements in optical techniques and imaging in the diagnosis and management of bladder cancer","Rose TL, Lotan Y.","Urol Oncol. 2018 Mar;36(3):97-102. doi: 10.1016/j.urolonc.2017.11.014. Epub 2017 Dec 26.","Rose TL","Urol Oncol","2018","2017/12/31","","","10.1016/j.urolonc.2017.11.014"
"18367114","Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancer","Ecke TH, Schlechte HH, Gunia S, Lenk SV, Loening SA.","Urol Oncol. 2008 Sep-Oct;26(5):470-3. doi: 10.1016/j.urolonc.2007.12.005. Epub 2008 Mar 4.","Ecke TH","Urol Oncol","2008","2008/03/28","","","10.1016/j.urolonc.2007.12.005"
"26835590","Podoplanin serum and urine concentration in transitional bladder cancer","Sankiewicz A, Guszcz T, Mena-Hortelano R, Zukowski K, Gorodkiewicz E.","Cancer Biomark. 2016;16(3):343-50. doi: 10.3233/CBM-160572.","Sankiewicz A","Cancer Biomark","2016","2016/02/03","","","10.3233/CBM-160572"
"11569234","[Diagnosis of bladder cancer]","Kozlov VP, Zubarev AV, Grishin MA, Nasnikova IIu, Kovalev AA, Aristov AV.","Urologiia. 2001 Jul-Aug;(4):36-9.","Kozlov VP","Urologiia","2001","2001/09/25","","",""
"20723929","Myopodin methylation is associated with clinical outcome in patients with T1G3 bladder cancer","Alvarez-Múgica M, Cebrian V, Fernández-Gómez JM, Fresno F, Escaf S, Sánchez-Carbayo M.","J Urol. 2010 Oct;184(4):1507-13. doi: 10.1016/j.juro.2010.05.085. Epub 2010 Aug 17.","Alvarez-Múgica M","J Urol","2010","2010/08/21","","","10.1016/j.juro.2010.05.085"
"31054930","Expression analysis of a panel of long non-coding RNAs (lncRNAs) revealed their potential as diagnostic biomarkers in bladder cancer","Abdolmaleki F, Ghafoui-Fard S, Taheri M, Mordadi A, Afsharpad M, Varmazyar S, Nazparvar B, Oskooei VK, Omrani MD.","Genomics. 2020 Jan;112(1):677-682. doi: 10.1016/j.ygeno.2019.04.020. Epub 2019 May 2.","Abdolmaleki F","Genomics","2020","2019/05/06","","","10.1016/j.ygeno.2019.04.020"
"5856357","[Telecobalt irradiation of bladder cancer]","van der Werfmessing B.","J Belge Radiol. 1965;48(6):653-64.","van der Werfmessing B","J Belge Radiol","1965","1965/01/01","","",""
"16399416","Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers","Habuchi T, Marberger M, Droller MJ, Hemstreet GP 3rd, Grossman HB, Schalken JA, Schmitz-Dräger BJ, Murphy WM, Bono AV, Goebell P, Getzenberg RH, Hautmann SH, Messing E, Fradet Y, Lokeshwar VB.","Urology. 2005 Dec;66(6 Suppl 1):64-74. doi: 10.1016/j.urology.2005.08.065.","Habuchi T","Urology","2005","2006/01/10","","","10.1016/j.urology.2005.08.065"
"26679712","Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma","Geynisman DM, Handorf E, Wong YN, Doyle J, Plimack ER, Horwitz EM, Canter DJ, Uzzo RG, Kutikov A, Smaldone MC.","Cancer Med. 2016 Feb;5(2):192-9. doi: 10.1002/cam4.577. Epub 2015 Dec 18.","Geynisman DM","Cancer Med","2016","2015/12/19","PMC4735777","","10.1002/cam4.577"
"32620207","[Immunotherapies in non-muscle invasive bladder cancer: immunotherapies and NMIBC]","Loriot Y, Rouprêt M.","Bull Cancer. 2020 Jun;107(5S):S49-S55. doi: 10.1016/S0007-4551(20)30278-2.","Loriot Y","Bull Cancer","2020","2020/07/05","","","10.1016/S0007-4551(20)30278-2"
"8275191","A prospective study of diet, smoking, and lower urinary tract cancer","Chyou PH, Nomura AM, Stemmermann GN.","Ann Epidemiol. 1993 May;3(3):211-6. doi: 10.1016/1047-2797(93)90021-u.","Chyou PH","Ann Epidemiol","1993","1993/05/01","","","10.1016/1047-2797(93)90021-u"
"11257650","Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance","Donat SM, Genega EM, Herr HW, Reuter VE.","J Urol. 2001 Apr;165(4):1117-20.","Donat SM","J Urol","2001","2001/03/21","","",""
"25224572","Re: Paolo Gontero, Richard Sylvester, Francesca Pisano, et al. Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. Eur Urol 2015;67:74-82","Montorsi F, Gandaglia G.","Eur Urol. 2015 Jan;67(1):e7. doi: 10.1016/j.eururo.2014.08.062. Epub 2014 Sep 12.","Montorsi F","Eur Urol","2015","2014/09/17","","","10.1016/j.eururo.2014.08.062"
"17950990","Editorial comment on: prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials","Sylvester RJ.","Eur Urol. 2008 May;53(5):1002. doi: 10.1016/j.eururo.2007.10.007. Epub 2007 Oct 15.","Sylvester RJ","Eur Urol","2008","2007/10/24","","","10.1016/j.eururo.2007.10.007"
"30257376","Baicalein inhibits proliferation and migration of bladder cancer cell line T24 by down-regulation of microRNA-106","Jiang L, Song H, Guo H, Wang C, Lu Z.","Biomed Pharmacother. 2018 Nov;107:1583-1590. doi: 10.1016/j.biopha.2018.08.107. Epub 2018 Sep 6.","Jiang L","Biomed Pharmacother","2018","2018/09/28","","","10.1016/j.biopha.2018.08.107"
"3301367","A phase II study of carboplatin in metastatic transitional cell carcinoma of the bladder (a report of the Medical Research Council Working Party on Urological Cancer, Subgroup in Advanced Bladder Cancer)","","Eur J Cancer Clin Oncol. 1987 Apr;23(4):375-7.","","Eur J Cancer Clin Oncol","1987","1987/04/01","","",""
"24887046","Smoking and smoking cessation effects on oncological outcomes in nonmuscle invasive bladder cancer","Simonis K, Shariat SF, Rink M; Urothelial Cancer Working Group of the Young Academic Urologists (YAU) Working Party of the European Association of Urology (EAU).","Curr Opin Urol. 2014 Sep;24(5):492-9. doi: 10.1097/MOU.0000000000000079.","Simonis K","Curr Opin Urol","2014","2014/06/03","","","10.1097/MOU.0000000000000079"
"12042039","Lymphocytic infiltration of bladder after local cellular immunotherapy","Ingram M, Bishai MB, Techy GB, Narayan KS, Saroufeem R, Yazan O, Marshall CE.","Cytotherapy. 2000;2(4):297-301. doi: 10.1080/146532400539233.","Ingram M","Cytotherapy","2000","2002/06/04","","","10.1080/146532400539233"
"31724659","Targeted multifunctional nanomaterials with MRI, chemotherapy and photothermal therapy for the diagnosis and treatment of bladder cancer","Tao K , Liu S , Wang L , Qiu H , Li B , Zhang M , Guo M , Liu H , Zhang X , Liu Y , Hou Y , Zhang H .","Biomater Sci. 2019 Dec 17;8(1):342-352. doi: 10.1039/c9bm01377f.","Tao K","Biomater Sci","2019","2019/11/15","","","10.1039/c9bm01377f"
"10444795","[Occupational risk factors for bladder carcinoma. A case control study]","Golka K, Bandel T, Reckwitz T, Urfer W, Bolt HM, Bremicker KD, Neugebauer W, Schulze H.","Urologe A. 1999 Jul;38(4):358-63. doi: 10.1007/s001200050298.","Golka K","Urologe A","1999","1999/08/13","","","10.1007/s001200050298"
"12421448","Detection of bladder cancer by multitarget multicolour FISH: comparative analysis on archival cytology and paraffin-embedded tissue","Mezzelani A, Dagrada G, Alasio L, Sozzi G, Pilotti S.","Cytopathology. 2002 Oct;13(5):317-25. doi: 10.1046/j.1365-2303.2002.00426.x.","Mezzelani A","Cytopathology","2002","2002/11/08","","","10.1046/j.1365-2303.2002.00426.x"
"16093857","Impact of socioeconomic status on bladder cancer outcome","Shackley DC, Clarke NW.","Curr Opin Urol. 2005 Sep;15(5):328-31. doi: 10.1097/01.mou.0000174965.26439.d1.","Shackley DC","Curr Opin Urol","2005","2005/08/12","","","10.1097/01.mou.0000174965.26439.d1"
"21483670","Spotlight on differentially expressed genes in urinary bladder cancer","Zaravinos A, Lambrou GI, Volanis D, Delakas D, Spandidos DA.","PLoS One. 2011 Apr 5;6(4):e18255. doi: 10.1371/journal.pone.0018255.","Zaravinos A","PLoS One","2011","2011/04/13","PMC3071699","","10.1371/journal.pone.0018255"
"26320383","Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study","Morales EE, Grill S, Svatek RS, Kaushik D, Thompson IM Jr, Ankerst DP, Liss MA.","Eur Urol. 2016 Mar;69(3):407-10. doi: 10.1016/j.eururo.2015.08.029. Epub 2015 Aug 28.","Morales EE","Eur Urol","2016","2015/09/01","","","10.1016/j.eururo.2015.08.029"
"6518243","Data analytic methods for matched case-control studies","Pregibon D.","Biometrics. 1984 Sep;40(3):639-51.","Pregibon D","Biometrics","1984","1984/09/01","","",""
"20709369","Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy","Canter D, Viterbo R, Kutikov A, Wong YN, Plimack E, Zhu F, Oblaczynski M, Berberian R, Chen DY, Greenberg RE, Uzzo RG, Boorjian SA.","Urology. 2011 Jan;77(1):160-5. doi: 10.1016/j.urology.2010.03.091. Epub 2010 Aug 14.","Canter D","Urology","2011","2010/08/17","","","10.1016/j.urology.2010.03.091"
"15312364","[Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer]","Hao GY, Zhang WD, Chen YH, Zhang DX, Zhang YH.","Zhonghua Zhong Liu Za Zhi. 2004 May;26(5):283-6.","Hao GY","Zhonghua Zhong Liu Za Zhi","2004","2004/08/18","","",""
"27041469","Change in Management Based on Pathologic Second Opinion Among Bladder Cancer Patients Presenting to a Comprehensive Cancer Center: Implications for Clinical Practice","Luchey AM, Manimala NJ, Dickinson S, Dhillon J, Agarwal G, Lockhart JL, Spiess PE, Sexton WJ, Pow-Sang JM, Gilbert SM, Poch MA.","Urology. 2016 Jul;93:130-4. doi: 10.1016/j.urology.2016.01.048. Epub 2016 Mar 31.","Luchey AM","Urology","2016","2016/04/05","","","10.1016/j.urology.2016.01.048"
"7690149","Effects of bleomycin with iododeoxyuridine, 5'-amino-5'-deoxythymidine, and radiation in a human bladder cancer cell line","Kunugi KA, Lindstrom MJ, Kinsella TJ.","Radiat Res. 1993 Aug;135(2):262-8.","Kunugi KA","Radiat Res","1993","1993/08/01","","",""
"27311600","Intravesical endometriosis mimicking bladder cancer","Ker CR, Lin KL, Long CY.","Int Urogynecol J. 2016 Oct;27(10):1605-6. doi: 10.1007/s00192-016-3060-2. Epub 2016 Jun 16.","Ker CR","Int Urogynecol J","2016","2016/06/18","","","10.1007/s00192-016-3060-2"
"23040254","Current role of radiation therapy for bladder cancer","Sandler HM, Mirhadi AJ.","Semin Oncol. 2012 Oct;39(5):583-7. doi: 10.1053/j.seminoncol.2012.08.005.","Sandler HM","Semin Oncol","2012","2012/10/09","","","10.1053/j.seminoncol.2012.08.005"
"21334346","A mathematical model of combined bacillus Calmette-Guerin (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer","Bunimovich-Mendrazitsky S, Claude Gluckman J, Chaskalovic J.","J Theor Biol. 2011 May 21;277(1):27-40. doi: 10.1016/j.jtbi.2011.02.008. Epub 2011 Feb 18.","Bunimovich-Mendrazitsky S","J Theor Biol","2011","2011/02/22","","","10.1016/j.jtbi.2011.02.008"
"31005155","Non-invasive diagnosis of bladder cancer by detecting telomerase activity in human urine using hybridization chain reaction and dynamic light scattering","Li T, Zou L, Zhang J, Li G, Ling L.","Anal Chim Acta. 2019 Aug 13;1065:90-97. doi: 10.1016/j.aca.2019.03.039. Epub 2019 Mar 20.","Li T","Anal Chim Acta","2019","2019/04/22","","","10.1016/j.aca.2019.03.039"
"26218634","Genetic subtypes of invasive bladder cancer","McConkey DJ, Choi W, Dinney CP.","Curr Opin Urol. 2015 Sep;25(5):449-58. doi: 10.1097/MOU.0000000000000200.","McConkey DJ","Curr Opin Urol","2015","2015/07/29","","","10.1097/MOU.0000000000000200"
"10536351","Quick-staining urinary cytology and bladder wash image analysis with an integrated risk classification: a worthwhile improvement in the follow-up of bladder cancer?","Wiener HG, Remkes GW, Schatzl G, Susani M, Breitenecker G.","Cancer. 1999 Oct 25;87(5):263-9.","Wiener HG","Cancer","1999","1999/10/28","","",""
"17296271","Blood cadmium may be associated with bladder carcinogenesis: the Belgian case-control study on bladder cancer","Kellen E, Zeegers MP, Hond ED, Buntinx F.","Cancer Detect Prev. 2007;31(1):77-82. doi: 10.1016/j.cdp.2006.12.001. Epub 2007 Feb 12.","Kellen E","Cancer Detect Prev","2007","2007/02/14","","","10.1016/j.cdp.2006.12.001"
"10491513","Progression of T1 bladder tumors: better staging or better biology?","Herr HW, Reuter VE.","Cancer. 1999 Sep 15;86(6):908-12. doi: 10.1002/(sici)1097-0142(19990915)86:6<908::aid-cncr2>3.0.co;2-e.","Herr HW","Cancer","1999","1999/09/24","","","10.1002/(sici)1097-0142(19990915)86:6<908::aid-cncr2>3.0.co;2-e"
"19237611","Proepithelin is an autocrine growth factor for bladder cancer","Lovat F, Bitto A, Xu SQ, Fassan M, Goldoni S, Metalli D, Wubah V, McCue P, Serrero G, Gomella LG, Baffa R, Iozzo RV, Morrione A.","Carcinogenesis. 2009 May;30(5):861-8. doi: 10.1093/carcin/bgp050. Epub 2009 Feb 23.","Lovat F","Carcinogenesis","2009","2009/02/25","PMC2675649","","10.1093/carcin/bgp050"
"24316677","LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants","Andreotti G, Karami S, Pfeiffer RM, Hurwitz L, Liao LM, Weinstein SJ, Albanes D, Virtamo J, Silverman DT, Rothman N, Moore LE.","Epigenetics. 2014 Mar;9(3):404-15. doi: 10.4161/epi.27386. Epub 2013 Dec 6.","Andreotti G","Epigenetics","2014","2013/12/10","PMC4053459","","10.4161/epi.27386"
"23749485","Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis","Gong M, Yi Q, Wang W.","Tumour Biol. 2013 Oct;34(5):2551-6. doi: 10.1007/s13277-013-0799-7. Epub 2013 Jun 8.","Gong M","Tumour Biol","2013","2013/06/11","","","10.1007/s13277-013-0799-7"
"28398114","Voided urine versus bladder washing cytology for detection of urothelial carcinoma: which is better?","Keller AK, Jensen JB.","Scand J Urol. 2017 Aug;51(4):290-292. doi: 10.1080/21681805.2017.1310130. Epub 2017 Apr 11.","Keller AK","Scand J Urol","2017","2017/04/12","","","10.1080/21681805.2017.1310130"
"19020721","Decreased expression of galectin-3 predicts tumour recurrence in pTa bladder cancer","Kramer MW, Kuczyk MA, Hennenlotter J, Serth J, Schilling D, Stenzl A, Merseburger AS.","Oncol Rep. 2008 Dec;20(6):1403-8.","Kramer MW","Oncol Rep","2008","2008/11/21","","",""
"819136","Proliferative epithelial lesions of the urinary bladder in cynomolgus monkeys (Macaca fascicularis) infected with Schistosoma intercalatum","Cheever AW, Kuntz RE, Moore JA, Huang TC.","Cancer Res. 1976 Aug;36(8):2928-31.","Cheever AW","Cancer Res","1976","1976/08/01","","",""
"2841992","Development of bladder tumour containing HPV type 11 DNA after renal transplantation","Querci della Rovere G, Oliver RT, McCance DJ, Castro JE.","Br J Urol. 1988 Jul;62(1):36-8. doi: 10.1111/j.1464-410x.1988.tb04261.x.","Querci della Rovere G","Br J Urol","1988","1988/07/01","","","10.1111/j.1464-410x.1988.tb04261.x"
"15963211","Overactive bladder: achieving a differential diagnosis from other lower urinary tract conditions","Nitti V, Taneja S.","Int J Clin Pract. 2005 Jul;59(7):825-30. doi: 10.1111/j.1742-1241.2005.00490.x.","Nitti V","Int J Clin Pract","2005","2005/06/21","","","10.1111/j.1742-1241.2005.00490.x"
"11297759","Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. a marker for invasive bladder cancer?","Aktas D, Ozen H, Atsu N, Tekin A, Sozen S, Tuncbilek E.","Cancer Genet Cytogenet. 2001 Feb;125(1):1-4. doi: 10.1016/s0165-4608(00)00307-1.","Aktas D","Cancer Genet Cytogenet","2001","2001/04/12","","","10.1016/s0165-4608(00)00307-1"
"31109837","The impact of pathologic response to neoadjuvant chemotherapy on conditional survival among patients with muscle-invasive bladder cancer","Waingankar N, Jia R, Marqueen KE, Audenet F, Sfakianos JP, Mehrazin R, Ferket BS, Mazumdar M, Galsky MD.","Urol Oncol. 2019 Sep;37(9):572.e21-572.e28. doi: 10.1016/j.urolonc.2019.04.027. Epub 2019 May 18.","Waingankar N","Urol Oncol","2019","2019/05/22","","","10.1016/j.urolonc.2019.04.027"
"1503414","Resistance of MGH-U1 bladder cancer spheroids to vincristine","Erlichman C, Wu A.","Anticancer Res. 1992 Jul-Aug;12(4):1233-6.","Erlichman C","Anticancer Res","1992","1992/07/01","","",""
"10419409","Intravesical treatment of bladder cancer: current problems and needs","Schmitz-Dräger BJ, Müller M.","Urol Int. 1998;61(4):199-205. doi: 10.1159/000030329.","Schmitz-Dräger BJ","Urol Int","1998","1999/07/27","","","10.1159/000030329"
"16641915","Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer","Andersen JB, Aaboe M, Borden EC, Goloubeva OG, Hassel BA, Orntoft TF.","Br J Cancer. 2006 May 22;94(10):1465-71. doi: 10.1038/sj.bjc.6603099.","Andersen JB","Br J Cancer","2006","2006/04/28","PMC2361278","","10.1038/sj.bjc.6603099"
"2607167","[Adjuvant chemotherapy using adriamycin and cisplatin in infiltrating cancer of the bladder. Prospective study of 49 cases]","Azab M, Theodore C, Cukier J, Beurton D, Gilles E, Droz JP.","J Urol (Paris). 1989;95(8):459-63.","Azab M","J Urol (Paris)","1989","1989/01/01","","",""
"3963010","Cancer risk among artistic painters","Miller BA, Silverman DT, Hoover RN, Blair A.","Am J Ind Med. 1986;9(3):281-7. doi: 10.1002/ajim.4700090311.","Miller BA","Am J Ind Med","1986","1986/01/01","","","10.1002/ajim.4700090311"
"1564839","[Mainz pouch with umbilical stoma]","Mori Y, Shima H, Ihara H, Yabumoto H, Ikoma F.","Nihon Hinyokika Gakkai Zasshi. 1992 Mar;83(3):383-9. doi: 10.5980/jpnjurol1989.83.383.","Mori Y","Nihon Hinyokika Gakkai Zasshi","1992","1992/03/01","","","10.5980/jpnjurol1989.83.383"
"24014088","Association between the cytotoxic T-lymphocyte antigen 4 +49A/G polymorphism and bladder cancer risk","Wang L, Su G, Zhao X, Cai Y, Cai X, Zhang J, Liu J, Wang T, Wang J.","Tumour Biol. 2014 Feb;35(2):1139-42. doi: 10.1007/s13277-013-1152-x. Epub 2013 Sep 8.","Wang L","Tumour Biol","2014","2013/09/10","","","10.1007/s13277-013-1152-x"
"15606333","Advances in intravesical therapy of urinary bladder cancer","Malmström PU.","Expert Rev Anticancer Ther. 2004 Dec;4(6):1057-67. doi: 10.1586/14737140.4.6.1057.","Malmström PU","Expert Rev Anticancer Ther","2004","2004/12/21","","","10.1586/14737140.4.6.1057"
"30033046","Conventional and PD-L1-expressing Regulatory T Cells are Enriched During BCG Therapy and may Limit its Efficacy","Chevalier MF, Schneider AK, Cesson V, Dartiguenave F, Lucca I, Jichlinski P, Nardelli-Haefliger D, Derré L.","Eur Urol. 2018 Nov;74(5):540-544. doi: 10.1016/j.eururo.2018.06.045. Epub 2018 Jul 19.","Chevalier MF","Eur Urol","2018","2018/07/24","","","10.1016/j.eururo.2018.06.045"
"25074295","External validation of European Organization for Research and Treatment of Cancer and Spanish Urological Club for Oncological Treatment scoring models to predict recurrence and progression in Japanese patients with non-muscle invasive bladder cancer treated with bacillus Calmette-Guérin","Kohjimoto Y, Kusumoto H, Nishizawa S, Kikkawa K, Kodama Y, Ko M, Matsumura N, Hara I.","Int J Urol. 2014 Dec;21(12):1201-7. doi: 10.1111/iju.12572. Epub 2014 Jul 30.","Kohjimoto Y","Int J Urol","2014","2014/07/31","","","10.1111/iju.12572"
"1016832","Radiotherapy in the treatment of recurrent bladder cancer","Rider WD, Evans DH.","Br J Urol. 1976;48(7):595-601. doi: 10.1111/j.1464-410x.1976.tb06706.x.","Rider WD","Br J Urol","1976","1976/01/01","","","10.1111/j.1464-410x.1976.tb06706.x"
"11392442","Medical management of patients with refractory carcinoma in situ of the bladder","Kim JC, Steinberg GD.","Drugs Aging. 2001;18(5):335-44. doi: 10.2165/00002512-200118050-00004.","Kim JC","Drugs Aging","2001","2001/06/08","","","10.2165/00002512-200118050-00004"
"1556050","Chemotherapy for metastatic bladder cancer","Kantoff PW, Scher HI.","Hematol Oncol Clin North Am. 1992 Feb;6(1):195-203.","Kantoff PW","Hematol Oncol Clin North Am","1992","1992/02/01","","",""
"25939538","Loss of AQP3 protein expression is associated with worse progression-free and cancer-specific survival in patients with muscle-invasive bladder cancer","Rubenwolf P, Thomas C, Denzinger S, Hartmann A, Burger M, Georgopoulos NT, Otto W.","World J Urol. 2015 Dec;33(12):1959-64. doi: 10.1007/s00345-015-1574-8. Epub 2015 May 5.","Rubenwolf P","World J Urol","2015","2015/05/06","","","10.1007/s00345-015-1574-8"
"28993060","Routine bladder cancer treatment dictates divergence from trial-derived regimens: Results of treatment at 44 radiotherapy centers","Ahamad A, Martinez A, Salenius S, Ross R, Efstathiou J, Fernandez E.","Urol Oncol. 2018 Jan;36(1):9.e19-9.e25. doi: 10.1016/j.urolonc.2017.09.010. Epub 2017 Oct 6.","Ahamad A","Urol Oncol","2018","2017/10/11","","","10.1016/j.urolonc.2017.09.010"
"2601593","[Dynamic fractionation of the radiation dosage combined with the local use of metronidazole in bladder cancer]","Pereslegin IA, Vinogradskiĭ AG, Mufazalov FF.","Med Radiol (Mosk). 1989 Dec;34(12):45-9.","Pereslegin IA","Med Radiol (Mosk)","1989","1989/12/01","","",""
"3538602","[Determining the degree of local spreading of cancer of the bladder]","Matveev BP, Shipilov VI, Toktomushev AT.","Urol Nefrol (Mosk). 1986 Sep-Oct;(5):69-73.","Matveev BP","Urol Nefrol (Mosk)","1986","1986/09/01","","",""
"10339668","Detection of basic fibroblast growth factor mRNA in urinary bladder cancer: correlation with local relapses","Gazzaniga P, Gandini O, Gradilone A, Silvestri I, Giuliani L, Magnanti M, Gallucci M, Saccani G, Frati L, Agliano AM.","Int J Oncol. 1999 Jun;14(6):1123-7. doi: 10.3892/ijo.14.6.1123.","Gazzaniga P","Int J Oncol","1999","1999/05/26","","","10.3892/ijo.14.6.1123"
"1405172","[A case of scrotal bladder hernia containing bladder cancer]","Kawamura S, Kurosawa T, Noro K, Seino K, Koike H, Fujizuka I, Fujioka T, Kubo T, Ohori T.","Nihon Hinyokika Gakkai Zasshi. 1992 Aug;83(8):1334-7. doi: 10.5980/jpnjurol1989.83.1334.","Kawamura S","Nihon Hinyokika Gakkai Zasshi","1992","1992/08/01","","","10.5980/jpnjurol1989.83.1334"
"8664919","[T1G3 bladder tumors: 5 years later]","Pegoraro C, Bondovalli C, Dall'Oglio B, Schiavon L, Luciano M, Parma A.","Arch Ital Urol Androl. 1996 Feb;68(1):35-8.","Pegoraro C","Arch Ital Urol Androl","1996","1996/02/01","","",""
"28502307","[Knock-down of DAB2 interacting protein (DAB2IP) promotes proliferation and inhibits apoptosis of bladder cancer cells]","Zhang K, Wang W, Wu K, Ding C, Zhu J, DU Y, Guan Z, Wang X, Fan J.","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 May;33(5):668-676.","Zhang K","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi","2017","2017/05/16","","",""
"31100242","Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy","Zaffuto E, Bandini M, Moschini M, Leyh-Bannurah SR, Gazdovich S, Dell'Oglio P, Gallina A, Shariat SF, Briganti A, Montorsi F, Saad F, Karakiewicz PI.","Eur Urol Oncol. 2018 Jun;1(2):169-175. doi: 10.1016/j.euo.2018.02.001. Epub 2018 May 15.","Zaffuto E","Eur Urol Oncol","2018","2019/05/18","","","10.1016/j.euo.2018.02.001"
"27511986","Clinical predictors for high-grade bladder cancer before first-time transurethral resection of the bladder tumor: a retrospective cohort study","Wakai K, Utsumi T, Oka R, Endo T, Yano M, Kamijima S, Kamiya N, Hiruta N, Suzuki H.","Jpn J Clin Oncol. 2016 Oct;46(10):964-967. doi: 10.1093/jjco/hyw111. Epub 2016 Aug 10.","Wakai K","Jpn J Clin Oncol","2016","2016/08/12","","","10.1093/jjco/hyw111"
"10223496","Urinary diversion-related outcome in patients with pelvic recurrence after radical cystectomy for bladder cancer","Tefilli MV, Gheiler EL, Tiguert R, Grignon DJ, Forman JD, Pontes JE, Wood DP Jr.","Urology. 1999 May;53(5):999-1004. doi: 10.1016/s0090-4295(98)00623-2.","Tefilli MV","Urology","1999","1999/05/01","","","10.1016/s0090-4295(98)00623-2"
"18774458","Bladder cancer","Dinney CP.","Urol Oncol. 2008 Sep-Oct;26(5):479-80. doi: 10.1016/j.urolonc.2008.03.020.","Dinney CP","Urol Oncol","2008","2008/09/09","","","10.1016/j.urolonc.2008.03.020"
"17410978","[The usefulness of pelvic lymphadenectomy in bladder cancer]","Monzó JI, Herranz Amo F, Cabello Benavente R, Hernández Fernández C.","Actas Urol Esp. 2007 Jan;31(1):1-6. doi: 10.1016/s0210-4806(07)73585-4.","Monzó JI","Actas Urol Esp","2007","2007/04/07","","","10.1016/s0210-4806(07)73585-4"
"24304018","Cytokine gene modification of bladder cancer cells for the establishment of bladder cancer vaccine","Saito S, Tazaki H, Heston WD, Fair WR.","Int J Urol. 1996 Jan;3(1 Suppl):S35-9. doi: 10.1111/j.1442-2042.1996.tb00080.x.","Saito S","Int J Urol","1996","2013/12/06","","","10.1111/j.1442-2042.1996.tb00080.x"
"23774957","Bladder cancer: Elderly and female patients fare the worst and deserve better","Witjes JA.","Nat Rev Urol. 2013 Jul;10(7):371-2. doi: 10.1038/nrurol.2013.130. Epub 2013 Jun 18.","Witjes JA","Nat Rev Urol","2013","2013/06/19","","","10.1038/nrurol.2013.130"
"19997963","Emerging targeted therapies for bladder cancer: a disease waiting for a drug","Dovedi SJ, Davies BR.","Cancer Metastasis Rev. 2009 Dec;28(3-4):355-67. doi: 10.1007/s10555-009-9192-9.","Dovedi SJ","Cancer Metastasis Rev","2009","2009/12/10","","","10.1007/s10555-009-9192-9"
"482963","Familial urinary bladder cancer","Purtilo DT, McCarthy B, Yang JP, Friedell GH.","Semin Oncol. 1979 Jun;6(2):254-6.","Purtilo DT","Semin Oncol","1979","1979/06/01","","",""
"14620278","Impact of primary tumour characteristics on the survival of patients with lymph node metastases in bladder cancer following radical cystectomy","Nabi G, Seth A, Dogra PN, Hemal AK, Gupta NP.","Int Urol Nephrol. 2003;35(1):25-8. doi: 10.1023/a:1025950231749.","Nabi G","Int Urol Nephrol","2003","2003/11/19","","","10.1023/a:1025950231749"
"16415269","Bladder cancer mortality and private well use in New England: an ecological study","Ayotte JD, Baris D, Cantor KP, Colt J, Robinson GR Jr, Lubin JH, Karagas M, Hoover RN, Fraumeni JF Jr, Silverman DT.","J Epidemiol Community Health. 2006 Feb;60(2):168-72. doi: 10.1136/jech.2005.038620.","Ayotte JD","J Epidemiol Community Health","2006","2006/01/18","PMC2566149","","10.1136/jech.2005.038620"
"10443721","Intravesical bacille Calmette-Guérin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up","Hurle R, Losa A, Manzetti A, Lembo A.","Urology. 1999 Aug;54(2):258-63. doi: 10.1016/s0090-4295(99)00116-8.","Hurle R","Urology","1999","1999/08/12","","","10.1016/s0090-4295(99)00116-8"
"7041378","A study on the etiological factors of bilharzial bladder cancer in Egypt. 6. The possible role of urinary bacteria","El-Aaser AA, El-Merzabani MM, Higgy NA, El-Habet AE.","Tumori. 1982 Feb 28;68(1):23-8.","El-Aaser AA","Tumori","1982","1982/02/28","","",""
"24139809","Novel urinary markers for detection of bladder cancer-are we failing?","Klatte T, Shariat SF.","J Urol. 2014 Jan;191(1):9-10. doi: 10.1016/j.juro.2013.10.056. Epub 2013 Oct 16.","Klatte T","J Urol","2014","2013/10/22","","","10.1016/j.juro.2013.10.056"
"25151017","Inflammatory biomarkers and bladder cancer prognosis: a systematic review","Masson-Lecomte A, Rava M, Real FX, Hartmann A, Allory Y, Malats N.","Eur Urol. 2014 Dec;66(6):1078-91. doi: 10.1016/j.eururo.2014.07.033. Epub 2014 Aug 20.","Masson-Lecomte A","Eur Urol","2014","2014/08/25","","","10.1016/j.eururo.2014.07.033"
"2978981","[Oncogenes and oncogene products in urogenital cancer cells]","Deguchi N, Tachibana M, Tazaki H.","Hum Cell. 1988 Mar;1(1):20-4.","Deguchi N","Hum Cell","1988","1988/03/01","","",""
"29169705","Clinical usefulness of random biopsies in diagnosis and treatment of non-muscle invasive bladder cancer: Systematic review and meta-analysis","Subiela JD, Palou J, Esquinas C, Fernández Gómez JM, Rodríguez Faba O.","Actas Urol Esp. 2018 Jun;42(5):285-298. doi: 10.1016/j.acuro.2017.10.001. Epub 2017 Nov 21.","Subiela JD","Actas Urol Esp","2018","2017/11/25","","","10.1016/j.acuro.2017.10.001"
"28580540","Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer","Choe J, Braschi-Amirfarzan M, Tirumani SH, Shinagare AB, Kim KW, Ramaiya NH, Krajewski KM.","Abdom Radiol (NY). 2017 Nov;42(11):2710-2724. doi: 10.1007/s00261-017-1195-3.","Choe J","Abdom Radiol (NY)","2017","2017/06/06","","","10.1007/s00261-017-1195-3"
"15892763","Occupational bladder cancer in New Zealand: a 1-year review of cases notified to the New Zealand Cancer Registry","Dryson E, Walls C, McLean D, Pearce N.","Intern Med J. 2005 Jun;35(6):343-7. doi: 10.1111/j.1445-5994.2005.00834.x.","Dryson E","Intern Med J","2005","2005/05/17","","","10.1111/j.1445-5994.2005.00834.x"
"27461832","Urinary bladder carcinoma with divergent differentiation featuring small cell carcinoma, sarcomatoid carcinoma, and liposarcomatous component","Yasui M, Morikawa T, Nakagawa T, Miyakawa J, Maeda D, Homma Y, Fukayama M.","Pathol Res Pract. 2016 Sep;212(9):833-7. doi: 10.1016/j.prp.2016.04.014. Epub 2016 May 18.","Yasui M","Pathol Res Pract","2016","2016/07/28","","","10.1016/j.prp.2016.04.014"
"4057573","[Multidisciplinary therapy of urogenital cancer]","Matsumura Y.","Gan No Rinsho. 1985 Jul;31(9 Suppl):1165-9.","Matsumura Y","Gan No Rinsho","1985","1985/07/01","","",""
"19326429","BAMBI gene is epigenetically silenced in subset of high-grade bladder cancer","Khin SS, Kitazawa R, Win N, Aye TT, Mori K, Kondo T, Kitazawa S.","Int J Cancer. 2009 Jul 15;125(2):328-38. doi: 10.1002/ijc.24318.","Khin SS","Int J Cancer","2009","2009/03/28","","","10.1002/ijc.24318"
"4070677","Treatment of bladder tumors by iridium 192 implantation. The Créteil technique","Mazeron JJ, Marinello G, Leung S, Le Bourgeois JP, Abbou CC, Auvert J, Pierquin B.","Radiother Oncol. 1985;4(2):111-9. doi: 10.1016/s0167-8140(85)80097-9.","Mazeron JJ","Radiother Oncol","1985","1985/01/01","","","10.1016/s0167-8140(85)80097-9"
"28427860","Differential mTOR pathway profiles in bladder cancer cell line subtypes to predict sensitivity to mTOR inhibition","Hau AM, Nakasaki M, Nakashima K, Krish G, Hansel DE.","Urol Oncol. 2017 Oct;35(10):593-599. doi: 10.1016/j.urolonc.2017.03.025. Epub 2017 Apr 18.","Hau AM","Urol Oncol","2017","2017/04/22","","","10.1016/j.urolonc.2017.03.025"
"27268930","Stage of bladder cancer in Central Europe - Polish perspective","Poletajew S, Biernacki R, Buraczynski P, Chojnacki J, Czarniecki S, Gajewska D, Pohaba T, Sondka J, Skrzypczyk M, Suchojad T, Wojtkowiak D, Zaforemski B, Zapala L, Zemla A, Radziszewski P.","Neoplasma. 2016;63(4):642-7. doi: 10.4149/neo_2016_420.","Poletajew S","Neoplasma","2016","2016/06/09","","","10.4149/neo_2016_420"
"25801242","Association of TP53 gene polymorphisms with susceptibility of bladder cancer in Bangladeshi population","Hosen MB, Salam MA, Islam MF, Hossain A, Hawlader MZ, Kabir Y.","Tumour Biol. 2015 Aug;36(8):6369-74. doi: 10.1007/s13277-015-3324-3. Epub 2015 Mar 25.","Hosen MB","Tumour Biol","2015","2015/03/25","","","10.1007/s13277-015-3324-3"
"20446067","Bladder cancer: can we move beyond chemotherapy?","Siefker-Radtke A.","Curr Oncol Rep. 2010 Jul;12(4):278-83. doi: 10.1007/s11912-010-0104-5.","Siefker-Radtke A","Curr Oncol Rep","2010","2010/05/07","","","10.1007/s11912-010-0104-5"
"25693085","Comparison of pathological staging and grading of urothelial bladder carcinoma in post-transurethral resection and post-radical cystectomy specimens","Poletajew S, Fus Ł, Walędziak M, Pomada P, Ciechańska J, Wasiutyński A, Radziszewski P, Górnicka B.","Pol J Pathol. 2014 Dec;65(4):305-12. doi: 10.5114/pjp.2014.48192.","Poletajew S","Pol J Pathol","2014","2015/02/19","","","10.5114/pjp.2014.48192"
"30463072","Human Epidermal Growth Factor Receptor 2 in Non-Muscle Invasive Bladder Cancer: Issues in Assessment Methods and Its Role as Prognostic/Predictive Marker and Putative Therapeutic Target: A Comprehensive Review","Sanguedolce F, Russo D, Mancini V, Selvaggio O, Calò B, Carrieri G, Cormio L.","Urol Int. 2019;102(3):249-261. doi: 10.1159/000494359. Epub 2018 Nov 21.","Sanguedolce F","Urol Int","2019","2018/11/22","","","10.1159/000494359"
"25891345","Adjunctive use of narrow band imaging during transurethral resection/vaporization of bladder tumors to aid In identifying mucosal and sub-mucosal hypervascularity","Diorio GJ, Canter DJ.","Can J Urol. 2015 Apr;22(2):7763-6.","Diorio GJ","Can J Urol","2015","2015/04/21","","",""
"21563157","Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer","Shang PF, Kwong J, Wang ZP, Tian J, Jiang L, Yang K, Yue ZJ, Tian JQ.","Cochrane Database Syst Rev. 2011 May 11;(5):CD006885. doi: 10.1002/14651858.CD006885.pub2.","Shang PF","Cochrane Database Syst Rev","2011","2011/05/13","","","10.1002/14651858.CD006885.pub2"
"25986790","Re: Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity","Chang SS.","J Urol. 2015 Jun;193(6):1932. doi: 10.1016/j.juro.2015.03.011. Epub 2015 Mar 13.","Chang SS","J Urol","2015","2015/05/20","","","10.1016/j.juro.2015.03.011"
"8203054","Complications in a personal series of one hundred and five radical cystectomies: specific problems in a developing country","Srinivas V, Nagapurkar N, Choudary R, Alvani A, Mehta H, Phadke AG.","Urol Int. 1994;52(3):151-3. doi: 10.1159/000282595.","Srinivas V","Urol Int","1994","1994/01/01","","","10.1159/000282595"
"6435300","T3 bladder cancer: salvage rather than elective cystectomy after radiotherapy","Hope-Stone HF, Oliver RT, England HR, Blandy JP.","Urology. 1984 Oct;24(4):315-20. doi: 10.1016/0090-4295(84)90199-7.","Hope-Stone HF","Urology","1984","1984/10/01","","","10.1016/0090-4295(84)90199-7"
"29778583","A novel view on the pathogenesis of complications after intravesical BCG for bladder cancer","Bilsen MP, van Meijgaarden KE, de Jong HK, Joosten SA, Prins C, Kroft LJM, Jonker JT, Crobach S, Pelger RC, Ottenhoff THM, Arend SM.","Int J Infect Dis. 2018 Jul;72:63-68. doi: 10.1016/j.ijid.2018.05.006. Epub 2018 May 17.","Bilsen MP","Int J Infect Dis","2018","2018/05/21","","","10.1016/j.ijid.2018.05.006"
"367594","Chemotherapy and genitourinary oncology. I. Bladder cancer","Carter SK.","Cancer Treat Rev. 1978 Jun;5(2):85-93. doi: 10.1016/s0305-7372(78)80008-5.","Carter SK","Cancer Treat Rev","1978","1978/06/01","","","10.1016/s0305-7372(78)80008-5"
"19441882","Hexylaminolevulinate photodynamic diagnosis for multifocal recurrent nonmuscle invasive bladder cancer","Ray ER, Chatterton K, Thomas K, Khan MS, Chandra A, O'Brien TS.","J Endourol. 2009 Jun;23(6):983-8. doi: 10.1089/end.2008.0642.","Ray ER","J Endourol","2009","2009/05/16","","","10.1089/end.2008.0642"
"15538218","Health related quality of life assessments for patients with bladder cancer","Parkinson JP, Konety BR.","J Urol. 2004 Dec;172(6 Pt 1):2130-6. doi: 10.1097/01.ju.0000139445.49500.24.","Parkinson JP","J Urol","2004","2004/11/13","","","10.1097/01.ju.0000139445.49500.24"
"6708220","Vitamin B12 deficiency after irradiation for bladder carcinoma","Kinn AC, Lantz B.","J Urol. 1984 May;131(5):888-90. doi: 10.1016/s0022-5347(17)50695-3.","Kinn AC","J Urol","1984","1984/05/01","","","10.1016/s0022-5347(17)50695-3"
"17904669","Fiducial markers in external beam radiotherapy for bladder cancer","Lalondrelle S, Thompson A, Khoo V.","Radiother Oncol. 2007 Nov;85(2):324. doi: 10.1016/j.radonc.2007.08.011. Epub 2007 Sep 29.","Lalondrelle S","Radiother Oncol","2007","2007/10/02","","","10.1016/j.radonc.2007.08.011"
"589345","Chemotherapy in bladder cancer","","Br Med J. 1977 Dec 17;2(6102):1562-3.","","Br Med J","1977","1977/12/17","PMC1632694","",""
"20250699","[Early diagnosis of bladder cancer]","BOURQUE JP.","Union Med Can. 1947 Jan;76(1):58-60.","BOURQUE JP","Union Med Can","1947","2010/03/19","","",""
"10719370","Genetic modeling of human urinary bladder carcinogenesis","Czerniak B, Li L, Chaturvedi V, Ro JY, Johnston DA, Hodges S, Benedict WF.","Genes Chromosomes Cancer. 2000 Apr;27(4):392-402.","Czerniak B","Genes Chromosomes Cancer","2000","2000/03/17","","",""
"9820833","Safe drinking water: a public health challenge","Wigle DT.","Chronic Dis Can. 1998;19(3):103-7.","Wigle DT","Chronic Dis Can","1998","1998/11/20","","",""
"11806441","Advanced bladder cancer in a young female: a case report","Masuda A, Minakmi S, Usui Y, Arihara K, Nagata Y, Kawamura N.","Tokai J Exp Clin Med. 2001 Jul;26(2):39-43.","Masuda A","Tokai J Exp Clin Med","2001","2002/01/25","","",""
"2714314","Immunoprophylaxis with Calmette-Guérin bacillus in recurrent superficial bladder tumors","Llopis B, Vera-Donoso CD, Gallego J, Boronat F, Jiménez-Cruz JF.","Eur Urol. 1989;16(1):28-30. doi: 10.1159/000471524.","Llopis B","Eur Urol","1989","1989/01/01","","","10.1159/000471524"
"32622992","N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: An updated meta-analysis based on 54 case-control studies","Song Y, Qi X, Liu X.","Gene. 2020 Oct 5;757:144924. doi: 10.1016/j.gene.2020.144924. Epub 2020 Jul 2.","Song Y","Gene","2020","2020/07/06","","","10.1016/j.gene.2020.144924"
"23139773","The association of RAS association domain family Protein1A (RASSF1A) methylation states and bladder cancer risk: a systematic review and meta-analysis","Gao T, Wang S, He B, Pan Y, Song G, Gu L, Chen L, Nie Z, Xu Y, Li R.","PLoS One. 2012;7(11):e48300. doi: 10.1371/journal.pone.0048300. Epub 2012 Nov 6.","Gao T","PLoS One","2012","2012/11/10","PMC3491061","","10.1371/journal.pone.0048300"
"10604318","Urothelial cancer--mucosally confined disease can be aggressive","Droller MJ.","J Urol. 2000 Jan;163(1):79-80.","Droller MJ","J Urol","2000","1999/12/22","","",""
"6698083","The value of histologic grading and staging, random biopsies, tumor and bladder mucosa blood group antigens, in predicting progression of superficial bladder cancer","Huland H, Klöppel G, Otto U, Droese M.","Eur Urol. 1984;10(1):28-31. doi: 10.1159/000463506.","Huland H","Eur Urol","1984","1984/01/01","","","10.1159/000463506"
"1370606","Radiotherapy as a treatment for bladder cancer","Costello AJ, Bowsher WG.","Aust N Z J Surg. 1992 Jan;62(1):81-2; discussion 82-3. doi: 10.1111/j.1445-2197.1992.tb05361.x.","Costello AJ","Aust N Z J Surg","1992","1992/01/01","","","10.1111/j.1445-2197.1992.tb05361.x"
"25323612","An Extended Time Frame for VTE Risk in Bladder Cancer","Raj GV, Araghizadeh F.","Oncology (Williston Park). 2014 Oct;28(10):861-2.","Raj GV","Oncology (Williston Park)","2014","2014/10/18","","",""
"671604","Nitrosamine formation in bladder infections and its role in the etiology of bladder cancer","Radomski JL, Greenwald D, Hearn WL, Block NL, Woods FM.","J Urol. 1978 Jul;120(1):48-50. doi: 10.1016/s0022-5347(17)57035-4.","Radomski JL","J Urol","1978","1978/07/01","","","10.1016/s0022-5347(17)57035-4"
"3589522","Pre-cystectomy chemotherapy in patients with muscle infiltrating bladder carcinoma. A multicentre feasibility study","Fosså SD, Dingsør E, Johannessen NB, Kvarstein B, Stenwig AE, Urnes T, Waehre H, Ogreid P.","Scand J Urol Nephrol. 1987;21(1):39-42. doi: 10.3109/00365598709180288.","Fosså SD","Scand J Urol Nephrol","1987","1987/01/01","","","10.3109/00365598709180288"
"28592119","Tea Polyphenol inhibits autophagy to sensitize Epirubicin-induced apoptosis in human bladder cancer cells","Gu W, Lin Y, Gou X, He W.","Neoplasma. 2017;64(5):674-680. doi: 10.4149/neo_2017_504.","Gu W","Neoplasma","2017","2017/06/09","","","10.4149/neo_2017_504"
"11101095","Organ preservation by external beam and afterloading interstitial radiation in patients with muscle infiltrating bladder cancer","Wijnmaalen A, Boeken Kruger CC.","Semin Urol Oncol. 2000 Nov;18(4):308-12.","Wijnmaalen A","Semin Urol Oncol","2000","2000/12/02","","",""
"16697781","Bladder cancer: in search of the right operation for the right patient","Fisher HA.","J Urol. 2006 Jun;175(6):1987-8. doi: 10.1016/j.juro.2006.03.012.","Fisher HA","J Urol","2006","2006/05/16","","","10.1016/j.juro.2006.03.012"
"31849465","Tunneling Nanotubes Mediated microRNA-155 Intercellular Transportation Promotes Bladder Cancer Cells' Invasive and Proliferative Capacity","Lu JJ, Yang WM, Li F, Zhu W, Chen Z.","Int J Nanomedicine. 2019 Dec 10;14:9731-9743. doi: 10.2147/IJN.S217277. eCollection 2019.","Lu JJ","Int J Nanomedicine","2019","2019/12/19","PMC6911338","","10.2147/IJN.S217277"
"4446204","Urokinase inhibitor in patients with bladder cancer","Hisazumi H, Naito K, Misaki T, Kosaka S.","Urol Res. 1974 Dec 20;2(3):137-42. doi: 10.1007/BF00254731.","Hisazumi H","Urol Res","1974","1974/12/20","","","10.1007/BF00254731"
"27803966","Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer","Sui W, Matulay JT, Onyeji IC, Theofanides MC, James MB, RoyChoudhury A, Wenske S, DeCastro GJ.","World J Urol. 2017 Jul;35(7):1055-1061. doi: 10.1007/s00345-016-1962-8. Epub 2016 Nov 1.","Sui W","World J Urol","2017","2016/11/03","","","10.1007/s00345-016-1962-8"
"16710680","[Effect mechanism of intravesical BCG immunotherapy of superficial bladder cancer]","Böhle A, Suttmann H, Brandau S.","Urologe A. 2006 May;45(5):629-33, 635-6. doi: 10.1007/s00120-006-1059-x.","Böhle A","Urologe A","2006","2006/05/20","","","10.1007/s00120-006-1059-x"
"18810651","Quantitative risk stratification and individual comprehensive therapy for invasive bladder cancers in China","Niu HT, Shao SX, Zhang ZL, Wu S, Cheng B, Pang de Q, E YJ, Dong SG, Sun G, Chang JW.","Int Urol Nephrol. 2009;41(3):571-7. doi: 10.1007/s11255-008-9470-4. Epub 2008 Sep 23.","Niu HT","Int Urol Nephrol","2009","2008/09/24","","","10.1007/s11255-008-9470-4"
"3230746","[Improvement of the determination of urinary tissue polypeptide antigen (TPA) and the clinical study in bladder cancer patients]","Morimoto S, Yoshida M, Yasukawa S, Uekado Y, Yoshida T, Aoshi H, Ebisuno S, Ohkawa T.","Nihon Hinyokika Gakkai Zasshi. 1988 Dec;79(12):1954-61. doi: 10.5980/jpnjurol1928.79.12_1954.","Morimoto S","Nihon Hinyokika Gakkai Zasshi","1988","1988/12/01","","","10.5980/jpnjurol1928.79.12_1954"
"29066649","Urothelial carcinoma in an orthotopic neobladder: an unusual pattern of recurrence and metastasis","Groen VH, Lock TMTWT, Keizer B, Horenblas S, Meijer RP.","BMJ Case Rep. 2017 Oct 24;2017:bcr2017221052. doi: 10.1136/bcr-2017-221052.","Groen VH","BMJ Case Rep","2017","2017/10/26","PMC5665183","","10.1136/bcr-2017-221052"
"29558755","Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder","Erdem GU, Dogan M, Sakin A, Oruc Z, Yaman E, Yesil Cinkir H, Uysal M, Bozkurt O, Ozturk B, Aytekin A, Ozcelik M, Bahceci A, Cakiroglu U, Turhal S, Sahin S, Uncu D, Zengin N.","Oncol Res Treat. 2018;41(4):220-225. doi: 10.1159/000486598. Epub 2018 Mar 21.","Erdem GU","Oncol Res Treat","2018","2018/03/21","","","10.1159/000486598"
"29422113","Puerarin Inhibits Proliferation and Induces Apoptosis by Upregulation of miR-16 in Bladder Cancer Cell Line T24","Liu X, Li S, Li Y, Cheng B, Tan B, Wang G.","Oncol Res. 2018 Sep 14;26(8):1227-1234. doi: 10.3727/096504018X15178736525106. Epub 2018 Feb 8.","Liu X","Oncol Res","2018","2018/02/10","","","10.3727/096504018X15178736525106"
"18661419","The normal tissue sparing potential of adaptive strategies in radiotherapy of bladder cancer","Wright P, Redpath AT, Høyer M, Grau C, Muren LP.","Acta Oncol. 2008;47(7):1382-9. doi: 10.1080/02841860802266763.","Wright P","Acta Oncol","2008","2008/07/29","","","10.1080/02841860802266763"
"21081471","Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study","Gago-Dominguez M, Jiang X, Conti DV, Castelao JE, Stern MC, Cortessis VK, Pike MC, Xiang YB, Gao YT, Yuan JM, Van Den Berg DJ.","Carcinogenesis. 2011 Feb;32(2):197-202. doi: 10.1093/carcin/bgq233. Epub 2010 Nov 15.","Gago-Dominguez M","Carcinogenesis","2011","2010/11/18","PMC3026841","","10.1093/carcin/bgq233"
"25731395","[Synchronous male bladder cancer and breast cancer - a case report]","Yabe N, Murai S, Kunugi C, Nakadai J, Oto I, Yoshikawa T, Kitasato K, Shimizu H, Nakamura A, Masuda A, Miyazaki Y, Ohashi M, Jinno H, Kitagawa Y.","Gan To Kagaku Ryoho. 2014 Nov;41(12):1978-80.","Yabe N","Gan To Kagaku Ryoho","2014","2015/03/04","","",""
"12160910","Alcohol drinking and bladder cancer","Pelucchi C, Negri E, Franceschi S, Talamini R, La Vecchia C.","J Clin Epidemiol. 2002 Jul;55(7):637-41. doi: 10.1016/s0895-4356(02)00397-9.","Pelucchi C","J Clin Epidemiol","2002","2002/08/06","","","10.1016/s0895-4356(02)00397-9"
"5766509","The roentgenographic assessment of bladder tumors. A comparison of the diagnostic accuracy of roentgenographic techniques","Lang EK.","Cancer. 1969 Mar;23(3):717-24. doi: 10.1002/1097-0142(196903)23:3<717::aid-cncr2820230327>3.0.co;2-w.","Lang EK","Cancer","1969","1969/03/01","","","10.1002/1097-0142(196903)23:3<717::aid-cncr2820230327>3.0.co;2-w"
"31757295","Salvage Therapy for Non-muscle-invasive Bladder Cancer: Novel Intravesical Agents","Khaled D, Taylor J, Holzbeierlein J.","Urol Clin North Am. 2020 Feb;47(1):119-128. doi: 10.1016/j.ucl.2019.09.014.","Khaled D","Urol Clin North Am","2020","2019/11/24","","","10.1016/j.ucl.2019.09.014"
"14624933","Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer","Vasala K, Pääkkö P, Turpeenniemi-Hujanen T.","Urology. 2003 Nov;62(5):952-7. doi: 10.1016/s0090-4295(03)00660-5.","Vasala K","Urology","2003","2003/11/20","","","10.1016/s0090-4295(03)00660-5"
"1827328","Optimal management of superficial bladder cancer","Witjes JA, Debruyne FM.","Eur J Cancer. 1991;27(3):330-3. doi: 10.1016/0277-5379(91)90541-k.","Witjes JA","Eur J Cancer","1991","1991/01/01","","","10.1016/0277-5379(91)90541-k"
"2239600","[Granulomatous prostatitis after intravesical BCG immunotherapy of superficial bladder cancer: a case report]","Sai S, Sakakibara T, Takashi M, Sakata T, Miyake K.","Hinyokika Kiyo. 1990 Aug;36(8):953-5.","Sai S","Hinyokika Kiyo","1990","1990/08/01","","",""
"20810543","Sulforaphane inhibits 4-aminobiphenyl-induced DNA damage in bladder cells and tissues","Ding Y, Paonessa JD, Randall KL, Argoti D, Chen L, Vouros P, Zhang Y.","Carcinogenesis. 2010 Nov;31(11):1999-2003. doi: 10.1093/carcin/bgq183. Epub 2010 Sep 1.","Ding Y","Carcinogenesis","2010","2010/09/03","PMC2966557","","10.1093/carcin/bgq183"
"3181243","Therapeutic options for patients with invasive bladder cancer: the Stanford experience","Freiha FS.","Eur Urol. 1988;14 Suppl 1:43. doi: 10.1159/000473042.","Freiha FS","Eur Urol","1988","1988/01/01","","","10.1159/000473042"
"24857102","The geriatrics and genetics behind bladder cancer","Milowsky MI, Kim WY.","Am Soc Clin Oncol Educ Book. 2014:e192-5. doi: 10.14694/EdBook_AM.2014.34.e192.","Milowsky MI","Am Soc Clin Oncol Educ Book","2014","2014/05/27","","","10.14694/EdBook_AM.2014.34.e192"
"25569706","Antiangiogenesis as the novel mechanism for justicidin A in the anticancer effect on human bladder cancer","Wang YW, Chuang JJ, Chang TY, Won SJ, Tsai HW, Lee CT, Cheng HL, Tzai TS, Liu HS, Chow NH.","Anticancer Drugs. 2015 Apr;26(4):428-36. doi: 10.1097/CAD.0000000000000203.","Wang YW","Anticancer Drugs","2015","2015/01/09","","","10.1097/CAD.0000000000000203"
"16019767","T1 G1 urinary bladder carcinoma: fact or fiction?","Mikulowski P, Hellsten S.","Scand J Urol Nephrol. 2005;39(2):135-7. doi: 10.1080/00365590510031219.","Mikulowski P","Scand J Urol Nephrol","2005","2005/07/16","","","10.1080/00365590510031219"
"22156293","Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis","Li D, Liu H, Yan L, Tang Y, Ren J, Xu Z.","Urol Int. 2012;88(1):88-94. doi: 10.1159/000331931. Epub 2011 Dec 9.","Li D","Urol Int","2012","2011/12/14","","","10.1159/000331931"
"28752351","The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis","Tang X, Du P, Yang Y.","Int J Clin Oncol. 2017 Oct;22(5):817-825. doi: 10.1007/s10147-017-1171-5. Epub 2017 Jul 27.","Tang X","Int J Clin Oncol","2017","2017/07/29","","","10.1007/s10147-017-1171-5"
"28881475","The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy","Welty CJ, Sanford TH, Wright JL, Carroll PR, Cooperberg MR, Meng MV, Porten SP.","Cancer. 2017 Dec 1;123(23):4574-4582. doi: 10.1002/cncr.30918. Epub 2017 Sep 7.","Welty CJ","Cancer","2017","2017/09/08","","","10.1002/cncr.30918"
"18934332","[Total cystectomy for bladder cancer]","DUFOUR.","Brux Med. 1948 Aug 1;28(31):1604.","DUFOUR","Brux Med","1948","1948/08/01","","",""
"21054080","High-magnification vascular imaging to reject false-positive sites in situ during Hexvix® fluorescence cystoscopy","Lovisa B, Jichlinski P, Weber BC, Aymon D, van den Bergh H, Wagnières G.","J Biomed Opt. 2010 Sep-Oct;15(5):051606. doi: 10.1117/1.3484257.","Lovisa B","J Biomed Opt","2010","2010/11/09","","","10.1117/1.3484257"
"30105454","Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer","Fernández MI, Brausi M, Clark PE, Cookson MS, Grossman HB, Khochikar M, Kiemeney LA, Malavaud B, Sanchez-Salas R, Soloway MS, Svatek RS, Vikram R, Vrieling A, Kamat AM.","World J Urol. 2019 Jan;37(1):3-13. doi: 10.1007/s00345-018-2436-y. Epub 2018 Aug 13.","Fernández MI","World J Urol","2019","2018/08/15","","","10.1007/s00345-018-2436-y"
"8477315","Multivariate analysis of progression in superficial bladder cancer","Sánchez de la Muela P, Rosell D, Agüera L, De Castro F, Isa W, Robles JE, Zudaire JJ, Berián JM.","Br J Urol. 1993 Mar;71(3):284-9. doi: 10.1111/j.1464-410x.1993.tb15944.x.","Sánchez de la Muela P","Br J Urol","1993","1993/03/01","","","10.1111/j.1464-410x.1993.tb15944.x"
"25800468","Diagnostic accuracy of intraoperative frozen sections during radical cystectomy does not affect disease-free or overall survival: a study of 364 patients with urothelial carcinoma of the urinary bladder","Reder NP, Maxwell SP, Pambuccian SE, Barkan GA.","Ann Diagn Pathol. 2015 Jun;19(3):107-12. doi: 10.1016/j.anndiagpath.2015.02.005. Epub 2015 Mar 5.","Reder NP","Ann Diagn Pathol","2015","2015/03/25","","","10.1016/j.anndiagpath.2015.02.005"
"10457915","Human bladder cancer: epidemiological, pathological and mechanistic aspects","La Vecchia C, Airoldi L.","IARC Sci Publ. 1999;(147):139-57.","La Vecchia C","IARC Sci Publ","1999","1999/08/24","","",""
"8377508","Second primary bladder cancer following pelvic irradiation for other malignancies","Ravi R.","J Surg Oncol. 1993 Sep;54(1):60-3. doi: 10.1002/jso.2930540116.","Ravi R","J Surg Oncol","1993","1993/09/01","","","10.1002/jso.2930540116"
"25748177","Synergy of Histone-Deacetylase Inhibitor AR-42 with Cisplatin in Bladder Cancer","Li DR, Zhang H, Peek E, Wang S, Du L, Li G, Chin AI.","J Urol. 2015 Aug;194(2):547-55. doi: 10.1016/j.juro.2015.02.2918. Epub 2015 Mar 3.","Li DR","J Urol","2015","2015/03/10","PMC6371809","NIHMS1010101","10.1016/j.juro.2015.02.2918"
"22633802","Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer","Bertz S, Otto W, Denzinger S, Wieland WF, Burger M, Stöhr R, Link S, Hofstädter F, Hartmann A.","Eur Urol. 2014 Jan;65(1):218-26. doi: 10.1016/j.eururo.2012.05.033. Epub 2012 May 19.","Bertz S","Eur Urol","2014","2012/05/29","","","10.1016/j.eururo.2012.05.033"
"27560554","Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective: results from a prospective intervention study","Liedberg F, Gerdtham U, Gralén K, Gudjonsson S, Jahnson S, Johansson I, Hagberg O, Larsson S, Lind AK, Löfgren A, Wanegård J, Åberg H, Nilbert M.","Br J Cancer. 2016 Sep 27;115(7):770-5. doi: 10.1038/bjc.2016.265. Epub 2016 Aug 25.","Liedberg F","Br J Cancer","2016","2016/08/26","PMC5046212","","10.1038/bjc.2016.265"
"20083267","Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry","Ploeg M, Aben KK, Hulsbergen-van de Kaa CA, Schoenberg MP, Witjes JA, Kiemeney LA.","J Urol. 2010 Mar;183(3):915-20. doi: 10.1016/j.juro.2009.11.018. Epub 2010 Jan 18.","Ploeg M","J Urol","2010","2010/01/20","","","10.1016/j.juro.2009.11.018"
"25391391","Immunological basis in the pathogenesis and treatment of bladder cancer","Thompson DB, Siref LE, Feloney MP, Hauke RJ, Agrawal DK.","Expert Rev Clin Immunol. 2015 Feb;11(2):265-79. doi: 10.1586/1744666X.2015.983082. Epub 2014 Nov 13.","Thompson DB","Expert Rev Clin Immunol","2015","2014/11/14","PMC4637163","NIHMS732932","10.1586/1744666X.2015.983082"
"26144336","FGFR3 Down-Regulation is Involved in bacillus Calmette-Guérin Induced Bladder Tumor Growth Inhibition","Langle YV, Belgorosky D, Prack McCormick B, Sahores A, Góngora A, Baldi A, Lanari C, Lamb C, Eiján AM.","J Urol. 2016 Jan;195(1):188-97. doi: 10.1016/j.juro.2015.06.093. Epub 2015 Jul 2.","Langle YV","J Urol","2016","2015/07/07","","","10.1016/j.juro.2015.06.093"
"31067166","Re: Characterization of Late Recurrence after Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients","Chang SS.","J Urol. 2019 Aug;202(2):209. doi: 10.1097/01.JU.0000559622.28283.85. Epub 2019 Jul 8.","Chang SS","J Urol","2019","2019/05/09","","","10.1097/01.JU.0000559622.28283.85"
"12808860","An evaluation of a nurse-led cystoscopy surveillance service","Taylor J.","Prof Nurse. 2003 Jun;18(10):580-3.","Taylor J","Prof Nurse","2003","2003/06/18","","",""
"2218575","Endpoints of clinical trials in invasive bladder cancer","Tannock IF.","Semin Oncol. 1990 Oct;17(5):619-27.","Tannock IF","Semin Oncol","1990","1990/10/01","","",""
"23819923","Human β-defensin 2 may inhibit internalisation of bacillus Calmette-Guérin (BCG) in bladder cancer cells","Kim JH, Kim SJ, Lee KM, Chang IH.","BJU Int. 2013 Oct;112(6):781-90. doi: 10.1111/bju.12196. Epub 2013 Jul 2.","Kim JH","BJU Int","2013","2013/07/04","","","10.1111/bju.12196"
"30421598","Bacillus Calmette-Guérin unresponsiveness in non-muscle-invasive bladder cancer patients: what the urologists should know","Moschini M, Zamboni S, Mattei A, Amparore D, Fiori C, De Dominicis C, Esperto F; European Association of Urology - European Society of Resident Urologists (EAU-ESRU).","Minerva Urol Nefrol. 2019 Feb;71(1):17-30. doi: 10.23736/S0393-2249.18.03309-X. Epub 2018 Nov 7.","Moschini M","Minerva Urol Nefrol","2019","2018/11/14","","","10.23736/S0393-2249.18.03309-X"
"4465158","Rapid and selective induction of urinary bladder cancer in rats with N-ethyl-N-(4-hydroxybutyl)nitrosoamine and by its principal urinary metabolite","Hashimoto Y, Iiyoshi M, Okada M.","Gan. 1974 Dec;65(6):565-6.","Hashimoto Y","Gan","1974","1974/12/01","","",""
"20828379","17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells","Karkoulis PK, Stravopodis DJ, Margaritis LH, Voutsinas GE.","BMC Cancer. 2010 Sep 9;10:481. doi: 10.1186/1471-2407-10-481.","Karkoulis PK","BMC Cancer","2010","2010/09/11","PMC2944179","","10.1186/1471-2407-10-481"
"20943643","New agents for bladder cancer","Bellmunt J, Guix M.","Ann Oncol. 2010 Oct;21 Suppl 7:vii56-8. doi: 10.1093/annonc/mdq367.","Bellmunt J","Ann Oncol","2010","2010/10/15","","","10.1093/annonc/mdq367"
"6349744","Adjuvant chemotherapy with doxorubicin (Adriamycin) and 5-fluorouracil in T3, NX, MO bladder cancer treated with radiotherapy","Richards B, Bastable JR, Freedman L, Glashan RW, Harris G, Newling DW, Robinson MR, Smith PH.","Br J Urol. 1983 Aug;55(4):386-91. doi: 10.1111/j.1464-410x.1983.tb03328.x.","Richards B","Br J Urol","1983","1983/08/01","","","10.1111/j.1464-410x.1983.tb03328.x"
"1732596","Intravesical instillations of 4-epi-doxorubicin (epirubicin) in the prophylactic treatment of superficial bladder cancer: results of a controlled prospective study","Melekos MD, Dauaher H, Fokaefs E, Barbalias G.","J Urol. 1992 Feb;147(2):371-5. doi: 10.1016/s0022-5347(17)37240-3.","Melekos MD","J Urol","1992","1992/02/01","","","10.1016/s0022-5347(17)37240-3"
"31180522","(‑)‑Epigallocatechin‑3‑gallate inhibits bladder cancer stem cells via suppression of sonic hedgehog pathway","Sun X, Song J, Li E, Geng H, Li Y, Yu D, Zhong C.","Oncol Rep. 2019 Jul;42(1):425-435. doi: 10.3892/or.2019.7170. Epub 2019 May 24.","Sun X","Oncol Rep","2019","2019/06/11","","","10.3892/or.2019.7170"
"1212396","Proceedings: Industrial bladder cancer--then and now","Parkes HG.","Br J Cancer. 1975 Aug;32(2):257-8. doi: 10.1038/bjc.1975.204.","Parkes HG","Br J Cancer","1975","1975/08/01","PMC2024895","","10.1038/bjc.1975.204"
"20062070","Bladder cancer: meta-analysis of BCG versus mitomycin C--a deeper insight?","Böhle A.","Nat Rev Urol. 2010 Jan;7(1):8-10. doi: 10.1038/nrurol.2009.253.","Böhle A","Nat Rev Urol","2010","2010/01/12","","","10.1038/nrurol.2009.253"
"9049656","Locoregional IL-2 immunotherapy of bladder cancer","Santoni A, Velotti F, Giuffrida A, Santoni G, Piccoli M.","Immunopharmacol Immunotoxicol. 1997 Feb;19(1):1-13. doi: 10.3109/08923979709038530.","Santoni A","Immunopharmacol Immunotoxicol","1997","1997/02/01","","","10.3109/08923979709038530"
"3930081","[Intra-cavity thermo-chemotherapy of bladder cancer: clinical use and nursing care]","Yang HP, Gao YJ.","Zhonghua Hu Li Za Zhi. 1985 Aug;20(4):207-8.","Yang HP","Zhonghua Hu Li Za Zhi","1985","1985/08/01","","",""
"15091293","Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation","Lamm SH, Engel A, Kruse MB, Feinleib M, Byrd DM, Lai S, Wilson R.","J Occup Environ Med. 2004 Mar;46(3):298-306. doi: 10.1097/01.jom.0000116801.67556.8f.","Lamm SH","J Occup Environ Med","2004","2004/04/20","","","10.1097/01.jom.0000116801.67556.8f"
"18514770","Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma","Gkialas I, Papadopoulos G, Iordanidou L, Stathouros G, Tzavara C, Gregorakis A, Lykourinas M.","Urology. 2008 Nov;72(5):1159-63. doi: 10.1016/j.urology.2008.04.009. Epub 2008 Jun 2.","Gkialas I","Urology","2008","2008/06/03","","","10.1016/j.urology.2008.04.009"
"3772536","Screening workers exposed to suspect bladder carcinogens","Cartwright RA.","J Occup Med. 1986 Oct;28(10):1017-9. doi: 10.1097/00043764-198610000-00023.","Cartwright RA","J Occup Med","1986","1986/10/01","","","10.1097/00043764-198610000-00023"
"15281322","Radiotherapy and chemotherapy for invasive bladder cancer","Javle M, Raghavan D.","Cancer Surv. 1998;31:149-60.","Javle M","Cancer Surv","1998","2004/07/30","","",""
"25754262","Biodistribution of Evans blue in an orthotopic AY-27 rat bladder urothelial cell carcinoma model: implication for the improved diagnosis of non-muscle-invasive bladder cancer (NMIBC) using dye-guided white-light cystoscopy","Elsen S, Lerut E, Van Cleynenbreugel B, van der Aa F, van Poppel H, de Witte PA.","BJU Int. 2015 Sep;116(3):468-77. doi: 10.1111/bju.13113. Epub 2015 Apr 30.","Elsen S","BJU Int","2015","2015/03/11","","","10.1111/bju.13113"
"28193625","Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics","Sin MLY, Mach KE, Sinha R, Wu F, Trivedi DR, Altobelli E, Jensen KC, Sahoo D, Lu Y, Liao JC.","Clin Cancer Res. 2017 Jul 15;23(14):3700-3710. doi: 10.1158/1078-0432.CCR-16-2610. Epub 2017 Feb 13.","Sin MLY","Clin Cancer Res","2017","2017/02/15","PMC5873297","NIHMS852351","10.1158/1078-0432.CCR-16-2610"
"29595036","Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population","Li Z, Niu Y.","Minerva Urol Nefrol. 2019 Apr;71(2):161-167. doi: 10.23736/S0393-2249.18.03004-7. Epub 2018 Mar 28.","Li Z","Minerva Urol Nefrol","2019","2018/03/30","","","10.23736/S0393-2249.18.03004-7"
"28920525","Can urologists accurately stage and grade urothelial bladder cancer by assessing endoscopic photographs?","Dekalo S, Matzkin H, Mabjeesh NJ.","J Telemed Telecare. 2018 Oct;24(9):603-607. doi: 10.1177/1357633X17727773. Epub 2017 Sep 18.","Dekalo S","J Telemed Telecare","2018","2017/09/19","","","10.1177/1357633X17727773"
"3181233","Human bladder cancer grown as xenografts and in tissue culture as models of the biology and treatment of invasive bladder cancer","Russell PJ, Brown J, Russell P, Wass J, Carrington N, Raghavan D.","Eur Urol. 1988;14 Suppl 1:15-6. doi: 10.1159/000473031.","Russell PJ","Eur Urol","1988","1988/01/01","","","10.1159/000473031"
"15756068","Bladder carcinoma during pregnancy","Spahn M, Bader P, Westermann D, Echtle D, Frohneberg D.","Urol Int. 2005;74(2):153-9. doi: 10.1159/000083287.","Spahn M","Urol Int","2005","2005/03/10","","","10.1159/000083287"
"872122","Histopathological evaluation of the inhibition of rat bladder carcinogenesis by 13-cis-retinoic acid","Squire RA, Sporn MB, Brown CC, Smith JM, Wenk ML, Springer S.","Cancer Res. 1977 Aug;37(8 Pt 2):2930-6.","Squire RA","Cancer Res","1977","1977/08/01","","",""
"24447105","Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancer","Kramer MW, Abdelkawi IF, Wolters M, Bach T, Gross AJ, Nagele U, Conort P, Merseburger AS, Kuczyk MA, Herrmann TR.","Minim Invasive Ther Allied Technol. 2014 Aug;23(4):206-13. doi: 10.3109/13645706.2014.880065. Epub 2014 Jan 21.","Kramer MW","Minim Invasive Ther Allied Technol","2014","2014/01/23","","","10.3109/13645706.2014.880065"
"2367625","[Prostatic and bladder cancer--desiderata of the urologist as regards diagnostic imaging]","Schnorr D.","Radiol Diagn (Berl). 1990;31(3):193-7.","Schnorr D","Radiol Diagn (Berl)","1990","1990/01/01","","",""
"16042726","An office-based immunodiagnostic assay for detecting urinary nuclear matrix protein 52 in patients with bladder cancer","Attallah AM, Sakr HA, Ismail H, Abdel-Hady el-SK, El-Dosoky I.","BJU Int. 2005 Aug;96(3):334-9. doi: 10.1111/j.1464-410X.2005.05627.x.","Attallah AM","BJU Int","2005","2005/07/27","","","10.1111/j.1464-410X.2005.05627.x"
"23949293","Human papillomavirus detection in Moroccan patients with bladder cancer","Berrada N, Al-Bouzidi A, Ameur A, Abbar M, El-Mzibri M, Ameziane-El-Hassani R, Benbacer L, Khyatti M, Qmichou Z, Amzazi S, Attaleb M.","J Infect Dev Ctries. 2013 Aug 15;7(8):586-92. doi: 10.3855/jidc.3068.","Berrada N","J Infect Dev Ctries","2013","2013/08/17","","","10.3855/jidc.3068"
"12536940","[AFU recommendations 1998. ""Committee on Cancer of the French Association of Urology""]","Rischmann P, Bittard H, Chopin D, Coloby P, Davin JL, Irani J, Lebret T, Lefrère MA, Maidenberg M, Marechal JM, Pariente JL, Theodore C; Committee on Cancer of the French Association of Urology.","Prog Urol. 2002 Nov;12(5):1159-60.","Rischmann P","Prog Urol","2002","2003/01/23","","",""
"3709583","Treatment of T2/T3 bladder carcinoma: total cystectomy with and without preoperative irradiation","Fosså SD, Ous S, Tveter K, Otnes B, Igesund A, Dingsør E, Aunan O, Taksdahl S, Scott-Knudsen O, Lund E.","Eur Urol. 1986;12(3):158-63.","Fosså SD","Eur Urol","1986","1986/01/01","","",""
"26462022","Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus","Zhang T, Wu K, Ding C, Sun K, Guan Z, Wang X, Hsieh JT, He D, Fan J.","Oncotarget. 2015 Nov 10;6(35):37782-91. doi: 10.18632/oncotarget.5622.","Zhang T","Oncotarget","2015","2015/10/14","PMC4741965","","10.18632/oncotarget.5622"
"8018570","Radical treatment for primary bladder cancer: where are we and where do we go from here? A review","Duchesne GM.","Clin Oncol (R Coll Radiol). 1994;6(2):121-6. doi: 10.1016/s0936-6555(05)80115-3.","Duchesne GM","Clin Oncol (R Coll Radiol)","1994","1994/01/01","","","10.1016/s0936-6555(05)80115-3"
"25323611","Venous thromboembolism and bleeding risk in bladder cancer","Thomas AZ, Kamat AM.","Oncology (Williston Park). 2014 Oct;28(10):854-5, 861.","Thomas AZ","Oncology (Williston Park)","2014","2014/10/18","","",""
"19913828","Are biomarkers for bladder cancer beneficial?","Grossman HB.","J Urol. 2010 Jan;183(1):11-2. doi: 10.1016/j.juro.2009.10.052.","Grossman HB","J Urol","2010","2009/11/17","","","10.1016/j.juro.2009.10.052"
"11203076","Markers for recurrence of superficial bladder cancer: what is valid?","Droller MJ.","J Urol. 2000 Nov;164(5):1840-1. doi: 10.1097/00005392-200011000-00112.","Droller MJ","J Urol","2000","2001/02/24","","","10.1097/00005392-200011000-00112"
"24762081","SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk","Bui HT, Fujimoto N, Kubo T, Inatomi H, Matsumoto T.","Cancer Invest. 2014 Jul;32(6):256-61. doi: 10.3109/07357907.2014.907421. Epub 2014 Apr 24.","Bui HT","Cancer Invest","2014","2014/04/26","","","10.3109/07357907.2014.907421"
"1301570","Mechanisms of action of BCG in superficial bladder cancer","Ratliff TL.","Prog Clin Biol Res. 1992;378:103-9.","Ratliff TL","Prog Clin Biol Res","1992","1992/01/01","","",""
"17639381","Computed tomographic appearance of urachal carcinoma associated with urachal diverticulum misdiagnosed by cystoscopy","Machida H, Ueno E, Nakazawa H, Fujimura M, Kihara T.","Abdom Imaging. 2008 May-Jun;33(3):363-6. doi: 10.1007/s00261-007-9256-7.","Machida H","Abdom Imaging","2008","2007/07/20","","","10.1007/s00261-007-9256-7"
"28221404","[The care process for bladder cancer should be reassessed]","Holmäng S.","Lakartidningen. 2017 Feb 20;114:EFLD.","Holmäng S","Lakartidningen","2017","2017/02/22","","",""
"12217780","Urine test for bladder cancer","Burton A.","Lancet Oncol. 2002 Sep;3(9):522. doi: 10.1016/s1470-2045(02)00863-x.","Burton A","Lancet Oncol","2002","2002/09/10","","","10.1016/s1470-2045(02)00863-x"
"3347983","Urologic considerations in treating superficial bladder cancer. Symposium. October 17, 1987, Bermuda. Proceedings","","Urology. 1988 Mar;31(3 Suppl):1-36.","","Urology","1988","1988/03/01","","",""
"10072625","Reliability of the routine cytological diagnosis in bladder cancer","Páez A, Coba JM, Murillo N, Fernández P, de la Cal MA, Luján M, Berenguer A.","Eur Urol. 1999;35(3):228-32. doi: 10.1159/000019851.","Páez A","Eur Urol","1999","1999/03/11","","","10.1159/000019851"
"21408190","Tyrosine kinase ETK/BMX is up-regulated in bladder cancer and predicts poor prognosis in patients with cystectomy","Guo S, Sun F, Guo Z, Li W, Alfano A, Chen H, Magyar CE, Huang J, Chai TC, Qiu S, Qiu Y.","PLoS One. 2011 Mar 7;6(3):e17778. doi: 10.1371/journal.pone.0017778.","Guo S","PLoS One","2011","2011/03/17","PMC3049795","","10.1371/journal.pone.0017778"
"7511149","Serum TPS versus TPA in Egyptian bladder cancer patients","Halim AB, el-Ahmady O, Hamza S, Aboul-Ela M, Oehr P.","Int J Biol Markers. 1993 Oct-Dec;8(4):221-6.","Halim AB","Int J Biol Markers","1993","1993/10/01","","",""
"6332786","Tumour regression after intralesional injection of interleukin 2 (IL-2) in bladder cancer. Preliminary report","Pizza G, Severini G, Menniti D, De Vinci C, Corrado F.","Int J Cancer. 1984 Sep 15;34(3):359-67. doi: 10.1002/ijc.2910340312.","Pizza G","Int J Cancer","1984","1984/09/15","","","10.1002/ijc.2910340312"
"28753839","Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis","Naselli A, Hurle R, Paparella S, Buffi NM, Lughezzani G, Lista G, Casale P, Saita A, Lazzeri M, Guazzoni G.","Eur Urol Focus. 2018 Jul;4(4):558-567. doi: 10.1016/j.euf.2016.12.011. Epub 2017 Jan 13.","Naselli A","Eur Urol Focus","2018","2017/07/30","","","10.1016/j.euf.2016.12.011"
"30381980","Clinical validation of a novel thermophysical bladder model designed to improve the accuracy of hyperthermia treatment planning in the pelvic region","Schooneveldt G, Kok HP, Bakker A, Geijsen ED, Rasch CRN, Rosette JJMCH, Hulshof MCCM, Reijke TM, Crezee H.","Int J Hyperthermia. 2018;35(1):383-397. doi: 10.1080/02656736.2018.1506164. Epub 2018 Nov 1.","Schooneveldt G","Int J Hyperthermia","2018","2018/11/02","","","10.1080/02656736.2018.1506164"
"9168188","Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer","Kinoshita H, Ogawa O, Kakehi Y, Mishina M, Mitsumori K, Itoh N, Yamada H, Terachi T, Yoshida O.","J Natl Cancer Inst. 1997 May 21;89(10):724-30. doi: 10.1093/jnci/89.10.724.","Kinoshita H","J Natl Cancer Inst","1997","1997/05/21","","","10.1093/jnci/89.10.724"
"26392109","The role of Kaposi's sarcoma-associated herpesvirus infection in the proliferation of human bladder cancer cells","Lee J, Jeon H, Yoo SM, Park J, Lee MS.","Tumour Biol. 2016 Feb;37(2):2587-96. doi: 10.1007/s13277-015-4096-5. Epub 2015 Sep 21.","Lee J","Tumour Biol","2016","2015/09/23","","","10.1007/s13277-015-4096-5"
"6805634","Bladder cancer mortality trends","Davies JM.","Br Med J (Clin Res Ed). 1982 May 29;284(6329):1632. doi: 10.1136/bmj.284.6329.1632-b.","Davies JM","Br Med J (Clin Res Ed)","1982","1982/05/29","PMC1498544","","10.1136/bmj.284.6329.1632-b"
"27265680","A Comprehensive Investigation toward the Indicative Proteins of Bladder Cancer in Urine: From Surveying Cell Secretomes to Verifying Urine Proteins","Guo J, Ren Y, Hou G, Wen B, Xian F, Chen Z, Cui P, Xie Y, Zi J, Lin L, Wu S, Li Z, Wu L, Lou X, Liu S.","J Proteome Res. 2016 Jul 1;15(7):2164-77. doi: 10.1021/acs.jproteome.6b00106. Epub 2016 Jun 14.","Guo J","J Proteome Res","2016","2016/06/07","","","10.1021/acs.jproteome.6b00106"
"26282902","Expression of inflammasome-related genes in bladder cancer and their association with cytokeratin 20 messenger RNA","Poli G, Brancorsini S, Cochetti G, Barillaro F, Egidi MG, Mearini E.","Urol Oncol. 2015 Dec;33(12):505.e1-7. doi: 10.1016/j.urolonc.2015.07.012. Epub 2015 Aug 15.","Poli G","Urol Oncol","2015","2015/08/19","","","10.1016/j.urolonc.2015.07.012"
"16284957","Total and specific fluid consumption as determinants of bladder cancer risk","Villanueva CM, Cantor KP, King WD, Jaakkola JJ, Cordier S, Lynch CF, Porru S, Kogevinas M.","Int J Cancer. 2006 Apr 15;118(8):2040-7. doi: 10.1002/ijc.21587.","Villanueva CM","Int J Cancer","2006","2005/11/15","","","10.1002/ijc.21587"
"8174472","[The influence of combined surgery for bladder cancer and bladder-neck obstruction on the recurrence of bladder cancer]","Ding KJ.","Zhonghua Zhong Liu Za Zhi. 1993 Jul;15(4):311-3.","Ding KJ","Zhonghua Zhong Liu Za Zhi","1993","1993/07/01","","",""
"21298219","Role of re-resection in non-muscle-invasive bladder cancer","Herr HW.","ScientificWorldJournal. 2011 Feb 3;11:283-8. doi: 10.1100/tsw.2011.29.","Herr HW","ScientificWorldJournal","2011","2011/02/08","PMC5720095","","10.1100/tsw.2011.29"
"64910","Bladder cancer in car workers","Baxter PJ, White WG, Barnes GM.","Lancet. 1977 Feb 12;1(8007):377. doi: 10.1016/s0140-6736(77)91192-8.","Baxter PJ","Lancet","1977","1977/02/12","","","10.1016/s0140-6736(77)91192-8"
"21110760","Expression profiling for bladder cancer: strategies to uncover prognostic factors","Bartsch G, Mitra AP, Cote RJ.","Expert Rev Anticancer Ther. 2010 Dec;10(12):1945-54. doi: 10.1586/era.10.131.","Bartsch G","Expert Rev Anticancer Ther","2010","2010/11/30","PMC3030446","NIHMS264169","10.1586/era.10.131"
"20598352","Prognostic significance of Aurora-A expression in human bladder cancer","Lei Y, Yan S, Ming-De L, Na L, Rui-Fa H.","Acta Histochem. 2011 Sep;113(5):514-8. doi: 10.1016/j.acthis.2010.05.004. Epub 2010 Jul 2.","Lei Y","Acta Histochem","2011","2010/07/06","","","10.1016/j.acthis.2010.05.004"
"19190164","Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urothelia","Rosser CJ, Liu L, Sun Y, Villicana P, McCullers M, Porvasnik S, Young PR, Parker AS, Goodison S.","Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):444-53. doi: 10.1158/1055-9965.EPI-08-1002. Epub 2009 Feb 3.","Rosser CJ","Cancer Epidemiol Biomarkers Prev","2009","2009/02/05","PMC2729268","NIHMS126964","10.1158/1055-9965.EPI-08-1002"
"28970593","Occupations and the Risk of Bladder Cancer in Yazd Province: A Case-Control Study","Farzaneh F, Mehrparvar AH, Lotfi MH.","Int J Occup Environ Med. 2017 Oct;8(4):191-198. doi: 10.15171/ijoem.2017.1085.","Farzaneh F","Int J Occup Environ Med","2017","2017/10/04","PMC6679604","","10.15171/ijoem.2017.1085"
"21290867","[Fluorescence guided endoscopy: improvement in the management of bladder cancer]","Uffer M, Jichlinski P.","Rev Med Suisse. 2010 Dec 8;6(274):2352-4.","Uffer M","Rev Med Suisse","2010","2011/02/05","","",""
"11905732","St John's wort helps to fight bladder cancer","Orellane C.","Lancet Oncol. 2001 Jul;2(7):399.","Orellane C","Lancet Oncol","2001","2002/03/22","","",""
"26819209","Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy","Yoshida T, Kinoshita H, Yoshida K, Mishima T, Yanishi M, Inui H, Komai Y, Sugi M, Inoue T, Murota T, Fukui K, Harada J, Kawa G, Matsuda T.","Tumour Biol. 2016 Aug;37(8):10067-74. doi: 10.1007/s13277-016-4874-8. Epub 2016 Jan 27.","Yoshida T","Tumour Biol","2016","2016/01/29","","","10.1007/s13277-016-4874-8"
"9533519","Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes","Lee DH, Yang SC, Hong SJ, Chung BH, Kim IY.","Clin Cancer Res. 1998 Mar;4(3):535-8.","Lee DH","Clin Cancer Res","1998","1998/05/14","","",""
"7019526","[Flow cytometry in urinary tract malignancies. I. Cytological diagnosis by DNA histogram of exfoliative cells in bladder cancer (author's transl)]","Akiyama T, Nagai N, Matsuura T, Iguchi M, Yachiku S, Kurita T.","Nihon Hinyokika Gakkai Zasshi. 1981 Feb;72(2):178-84.","Akiyama T","Nihon Hinyokika Gakkai Zasshi","1981","1981/02/01","","",""
"23680310","Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer","Sternberg IA, Keren Paz GE, Chen LY, Herr HW, Donat SM, Bochner BH, Dalbagni G.","J Urol. 2013 Oct;190(4):1187-91. doi: 10.1016/j.juro.2013.05.020. Epub 2013 May 13.","Sternberg IA","J Urol","2013","2013/05/18","","","10.1016/j.juro.2013.05.020"
"25263481","CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance","Afonso J, Santos LL, Miranda-Gonçalves V, Morais A, Amaro T, Longatto-Filho A, Baltazar F.","Mol Carcinog. 2015 Nov;54(11):1451-66. doi: 10.1002/mc.22222. Epub 2014 Sep 27.","Afonso J","Mol Carcinog","2015","2014/09/30","","","10.1002/mc.22222"
"22644299","An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer","Miah S, Dudziec E, Drayton RM, Zlotta AR, Morgan SL, Rosario DJ, Hamdy FC, Catto JW.","Br J Cancer. 2012 Jun 26;107(1):123-8. doi: 10.1038/bjc.2012.221. Epub 2012 May 29.","Miah S","Br J Cancer","2012","2012/05/31","PMC3389418","","10.1038/bjc.2012.221"
"14732225","Combined chemotherapeutic and photodynamic treatment on human bladder cells by hematoporphyrin-platinum(II) conjugates","Lottner C, Knuechel R, Bernhardt G, Brunner H.","Cancer Lett. 2004 Jan 20;203(2):171-80. doi: 10.1016/j.canlet.2003.09.001.","Lottner C","Cancer Lett","2004","2004/01/21","","","10.1016/j.canlet.2003.09.001"
"30200080","EORTC risk tables are more suitable for Chinese patients with nonmuscle-invasive bladder cancer than AUA risk stratification","Wang H, Ding W, Jiang G, Gou Y, Sun C, Chen Z, Xu K, Xia G.","Medicine (Baltimore). 2018 Sep;97(36):e12006. doi: 10.1097/MD.0000000000012006.","Wang H","Medicine (Baltimore)","2018","2018/09/12","PMC6133586","","10.1097/MD.0000000000012006"
"497911","Management of primary bladder cancer by a multidisciplinary team","Collins WE, Catton GE, Hussey A, Baker RG, Last JM.","Can J Surg. 1979 Sep;22(5):431-4.","Collins WE","Can J Surg","1979","1979/09/01","","",""
"2782947","Chlorinated drinking water and bladder cancer: effect of misclassification on risk estimates","Lynch CF, Woolson RF, O'Gorman T, Cantor KP.","Arch Environ Health. 1989 Jul-Aug;44(4):252-9. doi: 10.1080/00039896.1989.9935891.","Lynch CF","Arch Environ Health","1989","1989/07/01","","","10.1080/00039896.1989.9935891"
"25928508","Risk groups in bladder cancer patients treated with radical cystectomy","Mallen E, Gil P, Gil MJ.","Int Braz J Urol. 2015 Jan-Feb;41(1):30-9. doi: 10.1590/S1677-5538.IBJU.2015.01.06.","Mallen E","Int Braz J Urol","2015","2015/05/01","PMC4752054","","10.1590/S1677-5538.IBJU.2015.01.06"
"2374325","[Killer activities of peripheral blood mononuclear cells in patients with bladder cancer]","Okaneya T, Ogawa A.","Nihon Hinyokika Gakkai Zasshi. 1990 Apr;81(4):532-7. doi: 10.5980/jpnjurol1989.81.532.","Okaneya T","Nihon Hinyokika Gakkai Zasshi","1990","1990/04/01","","","10.5980/jpnjurol1989.81.532"
"27316585","The potential effect of age on the natural behavior of bladder cancer: Does urothelial cell carcinoma progress differently in various age groups?","Gunlusoy B, Ceylan Y, Degirmenci T, Aydogdu O, Bozkurt IH, Yonguc T, Sen V, Kozacioglu Z.","Kaohsiung J Med Sci. 2016 May;32(5):261-6. doi: 10.1016/j.kjms.2016.03.002. Epub 2016 Apr 10.","Gunlusoy B","Kaohsiung J Med Sci","2016","2016/06/19","","","10.1016/j.kjms.2016.03.002"
"8074800","Bladder cancer: advances in biology and treatment","Bosl GJ, Fair WR, Herr HW, Bajorin DF, Dalbagni G, Sarkis AS, Reuter VE, Cordon-Cardo C, Sheinfeld J, Scher HI.","Crit Rev Oncol Hematol. 1994 Feb;16(1):33-70. doi: 10.1016/1040-8428(94)90041-8.","Bosl GJ","Crit Rev Oncol Hematol","1994","1994/02/01","","","10.1016/1040-8428(94)90041-8"
"30712233","Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma","Palangi A, Shakhssalim N, Parvin M, Bayat S, Allameh A.","Clin Transl Oncol. 2019 Sep;21(9):1240-1249. doi: 10.1007/s12094-019-02049-3. Epub 2019 Feb 2.","Palangi A","Clin Transl Oncol","2019","2019/02/04","","","10.1007/s12094-019-02049-3"
"27823983","Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts","Wei L, Chintala S, Ciamporcero E, Ramakrishnan S, Elbanna M, Wang J, Hu Q, Glenn ST, Murakami M, Liu L, Gomez EC, Sun Y, Conroy J, Miles KM, Malathi K, Ramaiah S, Anbarasu A, Woloszynska-Read A, Johnson CS, Conroy J, Liu S, Morrison CD, Pili R.","Oncotarget. 2016 Nov 22;7(47):76374-76389. doi: 10.18632/oncotarget.13062.","Wei L","Oncotarget","2016","2016/11/09","PMC5363516","","10.18632/oncotarget.13062"
"12426865","[Prospective study of effectiveness. Reoperation (re-TUR) in superficial bladder carcinoma]","Vögeli TA, Grimm MO, Simon X, Ackermann R.","Urologe A. 2002 Sep;41(5):470-4. doi: 10.1007/s00120-001-0158-y.","Vögeli TA","Urologe A","2002","2002/11/13","","","10.1007/s00120-001-0158-y"
"22733495","Association of inflammatory chemokine gene CCL2I/D with bladder cancer risk in North Indian population","Singh V, Srivastava P, Srivastava N, Kapoor R, Mittal RD.","Mol Biol Rep. 2012 Oct;39(10):9827-34. doi: 10.1007/s11033-012-1849-8. Epub 2012 Jun 26.","Singh V","Mol Biol Rep","2012","2012/06/27","","","10.1007/s11033-012-1849-8"
"32468091","[Immuno-oncological therapeutic options in high-risk non-muscle invasive bladder cancer]","Kramer MW, Gakis G.","Urologe A. 2020 Jul;59(7):784-789. doi: 10.1007/s00120-020-01233-6.","Kramer MW","Urologe A","2020","2020/05/30","","","10.1007/s00120-020-01233-6"
"7555241","Intravesical instillation of interleukin-2. An effective method for preventing the recurrence of bladder cancer","Jin F, Yu M.","Chin Med J (Engl). 1995 May;108(5):373-6.","Jin F","Chin Med J (Engl)","1995","1995/05/01","","",""
"20534387","[Treatment strategies for metastatic patients in bladder cancer]","Théodore C.","Bull Cancer. 2010;97 Suppl Cancer de la vessie:27-33. doi: 10.1684/bdc.2010.1131.","Théodore C","Bull Cancer","2010","2010/06/11","","","10.1684/bdc.2010.1131"
"8911359","Cyclophosphamide associated bladder cancer--a highly aggressive disease: analysis of 12 cases","Fernandes ET, Manivel JC, Reddy PK, Ercole CJ.","J Urol. 1996 Dec;156(6):1931-3.","Fernandes ET","J Urol","1996","1996/12/01","","",""
"28332134","Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre","Böthig R, Kurze I, Fiebag K, Kaufmann A, Schöps W, Kadhum T, Zellner M, Golka K.","Int Urol Nephrol. 2017 Jun;49(6):983-994. doi: 10.1007/s11255-017-1570-6. Epub 2017 Mar 22.","Böthig R","Int Urol Nephrol","2017","2017/03/24","","","10.1007/s11255-017-1570-6"
"28314321","A Survival Score for Patients Assigned to Palliative Radiotherapy for Metastatic Bladder Cancer","Rades D, Manig L, Janssen S, Schild SE.","Anticancer Res. 2017 Mar;37(3):1481-1484. doi: 10.21873/anticanres.11473.","Rades D","Anticancer Res","2017","2017/03/19","","","10.21873/anticanres.11473"
"21361708","Tissue responses to hexyl 5-aminolevulinate-induced photodynamic treatment in syngeneic orthotopic rat bladder cancer model: possible pathways of action","Arum CJ, Gederaas OA, Larsen EL, Randeberg LL, Hjelde A, Krokan HE, Svaasand LO, Chen D, Zhao CM.","J Biomed Opt. 2011 Feb;16(2):028001. doi: 10.1117/1.3536536.","Arum CJ","J Biomed Opt","2011","2011/03/03","","","10.1117/1.3536536"
"24089460","Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants","Mir MC, Stephenson AJ, Grubb RL 3rd, Black A, Kibel AS, Izmirlian G.","Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2241-9. doi: 10.1158/1055-9965.EPI-13-0632. Epub 2013 Oct 2.","Mir MC","Cancer Epidemiol Biomarkers Prev","2013","2013/10/04","PMC3876874","NIHMS529123","10.1158/1055-9965.EPI-13-0632"
"6413432","Preliminary identification of a tumor-associated glycoprotein in bilharzial bladder cancer urine","Higashi GI, El-Asfahani AM.","Int J Cancer. 1983 Oct 15;32(4):445-8. doi: 10.1002/ijc.2910320409.","Higashi GI","Int J Cancer","1983","1983/10/15","","","10.1002/ijc.2910320409"
"32316020","Quality of Patient Information by Urologists Is Associated with Mental Distress in Bladder Cancer Patients","Mani J, Neuberth MT, Fettel J, Senf B, Khoder W, Vallo S.","Oncol Res Treat. 2020;43(5):228-236. doi: 10.1159/000507094. Epub 2020 Apr 21.","Mani J","Oncol Res Treat","2020","2020/04/22","","","10.1159/000507094"
"24083733","Age at diagnosis in bladder cancer: does opium addiction play a role?","Karbakhsh M, Dabbagh N, Shabani A, Tabibi A, Akhavizadegan H.","Asian Pac J Cancer Prev. 2013;14(8):4723-5. doi: 10.7314/apjcp.2013.14.8.4723.","Karbakhsh M","Asian Pac J Cancer Prev","2013","2013/10/03","","","10.7314/apjcp.2013.14.8.4723"
"2058066","[Intravesical prevention of recurrence of superficial urinary bladder cancer with BCG and KLH. A prospective randomized study]","Kälble T, Möhring K, Ikinger U, Riedasch G, Staehler G.","Urologe A. 1991 Mar;30(2):118-21.","Kälble T","Urologe A","1991","1991/03/01","","",""
"19235433","New drugs currently available in non-muscle invasive bladder cancer: update on gemcitabine studies","Gontero P, Fiorito C, Lucca I, Valentino F, Tizzani A.","Arch Ital Urol Androl. 2008 Dec;80(4):162-6.","Gontero P","Arch Ital Urol Androl","2008","2009/02/25","","",""
"3448760","Biochemical and immunologic diagnosis of cancer. Urinary bladder cancer","Paulie S.","Tumour Biol. 1987;8(2-3):103-4.","Paulie S","Tumour Biol","1987","1987/01/01","","",""
"428404","Therapy of urothelial bladder tumors. Results of a retrospective study of 615 cases","Rübben H, Lutzeyer W, Bubenzer J.","Eur Urol. 1979;5(1):1-6. doi: 10.1159/000473050.","Rübben H","Eur Urol","1979","1979/01/01","","","10.1159/000473050"
"19288592","Robotic-assisted laparoscopic pelvic lymphadenectomy for bladder cancer: a surgical atlas","Pruthi RS, Wallen EM.","J Laparoendosc Adv Surg Tech A. 2009 Feb;19(1):71-4. doi: 10.1089/lap.2008.0207.","Pruthi RS","J Laparoendosc Adv Surg Tech A","2009","2009/03/17","","","10.1089/lap.2008.0207"
"24595934","Efficacy and safety of potassium-titanyl- phosphate laser vaporization for clinically non-muscle invasive bladder cancer","Yang D, Xue B, Zang Y, Liu X, Zhu J, Zhou Y, Shan Y.","Urol J. 2014 Mar 3;11(1):1258-63.","Yang D","Urol J","2014","2014/03/06","","",""
"20486035","[Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis]","Kausch I, Sommerauer M, Montorsi F, Stenzl A, Jacqmin D, Jichlinski P, Jocham D, Ziegler A, Vonthein R.","Aktuelle Urol. 2010 May;41(3):171-7. doi: 10.1055/s-0030-1247363. Epub 2010 May 18.","Kausch I","Aktuelle Urol","2010","2010/05/21","","","10.1055/s-0030-1247363"
"26939702","BRD4 Regulates EZH2 Transcription through Upregulation of C-MYC and Represents a Novel Therapeutic Target in Bladder Cancer","Wu X, Liu D, Tao D, Xiang W, Xiao X, Wang M, Wang L, Luo G, Li Y, Zeng F, Jiang G.","Mol Cancer Ther. 2016 May;15(5):1029-42. doi: 10.1158/1535-7163.MCT-15-0750. Epub 2016 Mar 3.","Wu X","Mol Cancer Ther","2016","2016/03/05","","","10.1158/1535-7163.MCT-15-0750"
"15989033","[Extracorporeal lithotripsy of ureteral calculi after cystectomy with ureterosygmoanastomosis in progressive bladder cancer]","Erman AM, Miroshnikov VM.","Urologiia. 2005 Mar-Apr;(2):66-8.","Erman AM","Urologiia","2005","2005/07/02","","",""
"11145048","Cystitis, bladder cancer, and myelodysplasia in patients with Wegener's granulomatosis: comment on the article by Reinhold-Keller et al","Sneller MC.","Arthritis Rheum. 2000 Dec;43(12):2853-5. doi: 10.1002/1529-0131(200012)43:12<2853::AID-ANR30>3.0.CO;2-G.","Sneller MC","Arthritis Rheum","2000","2001/01/06","","","10.1002/1529-0131(200012)43:12<2853::AID-ANR30>3.0.CO;2-G"
"26982375","The case for salvage cystectomy after pelvic radiation","Calderone CE, Lerner SP, Taylor JM.","Minerva Urol Nefrol. 2016 Apr;68(2):161-71. Epub 2016 Mar 16.","Calderone CE","Minerva Urol Nefrol","2016","2016/03/17","","",""
"23070534","High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment","Faba OR, Palou J, Breda A, Villavicencio H.","World J Urol. 2012 Dec;30(6):833-40. doi: 10.1007/s00345-012-0967-1. Epub 2012 Oct 16.","Faba OR","World J Urol","2012","2012/10/17","","","10.1007/s00345-012-0967-1"
"7438324","Misonidazole in the preoperative and radical radiotherapy of bladder cancer","Awwad HK, El Merzabani MM, El Badawy S, Ezzat S, Akoush H, Abd El Moneim H, Saiid A, Soliman O, Khafagy M, Burgers MV.","Cancer Clin Trials. 1980 Fall;3(3):275-80.","Awwad HK","Cancer Clin Trials","1980","1980/01/01","","",""
"18630839","A study of the reproducibility of a fluorescence in situ hybridization bladder cancer detection assay","Brankley SM, Adams EJ, Christensen MR, Everts CR, Lund JD, Oberg TN, Plagge AM, Zieman AH, Kipp BR, Halling KC.","Anal Quant Cytol Histol. 2008 Jun;30(3):145-51.","Brankley SM","Anal Quant Cytol Histol","2008","2008/07/18","","",""
"21268545","What happens if nothing happens?--History of an untreated urothelial carcinoma of the bladder","Gerullis H, Ecke TH, Wishahi M, Georgas E, Eimer C, Otto T.","J Egypt Soc Parasitol. 2010 Dec;40(3):789-96.","Gerullis H","J Egypt Soc Parasitol","2010","2011/01/28","","",""
"2742354","[Analysis of lymphocyte subpopulations of the bladder following endovesical immunotherapy using BCG]","Peuchmaur M, Vieillefond A, Benoit G, Jardin A.","Ann Urol (Paris). 1989;23(3):246-50.","Peuchmaur M","Ann Urol (Paris)","1989","1989/01/01","","",""
"30044600","Analysis of the association between bladder carcinoma and arsenic concentration in soil and water in southeast Brazil","Cha JD, Lourenço DB, Korkes F.","Int Braz J Urol. 2018 Sep-Oct;44(5):906-913. doi: 10.1590/S1677-5538.IBJU.2017.0543.","Cha JD","Int Braz J Urol","2018","2018/07/26","PMC6237532","","10.1590/S1677-5538.IBJU.2017.0543"
"8749948","Immunohistochemical analysis of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer: positive immunostaining and radiosensitivity","Ogura K, Habuchi T, Yamada H, Ogawa O, Yoshida O.","Int J Urol. 1995 Nov;2(5):302-8.","Ogura K","Int J Urol","1995","1995/11/01","","",""
"3723905","[Reactivity of anti-human bladder cancer monoclonal antibodies with bladder tumor tissues]","Kagawa S, Takigawa H, Kurokawa K, Masuko T, Hashimoto Y.","Nihon Hinyokika Gakkai Zasshi. 1986 Jan;77(1):133-9. doi: 10.5980/jpnjurol1928.77.1_133.","Kagawa S","Nihon Hinyokika Gakkai Zasshi","1986","1986/01/01","","","10.5980/jpnjurol1928.77.1_133"
"23288215","Predictive values of urinary bladder tumor markers survivin and soluble-Fas comparison with cystoscopy and bladder tumor antigen","Ganas V, Kalaitzis C, Sountoulides P, Giannakopoulos S, Touloupidis S.","Minerva Urol Nefrol. 2012 Dec;64(4):279-85.","Ganas V","Minerva Urol Nefrol","2012","2013/01/05","","",""
"29169339","An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment","Huebner D, Rieger C, Bergmann R, Ullrich M, Meister S, Toma M, Wiedemuth R, Temme A, Novotny V, Wirth MP, Bachmann M, Pietzsch J, Fuessel S.","BMC Cancer. 2017 Nov 23;17(1):790. doi: 10.1186/s12885-017-3778-3.","Huebner D","BMC Cancer","2017","2017/11/25","PMC5701455","","10.1186/s12885-017-3778-3"
"24627238","Organ preservation for muscle-invasive bladder cancer by preoperative intra-arterial chemotherapy and transurethral resection","Han B, Liang S, Jing Y, Cui D, An X, Zou Q, Wei H, Xia S.","Med Oncol. 2014 Apr;31(4):912. doi: 10.1007/s12032-014-0912-9. Epub 2014 Mar 14.","Han B","Med Oncol","2014","2014/03/15","","","10.1007/s12032-014-0912-9"
"7129893","[Importance of serum and urine CEA determinations in the diagnosis of bladder cancer]","Adolphs HD, Oehr P.","Helv Chir Acta. 1982 Aug;49(3-4):307-11.","Adolphs HD","Helv Chir Acta","1982","1982/08/01","","",""
"15852676","[Urethral recurrence and distant metastases of bladder cancer 9 years after cystectomy and neobladder]","Kato S, Ito Y, Nishino Y, Ban Y, Deguchi T.","Hinyokika Kiyo. 2005 Mar;51(3):195-7.","Kato S","Hinyokika Kiyo","2005","2005/04/28","","",""
"9140460","Cytogenetics of bladder cancer","Gibas Z, Gibas L.","Cancer Genet Cytogenet. 1997 May;95(1):108-15. doi: 10.1016/s0165-4608(96)00295-6.","Gibas Z","Cancer Genet Cytogenet","1997","1997/05/01","","","10.1016/s0165-4608(96)00295-6"
"11745497","Hair dye use and bladder cancer","Miller AB, Bartsch H.","Int J Cancer. 2001 Dec 15;94(6):901-2. doi: 10.1002/ijc.1562.","Miller AB","Int J Cancer","2001","2001/12/18","","","10.1002/ijc.1562"
"28266904","Clinical relevance of narrow-band imaging in flexible cystoscopy: the DaBlaCa-7 study","Drejer D, Béji S, Munk Nielsen A, Høyer S, Wrist Lam G, Jensen JB.","Scand J Urol. 2017 Apr;51(2):120-123. doi: 10.1080/21681805.2017.1295101. Epub 2017 Mar 7.","Drejer D","Scand J Urol","2017","2017/03/08","","","10.1080/21681805.2017.1295101"
"18008359","Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy","Shariat SF, Karakiewicz PI, Ashfaq R, Lerner SP, Palapattu GS, Cote RJ, Sagalowsky AI, Lotan Y.","Cancer. 2008 Jan 15;112(2):315-25. doi: 10.1002/cncr.23162.","Shariat SF","Cancer","2008","2007/11/17","","","10.1002/cncr.23162"
"25150583","Effects of TSP-1-696 C/T polymorphism on bladder cancer susceptibility and clinicopathologic features","Gu J, Tao J, Yang X, Li P, Yang X, Qin C, Cao Q, Cai H, Zhang Z, Wang M, Gu M, Lu Q, Yin C.","Cancer Genet. 2014 Jun;207(6):247-52. doi: 10.1016/j.cancergen.2014.06.023. Epub 2014 Jun 26.","Gu J","Cancer Genet","2014","2014/08/25","","","10.1016/j.cancergen.2014.06.023"
"16557569","Understanding urothelial carcinoma through cancer pathways","Schulz WA.","Int J Cancer. 2006 Oct 1;119(7):1513-8. doi: 10.1002/ijc.21852.","Schulz WA","Int J Cancer","2006","2006/03/25","","","10.1002/ijc.21852"
"29765120","Oncological Outcome of Primary and Secondary Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis","Ge P, Wang L, Lu M, Mao L, Li W, Wen R, Lin J, Wang J, Chen J.","Sci Rep. 2018 May 15;8(1):7543. doi: 10.1038/s41598-018-26002-6.","Ge P","Sci Rep","2018","2018/05/17","PMC5954122","","10.1038/s41598-018-26002-6"
"8557553","Transitional cell carcinoma of the distal portion of ureter protruding into the sigmoid conduit six years after cystoprostatectomy","Elisco A, Finkelstein LH.","J Am Osteopath Assoc. 1995 Oct;95(10):613-6.","Elisco A","J Am Osteopath Assoc","1995","1995/10/01","","",""
"24549798","[Squamous cell lesions of the urinary bladder]","Rausch S, Gaisa N, Youssef RF, Lotan Y, Stenzl A, Kälble T.","Urologe A. 2014 Mar;53(3):368, 370-4. doi: 10.1007/s00120-013-3406-z.","Rausch S","Urologe A","2014","2014/02/20","","","10.1007/s00120-013-3406-z"
"26857137","RE: Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms","Selinski S, Krech E, Ovsiannikov D, Blaszkewicz M, Hengstler JG, Golka K.","J Natl Cancer Inst. 2016 Feb 7;108(3):djv440. doi: 10.1093/jnci/djv440. Print 2016 Mar.","Selinski S","J Natl Cancer Inst","2016","2016/02/10","","","10.1093/jnci/djv440"
"7785120","[The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer (experimental clinical research)]","Bocharova OA, Matveev BP, Baryshnikov AIu, Figurin KM, Serebriakova RV, Bodrova NB.","Urol Nefrol (Mosk). 1995 Mar-Apr;(2):46-7.","Bocharova OA","Urol Nefrol (Mosk)","1995","1995/03/01","","",""
"3931329","Economic aspects of treatment of superficial bladder cancer","Sudovar S.","Urology. 1985 Oct;26(4 Suppl):57-61.","Sudovar S","Urology","1985","1985/10/01","","",""
"26586476","Open radical cystectomy: still the gold standard for muscle invasive bladder cancer","Kiss B, Burkhard FC, Thalmann GN.","World J Urol. 2016 Jan;34(1):33-9. doi: 10.1007/s00345-015-1729-7. Epub 2015 Nov 19.","Kiss B","World J Urol","2016","2015/11/21","","","10.1007/s00345-015-1729-7"
"26983576","Tetrandrine reverses epithelial-mesenchymal transition in bladder cancer by downregulating Gli-1","Zhang Y, Liu W, He W, Zhang Y, Deng X, Ma Y, Zeng J, Kou B.","Int J Oncol. 2016 May;48(5):2035-42. doi: 10.3892/ijo.2016.3415. Epub 2016 Mar 3.","Zhang Y","Int J Oncol","2016","2016/03/18","","","10.3892/ijo.2016.3415"
"6785454","The effect of mitomycin C on superficial bladder cancer","Soloway MS, Murphy WM, DeFuria MD, Crooke S, Finebaum P.","J Urol. 1981 May;125(5):646-8. doi: 10.1016/s0022-5347(17)55149-6.","Soloway MS","J Urol","1981","1981/05/01","","","10.1016/s0022-5347(17)55149-6"
"2393798","Fractionated urinary cytology in the follow-up of bladder cancer","Hastie KJ, Ahmad R, Moisey CU.","Br J Urol. 1990 Jul;66(1):40-1. doi: 10.1111/j.1464-410x.1990.tb14862.x.","Hastie KJ","Br J Urol","1990","1990/07/01","","","10.1111/j.1464-410x.1990.tb14862.x"
"18184466","[Impact of preservation of distal prostatic capsula and seminal vesicle on functions of orthotopic ideal neobladder and erectile function of bladder cancer patients]","Wang XH, Luo X, Chen SQ.","Ai Zheng. 2008 Jan;27(1):62-5.","Wang XH","Ai Zheng","2008","2008/01/11","","",""
"13585366","THERAPY in urinary bladder cancer","","Cancer Bull. 1958 Sep-Oct;10(5):86-7.","","Cancer Bull","1958","1958/09/01","","",""
"12536903","[Epidemiology. Status of bladder cancer in the world in the year 2000]","","Prog Urol. 2002 Nov;12(5):763-7.","","Prog Urol","2002","2003/01/23","","",""
"10419345","Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee","van der Meijden A, Oosterlinck W, Brausi M, Kurth KH, Sylvester R, de Balincourt C.","Eur Urol. 1999 Apr;35(4):267-71. doi: 10.1159/000019859.","van der Meijden A","Eur Urol","1999","1999/07/27","","","10.1159/000019859"
"10577680","Radiotherapy in bladder cancer","Sengeløv L, von der Maase H.","Radiother Oncol. 1999 Jul;52(1):1-14. doi: 10.1016/s0167-8140(99)00090-0.","Sengeløv L","Radiother Oncol","1999","1999/11/30","","","10.1016/s0167-8140(99)00090-0"
"4675169","[Chemotherapy of bladder cancer and malignant renal cancer]","Kuroda K, Suzuki K, Ogata J, Saito S, Tazaki H.","Nihon Hinyokika Gakkai Zasshi. 1972 Sep;63(9):735-43.","Kuroda K","Nihon Hinyokika Gakkai Zasshi","1972","1972/09/01","","",""
"20843171","Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival","Offersen BV, Knap MM, Horsman MR, Verheijen J, Hanemaaijer R, Overgaard J.","Acta Oncol. 2010 Nov;49(8):1283-7. doi: 10.3109/0284186X.2010.509109. Epub 2010 Sep 15.","Offersen BV","Acta Oncol","2010","2010/09/17","","","10.3109/0284186X.2010.509109"
"27147435","Quantitative Evaluation of Heavy Metals and Trace Elements in the Urinary Bladder: Comparison Between Cancerous, Adjacent Non-cancerous and Normal Cadaveric Tissue","Abdel-Gawad M, Elsobky E, Shalaby MM, Abd-Elhameed M, Abdel-Rahim M, Ali-El-Dein B.","Biol Trace Elem Res. 2016 Dec;174(2):280-286. doi: 10.1007/s12011-016-0724-1. Epub 2016 May 5.","Abdel-Gawad M","Biol Trace Elem Res","2016","2016/05/06","","","10.1007/s12011-016-0724-1"
"8694539","TPA prognostic value in superficial bladder cancer","Filella X, Menendez V, Molina R, Alcover J, Carretero P, Ballesta AM.","Anticancer Res. 1996 Jul-Aug;16(4B):2173-5.","Filella X","Anticancer Res","1996","1996/07/01","","",""
"11547057","Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer","Bernardini S, Fauconnet S, Chabannes E, Henry PC, Adessi G, Bittard H.","J Urol. 2001 Oct;166(4):1275-9.","Bernardini S","J Urol","2001","2001/09/08","","",""
"23451041","BCG-mediated bladder cancer immunotherapy: identifying determinants of treatment response using a calibrated mathematical model","Rentsch CA, Biot C, Gsponer JR, Bachmann A, Albert ML, Breban R.","PLoS One. 2013;8(2):e56327. doi: 10.1371/journal.pone.0056327. Epub 2013 Feb 25.","Rentsch CA","PLoS One","2013","2013/03/02","PMC3581521","","10.1371/journal.pone.0056327"
"22265971","MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression","Fei X, Qi M, Wu B, Song Y, Wang Y, Li T.","FEBS Lett. 2012 Feb 17;586(4):392-7. doi: 10.1016/j.febslet.2012.01.006. Epub 2012 Jan 16.","Fei X","FEBS Lett","2012","2012/01/24","","","10.1016/j.febslet.2012.01.006"
"8841001","Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers","O'Brien TS, Fox SB, Dickinson AJ, Turley H, Westwood M, Moghaddam A, Gatter KC, Bicknell R, Harris AL.","Cancer Res. 1996 Oct 15;56(20):4799-804.","O'Brien TS","Cancer Res","1996","1996/10/15","","",""
"12875971","Gene discovery in bladder cancer progression using cDNA microarrays","Sanchez-Carbayo M, Socci ND, Lozano JJ, Li W, Charytonowicz E, Belbin TJ, Prystowsky MB, Ortiz AR, Childs G, Cordon-Cardo C.","Am J Pathol. 2003 Aug;163(2):505-16. doi: 10.1016/S0002-9440(10)63679-6.","Sanchez-Carbayo M","Am J Pathol","2003","2003/07/24","PMC1868230","","10.1016/S0002-9440(10)63679-6"
"18398596","[Bladder carcinoma cell lines as models of the pathobiology of bladder cancer. Review of the literature and establishment of a new progression series]","Hatina J, Huckenbeck W, Rieder H, Seifert HH, Schulz WA.","Urologe A. 2008 Jun;47(6):724-34. doi: 10.1007/s00120-008-1687-4.","Hatina J","Urologe A","2008","2008/04/10","","","10.1007/s00120-008-1687-4"
"10840098","Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors","Giannopoulos A, Manousakas T, Mitropoulos D, Botsoli-Stergiou E, Constantinides C, Giannopoulou M, Choremi-Papadopoulou H.","Urology. 2000 Jun;55(6):871-5. doi: 10.1016/s0090-4295(00)00489-1.","Giannopoulos A","Urology","2000","2000/06/07","","","10.1016/s0090-4295(00)00489-1"
"17270661","Extrapulmonary small cell carcinoma of the bladder","Shahab N.","Semin Oncol. 2007 Feb;34(1):15-21. doi: 10.1053/j.seminoncol.2006.10.025.","Shahab N","Semin Oncol","2007","2007/02/03","","","10.1053/j.seminoncol.2006.10.025"
"7827849","Positron emission tomography with L-methyl-11C-methionine in the monitoring of therapy response in muscle-invasive transitional cell carcinoma of the urinary bladder","Letocha H, Ahlström H, Malmström PU, Westlin JE, Fasth KJ, Nilsson S.","Br J Urol. 1994 Dec;74(6):767-74. doi: 10.1111/j.1464-410x.1994.tb07123.x.","Letocha H","Br J Urol","1994","1994/12/01","","","10.1111/j.1464-410x.1994.tb07123.x"
"7117342","Intravesical single and combination therapy in superficial bladder cancer. An experimental study","Rübben H, Dahm HH, von Uelft W, Rüttgers L, Friedrichs R, Lutzeyer W.","Eur Urol. 1982;8(5):284-90. doi: 10.1159/000473537.","Rübben H","Eur Urol","1982","1982/01/01","","","10.1159/000473537"
"14518384","[A case of inguinal lymph node metastasis and urethral remnant tumor arising eight years after cystourethrectomy for bladder cancer]","Uemura M, Nakagawa M, Mukai M, Kanno N, Nishimura K, Miyoshi S, Yoshida K, Kawano K.","Hinyokika Kiyo. 2003 Aug;49(8):471-3.","Uemura M","Hinyokika Kiyo","2003","2003/10/02","","",""
"6726902","Radical cystectomy in the elderly patient","Skinner EC, Lieskovsky G, Skinner DG.","J Urol. 1984 Jun;131(6):1065-8. doi: 10.1016/s0022-5347(17)50808-3.","Skinner EC","J Urol","1984","1984/06/01","","","10.1016/s0022-5347(17)50808-3"
"3409229","Malignant properties of sublines selected from a human bladder cancer cell line that contains an activated c-Ha-ras oncogene","Kovnat A, Buick RN, Choo B, De Harven E, Kopelyan I, Trent JM, Tannock IF.","Cancer Res. 1988 Sep 1;48(17):4993-5000.","Kovnat A","Cancer Res","1988","1988/09/01","","",""
"25309904","Evolution of network biomarkers from early to late stage bladder cancer samples","Wong YH, Li CW, Chen BS.","Biomed Res Int. 2014;2014:159078. doi: 10.1155/2014/159078. Epub 2014 Sep 18.","Wong YH","Biomed Res Int","2014","2014/10/14","PMC4189772","","10.1155/2014/159078"
"18725381","Bladder cancer risks in workers manufacturing chemicals for the rubber industry","Sorahan T.","Occup Med (Lond). 2008 Oct;58(7):496-501. doi: 10.1093/occmed/kqn104. Epub 2008 Aug 25.","Sorahan T","Occup Med (Lond)","2008","2008/08/30","","","10.1093/occmed/kqn104"
"20840328","Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma","Rioja J, Bandrés E, Rosell Costa D, Rincón A, López I, Zudaire Bergera JJ, García Foncillas J, Gil MJ, Panizo A, Plaza L, Rioja LA, Berián Polo JM.","BJU Int. 2011 Jun;107(11):1833-8. doi: 10.1111/j.1464-410X.2010.09653.x. Epub 2010 Sep 14.","Rioja J","BJU Int","2011","2010/09/16","","","10.1111/j.1464-410X.2010.09653.x"
"19235429","New therapeutical approaches for non muscle invasive bladder cancer","Volpe A, Racioppi M, Sacco E, Bongiovanni L, D'Agostino D, Cappa E, Pinto F, Gardi M, Totaro A, Bassi P.","Arch Ital Urol Androl. 2008 Dec;80(4):136-42.","Volpe A","Arch Ital Urol Androl","2008","2009/02/25","","",""
"12201939","Intravesical instillations of interferon gamma in the prophylaxis of high risk superficial bladder cancer--results of a controlled prospective study","Stavropoulos NE, Hastazeris K, Filiadis I, Mihailidis I, Ioachim E, Liamis Z, Kalomiris P.","Scand J Urol Nephrol. 2002;36(3):218-22. doi: 10.1080/003655902320131910.","Stavropoulos NE","Scand J Urol Nephrol","2002","2002/08/31","","","10.1080/003655902320131910"
"17603559","Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents","Moussa O, Riker JM, Klein J, Fraig M, Halushka PV, Watson DK.","Oncogene. 2008 Jan 3;27(1):55-62. doi: 10.1038/sj.onc.1210629. Epub 2007 Jul 2.","Moussa O","Oncogene","2008","2007/07/03","","","10.1038/sj.onc.1210629"
"32125546","Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan","Ikeda A, Kojima T, Kawai K, Hinotsu S, Keino N, Shiga K, Miyake H, Miyata Y, Enomoto Y, Shimizu F, Anai S, Matsuyama H, Suzuki C, Kanimoto Y, Shigeta K, Naito S, Akaza H, Nishiyama H.","Int J Clin Oncol. 2020 Jun;25(6):1163-1169. doi: 10.1007/s10147-020-01634-9. Epub 2020 Mar 3.","Ikeda A","Int J Clin Oncol","2020","2020/03/04","PMC7261273","","10.1007/s10147-020-01634-9"
"27371842","[The establishment of 5637 bladder cancer cell line with stable overexpression of miR-449c]","Wan P, Huang Y, Wang Z, Wang H, Shi J, Yang J, Chen Z.","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Jun;32(6):760-3.","Wan P","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi","2016","2016/07/03","","",""
"1018707","[Early diagnosis of bladder cancer]","Lent V.","Minerva Urol. 1976 May-Jun;28(3):136-41.","Lent V","Minerva Urol","1976","1976/05/01","","",""
"9800121","Retinoids in the chemoprevention of bladder cancer","Sabichi AL, Lerner SP, Grossman HB, Lippman SM.","Curr Opin Oncol. 1998 Sep;10(5):479-84. doi: 10.1097/00001622-199809000-00019.","Sabichi AL","Curr Opin Oncol","1998","1998/11/04","","","10.1097/00001622-199809000-00019"
"20610278","Molecular pathways of urothelial development and bladder tumorigenesis","Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C.","Urol Oncol. 2010 Jul-Aug;28(4):401-8. doi: 10.1016/j.urolonc.2009.04.019.","Castillo-Martin M","Urol Oncol","2010","2010/07/09","","","10.1016/j.urolonc.2009.04.019"
"27820650","Upregulation of miR-3658 in bladder cancer and tumor progression","Chen YJ, Wang HF, Liang M, Zou RC, Tang ZR, Wang JS.","Genet Mol Res. 2016 Nov 3;15(4). doi: 10.4238/gmr15049048.","Chen YJ","Genet Mol Res","2016","2016/11/08","","","10.4238/gmr15049048"
"29483814","Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study","Yang SL, Wang JJ, Chen M, Xu L, Li N, Luo YL, Bu L, Zhang MN, Li H, Su BL.","Int J Med Sci. 2018 Jan 8;15(3):228-237. doi: 10.7150/ijms.22408. eCollection 2018.","Yang SL","Int J Med Sci","2018","2018/02/28","PMC5820852","","10.7150/ijms.22408"
"23299537","Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients","Wagener N, Bulkescher J, Macher-Goeppinger S, Karapanagiotou-Schenkel I, Hatiboglu G, Abdel-Rahim M, Abol-Enein H, Ghoneim MA, Bastian PJ, Müller SC, Haferkamp A, Hohenfellner M, Hoppe-Seyler F, Hoppe-Seyler K.","Br J Cancer. 2013 Mar 5;108(4):973-82. doi: 10.1038/bjc.2012.573. Epub 2013 Jan 8.","Wagener N","Br J Cancer","2013","2013/01/10","PMC3590653","","10.1038/bjc.2012.573"
"10696250","Telomerase in human bladder cancer","Liu BC, Loughlin KR.","Urol Clin North Am. 2000 Feb;27(1):115-23, x. doi: 10.1016/s0094-0143(05)70239-1.","Liu BC","Urol Clin North Am","2000","2000/03/04","","","10.1016/s0094-0143(05)70239-1"
"16917216","Gemcitabine and cisplatin after radical cystectomy for bladder cancer in an adjuvant setting: feasibility study from the Genito-Urinary Group of the French Federation of Cancer Centers","Fléchon A, Fizazi K, Gourgou-Bourgade S, Théodore C, Beuzeboc P, Geoffrois L, Mottet N, Chevreau C, Culine S.","Anticancer Drugs. 2006 Jul;17(6):705-8. doi: 10.1097/01.cad.0000210337.85526.cc.","Fléchon A","Anticancer Drugs","2006","2006/08/19","","","10.1097/01.cad.0000210337.85526.cc"
"2930712","Prognostic factors in a T3 bladder cancer trial. Co-operative Urological Cancer Group","Babiker A, Shearer RJ, Chilvers CE.","Br J Cancer. 1989 Mar;59(3):441-4. doi: 10.1038/bjc.1989.90.","Babiker A","Br J Cancer","1989","1989/03/01","PMC2247062","","10.1038/bjc.1989.90"
"25512208","Bladder cancer: Urinary tract infection increases risk","Stone L.","Nat Rev Urol. 2015 Jan;12(1):4. doi: 10.1038/nrurol.2014.343. Epub 2014 Dec 16.","Stone L","Nat Rev Urol","2015","2014/12/17","","","10.1038/nrurol.2014.343"
"26759323","Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy","Wang L, Zhou M, Feng C, Gao P, Ding G, Zhou Z, Jiang H, Wu Z, Ding Q.","Int Urol Nephrol. 2016 Apr;48(4):495-501. doi: 10.1007/s11255-015-1197-4. Epub 2016 Jan 12.","Wang L","Int Urol Nephrol","2016","2016/01/14","","","10.1007/s11255-015-1197-4"
"28807631","Chitosan hydrochloride has no detrimental effect on bladder urothelial cancer cells","Višnjar T, Jerman UD, Veranič P, Kreft ME.","Toxicol In Vitro. 2017 Oct;44:403-413. doi: 10.1016/j.tiv.2017.08.008. Epub 2017 Aug 12.","Višnjar T","Toxicol In Vitro","2017","2017/08/16","","","10.1016/j.tiv.2017.08.008"
"1195467","Evaluation of biological markers in bladder cancer","Wajsman Z, Merrin CE, Chu TM, Moore RH, Murphy GP.","J Urol. 1975 Dec;114(6):879-93. doi: 10.1016/s0022-5347(17)67164-7.","Wajsman Z","J Urol","1975","1975/12/01","","","10.1016/s0022-5347(17)67164-7"
"22368893","Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer: experience at Sindh Institute of Urology & Transplantation (SIUT)","Tunio MA, Hashmi A, Rafi M, Qayyum A, Masood R.","J Pak Med Assoc. 2011 Jan;61(1):6-10.","Tunio MA","J Pak Med Assoc","2011","2012/02/29","","",""
"2591423","Bladder tumors invading the lamina propria (stage A/T1): influence of endovesical bacillus Calmette-Guérin therapy on recurrence and progression","Boccon-Gibod L, Leleu C, Herve JM, Belas M, Steg A.","Eur Urol. 1989;16(6):401-4. doi: 10.1159/000471630.","Boccon-Gibod L","Eur Urol","1989","1989/01/01","","","10.1159/000471630"
"11011962","Epithelial mucin expression in bladder cancer: correlation with pathological and clinical parameters","Syrigos KN, Deonarain DM, Karayiannakis A, Waxman J, Krausz T, Pignatelli M.","Urol Res. 2000 Aug;28(4):241-5. doi: 10.1007/s002400000110.","Syrigos KN","Urol Res","2000","2000/09/30","","","10.1007/s002400000110"
"32500545","Editorial Comment from Dr Shin to Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer","Shin T.","Int J Urol. 2020 Aug;27(8):655. doi: 10.1111/iju.14282. Epub 2020 Jun 4.","Shin T","Int J Urol","2020","2020/06/06","","","10.1111/iju.14282"
"22615872","Long interspersed nuclear element-1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potential","Patchsung M, Boonla C, Amnattrakul P, Dissayabutra T, Mutirangura A, Tosukhowong P.","PLoS One. 2012;7(5):e37009. doi: 10.1371/journal.pone.0037009. Epub 2012 May 15.","Patchsung M","PLoS One","2012","2012/05/23","PMC3352860","","10.1371/journal.pone.0037009"
"10454066","Occupation and bladder cancer in European women","Mannetje A, Kogevinas M, Chang-Claude J, Cordier S, González CA, Hours M, Jöckel KH, Bolm-Audorff U, Lynge E, Porru S, Donato F, Ranft U, Serra C, Tzonou A, Vineis P, Wahrendorf J, Boffetta P.","Cancer Causes Control. 1999 Jun;10(3):209-17. doi: 10.1023/a:1008852127139.","Mannetje A","Cancer Causes Control","1999","1999/08/24","","","10.1023/a:1008852127139"
"18609266","Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer","Jancke G, Damm O, Rosell J, Jahnson S.","Scand J Urol Nephrol. 2008;42(5):417-21. doi: 10.1080/00365590802016302.","Jancke G","Scand J Urol Nephrol","2008","2008/07/09","","","10.1080/00365590802016302"
"30348690","Feasibility and Characteristics of Pressurized Aerosol Chemotherapy (PAC) in the Bladder as a Therapeutical Option in Early-stage Urinary Bladder Cancer","Mikolajczyk A, Khosrawipour V, Schubert J, Plociennik M, Nowak K, Fahr C, Chaudhry H, Khosrawipour T.","In Vivo. 2018 Nov-Dec;32(6):1369-1372. doi: 10.21873/invivo.11388.","Mikolajczyk A","In Vivo","2018","2018/10/24","PMC6365759","","10.21873/invivo.11388"
"24573199","Detection of tumor-associated antigens in culture supernatants using autoantibodies in sera from patients with bladder cancer","Minami S, Nagashio R, Ueda J, Matsumoto K, Goshima N, Hattori M, Hachimura K, Iwamura M, Sato Y.","Biomed Res. 2014;35(1):25-35. doi: 10.2220/biomedres.35.25.","Minami S","Biomed Res","2014","2014/02/28","","","10.2220/biomedres.35.25"
"25678415","Intra-arterial chemotherapy for muscle-invasive bladder cancer following transurethral resection","Liang S, Zou Q, Han B, Jing Y, Cui D, An X, Gao Y, Hu J, Xia S.","Urol Int. 2015;94(4):406-11. doi: 10.1159/000369301. Epub 2015 Feb 12.","Liang S","Urol Int","2015","2015/02/14","","","10.1159/000369301"
"27458279","National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer","Pal SK, Agarwal N, Boorjian SA, Hahn NM, Siefker-Radtke AO, Clark PE, Plimack ER.","J Clin Oncol. 2016 Sep 20;34(27):3346-8. doi: 10.1200/JCO.2016.68.1429. Epub 2016 Jul 25.","Pal SK","J Clin Oncol","2016","2016/07/27","PMC5379635","NIHMS852991","10.1200/JCO.2016.68.1429"
"27611951","Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer","Zhou J, Dong D, Cheng R, Wang Y, Jiang S, Zhu Y, Fan L, Mao X, Gui Y, Li Z, Li X, Shi B.","Oncotarget. 2016 Nov 8;7(45):72767-72776. doi: 10.18632/oncotarget.11889.","Zhou J","Oncotarget","2016","2016/09/10","PMC5341943","","10.18632/oncotarget.11889"
"23210587","Adaptive radiotherapy for muscle-invasive bladder cancer: optimisation of plan sizes","Kuyumcian A, Pham D, Thomas JM, Law A, Willis D, Kron T, Foroudi F.","J Med Imaging Radiat Oncol. 2012 Dec;56(6):661-7. doi: 10.1111/j.1754-9485.2012.02436.x. Epub 2012 Sep 12.","Kuyumcian A","J Med Imaging Radiat Oncol","2012","2012/12/06","","","10.1111/j.1754-9485.2012.02436.x"
"8365439","Predicting the outcome of radical radiotherapy for invasive bladder cancer","Vale JA, A'Hern RP, Liu K, Hendry WF, Whitfield HN, Plowman PN, Sowter C, Slavin G.","Eur Urol. 1993;24(1):48-51. doi: 10.1159/000474261.","Vale JA","Eur Urol","1993","1993/01/01","","","10.1159/000474261"
"12837463","Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor","Okegawa T, Kinjo M, Horie S, Nutahara K, Higashihara E.","Urology. 2003 Jul;62(1):182-6. doi: 10.1016/s0090-4295(03)00238-3.","Okegawa T","Urology","2003","2003/07/03","","","10.1016/s0090-4295(03)00238-3"
"8933512","Is microstaging of early invasive cancer of the urinary bladder possible or useful?","Platz CE, Cohen MB, Jones MP, Olson DB, Lynch CF.","Mod Pathol. 1996 Nov;9(11):1035-9.","Platz CE","Mod Pathol","1996","1996/11/01","","",""
"24670247","Animal models of urinary bladder cancer and their application to novel drug discovery","Oliveira PA, Arantes-Rodrigues R, Vasconcelos-Nóbrega C.","Expert Opin Drug Discov. 2014 May;9(5):485-503. doi: 10.1517/17460441.2014.902930. Epub 2014 Mar 26.","Oliveira PA","Expert Opin Drug Discov","2014","2014/03/28","","","10.1517/17460441.2014.902930"
"20354664","Treatment results of radiation therapy for muscle-invasive bladder cancer","Langsenlehner T, Döller C, Quehenberger F, Stranzl-Lawatsch H, Langsenlehner U, Pummer K, Kapp KS.","Strahlenther Onkol. 2010 Apr;186(4):203-9. doi: 10.1007/s00066-010-2053-1. Epub 2010 Mar 26.","Langsenlehner T","Strahlenther Onkol","2010","2010/04/01","","","10.1007/s00066-010-2053-1"
"19752870","Bladder cancer in spinal cord injury patients","Kalisvaart JF, Katsumi HK, Ronningen LD, Hovey RM.","Spinal Cord. 2010 Mar;48(3):257-61. doi: 10.1038/sc.2009.118. Epub 2009 Sep 15.","Kalisvaart JF","Spinal Cord","2010","2009/09/16","","","10.1038/sc.2009.118"
"26080829","Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin","Zhu H, Yun F, Shi X, Wang D.","Int J Mol Med. 2015 Aug;36(2):595-601. doi: 10.3892/ijmm.2015.2250. Epub 2015 Jun 17.","Zhu H","Int J Mol Med","2015","2015/06/18","","","10.3892/ijmm.2015.2250"
"21794063","Percivall Pott, the environment and cancer","Herr HW.","BJU Int. 2011 Aug;108(4):479-81. doi: 10.1111/j.1464-410X.2011.10487.x.","Herr HW","BJU Int","2011","2011/07/29","","","10.1111/j.1464-410X.2011.10487.x"
"24155119","Genetic score of multiple risk-associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer","Wang P, Ye D, Guo J, Liu F, Jiang H, Gong J, Gu C, Shao Q, Sun J, Zheng SL, Yu H, Lin X, Xia G, Fang Z, Zhu Y, Ding Q, Xu J.","Genes Chromosomes Cancer. 2014 Jan;53(1):98-105. doi: 10.1002/gcc.22121. Epub 2013 Oct 24.","Wang P","Genes Chromosomes Cancer","2014","2013/10/25","","","10.1002/gcc.22121"
"11547059","Heparanase protein and gene expression in bladder cancer","Gohji K, Okamoto M, Kitazawa S, Toyoshima M, Dong J, Katsuoka Y, Nakajima M.","J Urol. 2001 Oct;166(4):1286-90.","Gohji K","J Urol","2001","2001/09/08","","",""
"9817311","Markers in bladder cancer--issues to consider","Droller MJ.","J Urol. 1998 Dec;160(6 Pt 1):2009-10.","Droller MJ","J Urol","1998","1998/11/17","","",""
"21529900","Pazopanib synergizes with docetaxel in the treatment of bladder cancer cells","Li Y, Yang X, Su LJ, Flaig TW.","Urology. 2011 Jul;78(1):233.e7-13. doi: 10.1016/j.urology.2011.02.041. Epub 2011 Apr 29.","Li Y","Urology","2011","2011/05/03","PMC3126899","NIHMS282015","10.1016/j.urology.2011.02.041"
"22386115","[EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update]","Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, Rouprêt M; Asociación Europea de Urología.","Actas Urol Esp. 2012 Jul-Aug;36(7):389-402. doi: 10.1016/j.acuro.2011.12.001. Epub 2012 Mar 2.","Babjuk M","Actas Urol Esp","2012","2012/03/06","","","10.1016/j.acuro.2011.12.001"
"8701804","Cytokines in superficial bladder cancer","da Silva FC.","Acta Urol Belg. 1996 May;64(2):29-30.","da Silva FC","Acta Urol Belg","1996","1996/05/01","","",""
"3445862","[Endoscopic ethanol injection treatment for bladder cancer]","Hata M, Nakajima F, Takao M, Odajima K, Ieda K, Fujioka T, Nakamura H.","Hinyokika Kiyo. 1987 Nov;33(11):1794-9.","Hata M","Hinyokika Kiyo","1987","1987/11/01","","",""
"24241960","Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer","Wang L, Feng C, Ding G, Ding Q, Zhou Z, Jiang H, Wu Z.","Tumour Biol. 2014 Apr;35(4):2989-95. doi: 10.1007/s13277-013-1384-9. Epub 2013 Nov 17.","Wang L","Tumour Biol","2014","2013/11/19","","","10.1007/s13277-013-1384-9"
"30359551","Serine/threonine kinase 32C is overexpressed in bladder cancer and contributes to tumor progression","Sun E, Liu K, Zhao K, Wang L.","Cancer Biol Ther. 2019;20(3):307-320. doi: 10.1080/15384047.2018.1529098. Epub 2018 Oct 25.","Sun E","Cancer Biol Ther","2019","2018/10/26","PMC6370379","","10.1080/15384047.2018.1529098"
"31661119","Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis","Sun N, Liang Y, Chen Y, Wang L, Li D, Liang Z, Sun L, Wang Y, Niu H.","Int J Mol Med. 2019 Dec;44(6):2189-2200. doi: 10.3892/ijmm.2019.4385. Epub 2019 Oct 25.","Sun N","Int J Mol Med","2019","2019/10/30","PMC6844601","","10.3892/ijmm.2019.4385"
"8351472","A study of prognosis and clinicopathology of bladder cancer to blood group type of host patients in Japan","Yamada T, Fukui I, Yokokawa M, Oshima H.","Scand J Urol Nephrol. 1993;27(2):199-203. doi: 10.3109/00365599309181249.","Yamada T","Scand J Urol Nephrol","1993","1993/01/01","","","10.3109/00365599309181249"
"24656061","Predictors of preoperative delays before radical cystectomy for bladder cancer in Quebec, Canada: a population-based study","Santos F, Dragomir A, Kassouf W, Franco EL, Aprikian A.","BJU Int. 2015 Mar;115(3):389-96. doi: 10.1111/bju.12742. Epub 2014 Jul 27.","Santos F","BJU Int","2015","2014/03/25","","","10.1111/bju.12742"
"8293406","Serum tissue polypeptide antigen (S-TPA) in bladder cancer as a tumor marker. A prospective study","Maulard C, Toubert ME, Chretien Y, Delanian S, Dufour B, Housset M.","Cancer. 1994 Jan 15;73(2):394-8. doi: 10.1002/1097-0142(19940115)73:2<394::aid-cncr2820730226>3.0.co;2-y.","Maulard C","Cancer","1994","1994/01/15","","","10.1002/1097-0142(19940115)73:2<394::aid-cncr2820730226>3.0.co;2-y"
"10810416","Usefulness of urinary nuclear matrix protein 22 (NMP22) as a marker for transitional cell carcinoma of the bladder","Menendez V, Filella X, Alcover JA, Molina R, Mallafre JM, Ballesta AM, Talbot-Wright R.","Anticancer Res. 2000 Mar-Apr;20(2B):1169-72.","Menendez V","Anticancer Res","2000","2000/05/16","","",""
"26629935","Suppression of Cellular Proliferation and Invasion by HMGB1 Knockdown in Bladder Urothelial Carcinoma Cells","Liao H, Xiao Y, Hu Y, Xiao Y, Yin Z, Liu L.","Oncol Res. 2014;22(5-6):235-45. doi: 10.3727/096504015X14267282610858.","Liao H","Oncol Res","2014","2015/12/03","","","10.3727/096504015X14267282610858"
"8862674","A new flow cytometric approach to the analysis of DNA and a second parameter","Kusuda L, Melamed MR.","Anal Quant Cytol Histol. 1996 Aug;18(4):309-15.","Kusuda L","Anal Quant Cytol Histol","1996","1996/08/01","","",""
"14704110","Radiotherapy for muscle-invasive urinary bladder cancer in elderly patients","Agranovich A, Czaykowski P, Hui D, Pickles T, Kwan W.","Can J Urol. 2003 Dec;10(6):2056-61.","Agranovich A","Can J Urol","2003","2004/01/06","","",""
"29599373","Clinicopathological Profiling of LC3B, an Autophagy Marker, and ESRRA (Estrogen-related Receptor-alpha) in Muscle-invasive Bladder Cancer","Kim S, Lee AJ, Yeo MK, Na YG, Kim JY, Cho MJ, Kim JS, Jo EK, Kim JM.","Anticancer Res. 2018 Apr;38(4):2429-2437. doi: 10.21873/anticanres.12495.","Kim S","Anticancer Res","2018","2018/03/31","","","10.21873/anticanres.12495"
"3362903","Evaluation of response by CT in patients with advanced bladder cancer treated with cisplatinum/methotrexate","Sager EM, Fosså SD, Ous S, Johannessen N.","Prog Clin Biol Res. 1988;260:499-510.","Sager EM","Prog Clin Biol Res","1988","1988/01/01","","",""
"1450848","Preliminary results of concurrent cisplatin and radiation therapy in locally advanced bladder cancer","Utsunomiya M, Itoh H, Yoshioka T, Masaki N, Itatani H.","Br J Urol. 1992 Oct;70(4):399-403. doi: 10.1111/j.1464-410x.1992.tb15796.x.","Utsunomiya M","Br J Urol","1992","1992/10/01","","","10.1111/j.1464-410x.1992.tb15796.x"
"23752272","Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms?","Dudek AM, Grotenhuis AJ, Vermeulen SH, Kiemeney LA, Verhaegh GW.","Int J Mol Sci. 2013 Jun 10;14(6):12346-66. doi: 10.3390/ijms140612346.","Dudek AM","Int J Mol Sci","2013","2013/06/12","PMC3709789","","10.3390/ijms140612346"
"12576868","Connexin 26 is abnormally expressed in bladder cancer","Gee J, Tanaka M, Grossman HB.","J Urol. 2003 Mar;169(3):1135-7. doi: 10.1097/01.ju.0000041954.91331.df.","Gee J","J Urol","2003","2003/02/11","","","10.1097/01.ju.0000041954.91331.df"
"21152875","Human papillomavirus and non-muscle invasive urothelial bladder cancer: potential relationship from a pilot study","Cai T, Mazzoli S, Meacci F, Nesi G, Geppetti P, Malossini G, Bartoletti R.","Oncol Rep. 2011 Feb;25(2):485-9. doi: 10.3892/or.2010.1083. Epub 2010 Dec 8.","Cai T","Oncol Rep","2011","2010/12/15","","","10.3892/or.2010.1083"
"6538242","Pre-cystectomy intra-arterial cis-diamminedichloroplatinum II with local bladder hyperthermia for bladder cancer","Jacobs SC, McCellan SL, Maher C, Lawson RK.","J Urol. 1984 Mar;131(3):473-6. doi: 10.1016/s0022-5347(17)50456-5.","Jacobs SC","J Urol","1984","1984/03/01","","","10.1016/s0022-5347(17)50456-5"
"29578150","Elevated expression of matrix metalloproteinase-9 is associated with bladder cancer pathogenesis","Wu GJ, Bao JS, Yue ZJ, Zeng FC, Cen S, Tang ZY, Kang XL.","J Cancer Res Ther. 2018;14(Supplement):S54-S59. doi: 10.4103/0973-1482.163761.","Wu GJ","J Cancer Res Ther","2018","2018/03/27","","","10.4103/0973-1482.163761"
"17868423","Total or partial prostate sparing cystectomy for invasive bladder cancer: long-term implications on erectile function","Davila HH, Weber T, Burday D, Thurman S, Carrion R, Salup R, Lockhart JL.","BJU Int. 2007 Nov;100(5):1026-9. doi: 10.1111/j.1464-410X.2007.07169.x. Epub 2007 Sep 14.","Davila HH","BJU Int","2007","2007/09/18","","","10.1111/j.1464-410X.2007.07169.x"
"3480378","Bladder cancer, drinking water source, and tap water consumption: a case-control study","Cantor KP, Hoover R, Hartge P, Mason TJ, Silverman DT, Altman R, Austin DF, Child MA, Key CR, Marrett LD, et al.","J Natl Cancer Inst. 1987 Dec;79(6):1269-79.","Cantor KP","J Natl Cancer Inst","1987","1987/12/01","","",""
"22676953","Sunitinib malate provides activity against murine bladder tumor growth and invasion in a preclinical orthotopic model","Chan ES, Patel AR, Hansel DE, Larchian WA, Heston WD.","Urology. 2012 Sep;80(3):736.e1-5. doi: 10.1016/j.urology.2012.04.038. Epub 2012 Jun 5.","Chan ES","Urology","2012","2012/06/09","","","10.1016/j.urology.2012.04.038"
"10364753","Intravesical instillation of mitomycin-C in 242 patients with superficial bladder cancer at high risk of recurrence: long-term results","Hurle R, Manzetti A, Losa A, Micheli E, Ranieri A, Chinaglia D, Lembo A.","Urol Int. 1998;61(4):220-6. doi: 10.1159/000030333.","Hurle R","Urol Int","1998","1999/06/12","","","10.1159/000030333"
"26078839","The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study","Shim JS, Choi H, Noh TI, Tae JH, Yoon SG, Kang SH, Bae JH, Park HS, Park JY.","Korean J Urol. 2015 Jun;56(6):429-34. doi: 10.4111/kju.2015.56.6.429. Epub 2015 May 28.","Shim JS","Korean J Urol","2015","2015/06/17","PMC4462632","","10.4111/kju.2015.56.6.429"
"27050274","MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5","Xu T, Qin L, Zhu Z, Wang X, Liu Y, Fan Y, Zhong S, Wang X, Zhang X, Xia L, Zhang X, Xu C, Shen Z.","Oncotarget. 2016 May 10;7(19):27445-57. doi: 10.18632/oncotarget.8479.","Xu T","Oncotarget","2016","2016/04/07","PMC5053662","","10.18632/oncotarget.8479"
"8079692","[A vesicoileal fistula secondary to bladder cancer]","Reig Ruiz C, Vallejo Gil C, Lorente Garín JA, Vila Barja J, Morote Robles J, Soler Roselló A.","Actas Urol Esp. 1994 May;18(5):615-8.","Reig Ruiz C","Actas Urol Esp","1994","1994/05/01","","",""
"19458995","Diagnosis of bladder cancer: contrast-enhanced ultrasound","Nicolau C, Bunesch L, Sebastia C, Salvador R.","Abdom Imaging. 2010 Aug;35(4):494-503. doi: 10.1007/s00261-009-9540-9. Epub 2009 May 21.","Nicolau C","Abdom Imaging","2010","2009/05/22","","","10.1007/s00261-009-9540-9"
"3679595","DNA cytometry and cytology by quantitative fluorescence image analysis in symptomatic bladder cancer patients","Bass RA, Hemstreet GP 3rd, Honker NA, Hurst RE, Doggett RS.","Int J Cancer. 1987 Nov 15;40(5):698-705. doi: 10.1002/ijc.2910400522.","Bass RA","Int J Cancer","1987","1987/11/15","","","10.1002/ijc.2910400522"
"3746497","Interventions in high-risk occupational cohorts: a cross-sectional demonstration project","Tillett S, Ringen K, Schulte P, McDougall V, Miller K, Samuels S.","J Occup Med. 1986 Aug;28(8):719-27. doi: 10.1097/00043764-198608000-00035.","Tillett S","J Occup Med","1986","1986/08/01","","","10.1097/00043764-198608000-00035"
"22981672","ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder","Burger M, Oosterlinck W, Konety B, Chang S, Gudjonsson S, Pruthi R, Soloway M, Solsona E, Sved P, Babjuk M, Brausi MA, Cheng C, Comperat E, Dinney C, Otto W, Shah J, Thürof J, Witjes JA; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012.","Eur Urol. 2013 Jan;63(1):36-44. doi: 10.1016/j.eururo.2012.08.061. Epub 2012 Sep 5.","Burger M","Eur Urol","2013","2012/09/18","","","10.1016/j.eururo.2012.08.061"
"15206215","[Neoadjuvant chemotherapy: meta-analysis and interpretation of results in bladder cancer]","Pollera CF.","Suppl Tumori. 2004 Jul-Aug;3(4):S59-61.","Pollera CF","Suppl Tumori","2004","2004/06/23","","",""
"1385130","A new marker for early detection and indicator of progression of cancer of the bladder. Preliminary results with Ag-NOR index in 38 cases of superficial bladder cancer","Marandola P, Lardennois B, Ploton D, Derenzini M, Treré D, Campo B, Valentino V, Tronci A, Roggia A, Broggini P, et al.","Eur Urol. 1992;21 Suppl 1:31-3. doi: 10.1159/000474884.","Marandola P","Eur Urol","1992","1992/01/01","","","10.1159/000474884"
"11396238","Tumor markers in stage P1 bladder cancer","Stavropoulos NE, Ioachim E, Charchanti A, Michael MC, Kitsiou E, Mihailidis I, Hastazeris K, Agnantis NJ.","Anticancer Res. 2001 Mar-Apr;21(2B):1495-8.","Stavropoulos NE","Anticancer Res","2001","2001/06/09","","",""
"31207288","Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells","Cucci MA, Compagnone A, Daga M, Grattarola M, Ullio C, Roetto A, Palmieri A, Rosa AC, Argenziano M, Cavalli R, Simile MM, Pascale RM, Dianzani C, Barrera G, Pizzimenti S.","Free Radic Biol Med. 2019 Sep;141:205-219. doi: 10.1016/j.freeradbiomed.2019.06.009. Epub 2019 Jun 15.","Cucci MA","Free Radic Biol Med","2019","2019/06/18","","","10.1016/j.freeradbiomed.2019.06.009"
"6897634","An epidemiological case-control study of bladder cancer in males from a predominantly rural district","Mommsen S, Aagaard J, Sell A.","Eur J Cancer Clin Oncol. 1982 Nov;18(11):1205-10. doi: 10.1016/0277-5379(82)90103-1.","Mommsen S","Eur J Cancer Clin Oncol","1982","1982/11/01","","","10.1016/0277-5379(82)90103-1"
"31434998","Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer","Joice GA, Bivalacqua TJ, Kates M.","Nat Rev Urol. 2019 Oct;16(10):599-612. doi: 10.1038/s41585-019-0220-4. Epub 2019 Aug 21.","Joice GA","Nat Rev Urol","2019","2019/08/23","","","10.1038/s41585-019-0220-4"
"26100328","Commentary on ""Racial variation in the quality of surgical care for bladder cancer."" Barocas DA, Alvarez J, Koyama T, Anderson CB, Gray DT, Fowke JH, You C, Chang SS, Cookson MS, Smith JA Jr, Penson DF, Department of Urologic Surgery, Vanderbilt University, Nashville, Tennessee; Center for Surgical Quality and Outcomes Research, Vanderbilt University, Nashville, Tennessee.: Cancer. 2014 Apr 1;120(7):1018-25. doi:10.1002/cncr.28520. [Epub 2013 Dec 11]","Hollenbeck B.","Urol Oncol. 2016 May;34(5):251-2. doi: 10.1016/j.urolonc.2015.02.018. Epub 2015 Jun 20.","Hollenbeck B","Urol Oncol","2016","2015/06/24","","","10.1016/j.urolonc.2015.02.018"
"30268126","Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer","Zhan Y, Du L, Wang L, Jiang X, Zhang S, Li J, Yan K, Duan W, Zhao Y, Wang L, Wang Y, Wang C.","Mol Cancer. 2018 Sep 29;17(1):142. doi: 10.1186/s12943-018-0893-y.","Zhan Y","Mol Cancer","2018","2018/10/01","PMC6162963","","10.1186/s12943-018-0893-y"
"25866762","Bladder carcinoma data with clinical risk factors and molecular markers: a cluster analysis","Redondo-Gonzalez E, de Castro LN, Moreno-Sierra J, Maestro de las Casas ML, Vera-Gonzalez V, Ferrari DG, Corchado JM.","Biomed Res Int. 2015;2015:168682. doi: 10.1155/2015/168682. Epub 2015 Mar 19.","Redondo-Gonzalez E","Biomed Res Int","2015","2015/04/14","PMC4383273","","10.1155/2015/168682"
"2280084","[DNA content in 51 deparaffinized pT1 urothelial tumors. A follow-up of more than 6 years. Clinical evaluation, correlation with survival]","Bittard H, Lamy B, Billerey C, Khenifar E.","J Urol (Paris). 1990;96(6):311-3.","Bittard H","J Urol (Paris)","1990","1990/01/01","","",""
"6656056","[In vitro sensitivity of human bladder cancer cell lines to various sex steroid hormones--effect of estradiol-17 beta on T24 cells and 253J cells]","Yoshimoto J.","Nihon Hinyokika Gakkai Zasshi. 1983 Jun;74(6):897-906. doi: 10.5980/jpnjurol1928.74.6_897.","Yoshimoto J","Nihon Hinyokika Gakkai Zasshi","1983","1983/06/01","","","10.5980/jpnjurol1928.74.6_897"
"19016022","Treatment options for high-risk T1 bladder cancer: status quo and future perspectives of radiochemotherapy","Weiss C, Ott OJ, Wittlinger M, Krause SF, Fietkau R, Sauer R, Rödel C.","Strahlenther Onkol. 2008 Sep;184(9):443-9. doi: 10.1007/s00066-008-1855-x. Epub 2008 Sep 19.","Weiss C","Strahlenther Onkol","2008","2008/11/19","","","10.1007/s00066-008-1855-x"
"8893870","Therapy of superficial bladder cancer","Nseyo UO, Lamm DL.","Semin Oncol. 1996 Oct;23(5):598-604.","Nseyo UO","Semin Oncol","1996","1996/10/01","","",""
"15045143","Does warfarin therapy influence the risk of bladder cancer?","Blumentals WA, Foulis PR, Schwartz SW, Mason TJ.","Thromb Haemost. 2004 Apr;91(4):801-5. doi: 10.1160/TH03-08-0553.","Blumentals WA","Thromb Haemost","2004","2004/03/27","","","10.1160/TH03-08-0553"
"28583312","Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study","Dyrskjøt L, Reinert T, Algaba F, Christensen E, Nieboer D, Hermann GG, Mogensen K, Beukers W, Marquez M, Segersten U, Høyer S, Ulhøi BP, Hartmann A, Stöhr R, Wach S, Nawroth R, Schwamborn K, Tulic C, Simic T, Junker K, Harving N, Petersen AC, Jensen JB, Keck B, Grimm MO, Horstmann M, Maurer T, Steyerberg EW, Zwarthoff EC, Real FX, Malats N, Malmström PU, Ørntoft TF.","Eur Urol. 2017 Sep;72(3):461-469. doi: 10.1016/j.eururo.2017.05.040. Epub 2017 Jun 2.","Dyrskjøt L","Eur Urol","2017","2017/06/07","","","10.1016/j.eururo.2017.05.040"
"11037655","[Radical cystectomy in the treatment of cancer of the bladder]","Herranz Amo F, Díez Cordero JM, Verdú Tartajo F, Bielsa Carrillo A, García Burgos J, Subirá Ríos D, Castaño González I.","Arch Esp Urol. 2000 Sep;53(7):619-24.","Herranz Amo F","Arch Esp Urol","2000","2000/10/19","","",""
"26219472","Urinary cytology in bladder cancer: why is it still relevant?","Comploj E, Trenti E, Palermo S, Pycha A, Mian C.","Urologia. 2015 Oct-Dec;82(4):203-5. doi: 10.5301/uro.5000129. Epub 2015 Jul 15.","Comploj E","Urologia","2015","2015/07/30","","","10.5301/uro.5000129"
"6369720","Molecular markers in the diagnosis and prognosis of bladder cancer","Lange PH, Limas C.","Urology. 1984 Apr;23(4 Suppl):46-54. doi: 10.1016/s0090-4295(84)80069-2.","Lange PH","Urology","1984","1984/04/01","","","10.1016/s0090-4295(84)80069-2"
"23540780","New agents for bacillus Calmette-Guérin-refractory bladder cancer","Ahn JJ, McKiernan JM.","Urol Clin North Am. 2013 May;40(2):219-32. doi: 10.1016/j.ucl.2013.01.008. Epub 2013 Mar 5.","Ahn JJ","Urol Clin North Am","2013","2013/04/02","","","10.1016/j.ucl.2013.01.008"
"24937311","Use of mode of action data to inform a dose-response assessment for bladder cancer following exposure to inorganic arsenic","Gentry PR, Yager JW, Clewell RA, Clewell HJ 3rd.","Toxicol In Vitro. 2014 Oct;28(7):1196-205. doi: 10.1016/j.tiv.2014.05.011. Epub 2014 Jun 14.","Gentry PR","Toxicol In Vitro","2014","2014/06/18","","","10.1016/j.tiv.2014.05.011"
"27117749","The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results","Naito S, Algaba F, Babjuk M, Bryan RT, Sun YH, Valiquette L, de la Rosette J; CROES Narrow Band Imaging Global Study Group.","Eur Urol. 2016 Sep;70(3):506-15. doi: 10.1016/j.eururo.2016.03.053. Epub 2016 Apr 23.","Naito S","Eur Urol","2016","2016/04/28","","","10.1016/j.eururo.2016.03.053"
"17121885","Nomograms provide improved accuracy for predicting survival after radical cystectomy","Shariat SF, Karakiewicz PI, Palapattu GS, Amiel GE, Lotan Y, Rogers CG, Vazina A, Bastian PJ, Gupta A, Sagalowsky AI, Schoenberg M, Lerner SP.","Clin Cancer Res. 2006 Nov 15;12(22):6663-76. doi: 10.1158/1078-0432.CCR-06-0372.","Shariat SF","Clin Cancer Res","2006","2006/11/24","","","10.1158/1078-0432.CCR-06-0372"
"10458383","Re: Hydronephrosis as a prognostic indicator in bladder cancer patients","Leibovitch I.","J Urol. 1999 Sep;162(3 Pt 1):808. doi: 10.1097/00005392-199909010-00062.","Leibovitch I","J Urol","1999","1999/08/24","","","10.1097/00005392-199909010-00062"
"22339742","Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder","Hindson BR, Turner SL, Millar JL, Foroudi F, Gogna NK, Skala M, Kneebone A, Christie DR, Lehman M, Wiltshire KL, Tai KH; RANZCR Faculty of Radiation Oncology Genito-Urinary Group (FROGG).","J Med Imaging Radiat Oncol. 2012 Feb;56(1):18-30. doi: 10.1111/j.1754-9485.2011.02336.x.","Hindson BR","J Med Imaging Radiat Oncol","2012","2012/02/21","","","10.1111/j.1754-9485.2011.02336.x"
"20083643","Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population","Wang S, Tang J, Wang M, Yuan L, Zhang Z.","Carcinogenesis. 2010 Apr;31(4):621-4. doi: 10.1093/carcin/bgp323. Epub 2010 Jan 18.","Wang S","Carcinogenesis","2010","2010/01/20","","","10.1093/carcin/bgp323"
"25882565","Surgical advances in bladder cancer: at what cost?","Johnson DC, Greene PS, Nielsen ME.","Urol Clin North Am. 2015 May;42(2):235-52, ix. doi: 10.1016/j.ucl.2015.01.005. Epub 2015 Mar 3.","Johnson DC","Urol Clin North Am","2015","2015/04/18","","","10.1016/j.ucl.2015.01.005"
"7659187","Radiotherapy plus fifth day carboplatin in locally advanced bladder cancer","Radosević-Jelić L, Pekmezović T, Borkovacki R, Marković V.","Neoplasma. 1995;42(4):203-6.","Radosević-Jelić L","Neoplasma","1995","1995/01/01","","",""
"7817458","[Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer]","Stöckle M.","Urologe A. 1994 Nov;33(6):568-75.","Stöckle M","Urologe A","1994","1994/11/01","","",""
"15150549","Bladder cancer: worse survival in women from deprived areas","Moran A, Sowerbutts AM, Collins S, Clarke N, Cowan R.","Br J Cancer. 2004 Jun 1;90(11):2142-4. doi: 10.1038/sj.bjc.6601847.","Moran A","Br J Cancer","2004","2004/05/20","PMC2409491","","10.1038/sj.bjc.6601847"
"1255884","The interaction of host immunocompetence and tumor aggressiveness in superficial bladder carcinoma","Decenzo JM, Leadbetter GW Jr.","J Urol. 1976 Mar;115(3):262-3. doi: 10.1016/s0022-5347(17)59164-8.","Decenzo JM","J Urol","1976","1976/03/11","","","10.1016/s0022-5347(17)59164-8"
"30893148","Immunotherapy in nonmuscle invasive bladder cancer: current and emerging treatments","Gupta M, Kates M, Bivalacqua TJ.","Curr Opin Oncol. 2019 May;31(3):183-187. doi: 10.1097/CCO.0000000000000533.","Gupta M","Curr Opin Oncol","2019","2019/03/21","","","10.1097/CCO.0000000000000533"
"7018669","Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients","Winters WD, Lamm DL.","Cancer Res. 1981 Jul;41(7):2672-6.","Winters WD","Cancer Res","1981","1981/07/01","","",""
"21760912","Expression of RFC/SLC19A1 is associated with tumor type in bladder cancer patients","Abdel-Haleem AM, El-Zeiry MI, Mahran LG, Abou-Aisha K, Rady MH, Rohde J, Mostageer M, Spahn-Langguth H.","PLoS One. 2011;6(7):e21820. doi: 10.1371/journal.pone.0021820. Epub 2011 Jul 8.","Abdel-Haleem AM","PLoS One","2011","2011/07/16","PMC3132752","","10.1371/journal.pone.0021820"
"22512969","Initial North American experience with the use of the Olympus Button Electrode for vaporization of bladder tumors","Canter DJ, Ogan K, Master VA.","Can J Urol. 2012 Apr;19(2):6211-6.","Canter DJ","Can J Urol","2012","2012/04/20","","",""
"28359179","Tackling non-muscle invasive bladder cancer in the clinic","Woldu SL, Şanli Ö, Lotan Y.","Expert Rev Anticancer Ther. 2017 May;17(5):467-480. doi: 10.1080/14737140.2017.1313119. Epub 2017 Apr 11.","Woldu SL","Expert Rev Anticancer Ther","2017","2017/04/01","","","10.1080/14737140.2017.1313119"
"7563393","Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC","Scher HI.","J Urol. 1995 Nov;154(5):1969.","Scher HI","J Urol","1995","1995/11/01","","",""
"2217413","Neo-adjuvant intra-arterial chemotherapy in locally advanced bladder cancer","Chechile G, Montie J, Pontes JE, Bukowski RM.","Prog Clin Biol Res. 1990;353:153-61.","Chechile G","Prog Clin Biol Res","1990","1990/01/01","","",""
"4654526","The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer","Dretler SP, Ragsdale BD, Leadbetter WF.","Trans Am Assoc Genitourin Surg. 1972;64:79-84.","Dretler SP","Trans Am Assoc Genitourin Surg","1972","1972/01/01","","",""
"6886875","Staging of urinary bladder cancer by computerized tomography compared to clinical staging and postoperative pathological staging","Fryjordet A, Skåtun J.","J Oslo City Hosp. 1983 Jun;33(6):76-9.","Fryjordet A","J Oslo City Hosp","1983","1983/06/01","","",""
"25339064","Revisiting structure, process, and outcome","Gilbert SM.","Cancer. 2015 Feb 1;121(3):328-30. doi: 10.1002/cncr.29070. Epub 2014 Oct 22.","Gilbert SM","Cancer","2015","2014/10/24","","","10.1002/cncr.29070"
"2918724","Limitations of flow cytometric DNA analysis for the diagnosis of bladder cancer","Boileau MA, Swartz D, Schmidt KL, Schmidt WA.","J Surg Oncol. 1989 Mar;40(3):194-200. doi: 10.1002/jso.2930400313.","Boileau MA","J Surg Oncol","1989","1989/03/01","","","10.1002/jso.2930400313"
"18895914","[Primitive cancer of the gallbladder]","LARRE H.","Dia Med. 1947 May 19;19(22):768-72.","LARRE H","Dia Med","1947","1947/05/19","","",""
"11441942","A systematic overview of chemotherapy effects in urothelial bladder cancer","Nilsson S, Ragnhammar P, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.","Acta Oncol. 2001;40(2-3):371-90. doi: 10.1080/02841860151116466.","Nilsson S","Acta Oncol","2001","2001/07/10","","","10.1080/02841860151116466"
"19375957","A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer","Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, Jocham D, Warnecke JM, Sczakiel G.","Urol Oncol. 2010 Nov-Dec;28(6):655-61. doi: 10.1016/j.urolonc.2009.01.027. Epub 2009 Apr 17.","Hanke M","Urol Oncol","2010","2009/04/21","","","10.1016/j.urolonc.2009.01.027"
"18513850","Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker","Pignot G, Bieche I, Vacher S, Güet C, Vieillefond A, Debré B, Lidereau R, Amsellem-Ouazana D.","Eur Urol. 2009 Oct;56(4):678-88. doi: 10.1016/j.eururo.2008.05.027. Epub 2008 May 23.","Pignot G","Eur Urol","2009","2008/06/03","","","10.1016/j.eururo.2008.05.027"
"30755233","The role of oncostatin M receptor gene polymorphisms in bladder cancer","Deng S, He SY, Zhao P, Zhang P.","World J Surg Oncol. 2019 Feb 12;17(1):30. doi: 10.1186/s12957-018-1555-7.","Deng S","World J Surg Oncol","2019","2019/02/14","PMC6371456","","10.1186/s12957-018-1555-7"
"24315309","Enhanced antitumor efficacy of integrin-targeted oncolytic adenovirus AxdAdB3-F/RGD on bladder cancer","Wang H, Cai Z, Yang F, Luo J, Satoh M, Arai Y, Li D.","Urology. 2014 Feb;83(2):508.e13-9. doi: 10.1016/j.urology.2013.10.025. Epub 2013 Dec 6.","Wang H","Urology","2014","2013/12/10","","","10.1016/j.urology.2013.10.025"
"3168855","Cancer of the urinary bladder at Kenyatta National Hospital as seen by physicians: a retrospective study (1979-1984)","Otieno LS, Mc'Ligeyo SO, Kimani FM.","East Afr Med J. 1988 Apr;65(4):224-9.","Otieno LS","East Afr Med J","1988","1988/04/01","","",""
"20405743","[Optimization of the operative treatment of patients of elderly and senile age with superficial bladder cancer]","Kazarov RL, Kazarov LR, Kagan OF, Kheĭfets VKh, Khrolovich AB.","Adv Gerontol. 2009;22(4):695-9.","Kazarov RL","Adv Gerontol","2009","2010/04/22","","",""
"16497827","Neo-adjuvant chemotherapy for muscle-invasive bladder cancer: a look ahead","Sawhney R, Bourgeois D, Chaudhary UB.","Ann Oncol. 2006 Sep;17(9):1360-9. doi: 10.1093/annonc/mdl008. Epub 2006 Feb 23.","Sawhney R","Ann Oncol","2006","2006/02/25","","","10.1093/annonc/mdl008"
"22729812","The value of the preoperative FISH test in unscreened bladder cancer patients with TUR indications","Petrov SV, Malkhasyan KA, Ulyanin MY, Abdrakhmanov EF, Khasanov RSh.","Pathol Oncol Res. 2012 Oct;18(4):1059-66. doi: 10.1007/s12253-012-9544-6. Epub 2012 Jun 23.","Petrov SV","Pathol Oncol Res","2012","2012/06/26","","","10.1007/s12253-012-9544-6"
"4992880","Clinical staging system for carcinoma of the urinary bladder","","CA Cancer J Clin. 1968 Sep-Oct;18(5):284-6. doi: 10.3322/canjclin.18.5.284.","","CA Cancer J Clin","1968","1968/09/01","","","10.3322/canjclin.18.5.284"
"18149849","[Partial cystectomy in the treatment of bladder cancer]","PATOIR G.","Lille Chir. 1949 Jan-Feb;4(19):37.","PATOIR G","Lille Chir","1949","1949/01/01","","",""
"4114434","[Cancer of the bladder]","","Urol Int. 1971;26(6):425-44.","","Urol Int","1971","1971/01/01","","",""
"24053616","Preoperative serum albumin is associated with mortality and complications after radical cystectomy","Garg T, Chen LY, Kim PH, Zhao PT, Herr HW, Donat SM.","BJU Int. 2014 Jun;113(6):918-23. doi: 10.1111/bju.12405.","Garg T","BJU Int","2014","2013/09/24","PMC4203702","NIHMS517240","10.1111/bju.12405"
"15833511","Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy?","Hong SK, Kwak C, Jeon HG, Lee E, Lee SE.","Urology. 2005 Apr;65(4):697-702. doi: 10.1016/j.urology.2004.10.048.","Hong SK","Urology","2005","2005/04/19","","","10.1016/j.urology.2004.10.048"
"7923182","E-cadherin expression determines the mode of replacement of normal urothelium by human bladder carcinoma cells","Rebel JM, Thijssen CD, Vermey M, Delouvée A, Zwarthoff EC, Van der Kwast TH.","Cancer Res. 1994 Oct 15;54(20):5488-92.","Rebel JM","Cancer Res","1994","1994/10/15","","",""
"1433633","Clinical evidence of systemic persistence of bacillus Calmette-Guerin: long-term pulmonary bacillus Calmette-Guerin infection after intravesical therapy for bladder cancer and subsequent cystectomy","Böhle A, Kirsten D, Schröder KH, Knipper A, Fornara P, Magnussen H, Jocham D.","J Urol. 1992 Dec;148(6):1894-7. doi: 10.1016/s0022-5347(17)37063-5.","Böhle A","J Urol","1992","1992/12/01","","","10.1016/s0022-5347(17)37063-5"
"27671517","5-Aminolevulinic acid in intraoperative photodynamic therapy of bladder cancer (results of multicenter trial)","Filonenko EV, Kaprin AD, Alekseev BY, Apolikhin OI, Slovokhodov EK, Ivanova-Radkevich VI, Urlova AN.","Photodiagnosis Photodyn Ther. 2016 Dec;16:106-109. doi: 10.1016/j.pdpdt.2016.09.009. Epub 2016 Oct 17.","Filonenko EV","Photodiagnosis Photodyn Ther","2016","2016/09/28","","","10.1016/j.pdpdt.2016.09.009"
"15963113","The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer","Jain S, Kockelbergh RC.","BJU Int. 2005 Jul;96(1):17-21. doi: 10.1111/j.1464-410X.2004.05559.x.","Jain S","BJU Int","2005","2005/06/21","","","10.1111/j.1464-410X.2004.05559.x"
"12604129","Overview of gemcitabine triplets in metastatic bladder cancer","de Wit R, Bellmunt J.","Crit Rev Oncol Hematol. 2003 Feb;45(2):191-7. doi: 10.1016/s1040-8428(02)00079-3.","de Wit R","Crit Rev Oncol Hematol","2003","2003/02/27","","","10.1016/s1040-8428(02)00079-3"
"30089338","[Post-Operative Immediate Single Instillation of Chemotherapy as Prevention of Recurrence after Transurethral Resection of Intermediate-High Risk Non-Muscle-Invasive Bladder Cancer]","Sugiura S, Noto N, Koizumi M, Takamoto D, Fujikawa N, Ikeda I.","Hinyokika Kiyo. 2018 Jul;64(7):297-301. doi: 10.14989/ActaUrolJap_64_7_297.","Sugiura S","Hinyokika Kiyo","2018","2018/08/09","","","10.14989/ActaUrolJap_64_7_297"
"7557751","Human bladder cancer: evidence for a potential irritation-induced mechanism","Burin GJ, Gibb HJ, Hill RN.","Food Chem Toxicol. 1995 Sep;33(9):785-95. doi: 10.1016/0278-6915(95)00045-4.","Burin GJ","Food Chem Toxicol","1995","1995/09/01","","","10.1016/0278-6915(95)00045-4"
"23839668","Preoperative risk factors related to bladder cancer rehabilitation: a registry study","Jensen BT, Laustsen S, Petersen AK, Borre M, Soendergaard I, Ernst-Jensen KM, Lash TL, Borre M.","Eur J Clin Nutr. 2013 Sep;67(9):917-21. doi: 10.1038/ejcn.2013.120. Epub 2013 Jul 10.","Jensen BT","Eur J Clin Nutr","2013","2013/07/11","","","10.1038/ejcn.2013.120"
"9652833","Radiotherapy of bladder cancer: relevance of bladder volume changes in planning boost treatment","Miralbell R, Nouet P, Rouzaud M, Bardina A, Hejira N, Schneider D.","Int J Radiat Oncol Biol Phys. 1998 Jul 1;41(4):741-6. doi: 10.1016/s0360-3016(98)00131-x.","Miralbell R","Int J Radiat Oncol Biol Phys","1998","1998/07/04","","","10.1016/s0360-3016(98)00131-x"
"25777682","Neutrophil-Lymphocyte Ratio and Pathological Response to Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer","Seah JA, Leibowitz-Amit R, Atenafu EG, Alimohamed N, Knox JJ, Joshua AM, Sridhar SS.","Clin Genitourin Cancer. 2015 Aug;13(4):e229-e233. doi: 10.1016/j.clgc.2015.02.001. Epub 2015 Feb 7.","Seah JA","Clin Genitourin Cancer","2015","2015/03/18","","","10.1016/j.clgc.2015.02.001"
"12780829","Urinary markers in bladder cancer","Bailey MJ.","BJU Int. 2003 Jun;91(9):772-3. doi: 10.1046/j.1464-410x.2003.04250.x.","Bailey MJ","BJU Int","2003","2003/06/05","","","10.1046/j.1464-410x.2003.04250.x"
"8873383","The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes","Stadler WM, Olopade OI.","Urol Res. 1996;24(4):239-44. doi: 10.1007/BF00295899.","Stadler WM","Urol Res","1996","1996/01/01","","","10.1007/BF00295899"
"8308968","The cure of bladder cancer: the need for multidisciplinary efforts","Vogelzang NJ, Stadler W, Rukstalis D.","J Urol. 1994 Mar;151(3):605-6. doi: 10.1016/s0022-5347(17)35028-0.","Vogelzang NJ","J Urol","1994","1994/03/01","","","10.1016/s0022-5347(17)35028-0"
"22621963","Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-Study","Banek S, Schwentner C, Täger D, Pesch B, Nasterlack M, Leng G, Gawrych K, Bonberg N, Johnen G, Kluckert M, Gakis G, Todenhöfer T, Hennenlotter J, Brüning T, Stenzl A; UroScreen Study Group.","Urol Oncol. 2013 Nov;31(8):1656-62. doi: 10.1016/j.urolonc.2012.04.015. Epub 2012 May 22.","Banek S","Urol Oncol","2013","2012/05/25","","","10.1016/j.urolonc.2012.04.015"
"28842247","Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database","Fischer-Valuck BW, Rao YJ, Rudra S, Przybysz D, Germino E, Samson P, Baumann BC, Gay H, Michalski J.","J Urol. 2018 Feb;199(2):416-423. doi: 10.1016/j.juro.2017.08.086. Epub 2017 Aug 24.","Fischer-Valuck BW","J Urol","2018","2017/08/27","","","10.1016/j.juro.2017.08.086"
"16697800","Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder","Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, Gupta A, Vazina A, Gilad A, Sagalowsky AI, Lerner SP, Schoenberg MP.","J Urol. 2006 Jun;175(6):2048-53; discussion 2053. doi: 10.1016/S0022-5347(06)00317-X.","Rogers CG","J Urol","2006","2006/05/16","","","10.1016/S0022-5347(06)00317-X"
"18842797","Cultured milk, yogurt, and dairy intake in relation to bladder cancer risk in a prospective study of Swedish women and men","Larsson SC, Andersson SO, Johansson JE, Wolk A.","Am J Clin Nutr. 2008 Oct;88(4):1083-7. doi: 10.1093/ajcn/88.4.1083.","Larsson SC","Am J Clin Nutr","2008","2008/10/10","","","10.1093/ajcn/88.4.1083"
"21296399","Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder","Ghoneim IA, Miocinovic R, Stephenson AJ, Garcia JA, Gong MC, Campbell SC, Hansel DE, Fergany AF.","Urology. 2011 Apr;77(4):867-70. doi: 10.1016/j.urology.2010.11.043. Epub 2011 Feb 5.","Ghoneim IA","Urology","2011","2011/02/08","","","10.1016/j.urology.2010.11.043"
"2074501","National estimates of occupational exposure to animal bladder tumorigens","Ruder AM, Fine LJ, Sundin DS.","J Occup Med. 1990 Sep;32(9):797-805. doi: 10.1097/00043764-199009000-00009.","Ruder AM","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00009"
"17512514","Use of an interferon-gamma based assay to assess bladder cancer patients treated with intravesical BCG and exposed to tuberculosis","Silverman MS, Reynolds D, Kavsak PA, Garay J, Daly A, Davis I.","Clin Biochem. 2007 Aug;40(12):913-5. doi: 10.1016/j.clinbiochem.2007.04.006. Epub 2007 Apr 27.","Silverman MS","Clin Biochem","2007","2007/05/22","","","10.1016/j.clinbiochem.2007.04.006"
"9004434","The combined effects of high-energy shock waves and ionising radiation on a human bladder cancer cell line","Fickweiler S, Steinbach P, Wörle K, Hofstädter F.","Ultrasound Med Biol. 1996;22(8):1097-102. doi: 10.1016/s0301-5629(96)00124-x.","Fickweiler S","Ultrasound Med Biol","1996","1996/01/01","","","10.1016/s0301-5629(96)00124-x"
"17060081","Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancer","Berggren de Verdier PJ, Kumar R, Adolfsson J, Larsson P, Norming U, Onelöv E, Wijkström H, Steineck G, Hemminki K.","Scand J Urol Nephrol. 2006;40(5):363-9. doi: 10.1080/00365590600795396.","Berggren de Verdier PJ","Scand J Urol Nephrol","2006","2006/10/25","","","10.1080/00365590600795396"
"17531466","Occurrence of both bladder and prostate cancer in five cancer registries in Belgium, The Netherlands and the United Kingdom","Kellen E, Zeegers MP, Dirx M, Houterman S, Droste J, Lawrence G, Truyers C, Bruckers L, Molenberghs G, Joniau S, Buntinx F.","Eur J Cancer. 2007 Jul;43(11):1694-700. doi: 10.1016/j.ejca.2007.04.011. Epub 2007 May 24.","Kellen E","Eur J Cancer","2007","2007/05/29","","","10.1016/j.ejca.2007.04.011"
"36279","A study on the aetiological factors of bilharzial bladder cancer in Egypt--2. Nitrosamines and their precursors in Egyptian dairy products","El-Aaser AA, El-Merzabani MM, Zakhary NI.","Eur J Cancer. 1979 Mar;15(3):293-8. doi: 10.1016/0014-2964(79)90040-9.","El-Aaser AA","Eur J Cancer","1979","1979/03/01","","","10.1016/0014-2964(79)90040-9"
"19514355","[Detection of oncoprotein E7 HPV16 in the cancer and normal urinary bladder urothelium]","Volgareva GM, Zavalishina LE, Golovina DA, Andreeva IuIu, Ermilova VD, Cheban NL, Kuevda DA, Trofimova OB, Shipulina OIu, Pavlova LS, Petrov AN, Matveev VB, Shtil' AA, Frank GA.","Arkh Patol. 2009 Jan-Feb;71(1):29-30.","Volgareva GM","Arkh Patol","2009","2009/06/12","","",""
"7410009","Induction of a transplantable urinary bladder carcinoma in dogs","Harzmann R, Gericke D, Altenähr E, Bichler KH.","Invest Urol. 1980 Jul;18(1):24-8.","Harzmann R","Invest Urol","1980","1980/07/01","","",""
"19690542","Prostate cancer as a first and second cancer: effect of family history","Zhang H, Bermejo JL, Sundquist J, Hemminki K.","Br J Cancer. 2009 Sep 15;101(6):935-9. doi: 10.1038/sj.bjc.6605263. Epub 2009 Aug 18.","Zhang H","Br J Cancer","2009","2009/08/20","PMC2743371","","10.1038/sj.bjc.6605263"
"25851271","Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy","Moschini M, Sharma V, Dell'oglio P, Cucchiara V, Gandaglia G, Cantiello F, Zattoni F, Pellucchi F, Briganti A, Damiano R, Montorsi F, Salonia A, Colombo R.","BJU Int. 2016 Apr;117(4):604-10. doi: 10.1111/bju.13146. Epub 2015 Jun 3.","Moschini M","BJU Int","2016","2015/04/09","","","10.1111/bju.13146"
"29791078","Molecular subtype classification of urothelial carcinoma in Lynch syndrome","Therkildsen C, Eriksson P, Höglund M, Jönsson M, Sjödahl G, Nilbert M, Liedberg F.","Mol Oncol. 2018 Aug;12(8):1286-1295. doi: 10.1002/1878-0261.12325. Epub 2018 Jun 19.","Therkildsen C","Mol Oncol","2018","2018/05/24","PMC6068353","","10.1002/1878-0261.12325"
"21164419","[Endosurgery in treatment of urinary bladder cancer in elderly patients]","Alferov SM, Grishin MA, Emel'ianenko AV.","Khirurgiia (Mosk). 2010;(9):30-5.","Alferov SM","Khirurgiia (Mosk)","2010","2010/12/18","","",""
"30361899","Sonic Hedgehog Expression is Associated with Lymph Node Invasion in Urothelial Bladder Cancer","Nedjadi T, Salem N, Khayyat D, Al-Sayyad A, Al-Ammari A, Al-Maghrabi J.","Pathol Oncol Res. 2019 Jul;25(3):1067-1073. doi: 10.1007/s12253-018-0477-6. Epub 2018 Oct 25.","Nedjadi T","Pathol Oncol Res","2019","2018/10/27","PMC6614154","","10.1007/s12253-018-0477-6"
"11477133","What we could do now: molecular pathology of bladder cancer","Knowles MA.","Mol Pathol. 2001 Aug;54(4):215-21. doi: 10.1136/mp.54.4.215.","Knowles MA","Mol Pathol","2001","2001/07/31","PMC1187069","","10.1136/mp.54.4.215"
"24360658","Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs","Ganapathi RN, Ganapathi MK.","Urol Oncol. 2014 Jan;32(1):1-4. doi: 10.1016/j.urolonc.2013.08.027.","Ganapathi RN","Urol Oncol","2014","2013/12/24","","","10.1016/j.urolonc.2013.08.027"
"21906965","The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer","Morgan TM, Barocas DA, Chang SS, Phillips SE, Salem S, Clark PE, Penson DF, Smith JA Jr, Cookson MS.","Urol Oncol. 2013 Aug;31(6):871-7. doi: 10.1016/j.urolonc.2011.07.012. Epub 2011 Sep 9.","Morgan TM","Urol Oncol","2013","2011/09/13","PMC3253245","NIHMS325179","10.1016/j.urolonc.2011.07.012"
"28756304","Chemomechanically engineered 3D organotypic platforms of bladder cancer dormancy and reactivation","Pavan Grandhi TS, Potta T, Nitiyanandan R, Deshpande I, Rege K.","Biomaterials. 2017 Oct;142:171-185. doi: 10.1016/j.biomaterials.2017.07.008. Epub 2017 Jul 7.","Pavan Grandhi TS","Biomaterials","2017","2017/07/31","","","10.1016/j.biomaterials.2017.07.008"
"7615360","Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer","Sauter G, Moch H, Carroll P, Kerschmann R, Mihatsch MJ, Waldman FM.","Int J Cancer. 1995 Apr 21;64(2):99-103. doi: 10.1002/ijc.2910640205.","Sauter G","Int J Cancer","1995","1995/04/21","","","10.1002/ijc.2910640205"
"7940124","Preliminary results of bladder-preserving therapy with definitive radiotherapy and intraarterial infusion of chemotherapy","Tsujii H, Akaza H, Ohtani M, Miyanaga N, Shimazoi T, Uchida K, Koiso K, Tsuji H, Okumura T, Ohara K.","Strahlenther Onkol. 1994 Sep;170(9):531-7.","Tsujii H","Strahlenther Onkol","1994","1994/09/01","","",""
"15615657","Peri-operative management of ablative and reconstructive surgery for invasive bladder cancer in the elderly","Maffezzini M, Gerbi G, Campodonico F, Parodi D, Capponi G, Spina A, Guerrieri AM.","Surg Oncol. 2004 Dec;13(4):197-200. doi: 10.1016/j.suronc.2004.09.006.","Maffezzini M","Surg Oncol","2004","2004/12/24","","","10.1016/j.suronc.2004.09.006"
"30549868","[Chemotherapy against bladder cancer in geriatric patients]","Nagao K, Matsuyama H.","Nihon Rinsho. 2017 Apr;75(4):615-619.","Nagao K","Nihon Rinsho","2017","2018/12/15","","",""
"9412800","Bard BTA test compared with voided urine cytology in the diagnosis of recurrent bladder cancer","Leyh H, Mazeman E.","Eur Urol. 1997;32(4):425-8.","Leyh H","Eur Urol","1997","1997/01/01","","",""
"18558323","[Prognostic value of lymph node dissections in bladder cancer treated with radical cystectomy]","Braud G, Battisti S, Karam G, Bouchot O, Rigaud J.","Prog Urol. 2008 Jun;18(6):351-7. doi: 10.1016/j.purol.2008.02.007. Epub 2008 Apr 18.","Braud G","Prog Urol","2008","2008/06/19","","","10.1016/j.purol.2008.02.007"
"11293494","Evaluation of the NMP22 test and comparison with voided urine cytology in the detection of bladder cancer","Lee KH.","Yonsei Med J. 2001 Feb;42(1):14-8. doi: 10.3349/ymj.2001.42.1.14.","Lee KH","Yonsei Med J","2001","2001/04/11","","","10.3349/ymj.2001.42.1.14"
"28801444","Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study","Oughton JB, Poad H, Twiddy M, Collinson M, Hiley V, Gordon K, Johnson M, Jain S, Noon AP, Chahal R, Simms M, Dooldeniya M, Koenig P, Goodwin L, Brown JM, Catto JWF; BRAVO study group.","BMJ Open. 2017 Aug 11;7(8):e017913. doi: 10.1136/bmjopen-2017-017913.","Oughton JB","BMJ Open","2017","2017/08/13","PMC5724134","","10.1136/bmjopen-2017-017913"
"17085118","Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium","Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.","J Urol. 2006 Dec;176(6 Pt 1):2414-22; discussion 2422. doi: 10.1016/j.juro.2006.08.004.","Shariat SF","J Urol","2006","2006/11/07","","","10.1016/j.juro.2006.08.004"
"20471156","Reply from authors re: Marko Babjuk. Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectives. Eur Urol 2010;58:191-2 and Giacomo Novara, Vincenzo Ficarra. Does routine second transurethral resection affect the long-term outcome of patients with T1 bladder cancer? Why a flawed randomized controlled trial cannot address the issue. Eur Urol 2010;58:193-4","Divrik RT, Sahin AF, Ergör G.","Eur Urol. 2010 Aug;58(2):195-6. doi: 10.1016/j.eururo.2010.04.029. Epub 2010 May 8.","Divrik RT","Eur Urol","2010","2010/05/18","","","10.1016/j.eururo.2010.04.029"
"28753817","Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up","Vind-Kezunovic S, Bouchelouche K, Ipsen P, Høyer S, Bell C, Bjerggaard Jensen J.","Eur Urol Focus. 2019 Jan;5(1):90-96. doi: 10.1016/j.euf.2017.06.005. Epub 2017 Jun 23.","Vind-Kezunovic S","Eur Urol Focus","2019","2017/07/30","","","10.1016/j.euf.2017.06.005"
"7129909","[Urinary pH and superficial bladder cancer]","Hallwachs O, Dorn R.","Helv Chir Acta. 1982 Aug;49(3-4):405-7.","Hallwachs O","Helv Chir Acta","1982","1982/08/01","","",""
"29406055","Kidney, Ureteral, and Bladder Cancer: A Primer for the Internist","Arora HC, Fascelli M, Zhang JH, Isharwal S, Campbell SC.","Med Clin North Am. 2018 Mar;102(2):231-249. doi: 10.1016/j.mcna.2017.10.002.","Arora HC","Med Clin North Am","2018","2018/02/07","","","10.1016/j.mcna.2017.10.002"
"15088900","Comparison of cytology and nuclear matrix protein 22 (NMP 22) for the detection and follow-up of bladder-cancer","Lahme S, Bichler KH, Feil G, Zumbrägel A, Götz T.","Adv Exp Med Biol. 2003;539(Pt A):111-9. doi: 10.1007/978-1-4419-8889-8_9.","Lahme S","Adv Exp Med Biol","2003","2004/04/20","","","10.1007/978-1-4419-8889-8_9"
"11938936","[Separation of human bladder cancer cells from bone marrow with a kind of immunomagnetic microspheres]","Kang J, Samten B, Xie S, Wei S.","Yao Xue Xue Bao. 1998;33(1):52-6.","Kang J","Yao Xue Xue Bao","1998","2002/04/10","","",""
"18148138","[Bladder cancer, total cystectomy and bilateral ureterointestinal implantation at the same time]","VERRIERE P.","Lyon Med. 1949 Aug 14;182(33):108.","VERRIERE P","Lyon Med","1949","1949/08/14","","",""
"21013150","[Our position on the problem of treating bladder cancer]","BISQUERTT TJ.","Arch Soc Cir Hosp. 1945 Sep;15:617-22.","BISQUERTT TJ","Arch Soc Cir Hosp","1945","2010/10/29","","",""
"18188671","The changing patterns of bladder cancer in Egypt over the past 26 years","Felix AS, Soliman AS, Khaled H, Zaghloul MS, Banerjee M, El-Baradie M, El-Kalawy M, Abd-Elsayed AA, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Wilson ML.","Cancer Causes Control. 2008 May;19(4):421-9. doi: 10.1007/s10552-007-9104-7. Epub 2008 Jan 10.","Felix AS","Cancer Causes Control","2008","2008/01/12","PMC4274945","NIHMS649876","10.1007/s10552-007-9104-7"
"18618299","Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy","Røe K, Muren LP, Rørvik J, Olsen DR, Dahl O, Bakke A, Malinen E.","Acta Oncol. 2008;47(7):1257-64. doi: 10.1080/02841860802244174.","Røe K","Acta Oncol","2008","2008/07/12","","","10.1080/02841860802244174"
"23584348","Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis","Abern MR, Owusu RA, Anderson MR, Rampersaud EN, Inman BA.","J Natl Compr Canc Netw. 2013 Apr 1;11(4):477-84. doi: 10.6004/jnccn.2013.0060.","Abern MR","J Natl Compr Canc Netw","2013","2013/04/16","","","10.6004/jnccn.2013.0060"
"19448670","A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas","Hernando E, Sarmentero-Estrada J, Koppie T, Belda-Iniesta C, Ramírez de Molina V, Cejas P, Ozu C, Le C, Sánchez JJ, González-Barón M, Koutcher J, Cordón-Cardó C, Bochner BH, Lacal JC, Ramírez de Molina A.","Oncogene. 2009 Jul 2;28(26):2425-35. doi: 10.1038/onc.2009.91. Epub 2009 May 18.","Hernando E","Oncogene","2009","2009/05/19","PMC2908237","NIHMS199862","10.1038/onc.2009.91"
"15538283","Use of prostate specific antigen to measure bladder tumor growth in a mouse orthotopic model","Luo Y, Chen X, O'donnell MA.","J Urol. 2004 Dec;172(6 Pt 1):2414-20. doi: 10.1097/01.ju.0000143860.50878.b1.","Luo Y","J Urol","2004","2004/11/13","","","10.1097/01.ju.0000143860.50878.b1"
"21870090","Bladder carcinoma in a 31-year-old female spina bifida patient with an auto-augmented bladder","Veenboer PW, de Kort LM.","Int Urol Nephrol. 2012 Aug;44(4):1027-30. doi: 10.1007/s11255-011-0046-3. Epub 2011 Aug 26.","Veenboer PW","Int Urol Nephrol","2012","2011/08/27","PMC3401495","","10.1007/s11255-011-0046-3"
"2231954","The kinetics of cellular proliferation in rat urinary bladder treated with N-butyl-N-(4-hydroxybutyl)nitrosamine","Tsujihashi H, Matsuda H, Uejima S, Akiyama T, Kurita T.","J Urol. 1990 Dec;144(6):1493-6. doi: 10.1016/s0022-5347(17)39784-7.","Tsujihashi H","J Urol","1990","1990/12/01","","","10.1016/s0022-5347(17)39784-7"
"20608148","The role and extension of lymphadenectomy in bladder cancer: a review of the current literature","Mogorovich A, Giannarini G, Manassero F, De Maria M, Fiorini G, Di Paola G, Selli C.","Arch Ital Urol Androl. 2009 Dec;81(4):233-41.","Mogorovich A","Arch Ital Urol Androl","2009","2010/07/09","","",""
"19034344","Initial results of retrospective study: preoperative transurethral excision plus chemotherapy and radiation therapy and trial of bladder preservation","Gamal El-Deen HS.","J Egypt Natl Canc Inst. 2007 Jun;19(2):133-46.","Gamal El-Deen HS","J Egypt Natl Canc Inst","2007","2008/11/27","","",""
"25403247","Bladder cancer: On the dot--targeted molecular imaging","Stone L.","Nat Rev Urol. 2015 Jan;12(1):6. doi: 10.1038/nrurol.2014.318. Epub 2014 Nov 18.","Stone L","Nat Rev Urol","2015","2014/11/19","","","10.1038/nrurol.2014.318"
"2869213","Superficial bladder cancer: drugs or diathermy?","","Lancet. 1986 Mar 1;1(8479):479-80. doi: 10.1016/s0140-6736(86)92934-x.","","Lancet","1986","1986/03/01","","","10.1016/s0140-6736(86)92934-x"
"8073548","Results of transurethral resection and intravesical doxorubicin prophylaxis in patients with T1G3 bladder cancer","Bono AV, Benvenuti C, Damiano G, Lovisolo J.","Urology. 1994 Sep;44(3):329-34; discussion 334-5. doi: 10.1016/s0090-4295(94)80086-3.","Bono AV","Urology","1994","1994/09/01","","","10.1016/s0090-4295(94)80086-3"
"12805322","Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy","Pagliaro LC, Keyhani A, Williams D, Woods D, Liu B, Perrotte P, Slaton JW, Merritt JA, Grossman HB, Dinney CP.","J Clin Oncol. 2003 Jun 15;21(12):2247-53. doi: 10.1200/JCO.2003.09.138.","Pagliaro LC","J Clin Oncol","2003","2003/06/14","","","10.1200/JCO.2003.09.138"
"10700908","[Case report of a patient with invading bladder cancer and lymph node swelling which decreased following 5'-DFUR treatment]","Soga H, Hayashida H, Yoshiki T, Higuchi K, Okada Y.","Gan To Kagaku Ryoho. 2000 Feb;27(2):311-4.","Soga H","Gan To Kagaku Ryoho","2000","2000/03/04","","",""
"7086976","Immunoprophylaxis of a murine bladder cancer with high dose BCG immunizations","Pang AS, Morales A.","J Urol. 1982 May;127(5):1006-9. doi: 10.1016/s0022-5347(17)54175-0.","Pang AS","J Urol","1982","1982/05/01","","","10.1016/s0022-5347(17)54175-0"
"29429897","Role of immunotherapy in bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer","Mukherjee N, Svatek RS, Mansour AM.","Urol Oncol. 2018 Mar;36(3):103-108. doi: 10.1016/j.urolonc.2017.12.020. Epub 2018 Feb 9.","Mukherjee N","Urol Oncol","2018","2018/02/13","PMC6428193","NIHMS1016248","10.1016/j.urolonc.2017.12.020"
"21343564","DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer","Marsit CJ, Koestler DC, Christensen BC, Karagas MR, Houseman EA, Kelsey KT.","J Clin Oncol. 2011 Mar 20;29(9):1133-9. doi: 10.1200/JCO.2010.31.3577. Epub 2011 Feb 22.","Marsit CJ","J Clin Oncol","2011","2011/02/24","PMC3083868","","10.1200/JCO.2010.31.3577"
"20346034","Bladder cancer in cystoscopically normal-appearing mucosa: a case of mistaken identity?","Herr HW, Al-Ahmadie H, Dalbagni G, Reuter VE.","BJU Int. 2010 Nov;106(10):1499-501. doi: 10.1111/j.1464-410X.2010.09332.x.","Herr HW","BJU Int","2010","2010/03/30","","","10.1111/j.1464-410X.2010.09332.x"
"30895765","Bladder-sparing treatment in MIBC: where do we stand?","Murali-Krishnan S, Pang KH, Greco F, Fiori C, Catto JW, Vavassori VL, Esperto F; EAU-ESRU (European Associations of Urology-European Society of Residents Urologist).","Minerva Urol Nefrol. 2019 Apr;71(2):101-112. doi: 10.23736/S0393-2249.19.03317-4. Epub 2019 Mar 18.","Murali-Krishnan S","Minerva Urol Nefrol","2019","2019/03/22","","","10.23736/S0393-2249.19.03317-4"
"23098122","Follow-up procedures for non-muscle-invasive bladder cancer: an update","Anastasiadis A, Cordeiro E, Bus MT, Alivizatos G, de la Rosette JJ, de Reijke TM.","Expert Rev Anticancer Ther. 2012 Sep;12(9):1229-41. doi: 10.1586/era.12.98.","Anastasiadis A","Expert Rev Anticancer Ther","2012","2012/10/27","","","10.1586/era.12.98"
"27221848","Predictive Effect of Preoperative Anemia on Long-Term Survival Outcomes with Non-Muscle Invasive Bladder Cancer","Celik O, Akand M, Keskin MZ, Ekin RG, Yoldas M, Ilbey YO.","Asian Pac J Cancer Prev. 2016;17(4):1755-8. doi: 10.7314/apjcp.2016.17.4.1755.","Celik O","Asian Pac J Cancer Prev","2016","2016/05/26","","","10.7314/apjcp.2016.17.4.1755"
"2585915","[Factors influencing the recurrence rate and metastatic rate of bladder cancer]","Kondo I, Moriyama M, Murai T.","Nihon Hinyokika Gakkai Zasshi. 1989 Aug;80(8):1168-74. doi: 10.5980/jpnjurol1989.80.1168.","Kondo I","Nihon Hinyokika Gakkai Zasshi","1989","1989/08/01","","","10.5980/jpnjurol1989.80.1168"
"31015520","The immune mediated role of extracellular HMGB1 in a heterotopic model of bladder cancer radioresistance","Ayoub M, Shinde-Jadhav S, Mansure JJ, Alvarez F, Connell T, Seuntjens J, Piccirillo CA, Kassouf W.","Sci Rep. 2019 Apr 23;9(1):6348. doi: 10.1038/s41598-019-42864-w.","Ayoub M","Sci Rep","2019","2019/04/25","PMC6478679","","10.1038/s41598-019-42864-w"
"2004229","Transferrin receptor activity as a marker in transitional cell carcinoma of the bladder","Başar I, Ayhan A, Bircan K, Ergen A, Taşar C.","Br J Urol. 1991 Feb;67(2):165-8. doi: 10.1111/j.1464-410x.1991.tb15101.x.","Başar I","Br J Urol","1991","1991/02/01","","","10.1111/j.1464-410x.1991.tb15101.x"
"7719369","[T1 G3 bladder tumors: the respective role of BCG and cystectomy]","Pfister C, Landé P, Hervé JM, Barré P, Barbagelatta M, Camey M, Botto H.","Prog Urol. 1995 Apr;5(2):231-7.","Pfister C","Prog Urol","1995","1995/04/01","","",""
"22282102","[Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies]","Rink M, Chun FK, Chromecki TF, Fajkovic H, Dahlem R, Fisch M, Shariat SF.","Urologe A. 2012 Jun;51(6):820-8. doi: 10.1007/s00120-011-2769-2.","Rink M","Urologe A","2012","2012/01/28","","","10.1007/s00120-011-2769-2"
"22500655","High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer","Szarvas T, vom Dorp F, Niedworok C, Melchior-Becker A, Fischer JW, Singer BB, Reis H, Bánkfalvi Á, Schmid KW, Romics I, Ergün S, Rübben H.","BJU Int. 2012 Sep;110(6 Pt B):E308-17. doi: 10.1111/j.1464-410X.2012.11149.x. Epub 2012 Apr 13.","Szarvas T","BJU Int","2012","2012/04/17","","","10.1111/j.1464-410X.2012.11149.x"
"22487512","Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference?","Badalato GM, Gaya JM, Hruby G, Patel T, Kates M, Sadeghi N, Benson MC, McKiernan JM.","BJU Int. 2012 Nov;110(10):1471-7. doi: 10.1111/j.1464-410X.2012.11116.x. Epub 2012 Apr 4.","Badalato GM","BJU Int","2012","2012/04/11","","","10.1111/j.1464-410X.2012.11116.x"
"2217431","Neo-adjuvant cisplatinum in locally advanced urothelial bladder cancer: a prospective randomized study of the group CUETO","Martinez-Piñeiro JA, Jimenez Leon J, Gonzalez Martin M, Arocena Lanz F, Ramos Roncero C, Flores N, Portillo JA, Escudero A, Jimenez Cruz F, Isorna S.","Prog Clin Biol Res. 1990;353:95-103.","Martinez-Piñeiro JA","Prog Clin Biol Res","1990","1990/01/01","","",""
"27357064","Evaluation of RNA and DNA extraction from liquid-based cytology specimens","Fujii T, Asano A, Shimada K, Tatsumi Y, Obayashi C, Konishi N.","Diagn Cytopathol. 2016 Oct;44(10):833-40. doi: 10.1002/dc.23524. Epub 2016 Jun 30.","Fujii T","Diagn Cytopathol","2016","2016/07/01","","","10.1002/dc.23524"
"1855845","Urinary nitrate, nitrite and N-nitroso compounds in bladder cancer patients with schistosomiasis (bilharzia)","Tricker AR, Mostafa MH, Spiegelhalder B, Preussmann R.","IARC Sci Publ. 1991;(105):178-81.","Tricker AR","IARC Sci Publ","1991","1991/01/01","","",""
"16476519","Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines","Lehmann J, Retz M, Sidhu SS, Suttmann H, Sell M, Paulsen F, Harder J, Unteregger G, Stöckle M.","Eur Urol. 2006 Jul;50(1):141-7. doi: 10.1016/j.eururo.2005.12.043. Epub 2006 Jan 6.","Lehmann J","Eur Urol","2006","2006/02/16","","","10.1016/j.eururo.2005.12.043"
"9245175","[Life style and occupational risk factors in bladder carcinoma]","Bento MJ, Barros H.","Acta Med Port. 1997 Jan;10(1):39-45.","Bento MJ","Acta Med Port","1997","1997/01/01","","",""
"29761307","Intravesical bacillus Calmette-Guerin therapy after second transurethral resection for primary T1 bladder cancer","Baba M, Kageyama S, Yoshida T, Fujiwara R, Kim CJ, Takimoto K, Nagasawa M, Soga H, Nagatani Y, Nishikawa Z, Kawauchi A.","Int J Clin Oncol. 2018 Oct;23(5):951-956. doi: 10.1007/s10147-018-1292-5. Epub 2018 May 14.","Baba M","Int J Clin Oncol","2018","2018/05/16","","","10.1007/s10147-018-1292-5"
"19537835","Management of bladder cancer: current and emerging strategies","Agarwal N, Hussain M.","Drugs. 2009 Jun 18;69(9):1173-87. doi: 10.2165/00003495-200969090-00003.","Agarwal N","Drugs","2009","2009/06/23","","","10.2165/00003495-200969090-00003"
"12460793","Comments on article by C. Sternberg. Eur J Cancer 2002, 38, 460-467","Hoskin PJ.","Eur J Cancer. 2002 Dec;38(18):2476. doi: 10.1016/s0959-8049(02)00246-0.","Hoskin PJ","Eur J Cancer","2002","2002/12/04","","","10.1016/s0959-8049(02)00246-0"
"1301572","Post cystectomy adjuvant chemotherapy: a clinical routine?","Sternberg CN.","Prog Clin Biol Res. 1992;378:117-24.","Sternberg CN","Prog Clin Biol Res","1992","1992/01/01","","",""
"8990112","p53 and treatment of bladder cancer","Cote RJ, Esrig D, Groshen S, Jones PA, Skinner DG.","Nature. 1997 Jan 9;385(6612):123-5. doi: 10.1038/385123b0.","Cote RJ","Nature","1997","1997/01/09","","","10.1038/385123b0"
"8540864","BCG in bladder cancer--a warning","Nicol D.","Aust N Z J Med. 1995 Aug;25(4):275-7. doi: 10.1111/j.1445-5994.1995.tb01888.x.","Nicol D","Aust N Z J Med","1995","1995/08/01","","","10.1111/j.1445-5994.1995.tb01888.x"
"17510383","Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression","Chen Z, Yang J, Wang G, Song B, Li J, Xu Z.","Cancer Res. 2007 May 15;67(10):4578-85. doi: 10.1158/0008-5472.CAN-06-0877.","Chen Z","Cancer Res","2007","2007/05/19","","","10.1158/0008-5472.CAN-06-0877"
"9586309","[Tumor bladder antigen (TBA). A new method for the diagnosis and detection of recurrence of bladder cancer]","Escaf Barmadah S, Martín Benito JL, Fernández Gómez JM, San Martín Blanco A, Pérez Gracia FJ, Rodríguez Martínez JJ.","Arch Esp Urol. 1998 Mar;51(2):129-36.","Escaf Barmadah S","Arch Esp Urol","1998","1998/05/20","","",""
"20831498","A comparison of three different adaptive strategies in image-guided radiotherapy of bladder cancer","Vestergaard A, Søndergaard J, Petersen JB, Høyer M, Muren LP.","Acta Oncol. 2010 Oct;49(7):1069-76. doi: 10.3109/0284186X.2010.501813.","Vestergaard A","Acta Oncol","2010","2010/09/14","","","10.3109/0284186X.2010.501813"
"2959312","Bladder cancer in rubber workers","Whitty F.","Br J Ind Med. 1987 Sep;44(9):647. doi: 10.1136/oem.44.9.647.","Whitty F","Br J Ind Med","1987","1987/09/01","PMC1007893","","10.1136/oem.44.9.647"
"22129909","Benzalkonium bromide as a new potential instillation drug for bladder cancer: hypothesis and pilot study","Xu R, Zhang L, Zhao X, Jiang H, Lu Q, Zhong Z, Hou Y.","Med Sci Monit. 2011 Dec;17(12):HY36-9. doi: 10.12659/msm.882110.","Xu R","Med Sci Monit","2011","2011/12/02","PMC3628137","","10.12659/msm.882110"
"32068492","Tumor Location and Pathological Features of Latent and Incidental Prostate Cancer in Contemporary Japanese Men","Inaba H, Kimura T, Onuma H, Sato S, Kido M, Yamamoto T, Fukuda Y, Takahashi H, Egawa S.","J Urol. 2020 Aug;204(2):267-272. doi: 10.1097/JU.0000000000000804. Epub 2020 Feb 18.","Inaba H","J Urol","2020","2020/02/19","","","10.1097/JU.0000000000000804"
"19880815","Are smokers now at higher risk of bladder cancer? Are changes in cigarettes to blame?","Tuma RS.","J Natl Cancer Inst. 2009 Nov 18;101(22):1532-4. doi: 10.1093/jnci/djp420. Epub 2009 Oct 30.","Tuma RS","J Natl Cancer Inst","2009","2009/11/03","","","10.1093/jnci/djp420"
"6682152","Combined cis-platinum and radiation therapy in patients with stages pT3 and pT4 bladder cancer: a pilot study","Jakse G, Frommhold H, Marberger H.","J Urol. 1983 Mar;129(3):502-4.","Jakse G","J Urol","1983","1983/03/01","","",""
"17121717","[Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo]","Zhao GZ, Tan WL, Zheng SB, Wu YD, Xie Y, Zhu WH.","Nan Fang Yi Ke Da Xue Xue Bao. 2006 Nov;26(11):1623-5, 1628.","Zhao GZ","Nan Fang Yi Ke Da Xue Xue Bao","2006","2006/11/24","","",""
"7807769","[Experience of ileal neobladder for bladder cancer by Hautmann procedure]","Yamada T, Masuda H, Nagahama K, Atai G, Tsukamoto T, Kawakami S, Watanabe T, Nagamatsu H, Negishi T.","Nihon Hinyokika Gakkai Zasshi. 1994 Nov;85(11):1616-21. doi: 10.5980/jpnjurol1989.85.1616.","Yamada T","Nihon Hinyokika Gakkai Zasshi","1994","1994/11/01","","","10.5980/jpnjurol1989.85.1616"
"16145378","Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial","Martínez-Piñeiro JA, Martínez-Piñeiro L, Solsona E, Rodríguez RH, Gómez JM, Martín MG, Molina JR, Collado AG, Flores N, Isorna S, Pertusa C, Rabadán M, Astobieta A, Camacho JE, Arribas S, Madero R; Club Urológico Español de Tratamiento Oncológico (CUETO).","J Urol. 2005 Oct;174(4 Pt 1):1242-7. doi: 10.1097/01.ju.0000173919.28835.aa.","Martínez-Piñeiro JA","J Urol","2005","2005/09/08","","","10.1097/01.ju.0000173919.28835.aa"
"16794242","The role of perioperative chemotherapy in the treatment of urothelial cancer","Cohen SM, Goel A, Phillips J, Ennis RD, Grossbard ML.","Oncologist. 2006 Jun;11(6):630-40. doi: 10.1634/theoncologist.11-6-630.","Cohen SM","Oncologist","2006","2006/06/24","","","10.1634/theoncologist.11-6-630"
"20546051","Transurethral resection in one piece (TURBO) is an accurate tool for pathological staging of bladder tumor","Ukai R, Hashimoto K, Iwasa T, Nakayama H.","Int J Urol. 2010 Aug;17(8):708-14. doi: 10.1111/j.1442-2042.2010.02571.x. Epub 2010 Jun 9.","Ukai R","Int J Urol","2010","2010/06/16","","","10.1111/j.1442-2042.2010.02571.x"
"3053201","Precursor lesions of invasive bladder cancer","Koss LG.","Eur Urol. 1988;14 Suppl 1:4-6. doi: 10.1159/000473027.","Koss LG","Eur Urol","1988","1988/01/01","","","10.1159/000473027"
"7317744","The early changes in the development of bladder cancer in patients exposed to known industrial carcinogens","Glashan RW, Wijesinghe DP, Riley A.","Br J Urol. 1981 Dec;53(6):571-7. doi: 10.1111/j.1464-410x.1981.tb03263.x.","Glashan RW","Br J Urol","1981","1981/12/01","","","10.1111/j.1464-410x.1981.tb03263.x"
"18898273","[Partial cystectomy for cancer and functional recovery]","MACQUET.","Toulouse Med. 1947;48:33-6.","MACQUET","Toulouse Med","1947","1947/01/01","","",""
"1378746","Unconventional fractionation for palliative radiotherapy of urinary bladder cancer. A retrospective review of 94 patients","Salminen E.","Acta Oncol. 1992;31(4):449-54. doi: 10.3109/02841869209088288.","Salminen E","Acta Oncol","1992","1992/01/01","","","10.3109/02841869209088288"
"8417214","Image cytometric deoxyribonucleic acid analysis of urine specimens as an adjunct to visual cytology in the detection of urothelial cell carcinoma","Amberson JB, Laino JP.","J Urol. 1993 Jan;149(1):42-5. doi: 10.1016/s0022-5347(17)35993-1.","Amberson JB","J Urol","1993","1993/01/01","","","10.1016/s0022-5347(17)35993-1"
"2692109","[Present aspects and problems regarding occupational bladder cancer due to exposure to aromatic amines]","Yamamura J.","J UOEH. 1989 Dec 1;11(4):495-504. doi: 10.7888/juoeh.11.495.","Yamamura J","J UOEH","1989","1989/12/01","","","10.7888/juoeh.11.495"
"18934369","Carcinoma of the bladder","CAMPBELL RI.","Med J Aust. 1948 Jul 31;2(5):136.","CAMPBELL RI","Med J Aust","1948","1948/07/31","","",""
"20302611","A case of high-grade leiomyosarcoma of the bladder with delayed onset and very poor prognosis","Ricciardi E, Maniglio P, Schimberni M, Moscarini M.","World J Surg Oncol. 2010 Mar 19;8:16. doi: 10.1186/1477-7819-8-16.","Ricciardi E","World J Surg Oncol","2010","2010/03/23","PMC2847558","","10.1186/1477-7819-8-16"
"26658887","Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomy","Novotny V, Froehner M, Koch R, Zastrow S, Heberling U, Leike S, Hübler M, Wirth MP.","World J Urol. 2016 Aug;34(8):1123-9. doi: 10.1007/s00345-015-1744-8. Epub 2015 Dec 11.","Novotny V","World J Urol","2016","2015/12/15","","","10.1007/s00345-015-1744-8"
"23125008","Expression of beclin 1 in bladder cancer and its clinical significance","Liu GH, Zhong Q, Ye YL, Wang HB, Hu LJ, Qin ZK, Zeng MS, Zeng BH.","Int J Biol Markers. 2013 Apr 23;28(1):56-62. doi: 10.5301/JBM.2012.9769.","Liu GH","Int J Biol Markers","2013","2012/11/06","","","10.5301/JBM.2012.9769"
"28423359","Epithelial-mesenchymal transition induced by GRO-α-CXCR2 promotes bladder cancer recurrence after intravesical chemotherapy","Chen L, Pan XW, Huang H, Gao Y, Yang QW, Wang LH, Cui XG, Xu DF.","Oncotarget. 2017 Jul 11;8(28):45274-45285. doi: 10.18632/oncotarget.16786.","Chen L","Oncotarget","2017","2017/04/20","PMC5542185","","10.18632/oncotarget.16786"
"27769440","Gelatin-modified gold nanoparticles for direct detection of urinary total gelatinase activity: Diagnostic value in bladder cancer","Nossier AI, Mohammed OS, Fakhr El-Deen RR, Zaghloul AS, Eissa S.","Talanta. 2016 Dec 1;161:511-519. doi: 10.1016/j.talanta.2016.09.015. Epub 2016 Sep 5.","Nossier AI","Talanta","2016","2016/10/23","","","10.1016/j.talanta.2016.09.015"
"1426663","Long-term immunobiological effects of intravesical bacillus Calmette-Guérin against bladder carcinoma recurrences","Böhle A, Busemann E, Gerdes J, Ulmer AJ, Flad HD, Jocham D.","Dev Biol Stand. 1992;77:199-209.","Böhle A","Dev Biol Stand","1992","1992/01/01","","",""
"21695596","The nucleosome binding protein NSBP1 is highly expressed in human bladder cancer and promotes the proliferation and invasion of bladder cancer cells","Wahafu W, He ZS, Zhang XY, Zhang CJ, Yao K, Hao H, Song G, He Q, Li XS, Zhou LQ.","Tumour Biol. 2011 Oct;32(5):931-9. doi: 10.1007/s13277-011-0195-0. Epub 2011 Jun 22.","Wahafu W","Tumour Biol","2011","2011/06/23","","","10.1007/s13277-011-0195-0"
"21478038","Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth","Zhang H, Jiang H, Wang W, Gong J, Zhang L, Chen Z, Ding Q.","Urol Oncol. 2012 Nov-Dec;30(6):920-7. doi: 10.1016/j.urolonc.2010.10.003. Epub 2011 Apr 7.","Zhang H","Urol Oncol","2012","2011/04/12","","","10.1016/j.urolonc.2010.10.003"
"21835428","High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patients","Seiler R, von Gunten M, Thalmann GN, Fleischmann A.","Hum Pathol. 2012 Feb;43(2):269-75. doi: 10.1016/j.humpath.2011.04.030. Epub 2011 Aug 10.","Seiler R","Hum Pathol","2012","2011/08/13","","","10.1016/j.humpath.2011.04.030"
"23342389","Inhibition of bladder tumor growth by chitooligosaccharides in an experimental carcinogenesis model","Fernandes JC, Sereno J, Garrido P, Parada B, Cunha MF, Reis F, Pintado ME, Santos-Silva A.","Mar Drugs. 2012 Dec;10(12):2661-75. doi: 10.3390/md10122661.","Fernandes JC","Mar Drugs","2012","2013/01/25","PMC3528117","","10.3390/md10122661"
"12201938","Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive?","Raitanen MP, Aine RA, Kaasinen ES, Liukkonen TJ, Kylmälä TM, Huhtala H, Tammela TL; Finnbladder Group.","Scand J Urol Nephrol. 2002;36(3):213-7. doi: 10.1080/003655902320131901.","Raitanen MP","Scand J Urol Nephrol","2002","2002/08/31","","","10.1080/003655902320131901"
"11096242","The term 'superficial bladder cancer' should be abandoned","Murphy WM.","Eur Urol. 2000 Nov;38(5):597-9. doi: 10.1159/000020337.","Murphy WM","Eur Urol","2000","2000/11/30","","","10.1159/000020337"
"445409","Regional lymph node reactivity in explanted bladder cancer of mice as measured by flow cytometry","Collste LG, Darzynkiewicz Z, Traganos F, Sharpless TK, Whitmore WF Jr, Melamed MR.","Cancer Res. 1979 Jun;39(6 Pt 1):2120-4.","Collste LG","Cancer Res","1979","1979/06/01","","",""
"25973088","Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer","Zhao XL, Zhao ZH, Xu WC, Hou JQ, Du XY.","Int J Clin Exp Pathol. 2015 Feb 1;8(2):1954-60. eCollection 2015.","Zhao XL","Int J Clin Exp Pathol","2015","2015/05/15","PMC4396312","",""
"18316576","Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin","Hadaschik BA, Adomat H, Fazli L, Fradet Y, Andersen RJ, Gleave ME, So AI.","Clin Cancer Res. 2008 Mar 1;14(5):1510-8. doi: 10.1158/1078-0432.CCR-07-4475.","Hadaschik BA","Clin Cancer Res","2008","2008/03/05","","","10.1158/1078-0432.CCR-07-4475"
"12684390","The need to embrace molecular profiling of tumor cells in prostate and bladder cancer","Duggan BJ, McKnight JJ, Williamson KE, Loughrey M, O'Rourke D, Hamilton PW, Johnston SR, Schulman CC, Zlotta AR.","Clin Cancer Res. 2003 Apr;9(4):1240-7.","Duggan BJ","Clin Cancer Res","2003","2003/04/10","","",""
"9144897","Current concepts in the role of intravesical instillations in the therapy and prophylaxis of superficial transitional-cell cancer of the bladder. The Finnbladder Research Group","Alfthan O, Jauhiainen K, Kaasinen E, Liukkonen T.","World J Urol. 1997;15(2):89-95. doi: 10.1007/BF02201978.","Alfthan O","World J Urol","1997","1997/01/01","","","10.1007/BF02201978"
"6445220","Bladder cancer as a prescribed industrial disease","Somerville SM, Davies JM, Hendry WF, Williams G.","Br Med J. 1980 Mar 22;280(6217):867. doi: 10.1136/bmj.280.6217.867-b.","Somerville SM","Br Med J","1980","1980/03/22","PMC1601018","","10.1136/bmj.280.6217.867-b"
"22714124","Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma","van der Horst G, Bos L, van der Pluijm G.","Mol Cancer Res. 2012 Aug;10(8):995-1009. doi: 10.1158/1541-7786.MCR-12-0274. Epub 2012 Jun 19.","van der Horst G","Mol Cancer Res","2012","2012/06/21","","","10.1158/1541-7786.MCR-12-0274"
"22944145","Diagnostic values of urine CYFRA21-1, NMP22, UBC, and FDP for the detection of bladder cancer","Jeong S, Park Y, Cho Y, Kim YR, Kim HS.","Clin Chim Acta. 2012 Dec 24;414:93-100. doi: 10.1016/j.cca.2012.08.018. Epub 2012 Aug 25.","Jeong S","Clin Chim Acta","2012","2012/09/05","","","10.1016/j.cca.2012.08.018"
"12209982","Non-invasive molecular detection of bladder cancer recurrence","Amira N, Mourah S, Rozet F, Teillac P, Fiet J, Aubin P, Cortesse A, Desgrandchamps F, Le Duc A, Cussenot O, Soliman H.","Int J Cancer. 2002 Sep 20;101(3):293-7. doi: 10.1002/ijc.10561.","Amira N","Int J Cancer","2002","2002/09/05","","","10.1002/ijc.10561"
"25385059","Knowledge of the harms of tobacco use among patients with bladder cancer","Bassett JC, Gore JL, Kwan L, Ritch CR, Barocas DA, Penson DF, McCarthy WJ, Saigal CS.","Cancer. 2014 Dec 15;120(24):3914-22. doi: 10.1002/cncr.28915. Epub 2014 Nov 10.","Bassett JC","Cancer","2014","2014/11/12","","","10.1002/cncr.28915"
"23374147","Immunomodulatory effects of total intravenous and balanced inhalation anesthesia in patients with bladder cancer undergoing elective radical cystectomy: preliminary results","Sofra M, Fei PC, Fabrizi L, Marcelli ME, Claroni C, Gallucci M, Ensoli F, Forastiere E.","J Exp Clin Cancer Res. 2013 Feb 3;32(1):6. doi: 10.1186/1756-9966-32-6.","Sofra M","J Exp Clin Cancer Res","2013","2013/02/05","PMC3577511","","10.1186/1756-9966-32-6"
"10783912","The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer","Salagovic J, Kalina I, Habalová V, Hrivnák M, Valanský L, Biros E.","Physiol Res. 1999;48(6):465-71.","Salagovic J","Physiol Res","1999","2000/04/28","","",""
"12031870","BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer","Bassi P.","Surg Oncol. 2002 Jun;11(1-2):77-83. doi: 10.1016/s0960-7404(02)00008-7.","Bassi P","Surg Oncol","2002","2002/05/29","","","10.1016/s0960-7404(02)00008-7"
"18592765","[Initial experience in the diagnosis and treatment of superficial bladder tumors with Hexvix]","Abascal Junquera JM, Hevia Suárez M, Abascal García JM, Estébanez C, Astudillo A, Abascal R.","Arch Esp Urol. 2008 May;61(4):475-82; discussion 482-3. doi: 10.4321/s0004-06142008000400003.","Abascal Junquera JM","Arch Esp Urol","2008","2008/07/03","","","10.4321/s0004-06142008000400003"
"30633177","Intraoperative hypothermia is a significant prognostic predictor of radical cystectomy especially for stage II muscle-invasive bladder cancer","Morozumi K, Mitsuzuka K, Takai Y, Katsumata Y, Kuromoto A, Hoshi S, Numahata K, Arai Y.","Medicine (Baltimore). 2019 Jan;98(2):e13962. doi: 10.1097/MD.0000000000013962.","Morozumi K","Medicine (Baltimore)","2019","2019/01/12","PMC6336635","","10.1097/MD.0000000000013962"
"16515972","Prediction of extravesical disease by preoperative serum markers in patients with clinically organ confined invasive bladder cancer","Margel D, Tal R, Neuman A, Konichezky M, Sella A, Baniel J.","J Urol. 2006 Apr;175(4):1253-7; discussion 1257. doi: 10.1016/S0022-5347(05)00699-3.","Margel D","J Urol","2006","2006/03/07","","","10.1016/S0022-5347(05)00699-3"
"31160277","CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer","Maeda S, Murakami K, Inoue A, Yonezawa T, Matsuki N.","Cancer Immunol Res. 2019 Jul;7(7):1175-1187. doi: 10.1158/2326-6066.CIR-18-0751. Epub 2019 Jun 3.","Maeda S","Cancer Immunol Res","2019","2019/06/05","","","10.1158/2326-6066.CIR-18-0751"
"30061076","Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?","Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid HA, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Dominguez-Escrig JL, Hernández V, Peyronnet B, Seisen T, Soukup V; European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder Cancer.","Eur Urol Focus. 2018 Jul;4(4):525-528. doi: 10.1016/j.euf.2018.07.023. Epub 2018 Jul 27.","Babjuk M","Eur Urol Focus","2018","2018/08/01","","","10.1016/j.euf.2018.07.023"
"3652008","Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapy","Têtu B, Katz RL, Kalter SP, von Eschenbach AC, Barlogie B.","Cancer. 1987 Oct 15;60(8):1815-22. doi: 10.1002/1097-0142(19871015)60:8<1815::aid-cncr2820600824>3.0.co;2-1.","Têtu B","Cancer","1987","1987/10/15","","","10.1002/1097-0142(19871015)60:8<1815::aid-cncr2820600824>3.0.co;2-1"
"311054","[Immunotherapy with oral BCG in cancer of the bladder]","Netto Júnior NR, de Salvo Reinato JA, Teixeira LC, De Bellis N.","AMB Rev Assoc Med Bras. 1978 Oct;24(10):358-60.","Netto Júnior NR","AMB Rev Assoc Med Bras","1978","1978/10/01","","",""
"30734514","Unusual radiologic manifestation of pseudoprogression in pulmonary metastases after durvalumab treatment in metastatic bladder urothelial cancer","Kim EY, Park I, Kim YS, Ahn HK, Lee HY, Kim JH.","Thorac Cancer. 2019 Apr;10(4):1016-1018. doi: 10.1111/1759-7714.12994. Epub 2019 Feb 7.","Kim EY","Thorac Cancer","2019","2019/02/09","PMC6449229","","10.1111/1759-7714.12994"
"18914792","Results of radiation therapy of bladder cancer","MARSHALL VF.","N Y State J Med. 1948 Apr 15;48(8):875.","MARSHALL VF","N Y State J Med","1948","1948/04/15","","",""
"18815913","The epidemiology of bladder cancer in Russia","Pushkar DY, Govorov AV, Matveev VB.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):21-4. doi: 10.1080/03008880802365024.","Pushkar DY","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802365024"
"10720866","Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer","Marano A, Pan Y, Li C, Pagliarulo A, Elmberger G, Tribukait B, Ekman P, Bergerheim U.","Eur Urol. 2000 Mar;37(3):358-65. doi: 10.1159/000052370.","Marano A","Eur Urol","2000","2000/03/18","","","10.1159/000052370"
"29949785","Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer","Wang J, Fang R, Wang L, Chen G, Wang H, Wang Z, Zhao D, Pavlov VN, Kabirov I, Wang Z, Guo P, Peng L, Xu W.","Cell Physiol Biochem. 2018;47(4):1565-1577. doi: 10.1159/000490875. Epub 2018 Jun 27.","Wang J","Cell Physiol Biochem","2018","2018/06/28","","","10.1159/000490875"
"20802236","DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer","Wilhelm-Benartzi CS, Koestler DC, Houseman EA, Christensen BC, Wiencke JK, Schned AR, Karagas MR, Kelsey KT, Marsit CJ.","Carcinogenesis. 2010 Nov;31(11):1972-6. doi: 10.1093/carcin/bgq178. Epub 2010 Aug 28.","Wilhelm-Benartzi CS","Carcinogenesis","2010","2010/08/31","PMC2966555","","10.1093/carcin/bgq178"
"20960501","Gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer: Long-term cumulative results of 2 prospective single-institution studies","Caffo O, Fellin G, Graffer U, Mussari S, Tomio L, Galligioni E.","Cancer. 2011 Mar 15;117(6):1190-6. doi: 10.1002/cncr.25667. Epub 2010 Oct 19.","Caffo O","Cancer","2011","2010/10/21","","","10.1002/cncr.25667"
"18087279","Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays","Aleman A, Adrien L, Lopez-Serra L, Cordon-Cardo C, Esteller M, Belbin TJ, Sanchez-Carbayo M.","Br J Cancer. 2008 Jan 29;98(2):466-73. doi: 10.1038/sj.bjc.6604143. Epub 2007 Dec 18.","Aleman A","Br J Cancer","2008","2007/12/19","PMC2361432","","10.1038/sj.bjc.6604143"
"28007367","Exercise Decreases and Smoking Increases Bladder Cancer Mortality","Liss MA, White M, Natarajan L, Parsons JK.","Clin Genitourin Cancer. 2017 Jun;15(3):391-395. doi: 10.1016/j.clgc.2016.11.006. Epub 2016 Dec 1.","Liss MA","Clin Genitourin Cancer","2017","2016/12/24","PMC5805463","NIHMS939013","10.1016/j.clgc.2016.11.006"
"29473387","Elderly patient with atypical leiomyoma of the bladder presenting as flank pain: A case report","Ameli M, Rahmandoost M.","Arch Ital Urol Androl. 2017 Dec 31;89(4):327-328. doi: 10.4081/aiua.2017.4.327.","Ameli M","Arch Ital Urol Androl","2017","2018/02/24","","","10.4081/aiua.2017.4.327"
"11556471","Risk factors of urethral involvement of bladder cancer after radical cystectomy with orthotopic neobladder in females","Kochakarn W, Chaimuangraj S, Leenanupunth C, Muangman V.","J Med Assoc Thai. 2001 Jun;84(6):889-92.","Kochakarn W","J Med Assoc Thai","2001","2001/09/15","","",""
"31757292","Bacillus Calmette-Guérin Salvage Therapy: Definitions and Context","Konety BR, Narayan VM, Dinney CPN.","Urol Clin North Am. 2020 Feb;47(1):1-4. doi: 10.1016/j.ucl.2019.09.002.","Konety BR","Urol Clin North Am","2020","2019/11/24","","","10.1016/j.ucl.2019.09.002"
"8796883","Rb gene therapy for bladder cancer","Featherstone C.","Mol Med Today. 1996 May;2(5):182-3. doi: 10.1016/1357-4310(96)88761-2.","Featherstone C","Mol Med Today","1996","1996/05/01","","","10.1016/1357-4310(96)88761-2"
"5530226","[Occupational bladder cancer]","Ishizu S.","Gan No Rinsho. 1970 Nov;16(11):1061-3.","Ishizu S","Gan No Rinsho","1970","1970/11/01","","",""
"20374648","Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways","Marra E, Uva P, Viti V, Simonelli V, Dogliotti E, De Rinaldis E, Lahm A, La Monica N, Nicosia A, Ciliberto G, Palombo F.","BMC Cancer. 2010 Apr 7;10:129. doi: 10.1186/1471-2407-10-129.","Marra E","BMC Cancer","2010","2010/04/09","PMC2858747","","10.1186/1471-2407-10-129"
"2119844","Assessment of factors influencing the outcome of radiotherapy for bladder cancer","Davidson SE, Symonds RP, Snee MP, Upadhyay S, Habeshaw T, Robertson AG.","Br J Urol. 1990 Sep;66(3):288-93. doi: 10.1111/j.1464-410x.1990.tb14929.x.","Davidson SE","Br J Urol","1990","1990/09/01","","","10.1111/j.1464-410x.1990.tb14929.x"
"23127333","The inhibition of human bladder cancer growth by calcium carbonate/CaIP6 nanocomposite particles delivering AIB1 siRNA","Wei J, Cheang T, Tang B, Xia H, Xing Z, Chen Z, Fang Y, Chen W, Xu A, Wang S, Luo J.","Biomaterials. 2013 Jan;34(4):1246-54. doi: 10.1016/j.biomaterials.2012.09.068. Epub 2012 Nov 3.","Wei J","Biomaterials","2013","2012/11/07","","","10.1016/j.biomaterials.2012.09.068"
"10492213","Re: Comparison of screening methods in the detection of bladder cancer","Johnston B, Morales A.","J Urol. 1999 Oct;162(4):1388-9.","Johnston B","J Urol","1999","1999/09/24","","",""
"9590747","[Relationship between the abnormal expression of CD44 gene and bladder cancer]","Wu Z, Zhang Y, Liu D.","Zhonghua Wai Ke Za Zhi. 1996 Nov;34(11):645-7.","Wu Z","Zhonghua Wai Ke Za Zhi","1996","1996/11/01","","",""
"19758621","Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","Fernandez-Gomez J, Madero R, Solsona E, Unda M, Martinez-Piñeiro L, Gonzalez M, Portillo J, Ojea A, Pertusa C, Rodriguez-Molina J, Camacho JE, Rabadan M, Astobieta A, Montesinos M, Isorna S, Muntañola P, Gimeno A, Blas M, Martinez-Piñeiro JA.","J Urol. 2009 Nov;182(5):2195-203. doi: 10.1016/j.juro.2009.07.016. Epub 2009 Sep 16.","Fernandez-Gomez J","J Urol","2009","2009/09/18","","","10.1016/j.juro.2009.07.016"
"30075175","MiR-302b regulates cell functions and acts as a potential biomarker to predict recurrence in bladder cancer","Li Z, Zhou L, Lin C, Pan X, Xie J, Zhao L, Quan J, Xu J, Guan X, Xu W, Li H, Chen Y, Lai Y.","Life Sci. 2018 Sep 15;209:15-23. doi: 10.1016/j.lfs.2018.07.057. Epub 2018 Jul 31.","Li Z","Life Sci","2018","2018/08/04","","","10.1016/j.lfs.2018.07.057"
"12650028","[Diagnosis and therapy of superficial tumors of the urinary bladder]","Babjuk M, Dvorácek J.","Cas Lek Cesk. 2002 Nov 22;141(23):723-8.","Babjuk M","Cas Lek Cesk","2002","2003/03/26","","",""
"20290750","Adenocarcinoma of the vault of the urinary bladder","DREYFUSS ML.","Urol Cutaneous Rev. 1947 Jan;51(1):1-3.","DREYFUSS ML","Urol Cutaneous Rev","1947","2010/03/19","","",""
"20150621","Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effects on the adhesion and migration of bladder cancer cells in vitro","Zhang N, Sanders AJ, Ye L, Kynaston HG, Jiang WG.","Anticancer Res. 2010 Jan;30(1):87-95.","Zhang N","Anticancer Res","2010","2010/02/13","","",""
"29181804","Vigorous intensity aerobic interval exercise in bladder cancer patients prior to radical cystectomy: a feasibility randomised controlled trial","Banerjee S, Manley K, Shaw B, Lewis L, Cucato G, Mills R, Rochester M, Clark A, Saxton JM.","Support Care Cancer. 2018 May;26(5):1515-1523. doi: 10.1007/s00520-017-3991-2. Epub 2017 Nov 27.","Banerjee S","Support Care Cancer","2018","2017/11/29","","","10.1007/s00520-017-3991-2"
"15703096","Cystectomy with orthotopic reconstruction following radical retropubic prostatectomy","Miotto A Jr, Dall'Oglio M, Srougi M.","Int Braz J Urol. 2004 Mar-Apr;30(2):125-7. doi: 10.1590/s1677-55382004000200009.","Miotto A Jr","Int Braz J Urol","2004","2005/02/11","","","10.1590/s1677-55382004000200009"
"7317751","Transitional cell carcinoma involving the prostate--an unfavourable prognostic sign in the management of bladder cancer?","Kirk D, Savage A, Makepeace AR, Gostelow BE.","Br J Urol. 1981 Dec;53(6):610-2. doi: 10.1111/j.1464-410x.1981.tb03272.x.","Kirk D","Br J Urol","1981","1981/12/01","","","10.1111/j.1464-410x.1981.tb03272.x"
"22446336","Tumorigenic and prognostic significance of RASSF1A expression in low-grade (WHO grade 1 and grade 2) nonmuscle-invasive bladder cancer","Ha YS, Jeong P, Kim JS, Kwon WA, Kim IY, Yun SJ, Kim GY, Choi YH, Moon SK, Kim WJ.","Urology. 2012 Jun;79(6):1411.e1-6. doi: 10.1016/j.urology.2012.01.042. Epub 2012 Mar 23.","Ha YS","Urology","2012","2012/03/27","","","10.1016/j.urology.2012.01.042"
"23590830","Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden","Sabir EF, Holmäng S, Liedberg F, Ljungberg B, Malmström PU, Månsson W, Wijkström H, Jahnson S.","Scand J Urol. 2013 Dec;47(6):483-90. doi: 10.3109/21681805.2013.787118. Epub 2013 Apr 16.","Sabir EF","Scand J Urol","2013","2013/04/18","","","10.3109/21681805.2013.787118"
"22126728","Current management of muscle-invasive bladder cancer","Sancho G, Maroto P, Palou J.","Clin Transl Oncol. 2011 Dec;13(12):855-61. doi: 10.1007/s12094-011-0746-2.","Sancho G","Clin Transl Oncol","2011","2011/12/01","","","10.1007/s12094-011-0746-2"
"26810322","The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder","Jo JK, Jeong SJ, Hong SK, Byun SS, Lee SE, Oh JJ.","Int Urol Nephrol. 2016 Apr;48(4):489-94. doi: 10.1007/s11255-016-1219-x. Epub 2016 Jan 25.","Jo JK","Int Urol Nephrol","2016","2016/01/27","","","10.1007/s11255-016-1219-x"
"26847182","The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis","Soubra A, Hayward D, Dahm P, Goldfarb R, Froehlich J, Jha G, Konety BR.","World J Urol. 2016 Sep;34(9):1229-37. doi: 10.1007/s00345-016-1772-z. Epub 2016 Feb 4.","Soubra A","World J Urol","2016","2016/02/06","","","10.1007/s00345-016-1772-z"
"14501712","Serum vitamins and the subsequent risk of bladder cancer","Nomura AM, Lee J, Stemmermann GN, Franke AA.","J Urol. 2003 Oct;170(4 Pt 1):1146-50. doi: 10.1097/01.ju.0000086040.24795.ad.","Nomura AM","J Urol","2003","2003/09/23","","","10.1097/01.ju.0000086040.24795.ad"
"29157296","Biomarkers for immunotherapy in bladder cancer: a moving target","Aggen DH, Drake CG.","J Immunother Cancer. 2017 Nov 21;5(1):94. doi: 10.1186/s40425-017-0299-1.","Aggen DH","J Immunother Cancer","2017","2017/11/22","PMC5697433","","10.1186/s40425-017-0299-1"
"1425831","Tissue polypeptide antigen for monitoring of advanced bladder cancer after MVEC chemotherapy","Schmidt A, Bub P, Rüther U, Eisenberger F.","Eur Urol. 1992;21 Suppl 1:10-2. doi: 10.1159/000474879.","Schmidt A","Eur Urol","1992","1992/01/01","","","10.1159/000474879"
"27416787","Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer","Alimi Q, Verhoest G, Kammerer-Jacquet SF, Mathieu R, Rioux-Leclercq N, Manunta A, Laguerre B, Guille F, Bensalah K, Peyronnet B.","Int J Urol. 2016 Oct;23(10):840-846. doi: 10.1111/iju.13164. Epub 2016 Jul 15.","Alimi Q","Int J Urol","2016","2016/07/16","","","10.1111/iju.13164"
"11454992","Mapping and genome sequence analysis of chromosome 5 regions involved in bladder cancer progression","Kram A, Li L, Zhang RD, Yoon DS, Ro JY, Johnston D, Grossman HB, Scherer S, Czerniak B.","Lab Invest. 2001 Jul;81(7):1039-48. doi: 10.1038/labinvest.3780315.","Kram A","Lab Invest","2001","2001/07/17","","","10.1038/labinvest.3780315"
"29720561","Androgen Receptor Signaling Reduces Radiosensitivity in Bladder Cancer","Ide H, Inoue S, Mizushima T, Jiang G, Chuang KH, Oya M, Miyamoto H.","Mol Cancer Ther. 2018 Jul;17(7):1566-1574. doi: 10.1158/1535-7163.MCT-17-1061. Epub 2018 May 2.","Ide H","Mol Cancer Ther","2018","2018/05/04","","","10.1158/1535-7163.MCT-17-1061"
"7642415","Alternating chemo-radiotherapy in bladder cancer: a conservative approach","Orsatti M, Curotto A, Canobbio L, Guarneri D, Scarpati D, Venturini M, Franzone P, Giudici S, Martorana G, Boccardo F, et al.","Int J Radiat Oncol Biol Phys. 1995 Aug 30;33(1):173-8. doi: 10.1016/0360-3016(95)00136-M.","Orsatti M","Int J Radiat Oncol Biol Phys","1995","1995/08/30","","","10.1016/0360-3016(95)00136-M"
"24500943","Fluid intake and risk of bladder cancer in the Nurses' Health Studies","Zhou J, Kelsey KT, Giovannucci E, Michaud DS.","Int J Cancer. 2014 Sep 1;135(5):1229-37. doi: 10.1002/ijc.28764. Epub 2014 Feb 20.","Zhou J","Int J Cancer","2014","2014/02/07","PMC4213947","NIHMS636417","10.1002/ijc.28764"
"8687218","[In vitro direct antiproliferative activity and in vivo antitumor activity of bropirimine against bladder cancer]","Tahara M, Nomura S, Takahashi M, Takagi H, Hashimoto M, Eto H, Kamidono S.","Gan To Kagaku Ryoho. 1996 Jul;23(8):1039-44.","Tahara M","Gan To Kagaku Ryoho","1996","1996/07/01","","",""
"10917561","N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction","Green J, Banks E, Berrington A, Darby S, Deo H, Newton R.","Br J Cancer. 2000 Aug;83(3):412-7. doi: 10.1054/bjoc.2000.1265.","Green J","Br J Cancer","2000","2000/08/06","PMC2374558","","10.1054/bjoc.2000.1265"
"31443756","Can intravesical application of paracetamol benefit the chemotherapy treatment of bladder cancer?","Öksüz E, Buğday MS.","Med Hypotheses. 2019 Oct;131:109322. doi: 10.1016/j.mehy.2019.109322. Epub 2019 Jul 22.","Öksüz E","Med Hypotheses","2019","2019/08/25","","","10.1016/j.mehy.2019.109322"
"3617261","Carcinoma of the renal pelvis and bladder associated with sarcoidosis: a case report","Fukutani K, Kawabe K, Moriyama N, Kitamura T, Murakami T.","Urol Int. 1987;42(3):224-6. doi: 10.1159/000281907.","Fukutani K","Urol Int","1987","1987/01/01","","","10.1159/000281907"
"18908968","Bilharziasis and bilharzial cancer of the bladder","IBRAHIM H.","Ann R Coll Surg Engl. 1948 Mar;2(3):129-41.","IBRAHIM H","Ann R Coll Surg Engl","1948","1948/03/01","PMC1940191","",""
"4132785","Radiotherapy of advanced localized bladder cancer","Green N, George FW 3rd.","J Urol. 1974 May;111(5):611-2. doi: 10.1016/s0022-5347(17)60027-2.","Green N","J Urol","1974","1974/05/01","","","10.1016/s0022-5347(17)60027-2"
"31562019","MiR-188-5p and MiR-141-3p influence prognosis of bladder cancer and promote bladder cancer synergistically","Yang X, Wang P.","Pathol Res Pract. 2019 Nov;215(11):152598. doi: 10.1016/j.prp.2019.152598. Epub 2019 Aug 17.","Yang X","Pathol Res Pract","2019","2019/09/29","","","10.1016/j.prp.2019.152598"
"8840487","Results of radical cystectomy and pelvic lymphadenectomy for bladder cancer with pelvic node metastases","Bretheau D, Ponthieu A.","Urol Int. 1996;57(1):27-31. doi: 10.1159/000282872.","Bretheau D","Urol Int","1996","1996/01/01","","","10.1159/000282872"
"4026214","[Cancer of the bladder. Importance of the assessment of lymph node involvement in the selection of therapy]","Boccon-Gibod L, Steg A.","Ann Urol (Paris). 1985;19(4):223-4.","Boccon-Gibod L","Ann Urol (Paris)","1985","1985/01/01","","",""
"9816267","Predictive value of p53 mutations analyzed in bladder washings for progression of high-risk superficial bladder cancer","Vet JA, Witjes JA, Marras SA, Hessels D, van der Poel HG, Debruyne FM, Schalken JA.","Clin Cancer Res. 1996 Jun;2(6):1055-61.","Vet JA","Clin Cancer Res","1996","1996/06/01","","",""
"9672255","Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer","Stein JP, Ginsberg DA, Grossfeld GD, Chatterjee SJ, Esrig D, Dickinson MG, Groshen S, Taylor CR, Jones PA, Skinner DG, Cote RJ.","J Natl Cancer Inst. 1998 Jul 15;90(14):1072-9. doi: 10.1093/jnci/90.14.1072.","Stein JP","J Natl Cancer Inst","1998","1998/07/22","","","10.1093/jnci/90.14.1072"
"31111675","Causes of death in long-term bladder cancer survivors: A population-based study","Kong J, Diao X, Diao F, Fan X, Zheng J, Yan D, Huang J, Qin H, Lin T.","Asia Pac J Clin Oncol. 2019 Oct;15(5):e167-e174. doi: 10.1111/ajco.13156. Epub 2019 May 20.","Kong J","Asia Pac J Clin Oncol","2019","2019/05/22","","","10.1111/ajco.13156"
"20108538","HAL fluorescence cystoscopy and TURB one year of Romanian experience","Geavlete B, Mulţescu R, Georgescu D, Jecu M, Geavlete P.","J Med Life. 2009 Apr-Jun;2(2):185-90.","Geavlete B","J Med Life","2009","2010/01/30","PMC3018986","",""
"4035840","Results of radical cystectomy for primary bladder cancer. Retrospective study of more than 200 cases","Giuliani L, Giberti C, Martorana G, Bonamini A, Natta GD, Rovida S.","Urology. 1985 Sep;26(3):243-8. doi: 10.1016/0090-4295(85)90119-0.","Giuliani L","Urology","1985","1985/09/01","","","10.1016/0090-4295(85)90119-0"
"1333885","Association of bovine papillomavirus type 2 and bracken fern with bladder cancer in cattle","Campo MS, Jarrett WF, Barron R, O'Neil BW, Smith KT.","Cancer Res. 1992 Dec 15;52(24):6898-904.","Campo MS","Cancer Res","1992","1992/12/15","","",""
"23394702","Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer","Cimino GD, Pan CX, Henderson PT.","Bioanalysis. 2013 Feb;5(3):369-91. doi: 10.4155/bio.12.325.","Cimino GD","Bioanalysis","2013","2013/02/12","PMC3644565","NIHMS457247","10.4155/bio.12.325"
"15153335","Urine telomerase: an important marker in the diagnosis of bladder cancer","Sanchini MA, Bravaccini S, Medri L, Gunelli R, Nanni O, Monti F, Baccarani PC, Ravaioli A, Bercovich E, Amadori D, Calistri D.","Neoplasia. 2004 May-Jun;6(3):234-9. doi: 10.1593/neo.03433.","Sanchini MA","Neoplasia","2004","2004/05/22","PMC1502100","","10.1593/neo.03433"
"8908649","Predictive value of DNA ploidy in bladder cancer treated with preoperative radiation therapy and cystectomy","Granfors T, Duchek M, Tomic R, Roos G, Ljungberg B.","Scand J Urol Nephrol. 1996 Aug;30(4):281-5. doi: 10.3109/00365599609182307.","Granfors T","Scand J Urol Nephrol","1996","1996/08/01","","","10.3109/00365599609182307"
"6879880","Therapeutic efficacy of salvage cystectomy. Do results reflect natural history of bladder cancer?","Droller MJ, Walsh PC.","Urology. 1983 Aug;22(2):118-22. doi: 10.1016/0090-4295(83)90489-2.","Droller MJ","Urology","1983","1983/08/01","","","10.1016/0090-4295(83)90489-2"
"18462352","The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer","Herrmann E, Stöter E, van Ophoven A, Bierer S, Bolenz C, Hertle L, Wülfing C.","Int J Urol. 2008 Jul;15(7):607-11. doi: 10.1111/j.1442-2042.2008.02059.x. Epub 2008 May 2.","Herrmann E","Int J Urol","2008","2008/05/09","","","10.1111/j.1442-2042.2008.02059.x"
"22524797","Clinical application of the adenosine triphosphate-based response assay in intravesical chemotherapy for superficial bladder cancer","Ge WQ, Pu JX, Zheng SY.","Asian Pac J Cancer Prev. 2012;13(2):689-92. doi: 10.7314/apjcp.2012.13.2.689.","Ge WQ","Asian Pac J Cancer Prev","2012","2012/04/25","","","10.7314/apjcp.2012.13.2.689"
"25731558","[A case of adenocarcinoma occurring in the bladder mucosa after a surgical operation for colovesical fistula]","Fujimoto T, Abe T, Okabe Y, Johshima K, Fukuyama K, Noda T, Shimoike N, Maekawa H, Tada S, Iwata T, Yoshimoto Y, Fujikawa T, Tanaka A.","Gan To Kagaku Ryoho. 2014 Nov;41(12):2462-4.","Fujimoto T","Gan To Kagaku Ryoho","2014","2015/03/04","","",""
"27333654","[BCG Immunotherapy Against Non-Muscle Invasive Bladder Cancer: Recent Results, Current Studies and Future Perspectives]","Takeuchi A, Shiota M, Tatsugami K, Yokomizo A, Eto M.","Fukuoka Igaku Zasshi. 2016 Jan;107(1):8-11.","Takeuchi A","Fukuoka Igaku Zasshi","2016","2016/06/24","","",""
"2129003","Current concepts in the management of superficial bladder cancer","Soloway MS.","Arch Esp Urol. 1990;43 Suppl 2:115-21.","Soloway MS","Arch Esp Urol","1990","1990/01/01","","",""
"1948642","[Radiotherapy in the interdisciplinary approach to the treatment of bladder carcinoma]","Dunst J.","Strahlenther Onkol. 1991 Oct;167(10):563-80.","Dunst J","Strahlenther Onkol","1991","1991/10/01","","",""
"25559810","Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients","Martin-Doyle W, Leow JJ, Orsola A, Chang SL, Bellmunt J.","J Clin Oncol. 2015 Feb 20;33(6):643-50. doi: 10.1200/JCO.2014.57.6967. Epub 2015 Jan 5.","Martin-Doyle W","J Clin Oncol","2015","2015/01/07","","","10.1200/JCO.2014.57.6967"
"12214449","[Tumors in the elderly]","Rübben H, Lümmen G.","Urologe A. 2002 Jul;41(4):333-7. doi: 10.1007/s00120-002-0217-z.","Rübben H","Urologe A","2002","2002/09/07","","","10.1007/s00120-002-0217-z"
"7272964","Scanning electron microscopic features of human urinary bladder cancer","Jacobs JB, Cohen SM, Farrow GM, Friedell GH.","Cancer. 1981 Sep 15;48(6):1399-409. doi: 10.1002/1097-0142(19810915)48:6<1399::aid-cncr2820480623>3.0.co;2-c.","Jacobs JB","Cancer","1981","1981/09/15","","","10.1002/1097-0142(19810915)48:6<1399::aid-cncr2820480623>3.0.co;2-c"
"24947315","Editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading","Todenhöfer T, Schwentner C.","Int J Urol. 2014 Oct;21(10):973. doi: 10.1111/iju.12516. Epub 2014 Jun 19.","Todenhöfer T","Int J Urol","2014","2014/06/21","","","10.1111/iju.12516"
"29405724","Histonedeacetylase 1 mRNA has elevated expression in clinical specimen of bladder cancer","Alivand M, Soufi RT, Madani AH, Esmaeili SN, Vaziri HR, Sohani MM, Rafati M, Hamami P, Ajamian F.","Bratisl Lek Listy. 2018;119(1):12-16. doi: 10.4149/BLL_2018_003.","Alivand M","Bratisl Lek Listy","2018","2018/02/07","","","10.4149/BLL_2018_003"
"29676191","Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer","Sjöström C, Thorstenson A, Ströck V, Hosseini-Aliabad A, Aljabery F, Liedberg F, Sherif A, Malmström PU, Rosell J, Gårdmark T, Jahnson S.","Scand J Urol. 2018 Jun;52(3):186-193. doi: 10.1080/21681805.2018.1462254. Epub 2018 Apr 20.","Sjöström C","Scand J Urol","2018","2018/04/21","","","10.1080/21681805.2018.1462254"
"7941116","[The characteristics of the hormonal status in women with bladder neoplasms]","Prianichnikova MB.","Urol Nefrol (Mosk). 1993 Jan-Feb;(1):14-6.","Prianichnikova MB","Urol Nefrol (Mosk)","1993","1993/01/01","","",""
"29459997","The effects of intra-arterial chemotherapy on bladder preservation in patients with T1 stage bladder cancer","Liu Z, Ye Y, Li X, Guo S, Jiang L, Dong P, Li Y, Shi Y, Fan W, Cao Y, Yao K, Qin Z, Han H, Zhou F, Liu Z.","World J Urol. 2018 Aug;36(8):1191-1200. doi: 10.1007/s00345-018-2199-5. Epub 2018 Feb 19.","Liu Z","World J Urol","2018","2018/02/21","","","10.1007/s00345-018-2199-5"
"11512394","[Bladder cancer]","Fernández Mena FJ, Moreno-Torres YC.","Arch Esp Urol. 2001 Jul-Aug;54(6):493-510.","Fernández Mena FJ","Arch Esp Urol","2001","2001/08/22","","",""
"32585158","Characterization of Tumor Blood Vasculature Expression of Human Invasive Bladder Cancer by Laser Capture Microdissection and Transcriptional Profiling","Roudnicky F, Poyet C, Buser L, Saba K, Wild P, Otto VI, Detmar M.","Am J Pathol. 2020 Sep;190(9):1960-1970. doi: 10.1016/j.ajpath.2020.05.020. Epub 2020 Jun 23.","Roudnicky F","Am J Pathol","2020","2020/06/26","","","10.1016/j.ajpath.2020.05.020"
"3482685","[Blood groups and bladder cancer]","Tan LB, Huang CH, Chiang CP, Chou YH, Wang CC, Liu LH.","Gaoxiong Yi Xue Ke Xue Za Zhi. 1986 Nov;2(11):677-81.","Tan LB","Gaoxiong Yi Xue Ke Xue Za Zhi","1986","1986/11/01","","",""
"7994784","Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory. Nara Uro-oncology Research Group. (NUORG)","Hirao Y, Ozono S, Momose H, Okajima E, Hiramatsu T, Yoshida K, Fukushima S, Ohashi Y.","Cancer Chemother Pharmacol. 1994;35 Suppl:S36-40. doi: 10.1007/BF00686917.","Hirao Y","Cancer Chemother Pharmacol","1994","1994/01/01","","","10.1007/BF00686917"
"26033321","Robot-assisted intracorporeal pyramid neobladder","Tan WS, Sridhar A, Goldstraw M, Zacharakis E, Nathan S, Hines J, Cathcart P, Briggs T, Kelly JD.","BJU Int. 2015 Nov;116(5):771-9. doi: 10.1111/bju.13189. Epub 2015 Jul 14.","Tan WS","BJU Int","2015","2015/06/03","","","10.1111/bju.13189"
"10945601","Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer","Muto S, Horie S, Takahashi S, Tomita K, Kitamura T.","Cancer Res. 2000 Aug 1;60(15):4021-5.","Muto S","Cancer Res","2000","2000/08/17","","",""
"24856485","Lipiodol as a fiducial marker for image-guided radiation therapy for bladder cancer","Freilich JM, Spiess PE, Biagioli MC, Fernandez DC, Shi EJ, Hunt DC, Gupta S, Wilder RB.","Int Braz J Urol. 2014 Mar-Apr;40(2):190-7. doi: 10.1590/S1677-5538.IBJU.2014.02.08.","Freilich JM","Int Braz J Urol","2014","2014/05/27","","","10.1590/S1677-5538.IBJU.2014.02.08"
"8893871","Surgical therapy for locally advanced bladder cancer","Bales GT, Kim H, Steinberg GD.","Semin Oncol. 1996 Oct;23(5):605-13.","Bales GT","Semin Oncol","1996","1996/10/01","","",""
"29370848","Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer","Li Y, Diao F, Shi S, Li K, Zhu W, Wu S, Lin T.","Chin J Cancer. 2018 Jan 26;37(1):3. doi: 10.1186/s40880-018-0269-0.","Li Y","Chin J Cancer","2018","2018/01/27","PMC5785867","","10.1186/s40880-018-0269-0"
"11829887","[Multiple inhibitory mechanisms of wild-type p16 gene transfer into human bladder cells by retroviral vector]","Wu Y, Ma T, Wu H, Zhang W, Wu C.","Zhonghua Wai Ke Za Zhi. 1999 Aug;37(8):456-8.","Wu Y","Zhonghua Wai Ke Za Zhi","1999","2002/02/07","","",""
"27924948","FOXA1, GATA3 and PPARɣ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines","Warrick JI, Walter V, Yamashita H, Chung E, Shuman L, Amponsa VO, Zheng Z, Chan W, Whitcomb TL, Yue F, Iyyanki T, Kawasawa YI, Kaag M, Guo W, Raman JD, Park JS, DeGraff DJ.","Sci Rep. 2016 Dec 7;6:38531. doi: 10.1038/srep38531.","Warrick JI","Sci Rep","2016","2016/12/08","PMC5141480","","10.1038/srep38531"
"28397105","Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer","Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C.","Med Oncol. 2017 May;34(5):90. doi: 10.1007/s12032-017-0955-9. Epub 2017 Apr 10.","Kusaka A","Med Oncol","2017","2017/04/12","","","10.1007/s12032-017-0955-9"
"26922914","Systemic therapy for metastatic bladder cancer in 2016 and beyond","Collazo-Lorduy A, Galsky MD.","Future Oncol. 2016 May;12(9):1179-92. doi: 10.2217/fon-2015-0020. Epub 2016 Feb 29.","Collazo-Lorduy A","Future Oncol","2016","2016/03/01","","","10.2217/fon-2015-0020"
"28689694","Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion?","Audenet F, Retinger C, Chien C, Benfante NE, Bochner BH, Donat SM, Herr HW, Dalbagni G.","Urol Oncol. 2017 Oct;35(10):603.e1-603.e5. doi: 10.1016/j.urolonc.2017.06.042. Epub 2017 Jul 6.","Audenet F","Urol Oncol","2017","2017/07/11","PMC5643222","NIHMS891053","10.1016/j.urolonc.2017.06.042"
"23017513","Disease specific mortality in patients with low risk bladder cancer and the impact of cystoscopic surveillance","Linton KD, Rosario DJ, Thomas F, Rubin N, Goepel JR, Abbod MF, Catto JW.","J Urol. 2013 Mar;189(3):828-33. doi: 10.1016/j.juro.2012.09.084. Epub 2012 Sep 24.","Linton KD","J Urol","2013","2012/09/29","","","10.1016/j.juro.2012.09.084"
"7553289","Combined intraarterial cisplatin infusion and radiation therapy for invasive bladder cancer","Mizoguchi H, Nomura Y, Terada K, Nakagawa M, Ogata J.","Int J Urol. 1995 May;2(2):17-23. doi: 10.1111/j.1442-2042.1995.tb00614.x.","Mizoguchi H","Int J Urol","1995","1995/05/01","","","10.1111/j.1442-2042.1995.tb00614.x"
"26310514","Robot-assisted radical cystectomy","Kurpad R, Woods M.","J Surg Oncol. 2015 Dec;112(7):728-35. doi: 10.1002/jso.24009. Epub 2015 Aug 27.","Kurpad R","J Surg Oncol","2015","2015/08/28","","","10.1002/jso.24009"
"3616408","Temporal aspects of bladder carcinogenesis","Vineis P, Estève J.","Toxicol Pathol. 1987;15(2):234-7. doi: 10.1177/019262338701500218.","Vineis P","Toxicol Pathol","1987","1987/01/01","","","10.1177/019262338701500218"
"25596645","Bcl-2 predicts response to neoadjuvant chemotherapy and is overexpressed in lymph node metastases of urothelial cancer of the bladder","Kiss B, Skuginna V, Fleischmann A, Bell RH, Collins C, Thalmann GN, Seiler R.","Urol Oncol. 2015 Apr;33(4):166.e1-8. doi: 10.1016/j.urolonc.2014.12.005. Epub 2015 Jan 14.","Kiss B","Urol Oncol","2015","2015/01/19","","","10.1016/j.urolonc.2014.12.005"
"6702052","Cytologic spectrum of bladder cancer","Gamarra MC, Zein T.","Urology. 1984 Mar;23(3 Suppl):23-6. doi: 10.1016/s0090-4295(84)80110-7.","Gamarra MC","Urology","1984","1984/03/01","","","10.1016/s0090-4295(84)80110-7"
"19020884","The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer","Hadjizacharia P, Stein JP, Cai J, Miranda G.","World J Urol. 2009 Feb;27(1):33-8. doi: 10.1007/s00345-008-0345-1. Epub 2008 Nov 20.","Hadjizacharia P","World J Urol","2009","2008/11/21","","","10.1007/s00345-008-0345-1"
"23382838","Genotoxic effect of N-hydroxy-4-acetylaminobiphenyl on human DNA: implications in bladder cancer","Shahab U, Moinuddin, Ahmad S, Dixit K, Habib S, Alam K, Ali A.","PLoS One. 2013;8(1):e53205. doi: 10.1371/journal.pone.0053205. Epub 2013 Jan 31.","Shahab U","PLoS One","2013","2013/02/06","PMC3561383","","10.1371/journal.pone.0053205"
"12898033","[Urinary cytology in cases of bladder cancer: a critical evaluation]","Rathert P.","Urologe A. 2003 Jul;42(7):908-11. doi: 10.1007/s00120-003-0311-x. Epub 2003 Mar 26.","Rathert P","Urologe A","2003","2003/08/05","","","10.1007/s00120-003-0311-x"
"268123","Microhematuria found by mass screening of apparently healthy males","Freni SC, Freni-Titulaer LW.","Acta Cytol. 1977 May-Jun;21(3):421-3.","Freni SC","Acta Cytol","1977","1977/05/01","","",""
"27669755","Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup","Baldia PH, Maurer A, Heide T, Rose M, Stoehr R, Hartmann A, Williams SV, Knowles MA, Knuechel R, Gaisa NT.","Oncotarget. 2016 Nov 1;7(44):71429-71439. doi: 10.18632/oncotarget.12198.","Baldia PH","Oncotarget","2016","2016/09/28","PMC5342089","","10.18632/oncotarget.12198"
"9288858","Treatment outcome following radiotherapy in elderly patients with bladder cancer","Sengeløv L, Klintorp S, Havsteen H, Kamby C, Hansen SL, von der Maase H.","Radiother Oncol. 1997 Jul;44(1):53-8. doi: 10.1016/s0167-8140(97)00069-8.","Sengeløv L","Radiother Oncol","1997","1997/07/01","","","10.1016/s0167-8140(97)00069-8"
"23115943","Carcinoma in situ of urinary bladder: incidence, treatment and clinical outcomes during ten-year follow-up","Librenjak D, Novaković ZS, Milostić K.","Acta Clin Croat. 2012 Jun;51(2):201-7.","Librenjak D","Acta Clin Croat","2012","2012/11/03","","",""
"28964932","Predictors of female genital organ involvement in radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective analysis of 112 female patients","Choi SY, Yoo S, Han JH, Jeong IG, Hong B, Hong JH, Ahn H, Kim CS, You D.","Int J Surg. 2017 Nov;47:101-106. doi: 10.1016/j.ijsu.2017.09.059. Epub 2017 Sep 28.","Choi SY","Int J Surg","2017","2017/10/02","","","10.1016/j.ijsu.2017.09.059"
"20568111","Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can)","Häggström C, Stocks T, Rapp K, Bjørge T, Lindkvist B, Concin H, Engeland A, Manjer J, Ulmer H, Selmer R, Tretli S, Hallmans G, Jonsson H, Stattin P.","Int J Cancer. 2011 Apr 15;128(8):1890-8. doi: 10.1002/ijc.25521.","Häggström C","Int J Cancer","2011","2010/06/23","","","10.1002/ijc.25521"
"8266861","[Ileal low pressure bladder substitute with a tubular afferent limb: report of two cases]","Suzuki H, Yanagi S, Kuramochi H, Namiki T.","Hinyokika Kiyo. 1993 Oct;39(10):943-6.","Suzuki H","Hinyokika Kiyo","1993","1993/10/01","","",""
"2461643","[Multivariate evaluation of survival factors and postoperative adjuvant chemotherapy in patients with bladder cancer treated by radical cystectomy]","Takashi M, Murase T, Aota Y, Nagai T, Kinjo T, Sabashi M, Shimoji T, Miyake K, Hamajma N, Mizuno S.","Hinyokika Kiyo. 1988 Aug;34(8):1377-81.","Takashi M","Hinyokika Kiyo","1988","1988/08/01","","",""
"19465410","Automobile industry occupations and bladder cancer: a population-based case-control study in southeastern Michigan, USA","Kobrosly RW, Meliker JR, Nriagu JO.","Occup Environ Med. 2009 Oct;66(10):650-6. doi: 10.1136/oem.2008.041616. Epub 2009 May 21.","Kobrosly RW","Occup Environ Med","2009","2009/05/26","","","10.1136/oem.2008.041616"
"20447989","Bladder cancer among hairdressers: a meta-analysis","Harling M, Schablon A, Schedlbauer G, Dulon M, Nienhaus A.","Occup Environ Med. 2010 May;67(5):351-8. doi: 10.1136/oem.2009.050195.","Harling M","Occup Environ Med","2010","2010/05/08","PMC2981018","","10.1136/oem.2009.050195"
"16688457","Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays?","Krause FS, Rauch A, Schrott KM, Engehausen DG.","World J Urol. 2006 Sep;24(4):418-22. doi: 10.1007/s00345-006-0086-y. Epub 2006 May 11.","Krause FS","World J Urol","2006","2006/05/12","","","10.1007/s00345-006-0086-y"
"5634847","Cancer of human bladder. Responses of tumor xenografts to chemotherapy and radiotherapy","Kaufman JJ, Lichtenauer P.","Cancer. 1968 Jan;21(1):1-8. doi: 10.1002/1097-0142(196801)21:1<1::aid-cncr2820210102>3.0.co;2-5.","Kaufman JJ","Cancer","1968","1968/01/01","","","10.1002/1097-0142(196801)21:1<1::aid-cncr2820210102>3.0.co;2-5"
"19219612","Impact of marital status in patients undergoing radical cystectomy for bladder cancer","Pruthi RS, Lentz AC, Sand M, Kouba E, Wallen EM.","World J Urol. 2009 Aug;27(4):573-6. doi: 10.1007/s00345-009-0380-6. Epub 2009 Feb 15.","Pruthi RS","World J Urol","2009","2009/02/17","","","10.1007/s00345-009-0380-6"
"27599849","Plasma and urine DNA levels are related to microscopic hematuria in patients with bladder urothelial carcinoma","de Almeida EF, Abdalla TE, Arrym TP, de Oliveira Delgado P, Wroclawski ML, da Costa Aguiar Alves B, de S Gehrke F, Azzalis LA, Alves S, Tobias-Machado M, de Lima Pompeo AC, Fonseca FL.","Clin Biochem. 2016 Nov;49(16-17):1274-1277. doi: 10.1016/j.clinbiochem.2016.08.021. Epub 2016 Sep 4.","de Almeida EF","Clin Biochem","2016","2016/09/08","","","10.1016/j.clinbiochem.2016.08.021"
"31353632","Editorial Comment from Dr Kojima to Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cystectomy","Kojima T.","Int J Urol. 2019 Oct;26(10):1012. doi: 10.1111/iju.14074. Epub 2019 Jul 28.","Kojima T","Int J Urol","2019","2019/07/30","","","10.1111/iju.14074"
"16364760","Multitarget fluorescence in situ hybridization and melanoma antigen genes analysis in primary bladder carcinoma","Kang JU, Koo SH, Jeong TE, Kwon KC, Park JW, Jeon CH.","Cancer Genet Cytogenet. 2006 Jan 1;164(1):32-8. doi: 10.1016/j.cancergencyto.2005.06.006.","Kang JU","Cancer Genet Cytogenet","2006","2005/12/21","","","10.1016/j.cancergencyto.2005.06.006"
"30614803","MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer","Wang JR, Liu B, Zhou L, Huang YX.","Cancer Biomark. 2019;24(2):159-172. doi: 10.3233/CBM-182000.","Wang JR","Cancer Biomark","2019","2019/01/08","","","10.3233/CBM-182000"
"11134199","Transurethral resection of muscle-invasive bladder cancer: 10-year outcome","Herr HW.","J Clin Oncol. 2001 Jan 1;19(1):89-93. doi: 10.1200/JCO.2001.19.1.89.","Herr HW","J Clin Oncol","2001","2001/01/03","","","10.1200/JCO.2001.19.1.89"
"2472867","Binding of wheat and peanut lectins to human transitional cell carcinomas. Correlation with histopathologic grade, invasion, and DNA ploidy","Langkilde NC, Wolf H, Orntoft TF.","Cancer. 1989 Aug 15;64(4):849-53. doi: 10.1002/1097-0142(19890815)64:4<849::aid-cncr2820640415>3.0.co;2-p.","Langkilde NC","Cancer","1989","1989/08/15","","","10.1002/1097-0142(19890815)64:4<849::aid-cncr2820640415>3.0.co;2-p"
"10473990","Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer","Fujii Y, Fukui I, Kihara K, Tsujii T, Kageyama Y, Oshima H.","Eur Urol. 1999 Oct;36(4):309-13. doi: 10.1159/000020010.","Fujii Y","Eur Urol","1999","1999/09/04","","","10.1159/000020010"
"27141014","Serum and urinary endocan levels for bladder cancer diagnosis","Hu ZD.","Ann Clin Biochem. 2016 Nov;53(6):717. doi: 10.1177/0004563216645623. Epub 2016 Jul 19.","Hu ZD","Ann Clin Biochem","2016","2016/05/04","","","10.1177/0004563216645623"
"2425786","A nursing perspective on laser use in treating superficial bladder cancer","Iammarino PJ.","AUAA J. 1986 Apr-Jun;6(4):7-9.","Iammarino PJ","AUAA J","1986","1986/04/01","","",""
"5949852","[Clinical and pathological studies on partial cystectomy for urinary bladder cancer. I. Clinical pictures and follow-up studies]","Suzuki K, Sugita A, Miura T, Kato M, Onodera Y.","Nihon Hinyokika Gakkai Zasshi. 1966 Apr;57(4):380-7. doi: 10.5980/jpnjurol1928.57.4_380.","Suzuki K","Nihon Hinyokika Gakkai Zasshi","1966","1966/04/01","","","10.5980/jpnjurol1928.57.4_380"
"11072163","The correlation between spontaneous and radiation-induced apoptosis in T3B bladder cancer (histological grade G3), and the precedence between the two kinds of apoptosis for predicting clinical prognosis","Harada S, Sato R, Nakamura R, Oikawa H, Oikawa H, Ohgi S, Tamakawa Y, Yanagisawa T.","Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1059-67. doi: 10.1016/s0360-3016(00)00675-1.","Harada S","Int J Radiat Oncol Biol Phys","2000","2000/11/10","","","10.1016/s0360-3016(00)00675-1"
"9915422","Noninvasive detection of bladder cancer with the BTA stat test","Pode D, Shapiro A, Wald M, Nativ O, Laufer M, Kaver I.","J Urol. 1999 Feb;161(2):443-6.","Pode D","J Urol","1999","1999/01/23","","",""
"25568512","Impact of complications and bladder cancer stage on quality of life in patients with different types of urinary diversions","Prcic A, Aganovic D, Hadziosmanovic O.","Med Arch. 2013 Dec;67(6):418-22. doi: 10.5455/medarh.2013.67.418-422. Epub 2013 Dec 28.","Prcic A","Med Arch","2013","2015/01/09","PMC4272483","","10.5455/medarh.2013.67.418-422"
"5796395","Pathology as related to tryptophan metabolite excretion, occupational history, and smoking habits in patients with bladder cancer","Friedell GH, Burney SW, Bell JR, Soto E.","J Natl Cancer Inst. 1969 Jul;43(1):303-6.","Friedell GH","J Natl Cancer Inst","1969","1969/07/01","","",""
"31212967","Integrative Analysis of Genomic and Clinical Data Reveals Intrinsic Characteristics of Bladder Urothelial Carcinoma Progression","Zhou B, Guo R.","Genes (Basel). 2019 Jun 17;10(6):464. doi: 10.3390/genes10060464.","Zhou B","Genes (Basel)","2019","2019/06/20","PMC6628253","","10.3390/genes10060464"
"31595343","A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma","Nagumo Y, Kojima T, Shiga M, Kandori S, Kimura T, Takaoka EI, Onozawa M, Miyazaki J, Kawai K, Ishikawa H, Sakurai H, Nishiyama H.","Int J Clin Oncol. 2020 Feb;25(2):354-361. doi: 10.1007/s10147-019-01553-4. Epub 2019 Oct 8.","Nagumo Y","Int J Clin Oncol","2020","2019/10/10","","","10.1007/s10147-019-01553-4"
"31864899","Urologic Principles Define the Standards for Successful Bladder Preservation in Muscle-invasive Bladder Cancer","Herr H.","Eur Urol Focus. 2020 Jul 15;6(4):630-631. doi: 10.1016/j.euf.2019.12.003. Epub 2019 Dec 18.","Herr H","Eur Urol Focus","2020","2019/12/23","","","10.1016/j.euf.2019.12.003"
"12792907","Gene products involved in metastasis of bladder cancer","Davies BR.","Histol Histopathol. 2003 Jul;18(3):969-80. doi: 10.14670/HH-18.969.","Davies BR","Histol Histopathol","2003","2003/06/07","","","10.14670/HH-18.969"
"2078065","[Intravesical echography. I. Anatomical correlation]","Passas J, Espuela R, Leyva O, Rodríguez A, de Castro M, Polo G.","Arch Esp Urol. 1990;43 Suppl 1:25-34.","Passas J","Arch Esp Urol","1990","1990/01/01","","",""
"18923361","Screening for bladder cancer using urine-based tumor markers","Svatek RS, Lotan Y, Karakiewizc PI, Shariat SF.","Minerva Urol Nefrol. 2008 Dec;60(4):247-53.","Svatek RS","Minerva Urol Nefrol","2008","2008/10/17","","",""
"2364965","Multiple mucosal biopsies and postoperative urinary cytology in patients with bladder cancer","Gil-Salom M, Sánchez MC, Chuan P, Clar F, Santamaría J, García-Sisamón F.","Eur Urol. 1990;17(4):281-5. doi: 10.1159/000480134.","Gil-Salom M","Eur Urol","1990","1990/01/01","","","10.1159/000480134"
"8734736","Radiotherapy for stage T3b transitional cell carcinoma of the bladder","Pollack A, Zagars GZ.","Semin Urol Oncol. 1996 May;14(2):86-95.","Pollack A","Semin Urol Oncol","1996","1996/05/01","","",""
"25037483","Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer","Yafi FA, Brimo F, Steinberg J, Aprikian AG, Tanguay S, Kassouf W.","Urol Oncol. 2015 Feb;33(2):66.e25-31. doi: 10.1016/j.urolonc.2014.06.008. Epub 2014 Jul 15.","Yafi FA","Urol Oncol","2015","2014/07/20","","","10.1016/j.urolonc.2014.06.008"
"17593092","Upper urinary tract recurrence following radical cystectomy for bladder cancer","Furukawa J, Miyake H, Hara I, Takenaka A, Fujisawa M.","Int J Urol. 2007 Jun;14(6):496-9. doi: 10.1111/j.1442-2042.2007.01776.x.","Furukawa J","Int J Urol","2007","2007/06/27","","","10.1111/j.1442-2042.2007.01776.x"
"24332508","Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series","Bruins HM, Arends TJ, Pelkman M, Hulsbergen-van de Kaa CA, van der Heijden AG, Witjes JA.","Clin Genitourin Cancer. 2014 Jun;12(3):190-5. doi: 10.1016/j.clgc.2013.11.004. Epub 2013 Nov 12.","Bruins HM","Clin Genitourin Cancer","2014","2013/12/17","","","10.1016/j.clgc.2013.11.004"
"18222604","Considerations on the use of urine markers for bladder cancer","van Rhijn BW.","Eur Urol. 2008 May;53(5):880-1. doi: 10.1016/j.eururo.2008.01.043. Epub 2008 Jan 22.","van Rhijn BW","Eur Urol","2008","2008/01/29","","","10.1016/j.eururo.2008.01.043"
"24721970","Diagnosis of bladder cancer and prediction of survival by urinary metabolomics","Jin X, Yun SJ, Jeong P, Kim IY, Kim WJ, Park S.","Oncotarget. 2014 Mar 30;5(6):1635-45. doi: 10.18632/oncotarget.1744.","Jin X","Oncotarget","2014","2014/04/12","PMC4039236","","10.18632/oncotarget.1744"
"621817","Adjuvant chemotherapy for bladder cancer with doxorubicin hydrochloride and cyclophosphamide: preliminary report","Merrin C, Beckley S.","J Urol. 1978 Jan;119(1):62-3. doi: 10.1016/s0022-5347(17)57384-x.","Merrin C","J Urol","1978","1978/01/01","","","10.1016/s0022-5347(17)57384-x"
"1926656","Characterization of peripheral blood T-cell subpopulation of bladder cancer patients","Greenstein A, Pecht M, Kaver I, Trainin N, Braf Z.","Urol Res. 1991;19(4):219-22. doi: 10.1007/BF00305298.","Greenstein A","Urol Res","1991","1991/01/01","","","10.1007/BF00305298"
"2117289","Follow up of patients receiving treatment for superficial bladder cancer with mitomycin C and BCG","Soloway MS.","Prog Clin Biol Res. 1990;350:71-9.","Soloway MS","Prog Clin Biol Res","1990","1990/01/01","","",""
"9488944","[A randomized study on intravesical pirarubicin (THP) chemoprophylaxis of recurrence after transurethral resection of superficial bladder cancer]","Miki T, Nonomura N, Kojima Y, Okuyama A, Nakano E, Kiyohara H, Fujioka H, Koide T, Wakatsuki A, Kuroda H, Sugao H, Seguti T, Takeyama M, Yamaguchi S.","Hinyokika Kiyo. 1997 Dec;43(12):907-12.","Miki T","Hinyokika Kiyo","1997","1998/03/07","","",""
"30731013","Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial Cancer","Alhalabi O, Shah AY, Lemke EA, Gao J.","Oncology (Williston Park). 2019 Jan 17;33(1):11-8.","Alhalabi O","Oncology (Williston Park)","2019","2019/02/08","","",""
"8401637","Adjuvant chemotherapy following radical cystectomy","Sternberg CN.","World J Urol. 1993;11(3):169-74. doi: 10.1007/BF00211414.","Sternberg CN","World J Urol","1993","1993/01/01","","","10.1007/BF00211414"
"18022132","Urinary bladder adenocarcinoma arising in a spina bifida patient","Bitar M, Mandel E, Kirschenbaum AM, Unger PD.","Ann Diagn Pathol. 2007 Dec;11(6):453-6. doi: 10.1016/j.anndiagpath.2006.06.002. Epub 2007 Jul 24.","Bitar M","Ann Diagn Pathol","2007","2007/11/21","","","10.1016/j.anndiagpath.2006.06.002"
"5452781","[Cancer of the exstrophied bladder (3 cases)]","Couvelaire R, Dufour B, Bonnaud P, Camplez P.","J Urol Nephrol (Paris). 1970 Jun;76(6):507-16.","Couvelaire R","J Urol Nephrol (Paris)","1970","1970/06/01","","",""
"10458411","Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder","Li SM, Zhang ZT, Chan S, McLenan O, Dixon C, Taneja S, Lepor H, Sun TT, Wu XR.","J Urol. 1999 Sep;162(3 Pt 1):931-5. doi: 10.1097/00005392-199909010-00093.","Li SM","J Urol","1999","1999/08/24","","","10.1097/00005392-199909010-00093"
"8928334","[Leiomyosarcoma of the bladder 8 years after radiation therapy for bladder cancer]","Arutiunian NO, Figurin KM.","Urol Nefrol (Mosk). 1996 May-Jun;(3):45-6.","Arutiunian NO","Urol Nefrol (Mosk)","1996","1996/05/01","","",""
"31268162","SOX4 regulates invasion of bladder cancer cells via repression of WNT5a","Moran JD, Kim HH, Li Z, Moreno CS.","Int J Oncol. 2019 Aug;55(2):359-370. doi: 10.3892/ijo.2019.4832. Epub 2019 Jun 26.","Moran JD","Int J Oncol","2019","2019/07/04","PMC6615919","","10.3892/ijo.2019.4832"
"7920741","Laparoscopic pelvic lymphnodes dissection for prostate and bladder cancer: indication, techniques and results","Puppo P, Perachino M, Ricciotti G, Carmignani G, Maffezzini M.","Arch Ital Urol Androl. 1994 Jun;66(3):117-23.","Puppo P","Arch Ital Urol Androl","1994","1994/06/01","","",""
"29857077","The Role of Vitamin D Receptor Polymorphisms in Predicting the Response to Therapy for Nonmuscle Invasive Bladder Carcinoma","Wang Z, Lim YK, Lim HCC, Chan YH, Ngiam N, Raman Nee Mani L, Esuvaranathan K, Ng CF, Teoh J, Chan E, Mahendran R, Chiong E.","J Urol. 2018 Oct;200(4):737-742. doi: 10.1016/j.juro.2018.05.120. Epub 2018 May 30.","Wang Z","J Urol","2018","2018/06/02","","","10.1016/j.juro.2018.05.120"
"24733278","Perioperative chemotherapy for muscle-invasive bladder cancer: A population-based outcomes study","Booth CM, Siemens DR, Li G, Peng Y, Tannock IF, Kong W, Berman DM, Mackillop WJ.","Cancer. 2014 Jun 1;120(11):1630-8. doi: 10.1002/cncr.28510. Epub 2014 Apr 14.","Booth CM","Cancer","2014","2014/04/16","","","10.1002/cncr.28510"
"9417299","[Cellular proliferation, expression of p53, EGFR and apoptosis index of healthy mucosa of the bladder with TCC; pre- and post-intravesical BCG immunohistochemical study]","Boccafoschi C, Montefiore F, Pavesi M, Pastormerlo M, Betta PG.","Arch Ital Urol Androl. 1997 Sep;69(4):279-81.","Boccafoschi C","Arch Ital Urol Androl","1997","1998/01/07","","",""
"25442053","Therapeutic options in high-risk non-muscle-invasive bladder cancer during the current worldwide shortage of bacille Calmette-Guérin","Mostafid AH, Palou Redorta J, Sylvester R, Witjes JA.","Eur Urol. 2015 Mar;67(3):359-60. doi: 10.1016/j.eururo.2014.11.031. Epub 2014 Nov 28.","Mostafid AH","Eur Urol","2015","2014/12/03","","","10.1016/j.eururo.2014.11.031"
"29737231","Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer","D'Andrea D, Hassler MR, Abufaraj M, Soria F, Ertl IE, Ilijazi D, Mari A, Foerster B, Egger G, Shariat SF.","Expert Rev Anticancer Ther. 2018 Jul;18(7):695-703. doi: 10.1080/14737140.2018.1474104. Epub 2018 May 9.","D'Andrea D","Expert Rev Anticancer Ther","2018","2018/05/09","","","10.1080/14737140.2018.1474104"
"30565299","Variants and new entities of bladder cancer","Lopez-Beltran A, Henriques V, Montironi R, Cimadamore A, Raspollini MR, Cheng L.","Histopathology. 2019 Jan;74(1):77-96. doi: 10.1111/his.13752.","Lopez-Beltran A","Histopathology","2019","2018/12/20","","","10.1111/his.13752"
"26161701","Rapid detection of urinary long non-coding RNA urothelial carcinoma associated one using a PCR-free nanoparticle-based assay","Eissa S, Matboli M, Essawy NO, Shehta M, Kotb YM.","Biomarkers. 2015;20(3):212-7. doi: 10.3109/1354750X.2015.1062918. Epub 2015 Jul 13.","Eissa S","Biomarkers","2015","2015/07/11","","","10.3109/1354750X.2015.1062918"
"12761483","Does fluid intake influence the risk for urinary incontinence, urinary tract infection, and bladder cancer?","Gray M, Krissovich M.","J Wound Ostomy Continence Nurs. 2003 May;30(3):126-31. doi: 10.1067/mjw.2003.117.","Gray M","J Wound Ostomy Continence Nurs","2003","2003/05/23","","","10.1067/mjw.2003.117"
"22515472","Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract","Kondo T, Tanabe K.","Int J Urol. 2012 Aug;19(8):710-21. doi: 10.1111/j.1442-2042.2012.03009.x. Epub 2012 Apr 19.","Kondo T","Int J Urol","2012","2012/04/21","","","10.1111/j.1442-2042.2012.03009.x"
"18625568","The impact of marriage on bladder cancer mortality","Nelles JL, Joseph SA, Konety BR.","Urol Oncol. 2009 May-Jun;27(3):263-7. doi: 10.1016/j.urolonc.2008.04.016. Epub 2008 Jul 14.","Nelles JL","Urol Oncol","2009","2008/07/16","","","10.1016/j.urolonc.2008.04.016"
"1156568","An epidemiological study of occupational bladder tumours in the dye industry of Japan","Tsuchiya K, Okubo T, Ishizu S.","Br J Ind Med. 1975 Aug;32(3):203-9. doi: 10.1136/oem.32.3.203.","Tsuchiya K","Br J Ind Med","1975","1975/08/01","PMC1008059","","10.1136/oem.32.3.203"
"31056435","Molecular subtypes applied to a population-based modern cystectomy series do not predict cancer-specific survival","Kollberg P, Chebil G, Eriksson P, Sjödahl G, Liedberg F.","Urol Oncol. 2019 Oct;37(10):791-799. doi: 10.1016/j.urolonc.2019.04.010. Epub 2019 May 2.","Kollberg P","Urol Oncol","2019","2019/05/07","","","10.1016/j.urolonc.2019.04.010"
"24069260","Downregulation of GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6","Liu Z, Wang W, Jiang J, Bao E, Xu D, Zeng Y, Tao L, Qiu J.","PLoS One. 2013 Sep 17;8(9):e73991. doi: 10.1371/journal.pone.0073991. eCollection 2013.","Liu Z","PLoS One","2013","2013/09/27","PMC3775789","","10.1371/journal.pone.0073991"
"15885889","Exon 3 polymorphisms and haplotypes of O6-methylguanine-DNA methyltransferase and risk of bladder cancer in southern China: a case-control analysis","Li C, Liu J, Li A, Qian L, Wang X, Wei Q, Zhou J, Zhang Z.","Cancer Lett. 2005 Sep 8;227(1):49-57. doi: 10.1016/j.canlet.2005.03.043.","Li C","Cancer Lett","2005","2005/05/12","","","10.1016/j.canlet.2005.03.043"
"19234707","Updates in intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer","Di Stasi SM, Riedl C.","World J Urol. 2009 Jun;27(3):325-30. doi: 10.1007/s00345-009-0389-x. Epub 2009 Feb 21.","Di Stasi SM","World J Urol","2009","2009/02/24","","","10.1007/s00345-009-0389-x"
"8275221","The association of bladder cancer risk with ethnicity, gender, and smoking","Anton-Culver H, Lee-Feldstein A, Taylor TH.","Ann Epidemiol. 1993 Jul;3(4):429-33. doi: 10.1016/1047-2797(93)90072-c.","Anton-Culver H","Ann Epidemiol","1993","1993/07/01","","","10.1016/1047-2797(93)90072-c"
"28631098","Urolithins impair cell proliferation, arrest the cell cycle and induce apoptosis in UMUC3 bladder cancer cells","Liberal J, Carmo A, Gomes C, Cruz MT, Batista MT.","Invest New Drugs. 2017 Dec;35(6):671-681. doi: 10.1007/s10637-017-0483-7. Epub 2017 Jun 20.","Liberal J","Invest New Drugs","2017","2017/06/21","","","10.1007/s10637-017-0483-7"
"30467945","Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer","Zhang S, Du L, Wang L, Jiang X, Zhan Y, Li J, Yan K, Duan W, Zhao Y, Wang L, Wang Y, Shi Y, Wang C.","J Cell Mol Med. 2019 Feb;23(2):1396-1405. doi: 10.1111/jcmm.14042. Epub 2018 Nov 23.","Zhang S","J Cell Mol Med","2019","2018/11/24","PMC6349164","","10.1111/jcmm.14042"
"31565867","Caspase recruitment domain family member 10 regulates carbamoyl phosphate synthase 1 and promotes cancer growth in bladder cancer cells","Liu X, Zhang X, Bi J, Li Z, Zhang Z, Kong C.","J Cell Mol Med. 2019 Dec;23(12):8128-8138. doi: 10.1111/jcmm.14683. Epub 2019 Sep 29.","Liu X","J Cell Mol Med","2019","2019/10/01","PMC6850932","","10.1111/jcmm.14683"
"30911811","The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy","Zamboni S, Moschini M, Gallina A, Colombo R, Montorsi F, Briganti A, Salonia A, Antonelli A, Simeone C, Belotti S, Cristinelli L, Mattei A, Baumeister P.","World J Urol. 2019 Dec;37(12):2707-2714. doi: 10.1007/s00345-019-02734-6. Epub 2019 Mar 25.","Zamboni S","World J Urol","2019","2019/03/27","","","10.1007/s00345-019-02734-6"
"19299556","Bladder cancer: modeling and translation","Rosenberg JE, Hahn WC.","Genes Dev. 2009 Mar 15;23(6):655-9. doi: 10.1101/gad.1789109.","Rosenberg JE","Genes Dev","2009","2009/03/21","","","10.1101/gad.1789109"
"11246737","The National Bladder Cancer Group's experience: invasive and metastatic bladder cancer selected reports","Prout GR Jr, Kaufman DS.","Semin Urol Oncol. 2001 Feb;19(1):66-8.","Prout GR Jr","Semin Urol Oncol","2001","2001/03/15","","",""
"17115230","Neoadjuvant chemotherapy for bladder cancer","Black PC, Brown GA, Grossman HB, Dinney CP.","World J Urol. 2006 Nov;24(5):531-42. doi: 10.1007/s00345-006-0113-z.","Black PC","World J Urol","2006","2006/11/23","","","10.1007/s00345-006-0113-z"
"18565172","Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience","Gao X, Ren S, Xu C, Sun Y.","BJU Int. 2008 Nov;102(9):1115-8. doi: 10.1111/j.1464-410X.2008.07814.x. Epub 2008 Jun 19.","Gao X","BJU Int","2008","2008/06/21","","","10.1111/j.1464-410X.2008.07814.x"
"11150151","[Polyarthritis as a rare complication in BCG immunoprophylaxis of urinary bladder cancer]","Varentsov GI, Zakhmatov IuM, Kornev AI, Otvetchikov IN.","Urologiia. 1999 Sep-Oct;(5):29-30.","Varentsov GI","Urologiia","1999","2001/01/10","","",""
"15279879","Is embryo-cryopreservation really neutral? A new long-term effect of embryo freezing in mice: protection of adults from induced cancer according to strain and sex","Auroux M, Cerutti I, Ducot B, Loeuillet A.","Reprod Toxicol. 2004 Aug-Sep;18(6):813-8. doi: 10.1016/j.reprotox.2004.04.010.","Auroux M","Reprod Toxicol","2004","2004/07/29","","","10.1016/j.reprotox.2004.04.010"
"2178939","Long-term versus short-term doxorubicin hydrochloride instillation after transurethral resection of superficial bladder cancer","Flamm J.","Eur Urol. 1990;17(2):119-24. doi: 10.1159/000464018.","Flamm J","Eur Urol","1990","1990/01/01","","","10.1159/000464018"
"6184744","Curative and palliative radiotherapy of bladder cancer. A retrospective study of 11 years experience","Shehata WM, Meyer RL, Costandi YT.","Radiology. 1983 Feb;146(2):523-6. doi: 10.1148/radiology.146.2.6184744.","Shehata WM","Radiology","1983","1983/02/01","","","10.1148/radiology.146.2.6184744"
"12084297","Immunotherapy for bladder cancer","Kamat AM, Lamm DL.","Curr Urol Rep. 2001 Feb;2(1):62-9. doi: 10.1007/s11934-001-0027-7.","Kamat AM","Curr Urol Rep","2001","2002/06/27","","","10.1007/s11934-001-0027-7"
"3895852","[The study on Thomsen-Friedenreich antigen in bladder tumor]","Oda Y.","Hinyokika Kiyo. 1985 Mar;31(3):407-18.","Oda Y","Hinyokika Kiyo","1985","1985/03/01","","",""
"1467859","Urologists' attitudes to the management of bladder cancer","Lynch TH, Waymont B, Dunn JA, Wallace DM.","Br J Urol. 1992 Nov;70(5):522-5.","Lynch TH","Br J Urol","1992","1992/11/01","","",""
"22488090","Penile metastasis from primary bladder cancer: a study of 8 cases and review of the literature","Zhu YP, Yao XD, Zhang HL, Shen YJ, Huang D, Ye DW.","Onkologie. 2012;35(4):196-9. doi: 10.1159/000337405. Epub 2012 Mar 15.","Zhu YP","Onkologie","2012","2012/04/11","","","10.1159/000337405"
"482102","[Paraneoplastic hypercalcaemia in a case of carcinoma of the bladder. Demonstration in the tumour of a substance with parathormone activity (author's transl)]","Becq-Giraudon B, Marechaud R, Pouget Abadie JF, Sudre Y.","Nouv Presse Med. 1979 Apr 7;8(16):1333-5.","Becq-Giraudon B","Nouv Presse Med","1979","1979/04/07","","",""
"23975218","[Muscle invasive bladder cancer after radical cystectomy. Prognostic factors of adjuvant chemotherapy]","Thissen AK, Pfister D, Heidenreich A.","Urologe A. 2013 Sep;52(9):1233-41. doi: 10.1007/s00120-013-3311-5.","Thissen AK","Urologe A","2013","2013/08/27","","","10.1007/s00120-013-3311-5"
"30961575","Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer","Yasui M, Kawahara T, Izumi K, Yao M, Ishiguro Y, Ishiguro H, Uemura H, Miyoshi Y.","BMC Cancer. 2019 Apr 8;19(1):331. doi: 10.1186/s12885-019-5512-9.","Yasui M","BMC Cancer","2019","2019/04/10","PMC6454612","","10.1186/s12885-019-5512-9"
"24629527","Are EORTC risk tables suitable for Chinese patients with non-muscle-invasive bladder cancer?","Ding W, Chen Z, Gou Y, Sun C, Xu K, Tan J, Tong S, Xia G, Ding Q.","Cancer Epidemiol. 2014 Apr;38(2):157-61. doi: 10.1016/j.canep.2014.02.001. Epub 2014 Mar 11.","Ding W","Cancer Epidemiol","2014","2014/03/18","","","10.1016/j.canep.2014.02.001"
"354775","Inverted papilloma of the bladder: a distinct urological lesion","Caro DJ, Tessler A.","Cancer. 1978 Aug;42(2):708-13. doi: 10.1002/1097-0142(197808)42:2<708::aid-cncr2820420242>3.0.co;2-7.","Caro DJ","Cancer","1978","1978/08/01","","","10.1002/1097-0142(197808)42:2<708::aid-cncr2820420242>3.0.co;2-7"
"23945326","[A case of bladder cancer producing granulocyte colony-stimulating factor and interleukin-6 causing respiratory failure treated with neoadjuvant systemic chemotherapy along with sivelestat]","Matsuzaki K, Okumi M, Kishimoto N, Yazawa K, Miyagawa Y, Uchida K, Nonomura N.","Hinyokika Kiyo. 2013 Jul;59(7):443-7.","Matsuzaki K","Hinyokika Kiyo","2013","2013/08/16","","",""
"18864631","[About the treatment of cancer vesicae]","ANDREASSEN M.","Nord Med. 1948 Apr 30;37(18):900.","ANDREASSEN M","Nord Med","1948","1948/04/30","","",""
"7751883","Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC","Sarkis AS, Bajorin DF, Reuter VE, Herr HW, Netto G, Zhang ZF, Schultz PK, Cordon-Cardo C, Scher HI.","J Clin Oncol. 1995 Jun;13(6):1384-90. doi: 10.1200/JCO.1995.13.6.1384.","Sarkis AS","J Clin Oncol","1995","1995/06/01","","","10.1200/JCO.1995.13.6.1384"
"26945449","Expression of Cancer Stem Cell Markers OCT4 and CD133 in Transitional Cell Carcinomas","Sedaghat S, Gheytanchi E, Asgari M, Roudi R, Keymoosi H, Madjd Z.","Appl Immunohistochem Mol Morphol. 2017 Mar;25(3):196-202. doi: 10.1097/PAI.0000000000000291.","Sedaghat S","Appl Immunohistochem Mol Morphol","2017","2016/03/06","","","10.1097/PAI.0000000000000291"
"15994003","EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ","van der Meijden AP, Sylvester R, Oosterlinck W, Solsona E, Boehle A, Lobel B, Rintala E; EAU Working Party on Non Muscle Invasive Bladder Cancer.","Eur Urol. 2005 Sep;48(3):363-71. doi: 10.1016/j.eururo.2005.05.011.","van der Meijden AP","Eur Urol","2005","2005/07/05","","","10.1016/j.eururo.2005.05.011"
"21000064","Cancer in diverticulum of the bladder; a pitfall to the resectionist","MUELLNER SR.","J Urol. 1946 Oct;56:427. doi: 10.1016/s0022-5347(17)69825-2.","MUELLNER SR","J Urol","1946","2010/10/29","","","10.1016/s0022-5347(17)69825-2"
"22110102","Tobacco smoking and bladder cancer","Dowdy D.","JAMA. 2011 Nov 23;306(20):2216-7; author reply 2217. doi: 10.1001/jama.2011.1717.","Dowdy D","JAMA","2011","2011/11/24","","","10.1001/jama.2011.1717"
"30280185","Suppressing cell growth and inducing apoptosis by inhibiting miR‑23a‑5p in human bladder cancer","Li Y, Quan J, Pan X, Zhou J, He A, Lai Y, Zhou G.","Mol Med Rep. 2018 Dec;18(6):5256-5260. doi: 10.3892/mmr.2018.9527. Epub 2018 Oct 2.","Li Y","Mol Med Rep","2018","2018/10/04","","","10.3892/mmr.2018.9527"
"10492212","Re: Comparison of screening methods in the detection of bladder cancer","Anderson J.","J Urol. 1999 Oct;162(4):1388; author reply 1389. doi: 10.1016/s0022-5347(05)68305-x.","Anderson J","J Urol","1999","1999/09/24","","","10.1016/s0022-5347(05)68305-x"
"28888228","Transperineal cryotherapy for unresectable muscle invasive bladder cancer: preliminary experience with 7 male patients","Zhang Q, Zhang S, Zhang S, Wang W, Zhao X, Deng Y, Lian H, Guo H.","BMC Urol. 2017 Sep 9;17(1):81. doi: 10.1186/s12894-017-0270-y.","Zhang Q","BMC Urol","2017","2017/09/11","PMC5591566","","10.1186/s12894-017-0270-y"
"30447841","Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging Scenarios","Gallan AJ, Choy B, Paner GP.","Surg Pathol Clin. 2018 Dec;11(4):775-795. doi: 10.1016/j.path.2018.07.006.","Gallan AJ","Surg Pathol Clin","2018","2018/11/19","","","10.1016/j.path.2018.07.006"
"21006757","Indications for roentgen therapy of bladder carcinomas","BUSCHKE F, CANTRIL ST.","Surg Gynecol Obstet. 1946 Jan;82:29-35.","BUSCHKE F","Surg Gynecol Obstet","1946","2010/10/29","","",""
"872102","Assessment and management of deeply invasive and metastatic lesions","Whitmore WF Jr.","Cancer Res. 1977 Aug;37(8 Pt 2):2756-8.","Whitmore WF Jr","Cancer Res","1977","1977/08/01","","",""
"19542673","Small cell carcinoma of the urinary bladder: a case report and review of the literature","Ismaili N, Ghanem S, Mellas N, Afqir S, Taleb M, Amrani M, Gamra L, Errihani H.","J Cancer Res Ther. 2009 Apr-Jun;5(2):133-6. doi: 10.4103/0973-1482.52790.","Ismaili N","J Cancer Res Ther","2009","2009/06/23","","","10.4103/0973-1482.52790"
"4792284","Preoperative irradiation and radical cystectomy for bladder cancer","Reid EC, Mount BM, Sullivan N.","Urology. 1973 Jan;1(1):42-5. doi: 10.1016/0090-4295(73)90111-8.","Reid EC","Urology","1973","1973/01/01","","","10.1016/0090-4295(73)90111-8"
"28469275","Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non-muscle-invasive bladder cancer patients","Tae BS, Kim JK, Kang M, Jeong CW, Kwak C, Kim HH, Ku JH.","Sci Rep. 2017 May 3;7(1):1380. doi: 10.1038/s41598-017-01532-7.","Tae BS","Sci Rep","2017","2017/05/05","PMC5431111","","10.1038/s41598-017-01532-7"
"25556483","Can recurrence and progression be predicted by HYAL-1 expression in primary T1 bladder cancer?","Mammadov E, Aslan G, Tuna B, Bozkurt O, Yorukoglu K.","Asian Pac J Cancer Prev. 2014;15(23):10401-5. doi: 10.7314/apjcp.2014.15.23.10401.","Mammadov E","Asian Pac J Cancer Prev","2014","2015/01/06","","","10.7314/apjcp.2014.15.23.10401"
"30120501","Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis","Crozier J, Papa N, Perera M, Ngo B, Bolton D, Sengupta S, Lawrentschuk N.","World J Urol. 2019 Apr;37(4):667-690. doi: 10.1007/s00345-018-2439-8. Epub 2018 Aug 17.","Crozier J","World J Urol","2019","2018/08/19","","","10.1007/s00345-018-2439-8"
"12671022","Genetic instability in bladder cancer assessed by the comet assay","Schabath MB, Spitz MR, Grossman HB, Zhang K, Dinney CP, Zheng PJ, Wu X.","J Natl Cancer Inst. 2003 Apr 2;95(7):540-7. doi: 10.1093/jnci/95.7.540.","Schabath MB","J Natl Cancer Inst","2003","2003/04/03","","","10.1093/jnci/95.7.540"
"2752254","CA-50 as tumour marker in transitional bladder carcinoma","Tizzani A, Casetta G, Piana P, Piantino P.","Br J Urol. 1989 Jun;63(6):616-8. doi: 10.1111/j.1464-410x.1989.tb05256.x.","Tizzani A","Br J Urol","1989","1989/06/01","","","10.1111/j.1464-410x.1989.tb05256.x"
"531259","[Clinical significance of urinary CEA measurement as a screening test of bladder cancer (author's transl)]","Oshiumi Y, Yagi H, Nishitani H, Yamawaki H, Nakayama C, Kamoi I, Matsuura K, Momose S.","Radioisotopes. 1979 Jun;28(6):367-70. doi: 10.3769/radioisotopes.28.6_367.","Oshiumi Y","Radioisotopes","1979","1979/06/01","","","10.3769/radioisotopes.28.6_367"
"3828710","Are biopsies from the prostatic urethra useful in patients with superficial bladder carcinoma?","Rikken CH, van Helsdingen PJ, Kazzaz BA.","Br J Urol. 1987 Feb;59(2):145-7. doi: 10.1111/j.1464-410x.1987.tb04806.x.","Rikken CH","Br J Urol","1987","1987/02/01","","","10.1111/j.1464-410x.1987.tb04806.x"
"9643665","Significance of bladder neck involvement on progression in superficial bladder cancer","Fujii Y, Fukui I, Kihara K, Tsujii T, Ishizaka K, Kageyama Y, Kawakami S, Oshima H.","Eur Urol. 1998;33(5):464-8. doi: 10.1159/000019636.","Fujii Y","Eur Urol","1998","1998/06/27","","","10.1159/000019636"
"15879848","Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the surveillance, epidemiology, and end results program","Konety BR, Dhawan V, Allareddy V, Joslyn SA.","J Urol. 2005 Jun;173(6):2085-9. doi: 10.1097/01.ju.0000158137.30303.65.","Konety BR","J Urol","2005","2005/05/10","","","10.1097/01.ju.0000158137.30303.65"
"31100252","Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial","Witjes JA, Morote J, Cornel EB, Gakis G, van Valenberg FJP, Lozano F, Sternberg IA, Willemsen E, Hegemann ML, Paitan Y, Leibovitch I.","Eur Urol Oncol. 2018 Sep;1(4):307-313. doi: 10.1016/j.euo.2018.06.011. Epub 2018 Jul 17.","Witjes JA","Eur Urol Oncol","2018","2019/05/18","","","10.1016/j.euo.2018.06.011"
"11676350","Urine tissue-polypeptide-specific antigen (TPS) as a marker for bladder cancer","Boman H, Hedelin H, Holmäng S.","Scand J Urol Nephrol. 2001 Sep;35(4):270-4. doi: 10.1080/003655901750425828.","Boman H","Scand J Urol Nephrol","2001","2001/10/26","","","10.1080/003655901750425828"
"17366596","Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI)","Gilbert SM, Wood DP, Dunn RL, Weizer AZ, Lee CT, Montie JE, Wei JT.","Cancer. 2007 May 1;109(9):1756-62. doi: 10.1002/cncr.22556.","Gilbert SM","Cancer","2007","2007/03/17","","","10.1002/cncr.22556"
"28463831","LncROR Promotes Bladder Cancer Cell Proliferation, Migration, and Epithelial-Mesenchymal Transition","Chen Y, Peng Y, Xu Z, Ge B, Xiang X, Zhang T, Gao L, Shi H, Wang C, Huang J.","Cell Physiol Biochem. 2017;41(6):2399-2410. doi: 10.1159/000475910. Epub 2017 May 3.","Chen Y","Cell Physiol Biochem","2017","2017/05/03","","","10.1159/000475910"
"1512829","Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy","Cookson MS, Sarosdy MF.","J Urol. 1992 Sep;148(3):797-801. doi: 10.1016/s0022-5347(17)36724-1.","Cookson MS","J Urol","1992","1992/09/01","","","10.1016/s0022-5347(17)36724-1"
"2264542","[A clinical study of associated bladder cancer in patients with renal pelvic and ureteral cancer]","Togashi M, Toyota K, Kashiwagi A, Asano Y, Nagamori S, Seki T, Koyanagi T, Maru A.","Hinyokika Kiyo. 1990 Oct;36(10):1141-7.","Togashi M","Hinyokika Kiyo","1990","1990/10/01","","",""
"31346955","Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality risk","McFerrin C, Raza SJ, May A, Davaro F, Siddiqui S, Hamilton Z.","Int Urol Nephrol. 2019 Oct;51(10):1755-1762. doi: 10.1007/s11255-019-02247-6. Epub 2019 Jul 25.","McFerrin C","Int Urol Nephrol","2019","2019/07/27","","","10.1007/s11255-019-02247-6"
"2477041","Clinicopathological significance of immunoreactive beta-hCG production by bladder cancer","Oliver RT, Stephenson C, Collino CE, Parkinson MC.","Mol Biother. 1988;1(1):43-5.","Oliver RT","Mol Biother","1988","1988/01/01","","",""
"17941819","Proteome-based diagnostics and prognosis of bladder transitional cell carcinoma","Wu TF, Ku WL, Tsay YG.","Expert Rev Proteomics. 2007 Oct;4(5):639-47. doi: 10.1586/14789450.4.5.639.","Wu TF","Expert Rev Proteomics","2007","2007/10/19","","","10.1586/14789450.4.5.639"
"24146910","Overexpression of N-Myc downstream-regulated gene 2 (NDRG2) regulates the proliferation and invasion of bladder cancer cells in vitro and in vivo","Li R, Yu C, Jiang F, Gao L, Li J, Wang Y, Beckwith N, Yao L, Zhang J, Wu G.","PLoS One. 2013 Oct 16;8(10):e76689. doi: 10.1371/journal.pone.0076689. eCollection 2013.","Li R","PLoS One","2013","2013/10/23","PMC3797857","","10.1371/journal.pone.0076689"
"21725290","Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature","Samplaski MK, Heston W, Elson P, Magi-Galluzzi C, Hansel DE.","Mod Pathol. 2011 Nov;24(11):1521-9. doi: 10.1038/modpathol.2011.112. Epub 2011 Jul 1.","Samplaski MK","Mod Pathol","2011","2011/07/05","","","10.1038/modpathol.2011.112"
"15367573","Alcohol consumption and the risk of bladder cancer in the Framingham Heart Study","Djoussé L, Schatzkin A, Chibnik LB, D'Agostino RB, Kreger BE, Ellison RC.","J Natl Cancer Inst. 2004 Sep 15;96(18):1397-400. doi: 10.1093/jnci/djh263.","Djoussé L","J Natl Cancer Inst","2004","2004/09/16","","","10.1093/jnci/djh263"
"25554606","Comparative analysis of the incidence of bladder cancer in the communities of Andalusia, Catalonia and Madrid in 2011","Cózar JM, Miñana B, Palou-Redorta J, Medina RA, de la Rosa-Kehrmann F, Lozano-Palacio F, Ribal-Caparrós MJ, Hernández-Fernández C, Castiñeiras-Fernández JJ, Requena MJ, Moreno-Sierra J, Carballido-Rodríguez J, Baena-González V.","Actas Urol Esp. 2015 Sep;39(7):420-8. doi: 10.1016/j.acuro.2014.11.003. Epub 2014 Dec 29.","Cózar JM","Actas Urol Esp","2015","2015/01/03","","","10.1016/j.acuro.2014.11.003"
"16536777","Ileocaecal vs ileal neobladder after radical cystectomy in patients with bladder cancer: a comparative study","Khafagy M, Shaheed FA, Moneim TA.","BJU Int. 2006 Apr;97(4):799-804. doi: 10.1111/j.1464-410X.2006.05996.x.","Khafagy M","BJU Int","2006","2006/03/16","","","10.1111/j.1464-410X.2006.05996.x"
"6384160","Radical irradiation and misonidazole for T2 grade III and T3 bladder cancer: 2 year follow-up","Abratt RP, Barnes DR, Hammond JA, Sarembok LA, Tucker RD, Williams AM.","Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1719-20. doi: 10.1016/0360-3016(84)90535-2.","Abratt RP","Int J Radiat Oncol Biol Phys","1984","1984/09/01","","","10.1016/0360-3016(84)90535-2"
"18372010","Relationship between patient age and superficial transitional cell carcinoma characteristics","Shi B, Zhang K, Zhang J, Chen J, Zhang N, Xu Z.","Urology. 2008 Jun;71(6):1186-90. doi: 10.1016/j.urology.2008.01.062. Epub 2008 Apr 18.","Shi B","Urology","2008","2008/03/29","","","10.1016/j.urology.2008.01.062"
"23979666","Toll-like receptors in urothelial cells--targets for cancer immunotherapy","LaRue H, Ayari C, Bergeron A, Fradet Y.","Nat Rev Urol. 2013 Sep;10(9):537-45. doi: 10.1038/nrurol.2013.153. Epub 2013 Aug 27.","LaRue H","Nat Rev Urol","2013","2013/08/28","","","10.1038/nrurol.2013.153"
"16632191","Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer","Sherif A, Garske U, de la Torre M, Thörn M.","Eur Urol. 2006 Jul;50(1):83-91. doi: 10.1016/j.eururo.2006.03.002. Epub 2006 Mar 20.","Sherif A","Eur Urol","2006","2006/04/25","","","10.1016/j.eururo.2006.03.002"
"1408062","[Changes in the activity of natural killer cells in superficial bladder cancer during intravesical BCG therapy]","Samodai L, Dankó K.","Orv Hetil. 1992 Sep 6;133(36):2283-6, 2291-2.","Samodai L","Orv Hetil","1992","1992/09/06","","",""
"10022124","Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer","Czerniak B, Chaturvedi V, Li L, Hodges S, Johnston D, Roy JY, Luthra R, Logothetis C, Von Eschenbach AC, Grossman HB, Benedict WF, Batsakis JG.","Oncogene. 1999 Feb 4;18(5):1185-96. doi: 10.1038/sj.onc.1202385.","Czerniak B","Oncogene","1999","1999/02/18","","","10.1038/sj.onc.1202385"
"1006869","The role of urine in the etiology of cancer of the urinary bladder","Parkash O, Kiesswetter H.","Urol Int. 1976;31(5):343-8. doi: 10.1159/000280070.","Parkash O","Urol Int","1976","1976/01/01","","","10.1159/000280070"
"28530072","[FACTORS PREDICTING OVERALL AND DISEASE-FREE SURVIVAL AFTER SURGERY FOR INVASIVE BLADDER CANCER]","Fried E, Yutkin V, Pode D, Shapiro A, Hidas G, Gielchinsky I, Landau EH, Rosenberg S, Duvdevani M, Gofrit ON.","Harefuah. 2016 Nov;155(11):660-664.","Fried E","Harefuah","2016","2017/05/23","","",""
"10450007","Comparison of the nuclear matrix protein 22 with voided urine cytology and BTA stat test in the diagnosis of transitional cell carcinoma of the bladder","Sözen S, Biri H, Sinik Z, Küpeli B, Alkibay T, Bozkirli I.","Eur Urol. 1999 Sep;36(3):225-9. doi: 10.1159/000068002.","Sözen S","Eur Urol","1999","1999/08/18","","","10.1159/000068002"
"31253132","Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities","Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, Zapater-Moros A, Díaz-Almirón M, Arevalillo JM, Ferrer-Gómez M, Navarro H, Maín P, Espinosa E, Pinto Á, Vara JÁF.","BMC Cancer. 2019 Jun 28;19(1):636. doi: 10.1186/s12885-019-5858-z.","Trilla-Fuertes L","BMC Cancer","2019","2019/06/30","PMC6599340","","10.1186/s12885-019-5858-z"
"21208365","Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt","Salem S, Mitchell RE, El-Alim El-Dorey A, Smith JA, Barocas DA.","BJU Int. 2011 Jan;107(2):206-11. doi: 10.1111/j.1464-410X.2010.09622.x. Epub 2010 Sep 21.","Salem S","BJU Int","2011","2011/01/07","","","10.1111/j.1464-410X.2010.09622.x"
"23959905","Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo","Bowman KJ, Al-Moneef MM, Sherwood BT, Colquhoun AJ, Goddard JC, Griffiths TR, Payne D, Singh S, Butterworth PC, Khan MA, Summerton DJ, Steward WP, McKelvey-Martin VJ, McKeown SR, Kockelbergh RC, Mellon JK, Symonds RP, Jones GD.","Int J Cancer. 2014 Mar 1;134(5):1102-11. doi: 10.1002/ijc.28437. Epub 2013 Oct 8.","Bowman KJ","Int J Cancer","2014","2013/08/21","","","10.1002/ijc.28437"
"28139689","NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo","Cui X, Shen D, Kong C, Zhang Z, Zeng Y, Lin X, Liu X.","Sci Rep. 2017 Jan 31;7:40723. doi: 10.1038/srep40723.","Cui X","Sci Rep","2017","2017/02/01","PMC5282527","","10.1038/srep40723"
"27908636","Impact of neoadjuvant chemotherapy on complications of minimally invasive radical cystectomy","Lizée D, Salas RS, Barret E, Galiano M, Di Trapani E, Montorsi F, Cathelineau X.","Actas Urol Esp. 2017 Mar;41(2):88-96. doi: 10.1016/j.acuro.2016.05.008. Epub 2016 Nov 28.","Lizée D","Actas Urol Esp","2017","2016/12/03","","","10.1016/j.acuro.2016.05.008"
"1810450","BCG therapy for superficial bladder cancer: fundamental aspects","Hudson ML, Ratliff TL.","In Vivo. 1991 Nov-Dec;5(6):643-6.","Hudson ML","In Vivo","1991","1991/11/01","","",""
"31185324","Diagnostic accuracy of optical coherence tomography for bladder cancer: A systematic review and meta-analysis","Xiong YQ, Tan J, Liu YM, Li YZ, You FF, Zhang MY, Chen Q, Zou K, Sun X.","Photodiagnosis Photodyn Ther. 2019 Sep;27:298-304. doi: 10.1016/j.pdpdt.2019.06.006. Epub 2019 Jun 8.","Xiong YQ","Photodiagnosis Photodyn Ther","2019","2019/06/12","","","10.1016/j.pdpdt.2019.06.006"
"15375002","A functional polymorphism in RGS6 modulates the risk of bladder cancer","Berman DM, Wang Y, Liu Z, Dong Q, Burke LA, Liotta LA, Fisher R, Wu X.","Cancer Res. 2004 Sep 15;64(18):6820-6. doi: 10.1158/0008-5472.CAN-04-1916.","Berman DM","Cancer Res","2004","2004/09/18","","","10.1158/0008-5472.CAN-04-1916"
"15491744","Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma","Tsui KH, Cheng AJ, Chang Pe, Pan TL, Yung BY.","Urology. 2004 Oct;64(4):839-44. doi: 10.1016/j.urology.2004.05.020.","Tsui KH","Urology","2004","2004/10/20","","","10.1016/j.urology.2004.05.020"
"28705739","Long noncoding RNA linc00346 promotes the malignant phenotypes of bladder cancer","Ye T, Ding W, Wang N, Huang H, Pan Y, Wei A.","Biochem Biophys Res Commun. 2017 Sep 9;491(1):79-84. doi: 10.1016/j.bbrc.2017.07.045. Epub 2017 Jul 11.","Ye T","Biochem Biophys Res Commun","2017","2017/07/15","","","10.1016/j.bbrc.2017.07.045"
"21826882","Giant scrotal lymphedema as unique onset sign of muscle-invasive bladder cancer. The risk of a misdiagnosis","Boscolo-Berto R, Viel G, Lamon C, Agostini A, Vezzaro R, Gardiman M, Montisci M, Raduazzo DI.","Arch Ital Urol Androl. 2011 Jun;83(2):95-8.","Boscolo-Berto R","Arch Ital Urol Androl","2011","2011/08/11","","",""
"25304790","Significance of ERBB2 overexpression in therapeutic resistance and cancer-specific survival in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach","Inoue M, Koga F, Yoshida S, Tamura T, Fujii Y, Ito E, Kihara K.","Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):303-11. doi: 10.1016/j.ijrobp.2014.05.043.","Inoue M","Int J Radiat Oncol Biol Phys","2014","2014/10/12","","","10.1016/j.ijrobp.2014.05.043"
"406039","Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder","Farrow GM, Utz DC, Rife CC, Greene LF.","Cancer Res. 1977 Aug;37(8 Pt 2):2794-8.","Farrow GM","Cancer Res","1977","1977/08/01","","",""
"30747883","Re: Comparing Survival Outcomes and Costs Associated with Radical Cystectomy and Trimodal Therapy for Older Adults with Muscle-Invasive Bladder Cancer","Griebling TL.","J Urol. 2019 May;201(5):837. doi: 10.1097/01.JU.0000553996.66966.57.","Griebling TL","J Urol","2019","2019/02/13","","","10.1097/01.JU.0000553996.66966.57"
"10223497","Numerical chromosomal aberrations in muscle invasive squamous cell and transitional cell cancer of the urinary bladder: an alternative to classic prognostic indicators?","Pycha A, Mian C, Posch B, Haitel A, Mokhtar AA, El-Baz M, Ghoneim MA, Marberger M.","Urology. 1999 May;53(5):1005-10. doi: 10.1016/s0090-4295(98)00626-8.","Pycha A","Urology","1999","1999/05/01","","","10.1016/s0090-4295(98)00626-8"
"8221642","Evidence for two bladder cancer suppressor loci on human chromosome 9","Ruppert JM, Tokino K, Sidransky D.","Cancer Res. 1993 Nov 1;53(21):5093-5.","Ruppert JM","Cancer Res","1993","1993/11/01","","",""
"24704017","Combined chemohyperthermia: 10-year single center experience in 160 patients with nonmuscle invasive bladder cancer","Arends TJ, van der Heijden AG, Witjes JA.","J Urol. 2014 Sep;192(3):708-13. doi: 10.1016/j.juro.2014.03.101. Epub 2014 Apr 1.","Arends TJ","J Urol","2014","2014/04/08","","","10.1016/j.juro.2014.03.101"
"15947586","Local recurrence after cystectomy and survival of patients with bladder cancer: a population based study in greater amsterdam","Visser O, Nieuwenhuijzen JA, Horenblas S; Members of the Urological Oncology Working Group of the Comprehensive Cancer Centre Amsterdam.","J Urol. 2005 Jul;174(1):97-102. doi: 10.1097/01.ju.0000162055.58405.96.","Visser O","J Urol","2005","2005/06/11","","","10.1097/01.ju.0000162055.58405.96"
"18485039","Impact of tumour volume on surgical and pathological outcomes after robot-assisted radical cystectomy","Yuh B, Padalino J, Butt ZM, Tan W, Wilding GE, Kim HL, Mohler JL, Guru KA.","BJU Int. 2008 Sep;102(7):840-3. doi: 10.1111/j.1464-410X.2008.07737.x. Epub 2008 May 15.","Yuh B","BJU Int","2008","2008/05/20","","","10.1111/j.1464-410X.2008.07737.x"
"25077351","Detecting bladder cancer using volatile analyses: is this the future?","Costello Bde L, Ratcliffe N.","Bioanalysis. 2014 May;6(9):1147-50. doi: 10.4155/bio.14.44.","Costello Bde L","Bioanalysis","2014","2014/08/01","","","10.4155/bio.14.44"
"14632837","Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a new standard of care?","Feneley MR, Harland S.","BJU Int. 2003 Dec;92(9):877-8. doi: 10.1111/j.1464-410x.2003.04535.x.","Feneley MR","BJU Int","2003","2003/11/25","","","10.1111/j.1464-410x.2003.04535.x"
"30069580","Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder","Alanee S, Alvarado-Cabrero I, Murugan P, Kumar R, Nepple KG, Paner GP, Patel MI, Raspollini MR, Lopez-Beltran A, Konety BR.","World J Urol. 2019 Jan;37(1):107-114. doi: 10.1007/s00345-018-2421-5. Epub 2018 Aug 1.","Alanee S","World J Urol","2019","2018/08/03","","","10.1007/s00345-018-2421-5"
"21840119","Identifying risk factors in patients with non-muscle-invasive bladder cancer: clinical implications","Schmitz-Dräger BJ.","Eur Urol. 2011 Oct;60(4):721-3. doi: 10.1016/j.eururo.2011.07.065. Epub 2011 Aug 5.","Schmitz-Dräger BJ","Eur Urol","2011","2011/08/16","","","10.1016/j.eururo.2011.07.065"
"1565903","Intravesical therapy: does it affect the natural history of superficial bladder cancer?","Lamm DL, Griffith JG.","Semin Urol. 1992 Feb;10(1):39-44.","Lamm DL","Semin Urol","1992","1992/02/01","","",""
"5624370","[Clinical and pathological studies on radical total cystectomy for urinary bladder cancer. I. Clinical picutres and follow-studies]","Suzuki K, Sugita A, Miura T, Kato M, Onodera Y.","Nihon Hinyokika Gakkai Zasshi. 1967 Apr;58(4):404-16. doi: 10.5980/jpnjurol1928.58.4_404.","Suzuki K","Nihon Hinyokika Gakkai Zasshi","1967","1967/04/01","","","10.5980/jpnjurol1928.58.4_404"
"11059567","Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder","Sawczuk IS, Bagiella E, Sawczuk AT, Yun EJ.","Cancer Detect Prev. 2000;24(4):364-8.","Sawczuk IS","Cancer Detect Prev","2000","2000/11/04","","",""
"1305683","Intervention strategies for chemoprevention of bladder cancer","Sheinfeld J, Herr HW.","J Cell Biochem Suppl. 1992;16I:173-4. doi: 10.1002/jcb.240501332.","Sheinfeld J","J Cell Biochem Suppl","1992","1992/01/01","","","10.1002/jcb.240501332"
"5523213","[Total cystectomy with enterocystoplasty for trigonal infiltrating bladder cancer after irradiation by telecobalt (tumor 3 500 r or accelerated 1,200 r)]","Camey M.","J Urol Nephrol (Paris). 1970 Dec;76(12):399-403.","Camey M","J Urol Nephrol (Paris)","1970","1970/12/01","","",""
"25012094","Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy","Maurer T, Horn T, Souvatzoglou M, Eiber M, Beer AJ, Heck MM, Haller B, Gschwend JE, Schwaiger M, Treiber U, Krause BJ.","Urol Int. 2014;93(2):207-13. doi: 10.1159/000357686. Epub 2014 Jul 9.","Maurer T","Urol Int","2014","2014/07/12","","","10.1159/000357686"
"23394492","Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy","Keck B, Wach S, Stoehr R, Kunath F, Bertz S, Lehmann J, Stöckle M, Taubert H, Wullich B, Hartmann A.","BMC Cancer. 2013 Feb 8;13:71. doi: 10.1186/1471-2407-13-71.","Keck B","BMC Cancer","2013","2013/02/12","PMC3572418","","10.1186/1471-2407-13-71"
"26105083","Urine biomarkers of schistosomiais and its associated bladder cancer","Eissa S, Matboli M, Shawky S, Essawy NO.","Expert Rev Anti Infect Ther. 2015 Aug;13(8):985-93. doi: 10.1586/14787210.2015.1051032. Epub 2015 Jun 23.","Eissa S","Expert Rev Anti Infect Ther","2015","2015/06/25","","","10.1586/14787210.2015.1051032"
"1755417","[Treatment of 300 patients with bladder cancer]","Mori Y, Arima M, Shimada K, Shima H, Ihara H, Yabumoto H, Hosokawa S, Taguchi K, Ikoma F.","Hinyokika Kiyo. 1991 Oct;37(10):1235-41.","Mori Y","Hinyokika Kiyo","1991","1991/10/01","","",""
"4701704","The concentration of free and conjugated 3-hydroxyanthranilic acid in the urine of bladder tumour patients before and after therapy, measured with an enzymatic method","Teulings FA, Fokkens W, Kaalen JG, van der Werf-Messing B.","Br J Cancer. 1973 Apr;27(4):316-22. doi: 10.1038/bjc.1973.38.","Teulings FA","Br J Cancer","1973","1973/04/01","PMC2008782","","10.1038/bjc.1973.38"
"24399114","Dendritic cells in blood and urine samples from bladder cancer patients undergoing BCG immunotherapy","Rossi R, Lichtner M, Iori F, Ermocida A, Mascia C, Mengoni F, Sauzullo I, Dini D, Mastroianni CM, Vullo V.","Arch Ital Urol Androl. 2013 Dec 31;85(4):157-63. doi: 10.4081/aiua.2013.4.157.","Rossi R","Arch Ital Urol Androl","2013","2014/01/09","","","10.4081/aiua.2013.4.157"
"23106193","Preoperative prediction of malignant involvement of resected ureters in patients undergoing radical cystectomy for bladder cancer","Gondo T, Nakashima J, Ohno Y, Hashimoto T, Takizawa I, Sakamoto N, Horiguchi Y, Aoyagi T, Ohori M, Tachibana M.","Int J Urol. 2013 May;20(5):501-6. doi: 10.1111/j.1442-2042.2012.03203.x. Epub 2012 Oct 29.","Gondo T","Int J Urol","2013","2012/10/31","","","10.1111/j.1442-2042.2012.03203.x"
"25649031","Use of the nuclear matrix protein 22 Bladder Chek test™ in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer","Balci M, Tuncel A, Guzel O, Aslan Y, Sezgin T, Bilgin O, Senel C, Atan A.","Int Urol Nephrol. 2015 Mar;47(3):473-7. doi: 10.1007/s11255-015-0921-4. Epub 2015 Feb 4.","Balci M","Int Urol Nephrol","2015","2015/02/05","","","10.1007/s11255-015-0921-4"
"22434483","[Imperative cystectomy in patients at risk. Ileal conduit or ureterocutaneostomy?]","Degener S, Brandt AS, Lazica DA, von Rundstedt FC, Mathers MJ, Roth S.","Urologe A. 2012 Sep;51(9):1220-7. doi: 10.1007/s00120-012-2829-2.","Degener S","Urologe A","2012","2012/03/22","","","10.1007/s00120-012-2829-2"
"28544300","Bladder cancer diagnosis during haematuria investigation - implications for practice guidelines","Ngo B, Papa N, Perera M, Bolton D, Sengupta S.","BJU Int. 2017 May;119 Suppl 5:53-54. doi: 10.1111/bju.13870.","Ngo B","BJU Int","2017","2017/05/26","","","10.1111/bju.13870"
"12271408","Visualisation of bladder cancer using (11)C-choline PET: first clinical experience","de Jong IJ, Pruim J, Elsinga PH, Jongen MM, Mensink HJ, Vaalburg W.","Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1283-8. doi: 10.1007/s00259-002-0881-7. Epub 2002 Jul 27.","de Jong IJ","Eur J Nucl Med Mol Imaging","2002","2002/09/25","","","10.1007/s00259-002-0881-7"
"27793008","Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer","Duan W, Du L, Jiang X, Wang R, Yan S, Xie Y, Yan K, Wang Q, Wang L, Zhang X, Pan H, Yang Y, Wang C.","Oncotarget. 2016 Nov 29;7(48):78850-78858. doi: 10.18632/oncotarget.12880.","Duan W","Oncotarget","2016","2016/10/30","PMC5346682","","10.18632/oncotarget.12880"
"22335320","Screening for bladder cancer: recommendation statement","U.S. Preventive Services Task Force.","Am Fam Physician. 2012 Feb 15;85(4):397-9.","U.S. Preventive Services Task Force","Am Fam Physician","2012","2012/02/17","","",""
"20491646","Positron Emission Tomography and Computer Tomography (PET/CT) in Prostate, Bladder, and Testicular Cancers","Zouhair A, Ozsahin M, Schaffer M, Albrecht S, Camus F, Jichlinski P, Mirimanoff RO, Bischof Delaloye A, Meuwly JY, Prior JO.","Curr Med Chem. 2010;17(23):2492-502. doi: 10.2174/092986710791556014.","Zouhair A","Curr Med Chem","2010","2010/05/25","","","10.2174/092986710791556014"
"10226813","Transmurally absorbed intravesical chemotherapy with dimethylsulfoxide in an animal model","Yaman O, Ozdiler E, Sözen S, Göğüş O.","Int J Urol. 1999 Feb;6(2):87-92. doi: 10.1046/j.1442-2042.1999.00623.x.","Yaman O","Int J Urol","1999","1999/05/05","","","10.1046/j.1442-2042.1999.00623.x"
"23325617","High FOXM1 expression was associated with bladder carcinogenesis","Liu D, Zhang Z, Kong CZ.","Tumour Biol. 2013 Apr;34(2):1131-8. doi: 10.1007/s13277-013-0654-x. Epub 2013 Jan 17.","Liu D","Tumour Biol","2013","2013/01/18","","","10.1007/s13277-013-0654-x"
"10920579","Invasive bladder cancer after cyclophosphamide administration for nephrotic syndrome--a case report","Nakamoto T, Kasaoka Y, Ikegami Y, Usui T.","Hiroshima J Med Sci. 2000 Jun;49(2):121-3.","Nakamoto T","Hiroshima J Med Sci","2000","2000/08/02","","",""
"24627131","NRP-1 expression in bladder cancer and its implications for tumor progression","Cheng W, Fu D, Wei ZF, Xu F, Xu XF, Liu YH, Ge JP, Tian F, Han CH, Zhang ZY, Zhou LM.","Tumour Biol. 2014 Jun;35(6):6089-94. doi: 10.1007/s13277-014-1806-3. Epub 2014 Mar 14.","Cheng W","Tumour Biol","2014","2014/03/15","","","10.1007/s13277-014-1806-3"
"23666588","The number of nodes removed as well as the template of the dissection is independently correlated to cancer-specific survival after radical cystectomy for muscle-invasive bladder cancer","Brunocilla E, Pernetti R, Schiavina R, Borghesi M, Vagnoni V, Rocca GC, Borgatti F, Concetti S, Martorana G.","Int Urol Nephrol. 2013 Jun;45(3):711-9. doi: 10.1007/s11255-013-0461-8. Epub 2013 May 12.","Brunocilla E","Int Urol Nephrol","2013","2013/05/14","","","10.1007/s11255-013-0461-8"
"24697672","A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer","Sousa A, Inman BA, Piñeiro I, Monserrat V, Pérez A, Aparici V, Gómez I, Neira P, Uribarri C.","Int J Hyperthermia. 2014 May;30(3):166-70. doi: 10.3109/02656736.2014.900194. Epub 2014 Apr 3.","Sousa A","Int J Hyperthermia","2014","2014/04/05","","","10.3109/02656736.2014.900194"
"1764561","Risk of urinary bladder cancer among blacks and whites: the role of cigarette use and occupation","Burns PB, Swanson GM.","Cancer Causes Control. 1991 Nov;2(6):371-9. doi: 10.1007/BF00054297.","Burns PB","Cancer Causes Control","1991","1991/11/01","","","10.1007/BF00054297"
"32203532","The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder cancer (NMIBC)","Rezaee ME, Lynch KE, Li Z, MacKenzie TA, Seigne JD, Robertson DJ, Sirovich B, Goodney PP, Schroeck FR.","PLoS One. 2020 Mar 23;15(3):e0230417. doi: 10.1371/journal.pone.0230417. eCollection 2020.","Rezaee ME","PLoS One","2020","2020/03/24","PMC7089561","","10.1371/journal.pone.0230417"
"28388880","A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection","Lavery HJ, Zaharieva B, McFaddin A, Heerema N, Pohar KS.","BMC Cancer. 2017 Apr 7;17(1):247. doi: 10.1186/s12885-017-3227-3.","Lavery HJ","BMC Cancer","2017","2017/04/09","PMC5383950","","10.1186/s12885-017-3227-3"
"4757548","Comparison of bladder washings and urine cytology in the diagnosis of bladder cancer","Trott PA, Edwards L.","J Urol. 1973 Dec;110(6):664-6. doi: 10.1016/s0022-5347(17)60309-4.","Trott PA","J Urol","1973","1973/12/01","","","10.1016/s0022-5347(17)60309-4"
"2750753","Occupation and bladder cancer in Utah","Schumacher MC, Slattery ML, West DW.","Am J Ind Med. 1989;16(1):89-102. doi: 10.1002/ajim.4700160110.","Schumacher MC","Am J Ind Med","1989","1989/01/01","","","10.1002/ajim.4700160110"
"7933179","Urethral involvement in female bladder cancer patients: mapping of 47 consecutive cysto-urethrectomy specimens","Coloby PJ, Kakizoe T, Tobisu K, Sakamoto M.","J Urol. 1994 Nov;152(5 Pt 1):1438-42. doi: 10.1016/s0022-5347(17)32440-0.","Coloby PJ","J Urol","1994","1994/11/01","","","10.1016/s0022-5347(17)32440-0"
"29778322","History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy","Kayama E, Kikuchi E, Fukumoto K, Shirotake S, Miyazaki Y, Hakozaki K, Kaneko G, Yoshimine S, Tanaka N, Takahiro M, Kanai K, Oyama M, Nakajima Y, Hara S, Monma T, Oya M.","Clin Genitourin Cancer. 2018 Oct;16(5):e969-e976. doi: 10.1016/j.clgc.2018.04.004. Epub 2018 Apr 28.","Kayama E","Clin Genitourin Cancer","2018","2018/05/21","","","10.1016/j.clgc.2018.04.004"
"29144943","Re: Propensity Score Analysis of Radical Cystectomy versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic","Chang SS.","J Urol. 2017 Dec;198(6):1208. doi: 10.1016/j.juro.2017.09.043. Epub 2017 Sep 19.","Chang SS","J Urol","2017","2017/11/18","","","10.1016/j.juro.2017.09.043"
"25984525","Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer","Brunetti J, Falciani C, Lelli B, Minervini A, Ravenni N, Depau L, Siena G, Tenori E, Menichetti S, Pini A, Carini M, Bracci L.","Biomed Res Int. 2015;2015:173507. doi: 10.1155/2015/173507. Epub 2015 Apr 23.","Brunetti J","Biomed Res Int","2015","2015/05/19","PMC4423026","","10.1155/2015/173507"
"24833245","Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy","Clifton MM, Psutka SP, Boorjian SA, Cheville JC, Thapa P, Thompson RH, Tollefson MK, Karnes RJ, Frank I.","World J Urol. 2015 Mar;33(3):373-9. doi: 10.1007/s00345-014-1319-0. Epub 2014 May 15.","Clifton MM","World J Urol","2015","2014/05/17","","","10.1007/s00345-014-1319-0"
"28287737","Large-Scale SRM Screen of Urothelial Bladder Cancer Candidate Biomarkers in Urine","Duriez E, Masselon CD, Mesmin C, Court M, Demeure K, Allory Y, Malats N, Matondo M, Radvanyi F, Garin J, Domon B.","J Proteome Res. 2017 Apr 7;16(4):1617-1631. doi: 10.1021/acs.jproteome.6b00979. Epub 2017 Mar 23.","Duriez E","J Proteome Res","2017","2017/03/14","","","10.1021/acs.jproteome.6b00979"
"29133939","Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy","Felsenstein KM, Theodorescu D.","Nat Rev Urol. 2018 Feb;15(2):92-111. doi: 10.1038/nrurol.2017.179. Epub 2017 Nov 14.","Felsenstein KM","Nat Rev Urol","2018","2017/11/15","","","10.1038/nrurol.2017.179"
"20303532","Six-transmembrane epithelial antigen of the prostate as an immunotherapeutic target for renal cell and bladder cancer","Azumi M, Kobayashi H, Aoki N, Sato K, Kimura S, Kakizaki H, Tateno M.","J Urol. 2010 May;183(5):2036-44. doi: 10.1016/j.juro.2009.12.094. Epub 2010 Mar 19.","Azumi M","J Urol","2010","2010/03/23","","","10.1016/j.juro.2009.12.094"
"24026059","[Photodynamic therapy of bladder cancer. A new option]","Neuhaus J, Schastak S, Berndt M, Walther J, Dietel A, Sieger N, Stolzenburg JU.","Urologe A. 2013 Sep;52(9):1225-32. doi: 10.1007/s00120-013-3306-2.","Neuhaus J","Urologe A","2013","2013/09/13","","","10.1007/s00120-013-3306-2"
"17619739","Natural history, recurrence, and progression in superficial bladder cancer","Sylvester RJ.","ScientificWorldJournal. 2006 Mar 27;6:2617-25. doi: 10.1100/tsw.2006.404.","Sylvester RJ","ScientificWorldJournal","2006","2007/07/11","PMC5917231","","10.1100/tsw.2006.404"
"22986152","Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE)","Li F, Chen DN, He CW, Zhou Y, Olkkonen VM, He N, Chen W, Wan P, Chen SS, Zhu YT, Lan KJ, Tan WL.","J Proteomics. 2012 Dec 21;77:225-36. doi: 10.1016/j.jprot.2012.09.002. Epub 2012 Sep 9.","Li F","J Proteomics","2012","2012/09/19","","","10.1016/j.jprot.2012.09.002"
"25918190","Correlation of Increased Expression of MicroRNA-155 in Bladder Cancer and Prognosis","Wang H, Men CP.","Lab Med. 2015 Spring;46(2):118-22. doi: 10.1309/LMWR9CEA2K2XVSOX.","Wang H","Lab Med","2015","2015/04/29","","","10.1309/LMWR9CEA2K2XVSOX"
"16762487","Elevated microsatellite instability at selected tetranucleotide repeats does not correlate with clinicopathologic features of bladder cancer","Burger M, Burger SJ, Denzinger S, Wild PJ, Wieland WF, Blaszyk H, Obermann EC, Stoehr R, Hartmann A.","Eur Urol. 2006 Oct;50(4):770-5; discussion 776. doi: 10.1016/j.eururo.2006.04.010. Epub 2006 May 2.","Burger M","Eur Urol","2006","2006/06/10","","","10.1016/j.eururo.2006.04.010"
"23319010","Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program","Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Datar RH, Skinner EC, Stein JP, Groshen S, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ.","Cancer. 2013 Feb 15;119(4):756-65. doi: 10.1002/cncr.27763. Epub 2013 Jan 14.","Mitra AP","Cancer","2013","2013/01/16","PMC3565093","NIHMS393599","10.1002/cncr.27763"
"20528482","Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise","Zachos I, Konstantinopoulos PA, Tzortzis V, Gravas S, Karatzas A, Karamouzis MV, Melekos M, Papavassiliou AG.","Expert Opin Investig Drugs. 2010 Jul;19(7):875-87. doi: 10.1517/13543784.2010.496450.","Zachos I","Expert Opin Investig Drugs","2010","2010/06/10","","","10.1517/13543784.2010.496450"
"23645214","Cytogenetic characterization of an N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse papillary urothelial carcinoma","Arantes-Rodrigues R, Pinto-Leite R, da Costa RG, Colaço A, Lopes C, Oliveira P.","Tumour Biol. 2013 Oct;34(5):2691-6. doi: 10.1007/s13277-013-0820-1. Epub 2013 May 5.","Arantes-Rodrigues R","Tumour Biol","2013","2013/05/07","","","10.1007/s13277-013-0820-1"
"2028562","Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis","de Boer EC, de Jong WH, van der Meijden AP, Steerenberg PA, Witjes F, Vegt PD, Debruyne FM, Ruitenberg EJ.","Urol Res. 1991;19(1):45-50. doi: 10.1007/BF00294021.","de Boer EC","Urol Res","1991","1991/01/01","","","10.1007/BF00294021"
"18516915","[Study on the diagnosis of urothelial cancer using multi-colour fluorescence in situ hybridization (FISH)--comparative analysis between FISH and cytology]","Onishi T, Ichikawa T, Igarashi T.","Hinyokika Kiyo. 2008 Apr;54(4):253-6.","Onishi T","Hinyokika Kiyo","2008","2008/06/04","","",""
"24856486","Incidence and clinical characteristics of lower urinary tract symptoms as a presenting symptom for patients with newly diagnosed bladder cancer","Dobbs RW, Hugar LA, Revenig LM, Al-Qassab S, Petros JA, Ritenour CW, Issa MM, Canter DJ.","Int Braz J Urol. 2014 Mar-Apr;40(2):198-203. doi: 10.1590/S1677-5538.IBJU.2014.02.09.","Dobbs RW","Int Braz J Urol","2014","2014/05/27","","","10.1590/S1677-5538.IBJU.2014.02.09"
"22857752","Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: does it reduce recurrences?","Karaolides T, Skolarikos A, Bourdoumis A, Konandreas A, Mygdalis V, Thanos A, Deliveliotis C.","Urology. 2012 Aug;80(2):354-9. doi: 10.1016/j.urology.2012.03.067.","Karaolides T","Urology","2012","2012/08/04","","","10.1016/j.urology.2012.03.067"
"24618866","Spontaneous bladder rupture of a urinary bladder with non-muscle invasive bladder cancer","Hadjipavlou M, Tharakan T, Khan SA, Swinn M.","BMJ Case Rep. 2014 Mar 11;2014:bcr2013201972. doi: 10.1136/bcr-2013-201972.","Hadjipavlou M","BMJ Case Rep","2014","2014/03/13","PMC3962892","","10.1136/bcr-2013-201972"
"894803","Cystectomy after radiotherapeutic ablation of invasive transitional cell cancer","Deweerd JH, Colby MY Jr, Myers RP, Cupps RE.","J Urol. 1977 Aug;118(2):260-1. doi: 10.1016/s0022-5347(17)57966-5.","Deweerd JH","J Urol","1977","1977/08/01","","","10.1016/s0022-5347(17)57966-5"
"26192362","Expression of hepaCAM inhibits bladder cancer cell proliferation via a Wnt/β-catenin-dependent pathway in vitro and in vivo","Du HF, Ou LP, Lv CK, Yang X, Song XD, Fan YR, Wu XH, Luo CL.","Cancer Biol Ther. 2015;16(10):1502-13. doi: 10.1080/15384047.2015.1071732. Epub 2015 Jul 20.","Du HF","Cancer Biol Ther","2015","2015/07/21","PMC4846132","","10.1080/15384047.2015.1071732"
"15981423","[Ileal neobladder with double chimney. Ureterointestinal anastomosis]","Aguirre Benites F, Duarte Ojeda JM, Pamplona Casamayor M, Díaz González R, Leiva Galvis O.","Actas Urol Esp. 2005 Apr;29(4):360-4. doi: 10.1016/s0210-4806(05)73256-3.","Aguirre Benites F","Actas Urol Esp","2005","2005/06/29","","","10.1016/s0210-4806(05)73256-3"
"21382275","Physiological analysis of 8-ISO-PGF2 alpha: a homeostatic agent in superficial bladder cancer","Verratti V, Brunetti L, Tenaglia R, Chiavaroli A, Ferrante C, Leone S, Orlando G, Berardinelli F, Di Giulio C, Vacca M.","J Biol Regul Homeost Agents. 2011 Jan-Mar;25(1):71-6.","Verratti V","J Biol Regul Homeost Agents","2011","2011/03/09","","",""
"18675503","Editorial comment on: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology","Colombo R.","Eur Urol. 2009 Jan;55(1):175-6. doi: 10.1016/j.eururo.2008.07.033. Epub 2008 Jul 18.","Colombo R","Eur Urol","2009","2008/08/05","","","10.1016/j.eururo.2008.07.033"
"877115","Demonstration of nitrosamines in human urine: preliminary observations on a possible etiology for bladder cancer in association with chronic urinary tract infections","Hicks RM, Walters CL, Elsebai I, Aasser AB, Merzabani ME, Gough TA.","Proc R Soc Med. 1977 Jun;70(6):413-7.","Hicks RM","Proc R Soc Med","1977","1977/06/01","PMC1543164","",""
"6917442","[Bladder neoplasms]","Barnaud P, Guillotreau J, Mackoumbou A.","Soins Pathol Trop. 1981 Dec;(32):23-5.","Barnaud P","Soins Pathol Trop","1981","1981/12/01","","",""
"15467510","Gross hematuria 10 years after radical cystectomy: adenomatous polyp","Leonardo C, De Nunzio C, Rondoni M, Leonardo F.","Minerva Urol Nefrol. 2004 Sep;56(3):325-6.","Leonardo C","Minerva Urol Nefrol","2004","2004/10/07","","",""
"1490505","Value of random mucosal biopsies in the management of superficial bladder cancer","Mufti GR, Singh M.","Eur Urol. 1992;22(4):288-93. doi: 10.1159/000474774.","Mufti GR","Eur Urol","1992","1992/01/01","","","10.1159/000474774"
"16133380","FDG-PET for preoperative staging of bladder cancer","Drieskens O, Oyen R, Van Poppel H, Vankan Y, Flamen P, Mortelmans L.","Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1412-7. doi: 10.1007/s00259-005-1886-9. Epub 2005 Aug 31.","Drieskens O","Eur J Nucl Med Mol Imaging","2005","2005/09/01","","","10.1007/s00259-005-1886-9"
"18942405","[Prognosis for therapeutic effectiveness of radiotherapy in the combined treatment of cancer]","Ivanov SD.","Vopr Onkol. 2008;54(4):483-9.","Ivanov SD","Vopr Onkol","2008","2008/10/24","","",""
"11696817","Analysis of the gene expression of SPARC and its prognostic value for bladder cancer","Yamanaka M, Kanda K, Li NC, Fukumori T, Oka N, Kanayama HO, Kagawa S.","J Urol. 2001 Dec;166(6):2495-9.","Yamanaka M","J Urol","2001","2001/11/07","","",""
"10657956","White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer","Peluso M, Airoldi L, Magagnotti C, Fiorini L, Munnia A, Hautefeuille A, Malaveille C, Vineis P.","Carcinogenesis. 2000 Feb;21(2):183-7. doi: 10.1093/carcin/21.2.183.","Peluso M","Carcinogenesis","2000","2000/02/05","","","10.1093/carcin/21.2.183"
"22339740","Thoughtful, practical and timely radiation therapy guidelines for patients with muscle-invasive bladder cancer","Shipley WU.","J Med Imaging Radiat Oncol. 2012 Feb;56(1):4. doi: 10.1111/j.1754-9485.2011.02339.x.","Shipley WU","J Med Imaging Radiat Oncol","2012","2012/02/21","","","10.1111/j.1754-9485.2011.02339.x"
"10367864","Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines","Morcos E, Jansson OT, Adolfsson J, Kratz G, Wiklund NP.","Urology. 1999 Jun;53(6):1252-7. doi: 10.1016/s0090-4295(99)00033-3.","Morcos E","Urology","1999","1999/06/15","","","10.1016/s0090-4295(99)00033-3"
"17572188","Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion","Lee CT, Dunn RL, Ingold C, Montie JE, Wood DP Jr.","Urology. 2007 Jun;69(6):1068-72. doi: 10.1016/j.urology.2007.02.064.","Lee CT","Urology","2007","2007/06/19","","","10.1016/j.urology.2007.02.064"
"23894577","Use of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studies","Zhang H, Jiang D, Li X.","PLoS One. 2013 Jul 19;8(7):e70008. doi: 10.1371/journal.pone.0070008. Print 2013.","Zhang H","PLoS One","2013","2013/07/30","PMC3716767","","10.1371/journal.pone.0070008"
"5157845","Tumors of the urinary bladder: an analysis of the occupations of 1,030 patients in Leeds, England","Anthony HM, Thomas GM, Cole P, Hoover R.","J Natl Cancer Inst. 1971 May;46(5):1111-3.","Anthony HM","J Natl Cancer Inst","1971","1971/05/01","","",""
"3957199","[Bladder cancer--a consequence of industrialization?]","Gericke D, Harzmann R.","Fortschr Med. 1986 Jan 16;104(3):33-7.","Gericke D","Fortschr Med","1986","1986/01/16","","",""
"30575800","Refining existing knowledge and management of bladder cancer","Teo MY, Rosenberg JE.","Nat Rev Urol. 2019 Feb;16(2):75-76. doi: 10.1038/s41585-018-0137-3.","Teo MY","Nat Rev Urol","2019","2018/12/22","","","10.1038/s41585-018-0137-3"
"18864630","[The treatment of cancer vesicae urinariae]","STROMBECK JP.","Nord Med. 1948 Apr 30;37(18):899.","STROMBECK JP","Nord Med","1948","1948/04/30","","",""
"8266875","[Bladder cancer associated with growth hormone-producing pituitary tumor: a case report]","Kamijo T, Sato T, Yanagizawa R, Kishi H.","Hinyokika Kiyo. 1993 Nov;39(11):1051-3.","Kamijo T","Hinyokika Kiyo","1993","1993/11/01","","",""
"24582117","Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes","Kaimakliotis HZ, Monn MF, Cheng L, Masterson TA, Cary KC, Pedrosa JA, Foster RS, Koch MO, Bihrle R.","Urology. 2014 May;83(5):1112-6. doi: 10.1016/j.urology.2013.12.035. Epub 2014 Feb 26.","Kaimakliotis HZ","Urology","2014","2014/03/04","","","10.1016/j.urology.2013.12.035"
"1746077","Is the neodymium:YAG laser effective therapy for invasive bladder cancer?","Tarantino AE, Aretz HT, Libertino JA, Bihrle W 3rd, Dowd JB.","Urology. 1991 Dec;38(6):514-8. doi: 10.1016/0090-4295(91)80167-6.","Tarantino AE","Urology","1991","1991/12/01","","","10.1016/0090-4295(91)80167-6"
"7083118","Extramedullary plasmacytoma of the bladder: a case report and review of literature","Yang C, Motteram R, Sandeman TF.","Cancer. 1982 Jul 1;50(1):146-9. doi: 10.1002/1097-0142(19820701)50:1<146::aid-cncr2820500127>3.0.co;2-x.","Yang C","Cancer","1982","1982/07/01","","","10.1002/1097-0142(19820701)50:1<146::aid-cncr2820500127>3.0.co;2-x"
"29960059","Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiation Therapy","Tanaka H, Yoshida S, Koga F, Toda K, Yoshimura R, Nakajima Y, Sugawara E, Akashi T, Waseda Y, Inoue M, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.","Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1408-1416. doi: 10.1016/j.ijrobp.2018.06.030. Epub 2018 Jun 28.","Tanaka H","Int J Radiat Oncol Biol Phys","2018","2018/07/01","","","10.1016/j.ijrobp.2018.06.030"
"19755987","Bladder cancer in cancer patients: population-based estimates from a large Swedish study","Bermejo JL, Sundquist J, Hemminki K.","Br J Cancer. 2009 Oct 6;101(7):1091-9. doi: 10.1038/sj.bjc.6605325. Epub 2009 Sep 15.","Bermejo JL","Br J Cancer","2009","2009/09/17","PMC2768080","","10.1038/sj.bjc.6605325"
"21985225","Early vs delayed radical cystectomy for 'high-risk' carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival","Khochikar M.","BJU Int. 2011 Oct;108(8 Pt 2):E288-9. doi: 10.1111/j.1464-410X.2011.10539.x.","Khochikar M","BJU Int","2011","2011/10/12","","","10.1111/j.1464-410X.2011.10539.x"
"25355698","Endoscopic molecular imaging of human bladder cancer using a CD47 antibody","Pan Y, Volkmer JP, Mach KE, Rouse RV, Liu JJ, Sahoo D, Chang TC, Metzner TJ, Kang L, van de Rijn M, Skinner EC, Gambhir SS, Weissman IL, Liao JC.","Sci Transl Med. 2014 Oct 29;6(260):260ra148. doi: 10.1126/scitranslmed.3009457. Epub 2014 Oct 29.","Pan Y","Sci Transl Med","2014","2014/10/31","","","10.1126/scitranslmed.3009457"
"9313045","[Prognostic value of lymphatic metastasis in bladder cancer]","Martínez-Piñeiro L, Madrid J, Julve E, García Cardoso JV, Ortega L, de la Peña J, Martínez-Piñeiro JA.","Arch Esp Urol. 1997 May;50(4):365-71.","Martínez-Piñeiro L","Arch Esp Urol","1997","1997/05/01","","",""
"6399935","[Schistosomiasis and cancer of the bladder]","Díaz Hernández A, Lazo Lopetegui O, Ruiz Pérez A, Ramos García A, Pérez Avila J.","Rev Cubana Med Trop. 1984 Sep-Dec;36(3):258-63.","Díaz Hernández A","Rev Cubana Med Trop","1984","1984/09/01","","",""
"4698002","Screening for bladder cancer in the rubber industry","Parkes HG.","Proc R Soc Med. 1973 Mar;66(3):289.","Parkes HG","Proc R Soc Med","1973","1973/03/01","PMC1644837","",""
"28033148","Transurethral en bloc resection of nonmuscle invasive bladder cancer: trend or hype","Herrmann TR, Wolters M, Kramer MW.","Curr Opin Urol. 2017 Mar;27(2):182-190. doi: 10.1097/MOU.0000000000000377.","Herrmann TR","Curr Opin Urol","2017","2016/12/30","","","10.1097/MOU.0000000000000377"
"31364733","Plasma miR‑15b‑5p and miR‑590‑5p for distinguishing patients with bladder cancer from healthy individuals","Tölle A, Buckendahl L, Jung K.","Oncol Rep. 2019 Oct;42(4):1609-1620. doi: 10.3892/or.2019.7247. Epub 2019 Jul 24.","Tölle A","Oncol Rep","2019","2019/08/01","","","10.3892/or.2019.7247"
"32020241","[Urinary bladder cancer as a late sequela of spinal cord injury : Decision-making aids for assessment of this causal association]","Böthig R, Schöps W, Zellner M, Fiebag K, Kowald B, Hirschfeld S, Thietje R, Kurze I, Böhme H, Kaufmann A, Jungmann O, Zumbé J, Porres D, Lümmen G, Nehiba M, Kadhum T, Forchert M, Golka K.","Urologe A. 2020 Jun;59(6):700-709. doi: 10.1007/s00120-020-01124-w.","Böthig R","Urologe A","2020","2020/02/06","","","10.1007/s00120-020-01124-w"
"18239842","Cystoscopy for lower urinary tract symptoms in urogynecologic practice: the likelihood of finding bladder cancer","Goldberg RP, Sherman W, Sand PK.","Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jul;19(7):991-4. doi: 10.1007/s00192-007-0555-x. Epub 2008 Feb 1.","Goldberg RP","Int Urogynecol J Pelvic Floor Dysfunct","2008","2008/02/02","","","10.1007/s00192-007-0555-x"
"14734003","Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan","Nishiyama H, Habuchi T, Watanabe J, Teramukai S, Tada H, Ono Y, Ohshima S, Fujimoto K, Hirao Y, Fukushima M, Ogawa O.","Eur Urol. 2004 Feb;45(2):176-81. doi: 10.1016/j.eururo.2003.09.011.","Nishiyama H","Eur Urol","2004","2004/01/22","","","10.1016/j.eururo.2003.09.011"
"2916296","Flow cytometric study comparing paired bladder washing and voided urine for bladder cancer detection","Konchuba AM, Schellhammer PF, Alexander JP, Wright GL Jr.","Urology. 1989 Feb;33(2):89-96. doi: 10.1016/0090-4295(89)90002-2.","Konchuba AM","Urology","1989","1989/02/01","","","10.1016/0090-4295(89)90002-2"
"22961325","Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer","Yun SJ, Jeong P, Kim WT, Kim TH, Lee YS, Song PH, Choi YH, Kim IY, Moon SK, Kim WJ.","Int J Oncol. 2012 Nov;41(5):1871-8. doi: 10.3892/ijo.2012.1622. Epub 2012 Sep 6.","Yun SJ","Int J Oncol","2012","2012/09/11","","","10.3892/ijo.2012.1622"
"25051025","New imaging techniques for nonmuscle invasive bladder cancer","von Rundstedt FC, Lerner SP.","Curr Opin Urol. 2014 Sep;24(5):532-9. doi: 10.1097/MOU.0000000000000093.","von Rundstedt FC","Curr Opin Urol","2014","2014/07/23","","","10.1097/MOU.0000000000000093"
"2212829","[Clinical study of preoperative radiotherapy of bladder cancer]","Shimada H, Imanaka K, Hashimura T, Hirota S, Yonezawa K, Soezima T, Izumiyama K, Kono M, Goji K, Hamami M, et al.","Nihon Gan Chiryo Gakkai Shi. 1990 Jul 20;25(7):1385-90.","Shimada H","Nihon Gan Chiryo Gakkai Shi","1990","1990/07/20","","",""
"22921716","Reply to Jai Prakash, Apul Goel and Manish Garg's Letter to the Editor re: Anobel Y. Odisho, Anna B. Berry, Ardalan E. Ahmad, Matthew R. Cooperberg, Peter R. Carroll, Badrinath R. Konety. Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.019","Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR.","Eur Urol. 2012 Nov;62(5):e88. doi: 10.1016/j.eururo.2012.08.019. Epub 2012 Aug 20.","Odisho AY","Eur Urol","2012","2012/08/28","","","10.1016/j.eururo.2012.08.019"
"6448317","Effect of irradiation on the immunocompetence of peripheral blood and regional lymph node lymphocytes in bladder cancer","Herr HW.","J Surg Res. 1980 Jun;28(6):497-500. doi: 10.1016/0022-4804(80)90041-4.","Herr HW","J Surg Res","1980","1980/06/01","","","10.1016/0022-4804(80)90041-4"
"524032","Effects of 13-cis and all-trans-retinoic acid on the development of bladder cancer in rats: an ultrastructural study","Tannenbaum M, Tannenbaum S, Richelo BN, Trown PW.","Scan Electron Microsc. 1979;(3):673-8.","Tannenbaum M","Scan Electron Microsc","1979","1979/01/01","","",""
"11549575","Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals","Bornman DM, Mathew S, Alsruhe J, Herman JG, Gabrielson E.","Am J Pathol. 2001 Sep;159(3):831-5. doi: 10.1016/S0002-9440(10)61758-0.","Bornman DM","Am J Pathol","2001","2001/09/11","PMC1850472","","10.1016/S0002-9440(10)61758-0"
"982217","Schistosomiasis and carcinoma of the bladder in Zambia","Bhagwandeen SB.","S Afr Med J. 1976 Sep 25;50(41):1616-20.","Bhagwandeen SB","S Afr Med J","1976","1976/09/25","","",""
"25131659","MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays","Steurer S, Singer JM, Rink M, Chun F, Dahlem R, Simon R, Burandt E, Stahl P, Terracciano L, Schlomm T, Wagner W, Höppner W, Omidi M, Kraus O, Kwiatkowski M, Doh O, Fisch M, Soave A, Sauter G, Wurlitzer M, Schlüter H, Minner S.","Urol Oncol. 2014 Nov;32(8):1225-33. doi: 10.1016/j.urolonc.2014.06.007. Epub 2014 Aug 15.","Steurer S","Urol Oncol","2014","2014/08/19","","","10.1016/j.urolonc.2014.06.007"
"19887521","Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancer","Shirotake S, Kikuchi E, Matsumoto K, Yazawa S, Kosaka T, Miyajima A, Nakagawa K, Oya M.","Jpn J Clin Oncol. 2010 Mar;40(3):247-51. doi: 10.1093/jjco/hyp147. Epub 2009 Nov 3.","Shirotake S","Jpn J Clin Oncol","2010","2009/11/06","","","10.1093/jjco/hyp147"
"3932690","Saccharin. Review of safety issues. Council on Scientific Affairs","","JAMA. 1985 Nov 8;254(18):2622-4.","","JAMA","1985","1985/11/08","","",""
"27302778","Re: Does Radical Cystectomy Outperform Other Bladder Preservative Treatments in Elderly Patients with Advanced Bladder Cancer?","Griebling TL.","J Urol. 2016 Apr;195(4 Pt 1):904-6. doi: 10.1016/j.juro.2016.01.072. Epub 2016 Jan 22.","Griebling TL","J Urol","2016","2016/06/16","","","10.1016/j.juro.2016.01.072"
"24566815","Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States","Keegan KA, Zaid HB, Patel SG, Chang SS.","Curr Urol Rep. 2014 Apr;15(4):394. doi: 10.1007/s11934-014-0394-5.","Keegan KA","Curr Urol Rep","2014","2014/02/26","PMC4469382","NIHMS610846","10.1007/s11934-014-0394-5"
"19819539","Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer","Stephenson AJ, Gong MC, Campbell SC, Fergany AF, Hansel DE.","Urology. 2010 Feb;75(2):382-6. doi: 10.1016/j.urology.2009.07.1259. Epub 2009 Oct 12.","Stephenson AJ","Urology","2010","2009/10/13","","","10.1016/j.urology.2009.07.1259"
"28222066","Atezolizumab (Tecentriq) for bladder cancer and NSCLC","","Med Lett Drugs Ther. 2017 Feb 27;59(1515):e40-e41.","","Med Lett Drugs Ther","2017","2017/02/22","","",""
"25385733","Neoadjuvant phase II studies of modified methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer","Adesunloye BA.","J Clin Oncol. 2014 Dec 20;32(36):4170. doi: 10.1200/JCO.2014.57.9318. Epub 2014 Nov 10.","Adesunloye BA","J Clin Oncol","2014","2014/11/12","","","10.1200/JCO.2014.57.9318"
"10762637","Accumulation of intracellular platinum is correlated with intrinsic cisplatin resistance in human bladder cancer cell lines","Koga H, Kotoh S, Nakashima M, Yokomizo A, Tanaka M, Naito S.","Int J Oncol. 2000 May;16(5):1003-7. doi: 10.3892/ijo.16.5.1003.","Koga H","Int J Oncol","2000","2000/04/14","","","10.3892/ijo.16.5.1003"
"3090275","Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity","Groos E, Masters JR.","J Urol. 1986 Aug;136(2):399-402. doi: 10.1016/s0022-5347(17)44880-4.","Groos E","J Urol","1986","1986/08/01","","","10.1016/s0022-5347(17)44880-4"
"3805235","Black/white differences in bladder cancer patient survival","Hankey BF, Myers MH.","J Chronic Dis. 1987;40(1):65-73. doi: 10.1016/0021-9681(87)90097-x.","Hankey BF","J Chronic Dis","1987","1987/01/01","","","10.1016/0021-9681(87)90097-x"
"16734861","Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24","Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.","Int J Urol. 2006 Apr;13(4):415-9. doi: 10.1111/j.1442-2042.2006.01309.x.","Roomi MW","Int J Urol","2006","2006/06/01","","","10.1111/j.1442-2042.2006.01309.x"
"19175000","[Urinary bladder cancer producing granulocyte-colony stimulating factor: a case report and review of the literature]","Yoshino T, Yoneda K.","Hinyokika Kiyo. 2008 Dec;54(12):775-8.","Yoshino T","Hinyokika Kiyo","2008","2009/01/30","","",""
"23267737","Pioglitazone causing urinary bladder cancer? While waiting for the result of the debate, suggestions for physicians","Cagiltay E, Tuncel T, Yönem A, Ozdemir G.","Eur J Intern Med. 2013 Mar;24(2):e21-2. doi: 10.1016/j.ejim.2012.12.002. Epub 2012 Dec 23.","Cagiltay E","Eur J Intern Med","2013","2012/12/27","","","10.1016/j.ejim.2012.12.002"
"17237045","Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models","Matsui S, Ito M, Nishiyama H, Uno H, Kotani H, Watanabe J, Guilford P, Reeve A, Fukushima M, Ogawa O.","Bioinformatics. 2007 Mar 15;23(6):732-8. doi: 10.1093/bioinformatics/btl663. Epub 2007 Jan 18.","Matsui S","Bioinformatics","2007","2007/01/24","","","10.1093/bioinformatics/btl663"
"7902828","Expression and shedding of ICAM-1 in bladder cancer and its immunotherapy","Jackson AM, Alexandrov AB, Gribben SC, Esuvarnathan K, James K.","Int J Cancer. 1993 Dec 2;55(6):921-5. doi: 10.1002/ijc.2910550608.","Jackson AM","Int J Cancer","1993","1993/12/02","","","10.1002/ijc.2910550608"
"26924873","Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes","Nagata M, Muto S, Horie S.","Dis Markers. 2016;2016:8205836. doi: 10.1155/2016/8205836. Epub 2016 Jan 26.","Nagata M","Dis Markers","2016","2016/03/01","PMC4746343","","10.1155/2016/8205836"
"18903558","Mucous adenocarcinoma of the urinary bladder","HOWARD AH, BERGMAN RT.","J Urol. 1948 Mar;59(3):455-60. doi: 10.1016/s0022-5347(17)69397-2.","HOWARD AH","J Urol","1948","1948/03/01","","","10.1016/s0022-5347(17)69397-2"
"28027868","Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis","Chou R, Selph S, Buckley DI, Fu R, Griffin JC, Grusing S, Gore JL.","J Urol. 2017 May;197(5):1189-1199. doi: 10.1016/j.juro.2016.12.090. Epub 2016 Dec 24.","Chou R","J Urol","2017","2016/12/29","","","10.1016/j.juro.2016.12.090"
"10582685","Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer","Richter J, Wagner U, Schraml P, Maurer R, Alund G, Knönagel H, Moch H, Mihatsch MJ, Gasser TC, Sauter G.","Cancer Res. 1999 Nov 15;59(22):5687-91.","Richter J","Cancer Res","1999","1999/12/03","","",""
"32538807","[Recommendations on bladder cancer Management during COVID-19 pandemia: lessons learned and future plans.]","de la Peña E, Hernández V, Guijarro A, Castro A, Losa JE, Martel J, Aguilar E, Llorente C.","Arch Esp Urol. 2020 Jun;73(5):374-383.","de la Peña E","Arch Esp Urol","2020","2020/06/16","","",""
"7928456","Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors","Pollack A, Zagars GK, Swanson DA.","Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):267-77. doi: 10.1016/0360-3016(94)90004-3.","Pollack A","Int J Radiat Oncol Biol Phys","1994","1994/09/30","","","10.1016/0360-3016(94)90004-3"
"15746031","Nucleotide excision repair, oxidative damage, DNA sequence polymorphisms, and cancer treatment","Hutsell SQ, Sancar A.","Clin Cancer Res. 2005 Feb 15;11(4):1355-7. doi: 10.1158/1078-0432.CCR-05-0024.","Hutsell SQ","Clin Cancer Res","2005","2005/03/05","","","10.1158/1078-0432.CCR-05-0024"
"24072383","Diffusion-weighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection","Wang HJ, Pui MH, Guo Y, Yang D, Pan BT, Zhou XH.","Abdom Imaging. 2014 Feb;39(1):135-41. doi: 10.1007/s00261-013-0038-0.","Wang HJ","Abdom Imaging","2014","2013/09/28","","","10.1007/s00261-013-0038-0"
"3618314","[Planned preoperative radiotherapy and radical cystectomy in the management of bladder cancer]","Cedeño Gómez R, Gross de Blum S, Pérez Ulloa V, Botta Fernández MT, Alvarez Cabezas G.","Actas Urol Esp. 1987 Mar-Apr;11(2):160-5.","Cedeño Gómez R","Actas Urol Esp","1987","1987/03/01","","",""
"8709375","Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer","Okamura T, Tozawa K, Yamada Y, Sakagami H, Ueda K, Kohri K.","J Urol. 1996 Sep;156(3):967-71.","Okamura T","J Urol","1996","1996/09/01","","",""
"16471327","C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results","Leonardo C, Merola R, Orlandi G, Leonardo F, Rondoni M, De Nunzio C.","J Exp Clin Cancer Res. 2005 Dec;24(4):633-8.","Leonardo C","J Exp Clin Cancer Res","2005","2006/02/14","","",""
"16894568","Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study","Cantwell MM, Lacey JV Jr, Schairer C, Schatzkin A, Michaud DS.","Int J Cancer. 2006 Nov 15;119(10):2398-401. doi: 10.1002/ijc.22175.","Cantwell MM","Int J Cancer","2006","2006/08/09","","","10.1002/ijc.22175"
"1353119","Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM","Kimiya K, Naito S, Soejima T, Sakamoto N, Kotoh S, Kumazawa J, Tsuruo T.","J Urol. 1992 Aug;148(2 Pt 1):441-5. doi: 10.1016/s0022-5347(17)36624-7.","Kimiya K","J Urol","1992","1992/08/01","","","10.1016/s0022-5347(17)36624-7"
"15816388","[Which role and which tools in the screening of bladder cancer today?]","Pfister C.","Prog Urol. 2003 Nov;13(5 Suppl 2):1225-6.","Pfister C","Prog Urol","2003","2005/04/09","","",""
"6710729","In vivo mapping of bladder cancer (chromocystoscopy for in vivo detection of neoplastic urothelial surfaces)","Gill WB, Strauss FH.","Urology. 1984 Apr;23(4 Suppl):63-6. doi: 10.1016/s0090-4295(84)80071-0.","Gill WB","Urology","1984","1984/04/01","","","10.1016/s0090-4295(84)80071-0"
"24332507","General adherence to guideline recommendations on initial diagnosis of bladder cancer in the United States and influencing factors","Karl A, Adejoro O, Saigal C, Konety B; Urologic Diseases in America Project.","Clin Genitourin Cancer. 2014 Aug;12(4):270-7. doi: 10.1016/j.clgc.2013.11.003. Epub 2013 Nov 14.","Karl A","Clin Genitourin Cancer","2014","2013/12/17","","","10.1016/j.clgc.2013.11.003"
"11132446","[Urothelial papillary neoplasms of low malignant potential. Retrospective studies]","Alvarez Kindelan J, López Beltrán A, Requena Tapia MJ.","Actas Urol Esp. 2000 Oct;24(9):743-8. doi: 10.1016/s0210-4806(00)72537-x.","Alvarez Kindelan J","Actas Urol Esp","2000","2001/01/02","","","10.1016/s0210-4806(00)72537-x"
"11760355","[Palliation of urothelial carcinoma of the bladder]","Weissbach L.","Urologe A. 2001 Nov;40(6):475-9. doi: 10.1007/s001200170011.","Weissbach L","Urologe A","2001","2002/01/05","","","10.1007/s001200170011"
"1949460","Partial cystectomy for bladder cancer. A new technique","Haddad FS.","Urology. 1991 Nov;38(5):458-9. doi: 10.1016/0090-4295(91)80239-4.","Haddad FS","Urology","1991","1991/11/01","","","10.1016/0090-4295(91)80239-4"
"7341421","Correlation of cytology with histopathology and cystoscopy in urinary bladder tumours","Javali D, Singh SM, Gupta NP, Wadhwa SN.","Indian J Cancer. 1981 Dec;18(4):241-4.","Javali D","Indian J Cancer","1981","1981/12/01","","",""
"6741759","[Cancer of the bladder occurring in occupational dye users: report of two cases]","Ando M, Takeda H, Mizuo T, Yokokawa M, Ushiyama T.","Hinyokika Kiyo. 1984 Feb;30(2):223-8.","Ando M","Hinyokika Kiyo","1984","1984/02/01","","",""
"30539751","The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancer","Aljabery F, Shabo I, Gimm O, Jahnson S, Olsson H.","Urol Oncol. 2018 Dec;36(12):530.e7-530.e18. doi: 10.1016/j.urolonc.2018.05.025. Epub 2018 Oct 24.","Aljabery F","Urol Oncol","2018","2018/12/13","","","10.1016/j.urolonc.2018.05.025"
"8653320","A retrospective study of the investigation and management of muscle-invasive bladder cancer in the South West Region","Dickinson AJ, Howe K, Bedford C, Sanders T, Prentice A, Sibley GN.","Br J Urol. 1996 Jan;77(1):70-5. doi: 10.1046/j.1464-410x.1996.82611.x.","Dickinson AJ","Br J Urol","1996","1996/01/01","","","10.1046/j.1464-410x.1996.82611.x"
"10052882","The role of Ki67 proliferation assessment in predicting local control in bladder cancer patients treated by radical radiation therapy","Lara PC, Rey A, Santana C, Afonso JL, Diaz JM, González GJ, Apolinario R.","Radiother Oncol. 1998 Nov;49(2):163-7. doi: 10.1016/s0167-8140(98)00033-4.","Lara PC","Radiother Oncol","1998","1999/03/03","","","10.1016/s0167-8140(98)00033-4"
"15017199","Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced bladder cancer: a study by the Hellenic Cooperative Oncology Group","Bamias A, Deliveliotis Ch, Aravantinos G, Kalofonos Ch, Karayiannis A, Dimopoulos MA; Hellenic Cooperative Oncology Group.","J Urol. 2004 Apr;171(4):1467-70. doi: 10.1097/01.ju.0000118956.96871.18.","Bamias A","J Urol","2004","2004/03/17","","","10.1097/01.ju.0000118956.96871.18"
"20549700","MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3","Huang L, Luo J, Cai Q, Pan Q, Zeng H, Guo Z, Dong W, Huang J, Lin T.","Int J Cancer. 2011 Apr 15;128(8):1758-69. doi: 10.1002/ijc.25509.","Huang L","Int J Cancer","2011","2010/06/16","","","10.1002/ijc.25509"
"30320536","Occupational variation in bladder cancer in Nordic males adjusted with approximated smoking prevalence","Hadkhale K, Martinsen JI, Weiderpass E, Kjærheim K, Sparén P, Tryggvadóttir L, Lynge E, Pukkala E.","Acta Oncol. 2019 Jan;58(1):29-37. doi: 10.1080/0284186X.2018.1518591. Epub 2018 Oct 15.","Hadkhale K","Acta Oncol","2019","2018/10/16","","","10.1080/0284186X.2018.1518591"
"27498850","Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder Cancer","Leibowitz-Amit R, Israel A, Gal M, Atenafu EA, Symon Z, Portnoy O, Laufer M, Dotan Z, Ramon J, Avni D, Fridman E, Berger R.","Clin Oncol (R Coll Radiol). 2016 Dec;28(12):790-796. doi: 10.1016/j.clon.2016.07.007. Epub 2016 Aug 5.","Leibowitz-Amit R","Clin Oncol (R Coll Radiol)","2016","2016/08/09","","","10.1016/j.clon.2016.07.007"
"23986339","Invasive bladder cancer: ignoring the data","Raghavan D.","Oncologist. 2013;18(8):895-6. doi: 10.1634/theoncologist.2013-0281.","Raghavan D","Oncologist","2013","2013/08/30","PMC3755924","","10.1634/theoncologist.2013-0281"
"11387435","BCG immunotherapy for superficial bladder cancer","Lane T.","J R Soc Med. 2001 Jun;94(6):316. doi: 10.1177/014107680109400630.","Lane T","J R Soc Med","2001","2001/06/02","PMC1281547","","10.1177/014107680109400630"
"5043966","[Regional metastasis in bladder cancer (lymphography data)]","Sitdykov EN, Akhmetova SM.","Vopr Onkol. 1972;18(5):34-6.","Sitdykov EN","Vopr Onkol","1972","1972/01/01","","",""
"18593617","Role of neutrophils in BCG immunotherapy for bladder cancer","Simons MP, O'Donnell MA, Griffith TS.","Urol Oncol. 2008 Jul-Aug;26(4):341-5. doi: 10.1016/j.urolonc.2007.11.031.","Simons MP","Urol Oncol","2008","2008/07/03","PMC2493065","NIHMS59003","10.1016/j.urolonc.2007.11.031"
"25730066","Association between B7-H1 expression and bladder cancer: a meta-analysis","Wang YU, Liu AN, Zhao SH.","Genet Mol Res. 2015 Feb 13;14(1):1277-86. doi: 10.4238/2015.February.13.6.","Wang YU","Genet Mol Res","2015","2015/03/03","","","10.4238/2015.February.13.6"
"8646239","Incidence of urethral tumor involvement in 910 men with bladder cancer","Erckert M, Stenzl A, Falk M, Bartsch G.","World J Urol. 1996;14(1):3-8. doi: 10.1007/BF01836337.","Erckert M","World J Urol","1996","1996/01/01","","","10.1007/BF01836337"
"24486024","The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study","Gandaglia G, Popa I, Abdollah F, Schiffmann J, Shariat SF, Briganti A, Montorsi F, Trinh QD, Karakiewicz PI, Sun M.","Eur Urol. 2014 Sep;66(3):561-8. doi: 10.1016/j.eururo.2014.01.014. Epub 2014 Jan 24.","Gandaglia G","Eur Urol","2014","2014/02/04","","","10.1016/j.eururo.2014.01.014"
"8632538","The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up","Tolley DA, Parmar MK, Grigor KM, Lallemand G, Benyon LL, Fellows J, Freedman LS, Grigor KM, Hall RR, Hargreave TB, Munson K, Newling DW, Richards B, Robinson MR, Rose MB, Smith PH, Williams JL, Whelan P.","J Urol. 1996 Apr;155(4):1233-8.","Tolley DA","J Urol","1996","1996/04/01","","",""
"12826031","Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology","Talaska G.","J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2003 May;21(1):29-43. doi: 10.1081/GNC-120021372.","Talaska G","J Environ Sci Health C Environ Carcinog Ecotoxicol Rev","2003","2003/06/27","","","10.1081/GNC-120021372"
"17650334","Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice","Taylor JA 3rd, Kuchel GA, Hegde P, Voznesensky OS, Claffey K, Tsimikas J, Leng L, Bucala R, Pilbeam C.","BMC Cancer. 2007 Jul 24;7:135. doi: 10.1186/1471-2407-7-135.","Taylor JA 3rd","BMC Cancer","2007","2007/07/26","PMC1939709","","10.1186/1471-2407-7-135"
"11232958","Two patients with N3 bladder cancer successfully treated by internal iliac arterial infusion chemotherapy and irradiation: case reports","Hoshi S, Suzuki KI, Shintaku I, Sato K, Kaihou Y, Namima T, Satoh M, Ohyama C, Orikasa S.","Am J Clin Oncol. 2001 Feb;24(1):87-90. doi: 10.1097/00000421-200102000-00017.","Hoshi S","Am J Clin Oncol","2001","2001/03/10","","","10.1097/00000421-200102000-00017"
"17936813","Comparison of laparoscopic and open radical cystoprostatectomy for localized bladder cancer with 3-year oncological followup: a single surgeon experience","Hemal AK, Kolla SB.","J Urol. 2007 Dec;178(6):2340-3. doi: 10.1016/j.juro.2007.08.020. Epub 2007 Oct 22.","Hemal AK","J Urol","2007","2007/10/16","","","10.1016/j.juro.2007.08.020"
"17965422","Background Variables for the Patients with Invasive Bladder Cancer Suitable for Bladder-preserving Therapy","Miyanaga N, Akaza H, Hinotsu S, Joraku A, Oikawa T, Sekido N, Kawai K, Shimazui T.","Jpn J Clin Oncol. 2007 Nov;37(11):852-7. doi: 10.1093/jjco/hym129. Epub 2007 Oct 26.","Miyanaga N","Jpn J Clin Oncol","2007","2007/10/30","","","10.1093/jjco/hym129"
"6710726","Estimation of changes in bladder cancer mortality and prevalence of diagnosed cases","Ellwein LB, Greenfield RE, Friedell GH, Hilgar AG.","Urology. 1984 Apr;23(4 Suppl):135-42. doi: 10.1016/s0090-4295(84)80084-9.","Ellwein LB","Urology","1984","1984/04/01","","","10.1016/s0090-4295(84)80084-9"
"6710725","Chemotherapy of murine bladder cancer: in vitro and in vivo","Niell HB, Soloway MS, Matheny RB, Blatnik A.","Urology. 1984 Apr;23(4 Suppl):124-8. doi: 10.1016/s0090-4295(84)80082-5.","Niell HB","Urology","1984","1984/04/01","","","10.1016/s0090-4295(84)80082-5"
"2203672","Current status of urinary cytology in the evaluation of bladder neoplasms","Murphy WM.","Hum Pathol. 1990 Sep;21(9):886-96. doi: 10.1016/0046-8177(90)90171-z.","Murphy WM","Hum Pathol","1990","1990/09/01","","","10.1016/0046-8177(90)90171-z"
"27072610","Neoadjuvant Chemotherapy in Neuroendocrine Bladder Cancer: A Case Report","Prelaj A, Rebuzzi SE, Magliocca FM, Speranza I, Corongiu E, Borgoni G, Perugia G, Liberti M, Bianco V.","Am J Case Rep. 2016 Apr 13;17:248-53. doi: 10.12659/ajcr.896989.","Prelaj A","Am J Case Rep","2016","2016/04/14","PMC4831333","","10.12659/ajcr.896989"
"28705539","Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients","Bosschieter J, Nieuwenhuijzen JA, van Ginkel T, Vis AN, Witte B, Newling D, Beckers GMA, van Moorselaar RJA.","Eur Urol. 2018 Feb;73(2):226-232. doi: 10.1016/j.eururo.2017.06.038. Epub 2017 Jul 10.","Bosschieter J","Eur Urol","2018","2017/07/15","","","10.1016/j.eururo.2017.06.038"
"23606819","Can neutrophil-lymphocyte ratio and lymph node density be used as prognostic factors in patients undergoing radical cystectomy?","Demirtaş A, Sabur V, Akınsal EC, Demirci D, Ekmekcioglu O, Gulmez I, Tatlisen A.","ScientificWorldJournal. 2013 Mar 31;2013:703579. doi: 10.1155/2013/703579. Print 2013.","Demirtaş A","ScientificWorldJournal","2013","2013/04/23","PMC3628500","","10.1155/2013/703579"
"29545048","Leo Szilard's Bladder Cancer: Survival in the Nuclear Era","Wyner LM.","Urology. 2018 Jun;116:17-19. doi: 10.1016/j.urology.2018.02.020. Epub 2018 Mar 12.","Wyner LM","Urology","2018","2018/03/17","","","10.1016/j.urology.2018.02.020"
"24368697","Bladder cancer incidence among workers exposed to o-toluidine, aniline and nitrobenzene at a rubber chemical manufacturing plant","Carreón T, Hein MJ, Hanley KW, Viet SM, Ruder AM.","Occup Environ Med. 2014 Mar;71(3):175-82. doi: 10.1136/oemed-2013-101873. Epub 2013 Dec 24.","Carreón T","Occup Environ Med","2014","2013/12/26","PMC4548974","NIHMS710919","10.1136/oemed-2013-101873"
"6347356","A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study","Soloway MS, Einstein A, Corder MP, Bonney W, Prout GR Jr, Coombs J.","Cancer. 1983 Sep 1;52(5):767-72. doi: 10.1002/1097-0142(19830901)52:5<767::aid-cncr2820520502>3.0.co;2-p.","Soloway MS","Cancer","1983","1983/09/01","","","10.1002/1097-0142(19830901)52:5<767::aid-cncr2820520502>3.0.co;2-p"
"23184052","Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk","Liu ZH, Bao ED.","Mol Biol Rep. 2013 Mar;40(3):2389-95. doi: 10.1007/s11033-012-2319-z. Epub 2012 Nov 27.","Liu ZH","Mol Biol Rep","2013","2012/11/28","","","10.1007/s11033-012-2319-z"
"23957696","Current intravesical therapy for non-muscle invasive bladder cancer","van Lingen AV, Witjes JA.","Expert Opin Biol Ther. 2013 Oct;13(10):1371-85. doi: 10.1517/14712598.2013.824421. Epub 2013 Aug 20.","van Lingen AV","Expert Opin Biol Ther","2013","2013/08/21","","","10.1517/14712598.2013.824421"
"11953885","The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer","Turner KJ, Crew JP, Wykoff CC, Watson PH, Poulsom R, Pastorek J, Ratcliffe PJ, Cranston D, Harris AL.","Br J Cancer. 2002 Apr 22;86(8):1276-82. doi: 10.1038/sj.bjc.6600215.","Turner KJ","Br J Cancer","2002","2002/04/16","PMC2375338","","10.1038/sj.bjc.6600215"
"2417464","[Hyperthermic perfusion therapy using peplomycin for bladder cancer]","Nakajima K, Hisazumi H, Misaki T, Sugata T, Koshida K, Saito Y, Naito K, Kameda K, Taya T, Miyazaki K, et al.","Hinyokika Kiyo. 1985 Sep;31(9):1559-63.","Nakajima K","Hinyokika Kiyo","1985","1985/09/01","","",""
"19930730","[Diagnosis of urothelial carcinoma by the general practitioner--significance of haematuria]","Blanker MH.","Ned Tijdschr Geneeskd. 2009;153:A1198.","Blanker MH","Ned Tijdschr Geneeskd","2009","2009/11/26","","",""
"25572961","Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer","Semilia M, Hennenlotter J, Pavone C, Bischoff T, Kühs U, Gakis G, Bedke J, Stenzl A, Schwentner C, Todenhöfer T.","World J Urol. 2015 Oct;33(10):1403-9. doi: 10.1007/s00345-014-1473-4. Epub 2015 Jan 9.","Semilia M","World J Urol","2015","2015/01/10","","","10.1007/s00345-014-1473-4"
"23827655","Involvement of Th17 cells in patients of urothelial carcinoma of bladder","Chugh S, Anand V, Swaroop L, Sharma M, Seth A, Sharma A.","Hum Immunol. 2013 Oct;74(10):1258-62. doi: 10.1016/j.humimm.2013.06.032. Epub 2013 Jul 1.","Chugh S","Hum Immunol","2013","2013/07/06","","","10.1016/j.humimm.2013.06.032"
"1462102","Expression of blood group antigens in bladder cancer: current concepts","Sheinfeld J, Reuter VE, Fair WR, Cordon-Cardo C.","Semin Surg Oncol. 1992 Sep-Oct;8(5):308-15. doi: 10.1002/ssu.2980080510.","Sheinfeld J","Semin Surg Oncol","1992","1992/09/01","","","10.1002/ssu.2980080510"
"11692797","[Second resection in patients with Ta-T1 bladder tumors]","Rodríguez-Rubio Cortadellas FI, Garrido Insua S, Rivas Aguayo D, Hens Pérez A, Bachiller Burgos J, Beltrán Aguilar V, Varo Solís C, Sánchez Bernal C, Juárez Soto A, González Moreno D.","Actas Urol Esp. 2001 Sep;25(8):553-8. doi: 10.1016/s0210-4806(01)72671-x.","Rodríguez-Rubio Cortadellas FI","Actas Urol Esp","2001","2001/11/06","","","10.1016/s0210-4806(01)72671-x"
"20173363","Accuracy of the extent of bladder cancer nodal metastases found at pelvic lymphadenectomy at the time of cystectomy: relation to primary tumor stage","Rabbani F, Lee C, Chang SS, Lerner SP, Wood DP, Herr HW.","Urol Int. 2010;84(1):14-22. doi: 10.1159/000273460. Epub 2010 Feb 17.","Rabbani F","Urol Int","2010","2010/02/23","","","10.1159/000273460"
"1159914","Clinical evaluation of urinary and serum carcinoembryonic antigen in bladder cancer","Fraser RA, Ravry MJ, Segura JW, Go VL.","J Urol. 1975 Aug;114(2):226-9. doi: 10.1016/s0022-5347(17)66992-1.","Fraser RA","J Urol","1975","1975/08/01","","","10.1016/s0022-5347(17)66992-1"
"23272967","Unified multi-target approach for the rational in silico design of anti-bladder cancer agents","Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MN.","Anticancer Agents Med Chem. 2013 Jun;13(5):791-800. doi: 10.2174/1871520611313050013.","Speck-Planche A","Anticancer Agents Med Chem","2013","2013/01/01","","","10.2174/1871520611313050013"
"16899613","Effect of human leukocyte antigen class I expression of tumor cells on outcome of intravesical instillation of bacillus calmette-guerin immunotherapy for bladder cancer","Kitamura H, Torigoe T, Honma I, Sato E, Asanuma H, Hirohashi Y, Sato N, Tsukamoto T.","Clin Cancer Res. 2006 Aug 1;12(15):4641-4. doi: 10.1158/1078-0432.CCR-06-0595.","Kitamura H","Clin Cancer Res","2006","2006/08/11","","","10.1158/1078-0432.CCR-06-0595"
"20689253","Bladder preservation strategy based on combined therapy in patients with muscle-invasive bladder cancer: management and results at long-term follow-up","Villavicencio H, Rodriguez Faba O, Palou J, Gausa L, Algaba F, Marcuello E.","Urol Int. 2010;85(3):281-6. doi: 10.1159/000316076. Epub 2010 Jul 30.","Villavicencio H","Urol Int","2010","2010/08/07","","","10.1159/000316076"
"30021247","Amyloid precursor protein is overexpressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors","Zhang D, Zhou C, Li Y, Gao L, Pang Z, Yin G, Shi B.","Int J Urol. 2018 Sep;25(9):808-816. doi: 10.1111/iju.13726. Epub 2018 Jul 18.","Zhang D","Int J Urol","2018","2018/07/19","","","10.1111/iju.13726"
"31386310","Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer","Dugas SG, Müller DC, Le Magnen C, Federer-Gsponer J, Seifert HH, Ruiz C, Savic Prince S, Vlajnic T, Zellweger T, Mertz KD, Bacon JVW, Wyatt AW, Rentsch CA, Bubendorf L.","Cancer Cytopathol. 2019 Sep;127(9):578-585. doi: 10.1002/cncy.22167. Epub 2019 Aug 6.","Dugas SG","Cancer Cytopathol","2019","2019/08/07","","","10.1002/cncy.22167"
"28683008","Tar, nicotine and carbon monoxide yield of UK cigarettes and the risk of non-muscle-invasive and muscle-invasive bladder cancer","van Osch FHM, Pauwels CGGM, Jochems SHJ, Fayokun R, James ND, Wallace DMA, Cheng KK, Bryan RT, van Schooten FJ, Zeegers MP.","Eur J Cancer Prev. 2019 Jan;28(1):40-44. doi: 10.1097/CEJ.0000000000000404.","van Osch FHM","Eur J Cancer Prev","2019","2017/07/07","","","10.1097/CEJ.0000000000000404"
"9179670","Immunohistochemical study of tumor-infiltrating lymphocytes before and after intravesical bacillus Calmette-Guérin treatment for superficial bladder cancer","Honda S, Sakamoto Y, Fujime M, Kitagawa R.","Int J Urol. 1997 Jan;4(1):68-73. doi: 10.1111/j.1442-2042.1997.tb00143.x.","Honda S","Int J Urol","1997","1997/01/01","","","10.1111/j.1442-2042.1997.tb00143.x"
"8030167","Diagnostic problems of urine cytology on initial follow-up after intravesical immunotherapy with Calmette-Guérin bacillus for superficial bladder cancer","Mack D, Frick J.","Urol Int. 1994;52(4):204-7. doi: 10.1159/000282609.","Mack D","Urol Int","1994","1994/01/01","","","10.1159/000282609"
"23799002","Combining mTOR inhibition with radiation improves antitumor activity in bladder cancer cells in vitro and in vivo: a novel strategy for treatment","Nassim R, Mansure JJ, Chevalier S, Cury F, Kassouf W.","PLoS One. 2013 Jun 17;8(6):e65257. doi: 10.1371/journal.pone.0065257. Print 2013.","Nassim R","PLoS One","2013","2013/06/27","PMC3684614","","10.1371/journal.pone.0065257"
"19953417","Traffic air pollution and risk of death from bladder cancer in Taiwan using petrol station density as a pollutant indicator","Ho CK, Peng CY, Yang CY.","J Toxicol Environ Health A. 2010;73(1):23-32. doi: 10.1080/15287390903248869.","Ho CK","J Toxicol Environ Health A","2010","2009/12/03","","","10.1080/15287390903248869"
"31600961","Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice","Martin KA, Hum NR, Sebastian A, He W, Siddiqui S, Ghosh PM, Pan CX, de Vere White R, Loots GG.","Int J Mol Sci. 2019 Oct 9;20(20):4983. doi: 10.3390/ijms20204983.","Martin KA","Int J Mol Sci","2019","2019/10/12","PMC6829260","","10.3390/ijms20204983"
"21683396","Specific protein patterns characterize metastatic potential of advanced bladder cancer","Pilchowski R, Stöhr R, von Eggeling F, Hartmann A, Wunderlich H, Junker K.","J Urol. 2011 Aug;186(2):713-20. doi: 10.1016/j.juro.2011.03.124. Epub 2011 Jun 17.","Pilchowski R","J Urol","2011","2011/06/21","","","10.1016/j.juro.2011.03.124"
"17021825","False-positive lesions detected by fluorescence cystoscopy: any association with p53 and p16 expression?","Hendricksen K, Moonen PM, der Heijden AG, Witjes JA.","World J Urol. 2006 Nov;24(5):597-601. doi: 10.1007/s00345-006-0109-8. Epub 2006 Sep 22.","Hendricksen K","World J Urol","2006","2006/10/06","","","10.1007/s00345-006-0109-8"
"3130357","Validity of short-term examination for antipromoters of bladder carcinogenesis","Kakizoe T, Takai K, Tobisu K, Ohtani M, Sato S.","Jpn J Cancer Res. 1988 Feb;79(2):231-5. doi: 10.1111/j.1349-7006.1988.tb01581.x.","Kakizoe T","Jpn J Cancer Res","1988","1988/02/01","PMC5917457","","10.1111/j.1349-7006.1988.tb01581.x"
"8023040","A comparison of three approaches to estimate exposure-specific incidence rates from population-based case-control data","Benichou J, Wacholder S.","Stat Med. 1994 Mar 15-Apr 15;13(5-7):651-61. doi: 10.1002/sim.4780130526.","Benichou J","Stat Med","1994","1994/03/15","","","10.1002/sim.4780130526"
"16504266","Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder","Yamasaki Y, Smith C, Weisz D, van Huizen I, Xuan J, Moussa M, Stitt L, Hideki S, Cherian MG, Izawa JI.","Urology. 2006 Mar;67(3):530-5. doi: 10.1016/j.urology.2005.09.033. Epub 2006 Feb 28.","Yamasaki Y","Urology","2006","2006/03/01","","","10.1016/j.urology.2005.09.033"
"10895330","Cystoscopic diagnosis of bladder cancer by intravesical instillation of 5-aminolevulinic acid induced porphyrin fluorescence--the Singapore experience","Cheng CW, Lau WK, Tan PH, Olivo M.","Ann Acad Med Singap. 2000 Mar;29(2):153-8.","Cheng CW","Ann Acad Med Singap","2000","2000/07/15","","",""
"4447786","Smoking and bladder cancer in Egypt","Makhyoun NA.","Br J Cancer. 1974 Dec;30(6):577-81. doi: 10.1038/bjc.1974.238.","Makhyoun NA","Br J Cancer","1974","1974/12/01","PMC2009323","","10.1038/bjc.1974.238"
"292807","Estimation of relative risk from vital data: smoking and cancers of the lung and bladder","Stevens RG, Moolgavkar SH.","J Natl Cancer Inst. 1979 Dec;63(6):1351-7.","Stevens RG","J Natl Cancer Inst","1979","1979/12/01","","",""
"27699608","Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy","Hirasawa Y, Nakashima J, Yunaiyama D, Sugihara T, Gondo T, Nakagami Y, Horiguchi Y, Ohno Y, Namiki K, Ohori M, Tokuuye K, Tachibana M.","Ann Surg Oncol. 2016 Dec;23(Suppl 5):1048-1054. doi: 10.1245/s10434-016-5606-4. Epub 2016 Oct 3.","Hirasawa Y","Ann Surg Oncol","2016","2016/10/05","","","10.1245/s10434-016-5606-4"
"28799673","TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer","Yan L, Li Q, Yang J, Qiao B.","J Cell Biochem. 2018 Feb;119(2):1791-1803. doi: 10.1002/jcb.26340. Epub 2017 Sep 11.","Yan L","J Cell Biochem","2018","2017/08/12","","","10.1002/jcb.26340"
"30528231","The lncRNA ELF3-AS1 promotes bladder cancer progression by interaction with Krüppel-like factor 8","Guo Y, Chen D, Su X, Chen J, Li Y.","Biochem Biophys Res Commun. 2019 Jan 15;508(3):762-768. doi: 10.1016/j.bbrc.2018.11.183. Epub 2018 Dec 7.","Guo Y","Biochem Biophys Res Commun","2019","2018/12/12","","","10.1016/j.bbrc.2018.11.183"
"3362894","Ureterosigmoidostomy after cystectomy for bladder cancer: our experience","Pisani E, Gonnella G, Dormia G.","Prog Clin Biol Res. 1988;260:375-6.","Pisani E","Prog Clin Biol Res","1988","1988/01/01","","",""
"29509244","HMGN5 expression in bladder cancer tissue and its role on prognosis","Wu J, Wang J.","Eur Rev Med Pharmacol Sci. 2018 Feb;22(4):970-975. doi: 10.26355/eurrev_201802_14378.","Wu J","Eur Rev Med Pharmacol Sci","2018","2018/03/07","","","10.26355/eurrev_201802_14378"
"2658819","[Urogenital cancer]","Koiso K, Rinsho K, Nemoto R, Ishikawa H, Ohtani M, Uchida K, Noguchi R.","Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-1):971-7.","Koiso K","Gan To Kagaku Ryoho","1989","1989/04/01","","",""
"8053719","[Is bladder conservation possible in infiltrating cancer?]","Martínez-Piñeiro JA, Martínez-Piñeiro L.","Arch Esp Urol. 1994 May;47(4):337-42.","Martínez-Piñeiro JA","Arch Esp Urol","1994","1994/05/01","","",""
"10484853","[Molecular biology of bladder cancer]","Rosell Costa D, Zudaire JJ, Robles JE, Berián Polo JM.","Arch Esp Urol. 1999 Jul-Aug;52(6):693-705.","Rosell Costa D","Arch Esp Urol","1999","1999/09/15","","",""
"29156599","Illumination of a Vision-How Arthur Rimbaud Will Give Us Motivation to Find New Input into Bladder Cancer Biomarker Research","Ecke TH, Otto T.","Int J Mol Sci. 2017 Nov 19;18(11):2463. doi: 10.3390/ijms18112463.","Ecke TH","Int J Mol Sci","2017","2017/11/22","PMC5713429","","10.3390/ijms18112463"
"24105457","Isomorphic red blood cells using automated urine flow cytometry is a reliable method in diagnosis of bladder cancer","Muto S, Sugiura S, Nakajima A, Horiuchi A, Inoue M, Saito K, Isotani S, Yamaguchi R, Ide H, Horie S.","Int J Clin Oncol. 2014 Oct;19(5):928-34. doi: 10.1007/s10147-013-0623-9. Epub 2013 Oct 9.","Muto S","Int J Clin Oncol","2014","2013/10/10","","","10.1007/s10147-013-0623-9"
"15059347","[Effect of mouse uroplakin II promoter on human bladder cancer cell line]","Zhu HJ, Zhang ZQ, Zeng XF, Wei SS, Xu CX, Huang GJ, Guo YL.","Zhonghua Zhong Liu Za Zhi. 2004 Jan;26(1):22-5.","Zhu HJ","Zhonghua Zhong Liu Za Zhi","2004","2004/04/03","","",""
"29605462","High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer","Li Q, Li C, Chen J, Liu P, Cui Y, Zhou X, Li H, Zu X.","Urol Oncol. 2018 Jun;36(6):310.e15-310.e22. doi: 10.1016/j.urolonc.2018.02.019. Epub 2018 Mar 28.","Li Q","Urol Oncol","2018","2018/04/02","","","10.1016/j.urolonc.2018.02.019"
"2751654","Elastase activities of human bladder cancer cell lines derived from high grade invasive tumours","Grant AJ, Russell PJ, Raghavan D.","Biochem Biophys Res Commun. 1989 Jul 14;162(1):308-15. doi: 10.1016/0006-291x(89)91997-9.","Grant AJ","Biochem Biophys Res Commun","1989","1989/07/14","","","10.1016/0006-291x(89)91997-9"
"12727337","Selective reovirus killing of bladder cancer in a co-culture spheroid model","Kilani RT, Tamimi Y, Hanel EG, Wong KK, Karmali S, Lee PW, Moore RB.","Virus Res. 2003 May;93(1):1-12. doi: 10.1016/s0168-1702(03)00045-5.","Kilani RT","Virus Res","2003","2003/05/03","","","10.1016/s0168-1702(03)00045-5"
"14972509","Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status","Maas S, Warskulat U, Steinhoff C, Mueller W, Grimm MO, Schulz WA, Seifert HH.","Urology. 2004 Feb;63(2):392-7. doi: 10.1016/j.urology.2003.08.023.","Maas S","Urology","2004","2004/02/20","","","10.1016/j.urology.2003.08.023"
"26838030","Complete loss of STAG2 expression is an indicator of good prognosis in patients with bladder cancer","Qiao Y, Zhu X, Li A, Yang S, Zhang J.","Tumour Biol. 2016 Aug;37(8):10279-86. doi: 10.1007/s13277-016-4894-4. Epub 2016 Feb 2.","Qiao Y","Tumour Biol","2016","2016/02/04","","","10.1007/s13277-016-4894-4"
"3193504","The potency-sparing radical cystectomy: does it compromise the completeness of the cancer resection?","Pritchett TR, Schiff WM, Klatt E, Lieskovsky G, Skinner DG.","J Urol. 1988 Dec;140(6):1400-3. doi: 10.1016/s0022-5347(17)42055-6.","Pritchett TR","J Urol","1988","1988/12/01","","","10.1016/s0022-5347(17)42055-6"
"29472156","Novel biomarkers in bladder cancer","Cheng ML, Iyer G.","Urol Oncol. 2018 Mar;36(3):115-119. doi: 10.1016/j.urolonc.2018.01.009. Epub 2018 Feb 19.","Cheng ML","Urol Oncol","2018","2018/02/24","","","10.1016/j.urolonc.2018.01.009"
"30755618","Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer","Wu S, Ou T, Xing N, Lu J, Wan S, Wang C, Zhang X, Yang F, Huang Y, Cai Z.","Nat Commun. 2019 Feb 12;10(1):720. doi: 10.1038/s41467-019-08576-5.","Wu S","Nat Commun","2019","2019/02/14","PMC6372626","","10.1038/s41467-019-08576-5"
"24469858","Oncologic outcomes between open and robotic-assisted radical cystectomy: a propensity score matched analysis","Ahdoot M, Almario L, Araya H, Busch J, Conti S, Gonzalgo ML.","World J Urol. 2014 Dec;32(6):1441-6. doi: 10.1007/s00345-014-1242-4. Epub 2014 Jan 28.","Ahdoot M","World J Urol","2014","2014/01/29","","","10.1007/s00345-014-1242-4"
"30663202","Old instillations and new implications for bladder cancer: the urinary microbiome and intravesical BCG","Bajic P, Wolfe AJ, Gupta GN.","BJU Int. 2019 Jul;124(1):7-8. doi: 10.1111/bju.14683. Epub 2019 Feb 8.","Bajic P","BJU Int","2019","2019/01/22","","","10.1111/bju.14683"
"29303414","Expression of aromatase in tumor related stroma is associated with human bladder cancer progression","Wu S, Ye J, Wang Z, Lin SX, Lu M, Liang Y, Zhu X, Olumi AF, Zhong WD, Wu CL.","Cancer Biol Ther. 2018 Mar 4;19(3):175-180. doi: 10.1080/15384047.2017.1414762. Epub 2018 Jan 17.","Wu S","Cancer Biol Ther","2018","2018/01/06","PMC5790358","","10.1080/15384047.2017.1414762"
"8319113","[Risk factors in bladder cancer. A case-control study in the department of Hérault, France]","Grémy F, Momas I, Daures JP.","Bull Acad Natl Med. 1993 Jan;177(1):47-60; discussion 60-2.","Grémy F","Bull Acad Natl Med","1993","1993/01/01","","",""
"22236518","Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers","Chen YT, Chen HW, Domanski D, Smith DS, Liang KH, Wu CC, Chen CL, Chung T, Chen MC, Chang YS, Parker CE, Borchers CH, Yu JS.","J Proteomics. 2012 Jun 27;75(12):3529-45. doi: 10.1016/j.jprot.2011.12.031. Epub 2012 Jan 3.","Chen YT","J Proteomics","2012","2012/01/13","","","10.1016/j.jprot.2011.12.031"
"28464906","Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial","Fonteyne V, Dirix P, Junius S, Rammant E, Ost P, De Meerleer G, Swimberghe M, Decaestecker K.","BMC Cancer. 2017 May 2;17(1):308. doi: 10.1186/s12885-017-3302-9.","Fonteyne V","BMC Cancer","2017","2017/05/04","PMC5414216","","10.1186/s12885-017-3302-9"
"25936588","High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol","Tanabe K, Yoshida S, Koga F, Inoue M, Kobayashi S, Ishioka J, Tamura T, Sugawara E, Saito K, Akashi T, Fujii Y, Kihara K.","Clin Genitourin Cancer. 2015 Aug;13(4):e243-e251. doi: 10.1016/j.clgc.2015.03.002. Epub 2015 Mar 27.","Tanabe K","Clin Genitourin Cancer","2015","2015/05/05","","","10.1016/j.clgc.2015.03.002"
"12726927","Adenosine deaminase and xanthine oxidase activities in bladder washing fluid from patients with bladder cancer: a preliminary study","Güleç M, Akin H, Yüce H H, Ergin E, Elyas H, Yalçin O, Akyol O.","Clin Biochem. 2003 May;36(3):193-6. doi: 10.1016/s0009-9120(02)00452-6.","Güleç M","Clin Biochem","2003","2003/05/03","","","10.1016/s0009-9120(02)00452-6"
"2418959","Bladder cancer xenografts: a model of tumor cell heterogeneity","Russell PJ, Raghavan D, Gregory P, Philips J, Wills EJ, Jelbart M, Wass J, Zbroja RA, Vincent PC.","Cancer Res. 1986 Apr;46(4 Pt 2):2035-40.","Russell PJ","Cancer Res","1986","1986/04/01","","",""
"23146082","Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection","Sternberg IA, Keren Paz GE, Chen LY, Herr HW, Dalbagni G.","BJU Int. 2013 Jul;112(1):54-9. doi: 10.1111/j.1464-410X.2012.11391.x. Epub 2012 Nov 13.","Sternberg IA","BJU Int","2013","2012/11/14","","","10.1111/j.1464-410X.2012.11391.x"
"30254383","Intravesical device-assisted therapies for non-muscle-invasive bladder cancer","Tan WS, Kelly JD.","Nat Rev Urol. 2018 Nov;15(11):667-685. doi: 10.1038/s41585-018-0092-z.","Tan WS","Nat Rev Urol","2018","2018/09/27","","","10.1038/s41585-018-0092-z"
"25154777","The role of the urologist in smoking cessation: why is it important?","Sosnowski R, Przewoźniak K.","Urol Oncol. 2015 Jan;33(1):30-39. doi: 10.1016/j.urolonc.2014.07.011. Epub 2014 Aug 22.","Sosnowski R","Urol Oncol","2015","2014/08/27","","","10.1016/j.urolonc.2014.07.011"
"29787740","Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study","Mazza P, Moran GW, Li G, Robins DJ, Matulay JT, Herr HW, Decastro GJ, McKiernan JM, Anderson CB.","J Urol. 2018 Nov;200(5):1005-1013. doi: 10.1016/j.juro.2018.05.078. Epub 2018 May 19.","Mazza P","J Urol","2018","2018/05/23","PMC7543664","NIHMS1625087","10.1016/j.juro.2018.05.078"
"26808412","Metabolic alterations in bladder cancer: applications for cancer imaging","Whyard T, Waltzer WC, Waltzer D, Romanov V.","Exp Cell Res. 2016 Feb 1;341(1):77-83. doi: 10.1016/j.yexcr.2016.01.005. Epub 2016 Jan 22.","Whyard T","Exp Cell Res","2016","2016/01/26","","","10.1016/j.yexcr.2016.01.005"
"27265130","Loss of Cell Differentiation in HPV-Associated Bladder Cancer","Golovina DA, Ermilova VD, Zavalishina LE, Andreeva YY, Matveev VB, Frank GA, Volgareva GM.","Bull Exp Biol Med. 2016 May;161(1):96-8. doi: 10.1007/s10517-016-3354-x. Epub 2016 Jun 6.","Golovina DA","Bull Exp Biol Med","2016","2016/06/07","","","10.1007/s10517-016-3354-x"
"32500535","Editorial Comment from Dr Adomi et al. to Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer","Adomi S, Fujita K, Yoshimura K, Uemura H.","Int J Urol. 2020 Aug;27(8):655-656. doi: 10.1111/iju.14284. Epub 2020 Jun 4.","Adomi S","Int J Urol","2020","2020/06/06","","","10.1111/iju.14284"
"30657403","Web-Based Tool to Facilitate Shared Decision Making With Regard to Neoadjuvant Chemotherapy Use in Muscle-Invasive Bladder Cancer","Galsky MD, Diefenbach M, Mohamed N, Baker C, Pokhriya S, Rogers J, Atreja A, Hu L, Tsao CK, Sfakianos J, Mehrazin R, Waingankar N, Oh WK, Mazumdar M, Ferket BS.","JCO Clin Cancer Inform. 2017 Nov;1:1-12. doi: 10.1200/CCI.17.00116.","Galsky MD","JCO Clin Cancer Inform","2017","2019/01/19","PMC6874030","","10.1200/CCI.17.00116"
"28743155","Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology","Vetterlein MW, Wankowicz SAM, Seisen T, Lander R, Löppenberg B, Chun FK, Menon M, Sun M, Barletta JA, Choueiri TK, Bellmunt J, Trinh QD, Preston MA.","Cancer. 2017 Nov 15;123(22):4346-4355. doi: 10.1002/cncr.30907. Epub 2017 Jul 25.","Vetterlein MW","Cancer","2017","2017/07/26","","","10.1002/cncr.30907"
"6312581","[Aromatic amines in the work environment and urothelial tumors]","Conso F.","Sem Hop. 1983 Sep 1;59(29-30):2103-6.","Conso F","Sem Hop","1983","1983/09/01","","",""
"31305463","Predicting recurrence of nonmuscle-invasive bladder cancer (Ta-T1): A study based on 477 patients","Lu M, Chen S, Zhou Q, Wang L, Peng T, Wang G.","Medicine (Baltimore). 2019 Jul;98(28):e16426. doi: 10.1097/MD.0000000000016426.","Lu M","Medicine (Baltimore)","2019","2019/07/16","PMC6641864","","10.1097/MD.0000000000016426"
"30969956","Update on perioperative systemic therapy for urothelial carcinoma","Rouvinov K, Plimack ER, Zibelman M, Ghatalia P, Geynisman DM.","Clin Adv Hematol Oncol. 2019 Mar;17(3):176-183.","Rouvinov K","Clin Adv Hematol Oncol","2019","2019/04/11","","",""
"16328066","Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder","Turyn J, Matuszewski M, Schlichtholz B.","Oncol Rep. 2006 Jan;15(1):259-65.","Turyn J","Oncol Rep","2006","2005/12/06","","",""
"22237993","Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer","Yang GL, Zhang LH, Bo JJ, Huo XJ, Chen HG, Cao M, Liu DM, Huang YR.","J Surg Oncol. 2012 Jul 1;106(1):57-61. doi: 10.1002/jso.23040. Epub 2012 Jan 11.","Yang GL","J Surg Oncol","2012","2012/01/13","","","10.1002/jso.23040"
"8322625","[Treatment results of total cystectomy for patients with bladder cancer]","Kanamaru H, Shirahase T, Moroi S, Kihara Y, Okuno H, Kuo JY, Taniguchi T, Arai Y, Tanaka Y, Okada Y, et al.","Hinyokika Kiyo. 1993 May;39(5):433-8.","Kanamaru H","Hinyokika Kiyo","1993","1993/05/01","","",""
"27000283","[A study of non-muscle-invasive bladder cancer therapy : Treatment of high-grade non-muscle-invasive urothelial carcinoma of the bladder with the standard number and dosage of intravesical BCG instillations versus a reduced number intravesical BCG instillations at the standard dosage: A European Association of Urology Research Foundation randomized phase 3 study - NIMBUS - AB 37/10 of the AUO]","Rexer H.","Urologe A. 2016 Apr;55(4):528-31. doi: 10.1007/s00120-016-0051-3.","Rexer H","Urologe A","2016","2016/03/23","","","10.1007/s00120-016-0051-3"
"11299737","Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells","Kawakami S, Kageyama Y, Fujii Y, Kihara K, Oshima H.","Anticancer Res. 2001 Jan-Feb;21(1A):213-9.","Kawakami S","Anticancer Res","2001","2001/04/13","","",""
"21086633","[Are human papillomaviruses responsible for the occurrence of bladder cancer]","Volgareva GM, Zavalishina LÉ, Trofimova OB, Korolenkova LI, Khachaturian AV, Andreeva IuIu, Ermilova VD, Cheban NL, Kuevda DA, Shipulina OIu, Glazunova VA, Golovina DA, Petrov AN, Matveev VB, Frank GA.","Arkh Patol. 2010 Jul-Aug;72(4):24-7.","Volgareva GM","Arkh Patol","2010","2010/11/20","","",""
"28195264","The diagnostic value of cytohistological urine analysis and cytokeratin 20 in malignant and atypical urothelial cells","Negri S, Biavati P, Bondi A.","Pathologica. 2016 Sep;108(3):130-135.","Negri S","Pathologica","2016","2017/02/15","","",""
"14764641","Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine","Kageyama S, Isono T, Iwaki H, Wakabayashi Y, Okada Y, Kontani K, Yoshimura K, Terai A, Arai Y, Yoshiki T.","Clin Chem. 2004 May;50(5):857-66. doi: 10.1373/clinchem.2003.027425. Epub 2004 Feb 5.","Kageyama S","Clin Chem","2004","2004/02/07","","","10.1373/clinchem.2003.027425"
"4692374","Preoperative irradiation in the surgical treatment of transitional cell cancer of the bladder: preliminary report based on 12 years of experience","Scott R Jr, Koff WJ, Hudgins PT, McCullough D.","J Urol. 1973 Mar;109(3):405-8. doi: 10.1016/s0022-5347(17)60436-1.","Scott R Jr","J Urol","1973","1973/03/01","","","10.1016/s0022-5347(17)60436-1"
"29119388","Potentialities of MicroRNA Diagnosis in Patients with Bladder Cancer","Shegay PV, Zhavoronkov AA, Gaifullin NM, Vorob'ev NV, Alekseev BY, Popov SV, Garazha AV, Buzdin AA, Kaprin AD.","Bull Exp Biol Med. 2017 Nov;164(1):106-108. doi: 10.1007/s10517-017-3935-3. Epub 2017 Nov 9.","Shegay PV","Bull Exp Biol Med","2017","2017/11/10","","","10.1007/s10517-017-3935-3"
"15867482","Evaluation of pain caused by urethrocystoscopy in patients with superficial bladder cancer: a perspective of quality of life","Müezzinoglu T, Ceylan Y, Temeltaş G, Lekili M, Büyüksu C.","Onkologie. 2005 May;28(5):260-4. doi: 10.1159/000085110. Epub 2005 Apr 29.","Müezzinoglu T","Onkologie","2005","2005/05/04","","","10.1159/000085110"
"29628318","Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer","Klapheke A, Yap SA, Pan K, Cress RD.","Urol Oncol. 2018 Jun;36(6):308.e19-308.e25. doi: 10.1016/j.urolonc.2018.03.008. Epub 2018 Apr 5.","Klapheke A","Urol Oncol","2018","2018/04/10","PMC5960436","NIHMS951239","10.1016/j.urolonc.2018.03.008"
"6676576","[Urethral occurrence of bladder cancer following cystectomy]","Akaza H, Ootani M, Kawabe K, Koiso K, Niijima T.","Nihon Hinyokika Gakkai Zasshi. 1983 Aug;74(8):1436-9. doi: 10.5980/jpnjurol1928.74.8_1436.","Akaza H","Nihon Hinyokika Gakkai Zasshi","1983","1983/08/01","","","10.5980/jpnjurol1928.74.8_1436"
"14713777","Microscopic and gross extravesical extension in pathological staging of bladder cancer","Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J, Groshen S, Cote RJ, Lieskovsky G, Quinn DI, Skinner DG.","J Urol. 2004 Feb;171(2 Pt 1):640-5. doi: 10.1097/01.ju.0000108664.39035.51.","Quek ML","J Urol","2004","2004/01/10","","","10.1097/01.ju.0000108664.39035.51"
"19882920","[A case of pulmonary metastases from bladder cancer, suspected of recurrent Wegener's granulomatosis]","Sekiya M, Ichikawa M, Tsutsui A, Yoshimi K, Suzuki T, Seyama K, Uekusa T, Takahashi K.","Nihon Kokyuki Gakkai Zasshi. 2009 Oct;47(10):943-6.","Sekiya M","Nihon Kokyuki Gakkai Zasshi","2009","2009/11/04","","",""
"23588401","Role of oestrogen receptors in bladder cancer development","Hsu I, Vitkus S, Da J, Yeh S.","Nat Rev Urol. 2013 Jun;10(6):317-26. doi: 10.1038/nrurol.2013.53. Epub 2013 Apr 16.","Hsu I","Nat Rev Urol","2013","2013/04/17","","","10.1038/nrurol.2013.53"
"30758125","Palliative care use amongst patients with bladder cancer","Hugar LA, Lopa SH, Yabes JG, Yu JA, Turner RM 2nd, Fam MM, MacLeod LC, Davies BJ, Smith AB, Jacobs BL.","BJU Int. 2019 Jun;123(6):968-975. doi: 10.1111/bju.14708. Epub 2019 Mar 12.","Hugar LA","BJU Int","2019","2019/02/14","","","10.1111/bju.14708"
"26617115","[Recent advances in bladder urothelial carcinogenesis]","Pignot G, le Goux C, Bieche I.","Bull Cancer. 2015 Dec;102(12):1020-35. doi: 10.1016/j.bulcan.2015.10.004. Epub 2015 Nov 23.","Pignot G","Bull Cancer","2015","2015/12/01","","","10.1016/j.bulcan.2015.10.004"
"3802030","Treatment of advanced bladder carcinoma with irradiation and concomitant 5-fluorouracil infusion","Rotman M, Macchia R, Silverstein M, Aziz H, Choi K, Rosenthal J, Braverman A, Laungani GB.","Cancer. 1987 Feb 15;59(4):710-4. doi: 10.1002/1097-0142(19870215)59:4<710::aid-cncr2820590408>3.0.co;2-u.","Rotman M","Cancer","1987","1987/02/15","","","10.1002/1097-0142(19870215)59:4<710::aid-cncr2820590408>3.0.co;2-u"
"8712040","[Post-TUR radiotherapy in the treatment of locally advanced bladder tumor]","Fernández Rodríguez A, Cueto Ladrón de Guevara J, Martínez Torres JL, Castillo Pérez I, García Puche JL, Zuluaga Gómez A.","Actas Urol Esp. 1996 Mar;20(3):242-6.","Fernández Rodríguez A","Actas Urol Esp","1996","1996/03/01","","",""
"28888400","Characterization of inflammasome-related genes in urine sediments of patients receiving intravesical BCG therapy","Poli G, Cochetti G, Boni A, Egidi MG, Brancorsini S, Mearini E.","Urol Oncol. 2017 Dec;35(12):674.e19-674.e24. doi: 10.1016/j.urolonc.2017.08.004. Epub 2017 Sep 6.","Poli G","Urol Oncol","2017","2017/09/11","","","10.1016/j.urolonc.2017.08.004"
"19209780","Genetic polymorphism of glutathione-S-transferase (GST-M1 and GST-T1) in schistosomiasis -associated bladder cancer in Egyptian patients","El Nouby KA, Abd El Hameed AH, Negm OE, Hamouda HE, El Gamal OM, Ismail GM.","J Egypt Soc Parasitol. 2008 Dec;38(3):991-1006.","El Nouby KA","J Egypt Soc Parasitol","2008","2009/02/13","","",""
"8472331","N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers","Hayes RB, Bi W, Rothman N, Broly F, Caporaso N, Feng P, You X, Yin S, Woosley RL, Meyer UA.","Carcinogenesis. 1993 Apr;14(4):675-8. doi: 10.1093/carcin/14.4.675.","Hayes RB","Carcinogenesis","1993","1993/04/01","","","10.1093/carcin/14.4.675"
"17368754","Sunitinib malate and sorafenib may be beneficial at the treatment of advanced bladder cancer due to their anti-angiogenic effects","Silay MS, Miroglu C.","Med Hypotheses. 2007;69(4):892-5. doi: 10.1016/j.mehy.2007.01.065. Epub 2007 Mar 26.","Silay MS","Med Hypotheses","2007","2007/03/21","","","10.1016/j.mehy.2007.01.065"
"20807831","Selenium and bladder cancer risk: a meta-analysis","Amaral AF, Cantor KP, Silverman DT, Malats N.","Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2407-15. doi: 10.1158/1055-9965.EPI-10-0544. Epub 2010 Aug 31.","Amaral AF","Cancer Epidemiol Biomarkers Prev","2010","2010/09/03","PMC6982398","NIHMS279973","10.1158/1055-9965.EPI-10-0544"
"27730369","Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy","Yoshida T, Kinoshita H, Fukui K, Matsuzaki T, Yoshida K, Mishima T, Yanishi M, Komai Y, Sugi M, Inoue T, Murota T, Matsuda T.","Ann Surg Oncol. 2017 Mar;24(3):823-831. doi: 10.1245/s10434-016-5534-3. Epub 2016 Oct 11.","Yoshida T","Ann Surg Oncol","2017","2016/10/13","","","10.1245/s10434-016-5534-3"
"23494336","[Quality of care in patients with newly diagnosed bladder cancer: a prospective assessment in northern Germany]","Reek C, Rink M, Bloch M, Hansen J, Chun FK, Schneider A, Busche J, Fisch M.","Urologe A. 2013 Jul;52(7):986-90. doi: 10.1007/s00120-013-3134-4.","Reek C","Urologe A","2013","2013/03/16","","","10.1007/s00120-013-3134-4"
"9158535","Management of superficial bladder cancer","Crew JP, Cranston D.","Br J Urol. 1997 May;79(5):818.","Crew JP","Br J Urol","1997","1997/05/01","","",""
"860470","[State of renal function in patients with cancer of the urinary bladder]","Poliakov FF.","Vrach Delo. 1977 Feb;(2):77-81.","Poliakov FF","Vrach Delo","1977","1977/02/01","","",""
"11336327","Bladder cancer mortality rates by prefectures in Japan","Yamamoto S.","Jpn J Clin Oncol. 2001 Mar;31(3):130.","Yamamoto S","Jpn J Clin Oncol","2001","2001/05/05","","",""
"24357085","A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors","Dancik GM, Owens CR, Iczkowski KA, Theodorescu D.","Stem Cells. 2014 Apr;32(4):974-82. doi: 10.1002/stem.1625.","Dancik GM","Stem Cells","2014","2013/12/21","PMC3960367","NIHMS548780","10.1002/stem.1625"
"6831638","Tobacco as a risk factor in bladder cancer","Mommsen S, Aagaard J.","Carcinogenesis. 1983;4(3):335-8. doi: 10.1093/carcin/4.3.335.","Mommsen S","Carcinogenesis","1983","1983/01/01","","","10.1093/carcin/4.3.335"
"27012825","Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis","Wang C, Ge Q, Zhang Q, Chen Z, Hu J, Li F, Ye Z.","J Exp Clin Cancer Res. 2016 Mar 25;35:53. doi: 10.1186/s13046-016-0329-8.","Wang C","J Exp Clin Cancer Res","2016","2016/03/26","PMC4807596","","10.1186/s13046-016-0329-8"
"6820893","[Effect of cis-diamminedichloroplatinum (II) (CDDP) on bladder cancer on rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)]","Miyakawa M, Yoshida O.","Gan To Kagaku Ryoho. 1982 Feb;9(2):258-62.","Miyakawa M","Gan To Kagaku Ryoho","1982","1982/02/01","","",""
"30730413","Accurate Quantification of Residual Cancer Cells in Pelvic Washing Reveals Association with Cancer Recurrence Following Robot-Assisted Radical Cystectomy","Wei L, Hussein AA, Ma Y, Azabdaftari G, Ahmed Y, Wong LP, Hu Q, Luo W, Cranwell VN, Bunch BL, Kozlowski JD, Singh PK, Glenn ST, Smith G, Johnson CS, Liu S, Guru KA.","J Urol. 2019 Jun;201(6):1105-1114. doi: 10.1097/JU.0000000000000142.","Wei L","J Urol","2019","2019/02/08","PMC6784327","NIHMS1050364","10.1097/JU.0000000000000142"
"30381128","[Influence of perioperative leukodeplated red blood cell transfusion on immune function of patients with bladder cancer]","Shi J, Gao B, Yang Y, Yang L, Li X.","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018 Jul;34(7):632-636.","Shi J","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi","2018","2018/11/02","","",""
"2091728","[Adjuvant chemotherapy in carcinoma of the bladder: current results and prospects]","Ficorella C, Iavarone C, Tomao S, Felici A, Battisti G, Stio F, Guarnieri F, Brescia A, Marigliani M, Messinetti S.","G Chir. 1990 Nov-Dec;11(11-12):650-1.","Ficorella C","G Chir","1990","1990/11/01","","",""
"7389773","The curability if invasive bladder cancer treated by radical cystectomy","Bredael JJ, Croker BP, Glenn JF.","Eur Urol. 1980;6(4):206-10. doi: 10.1159/000473332.","Bredael JJ","Eur Urol","1980","1980/01/01","","","10.1159/000473332"
"28206971","Impact of vascular endothelial growth factor gene-gene and gene-smoking interaction and haplotype combination on bladder cancer risk in Chinese population","Fu D, Li P, Cheng W, Tian F, Xu X, Yi X, Tang C, Wang Y, Hu Q, Zhang Z.","Oncotarget. 2017 Apr 4;8(14):22927-22935. doi: 10.18632/oncotarget.15287.","Fu D","Oncotarget","2017","2017/02/17","PMC5410274","","10.18632/oncotarget.15287"
"25314075","NOTch just a bladder control problem","Xu K, Bägli DJ, Egan SE.","Cancer Cell. 2014 Oct 13;26(4):452-4. doi: 10.1016/j.ccell.2014.09.018.","Xu K","Cancer Cell","2014","2014/10/15","","","10.1016/j.ccell.2014.09.018"
"7218804","Urinary immunoglobulin A in the diagnosis of bladder cancer","Betkerur V, Baumgartner G, Talluri K, Sharifi R, Nagubadi S, Guinan P.","J Surg Oncol. 1981;16(3):215-7. doi: 10.1002/jso.2930160303.","Betkerur V","J Surg Oncol","1981","1981/01/01","","","10.1002/jso.2930160303"
"16264831","What is the role of radiotherapy in bladder-preserving cancer therapy?","Rödel C, Sauer R.","Nat Clin Pract Oncol. 2005 Jan;2(1):4-5. doi: 10.1038/ncponc0052.","Rödel C","Nat Clin Pract Oncol","2005","2005/11/03","","","10.1038/ncponc0052"
"6699955","Risk of local urethral recurrence after radical cystectomy for bladder cancer","Beahrs JR, Fleming TR, Zincke H.","J Urol. 1984 Feb;131(2):264-6. doi: 10.1016/s0022-5347(17)50341-9.","Beahrs JR","J Urol","1984","1984/02/01","","","10.1016/s0022-5347(17)50341-9"
"11342899","E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup","Byrne RR, Shariat SF, Brown R, Kattan MW, Morton RA JR, Wheeler TM, Lerner SP.","J Urol. 2001 May;165(5):1473-9.","Byrne RR","J Urol","2001","2001/05/09","","",""
"25784270","[Diagnostics of nonmuscle-invasive urothelial cell carcinoma of the bladder]","Tschirdewahn S, Vom Dorp F.","Urologe A. 2015 Apr;54(4):480-3. doi: 10.1007/s00120-015-3772-9.","Tschirdewahn S","Urologe A","2015","2015/03/19","","","10.1007/s00120-015-3772-9"
"31382543","Special Issue on Molecular Research Efforts in Urothelial Carcinoma: Summary of Included Topics","Hutterer GC.","Int J Mol Sci. 2019 Aug 2;20(15):3790. doi: 10.3390/ijms20153790.","Hutterer GC","Int J Mol Sci","2019","2019/08/07","PMC6695741","","10.3390/ijms20153790"
"25459358","Contemporary bladder cancer: variant histology may be a significant driver of disease","Monn MF, Kaimakliotis HZ, Pedrosa JA, Cary KC, Bihrle R, Cheng L, Koch MO.","Urol Oncol. 2015 Jan;33(1):18.e15-18.e20. doi: 10.1016/j.urolonc.2014.10.001. Epub 2014 Nov 1.","Monn MF","Urol Oncol","2015","2014/12/03","","","10.1016/j.urolonc.2014.10.001"
"31694589","Management of non-muscle-invasive bladder cancer: quality of clinical practice guidelines and variations in recommendations","Zhang J, Wang Y, Weng H, Wang D, Han F, Huang Q, Deng T, Wang X, Jin Y.","BMC Cancer. 2019 Nov 6;19(1):1054. doi: 10.1186/s12885-019-6304-y.","Zhang J","BMC Cancer","2019","2019/11/08","PMC6836507","","10.1186/s12885-019-6304-y"
"9392543","Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192","Wijnmaalen A, Helle PA, Koper PC, Jansen PP, Hanssens PE, Boeken Kruger CG, van Putten WL.","Int J Radiat Oncol Biol Phys. 1997 Dec 1;39(5):1043-52. doi: 10.1016/s0360-3016(97)00375-1.","Wijnmaalen A","Int J Radiat Oncol Biol Phys","1997","1997/12/10","","","10.1016/s0360-3016(97)00375-1"
"23954582","Intravaginal and subcutaneous immunization induced vaccine specific CD8 T cells and tumor regression in the bladder","Domingos-Pereira S, Derré L, Warpelin-Decrausaz L, Haefliger JA, Romero P, Jichlinski P, Nardelli-Haefliger D.","J Urol. 2014 Mar;191(3):814-22. doi: 10.1016/j.juro.2013.08.009. Epub 2013 Aug 13.","Domingos-Pereira S","J Urol","2014","2013/08/20","","","10.1016/j.juro.2013.08.009"
"22764455","Non-occupational risk factors of urinary bladder cancer in Faisalabad and Lahore, Pakistan","Ahmad MR, Pervaiz MK, Pervaiz G.","J Pak Med Assoc. 2012 Mar;62(3):236-9.","Ahmad MR","J Pak Med Assoc","2012","2012/07/07","","",""
"3439817","[Employment in the petrochemical industries and cancer of the bladder in males]","Bravo MP, del Rey Calero J, Conde M.","Arch Esp Urol. 1987 Nov-Dec;40(9):632-4.","Bravo MP","Arch Esp Urol","1987","1987/11/01","","",""
"19389006","Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology","Barocas DA, Patel SG, Chang SS, Clark PE, Smith JA Jr, Cookson MS.","BJU Int. 2009 Oct;104(8):1091-7. doi: 10.1111/j.1464-410X.2009.08558.x. Epub 2009 Apr 15.","Barocas DA","BJU Int","2009","2009/04/25","","","10.1111/j.1464-410X.2009.08558.x"
"26230405","microRNA-21 Regulates Cell Proliferation and Migration and Cross Talk with PTEN and p53 in Bladder Cancer","Lei M, Xie W, Sun E, Sun Y, Tian D, Liu C, Han R, Li N, Liu M, Han R, Liu L.","DNA Cell Biol. 2015 Oct;34(10):626-32. doi: 10.1089/dna.2015.2868. Epub 2015 Jul 31.","Lei M","DNA Cell Biol","2015","2015/08/01","","","10.1089/dna.2015.2868"
"18030008","[Neoadjuvant chemotherapy in muscle-invasive bladder cancer]","Miyanaga N, Akaza H.","Gan To Kagaku Ryoho. 2007 Nov;34(11):1745-9.","Miyanaga N","Gan To Kagaku Ryoho","2007","2007/11/22","","",""
"31400955","[Organ preservation by chemoradiation for bladder cancer]","Durdux C, Fabiano E, Méjean A.","Cancer Radiother. 2019 Oct;23(6-7):732-736. doi: 10.1016/j.canrad.2019.06.005. Epub 2019 Aug 7.","Durdux C","Cancer Radiother","2019","2019/08/12","","","10.1016/j.canrad.2019.06.005"
"12350512","Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer","Sachs MD, Rauen KA, Ramamurthy M, Dodson JL, De Marzo AM, Putzi MJ, Schoenberg MP, Rodriguez R.","Urology. 2002 Sep;60(3):531-6. doi: 10.1016/s0090-4295(02)01748-x.","Sachs MD","Urology","2002","2002/09/28","","","10.1016/s0090-4295(02)01748-x"
"22101115","Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin","Palou J, Sylvester RJ, Faba OR, Parada R, Peña JA, Algaba F, Villavicencio H.","Eur Urol. 2012 Jul;62(1):118-25. doi: 10.1016/j.eururo.2011.10.029. Epub 2011 Oct 25.","Palou J","Eur Urol","2012","2011/11/22","","","10.1016/j.eururo.2011.10.029"
"24616912","Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch","Han B, Cui D, Jing Y, Hong Y, Xia S.","World J Urol. 2014 Feb;32(1):149-55. doi: 10.1007/s00345-012-1020-0.","Han B","World J Urol","2014","2014/03/12","","","10.1007/s00345-012-1020-0"
"11832724","A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer","Soulié M, Straub M, Gamé X, Seguin P, De Petriconi R, Plante P, Hautmann RE.","J Urol. 2002 Mar;167(3):1325-8.","Soulié M","J Urol","2002","2002/02/08","","",""
"30463687","MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells","Luan T, Fu S, Huang L, Zuo Y, Ding M, Li N, Chen J, Wang H, Wang J.","Exp Cell Res. 2018 Dec 15;373(1-2):188-197. doi: 10.1016/j.yexcr.2018.10.013. Epub 2018 Oct 25.","Luan T","Exp Cell Res","2018","2018/11/23","","","10.1016/j.yexcr.2018.10.013"
"10589764","TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer","Qureshi KN, Griffiths TR, Robinson MC, Marsh C, Roberts JT, Hall RR, Lunec J, Neal DE.","Clin Cancer Res. 1999 Nov;5(11):3500-7.","Qureshi KN","Clin Cancer Res","1999","1999/12/10","","",""
"29288002","M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancer","Aljabery F, Olsson H, Gimm O, Jahnson S, Shabo I.","Urol Oncol. 2018 Apr;36(4):159.e19-159.e26. doi: 10.1016/j.urolonc.2017.11.020. Epub 2017 Dec 26.","Aljabery F","Urol Oncol","2018","2017/12/31","","","10.1016/j.urolonc.2017.11.020"
"9594163","[Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients]","Zhang H, Zhao Z, Sun H.","Zhonghua Wai Ke Za Zhi. 1996 Sep;34(9):560-2.","Zhang H","Zhonghua Wai Ke Za Zhi","1996","1996/09/01","","",""
"8483201","Late invasive recurrence despite long-term surveillance for superficial bladder cancer","Thompson RA Jr, Campbell EW Jr, Kramer HC, Jacobs SC, Naslund MJ.","J Urol. 1993 May;149(5):1010-1. doi: 10.1016/s0022-5347(17)36282-1.","Thompson RA Jr","J Urol","1993","1993/05/01","","","10.1016/s0022-5347(17)36282-1"
"8102431","Genetic alterations in bladder cancer","Dalbagni G, Presti J, Reuter V, Fair WR, Cordon-Cardo C.","Lancet. 1993 Aug 21;342(8869):469-71. doi: 10.1016/0140-6736(93)91595-d.","Dalbagni G","Lancet","1993","1993/08/21","","","10.1016/0140-6736(93)91595-d"
"24459064","Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer","Pinto-Leite R, Carreira I, Melo J, Ferreira SI, Ribeiro I, Ferreira J, Filipe M, Bernardo C, Arantes-Rodrigues R, Oliveira P, Santos L.","Tumour Biol. 2014 May;35(5):4599-617. doi: 10.1007/s13277-013-1604-3. Epub 2014 Jan 24.","Pinto-Leite R","Tumour Biol","2014","2014/01/25","","","10.1007/s13277-013-1604-3"
"8194925","Occupation and bladder cancer in Pordenone (north-east Italy): a case-control study","Barbone F, Franceschi S, Talamini R, Bidoli E, La Vecchia C.","Int J Epidemiol. 1994 Feb;23(1):58-65. doi: 10.1093/ije/23.1.58.","Barbone F","Int J Epidemiol","1994","1994/02/01","","","10.1093/ije/23.1.58"
"26851042","Prognostic Significance of Preoperative Urine Cytology in Low-grade Non-muscle-invasive Bladder Cancer","Kiyoshima K, Akitake M, Shiota M, Takeuchi A, Takahashi R, Inokuchi J, Tatsugami K, Yokomizo A, Eto M.","Anticancer Res. 2016 Feb;36(2):799-802.","Kiyoshima K","Anticancer Res","2016","2016/02/07","","",""
"10696256","Interferons and bladder cancer","Brown DH, Wagner TT, Bahnson RR.","Urol Clin North Am. 2000 Feb;27(1):171-8, xi. doi: 10.1016/s0094-0143(05)70245-7.","Brown DH","Urol Clin North Am","2000","2000/03/04","","","10.1016/s0094-0143(05)70245-7"
"22077821","Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, Osaka Medical College regimen","Azuma H, Inamoto T, Takahara K, Ibuki N, Nomi H, Yamamoto K, Narumi Y, Ubai T.","Int J Urol. 2012 Jan;19(1):26-38. doi: 10.1111/j.1442-2042.2011.02856.x. Epub 2011 Nov 13.","Azuma H","Int J Urol","2012","2011/11/15","","","10.1111/j.1442-2042.2011.02856.x"
"21147498","ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival","Zhu Y, Yu M, Li Z, Kong C, Bi J, Li J, Gao Z, Li Z.","Urology. 2011 Feb;77(2):510.e1-5. doi: 10.1016/j.urology.2010.09.022. Epub 2010 Dec 13.","Zhu Y","Urology","2011","2010/12/15","","","10.1016/j.urology.2010.09.022"
"27161431","Overall and recurrence-free survival among black and white bladder cancer patients in an equal-access health system","Schinkel JK, Shao S, Zahm SH, McGlynn KA, Shriver CD, Zhu K.","Cancer Epidemiol. 2016 Jun;42:154-8. doi: 10.1016/j.canep.2016.04.012. Epub 2016 May 6.","Schinkel JK","Cancer Epidemiol","2016","2016/05/11","PMC5727912","NIHMS924440","10.1016/j.canep.2016.04.012"
"19793380","Biomarkers in bladder cancer","Bryan RT, Zeegers MP, James ND, Wallace DM, Cheng KK.","BJU Int. 2010 Mar;105(5):608-13. doi: 10.1111/j.1464-410X.2009.08880.x. Epub 2009 Sep 29.","Bryan RT","BJU Int","2010","2009/10/02","","","10.1111/j.1464-410X.2009.08880.x"
"29948049","Modeling human bladder cancer","Ringuette-Goulet C, Bolduc S, Pouliot F.","World J Urol. 2018 Nov;36(11):1759-1766. doi: 10.1007/s00345-018-2369-5. Epub 2018 Jun 14.","Ringuette-Goulet C","World J Urol","2018","2018/06/28","","","10.1007/s00345-018-2369-5"
"24028766","Modulating the immune response to Bacillus Calmette-Guérin (BCG): a novel way to increase the immunotherapeutic effect of BCG for treatment of bladder cancer?","Sapre N, Corcoran NM.","BJU Int. 2013 Oct;112(6):852-3. doi: 10.1111/bju.12261.","Sapre N","BJU Int","2013","2013/09/14","","","10.1111/bju.12261"
"9615207","Locally advanced bladder cancer. Radiation therapy and chemotherapy","Gospodarowicz MK.","Eur Urol. 1998;33 Suppl 4:27-31. doi: 10.1159/000052261.","Gospodarowicz MK","Eur Urol","1998","1998/06/06","","","10.1159/000052261"
"6676558","[Early effects of preoperative radiation therapy for invasive bladder cancer]","Isaka S, Igarashi T, Ito H, Murakami M, Akimoto S, Shimazaki J, Matsuzaki O, Morita S, Tsunemoto H, Nakayama T.","Nihon Hinyokika Gakkai Zasshi. 1983 Oct;74(10):1778-83. doi: 10.5980/jpnjurol1928.74.10_1778.","Isaka S","Nihon Hinyokika Gakkai Zasshi","1983","1983/10/01","","","10.5980/jpnjurol1928.74.10_1778"
"1858591","[Complete remission of lung metastases of bladder tumor treated by small dosage of UFT: a case report]","Fukuoka H, Takeda M, Nomura S, Ogawa T, Sakanishi S.","Hinyokika Kiyo. 1991 May;37(5):541-4.","Fukuoka H","Hinyokika Kiyo","1991","1991/05/01","","",""
"4806167","The geographical pathology of cancer of the bladder","Higginson J.","Cancro. 1973;26(3):127-30.","Higginson J","Cancro","1973","1973/01/01","","",""
"21738036","Familial bladder cancer and the related genes","Hemminki K, Bermejo JL, Ji J, Kumar R.","Curr Opin Urol. 2011 Sep;21(5):386-92. doi: 10.1097/MOU.0b013e32834958ff.","Hemminki K","Curr Opin Urol","2011","2011/07/09","","","10.1097/MOU.0b013e32834958ff"
"18598789","Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer","Goh AC, Tresser NJ, Shen SS, Lerner SP.","Urology. 2008 Jul;72(1):133-7. doi: 10.1016/j.urology.2008.02.002.","Goh AC","Urology","2008","2008/07/05","","","10.1016/j.urology.2008.02.002"
"18139308","[Primary carcinoma of the gallbladder]","GONZALEZ BARQUERA J.","Rev Invest Clin. 1949 Jul;1(4):223-8.","GONZALEZ BARQUERA J","Rev Invest Clin","1949","1949/07/01","","",""
"11285791","BCG immunotherapy for superficial bladder cancer","Lockyer CR, Gillatt DA.","J R Soc Med. 2001 Mar;94(3):119-23. doi: 10.1177/014107680109400305.","Lockyer CR","J R Soc Med","2001","2001/04/05","PMC1297926","","10.1177/014107680109400305"
"16312844","4-year experience in conservative management of muscle-infiltrating bladder cancer","Lozzi V, Abenavoli FM, Grassetti U, Bonito M, Spampinato FL, Di Palma M, Majola L, Pavese I.","J Chemother. 1989 Jul;1(4 Suppl):1225-6.","Lozzi V","J Chemother","1989","1989/07/01","","",""
"3159062","Laser treatment of bladder cancer","Smith JA Jr.","Semin Urol. 1985 Feb;3(1):2-9.","Smith JA Jr","Semin Urol","1985","1985/02/01","","",""
"1624255","The significance of serum lipid-bound sialic acid in bladder tumours","Oztokatli A, Ozkardeş H, Ovül E, Erol D.","Int Urol Nephrol. 1992;24(2):125-9. doi: 10.1007/BF02549639.","Oztokatli A","Int Urol Nephrol","1992","1992/01/01","","","10.1007/BF02549639"
"361202","Cellular content of carcinoembryonic antigen in urothelial carcinoma","Wahren B.","Cancer. 1978 Sep;42(3 Suppl):1533-9. doi: 10.1002/1097-0142(197809)42:3+<1533::aid-cncr2820420827>3.0.co;2-t.","Wahren B","Cancer","1978","1978/09/01","","","10.1002/1097-0142(197809)42:3+<1533::aid-cncr2820420827>3.0.co;2-t"
"21557837","High risk bladder cancer: current management and survival","Leliveld AM, Bastiaannet E, Doornweerd BH, Schaapveld M, de Jong IJ.","Int Braz J Urol. 2011 Mar-Apr;37(2):203-10; discussion 210-2. doi: 10.1590/s1677-55382011000200007.","Leliveld AM","Int Braz J Urol","2011","2011/05/12","","","10.1590/s1677-55382011000200007"
"30684034","SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer","Leow JJ, Bedke J, Chamie K, Collins JW, Daneshmand S, Grivas P, Heidenreich A, Messing EM, Royce TJ, Sankin AI, Schoenberg MP, Shipley WU, Villers A, Efstathiou JA, Bellmunt J, Stenzl A.","World J Urol. 2019 Jan;37(1):61-83. doi: 10.1007/s00345-018-2606-y. Epub 2019 Jan 25.","Leow JJ","World J Urol","2019","2019/01/27","","","10.1007/s00345-018-2606-y"
"20733272","Is repeat transurethral resection effective and necessary in patients with T1 bladder carcinoma?","Yucel M, Hatipoglu NK, Atakanli C, Yalcinkaya S, Dedekarginoglu G, Saracoglu U, Aras E.","Urol Int. 2010;85(3):276-80. doi: 10.1159/000316073. Epub 2010 Aug 21.","Yucel M","Urol Int","2010","2010/08/25","","","10.1159/000316073"
"19144683","Indications, extent, and benefits of pelvic lymph node dissection for patients with bladder and prostate cancer","Thurairaja R, Studer UE, Burkhard FC.","Oncologist. 2009 Jan;14(1):40-51. doi: 10.1634/theoncologist.2008-0123. Epub 2009 Jan 14.","Thurairaja R","Oncologist","2009","2009/01/16","","","10.1634/theoncologist.2008-0123"
"29808692","[Urinary MicroRNAs as Potential Biomarkers of Bladder Cancer]","Juráček J, Staník M, Peltanová B, Adamcová S, Doležel J, Fedorko M, Radová L, Slabý O.","Klin Onkol. 2018 Spring;31(Supplementum1):155-157.","Juráček J","Klin Onkol","2018","2018/05/30","","",""
"12209761","Pathologic evaluation of radical cystectomy specimens","Herr HW.","Cancer. 2002 Aug 1;95(3):668-9. doi: 10.1002/cncr.10688.","Herr HW","Cancer","2002","2002/09/05","","","10.1002/cncr.10688"
"18106394","Diffusely infiltrative carcinoma of the neck of the urinary bladder","HIRSCH EF.","Ill Med J. 1949 Jan;95(1):51-3.","HIRSCH EF","Ill Med J","1949","1949/01/01","","",""
"23127231","Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer","Matsubara N, Mukai H, Naito Y, Nezu M, Itoh K.","Asia Pac J Clin Oncol. 2013 Dec;9(4):310-7. doi: 10.1111/ajco.12017. Epub 2012 Nov 6.","Matsubara N","Asia Pac J Clin Oncol","2013","2012/11/07","PMC3933765","","10.1111/ajco.12017"
"17927517","Examining the co-occurrence of bladder and prostate cancer: a worthwhile investigation?","Kellen E, Zeegers MP, Joniau S, Buntinx F.","Future Oncol. 2007 Oct;3(5):515-9. doi: 10.2217/14796694.3.5.515.","Kellen E","Future Oncol","2007","2007/10/12","","","10.2217/14796694.3.5.515"
"5744916","[Radiotherapy of patients with inoperable cancer of the urinary bladder]","Svistunov IA.","Vrach Delo. 1968 Nov;11:81-4.","Svistunov IA","Vrach Delo","1968","1968/11/01","","",""
"10665652","Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human bladder cancer","Tanaka T, Yoshiki T, Arai Y, Higuchi K, Kageyama S, Ogawa Y, Isono T, Okada Y.","Jpn J Cancer Res. 1999 Dec;90(12):1344-50. doi: 10.1111/j.1349-7006.1999.tb00718.x.","Tanaka T","Jpn J Cancer Res","1999","2000/02/09","PMC5926031","","10.1111/j.1349-7006.1999.tb00718.x"
"1536914","Bladder cancer, parity, and age at first birth","Cantor KP, Lynch CF, Johnson D.","Cancer Causes Control. 1992 Jan;3(1):57-62. doi: 10.1007/BF00051913.","Cantor KP","Cancer Causes Control","1992","1992/01/01","","","10.1007/BF00051913"
"151485","A cell line derived from BBN (N-butyl-N-[4-hydroxybutyl]-nitrosamine)-induced rat bladder cancer: establishment and scanning electron microscopic cell surface characteristics","Nishi M.","Acta Med Okayama. 1978 Jul;32(3):181-205.","Nishi M","Acta Med Okayama","1978","1978/07/01","","",""
"28972608","Photochemical internalization in bladder cancer - development of an orthotopic in vivo model","Gederaas OA, Johnsson A, Berg K, Manandhar R, Shrestha C, Skåre D, Ekroll IK, Høgset A, Hjelde A.","Photochem Photobiol Sci. 2017 Nov 8;16(11):1664-1676. doi: 10.1039/c7pp00176b.","Gederaas OA","Photochem Photobiol Sci","2017","2017/10/04","","","10.1039/c7pp00176b"
"11802806","Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse","Lim BK, Mahendran R, Lee YK, Bay BH.","Jpn J Cancer Res. 2002 Jan;93(1):36-41. doi: 10.1111/j.1349-7006.2002.tb01198.x.","Lim BK","Jpn J Cancer Res","2002","2002/01/23","PMC5926873","","10.1111/j.1349-7006.2002.tb01198.x"
"30317582","Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma","Qiu JG, Shi DY, Liu X, Zheng XX, Wang L, Li Q.","J Cell Physiol. 2019 May;234(5):6976-6982. doi: 10.1002/jcp.27440. Epub 2018 Oct 14.","Qiu JG","J Cell Physiol","2019","2018/10/15","","","10.1002/jcp.27440"
"7850326","Results of radiotherapy on ureteric obstruction in muscle-invasive bladder cancer","Honnens de Lichtenberg M, Miskowiak J, Rolff H.","Br J Urol. 1995 Feb;75(2):197-9. doi: 10.1111/j.1464-410x.1995.tb07311.x.","Honnens de Lichtenberg M","Br J Urol","1995","1995/02/01","","","10.1111/j.1464-410x.1995.tb07311.x"
"9748689","Histological evaluation of the effects of electropermeabilization after administration of bleomycin on bladder cancer in the rat","Kubota Y, Nakada T, Yanai H, Itoh K, Sasagawa I, Kawai K.","Eur Urol. 1998 Oct;34(4):372-6. doi: 10.1159/000019743.","Kubota Y","Eur Urol","1998","1998/09/28","","","10.1159/000019743"
"25664945","Prognostic factors in urothelial carcinoma of the bladder: histologic and molecular correlates","Solomon JP, Hansel DE.","Adv Anat Pathol. 2015 Mar;22(2):102-12. doi: 10.1097/PAP.0000000000000050.","Solomon JP","Adv Anat Pathol","2015","2015/02/10","","","10.1097/PAP.0000000000000050"
"21983220","Urinary thromboxane B2 and thromboxane receptors in bladder cancer: opportunity for detection and monitoring","Moussa O, Ciupek A, Watson DK, Halushka PV.","Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):41-4. doi: 10.1016/j.prostaglandins.2011.09.002. Epub 2011 Sep 29.","Moussa O","Prostaglandins Other Lipid Mediat","2011","2011/10/11","PMC3215826","NIHMS329246","10.1016/j.prostaglandins.2011.09.002"
"22986753","Meta-analysis shows strong positive association of the TNF-α gene with tumor stage in bladder cancer","Yang Z, Lv Y, Lv Y, Wang Y.","Urol Int. 2012;89(3):337-41. doi: 10.1159/000341701. Epub 2012 Sep 14.","Yang Z","Urol Int","2012","2012/09/19","","","10.1159/000341701"
"16804724","Prognostic value of cell cycle regulatory proteins in muscle-infiltrating bladder cancer","Galmozzi F, Rubagotti A, Romagnoli A, Carmignani G, Perdelli L, Gatteschi B, Boccardo F.","J Cancer Res Clin Oncol. 2006 Dec;132(12):757-64. doi: 10.1007/s00432-006-0123-7. Epub 2006 Jun 21.","Galmozzi F","J Cancer Res Clin Oncol","2006","2006/06/29","","","10.1007/s00432-006-0123-7"
"25935564","A Case of Advanced Mucinous Adenocarcinoma of Bladder in an Adult Patient Treated With Capecitabine-Based Chemotherapy and Review of Literature","Messina C, Dellepiane C, Caroti C, Sarocchi F, Ravetti GL, Boccardo F, Spina B.","Clin Genitourin Cancer. 2015 Oct;13(5):e365-8. doi: 10.1016/j.clgc.2015.04.002. Epub 2015 Apr 15.","Messina C","Clin Genitourin Cancer","2015","2015/05/04","","","10.1016/j.clgc.2015.04.002"
"30256260","Editorial comment","Kamat AM, Gontero P.","Curr Opin Urol. 2018 Nov;28(6):555-556. doi: 10.1097/MOU.0000000000000551.","Kamat AM","Curr Opin Urol","2018","2018/09/27","","","10.1097/MOU.0000000000000551"
"9114523","[Treatment of superficial bladder tumors]","Chopin DK.","Rev Prat. 1997 Feb 15;47(4):382-7.","Chopin DK","Rev Prat","1997","1997/02/15","","",""
"23392718","Over-expression of LRIG3 suppresses growth and invasion of bladder cancer cells","Qi Y, Chang L, Li H, Yu G, Xiao W, Xia D, Guan W, Yang Y, Lang B, Deng KL, Yao WM, Ye ZQ, Zhuang QY.","J Huazhong Univ Sci Technolog Med Sci. 2013 Feb;33(1):111-116. doi: 10.1007/s11596-013-1081-3. Epub 2013 Feb 8.","Qi Y","J Huazhong Univ Sci Technolog Med Sci","2013","2013/02/09","","","10.1007/s11596-013-1081-3"
"11560967","Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer","Sternberg CN, Parmar MK.","J Clin Oncol. 2001 Sep 15;19(18 Suppl):21S-26S.","Sternberg CN","J Clin Oncol","2001","2001/09/19","","",""
"4299403","[Neoplasms on bladder exstrophy]","Chelloul N, Gubler JP, Jouannelle A, Michon J, Roujeau J.","Bull Cancer. 1967 Oct-Dec;54(4):447-62.","Chelloul N","Bull Cancer","1967","1967/10/01","","",""
"12394686","Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","Sylvester RJ, van der MEIJDEN AP, Lamm DL.","J Urol. 2002 Nov;168(5):1964-70. doi: 10.1097/01.ju.0000034450.80198.1c.","Sylvester RJ","J Urol","2002","2002/10/24","","","10.1097/01.ju.0000034450.80198.1c"
"24885195","Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts","Andersson G, Wennersten C, Gaber A, Boman K, Nodin B, Uhlén M, Segersten U, Malmström PU, Jirström K.","BMC Urol. 2014 May 12;14:36. doi: 10.1186/1471-2490-14-36.","Andersson G","BMC Urol","2014","2014/06/03","PMC4049499","","10.1186/1471-2490-14-36"
"31593370","Generic Isolated Cell Image Generator","Scalbert M, Couzinie-Devy F, Fezzani R.","Cytometry A. 2019 Nov;95(11):1198-1206. doi: 10.1002/cyto.a.23899. Epub 2019 Oct 8.","Scalbert M","Cytometry A","2019","2019/10/09","PMC6899488","","10.1002/cyto.a.23899"
"30851984","The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival Probability","Kim J, Kwiatkowski D, McConkey DJ, Meeks JJ, Freeman SS, Bellmunt J, Getz G, Lerner SP.","Eur Urol. 2019 Jun;75(6):961-964. doi: 10.1016/j.eururo.2019.02.017. Epub 2019 Mar 7.","Kim J","Eur Urol","2019","2019/03/11","","","10.1016/j.eururo.2019.02.017"
"19635207","[Meta-analysis of fluorescence in situ hybridization and cytology for diagnosis of bladder cancer]","Yang MG, Zhao XK, Hou Y, Xiao N.","Ai Zheng. 2009 Jun;28(6):655-62.","Yang MG","Ai Zheng","2009","2009/07/29","","",""
"13982457","[On the etiology of bladder cancer]","ROHL L.","Urologe. 1963 Mar 25;2:57-61.","ROHL L","Urologe","1963","1963/03/25","","",""
"12180229","Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis","Raitanen MP, Aine R, Rintala E, Kallio J, Rajala P, Juusela H, Tammela TL; FinnBladder Group.","Eur Urol. 2002 Mar;41(3):284-9. doi: 10.1016/s0302-2838(02)00006-4.","Raitanen MP","Eur Urol","2002","2002/08/16","","","10.1016/s0302-2838(02)00006-4"
"12081782","Antisense Bcl2 oligonucleotide in cisplatin-resistant bladder cancer cell lines","Hong JH, Lee E, Hong J, Shin YJ, Ahn H.","BJU Int. 2002 Jul;90(1):113-7. doi: 10.1046/j.1464-410x.2002.02799.x.","Hong JH","BJU Int","2002","2002/06/26","","","10.1046/j.1464-410x.2002.02799.x"
"15250149","[Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma]","He J, Chen Y, Li H, Lu Y, Yan Y, Tan X.","Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2004 Jun;21(3):428-32.","He J","Sheng Wu Yi Xue Gong Cheng Xue Za Zhi","2004","2004/07/15","","",""
"30010255","The increased expression of Piezo1 and Piezo2 ion channels in human and mouse bladder carcinoma","Etem EÖ, Ceylan GG, Özaydın S, Ceylan C, Özercan I, Kuloğlu T.","Adv Clin Exp Med. 2018 Aug;27(8):1025-1031. doi: 10.17219/acem/71080.","Etem EÖ","Adv Clin Exp Med","2018","2018/07/17","","","10.17219/acem/71080"
"29879397","Effectiveness of Transurethral Resection plus Systemic Chemotherapy as Definitive Treatment for Muscle Invasive Bladder Cancer in Population Level Data","Audenet F, Waingankar N, Ferket BS, Niglio SA, Marqueen KE, Sfakianos JP, Galsky MD.","J Urol. 2018 Nov;200(5):996-1004. doi: 10.1016/j.juro.2018.06.001. Epub 2018 Jun 4.","Audenet F","J Urol","2018","2018/06/08","","","10.1016/j.juro.2018.06.001"
"22942715","Chemopreventive efficacy of Atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties","Parada B, Reis F, Pinto A, Sereno J, Xavier-Cunha M, Neto P, Rocha-Pereira P, Mota A, Figueiredo A, Teixeira F.","Int J Mol Sci. 2012;13(7):8482-99. doi: 10.3390/ijms13078482. Epub 2012 Jul 9.","Parada B","Int J Mol Sci","2012","2012/09/04","PMC3430246","","10.3390/ijms13078482"
"10832947","Fatal bladder cancer and dermatomyositis","Federman DG, Radonich M, Kirsner RS.","South Med J. 2000 May;93(5):492-3.","Federman DG","South Med J","2000","2000/06/01","","",""
"27432935","Management Considerations After Cystectomy for Bladder Cancer","Eapen LJ, MacRae RM.","J Clin Oncol. 2016 Sep 10;34(26):3228. doi: 10.1200/JCO.2016.67.9423. Epub 2016 Jul 18.","Eapen LJ","J Clin Oncol","2016","2016/07/20","","","10.1200/JCO.2016.67.9423"
"17910129","Current world literature. Bladder cancer","","Curr Opin Urol. 2007 Sep;17(5):378-80.","","Curr Opin Urol","2007","2007/10/04","","",""
"14657442","Chemotherapy for bladder cancer","Muñoz A, Barceló JR, López-Vivanco G.","N Engl J Med. 2003 Dec 4;349(23):2272-3; author reply 2272-3. doi: 10.1056/NEJM200312043492323.","Muñoz A","N Engl J Med","2003","2003/12/06","","","10.1056/NEJM200312043492323"
"3343745","M-VAC chemotherapy in the management of locally advanced bladder cancer","Skinner DG.","J Urol. 1988 Mar;139(3):570. doi: 10.1016/s0022-5347(17)42528-6.","Skinner DG","J Urol","1988","1988/03/01","","","10.1016/s0022-5347(17)42528-6"
"12686813","Defining bacillus Calmette-Guerin refractory superficial bladder tumors","Herr HW, Dalbagni G.","J Urol. 2003 May;169(5):1706-8. doi: 10.1097/01.ju.0000062605.92268.c6.","Herr HW","J Urol","2003","2003/04/11","","","10.1097/01.ju.0000062605.92268.c6"
"21789897","Significant association of caveolin-1 genotypes with bladder cancer susceptibility in Taiwan","Bau DT, Chang CH, Tsai RY, Wang HC, Wang RF, Tsai CW, Yao CH, Chen YS, Shyue SK, Huang CY.","Chin J Physiol. 2011 Jun 30;54(3):153-60. doi: 10.4077/cjp.2011.amm009.","Bau DT","Chin J Physiol","2011","2011/07/28","","","10.4077/cjp.2011.amm009"
"2601075","[Clinicopathological study on microscopic urinalysis as screening for malignant cells]","Kawabe T, Kaneoka A, Koichi K, Murakami N, Kuroki T, Kinugasa M, Miyake S, Takasu K.","Rinsho Byori. 1989 Oct;37(10):1167-72.","Kawabe T","Rinsho Byori","1989","1989/10/01","","",""
"30206026","Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008-2015","Fisher MD, Shenolikar R, Miller PJ, Fenton M, Walker MS.","Clin Genitourin Cancer. 2018 Dec;16(6):e1171-e1179. doi: 10.1016/j.clgc.2018.07.025. Epub 2018 Aug 11.","Fisher MD","Clin Genitourin Cancer","2018","2018/09/13","","","10.1016/j.clgc.2018.07.025"
"748783","Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer","Soloway MS, Martino C, Hyatt C, Marrone JC.","Natl Cancer Inst Monogr. 1978 Dec;(49):293-300.","Soloway MS","Natl Cancer Inst Monogr","1978","1978/12/01","","",""
"6080888","[Results of treatment of cancer of the urinary bladder]","Couvelaire R.","Pol Przegl Chir. 1967 Oct;39(10):Suppl:1045-50.","Couvelaire R","Pol Przegl Chir","1967","1967/10/01","","",""
"9395906","Two types of micturitions of ileal neobladder","Onodera Y, Matsumoto K, Yogi S, Sasaki H, Ikeuchi T, Kai Y.","Hinyokika Kiyo. 1997 Oct;43(10):713-8.","Onodera Y","Hinyokika Kiyo","1997","1997/12/13","","",""
"23563166","Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression","Delto JC, Kobayashi T, Benson M, McKiernan J, Abate-Shen C.","Oncotarget. 2013 Feb;4(2):269-76. doi: 10.18632/oncotarget.852.","Delto JC","Oncotarget","2013","2013/04/09","PMC3712572","","10.18632/oncotarget.852"
"11521797","A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer","Hussain SA, Moffitt DD, Glaholm JG, Peake D, Wallace DM, James ND.","Ann Oncol. 2001 Jul;12(7):929-35. doi: 10.1023/a:1011133820532.","Hussain SA","Ann Oncol","2001","2001/08/28","","","10.1023/a:1011133820532"
"19818076","Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients","Chuang KL, Chuang HC, Ng KF, Chang YH, Wu CT, Chuang CK, Liao SK, Pang ST.","BJU Int. 2010 May;105(10):1413-6. doi: 10.1111/j.1464-410X.2009.08917.x. Epub 2009 Oct 10.","Chuang KL","BJU Int","2010","2009/10/13","","","10.1111/j.1464-410X.2009.08917.x"
"24169493","Significance of positive urine cytology on progression and cancer-specific mortality of non--muscle-invasive bladder cancer","Koga F, Kobayashi S, Fujii Y, Ishioka J, Yokoyama M, Nakanishi Y, Matsuoka Y, Numao N, Saito K, Masuda H, Kihara K.","Clin Genitourin Cancer. 2014 Jun;12(3):e87-93. doi: 10.1016/j.clgc.2013.07.007. Epub 2013 Oct 26.","Koga F","Clin Genitourin Cancer","2014","2013/10/31","","","10.1016/j.clgc.2013.07.007"
"30291813","Validating the predictors of outcomes after radical cystectomy for bladder cancer","Woldu SL, Sanli O, Clinton TN, Lotan Y.","Cancer. 2019 Jan 15;125(2):223-231. doi: 10.1002/cncr.31799. Epub 2018 Oct 6.","Woldu SL","Cancer","2019","2018/10/07","","","10.1002/cncr.31799"
"24146840","Lack of decorin expression by human bladder cancer cells offers new tools in the therapy of urothelial malignancies","Sainio A, Nyman M, Lund R, Vuorikoski S, Boström P, Laato M, Boström PJ, Järveläinen H.","PLoS One. 2013 Oct 11;8(10):e76190. doi: 10.1371/journal.pone.0076190. eCollection 2013.","Sainio A","PLoS One","2013","2013/10/23","PMC3795759","","10.1371/journal.pone.0076190"
"23893383","The CCND1 G870A polymorphism and susceptibility to bladder cancer","Li J, Luo F, Zhang H, Li L, Xu Y.","Tumour Biol. 2014 Jan;35(1):171-7. doi: 10.1007/s13277-013-1021-7. Epub 2013 Jul 28.","Li J","Tumour Biol","2014","2013/07/30","","","10.1007/s13277-013-1021-7"
"29684744","The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review","Khetrapal P, Lee MWL, Tan WS, Dong L, de Winter P, Feber A, Kelly JD.","Cancer Treat Rev. 2018 May;66:56-63. doi: 10.1016/j.ctrv.2018.03.007. Epub 2018 Apr 17.","Khetrapal P","Cancer Treat Rev","2018","2018/04/24","","","10.1016/j.ctrv.2018.03.007"
"30846479","Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer","Vantaku V, Dong J, Ambati CR, Perera D, Donepudi SR, Amara CS, Putluri V, Ravi SS, Robertson MJ, Piyarathna DWB, Villanueva M, von Rundstedt FC, Karanam B, Ballester LY, Terris MK, Bollag RJ, Lerner SP, Apolo AB, Villanueva H, Lee M, Sikora AG, Lotan Y, Sreekumar A, Coarfa C, Putluri N.","Clin Cancer Res. 2019 Jun 15;25(12):3689-3701. doi: 10.1158/1078-0432.CCR-18-1515. Epub 2019 Mar 7.","Vantaku V","Clin Cancer Res","2019","2019/03/09","PMC6571061","NIHMS1523810","10.1158/1078-0432.CCR-18-1515"
"25434791","Health related quality of life in patients with bladder cancer: a cross-sectional survey and validation study of the Hungarian version of the Bladder Cancer Index","Hevér NV, Péntek M, Balló A, Gulácsi L, Baji P, Brodszky V, Damásdi M, Bognár Z, Tóth G, Buzogány I, Szántó Á.","Pathol Oncol Res. 2015 Jul;21(3):619-27. doi: 10.1007/s12253-014-9866-7. Epub 2014 Dec 1.","Hevér NV","Pathol Oncol Res","2015","2014/12/02","","","10.1007/s12253-014-9866-7"
"5515121","[Bladder cancer: endoscopy and stages of clinical infiltration]","Gourdeau Y.","Laval Med. 1970 Jan;41(1):39-43.","Gourdeau Y","Laval Med","1970","1970/01/01","","",""
"23735471","Prostate-sparing radical cystectomy for selected patients with bladder cancer","Macek P, Sanchez-Salas R, Rozet F, Barret E, Galiano M, Hanus T, Cathelineau X.","Urol Int. 2013;91(1):89-96. doi: 10.1159/000348332. Epub 2013 May 28.","Macek P","Urol Int","2013","2013/06/06","","","10.1159/000348332"
"25965824","MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1","Peng Y, Dong W, Lin TX, Zhong GZ, Liao B, Wang B, Gu P, Huang L, Xie Y, Lu FD, Chen X, Xie WB, He W, Wu SX, Huang J.","Oncotarget. 2015 Jun 30;6(18):16043-58. doi: 10.18632/oncotarget.3755.","Peng Y","Oncotarget","2015","2015/05/13","PMC4599255","","10.18632/oncotarget.3755"
"22117154","The dilemma of cystectomy in old-old and oldest-old patients","Pycha A, Comploj E.","Expert Rev Anticancer Ther. 2011 Dec;11(12):1863-70. doi: 10.1586/era.11.188.","Pycha A","Expert Rev Anticancer Ther","2011","2011/11/26","","","10.1586/era.11.188"
"21606972","The role of lymphadenectomy for upper tract urothelial carcinoma","Messer J, Lin YK, Raman JD.","Nat Rev Urol. 2011 May 24;8(7):394-401. doi: 10.1038/nrurol.2011.78.","Messer J","Nat Rev Urol","2011","2011/05/25","","","10.1038/nrurol.2011.78"
"31176961","Secular trends in incidence and mortality of bladder cancer in China, 1990-2017: A joinpoint and age-period-cohort analysis","Liu X, Jiang J, Yu C, Wang Y, Sun Y, Tang J, Chen T, Bi Y, Liu Y, Zhang ZJ.","Cancer Epidemiol. 2019 Aug;61:95-103. doi: 10.1016/j.canep.2019.05.011. Epub 2019 Jun 6.","Liu X","Cancer Epidemiol","2019","2019/06/10","","","10.1016/j.canep.2019.05.011"
"2618906","[Clinical problems in patients who were exposed to carcinogens]","Kotake T.","Hinyokika Kiyo. 1989 Dec;35(12):2063-7.","Kotake T","Hinyokika Kiyo","1989","1989/12/01","","",""
"24964787","Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell lines","Rathore K, Cekanova M.","BMC Cancer. 2014 Jun 25;14:465. doi: 10.1186/1471-2407-14-465.","Rathore K","BMC Cancer","2014","2014/06/27","PMC4082678","","10.1186/1471-2407-14-465"
"17382800","Immunotherapeutic strategies for high-risk bladder cancer","Sharma P, Old LJ, Allison JP.","Semin Oncol. 2007 Apr;34(2):165-72. doi: 10.1053/j.seminoncol.2006.12.004.","Sharma P","Semin Oncol","2007","2007/03/27","PMC6009830","NIHMS950694","10.1053/j.seminoncol.2006.12.004"
"18877202","[The infiltrating vesicular mole circumscribed chorionitheliomatous]","DE GIORGI L.","Arch Ostet Ginecol. 1948 May-Jun;53(3):145-75.","DE GIORGI L","Arch Ostet Ginecol","1948","1948/05/01","","",""
"15036674","Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies","Sherif A, Holmberg L, Rintala E, Mestad O, Nilsson J, Nilsson S, Malmström PU; Nordic Urothelial Cancer Group.","Eur Urol. 2004 Mar;45(3):297-303. doi: 10.1016/j.eururo.2003.09.019.","Sherif A","Eur Urol","2004","2004/03/24","","","10.1016/j.eururo.2003.09.019"
"17397268","Effect of various natural products on growth of bladder cancer cells: two promising mushroom extracts","Konno S.","Altern Med Rev. 2007 Mar;12(1):63-8.","Konno S","Altern Med Rev","2007","2007/04/03","","",""
"1924851","Dose fractionation and tumour repopulation in radiotherapy for bladder cancer","Maciejewski B, Majewski S.","Radiother Oncol. 1991 Jul;21(3):163-70. doi: 10.1016/0167-8140(91)90033-d.","Maciejewski B","Radiother Oncol","1991","1991/07/01","","","10.1016/0167-8140(91)90033-d"
"3863577","Current status and controversies in the management of genito-urinary cancer","Raghavan D.","Aust N Z J Surg. 1985 Jun;55(3):243-8. doi: 10.1111/j.1445-2197.1985.tb00081.x.","Raghavan D","Aust N Z J Surg","1985","1985/06/01","","","10.1111/j.1445-2197.1985.tb00081.x"
"29650137","Lymphadenectomy for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma","Sathianathen NJ, Risk MC, Konety BR.","Urol Clin North Am. 2018 May;45(2):215-228. doi: 10.1016/j.ucl.2017.12.006. Epub 2018 Feb 21.","Sathianathen NJ","Urol Clin North Am","2018","2018/04/14","","","10.1016/j.ucl.2017.12.006"
"9524620","Radiotherapy alone or radiochemotherapy with platin derivatives following transurethral resection of the bladder. Organ preservation and survival after treatment of bladder cancer","Birkenhake S, Martus P, Kühn R, Schrott KM, Sauer R.","Strahlenther Onkol. 1998 Mar;174(3):121-7. doi: 10.1007/BF03038494.","Birkenhake S","Strahlenther Onkol","1998","1998/04/03","","","10.1007/BF03038494"
"2515812","[Mitomycin C in the topical treatment of superficial neoplasms of the bladder]","Milani C, Bassi PF, Meneghini A, Giunta A, Tejerizo JC, dal Bianco M, Zattoni F, Garbeglio A.","Arch Esp Urol. 1989 Oct;42(8):761-7.","Milani C","Arch Esp Urol","1989","1989/10/01","","",""
"27312316","Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy","Duivenvoorden WC, Daneshmand S, Canter D, Lotan Y, Black PC, Abdi H, van Rhijn BW, Fransen van de Putte EE, Zareba P, Koskinen I, Kassouf W, Traboulsi SL, Kukreja JE, Boström PJ, Shayegan B, Pinthus JH.","J Urol. 2016 Dec;196(6):1627-1633. doi: 10.1016/j.juro.2016.06.017. Epub 2016 Jun 14.","Duivenvoorden WC","J Urol","2016","2016/06/18","","","10.1016/j.juro.2016.06.017"
"8913728","Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb","Bell SM, Zuo J, Myers RM, Knowles MA.","Genes Chromosomes Cancer. 1996 Oct;17(2):108-17. doi: 10.1002/(SICI)1098-2264(199610)17:2<108::AID-GCC6>3.0.CO;2-9.","Bell SM","Genes Chromosomes Cancer","1996","1996/10/01","","","10.1002/(SICI)1098-2264(199610)17:2<108::AID-GCC6>3.0.CO;2-9"
"2304308","[Statistical evaluation of determinants of progression of superficial bladder cancer by proportional hazards model]","Takashi M, Sakata T, Murase T, Takagi Y, Nagai T, Sahashi M, Shimoji T, Miyake K, Hamajima N.","Nihon Hinyokika Gakkai Zasshi. 1990 Jan;81(1):116-21. doi: 10.5980/jpnjurol1989.81.116.","Takashi M","Nihon Hinyokika Gakkai Zasshi","1990","1990/01/01","","","10.5980/jpnjurol1989.81.116"
"12187204","Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study--FinnBladder III long-term results","Rajala P, Kaasinen E, Raitanen M, Liukkonen T, Rintala E; Finnbladder Group.","J Urol. 2002 Sep;168(3):981-5. doi: 10.1097/01.ju.0000026417.33622.7d.","Rajala P","J Urol","2002","2002/08/21","","","10.1097/01.ju.0000026417.33622.7d"
"12865920","Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer","Agerbaek M, Alsner J, Marcussen N, Lundbeck F, von der Maase H.","Br J Cancer. 2003 Jul 21;89(2):298-304. doi: 10.1038/sj.bjc.6601063.","Agerbaek M","Br J Cancer","2003","2003/07/17","PMC2394264","","10.1038/sj.bjc.6601063"
"27564274","Extraperitoneal versus transperitoneal laparoscopic radical cystectomy for selected elderly bladder cancer patients: a single center experience","Feng L, Song J, Wu M, Tian Y, Zhang D.","Int Braz J Urol. 2016 Jul-Aug;42(4):655-62. doi: 10.1590/S1677-5538.IBJU.2015.0608.","Feng L","Int Braz J Urol","2016","2016/08/27","PMC5006759","","10.1590/S1677-5538.IBJU.2015.0608"
"14597895","[Bladder tumors and molecular markers. Current status and perspectives]","Molinié V, Longchampt E, Ouazana D, Lebret T.","Ann Pathol. 2003 Sep;23(4):306-31.","Molinié V","Ann Pathol","2003","2003/11/05","","",""
"24276082","Bladder cancer: Progress in defining progression in NMIBC","Gierth M, Burger M.","Nat Rev Urol. 2013 Dec;10(12):684-5. doi: 10.1038/nrurol.2013.270. Epub 2013 Nov 26.","Gierth M","Nat Rev Urol","2013","2013/11/27","","","10.1038/nrurol.2013.270"
"28821822","Bladder Cancer Treatment Response Assessment in CT using Radiomics with Deep-Learning","Cha KH, Hadjiiski L, Chan HP, Weizer AZ, Alva A, Cohan RH, Caoili EM, Paramagul C, Samala RK.","Sci Rep. 2017 Aug 18;7(1):8738. doi: 10.1038/s41598-017-09315-w.","Cha KH","Sci Rep","2017","2017/08/20","PMC5562694","","10.1038/s41598-017-09315-w"
"26597614","Bladder cancer in 2015: Improving indication, technique and outcome of radical cystectomy","Witjes JA.","Nat Rev Urol. 2016 Feb;13(2):74-6. doi: 10.1038/nrurol.2015.272. Epub 2015 Nov 24.","Witjes JA","Nat Rev Urol","2016","2015/11/25","","","10.1038/nrurol.2015.272"
"9815851","Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer","Bochner BH, Esrig D, Groshen S, Dickinson M, Weidner N, Nichols PW, Skinner DG, Cote RJ.","Clin Cancer Res. 1997 Sep;3(9):1615-22.","Bochner BH","Clin Cancer Res","1997","1998/11/17","","",""
"29280915","Bladder cancer risk in users of selected drugs for cardiovascular disease prevention","Guercio V, Turati F, Bosetti C, Polesel J, Serraino D, Montella M, Libra M, Galfano A, La Vecchia C, Tavani A.","Eur J Cancer Prev. 2019 Mar;28(2):76-80. doi: 10.1097/CEJ.0000000000000419.","Guercio V","Eur J Cancer Prev","2019","2017/12/28","","","10.1097/CEJ.0000000000000419"
"926277","Bladder cancer and squamous metaplasia in spinal cord injury patients","Kaufman JM, Fam B, Jacobs SC, Gabilondo F, Yalla S, Kane JP, Rossier AB.","J Urol. 1977 Dec;118(6):967-71. doi: 10.1016/s0022-5347(17)58266-x.","Kaufman JM","J Urol","1977","1977/12/01","","","10.1016/s0022-5347(17)58266-x"
"18675502","Editorial comment on: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology","Hautmann RE.","Eur Urol. 2009 Jan;55(1):174. doi: 10.1016/j.eururo.2008.07.032. Epub 2008 Jul 18.","Hautmann RE","Eur Urol","2009","2008/08/05","","","10.1016/j.eururo.2008.07.032"
"31214962","The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer","Setti Boubaker N, Cicchillitti L, Said R, Gurtner A, Ayed H, Blel A, Karray O, Essid MA, Gharbi M, Bouzouita A, Rammeh Rommeni S, Chebil M, Piaggio G, Ouerhani S.","Mol Biol Rep. 2019 Oct;46(5):4743-4750. doi: 10.1007/s11033-019-04920-6. Epub 2019 Jun 18.","Setti Boubaker N","Mol Biol Rep","2019","2019/06/20","","","10.1007/s11033-019-04920-6"
"17018729","Muscle invasive and metastatic bladder cancer","Sternberg CN.","Ann Oncol. 2006 Sep;17 Suppl 10:x23-30. doi: 10.1093/annonc/mdl231.","Sternberg CN","Ann Oncol","2006","2006/10/05","","","10.1093/annonc/mdl231"
"9917507","Interphase cytogenetic diagnosis of bladder cancer on cells from urine and bladder washing","Junker K, Werner W, Mueller C, Ebert W, Schubert J, Claussen U.","Int J Oncol. 1999 Feb;14(2):309-13. doi: 10.3892/ijo.14.2.309.","Junker K","Int J Oncol","1999","1999/01/26","","","10.3892/ijo.14.2.309"
"28087131","Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy","Moschini M, Dell'Oglio P, Luciano' R, Gandaglia G, Soria F, Mattei A, Klatte T, Damiano R, Shariat SF, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A.","Urol Oncol. 2017 Jun;35(6):335-341. doi: 10.1016/j.urolonc.2016.12.006. Epub 2017 Jan 10.","Moschini M","Urol Oncol","2017","2017/01/15","","","10.1016/j.urolonc.2016.12.006"
"25595732","Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy","Gakis G, Ngamsri T, Rausch S, Mischinger J, Todenhöfer T, Schwentner C, Schmid MA, Hassan FA, Renninger M, Stenzl A.","World J Urol. 2015 Oct;33(10):1429-37. doi: 10.1007/s00345-015-1485-8. Epub 2015 Jan 17.","Gakis G","World J Urol","2015","2015/01/18","","","10.1007/s00345-015-1485-8"
"15549188","Current status of radiation therapy and combined-modality treatment for bladder cancer","Rödel C.","Strahlenther Onkol. 2004 Nov;180(11):701-9. doi: 10.1007/s00066-004-9195-y.","Rödel C","Strahlenther Onkol","2004","2004/11/19","","","10.1007/s00066-004-9195-y"
"10203279","Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort","Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci EL.","J Natl Cancer Inst. 1999 Apr 7;91(7):605-13. doi: 10.1093/jnci/91.7.605.","Michaud DS","J Natl Cancer Inst","1999","1999/04/15","","","10.1093/jnci/91.7.605"
"29395952","Recent developments in the treatment of advanced bladder cancer","Godwin JL, Hoffman-Censits J, Plimack E.","Urol Oncol. 2018 Mar;36(3):109-114. doi: 10.1016/j.urolonc.2017.12.018. Epub 2018 Feb 1.","Godwin JL","Urol Oncol","2018","2018/02/04","","","10.1016/j.urolonc.2017.12.018"
"29160225","Phosphatidylserine targeted single-walled carbon nanotubes for photothermal ablation of bladder cancer","Virani NA, Davis C, McKernan P, Hauser P, Hurst RE, Slaton J, Silvy RP, Resasco DE, Harrison RG.","Nanotechnology. 2018 Jan 19;29(3):035101. doi: 10.1088/1361-6528/aa9c0c.","Virani NA","Nanotechnology","2018","2017/11/22","","","10.1088/1361-6528/aa9c0c"
"11061940","Plasma glutathione S-transferase pi 1-1 AND alpha 1-1 levels in patients with bladder cancer","Berendsen CL, Mulder TP, Peters WH.","J Urol. 2000 Dec;164(6):2126-8.","Berendsen CL","J Urol","2000","2000/11/04","","",""
"18569594","N-acetyltransferase-2 and medical history in bladder cancer cases with a suspected occupational disease (BK 1301) in Germany","Weistenhofer W, Blaszkewicz M, Bolt HM, Golka K.","J Toxicol Environ Health A. 2008;71(13-14):906-10. doi: 10.1080/15287390801988681.","Weistenhofer W","J Toxicol Environ Health A","2008","2008/06/24","","","10.1080/15287390801988681"
"24373801","The prevalence of persistent prostate cancer after radiotherapy detected at radical cystoprostatectomy for bladder cancer","Meeks JJ, Kern SQ, Dalbagni G, Eastham JA, Sandhu JS.","J Urol. 2014 Jun;191(6):1760-3. doi: 10.1016/j.juro.2013.12.037. Epub 2013 Dec 25.","Meeks JJ","J Urol","2014","2013/12/31","","","10.1016/j.juro.2013.12.037"
"1770697","[Intra-arterial cisplatin and concurrent radiation for invasive bladder cancer]","Miyanaga N, Ohtani M, Noguchi R, Uchida K, Akaza H, Koiso K, Tatsuzaki H, Ohara K, Tsuji H, Inada T, et al.","Nihon Hinyokika Gakkai Zasshi. 1991 Oct;82(10):1583-7. doi: 10.5980/jpnjurol1989.82.1583.","Miyanaga N","Nihon Hinyokika Gakkai Zasshi","1991","1991/10/01","","","10.5980/jpnjurol1989.82.1583"
"12917510","New diagnostic strategies in the detection and staging of bladder cancer","Jichlinski P.","Curr Opin Urol. 2003 Sep;13(5):351-5. doi: 10.1097/00042307-200309000-00001.","Jichlinski P","Curr Opin Urol","2003","2003/08/15","","","10.1097/00042307-200309000-00001"
"20017108","Small cell carcinoma of the urinary bladder","Pant-Purohit M, Lopez-Beltran A, Montironi R, MacLennan GT, Cheng L.","Histol Histopathol. 2010 Feb;25(2):217-21. doi: 10.14670/HH-25.217.","Pant-Purohit M","Histol Histopathol","2010","2009/12/18","","","10.14670/HH-25.217"
"31009297","Association between Inflammatory Potential of Diet and Bladder Cancer Risk: Results of 3 United States Prospective Cohort Studies","Abufaraj M, Tabung FK, Shariat SF, Moschini M, Devore E, Papantoniou K, Yang L, Strohmaier S, Rohrer F, Markt SC, Zhang X, Giovannucci E, Schernhammer E.","J Urol. 2019 Sep;202(3):484-489. doi: 10.1097/JU.0000000000000279. Epub 2019 Aug 8.","Abufaraj M","J Urol","2019","2019/04/23","","","10.1097/JU.0000000000000279"
"1924440","Organ conservation in deeply invasive bladder cancer","Fair WR.","Prog Clin Biol Res. 1991;370:119-26.","Fair WR","Prog Clin Biol Res","1991","1991/01/01","","",""
"3656526","Influence of blood group type on the natural history of superficial bladder cancer","Orihuela E, Shahon RS.","J Urol. 1987 Oct;138(4):758-9. doi: 10.1016/s0022-5347(17)43363-5.","Orihuela E","J Urol","1987","1987/10/01","","","10.1016/s0022-5347(17)43363-5"
"26700670","MicroRNA-148a represents an independent prognostic marker in bladder cancer","Ma L, Xu Z, Xu C, Jiang X.","Tumour Biol. 2016 Jun;37(6):7915-20. doi: 10.1007/s13277-015-4688-0. Epub 2015 Dec 23.","Ma L","Tumour Biol","2016","2015/12/25","","","10.1007/s13277-015-4688-0"
"30883984","CARLo-7-A plausible biomarker for bladder cancer","Amir H, Khan MA, Feroz S, Bibi N, Nawaz M, Mehmood A, Yousuf A, Khawaja MA, Khadim MT, Tariq A.","Int J Exp Pathol. 2019 Feb;100(1):25-31. doi: 10.1111/iep.12305. Epub 2019 Mar 18.","Amir H","Int J Exp Pathol","2019","2019/03/19","PMC6463395","","10.1111/iep.12305"
"8719152","Problems in assessing screening experience in observational studies of screening efficacy: example of urinalysis screening for bladder cancer","Friedman GD, Hiatt RA, Quesenberry CP Jr, Selby JV, Weiss NS.","J Med Screen. 1995;2(4):219-23. doi: 10.1177/096914139500200409.","Friedman GD","J Med Screen","1995","1995/01/01","","","10.1177/096914139500200409"
"22532166","Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer","Ho PL, Lay EJ, Jian W, Parra D, Chan KS.","Cancer Res. 2012 Jul 1;72(13):3135-42. doi: 10.1158/0008-5472.CAN-11-3195. Epub 2012 Apr 24.","Ho PL","Cancer Res","2012","2012/04/26","PMC3418917","NIHMS375279","10.1158/0008-5472.CAN-11-3195"
"9863934","Bladder cancer risk in patients with spinal cord injury","Vereczkey ZA, Schmeidler J, Binard JE, Bauman WA.","J Spinal Cord Med. 1998 Jul;21(3):230-9. doi: 10.1080/10790268.1998.11719532.","Vereczkey ZA","J Spinal Cord Med","1998","1998/12/24","","","10.1080/10790268.1998.11719532"
"25653521","Clinical and pathological implications of miRNA in bladder cancer","Braicu C, Cojocneanu-Petric R, Chira S, Truta A, Floares A, Petrut B, Achimas-Cadariu P, Berindan-Neagoe I.","Int J Nanomedicine. 2015 Jan 20;10:791-800. doi: 10.2147/IJN.S72904. eCollection 2015.","Braicu C","Int J Nanomedicine","2015","2015/02/06","PMC4309789","","10.2147/IJN.S72904"
"24858164","Clinicopathologic features and treatment outcome of urinary bladder neoplasm","Hooda MN, Siddique FH, Nabi S, Islam MW, Ara K, Bhuiyan ZI.","Mymensingh Med J. 2014 Apr;23(2):341-4.","Hooda MN","Mymensingh Med J","2014","2014/05/27","","",""
"23444116","Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era","Takaoka E, Matsui Y, Inoue T, Miyazaki J, Nakashima M, Kimura T, Oikawa T, Kawai K, Yoshimura K, Habuchi T, Ogawa O, Nishiyama H.","Jpn J Clin Oncol. 2013 Apr;43(4):404-9. doi: 10.1093/jjco/hyt016. Epub 2013 Feb 26.","Takaoka E","Jpn J Clin Oncol","2013","2013/02/28","","","10.1093/jjco/hyt016"
"6162049","[Light and electron microscopic changes in bladder tumor cells after intravesical instillation and hyperthermic vesical irrigation of bleomycin (author's transl)]","Moriyama N, Ito K.","Nihon Hinyokika Gakkai Zasshi. 1980 Nov;71(11):1371-83. doi: 10.5980/jpnjurol1928.71.11_1371.","Moriyama N","Nihon Hinyokika Gakkai Zasshi","1980","1980/11/01","","","10.5980/jpnjurol1928.71.11_1371"
"11584067","Re: Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine","Nersesyan AK.","J Natl Cancer Inst. 2001 Oct 3;93(19):1492-3. doi: 10.1093/jnci/93.19.1492.","Nersesyan AK","J Natl Cancer Inst","2001","2001/10/05","","","10.1093/jnci/93.19.1492"
"30499053","Short rare minisatellite variant of BORIS-MS2 is related to bladder cancer susceptibility","Kim TN, Kim WT, Jeong MS, Mun MH, Kim MH, Lee JZ, Leem SH.","Genes Genomics. 2019 Feb;41(2):249-256. doi: 10.1007/s13258-018-0771-4. Epub 2018 Nov 29.","Kim TN","Genes Genomics","2019","2018/12/01","","","10.1007/s13258-018-0771-4"
"20493444","[Management of non invasive bladder cancers. T1Ga urothelial cell carcinoma: benefit of immediate post operative instillation?]","Rouprêt M, Guillotreau J, Irani J, Zerbib M.","Prog Urol. 2010 Mar;20 Suppl 1:S46-9. doi: 10.1016/S1166-7087(10)70026-9.","Rouprêt M","Prog Urol","2010","2010/05/25","","","10.1016/S1166-7087(10)70026-9"
"31760524","The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial","Eroglu A, Ekin RG, Koc G, Divrik RT.","Int J Clin Oncol. 2020 Apr;25(4):698-704. doi: 10.1007/s10147-019-01581-0. Epub 2019 Nov 23.","Eroglu A","Int J Clin Oncol","2020","2019/11/25","","","10.1007/s10147-019-01581-0"
"24477880","[Follow-up care - consequences of urinary diversion after bladder cancer]","Degener S, Roth S, Mathers MJ, Ubrig B.","Urologe A. 2014 Feb;53(2):253-62; quiz 263-4. doi: 10.1007/s00120-013-3376-1.","Degener S","Urologe A","2014","2014/01/31","","","10.1007/s00120-013-3376-1"
"661044","[The recurrence after conservative therapy of bladder cancer (author's transl)]","Saito K, Kubota Y, Takai S.","Nihon Hinyokika Gakkai Zasshi. 1978 Mar;69(3):373-80. doi: 10.5980/jpnjurol1928.69.3_373.","Saito K","Nihon Hinyokika Gakkai Zasshi","1978","1978/03/01","","","10.5980/jpnjurol1928.69.3_373"
"28132875","The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer","Abbaoui B, Telu KH, Lucas CR, Thomas-Ahner JM, Schwartz SJ, Clinton SK, Freitas MA, Mortazavi A.","J Proteomics. 2017 Mar 6;156:94-103. doi: 10.1016/j.jprot.2017.01.013. Epub 2017 Jan 27.","Abbaoui B","J Proteomics","2017","2017/01/31","PMC5324139","NIHMS850704","10.1016/j.jprot.2017.01.013"
"21670750","Bladder cancer: are provider volumes a suitable measure of quality of care?","Casey RG, So AI.","Nat Rev Urol. 2011 Jun 14;8(7):361-3. doi: 10.1038/nrurol.2011.86.","Casey RG","Nat Rev Urol","2011","2011/06/15","","","10.1038/nrurol.2011.86"
"5065565","[Studies on circulating tumor cells in patients with bladder cancer]","Katsumi T.","Nihon Hinyokika Gakkai Zasshi. 1972 Mar;63(3):215-28. doi: 10.5980/jpnjurol1928.63.3_215.","Katsumi T","Nihon Hinyokika Gakkai Zasshi","1972","1972/03/01","","","10.5980/jpnjurol1928.63.3_215"
"24920641","External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort","Chen LM, Chang M, Dai Y, Chai KX, Dyrskjøt L, Sanchez-Carbayo M, Szarvas T, Zwarthoff EC, Lokeshwar V, Jeronimo C, Parker AS, Ross S, Borre M, Orntoft TF, Jaeger T, Beukers W, Lopez LE, Henrique R, Young PR, Urquidi V, Goodison S, Rosser CJ.","Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1804-12. doi: 10.1158/1055-9965.EPI-14-0029. Epub 2014 Jun 11.","Chen LM","Cancer Epidemiol Biomarkers Prev","2014","2014/06/13","PMC4154967","NIHMS603810","10.1158/1055-9965.EPI-14-0029"
"16600721","Cancer specific outcomes in patients with pT0 disease following radical cystectomy","Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Lotan Y, Vazina A, Gupta A, Sagalowsky AI, Lerner SP, Schoenberg MP; Bladder Cancer Research Consortium.","J Urol. 2006 May;175(5):1645-9; discussion 1649. doi: 10.1016/S0022-5347(05)00995-X.","Palapattu GS","J Urol","2006","2006/04/08","","","10.1016/S0022-5347(05)00995-X"
"2453903","Combined treatment of advanced bladder carcinoma","Bichler KH, Flüchter SH, Erdmann WD, Strohmaier WL, Steimann J.","Recent Results Cancer Res. 1988;107:222-5. doi: 10.1007/978-3-642-83260-4_33.","Bichler KH","Recent Results Cancer Res","1988","1988/01/01","","","10.1007/978-3-642-83260-4_33"
"8494779","A potential cause of bladder cancer","King WJ.","Br J Ind Med. 1993 Apr;50(4):380-1. doi: 10.1136/oem.50.4.380.","King WJ","Br J Ind Med","1993","1993/04/01","PMC1061297","","10.1136/oem.50.4.380"
"7074499","Aluminum reduction and bladder cancer","Dunkley GC.","Can Med Assoc J. 1982 May 1;126(9):1026.","Dunkley GC","Can Med Assoc J","1982","1982/05/01","PMC1863266","",""
"14224198","[RADIOLOGICAL TREATMENT OF BLADDER CANCER]","VAN DER WERF MESSINGB.","Ned Tijdschr Geneeskd. 1964 Sep 26;108:1852-6.","VAN DER WERF MESSINGB","Ned Tijdschr Geneeskd","1964","1964/09/26","","",""
"25566965","Regulation of growth of human bladder cancer by miR-192","Jin Y, Lu J, Wen J, Shen Y, Wen X.","Tumour Biol. 2015 May;36(5):3791-7. doi: 10.1007/s13277-014-3020-8. Epub 2015 Jan 9.","Jin Y","Tumour Biol","2015","2015/01/09","","","10.1007/s13277-014-3020-8"
"18533230","Decreased bladder cancer growth in parous mice","Johnson AM, O'Connell MJ, Messing EM, Reeder JE.","Urology. 2008 Sep;72(3):470-3. doi: 10.1016/j.urology.2008.04.028. Epub 2008 Jun 4.","Johnson AM","Urology","2008","2008/06/06","","","10.1016/j.urology.2008.04.028"
"11435814","Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy","Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE.","J Urol. 2001 Jul;166(1):19-23.","Mills RD","J Urol","2001","2001/07/04","","",""
"12361899","After cystectomy, is it justified to perform a bladder replacement for patients with lymph node positive bladder cancer?","Lebret T, Herve JM, Yonneau L, Molinie V, Barre P, Lugagne PM, Butreau M, Mignot L, Botto H.","Eur Urol. 2002 Oct;42(4):344-9; discussion 349. doi: 10.1016/s0302-2838(02)00320-2.","Lebret T","Eur Urol","2002","2002/10/04","","","10.1016/s0302-2838(02)00320-2"
"6642755","Artificial sweeteners and absence of bladder cancer risk in Copenhagen","Møller-Jensen O, Knudsen JB, Sørensen BL, Clemmesen J.","Int J Cancer. 1983 Nov 15;32(5):577-82. doi: 10.1002/ijc.2910320510.","Møller-Jensen O","Int J Cancer","1983","1983/11/15","","","10.1002/ijc.2910320510"
"17113703","Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy","Nielsen ME, Shariat SF, Karakiewicz PI, Lotan Y, Rogers CG, Amiel GE, Bastian PJ, Vazina A, Gupta A, Lerner SP, Sagalowsky AI, Schoenberg MP, Palapattu GS; Bladder Cancer Research Consortium (BCRC).","Eur Urol. 2007 Mar;51(3):699-706; discussion 706-8. doi: 10.1016/j.eururo.2006.11.004. Epub 2006 Nov 13.","Nielsen ME","Eur Urol","2007","2006/11/23","","","10.1016/j.eururo.2006.11.004"
"3335421","Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation","Russell PJ, Jelbart M, Wills E, Singh S, Wass J, Wotherspoon J, Raghavan D.","Int J Cancer. 1988 Jan 15;41(1):74-82. doi: 10.1002/ijc.2910410115.","Russell PJ","Int J Cancer","1988","1988/01/15","","","10.1002/ijc.2910410115"
"5577210","Blood vessel invasion in human bladder cancer","Bell JT, Burney SW, Friedell GH.","J Urol. 1971 May;105(5):675-8. doi: 10.1016/s0022-5347(17)61605-7.","Bell JT","J Urol","1971","1971/05/01","","","10.1016/s0022-5347(17)61605-7"
"28393623","Clinical Comparison of Conventional and Mobile Endockscope Videocystoscopy Using an Air or Fluid Medium","Dutta R, Yoon R, Patel RM, Spradling K, Okhunov Z, Sohn W, Lee HJ, Landman J, Clayman RV.","J Endourol. 2017 Jun;31(6):593-597. doi: 10.1089/end.2017.0088. Epub 2017 May 8.","Dutta R","J Endourol","2017","2017/04/11","","","10.1089/end.2017.0088"
"30513851","UBC(®) Rapid Test-A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-Study","Ecke TH, Weiß S, Stephan C, Hallmann S, Arndt C, Barski D, Otto T, Gerullis H.","Int J Mol Sci. 2018 Dec 2;19(12):3841. doi: 10.3390/ijms19123841.","Ecke TH","Int J Mol Sci","2018","2018/12/06","PMC6321532","","10.3390/ijms19123841"
"7954321","Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer","Matsuyama H, Bergerheim US, Nilsson I, Pan Y, Skoog L, Tribukait B, Ekman P.","Cancer Genet Cytogenet. 1994 Oct 15;77(2):118-24. doi: 10.1016/0165-4608(94)90226-7.","Matsuyama H","Cancer Genet Cytogenet","1994","1994/10/15","","","10.1016/0165-4608(94)90226-7"
"25199720","Next-generation RNA sequencing of archival formalin-fixed paraffin-embedded urothelial bladder cancer","Liu Y, Noon AP, Aguiar Cabeza E, Shen J, Kuk C, Ilczynski C, Ni R, Sukhu B, Chan K, Barbosa-Morais NL, Hermanns T, Blencowe BJ, Azad A, van der Kwast TH, Catto JW, Zlotta AR, Wrana JL.","Eur Urol. 2014 Dec;66(6):982-6. doi: 10.1016/j.eururo.2014.07.045. Epub 2014 Sep 6.","Liu Y","Eur Urol","2014","2014/09/10","","","10.1016/j.eururo.2014.07.045"
"18067216","Urachal mucinous adenocarcinoma: a case report","Kountourakis P, Ardavanis A, Mantzaris I, Mitsaka D, Rigatos G.","J BUON. 2007 Oct-Dec;12(4):547-8.","Kountourakis P","J BUON","2007","2007/12/11","","",""
"27911277","GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis","Yu C, Hequn C, Longfei L, Long W, Zhi C, Feng Z, Jinbo C, Chao L, Xiongbing Z.","Oncotarget. 2017 Jan 10;8(2):3246-3258. doi: 10.18632/oncotarget.13702.","Yu C","Oncotarget","2017","2016/12/03","PMC5356879","","10.18632/oncotarget.13702"
"22150596","Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies","Hermann GG, Mogensen K, Toft BG, Glenthøj A, Pedersen HM.","Scand J Urol Nephrol. 2012 Feb;46(1):31-6. doi: 10.3109/00365599.2011.637954. Epub 2011 Dec 12.","Hermann GG","Scand J Urol Nephrol","2012","2011/12/14","","","10.3109/00365599.2011.637954"
"31486418","Thyroid Receptor-Interacting Protein 13 is Correlated with Progression and Poor Prognosis in Bladder Cancer","Niu L, Gao Z, Cui Y, Yang X, Li H.","Med Sci Monit. 2019 Sep 5;25:6660-6668. doi: 10.12659/MSM.917112.","Niu L","Med Sci Monit","2019","2019/09/06","PMC6752094","","10.12659/MSM.917112"
"5796390","Induction of intestinal and urinary bladder cancer in rats by feeding bracken fern (Pteris aquilina)","Pamukcu AM, Price JM.","J Natl Cancer Inst. 1969 Jul;43(1):275-81.","Pamukcu AM","J Natl Cancer Inst","1969","1969/07/01","","",""
"25981333","The Estrogen Pathway: Estrogen Receptor-α, Progesterone Receptor, and Estrogen Receptor-β Expression in Radical Cystectomy Urothelial Cell Carcinoma Specimens","Tan W, Boorjian S, Advani P, Farmer S, Lohse C, Cheville J, Kwon E, Leibovich B.","Clin Genitourin Cancer. 2015 Oct;13(5):476-84. doi: 10.1016/j.clgc.2015.04.001. Epub 2015 Apr 15.","Tan W","Clin Genitourin Cancer","2015","2015/05/19","","","10.1016/j.clgc.2015.04.001"
"29670331","Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis","Lyu L, Huang LQ, Huang T, Xiang W, Yuan JD, Zhang CH.","Drug Des Devel Ther. 2018 Apr 5;12:743-756. doi: 10.2147/DDDT.S161821. eCollection 2018.","Lyu L","Drug Des Devel Ther","2018","2018/04/20","PMC5896666","","10.2147/DDDT.S161821"
"28845943","[Laparoscopic cystoprostatvesiculeectomy with orthotopic excentric ileal bladder substitution]","Glybochko PV, Alyaev YG, Shpot' EV, Pshi-Khachev AM, Mosyakova KM, Nikolaeva AS.","Urologiia. 2017 Jul;(3):78-83. doi: 10.18565/urol.2017.3.78-83.","Glybochko PV","Urologiia","2017","2017/08/29","","","10.18565/urol.2017.3.78-83"
"26382220","Potential Effect of Antiplatelet and Anticoagulant Therapy on the Timing of the Diagnosis of Bladder Cancer","Moschini M, Karnes RJ, Suardi N, Bianchi M, Pellucchi F, Rocchini L, Damiano R, Serretta V, Salonia A, Montorsi F, Briganti A, Colombo R.","Clin Genitourin Cancer. 2016 Jun;14(3):e245-50. doi: 10.1016/j.clgc.2015.08.003. Epub 2015 Aug 18.","Moschini M","Clin Genitourin Cancer","2016","2015/09/19","","","10.1016/j.clgc.2015.08.003"
"9675922","[Local recurrence after radical cystectomy for cancer of the bladder]","Herranz Amo F, Verdú Tartajo F, Díez Cordero JM, Bueno Chomón G, Leal Hernández F, Bielsa Carrillo A.","Actas Urol Esp. 1998 May;22(5):417-22.","Herranz Amo F","Actas Urol Esp","1998","1998/07/24","","",""
"23357883","Use of urostomy bags in the management of perioperative urine leakage after radical cystectomy","Li X, Fang Q, Ji H, Pan J, Zhang J, Li Z, Chen M, Wu X, Zhou Z, Chen Z.","Cancer Nurs. 2014 May-Jun;37(3):170-4. doi: 10.1097/NCC.0b013e318277db29.","Li X","Cancer Nurs","2014","2013/01/30","","","10.1097/NCC.0b013e318277db29"
"22200788","p53 codon 72 polymorphism as a progression index for bladder cancer","Lin HY, Huang CH, Yu TJ, Wu WJ, Yang MC, Lung FW.","Oncol Rep. 2012 Apr;27(4):1193-9. doi: 10.3892/or.2011.1610. Epub 2011 Dec 22.","Lin HY","Oncol Rep","2012","2011/12/28","PMC3583606","","10.3892/or.2011.1610"
"10447660","Case-referent study on occupational risk factors for bladder cancer in southern Israel","Carel R, Levitas-Langman A, Kordysh E, Goldsmith J, Friger M.","Int Arch Occup Environ Health. 1999 Aug;72(5):304-8. doi: 10.1007/s004200050379.","Carel R","Int Arch Occup Environ Health","1999","1999/08/14","","","10.1007/s004200050379"
"31327166","Editorial Comment from Dr Kobayashi to Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cystectomy","Kobayashi T.","Int J Urol. 2019 Oct;26(10):1013. doi: 10.1111/iju.14075. Epub 2019 Jul 21.","Kobayashi T","Int J Urol","2019","2019/07/22","","","10.1111/iju.14075"
"14676805","Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity","Moneef MA, Sherwood BT, Bowman KJ, Kockelbergh RC, Symonds RP, Steward WP, Mellon JK, Jones GD.","Br J Cancer. 2003 Dec 15;89(12):2271-6. doi: 10.1038/sj.bjc.6601333.","Moneef MA","Br J Cancer","2003","2003/12/17","PMC2395287","","10.1038/sj.bjc.6601333"
"23831192","Role of oxidative stress in cytotoxicity of grape seed extract in human bladder cancer cells","Raina K, Tyagi A, Kumar D, Agarwal R, Agarwal C.","Food Chem Toxicol. 2013 Nov;61:187-95. doi: 10.1016/j.fct.2013.06.039. Epub 2013 Jul 3.","Raina K","Food Chem Toxicol","2013","2013/07/09","PMC3851932","NIHMS502367","10.1016/j.fct.2013.06.039"
"10569545","Comparative sensitivity of urinary CYFRA 21-1, urinary bladder cancer antigen, tissue polypeptide antigen, tissue polypeptide antigen and NMP22 to detect bladder cancer","Sánchez-Carbayo M, Herrero E, Megías J, Mira A, Soria F.","J Urol. 1999 Dec;162(6):1951-6. doi: 10.1016/s0022-5347(05)68076-7.","Sánchez-Carbayo M","J Urol","1999","1999/11/24","","","10.1016/s0022-5347(05)68076-7"
"7853580","Management of transitional cell carcinoma involving von Brunn's nests","Dinney CP, Ramirez EI, Swanson DA, Ro JY, Babaian RJ, von Eschenbach AC.","J Urol. 1995 Mar;153(3 Pt 2):944-9.","Dinney CP","J Urol","1995","1995/03/01","","",""
"30942440","Tumor‑suppressive microRNA‑223 targets WDR62 directly in bladder cancer","Sugita S, Yoshino H, Yonemori M, Miyamoto K, Matsushita R, Sakaguchi T, Itesako T, Tatarano S, Nakagawa M, Enokida H.","Int J Oncol. 2019 Jun;54(6):2222-2236. doi: 10.3892/ijo.2019.4762. Epub 2019 Mar 22.","Sugita S","Int J Oncol","2019","2019/04/04","","","10.3892/ijo.2019.4762"
"2195581","[Prostatic and bladder cancer--possibilities and limitations of diagnostic imaging]","Stobbe G, Sandring KH.","Radiol Diagn (Berl). 1990;31(3):199-204.","Stobbe G","Radiol Diagn (Berl)","1990","1990/01/01","","",""
"11842742","Invasive bladder cancer: organ preservation by radiochemotherapy","Rödel C, Grabenbauer GG, Kühn R, Dunst J, Papadopoulos T, Schrott KM, Sauer R.","Front Radiat Ther Oncol. 2002;36:118-30. doi: 10.1159/000061334.","Rödel C","Front Radiat Ther Oncol","2002","2002/02/15","","","10.1159/000061334"
"10738206","World Health Organization and International Society of Urological Pathology classification and two-number grading system of bladder tumors: reply","Cheng L, Bostwick DG.","Cancer. 2000 Apr 1;88(7):1513-6. doi: 10.1002/(sici)1097-0142(20000401)88:7<1513::aid-cncr2>3.0.co;2-g.","Cheng L","Cancer","2000","2000/03/30","","","10.1002/(sici)1097-0142(20000401)88:7<1513::aid-cncr2>3.0.co;2-g"
"3809592","The growth and histological characteristics of a series of human bladder cancer xenografts","Hay JH, Busuttil A, Steel CM, Duncan W.","Radiother Oncol. 1986 Dec;7(4):331-40. doi: 10.1016/s0167-8140(86)80063-9.","Hay JH","Radiother Oncol","1986","1986/12/01","","","10.1016/s0167-8140(86)80063-9"
"11005450","Management of superficial bladder cancer: what is new?","Malmström PU.","Curr Opin Urol. 2000 Sep;10(5):447-51. doi: 10.1097/00042307-200009000-00014.","Malmström PU","Curr Opin Urol","2000","2000/09/27","","","10.1097/00042307-200009000-00014"
"22976798","Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR","Dyrskjøt L, Reinert T, Novoradovsky A, Zuiverloon TC, Beukers W, Zwarthoff E, Malats N, Real FX, Segersten U, Malmström PU, Knowles M, Hurst C, Sorge J, Borre M, Orntoft TF.","Br J Cancer. 2012 Oct 9;107(8):1392-8. doi: 10.1038/bjc.2012.412. Epub 2012 Sep 13.","Dyrskjøt L","Br J Cancer","2012","2012/09/15","PMC3494423","","10.1038/bjc.2012.412"
"26462026","Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies","Cai Q, Wu Y, Guo Z, Gong R, Tang Y, Yang K, Li X, Guo X, Niu Y, Zhao Y.","Oncotarget. 2015 Nov 10;6(35):37500-10. doi: 10.18632/oncotarget.6061.","Cai Q","Oncotarget","2015","2015/10/14","PMC4741944","","10.18632/oncotarget.6061"
"30514109","Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy: a qualitative interview study","Rammant E, Fonteyne V, Decaestecker K, Bultijnck R, Deforche B, Pieters R, Ost P, Verhaeghe S, Van Hecke A.","Clin Rehabil. 2019 Apr;33(4):750-761. doi: 10.1177/0269215518815531. Epub 2018 Dec 4.","Rammant E","Clin Rehabil","2019","2018/12/06","","","10.1177/0269215518815531"
"30320898","Starvation-induced autophagy promotes the invasion and migration of human bladder cancer cells via TGF-β1/Smad3-mediated epithelial-mesenchymal transition activation","Tong H, Yin H, Hossain MA, Wang Y, Wu F, Dong X, Gao S, Zhan K, He W.","J Cell Biochem. 2019 Apr;120(4):5118-5127. doi: 10.1002/jcb.27788. Epub 2018 Oct 15.","Tong H","J Cell Biochem","2019","2018/10/16","","","10.1002/jcb.27788"
"3242363","[Experimental model of urinary bladder tumor in rats for evaluation of chemotherapeutic agents]","Hirao Y, Momose H, Samma S, Ozono S, Babaya K, Okajima E.","Hinyokika Kiyo. 1988 Nov;34(11):1885-93.","Hirao Y","Hinyokika Kiyo","1988","1988/11/01","","",""
"21468549","Claudin-11 decreases the invasiveness of bladder cancer cells","Awsare NS, Martin TA, Haynes MD, Matthews PN, Jiang WG.","Oncol Rep. 2011 Jun;25(6):1503-9. doi: 10.3892/or.2011.1244. Epub 2011 Apr 4.","Awsare NS","Oncol Rep","2011","2011/04/07","","","10.3892/or.2011.1244"
"21851540","Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer","Boström PJ, Alkhateeb S, Trottier G, Athanasopoulos PZ, Mirtti T, Kortekangas H, Laato M, van Rhijn B, van der Kwast T, Fleshner NE, Jewett MA, Finelli A, Zlotta AR.","BJU Int. 2012 Jan;109(1):70-6. doi: 10.1111/j.1464-410X.2011.10371.x. Epub 2011 Aug 18.","Boström PJ","BJU Int","2012","2011/08/20","","","10.1111/j.1464-410X.2011.10371.x"
"7515769","Direct and indirect effects of recombinant human granulocyte-colony stimulating factor on in vitro colony formation of human bladder cancer cells","Shameem IA, Kurisu H, Matsuyama H, Shimabukuro T, Naito K.","Cancer Immunol Immunother. 1994 Jun;38(6):353-7. doi: 10.1007/BF01517203.","Shameem IA","Cancer Immunol Immunother","1994","1994/06/01","","","10.1007/BF01517203"
"3756832","Risk factors for bladder cancer in a cohort exposed to aromatic amines","Schulte PA, Ringen K, Hemstreet GP, Altekruse EB, Gullen WH, Tillett S, Allsbrook WC Jr, Crosby JH, Witherington R, Stringer W, et al.","Cancer. 1986 Nov 1;58(9):2156-62. doi: 10.1002/1097-0142(19861101)58:9<2156::aid-cncr2820580933>3.0.co;2-y.","Schulte PA","Cancer","1986","1986/11/01","","","10.1002/1097-0142(19861101)58:9<2156::aid-cncr2820580933>3.0.co;2-y"
"17382147","Robot-assisted radical cystectomy and pelvic lymph node dissection: initial experience at Roswell Park Cancer Institute","Guru KA, Kim HL, Piacente PM, Mohler JL.","Urology. 2007 Mar;69(3):469-74. doi: 10.1016/j.urology.2006.10.037.","Guru KA","Urology","2007","2007/03/27","","","10.1016/j.urology.2006.10.037"
"2793235","Risk of bladder cancer by source and type of tobacco exposure: a case-control study","Burch JD, Rohan TE, Howe GR, Risch HA, Hill GB, Steele R, Miller AB.","Int J Cancer. 1989 Oct 15;44(4):622-8. doi: 10.1002/ijc.2910440411.","Burch JD","Int J Cancer","1989","1989/10/15","","","10.1002/ijc.2910440411"
"23751826","Utility of 67Ga scintigraphy in disseminated infection after BCG instillation for treatment of bladder carcinoma","Dominguez ML, Ortiz A, Rayo JI, Serrano J, Infante JR, Garcia L, Duran C.","Clin Nucl Med. 2013 Aug;38(8):658-60. doi: 10.1097/RLU.0b013e3182952c8b.","Dominguez ML","Clin Nucl Med","2013","2013/06/12","","","10.1097/RLU.0b013e3182952c8b"
"8898610","Postmenopausal cystitis. Bladder cancer may be a cause, but interstitial cystitis is an unusual differential diagnosis","Turner W, Eardley I, Joyce AD, Harnden P.","BMJ. 1996 Oct 26;313(7064):1079. doi: 10.1136/bmj.313.7064.1079a.","Turner W","BMJ","1996","1996/10/26","PMC2352407","","10.1136/bmj.313.7064.1079a"
"7853585","Bladder cancer: the power of study design, interpretation of data and clinical application","Droller MJ.","J Urol. 1995 Mar;153(3 Pt 2):974-5. doi: 10.1016/s0022-5347(01)67615-8.","Droller MJ","J Urol","1995","1995/03/01","","","10.1016/s0022-5347(01)67615-8"
"22915241","Retrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapy","D'Souza AM, Pohar KS, Arif T, Geyer S, Zynger DL.","Virchows Arch. 2012 Oct;461(4):467-74. doi: 10.1007/s00428-012-1249-4. Epub 2012 Aug 23.","D'Souza AM","Virchows Arch","2012","2012/08/24","","","10.1007/s00428-012-1249-4"
"7279428","Bladder cancer after spinal cord injury","El-Masri WS, Fellows G.","Paraplegia. 1981;19(5):265-70. doi: 10.1038/sc.1981.52.","El-Masri WS","Paraplegia","1981","1981/01/01","","","10.1038/sc.1981.52"
"18454792","Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study","Walz J, Shariat SF, Suardi N, Perrotte P, Lotan Y, Palapattu GS, Gupta A, Bastian PJ, Rogers CG, Vazina A, Amiel GE, Sagalowsky AI, Schoenberg M, Lerner SP, Karakiewicz PI.","BJU Int. 2008 Jun;101(11):1356-61. doi: 10.1111/j.1464-410X.2008.07524.x.","Walz J","BJU Int","2008","2008/05/06","","","10.1111/j.1464-410X.2008.07524.x"
"19414495","Quantitative exposure to metalworking fluids and bladder cancer incidence in a cohort of autoworkers","Friesen MC, Costello S, Eisen EA.","Am J Epidemiol. 2009 Jun 15;169(12):1471-8. doi: 10.1093/aje/kwp073. Epub 2009 May 4.","Friesen MC","Am J Epidemiol","2009","2009/05/06","","","10.1093/aje/kwp073"
"24127730","Investigation of poorer bladder cancer survival in women in NSW, Australia: a data linkage study","Tracey E, Watt H, Currow D, Young J, Armstrong B.","BJU Int. 2014 Mar;113(3):437-48. doi: 10.1111/bju.12496.","Tracey E","BJU Int","2014","2013/10/17","","","10.1111/bju.12496"
"26743671","Evolving concepts in muscle-invasive bladder cancer","Black PC, Kassouf W.","World J Urol. 2016 Jan;34(1):1-2. doi: 10.1007/s00345-015-1755-5.","Black PC","World J Urol","2016","2016/01/09","","","10.1007/s00345-015-1755-5"
"26780324","The Role of Surgery in Local Recurrences after Radical Cystectomy for Bladder Cancer","Vilaseca A, Huguet J, Pérez M, Camacho D, García-Cruz E, José Ribal M, Alcaraz A.","Urol Int. 2016;96(2):132-5. doi: 10.1159/000443336. Epub 2016 Jan 19.","Vilaseca A","Urol Int","2016","2016/01/19","","","10.1159/000443336"
"4800131","[Statistical studies on the causes of death of bladder cancer]","Terao E, Suzuki S, Shimaya M.","Nihon Hinyokika Gakkai Zasshi. 1973 Feb;64(2):105-12. doi: 10.5980/jpnjurol1928.64.2_105.","Terao E","Nihon Hinyokika Gakkai Zasshi","1973","1973/02/01","","","10.5980/jpnjurol1928.64.2_105"
"26972501","Words of Wisdom. Re: Radical Cystectomy vs. Chemoradiation in T2-4aN0M0 Bladder Cancer: A Case-control Study","Gray PJ, Efstathiou JA, Shipley WU.","Eur Urol. 2016 Apr;69(4):757-8. doi: 10.1016/j.eururo.2016.01.022. Epub 2016 Feb 18.","Gray PJ","Eur Urol","2016","2016/03/15","","","10.1016/j.eururo.2016.01.022"
"1293477","[Acetylation phenotype as a biomarker of sensitivity to the carcinogenic effect of aromatic amines]","Indulski JA, Krajewska B, Lutz W.","Med Pr. 1992;43(5):427-35.","Indulski JA","Med Pr","1992","1992/01/01","","",""
"19846987","The follow-up of patients with non-muscle-invasive bladder cancer by urine cytology, abdominal ultrasound and urine CYFRA 21-1: a pilot study","Nisman B, Yutkin V, Peretz T, Shapiro A, Barak V, Pode D.","Anticancer Res. 2009 Oct;29(10):4281-5.","Nisman B","Anticancer Res","2009","2009/10/23","","",""
"12705991","Long-term surveillance of bladder tumours: current practice in the United Kingdom and Ireland","Wazait HD, Al-Bhueissi SZ, Patel HR, Nathan MS, Miller RA.","Eur Urol. 2003 May;43(5):485-8; discussion 488. doi: 10.1016/s0302-2838(03)00052-6.","Wazait HD","Eur Urol","2003","2003/04/23","","","10.1016/s0302-2838(03)00052-6"
"31299088","Optimizing cystectomy outcomes","Porten SP, Master VA.","Cancer. 2019 Oct 15;125(20):3502-3503. doi: 10.1002/cncr.32359. Epub 2019 Jul 12.","Porten SP","Cancer","2019","2019/07/13","","","10.1002/cncr.32359"
"30712971","Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer","Efstathiou JA, Mouw KW, Gibb EA, Liu Y, Wu CL, Drumm MR, da Costa JB, du Plessis M, Wang NQ, Davicioni E, Feng FY, Seiler R, Black PC, Shipley WU, Miyamoto DT.","Eur Urol. 2019 Jul;76(1):59-68. doi: 10.1016/j.eururo.2019.01.011. Epub 2019 Feb 1.","Efstathiou JA","Eur Urol","2019","2019/02/05","PMC6571058","NIHMS1520464","10.1016/j.eururo.2019.01.011"
"11109819","[Granulocyte colony-stimulating factor producing undifferentiated carcinoma of urinary bladder: a case report]","Kajio K, Hasegawa Y, Ihara K, Harada S, Kawauchi S, Fukuda T, Naito S.","Nihon Hinyokika Gakkai Zasshi. 2000 Oct-Nov;91(10-11):679-82. doi: 10.5980/jpnjurol1989.91.679.","Kajio K","Nihon Hinyokika Gakkai Zasshi","2000","2000/12/08","","","10.5980/jpnjurol1989.91.679"
"10331854","Caffeine-increased radiosensitivity is not dependent on a loss of G2/M arrest or apoptosis in bladder cancer cell lines","Ribeiro JC, Barnetson AR, Jackson P, Ow K, Links M, Russell PJ.","Int J Radiat Biol. 1999 Apr;75(4):481-92. doi: 10.1080/095530099140410.","Ribeiro JC","Int J Radiat Biol","1999","2001/02/07","","","10.1080/095530099140410"
"4045208","[Iridium curietherapy in conservative treatment of infiltrating cancer of the bladder]","Gérard JP, De Laroche G, Ardiet JM, Romestaing P, Auque JR.","J Urol (Paris). 1985;91(3):139-44.","Gérard JP","J Urol (Paris)","1985","1985/01/01","","",""
"28545273","[Ileo-vaginal fistula caused by bladder cancer recurrence after posterior colporrhaphy: a case report]","Wang YN, Wang FD, Zhu L.","Zhonghua Fu Chan Ke Za Zhi. 2017 May 25;52(5):343. doi: 10.3760/cma.j.issn.0529-567X.2017.05.012.","Wang YN","Zhonghua Fu Chan Ke Za Zhi","2017","2017/05/27","","","10.3760/cma.j.issn.0529-567X.2017.05.012"
"24922674","Long-term follow-up of intermediate-risk non-muscle invasive bladder cancer sub-classified by multi-coloured FISH","Mian C, Comploj E, Resnyak E, Trenti E, Palermo S, Lodde M, Pycha A, Ambrosini-Spaltro A, Dechet CB, Pycha A.","Anticancer Res. 2014 Jun;34(6):3067-71.","Mian C","Anticancer Res","2014","2014/06/13","","",""
"3796432","Occupation and bladder cancer in females","Maffi L, Vineis P.","Med Lav. 1986 Sep-Oct;77(5):511-4.","Maffi L","Med Lav","1986","1986/09/01","","",""
"9144900","The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladder","Shelfo SW, Soloway MS.","World J Urol. 1997;15(2):107-11. doi: 10.1007/BF02201981.","Shelfo SW","World J Urol","1997","1997/01/01","","","10.1007/BF02201981"
"28796367","HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/β-catenin signaling","Chen Z, Zhou L, Wang L, Kazobinka G, Zhang X, Han X, Li B, Hou T.","Mol Carcinog. 2018 Jan;57(1):12-21. doi: 10.1002/mc.22715. Epub 2017 Sep 2.","Chen Z","Mol Carcinog","2018","2017/08/11","","","10.1002/mc.22715"
"4049627","Use of mitomycin as prophylaxis following endoscopic resection of superficial bladder cancer","Huland H, Otto U.","Urology. 1985 Oct;26(4 Suppl):32-5.","Huland H","Urology","1985","1985/10/01","","",""
"15711363","A novel expression of macrophage derived chemokine in human bladder cancer","Yamada H, Luo Y, Matsumoto T, O'Donnell MA.","J Urol. 2005 Mar;173(3):990-5. doi: 10.1097/01.ju.0000155188.04120.f8.","Yamada H","J Urol","2005","2005/02/16","","","10.1097/01.ju.0000155188.04120.f8"
"30338466","Optimizing Nutrition Prior to Radical Cystectomy","Oberle AD, West JM, Tobert CM, Conley GL, Nepple KG.","Curr Urol Rep. 2018 Oct 18;19(12):99. doi: 10.1007/s11934-018-0854-4.","Oberle AD","Curr Urol Rep","2018","2018/10/20","PMC6329587","NIHMS1003462","10.1007/s11934-018-0854-4"
"15036676","Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR","Retz M, Lehmann J, Szysnik C, Zwank S, Venzke T, Röder C, Kalthoff H, Basbaum C, Stöckle M.","Eur Urol. 2004 Mar;45(3):314-9. doi: 10.1016/j.eururo.2003.10.011.","Retz M","Eur Urol","2004","2004/03/24","","","10.1016/j.eururo.2003.10.011"
"17450546","Bladder cancer and occupation: a report from the Belgian case-control study on bladder cancer risk","Reulen RC, Kellen E, Buntinx F, Zeegers MP.","Am J Ind Med. 2007 Jun;50(6):449-54. doi: 10.1002/ajim.20469.","Reulen RC","Am J Ind Med","2007","2007/04/24","","","10.1002/ajim.20469"
"3761437","Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer","Murphy WM, Emerson LD, Chandler RW, Moinuddin SM, Soloway MS.","J Urol. 1986 Oct;136(4):815-9. doi: 10.1016/s0022-5347(17)45088-9.","Murphy WM","J Urol","1986","1986/10/01","","","10.1016/s0022-5347(17)45088-9"
"22177147","Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes","Meijer RP, Nunnink CJ, Wassenaar AE, Bex A, van der Poel HG, van Rhijn BW, Meinhardt W, Horenblas S.","J Urol. 2012 Feb;187(2):446-50. doi: 10.1016/j.juro.2011.10.029. Epub 2011 Dec 15.","Meijer RP","J Urol","2012","2011/12/20","","","10.1016/j.juro.2011.10.029"
"31600114","Neoadjuvant Chemotherapy is Not Associated with Adverse Perioperative Outcomes after Robot-Assisted Radical Cystectomy: A Case for Increased Use from the IRCC","Aldhaam NA, Elsayed AS, Jing Z, Richstone L, Wagner AA, Rha KH, Yuh B, Palou J, Khan MS, Menon M, Roupret M, Balbay D, Hosseini A, Wiklund P, Gaboardi F, Maatman TJ, Mottrie A, Wijburg C, Stöckle M, Hemal A, Kim E, Kaouk J, Hussein AA, Guru KA.","J Urol. 2020 Jan;203(1):57-61. doi: 10.1097/JU.0000000000000445. Epub 2019 Jul 17.","Aldhaam NA","J Urol","2020","2019/10/11","","","10.1097/JU.0000000000000445"
"3103810","Bilharziasis in malignant tumours of the urinary bladder","Al-Shukri S, Alwan MH, Nayef M, Rahman AA.","Br J Urol. 1987 Jan;59(1):59-62. doi: 10.1111/j.1464-410x.1987.tb04580.x.","Al-Shukri S","Br J Urol","1987","1987/01/01","","","10.1111/j.1464-410x.1987.tb04580.x"
"22313727","The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer","Richterstetter M, Wullich B, Amann K, Haeberle L, Engehausen DG, Goebell PJ, Krause FS.","BJU Int. 2012 Jul;110(2 Pt 2):E76-9. doi: 10.1111/j.1464-410X.2011.10904.x. Epub 2012 Feb 7.","Richterstetter M","BJU Int","2012","2012/02/09","","","10.1111/j.1464-410X.2011.10904.x"
"3674785","[A new hypothesis on the natural history of bladder cancer based on the study of tumor DNA levels by flow cytometry]","Devonec M.","Ann Urol (Paris). 1987;21(4):250-6.","Devonec M","Ann Urol (Paris)","1987","1987/01/01","","",""
"23884261","Maternal bladder cancer diagnosed at routine first-trimester obstetric ultrasound examination","Yeaton-Massey A, Brookfield KF, Aziz N, Mrazek-Pugh B, Chueh J.","Obstet Gynecol. 2013 Aug;122(2 Pt 2):464-7. doi: 10.1097/AOG.0b013e31828c5a4d.","Yeaton-Massey A","Obstet Gynecol","2013","2013/07/26","","","10.1097/AOG.0b013e31828c5a4d"
"7159876","Natural antibody to a human bladder carcinoma cell line","Grossman HB.","Cancer Immunol Immunother. 1982;13(2):89-92. doi: 10.1007/BF00205306.","Grossman HB","Cancer Immunol Immunother","1982","1982/01/01","","","10.1007/BF00205306"
"9915445","Radical cystoprostatectomy: an extraperitoneal retrograde approach","Kulkarni JN, Gulla RI, Tongaonkar HB, Kashyapi BD, Rajyaguru KB.","J Urol. 1999 Feb;161(2):545-8. doi: 10.1016/s0022-5347(01)61946-3.","Kulkarni JN","J Urol","1999","1999/01/23","","","10.1016/s0022-5347(01)61946-3"
"1466119","Managing superficial bladder cancer: an overview","Soloway MS.","Urology. 1992 Dec;40(6 Suppl):5-10.","Soloway MS","Urology","1992","1992/12/01","","",""
"11122869","Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer","Natale RB.","Curr Oncol Rep. 2000 Sep;2(5):386-93. doi: 10.1007/s11912-000-0057-1.","Natale RB","Curr Oncol Rep","2000","2000/12/21","","","10.1007/s11912-000-0057-1"
"6677790","[Effect of reduced glutathione on N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancer in rats]","Komatsu H, Kakizoe T, Nishio Y, Honma Y, Niijima T.","Nihon Hinyokika Gakkai Zasshi. 1983 Dec;74(12):2077-80. doi: 10.5980/jpnjurol1928.74.12_2077.","Komatsu H","Nihon Hinyokika Gakkai Zasshi","1983","1983/12/01","","","10.5980/jpnjurol1928.74.12_2077"
"18815927","Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression","Malats N.","Scand J Urol Nephrol Suppl. 2008 Sep;(218):131-40. doi: 10.1080/03008880802285172.","Malats N","Scand J Urol Nephrol Suppl","2008","2008/12/05","","","10.1080/03008880802285172"
"6699956","Management of the urethra in men undergoing radical cystectomy for bladder cancer","Zabbo A, Montie JE.","J Urol. 1984 Feb;131(2):267-8. doi: 10.1016/s0022-5347(17)50342-0.","Zabbo A","J Urol","1984","1984/02/01","","","10.1016/s0022-5347(17)50342-0"
"26777686","[Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment]","Neuzillet Y, Colin P, Comperat E, Dubosq F, Houede N, Larre S, Masson-Lecomte A, Pignot G, Puech P, Roumiguie M, Xylinas E, Mejean A, Roupret M.","Prog Urol. 2016 Mar;26(3):181-90. doi: 10.1016/j.purol.2015.12.002. Epub 2016 Jan 8.","Neuzillet Y","Prog Urol","2016","2016/01/19","","","10.1016/j.purol.2015.12.002"
"29907142","MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer","Liu H, He W, Wang B, Xu K, Han J, Zheng J, Ren J, Shao L, Bo S, Lu S, Lin T, Huang J.","BMC Cancer. 2018 Jun 15;18(1):659. doi: 10.1186/s12885-018-4571-7.","Liu H","BMC Cancer","2018","2018/06/17","PMC6003132","","10.1186/s12885-018-4571-7"
"18592166","Micropapillary component of urothelial carcinoma detected in transurethral resection of bladder tumor (TUR-BT) tissues: a case report","Ohtsuki Y, Ochi K, Okada Y, Kato M, Lee GH, Furihata M.","Med Mol Morphol. 2008 Jun;41(2):113-6. doi: 10.1007/s00795-007-0392-5. Epub 2008 Jul 1.","Ohtsuki Y","Med Mol Morphol","2008","2008/07/02","","","10.1007/s00795-007-0392-5"
"24500962","[A serious complication after bladder embolisation due to massive tissue necrosis in the gluteal region]","Osmonov DK, Aksenov AV, Naumann CM, Jünemann KP.","Aktuelle Urol. 2014 Jan;45(1):50-3. doi: 10.1055/s-0033-1363275. Epub 2014 Feb 5.","Osmonov DK","Aktuelle Urol","2014","2014/02/07","","","10.1055/s-0033-1363275"
"16229378","[Recurrence of bladder cancer in fossa navicularis 17 months after cystourethrectomy: a case report]","Nakane K, Katoh T, Yokoi S, Ehara H, Takahashi Y, Ishihara S, Deguchi T.","Hinyokika Kiyo. 2005 Sep;51(9):631-3.","Nakane K","Hinyokika Kiyo","2005","2005/10/19","","",""
"26148067","Urinary diversion: tailored solutions for individual patients","Pycha A, Burger M, Palermo S.","Curr Opin Urol. 2015 Sep;25(5):436-40. doi: 10.1097/MOU.0000000000000205.","Pycha A","Curr Opin Urol","2015","2015/07/07","","","10.1097/MOU.0000000000000205"
"19800544","[Primary upper urinary tract tumors and subsequent location in the bladder]","Azémar MD, Audouin M, Revaux A, Misraï V, Comperat E, Bitker MO, Chartier-Kastler E, Richard F, Cussenot O, Rouprêt M.","Prog Urol. 2009 Oct;19(9):583-8. doi: 10.1016/j.purol.2009.03.007. Epub 2009 May 9.","Azémar MD","Prog Urol","2009","2009/10/06","","","10.1016/j.purol.2009.03.007"
"28082741","Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer","Song BN, Kim SK, Chu IS.","Exp Mol Med. 2017 Jan 13;49(1):e282. doi: 10.1038/emm.2016.120.","Song BN","Exp Mol Med","2017","2017/01/14","PMC5291834","","10.1038/emm.2016.120"
"28319171","A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable","van Kessel KE, van de Werken HJ, Lurkin I, Ziel-van der Made AC, Zwarthoff EC, Boormans JL.","PLoS One. 2017 Mar 20;12(3):e0174039. doi: 10.1371/journal.pone.0174039. eCollection 2017.","van Kessel KE","PLoS One","2017","2017/03/21","PMC5358850","","10.1371/journal.pone.0174039"
"27516352","The clinical value of PSA increase during intravesical adjuvant therapy for nonmuscle-invasive bladder cancer","Serretta V, Gesolfo CS, Di Maida F, Caruana G, Rocchini L, Moschini M, Colombo R, Simonato A.","Urologia. 2016 Sep 26;83(3):145-148. doi: 10.5301/uro.5000189. Epub 2016 Aug 11.","Serretta V","Urologia","2016","2016/08/13","","","10.5301/uro.5000189"
"20284831","The hormonal therapy of vesical carcinoma","GRANT O, LICH R Jr.","Urol Cutaneous Rev. 1946 Nov;50(11):648.","GRANT O","Urol Cutaneous Rev","1946","2010/03/19","","",""
"22965680","An additive-multiplicative rates model for recurrent event data with informative terminal event","Sun L, Kang F.","Lifetime Data Anal. 2013 Jan;19(1):117-37. doi: 10.1007/s10985-012-9228-2. Epub 2012 Sep 11.","Sun L","Lifetime Data Anal","2013","2012/09/12","","","10.1007/s10985-012-9228-2"
"19569251","Survival disparities among African American women with invasive bladder cancer in Florida","Brookfield KF, Cheung MC, Gomez C, Yang R, Nieder AM, Lee DJ, Koniaris LG.","Cancer. 2009 Sep 15;115(18):4196-209. doi: 10.1002/cncr.24497.","Brookfield KF","Cancer","2009","2009/07/02","","","10.1002/cncr.24497"
"10599448","Tumor cell motility. A novel therapeutic target in bladder carcinoma, experimental and clinical results","Otto T, Lümmen G, Be A, Rübben H, Raz A.","Adv Exp Med Biol. 1999;462:469-76.","Otto T","Adv Exp Med Biol","1999","1999/12/22","","",""
"27668704","A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy","Soave A, Riethdorf S, Dahlem R, von Amsberg G, Minner S, Weisbach L, Engel O, Fisch M, Pantel K, Rink M.","Int J Cancer. 2017 Jan 15;140(2):381-389. doi: 10.1002/ijc.30445. Epub 2016 Oct 11.","Soave A","Int J Cancer","2017","2016/09/27","","","10.1002/ijc.30445"
"29587848","Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis","Hashmi AA, Hussain ZF, Irfan M, Edhi MM, Kanwal S, Faridi N, Khan A.","BMC Res Notes. 2018 Mar 27;11(1):207. doi: 10.1186/s13104-018-3319-4.","Hashmi AA","BMC Res Notes","2018","2018/03/29","PMC5870198","","10.1186/s13104-018-3319-4"
"2372672","Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancer","Lipponen PK, Collan Y, Eskelinen MJ, Pesonen E, Sotarauta M, Nordling S.","Br J Urol. 1990 Jun;65(6):589-97. doi: 10.1111/j.1464-410x.1990.tb14826.x.","Lipponen PK","Br J Urol","1990","1990/06/01","","","10.1111/j.1464-410x.1990.tb14826.x"
"16327307","Interaction effect in bladder cancer between N-acetyltransferase 2 genotype and alcohol drinking","Lu CM, Chung MC, Huang CH, Ko YC.","Urol Int. 2005;75(4):360-4. doi: 10.1159/000089175.","Lu CM","Urol Int","2005","2005/12/06","","","10.1159/000089175"
"15734831","Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas","Ohlsson G, Moreira JM, Gromov P, Sauter G, Celis JE.","Mol Cell Proteomics. 2005 Apr;4(4):570-81. doi: 10.1074/mcp.M500017-MCP200. Epub 2005 Feb 25.","Ohlsson G","Mol Cell Proteomics","2005","2005/03/01","","","10.1074/mcp.M500017-MCP200"
"17483810","The management of superficial bladder cancer","Dalbagni G.","Nat Clin Pract Urol. 2007 May;4(5):254-60. doi: 10.1038/ncpuro0784.","Dalbagni G","Nat Clin Pract Urol","2007","2007/05/08","","","10.1038/ncpuro0784"
"26278365","Urothelial carcinoma with squamous differentiation: response to chemotherapy and radiation","Clark PE.","Urol Oncol. 2015 Oct;33(10):434-6. doi: 10.1016/j.urolonc.2015.06.019. Epub 2015 Aug 14.","Clark PE","Urol Oncol","2015","2015/08/18","","","10.1016/j.urolonc.2015.06.019"
"16507795","Urine telomerase and bladder cancer detection","Weikert S, Christoph F, Miller K.","JAMA. 2006 Mar 1;295(9):998-9; author reply 999. doi: 10.1001/jama.295.9.998-b.","Weikert S","JAMA","2006","2006/03/02","","","10.1001/jama.295.9.998-b"
"10851499","Significance of cytotoxic activity of peripheral blood lymphocytes against autologous tumor cells in patients with bladder cancer","Mizutani Y, Okada Y, Yoshida O, Bonavida B.","Cancer Biother Radiopharm. 1996 Dec;11(6):385-91. doi: 10.1089/cbr.1996.11.385.","Mizutani Y","Cancer Biother Radiopharm","1996","1996/12/01","","","10.1089/cbr.1996.11.385"
"32622321","Facing treatment of non-urothelial bladder cancers in the immunotherapy era","Grilo I, Rodrigues C, Soares A, Grande E.","Crit Rev Oncol Hematol. 2020 Sep;153:103034. doi: 10.1016/j.critrevonc.2020.103034. Epub 2020 Jun 20.","Grilo I","Crit Rev Oncol Hematol","2020","2020/07/05","","","10.1016/j.critrevonc.2020.103034"
"27077498","Recent perspectives of bladder cancer diagnostics","Zhang Y, Xu F, Zhang FQ, Song L, Chen C.","Minerva Med. 2016 Jun;107(3):162-6. Epub 2016 Apr 14.","Zhang Y","Minerva Med","2016","2016/04/15","","",""
"10679914","Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer","Gildea JJ, Golden WL, Harding MA, Theodorescu D.","Genes Chromosomes Cancer. 2000 Mar;27(3):252-63. doi: 10.1002/(sici)1098-2264(200003)27:3<252::aid-gcc5>3.0.co;2-9.","Gildea JJ","Genes Chromosomes Cancer","2000","2000/02/19","","","10.1002/(sici)1098-2264(200003)27:3<252::aid-gcc5>3.0.co;2-9"
"30426533","NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p","Xu Z, Huang B, Zhang Q, He X, Wei H, Zhang D.","J Cell Biochem. 2019 Apr;120(4):6596-6604. doi: 10.1002/jcb.27954. Epub 2018 Nov 13.","Xu Z","J Cell Biochem","2019","2018/11/15","","","10.1002/jcb.27954"
"26177233","Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma","Fazel J, Rötzer S, Seidl C, Feuerecker B, Autenrieth M, Weirich G, Bruchertseifer F, Morgenstern A, Senekowitsch-Schmidtke R.","Cancer Biol Ther. 2015;16(10):1526-34. doi: 10.1080/15384047.2015.1071735. Epub 2015 Jul 15.","Fazel J","Cancer Biol Ther","2015","2015/07/16","PMC4846129","","10.1080/15384047.2015.1071735"
"20608931","Urothelial carcinoma of the bladder with seminal vesicle invasion: prognostic significance","You D, Kim SC, Jeong IG, Hong JH, Ro JY, Ahn H, Kim CS.","BJU Int. 2010 Dec;106(11):1657-61. doi: 10.1111/j.1464-410X.2010.09494.x.","You D","BJU Int","2010","2010/07/09","","","10.1111/j.1464-410X.2010.09494.x"
"16314195","Elevation of hyaluronidase-1 and soluble intercellular adhesion molecule-1 helps select bladder cancer patients at risk of invasion","Aboughalia AH.","Arch Med Res. 2006 Jan;37(1):109-16. doi: 10.1016/j.arcmed.2005.04.019.","Aboughalia AH","Arch Med Res","2006","2005/11/30","","","10.1016/j.arcmed.2005.04.019"
"30579759","[Evaluation of the learning curve of laparoscopic radical cystectomy for cancer: Morbidity and oncological results]","Moudouni SM, Latabi A, Mouaad A, Lakmichi MA, Dahami Z, Sarf I.","Prog Urol. 2019 Jan;29(1):50-62. doi: 10.1016/j.purol.2018.09.001. Epub 2018 Dec 20.","Moudouni SM","Prog Urol","2019","2018/12/24","","","10.1016/j.purol.2018.09.001"
"11689147","Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer","Fukui T, Nonomura N, Tokizane T, Sato E, Ono Y, Harada Y, Nishimura K, Takahara S, Okuyama A.","Mol Urol. 2001 Spring;5(1):19-23. doi: 10.1089/109153601750124249.","Fukui T","Mol Urol","2001","2001/11/02","","","10.1089/109153601750124249"
"28734596","Developments in urologic oncology «OncoForum»: The best of 2016","Gómez-Veiga F, Alcaraz-Asensio A, Burgos-Revilla J, Cózar-Olmo JM.","Actas Urol Esp. 2017 Nov;41(9):543-551. doi: 10.1016/j.acuro.2017.07.001. Epub 2017 Jul 19.","Gómez-Veiga F","Actas Urol Esp","2017","2017/07/24","","","10.1016/j.acuro.2017.07.001"
"15283885","Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy","Bianco FJ Jr, Justa D, Grignon DJ, Sakr WA, Pontes JE, Wood DP Jr.","Urol Oncol. 2004 Jul-Aug;22(4):290-4. doi: 10.1016/S1078-1439(03)00144-3.","Bianco FJ Jr","Urol Oncol","2004","2004/07/31","","","10.1016/S1078-1439(03)00144-3"
"3205999","Comparing the effects of different durations of the same therapy","Freedman LS, de Stavola BL.","Stat Med. 1988 Oct;7(10):1013-21. doi: 10.1002/sim.4780071003.","Freedman LS","Stat Med","1988","1988/10/01","","","10.1002/sim.4780071003"
"28272009","Neoadjuvant Chemotherapy: A New Standard for Muscle Invasive Bladder Cancer?","Ismaili N.","Gulf J Oncolog. 2017 Jan;1(23):82-85.","Ismaili N","Gulf J Oncolog","2017","2017/03/09","","",""
"24004025","PTEN deletions are related to disease progression and unfavourable prognosis in early bladder cancer","Cordes I, Kluth M, Zygis D, Rink M, Chun F, Eichelberg C, Dahlem R, Fisch M, Höppner W, Wagner W, Doh O, Terracciano L, Simon R, Wilczak W, Sauter G, Minner S.","Histopathology. 2013 Nov;63(5):670-7. doi: 10.1111/his.12209. Epub 2013 Sep 5.","Cordes I","Histopathology","2013","2013/09/06","","","10.1111/his.12209"
"19141773","Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer","Margulis V, Lotan Y, Karakiewicz PI, Fradet Y, Ashfaq R, Capitanio U, Montorsi F, Bastian PJ, Nielsen ME, Müller SC, Rigaud J, Heukamp LC, Netto G, Lerner SP, Sagalowsky AI, Shariat SF.","J Natl Cancer Inst. 2009 Jan 21;101(2):114-9. doi: 10.1093/jnci/djn451. Epub 2009 Jan 13.","Margulis V","J Natl Cancer Inst","2009","2009/01/15","","","10.1093/jnci/djn451"
"30381445","Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target","Martin DT, Shen H, Steinbach-Rankins JM, Zhu X, Johnson KK, Syed J, Saltzman WM, Weiss RM.","Mol Cancer Ther. 2019 Feb;18(2):413-420. doi: 10.1158/1535-7163.MCT-17-1079. Epub 2018 Oct 31.","Martin DT","Mol Cancer Ther","2019","2018/11/02","PMC6363894","NIHMS1509823","10.1158/1535-7163.MCT-17-1079"
"2593174","Epidemiologic study of insecticide exposures, obesity, and risk of bladder cancer in household dogs","Glickman LT, Schofer FS, McKee LJ, Reif JS, Goldschmidt MH.","J Toxicol Environ Health. 1989;28(4):407-14. doi: 10.1080/15287398909531360.","Glickman LT","J Toxicol Environ Health","1989","1989/01/01","","","10.1080/15287398909531360"
"8455238","The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results","Lerner SP, Skinner DG, Lieskovsky G, Boyd SD, Groshen SL, Ziogas A, Skinner E, Nichols P, Hopwood B.","J Urol. 1993 Apr;149(4):758-64; discussion 764-5. doi: 10.1016/s0022-5347(17)36200-6.","Lerner SP","J Urol","1993","1993/04/01","","","10.1016/s0022-5347(17)36200-6"
"27829531","Patterns of Referral to Radiation Oncology among Patients with Bladder Cancer: a Population-based Study","Quirt JS, Siemens DR, Zaza K, Mackillop WJ, Booth CM.","Clin Oncol (R Coll Radiol). 2017 Mar;29(3):171-179. doi: 10.1016/j.clon.2016.09.018. Epub 2016 Nov 6.","Quirt JS","Clin Oncol (R Coll Radiol)","2017","2016/11/11","","","10.1016/j.clon.2016.09.018"
"17935905","Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy","Weiss C, Wittlinger M, Engehausen DG, Krause FS, Ott OJ, Dunst J, Sauer R, Rödel C.","Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1502-6. doi: 10.1016/j.ijrobp.2007.08.007. Epub 2007 Nov 1.","Weiss C","Int J Radiat Oncol Biol Phys","2008","2007/10/16","","","10.1016/j.ijrobp.2007.08.007"
"26486968","Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series","Gendy R, Delprado W, Brenner P, Brooks A, Coombes G, Cozzi P, Nash P, Patel MI.","BJU Int. 2016 Apr;117 Suppl 4:54-9. doi: 10.1111/bju.13265. Epub 2015 Oct 21.","Gendy R","BJU Int","2016","2015/10/22","","","10.1111/bju.13265"
"18648942","Exercise programming and counseling preferences in bladder cancer survivors: a population-based study","Karvinen KH, Courneya KS, Venner P, North S.","J Cancer Surviv. 2007 Mar;1(1):27-34. doi: 10.1007/s11764-007-0010-5.","Karvinen KH","J Cancer Surviv","2007","2008/07/24","","","10.1007/s11764-007-0010-5"
"1394821","Use of methotrexate, vinblastine, adriamycin, and cisplatin in combination with radiation and hyperthermia as neo-adjuvant therapy for bladder cancer","Noguchi S, Kubota Y, Miura T, Shuin T, Hosaka M.","Cancer Chemother Pharmacol. 1992;30 Suppl:S63-5. doi: 10.1007/BF00686945.","Noguchi S","Cancer Chemother Pharmacol","1992","1992/01/01","","","10.1007/BF00686945"
"15066297","Treatment margins and treatment fractionation in conformal radiotherapy of muscle-invading urinary bladder cancer","Muren LP, Redpath AT, McLaren DB.","Radiother Oncol. 2004 Apr;71(1):65-71. doi: 10.1016/j.radonc.2004.02.003.","Muren LP","Radiother Oncol","2004","2004/04/07","","","10.1016/j.radonc.2004.02.003"
"21014945","Infiltrating carcinoma of the urinary bladder; diagnosis and clinical evaluation of curability","JEWETT HJ, STRONG GH.","South Med J. 1946 Mar;39:203-8. doi: 10.1097/00007611-194603000-00003.","JEWETT HJ","South Med J","1946","2010/10/29","","","10.1097/00007611-194603000-00003"
"24927357","Queyrat erythroplasia accompanied by bladder cancer in a circumcised male","Öztürk S, Uçak H.","Indian J Med Res. 2014 Apr;139(4):650-1.","Öztürk S","Indian J Med Res","2014","2014/06/14","PMC4078510","",""
"23672427","Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer","Mohammed MA, Seleim MF, Abdalla MS, Sharada HM, Abdel Wahab AH.","BMC Urol. 2013 May 14;13:25. doi: 10.1186/1471-2490-13-25.","Mohammed MA","BMC Urol","2013","2013/05/16","PMC3656799","","10.1186/1471-2490-13-25"
"10484844","[Exclusive radiotherapy in bladder cancer]","Romero Fernández J, de la Torre Tomás A, Aragón de la Cruz G.","Arch Esp Urol. 1999 Jul-Aug;52(6):599-613.","Romero Fernández J","Arch Esp Urol","1999","1999/09/15","","",""
"1483949","Analysis by step sectioning of early invasive bladder cancer with special reference to G3.pT1 disease","Kakizoe T, Tobisu K, Mizutani T, Tsutsumi M, Tanaka Y, Sakamoto M.","Jpn J Cancer Res. 1992 Dec;83(12):1354-8. doi: 10.1111/j.1349-7006.1992.tb02769.x.","Kakizoe T","Jpn J Cancer Res","1992","1992/12/01","PMC5918733","","10.1111/j.1349-7006.1992.tb02769.x"
"26887180","[NURSING CARE TO A PATIENT WITH INTRAVESICAL TREATMENT]","Marcos Espino MP, Tizón Bouza E.","Rev Enferm. 2015 Dec;38(12):60-7.","Marcos Espino MP","Rev Enferm","2015","2016/02/19","","",""
"9829715","Barbiturates, smoking, and bladder cancer risk","Habel LA, Bull SA, Friedman GD.","Cancer Epidemiol Biomarkers Prev. 1998 Nov;7(11):1049-50.","Habel LA","Cancer Epidemiol Biomarkers Prev","1998","1998/11/26","","",""
"17408169","[Intravesical therapy: Influence on superficial bladder cancer progression]","García Rodríguez J, Fernández Gómez JM, Escaf Barmadah S, Alvarez Múgica M, Rodríguez Robles L, Martín Benito JL, San Martín Blanco A, Regadera Sejas J.","Arch Esp Urol. 2007 Jan-Feb;60(1):31-5.","García Rodríguez J","Arch Esp Urol","2007","2007/04/06","","",""
"30142792","CDCA8 expression and its clinical relevance in patients with bladder cancer","Bi Y, Chen S, Jiang J, Yao J, Wang G, Zhou Q, Li S.","Medicine (Baltimore). 2018 Aug;97(34):e11899. doi: 10.1097/MD.0000000000011899.","Bi Y","Medicine (Baltimore)","2018","2018/08/26","PMC6112995","","10.1097/MD.0000000000011899"
"2653300","A controlled trial of misonidazole in the curative treatment of infiltrating bladder cancer","Bydder PV, Burry AF, Gowland S, Bourne RG, Chapman P, Firth LA, Gray AJ, McIlroy R.","Australas Radiol. 1989 Feb;33(1):8-14. doi: 10.1111/j.1440-1673.1989.tb03227.x.","Bydder PV","Australas Radiol","1989","1989/02/01","","","10.1111/j.1440-1673.1989.tb03227.x"
"15774241","Using tree analysis pattern and SELDI-TOF-MS to discriminate transitional cell carcinoma of the bladder cancer from noncancer patients","Liu W, Guan M, Wu D, Zhang Y, Wu Z, Xu M, Lu Y.","Eur Urol. 2005 Apr;47(4):456-62. doi: 10.1016/j.eururo.2004.10.006. Epub 2004 Nov 11.","Liu W","Eur Urol","2005","2005/03/19","","","10.1016/j.eururo.2004.10.006"
"1302409","[Clinical experience with BCG immune prevention in superficial bladder cancer]","Bach D, Romics I, Rüssel C.","Urologe A. 1992 Sep;31(5):296-301.","Bach D","Urologe A","1992","1992/09/01","","",""
"19632765","Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer","Dalbagni G, Vora K, Kaag M, Cronin A, Bochner B, Donat SM, Herr HW.","Eur Urol. 2009 Dec;56(6):903-10. doi: 10.1016/j.eururo.2009.07.005. Epub 2009 Jul 17.","Dalbagni G","Eur Urol","2009","2009/07/28","","","10.1016/j.eururo.2009.07.005"
"29155338","Financial Toxicity among Patients with Bladder Cancer: Reasons for Delay in Care and Effect on Quality of Life","Casilla-Lennon MM, Choi SK, Deal AM, Bensen JT, Narang G, Filippou P, McCormick B, Pruthi R, Wallen E, Tan HJ, Woods M, Nielsen M, Smith A.","J Urol. 2018 May;199(5):1166-1173. doi: 10.1016/j.juro.2017.10.049. Epub 2017 Nov 16.","Casilla-Lennon MM","J Urol","2018","2017/11/21","PMC5947876","NIHMS957227","10.1016/j.juro.2017.10.049"
"21273026","Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis HMGA2 as a prognostic marker of bladder cancer","Yang GL, Zhang LH, Bo JJ, Hou KL, Cai X, Chen YY, Li H, Liu DM, Huang YR.","Eur J Surg Oncol. 2011 Mar;37(3):265-71. doi: 10.1016/j.ejso.2011.01.004. Epub 2011 Jan 26.","Yang GL","Eur J Surg Oncol","2011","2011/01/29","","","10.1016/j.ejso.2011.01.004"
"26036261","Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft","Inamoto T, Taniguchi K, Takahara K, Iwatsuki A, Takai T, Komura K, Yoshikawa Y, Uchimoto T, Saito K, Tanda N, Kouno J, Minami K, Uehara H, Hirano H, Nomi H, Kiyama S, Akao Y, Azuma H.","Oncotarget. 2015 Aug 28;6(25):21628-35. doi: 10.18632/oncotarget.4129.","Inamoto T","Oncotarget","2015","2015/06/04","PMC4673291","","10.18632/oncotarget.4129"
"12696185","[Centrosome isolation from cultured bladder cancer cells--p53 mutation and centrosome hyperamplification]","Kawamura K, Moriyama M, Suga K, Shiba N, Tanaka T, Ikeda R, Suzuki K.","Hinyokika Kiyo. 2003 Feb;49(2):69-74.","Kawamura K","Hinyokika Kiyo","2003","2003/04/17","","",""
"20798943","[Characterisation of DNA methylation biomarkers for bladder cancer]","Antony P, Rose M, Gaisa NT, Alkaya S, Heidenreich A, Knüchel R, Dahl E.","Pathologe. 2010 Oct;31 Suppl 2:244-50. doi: 10.1007/s00292-010-1367-1.","Antony P","Pathologe","2010","2010/08/28","","","10.1007/s00292-010-1367-1"
"10854504","Lung and bladder cancer among workers in a Norwegian aluminium reduction plant","Romundstad P, Haldorsen T, Andersen A.","Occup Environ Med. 2000 Jul;57(7):495-9. doi: 10.1136/oem.57.7.495.","Romundstad P","Occup Environ Med","2000","2000/06/16","PMC1739994","","10.1136/oem.57.7.495"
"19224168","Costimulatory molecule B7-H1 on the immune escape of bladder cancer and its clinical significance","Wang Y, Zhuang Q, Zhou S, Hu Z, Lan R.","J Huazhong Univ Sci Technolog Med Sci. 2009 Feb;29(1):77-9. doi: 10.1007/s11596-009-0116-2. Epub 2009 Feb 18.","Wang Y","J Huazhong Univ Sci Technolog Med Sci","2009","2009/02/19","","","10.1007/s11596-009-0116-2"
"23656972","The natural history of secondary muscle-invasive bladder cancer","Hidas G, Pode D, Shapiro A, Katz R, Appelbaum L, Pizov G, Zorn KC, Landau EH, Duvdevani M, Gofrit ON.","BMC Urol. 2013 May 8;13:23. doi: 10.1186/1471-2490-13-23.","Hidas G","BMC Urol","2013","2013/05/10","PMC3655874","","10.1186/1471-2490-13-23"
"29727914","Germline mutations in DNA repair genes are associated with bladder cancer risk and unfavourable prognosis","Na R, Wu Y, Jiang G, Yu H, Lin X, Wang M, Conran CA, Fantus RJ, Zhang N, Liu S, Helfand BT, Zheng SL, Isaacs WB, Ding Q, Shen Z, Xu J.","BJU Int. 2018 Nov;122(5):808-813. doi: 10.1111/bju.14370. Epub 2018 Jun 4.","Na R","BJU Int","2018","2018/05/05","","","10.1111/bju.14370"
"18325050","Predicting survival after radical cystectomy for bladder cancer","Margulis V, Lotan Y, Montorsi F, Shariat SF.","BJU Int. 2008 Jul;102(1):15-22. doi: 10.1111/j.1464-410X.2008.07594.x. Epub 2008 Mar 5.","Margulis V","BJU Int","2008","2008/03/08","","","10.1111/j.1464-410X.2008.07594.x"
"30146736","Circular RNA circ-VANGL1 as a competing endogenous RNA contributes to bladder cancer progression by regulating miR-605-3p/VANGL1 pathway","Zeng Z, Zhou W, Duan L, Zhang J, Lu X, Jin L, Yu Y.","J Cell Physiol. 2019 Apr;234(4):3887-3896. doi: 10.1002/jcp.27162. Epub 2018 Aug 26.","Zeng Z","J Cell Physiol","2019","2018/08/28","","","10.1002/jcp.27162"
"28418913","Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer","Yang G, Shen W, Zhang Y, Liu M, Zhang L, Liu Q, Lu HH, Bo J.","Oncotarget. 2017 Jun 13;8(24):38378-38388. doi: 10.18632/oncotarget.16386.","Yang G","Oncotarget","2017","2017/04/19","PMC5503539","","10.18632/oncotarget.16386"
"20942828","Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer","Salinas-Sánchez AS, Sánchez-Sánchez F, Donate-Moreno MJ, Rubio-del-Campo A, Gimenez-Bachs JM, Lorenzo-Romero JG, Serrano-Oviedo L, Escribano J.","BJU Int. 2011 Jun;107(11):1825-32. doi: 10.1111/j.1464-410X.2010.09683.x. Epub 2010 Oct 13.","Salinas-Sánchez AS","BJU Int","2011","2010/10/15","","","10.1111/j.1464-410X.2010.09683.x"
"22460763","Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study","Neumann A, Weill A, Ricordeau P, Fagot JP, Alla F, Allemand H.","Diabetologia. 2012 Jul;55(7):1953-62. doi: 10.1007/s00125-012-2538-9. Epub 2012 Mar 31.","Neumann A","Diabetologia","2012","2012/03/31","PMC3369136","","10.1007/s00125-012-2538-9"
"21302615","Influence of stage discrepancy on outcome in patients treated with radical cystectomy","Ku JH, Moon KC, Kwak C, Kim HH.","Tumori. 2010 Sep-Oct;96(5):699-703.","Ku JH","Tumori","2010","2011/02/10","","",""
"17135787","Additional gene therapy with rAAV-wt-p53 enhanced the efficacy of cisplatin in human bladder cancer cells","Ruifa H, Liwei L, Binxin L, Ximing L.","Urol Int. 2006;77(4):355-61. doi: 10.1159/000096341.","Ruifa H","Urol Int","2006","2006/12/01","","","10.1159/000096341"
"20123359","Novel intravesical therapies for non-muscle-invasive bladder cancer refractory to BCG","Barlow LJ, Seager CM, Benson MC, McKiernan JM.","Urol Oncol. 2010 Jan-Feb;28(1):108-11. doi: 10.1016/j.urolonc.2009.03.029.","Barlow LJ","Urol Oncol","2010","2010/02/04","","","10.1016/j.urolonc.2009.03.029"
"2972405","[Electron microscopic observation on human bladder cancer tissue after photodynamic therapy]","Zhou CN.","Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1988 Jun;10(3):176-8.","Zhou CN","Zhongguo Yi Xue Ke Xue Yuan Xue Bao","1988","1988/06/01","","",""
"12831943","Integrated analysis of glucose, lipid, and urea metabolism in patients with bladder cancer. Impact of tumor stage","Lattermann R, Geisser W, Georgieff M, Wachter U, Goertz A, Gnann R, Schricker T.","Nutrition. 2003 Jul-Aug;19(7-8):589-92. doi: 10.1016/s0899-9007(03)00055-8.","Lattermann R","Nutrition","2003","2003/07/02","","","10.1016/s0899-9007(03)00055-8"
"28875523","Alcohol consumption and bladder cancer risk with or without the flushing response: The Japan Public Health Center-based Prospective Study","Masaoka H, Matsuo K, Sawada N, Yamaji T, Goto A, Shimazu T, Iwasaki M, Inoue M, Eto M, Tsugane S; Japan Public Health Center-based Prospective Study Group.","Int J Cancer. 2017 Dec 15;141(12):2480-2488. doi: 10.1002/ijc.31028. Epub 2017 Sep 15.","Masaoka H","Int J Cancer","2017","2017/09/07","","","10.1002/ijc.31028"
"23291077","[Laparoscopic radical cystectomy with orthotopic ileal neobladder in the treatment of invasive bladder cancer]","Wang SY, Zhou CW, Chen -, Shu -, Liu YQ.","Zhonghua Zhong Liu Za Zhi. 2012 Oct;34(10):793-6. doi: 10.3760/cma.j.issn.0253-3766.2012.10.016.","Wang SY","Zhonghua Zhong Liu Za Zhi","2012","2013/01/08","","","10.3760/cma.j.issn.0253-3766.2012.10.016"
"24485885","Radical radiotherapy for bladder cancer - contemporary outcomes from a UK centre","Lorimer CF, Adam J, Lim KH, Nikapota A.","Clin Oncol (R Coll Radiol). 2014 Apr;26(4):240. doi: 10.1016/j.clon.2014.01.007. Epub 2014 Jan 30.","Lorimer CF","Clin Oncol (R Coll Radiol)","2014","2014/02/04","","","10.1016/j.clon.2014.01.007"
"17321328","Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer","Marín-Aguilera M, Mengual L, Ribal MJ, Burset M, Arce Y, Ars E, Oliver A, Villavicencio H, Algaba F, Alcaraz A.","Cancer Genet Cytogenet. 2007 Mar;173(2):131-5. doi: 10.1016/j.cancergencyto.2006.10.011.","Marín-Aguilera M","Cancer Genet Cytogenet","2007","2007/02/27","","","10.1016/j.cancergencyto.2006.10.011"
"30604486","Molecular profiling in muscle-invasive bladder cancer: more than the sum of its parts","Sjödahl G, Jackson CL, Bartlett JM, Siemens DR, Berman DM.","J Pathol. 2019 Apr;247(5):563-573. doi: 10.1002/path.5230. Epub 2019 Feb 20.","Sjödahl G","J Pathol","2019","2019/01/04","","","10.1002/path.5230"
"31015643","Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities","Martínez-Bosch N, Rodriguez-Vida A, Juanpere N, Lloreta J, Rovira A, Albanell J, Bellmunt J, Navarro P.","Nat Rev Urol. 2019 Jul;16(7):433-445. doi: 10.1038/s41585-019-0183-5.","Martínez-Bosch N","Nat Rev Urol","2019","2019/04/25","","","10.1038/s41585-019-0183-5"
"1942270","Bladder cancer in spinal cord injury patients","Bickel A, Culkin DJ, Wheeler JS Jr.","J Urol. 1991 Nov;146(5):1240-2. doi: 10.1016/s0022-5347(17)38058-8.","Bickel A","J Urol","1991","1991/11/11","","","10.1016/s0022-5347(17)38058-8"
"12826689","Malignant priapism secondary to bladder cancer","Guvel S, Kilinc F, Torun D, Egilmez T, Ozkardes H.","J Androl. 2003 Jul-Aug;24(4):499-500. doi: 10.1002/j.1939-4640.2003.tb02701.x.","Guvel S","J Androl","2003","2003/06/27","","","10.1002/j.1939-4640.2003.tb02701.x"
"17293655","Impact of the level of muscle invasion in organ-confined bladder cancer","Girgin C, Sezer A, Delibaş M, Sahin O, Oder M, Dinçel C.","Urol Int. 2007;78(2):145-9. doi: 10.1159/000098073.","Girgin C","Urol Int","2007","2007/02/13","","","10.1159/000098073"
"18121287","Carcinoma of lung simulating primary carcinoma of urinary bladder; a case report","HAINES JS, GRABSTALD H, et al.","Urol Cutaneous Rev. 1949 Jun;53(6):324-7.","HAINES JS","Urol Cutaneous Rev","1949","1949/06/01","","",""
"17203164","Dietary beta-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice","Miyazawa K, Miyamoto S, Suzuki R, Yasui Y, Ikeda R, Kohno H, Yano M, Tanaka T, Hata K, Suzuki K.","Oncol Rep. 2007 Feb;17(2):297-304.","Miyazawa K","Oncol Rep","2007","2007/01/05","","",""
"7555391","[Tumor recurrence prevention using photodynamic therapy after treatment of bladder cancer]","Sun X, Li H, Wang M.","Zhonghua Wai Ke Za Zhi. 1995 Mar;33(3):179-80.","Sun X","Zhonghua Wai Ke Za Zhi","1995","1995/03/01","","",""
"20513529","The loss of 8p23.3 is a novel marker for predicting progression and recurrence of bladder tumors without muscle invasion","Eguchi S, Yamamoto Y, Sakano S, Chochi Y, Nakao M, Kawauchi S, Furuya T, Oga A, Matsuyama H, Sasaki K.","Cancer Genet Cytogenet. 2010 Jul 1;200(1):16-22. doi: 10.1016/j.cancergencyto.2010.03.007.","Eguchi S","Cancer Genet Cytogenet","2010","2010/06/02","","","10.1016/j.cancergencyto.2010.03.007"
"682246","Management of the urethra in patients undergoing radical cystectomy for bladder carcinoma","Raz S, Mclorie G, Johnson S, Skinner DG.","J Urol. 1978 Sep;120(3):298-300. doi: 10.1016/s0022-5347(17)57144-x.","Raz S","J Urol","1978","1978/09/01","","","10.1016/s0022-5347(17)57144-x"
"20548022","Bladder cancer mortality of workers exposed to aromatic amines: a 58-year follow-up","Pira E, Piolatto G, Negri E, Romano C, Boffetta P, Lipworth L, McLaughlin JK, La Vecchia C.","J Natl Cancer Inst. 2010 Jul 21;102(14):1096-9. doi: 10.1093/jnci/djq214. Epub 2010 Jun 14.","Pira E","J Natl Cancer Inst","2010","2010/06/16","","","10.1093/jnci/djq214"
"219505","[Carcinoma in situ of the bladder. Apropos of 10 cases]","Steg A.","Sem Hop. 1978 Dec 18-25;54(45-46):1445-56.","Steg A","Sem Hop","1978","1978/12/18","","",""
"9079749","Clinical assessment of fluorescence cytoscopy during transurethral bladder resection in superficial bladder cancer","Jichlinski P, Wagnières G, Forrer M, Mizeret J, Guillou L, Oswald M, Schmidlin F, Graber P, Van den Bergh H, Leisinger HJ.","Urol Res. 1997;25 Suppl 1:S3-6. doi: 10.1007/BF00942040.","Jichlinski P","Urol Res","1997","1997/01/01","","","10.1007/BF00942040"
"28688872","Paraganglioma of the Urinary Bladder: A Series of 22 Cases in a Single Center","Zhai H, Ma X, Nie W, Li H, Peng C, Li X, Zhang Y, Zhang X.","Clin Genitourin Cancer. 2017 Oct;15(5):e765-e771. doi: 10.1016/j.clgc.2017.03.010. Epub 2017 Mar 28.","Zhai H","Clin Genitourin Cancer","2017","2017/07/10","","","10.1016/j.clgc.2017.03.010"
"18589634","[Clinicopathological characteristics of micropapillary variant of urinary bladder carcinoma]","Radulović P, Pavić I, Marusić Z, Perić-Balja M, Znaor A, Kraus O, Kruslin B.","Lijec Vjesn. 2008 Jan-Feb;130(1-2):1-3.","Radulović P","Lijec Vjesn","2008","2008/07/01","","",""
"32678492","FOXO1 inactivation induces cisplatin resistance in bladder cancer","Ide H, Goto T, Teramoto Y, Mizushima T, Jiang G, Nagata Y, Inoue S, Baras AS, Kashiwagi E, Miyamoto H.","Cancer Sci. 2020 Sep;111(9):3397-3400. doi: 10.1111/cas.14557. Epub 2020 Jul 17.","Ide H","Cancer Sci","2020","2020/07/18","PMC7469822","","10.1111/cas.14557"
"28647740","Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy","Miyake M, Morizawa Y, Hori S, Marugami N, Iida K, Ohnishi K, Gotoh D, Tatsumi Y, Nakai Y, Inoue T, Anai S, Torimoto K, Aoki K, Tanaka N, Shimada K, Konishi N, Fujimoto K.","Oncology. 2017;93(4):259-269. doi: 10.1159/000477405. Epub 2017 Jun 24.","Miyake M","Oncology","2017","2017/06/26","","","10.1159/000477405"
"16419470","[The role of preserving therapy of invasive cancer of the urinary bladder]","Matveev BP, Sallum SD, Kamolov BSh, Figurin KM, Matveev VB, Volkova MI.","Urologiia. 2005 Nov-Dec;(6):3-6.","Matveev BP","Urologiia","2005","2006/01/20","","",""
"23497292","Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors","Gacci M, Saleh O, Cai T, Gore JL, D'Elia C, Minervini A, Masieri L, Giannessi C, Lanciotti M, Varca V, Simonato A, Serni S, Carmignani G, Carini M.","Health Qual Life Outcomes. 2013 Mar 12;11:43. doi: 10.1186/1477-7525-11-43.","Gacci M","Health Qual Life Outcomes","2013","2013/03/19","PMC3600042","","10.1186/1477-7525-11-43"
"11723435","[Neoadjuvant chemotherapy and conservative surgery in invasive bladder cancer. Personal experience]","Fischetti G, Barrese F, Cuzari S, Marino C, Mariani S, Morello P.","Minerva Urol Nefrol. 2001 Sep;53(3):119-23.","Fischetti G","Minerva Urol Nefrol","2001","2001/11/28","","",""
"23384236","Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer","Meeks JJ, Taylor JM, Matsushita K, Herr HW, Donat SM, Bochner BH, Dalbagni G.","BJU Int. 2013 Jun;111(8):E325-30. doi: 10.1111/j.1464-410X.2012.11751.x. Epub 2013 Feb 5.","Meeks JJ","BJU Int","2013","2013/02/07","","","10.1111/j.1464-410X.2012.11751.x"
"9166096","Metastatic bladder cancer: advances in treatment","Stadler WM, Kuzel TM, Raghavan D, Levine E, Vogelzang NJ, Roth B, Dorr FA.","Eur J Cancer. 1997 Jan;33 Suppl 1:S23-6. doi: 10.1016/s0959-8049(96)00337-1.","Stadler WM","Eur J Cancer","1997","1997/01/01","","","10.1016/s0959-8049(96)00337-1"
"31487512","Age Differences in Patient-reported Psychological and Physical Distress Symptoms in Bladder Cancer Patients - A Cross Sectional Study","Ajaj R, Berlin A, Klaassen Z, Chandrasekar T, Wallis CJD, Ahmad AE, Herrera Cáceres JO, Leao R, Petrella AR, Fleshner N, Matthew A, Kulkarni GS, Goldberg H.","Urology. 2019 Dec;134:154-162. doi: 10.1016/j.urology.2019.08.032. Epub 2019 Sep 2.","Ajaj R","Urology","2019","2019/09/06","","","10.1016/j.urology.2019.08.032"
"6427484","Studies of mitomycin C absorption after intravesical treatment of superficial bladder tumors","Wajsman Z, Dhafir RA, Pfeffer M, MacDonald S, Block A, Dragone N, Pontes JE.","J Urol. 1984 Jul;132(1):30-3. doi: 10.1016/s0022-5347(17)49450-x.","Wajsman Z","J Urol","1984","1984/07/01","","","10.1016/s0022-5347(17)49450-x"
"16536794","Is adjuvant chemotherapy for bladder cancer safer in patients with an ileal conduit than a neobladder?","Sofikerim M, Tatlişen A.","BJU Int. 2006 Apr;97(4):869. doi: 10.1111/j.1464-410X.2006.06163_4.x.","Sofikerim M","BJU Int","2006","2006/03/16","","","10.1111/j.1464-410X.2006.06163_4.x"
"12828175","[Microsatellite instability in urine sediments from patients with transitional cell carcinoma of bladder and its clinical value]","Lü Y, Tang D, Yu L, Ding Y, Liu L, Guo Y.","Zhonghua Wai Ke Za Zhi. 2000 Apr;38(4):294-6.","Lü Y","Zhonghua Wai Ke Za Zhi","2000","2003/06/28","","",""
"30367204","Prospective evaluation of the performances of narrow-band imaging flexible videoscopy relative to white-light imaging flexible videoscopy, in patients scheduled for transurethral resection of a primary NMIBC","Dalgaard LP, Zare R, Gaya JM, Redorta JP, Roumiguié M, Filleron T, Malavaud B.","World J Urol. 2019 Aug;37(8):1615-1621. doi: 10.1007/s00345-018-2537-7. Epub 2018 Oct 26.","Dalgaard LP","World J Urol","2019","2018/10/28","","","10.1007/s00345-018-2537-7"
"21110756","Optimal timing of radical cystectomy in T1 high-grade bladder cancer","Boström PJ, Alkhateeb S, van Rhijn BW, Kuk C, Zlotta AR.","Expert Rev Anticancer Ther. 2010 Dec;10(12):1891-902. doi: 10.1586/era.10.183.","Boström PJ","Expert Rev Anticancer Ther","2010","2010/11/30","","","10.1586/era.10.183"
"30740862","The impact of non-urothelial variant histology on oncological outcomes following radical cystectomy","Stroman L, Nair R, Russell B, Malik N, Desai A, Chandra A, Thurairaja R, Dasgupta P, Khan MS, Malde S.","BJU Int. 2019 Sep;124(3):418-423. doi: 10.1111/bju.14704. Epub 2019 Mar 4.","Stroman L","BJU Int","2019","2019/02/12","","","10.1111/bju.14704"
"25824695","Hypoxia regulates the expression and localization of CCAAT/enhancer binding protein α by hypoxia inducible factor-1α in bladder transitional carcinoma cells","Xue M, Li X, Chen W.","Mol Med Rep. 2015 Aug;12(2):2121-7. doi: 10.3892/mmr.2015.3563. Epub 2015 Mar 27.","Xue M","Mol Med Rep","2015","2015/04/01","","","10.3892/mmr.2015.3563"
"28659584","The gender difference and mortality-to-incidence ratio relate to health care disparities in bladder cancer: National estimates from 33 countries","Wang SC, Sung WW, Kao YL, Hsieh TY, Chen WJ, Chen SL, Chang HR.","Sci Rep. 2017 Jun 28;7(1):4360. doi: 10.1038/s41598-017-04083-z.","Wang SC","Sci Rep","2017","2017/06/30","PMC5489533","","10.1038/s41598-017-04083-z"
"22425077","Is bilateral extended pelvic lymphadenectomy necessary for strictly unilateral invasive bladder cancer?","Roth B, Zehnder P, Birkhäuser FD, Burkhard FC, Thalmann GN, Studer UE.","J Urol. 2012 May;187(5):1577-82. doi: 10.1016/j.juro.2011.12.106. Epub 2012 Mar 14.","Roth B","J Urol","2012","2012/03/20","","","10.1016/j.juro.2011.12.106"
"8683890","[Trial of bladder sparing for patients with invasive bladder cancer by transurethral resection and intra-arterial chemotherapy]","Yoshii S, Fuzii N, Saitoh T, Yamamoto R, Ishida N, Hosoi Y, Tahara M.","Nihon Hinyokika Gakkai Zasshi. 1996 Jan;87(1):27-34. doi: 10.5980/jpnjurol1989.87.27.","Yoshii S","Nihon Hinyokika Gakkai Zasshi","1996","1996/01/01","","","10.5980/jpnjurol1989.87.27"
"24036903","The Lin28/let-7a/c-Myc pathway plays a role in non-muscle invasive bladder cancer","Li Y, Liu H, Lai C, Du X, Su Z, Gao S.","Cell Tissue Res. 2013 Nov;354(2):533-41. doi: 10.1007/s00441-013-1715-6. Epub 2013 Sep 15.","Li Y","Cell Tissue Res","2013","2013/09/17","","","10.1007/s00441-013-1715-6"
"12855255","Molecular prognostication in bladder cancer--a current perspective","Quek ML, Quinn DI, Daneshmand S, Stein JP.","Eur J Cancer. 2003 Jul;39(11):1501-10. doi: 10.1016/s0959-8049(03)00300-9.","Quek ML","Eur J Cancer","2003","2003/07/12","","","10.1016/s0959-8049(03)00300-9"
"30632279","Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder Cancer","Critselis E, Rava M, Marquez M, Lygirou V, Chatzicharalambous D, Liapi P, Lichtinghagen R, Brand K, Cecchini L, Vlahou A, Malats N, Zoidakis J.","Proteomics Clin Appl. 2019 Mar;13(2):e1800148. doi: 10.1002/prca.201800148. Epub 2019 Jan 30.","Critselis E","Proteomics Clin Appl","2019","2019/01/12","","","10.1002/prca.201800148"
"29319922","The effect of timing of an immediate instillation of mitomycin C after transurethral resection in 941 patients with non-muscle-invasive bladder cancer","Bosschieter J, van Moorselaar RJA, Vis AN, van Ginkel T, Lissenberg-Witte BI, Beckers GMA, Nieuwenhuijzen JA.","BJU Int. 2018 Oct;122(4):571-575. doi: 10.1111/bju.14124. Epub 2018 Jan 31.","Bosschieter J","BJU Int","2018","2018/01/11","","","10.1111/bju.14124"
"19035884","Bladder cancer, pathological classification and staging","Tavora F, Epstein JI.","BJU Int. 2008 Nov;102(9 Pt B):1216-20. doi: 10.1111/j.1464-410X.2008.07962.x.","Tavora F","BJU Int","2008","2008/11/28","","","10.1111/j.1464-410X.2008.07962.x"
"14963351","Examination of tumorigenesis of precursor lesions in bladder cancer by in situ hybridization","Krause S, Feil G, Beiter T, Pressler H, Schrott KM, Bichler KH.","Urol Int. 2004;72(2):118-22. doi: 10.1159/000075964.","Krause S","Urol Int","2004","2004/02/14","","","10.1159/000075964"
"22425105","National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive bladder cancer","Cookson MS, Chang SS, Oefelein MG, Gallagher JR, Schwartz B, Heap K.","J Urol. 2012 May;187(5):1571-6. doi: 10.1016/j.juro.2011.12.056. Epub 2012 Mar 14.","Cookson MS","J Urol","2012","2012/03/20","","","10.1016/j.juro.2011.12.056"
"26777259","Intravesical and alternative bladder-preservation therapies in the management of non-muscle-invasive bladder cancer unresponsive to bacillus Calmette-Guérin","Steinberg RL, Thomas LJ, Nepple KG.","Urol Oncol. 2016 Jun;34(6):279-89. doi: 10.1016/j.urolonc.2015.12.004. Epub 2016 Jan 14.","Steinberg RL","Urol Oncol","2016","2016/01/19","","","10.1016/j.urolonc.2015.12.004"
"16753366","Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy","Kassouf W, Leibovici D, Munsell MF, Dinney CP, Grossman HB, Kamat AM.","J Urol. 2006 Jul;176(1):53-7; discussion 57. doi: 10.1016/S0022-5347(06)00510-6.","Kassouf W","J Urol","2006","2006/06/07","","","10.1016/S0022-5347(06)00510-6"
"31176613","Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer","Schulz GB, Grimm T, Sers C, Riemer P, Elmasry M, Kirchner T, Stief CG, Karl A, Horst D.","Urol Oncol. 2019 Aug;37(8):530.e9-530.e18. doi: 10.1016/j.urolonc.2019.05.011. Epub 2019 Jun 5.","Schulz GB","Urol Oncol","2019","2019/06/10","","","10.1016/j.urolonc.2019.05.011"
"5796384","Assessment of industrial bladder cancer hazards from experimental data","Munn A.","J Natl Cancer Inst. 1969 Jul;43(1):227-31.","Munn A","J Natl Cancer Inst","1969","1969/07/01","","",""
"10615098","Cancer incidence and cause specific mortality among workers in two Norwegian aluminum reduction plants","Romundstad P, Haldorsen T, Andersen A.","Am J Ind Med. 2000 Feb;37(2):175-83. doi: 10.1002/(sici)1097-0274(200002)37:2<175::aid-ajim3>3.0.co;2-t.","Romundstad P","Am J Ind Med","2000","1999/12/30","","","10.1002/(sici)1097-0274(200002)37:2<175::aid-ajim3>3.0.co;2-t"
"7941156","[Urinary diversion in cystectomy in bladder cancer patients]","Komiakov BK.","Urol Nefrol (Mosk). 1993 May-Jun;(3):25-8.","Komiakov BK","Urol Nefrol (Mosk)","1993","1993/05/01","","",""
"22967815","NMR-based metabolomics study of canine bladder cancer","Zhang J, Wei S, Liu L, Nagana Gowda GA, Bonney P, Stewart J, Knapp DW, Raftery D.","Biochim Biophys Acta. 2012 Nov;1822(11):1807-14. doi: 10.1016/j.bbadis.2012.08.001. Epub 2012 Aug 8.","Zhang J","Biochim Biophys Acta","2012","2012/09/13","","","10.1016/j.bbadis.2012.08.001"
"9888462","Mycobacterium phlei cell wall complex directly induces apoptosis in human bladder cancer cells","Filion MC, Lépicier P, Morales A, Phillips NC.","Br J Cancer. 1999 Jan;79(2):229-35. doi: 10.1038/sj.bjc.6690038.","Filion MC","Br J Cancer","1999","1999/01/15","PMC2362191","","10.1038/sj.bjc.6690038"
"31097388","Quality Control Indicators for Transurethral Resection of Non-Muscle-Invasive Bladder Cancer","Akand M, Muilwijk T, Raskin Y, De Vrieze M, Joniau S, Van Der Aa F.","Clin Genitourin Cancer. 2019 Aug;17(4):e784-e792. doi: 10.1016/j.clgc.2019.04.014. Epub 2019 Apr 19.","Akand M","Clin Genitourin Cancer","2019","2019/05/18","","","10.1016/j.clgc.2019.04.014"
"17710407","p53 and retinoblastoma pathways in bladder cancer","Mitra AP, Birkhahn M, Cote RJ.","World J Urol. 2007 Dec;25(6):563-71. doi: 10.1007/s00345-007-0197-0. Epub 2007 Aug 21.","Mitra AP","World J Urol","2007","2007/08/22","","","10.1007/s00345-007-0197-0"
"8618283","Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group","Malmström PU, Rintala E, Wahlqvist R, Hellström P, Hellsten S, Hannisdal E.","J Urol. 1996 Jun;155(6):1903-6.","Malmström PU","J Urol","1996","1996/06/01","","",""
"29305205","Associations Between Travel Distance, Hospital Volume, and Outcomes Following Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer","Xia L, Taylor BL, Mamtani R, Christodouleas JP, Guzzo TJ.","Urology. 2018 Apr;114:87-94. doi: 10.1016/j.urology.2017.12.014. Epub 2018 Jan 2.","Xia L","Urology","2018","2018/01/07","","","10.1016/j.urology.2017.12.014"
"4766020","Cancer of bladder. Experiences of a health maintenance organization","Campbell HJ.","Urology. 1973 Dec;2(6):637-42. doi: 10.1016/0090-4295(73)90325-7.","Campbell HJ","Urology","1973","1973/12/01","","","10.1016/0090-4295(73)90325-7"
"31200838","Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials","Bandini M, Briganti A, Plimack ER, Niegisch G, Yu EY, Bamias A, Agarwal N, Sridhar SS, Sternberg CN, Vaishampayan U, Théodore C, Rosenberg JE, Bellmunt J, Galsky MD, Montorsi F, Necchi A.","Eur Urol Oncol. 2019 May;2(3):248-256. doi: 10.1016/j.euo.2018.08.009. Epub 2018 Sep 7.","Bandini M","Eur Urol Oncol","2019","2019/06/16","","","10.1016/j.euo.2018.08.009"
"27015551","shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells","Li J, Zhuang C, Liu Y, Chen M, Zhou Q, Chen Z, He A, Zhao G, Guo Y, Wu H, Cai Z, Huang W.","Oncotarget. 2016 May 17;7(20):28989-97. doi: 10.18632/oncotarget.8259.","Li J","Oncotarget","2016","2016/03/26","PMC5045372","","10.18632/oncotarget.8259"
"28982898","The Use of External-beam Radiotherapy for Muscle-invasive Bladder Cancer in Elderly or Medically-fragile Patients","Aizawa R, Sakamoto M, Orito N, Kono M, Ogura M, Negoro Y, Sagoh T, Tsukahara K, Komatsu K, Noguchi M.","Anticancer Res. 2017 Oct;37(10):5761-5766. doi: 10.21873/anticanres.12016.","Aizawa R","Anticancer Res","2017","2017/10/07","","","10.21873/anticanres.12016"
"14532773","Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors","Zietman AL, Sacco D, Skowronski U, Gomery P, Kaufman DS, Clark JA, Talcott JA, Shipley WU.","J Urol. 2003 Nov;170(5):1772-6. doi: 10.1097/01.ju.0000093721.23249.c3.","Zietman AL","J Urol","2003","2003/10/09","","","10.1097/01.ju.0000093721.23249.c3"
"20240899","Occupational cancer of the bladder","GOLDBLATT MW.","Br Med Bull. 1946;4(5-6):405-17. doi: 10.1093/oxfordjournals.bmb.a072835.","GOLDBLATT MW","Br Med Bull","1946","2010/03/19","","","10.1093/oxfordjournals.bmb.a072835"
"16140072","Bladder cancer with obstructive uremia: oncologic outcome after definitive surgical management","El-Tabey NA, Osman Y, Mosbah A, Mohsen T, Abol-Enein H.","Urology. 2005 Sep;66(3):531-5. doi: 10.1016/j.urology.2005.04.021.","El-Tabey NA","Urology","2005","2005/09/06","","","10.1016/j.urology.2005.04.021"
"31671027","Targeting FGFR in bladder cancer: ready for clinical practice?","De Keukeleire S, De Maeseneer D, Jacobs C, Rottey S.","Acta Clin Belg. 2020 Feb;75(1):49-56. doi: 10.1080/17843286.2019.1685738. Epub 2019 Oct 31.","De Keukeleire S","Acta Clin Belg","2020","2019/11/01","","","10.1080/17843286.2019.1685738"
"1942339","Transitional cell carcinoma of the urethra in men following cystectomy for bladder cancer: multivariate analysis for risk factors","Tobisu K, Tanaka Y, Mizutani T, Kakizoe T.","J Urol. 1991 Dec;146(6):1551-3; discussion 1553-4. doi: 10.1016/s0022-5347(17)38163-6.","Tobisu K","J Urol","1991","1991/12/01","","","10.1016/s0022-5347(17)38163-6"
"25085780","Heterogeneity research in muscle-invasive bladder cancer based on differential protein expression analysis","Liu PF, Cao YW, Jiang HP, Wang YH, Yang XC, Wang XS, Niu HT.","Med Oncol. 2014 Sep;31(9):21. doi: 10.1007/s12032-014-0021-9. Epub 2014 Aug 2.","Liu PF","Med Oncol","2014","2014/08/03","","","10.1007/s12032-014-0021-9"
"24518698","Sarcomatoid variant of urothelial carcinoma of the urinary bladder","Bansal A, Kumar N, Sharma SC.","J Cancer Res Ther. 2013 Oct-Dec;9(4):571-3. doi: 10.4103/0973-1482.126449.","Bansal A","J Cancer Res Ther","2013","2014/02/13","","","10.4103/0973-1482.126449"
"30722118","The impact of minimal invasive surgery on early complications and mortality after radical cystectomy for muscle-invasive urothelial bladder cancer","Boc A, Crisan N, Vesa SC, Coman I, Stanca VD, Andras I.","J BUON. 2018 Dec;23(7):104-110.","Boc A","J BUON","2018","2019/02/06","","",""
"25278169","In reply to Krabbe et al","Izmirlian G, Paciorek J.","Urol Oncol. 2015 Jan;33(1):49-51. doi: 10.1016/j.urolonc.2014.08.010. Epub 2014 Sep 30.","Izmirlian G","Urol Oncol","2015","2014/10/04","","","10.1016/j.urolonc.2014.08.010"
"19285786","Editorial comment on: A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications","Bryan RT.","Eur Urol. 2009 Aug;56(2):297. doi: 10.1016/j.eururo.2009.02.039. Epub 2009 Mar 13.","Bryan RT","Eur Urol","2009","2009/03/17","","","10.1016/j.eururo.2009.02.039"
"12576821","Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy","Leissner J, Koeppen C, Wolf HK.","J Urol. 2003 Mar;169(3):955-60. doi: 10.1097/01.ju.0000043639.55877.17.","Leissner J","J Urol","2003","2003/02/11","","","10.1097/01.ju.0000043639.55877.17"
"11776628","[Adenocarcinoma of the urinary bladder: a report of 27 cases]","Shou J, Ma J, Xu B.","Zhonghua Zhong Liu Za Zhi. 1999 Nov;21(6):461-3.","Shou J","Zhonghua Zhong Liu Za Zhi","1999","2002/01/05","","",""
"3934829","Salvage cystectomy following failed definitive radiation therapy for transitional cell carcinoma of bladder","Konnak JW, Grossman HB.","Urology. 1985 Dec;26(6):550-3. doi: 10.1016/0090-4295(85)90358-9.","Konnak JW","Urology","1985","1985/12/01","","","10.1016/0090-4295(85)90358-9"
"28774300","Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles","Shi HB, Yu JX, Yu JX, Feng Z, Zhang C, Li GY, Zhao RN, Yang XB.","World J Surg Oncol. 2017 Aug 3;15(1):147. doi: 10.1186/s12957-017-1201-9.","Shi HB","World J Surg Oncol","2017","2017/08/05","PMC5543742","","10.1186/s12957-017-1201-9"
"12814676","Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?","Kuczyk M, Turkeri L, Hammerer P, Ravery V; European Society for Oncological Urology.","Eur Urol. 2003 Jul;44(1):57-64. doi: 10.1016/s0302-2838(03)00150-7.","Kuczyk M","Eur Urol","2003","2003/06/20","","","10.1016/s0302-2838(03)00150-7"
"11127920","WAF1/p21 protein expression is an independent prognostic indicator in superficial and invasive bladder cancer","Korkolopoulou P, Konstantinidou AE, Thomas-Tsagli E, Christodoulou P, Kapralos P, Davaris P.","Appl Immunohistochem Mol Morphol. 2000 Dec;8(4):285-92.","Korkolopoulou P","Appl Immunohistochem Mol Morphol","2000","2000/12/29","","",""
"18641929","[First experience with the laparoscopic radical cystectomy]","Bauer W, Lamche M, Schramek P.","Wien Med Wochenschr. 2008;158(11-12):300-2. doi: 10.1007/s10354-008-0554-7.","Bauer W","Wien Med Wochenschr","2008","2008/07/22","","","10.1007/s10354-008-0554-7"
"30404578","Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis","Teng J, Ai X, Jia Z, Wang K, Guan Y, Guo Y.","Cancer Biol Ther. 2019;20(4):552-561. doi: 10.1080/15384047.2018.1538613. Epub 2018 Nov 7.","Teng J","Cancer Biol Ther","2019","2018/11/09","PMC6422487","","10.1080/15384047.2018.1538613"
"24286506","Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer","Jancke G, Rosell J, Jahnson S.","Scand J Urol. 2014 Jun;48(3):276-83. doi: 10.3109/21681805.2013.864327. Epub 2013 Nov 29.","Jancke G","Scand J Urol","2014","2013/11/30","","","10.3109/21681805.2013.864327"
"24420527","Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer","Goossens-Laan CA, Leliveld AM, Verhoeven RH, Kil PJ, de Bock GH, Hulshof MC, de Jong IJ, Coebergh JW.","Int J Cancer. 2014 Aug 15;135(4):905-12. doi: 10.1002/ijc.28716. Epub 2014 Jan 25.","Goossens-Laan CA","Int J Cancer","2014","2014/01/15","","","10.1002/ijc.28716"
"27771127","Should we Refrain from Performing Oophorectomy in Conjunction with Radical Cystectomy for Bladder Cancer?","Liedberg F, Jancke G, Sörenby A, Kannisto P.","Eur Urol. 2017 Jun;71(6):851-853. doi: 10.1016/j.eururo.2016.10.010. Epub 2016 Oct 20.","Liedberg F","Eur Urol","2017","2016/10/25","","","10.1016/j.eururo.2016.10.010"
"24520177","Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology","Damrauer JS, Hoadley KA, Chism DD, Fan C, Tiganelli CJ, Wobker SE, Yeh JJ, Milowsky MI, Iyer G, Parker JS, Kim WY.","Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3110-5. doi: 10.1073/pnas.1318376111. Epub 2014 Feb 11.","Damrauer JS","Proc Natl Acad Sci U S A","2014","2014/02/13","PMC3939870","","10.1073/pnas.1318376111"
"16037701","Prognostic factors in a recent series of patients treated with radical cystectomy for bladder cancer","Novara G, Ficarra V, Alrabi N, Dalpiaz O, Martignoni G, Galfano A, Cavalleri S, Artibani W.","Urol Int. 2005;75(1):10-6. doi: 10.1159/000085920.","Novara G","Urol Int","2005","2005/07/23","","","10.1159/000085920"
"20006856","How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage?","Dangle PP, Gong MC, Bahnson RR, Pohar KS.","J Urol. 2010 Feb;183(2):499-503. doi: 10.1016/j.juro.2009.09.080. Epub 2009 Dec 14.","Dangle PP","J Urol","2010","2009/12/17","","","10.1016/j.juro.2009.09.080"
"3339725","The predictive value of flow cytometric information in the clinical management of stage O (Ta) bladder cancer","deVere White RW, Deitch AD, West B, Fitzpatrick JM.","J Urol. 1988 Feb;139(2):279-82. doi: 10.1016/s0022-5347(17)42386-x.","deVere White RW","J Urol","1988","1988/02/01","","","10.1016/s0022-5347(17)42386-x"
"12611221","[Intradiverticular bladder tumor: C.T. assessment]","Villanueva Rincón JM, Pérez Ramírez Mdel C, Milanés Nivia B, de Miguel Gil M, Carnero González F, Siaj FA, de Tena-Dávila Ruiz M.","Arch Esp Urol. 2002 Dec;55(10):1235-40.","Villanueva Rincón JM","Arch Esp Urol","2002","2003/03/04","","",""
"31576517","Integrated analysis of quantitative proteome and transcriptional profiles reveals abnormal gene expression and signal pathway in bladder cancer","Liao S, Ou M, Lai L, Lin H, Zou Y, Yu Y, Li X, Dai Y, Sui W.","Genes Genomics. 2019 Dec;41(12):1493-1503. doi: 10.1007/s13258-019-00868-w. Epub 2019 Oct 1.","Liao S","Genes Genomics","2019","2019/10/03","","","10.1007/s13258-019-00868-w"
"24090779","[Surgical treatment of metastatic urothelial carcinoma of the bladder: Review of the Cancer Committee of the French Association of Urology]","Neuzillet Y, Larré S, Comperat E, Rouprêt M, Pignot G, Houede N, Quintens H, Wallerand H, Roy C, Soulie M, Pfister C; les membres du Comité de cancérologie de l’Association française d’urologie.","Prog Urol. 2013 Oct;23(12):951-7. doi: 10.1016/j.purol.2013.03.004. Epub 2013 Apr 17.","Neuzillet Y","Prog Urol","2013","2013/10/05","","","10.1016/j.purol.2013.03.004"
"27571748","miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc","Wang J, Zhao X, Shi J, Pan Y, Chen Q, Leng P, Wang Y.","Oncol Rep. 2016 Oct;36(4):2049-58. doi: 10.3892/or.2016.5040. Epub 2016 Aug 25.","Wang J","Oncol Rep","2016","2016/08/31","","","10.3892/or.2016.5040"
"27244887","Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer","Lu CS, Shieh GS, Wang CT, Su BH, Su YC, Chen YC, Su WC, Wu P, Yang WH, Shiau AL, Wu CL.","Oncotarget. 2017 May 9;8(19):30844-30858. doi: 10.18632/oncotarget.9602.","Lu CS","Oncotarget","2017","2016/06/01","PMC5458172","","10.18632/oncotarget.9602"
"8102183","T-cell subsets required for intravesical BCG immunotherapy for bladder cancer","Ratliff TL, Ritchey JK, Yuan JJ, Andriole GL, Catalona WJ.","J Urol. 1993 Sep;150(3):1018-23. doi: 10.1016/s0022-5347(17)35678-1.","Ratliff TL","J Urol","1993","1993/09/01","","","10.1016/s0022-5347(17)35678-1"
"8019981","Evidence of possible carcinogenesis during conformational changes in bladder mucosa induced by bladder outlet obstruction","Lin SY, Liang RC, Hsu HS, Lin AT.","Cancer Lett. 1994 May 16;79(2):221-6. doi: 10.1016/0304-3835(94)90263-1.","Lin SY","Cancer Lett","1994","1994/05/16","","","10.1016/0304-3835(94)90263-1"
"4954824","[Considerations on the technic and results of treatment of bladder cancer by use of high energy radiations]","Legré J, Santamaria F, Amalric R, Clément R.","J Radiol Electrol Med Nucl. 1965 Nov;46(11):793-5.","Legré J","J Radiol Electrol Med Nucl","1965","1965/11/01","","",""
"9461787","[The organization of the diagnosis and treatment of patients with bladder tumors in Rostov Province]","Polianichko MF, Zaderin VP.","Urol Nefrol (Mosk). 1997 Nov-Dec;(6):38-40.","Polianichko MF","Urol Nefrol (Mosk)","1997","1998/02/14","","",""
"29650132","Optimal Timing of Chemotherapy and Surgery in Patients with Muscle-Invasive Bladder Cancer and Upper Urinary Tract Urothelial Carcinoma","Tabayoyong W, Li R, Gao J, Kamat A.","Urol Clin North Am. 2018 May;45(2):155-167. doi: 10.1016/j.ucl.2017.12.002. Epub 2018 Feb 21.","Tabayoyong W","Urol Clin North Am","2018","2018/04/14","","","10.1016/j.ucl.2017.12.002"
"20664240","Radical cystectomy for bladder cancer in the 70+ population: a nation-wide registry analysis of 845 patients","Madersbacher S, Bauer W, Willinger M, Wehrberger C, Berger I, Brössner C.","Urol Int. 2010;85(3):287-90. doi: 10.1159/000316100. Epub 2010 Jul 23.","Madersbacher S","Urol Int","2010","2010/07/29","","","10.1159/000316100"
"15830610","[Asymptomatic bladder cancer evaluated by gynecological sonography]","Szabó I, Nyirády P.","Orv Hetil. 2005 Feb 27;146(9):425-7.","Szabó I","Orv Hetil","2005","2005/04/16","","",""
"15602826","Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in shanghai population: occupational and non-occupational bladder cancer patient groups","Ma QW, Lin GF, Chen JG, Xiang CQ, Guo WC, Golka K, Shen JH.","Biomed Environ Sci. 2004 Sep;17(3):291-8.","Ma QW","Biomed Environ Sci","2004","2004/12/18","","",""
"109416","Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats","Nieh PT, Daly JJ, Irwin RJ, Prout GR Jr.","Invest Urol. 1979 May;16(6):486-8.","Nieh PT","Invest Urol","1979","1979/05/01","","",""
"1499633","The role of serum laminin P1 in the diagnosis of transitional cell carcinoma of the bladder","Abou Farha KM, Menheere PP, Bruins JL, Kester AD, Janknegt R.","Eur Urol. 1992;21(3):240-4. doi: 10.1159/000474846.","Abou Farha KM","Eur Urol","1992","1992/01/01","","","10.1159/000474846"
"30117016","miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a","Cao J, Wang Q, Wu G, Li S, Wang Q.","Int Urol Nephrol. 2018 Oct;50(10):1811-1819. doi: 10.1007/s11255-018-1959-x. Epub 2018 Aug 16.","Cao J","Int Urol Nephrol","2018","2018/08/18","","","10.1007/s11255-018-1959-x"
"18543323","Intravesical BCG for bladder cancer: how much is enough?","Kamat AM.","Cancer. 2008 Aug 15;113(4):674-6. doi: 10.1002/cncr.23628.","Kamat AM","Cancer","2008","2008/06/11","","","10.1002/cncr.23628"
"23813287","Innovations in the endoscopic management of bladder cancer: is the era of white light cystoscopy over","Soria F, Gurioli A, Peraldo F, Oderda M, Giona S, Ambrosini E, Frea B, Gontero P.","Urologia. 2013 Jun;80 Spec No 1:1-8. doi: 10.5301/RU.2013.11151. Epub 2013 May 27.","Soria F","Urologia","2013","2013/07/02","","","10.5301/RU.2013.11151"
"27690298","Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas?","Sundararaghavan VL, Sindhwani P, Hinds TD Jr.","Oncotarget. 2017 Jan 10;8(2):3640-3648. doi: 10.18632/oncotarget.12277.","Sundararaghavan VL","Oncotarget","2017","2016/10/01","PMC5356909","","10.18632/oncotarget.12277"
"29689562","Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies","Wu S, Zhao X, Wang Y, Zhong Z, Zhang L, Cao J, Ai K, Xu R.","Cell Physiol Biochem. 2018;46(4):1352-1364. doi: 10.1159/000489152. Epub 2018 Apr 18.","Wu S","Cell Physiol Biochem","2018","2018/04/25","","","10.1159/000489152"
"22998125","Perivesical fat invasion in bladder cancer: implications for prognosis comparing pT2b, pT3a and pT3b stages and consequences for adjuvant chemotherapy indications","Neuzillet Y, Lebret T, Molinie V, Yonneau L, Herve JM, Theodore C, Botto H.","BJU Int. 2012 Dec;110(11):1736-41. doi: 10.1111/j.1464-410X.2012.11104.x. Epub 2012 Mar 30.","Neuzillet Y","BJU Int","2012","2012/09/25","","","10.1111/j.1464-410X.2012.11104.x"
"21504647","New findings in bladder and prostate cancer: highlights from the 26th annual congress of the European Association of Urology, March 18-22, 2011, Vienna, Austria","Farr A, Herout R, Margreiter M, Tosev G, Djavan B.","Can J Urol. 2011 Apr;18(2):5601-7.","Farr A","Can J Urol","2011","2011/04/21","","",""
"1949371","Combined cisplatin and radiation therapy for advanced bladder cancer","Matsushima M, Tajima M, Kase T, Harada M, Takanami M, Yagishita T, Sawamura Y, Shirai M, Kaneko I, Kuwashima A, et al.","Urol Int. 1991;47 Suppl 1:138-42. doi: 10.1159/000282273.","Matsushima M","Urol Int","1991","1991/01/01","","","10.1159/000282273"
"30633323","Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?","Cole AP, Fletcher SA, Berg S, Nabi J, Mahal BA, Sonpavde GP, Nguyen PL, Lipsitz SR, Sun M, Choueiri TK, Preston MA, Kibel AS, Trinh QD.","Cancer. 2019 Apr 15;125(8):1319-1329. doi: 10.1002/cncr.31926. Epub 2019 Jan 11.","Cole AP","Cancer","2019","2019/01/12","","","10.1002/cncr.31926"
"13558161","[Bladder cancer]","BIBUS B.","Wien Med Wochenschr. 1958 Apr 12;108(15):315-8.","BIBUS B","Wien Med Wochenschr","1958","1958/04/12","","",""
"17164760","Gonorrhoea and male bladder cancer in a prospective study","Michaud DS, Platz EA, Giovannucci E.","Br J Cancer. 2007 Jan 15;96(1):169-71. doi: 10.1038/sj.bjc.6603510. Epub 2006 Dec 12.","Michaud DS","Br J Cancer","2007","2006/12/14","PMC2360207","","10.1038/sj.bjc.6603510"
"24043525","[Bladder cancer - neoadjuvant therapy with cisplatin and gemcitabine]","Schmid SC, Gschwend JE, Retz M.","Aktuelle Urol. 2013 Sep;44(5):340-2. doi: 10.1055/s-0033-1356861. Epub 2013 Sep 16.","Schmid SC","Aktuelle Urol","2013","2013/09/18","","","10.1055/s-0033-1356861"
"19151604","Expression of VEGF in urinary bladder transitional cell carcinoma in an Iraqi population subjected to depleted uranium: an immunohistochemical study","Al-Abbasi DS, Al-Janabi AA, Al-Toriahi KM, Jabor TA, Yasseen AA.","Appl Immunohistochem Mol Morphol. 2009 Jul;17(4):307-11. doi: 10.1097/PAI.0b013e3181941794.","Al-Abbasi DS","Appl Immunohistochem Mol Morphol","2009","2009/01/20","","","10.1097/PAI.0b013e3181941794"
"8239697","[Usefulness of BFP for screening of early urinary bladder cancer]","Ishii M, Seino Y, Tari K.","Gan To Kagaku Ryoho. 1993 Nov;20(14):2255-7.","Ishii M","Gan To Kagaku Ryoho","1993","1993/11/01","","",""
"26763933","METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion","Zhang Z, Zhang G, Kong C, Zhan B, Dong X, Man X.","Sci Rep. 2016 Jan 14;6:19261. doi: 10.1038/srep19261.","Zhang Z","Sci Rep","2016","2016/01/15","PMC4725887","","10.1038/srep19261"
"25927589","Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer","Lin YL, Wang YL, Ma JG, Li WP.","J Exp Clin Cancer Res. 2014 Aug 22;33(1):68. doi: 10.1186/s13046-014-0068-7.","Lin YL","J Exp Clin Cancer Res","2014","2015/05/01","PMC4237820","","10.1186/s13046-014-0068-7"
"27191066","Re: Variation in Performance of Candidate Surgical Quality Measures for Muscle-Invasive Bladder Cancer by Hospital Type","Chang SS.","J Urol. 2016 Jun;195(6):1721-2. doi: 10.1016/j.juro.2016.03.025. Epub 2016 Mar 19.","Chang SS","J Urol","2016","2016/05/19","","","10.1016/j.juro.2016.03.025"
"6385022","Bladder cancer in the pre-cystoscopic era","Zorgniotti AW.","Prog Clin Biol Res. 1984;162A:1-9.","Zorgniotti AW","Prog Clin Biol Res","1984","1984/01/01","","",""
"24018020","Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials","Leow JJ, Martin-Doyle W, Rajagopal PS, Patel CG, Anderson EM, Rothman AT, Cote RJ, Urun Y, Chang SL, Choueiri TK, Bellmunt J.","Eur Urol. 2014 Jul;66(1):42-54. doi: 10.1016/j.eururo.2013.08.033. Epub 2013 Aug 28.","Leow JJ","Eur Urol","2014","2013/09/11","","","10.1016/j.eururo.2013.08.033"
"19419018","Bladder cancer: clinical practice","Rabinowits G, Laber DA.","J Ky Med Assoc. 2009 Apr;107(4):129-33.","Rabinowits G","J Ky Med Assoc","2009","2009/05/08","","",""
"28478044","Bladder Cancer in the Elderly","Babjuk M.","Eur Urol. 2018 Jan;73(1):51-52. doi: 10.1016/j.eururo.2017.04.018. Epub 2017 May 4.","Babjuk M","Eur Urol","2018","2017/05/08","","","10.1016/j.eururo.2017.04.018"
"27699256","Claudin-low bladder tumors are immune infiltrated and actively immune suppressed","Kardos J, Chai S, Mose LE, Selitsky SR, Krishnan B, Saito R, Iglesia MD, Milowsky MI, Parker JS, Kim WY, Vincent BG.","JCI Insight. 2016 Mar 17;1(3):e85902. doi: 10.1172/jci.insight.85902.","Kardos J","JCI Insight","2016","2016/10/05","PMC5033914","","10.1172/jci.insight.85902"
"9208315","[Clinical outcome of bladder preserving therapy for superficial high-grade bladder cancer]","Chiba K, Hirokawa M, Saito K, Urushibara M, Yumura Y, Saito K, Okada Y.","Hinyokika Kiyo. 1997 May;43(5):329-32.","Chiba K","Hinyokika Kiyo","1997","1997/05/01","","",""
"8221571","Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients","Fosså SD, Waehre H, Aass N, Jacobsen AB, Olsen DR, Ous S.","Cancer. 1993 Nov 15;72(10):3036-43. doi: 10.1002/1097-0142(19931115)72:10<3036::aid-cncr2820721028>3.0.co;2-b.","Fosså SD","Cancer","1993","1993/11/15","","","10.1002/1097-0142(19931115)72:10<3036::aid-cncr2820721028>3.0.co;2-b"
"16116607","Surgical treatment of bladder carcinoma: why is it underutilized?","Smith JA Jr.","Cancer. 2005 Oct 15;104(8):1563-6. doi: 10.1002/cncr.21352.","Smith JA Jr","Cancer","2005","2005/08/24","","","10.1002/cncr.21352"
"8401636","Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer","Patard JJ, Chopin DK, Boccon-Gibod L.","World J Urol. 1993;11(3):165-8. doi: 10.1007/BF00211413.","Patard JJ","World J Urol","1993","1993/01/01","","","10.1007/BF00211413"
"2627635","The fate of G3pT1 bladder cancer","Jenkins BJ, Nauth-Misir RR, Martin JE, Fowler CG, Hope-Stone HF, Blandy JP.","Br J Urol. 1989 Dec;64(6):608-10. doi: 10.1111/j.1464-410x.1989.tb05319.x.","Jenkins BJ","Br J Urol","1989","1989/12/01","","","10.1111/j.1464-410x.1989.tb05319.x"
"3297285","Invasive bladder carcinoma. The importance of initial transurethral surgery and other significant prognostic factors for improved survival with full-dose irradiation","Shipley WU, Prout GR Jr, Kaufman SD, Perrone TL.","Cancer. 1987 Aug 1;60(3 Suppl):514-20. doi: 10.1002/1097-0142(19870801)60:3+<514::aid-cncr2820601513>3.0.co;2-m.","Shipley WU","Cancer","1987","1987/08/01","","","10.1002/1097-0142(19870801)60:3+<514::aid-cncr2820601513>3.0.co;2-m"
"14463219","Surgical treatment of bladder cancer","LEADBETTER WF.","Proc Natl Cancer Conf. 1960;4:477-82.","LEADBETTER WF","Proc Natl Cancer Conf","1960","1960/01/01","","",""
"21047201","Nucleotide excision repair gene polymorphisms may predict acute toxicity in patients treated with chemoradiotherapy for bladder cancer","Sakano S, Hinoda Y, Sasaki M, Wada T, Matsumoto H, Eguchi S, Shinohara A, Kawai Y, Hara T, Nagao K, Hara T, Naito K, Matsuyama H.","Pharmacogenomics. 2010 Oct;11(10):1377-87. doi: 10.2217/pgs.10.106.","Sakano S","Pharmacogenomics","2010","2010/11/05","","","10.2217/pgs.10.106"
"19588868","[A case report: recurrence of urothelial cancer in an ileal conduit]","Sengiku A, Nishiyama H, Shimizu T, Watanabe J, Soda T, Kamba T, Yoshimura K, Kanematsu A, Nakamura E, Kamoto T, Ogawa O.","Hinyokika Kiyo. 2009 Jun;55(6):345-8.","Sengiku A","Hinyokika Kiyo","2009","2009/07/11","","",""
"15661051","Expression of thymidine phosphorylase in human superficial bladder cancer","Shimabukuro T, Matsuyama H, Baba Y, Jojima K, Suyama K, Aoki A, Suga A, Yamamoto N, Naito K.","Int J Urol. 2005 Jan;12(1):29-34. doi: 10.1111/j.1442-2042.2004.00992.x.","Shimabukuro T","Int J Urol","2005","2005/01/22","","","10.1111/j.1442-2042.2004.00992.x"
"15878100","Phase II study of radiochemotherapy with vinblastine in invasive bladder cancer","Kragelj B, Zaletel-Kragelj L, Sedmak B, Cufer T, Cervek J.","Radiother Oncol. 2005 Apr;75(1):44-7. doi: 10.1016/j.radonc.2005.01.007. Epub 2005 Apr 18.","Kragelj B","Radiother Oncol","2005","2005/05/10","","","10.1016/j.radonc.2005.01.007"
"25623697","Association between cannabis use and the risk of bladder cancer: results from the California Men's Health Study","Thomas AA, Wallner LP, Quinn VP, Slezak J, Van Den Eeden SK, Chien GW, Jacobsen SJ.","Urology. 2015 Feb;85(2):388-92. doi: 10.1016/j.urology.2014.08.060. Epub 2014 Nov 1.","Thomas AA","Urology","2015","2015/01/28","","","10.1016/j.urology.2014.08.060"
"24356919","A feasibility study of peritoneum preservation in radical cystectomy with extraperitonealization of orthotopic neobladder for invasive high-grade bladder cancer: a preliminary analysis","Park DS, Gong IH, Choi DK, Hwang JH, Kang MH, Oh JJ.","Int Urol Nephrol. 2014 Jun;46(6):1107-13. doi: 10.1007/s11255-013-0632-7. Epub 2013 Dec 20.","Park DS","Int Urol Nephrol","2014","2013/12/21","","","10.1007/s11255-013-0632-7"
"26274747","The role of WNT signalling in urothelial cell carcinoma","Ahmad I.","Ann R Coll Surg Engl. 2015 Oct;97(7):481-6. doi: 10.1308/rcsann.2015.0008. Epub 2015 Aug 14.","Ahmad I","Ann R Coll Surg Engl","2015","2015/08/15","PMC5210134","","10.1308/rcsann.2015.0008"
"6767860","Rationale for intensive intravesical chemotherapy for superficial bladder cancer","Soloway MS.","J Urol. 1980 Apr;123(4):461-6. doi: 10.1016/s0022-5347(17)55976-5.","Soloway MS","J Urol","1980","1980/04/01","","","10.1016/s0022-5347(17)55976-5"
"7812303","Unsuspected neoplastic disease of ureteric stump in patients undergoing cystectomy for bladder cancer","Vecchioli-Scaldazza C.","Arch Ital Urol Androl. 1994 Dec;66(5):245-7.","Vecchioli-Scaldazza C","Arch Ital Urol Androl","1994","1994/12/01","","",""
"30527358","Knockdown of lncRNA SNHG7 inhibited cell proliferation and migration in bladder cancer through activating Wnt/β-catenin pathway","Chen Y, Peng Y, Xu Z, Ge B, Xiang X, Zhang T, Gao L, Shi H, Wang C, Huang J.","Pathol Res Pract. 2019 Feb;215(2):302-307. doi: 10.1016/j.prp.2018.11.015. Epub 2018 Nov 24.","Chen Y","Pathol Res Pract","2019","2018/12/12","","","10.1016/j.prp.2018.11.015"
"29334958","Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer","Zapała P, Dybowski B, Poletajew S, Białek Ł, Niewczas A, Radziszewski P.","World J Surg Oncol. 2018 Jan 15;16(1):6. doi: 10.1186/s12957-018-1310-0.","Zapała P","World J Surg Oncol","2018","2018/01/17","PMC5769235","","10.1186/s12957-018-1310-0"
"2500887","[Invasive tumors of the bladder. A study of 56 cases treated at the Gustave-Roussy Institute by total cystectomy and radiotherapy]","Raoul Y, Wibault P, Giacchetti S, Court B, Perrin B, Travagli JP, Droz JP, Eschwege F.","Ann Urol (Paris). 1989;23(3):205-11.","Raoul Y","Ann Urol (Paris)","1989","1989/01/01","","",""
"3362878","Applications of the xenograft as a model of invasive transitional cell carcinoma of the bladder","Russell PJ, Raghavan D, Philips J, Gregory P.","Prog Clin Biol Res. 1988;260:167-81.","Russell PJ","Prog Clin Biol Res","1988","1988/01/01","","",""
"2218568","Chemotherapy for invasive bladder cancer: neoadjuvant versus adjuvant","Scher HI.","Semin Oncol. 1990 Oct;17(5):555-65.","Scher HI","Semin Oncol","1990","1990/10/01","","",""
"22618669","[Non-muscle invasive transitional cell carcinoma of the bladder. New developments in diagnostics and therapy]","Sommerauer M, Jocham D, Laturnus JM.","Urologe A. 2012 Jun;51(6):791-7. doi: 10.1007/s00120-012-2897-3.","Sommerauer M","Urologe A","2012","2012/05/24","","","10.1007/s00120-012-2897-3"
"22559978","Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I","Fabris VT, Lodillinsky C, Pampena MB, Belgorosky D, Lanari C, Eiján AM.","Cancer Genet. 2012 Apr;205(4):168-76. doi: 10.1016/j.cancergen.2012.02.002.","Fabris VT","Cancer Genet","2012","2012/05/08","","","10.1016/j.cancergen.2012.02.002"
"15083187","A population-based study of immunohistochemical detection of p53 alteration in bladder cancer","Kelsey KT, Hirao T, Schned A, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR.","Br J Cancer. 2004 Apr 19;90(8):1572-6. doi: 10.1038/sj.bjc.6601748.","Kelsey KT","Br J Cancer","2004","2004/04/15","PMC2409723","","10.1038/sj.bjc.6601748"
"12647367","[HER-2 and TOP 2A gene amplifications in urinary bladder carcinoma]","Simon R, Atefy R, Wagner U, Forster T, Fijan A, Bruderer J, Wilber K, Mihatsch MJ, Gasser T, Sauter G.","Verh Dtsch Ges Pathol. 2002;86:176-83.","Simon R","Verh Dtsch Ges Pathol","2002","2003/03/22","","",""
"27049808","Extended versus superextended lymph-node dissection in radical cystectomy: subgroup analysis of possible recurrence-free survival benefit","Møller MK, Høyer S, Jensen JB.","Scand J Urol. 2016 Jun;50(3):175-80. doi: 10.3109/21681805.2015.1132473. Epub 2016 Apr 6.","Møller MK","Scand J Urol","2016","2016/04/07","","","10.3109/21681805.2015.1132473"
"18241249","Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma","Liu H, Schwartz MJ, Hwang DH, Scherr DS.","BJU Int. 2008 Apr;101(7):894-901. doi: 10.1111/j.1464-410X.2008.07459.x. Epub 2008 Jan 30.","Liu H","BJU Int","2008","2008/02/05","","","10.1111/j.1464-410X.2008.07459.x"
"16538171","Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis","Li C, Wu W, Liu J, Qian L, Li A, Yang K, Wei Q, Zhou J, Zhang Z.","Pharmacogenet Genomics. 2006 Apr;16(4):245-51. doi: 10.1097/01.fpc.0000194425.58511.a7.","Li C","Pharmacogenet Genomics","2006","2006/03/16","","","10.1097/01.fpc.0000194425.58511.a7"
"26077309","[Neoadjuvant or Adjuvant Chemotherapy for Bladder Cancer?]","Hupe MC, Kramer MW, Kuczyk MA, Merseburger AS.","Aktuelle Urol. 2015 May;46(3):242-7. doi: 10.1055/s-0035-1549948. Epub 2015 Jun 12.","Hupe MC","Aktuelle Urol","2015","2015/06/17","","","10.1055/s-0035-1549948"
"1499624","Review of cytometric methods in the assessment of prognosis in transitional cell bladder cancer","Lipponen PK.","Eur Urol. 1992;21(3):177-83. doi: 10.1159/000474833.","Lipponen PK","Eur Urol","1992","1992/01/01","","","10.1159/000474833"
"18685357","Predicting outcomes in patients with urologic cancers","Karakiewicz PI, Hutterer GC.","Curr Opin Support Palliat Care. 2007 Oct;1(3):153-68. doi: 10.1097/SPC.0b013e3282f125ec.","Karakiewicz PI","Curr Opin Support Palliat Care","2007","2008/08/08","","","10.1097/SPC.0b013e3282f125ec"
"18260354","[Port-site metastasis after retroperitoneoscopy-assisted nephroureterectomy and cystectomy for bladder cancer invading the ureter: a case report]","Segawa N, Azuma H, Takahara K, Hamada S, Kotake Y, Tsuji M, Katsuokai Y.","Hinyokika Kiyo. 2008 Jan;54(1):13-6.","Segawa N","Hinyokika Kiyo","2008","2008/02/12","","",""
"30910345","Reply from Authors re: Ananya Choudhury, Peter J. Hoskin. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues. Eur Urol 2019;76:69-70: Towards Biomarker-Informed Management of Muscle-Invasive Bladder Cancer","Mouw KW, Miyamoto DT, Efstathiou JA.","Eur Urol. 2019 Jul;76(1):71-72. doi: 10.1016/j.eururo.2019.03.009. Epub 2019 Mar 23.","Mouw KW","Eur Urol","2019","2019/03/27","","","10.1016/j.eururo.2019.03.009"
"25400757","B7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma","Fan M, Zhuang Q, Chen Y, Ding T, Yao H, Chen L, He X, Xu X.","Int J Clin Exp Pathol. 2014 Sep 15;7(10):6768-75. eCollection 2014.","Fan M","Int J Clin Exp Pathol","2014","2014/11/18","PMC4230072","",""
"21979371","Identifying better practices for early-stage bladder cancer","Hollingsworth JM, Zhang YS, Miller DC, Skolarus TA, Wood DP, Lee CT, Montie JE, Hollenbeck BK.","Med Care. 2011 Dec;49(12):1112-7. doi: 10.1097/MLR.0b013e3182353baf.","Hollingsworth JM","Med Care","2011","2011/10/08","","","10.1097/MLR.0b013e3182353baf"
"19041812","[Mortality and morbidity of radical cystectomy for bladder cancer in patients over the age of 75]","Braud G, Battisti S, Karam G, Bouchot O, Rigaud J.","Prog Urol. 2008 Dec;18(13):1062-7. doi: 10.1016/j.purol.2008.07.009. Epub 2008 Oct 18.","Braud G","Prog Urol","2008","2008/12/02","","","10.1016/j.purol.2008.07.009"
"8347788","Smoking and bladder cancer risk in blacks and whites in the United States","Hartge P, Silverman DT, Schairer C, Hoover RN.","Cancer Causes Control. 1993 Jul;4(4):391-4. doi: 10.1007/BF00051343.","Hartge P","Cancer Causes Control","1993","1993/07/01","","","10.1007/BF00051343"
"988405","[Hydrostatic pressure treatment for the bladder cancer (The 3rd report) (author's transl)]","Hirose K, Imao S, Akaza H, Shiokawa E, Seto T.","Nihon Hinyokika Gakkai Zasshi. 1976 Aug;67(8):601-14. doi: 10.5980/jpnjurol1928.67.8_601.","Hirose K","Nihon Hinyokika Gakkai Zasshi","1976","1976/08/01","","","10.5980/jpnjurol1928.67.8_601"
"3235966","Comparative study on the high prevalence of bladder cancer in the blackfoot disease endemic area in Taiwan","Chiang HS, Hong CL, Guo HR, Lee EF, Chen TY.","Taiwan Yi Xue Hui Za Zhi. 1988 Nov;87(11):1074-80.","Chiang HS","Taiwan Yi Xue Hui Za Zhi","1988","1988/11/01","","",""
"2964661","Photodynamic therapy of human bladder cancer cells in vitro correlated with cellular fluorescence levels of Photofrin-II","Williams RD, Runge TC.","Photochem Photobiol. 1987 Nov;46(5):733-7. doi: 10.1111/j.1751-1097.1987.tb04840.x.","Williams RD","Photochem Photobiol","1987","1987/11/01","","","10.1111/j.1751-1097.1987.tb04840.x"
"18058798","Tissue factor expression correlates with disease-specific survival in patients with node-negative muscle-invasive bladder cancer","Patry G, Hovington H, Larue H, Harel F, Fradet Y, Lacombe L.","Int J Cancer. 2008 Apr 1;122(7):1592-7. doi: 10.1002/ijc.23240.","Patry G","Int J Cancer","2008","2007/12/07","","","10.1002/ijc.23240"
"24120776","Re: Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program","Wood DP.","J Urol. 2013 Nov;190(5):1714. doi: 10.1016/j.juro.2013.07.038. Epub 2013 Jul 26.","Wood DP","J Urol","2013","2013/10/15","","","10.1016/j.juro.2013.07.038"
"23125074","MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas","Mengus C, Schultz-Thater E, Coulot J, Kastelan Z, Goluza E, Coric M, Spagnoli GC, Hudolin T.","Int J Cancer. 2013 May 15;132(10):2459-63. doi: 10.1002/ijc.27914. Epub 2012 Nov 16.","Mengus C","Int J Cancer","2013","2012/11/06","","","10.1002/ijc.27914"
"9810218","Radical cystectomy for invasive bladder cancer--a local experience","Abratt RP, Shepherd LC, Pontin AR, Barnes RD, Ball HS.","S Afr J Surg. 1998 Aug;36(3):87-9; discussion 89-90.","Abratt RP","S Afr J Surg","1998","1998/11/12","","",""
"28780557","Occupational variation in incidence of bladder cancer: a comparison of population-representative cohorts from Nordic countries and Canada","Hadkhale K, MacLeod J, Demers PA, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Anne Harris M, Tjepkema M, Peters PA, Pukkala E.","BMJ Open. 2017 Aug 4;7(8):e016538. doi: 10.1136/bmjopen-2017-016538.","Hadkhale K","BMJ Open","2017","2017/08/07","PMC5629726","","10.1136/bmjopen-2017-016538"
"17139196","Overexpression of human chorionic gonadotropin beta genes 3, 5 and 8 in tumor tissue and urinary cells of bladder cancer patients","Hotakainen K, Lintula S, Jarvinen R, Paju A, Stenman J, Rintala E, Stenman UH.","Tumour Biol. 2007;28(1):52-6. doi: 10.1159/000097703. Epub 2006 Dec 1.","Hotakainen K","Tumour Biol","2007","2006/12/02","","","10.1159/000097703"
"14632861","Outcome of patients with continent urinary reconstruction and a solitary functioning kidney","Shaaban AA, Mosbah A, Abdel-Latif M, Mohsen T, Mokhtar AA.","BJU Int. 2003 Dec;92(9):987-92. doi: 10.1111/j.1464-410x.2003.04534.x.","Shaaban AA","BJU Int","2003","2003/11/25","","","10.1111/j.1464-410x.2003.04534.x"
"28982876","Radical Cystectomy Versus Chemoradiation for Muscle-invasive Bladder Cancer: Impact of Treatment Facility and Sociodemographics","Haque W, Verma V, Butler EB, Teh BS.","Anticancer Res. 2017 Oct;37(10):5603-5608. doi: 10.21873/anticanres.11994.","Haque W","Anticancer Res","2017","2017/10/07","","","10.21873/anticanres.11994"
"27824327","18F-FDG PET/CT in Bladder Cancer","Tagliabue L, Russo G, Lucignani G.","Clin Nucl Med. 2016 Dec;41(12):e522-e524. doi: 10.1097/RLU.0000000000001403.","Tagliabue L","Clin Nucl Med","2016","2016/11/09","","","10.1097/RLU.0000000000001403"
"31067165","Re: Extended versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial","Chang SS.","J Urol. 2019 Aug;202(2):208-209. doi: 10.1097/JU.0000000000000332. Epub 2019 Jul 8.","Chang SS","J Urol","2019","2019/05/09","","","10.1097/JU.0000000000000332"
"27628792","Re: Investigation of Multisequence Magnetic Resonance Imaging for Detection of Recurrent Tumor after Transurethral Resection for Bladder Cancer","Chang SS.","J Urol. 2016 Oct;196(4):1045. doi: 10.1016/j.juro.2016.07.050. Epub 2016 Jul 18.","Chang SS","J Urol","2016","2016/09/16","","","10.1016/j.juro.2016.07.050"
"23571005","Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy","Lotan Y, Bagrodia A, Passoni N, Rachakonda V, Kapur P, Arriaga Y, Bolenz C, Margulis V, Raj GV, Sagalowsky AI, Shariat SF.","Eur Urol. 2013 Sep;64(3):465-71. doi: 10.1016/j.eururo.2013.03.043. Epub 2013 Apr 3.","Lotan Y","Eur Urol","2013","2013/04/11","","","10.1016/j.eururo.2013.03.043"
"28753772","Occupation and Bladder Cancer Phenotype: Identification of Workplace Patterns That Increase the Risk of Advanced Disease Beyond Overall Incidence","Noon AP, Martinsen JI, Catto JWF, Pukkala E.","Eur Urol Focus. 2018 Sep;4(5):725-730. doi: 10.1016/j.euf.2016.06.014. Epub 2016 Jul 20.","Noon AP","Eur Urol Focus","2018","2017/07/30","","","10.1016/j.euf.2016.06.014"
"25352195","A comparative study of fast-track versus [corrected] conventional surgery in patients undergoing laparoscopic radical cystectomy and ileal conduit diversion: Chinese experience","Guan X, Liu L, Lei X, Zu X, Li Y, Chen M, Wang L, Qi L.","Sci Rep. 2014 Oct 29;4:6820. doi: 10.1038/srep06820.","Guan X","Sci Rep","2014","2014/10/30","PMC4212226","","10.1038/srep06820"
"21413160","Digitized microscopy in the diagnosis of bladder cancer: analysis of >3000 cases during a 7-month period","Marganski WA, El-Sirgany Costa V, Kilpatrick MW, Tafas T, Yim J, Matthews M.","Cancer Cytopathol. 2011 Aug 25;119(4):279-89. doi: 10.1002/cncy.20145. Epub 2011 Mar 16.","Marganski WA","Cancer Cytopathol","2011","2011/03/18","","","10.1002/cncy.20145"
"8026921","Total cystectomy after intravesical bacillus Calmette-Guérin (Tokyo strain) therapy for superficial bladder cancer: experience in Japan","Takashi M, Kondo A, Nakano Y, Takagi Y, Sakata T, Miyake K.","Int Urol Nephrol. 1994;26(1):33-42. doi: 10.1007/BF02768242.","Takashi M","Int Urol Nephrol","1994","1994/01/01","","","10.1007/BF02768242"
"1444216","Histological and quantitative prognostic factors in transitional cell bladder cancer treated by cystectomy","Lipponen PK.","Anticancer Res. 1992 Sep-Oct;12(5):1527-32.","Lipponen PK","Anticancer Res","1992","1992/09/01","","",""
"19453535","Inter-observer variability of clinical target volume delineation for bladder cancer using CT and cone beam CT","Foroudi F, Haworth A, Pangehel A, Wong J, Roxby P, Duchesne G, Williams S, Tai KH.","J Med Imaging Radiat Oncol. 2009 Feb;53(1):100-6. doi: 10.1111/j.1754-9485.2009.02044.x.","Foroudi F","J Med Imaging Radiat Oncol","2009","2009/05/21","","","10.1111/j.1754-9485.2009.02044.x"
"27018306","Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer","Chen M, Zhuang C, Liu Y, Li J, Dai F, Xia M, Zhan Y, Lin J, Chen Z, He A, Xu W, Zhao G, Guo Y, Cai Z, Huang W.","Cancer Lett. 2016 Jun 28;376(1):155-64. doi: 10.1016/j.canlet.2016.03.037. Epub 2016 Mar 24.","Chen M","Cancer Lett","2016","2016/03/29","","","10.1016/j.canlet.2016.03.037"
"3669160","Conservative management of muscle-infiltrating bladder cancer: prospective experience","Herr HW.","J Urol. 1987 Nov;138(5):1162-3. doi: 10.1016/s0022-5347(17)43535-x.","Herr HW","J Urol","1987","1987/11/01","","","10.1016/s0022-5347(17)43535-x"
"22198726","Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment?","Tritschler S, Mosler C, Straub J, Buchner A, Karl A, Graser A, Stief C, Tilki D.","World J Urol. 2012 Dec;30(6):827-31. doi: 10.1007/s00345-011-0817-6. Epub 2011 Dec 25.","Tritschler S","World J Urol","2012","2011/12/27","","","10.1007/s00345-011-0817-6"
"3059654","c-myc oncoprotein levels in bladder cancer","Masters JR, Vesey SG, Munn CF, Evan GI, Watson JV.","Urol Res. 1988;16(5):341-4. doi: 10.1007/BF00256039.","Masters JR","Urol Res","1988","1988/01/01","","","10.1007/BF00256039"
"3474046","Assessment of serum CA 19.9 as a tumour marker in patients with carcinoma of the bladder and prostate","Abel PD, Cornell C, Buamah PK, Williams G.","Br J Urol. 1987 May;59(5):427-9. doi: 10.1111/j.1464-410x.1987.tb04840.x.","Abel PD","Br J Urol","1987","1987/05/01","","","10.1111/j.1464-410x.1987.tb04840.x"
"18593616","Understanding intravesical BCG: A window to the future treatment of noninvasive bladder cancer","Loughlin KR.","Urol Oncol. 2008 Jul-Aug;26(4):339-40. doi: 10.1016/j.urolonc.2008.02.001.","Loughlin KR","Urol Oncol","2008","2008/07/03","","","10.1016/j.urolonc.2008.02.001"
"6644886","Superficial bladder cancer: progression and recurrence","Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, Hawkins IR.","J Urol. 1983 Dec;130(6):1083-6. doi: 10.1016/s0022-5347(17)51695-x.","Heney NM","J Urol","1983","1983/12/01","","","10.1016/s0022-5347(17)51695-x"
"3849405","Modulation of carcinogenesis in the urinary bladder by retinoids","Hicks RM, Turton JA, Chowaniec J, Tomlinson CN, Gwynne J, Nandra K, Chrysostomou E, Pedrick M.","Ciba Found Symp. 1985;113:168-90. doi: 10.1002/9780470720943.ch11.","Hicks RM","Ciba Found Symp","1985","1985/01/01","","","10.1002/9780470720943.ch11"
"20085479","Meta-analyses of occupational exposure as a painter and lung and bladder cancer morbidity and mortality 1950-2008","Bachand A, Mundt KA, Mundt DJ, Carlton LE.","Crit Rev Toxicol. 2010;40(2):101-25. doi: 10.3109/10408440903352826.","Bachand A","Crit Rev Toxicol","2010","2010/01/21","","","10.3109/10408440903352826"
"30466905","MR Imaging of the Urinary Bladder: Added Value of PET-MR Imaging","Altun E.","Magn Reson Imaging Clin N Am. 2019 Feb;27(1):105-115. doi: 10.1016/j.mric.2018.09.005.","Altun E","Magn Reson Imaging Clin N Am","2019","2018/11/24","","","10.1016/j.mric.2018.09.005"
"11849152","Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement","Hara I, Miyake H, Hara S, Gotoh A, Nakamura I, Okada H, Arakawa S, Kamidono S.","BJU Int. 2002 Jan;89(1):10-3. doi: 10.1046/j.1464-4096.2001.01475.x.","Hara I","BJU Int","2002","2002/02/19","","","10.1046/j.1464-4096.2001.01475.x"
"23270926","miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR","Xu C, Zeng Q, Xu W, Jiao L, Chen Y, Zhang Z, Wu C, Jin T, Pan A, Wei R, Yang B, Sun Y.","Mol Cancer Ther. 2013 Feb;12(2):207-19. doi: 10.1158/1535-7163.MCT-12-0273. Epub 2012 Dec 27.","Xu C","Mol Cancer Ther","2013","2012/12/29","","","10.1158/1535-7163.MCT-12-0273"
"21458152","Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer","Zlotta AR, Roumeguere T, Kuk C, Alkhateeb S, Rorive S, Lemy A, van der Kwast TH, Fleshner NE, Jewett MA, Finelli A, Schulman C, Lotan Y, Shariat SF, Nortier J.","Eur Urol. 2011 Jun;59(6):1026-31. doi: 10.1016/j.eururo.2011.03.027. Epub 2011 Apr 1.","Zlotta AR","Eur Urol","2011","2011/04/05","","","10.1016/j.eururo.2011.03.027"
"6673102","Cutting oils and bladder cancer","Vineis P, Di Prima S.","Scand J Work Environ Health. 1983 Oct;9(5):449-50. doi: 10.5271/sjweh.2390.","Vineis P","Scand J Work Environ Health","1983","1983/10/01","","","10.5271/sjweh.2390"
"6490336","Bladder cancer in Iowa","Narayana AS, Weyer PJ.","Iowa Med. 1984 Oct;74(10):423-8.","Narayana AS","Iowa Med","1984","1984/10/01","","",""
"3481460","Transurethral surgery in the treatment of invasive bladder cancer (T1 and T2)","Wolf H, Iversen HG, Rosenkilde P, Schrøder T.","Scand J Urol Nephrol Suppl. 1987;104:127-32.","Wolf H","Scand J Urol Nephrol Suppl","1987","1987/01/01","","",""
"1710614","Pelvic palliation radiotherapy of advanced bladder cancer","Fosså SD.","Int J Radiat Oncol Biol Phys. 1991 Jun;20(6):1379. doi: 10.1016/0360-3016(91)90254-2.","Fosså SD","Int J Radiat Oncol Biol Phys","1991","1991/06/01","","","10.1016/0360-3016(91)90254-2"
"22331730","The correlation between TWIST, E-cadherin, and beta-catenin in human bladder cancer","Shen CH, Wu JD, Jou YC, Cheng MC, Lin CT, Chen PC, Tseng YS, Shi CS, Chen SY, Chang DC, Lee YR.","J BUON. 2011 Oct-Dec;16(4):733-7.","Shen CH","J BUON","2011","2012/02/15","","",""
"8355435","[Statistical analysis of recurrent factors in superficial bladder cancer. Natural history of superficial bladder cancer]","Kobashi K.","Nihon Hinyokika Gakkai Zasshi. 1993 Jul;84(7):1188-96. doi: 10.5980/jpnjurol1989.84.1188.","Kobashi K","Nihon Hinyokika Gakkai Zasshi","1993","1993/07/01","","","10.5980/jpnjurol1989.84.1188"
"15760705","Different adhesion and migration properties of human HCV29 non-malignant urothelial and T24 bladder cancer cells: role of glycosylation","Przybyło M, Lityńska A, Pocheć E.","Biochimie. 2005 Feb;87(2):133-42. doi: 10.1016/j.biochi.2004.12.003.","Przybyło M","Biochimie","2005","2005/03/12","","","10.1016/j.biochi.2004.12.003"
"21361183","Finite element based bladder modeling for image-guided radiotherapy of bladder cancer","Chai X, van Herk M, van de Kamer JB, Hulshof MC, Remeijer P, Lotz HT, Bel A.","Med Phys. 2011 Jan;38(1):142-50. doi: 10.1118/1.3523624.","Chai X","Med Phys","2011","2011/03/03","","","10.1118/1.3523624"
"31292267","Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2)","Merten R, Ott O, Haderlein M, Bertz S, Hartmann A, Wullich B, Keck B, Kühn R, Rödel CM, Weiss C, Gall C, Uter W, Fietkau R.","Oncologist. 2019 Dec;24(12):e1341-e1350. doi: 10.1634/theoncologist.2018-0280. Epub 2019 Jul 10.","Merten R","Oncologist","2019","2019/07/12","PMC6975936","","10.1634/theoncologist.2018-0280"
"15602170","Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 u.s.counties and 30 years of observation","Taeger D, Pesch B.","J Occup Environ Med. 2004 Oct;46(10):1007-8; author reply 1009. doi: 10.1097/01.jom.0000141655.00168.0d.","Taeger D","J Occup Environ Med","2004","2004/12/17","","","10.1097/01.jom.0000141655.00168.0d"
"20272624","Transurethral resection and deep X-ray therapy in the surgical management of cancer of the bladder","TORRES LF Jr, CHIKIAMCO PS.","J Philipp Med Assoc. 1947 Oct;23(10):453.","TORRES LF Jr","J Philipp Med Assoc","1947","2010/03/19","","",""
"18629841","Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting","Gallagher DJ, Milowsky MI, Bajorin DF.","Cancer. 2008 Sep 15;113(6):1284-93. doi: 10.1002/cncr.23692.","Gallagher DJ","Cancer","2008","2008/07/17","","","10.1002/cncr.23692"
"19813320","Bladder cancer. Clinical practice guidelines in oncology","Montie JE, Bahnson RR, Cohen SM, Drucker B, Eisenberger MA, El-Galley R, Herr HW, Hudes GR, Kuzel TM, Lange PH, Patterson A, Pollack A, Richie JP, Seigne J, Shipley WU, Small EJ, Trump DL, Walther PJ, Wilson TG; National Comprehensive Cancer Network.","J Natl Compr Canc Netw. 2005 Jan;3(1):4-5, 19-34.","Montie JE","J Natl Compr Canc Netw","2005","2009/10/10","","",""
"29762827","Upregulation of long non-coding RNA HNF1A-AS1 is associated with poor prognosis in urothelial carcinoma of the bladder","Wang YH, Liu YH, Ji YJ, Wei Q, Gao TB.","Eur Rev Med Pharmacol Sci. 2018 Apr;22(8):2261-2265. doi: 10.26355/eurrev_201804_14813.","Wang YH","Eur Rev Med Pharmacol Sci","2018","2018/05/16","","","10.26355/eurrev_201804_14813"
"9801094","Nephrogenic adenoma in renal transplant recipients: a truly benign lesion?","Pycha A, Mian C, Reiter WJ, Brössner C, Haitel A, Wiener H, Maier U, Marberger M.","Urology. 1998 Nov;52(5):756-61. doi: 10.1016/s0090-4295(98)00371-9.","Pycha A","Urology","1998","1998/11/04","","","10.1016/s0090-4295(98)00371-9"
"18403091","Editorial comment on: laparoscopic and robotic assisted radical cystectomy for bladder cancer: a critical analysis","Dasgupta P.","Eur Urol. 2008 Jul;54(1):62-3. doi: 10.1016/j.eururo.2008.03.077. Epub 2008 Apr 1.","Dasgupta P","Eur Urol","2008","2008/04/12","","","10.1016/j.eururo.2008.03.077"
"3624037","A critique of a randomized trial of bladder cancer treated with neutrons","Narayan K.","Int J Radiat Oncol Biol Phys. 1987 Oct;13(10):1604-5. doi: 10.1016/0360-3016(87)90336-1.","Narayan K","Int J Radiat Oncol Biol Phys","1987","1987/10/01","","","10.1016/0360-3016(87)90336-1"
"4065728","[The treatment of bladder cancer with Bacillus Calmette Guerin (BCG)]","Meretyk S, Pode D, Shapiro A.","Harefuah. 1985 Jun 16;108(12):607-8.","Meretyk S","Harefuah","1985","1985/06/16","","",""
"28139790","Formononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN","Wu Y, Zhang X, Li Z, Yan H, Qin J, Li T.","Food Funct. 2017 Mar 22;8(3):1061-1066. doi: 10.1039/c6fo01535b.","Wu Y","Food Funct","2017","2017/02/01","","","10.1039/c6fo01535b"
"29255240","Bladder cancer: Multi-omic profiling refines the molecular view","Hurst CD, Knowles MA.","Nat Rev Clin Oncol. 2018 Apr;15(4):203-204. doi: 10.1038/nrclinonc.2017.195. Epub 2017 Dec 19.","Hurst CD","Nat Rev Clin Oncol","2018","2017/12/20","","","10.1038/nrclinonc.2017.195"
"3940224","Influence of clonogenic assay methodology on measurement of drug sensitivities in vitro","Hepburn PJ, Masters JR.","Cancer Chemother Pharmacol. 1986;16(1):80-2. doi: 10.1007/BF00255293.","Hepburn PJ","Cancer Chemother Pharmacol","1986","1986/01/01","","","10.1007/BF00255293"
"23688987","[Construction of full-length human bladder cancer-specific antibody libraries based on mammalian display technology]","Lan K, Zhang Z, Liang Z, Wang J, Lou H, Zhou Y, Liu S, Li C, Tan W, Zhou C.","Nan Fang Yi Ke Da Xue Xue Bao. 2013 May;33(5):684-91.","Lan K","Nan Fang Yi Ke Da Xue Xue Bao","2013","2013/05/22","","",""
"2313796","The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin","Bretton PR, Herr HW, Kimmel M, Whitmore WF Jr, Laudone V, Oettgen HF, Fair WR.","J Urol. 1990 Apr;143(4):710-2; discussion 712-3. doi: 10.1016/s0022-5347(17)40067-x.","Bretton PR","J Urol","1990","1990/04/01","","","10.1016/s0022-5347(17)40067-x"
"31563847","Food consumption, meat cooking methods and diet diversity and the risk of bladder cancer","Di Maso M, Turati F, Bosetti C, Montella M, Libra M, Negri E, Ferraroni M, La Vecchia C, Serraino D, Polesel J.","Cancer Epidemiol. 2019 Dec;63:101595. doi: 10.1016/j.canep.2019.101595. Epub 2019 Sep 26.","Di Maso M","Cancer Epidemiol","2019","2019/09/30","","","10.1016/j.canep.2019.101595"
"28749918","Immunotherapy in urothelial cancer, part 2: adjuvant, neoadjuvant, and adjunctive treatment","Yu SS, Ballas LK, Skinner EC, Dorff TB, Sadeghi S, Quinn DI.","Clin Adv Hematol Oncol. 2017 Jul;15(7):543-551.","Yu SS","Clin Adv Hematol Oncol","2017","2017/07/28","PMC7523177","NIHMS1628297",""
"30369224","[A Case of Urachal Carcinoma Treated with Laparoscopic Resection of Urachal Remnants with Partial Cystectomy that was Difficult to Diagnose Preoperatively by Transurethral Biopsy]","Sasahara T, Sasaki H, Yoshiyama Y, Kimura S, Egawa S.","Hinyokika Kiyo. 2018 Aug;64(8):345-348. doi: 10.14989/ActaUrolJap_64_8_345.","Sasahara T","Hinyokika Kiyo","2018","2018/10/30","","","10.14989/ActaUrolJap_64_8_345"
"25703910","Association between tissue miR-141, miR-200c and miR-30b and bladder cancer: a matched case-control study","Mahdavinezhad A, Mousavibahar SH, Poorolajal J, Yadegarazari R, Jafari M, Shabab N, Saidijam M.","Urol J. 2015 Feb 22;12(1):2010-3.","Mahdavinezhad A","Urol J","2015","2015/02/24","","",""
"25072257","The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer","Hemdan T, Lindén M, Lind SB, Namuduri AV, Sjöstedt E, de Ståhl TD, Asplund A, Malmström PU, Segersten U.","Br J Cancer. 2014 Sep 9;111(6):1180-7. doi: 10.1038/bjc.2014.427. Epub 2014 Jul 29.","Hemdan T","Br J Cancer","2014","2014/07/30","PMC4453855","","10.1038/bjc.2014.427"
"22065058","Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in patients with bladder cancer","Ichihara K, Kitamura H, Masumori N, Fukuta F, Tsukamoto T.","Int J Clin Oncol. 2013 Feb;18(1):75-80. doi: 10.1007/s10147-011-0346-8. Epub 2011 Nov 8.","Ichihara K","Int J Clin Oncol","2013","2011/11/09","","","10.1007/s10147-011-0346-8"
"25704048","Quiz page March 2015: unexplained kidney failure in a patient with bladder cancer. AKI secondary to metastatic infiltration of the kidneys by poorly differentiated urothelial cancer","Shukla P, Bindal P, Gupta A, Lohr JW, Arora P.","Am J Kidney Dis. 2015 Mar;65(3):A17-9. doi: 10.1053/j.ajkd.2014.11.012.","Shukla P","Am J Kidney Dis","2015","2015/02/24","","","10.1053/j.ajkd.2014.11.012"
"21773973","Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer","Inoue K, Fukuhara H, Shimamoto T, Kamada M, Iiyama T, Miyamura M, Kurabayashi A, Furihata M, Tanimura M, Watanabe H, Shuin T.","Cancer. 2012 Feb 15;118(4):1062-74. doi: 10.1002/cncr.26378. Epub 2011 Jul 19.","Inoue K","Cancer","2012","2011/07/21","","","10.1002/cncr.26378"
"24019014","Extracellular vesicle-mediated transfer of membranous components from the highly malignant T24 urinary carcinoma cell line to the non-malignant RT4 urinary papilloma cell line","Ogorevc E, Hudoklin S, Veranič P, Kralj-Iglič V.","Protoplasma. 2014 May;251(3):699-702. doi: 10.1007/s00709-013-0544-5. Epub 2013 Sep 10.","Ogorevc E","Protoplasma","2014","2013/09/11","","","10.1007/s00709-013-0544-5"
"7431499","Staging of bladder cancer by ultrasonography: a new technique by transurethral intravesical scanning","Nakamura S, Niijima T.","J Urol. 1980 Sep;124(3):341-4. doi: 10.1016/s0022-5347(17)55438-5.","Nakamura S","J Urol","1980","1980/09/01","","","10.1016/s0022-5347(17)55438-5"
"17479401","Functional polymorphisms of JWA gene are associated with risk of bladder cancer","Li CP, Zhu YJ, Chen R, Wu W, Li AP, Liu J, Liu QZ, Wei QY, Zhang ZD, Zhou JW.","J Toxicol Environ Health A. 2007 Jun;70(11):876-84. doi: 10.1080/15287390701285824.","Li CP","J Toxicol Environ Health A","2007","2007/05/05","","","10.1080/15287390701285824"
"23275325","The association between the recurrence of solitary non-muscle invasive bladder cancer and tumor infiltrating lymphocytes","Krpina K, Babarović E, Dorđević G, Fuckar Z, Jonjić N.","Croat Med J. 2012 Dec;53(6):598-604. doi: 10.3325/cmj.2012.53.598.","Krpina K","Croat Med J","2012","2013/01/01","PMC3541585","","10.3325/cmj.2012.53.598"
"18381463","Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer","Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X.","Cancer Res. 2008 Apr 1;68(7):2530-7. doi: 10.1158/0008-5472.CAN-07-5991.","Yang H","Cancer Res","2008","2008/04/03","","","10.1158/0008-5472.CAN-07-5991"
"15302512","Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer","Boorjian S, Ugras S, Mongan NP, Gudas LJ, You X, Tickoo SK, Scherr DS.","Urology. 2004 Aug;64(2):383-8. doi: 10.1016/j.urology.2004.03.025.","Boorjian S","Urology","2004","2004/08/11","","","10.1016/j.urology.2004.03.025"
"26683632","New Strategies in Bladder Cancer: A Second Coming for Immunotherapy","Ghasemzadeh A, Bivalacqua TJ, Hahn NM, Drake CG.","Clin Cancer Res. 2016 Feb 15;22(4):793-801. doi: 10.1158/1078-0432.CCR-15-1135. Epub 2015 Dec 18.","Ghasemzadeh A","Clin Cancer Res","2016","2015/12/20","PMC4825862","NIHMS745549","10.1158/1078-0432.CCR-15-1135"
"1514212","[Is down-staging of advanced bladder cancer by neoadjuvant chemotherapy possible?--MVEC protocol]","Hoch V, Noll F, Schreiter F.","Urologe A. 1992 Jul;31(4):243-6.","Hoch V","Urologe A","1992","1992/07/01","","",""
"16144528","The immunotherapy of prostate and bladder cancer","Totterman TH, Loskog A, Essand M.","BJU Int. 2005 Oct;96(5):728-35. doi: 10.1111/j.1464-410X.2005.05772.x.","Totterman TH","BJU Int","2005","2005/09/08","","","10.1111/j.1464-410X.2005.05772.x"
"7139539","Hodgkin's disease involving the urinary bladder diagnosed by urinary cytology: a case report","Bocian JJ, Flam MS, Mendoza CA.","Cancer. 1982 Dec 1;50(11):2482-5. doi: 10.1002/1097-0142(19821201)50:11<2482::aid-cncr2820501137>3.0.co;2-v.","Bocian JJ","Cancer","1982","1982/12/01","","","10.1002/1097-0142(19821201)50:11<2482::aid-cncr2820501137>3.0.co;2-v"
"31449345","QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling","Shi F, Deng Z, Zhou Z, Jiang CY, Zhao RZ, Sun F, Cui D, Bei XY, Yang BY, Sun Q, Wang XJ, Wu Q, Xia SJ, Han BM.","J Cell Mol Med. 2019 Oct;23(10):6578-6594. doi: 10.1111/jcmm.14481. Epub 2019 Aug 26.","Shi F","J Cell Mol Med","2019","2019/08/27","PMC6787450","","10.1111/jcmm.14481"
"15517903","Novel recurrent structural chromosomal aberrations in primary bladder cancer","Panani AD, Ferti AD, Raptis SA, Roussos C.","Anticancer Res. 2004 Sep-Oct;24(5A):2967-74.","Panani AD","Anticancer Res","2004","2004/11/03","","",""
"10608059","[Our experience with 1 mg BCG vaccine instillation in T1 stage cancer of the bladder]","Rivera P, Orio M, Hinostroza J, Venegas P, Pastor P, Gorena M, Lagos M, Pinochet R.","Actas Urol Esp. 1999 Oct;23(9):757-62. doi: 10.1016/s0210-4806(99)72366-1.","Rivera P","Actas Urol Esp","1999","1999/12/23","","","10.1016/s0210-4806(99)72366-1"
"19021623","Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Guérin immunotherapy?","Gofrit ON, Pode D, Pizov G, Zorn KC, Katz R, Shapiro A.","BJU Int. 2009 Apr;103(7):905-8. doi: 10.1111/j.1464-410X.2008.08210.x. Epub 2008 Nov 19.","Gofrit ON","BJU Int","2009","2008/11/22","","","10.1111/j.1464-410X.2008.08210.x"
"20399454","The role of tumor-free status in repeat resection before intravesical bacillus Calmette-Guerin for high grade Ta, T1 and CIS bladder cancer","Guevara A, Salomon L, Allory Y, Ploussard G, de la Taille A, Paul A, Yiou R, Hoznek A, Dahan M, Abbou CC, Vordos D.","J Urol. 2010 Jun;183(6):2161-4. doi: 10.1016/j.juro.2010.02.026.","Guevara A","J Urol","2010","2010/04/20","","","10.1016/j.juro.2010.02.026"
"8677539","Management of prostate and bladder cancer in the elderly","Dreicer R, Cooper CS, Williams RD.","Urol Clin North Am. 1996 Feb;23(1):87-97. doi: 10.1016/s0094-0143(05)70295-0.","Dreicer R","Urol Clin North Am","1996","1996/02/01","","","10.1016/s0094-0143(05)70295-0"
"7146375","[Diagnostic possibilities of sedimentary pneumocystography and pneumocystopericystography in bladder cancer]","Filjanova VP.","Radiol Diagn (Berl). 1982;23(4):501-8.","Filjanova VP","Radiol Diagn (Berl)","1982","1982/01/01","","",""
"22105318","Chemotherapy for bladder cancer in patients with impaired renal function","Nicholson S.","Nat Rev Urol. 2011 Nov 22;9(1):52-7. doi: 10.1038/nrurol.2011.176.","Nicholson S","Nat Rev Urol","2011","2011/11/23","","","10.1038/nrurol.2011.176"
"19877112","Racial differences in treatment and outcomes among patients with early stage bladder cancer","Hollenbeck BK, Dunn RL, Ye Z, Hollingsworth JM, Lee CT, Birkmeyer JD.","Cancer. 2010 Jan 1;116(1):50-6. doi: 10.1002/cncr.24701.","Hollenbeck BK","Cancer","2010","2009/10/31","PMC2807891","NIHMS149931","10.1002/cncr.24701"
"19903839","Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors","Kamat AM, Tharakan ST, Sung B, Aggarwal BB.","Cancer Res. 2009 Dec 1;69(23):8958-66. doi: 10.1158/0008-5472.CAN-09-2045. Epub 2009 Nov 10.","Kamat AM","Cancer Res","2009","2009/11/12","","","10.1158/0008-5472.CAN-09-2045"
"7349809","Urinary alpha-naphthyl acetate esterases: a preliminary screening test for bladder cancer","El-Sewedy SM, Arafa AM, Mostafa MH, El-Zoghby SM.","Cancer Detect Prev. 1981;4(1-4):455-9.","El-Sewedy SM","Cancer Detect Prev","1981","1981/01/01","","",""
"26951946","Moving Towards Minimally Invasive Genomically Based Diagnosis and Monitoring of Bladder Cancer","Rentsch CA, Müller DC, Ruiz C, Bubendorf L.","Eur Urol. 2016 Jul;70(1):83-84. doi: 10.1016/j.eururo.2016.02.050. Epub 2016 Mar 4.","Rentsch CA","Eur Urol","2016","2016/03/09","","","10.1016/j.eururo.2016.02.050"
"10589117","[The BTA stat test in the follow-up for bladder cancer]","Gutiérrez Baños JL, Martín García B, de Diego Rodríguez E, Hernández Rodríguez R, Portillo Martín JA, Correas Gómez MA, del Valle Schaan JI, Roca Edreira A, Rado Velázquez MA.","Arch Esp Urol. 1999 Oct;52(8):856-61.","Gutiérrez Baños JL","Arch Esp Urol","1999","1999/12/10","","",""
"20097512","Survival after cystectomy for invasive bladder cancer","de Vries RR, Nieuwenhuijzen JA, Vincent A, van Tinteren H, Horenblas S.","Eur J Surg Oncol. 2010 Mar;36(3):292-7. doi: 10.1016/j.ejso.2009.11.012. Epub 2010 Jan 25.","de Vries RR","Eur J Surg Oncol","2010","2010/01/26","","","10.1016/j.ejso.2009.11.012"
"1450063","Recombinant tumor necrosis factor for superficial bladder tumors","Sternberg CN, Arena MG, Pansadoro V, Calabresi F, D'Agnano I, De Carli P, Zeuli M, Cancrini A, Rosenkaimer F, Zupi G.","Ann Oncol. 1992 Nov;3(9):741-5. doi: 10.1093/oxfordjournals.annonc.a058331.","Sternberg CN","Ann Oncol","1992","1992/11/01","","","10.1093/oxfordjournals.annonc.a058331"
"24054824","[Quality of life and overall survival in high risk patients after radical cystectomy with a simple urinary derivation]","Mucciardi G, Macchione L, Galì A, di Benedetto A, Subba E, Pappalardo R, Mucciardi M, Butticè S, Inferrera A, Magno C.","Cir Esp. 2015 Jun-Jul;93(6):368-74. doi: 10.1016/j.ciresp.2013.03.012. Epub 2013 Sep 17.","Mucciardi G","Cir Esp","2015","2013/09/24","","","10.1016/j.ciresp.2013.03.012"
"25174656","Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy","Svatek RS, Clinton TN, Wilson CA, Kamat AM, Grossman HB, Dinney CP, Shah JB.","Urology. 2014 Nov;84(5):1147-51. doi: 10.1016/j.urology.2014.05.011. Epub 2014 Aug 28.","Svatek RS","Urology","2014","2014/09/02","","","10.1016/j.urology.2014.05.011"
"196750","C-type virus particles in the transplantable mouse bladder tumour FCB grown in vitro","Flaks A.","Cancer Lett. 1977 Jul;3(1-2):65-70. doi: 10.1016/s0304-3835(77)94211-2.","Flaks A","Cancer Lett","1977","1977/07/01","","","10.1016/s0304-3835(77)94211-2"
"14492722","[Clinical reminder and therapeutic possibilities in bladder cancer]","ROBERT F.","Vie Med. 1961 Oct;42:1314-20.","ROBERT F","Vie Med","1961","1961/10/01","","",""
"21196690","Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study","Gontero P, Oderda M, Altieri V, Bartoletti R, Cai T, Colombo R, Curotto A, Di Stasi S, Maffezzini M, Tamagno S, Serretta V, Sogni F, Terrone C, Tizzani A, Morgia G, Mirone V, Carmignani G.","Urol Int. 2011;86(1):19-24. doi: 10.1159/000321926. Epub 2010 Dec 30.","Gontero P","Urol Int","2011","2011/01/04","","","10.1159/000321926"
"32003181","[Current trends in the method used for urine derivation after radical cystectomy for muscle-invasive bladder cancer]","Proskokov AA, Darenkov SP, Agabekian AA, Trofimchuk AD.","Urologiia. 2019 Dec 31;(6):120-124.","Proskokov AA","Urologiia","2019","2020/02/01","","",""
"2456406","Quantitative analysis of keratin 18 in the urine of patients with bladder cancer","Baker WC, deVere White R, Rossitto PV, Min BH, Cardiff RD.","J Urol. 1988 Aug;140(2):436-9. doi: 10.1016/s0022-5347(17)41652-1.","Baker WC","J Urol","1988","1988/08/01","","","10.1016/s0022-5347(17)41652-1"
"6634141","[Primary planocellular cancer of the bladder]","Kondás J.","Orv Hetil. 1983 Aug 7;124(32):1931-6.","Kondás J","Orv Hetil","1983","1983/08/07","","",""
"25095637","[Cathepsin D and B activity in the serum of patients with urothelial bladder cancer]","Guszcz T, Swieczkowska M, Milewska E, Gorodkiewicz E, Kozłowski R, Roszkowska-Jakimiec W.","Pol Merkur Lekarski. 2014 Jun;36(216):386-8.","Guszcz T","Pol Merkur Lekarski","2014","2014/08/07","","",""
"17296362","Pattern of recurrence changes in noninvasive bladder tumors observed during 2 decades","Mariappan P, Smith G, Lamb AD, Grigor KM, Tolley DA.","J Urol. 2007 Mar;177(3):867-75; discussion 875. doi: 10.1016/j.juro.2006.10.048.","Mariappan P","J Urol","2007","2007/02/14","","","10.1016/j.juro.2006.10.048"
"30343012","Strategies for managing multi-patient 3D mass spectrometry imaging data","Vos DRN, Jansen I, Lucas M, Paine MRL, de Boer OJ, Meijer SL, Savci-Heijink CD, Marquering HA, de Bruin DM, Heeren RMA, Ellis SR, Balluff B.","J Proteomics. 2019 Feb 20;193:184-191. doi: 10.1016/j.jprot.2018.10.008. Epub 2018 Oct 19.","Vos DRN","J Proteomics","2019","2018/10/22","","","10.1016/j.jprot.2018.10.008"
"20137863","Behavior of lipiodol markers during image guided radiotherapy of bladder cancer","Chai X, van Herk M, van de Kamer JB, Remeijer P, Bex A, Betgen A, De Reijke TM, Hulshof MC, Pos FJ, Bel A.","Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):309-14. doi: 10.1016/j.ijrobp.2009.08.019. Epub 2010 Feb 4.","Chai X","Int J Radiat Oncol Biol Phys","2010","2010/02/09","","","10.1016/j.ijrobp.2009.08.019"
"20587513","Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells","Harada Y, Kanehira M, Fujisawa Y, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y, Katagiri T.","Cancer Res. 2010 Jul 15;70(14):5829-39. doi: 10.1158/0008-5472.CAN-10-0255. Epub 2010 Jun 29.","Harada Y","Cancer Res","2010","2010/07/01","","","10.1158/0008-5472.CAN-10-0255"
"16724691","Association of cyclooxygenase-2 immunoreactivity with tumor recurrence and disease progression in superficial urothelial bladder cancer","Mokos I, Jakić-Razumović J, Mareković Z, Pasini J.","Tumori. 2006 Mar-Apr;92(2):124-9.","Mokos I","Tumori","2006","2006/05/27","","",""
"2129004","Evaluation of principles in intravesical chemo- and immunotherapy for superficial bladder cancer","Jauhiainen K, Rintala E, Kaasinen E, Ruutu M, Alfthan O.","Arch Esp Urol. 1990;43 Suppl 2:159-64.","Jauhiainen K","Arch Esp Urol","1990","1990/01/01","","",""
"9123696","Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis): its impact on management","Solsona E, Iborra I, Ricós JV, Dumont R, Casanova JL, Calabuig C.","Urology. 1997 Mar;49(3):347-52. doi: 10.1016/S0090-4295(96)00571-7.","Solsona E","Urology","1997","1997/03/01","","","10.1016/S0090-4295(96)00571-7"
"12586807","Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy","Madersbacher S, Hochreiter W, Burkhard F, Thalmann GN, Danuser H, Markwalder R, Studer UE.","J Clin Oncol. 2003 Feb 15;21(4):690-6. doi: 10.1200/JCO.2003.05.101.","Madersbacher S","J Clin Oncol","2003","2003/02/15","","","10.1200/JCO.2003.05.101"
"21263192","Evaluation of urinary proepithelin as a potential biomarker for bladder cancer detection and prognosis in Egyptian patients","Selmy MA, Ibrahim GH, El Serafi TI, Ghobeish AA.","Cancer Biomark. 2010;7(3):163-70. doi: 10.3233/CBM-2010-0186.","Selmy MA","Cancer Biomark","2010","2011/01/26","","","10.3233/CBM-2010-0186"
"726000","The activities of urinary alpha-esterases in bilharziasis and their possible role in the diagnosis of bilharzial bladder cancer in Egypt","el-Sewedy SM, Arafa A, Abdel-Aal G, Mostafa MH.","Trans R Soc Trop Med Hyg. 1978;72(5):525-8. doi: 10.1016/0035-9203(78)90176-1.","el-Sewedy SM","Trans R Soc Trop Med Hyg","1978","1978/01/01","","","10.1016/0035-9203(78)90176-1"
"22689126","[Relationship between bladder cancer and infection by human papillomavirus]","Jiménez-Pacheco A.","Rev Med Chil. 2012 Mar;140(3):406-7. doi: 10.4067/S0034-98872012000300021.","Jiménez-Pacheco A","Rev Med Chil","2012","2012/06/13","","","10.4067/S0034-98872012000300021"
"27775025","Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers","Skowron KB, Pitroda SP, Namm JP, Balogun O, Beckett MA, Zenner ML, Fayanju O, Huang X, Fernandez C, Zheng W, Qiao G, Chin R, Kron SJ, Khodarev NN, Posner MC, Steinberg GD, Weichselbaum RR.","Sci Rep. 2016 Oct 24;6:35854. doi: 10.1038/srep35854.","Skowron KB","Sci Rep","2016","2016/10/25","PMC5075783","","10.1038/srep35854"
"11999461","Molecular aspects of bladder cancer III. Prognostic markers of bladder cancer","Kausch I, Böhle A.","Eur Urol. 2002 Jan;41(1):15-29. doi: 10.1016/s0302-2838(01)00007-0.","Kausch I","Eur Urol","2002","2002/05/10","","","10.1016/s0302-2838(01)00007-0"
"31646822","Prediction of recurrence in non-muscle invasive bladder cancer patients. Do patient characteristics matter?","Ucpinar B, Erbin A, Ayranci A, Caglar U, Alis D, Basal S, Sarilar O, Fatih Akbulut M.","J BUON. 2019 Jul-Aug;24(4):1659-1665.","Ucpinar B","J BUON","2019","2019/10/25","","",""
"30360300","Re: Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review","Griebling TL.","J Urol. 2018 Nov;200(5):922. doi: 10.1016/j.juro.2018.07.080. Epub 2018 Aug 8.","Griebling TL","J Urol","2018","2018/10/27","","","10.1016/j.juro.2018.07.080"
"2329605","Flow cytometric analysis of primary and metastatic bladder cancer","Badalament RA, O'Toole RV, Keyhani-Rofagha S, Barkley C, Kenworthy P, Accetta P, Wise H 2nd, Perez JF, Drago JR.","J Urol. 1990 May;143(5):912-5; discussion 915-6. doi: 10.1016/s0022-5347(17)40134-0.","Badalament RA","J Urol","1990","1990/05/01","","","10.1016/s0022-5347(17)40134-0"
"29451296","Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery","Liu X, Cheng X, Liu X, He L, Zhang W, Wang Y, Sun W, Ji Z.","Int J Cancer. 2018 Jul 15;143(2):408-418. doi: 10.1002/ijc.31323. Epub 2018 Mar 2.","Liu X","Int J Cancer","2018","2018/02/17","","","10.1002/ijc.31323"
"18914794","Segmental resection of the bladder for cancer","DREW JE.","N Y State J Med. 1948 Apr 15;48(8):877.","DREW JE","N Y State J Med","1948","1948/04/15","","",""
"19757199","Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder","Hazzaa SM, Elashry OM, Afifi IK.","Pathol Oncol Res. 2010 Mar;16(1):101-9. doi: 10.1007/s12253-009-9196-3. Epub 2009 Sep 9.","Hazzaa SM","Pathol Oncol Res","2010","2009/09/17","","","10.1007/s12253-009-9196-3"
"26138586","Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis","Eissa S, Matboli M, Essawy NO, Kotb YM.","Tumour Biol. 2015 Dec;36(12):9545-52. doi: 10.1007/s13277-015-3722-6. Epub 2015 Jul 3.","Eissa S","Tumour Biol","2015","2015/07/04","","","10.1007/s13277-015-3722-6"
"30719824","Sulfasalazine could modulate the CD44v9-xCT system and enhance cisplatin-induced cytotoxic effects in metastatic bladder cancer","Ogihara K, Kikuchi E, Okazaki S, Hagiwara M, Takeda T, Matsumoto K, Kosaka T, Mikami S, Saya H, Oya M.","Cancer Sci. 2019 Apr;110(4):1431-1441. doi: 10.1111/cas.13960. Epub 2019 Mar 1.","Ogihara K","Cancer Sci","2019","2019/02/06","PMC6447829","","10.1111/cas.13960"
"12722327","[Cavitary pulmonary metastasis from bladder cancer: a case report]","Yamasaki A, Nakamoto M, Sano H, Yasuda K, Sako T, Watanabe M, Matsumoto S, Tomita K, Igishi T, Hitsuda Y, Shimizu E.","Nihon Kokyuki Gakkai Zasshi. 2003 Feb;41(2):95-8.","Yamasaki A","Nihon Kokyuki Gakkai Zasshi","2003","2003/05/02","","",""
"28498480","Miconazole induces apoptosis via the death receptor 5-dependent and mitochondrial-mediated pathways in human bladder cancer cells","Yuan SY, Shiau MY, Ou YC, Huang YC, Chen CC, Cheng CL, Chiu KY, Wang SS, Tsai KJ.","Oncol Rep. 2017 Jun;37(6):3606-3616. doi: 10.3892/or.2017.5608. Epub 2017 Apr 27.","Yuan SY","Oncol Rep","2017","2017/05/13","","","10.3892/or.2017.5608"
"28378639","Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer","Kumari N, Agrawal U, Mishra AK, Kumar A, Vasudeva P, Mohanty NK, Saxena S.","Tumour Biol. 2017 Apr;39(4):1010428317697552. doi: 10.1177/1010428317697552.","Kumari N","Tumour Biol","2017","2017/04/06","","","10.1177/1010428317697552"
"22742565","Germline prognostic markers for urinary bladder cancer: obstacles and opportunities","Chang DW, Gu J, Wu X.","Urol Oncol. 2012 Jul-Aug;30(4):524-32. doi: 10.1016/j.urolonc.2012.04.003.","Chang DW","Urol Oncol","2012","2012/06/30","PMC3824379","NIHMS522698","10.1016/j.urolonc.2012.04.003"
"1641544","Application of lasers in bladder cancer","Hofstetter AG.","Semin Surg Oncol. 1992 Jul-Aug;8(4):214-6. doi: 10.1002/ssu.2980080406.","Hofstetter AG","Semin Surg Oncol","1992","1992/07/01","","","10.1002/ssu.2980080406"
"24197083","[Neoadjuvant, inductive or adjuvant chemotherapy of bladder cancer]","Ohlmann CH, De Santis M.","Urologe A. 2013 Nov;52(11):1534-8, 1540. doi: 10.1007/s00120-013-3249-7.","Ohlmann CH","Urologe A","2013","2013/11/08","","","10.1007/s00120-013-3249-7"
"11741132","Significance of fluorescence cystoscopy for diagnosis of superficial bladder cancer after intravesical instillation of delta aminolevulinic acid","Ehsan A, Sommer F, Haupt G, Engelmann U.","Urol Int. 2001;67(4):298-304. doi: 10.1159/000051007.","Ehsan A","Urol Int","2001","2001/12/13","","","10.1159/000051007"
"5142970","[Blood group (ABO) and chromosome mosaicism in an old man with bladder cancer]","Rasore-Quartino A, Galletti A.","Pathologica. 1971 Jan-Feb;63(915):37-41.","Rasore-Quartino A","Pathologica","1971","1971/01/01","","",""
"27924711","Occupational risk factors for relapse-free survival in bladder cancer patients","Selinski S, Bürger H, Blaszkewicz M, Otto T, Volkert F, Moormann O, Niedner H, Hengstler JG, Golka K.","J Toxicol Environ Health A. 2016;79(22-23):1136-1143. doi: 10.1080/15287394.2016.1219606.","Selinski S","J Toxicol Environ Health A","2016","2016/12/08","","","10.1080/15287394.2016.1219606"
"10705880","Arsenic in drinking water and bladder cancer","Steinmaus C, Moore L, Hopenhayn-Rich C, Biggs ML, Smith AH.","Cancer Invest. 2000;18(2):174-82. doi: 10.3109/07357900009038249.","Steinmaus C","Cancer Invest","2000","2000/03/08","","","10.3109/07357900009038249"
"20268627","Total cystectomy for carcinoma of the bladder","HIGGINS CC.","J Am Med Assoc. 1947 Nov 8;135(10):619-22. doi: 10.1001/jama.1947.02890100013004.","HIGGINS CC","J Am Med Assoc","1947","2010/03/19","","","10.1001/jama.1947.02890100013004"
"8090898","Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging","Kim B, Semelka RC, Ascher SM, Chalpin DB, Carroll PR, Hricak H.","Radiology. 1994 Oct;193(1):239-45. doi: 10.1148/radiology.193.1.8090898.","Kim B","Radiology","1994","1994/10/01","","","10.1148/radiology.193.1.8090898"
"8712751","Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma","Jurincic-Winkler CD, von der Kammer H, Beuth J, Scheit KH, Klippel KF.","Anticancer Res. 1996 Jul-Aug;16(4A):2105-10.","Jurincic-Winkler CD","Anticancer Res","1996","1996/07/01","","",""
"11423017","The value of cystoscopy, prostate biopsy and frozen-section urethral biopsy prior to orthotopic neobladder substitution","Bulbul MA, Wazzan W, Nasr R, Hemady K.","Can J Urol. 2001 Jun;8(3):1290-2.","Bulbul MA","Can J Urol","2001","2001/06/26","","",""
"473445","Effect of intralesional and systemic BCG-application or a combined cyclophosphamide/BCG treatment on experimental bladder cancer","Adolphs HD, Thiele J, Kiel H.","Urol Res. 1979 Jun 22;7(2):71-8. doi: 10.1007/BF00254684.","Adolphs HD","Urol Res","1979","1979/06/22","","","10.1007/BF00254684"
"30840318","Treatment delays for muscle-invasive bladder cancer","Masic S, Smaldone MC.","Cancer. 2019 Jun 15;125(12):1973-1975. doi: 10.1002/cncr.32047. Epub 2019 Mar 6.","Masic S","Cancer","2019","2019/03/07","","","10.1002/cncr.32047"
"21052889","Suppression of bladder cancer growth in mice by adeno-associated virus vector-mediated endostatin expression","Pan JG, Zhou X, Zeng GW, Han RF.","Tumour Biol. 2011 Apr;32(2):301-10. doi: 10.1007/s13277-010-0122-9. Epub 2010 Oct 30.","Pan JG","Tumour Biol","2011","2010/11/06","","","10.1007/s13277-010-0122-9"
"689839","The initiation, progress, and diagnosis of dog bladder cancer induced by 4-aminobiphenyl","Block NL, Sigel MM, Lynne CM, Ng AB, Grosberg RA.","Invest Urol. 1978 Jul;16(1):50-4.","Block NL","Invest Urol","1978","1978/07/01","","",""
"18663644","Characterisation of radiotherapy planning volumes using textural analysis","Nailon WH, Redpath AT, McLaren DB.","Acta Oncol. 2008;47(7):1303-8. doi: 10.1080/02841860802256467.","Nailon WH","Acta Oncol","2008","2008/07/30","","","10.1080/02841860802256467"
"11275731","Dag-1 carcinoma cell in studying the mechanisms of progression and therapeutic resistance in bladder cancer","Champelovier P, Besse A, Boucard N, Simon A, Leroux D, Pinel N, Praloran V, Seigneurin D.","Eur Urol. 2001 Mar;39(3):343-8. doi: 10.1159/000052465.","Champelovier P","Eur Urol","2001","2001/03/29","","","10.1159/000052465"
"30226613","UCA1 overexpression is associated with less aggressive subtypes of bladder cancer","Lebrun L, Milowich D, Le Mercier M, Allard J, Van Eycke YR, Roumeguere T, Decaestecker C, Salmon I, Rorive S.","Oncol Rep. 2018 Nov;40(5):2497-2506. doi: 10.3892/or.2018.6697. Epub 2018 Sep 10.","Lebrun L","Oncol Rep","2018","2018/09/19","PMC6151879","","10.3892/or.2018.6697"
"22126150","Epigenetics of kidney cancer and bladder cancer","Hoffman AM, Cairns P.","Epigenomics. 2011 Feb;3(1):19-34. doi: 10.2217/epi.10.64.","Hoffman AM","Epigenomics","2011","2011/12/01","PMC3314381","NIHMS362391","10.2217/epi.10.64"
"25400728","Expression and function of SIRT6 in muscle invasive urothelial carcinoma of the bladder","Wu M, Dickinson SI, Wang X, Zhang J.","Int J Clin Exp Pathol. 2014 Sep 15;7(10):6504-13. eCollection 2014.","Wu M","Int J Clin Exp Pathol","2014","2014/11/18","PMC4230126","",""
"17698105","Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems","Schned AR, Andrew AS, Marsit CJ, Zens MS, Kelsey KT, Karagas MR.","J Urol. 2007 Oct;178(4 Pt 1):1196-200; discussion 1200. doi: 10.1016/j.juro.2007.05.126. Epub 2007 Aug 14.","Schned AR","J Urol","2007","2007/08/19","","","10.1016/j.juro.2007.05.126"
"7445510","Cancer of the urinary bladder: international mortality patterns and trends","Staszewski J.","World Health Stat Q. 1980;33(1):27-41.","Staszewski J","World Health Stat Q","1980","1980/01/01","","",""
"25227574","Identification of frequent differentially methylated region in sporadic bladder cancers","Hasegawa R, Fujiwara K, Obinata D, Kawashima H, Shinojima Y, Igarashi J, Wang X, Ghosh S, Nagase H, Takahashi S.","Urol Int. 2015;94(4):479-84. doi: 10.1159/000365197. Epub 2014 Sep 6.","Hasegawa R","Urol Int","2015","2014/09/18","","","10.1159/000365197"
"20995311","The treatment of carcinoma of the bladder","ADAMS P, HUNT HB.","Nebr State Med J. 1946 Sep;31:373-6.","ADAMS P","Nebr State Med J","1946","2010/10/29","","",""
"402621","Topic of cancer. Clinical comments and critique of an audit of urinary bladder tumors","Fifer WR.","QRB Qual Rev Bull. 1977 Jan;3(1):11-9.","Fifer WR","QRB Qual Rev Bull","1977","1977/01/01","","",""
"20675267","Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain","Cantor KP, Villanueva CM, Silverman DT, Figueroa JD, Real FX, Garcia-Closas M, Malats N, Chanock S, Yeager M, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castaño-Vinyals G, Samanic C, Rothman N, Kogevinas M.","Environ Health Perspect. 2010 Nov;118(11):1545-50. doi: 10.1289/ehp.1002206.","Cantor KP","Environ Health Perspect","2010","2010/08/03","PMC2974691","","10.1289/ehp.1002206"
"3064861","Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report","Shearer RJ, Chilvers CF, Bloom HJ, Bliss JM, Horwich A, Babiker A.","Br J Urol. 1988 Dec;62(6):558-64. doi: 10.1111/j.1464-410x.1988.tb04426.x.","Shearer RJ","Br J Urol","1988","1988/12/01","","","10.1111/j.1464-410x.1988.tb04426.x"
"18880469","Carcinoma of the urinary bladder; a pathologic study with special reference to invasiveness and vascular invasion","McDONALD JR, THOMPSON GJ.","J Urol. 1948 Sep;60(3):435-45. doi: 10.1016/s0022-5347(17)69257-7.","McDONALD JR","J Urol","1948","1948/09/01","","","10.1016/s0022-5347(17)69257-7"
"31950922","Outcomes of bladder preservation therapy on survival in patients with muscle-invasive bladder cancer","Özaydın Ş, Ataş E, Karadurmuş N, Emirzeoğlu L, Arpacı F.","Arch Esp Urol. 2020 Jan;73(1):41-46.","Özaydın Ş","Arch Esp Urol","2020","2020/01/18","","",""
"23972522","Re: Günter Niegisch, Anja Lorch, Michael J. Droller, Hugh J. Lavery, Kristian D. Stensland, Peter Albers. Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit? Eur Urol 2013;64:355-7","Black P, Kassouf W.","Eur Urol. 2014 Jan;65(1):e8-9. doi: 10.1016/j.eururo.2013.08.016. Epub 2013 Aug 17.","Black P","Eur Urol","2014","2013/08/27","","","10.1016/j.eururo.2013.08.016"
"27787873","Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710","Ojerholm E, Smith A, Hwang WT, Baumann BC, Tucker KN, Lerner SP, Mamtani R, Boursi B, Christodouleas JP.","Cancer. 2017 Mar 1;123(5):794-801. doi: 10.1002/cncr.30422. Epub 2016 Oct 27.","Ojerholm E","Cancer","2017","2016/10/28","PMC5319875","NIHMS830825","10.1002/cncr.30422"
"27581238","[S3 guideline for bladder cancer : Claim and reality - a critical commentary from the guideline coordinators]","Retz M, Maisch P, Gschwend JE.","Urologe A. 2016 Sep;55(9):1188-91. doi: 10.1007/s00120-016-0196-0.","Retz M","Urologe A","2016","2016/09/02","","","10.1007/s00120-016-0196-0"
"23342660","[Clonal origin of multiple foci of urinary bladder cancer]","Babaian AIu, Andreeva IuIu, Zaletaev DV, Nemtsova MV.","Arkh Patol. 2012 Sep-Oct;74(5):44-50.","Babaian AIu","Arkh Patol","2012","2013/01/25","","",""
"1305678","Activity of 4-HPR in superficial bladder cancer using DNA flow cytometry as an intermediate endpoint","Decensi A, Bruno S, Giaretti W, Torrisi R, Curotto A, Gatteschi B, Geido E, Polizzi A, Costantini M, Bruzzi P, et al.","J Cell Biochem Suppl. 1992;16I:139-47. doi: 10.1002/jcb.240501327.","Decensi A","J Cell Biochem Suppl","1992","1992/01/01","","","10.1002/jcb.240501327"
"27364982","Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer","Buisan O, Orsola A, Areal J, Font A, Oliveira M, Martinez R, Ibarz L.","Clin Genitourin Cancer. 2017 Feb;15(1):145-151.e2. doi: 10.1016/j.clgc.2016.05.004. Epub 2016 Jun 1.","Buisan O","Clin Genitourin Cancer","2017","2016/07/02","","","10.1016/j.clgc.2016.05.004"
"22768238","A microRNA-7 binding site polymorphism in HOXB5 leads to differential gene expression in bladder cancer","Luo J, Cai Q, Wang W, Huang H, Zeng H, He W, Deng W, Yu H, Chan E, Ng CF, Huang J, Lin T.","PLoS One. 2012;7(6):e40127. doi: 10.1371/journal.pone.0040127. Epub 2012 Jun 29.","Luo J","PLoS One","2012","2012/07/07","PMC3387002","","10.1371/journal.pone.0040127"
"1980959","Molecular analysis of human bladder cancer","Olumi AF, Skinner EC, Tsai YC, Jones PA.","Semin Urol. 1990 Nov;8(4):270-7.","Olumi AF","Semin Urol","1990","1990/11/01","","",""
"23083868","Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer","Rink M, Xylinas E, Babjuk M, Hansen J, Pycha A, Comploj E, Lotan Y, Sun M, Karakiewicz PI, Abdennabi J, Fajkovic H, Loidl W, Chun FK, Fisch M, Scherr DS, Shariat SF.","J Urol. 2012 Dec;188(6):2120-7. doi: 10.1016/j.juro.2012.08.029. Epub 2012 Oct 18.","Rink M","J Urol","2012","2012/10/23","","","10.1016/j.juro.2012.08.029"
"28889380","Detection of APOBEC3 Proteins and Catalytic Activity in Urothelial Carcinoma","Jaguva Vasudevan AA, Goering W, Häussinger D, Münk C.","Methods Mol Biol. 2018;1655:97-107. doi: 10.1007/978-1-4939-7234-0_8.","Jaguva Vasudevan AA","Methods Mol Biol","2018","2017/09/11","","","10.1007/978-1-4939-7234-0_8"
"2728130","Bladder carcinoma in patients less than 40 years of age","Witjes JA, Debruyne FM.","Urol Int. 1989;44(2):81-3. doi: 10.1159/000281475.","Witjes JA","Urol Int","1989","1989/01/01","","","10.1159/000281475"
"8164050","Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer","Herr HW, Scher HI.","J Clin Oncol. 1994 May;12(5):975-80. doi: 10.1200/JCO.1994.12.5.975.","Herr HW","J Clin Oncol","1994","1994/05/01","","","10.1200/JCO.1994.12.5.975"
"6504903","Cobalt therapy prophylaxis of recurrence of T1 bladder cancer","Pow-Sang J, Zaharia M, Ramirez G, Garcia J, Benavente V, Gonzales J.","Prog Clin Biol Res. 1984;162B:33-7.","Pow-Sang J","Prog Clin Biol Res","1984","1984/01/01","","",""
"29345160","Inherited forms of bladder cancer: a review of Lynch syndrome and other inherited conditions","Phelan A, Lopez-Beltran A, Montironi R, Zhang S, Raspollini MR, Cheng M, Kaimakliotis HZ, Koch MO, Cheng L.","Future Oncol. 2018 Feb;14(3):277-290. doi: 10.2217/fon-2017-0346. Epub 2018 Jan 18.","Phelan A","Future Oncol","2018","2018/01/19","","","10.2217/fon-2017-0346"
"25551284","MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44","Yu G, Yao W, Xiao W, Li H, Xu H, Lang B.","J Exp Clin Cancer Res. 2014 Dec 31;33(1):779. doi: 10.1186/s13046-014-0115-4.","Yu G","J Exp Clin Cancer Res","2014","2015/01/01","PMC4311467","","10.1186/s13046-014-0115-4"
"872112","Current state of classification and staging of bladder cancer","Skinner DG.","Cancer Res. 1977 Aug;37(8 Pt 2):2838-42.","Skinner DG","Cancer Res","1977","1977/08/01","","",""
"1698117","Flow cytometric DNA analysis after immunoselection of bladder tumor cells with monoclonal antibody DU83.21","Wright GL Jr, Alexander JP, Konchuba AM, Schellhammer PF, Schlossberg SM.","Cancer. 1990 Sep 15;66(6):1242-52. doi: 10.1002/1097-0142(19900915)66:6<1242::aid-cncr2820660626>3.0.co;2-y.","Wright GL Jr","Cancer","1990","1990/09/25","","","10.1002/1097-0142(19900915)66:6<1242::aid-cncr2820660626>3.0.co;2-y"
"22086680","Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice","Yoon JI, Kim SI, Tommasi S, Besaratinia A.","Cancer Prev Res (Phila). 2012 Feb;5(2):299-308. doi: 10.1158/1940-6207.CAPR-11-0309. Epub 2011 Nov 15.","Yoon JI","Cancer Prev Res (Phila)","2012","2011/11/17","","","10.1158/1940-6207.CAPR-11-0309"
"10792176","Induction of apoptosis by mitomycin-C in an ex vivo model of bladder cancer","Kelly JD, Williamson KE, Weir HP, McManus DT, Hamilton PW, Keane PF, Johnston SR.","BJU Int. 2000 May;85(7):911-7. doi: 10.1046/j.1464-410x.2000.00667.x.","Kelly JD","BJU Int","2000","2000/05/03","","","10.1046/j.1464-410x.2000.00667.x"
"9224308","Prognostic value of Ki-67 for recurrence and progression of superficial bladder cancer","Asakura T, Takano Y, Iki M, Suwa Y, Noguchi S, Kubota Y, Masuda M.","J Urol. 1997 Aug;158(2):385-8.","Asakura T","J Urol","1997","1997/08/01","","",""
"24752096","[Value of dual-phase (18)F-FDG PET/CT in preoperative staging of bladder cancer]","Li H, Wu H, Wang Q, Han Y, Wang Q.","Nan Fang Yi Ke Da Xue Xue Bao. 2014 Apr;34(4):500-3.","Li H","Nan Fang Yi Ke Da Xue Xue Bao","2014","2014/04/23","","",""
"20067461","Survival of patients with bladder cancer from a UK hospital: a 10-year follow-up study","Low VJ, Wang D, Abel PD.","BJU Int. 2010 Jun;105(12):1667-71. doi: 10.1111/j.1464-410X.2009.09071.x. Epub 2010 Jan 8.","Low VJ","BJU Int","2010","2010/01/14","","","10.1111/j.1464-410X.2009.09071.x"
"30205925","[ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology]","Pignot G, Houédé N, Roumiguié M, Audenet F, Brunelle S, Colin P, Compérat E, Larré S, Masson-Lecomte A, Neuzillet Y, Xylinas E, Méjean A, Rouprêt M; les membres du CCAFU Vessie.","Prog Urol. 2018 Oct;28(12):567-574. doi: 10.1016/j.purol.2018.07.003. Epub 2018 Sep 8.","Pignot G","Prog Urol","2018","2018/09/13","","","10.1016/j.purol.2018.07.003"
"11130620","Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men","Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci E.","Am J Epidemiol. 2000 Dec 15;152(12):1145-53. doi: 10.1093/aje/152.12.1145.","Michaud DS","Am J Epidemiol","2000","2000/12/29","","","10.1093/aje/152.12.1145"
"24586564","Prognostic relevance of urinary bladder cancer susceptibility loci","Grotenhuis AJ, Dudek AM, Verhaegh GW, Witjes JA, Aben KK, van der Marel SL, Vermeulen SH, Kiemeney LA.","PLoS One. 2014 Feb 25;9(2):e89164. doi: 10.1371/journal.pone.0089164. eCollection 2014.","Grotenhuis AJ","PLoS One","2014","2014/03/04","PMC3934869","","10.1371/journal.pone.0089164"
"15277356","Protein profiling in urine for the diagnosis of bladder cancer","Vlahou A, Giannopoulos A, Gregory BW, Manousakas T, Kondylis FI, Wilson LL, Schellhammer PF, Wright GL Jr, Semmes OJ.","Clin Chem. 2004 Aug;50(8):1438-41. doi: 10.1373/clinchem.2003.028035.","Vlahou A","Clin Chem","2004","2004/07/28","","","10.1373/clinchem.2003.028035"
"28625024","[Post-Operative Single Immediate Intravesical Instillation Chemotherapy as Prophylaxis for Reccurence after Transurethral Resection of Low Risk Non-Muscle-Invasive Bladder Cancer]","Sugiura S, Noto N, Koizumi M, Takamoto D, Fujikawa N, Ikeda I.","Hinyokika Kiyo. 2017 May;63(5):183-187. doi: 10.14989/ActaUrolJap_63_5_183.","Sugiura S","Hinyokika Kiyo","2017","2017/06/19","","","10.14989/ActaUrolJap_63_5_183"
"12900006","Combination of intravesical chemotherapy and hyperthermia for the treatment of superficial bladder cancer: preliminary clinical experience","Colombo R, Salonia A, Da Pozzo LF, Naspro R, Freschi M, Paroni R, Pavone-Macaluso M, Rigatti P.","Crit Rev Oncol Hematol. 2003 Aug;47(2):127-39. doi: 10.1016/s1040-8428(03)00076-3.","Colombo R","Crit Rev Oncol Hematol","2003","2003/08/06","","","10.1016/s1040-8428(03)00076-3"
"20272535","Cancer of the bladder and prostate","HUGGINS C, JOHNSON MA.","J Am Med Assoc. 1947 Dec 27;135(17):1146-52. doi: 10.1001/jama.1947.62890170001007.","HUGGINS C","J Am Med Assoc","1947","2010/03/19","","","10.1001/jama.1947.62890170001007"
"29468604","Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014","Groeben C, Koch R, Baunacke M, Schmid M, Borkowetz A, Wirth MP, Huber J.","Ann Surg Oncol. 2018 Nov;25(12):3502-3509. doi: 10.1245/s10434-018-6381-1. Epub 2018 Feb 21.","Groeben C","Ann Surg Oncol","2018","2018/02/23","","","10.1245/s10434-018-6381-1"
"617536","Radiation therapy of experimental murine bladder cancer - synergism with cisplatinum diamminedichloride","Soloway MS, Gehrki G.","Surg Forum. 1977;28:559-61.","Soloway MS","Surg Forum","1977","1977/01/01","","",""
"9634071","The use of the bladder-tumour associated analyte test to determine the type of cystoscopy in the follow-up of patients with bladder cancer","Kirollos MM.","Br J Urol. 1998 May;81(5):781-2.","Kirollos MM","Br J Urol","1998","1998/06/20","","",""
"32123936","Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer","Shiota M, Fujimoto N, Yamamoto Y, Takeuchi A, Tatsugami K, Uchiumi T, Matsuyama H, Eto M.","Cancer Immunol Immunother. 2020 Jul;69(7):1155-1163. doi: 10.1007/s00262-020-02533-8. Epub 2020 Mar 2.","Shiota M","Cancer Immunol Immunother","2020","2020/03/04","","","10.1007/s00262-020-02533-8"
"12623505","Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer -- Nordic cystectomy trial 2","Sherif A, Rintala E, Mestad O, Nilsson J, Holmberg L, Nilsson S, Malmström PU; Nordic Urothelial Cancer Group.","Scand J Urol Nephrol. 2002;36(6):419-25. doi: 10.1080/003655902762467567.","Sherif A","Scand J Urol Nephrol","2002","2003/03/08","","","10.1080/003655902762467567"
"1879967","Diet and bladder cancer in Spain: a multi-centre case-control study","Riboli E, González CA, López-Abente G, Errezola M, Izarzugaza I, Escolar A, Nebot M, Hémon B, Agudo A.","Int J Cancer. 1991 Sep 9;49(2):214-9. doi: 10.1002/ijc.2910490212.","Riboli E","Int J Cancer","1991","1991/09/09","","","10.1002/ijc.2910490212"
"24040330","Glutathione S-transferase T1, O1 and O2 polymorphisms are associated with survival in muscle invasive bladder cancer patients","Djukic TI, Savic-Radojevic AR, Pekmezovic TD, Matic MG, Pljesa-Ercegovac MS, Coric VM, Radic TM, Suvakov SR, Krivic BN, Dragicevic DP, Simic TP.","PLoS One. 2013 Sep 11;8(9):e74724. doi: 10.1371/journal.pone.0074724. eCollection 2013.","Djukic TI","PLoS One","2013","2013/09/17","PMC3770566","","10.1371/journal.pone.0074724"
"29859728","Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry","Daneshmand S, Bazargani ST, Bivalacqua TJ, Holzbeierlein JM, Willard B, Taylor JM, Liao JC, Pohar K, Tierney J, Konety B; Blue Light Cystoscopy with Cysview Registry Group.","Urol Oncol. 2018 Aug;36(8):361.e1-361.e6. doi: 10.1016/j.urolonc.2018.04.013. Epub 2018 May 30.","Daneshmand S","Urol Oncol","2018","2018/06/04","","","10.1016/j.urolonc.2018.04.013"
"24856484","Re-examination of the natural history of high-grade T1 bladder cancer using a large contemporary cohort","Canter DJ, Revenig LM, Smith ZL, Dobbs RW, Malkowicz SB, Issa MM, Guzzo TJ.","Int Braz J Urol. 2014 Mar-Apr;40(2):172-8. doi: 10.1590/S1677-5538.IBJU.2014.02.06.","Canter DJ","Int Braz J Urol","2014","2014/05/27","","","10.1590/S1677-5538.IBJU.2014.02.06"
"22013484","Tumor and microenvironment modification during progression of murine orthotopic bladder cancer","Tham SM, Ng KH, Pook SH, Esuvaranathan K, Mahendran R.","Clin Dev Immunol. 2011;2011:865684. doi: 10.1155/2011/865684. Epub 2011 Oct 13.","Tham SM","Clin Dev Immunol","2011","2011/10/21","PMC3195679","","10.1155/2011/865684"
"17333520","Pathological review of internal genitalia after anterior exenteration for bladder cancer in women. Evaluating risk factors for female organ involvement","Varkarakis IM, Pinggera G, Antoniou N, Constantinides K, Chrisofos M, Deliveliotis C.","Int Urol Nephrol. 2007;39(4):1015-21. doi: 10.1007/s11255-006-9158-6. Epub 2007 Mar 1.","Varkarakis IM","Int Urol Nephrol","2007","2007/03/03","","","10.1007/s11255-006-9158-6"
"29524970","Analysis of bladder cancer subtypes in neurogenic bladder tumors","Manach Q, Cussenot O, Rouprêt M, Gamé X, Chartier-Kastler E, Reus C, Camparo P, Compérat E, Phé V.","Can J Urol. 2018 Feb;25(1):9161-9167.","Manach Q","Can J Urol","2018","2018/03/12","","",""
"20279575","Carcinoma of the bladder; a classification of epithelial tumors and a study of the effects of external radiation","COLBY FH, SNIFFEN RC.","J Urol. 1947 Jan;57(1):133-9. doi: 10.1016/s0022-5347(17)69604-6.","COLBY FH","J Urol","1947","2010/03/19","","","10.1016/s0022-5347(17)69604-6"
"14533194","Combination with CD/5-FC gene therapy enhances killing of human bladder-cancer cells by radiation","Zhang Z, Shirakawa T, Hinata N, Matsumoto A, Fujisawa M, Okada H, Kamidono S, Matsuo M, Gotoh A.","J Gene Med. 2003 Oct;5(10):860-867. doi: 10.1002/jgm.408.","Zhang Z","J Gene Med","2003","2003/10/09","","","10.1002/jgm.408"
"2302672","Urethral involvement in female patients with bladder cancer. A study of 22 cystectomy specimens","De Paepe ME, André R, Mahadevia P.","Cancer. 1990 Mar 1;65(5):1237-41. doi: 10.1002/1097-0142(19900301)65:5<1237::aid-cncr2820650534>3.0.co;2-r.","De Paepe ME","Cancer","1990","1990/03/01","","","10.1002/1097-0142(19900301)65:5<1237::aid-cncr2820650534>3.0.co;2-r"
"25443267","Treatment and survival in patients with recurrent high-risk non-muscle-invasive bladder cancer","Chamie K, Ballon-Landa E, Daskivich TJ, Bassett JC, Lai J, Hanley JM, Konety BR, Litwin MS, Saigal CS; Urologic Diseases in America Project.","Urol Oncol. 2015 Jan;33(1):20.e9-20.e17. doi: 10.1016/j.urolonc.2014.08.016. Epub 2014 Nov 7.","Chamie K","Urol Oncol","2015","2014/12/03","PMC4274185","NIHMS633893","10.1016/j.urolonc.2014.08.016"
"23179944","Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique","Nayak B, Dogra PN, Naswa N, Kumar R.","Eur J Nucl Med Mol Imaging. 2013 Feb;40(3):386-93. doi: 10.1007/s00259-012-2294-6. Epub 2012 Nov 24.","Nayak B","Eur J Nucl Med Mol Imaging","2013","2012/11/27","","","10.1007/s00259-012-2294-6"
"25242381","Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy","Rouanne M, Girma A, Neuzillet Y, Vilain D, Radulescu C, Letang N, Yonneau L, Hervé JM, Botto H, Le Stanc E, Lebret T.","Eur J Surg Oncol. 2014 Dec;40(12):1724-30. doi: 10.1016/j.ejso.2014.08.479. Epub 2014 Sep 9.","Rouanne M","Eur J Surg Oncol","2014","2014/09/23","","","10.1016/j.ejso.2014.08.479"
"15311037","Association between volume and charges for most frequently performed ambulatory and nonambulatory surgery for bladder cancer. Is more cheaper?","Konety BR, Dhawan V, Allareddy V, O'Donnell MA.","J Urol. 2004 Sep;172(3):1056-61. doi: 10.1097/01.ju.0000136382.51688.21.","Konety BR","J Urol","2004","2004/08/18","","","10.1097/01.ju.0000136382.51688.21"
"12629332","The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer","Smith ND, Rubenstein JN, Eggener SE, Kozlowski JM.","J Urol. 2003 Apr;169(4):1219-28. doi: 10.1097/01.ju.0000056085.58221.80.","Smith ND","J Urol","2003","2003/03/12","","","10.1097/01.ju.0000056085.58221.80"
"12884874","Lymphadenopathy of sinus histiocytosis mimicking metastatic bladder cancer: a case report","Asano T, Ohtsuka Y, Takagi K, Aida J, Okada Y, Ito Y.","Int J Clin Oncol. 2003 Jun;8(3):184-6. doi: 10.1007/s10147-003-0326-8.","Asano T","Int J Clin Oncol","2003","2003/07/30","","","10.1007/s10147-003-0326-8"
"30261082","Prediction of intravesical recurrence of non-muscle-invasive bladder cancer by evaluation of intratumoral Foxp3+ T cells in the primary transurethral resection of bladder tumor specimens","Murai R, Itoh Y, Kageyama S, Nakayama M, Ishigaki H, Teramoto K, Narita M, Yoshida T, Tomita K, Kobayashi KI, Wada A, Nagasawa M, Kubota S, Ogasawara K, Kawauchi A.","PLoS One. 2018 Sep 27;13(9):e0204745. doi: 10.1371/journal.pone.0204745. eCollection 2018.","Murai R","PLoS One","2018","2018/09/28","PMC6160186","","10.1371/journal.pone.0204745"
"15330506","FISH--a new noninvasive method for the diagnosis of urinary bladder carcinomas","Lübbe L, Nowack R, May M, Ullmann K, Gunia S, Kaufmann O, Hakenberg O, Muche J, Hoschke B.","Clin Lab. 2004;50(7-8):395-402.","Lübbe L","Clin Lab","2004","2004/08/28","","",""
"29848133","Therapeutic strategies for upper tract urothelial carcinoma","Freifeld Y, Krabbe LM, Clinton TN, Woldu SL, Margulis V.","Expert Rev Anticancer Ther. 2018 Aug;18(8):765-774. doi: 10.1080/14737140.2018.1481395. Epub 2018 Jun 8.","Freifeld Y","Expert Rev Anticancer Ther","2018","2018/06/01","","","10.1080/14737140.2018.1481395"
"7669571","Heat shock protein expression in testis and bladder cancer cell lines exhibiting differential sensitivity to heat","Richards EH, Hickman JA, Masters JR.","Br J Cancer. 1995 Sep;72(3):620-6. doi: 10.1038/bjc.1995.383.","Richards EH","Br J Cancer","1995","1995/09/01","PMC2033863","","10.1038/bjc.1995.383"
"5774215","Role of tryptophan metabolites in urinary bladder cancer","Bryan GT.","Am Ind Hyg Assoc J. 1969 Jan-Feb;30(1):27-34. doi: 10.1080/00028896909343075.","Bryan GT","Am Ind Hyg Assoc J","1969","1969/01/01","","","10.1080/00028896909343075"
"4085529","Short-term and long-term effect of prophylactic treatment of superficial bladder cancer with intravesical adriamycin","Fosså SD, Urnes T, Ous S.","Eur Urol. 1985;11(6):382-5. doi: 10.1159/000472545.","Fosså SD","Eur Urol","1985","1985/01/01","","","10.1159/000472545"
"2758391","Histologic changes in the urinary bladder in relation to cigarette smoking and use of artificial sweeteners","Auerbach O, Garfinkel L.","Cancer. 1989 Sep 1;64(5):983-7. doi: 10.1002/1097-0142(19890901)64:5<983::aid-cncr2820640502>3.0.co;2-9.","Auerbach O","Cancer","1989","1989/09/01","","","10.1002/1097-0142(19890901)64:5<983::aid-cncr2820640502>3.0.co;2-9"
"30669187","Editorial Comment from Dr Miyata et al. to Impact of serum sodium concentration on survival outcomes in patients with invasive bladder cancer without metastasis treated by cystectomy","Miyata Y, Matsuo T, Sakai H.","Int J Urol. 2019 Mar;26(3):432. doi: 10.1111/iju.13893. Epub 2019 Jan 22.","Miyata Y","Int J Urol","2019","2019/01/23","","","10.1111/iju.13893"
"30131436","Soy Isoflavone Intake and Bladder Cancer Risk in Japan: From the Takayama Study","Wada K, Tsuji M, Tamura T, Konishi K, Goto Y, Mizuta F, Koda S, Uji T, Hori A, Tanabashi S, Matsushita S, Tokimitsu N, Nagata C.","Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1371-1375. doi: 10.1158/1055-9965.EPI-18-0283. Epub 2018 Aug 21.","Wada K","Cancer Epidemiol Biomarkers Prev","2018","2018/08/23","","","10.1158/1055-9965.EPI-18-0283"
"20067452","Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial","Bolenz C, Herrmann E, Bastian PJ, Michel MS, Wülfing C, Tiemann A, Buchner A, Stief CG, Fritsche HM, Burger M, Wieland WF, Höfner T, Haferkamp A, Hohenfellner M, Müller SC, Ströbel P, Trojan L.","BJU Int. 2010 Aug;106(4):493-9. doi: 10.1111/j.1464-410X.2009.09166.x. Epub 2010 Jan 8.","Bolenz C","BJU Int","2010","2010/01/14","","","10.1111/j.1464-410X.2009.09166.x"
"28398951","Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances","Paner GP, Montironi R, Amin MB.","Adv Anat Pathol. 2017 May;24(3):113-127. doi: 10.1097/PAP.0000000000000152.","Paner GP","Adv Anat Pathol","2017","2017/04/12","","","10.1097/PAP.0000000000000152"
"6810530","Systemic mitomycin C versus cisplatin: comparison of antitumor activity in primary murine bladder cancer","Hopkins SC, Matheny R, Soloway MS.","Urology. 1982 Aug;20(2):157-9. doi: 10.1016/0090-4295(82)90348-x.","Hopkins SC","Urology","1982","1982/08/01","","","10.1016/0090-4295(82)90348-x"
"20628239","Exon 2 methylation inhibits hepaCAM expression in transitional cell carcinoma of the bladder","Pan C, Wu X, Luo C, Yang S, Pu J, Wang C, Shen S.","Urol Int. 2010;85(3):347-54. doi: 10.1159/000318889. Epub 2010 Jul 13.","Pan C","Urol Int","2010","2010/07/15","","","10.1159/000318889"
"29804311","Bladder cancer in nonagenarians: a multicentre study of 123 patients","Eredics K, Bretterbauer KM, Comploj E, Friedl A, Gschliesser T, Lenart S, Seklehner S, Wimpissinger F, Madersbacher S.","BJU Int. 2018 Dec;122(6):1010-1015. doi: 10.1111/bju.14419. Epub 2018 Jul 26.","Eredics K","BJU Int","2018","2018/05/28","","","10.1111/bju.14419"
"29471596","[Clinical Benefits of Transurethral Resection Under Narrow Band Imaging for Non-Muscle Invasive Bladder Cancer]","Mita K, Kobatake K, Ohara S, Kato M.","Hinyokika Kiyo. 2018 Jan;64(1):1-6. doi: 10.14989/ActaUrolJap_64_1_1.","Mita K","Hinyokika Kiyo","2018","2018/02/23","","","10.14989/ActaUrolJap_64_1_1"
"15565330","Immunotherapy for superficial bladder cancer","Schenk-Braat EA, Bangma CH.","Cancer Immunol Immunother. 2005 May;54(5):414-23. doi: 10.1007/s00262-004-0621-x. Epub 2004 Nov 23.","Schenk-Braat EA","Cancer Immunol Immunother","2005","2004/11/27","","","10.1007/s00262-004-0621-x"
"31253481","Indoleamine-2,3-dioxygenase-1 expression predicts poorer survival and up-regulates ZEB2 expression in human early stage bladder cancer","Tsai YS, Jou YC, Tsai HT, Cheong IS, Tzai TS.","Urol Oncol. 2019 Nov;37(11):810.e17-810.e27. doi: 10.1016/j.urolonc.2019.05.005. Epub 2019 Jun 26.","Tsai YS","Urol Oncol","2019","2019/06/30","","","10.1016/j.urolonc.2019.05.005"
"31233191","Tumor‑infiltrating M2 macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer","Xue Y, Tong L, LiuAnwei Liu F, Liu A, Zeng S, Xiong Q, Yang Z, He X, Sun Y, Xu C.","Oncol Rep. 2019 Aug;42(2):581-594. doi: 10.3892/or.2019.7196. Epub 2019 Jun 12.","Xue Y","Oncol Rep","2019","2019/06/25","PMC6610042","","10.3892/or.2019.7196"
"7324293","[Computer-based measurements of bladder cancer urothelial cells by high-resolution microscopic-cytophotometric system (author's transl)]","Aeikens B, Liedtke CE, Haussman G, Knitsch G, Hartmann F.","Urol Int. 1981;36(5):298-306. doi: 10.1159/000280774.","Aeikens B","Urol Int","1981","1981/01/01","","","10.1159/000280774"
"8709344","Mycobacterium cell wall: an alternative to intravesical bacillus Calmette Guerin (BCG) therapy in orthotopic murine bladder cancer","Chin JL, Kadhim SA, Batislam E, Karlik SJ, Garcia BM, Nickel JC, Morales A.","J Urol. 1996 Sep;156(3):1189-93. doi: 10.1016/s0022-5347(01)65748-3.","Chin JL","J Urol","1996","1996/09/01","","","10.1016/s0022-5347(01)65748-3"
"20998258","Carcinoma of the bladder","FLOCKS RH.","Can Med Assoc J. 1946 Oct;55:348-56.","FLOCKS RH","Can Med Assoc J","1946","2010/10/29","","",""
"29644616","Genetic aberrations of the K-ras proto-oncogene in bladder cancer in relation to pesticide exposure","Hameed DA, Yassa HA, Agban MN, Hanna RT, Elderwy AM, Zwaita MA.","Environ Sci Pollut Res Int. 2018 Aug;25(22):21535-21542. doi: 10.1007/s11356-018-1840-6. Epub 2018 Apr 12.","Hameed DA","Environ Sci Pollut Res Int","2018","2018/04/13","","","10.1007/s11356-018-1840-6"
"15978568","Patient-recognition data-mining model for BCG-plus interferon immunotherapy bladder cancer treatment","Shah SC, Kusiak A, O'Donnell MA.","Comput Biol Med. 2006 Jun;36(6):634-55. doi: 10.1016/j.compbiomed.2005.03.007. Epub 2005 Jun 22.","Shah SC","Comput Biol Med","2006","2005/06/28","","","10.1016/j.compbiomed.2005.03.007"
"10482489","Observations on the effect of abolishing analgesic abuse and reducing smoking on cancers of the kidney and bladder in New South Wales, Australia, 1972-1995","McCredie M, Stewart J, Smith D, Supramaniam R, Williams S.","Cancer Causes Control. 1999 Aug;10(4):303-11. doi: 10.1023/a:1008900319043.","McCredie M","Cancer Causes Control","1999","1999/09/11","","","10.1023/a:1008900319043"
"1546409","Value of urine cytology versus bladder washing in bladder cancer","Matzkin H, Moinuddin SM, Soloway MS.","Urology. 1992 Mar;39(3):201-3. doi: 10.1016/0090-4295(92)90288-8.","Matzkin H","Urology","1992","1992/03/01","","","10.1016/0090-4295(92)90288-8"
"12545628","[Prognostic value of tumor location of urothelial tumors of the bladder, after total cystectomy]","Martin M, Bernardini S, Kleinclauss F, Della Negra E, Henry PC, Bittard H.","Prog Urol. 2002 Dec;12(6):1221-7.","Martin M","Prog Urol","2002","2003/01/28","","",""
"29642505","BMP9 Promotes the Proliferation and Migration of Bladder Cancer Cells through Up-Regulating lncRNA UCA1","Gou L, Liu M, Xia J, Wan Q, Jiang Y, Sun S, Tang M, Zhou L, He T, Zhang Y.","Int J Mol Sci. 2018 Apr 8;19(4):1116. doi: 10.3390/ijms19041116.","Gou L","Int J Mol Sci","2018","2018/04/13","PMC5979556","","10.3390/ijms19041116"
"15455244","Adaptive doses of irradiation-an approach to a new therapy concept for bladder cancer?","Schaffer M, Schwarz SB, Kulka U, Busch M, Dühmke E.","Radiat Environ Biophys. 2004 Dec;43(4):271-6. doi: 10.1007/s00411-004-0256-5. Epub 2004 Sep 29.","Schaffer M","Radiat Environ Biophys","2004","2004/09/30","","","10.1007/s00411-004-0256-5"
"31626080","Periodically rotated overlapping parallel lines with enhanced reconstruction acquisition to improve motion-induced artifacts in bladder cancer imaging: Initial findings","Nguyen HT, Shah ZK, Mortazavi A, Pohar KS, Wei L, Zynger DL, Knopp MV.","Medicine (Baltimore). 2019 Oct;98(42):e17075. doi: 10.1097/MD.0000000000017075.","Nguyen HT","Medicine (Baltimore)","2019","2019/10/19","PMC6824794","","10.1097/MD.0000000000017075"
"24675483","Shortcomings in bladder cancer etiology research and a model for its prevention","Radosavljevic V, Belojevic G.","Tumori. 2014 Jan-Feb;100(1):1-8. doi: 10.1700/1430.15807.","Radosavljevic V","Tumori","2014","2014/03/29","","","10.1700/1430.15807"
"30395172","Cell-type-specific CD73 expression is an independent prognostic factor in bladder cancer","Koivisto MK, Tervahartiala M, Kenessey I, Jalkanen S, Boström PJ, Salmi M.","Carcinogenesis. 2019 Mar 12;40(1):84-92. doi: 10.1093/carcin/bgy154.","Koivisto MK","Carcinogenesis","2019","2018/11/06","","","10.1093/carcin/bgy154"
"16923503","EUS-guided FNA for the diagnosis of recurrent bladder cancer through the ileal conduit: a novel approach","Eloubeidi MA, Varadarajulu S, El-Galley R, Bueschen AJ, Eltoum I.","Gastrointest Endosc. 2006 Sep;64(3):450-3. doi: 10.1016/j.gie.2006.02.050. Epub 2006 Jun 6.","Eloubeidi MA","Gastrointest Endosc","2006","2006/08/23","","","10.1016/j.gie.2006.02.050"
"16525693","Comparative study of intelligent models for the prediction of bladder cancer progression","Abbod MF, Linkens DA, Catto JW, Hamdy FC.","Oncol Rep. 2006;15 Spec no.:1019-22. doi: 10.3892/or.15.4.1019.","Abbod MF","Oncol Rep","2006","2006/03/10","","","10.3892/or.15.4.1019"
"1517282","Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two-grade classification system for TCC based on mitotic index","Lipponen PK, Eskelinen MJ, Jauhiainen K, Harju E, Terho P, Haapasalo H.","J Cancer Res Clin Oncol. 1992;118(8):615-20. doi: 10.1007/BF01211807.","Lipponen PK","J Cancer Res Clin Oncol","1992","1992/01/01","","","10.1007/BF01211807"
"16816072","Comparative outcomes of bladder cancer","Cárdenas-Turanzas M, Cooksley C, Pettaway CA, Sabichi A, Grossman HB, Elting L.","Obstet Gynecol. 2006 Jul;108(1):169-75. doi: 10.1097/01.AOG.0000223885.25192.91.","Cárdenas-Turanzas M","Obstet Gynecol","2006","2006/07/04","","","10.1097/01.AOG.0000223885.25192.91"
"1300747","[The quality of life of patients after cystectomy for cancer]","Gotsadze DT, Pirtskhalaishvili GG.","Vopr Onkol. 1992;38(4):489-93.","Gotsadze DT","Vopr Onkol","1992","1992/01/01","","",""
"3487405","Interleukin-2 production during intravesical bacille Calmette-Guerin therapy for bladder cancer","Ratliff TL, Haaff EO, Catalona WJ.","Clin Immunol Immunopathol. 1986 Aug;40(2):375-9. doi: 10.1016/0090-1229(86)90043-7.","Ratliff TL","Clin Immunol Immunopathol","1986","1986/08/01","","","10.1016/0090-1229(86)90043-7"
"2034200","NIOSH alert: request for assistance in preventing bladder cancer from exposure to o-toluidine and aniline","Centers for Disease Control (CDC).","MMWR Morb Mortal Wkly Rep. 1991 May 31;40(21):353-4.","Centers for Disease Control (CDC)","MMWR Morb Mortal Wkly Rep","1991","1991/05/31","","",""
"8522858","[Predictive value of urinary cytology in the diagnosis of urothelial tumors]","Benizri E, Volpe P, Bastéris B, Poisson J, Chevallier D, Peyrottes A, Colomb F, Amiel J, Kermarec J, Toubol J.","J Urol (Paris). 1995;101(2):77-9.","Benizri E","J Urol (Paris)","1995","1995/01/01","","",""
"9309138","[Tumor suppressive function of gelsolin]","Kuzumaki N, Tanaka M, Sakai N, Fujita H.","Gan To Kagaku Ryoho. 1997 Sep;24(11):1436-41.","Kuzumaki N","Gan To Kagaku Ryoho","1997","1997/10/06","","",""
"28560602","Progression to T1 High Grade (T1HG) from a Lower Stage/Grade is Associated with Poorer Survival Outcomes than Initial Diagnosis with T1HG Bladder Cancer","Kim JK, Jeong CW, Kwak C, Kim HH, Ku JH.","Ann Surg Oncol. 2017 Aug;24(8):2413-2419. doi: 10.1245/s10434-017-5902-7. Epub 2017 May 30.","Kim JK","Ann Surg Oncol","2017","2017/06/01","","","10.1245/s10434-017-5902-7"
"10673790","[Role of urinary cytology in the study of bladder cancer. Comparison with the BTA test]","Iori F, De Matteis A, Frioni D, De Dominicis C, Leonardo C, Vahedi M, Laurenti C.","Arch Ital Urol Androl. 1999 Dec;71(5):279-82.","Iori F","Arch Ital Urol Androl","1999","2000/02/16","","",""
"18858056","Carcinoma and sarcoma of bladder; report of unusual simultaneous occurrence of both tumors","MACKLES A, IMMERGUT S, et al.","J Urol. 1948 Jun;59(6):1121-6. doi: 10.1016/s0022-5347(17)69487-4.","MACKLES A","J Urol","1948","1948/06/01","","","10.1016/s0022-5347(17)69487-4"
"2169999","Myxoid malignant fibrous histiocytoma of the bladder","Oesterling JE, Epstein JI, Brendler CB.","Cancer. 1990 Oct 15;66(8):1836-42. doi: 10.1002/1097-0142(19901015)66:8<1836::aid-cncr2820660832>3.0.co;2-y.","Oesterling JE","Cancer","1990","1990/10/15","","","10.1002/1097-0142(19901015)66:8<1836::aid-cncr2820660832>3.0.co;2-y"
"1378910","Urinary tissue factor levels in transitional cell carcinoma of the bladder","Adamson AS, Francis JL, Roath OS, Witherow RO, Snell ME.","J Urol. 1992 Aug;148(2 Pt 1):449-52. doi: 10.1016/s0022-5347(17)36626-0.","Adamson AS","J Urol","1992","1992/08/01","","","10.1016/s0022-5347(17)36626-0"
"18692879","Aberrant prothymosin-alpha expression in human bladder cancer","Tsai YS, Jou YC, Lee GF, Chen YC, Shiau AL, Tsai HT, Wu CL, Tzai TS.","Urology. 2009 Jan;73(1):188-92. doi: 10.1016/j.urology.2008.05.031. Epub 2008 Aug 9.","Tsai YS","Urology","2009","2008/08/12","","","10.1016/j.urology.2008.05.031"
"18139967","[About five recent cases of bladder cancer]","LEGAULT JP.","Union Med Can. 1949 Sep;78(9):1079.","LEGAULT JP","Union Med Can","1949","1949/09/01","","",""
"23914742","Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA","López V, González-Peramato P, Suela J, Serrano A, Algaba F, Cigudosa JC, Vidal A, Bellmunt J, Heredero O, Sánchez-Carbayo M.","J Transl Med. 2013 Aug 1;11:182. doi: 10.1186/1479-5876-11-182.","López V","J Transl Med","2013","2013/08/07","PMC3750577","","10.1186/1479-5876-11-182"
"18990150","Thymidylate synthase was associated with patient prognosis and the response to adjuvant therapy in bladder cancer","Li Y, Li X, Dai H, Sun X, Li J, Yang F, Gu H, Yang Y, Jin Z, Chu Y, Jin X, Kakehi Y, Wu X.","BJU Int. 2009 Feb;103(4):547-52. doi: 10.1111/j.1464-410X.2008.08099.x. Epub 2008 Oct 16.","Li Y","BJU Int","2009","2008/11/08","","","10.1111/j.1464-410X.2008.08099.x"
"617696","[A case of explosive bilharzic cancer of the bladder]","Auvert J, Perrin JL, Abbou CC.","J Urol Nephrol (Paris). 1977;83 Suppl 2:369.","Auvert J","J Urol Nephrol (Paris)","1977","1977/01/01","","",""
"26408880","Apoptosis-inducing effects of lentinan on the proliferation of human bladder cancer T24 cells","Bao L, Wang Y, Ma R, Ren X, Cheng R, B A.","Pak J Pharm Sci. 2015 Sep;28(5):1595-600.","Bao L","Pak J Pharm Sci","2015","2015/09/27","","",""
"16566978","Association of PAX5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder","Babjuk M, Soukup V, Mares J, Dusková J, Pecen L, Pesl M, Pavlík I, DvorRcek J.","Urology. 2006 Apr;67(4):756-61. doi: 10.1016/j.urology.2005.10.053. Epub 2006 Mar 29.","Babjuk M","Urology","2006","2006/03/29","","","10.1016/j.urology.2005.10.053"
"20015287","Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors","Seow SW, Cai S, Rahmat JN, Bay BH, Lee YK, Chan YH, Mahendran R.","Cancer Sci. 2010 Mar;101(3):751-8. doi: 10.1111/j.1349-7006.2009.01426.x. Epub 2009 Nov 6.","Seow SW","Cancer Sci","2010","2009/12/18","","","10.1111/j.1349-7006.2009.01426.x"
"6002441","[Some data on cancer of the urinary bladder in Egypt]","Demin VN.","Urol Nefrol (Mosk). 1966 Nov-Dec;31(6):44-6.","Demin VN","Urol Nefrol (Mosk)","1966","1966/11/01","","",""
"25218240","Expression level of dihydropyrimidine dehydrogenase is associated with clinical outcome in patients with T1G3 bladder cancer treated with Bacillus Calmette-Guerin","Ide H, Kikuchi E, Mikami S, Miyajima A, Oya M.","BMC Res Notes. 2014 Sep 13;7:646. doi: 10.1186/1756-0500-7-646.","Ide H","BMC Res Notes","2014","2014/09/15","PMC4169840","","10.1186/1756-0500-7-646"
"30241738","Découverte inattendue d’une métastase vésicale d’un cancer du sein","Denize J, Bugel H, Bou Nasr E, Delcourt C, Lefebure A.","Gynecol Obstet Fertil Senol. 2018 Nov;46(10-11):749-750. doi: 10.1016/j.gofs.2018.08.003. Epub 2018 Sep 18.","Denize J","Gynecol Obstet Fertil Senol","2018","2018/09/23","","","10.1016/j.gofs.2018.08.003"
"15072883","Expression of lung resistance-related protein in transitional cell carcinoma of bladder","Zhu Y, Kong C, Zeng Y, Sun Z, Gao H.","Urology. 2004 Apr;63(4):694-8. doi: 10.1016/j.urology.2003.11.021.","Zhu Y","Urology","2004","2004/04/10","","","10.1016/j.urology.2003.11.021"
"19154503","A chemosensitivity test to individualize intravesical treatment for non-muscle-invasive bladder cancer","Gazzaniga P, Gradilone A, de Berardinis E, Sciarra A, Cristini C, Naso G, di Silverio F, Frati L, Aglianò AM.","BJU Int. 2009 Jul;104(2):184-8. doi: 10.1111/j.1464-410X.2008.08342.x. Epub 2009 Jan 19.","Gazzaniga P","BJU Int","2009","2009/01/22","","","10.1111/j.1464-410X.2008.08342.x"
"15868902","Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model","Perabo FG, Demant AW, Wirger A, Schmidt DH, Sitia M, Wardelmann E, Müller SC, Kohn EC.","Anticancer Res. 2005 Mar-Apr;25(2A):725-9.","Perabo FG","Anticancer Res","2005","2005/05/05","","",""
"9394909","High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder","Pham HT, Soloway MS.","Semin Urol Oncol. 1997 Aug;15(3):147-53.","Pham HT","Semin Urol Oncol","1997","1997/08/01","","",""
"21943777","Re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU Guidelines. Eur Urol 2011;59:1009-18","Sundar S.","Eur Urol. 2011 Dec;60(6):e51. doi: 10.1016/j.eururo.2011.08.079. Epub 2011 Sep 17.","Sundar S","Eur Urol","2011","2011/09/28","","","10.1016/j.eururo.2011.08.079"
"14659044","Clinical aspects for the use of DNA image cytometry in detection of bladder cancer: a valuable tool?","Krause FS, Feil G, Bichler KH, Schrott KM, Akcetin ZY.","DNA Cell Biol. 2003 Nov;22(11):721-5. doi: 10.1089/104454903770946692.","Krause FS","DNA Cell Biol","2003","2003/12/09","","","10.1089/104454903770946692"
"5410693","Advanced cancer of the urinary bladder. An analysis of the results of radiotherapy alone vs. radiotherapy and concomitant 5-fluorouracil; a prospective randomized study of 36 cases","Edland RW, Wear JB Jr, Ansfield FJ.","Am J Roentgenol Radium Ther Nucl Med. 1970 Jan;108(1):124-9. doi: 10.2214/ajr.108.1.124.","Edland RW","Am J Roentgenol Radium Ther Nucl Med","1970","1970/01/01","","","10.2214/ajr.108.1.124"
"16979723","Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer--analysis of role of pelvic lymph node dissection","Honma I, Masumori N, Sato E, Maeda T, Hirobe M, Kitamura H, Takahashi A, Itoh N, Tamakawa M, Tsukamoto T.","Urology. 2006 Sep;68(3):543-8. doi: 10.1016/j.urology.2006.03.049. Epub 2006 Sep 18.","Honma I","Urology","2006","2006/09/19","","","10.1016/j.urology.2006.03.049"
"28753746","Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer","Colombo R, Hurle R, Moschini M, Freschi M, Colombo P, Colecchia M, Ferrari L, Lucianò R, Conti G, Magnani T, Capogrosso P, Conti A, Pasini L, Burgio G, Guazzoni G, Patriarca C.","Eur Urol Focus. 2018 Jan;4(1):87-93. doi: 10.1016/j.euf.2016.06.004. Epub 2016 Jun 15.","Colombo R","Eur Urol Focus","2018","2017/07/30","","","10.1016/j.euf.2016.06.004"
"26073099","Prediction of mortality after radical cystectomy for bladder cancer by machine learning techniques","Wang G, Lam KM, Deng Z, Choi KS.","Comput Biol Med. 2015 Aug;63:124-32. doi: 10.1016/j.compbiomed.2015.05.015. Epub 2015 May 29.","Wang G","Comput Biol Med","2015","2015/06/16","","","10.1016/j.compbiomed.2015.05.015"
"31030231","The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy","Renninger M, Fahmy O, Schubert T, Schmid MA, Hassan F, Stenzl A, Gakis G.","World J Urol. 2020 Feb;38(2):397-406. doi: 10.1007/s00345-019-02780-0. Epub 2019 Apr 27.","Renninger M","World J Urol","2020","2019/04/29","","","10.1007/s00345-019-02780-0"
"27613302","[Tumorigenesis from a pathological perspective : Tumor spread and epigenetically regulated genes in bladder cancer]","Gaisa NT.","Pathologe. 2016 Nov;37(Suppl 2):196-203. doi: 10.1007/s00292-016-0207-3.","Gaisa NT","Pathologe","2016","2016/09/11","","","10.1007/s00292-016-0207-3"
"12926068","cIAP-2 block apoptotic events in bladder cancer cells","Jönsson G, Paulie S, Grandien A.","Anticancer Res. 2003 Jul-Aug;23(4):3311-6.","Jönsson G","Anticancer Res","2003","2003/08/21","","",""
"19288008","The role of Id-1 in chemosensitivity and epirubicin-induced apoptosis in bladder cancer cells","Hu H, Han HY, Wang YL, Zhang XP, Chua CW, Wong YC, Wang XF, Ling MT, Xu KX.","Oncol Rep. 2009 Apr;21(4):1053-9. doi: 10.3892/or_00000323.","Hu H","Oncol Rep","2009","2009/03/17","","","10.3892/or_00000323"
"15882724","Differences between urologists in United States and Canada in approach to bladder cancer","Chung D, Hersey K, Fleshner N.","Urology. 2005 May;65(5):919-25. doi: 10.1016/j.urology.2004.11.028.","Chung D","Urology","2005","2005/05/11","","","10.1016/j.urology.2004.11.028"
"24396870","Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1","Han Y, Liu Y, Zhang H, Wang T, Diao R, Jiang Z, Gui Y, Cai Z.","FEBS Lett. 2013 Nov 29;587(23):3875-82.","Han Y","FEBS Lett","2013","2014/01/08","","",""
"21956088","The androgen receptor and stem cell pathways in prostate and bladder cancers (review)","Marcinkiewicz K, Scotland KB, Boorjian SA, Nilsson EM, Persson JL, Abrahamsson PA, Allegrucci C, Hughes IA, Gudas LJ, Mongan NP.","Int J Oncol. 2012 Jan;40(1):5-12. doi: 10.3892/ijo.2011.1212. Epub 2011 Sep 28.","Marcinkiewicz K","Int J Oncol","2012","2011/09/30","PMC4371775","NIHMS633240","10.3892/ijo.2011.1212"
"27907054","DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis","Dai L, Ma C, Zhang Z, Zeng S, Liu A, Tang S, Ren Q, Sun Y, Xu C.","PLoS One. 2016 Dec 1;11(12):e0167228. doi: 10.1371/journal.pone.0167228. eCollection 2016.","Dai L","PLoS One","2016","2016/12/02","PMC5132202","","10.1371/journal.pone.0167228"
"16012709","Molecular clonal analysis of recurrent bladder cancer","Junker K, Wolf M, Schubert J.","Oncol Rep. 2005 Aug;14(2):319-23.","Junker K","Oncol Rep","2005","2005/07/14","","",""
"20279574","Mucinous adenocarcinoma of the bladder","PATCH FS, PRITCHARD JE.","J Urol. 1947 Jan;57(1):126-32. doi: 10.1016/s0022-5347(17)69603-4.","PATCH FS","J Urol","1947","2010/03/19","","","10.1016/s0022-5347(17)69603-4"
"31089397","Prognostic Significance of the Lymphocyte-to-Monocyte Ratio in Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis of 5638 Individuals","Ma JY, Hu G, Liu Q.","Dis Markers. 2019 Apr 4;2019:7593560. doi: 10.1155/2019/7593560. eCollection 2019.","Ma JY","Dis Markers","2019","2019/05/16","PMC6476040","","10.1155/2019/7593560"
"29226853","Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis","Xiong J, Xiong K, Bing Z.","Cancer Biomark. 2018 Feb 14;21(3):535-546. doi: 10.3233/CBM-170314.","Xiong J","Cancer Biomark","2018","2017/12/12","","","10.3233/CBM-170314"
"30041283","Expression of receptor activator of nuclear factor kappa B ligand in bladder cancer","Ohtaka M, Kawahara T, Ishiguro Y, Sharma M, Yao M, Miyamoto H, Uemura H.","Int J Urol. 2018 Oct;25(10):901-902. doi: 10.1111/iju.13756. Epub 2018 Jul 24.","Ohtaka M","Int J Urol","2018","2018/07/25","","","10.1111/iju.13756"
"28479117","Health care services utilization during the last 6 months of life among patients with bladder cancer who underwent radical cystectomy in Quebec, Canada","Zakaria AS, Santos F, Dragomir A, Kassouf W, Tanguay S, Aprikian A.","Urol Oncol. 2017 Sep;35(9):539.e1-539.e7. doi: 10.1016/j.urolonc.2017.04.005. Epub 2017 May 4.","Zakaria AS","Urol Oncol","2017","2017/05/09","","","10.1016/j.urolonc.2017.04.005"
"30690810","Editorial Comment to Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer","Teishima J, Matsubara A.","Int J Urol. 2019 Mar;26(3):340-341. doi: 10.1111/iju.13906. Epub 2019 Jan 28.","Teishima J","Int J Urol","2019","2019/01/29","","","10.1111/iju.13906"
"27267320","lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence","Zhang S, Zhong G, He W, Yu H, Huang J, Lin T.","J Urol. 2016 Oct;196(4):1270-8. doi: 10.1016/j.juro.2016.05.107. Epub 2016 Jun 5.","Zhang S","J Urol","2016","2016/06/09","","","10.1016/j.juro.2016.05.107"
"22460090","Increased expression of DNA repair gene XPF enhances resistance to hydroxycamptothecin in bladder cancer","Li J, Zhang J, Liu Y, Ye G.","Med Sci Monit. 2012 Apr;18(4):BR156-62. doi: 10.12659/msm.882618.","Li J","Med Sci Monit","2012","2012/03/31","PMC3560829","","10.12659/msm.882618"
"22119253","Up-regulation of plakophilin-2 and Down-regulation of plakophilin-3 are correlated with invasiveness in bladder cancer","Takahashi H, Nakatsuji H, Takahashi M, Avirmed S, Fukawa T, Takemura M, Fukumori T, Kanayama H.","Urology. 2012 Jan;79(1):240.e1-8. doi: 10.1016/j.urology.2011.08.049. Epub 2011 Nov 25.","Takahashi H","Urology","2012","2011/11/29","","","10.1016/j.urology.2011.08.049"
"18291016","Urine-based markers in bladder cancer: future prospects","McNeil BK, Getzenberg RH.","BJU Int. 2008 Mar;101(6):668-9. doi: 10.1111/j.1464-410X.2007.07439.x.","McNeil BK","BJU Int","2008","2008/02/23","","","10.1111/j.1464-410X.2007.07439.x"
"3546888","[Pathological staging of bladder cancer by percutaneous needle biopsy of all layers of the bladder wall]","Tochigi T, Yoshikawa K, Hoshi S, Orikasa S, Ono K, Katoh M.","Nihon Hinyokika Gakkai Zasshi. 1986 Oct;77(10):1578-84. doi: 10.5980/jpnjurol1928.77.10_1578.","Tochigi T","Nihon Hinyokika Gakkai Zasshi","1986","1986/10/01","","","10.5980/jpnjurol1928.77.10_1578"
"20042437","Dairy intake and the risk of bladder cancer in the Netherlands Cohort Study on Diet and Cancer","Keszei AP, Schouten LJ, Goldbohm RA, van den Brandt PA.","Am J Epidemiol. 2010 Feb 15;171(4):436-46. doi: 10.1093/aje/kwp399. Epub 2009 Dec 30.","Keszei AP","Am J Epidemiol","2010","2010/01/01","","","10.1093/aje/kwp399"
"25214293","[Should we propose a systematic second transurethral resection of the bladder for all high-risk non-muscle invasive bladder cancers?]","Lipsker A, Hammoudi Y, Parier B, Drai J, Bahi R, Bessede T, Patard JJ, Pignot G.","Prog Urol. 2014 Sep;24(10):640-5. doi: 10.1016/j.purol.2014.03.006. Epub 2014 Apr 29.","Lipsker A","Prog Urol","2014","2014/09/13","","","10.1016/j.purol.2014.03.006"
"1499608","Analysis of criteria for grading bladder cancer in urine cytological tumor diagnosis by means of an expert system","Nafe R, Roth S, Rathert P.","Eur Urol. 1992;21(2):103-9. doi: 10.1159/000474813.","Nafe R","Eur Urol","1992","1992/01/01","","","10.1159/000474813"
"4051447","Hepatic acetylator phenotype in bladder cancer patients","Ladero JM, Kwok CK, Jara C, Fernandez L, Silmi AM, Tapia D, Uson AC.","Ann Clin Res. 1985;17(3):96-9.","Ladero JM","Ann Clin Res","1985","1985/01/01","","",""
"17998728","A prospective study evaluating surgery and chemo radiation in muscle invasive bladder cancer","Haresh KP, Julka PK, Sharma DN, Rath GK, Prabhakar R, Seth A.","J Cancer Res Ther. 2007 Apr-Jun;3(2):81-5. doi: 10.4103/0973-1482.34684.","Haresh KP","J Cancer Res Ther","2007","2007/11/14","","","10.4103/0973-1482.34684"
"12352459","Prostaglandin E2 production and cyclooxygenase-2 induction in human urinary tract infections and bladder cancer","Wheeler MA, Hausladen DA, Yoon JH, Weiss RM.","J Urol. 2002 Oct;168(4 Pt 1):1568-73. doi: 10.1097/01.ju.0000030583.31299.80.","Wheeler MA","J Urol","2002","2002/09/28","","","10.1097/01.ju.0000030583.31299.80"
"19846907","Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer","Gee JR, Burmeister CB, Havighurst TC, Kim K.","Anticancer Res. 2009 Oct;29(10):3769-75.","Gee JR","Anticancer Res","2009","2009/10/23","PMC2955297","NIHMS235481",""
"25015855","Reduced glucocorticoid receptor expression predicts bladder tumor recurrence and progression","Ishiguro H, Kawahara T, Zheng Y, Netto GJ, Miyamoto H.","Am J Clin Pathol. 2014 Aug;142(2):157-64. doi: 10.1309/AJCPU8UCEZYG4WTV.","Ishiguro H","Am J Clin Pathol","2014","2014/07/13","PMC4337856","NIHMS662078","10.1309/AJCPU8UCEZYG4WTV"
"28534961","Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells","Chen M, Lv JM, Ye JQ, Cui XG, Qu FJ, Chen L, Liu X, Pan XW, Li L, Huang H, Yang QW, Chen J, Wang LH, Gao Y, Xu DF.","Int J Oncol. 2017 Jul;51(1):39-48. doi: 10.3892/ijo.2017.3997. Epub 2017 May 16.","Chen M","Int J Oncol","2017","2017/05/24","PMC5467789","","10.3892/ijo.2017.3997"
"1142521","Partial cystectomy in the treatment of bladder cancer","Evans RA, Texter JH Jr.","J Urol. 1975 Sep;114(3):391-3. doi: 10.1016/s0022-5347(17)67037-x.","Evans RA","J Urol","1975","1975/09/11","","","10.1016/s0022-5347(17)67037-x"
"21437837","[Bladder cancer screening with urine-based tumour markers - occupational medical experience]","Nasterlack M, Feil G, Leng G, Pesch B, Huber S, Sievert KD, Johnen G, Taeger D, Mayer T, Kluckert M, Brüning T, Stenzl A.","Aktuelle Urol. 2011 Mar;42(2):128-34. doi: 10.1055/s-0031-1271424. Epub 2011 Mar 24.","Nasterlack M","Aktuelle Urol","2011","2011/03/26","","","10.1055/s-0031-1271424"
"24331576","EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer","May M, Burger M, Brookman-May S, Stief CG, Fritsche HM, Roigas J, Zacharias M, Bader M, Mandel P, Gilfrich C, Seitz M, Tilki D.","Clin Genitourin Cancer. 2014 Aug;12(4):278-86. doi: 10.1016/j.clgc.2013.11.014. Epub 2013 Nov 13.","May M","Clin Genitourin Cancer","2014","2013/12/17","","","10.1016/j.clgc.2013.11.014"
"20290759","Carcinoma of urinary bladder with unusual metastases in a young male; clinicopathologic case report","BOUTON SM Jr, SCHANZ RF.","Urol Cutaneous Rev. 1947 Jan;51(1):33-6.","BOUTON SM Jr","Urol Cutaneous Rev","1947","2010/03/19","","",""
"23083874","Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer","Djaladat H, Bruins HM, Miranda G, Cai J, Skinner EC, Daneshmand S.","J Urol. 2012 Dec;188(6):2134-8. doi: 10.1016/j.juro.2012.08.024. Epub 2012 Oct 18.","Djaladat H","J Urol","2012","2012/10/23","","","10.1016/j.juro.2012.08.024"
"22248521","Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure","Fernández MI, López JF, Vivaldi B, Coz F.","J Urol. 2012 Mar;187(3):856-61. doi: 10.1016/j.juro.2011.10.157. Epub 2012 Jan 15.","Fernández MI","J Urol","2012","2012/01/18","","","10.1016/j.juro.2011.10.157"
"21454009","Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines","Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA; European Association of Urology (EAU).","Eur Urol. 2011 Jun;59(6):1009-18. doi: 10.1016/j.eururo.2011.03.023. Epub 2011 Mar 23.","Stenzl A","Eur Urol","2011","2011/04/02","","","10.1016/j.eururo.2011.03.023"
"14566826","HER-2 and TOP2A coamplification in urinary bladder cancer","Simon R, Atefy R, Wagner U, Forster T, Fijan A, Bruderer J, Wilber K, Mihatsch MJ, Gasser T, Sauter G.","Int J Cancer. 2003 Dec 10;107(5):764-72. doi: 10.1002/ijc.11477.","Simon R","Int J Cancer","2003","2003/10/21","","","10.1002/ijc.11477"
"10661347","Prognostic factors in invasive bladder carcinoma treated by combined modality protocol (organ-sparing approach)","Matos T, Cufer T, Cervek J, Bornstnar S, Kragelj B, Zumer-Pregelj M.","Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):403-9. doi: 10.1016/s0360-3016(99)00385-5.","Matos T","Int J Radiat Oncol Biol Phys","2000","2000/02/08","","","10.1016/s0360-3016(99)00385-5"
"6529950","Salvage cystectomy: the case for a combined abdominoperineal approach","Boccon Gibod L, Leleu C, Steg A.","Eur Urol. 1984;10(6):370-1. doi: 10.1159/000463836.","Boccon Gibod L","Eur Urol","1984","1984/01/01","","","10.1159/000463836"
"9477183","Significance of the BTA test in bladder cancer: a multicenter trial. BTA Study Group Japan","Miyanaga N, Akaza H, Kameyama S, Hachiya T, Ozono S, Kuroda M, Koga H, Koiso K.","Int J Urol. 1997 Nov;4(6):557-60. doi: 10.1111/j.1442-2042.1997.tb00308.x.","Miyanaga N","Int J Urol","1997","1998/02/26","","","10.1111/j.1442-2042.1997.tb00308.x"
"30654104","Low serum 25-hydroxyvitamin D is associated with increased bladder cancer risk: A systematic review and evidence of a potential mechanism","Dunn JA, Jefferson K, MacDonald D, Iqbal G, Bland R.","J Steroid Biochem Mol Biol. 2019 Apr;188:134-140. doi: 10.1016/j.jsbmb.2019.01.002. Epub 2019 Jan 14.","Dunn JA","J Steroid Biochem Mol Biol","2019","2019/01/18","","","10.1016/j.jsbmb.2019.01.002"
"5554091","Hydronephrosis and survival rate in bladder cancer","Yu R, Goldfarb M, Bayuk J.","Int Surg. 1971 Apr;55(4):283-7.","Yu R","Int Surg","1971","1971/04/01","","",""
"3238838","[Is bladder wall resection in cancer of the urinary bladder obsolete?]","Kollwitz AA, Mangel J, Wechsel HW.","Urologe A. 1988 Nov;27(6):352-5.","Kollwitz AA","Urologe A","1988","1988/11/01","","",""
"11514784","Diagnosis and management of superficial bladder cancer","Amling CL.","Curr Probl Cancer. 2001 Jul-Aug;25(4):219-78. doi: 10.1067/mcn.2001.117539.","Amling CL","Curr Probl Cancer","2001","2001/08/22","","","10.1067/mcn.2001.117539"
"29335609","Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy","Peng D, Zhang CJ, Gong YQ, Hao H, Guan B, Li XS, Zhou LQ.","Sci Rep. 2018 Jan 15;8(1):794. doi: 10.1038/s41598-018-19146-y.","Peng D","Sci Rep","2018","2018/01/17","PMC5768698","","10.1038/s41598-018-19146-y"
"21154810","Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility","Kawata N, Tsuchiya N, Horikawa Y, Inoue T, Tsuruta H, Maita S, Satoh S, Mitobe Y, Narita S, Habuchi T.","Int J Cancer. 2011 Oct 15;129(8):1872-80. doi: 10.1002/ijc.25850. Epub 2011 Mar 8.","Kawata N","Int J Cancer","2011","2010/12/15","","","10.1002/ijc.25850"
"1277156","Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy","Farrow GM, Utz DC, Rife CC.","Cancer Res. 1976 Jul;36(7 PT 2):2495-501.","Farrow GM","Cancer Res","1976","1976/07/01","","",""
"9615198","Molecular cytogenetics of bladder cancer progression","Sauter G, Moch H, Mihatsch MJ, Gasser TC.","Eur Urol. 1998;33 Suppl 4:9-10. doi: 10.1159/000052252.","Sauter G","Eur Urol","1998","1998/06/06","","","10.1159/000052252"
"26733163","Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients","Liu X, Yao D, Liu C, Cao Y, Yang Q, Sun Z, Liu D.","Tumour Biol. 2016 Jun;37(6):8367-74. doi: 10.1007/s13277-015-4703-5. Epub 2016 Jan 5.","Liu X","Tumour Biol","2016","2016/01/07","","","10.1007/s13277-015-4703-5"
"10203616","Prognostic value of p27Kip1 and p21WAF/Cip protein expression in muscle invasive bladder cancer","Kuczyk MA, Machtens S, Bokemeyer C, Hradil K, Macheel I, Jetscho V, Hartmann J, Thon WF, Jonas U, Serth J.","Oncol Rep. 1999 May-Jun;6(3):687-93. doi: 10.3892/or.6.3.687.","Kuczyk MA","Oncol Rep","1999","1999/04/16","","","10.3892/or.6.3.687"
"16100943","Effects of exogenous wild-type P16 gene transfection on the expression of cell cycle-related proteins in bladder cancer cell line","Li L, Yang T, Lian X.","Cancer Invest. 2005;23(4):309-15. doi: 10.1081/cnv-58815.","Li L","Cancer Invest","2005","2005/08/17","","","10.1081/cnv-58815"
"8996338","Is routine excretory urography necessary at first diagnosis of bladder cancer?","Goessl C, Knispel HH, Miller K, Klän R.","J Urol. 1997 Feb;157(2):480-1.","Goessl C","J Urol","1997","1997/02/01","","",""
"15237578","Non-occupational risk factors for bladder cancer: a case-control study","Radosavljević V, Janković S, Marinković J, Dokić M.","Tumori. 2004 Mar-Apr;90(2):175-80.","Radosavljević V","Tumori","2004","2004/07/09","","",""
"7721515","Occupational exposure to polycyclic aromatic hydrocarbons and the risk of bladder cancer: a French case-control study","Clavel J, Mandereau L, Limasset JC, Hémon D, Cordier S.","Int J Epidemiol. 1994 Dec;23(6):1145-53. doi: 10.1093/ije/23.6.1145.","Clavel J","Int J Epidemiol","1994","1994/12/01","","","10.1093/ije/23.6.1145"
"22748884","Re: Li et al.: Milk and dairy consumption and risk of bladder cancer: a meta-analysis (Urology 2011;78:1298-1305)","Zhang ZH, Yang LS, Sun YH.","Urology. 2012 Jul;80(1):231-2; author reply 232. doi: 10.1016/j.urology.2012.02.037.","Zhang ZH","Urology","2012","2012/07/04","","","10.1016/j.urology.2012.02.037"
"24729055","Conceptualizing global health-related quality of life in bladder cancer","Perlis N, Krahn M, Alibhai S, Finelli A, Ritvo P, Bremner KE, Kulkarni G.","Qual Life Res. 2014 Oct;23(8):2153-67. doi: 10.1007/s11136-014-0685-9. Epub 2014 Apr 13.","Perlis N","Qual Life Res","2014","2014/04/15","","","10.1007/s11136-014-0685-9"
"29454321","Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer","Pulido M, Roubaud G, Cazeau AL, Mahammedi H, Vedrine L, Joly F, Mourey L, Pfister C, Goberna A, Lortal B, Bellera C, Pourquier P, Houédé N.","BMC Cancer. 2018 Feb 17;18(1):194. doi: 10.1186/s12885-018-4059-5.","Pulido M","BMC Cancer","2018","2018/02/19","PMC5816357","","10.1186/s12885-018-4059-5"
"28521777","CIP2A mediates fibronectin-induced bladder cancer cell proliferation by stabilizing β-catenin","Gao F, Xu T, Wang X, Zhong S, Chen S, Zhang M, Zhang X, Shen Y, Wang X, Xu C, Shen Z.","J Exp Clin Cancer Res. 2017 May 18;36(1):70. doi: 10.1186/s13046-017-0539-8.","Gao F","J Exp Clin Cancer Res","2017","2017/05/20","PMC5437599","","10.1186/s13046-017-0539-8"
"10604314","Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome","Herr HW.","J Urol. 2000 Jan;163(1):60-1; discussion 61-2.","Herr HW","J Urol","2000","1999/12/22","","",""
"2593431","[Mainz pouch using the appendix as the efferent limb]","Yokoyama M, Iwata H, Matsumoro A, Takeuchi M.","Nihon Hinyokika Gakkai Zasshi. 1989 Nov;80(11):1584-8. doi: 10.5980/jpnjurol1989.80.1584.","Yokoyama M","Nihon Hinyokika Gakkai Zasshi","1989","1989/11/01","","","10.5980/jpnjurol1989.80.1584"
"22104567","IL-4 and TNF-α polymorphisms are associated with risk of multiple superficial tumors or carcinoma in situ development","Lima L, Silva J, Amaro T, Morais A, Lopes C, Medeiros R, Videira PA, Santos L.","Urol Int. 2011;87(4):457-63. doi: 10.1159/000331882. Epub 2011 Nov 18.","Lima L","Urol Int","2011","2011/11/23","","","10.1159/000331882"
"22335321","Screening for bladder cancer","Croswell J, Fall B.","Am Fam Physician. 2012 Feb 15;85(4):401-2.","Croswell J","Am Fam Physician","2012","2012/02/17","","",""
"1396941","Optimal BCG treatment of superficial bladder cancer as defined by American trials","Lamm DL.","Eur Urol. 1992;21 Suppl 2:12-6. doi: 10.1159/000474915.","Lamm DL","Eur Urol","1992","1992/01/01","","","10.1159/000474915"
"17956523","Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients","Denzinger S, Otto W, Fritsche HM, Roessler W, Wieland WF, Hartmann A, Burger M.","Int J Urol. 2007 Nov;14(11):995-9; discussion 999. doi: 10.1111/j.1442-2042.2007.01890.x.","Denzinger S","Int J Urol","2007","2007/10/25","","","10.1111/j.1442-2042.2007.01890.x"
"1156320","Feulgen-DNA-values in transitional cell carcinoma of the human urinary bladder","Fossä SD.","Beitr Pathol. 1975 May;155(1):44-55.","Fossä SD","Beitr Pathol","1975","1975/05/01","","",""
"4039083","[Prevention of recurrence in urinary bladder tumors by intravesical instillation treatment with adriamycin]","Flamm J, Grof F.","Urologe A. 1985 Jan;24(1):31-5.","Flamm J","Urologe A","1985","1985/01/01","","",""
"14532775","Editorial: Bladder cancer. How can we make a difference?","Soloway MS.","J Urol. 2003 Nov;170(5):1781-2. doi: 10.1097/01.ju.0000092149.02524.65.","Soloway MS","J Urol","2003","2003/10/09","","","10.1097/01.ju.0000092149.02524.65"
"20248233","Mucinous adenocarcinoma of urachus, invading the urinary bladder","CAWKER CA.","Can Med Assoc J. 1947 Jul;57(1):58-60.","CAWKER CA","Can Med Assoc J","1947","2010/03/19","PMC1590663","",""
"31239240","Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry","Sung JM, Martin JW, Jefferson FA, Sidhom DA, Piranviseh K, Huang M, Nguyen N, Chang J, Ziogas A, Anton-Culver H, Youssef RF.","Clin Genitourin Cancer. 2019 Oct;17(5):e995-e1002. doi: 10.1016/j.clgc.2019.05.008. Epub 2019 May 31.","Sung JM","Clin Genitourin Cancer","2019","2019/06/27","","","10.1016/j.clgc.2019.05.008"
"24468513","18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer","Mertens LS, Mir MC, Scott AM, Lee ST, Fioole-Bruining A, Vegt E, Vogel WV, Manecksha R, Bolton D, Davis ID, Horenblas S, van Rhijn BW, Lawrentschuk N.","Urology. 2014 Feb;83(2):393-8. doi: 10.1016/j.urology.2013.10.032.","Mertens LS","Urology","2014","2014/01/29","","","10.1016/j.urology.2013.10.032"
"3967183","Bladder cancer risk and pipes, cigars, and smokeless tobacco","Hartge P, Hoover R, Kantor A.","Cancer. 1985 Feb 15;55(4):901-6. doi: 10.1002/1097-0142(19850215)55:4<901::aid-cncr2820550432>3.0.co;2-q.","Hartge P","Cancer","1985","1985/02/15","","","10.1002/1097-0142(19850215)55:4<901::aid-cncr2820550432>3.0.co;2-q"
"20509007","CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer","Xue YJ, Lu Q, Sun ZX.","Med Oncol. 2011 Dec;28(4):1363-72. doi: 10.1007/s12032-010-9582-4. Epub 2010 May 28.","Xue YJ","Med Oncol","2011","2010/05/29","","","10.1007/s12032-010-9582-4"
"22122739","Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic","Blick CG, Nazir SA, Mallett S, Turney BW, Onwu NN, Roberts IS, Crew JP, Cowan NC.","BJU Int. 2012 Jul;110(1):84-94. doi: 10.1111/j.1464-410X.2011.10664.x. Epub 2011 Nov 28.","Blick CG","BJU Int","2012","2011/11/30","","","10.1111/j.1464-410X.2011.10664.x"
"29710461","Overexpression of CRNDE promotes the progression of bladder cancer","Cheng J, Chen J, Zhang X, Mei H, Wang F, Cai Z.","Biomed Pharmacother. 2018 Mar;99:638-644. doi: 10.1016/j.biopha.2017.12.055. Epub 2018 Feb 20.","Cheng J","Biomed Pharmacother","2018","2018/05/02","","","10.1016/j.biopha.2017.12.055"
"23453340","Multidisciplinary management of patients with localized bladder cancer","Khurana KK, Garcia JA, Tendulkar RD, Stephenson AJ.","Surg Oncol Clin N Am. 2013 Apr;22(2):357-73. doi: 10.1016/j.soc.2012.12.008. Epub 2012 Dec 29.","Khurana KK","Surg Oncol Clin N Am","2013","2013/03/05","","","10.1016/j.soc.2012.12.008"
"25804644","Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment","Avgeris M, Mavridis K, Tokas T, Stravodimos K, Fragoulis EG, Scorilas A.","Carcinogenesis. 2015 May;36(5):528-37. doi: 10.1093/carcin/bgv024. Epub 2015 Mar 24.","Avgeris M","Carcinogenesis","2015","2015/03/26","","","10.1093/carcin/bgv024"
"30624081","Population-based validation of the National Comprehensive Cancer Network recommendations for baseline imaging for bladder cancer: a case for routine baseline bone scan?","Abdel-Rahman O.","J Comp Eff Res. 2019 Feb;8(3):157-163. doi: 10.2217/cer-2018-0113. Epub 2019 Jan 9.","Abdel-Rahman O","J Comp Eff Res","2019","2019/01/10","","","10.2217/cer-2018-0113"
"8791043","Cytophotometry in the monitoring of bladder cancer under intravesical chemotherapy","Simak R, Wiener H, Foeger A, Susani M, Zhang ZF, Maier U, Marberger M.","Eur Urol. 1996;29(4):391-8. doi: 10.1159/000473785.","Simak R","Eur Urol","1996","1996/01/01","","","10.1159/000473785"
"24012496","Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness","Wu K, Ning Z, Zeng J, Fan J, Zhou J, Zhang T, Zhang L, Chen Y, Gao Y, Wang B, Guo P, Li L, Wang X, He D.","Cell Signal. 2013 Dec;25(12):2625-33. doi: 10.1016/j.cellsig.2013.08.028. Epub 2013 Sep 4.","Wu K","Cell Signal","2013","2013/09/10","","","10.1016/j.cellsig.2013.08.028"
"11257654","Urethral recurrence after radical radiotherapy for bladder cancer","Cresswell J, Roberts JT, Neal DE.","J Urol. 2001 Apr;165(4):1135-7.","Cresswell J","J Urol","2001","2001/03/21","","",""
"31412742","Current advances in BCG-unresponsive non-muscle invasive bladder cancer","Tse J, Singla N, Ghandour R, Lotan Y, Margulis V.","Expert Opin Investig Drugs. 2019 Sep;28(9):757-770. doi: 10.1080/13543784.2019.1655730. Epub 2019 Aug 15.","Tse J","Expert Opin Investig Drugs","2019","2019/08/16","","","10.1080/13543784.2019.1655730"
"10798921","Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial","Droller MJ.","J Urol. 2000 May;163(5):1602-3.","Droller MJ","J Urol","2000","2000/05/08","","",""
"7090277","[Bladder cancer in patients with schistosomiasis of the urinary system]","Al' Shukri SKh.","Vopr Onkol. 1982;28(4):83-4.","Al' Shukri SKh","Vopr Onkol","1982","1982/01/01","","",""
"11562747","Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells","Satoh M, Ito A, Nojiri H, Handa K, Numahata K, Ohyama C, Saito S, Hoshi S, Hakomori SI.","Int J Oncol. 2001 Oct;19(4):723-31.","Satoh M","Int J Oncol","2001","2001/09/20","","",""
"28498805","FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes","Rinaldetti S, Wirtz RM, Worst TS, Eckstein M, Weiss CA, Breyer J, Otto W, Bolenz C, Hartmann A, Erben P.","Oncotarget. 2017 Jul 18;8(29):47595-47606. doi: 10.18632/oncotarget.17394.","Rinaldetti S","Oncotarget","2017","2017/05/13","PMC5564590","","10.18632/oncotarget.17394"
"28815271","The Prolidase Activity, Oxidative Stress, and Nitric Oxide Levels of Bladder Tissues with or Without Tumor in Patients with Bladder Cancer","Gecit İ, Eryılmaz R, Kavak S, Meral İ, Demir H, Pirinççi N, Güneş M, Taken K.","J Membr Biol. 2017 Oct;250(5):455-459. doi: 10.1007/s00232-017-9971-0. Epub 2017 Aug 16.","Gecit İ","J Membr Biol","2017","2017/08/18","","","10.1007/s00232-017-9971-0"
"27495060","rs1495741 as a tag single nucleotide polymorphism of N-acetyltransferase 2 acetylator phenotype associates bladder cancer risk and interacts with smoking: A systematic review and meta-analysis","Ma C, Gu L, Yang M, Zhang Z, Zeng S, Song R, Xu C, Sun Y.","Medicine (Baltimore). 2016 Aug;95(31):e4417. doi: 10.1097/MD.0000000000004417.","Ma C","Medicine (Baltimore)","2016","2016/08/07","PMC4979814","","10.1097/MD.0000000000004417"
"8551712","[Bladder cancer in spinal cord injury patient. A case report]","Kuwahara T, Kudo J, Tanaka J.","Nihon Hinyokika Gakkai Zasshi. 1995 Nov;86(11):1681-4. doi: 10.5980/jpnjurol1989.86.1681.","Kuwahara T","Nihon Hinyokika Gakkai Zasshi","1995","1995/11/01","","","10.5980/jpnjurol1989.86.1681"
"7603081","Skin metastasis of bladder carcinoma. A case report","Serel TA, Ozdemir G, Yaman LS, Ozdemir H.","Mater Med Pol. 1994 Jul-Sep;26(3):113-4.","Serel TA","Mater Med Pol","1994","1994/07/01","","",""
"25605182","Prognostic significance of Nestin expression in pT1 high- grade bladder urothelial carcinoma patients treated with intravesical BCG","Sen V, Bozkurt O, Demir O, Tuna B, Yorukoglu K, Ellidokuz H, Mungan U.","Asian Pac J Cancer Prev. 2014;15(24):10813-7. doi: 10.7314/apjcp.2014.15.24.10813.","Sen V","Asian Pac J Cancer Prev","2014","2015/01/22","","","10.7314/apjcp.2014.15.24.10813"
"26014226","Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer","Du M, Shi D, Yuan L, Li P, Chu H, Qin C, Yin C, Zhang Z, Wang M.","Sci Rep. 2015 May 27;5:10437. doi: 10.1038/srep10437.","Du M","Sci Rep","2015","2015/05/28","PMC4444850","","10.1038/srep10437"
"9598473","Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy?","Hautmann RE, Paiss T.","J Urol. 1998 Jun;159(6):1845-50.","Hautmann RE","J Urol","1998","1998/05/23","","",""
"19450825","Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker","Lotan Y, Elias K, Svatek RS, Bagrodia A, Nuss G, Moran B, Sagalowsky AI.","J Urol. 2009 Jul;182(1):52-7; discussion 58. doi: 10.1016/j.juro.2009.02.142. Epub 2009 May 17.","Lotan Y","J Urol","2009","2009/05/20","","","10.1016/j.juro.2009.02.142"
"32232691","A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables","Miyake M, Matsuyama H, Teramukai S, Kinoshita F, Yokota I, Matsumoto H, Shimada K, Kinjyo M, Shimokama T, Okumura K, Yomenori M, Enokida H, Nakagawa M, Nakai Y, Fujimoto K; Nishinihon Uro-oncology Extensive Collaboration group.","Int J Clin Oncol. 2020 Jul;25(7):1364-1376. doi: 10.1007/s10147-020-01654-5. Epub 2020 Mar 30.","Miyake M","Int J Clin Oncol","2020","2020/04/02","","","10.1007/s10147-020-01654-5"
"9886594","Analysis of the peripheral blood lymphocyte subsets in patients with bladder carcinoma","Soygür T, Bedük Y, Yaman O, Yilmaz E, Tokgöz G, Gögüş O.","Urology. 1999 Jan;53(1):88-91. doi: 10.1016/s0090-4295(98)00447-6.","Soygür T","Urology","1999","1999/01/14","","","10.1016/s0090-4295(98)00447-6"
"30003574","Concordance of PD-L1 expression in matched urothelial bladder cancer specimens","de Jong JJ, Stoop H, Nieboer D, Boormans JL, van Leenders GJLH.","Histopathology. 2018 Dec;73(6):983-989. doi: 10.1111/his.13710. Epub 2018 Sep 25.","de Jong JJ","Histopathology","2018","2018/07/14","","","10.1111/his.13710"
"7553298","Optimal staging procedures, including imaging, to define prognosis of bladder cancer","Paulson D, Denis L, Orikasa S, Bartolucci A, Bouffioux C, Hirao Y, Jewett MA, Pagano F, Pontes JE.","Int J Urol. 1995 Jun;2 Suppl 2:1-7. doi: 10.1111/j.1442-2042.1995.tb00474.x.","Paulson D","Int J Urol","1995","1995/06/01","","","10.1111/j.1442-2042.1995.tb00474.x"
"25623749","Inhibition of human bladder cancer growth by a suicide gene delivered by JC polyomavirus virus-like particles in a mouse model","Fang CY, Tsai YD, Lin MC, Wang M, Chen PL, Chao CN, Huang YL, Chang D, Shen CH.","J Urol. 2015 Jun;193(6):2100-6. doi: 10.1016/j.juro.2015.01.084. Epub 2015 Jan 24.","Fang CY","J Urol","2015","2015/01/28","","","10.1016/j.juro.2015.01.084"
"27626805","Protein Profiling of Bladder Urothelial Cell Carcinoma","Hu J, Ye F, Cui M, Lee P, Wei C, Hao Y, Wang X, Wang Y, Lu Z, Galsky M, McBride R, Wang L, Wang D, Cordon-Cardo C, Wang C, Zhang DY.","PLoS One. 2016 Sep 14;11(9):e0161922. doi: 10.1371/journal.pone.0161922. eCollection 2016.","Hu J","PLoS One","2016","2016/09/15","PMC5023150","","10.1371/journal.pone.0161922"
"16700038","Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue","Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, Sonpavde G, Ayala GE, Younes M, Lerner SP.","Cancer. 2006 Jun 15;106(12):2610-6. doi: 10.1002/cncr.21945.","Shen SS","Cancer","2006","2006/05/16","","","10.1002/cncr.21945"
"8931293","Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells","Bachor R, Reich E, Rück A, Hautmann R.","Urol Res. 1996;24(5):285-9. doi: 10.1007/BF00304778.","Bachor R","Urol Res","1996","1996/01/01","","","10.1007/BF00304778"
"26256521","Fine-tuning Risk Stratification for Non-Muscle-invasive Bladder Cancer","Black PC.","Eur Urol. 2016 Jan;69(1):70-1. doi: 10.1016/j.eururo.2015.07.034.","Black PC","Eur Urol","2016","2015/08/11","","","10.1016/j.eururo.2015.07.034"
"20661575","[EMMPRIN (CD147). A prognostic and potentially therapeutic marker in urothelial cancer]","Nawroth R, Hartmann A, Wild P, Lehmann J, Stöhr R, Gschwend JE, Retz M.","Pathologe. 2010 Oct;31 Suppl 2:251-4. doi: 10.1007/s00292-010-1328-8.","Nawroth R","Pathologe","2010","2010/07/28","","","10.1007/s00292-010-1328-8"
"10591254","Use of urine-based markers for detection and monitoring of bladder cancer","Pirtskalaishvili G, Getzenberg RH, Konety BR.","Tech Urol. 1999 Dec;5(4):179-84.","Pirtskalaishvili G","Tech Urol","1999","1999/12/11","","",""
"8290916","Neoadjuvant chemotherapy in bladder cancer: a randomized study. Nordic Cystectomy Trial I","Rintala E, Hannisdahl E, Fosså SD, Hellsten S, Sander S.","Scand J Urol Nephrol. 1993;27(3):355-62. doi: 10.3109/00365599309180447.","Rintala E","Scand J Urol Nephrol","1993","1993/01/01","","","10.3109/00365599309180447"
"23618510","Environmental non-occupational risk factors associated with bladder cancer","Ferrís J, Berbel O, Alonso-López J, Garcia J, Ortega JA.","Actas Urol Esp. 2013 Oct;37(9):579-86. doi: 10.1016/j.acuro.2013.02.004. Epub 2013 Apr 22.","Ferrís J","Actas Urol Esp","2013","2013/04/27","PMC5176016","NIHMS836020","10.1016/j.acuro.2013.02.004"
"22917984","ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings","Sternberg CN, Bellmunt J, Sonpavde G, Siefker-Radtke AO, Stadler WM, Bajorin DF, Dreicer R, George DJ, Milowsky MI, Theodorescu D, Vaughn DJ, Galsky MD, Soloway MS, Quinn DI; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012.","Eur Urol. 2013 Jan;63(1):58-66. doi: 10.1016/j.eururo.2012.08.010. Epub 2012 Aug 14.","Sternberg CN","Eur Urol","2013","2012/08/25","","","10.1016/j.eururo.2012.08.010"
"27776348","Prognostic value of vascular mimicry in patients with urothelial carcinoma of the bladder after radical cystectomy","Zhou L, Chang Y, Xu L, Hoang ST, Liu Z, Fu Q, Lin Z, Xu J.","Oncotarget. 2016 Nov 15;7(46):76214-76223. doi: 10.18632/oncotarget.12775.","Zhou L","Oncotarget","2016","2016/10/25","PMC5342808","","10.18632/oncotarget.12775"
"20178391","Terpenoids induce cell cycle arrest and apoptosis from the stems of Celastrus kusanoi associated with reactive oxygen species","Chen HL, Lin KW, Huang AM, Tu HY, Wei BL, Hour TC, Yen MH, Pu YS, Lin CN.","J Agric Food Chem. 2010 Mar 24;58(6):3808-12. doi: 10.1021/jf903833a.","Chen HL","J Agric Food Chem","2010","2010/02/25","","","10.1021/jf903833a"
"24993616","Sulforaphane induces apoptosis in T24 human urinary bladder cancer cells through a reactive oxygen species-mediated mitochondrial pathway: the involvement of endoplasmic reticulum stress and the Nrf2 signaling pathway","Jo GH, Kim GY, Kim WJ, Park KY, Choi YH.","Int J Oncol. 2014 Oct;45(4):1497-506. doi: 10.3892/ijo.2014.2536. Epub 2014 Jul 4.","Jo GH","Int J Oncol","2014","2014/07/05","","","10.3892/ijo.2014.2536"
"31171223","Urinary metabolomic signature of muscle-invasive bladder cancer: A multiplatform approach","Jacyna J, Wawrzyniak R, Balayssac S, Gilard V, Malet-Martino M, Sawicka A, Kordalewska M, Nowicki Ł, Kurek E, Bulska E, Patejko M, Markuszewski M, Gutknecht P, Matuszewski M, Siebert J, Kaliszan R, Markuszewski MJ.","Talanta. 2019 Sep 1;202:572-579. doi: 10.1016/j.talanta.2019.05.039. Epub 2019 May 9.","Jacyna J","Talanta","2019","2019/06/08","","","10.1016/j.talanta.2019.05.039"
"11091353","Invasive bladder cancer: a single-institution experience with bladder-sparing approach","Zapatero A, Martín de Vidales C, Marín A, Cerezo L, Arellano R, Rabadán M, Pérez-Torrubia A.","Int J Cancer. 2000 Oct 20;90(5):287-94.","Zapatero A","Int J Cancer","2000","2000/11/25","","",""
"26382775","Re: MPDL3280A (Anti-PD-L1) Treatment Leads to Clinical Activity in Metastatic Bladder Cancer","Chang SS.","J Urol. 2015 Oct;194(4):956. doi: 10.1016/j.juro.2015.07.017. Epub 2015 Jul 10.","Chang SS","J Urol","2015","2015/09/19","","","10.1016/j.juro.2015.07.017"
"23886181","Oxidative stress induces hypomethylation of LINE-1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line","Wongpaiboonwattana W, Tosukhowong P, Dissayabutra T, Mutirangura A, Boonla C.","Asian Pac J Cancer Prev. 2013;14(6):3773-8. doi: 10.7314/apjcp.2013.14.6.3773.","Wongpaiboonwattana W","Asian Pac J Cancer Prev","2013","2013/07/27","","","10.7314/apjcp.2013.14.6.3773"
"8543669","Pathology of canine bladder and urethral cancer and correlation with tumour progression and survival","Valli VE, Norris A, Jacobs RM, Laing E, Withrow S, Macy D, Tomlinson J, McCaw D, Ogilvie GK, Pidgeon G, et al.","J Comp Pathol. 1995 Aug;113(2):113-30. doi: 10.1016/s0021-9975(05)80027-1.","Valli VE","J Comp Pathol","1995","1995/08/01","","","10.1016/s0021-9975(05)80027-1"
"20451422","Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology","Youssef RF, Schlomer BJ, Ho R, Sagalowsky AI, Ashfaq R, Lotan Y.","Urol Oncol. 2012 May-Jun;30(3):273-7. doi: 10.1016/j.urolonc.2010.02.012. Epub 2010 May 6.","Youssef RF","Urol Oncol","2012","2010/05/11","","","10.1016/j.urolonc.2010.02.012"
"6610297","[The study of infiltrating lymphocytes in the tissues of bladder carcinoma]","Fujimoto Y, Hasegawa Y, Kato N, Sakai S, Kuriyama M, Kawada Y, Nishiura T, Takeuchi T, Isogai K.","Hinyokika Kiyo. 1983 Sep;29(9):1037-45.","Fujimoto Y","Hinyokika Kiyo","1983","1983/09/01","","",""
"17382713","Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer","Raj GV, Herr H, Serio AM, Donat SM, Bochner BH, Vickers AJ, Dalbagni G.","J Urol. 2007 Apr;177(4):1283-6; discussion 1286. doi: 10.1016/j.juro.2006.11.090.","Raj GV","J Urol","2007","2007/03/27","","","10.1016/j.juro.2006.11.090"
"28214283","Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer","Abufaraj M, Shariat SF, Haitel A, Moschini M, Foerster B, Chłosta P, Gust K, Babjuk M, Briganti A, Karakiewicz PI, Albrecht W.","Urol Oncol. 2017 May;35(5):264-271. doi: 10.1016/j.urolonc.2017.01.012. Epub 2017 Feb 14.","Abufaraj M","Urol Oncol","2017","2017/02/19","","","10.1016/j.urolonc.2017.01.012"
"2232427","[Upper urinary tract tumors following bladder cancer]","Yoshimura K, Tomooka Y, Maeda O, Saiki S, Kinouchi T, Kuroda M, Miki T, Usami M, Nakamura M, Kotake T.","Nihon Hinyokika Gakkai Zasshi. 1990 Sep;81(9):1362-6. doi: 10.5980/jpnjurol1989.81.1362.","Yoshimura K","Nihon Hinyokika Gakkai Zasshi","1990","1990/09/01","","","10.5980/jpnjurol1989.81.1362"
"3395572","Occupational factors and the incidence of cancer of the bladder in Canada","Risch HA, Burch JD, Miller AB, Hill GB, Steele R, Howe GR.","Br J Ind Med. 1988 Jun;45(6):361-7. doi: 10.1136/oem.45.6.361.","Risch HA","Br J Ind Med","1988","1988/06/01","PMC1009613","","10.1136/oem.45.6.361"
"25291984","Exposure to polycyclic aromatic hydrocarbons (PAHs) and bladder cancer: evaluation from a gene-environment perspective in a hospital-based case-control study in the Canary Islands (Spain)","Boada LD, Henríquez-Hernández LA, Navarro P, Zumbado M, Almeida-González M, Camacho M, Álvarez-León EE, Valencia-Santana JA, Luzardo OP.","Int J Occup Environ Health. 2015;21(1):23-30. doi: 10.1179/2049396714Y.0000000085. Epub 2014 Oct 8.","Boada LD","Int J Occup Environ Health","2015","2014/10/09","PMC4273516","","10.1179/2049396714Y.0000000085"
"20505025","Innovative image-guided CyberKnife stereotactic radiotherapy for bladder cancer","Thariat J, Trimaud R, Angellier G, Caullery M, Amiel J, Bondiau PY, Gerard JP.","Br J Radiol. 2010 Jun;83(990):e118-21. doi: 10.1259/bjr/26397829.","Thariat J","Br J Radiol","2010","2010/05/28","PMC3473597","","10.1259/bjr/26397829"
"3102756","The effect of nutritional status and support on morbidity and mortality of bladder cancer patients treated by radical cystectomy","Mohler JL, Flanigan RC.","J Urol. 1987 Mar;137(3):404-7. doi: 10.1016/s0022-5347(17)44049-3.","Mohler JL","J Urol","1987","1987/03/01","","","10.1016/s0022-5347(17)44049-3"
"30348146","Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer","Getzler I, Bahouth Z, Nativ O, Rubinstein J, Halachmi S.","BMC Urol. 2018 Oct 22;18(1):90. doi: 10.1186/s12894-018-0404-x.","Getzler I","BMC Urol","2018","2018/10/24","PMC6198354","","10.1186/s12894-018-0404-x"
"28972965","Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets","Morera DS, Hennig MS, Talukder A, Lokeshwar SD, Wang J, Garcia-Roig M, Ortiz N, Yates TJ, Lopez LE, Kallifatidis G, Kramer MW, Jordan AR, Merseburger AS, Manoharan M, Soloway MS, Terris MK, Lokeshwar VB.","Br J Cancer. 2017 Nov 7;117(10):1507-1517. doi: 10.1038/bjc.2017.318. Epub 2017 Oct 3.","Morera DS","Br J Cancer","2017","2017/10/04","PMC5680466","","10.1038/bjc.2017.318"
"17653452","Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy","Wang P, Luo JD, Wu WF, Wang S, Cai SL, Shen BH, Shi SF, Wei KX, Zhang ZG, Chen ZD.","Braz J Med Biol Res. 2007 Jul;40(7):979-84. doi: 10.1590/s0100-879x2006005000104.","Wang P","Braz J Med Biol Res","2007","2007/07/27","","","10.1590/s0100-879x2006005000104"
"29187470","The Genomic Alterations of 5α-Reductases and Their Inhibitor Finasteride's Effect in Bladder Cancer","Chen CC, Huang CP, Tsai YT, Hseih TF, Shyr CR.","Anticancer Res. 2017 Dec;37(12):6893-6898. doi: 10.21873/anticanres.12152.","Chen CC","Anticancer Res","2017","2017/12/01","","","10.21873/anticanres.12152"
"17619762","The role of pelvic lymphadenectomy in the management of prostate and bladder cancer","Woods ME, Ouwenga M, Quek ML.","ScientificWorldJournal. 2007 Mar 2;7:789-99. doi: 10.1100/tsw.2007.148.","Woods ME","ScientificWorldJournal","2007","2007/07/11","PMC5901148","","10.1100/tsw.2007.148"
"16400682","Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis","Sheng KH, Yao YC, Chuang SS, Wu H, Wu TF.","Proteomics. 2006 Feb;6(3):1058-65. doi: 10.1002/pmic.200402015.","Sheng KH","Proteomics","2006","2006/01/10","","","10.1002/pmic.200402015"
"11287519","Intraarterial low-dose cisplatin via an indwelling port and concurrent radiotherapy for invasive bladder cancer","Ganaha F, Yamada T, Ujita M, Irie T, Fukuda Y, Fukuda K.","J Vasc Interv Radiol. 2001 Mar;12(3):379-84. doi: 10.1016/s1051-0443(07)61921-6.","Ganaha F","J Vasc Interv Radiol","2001","2001/04/05","","","10.1016/s1051-0443(07)61921-6"
"31955206","The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer","Miyata H, Osawa T, Abe T, Kikuchi H, Matsumoto R, Maruyama S, Nishioka K, Shimizu S, Hashimoto T, Shirato H, Shinohara N.","Jpn J Clin Oncol. 2020 May 5;50(5):609-616. doi: 10.1093/jjco/hyz211.","Miyata H","Jpn J Clin Oncol","2020","2020/01/20","PMC7202139","","10.1093/jjco/hyz211"
"21789798","[Molecular markers for the diagnosis of non-muscle-invasive bladder cancer]","Glybchenko PV, Shakhpazian NK, Ponukalin AN, Zakharova NB.","Klin Lab Diagn. 2011 May;(5):16-20.","Glybchenko PV","Klin Lab Diagn","2011","2011/07/27","","",""
"10379791","Intravesical bacillus calmette-guerin (BCG) as inducer of tumor-suppressing proteins p53 and p21 Waf1-Cip1 during treatment of superficial bladder cancer","Fontana D, Bellina M, Galietti F, Scoffone C, Cagnazzi E, Guercio S, Cappia S, Pozzi E.","J Urol. 1999 Jul;162(1):225-30. doi: 10.1097/00005392-199907000-00072.","Fontana D","J Urol","1999","1999/06/24","","","10.1097/00005392-199907000-00072"
"28456541","Long-term Health-related Quality of Life Outcomes Following Radical Cystectomy","Gellhaus PT, Cary C, Kaimakliotis HZ, Johnson CS, Weiner M, Koch MO, Bihrle R.","Urology. 2017 Aug;106:82-86. doi: 10.1016/j.urology.2017.03.053. Epub 2017 Apr 26.","Gellhaus PT","Urology","2017","2017/05/01","","","10.1016/j.urology.2017.03.053"
"1619945","Adenocarcinoma of the urachus","Ravi R, Shrivastava BR, Chandrasekhar GM, Prahlad S, Balasubramanian KV, Mallikarjuna VS.","J Surg Oncol. 1992 Jul;50(3):201-3. doi: 10.1002/jso.2930500315.","Ravi R","J Surg Oncol","1992","1992/07/01","","","10.1002/jso.2930500315"
"26507079","Urinary biomarkers are unreliable for diagnosing bladder cancer, study finds","Wise J.","BMJ. 2015 Oct 27;351:h5652. doi: 10.1136/bmj.h5652.","Wise J","BMJ","2015","2015/10/29","","","10.1136/bmj.h5652"
"26109677","Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis","Matsumoto R, Takada N, Abe T, Minami K, Harabayashi T, Nagamori S, Hatanaka KC, Miyajima N, Tsuchiya K, Maruyama S, Murai S, Shinohara N.","Jpn J Clin Oncol. 2015 Sep;45(9):874-80. doi: 10.1093/jjco/hyv091. Epub 2015 Jun 24.","Matsumoto R","Jpn J Clin Oncol","2015","2015/06/26","","","10.1093/jjco/hyv091"
"2116083","[Prophylactic effect of UFT on the recurrence of bladder cancer]","Naito K, Hisazumi H, Saka A, Nakamura T, Kanda S, Mikawa I, Ejiri S, Miyagi T, Katsumi T, Kitagawa K, et al.","Hinyokika Kiyo. 1990 Apr;36(4):487-94.","Naito K","Hinyokika Kiyo","1990","1990/04/01","","",""
"21447663","Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study","Lewis JD, Ferrara A, Peng T, Hedderson M, Bilker WB, Quesenberry CP Jr, Vaughn DJ, Nessel L, Selby J, Strom BL.","Diabetes Care. 2011 Apr;34(4):916-22. doi: 10.2337/dc10-1068.","Lewis JD","Diabetes Care","2011","2011/03/31","PMC3064051","","10.2337/dc10-1068"
"17204516","A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke","Alberg AJ, Kouzis A, Genkinger JM, Gallicchio L, Burke AE, Hoffman SC, Diener-West M, Helzlsouer KJ, Comstock GW.","Am J Epidemiol. 2007 Mar 15;165(6):660-6. doi: 10.1093/aje/kwk047. Epub 2007 Jan 4.","Alberg AJ","Am J Epidemiol","2007","2007/01/06","","","10.1093/aje/kwk047"
"2625819","[The analysis of the difference in anti-cancer drug sensitivity of 3 clones separated from bladder cancer cell line]","Terashima Y, Hattori T, Kanamori S, Akimoto M.","Nihon Hinyokika Gakkai Zasshi. 1989 Dec;80(12):1720-7. doi: 10.5980/jpnjurol1989.80.1720.","Terashima Y","Nihon Hinyokika Gakkai Zasshi","1989","1989/12/01","","","10.5980/jpnjurol1989.80.1720"
"31928466","Re: Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-Muscle-Invasive Bladder Cancer","Chang SS.","J Urol. 2020 Apr;203(4):661. doi: 10.1097/JU.0000000000000729.02. Epub 2020 Jan 13.","Chang SS","J Urol","2020","2020/01/14","","","10.1097/JU.0000000000000729.02"
"6820897","[Bladder cancer: chemotherapy of advanced bladder cancer]","Koiso K.","Gan To Kagaku Ryoho. 1982 Mar;9(3):377-86.","Koiso K","Gan To Kagaku Ryoho","1982","1982/03/01","","",""
"23433891","Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: a contemporary review with focus on nonbilharzial squamous cell carcinoma","Rausch S, Lotan Y, Youssef RF.","Urol Oncol. 2014 Jan;32(1):32.e11-6. doi: 10.1016/j.urolonc.2012.11.020. Epub 2013 Feb 20.","Rausch S","Urol Oncol","2014","2013/02/26","","","10.1016/j.urolonc.2012.11.020"
"3888903","The value of transurethral sonography in tumours of the urinary bladder","Schickel W, Müller GW, Friebel H, Richter A.","Int Urol Nephrol. 1985;17(1):23-7. doi: 10.1007/BF02089399.","Schickel W","Int Urol Nephrol","1985","1985/01/01","","","10.1007/BF02089399"
"3433020","Lewis blood group antigens in urine sediments from patients with urinary bladder carcinoma","Mårtensson S, Brodin T, Chester MA, Colleen S, Lundblad A.","Scand J Urol Nephrol. 1987;21(3):197-201. doi: 10.3109/00365598709180321.","Mårtensson S","Scand J Urol Nephrol","1987","1987/01/01","","","10.3109/00365598709180321"
"17962949","Survivin: a promising biomarker for detection and prognosis of bladder cancer","Margulis V, Lotan Y, Shariat SF.","World J Urol. 2008 Feb;26(1):59-65. doi: 10.1007/s00345-007-0219-y. Epub 2007 Oct 26.","Margulis V","World J Urol","2008","2007/10/27","","","10.1007/s00345-007-0219-y"
"18122827","Hyperleukocytosis occurring in carcinoma of the bladder","SUSSMAN LN, LITWINS J.","N Y State J Med. 1949 Jan 15;49(2):174-6.","SUSSMAN LN","N Y State J Med","1949","1949/01/15","","",""
"26551459","Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer","Chen T, Xie W, Xie L, Sun Y, Zhang Y, Shen Z, Sha N, Xu H, Wu Z, Hu H, Wu C.","Biochem Biophys Res Commun. 2015 Dec 25;468(4):666-70. doi: 10.1016/j.bbrc.2015.11.013. Epub 2015 Nov 6.","Chen T","Biochem Biophys Res Commun","2015","2015/11/10","","","10.1016/j.bbrc.2015.11.013"
"5036005","Intravenous Methotrexate in the treatment of advanced bladder cancer","Burfield GD.","Br J Urol. 1972 Feb;44(1):121.","Burfield GD","Br J Urol","1972","1972/02/01","","",""
"16945772","Use of selenium in chemoprevention of bladder cancer","Brinkman M, Buntinx F, Muls E, Zeegers MP.","Lancet Oncol. 2006 Sep;7(9):766-74. doi: 10.1016/S1470-2045(06)70862-2.","Brinkman M","Lancet Oncol","2006","2006/09/02","","","10.1016/S1470-2045(06)70862-2"
"17457655","Mathematical model of BCG immunotherapy in superficial bladder cancer","Bunimovich-Mendrazitsky S, Shochat E, Stone L.","Bull Math Biol. 2007 Aug;69(6):1847-70. doi: 10.1007/s11538-007-9195-z. Epub 2007 Apr 25.","Bunimovich-Mendrazitsky S","Bull Math Biol","2007","2007/04/26","","","10.1007/s11538-007-9195-z"
"1705974","Flow cytometry detection and evaluation of bladder tumors","Melamed MR.","J Occup Med. 1990 Sep;32(9):829-33. doi: 10.1097/00043764-199009000-00014.","Melamed MR","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00014"
"22743257","Advanced transitional cell carcinoma of the bladder in a 16-year-old girl with Hinman syndrome","Ghousheh AI, Durkee CT, Groth TW.","Urology. 2012 Nov;80(5):1141-3. doi: 10.1016/j.urology.2012.04.057. Epub 2012 Jun 27.","Ghousheh AI","Urology","2012","2012/06/30","","","10.1016/j.urology.2012.04.057"
"16831510","Adjuvant chemotherapy for bladder cancer: the chance for meta-analyses comparison","Bria E, Ruggeri EM, Pollera CF, Terzoli E, Cognetti F, Giannarelli D.","Eur Urol. 2007 Feb;51(2):576-7. doi: 10.1016/j.eururo.2006.06.021. Epub 2006 Jun 30.","Bria E","Eur Urol","2007","2006/07/13","","","10.1016/j.eururo.2006.06.021"
"24267105","Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancer","Martini T, Mayr R, Wehrberger C, Dechet C, Lodde M, Palermo S, Trenti E, Comploj E, Pycha A, Madersbacher S.","Int Braz J Urol. 2013 Sep-Oct;39(5):622-30. doi: 10.1590/S1677-5538.IBJU.2013.05.03.","Martini T","Int Braz J Urol","2013","2013/11/26","","","10.1590/S1677-5538.IBJU.2013.05.03"
"24616582","Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the mammalian target of rapamycin signaling pathway","Kim SJ, Seo HK, Seo HH, Lee SJ, Kwon JK, Lee TJ, Chi BH, Chang IH.","J Korean Med Sci. 2014 Mar;29(3):343-50. doi: 10.3346/jkms.2014.29.3.343. Epub 2014 Feb 27.","Kim SJ","J Korean Med Sci","2014","2014/03/12","PMC3945128","","10.3346/jkms.2014.29.3.343"
"31755155","Bacillus Calmette-Guérin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections","Larsen ES, Joensen UN, Poulsen AM, Goletti D, Johansen IS.","APMIS. 2020 Feb;128(2):92-103. doi: 10.1111/apm.13011. Epub 2020 Jan 28.","Larsen ES","APMIS","2020","2019/11/23","","","10.1111/apm.13011"
"9615208","An update of selective bladder preservation by combined modality therapy for invasive bladder cancer","Shipley WU, Kaufman DS, Heney NM, Althausen AF, Zietman AL.","Eur Urol. 1998;33 Suppl 4:32-4. doi: 10.1159/000052262.","Shipley WU","Eur Urol","1998","1998/06/06","","","10.1159/000052262"
"28275033","Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy","Dell'Oglio P, Tian Z, Leyh-Bannurah SR, Trudeau V, Larcher A, Moschini M, Di Trapani E, Capitanio U, Briganti A, Montorsi F, Saad F, Karakiewicz PI.","J Natl Compr Canc Netw. 2017 Mar;15(3):327-333. doi: 10.6004/jnccn.2017.0032.","Dell'Oglio P","J Natl Compr Canc Netw","2017","2017/03/10","","","10.6004/jnccn.2017.0032"
"28135623","Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer","Buttigliero C, Tucci M, Vignani F, Scagliotti GV, Di Maio M.","Cancer Treat Rev. 2017 Mar;54:1-9. doi: 10.1016/j.ctrv.2017.01.002. Epub 2017 Jan 11.","Buttigliero C","Cancer Treat Rev","2017","2017/01/31","","","10.1016/j.ctrv.2017.01.002"
"24239468","Second-line chemotherapy for advanced bladder cancer: a survey of current UK practice","Lamb BW, Vasdev N, Jalil RT, McMenemin R, Hughes S, Payne H, Green JS.","Urol Oncol. 2014 Jan;32(1):52.e11-7. doi: 10.1016/j.urolonc.2013.08.008. Epub 2013 Nov 13.","Lamb BW","Urol Oncol","2014","2013/11/19","","","10.1016/j.urolonc.2013.08.008"
"23635261","Fusion of planning CT and cystoscopy images for bladder tumor delineation: a feasibility study","Dees-Ribbers HM, Pos FJ, Betgen A, Bex A, Hulshof MC, Remeijer P, van Herk M.","Med Phys. 2013 May;40(5):051713. doi: 10.1118/1.4799842.","Dees-Ribbers HM","Med Phys","2013","2013/05/03","","","10.1118/1.4799842"
"7637244","[An analysis of factors related to recurrence of superficial bladder cancer after transurethral resection]","Tashiro K, Nakajo H, Iwamuro S, Furuta A, Iwanaga S, Ohishi Y, Igarashi H, Kawashima A, Sugiyama K, Kido A, et al.","Nihon Hinyokika Gakkai Zasshi. 1995 Jul;86(7):1272-8. doi: 10.5980/jpnjurol1989.86.1272.","Tashiro K","Nihon Hinyokika Gakkai Zasshi","1995","1995/07/01","","","10.5980/jpnjurol1989.86.1272"
"16391825","Bacillus Calmette-Guérin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells","Lodillinsky C, Umerez MS, Jasnis MA, Casabé A, Sandes E, Eiján AM.","Int J Mol Med. 2006 Feb;17(2):269-73.","Lodillinsky C","Int J Mol Med","2006","2006/01/05","","",""
"19549121","Improved detection and reduced early recurrence of non-muscle-invasive bladder cancer using hexaminolaevulinate fluorescence cystoscopy: results of a multicentre prospective randomized study (PC B305)","Mostafid H, Bunce C; Action on Bladder Cancer Group.","BJU Int. 2009 Oct;104(7):889-90. doi: 10.1111/j.1464-410X.2009.08691.x. Epub 2009 Jun 22.","Mostafid H","BJU Int","2009","2009/06/25","","","10.1111/j.1464-410X.2009.08691.x"
"6702053","Intravesical adriamycin therapy for bladder cancer. Long-term results","Pontes JE, Dhabuwala CB, Pierce JM Jr.","Urology. 1984 Mar;23(3 Suppl):35-6. doi: 10.1016/s0090-4295(84)80113-2.","Pontes JE","Urology","1984","1984/03/01","","","10.1016/s0090-4295(84)80113-2"
"608820","Experiences in treating cancer of the bladder","Wojewski A, Zajaczkowski T.","Int Urol Nephrol. 1977;9(3):231-4. doi: 10.1007/BF02082168.","Wojewski A","Int Urol Nephrol","1977","1977/01/01","","","10.1007/BF02082168"
"23811703","Primary bladder preservation treatment for urothelial bladder cancer","Biagioli MC, Fernandez DC, Spiess PE, Wilder RB.","Cancer Control. 2013 Jul;20(3):188-99. doi: 10.1177/107327481302000307.","Biagioli MC","Cancer Control","2013","2013/07/02","","","10.1177/107327481302000307"
"10233464","Antitumour effects of the angiogenesis inhibitor AGM-1470 on rat urinary bladder tumours induced by N-butyl-N-(4-hydroxybutyl) nitrosamine","Osawa S, Terashima Y, Kimura G, Akimoto M.","BJU Int. 1999 Jan;83(1):123-8. doi: 10.1046/j.1464-410x.1999.00911.x.","Osawa S","BJU Int","1999","1999/05/08","","","10.1046/j.1464-410x.1999.00911.x"
"8118380","Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer","Zhang ZF, Sarkis AS, Cordon-Cardo C, Dalbagni G, Melamed J, Aprikian A, Pollack D, Sheinfeld J, Herr HW, Fair WR, et al.","Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):19-24.","Zhang ZF","Cancer Epidemiol Biomarkers Prev","1994","1994/01/01","","",""
"22999456","Long-term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer: neoadjuvant chemotherapy and concurrent radio-chemotherapy","Zapatero A, Martin De Vidales C, Arellano R, Ibañez Y, Bocardo G, Perez M, Rabadan M, García Vicente F, Cruz Conde JA, Olivier C.","Urology. 2012 Nov;80(5):1056-62. doi: 10.1016/j.urology.2012.07.045. Epub 2012 Sep 19.","Zapatero A","Urology","2012","2012/09/25","","","10.1016/j.urology.2012.07.045"
"30724858","Re: A Prospective Randomized Pilot Study Evaluating an ERAS Protocol versus a Standard Protocol for Patients Treated with Radical Cystectomy and Urinary Diversion for Bladder Cancer","Wang DS.","J Urol. 2019 May;201(5):835. doi: 10.1097/JU.0000000000000154.","Wang DS","J Urol","2019","2019/02/07","","","10.1097/JU.0000000000000154"
"2074516","Evaluation of DNA flow cytometry as a screening test for bladder cancer","Deitch AD, Anderson KA, deVere White RW.","J Occup Med. 1990 Sep;32(9):898-903. doi: 10.1097/00043764-199009000-00029.","Deitch AD","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00029"
"28685181","Oncologic surveillance following radical cystectomy: an individualized risk-based approach","Merrill SB, Boorjian SA, Thompson RH, Psutka SP, Cheville JC, Thapa P, Tollefson MK, Frank I.","World J Urol. 2017 Dec;35(12):1863-1869. doi: 10.1007/s00345-017-2068-7. Epub 2017 Jul 6.","Merrill SB","World J Urol","2017","2017/07/08","","","10.1007/s00345-017-2068-7"
"31532284","Re: Evaluation of Cause of Death after Radical Cystectomy for Patients with Bladder Cancer: The Impact of Age at the Time of Surgery","Griebling TL.","J Urol. 2019 Dec;202(6):1076-1077. doi: 10.1097/01.JU.0000585760.26685.c4. Epub 2019 Sep 18.","Griebling TL","J Urol","2019","2019/09/19","","","10.1097/01.JU.0000585760.26685.c4"
"24669384","Bacillus Calmette-Guerin and bladder cancer: helpful packaging","","Prescrire Int. 2014 Feb;23(146):41-2.","","Prescrire Int","2014","2014/03/27","","",""
"25530608","Trends in operative caseload and mortality rates after radical cystectomy for bladder cancer in England for 1998-2010","Hounsome LS, Verne J, McGrath JS, Gillatt DA.","Eur Urol. 2015 Jun;67(6):1056-1062. doi: 10.1016/j.eururo.2014.12.002. Epub 2014 Dec 17.","Hounsome LS","Eur Urol","2015","2014/12/23","","","10.1016/j.eururo.2014.12.002"
"31479417","An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer","Lian P, Wang Q, Zhao Y, Chen C, Sun X, Li H, Deng J, Zhang H, Ji Z, Zhang X, Huang Q.","Aging (Albany NY). 2019 Sep 3;11(17):6930-6940. doi: 10.18632/aging.102225. Epub 2019 Sep 3.","Lian P","Aging (Albany NY)","2019","2019/09/04","PMC6756879","","10.18632/aging.102225"
"29674277","Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143","An Q, Zhou L, Xu N.","Biomed Pharmacother. 2018 Jul;103:415-420. doi: 10.1016/j.biopha.2018.03.138. Epub 2018 Apr 24.","An Q","Biomed Pharmacother","2018","2018/04/21","","","10.1016/j.biopha.2018.03.138"
"21302726","Radical surgical treatment of the urinary bladder cancer in patients over the age of 60--our experiences","Maricić A, Valencić M, Oguić R, Rahelić D, Krpina K, Materljan M.","Coll Antropol. 2010 Apr;34 Suppl 2:223-8.","Maricić A","Coll Antropol","2010","2011/02/10","","",""
"18693589","Single instillation of mitomycin C reduces 1st year recurrence following transurethral resection of non-muscle invasive bladder cancer","Ather MH, Aziz S, Sulaiman MN.","J Ayub Med Coll Abbottabad. 2007 Oct-Dec;19(4):18-20.","Ather MH","J Ayub Med Coll Abbottabad","2007","2008/08/13","","",""
"603661","Photodinamic effect and fluorescence in the diagnosis and therapy of the cancer of the bladder","Fedi B.","Boll Soc Ital Biol Sper. 1977 Jul 30;53(14):1138-44.","Fedi B","Boll Soc Ital Biol Sper","1977","1977/07/30","","",""
"27053367","Reducing understaging of bladder cancer with the aid of photodynamic cystoscopy","Sfetsas K, Mitropoulos D.","J Egypt Natl Canc Inst. 2016 Jun;28(2):89-94. doi: 10.1016/j.jnci.2016.03.002. Epub 2016 Apr 1.","Sfetsas K","J Egypt Natl Canc Inst","2016","2016/04/08","","","10.1016/j.jnci.2016.03.002"
"22682991","Re: Siobhan P. Lynch, Yu Shen, Ashish Kamat, et al. neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.020","Ismaili N.","Eur Urol. 2012 Sep;62(3):e65-6. doi: 10.1016/j.eururo.2012.05.061. Epub 2012 Jun 5.","Ismaili N","Eur Urol","2012","2012/06/12","","","10.1016/j.eururo.2012.05.061"
"28272691","The effect of curcumin on bladder tumor in rat model","Pan ZJ, Deng N, Zou ZH, Chen GX.","Eur Rev Med Pharmacol Sci. 2017 Feb;21(4):884-889.","Pan ZJ","Eur Rev Med Pharmacol Sci","2017","2017/03/09","","",""
"18144692","A technique for the extension of radical surgery in the treatment of vesical cancer","MARSHALL VJ, WHITEMORE WF Jr.","Cancer. 1949 May;2(3):424-8. doi: 10.1002/1097-0142(194905)2:3<424::aid-cncr2820020306>3.0.co;2-y.","MARSHALL VJ","Cancer","1949","1949/05/01","","","10.1002/1097-0142(194905)2:3<424::aid-cncr2820020306>3.0.co;2-y"
"8893872","Conservative surgery, patient selection, and chemoradiation as organ-preserving treatment for muscle-invading bladder cancer","Douglas RM, Kaufman DS, Zietman AL, Althausen AF, Heney NM, Shipley WU.","Semin Oncol. 1996 Oct;23(5):614-20.","Douglas RM","Semin Oncol","1996","1996/10/01","","",""
"23810438","Smooth muscle tumor of uncertain malignant potential of the urinary bladder: a case report and review of the literature","Zukerman Z, Schiavina R, Borghesi M, Brunocilla E, Vagnoni V, Pirini MG, Grigioni WF, Martorana G.","Clin Genitourin Cancer. 2013 Dec;11(4):e6-9. doi: 10.1016/j.clgc.2013.04.023. Epub 2013 Jun 26.","Zukerman Z","Clin Genitourin Cancer","2013","2013/07/02","","","10.1016/j.clgc.2013.04.023"
"25179987","[Efficacy of prophylactic intravesical mitomycin C in patients with non-muscle-invasive bladder cancer]","Ohsugi H, Kitamura Y, Manabe Y, Masuda N, Ito H, Mishina M, Okuno H.","Hinyokika Kiyo. 2014 Aug;60(8):375-9.","Ohsugi H","Hinyokika Kiyo","2014","2014/09/03","","",""
"18549342","Evolution of intravesical immunotherapy for bladder cancer: mycobacterial cell wall preparation as a promising agent","Morales A.","Expert Opin Investig Drugs. 2008 Jul;17(7):1067-73. doi: 10.1517/13543784.17.7.1067.","Morales A","Expert Opin Investig Drugs","2008","2008/06/14","","","10.1517/13543784.17.7.1067"
"31255724","CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression","Zheng F, Wang M, Li Y, Huang C, Tao D, Xie F, Zhang H, Sun J, Zhang C, Gu C, Wang Z, Jiang G.","Cancer Lett. 2019 Sep 28;460:139-151. doi: 10.1016/j.canlet.2019.06.018. Epub 2019 Jun 27.","Zheng F","Cancer Lett","2019","2019/07/01","","","10.1016/j.canlet.2019.06.018"
"3857373","Truck driving and bladder cancer mortality in rural New England","Hoar SK, Hoover R.","J Natl Cancer Inst. 1985 Apr;74(4):771-4.","Hoar SK","J Natl Cancer Inst","1985","1985/04/01","","",""
"7563327","Combination chemotherapy with intra-arterial cisplatin and doxorubicin plus intravenous methotrexate and vincristine for locally advanced bladder cancer. Kyushu University Urological and Radiological Oncology Group","Naito S, Kuroiwa T, Ueda T, Hasuo K, Masuda K, Kumazawa J.","J Urol. 1995 Nov;154(5):1704-9.","Naito S","J Urol","1995","1995/11/01","","",""
"23088996","A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens","Hansel DE, Amin MB, Comperat E, Cote RJ, Knüchel R, Montironi R, Reuter VE, Soloway MS, Umar SA, Van der Kwast TH.","Eur Urol. 2013 Feb;63(2):321-32. doi: 10.1016/j.eururo.2012.10.008. Epub 2012 Oct 12.","Hansel DE","Eur Urol","2013","2012/10/24","","","10.1016/j.eururo.2012.10.008"
"2494950","[Case report of a complete regression of para-aortic lymph node metastasis from bladder cancer by oral administration of UFT]","Nakano E, Iwasaki A, Seguchi T, Sugao H, Yoshioka T, Tada Y, Matsuda M, Sonoda T.","Gan To Kagaku Ryoho. 1989 Mar;16(3 Pt 1):415-7.","Nakano E","Gan To Kagaku Ryoho","1989","1989/03/01","","",""
"20399461","Radical cystectomy in octogenarians--does morbidity outweigh the potential survival benefits?","Donat SM, Siegrist T, Cronin A, Savage C, Milowsky MI, Herr HW.","J Urol. 2010 Jun;183(6):2171-7. doi: 10.1016/j.juro.2010.02.015.","Donat SM","J Urol","2010","2010/04/20","","","10.1016/j.juro.2010.02.015"
"19207607","Risk of concomitant carcinoma in situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases","Hara T, Takahashi M, Gondo T, Nagao K, Ohmi C, Sakano S, Naito K, Matsuyama H.","Int J Urol. 2009 Mar;16(3):293-8. doi: 10.1111/j.1442-2042.2008.02241.x. Epub 2009 Jan 20.","Hara T","Int J Urol","2009","2009/02/12","","","10.1111/j.1442-2042.2008.02241.x"
"3400349","[Lymphogenous metastasis of urinary bladder cancer]","Matz M, Wehnert J, Justus J.","Z Urol Nephrol. 1988 Apr;81(4):213-7.","Matz M","Z Urol Nephrol","1988","1988/04/01","","",""
"26615419","Association of FokI polymorphism of vitamin D receptor with urothelial bladder cancer in Tunisians: role of tobacco smoking and plasma vitamin D concentration","Ben Fradj MK, Kallel A, Gargouri MM, Chehida MA, Sallemi A, Ouanes Y, Rhouma SB, Riadh J, Feki M, Nouira Y, Kaabachi N.","Tumour Biol. 2016 May;37(5):6197-203. doi: 10.1007/s13277-015-4496-6. Epub 2015 Nov 28.","Ben Fradj MK","Tumour Biol","2016","2015/11/30","","","10.1007/s13277-015-4496-6"
"29731413","Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study","Sathianathen NJ, Fan Y, Jarosek SL, Lawrentschuk NL, Konety BR.","Urol Oncol. 2018 Jul;36(7):338.e13-338.e17. doi: 10.1016/j.urolonc.2018.03.020. Epub 2018 May 3.","Sathianathen NJ","Urol Oncol","2018","2018/05/08","","","10.1016/j.urolonc.2018.03.020"
"17042983","[Analysis of the characteristics of patients with bladder cancer diagnosed of multiple neoplasms in the health district of León (Spain)]","Muela Molinero A, Jorquera Plaza F, Ribas Ariño T, Malagón Rojo R, Santos Calderón JA, Espinel Díez V, Olcoz Goñi JL, Quiroga Prado L.","Rev Clin Esp. 2006 Oct;206(9):422-7. doi: 10.1157/13093466.","Muela Molinero A","Rev Clin Esp","2006","2006/10/18","","","10.1157/13093466"
"24090000","A retrospective study of prostate cancer cases mimicking urothelial cell carcinoma of the bladder","Liu R, Xie X, Zhang Z, Xu Y.","Eur J Med Res. 2013 Oct 3;18(1):36. doi: 10.1186/2047-783X-18-36.","Liu R","Eur J Med Res","2013","2013/10/05","PMC3851773","","10.1186/2047-783X-18-36"
"14693272","Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin","Pagliaro LC, Keyhani A, Liu B, Perrotte P, Wilson D, Dinney CP.","Urol Oncol. 2003 Nov-Dec;21(6):456-62. doi: 10.1016/s1078-1439(03)00032-2.","Pagliaro LC","Urol Oncol","2003","2003/12/25","","","10.1016/s1078-1439(03)00032-2"
"2399387","Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience","Fair WR, Scher H, Herr H, Morse M, Sogani P, Bosi G, Dershaw D, Reuter V, Curley T, et al.","Semin Urol. 1990 Aug;8(3):190-6.","Fair WR","Semin Urol","1990","1990/08/01","","",""
"30024509","The effect of marital status on the survival of patients with bladder urothelial carcinoma: A SEER database analysis","Niu Q, Lu Y, Wu Y, Xu S, Shi Q, Huang T, Zhou G, Gu X, Yu J.","Medicine (Baltimore). 2018 Jul;97(29):e11378. doi: 10.1097/MD.0000000000011378.","Niu Q","Medicine (Baltimore)","2018","2018/07/20","PMC6086512","","10.1097/MD.0000000000011378"
"24603101","Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder","Spaliviero M, Dalbagni G, Bochner BH, Poon BY, Huang H, Al-Ahmadie HA, Donahue TF, Taylor JM, Meeks JJ, Sjoberg DD, Donat SM, Reuter VE, Herr HW.","J Urol. 2014 Sep;192(3):702-7. doi: 10.1016/j.juro.2014.02.2565. Epub 2014 Mar 3.","Spaliviero M","J Urol","2014","2014/03/08","PMC4465582","NIHMS678893","10.1016/j.juro.2014.02.2565"
"17270622","Reliability of frozen section examination of external iliac, hypogastric, and obturator lymph nodes during radical cystectomy: a multicenter study","Adsan O, Baltaci S, Cal C, Büyükalpelli R, Uğurlu O, Bozlu M, Türkölmez K, Sahin H, Elhan A.","Urology. 2007 Jan;69(1):83-6. doi: 10.1016/j.urology.2006.09.042.","Adsan O","Urology","2007","2007/02/03","","","10.1016/j.urology.2006.09.042"
"11480725","Micropapillary variant of transitional cell carcinoma of the urinary bladder: a report of three cases with cytologic diagnosis in urine specimens","Ylagan LR, Humphrey PA.","Acta Cytol. 2001 Jul-Aug;45(4):599-604. doi: 10.1159/000327871.","Ylagan LR","Acta Cytol","2001","2001/08/02","","","10.1159/000327871"
"26627132","A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature","Messina C, Zanardi E, Dellepiane C, Tomasello L, Colecchia M, Ravetti GL, Boccardo F, Spina B.","Clin Genitourin Cancer. 2016 Feb;14(1):e139-42. doi: 10.1016/j.clgc.2015.10.012. Epub 2015 Oct 28.","Messina C","Clin Genitourin Cancer","2016","2015/12/03","","","10.1016/j.clgc.2015.10.012"
"1565901","Markers of prognosis in superficial bladder cancer","Fradet Y.","Semin Urol. 1992 Feb;10(1):28-38.","Fradet Y","Semin Urol","1992","1992/02/01","","",""
"28826703","Exploring exposure to Agent Orange and increased mortality due to bladder cancer","Mossanen M, Kibel AS, Goldman RH.","Urol Oncol. 2017 Nov;35(11):627-632. doi: 10.1016/j.urolonc.2017.07.030. Epub 2017 Aug 18.","Mossanen M","Urol Oncol","2017","2017/08/23","","","10.1016/j.urolonc.2017.07.030"
"3045340","Anal submucosal injection: a new route for drug administration in pelvic malignancies. II. Methotrexate anal injection in the treatment of advanced bladder cancer. Preliminary study","Shafik A, Haddad S, Elwan F, el-Metnawi W, Olfat E.","J Urol. 1988 Sep;140(3):501-5. doi: 10.1016/s0022-5347(17)41702-2.","Shafik A","J Urol","1988","1988/09/01","","","10.1016/s0022-5347(17)41702-2"
"22447951","Editorial: MMP-2 and MMP-9 in lymph-node-positive bladder cancer","Hegarty PK.","J Clin Pathol. 2012 May;65(5):470-1. doi: 10.1136/jclinpath-2011-200360. Epub 2012 Mar 24.","Hegarty PK","J Clin Pathol","2012","2012/03/27","","","10.1136/jclinpath-2011-200360"
"22579049","Re: Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol 2012;61:705-11","Goyal NK, Garg M, Goel A.","Eur Urol. 2012 Aug;62(2):e41; author reply e42. doi: 10.1016/j.eururo.2012.04.054. Epub 2012 May 8.","Goyal NK","Eur Urol","2012","2012/05/15","","","10.1016/j.eururo.2012.04.054"
"18581675","[The use of NMP22 Bladder-Chek for the diagnosis and follow-up bladder cancer]","Gonzalo Rodríguez V, Sanz Justo L, de Miguel Santamaría I, Martínez de Iturrate J, Fernández del Busto E.","Arch Esp Urol. 2008 Apr;61(3):377-84. doi: 10.4321/s0004-06142008000300004.","Gonzalo Rodríguez V","Arch Esp Urol","2008","2008/06/28","","","10.4321/s0004-06142008000300004"
"22342412","Editorial comment","Herr HW.","Urology. 2012 Apr;79(4):851-2; author reply 852. doi: 10.1016/j.urology.2011.08.082. Epub 2012 Feb 18.","Herr HW","Urology","2012","2012/02/21","","","10.1016/j.urology.2011.08.082"
"11309425","Intravesical therapy for bladder cancer: empiricism at the helm","Montie JE.","J Natl Cancer Inst. 2001 Apr 18;93(8):572-3. doi: 10.1093/jnci/93.8.572.","Montie JE","J Natl Cancer Inst","2001","2001/04/20","","","10.1093/jnci/93.8.572"
"7170818","[Bladder cancer as late result of urethral injury]","Oehler D, Haupt R.","Z Arztl Fortbild (Jena). 1982 Dec 15;76(24):1029-31.","Oehler D","Z Arztl Fortbild (Jena)","1982","1982/12/15","","",""
"6805549","Blood group antigens and bladder cancer","Bishop MC.","Br Med J (Clin Res Ed). 1982 May 15;284(6327):1426-7. doi: 10.1136/bmj.284.6327.1426-a.","Bishop MC","Br Med J (Clin Res Ed)","1982","1982/05/15","PMC1498351","","10.1136/bmj.284.6327.1426-a"
"2809378","[Clinical effects of hyperthermia treatment for recurrent bladder cancer]","Ueda K, Sakagami H, Ohtaguro K, Ikeda K.","Nihon Gan Chiryo Gakkai Shi. 1989 Aug 20;24(8):1521-5.","Ueda K","Nihon Gan Chiryo Gakkai Shi","1989","1989/08/20","","",""
"24549769","Extravasation during bladder cancer metastasis requires cortactin‑mediated invadopodia formation","Tokui N, Yoneyama MS, Hatakeyama S, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S.","Mol Med Rep. 2014 Apr;9(4):1142-6. doi: 10.3892/mmr.2014.1965. Epub 2014 Feb 19.","Tokui N","Mol Med Rep","2014","2014/02/20","","","10.3892/mmr.2014.1965"
"26583595","Urachal cancer: contemporary review of the pathological, surgical, and prognostic aspects of this rare disease","Behrendt MA, DE Jong J, VAN Rhijn BW.","Minerva Urol Nefrol. 2016 Apr;68(2):172-84. Epub 2015 Nov 18.","Behrendt MA","Minerva Urol Nefrol","2016","2015/11/20","","",""
"4961472","Enhancement of regional bladder megavoltage irradiation in bladder cancer using local bladder hyperthermia","Cockett AT, Kazmin M, Nakamura R, Fingerhut A, Stein JJ.","J Urol. 1967 Jun;97(6):1034-9. doi: 10.1016/s0022-5347(17)63170-7.","Cockett AT","J Urol","1967","1967/06/01","","","10.1016/s0022-5347(17)63170-7"
"6168090","Practical utility of specific red cell adherence test in bladder cancer","Catalona WJ.","Urology. 1981 Aug;18(2):113-7. doi: 10.1016/0090-4295(81)90417-9.","Catalona WJ","Urology","1981","1981/08/01","","","10.1016/0090-4295(81)90417-9"
"26547385","Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study","Murthy V, Masodkar R, Kalyani N, Mahantshetty U, Bakshi G, Prakash G, Joshi A, Prabhash K, Ghonge S, Shrivastava S.","Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):60-66. doi: 10.1016/j.ijrobp.2015.09.010. Epub 2015 Sep 16.","Murthy V","Int J Radiat Oncol Biol Phys","2016","2015/11/09","","","10.1016/j.ijrobp.2015.09.010"
"8625366","Phenotypic, functional and molecular analysis of lymphocytes associated with bladder cancer","Bruno S, Machí AM, Semino C, Meta M, Ponte M, Varaldo M, Curotto A, Ferlazzo G, Decensi A, Melioli G.","Cancer Immunol Immunother. 1996 Jan;42(1):47-54. doi: 10.1007/s002620050250.","Bruno S","Cancer Immunol Immunother","1996","1996/01/01","","","10.1007/s002620050250"
"25388353","Snail is an independent prognostic indicator for predicting recurrence and progression in non-muscle-invasive bladder cancer","Gou Y, Ding W, Xu K, Wang H, Chen Z, Tan J, Xia G, Ding Q.","Int Urol Nephrol. 2015 Feb;47(2):289-93. doi: 10.1007/s11255-014-0874-z. Epub 2014 Nov 12.","Gou Y","Int Urol Nephrol","2015","2014/11/13","","","10.1007/s11255-014-0874-z"
"19955836","Menthol induces cell death via the TRPM8 channel in the human bladder cancer cell line T24","Li Q, Wang X, Yang Z, Wang B, Li S.","Oncology. 2009;77(6):335-41. doi: 10.1159/000264627. Epub 2009 Dec 2.","Li Q","Oncology","2009","2009/12/04","","","10.1159/000264627"
"20255665","Bilharzial carcinoma of the urinary bladder: a note on some unusual cases","MAKAR N, FAWZY RM.","J Egypt Med Assoc. 1947 May;30(5):261-6.","MAKAR N","J Egypt Med Assoc","1947","2010/03/19","","",""
"11374324","Neo-adjuvant chemotherapy in invasive bladder cancer","Sternberg CN, Calabrò F.","World J Urol. 2001 Apr;19(2):94-8. doi: 10.1007/s003450000190.","Sternberg CN","World J Urol","2001","2001/05/26","","","10.1007/s003450000190"
"24073396","Hyperthermia as adjunct to intravesical chemotherapy for bladder cancer","Owusu RA, Abern MR, Inman BA.","Biomed Res Int. 2013;2013:262313. doi: 10.1155/2013/262313. Epub 2013 Sep 1.","Owusu RA","Biomed Res Int","2013","2013/09/28","PMC3773892","","10.1155/2013/262313"
"30615894","The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics","Bajic P, Wolfe AJ, Gupta GN.","Urology. 2019 Apr;126:10-15. doi: 10.1016/j.urology.2018.12.034. Epub 2019 Jan 4.","Bajic P","Urology","2019","2019/01/08","","","10.1016/j.urology.2018.12.034"
"21833592","HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response","Codolo G, Fassan M, Munari F, Volpe A, Bassi P, Rugge M, Pagano F, D'Elios MM, de Bernard M.","Cancer Immunol Immunother. 2012 Jan;61(1):31-40. doi: 10.1007/s00262-011-1087-2. Epub 2011 Aug 11.","Codolo G","Cancer Immunol Immunother","2012","2011/08/12","","","10.1007/s00262-011-1087-2"
"111322","Adjuvant therapy of T1 bladder carcinoma: preliminary results of an EORTC randomized study","Schulman C, Sylvester R, Robinson M, Smith P, Lachand A, Denis L, Pavone-Macaluso M, De Pauw M, Staquet M.","Recent Results Cancer Res. 1978;68:338-45. doi: 10.1007/978-3-642-81332-0_51.","Schulman C","Recent Results Cancer Res","1978","1978/01/01","","","10.1007/978-3-642-81332-0_51"
"20289869","Early papillary carcinoma of bladder","GORDON H, BOWEN JA, et al.","Ky Med J. 1947 Apr;45(4):116-9.","GORDON H","Ky Med J","1947","2010/03/19","","",""
"20130884","Impact of patient age on outcome following bladder-preserving treatment for non-muscle-invasive bladder cancer","Kohjimoto Y, Iba A, Shintani Y, Inagaki T, Uekado Y, Hara I.","World J Urol. 2010 Aug;28(4):425-30. doi: 10.1007/s00345-010-0514-x. Epub 2010 Feb 4.","Kohjimoto Y","World J Urol","2010","2010/02/05","","","10.1007/s00345-010-0514-x"
"31302372","Large nested urothelial carcinoma: A clinicopathological study of 22 cases on transurethral resection materials","Hacıhasanoğlu E, Behzatoğlu K.","Ann Diagn Pathol. 2019 Oct;42:7-11. doi: 10.1016/j.anndiagpath.2019.06.005. Epub 2019 Jun 15.","Hacıhasanoğlu E","Ann Diagn Pathol","2019","2019/07/15","","","10.1016/j.anndiagpath.2019.06.005"
"28033269","Application of dual-energy spectral CT imaging in differential diagnosis of bladder cancer and benign prostate hyperplasia","Chen A, Liu A, Liu J, Tian S, Wang H, Liu Y.","Medicine (Baltimore). 2016 Dec;95(52):e5705. doi: 10.1097/MD.0000000000005705.","Chen A","Medicine (Baltimore)","2016","2016/12/30","PMC5207565","","10.1097/MD.0000000000005705"
"21356086","Spatio-temporal patterns of bladder cancer incidence in Utah (1973-2004) and their association with the presence of toxic release inventory sites","Fortunato L, Abellan JJ, Beale L, LeFevre S, Richardson S.","Int J Health Geogr. 2011 Feb 28;10:16. doi: 10.1186/1476-072X-10-16.","Fortunato L","Int J Health Geogr","2011","2011/03/02","PMC3058003","","10.1186/1476-072X-10-16"
"12686814","Immunotherapy for bladder cancer. Is the black box becoming grayer?","Grossman HB.","J Urol. 2003 May;169(5):1709. doi: 10.1097/01.ju.0000057803.36190.0b.","Grossman HB","J Urol","2003","2003/04/11","","","10.1097/01.ju.0000057803.36190.0b"
"19762144","Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles","Birkhahn M, Mitra AP, Williams AJ, Lam G, Ye W, Datar RH, Balic M, Groshen S, Steven KE, Cote RJ.","Eur Urol. 2010 Jan;57(1):12-20. doi: 10.1016/j.eururo.2009.09.013. Epub 2009 Sep 9.","Birkhahn M","Eur Urol","2010","2009/09/19","PMC2828516","NIHMS144072","10.1016/j.eururo.2009.09.013"
"22995974","ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion","Hautmann RE, Abol-Enein H, Davidsson T, Gudjonsson S, Hautmann SH, Holm HV, Lee CT, Liedberg F, Madersbacher S, Manoharan M, Mansson W, Mills RD, Penson DF, Skinner EC, Stein R, Studer UE, Thueroff JW, Turner WH, Volkmer BG, Xu A; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012.","Eur Urol. 2013 Jan;63(1):67-80. doi: 10.1016/j.eururo.2012.08.050. Epub 2012 Aug 31.","Hautmann RE","Eur Urol","2013","2012/09/22","","","10.1016/j.eururo.2012.08.050"
"17555476","Prognostic significance of p27Kip1 expression in bladder cancer","Rabbani F, Koppie TM, Charytonowicz E, Drobnjak M, Bochner BH, Cordon-Cardo C.","BJU Int. 2007 Aug;100(2):259-63. doi: 10.1111/j.1464-410X.2007.06927.x. Epub 2007 Jun 6.","Rabbani F","BJU Int","2007","2007/06/09","","","10.1111/j.1464-410X.2007.06927.x"
"1785001","Instillation therapy in superficial urinary bladder cancer. Finnbladder Group","Jauhiainen KE, Alfthan OS.","Scand J Urol Nephrol Suppl. 1991;138:179-85.","Jauhiainen KE","Scand J Urol Nephrol Suppl","1991","1991/01/01","","",""
"27353436","Immunochemical and molecular assessment of urothelial neoplasms and aspects of the 2016 World Health Organization classification","Compérat E, Varinot J.","Histopathology. 2016 Nov;69(5):717-726. doi: 10.1111/his.13025. Epub 2016 Sep 16.","Compérat E","Histopathology","2016","2016/06/30","","","10.1111/his.13025"
"3362906","Preoperative chemotherapy in T3-T4 Nx Mo bladder cancer with cisplatinum and methotrexate","Denis L, Da Silva FC, Hendrickx L.","Prog Clin Biol Res. 1988;260:571-7.","Denis L","Prog Clin Biol Res","1988","1988/01/01","","",""
"15989024","[Renal function after cystectomy and intestinal plastic surgery in cancer of the urinary bladder]","Sidorov VA, Shaplygin LV, Sitnikov NV, Furashov DV, Deviatov AS.","Urologiia. 2005 Mar-Apr;(2):32-5.","Sidorov VA","Urologiia","2005","2005/07/02","","",""
"28472906","Which checkpoint inhibitor? An embarrassment of riches for bladder cancer","Gill DM, Sonpavde G, Pal SK, Agarwal N.","Immunotherapy. 2017 May;9(6):463-466. doi: 10.2217/imt-2017-0033.","Gill DM","Immunotherapy","2017","2017/05/06","","","10.2217/imt-2017-0033"
"21397964","'Plan of the day' adaptive radiotherapy for bladder cancer using helical tomotherapy","Murthy V, Master Z, Adurkar P, Mallick I, Mahantshetty U, Bakshi G, Tongaonkar H, Shrivastava S.","Radiother Oncol. 2011 Apr;99(1):55-60. doi: 10.1016/j.radonc.2011.01.027. Epub 2011 Mar 11.","Murthy V","Radiother Oncol","2011","2011/03/15","","","10.1016/j.radonc.2011.01.027"
"18645685","Incidental prostate cancer in radical cystoprostatectomy specimens","Jin XD, Chen ZD, Wang B, Cai SL, Yao XL, Jin BY.","Asian J Androl. 2008 Sep;10(5):809-14. doi: 10.1111/j.1745-7262.2008.00420.x.","Jin XD","Asian J Androl","2008","2008/07/23","","","10.1111/j.1745-7262.2008.00420.x"
"7750526","Improving the safety of BCG immunotherapy by dose reduction. Cooperative Group CUETO","Martínez-Piñeiro JA, Solsona E, Flores N, Isorna S.","Eur Urol. 1995;27 Suppl 1:13-8. doi: 10.1159/000475203.","Martínez-Piñeiro JA","Eur Urol","1995","1995/01/01","","","10.1159/000475203"
"15717964","Laparoscopic radical cystectomy with ileal conduit diversion","van Velthoven RF, Piechaud T.","Curr Urol Rep. 2005 Mar;6(2):93-100. doi: 10.1007/s11934-005-0074-6.","van Velthoven RF","Curr Urol Rep","2005","2005/02/19","","","10.1007/s11934-005-0074-6"
"5547568","Bladder cancer and occupation","","Br Med J. 1971 Mar 6;1(5748):517-8.","","Br Med J","1971","1971/03/06","PMC1795276","",""
"8287737","Flow and image cytometry for DNA analysis in bladder washings: improved concordance by using internal reference for flow","Chabanas A, Rambeaud JJ, Seigneurin D, Fradet Y, Lawrence JJ, Faure G.","Cytometry. 1993 Nov;14(8):943-50. doi: 10.1002/cyto.990140814.","Chabanas A","Cytometry","1993","1993/11/01","","","10.1002/cyto.990140814"
"24976179","Editorial comment from Dr Borkowska to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading","Borkowska EM.","Int J Urol. 2014 Oct;21(10):974-5. doi: 10.1111/iju.12535. Epub 2014 Jun 26.","Borkowska EM","Int J Urol","2014","2014/07/01","","","10.1111/iju.12535"
"15758827","Re: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials","Stewart AB, Mostafid H.","J Urol. 2005 Apr;173(4):1433; author reply 1433.","Stewart AB","J Urol","2005","2005/03/11","","",""
"28324890","Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer","Sakaguchi T, Yoshino H, Yonemori M, Miyamoto K, Sugita S, Matsushita R, Itesako T, Tatarano S, Nakagawa M, Enokida H.","Br J Cancer. 2017 Apr 11;116(8):1077-1087. doi: 10.1038/bjc.2017.43. Epub 2017 Mar 21.","Sakaguchi T","Br J Cancer","2017","2017/03/22","PMC5396103","","10.1038/bjc.2017.43"
"21517233","TP53 - molecular soldier's mutations in bladder cancer in the Kashmiri population","Nanda MS, Shah ZA, Sameer AS, Syeed N, Murtaza I, Siddiqi MA, Ali A.","Asian Pac J Cancer Prev. 2011;12(1):67-72.","Nanda MS","Asian Pac J Cancer Prev","2011","2011/04/27","","",""
"11433751","[Prophylactic effect of pirarubicin (THP) on postoperative recurrence of superficial bladder cancer in terms of intravesical retention time]","Nonomura N, Nishimura K, Okuyama A, Miki T, Kishimoto T, Kiyohara H, Wakatsuki A, Fujioka H, Kuroda H, Nakano E, Takeyama M, Koide T, Yamaguchi S.","Hinyokika Kiyo. 2001 May;47(5):315-9.","Nonomura N","Hinyokika Kiyo","2001","2001/07/04","","",""
"27448817","Cytokeratin-19 fragment in the diagnosis of bladder carcinoma","Guo XG, Long JJ.","Tumour Biol. 2016 Oct;37(10):14329-14330. doi: 10.1007/s13277-016-5223-7. Epub 2016 Jul 22.","Guo XG","Tumour Biol","2016","2016/07/25","","","10.1007/s13277-016-5223-7"
"18635238","RUNX3 methylation and the potential to predict the behavior of bladder cancer","Knapp DW.","J Urol. 2008 Sep;180(3):806-7. doi: 10.1016/j.juro.2008.06.073. Epub 2008 Jul 17.","Knapp DW","J Urol","2008","2008/07/19","","","10.1016/j.juro.2008.06.073"
"14670539","Correlation between p53 mutations and HPV in bilharzial bladder cancer","Khaled HM, Bahnassi AA, Zekri AR, Kassem HA, Mokhtar N.","Urol Oncol. 2003 Sep-Oct;21(5):334-41. doi: 10.1016/s1078-1439(03)00014-0.","Khaled HM","Urol Oncol","2003","2003/12/13","","","10.1016/s1078-1439(03)00014-0"
"2289518","Volume-corrected mitotic index and mitotic activity index in transitional cell bladder cancer","Lipponen PK, Eskelinen MJ.","Eur Urol. 1990;18(4):258-62. doi: 10.1159/000463925.","Lipponen PK","Eur Urol","1990","1990/01/01","","","10.1159/000463925"
"25183704","Likelihood of bladder cancer associated with non-visible haematuria is quantified for first time","Sayburn A.","BMJ. 2014 Sep 1;349:g5415. doi: 10.1136/bmj.g5415.","Sayburn A","BMJ","2014","2014/09/04","","","10.1136/bmj.g5415"
"17149384","A case of T2 muscle-invasive bladder cancer treated with neoadjuvant chemotherapy","Gilbert SM, Lee CT.","Nat Clin Pract Urol. 2006 Dec;3(12):675-9. doi: 10.1038/ncpuro0655.","Gilbert SM","Nat Clin Pract Urol","2006","2006/12/07","","","10.1038/ncpuro0655"
"6841985","[Role of radiotherapy in the treatment of bladder cancer. Comments apropos of 178 cases]","Beurton D, Moller M, Cukier J.","J Urol (Paris). 1983;89(1):1-10.","Beurton D","J Urol (Paris)","1983","1983/01/01","","",""
"7819043","Expression of p53 in urothelial cell cultures from tumour-bearing and tumour-free patients","Harney J, Murphy DM, Jones M, Mothersill C.","Br J Cancer. 1995 Jan;71(1):25-9. doi: 10.1038/bjc.1995.6.","Harney J","Br J Cancer","1995","1995/01/01","PMC2033449","","10.1038/bjc.1995.6"
"30415317","The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside","Duplisea JJ, Mokkapati S, Plote D, Schluns KS, McConkey DJ, Yla-Herttuala S, Parker NR, Dinney CP.","World J Urol. 2019 Oct;37(10):2041-2049. doi: 10.1007/s00345-018-2553-7. Epub 2018 Nov 11.","Duplisea JJ","World J Urol","2019","2018/11/12","PMC6511323","NIHMS1512220","10.1007/s00345-018-2553-7"
"1606880","Urothelial toxicity following conditioning therapy in bone marrow transplantation and bladder cancer: morphologic and morphometric comparison by exfoliative urinary cytology","Stella F, Battistelli S, Marcheggiani F, De Santis M, Donnorso RP, Baronciani D, Durazzi SM, Troccoli R, Lucarelli G.","Diagn Cytopathol. 1992;8(3):216-21. doi: 10.1002/dc.2840080306.","Stella F","Diagn Cytopathol","1992","1992/01/01","","","10.1002/dc.2840080306"
"22421353","Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development","Wu K, Zeng J, Zhou J, Fan J, Chen Y, Wang Z, Zhang T, Wang X, He D.","Urol Oncol. 2013 Nov;31(8):1751-60. doi: 10.1016/j.urolonc.2012.02.001. Epub 2012 Mar 14.","Wu K","Urol Oncol","2013","2012/03/17","","","10.1016/j.urolonc.2012.02.001"
"8638353","A comparison of the W-stapled ileal reservoir with hand-sewn reservoirs for orthotopic bladder replacement","Montie JE, Pontes JE, Powell IJ.","Urology. 1996 Apr;47(4):476-81. doi: 10.1016/S0090-4295(99)80480-4.","Montie JE","Urology","1996","1996/04/01","","","10.1016/S0090-4295(99)80480-4"
"17063350","[Urine cytology and urine markers. Significance for clinical practice]","Tritschler S, Zaak D, Knuechel R, Stief CG.","Urologe A. 2006 Nov;45(11):W1441-7; quiz W1448. doi: 10.1007/s00120-006-1217-1.","Tritschler S","Urologe A","2006","2006/10/26","","","10.1007/s00120-006-1217-1"
"2672010","Mechanisms of action of intravesical BCG for bladder cancer","Ratliff TL.","Prog Clin Biol Res. 1989;310:107-22.","Ratliff TL","Prog Clin Biol Res","1989","1989/01/01","","",""
"11815300","Bladder cancer detection with urinary survivin, an inhibitor of apoptosis","Sharp JD, Hausladen DA, Maher MG, Wheeler MA, Altieri DC, Weiss RM.","Front Biosci. 2002 Feb 1;7:e36-41. doi: 10.2741/sharp.","Sharp JD","Front Biosci","2002","2002/01/30","","","10.2741/sharp"
"26110401","Modulated Raman Spectroscopy for Enhanced Cancer Diagnosis at the Cellular Level","De Luca AC, Dholakia K, Mazilu M.","Sensors (Basel). 2015 Jun 11;15(6):13680-704. doi: 10.3390/s150613680.","De Luca AC","Sensors (Basel)","2015","2015/06/26","PMC4507596","","10.3390/s150613680"
"30753532","Histologic variants associated with biological aggressiveness and poor prognosis in patients treated with radical cystectomy","Koguchi D, Matsumoto K, Ikeda M, Taoka Y, Hirayama T, Murakami Y, Utsunomiya T, Matsuda D, Okuno N, Irie A, Iwamura M.","Jpn J Clin Oncol. 2019 Apr 1;49(4):373-378. doi: 10.1093/jjco/hyz015.","Koguchi D","Jpn J Clin Oncol","2019","2019/02/13","","","10.1093/jjco/hyz015"
"20239040","A comparison of radiation and surgery for cancer of the bladder","MARSHALL VF.","J Am Med Assoc. 1947 Jun 7;134(6):501-7. doi: 10.1001/jama.1947.02880230011004.","MARSHALL VF","J Am Med Assoc","1947","2010/03/19","","","10.1001/jama.1947.02880230011004"
"219366","Preliminary studies of sera and urine from patients with bladder cancer","Hollinshead AC.","Natl Cancer Inst Monogr. 1978 Dec;(49):193-7.","Hollinshead AC","Natl Cancer Inst Monogr","1978","1978/12/01","","",""
"8497923","Conservative treatment for T2-T4 bladder cancer with primary chemotherapy and radiotherapy: a pilot study","Cruciani G, Dazzi C, Montanari F, Voce S, Salerno V, Giannini M, Emiliani E, Marangolo M.","Tumori. 1993 Feb 28;79(1):53-7.","Cruciani G","Tumori","1993","1993/02/28","","",""
"19908257","Cytoplasmic mislocalization of the orphan nuclear receptor Nurr1 is a prognostic factor in bladder cancer","Inamoto T, Czerniak BA, Dinney CP, Kamat AM.","Cancer. 2010 Jan 15;116(2):340-6. doi: 10.1002/cncr.24737.","Inamoto T","Cancer","2010","2009/11/13","","","10.1002/cncr.24737"
"21736846","Intake of α-linolenic acid and other fatty acids in relation to the risk of bladder cancer: results from the New Hampshire case-control study","Brinkman MT, Karagas MR, Zens MS, Schned AR, Reulen RC, Zeegers MP.","Br J Nutr. 2011 Oct;106(7):1070-7. doi: 10.1017/S0007114511001346. Epub 2011 May 10.","Brinkman MT","Br J Nutr","2011","2011/07/09","PMC3321546","NIHMS362291","10.1017/S0007114511001346"
"1949363","Combined therapy of interleukin 2 with cyclophosphamide or bacillus Calmette-Guérin against implanted bladder cancer cells in mice","Wada S, Ikemoto S, Terada T, Tanaka H, Kamizuru M, Sakamoto W, Kishimoto T, Maekawa M.","Urol Int. 1991;47 Suppl 1:104-7. doi: 10.1159/000282265.","Wada S","Urol Int","1991","1991/01/01","","","10.1159/000282265"
"24662746","Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition","Jing Y, Cui D, Guo W, Jiang J, Jiang B, Lu Y, Zhao W, Wang X, Jiang Q, Han B, Xia S.","Cancer Lett. 2014 Jun 28;348(1-2):135-45. doi: 10.1016/j.canlet.2014.03.018. Epub 2014 Mar 21.","Jing Y","Cancer Lett","2014","2014/03/26","","","10.1016/j.canlet.2014.03.018"
"25313765","The prognosis of patients less than 40 years with bladder cancer","Na SW, Yu SH, Kim KH, Hwang EC, Jung SI, Kwon DD, Kang TW.","J Cancer Res Ther. 2014 Jul-Sep;10(3):710-4. doi: 10.4103/0973-1482.137928.","Na SW","J Cancer Res Ther","2014","2014/10/15","","","10.4103/0973-1482.137928"
"28025963","Association between pioglitazone use and the risk of bladder cancer among subjects with diabetes mellitus: a dose-response meta-analysis ","Li Z, Sun M, Wang F, Shi J, Wang K.","Int J Clin Pharmacol Ther. 2017 Mar;55(3):210-219. doi: 10.5414/CP202670.","Li Z","Int J Clin Pharmacol Ther","2017","2016/12/28","","","10.5414/CP202670"
"4096482","Upper urinary tract transitional cell carcinoma after total cystectomy for bladder cancer","Lindell O, Lehtonen T.","Ann Chir Gynaecol. 1985;74(6):288-93.","Lindell O","Ann Chir Gynaecol","1985","1985/01/01","","",""
"9393304","The agreement among urological experts on the diagnostic management of patients with common urological problems","Hansen MV, Zdanowski A.","Br J Urol. 1997 Nov;80(5):787-92. doi: 10.1046/j.1464-410x.1997.d01-5338.x.","Hansen MV","Br J Urol","1997","1997/12/11","","","10.1046/j.1464-410x.1997.d01-5338.x"
"27908681","Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer","Soria F, Moschini M, Abufaraj M, Wirth GJ, Foerster B, Gust KM, Özsoy M, Briganti A, Gontero P, Mathieu R, Rouprêt M, Karakiewicz PI, Shariat SF.","Urol Oncol. 2017 Mar;35(3):113.e9-113.e14. doi: 10.1016/j.urolonc.2016.10.021. Epub 2016 Nov 28.","Soria F","Urol Oncol","2017","2016/12/03","","","10.1016/j.urolonc.2016.10.021"
"17628296","Long-term outcome of radiation-based conservation therapy for invasive bladder cancer","Chung PW, Bristow RG, Milosevic MF, Yi QL, Jewett MA, Warde PR, Catton CN, McLean M, Moore M, Tannock IF, Gospodarowicz MK.","Urol Oncol. 2007 Jul-Aug;25(4):303-9. doi: 10.1016/j.urolonc.2006.09.015.","Chung PW","Urol Oncol","2007","2007/07/14","","","10.1016/j.urolonc.2006.09.015"
"10422439","[Clinical significance of urothelial dysplasia concomitant with superficial bladder cancer]","Ishii T, Takeuchi F, Hiratsuka Y, Ariyoshi A.","Nihon Hinyokika Gakkai Zasshi. 1999 Jun;90(6):633-8. doi: 10.5980/jpnjurol1989.90.633.","Ishii T","Nihon Hinyokika Gakkai Zasshi","1999","1999/07/28","","","10.5980/jpnjurol1989.90.633"
"11888672","p53 codon 72 polymorphism and its association with bladder cancer","Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA.","Cancer Lett. 2002 May 28;179(2):175-83. doi: 10.1016/s0304-3835(01)00867-9.","Soulitzis N","Cancer Lett","2002","2002/03/13","","","10.1016/s0304-3835(01)00867-9"
"25119010","Cadmium in urothelial carcinoma of the bladder","Golabek T, Darewicz B, Kudelski J, Socha K, Markiewicz-Zukowska R, Chlosta P, Okoń K, Borawska M.","Pol J Pathol. 2014 Mar;65(1):55-9. doi: 10.5114/pjp.2014.42670.","Golabek T","Pol J Pathol","2014","2014/08/15","","","10.5114/pjp.2014.42670"
"29724418","ACR Appropriateness Criteria(®) Pretreatment Staging of Muscle-Invasive Bladder Cancer","Expert Panel on Urologic Imaging:, van der Pol CB, Sahni VA, Eberhardt SC, Oto A, Akin O, Alexander LF, Allen BC, Coakley FV, Froemming AT, Fulgham PF, Hosseinzadeh K, Maranchie JK, Mody RN, Schieda N, Schuster DM, Venkatesan AM, Wang CL, Lockhart ME.","J Am Coll Radiol. 2018 May;15(5S):S150-S159. doi: 10.1016/j.jacr.2018.03.020.","Expert Panel on Urologic Imaging:","J Am Coll Radiol","2018","2018/05/05","","","10.1016/j.jacr.2018.03.020"
"15191002","A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice?","Shelley MD, Wilt TJ, Barber J, Mason MD.","Clin Oncol (R Coll Radiol). 2004 May;16(3):166-71. doi: 10.1016/j.clon.2003.10.001.","Shelley MD","Clin Oncol (R Coll Radiol)","2004","2004/06/12","","","10.1016/j.clon.2003.10.001"
"31310599","Expression of Testis-Specific Gene Antigen 10 (TSGA10) is Associated with Apoptosis and Cell Migration in Bladder Cancer Cells and Tumor Stage and Overall Survival in Patients with Bladder Cancer","Wu D, Lin J, Zhu Y, Zhang H, Zhong Y.","Med Sci Monit. 2019 Jul 16;25:5289-5298. doi: 10.12659/MSM.915682.","Wu D","Med Sci Monit","2019","2019/07/17","PMC6652375","","10.12659/MSM.915682"
"16691242","Management of panurothelial disease in superficial bladder cancer","Srougi M, Antunes AA, Dall'Oglio MF, Cury J.","Nat Clin Pract Urol. 2006 May;3(5):284-8. doi: 10.1038/ncpuro0489.","Srougi M","Nat Clin Pract Urol","2006","2006/05/13","","","10.1038/ncpuro0489"
"22201870","Bladder tumors and aromatic amines - historical milestones from Ludwig Rehn to Wilhelm Hueper","Dietrich HG, Golka K.","Front Biosci (Elite Ed). 2012 Jan 1;4:279-88. doi: 10.2741/375.","Dietrich HG","Front Biosci (Elite Ed)","2012","2011/12/29","","","10.2741/375"
"5162141","[Repeated lymphography in cancer of the urinary bladder]","Khananshvili IaA, Tsyb AF, Dunchik VN, Nestaiko OV.","Med Radiol (Mosk). 1971 Nov;16(11):21-5.","Khananshvili IaA","Med Radiol (Mosk)","1971","1971/11/01","","",""
"16126325","Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer","Delongchamps NB, Mao K, Theng H, Zerbib M, Debré B, Peyromaure M.","Eur Urol. 2005 Dec;48(6):946-50. doi: 10.1016/j.eururo.2005.07.008. Epub 2005 Aug 2.","Delongchamps NB","Eur Urol","2005","2005/08/30","","","10.1016/j.eururo.2005.07.008"
"29221636","Urothelial neoplasms in pediatric and young adult patients: A large single-center series","Saltsman JA, Malek MM, Reuter VE, Hammond WJ, Danzer E, Herr HW, LaQuaglia MP.","J Pediatr Surg. 2018 Feb;53(2):306-309. doi: 10.1016/j.jpedsurg.2017.11.024. Epub 2017 Nov 14.","Saltsman JA","J Pediatr Surg","2018","2017/12/10","PMC5828877","NIHMS920563","10.1016/j.jpedsurg.2017.11.024"
"25214475","Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma","Singh PK, Srivastava AK, Dalela D, Rath SK, Goel MM, Bhatt ML.","Immunobiology. 2015 Jan;220(1):68-73. doi: 10.1016/j.imbio.2014.08.018. Epub 2014 Sep 1.","Singh PK","Immunobiology","2015","2014/09/13","","","10.1016/j.imbio.2014.08.018"
"2231190","Bacillus Calmette-Guérin-treated superficial bladder cancer: correlation of morphology with immunophenotyping","Leong AS, Wannakrairot P, Jose J, Milios J.","J Pathol. 1990 Sep;162(1):35-41. doi: 10.1002/path.1711620108.","Leong AS","J Pathol","1990","1990/09/01","","","10.1002/path.1711620108"
"10923492","[10-Hydroxycamptothecin induces apoptosis in human T24 urinary bladder cancer cells]","Fan J, Tang X, Zhang X.","Zhonghua Yi Xue Za Zhi. 1998 Apr;78(4):301-4.","Fan J","Zhonghua Yi Xue Za Zhi","1998","2000/08/03","","",""
"31144582","Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe)","Jahnson S, Gårdmark T, Hosseini A, Jerlström T, Liedberg F, Malmström PU, Rosell J, Sherif A, Ströck V, Häggström C, Holmberg L, Aljabery F.","Scand J Urol. 2019 Aug;53(4):200-205. doi: 10.1080/21681805.2019.1621377. Epub 2019 May 30.","Jahnson S","Scand J Urol","2019","2019/05/31","","","10.1080/21681805.2019.1621377"
"24329492","Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition","Jitao W, Jinchen H, Qingzuo L, Li C, Lei S, Jianming W, Zhenli G.","Andrologia. 2014 Dec;46(10):1128-33. doi: 10.1111/and.12203. Epub 2013 Dec 16.","Jitao W","Andrologia","2014","2013/12/17","","","10.1111/and.12203"
"20553213","Current status of radiation therapy for bladder cancer","Sandler HM, Mirhadi AJ.","Expert Rev Anticancer Ther. 2010 Jun;10(6):895-901. doi: 10.1586/era.10.34.","Sandler HM","Expert Rev Anticancer Ther","2010","2010/06/18","","","10.1586/era.10.34"
"21533858","Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence","Huang P, Chen J, Wang L, Na Y, Kaku H, Ueki H, Sasaki K, Yamaguchi K, Zhang K, Saika T, Nasu Y, Watanabe M, Kumon H.","Med Oncol. 2012 Jun;29(2):829-34. doi: 10.1007/s12032-011-9962-4. Epub 2011 May 1.","Huang P","Med Oncol","2012","2011/05/03","","","10.1007/s12032-011-9962-4"
"24909719","Complex of molecular genetic and immunohistochemical methods for detection of human papillomavirus in the bladder cancer epithelium","Golovina DA, Trofimova OB, Ermilova VD, Matveev VB, Volgareva GM.","Bull Exp Biol Med. 2014 May;157(1):70-3. doi: 10.1007/s10517-014-2494-0. Epub 2014 Jun 10.","Golovina DA","Bull Exp Biol Med","2014","2014/06/10","","","10.1007/s10517-014-2494-0"
"18788485","[Radical cystectomy as a muscle-invasive bladder cancer treatment in elderly patients]","March Villalba JA, Martínez Jabaloyas JM, Pastor Hernández F, Günthner Stefan FJ, Rodríguez Navarro R, Chuan Nuez P.","Actas Urol Esp. 2008 Jul-Aug;32(7):696-704. doi: 10.1016/s0210-4806(08)73917-2.","March Villalba JA","Actas Urol Esp","2008","2008/09/16","","","10.1016/s0210-4806(08)73917-2"
"6745560","Rapid induction of carcinoma in situ in dog urinary bladder by sequential treatment with N-methyl-N'-nitrosourea and N-butyl-N-(4-hydroxybutyl)-nitrosamine","Samma S, Uemura H, Tabata S, Iwai A, Nakatsuji F, Matsuki H, Babaya K, Hirao Y, Okajima E.","Gan. 1984 May;75(5):385-7.","Samma S","Gan","1984","1984/05/01","","",""
"9815765","Bladder tissue pharmacokinetics and antitumor effect of intravesical 5-fluorouridine","Song D, Wientjes MG, Gan Y, Au JL.","Clin Cancer Res. 1997 Jun;3(6):901-9.","Song D","Clin Cancer Res","1997","1997/06/01","","",""
"7581498","The procarcinogen hypothesis for bladder cancer: activities of individual drug metabolizing enzymes as risk factors","Branch RA, Chern HD, Adedoyin A, Romkes-Sparks M, Lesnick TG, Persad R, Wilkinson GR, Fleming CM, Dickinson AJ, Sibley G, et al.","Pharmacogenetics. 1995;5 Spec No:S97-102. doi: 10.1097/00008571-199512001-00009.","Branch RA","Pharmacogenetics","1995","1995/01/01","","","10.1097/00008571-199512001-00009"
"6384610","Production and characterization of monoclonal antibodies to the established human bladder cancer cell lines","Sasaki M.","Keio J Med. 1984 Apr;33(1):39-56. doi: 10.2302/kjm.33.39.","Sasaki M","Keio J Med","1984","1984/04/01","","","10.2302/kjm.33.39"
"20889919","Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer","Naito S, Bilim V, Yuuki K, Ugolkov A, Motoyama T, Nagaoka A, Kato T, Tomita Y.","Clin Cancer Res. 2010 Nov 1;16(21):5124-32. doi: 10.1158/1078-0432.CCR-10-0275. Epub 2010 Oct 1.","Naito S","Clin Cancer Res","2010","2010/10/05","","","10.1158/1078-0432.CCR-10-0275"
"28182356","Association between N-Acetyltransferase 2 Polymorphism and Bladder Cancer Risk: a Meta-Analysis in a Single Ethnic Group","Xu WJ, Wen LP, Jiang XX, Ye LY, Meng FH, Guan S, Qian YJ, Wei JF.","Clin Lab. 2017 Feb 1;63(2):287-293. doi: 10.7754/Clin.Lab.2016.160803.","Xu WJ","Clin Lab","2017","2017/02/10","","","10.7754/Clin.Lab.2016.160803"
"27133288","Discovery of urine biomarkers for bladder cancer via global metabolomics","Shi H, Li X, Zhang Q, Yang H, Zhang X.","Biomarkers. 2016 Nov;21(7):578-88. doi: 10.3109/1354750X.2016.1171903. Epub 2016 May 2.","Shi H","Biomarkers","2016","2016/05/03","","","10.3109/1354750X.2016.1171903"
"28501826","Urothelial papilloma: a rare cause of gross haematuria in childhood","Ribeiro A, Pereira M, Reis A, Ferreira G.","BMJ Case Rep. 2017 May 13;2017:bcr2017219341. doi: 10.1136/bcr-2017-219341.","Ribeiro A","BMJ Case Rep","2017","2017/05/15","PMC5612437","","10.1136/bcr-2017-219341"
"18133162","Carcinoma of the bladder","JACOBS A, RICHES EW, MILLEN JL.","Br J Radiol. 1949 Jul;22(259):393-405. doi: 10.1259/0007-1285-22-259-393.","JACOBS A","Br J Radiol","1949","1949/07/01","","","10.1259/0007-1285-22-259-393"
"20988067","Treatment of carcinoma of the bladder for the past five years with special reference to the closed method of treatment","MILNER WA.","J Urol. 1946 Jun;55:607-12. doi: 10.1016/s0022-5347(17)69954-3.","MILNER WA","J Urol","1946","2010/10/29","","","10.1016/s0022-5347(17)69954-3"
"23478848","FDG PET/CT and renal scan demonstrations of carcinoma in the urinary bladder and bladder diverticulum","Liu Y.","Clin Nucl Med. 2013 Jul;38(7):580-1. doi: 10.1097/RLU.0b013e318286c03e.","Liu Y","Clin Nucl Med","2013","2013/03/13","","","10.1097/RLU.0b013e318286c03e"
"1768062","Interrelation between western type cancers and non-western type cancers as regards their risk variations in time and space. III. A contrast between bladder cancer and stomach cancer","Kodama M, Kodama T, Kodama M.","Anticancer Res. 1991 Sep-Oct;11(5):1895-904.","Kodama M","Anticancer Res","1991","1991/09/01","","",""
"8281514","A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors","Meloni AM, Peier AM, Haddad FS, Powell IJ, Block AW, Huben RP, Todd I, Potter W, Sandberg AA.","Cancer Genet Cytogenet. 1993 Dec;71(2):105-18. doi: 10.1016/0165-4608(93)90015-e.","Meloni AM","Cancer Genet Cytogenet","1993","1993/12/01","","","10.1016/0165-4608(93)90015-e"
"27428950","Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer","Hojeij R, Domingos-Pereira S, Nkosi M, Gharbi D, Derré L, Schiller JT, Jichlinski P, Nardelli-Haefliger D.","Int J Mol Sci. 2016 Jul 14;17(7):1125. doi: 10.3390/ijms17071125.","Hojeij R","Int J Mol Sci","2016","2016/07/19","PMC4964499","","10.3390/ijms17071125"
"30589047","Transurethral endoscopic submucosal en bloc dissection for nonmuscle invasive bladder cancer: A comparison study of HybridKnife-assisted versus conventional dissection technique","Cheng YY, Sun Y, Li J, Liang L, Zou TJ, Qu WX, Jiang YZ, Ren W, Du C, Du SK, Zhao WC.","J Cancer Res Ther. 2018;14(7):1606-1612. doi: 10.4103/jcrt.JCRT_786_17.","Cheng YY","J Cancer Res Ther","2018","2018/12/28","","","10.4103/jcrt.JCRT_786_17"
"29368083","Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder","Kulac I, Arslankoz S, Netto GJ, Ertoy Baydar D.","Virchows Arch. 2018 Jun;472(6):969-974. doi: 10.1007/s00428-018-2302-8. Epub 2018 Jan 24.","Kulac I","Virchows Arch","2018","2018/01/26","","","10.1007/s00428-018-2302-8"
"24240162","Direct detection of hyaluronidase in urine using cationic gold nanoparticles: a potential diagnostic test for bladder cancer","Nossier AI, Eissa S, Ismail MF, Hamdy MA, Azzazy HM.","Biosens Bioelectron. 2014 Apr 15;54:7-14. doi: 10.1016/j.bios.2013.10.024. Epub 2013 Oct 31.","Nossier AI","Biosens Bioelectron","2014","2013/11/19","","","10.1016/j.bios.2013.10.024"
"9208322","[Bladder cancer in patients with spinal cord injury: report of two cases]","Sugimoto K, Umekawa T, Park YC, Kurita T.","Hinyokika Kiyo. 1997 May;43(5):359-62.","Sugimoto K","Hinyokika Kiyo","1997","1997/05/01","","",""
"23014837","Urothelial carcinomas of the upper urinary tract are now recognised as a true and distinct entity from bladder cancer and belong fully to the broad spectrum of onco-urologic neoplasms","Rouprêt M, Colin P.","World J Urol. 2013 Feb;31(1):1-3. doi: 10.1007/s00345-012-0958-2. Epub 2012 Sep 27.","Rouprêt M","World J Urol","2013","2012/09/28","","","10.1007/s00345-012-0958-2"
"18334113","[Effects of survivin small interfering RNA on biological behaviors of bladder cancer T24 cells]","Wang XL, Hou JQ, Wen DG, He J.","Ai Zheng. 2008 Mar;27(3):253-7.","Wang XL","Ai Zheng","2008","2008/03/13","","",""
"21970881","Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer","Tanaka N, Miyajima A, Kosaka T, Miyazaki Y, Shirotake S, Shirakawa H, Kikuchi E, Oya M.","Br J Cancer. 2011 Oct 25;105(9):1331-7. doi: 10.1038/bjc.2011.399. Epub 2011 Oct 4.","Tanaka N","Br J Cancer","2011","2011/10/06","PMC3241561","","10.1038/bjc.2011.399"
"23332382","Intrafraction bladder motion in radiation therapy estimated from pretreatment and posttreatment volumetric imaging","Foroudi F, Pham D, Bressel M, Gill S, Kron T.","Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):77-82. doi: 10.1016/j.ijrobp.2012.11.035. Epub 2013 Jan 16.","Foroudi F","Int J Radiat Oncol Biol Phys","2013","2013/01/22","","","10.1016/j.ijrobp.2012.11.035"
"17164382","Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk","Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE.","Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2537-41. doi: 10.1158/1055-9965.EPI-06-0288.","Sak SC","Cancer Epidemiol Biomarkers Prev","2006","2006/12/14","","","10.1158/1055-9965.EPI-06-0288"
"11869833","The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences","Golka K, Prior V, Blaszkewicz M, Bolt HM.","Toxicol Lett. 2002 Mar 10;128(1-3):229-41. doi: 10.1016/s0378-4274(01)00544-6.","Golka K","Toxicol Lett","2002","2002/03/01","","","10.1016/s0378-4274(01)00544-6"
"3677105","Occupational risks for bladder cancer among men in Sweden","Malker HS, McLaughlin JK, Silverman DT, Ericsson JL, Stone BJ, Weiner JA, Malker BK, Blot WJ.","Cancer Res. 1987 Dec 15;47(24 Pt 1):6763-6.","Malker HS","Cancer Res","1987","1987/12/15","","",""
"28628011","[CRITERIA FOR SELECTION OF TUMOR CELLS AND PROSPECTS FOR SPECIFIC IMMUNOTHERAPY FOR BLADDER CANCER]","Slavyanskaya T, -Salnikova S, Sepiashvili R.","Georgian Med News. 2017 May;(266):26-34.","Slavyanskaya T","Georgian Med News","2017","2017/06/20","","",""
"30134837","Circular RNA CEP128 acts as a sponge of miR-145-5p in promoting the bladder cancer progression via regulating SOX11","Wu Z, Huang W, Wang X, Wang T, Chen Y, Chen B, Liu R, Bai P, Xing J.","Mol Med. 2018 Jul 31;24(1):40. doi: 10.1186/s10020-018-0039-0.","Wu Z","Mol Med","2018","2018/08/24","PMC6069875","","10.1186/s10020-018-0039-0"
"10494287","Diagnosis and grading of bladder cancer and associated lesions","Bostwick DG, Ramnani D, Cheng L.","Urol Clin North Am. 1999 Aug;26(3):493-507. doi: 10.1016/s0094-0143(05)70197-x.","Bostwick DG","Urol Clin North Am","1999","1999/09/24","","","10.1016/s0094-0143(05)70197-x"
"21924546","Re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU Guidelines. Eur Urol 2011;59:1009-18","Bossi A.","Eur Urol. 2011 Dec;60(6):e52; author reply e53. doi: 10.1016/j.eururo.2011.07.070. Epub 2011 Sep 9.","Bossi A","Eur Urol","2011","2011/09/20","","","10.1016/j.eururo.2011.07.070"
"19249799","Neuromyotonia as paraneoplastic manifestation of bladder carcinoma","Forte F, Pretegiani E, Battisti C, Sicurelli F, Federico A.","J Neurol Sci. 2009 May 15;280(1-2):111-2. doi: 10.1016/j.jns.2009.01.022. Epub 2009 Feb 27.","Forte F","J Neurol Sci","2009","2009/03/03","","","10.1016/j.jns.2009.01.022"
"24332648","Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder","Xylinas E, Kluth LA, Lotan Y, Daneshmand S, Rieken M, Karakiewicz PI, Shariat SF.","Urol Oncol. 2014 Apr;32(3):230-42. doi: 10.1016/j.urolonc.2013.06.009. Epub 2013 Dec 12.","Xylinas E","Urol Oncol","2014","2013/12/17","","","10.1016/j.urolonc.2013.06.009"
"12486903","[Sudden bilateral hearing loss disclosing meningeal carcinomatosis]","Boukriche Y, Bouccara D, Cyna-Gorse F, Dehais C, Felce-Dachez M, Masson C.","Rev Neurol (Paris). 2002 Jul;158(6-7):728-30.","Boukriche Y","Rev Neurol (Paris)","2002","2002/12/19","","",""
"3602967","The Copenhagen case-referent study on bladder cancer. Risks among drivers, painters and certain other occupations","Jensen OM, Wahrendorf J, Knudsen JB, Sørensen BL.","Scand J Work Environ Health. 1987 Apr;13(2):129-34. doi: 10.5271/sjweh.2070.","Jensen OM","Scand J Work Environ Health","1987","1987/04/01","","","10.5271/sjweh.2070"
"17040057","[Bladder cancer with skin metastasis: a case report]","Segawa N, Kotake Y, Hamada S, Takahara K, Azuma H, Katsuoka Y, Tsuji M.","Hinyokika Kiyo. 2006 Sep;52(9):711-4.","Segawa N","Hinyokika Kiyo","2006","2006/10/17","","",""
"28818537","Predicting Grade and Stage at Cystoscopy in Newly Presenting Bladder Cancers-a Prospective Double-Blind Clinical Study","Mariappan P, Lavin V, Phua CQ, Khan SAA, Donat R, Smith G.","Urology. 2017 Nov;109:134-139. doi: 10.1016/j.urology.2017.08.007. Epub 2017 Aug 14.","Mariappan P","Urology","2017","2017/08/19","","","10.1016/j.urology.2017.08.007"
"30458442","miR-1-3p Contributes to Cell Proliferation and Invasion by Targeting Glutaminase in Bladder Cancer Cells","Zhang J, Wang L, Mao S, Liu M, Zhang W, Zhang Z, Guo Y, Huang B, Yan Y, Huang Y, Yao X.","Cell Physiol Biochem. 2018;51(2):513-527. doi: 10.1159/000495273. Epub 2018 Nov 20.","Zhang J","Cell Physiol Biochem","2018","2018/11/21","","","10.1159/000495273"
"2221929","[A comparative clinical trial of UFT medication and intravesical BCG in the recurrence of superficial bladder cancer. Study Group of UFT and BCG adjuvant therapy for bladder cancer]","Oda H, Seki N, Nabeshima S, Oda T, Nishio S, Yokoyama M, Iwata H, Takeuchi M, Matsumoto A, Terado T, et al.","Gan To Kagaku Ryoho. 1990 Oct;17(10):2051-5.","Oda H","Gan To Kagaku Ryoho","1990","1990/10/01","","",""
"22218302","Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer","Zhai Z, Wang Z, Fu S, Lu J, Wang F, Li R, Zhang H, Li S, Hou Z, Wang H, Rodriguez R.","Gene Ther. 2012 Nov;19(11):1065-74. doi: 10.1038/gt.2011.180. Epub 2012 Jan 5.","Zhai Z","Gene Ther","2012","2012/01/06","PMC3684261","NIHMS404079","10.1038/gt.2011.180"
"10954902","Intravesical and intravenous therapy of human bladder cancer by the herpes vector G207","Oyama M, Ohigashi T, Hoshi M, Nakashima J, Tachibana M, Murai M, Uyemura K, Yazaki T.","Hum Gene Ther. 2000 Aug 10;11(12):1683-93. doi: 10.1089/10430340050111331.","Oyama M","Hum Gene Ther","2000","2000/08/24","","","10.1089/10430340050111331"
"27922685","5‑bromo‑3‑(3‑hydroxyprop‑1‑ynyl)‑2H‑pyran‑2‑one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways","Yu GQ, Dou ZL, Jia ZH.","Mol Med Rep. 2017 Jan;15(1):153-159. doi: 10.3892/mmr.2016.5991. Epub 2016 Dec 6.","Yu GQ","Mol Med Rep","2017","2016/12/07","PMC5355715","","10.3892/mmr.2016.5991"
"24687305","Maslinic acid induced apoptosis in bladder cancer cells through activating p38 MAPK signaling pathway","Zhang S, Ding D, Zhang X, Shan L, Liu Z.","Mol Cell Biochem. 2014 Jul;392(1-2):281-7. doi: 10.1007/s11010-014-2038-y. Epub 2014 Apr 1.","Zhang S","Mol Cell Biochem","2014","2014/04/02","","","10.1007/s11010-014-2038-y"
"16327984","Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancer","Hotakainen K, Bjartell A, Sankila A, Järvinen R, Paju A, Rintala E, Haglund C, Stenman UH.","Int J Oncol. 2006 Jan;28(1):95-101. doi: 10.3892/ijo.28.1.95.","Hotakainen K","Int J Oncol","2006","2005/12/06","","","10.3892/ijo.28.1.95"
"25385734","Neoadjuvant chemotherapy for muscle-invasive bladder cancer: are we asking the right questions?","Aragon-Ching JB.","J Clin Oncol. 2014 Dec 20;32(36):4169-70. doi: 10.1200/JCO.2014.57.3154. Epub 2014 Nov 10.","Aragon-Ching JB","J Clin Oncol","2014","2014/11/12","","","10.1200/JCO.2014.57.3154"
"25385728","Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy in bladder cancer: ready for prime time?","Pouessel D, Gauthier H, Serrate C, Pfister C, Culine S.","J Clin Oncol. 2014 Dec 20;32(36):4168-9. doi: 10.1200/JCO.2014.58.0498. Epub 2014 Nov 10.","Pouessel D","J Clin Oncol","2014","2014/11/12","","","10.1200/JCO.2014.58.0498"
"1951057","Preventing bladder cancer from exposure to o-toluidine and aniline","","Am Ind Hyg Assoc J. 1991 May;52(5):A260, A262.","","Am Ind Hyg Assoc J","1991","1991/05/01","","",""
"23587508","Neoadjuvant chemotherapy in the treatment of muscle invasive bladder cancer with mixed histology","Lin J, Whalen M, Holder D, Hruby G, Decastro GJ, McKiernan J.","Can J Urol. 2013 Apr;20(2):6690-5.","Lin J","Can J Urol","2013","2013/04/17","","",""
"18094560","[Evaluation of urine NMP22 point-of-care test for the screening of bladder cancer]","Ihm CH, Kim JM, Sohn YH.","Korean J Lab Med. 2007 Apr;27(2):106-10. doi: 10.3343/kjlm.2007.27.2.106.","Ihm CH","Korean J Lab Med","2007","2007/12/21","","","10.3343/kjlm.2007.27.2.106"
"26497825","Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit","VanderWalde NA, Chi MT, Hurria A, Galsky MD, Nielsen ME.","World J Urol. 2016 Jan;34(1):3-11. doi: 10.1007/s00345-015-1708-z. Epub 2015 Oct 23.","VanderWalde NA","World J Urol","2016","2015/10/27","","","10.1007/s00345-015-1708-z"
"26524475","Enough is enough: Adequacy of voided urine cytology","Barkan GA.","Cancer Cytopathol. 2016 Mar;124(3):163-6. doi: 10.1002/cncy.21635. Epub 2015 Nov 2.","Barkan GA","Cancer Cytopathol","2016","2015/11/03","","","10.1002/cncy.21635"
"28445934","Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer","Zhu XX, Yan YW, Ai CZ, Jiang S, Xu SS, Niu M, Wang XZ, Zhong GS, Lu XF, Xue Y, Tian S, Li G, Tang S, Jiang YZ.","Oncotarget. 2017 Apr 11;8(15):24483-24490. doi: 10.18632/oncotarget.15522.","Zhu XX","Oncotarget","2017","2017/04/28","PMC5421864","","10.18632/oncotarget.15522"
"16249419","Relevance of urine telomerase in the diagnosis of bladder cancer","Sanchini MA, Gunelli R, Nanni O, Bravaccini S, Fabbri C, Sermasi A, Bercovich E, Ravaioli A, Amadori D, Calistri D.","JAMA. 2005 Oct 26;294(16):2052-6. doi: 10.1001/jama.294.16.2052.","Sanchini MA","JAMA","2005","2005/10/27","","","10.1001/jama.294.16.2052"
"18682944","Intravesical administration of gammadelta T cells successfully prevents the growth of bladder cancer in the murine model","Yuasa T, Sato K, Ashihara E, Takeuchi M, Maita S, Tsuchiya N, Habuchi T, Maekawa T, Kimura S.","Cancer Immunol Immunother. 2009 Apr;58(4):493-502. doi: 10.1007/s00262-008-0571-9. Epub 2008 Aug 6.","Yuasa T","Cancer Immunol Immunother","2009","2008/08/07","","","10.1007/s00262-008-0571-9"
"2218572","Neobladders: clinical management and considerations for patients receiving chemotherapy","Broderick GA, Stone AR, deVere White R.","Semin Oncol. 1990 Oct;17(5):598-605.","Broderick GA","Semin Oncol","1990","1990/10/01","","",""
"11803781","[Survival in patients treated with radical cystectomy for bladder carcinoma]","Segura Martín M, Salinas Sánchez AS, Lorenzo Romero JG, Hernández Millán I, Giménez Bachs JM, Virseda Rodríguez JA.","Actas Urol Esp. 2001 Nov-Dec;25(10):737-45. doi: 10.1016/s0210-4806(01)72710-6.","Segura Martín M","Actas Urol Esp","2001","2002/01/24","","","10.1016/s0210-4806(01)72710-6"
"24366484","Functional mononucleotide repeat polymorphism in the promoter region of HGF is associated with risk and malignant aggressiveness of bladder cancer","Chiba S, Tsuchiya N, Horikawa Y, Narita S, Inoue T, Akihama S, Saito M, Numakura K, Tsuruta H, Huang M, Satoh S, Habuchi T.","Int J Oncol. 2014 Mar;44(3):678-84. doi: 10.3892/ijo.2013.2221. Epub 2013 Dec 20.","Chiba S","Int J Oncol","2014","2013/12/25","","","10.3892/ijo.2013.2221"
"11125421","Effects of bradykinin on cytoplasmic calcium and motility in murine bladder tumor cells","Baba K, Yamaguchi O.","J Urol. 2001 Jan;165(1):259-62. doi: 10.1097/00005392-200101000-00075.","Baba K","J Urol","2001","2000/12/23","","","10.1097/00005392-200101000-00075"
"20223134","[Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy]","Huguet J, Gaya JM, Sabaté S, Palou J, Villavicencio H.","Actas Urol Esp. 2010 Jan;34(1):63-70.","Huguet J","Actas Urol Esp","2010","2010/03/13","","",""
"8692531","Intravesical bacillus Calmette-Guérin versus epirubicin in the prophylaxis of recurrent and/or multiple superficial bladder tumours","Melekos MD, Zarakovitis IE, Fokaefs ED, Dandinis K, Chionis H, Bouropoulos C, Dauaher H.","Oncology. 1996 Jul-Aug;53(4):281-8. doi: 10.1159/000227574.","Melekos MD","Oncology","1996","1996/07/01","","","10.1159/000227574"
"7913098","Induction of ICAM 1 expression on bladder tumours by BCG immunotherapy","Jackson AM, Alexandroff AB, McIntyre M, Esuvaranathan K, James K, Chisholm GD.","J Clin Pathol. 1994 Apr;47(4):309-12. doi: 10.1136/jcp.47.4.309.","Jackson AM","J Clin Pathol","1994","1994/04/01","PMC501932","","10.1136/jcp.47.4.309"
"19076140","Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer","Capitanio U, Suardi N, Shariat SF, Lotan Y, Palapattu GS, Bastian PJ, Gupta A, Vazina A, Schoenberg M, Lerner SP, Sagalowsky AI, Karakiewicz PI.","BJU Int. 2009 May;103(10):1359-62. doi: 10.1111/j.1464-410X.2008.08212.x. Epub 2008 Dec 8.","Capitanio U","BJU Int","2009","2008/12/17","","","10.1111/j.1464-410X.2008.08212.x"
"8362122","Treatment of high-stage bladder cancer: case for adjunctive chemotherapy","Walther PJ.","Semin Urol. 1993 May;11(2):69-73.","Walther PJ","Semin Urol","1993","1993/05/01","","",""
"14225724","[ON THE SURGICAL TREATMENT OF PATIENTS WITH BLADDER CANCER]","PYTEL AIa.","Urol Mosc. 1964 May-Jun;29:33-48.","PYTEL AIa","Urol Mosc","1964","1964/05/01","","",""
"7658585","Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice","Dinney CP, Fishbeck R, Singh RK, Eve B, Pathak S, Brown N, Xie B, Fan D, Bucana CD, Fidler IJ, et al.","J Urol. 1995 Oct;154(4):1532-8.","Dinney CP","J Urol","1995","1995/10/01","","",""
"22965138","Extravasation of intravesical chemotherapy for non-muscle-invasive bladder cancer","Mertens LS, Meinhardt W, Rier WB, Nooter RI, Horenblas S.","Urol Int. 2012;89(3):332-6. doi: 10.1159/000341900. Epub 2012 Sep 5.","Mertens LS","Urol Int","2012","2012/09/12","","","10.1159/000341900"
"27082503","Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells","Liao YX, Zeng JM, Zhou JJ, Yang GH, Ding K, Zhang XJ.","Mol Med Rep. 2016 Jun;13(6):4872-8. doi: 10.3892/mmr.2016.5127. Epub 2016 Apr 14.","Liao YX","Mol Med Rep","2016","2016/04/16","","","10.3892/mmr.2016.5127"
"18569584","Elevated bladder cancer risk due to colorants--a statewide case-control study in North Rhine-Westphalia, Germany","Golka K, Heitmann P, Gieseler F, Hodzic J, Masche N, Bolt HM, Geller F.","J Toxicol Environ Health A. 2008;71(13-14):851-5. doi: 10.1080/15287390801985869.","Golka K","J Toxicol Environ Health A","2008","2008/06/24","","","10.1080/15287390801985869"
"23114535","DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma","Conconi D, Panzeri E, Redaelli S, Bovo G, Volante M, Viganò P, Strada G, Dalprà L, Bentivegna A.","BMC Res Notes. 2012 Oct 31;5:607. doi: 10.1186/1756-0500-5-607.","Conconi D","BMC Res Notes","2012","2012/11/02","PMC3598781","","10.1186/1756-0500-5-607"
"3810056","The value of CT in detecting pelvic lymph node metastases in cases of bladder and prostate carcinoma","Salo JO, Kivisaari L, Rannikko S, Lehtonen T.","Scand J Urol Nephrol. 1986;20(4):261-5. doi: 10.3109/00365598609024509.","Salo JO","Scand J Urol Nephrol","1986","1986/01/01","","","10.3109/00365598609024509"
"15783115","Microvessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis","Canoğlu A, Göğüş C, Bedük Y, Orhan D, Tulunay O, Baltaci S.","Int Urol Nephrol. 2004;36(3):401-5. doi: 10.1007/s11255-004-8869-9.","Canoğlu A","Int Urol Nephrol","2004","2005/03/24","","","10.1007/s11255-004-8869-9"
"12508466","[Superficial cancer of the bladder: 2 different types of frequently mixed up tumors]","García González R.","Actas Urol Esp. 2002 Oct;26(9):711. doi: 10.1016/s0210-4806(02)72850-7.","García González R","Actas Urol Esp","2002","2003/01/02","","","10.1016/s0210-4806(02)72850-7"
"30200146","The role of fluorescence in situ hybridization to predict patient response to intravesical Bacillus Calmette-Guérin therapy for bladder cancer: A diagnostic meta-analysis and systematic review","Bao Y, Tu X, Chang T, Qiu S, Yang L, Geng J, Quan L, Wei Q.","Medicine (Baltimore). 2018 Sep;97(36):e12227. doi: 10.1097/MD.0000000000012227.","Bao Y","Medicine (Baltimore)","2018","2018/09/12","PMC6133599","","10.1097/MD.0000000000012227"
"29044177","Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder","Wang H, Wang Y, Kota KK, Sun B, Kallakury B, Mikhail NN, Sayed D, Mokhtar A, Maximous D, Yassin EH, Sun SX, Chen X, Loffredo CA, Zheng YL.","Sci Rep. 2017 Oct 18;7(1):13493. doi: 10.1038/s41598-017-13976-y.","Wang H","Sci Rep","2017","2017/10/19","PMC5647374","","10.1038/s41598-017-13976-y"
"30426013","Assessment of Pain Management, Acceptance of Illness, and Adjustment to Life with Cancer in Patients with Nonmuscle Invasive Bladder Cancer","Krajewski W, Mazur M, Poterek A, Pastuszak A, Halska U, Tukiendorf A, Rymaszewska J, Zdrojowy R.","Biomed Res Int. 2018 Oct 22;2018:7598632. doi: 10.1155/2018/7598632. eCollection 2018.","Krajewski W","Biomed Res Int","2018","2018/11/15","PMC6217895","","10.1155/2018/7598632"
"30972950","Vitamin D(3) enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk","Bunch BL, Ma Y, Attwood K, Amable L, Luo W, Morrison C, Guru KA, Woloszynska-Read A, Hershberger PA, Trump DL, Johnson CS.","Cancer Med. 2019 May;8(5):2449-2461. doi: 10.1002/cam4.2119. Epub 2019 Apr 10.","Bunch BL","Cancer Med","2019","2019/04/12","PMC6537042","","10.1002/cam4.2119"
"8026922","Bladder cancer following prostate cancer--an analysis of risk factors","Wegner HE, Meier T, Klän R, Dieckmann KP.","Int Urol Nephrol. 1994;26(1):43-51. doi: 10.1007/BF02768243.","Wegner HE","Int Urol Nephrol","1994","1994/01/01","","","10.1007/BF02768243"
"13778030","[Bladder cancer and telecobalt therapy]","TRIAL R, ROZE R.","Strahlentherapie. 1960 Nov;113:369-78.","TRIAL R","Strahlentherapie","1960","1960/11/01","","",""
"2039708","The diagnostic significance of lactate dehydrogenase isoenzymes in urinary cytology","Nishikawa A, Tanaka T, Takeuchi T, Fujihiro S, Mori H.","Br J Cancer. 1991 May;63(5):819-21. doi: 10.1038/bjc.1991.181.","Nishikawa A","Br J Cancer","1991","1991/05/01","PMC1972382","","10.1038/bjc.1991.181"
"22541905","[French translation and linguistic validation of the questionnaire Bladder Cancer Index (BCI)]","Gaunez N, Larré S, Pirès C, Doré B, Wei J, Pfister C, Irani J.","Prog Urol. 2010 May;22(6):350-3. doi: 10.1016/j.purol.2011.12.004. Epub 2012 Jan 20.","Gaunez N","Prog Urol","2010","2012/05/01","","","10.1016/j.purol.2011.12.004"
"18860795","Treatment of bladder carcinoma by total cystectomy","GOODHOPE CD.","Northwest Med. 1948 May;47(5):341-3.","GOODHOPE CD","Northwest Med","1948","1948/05/01","","",""
"27329810","ALKBH8 promotes bladder cancer growth and progression through regulating the expression of survivin","Ohshio I, Kawakami R, Tsukada Y, Nakajima K, Kitae K, Shimanoe T, Saigo Y, Hase H, Ueda Y, Jingushi K, Tsujikawa K.","Biochem Biophys Res Commun. 2016 Aug 26;477(3):413-8. doi: 10.1016/j.bbrc.2016.06.084. Epub 2016 Jun 18.","Ohshio I","Biochem Biophys Res Commun","2016","2016/06/23","","","10.1016/j.bbrc.2016.06.084"
"30145025","Health related quality of life after urinary diversion. Which technique is better?","Moeen AM, Safwat AS, Gadelmoula MM, Moeen SM, Abonnoor AEI, Abbas WM, ElGanainy EO, El-Taher AM.","J Egypt Natl Canc Inst. 2018 Sep;30(3):93-97. doi: 10.1016/j.jnci.2018.08.001. Epub 2018 Aug 23.","Moeen AM","J Egypt Natl Canc Inst","2018","2018/08/27","","","10.1016/j.jnci.2018.08.001"
"2578087","Clinically occult bladder cancer diagnosis. Trial using ultraviolet cystoscopy","Devonec M, Lenz P, Bouvier R, Blanc-Brunat N, Dubernard JM.","Cancer. 1985 Jan 15;55(2):468-71. doi: 10.1002/1097-0142(19850115)55:2<468::aid-cncr2820550230>3.0.co;2-x.","Devonec M","Cancer","1985","1985/01/15","","","10.1002/1097-0142(19850115)55:2<468::aid-cncr2820550230>3.0.co;2-x"
"5624121","Influence of a papilloma vaccine on chronic bovine enzootic hematuria","Pamukcu AM, Olson C, Goksoy SK.","Cancer Res. 1967 Nov;27(11):2197-200.","Pamukcu AM","Cancer Res","1967","1967/11/01","","",""
"1305696","Intermediate endpoint biomarkers for chemoprevention","Hemstreet GP 3rd, Rao JY, Hurst RE, Bonner RB, Jones PL, Vaidya AM, Fradet Y, Moon RC, Kelloff GJ.","J Cell Biochem Suppl. 1992;16I:93-110. doi: 10.1002/jcb.240501320.","Hemstreet GP 3rd","J Cell Biochem Suppl","1992","1992/01/01","","","10.1002/jcb.240501320"
"26057453","Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer","Matsushita R, Seki N, Chiyomaru T, Inoguchi S, Ishihara T, Goto Y, Nishikawa R, Mataki H, Tatarano S, Itesako T, Nakagawa M, Enokida H.","Br J Cancer. 2015 Jul 14;113(2):282-9. doi: 10.1038/bjc.2015.195. Epub 2015 Jun 9.","Matsushita R","Br J Cancer","2015","2015/06/10","PMC4506384","","10.1038/bjc.2015.195"
"24347490","USP28 is a potential prognostic marker for bladder cancer","Guo G, Xu Y, Gong M, Cao Y, An R.","Tumour Biol. 2014 May;35(5):4017-22. doi: 10.1007/s13277-013-1525-1. Epub 2013 Dec 18.","Guo G","Tumour Biol","2014","2013/12/19","","","10.1007/s13277-013-1525-1"
"28247741","[A systematic review and meta-analysis to assess the recurrence-free survival in non-muscle invasive bladder cancer after transurethral resection guided by 5-aminolevulinic acid-induced photodynamic diagnosis compared with white-light transurethral resect]","Rolevich AI, Evmenenko AA.","Urologiia. 2016 Aug;(4):137-146.","Rolevich AI","Urologiia","2016","2017/03/02","","",""
"3676670","Bladder cancer flow cytometry profiles in relation to histological grade and stage","Hadjissotiriou GG, Green DK, Smith G, McIntyre MA, Hargreave TB, Chisholm GD.","Br J Urol. 1987 Sep;60(3):239-47. doi: 10.1111/j.1464-410x.1987.tb05491.x.","Hadjissotiriou GG","Br J Urol","1987","1987/09/01","","","10.1111/j.1464-410x.1987.tb05491.x"
"24951323","Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy","Koie T, Ohyama C, Yamamoto H, Hatakeyama S, Imai A, Yoneyama T, Hashimoto Y, Kitayam M, Hirota K.","Urol Oncol. 2014 Aug;32(6):820-5. doi: 10.1016/j.urolonc.2014.03.010. Epub 2014 Jun 18.","Koie T","Urol Oncol","2014","2014/06/22","","","10.1016/j.urolonc.2014.03.010"
"5356181","[Late results of combined treatment of cancer of the urinary bladder]","Polonskii BL, Goikhberg MI, Zuenko LT, Khodachenko VM.","Vopr Onkol. 1969;15(8):75-80.","Polonskii BL","Vopr Onkol","1969","1969/01/01","","",""
"16773629","Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder","Dash A, Galsky MD, Vickers AJ, Serio AM, Koppie TM, Dalbagni G, Bochner BH.","Cancer. 2006 Aug 1;107(3):506-13. doi: 10.1002/cncr.22031.","Dash A","Cancer","2006","2006/06/15","","","10.1002/cncr.22031"
"9666687","[The efficacy of re-TUR after 3 weeks of initial TUR treatment for locally advanced bladder cancer]","Chiba K, Hirokawa M, Saitoh K, Yumura Y, Saitoh K, Okada Y, Hashiba T, Tomoda T.","Nihon Hinyokika Gakkai Zasshi. 1998 Jun;89(6):604-8. doi: 10.5980/jpnjurol1989.89.604.","Chiba K","Nihon Hinyokika Gakkai Zasshi","1998","1998/07/17","","","10.5980/jpnjurol1989.89.604"
"17850360","Bladder carcinoma among live-donor renal transplant recipients: a single-centre experience and a review of the literature","Kamal MM, Soliman SM, Shokeir AA, Abol-Enein H, Ghoneim MA.","BJU Int. 2008 Jan;101(1):30-5. doi: 10.1111/j.1464-410X.2007.07210.x. Epub 2007 Sep 10.","Kamal MM","BJU Int","2008","2007/09/14","","","10.1111/j.1464-410X.2007.07210.x"
"4419334","Proceedings: Clinical evaluation of CEA in urine of patients with bladder carcinoma","Korsten CB, Persijn JP, Renaud J.","Br J Cancer. 1974 Aug;30(2):174-5. doi: 10.1038/bjc.1974.137.","Korsten CB","Br J Cancer","1974","1974/08/01","PMC2009268","","10.1038/bjc.1974.137"
"22030373","Smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center","Guzzo TJ, Hockenberry MS, Mucksavage P, Bivalacqua TJ, Schoenberg MP.","Urology. 2012 Jan;79(1):166-71. doi: 10.1016/j.urology.2011.06.055. Epub 2011 Oct 26.","Guzzo TJ","Urology","2012","2011/10/28","","","10.1016/j.urology.2011.06.055"
"1445507","Clonal origin of bladder cancer","Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B.","N Engl J Med. 1992 Mar 12;326(11):737-40. doi: 10.1056/NEJM199203123261104.","Sidransky D","N Engl J Med","1992","1992/03/12","","","10.1056/NEJM199203123261104"
"15036675","Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology","Shariat SF, Casella R, Wians FH Jr, Ashfaq R, Balko J, Sulser T, Gasser TC, Sagalowsky AI.","Eur Urol. 2004 Mar;45(3):304-13; author reply 313. doi: 10.1016/j.eururo.2003.10.020.","Shariat SF","Eur Urol","2004","2004/03/24","","","10.1016/j.eururo.2003.10.020"
"25956189","Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic review","Feuerstein MA, Jacobs M, Piciocchi A, Bochner B, Pusic A, Fayers P, Blazeby J, Efficace F; Patient-Reported Outcome Measurements Over Time In Oncology-PROMOTION Registry.","Urol Oncol. 2015 Jul;33(7):331.e17-23. doi: 10.1016/j.urolonc.2015.04.002. Epub 2015 May 5.","Feuerstein MA","Urol Oncol","2015","2015/05/10","PMC4466160","NIHMS679792","10.1016/j.urolonc.2015.04.002"
"22762480","Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer","Lightfoot AJ, Rosevear HM, Nepple KG, O'Donnell MA.","Int J Urol. 2012 Nov;19(11):988-93. doi: 10.1111/j.1442-2042.2012.03089.x. Epub 2012 Jul 4.","Lightfoot AJ","Int J Urol","2012","2012/07/06","","","10.1111/j.1442-2042.2012.03089.x"
"9154312","Limits of flow-cytometry histogram analysis methods to assess bladder tumour antigen expression","Chabanas A, Rambeaud JJ, Huo HH, Seigneurin D, Lawrence JJ.","Anal Cell Pathol. 1997;13(1):39-47. doi: 10.1155/1997/312514.","Chabanas A","Anal Cell Pathol","1997","1997/01/01","PMC4617583","","10.1155/1997/312514"
"10529015","Human urinary bladder carcinoma cell lines respond to treatment with alkylphosphocholines","Konstantinov SM, Berger MR.","Cancer Lett. 1999 Oct 1;144(2):153-60. doi: 10.1016/s0304-3835(99)00219-0.","Konstantinov SM","Cancer Lett","1999","1999/10/21","","","10.1016/s0304-3835(99)00219-0"
"12767367","Relative importance of sources of symptom-induced distress in urinary bladder cancer survivors","Henningsohn L, Wijkström H, Steven K, Pedersen J, Ahlstrand C, Aus G, Kallestrup EB, Bergmark K, Onelöv E, Steineck G.","Eur Urol. 2003 Jun;43(6):651-62. doi: 10.1016/s0302-2838(03)00135-0.","Henningsohn L","Eur Urol","2003","2003/05/28","","","10.1016/s0302-2838(03)00135-0"
"11351257","Molecular cytogenetic alterations associated with rapid tumor cell proliferation in advanced urinary bladder cancer","Tomovska S, Richter J, Süess K, Wagner U, Rozenblum E, Gasser TC, Moch H, Mihatsch MJ, Sauter G, Schraml P.","Int J Oncol. 2001 Jun;18(6):1239-44. doi: 10.3892/ijo.18.6.1239.","Tomovska S","Int J Oncol","2001","2001/05/15","","","10.3892/ijo.18.6.1239"
"12964816","Analytical and clinical evaluation of a new urinary tumor marker: bladder tumor fibronectin in diagnosis and follow-up of bladder cancer","Mutlu N, Turkeri L, Emerk K.","Clin Chem Lab Med. 2003 Aug;41(8):1069-74. doi: 10.1515/CCLM.2003.165.","Mutlu N","Clin Chem Lab Med","2003","2003/09/11","","","10.1515/CCLM.2003.165"
"25648542","The role of genomics in the management of advanced bladder cancer","Guancial EA, Rosenberg JE.","Curr Treat Options Oncol. 2015 Jan;16(1):319. doi: 10.1007/s11864-014-0319-z.","Guancial EA","Curr Treat Options Oncol","2015","2015/02/05","","","10.1007/s11864-014-0319-z"
"22087730","Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance","Malmström PU, Grabe M, Haug ES, Hellström P, Hermann GG, Mogensen K, Raitanen M, Wahlqvist R.","Scand J Urol Nephrol. 2012 Apr;46(2):108-16. doi: 10.3109/00365599.2011.633279. Epub 2011 Nov 16.","Malmström PU","Scand J Urol Nephrol","2012","2011/11/18","","","10.3109/00365599.2011.633279"
"3787198","A prospective randomized study on neodymium-YAG laser irradiation versus TUR in the treatment of urinary bladder cancer","Beisland HO, Seland P.","Scand J Urol Nephrol. 1986;20(3):209-12. doi: 10.3109/00365598609024496.","Beisland HO","Scand J Urol Nephrol","1986","1986/01/01","","","10.3109/00365598609024496"
"24231253","6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer","Shen H, Morrison CD, Zhang J, Underwood W 3rd, Yang N, Frangou C, Eng K, Head K, Bollag RJ, Kavuri SK, Rojiani AM, Li Y, Yan L, Hill A, Woloszynska-Read A, Wang J, Liu S, Trump DL, Candace JS.","Oncotarget. 2013 Nov;4(11):2124-34. doi: 10.18632/oncotarget.1485.","Shen H","Oncotarget","2013","2013/11/16","PMC3875774","","10.18632/oncotarget.1485"
"21452155","The prognostic value of hydronephrosis in bladder cancer treated by radical cystectomy","Lin HY, Wang SZ, Chen JX, Chen LW, Xiao J.","Urologia. 2011 Jan-Mar;78(1):17-21. doi: 10.5301/ru.2011.6444.","Lin HY","Urologia","2011","2011/04/01","","","10.5301/ru.2011.6444"
"3768837","Clinical significance of A, B, H isoantigen deletion of urothelial cells in bladder carcinoma","Borgström E, Wahren B.","Cancer. 1986 Dec 1;58(11):2428-34. doi: 10.1002/1097-0142(19861201)58:11<2428::aid-cncr2820581113>3.0.co;2-i.","Borgström E","Cancer","1986","1986/12/01","","","10.1002/1097-0142(19861201)58:11<2428::aid-cncr2820581113>3.0.co;2-i"
"27416975","Insignificant role of bacillus Calmette-Guérin maintenance therapy after complete transurethral resection of bladder tumor for intermediate- and high-risk non-muscle-invasive bladder cancer: Results from a randomized trial","Nakai Y, Anai S, Tanaka N, Chihara Y, Haramoto M, Otani T, Nakagawa Y, Hirao Y, Konishi N, Fujimoto K.","Int J Urol. 2016 Oct;23(10):854-860. doi: 10.1111/iju.13167. Epub 2016 Jul 15.","Nakai Y","Int J Urol","2016","2016/07/16","","","10.1111/iju.13167"
"28245479","Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection","Nakamura Y, Yoshida S, Tanaka H, Inoue M, Ito M, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K.","Urol Int. 2017;98(3):298-303. doi: 10.1159/000456722. Epub 2017 Mar 1.","Nakamura Y","Urol Int","2017","2017/03/01","","","10.1159/000456722"
"19424629","Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer","Fauconnet S, Bernardini S, Lascombe I, Boiteux G, Clairotte A, Monnien F, Chabannes E, Bittard H.","Oncol Rep. 2009 Jun;21(6):1495-504. doi: 10.3892/or_00000380.","Fauconnet S","Oncol Rep","2009","2009/05/09","","","10.3892/or_00000380"
"17719169","Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results","Witjes JA, Hendricksen K.","Eur Urol. 2008 Jan;53(1):45-52. doi: 10.1016/j.eururo.2007.08.015. Epub 2007 Aug 20.","Witjes JA","Eur Urol","2008","2007/08/28","","","10.1016/j.eururo.2007.08.015"
"29929902","Prostate sparing cystectomy for bladder cancer: A two-center study","Voskuilen CS, Fransen van de Putte EE, Pérez-Reggeti JI, van Werkhoven E, Mertens LS, van Rhijn BWG, Saad M, Bex A, Cathelineau X, van der Poel HG, Horenblas S, Sanchez-Salas R, Meijer RP.","Eur J Surg Oncol. 2018 Sep;44(9):1446-1452. doi: 10.1016/j.ejso.2018.05.032. Epub 2018 Jun 8.","Voskuilen CS","Eur J Surg Oncol","2018","2018/06/23","","","10.1016/j.ejso.2018.05.032"
"7542171","Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor","Tachibana M, Miyakawa A, Tazaki H, Nakamura K, Kubo A, Hata J, Nishi T, Amano Y.","Cancer Res. 1995 Aug 1;55(15):3438-43.","Tachibana M","Cancer Res","1995","1995/08/01","","",""
"5684801","[Cancer of the bladder in the African. Apropos of 31 observations]","Carayon A, Colomar R, Piquard B.","Med Trop (Mars). 1968 Jan-Feb;28(1):16-26.","Carayon A","Med Trop (Mars)","1968","1968/01/01","","",""
"18367107","The impact of variant histology on the outcome of bladder cancer treated with curative intent","Black PC, Brown GA, Dinney CP.","Urol Oncol. 2009 Jan-Feb;27(1):3-7. doi: 10.1016/j.urolonc.2007.07.010. Epub 2008 Jan 14.","Black PC","Urol Oncol","2009","2008/03/28","","","10.1016/j.urolonc.2007.07.010"
"18048815","p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer","George B, Datar RH, Wu L, Cai J, Patten N, Beil SJ, Groshen S, Stein J, Skinner D, Jones PA, Cote RJ.","J Clin Oncol. 2007 Dec 1;25(34):5352-8. doi: 10.1200/JCO.2006.10.4125.","George B","J Clin Oncol","2007","2007/12/01","","","10.1200/JCO.2006.10.4125"
"14686701","Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells","Horiguchi Y, Kuroda K, Nakashima J, Murai M, Umezawa K.","Expert Rev Anticancer Ther. 2003 Dec;3(6):793-8. doi: 10.1586/14737140.3.6.793.","Horiguchi Y","Expert Rev Anticancer Ther","2003","2003/12/23","","","10.1586/14737140.3.6.793"
"22446338","Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy","Gondo T, Nakashima J, Ohno Y, Choichiro O, Horiguchi Y, Namiki K, Yoshioka K, Ohori M, Hatano T, Tachibana M.","Urology. 2012 May;79(5):1085-91. doi: 10.1016/j.urology.2011.11.070. Epub 2012 Mar 23.","Gondo T","Urology","2012","2012/03/27","","","10.1016/j.urology.2011.11.070"
"24466131","Human insulin does not increase bladder cancer risk","Tseng CH.","PLoS One. 2014 Jan 20;9(1):e86517. doi: 10.1371/journal.pone.0086517. eCollection 2014.","Tseng CH","PLoS One","2014","2014/01/28","PMC3896459","","10.1371/journal.pone.0086517"
"12577575","[Treatment of patients with invasive bladder cancer]","Varlamov SA, Lazarev AF, Neĭmark AI, Tat'ianin VIu, Ganov DI, P'iankova NIu.","Urologiia. 2002 Nov-Dec;(6):30-4.","Varlamov SA","Urologiia","2002","2003/02/13","","",""
"27010533","Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer","Koukourakis MI, Kakouratos C, Kalamida D, Bampali Z, Mavropoulou S, Sivridis E, Giatromanolaki A.","Int J Radiat Biol. 2016 Jul;92(7):353-63. doi: 10.3109/09553002.2016.1162921. Epub 2016 Mar 24.","Koukourakis MI","Int J Radiat Biol","2016","2016/03/25","","","10.3109/09553002.2016.1162921"
"11480721","Tumor markers in the detection of recurrent transitional cell carcinoma of the bladder: a brief review","Zaher A, Sheridan T.","Acta Cytol. 2001 Jul-Aug;45(4):575-81. doi: 10.1159/000327867.","Zaher A","Acta Cytol","2001","2001/08/02","","","10.1159/000327867"
"8455233","Results of 4 years of experience with bladder replacement using an ileocecal segment with multiple transverse teniamyotomies","Alcini E, D'Addessi A, Racioppi M, Menchinelli P, Anastasio G, Grassetti F, Destito A, Giustacchini M.","J Urol. 1993 Apr;149(4):735-8. doi: 10.1016/s0022-5347(17)36195-5.","Alcini E","J Urol","1993","1993/04/01","","","10.1016/s0022-5347(17)36195-5"
"9865914","Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade","Bianco FJ Jr, Gervasi DC, Tiguert R, Grignon DJ, Pontes JE, Crissman JD, Fridman R, Wood DP Jr.","Clin Cancer Res. 1998 Dec;4(12):3011-6.","Bianco FJ Jr","Clin Cancer Res","1998","1998/12/29","","",""
"15483019","Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy?","Madersbacher S, Thalmann GN, Fritsch JC, Studer UE.","J Clin Oncol. 2004 Oct 15;22(20):4103-8. doi: 10.1200/JCO.2004.04.127.","Madersbacher S","J Clin Oncol","2004","2004/10/16","","","10.1200/JCO.2004.04.127"
"26569509","Valrubicin in refractory non-muscle invasive bladder cancer","Sharma P, Zargar-Shoshtari K, Sexton WJ.","Expert Rev Anticancer Ther. 2015;15(12):1379-87. doi: 10.1586/14737140.2015.1115350. Epub 2015 Nov 16.","Sharma P","Expert Rev Anticancer Ther","2015","2015/11/17","","","10.1586/14737140.2015.1115350"
"31214952","Optical biopsy of bladder cancer using confocal laser endomicroscopy","Wu J, Wang YC, Dai B, Ye DW, Zhu YP.","Int Urol Nephrol. 2019 Sep;51(9):1473-1479. doi: 10.1007/s11255-019-02197-z. Epub 2019 Jun 13.","Wu J","Int Urol Nephrol","2019","2019/06/20","","","10.1007/s11255-019-02197-z"
"28464520","Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m(2) ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression","Blute ML Jr, Kucherov V, Rushmer TJ, Damodaran S, Shi F, Abel EJ, Jarrard DF, Richards KA, Messing EM, Downs TM.","BJU Int. 2017 Sep;120(3):387-393. doi: 10.1111/bju.13904. Epub 2017 Jun 23.","Blute ML Jr","BJU Int","2017","2017/05/03","","","10.1111/bju.13904"
"31160192","Moreau Strain Bacillus Calmette-Guérin Low Versus Standard Dose in the Treatment of High-Grade T1 Bladder Cancer: A Retrospective Observational Cohort Study","Carneiro BDB, Sanches BCF, Andrade DL, Voris BRI, Reis LO.","Clin Genitourin Cancer. 2019 Aug;17(4):e779-e783. doi: 10.1016/j.clgc.2019.04.003. Epub 2019 Apr 16.","Carneiro BDB","Clin Genitourin Cancer","2019","2019/06/05","","","10.1016/j.clgc.2019.04.003"
"2311071","The epidermal growth factor receptor and the prognosis of bladder cancer","Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL.","Cancer. 1990 Apr 1;65(7):1619-25. doi: 10.1002/1097-0142(19900401)65:7<1619::aid-cncr2820650728>3.0.co;2-q.","Neal DE","Cancer","1990","1990/04/01","","","10.1002/1097-0142(19900401)65:7<1619::aid-cncr2820650728>3.0.co;2-q"
"31773297","Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer","Xu S, Yao Q, Liu G, Jin D, Chen H, Xu J, Li Z, Wu G.","Eur Radiol. 2020 Mar;30(3):1804-1812. doi: 10.1007/s00330-019-06484-2. Epub 2019 Nov 26.","Xu S","Eur Radiol","2020","2019/11/28","","","10.1007/s00330-019-06484-2"
"19637316","Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development","Zieger K, Marcussen N, Borre M, Ørntoft TF, Dyrskjøt L.","Int J Cancer. 2009 Nov 1;125(9):2095-103. doi: 10.1002/ijc.24619.","Zieger K","Int J Cancer","2009","2009/07/29","","","10.1002/ijc.24619"
"25300161","Re: Defining the potential of neoadjuvant chemotherapy use as a quality indicator for bladder cancer care: G. Vemana, K. G. Nepple, J. Vetter, G. Sandhu and S. A. Strope J Urol 2014; 192: 43-49","Goonewardene SS, Bahl A, Persad R.","J Urol. 2015 Jan;193(1):370-1. doi: 10.1016/j.juro.2014.07.119. Epub 2014 Oct 7.","Goonewardene SS","J Urol","2015","2014/10/11","","","10.1016/j.juro.2014.07.119"
"17593786","[Diagnosis and treatment of superficial bladder cancers]","Caremel R, Pfister C.","Rev Prat. 2007 Mar 31;57(6):621-7.","Caremel R","Rev Prat","2007","2007/06/28","","",""
"20257664","The surgical treatment of carcinoma of the bladder","PRIESTLEY JT.","Collect Papers Mayo Clinic Mayo Found. 1946-1947;38:191-8.","PRIESTLEY JT","Collect Papers Mayo Clinic Mayo Found","1946","2010/03/19","","",""
"11741131","Phase 1/2 study of synchronous methotrexate, cisplatin, vincristine (MOPq10) chemotherapy and radiation for patients with locally advanced bladder cancer","Goonewardene TI, Bozcuk H, Oliver RT, Barua J, Nargund V, Philip T, Mair G, Gibbs S.","Urol Int. 2001;67(4):293-7. doi: 10.1159/000051006.","Goonewardene TI","Urol Int","2001","2001/12/13","","","10.1159/000051006"
"6883290","Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study","Anderström C, Johansson SL, von Schultz L.","Cancer. 1983 Oct 1;52(7):1273-80. doi: 10.1002/1097-0142(19831001)52:7<1273::aid-cncr2820520724>3.0.co;2-7.","Anderström C","Cancer","1983","1983/10/01","","","10.1002/1097-0142(19831001)52:7<1273::aid-cncr2820520724>3.0.co;2-7"
"18119089","Primary mucus secreting adenocarcinoma of the bladder","KRETSCHMER HL.","J Urol. 1949 Apr;61(4):754-65. doi: 10.1016/s0022-5347(17)69138-9.","KRETSCHMER HL","J Urol","1949","1949/04/01","","","10.1016/s0022-5347(17)69138-9"
"20185992","[An analysis of upper urinary tract recurrence following radical cystectomy for bladder cancer]","Sugi M, Fukui K, Yoshida K, Inui H, Kawakita S, Murota T, Kinoshita H, Matsuda T.","Hinyokika Kiyo. 2010 Feb;56(2):87-90.","Sugi M","Hinyokika Kiyo","2010","2010/02/27","","",""
"30791940","New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment","Criscuolo D, Morra F, Giannella R, Visconti R, Cerrato A, Celetti A.","J Exp Clin Cancer Res. 2019 Feb 22;38(1):91. doi: 10.1186/s13046-019-1089-z.","Criscuolo D","J Exp Clin Cancer Res","2019","2019/02/23","PMC6385418","","10.1186/s13046-019-1089-z"
"26098648","[Diagnostic significance of protein NMP22 in bladder cancer]","Rybotycka Z, Długosz A.","Pol Merkur Lekarski. 2015 Jun;38(228):309-14.","Rybotycka Z","Pol Merkur Lekarski","2015","2015/06/23","","",""
"24635493","Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: a mini-review","Wieczorek E, Wasowicz W, Gromadzinska J, Reszka E.","Int J Urol. 2014 Aug;21(8):744-52. doi: 10.1111/iju.12431. Epub 2014 Mar 17.","Wieczorek E","Int J Urol","2014","2014/03/19","","","10.1111/iju.12431"
"1527402","[Cancer of the urachus. A rare form of tumors of the bladder]","Vergos M, Messina MH, Lhomme Desages B, Chapuis O.","J Urol (Paris). 1992;98(1):56-9.","Vergos M","J Urol (Paris)","1992","1992/01/01","","",""
"21807455","Re: Hassan Abol-Enein, Derya Tilki, Ahmed Mosbah, et al. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. Eur Urol 2011;60:572-7","Zhang H, Ye D.","Eur Urol. 2011 Nov;60(5):e48. doi: 10.1016/j.eururo.2011.07.042. Epub 2011 Jul 26.","Zhang H","Eur Urol","2011","2011/08/03","","","10.1016/j.eururo.2011.07.042"
"3197062","[Non-adjuvant chemotherapy of bladder neoplasms stage T3-4 using NO-x and MO. Preliminary results of the urogenital study group of the European Organization for Research and Treatment of Cancer]","Bollack C, Jacqmin D, Splinter TA, De Pauw M.","Cas Lek Cesk. 1988 Aug 26;127(35):1098-100.","Bollack C","Cas Lek Cesk","1988","1988/08/26","","",""
"29793447","B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients","Xie H, Zhu Y, Zhang J, Liu Z, Fu H, Cao Y, Li G, Shen Y, Dai B, Xu J, Ye D.","BMC Cancer. 2018 May 24;18(1):590. doi: 10.1186/s12885-018-4497-0.","Xie H","BMC Cancer","2018","2018/05/26","PMC5968541","","10.1186/s12885-018-4497-0"
"1949368","Clinical evaluation of adjuvant chemotherapy for high stage bladder cancer","Uekado Y, Hirano A, Shinka T, Ohkawa T.","Urol Int. 1991;47 Suppl 1:123-6. doi: 10.1159/000282270.","Uekado Y","Urol Int","1991","1991/01/01","","","10.1159/000282270"
"22616552","ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy","Sun JM, Sung JY, Park SH, Kwon GY, Jeong BC, Seo SI, Jeon SS, Lee HM, Jo J, Choi HY, Lim HY.","BMC Cancer. 2012 May 22;12:187. doi: 10.1186/1471-2407-12-187.","Sun JM","BMC Cancer","2012","2012/05/24","PMC3404914","","10.1186/1471-2407-12-187"
"26700664","Akt activation correlates with the tumor aggressiveness in Tunisian patients with bladder cancer","Ben Bahria-Sediki I, Sampaio C, Chebil M, Cherif M, Zermani R, Rammeh S, Ben Ammar El Gaaied A, Bettaieb A.","Tumour Biol. 2016 Jun;37(6):7873-9. doi: 10.1007/s13277-015-4678-2. Epub 2015 Dec 23.","Ben Bahria-Sediki I","Tumour Biol","2016","2015/12/25","","","10.1007/s13277-015-4678-2"
"14632845","Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer","Friedrich MG, Toma MI, Hellstern A, Pantel K, Weisenberger DJ, Noldus J, Huland H.","BJU Int. 2003 Dec;92(9):911-4. doi: 10.1111/j.1464-410x.2003.04528.x.","Friedrich MG","BJU Int","2003","2003/11/25","","","10.1111/j.1464-410x.2003.04528.x"
"27377079","Prognostic impact of ReTURB in high grade T1 primary bladder cancer","Sanseverino R, Napodano G, Campitelli A, Addesso M.","Arch Ital Urol Androl. 2016 Jul 4;88(2):81-5. doi: 10.4081/aiua.2016.2.81.","Sanseverino R","Arch Ital Urol Androl","2016","2016/07/06","","","10.4081/aiua.2016.2.81"
"17993339","Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, Wolf JS Jr, Schellhammer PF.","J Urol. 2007 Dec;178(6):2314-30. doi: 10.1016/j.juro.2007.09.003.","Hall MC","J Urol","2007","2007/11/13","","","10.1016/j.juro.2007.09.003"
"21424043","Photodynamic diagnosis of non-muscle invasive bladder cancer using hexaminolevulinic acid","Drăgoescu O, Tomescu P, Pănuş A, Enache M, Maria C, Stoica L, Pleşea IE.","Rom J Morphol Embryol. 2011;52(1):123-7.","Drăgoescu O","Rom J Morphol Embryol","2011","2011/03/23","","",""
"9393299","Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome","Herr HW.","Br J Urol. 1997 Nov;80(5):762-5. doi: 10.1046/j.1464-410x.1997.00431.x.","Herr HW","Br J Urol","1997","1997/12/11","","","10.1046/j.1464-410x.1997.00431.x"
"19826825","Practice patterns and recurrence after partial cystectomy for bladder cancer","Fahmy N, Aprikian A, Tanguay S, Mahmud SM, Al-Otaibi M, Jeyaganth S, Amin M, Kassouf W.","World J Urol. 2010 Aug;28(4):419-23. doi: 10.1007/s00345-009-0478-x. Epub 2009 Oct 14.","Fahmy N","World J Urol","2010","2009/10/15","","","10.1007/s00345-009-0478-x"
"17949235","Molecular cytogenetic characterization and diagnostics of bladder cancer","Houskova L, Zemanova Z, Babjuk M, Melichercikova J, Pesl M, Michalova K.","Neoplasma. 2007;54(6):511-6.","Houskova L","Neoplasma","2007","2007/10/24","","",""
"25292079","Interleukin-12 and interleukin-6 gene polymorphisms and risk of bladder cancer in the Iranian population","Ebadi N, Jahed M, Mivehchi M, Majidizadeh T, Asgary M, Hosseini SA.","Asian Pac J Cancer Prev. 2014;15(18):7869-73. doi: 10.7314/apjcp.2014.15.18.7869.","Ebadi N","Asian Pac J Cancer Prev","2014","2014/10/09","","","10.7314/apjcp.2014.15.18.7869"
"21816094","Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis","Msaouel P, Koutsilieris M.","BMC Cancer. 2011 Aug 4;11:336. doi: 10.1186/1471-2407-11-336.","Msaouel P","BMC Cancer","2011","2011/08/06","PMC3161042","","10.1186/1471-2407-11-336"
"31795581","[Study on the disease burden of cancer attributed to the dietary inorganic arsenic exposure in Chinese population in 2013]","Zhou YJ, Wangyi YBN, Song Y, Yan YZ, Huang J, Zhang L, Wei S.","Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Dec 6;53(12):1247-1252. doi: 10.3760/cma.j.issn.0253-9624.2019.12.009.","Zhou YJ","Zhonghua Yu Fang Yi Xue Za Zhi","2019","2019/12/05","","","10.3760/cma.j.issn.0253-9624.2019.12.009"
"26496799","Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy","Pan XW, Li L, Huang Y, Huang H, Xu DF, Gao Y, Chen L, Ren JZ, Cao JW, Hong Y, Cui XG.","Oncol Rep. 2016 Jan;35(1):334-42. doi: 10.3892/or.2015.4335. Epub 2015 Oct 16.","Pan XW","Oncol Rep","2016","2015/10/27","","","10.3892/or.2015.4335"
"2804896","Correlation of tumor necrosis factor and prostaglandin E2 production of monocytes in bladder cancer patients","Ikemoto S, Kishimoto T, Nishio S, Wada S, Maekawa M.","Cancer. 1989 Nov 15;64(10):2076-80. doi: 10.1002/1097-0142(19891115)64:10<2076::aid-cncr2820641018>3.0.co;2-x.","Ikemoto S","Cancer","1989","1989/11/15","","","10.1002/1097-0142(19891115)64:10<2076::aid-cncr2820641018>3.0.co;2-x"
"12494866","Short-term effects of TNP-470 in combination with cisplatin in the rat model of bladder cancer","Zhang X, Yamashita M, Uetsuki H, Kakehi Y.","In Vivo. 2002 Sep-Oct;16(5):293-7.","Zhang X","In Vivo","2002","2002/12/24","","",""
"10638984","Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression","Crew JP, Fuggle S, Bicknell R, Cranston DW, de Benedetti A, Harris AL.","Br J Cancer. 2000 Jan;82(1):161-6. doi: 10.1054/bjoc.1999.0894.","Crew JP","Br J Cancer","2000","2000/01/19","PMC2363195","","10.1054/bjoc.1999.0894"
"19660438","Cytotoxic activity of gemcitabine in cultured cell lines derived from histologically different types of bladder cancer: role of thymidine kinase 2","Damaraju S, Damaraju VL, Mowles D, Sawyer MB, Damaraju S, Cass CE.","Biochem Pharmacol. 2010 Jan 1;79(1):21-9. doi: 10.1016/j.bcp.2009.07.018. Epub 2009 Aug 4.","Damaraju S","Biochem Pharmacol","2010","2009/08/08","","","10.1016/j.bcp.2009.07.018"
"8620437","Specific sequences of fibronectin activate the protein kinase C signal transduction pathway in invasive bladder cancer","Margolis EJ, Choi JC, Shu WP, Liu BC.","Cancer Lett. 1996 Feb 27;100(1-2):163-8. doi: 10.1016/0304-3835(95)04096-x.","Margolis EJ","Cancer Lett","1996","1996/02/27","","","10.1016/0304-3835(95)04096-x"
"1957729","[Bladder replacement by entero-cystoplasty after radical cystectomy for bladder cancer--the urethral Kock pouch]","Kanai S, Yasuharu T, Sahashi M, Takashi M, Takamura S, Okamura K, Shimoji T, Miyake K.","Hinyokika Kiyo. 1991 Aug;37(8):863-7.","Kanai S","Hinyokika Kiyo","1991","1991/08/01","","",""
"25169033","Computed tomography imaging-guided percutaneous argon-helium cryoablation of muscle-invasive bladder cancer: initial experience in 32 patients","Sun L, Zhang W, Liu H, Yuan J, Liu W, Yang Y.","Cryobiology. 2014 Oct;69(2):318-22. doi: 10.1016/j.cryobiol.2014.08.006. Epub 2014 Aug 26.","Sun L","Cryobiology","2014","2014/08/30","","","10.1016/j.cryobiol.2014.08.006"
"31540198","Does Health Insurance Modify the Association Between Race and Cancer-Specific Survival in Patients with Urinary Bladder Malignancy in the U.S.?","Morales J, Malles A, Kimble M, Rodriguez de la Vega P, Castro G, Nieder AM, Barengo NC.","Int J Environ Res Public Health. 2019 Sep 13;16(18):3393. doi: 10.3390/ijerph16183393.","Morales J","Int J Environ Res Public Health","2019","2019/09/22","PMC6765928","","10.3390/ijerph16183393"
"11832143","[Telomerase activity and cellular apoptosis of bladder cancers]","Qin Z, Mei H, Dai Y, Wang X, Chen X, Chen Q.","Zhonghua Wai Ke Za Zhi. 2000 Sep;38(9):697-9.","Qin Z","Zhonghua Wai Ke Za Zhi","2000","2002/02/08","","",""
"28218359","Diagnostic value of smoothelin and vimentin in differentiating muscularis propria from muscularis mucosa of bladder carcinoma","Elkady N, Abdou AG, Kandil M, Ghanem N.","Int J Biol Markers. 2017 Jul 24;32(3):e305-e312. doi: 10.5301/jbm.5000252.","Elkady N","Int J Biol Markers","2017","2017/02/21","","","10.5301/jbm.5000252"
"2501516","Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)","Parmar MK, Freedman LS, Hargreave TB, Tolley DA.","J Urol. 1989 Aug;142(2 Pt 1):284-8. doi: 10.1016/s0022-5347(17)38731-1.","Parmar MK","J Urol","1989","1989/08/01","","","10.1016/s0022-5347(17)38731-1"
"20967397","Evaluation of a gas sensor array and pattern recognition for the identification of bladder cancer from urine headspace","Weber CM, Cauchi M, Patel M, Bessant C, Turner C, Britton LE, Willis CM.","Analyst. 2011 Jan 21;136(2):359-64. doi: 10.1039/c0an00382d. Epub 2010 Oct 22.","Weber CM","Analyst","2011","2010/10/23","","","10.1039/c0an00382d"
"16142350","Expression of HIF-1alpha and Glut-1 in human bladder cancer","Palit V, Phillips RM, Puri R, Shah T, Bibby MC.","Oncol Rep. 2005 Oct;14(4):909-13. doi: 10.3892/or.14.4.909.","Palit V","Oncol Rep","2005","2005/09/06","","","10.3892/or.14.4.909"
"3242366","[Animal models of bladder cancer]","Fukushima S.","Hinyokika Kiyo. 1988 Nov;34(11):1923-7.","Fukushima S","Hinyokika Kiyo","1988","1988/11/01","","",""
"24123021","Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer","Kitagawa Y, Izumi K, Miwa S, Kadono Y, Konaka H, Mizokami A, Namiki M.","Anticancer Res. 2013 Oct;33(10):4497-503.","Kitagawa Y","Anticancer Res","2013","2013/10/15","","",""
"26044108","Re: Enhanced Recovery Protocol after Radical Cystectomy for Bladder Cancer: S. Daneshmand, H. Ahmadi, A. K. Schuckman, A. P. Mitra, J. Cai, G. Miranda and H. Djaladat J Urol 2014;192:50-56","Gangkak G, Giri V, Yadav SS.","J Urol. 2015 Sep;194(3):852-3; discussion 853. doi: 10.1016/j.juro.2015.02.2950. Epub 2015 Jun 1.","Gangkak G","J Urol","2015","2015/06/06","","","10.1016/j.juro.2015.02.2950"
"5778232","Pheochromocytoma of the urinary bladder","Albores-Saavedra J, Maldonado ME, Ibarra J, Rodriguez HA.","Cancer. 1969 May;23(5):1110-8. doi: 10.1002/1097-0142(196905)23:5<1110::aid-cncr2820230515>3.0.co;2-c.","Albores-Saavedra J","Cancer","1969","1969/05/01","","","10.1002/1097-0142(196905)23:5<1110::aid-cncr2820230515>3.0.co;2-c"
"18237853","A robotic future for bladder cancer?","Guru KA, Nyquist J, Perlmutter A, Peabody JO.","Lancet Oncol. 2008 Feb;9(2):184. doi: 10.1016/S1470-2045(08)70031-7.","Guru KA","Lancet Oncol","2008","2008/02/02","","","10.1016/S1470-2045(08)70031-7"
"29730921","[Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer]","Ding XL, Yang DL, Yan RP, Li ZP, Ye CW, He J, Yu L, He SC, Li HD.","Zhonghua Zhong Liu Za Zhi. 2018 Apr 23;40(4):308-312. doi: 10.3760/cma.j.issn.0253-3766.2018.04.014.","Ding XL","Zhonghua Zhong Liu Za Zhi","2018","2018/05/08","","","10.3760/cma.j.issn.0253-3766.2018.04.014"
"3909239","Irradiation therapy with multiple small fractions per day in urinary bladder cancer","Edsmyr F, Andersson L, Esposti PL, Littbrand B, Nilsson B.","Radiother Oncol. 1985 Nov;4(3):197-203. doi: 10.1016/s0167-8140(85)80084-0.","Edsmyr F","Radiother Oncol","1985","1985/11/01","","","10.1016/s0167-8140(85)80084-0"
"31188799","Intrinsic Molecular Subclassification of Urothelial Carcinoma of the Bladder: Are We Finally there?","Akhtar M, Al-Bozom IA, Ben Gashir M, Taha NM.","Adv Anat Pathol. 2019 Jul;26(4):251-256. doi: 10.1097/PAP.0000000000000235.","Akhtar M","Adv Anat Pathol","2019","2019/06/13","","","10.1097/PAP.0000000000000235"
"22815224","Classification of samples into two or more ordered populations with application to a cancer trial","Conde D, Fernández MA, Rueda C, Salvador B.","Stat Med. 2012 Dec 10;31(28):3773-86. doi: 10.1002/sim.5476. Epub 2012 Jul 19.","Conde D","Stat Med","2012","2012/07/21","","","10.1002/sim.5476"
"26990295","Urothelial cancer of the urinary bladder: can lessons learned be applied to the upper urinary tract?","Krabbe LM, Hutchinson RC, Margulis V.","Minerva Urol Nefrol. 2016 Aug;68(4):396-408. Epub 2016 Mar 18.","Krabbe LM","Minerva Urol Nefrol","2016","2016/03/19","","",""
"6541340","A murine model for bladder cancer","Murphy GP, Sandberg AA, Pontes JE, Ochi H, Yoshida M, Williams PD.","Prog Clin Biol Res. 1984;162A:177-200.","Murphy GP","Prog Clin Biol Res","1984","1984/01/01","","",""
"27119962","[Bladder-sparing therapy as an alternative to cystectomy : Commentary on organ-sparing therapy in bladder cancer]","Burger M.","Urologe A. 2016 May;55(5):615. doi: 10.1007/s00120-016-0085-6.","Burger M","Urologe A","2016","2016/04/28","","","10.1007/s00120-016-0085-6"
"1404660","Localization and identification of T-(Gal beta 1-3GalNAc alpha 1-O-R) and T-like antigens in experimental rat bladder cancer","Langkilde NC, Wolf H, Clausen H, Orntoft TF.","J Urol. 1992 Oct;148(4):1279-84. doi: 10.1016/s0022-5347(17)36892-1.","Langkilde NC","J Urol","1992","1992/10/01","","","10.1016/s0022-5347(17)36892-1"
"30579971","XPC deficiency leads to centrosome amplification by inhibiting BRCA1 expression upon cisplatin-mediated DNA damage in human bladder cancer","Wang H, Huang Y, Shi J, Zhi Y, Yuan F, Yu J, Chen Z, Yang J.","Cancer Lett. 2019 Mar 1;444:136-146. doi: 10.1016/j.canlet.2018.12.004. Epub 2018 Dec 21.","Wang H","Cancer Lett","2019","2018/12/24","","","10.1016/j.canlet.2018.12.004"
"27106005","Can immediate second resection be an alternative to standardized second transurethral resection of bladder tumors?","Doğantekin E, Girgin C, Görgel SN, Soylemez H, Dinçel Ç.","Kaohsiung J Med Sci. 2016 Mar;32(3):147-51. doi: 10.1016/j.kjms.2016.02.002. Epub 2016 Mar 21.","Doğantekin E","Kaohsiung J Med Sci","2016","2016/04/24","","","10.1016/j.kjms.2016.02.002"
"26802582","Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival","von Rundstedt FC, Rajapakshe K, Ma J, Arnold JM, Gohlke J, Putluri V, Krishnapuram R, Piyarathna DB, Lotan Y, Gödde D, Roth S, Störkel S, Levitt JM, Michailidis G, Sreekumar A, Lerner SP, Coarfa C, Putluri N.","J Urol. 2016 Jun;195(6):1911-9. doi: 10.1016/j.juro.2016.01.039. Epub 2016 Jan 21.","von Rundstedt FC","J Urol","2016","2016/01/24","PMC4861129","","10.1016/j.juro.2016.01.039"
"12379873","Molecular detection approaches for smoking associated tumors","Hu YC, Sidransky D, Ahrendt SA.","Oncogene. 2002 Oct 21;21(48):7289-97. doi: 10.1038/sj.onc.1205805.","Hu YC","Oncogene","2002","2002/10/16","","","10.1038/sj.onc.1205805"
"1192433","Bladder calculi and urothelial hyperplasia with papillomatosis in the rat following insertion of chalk powder in the bladder cavity with subsequent trauma of the bladder wall","Toyoshima K, Leighton J.","Cancer Res. 1975 Dec;35(12):3786-91.","Toyoshima K","Cancer Res","1975","1975/12/01","","",""
"9610789","p53 mutations in cyclophosphamide-associated bladder cancer","Khan MA, Travis LB, Lynch CF, Soini Y, Hruszkewycz AM, Delgado RM, Holowaty EJ, van Leeuwen FE, Glimelius B, Stovall M, Boice JD Jr, Tarone RE, Bennett WP.","Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):397-403.","Khan MA","Cancer Epidemiol Biomarkers Prev","1998","1998/06/04","","",""
"11942327","The effects of meglumine gamma linolenic acid (MeGLA) on an organ culture model of superficial bladder cancer","Crook TJ, Dyer JP, McCormick RI, Birch BR, Cooper AJ.","Urol Res. 2002 Mar;30(1):59-65. doi: 10.1007/s00240-001-0224-3.","Crook TJ","Urol Res","2002","2002/04/11","","","10.1007/s00240-001-0224-3"
"21678333","WITHDRAWN: Neoadjuvant cisplatin for advanced bladder cancer","Advanced Bladder Cancer Meta-analysis Collaboration.","Cochrane Database Syst Rev. 2011 Jun 15;(6):CD001426. doi: 10.1002/14651858.CD001426.pub2.","Advanced Bladder Cancer Meta-analysis Collaboration","Cochrane Database Syst Rev","2011","2011/06/17","","","10.1002/14651858.CD001426.pub2"
"10765099","The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group Study","deVere White RW, Deitch AD, Daneshmand S, Blumenstein B, Lowe BA, Sagalowsky AI, Smith JA Jr, Schellhammer PF, Stanisic TH, Grossman HB, Messing E, Crissman JD, Crawford ED.","Eur Urol. 2000 May;37(5):595-600. doi: 10.1159/000020198.","deVere White RW","Eur Urol","2000","2000/04/15","","","10.1159/000020198"
"12441324","Arsenic-related chromosomal alterations in bladder cancer","Moore LE, Smith AH, Eng C, Kalman D, DeVries S, Bhargava V, Chew K, Moore D 2nd, Ferreccio C, Rey OA, Waldman FM.","J Natl Cancer Inst. 2002 Nov 20;94(22):1688-96. doi: 10.1093/jnci/94.22.1688.","Moore LE","J Natl Cancer Inst","2002","2002/11/21","","","10.1093/jnci/94.22.1688"
"7591228","Loss of ABH antigen expression in bladder cancer is not caused by loss of heterozygosity of the ABO locus","Meldgaard P, Johnson PH, Langkilde NC, Wolf H, Orntoft TF.","Int J Cancer. 1995 Nov 3;63(3):341-4. doi: 10.1002/ijc.2910630306.","Meldgaard P","Int J Cancer","1995","1995/11/03","","","10.1002/ijc.2910630306"
"7715013","Mosaicism in human epithelium: macroscopic monoclonal patches cover the urothelium","Tsai YC, Simoneau AR, Spruck CH 3rd, Nichols PW, Steven K, Buckley JD, Jones PA.","J Urol. 1995 May;153(5):1697-700. doi: 10.1016/s0022-5347(01)67507-4.","Tsai YC","J Urol","1995","1995/05/01","","","10.1016/s0022-5347(01)67507-4"
"22166828","[A case of primary urinary bladder and ureter cancer with a choriocarcinoma]","Inoue T, Sugi M, Masuda T, Nishida T, Kawakita S, Kawa G, Murota T, Kinoshita H, Matsuda T.","Hinyokika Kiyo. 2011 Nov;57(11):633-7.","Inoue T","Hinyokika Kiyo","2011","2011/12/15","","",""
"19816387","Robotic radical cystectomy for bladder cancer","Ismail AF, Dasgupta P, Shabbir M, Khan MS.","Minerva Urol Nefrol. 2009 Dec;61(4):341-50.","Ismail AF","Minerva Urol Nefrol","2009","2009/10/10","","",""
"9011976","[Arthritis after BCG treatment of bladder cancer. A rare complication]","Rødevand E, Faxvaag A, Ostensen M, Brevik B.","Tidsskr Nor Laegeforen. 1996 Nov 10;116(27):3231-2.","Rødevand E","Tidsskr Nor Laegeforen","1996","1996/11/10","","",""
"1499634","A system for focal intracavitary irradiation of bladder cancer with remote iridium-192 afterloading","Bex A, Rübben H, Feldmann HJ, Ammon J.","Eur Urol. 1992;21(3):245-9. doi: 10.1159/000474847.","Bex A","Eur Urol","1992","1992/01/01","","","10.1159/000474847"
"25550801","miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT","Zeng T, Peng L, Chao C, Fu B, Wang G, Wang Y, Zhu X.","Int J Clin Exp Pathol. 2014 Oct 15;7(11):7653-62. eCollection 2014.","Zeng T","Int J Clin Exp Pathol","2014","2015/01/01","PMC4270518","",""
"2496468","[Clinical experience on the use of total parenteral nutrition in patients subjected to radical cystectomy intervention for infiltrating neoplasms of the bladder]","Del Boca C, Furiosi D, Bolis C, Ferrari C.","Arch Ital Urol Nefrol Androl. 1989 Mar;61(1):69-75.","Del Boca C","Arch Ital Urol Nefrol Androl","1989","1989/03/01","","",""
"23351086","Intravesical bacille Calmette-Guérin (BCG) in immunologically compromised patients with bladder cancer","Herr HW, Dalbagni G.","BJU Int. 2013 May;111(6):984-7. doi: 10.1111/j.1464-410X.2012.11778.x. Epub 2013 Jan 25.","Herr HW","BJU Int","2013","2013/01/29","","","10.1111/j.1464-410X.2012.11778.x"
"30851243","High LINC00536 expression promotes tumor progression and poor prognosis in bladder cancer","Li R, Zhang L, Qin Z, Wei Y, Deng Z, Zhu C, Tang J, Ma L.","Exp Cell Res. 2019 May 1;378(1):32-40. doi: 10.1016/j.yexcr.2019.03.009. Epub 2019 Mar 6.","Li R","Exp Cell Res","2019","2019/03/10","","","10.1016/j.yexcr.2019.03.009"
"13502916","Some aspects of bladder cancer","GODWIN JT.","J Urol. 1958 Jan;79(1):84-6. doi: 10.1016/s0022-5347(17)66237-2.","GODWIN JT","J Urol","1958","1958/01/01","","","10.1016/s0022-5347(17)66237-2"
"30741358","Treatment Approaches for Cisplatin-Ineligible Patients with Invasive Bladder Cancer","Einstein DJ, Sonpavde G.","Curr Treat Options Oncol. 2019 Feb 11;20(2):12. doi: 10.1007/s11864-019-0609-6.","Einstein DJ","Curr Treat Options Oncol","2019","2019/02/12","","","10.1007/s11864-019-0609-6"
"3606148","[Doxorubicin intra-arterial chemotherapy combined with low-dose irradiation in bladder cancer]","Uyama T, Higa I, Shiotsu T, Fujita J, Yamamoto A, Aga Y.","Gan To Kagaku Ryoho. 1987 Jul;14(7):2293-9.","Uyama T","Gan To Kagaku Ryoho","1987","1987/07/01","","",""
"26462931","Significance of second transurethral resection on patient outcomes in muscle-invasive bladder cancer patients treated with bladder-preserving multimodal therapy","Suer E, Hamidi N, Gokce MI, Gulpinar O, Turkolmez K, Beduk Y, Baltaci S.","World J Urol. 2016 Jun;34(6):847-51. doi: 10.1007/s00345-015-1710-5. Epub 2015 Oct 13.","Suer E","World J Urol","2016","2015/10/15","","","10.1007/s00345-015-1710-5"
"10954628","Primary superficial bladder cancer risk groups according to progression, mortality and recurrence","Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Algaba F, Vicente-Rodríguez J.","J Urol. 2000 Sep;164(3 Pt 1):680-4. doi: 10.1016/s0022-5347(05)67280-1.","Millán-Rodríguez F","J Urol","2000","2000/08/23","","","10.1016/s0022-5347(05)67280-1"
"28478043","Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review","Fonteyne V, Ost P, Bellmunt J, Droz JP, Mongiat-Artus P, Inman B, Paillaud E, Saad F, Ploussard G.","Eur Urol. 2018 Jan;73(1):40-50. doi: 10.1016/j.eururo.2017.03.019. Epub 2017 May 3.","Fonteyne V","Eur Urol","2018","2017/05/08","","","10.1016/j.eururo.2017.03.019"
"16882065","Possible correlation between polymorphism in the tumor necrosis factor-beta gene and the clinicopathological features of bladder cancer in Japanese patients","Nonomura N, Tokizane T, Nakayama M, Inoue H, Nishimura K, Muramatsu M, Okuyama A.","Int J Urol. 2006 Jul;13(7):971-6. doi: 10.1111/j.1442-2042.2006.01450.x.","Nonomura N","Int J Urol","2006","2006/08/03","","","10.1111/j.1442-2042.2006.01450.x"
"27866245","The impact of socioeconomic status on perioperative complications and oncologic outcomes in patients undergoing radical cystectomy","Golombos DM, O'Malley P, Lewicki P, Nguyen DP, Stone BV, Al Hussein Al Awamlh B, Scherr DS.","World J Urol. 2017 Jul;35(7):1063-1071. doi: 10.1007/s00345-016-1972-6. Epub 2016 Nov 19.","Golombos DM","World J Urol","2017","2016/11/21","","","10.1007/s00345-016-1972-6"
"11919465","Comparative study of peptides isolated from class I antigen groove of urological specimens. a further step toward the future of peptide therapy in bladder cancer patients","Torabi-Pour N, Nouri AM, Saffie R, Oliver RT.","Urol Int. 2002;68(3):183-8. doi: 10.1159/000048447.","Torabi-Pour N","Urol Int","2002","2002/03/29","","","10.1159/000048447"
"15713770","Detection of bladder cancer using a point-of-care proteomic assay","Grossman HB, Messing E, Soloway M, Tomera K, Katz G, Berger Y, Shen Y.","JAMA. 2005 Feb 16;293(7):810-6. doi: 10.1001/jama.293.7.810.","Grossman HB","JAMA","2005","2005/02/17","","","10.1001/jama.293.7.810"
"10468735","MUC1 mucin as a tumour marker in bladder cancer","Simms MS, Hughes OD, Limb M, Price MR, Bishop MC.","BJU Int. 1999 Aug;84(3):350-2. doi: 10.1046/j.1464-410x.1999.00150.x.","Simms MS","BJU Int","1999","1999/09/01","","","10.1046/j.1464-410x.1999.00150.x"
"3806155","Superficial bladder cancer: the primacy of grade in the development of invasive disease","Torti FM, Lum BL, Aston D, MacKenzie N, Faysel M, Shortliffe LD, Freiha F.","J Clin Oncol. 1987 Jan;5(1):125-30. doi: 10.1200/JCO.1987.5.1.125.","Torti FM","J Clin Oncol","1987","1987/01/01","","","10.1200/JCO.1987.5.1.125"
"29305631","The risk of bladder cancer in patients with urinary calculi: a meta-analysis","Yu Z, Yue W, Jiuzhi L, Youtao J, Guofei Z, Wenbin G.","Urolithiasis. 2018 Nov;46(6):573-579. doi: 10.1007/s00240-017-1033-7. Epub 2018 Jan 5.","Yu Z","Urolithiasis","2018","2018/01/07","","","10.1007/s00240-017-1033-7"
"2016551","[Low pressure bladder replacement after total cysto-prostatectomy. Apropos of a series of 40 patients]","Peyret C, Géraud M, Conquy S, Martinache PR, Flam T, Zerbib M, Steg A, Debré B.","J Urol (Paris). 1991;97(1):37-42.","Peyret C","J Urol (Paris)","1991","1991/01/01","","",""
"8015077","Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder","Sarkis AS, Dalbagni G, Cordon-Cardo C, Melamed J, Zhang ZF, Sheinfeld J, Fair WR, Herr HW, Reuter VE.","J Urol. 1994 Aug;152(2 Pt 1):388-92. doi: 10.1016/s0022-5347(17)32745-3.","Sarkis AS","J Urol","1994","1994/08/01","","","10.1016/s0022-5347(17)32745-3"
"9694595","Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review","Patard JJ, Saint F, Velotti F, Abbou CC, Chopin DK.","Urol Res. 1998;26(3):155-9. doi: 10.1007/s002400050039.","Patard JJ","Urol Res","1998","1998/08/07","","","10.1007/s002400050039"
"6155204","Bladder cancer diagnosis by flow cytometry. Correlation between cell samples from biopsy and bladder irrigation fluid","Collste LG, Devonec M, Darzynkiewicz Z, Traganos F, Sharpless TK, Whitmore WF Jr, Melamed MR.","Cancer. 1980 May 1;45(9):2389-94. doi: 10.1002/1097-0142(19800501)45:9<2389::aid-cncr2820450925>3.0.co;2-y.","Collste LG","Cancer","1980","1980/05/01","","","10.1002/1097-0142(19800501)45:9<2389::aid-cncr2820450925>3.0.co;2-y"
"27363013","Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma","Huang M, Zhong Z, Lv M, Shu J, Tian Q, Chen J.","Oncotarget. 2016 Jul 26;7(30):47186-47200. doi: 10.18632/oncotarget.9706.","Huang M","Oncotarget","2016","2016/07/01","PMC5216934","","10.18632/oncotarget.9706"
"6677963","[Preoperative curietherapy using iridium 192 in cancer of the bladder]","Mazeron JJ, Botto H, Auvert J, Pierquin B.","Radiol Med. 1983 Nov;69(11):874-5.","Mazeron JJ","Radiol Med","1983","1983/11/01","","",""
"21005424","Xanthoma and carcinoma in a diverticulum of the urinary bladder","SCHOLL AJ.","Trans Am Assoc Genitourin Surg. 1945;37:67-71.","SCHOLL AJ","Trans Am Assoc Genitourin Surg","1945","2010/10/29","","",""
"24719024","Educational opportunities in bladder cancer: increasing cystoscopic adherence and the availability of smoking-cessation programs","Kowalkowski MA, Goltz HH, Petersen NJ, Amiel GE, Lerner SP, Latini DM.","J Cancer Educ. 2014 Dec;29(4):739-45. doi: 10.1007/s13187-014-0649-3.","Kowalkowski MA","J Cancer Educ","2014","2014/04/11","PMC4412159","NIHMS683424","10.1007/s13187-014-0649-3"
"20239041","The surgical treatment of carcinoma of the bladder","PRIESTLEY JT.","J Am Med Assoc. 1947 Jun 7;134(6):507-13. doi: 10.1001/jama.1947.02880230017005.","PRIESTLEY JT","J Am Med Assoc","1947","2010/03/19","","","10.1001/jama.1947.02880230017005"
"15963111","Molecular staging of bladder cancer","Mitra AP, Datar RH, Cote RJ.","BJU Int. 2005 Jul;96(1):7-12. doi: 10.1111/j.1464-410X.2005.05557.x.","Mitra AP","BJU Int","2005","2005/06/21","","","10.1111/j.1464-410X.2005.05557.x"
"7897925","Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer","Lamm DL.","Nihon Hinyokika Gakkai Zasshi. 1995 Jan;86(1):9-10. doi: 10.5980/jpnjurol.86.9.","Lamm DL","Nihon Hinyokika Gakkai Zasshi","1995","1995/01/01","","","10.5980/jpnjurol.86.9"
"26932334","[Advanced Adenocarcinoma of the Bladder after Augmentation Gastrocystoplasty]","Kono Y, Terada N, Takashima Y, Hikami K, Hida T, Goto S, Sunada T, Okada Y, Shibasaki N, Negoro H, Kobayashi T, Yamasaki T, Matsui Y, Inoue T, Kamba T, Ogawa O.","Hinyokika Kiyo. 2016 Jan;62(1):33-7.","Kono Y","Hinyokika Kiyo","2016","2016/03/03","","",""
"15281318","Molecular biological changes in bladder cancer","Qureshi KN, Lunec J, Neal DE.","Cancer Surv. 1998;31:77-97.","Qureshi KN","Cancer Surv","1998","2004/07/30","","",""
"19863529","The prognostic significance of bladder neck invasion in prostate cancer: is microscopic involvement truly a T4 disease?","Ploussard G, Rotondo S, Salomon L.","BJU Int. 2010 Mar;105(6):776-81. doi: 10.1111/j.1464-410X.2009.08957.x. Epub 2009 Oct 26.","Ploussard G","BJU Int","2010","2009/10/30","","","10.1111/j.1464-410X.2009.08957.x"
"31169020","Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer","Liu L, Wu SQ, Zhu X, Xu R, Ai K, Zhang L, Zhao XK.","Neoplasma. 2019 Jun 3;66(5):736-745. doi: 10.4149/neo_2019_190107N25. Print 2019 Sep.","Liu L","Neoplasma","2019","2019/06/07","","","10.4149/neo_2019_190107N25"
"22845409","Contemporary management of muscle-invasive bladder cancer","Dall'Era MA, Cheng L, Pan CX.","Expert Rev Anticancer Ther. 2012 Jul;12(7):941-50. doi: 10.1586/era.12.60.","Dall'Era MA","Expert Rev Anticancer Ther","2012","2012/08/01","PMC3494992","NIHMS415850","10.1586/era.12.60"
"10037369","NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer","Zippe C, Pandrangi L, Agarwal A.","J Urol. 1999 Jan;161(1):62-5.","Zippe C","J Urol","1999","1999/02/26","","",""
"2359180","A new 180 kDa. urine protein marker associated with bladder cancer","Zhau HY, Babaian RJ, Hong SJ.","J Urol. 1990 Jul;144(1):47-52. doi: 10.1016/s0022-5347(17)39363-1.","Zhau HY","J Urol","1990","1990/07/01","","","10.1016/s0022-5347(17)39363-1"
"30741659","Bladder cancer with Indian ink","Elizalde Benito FX, Ucar Terren A, Monzón Alebesque F, Urra Palos M, Elizalde Benito ÁG.","Arch Esp Urol. 2019 Jan;72(1):89-90.","Elizalde Benito FX","Arch Esp Urol","2019","2019/02/12","","",""
"24656090","Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer","Szarvas T, Reis H, Kramer G, Shariat SF, Vom Dorp F, Tschirdewahn S, Schmid KW, Kovalszky I, Rübben H.","Hum Pathol. 2014 Apr;45(4):674-82. doi: 10.1016/j.humpath.2013.10.036. Epub 2013 Dec 18.","Szarvas T","Hum Pathol","2014","2014/03/25","","","10.1016/j.humpath.2013.10.036"
"20560950","Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy","Canter D, Long C, Kutikov A, Plimack E, Saad I, Oblaczynski M, Zhu F, Viterbo R, Chen DY, Uzzo RG, Greenberg RE, Boorjian SA.","BJU Int. 2011 Jan;107(1):58-62. doi: 10.1111/j.1464-410X.2010.09442.x.","Canter D","BJU Int","2011","2010/06/22","","","10.1111/j.1464-410X.2010.09442.x"
"31067463","Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer","Guo CC, Majewski T, Zhang L, Yao H, Bondaruk J, Wang Y, Zhang S, Wang Z, Lee JG, Lee S, Cogdell D, Zhang M, Wei P, Grossman HB, Kamat A, Duplisea JJ, Ferguson JE 3rd, Huang H, Dadhania V, Gao J, Dinney C, Weinstein JN, Baggerly K, McConkey D, Czerniak B.","Cell Rep. 2019 May 7;27(6):1781-1793.e4. doi: 10.1016/j.celrep.2019.04.048.","Guo CC","Cell Rep","2019","2019/05/09","PMC6546434","NIHMS1528840","10.1016/j.celrep.2019.04.048"
"24451595","International variations in bladder cancer incidence and mortality","Chavan S, Bray F, Lortet-Tieulent J, Goodman M, Jemal A.","Eur Urol. 2014 Jul;66(1):59-73. doi: 10.1016/j.eururo.2013.10.001. Epub 2013 Oct 16.","Chavan S","Eur Urol","2014","2014/01/24","","","10.1016/j.eururo.2013.10.001"
"23968261","Implementation of adaptive radiation therapy for urinary bladder carcinoma: imaging, planning and image guidance","Tuomikoski L, Korhonen J, Collan J, Keyriläinen J, Visapää H, Sairanen J, Saarilahti K, Tenhunen M.","Acta Oncol. 2013 Oct;52(7):1451-7. doi: 10.3109/0284186X.2013.813639. Epub 2013 Aug 23.","Tuomikoski L","Acta Oncol","2013","2013/08/24","","","10.3109/0284186X.2013.813639"
"18501714","UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion","Wang F, Li X, Xie X, Zhao L, Chen W.","FEBS Lett. 2008 Jun 11;582(13):1919-27. doi: 10.1016/j.febslet.2008.05.012. Epub 2008 May 22.","Wang F","FEBS Lett","2008","2008/05/27","","","10.1016/j.febslet.2008.05.012"
"4718673","Effect of the urine and calculus formation on the incidence of bladder tumors in rats implanted with paraffin wax pellets","Chapman WH, Kirchheim D, McRoberts JW.","Cancer Res. 1973 Jun;33(6):1225-9.","Chapman WH","Cancer Res","1973","1973/06/01","","",""
"16596191","Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells","Park C, Kim GY, Kim GD, Choi BT, Park YM, Choi YH.","Oncol Rep. 2006 May;15(5):1225-31.","Park C","Oncol Rep","2006","2006/04/06","","",""
"19567298","Editorial comment","Herr HW.","Urology. 2009 Jul;74(1):166. doi: 10.1016/j.urology.2009.01.025.","Herr HW","Urology","2009","2009/07/02","","","10.1016/j.urology.2009.01.025"
"25477183","Role of fibroblast growth factor in squamous cell carcinoma of the bladder: prognostic biomarker and potential therapeutic target","Youssef RF, Kapur P, Mosbah A, Abol-Enein H, Ghoneim M, Lotan Y.","Urol Oncol. 2015 Mar;33(3):111.e1-7. doi: 10.1016/j.urolonc.2014.09.020. Epub 2014 Dec 2.","Youssef RF","Urol Oncol","2015","2014/12/06","","","10.1016/j.urolonc.2014.09.020"
"22023065","Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer","Choudhury A, Cowan R.","BJU Int. 2011 Nov;108(9):E313. doi: 10.1111/j.1464-410X.2011.10672_3.x.","Choudhury A","BJU Int","2011","2011/10/26","","","10.1111/j.1464-410X.2011.10672_3.x"
"1497382","Investigation of a reported cluster of bladder cancer cases in the Pottstown/Phoenixville area of Pennsylvania","Balbus-Kornfeld JM, Frumkin H.","Arch Environ Health. 1992 Jul-Aug;47(4):285-91. doi: 10.1080/00039896.1992.9938363.","Balbus-Kornfeld JM","Arch Environ Health","1992","1992/07/01","","","10.1080/00039896.1992.9938363"
"28676151","Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival","Abrahamsson J, Aaltonen K, Engilbertsson H, Liedberg F, Patschan O, Rydén L, Sjödahl G, Gudjonsson S.","Urol Oncol. 2017 Oct;35(10):606.e9-606.e16. doi: 10.1016/j.urolonc.2017.05.021. Epub 2017 Jul 1.","Abrahamsson J","Urol Oncol","2017","2017/07/06","","","10.1016/j.urolonc.2017.05.021"
"30509868","A delay ≥8 weeks to neoadjuvant chemotherapy before radical cystectomy increases the risk of upstaging","Audenet F, Sfakianos JP, Waingankar N, Ruel NH, Galsky MD, Yuh BE, Gin GE.","Urol Oncol. 2019 Feb;37(2):116-122. doi: 10.1016/j.urolonc.2018.11.011. Epub 2018 Dec 1.","Audenet F","Urol Oncol","2019","2018/12/05","","","10.1016/j.urolonc.2018.11.011"
"23726643","Radical cystectomy and orthotopic urinary reconstruction in patients with bladder cancer after renal transplantation: clinical outcomes and description of technique","Moses KA, Bochner BH, Prabharasuth D, Sfakianos JP, Bernstein M, Herr HW, Dalbagni G.","Transplant Proc. 2013 May;45(4):1661-6. doi: 10.1016/j.transproceed.2012.10.050.","Moses KA","Transplant Proc","2013","2013/06/04","PMC4167061","NIHMS530269","10.1016/j.transproceed.2012.10.050"
"7666665","Partial cystectomy for invasive bladder cancer","Dandekar NP, Tongaonkar HB, Dalal AV, Kulkarni JN, Kamat MR.","J Surg Oncol. 1995 Sep;60(1):24-9. doi: 10.1002/jso.2930600106.","Dandekar NP","J Surg Oncol","1995","1995/09/01","","","10.1002/jso.2930600106"
"11310209","Production and characterisation of a C595 antibody-99mTc conjugate for immunoscintigraphy of bladder cancer","Simms MS, Murray A, Denton G, Scholfield DP, Price MR, Perkins AC, Bishop MC.","Urol Res. 2001 Feb;29(1):13-9. doi: 10.1007/s002400000147.","Simms MS","Urol Res","2001","2001/04/20","","","10.1007/s002400000147"
"30747864","Re: Predicting Local Failure after Radical Cystectomy in Patients with Bladder Cancer: Implications for the Selection of Candidates at Adjuvant Radiation Therapy","Chang SS.","J Urol. 2019 May;201(5):857. doi: 10.1097/JU.0000000000000166.","Chang SS","J Urol","2019","2019/02/13","","","10.1097/JU.0000000000000166"
"6367189","Tumor markers in bladder cancer","Huben RP.","Urology. 1984 Mar;23(3 Suppl):10-4. doi: 10.1016/s0090-4295(84)80108-9.","Huben RP","Urology","1984","1984/03/01","","","10.1016/s0090-4295(84)80108-9"
"4810758","Immunologic reduction of bladder cancer recurrence rate","Olsson CA, Chute R, Rao CN.","J Urol. 1974 Feb;111(2):173-6. doi: 10.1016/s0022-5347(17)59919-x.","Olsson CA","J Urol","1974","1974/02/01","","","10.1016/s0022-5347(17)59919-x"
"25928257","miR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1","Liu J, Cao J, Zhao X.","BMC Urol. 2015 Apr 28;15:36. doi: 10.1186/s12894-015-0028-3.","Liu J","BMC Urol","2015","2015/05/01","PMC4423111","","10.1186/s12894-015-0028-3"
"9206877","[The diagnosis and treatment of bladder cancer metastases]","Kariakin OB, Grishin GN, Volodina TV.","Urol Nefrol (Mosk). 1997 Mar-Apr;(2):22-5.","Kariakin OB","Urol Nefrol (Mosk)","1997","1997/03/01","","",""
"27492420","The bladder cancer drug market","Nawaz K, Webster RM.","Nat Rev Drug Discov. 2016 Sep;15(9):599-600. doi: 10.1038/nrd.2016.141. Epub 2016 Aug 5.","Nawaz K","Nat Rev Drug Discov","2016","2016/08/06","","","10.1038/nrd.2016.141"
"26305667","Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in Sweden","Rose JB, Armstrong S, Hermann GG, Kjellberg J, Malmström PU.","BJU Int. 2016 Jun;117(6B):E102-13. doi: 10.1111/bju.13261. Epub 2015 Oct 29.","Rose JB","BJU Int","2016","2015/08/26","","","10.1111/bju.13261"
"8413442","New approaches to the treatment of bladder cancer","Scher HI.","N Engl J Med. 1993 Nov 4;329(19):1420-1. doi: 10.1056/NEJM199311043291912.","Scher HI","N Engl J Med","1993","1993/11/04","","","10.1056/NEJM199311043291912"
"10647699","Neural network analysis of clinicopathological and molecular markers in bladder cancer","Qureshi KN, Naguib RN, Hamdy FC, Neal DE, Mellon JK.","J Urol. 2000 Feb;163(2):630-3.","Qureshi KN","J Urol","2000","2000/01/27","","",""
"29637216","[Advanced bladder cancer : From chemo- to immunotherapy]","Horn T, Krege S, Retz M.","Urologe A. 2018 Jun;57(6):686-692. doi: 10.1007/s00120-018-0626-2.","Horn T","Urologe A","2018","2018/04/12","","","10.1007/s00120-018-0626-2"
"8212437","Hsp-27 has no diagnostic or prognostic significance in prostate or bladder cancers","Storm FK, Mahvi DM, Gilchrist KW.","Urology. 1993 Oct;42(4):379-82. doi: 10.1016/0090-4295(93)90361-d.","Storm FK","Urology","1993","1993/10/01","","","10.1016/0090-4295(93)90361-d"
"23102779","Antitumor effects of exogenous ganglioside GM3 on bladder cancer in an orthotopic cancer model","Wang H, Isaji T, Satoh M, Li D, Arai Y, Gu J.","Urology. 2013 Jan;81(1):210.e11-5. doi: 10.1016/j.urology.2012.08.015. Epub 2012 Oct 24.","Wang H","Urology","2013","2012/10/30","","","10.1016/j.urology.2012.08.015"
"28555706","Can We Predict Morbidity and Mortality of Patients Aged 75 Years and Older Undergoing Cystectomy?","Atallah F, Letocart P, Malavaud B, Ahmad M, Mazerolles M, Minville V.","J Frailty Aging. 2017;6(2):72-75. doi: 10.14283/jfa.2017.5.","Atallah F","J Frailty Aging","2017","2017/05/31","","","10.14283/jfa.2017.5"
"7069828","The clonogenic growth of cells derived from bladder barbotage in patients with transitional cell carcinoma of the bladder: a preliminary report","Niell HB, Soloway MS, Nissenkorn I.","J Urol. 1982 Apr;127(4):668-70. doi: 10.1016/s0022-5347(17)53985-3.","Niell HB","J Urol","1982","1982/04/01","","","10.1016/s0022-5347(17)53985-3"
"1451070","Concurrent vinblastine and radiation therapy in bladder cancer","Kragelj B, Jereb B, Kragelj L, Stanonik M.","Cancer. 1992 Dec 15;70(12):2885-90. doi: 10.1002/1097-0142(19921215)70:12<2885::aid-cncr2820701227>3.0.co;2-u.","Kragelj B","Cancer","1992","1992/12/15","","","10.1002/1097-0142(19921215)70:12<2885::aid-cncr2820701227>3.0.co;2-u"
"1393440","Intravesical instillation of beta-interferon in the treatment of bladder cancer","Migliari R, el Demiry M, Muscas G, Usai E.","Br J Urol. 1992 Aug;70(2):169-73. doi: 10.1111/j.1464-410x.1992.tb15697.x.","Migliari R","Br J Urol","1992","1992/08/01","","","10.1111/j.1464-410x.1992.tb15697.x"
"32022366","Editorial Comment from Dr Abe to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort","Abe T.","Int J Urol. 2020 Mar;27(3):256-257. doi: 10.1111/iju.14193. Epub 2020 Feb 5.","Abe T","Int J Urol","2020","2020/02/06","","","10.1111/iju.14193"
"30022273","Declining Use of Orthotopic Reconstruction for Bladder Cancer","Hautmann R, Bolenz C.","Ann Surg Oncol. 2018 Nov;25(12):3421-3422. doi: 10.1245/s10434-018-6570-y. Epub 2018 Jul 18.","Hautmann R","Ann Surg Oncol","2018","2018/07/20","","","10.1245/s10434-018-6570-y"
"12788178","Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer","Chen WC, Liaw CC, Chuang CK, Chen MF, Chen CS, Lin PY, Chang PL, Chu SH, Wu CT, Hong JH.","Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):726-33. doi: 10.1016/s0360-3016(03)00124-x.","Chen WC","Int J Radiat Oncol Biol Phys","2003","2003/06/06","","","10.1016/s0360-3016(03)00124-x"
"30044593","The present and future enhanced recovery after surgery for bladder cancer","Poch MA, Patel S, Garcia-Getting R.","Int Braz J Urol. 2018 Nov-Dec;44(6):1266-1271. doi: 10.1590/S1677-5538.IBJU.2017.0282.","Poch MA","Int Braz J Urol","2018","2018/07/26","PMC6442167","","10.1590/S1677-5538.IBJU.2017.0282"
"19264423","Improvement of bladder cancer immunotherapy by creating a recombinant Bacille Calmette-Gu'erin which secrets p53 protein","Amirkhah R, Khanahmad H, Abolhassani M, Pooya M, Movassagh H, Shokrgozar MA.","Med Hypotheses. 2009 Jun;72(6):754. doi: 10.1016/j.mehy.2009.01.035. Epub 2009 Mar 4.","Amirkhah R","Med Hypotheses","2009","2009/03/07","","","10.1016/j.mehy.2009.01.035"
"8886906","Intravesical therapy of bladder cancer: an immunotherapy success story","Morales A.","Int J Urol. 1996 Sep;3(5):329-33. doi: 10.1111/j.1442-2042.1996.tb00548.x.","Morales A","Int J Urol","1996","1996/09/01","","","10.1111/j.1442-2042.1996.tb00548.x"
"23307254","Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer","Ruan J, Wei B, Xu Z, Yang S, Zhou Y, Yu M, Liang J, Jin K, Huang X, Lu P, Cheng H.","Med Oncol. 2013 Mar;30(1):445. doi: 10.1007/s12032-012-0445-z. Epub 2013 Jan 10.","Ruan J","Med Oncol","2013","2013/01/12","","","10.1007/s12032-012-0445-z"
"19954353","Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer","Xishuang S, Deyong Y, Xiangyu C, Tao J, Quanlin L, Hongwei G, Jibin Y, Dongjun W, Zhongzhou H, Jianbo W, Lina W, Lin Y.","J Endourol. 2010 Jan;24(1):69-73. doi: 10.1089/end.2009.0171.","Xishuang S","J Endourol","2010","2009/12/04","","","10.1089/end.2009.0171"
"20268626","Twenty-five years of radon treatment of cancer of the bladder","BARRINGER BS.","J Am Med Assoc. 1947 Nov 8;135(10):616-8. doi: 10.1001/jama.1947.02890100010003.","BARRINGER BS","J Am Med Assoc","1947","2010/03/19","","","10.1001/jama.1947.02890100010003"
"11848469","Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade","Mahdy E, Pan Y, Wang N, Malmström PU, Ekman P, Bergerheim U.","Anticancer Res. 2001 Sep-Oct;21(5):3167-73.","Mahdy E","Anticancer Res","2001","2002/02/19","","",""
"12725329","p53 mutations detection in urinary bladder cancer in the Greek population: application of the NIRCA assay","Goudopoulou A, Saetta A, Korkolopoulou P, Patsouris E, Fanourakis G, Miaouli M, Thomas-Tsagli E, Davaris PS.","J Exp Clin Cancer Res. 2003 Mar;22(1):99-105.","Goudopoulou A","J Exp Clin Cancer Res","2003","2003/05/03","","",""
"18585635","[Bacillus of Calmette-Guérin immunotherapy: which protocol?]","Saint F.","Prog Urol. 2008 May;18 Suppl 5:S99-104. doi: 10.1016/S1166-7087(08)72485-0.","Saint F","Prog Urol","2008","2008/07/01","","","10.1016/S1166-7087(08)72485-0"
"26683751","Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy During Radical Cystectomy: A Sensitivity Curve Analysis","Moschini M, Karnes RJ, Gandaglia G, Luzzago S, Dell'Oglio P, Rossi MS, di Trapani E, La Croce G, Damiano R, Salonia A, Shariat SF, Montorsi F, Briganti A, Gallina A, Colombo R.","Urology. 2016 Feb;88:97-103. doi: 10.1016/j.urology.2015.12.005. Epub 2015 Dec 9.","Moschini M","Urology","2016","2015/12/20","","","10.1016/j.urology.2015.12.005"
"16401399","Distribution of photosensitizers in bladder cancer spheroids: implications for intravesical instillation of photosensitizers for photodynamic therapy of bladder cancer","Xiao Z, Hansen CB, Allen TM, Miller GG, Moore RB.","J Pharm Pharm Sci. 2005 Sep 28;8(3):536-43.","Xiao Z","J Pharm Pharm Sci","2005","2006/01/13","","",""
"31230855","[Optical coherence tomography of bladder resection specimen]","Anract J, Duquesne I, Montagne P, Sibony M, Beuvon F, Peyromaure M, Barry Delongchamps N.","Prog Urol. 2019 Jul-Aug;29(8-9):449-455. doi: 10.1016/j.purol.2019.05.005. Epub 2019 Jun 20.","Anract J","Prog Urol","2019","2019/06/25","","","10.1016/j.purol.2019.05.005"
"22999117","[Radical cystectomy for urothelial bladder cancer: prognostic impact of lymph node metastasis and soft tissue surgical margins]","Toledano H, Bastide C, Thoulouzan M, Arroua F, Carcenac A, Ragni E, Huyghe E, Plante P, Rossi D, Soulie M.","Prog Urol. 2012 Oct;22(12):705-10. doi: 10.1016/j.purol.2012.07.011. Epub 2012 Aug 29.","Toledano H","Prog Urol","2012","2012/09/25","","","10.1016/j.purol.2012.07.011"
"27287241","[Social medical/public health assessment of bladder cancer after curative and adjuvant therapy]","Zermann DH, Vahlensieck W, Hoffmann W.","Urologe A. 2016 Oct;55(10):1335-1338. doi: 10.1007/s00120-016-0155-9.","Zermann DH","Urologe A","2016","2016/06/12","","","10.1007/s00120-016-0155-9"
"20726978","Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin","Shiota M, Tsunoda T, Song Y, Yokomizo A, Tada Y, Oda Y, Naito S.","BJU Int. 2011 Apr;107(7):1148-53. doi: 10.1111/j.1464-410X.2010.09535.x. Epub 2010 Aug 19.","Shiota M","BJU Int","2011","2010/08/24","","","10.1111/j.1464-410X.2010.09535.x"
"18403090","Editorial comment on: laparoscopic and robotic assisted radical cystectomy for bladder cancer: a critical analysis","Stolzenburg JU, Liatsikos EN.","Eur Urol. 2008 Jul;54(1):63-4. doi: 10.1016/j.eururo.2008.03.078. Epub 2008 Apr 1.","Stolzenburg JU","Eur Urol","2008","2008/04/12","","","10.1016/j.eururo.2008.03.078"
"1357809","Epidermal growth factor receptor and bladder cancer: a review","Neal DE, Mellon K.","Urol Int. 1992;48(4):365-71. doi: 10.1159/000282357.","Neal DE","Urol Int","1992","1992/01/01","","","10.1159/000282357"
"2831650","Long-term survival with metastatic signet ring cell bladder cancer","Sagalowsky AI.","Urology. 1988 Mar;31(3):283. doi: 10.1016/0090-4295(88)90161-6.","Sagalowsky AI","Urology","1988","1988/03/01","","","10.1016/0090-4295(88)90161-6"
"7383136","Artificial sweetner and bladder cancer","Ozonoff D.","N Engl J Med. 1980 Aug 7;303(6):341-2. doi: 10.1056/nejm198008073030617.","Ozonoff D","N Engl J Med","1980","1980/08/07","","","10.1056/nejm198008073030617"
"18398594","[Diagnostic radiology of the pelvis. Prostate cancer, bladder cancer, and incontinence]","Mueller-Lisse M B A UG.","Radiologe. 2008 Apr;48(4):397-410; quiz 411-2. doi: 10.1007/s00117-008-1648-3.","Mueller-Lisse M B A UG","Radiologe","2008","2008/04/10","","","10.1007/s00117-008-1648-3"
"28818454","The anti-tumor effect of intravesical administration of normal urothelial cells on bladder cancer","Huang CP, Chen CC, Shyr CR.","Cytotherapy. 2017 Oct;19(10):1233-1245. doi: 10.1016/j.jcyt.2017.06.010. Epub 2017 Aug 14.","Huang CP","Cytotherapy","2017","2017/08/19","","","10.1016/j.jcyt.2017.06.010"
"11693804","Human papilloma virus infection and overexpression of p53 protein in bilharzial bladder cancer","Khaled HM, Raafat A, Mokhtar N, Zekri AR, Gaballah H.","Tumori. 2001 Jul-Aug;87(4):256-61.","Khaled HM","Tumori","2001","2001/11/06","","",""
"19773042","Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion--a prospective cohort study with a systematic review of literature","Somani BK, Gimlin D, Fayers P, N'dow J.","Urology. 2009 Nov;74(5):1138-43. doi: 10.1016/j.urology.2009.05.087. Epub 2009 Sep 20.","Somani BK","Urology","2009","2009/09/24","","","10.1016/j.urology.2009.05.087"
"31327502","Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results","Ma B, Li Y, Han S, Jiang X, Zhao Y, Guo J, Quan C, Niu Y.","Eur J Surg Oncol. 2019 Oct;45(10):1993-1999. doi: 10.1016/j.ejso.2019.07.018. Epub 2019 Jul 16.","Ma B","Eur J Surg Oncol","2019","2019/07/23","","","10.1016/j.ejso.2019.07.018"
"17671678","Fluorescence detection of bladder cancer using urine cytology","Fu CY, Ng BK, Razul SG, Chin WW, Tan PH, Lau WK, Olivo M.","Int J Oncol. 2007 Sep;31(3):525-30.","Fu CY","Int J Oncol","2007","2007/08/03","","",""
"31823654","ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer","Sonpavde G, Necchi A, Gupta S, Steinberg GD, Gschwend JE, Van Der Heijden MS, Garzon N, Ibrahim M, Raybold B, Liaw D, Rutstein M, Galsky MD.","Future Oncol. 2020 Jan;16(2):4359-4368. doi: 10.2217/fon-2019-0611. Epub 2019 Dec 11.","Sonpavde G","Future Oncol","2020","2019/12/12","","","10.2217/fon-2019-0611"
"30844807","Comparison of Outcomes between Standard and Palliative Management for High Grade Non-Muscle Invasive Bladder Cancer in Patients Older than 85 Years","Carrion A, Díaz F, Raventós C, Lozano F, Piñero A, Morote J.","Urol Int. 2019;102(3):277-283. doi: 10.1159/000496802. Epub 2019 Mar 7.","Carrion A","Urol Int","2019","2019/03/08","","","10.1159/000496802"
"31331865","Short-term Mortality Associated with Definitive Chemoradiotherapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer","Haque W, Verma V, Aghazadeh M, Darcourt J, Butler EB, Teh BS.","Clin Genitourin Cancer. 2019 Oct;17(5):e1069-e1079. doi: 10.1016/j.clgc.2019.06.015. Epub 2019 Jul 2.","Haque W","Clin Genitourin Cancer","2019","2019/07/24","","","10.1016/j.clgc.2019.06.015"
"27823975","Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis","Kang W, Cui Z, Chen Q, Zhang D, Zhang H, Jin X.","Oncotarget. 2017 Apr 4;8(14):23880-23890. doi: 10.18632/oncotarget.13054.","Kang W","Oncotarget","2017","2016/11/09","PMC5410352","","10.18632/oncotarget.13054"
"6457159","Adherent suppressor cells in the blood of patients with bladder cancer","Herr HW.","J Urol. 1981 Oct;126(4):457-60. doi: 10.1016/s0022-5347(17)54574-7.","Herr HW","J Urol","1981","1981/10/01","","","10.1016/s0022-5347(17)54574-7"
"3971353","Cigarette smoking and bladder cancer in females","Vineis P, Ciccone G, Ghisetti V, Terracini B.","Cancer Lett. 1985 Feb;26(1):61-6. doi: 10.1016/0304-3835(85)90173-9.","Vineis P","Cancer Lett","1985","1985/02/01","","","10.1016/0304-3835(85)90173-9"
"6676581","[Clinical evaluation of total cystectomy on patients with bladder cancer]","Uekado Y, Ogawa T, Hirano A, Funaoka N, Sawada Y, Miyazaki Y, Mori K, Ebisuno S, Shinka T, Nakamura J, et al.","Nihon Hinyokika Gakkai Zasshi. 1983 Sep;74(9):1509-17. doi: 10.5980/jpnjurol1928.74.9_1509.","Uekado Y","Nihon Hinyokika Gakkai Zasshi","1983","1983/09/01","","","10.5980/jpnjurol1928.74.9_1509"
"24973047","Surgical landscape of radical cystectomy for bladder cancer in France over the last 10 years","Léon P, Seisen T, Rouprêt M.","World J Urol. 2015 Jun;33(6):889-90. doi: 10.1007/s00345-014-1352-z. Epub 2014 Jun 28.","Léon P","World J Urol","2015","2014/06/29","","","10.1007/s00345-014-1352-z"
"25771977","Inhibition of bladder cancer cell proliferation by allyl isothiocyanate (mustard essential oil)","Sávio AL, da Silva GN, Salvadori DM.","Mutat Res. 2015 Jan;771:29-35. doi: 10.1016/j.mrfmmm.2014.11.004. Epub 2014 Dec 11.","Sávio AL","Mutat Res","2015","2015/03/17","","","10.1016/j.mrfmmm.2014.11.004"
"17293654","Significance of collagenase 3 (matrix metalloproteinase 13) in invasive bladder cancer: correlation with pathological parameters","Rodríguez Faba O, Fernández Gómez JM, Palou Redorta J, Escaf Barmadah S, Vizoso F, Villavicencio Mavrich H.","Urol Int. 2007;78(2):140-4. doi: 10.1159/000098072.","Rodríguez Faba O","Urol Int","2007","2007/02/13","","","10.1159/000098072"
"21159291","[An approach to a mix neuroendocrine bladder cancer]","Navarro Medina P, Camacho García C, Blanco Diez A, Barroso Deyne E, Armas Molina J, Artiles Hernández JL, Chesa Ponce N.","Actas Urol Esp. 2010 Nov;34(10):903-5.","Navarro Medina P","Actas Urol Esp","2010","2010/12/17","","",""
"17920185","Re: Paula M.J. Moonen, Judith M.J.E. Bakkers, Lambertus A.L.M. Kiemenay et al. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol 2007;52:464-9","Cai T, Mazzoli S, Mondaini N, Bartoletti R.","Eur Urol. 2008 Apr;53(4):858-9; author reply 859. doi: 10.1016/j.eururo.2007.09.041. Epub 2007 Oct 2.","Cai T","Eur Urol","2008","2007/10/09","","","10.1016/j.eururo.2007.09.041"
"2021028","Use of intravesical BCG for bladder cancer. Proceedings of a symposium. May 20, 1989, Key West, Florida","","Urology. 1991;37(5 Suppl):1-32.","","Urology","1991","1991/01/01","","",""
"7551871","Development of a life quality questionnaire in bladder cancer surgery","Biermann CW, Schmidt C, Küchler T.","Br J Urol. 1995 Sep;76(3):412-3.","Biermann CW","Br J Urol","1995","1995/09/01","","",""
"6382740","T-antigen and bladder cancer","Blum MD.","Urology. 1984 Sep;24(3):300. doi: 10.1016/0090-4295(84)90367-4.","Blum MD","Urology","1984","1984/09/01","","","10.1016/0090-4295(84)90367-4"
"12639682","Clinical significance of heat shock protein-70 expression in bladder cancer","Syrigos KN, Harrington KJ, Karayiannakis AJ, Sekara E, Chatziyianni E, Syrigou EI, Waxman J.","Urology. 2003 Mar;61(3):677-80. doi: 10.1016/s0090-4295(02)02289-6.","Syrigos KN","Urology","2003","2003/03/18","","","10.1016/s0090-4295(02)02289-6"
"23414478","Elevated IL-17A levels in early stages of bladder cancer regardless of smoking status","Doroudchi M, Saidi M, Malekzadeh M, Golmoghaddam H, Khezri A, Ghaderi A.","Future Oncol. 2013 Feb;9(2):295-304. doi: 10.2217/fon.12.180.","Doroudchi M","Future Oncol","2013","2013/02/19","","","10.2217/fon.12.180"
"19767220","Fibulin-5 is down-regulated in urothelial carcinoma of bladder and inhibits growth and invasion of human bladder cancer cell line 5637","Hu Z, Ai Q, Xu H, Ma X, Li HZ, Shi TP, Wang C, Gong DJ, Zhang X.","Urol Oncol. 2011 Jul-Aug;29(4):430-5. doi: 10.1016/j.urolonc.2009.06.004. Epub 2009 Sep 19.","Hu Z","Urol Oncol","2011","2009/09/22","","","10.1016/j.urolonc.2009.06.004"
"3503339","[Bladder cancer, primary and during pregnancy]","Perucca E, Yurać C, Fritis M, Castillo J, Alvarado O.","Rev Chil Obstet Ginecol. 1986;51(2):113-6.","Perucca E","Rev Chil Obstet Ginecol","1986","1986/01/01","","",""
"1495202","[Immunological study of induction of metallothionein in bladder cancers]","Saika T.","Nihon Hinyokika Gakkai Zasshi. 1992 May;83(5):643-9. doi: 10.5980/jpnjurol1989.83.643.","Saika T","Nihon Hinyokika Gakkai Zasshi","1992","1992/05/01","","","10.5980/jpnjurol1989.83.643"
"31262149","Bladder sparing surgery in high-grade bladder cancer","Yakovlev PG, Klyushin DA, Vereshchako RI.","Exp Oncol. 2019 Jun;41(2):160-165. doi: 10.32471/exp-oncology.2312-8852.vol-41-no-2.13207.","Yakovlev PG","Exp Oncol","2019","2019/07/03","","","10.32471/exp-oncology.2312-8852.vol-41-no-2.13207"
"26195445","Bladder cancer: Cancer cell sampling and storage-new filtration device aids collection from urine","Stone L.","Nat Rev Urol. 2015 Aug;12(8):420. doi: 10.1038/nrurol.2015.175. Epub 2015 Jul 21.","Stone L","Nat Rev Urol","2015","2015/07/22","","","10.1038/nrurol.2015.175"
"29848696","Differential Expression of IGF-I Transcripts in Bladder Cancer","Mourmouras N, Philippou A, Christopoulos P, Kostoglou K, Grivaki C, Konstantinidis C, Serafetinides E, Delakas D, Koutsilieris M.","Anticancer Res. 2018 Jun;38(6):3453-3459. doi: 10.21873/anticanres.12614.","Mourmouras N","Anticancer Res","2018","2018/06/01","","","10.21873/anticanres.12614"
"2119050","A progress report on the results of multimodality therapy for muscle-invasive bladder cancer","Prout GR Jr, Shipley WU, Kaufman DS, Griffin PP, Heney NM.","Semin Urol. 1990 Aug;8(3):201-4.","Prout GR Jr","Semin Urol","1990","1990/08/01","","",""
"17203266","[Palliative therapy concepts for patients with urothelial cancer of the urinary bladder]","Vom Dorp F, Börgermann C, Rübben H.","Urologe A. 2007 Jan;46(1):54-5. doi: 10.1007/s00120-006-1276-3.","Vom Dorp F","Urologe A","2007","2007/01/05","","","10.1007/s00120-006-1276-3"
"2501099","Preoperative intra-arterial infusion chemotherapy for patients with bladder cancer","Kubota Y, Kakizaki H, Numasawa K, Suzuki K, Kato H.","Eur Urol. 1989;16(3):189-94. doi: 10.1159/000471567.","Kubota Y","Eur Urol","1989","1989/01/01","","","10.1159/000471567"
"16961280","Smac/DIABLO promotes mitomycin C-induced apoptosis of bladder cancer T24 cells","Wang L, Fuqing Z, Zheng L, Tong Q.","J Huazhong Univ Sci Technolog Med Sci. 2006;26(3):317-8, 328. doi: 10.1007/BF02829562.","Wang L","J Huazhong Univ Sci Technolog Med Sci","2006","2006/09/12","","","10.1007/BF02829562"
"575119","Radiation Therapy and cis-diammine-dichloroplatinum (II) in transplantable and primary murine bladder cancer","Soloway MS, Morris CR, Sudderth B.","Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1355-60. doi: 10.1016/0360-3016(79)90669-2.","Soloway MS","Int J Radiat Oncol Biol Phys","1979","1979/08/01","","","10.1016/0360-3016(79)90669-2"
"30744595","Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling","Goulet CR, Champagne A, Bernard G, Vandal D, Chabaud S, Pouliot F, Bolduc S.","BMC Cancer. 2019 Feb 11;19(1):137. doi: 10.1186/s12885-019-5353-6.","Goulet CR","BMC Cancer","2019","2019/02/13","PMC6371428","","10.1186/s12885-019-5353-6"
"30868320","Back pain following instillations of BCG for superficial bladder cancer is not a reactive complication: review of 30 Mycobacterium bovis BCG vertebral osteomyelitis cases","Cadiou S, Al Tabaa O, Nguyen CD, Faccin M, Guillin R, Revest M, Guggenbuhl P, Houvenagel E, Pertuiset E, Coiffier G.","Clin Rheumatol. 2019 Jun;38(6):1773-1783. doi: 10.1007/s10067-019-04500-w. Epub 2019 Mar 13.","Cadiou S","Clin Rheumatol","2019","2019/03/15","","","10.1007/s10067-019-04500-w"
"16442208","Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K.","Eur Urol. 2006 Mar;49(3):466-5; discussion 475-7. doi: 10.1016/j.eururo.2005.12.031. Epub 2006 Jan 17.","Sylvester RJ","Eur Urol","2006","2006/01/31","","","10.1016/j.eururo.2005.12.031"
"22928881","A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer","Mitra AP, Skinner EC, Miranda G, Daneshmand S.","BJU Int. 2013 Feb;111(2):240-8. doi: 10.1111/j.1464-410X.2012.11424.x. Epub 2012 Aug 29.","Mitra AP","BJU Int","2013","2012/08/30","","","10.1111/j.1464-410X.2012.11424.x"
"1396947","BCG in superficial bladder cancer: a review of phase III European trials","Pagano F, Bassi P, Milani C, Piazza N, Meneghini A, Garbeglio A.","Eur Urol. 1992;21 Suppl 2:7-11. doi: 10.1159/000474914.","Pagano F","Eur Urol","1992","1992/01/01","","","10.1159/000474914"
"2712609","Quality of life in patients with advanced bladder cancer treated by tumorectomy and systemic adjuvant polychemotherapy (M-VAC). Our experience in 14 cases","Valente R, Marini F, Signori GB, Martino F.","Arch Esp Urol. 1989 Jan-Feb;42(1):87-9.","Valente R","Arch Esp Urol","1989","1989/01/01","","",""
"90388","Bladder cancer treatment considerations for metastatic disease","Hahn RG.","Semin Oncol. 1979 Jun;6(2):236-9.","Hahn RG","Semin Oncol","1979","1979/06/01","","",""
"25895760","Re: Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis","Chang SS.","J Urol. 2015 May;193(5):1517-8. doi: 10.1016/j.juro.2015.02.028. Epub 2015 Feb 10.","Chang SS","J Urol","2015","2015/04/22","","","10.1016/j.juro.2015.02.028"
"6483905","Epidemiology of bladder cancer","Bouffioux CR.","Prog Clin Biol Res. 1984;162A:11-25.","Bouffioux CR","Prog Clin Biol Res","1984","1984/01/01","","",""
"18472066","[Place of laparoscopic radical cystectomy in the treatment of invasive bladder urothelial carcinoma]","Lesur G, Rouprêt M.","Prog Urol. 2008 Mar;18(3):145-51. doi: 10.1016/j.purol.2007.08.001. Epub 2008 Apr 18.","Lesur G","Prog Urol","2008","2008/05/13","","","10.1016/j.purol.2007.08.001"
"31929567","Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504","Chen Q, Fu L.","PLoS One. 2020 Jan 13;15(1):e0227568. doi: 10.1371/journal.pone.0227568. eCollection 2020.","Chen Q","PLoS One","2020","2020/01/14","PMC6957147","","10.1371/journal.pone.0227568"
"6067880","Clinical experiences of bladder reconstruction using preserved bladder and gelatin sponge bladder in the case of bladder cancer","Tsuji I, Kuroda K, Fujieda J, Shiraishi Y, Kunishima K.","J Urol. 1967 Jul;98(1):91-2. doi: 10.1016/s0022-5347(17)62828-3.","Tsuji I","J Urol","1967","1967/07/01","","","10.1016/s0022-5347(17)62828-3"
"3903222","Elastase--does this enzyme play any role in bladder cancer invasion?","Nemoto S, Koiso K, Aoyagi K, Tojo S.","J Urol. 1985 Nov;134(5):996-8. doi: 10.1016/s0022-5347(17)47574-4.","Nemoto S","J Urol","1985","1985/11/01","","","10.1016/s0022-5347(17)47574-4"
"31297862","Depletion of NBR1 in urothelial carcinoma cells enhances rapamycin-induced apoptosis through impaired autophagy and mitochondrial dysfunction","Kim MJ, Hwang GY, Cho MJ, Chi BH, Park SI, Chang IH, Whang YM.","J Cell Biochem. 2019 Nov;120(11):19186-19201. doi: 10.1002/jcb.29248. Epub 2019 Jul 11.","Kim MJ","J Cell Biochem","2019","2019/07/13","","","10.1002/jcb.29248"
"17443281","Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy","Horikawa Y, Kumazawa T, Narita S, Inoue T, Yuasa T, Matsuura S, Nanjo H, Satoh S, Tsuchiya N, Habuchi T.","Int J Clin Oncol. 2007 Apr;12(2):131-6. doi: 10.1007/s10147-006-0637-7. Epub 2007 Apr 27.","Horikawa Y","Int J Clin Oncol","2007","2007/04/20","","","10.1007/s10147-006-0637-7"
"17641799","Molecular changes in superficial bladder cancer","Vrabie CD, Petrescu A, Waller M.","Rom J Morphol Embryol. 2007;48(2):131-8.","Vrabie CD","Rom J Morphol Embryol","2007","2007/07/21","","",""
"15593322","Three-dimensional ultrasonographic findings in bladder cancer","Huang WC, Yang SH, Yang JM.","Ultrasound Obstet Gynecol. 2005 Jan;25(1):92-4. doi: 10.1002/uog.1790.","Huang WC","Ultrasound Obstet Gynecol","2005","2004/12/14","","","10.1002/uog.1790"
"25894962","The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients","Liu S, Yang T, Na R, Hu M, Zhang L, Fu Y, Jiang H, Ding Q.","Int Urol Nephrol. 2015 Jun;47(6):951-8. doi: 10.1007/s11255-015-0980-6. Epub 2015 Apr 19.","Liu S","Int Urol Nephrol","2015","2015/04/21","","","10.1007/s11255-015-0980-6"
"25150308","Targeting HMGB1 inhibits bladder cancer cells bioactivity by lentivirus-mediated RNA interference","Wang W, Zhu H, Zhang H, Zhang L, Ding Q, Jiang H.","Neoplasma. 2014;61(6):638-46. doi: 10.4149/neo_2014_079.","Wang W","Neoplasma","2014","2014/08/24","","","10.4149/neo_2014_079"
"6640837","Intravesical chemotherapy in urinary bladder cancer","Edsmyr F, Anderson L, Esposti PL.","Cancer Chemother Pharmacol. 1983;11 Suppl:S67-8. doi: 10.1007/BF00256722.","Edsmyr F","Cancer Chemother Pharmacol","1983","1983/01/01","","","10.1007/BF00256722"
"24913152","Eosinophilia in routine blood samples as a biomarker for solid tumor development - A study based on the Copenhagen Primary Care Differential Count (CopDiff) Database","Andersen CL, Siersma VD, Hasselbalch HC, Lindegaard H, Vestergaard H, Felding P, de Fine Olivarius N, Bjerrum OW.","Acta Oncol. 2014 Sep;53(9):1245-50. doi: 10.3109/0284186X.2014.887857. Epub 2014 Mar 10.","Andersen CL","Acta Oncol","2014","2014/06/11","","","10.3109/0284186X.2014.887857"
"26117494","Urologic cancers in Korea","Koo KC, Lee KS, Chung BH.","Jpn J Clin Oncol. 2015 Sep;45(9):805-11. doi: 10.1093/jjco/hyv096. Epub 2015 Jun 27.","Koo KC","Jpn J Clin Oncol","2015","2015/06/29","","","10.1093/jjco/hyv096"
"9612689","Molecular genetic alterations of c-myc oncogene in superficial and locally advanced bladder cancer","Sardi I, Dal Canto M, Bartoletti R, Guazzelli R, Travaglini F, Montali E.","Eur Urol. 1998;33(4):424-30. doi: 10.1159/000019629.","Sardi I","Eur Urol","1998","1998/06/05","","","10.1159/000019629"
"2473571","[Endovascular therapy in locally disseminated bladder cancer]","Raĭkevich NP, Spirin VA, Ponukalin AN.","Vopr Onkol. 1989;35(6):711-4.","Raĭkevich NP","Vopr Onkol","1989","1989/01/01","","",""
"9211674","[BCG therapy of superficial bladder cancer. Current status of clinical aspects and research]","","Urologe A. 1993 Mar;32(2 [bcg-therap]):1-12.","","Urologe A","1993","1993/03/01","","",""
"442305","[Cryosurgical treatment of bladder cancer]","Goĭkhberg MI, Zaparin VK, Klimenko IA, Kinevskiĭ OF.","Urol Nefrol (Mosk). 1979 Mar-Apr;(2):24-7.","Goĭkhberg MI","Urol Nefrol (Mosk)","1979","1979/03/01","","",""
"25050759","Far from resolved: stromal cell-based iTRAQ research of muscle-invasive bladder cancer regarding heterogeneity","Liu PF, Wang YH, Cao YW, Jiang HP, Yang XC, Wang XS, Niu HT.","Oncol Rep. 2014 Oct;32(4):1489-96. doi: 10.3892/or.2014.3340. Epub 2014 Jul 18.","Liu PF","Oncol Rep","2014","2014/07/23","","","10.3892/or.2014.3340"
"15736422","Numerical aberrations of chromosomes 9 and 11 detected by FISH in Greek bladder cancer patients","Panani AD, Babanaraki A, Malianga E, Roussos Ch.","Anticancer Res. 2004 Nov-Dec;24(6):3857-61.","Panani AD","Anticancer Res","2004","2005/03/02","","",""
"31630869","Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancer","Voskuilen CS, Bosschieter J, van Werkhoven E, Hendricksen K, Vis AN, Witteveen T, Pieters BR, Burger M, Bex A, van der Poel HG, Moonen LM, Horenblas S, Nieuwenhuijzen JA, van Rhijn BWG.","Radiother Oncol. 2019 Dec;141:130-136. doi: 10.1016/j.radonc.2019.09.026. Epub 2019 Oct 17.","Voskuilen CS","Radiother Oncol","2019","2019/10/22","","","10.1016/j.radonc.2019.09.026"
"29699838","Perioperative and mid-term oncologic outcomes of robotic assisted radical cystectomy with totally intracorporeal neobladder: Results of a propensity score matched comparison with open cohort from a single-centre series","Simone G, Tuderti G, Misuraca L, Anceschi U, Ferriero M, Minisola F, Guaglianone S, Gallucci M.","Eur J Surg Oncol. 2018 Sep;44(9):1432-1438. doi: 10.1016/j.ejso.2018.04.006. Epub 2018 Apr 17.","Simone G","Eur J Surg Oncol","2018","2018/04/28","","","10.1016/j.ejso.2018.04.006"
"17507625","Prognostic effect of DNA aneuploidy from bladder washings in superficial bladder cancer","Puntoni M, Zanardi S, Branchi D, Bruno S, Curotto A, Varaldo M, Bruzzi P, Decensi A.","Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):979-83. doi: 10.1158/1055-9965.EPI-06-0538.","Puntoni M","Cancer Epidemiol Biomarkers Prev","2007","2007/05/18","","","10.1158/1055-9965.EPI-06-0538"
"27125965","Low awareness of risk factors among bladder cancer survivors: New evidence and a literature overview","Westhoff E, Maria de Oliveira-Neumayer J, Aben KK, Vrieling A, Kiemeney LA.","Eur J Cancer. 2016 Jun;60:136-45. doi: 10.1016/j.ejca.2016.03.071. Epub 2016 Apr 25.","Westhoff E","Eur J Cancer","2016","2016/04/30","","","10.1016/j.ejca.2016.03.071"
"24535583","Urological complications of illicit drug use","Skeldon SC, Goldenberg SL.","Nat Rev Urol. 2014 Mar;11(3):169-77. doi: 10.1038/nrurol.2014.22. Epub 2014 Feb 18.","Skeldon SC","Nat Rev Urol","2014","2014/02/19","","","10.1038/nrurol.2014.22"
"22954205","Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours","Olsson H, Hultman P, Rosell J, Jahnson S.","Scand J Urol. 2013 Jun;47(3):188-95. doi: 10.3109/00365599.2012.719539. Epub 2012 Sep 7.","Olsson H","Scand J Urol","2013","2012/09/08","","","10.3109/00365599.2012.719539"
"7165533","[Chronic cystitis in the aspect of its relationship with precancerous conditions]","Romanenko AM.","Arkh Patol. 1982;44(12):52-8.","Romanenko AM","Arkh Patol","1982","1982/01/01","","",""
"25245242","Bladder cancer: microscopic haematuria associated with increased risk","Fenner A.","Nat Rev Urol. 2014 Nov;11(11):606. doi: 10.1038/nrurol.2014.271. Epub 2014 Sep 23.","Fenner A","Nat Rev Urol","2014","2014/09/24","","","10.1038/nrurol.2014.271"
"16253165","[The molecular mechanism of PML in inducing apoptosis of bladder cancer cell line]","Li L, He DL, He H, Wang XY, Zhang LL, Luo Y, Nan XY.","Zhonghua Yi Xue Za Zhi. 2005 Jul 6;85(25):1766-9.","Li L","Zhonghua Yi Xue Za Zhi","2005","2005/10/29","","",""
"12855634","Microvessel density at presentation predicts subsequent muscle invasion in superficial bladder cancer","Goddard JC, Sutton CD, Furness PN, O'Byrne KJ, Kockelbergh RC.","Clin Cancer Res. 2003 Jul;9(7):2583-6.","Goddard JC","Clin Cancer Res","2003","2003/07/12","","",""
"7463915","[Treatment of invasive bladder cancer (author's transl)]","Moridono S.","Nihon Hinyokika Gakkai Zasshi. 1980 Oct;71(10):1152-6.","Moridono S","Nihon Hinyokika Gakkai Zasshi","1980","1980/10/01","","",""
"17280911","Nonurothelial cancer of the bladder","Abol-Enein H, Kava BR, Carmack AJ.","Urology. 2007 Jan;69(1 Suppl):93-104. doi: 10.1016/j.urology.2006.08.1107.","Abol-Enein H","Urology","2007","2007/02/07","","","10.1016/j.urology.2006.08.1107"
"3974078","Risk for bladder cancer. Psychological impact of notification","Hornsby JL, Sappington JT, Mongan P, Gullen WH, Bono SF, Altekruse E.","JAMA. 1985 Apr 5;253(13):1899-902.","Hornsby JL","JAMA","1985","1985/04/05","","",""
"24893613","Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion","Franco R, Zappavigna S, Gigantino V, Luce A, Cantile M, Cerrone M, Facchini G, Perdonà S, Pignata S, Di Lorenzo G, Chieffi S, Vitale G, De Sio M, Sgambato A, Botti G, Yousif AM, Novellino E, Grieco P, Caraglia M.","J Exp Clin Cancer Res. 2014 Jun 3;33(1):48. doi: 10.1186/1756-9966-33-48.","Franco R","J Exp Clin Cancer Res","2014","2014/06/05","PMC4061920","","10.1186/1756-9966-33-48"
"31171537","Urinary bladder mass with emphysematous cystitis: double whammy","Parmar KM, Sharma G, Rai T.","BMJ Case Rep. 2019 Jun 5;12(6):e230772. doi: 10.1136/bcr-2019-230772.","Parmar KM","BMJ Case Rep","2019","2019/06/08","PMC6557529","","10.1136/bcr-2019-230772"
"31851158","Bladder-sparing treatment of nonmetastatic muscle-invasive bladder cancer","Ericson KJ, Murthy PB, Bryk DJ, Ramkumar RR, Broughman JR, Khanna A, Mian OY, Campbell SC.","Clin Adv Hematol Oncol. 2019 Dec;17(12):697-707.","Ericson KJ","Clin Adv Hematol Oncol","2019","2019/12/19","","",""
"28717136","Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer","Patel KM, van der Vos KE, Smith CG, Mouliere F, Tsui D, Morris J, Chandrananda D, Marass F, van den Broek D, Neal DE, Gnanapragasam VJ, Forshew T, van Rhijn BW, Massie CE, Rosenfeld N, van der Heijden MS.","Sci Rep. 2017 Jul 17;7(1):5554. doi: 10.1038/s41598-017-05623-3.","Patel KM","Sci Rep","2017","2017/07/19","PMC5514073","","10.1038/s41598-017-05623-3"
"18262338","Polymorphisms in the H19 gene and the risk of bladder cancer","Verhaegh GW, Verkleij L, Vermeulen SH, den Heijer M, Witjes JA, Kiemeney LA.","Eur Urol. 2008 Nov;54(5):1118-26. doi: 10.1016/j.eururo.2008.01.060. Epub 2008 Feb 4.","Verhaegh GW","Eur Urol","2008","2008/02/12","","","10.1016/j.eururo.2008.01.060"
"17290403","Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study","Genkinger JM, De Vivo I, Stampfer MJ, Giovannucci E, Michaud DS.","Int J Cancer. 2007 May 15;120(10):2221-5. doi: 10.1002/ijc.22546.","Genkinger JM","Int J Cancer","2007","2007/02/10","","","10.1002/ijc.22546"
"29519561","The role of neural precursor cell-expressed developmentally down-regulated protein 9 in predicting bacillus Calmette-Guerin response in nonmuscle invasive bladder cancer","El-Babouly IM, Desoky EAE, El Sayed D, Ali MM, Harb OA, Ragab A, Sakr AM, Fawzi AM, Salama NM, Samaha II.","Urol Oncol. 2018 May;36(5):242.e9-242.e14. doi: 10.1016/j.urolonc.2018.02.002. Epub 2018 Mar 5.","El-Babouly IM","Urol Oncol","2018","2018/03/10","","","10.1016/j.urolonc.2018.02.002"
"18704627","p53 and chemosensitivity in bladder cancer","Nishiyama H, Watanabe J, Ogawa O.","Int J Clin Oncol. 2008 Aug;13(4):282-6. doi: 10.1007/s10147-008-0815-x. Epub 2008 Aug 15.","Nishiyama H","Int J Clin Oncol","2008","2008/08/16","","","10.1007/s10147-008-0815-x"
"28065960","Urinary bladder cancer in adults: a histopathological experience from Madinah, Saudi Arabia","El-Siddig AA, Albasri AM, Hussainy AS, Alhujaily AS.","J Pak Med Assoc. 2017 Jan;67(1):83-86.","El-Siddig AA","J Pak Med Assoc","2017","2017/01/10","","",""
"24852426","Evaluation of urinary XIAP as a diagnostic biomarker of carcinoma of urinary bladder","Srivastava AK, Singh PK, Singh D, Dalela D, Rath SK, Goel MM, Bhatt ML.","Tumour Biol. 2014 Aug;35(8):8243-8. doi: 10.1007/s13277-014-2026-6. Epub 2014 May 23.","Srivastava AK","Tumour Biol","2014","2014/05/24","","","10.1007/s13277-014-2026-6"
"12597948","Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer","Shariat SF, Kim J, Nguyen C, Wheeler TM, Lerner SP, Slawin KM.","Urology. 2003 Feb;61(2):359-64. doi: 10.1016/s0090-4295(02)02253-7.","Shariat SF","Urology","2003","2003/02/25","","","10.1016/s0090-4295(02)02253-7"
"26943643","The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy","Parker WP, Ho PL, Boorjian SA, Melquist JJ, Thapa P, Holzbeierlein JM, Frank I, Kamat AM, Lee EK.","World J Urol. 2016 Nov;34(11):1561-1566. doi: 10.1007/s00345-016-1801-y. Epub 2016 Mar 4.","Parker WP","World J Urol","2016","2016/03/05","","","10.1007/s00345-016-1801-y"
"17119258","Carcinogen exposure and epigenetic silencing in bladder cancer","Marsit CJ, Karagas MR, Schned A, Kelsey KT.","Ann N Y Acad Sci. 2006 Sep;1076:810-21. doi: 10.1196/annals.1371.031.","Marsit CJ","Ann N Y Acad Sci","2006","2006/11/23","","","10.1196/annals.1371.031"
"3773123","Cystoprostatectomy for bladder cancer with preservation of potency and no stoma","Javadpour N.","J Urol. 1986 Dec;136(6):1377. doi: 10.1016/s0022-5347(17)45342-0.","Javadpour N","J Urol","1986","1986/12/01","","","10.1016/s0022-5347(17)45342-0"
"26032095","Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy","Zhang GM, Zhu Y, Luo L, Wan FN, Zhu YP, Sun LJ, Ye DW.","Tumour Biol. 2015 Nov;36(11):8537-43. doi: 10.1007/s13277-015-3613-x. Epub 2015 Jun 2.","Zhang GM","Tumour Biol","2015","2015/06/03","","","10.1007/s13277-015-3613-x"
"30061255","Partial Bladder Boost Using Lipiodol Marking During Image-guided Radiotherapy for Bladder Cancer","Nakamura R, Kakuhara H, Kikuchi K, Segawa T, Oikawa H, Iwasaki K, Obara W, Ariga H.","Anticancer Res. 2018 Aug;38(8):4827-4831. doi: 10.21873/anticanres.12793.","Nakamura R","Anticancer Res","2018","2018/08/01","","","10.21873/anticanres.12793"
"23011100","Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study","Koie T, Ohyama C, Hashimoto Y, Hatakeyama S, Yamamoto H, Yoneyama T, Kamimura N.","Int J Clin Oncol. 2013 Aug;18(4):724-30. doi: 10.1007/s10147-012-0447-z. Epub 2012 Jul 19.","Koie T","Int J Clin Oncol","2013","2012/09/27","","","10.1007/s10147-012-0447-z"
"32318904","Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study","Yao Z, Jiang Y, Zhu X, Wu B, Bai S.","Int J Clin Oncol. 2020 Jul;25(7):1377-1384. doi: 10.1007/s10147-020-01679-w. Epub 2020 Apr 21.","Yao Z","Int J Clin Oncol","2020","2020/04/23","","","10.1007/s10147-020-01679-w"
"3856989","Urine eosinophilia in bladder cancer","Lowe D, Fletcher CD, Carpenter G.","Acta Cytol. 1985 Mar-Apr;29(2):187.","Lowe D","Acta Cytol","1985","1985/03/01","","",""
"28402146","Long-term floating control-released intravesical preparation of 5-fluorouracil for the local treatment of bladder cancer","Wang LH, Shang L, Shan DY, Che X.","Drug Dev Ind Pharm. 2017 Aug;43(8):1343-1350. doi: 10.1080/03639045.2017.1318898. Epub 2017 Apr 27.","Wang LH","Drug Dev Ind Pharm","2017","2017/04/13","","","10.1080/03639045.2017.1318898"
"27517637","Combination immunotherapy in genitourinary malignancies","Hoffman-Censits J, Wilde L.","Curr Opin Urol. 2016 Nov;26(6):523-8. doi: 10.1097/MOU.0000000000000336.","Hoffman-Censits J","Curr Opin Urol","2016","2016/08/13","","","10.1097/MOU.0000000000000336"
"30181416","NCCN Guidelines Insights: Bladder Cancer, Version 5.2018","Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Downs TM, Efstathiou JA, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Petrylak DP, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Tward J, Wile G, Johnson-Chilla A, Dwyer MA, Gurski LA.","J Natl Compr Canc Netw. 2018 Sep;16(9):1041-1053. doi: 10.6004/jnccn.2018.0072.","Flaig TW","J Natl Compr Canc Netw","2018","2018/09/06","","","10.6004/jnccn.2018.0072"
"21074202","Usefulness of the Spanish Urological Club for Oncological Treatment scoring model to predict nonmuscle invasive bladder cancer recurrence in patients treated with intravesical bacillus Calmette-Guérin plus interferon-α","Rosevear HM, Lightfoot AJ, Nepple KG, O'Donnell MA.","J Urol. 2011 Jan;185(1):67-71. doi: 10.1016/j.juro.2010.08.083. Epub 2010 Nov 12.","Rosevear HM","J Urol","2011","2010/11/16","","","10.1016/j.juro.2010.08.083"
"15126879","Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer kotcc-1 cells","Miyake H, Eto H, Hara I, So A, Li D, Gleave ME.","J Urol. 2004 Jun;171(6 Pt 1):2477-81. doi: 10.1097/01.ju.0000118382.89456.f7.","Miyake H","J Urol","2004","2004/05/06","","","10.1097/01.ju.0000118382.89456.f7"
"26874973","Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer","Giunchi F, Panzacchi R, Capizzi E, Schiavina R, Brunocilla E, Martorana G, D'Errico A, Fiorentino M.","Clin Genitourin Cancer. 2016 Aug;14(4):e307-12. doi: 10.1016/j.clgc.2016.01.002. Epub 2016 Jan 22.","Giunchi F","Clin Genitourin Cancer","2016","2016/02/15","","","10.1016/j.clgc.2016.01.002"
"9181927","[Levels of monokines in peripheral monocytes in patients with superficial tumors of the bladder treated with BCG. Results after 1- and 3-year follow-up]","Iantorno R, Nicolai M, Menna C, Tenaglia R.","Arch Ital Urol Androl. 1997 Feb;69 Suppl 1:69-70.","Iantorno R","Arch Ital Urol Androl","1997","1997/02/01","","",""
"30269132","The Optimal Timing of Restaging Resection before Introduction of Bacillus Calmette-Guerin Immunotherapy in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer","Krajewski W, Zdrojowy R, Dembowski J, Poletajew S, Wróbel M, Łuczak M, Tukiendorf A, Kolodziej A.","Urol Int. 2019;102(1):60-68. doi: 10.1159/000491642. Epub 2018 Sep 28.","Krajewski W","Urol Int","2019","2018/10/01","","","10.1159/000491642"
"2912021","Neoadjuvant or definitive alternating chemotherapy and radiotherapy for infiltrating bladder cancer","Venturini M, Merlano M, Michelotti A, Martorana G, Curotto A, Scarpati D, Orsatti M, Giuliani L, Rosso R.","Am J Clin Oncol. 1989 Feb;12(1):63-7. doi: 10.1097/00000421-198902000-00015.","Venturini M","Am J Clin Oncol","1989","1989/02/01","","","10.1097/00000421-198902000-00015"
"9679940","Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer","Droller MJ.","J Urol. 1998 Aug;160(2):619-20.","Droller MJ","J Urol","1998","1998/07/29","","",""
"8689512","Bladder cancer producing granulocyte colony-stimulating factor: a case report","Nishimura K, Higashino M, Hara T, Oka T.","Int J Urol. 1996 Mar;3(2):152-4. doi: 10.1111/j.1442-2042.1996.tb00502.x.","Nishimura K","Int J Urol","1996","1996/03/01","","","10.1111/j.1442-2042.1996.tb00502.x"
"31036156","Epigenetic regulation of mammalian Hedgehog signaling to the stroma determines the molecular subtype of bladder cancer","Kim S, Kim Y, Kong J, Kim E, Choi JH, Yuk HD, Lee H, Kim HR, Lee KH, Kang M, Roe JS, Moon KC, Kim S, Ku JH, Shin K.","Elife. 2019 Apr 30;8:e43024. doi: 10.7554/eLife.43024.","Kim S","Elife","2019","2019/05/01","PMC6597241","","10.7554/eLife.43024"
"30168296","Optical sensory arrays for the detection of urinary bladder cancer-related volatile organic compounds","Zhu S, Corsetti S, Wang Q, Li C, Huang Z, Nabi G.","J Biophotonics. 2019 Oct;12(10):e201800165. doi: 10.1002/jbio.201800165. Epub 2019 Jul 28.","Zhu S","J Biophotonics","2019","2018/09/01","PMC7065633","","10.1002/jbio.201800165"
"5836781","[Combination of surgical treatment with implantation of granules of Au-198 in cancer of the urinary bladder]","Paces V, Hlasivec Z, Skrland B.","Rozhl Chir. 1965 Jun;44(6):413-7.","Paces V","Rozhl Chir","1965","1965/06/01","","",""
"7658531","Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: a pathological review of female cystectomy specimens","Stein JP, Cote RJ, Freeman JA, Esrig D, Elmajian DA, Groshen S, Skinner EC, Boyd SD, Lieskovsky G, Skinner DG.","J Urol. 1995 Oct;154(4):1329-33.","Stein JP","J Urol","1995","1995/10/01","","",""
"24669804","Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer","Juang T, Stauffer PR, Craciunescu OA, Maccarini PF, Yuan Y, Das SK, Dewhirst MW, Inman BA, Vujaskovic Z.","Int J Hyperthermia. 2014 May;30(3):176-83. doi: 10.3109/02656736.2014.898338. Epub 2014 Mar 26.","Juang T","Int J Hyperthermia","2014","2014/03/28","PMC4157366","NIHMS622206","10.3109/02656736.2014.898338"
"10398139","Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer","Wagner U, Süess K, Luginbühl T, Schmid U, Ackermann D, Zellweger T, Maurer R, Alund G, Knönagel H, Rist M, Jordan P, Moch H, Mihatsch MJ, Gasser TC, Sauter G.","J Pathol. 1999 May;188(1):44-50. doi: 10.1002/(SICI)1096-9896(199905)188:1<44::AID-PATH320>3.0.CO;2-Q.","Wagner U","J Pathol","1999","1999/07/09","","","10.1002/(SICI)1096-9896(199905)188:1<44::AID-PATH320>3.0.CO;2-Q"
"23176070","Purinergic signalling in the lower urinary tract","Burnstock G.","Acta Physiol (Oxf). 2013 Jan;207(1):40-52. doi: 10.1111/apha.12012. Epub 2012 Nov 26.","Burnstock G","Acta Physiol (Oxf)","2013","2012/11/27","","","10.1111/apha.12012"
"30811784","Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients","Kijima T, Tanaka H, Koga F, Masuda H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.","BJU Int. 2019 Aug;124(2):242-250. doi: 10.1111/bju.14736. Epub 2019 Apr 3.","Kijima T","BJU Int","2019","2019/02/28","","","10.1111/bju.14736"
"27973635","α(v)β(3)-Isoform specific erbium complexes highly specific for bladder cancer imaging and photodynamic therapy","Zhou Y, Chan CF, Kwong DW, Law GL, Cobb S, Wong WK, Wong KL.","Chem Commun (Camb). 2017 Jan 3;53(3):557-560. doi: 10.1039/c6cc09246b.","Zhou Y","Chem Commun (Camb)","2017","2016/12/16","","","10.1039/c6cc09246b"
"30642841","Serum Metabolic Profiling Identified a Distinct Metabolic Signature in Bladder Cancer Smokers: A Key Metabolic Enzyme Associated with Patient Survival","Amara CS, Ambati CR, Vantaku V, Badrajee Piyarathna DW, Donepudi SR, Ravi SS, Arnold JM, Putluri V, Chatta G, Guru KA, Badr H, Terris MK, Bollag RJ, Sreekumar A, Apolo AB, Putluri N.","Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):770-781. doi: 10.1158/1055-9965.EPI-18-0936. Epub 2019 Jan 14.","Amara CS","Cancer Epidemiol Biomarkers Prev","2019","2019/01/16","PMC6449217","NIHMS1518034","10.1158/1055-9965.EPI-18-0936"
"27466910","Arsenic Levels in Drinking Water Linked to Bladder Cancer in New England","Zolot J.","Am J Nurs. 2016 Aug;116(8):16. doi: 10.1097/01.NAJ.0000490158.36747.67.","Zolot J","Am J Nurs","2016","2016/07/29","","","10.1097/01.NAJ.0000490158.36747.67"
"3712629","Intestinal strictures complicating preoperative radiation therapy followed by radical cystectomy","Hillyard RW Jr, el-Mahdi AM, Schellhammer PF.","J Urol. 1986 Jul;136(1):98-101. doi: 10.1016/s0022-5347(17)44744-6.","Hillyard RW Jr","J Urol","1986","1986/07/01","","","10.1016/s0022-5347(17)44744-6"
"3609087","Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma","Pagano F, Garbeglio A, Milani C, Bassi P, Pegoraro V.","Eur Urol. 1987;13(3):145-9.","Pagano F","Eur Urol","1987","1987/01/01","","",""
"11069404","The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer","Yamamoto Y, Nasu Y, Saika T, Akaeda T, Tsushima T, Kumon H.","BJU Int. 2000 Nov;86(7):802-4. doi: 10.1046/j.1464-410x.2000.00911.x.","Yamamoto Y","BJU Int","2000","2000/11/09","","","10.1046/j.1464-410x.2000.00911.x"
"31991242","The top 100 most cited manuscripts in bladder cancer: A bibliometric analysis (review article)","Mainwaring A, Bullock N, Ellul T, Hughes O, Featherstone J.","Int J Surg. 2020 Mar;75:130-138. doi: 10.1016/j.ijsu.2020.01.128. Epub 2020 Jan 25.","Mainwaring A","Int J Surg","2020","2020/01/29","","","10.1016/j.ijsu.2020.01.128"
"17082940","Bladder-sparing approaches to invasive disease","Efstathiou JA, Zietman AL, Kaufman DS, Heney NM, Coen JJ, Shipley WU.","World J Urol. 2006 Nov;24(5):517-29. doi: 10.1007/s00345-006-0114-y.","Efstathiou JA","World J Urol","2006","2006/11/04","","","10.1007/s00345-006-0114-y"
"18898258","Infiltrating carcinoma of the bladder; curability by segmental resection","JEWETT HJ, CASON JF.","South Med J. 1948 Feb;41(2):158-62. doi: 10.1097/00007611-194802000-00013.","JEWETT HJ","South Med J","1948","1948/02/01","","","10.1097/00007611-194802000-00013"
"14665865","A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder","Koga H, Kuroiwa K, Yamaguchi A, Osada Y, Tsuneyoshi M, Naito S.","J Urol. 2004 Jan;171(1):153-7. doi: 10.1097/01.ju.0000100386.07370.0a.","Koga H","J Urol","2004","2003/12/11","","","10.1097/01.ju.0000100386.07370.0a"
"29540343","Genome-Wide DNA Methylation in Prediagnostic Blood and Bladder Cancer Risk in the Women's Health Initiative","Jordahl KM, Randolph TW, Song X, Sather CL, Tinker LF, Phipps AI, Kelsey KT, White E, Bhatti P.","Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):689-695. doi: 10.1158/1055-9965.EPI-17-0951. Epub 2018 Mar 14.","Jordahl KM","Cancer Epidemiol Biomarkers Prev","2018","2018/03/16","PMC5984694","NIHMS952184","10.1158/1055-9965.EPI-17-0951"
"29171098","Can bladder preservation therapy come to the center stage?","Inamoto T, Ibuki N, Komura K, Juri H, Yamamoto K, Yamamoto K, Fujita K, Nonomura N, Narumi Y, Azuma H.","Int J Urol. 2018 Feb;25(2):134-140. doi: 10.1111/iju.13495. Epub 2017 Nov 23.","Inamoto T","Int J Urol","2018","2017/11/25","","","10.1111/iju.13495"
"8709371","Transforming growth factors-beta 1 and beta 2 in serum and urine from patients with bladder carcinoma","Eder IE, Stenzl A, Hobisch A, Cronauer MV, Bartsch G, Klocker H.","J Urol. 1996 Sep;156(3):953-7.","Eder IE","J Urol","1996","1996/09/01","","",""
"26850780","Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution","Moschini M, Bianchi M, Rossi MS, Dell׳Oglio P, Gandaglia G, Fossati N, Mattei A, Damiano R, Shariat SF, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A.","Urol Oncol. 2016 Jun;34(6):256.e7-256.e13. doi: 10.1016/j.urolonc.2015.12.016. Epub 2016 Feb 2.","Moschini M","Urol Oncol","2016","2016/02/07","","","10.1016/j.urolonc.2015.12.016"
"29678899","ZFAS1 functions as an oncogenic long non-coding RNA in bladder cancer","Yang H, Li G, Cheng B, Jiang R.","Biosci Rep. 2018 May 15;38(3):BSR20180475. doi: 10.1042/BSR20180475. Print 2018 May 15.","Yang H","Biosci Rep","2018","2018/04/22","PMC6048211","","10.1042/BSR20180475"
"16858999","[Design of automatic radiotherapy of locally spread cancer of the urinary bladder]","Kaprin AD, Pan'shin GA, Titova VA, Ivashin AV, Shafir II, Belle TS.","Urologiia. 1999 Nov-Dec;(6):20-6.","Kaprin AD","Urologiia","1999","2006/07/25","","",""
"30977157","The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells","Ye X, Guo J, Zhang H, Meng Q, Ma Y, Lin R, Yi X, Lu H, Bai X, Cheng J.","J Cell Biochem. 2019 Aug;120(8):13841-13852. doi: 10.1002/jcb.28657. Epub 2019 Apr 11.","Ye X","J Cell Biochem","2019","2019/04/13","","","10.1002/jcb.28657"
"31354888","KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo","Tian DW, Wu ZL, Jiang LM, Gao J, Wu CL, Hu HL.","Dis Markers. 2019 Jul 3;2019:4824902. doi: 10.1155/2019/4824902. eCollection 2019.","Tian DW","Dis Markers","2019","2019/07/30","PMC6636440","","10.1155/2019/4824902"
"6444585","Chemotherapy for bladder cancer with neocarzinostatin: evaluation of systemic administration","Sakamoto S, Ogata J, Ikegami K, Maeda H.","Eur J Cancer. 1980 Jan;16(1):103-13. doi: 10.1016/0014-2964(80)90115-2.","Sakamoto S","Eur J Cancer","1980","1980/01/01","","","10.1016/0014-2964(80)90115-2"
"24058522","Therapeutic outcome of fluorescence cystoscopy guided transurethral resection in patients with non-muscle invasive bladder cancer: a meta-analysis of randomized controlled trials","Yuan H, Qiu J, Liu L, Zheng S, Yang L, Liu Z, Pu C, Li J, Wei Q, Han P.","PLoS One. 2013 Sep 13;8(9):e74142. doi: 10.1371/journal.pone.0074142. eCollection 2013.","Yuan H","PLoS One","2013","2013/09/24","PMC3772837","","10.1371/journal.pone.0074142"
"7411712","Transitional cell carcinoma of the bladder in patients with renal pelvic and ureteral cancer","Kakizoe T, Fujita J, Murase T, Matsumoto K, Kishi K.","J Urol. 1980 Jul;124(1):17-9. doi: 10.1016/s0022-5347(17)55269-6.","Kakizoe T","J Urol","1980","1980/07/01","","","10.1016/s0022-5347(17)55269-6"
"25160608","Long-term outcomes in treatment of invasive bladder cancer with concomitant boost and accelerated hyperfractionated radiation therapy","Canyilmaz E, Yavuz MN, Serdar L, Uslu GH, Zengin AY, Aynaci O, Haciislamoglu E, Bahat Z, Yoney A.","Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):562-9. doi: 10.1016/j.ijrobp.2014.06.055. Epub 2014 Aug 23.","Canyilmaz E","Int J Radiat Oncol Biol Phys","2014","2014/08/28","","","10.1016/j.ijrobp.2014.06.055"
"29730950","Emerging intravesical drugs for the treatment of non muscle-invasive bladder cancer","Crijnen J, De Reijke TM.","Expert Opin Emerg Drugs. 2018 Jun;23(2):135-147. doi: 10.1080/14728214.2018.1474201. Epub 2018 May 16.","Crijnen J","Expert Opin Emerg Drugs","2018","2018/05/08","","","10.1080/14728214.2018.1474201"
"1984084","Enhancing effect of partial cystectomy on rat urinary bladder carcinogenesis","Tsujihashi H, Nakanishi A, Matsuda H, Uejima S, Kurita T.","J Urol. 1991 Jan;145(1):168-70. doi: 10.1016/s0022-5347(17)38283-6.","Tsujihashi H","J Urol","1991","1991/01/01","","","10.1016/s0022-5347(17)38283-6"
"26118200","Improved Target Cell Selection and Counting Method for UroVysion Fluorescence in Situ Hybridization","Hattori S, Kikuchi A, Sawamura T, Daimaru O, Horie M, Deguchi T.","Clin Lab. 2015;61(5-6):637-42. doi: 10.7754/clin.lab.2014.140903.","Hattori S","Clin Lab","2015","2015/06/30","","","10.7754/clin.lab.2014.140903"
"22951004","Scrotal metastasis from a nonmuscle-infiltrative bladder cancer: a surprising clinical evolution","Nouhaud FX, Di Fiore F, Noël N, Gobet F, Pfister C.","Urology. 2012 Oct;80(4):e37-8. doi: 10.1016/j.urology.2012.06.029. Epub 2012 Aug 28.","Nouhaud FX","Urology","2012","2012/09/07","","","10.1016/j.urology.2012.06.029"
"16217396","Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro","Ratliff TL.","J Urol. 2005 Nov;174(5):2065. doi: 10.1097/01.ju.0000183078.11059.00.","Ratliff TL","J Urol","2005","2005/10/12","","","10.1097/01.ju.0000183078.11059.00"
"4692375","The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer","Dretler SP, Ragsdale BD, Leadbetter WF.","J Urol. 1973 Mar;109(3):414-6. doi: 10.1016/s0022-5347(17)60438-5.","Dretler SP","J Urol","1973","1973/03/01","","","10.1016/s0022-5347(17)60438-5"
"22313616","Prognostic significance of Bacillus Calmette-Guérin failure classification in non-muscle-invasive bladder cancer","Shirakawa H, Kikuchi E, Tanaka N, Matsumoto K, Miyajima A, Nakamura S, Oya M.","BJU Int. 2012 Sep;110(6 Pt B):E216-21. doi: 10.1111/j.1464-410X.2011.10894.x. Epub 2012 Feb 7.","Shirakawa H","BJU Int","2012","2012/02/09","","","10.1111/j.1464-410X.2011.10894.x"
"1433540","Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group","Prout GR Jr, Barton BA, Griffin PP, Friedell GH.","J Urol. 1992 Nov;148(5):1413-9. doi: 10.1016/s0022-5347(17)36924-0.","Prout GR Jr","J Urol","1992","1992/11/11","","","10.1016/s0022-5347(17)36924-0"
"9310788","[Treatment outcome of radical cystectomy during a 10-year period (June 1984-September 1994) at Department of Urology, Fukui Medical School]","Saikawa S, Kanamaru H, Akino H, Nishibuchi S, Isomatsu Y, Muranaka K, Kanimoto Y, Okada K.","Hinyokika Kiyo. 1997 Aug;43(8):605-10.","Saikawa S","Hinyokika Kiyo","1997","1997/08/01","","",""
"15368130","[Experimental investigations of the optimal therapy of systemic BCG infection in vivo]","Jurczok A, Zacharias M, Böhle A, Fornara P, Jocham D.","Aktuelle Urol. 2004 Sep;35(5):406-12. doi: 10.1055/s-2004-818541.","Jurczok A","Aktuelle Urol","2004","2004/09/16","","","10.1055/s-2004-818541"
"12544349","Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk","Zhao H, Grossman HB, Spitz MR, Lerner SP, Zhang K, Wu X.","J Urol. 2003 Feb;169(2):714-7. doi: 10.1097/01.ju.0000036380.10325.2a.","Zhao H","J Urol","2003","2003/01/25","","","10.1097/01.ju.0000036380.10325.2a"
"16516037","Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer","Decobert M, Larue H, Bergeron A, Harel F, Pfister C, Rousseau F, Lacombe L, Fradet Y.","J Urol. 2006 Apr;175(4):1506-11. doi: 10.1016/S0022-5347(05)00653-1.","Decobert M","J Urol","2006","2006/03/07","","","10.1016/S0022-5347(05)00653-1"
"19287953","Progressive increase of genetic alteration in urinary bladder cancer by combined allelotyping analysis and comparative genomic hybridization","Chan MW, Hui AB, Yip SK, Ng CF, Lo KW, Tong JH, Chan AW, Cheung HY, Wong WS, Chan PS, Lai FM, To KF.","Int J Oncol. 2009 Apr;34(4):963-70. doi: 10.3892/ijo_00000222.","Chan MW","Int J Oncol","2009","2009/03/17","","","10.3892/ijo_00000222"
"9461004","High expression of Wnt7b in human superficial bladder cancer vs invasive bladder cancer","Bui TD, O'Brien T, Crew J, Cranston D, Harris AL.","Br J Cancer. 1998;77(2):319-24. doi: 10.1038/bjc.1998.49.","Bui TD","Br J Cancer","1998","1998/02/14","PMC2151239","","10.1038/bjc.1998.49"
"27862976","Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer","Chen X, Gu P, Xie R, Han J, Liu H, Wang B, Xie W, Xie W, Zhong G, Chen C, Xie S, Jiang N, Lin T, Huang J.","J Cell Mol Med. 2017 Jul;21(7):1266-1279. doi: 10.1111/jcmm.12999. Epub 2016 Nov 10.","Chen X","J Cell Mol Med","2017","2016/11/19","PMC5487918","","10.1111/jcmm.12999"
"9076471","Abnormal c-myc oncogene DNA methylation in human bladder cancer: possible role in tumor progression","Sardi I, Dal Canto M, Bartoletti R, Montali E.","Eur Urol. 1997;31(2):224-30. doi: 10.1159/000474455.","Sardi I","Eur Urol","1997","1997/01/01","","","10.1159/000474455"
"31100250","Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients","Psutka SP, Barocas DA, Catto JWF, Gore JL, Lee CT, Morgan TM, Master VA, Necchi A, Rouprêt M, Boorjian SA.","Eur Urol Oncol. 2018 Sep;1(4):292-304. doi: 10.1016/j.euo.2018.05.010. Epub 2018 Jun 19.","Psutka SP","Eur Urol Oncol","2018","2019/05/18","","","10.1016/j.euo.2018.05.010"
"18898744","Papillary carcinoma of a bladder diverticulum treated by transurethral resection","MADISON BB.","J Urol. 1948 Jan;59(1):42. doi: 10.1016/s0022-5347(17)69340-6.","MADISON BB","J Urol","1948","1948/01/01","","","10.1016/s0022-5347(17)69340-6"
"28184944","Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network","Li W, Liu J, Zou D, Cai X, Wang J, Wang J, Zhu L, Zhao L, Ou R, Xu Y.","Oncol Rep. 2017 Mar;37(3):1461-1468. doi: 10.3892/or.2017.5433. Epub 2017 Feb 7.","Li W","Oncol Rep","2017","2017/02/11","","","10.3892/or.2017.5433"
"27044355","Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer","Takayama T, Kubo T, Morikawa A, Morita T, Nagano O, Saya H.","Med Oncol. 2016 May;33(5):45. doi: 10.1007/s12032-016-0760-x. Epub 2016 Apr 4.","Takayama T","Med Oncol","2016","2016/04/06","","","10.1007/s12032-016-0760-x"
"4585835","Low mortality cystectomy in bladder cancer","Schoenberg HW, Gregory JG, Murphy JJ.","J Urol. 1973 Dec;110(6):671-4. doi: 10.1016/s0022-5347(17)60311-2.","Schoenberg HW","J Urol","1973","1973/12/01","","","10.1016/s0022-5347(17)60311-2"
"18653384","Long-term follow up of enteric bladder augmentations: the risk for malignancy","Husmann DA, Rathbun SR.","J Pediatr Urol. 2008 Oct;4(5):381-5; discussion 386. doi: 10.1016/j.jpurol.2008.06.003. Epub 2008 Jul 23.","Husmann DA","J Pediatr Urol","2008","2008/07/26","","","10.1016/j.jpurol.2008.06.003"
"11271984","Maintenance therapy for superficial bladder cancer","Baselli EC, Greenberg RE.","Oncology (Williston Park). 2001 Jan;15(1):85-8; discussion 88-91.","Baselli EC","Oncology (Williston Park)","2001","2001/03/29","","",""
"18257856","Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma","Hutterer GC, Karakiewicz PI, Zippe C, Lüdecke G, Boman H, Sanchez-Carbayo M, Casella R, Mian C, Friedrich MG, Eissa S, Akaza H, Serretta V, Hedelin H, Rupesh R, Miyanaga N, Sagalowsky AI, Perrotte P, Lotan Y, Marberger MJ, Shariat SF.","BJU Int. 2008 Mar;101(5):561-5. doi: 10.1111/j.1464-410X.2007.07352.x.","Hutterer GC","BJU Int","2008","2008/02/09","","","10.1111/j.1464-410X.2007.07352.x"
"31781939","Variant Histology in Bladder Cancer-Current Understanding of Pathologic Subtypes","Aron M.","Curr Urol Rep. 2019 Nov 28;20(12):80. doi: 10.1007/s11934-019-0949-6.","Aron M","Curr Urol Rep","2019","2019/11/30","","","10.1007/s11934-019-0949-6"
"19913883","Long-term outcome of patients with a negative work-up for asymptomatic microhematuria","Madeb R, Golijanin D, Knopf J, Davis M, Feng C, Fender A, Stephenson L, Messing EM.","Urology. 2010 Jan;75(1):20-5. doi: 10.1016/j.urology.2009.06.107. Epub 2009 Nov 13.","Madeb R","Urology","2010","2009/11/17","","","10.1016/j.urology.2009.06.107"
"23926174","Age, tumour stage, and preoperative serum albumin level are independent predictors of mortality after radical cystectomy for treatment of bladder cancer in Hong Kong Chinese","Chan ES, Yip SK, Hou SM, Cheung HY, Lee WM, Ng CF.","Hong Kong Med J. 2013 Oct;19(5):400-6. doi: 10.12809/hkmj133964. Epub 2013 Aug 8.","Chan ES","Hong Kong Med J","2013","2013/08/09","","","10.12809/hkmj133964"
"2046199","[Bladder replacement with sigmoid colon for bladder cancer]","Nishimura N, Suzu H, Yushita Y, Yamashita S, Kanetake H, Saito Y, Sakuragi T.","Nihon Hinyokika Gakkai Zasshi. 1991 Jan;82(1):41-6. doi: 10.5980/jpnjurol1989.82.41.","Nishimura N","Nihon Hinyokika Gakkai Zasshi","1991","1991/01/01","","","10.5980/jpnjurol1989.82.41"
"24947451","Response to editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading","Lodde M, Mian C, Mayr R, Comploj E, Trenti E, Melotti R, Campodonico F, Maffezzini M, Fritsche HM, Pycha A.","Int J Urol. 2014 Oct;21(10):974. doi: 10.1111/iju.12531. Epub 2014 Jun 19.","Lodde M","Int J Urol","2014","2014/06/21","","","10.1111/iju.12531"
"14528080","Favorable outcome of preoperative low dose chemoradiotherapy against muscle-invasive bladder cancer","Kageyama Y, Yokoyama M, Sakai Y, Saito K, Koga F, Yano M, Arai G, Hyochi N, Masuda H, Fujii Y, Kawakami S, Kobayashi T, Kihara K.","Am J Clin Oncol. 2003 Oct;26(5):504-7. doi: 10.1097/01.coc.0000037665.11701.22.","Kageyama Y","Am J Clin Oncol","2003","2003/10/07","","","10.1097/01.coc.0000037665.11701.22"
"3222487","Estimates of the risk of bladder tumor promotion by saccharin in rats","Gaylor DW, Kadlubar FF, West RW.","Regul Toxicol Pharmacol. 1988 Dec;8(4):467-70. doi: 10.1016/0273-2300(88)90046-3.","Gaylor DW","Regul Toxicol Pharmacol","1988","1988/12/01","","","10.1016/0273-2300(88)90046-3"
"5013536","Correlation of selective arteriography in the staging of bladder tumors","Winterberger AR, Kenny GM, Choi SH, Murphy GP.","Cancer. 1972 Feb;29(2):332-7. doi: 10.1002/1097-0142(197202)29:2<332::aid-cncr2820290211>3.0.co;2-e.","Winterberger AR","Cancer","1972","1972/02/01","","","10.1002/1097-0142(197202)29:2<332::aid-cncr2820290211>3.0.co;2-e"
"3903223","The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study","Meyers FJ, Palmer JM, Freiha FS, Harker EG, Shortliffe LD, Hannigan J, McWhirter K, Torti FM.","J Urol. 1985 Dec;134(6):1118-21. doi: 10.1016/s0022-5347(17)47651-8.","Meyers FJ","J Urol","1985","1985/12/01","","","10.1016/s0022-5347(17)47651-8"
"9183630","Establishment and characterization of two human bladder cancer cell lines","Naito S, Kotoh S, Koga H, Hasegawa S, Yamasaki T, Noma H, Kumazawa J.","Hum Cell. 1996 Mar;9(1):49-56.","Naito S","Hum Cell","1996","1996/03/01","","",""
"10678025","[Diagnostic value of CD44 splice variants in urine exfoliated cells of bladder cancer]","Wu Z, Zhang Y, Liu D.","Zhonghua Wai Ke Za Zhi. 1997 Sep;35(9):533-5.","Wu Z","Zhonghua Wai Ke Za Zhi","1997","2000/03/04","","",""
"12397652","A new method of implanting orthotopic rat bladder tumor for experimental therapies","Bisson JF, Parache RM, Droulle P, Notter D, Vigneron C, Guillemin F.","Int J Cancer. 2002 Nov 20;102(3):280-5. doi: 10.1002/ijc.10595.","Bisson JF","Int J Cancer","2002","2002/10/25","","","10.1002/ijc.10595"
"22643704","Metastatic bladder cancer: anything new?","Calabrò F, Sternberg CN.","Curr Opin Support Palliat Care. 2012 Sep;6(3):304-9. doi: 10.1097/SPC.0b013e3283552d19.","Calabrò F","Curr Opin Support Palliat Care","2012","2012/05/31","","","10.1097/SPC.0b013e3283552d19"
"15117811","Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study","Lin J, Spitz MR, Wang Y, Schabath MB, Gorlov IP, Hernandez LM, Pillow PC, Grossman HB, Wu X.","Carcinogenesis. 2004 Sep;25(9):1639-47. doi: 10.1093/carcin/bgh175. Epub 2004 Apr 29.","Lin J","Carcinogenesis","2004","2004/05/01","","","10.1093/carcin/bgh175"
"16793197","Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy","Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, Lerner SP, Sagalowsky AI, Lotan Y.","Eur Urol. 2007 Jan;51(1):137-49; discussion 149-51. doi: 10.1016/j.eururo.2006.05.021. Epub 2006 Jun 8.","Shariat SF","Eur Urol","2007","2006/06/24","","","10.1016/j.eururo.2006.05.021"
"25706919","MicroRNA-214 suppresses oncogenesis and exerts impact on prognosis by targeting PDRG1 in bladder cancer","Wang J, Zhang X, Wang L, Yang Y, Dong Z, Wang H, Du L, Wang C.","PLoS One. 2015 Feb 23;10(2):e0118086. doi: 10.1371/journal.pone.0118086. eCollection 2015.","Wang J","PLoS One","2015","2015/02/24","PMC4338228","","10.1371/journal.pone.0118086"
"8174080","Nonrandom changes of chromosome 10 in bladder cancer. Detection by FISH to interphase nuclei","Wang MR, Perissel B, Taillandier J, Kémény JL, Fonck Y, Lautier A, Benkhalifa M, Malet P.","Cancer Genet Cytogenet. 1994 Mar;73(1):8-10. doi: 10.1016/0165-4608(94)90175-9.","Wang MR","Cancer Genet Cytogenet","1994","1994/03/01","","","10.1016/0165-4608(94)90175-9"
"20253833","Urachal cysts with malignant invasion of the bladder; three case reports","PRENTIS RJ.","Calif Med. 1947 Aug;67(2):103.","PRENTIS RJ","Calif Med","1947","2010/03/19","","",""
"22544645","The long-term outcome of treated high-risk nonmuscle-invasive bladder cancer: time to change treatment paradigm?","Thomas F, Rosario DJ, Rubin N, Goepel JR, Abbod MF, Catto JW.","Cancer. 2012 Nov 15;118(22):5525-34. doi: 10.1002/cncr.27587. Epub 2012 Apr 27.","Thomas F","Cancer","2012","2012/05/01","","","10.1002/cncr.27587"
"9373911","A histopathological mapping study of the urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in dogs","Okajima E, Ozono S, Yoshida K, Samma S, Momose H, Iwai A, Uemura H, Tabata S, Tsumatani K, Hirao Y, Tsunemi K.","Urol Res. 1997;25(5):315-23. doi: 10.1007/BF01294657.","Okajima E","Urol Res","1997","1997/01/01","","","10.1007/BF01294657"
"15928434","Association of parasitic infections and cancers","Khurana S, Dubey ML, Malla N.","Indian J Med Microbiol. 2005 Apr;23(2):74-9. doi: 10.4103/0255-0857.16044.","Khurana S","Indian J Med Microbiol","2005","2005/06/02","","","10.4103/0255-0857.16044"
"314579","Stage D squamous cancer of the bladder: report of a seven-year survival after cystectomy","Mackenzie AR, Scheinman HZ.","Mt Sinai J Med. 1979 Jul-Aug;46(4):408-10.","Mackenzie AR","Mt Sinai J Med","1979","1979/07/01","","",""
"7536461","Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization","Kallioniemi A, Kallioniemi OP, Citro G, Sauter G, DeVries S, Kerschmann R, Caroll P, Waldman F.","Genes Chromosomes Cancer. 1995 Mar;12(3):213-9. doi: 10.1002/gcc.2870120309.","Kallioniemi A","Genes Chromosomes Cancer","1995","1995/03/01","","","10.1002/gcc.2870120309"
"29169421","[miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway]","Li X, Han X, Yang J, Sun J, Wei P.","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 Oct;33(10):1360-1364.","Li X","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi","2017","2017/11/25","","",""
"24011266","Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection","Miyake M, Ross S, Lawton A, Chang M, Dai Y, Mengual L, Alcaraz A, Giacoia EG, Goodison S, Rosser CJ.","BMC Urol. 2013 Sep 5;13:42. doi: 10.1186/1471-2490-13-42.","Miyake M","BMC Urol","2013","2013/09/10","PMC3846766","","10.1186/1471-2490-13-42"
"10802362","Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program","Arias F, Domínguez MA, Martínez E, Illarramendi JJ, Miquelez S, Pascual I, Marcos M.","Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):373-8. doi: 10.1016/s0360-3016(00)00444-2.","Arias F","Int J Radiat Oncol Biol Phys","2000","2000/05/10","","","10.1016/s0360-3016(00)00444-2"
"16710030","Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?","Weiss C, Wolze C, Engehausen DG, Ott OJ, Krause FS, Schrott KM, Dunst J, Sauer R, Rödel C.","J Clin Oncol. 2006 May 20;24(15):2318-24. doi: 10.1200/JCO.2006.05.8149.","Weiss C","J Clin Oncol","2006","2006/05/20","","","10.1200/JCO.2006.05.8149"
"29174465","Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65","Choi W, McConkey D.","Eur Urol. 2018 Apr;73(4):e104-e105. doi: 10.1016/j.eururo.2017.11.003. Epub 2017 Nov 23.","Choi W","Eur Urol","2018","2017/11/28","","","10.1016/j.eururo.2017.11.003"
"22842680","Strategies to prevent progression of high-risk bladder cancer at initial diagnosis","Ku JH, Lerner SP.","Curr Opin Urol. 2012 Sep;22(5):405-14. doi: 10.1097/MOU.0b013e328356adff.","Ku JH","Curr Opin Urol","2012","2012/07/31","","","10.1097/MOU.0b013e328356adff"
"30606990","Suberoylanilide Hydroxamic Acid Can Re-sensitize a Cisplatin-Resistant Human Bladder Cancer","Ryu H, Jin H, Ho JN, Bae J, Lee E, Lee SE, Lee S.","Biol Pharm Bull. 2019;42(1):66-72. doi: 10.1248/bpb.b18-00545.","Ryu H","Biol Pharm Bull","2019","2019/01/05","","","10.1248/bpb.b18-00545"
"7946444","The value of three-dimensional radiotherapy planning in advanced carcinoma of the urinary bladder based on computed tomography","Larsen LE, Engelholm SA.","Acta Oncol. 1994;33(6):655-9. doi: 10.3109/02841869409121778.","Larsen LE","Acta Oncol","1994","1994/01/01","","","10.3109/02841869409121778"
"1514203","[Adjuvant and neoadjuvant therapy in bladder and prostatic cancer]","Goepel M, Otto T.","Urologe A. 1992 Jul;31(4):211-2.","Goepel M","Urologe A","1992","1992/07/01","","",""
"29576265","Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer","Sarfaty M, Hall PS, Chan KKW, Virik K, Leshno M, Gordon N, Moore A, Neiman V, Rosenbaum E, Goldstein DA.","Eur Urol. 2018 Jul;74(1):57-62. doi: 10.1016/j.eururo.2018.03.006. Epub 2018 Mar 22.","Sarfaty M","Eur Urol","2018","2018/03/27","","","10.1016/j.eururo.2018.03.006"
"1558806","A descriptive study of occupation and bladder cancer in England and Wales","Dolin PJ.","Br J Cancer. 1992 Mar;65(3):476-8. doi: 10.1038/bjc.1992.96.","Dolin PJ","Br J Cancer","1992","1992/03/01","PMC1977622","","10.1038/bjc.1992.96"
"8160317","[The results of the diversion of urine into a large-intestine reservoir]","Gotsadze DT, Pirtskhalashvili GG, Chovelidze ShG, Chigogidze TG.","Urol Nefrol (Mosk). 1993 Nov-Dec;(6):28-30.","Gotsadze DT","Urol Nefrol (Mosk)","1993","1993/11/01","","",""
"31252002","Compliance With American Urological Association Guidelines for Nonmuscle Invasive Bladder Cancer Remains Poor: Assessing Factors Associated With Noncompliance and Survival in a Rural State","Tobert CM, Nepple KG, McDowell BD, Charlton ME, Mott SL, Gruca TS, Quast L, Erickson BA.","Urology. 2019 Oct;132:150-155. doi: 10.1016/j.urology.2019.06.021. Epub 2019 Jun 25.","Tobert CM","Urology","2019","2019/06/29","PMC6916249","NIHMS1060356","10.1016/j.urology.2019.06.021"
"8422636","Late results in patients treated with pi-mesons for bladder cancer","Studer UE, Gerber E, Zimmermann A, Kraft R, von Essen CF.","Cancer. 1993 Jan 15;71(2):439-47. doi: 10.1002/1097-0142(19930115)71:2<439::aid-cncr2820710226>3.0.co;2-z.","Studer UE","Cancer","1993","1993/01/15","","","10.1002/1097-0142(19930115)71:2<439::aid-cncr2820710226>3.0.co;2-z"
"21223815","[Clinical features of urological malignancies with paraneoplastic syndromes]","Yang Y, Mao QZ, Li HZ, Rong S, Yan WG, Ji ZG, Liu GH, Xu WF, Xiao H, Wang HJ.","Zhonghua Yi Xue Za Zhi. 2010 Dec 28;90(48):3411-4.","Yang Y","Zhonghua Yi Xue Za Zhi","2010","2011/01/13","","",""
"20359136","[Validation of a screening method for occupational bladder cancer]","Borchini R, Bonzini M, Veronesi G, Fava C, Carenzi MC, Mombelli S, Marconi A, Bono AV, Ferrario MM.","Med Lav. 2009 Nov-Dec;100(6):438-47.","Borchini R","Med Lav","2009","2010/04/03","","",""
"16614700","Experimental bladder carcinogenesis-rodent models","Oliveira PA, Colaco A, De la Cruz P LF, Lopes C.","Exp Oncol. 2006 Mar;28(1):2-11.","Oliveira PA","Exp Oncol","2006","2006/04/15","","",""
"25955868","Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer","Timirci-Kahraman O, Ozkan NE, Turan S, Farooqi AA, Verim L, Ozturk T, Inal-Gultekin G, Isbir T, Ozturk O, Yaylim I.","Genet Test Mol Biomarkers. 2015 Jun;19(6):309-15. doi: 10.1089/gtmb.2015.0050. Epub 2015 May 8.","Timirci-Kahraman O","Genet Test Mol Biomarkers","2015","2015/05/09","","","10.1089/gtmb.2015.0050"
"9117216","Nuclear accumulation of mutant p53 protein: a possible predictor of failure of intravesical therapy in bladder cancer","Caliskan M, Türkeri LN, Mansuroglu B, Toktas G, Aksoy B, Unlüer E, Akdas A.","Br J Urol. 1997 Mar;79(3):373-7. doi: 10.1046/j.1464-410x.1997.06911.x.","Caliskan M","Br J Urol","1997","1997/03/01","","","10.1046/j.1464-410x.1997.06911.x"
"27766490","Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer","Li HM, Azhati B, Rexiati M, Wang WG, Li XD, Liu Q, Wang YJ.","Int Urol Nephrol. 2017 Jan;49(1):69-76. doi: 10.1007/s11255-016-1441-6. Epub 2016 Oct 20.","Li HM","Int Urol Nephrol","2017","2016/10/22","","","10.1007/s11255-016-1441-6"
"15251942","Molecular serological diagnosis in transitional cell bladder cancer","von Knobloch R, Brandt H, Hofmann R.","Ann N Y Acad Sci. 2004 Jun;1022:70-5. doi: 10.1196/annals.1318.012.","von Knobloch R","Ann N Y Acad Sci","2004","2004/07/15","","","10.1196/annals.1318.012"
"29673906","Interest of next-generation sequencing in BCG-treated high-risk bladder cancer","Jungels C, Martinez Chanza N, Albisinni S, Mercier M, d'Haene N, Rorive S, Roumeguère T.","Prog Urol. 2018 May;28(6):344-350. doi: 10.1016/j.purol.2018.03.008. Epub 2018 Apr 17.","Jungels C","Prog Urol","2018","2018/04/21","","","10.1016/j.purol.2018.03.008"
"20701068","Comparison between incidentally and clinically detected prostate cancer: implications for prostate cancer screening programs and focal therapy","Mazzucchelli R, Montironi R, Morichetti D, Scarpelli M, Lopez-Beltran A, Cheng L.","Anal Quant Cytol Histol. 2010 Jun;32(3):151-4.","Mazzucchelli R","Anal Quant Cytol Histol","2010","2010/08/13","","",""
"29049231","Dose, duration and strain of bacillus Calmette-Guerin in the treatment of nonmuscle invasive bladder cancer: Meta-analysis of randomized clinical trials","Quan Y, Jeong CW, Kwak C, Kim HH, Kim HS, Ku JH.","Medicine (Baltimore). 2017 Oct;96(42):e8300. doi: 10.1097/MD.0000000000008300.","Quan Y","Medicine (Baltimore)","2017","2017/10/20","PMC5662397","","10.1097/MD.0000000000008300"
"32037303","Expeditious Radical Cystectomy in Patients with High-risk Bladder Cancer Remains an Important Part of Patient Care","Bochner BH.","Eur Urol Oncol. 2020 Apr;3(2):250-251. doi: 10.1016/j.euo.2020.01.004. Epub 2020 Feb 7.","Bochner BH","Eur Urol Oncol","2020","2020/02/11","","","10.1016/j.euo.2020.01.004"
"29102254","A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer","Fahmy O, Khairul-Asri MG, Schubert T, Renninger M, Malek R, Kübler H, Stenzl A, Gakis G.","Urol Oncol. 2018 Feb;36(2):43-53. doi: 10.1016/j.urolonc.2017.10.002. Epub 2017 Nov 6.","Fahmy O","Urol Oncol","2018","2017/11/06","","","10.1016/j.urolonc.2017.10.002"
"28916750","Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer","Thomsen MBH, Nordentoft I, Lamy P, Vang S, Reinert L, Mapendano CK, Høyer S, Ørntoft TF, Jensen JB, Dyrskjøt L.","Sci Rep. 2017 Sep 15;7(1):11702. doi: 10.1038/s41598-017-11291-0.","Thomsen MBH","Sci Rep","2017","2017/09/17","PMC5600970","","10.1038/s41598-017-11291-0"
"7484528","[Clinical investigation of grade-up superficial bladder cancer]","Noguchi S, Kubota Y, Masuda M, Shuin T, Yao M, Hosaka M.","Hinyokika Kiyo. 1995 Sep;41(9):659-64.","Noguchi S","Hinyokika Kiyo","1995","1995/09/01","","",""
"12081769","Ileal T-pouch as a urinary continent cutaneous diversion: clinical and urodynamic evaluation","Marino G, Laudi M.","BJU Int. 2002 Jul;90(1):47-50. doi: 10.1046/j.1464-410x.2002.02784.x.","Marino G","BJU Int","2002","2002/06/26","","","10.1046/j.1464-410x.2002.02784.x"
"26928572","Predicting occult lymph node-positive disease at the time of radical cystectomy: a systematic review","Zargar H, Zargar-Shoshtari K, Dundee P, Black PC.","Minerva Urol Nefrol. 2016 Apr;68(2):112-24. Epub 2016 Feb 29.","Zargar H","Minerva Urol Nefrol","2016","2016/03/02","","",""
"11435827","Screening and monitoring for bladder cancer: refining the use of NMP22","Ponsky LE, Sharma S, Pandrangi L, Kedia S, Nelson D, Agarwal A, Zippe CD.","J Urol. 2001 Jul;166(1):75-8.","Ponsky LE","J Urol","2001","2001/07/04","","",""
"29784744","The Changing Treatment Landscape for Metastatic Urothelial Carcinoma","Flaig TW.","J Natl Compr Canc Netw. 2018 May;16(5S):636-638. doi: 10.6004/jnccn.2018.0051.","Flaig TW","J Natl Compr Canc Netw","2018","2018/05/23","","","10.6004/jnccn.2018.0051"
"27077499","Challenges with in vitro and in vivo experimental models of urinary bladder cancer for novel drug discovery","Oliveira PA, Gil da Costa RM, Vasconcelos-Nóbrega C, Arantes-Rodrigues R, Pinto-Leite R.","Expert Opin Drug Discov. 2016 Jun;11(6):599-607. doi: 10.1080/17460441.2016.1174690. Epub 2016 Apr 28.","Oliveira PA","Expert Opin Drug Discov","2016","2016/04/15","","","10.1080/17460441.2016.1174690"
"30178038","Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder Cancer","Peyton CC, Tang D, Reich RR, Azizi M, Chipollini J, Pow-Sang JM, Manley B, Spiess PE, Poch MA, Sexton WJ, Fishman M, Zhang J, Gilbert SM.","JAMA Oncol. 2018 Nov 1;4(11):1535-1542. doi: 10.1001/jamaoncol.2018.3542.","Peyton CC","JAMA Oncol","2018","2018/09/05","PMC6248089","","10.1001/jamaoncol.2018.3542"
"16418181","Association of the PIG3 promoter polymorphism with invasive bladder cancer in a Japanese population","Ito M, Nishiyama H, Watanabe J, Kawanishi H, Takahashi T, Kamoto T, Habuchi T, Ogawa O.","Jpn J Clin Oncol. 2006 Feb;36(2):116-20. doi: 10.1093/jjco/hyi225. Epub 2006 Jan 17.","Ito M","Jpn J Clin Oncol","2006","2006/01/19","","","10.1093/jjco/hyi225"
"30719818","Prothymosin-α enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer","Tsai YS, Jou YC, Tsai HT, Shiau AL, Wu CL, Tzai TS.","Cancer Sci. 2019 Apr;110(4):1208-1219. doi: 10.1111/cas.13963. Epub 2019 Mar 5.","Tsai YS","Cancer Sci","2019","2019/02/06","PMC6447842","","10.1111/cas.13963"
"1776857","Interferon alfa 2a in superficial bladder cancer prophylaxis: toleration and long-term follow-up. A phase I-II study","Bartoletti R, Massimini G, Criscuolo D, Rizzo M.","Anticancer Res. 1991 Nov-Dec;11(6):2167-70.","Bartoletti R","Anticancer Res","1991","1991/11/01","","",""
"16083032","[Effectiveness of neoadjuvant chemotherapy for the patients with locally invasive bladder cancer]","Noguchi S, Takase K, Yoshida M, Yumura Y, Yamashita Y, Oogo Y, Miyoshi Y.","Nihon Hinyokika Gakkai Zasshi. 2005 Jul;96(5):548-53. doi: 10.5980/jpnjurol1989.96.548.","Noguchi S","Nihon Hinyokika Gakkai Zasshi","2005","2005/08/09","","","10.5980/jpnjurol1989.96.548"
"22575915","Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy","Bruins HM, Dorin RP, Rubino B, Miranda G, Cai J, Daneshmand S, Skinner EC.","Eur Urol. 2012 Oct;62(4):671-6. doi: 10.1016/j.eururo.2012.04.050. Epub 2012 May 4.","Bruins HM","Eur Urol","2012","2012/05/12","","","10.1016/j.eururo.2012.04.050"
"26838193","Diabetes is an Important Risk Factor for Metastasis in Non- Muscle-Invasive Bladder Cancer","Ozer K, Horsanali MO, Gorgel SN, Ozbek E.","Asian Pac J Cancer Prev. 2016;17(1):105-8. doi: 10.7314/apjcp.2016.17.1.105.","Ozer K","Asian Pac J Cancer Prev","2016","2016/02/04","","","10.7314/apjcp.2016.17.1.105"
"26101785","Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer","Kato T, Nomura K, Kondo F, Wakisaka M, Komiya A.","ScientificWorldJournal. 2015;2015:325305. doi: 10.1155/2015/325305. Epub 2015 May 21.","Kato T","ScientificWorldJournal","2015","2015/06/24","PMC4458547","","10.1155/2015/325305"
"31129781","Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience","Tseng WH, Liu CL, Huang SK, Liao AC, Kuo JR, Hun SH, Chen CH, Su CC, Wang JC, Lee KH, Shen KH, Li CF.","Int Urol Nephrol. 2019 Aug;51(8):1335-1342. doi: 10.1007/s11255-019-02172-8. Epub 2019 May 25.","Tseng WH","Int Urol Nephrol","2019","2019/05/27","","","10.1007/s11255-019-02172-8"
"27591936","Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells","Pan J, Li X, Wu W, Xue M, Hou H, Zhai W, Chen W.","Cancer Lett. 2016 Nov 1;382(1):64-76. doi: 10.1016/j.canlet.2016.08.015. Epub 2016 Aug 31.","Pan J","Cancer Lett","2016","2016/09/05","","","10.1016/j.canlet.2016.08.015"
"30355587","Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer","D Elia C, Pycha A, Folchini DM, Mian C, Hanspeter E, Schwienbacher C, Vjaters E, Pycha A, Trenti E.","J Clin Pathol. 2019 Feb;72(2):140-144. doi: 10.1136/jclinpath-2018-205393. Epub 2018 Oct 24.","D Elia C","J Clin Pathol","2019","2018/10/26","","","10.1136/jclinpath-2018-205393"
"29185045","Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer","Matsumoto A, Nakagawa T, Kanatani A, Ikeda M, Kawai T, Miyakawa J, Taguchi S, Naito A, Otsuka M, Nakanishi Y, Suzuki M, Koga F, Nagase Y, Kondo Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.","World J Urol. 2018 Feb;36(2):249-256. doi: 10.1007/s00345-017-2141-2. Epub 2017 Nov 28.","Matsumoto A","World J Urol","2018","2017/11/30","","","10.1007/s00345-017-2141-2"
"19589244","Subpopulations of stem-like cells in side population cells from the human bladder transitional cell cancer cell line T24","Ning ZF, Huang YJ, Lin TX, Zhou YX, Jiang C, Xu KW, Huang H, Yin XB, Huang J.","J Int Med Res. 2009 May-Jun;37(3):621-30. doi: 10.1177/147323000903700304.","Ning ZF","J Int Med Res","2009","2009/07/11","","","10.1177/147323000903700304"
"20371116","Clarification about bladder cancer and shisha smoking in Egypt","Chaouachi K.","Cancer Epidemiol. 2010 Apr;34(2):220. doi: 10.1016/j.canep.2010.01.001.","Chaouachi K","Cancer Epidemiol","2010","2010/04/08","","","10.1016/j.canep.2010.01.001"
"12354339","Prevention of recurrent superficial bladder cancer","Aso Y.","Curr Urol Rep. 2002 Oct;3(5):335-6. doi: 10.1007/s11934-002-0071-y.","Aso Y","Curr Urol Rep","2002","2002/10/02","","","10.1007/s11934-002-0071-y"
"3256659","Follow up of bladder cancer--the use of screening tests in predicting asymptomatic recurrence","Moran BJ, Davies PR, Twoomey PA.","J R Coll Gen Pract. 1988 Sep;38(314):422.","Moran BJ","J R Coll Gen Pract","1988","1988/09/01","PMC1711577","",""
"28982896","ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder","D'Andrea D, Moschini M, Soria F, Gust KM, Briganti A, Karakiewicz PI, Rouprêt M, Shariat SF.","Anticancer Res. 2017 Oct;37(10):5747-5753. doi: 10.21873/anticanres.12014.","D'Andrea D","Anticancer Res","2017","2017/10/07","","","10.21873/anticanres.12014"
"23358830","[Predictors for presence of residual tumor in follow-up transurethral resection of bladder tumors: single center results]","Hartinger J, Häußermann R, Olbert P, Hofmann R, Hegele A.","Urologe A. 2013 Apr;52(4):557-61. doi: 10.1007/s00120-012-3109-x.","Hartinger J","Urologe A","2013","2013/01/30","","","10.1007/s00120-012-3109-x"
"10811567","Metallothionein isoform 3 as a potential biomarker for human bladder cancer","Sens MA, Somji S, Lamm DL, Garrett SH, Slovinsky F, Todd JH, Sens DA.","Environ Health Perspect. 2000 May;108(5):413-8. doi: 10.1289/ehp.00108413.","Sens MA","Environ Health Perspect","2000","2000/05/16","PMC1638035","","10.1289/ehp.00108413"
"8648834","Nephrogenic adenoma of the bladder in renal transplant recipients: a report of 9 cases with assessment of deoxyribonucleic acid ploidy and long-term followup","Fournier G, Menut P, Moal MC, Hardy E, Volant A, Mangin P.","J Urol. 1996 Jul;156(1):41-4. doi: 10.1016/s0022-5347(01)65932-9.","Fournier G","J Urol","1996","1996/07/01","","","10.1016/s0022-5347(01)65932-9"
"19335155","Bacillus Calmette-Guérin for upper tract urothelial cancer: is there a role?","Rastinehad AR, Smith AD.","J Endourol. 2009 Apr;23(4):563-8. doi: 10.1089/end.2008.0164.","Rastinehad AR","J Endourol","2009","2009/04/02","","","10.1089/end.2008.0164"
"30303415","The effect of air pockets in the urinary bladder on the temperature distribution during loco-regional hyperthermia treatment of bladder cancer patients","Schooneveldt G, Kok HP, Bakker A, Geijsen ED, Hulshof MCCM, Reijke TM, Crezee J.","Int J Hyperthermia. 2018;35(1):441-449. doi: 10.1080/02656736.2018.1506890. Epub 2018 Oct 10.","Schooneveldt G","Int J Hyperthermia","2018","2018/10/11","","","10.1080/02656736.2018.1506890"
"19494853","Diagnosis of urothelial carcinoma from urine","Têtu B.","Mod Pathol. 2009 Jun;22 Suppl 2:S53-9. doi: 10.1038/modpathol.2008.193.","Têtu B","Mod Pathol","2009","2009/06/05","","","10.1038/modpathol.2008.193"
"30612154","Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors","Zhou Z, Zhao S, Lu Y, Wu J, Li Y, Gao Z, Yang D, Cui Y.","World J Urol. 2019 Jun;37(6):1075-1084. doi: 10.1007/s00345-019-02628-7. Epub 2019 Jan 5.","Zhou Z","World J Urol","2019","2019/01/07","","","10.1007/s00345-019-02628-7"
"20857258","MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24","Cao Y, Yu SL, Wang Y, Guo GY, Ding Q, An RH.","Tumour Biol. 2011 Feb;32(1):179-88. doi: 10.1007/s13277-010-0111-z. Epub 2010 Sep 21.","Cao Y","Tumour Biol","2011","2010/09/22","","","10.1007/s13277-010-0111-z"
"22125450","Update on chemotherapy in the treatment of urothelial carcinoma","Costantini C, Millard F.","ScientificWorldJournal. 2011;11:1981-94. doi: 10.1100/2011/590175. Epub 2011 Oct 26.","Costantini C","ScientificWorldJournal","2011","2011/11/30","PMC3217602","","10.1100/2011/590175"
"25027685","Critical analysis of the 2010 TNM classification in patients with lymph node-positive bladder cancer: influence of lymph node disease burden","Pedrosa JA, Kaimakliotis HZ, Monn MF, Cary KC, Masterson TA, Rice KR, Foster RS, Bihrle R, Koch MO, Cheng L.","Urol Oncol. 2014 Oct;32(7):1003-9. doi: 10.1016/j.urolonc.2014.04.002. Epub 2014 Jul 11.","Pedrosa JA","Urol Oncol","2014","2014/07/17","","","10.1016/j.urolonc.2014.04.002"
"25738263","Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer","Wang L, Liu Y, Du L, Li J, Jiang X, Zheng G, Qu A, Wang H, Wang L, Zhang X, Liu H, Pan H, Yang Y, Wang C.","Mol Med Rep. 2015 Jul;12(1):615-22. doi: 10.3892/mmr.2015.3428. Epub 2015 Mar 4.","Wang L","Mol Med Rep","2015","2015/03/05","","","10.3892/mmr.2015.3428"
"31196361","A Molecular Beacon Based Surface-Enhanced Raman Scattering Nanotag for Noninvasive Diagnosis of Bladder Cancer","Zhang P, Zhang Y, Liu W, Cui D, Zhao X, Song J, Guo T, Ni H, Zhang M, Zhang H, Yang T, Chen G, Wang L, Fan J.","J Biomed Nanotechnol. 2019 Jul 1;15(7):1589-1597. doi: 10.1166/jbn.2019.2780.","Zhang P","J Biomed Nanotechnol","2019","2019/06/15","","","10.1166/jbn.2019.2780"
"2005633","Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline","Ward E, Carpenter A, Markowitz S, Roberts D, Halperin W.","J Natl Cancer Inst. 1991 Apr 3;83(7):501-6. doi: 10.1093/jnci/83.7.501.","Ward E","J Natl Cancer Inst","1991","1991/04/03","","","10.1093/jnci/83.7.501"
"17089048","Expression of KITENIN, a KAI1/CD82 binding protein and metastasis enhancer, in bladder cancer cell lines: relationship to KAI1/CD82 levels and invasive behaviour","Rowe A, Jackson P.","Oncol Rep. 2006 Dec;16(6):1267-72.","Rowe A","Oncol Rep","2006","2006/11/08","","",""
"30053144","Immune Checkpoint Inhibitors Effective in Urothelial Cancer","Brower V.","J Natl Cancer Inst. 2017 May 1;109(5). doi: 10.1093/jnci/djx110.","Brower V","J Natl Cancer Inst","2017","2018/07/28","","","10.1093/jnci/djx110"
"27432454","Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer","Shiota M, Yokomizo A, Takeuchi A, Inokuchi J, Tatsugami K, Ohga S, Sasaki T, Nakamura K, Honda H, Eto M.","Jpn J Clin Oncol. 2016 Oct;46(10):952-957. doi: 10.1093/jjco/hyw098. Epub 2016 Jul 18.","Shiota M","Jpn J Clin Oncol","2016","2016/07/20","","","10.1093/jjco/hyw098"
"24896845","Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansion","Gomes-Giacoia E, Miyake M, Goodison S, Sriharan A, Zhang G, You L, Egan JO, Rhode PR, Parker AS, Chai KX, Wong HC, Rosser CJ.","PLoS One. 2014 Jun 4;9(6):e96705. doi: 10.1371/journal.pone.0096705. eCollection 2014.","Gomes-Giacoia E","PLoS One","2014","2014/06/05","PMC4045574","","10.1371/journal.pone.0096705"
"15900578","Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer","Weikert S, Krause H, Wolff I, Christoph F, Schrader M, Emrich T, Miller K, Müller M.","Int J Cancer. 2005 Nov 1;117(2):274-80. doi: 10.1002/ijc.21168.","Weikert S","Int J Cancer","2005","2005/05/19","","","10.1002/ijc.21168"
"16515974","Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?","Divrik T, Yildirim U, Eroğlu AS, Zorlu F, Ozen H.","J Urol. 2006 Apr;175(4):1258-61. doi: 10.1016/S0022-5347(05)00689-0.","Divrik T","J Urol","2006","2006/03/07","","","10.1016/S0022-5347(05)00689-0"
"28749907","Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease","Yu SS, Dorff TB, Ballas LK, Sadeghi S, Skinner EC, Quinn DI.","Clin Adv Hematol Oncol. 2017 Jun;15(6):466-477.","Yu SS","Clin Adv Hematol Oncol","2017","2017/07/28","PMC7515771","NIHMS1628299",""
"22614202","Absence of urine production due to renal failure enables clear visualization of primary urinary bladder carcinoma on 18F-FDG PET/CT","Bertagna F, Motta F, Fisogni S, Lena MS, Lucchini S, Giubbini R.","Clin Nucl Med. 2012 Jun;37(6):611-3. doi: 10.1097/RLU.0b013e3182443799.","Bertagna F","Clin Nucl Med","2012","2012/05/23","","","10.1097/RLU.0b013e3182443799"
"27444991","Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle-invasive bladder cancer","Onishi T, Sugino Y, Shibahara T, Masui S, Yabana T, Sasaki T.","BJU Int. 2017 Feb;119(2):276-282. doi: 10.1111/bju.13599. Epub 2016 Aug 18.","Onishi T","BJU Int","2017","2016/07/23","","","10.1111/bju.13599"
"20242262","Total cystectomy for carcinoma of the bladder","EWERT EE.","Surg Clin North Am. 1947 Jun;27(3):700-8. doi: 10.1016/s0039-6109(16)32155-7.","EWERT EE","Surg Clin North Am","1947","2010/03/19","","","10.1016/s0039-6109(16)32155-7"
"27776977","Emerging role of checkpoint inhibition in localized bladder cancer","Singh P, Black P.","Urol Oncol. 2016 Dec;34(12):548-555. doi: 10.1016/j.urolonc.2016.09.004. Epub 2016 Oct 21.","Singh P","Urol Oncol","2016","2016/10/26","","","10.1016/j.urolonc.2016.09.004"
"24175784","Can reproductive characteristics predict bladder cancer in women with haematuria?","Yavuzcan A, Caglar M, Kayikci MA, Basaran E, Tekin A, Ozdemir E, Dilbaz S, Ustun Y, Cam HK.","Asian Pac J Cancer Prev. 2013;14(9):5107-10. doi: 10.7314/apjcp.2013.14.9.5107.","Yavuzcan A","Asian Pac J Cancer Prev","2013","2013/11/02","","","10.7314/apjcp.2013.14.9.5107"
"15180611","Patients with bladder and lung cancer: a long-term outcome analysis","El-Hakim A, Smith AD, Weiss G.","BJU Int. 2004 Jun;93(9):1225-7. doi: 10.1111/j.1464-410X.2004.04842.x.","El-Hakim A","BJU Int","2004","2004/06/08","","","10.1111/j.1464-410X.2004.04842.x"
"26921394","High Sensitivity of an Ha-RAS Transgenic Model of Superficial Bladder Cancer to Metformin Is Associated with ∼240-Fold Higher Drug Concentration in Urine than Serum","Liu Z, Yokoyama NN, Blair CA, Li X, Avizonis D, Wu XR, Uchio E, Youssef R, McClelland M, Pollak M, Zi X.","Mol Cancer Ther. 2016 Mar;15(3):430-8. doi: 10.1158/1535-7163.MCT-15-0714-T. Epub 2016 Feb 26.","Liu Z","Mol Cancer Ther","2016","2016/02/28","PMC4783238","NIHMS751789","10.1158/1535-7163.MCT-15-0714-T"
"21725879","The regulatory effects of polyporus polysaccharide on the nuclear factor kappa B signal pathway of bladder cancer cells stimulated by Bacillus Calmette-Guerin","Wei JA, Zeng X, Han L, Huang Y.","Chin J Integr Med. 2011 Jul;17(7):531-6. doi: 10.1007/s11655-010-0787-y. Epub 2011 Jul 3.","Wei JA","Chin J Integr Med","2011","2011/07/05","","","10.1007/s11655-010-0787-y"
"31112107","Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA","Morera DS, Hasanali SL, Belew D, Ghosh S, Klaassen Z, Jordan AR, Wang J, Terris MK, Bollag RJ, Merseburger AS, Stenzl A, Soloway MS, Lokeshwar VB.","J Urol. 2020 Jan;203(1):62-72. doi: 10.1097/JU.0000000000000351. Epub 2019 May 21.","Morera DS","J Urol","2020","2019/05/22","","","10.1097/JU.0000000000000351"
"15514684","In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer","Sudarshan S, Holman DH, Hyer ML, Voelkel-Johnson C, Dong JY, Norris JS.","Cancer Gene Ther. 2005 Jan;12(1):12-8. doi: 10.1038/sj.cgt.7700746.","Sudarshan S","Cancer Gene Ther","2005","2004/10/30","","","10.1038/sj.cgt.7700746"
"6823955","Estimating attributable risk from case-control studies","Whittemore AS.","Am J Epidemiol. 1983 Jan;117(1):76-85. doi: 10.1093/oxfordjournals.aje.a113518.","Whittemore AS","Am J Epidemiol","1983","1983/01/01","","","10.1093/oxfordjournals.aje.a113518"
"2218570","Radiotherapy combined with chemotherapy in treatment of muscle-invasive bladder carcinoma","Porter AT.","Semin Oncol. 1990 Oct;17(5):583-9.","Porter AT","Semin Oncol","1990","1990/10/01","","",""
"8434421","A proposed simplified staging system of invasive bladder tumors","Herr HW.","Urol Int. 1993;50(1):17-20. doi: 10.1159/000282441.","Herr HW","Urol Int","1993","1993/01/01","","","10.1159/000282441"
"28796929","Safe and effective administration of BCG for bladder carcinoma in situ after umbilical cord blood stem cell transplantation","Magaribuchi T, Akamatsu S, Kobayashi T, Kawabata H, Yamasaki T, Inoue T, Ogawa O.","Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12758. Epub 2017 Sep 25.","Magaribuchi T","Transpl Infect Dis","2017","2017/08/11","","","10.1111/tid.12758"
"22816131","Optimum conditions of ultrasound-mediated destruction of bubble liposome for siRNA transfer in bladder cancer","Fujisawa S, Arakawa H, Suzuki R, Maruyama K, Kodama T, Yasunaga M, Koga Y, Matsumura Y.","Ther Deliv. 2010 Aug;1(2):247-55. doi: 10.4155/tde.10.23.","Fujisawa S","Ther Deliv","2010","2012/07/21","","","10.4155/tde.10.23"
"10650812","Analysis of 4-ABP-DNA adducts and p53 alterations in urinary bladder carcinoma","Romano G, Garagnani L, Boninsegna A, Ferrari P, Flamini G, De Gaetani C, Sgambato A, Giovanni F, Curigliano G, Ferretti G, Cittadini A, Trentini G.","Anticancer Res. 1999 Sep-Oct;19(5C):4571-6.","Romano G","Anticancer Res","1999","2000/01/29","","",""
"28588015","Intravesical BCG Induces CD4(+) T-Cell Expansion in an Immune Competent Model of Bladder Cancer","Kates M, Nirschl T, Sopko NA, Matsui H, Kochel CM, Reis LO, Netto GJ, Hoque MO, Hahn NM, McConkey DJ, Baras AS, Drake CG, Bivalacqua TJ.","Cancer Immunol Res. 2017 Jul;5(7):594-603. doi: 10.1158/2326-6066.CIR-16-0267. Epub 2017 Jun 6.","Kates M","Cancer Immunol Res","2017","2017/06/08","PMC5536898","NIHMS882826","10.1158/2326-6066.CIR-16-0267"
"31119584","Dihydrotestosterone increases the risk of bladder cancer in men","Gil D, Zarzycka M, Dulińska-Litewka J, Ciołczyk-Wierzbicka D, Lekka M, Laidler P.","Hum Cell. 2019 Jul;32(3):379-389. doi: 10.1007/s13577-019-00255-3. Epub 2019 May 22.","Gil D","Hum Cell","2019","2019/05/24","PMC6570698","","10.1007/s13577-019-00255-3"
"26215559","Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma","Krpina K, Babarović E, Jonjić N.","Virchows Arch. 2015 Oct;467(4):443-8. doi: 10.1007/s00428-015-1808-6. Epub 2015 Jul 28.","Krpina K","Virchows Arch","2015","2015/07/29","","","10.1007/s00428-015-1808-6"
"511629","Cancer of the bilharzial bladder","Chevlen EM, Awwad HK, Ziegler JL, Elsebai I.","Int J Radiat Oncol Biol Phys. 1979 Jul;5(7):921-6. doi: 10.1016/0360-3016(79)90595-9.","Chevlen EM","Int J Radiat Oncol Biol Phys","1979","1979/07/01","","","10.1016/0360-3016(79)90595-9"
"21908193","Structural requirement of arylindolylpropenones as anti-bladder carcinoma cells agents","Martel-Frachet V, Kadri M, Boumendjel A, Ronot X.","Bioorg Med Chem. 2011 Oct 15;19(20):6143-8. doi: 10.1016/j.bmc.2011.08.015. Epub 2011 Aug 16.","Martel-Frachet V","Bioorg Med Chem","2011","2011/09/13","","","10.1016/j.bmc.2011.08.015"
"1546564","[Study of preventive effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU) or combination of HCFU and 2.5-di-O-acetyl-D-glucaro (1-4) (6-3) dilactone (SLA) after preservative operation against bladder cancer]","Wada S, Yasumoto R, Kashihara N, Kishimoto T, Maekawa M, Hayahara N, Kawakita J, Nishijima T, Morikawa Y, Horii A, et al.","Hinyokika Kiyo. 1992 Jan;38(1):19-24.","Wada S","Hinyokika Kiyo","1992","1992/01/01","","",""
"22385990","Bladder cancer risk from occupational and environmental exposures","Kiriluk KJ, Prasad SM, Patel AR, Steinberg GD, Smith ND.","Urol Oncol. 2012 Mar-Apr;30(2):199-211. doi: 10.1016/j.urolonc.2011.10.010.","Kiriluk KJ","Urol Oncol","2012","2012/03/06","","","10.1016/j.urolonc.2011.10.010"
"22249975","Overexpression of RIN1 associates with tumor grade and progression in patients of bladder urothelial carcinoma","Shan GY, Zhang Z, Chen QG, Yu XY, Liu GB, Kong CZ.","Tumour Biol. 2012 Jun;33(3):847-55. doi: 10.1007/s13277-011-0311-1. Epub 2012 Jan 17.","Shan GY","Tumour Biol","2012","2012/01/18","","","10.1007/s13277-011-0311-1"
"9749086","[Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival]","Chauvet B, Félix-Faure C, Davin JL, Choquenet C, Alfonsi M, Reboul F.","Cancer Radiother. 1998 Apr;2 Suppl 1:85s-91s.","Chauvet B","Cancer Radiother","1998","1998/09/28","","",""
"3907021","[Results of percutaneous radiotherapy of bladder cancer using 1 and 2 series of irradiation]","Kob D, Arndt J, Kriester A, Schwenk M, Kloetzer KH.","Strahlentherapie. 1985 Nov;161(11):673-7.","Kob D","Strahlentherapie","1985","1985/11/01","","",""
"15281317","Molecular genetics of bladder cancer: pathways of development and progression","Knowles MA.","Cancer Surv. 1998;31:49-76.","Knowles MA","Cancer Surv","1998","2004/07/30","","",""
"25451834","The effect of concomitant carcinoma in situ on neoadjuvant chemotherapy for urothelial cell carcinoma of the bladder: inferior pathological outcomes but no effect on survival","Parker WP, Ho PL, Melquist JJ, Scott K, Holzbeierlein JM, Lopez-Corona E, Kamat AM, Lee EK.","J Urol. 2015 May;193(5):1494-9. doi: 10.1016/j.juro.2014.11.003. Epub 2014 Nov 11.","Parker WP","J Urol","2015","2014/12/03","","","10.1016/j.juro.2014.11.003"
"26680629","The Impact of Radical Cystectomy and Urinary Diversion on Suicidal Death in Patients With Bladder Cancer","Klaassen Z, DiBianco JM, Jen RP, Harper B, Yaguchi G, Reinstatler L, Woodard C, Moses KA, Terris MK, Madi R.","J Wound Ostomy Continence Nurs. 2016 Mar-Apr;43(2):152-7. doi: 10.1097/WON.0000000000000188.","Klaassen Z","J Wound Ostomy Continence Nurs","2016","2015/12/19","","","10.1097/WON.0000000000000188"
"27300769","Nested quantitative PCR approach for urinary cell-free EZH2 mRNA and its potential clinical application in bladder cancer","Zhang X, Zhang Y, Liu X, Liu T, Li P, Du L, Yang Y, Wang L, Wang C.","Int J Cancer. 2016 Oct 15;139(8):1830-8. doi: 10.1002/ijc.30230. Epub 2016 Jun 28.","Zhang X","Int J Cancer","2016","2016/06/15","","","10.1002/ijc.30230"
"15963628","Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder","Shariat SF, Herman MP, Casella R, Lotan Y, Karam JA, Stenman UH.","Eur Urol. 2005 Sep;48(3):424-31. doi: 10.1016/j.eururo.2005.04.034.","Shariat SF","Eur Urol","2005","2005/06/21","","","10.1016/j.eururo.2005.04.034"
"13496215","Some aspects of bladder cancer","GODWIN JT.","Trans Southeast Sect Am Urol Assoc. 1957;21:125-7.","GODWIN JT","Trans Southeast Sect Am Urol Assoc","1957","1957/01/01","","",""
"24411280","Reply from authors re: Lambertus A. Kiemeney. The global risk of bladder cancer: let's just do something about it! Eur Urol 2014;66:74-5","Jemal A, Lortet-Tieulent J, Bray F.","Eur Urol. 2014 Jul;66(1):76. doi: 10.1016/j.eururo.2013.12.028. Epub 2013 Dec 31.","Jemal A","Eur Urol","2014","2014/01/14","","","10.1016/j.eururo.2013.12.028"
"9615209","Nordic prospective trials of radical cystectomy and neoadjuvant chemotherapy. The Nordic Cooperative Bladder Cancer Study Group","Hellsten S, Rintala E, Wahlqvist R, Malmström PU.","Eur Urol. 1998;33 Suppl 4:35-8. doi: 10.1159/000052263.","Hellsten S","Eur Urol","1998","1998/06/06","","","10.1159/000052263"
"23652315","Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer","Boman K, Larsson AH, Segersten U, Kuteeva E, Johannesson H, Nodin B, Eberhard J, Uhlén M, Malmström PU, Jirström K.","Br J Cancer. 2013 Jun 11;108(11):2321-8. doi: 10.1038/bjc.2013.215. Epub 2013 May 7.","Boman K","Br J Cancer","2013","2013/05/09","PMC3681027","","10.1038/bjc.2013.215"
"4091693","[Morphology of precancerous mucosal changes in the bladder]","Romanenko AM.","Arkh Patol. 1985;47(11):25-32.","Romanenko AM","Arkh Patol","1985","1985/01/01","","",""
"24265292","Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours","Rose M, Gaisa NT, Antony P, Fiedler D, Heidenreich A, Otto W, Denzinger S, Bertz S, Hartmann A, Karl A, Knüchel R, Dahl E.","Carcinogenesis. 2014 Mar;35(3):727-36. doi: 10.1093/carcin/bgt375. Epub 2013 Nov 21.","Rose M","Carcinogenesis","2014","2013/11/23","","","10.1093/carcin/bgt375"
"24375315","Evaluation of urinary HURP mRNA as a marker for detection of bladder cancer: relation to bilharziasis","Eissa S, Matboli M, Mansour A, Mohamed S, Awad N, Kotb YM.","Med Oncol. 2014 Feb;31(2):804. doi: 10.1007/s12032-013-0804-4. Epub 2013 Dec 28.","Eissa S","Med Oncol","2014","2013/12/31","","","10.1007/s12032-013-0804-4"
"10845722","Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model","Horiguchi Y, Larchian WA, Kaplinsky R, Fair WR, Heston WD.","Gene Ther. 2000 May;7(10):844-51. doi: 10.1038/sj.gt.3301157.","Horiguchi Y","Gene Ther","2000","2000/06/14","","","10.1038/sj.gt.3301157"
"22958598","Cost-effective treatment of low-risk carcinoma not invading bladder muscle","Green DA, Rink M, Cha EK, Xylinas E, Chughtai B, Scherr DS, Shariat SF, Lee RK.","BJU Int. 2013 Mar;111(3 Pt B):E78-84. doi: 10.1111/j.1464-410X.2012.11454.x. Epub 2012 Sep 7.","Green DA","BJU Int","2013","2012/09/11","","","10.1111/j.1464-410X.2012.11454.x"
"3433584","Multivariate evaluation of prognostic determinants in bladder cancer patients","Takashi M, Murase T, Mizuno S, Hamajima N, Ohno Y.","Urol Int. 1987;42(5):368-74. doi: 10.1159/000281996.","Takashi M","Urol Int","1987","1987/01/01","","","10.1159/000281996"
"6013207","[Studies on carcinoma of the urinary bladder. I. Statistical and epidemiological studies on cancer of the bladder in Japanese]","Yoshida O.","Hinyokika Kiyo. 1966 Oct;12(10):1040-64.","Yoshida O","Hinyokika Kiyo","1966","1966/10/01","","",""
"26292086","uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder--Possible Clinical Implications","Dohn LH, Pappot H, Iversen BR, Illemann M, Høyer-Hansen G, Christensen IJ, Thind P, Salling L, von der Maase H, Laerum OD.","PLoS One. 2015 Aug 20;10(8):e0135824. doi: 10.1371/journal.pone.0135824. eCollection 2015.","Dohn LH","PLoS One","2015","2015/08/21","PMC4546385","","10.1371/journal.pone.0135824"
"20473948","Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer","Wiklund ED, Bramsen JB, Hulf T, Dyrskjøt L, Ramanathan R, Hansen TB, Villadsen SB, Gao S, Ostenfeld MS, Borre M, Peter ME, Ørntoft TF, Kjems J, Clark SJ.","Int J Cancer. 2011 Mar 15;128(6):1327-34. doi: 10.1002/ijc.25461.","Wiklund ED","Int J Cancer","2011","2010/05/18","","","10.1002/ijc.25461"
"26782034","[Specific types of bladder cancer]","Bertz S, Hartmann A, Knüchel-Clarke R, Gaisa NT.","Pathologe. 2016 Feb;37(1):40-51. doi: 10.1007/s00292-015-0129-5.","Bertz S","Pathologe","2016","2016/01/20","","","10.1007/s00292-015-0129-5"
"4083214","[Fundamental studies on intravesical instillation of cis-diamminedichloroplatinum for treatment of urinary bladder tumors. II. On the effects of intravesical instillation of cis-diamminedichloroplatinum in bladder cancer patients]","Hirao Y, Iwai A, Moriya A, Matsuki H, Yoshida Y, Komada S, Sasaki K, Kubota K, Sanma S, Babaya K, et al.","Hinyokika Kiyo. 1985 Sep;31(9):1565-73.","Hirao Y","Hinyokika Kiyo","1985","1985/09/01","","",""
"3611886","[Balloon occluded arterial infusion of cisplatin in combination with angiotensin II in the treatment of bladder cancer]","Onohara S, Oyama T, Kobayashi H, Uchiyama N, Yano T, Inoue H, Itoh Y, Shinohara S, Shirahama T, Ohi Y.","Nihon Gan Chiryo Gakkai Shi. 1987 Feb 20;22(1):1-6.","Onohara S","Nihon Gan Chiryo Gakkai Shi","1987","1987/02/20","","",""
"7565855","Translumbar amputation: the longest survivor--a case update","Mackenzie AR.","Mt Sinai J Med. 1995 Sep;62(4):305-7.","Mackenzie AR","Mt Sinai J Med","1995","1995/09/01","","",""
"21008834","Cystectomy for carcinoma of the bladder","SWEETSER TH.","Minn Med. 1945 Dec;28:987-92.","SWEETSER TH","Minn Med","1945","2010/10/29","","",""
"18840529","-(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro","Macoska JA, Adsule S, Tantivejkul K, Wang S, Pienta KJ, Lee CT.","Pharmacol Res. 2008 Nov-Dec;58(5-6):323-31. doi: 10.1016/j.phrs.2008.09.005. Epub 2008 Sep 16.","Macoska JA","Pharmacol Res","2008","2008/10/09","","","10.1016/j.phrs.2008.09.005"
"23394881","Fiber-substituted conditionally replicating adenovirus Ad5F35 induces oncolysis of human bladder cancer cells in in vitro analysis","Gotoh A, Nagaya H, Kanno T, Tagawa M, Nishizaki T.","Urology. 2013 Apr;81(4):920.e7-11. doi: 10.1016/j.urology.2012.12.023. Epub 2013 Feb 8.","Gotoh A","Urology","2013","2013/02/12","","","10.1016/j.urology.2012.12.023"
"8221653","Enhancement of rat urinary bladder tumorigenesis by lipopolysaccharide-induced inflammation","Kawai K, Yamamoto M, Kameyama S, Kawamata H, Rademaker A, Oyasu R.","Cancer Res. 1993 Nov 1;53(21):5172-5.","Kawai K","Cancer Res","1993","1993/11/01","","",""
"11142527","Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries","Sala M, Cordier S, Chang-Claude J, Donato F, Escolar-Pujolar A, Fernandez F, González CA, Greiser E, Jöckel KH, Lynge E, Mannetje A, Pohlabeln H, Porru S, Serra C, Tzonou A, Vineis P, Wahrendorf J, Boffetta P, Kogevina M.","Cancer Causes Control. 2000 Dec;11(10):925-31. doi: 10.1023/a:1026524014954.","Sala M","Cancer Causes Control","2000","2001/01/06","","","10.1023/a:1026524014954"
"16025482","Low utility of CYFRA 21-1 serum levels for diagnosis and follow-up in bladder cancer patients","Fatela-Cantillo D, Fernández-Suárez A, Menéndez V, Galán JA, Filella X.","J Clin Lab Anal. 2005;19(4):167-71. doi: 10.1002/jcla.20072.","Fatela-Cantillo D","J Clin Lab Anal","2005","2005/07/19","PMC6808099","","10.1002/jcla.20072"
"10629118","Nuclear structural proteins as biomarkers of cancer","Konety BR, Getzenberg RH.","J Cell Biochem. 1999;Suppl 32-33:183-91. doi: 10.1002/(sici)1097-4644(1999)75:32+<183::aid-jcb22>3.3.co;2-1.","Konety BR","J Cell Biochem","1999","2000/01/11","","","10.1002/(sici)1097-4644(1999)75:32+<183::aid-jcb22>3.3.co;2-1"
"5500710","The carcinogenic activity of dibutylnitrosamine in IF x C57 mice","Wood M, Flaks A, Clayson DB.","Eur J Cancer. 1970 Oct;6(5):433-40. doi: 10.1016/0014-2964(70)90042-3.","Wood M","Eur J Cancer","1970","1970/10/01","","","10.1016/0014-2964(70)90042-3"
"24069434","The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder","Niedworok C, Kretschmer I, Röck K, Vom Dorp F, Szarvas T, Heß J, Freudenberger T, Melchior-Becker A, Rübben H, Fischer JW.","PLoS One. 2013 Sep 17;8(9):e75681. doi: 10.1371/journal.pone.0075681. eCollection 2013.","Niedworok C","PLoS One","2013","2013/09/27","PMC3775893","","10.1371/journal.pone.0075681"
"4757904","Proceedings: Total cystectomy. An editorial overview","Wallace DM.","Cancer. 1973 Nov;32(5):1078-83. doi: 10.1002/1097-0142(197311)32:5<1078::aid-cncr2820320510>3.0.co;2-s.","Wallace DM","Cancer","1973","1973/11/01","","","10.1002/1097-0142(197311)32:5<1078::aid-cncr2820320510>3.0.co;2-s"
"23706569","Re: Caroline E. Weibull, Sandra Eloranta, Daniel Altman, Anna L.V. Johansson, Mats Lambe. Childbearing and the risk of bladder cancer: a nationwide population-based cohort study. Eur Urol 2013;63:733-8","Selinski S, Ovsiannikov D, Hengstler JG, Golka K.","Eur Urol. 2013 Oct;64(4):e80. doi: 10.1016/j.eururo.2013.05.019. Epub 2013 May 14.","Selinski S","Eur Urol","2013","2013/05/28","","","10.1016/j.eururo.2013.05.019"
"7817455","[Photodynamic procedures in urology]","Jocham D.","Urologe A. 1994 Nov;33(6):547-52.","Jocham D","Urologe A","1994","1994/11/01","","",""
"20605198","Prognostic value of loss of heterozygosity at chromosome 9p in non-muscle-invasive bladder cancer","Ploussard G, Dubosq F, Soliman H, Verine J, Desgrandchamps F, De Thé H, Mongiat-Artus P.","Urology. 2010 Aug;76(2):513.e13-8. doi: 10.1016/j.urology.2010.03.037.","Ploussard G","Urology","2010","2010/07/08","","","10.1016/j.urology.2010.03.037"
"29377654","Peptide-Mediated Targeting Mesoporous Silica Nanoparticles: A Novel Tool for Fighting Bladder Cancer","Sweeney SK, Luo Y, O'Donnell MA, Assouline JG.","J Biomed Nanotechnol. 2017 Feb;13(2):232-42. doi: 10.1166/jbn.2017.2339.","Sweeney SK","J Biomed Nanotechnol","2017","2018/01/30","","","10.1166/jbn.2017.2339"
"18383514","Separating surgical quality from causality--gaining perspective in the debate on lymph node count and extent of lymphadenectomy","Gilbert SM.","Cancer. 2008 Jun;112(11):2331-3. doi: 10.1002/cncr.23471.","Gilbert SM","Cancer","2008","2008/04/03","","","10.1002/cncr.23471"
"28225635","Role of Imaging in the Local Staging of Urothelial Carcinoma of the Bladder","Lee CH, Tan CH, Faria SC, Kundra V.","AJR Am J Roentgenol. 2017 Jun;208(6):1193-1205. doi: 10.2214/AJR.16.17114. Epub 2017 Feb 22.","Lee CH","AJR Am J Roentgenol","2017","2017/02/23","","","10.2214/AJR.16.17114"
"19083002","Management of bladder cancer and urinary tract reconstruction : dedicated to the memory of John P. Stein, 14 June 1962-11 April 2008","Skinner DG.","World J Urol. 2009 Feb;27(1):1-2. doi: 10.1007/s00345-008-0356-y.","Skinner DG","World J Urol","2009","2008/12/17","","","10.1007/s00345-008-0356-y"
"20683150","Frequency of P16INK4a and P14ARF genes methylation and its impact on bladder cancer cases in north Indian population","Ali Hosseini S, Sobti RC, Malekzadeh K, Singh SK, Joshi K.","Dis Markers. 2010;28(6):361-8. doi: 10.3233/DMA-2010-0716.","Ali Hosseini S","Dis Markers","2010","2010/08/05","PMC3833423","","10.3233/DMA-2010-0716"
"25337764","More on robot-assisted laparoscopic radical cystectomy","Bochner BH, Laudone VP; Memorial Sloan Kettering Cancer Center Bladder Cancer Surgical Trials Group.","N Engl J Med. 2014 Oct 23;371(17):1655. doi: 10.1056/NEJMc1410504.","Bochner BH","N Engl J Med","2014","2014/10/23","","","10.1056/NEJMc1410504"
"24331573","Lymphovascular invasion in high grade T1 bladder cancer: are more aggressive treatments needed?","Borghesi M, Brunocilla E, Schiavina R, Martorana G.","Clin Genitourin Cancer. 2014 Apr;12(2):e59-60. doi: 10.1016/j.clgc.2013.03.002. Epub 2013 Nov 13.","Borghesi M","Clin Genitourin Cancer","2014","2013/12/17","","","10.1016/j.clgc.2013.03.002"
"8017849","The relationship between tumor size and chemosensitivity of murine bladder cancer","Lee KE, Fujioka T, Kubota T, Hoffman R.","Anticancer Res. 1994 Mar-Apr;14(2A):465-8.","Lee KE","Anticancer Res","1994","1994/03/01","","",""
"9923932","Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer","Neuhaus M, Wagner U, Schmid U, Ackermann D, Zellweger T, Maurer R, Alund G, Knönagel H, Rist M, Moch H, Mihatsch MJ, Gasser TC, Sauter G.","Hum Pathol. 1999 Jan;30(1):81-6. doi: 10.1016/s0046-8177(99)90305-2.","Neuhaus M","Hum Pathol","1999","1999/01/29","","","10.1016/s0046-8177(99)90305-2"
"22419246","Bias in relative survival methods when using incorrect life-tables: lung and bladder cancer by smoking status and ethnicity in New Zealand","Blakely T, Soeberg M, Carter K, Costilla R, Atkinson J, Sarfati D.","Int J Cancer. 2012 Sep 15;131(6):E974-82. doi: 10.1002/ijc.27531. Epub 2012 Apr 25.","Blakely T","Int J Cancer","2012","2012/03/16","","","10.1002/ijc.27531"
"7717156","[Staging error in bladder carcinoma: anatomo-clinical correlation]","Sánchez-Chapado M, Angulo JC, Hontoria H, Guil M, Dehaini A, Lera R.","Actas Urol Esp. 1995 Jan;19(1):32-9.","Sánchez-Chapado M","Actas Urol Esp","1995","1995/01/01","","",""
"15266415","Aggressive bladder carcinoma in a child","Lezama-del Valle P, Jerkins GR, Rao BN, Santana VM, Fuller C, Merchant TE.","Pediatr Blood Cancer. 2004 Sep;43(3):285-8. doi: 10.1002/pbc.20100.","Lezama-del Valle P","Pediatr Blood Cancer","2004","2004/07/22","","","10.1002/pbc.20100"
"8558719","Adenoviral-p53 gene transfer to orthotopic and peritoneal murine bladder cancer","Werthman PE, Drazan KE, Rosenthal JT, Khalili R, Shaked A.","J Urol. 1996 Feb;155(2):753-6.","Werthman PE","J Urol","1996","1996/02/01","","",""
"30066439","Cost-effectiveness of surveillance schedules in older adults with non-muscle-invasive bladder cancer","Heijnsdijk EAM, Nieboer D, Garg T, Lansdorp-Vogelaar I, de Koning HJ, Nielsen ME.","BJU Int. 2019 Feb;123(2):307-312. doi: 10.1111/bju.14502. Epub 2018 Aug 27.","Heijnsdijk EAM","BJU Int","2019","2018/08/02","PMC6378589","","10.1111/bju.14502"
"26739071","[Expression of Maspin in bladder carcinoma and the relationship between Maspin and lymph node metastasis]","Tang Y, Zu X, Xiong Y, Zhang X.","Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015 Dec;40(12):1306-12. doi: 10.11817/j.issn.1672-7347.2015.12.004.","Tang Y","Zhong Nan Da Xue Xue Bao Yi Xue Ban","2015","2016/01/08","","","10.11817/j.issn.1672-7347.2015.12.004"
"28289079","Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models","Potts KG, Irwin CR, Favis NA, Pink DB, Vincent KM, Lewis JD, Moore RB, Hitt MM, Evans DH.","EMBO Mol Med. 2017 May;9(5):638-654. doi: 10.15252/emmm.201607296.","Potts KG","EMBO Mol Med","2017","2017/03/15","PMC5412795","","10.15252/emmm.201607296"
"21426474","Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity","Kamat AM, Karam JA, Grossman HB, Kader AK, Munsell M, Dinney CP.","BJU Int. 2011 Oct;108(7):1119-23. doi: 10.1111/j.1464-410X.2010.10026.x. Epub 2011 Mar 22.","Kamat AM","BJU Int","2011","2011/03/24","","","10.1111/j.1464-410X.2010.10026.x"
"32022310","Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort","Tanaka H, Fujii Y.","Int J Urol. 2020 Mar;27(3):257. doi: 10.1111/iju.14194. Epub 2020 Feb 5.","Tanaka H","Int J Urol","2020","2020/02/06","","","10.1111/iju.14194"
"21851184","Response to Lammers and Witjes article: new developments in intravesical therapy for non-muscle-invasive bladder cancer","Steinberg GD.","Expert Rev Anticancer Ther. 2011 Sep;11(9):1331-2. doi: 10.1586/era.11.45. Epub 2011 Aug 18.","Steinberg GD","Expert Rev Anticancer Ther","2011","2011/08/20","","","10.1586/era.11.45"
"19836215","The effect on pelvic lymph node dose after reducing the internal margin of the planning target volume for bladder cancer","Thomson AH, Watterson A, Liddicoat A.","Clin Oncol (R Coll Radiol). 2009 Dec;21(10):787-8. doi: 10.1016/j.clon.2009.09.021.","Thomson AH","Clin Oncol (R Coll Radiol)","2009","2009/10/20","","","10.1016/j.clon.2009.09.021"
"22332891","Design and preliminary study of custom laser scanning cystoscope for automated bladder surveillance","Yoon WJ, Brown MA, Reinhall PG, Park S, Seibel EJ.","Minim Invasive Ther Allied Technol. 2012 Sep;21(5):320-8. doi: 10.3109/13645706.2011.653374. Epub 2012 Feb 14.","Yoon WJ","Minim Invasive Ther Allied Technol","2012","2012/02/16","","","10.3109/13645706.2011.653374"
"25667459","Cantharidin induces DNA damage and inhibits DNA repair-associated protein expressions in TSGH8301 human bladder cancer cell","Kuo JH, Shih TY, Lin JP, Lai KC, Lin ML, Yang MD, Chung JG.","Anticancer Res. 2015 Feb;35(2):795-804.","Kuo JH","Anticancer Res","2015","2015/02/11","","",""
"25575731","Studies of the photosensitizer disulfonated meso-tetraphenyl chlorin in an orthotopic rat bladder tumor model","Baglo Y, Peng Q, Hagen L, Berg K, Høgset A, Drabløs F, Gederaas OA.","Photodiagnosis Photodyn Ther. 2015 Mar;12(1):58-66. doi: 10.1016/j.pdpdt.2014.12.005. Epub 2015 Jan 6.","Baglo Y","Photodiagnosis Photodyn Ther","2015","2015/01/11","","","10.1016/j.pdpdt.2014.12.005"
"16972628","[A case of ureteral carcinoma at 11 years after radical cystectomy and rectal bladder reconstruction: a case report]","Shigemura K, Arakawa S, Yuen K, Kataoka N, Fujisawa M.","Hinyokika Kiyo. 2006 Aug;52(8):637-40.","Shigemura K","Hinyokika Kiyo","2006","2006/09/16","","",""
"2074506","Historical and modern role of cystoscopy and bladder mucosal biopsy in detecting bladder cancer in a high-risk population","Prout GR Jr.","J Occup Med. 1990 Sep;32(9):834-7. doi: 10.1097/00043764-199009000-00015.","Prout GR Jr","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00015"
"21737624","The therapeutic effects of R8-liposome-BCG-CWS on BBN-induced rat urinary bladder carcinoma","Miyazaki J, Nishiyama H, Yano I, Nakaya A, Kohama H, Kawai K, Joraku A, Nakamura T, Harashima H, Akaza H.","Anticancer Res. 2011 Jun;31(6):2065-71.","Miyazaki J","Anticancer Res","2011","2011/07/09","","",""
"30291519","Macrophage polarization as a novel weapon in conditioning tumor microenvironment for bladder cancer: can we turn demons into gods?","Rubio C, Munera-Maravilla E, Lodewijk I, Suarez-Cabrera C, Karaivanova V, Ruiz-Palomares R, Paramio JM, Dueñas M.","Clin Transl Oncol. 2019 Apr;21(4):391-403. doi: 10.1007/s12094-018-1952-y. Epub 2018 Oct 5.","Rubio C","Clin Transl Oncol","2019","2018/10/07","","","10.1007/s12094-018-1952-y"
"18247016","Neoadjuvant chemotherapy for bladder cancer","Sonpavde G, Lerner SP.","Oncology (Williston Park). 2007 Dec;21(14):1673-81; discussion 1686-8, 1691, 1694.","Sonpavde G","Oncology (Williston Park)","2007","2008/02/06","","",""
"15821470","Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?","Hafron J, Mitra N, Dalbagni G, Bochner B, Herr H, Donat SM.","J Urol. 2005 May;173(5):1513-7. doi: 10.1097/01.ju.0000154352.54965.14.","Hafron J","J Urol","2005","2005/04/12","","","10.1097/01.ju.0000154352.54965.14"
"17456386","[Antisense RNA of survivin gene enhances the taxol-induced apoptosis and sensitivity to chemotherapy drugs in bladder cancer cells: an in vitro experiment]","Wang ZH, Ye Q, Huang DY, Hu ZQ, Ye ZQ, Yang N, Liu H, Zhuang QY, Yang WM, Liu JH, Zhang X.","Zhonghua Yi Xue Za Zhi. 2007 Feb 6;87(6):419-22.","Wang ZH","Zhonghua Yi Xue Za Zhi","2007","2007/04/26","","",""
"11411098","[Clinical evaluation of urinary nuclear matrix protein 22 as a marker for bladder cancer]","Kurokawa S, Morita T, Muraishi O, Tokue A.","Hinyokika Kiyo. 2001 Apr;47(4):247-50.","Kurokawa S","Hinyokika Kiyo","2001","2001/06/20","","",""
"28321693","Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer","Sun X, Hoadley KA, Kim WY, Furberg H, Olshan AF, Troester MA.","Cancer Causes Control. 2017 Jun;28(6):539-544. doi: 10.1007/s10552-017-0885-z. Epub 2017 Mar 20.","Sun X","Cancer Causes Control","2017","2017/03/22","PMC5477976","NIHMS861589","10.1007/s10552-017-0885-z"
"2637238","Continent sigmoid bladder after cystectomy: 20 years' experience","Novak R, Kraus O, Dimanovski J.","Int Urol Nephrol. 1989;21(6):609-15. doi: 10.1007/BF02559617.","Novak R","Int Urol Nephrol","1989","1989/01/01","","","10.1007/BF02559617"
"28342660","Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer","Soria F, Lucca I, Moschini M, Mathieu R, Rouprêt M, Karakiewicz PI, Briganti A, Rink M, Gust KM, Hassler MR, Foerster B, Abufarraj M, Haitel A, Klatte T, Shariat SF.","Urol Oncol. 2017 Jun;35(6):356-362. doi: 10.1016/j.urolonc.2017.02.009. Epub 2017 Mar 23.","Soria F","Urol Oncol","2017","2017/03/27","","","10.1016/j.urolonc.2017.02.009"
"29224950","mRNA, microRNA and lncRNA as novel bladder tumor markers","Wieczorek E, Reszka E.","Clin Chim Acta. 2018 Feb;477:141-153. doi: 10.1016/j.cca.2017.12.009. Epub 2017 Dec 7.","Wieczorek E","Clin Chim Acta","2018","2017/12/12","","","10.1016/j.cca.2017.12.009"
"18502346","Peritoneal carcinomatosis in urinary bladder cancer","Turkbey B, Basaran C, Karcaaltincaba M, Akpinar E, Oguz B, Akata D, Ozmen MN, Akhan O.","Clin Imaging. 2008 May-Jun;32(3):192-5. doi: 10.1016/j.clinimag.2007.10.024.","Turkbey B","Clin Imaging","2008","2008/05/27","","","10.1016/j.clinimag.2007.10.024"
"10389995","Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study","Lange N, Jichlinski P, Zellweger M, Forrer M, Marti A, Guillou L, Kucera P, Wagnières G, van den Bergh H.","Br J Cancer. 1999 Apr;80(1-2):185-93. doi: 10.1038/sj.bjc.6690338.","Lange N","Br J Cancer","1999","1999/07/02","PMC2363006","","10.1038/sj.bjc.6690338"
"26844572","Emerging Immunotargets in Bladder Cancer","Massari F, Ciccarese C, Vau N, Santoni M, Montironi R, Cheng L, Marques RC, Scarpelli M, Fonseca J, Matrana MR, Holger M, Cascinu S, Tortora G, Lopez-Beltran A.","Curr Drug Targets. 2016;17(7):757-70. doi: 10.2174/1389450117666160201105537.","Massari F","Curr Drug Targets","2016","2016/02/05","","","10.2174/1389450117666160201105537"
"27477523","Editorial Comment to Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer","Yuasa T.","Int J Urol. 2016 Oct;23(10):846-847. doi: 10.1111/iju.13178. Epub 2016 Jul 31.","Yuasa T","Int J Urol","2016","2016/08/02","","","10.1111/iju.13178"
"2765768","Combination of blood group ABH antigen status and DNA ploidy as independent prognostic factor in transitional cell carcinoma of the urinary bladder","Malmström PU, Norlén BJ, Andersson B, Busch C.","Br J Urol. 1989 Jul;64(1):49-55. doi: 10.1111/j.1464-410x.1989.tb05521.x.","Malmström PU","Br J Urol","1989","1989/07/01","","","10.1111/j.1464-410x.1989.tb05521.x"
"3534313","Beta-2-microglobulins as a differentiation marker in bladder cancer","Walton GR, McCue PA, Graham SD Jr.","J Urol. 1986 Dec;136(6):1197-200. doi: 10.1016/s0022-5347(17)45281-5.","Walton GR","J Urol","1986","1986/12/01","","","10.1016/s0022-5347(17)45281-5"
"28185020","Natural course of asymptomatic abnormal prostate findings incidentally detected by CT after intravesical BCG therapy","Matsushima M, Kikuchi E, Akita H, Miyajima A, Oya M, Jinzaki M.","Int J Clin Oncol. 2017 Jun;22(3):554-562. doi: 10.1007/s10147-017-1096-z. Epub 2017 Feb 10.","Matsushima M","Int J Clin Oncol","2017","2017/02/11","","","10.1007/s10147-017-1096-z"
"27272203","Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer","Dabi Y, Rouscoff Y, Anract J, Delongchamps NB, Sibony M, Saighi D, Zerbib M, Peyraumore M, Xylinas E.","World J Urol. 2017 Feb;35(2):229-235. doi: 10.1007/s00345-016-1852-0. Epub 2016 Jun 6.","Dabi Y","World J Urol","2017","2016/06/09","","","10.1007/s00345-016-1852-0"
"25535740","Attenuated NER expressions of XPF and XPC associated with smoking are involved in the recurrence of bladder cancer","Qiu J, Wang X, Meng X, Zheng Y, Li G, Ma J, Ye G, Li Y, Li J.","PLoS One. 2014 Dec 23;9(12):e115224. doi: 10.1371/journal.pone.0115224. eCollection 2014.","Qiu J","PLoS One","2014","2014/12/24","PMC4275238","","10.1371/journal.pone.0115224"
"17332134","Bladder cancer incidence and exposure to polycyclic aromatic hydrocarbons among asphalt pavers","Burstyn I, Kromhout H, Johansen C, Langard S, Kauppinen T, Shaham J, Ferro G, Boffetta P.","Occup Environ Med. 2007 Aug;64(8):520-6. doi: 10.1136/oem.2006.029801. Epub 2007 Mar 1.","Burstyn I","Occup Environ Med","2007","2007/03/03","PMC2078500","","10.1136/oem.2006.029801"
"31172281","Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis","Vartolomei MD, Iwata T, Roth B, Kimura S, Mathieu R, Ferro M, Shariat SF, Seitz C.","World J Urol. 2019 Nov;37(11):2313-2324. doi: 10.1007/s00345-019-02825-4. Epub 2019 Jun 6.","Vartolomei MD","World J Urol","2019","2019/06/08","","","10.1007/s00345-019-02825-4"
"10579079","Surgery for invasive bladder tumors: technique and outcome","Clark PE, Klein EA.","Curr Opin Urol. 1999 Sep;9(5):413-8. doi: 10.1097/00042307-199909000-00008.","Clark PE","Curr Opin Urol","1999","1999/12/01","","","10.1097/00042307-199909000-00008"
"20290726","Total cystectomy for infiltrating carcinoma of the bladder","RITTER JS.","J Urol. 1947 Apr;57(4):719-29. doi: 10.1016/s0022-5347(17)69690-3.","RITTER JS","J Urol","1947","2010/03/19","","","10.1016/s0022-5347(17)69690-3"
"23702508","Imaging findings of atypical leiomyoma of the urinary bladder simulating bladder cancer: a case report and literature review","Wu S.","Med Ultrason. 2013 Jun;15(2):161-3. doi: 10.11152/mu.2013.2066.152.sw1.","Wu S","Med Ultrason","2013","2013/05/25","","","10.11152/mu.2013.2066.152.sw1"
"28751166","Clinical and demographic characteristics among patients with urothelial carcinomas of the upper urinary tract and bladder in Taiwan","Shen CH, Chiou HY, Tung MC, Wu CC, Kao WT, Wang YH, Juang GD.","J Chin Med Assoc. 2017 Sep;80(9):563-568. doi: 10.1016/j.jcma.2017.03.008. Epub 2017 Jul 24.","Shen CH","J Chin Med Assoc","2017","2017/07/29","","","10.1016/j.jcma.2017.03.008"
"1277157","Membrane changes during urothelial hyperplasia and neoplasia","Hicks RM, Wakefield JJ.","Cancer Res. 1976 Jul;36(7 PT 2):2502-7.","Hicks RM","Cancer Res","1976","1976/07/01","","",""
"16925739","What has been learned from meta-analyses of neoadjuvant and adjuvant chemotherapy in bladder cancer?","Sternberg CN, Collette L.","BJU Int. 2006 Sep;98(3):487-9. doi: 10.1111/j.1464-410X.2006.06371.x.","Sternberg CN","BJU Int","2006","2006/08/24","","","10.1111/j.1464-410X.2006.06371.x"
"1827327","Neoadjuvant and adjuvant therapy for invasive bladder tumors","Dirix LY, Van Oosterom AT.","Eur J Cancer. 1991;27(3):326-30. doi: 10.1016/0277-5379(91)90540-t.","Dirix LY","Eur J Cancer","1991","1991/01/01","","","10.1016/0277-5379(91)90540-t"
"9815630","Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations","Zhang FF, Arber DA, Wilson TG, Kawachi MH, Slovak ML.","Clin Cancer Res. 1997 Dec;3(12 Pt 1):2317-28.","Zhang FF","Clin Cancer Res","1997","1998/11/17","","",""
"19381080","Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer","Tran E, Souhami L, Tanguay S, Rajan R.","Am J Clin Oncol. 2009 Aug;32(4):333-7. doi: 10.1097/COC.0b013e31818b9486.","Tran E","Am J Clin Oncol","2009","2009/04/22","","","10.1097/COC.0b013e31818b9486"
"17987533","[Fluorescence diagnosis and photodynamic therapy in urology]","Stepp H, Waidelich R.","Aktuelle Urol. 2007 Nov;38(6):455-64. doi: 10.1055/s-2007-980149.","Stepp H","Aktuelle Urol","2007","2007/11/08","","","10.1055/s-2007-980149"
"7019784","A national trial on the treatment of invasive bladder cancer","Arnold EP, Bailey C, Burry AF, Bydder PV, Firth LA, Gowland S, Gray AJ, Mcllroy R.","N Z Med J. 1981 Apr 22;93(682):273-5.","Arnold EP","N Z Med J","1981","1981/04/22","","",""
"1611115","Interferon-alpha 2b instillation prophylaxis in superficial bladder cancer--a prospective, controlled three-armed trial. Project Group Bochum--Interferon and Superficial Bladder Cancer","Engelmann U, Knopf HJ, Graff J.","Anticancer Drugs. 1992 May;3 Suppl 1:33-7.","Engelmann U","Anticancer Drugs","1992","1992/05/01","","",""
"9168192","Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess","Stephens ER.","J Natl Cancer Inst. 1997 May 21;89(10):734-5; author reply 735-6.","Stephens ER","J Natl Cancer Inst","1997","1997/05/21","","",""
"29847834","Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis","Ha HK, Koo PJ, Kim SJ.","Oncology. 2018;95(1):31-38. doi: 10.1159/000488200. Epub 2018 May 30.","Ha HK","Oncology","2018","2018/05/31","","","10.1159/000488200"
"26830497","A multiplex immunoassay for the non-invasive detection of bladder cancer","Shimizu Y, Furuya H, Bryant Greenwood P, Chan O, Dai Y, Thornquist MD, Goodison S, Rosser CJ.","J Transl Med. 2016 Jan 30;14:31. doi: 10.1186/s12967-016-0783-2.","Shimizu Y","J Transl Med","2016","2016/02/03","PMC4736707","","10.1186/s12967-016-0783-2"
"1635123","Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study","Stöckle M, Meyenburg W, Wellek S, Voges G, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R.","J Urol. 1992 Aug;148(2 Pt 1):302-6; discussion 306-7. doi: 10.1016/s0022-5347(17)36578-3.","Stöckle M","J Urol","1992","1992/08/01","","","10.1016/s0022-5347(17)36578-3"
"6445776","Phase II trial of neocarzinostatin in patients with bladder and prostatic cancer: toxicity of a five-day iv bolus schedule","Natale RB, Yagoda A, Watson RC, Stover DE.","Cancer. 1980 Jun 1;45(11):2836-42. doi: 10.1002/1097-0142(19800601)45:11<2836::aid-cncr2820451120>3.0.co;2-7.","Natale RB","Cancer","1980","1980/06/01","","","10.1002/1097-0142(19800601)45:11<2836::aid-cncr2820451120>3.0.co;2-7"
"23235278","[A case of long-term survivor after combined modality therapy for brain metastasis of bladder carcinoma]","Yasuda K, Nakamura M, Takamoto D, Sanjo H, Gohbara A, Teranishi J, Yumura Y, Miyoshi Y, Kondo K, Noguchi K, Kubota Y.","Hinyokika Kiyo. 2012 Oct;58(10):553-6.","Yasuda K","Hinyokika Kiyo","2012","2012/12/14","","",""
"2033686","Efficacy of gadolinium-diethylenetriaminepentaacetic acid-enhanced magnetic resonance imaging for differentiation between superficial and muscle-invasive tumor of the bladder: a comparative study with computerized tomography and transurethral ultrasonography","Tachibana M, Baba S, Deguchi N, Jitsukawa S, Hata M, Tazaki H, Tanimoto A, Yuasa Y, Hiramatsu K.","J Urol. 1991 Jun;145(6):1169-73. doi: 10.1016/s0022-5347(17)38564-6.","Tachibana M","J Urol","1991","1991/06/01","","","10.1016/s0022-5347(17)38564-6"
"21116131","IAP and death receptors-targeted therapies in bladder cancer","Jin Z.","Cancer Biol Ther. 2010 Dec 1;10(11):1098-100. doi: 10.4161/cbt.10.11.14219. Epub 2010 Dec 1.","Jin Z","Cancer Biol Ther","2010","2010/12/01","","","10.4161/cbt.10.11.14219"
"6427483","Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival","Huland H, Otto U, Droese M, Klöppel G.","J Urol. 1984 Jul;132(1):27-9. doi: 10.1016/s0022-5347(17)49449-3.","Huland H","J Urol","1984","1984/07/01","","","10.1016/s0022-5347(17)49449-3"
"16740387","Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain","Kogevinas M, Fernandez F, Garcia-Closas M, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castano-Vinyals G, Yeager M, Chanock SJ, Lloreta J, Rothman N, Real FX, Dosemeci M, Malats N, Silverman D.","Eur J Cancer. 2006 Jul;42(10):1448-54. doi: 10.1016/j.ejca.2006.02.009. Epub 2006 Jun 5.","Kogevinas M","Eur J Cancer","2006","2006/06/03","","","10.1016/j.ejca.2006.02.009"
"26014498","Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer","Zhou B, Zhang P, Tang T, Liao H, Zhang K, Pu Y, Chen P, Song Y, Zhang L.","BMC Cancer. 2015 May 27;15:433. doi: 10.1186/s12885-015-1459-7.","Zhou B","BMC Cancer","2015","2015/05/28","PMC4445811","","10.1186/s12885-015-1459-7"
"7563328","The prostate involvement as prognostic factor in patients with superficial bladder tumors","Solsona E, Iborra I, Ricós JV, Monrós JL, Casanova JL, Almenar S.","J Urol. 1995 Nov;154(5):1710-3.","Solsona E","J Urol","1995","1995/11/01","","",""
"1988367","Histological and urinary reactivity of monoclonal antibody 1BE12 in bladder carcinoma. Purification of the antigen from urine","Pancino G, Toubert ME, Osinaga E, Chatelet F, Leroy M, Schlageter MH, Desroys du Roure F, Calvo F, Teillac P, Najean Y, et al.","Int J Cancer. 1991 Jan 21;47(2):221-6. doi: 10.1002/ijc.2910470210.","Pancino G","Int J Cancer","1991","1991/01/21","","","10.1002/ijc.2910470210"
"25039670","Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection","Munari E, Chaux A, Maldonado L, Compérat E, Varinot J, Bivalacqua TJ, Hoque MO, Netto GJ.","Histopathology. 2015 Jan;66(2):262-9. doi: 10.1111/his.12499. Epub 2015 Jan 7.","Munari E","Histopathology","2015","2014/07/22","","","10.1111/his.12499"
"4123535","Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?","O'Toole C, Perlmann P, Wigzell H, Unsgaard B, Zetterlund CG.","Lancet. 1973 May 19;1(7812):1085-8. doi: 10.1016/s0140-6736(73)90396-6.","O'Toole C","Lancet","1973","1973/05/19","","","10.1016/s0140-6736(73)90396-6"
"6637164","[Therapy of bladder cancer. Value of transurethral resection--treatment results]","Raschke P, Rothkopf M.","Z Urol Nephrol. 1983 Jun;76(6):369-82.","Raschke P","Z Urol Nephrol","1983","1983/06/01","","",""
"1277158","Early lesions in experimental bladder cancer: experimental design and light microscopic findings","Cohen SM, Jacobs JB, Arai M, Johansson S, Friedell GH.","Cancer Res. 1976 Jul;36(7 PT 2):2508-11.","Cohen SM","Cancer Res","1976","1976/07/01","","",""
"19801959","Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure","Golka K, Hermes M, Selinski S, Blaszkewicz M, Bolt HM, Roth G, Dietrich H, Prager HM, Ickstadt K, Hengstler JG.","Pharmacogenet Genomics. 2009 Nov;19(11):903-6. doi: 10.1097/FPC.0b013e328331b554.","Golka K","Pharmacogenet Genomics","2009","2009/10/06","","","10.1097/FPC.0b013e328331b554"
"6813292","[Intravesical chemical prevention of recurrence of superficial urothelial bladder cancer. Progress report of the Urology Clinic of Mainz University 1975-1981]","Jacobi GH, Engelmann U, Frohneberg D, Thüroff JW.","Helv Chir Acta. 1982 Aug;49(3-4):345-8.","Jacobi GH","Helv Chir Acta","1982","1982/08/01","","",""
"25564753","Radiographer-led plan selection for bladder cancer radiotherapy: initiating a training programme and maintaining competency","McNair HA, Hafeez S, Taylor H, Lalondrelle S, McDonald F, Hansen VN, Huddart R.","Br J Radiol. 2015 Apr;88(1048):20140690. doi: 10.1259/bjr.20140690. Epub 2015 Jan 7.","McNair HA","Br J Radiol","2015","2015/01/08","","","10.1259/bjr.20140690"
"28815808","Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation","Wang F, Wu LM, Hua XL, Zhao ZZ, Chen XX, Xu JR.","J Magn Reson Imaging. 2018 Apr;47(4):1054-1060. doi: 10.1002/jmri.25839. Epub 2017 Aug 17.","Wang F","J Magn Reson Imaging","2018","2017/08/18","","","10.1002/jmri.25839"
"12460916","Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling","Harding MA, Arden KC, Gildea JW, Gildea JJ, Perlman EJ, Viars C, Theodorescu D.","Cancer Res. 2002 Dec 1;62(23):6981-9.","Harding MA","Cancer Res","2002","2002/12/04","","",""
"471127","Nucleolar morphology in estimation of urinary bladder cancer in man: study on surface contact preparations","Pazourek J.","Neoplasma. 1979;26(2):201-4.","Pazourek J","Neoplasma","1979","1979/01/01","","",""
"31481549","Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: a study protocol for a randomised trial of clinical and cost-effectiveness","Tandogdu Z, Lewis R, Duncan A, Penegar S, McDonald A, Vale L, Shen J, Kelly JD, Pickard R, N Dow J, Ramsay C, Mostafid H, Mariappan P, Nabi G, Creswell J, Lazarowicz H, McGrath J, Taylor E, Clark E, Maclennan G, Norrie J, Hall E, Heer R; PHOTO Trial Management Group.","BMJ Open. 2019 Sep 3;9(9):e022268. doi: 10.1136/bmjopen-2018-022268.","Tandogdu Z","BMJ Open","2019","2019/09/05","PMC6731798","","10.1136/bmjopen-2018-022268"
"29277778","Placental Growth Factor in Bladder Cancer Compared to the Diagnostic Accuracy and Prognostic Performance of Vascular Endothelial Growth Factor A","Soukup V, Čapoun O, Pešl M, Sobotka R, Vávřová L, Hanuš T, Zima T, Kalousová M.","Anticancer Res. 2018 Jan;38(1):239-246. doi: 10.21873/anticanres.12213.","Soukup V","Anticancer Res","2018","2017/12/27","","","10.21873/anticanres.12213"
"26342199","ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression","Kawahara T, Shareef HK, Aljarah AK, Ide H, Li Y, Kashiwagi E, Netto GJ, Zheng Y, Miyamoto H.","Oncotarget. 2015 Oct 6;6(30):29860-76. doi: 10.18632/oncotarget.5007.","Kawahara T","Oncotarget","2015","2015/09/06","PMC4745768","","10.18632/oncotarget.5007"
"22414281","Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer","Yoshida S, Koga F, Kobayashi S, Ishii C, Tanaka H, Tanaka H, Komai Y, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K.","Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e21-7. doi: 10.1016/j.ijrobp.2011.11.065. Epub 2012 Mar 11.","Yoshida S","Int J Radiat Oncol Biol Phys","2012","2012/03/15","","","10.1016/j.ijrobp.2011.11.065"
"30556853","High-glucose promotes proliferation of human bladder cancer T24 cells by activating Wnt/β-catenin signaling pathway","Gao L, Xu FM, Shi WJ, Zhang S, Lu YL, Zhao DK, Long YF, Teng RB, Ge B.","Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8151-8160. doi: 10.26355/eurrev_201812_16507.","Gao L","Eur Rev Med Pharmacol Sci","2018","2018/12/18","","","10.26355/eurrev_201812_16507"
"27622605","Lentivirus-mediated p21/Waf-1 short hairpin RNA enhances the cytotoxic effects and replicative potential of a bladder cancer-specific oncolytic adenovirus in vitro","Shi J, Fu S, Wang L, Tao Y, Rodriguez R, Wang Z.","Anticancer Drugs. 2017 Jan;28(1):88-96. doi: 10.1097/CAD.0000000000000433.","Shi J","Anticancer Drugs","2017","2016/09/14","","","10.1097/CAD.0000000000000433"
"1636067","Bladder cancer in the spinal cord-injured patient with long-term catheterization: a casual relationship?","Esrig D, McEvoy K, Bennett CJ.","Semin Urol. 1992 May;10(2):102-8.","Esrig D","Semin Urol","1992","1992/05/01","","",""
"18703273","Re: Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill. Laparoscopic and robotic-assisted radical cystectomy for bladder cancer: a critical analysis. Eur Urol 2008;54:54-64","Simonato A, Gregori A.","Eur Urol. 2009 Jan;55(1):e13-4. doi: 10.1016/j.eururo.2008.07.070. Epub 2008 Aug 3.","Simonato A","Eur Urol","2009","2008/08/16","","","10.1016/j.eururo.2008.07.070"
"17349535","Do we need a geriatric assessment for a better surgical treatment in older patients with bladder cancer?","Bernardi D, Errante D, Merlo A.","Urol Oncol. 2007 Mar-Apr;25(2):168; author reply 168-9. doi: 10.1016/j.urolonc.2006.09.005.","Bernardi D","Urol Oncol","2007","2007/03/14","","","10.1016/j.urolonc.2006.09.005"
"7411713","Cytology of bladder carcinoma","El-Bolkainy MN.","J Urol. 1980 Jul;124(1):20-2. doi: 10.1016/s0022-5347(17)55271-4.","El-Bolkainy MN","J Urol","1980","1980/07/01","","","10.1016/s0022-5347(17)55271-4"
"3607736","Ring chromosomes in bladder cancer","Milasin J, Mićić M, Mićić S, Diklić V.","Cancer Genet Cytogenet. 1987 Sep;28(1):183-4. doi: 10.1016/0165-4608(87)90370-0.","Milasin J","Cancer Genet Cytogenet","1987","1987/09/01","","","10.1016/0165-4608(87)90370-0"
"24921905","Variant histology: role in management and prognosis of nonmuscle invasive bladder cancer","Porten SP, Willis D, Kamat AM.","Curr Opin Urol. 2014 Sep;24(5):517-23. doi: 10.1097/MOU.0000000000000089.","Porten SP","Curr Opin Urol","2014","2014/06/13","","","10.1097/MOU.0000000000000089"
"22126151","Global epigenetic profiling in bladder cancer","Dudziec E, Goepel JR, Catto JW.","Epigenomics. 2011 Feb;3(1):35-45. doi: 10.2217/epi.10.71.","Dudziec E","Epigenomics","2011","2011/12/01","","","10.2217/epi.10.71"
"25347370","Conventional and diffusion-weighted MRI features in diagnosis of metastatic lymphadenopathy in bladder cancer","Wollin DA, Deng FM, Huang WC, Babb JS, Rosenkrantz AB.","Can J Urol. 2014 Oct;21(5):7454-9.","Wollin DA","Can J Urol","2014","2014/10/28","","",""
"8364209","Effects of agents that inhibit cellular iron incorporation on bladder cancer cell proliferation","Seligman PA, Schleicher RB, Siriwardana G, Domenico J, Gelfand EW.","Blood. 1993 Sep 1;82(5):1608-17.","Seligman PA","Blood","1993","1993/09/01","","",""
"18280556","Urethral recurrence in a woman after continent orthotopic urinary diversion for bladder cancer","Stein JP, Hertz J, Nichols PW.","Urology. 2008 Apr;71(4):755.e1-2. doi: 10.1016/j.urology.2007.11.068. Epub 2008 Feb 15.","Stein JP","Urology","2008","2008/02/19","","","10.1016/j.urology.2007.11.068"
"409478","A comparative study of two preoperative radiation regimens with cystectomy for bladder cancer","Whitmore WF Jr, Batata MA, Hilaris BS, Reddy GN, Unal A, Ghoneim MA, Grabstald H, Chu F.","Cancer. 1977 Sep;40(3):1077-86. doi: 10.1002/1097-0142(197709)40:3<1077::aid-cncr2820400316>3.0.co;2-r.","Whitmore WF Jr","Cancer","1977","1977/09/01","","","10.1002/1097-0142(197709)40:3<1077::aid-cncr2820400316>3.0.co;2-r"
"4040097","Histopathological evaluation of rat urinary bladders from the IRDC two-generation bioassay of sodium saccharin","Squire RA.","Food Chem Toxicol. 1985 Apr-May;23(4-5):491-7. doi: 10.1016/0278-6915(85)90143-7.","Squire RA","Food Chem Toxicol","1985","1985/04/01","","","10.1016/0278-6915(85)90143-7"
"3095278","A report of a randomized trial of d(15)+Be neutrons compared with megavoltage X ray therapy of bladder cancer","Catterall M, Bewley DR.","Int J Radiat Oncol Biol Phys. 1986 Nov;12(11):2053. doi: 10.1016/0360-3016(86)90148-3.","Catterall M","Int J Radiat Oncol Biol Phys","1986","1986/11/01","","","10.1016/0360-3016(86)90148-3"
"19148551","Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy","Beecken WD, Engl T, Jonas D, Blaheta RA.","Int J Mol Med. 2009 Feb;23(2):261-6.","Beecken WD","Int J Mol Med","2009","2009/01/17","","",""
"20099381","Cigarette smoking and bladder cancer: a new twist in an old saga?","Alberg AJ, Hébert JR.","J Natl Cancer Inst. 2010 Jan 20;102(2):138. doi: 10.1093/jnci/djp474.","Alberg AJ","J Natl Cancer Inst","2010","2010/01/26","PMC2808349","","10.1093/jnci/djp474"
"7614405","Combined intraarterial cisplatin infusion and radiation therapy for invasive bladder cancer","Mizoguchi H, Nomura Y, Terada K, Nakagawa M, Ogata J.","Int J Urol. 1995 Mar;2(1):17-23.","Mizoguchi H","Int J Urol","1995","1995/03/01","","",""
"28661109","[THE MULTIDISCIPLINARY MUSCLE INVASIVE BLADDER CANCER CLINIC AT THE RABIN MEDICAL CENTER]","Noroheimer S, Ozalvo R, Abramovich A, Fenig E, Domachevsky L, Yakimov M, Baniel J, Yossepowitch O, Kedar D, Neiman V, Rosenbaum E, Margel D.","Harefuah. 2017 Jun;156(6):349-352.","Noroheimer S","Harefuah","2017","2017/06/30","","",""
"23169479","microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer","Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B, Amsellem-Ouazana D, Bieche I.","Int J Cancer. 2013 Jun 1;132(11):2479-91. doi: 10.1002/ijc.27949. Epub 2013 Feb 25.","Pignot G","Int J Cancer","2013","2012/11/22","","","10.1002/ijc.27949"
"4010740","Heavy phenacetin use and bladder cancer in women aged 20 to 49 years","Piper JM, Tonascia J, Matanoski GM.","N Engl J Med. 1985 Aug 1;313(5):292-5. doi: 10.1056/NEJM198508013130504.","Piper JM","N Engl J Med","1985","1985/08/01","","","10.1056/NEJM198508013130504"
"26995008","Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer","Li CE, Chien CS, Chuang YC, Chang YI, Tang HP, Kang CH.","Int Urol Nephrol. 2016 Jun;48(6):993-9. doi: 10.1007/s11255-016-1264-5. Epub 2016 Mar 19.","Li CE","Int Urol Nephrol","2016","2016/03/21","","","10.1007/s11255-016-1264-5"
"25626182","The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update","Smith ND, Castle EP, Gonzalgo ML, Svatek RS, Weizer AZ, Montgomery JS, Pruthi RS, Woods ME, Tollefson MK, Konety BR, Shabsigh A, Krupski T, Barocas DA, Dash A, Quek ML, Kibel AS, Parekh DJ.","BJU Int. 2015 Feb;115(2):198-205. doi: 10.1111/bju.12699.","Smith ND","BJU Int","2015","2015/01/28","PMC4906442","NIHMS792364","10.1111/bju.12699"
"15526230","[The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer]","Daniltchenko D, Riedl C, Koenig F, Daha LK, Sachs M, Schnorr D.","Aktuelle Urol. 2004 Nov;35(6):497-501. doi: 10.1055/s-2004-818544.","Daniltchenko D","Aktuelle Urol","2004","2004/11/05","","","10.1055/s-2004-818544"
"21481014","Clinical significance of immediate urine cytology after transurethral resection of bladder tumor in patients with non-muscle invasive bladder cancer","Shin YS, Kim SD, Cha JS, Kim MK, Jeong YB, Kim HJ.","Int J Urol. 2011 Jun;18(6):439-43. doi: 10.1111/j.1442-2042.2011.02766.x. Epub 2011 Apr 11.","Shin YS","Int J Urol","2011","2011/04/13","","","10.1111/j.1442-2042.2011.02766.x"
"23046343","Options for diagnosis and treatment of urachal carcinoma","Zhang J, Wu J.","Asia Pac J Clin Oncol. 2013 Jun;9(2):117-22. doi: 10.1111/j.1743-7563.2012.01592.x. Epub 2012 Oct 9.","Zhang J","Asia Pac J Clin Oncol","2013","2012/10/11","","","10.1111/j.1743-7563.2012.01592.x"
"26080092","Perioperative Blood Transfusion Promotes Worse Outcomes of Bladder Cancer after Radical Cystectomy: A Systematic Review and Meta-Analysis","Wang YL, Jiang B, Yin FF, Shi HQ, Xu XD, Zheng SS, Wu S, Hou SC.","PLoS One. 2015 Jun 16;10(6):e0130122. doi: 10.1371/journal.pone.0130122. eCollection 2015.","Wang YL","PLoS One","2015","2015/06/17","PMC4469696","","10.1371/journal.pone.0130122"
"16705457","Rapid diagnosis and follow up of bladder cancer patients using urinary high molecular weight cytokeratins","Attallah AM, Sakr HA, Ismail H, Ismail MF, Ibrahim AS, El-Sharabasy MM, El-Dosoky I.","World J Urol. 2006 Aug;24(3):345-52. doi: 10.1007/s00345-006-0100-4. Epub 2006 May 17.","Attallah AM","World J Urol","2006","2006/05/18","","","10.1007/s00345-006-0100-4"
"1529810","[Clinical studies of patients with bladder cancers]","Nakagawa Y, Matsuda T, Kawamura H, Murota T, Ohara T, Komatsu Y.","Hinyokika Kiyo. 1992 Apr;38(4):389-94.","Nakagawa Y","Hinyokika Kiyo","1992","1992/04/01","","",""
"2359220","[Intravesical bacillus Calmette-Guerin instillation therapy in superficial bladder cancers--clinical study on prognostic factors]","Shinka T, Hirano A, Uekado Y, Ohkawa T.","Nihon Hinyokika Gakkai Zasshi. 1990 Mar;81(3):425-32. doi: 10.5980/jpnjurol1989.81.425.","Shinka T","Nihon Hinyokika Gakkai Zasshi","1990","1990/03/01","","","10.5980/jpnjurol1989.81.425"
"23817891","Comparative survival following different treatment modalities for stage T2 bladder cancer in octogenarians","Trulson JJ, Sharma P, Haden T, Kheterpal E, Pokala N.","World J Urol. 2014 Apr;32(2):425-9. doi: 10.1007/s00345-013-1123-2. Epub 2013 Jul 2.","Trulson JJ","World J Urol","2014","2013/07/03","","","10.1007/s00345-013-1123-2"
"31771768","[Optimizing the management of bladder cancer in older patients]","Neuzillet Y, Geiss R, Paillaud E, Mongiat-Artus P.","Prog Urol. 2019 Nov;29(14):849-864. doi: 10.1016/j.purol.2019.08.273.","Neuzillet Y","Prog Urol","2019","2019/11/28","","","10.1016/j.purol.2019.08.273"
"31123937","Peri-operative efficacy and long-term survival benefit of robotic-assisted radical cystectomy in septuagenarian patients compared with younger patients: a nationwide multi-institutional study in Japan","Iwamoto H, Morizane S, Koie T, Shiroki R, Kawakita M, Gondo T, Matsumoto K, Habuchi T, Sunada H, Endo Y, Noma H, Takenaka A, Kanayama H.","Int J Clin Oncol. 2019 Dec;24(12):1588-1595. doi: 10.1007/s10147-019-01470-6. Epub 2019 May 23.","Iwamoto H","Int J Clin Oncol","2019","2019/05/25","","","10.1007/s10147-019-01470-6"
"7613858","Molecular genetics of bladder cancer","Knowles MA.","Br J Urol. 1995 Jun;75 Suppl 1:57-66.","Knowles MA","Br J Urol","1995","1995/06/01","","",""
"9120913","P53 accumulation, deoxyribonucleic acid ploidy and progression of bladder cancer","Raitanen MP, Tammela TL, Kallioinen M, Isola J.","J Urol. 1997 Apr;157(4):1250-3.","Raitanen MP","J Urol","1997","1997/04/01","","",""
"11469512","A preliminary study on the carcinogenicity of the common fern Onychium contiguum","Dawra RK, Sharma OP, Somvanshi R.","Vet Res Commun. 2001 Jul;25(5):413-20. doi: 10.1023/a:1010650911942.","Dawra RK","Vet Res Commun","2001","2001/07/27","","","10.1023/a:1010650911942"
"6542270","[Dysplastic urothelial changes in patients with bladder cancer]","Csapó Z, Kolozsy Z, Dauda G, Mohácsi L.","Urologe A. 1984 Sep;23(5):281-4.","Csapó Z","Urologe A","1984","1984/09/01","","",""
"18774459","Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer","Lerner SP, Shen S.","Urol Oncol. 2008 Sep-Oct;26(5):481-5. doi: 10.1016/j.urolonc.2008.03.002.","Lerner SP","Urol Oncol","2008","2008/09/09","","","10.1016/j.urolonc.2008.03.002"
"15892835","Re: Where are the 'poster boys' for bladder cancer?","Gidwani AL, Brown R.","BJU Int. 2005 Jun;95(9):1368-9. doi: 10.1111/j.1464-410X.2005.05593_3.x.","Gidwani AL","BJU Int","2005","2005/05/17","","","10.1111/j.1464-410X.2005.05593_3.x"
"11745498","Use of permanent hair dyes and bladder-cancer risk","Henley SJ, Thun MJ.","Int J Cancer. 2001 Dec 15;94(6):903-6. doi: 10.1002/ijc.1547.","Henley SJ","Int J Cancer","2001","2001/12/18","","","10.1002/ijc.1547"
"2681016","Occupation and bladder cancer in Spain: a multi-centre case-control study","González CA, López-Abente G, Errezola M, Escolar A, Riboli E, Izarzugaza I, Nebot M.","Int J Epidemiol. 1989 Sep;18(3):569-77. doi: 10.1093/ije/18.3.569.","González CA","Int J Epidemiol","1989","1989/09/01","","","10.1093/ije/18.3.569"
"16964384","Effect of sulforaphane on cell growth, G(0)/G(1) phase cell progression and apoptosis in human bladder cancer T24 cells","Shan Y, Sun C, Zhao X, Wu K, Cassidy A, Bao Y.","Int J Oncol. 2006 Oct;29(4):883-8.","Shan Y","Int J Oncol","2006","2006/09/12","","",""
"4009982","Multiple primary cancers (MPC) associated with bladder cancer: an analysis of the clinical and autopsy cases in Japan","Kotake T, Kiyohara H.","Jpn J Clin Oncol. 1985 Apr;15 Suppl 1:201-10.","Kotake T","Jpn J Clin Oncol","1985","1985/04/01","","",""
"15475431","Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer","Yamamoto Y, Matsuyama H, Furuya T, Oga A, Yoshihiro S, Okuda M, Kawauchi S, Sasaki K, Naito K.","Clin Cancer Res. 2004 Oct 1;10(19):6449-55. doi: 10.1158/1078-0432.CCR-04-0773.","Yamamoto Y","Clin Cancer Res","2004","2004/10/12","","","10.1158/1078-0432.CCR-04-0773"
"28049550","GEC-ESTRO/ACROP recommendations for performing bladder-sparing treatment with brachytherapy for muscle-invasive bladder carcinoma","Pieters BR, van der Steen-Banasik E, Smits GA, De Brabandere M, Bossi A, Van Limbergen E.","Radiother Oncol. 2017 Mar;122(3):340-346. doi: 10.1016/j.radonc.2016.12.022. Epub 2016 Dec 31.","Pieters BR","Radiother Oncol","2017","2017/01/05","","","10.1016/j.radonc.2016.12.022"
"14759720","Breast cancer presenting initially with urinary incontinence: a case of bladder metastasis from breast cancer","Soon PS, Lynch W, Schwartz P.","Breast. 2004 Feb;13(1):69-71. doi: 10.1016/j.breast.2003.09.005.","Soon PS","Breast","2004","2004/02/05","","","10.1016/j.breast.2003.09.005"
"17452976","Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis","Kanehira M, Harada Y, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y, Katagiri T.","Oncogene. 2007 Sep 27;26(44):6448-55. doi: 10.1038/sj.onc.1210466. Epub 2007 Apr 23.","Kanehira M","Oncogene","2007","2007/04/25","","","10.1038/sj.onc.1210466"
"26107200","OK-432 Suppresses Proliferation and Metastasis by Tumor Associated Macrophages in Bladder Cancer","Tian YF, Tang K, Guan W, Yang T, Xu H, Zhuang QY, Ye ZQ.","Asian Pac J Cancer Prev. 2015;16(11):4537-42. doi: 10.7314/apjcp.2015.16.11.4537.","Tian YF","Asian Pac J Cancer Prev","2015","2015/06/25","","","10.7314/apjcp.2015.16.11.4537"
"27082128","Viscoelastic properties of human bladder tumours","Barnes SC, Lawless BM, Shepherd DET, Espino DM, Bicknell GR, Bryan RT.","J Mech Behav Biomed Mater. 2016 Aug;61:250-257. doi: 10.1016/j.jmbbm.2016.03.012. Epub 2016 Mar 24.","Barnes SC","J Mech Behav Biomed Mater","2016","2016/04/16","","","10.1016/j.jmbbm.2016.03.012"
"24420616","Adjuvant chemotherapy is associated with decreased mortality after radical cystectomy for locally advanced bladder cancer","Yelfimov DA, Frank I, Boorjian SA, Thapa P, Cheville JC, Tollefson MK.","World J Urol. 2014 Dec;32(6):1463-8. doi: 10.1007/s00345-014-1236-2. Epub 2014 Jan 14.","Yelfimov DA","World J Urol","2014","2014/01/15","","","10.1007/s00345-014-1236-2"
"9698673","Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer","Amann B, Perabo FG, Wirger A, Hugenschmidt H, Schultze-Seemann W.","Br J Urol. 1998 Jul;82(1):118-21. doi: 10.1046/j.1464-410x.1998.00675.x.","Amann B","Br J Urol","1998","1998/08/12","","","10.1046/j.1464-410x.1998.00675.x"
"603836","Hair dyes and bladder cancer","Jain M, Morgan RW, Elinson L.","Can Med Assoc J. 1977 Nov 19;117(10):1131-3.","Jain M","Can Med Assoc J","1977","1977/11/19","PMC1880297","",""
"9394910","Early cystectomy for clinical stage T1 transitional cell carcinoma of the bladder","Esrig D, Freeman JA, Stein JP, Skinner DG.","Semin Urol Oncol. 1997 Aug;15(3):154-60.","Esrig D","Semin Urol Oncol","1997","1997/08/01","","",""
"2144178","Bladder cancer screening study initiated by Fox Chase","","Oncology (Williston Park). 1990 Jan;4(1):16.","","Oncology (Williston Park)","1990","1990/01/01","","",""
"26475274","Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy","Siddiqui KM, Izawa JI.","World J Urol. 2016 Jan;34(1):19-24. doi: 10.1007/s00345-015-1706-1. Epub 2015 Oct 16.","Siddiqui KM","World J Urol","2016","2015/10/18","","","10.1007/s00345-015-1706-1"
"31532291","Re: Prognostic Significance of Lymphatic, Vascular and Perineural Invasion for Bladder Cancer Patients Treated by Radical Cystectomy","Chang SS.","J Urol. 2019 Dec;202(6):1097. doi: 10.1097/01.JU.0000585772.80050.5c. Epub 2019 Sep 18.","Chang SS","J Urol","2019","2019/09/19","","","10.1097/01.JU.0000585772.80050.5c"
"17904728","When and how to treat superficial and muscle-invasive bladder cancer","Zlotta AR.","Eur Urol. 2007 Dec;52(6):1554-7. doi: 10.1016/j.eururo.2007.09.033. Epub 2007 Sep 25.","Zlotta AR","Eur Urol","2007","2007/10/02","","","10.1016/j.eururo.2007.09.033"
"17335595","Comparison of the clinical and pathologic staging in patients undergoing radical cystectomy for bladder cancer","McLaughlin S, Shephard J, Wallen E, Maygarden S, Carson CC, Pruthi RS.","Int Braz J Urol. 2007 Jan-Feb;33(1):25-31; discussion 31-2. doi: 10.1590/s1677-55382007000100005.","McLaughlin S","Int Braz J Urol","2007","2007/03/06","","","10.1590/s1677-55382007000100005"
"22947580","Clinical features of bladder cancer in primary care","Shephard EA, Stapley S, Neal RD, Rose P, Walter FM, Hamilton WT.","Br J Gen Pract. 2012 Sep;62(602):e598-604. doi: 10.3399/bjgp12X654560.","Shephard EA","Br J Gen Pract","2012","2012/09/06","PMC3426598","","10.3399/bjgp12X654560"
"25443270","Quality of life in patients with non-muscle-invasive bladder cancer: one-year results of a multicentre prospective cohort study","Schmidt S, Francés A, Lorente Garin JA, Juanpere N, Lloreta Trull J, Bonfill X, Martinez-Zapata MJ, Morales Suarez-Varela M, de la Cruz J, Emparanza JI, Sánchez MJ, Zamora J, Pijoan JI, Alonso J, Ferrer M.","Urol Oncol. 2015 Jan;33(1):19.e7-19.e15. doi: 10.1016/j.urolonc.2014.09.012. Epub 2014 Oct 22.","Schmidt S","Urol Oncol","2015","2014/12/03","","","10.1016/j.urolonc.2014.09.012"
"29059779","Re: Profiling of Long Non-Coding RNAs Identifies LINC00958 and LINC01296 as Candidate Oncogenes in Bladder Cancer","Atala A.","J Urol. 2017 Nov;198(5):983-985. doi: 10.1016/j.juro.2017.08.008. Epub 2017 Aug 9.","Atala A","J Urol","2017","2017/10/25","","","10.1016/j.juro.2017.08.008"
"25239998","Unusual metastatic spread of bladder cancer","Garth R, Sathyanarayana V, Kapur K.","BMJ Case Rep. 2014 Sep 19;2014:bcr2014206013. doi: 10.1136/bcr-2014-206013.","Garth R","BMJ Case Rep","2014","2014/09/21","PMC4170298","","10.1136/bcr-2014-206013"
"30367268","Management of High-grade T1 Urothelial Carcinoma","Reisz PA, Laviana AA, Chang SS.","Curr Urol Rep. 2018 Oct 26;19(12):103. doi: 10.1007/s11934-018-0850-8.","Reisz PA","Curr Urol Rep","2018","2018/10/28","","","10.1007/s11934-018-0850-8"
"23861976","A pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace","Khalid T, White P, De Lacy Costello B, Persad R, Ewen R, Johnson E, Probert CS, Ratcliffe N.","PLoS One. 2013 Jul 8;8(7):e69602. doi: 10.1371/journal.pone.0069602. Print 2013.","Khalid T","PLoS One","2013","2013/07/18","PMC3704674","","10.1371/journal.pone.0069602"
"20610280","Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression","McConkey DJ, Lee S, Choi W, Tran M, Majewski T, Lee S, Siefker-Radtke A, Dinney C, Czerniak B.","Urol Oncol. 2010 Jul-Aug;28(4):429-40. doi: 10.1016/j.urolonc.2010.04.008.","McConkey DJ","Urol Oncol","2010","2010/07/09","PMC2901550","NIHMS210390","10.1016/j.urolonc.2010.04.008"
"20001606","Urinary diversion after cystectomy for bladder cancer: a population-based study in Sweden","Jahnson S, Damm O, Hellsten S, Holmäng S, Liedberg F, Ljungberg B, Malmström PU, Månsson W, Rosell J, Wijkstöm H.","Scand J Urol Nephrol. 2010 Mar;44(2):69-75. doi: 10.3109/00365590903449357.","Jahnson S","Scand J Urol Nephrol","2010","2009/12/17","","","10.3109/00365590903449357"
"26143111","Combining Mitomycin C and Regional 70 MHz Hyperthermia in Patients with Nonmuscle Invasive Bladder Cancer: A Pilot Study","Geijsen ED, de Reijke TM, Koning CC, Zum Vörde Sive Vörding PJ, de la Rosette JJ, Rasch CR, van Os RM, Crezee J.","J Urol. 2015 Nov;194(5):1202-8. doi: 10.1016/j.juro.2015.05.102. Epub 2015 Jul 2.","Geijsen ED","J Urol","2015","2015/07/06","","","10.1016/j.juro.2015.05.102"
"20603439","BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer","Font A, Taron M, Gago JL, Costa C, Sánchez JJ, Carrato C, Mora M, Celiz P, Perez L, Rodríguez D, Gimenez-Capitan A, Quiroga V, Benlloch S, Ibarz L, Rosell R.","Ann Oncol. 2011 Jan;22(1):139-144. doi: 10.1093/annonc/mdq333. Epub 2010 Jul 5.","Font A","Ann Oncol","2011","2010/07/07","","","10.1093/annonc/mdq333"
"32120459","Bladder cancer in women: a Sri Lankan study","Goonewardena SAS, Jayarajah U, de Silva MVC, Kuruppu SN, Fernando DMH, Herath KB.","Ceylon Med J. 2019 Sep 30;64(3):98-102. doi: 10.4038/cmj.v64i3.8952.","Goonewardena SAS","Ceylon Med J","2019","2020/03/03","","","10.4038/cmj.v64i3.8952"
"25947114","Characterization and noninvasive diagnosis of bladder cancer with serum surface enhanced Raman spectroscopy and genetic algorithms","Li S, Li L, Zeng Q, Zhang Y, Guo Z, Liu Z, Jin M, Su C, Lin L, Xu J, Liu S.","Sci Rep. 2015 May 7;5:9582. doi: 10.1038/srep09582.","Li S","Sci Rep","2015","2015/05/08","PMC4423238","","10.1038/srep09582"
"23540782","The conundrum of prostatic urethral involvement","Ingimarsson JP, Seigne JD.","Urol Clin North Am. 2013 May;40(2):249-59. doi: 10.1016/j.ucl.2013.01.010. Epub 2013 Feb 13.","Ingimarsson JP","Urol Clin North Am","2013","2013/04/02","","","10.1016/j.ucl.2013.01.010"
"6465859","Adjuvant immunotherapy of N-[4(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder tumors","Ibraheim EH, El Kappany H, Nigam VN, Brailovsky CA, Madarnas P, Elhilali MM.","Anticancer Res. 1984 May-Jun;4(3):209-13.","Ibraheim EH","Anticancer Res","1984","1984/05/01","","",""
"17253068","[Pronostic factors in recurrence and progression of superficial bladder cancer. Risk groups (part I)]","García Rodríguez J, Fernández Gómez JM, Escaf Barmadah S, González Alvarez RC, Rodríguez Robles L, Miranda Aranzubia O.","Actas Urol Esp. 2006 Nov-Dec;30(10):998-1008. doi: 10.1016/s0210-4806(06)73576-8.","García Rodríguez J","Actas Urol Esp","2006","2007/01/27","","","10.1016/s0210-4806(06)73576-8"
"25964541","Preliminary Results of a Multicentre Study of the UBC Rapid Test for Detection of Urinary Bladder Cancer","Ecke TH, Arndt C, Stephan C, Hallmann S, Lux O, Otto T, Ruttloff J, Gerullis H.","Anticancer Res. 2015 May;35(5):2651-5.","Ecke TH","Anticancer Res","2015","2015/05/13","","",""
"26717786","[A CASE OF ADVANCED BLADDER NEUROENDOCRINE CARCINOMA (SMALL CELL CARCINOMA) SIGNIFICANTLY IMPROVED BY LOW DOSE OF ORAL TEGAFUR-URACIL]","Nomi H, Takahara K, Minami K, Maenosono R, Matsunaga T, Yoshikawa Y, Tsujino T, Hirano H, Inamoto T, Yamamoto I, Tsuji M, Kiyama S, Azuma H.","Nihon Hinyokika Gakkai Zasshi. 2015 Oct;106(4):269-73. doi: 10.5980/jpnjurol.106.269.","Nomi H","Nihon Hinyokika Gakkai Zasshi","2015","2016/01/01","","","10.5980/jpnjurol.106.269"
"17346275","Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha","Yang JL, Qu XJ, Hayes VM, Brenner PC, Russell PJ, Goldstein D.","BJU Int. 2007 Jun;99(6):1539-45. doi: 10.1111/j.1464-410X.2007.06778.x. Epub 2007 Mar 6.","Yang JL","BJU Int","2007","2007/03/10","","","10.1111/j.1464-410X.2007.06778.x"
"9730148","Transitional cell carcinoma of the urethra in men and women associated with bladder cancer","Kakizoe T, Tobisu K.","Jpn J Clin Oncol. 1998 Jun;28(6):357-9. doi: 10.1093/jjco/28.6.357.","Kakizoe T","Jpn J Clin Oncol","1998","1998/09/08","","","10.1093/jjco/28.6.357"
"30851902","The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy","Marks P, Gild P, Soave A, Janisch F, Minner S, Engel O, Vetterlein MW, Shariat SF, Sauter G, Dahlem R, Fisch M, Rink M.","Surg Oncol. 2019 Mar;28:208-213. doi: 10.1016/j.suronc.2019.01.008. Epub 2019 Jan 30.","Marks P","Surg Oncol","2019","2019/03/11","","","10.1016/j.suronc.2019.01.008"
"20029473","Time-trend in epidemiological and pathological features of schistosoma-associated bladder cancer","Zaghloul MS, Nouh A, Moneer M, El-Baradie M, Nazmy M, Younis A.","J Egypt Natl Canc Inst. 2008 Jun;20(2):168-74.","Zaghloul MS","J Egypt Natl Canc Inst","2008","2009/12/24","","",""
"13449477","[Physical therapy of bladder cancer]","LANGE J.","J Med Bord. 1957 Jun;134(6):824-32.","LANGE J","J Med Bord","1957","1957/06/01","","",""
"18206936","Metastatic adenocarcinoma after augmentation gastrocystoplasty","Vemulakonda VM, Lendvay TS, Shnorhavorian M, Joyner BD, Kaplan H, Mitchell ME, Grady RW.","J Urol. 2008 Mar;179(3):1094-6; discussion 1097. doi: 10.1016/j.juro.2007.10.089. Epub 2008 Jan 18.","Vemulakonda VM","J Urol","2008","2008/01/22","","","10.1016/j.juro.2007.10.089"
"26290438","MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1","Yao K, He L, Gan Y, Zeng Q, Dai Y, Tan J.","Diagn Pathol. 2015 Aug 20;10:146. doi: 10.1186/s13000-015-0372-3.","Yao K","Diagn Pathol","2015","2015/08/21","PMC4546080","","10.1186/s13000-015-0372-3"
"30916420","Impact of sex difference on survival of bladder cancer: A population-based registry data in Japan","Nakayama M, Ito Y, Hatano K, Nakai Y, Kakimoto KI, Miyashiro I, Nishimura K.","Int J Urol. 2019 Jun;26(6):649-654. doi: 10.1111/iju.13955. Epub 2019 Mar 27.","Nakayama M","Int J Urol","2019","2019/03/28","","","10.1111/iju.13955"
"3473252","Changing cigarette habits and bladder cancer risk: a case-control study","Hartge P, Silverman D, Hoover R, Schairer C, Altman R, Austin D, Cantor K, Child M, Key C, Marrett LD, et al.","J Natl Cancer Inst. 1987 Jun;78(6):1119-25.","Hartge P","J Natl Cancer Inst","1987","1987/06/01","","",""
"18082932","Editorial comment on: the value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer","Pycha A.","Eur Urol. 2008 Aug;54(2):408. doi: 10.1016/j.eururo.2007.11.053. Epub 2007 Dec 7.","Pycha A","Eur Urol","2008","2007/12/18","","","10.1016/j.eururo.2007.11.053"
"12494519","[The analysis of thymidine phosphorylase examined by ELISA in bladder cancer]","Saegusa M, Takao A, Manabe D, Ichikawa T, Aramaki K, Nakayama Y, Yamada D.","Nihon Hinyokika Gakkai Zasshi. 2002 Nov;93(7):743-9. doi: 10.5980/jpnjurol1989.93.743.","Saegusa M","Nihon Hinyokika Gakkai Zasshi","2002","2002/12/24","","","10.5980/jpnjurol1989.93.743"
"18425359","TP53 gene mutations as an independent marker for urinary bladder cancer progression","Ecke TH, Sachs MD, Lenk SV, Loening SA, Schlechte HH.","Int J Mol Med. 2008 May;21(5):655-61.","Ecke TH","Int J Mol Med","2008","2008/04/22","","",""
"28683751","A novel transurethral resection technique for superficial bladder tumor: retrograde en bloc resection","Zhang KY, Xing JC, Li W, Wu Z, Chen B, Bai DY.","World J Surg Oncol. 2017 Jul 6;15(1):125. doi: 10.1186/s12957-017-1192-6.","Zhang KY","World J Surg Oncol","2017","2017/07/08","PMC5501371","","10.1186/s12957-017-1192-6"
"25323766","Epigenetic repression of regulator of G-protein signaling 2 by ubiquitin-like with PHD and ring-finger domain 1 promotes bladder cancer progression","Ying L, Lin J, Qiu F, Cao M, Chen H, Liu Z, Huang Y.","FEBS J. 2015 Jan;282(1):174-82. doi: 10.1111/febs.13116. Epub 2014 Dec 3.","Ying L","FEBS J","2015","2014/10/18","","","10.1111/febs.13116"
"9855120","Results of transurethral resection plus adjuvant intravesical chemotherapy for superficial bladder cancer","Nomi M, Gohji K, Okamoto M, Takenaka A, Ono Y, Fujii A.","Int J Urol. 1998 Nov;5(6):534-9. doi: 10.1111/j.1442-2042.1998.tb00407.x.","Nomi M","Int J Urol","1998","1998/12/17","","","10.1111/j.1442-2042.1998.tb00407.x"
"24937673","Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer","Hunter BA, Eustace A, Irlam JJ, Valentine HR, Denley H, Oguejiofor KK, Swindell R, Hoskin PJ, Choudhury A, West CM.","Br J Cancer. 2014 Jul 29;111(3):437-43. doi: 10.1038/bjc.2014.315. Epub 2014 Jun 17.","Hunter BA","Br J Cancer","2014","2014/06/18","PMC4119984","","10.1038/bjc.2014.315"
"31177855","Value of quantitative and qualitative analyses of serum and urine cell-free DNA as diagnostic tools for bladder cancer: a meta-analysis","Cao Z, Peng L, He K, Wang X, Lu Y, Zhang Y, Bi L.","Expert Rev Anticancer Ther. 2019 Jul;19(7):645-653. doi: 10.1080/14737140.2019.1626723. Epub 2019 Jul 12.","Cao Z","Expert Rev Anticancer Ther","2019","2019/06/11","","","10.1080/14737140.2019.1626723"
"21875290","Epidemiologic status of bladder cancer in Shiraz, southern Iran","Salehi A, Khezri AA, Malekmakan L, Aminsharifi A.","Asian Pac J Cancer Prev. 2011;12(5):1323-7.","Salehi A","Asian Pac J Cancer Prev","2011","2011/08/31","","",""
"18630455","Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of favorable prognosis","Vasala K, Pääkko P, Turpeenniemi-Hujanen T.","Anticancer Res. 2008 May-Jun;28(3B):1757-61.","Vasala K","Anticancer Res","2008","2008/07/18","","",""
"15130900","Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide","Knight A, Askling J, Granath F, Sparen P, Ekbom A.","Ann Rheum Dis. 2004 Oct;63(10):1307-11. doi: 10.1136/ard.2003.019125. Epub 2004 May 6.","Knight A","Ann Rheum Dis","2004","2004/05/08","PMC1754772","","10.1136/ard.2003.019125"
"8078543","Hubert Humphrey's bladder cancer","Braund WJ.","N Engl J Med. 1994 Sep 29;331(13):880; author reply 880-1. doi: 10.1056/NEJM199409293311316.","Braund WJ","N Engl J Med","1994","1994/09/29","","","10.1056/NEJM199409293311316"
"3809179","Surgical techniques in the management of patients with superficial bladder cancer","Soloway MS, Kurth KH, Herr H, Huland H, Denis L, Suzuki K, Blandy J, Hisazumi H, Koontz W, Tsugawa R.","Prog Clin Biol Res. 1986;221:123-32.","Soloway MS","Prog Clin Biol Res","1986","1986/01/01","","",""
"7511275","In vitro studies on the pathogenesis of bladder cancer","Masters JR, Petzoldt JL.","Verh Dtsch Ges Pathol. 1993;77:157-60.","Masters JR","Verh Dtsch Ges Pathol","1993","1993/01/01","","",""
"3201654","Contemporary cystectomy versus preoperative radiation plus cystectomy for bladder cancer","Kaplan SA, Sawczuk IS, O'Toole K, Olsson CA.","Urology. 1988 Dec;32(6):485-91. doi: 10.1016/s0090-4295(98)90026-7.","Kaplan SA","Urology","1988","1988/12/01","","","10.1016/s0090-4295(98)90026-7"
"9924431","Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up","Lipponen P, Aaltoma S, Kosma VM, Ala-Opas M, Eskelinen M.","J Pathol. 1998 Oct;186(2):157-64. doi: 10.1002/(SICI)1096-9896(1998100)186:2<157::AID-PATH169>3.0.CO;2-M.","Lipponen P","J Pathol","1998","1999/01/30","","","10.1002/(SICI)1096-9896(1998100)186:2<157::AID-PATH169>3.0.CO;2-M"
"6336979","Analysis of human urine for mutagens associated with carcinoma of the bilharzial bladder by the Ames Salmonella plate assay","Everson RB, Gad-El-Mawla NM, Attia MA, Chevlen EM, Thorgeirsson SS, Alexander LA, Flack PM, Staiano N, Ziegler JL.","Cancer. 1983 Feb 1;51(3):371-7. doi: 10.1002/1097-0142(19830201)51:3<371::aid-cncr2820510302>3.0.co;2-5.","Everson RB","Cancer","1983","1983/02/01","","","10.1002/1097-0142(19830201)51:3<371::aid-cncr2820510302>3.0.co;2-5"
"15801485","A case-control study of occupational risk factors for bladder cancer in Canada","Gaertner RR, Trpeski L, Johnson KC; Canadian Cancer Registries Epidemiology Research Group.","Cancer Causes Control. 2004 Dec;15(10):1007-19. doi: 10.1007/s10552-004-1448-7.","Gaertner RR","Cancer Causes Control","2004","2005/04/02","","","10.1007/s10552-004-1448-7"
"2074509","Screening workers exposed to 4,4'-methylenebis(2-chloroaniline) for bladder cancer by cystoscopy","Ward E, Halperin W, Thun M, Grossman HB, Fink B, Koss L, Osorio AM, Schulte P.","J Occup Med. 1990 Sep;32(9):865-8. doi: 10.1097/00043764-199009000-00020.","Ward E","J Occup Med","1990","1990/09/01","","","10.1097/00043764-199009000-00020"
"2702405","Blood group antigen expression in frozen sections of presenting bladder cancer: 3-year prospective follow-up of prognostic value","Abel PD, Thorpe SJ, Williams G.","Br J Urol. 1989 Feb;63(2):171-5. doi: 10.1111/j.1464-410x.1989.tb05158.x.","Abel PD","Br J Urol","1989","1989/02/01","","","10.1111/j.1464-410x.1989.tb05158.x"
"13471949","Treatment of bladder cancer by megavoltage therapy","SWINNEY J.","Br J Urol. 1957 Sep;29(3):241-3. doi: 10.1111/j.1464-410x.1957.tb09344.x.","SWINNEY J","Br J Urol","1957","1957/09/01","","","10.1111/j.1464-410x.1957.tb09344.x"
"21184264","Bladder cancer mortality trends and patterns in Córdoba, Argentina (1986-2006)","Pou SA, Osella AR, Diaz Mdel P.","Cancer Causes Control. 2011 Mar;22(3):407-15. doi: 10.1007/s10552-010-9711-6. Epub 2010 Dec 24.","Pou SA","Cancer Causes Control","2011","2010/12/25","","","10.1007/s10552-010-9711-6"
"26817989","Hospitalization for transurethral bladder resection reduces quality of life in Danish patients with non-muscle-invasive bladder tumour","Mogensen K, Christensen KB, Vrang ML, Hermann GG.","Scand J Urol. 2016 Jun;50(3):170-4. doi: 10.3109/21681805.2015.1132762. Epub 2016 Jan 27.","Mogensen K","Scand J Urol","2016","2016/01/29","","","10.3109/21681805.2015.1132762"
"13530387","[Experience with E 39 in the treatment of bladder cancer]","BIBUS B, SALOMON W.","Urol Int. 1957;5(3):137-43. doi: 10.1159/000277304.","BIBUS B","Urol Int","1957","1957/01/01","","","10.1159/000277304"
"11233047","Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancer","Droller MJ.","J Urol. 2001 Feb;165(2):701-2.","Droller MJ","J Urol","2001","2001/03/10","","",""
"17688921","Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice","May M, Hakenberg OW, Gunia S, Pohling P, Helke C, Lübbe L, Nowack R, Siegsmund M, Hoschke B.","Urology. 2007 Sep;70(3):449-53. doi: 10.1016/j.urology.2007.04.023. Epub 2007 Aug 3.","May M","Urology","2007","2007/08/11","","","10.1016/j.urology.2007.04.023"
"9412812","p53 and MDM2 in the development and progression of bladder cancer","Schmitz-Dräger BJ, Kushima M, Goebell P, Jax TW, Gerharz CD, Bültel H, Schulz WA, Ebert T, Ackermann R.","Eur Urol. 1997;32(4):487-93.","Schmitz-Dräger BJ","Eur Urol","1997","1997/01/01","","",""
"21545201","Establishment of a fluorescent implantation metastasis model of bladder cancer and real-time microscopic detection in nude mice","Yang D, Wang H, Wang J, Zhang C, Xu H.","Asian Pac J Cancer Prev. 2011;12(2):393-6.","Yang D","Asian Pac J Cancer Prev","2011","2011/05/07","","",""
"8343911","Bladder cancer in patients undergoing haemodialysis","Morey A, Marco J, Alarcón A, Bestard J, Gascó J.","Br J Urol. 1993 Jun;71(6):761.","Morey A","Br J Urol","1993","1993/06/01","","",""
"462869","[3-hydroxyanthranilic acid content in the urine of bladder cancer patients]","Korosteleva TA, Kliucharev BV, Benteleva TA.","Vopr Onkol. 1979;25(6):36-9.","Korosteleva TA","Vopr Onkol","1979","1979/01/01","","",""
"27055134","Radio-Guided Lymph Node Mapping in Bladder Cancer Using SPECT/CT and Intraoperative γ-Probe Methods","Połom W, Markuszewski M, Cytawa W, Lass P, Matuszewski M.","Clin Nucl Med. 2016 Aug;41(8):e362-7. doi: 10.1097/RLU.0000000000001224.","Połom W","Clin Nucl Med","2016","2016/04/08","","","10.1097/RLU.0000000000001224"
"17919690","Midkine promoter-based conditionally replicative adenovirus for targeting midkine-expressing human bladder cancer model","Terao S, Shirakawa T, Kubo S, Bishunu A, Lee SJ, Goda K, Tsukuda M, Hamada K, Tagawa M, Takenaka A, Fujisawa M, Gotoh A.","Urology. 2007 Nov;70(5):1009-13. doi: 10.1016/j.urology.2007.07.003. Epub 2007 Oct 24.","Terao S","Urology","2007","2007/10/09","","","10.1016/j.urology.2007.07.003"
"30328534","Current Use and Promise of Urinary Markers for Urothelial Cancer","Tabayoyong W, Kamat AM.","Curr Urol Rep. 2018 Oct 17;19(12):96. doi: 10.1007/s11934-018-0857-1.","Tabayoyong W","Curr Urol Rep","2018","2018/10/18","","","10.1007/s11934-018-0857-1"
"6976831","Surgery and adjuvant chemotherapy with high-dose methotrexate and folinic acid rescue for infiltrating tumors of the bladder","Socquet Y.","Cancer Treat Rep. 1981;65 Suppl 1:187-9.","Socquet Y","Cancer Treat Rep","1981","1981/01/01","","",""
"3936564","Mitomycin C in superficial bladder cancer: 24-month follow-up","Somerville JJ, Newling DW, Richards B, Robinson MR, Smith PH.","Br J Urol. 1985 Dec;57(6):686-9. doi: 10.1111/j.1464-410x.1985.tb07032.x.","Somerville JJ","Br J Urol","1985","1985/12/01","","","10.1111/j.1464-410x.1985.tb07032.x"
"26519656","Inhibition of High Basal Level of Autophagy Induces Apoptosis in Human Bladder Cancer Cells","Lin YC, Lin JF, Wen SI, Yang SC, Tsai TF, Chen HE, Chou KY, Hwang TI.","J Urol. 2016 Apr;195(4 Pt 1):1126-35. doi: 10.1016/j.juro.2015.10.128. Epub 2015 Oct 28.","Lin YC","J Urol","2016","2015/11/01","","","10.1016/j.juro.2015.10.128"
"28438520","Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers","Terracciano D, Ferro M, Terreri S, Lucarelli G, D'Elia C, Musi G, de Cobelli O, Mirone V, Cimmino A.","Transl Res. 2017 Jun;184:108-117. doi: 10.1016/j.trsl.2017.03.005. Epub 2017 Apr 7.","Terracciano D","Transl Res","2017","2017/04/26","","","10.1016/j.trsl.2017.03.005"
"21680534","Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer","Eissa S, Swellam M, El-Khouly IM, Kassim SK, Shehata H, Mansour A, Esmat M, Nossier AI, Hamdy MA, Awad NM, El-Ahmady O.","Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1657-64. doi: 10.1158/1055-9965.EPI-11-0237. Epub 2011 Jun 15.","Eissa S","Cancer Epidemiol Biomarkers Prev","2011","2011/06/18","","","10.1158/1055-9965.EPI-11-0237"
"12900008","Orthotopic bladder reconstruction in women--what we have learned over the last decade","Stenzl A, Höltl L.","Crit Rev Oncol Hematol. 2003 Aug;47(2):147-54. doi: 10.1016/s1040-8428(03)00078-7.","Stenzl A","Crit Rev Oncol Hematol","2003","2003/08/06","","","10.1016/s1040-8428(03)00078-7"
"647688","Neovascularization in benign and malignant urinary bladder epithelial proliferative lesions of the rat observed in situ by scanning electron microscopy and autoradiography","Tatematsu M, Cohen SM, Fukushima S, Shirai T, Shinohara Y, Ito N.","Cancer Res. 1978 Jun;38(6):1792-800.","Tatematsu M","Cancer Res","1978","1978/06/01","","",""
"17311305","Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha","Esuvaranathan K, Chiong E, Thamboo TP, Chan YH, Kamaraj R, Mahendran R, Teh M.","Cancer. 2007 Mar 15;109(6):1097-105. doi: 10.1002/cncr.22503.","Esuvaranathan K","Cancer","2007","2007/02/22","","","10.1002/cncr.22503"
"26212449","Prognostic factors for conditional survival in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy","Kang M, Kim HS, Jeong CW, Kwak C, Kim HH, Ku JH.","Sci Rep. 2015 Jul 27;5:12171. doi: 10.1038/srep12171.","Kang M","Sci Rep","2015","2015/07/28","PMC4515743","","10.1038/srep12171"
"16541762","Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution","Shimabukuro T, Nakamura K, Uchiyama K, Tei Y, Aoki A, Naito K.","Hinyokika Kiyo. 2006 Feb;52(2):99-105.","Shimabukuro T","Hinyokika Kiyo","2006","2006/03/18","","",""
"15605770","[Study of nucleolar organizer regions in chromosomes of bladder cancer]","Korneev IA.","Vopr Onkol. 2004;50(4):449-53.","Korneev IA","Vopr Onkol","2004","2004/12/21","","",""
"2392744","[Flow cytometry in micturitional urine: its clinical application in cases of bladder cancer]","Dadone C, Botto A, Cocito PL, Ungari S, Zolfanelli R.","Minerva Urol Nefrol. 1990 Apr-Jun;42(2):77-80.","Dadone C","Minerva Urol Nefrol","1990","1990/04/01","","",""
"7306921","The impact of schistosomiasis on the pathology of bladder carcinoma","El-Bolkainy MN, Mokhtar NM, Ghoneim MA, Hussein MH.","Cancer. 1981 Dec 15;48(12):2643-8. doi: 10.1002/1097-0142(19811215)48:12<2643::aid-cncr2820481216>3.0.co;2-c.","El-Bolkainy MN","Cancer","1981","1981/12/15","","","10.1002/1097-0142(19811215)48:12<2643::aid-cncr2820481216>3.0.co;2-c"
"21956756","Detection of deleted in malignant brain tumors 1 and runt-related transcription factor 3 gene expressions in bladder carcinoma","Dodurga Y, Avcı CB, Satiroglu-Tufan NL, Tataroglu C, Kesen Z, Doğan ZO, Yılmaz S, Gündüz C.","Mol Biol Rep. 2012 Apr;39(4):4691-5. doi: 10.1007/s11033-011-1261-9. Epub 2011 Sep 29.","Dodurga Y","Mol Biol Rep","2012","2011/09/30","","","10.1007/s11033-011-1261-9"
"20148941","EZH2 silencing by RNA interference inhibits proliferation in bladder cancer cell lines","Zhang YB, Niu HT, Chang JW, Dong GL, Ma XB.","Eur J Cancer Care (Engl). 2011 Jan;20(1):106-12. doi: 10.1111/j.1365-2354.2009.01148.x.","Zhang YB","Eur J Cancer Care (Engl)","2011","2010/02/13","","","10.1111/j.1365-2354.2009.01148.x"
"12530027","Does P-glycoprotein-170 expression predict for chemoresistance in transitional cell carcinoma of the bladder?","Sanguedolce R, Calascibetta A, Porcasi R, Melloni D, Pavone C, Tomasino RM, Pavone-Macaluso M.","Anticancer Res. 2002 Sep-Oct;22(5):2971-6.","Sanguedolce R","Anticancer Res","2002","2003/01/18","","",""
"28081738","Silencing of Armadillo Repeat-Containing Protein 8 (ARMc8) Inhibits TGF-β-Induced EMT in Bladder Carcinoma UMUC3 Cells","Liang X, Men QL, Li YW, Li HC, Chong T, Li ZL.","Oncol Res. 2017 Jan 2;25(1):99-105. doi: 10.3727/096504016X14719078133609.","Liang X","Oncol Res","2017","2017/01/14","","","10.3727/096504016X14719078133609"
"9921921","Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers","Salagovic J, Kalina I, Stubna J, Habalová V, Hrivnák M, Valanský L, Kohút A, Biros E.","Neoplasma. 1998;45(5):312-7.","Salagovic J","Neoplasma","1998","1999/01/28","","",""
"32155403","Bipolar en Bloc Resection - Is it the Future in Non-Muscle Invasive Bladder Cancer?","Geavlete BF, Ene CV, Bălan GX, Bulai CA, Georgescu DA, Geavlete PA.","Chirurgia (Bucur). 2020 Jan-Feb;115(1):89-94. doi: 10.21614/chirurgia.115.1.89.","Geavlete BF","Chirurgia (Bucur)","2020","2020/03/11","","","10.21614/chirurgia.115.1.89"
"7459210","Effect of Schistosoma haematobium and N-butyl-N-(4-hydroxybutyl)nitrosamine on the development of urothelial neoplasia in the baboon","Hicks RM, James C, Webbe G.","Br J Cancer. 1980 Nov;42(5):730-55. doi: 10.1038/bjc.1980.308.","Hicks RM","Br J Cancer","1980","1980/11/01","PMC2010559","","10.1038/bjc.1980.308"
"2281644","[Transurethral resection in the treatment of locally advanced cancer of the bladder]","Shipilov VI, Pirtskhalaishvili GG.","Vopr Onkol. 1990;36(11):1369-71.","Shipilov VI","Vopr Onkol","1990","1990/01/01","","",""
"8275484","Combination versus single agent therapy in effecting complete therapeutic response in human bladder cancer: analysis of cisplatin and/or 5-fluorouracil in an in vivo survival model","Keane TE, Gingrich JR, Rosner G, Webb KS, Poulton SH, Walther PJ.","Cancer Res. 1994 Jan 15;54(2):475-81.","Keane TE","Cancer Res","1994","1994/01/15","","",""
"23770289","Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression","Lee EJ, Lee SJ, Kim S, Cho SC, Choi YH, Kim WJ, Moon SK.","Cell Signal. 2013 Oct;25(10):2025-38. doi: 10.1016/j.cellsig.2013.06.004. Epub 2013 Jun 11.","Lee EJ","Cell Signal","2013","2013/06/18","","","10.1016/j.cellsig.2013.06.004"
"17258791","Significance of TWIST expression and its association with E-cadherin in bladder cancer","Zhang Z, Xie D, Li X, Wong YC, Xin D, Guan XY, Chua CW, Leung SC, Na Y, Wang X.","Hum Pathol. 2007 Apr;38(4):598-606. doi: 10.1016/j.humpath.2006.10.004. Epub 2007 Jan 29.","Zhang Z","Hum Pathol","2007","2007/01/30","","","10.1016/j.humpath.2006.10.004"
"8455234","Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder","Tachibana M, Deguchi N, Baba S, Jitsukawa S, Hata M, Tazaki H.","J Urol. 1993 Apr;149(4):739-43. doi: 10.1016/s0022-5347(17)36196-7.","Tachibana M","J Urol","1993","1993/04/01","","","10.1016/s0022-5347(17)36196-7"
"17303014","High-grade T1 bladder cancer at the ureterovesical junction","Soloway M.","Curr Urol Rep. 2007 Mar;8(2):104-7. doi: 10.1007/s11934-007-0058-9.","Soloway M","Curr Urol Rep","2007","2007/02/17","","","10.1007/s11934-007-0058-9"
"9372265","Microsatellite-based cancer detection using capillary array electrophoresis and energy-transfer fluorescent primers","Wang Y, Hung SC, Linn JF, Steiner G, Glazer AN, Sidransky D, Mathies RA.","Electrophoresis. 1997 Sep;18(10):1742-9. doi: 10.1002/elps.1150181007.","Wang Y","Electrophoresis","1997","1998/02/12","","","10.1002/elps.1150181007"
"22649960","An innovative combined antero-retrograde approach for the resolution of the complete iatrogenic obliteration of ureteral ostium: a case report","Masciovecchio S, Galatioto GP, Saldutto P, Del Rosso A, Di Pierro ED, Toska E, Galica V, Vicentini C.","Arch Ital Urol Androl. 2012 Mar;84(1):39-41.","Masciovecchio S","Arch Ital Urol Androl","2012","2012/06/02","","",""
"29116175","Sniffer mice discriminate urine odours of patients with bladder cancer: A proof-of-principle study for non-invasive diagnosis of cancer-induced odours","Sato T, Katsuoka Y, Yoneda K, Nonomura M, Uchimoto S, Kobayakawa R, Kobayakawa K, Mizutani Y.","Sci Rep. 2017 Nov 7;7(1):14628. doi: 10.1038/s41598-017-15355-z.","Sato T","Sci Rep","2017","2017/11/09","PMC5676727","","10.1038/s41598-017-15355-z"
"23665400","Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure","Sternberg IA, Dalbagni G, Chen LY, Donat SM, Bochner BH, Herr HW.","J Urol. 2013 Nov;190(5):1686-91. doi: 10.1016/j.juro.2013.04.120. Epub 2013 May 7.","Sternberg IA","J Urol","2013","2013/05/14","","","10.1016/j.juro.2013.04.120"
"24756451","Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer","Schmid M, Shariat SF, Soave A, Engel O, Fisch M, Rink M.","Curr Urol Rep. 2014 Jun;15(6):409. doi: 10.1007/s11934-014-0409-2.","Schmid M","Curr Urol Rep","2014","2014/04/24","","","10.1007/s11934-014-0409-2"
"19500973","Pelvic lymphadenectomy during radical cystectomy: a review of the literature","Hurle R, Naspro R.","Surg Oncol. 2010 Dec;19(4):208-20. doi: 10.1016/j.suronc.2009.05.004. Epub 2009 Jun 4.","Hurle R","Surg Oncol","2010","2009/06/09","","","10.1016/j.suronc.2009.05.004"
"29122377","The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review","Abufaraj M, Dalbagni G, Daneshmand S, Horenblas S, Kamat AM, Kanzaki R, Zlotta AR, Shariat SF.","Eur Urol. 2018 Apr;73(4):543-557. doi: 10.1016/j.eururo.2017.09.030. Epub 2017 Nov 7.","Abufaraj M","Eur Urol","2018","2017/11/11","","","10.1016/j.eururo.2017.09.030"
"15947582","Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract","Elsässer-Beile U, Leiber C, Wolf P, Lucht M, Mengs U, Wetterauer U.","J Urol. 2005 Jul;174(1):76-9. doi: 10.1097/01.ju.0000163261.08619.d0.","Elsässer-Beile U","J Urol","2005","2005/06/11","","","10.1097/01.ju.0000163261.08619.d0"
"4959857","Efficacy of linear accelerator x-ray therapy in cancer of the bladder","Caldwell WL, Bagshaw MA, Kaplan HS.","J Urol. 1967 Feb;97(2):294-303. doi: 10.1016/s0022-5347(17)63030-1.","Caldwell WL","J Urol","1967","1967/02/01","","","10.1016/s0022-5347(17)63030-1"
"25202965","Quantitative apparent diffusion coefficient measurements obtained by 3-Tesla MRI are correlated with biomarkers of bladder cancer proliferative activity","Sevcenco S, Haitel A, Ponhold L, Susani M, Fajkovic H, Shariat SF, Hiess M, Spick C, Szarvas T, Baltzer PA.","PLoS One. 2014 Sep 9;9(9):e106866. doi: 10.1371/journal.pone.0106866. eCollection 2014.","Sevcenco S","PLoS One","2014","2014/09/10","PMC4159261","","10.1371/journal.pone.0106866"
"29108960","Perioperative morbidity, bowel function and oncologic outcome after radical cystectomy and ileal orthotopic neobladder reconstruction: Studer-pouch versus I-pouch","Mischinger J, Abdelhafez MF, Rausch S, Todenhöfer T, Neumann E, Aufderklamm S, Stenzl A, Gakis G.","Eur J Surg Oncol. 2018 Jan;44(1):178-184. doi: 10.1016/j.ejso.2017.10.208. Epub 2017 Oct 20.","Mischinger J","Eur J Surg Oncol","2018","2017/11/08","","","10.1016/j.ejso.2017.10.208"
"7271498","[Ultrastructure of the basic cell types of human transitional cell bladder cancer]","Gaĭyrov AG.","Arkh Patol. 1981;43(6):46-52.","Gaĭyrov AG","Arkh Patol","1981","1981/01/01","","",""
"17552951","The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy","Lambert EH, Pierorazio PM, Olsson CA, Benson MC, McKiernan JM, Poon S.","BJU Int. 2007 Jul;100(1):33-6. doi: 10.1111/j.1464-410X.2007.06912.x.","Lambert EH","BJU Int","2007","2007/06/08","","","10.1111/j.1464-410X.2007.06912.x"
"2169186","[A case of secondary bladder tumor the origin (gastric cancer) of which could not be identified before autopsy]","Mizutani Y, Hashimura T, Kitayama T, Toshimitsu T, Nonomura M.","Hinyokika Kiyo. 1990 May;36(5):605-8.","Mizutani Y","Hinyokika Kiyo","1990","1990/05/01","","",""
"9794224","Isolation and characterization of a novel bladder cancer cell line: inhibition by epidermal growth factor","Pratsinis H, Saetta A, Gagos S, Davaris P.","In Vitro Cell Dev Biol Anim. 1998 Oct;34(9):722-8. doi: 10.1007/s11626-998-0068-z.","Pratsinis H","In Vitro Cell Dev Biol Anim","1998","1998/10/30","","","10.1007/s11626-998-0068-z"
"28384195","Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study","Orré M, Latorzeff I, Fléchon A, Roubaud G, Brouste V, Gaston R, Piéchaud T, Richaud P, Chapet O, Sargos P.","PLoS One. 2017 Apr 6;12(4):e0174978. doi: 10.1371/journal.pone.0174978. eCollection 2017.","Orré M","PLoS One","2017","2017/04/07","PMC5383060","","10.1371/journal.pone.0174978"
"15862611","Optimal management of the T1G3 bladder cancer","Manoharan M, Soloway MS.","Urol Clin North Am. 2005 May;32(2):133-45. doi: 10.1016/j.ucl.2005.02.002.","Manoharan M","Urol Clin North Am","2005","2005/05/03","","","10.1016/j.ucl.2005.02.002"
"5452065","Cellular and humoral immune responses to human urinary bladder carcinomas","Bubeník J, Perlmann P, Helmstein K, Moberger G.","Int J Cancer. 1970 May 15;5(3):310-9. doi: 10.1002/ijc.2910050303.","Bubeník J","Int J Cancer","1970","1970/05/15","","","10.1002/ijc.2910050303"
"2830851","[Silica and cancer of the bladder in males]","Bravo MP, del Rey Calero J, Conde M.","Arch Esp Urol. 1987 Nov-Dec;40(9):635-7.","Bravo MP","Arch Esp Urol","1987","1987/11/01","","",""
"20164538","Taurine - a possible fingerprint biomarker in non-muscle invasive bladder cancer: A pilot study by 1H NMR spectroscopy","Srivastava S, Roy R, Singh S, Kumar P, Dalela D, Sankhwar SN, Goel A, Sonkar AA.","Cancer Biomark. 2010;6(1):11-20. doi: 10.3233/CBM-2009-0115.","Srivastava S","Cancer Biomark","2010","2010/02/19","","","10.3233/CBM-2009-0115"
"27764811","Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy","Patterson K, Arya L, Bottomley S, Morgan S, Cox A, Catto J, Bryant HE.","Oncotarget. 2016 Nov 15;7(46):76140-76150. doi: 10.18632/oncotarget.12683.","Patterson K","Oncotarget","2016","2016/10/21","PMC5342802","","10.18632/oncotarget.12683"
"25765383","Re: MR imaging of urinary bladder cancer for T-staging: a review and a pictorial essay of diffusion-weighted imaging","Siegel C.","J Urol. 2015 Mar;193(3):784. doi: 10.1016/j.juro.2014.12.058. Epub 2014 Dec 18.","Siegel C","J Urol","2015","2015/03/14","","","10.1016/j.juro.2014.12.058"
"3931328","Management of superficial bladder cancer in a community setting","Haas JA.","Urology. 1985 Oct;26(4 Suppl):51-4.","Haas JA","Urology","1985","1985/10/01","","",""
"30552938","Nonmuscle Invasive Bladder Cancer Influences Physical Health Related Quality of Life and Urinary Incontinence","Brisbane WG, Holt SK, Winters BR, Gore JL, Walsh TJ, Wright JL, Schade GR.","Urology. 2019 Mar;125:146-153. doi: 10.1016/j.urology.2018.11.038. Epub 2018 Dec 12.","Brisbane WG","Urology","2019","2018/12/16","","","10.1016/j.urology.2018.11.038"
"26194058","Sensing cisplatin-induced permeation of single live human bladder cancer cells by scanning electrochemical microscopy","Zhang MN, Ding Z, Long YT.","Analyst. 2015 Sep 7;140(17):6054-60. doi: 10.1039/c5an01148e.","Zhang MN","Analyst","2015","2015/07/22","","","10.1039/c5an01148e"
"7796287","Adjuvant chemotherapy for bladder cancer. Standard of care or unproven therapy?","Bahnson RR, Smith D, Trump D.","Surg Oncol Clin N Am. 1995 Apr;4(2):287.","Bahnson RR","Surg Oncol Clin N Am","1995","1995/04/01","","",""
"3891558","A review of epidemiological studies on artificial sweeteners and bladder cancer","Morgan RW, Wong O.","Food Chem Toxicol. 1985 Apr-May;23(4-5):529-33. doi: 10.1016/0278-6915(85)90147-4.","Morgan RW","Food Chem Toxicol","1985","1985/04/01","","","10.1016/0278-6915(85)90147-4"
"15491687","Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer","Pruthi RS, Derksen E, Gaston K, Wallen EM.","Urology. 2004 Oct;64(4):637-42. doi: 10.1016/j.urology.2004.04.047.","Pruthi RS","Urology","2004","2004/10/20","","","10.1016/j.urology.2004.04.047"
"15145160","Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer","Fokdal L, Honoré H, Høyer M, Meldgaard P, Fode K, von der Maase H.","Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):436-44. doi: 10.1016/j.ijrobp.2003.10.039.","Fokdal L","Int J Radiat Oncol Biol Phys","2004","2004/05/18","","","10.1016/j.ijrobp.2003.10.039"
"9191408","Are gamma delta T lymphocytes involved in intravesical bacillus Calmette-Guerin immunotherapy of bladder cancer?","Alexandroff AB, Black J, Bollina P, Esuvaranathan K, James K.","Biochem Soc Trans. 1997 May;25(2):363S. doi: 10.1042/bst025363s.","Alexandroff AB","Biochem Soc Trans","1997","1997/05/01","","","10.1042/bst025363s"
"13910260","Statistical study on mortality from bladder cancer","SEGI M, KURIHARA M, SEGI K, NARAI Y.","Tohoku J Exp Med. 1961 Sep 25;74:358-65. doi: 10.1620/tjem.74.358.","SEGI M","Tohoku J Exp Med","1961","1961/09/25","","","10.1620/tjem.74.358"
"25920992","External validation of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodes","Ramírez-Backhaus M, Fernández-Serra A, Rubio-Briones J, Cruz Garcia P, Calatrava A, Garcia Casado Z, Casanova Salas I, Rubio L, Solsona E, López-Guerrero JA.","Actas Urol Esp. 2015 Oct;39(8):473-81. doi: 10.1016/j.acuro.2015.02.002. Epub 2015 Apr 25.","Ramírez-Backhaus M","Actas Urol Esp","2015","2015/04/30","","","10.1016/j.acuro.2015.02.002"
"20397049","Bladder cancer metastasis to duodenum: an unusual presentation of obscure GI bleed","Girotra M, Jani N.","Dig Dis Sci. 2010 Jun;55(6):1801-2. doi: 10.1007/s10620-010-1204-7.","Girotra M","Dig Dis Sci","2010","2010/04/17","","","10.1007/s10620-010-1204-7"
"29116431","Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer","Li Q, Tang T, Zhang P, Liu C, Pu Y, Zhang Y, Song H, Wang Y, Song Y, Su M, Zhou B, Zhang L.","Fam Cancer. 2018 Oct;17(4):577-585. doi: 10.1007/s10689-017-0060-4.","Li Q","Fam Cancer","2018","2017/11/09","","","10.1007/s10689-017-0060-4"
"8402463","Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells","Bonner RB, Hemstreet GP 3rd, Fradet Y, Rao JY, Min KW, Hurst RE.","Cancer. 1993 Oct 15;72(8):2461-9. doi: 10.1002/1097-0142(19931015)72:8<2461::aid-cncr2820720826>3.0.co;2-c.","Bonner RB","Cancer","1993","1993/10/15","","","10.1002/1097-0142(19931015)72:8<2461::aid-cncr2820720826>3.0.co;2-c"
"20986570","Multiple primary carcinomas of the kidney and bladder","RAPPOPORT AE, NIXON CE, SALMERI EJ.","Am J Clin Pathol. 1946 May;16:341-6. doi: 10.1093/ajcp/16.5.341.","RAPPOPORT AE","Am J Clin Pathol","1946","2010/10/29","","","10.1093/ajcp/16.5.341"
"23760914","Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer","Liu H, Wu J, Xue S, Zhang Q, Ruan Y, Sun X, Xia S.","J Int Med Res. 2013 Aug;41(4):984-92. doi: 10.1177/0300060513477001. Epub 2013 Jun 12.","Liu H","J Int Med Res","2013","2013/06/14","","","10.1177/0300060513477001"
"22293934","Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes?","Kotb AF, Kovac E, Kassouf W, Chin J, Fradet Y, Izawa J, Estey E, Fairey A, Rendon R, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Drachenberg D, Aprikian AG.","World J Urol. 2012 Dec;30(6):761-7. doi: 10.1007/s00345-012-0832-2.","Kotb AF","World J Urol","2012","2012/02/02","","","10.1007/s00345-012-0832-2"
"30919984","Short- and long-term survival has improved after radical cystectomy for bladder cancer in Québec during the years 2000-2015","Wissing MD, Santos F, Zakaria AS, O'Flaherty A, Tanguay S, Kassouf W, Aprikian AG.","J Surg Oncol. 2019 Jun;119(8):1135-1144. doi: 10.1002/jso.25456. Epub 2019 Mar 28.","Wissing MD","J Surg Oncol","2019","2019/03/29","","","10.1002/jso.25456"
"10908841","Advanced bladder and urothelial cancers","Raghavan D.","Eur J Cancer. 2000 Jul;36 Suppl 2:1-6. doi: 10.1016/s0959-8049(00)00075-7.","Raghavan D","Eur J Cancer","2000","2000/07/26","","","10.1016/s0959-8049(00)00075-7"
"2642158","Urothelial malignancy","Fowler CG.","Chirurgie. 1989;115(9):694-7.","Fowler CG","Chirurgie","1989","1989/01/01","","",""
"712899","Squamous cell carcinoma of the bladder","Rous SN.","J Urol. 1978 Nov;120(5):561-2. doi: 10.1016/s0022-5347(17)57276-6.","Rous SN","J Urol","1978","1978/11/01","","","10.1016/s0022-5347(17)57276-6"
"1626203","Psychosocial adjustment and general state of health in patients with ileal conduit urinary diversion","Nordström G, Nyman CR, Theorell T.","Scand J Urol Nephrol. 1992;26(2):139-47. doi: 10.1080/00365599.1992.11690445.","Nordström G","Scand J Urol Nephrol","1992","1992/01/01","","","10.1080/00365599.1992.11690445"
"25688500","Urinary modified nucleosides as novel biomarkers for diagnosis and prognostic monitoring of urothelial bladder cancer","Zhang YR, Shi L, Wu H, Tang DD, Wang SM, Liu HM, Zhang LR, Song DK.","Tumori. 2014 Nov-Dec;100(6):660-6. doi: 10.1700/1778.19274.","Zhang YR","Tumori","2014","2015/02/18","","","10.1700/1778.19274"
"21424424","[Etiology and pathogenesis of overactive bladder]","Bschleipfer T, Wagenlehner F, Weidner W.","Urologe A. 2011 Apr;50(4):477-80. doi: 10.1007/s00120-011-2522-x.","Bschleipfer T","Urologe A","2011","2011/03/23","","","10.1007/s00120-011-2522-x"
"11751381","Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features","Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zöchbauer-Müller S, Farinas AJ, Vakar-Lopez F, Minna JD, Sagalowsky A, Czerniak B, Gazdar AF.","Cancer Res. 2001 Dec 15;61(24):8659-63.","Maruyama R","Cancer Res","2001","2001/12/26","","",""
"25542103","Efficacy of Zhuling polyporus polysaccharide with BCG to inhibit bladder carcinoma","Zhang GW, Qin GF, Han B, Li CX, Yang HG, Nie PH, Zeng X.","Carbohydr Polym. 2015 Mar 15;118:30-5. doi: 10.1016/j.carbpol.2014.11.012. Epub 2014 Nov 15.","Zhang GW","Carbohydr Polym","2015","2014/12/28","","","10.1016/j.carbpol.2014.11.012"
"25270213","[Aberrant expressions of β-catenin and ZEB1 in bladder cancer and their significance]","Ning Z, Wu K, Fan J, Wang B, Lv C, Zhu J, Wang X, Hsieh JT, He D.","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Oct;30(10):1080-3.","Ning Z","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi","2014","2014/10/02","","",""
"13934169","[The problem of treatment of bladder cancer]","MAYOR G.","Urologe. 1962 May 30;1:96-108.","MAYOR G","Urologe","1962","1962/05/30","","",""
"8456190","Radiochemotherapy for invasive carcinoma of the bladder","Shipley WU, Kaufmann DS, Griffin PP, Althausen AF, Heney NM, Prout GR Jr.","Recent Results Cancer Res. 1993;126:207-16. doi: 10.1007/978-3-642-84583-3_19.","Shipley WU","Recent Results Cancer Res","1993","1993/01/01","","","10.1007/978-3-642-84583-3_19"
"3362907","The cisplatin-methotrexate neo-adjuvant protocol as first-line therapy of bladder cancer. Present experience in Palermo","Ingargiola GB, Lamartina M, Cassata G, Corselli G, Serretta V, Caramia G, Rizzo FP, Pavone-Maculuso M.","Prog Clin Biol Res. 1988;260:579-83.","Ingargiola GB","Prog Clin Biol Res","1988","1988/01/01","","",""
"8664916","[Transitional carcinoma of the bladder at the T1G3 stage: personal experience]","Roggia A, Pozzi E, Malvestiti GM.","Arch Ital Urol Androl. 1996 Feb;68(1):25-8.","Roggia A","Arch Ital Urol Androl","1996","1996/02/01","","",""
"28141864","Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer","Matsuo T, Miyata Y, Asai A, Sagara Y, Furusato B, Fukuoka J, Sakai H.","PLoS One. 2017 Jan 31;12(1):e0171091. doi: 10.1371/journal.pone.0171091. eCollection 2017.","Matsuo T","PLoS One","2017","2017/02/01","PMC5283747","","10.1371/journal.pone.0171091"
"1851348","Impaired interferon-alpha production in whole-blood cultures from bladder cancer patients","Kuo JY, Nishio Y, Kanamaru H, Okada Y, Kita M, Imanishi J, Kishida T, Yoshida O.","Urol Res. 1991;19(1):51-6. doi: 10.1007/BF00294022.","Kuo JY","Urol Res","1991","1991/01/01","","","10.1007/BF00294022"
"24821880","Everything old is new again! Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer","Sternberg CN, Apolo AB.","J Clin Oncol. 2014 Jun 20;32(18):1868-70. doi: 10.1200/JCO.2014.55.4055. Epub 2014 May 12.","Sternberg CN","J Clin Oncol","2014","2014/05/14","","","10.1200/JCO.2014.55.4055"
"311735","Significance and prognostic value of morphology of regional lymph nodes and of peritumoral lymphocyte infiltration in bladder cancer","Martínez-Piñeiro JA, Gamallo C, Isorna S, Marrón C, Ortas J, Contreras F.","Eur Urol. 1979;5(1):7-13. doi: 10.1159/000473051.","Martínez-Piñeiro JA","Eur Urol","1979","1979/01/01","","","10.1159/000473051"
"15490466","Cancer mortality and incidence among a cohort of benzidine and dichlorobenzidine dye manufacturing workers","Rosenman KD, Reilly MJ.","Am J Ind Med. 2004 Nov;46(5):505-12. doi: 10.1002/ajim.20093.","Rosenman KD","Am J Ind Med","2004","2004/10/19","","","10.1002/ajim.20093"
"27071455","Bladder cancer: Angiogenesis as a therapeutic target in urothelial carcinoma","Sonpavde G, Bellmunt J.","Nat Rev Urol. 2016 Jun;13(6):306-7. doi: 10.1038/nrurol.2016.69. Epub 2016 Apr 13.","Sonpavde G","Nat Rev Urol","2016","2016/04/14","","","10.1038/nrurol.2016.69"
"24053715","Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies","Bi L, Huang H, Fan X, Li K, Xu K, Jiang C, Liu H, Dong W, Zhang S, Yang X, Lin T, Huang J.","BJU Int. 2014 May;113(5b):E39-48. doi: 10.1111/bju.12371.","Bi L","BJU Int","2014","2013/09/24","","","10.1111/bju.12371"
"26901314","Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer","Ward DG, Baxter L, Gordon NS, Ott S, Savage RS, Beggs AD, James JD, Lickiss J, Green S, Wallis Y, Wei W, James ND, Zeegers MP, Cheng KK, Mathews GM, Patel P, Griffiths M, Bryan RT.","PLoS One. 2016 Feb 22;11(2):e0149756. doi: 10.1371/journal.pone.0149756. eCollection 2016.","Ward DG","PLoS One","2016","2016/02/23","PMC4762704","","10.1371/journal.pone.0149756"
"16507796","Urine telomerase and bladder cancer detection","Liu BC.","JAMA. 2006 Mar 1;295(9):998; author reply 999. doi: 10.1001/jama.295.9.998-a.","Liu BC","JAMA","2006","2006/03/02","","","10.1001/jama.295.9.998-a"
"11199299","[Spontaneous extraperitoneal bladder perforation caused by bladder carcinoma]","Valero Puerta JA, Medina Pérez M, Monteagudo Parreño A, Enamorado Interiano R, Valpuesta Fernández I, Sánchez González M.","Actas Urol Esp. 2000 Nov-Dec;24(10):817-9.","Valero Puerta JA","Actas Urol Esp","2000","2001/02/24","","",""
"22070010","Histopathology of urinary bladder carcinoma: less common variants","Damjanov I, Golubović M.","Srp Arh Celok Lek. 2011 Sep-Oct;139(9-10):693-9.","Damjanov I","Srp Arh Celok Lek","2011","2011/11/11","","",""
"30176759","MicroRNA-325 Is a Potential Biomarker and Tumor Regulator in Human Bladder Cancer","Lin T, Zhou S, Gao H, Li Y, Sun L.","Technol Cancer Res Treat. 2018 Jan 1;17:1533033818790536. doi: 10.1177/1533033818790536.","Lin T","Technol Cancer Res Treat","2018","2018/09/05","PMC6122231","","10.1177/1533033818790536"
"17010016","EDTA-induced urothelial cell shedding for the treatment of superficial bladder cancer in the mouse","Nativ O, Dalal E, Hidas G, Aronson M.","Int J Urol. 2006 Oct;13(10):1344-6. doi: 10.1111/j.1442-2042.2006.01541.x.","Nativ O","Int J Urol","2006","2006/10/03","","","10.1111/j.1442-2042.2006.01541.x"
"27232933","Polyomavirus Replication and Smoking Are Independent Risk Factors for Bladder Cancer After Renal Transplantation","Liu S, Chaudhry MR, Berrebi AA, Papadimitriou JC, Drachenberg CB, Haririan A, Alexiev BA.","Transplantation. 2017 Jun;101(6):1488-1494. doi: 10.1097/TP.0000000000001260.","Liu S","Transplantation","2017","2016/05/28","","","10.1097/TP.0000000000001260"
"30811286","Neoadjuvant Immunotherapy in Muscle-Invasive Bladder Cancer: Time to Change Clinical Practice?","Zhang S.","J Clin Oncol. 2019 Apr 10;37(11):939. doi: 10.1200/JCO.18.01864. Epub 2019 Feb 27.","Zhang S","J Clin Oncol","2019","2019/02/28","","","10.1200/JCO.18.01864"
"4585930","Proceedings: Sarcoma of the bladder and prostate in children. Rationale for the role of radiation therapy based on a review of the literature and a report of fourteen additional patients","Tefft M, Jaffe N.","Cancer. 1973 Nov;32(5):1161-77. doi: 10.1002/1097-0142(197311)32:5<1161::aid-cncr2820320525>3.0.co;2-v.","Tefft M","Cancer","1973","1973/11/01","","","10.1002/1097-0142(197311)32:5<1161::aid-cncr2820320525>3.0.co;2-v"
"18387400","Urinary cytology and quantitative BTA and UBC tests in surveillance of patients with pTapT1 bladder urothelial carcinoma","Babjuk M, Soukup V, Pesl M, Kostírová M, Drncová E, Smolová H, Szakacsová M, Getzenberg R, Pavlík I, Dvorácek J.","Urology. 2008 Apr;71(4):718-22. doi: 10.1016/j.urology.2007.12.021.","Babjuk M","Urology","2008","2008/04/05","","","10.1016/j.urology.2007.12.021"
"3581037","Familial bladder cancer in an oncology clinic","Lynch HT, Kimberling WJ, Lynch JF, Brennan K.","Cancer Genet Cytogenet. 1987 Jul;27(1):161-5. doi: 10.1016/0165-4608(87)90270-6.","Lynch HT","Cancer Genet Cytogenet","1987","1987/07/01","","","10.1016/0165-4608(87)90270-6"
"26068073","Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model","Codolo G, Munari F, Fassan M, de Bernard M.","J Vis Exp. 2015 May 29;(99):e52743. doi: 10.3791/52743.","Codolo G","J Vis Exp","2015","2015/06/13","PMC4542989","","10.3791/52743"
"24674655","Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis","Leow JJ, Reese S, Trinh QD, Bellmunt J, Chung BI, Kibel AS, Chang SL.","BJU Int. 2015 May;115(5):713-21. doi: 10.1111/bju.12749. Epub 2015 Jan 26.","Leow JJ","BJU Int","2015","2014/03/29","","","10.1111/bju.12749"
"24657703","Molecular insights into mitochondrial dysfunction in cancer-related muscle wasting","Antunes D, Padrão AI, Maciel E, Santinha D, Oliveira P, Vitorino R, Moreira-Gonçalves D, Colaço B, Pires MJ, Nunes C, Santos LL, Amado F, Duarte JA, Domingues MR, Ferreira R.","Biochim Biophys Acta. 2014 Jun;1841(6):896-905. doi: 10.1016/j.bbalip.2014.03.004. Epub 2014 Mar 20.","Antunes D","Biochim Biophys Acta","2014","2014/03/25","","","10.1016/j.bbalip.2014.03.004"
"31158089","Familial Urinary Bladder Cancer with Other Cancers","Yu H, Hemminki O, Försti A, Sundquist K, Hemminki K.","Eur Urol Oncol. 2018 Dec;1(6):461-466. doi: 10.1016/j.euo.2018.06.002. Epub 2018 Jun 30.","Yu H","Eur Urol Oncol","2018","2019/06/04","","","10.1016/j.euo.2018.06.002"
"11345793","[Differences in survival of patients with bladder cancer depending on depth of muscle infiltration]","Herranz Amo F, Verdú Tartajo F, Díez Cordero JM, Bielsa Carrillo A, García Burgos J, Subirá Ríos D, Castaño González I.","Actas Urol Esp. 2001 Feb;25(2):110-4. doi: 10.1016/s0210-4806(01)72582-x.","Herranz Amo F","Actas Urol Esp","2001","2001/05/11","","","10.1016/s0210-4806(01)72582-x"
"18695904","GFP image analysis in the mouse orthotopic bladder cancer model","De Velasco MA, Tanaka M, Anai S, Tomioka A, Nishio K, Uemura H.","Oncol Rep. 2008 Sep;20(3):543-7.","De Velasco MA","Oncol Rep","2008","2008/08/13","","",""
"2217425","The role of surgery in initial staging and follow up","Herr HW.","Prog Clin Biol Res. 1990;353:35-43.","Herr HW","Prog Clin Biol Res","1990","1990/01/01","","",""
"23131975","Results of radical cystectomy with Mainz pouch II diversion (single institution experience)","Zhvania G, Mshvildadze Sh, Managadze G, Khvadagiani G.","Georgian Med News. 2012 Oct;(211):7-13.","Zhvania G","Georgian Med News","2012","2012/11/08","","",""
"5743558","Studies on tryptophan metabolism in bilharzial bladder cancer patients","Abdel-Tawab GA, Ibrahim EK, el-Masri A, al-Ghorab M, Makhyoun N.","Invest Urol. 1968 May;5(6):591-601.","Abdel-Tawab GA","Invest Urol","1968","1968/05/01","","",""
"8092120","Oral piritrexim in advanced bladder cancer: an effective drug after progression on MVAC chemotherapy?","Feun LG, Savaraj N, Benedetto P, Waldman S, Collier M, Clendennin NJ.","Am J Clin Oncol. 1994 Oct;17(5):448-51. doi: 10.1097/00000421-199410000-00019.","Feun LG","Am J Clin Oncol","1994","1994/10/01","","","10.1097/00000421-199410000-00019"
"23819486","Outpatient laser ablation of non-muscle-invasive bladder cancer: is it safe, tolerable and cost-effective?","Wong KA, Zisengwe G, Athanasiou T, O'Brien T, Thomas K.","BJU Int. 2013 Sep;112(5):561-7. doi: 10.1111/bju.12216. Epub 2013 Jul 2.","Wong KA","BJU Int","2013","2013/07/04","","","10.1111/bju.12216"
"9045940","Promoting effect of unilateral nephrectomy on urinary bladder carcinogenesis in rats","Saikawa S, Kanamaru H, Li B, Matsukawa S, Okada K.","Jpn J Cancer Res. 1996 Nov;87(11):1121-4. doi: 10.1111/j.1349-7006.1996.tb03121.x.","Saikawa S","Jpn J Cancer Res","1996","1996/11/01","PMC5921012","","10.1111/j.1349-7006.1996.tb03121.x"
"19764997","Association of TP53 and MDM2 polymorphisms with survival in bladder cancer patients treated with chemoradiotherapy","Shinohara A, Sakano S, Hinoda Y, Nishijima J, Kawai Y, Misumi T, Nagao K, Hara T, Matsuyama H.","Cancer Sci. 2009 Dec;100(12):2376-82. doi: 10.1111/j.1349-7006.2009.01331.x. Epub 2009 Aug 27.","Shinohara A","Cancer Sci","2009","2009/09/22","","","10.1111/j.1349-7006.2009.01331.x"
"8022138","[The results of long-term bladder cancer patient follow-up. The role of TUR in stage T1b and T2 bladder cancers]","Tsukamoto T, Fujioka T, Hatano T, Nakano H, Ishikawa K, Nagakubo I.","Nihon Hinyokika Gakkai Zasshi. 1994 May;85(5):760-7. doi: 10.5980/jpnjurol1989.85.760.","Tsukamoto T","Nihon Hinyokika Gakkai Zasshi","1994","1994/05/01","","","10.5980/jpnjurol1989.85.760"
"30424999","Diagnostic Accuracy of CT for Prediction of Bladder Cancer Treatment Response with and without Computerized Decision Support","Cha KH, Hadjiiski LM, Cohan RH, Chan HP, Caoili EM, Davenport MS, Samala RK, Weizer AZ, Alva A, Kirova-Nedyalkova G, Shampain K, Meyer N, Barkmeier D, Woolen S, Shankar PR, Francis IR, Palmbos P.","Acad Radiol. 2019 Sep;26(9):1137-1145. doi: 10.1016/j.acra.2018.10.010. Epub 2018 Nov 10.","Cha KH","Acad Radiol","2019","2018/11/15","PMC6510656","NIHMS1511209","10.1016/j.acra.2018.10.010"
"30227437","Are There Differences in Toxicity and Efficacy between Various Bacillus Calmette-Guerin Strains in Bladder Cancer Patients? Analysis of 844 Patients","Krajewski W, Matuszewski M, Poletajew S, Grzegrzółka J, Zdrojowy R, Kołodziej A.","Urol Int. 2018;101(3):277-284. doi: 10.1159/000492722. Epub 2018 Sep 18.","Krajewski W","Urol Int","2018","2018/09/19","","","10.1159/000492722"
"9713515","Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer","Miyake H, Hara I, Gohji K, Yamanaka K, Arakawa S, Kamidono S.","Anticancer Res. 1998 Jul-Aug;18(4C):3087-92.","Miyake H","Anticancer Res","1998","1998/08/26","","",""
"25882979","Persistent, Unexplained Leukocytosis Is a Paraneoplastic Syndrome Associated With a Poor Prognosis in Patients With Urothelial Carcinoma","Izard JP, Gore JL, Mostaghel EA, Wright JL, Yu EY.","Clin Genitourin Cancer. 2015 Aug;13(4):e253-e258. doi: 10.1016/j.clgc.2015.02.008. Epub 2015 Mar 5.","Izard JP","Clin Genitourin Cancer","2015","2015/04/18","","","10.1016/j.clgc.2015.02.008"
"21723794","Prognostic factors for survival in patients with recurrence of muscle invasive bladder cancer after treatment with curative intent","Ploeg M, Kums AC, Aben KK, van Lin EN, Smits G, Vergunst H, Viddeleer AC, Geboers AD, van Berkel H, van Boven E, Kiemeney LA, Witjes F.","Clin Genitourin Cancer. 2011 Sep;9(1):14-21. doi: 10.1016/j.clgc.2011.05.004. Epub 2011 Jul 1.","Ploeg M","Clin Genitourin Cancer","2011","2011/07/05","","","10.1016/j.clgc.2011.05.004"
"23613409","Small cell carcinoma of the bladder: a search of the current literature","Gkirlemis K, Miliadou A, Koukourakis G, Sotiropoulou-Lontou A.","J BUON. 2013 Jan-Mar;18(1):220-6.","Gkirlemis K","J BUON","2013","2013/04/25","","",""
"20450613","[Effects of 5-Aza-2'-deoxycitydine and trichostatin A on expression and apoptosis of ALDH1a2 gene in human bladder cancer cell lines]","Ju ZH, Ying MG, Ai X, Shi TP, Wang BJ, Wang C, Zhang GX, Zhang X.","Zhonghua Wai Ke Za Zhi. 2010 Mar 1;48(5):378-82.","Ju ZH","Zhonghua Wai Ke Za Zhi","2010","2010/05/11","","",""
"14574532","Urine and serum free IGF-1 levels in patients with bladder cancer: a brief report","Serel TA, Turan T, Soyupek S, Aybek Z, Perk H.","Urol Res. 2003 Oct;31(5):297-9. doi: 10.1007/s00240-003-0335-0. Epub 2003 Jul 8.","Serel TA","Urol Res","2003","2003/10/24","","","10.1007/s00240-003-0335-0"
"29111327","Overexpression of exchange protein directly activated by cAMP-1 (EPAC1) attenuates bladder cancer cell migration","Ichikawa H, Itsumi M, Kajioka S, Maki T, Lee K, Tomita M, Yamaoka S.","Biochem Biophys Res Commun. 2018 Jan 1;495(1):64-70. doi: 10.1016/j.bbrc.2017.10.142. Epub 2017 Oct 28.","Ichikawa H","Biochem Biophys Res Commun","2018","2017/11/08","","","10.1016/j.bbrc.2017.10.142"
"2771991","Bladder tumors invading the lamina propria (stage T1): influence of endovesical BCG therapy on recurrence and progression","Boccon-Gibod L, Leleu C, Herve JM, Belas M, Steg A.","Prog Clin Biol Res. 1989;310:161-9.","Boccon-Gibod L","Prog Clin Biol Res","1989","1989/01/01","","",""
"28628910","The Efficacy of Trimodal Chemoradiotherapy with Cisplatin as a Bladder-Preserving Strategy for the Treatment of Muscle-Invasive Bladder Cancer","Nagao K, Hara T, Nishijima J, Shimizu K, Fujii N, Kobayashi K, Kawai Y, Inoue R, Yamamoto Y, Matsumoto H, Matsuyama H.","Urol Int. 2017;99(4):446-452. doi: 10.1159/000477912. Epub 2017 Jun 21.","Nagao K","Urol Int","2017","2017/06/20","","","10.1159/000477912"
"9264274","A hot spot for p53 mutation in transitional cell carcinoma of the bladder: clues to the etiology of bladder cancer","Xu X, Stower MJ, Reid IN, Garner RC, Burns PA.","Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):611-6.","Xu X","Cancer Epidemiol Biomarkers Prev","1997","1997/08/01","","",""
"2300382","Tissue polypeptide antigen (TPA) in urinary bladder cancer cytology: a follow-up study","Senatore S, Zizzi L, Blasi C, Alfieri G, Saccani Jotti G, Gabrielli M, Luccarelli S.","Oncology. 1990;47(1):37-42. doi: 10.1159/000226782.","Senatore S","Oncology","1990","1990/01/01","","","10.1159/000226782"
"19447413","Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database","Fairey AS, Jacobsen NE, Chetner MP, Mador DR, Metcalfe JB, Moore RB, Rourke KF, Todd GT, Venner PM, Voaklander DC, Estey EP.","J Urol. 2009 Jul;182(1):85-92; discussion 93. doi: 10.1016/j.juro.2008.11.111. Epub 2009 May 17.","Fairey AS","J Urol","2009","2009/05/19","","","10.1016/j.juro.2008.11.111"
"22410682","CT urography for hematuria","Cowan NC.","Nat Rev Urol. 2012 Mar 13;9(4):218-26. doi: 10.1038/nrurol.2012.32.","Cowan NC","Nat Rev Urol","2012","2012/03/14","","","10.1038/nrurol.2012.32"
"12429307","Impact of a second transurethral resection on the staging of T1 bladder cancer","Dalbagni G, Herr HW, Reuter VE.","Urology. 2002 Nov;60(5):822-4; discussion 824-5. doi: 10.1016/s0090-4295(02)01920-9.","Dalbagni G","Urology","2002","2002/11/14","","","10.1016/s0090-4295(02)01920-9"
"2288054","Prognostication of bladder carcinoma by immunohistochemistry: refined and combined analysis of staining for MCA and CA50","Lipponen PK, Eskelinen MJ, Collan Y.","Urol Int. 1990;45(6):361-6. doi: 10.1159/000281740.","Lipponen PK","Urol Int","1990","1990/01/01","","","10.1159/000281740"
"3379693","Neodymium:YAG laser therapy for infiltrating bladder cancer","McPhee MS, Arnfield MR, Tulip J, Lakey WH.","J Urol. 1988 Jul;140(1):44-6. doi: 10.1016/s0022-5347(17)41481-9.","McPhee MS","J Urol","1988","1988/07/01","","","10.1016/s0022-5347(17)41481-9"
"8677547","[The use of BCG vaccine for preventing recurrences of superficial bladder cancer]","Tkachuk VN, al-Shukri AKh, al-Khani F.","Urol Nefrol (Mosk). 1996 Mar-Apr;(2):23-5.","Tkachuk VN","Urol Nefrol (Mosk)","1996","1996/03/01","","",""
"31366524","Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer","Akitake M, Yamaguchi A, Shiota M, Imada K, Tatsugami K, Yokomizo A, Naito S, Eto M.","Anticancer Res. 2019 Aug;39(8):4325-4328. doi: 10.21873/anticanres.13598.","Akitake M","Anticancer Res","2019","2019/08/02","","","10.21873/anticanres.13598"
"23877086","Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer","Tölle A, Jung M, Rabenhorst S, Kilic E, Jung K, Weikert S.","Oncol Rep. 2013 Oct;30(4):1949-56. doi: 10.3892/or.2013.2621. Epub 2013 Jul 18.","Tölle A","Oncol Rep","2013","2013/07/24","","","10.3892/or.2013.2621"
"2734923","[Malignant cells in voided urine from elderly men contacted by mail]","Fischer S.","Ugeskr Laeger. 1989 May 22;151(21):1322-5.","Fischer S","Ugeskr Laeger","1989","1989/05/22","","",""
"8261301","Superficial bladder cancer: timing of check cystoscopies in the first year","Morris SB, Shearer RJ, Gordon EM, Woodhouse CR.","Br J Urol. 1993 Oct;72(4):446-8. doi: 10.1111/j.1464-410x.1993.tb16174.x.","Morris SB","Br J Urol","1993","1993/10/01","","","10.1111/j.1464-410x.1993.tb16174.x"
"30093454","Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab","Raja R, Kuziora M, Brohawn PZ, Higgs BW, Gupta A, Dennis PA, Ranade K.","Clin Cancer Res. 2018 Dec 15;24(24):6212-6222. doi: 10.1158/1078-0432.CCR-18-0386. Epub 2018 Aug 9.","Raja R","Clin Cancer Res","2018","2018/08/11","","","10.1158/1078-0432.CCR-18-0386"
"3905730","A report of a randomized trial of d(15)+Be neutrons compared with megavoltage X ray therapy of bladder cancer","Duncan W, Arnott SJ, Jack WJ, MacDougall RH, Quilty PM, Rodger A, Kerr GR, Williams JR.","Int J Radiat Oncol Biol Phys. 1985 Dec;11(12):2043-9. doi: 10.1016/0360-3016(85)90082-3.","Duncan W","Int J Radiat Oncol Biol Phys","1985","1985/12/01","","","10.1016/0360-3016(85)90082-3"
"18503261","Concurrent decrease in IL-10 with development of immune-related adverse events in a patient treated with anti-CTLA-4 therapy","Sun J, Schiffman J, Raghunath A, Ng Tang D, Chen H, Sharma P.","Cancer Immun. 2008 May 27;8:9.","Sun J","Cancer Immun","2008","2008/05/28","PMC2935772","",""
"7834465","Organ and functional preservation in the management of genitourinary cancer: bladder, prostate, and penis","Kuten A, Liu L, Glicksman AS.","Cancer Invest. 1995;13(1):108-24. doi: 10.3109/07357909509024901.","Kuten A","Cancer Invest","1995","1995/01/01","","","10.3109/07357909509024901"
"29497859","Transurethral resection of bladder cancer on the lateral bladder wall without obturator nerve block: extent of adductor spasms using the monopolar versus bipolar technique-a prospective randomised study","Gramann T, Schwab C, Zumstein V, Betschart P, Meier M, Schmid HP, Engeler DS.","World J Urol. 2018 Jul;36(7):1085-1091. doi: 10.1007/s00345-018-2248-0. Epub 2018 Mar 1.","Gramann T","World J Urol","2018","2018/03/03","","","10.1007/s00345-018-2248-0"
"3492613","Intraluminal interleukin 2 and bacillus Calmette-Guerin for treatment of bladder cancer: a preliminary report","Merguerian PA, Donahue L, Cockett AT.","J Urol. 1987 Feb;137(2):216-9. doi: 10.1016/s0022-5347(17)43958-9.","Merguerian PA","J Urol","1987","1987/02/01","","","10.1016/s0022-5347(17)43958-9"
"7328969","[Experimental studies on regional therapy of urinary bladder cancer. 3. Effects of hyperthermic irrigation on transplanted bladder tumor in rabbit (author's transl)]","Nemoto R, Mori H, Iwata K, Abe R, Kato T, Harada M.","Nihon Hinyokika Gakkai Zasshi. 1981 Sep;72(9):1129-37. doi: 10.5980/jpnjurol1928.72.9_1129.","Nemoto R","Nihon Hinyokika Gakkai Zasshi","1981","1981/09/01","","","10.5980/jpnjurol1928.72.9_1129"
"16821348","[Study of urothelial bladder tumours in renal transplant recipients]","Neuzillet Y, Cabaniols L, Karam G, Salomon L, Barrou B, Petit J, Feuillu B, Lechevallier E.","Prog Urol. 2006 Jun;16(3):343-6.","Neuzillet Y","Prog Urol","2006","2006/07/11","","",""
"27846280","Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers","Kim D, Choi Y, Ireland J, Foreman O, Tam RN, Patel R, Schleifman EB, Motlhabi M, French D, Wong CV, Peters E, Molinero L, Raja R, Amler LC, Hampton GM, Lackner MR, Kabbarah O.","PLoS One. 2016 Nov 15;11(11):e0165856. doi: 10.1371/journal.pone.0165856. eCollection 2016.","Kim D","PLoS One","2016","2016/11/16","PMC5112874","","10.1371/journal.pone.0165856"
"27277599","Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Guérin immunotherapy?","Golabek T, Palou J, Rodríguez O, Gaya JM, Breda A, Villavicencio H.","World J Urol. 2017 Feb;35(2):237-243. doi: 10.1007/s00345-016-1856-9. Epub 2016 Jun 9.","Golabek T","World J Urol","2017","2016/06/10","","","10.1007/s00345-016-1856-9"
"11679798","Acetaminophen and the risk of renal and bladder cancer in the general practice research database","Kaye JA, Myers MW, Jick H.","Epidemiology. 2001 Nov;12(6):690-4. doi: 10.1097/00001648-200111000-00018.","Kaye JA","Epidemiology","2001","2001/10/27","","","10.1097/00001648-200111000-00018"
"17991551","Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion","Andius P, Johansson SL, Holmäng S.","Urology. 2007 Oct;70(4):758-62. doi: 10.1016/j.urology.2007.06.638.","Andius P","Urology","2007","2007/11/10","","","10.1016/j.urology.2007.06.638"
"22502569","In vivo testing of a prototype system providing simultaneous white light and near infrared autofluorescence image acquisition for detection of bladder cancer","Jacobson MC, deVere White R, Demos SG.","J Biomed Opt. 2012 Mar;17(3):036011. doi: 10.1117/1.JBO.17.3.036011.","Jacobson MC","J Biomed Opt","2012","2012/04/17","","","10.1117/1.JBO.17.3.036011"
"26776764","Curcumin reverses benzidine-induced cell proliferation by suppressing ERK1/2 pathway in human bladder cancer T24 cells","Sun X, Deng QF, Liang ZF, Zhang ZQ, Zhao L, Geng H, Xie DD, Wang Y, Yu DX, Zhong CY.","Exp Toxicol Pathol. 2016 Apr;68(4):215-22. doi: 10.1016/j.etp.2015.12.003. Epub 2016 Jan 5.","Sun X","Exp Toxicol Pathol","2016","2016/01/19","","","10.1016/j.etp.2015.12.003"
"8285171","[Cancer immunotherapy by murine bladder cancer cells transfected with mouse interferon-gamma gene]","Hashimura T, Hiura M, Yoshida O, Teramura Y, Kuribayashi K, Watanabe Y.","Hinyokika Kiyo. 1993 Dec;39(12):1205-8.","Hashimura T","Hinyokika Kiyo","1993","1993/12/01","","",""
"10794739","Current concepts in biomarker technology for bladder cancers","Burchardt M, Burchardt T, Shabsigh A, De La Taille A, Benson MC, Sawczuk I.","Clin Chem. 2000 May;46(5):595-605.","Burchardt M","Clin Chem","2000","2000/05/05","","",""
"10081101","[Lymph node staging of bladder neck carcinoma with positron emission tomography]","Bachor R, Kotzerke J, Reske SN, Hautmann R.","Urologe A. 1999 Jan;38(1):46-50. doi: 10.1007/s001200050244.","Bachor R","Urologe A","1999","1999/03/19","","","10.1007/s001200050244"
"27473428","The development of plasma pseudotargeted GC-MS metabolic profiling and its application in bladder cancer","Zhou Y, Song R, Zhang Z, Lu X, Zeng Z, Hu C, Liu X, Li Y, Hou J, Sun Y, Xu C, Xu G.","Anal Bioanal Chem. 2016 Sep;408(24):6741-9. doi: 10.1007/s00216-016-9797-0. Epub 2016 Jul 29.","Zhou Y","Anal Bioanal Chem","2016","2016/07/31","","","10.1007/s00216-016-9797-0"
"29371493","Risk-based Management of Non-muscle Invasive Bladder Cancer: Experience from Tribhuvan University Teaching Hospital","Luitel BR , Chalise PR , Nathani S , Gupta DK , Subedi P , Chapagain S , Sharma UK , Gyawali PR , Shrestha GK , Joshi BR .","Kathmandu Univ Med J (KUMJ). 2016 Oct.-Dec.;14(56):352-356.","Luitel BR","Kathmandu Univ Med J (KUMJ)","2016","2018/01/27","","",""
"10210566","Intravesical bacille Calmette-Guérin in the treatment of carcinoma in situ or high-grade superficial bladder carcinoma after radiotherapy for bladder carcinoma","Palou J, Sánchez-Martín FM, Rosales A, Salvador J, Algaba F, Vicente J.","BJU Int. 1999 Mar;83(4):429-31. doi: 10.1046/j.1464-410x.1999.00971.x.","Palou J","BJU Int","1999","1999/04/22","","","10.1046/j.1464-410x.1999.00971.x"
"31566930","Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancer","Shi J, Zhang P, Liu L, Min X, Xiao Y.","Mol Genet Genomic Med. 2019 Nov;7(11):e982. doi: 10.1002/mgg3.982. Epub 2019 Sep 30.","Shi J","Mol Genet Genomic Med","2019","2019/10/01","PMC6825849","","10.1002/mgg3.982"
"19199268","Heat shock protein expression independently predicts survival outcome in schistosomiasis-associated urinary bladder cancer","El-Meghawry El-Kenawy A, El-Kott AF, Hasan MS.","Int J Biol Markers. 2008 Oct-Dec;23(4):214-8. doi: 10.5301/jbm.2009.3728.","El-Meghawry El-Kenawy A","Int J Biol Markers","2008","2009/02/10","","","10.5301/jbm.2009.3728"
"19237174","Mechanisms of action of eicosapentaenoic acid in bladder cancer cells in vitro: alterations in mitochondrial metabolism, reactive oxygen species generation and apoptosis induction","Colquhoun A.","J Urol. 2009 Apr;181(4):1885-93. doi: 10.1016/j.juro.2008.11.092. Epub 2009 Feb 23.","Colquhoun A","J Urol","2009","2009/02/25","","","10.1016/j.juro.2008.11.092"
"17545525","A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer","Sanchez-Carbayo M, Socci ND, Kirchoff T, Erill N, Offit K, Bochner BH, Cordon-Cardo C.","Clin Cancer Res. 2007 Jun 1;13(11):3215-20. doi: 10.1158/1078-0432.CCR-07-0013.","Sanchez-Carbayo M","Clin Cancer Res","2007","2007/06/05","","","10.1158/1078-0432.CCR-07-0013"
"10791925","Expression of p21WAF1/CIP1 in bladder cancer: relation to schistosomiasis","Eissa S, Swelam M, Shaker Y, Abdel-Fattah M, Khalifa A.","IUBMB Life. 1999 Jul;48(1):115-9. doi: 10.1080/713803476.","Eissa S","IUBMB Life","1999","2000/05/03","","","10.1080/713803476"
"21566415","Diagnosis and management of urothelial carcinoma of the bladder","Tanaka MF, Sonpavde G.","Postgrad Med. 2011 May;123(3):43-55. doi: 10.3810/pgm.2011.05.2283.","Tanaka MF","Postgrad Med","2011","2011/05/14","","","10.3810/pgm.2011.05.2283"
"25132950","Altered gene expression profile after exposure to transforming growth factor β1 in the 253J human bladder cancer cell line","Lee C, Lee SH, Kim DS, Jeon YS, Lee NK, Lee SE.","Korean J Urol. 2014 Aug;55(8):542-50. doi: 10.4111/kju.2014.55.8.542. Epub 2014 Aug 8.","Lee C","Korean J Urol","2014","2014/08/19","PMC4131084","","10.4111/kju.2014.55.8.542"
"19933031","Radical cystectomy in the treatment of bladder cancer: oncological outcome and survival predictors","Ho CH, Huang CY, Lin WC, Chueh SC, Pu YS, Lai MK, Yu HJ, Huang KH.","J Formos Med Assoc. 2009 Nov;108(11):872-8. doi: 10.1016/S0929-6646(09)60419-8.","Ho CH","J Formos Med Assoc","2009","2009/11/26","","","10.1016/S0929-6646(09)60419-8"
"12899223","Evaluation of multiple recurrence events in superficial bladder cancer patients treated with intravesical bacillus Calmette-Guérin therapy using the Andersen-Gill's model","Takashi M, Wakai K, Hattori T, Ono Y, Ohshima S.","Int Urol Nephrol. 2002;34(3):329-34. doi: 10.1023/a:1024431519652.","Takashi M","Int Urol Nephrol","2002","2003/08/06","","","10.1023/a:1024431519652"
"7855971","Combined laparoscopic and transurethral neodymium: yttrium-aluminum-garnet laser treatment of invasive bladder cancer","Gerber GS, Chodak GW, Rukstalis DB.","Urology. 1995 Feb;45(2):230-3. doi: 10.1016/0090-4295(95)80010-7.","Gerber GS","Urology","1995","1995/02/01","","","10.1016/0090-4295(95)80010-7"
"6427417","The biology and treatment of superficial bladder cancer","Torti FM, Lum BL.","J Clin Oncol. 1984 May;2(5):505-31. doi: 10.1200/JCO.1984.2.5.505.","Torti FM","J Clin Oncol","1984","1984/05/01","","","10.1200/JCO.1984.2.5.505"
"24053469","Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages","Descotes F, Dessen P, Bringuier PP, Decaussin M, Martin PM, Adams M, Villers A, Lechevallier E, Rebillard X, Rodriguez-Lafrasse C, Devonec M, Paparel P, Perrin P, Lazar V, Ruffion A.","BJU Int. 2014 Feb;113(2):333-42. doi: 10.1111/bju.12364. Epub 2013 Oct 31.","Descotes F","BJU Int","2014","2013/09/24","","","10.1111/bju.12364"
"744823","The redundant factor method and bladder cancer mortality","Barrett JC.","J Epidemiol Community Health (1978). 1978 Dec;32(4):314-6. doi: 10.1136/jech.32.4.314.","Barrett JC","J Epidemiol Community Health (1978)","1978","1978/12/01","PMC1060969","","10.1136/jech.32.4.314"
"29321088","Upregulation of Long Noncoding RNA TUG1 Promotes Bladder Cancer Cell Proliferation, Migration, and Invasion by Inhibiting miR-29c","Guo P, Zhang G, Meng J, He Q, Li Z, Guan Y.","Oncol Res. 2018 Aug 23;26(7):1083-1091. doi: 10.3727/096504018X15152085755247. Epub 2018 Jan 10.","Guo P","Oncol Res","2018","2018/01/12","","","10.3727/096504018X15152085755247"
"5439001","Pitfalls of clinical versus microscpic staging of cancer of the bladder in relationship to potential curability","Baker R.","Am Surg. 1970 May;36(5):269-75.","Baker R","Am Surg","1970","1970/05/01","","",""
"23899093","The efficiency of the EORTC scoring system for the prediction of recurrence and progression of non-muscle-invasive bladder cancer treated by bacillus Calmette-Guerin immunotherapy","Ajili F, Darouiche A, Chebil M, Boubaker S.","Ultrastruct Pathol. 2013 Aug;37(4):249-53. doi: 10.3109/01913123.2013.786772.","Ajili F","Ultrastruct Pathol","2013","2013/08/01","","","10.3109/01913123.2013.786772"
"23336640","Unusual findings in a benign urachal tumor","Willson TD, Revesz E, Podbielski FJ, Connolly MM.","Am Surg. 2013 Feb;79(2):E76-7.","Willson TD","Am Surg","2013","2013/01/23","","",""
"19632819","Acute and late toxicity in radical radiotherapy for bladder cancer","Majewski W, Tarnawski R.","Clin Oncol (R Coll Radiol). 2009 Oct;21(8):598-609. doi: 10.1016/j.clon.2009.04.008. Epub 2009 Jul 25.","Majewski W","Clin Oncol (R Coll Radiol)","2009","2009/07/28","","","10.1016/j.clon.2009.04.008"
"28946549","Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway","Wang J, Ma W, Liu Y.","Cancer Biomark. 2017 Dec 6;20(4):425-434. doi: 10.3233/CBM-170188.","Wang J","Cancer Biomark","2017","2017/09/27","","","10.3233/CBM-170188"
"19076141","Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer?","Barbisan F, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Kirkali Z, Montironi R.","BJU Int. 2009 Apr;103(8):1058-63. doi: 10.1111/j.1464-410X.2008.08207.x. Epub 2008 Dec 8.","Barbisan F","BJU Int","2009","2008/12/17","","","10.1111/j.1464-410X.2008.08207.x"
"21015571","Open x-ray therapy in carcinoma of the bladder","ROSE DK.","J Urol. 1946 Mar;55:267-72. doi: 10.1016/s0022-5347(17)69908-7.","ROSE DK","J Urol","1946","2010/10/29","","","10.1016/s0022-5347(17)69908-7"
"2807782","BCG vaccine therapy for treatment of superficial bladder cancer","Damianov C, Patrashkov T, Tonchev T, Engibarov A, Kasabov V, Chouchkova M.","Int Urol Nephrol. 1989;21(3):305-12. doi: 10.1007/BF02559741.","Damianov C","Int Urol Nephrol","1989","1989/01/01","","","10.1007/BF02559741"
"24228105","High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder","Li W, Liu M, Feng Y, Huang YF, Xu YF, Che JP, Wang GC, Zheng JH.","Int J Clin Exp Pathol. 2013 Oct 15;6(11):2430-40. eCollection 2013.","Li W","Int J Clin Exp Pathol","2013","2013/11/15","PMC3816812","",""
"14756544","Prognostic value of p53 and MDM2 expression in bilharziasis-associated squamous cell carcinoma of the urinary bladder","El-Kenawy Ael-M, El-Kott AF, Khalil AM.","Int J Biol Markers. 2003 Oct-Dec;18(4):284-9. doi: 10.5301/jbm.2008.2927.","El-Kenawy Ael-M","Int J Biol Markers","2003","2004/02/06","","","10.5301/jbm.2008.2927"
"5581516","Morphological changes in the ureter in cases of bladder carcinoma","Schade RO, Turingen, Serck-Hanssen A, Swinney J.","Cancer. 1971 May;27(5):1267-72. doi: 10.1002/1097-0142(197105)27:5<1267::aid-cncr2820270535>3.0.co;2-p.","Schade RO","Cancer","1971","1971/05/01","","","10.1002/1097-0142(197105)27:5<1267::aid-cncr2820270535>3.0.co;2-p"
"3278140","Long-term survival and late development of bladder cancer in renal transplant patient with progressive multifocal leukoencephalopathy","Embrey JR, Silva FG, Helderman JH, Peters PC, Sagalowsky AI.","J Urol. 1988 Mar;139(3):580-1. doi: 10.1016/s0022-5347(17)42533-x.","Embrey JR","J Urol","1988","1988/03/01","","","10.1016/s0022-5347(17)42533-x"
"7935683","Accumulation of nuclear p53 and tumor progression in bladder cancer","Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC, Nichols PW, Skinner DG, Jones PA, Cote RJ.","N Engl J Med. 1994 Nov 10;331(19):1259-64. doi: 10.1056/NEJM199411103311903.","Esrig D","N Engl J Med","1994","1994/11/10","","","10.1056/NEJM199411103311903"
"8582219","[Multivariable analysis of survival in patients with transitional cell bladder carcinoma]","Li J, Xu X, Ding J.","Zhonghua Wai Ke Za Zhi. 1995 Jun;33(6):353-4.","Li J","Zhonghua Wai Ke Za Zhi","1995","1995/06/01","","",""
"27582092","Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma","Thomsen MB, Nordentoft I, Lamy P, Høyer S, Vang S, Hedegaard J, Borre M, Jensen JB, Ørntoft TF, Dyrskjøt L.","Mol Oncol. 2016 Nov;10(9):1450-1460. doi: 10.1016/j.molonc.2016.08.003. Epub 2016 Aug 17.","Thomsen MB","Mol Oncol","2016","2016/09/02","PMC5423216","","10.1016/j.molonc.2016.08.003"
"25936279","C-reactive protein in urologic cancers","Huang J, Baum Y, Alemozaffar M, Ogan K, Harris W, Kucuk O, Master VA.","Mol Aspects Med. 2015 Nov;45:28-36. doi: 10.1016/j.mam.2015.04.001. Epub 2015 Apr 29.","Huang J","Mol Aspects Med","2015","2015/05/05","","","10.1016/j.mam.2015.04.001"
"10579078","Recent perspectives in topical therapy in superficial bladder cancer","Böhle A, Durek C.","Curr Opin Urol. 1999 Sep;9(5):407-11. doi: 10.1097/00042307-199909000-00007.","Böhle A","Curr Opin Urol","1999","1999/12/01","","","10.1097/00042307-199909000-00007"
"27466500","Evaluation of Global Histone Acetylation Levels in Bladder Cancer Patients","Ellinger J, Schneider AC, Bachmann A, Kristiansen G, Müller SC, Rogenhofer S.","Anticancer Res. 2016 Aug;36(8):3961-4.","Ellinger J","Anticancer Res","2016","2016/07/29","","",""
"10643550","Urinary bladder cancer death rates in Europe","La Vecchia C, Lucchini F, Negri E, Levi F.","Ann Oncol. 1999 Dec;10(12):1529-30. doi: 10.1023/a:1008333804673.","La Vecchia C","Ann Oncol","1999","2000/01/22","","","10.1023/a:1008333804673"
"25564161","Presence of Concomitant Non-muscle-invasive Bladder Cancer in Chinese Patients with Upper Tract Urothelial Carcinoma: Risk Factors, Characteristics, and Predictive Value","Fang D, Zhang L, Li X, Yu W, Singla N, Zhao G, Xiong G, Song Y, He Q, He Z, Zhou L.","Ann Surg Oncol. 2015 Aug;22(8):2789-98. doi: 10.1245/s10434-014-4302-5. Epub 2015 Jan 7.","Fang D","Ann Surg Oncol","2015","2015/01/08","","","10.1245/s10434-014-4302-5"
"1394811","Prophylactic chemotherapy for primary and recurrent superficial bladder cancer: preliminary results. The Hokkaido University Bladder Cancer Collaborating Group","Togashi M, Shinohara N, Toyota K, Koyanagi T, Maru A, Fujieda J, Kawakura K, Nishida T, Ohashi N.","Cancer Chemother Pharmacol. 1992;30 Suppl:S21-5. doi: 10.1007/BF00686936.","Togashi M","Cancer Chemother Pharmacol","1992","1992/01/01","","","10.1007/BF00686936"
"23911682","Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality","Shoshany O, Mano R, Margel D, Baniel J, Yossepowitch O.","Urol Oncol. 2014 Jan;32(1):40.e17-22. doi: 10.1016/j.urolonc.2013.04.009. Epub 2013 Aug 2.","Shoshany O","Urol Oncol","2014","2013/08/06","","","10.1016/j.urolonc.2013.04.009"
"1305694","Evaluation of DNA flow cytometry as a screening test for bladder cancer","deVere White RW, Deitch AD.","J Cell Biochem Suppl. 1992;16I:80-4. doi: 10.1002/jcb.240501318.","deVere White RW","J Cell Biochem Suppl","1992","1992/01/01","","","10.1002/jcb.240501318"
"3066211","[The recurrence of bladder cancer in the glans and fossa navicularis of urethra following cystectomy]","Nagata Y, Tanaka M, Nakajima N, Tanikawa K, Matsushita K.","Hinyokika Kiyo. 1988 Jun;34(6):1043-6.","Nagata Y","Hinyokika Kiyo","1988","1988/06/01","","",""
"9502394","Urinary bladder carcinogenesis","Cohen SM.","Toxicol Pathol. 1998 Jan-Feb;26(1):121-7. doi: 10.1177/019262339802600114.","Cohen SM","Toxicol Pathol","1998","1998/03/21","","","10.1177/019262339802600114"
"25998509","Piwil 2 expression is correlated with disease-specific and progression-free survival of chemotherapy-treated bladder cancer patients","Taubert H, Wach S, Jung R, Pugia M, Keck B, Bertz S, Nolte E, Stoehr R, Lehmann J, Ohlmann CH, Stöckle M, Wullich B, Hartmann A.","Mol Med. 2015 May 13;21(1):371-80. doi: 10.2119/molmed.2014.00250.","Taubert H","Mol Med","2015","2015/05/23","PMC4534474","","10.2119/molmed.2014.00250"
"19394154","Defining the clinical target volume for bladder cancer radiotherapy treatment planning","Jenkins P, Anjarwalla S, Gilbert H, Kinder R.","Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1379-84. doi: 10.1016/j.ijrobp.2009.01.063. Epub 2009 Apr 23.","Jenkins P","Int J Radiat Oncol Biol Phys","2009","2009/04/28","","","10.1016/j.ijrobp.2009.01.063"
"8959320","The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts","Rothman N, Hayes RB, Zenser TV, DeMarini DM, Bi W, Hirvonen A, Talaska G, Bhatnagar VK, Caporaso NE, Brooks LR, Lakshmi VM, Feng P, Kashyap SK, You X, Eischen BT, Kashyap R, Shelton ML, Hsu FF, Jaeger M, Parikh DJ, Davis BB, Yin S, Bell DA.","Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):979-83.","Rothman N","Cancer Epidemiol Biomarkers Prev","1996","1996/12/01","","",""
"7553300","The design of clinical trials for new therapies in bladder cancer. Is it time for new strategies?","De Mulder PH, Williams R, Ohashi Y, Blumenstein BA, De Pauw M, Kumazawa J, Obata K, Sylvester R, Tolley D.","Int J Urol. 1995 Jun;2 Suppl 2:113-6. doi: 10.1111/j.1442-2042.1995.tb00484.x.","De Mulder PH","Int J Urol","1995","1995/06/01","","","10.1111/j.1442-2042.1995.tb00484.x"
"31115480","lncRNA ZEB1-AS1 promotes migration and metastasis of bladder cancer cells by post-transcriptional activation of ZEB1","Zhao X, Wang D, Ding Y, Zhou J, Liu G, Ji Z.","Int J Mol Med. 2019 Jul;44(1):196-206. doi: 10.3892/ijmm.2019.4187. Epub 2019 May 8.","Zhao X","Int J Mol Med","2019","2019/05/23","PMC6559313","","10.3892/ijmm.2019.4187"
"13209277","The influence of clinical and laboratory investigation in establishing current therapy of bladder cancer","BAKER R.","Bull N Y Acad Med. 1954 Dec;30(12):919-32.","BAKER R","Bull N Y Acad Med","1954","1954/12/01","PMC1804447","",""
"9652859","Clinical variability of target volume description in conformal radiotherapy planning","Logue JP, Sharrock CL, Cowan RA, Read G, Marrs J, Mott D.","Int J Radiat Oncol Biol Phys. 1998 Jul 1;41(4):929-31. doi: 10.1016/s0360-3016(98)00148-5.","Logue JP","Int J Radiat Oncol Biol Phys","1998","1998/07/04","","","10.1016/s0360-3016(98)00148-5"
"17018576","Assessment of long-term quality of life using the FACT-BL questionnaire in patients with an ileal conduit, continent reservoir, or orthotopic neobladder","Kikuchi E, Horiguchi Y, Nakashima J, Ohigashi T, Oya M, Nakagawa K, Miyajima A, Murai M.","Jpn J Clin Oncol. 2006 Nov;36(11):712-6. doi: 10.1093/jjco/hyl094. Epub 2006 Oct 3.","Kikuchi E","Jpn J Clin Oncol","2006","2006/10/05","","","10.1093/jjco/hyl094"
"9563875","p53 and RB expression predict progression in T1 bladder cancer","Grossman HB, Liebert M, Antelo M, Dinney CP, Hu SX, Palmer JL, Benedict WF.","Clin Cancer Res. 1998 Apr;4(4):829-34.","Grossman HB","Clin Cancer Res","1998","1998/05/14","","",""
"26692545","The atypical urothelial cell category in the Paris System: Strengthening the Achilles' heel","Brimo F, Auger M.","Cancer Cytopathol. 2016 May;124(5):305-6. doi: 10.1002/cncy.21668. Epub 2015 Dec 21.","Brimo F","Cancer Cytopathol","2016","2015/12/23","","","10.1002/cncy.21668"
"10212788","[Intra-arterial chemotherapy for invasive bladder cancer]","Ozono S, Kim SC, Takashima K, Tani Y, Okajima E, Hirao Y, Maruyama Y, Iwai A, Samma S, Momose H.","Hinyokika Kiyo. 1999 Feb;45(2):133-7.","Ozono S","Hinyokika Kiyo","1999","1999/04/23","","",""
"13222716","[The treatment of bladder cancer]","MAY F.","Klin Med Osterr Z Wiss Prakt Med. 1954 Aug 1;9(8):340-7.","MAY F","Klin Med Osterr Z Wiss Prakt Med","1954","1954/08/01","","",""
"30944184","Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial","Nicolazzo C, Busetto GM, Gradilone A, Sperduti I, Del Giudice F, Loreni F, Cortesi E, de Berardinis E, Gazzaniga P, Raimondi C.","Oncologist. 2019 May;24(5):612-616. doi: 10.1634/theoncologist.2018-0784. Epub 2019 Apr 3.","Nicolazzo C","Oncologist","2019","2019/04/05","PMC6516110","","10.1634/theoncologist.2018-0784"
"1606981","4'-epidoxorubicin versus mitomycin C intravesical chemoprophylaxis of superficial bladder cancer","da Silva FC, Ferrito F, Brandão T, Santos A.","Eur Urol. 1992;21(1):42-4. doi: 10.1159/000474798.","da Silva FC","Eur Urol","1992","1992/01/01","","","10.1159/000474798"
"23574966","Advances in bladder cancer imaging","Hafeez S, Huddart R.","BMC Med. 2013 Apr 10;11:104. doi: 10.1186/1741-7015-11-104.","Hafeez S","BMC Med","2013","2013/04/12","PMC3635890","","10.1186/1741-7015-11-104"
"26278363","Risk for Clostridium difficile infection after radical cystectomy for bladder cancer: Analysis of a contemporary series","Liu NW, Shatagopam K, Monn MF, Kaimakliotis HZ, Cary C, Boris RS, Mellon MJ, Masterson TA, Foster RS, Gardner TA, Bihrle R, House MG, Koch MO.","Urol Oncol. 2015 Dec;33(12):503.e17-22. doi: 10.1016/j.urolonc.2015.07.007. Epub 2015 Aug 14.","Liu NW","Urol Oncol","2015","2015/08/18","","","10.1016/j.urolonc.2015.07.007"
"9210905","New strategy of bio-chemoprevention on recurrence of superficial bladder cancer based on a hypothesis of the mechanism of recurrence","Akaza H.","Gan To Kagaku Ryoho. 1997 May;24 Suppl 1:253-6.","Akaza H","Gan To Kagaku Ryoho","1997","1997/05/01","","",""
"918691","Salvage cystectomy after radiation failure in patients with bladder carcinoma","Johnson DE, Lamy S, Bracken RB.","South Med J. 1977 Nov;70(11):1279-81. doi: 10.1097/00007611-197711000-00009.","Johnson DE","South Med J","1977","1977/11/01","","","10.1097/00007611-197711000-00009"
"9772871","'Nerve-sparing' cystectomy and substitution cystoplasty in patients of either sex: limitations and techniques","Venn SN, Popert RM, Mundy AR.","Br J Urol. 1998 Sep;82(3):361-5. doi: 10.1046/j.1464-410x.1998.00756.x.","Venn SN","Br J Urol","1998","1998/10/17","","","10.1046/j.1464-410x.1998.00756.x"
"11797447","[Risk factors for urinary bladder cancer]","Radosavljevic V, Jankovic S, Markovic-Denic Lj.","Srp Arh Celok Lek. 2001 Jul-Aug;129(7-8):180-2.","Radosavljevic V","Srp Arh Celok Lek","2001","2002/01/19","","",""
"30278482","DHCR24 predicts poor clinicopathological features of patients with bladder cancer: A STROBE-compliant study","Liu XP, Yin XH, Meng XY, Yan XH, Cao Y, Zeng XT, Wang XH.","Medicine (Baltimore). 2018 Sep;97(39):e11830. doi: 10.1097/MD.0000000000011830.","Liu XP","Medicine (Baltimore)","2018","2018/10/04","PMC6181456","","10.1097/MD.0000000000011830"
"25248470","Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival","Lee CY, Yang KL, Ko HL, Huang RY, Tsai PP, Chen MT, Lin YC, Hwang TI, Juang GD, Chi KH.","Radiat Oncol. 2014 Sep 24;9:213. doi: 10.1186/1748-717X-9-213.","Lee CY","Radiat Oncol","2014","2014/09/25","PMC4261984","","10.1186/1748-717X-9-213"
"8653688","The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers","O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL.","Cancer Res. 1996 Jun 1;56(11):2515-8.","O'Brien T","Cancer Res","1996","1996/06/01","","",""
"30787188","Mouse and human urothelial cancer organoids: A tool for bladder cancer research","Mullenders J, de Jongh E, Brousali A, Roosen M, Blom JPA, Begthel H, Korving J, Jonges T, Kranenburg O, Meijer R, Clevers HC.","Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4567-4574. doi: 10.1073/pnas.1803595116. Epub 2019 Feb 20.","Mullenders J","Proc Natl Acad Sci U S A","2019","2019/02/22","PMC6410883","","10.1073/pnas.1803595116"
"10796791","Neoadjuvant cisplatin for advanced bladder cancer","Advanced Bladder Cancer Overview Collaboration.","Cochrane Database Syst Rev. 2000;(2):CD001426. doi: 10.1002/14651858.CD001426.","Advanced Bladder Cancer Overview Collaboration","Cochrane Database Syst Rev","2000","2000/05/05","","","10.1002/14651858.CD001426"
"26055823","Implications of Definitive Prostate Cancer Therapy on Soft Tissue Margins and Survival in Patients Undergoing Radical Cystectomy for Bladder Urothelial Cancer","Luchey AM, Lin HY, Yue B, Agarwal G, Gilbert SM, Lockhart J, Poch MA, Pow-Sang JM, Spiess PE, Sexton WJ.","J Urol. 2015 Nov;194(5):1220-5. doi: 10.1016/j.juro.2015.05.091. Epub 2015 Jun 6.","Luchey AM","J Urol","2015","2015/06/10","","","10.1016/j.juro.2015.05.091"
"8754193","[Prognosis prediction in patients with transitional cell carcinoma of the urinary bladder]","Angulo Cuesta J, Sánchez Chapado M, Domínguez P, López JI, Flores N, Pontes EJ, Grignon DJ, Montie JE.","Arch Esp Urol. 1996 May;49(4):374-84.","Angulo Cuesta J","Arch Esp Urol","1996","1996/05/01","","",""
"14665360","Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis","Joudi FN, Smith BJ, O'Donnell MA, Konety BR.","Urology. 2003 Dec;62(6):1083-8. doi: 10.1016/s0090-4295(03)00765-9.","Joudi FN","Urology","2003","2003/12/11","","","10.1016/s0090-4295(03)00765-9"
"2749672","[Intravesical BCG vaccine in bladder cancer]","Beisland HO, Sander S.","Tidsskr Nor Laegeforen. 1989 Jun 20;109(17-18):1891-2.","Beisland HO","Tidsskr Nor Laegeforen","1989","1989/06/20","","",""
"7209420","Role of N-acetyltransferase phenotype in human susceptibility to bladder carcinogenic arylamines","Wolf H, Lower GM Jr, Bryan GT.","Scand J Urol Nephrol. 1980;14(2):161-5. doi: 10.3109/00365598009179555.","Wolf H","Scand J Urol Nephrol","1980","1980/01/01","","","10.3109/00365598009179555"
"11034738","Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer","Shelley MD, Court JB, Kynaston H, Wilt TJ, Fish RG, Mason M.","Cochrane Database Syst Rev. 2000;2000(4):CD001986. doi: 10.1002/14651858.CD001986.","Shelley MD","Cochrane Database Syst Rev","2000","2000/10/18","PMC7017976","","10.1002/14651858.CD001986"
"25365135","The Storz professional image enhancement system(spies) nonmuscle-invasive bladder cancer study:a multicenter international randomized controlled study","Gravas S, Stenzl A.","J Endourol. 2014 Nov;28(11):1254-5. doi: 10.1089/end.2014.1651.","Gravas S","J Endourol","2014","2014/11/04","","","10.1089/end.2014.1651"
"32006262","The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis","Li C, Gao L, Zhang J, Yang X, Liu C.","Lasers Med Sci. 2020 Jul;35(5):1025-1034. doi: 10.1007/s10103-020-02972-w. Epub 2020 Jan 31.","Li C","Lasers Med Sci","2020","2020/02/02","","","10.1007/s10103-020-02972-w"
"25316820","The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T-cell-dependent tumor immunity","Mangsbo SM, Broos S, Fletcher E, Veitonmäki N, Furebring C, Dahlén E, Norlén P, Lindstedt M, Tötterman TH, Ellmark P.","Clin Cancer Res. 2015 Mar 1;21(5):1115-26. doi: 10.1158/1078-0432.CCR-14-0913. Epub 2014 Oct 14.","Mangsbo SM","Clin Cancer Res","2015","2014/10/16","","","10.1158/1078-0432.CCR-14-0913"
"17611663","Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment","Szarvas T, Kovalszky I, Bedi K, Szendroi A, Majoros A, Riesz P, Füle T, László V, Kiss A, Romics I.","Oncol Rep. 2007 Aug;18(2):405-9.","Szarvas T","Oncol Rep","2007","2007/07/06","","",""
"589207","Cancer of the lung and bladder","Walter S, Anderson JT, Fahrenkrug L.","Br Med J. 1977 Nov 19;2(6098):1357. doi: 10.1136/bmj.2.6098.1357-d.","Walter S","Br Med J","1977","1977/11/19","PMC1632533","","10.1136/bmj.2.6098.1357-d"
"54447","Letter: Intravesical bleomycin in bladder cancer","Smith PH, McCollum CN.","JAMA. 1976 Mar 1;235(9):906-7.","Smith PH","JAMA","1976","1976/03/01","","",""
"28228618","Preventive effect of intravesical ozone supplementation on n-methyl-n-nitrosourea-induced non-muscle invasive bladder cancer in male rats","Teke K, Ozkan TA, Cebeci OO, Yilmaz H, Keles ME, Ozkan L, Dillioglugil MO, Yildiz DK, Dillioglugil O.","Exp Anim. 2017 Aug 5;66(3):191-198. doi: 10.1538/expanim.16-0093. Epub 2017 Feb 22.","Teke K","Exp Anim","2017","2017/02/24","PMC5543239","","10.1538/expanim.16-0093"
"16491221","[Experimental model of Walker 256 carcinosarcoma in rats bladder]","Dornelas CA, Almeida PR, Nascimento GL, Lima EB, Moraes MO.","Acta Cir Bras. 2006 Jan-Feb;21(1):38-42. doi: 10.1590/s0102-86502006000100009. Epub 2006 Feb 13.","Dornelas CA","Acta Cir Bras","2006","2006/02/24","","","10.1590/s0102-86502006000100009"
"11210165","Preoperative concurrent chemoradiotherapy against muscle-invasive bladder cancer: results of partial cystectomy in elderly or high-risk patients","Kageyama Y, Okada Y, Arai G, Hyochi N, Suzuki M, Masuda H, Hayashi T, Kawakami S, Okuno T, Ishizaka K, Kihara K.","Jpn J Clin Oncol. 2000 Dec;30(12):553-6. doi: 10.1093/jjco/hyd138.","Kageyama Y","Jpn J Clin Oncol","2000","2001/02/24","","","10.1093/jjco/hyd138"
"30535583","Updates on the use of intravesical therapies for non-muscle invasive bladder cancer: how, when and what","Peyton CC, Chipollini J, Azizi M, Kamat AM, Gilbert SM, Spiess PE.","World J Urol. 2019 Oct;37(10):2017-2029. doi: 10.1007/s00345-018-2591-1. Epub 2018 Dec 7.","Peyton CC","World J Urol","2019","2018/12/12","","","10.1007/s00345-018-2591-1"
"7965392","Expression of pS2 protein in transitional cell bladder tumours","Lipponen PK, Eskelinen MJ.","J Pathol. 1994 Aug;173(4):327-32. doi: 10.1002/path.1711730407.","Lipponen PK","J Pathol","1994","1994/08/01","","","10.1002/path.1711730407"
"22382007","Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer","Kim JS, Chae Y, Ha YS, Kim IY, Byun SS, Yun SJ, Kim WJ.","Clin Genitourin Cancer. 2012 Jun;10(2):114-20. doi: 10.1016/j.clgc.2011.12.003. Epub 2012 Feb 28.","Kim JS","Clin Genitourin Cancer","2012","2012/03/03","","","10.1016/j.clgc.2011.12.003"
"15352046","Dietary soy and increased risk of bladder cancer: a prospective cohort study of men in Shanghai, China","Sun CL, Yuan JM, Wang XL, Gao YT, Ross RK, Yu MC.","Int J Cancer. 2004 Nov 1;112(2):319-23. doi: 10.1002/ijc.20384.","Sun CL","Int J Cancer","2004","2004/09/08","","","10.1002/ijc.20384"
"8667069","Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer","Van den Abbeele AD, Tutrone RF, Berman RM, Baranowska-Kortylewicz J, Barclay PD, Richie JP, Adelstein SJ, Kassis AI.","J Nucl Med. 1996 Feb;37(2):315-20.","Van den Abbeele AD","J Nucl Med","1996","1996/02/01","","",""
"32020512","Robot-assisted orthotopic ""W"" ileal neobladder in male patients: step-by-step video-illustrated technique and preliminary outcomes","Nouhaud FX, Williams M, Yaxley W, Cho J, Perera M, Thangasamy I, Esler R, Coughlin G.","J Robot Surg. 2020 Oct;14(5):739-744. doi: 10.1007/s11701-020-01048-9. Epub 2020 Feb 4.","Nouhaud FX","J Robot Surg","2020","2020/02/06","","","10.1007/s11701-020-01048-9"
"15662607","Brachytherapy in the treatment of invasive bladder cancer","Pos F, Moonen L.","Semin Radiat Oncol. 2005 Jan;15(1):49-54. doi: 10.1016/j.semradonc.2004.07.012.","Pos F","Semin Radiat Oncol","2005","2005/01/22","","","10.1016/j.semradonc.2004.07.012"
"2201047","Overview of systemic treatment of bladder cancer and results with M-VAC therapy","Yagoda A.","Prog Clin Biol Res. 1990;350:87-99.","Yagoda A","Prog Clin Biol Res","1990","1990/01/01","","",""
"23003110","Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: a single center randomized controlled trial","Del Rosso A, Pace G, Masciovecchio S, Saldutto P, Galatioto GP, Vicentini C.","Int J Urol. 2013 Apr;20(4):399-403. doi: 10.1111/j.1442-2042.2012.03174.x. Epub 2012 Sep 25.","Del Rosso A","Int J Urol","2013","2012/09/26","","","10.1111/j.1442-2042.2012.03174.x"
"22012770","Volatile organic compounds as biomarkers of bladder cancer: Sensitivity and specificity using trained sniffer dogs","Willis CM, Britton LE, Harris R, Wallace J, Guest CM.","Cancer Biomark. 2010-2011;8(3):145-53. doi: 10.3233/CBM-2011-0208.","Willis CM","Cancer Biomark","2010","2011/10/21","","","10.3233/CBM-2011-0208"
"26513724","Mincle, an Innate Immune Receptor, Is Expressed in Urothelial Cancer Cells of Papillomavirus-Associated Urothelial Tumors of Cattle","Roperto S, Russo V, Esposito I, Ceccarelli DM, Paciello O, Avallone L, Capparelli R, Roperto F.","PLoS One. 2015 Oct 29;10(10):e0141624. doi: 10.1371/journal.pone.0141624. eCollection 2015.","Roperto S","PLoS One","2015","2015/10/30","PMC4626233","","10.1371/journal.pone.0141624"
"27753185","Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer","Fernández MI, Williams SB, Willis DL, Slack RS, Dickstein RJ, Parikh S, Chiong E, Siefker-Radtke AO, Guo CC, Czerniak BA, McConkey DJ, Shah JB, Pisters LL, Grossman HB, Dinney CP, Kamat AM.","BJU Int. 2017 May;119(5):684-691. doi: 10.1111/bju.13689. Epub 2016 Nov 11.","Fernández MI","BJU Int","2017","2016/10/19","","","10.1111/bju.13689"
"20984680","Prolapsed malignant tumor of the bladder as a complication of pregnancy","SHEFFERY JB.","Am J Obstet Gynecol. 1946 Jun;51:910. doi: 10.1016/s0002-9378(16)39975-6.","SHEFFERY JB","Am J Obstet Gynecol","1946","2010/10/29","","","10.1016/s0002-9378(16)39975-6"
"3591583","[Effect of partial cystectomy on BBN-induced rat bladder cancer]","Aota Y.","Hinyokika Kiyo. 1987 Feb;33(2):204-9.","Aota Y","Hinyokika Kiyo","1987","1987/02/01","","",""
"22245328","External validation of a biomarker based pre-cystectomy algorithm to predict nonorgan confined urothelial cancers","Margel D, Bostrom P, Baniel J, Yossepowitch O, Zlotta A, Fleshner N.","J Urol. 2012 Mar;187(3):840-4. doi: 10.1016/j.juro.2011.10.148. Epub 2012 Jan 15.","Margel D","J Urol","2012","2012/01/17","","","10.1016/j.juro.2011.10.148"
"13275048","[Surgical treatment of bladder cancer by substitute bladder from rectum]","UEBERMUTH H.","Zentralbl Chir. 1955;80(40):1642-9.","UEBERMUTH H","Zentralbl Chir","1955","1955/01/01","","",""
"7201343","Intravesical cisplatin for superficial bladder tumors","Blumenreich MS, Needles B, Yagoda A, Sogani P, Grabstald H, Whitmore WF Jr.","Cancer. 1982 Sep 1;50(5):863-5. doi: 10.1002/1097-0142(19820901)50:5<863::aid-cncr2820500509>3.0.co;2-q.","Blumenreich MS","Cancer","1982","1982/09/01","","","10.1002/1097-0142(19820901)50:5<863::aid-cncr2820500509>3.0.co;2-q"
"25743207","Laparoscopic Radical Cystectomy Versus Extraperitoneal Radical Cystectomy: Is the Extraperitoneal Technique Rewarding?","Zhao J, Zeng S, Zhang Z, Zhou T, Yang B, Song R, Sun Y, Xu C.","Clin Genitourin Cancer. 2015 Aug;13(4):e271-e277. doi: 10.1016/j.clgc.2015.01.006. Epub 2015 Jan 21.","Zhao J","Clin Genitourin Cancer","2015","2015/03/07","","","10.1016/j.clgc.2015.01.006"
"2200352","[Cancer of the bladder and hemodialysis]","De Sala O'Shea E, Morey Molina A, Ferrutxe Frau J, Gutiérrez Sanz-Gadea C, Alarcon Zurita A, Ozonas Moragues M.","Arch Esp Urol. 1990 May;43(4):359-63.","De Sala O'Shea E","Arch Esp Urol","1990","1990/05/01","","",""
"23388085","Predictors of the use of orthotopic bladder reconstruction after radical cystectomy for bladder cancer: data from a pilot study of 1756 cases 2004-2011","Hounsome LS, Abel GA, Verne J, Neal DE, Lyratzopoulos G.","BJU Int. 2013 Jun;111(7):1061-7. doi: 10.1111/j.1464-410X.2012.11644.x. Epub 2013 Feb 6.","Hounsome LS","BJU Int","2013","2013/02/08","","","10.1111/j.1464-410X.2012.11644.x"
"21766082","Urothelial bladder cancer with cavitary lung metastases","Kurian A, Lee J, Born A.","Can Respir J. 2011 May-Jun;18(3):e46-7. doi: 10.1155/2011/273241.","Kurian A","Can Respir J","2011","2011/07/19","PMC3328879","","10.1155/2011/273241"
"21278220","Randomized phase III trials of second-line chemotherapy in patients with advanced bladder cancer: progress and pitfalls","Bellmunt J, Choueiri TK, Schutz FA, Rosenberg JE.","Ann Oncol. 2011 Feb;22(2):245-7. doi: 10.1093/annonc/mdq684.","Bellmunt J","Ann Oncol","2011","2011/02/01","","","10.1093/annonc/mdq684"
"20517835","Circumcaval ureter with a synchronous ipsilateral transitional cell carcinoma of the upper urinary tract and the urinary bladder","Sallami S, Ben Rhouma S, Tanguour M, Rebai S, Cherif K, Kchir N, Nouira Y, Benrais N, Horchani A.","Tunis Med. 2010 May;88(5):357-9.","Sallami S","Tunis Med","2010","2010/06/03","","",""
"15343522","Prognostic factors in Bilharzial-related bladder cancer","Susani M, Haitel A, Marberger M.","Hum Pathol. 2004 Sep;35(9):1167-8; author reply 1168. doi: 10.1016/j.humpath.2004.05.002.","Susani M","Hum Pathol","2004","2004/09/03","","","10.1016/j.humpath.2004.05.002"
"31321869","A new horizon for bladder preservation in muscle-invasive bladder cancer","Filippou P, Smith AB.","BJU Int. 2019 Aug;124(2):184-185. doi: 10.1111/bju.14786.","Filippou P","BJU Int","2019","2019/07/20","","","10.1111/bju.14786"
"22360027","Outcome of trimodality protocol for invasive bladder cancer patients at Karachi, Pakistan","Tunio MA, Hashmi A, Qayyum A, Naimatullah N, Mohsin R, Sultan G.","J Pak Med Assoc. 2011 Sep;61(9):874-9.","Tunio MA","J Pak Med Assoc","2011","2012/02/25","","",""
"3541401","The metabolism of aromatic amines","Gorrod JW, Manson D.","Xenobiotica. 1986 Oct-Nov;16(10-11):933-55. doi: 10.3109/00498258609038975.","Gorrod JW","Xenobiotica","1986","1986/10/01","","","10.3109/00498258609038975"
"9679930","Prognostic significance of soluble Fas in the serum of patients with bladder cancer","Mizutani Y, Yoshida O, Bonavida B.","J Urol. 1998 Aug;160(2):571-6.","Mizutani Y","J Urol","1998","1998/07/29","","",""
"21005423","Infiltrating carcinoma of the bladder; relation of potential curability to depth of infiltration","JEWETT HJ.","Trans Am Assoc Genitourin Surg. 1945;37:51-65.","JEWETT HJ","Trans Am Assoc Genitourin Surg","1945","2010/10/29","","",""
"19385152","Magnetic resonance imaging of the urinary bladder: cancer staging and beyond","Haider EA, Jhaveri KS, O'Malley ME, Haider MA, Jewett MA, Rendon RA.","Can Assoc Radiol J. 2008 Dec;59(5):241-58.","Haider EA","Can Assoc Radiol J","2008","2009/04/24","","",""
"24943272","Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters","Nguyen HT, Jia G, Shah ZK, Pohar K, Mortazavi A, Zynger DL, Wei L, Yang X, Clark D, Knopp MV.","J Magn Reson Imaging. 2015 May;41(5):1374-82. doi: 10.1002/jmri.24663. Epub 2014 Jun 19.","Nguyen HT","J Magn Reson Imaging","2015","2014/06/20","PMC4298475","NIHMS653841","10.1002/jmri.24663"
"8200072","Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility","Lin HJ, Han CY, Bernstein DA, Hsiao W, Lin BK, Hardy S.","Carcinogenesis. 1994 May;15(5):1077-81. doi: 10.1093/carcin/15.5.1077.","Lin HJ","Carcinogenesis","1994","1994/05/01","","","10.1093/carcin/15.5.1077"
"24332641","Individualized management of advanced bladder cancer: Where do we stand?","Burgess EF.","Urol Oncol. 2015 Apr;33(4):187-95. doi: 10.1016/j.urolonc.2013.09.019. Epub 2013 Dec 12.","Burgess EF","Urol Oncol","2015","2013/12/17","","","10.1016/j.urolonc.2013.09.019"
"24444539","Pioglitazone use and the risk of bladder cancer","Kuo HW, Tiao MM, Ho SC, Yang CY.","Kaohsiung J Med Sci. 2014 Feb;30(2):94-7. doi: 10.1016/j.kjms.2013.09.011. Epub 2013 Oct 29.","Kuo HW","Kaohsiung J Med Sci","2014","2014/01/22","","","10.1016/j.kjms.2013.09.011"
"7248702","Intravenous urography in the follow-up of carcinoma of the bladder","Booth CM, Kellett MJ.","Br J Urol. 1981 Jun;53(3):246-9. doi: 10.1111/j.1464-410x.1981.tb06097.x.","Booth CM","Br J Urol","1981","1981/06/01","","","10.1111/j.1464-410x.1981.tb06097.x"
"20139762","Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis","Lopez-Beltran A, Amin MB, Oliveira PS, Montironi R, Algaba F, McKenney JK, de Torres I, Mazerolles C, Wang M, Cheng L.","Am J Surg Pathol. 2010 Mar;34(3):371-6. doi: 10.1097/PAS.0b013e3181cd385b.","Lopez-Beltran A","Am J Surg Pathol","2010","2010/02/09","","","10.1097/PAS.0b013e3181cd385b"
"9642990","[Immunohistochemical analysis of expression of angiogenic factors and tumor angiogenesis in superficial bladder cancer]","Ogura Y, Sato K, Kato T, Saito K, Enomoto K.","Nihon Hinyokika Gakkai Zasshi. 1998 May;89(5):529-37. doi: 10.5980/jpnjurol1989.89.529.","Ogura Y","Nihon Hinyokika Gakkai Zasshi","1998","1998/06/27","","","10.5980/jpnjurol1989.89.529"
"28768299","A Prospective Investigation of Coffee Drinking and Bladder Cancer Incidence in the United States","Loftfield E, Freedman ND, Inoue-Choi M, Graubard BI, Sinha R.","Epidemiology. 2017 Sep;28(5):685-693. doi: 10.1097/EDE.0000000000000676.","Loftfield E","Epidemiology","2017","2017/08/03","PMC5604321","NIHMS868390","10.1097/EDE.0000000000000676"
"16509789","Early history of endoscopic treatment of bladder tumors from Grunfeld's polypenkneipe to the Stern-McCarthy resectoscope","Herr HW.","J Endourol. 2006 Feb;20(2):85-91. doi: 10.1089/end.2006.20.85.","Herr HW","J Endourol","2006","2006/03/03","","","10.1089/end.2006.20.85"
"14665862","Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study","Leissner J, Ghoneim MA, Abol-Enein H, Thüroff JW, Franzaring L, Fisch M, Schulze H, Managadze G, Allhoff EP, el-Baz MA, Kastendieck H, Buhtz P, Kropf S, Hohenfellner R, Wolf HK.","J Urol. 2004 Jan;171(1):139-44. doi: 10.1097/01.ju.0000102302.26806.fb.","Leissner J","J Urol","2004","2003/12/11","","","10.1097/01.ju.0000102302.26806.fb"
"32350593","Rapid noninvasive detection of bladder cancer using survivin antibody-conjugated gold nanoparticles (GNPs) based on localized surface plasmon resonance (LSPR)","Jazayeri MH, Aghaie T, Nedaeinia R, Manian M, Nickho H.","Cancer Immunol Immunother. 2020 Sep;69(9):1833-1840. doi: 10.1007/s00262-020-02559-y. Epub 2020 Apr 30.","Jazayeri MH","Cancer Immunol Immunother","2020","2020/05/01","","","10.1007/s00262-020-02559-y"
"18670642","Molecular credentialing of rodent bladder carcinogenesis models","Williams PD, Lee JK, Theodorescu D.","Neoplasia. 2008 Aug;10(8):838-46. doi: 10.1593/neo.08432.","Williams PD","Neoplasia","2008","2008/08/02","PMC2481571","","10.1593/neo.08432"
"17172406","Combination therapy with IFN-alpha plus bortezomib induces apoptosis and inhibits angiogenesis in human bladder cancer cells","Papageorgiou A, Kamat A, Benedict WF, Dinney C, McConkey DJ.","Mol Cancer Ther. 2006 Dec;5(12):3032-41. doi: 10.1158/1535-7163.MCT-05-0474.","Papageorgiou A","Mol Cancer Ther","2006","2006/12/19","","","10.1158/1535-7163.MCT-05-0474"
"872103","The role of surgery in the potentially curative treatment of bladder carcinoma","Prout GR Jr.","Cancer Res. 1977 Aug;37(8 Pt 2):2764-70.","Prout GR Jr","Cancer Res","1977","1977/08/01","","",""
"29226744","The role of adjuvant chemotherapy in locally advanced bladder cancer","Haque W, Lewis GD, Verma V, Darcourt JG, Butler EB, Teh BS.","Acta Oncol. 2018 Apr;57(4):509-515. doi: 10.1080/0284186X.2017.1415461. Epub 2017 Dec 11.","Haque W","Acta Oncol","2018","2017/12/12","","","10.1080/0284186X.2017.1415461"
"2432280","Analyses of avidin-biotin complexes with lectins of membrane glycoproteins in the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine","Takai K, Kakizoe T, Sekine T, Sato S, Niijima T.","J Urol. 1987 Jan;137(1):136-9. doi: 10.1016/s0022-5347(17)43905-x.","Takai K","J Urol","1987","1987/01/01","","","10.1016/s0022-5347(17)43905-x"
"10606186","The relation between p53 overexpression and lymph node metastases in clinical stage t2 and t3a transitional cell bladder carcinoma","Uygur MC, Yaman I, Kutluay L, Altuğ U, Erol D.","J Exp Clin Cancer Res. 1999 Sep;18(3):391-5.","Uygur MC","J Exp Clin Cancer Res","1999","1999/12/22","","",""
"15967253","Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review","Pectasides D, Pectasides M, Nikolaou M.","Eur Urol. 2005 Jul;48(1):60-7; discussion 67-8. doi: 10.1016/j.eururo.2005.03.025. Epub 2005 Apr 7.","Pectasides D","Eur Urol","2005","2005/06/22","","","10.1016/j.eururo.2005.03.025"
"25990459","MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival","Xu Z, Yu YQ, Ge YZ, Zhu JG, Zhu M, Zhao YC, Xu LW, Yang XB, Geng LG, Dou QL, Jia RP.","Tumour Biol. 2015 Sep;36(10):8159-66. doi: 10.1007/s13277-015-3559-z. Epub 2015 May 20.","Xu Z","Tumour Biol","2015","2015/05/21","","","10.1007/s13277-015-3559-z"
"19181545","Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine","Lin HH, Ke HL, Huang SP, Wu WJ, Chen YK, Chang LL.","Urol Oncol. 2010 Nov-Dec;28(6):597-602. doi: 10.1016/j.urolonc.2008.12.008. Epub 2009 Jan 31.","Lin HH","Urol Oncol","2010","2009/02/03","","","10.1016/j.urolonc.2008.12.008"
"2291459","Cooperative study of therapy of superficial bladder cancer by intravesical instillation of pirarubicin","Matsumura Y.","Am J Clin Oncol. 1990;13 Suppl 1:S5-10. doi: 10.1097/00000421-199012001-00003.","Matsumura Y","Am J Clin Oncol","1990","1990/01/01","","","10.1097/00000421-199012001-00003"
"20239038","Infiltrating carcinoma of the bladder; application of pathologic observations to clinical diagnosis and prognosis","JEWETT HJ.","J Am Med Assoc. 1947 Jun 7;134(6):496-500. doi: 10.1001/jama.1947.02880230006002.","JEWETT HJ","J Am Med Assoc","1947","2010/03/19","","","10.1001/jama.1947.02880230006002"
"12131289","Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors","Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.","J Urol. 2002 Aug;168(2):465-9.","Eissa S","J Urol","2002","2002/07/20","","",""
"19193403","Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment?","Scosyrev E, Yao J, Messing E.","Urology. 2009 Apr;73(4):822-7. doi: 10.1016/j.urology.2008.11.042. Epub 2009 Feb 4.","Scosyrev E","Urology","2009","2009/02/06","","","10.1016/j.urology.2008.11.042"
"21244603","FOXP3 and survival in urinary bladder cancer","Winerdal ME, Marits P, Winerdal M, Hasan M, Rosenblatt R, Tolf A, Selling K, Sherif A, Winqvist O.","BJU Int. 2011 Nov;108(10):1672-8. doi: 10.1111/j.1464-410X.2010.10020.x. Epub 2011 Jan 18.","Winerdal ME","BJU Int","2011","2011/01/20","","","10.1111/j.1464-410X.2010.10020.x"
"24922698","Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma","Moschini M, Suardi N, Pellucchi F, Rocchini L, La Croce G, Capitanio U, Briganti A, Damiano R, Montorsi F, Colombo R.","Anticancer Res. 2014 Jun;34(6):3225-30.","Moschini M","Anticancer Res","2014","2014/06/13","","",""
"7534632","Bladder and kidney cancers","McCredie M.","Cancer Surv. 1994;19-20:343-68.","McCredie M","Cancer Surv","1994","1994/01/01","","",""
"7850327","Health-related quality of life after cystectomy: bladder substitution compared with ileal conduit diversion. A questionnaire survey","Bjerre BD, Johansen C, Steven K.","Br J Urol. 1995 Feb;75(2):200-5. doi: 10.1111/j.1464-410x.1995.tb07312.x.","Bjerre BD","Br J Urol","1995","1995/02/01","","","10.1111/j.1464-410x.1995.tb07312.x"
"19843069","Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer","Miyake M, Sugano K, Sugino H, Imai K, Matsumoto E, Maeda K, Fukuzono S, Ichikawa H, Kawashima K, Hirabayashi K, Kodama T, Fujimoto H, Kakizoe T, Kanai Y, Fujimoto K, Hirao Y.","Cancer Sci. 2010 Jan;101(1):250-8. doi: 10.1111/j.1349-7006.2009.01334.x. Epub 2009 Sep 1.","Miyake M","Cancer Sci","2010","2009/10/22","","","10.1111/j.1349-7006.2009.01334.x"
"17158540","Systemic chemotherapy for advanced bladder cancer: update and controversies","Garcia JA, Dreicer R.","J Clin Oncol. 2006 Dec 10;24(35):5545-51. doi: 10.1200/JCO.2006.08.0564.","Garcia JA","J Clin Oncol","2006","2006/12/13","","","10.1200/JCO.2006.08.0564"
"14862177","An experimental inquiry into the cause of industrial bladder cancer","BONSER GM, CLAYSON DB, JULL JW.","Lancet. 1951 Aug 18;2(6677):286-8. doi: 10.1016/s0140-6736(51)93281-3.","BONSER GM","Lancet","1951","1951/08/18","","","10.1016/s0140-6736(51)93281-3"
"10828663","Prognostic value of MIB-1 antibody labeling index to predict response to Bacillus Calmette-Guérin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancer","Lebret T, Becette V, Hervé JM, Molinié V, Barré P, Lugagne PM, Gentille A, Baglin AC, Botto H.","Eur Urol. 2000 Jun;37(6):654-9. doi: 10.1159/000020233.","Lebret T","Eur Urol","2000","2000/06/01","","","10.1159/000020233"
"20579709","Prognostic value of p53 and Ki-67 expression in intermediate-risk patients with nonmuscle-invasive bladder cancer receiving adjuvant intravesical mitomycin C therapy","Seo HK, Cho KS, Chung J, Joung JY, Park WS, Chung MK, Lee KH.","Urology. 2010 Aug;76(2):512.e1-7. doi: 10.1016/j.urology.2010.04.040. Epub 2010 Jun 26.","Seo HK","Urology","2010","2010/06/29","","","10.1016/j.urology.2010.04.040"
"2058065","[The value of differentiated transurethral resection in primary superficial bladder cancer]","Flamm J, Steiner R.","Urologe A. 1991 Mar;30(2):111-3.","Flamm J","Urologe A","1991","1991/03/01","","",""
"26906030","Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study","Bell MD, Yafi FA, Brimo F, Steinberg J, Aprikian AG, Tanguay S, Kassouf W.","World J Urol. 2016 Oct;34(10):1405-9. doi: 10.1007/s00345-016-1795-5. Epub 2016 Feb 23.","Bell MD","World J Urol","2016","2016/02/25","","","10.1007/s00345-016-1795-5"
"23529717","Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancer","Lee EK, Ye Y, Kamat AM, Wu X.","Cancer. 2013 May 1;119(9):1643-51. doi: 10.1002/cncr.27871. Epub 2013 Mar 25.","Lee EK","Cancer","2013","2013/03/27","PMC4004376","NIHMS413825","10.1002/cncr.27871"
"26165584","γ Irradiated Mycobacteria Enhance Survival in Bladder Tumor Bearing Mice Although Less Efficaciously than Live Mycobacteria","Noguera-Ortega E, Rabanal RM, Secanella-Fandos S, Torrents E, Luquin M, Julián E.","J Urol. 2016 Jan;195(1):198-205. doi: 10.1016/j.juro.2015.07.011. Epub 2015 Jul 10.","Noguera-Ortega E","J Urol","2016","2015/07/14","","","10.1016/j.juro.2015.07.011"
"27905153","Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer","Besiroglu H.","Int J Urol. 2017 Mar;24(3):242. doi: 10.1111/iju.13269. Epub 2016 Dec 1.","Besiroglu H","Int J Urol","2017","2016/12/02","","","10.1111/iju.13269"
"1189275","[Vesical parietography and pelvic arteriography in the diagnosis of bladder cancer]","Kulikov VA, Tsyb AF, Drozdovskiĭ BIa, Filianova VP, Mikhaĭlenko GG.","Vestn Rentgenol Radiol. 1975 May-Jun;(3):76-82.","Kulikov VA","Vestn Rentgenol Radiol","1975","1975/05/01","","",""
"8761373","Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence","Griffiths TR, Brotherick I, Bishop RI, White MD, McKenna DM, Horne CH, Shenton BK, Neal DE, Mellon JK.","Br J Cancer. 1996 Aug;74(4):579-84. doi: 10.1038/bjc.1996.404.","Griffiths TR","Br J Cancer","1996","1996/08/01","PMC2074678","","10.1038/bjc.1996.404"
"24657658","Secondary stimulation from Bacillus Calmette-Guérin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells","Thiel T, Ryk C, Chatzakos V, Hallén Grufman K, Bavand-Chobot N, Flygare J, Wiklund NP, de Verdier PJ.","Cancer Lett. 2014 Jun 28;348(1-2):119-25. doi: 10.1016/j.canlet.2014.03.014. Epub 2014 Mar 18.","Thiel T","Cancer Lett","2014","2014/03/25","","","10.1016/j.canlet.2014.03.014"
"7819040","p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder","Serth J, Kuczyk MA, Bokemeyer C, Hervatin C, Nafe R, Tan HK, Jonas U.","Br J Cancer. 1995 Jan;71(1):201-5. doi: 10.1038/bjc.1995.41.","Serth J","Br J Cancer","1995","1995/01/01","PMC2033435","","10.1038/bjc.1995.41"
"26357419","Effect of Increased Water Intake on Urinary DNA Adduct Levels and Mutagenicity in Smokers: A Randomized Study","Buendia Jimenez I, Richardot P, Picard P, Lepicard EM, De Meo M, Talaska G.","Dis Markers. 2015;2015:478150. doi: 10.1155/2015/478150. Epub 2015 Aug 18.","Buendia Jimenez I","Dis Markers","2015","2015/09/11","PMC4556072","","10.1155/2015/478150"
"22528227","Impact of 4HPR on the expression of E-Cad in human bladder transitional epithelial cancer cells T24","Wang E, Li J, Yang G, Zhong S, Liu T.","J Huazhong Univ Sci Technolog Med Sci. 2012 Apr;32(2):237-241. doi: 10.1007/s11596-012-0042-6. Epub 2012 Apr 20.","Wang E","J Huazhong Univ Sci Technolog Med Sci","2012","2012/04/25","","","10.1007/s11596-012-0042-6"
"15198005","[A case of urothelial cancer on a ureterocele]","Kadono Y, Yamamoto H, Tajika E.","Nihon Hinyokika Gakkai Zasshi. 2004 May;95(4):688-91. doi: 10.5980/jpnjurol1989.95.688.","Kadono Y","Nihon Hinyokika Gakkai Zasshi","2004","2004/06/17","","","10.5980/jpnjurol1989.95.688"
"10460404","Quality-of-life assessment in bladder cancer","van der Veen JH, van Andel G, Kurth KH.","World J Urol. 1999 Aug;17(4):219-24. doi: 10.1007/s003450050136.","van der Veen JH","World J Urol","1999","1999/08/25","","","10.1007/s003450050136"
"13897217","[Results of cystectomy in bladder cancer]","GASTEYER KH, MAERZ E.","Dtsch Med Wochenschr. 1962 Apr 20;87:809-11. doi: 10.1055/s-0028-1111833.","GASTEYER KH","Dtsch Med Wochenschr","1962","1962/04/20","","","10.1055/s-0028-1111833"
"25482946","M2muscarinic receptors inhibit cell proliferation and migration in urothelial bladder cancer cells","Pacini L, De Falco E, Di Bari M, Coccia A, Siciliano C, Ponti D, Pastore AL, Petrozza V, Carbone A, Tata AM, Calogero A.","Cancer Biol Ther. 2014;15(11):1489-98. doi: 10.4161/15384047.2014.955740.","Pacini L","Cancer Biol Ther","2014","2014/12/09","PMC4622460","","10.4161/15384047.2014.955740"
"22101376","Association of p53 codon 248 (exon7) with urinary bladder cancer risk in the North Indian population","Jaiswal PK, Goel A, Mittal RD.","Biosci Trends. 2011;5(5):205-10. doi: 10.5582/bst.2011.v5.5.205.","Jaiswal PK","Biosci Trends","2011","2011/11/22","","","10.5582/bst.2011.v5.5.205"
"29281848","Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle-invasive bladder cancer","Ritch CR, Balise R, Prakash NS, Alonzo D, Almengo K, Alameddine M, Venkatramani V, Punnen S, Parekh DJ, Gonzalgo ML.","BJU Int. 2018 May;121(5):745-751. doi: 10.1111/bju.14109. Epub 2018 Jan 22.","Ritch CR","BJU Int","2018","2017/12/28","","","10.1111/bju.14109"
"31035981","Is hysterectomy beneficial in radical cystectomy for female patient with urothelial carcinoma of bladder? A retrospective analysis of consecutive 112 cases from a single institution","Huang H, Yan B, Shang M, Liu L, Hao H, Xi Z.","BMC Urol. 2019 Apr 29;19(1):28. doi: 10.1186/s12894-019-0461-9.","Huang H","BMC Urol","2019","2019/05/01","PMC6489257","","10.1186/s12894-019-0461-9"
"18127379","Transurethral biopsy; an accurate method of determining the true malignancy of bladder carcinoma","MILNER WA.","J Urol. 1949 May;61(5):917-23; Disc., 929-9. doi: 10.1016/s0022-5347(17)69163-8.","MILNER WA","J Urol","1949","1949/05/01","","","10.1016/s0022-5347(17)69163-8"
"19997771","Strategies for molecular expression profiling in bladder cancer","Mitra AP, Bartsch CC, Cote RJ.","Cancer Metastasis Rev. 2009 Dec;28(3-4):317-26. doi: 10.1007/s10555-009-9196-5.","Mitra AP","Cancer Metastasis Rev","2009","2009/12/10","","","10.1007/s10555-009-9196-5"
"740968","[Cancer of the bladder: apropos of 169 cases]","Aramburo P, Otero J, De la Torre A.","Rev Clin Esp. 1978 Oct 15;151(1):33-7.","Aramburo P","Rev Clin Esp","1978","1978/10/15","","",""
"9061063","Early results of the value of p53 in predicting survival in a homogeneous cohort of patients with invasive bladder cancer treated with a neoadjuvant carboplatin-based regimen (M-CAVI)","Ribas A, Bellmunt J, Albanell J, De Torres I, Bermejo B, De Torres JA, Morote J, Gallardo E, Vera R, Carulla J, Sole-Calvo LA.","Tumori. 1996 Nov-Dec;82(6):554-9.","Ribas A","Tumori","1996","1996/11/01","","",""
"1514213","[Polychemotherapy in advanced bladder cancer. Practicality and clinical results]","Klän R, Knispel H, Huland H.","Urologe A. 1992 Jul;31(4):247-50.","Klän R","Urologe A","1992","1992/07/01","","",""
"12853792","Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer","Marti A, Jichlinski P, Lange N, Ballini JP, Guillou L, Leisinger HJ, Kucera P.","J Urol. 2003 Aug;170(2 Pt 1):428-32. doi: 10.1097/01.ju.0000075054.38441.2d.","Marti A","J Urol","2003","2003/07/11","","","10.1097/01.ju.0000075054.38441.2d"
"17147885","[Effects of small interfering RNA magnetic nanoparticles combination with external magnetic fields on survivin gene expression of bladder cancer cells and apoptosis]","Cao ZG, Zhu YP, Zhou SW, Liu JH, Qi L, Zhu M, Ye ZQ.","Zhonghua Wai Ke Za Zhi. 2006 Sep 15;44(18):1248-51.","Cao ZG","Zhonghua Wai Ke Za Zhi","2006","2006/12/07","","",""
"18148012","Cutaneous metastasis of bladder carcinoma","McCREA LE.","J Urol. 1949 Aug;62(2):158-62. doi: 10.1016/s0022-5347(17)68901-8.","McCREA LE","J Urol","1949","1949/08/01","","","10.1016/s0022-5347(17)68901-8"
"15329486","Effect of adjuvant transarterial infusion of anticancer agents after transurethral resection in patients with pT2a muscle invasive transitional cell carcinoma of the bladder: five and ten-year outcome","Shimizu H, Nishimura T, Kimura G, Matsuzawa I, Kondo Y.","J Nippon Med Sch. 2004 Aug;71(4):263-9. doi: 10.1272/jnms.71.263.","Shimizu H","J Nippon Med Sch","2004","2004/08/27","","","10.1272/jnms.71.263"
"12930427","Cyclooxygenase-2 promotes angiogenesis in pTa/T1 urothelial bladder carcinoma but does not predict recurrence","Friedrich MG, Toma MI, Petri S, Huland H.","BJU Int. 2003 Sep;92(4):389-92. doi: 10.1046/j.1464-410x.2003.04345.x.","Friedrich MG","BJU Int","2003","2003/08/22","","","10.1046/j.1464-410x.2003.04345.x"
"15821583","Over expression of hypoxia-inducible factor-1alpha in renal and bladder cancer cells increases tumorigenic potency","Kondo Y, Hamada J, Kobayashi C, Nakamura R, Suzuki Y, Kimata R, Nishimura T, Kitagawa T, Kunimoto M, Imura N, Hara S.","J Urol. 2005 May;173(5):1762-6. doi: 10.1097/01.ju.0000154343.35444.09.","Kondo Y","J Urol","2005","2005/04/12","","","10.1097/01.ju.0000154343.35444.09"
"22363243","An investigation into the cytotoxic effects of 13-acetoxysarcocrassolide from the soft coral Sarcophyton crassocaule on bladder cancer cells","Su CC, Su JH, Lin JJ, Chen CC, Hwang WI, Huang HH, Wu YJ.","Mar Drugs. 2011 Dec;9(12):2622-42. doi: 10.3390/md9122622. Epub 2011 Dec 13.","Su CC","Mar Drugs","2011","2012/02/25","PMC3280580","","10.3390/md9122622"
"23890180","Ultrasonographic findings related to prognosis in canine transitional cell carcinoma","Hanazono K, Fukumoto S, Endo Y, Ueno H, Kadosawa T, Uchide T.","Vet Radiol Ultrasound. 2014 Jan-Feb;55(1):79-84. doi: 10.1111/vru.12085. Epub 2013 Jul 26.","Hanazono K","Vet Radiol Ultrasound","2014","2013/07/30","","","10.1111/vru.12085"
"16098360","Bladder cancer screening and monitoring of 4,4'-methylenebis(2-chloroaniline) exposure among workers in Taiwan","Chen HI, Liou SH, Loh CH, Uang SN, Yu YC, Shih TS.","Urology. 2005 Aug;66(2):305-10. doi: 10.1016/j.urology.2005.02.031.","Chen HI","Urology","2005","2005/08/16","","","10.1016/j.urology.2005.02.031"
"14345591","[COMBINED SURGICAL AND RADIOLOGIC THERAPY. EXPERIENCES IN THE TREATMENT OF URINARY BLADDER CANCER]","MUSTAKALLIO S, LEPPAENEN MK.","Duodecim. 1965;81:702-7.","MUSTAKALLIO S","Duodecim","1965","1965/01/01","","",""
"11526485","Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease","Yoon DS, Li L, Zhang RD, Kram A, Ro JY, Johnston D, Grossman HB, Scherer S, Czerniak B.","Oncogene. 2001 Aug 16;20(36):5005-14. doi: 10.1038/sj.onc.1204612.","Yoon DS","Oncogene","2001","2001/08/30","","","10.1038/sj.onc.1204612"
"9407204","Does p53 immunostaining improve diagnostic accuracy in urine cytology?","Righi E, Rossi G, Ferrari G, Dotti A, De Gaetani C, Ferrari P, Trentini GP.","Diagn Cytopathol. 1997 Dec;17(6):436-9. doi: 10.1002/(sici)1097-0339(199712)17:6<436::aid-dc11>3.0.co;2-n.","Righi E","Diagn Cytopathol","1997","1998/01/04","","","10.1002/(sici)1097-0339(199712)17:6<436::aid-dc11>3.0.co;2-n"
"7877657","p53 and bladder cancer","Xing X.","N Engl J Med. 1995 Apr 6;332(14):957-8.","Xing X","N Engl J Med","1995","1995/04/06","","",""
"19303097","Activation of RAS family genes in urothelial carcinoma","Boulalas I, Zaravinos A, Karyotis I, Delakas D, Spandidos DA.","J Urol. 2009 May;181(5):2312-9. doi: 10.1016/j.juro.2009.01.011. Epub 2009 Mar 19.","Boulalas I","J Urol","2009","2009/03/24","","","10.1016/j.juro.2009.01.011"
"18082933","Editorial comment on: the value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer","Bubendorf L.","Eur Urol. 2008 Aug;54(2):407-8. doi: 10.1016/j.eururo.2007.11.052. Epub 2007 Dec 7.","Bubendorf L","Eur Urol","2008","2007/12/18","","","10.1016/j.eururo.2007.11.052"
"31200845","Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study","Weiner AB, Desai AS, Meeks JJ.","Eur Urol Oncol. 2019 May;2(3):304-310. doi: 10.1016/j.euo.2018.08.018. Epub 2018 Sep 14.","Weiner AB","Eur Urol Oncol","2019","2019/06/16","","","10.1016/j.euo.2018.08.018"
"29677905","Re: Evasion of Immunosurveillance by Genomic Alterations of PPARγ/RXRα in Bladder Cancer","Atala A.","J Urol. 2018 May;199(5):1115-1116. doi: 10.1016/j.juro.2018.02.015. Epub 2018 Feb 17.","Atala A","J Urol","2018","2018/04/22","","","10.1016/j.juro.2018.02.015"
"31357730","Fluorescence Enhancement Effect of TiO(2) Nanoparticles and Application for Photodynamic Diagnosis","Kanehira K, Yano Y, Hasumi H, Fukuhara H, Inoue K, Hanazaki K, Yao M.","Int J Mol Sci. 2019 Jul 28;20(15):3698. doi: 10.3390/ijms20153698.","Kanehira K","Int J Mol Sci","2019","2019/07/31","PMC6695909","","10.3390/ijms20153698"
"24120786","Re: Outpatient urological procedures in antibiotic-naïve patients with bladder cancer with asymptomatic bacteriuria","Schaeffer EM.","J Urol. 2013 Nov;190(5):1776. doi: 10.1016/j.juro.2013.07.040. Epub 2013 Jul 26.","Schaeffer EM","J Urol","2013","2013/10/15","","","10.1016/j.juro.2013.07.040"
"26394624","Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma","Breyer J, Gierth M, Shalekenov S, Aziz A, Schäfer J, Burger M, Denzinger S, Hofstädter F, Giedl C, Otto W.","World J Urol. 2016 May;34(5):709-16. doi: 10.1007/s00345-015-1690-5. Epub 2015 Sep 22.","Breyer J","World J Urol","2016","2015/09/24","","","10.1007/s00345-015-1690-5"
"24818854","Bladder cancer: root cause of bladder cancer revealed","Payton S.","Nat Rev Urol. 2014 Jun;11(6):302. doi: 10.1038/nrurol.2014.108. Epub 2014 May 13.","Payton S","Nat Rev Urol","2014","2014/05/14","","","10.1038/nrurol.2014.108"
"28619755","Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer","Railkar R, Krane LS, Li QQ, Sanford T, Siddiqui MR, Haines D, Vourganti S, Brancato SJ, Choyke PL, Kobayashi H, Agarwal PK.","Mol Cancer Ther. 2017 Oct;16(10):2201-2214. doi: 10.1158/1535-7163.MCT-16-0924. Epub 2017 Jun 15.","Railkar R","Mol Cancer Ther","2017","2017/06/17","PMC5628127","NIHMS885958","10.1158/1535-7163.MCT-16-0924"
"860473","[Combination of diabetes mellitus, urolithiasis and cancer of the urinary bladder]","Kuriĭ MF, Bondar' IP.","Vrach Delo. 1977 Feb;(2):88-9.","Kuriĭ MF","Vrach Delo","1977","1977/02/01","","",""
"29685374","A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer","Mari A, Kimura S, Foerster B, Abufaraj M, D'Andrea D, Gust KM, Shariat SF.","Urol Oncol. 2018 Jun;36(6):293-305. doi: 10.1016/j.urolonc.2018.03.018. Epub 2018 Apr 21.","Mari A","Urol Oncol","2018","2018/04/25","","","10.1016/j.urolonc.2018.03.018"
"18037228","Sickness and survival in bladder cancer: is comorbidity the crystal ball?","Konety BR.","Eur Urol. 2008 Mar;53(3):465-7. doi: 10.1016/j.eururo.2007.11.040. Epub 2007 Nov 20.","Konety BR","Eur Urol","2008","2007/11/27","","","10.1016/j.eururo.2007.11.040"
"6367191","Histopathology of bladder cancer and dysplasia","Englander LS.","Urology. 1984 Mar;23(3 Suppl):27-8. doi: 10.1016/s0090-4295(84)80111-9.","Englander LS","Urology","1984","1984/03/01","","","10.1016/s0090-4295(84)80111-9"
"30767131","Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory","Chung J, Kulkarni GS, Morash R, Matthew A, Papadakos J, Breau RH, Guttman D, Bender J, Jones JM.","Support Care Cancer. 2019 Oct;27(10):3877-3885. doi: 10.1007/s00520-019-4649-z. Epub 2019 Feb 14.","Chung J","Support Care Cancer","2019","2019/02/16","PMC6726665","","10.1007/s00520-019-4649-z"
"30070321","MiR-183 maintains canonical Wnt signaling activity and regulates growth and apoptosis in bladder cancer via targeting AXIN2","Chen D, Li SG, Chen JY, Xiao M.","Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4828-4836. doi: 10.26355/eurrev_201808_15618.","Chen D","Eur Rev Med Pharmacol Sci","2018","2018/08/03","","","10.26355/eurrev_201808_15618"
"28408175","An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer","Seiler R, Oo HZ, Tortora D, Clausen TM, Wang CK, Kumar G, Pereira MA, Ørum-Madsen MS, Agerbæk MØ, Gustavsson T, Nordmaj MA, Rich JR, Lallous N, Fazli L, Lee SS, Douglas J, Todenhöfer T, Esfandnia S, Battsogt D, Babcook JS, Al-Nakouzi N, Crabb SJ, Moskalev I, Kiss B, Davicioni E, Thalmann GN, Rennie PS, Black PC, Salanti A, Daugaard M.","Eur Urol. 2017 Jul;72(1):142-150. doi: 10.1016/j.eururo.2017.03.021. Epub 2017 Apr 10.","Seiler R","Eur Urol","2017","2017/04/15","","","10.1016/j.eururo.2017.03.021"
"28845940","[High oncogenic risk human papillomavirus and urinary bladder cancer]","Loran OB, Sinyakova LA, Gundorova LV, Kosov VA, Kosova IV, Pogodina IE, Kolbasov DN.","Urologiia. 2017 Jul;(3):60-66. doi: 10.18565/urol.2017.3.60-66.","Loran OB","Urologiia","2017","2017/08/29","","","10.18565/urol.2017.3.60-66"
"2201794","Low dose intravesical heparin as prophylaxis against recurrent noninvasive (stage Ta) bladder cancer","Bitsch M, Hermann GG, Andersen JP, Steven K.","J Urol. 1990 Sep;144(3):635-6. doi: 10.1016/s0022-5347(17)39542-3.","Bitsch M","J Urol","1990","1990/09/01","","","10.1016/s0022-5347(17)39542-3"
"20438408","Y chromosome loss is a frequent early event in urothelial bladder cancer","Minner S, Kilgué A, Stahl P, Weikert S, Rink M, Dahlem R, Fisch M, Höppner W, Wagner W, Bokemeyer C, Terracciano L, Simon R, Sauter G, Wilczak W.","Pathology. 2010 Jun;42(4):356-9. doi: 10.3109/00313021003767298.","Minner S","Pathology","2010","2010/05/05","","","10.3109/00313021003767298"
"12074817","Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy","Gschwend JE, Dahm P, Fair WR.","Eur Urol. 2002 Apr;41(4):440-8. doi: 10.1016/s0302-2838(02)00060-x.","Gschwend JE","Eur Urol","2002","2002/06/21","","","10.1016/s0302-2838(02)00060-x"
"11696819","Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2","Takahashi T, Kushiro A, Nomoto K, Uchida K, Morotomi M, Yokokura T, Akaza H.","J Urol. 2001 Dec;166(6):2506-11.","Takahashi T","J Urol","2001","2001/11/07","","",""
"18976938","Retinoblastoma protein expression predicts response to bacillus Calmette-Guérin immunotherapy in patients with T1G3 bladder cancer","Cormio L, Tolve I, Annese P, Saracino A, Zamparese R, Sanguedolce F, Bufo P, Battaglia M, Selvaggi FP, Carrieri G.","Urol Oncol. 2010 May-Jun;28(3):285-9. doi: 10.1016/j.urolonc.2008.08.003. Epub 2008 Oct 31.","Cormio L","Urol Oncol","2010","2008/11/04","","","10.1016/j.urolonc.2008.08.003"
"16949911","Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis","Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y.","Hum Pathol. 2006 Dec;37(12):1568-76. doi: 10.1016/j.humpath.2006.05.017. Epub 2006 Aug 10.","Shariat SF","Hum Pathol","2006","2006/09/05","","","10.1016/j.humpath.2006.05.017"
"17938574","Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cells","Belda-Iniesta C, Perona R, Carpeño Jde C, Cejas P, Casado E, Manguan-García C, Ibanez de Caceres I, Sanchez-Perez I, Andreu FB, Ferreira JA, Aguilera A, de la Peña J, Perez-Sánchez E, Madero R, Feliu J, Sereno M, González-Barón M.","Cancer Biol Ther. 2007 Oct;6(10):1600-5. doi: 10.4161/cbt.6.10.4726. Epub 2007 Jul 12.","Belda-Iniesta C","Cancer Biol Ther","2007","2007/10/17","","","10.4161/cbt.6.10.4726"
"451328","Multiparametric markers in the monitoring of cancer","Cooper EH.","Recent Results Cancer Res. 1979;67:97-103. doi: 10.1007/978-3-642-81320-7_15.","Cooper EH","Recent Results Cancer Res","1979","1979/01/01","","","10.1007/978-3-642-81320-7_15"
"3309367","Monocyte cytolytic factor in promoting monocyte-mediated lysis of bladder cancer cells by bacillus Calmette-Guerin","Catalona WJ.","J Urol. 1987 Oct;138(4):866. doi: 10.1016/s0022-5347(17)43405-7.","Catalona WJ","J Urol","1987","1987/10/01","","","10.1016/s0022-5347(17)43405-7"
"4815653","Occupational bladder cancer","Tepper LB.","J Ky Med Assoc. 1974 Mar;72(3):135-8.","Tepper LB","J Ky Med Assoc","1974","1974/03/01","","",""
"15333651","Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer","Brunner A, Mayerl C, Tzankov A, Verdorfer I, Tschörner I, Rogatsch H, Mikuz G.","J Clin Pathol. 2004 Sep;57(9):927-31. doi: 10.1136/jcp.2004.016576.","Brunner A","J Clin Pathol","2004","2004/08/31","PMC1770417","","10.1136/jcp.2004.016576"
"23936805","Licochalcone A-induced human bladder cancer T24 cells apoptosis triggered by mitochondria dysfunction and endoplasmic reticulum stress","Yuan X, Li D, Zhao H, Jiang J, Wang P, Ma X, Sun X, Zheng Q.","Biomed Res Int. 2013;2013:474272. doi: 10.1155/2013/474272. Epub 2013 Jul 7.","Yuan X","Biomed Res Int","2013","2013/08/13","PMC3722779","","10.1155/2013/474272"
"22378376","Chemoprevention with green propolis green propolis extracted in L-lysine versus carcinogenesis promotion with L-lysine in N-Butyl-N-[4-hydroxybutyl] nitrosamine (BBN) induced rat bladder cancer","Dornelas CA, Fechine-Jamacaru FV, Albuquerque IL, Magalhães HI, Souza AJ, Alves LA, Almeida PR, Lemos TL, Castro JD, Moraes ME, Moraes MO.","Acta Cir Bras. 2012 Feb;27(2):185-92. doi: 10.1590/s0102-86502012000200015.","Dornelas CA","Acta Cir Bras","2012","2012/03/02","","","10.1590/s0102-86502012000200015"
"28889378","Defining the Pathways of Urogenital Schistosomiasis-Associated Urothelial Carcinogenesis through Transgenic and Bladder Wall Egg Injection Models","Mbanefo EC, Hsieh MH.","Methods Mol Biol. 2018;1655:67-76. doi: 10.1007/978-1-4939-7234-0_6.","Mbanefo EC","Methods Mol Biol","2018","2017/09/11","","","10.1007/978-1-4939-7234-0_6"
"15643502","Expression of endothelin-1 and endothelin-A and -B receptors in invasive bladder cancer","Wülfing C, Eltze E, Piechota H, Abol-Enein H, Wülfing P, Bode ME, Hertle L, Sievert KD.","Oncol Rep. 2005 Feb;13(2):223-8.","Wülfing C","Oncol Rep","2005","2005/01/12","","",""
"18025801","Gain of 5p15.33 is associated with progression of bladder cancer","Yamamoto Y, Chochi Y, Matsuyama H, Eguchi S, Kawauchi S, Furuya T, Oga A, Kang JJ, Naito K, Sasaki K.","Oncology. 2007;72(1-2):132-8. doi: 10.1159/000111132. Epub 2007 Nov 15.","Yamamoto Y","Oncology","2007","2007/11/21","","","10.1159/000111132"
"29970242","Apparent diffusion coefficient values obtained by unenhanced MRI predicts disease-specific survival in bladder cancer","Sevcenco S, Maj-Hes AB, Hruby S, Ponhold L, Heinz-Peer G, Rauchenwald M, Marszalek M, Klingler HC, Polanec S, Baltzer PAT.","Clin Radiol. 2018 Oct;73(10):881-885. doi: 10.1016/j.crad.2018.05.022. Epub 2018 Jun 30.","Sevcenco S","Clin Radiol","2018","2018/07/05","","","10.1016/j.crad.2018.05.022"
"19568699","Bladder cancer and reproductive factors among women in Spain","Huang AT, Kogevinas M, Silverman DT, Malats N, Rothman N, Tardón A, Serra C, García-Closas R, Carrato A, Cantor KP.","Cancer Causes Control. 2009 Dec;20(10):1907-13. doi: 10.1007/s10552-009-9384-1.","Huang AT","Cancer Causes Control","2009","2009/07/02","PMC2889165","NIHMS151229","10.1007/s10552-009-9384-1"
"1466089","Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group","Aso Y, Akazan H.","Urol Int. 1992;49(3):125-9. doi: 10.1159/000282409.","Aso Y","Urol Int","1992","1992/01/01","","","10.1159/000282409"
"10828664","Glutathione S-transferase null genotypes in transitional cell bladder cancer: a case-control study","Georgiou I, Filiadis IF, Alamanos Y, Bouba I, Giannakopoulos X, Lolis D.","Eur Urol. 2000 Jun;37(6):660-4. doi: 10.1159/000020234.","Georgiou I","Eur Urol","2000","2000/06/01","","","10.1159/000020234"
"1834120","Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy","Lipponen PK, Eskelinen MJ, Nordling S.","Eur J Cancer. 1991;27(7):877-81. doi: 10.1016/0277-5379(91)90138-4.","Lipponen PK","Eur J Cancer","1991","1991/01/01","","","10.1016/0277-5379(91)90138-4"
"22843882","Cell-free serum DNA in patients with bladder cancer: results of a prospective multicenter study","Hauser S, Kogej M, Fechner G, Von Ruecker A, Bastian PJ, Von Pezold J, Vorreuther R, Lümmen G, Müller SC, Ellinger J.","Anticancer Res. 2012 Aug;32(8):3119-24.","Hauser S","Anticancer Res","2012","2012/07/31","","",""
"29668641","Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors","Balan D, Martha O, Chibelean CB, Tataru S, Voidezan S, Sin A, Matei VD, Vartolomei MD, Lucarelli G, Cioffi A, Del Giudice F, De Berardinis E, Borda A, Busetto GM, Ferro M, Pytel A, Porav-Hodade D.","Medicine (Baltimore). 2018 Apr;97(16):e0522. doi: 10.1097/MD.0000000000010522.","Balan D","Medicine (Baltimore)","2018","2018/04/19","PMC5916673","","10.1097/MD.0000000000010522"
"28386561","New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer","Chlosta PL, Golabek T, Nyirády P.","Biomed Res Int. 2017;2017:6467072. doi: 10.1155/2017/6467072. Epub 2017 Mar 13.","Chlosta PL","Biomed Res Int","2017","2017/04/08","PMC5366782","","10.1155/2017/6467072"
"11894999","Retrovirus-mediated transfer of prothymosin gene inhibits tumor growth and prolongs survival in murine bladder cancer","Shiau AL, Lin PR, Chang MY, Wu CL.","Gene Ther. 2001 Nov;8(21):1609-17. doi: 10.1038/sj.gt.3301568.","Shiau AL","Gene Ther","2001","2002/03/16","","","10.1038/sj.gt.3301568"
"16280742","Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study","Daniltchenko DI, Riedl CR, Sachs MD, Koenig F, Daha KL, Pflueger H, Loening SA, Schnorr D.","J Urol. 2005 Dec;174(6):2129-33, discussion 2133. doi: 10.1097/01.ju.0000181814.73466.14.","Daniltchenko DI","J Urol","2005","2005/11/11","","","10.1097/01.ju.0000181814.73466.14"
"10872670","Assessment of basal cell status and proliferative patterns in flat and papillary urothelial lesions: a contribution to the new WHO classification of the urothelial tumors of the urinary bladder","Helpap B, Köllermann J.","Hum Pathol. 2000 Jun;31(6):745-50. doi: 10.1053/hupa.2000.8224.","Helpap B","Hum Pathol","2000","2000/06/29","","","10.1053/hupa.2000.8224"
"16905986","Recent developments in molecular profiling of bladder cancer","Ørntoft TF, Zieger K, Dyrskjøt L.","Curr Opin Urol. 2006 Sep;16(5):377-81. doi: 10.1097/01.mou.0000240313.16324.d3.","Ørntoft TF","Curr Opin Urol","2006","2006/08/15","","","10.1097/01.mou.0000240313.16324.d3"
"8635935","Once weekly irradiation for carcinoma of the bladder","Rostom AY, Tahir S, Gershuny AR, Kandil A, Folkes A, White WF.","Int J Radiat Oncol Biol Phys. 1996 May 1;35(2):289-92. doi: 10.1016/0360-3016(96)00063-6.","Rostom AY","Int J Radiat Oncol Biol Phys","1996","1996/05/01","","","10.1016/0360-3016(96)00063-6"
"10941943","Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials","Huncharek M, Geschwind JF, Witherspoon B, McGarry R, Adcock D.","J Clin Epidemiol. 2000 Jul;53(7):676-80. doi: 10.1016/s0895-4356(99)00203-6.","Huncharek M","J Clin Epidemiol","2000","2000/08/15","","","10.1016/s0895-4356(99)00203-6"
"4624722","Local chemotherapy in bladder cancer","Gibson GR.","Br J Urol. 1972 Feb;44(1):121.","Gibson GR","Br J Urol","1972","1972/02/01","","",""
"29803657","The prognostic values of tumor-infiltrating neutrophils, lymphocytes and neutrophil/lymphocyte rates in bladder urothelial cancer","Liu K, Zhao K, Wang L, Sun E.","Pathol Res Pract. 2018 Aug;214(8):1074-1080. doi: 10.1016/j.prp.2018.05.010. Epub 2018 May 20.","Liu K","Pathol Res Pract","2018","2018/05/28","","","10.1016/j.prp.2018.05.010"
"25634585","Research progress of oncogene and tumor suppressor gene in bladder cancer","Zhang X, Han C, He J.","Panminerva Med. 2015 Dec;57(4):191-200. Epub 2015 Jan 29.","Zhang X","Panminerva Med","2015","2015/01/31","","",""
"8208315","Location of primary and recurrent superficial bladder tumors and benefits of selective biopsies","Hanus M, Matousková M.","Neoplasma. 1994;41(2):119-22.","Hanus M","Neoplasma","1994","1994/01/01","","",""
"23246108","Study on bladder cancer susceptibility and genetic polymorphisms of XPC, XPG, and CYP in smokers and non-smokers","Wen H, Feng CC, Fang ZJ, Xia GW, Jiang HW, Xu G, Huang XD, Ding Q.","Actas Urol Esp. 2013 May;37(5):259-65. doi: 10.1016/j.acuro.2012.04.007. Epub 2012 Dec 13.","Wen H","Actas Urol Esp","2013","2012/12/19","","","10.1016/j.acuro.2012.04.007"
"6492279","The clinicopathological features of metastatic superficial papillary bladder cancer","Matthews PN, Madden M, Bidgood KA, Fisher C.","J Urol. 1984 Nov;132(5):904-6. doi: 10.1016/s0022-5347(17)49939-3.","Matthews PN","J Urol","1984","1984/11/01","","","10.1016/s0022-5347(17)49939-3"
"29428524","The New Age of -omics in Urothelial Cancer - Re-wording Its Diagnosis and Treatment","Katsila T, Liontos M, Patrinos GP, Bamias A, Kardamakis D.","EBioMedicine. 2018 Feb;28:43-50. doi: 10.1016/j.ebiom.2018.01.044. Epub 2018 Feb 2.","Katsila T","EBioMedicine","2018","2018/02/12","PMC5835572","","10.1016/j.ebiom.2018.01.044"
"31283979","Palliative Radiation Therapy in Bladder Cancer-Importance of Patient Selection: A Retrospective Multicenter Study","Ali A, Song YP, Mehta S, Mistry H, Conroy R, Coyle C, Logue J, Tran A, Wylie J, Janjua T, Joseph L, Joseph J, Choudhury A.","Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):389-393. doi: 10.1016/j.ijrobp.2019.06.2541. Epub 2019 Jul 5.","Ali A","Int J Radiat Oncol Biol Phys","2019","2019/07/09","","","10.1016/j.ijrobp.2019.06.2541"
"6677700","[Lymphography and lymph node excision in bladder cancer. Apropos of a series]","Charbit L, Dana A, Beurton D, Michel JR, Cukier J.","J Urol (Paris). 1983;89(8):547-53.","Charbit L","J Urol (Paris)","1983","1983/01/01","","",""
"28753835","Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer","Kramer MW, Altieri V, Hurle R, Lusuardi L, Merseburger AS, Rassweiler J, Struck JP, Herrmann TRW.","Eur Urol Focus. 2017 Dec;3(6):567-576. doi: 10.1016/j.euf.2016.12.004. Epub 2017 Jan 11.","Kramer MW","Eur Urol Focus","2017","2017/07/30","","","10.1016/j.euf.2016.12.004"
"15150393","Mortality and cancer incidence among Lithuanian cement producing workers","Smailyte G, Kurtinaitis J, Andersen A.","Occup Environ Med. 2004 Jun;61(6):529-34. doi: 10.1136/oem.2003.009936.","Smailyte G","Occup Environ Med","2004","2004/05/20","PMC1763656","","10.1136/oem.2003.009936"
"872118","Management (control) of early bladder lesions","Prout GR Jr.","Cancer Res. 1977 Aug;37(8 Pt 2):2891-4.","Prout GR Jr","Cancer Res","1977","1977/08/01","","",""
"29745929","[Chemohyperthermia using MMC in non-muscle-invasive bladder cancer: Current status and future perspectives.]","Coenen JJMJH, van Valenberg FJP, Arends TJH, Witjes JA.","Arch Esp Urol. 2018 May;71(4):400-408.","Coenen JJMJH","Arch Esp Urol","2018","2018/05/11","","",""
"326395","Classification of the bladder cancer patient based on in vitro measurements of the immune response","Lange PH, Hakala TR, Fraley EE.","Cancer Res. 1977 Aug;37(8 Pt 2):2885-90.","Lange PH","Cancer Res","1977","1977/08/01","","",""
"18148587","Primary carcinoma in bladder diverticulum; case report","LUECHAUER KD.","Urol Cutaneous Rev. 1949 Oct;53(10):597.","LUECHAUER KD","Urol Cutaneous Rev","1949","1949/10/01","","",""
"18121514","Primary carcinoma in bladder diverticulum","ATCHESON DW.","Urol Cutaneous Rev. 1948 Dec;52(12):713-5.","ATCHESON DW","Urol Cutaneous Rev","1948","1948/12/01","","",""
"18569590","The influence of polymorphisms of glutathione S-transferases M1 and M3 on the development of human urothelial cancer","Golka K, Schmidt T, Seidel T, Dietrich H, Roemer HC, Lohlein D, Reckwitz T, Sokeland J, Weistenhofer W, Blaszkewicz M, Selinski S.","J Toxicol Environ Health A. 2008;71(13-14):881-6. doi: 10.1080/15287390801988087.","Golka K","J Toxicol Environ Health A","2008","2008/06/24","","","10.1080/15287390801988087"
"27375033","Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer","Alfred Witjes J, Lebret T, Compérat EM, Cowan NC, De Santis M, Bruins HM, Hernández V, Espinós EL, Dunn J, Rouanne M, Neuzillet Y, Veskimäe E, van der Heijden AG, Gakis G, Ribal MJ.","Eur Urol. 2017 Mar;71(3):462-475. doi: 10.1016/j.eururo.2016.06.020. Epub 2016 Jun 30.","Alfred Witjes J","Eur Urol","2017","2016/07/05","","","10.1016/j.eururo.2016.06.020"
"17270621","Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guérin immunotherapy","Margel D, Tal R, Golan S, Kedar D, Engelstein D, Baniel J.","Urology. 2007 Jan;69(1):78-82. doi: 10.1016/j.urology.2006.09.019.","Margel D","Urology","2007","2007/02/03","","","10.1016/j.urology.2006.09.019"
"439531","[The value of pelvic arteriography in the diagnosis and prognosis on bladder cancer (author's transl)]","Ono H, Nihira H, Shiraishi T.","Nihon Hinyokika Gakkai Zasshi. 1979 Mar;70(3):342-50. doi: 10.5980/jpnjurol1928.70.3_342.","Ono H","Nihon Hinyokika Gakkai Zasshi","1979","1979/03/01","","","10.5980/jpnjurol1928.70.3_342"
"2456038","[A new animal model for intravesical chemotherapy of bladder cancer]","Yamashita T, Ito J.","Gan To Kagaku Ryoho. 1988 Jul;15(7):2087-92.","Yamashita T","Gan To Kagaku Ryoho","1988","1988/07/01","","",""
"16514529","[The causes of urinary bladder cancer and possibilities of prevention]","Golka K, Rettenmeier AW, Goebell PJ.","Urologe A. 2006 Mar;45(3):361-7; quiz 368. doi: 10.1007/s00120-006-1018-6.","Golka K","Urologe A","2006","2006/03/04","","","10.1007/s00120-006-1018-6"
"2818965","Occupational bladder cancer and the hospital clinician","Brooke WE, Howe W, Smith AE.","Br J Ind Med. 1989 Oct;46(10):750-1. doi: 10.1136/oem.46.10.750-a.","Brooke WE","Br J Ind Med","1989","1989/10/01","PMC1009860","","10.1136/oem.46.10.750-a"
"11101090","Follow-up of patients with noninvasive and superficially invasive bladder cancer","Holmäng S.","Semin Urol Oncol. 2000 Nov;18(4):273-9.","Holmäng S","Semin Urol Oncol","2000","2000/12/02","","",""
"30907072","Hope and challenge: Precision medicine in bladder cancer","Su H, Jiang H, Tao T, Kang X, Zhang X, Kang D, Li S, Li C, Wang H, Yang Z, Zhang J, Li C.","Cancer Med. 2019 Apr;8(4):1806-1816. doi: 10.1002/cam4.1979. Epub 2019 Mar 24.","Su H","Cancer Med","2019","2019/03/26","PMC6488142","","10.1002/cam4.1979"
"7328967","[Experimental studies on regional therapy of urinary bladder cancer. 1. A model of urinary bladder carcinoma in the rabbit using transplantable V2 carcinoma (author's transl)]","Nemoto R, Mori H, Iwata K, Kato T, Abe R, Harada M.","Nihon Hinyokika Gakkai Zasshi. 1981 Sep;72(9):1113-9. doi: 10.5980/jpnjurol1928.72.9_1113.","Nemoto R","Nihon Hinyokika Gakkai Zasshi","1981","1981/09/01","","","10.5980/jpnjurol1928.72.9_1113"
"14678188","Lipomatosis of the bladder presenting as bladder cancer","Tulunay O, Gögüs C, Bedük Y, Kaygusuz G, Orhan D.","Int J Urol. 2004 Jan;11(1):56-7. doi: 10.1111/j.1442-2042.2004.00731.x.","Tulunay O","Int J Urol","2004","2003/12/18","","","10.1111/j.1442-2042.2004.00731.x"
"23612777","Estrogen receptor-β expression and pharmacological targeting in bladder cancer","Kauffman EC, Robinson BD, Downes M, Marcinkiewicz K, Vourganti S, Scherr DS, Gudas LJ, Mongan NP.","Oncol Rep. 2013 Jul;30(1):131-8. doi: 10.3892/or.2013.2416. Epub 2013 Apr 23.","Kauffman EC","Oncol Rep","2013","2013/04/25","PMC3729232","","10.3892/or.2013.2416"
"32352838","Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer","Gao L, Meng J, Zhang M, Fan S, Gao S, Wang X, Liang C.","DNA Cell Biol. 2020 Jun;39(6):1072-1089. doi: 10.1089/dna.2019.5224. Epub 2020 Apr 29.","Gao L","DNA Cell Biol","2020","2020/05/01","","","10.1089/dna.2019.5224"
"9770167","Mycobacterium bovis osteomyelitis involving a hip arthroplasty after intravesicular bacille Calmette-Guérin for bladder cancer","Guerra CE, Betts RF, O'Keefe RJ, Shilling JW.","Clin Infect Dis. 1998 Sep;27(3):639-40. doi: 10.1086/514714.","Guerra CE","Clin Infect Dis","1998","1998/10/14","","","10.1086/514714"
"30578357","Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA","Dudley JC, Schroers-Martin J, Lazzareschi DV, Shi WY, Chen SB, Esfahani MS, Trivedi D, Chabon JJ, Chaudhuri AA, Stehr H, Liu CL, Lim H, Costa HA, Nabet BY, Sin MLY, Liao JC, Alizadeh AA, Diehn M.","Cancer Discov. 2019 Apr;9(4):500-509. doi: 10.1158/2159-8290.CD-18-0825. Epub 2018 Dec 21.","Dudley JC","Cancer Discov","2019","2018/12/23","PMC6467650","NIHMS1517433","10.1158/2159-8290.CD-18-0825"
"5919056","Failure to induce bladder cancer in mice. Bladder implantation with paraffin wax pellets of lypholized urine from bilharzial patients","el-Ghaffar YA.","Cancer. 1966 Sep;19(9):1225-30. doi: 10.1002/1097-0142(196609)19:9<1225::aid-cncr2820190908>3.0.co;2-k.","el-Ghaffar YA","Cancer","1966","1966/09/01","","","10.1002/1097-0142(196609)19:9<1225::aid-cncr2820190908>3.0.co;2-k"
"23602406","Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data","Burger M, Grossman HB, Droller M, Schmidbauer J, Hermann G, Drăgoescu O, Ray E, Fradet Y, Karl A, Burgués JP, Witjes JA, Stenzl A, Jichlinski P, Jocham D.","Eur Urol. 2013 Nov;64(5):846-54. doi: 10.1016/j.eururo.2013.03.059. Epub 2013 Apr 8.","Burger M","Eur Urol","2013","2013/04/23","","","10.1016/j.eururo.2013.03.059"
"24265260","MR imaging of urinary bladder cancer for T-staging: a review and a pictorial essay of diffusion-weighted imaging","Takeuchi M, Sasaki S, Naiki T, Kawai N, Kohri K, Hara M, Shibamoto Y.","J Magn Reson Imaging. 2013 Dec;38(6):1299-309. doi: 10.1002/jmri.24227. Epub 2013 Nov 21.","Takeuchi M","J Magn Reson Imaging","2013","2013/11/23","","","10.1002/jmri.24227"
"2003988","Bladder cancer mortality of workers exposed to aromatic amines: an updated analysis","Piolatto G, Negri E, La Vecchia C, Pira E, Decarli A, Peto J.","Br J Cancer. 1991 Mar;63(3):457-9. doi: 10.1038/bjc.1991.106.","Piolatto G","Br J Cancer","1991","1991/03/01","PMC1971871","","10.1038/bjc.1991.106"
"23255547","Comparison of adaptive radiotherapy techniques for the treatment of bladder cancer","Webster GJ, Stratford J, Rodgers J, Livsey JE, Macintosh D, Choudhury A.","Br J Radiol. 2013 Jan;86(1021):20120433. doi: 10.1259/bjr.20120433.","Webster GJ","Br J Radiol","2013","2012/12/21","PMC4651060","","10.1259/bjr.20120433"
"27804056","Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project","Wilcox AN, Silverman DT, Friesen MC, Locke SJ, Russ DE, Hyun N, Colt JS, Figueroa JD, Rothman N, Moore LE, Koutros S.","Cancer Causes Control. 2016 Dec;27(12):1429-1435. doi: 10.1007/s10552-016-0821-7. Epub 2016 Nov 1.","Wilcox AN","Cancer Causes Control","2016","2016/11/03","PMC5114667","NIHMS826885","10.1007/s10552-016-0821-7"
"17483021","Solitary breast cancer metastasis to the bladder: an unusual occurrence","Zagha RM, Hamawy KJ.","Urol Oncol. 2007 May-Jun;25(3):236-9. doi: 10.1016/j.urolonc.2006.05.013.","Zagha RM","Urol Oncol","2007","2007/05/08","","","10.1016/j.urolonc.2006.05.013"
"9813934","Haematuria as the presenting symptom: experience from a tertiary referral centre in Sri Lanka","Goonewardena SA, Abeygunasekera AM.","Ceylon Med J. 1998 Sep;43(3):156-8.","Goonewardena SA","Ceylon Med J","1998","1998/11/14","","",""
"29548614","Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder","Hensley PJ, Goodwin J, Davenport DL, Strup SE, James A.","Clin Genitourin Cancer. 2018 Aug;16(4):e851-e858. doi: 10.1016/j.clgc.2018.02.007. Epub 2018 Feb 22.","Hensley PJ","Clin Genitourin Cancer","2018","2018/03/18","","","10.1016/j.clgc.2018.02.007"
"26452033","Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors","Ferreira-Teixeira M, Parada B, Rodrigues-Santos P, Alves V, Ramalho JS, Caramelo F, Sousa V, Reis F, Gomes CM.","Oncotarget. 2015 Nov 3;6(34):36185-201. doi: 10.18632/oncotarget.5517.","Ferreira-Teixeira M","Oncotarget","2015","2015/10/10","PMC4742170","","10.18632/oncotarget.5517"
"28639914","Long non-coding RNA urothelial carcinoma-associated 1 as a tumor biomarker for the diagnosis of urinary bladder cancer","Wang Z, Wang X, Zhang D, Yu Y, Cai L, Zhang C.","Tumour Biol. 2017 Jun;39(6):1010428317709990. doi: 10.1177/1010428317709990.","Wang Z","Tumour Biol","2017","2017/06/23","","","10.1177/1010428317709990"
"32239282","Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer","Semeniuk-Wojtaś A, Lubas A, Cierniak S, Brzóskowska U, Syryło T, Zieliński H, Stec R.","J Cancer Res Clin Oncol. 2020 Aug;146(8):2099-2108. doi: 10.1007/s00432-020-03202-0. Epub 2020 Apr 1.","Semeniuk-Wojtaś A","J Cancer Res Clin Oncol","2020","2020/04/03","PMC7324417","","10.1007/s00432-020-03202-0"
"16196100","Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer","Irmak S, Tilki D, Heukeshoven J, Oliveira-Ferrer L, Friedrich M, Huland H, Ergün S.","Proteomics. 2005 Nov;5(16):4296-304. doi: 10.1002/pmic.200402005.","Irmak S","Proteomics","2005","2005/10/01","","","10.1002/pmic.200402005"
"8693957","Intra-arterial chemotherapy for muscle-invasive urinary bladder cancer","Takahashi N, Nishimura S, Kawaguchi T.","Hinyokika Kiyo. 1996 Apr;42(4):263-8.","Takahashi N","Hinyokika Kiyo","1996","1996/04/01","","",""
"21575460","[Expression and significance of macrophage migration inhibitory factor in bladder urothelial cell carcinoma]","Guo YS, Dai YP, Li W, Liu LD.","Zhonghua Zhong Liu Za Zhi. 2011 Jan;33(1):28-31.","Guo YS","Zhonghua Zhong Liu Za Zhi","2011","2011/05/18","","",""
"20025478","Prognostic significance of apoptotic cell death in bladder cancer: a tissue microarray study on 179 urothelial carcinomas from cystectomy specimens","Karamitopoulou E, Rentsch CA, Markwalder R, Vallan C, Thalmann GN, Brunner T.","Pathology. 2010 Jan;42(1):37-42. doi: 10.3109/00313020903434397.","Karamitopoulou E","Pathology","2010","2009/12/23","","","10.3109/00313020903434397"
"1841171","Survival of patients with bladder cancer--analysis of prognostic factors","Matsuoka K, Ueda S, Ohyabu Y, Noda S.","Kurume Med J. 1991;38(4):281-6. doi: 10.2739/kurumemedj.38.281.","Matsuoka K","Kurume Med J","1991","1991/01/01","","","10.2739/kurumemedj.38.281"
"19565266","Hypermethylated SFRP1, but none of other nine genes ""informative"" for western countries, is valuable for bladder cancer detection in Mainland China","Sun J, Chen Z, Zhu T, Yu J, Ma K, Zhang H, He Y, Luo X, Zhu J.","J Cancer Res Clin Oncol. 2009 Dec;135(12):1717-27. doi: 10.1007/s00432-009-0619-z. Epub 2009 Jun 30.","Sun J","J Cancer Res Clin Oncol","2009","2009/07/01","","","10.1007/s00432-009-0619-z"
"28592583","Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer: a systematic review protocol","Rammant E, Bultijnck R, Sundahl N, Ost P, Pauwels NS, Deforche B, Pieters R, Decaestecker K, Fonteyne V.","BMJ Open. 2017 Jun 6;7(5):e016054. doi: 10.1136/bmjopen-2017-016054.","Rammant E","BMJ Open","2017","2017/06/09","PMC5726122","","10.1136/bmjopen-2017-016054"
"20709375","Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice","Scosyrev E, Yao J, Messing E.","Urology. 2010 Oct;76(4):908-13; discussion 914. doi: 10.1016/j.urology.2010.02.073. Epub 2010 Aug 14.","Scosyrev E","Urology","2010","2010/08/17","","","10.1016/j.urology.2010.02.073"
"20383630","[Gross haematuria as the primary symptom of extramedullary IgM plasmacytoma of the bladder]","Tsaur I, Probst M, Chow KU, Renne C, Cerovac I, Pelekanos C, Juengel E, Wedel SA, Bickeböller R, Karalis A.","Urologe A. 2010 Jul;49(7):850-4. doi: 10.1007/s00120-010-2293-9.","Tsaur I","Urologe A","2010","2010/04/13","","","10.1007/s00120-010-2293-9"
"21091799","Bacillus Calmette-Guérin treatment of non-muscle invasive bladder cancer","Sylvester RJ.","Int J Urol. 2011 Feb;18(2):113-20. doi: 10.1111/j.1442-2042.2010.02678.x. Epub 2010 Nov 22.","Sylvester RJ","Int J Urol","2011","2010/11/25","","","10.1111/j.1442-2042.2010.02678.x"
"15734775","Thermo-chemotherapy for intermediate or high-risk recurrent superficial bladder cancer patients","Moskovitz B, Meyer G, Kravtzov A, Gross M, Kastin A, Biton K, Nativ O.","Ann Oncol. 2005 Apr;16(4):585-9. doi: 10.1093/annonc/mdi124. Epub 2005 Feb 25.","Moskovitz B","Ann Oncol","2005","2005/03/01","","","10.1093/annonc/mdi124"
"4036385","[Possibilities for the use of exfoliative urine cytology in invasive and noninvasive bladder cancer]","Stadie G, Ebert W, Müller H.","Z Urol Nephrol. 1985 Jun;78(6):331-7.","Stadie G","Z Urol Nephrol","1985","1985/06/01","","",""
"15286471","Occupational exposure to carbon black and risk of cancer","Puntoni R, Ceppi M, Gennaro V, Ugolini D, Puntoni M, La Manna G, Casella C, Merlo DF.","Cancer Causes Control. 2004 Jun;15(5):511-6. doi: 10.1023/B:CACO.0000036446.29787.94.","Puntoni R","Cancer Causes Control","2004","2004/08/03","","","10.1023/B:CACO.0000036446.29787.94"
"68815","Current perspectives on palliative therapy in cancer of the bladder","Stewart BH, Novick AC.","Cancer Res. 1977 Aug;37(8 Pt 2):2781-8.","Stewart BH","Cancer Res","1977","1977/08/01","","",""
"8073537","Comparison of two routes of photosensitizer administration for photodynamic therapy of bladder cancer","Bachor R, Hautmann R, Hasan T.","Urol Res. 1994;22(1):21-3. doi: 10.1007/BF00431544.","Bachor R","Urol Res","1994","1994/01/01","","","10.1007/BF00431544"
"22763630","Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer?","Yang Z, Cheng J, Pan L, Hu S, Xu J, Zhang Y, Wang M, Zhang J, Ye D, Zhang Y.","Ann Nucl Med. 2012 Aug;26(7):571-7. doi: 10.1007/s12149-012-0614-3. Epub 2012 Jul 5.","Yang Z","Ann Nucl Med","2012","2012/07/06","","","10.1007/s12149-012-0614-3"
"2221933","[Single drug chemotherapy with 5-FU oral administration of bladder cancer]","Ueno M, Yoshikawa H, Hasegawa K, Sasaki H, Onodera Y, Ikeuchi T, Kai Y.","Gan To Kagaku Ryoho. 1990 Oct;17(10):2109-11.","Ueno M","Gan To Kagaku Ryoho","1990","1990/10/01","","",""
"3390772","Urinary diversion using the Kock ileal reservoir in patients with irradiated bowel","Orovan WL, Davis IR.","Can J Surg. 1988 Jul;31(4):243-5.","Orovan WL","Can J Surg","1988","1988/07/01","","",""
"31411974","Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer","Racioppi M, Di Gianfrancesco L, Ragonese M, Palermo G, Sacco E, Bassi P.","Eur Urol Oncol. 2019 Sep;2(5):576-583. doi: 10.1016/j.euo.2018.08.032. Epub 2018 Oct 6.","Racioppi M","Eur Urol Oncol","2019","2019/08/15","","","10.1016/j.euo.2018.08.032"
"11241896","DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma","Kumar NU, Dey P, Mondal AK, Singh SK, Vohra H.","Diagn Cytopathol. 2001 Mar;24(3):153-6. doi: 10.1002/1097-0339(200103)24:3<153::aid-dc1032>3.0.co;2-p.","Kumar NU","Diagn Cytopathol","2001","2001/03/10","","","10.1002/1097-0339(200103)24:3<153::aid-dc1032>3.0.co;2-p"
"26957615","Use of Palliative Chemotherapy for Advanced Bladder Cancer: Patterns of Care in Routine Clinical Practice","Robinson AG, Wei X, Mackillop WJ, Peng Y, Booth CM.","J Natl Compr Canc Netw. 2016 Mar;14(3):291-8. doi: 10.6004/jnccn.2016.0034.","Robinson AG","J Natl Compr Canc Netw","2016","2016/03/10","","","10.6004/jnccn.2016.0034"
"1924441","Organ conservation in bladder cancer","Newling DW.","Prog Clin Biol Res. 1991;370:127-30.","Newling DW","Prog Clin Biol Res","1991","1991/01/01","","",""
"11410485","Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder","Seraj MJ, Thomas AR, Chin JL, Theodorescu D.","Clin Cancer Res. 2001 Jun;7(6):1516-22.","Seraj MJ","Clin Cancer Res","2001","2001/06/19","","",""
"353306","Bladder cancer: early diagnosis and evaluation of biologic potential. A review of newer methods","Lessing JA.","J Urol. 1978 Jul;120(1):1-5. doi: 10.1016/s0022-5347(17)57020-2.","Lessing JA","J Urol","1978","1978/07/01","","","10.1016/s0022-5347(17)57020-2"
"3425524","[An autopsy case of untreated bladder cancer]","Pak K, Ishida A, Arai Y, Tomoyoshi T.","Hinyokika Kiyo. 1987 Aug;33(8):1261-5.","Pak K","Hinyokika Kiyo","1987","1987/08/01","","",""
"31002892","NF-κB inhibitor, BAY11-7082, suppresses M2 tumor-associated macrophage induced EMT potential via miR-30a/NF-κB/Snail signaling in bladder cancer cells","Zhang Q, Mao Z, Sun J.","Gene. 2019 Aug 20;710:91-97. doi: 10.1016/j.gene.2019.04.039. Epub 2019 Apr 16.","Zhang Q","Gene","2019","2019/04/20","","","10.1016/j.gene.2019.04.039"
"25939973","Paraneoplastic encephalopathy: an unusual presenting feature of bladder cancer metastasis","Thanarajasingam G, Milone M, Kohli M.","BMJ Case Rep. 2015 May 4;2015:bcr2014208913. doi: 10.1136/bcr-2014-208913.","Thanarajasingam G","BMJ Case Rep","2015","2015/05/06","PMC4434336","","10.1136/bcr-2014-208913"
"9933800","BTA stat and BTA TRAK: A comparative evaluation of urine testing for the diagnosis of transitional cell carcinoma of the bladder","Irani J, Desgrandchamps F, Millet C, Toubert ME, Bon D, Aubert J, Le Duc A.","Eur Urol. 1999 Feb;35(2):89-92. doi: 10.1159/000019824.","Irani J","Eur Urol","1999","1999/02/06","","","10.1159/000019824"
"12370752","Activity of E2F-dependent promoters in bladder carcinoma cells and their use for tumour-specific targeting of p53-induced apoptosis","Steinhoff C, Prior A, Reichmann G, Seifert HH, Schulz WA.","Int J Oncol. 2002 Nov;21(5):1033-40.","Steinhoff C","Int J Oncol","2002","2002/10/09","","",""
"16890724","Protective effects of plasma carotenoids on the risk of bladder cancer","Hung RJ, Zhang ZF, Rao JY, Pantuck A, Reuter VE, Heber D, Lu QY.","J Urol. 2006 Sep;176(3):1192-7. doi: 10.1016/j.juro.2006.04.030.","Hung RJ","J Urol","2006","2006/08/08","","","10.1016/j.juro.2006.04.030"
"20406841","Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma","Mengual L, Burset M, Ribal MJ, Ars E, Marín-Aguilera M, Fernández M, Ingelmo-Torres M, Villavicencio H, Alcaraz A.","Clin Cancer Res. 2010 May 1;16(9):2624-33. doi: 10.1158/1078-0432.CCR-09-3373. Epub 2010 Apr 20.","Mengual L","Clin Cancer Res","2010","2010/04/22","","","10.1158/1078-0432.CCR-09-3373"
"8975589","[Ethanol sclerotherapy in superficial bladder tumors]","Damyanov C.","Ann Urol (Paris). 1996;30(5):244-6.","Damyanov C","Ann Urol (Paris)","1996","1996/01/01","","",""
"8766083","[Preliminary results of a phase II randomized controlled trial comparing M-VAC and M-CAVI in patients with bladder cancer (T2-4 N0-1 M0)]","Bellmunt Molins J, Ribas A, Albanell J, Lorente Garín JA, de Torres Mateos JA, Morote Robles J, López Palacios MA, Banús Gassol JM, Casado Cobo S, Eres N, Solé Calvo LA.","Arch Esp Urol. 1996 Jun;49(5):465-72.","Bellmunt Molins J","Arch Esp Urol","1996","1996/06/01","","",""
"22643320","Automatic bladder segmentation on CBCT for multiple plan ART of bladder cancer using a patient-specific bladder model","Chai X, van Herk M, Betgen A, Hulshof M, Bel A.","Phys Med Biol. 2012 Jun 21;57(12):3945-62. doi: 10.1088/0031-9155/57/12/3945. Epub 2012 May 30.","Chai X","Phys Med Biol","2012","2012/05/31","","","10.1088/0031-9155/57/12/3945"
"31364495","Elderly patients undergoing cystectomy, comparing preoperative American Society of Anesthesiology and Eastern Cooperative Oncology Group scores and operative approaches","Martin C, West JM, Palermo S, Patel DP, Presson AP, Comploj E, Pycha A, Hancock JB, Dechet CB, Trenti E.","Urologia. 2019 Nov;86(4):183-188. doi: 10.1177/0391560319864846. Epub 2019 Jul 31.","Martin C","Urologia","2019","2019/08/01","","","10.1177/0391560319864846"
"19556153","Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removed","Jeong IG, Park J, Song K, Ro JY, Song C, Hong JH, Ahn H, Kim CS.","Urol Oncol. 2011 Mar-Apr;29(2):199-204. doi: 10.1016/j.urolonc.2009.04.006. Epub 2009 Jun 24.","Jeong IG","Urol Oncol","2011","2009/06/27","","","10.1016/j.urolonc.2009.04.006"
"11374319","Ludwig Rehn (1849-1930)--pioneering findings on the aetiology of bladder tumours","Dietrich H, Dietrich B.","World J Urol. 2001 Apr;19(2):151-3. doi: 10.1007/s003450100211.","Dietrich H","World J Urol","2001","2001/05/26","","","10.1007/s003450100211"
"806144","[Preoperative radiotherapy of bladder cancer]","Ernst H, Stolle E, Weber P, Scheffler A, Riedel B.","Strahlentherapie. 1975 Apr;149(4):341-5.","Ernst H","Strahlentherapie","1975","1975/04/01","","",""
"2767097","Impact of the category of early tumor recurrence on tumor progression in bladder tumors treated by transurethral resection","Lundbeck F, Jacobsen F, Vaeth M.","Eur Urol. 1989;16(4):291-4. doi: 10.1159/000471594.","Lundbeck F","Eur Urol","1989","1989/01/01","","","10.1159/000471594"
"8260189","Skin infiltration within a radiotherapy portal for metastatic bladder cancer--case report and review of the clinical literature","Roos DE, Wigg DR.","Acta Oncol. 1993;32(6):689-91. doi: 10.3109/02841869309092453.","Roos DE","Acta Oncol","1993","1993/01/01","","","10.3109/02841869309092453"
"15266312","Role of urothelial cells in BCG immunotherapy for superficial bladder cancer","Bevers RF, Kurth KH, Schamhart DH.","Br J Cancer. 2004 Aug 16;91(4):607-12. doi: 10.1038/sj.bjc.6602026.","Bevers RF","Br J Cancer","2004","2004/07/22","PMC2364784","","10.1038/sj.bjc.6602026"
"11836594","Prognostic significance of a combination of thymidylate synthase and dihydropyrimidine dehydrogenase activities in grades 1 and 2 superficial bladder cancer","Mizutani Y, Wada H, Yoshida O, Fukushima M, Bonavida B, Kawauchi A, Miki T.","Oncol Rep. 2002 Mar-Apr;9(2):289-92.","Mizutani Y","Oncol Rep","2002","2002/02/12","","",""
"30742945","Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM","Xie R, Chen X, Chen Z, Huang M, Dong W, Gu P, Zhang J, Zhou Q, Dong W, Han J, Wang X, Li H, Huang J, Lin T.","Cancer Lett. 2019 May 1;449:31-44. doi: 10.1016/j.canlet.2019.01.041. Epub 2019 Feb 10.","Xie R","Cancer Lett","2019","2019/02/12","","","10.1016/j.canlet.2019.01.041"
"1924447","Operative factors & tumor membrane antigen changes in escape from immune surveillance of bladder cancer","Oliver RT, Riddle P, Blandy JP.","Prog Clin Biol Res. 1991;370:161-8.","Oliver RT","Prog Clin Biol Res","1991","1991/01/01","","",""
"10723662","[Adenocarcinoma of the ileal segment with transitional cell carcinoma of the bladder following ileocytoplasty: a case report]","Sato M, Fukui S, Fujita I, Kawakita M, Matsuda T, Sakaida N, Okamura M, Yamanaka K, Den S.","Hinyokika Kiyo. 2000 Jan;46(1):33-6.","Sato M","Hinyokika Kiyo","2000","2000/03/21","","",""
"4089551","Flat intra-epithelial carcinoma in situ of the urinary bladder","Jacobsen F, Møller-Nielsen C, Mommsen S.","Scand J Urol Nephrol. 1985;19(4):253-5. doi: 10.3109/00365598509180265.","Jacobsen F","Scand J Urol Nephrol","1985","1985/01/01","","","10.3109/00365598509180265"
"22901221","P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians","Xu T, Xu ZC, Zou Q, Yu B, Huang XE.","Asian Pac J Cancer Prev. 2012;13(5):2349-54. doi: 10.7314/apjcp.2012.13.5.2349.","Xu T","Asian Pac J Cancer Prev","2012","2012/08/21","","","10.7314/apjcp.2012.13.5.2349"
"23565664","Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer","Boman K, Segersten U, Ahlgren G, Eberhard J, Uhlén M, Jirström K, Malmström PU.","BMC Urol. 2013 Apr 8;13:17. doi: 10.1186/1471-2490-13-17.","Boman K","BMC Urol","2013","2013/04/10","PMC3635919","","10.1186/1471-2490-13-17"
"25623694","A cost-effectiveness analysis of management of low-risk non-muscle-invasive bladder cancer using office-based fulguration","Al Hussein Al Awamlh B, Lee R, Chughtai B, Donat SM, Sandhu JS, Herr HW.","Urology. 2015 Feb;85(2):381-6. doi: 10.1016/j.urology.2014.09.041.","Al Hussein Al Awamlh B","Urology","2015","2015/01/28","","","10.1016/j.urology.2014.09.041"
"26748843","Microcytic carcinoma of the urinary bladder: Experience over 22 years","Velilla G, Carrión CJ, Portillo JA, Truán D, Azueta A, Fuentes J, Herrero E, Gala L.","Actas Urol Esp. 2016 Apr;40(3):195-200. doi: 10.1016/j.acuro.2015.11.008. Epub 2015 Dec 31.","Velilla G","Actas Urol Esp","2016","2016/01/11","","","10.1016/j.acuro.2015.11.008"
"30949839","Which treatment is best for patients with AJCC stage IV bladder cancer?","Mao W, Ma B, Huang X, Gu S, Luo M, Fan J, Geng J.","Int Urol Nephrol. 2019 Jul;51(7):1145-1156. doi: 10.1007/s11255-019-02105-5. Epub 2019 Apr 4.","Mao W","Int Urol Nephrol","2019","2019/04/06","","","10.1007/s11255-019-02105-5"
"30103393","Mediterranean Diet and Bladder Cancer Risk in Italy","Bravi F, Spei ME, Polesel J, Di Maso M, Montella M, Ferraroni M, Serraino D, Libra M, Negri E, La Vecchia C, Turati F.","Nutrients. 2018 Aug 10;10(8):1061. doi: 10.3390/nu10081061.","Bravi F","Nutrients","2018","2018/08/15","PMC6115823","","10.3390/nu10081061"
"20156648","Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines","Kodaira K, Kikuchi E, Kosugi M, Horiguchi Y, Matsumoto K, Kanai K, Suzuki E, Miyajima A, Nakagawa K, Tachibana M, Umezawa K, Oya M.","Urology. 2010 Apr;75(4):805-12. doi: 10.1016/j.urology.2009.11.048. Epub 2010 Feb 13.","Kodaira K","Urology","2010","2010/02/17","","","10.1016/j.urology.2009.11.048"
"24815844","Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population","Verim L, Timirci-Kahraman O, Akbulut H, Akbas A, Ozturk T, Turan S, Yaylim I, Ergen A, Ozturk O, Isbir T.","In Vivo. 2014 May-Jun;28(3):397-402.","Verim L","In Vivo","2014","2014/05/13","","",""
"26089655","Bladder cancer in the elderly patient: challenges and solutions","Guancial EA, Roussel B, Bergsma DP, Bylund KC, Sahasrabudhe D, Messing E, Mohile SG, Fung C.","Clin Interv Aging. 2015 Jun 10;10:939-49. doi: 10.2147/CIA.S74322. eCollection 2015.","Guancial EA","Clin Interv Aging","2015","2015/06/20","PMC4467651","","10.2147/CIA.S74322"
"27223070","Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population","Quan L, Chattopadhyay K, Nelson HH, Chan KK, Xiang YB, Zhang W, Wang R, Gao YT, Yuan JM.","Oncotarget. 2016 Jun 28;7(26):40012-40024. doi: 10.18632/oncotarget.9475.","Quan L","Oncotarget","2016","2016/05/26","PMC5129988","","10.18632/oncotarget.9475"
"1107601","Carcinoembryonic antigen and bladder carcinoma","Ionescu G, Romas NA, Ionascu L, Bennett S, Tannenbaum M, Veeneman RJ, Lattimer JK.","J Urol. 1976 Jan;115(1):46-8. doi: 10.1016/s0022-5347(17)59061-8.","Ionescu G","J Urol","1976","1976/01/01","","","10.1016/s0022-5347(17)59061-8"
"26338254","Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer","Brisuda A, Pazourkova E, Soukup V, Horinek A, Hrbáček J, Capoun O, Svobodova I, Pospisilova S, Korabecna M, Mares J, Hanuš T, Babjuk M.","Urol Int. 2016;96(1):25-31. doi: 10.1159/000438828. Epub 2015 Sep 3.","Brisuda A","Urol Int","2016","2015/09/05","","","10.1159/000438828"
"25394776","Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer","Beukers W, Kandimalla R, Masius RG, Vermeij M, Kranse R, van Leenders GJ, Zwarthoff EC.","Mod Pathol. 2015 Apr;28(4):515-22. doi: 10.1038/modpathol.2014.145. Epub 2014 Nov 14.","Beukers W","Mod Pathol","2015","2014/11/15","","","10.1038/modpathol.2014.145"
"25623698","Editorial comment","Koch MO.","Urology. 2015 Feb;85(2):392-3. doi: 10.1016/j.urology.2014.08.061.","Koch MO","Urology","2015","2015/01/28","","","10.1016/j.urology.2014.08.061"
"10559612","Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose","Heicappell R, Müller-Mattheis V, Reinhardt M, Vosberg H, Gerharz CD, Müller-Gärtner H, Ackermann R.","Eur Urol. 1999 Dec;36(6):582-7. doi: 10.1159/000020052.","Heicappell R","Eur Urol","1999","1999/11/24","","","10.1159/000020052"
"16406874","Risk factors for upper tract recurrence in patients undergoing long-term surveillance for stage ta bladder cancer","Canales BK, Anderson JK, Premoli J, Slaton JW.","J Urol. 2006 Jan;175(1):74-7. doi: 10.1016/S0022-5347(05)00071-6.","Canales BK","J Urol","2006","2006/01/13","","","10.1016/S0022-5347(05)00071-6"
"17220334","High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility","Huang M, Dinney CP, Lin X, Lin J, Grossman HB, Wu X.","Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):84-91. doi: 10.1158/1055-9965.EPI-06-0712.","Huang M","Cancer Epidemiol Biomarkers Prev","2007","2007/01/16","","","10.1158/1055-9965.EPI-06-0712"
"18451219","Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer","Kawanishi H, Matsui Y, Ito M, Watanabe J, Takahashi T, Nishizawa K, Nishiyama H, Kamoto T, Mikami Y, Tanaka Y, Jung G, Akiyama H, Nobumasa H, Guilford P, Reeve A, Okuno Y, Tsujimoto G, Nakamura E, Ogawa O.","Clin Cancer Res. 2008 May 1;14(9):2579-87. doi: 10.1158/1078-0432.CCR-07-1922.","Kawanishi H","Clin Cancer Res","2008","2008/05/03","","","10.1158/1078-0432.CCR-07-1922"
"17069962","Prepubic urethrectomy during radical cystoprostatectomy","Joniau S, Shabana W, Verlinde B, Van Poppel H.","Eur Urol. 2007 Apr;51(4):915-21. doi: 10.1016/j.eururo.2006.09.046. Epub 2006 Oct 19.","Joniau S","Eur Urol","2007","2006/10/31","","","10.1016/j.eururo.2006.09.046"
"5803864","Cancer of the bladder presenting as ""cystitis"" or ""prostatism""","Hamilton M.","Med J Aust. 1969 Jul 12;2(2):89-91.","Hamilton M","Med J Aust","1969","1969/07/12","","",""
"28247612","[Research progress on the effect of glucocorticoid receptor signaling pathways in bladder cancer]","Feng S, Chen J, Zheng Y.","Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016 May 25;45(6):655-660.","Feng S","Zhejiang Da Xue Xue Bao Yi Xue Ban","2016","2017/03/02","","",""
"1875490","Bacillus Calmette-Guerin and interleukin-2 for treatment of superficial bladder cancer","Cockett AT, Davis RS, Cos LR, Wheeless LL Jr.","J Urol. 1991 Sep;146(3):766-9; discussion 769-70. doi: 10.1016/s0022-5347(17)37916-8.","Cockett AT","J Urol","1991","1991/09/11","","","10.1016/s0022-5347(17)37916-8"
"26142924","Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer","Mariappan P, Rai B, El-Mokadem I, Anderson CH, Lee H, Stewart S, Donat R.","Urology. 2015 Aug;86(2):327-31. doi: 10.1016/j.urology.2015.04.015. Epub 2015 Jul 2.","Mariappan P","Urology","2015","2015/07/06","","","10.1016/j.urology.2015.04.015"
"18096307","Photodynamic diagnosis in urology: state-of-the-art","Jocham D, Stepp H, Waidelich R.","Eur Urol. 2008 Jun;53(6):1138-48. doi: 10.1016/j.eururo.2007.11.048. Epub 2007 Dec 10.","Jocham D","Eur Urol","2008","2007/12/22","","","10.1016/j.eururo.2007.11.048"
"30707342","Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy","Dotson A, May A, Davaro F, Raza SJ, Siddiqui S, Hamilton Z.","Int J Clin Oncol. 2019 Jun;24(6):706-711. doi: 10.1007/s10147-019-01409-x. Epub 2019 Feb 1.","Dotson A","Int J Clin Oncol","2019","2019/02/02","","","10.1007/s10147-019-01409-x"
"27380916","The current status of checkpoint inhibitors in metastatic bladder cancer","Fahmy O, Khairul-Asri MG, Stenzl A, Gakis G.","Clin Exp Metastasis. 2016 Oct;33(7):629-35. doi: 10.1007/s10585-016-9807-9. Epub 2016 Jul 5.","Fahmy O","Clin Exp Metastasis","2016","2016/07/07","","","10.1007/s10585-016-9807-9"
"12237997","[Enlarged pelvic lymph nodes after immunotherapy in a patient with bladder cancer]","Rissanen AM, Pekonen M, Terho R, Krees R, Katila ML.","Duodecim. 2002;118(10):1029-32.","Rissanen AM","Duodecim","2002","2002/09/20","","",""
"16880786","Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy","Sakano S, Wada T, Matsumoto H, Sugiyama S, Inoue R, Eguchi S, Ito H, Ohmi C, Matsuyama H, Naito K.","Br J Cancer. 2006 Sep 4;95(5):561-70. doi: 10.1038/sj.bjc.6603290. Epub 2006 Aug 1.","Sakano S","Br J Cancer","2006","2006/08/02","PMC2360681","","10.1038/sj.bjc.6603290"
"10327683","[Bladder tumor in pregnancy]","Fernández Borrell A, Peinado Ibarra F, Gómez-Sancha F, Teba del Pino F, Arellano Gañán R, Pereira Sanz I.","Actas Urol Esp. 1999 Feb;23(2):164-6.","Fernández Borrell A","Actas Urol Esp","1999","1999/05/18","","",""
"22653723","Long-term survival and onset of granulomatous pneumonia after lung metastasectomy in a patient with non-muscle-invasive bladder cancer","Arai S, Hasumi M, Shimizu N.","Int Urol Nephrol. 2012 Oct;44(5):1383-7. doi: 10.1007/s11255-012-0203-3. Epub 2012 Jun 1.","Arai S","Int Urol Nephrol","2012","2012/06/02","","","10.1007/s11255-012-0203-3"
"28403596","Blue light cystoscopy with hexylaminolevulinate: Our 7 years experience","Lacetera V, Cantoro U, Montesi L, Cantoro D, Cervelli B, Cicetti A, Gabrielloni G, Milella D, Montesi M, Morcellini R, Parri G, Recanatini E, Beatrici V.","Arch Ital Urol Androl. 2017 Mar 31;89(1):39-41. doi: 10.4081/aiua.2017.1.39.","Lacetera V","Arch Ital Urol Androl","2017","2017/04/14","","","10.4081/aiua.2017.1.39"
"11943336","Organophosphate-based pesticides and genetic damage implicated in bladder cancer","Webster LR, McKenzie GH, Moriarty HT.","Cancer Genet Cytogenet. 2002 Mar;133(2):112-7. doi: 10.1016/s0165-4608(01)00576-3.","Webster LR","Cancer Genet Cytogenet","2002","2002/04/12","","","10.1016/s0165-4608(01)00576-3"
"23517015","Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy","Krane LS, Richards KA, Kader AK, Davis R, Balaji KC, Hemal AK.","J Endourol. 2013 Aug;27(8):1046-50. doi: 10.1089/end.2012.0606.","Krane LS","J Endourol","2013","2013/03/23","","","10.1089/end.2012.0606"
"31543285","Global Versus Indian Perspective of Pioglitazone-induced Adverse Drug Reactions Including Bladder Cancer: A Comparative Retrospective Pharmacovigilance Analysis","Bhushan S, Ray RS, Prakash J, Singh GN.","Clin Ther. 2019 Nov;41(11):2252-2262. doi: 10.1016/j.clinthera.2019.08.018. Epub 2019 Sep 20.","Bhushan S","Clin Ther","2019","2019/09/24","","","10.1016/j.clinthera.2019.08.018"
"27059751","Rapid assessment of drug resistance of cancer cells to gefitinib and carboplatin using optical imaging","Luo Z, Samadzadeh KM, Nitin N.","Anal Biochem. 2016 Jul 1;504:50-8. doi: 10.1016/j.ab.2016.03.021. Epub 2016 Apr 5.","Luo Z","Anal Biochem","2016","2016/04/10","","","10.1016/j.ab.2016.03.021"
"16475713","Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma","Panani AD, Roussos C.","Anticancer Res. 2006 Jan-Feb;26(1A):319-23.","Panani AD","Anticancer Res","2006","2006/02/16","","",""
"7191578","[Saccharin and bladder cancer]","","S Afr Med J. 1980 Oct 4;58(14):545.","","S Afr Med J","1980","1980/10/04","","",""
"24304020","Clinical innovations in urologic oncology","Williams RD.","Int J Urol. 1996 Jan;3(1 Suppl):S40. doi: 10.1111/j.1442-2042.1996.tb00082.x.","Williams RD","Int J Urol","1996","2013/12/06","","","10.1111/j.1442-2042.1996.tb00082.x"
"28445936","Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer","Lin J, Zhan Y, Liu Y, Chen Z, Liang J, Li W, He A, Zhou L, Mei H, Wang F, Huang W.","Oncotarget. 2017 Apr 11;8(15):24202-24212. doi: 10.18632/oncotarget.15527.","Lin J","Oncotarget","2017","2017/04/28","PMC5421840","","10.18632/oncotarget.15527"
"10765080","Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer","Bono AV, Lovisolo JA, Saredi G.","Eur Urol. 2000 Apr;37(4):478-83. doi: 10.1159/000020171.","Bono AV","Eur Urol","2000","2000/04/15","","","10.1159/000020171"
"10500962","[The progress in diagnostic imaging for staging of bladder and prostate cancer: endorectal magnetic resonance imaging and magnetization transfer contrast]","Arima K, Hayashi N, Yanagawa M, Kawamura J, Kobayashi S, Takeda K, Sugimura Y.","Hinyokika Kiyo. 1999 Aug;45(8):553-7.","Arima K","Hinyokika Kiyo","1999","1999/09/29","","",""
"11340575","NK cells are essential for effective BCG immunotherapy","Brandau S, Riemensberger J, Jacobsen M, Kemp D, Zhao W, Zhao X, Jocham D, Ratliff TL, Böhle A.","Int J Cancer. 2001 Jun 1;92(5):697-702. doi: 10.1002/1097-0215(20010601)92:5<697::aid-ijc1245>3.0.co;2-z.","Brandau S","Int J Cancer","2001","2001/05/08","","","10.1002/1097-0215(20010601)92:5<697::aid-ijc1245>3.0.co;2-z"
"19553824","Genome-wide association studies in bladder cancer: first results and potential relevance","Kiemeney LA, Grotenhuis AJ, Vermeulen SH, Wu X.","Curr Opin Urol. 2009 Sep;19(5):540-6. doi: 10.1097/MOU.0b013e32832eb336.","Kiemeney LA","Curr Opin Urol","2009","2009/06/26","","","10.1097/MOU.0b013e32832eb336"
"19748172","In search of the perfect crystal ball for Ta urothelial cancer","Chin JL.","Eur Urol. 2010 Jan;57(1):21-2; discussion 23-4. doi: 10.1016/j.eururo.2009.09.014. Epub 2009 Sep 8.","Chin JL","Eur Urol","2010","2009/09/15","","","10.1016/j.eururo.2009.09.014"
"28259945","Rb deficiency accelerates progression of carcinoma of the urinary bladder in vivo and in vitro through inhibiting autophagy and apoptosis","Wang CY, Xu ZB, Wang JP, Jiao Y, Zhang B.","Int J Oncol. 2017 Apr;50(4):1221-1232. doi: 10.3892/ijo.2017.3889. Epub 2017 Feb 22.","Wang CY","Int J Oncol","2017","2017/03/06","","","10.3892/ijo.2017.3889"
"19394804","Improving radiotherapy for bladder cancer: an opportunity to integrate new technologies","Lalondrelle S, Huddart R.","Clin Oncol (R Coll Radiol). 2009 Jun;21(5):380-4. doi: 10.1016/j.clon.2009.03.005. Epub 2009 Apr 25.","Lalondrelle S","Clin Oncol (R Coll Radiol)","2009","2009/04/28","","","10.1016/j.clon.2009.03.005"
"6864916","Invasive bladder cancer: support for screening","Hopkins SC, Ford KS, Soloway MS.","J Urol. 1983 Jul;130(1):61-4. doi: 10.1016/s0022-5347(17)50953-2.","Hopkins SC","J Urol","1983","1983/07/01","","","10.1016/s0022-5347(17)50953-2"
"3134290","Microbial amino acid metabolites and bladder cancer: no evidence of promoting activity in man","Renwick AG, Thakrar A, Lawrie CA, George CF.","Hum Toxicol. 1988 May;7(3):267-72. doi: 10.1177/096032718800700307.","Renwick AG","Hum Toxicol","1988","1988/05/01","","","10.1177/096032718800700307"
"3161241","[Invasiveness and metastases of bladder cancer]","Samsonov VA.","Vopr Onkol. 1985;31(6):64-8.","Samsonov VA","Vopr Onkol","1985","1985/01/01","","",""
"24886404","Thrombomodulin expression regulates tumorigenesis in bladder cancer","Wu CT, Chang YH, Lin P, Chen WC, Chen MF.","BMC Cancer. 2014 May 28;14:375. doi: 10.1186/1471-2407-14-375.","Wu CT","BMC Cancer","2014","2014/06/03","PMC4051376","","10.1186/1471-2407-14-375"
"21482678","CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization","Overdevest JB, Thomas S, Kristiansen G, Hansel DE, Smith SC, Theodorescu D.","Cancer Res. 2011 Jun 1;71(11):3802-11. doi: 10.1158/0008-5472.CAN-11-0519. Epub 2011 Apr 11.","Overdevest JB","Cancer Res","2011","2011/04/13","PMC4283788","NIHMS647176","10.1158/0008-5472.CAN-11-0519"
"81814","Establishment and characterization of a new human urinary bladder carcinoma cell line (PS-1)","Sanford EJ, Geder L, Dagen JE, Laychock AM, Ladda R, Rohner TJ Jr.","Invest Urol. 1978 Nov;16(3):246-52.","Sanford EJ","Invest Urol","1978","1978/11/01","","",""
"30937606","Urothelial carcinoma of the upper urinary tract: preoperative pyuria is not correlated with bladder cancer recurrence and survival","Milojevic B, Dzamic Z, Bojanic N, Durutovic O, Janicic A, Kajmakovic B, Milojevic IG, Bumbasirevic U, Grubor N, Grujicic SS.","Int Urol Nephrol. 2019 May;51(5):831-838. doi: 10.1007/s11255-019-02133-1. Epub 2019 Apr 1.","Milojevic B","Int Urol Nephrol","2019","2019/04/03","","","10.1007/s11255-019-02133-1"
"30929845","High-precision Bladder Cancer Irradiation in the Elderly: Clinical Results for a Plan-of-the-day Integrated Boost Technique with Image Guidance Using Lipiodol Markers","Beulens AJW, van der Toorn PP, de Wildt MJ, Scheepens WA.","Eur Urol Oncol. 2019 Feb;2(1):39-46. doi: 10.1016/j.euo.2018.08.012. Epub 2018 Sep 7.","Beulens AJW","Eur Urol Oncol","2019","2019/04/02","","","10.1016/j.euo.2018.08.012"
"30903422","Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer","Guo X, Liu M, Hou H, Liu S, Zhang X, Zhang Y, Wu P, Pang C, Wang J.","Int J Clin Oncol. 2019 Aug;24(8):957-965. doi: 10.1007/s10147-019-01427-9. Epub 2019 Mar 22.","Guo X","Int J Clin Oncol","2019","2019/03/24","","","10.1007/s10147-019-01427-9"
"24274722","Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity","Johnson DC, Nielsen ME, Matthews J, Woods ME, Wallen EM, Pruthi RS, Milowsky MI, Smith AB.","BJU Int. 2014 Aug;114(2):221-8. doi: 10.1111/bju.12585. Epub 2014 Mar 14.","Johnson DC","BJU Int","2014","2013/11/27","PMC4033705","NIHMS545842","10.1111/bju.12585"
"26235376","Preoperative Patient Reported Mental Health is Associated with High Grade Complications after Radical Cystectomy","Sharma P, Henriksen CH, Zargar-Shoshtari K, Xin R, Poch MA, Pow-Sang JM, Sexton WJ, Spiess PE, Gilbert SM.","J Urol. 2016 Jan;195(1):47-52. doi: 10.1016/j.juro.2015.07.095. Epub 2015 Jul 31.","Sharma P","J Urol","2016","2015/08/04","PMC4924593","NIHMS781533","10.1016/j.juro.2015.07.095"
"22819422","The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature","Swietek N, Waldert M, Rom M, Schatzl G, Wiener HG, Susani M, Klatte T.","J Urol. 2012 Sep;188(3):748-53. doi: 10.1016/j.juro.2012.05.015. Epub 2012 Jul 20.","Swietek N","J Urol","2012","2012/07/24","","","10.1016/j.juro.2012.05.015"
"28578321","BCMab1-Ra, a novel immunotoxin that BCMab1 antibody coupled to Ricin A chain, can eliminate bladder tumor","Li C, Yan R, Yang Z, Wang H, Zhang R, Chen H, Wang J.","Oncotarget. 2017 Jul 11;8(28):46704-46705. doi: 10.18632/oncotarget.13504.","Li C","Oncotarget","2017","2017/06/05","PMC5542304","","10.18632/oncotarget.13504"
"26208817","Comparing RECIST with EORTC criteria in metastatic bladder cancer","Öztürk H.","J Cancer Res Clin Oncol. 2016 Jan;142(1):187-94. doi: 10.1007/s00432-015-2022-2. Epub 2015 Jul 25.","Öztürk H","J Cancer Res Clin Oncol","2016","2015/07/26","","","10.1007/s00432-015-2022-2"
"18765110","The invasive T1 bladder tumor: contemporary issues and rationale for radical cystectomy","Stein JP, Penson DF.","Curr Urol Rep. 2008 May;9(3):179-81. doi: 10.1007/s11934-008-0031-2.","Stein JP","Curr Urol Rep","2008","2008/09/04","","","10.1007/s11934-008-0031-2"
"24220339","MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos","Li S, Xu X, Xu X, Hu Z, Wu J, Zhu Y, Chen H, Mao Y, Lin Y, Luo J, Zheng X, Xie L.","Biochem Biophys Res Commun. 2013 Nov 29;441(4):976-81. doi: 10.1016/j.bbrc.2013.11.006. Epub 2013 Nov 9.","Li S","Biochem Biophys Res Commun","2013","2013/11/14","","","10.1016/j.bbrc.2013.11.006"
"4016726","The non-lethal effects of ionizing radiation and hyperthermia on colony growth in a human bladder cancer cell line","Mackillop WJ.","Cancer Lett. 1985 Jul;27(3):315-22. doi: 10.1016/0304-3835(85)90190-9.","Mackillop WJ","Cancer Lett","1985","1985/07/01","","","10.1016/0304-3835(85)90190-9"
"6421479","Delay of bladder cancer induction in rats treated with N-nitroso-N-butyl-N-(4-hydroxybutyl)amine by administration of sodium-2-mercaptoethanesulfonate (Mesna)","Tacchi AM, Schmähl D, Habs M.","Cancer Lett. 1984 Feb;22(1):89-94. doi: 10.1016/0304-3835(84)90048-x.","Tacchi AM","Cancer Lett","1984","1984/02/01","","","10.1016/0304-3835(84)90048-x"
"18588456","Bladder tumor markers: from hematuria to molecular diagnostics--where do we stand?","Shirodkar SP, Lokeshwar VB.","Expert Rev Anticancer Ther. 2008 Jul;8(7):1111-23. doi: 10.1586/14737140.8.7.1111.","Shirodkar SP","Expert Rev Anticancer Ther","2008","2008/07/01","PMC5515477","NIHMS823948","10.1586/14737140.8.7.1111"
"22377450","Reactive arthritis after the intravesical instillation of BCG","Macía Villa C, Sifuentes Giraldo W, Boteanu A, González Lanza M, Bachiller Corral J.","Reumatol Clin. 2012 Sep-Oct;8(5):284-6. doi: 10.1016/j.reuma.2011.11.009. Epub 2012 Feb 28.","Macía Villa C","Reumatol Clin","2012","2012/03/02","","","10.1016/j.reuma.2011.11.009"
"3014256","[Does diabetes affect the probability of cure and prolongation of life of oncological patients?]","Vodvarzhka P, Villaskhek I, Gold O, Kozubek S.","Med Radiol (Mosk). 1986 Jun;31(6):25-8.","Vodvarzhka P","Med Radiol (Mosk)","1986","1986/06/01","","",""
"29287969","Association Between Symptomatic Versus Asymptomatic Recurrence and Survival in Bladder Cancer","Osterman CK, Alanzi J, Lewis JD, Kaufman EL, Narayan V, Boursi B, Vajravelu RK, Scott FI, Malkowicz SB, Mamtani R.","Clin Genitourin Cancer. 2018 Jun;16(3):235-239. doi: 10.1016/j.clgc.2017.11.001. Epub 2017 Dec 6.","Osterman CK","Clin Genitourin Cancer","2018","2017/12/31","PMC5970004","NIHMS925900","10.1016/j.clgc.2017.11.001"
"30711312","Life quality evaluation in patients with bladder cancer: A systematic review","Mina S, Pardo Munevar CA, Osorio D, García-Perdomo HA.","Actas Urol Esp. 2019 May;43(4):198-204. doi: 10.1016/j.acuro.2018.07.006. Epub 2019 Jan 30.","Mina S","Actas Urol Esp","2019","2019/02/04","","","10.1016/j.acuro.2018.07.006"
"25845961","Words of wisdom. Re: MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer","Buchwald ZS, Efstathiou JA.","Eur Urol. 2015 May;67(5):975. doi: 10.1016/j.eururo.2014.12.065.","Buchwald ZS","Eur Urol","2015","2015/04/08","","","10.1016/j.eururo.2014.12.065"
"16854518","Re: Emilio Bria, Enzo Maria Ruggeri, Edmondo Terzoli, Francesco Cognetti, Camillo Francesco Pollera and Diana Giannarelli. Adjuvant chemotherapy for bladder cancer: the chance for meta-analyses comparison. Eur Urol 2007;51:576-7","Vale C, Stewart L, Tierney J.","Eur Urol. 2007 Feb;51(2):577-8. doi: 10.1016/j.eururo.2006.06.029. Epub 2006 Jul 7.","Vale C","Eur Urol","2007","2006/07/21","","","10.1016/j.eururo.2006.06.029"
"20850152","Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer","Stenzl A, Burger M, Fradet Y, Mynderse LA, Soloway MS, Witjes JA, Kriegmair M, Karl A, Shen Y, Grossman HB.","J Urol. 2010 Nov;184(5):1907-13. doi: 10.1016/j.juro.2010.06.148. Epub 2010 Sep 17.","Stenzl A","J Urol","2010","2010/09/21","PMC4327891","NIHMS661771","10.1016/j.juro.2010.06.148"
"31495492","ISYNA1 is overexpressed in bladder carcinoma and regulates cell proliferation and apoptosis","Guo X, Li HH, Hu J, Duan YX, Ren WG, Guo Q, Liu PH, Cui Y, Liu LF, Chen MF, Chen JB, Zu XB.","Biochem Biophys Res Commun. 2019 Nov 5;519(2):246-252. doi: 10.1016/j.bbrc.2019.08.129. Epub 2019 Sep 5.","Guo X","Biochem Biophys Res Commun","2019","2019/09/10","","","10.1016/j.bbrc.2019.08.129"
"17936837","Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer","Margel D, Tal R, Baniel J.","J Urol. 2007 Dec;178(6):2297-300; discussion 2300-1. doi: 10.1016/j.juro.2007.08.017. Epub 2007 Oct 22.","Margel D","J Urol","2007","2007/10/16","","","10.1016/j.juro.2007.08.017"
"28552713","Mass spectrometric detection combined with bioinformatic analysis identified possible protein markers and key pathways associated with bladder cancer","Wu Z, Wang S, Jiang F, Li Q, Wang C, Wang H, Zhang W, Xue P, Wang SL.","Gene. 2017 Aug 30;626:407-413. doi: 10.1016/j.gene.2017.05.054. Epub 2017 May 25.","Wu Z","Gene","2017","2017/05/30","","","10.1016/j.gene.2017.05.054"
"31500577","Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification","Yuk HD, Jeong CW, Kwak C, Kim HH, Moon KC, Ku JH.","BMC Cancer. 2019 Sep 9;19(1):897. doi: 10.1186/s12885-019-6042-1.","Yuk HD","BMC Cancer","2019","2019/09/11","PMC6734465","","10.1186/s12885-019-6042-1"
"22464897","The importance of transurethral resection in managing patients with urothelial cancer in the bladder: proposal for a transurethral resection of bladder tumor checklist","Pan D, Soloway MS.","Eur Urol. 2012 Jun;61(6):1199-203. doi: 10.1016/j.eururo.2012.03.018. Epub 2012 Mar 22.","Pan D","Eur Urol","2012","2012/04/03","","","10.1016/j.eururo.2012.03.018"
"26636903","Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness","Afonso J, Santos LL, Morais A, Amaro T, Longatto-Filho A, Baltazar F.","Cell Cycle. 2016;15(3):368-80. doi: 10.1080/15384101.2015.1121329. Epub 2015 Dec 4.","Afonso J","Cell Cycle","2016","2015/12/05","PMC4943695","","10.1080/15384101.2015.1121329"
"21239010","Urinary pH is highly associated with tumor recurrence during intravesical mitomycin C therapy for nonmuscle invasive bladder tumor","Maeda T, Kikuchi E, Matsumoto K, Miyajima A, Oya M.","J Urol. 2011 Mar;185(3):802-6. doi: 10.1016/j.juro.2010.10.081. Epub 2011 Jan 15.","Maeda T","J Urol","2011","2011/01/18","","","10.1016/j.juro.2010.10.081"
"17383082","Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer","Evans CP.","Eur Urol. 2007 Oct;52(4):1129-30. doi: 10.1016/j.eururo.2007.02.064.","Evans CP","Eur Urol","2007","2007/03/27","","","10.1016/j.eururo.2007.02.064"
"11341116","[Clinical prognostic factors in superficial cancer of the urinary bladder]","Busto Catañón L, Sánchez Merino JM, Picallo Sánchez JA, Gelabert Mas A.","Arch Esp Urol. 2001 Mar;54(2):131-8.","Busto Catañón L","Arch Esp Urol","2001","2001/05/09","","",""
"25001935","[Vimentin gene transfection promotes the invasion of bladder cancer SW780 cells]","Lu G, Ding J, Wang Z.","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Jul;30(7):713-6.","Lu G","Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi","2014","2014/07/09","","",""
"9126099","Preliminary ligation of vascular pedicles in male radical cystectomy","Fukui I, Izutani T, Yonese J, Oyama H, Kawai T.","Br J Urol. 1997 Apr;79(4):641-2. doi: 10.1046/j.1464-410x.1997.00158.x.","Fukui I","Br J Urol","1997","1997/04/01","","","10.1046/j.1464-410x.1997.00158.x"
"21607828","Lymph node metastasis mapping in extended lymphadenectomy to the level of the inferior mesenteric artery for bladder cancer","Kitamura H, Takei F, Nishida S, Muranaka T, Masumori N, Tsukamoto T.","Int J Clin Oncol. 2012 Feb;17(1):63-8. doi: 10.1007/s10147-011-0257-8. Epub 2011 May 25.","Kitamura H","Int J Clin Oncol","2012","2011/05/25","","","10.1007/s10147-011-0257-8"
"22749690","RETRACTED: Modified U-shaped ileal neobladder after radical cystectomy: assessment of functional outcomes and complications in Chinese patients","Zhong S, Zhu Z, Wang X, Pan C, Chen S, Shen Z.","Urol Oncol. 2013 Nov;31(8):1683-8. doi: 10.1016/j.urolonc.2012.05.009. Epub 2012 Jun 30.","Zhong S","Urol Oncol","2013","2012/07/04","","","10.1016/j.urolonc.2012.05.009"
"30455080","MicroRNA-93 promotes bladder cancer proliferation and invasion by targeting PEDF","Jiang H, Bu Q, Zeng M, Xia D, Wu A.","Urol Oncol. 2019 Feb;37(2):150-157. doi: 10.1016/j.urolonc.2018.08.001. Epub 2018 Nov 17.","Jiang H","Urol Oncol","2019","2018/11/21","","","10.1016/j.urolonc.2018.08.001"
"31038865","lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion","Zhang C, Wang W, Lin J, Xiao J, Tian Y.","Int Braz J Urol. 2019 May-Jun;45(3):549-559. doi: 10.1590/S1677-5538.IBJU.2018.0450.","Zhang C","Int Braz J Urol","2019","2019/05/01","PMC6786104","","10.1590/S1677-5538.IBJU.2018.0450"
"25964836","Does skip metastasis or other lymph node parameters have additional effects on survival of patients undergoing radical cystectomy for bladder cancer?","Ugurlu O, Baltaci S, Aslan G, Can C, Cal C, Elhan A, Turkeri L, Mungan A.","Korean J Urol. 2015 May;56(5):357-64. doi: 10.4111/kju.2015.56.5.357. Epub 2015 Apr 28.","Ugurlu O","Korean J Urol","2015","2015/05/13","PMC4426507","","10.4111/kju.2015.56.5.357"
"8449603","Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression","Xu HJ, Cairns P, Hu SX, Knowles MA, Benedict WF.","Int J Cancer. 1993 Mar 12;53(5):781-4. doi: 10.1002/ijc.2910530513.","Xu HJ","Int J Cancer","1993","1993/03/12","","","10.1002/ijc.2910530513"
"6438859","[Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences]","Schmähl D, Habs M, Tacchi AM.","Urologe A. 1984 Sep;23(5):291-6.","Schmähl D","Urologe A","1984","1984/09/01","","",""
"14755395","Adaptation to life after surgical removal of the bladder-an application of graphical Markov models for analysing longitudinal data","Hardt J, Petrak F, Filipas D, Egle UT.","Stat Med. 2004 Feb 28;23(4):649-66. doi: 10.1002/sim.1596.","Hardt J","Stat Med","2004","2004/02/03","","","10.1002/sim.1596"
"27427223","Effect of tumor location on survival in urinary bladder adenocarcinoma: A population-based analysis","Dutta R, Abdelhalim A, Martin JW, Vernez SL, Faltas B, Lotan Y, Youssef RF.","Urol Oncol. 2016 Dec;34(12):531.e1-531.e6. doi: 10.1016/j.urolonc.2016.06.009. Epub 2016 Jul 15.","Dutta R","Urol Oncol","2016","2016/07/19","","","10.1016/j.urolonc.2016.06.009"
"23098433","Primary small cell carcinoma of the urinary bladder--mini-review of the literature","Chhabra S, Hegde P, Singhal P.","Asian Pac J Cancer Prev. 2012;13(8):3549-53. doi: 10.7314/apjcp.2012.13.8.3549.","Chhabra S","Asian Pac J Cancer Prev","2012","2012/10/27","","","10.7314/apjcp.2012.13.8.3549"
"26270481","Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy","Pan CX, Zhang H, Tepper CG, Lin TY, Davis RR, Keck J, Ghosh PM, Gill P, Airhart S, Bult C, Gandara DR, Liu E, de Vere White RW.","PLoS One. 2015 Aug 13;10(8):e0134346. doi: 10.1371/journal.pone.0134346. eCollection 2015.","Pan CX","PLoS One","2015","2015/08/14","PMC4535951","","10.1371/journal.pone.0134346"
"8149184","Hyperthermic intravesical peplomycin perfusion treatment for bladder cancer","Uchibayashi T, Nakajima K, Hisazumi H, Nishino A, Miyoshi N.","Br J Urol. 1993 Jul;72(1):65-7. doi: 10.1111/j.1464-410x.1993.tb06460.x.","Uchibayashi T","Br J Urol","1993","1993/07/01","","","10.1111/j.1464-410x.1993.tb06460.x"
"28391606","BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned","Hayne D, Stockler M, McCombie SP, Lawrence N, Martin A, Sengupta S, Davis ID.","BJU Int. 2017 May;119 Suppl 5:55-57. doi: 10.1111/bju.13873.","Hayne D","BJU Int","2017","2017/04/10","","","10.1111/bju.13873"
"1556044","Epidemiology of bladder cancer","Silverman DT, Hartge P, Morrison AS, Devesa SS.","Hematol Oncol Clin North Am. 1992 Feb;6(1):1-30.","Silverman DT","Hematol Oncol Clin North Am","1992","1992/02/01","","",""
"17591743","Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer","Liakou CI, Narayanan S, Ng Tang D, Logothetis CJ, Sharma P.","Cancer Immun. 2007 Jun 26;7:10.","Liakou CI","Cancer Immun","2007","2007/06/27","PMC2935746","",""
"28087474","FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression","Lloreta J, Font-Tello A, Juanpere N, Frances A, Lorenzo M, Nonell L, de Muga S, Vázquez I, Cecchini L, Hernández-Llodrà S.","Hum Pathol. 2017 Apr;62:222-231. doi: 10.1016/j.humpath.2016.12.022. Epub 2017 Jan 11.","Lloreta J","Hum Pathol","2017","2017/01/15","","","10.1016/j.humpath.2016.12.022"
"7388764","Urinary bladder metastases from breast carcinoma","Haid M, Ignatoff J, Khandekar JD, Graham J, Holland J.","Cancer. 1980 Jul 1;46(1):229-32. doi: 10.1002/1097-0142(19800701)46:1<229::aid-cncr2820460138>3.0.co;2-o.","Haid M","Cancer","1980","1980/07/01","","","10.1002/1097-0142(19800701)46:1<229::aid-cncr2820460138>3.0.co;2-o"
"16217282","Treatment delay and prognosis in invasive bladder cancer","Liedberg F, Anderson H, Månsson W.","J Urol. 2005 Nov;174(5):1777-81; discussion 1781. doi: 10.1097/01.ju.0000177521.72678.61.","Liedberg F","J Urol","2005","2005/10/12","","","10.1097/01.ju.0000177521.72678.61"
"5677316","Rates, interview, and pathology study of cancer of the urinary bladder in New Orleans, Louisiana","Dunham LJ, Rabson AS, Stewart HL, Frank AS, Young JL.","J Natl Cancer Inst. 1968 Sep;41(3):683-709.","Dunham LJ","J Natl Cancer Inst","1968","1968/09/01","","",""
"9734137","[New chemotherapy regimens for advanced bladder cancer]","Fagbemi SO, Stadler WM.","Actas Urol Esp. 1998 Jun;22(6):548-9.","Fagbemi SO","Actas Urol Esp","1998","1998/09/12","","",""
"3185200","[Priority therapeutic methods in hepatology, gastroenterology and urologic oncology]","Granov AM.","Med Radiol (Mosk). 1988 Nov;33(11):26-30.","Granov AM","Med Radiol (Mosk)","1988","1988/11/01","","",""
"18336612","Early results of bladder-cancer screening in a high-risk population of heavy smokers","Steiner H, Bergmeister M, Verdorfer I, Granig T, Mikuz G, Bartsch G, Stoehr B, Brunner A.","BJU Int. 2008 Aug;102(3):291-6. doi: 10.1111/j.1464-410X.2008.07596.x. Epub 2008 Mar 11.","Steiner H","BJU Int","2008","2008/03/14","","","10.1111/j.1464-410X.2008.07596.x"
"31927310","TP63 isoform expression is linked with distinct clinical outcomes in cancer","Bankhead A 3rd, McMaster T, Wang Y, Boonstra PS, Palmbos PL.","EBioMedicine. 2020 Jan;51:102561. doi: 10.1016/j.ebiom.2019.11.022. Epub 2020 Jan 9.","Bankhead A 3rd","EBioMedicine","2020","2020/01/14","PMC6953644","","10.1016/j.ebiom.2019.11.022"
"22289431","Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches","Koga F, Fujii Y, Masuda H, Numao N, Yokoyama M, Ishioka J, Saito K, Kawakami S, Kihara K.","BJU Int. 2012 Sep;110(6 Pt B):E203-8. doi: 10.1111/j.1464-410X.2011.10874.x. Epub 2012 Jan 30.","Koga F","BJU Int","2012","2012/02/01","","","10.1111/j.1464-410X.2011.10874.x"
"18190823","Gene polymorphisms in bladder cancer","Franekova M, Halasova E, Bukovska E, Luptak J, Dobrota D.","Urol Oncol. 2008 Jan-Feb;26(1):1-8. doi: 10.1016/j.urolonc.2006.10.011. Epub 2007 Oct 29.","Franekova M","Urol Oncol","2008","2008/01/15","","","10.1016/j.urolonc.2006.10.011"
"7614398","Intravesical antitumor therapy immediately after transurethral resection of bladder cancer","Fujita K.","Int J Urol. 1994 Dec;1(4):341-4. doi: 10.1111/j.1442-2042.1994.tb00061.x.","Fujita K","Int J Urol","1994","1994/12/01","","","10.1111/j.1442-2042.1994.tb00061.x"
"25208816","Sarcopenia is more than simply documenting low skeletal muscle mass","Cintosun U, Tasci I, Binay Safer V, Safer U.","Cancer. 2015 Jan 1;121(1):159. doi: 10.1002/cncr.29016. Epub 2014 Sep 10.","Cintosun U","Cancer","2015","2014/09/12","","","10.1002/cncr.29016"
"9184445","[Long-term results of short-course preoperative radiotherapy and radical cystectomy for bladder cancer]","Hirabayashi N.","Nihon Hinyokika Gakkai Zasshi. 1997 May;88(5):528-34. doi: 10.5980/jpnjurol1989.88.528.","Hirabayashi N","Nihon Hinyokika Gakkai Zasshi","1997","1997/05/01","","","10.5980/jpnjurol1989.88.528"
"9240641","A feasibility study of high dose rate brachytherapy in solitary urinary bladder cancer","Soete G, Coen V, Verellen D, Keuppens F, De Boe V, Storme G.","Int J Radiat Oncol Biol Phys. 1997 Jul 1;38(4):743-7. doi: 10.1016/s0360-3016(97)00063-1.","Soete G","Int J Radiat Oncol Biol Phys","1997","1997/07/01","","","10.1016/s0360-3016(97)00063-1"
"25055270","Bladder malignancies on CT: the underrated role of CT in diagnosis","Raman SP, Fishman EK.","AJR Am J Roentgenol. 2014 Aug;203(2):347-54. doi: 10.2214/AJR.13.12021.","Raman SP","AJR Am J Roentgenol","2014","2014/07/24","","","10.2214/AJR.13.12021"
"2204733","Ureteral stump transitional cell carcinoma in a patient with recurrent superficial bladder cancer: an argument for complete nephroureterectomy in selected patients","Klee LW, Adams MC, Foster RS.","J Urol. 1990 Oct;144(4):972-3. doi: 10.1016/s0022-5347(17)39636-2.","Klee LW","J Urol","1990","1990/10/01","","","10.1016/s0022-5347(17)39636-2"
"21788729","Targeting molecular signaling pathways of Schistosoma haemotobium infection in bladder cancer","Botelho MC, Machado JC, Brindley PJ, Correia da Costa JM.","Virulence. 2011 Jul-Aug;2(4):267-79. doi: 10.4161/viru.2.4.16734. Epub 2011 Jul 1.","Botelho MC","Virulence","2011","2011/07/27","","","10.4161/viru.2.4.16734"
"19219610","The present and future burden of urinary bladder cancer in the world","Ploeg M, Aben KK, Kiemeney LA.","World J Urol. 2009 Jun;27(3):289-93. doi: 10.1007/s00345-009-0383-3. Epub 2009 Feb 15.","Ploeg M","World J Urol","2009","2009/02/17","PMC2694323","","10.1007/s00345-009-0383-3"
"27129876","p53 status correlates with the risk of progression in stage T1 bladder cancer: a meta-analysis","Du J, Wang SH, Yang Q, Chen QQ, Yao X.","World J Surg Oncol. 2016 Apr 30;14:137. doi: 10.1186/s12957-016-0890-9.","Du J","World J Surg Oncol","2016","2016/05/01","PMC4851770","","10.1186/s12957-016-0890-9"
"28655530","Variation in the Diagnostic Evaluation among Persons with Hematuria: Influence of Gender, Race and Risk Factors for Bladder Cancer","Ark JT, Alvarez JR, Koyama T, Bassett JC, Blot WJ, Mumma MT, Resnick MJ, You C, Penson DF, Barocas DA.","J Urol. 2017 Nov;198(5):1033-1038. doi: 10.1016/j.juro.2017.06.083. Epub 2017 Jun 24.","Ark JT","J Urol","2017","2017/06/29","PMC5827951","NIHMS944551","10.1016/j.juro.2017.06.083"
"21771710","Urinary bladder: normal appearance and mimics of malignancy at CT urography","Shinagare AB, Sadow CA, Sahni VA, Silverman SG.","Cancer Imaging. 2011 Jun 28;11(1):100-8. doi: 10.1102/1470-7330.2011.0017.","Shinagare AB","Cancer Imaging","2011","2011/07/21","PMC3205759","","10.1102/1470-7330.2011.0017"
"21994199","Urine cytology of micropapillary carcinoma of the urinary bladder","Sakuma T, Furuta M, Mimura A, Tanigawa N, Takamizu R, Kawano K.","Diagn Cytopathol. 2011 Nov;39(11):852-6. doi: 10.1002/dc.21573. Epub 2010 Nov 22.","Sakuma T","Diagn Cytopathol","2011","2011/10/14","","","10.1002/dc.21573"
"28791418","TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth","Gao SL, Kong CZ, Zhang Z, Li ZL, Bi JB, Liu XK.","Oncol Rep. 2017 Oct;38(4):1967-1976. doi: 10.3892/or.2017.5883. Epub 2017 Aug 7.","Gao SL","Oncol Rep","2017","2017/08/10","PMC5652943","","10.3892/or.2017.5883"
"28292646","Follow-up of elderly patients with urogenital cancers: Evaluation of geriatric care needs and related actions","Monfardini S, Morlino S, Valdagni R, Catanzaro M, Tafa A, Bortolato B, Petralia G, Bonetto E, Villa E, Picozzi S, Locatelli MC, Galetti G, Millul A, Albanese Y, Bianchi E, Panzarino C, Gerardi F, Beghi E.","J Geriatr Oncol. 2017 Jul;8(4):289-295. doi: 10.1016/j.jgo.2017.02.011. Epub 2017 Mar 11.","Monfardini S","J Geriatr Oncol","2017","2017/03/16","","","10.1016/j.jgo.2017.02.011"
"17404387","Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review","Kellen E, Hemelt M, Broberg K, Golka K, Kristensen VN, Hung RJ, Matullo G, Mittal RD, Porru S, Povey A, Schulz WA, Shen J, Buntinx F, Zeegers MP, Taioli E.","Am J Epidemiol. 2007 Jun 1;165(11):1221-30. doi: 10.1093/aje/kwm003. Epub 2007 Apr 2.","Kellen E","Am J Epidemiol","2007","2007/04/04","","","10.1093/aje/kwm003"
"11164145","E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder","Shariat SF, Pahlavan S, Baseman AG, Brown RM, Green AE, Wheeler TM, Lerner SP.","Urology. 2001 Jan;57(1):60-5. doi: 10.1016/s0090-4295(00)00892-x.","Shariat SF","Urology","2001","2001/02/13","","","10.1016/s0090-4295(00)00892-x"
"20123358","Are nomograms needed in the management of bladder cancer?","Nguyen CT, Stephenson AJ, Kattan MW.","Urol Oncol. 2010 Jan-Feb;28(1):102-7. doi: 10.1016/j.urolonc.2009.04.020.","Nguyen CT","Urol Oncol","2010","2010/02/04","","","10.1016/j.urolonc.2009.04.020"
"60499","Letter: Intravesical bleomycin in bladder cancer","Johnson DE, Bracken RB, Brown TE, Prestyako AW, Crooke ST.","JAMA. 1976 Sep 20;236(12):1353-4.","Johnson DE","JAMA","1976","1976/09/20","","",""
"18906164","Cystoscopic fulguration of many papillary carcinomata of the bladder","DESKIN R.","Urol Cutaneous Rev. 1947 Dec;51(12):669-71.","DESKIN R","Urol Cutaneous Rev","1947","1947/12/01","","",""
"25065995","Re: Jarow JP et al.: Clinical trial design for the development of new therapies for non-muscle-invasive bladder cancer: report of a Food and Drug Administration and American Urological Association public workshop (Urology 2014;83:262-265)","Amrhein J, Kamat AM, Morales A.","Urology. 2014 Aug;84(2):494-5. doi: 10.1016/j.urology.2014.03.034.","Amrhein J","Urology","2014","2014/07/29","","","10.1016/j.urology.2014.03.034"
"26844468","Complete Response and Fatigue Improvement With the Combined Use of Cyclophosphamide and Quercetin in a Patient With Metastatic Bladder Cancer: A Case Report","Di Lorenzo G, Pagliuca M, Perillo T, Zarrella A, Verde A, De Placido S, Buonerba C.","Medicine (Baltimore). 2016 Feb;95(5):e2598. doi: 10.1097/MD.0000000000002598.","Di Lorenzo G","Medicine (Baltimore)","2016","2016/02/05","PMC4748885","","10.1097/MD.0000000000002598"
"28752236","Opa interacting protein 5 acts as an oncogene in bladder cancer","He X, Hou J, Ping J, Wen D, He J.","J Cancer Res Clin Oncol. 2017 Nov;143(11):2221-2233. doi: 10.1007/s00432-017-2485-4. Epub 2017 Jul 27.","He X","J Cancer Res Clin Oncol","2017","2017/07/29","","","10.1007/s00432-017-2485-4"
"16541433","Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer","Svatek RS, Herman MP, Lotan Y, Casella R, Hsieh JT, Sagalowsky AI, Shariat SF.","Cancer. 2006 Apr 15;106(8):1701-7. doi: 10.1002/cncr.21795.","Svatek RS","Cancer","2006","2006/03/17","","","10.1002/cncr.21795"
"21325806","Is conventional urinary cytology still reliable for diagnosis of primary bladder carcinoma? Accuracy based on data linkage of a consecutive clinical series and cancer registry","Turco P, Houssami N, Bulgaresi P, Troni GM, Galanti L, Cariaggi MP, Cifarelli P, Crocetti E, Ciatto S.","Acta Cytol. 2011;55(2):193-6. doi: 10.1159/000320861. Epub 2011 Feb 15.","Turco P","Acta Cytol","2011","2011/02/18","","","10.1159/000320861"
"12796694","Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study","Jichlinski P, Guillou L, Karlsen SJ, Malmström PU, Jocham D, Brennhovd B, Johansson E, Gärtner T, Lange N, van den Bergh H, Leisinger HJ.","J Urol. 2003 Jul;170(1):226-9. doi: 10.1097/01.ju.0000060782.52358.04.","Jichlinski P","J Urol","2003","2003/06/11","","","10.1097/01.ju.0000060782.52358.04"
"17041887","Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?","Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH.","Cancer. 2006 Nov 15;107(10):2368-74. doi: 10.1002/cncr.22250.","Koppie TM","Cancer","2006","2006/10/17","","","10.1002/cncr.22250"
"3692621","Tobacco smoking, occupational exposure and bladder cancer in Argentina","Iscovich J, Castelletto R, Estève J, Muñoz N, Colanzi R, Coronel A, Deamezola I, Tassi V, Arslan A.","Int J Cancer. 1987 Dec 15;40(6):734-40. doi: 10.1002/ijc.2910400604.","Iscovich J","Int J Cancer","1987","1987/12/15","","","10.1002/ijc.2910400604"
"30932431","Partial cystectomy in young male for a urachal tumor masquerading a bladder leiomyoma","Sodo M, Spirito L, La Rocca R, Bracale U, Imbimbo C.","Arch Ital Urol Androl. 2019 Mar 29;91(1):51-52. doi: 10.4081/aiua.2019.1.51.","Sodo M","Arch Ital Urol Androl","2019","2019/04/02","","","10.4081/aiua.2019.1.51"
"19553822","The risk and prophylactic management of bladder cancer after various forms of radiotherapy","Shirodkar SP, Kishore TA, Soloway MS.","Curr Opin Urol. 2009 Sep;19(5):500-3. doi: 10.1097/MOU.0b013e32832eb3b3.","Shirodkar SP","Curr Opin Urol","2009","2009/06/26","","","10.1097/MOU.0b013e32832eb3b3"
"12776258","Gallium nitrate in the treatment of bladder cancer","Einhorn L.","Semin Oncol. 2003 Apr;30(2 Suppl 5):34-41. doi: 10.1016/s0093-7754(03)00174-x.","Einhorn L","Semin Oncol","2003","2003/05/31","","","10.1016/s0093-7754(03)00174-x"
"2202667","Carcinoma bladder: comparative evaluation of urinary cytology, excretory urography and ultrasonography","Ravi R, Rao RC, Ahlawat R, Berry M.","Indian J Cancer. 1990 Mar;27(1):55-61.","Ravi R","Indian J Cancer","1990","1990/03/01","","",""
"16835527","Fluorescence diagnosis of bladder cancer","Chatterton K, Ray E, O'Brien TS.","Br J Nurs. 2006 Jun 8-21;15(11):595-7. doi: 10.12968/bjon.2006.15.11.21226.","Chatterton K","Br J Nurs","2006","2006/07/13","","","10.12968/bjon.2006.15.11.21226"
"15384274","[Epidemiological characteristics of bladder tumors in the Cuenca area throughout a seventeen-year period]","García Mediero JM, Pérez López JM, de Cabo Ripoll M, Samblás García R, Rubio Bodemer MJ, Alvarez G, Reyes Guijarro R.","Actas Urol Esp. 2004 Jul-Aug;28(7):497-505. doi: 10.1016/s0210-4806(04)73119-8.","García Mediero JM","Actas Urol Esp","2004","2004/09/24","","","10.1016/s0210-4806(04)73119-8"
"29971674","Cancer Immune Therapy: Prognostic Significance and Implications for Therapy of PD-1 in BCG-Relapsing Bladder Cancer","Mukherjee N, Svatek R.","Ann Surg Oncol. 2018 Sep;25(9):2498-2499. doi: 10.1245/s10434-018-6610-7. Epub 2018 Jul 3.","Mukherjee N","Ann Surg Oncol","2018","2018/07/05","PMC6093201","NIHMS979601","10.1245/s10434-018-6610-7"
"26721441","LDH-A promotes malignant progression via activation of epithelial-to-mesenchymal transition and conferring stemness in muscle-invasive bladder cancer","Jiang F, Ma S, Xue Y, Hou J, Zhang Y.","Biochem Biophys Res Commun. 2016 Jan 22;469(4):985-92. doi: 10.1016/j.bbrc.2015.12.078. Epub 2015 Dec 22.","Jiang F","Biochem Biophys Res Commun","2016","2016/01/02","","","10.1016/j.bbrc.2015.12.078"
"7306987","Maintenance by saccharin of membrane alterations of rat bladder cells induced by subcarcinogenic treatment with bladder carcinogens","Kakizoe T, Komatsu H, Niijima T, Kawachi T, Sugimura T.","Cancer Res. 1981 Nov;41(11 Pt 1):4702-5.","Kakizoe T","Cancer Res","1981","1981/11/01","","",""
"20273482","The treatment of cancer of the bladder by radium needles","LENZ M, CAHILL GF, et al.","Am J Roentgenol Radium Ther. 1947 Oct;58(4):486-92.","LENZ M","Am J Roentgenol Radium Ther","1947","2010/03/19","","",""
"18696039","[Muscle-invasive urothelial carcinoma of the bladder. Detection and topography of micrometastases in lymph nodes]","Autenrieth M, Nawroth R, Semmlack S, Gschwend JE, Retz M.","Urologe A. 2008 Sep;47(9):1157-61. doi: 10.1007/s00120-008-1829-8.","Autenrieth M","Urologe A","2008","2008/08/13","","","10.1007/s00120-008-1829-8"
"24521893","[Value of combined detection of urinary Livin and Survivin mRNA expression in the early diagnosis of bladder cancer]","Jiang LL, Xie MM, Wang XR, Zhao Y, Wang ZJ.","Zhonghua Yi Xue Za Zhi. 2013 Nov 26;93(44):3520-2.","Jiang LL","Zhonghua Yi Xue Za Zhi","2013","2014/02/14","","",""
"28390739","Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy","Seiler R, Ashab HAD, Erho N, van Rhijn BWG, Winters B, Douglas J, Van Kessel KE, Fransen van de Putte EE, Sommerlad M, Wang NQ, Choeurng V, Gibb EA, Palmer-Aronsten B, Lam LL, Buerki C, Davicioni E, Sjödahl G, Kardos J, Hoadley KA, Lerner SP, McConkey DJ, Choi W, Kim WY, Kiss B, Thalmann GN, Todenhöfer T, Crabb SJ, North S, Zwarthoff EC, Boormans JL, Wright J, Dall'Era M, van der Heijden MS, Black PC.","Eur Urol. 2017 Oct;72(4):544-554. doi: 10.1016/j.eururo.2017.03.030. Epub 2017 Apr 5.","Seiler R","Eur Urol","2017","2017/04/10","","","10.1016/j.eururo.2017.03.030"
"19332735","Grade and stage at presentation do not predict mortality in patients with bladder cancer who survive their disease","Messing EM, Madeb R, Feng C, Stephenson L, Gilchrist KW, Young T, Gee J.","J Clin Oncol. 2009 May 20;27(15):2443-9. doi: 10.1200/JCO.2008.16.5951. Epub 2009 Mar 30.","Messing EM","J Clin Oncol","2009","2009/04/01","","","10.1200/JCO.2008.16.5951"
"25661830","Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based study","Leveridge MJ, Siemens DR, Mackillop WJ, Peng Y, Tannock IF, Berman DM, Booth CM.","Urology. 2015 Apr;85(4):791-8. doi: 10.1016/j.urology.2014.12.027. Epub 2015 Feb 7.","Leveridge MJ","Urology","2015","2015/02/10","","","10.1016/j.urology.2014.12.027"
"21198277","Role of NMP22 Bladder Check Test in early detection of bladder cancer with recurrence","Kundal VK, Pandith AA, Hamid A, Shah A, Kundal R, Wani SM.","Asian Pac J Cancer Prev. 2010;11(5):1279-82.","Kundal VK","Asian Pac J Cancer Prev","2010","2011/01/05","","",""
"16132401","Prostatic capsule- and nerve-sparing cystectomy in organ-confined bladder cancer: preliminary results","Martis G, D'Elia G, Diana M, Ombres M, Mastrangeli B.","World J Surg. 2005 Oct;29(10):1277-81. doi: 10.1007/s00268-005-7852-7.","Martis G","World J Surg","2005","2005/09/01","","","10.1007/s00268-005-7852-7"
"17115600","[Necessity of bladder extirpation performance in the treatment of severe complications of its cancer]","Stakhovs'kyĭ EO, St'opushkin SP, Vukalovych PS, Voĭlenko OA.","Klin Khir. 2006 Jul;(7):50-3.","Stakhovs'kyĭ EO","Klin Khir","2006","2006/11/23","","",""
"14981102","p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer","Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF, Lerner SP.","J Clin Oncol. 2004 Mar 15;22(6):1014-24. doi: 10.1200/JCO.2004.03.118. Epub 2004 Feb 23.","Shariat SF","J Clin Oncol","2004","2004/02/26","","","10.1200/JCO.2004.03.118"
"30100065","miR-7-5p acts as a tumor suppressor in bladder cancer by regulating the hedgehog pathway factor Gli3","Li J, Qiu M, An Y, Huang J, Gong C.","Biochem Biophys Res Commun. 2018 Sep 10;503(3):2101-2107. doi: 10.1016/j.bbrc.2018.07.166. Epub 2018 Aug 9.","Li J","Biochem Biophys Res Commun","2018","2018/08/14","","","10.1016/j.bbrc.2018.07.166"
"30887516","Identification of a nine-gene panel as a prognostic indicator for recurrence with muscle-invasive bladder cancer","Han Y, Zheng Q, Tian Y, Ji Z, Ye H.","J Surg Oncol. 2019 Jun;119(8):1145-1154. doi: 10.1002/jso.25446. Epub 2019 Mar 18.","Han Y","J Surg Oncol","2019","2019/03/20","","","10.1002/jso.25446"
"28188046","The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Non-muscle-invasive Bladder Cancer","Busetto GM, Ferro M, Del Giudice F, Antonini G, Chung BI, Sperduti I, Giannarelli D, Lucarelli G, Borghesi M, Musi G, de Cobelli O, De Berardinis E.","Clin Genitourin Cancer. 2017 Aug;15(4):e661-e666. doi: 10.1016/j.clgc.2017.01.011. Epub 2017 Jan 18.","Busetto GM","Clin Genitourin Cancer","2017","2017/02/12","","","10.1016/j.clgc.2017.01.011"
"16710678","[Value of systemic chemotherapy in bladder cancer]","Goebell PJ, vom Dorp F, Rübben H.","Urologe A. 2006 May;45(5):586, 588-90, 592-3. doi: 10.1007/s00120-006-1058-y.","Goebell PJ","Urologe A","2006","2006/05/20","","","10.1007/s00120-006-1058-y"
"10569614","Adriamycin-mediated potentiation of cytotoxicity against freshly isolated bladder cancer cells by autologous non-activated peripheral blood lymphocytes and tumor infiltrating lymphocytes","Mizutani Y, Yoshida O, Miki T.","J Urol. 1999 Dec;162(6):2170-5. doi: 10.1016/s0022-5347(05)68154-2.","Mizutani Y","J Urol","1999","1999/11/24","","","10.1016/s0022-5347(05)68154-2"
"7241674","Total cystectomy for bladder cancer","Mathur VK, Krahn HP, Ramsey EW.","J Urol. 1981 Jun;125(6):784-6. doi: 10.1016/s0022-5347(17)55202-7.","Mathur VK","J Urol","1981","1981/06/01","","","10.1016/s0022-5347(17)55202-7"
"13449966","[Real value of total cystectomy for the cure of bladder cancer]","CHAUVIN E.","J Urol Medicale Chir. 1957 Jan-Feb;63(1-2):46-50.","CHAUVIN E","J Urol Medicale Chir","1957","1957/01/01","","",""
"29556633","Proliferation activity in bladder tumors does not correlate with the pathological grading","Ştefănescu ML, Grosu F, Stoica LE, Schenker M, Mogoantă L, Bastian AE.","Rom J Morphol Embryol. 2017;58(4):1393-1400.","Ştefănescu ML","Rom J Morphol Embryol","2017","2018/03/21","","",""
"23258087","Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer","Yin X, Yu B, Tang Z, He B, Ren J, Xiao X, Tang W.","Cancer Gene Ther. 2013 Feb;20(2):77-81. doi: 10.1038/cgt.2012.86. Epub 2012 Dec 21.","Yin X","Cancer Gene Ther","2013","2012/12/22","","","10.1038/cgt.2012.86"
"15157205","Prognostic value of nuclear area index in patients with bladder cancer","Yusup A, Kanamaru H, Aoki Y, Saikawa S, Moriyama N, Oyama N, Akino H, Okada K, Yokoyama O.","Int J Urol. 2004 Jun;11(6):374-8. doi: 10.1111/j.1442-2042.2004.00813.x.","Yusup A","Int J Urol","2004","2004/05/26","","","10.1111/j.1442-2042.2004.00813.x"
"11544830","[Immunocorrective effect of alternating magnetic field in the postoperative period in malignant bladder cancer]","Zlatnik EIu, Kapkina NN, Zaderin VP, Zakora GI.","Vopr Onkol. 2001;47(3):312-4.","Zlatnik EIu","Vopr Onkol","2001","2001/09/08","","",""
"25410154","Pathological evaluation and quality of surgery in radical cystectomy in New South Wales, Australia","Ahmadi N, Delprado WJ, Brooks AJ, Brenner PC, Coombes GM, Grant A, Patel MI.","ANZ J Surg. 2015 Mar;85(3):145-9. doi: 10.1111/ans.12383. Epub 2014 Nov 19.","Ahmadi N","ANZ J Surg","2015","2014/11/21","","","10.1111/ans.12383"
"28053981","The Functional Haplotypes of CHRM3 Modulate mRNA Expression and Associate with Bladder Cancer among a Chinese Han Population in Kaohsiung City","Wang CT, Chen TM, Mei CT, Chang CF, Liu LL, Chiu KH, Wu TM, Lan YC, Liu WS, Chen YH, Lin YJ.","Biomed Res Int. 2016;2016:4052846. doi: 10.1155/2016/4052846. Epub 2016 Dec 7.","Wang CT","Biomed Res Int","2016","2017/01/06","PMC5174173","","10.1155/2016/4052846"
"19948444","Perioperative search for circulating tumor cells in patients undergoing radical cystectomy for bladder cancer","Karl A, Tritschler S, Hofmann S, Stief CG, Schindlbeck C.","Eur J Med Res. 2009 Nov 3;14(11):487-90. doi: 10.1186/2047-783x-14-11-487.","Karl A","Eur J Med Res","2009","2009/12/02","PMC3352289","","10.1186/2047-783x-14-11-487"
"13330140","[Indication of the so-called rectum-bladder in cystectomized bladder cancer patients]","BOEMINGHAUS H.","Chirurg. 1956 May;27(5):217-9.","BOEMINGHAUS H","Chirurg","1956","1956/05/01","","",""
"6836746","Bladder cancer and cigarette smoking in males: a case-control study","Vineis P, Frea B, Uberti E, Ghisetti V, Terracini B.","Tumori. 1983 Feb 28;69(1):17-22.","Vineis P","Tumori","1983","1983/02/28","","",""
"7508330","Is beta-human chorionic gonadotrophin production by transitional cell carcinoma of the bladder a marker of aggressive disease and resistance to radiotherapy?","Moutzouris G, Yannopoulos D, Barbatis C, Zaharof A, Theodorou C.","Br J Urol. 1993 Dec;72(6):907-9. doi: 10.1111/j.1464-410x.1993.tb16294.x.","Moutzouris G","Br J Urol","1993","1993/12/01","","","10.1111/j.1464-410x.1993.tb16294.x"
"2076932","Intravesical bacillus Calmette-Guérin administration in the prophylaxis of superficial bladder cancer","Melekos MD, Pantazakos A, Markou S, Skopa C, Athanassopoulos A, Barbalias G.","Int Urol Nephrol. 1990;22(5):433-40. doi: 10.1007/BF02549774.","Melekos MD","Int Urol Nephrol","1990","1990/01/01","","","10.1007/BF02549774"
"27502548","Contemporary evidence for robot-assisted radical cystectomy for treating bladder cancer","Satkunasivam R, Wallis CJ, Nam RK, Desai M, Gill IS.","Nat Rev Urol. 2016 Sep;13(9):533-9. doi: 10.1038/nrurol.2016.139. Epub 2016 Aug 9.","Satkunasivam R","Nat Rev Urol","2016","2016/08/10","","","10.1038/nrurol.2016.139"
"17178858","Matrix metalloproteinase polymorphisms and bladder cancer risk","Kader AK, Shao L, Dinney CP, Schabath MB, Wang Y, Liu J, Gu J, Grossman HB, Wu X.","Cancer Res. 2006 Dec 15;66(24):11644-8. doi: 10.1158/0008-5472.CAN-06-1212.","Kader AK","Cancer Res","2006","2006/12/21","","","10.1158/0008-5472.CAN-06-1212"
"12433737","No Association between toenail selenium levels and bladder cancer risk","Michaud DS, Hartman TJ, Taylor PR, Pietinen P, Alfthan G, Virtamo J, Albanes D.","Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1505-6.","Michaud DS","Cancer Epidemiol Biomarkers Prev","2002","2002/11/16","","",""
"28217825","Preoperative prediction of muscular invasiveness of bladder cancer with radiomic features on conventional MRI and its high-order derivative maps","Xu X, Liu Y, Zhang X, Tian Q, Wu Y, Zhang G, Meng J, Yang Z, Lu H.","Abdom Radiol (NY). 2017 Jul;42(7):1896-1905. doi: 10.1007/s00261-017-1079-6.","Xu X","Abdom Radiol (NY)","2017","2017/02/21","","","10.1007/s00261-017-1079-6"
"12672039","Cancer risks in hairdressers: assessment of carcinogenicity of hair dyes and gels","Czene K, Tiikkaja S, Hemminki K.","Int J Cancer. 2003 May 20;105(1):108-12. doi: 10.1002/ijc.11040.","Czene K","Int J Cancer","2003","2003/04/03","","","10.1002/ijc.11040"
"26390011","Radical cystectomy in the treatment of bladder cancer in Iceland: A population-based study","Björnsson O, Gudmundsson EO, Marteinsson VT, Jonsson E.","Scand J Urol. 2016;50(1):65-70. doi: 10.3109/21681805.2015.1085088. Epub 2015 Sep 21.","Björnsson O","Scand J Urol","2016","2015/09/22","","","10.3109/21681805.2015.1085088"
"14658273","[Diagnosis and treatment of recurrent surface cancer of the urinary bladder (early repeated cystoscopy and biopsy)]","Lopatkin NA, Martov AG, Gushchin BL, Gnatiuk AP, Ergakov DV, Serebrianyĭ SA.","Urologiia. 2003 Sep-Oct;(5):45-9.","Lopatkin NA","Urologiia","2003","2003/12/09","","",""
"15333680","Treatment of invasive bladder cancer: lessons from the past and perspective for the future","Tsukamoto T, Kitamura H, Takahashi A, Masumori N.","Jpn J Clin Oncol. 2004 Jun;34(6):295-306. doi: 10.1093/jjco/hyh048.","Tsukamoto T","Jpn J Clin Oncol","2004","2004/08/31","","","10.1093/jjco/hyh048"
"7483140","Photodynamic efficiency of liposome-administered tetramethyl hematoporphyrin in two human bladder cancer cell lines","Bachor R, Reich E, Miller K, Rück A, Hautmann R.","Urol Res. 1995;23(3):151-6. doi: 10.1007/BF00389566.","Bachor R","Urol Res","1995","1995/01/01","","","10.1007/BF00389566"
"30019864","Correlation between malnutrition, body mass index and complications in patients with urinary bladder cancer who underwent radical cystectomy","Swalarz M, Swalarz G, Juszczak K, Maciukiewicz P, Czurak K, Matuszewski M, Gajewska D, Słojewski M, Bogacki R, Bryniarski P, Paradysz A, Kadłubowski M, Drewa T, Genge E.","Adv Clin Exp Med. 2018 Aug;27(8):1141-1147. doi: 10.17219/acem/89863.","Swalarz M","Adv Clin Exp Med","2018","2018/07/19","","","10.17219/acem/89863"
"20423150","Analysis of secreted proteins for the study of bladder cancer cell aggressiveness","Makridakis M, Roubelakis MG, Bitsika V, Dimuccio V, Samiotaki M, Kossida S, Panayotou G, Coleman J, Candiano G, Anagnou NP, Vlahou A.","J Proteome Res. 2010 Jun 4;9(6):3243-59. doi: 10.1021/pr100189d.","Makridakis M","J Proteome Res","2010","2010/04/29","","","10.1021/pr100189d"
"11866883","Nonassociation of aryl hydrocarbon receptor genotypes with susceptibility to bladder cancer in Shanghai population","Zhang DS, Lin GF, Ma QW, Shen JH.","Acta Pharmacol Sin. 2002 Feb;23(2):188-92.","Zhang DS","Acta Pharmacol Sin","2002","2002/02/28","","",""
"17090976","[Bladder preservation possibilities in the treatment of muscle-invasive bladder cancer]","Asadauskiene J, Aleknavicius E, Zelviene TP, Jankevicius F.","Medicina (Kaunas). 2006;42(10):781-7.","Asadauskiene J","Medicina (Kaunas)","2006","2006/11/09","","",""
"9717824","Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer","Müller M, Krause H, Heicappell R, Tischendorf J, Shay JW, Miller K.","Clin Cancer Res. 1998 Aug;4(8):1949-54.","Müller M","Clin Cancer Res","1998","1998/08/26","","",""
"10484849","[Brachytherapy for urinary bladder cancer]","González González D, Haitze van der Veen J, Ypma AF, Blank LE, Hoestra CJ, Veen RE.","Arch Esp Urol. 1999 Jul-Aug;52(6):655-61.","González González D","Arch Esp Urol","1999","1999/09/15","","",""
"26927300","Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience","Moschini M, Karnes RJ, Sharma V, Gandaglia G, Fossati N, Dell'Oglio P, Cucchiara V, Capogrosso P, Shariat SF, Damiano R, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R.","Eur J Surg Oncol. 2016 May;42(5):735-43. doi: 10.1016/j.ejso.2016.02.011. Epub 2016 Feb 18.","Moschini M","Eur J Surg Oncol","2016","2016/03/02","","","10.1016/j.ejso.2016.02.011"
"2053238","Diabetes insipidus due to pituitary metastasis from bladder cancer","Kawamura J, Tsukamoto K, Yamakawa K, Tazima K, Tochigi H.","Urol Int. 1991;46(2):217-20. doi: 10.1159/000282139.","Kawamura J","Urol Int","1991","1991/01/01","","","10.1159/000282139"
"21247263","The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer","Zhang Z, Xu X, Zhang X, Chen X, Chen Q, Dong L, Hu Z, Li J, Gao J.","Acta Oncol. 2011 Oct;50(7):1111-8. doi: 10.3109/0284186X.2010.549838. Epub 2011 Jan 19.","Zhang Z","Acta Oncol","2011","2011/01/21","","","10.3109/0284186X.2010.549838"
"1117520","Lactic dehydrogenase isoenzymes in human bladder cancer","Bredin HC, Daly JJ, Prout GR Jr.","J Urol. 1975 Apr;113(4):487-90. doi: 10.1016/s0022-5347(17)59507-5.","Bredin HC","J Urol","1975","1975/04/11","","","10.1016/s0022-5347(17)59507-5"
"31781942","Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage","Packiam VT, Werntz RP, Steinberg GD.","Curr Urol Rep. 2019 Nov 28;20(12):84. doi: 10.1007/s11934-019-0952-y.","Packiam VT","Curr Urol Rep","2019","2019/11/30","","","10.1007/s11934-019-0952-y"
"25468134","Organ preservation—will data translate into reality for bladder cancer patients?","Chen RC.","Clin Oncol (R Coll Radiol). 2015 Mar;27(3):133-5. doi: 10.1016/j.clon.2014.11.002. Epub 2014 Nov 24.","Chen RC","Clin Oncol (R Coll Radiol)","2015","2014/12/04","","","10.1016/j.clon.2014.11.002"
"27576884","The Prevalence and Prognostic Significance of Polyomavirus Infection in Patients with Urothelial Carcinoma of the Bladder","Wu SW, Liou JH, Yeh KT, Hung TW, Chang HR.","Urol J. 2016 Aug 25;13(4):2773-8.","Wu SW","Urol J","2016","2016/09/01","","",""
"20562793","Mitomycin C for the treatment of bladder cancer","Volpe A, Racioppi M, D'Agostino D, Cappa E, Filianoti A, Bassi PF.","Minerva Urol Nefrol. 2010 Jun;62(2):133-44.","Volpe A","Minerva Urol Nefrol","2010","2010/06/22","","",""
"25744654","Urethral recurrence in women with orthotopic bladder substitutes: A multi-institutional study","Gakis G, Ali-El-Dein B, Babjuk M, Hrbacek J, Macek P, Burkhard FC, Thalmann GN, Shaaban AA, Stenzl A.","Urol Oncol. 2015 May;33(5):204.e17-23. doi: 10.1016/j.urolonc.2015.01.020. Epub 2015 Mar 3.","Gakis G","Urol Oncol","2015","2015/03/07","","","10.1016/j.urolonc.2015.01.020"
"15862617","Contemporary management of the urethra in patients after radical cystectomy for bladder cancer","Clark PE, Hall MC.","Urol Clin North Am. 2005 May;32(2):199-206. doi: 10.1016/j.ucl.2005.01.004.","Clark PE","Urol Clin North Am","2005","2005/05/03","","","10.1016/j.ucl.2005.01.004"
"1560487","Impact of schistosomiasis on urinary bladder cancer in the southern province of Saudi Arabia: review of 60 cases","Khurana P, Morad N, Khan AR, Shetty S, Ibrahim A, Patil K.","J Trop Med Hyg. 1992 Apr;95(2):149-51.","Khurana P","J Trop Med Hyg","1992","1992/04/01","","",""
"30482661","Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer","Royce TJ, Feldman AS, Mossanen M, Yang JC, Shipley WU, Pandharipande PV, Efstathiou JA.","Clin Genitourin Cancer. 2019 Feb;17(1):23-31.e3. doi: 10.1016/j.clgc.2018.09.023. Epub 2018 Oct 4.","Royce TJ","Clin Genitourin Cancer","2019","2018/11/29","","","10.1016/j.clgc.2018.09.023"
"6530875","Monocyte-mediated cytotoxicity on bladder cancer cells in vitro and its implication in the treatment of bladder cancer patients with bacillus Calmette-Guérin","Nakamura K.","Keio J Med. 1984 Nov;33(4):185-99. doi: 10.2302/kjm.33.185.","Nakamura K","Keio J Med","1984","1984/11/01","","","10.2302/kjm.33.185"
"21739270","[Peritoneal carcinomatosis after robotic-assisted radical cystectomy]","Epplen R, Pfister D, Heidenreich A.","Urologe A. 2011 Nov;50(11):1435-7. doi: 10.1007/s00120-011-2632-5.","Epplen R","Urologe A","2011","2011/07/09","","","10.1007/s00120-011-2632-5"
"30285005","The impact of morphine treatment on bladder cancer cell proliferation and apoptosis: in vitro studies","Harper P, Hald O, Lwaleed BA, Kyyaly A, Johnston D, Cooper AJ, Birch B.","Exp Oncol. 2018 Oct;40(3):190-193.","Harper P","Exp Oncol","2018","2018/10/05","","",""
"21851550","Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial","Barbieri CE, Cha EK, Chromecki TF, Dunning A, Lotan Y, Svatek RS, Scherr DS, Karakiewicz PI, Sun M, Mazumdar M, Shariat SF.","BJU Int. 2012 Mar;109(5):685-90. doi: 10.1111/j.1464-410X.2011.010419.x. Epub 2011 Aug 18.","Barbieri CE","BJU Int","2012","2011/08/20","","","10.1111/j.1464-410X.2011.010419.x"
"26657502","Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer","Zhang X, Zhang Y, Liu X, Fang A, Wang J, Yang Y, Wang L, Du L, Wang C.","Oncotarget. 2016 Jan 19;7(3):3255-66. doi: 10.18632/oncotarget.6487.","Zhang X","Oncotarget","2016","2015/12/15","PMC4823104","","10.18632/oncotarget.6487"
"25044253","Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort","Krabbe LM, Svatek RS, Shariat SF, Messing E, Lotan Y.","Urol Oncol. 2015 Feb;33(2):65.e19-25. doi: 10.1016/j.urolonc.2014.06.009. Epub 2014 Jul 16.","Krabbe LM","Urol Oncol","2015","2014/07/22","","","10.1016/j.urolonc.2014.06.009"
"16566734","Photodynamic applications in superficial bladder cancer: facts and hopes!","Jichlinski P.","J Environ Pathol Toxicol Oncol. 2006;25(1-2):441-51. doi: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.280.","Jichlinski P","J Environ Pathol Toxicol Oncol","2006","2006/03/29","","","10.1615/jenvironpatholtoxicoloncol.v25.i1-2.280"
"11057775","Concomitant presence of bladder cancer and neurogenic bladder in a patient with HTLV-1 carrier: a case report","Yagi H, Igawa M, Shiina H, Shigeno K.","Int Urol Nephrol. 2000;32(1):63-5. doi: 10.1023/a:1007104117250.","Yagi H","Int Urol Nephrol","2000","2000/11/01","","","10.1023/a:1007104117250"
"8697435","Molecular and genetic events in schistosomiasis-associated human bladder cancer: role of oncogenes and tumor suppressor genes","Badawi AF.","Cancer Lett. 1996 Aug 2;105(2):123-38. doi: 10.1016/0304-3835(96)04284-x.","Badawi AF","Cancer Lett","1996","1996/08/02","","","10.1016/0304-3835(96)04284-x"
"10523708","Inhibitory effect of shark liver oil on cutaneous angiogenesis induced in Balb/c mice by syngeneic sarcoma L-1, human urinary bladder and human kidney tumour cells","Skopinska-Rózewska E, Krotkiewski M, Sommer E, Rogala E, Filewska M, Bialas-Chromiec B, Pastewka K, Skurzak H.","Oncol Rep. 1999 Nov-Dec;6(6):1341-4. doi: 10.3892/or.6.6.1341.","Skopinska-Rózewska E","Oncol Rep","1999","1999/10/19","","","10.3892/or.6.6.1341"
"26481715","Narrow band imaging and bladder cancer: when and how","Naselli A, Puppo P.","Urologia. 2015 Oct;82 Suppl 2:S5-8. doi: 10.5301/uro.5000156. Epub 2015 Oct 9.","Naselli A","Urologia","2015","2015/10/21","","","10.5301/uro.5000156"
"11326660","Molecular genetic methods in the diagnosis of invasive bladder cancer","Krause FS, Feil G, Zumbrägel A, Bichler KH.","Anticancer Res. 2000 Nov-Dec;20(6D):5015-21.","Krause FS","Anticancer Res","2000","2001/05/01","","",""
"1556051","Molecular biology of bladder cancer","Borland RN, Brendler CB, Isaacs WB.","Hematol Oncol Clin North Am. 1992 Feb;6(1):31-9.","Borland RN","Hematol Oncol Clin North Am","1992","1992/02/01","","",""
"1728789","Stage B (P2/3A/N0) transitional cell carcinoma of bladder highly curable by radical cystectomy","Wishnow KI, Levinson AK, Johnson DE, Tenney DM, Grignon DJ, Ro JY, Ayala AJ, Logothetis CJ, Swanson DA, Babaian RJ, et al.","Urology. 1992 Jan;39(1):12-6. doi: 10.1016/0090-4295(92)90033-s.","Wishnow KI","Urology","1992","1992/01/01","","","10.1016/0090-4295(92)90033-s"
"29650143","Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma","Teo MY, Rosenberg JE.","Urol Clin North Am. 2018 May;45(2):287-295. doi: 10.1016/j.ucl.2017.12.011.","Teo MY","Urol Clin North Am","2018","2018/04/14","","","10.1016/j.ucl.2017.12.011"
"30005997","Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guérin","Bandari J, Maganty A, MacLeod LC, Davies BJ.","Eur Urol Focus. 2018 Jul;4(4):481-484. doi: 10.1016/j.euf.2018.06.018. Epub 2018 Jul 11.","Bandari J","Eur Urol Focus","2018","2018/07/15","","","10.1016/j.euf.2018.06.018"
"24411908","Re: diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer","Wood DP.","J Urol. 2014 Feb;191(2):556. doi: 10.1016/j.juro.2013.10.136. Epub 2013 Oct 29.","Wood DP","J Urol","2014","2014/01/14","","","10.1016/j.juro.2013.10.136"
"2522806","HLA-DR expression by high grade superficial bladder cancer treated with BCG","Prescott S, James K, Busuttil A, Hargreave TB, Chisholm GD, Smyth JF.","Br J Urol. 1989 Mar;63(3):264-9. doi: 10.1111/j.1464-410x.1989.tb05187.x.","Prescott S","Br J Urol","1989","1989/03/01","","","10.1111/j.1464-410x.1989.tb05187.x"
"23199207","Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer","Lin TY, Li YP, Zhang H, Luo J, Goodwin N, Gao T, White Rde V, Lam KS, Pan CX.","Nanomedicine (Lond). 2013 Aug;8(8):1239-51. doi: 10.2217/nnm.12.150. Epub 2012 Dec 2.","Lin TY","Nanomedicine (Lond)","2013","2012/12/04","PMC3664656","NIHMS436460","10.2217/nnm.12.150"
"11501752","Structural alterations of sugar chains in urine fibronectin from bladder cancer patients and its enzymatic mechanism","Guo JM, Zhang XY, Chen HL, Wang GM, Zhang YK.","J Cancer Res Clin Oncol. 2001 Aug;127(8):512-9. doi: 10.1007/s004320100245.","Guo JM","J Cancer Res Clin Oncol","2001","2001/08/15","","","10.1007/s004320100245"
"20434259","Re: Derya Tilki, Oliver Reich, Pierre I. Karakiewicz, et al. Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome. Eur Urol 2010;58:112-7","Herr HW.","Eur Urol. 2010 Aug;58(2):e21-2. doi: 10.1016/j.eururo.2010.04.023. Epub 2010 Apr 23.","Herr HW","Eur Urol","2010","2010/05/04","","","10.1016/j.eururo.2010.04.023"
"8797585","Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors","Shimazui T, Schalken JA, Giroldi LA, Jansen CF, Akaza H, Koiso K, Debruyne FM, Bringuier PP.","Cancer Res. 1996 Sep 15;56(18):4154-8.","Shimazui T","Cancer Res","1996","1996/09/15","","",""
"18085612","Hospital lymph node counts and survival after radical cystectomy","Hollenbeck BK, Ye Z, Wong SL, Montie JE, Birkmeyer JD.","Cancer. 2008 Feb 15;112(4):806-12. doi: 10.1002/cncr.23234.","Hollenbeck BK","Cancer","2008","2007/12/19","","","10.1002/cncr.23234"
"31798978","Prognosis of early stage small cell bladder cancer is not always dismal","Lim JH, Sundar S.","ESMO Open. 2019 Nov 13;4(6):e000559. doi: 10.1136/esmoopen-2019-000559. eCollection 2019.","Lim JH","ESMO Open","2019","2019/12/05","PMC6863661","","10.1136/esmoopen-2019-000559"
"5013534","Carcinosarcoma of the urinary bladder","Holtz F, Fox JE, Abell MR.","Cancer. 1972 Feb;29(2):294-304. doi: 10.1002/1097-0142(197202)29:2<294::aid-cncr2820290205>3.0.co;2-v.","Holtz F","Cancer","1972","1972/02/01","","","10.1002/1097-0142(197202)29:2<294::aid-cncr2820290205>3.0.co;2-v"
"11350401","Neoplasia in adult exstrophy patients","Smeulders N, Woodhouse CR.","BJU Int. 2001 May;87(7):623-8. doi: 10.1046/j.1464-410x.2001.02136.x.","Smeulders N","BJU Int","2001","2001/05/15","","","10.1046/j.1464-410x.2001.02136.x"
"23580383","[T1 high-grade bladder cancer - value of second operation with prognostuic parameters of first operation: analysis of 167 cases]","Lazica DA, Böttcher S, Degener S, von Rundstedt FC, Brandt AS, Roth S, Störkel S, Mathers MJ.","Aktuelle Urol. 2013 Mar;44(2):124-8. doi: 10.1055/s-0033-1334962. Epub 2013 Apr 11.","Lazica DA","Aktuelle Urol","2013","2013/04/13","","","10.1055/s-0033-1334962"
"10691829","The transverse colonic reservoir: the Unicamp technique","Ferreira U, Rodrigues Netto N Jr, Lucena R.","BJU Int. 2000 Mar;85(4):486-9. doi: 10.1046/j.1464-410x.2000.00522.x.","Ferreira U","BJU Int","2000","2000/02/26","","","10.1046/j.1464-410x.2000.00522.x"
"20093479","Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression","Tseng-Rogenski S, Gee J, Ignatoski KW, Kunju LP, Bucheit A, Kintner HJ, Morris D, Tallman C, Evron J, Wood CG, Grossman HB, Lee CT, Liebert M.","Am J Pathol. 2010 Mar;176(3):1462-8. doi: 10.2353/ajpath.2010.090875. Epub 2010 Jan 21.","Tseng-Rogenski S","Am J Pathol","2010","2010/01/23","PMC2832165","","10.2353/ajpath.2010.090875"
"18111855","The looped catheter ureteral stone extractor; perplexities in its construction and use","ELLIK M.","J Urol. 1949 Feb;61(2):351-8. doi: 10.1016/s0022-5347(17)69074-8.","ELLIK M","J Urol","1949","1949/02/01","","","10.1016/s0022-5347(17)69074-8"
"3099881","Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases","Smith G, Elton RA, Chisholm GD, Newsam JE, Hargreave TB.","Br J Urol. 1986 Dec;58(6):659-63. doi: 10.1111/j.1464-410x.1986.tb05907.x.","Smith G","Br J Urol","1986","1986/12/01","","","10.1111/j.1464-410x.1986.tb05907.x"
"6742274","Coffee consumption and risk of fatal cancers","Snowdon DA, Phillips RL.","Am J Public Health. 1984 Aug;74(8):820-3. doi: 10.2105/ajph.74.8.820.","Snowdon DA","Am J Public Health","1984","1984/08/01","PMC1651954","","10.2105/ajph.74.8.820"
"10938398","Binding of 125I after administration of 125I-EGF-dextran, 125I-EGF or 125I to human bladder cancer spheroids","Sjöström A, Bue P, Malmstrom P, Carlsson J.","Int J Oncol. 2000 Sep;17(3):559-64. doi: 10.3892/ijo.17.3.559.","Sjöström A","Int J Oncol","2000","2000/08/12","","","10.3892/ijo.17.3.559"
"32773805","[Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection]","Zhao SM, Yang TJ, Xu CM, Guo XF, Ma YK, Chen XJ, Li X, He CH.","Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Aug 18;52(4):701-704. doi: 10.19723/j.issn.1671-167X.2020.04.020.","Zhao SM","Beijing Da Xue Xue Bao Yi Xue Ban","2020","2020/08/11","PMC7433642","","10.19723/j.issn.1671-167X.2020.04.020"
"2728947","[Bladder cancer: study of mortality in Spain (1968-1982)]","Gil Mary A, Alfonso Sánchez JL, Cortés Vizcaino C, Saiz Sánchez C, Cortina Greus P.","Actas Urol Esp. 1989 Mar-Apr;13(2):85-9.","Gil Mary A","Actas Urol Esp","1989","1989/03/01","","",""
"7553306","What is the biology of invasion and metastasis in bladder cancer?","Kakizoe T, Fair WR, Smith PH, Algaba F, Ferrari P, Grossman HB, Zirkali Z, Tsukamoto T, Tachibana M.","Int J Urol. 1995 Jun;2 Suppl 2:58-63. doi: 10.1111/j.1442-2042.1995.tb00480.x.","Kakizoe T","Int J Urol","1995","1995/06/01","","","10.1111/j.1442-2042.1995.tb00480.x"
"24960468","Bladder biopsy of normal-appearing mucosa is not helpful in patients with unexplained positive cytology after nonmuscle invasive bladder cancer","Musser JE, O'Shaughnessy MJ, Kim PH, Herr HW.","J Urol. 2015 Jan;193(1):48-52. doi: 10.1016/j.juro.2014.06.068. Epub 2014 Jun 21.","Musser JE","J Urol","2015","2014/06/25","","","10.1016/j.juro.2014.06.068"
"16626857","Foreseeing cancer metastases","van der Poel HG.","Eur Urol. 2006 Oct;50(4):648-9. doi: 10.1016/j.eururo.2006.03.054. Epub 2006 Apr 7.","van der Poel HG","Eur Urol","2006","2006/04/22","","","10.1016/j.eururo.2006.03.054"
"18228189","[Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?]","Denzinger S, Burger M, Fritsche HM, Ganzer R, Blana A, Wieland WF, Otto W.","Aktuelle Urol. 2008 Jan;39(1):58-61; discussion 62-3. doi: 10.1055/s-2007-980147.","Denzinger S","Aktuelle Urol","2008","2008/01/30","","","10.1055/s-2007-980147"
"12135697","Diagnostic value of cytokeratin-18 as a tumor marker in bladder cancer","Ramazan Sekeroğlu M, Aydin S, Dülger H, Yilmaz Y, Bayrakli H, Noyan T.","Clin Biochem. 2002 Jun;35(4):327-31. doi: 10.1016/s0009-9120(02)00321-1.","Ramazan Sekeroğlu M","Clin Biochem","2002","2002/07/24","","","10.1016/s0009-9120(02)00321-1"
"10668938","Tissue polypeptide antigen and carcinoembryonic antigen lack diagnostic accuracy in urothelial carcinoma","Stefanović V, Mitić-Zlatković M, Ignjatović I, Vlajković M, Sćepović Z.","Int Urol Nephrol. 1999;31(4):443-9. doi: 10.1023/a:1007103009313.","Stefanović V","Int Urol Nephrol","1999","2000/02/11","","","10.1023/a:1007103009313"
"27000312","Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses","Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP.","Eur J Epidemiol. 2016 Sep;31(9):811-51. doi: 10.1007/s10654-016-0138-6. Epub 2016 Mar 21.","Al-Zalabani AH","Eur J Epidemiol","2016","2016/03/23","PMC5010611","","10.1007/s10654-016-0138-6"
"2713808","Chromosome 21q22 deletion. A specific chromosome change in a new bladder cancer subgroup","Babu VR, Miles BJ, Cerney JC, Weiss L, van Dyke DL.","Cancer Genet Cytogenet. 1989 Mar;38(1):127-9. doi: 10.1016/0165-4608(89)90173-8.","Babu VR","Cancer Genet Cytogenet","1989","1989/03/01","","","10.1016/0165-4608(89)90173-8"
"8720346","[Radiologic evaluation of parietal infiltration of bladder cancer (integrated imaging: US, TC, RM) and comparison with transurethral resection (TUR)]","Gauldi GF, Ceroni AM, Burrai L, Capuano R, Polettini E.","Clin Ter. 1995 Nov;146(11):691-711.","Gauldi GF","Clin Ter","1995","1995/11/01","","",""
"21000054","The bladder biopsy; an evaluation of the cystoscopic procedure","MELICOW MM.","J Urol. 1946 Sep;56:339-48. doi: 10.1016/s0022-5347(17)69815-x.","MELICOW MM","J Urol","1946","2010/10/29","","","10.1016/s0022-5347(17)69815-x"
"16771729","Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest","Li GC, Zhang X, Pan TJ, Chen Z, Ye ZQ.","Int J Urol. 2006 May;13(5):581-6. doi: 10.1111/j.1442-2042.2006.01344.x.","Li GC","Int J Urol","2006","2006/06/15","","","10.1111/j.1442-2042.2006.01344.x"
"26620583","Idiographic quality of life assessment before radical cystectomy","Anderson CB, Rapkin B, Reaves BC, Sun AJ, Morganstern B, Dalbagni G, Donat M, Herr HW, Laudone VP, Bochner BH.","Psychooncology. 2017 Feb;26(2):206-213. doi: 10.1002/pon.4025. Epub 2015 Nov 30.","Anderson CB","Psychooncology","2017","2015/12/02","PMC5540244","NIHMS884393","10.1002/pon.4025"
"3788301","[Dedifferentiated superficial bladder cancer with invasion of the lamina propria (pT1 GIII)]","Flamm J.","Z Urol Nephrol. 1986 Sep;79(9):511-6.","Flamm J","Z Urol Nephrol","1986","1986/09/01","","",""
"675898","Does cyclophosphamide induce bladder cancer?","Pearson RM, Soloway MS.","Urology. 1978 May;11(5):437-47. doi: 10.1016/0090-4295(78)90154-1.","Pearson RM","Urology","1978","1978/05/01","","","10.1016/0090-4295(78)90154-1"
"9259084","Epidemiology and etiology of bladder cancer","Johansson SL, Cohen SM.","Semin Surg Oncol. 1997 Sep-Oct;13(5):291-8. doi: 10.1002/(sici)1098-2388(199709/10)13:5<291::aid-ssu2>3.0.co;2-8.","Johansson SL","Semin Surg Oncol","1997","1997/09/01","","","10.1002/(sici)1098-2388(199709/10)13:5<291::aid-ssu2>3.0.co;2-8"
"30176832","Robot assisted radical cystectomy versus open radical cystectomy in bladder cancer (RACE): study protocol of a non-randomized comparative effectiveness study","Wijburg CJ, Michels CTJ, Oddens JR, Grutters JPC, Witjes JA, Rovers MM.","BMC Cancer. 2018 Sep 3;18(1):861. doi: 10.1186/s12885-018-4779-6.","Wijburg CJ","BMC Cancer","2018","2018/09/05","PMC6122745","","10.1186/s12885-018-4779-6"
"23322153","Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer","Ke HL, Chen M, Ye Y, Hildebrandt MA, Wu WJ, Wei H, Huang M, Chang DW, Dinney CP, Wu X.","Carcinogenesis. 2013 May;34(5):1006-11. doi: 10.1093/carcin/bgt006. Epub 2013 Jan 14.","Ke HL","Carcinogenesis","2013","2013/01/17","PMC3643413","","10.1093/carcin/bgt006"
"1479753","[Clinical results of prophylactic intravesical chemotherapy on superficial bladder cancer using the dye exclusion assay]","Irisawa C, Aikawa K, Ogihara M, Hashimoto T, Yamaguchi O, Shiraiwa Y, Koseki K.","Nihon Hinyokika Gakkai Zasshi. 1992 Nov;83(11):1828-34. doi: 10.5980/jpnjurol1989.83.1828.","Irisawa C","Nihon Hinyokika Gakkai Zasshi","1992","1992/11/01","","","10.5980/jpnjurol1989.83.1828"
"13426657","Subtotal cystectomy in treatment of bladder cancer","BAKER R, KELLY T, PUTNAM C, TEHAN T.","Bull Georgetown Univ Med Cent. 1957 May;10(5):136-40.","BAKER R","Bull Georgetown Univ Med Cent","1957","1957/05/01","","",""
"26224479","Down-regulation of Sphk2 suppresses bladder cancer progression","Sun E, Zhang W, Wang L, Wang A, Ma C, Lei M, Zhou X, Sun Y, Lu B, Liu L, Han R.","Tumour Biol. 2016 Jan;37(1):473-8. doi: 10.1007/s13277-015-3818-z. Epub 2015 Jul 31.","Sun E","Tumour Biol","2016","2015/07/31","","","10.1007/s13277-015-3818-z"
"29055653","Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review","Kamat AM, Li R, O'Donnell MA, Black PC, Roupret M, Catto JW, Comperat E, Ingersoll MA, Witjes WP, McConkey DJ, Witjes JA.","Eur Urol. 2018 May;73(5):738-748. doi: 10.1016/j.eururo.2017.10.003. Epub 2017 Oct 18.","Kamat AM","Eur Urol","2018","2017/10/23","","","10.1016/j.eururo.2017.10.003"
"20488473","XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome","Yang J, Xu Z, Li J, Zhang R, Zhang G, Ji H, Song B, Chen Z.","J Urol. 2010 Jul;184(1):336-43. doi: 10.1016/j.juro.2010.03.044. Epub 2010 May 20.","Yang J","J Urol","2010","2010/05/22","","","10.1016/j.juro.2010.03.044"
"16407052","Re: Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer","Brenner DJ, Hall EJ.","J Urol. 2006 Feb;175(2):788-9; author reply 789. doi: 10.1016/S0022-5347(05)00174-6.","Brenner DJ","J Urol","2006","2006/01/13","","","10.1016/S0022-5347(05)00174-6"
"7917372","Radical external beam radiotherapy of urinary bladder carcinoma. An analysis of results in 500 patients","Skołyszewski J, Reinfuss M, Weiss M.","Acta Oncol. 1994;33(5):561-5. doi: 10.3109/02841869409083936.","Skołyszewski J","Acta Oncol","1994","1994/01/01","","","10.3109/02841869409083936"
"2782958","[Mortality and complications from cystectomy of bladder cancer]","Chechile G, Villavicencio H, Solé Balcells FJ.","Arch Esp Urol. 1989 May;42(4):321-4.","Chechile G","Arch Esp Urol","1989","1989/05/01","","",""
"3281363","Superficial bladder cancer treated with intravesical bacillus Calmette-Guérin or adriamycin: follow-up report","Khanna OP, Son DL, Mazer H, Read J, Nugent D, Cottone R, Heeg M, Rezvan M, Viek N, Uhlman R, et al.","Urology. 1988 Apr;31(4):287-93. doi: 10.1016/0090-4295(88)90082-9.","Khanna OP","Urology","1988","1988/04/01","","","10.1016/0090-4295(88)90082-9"
"3084057","Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer","Cant JD, Murphy WM, Soloway MS.","Cancer. 1986 Jun 1;57(11):2119-22. doi: 10.1002/1097-0142(19860601)57:11<2119::aid-cncr2820571105>3.0.co;2-p.","Cant JD","Cancer","1986","1986/06/01","","","10.1002/1097-0142(19860601)57:11<2119::aid-cncr2820571105>3.0.co;2-p"
"8529731","Five-year results of neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy plus radical cystectomy in locally advanced bladder cancer","Scattoni V, Da Pozzo L, Nava L, Broglia L, Galli L, Torelli T, Campo B, Maffezzini M, Rigatti P.","Eur Urol. 1995;28(2):102-7. doi: 10.1159/000475030.","Scattoni V","Eur Urol","1995","1995/01/01","","","10.1159/000475030"
"1787510","L-tryptophan metabolites and bladder cancer","Ebinger G, Michotte Y.","J Rheumatol. 1991 Nov;18(11):1771.","Ebinger G","J Rheumatol","1991","1991/11/01","","",""
"25531192","The need for re-TUR of the bladder in non-muscle invasive bladder cancer: risk factors of tumor persistence in re-TUR specimens","Husillos Alonso A, Rodríguez Fernández E, Herranz Amo F, López López E, Aragón Chamizo J, Ramírez Martínez D, Durán Merino R, Hernández Fernández C.","Minerva Urol Nefrol. 2014 Dec;66(4):233-40.","Husillos Alonso A","Minerva Urol Nefrol","2014","2014/12/23","","",""
"11668510","Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells","Shirakawa T, Sasaki R, Gardner TA, Kao C, Zhang ZJ, Sugimura K, Matsuo M, Kamidono S, Gotoh A.","Int J Cancer. 2001 Oct 15;94(2):282-9. doi: 10.1002/ijc.1453.","Shirakawa T","Int J Cancer","2001","2001/10/23","","","10.1002/ijc.1453"
"23775870","Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles bladder cancer study","Catsburg CE, Gago-Dominguez M, Yuan JM, Castelao JE, Cortessis VK, Pike MC, Stern MC.","Int J Cancer. 2014 Jan 1;134(1):125-35. doi: 10.1002/ijc.28331. Epub 2013 Jul 15.","Catsburg CE","Int J Cancer","2014","2013/06/19","","","10.1002/ijc.28331"
"24433358","Total cystectomy for treatment of transitional cell carcinoma of the urethra and bladder trigone in a dog","Boston S, Singh A.","Vet Surg. 2014 Mar;43(3):294-300. doi: 10.1111/j.1532-950X.2014.12104.x. Epub 2014 Jan 16.","Boston S","Vet Surg","2014","2014/01/18","","","10.1111/j.1532-950X.2014.12104.x"
"30362682","Effect of variant histology presence and squamous differentiation on oncological results and patient's survival after radical cystectomy","Sefik E, Celik S, Basmaci I, Yarımoglu S, Bozkurt IH, Yonguc T, Gunlusoy B.","Arch Ital Urol Androl. 2018 Sep 30;90(3):172-175. doi: 10.4081/aiua.2018.3.172.","Sefik E","Arch Ital Urol Androl","2018","2018/10/27","","","10.4081/aiua.2018.3.172"
"10081853","Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: results of a small series and a review of the literature","Mydlo JH, Weinstein R, Shah S, Solliday M, Macchia RJ.","J Urol. 1999 Apr;161(4):1128-32.","Mydlo JH","J Urol","1999","1999/03/19","","",""
"3186949","[Results of combined surgical-radiologic therapy of bladder cancer from the point of view of optimizing dose fractionation]","Füller J, Kob D, Fritzsche V, Möller A, Pirlich W.","Radiobiol Radiother (Berl). 1988;29(4):455-61.","Füller J","Radiobiol Radiother (Berl)","1988","1988/01/01","","",""
"29955780","Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer","Williams SB, Shan Y, Jazzar U, Mehta HB, Baillargeon JG, Huo J, Senagore AJ, Orihuela E, Tyler DS, Swanson TA, Kamat AM.","JAMA Surg. 2018 Oct 1;153(10):881-889. doi: 10.1001/jamasurg.2018.1680.","Williams SB","JAMA Surg","2018","2018/06/30","PMC6584312","","10.1001/jamasurg.2018.1680"
"29185633","[Intravesical microwave thermo-chemotherapy for the treatment of non-invasive bladder cancer]","Benacka M, Benamran DA, Wirth G, Iselin CE.","Rev Med Suisse. 2017 Nov 29;13(585):2087-2091.","Benacka M","Rev Med Suisse","2017","2017/11/30","","",""
"26231311","Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1","Rausch S, Hennenlotter J, Teepe K, Kuehs U, Aufderklamm S, Bier S, Mischinger J, Gakis G, Stenzl A, Schwentner C, Todenhöfer T.","Urol Oncol. 2015 Oct;33(10):426.e21-9. doi: 10.1016/j.urolonc.2015.06.007. Epub 2015 Jul 29.","Rausch S","Urol Oncol","2015","2015/08/02","","","10.1016/j.urolonc.2015.06.007"
"23934264","A great option for elderly patients with locally invasive bladder cancer, BOAI-CDDP-radiation (OMC regimen)","Azuma H, Inamoto T, Takahara K, Nomi H, Hirano H, Uehara H, Komura K, Minami K, Kouno J, Kotake Y, Abe H, Takagi S, Ibuki N, Yamamoto K, Narumi Y, Kiyama S.","Int J Oncol. 2013 Oct;43(4):1087-94. doi: 10.3892/ijo.2013.2058. Epub 2013 Aug 8.","Azuma H","Int J Oncol","2013","2013/08/13","","","10.3892/ijo.2013.2058"
"11834391","Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guérin: 18-year experience","Pansadoro V, Emiliozzi P, de Paula F, Scarpone P, Pansadoro A, Sternberg CN.","Urology. 2002 Feb;59(2):227-31. doi: 10.1016/s0090-4295(01)01603-x.","Pansadoro V","Urology","2002","2002/02/09","","","10.1016/s0090-4295(01)01603-x"
"29642177","Companied P16 genetic and protein status together providing useful information on the clinical outcome of urinary bladder cancer","Pu X, Zhu L, Fu Y, Fan Z, Zheng J, Zhang B, Yang J, Guan W, Wu H, Ye Q, Huang Q.","Medicine (Baltimore). 2018 Apr;97(15):e0353. doi: 10.1097/MD.0000000000010353.","Pu X","Medicine (Baltimore)","2018","2018/04/12","PMC5908565","","10.1097/MD.0000000000010353"
"1867515","[Fever and leukemoid reaction in bladder cancer: report of a case]","Pérez Arbej JA, Nogueras Gimeno MA, Martínez Pérez E, Abad Menor F, Arnaiz Esteban F, Fernández Rosaenz J, Espuela Orgaz R.","Arch Esp Urol. 1991 Apr;44(3):309-12.","Pérez Arbej JA","Arch Esp Urol","1991","1991/04/01","","",""
"981032","[Telecobaltotherapy of bladder cancer]","Kobierska A, Karnicka-Młodkowska H, Zieliński T.","Pol Przegl Chir. 1976 Oct;48(10 A):1281-7.","Kobierska A","Pol Przegl Chir","1976","1976/10/01","","",""
"26443494","Editorial Comment to Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities","Ball MW.","Int J Urol. 2016 Jan;23(1):48. doi: 10.1111/iju.12964. Epub 2015 Oct 6.","Ball MW","Int J Urol","2016","2015/10/08","","","10.1111/iju.12964"
"17542024","Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients","Kamat AM, Dinney CP, Gee JR, Grossman HB, Siefker-Radtke AO, Tamboli P, Detry MA, Robinson TL, Pisters LL.","Cancer. 2007 Jul 1;110(1):62-7. doi: 10.1002/cncr.22756.","Kamat AM","Cancer","2007","2007/06/02","","","10.1002/cncr.22756"
"26479327","Organochlorine Pesticides Exposure and Bladder Cancer: Evaluation from a Gene-Environment Perspective in a Hospital-Based Case-Control Study in the Canary Islands (Spain)","Boada LD, Henríquez-Hernández LA, Zumbado M, Almeida-González M, Álvarez-León EE, Navarro P, Luzardo OP.","J Agromedicine. 2016;21(1):34-42. doi: 10.1080/1059924X.2015.1106374.","Boada LD","J Agromedicine","2016","2015/10/20","","","10.1080/1059924X.2015.1106374"
"9102201","Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors","Cordon-Cardo C, Zhang ZF, Dalbagni G, Drobnjak M, Charytonowicz E, Hu SX, Xu HJ, Reuter VE, Benedict WF.","Cancer Res. 1997 Apr 1;57(7):1217-21.","Cordon-Cardo C","Cancer Res","1997","1997/04/01","","",""
"27196763","Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals","Tao L, Qiu J, Jiang M, Song W, Yeh S, Yu H, Zang L, Xia S, Chang C.","Mol Cancer Ther. 2016 Aug;15(8):1943-1951. doi: 10.1158/1535-7163.MCT-15-0306. Epub 2016 May 11.","Tao L","Mol Cancer Ther","2016","2016/05/20","PMC5055306","NIHMS783960","10.1158/1535-7163.MCT-15-0306"
"18640773","Editorial comment on: Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience","Svatek RS, Shariat SF.","Eur Urol. 2009 Jan;55(1):185-6. doi: 10.1016/j.eururo.2008.07.019. Epub 2008 Jul 14.","Svatek RS","Eur Urol","2009","2008/07/22","","","10.1016/j.eururo.2008.07.019"
"12887363","Determinants of quality of life of bladder cancer survivors five years after treatment in France","Matsuda T, Aptel I, Exbrayat C, Grosclaude P.","Int J Urol. 2003 Aug;10(8):423-9. doi: 10.1046/j.1442-2042.2003.00657.x.","Matsuda T","Int J Urol","2003","2003/07/31","","","10.1046/j.1442-2042.2003.00657.x"
"18372016","Mortality after urologic cancer surgery: impact of non-index case volume","Gilbert SM, Dunn RL, Miller DC, Daignault S, Ye Z, Hollenbeck BK.","Urology. 2008 May;71(5):906-10. doi: 10.1016/j.urology.2007.12.035. Epub 2008 Apr 18.","Gilbert SM","Urology","2008","2008/03/29","","","10.1016/j.urology.2007.12.035"
"25286009","Efficacy and safety of MCNA in patients with nonmuscle invasive bladder cancer at high risk for recurrence and progression after failed treatment with bacillus Calmette-Guérin","Morales A, Herr H, Steinberg G, Given R, Cohen Z, Amrhein J, Kamat AM.","J Urol. 2015 Apr;193(4):1135-43. doi: 10.1016/j.juro.2014.09.109. Epub 2014 Oct 5.","Morales A","J Urol","2015","2014/10/07","","","10.1016/j.juro.2014.09.109"
"16640017","Urine test boosts detection of recurrent bladder cancer","Hilton L.","RN. 2006 Apr;69(4):3-4.","Hilton L","RN","2006","2006/04/28","","",""
"8291161","[Occupational bladder cancer]","Hinke K, Lings S.","Ugeskr Laeger. 1994 Jan 3;156(1):62-3.","Hinke K","Ugeskr Laeger","1994","1994/01/03","","",""
"1490510","DNA flow cytometry and neo-adjuvant chemotherapy/radiotherapy in operable muscle-invasive bladder carcinoma. A preliminary report","Jacobsen AB, Berner A, Juul M, Ous S, Pettersen EO, Fosså SD.","Eur Urol. 1992;22(4):316-22. doi: 10.1159/000474779.","Jacobsen AB","Eur Urol","1992","1992/01/01","","","10.1159/000474779"
"3318088","BCG in management of superficial bladder cancer","Guinan P, Crispen R, Rubenstein M.","Urology. 1987 Dec;30(6):515-9. doi: 10.1016/0090-4295(87)90428-6.","Guinan P","Urology","1987","1987/12/01","","","10.1016/0090-4295(87)90428-6"
"23845377","Re: NMR-based metabolomics study of canine bladder cancer","Atala A.","J Urol. 2013 Aug;190(2):808. doi: 10.1016/j.juro.2013.04.084. Epub 2013 May 2.","Atala A","J Urol","2013","2013/07/13","","","10.1016/j.juro.2013.04.084"
"2718282","[The content of the carcinoembryonic antigen in the blood serum of patients with bladder tumors at various stages of combined treatment in relation to the disease stage]","Makhlin NV, Strotskiĭ AV, Ryneĭskaia ES.","Urol Nefrol (Mosk). 1989 Jan-Feb;(1):49-51.","Makhlin NV","Urol Nefrol (Mosk)","1989","1989/01/01","","",""
"21924544","Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study","Cha EK, Tirsar LA, Schwentner C, Christos PJ, Mian C, Hennenlotter J, Martini T, Stenzl A, Pycha A, Shariat SF, Schmitz-Dräger BJ.","Eur Urol. 2012 Jan;61(1):185-92. doi: 10.1016/j.eururo.2011.08.073. Epub 2011 Sep 9.","Cha EK","Eur Urol","2012","2011/09/20","PMC3628750","NIHMS452465","10.1016/j.eururo.2011.08.073"
"22505326","Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk","Liu Y, Wang H, Lin T, Wei Q, Zhi Y, Yuan F, Song B, Yang J, Chen Z.","Oncol Rep. 2012 Jul;28(1):337-45. doi: 10.3892/or.2012.1759. Epub 2012 Apr 9.","Liu Y","Oncol Rep","2012","2012/04/17","","","10.3892/or.2012.1759"
"21487231","A six-week course of bacillus Calmette-Guérin prophylaxis is insufficient to prevent tumor recurrence in nonmuscle invasive bladder cancer with strong-positive expression of p53","Oh JJ, Ji SH, Choi DK, Gong IH, Kim TH, Park DS.","Oncology. 2010;79(5-6):440-6. doi: 10.1159/000327214. Epub 2011 Apr 11.","Oh JJ","Oncology","2010","2011/04/14","","","10.1159/000327214"
"12225437","Initial report of bladder carcinoma following combined bladder-drained pancreas and kidney transplantation","Highshaw RA, Tunuguntla HS, Perez RV, Gandour-Edwards R, Evans CP.","Clin Transplant. 2002 Oct;16(5):383-6. doi: 10.1034/j.1399-0012.2002.02034.x.","Highshaw RA","Clin Transplant","2002","2002/09/13","","","10.1034/j.1399-0012.2002.02034.x"
"9180156","Effects of bacillus Calmette-Guerin and interferon-alpha-2B on human bladder cancer in vitro","Zhang Y, Khoo HE, Esuvaranathan K.","Int J Cancer. 1997 May 29;71(5):851-7. doi: 10.1002/(sici)1097-0215(19970529)71:5<851::aid-ijc25>3.0.co;2-9.","Zhang Y","Int J Cancer","1997","1997/05/29","","","10.1002/(sici)1097-0215(19970529)71:5<851::aid-ijc25>3.0.co;2-9"
"14634390","Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy","Matsumoto K, Shariat SF, Casella R, Wheeler TM, Slawin KM, Lerner SP.","J Urol. 2003 Dec;170(6 Pt 1):2248-52. doi: 10.1097/01.ju.0000094189.93805.17.","Matsumoto K","J Urol","2003","2003/11/25","","","10.1097/01.ju.0000094189.93805.17"
"8456185","Immunocytology as a possible marker to identify patients who require prophylaxis","Huland E, Schneider A, Huland H.","Recent Results Cancer Res. 1993;126:143-50. doi: 10.1007/978-3-642-84583-3_14.","Huland E","Recent Results Cancer Res","1993","1993/01/01","","","10.1007/978-3-642-84583-3_14"
"1394817","Intra-arterial adriamycin chemotherapy in combination with radiotherapy for advanced bladder cancer","Sumiyoshi Y, Uyama T, Kagawa S.","Cancer Chemother Pharmacol. 1992;30 Suppl:S5-9. doi: 10.1007/BF00686933.","Sumiyoshi Y","Cancer Chemother Pharmacol","1992","1992/01/01","","","10.1007/BF00686933"
"27282414","Bladder tumor-targeted delivery of pro-apoptotic peptide for cancer therapy","Jung HK, Kim S, Park RW, Park JY, Kim IS, Lee B.","J Control Release. 2016 Aug 10;235:259-267. doi: 10.1016/j.jconrel.2016.06.008. Epub 2016 Jun 7.","Jung HK","J Control Release","2016","2016/06/11","","","10.1016/j.jconrel.2016.06.008"
"26634848","Predicting recurrence of non-muscle-invasive bladder cancer after transurethral resection","Ðug H, Jagodić S, Ahmetović-Ðug J, Selimović Z, Sulejmanović A.","Med Glas (Zenica). 2016 Feb 1;13(1):56-61. doi: 10.17392/824-16.","Ðug H","Med Glas (Zenica)","2016","2015/12/05","","","10.17392/824-16"
"31089737","Milk and Dairy Product Consumption and Bladder Cancer Risk: A Systematic Review and Meta-Analysis of Observational Studies","Bermejo LM, López-Plaza B, Santurino C, Cavero-Redondo I, Gómez-Candela C.","Adv Nutr. 2019 May 1;10(suppl_2):S224-S238. doi: 10.1093/advances/nmy119.","Bermejo LM","Adv Nutr","2019","2019/05/16","PMC6518155","","10.1093/advances/nmy119"
"17382181","Carcinoma in situ developing in an ileal neobladder","Ide H, Kikuchi E, Shinoda K, Mukai M, Murai M.","Urology. 2007 Mar;69(3):576.e9-11. doi: 10.1016/j.urology.2007.01.073.","Ide H","Urology","2007","2007/03/27","","","10.1016/j.urology.2007.01.073"
"26328914","Diagnostic and prognostic value of bladder cancer-related transcript markers in urine","Schmidt J, Propping C, Siow WY, Lohse-Fischer A, Toma M, Baldauf-Twelker A, Hakenberg OW, Wirth MP, Fuessel S.","J Cancer Res Clin Oncol. 2016 Feb;142(2):401-14. doi: 10.1007/s00432-015-2037-8. Epub 2015 Sep 2.","Schmidt J","J Cancer Res Clin Oncol","2016","2015/09/03","","","10.1007/s00432-015-2037-8"
"20534385","[Management of non invasive bladder tumours (NMIBC)]","Wallerand H.","Bull Cancer. 2010;97 Suppl Cancer de la vessie:11-7. doi: 10.1684/bdc.2010.1105.","Wallerand H","Bull Cancer","2010","2010/06/11","","","10.1684/bdc.2010.1105"
"26799841","Comparing the Efficiency and Safety of Bipolar and Monopolar Transurethral Resection for Non-Muscle Invasive Bladder Tumors: A Systematic Review and Meta-Analysis","Cui Y, Chen H, Liu L, Chen J, Qi L, Zu X.","J Laparoendosc Adv Surg Tech A. 2016 Mar;26(3):196-202. doi: 10.1089/lap.2015.0507. Epub 2016 Jan 22.","Cui Y","J Laparoendosc Adv Surg Tech A","2016","2016/01/23","","","10.1089/lap.2015.0507"
"10640531","p53 intron 7 polymorphisms in urinary bladder cancer patients and controls. Stockholm Bladder Cancer Group","Berggren P, Hemminki K, Steineck G.","Mutagenesis. 2000 Jan;15(1):57-60. doi: 10.1093/mutage/15.1.57.","Berggren P","Mutagenesis","2000","2000/01/21","","","10.1093/mutage/15.1.57"
"28125986","Clinical analysis of small cell carcinoma of the bladder in Chinese: nine case reports and literature reviews","Chen Z, Liu Q, Chen R, Liu Z, Li M, Ling Q, Wu L, Yang J, Liu X, Wang T, Hu Z, Guo X, Wang S, Yang W, Liu J.","World J Surg Oncol. 2017 Jan 26;15(1):33. doi: 10.1186/s12957-016-1079-y.","Chen Z","World J Surg Oncol","2017","2017/01/28","PMC5270252","","10.1186/s12957-016-1079-y"
"7542189","Urinary beta-HCG in benign and malignant urinary tract diseases","Halim AB, Barakat M, el-Zayat AM, Daw M, el-Ahmady O.","Dis Markers. 1995 Mar;12(2):109-15. doi: 10.1155/1994/179287.","Halim AB","Dis Markers","1995","1995/03/01","","","10.1155/1994/179287"
"8536277","Antiproliferative effects of bacillus Calmette-Guerin and interferon alpha 2b on human bladder cancer cells in vitro","Pryor K, Stricker P, Russell P, Golovsky D, Penny R.","Cancer Immunol Immunother. 1995 Nov;41(5):309-16. doi: 10.1007/BF01517219.","Pryor K","Cancer Immunol Immunother","1995","1995/11/01","","","10.1007/BF01517219"
"16903934","Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells","Hayashi T, Nishiyama K, Shirahama T.","Int J Urol. 2006 Aug;13(8):1086-91. doi: 10.1111/j.1442-2042.2006.01485.x.","Hayashi T","Int J Urol","2006","2006/08/15","","","10.1111/j.1442-2042.2006.01485.x"
"8455255","Lymphoepithelioma of the bladder: a clinicopathological study of 3 cases","Dinney CP, Ro JY, Babaian RJ, Johnson DE.","J Urol. 1993 Apr;149(4):840-1. doi: 10.1016/s0022-5347(17)36228-6.","Dinney CP","J Urol","1993","1993/04/01","","","10.1016/s0022-5347(17)36228-6"
"9144899","The use of the BTA Test in the detection of persistent or recurrent transitional-cell cancer of the bladder","Sarosdy MF.","World J Urol. 1997;15(2):103-6. doi: 10.1007/BF02201980.","Sarosdy MF","World J Urol","1997","1997/01/01","","","10.1007/BF02201980"
"27157247","Lymphovascular invasion is associated with oncologic outcomes following radical cystectomy for squamous cell carcinoma of the urinary bladder","Spradling K, Lotan Y, Shokeir A, Abol-Enein H, Mosbah A, Morgan JB, Ghoneim M, Youssef RF.","Urol Oncol. 2016 Sep;34(9):417.e1-8. doi: 10.1016/j.urolonc.2016.03.023. Epub 2016 May 3.","Spradling K","Urol Oncol","2016","2016/05/10","","","10.1016/j.urolonc.2016.03.023"
"2218574","Preemptive (neoadjuvant) chemotherapy: can analysis of eligibility criteria, prognostic factors, and tumor staging from different trials provide valid or useful comparisons?","Raghavan D, Wallace M.","Semin Oncol. 1990 Oct;17(5):613-8.","Raghavan D","Semin Oncol","1990","1990/10/01","","",""
"9275022","Characterization of a BMS-181174-resistant human bladder cancer cell line","Xia H, Bleicher RJ, Hu X, Srivastava SK, Gupta V, Zaren HA, Singh SV.","Br J Cancer. 1997;76(4):461-6. doi: 10.1038/bjc.1997.410.","Xia H","Br J Cancer","1997","1997/01/01","PMC2227981","","10.1038/bjc.1997.410"
"17431372","Complications of radical cystectomy","Buscarini M, Pasin E, Stein JP.","Minerva Urol Nefrol. 2007 Mar;59(1):67-87.","Buscarini M","Minerva Urol Nefrol","2007","2007/04/14","","",""
"20989839","Carcinoma of the bladder associated with presence of a stone","INGLIS JM.","Br Med J. 1946 Jul 6;2:13.","INGLIS JM","Br Med J","1946","2010/10/29","","",""
"27186722","Re: Recurrence Patterns after Open and Robot-Assisted Radical Cystectomy for Bladder Cancer","Cadeddu JA.","J Urol. 2016 May;195(5):1379-1380. doi: 10.1016/j.juro.2016.02.005. Epub 2016 Feb 8.","Cadeddu JA","J Urol","2016","2016/05/18","","","10.1016/j.juro.2016.02.005"
"16583496","Quick test for recurrent bladder cancer","","Health News. 2006 Apr;12(4):13.","","Health News","2006","2006/04/04","","",""
"9613241","Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy","Xiao Z, Miller GG, McCallum TJ, Brown KM, Lown JW, Tulip J, Moore RB.","Photochem Photobiol. 1998 May;67(5):573-83.","Xiao Z","Photochem Photobiol","1998","1998/06/05","","",""
"22110197","5-azacytidine reverses drug resistance in bladder cancer cells","Ramachandran K, Gordian E, Singal R.","Anticancer Res. 2011 Nov;31(11):3757-66.","Ramachandran K","Anticancer Res","2011","2011/11/24","","",""
"29749360","Utility of cystatin C as a potential bladder tumour biomarker confirmed by surface plasmon resonance technique","Tokarzewicz A, Guszcz T, Onopiuk A, Kozlowski R, Gorodkiewicz E.","Indian J Med Res. 2018 Jan;147(1):46-50. doi: 10.4103/ijmr.IJMR_124_16.","Tokarzewicz A","Indian J Med Res","2018","2018/05/12","PMC5967216","","10.4103/ijmr.IJMR_124_16"
"8578250","Pelvic lymphadenectomy (staging) in patients with bladder cancer laparoscopic versus open approach","Poulsen J, Krarup T.","Scand J Urol Nephrol Suppl. 1995;172:19-21.","Poulsen J","Scand J Urol Nephrol Suppl","1995","1995/01/01","","",""
"21339385","Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients","Bravaccini S, Casadio V, Gunelli R, Bucchi L, Zoli W, Amadori D, Silvestrini R, Calistri D.","Ann Oncol. 2011 Oct;22(10):2294-8. doi: 10.1093/annonc/mdq740. Epub 2011 Feb 21.","Bravaccini S","Ann Oncol","2011","2011/02/23","","","10.1093/annonc/mdq740"
"29514839","Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer","Fu H, Zhu Y, Wang Y, Liu Z, Zhang J, Xie H, Fu Q, Dai B, Ye D, Xu J.","Clin Cancer Res. 2018 Jul 1;24(13):3069-3078. doi: 10.1158/1078-0432.CCR-17-2687. Epub 2018 Mar 7.","Fu H","Clin Cancer Res","2018","2018/03/09","","","10.1158/1078-0432.CCR-17-2687"
"7370935","Carcinoma in situ of the bladder","Utz DC, Farrow GM, Rife CC, Segura JW, Zincke H.","Cancer. 1980 Apr 15;45(7 Suppl):1842-8.","Utz DC","Cancer","1980","1980/04/15","","",""
"7860618","Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer","Lipponen PK, Liukkonen TJ.","J Cancer Res Clin Oncol. 1995;121(1):44-50. doi: 10.1007/BF01202728.","Lipponen PK","J Cancer Res Clin Oncol","1995","1995/01/01","","","10.1007/BF01202728"
"16418465","Surveillance for recurrent bladder cancer using a point-of-care proteomic assay","Grossman HB, Soloway M, Messing E, Katz G, Stein B, Kassabian V, Shen Y.","JAMA. 2006 Jan 18;295(3):299-305. doi: 10.1001/jama.295.3.299.","Grossman HB","JAMA","2006","2006/01/19","","","10.1001/jama.295.3.299"
"25208939","Reply to sarcopenia is more than simply documenting low skeletal muscle mass","Tollefson MK, Psutka SP.","Cancer. 2015 Jan 1;121(1):159-60. doi: 10.1002/cncr.29017. Epub 2014 Sep 10.","Tollefson MK","Cancer","2015","2014/09/12","","","10.1002/cncr.29017"
"24284101","Porphyrins as urinary biomarkers for bladder cancer after 5-aminolevulinic acid (ALA) administration: the potential of photodynamic screening for tumors","Inoue K, Ota U, Ishizuka M, Kawada C, Fukuhara H, Shuin T, Okura I, Tanaka T, Ogura S.","Photodiagnosis Photodyn Ther. 2013 Dec;10(4):484-9. doi: 10.1016/j.pdpdt.2013.05.002. Epub 2013 Jun 10.","Inoue K","Photodiagnosis Photodyn Ther","2013","2013/11/29","","","10.1016/j.pdpdt.2013.05.002"
"6231971","Changes in compensation for occupationally induced bladder cancer","Glashan RW.","Br Med J (Clin Res Ed). 1984 Apr 21;288(6425):1181-2. doi: 10.1136/bmj.288.6425.1181.","Glashan RW","Br Med J (Clin Res Ed)","1984","1984/04/21","PMC1441350","","10.1136/bmj.288.6425.1181"
"30570877","MiR-194-5p inhibits cell migration and invasion in bladder cancer by targeting E2F3","Wang Y, Sun G, Wang C, Guo W, Tang Q, Wang M.","J BUON. 2018 Sep-Oct;23(5):1492-1499.","Wang Y","J BUON","2018","2018/12/21","","",""
"21052815","Reduction in arsenic intake from water has different impacts on lung cancer and bladder cancer in an arseniasis endemic area in Taiwan","Su CC, Lu JL, Tsai KY, Lian IeB.","Cancer Causes Control. 2011 Jan;22(1):101-8. doi: 10.1007/s10552-010-9679-2. Epub 2010 Nov 5.","Su CC","Cancer Causes Control","2011","2010/11/06","","","10.1007/s10552-010-9679-2"
"24840869","Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States","Apolo AB, Kim JW, Bochner BH, Steinberg SM, Bajorin DF, Kelly WK, Agarwal PK, Koppie TM, Kaag MG, Quinn DI, Vogelzang NJ, Sridhar SS.","Urol Oncol. 2014 Jul;32(5):637-44. doi: 10.1016/j.urolonc.2013.12.012. Epub 2014 May 16.","Apolo AB","Urol Oncol","2014","2014/05/21","PMC6771274","NIHMS1038426","10.1016/j.urolonc.2013.12.012"
"18397675","[New therapies for urologic cancer diseases. The Danish Society of Urology]","Lund L, Borre M, Hermann GG, Svolgaard N; Dansk Urologisk Selskab.","Ugeskr Laeger. 2008 Mar 17;170(12):1057.","Lund L","Ugeskr Laeger","2008","2008/04/10","","",""
"4296749","Mixed differentiation of primary carcinoma of the urinary bladder","Grace DA, Winter CC.","Cancer. 1968 Jun;21(6):1239-43. doi: 10.1002/1097-0142(196806)21:6<1239::aid-cncr2820210627>3.0.co;2-e.","Grace DA","Cancer","1968","1968/06/01","","","10.1002/1097-0142(196806)21:6<1239::aid-cncr2820210627>3.0.co;2-e"
"11692897","Role of ultrasonography and urinary cytology in diagnosing recurrence of superficial urinary bladder cancer compared to cystoscopy","Roy MK, Islam MF, Kibria SA.","Bangladesh Med Res Counc Bull. 2001 Apr;27(1):23-32.","Roy MK","Bangladesh Med Res Counc Bull","2001","2001/11/06","","",""
"25330156","MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3","Xiu Y, Liu Z, Xia S, Jin C, Yin H, Zhao W, Wu Q.","PLoS One. 2014 Oct 16;9(10):e109734. doi: 10.1371/journal.pone.0109734. eCollection 2014.","Xiu Y","PLoS One","2014","2014/10/21","PMC4199610","","10.1371/journal.pone.0109734"
"22705039","Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis","Zhu Z, Shen Z, Lu Y, Zhong S, Xu C.","Diabetes Res Clin Pract. 2012 Oct;98(1):159-63. doi: 10.1016/j.diabres.2012.05.006. Epub 2012 Jun 16.","Zhu Z","Diabetes Res Clin Pract","2012","2012/06/19","","","10.1016/j.diabres.2012.05.006"
"24223213","Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer","Niedworok C, Röck K, Kretschmer I, Freudenberger T, Nagy N, Szarvas T, Vom Dorp F, Reis H, Rübben H, Fischer JW.","PLoS One. 2013 Nov 6;8(11):e80084. doi: 10.1371/journal.pone.0080084. eCollection 2013.","Niedworok C","PLoS One","2013","2013/11/14","PMC3819308","","10.1371/journal.pone.0080084"
"27035227","MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1","Wu D, Niu X, Pan H, Zhou Y, Qu P, Zhou J.","Mol Med Rep. 2016 May;13(5):4379-85. doi: 10.3892/mmr.2016.5055. Epub 2016 Mar 28.","Wu D","Mol Med Rep","2016","2016/04/02","","","10.3892/mmr.2016.5055"
"17431810","Case report: differential diagnosis of isolated iliac lymphadenopathy following Bacillus Calmette-Guérin treatment for high-risk superficial bladder cancer","Biers SM, Di Marco A, Mostafid AH.","Int Urol Nephrol. 2007;39(4):1039-41. doi: 10.1007/s11255-007-9187-9. Epub 2007 Mar 13.","Biers SM","Int Urol Nephrol","2007","2007/04/14","","","10.1007/s11255-007-9187-9"
"14713761","Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy","Slaton JW, Millikan R, Inoue K, Karashima T, Czerniak B, Shen Y, Yang Y, Benedict WF, Dinney CP.","J Urol. 2004 Feb;171(2 Pt 1):570-4. doi: 10.1097/01.ju.0000108845.91485.20.","Slaton JW","J Urol","2004","2004/01/10","","","10.1097/01.ju.0000108845.91485.20"
"18380817","Clinical outcomes of bacillus Calmette-Guérin instillation therapy for carcinoma in situ of urinary bladder","Takenaka A, Yamada Y, Miyake H, Hara I, Fujisawa M.","Int J Urol. 2008 Apr;15(4):309-13. doi: 10.1111/j.1442-2042.2008.02012.x.","Takenaka A","Int J Urol","2008","2008/04/03","","","10.1111/j.1442-2042.2008.02012.x"
"14991581","Bladder cancer risk and personal hair dye use","Andrew AS, Schned AR, Heaney JA, Karagas MR.","Int J Cancer. 2004 Apr 20;109(4):581-6. doi: 10.1002/ijc.11729.","Andrew AS","Int J Cancer","2004","2004/03/03","","","10.1002/ijc.11729"
"1636226","Superficial bladder cancer","","Urol Clin North Am. 1992 Aug;19(3):421-620.","","Urol Clin North Am","1992","1992/08/01","","",""
"21425156","Diabetes and risk of bladder cancer: evidence from a case-control study in New England","MacKenzie T, Zens MS, Ferrara A, Schned A, Karagas MR.","Cancer. 2011 Apr 1;117(7):1552-6. doi: 10.1002/cncr.25641. Epub 2010 Nov 8.","MacKenzie T","Cancer","2011","2011/03/23","PMC3117102","NIHMS217053","10.1002/cncr.25641"
"6342702","Use of the tumour colony assay in the evaluation of patients with bladder cancer","Niell HB, Soloway MS.","Br J Urol. 1983 Jun;55(3):271-4. doi: 10.1111/j.1464-410x.1983.tb03296.x.","Niell HB","Br J Urol","1983","1983/06/01","","","10.1111/j.1464-410x.1983.tb03296.x"
"24791782","Incidence and risk factors of 30-day early and 90-day late morbidity and mortality of radical cystectomy during a 13-year follow-up: a comparative propensity-score matched analysis of complications between neobladder and ileal conduit","Kim SH, Yu A, Jung JH, Lee YJ, Lee ES.","Jpn J Clin Oncol. 2014 Jul;44(7):677-85. doi: 10.1093/jjco/hyu051. Epub 2014 May 3.","Kim SH","Jpn J Clin Oncol","2014","2014/05/06","","","10.1093/jjco/hyu051"
"9263625","Time for a change","Hryniuk W.","Cancer J Sci Am. 1997 Jul-Aug;3(4):209-10.","Hryniuk W","Cancer J Sci Am","1997","1997/07/01","","",""
"24931270","Micropapillary bladder cancer: current treatment patterns and review of the literature","Willis DL, Flaig TW, Hansel DE, Milowsky MI, Grubb RL, Al-Ahmadie HA, Plimack ER, Koppie TM, McConkey DJ, Dinney CP, Hoffman VA, Droller MJ, Messing E, Kamat AM.","Urol Oncol. 2014 Aug;32(6):826-32. doi: 10.1016/j.urolonc.2014.01.020. Epub 2014 Jun 13.","Willis DL","Urol Oncol","2014","2014/06/17","PMC4687398","NIHMS741049","10.1016/j.urolonc.2014.01.020"
"13919109","[Studies on urogenital tumors. 8. Clinical and pathological observations in bladder cancer]","TAKAI S, KODAMA N, IGAWA K.","Sapporo Igaku Zasshi. 1961 May-Jun;19:388-402.","TAKAI S","Sapporo Igaku Zasshi","1961","1961/05/01","","",""
"9679939","Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines","Droller MJ.","J Urol. 1998 Aug;160(2):618. doi: 10.1016/s0022-5347(01)62973-2.","Droller MJ","J Urol","1998","1998/07/29","","","10.1016/s0022-5347(01)62973-2"
"30224344","Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer","Seiler R, Gibb EA, Wang NQ, Oo HZ, Lam HM, van Kessel KE, Voskuilen CS, Winters B, Erho N, Takhar MM, Douglas J, Vakar-Lopez F, Crabb SJ, van Rhijn BWG, Fransen van de Putte EE, Zwarthoff EC, Thalmann GN, Davicioni E, Boormans JL, Dall'Era M, van der Heijden MS, Wright JL, Black PC.","Clin Cancer Res. 2019 Aug 15;25(16):5082-5093. doi: 10.1158/1078-0432.CCR-18-1106. Epub 2018 Sep 17.","Seiler R","Clin Cancer Res","2019","2018/09/19","","","10.1158/1078-0432.CCR-18-1106"
"7941172","[Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?]","Kriegmair M, Waidelich R, Baumgartner R, Lumper W, Ehsan A, Hofstetter A.","Urologe A. 1994 Jul;33(4):276-80.","Kriegmair M","Urologe A","1994","1994/07/01","","",""
"3232560","[Value of radical cystectomy in the treatment of infiltrating bladder cancer]","Pons R, Chéchile G, Sarroca J, Algaba F, Zungri E.","Actas Urol Esp. 1988 Nov-Dec;12(6):540-3.","Pons R","Actas Urol Esp","1988","1988/11/01","","",""
"990829","Cigarette smoking and cancer of bladder and lung","Dische S, Saunders MI, Lee M, Bennett MH.","Br Med J. 1976 Nov 13;2(6045):1174-5. doi: 10.1136/bmj.2.6045.1174.","Dische S","Br Med J","1976","1976/11/13","PMC1689550","","10.1136/bmj.2.6045.1174"
"9120914","Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer","Neulander E, Kaneti J, Chaimovitz C, Sion-Vardy N, Douvdevani A.","J Urol. 1997 Apr;157(4):1254-8; discussion 1258-9.","Neulander E","J Urol","1997","1997/04/01","","",""
"13193195","The relation of circumferential lymphatic spread of bladder cancer to indications for specific surgical treatment","BAKER R.","Med Ann Dist Columbia. 1954 Sep;23(9):475-9; passim.","BAKER R","Med Ann Dist Columbia","1954","1954/09/01","","",""
"17582933","Glitazones and bladder cancer","","Prescrire Int. 2007 Jun;16(89):113.","","Prescrire Int","2007","2007/06/23","","",""
"28345451","The impact of advanced proteomics in the search for markers and therapeutic targets of bladder cancer","Zhang H, Fan Y, Xia L, Gao C, Tong X, Wang H, Sun L, Ji T, Jin M, Gu B, Fan B.","Tumour Biol. 2017 Mar;39(3):1010428317691183. doi: 10.1177/1010428317691183.","Zhang H","Tumour Biol","2017","2017/03/28","","","10.1177/1010428317691183"
"23070389","[Solitary adrenal metastasis of bladder carcinoma : a case report]","Honda M, Suzuki K, Sugaya S, Kuruma H, Abe M, Koshitaka Y, Hasegawa Y, Kondo N, Egawa S.","Hinyokika Kiyo. 2012 Sep;58(9):495-7.","Honda M","Hinyokika Kiyo","2012","2012/10/17","","",""
"20610281","Considerations on implementing diagnostic markers into clinical decision making in bladder cancer","Lotan Y, Shariat SF, Schmitz-Dräger BJ, Sanchez-Carbayo M, Jankevicius F, Racioppi M, Minner SJ, Stöhr B, Bassi PF, Grossman HB.","Urol Oncol. 2010 Jul-Aug;28(4):441-8. doi: 10.1016/j.urolonc.2009.11.004.","Lotan Y","Urol Oncol","2010","2010/07/09","","","10.1016/j.urolonc.2009.11.004"
"25314078","Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors","Shin K, Lim A, Zhao C, Sahoo D, Pan Y, Spiekerkoetter E, Liao JC, Beachy PA.","Cancer Cell. 2014 Oct 13;26(4):521-33. doi: 10.1016/j.ccell.2014.09.001.","Shin K","Cancer Cell","2014","2014/10/15","PMC4326077","NIHMS632332","10.1016/j.ccell.2014.09.001"
"8770464","A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos","Kannio A, Ridanpää M, Koskinen H, Partanen T, Anttila S, Collan Y, Hietanen E, Vainio H, Husgafvel-Pursiainen K.","Cancer Epidemiol Biomarkers Prev. 1996 Jan;5(1):33-9.","Kannio A","Cancer Epidemiol Biomarkers Prev","1996","1996/01/01","","",""
"19468015","Marital status and survival following bladder cancer","Datta GD, Neville BA, Kawachi I, Datta NS, Earle CC.","J Epidemiol Community Health. 2009 Oct;63(10):807-13. doi: 10.1136/jech.2008.082438. Epub 2009 May 24.","Datta GD","J Epidemiol Community Health","2009","2009/05/27","","","10.1136/jech.2008.082438"
"27387124","Single-cell Sequencing Reveals Variants in ARID1A, GPRC5A and MLL2 Driving Self-renewal of Human Bladder Cancer Stem Cells","Yang Z, Li C, Fan Z, Liu H, Zhang X, Cai Z, Xu L, Luo J, Huang Y, He L, Liu C, Wu S.","Eur Urol. 2017 Jan;71(1):8-12. doi: 10.1016/j.eururo.2016.06.025. Epub 2016 Jul 4.","Yang Z","Eur Urol","2017","2016/07/09","","","10.1016/j.eururo.2016.06.025"
"19757694","Predictors of lymph node involvement in bladder cancer treated with radical cystectomy","Alam Z, Ather MH, Jamshaid A, Siddiqui KM, Sulaiman MN.","J Pak Med Assoc. 2009 Aug;59(8):516-9.","Alam Z","J Pak Med Assoc","2009","2009/09/18","","",""
"30654801","Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model","Furuya H, Chan OTM, Pagano I, Zhu C, Kim N, Peres R, Hokutan K, Alter S, Rhode P, Rosser CJ.","J Transl Med. 2019 Jan 17;17(1):29. doi: 10.1186/s12967-019-1778-6.","Furuya H","J Transl Med","2019","2019/01/19","PMC6337786","","10.1186/s12967-019-1778-6"
"15148768","[The significance of urine cytology three consecutive days after transurethral resection as a predictor of superficial bladder cancer recurrence]","Yumura Y, Takase K, Kato Y, Hamano A, Mikata K, Ogo Y, Noguchi S, Satomi Y.","Hinyokika Kiyo. 2004 Mar;50(3):171-6.","Yumura Y","Hinyokika Kiyo","2004","2004/05/20","","",""
"12111185","Influence of pertussis toxin on superficial bladder carcinoma in rats","Lümmen G, Sperling H, Eisenhardt A, vom Dorp F, Otto T, Rübben H.","Urol Res. 2002 Jul;30(3):199-203. doi: 10.1007/s00240-002-0250-9. Epub 2002 Jun 4.","Lümmen G","Urol Res","2002","2002/07/12","","","10.1007/s00240-002-0250-9"
"14726966","Anterior urethral recurrence of superficial bladder cancer: its clinical significance","Saika T, Tsushima T, Nasu Y, Arata R, Kaku H, Akebi N, Kusaka N, Kumon H.","Acta Med Okayama. 2003 Dec;57(6):293-7. doi: 10.18926/AMO/32815.","Saika T","Acta Med Okayama","2003","2004/01/17","","","10.18926/AMO/32815"
"30887202","Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center","Barchetti G, Simone G, Ceravolo I, Salvo V, Campa R, Del Giudice F, De Berardinis E, Buccilli D, Catalano C, Gallucci M, Catto JWF, Panebianco V.","Eur Radiol. 2019 Oct;29(10):5498-5506. doi: 10.1007/s00330-019-06117-8. Epub 2019 Mar 18.","Barchetti G","Eur Radiol","2019","2019/03/20","","","10.1007/s00330-019-06117-8"
"3972885","Proliferative pattern of urothelial bladder cancer and urothelial atypias","Helpap B, Schwabe HW, Adolphs HD.","J Cancer Res Clin Oncol. 1985;109(1):46-54. doi: 10.1007/BF01884254.","Helpap B","J Cancer Res Clin Oncol","1985","1985/01/01","","","10.1007/BF01884254"
"30284731","Micronuclei frequency in urothelial cells of bladder cancer patients, as a biomarker of prognosis","Espinoza F, Cecchini L, Morote J, Marcos R, Pastor S.","Environ Mol Mutagen. 2019 Mar;60(2):168-173. doi: 10.1002/em.22252. Epub 2018 Oct 4.","Espinoza F","Environ Mol Mutagen","2019","2018/10/05","","","10.1002/em.22252"
"20005748","The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy","Guzzo TJ, McNeil BK, Bivalacqua TJ, Elliott DJ, Sokoll LJ, Schoenberg MP.","Urol Oncol. 2012 Jan-Feb;30(1):44-8. doi: 10.1016/j.urolonc.2009.10.008. Epub 2009 Dec 16.","Guzzo TJ","Urol Oncol","2012","2009/12/17","","","10.1016/j.urolonc.2009.10.008"
"3756846","Susceptibility in urinary bladder cancer: acetyltransferase phenotypes and related risk factors","Mommsen S, Aagaard J.","Cancer Lett. 1986 Aug;32(2):199-205. doi: 10.1016/0304-3835(86)90120-5.","Mommsen S","Cancer Lett","1986","1986/08/01","","","10.1016/0304-3835(86)90120-5"
"9102628","[Long-term experience with prophylactic BCG therapy of high risk patients with superficial bladder tumors]","Prekopp G, Kiss T.","Orv Hetil. 1997 Mar 2;138(9):531-5.","Prekopp G","Orv Hetil","1997","1997/03/02","","",""
"24112045","Novel multisensor probe for monitoring bladder temperature during locoregional chemohyperthermia for nonmuscle-invasive bladder cancer: technical feasibility study","Cordeiro ER, Geijsen DE, Zum Vörde Sive Vörding PJ, Schooneveldt G, Sijbrands J, Hulshof MC, de la Rosette J, de Reijke TM, Crezee H.","J Endourol. 2013 Dec;27(12):1504-9. doi: 10.1089/end.2013.0179. Epub 2013 Oct 10.","Cordeiro ER","J Endourol","2013","2013/10/12","PMC3869465","","10.1089/end.2013.0179"
"9749072","[Treatment of cancer of the bladder in Québec. Results of a multicenter survey]","Brochet F.","Cancer Radiother. 1998 Apr;2 Suppl 1:17s-18s.","Brochet F","Cancer Radiother","1998","1998/09/28","","",""
"27316642","Controversial roles played by toll like receptor 4 in urinary bladder cancer; A systematic review","Afsharimoghaddam A, Soleimani M, Lashay A, Dehghani M, Sepehri Z.","Life Sci. 2016 Aug 1;158:31-6. doi: 10.1016/j.lfs.2016.06.013. Epub 2016 Jun 15.","Afsharimoghaddam A","Life Sci","2016","2016/06/19","","","10.1016/j.lfs.2016.06.013"
"18578665","Is there a role for FISH in the management and surveillance of patients with upper tract transitional-cell carcinoma?","Chen AA, Grasso M.","J Endourol. 2008 Jun;22(6):1371-4. doi: 10.1089/end.2008.0096.","Chen AA","J Endourol","2008","2008/06/27","","","10.1089/end.2008.0096"
"11204488","Oxidative stress of red blood cells during Bacillus Calmette-Guerin intravesical instillations","Mitropoulos D, Deliconstantinos G, Zervas A, Giannopoulos A, Kyriakou G, Dimopoulos C.","In Vivo. 2000 Nov-Dec;14(6):721-4.","Mitropoulos D","In Vivo","2000","2001/02/24","","",""
"2464713","[Carcinoembryonic antigen in tumor tissue and urine in cases with primary bladder cancer--a study by immunogold-silver staining and radioimmunoassay]","Kawano S.","Nihon Hinyokika Gakkai Zasshi. 1988 Mar;79(3):469-74. doi: 10.5980/jpnjurol1928.79.3_469.","Kawano S","Nihon Hinyokika Gakkai Zasshi","1988","1988/03/01","","","10.5980/jpnjurol1928.79.3_469"
"14754444","Rhenium-188 and copper-67 radiopharmaceuticals for the treatment of bladder cancer","Frier M.","Mini Rev Med Chem. 2004 Jan;4(1):61-8. doi: 10.2174/1389557043487510.","Frier M","Mini Rev Med Chem","2004","2004/02/03","","","10.2174/1389557043487510"
"23865317","[Long-term anti-cancer implants inhibiting the activity of tumor growth in animal models]","Yu M, Du Z, Xue J, Guo H, Wang R, Xiong W, Li C.","Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013 Jun;30(3):552-5.","Yu M","Sheng Wu Yi Xue Gong Cheng Xue Za Zhi","2013","2013/07/20","","",""
"16469039","The effect of serotonin and serotonin antagonists on bladder cancer cell proliferation","Siddiqui EJ, Shabbir MA, Mikhailidis DP, Mumtaz FH, Thompson CS.","BJU Int. 2006 Mar;97(3):634-9. doi: 10.1111/j.1464-410X.2006.06056.x.","Siddiqui EJ","BJU Int","2006","2006/02/14","","","10.1111/j.1464-410X.2006.06056.x"
"11547095","Re: Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach","John H, Hauri D.","J Urol. 2001 Oct;166(4):1402.","John H","J Urol","2001","2001/09/08","","",""
"15300146","Fluorescence cystoscopy and bladder surveillance","Joudi FN, Konety BR.","Curr Opin Urol. 2004 Sep;14(5):265-70. doi: 10.1097/00042307-200409000-00004.","Joudi FN","Curr Opin Urol","2004","2004/08/10","","","10.1097/00042307-200409000-00004"
"12954582","Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumours","Santos L, Costa C, Pereira S, Koch M, Amaro T, Cardoso F, Guimarães T, Bento MJ, Lobo F, Pinto S, Lopes C.","Ann Oncol. 2003 Sep;14(9):1419-24. doi: 10.1093/annonc/mdg377.","Santos L","Ann Oncol","2003","2003/09/05","","","10.1093/annonc/mdg377"
"8131020","The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Members of the Dutch South East Cooperative Urological Group","Witjes JA, Kiemeney LA, Schaafsma HE, Debruyn FM.","Br J Urol. 1994 Feb;73(2):172-6. doi: 10.1111/j.1464-410x.1994.tb07487.x.","Witjes JA","Br J Urol","1994","1994/02/01","","","10.1111/j.1464-410x.1994.tb07487.x"
"25895761","Re: Risk of fracture after radical cystectomy and urinary diversion for bladder cancer","Penson DF.","J Urol. 2015 May;193(5):1518. doi: 10.1016/j.juro.2015.02.061. Epub 2015 Feb 17.","Penson DF","J Urol","2015","2015/04/22","","","10.1016/j.juro.2015.02.061"
"27091055","Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population","Hua Q, Lv X, Gu X, Chen Y, Chu H, Du M, Gong W, Wang M, Zhang Z.","Mutagenesis. 2016 Sep;31(5):531-8. doi: 10.1093/mutage/gew018. Epub 2016 Apr 18.","Hua Q","Mutagenesis","2016","2016/04/20","","","10.1093/mutage/gew018"
"14322133","[GENERAL CONSIDERATIONS ON THE TREATMENT OF BLADDER CANCER]","COUVELAIRE R.","J Urol Nephrol (Paris). 1965 Jun;71:453-64.","COUVELAIRE R","J Urol Nephrol (Paris)","1965","1965/06/01","","",""
"18191762","Health risk behaviors: examining social inequalities in bladder and colorectal cancers","Goy J, Rosenberg MW, King WD.","Ann Epidemiol. 2008 Feb;18(2):156-62. doi: 10.1016/j.annepidem.2007.09.004.","Goy J","Ann Epidemiol","2008","2008/01/15","","","10.1016/j.annepidem.2007.09.004"
"23088986","Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancer","Urquidi V, Goodison S, Ross S, Chang M, Dai Y, Rosser CJ.","J Urol. 2012 Dec;188(6):2377-83. doi: 10.1016/j.juro.2012.07.094. Epub 2012 Oct 22.","Urquidi V","J Urol","2012","2012/10/24","PMC4013779","NIHMS517450","10.1016/j.juro.2012.07.094"
"2142808","[Neoadjuvant chemotherapy of locally advanced tumors of the bladder: preliminary experience]","Ruoppolo M, Bellorofonte C, Gritti A, Gozo M, Ferri PM, Tura M, Zaatar C, Tiraboschi B, Morosini D, Dell'Acqua S, et al.","Arch Ital Urol Nefrol Androl. 1990 Jun;62(2):243-8.","Ruoppolo M","Arch Ital Urol Nefrol Androl","1990","1990/06/01","","",""
"8834553","The case-control study as data missing by design: estimating risk differences","Wacholder S.","Epidemiology. 1996 Mar;7(2):144-50. doi: 10.1097/00001648-199603000-00007.","Wacholder S","Epidemiology","1996","1996/03/01","","","10.1097/00001648-199603000-00007"
"24901005","Bladder cancer and urothelial impairment: the role of TRPV1 as potential drug target","Mistretta F, Buffi NM, Lughezzani G, Lista G, Larcher A, Fossati N, Abrate A, Dell'Oglio P, Montorsi F, Guazzoni G, Lazzeri M.","Biomed Res Int. 2014;2014:987149. doi: 10.1155/2014/987149. Epub 2014 May 8.","Mistretta F","Biomed Res Int","2014","2014/06/06","PMC4034493","","10.1155/2014/987149"
"9679581","[Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group]","Uchida K, Takeshima H, Kikuchi K, Shimazui T, Miyanaga N, Kawai K, Akaza H, Tsuchiya A, Noguchi R, Hattori K, Manabe F, Matsuki K, Suzuki R, Ishikawa S, Kondo F, Kobayashi T, Koiso K.","Gan To Kagaku Ryoho. 1998 Jul;25(8):1179-87.","Uchida K","Gan To Kagaku Ryoho","1998","1998/07/29","","",""
"8535672","Further clinical experience with the ileal W-neobladder and a serous-lined extramural tunnel for orthotopic substitution","Abol-Enein H, Ghoneim MA.","Br J Urol. 1995 Nov;76(5):558-64. doi: 10.1111/j.1464-410x.1995.tb07778.x.","Abol-Enein H","Br J Urol","1995","1995/11/01","","","10.1111/j.1464-410x.1995.tb07778.x"
"29556618","Improved diagnosis and long-term recurrence rate reduction for non-muscle-invasive bladder cancer patients undergoing fluorescent hexylaminolevulinate photodynamic diagnosis","Drăgoescu PO, Tudorache Ş, Drocaş AI, Mitroi G, Pănuş A, Drăgoescu NAM, Meşină C, Mititelu CD, Stănculescu AD, Mohamed G, Tomescu PI.","Rom J Morphol Embryol. 2017;58(4):1279-1283.","Drăgoescu PO","Rom J Morphol Embryol","2017","2018/03/21","","",""
"14624348","[Interdisciplinary oncologic after-care exemplified by second primary tumors after bladder carcinoma]","Klotz T, Hofstädter F, Gerken M.","Urologe A. 2003 Nov;42(11):1485-90. doi: 10.1007/s00120-003-0396-2. Epub 2003 Jun 25.","Klotz T","Urologe A","2003","2003/11/19","","","10.1007/s00120-003-0396-2"
"19913255","Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer","Shariat SF, Chade DC, Karakiewicz PI, Ashfaq R, Isbarn H, Fradet Y, Bastian PJ, Nielsen ME, Capitanio U, Jeldres C, Montorsi F, Lerner SP, Sagalowsky AI, Cote RJ, Lotan Y.","J Urol. 2010 Jan;183(1):68-75. doi: 10.1016/j.juro.2009.08.115.","Shariat SF","J Urol","2010","2009/11/17","","","10.1016/j.juro.2009.08.115"
"25175170","ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder","Faraj SF, Chaux A, Gonzalez-Roibon N, Munari E, Ellis C, Driscoll T, Schoenberg MP, Bivalacqua TJ, Shih IeM, Netto GJ.","Hum Pathol. 2014 Nov;45(11):2233-9. doi: 10.1016/j.humpath.2014.07.003. Epub 2014 Jul 23.","Faraj SF","Hum Pathol","2014","2014/09/02","","","10.1016/j.humpath.2014.07.003"
"21005425","Total cystectomy for carcinoma","GRAVES RC, THOMSON RS.","Trans Am Assoc Genitourin Surg. 1945;37:73-92.","GRAVES RC","Trans Am Assoc Genitourin Surg","1945","2010/10/29","","",""
"21854534","Evans blue as a selective dye marker for white-light diagnosis of non-muscle-invasive bladder cancer: an in vitro study","Roelants M, Huygens A, Crnolatac I, Van Cleynenbreugel B, Lerut E, Van Poppel H, de Witte PA.","BJU Int. 2012 Jan;109(2):300-5. doi: 10.1111/j.1464-410X.2011.10465.x. Epub 2011 Aug 19.","Roelants M","BJU Int","2012","2011/08/23","","","10.1111/j.1464-410X.2011.10465.x"
"7609100","The loss of retinoblastoma gene in association with c-myc and transforming growth factor-beta 1 gene expression in human bladder cancer","Kubota Y, Miyamoto H, Noguchi S, Shuin T, Kitamura H, Xu HJ, Hu SX, Benedict WF.","J Urol. 1995 Aug;154(2 Pt 1):371-4. doi: 10.1097/00005392-199508000-00009.","Kubota Y","J Urol","1995","1995/08/01","","","10.1097/00005392-199508000-00009"
"22177145","Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers","Shariat SF, Chromecki TF, Cha EK, Karakiewicz PI, Sun M, Fradet Y, Isbarn H, Scherr DS, Bastian PJ, Pummer K, Fajkovic H, Sagalowsky AI, Ashfaq R, Doblinger M, Cote RJ, Lotan Y.","J Urol. 2012 Feb;187(2):457-62. doi: 10.1016/j.juro.2011.10.031. Epub 2011 Dec 15.","Shariat SF","J Urol","2012","2011/12/20","","","10.1016/j.juro.2011.10.031"
"23292999","Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis","van Roekel EH, Cheng KK, James ND, Wallace DM, Billingham LJ, Murray PG, Bryan RT, Zeegers MP.","Int J Cancer. 2013 Jul 15;133(2):446-54. doi: 10.1002/ijc.28017. Epub 2013 Feb 13.","van Roekel EH","Int J Cancer","2013","2013/01/08","","","10.1002/ijc.28017"
"30551873","Circular RNA circMTO1 suppresses bladder cancer metastasis by sponging miR-221 and inhibiting epithelial-to-mesenchymal transition","Li Y, Wan B, Liu L, Zhou L, Zeng Q.","Biochem Biophys Res Commun. 2019 Jan 22;508(4):991-996. doi: 10.1016/j.bbrc.2018.12.046. Epub 2018 Dec 11.","Li Y","Biochem Biophys Res Commun","2019","2018/12/16","","","10.1016/j.bbrc.2018.12.046"
"22732640","[Intradiverticular bladder tumours: review of the Cancer Committee of the French Association of Urology]","Neuzillet Y, Comperat E, Rouprêt M, Larre S, Roy C, Quintens H, Houede N, Pignot G, Wallerand H, Soulie M, Pfister C; Membres du Comité de cancérologie de l’Association française d’urologie.","Prog Urol. 2012 Jul;22(9):495-502. doi: 10.1016/j.purol.2012.03.008. Epub 2012 Apr 28.","Neuzillet Y","Prog Urol","2012","2012/06/27","","","10.1016/j.purol.2012.03.008"
"29281876","Concentration- Dependent Effects of Curcumin on 5-Fluorouracil Efficacy in Bladder Cancer Cells","Afsharmoghadam N, Haghighatian Z, Mazdak H, Mirkheshti N, Mehrabi Koushki R, Alavi SA.","Asian Pac J Cancer Prev. 2017 Dec 28;18(12):3225-3230. doi: 10.22034/APJCP.2017.18.12.3225.","Afsharmoghadam N","Asian Pac J Cancer Prev","2017","2017/12/29","PMC5980875","","10.22034/APJCP.2017.18.12.3225"
"28382976","Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer","Tan G, Wang H, Yuan J, Qin W, Dong X, Wu H, Meng P.","Sci Rep. 2017 Apr 6;7:46176. doi: 10.1038/srep46176.","Tan G","Sci Rep","2017","2017/04/07","PMC5382774","","10.1038/srep46176"
"27266688","[Clinical research of second resection on early stage primary bladder adenocarcinoma and literature review]","Xing QW, Wu Y, Cai B, Ma LM, Cheng B, Zhang YP.","Zhonghua Yi Xue Za Zhi. 2016 May 31;96(20):1585-7. doi: 10.3760/cma.j.issn.0376-2491.2016.20.009.","Xing QW","Zhonghua Yi Xue Za Zhi","2016","2016/06/09","","","10.3760/cma.j.issn.0376-2491.2016.20.009"
"23376707","Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder","Kluth LA, Xylinas E, Crivelli JJ, Passoni N, Comploj E, Pycha A, Chrystal J, Sun M, Karakiewicz PI, Gontero P, Lotan Y, Chun FK, Fisch M, Scherr DS, Shariat SF.","J Urol. 2013 Aug;190(2):480-6. doi: 10.1016/j.juro.2013.01.089. Epub 2013 Jan 31.","Kluth LA","J Urol","2013","2013/02/05","","","10.1016/j.juro.2013.01.089"
"872107","Current practice of urinary bladder cytology","Frable WJ, Paxson L, Barksdale JA, Koontz WW Jr.","Cancer Res. 1977 Aug;37(8 Pt 2):2800-5.","Frable WJ","Cancer Res","1977","1977/08/01","","",""
"23132611","Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis","Wang JK, Boorjian SA, Cheville JC, Kim SP, Tarrell RF, Thapa P, Frank I.","World J Urol. 2012 Dec;30(6):801-6. doi: 10.1007/s00345-012-0976-0. Epub 2012 Nov 7.","Wang JK","World J Urol","2012","2012/11/08","","","10.1007/s00345-012-0976-0"
"28040419","A novel treatment strategy for newly diagnosed high-grade T1 bladder cancer: Gemcitabine and cisplatin adjuvant chemotherapy-A single-institution experience","Yang GL, Zhang LH, Liu Q, Wang ZL, Duan XH, Huang YR, Bo JJ.","Urol Oncol. 2017 Feb;35(2):38.e9-38.e15. doi: 10.1016/j.urolonc.2016.08.017. Epub 2016 Dec 28.","Yang GL","Urol Oncol","2017","2017/01/02","","","10.1016/j.urolonc.2016.08.017"
"25238701","Significance of perivesical lymph nodes in radical cystectomy for bladder cancer","Hu B, Satkunasivam R, Schuckman A, Sherrod A, Cai J, Miranda G, Daneshmand S.","Urol Oncol. 2014 Nov;32(8):1158-65. doi: 10.1016/j.urolonc.2014.08.004. Epub 2014 Sep 17.","Hu B","Urol Oncol","2014","2014/09/21","","","10.1016/j.urolonc.2014.08.004"
"19428084","Efficacy of bacille Calmette-Guérin immunotherapy predicted by expression of antigen-presenting molecules and chemokines","Videira PA, Calais FM, Correia M, Ligeiro D, Crespo HJ, Calais F, Trindade H.","Urology. 2009 Oct;74(4):944-50. doi: 10.1016/j.urology.2009.02.053. Epub 2009 May 9.","Videira PA","Urology","2009","2009/05/12","","","10.1016/j.urology.2009.02.053"
"26469362","The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin","Gontero P, Sylvester R, Pisano F, Joniau S, Oderda M, Serretta V, Larré S, Di Stasi S, Van Rhijn B, Witjes AJ, Grotenhuis AJ, Colombo R, Briganti A, Babjuk M, Soukup V, Malmström PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha EK, Ardelt P, Vakarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Palou J.","BJU Int. 2016 Jul;118(1):44-52. doi: 10.1111/bju.13354. Epub 2015 Nov 6.","Gontero P","BJU Int","2016","2015/10/16","PMC5502757","NIHMS860337","10.1111/bju.13354"
"25197366","Prognostic significance of mucin expression in urothelial bladder cancer","Stojnev S, Ristic-Petrovic A, Velickovic LJ, Krstic M, Bogdanovic D, Khanh do T, Ristic A, Conic I, Stefanovic V.","Int J Clin Exp Pathol. 2014 Jul 15;7(8):4945-58. eCollection 2014.","Stojnev S","Int J Clin Exp Pathol","2014","2014/09/09","PMC4152056","",""
"15000308","[Cavernosal metastases from bladder tumour after cystoprostatectomy]","Mondet F, Mkaouar S, Chartier-Kastler E, Bitker MO, Delcourt A, Richard F.","Prog Urol. 2003 Dec;13(6):1330-3.","Mondet F","Prog Urol","2003","2004/03/06","","",""
"24693860","Evaluation of diagnostic accuracy of DNA methylation biomarkers for bladder cancer: a systematic review and meta-analysis","Chen H, Yu Y, Rong S, Wang H.","Biomarkers. 2014 May;19(3):189-97. doi: 10.3109/1354750X.2014.889211. Epub 2014 Apr 2.","Chen H","Biomarkers","2014","2014/04/04","","","10.3109/1354750X.2014.889211"
"8893873","Neoadjuvant and adjuvant chemotherapy in locally advanced bladder cancer","Sternberg CN.","Semin Oncol. 1996 Oct;23(5):621-32.","Sternberg CN","Semin Oncol","1996","1996/10/01","","",""
"6438644","Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols","Prout GR Jr, Kopp J.","Prog Clin Biol Res. 1984;162B:397-427.","Prout GR Jr","Prog Clin Biol Res","1984","1984/01/01","","",""
"19903170","Robot-assisted radical cystectomy: intermediate survival results at a mean follow-up of 25 months","Martin AD, Nunez RN, Pacelli A, Woods ME, Davis R, Thomas R, Andrews PE, Castle EP.","BJU Int. 2010 Jun;105(12):1706-9. doi: 10.1111/j.1464-410X.2009.09042.x. Epub 2009 Nov 9.","Martin AD","BJU Int","2010","2009/11/12","","","10.1111/j.1464-410X.2009.09042.x"
"3568036","Cytogenetics of bladder cancer: rearrangements of the short arm of chromosome 11","Vanni R, Peretti D, Scarpa RM, Usai E.","Cancer Detect Prev. 1987;10(5-6):401-3.","Vanni R","Cancer Detect Prev","1987","1987/01/01","","",""
"17680529","[Experimental study on bladder cancer by the small interfering RNA targeting survivin]","Hou JQ, He J, Wen DG, Wang XL.","Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Aug;24(4):401-4.","Hou JQ","Zhonghua Yi Xue Yi Chuan Xue Za Zhi","2007","2007/08/08","","",""
"26932430","β-catenin and SKP2 proteins as predictors of grade and stage of non-muscle invasive urothelial bladder carcinoma","Elsherif E, Elbaky TA, Elserafy F, Elkady N, Dawood M, Gaber MA, Badawy A, Gharabawy ME.","Chin Clin Oncol. 2016 Feb;5(1):6. doi: 10.3978/j.issn.2304-3865.2016.02.02.","Elsherif E","Chin Clin Oncol","2016","2016/03/03","","","10.3978/j.issn.2304-3865.2016.02.02"
"19220265","Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density","Wiesner C, Salzer A, Thomas C, Gellermann-Schultes C, Gillitzer R, Hampel C, Thüroff JW.","BJU Int. 2009 Aug;104(3):331-5. doi: 10.1111/j.1464-410X.2009.08403.x. Epub 2009 Feb 11.","Wiesner C","BJU Int","2009","2009/02/18","","","10.1111/j.1464-410X.2009.08403.x"
"7531137","[Staining test with methylene blue during resection of bladder cancer in 30 patients]","Jia WY, Li WL, Chen HG.","Zhonghua Wai Ke Za Zhi. 1994 Jun;32(6):351-3.","Jia WY","Zhonghua Wai Ke Za Zhi","1994","1994/06/01","","",""
"15342406","Ibuprofen inhibits survival of bladder cancer cells by induced expression of the p75NTR tumor suppressor protein","Khwaja F, Allen J, Lynch J, Andrews P, Djakiew D.","Cancer Res. 2004 Sep 1;64(17):6207-13. doi: 10.1158/0008-5472.CAN-03-3814.","Khwaja F","Cancer Res","2004","2004/09/03","","","10.1158/0008-5472.CAN-03-3814"
"4009824","Vaginal recurrence after cystectomy for bladder cancer","Chin JL, Wolf RM, Huben RP, Pontes JE.","J Urol. 1985 Jul;134(1):58-61. doi: 10.1016/s0022-5347(17)46978-3.","Chin JL","J Urol","1985","1985/07/01","","","10.1016/s0022-5347(17)46978-3"
"26269016","[The value of taking surgical margin specimens during transurethral resection of bladder tumor in the diagnosis and treatment of non-muscle invasive bladder cancer]","Qie Y, Hu H, Tian D.","Zhonghua Wai Ke Za Zhi. 2015 Mar;53(3):202-5.","Qie Y","Zhonghua Wai Ke Za Zhi","2015","2015/08/14","","",""
"31864368","Extended versus non-extended lymphadenectomy during radical cystectomy for patients with bladder cancer: a meta-analysis of the effect on long-term and short-term outcomes","Wang YC, Wu J, Dai B, Shen YJ, Ma CG, Ye DW, Zhu YP.","World J Surg Oncol. 2019 Dec 21;17(1):225. doi: 10.1186/s12957-019-1759-5.","Wang YC","World J Surg Oncol","2019","2019/12/23","PMC6925870","","10.1186/s12957-019-1759-5"
"20696818","Clinical outcomes of patients with pT0 bladder cancer after radical cystectomy: a single-institute experience","Fukuta F, Masumori N, Honma I, Muto M, Ichihara K, Kitamura H, Tsukamoto T.","Jpn J Clin Oncol. 2011 Jan;41(1):115-20. doi: 10.1093/jjco/hyq148. Epub 2010 Aug 9.","Fukuta F","Jpn J Clin Oncol","2011","2010/08/11","","","10.1093/jjco/hyq148"
"32878810","Gamma/Delta T-Cells Enhance Carboplatin-induced Cytotoxicity Towards Advanced Bladder Cancer Cells","Pan Y, Chiu YH, Chiu SC, Cho DY, Lee LM, Wen YC, Whang-Peng J, Hsiao CH, Shih PH.","Anticancer Res. 2020 Sep;40(9):5221-5227. doi: 10.21873/anticanres.14525.","Pan Y","Anticancer Res","2020","2020/09/04","","","10.21873/anticanres.14525"
"8281404","Urodynamic and clinical aspects of ileal low pressure bladder substitutes","Casanova GA, Springer JP, Gerber E, Studer UE.","Br J Urol. 1993 Nov;72(5 Pt 2):728-35. doi: 10.1111/j.1464-410x.1993.tb16257.x.","Casanova GA","Br J Urol","1993","1993/11/01","","","10.1111/j.1464-410x.1993.tb16257.x"
"12566821","Distal ureteral stenosis after early adjuvant intravesical mitomycin C application for superficial bladder cancer","Oehlschläger S, Loessnitzer A, Froehner M, Hakenberg OW, Manseck A, Wirth MP.","Urol Int. 2003;70(1):74-6. doi: 10.1159/000067698.","Oehlschläger S","Urol Int","2003","2003/02/05","","","10.1159/000067698"
"27766041","An Efficient Light-Inducible P53 Expression System for Inhibiting Proliferation of Bladder Cancer Cell","Lin F, Dong L, Wang W, Liu Y, Huang W, Cai Z.","Int J Biol Sci. 2016 Oct 18;12(10):1273-1278. doi: 10.7150/ijbs.16162. eCollection 2016.","Lin F","Int J Biol Sci","2016","2016/10/22","PMC5069448","","10.7150/ijbs.16162"
"5414742","Immune response to urinary bladder tumours in man","Bubeník J, Perlmann P, Helmstein K, Moberger G.","Int J Cancer. 1970 Jan 15;5(1):39-46. doi: 10.1002/ijc.2910050106.","Bubeník J","Int J Cancer","1970","1970/01/15","","","10.1002/ijc.2910050106"
"19588544","Combined effect of NAT2, MTR and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population","Ouerhani S, Rouissi K, Marrakchi R, Ben Slama MR, Sfaxi M, Chebil M, ElGaaied AB.","Cancer Detect Prev. 2009;32(5-6):395-402. doi: 10.1016/j.canep.2009.04.005.","Ouerhani S","Cancer Detect Prev","2009","2009/07/10","","","10.1016/j.canep.2009.04.005"
"27259667","Fibroblast growth factor receptor 1 and cytokeratin 20 expressions and their relation to prognostic variables in bladder cancer","Abdul-Maksoud RS, Shalaby SM, Elsayed WS, Elkady S.","Gene. 2016 Oct 15;591(2):320-6. doi: 10.1016/j.gene.2016.05.043. Epub 2016 May 31.","Abdul-Maksoud RS","Gene","2016","2016/06/05","","","10.1016/j.gene.2016.05.043"
"18398034","Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk","Tang L, Zirpoli GR, Guru K, Moysich KB, Zhang Y, Ambrosone CB, McCann SE.","Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):938-44. doi: 10.1158/1055-9965.EPI-07-2502.","Tang L","Cancer Epidemiol Biomarkers Prev","2008","2008/04/10","","","10.1158/1055-9965.EPI-07-2502"
"19365828","Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma: a ""split-sample"" study","Sullivan PS, Nooraie F, Sanchez H, Hirschowitz S, Levin M, Rao PN, Rao J.","Cancer. 2009 Jun 25;117(3):167-73. doi: 10.1002/cncy.20026.","Sullivan PS","Cancer","2009","2009/04/15","","","10.1002/cncy.20026"
"17971176","Declining mortality from bladder cancer in Europe","Ferlay J, Randi G, Bosetti C, Levi F, Negri E, Boyle P, La Vecchia C.","BJU Int. 2008 Jan;101(1):11-9. doi: 10.1111/j.1464-410X.2007.07239.x. Epub 2007 Oct 30.","Ferlay J","BJU Int","2008","2007/11/01","","","10.1111/j.1464-410X.2007.07239.x"
"27139193","Monitoring and malignancy concerns in patients with congenital bladder anomalies","Rove KO, Higuchi TT.","Curr Opin Urol. 2016 Jul;26(4):344-50. doi: 10.1097/MOU.0000000000000297.","Rove KO","Curr Opin Urol","2016","2016/05/04","","","10.1097/MOU.0000000000000297"
"30091881","[CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY OF MEDICAL ONCOLOGY CLINICAL GUIDELINES Part II: renal cell cancer, urinary bladder cancer, prostate cancer, testicular cancer]","Gnjidić M, Vojnović Ž, Čonkaš M, Čabo FG, Belev B, Budisavljević A, Gilja I, Plavetić ND, Šeparović R, Vrbanec D.","Lijec Vjesn. 2016 Jul-Aug;138(7-8):167-72.","Gnjidić M","Lijec Vjesn","2016","2018/08/10","","",""
"27032295","Perioperative and oncologic outcomes of robot-assisted vs. open radical cystectomy in bladder cancer patients: A comparison of two high-volume referral centers","Gandaglia G, Karl A, Novara G, de Groote R, Buchner A, D'Hondt F, Montorsi F, Stief C, Mottrie A, Gratzke C.","Eur J Surg Oncol. 2016 Nov;42(11):1736-1743. doi: 10.1016/j.ejso.2016.02.254. Epub 2016 Mar 19.","Gandaglia G","Eur J Surg Oncol","2016","2016/04/02","","","10.1016/j.ejso.2016.02.254"
"22019037","Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors","Pellucchi F, Freschi M, Ibrahim B, Rocchini L, Maccagnano C, Briganti A, Rigatti P, Montorsi F, Colombo R.","J Urol. 2011 Dec;186(6):2194-9. doi: 10.1016/j.juro.2011.07.070. Epub 2011 Oct 22.","Pellucchi F","J Urol","2011","2011/10/25","","","10.1016/j.juro.2011.07.070"
"498157","Phase II trial of cis-dichlorodiammineplatinum(II) in cancer of the bilharzial bladder","Gad-el-Mawla N, Chevlen E, Hamza R, Ziegler JL.","Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1577-8.","Gad-el-Mawla N","Cancer Treat Rep","1979","1979/09/01","","",""
"23682613","Hypermethylation of TWIST1 and NID2 in tumor tissues and voided urine in urinary bladder cancer patients","Yegin Z, Gunes S, Buyukalpelli R.","DNA Cell Biol. 2013 Jul;32(7):386-92. doi: 10.1089/dna.2013.2030. Epub 2013 May 19.","Yegin Z","DNA Cell Biol","2013","2013/05/21","","","10.1089/dna.2013.2030"
"29064650","The demographic features, clinical outcomes, prognosis and treatment options for patients with sarcomatoid carcinoma of the urinary bladder: a single centre experience","Robinson SP, Farooq A, Laniado M, Motiwala H.","Int Braz J Urol. 2018 Jan-Feb;44(1):45-52. doi: 10.1590/S1677-5538.IBJU.2016.0347.","Robinson SP","Int Braz J Urol","2018","2017/10/25","PMC5815531","","10.1590/S1677-5538.IBJU.2016.0347"
"29081034","Primary High-Grade Non-Muscle-Invasive Bladder Cancer: High NFκB Expression in Tumor Specimens Distinguishes Patients Who are at Risk for Disease Progression","Mitrakas L, Gravas S, Papandreou C, Koukoulis G, Karasavvidou F, Dimakopoulos G, Weingärtner K, Karatzas A, Zachos I, Tzortzis V.","Pathol Oncol Res. 2019 Jan;25(1):225-231. doi: 10.1007/s12253-017-0340-1. Epub 2017 Oct 28.","Mitrakas L","Pathol Oncol Res","2019","2017/10/30","","","10.1007/s12253-017-0340-1"
"26659909","Correlation of tumor-associated macrophages and NK cells with bladder cancer size and T stage in patients with solitary low-grade urothelial carcinoma","Krpina K, Babarović E, Španjol J, Đorđević G, Maurer T, Jonjić N.","Wien Klin Wochenschr. 2016 Apr;128(7-8):248-52. doi: 10.1007/s00508-015-0907-3. Epub 2015 Dec 11.","Krpina K","Wien Klin Wochenschr","2016","2015/12/15","","","10.1007/s00508-015-0907-3"
"2504487","Inhibitory action of alpha-difluoromethylornithine on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis","Uchida K, Seidenfeld J, Rademaker A, Oyasu R.","Cancer Res. 1989 Oct 1;49(19):5249-53.","Uchida K","Cancer Res","1989","1989/10/01","","",""
"3278481","Intraoperative electron-beam therapy and other bladder-sparing approaches to bladder carcinoma","Shipley W.","Urology. 1988 Feb;31(2 Suppl):18-21.","Shipley W","Urology","1988","1988/02/01","","",""
"2407335","A useful monoclonal antibody (BL2-10D1) to identify tumor cells in urine cytology","Longin A, Fontaniere B, Berger-Dutrieux N, Devonec M, Laurent JC.","Cancer. 1990 Mar 15;65(6):1412-7. doi: 10.1002/1097-0142(19900315)65:6<1412::aid-cncr2820650628>3.0.co;2-a.","Longin A","Cancer","1990","1990/03/15","","","10.1002/1097-0142(19900315)65:6<1412::aid-cncr2820650628>3.0.co;2-a"
"11340570","Optimization of differential photodynamic effectiveness between normal and tumor urothelial cells using 5-aminolevulinic acid-induced protoporphyrin IX as sensitizer","Seidl J, Rauch J, Krieg RC, Appel S, Baumgartner R, Knuechel R.","Int J Cancer. 2001 Jun 1;92(5):671-7. doi: 10.1002/1097-0215(20010601)92:5<671::aid-ijc1240>3.0.co;2-p.","Seidl J","Int J Cancer","2001","2001/05/08","","","10.1002/1097-0215(20010601)92:5<671::aid-ijc1240>3.0.co;2-p"
"7370934","Classification and staging of bladder carcinoma","Prout GR Jr.","Cancer. 1980 Apr 15;45(7 Suppl):1832-41.","Prout GR Jr","Cancer","1980","1980/04/15","","",""
"30122781","[A primary intestinal-derived adenocarcinoma in intestine bladder substitutes: a case report]","Qin ZJ, Bi H, Ma LL, Huang Y, Zhang F.","Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Aug 18;50(4):737-739.","Qin ZJ","Beijing Da Xue Xue Bao Yi Xue Ban","2018","2018/08/21","","",""
"21782482","Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?","Park J, Song C, Shin E, Hong JH, Kim CS, Ahn H.","Urol Oncol. 2013 Aug;31(6):849-56. doi: 10.1016/j.urolonc.2011.06.004. Epub 2011 Jul 22.","Park J","Urol Oncol","2013","2011/07/26","","","10.1016/j.urolonc.2011.06.004"
"8342414","[Microdoses of BCG vaccine for prophylaxis in bladder cancer stage T1]","Rivera P, Caffarena E, Cornejo H, Del Pino M, Fonerón A, Haemmersli J, Sepúlveda M, Ubilla A.","Actas Urol Esp. 1993 Apr;17(4):243-6.","Rivera P","Actas Urol Esp","1993","1993/04/01","","",""
"20968026","[A method for forming a urinary bladder from the sigmoid after radical cystectomy in patients with bladder cancer]","Shkol'nik MI, Polysalov VN, Timofeev DA, Belov AD, Shangin GB, Shumskiĭ IA.","Vopr Onkol. 2010;56(4):456-9.","Shkol'nik MI","Vopr Onkol","2010","2010/10/26","","",""
"2630674","[Cytogenetic analysis of human urinary bladder cancer]","Moriyama M, Kubota Y.","Rinsho Byori. 1989 Feb;Spec No 80:252-7.","Moriyama M","Rinsho Byori","1989","1989/02/01","","",""
"21284270","Why does Rhode Island have the greatest incidence of bladder cancer in the United States?","Faricy-Anderson KE, Fulton JP, Mega AE.","Med Health R I. 2010 Oct;93(10):308, 313-6.","Faricy-Anderson KE","Med Health R I","2010","2011/02/03","","",""
"31718944","Synthesis, characterization, and biological activity of a triphenylphosphonium-containing imidazolium salt against select bladder cancer cell lines","Stromyer ML, Southerland MR, Satyal U, Sikder RK, Weader DJ, Baughman JA, Youngs WJ, Abbosh PH.","Eur J Med Chem. 2020 Jan 1;185:111832. doi: 10.1016/j.ejmech.2019.111832. Epub 2019 Oct 31.","Stromyer ML","Eur J Med Chem","2020","2019/11/14","PMC7224591","NIHMS1586469","10.1016/j.ejmech.2019.111832"
"28650865","Effect of obesity on bladder cancer and renal cell carcinoma incidence and survival","Gild P, Ehdaie B, Kluth LA.","Curr Opin Urol. 2017 Sep;27(5):409-414. doi: 10.1097/MOU.0000000000000425.","Gild P","Curr Opin Urol","2017","2017/06/27","","","10.1097/MOU.0000000000000425"
"7511290","[Demonstration of gene amplification in urinary bladder cancer by fluorescent in situ hybridization (FISH)]","Sauter G, Moch H, Gudat F, Mihatsch MJ, Haley J, Meecker T, Waldman F.","Verh Dtsch Ges Pathol. 1993;77:247-51.","Sauter G","Verh Dtsch Ges Pathol","1993","1993/01/01","","",""
"5121671","Transitional cell hyperplasia in the bladders of dogs fed DL-tryptophan","Radomski JL, Glass EM, Deichmann WB.","Cancer Res. 1971 Nov;31(11):1690-4.","Radomski JL","Cancer Res","1971","1971/11/01","","",""
"27209348","The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review","Marchioni M, Primiceri G, Ingrosso M, Filograna R, Castellan P, De Francesco P, Schips L.","Clin Genitourin Cancer. 2016 Dec;14(6):473-484. doi: 10.1016/j.clgc.2016.04.008. Epub 2016 Apr 22.","Marchioni M","Clin Genitourin Cancer","2016","2016/05/23","","","10.1016/j.clgc.2016.04.008"
"3679773","Bladder cancer in 156 patients aged eighty years or more","Fitzpatrick JM, Durazi M, Butler MR, Lane V, O'Flynn JD.","Ir J Med Sci. 1987 Sep;156(9):259-61. doi: 10.1007/BF02954061.","Fitzpatrick JM","Ir J Med Sci","1987","1987/09/01","","","10.1007/BF02954061"
"30064163","[A Case of Metachronous Cancer Originating from Five Different Organs]","Murakami M, Kimura T, Iwamoto M, Honda M, Ishii G, Koike Y, Sasaki H, Furuta A, Miki K, Ikegami M, Egawa S.","Hinyokika Kiyo. 2018 May;64(5):231-234. doi: 10.14989/ActaUrolJap_64_5_231.","Murakami M","Hinyokika Kiyo","2018","2018/08/01","","","10.14989/ActaUrolJap_64_5_231"
"16001337","[The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer]","Heidenreich A, Ohlmann CH.","Aktuelle Urol. 2005 Jun;36(3):219-29. doi: 10.1055/s-2004-830279.","Heidenreich A","Aktuelle Urol","2005","2005/07/08","","","10.1055/s-2004-830279"
"14569999","Bibliography. Current world literature. Bladder cancer","","Curr Opin Urol. 2003 Sep;13(5):423-6.","","Curr Opin Urol","2003","2003/10/23","","",""
"1831033","Urinary tract reconstruction improves quality of life for men with bladder cancer","","Oncology (Williston Park). 1991 Apr;5(4):150, 157.","","Oncology (Williston Park)","1991","1991/04/01","","",""
"16753364","Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria","Sarosdy MF, Kahn PR, Ziffer MD, Love WR, Barkin J, Abara EO, Jansz K, Bridge JA, Johansson SL, Persons DL, Gibson JS.","J Urol. 2006 Jul;176(1):44-7. doi: 10.1016/S0022-5347(06)00576-3.","Sarosdy MF","J Urol","2006","2006/06/07","","","10.1016/S0022-5347(06)00576-3"
"19655763","Polymer-enhanced adenoviral transduction of CAR-negative bladder cancer cells","Kasman LM, Barua S, Lu P, Rege K, Voelkel-Johnson C.","Mol Pharm. 2009 Sep-Oct;6(5):1612-9. doi: 10.1021/mp9000958.","Kasman LM","Mol Pharm","2009","2009/08/07","PMC2757475","NIHMS137240","10.1021/mp9000958"
"12667716","Low IL-1alpha expression in bladder cancer tissue and survival","Seddighzadeh M, Larsson P, Ulfgren AC, Onelöv E, Berggren P, Tribukait B, Torstensson A, Norming U, Wijkström H, Linder S, Steineck G.","Eur Urol. 2003 Apr;43(4):362-8. doi: 10.1016/s0302-2838(03)00047-2.","Seddighzadeh M","Eur Urol","2003","2003/04/02","","","10.1016/s0302-2838(03)00047-2"
"19842028","The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls","Clague J, Cinciripini P, Blalock J, Wu X, Hudmon KS.","Behav Genet. 2010 Jan;40(1):49-58. doi: 10.1007/s10519-009-9301-0. Epub 2009 Oct 15.","Clague J","Behav Genet","2010","2009/10/21","PMC3719969","NIHMS470189","10.1007/s10519-009-9301-0"
"29191126","Intravesical radiofrequency induced hyperthermia enhances mitomycin C accumulation in tumour tissue","van Valenberg FJP, van der Heijden AG, Lammers RJM, Falke J, Arends TJH, Oosterwijk E, Witjes JA.","Int J Hyperthermia. 2018 Nov;34(7):988-993. doi: 10.1080/02656736.2017.1406618. Epub 2017 Dec 1.","van Valenberg FJP","Int J Hyperthermia","2018","2017/12/02","","","10.1080/02656736.2017.1406618"
"15677899","Fluid intake and urinary bladder cancer","Allam MF.","Eur J Cancer Prev. 2005 Feb;14(1):77-8. doi: 10.1097/00008469-200502000-00011.","Allam MF","Eur J Cancer Prev","2005","2005/01/29","","","10.1097/00008469-200502000-00011"
"3283708","Tryptophan, urinary quinolines, and bladder cancer","Williams DJ.","Nutr Cancer. 1988;11(2):81-2. doi: 10.1080/01635588809513973.","Williams DJ","Nutr Cancer","1988","1988/01/01","","","10.1080/01635588809513973"
"1830406","Serum and urine ferritin in patients with transitional cell carcinoma of the bladder","Migliari R, Mela Q, Ruggiero V, Scarpa RM, Migliari M, Pitzus F, Usai E.","Arch Ital Urol Nefrol Androl. 1991 Mar;63(1):141-5.","Migliari R","Arch Ital Urol Nefrol Androl","1991","1991/03/01","","",""
"4765371","Cilia in the epithelium of the urinary bladder during experimental carcinogenesis","Yalciner S, Friedell GH.","J Natl Cancer Inst. 1973 Aug;51(2):501-5.","Yalciner S","J Natl Cancer Inst","1973","1973/08/01","","",""
"25944080","Utility of SAM68 in the progression and prognosis for bladder cancer","Zhang Z, Yu C, Li Y, Jiang L, Zhou F.","BMC Cancer. 2015 May 6;15:364. doi: 10.1186/s12885-015-1367-x.","Zhang Z","BMC Cancer","2015","2015/05/07","PMC4425873","","10.1186/s12885-015-1367-x"
"1902559","Effects of carotenoid administration on bladder cancer prevention","Mathews-Roth MM, Lausen N, Drouin G, Richter A, Krinsky NI.","Oncology. 1991;48(3):177-9. doi: 10.1159/000226922.","Mathews-Roth MM","Oncology","1991","1991/01/01","","","10.1159/000226922"
"639055","Appearance of giant cells as a morphological response of rat bladder carcinoma cell line (Nara Bladder Tumor No. 2) to a continuous thermal gradient in tissue culture","Geisinger KR, Leighton J, Zealberg J.","Cancer Res. 1978 May;38(5):1223-30.","Geisinger KR","Cancer Res","1978","1978/05/01","","",""
"2915239","Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer","Eapen L, Stewart D, Danjoux C, Genest P, Futter N, Moors D, Irvine A, Crook J, Aitken S, Gerig L, et al.","J Clin Oncol. 1989 Feb;7(2):230-5. doi: 10.1200/JCO.1989.7.2.230.","Eapen L","J Clin Oncol","1989","1989/02/01","","","10.1200/JCO.1989.7.2.230"
"22779969","Primary and secondary malignant involvement of gynaecological organs at radical cystectomy for bladder cancer: review of literature and retrospective analysis of 360 cases","Salem H, El-Mazny A.","J Obstet Gynaecol. 2012 Aug;32(6):590-3. doi: 10.3109/01443615.2012.693980.","Salem H","J Obstet Gynaecol","2012","2012/07/12","","","10.3109/01443615.2012.693980"
"16734215","[Prostate cancer incidence on specimen of cystoprostatectomy for infiltrative bladder cancer]","Zerbib M, Bouchot O.","Prog Urol. 2005 Dec;15(6 Suppl 1):1262-5.","Zerbib M","Prog Urol","2005","2006/06/01","","",""
"26210894","EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin","Cambier S, Sylvester RJ, Collette L, Gontero P, Brausi MA, van Andel G, Kirkels WJ, Silva FC, Oosterlinck W, Prescott S, Kirkali Z, Powell PH, de Reijke TM, Turkeri L, Collette S, Oddens J.","Eur Urol. 2016 Jan;69(1):60-9. doi: 10.1016/j.eururo.2015.06.045. Epub 2015 Jul 23.","Cambier S","Eur Urol","2016","2015/07/27","","","10.1016/j.eururo.2015.06.045"
"4972303","The role of thiotepa instillations in bladder cancer","Veenema RJ.","JAMA. 1968 Dec 16;206(12):2725-6.","Veenema RJ","JAMA","1968","1968/12/16","","",""
"23870731","Concurrence of villous adenoma and non-muscle invasive bladder cancer arising in the bladder: a case report and review of the literature","Kato Y, Konari S, Obara W, Sugai T, Fujioka T.","BMC Urol. 2013 Jul 20;13:36. doi: 10.1186/1471-2490-13-36.","Kato Y","BMC Urol","2013","2013/07/23","PMC3726475","","10.1186/1471-2490-13-36"
"1337659","[Superficial and pedunculated signet ring cell carcinoma of the urinary bladder: a case report]","Murai T, Miura T, Kondo I, Fujii H.","Hinyokika Kiyo. 1992 Dec;38(12):1395-8.","Murai T","Hinyokika Kiyo","1992","1992/12/01","","",""
"9749073","[Treatment of superficial tumors of the bladder]","Patard JJ, Chopin D, Abbou CC.","Cancer Radiother. 1998 Apr;2 Suppl 1:19s-26s.","Patard JJ","Cancer Radiother","1998","1998/09/28","","",""
"9815569","Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer","Pollack A, Wu CS, Czerniak B, Zagars GK, Benedict WF, McDonnell TJ.","Clin Cancer Res. 1997 Oct;3(10):1823-9.","Pollack A","Clin Cancer Res","1997","1998/11/17","","",""
"9336151","Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer","Pollack A, Czerniak B, Zagars GK, Hu SX, Wu CS, Dinney CP, Chyle V, Benedict WF.","Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):687-95. doi: 10.1016/s0360-3016(97)00147-8.","Pollack A","Int J Radiat Oncol Biol Phys","1997","1997/10/23","","","10.1016/s0360-3016(97)00147-8"
"23327460","Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker data","Emmert-Streib F, Abogunrin F, de Matos Simoes R, Duggan B, Ruddock MW, Reid CN, Roddy O, White L, O'Kane HF, O'Rourke D, Anderson NH, Nambirajan T, Williamson KE.","BMC Med. 2013 Jan 17;11:12. doi: 10.1186/1741-7015-11-12.","Emmert-Streib F","BMC Med","2013","2013/01/19","PMC3570289","","10.1186/1741-7015-11-12"
"3116739","Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer","Baker WC, Russo MA, deVere White RW.","Urology. 1987 Oct;30(4):357-8. doi: 10.1016/0090-4295(87)90300-1.","Baker WC","Urology","1987","1987/10/01","","","10.1016/0090-4295(87)90300-1"
"26905174","Bladder cancer presenting with spontaneous subcapsular urinoma of kidney","Goyal NK, Goel A, Singh V, Sankhwar SN.","Indian J Cancer. 2015 Jul-Sep;52(3):473-4. doi: 10.4103/0019-509X.176744.","Goyal NK","Indian J Cancer","2015","2016/02/25","","","10.4103/0019-509X.176744"
"11337289","Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder?","Sağol O, Yörükoğlu K, Sis B, Tuna B, Ozer E, Güray M, Mungan U, Kirkali Z.","Urology. 2001 May;57(5):895-9. doi: 10.1016/s0090-4295(01)00905-0.","Sağol O","Urology","2001","2001/05/19","","","10.1016/s0090-4295(01)00905-0"
"22041857","Clinical usefulness of CEA, CA19-9, and CYFRA 21-1 as tumor markers for urothelial bladder carcinoma","Washino S, Hirai M, Matsuzaki A, Kobayashi Y.","Urol Int. 2011;87(4):420-8. doi: 10.1159/000327517. Epub 2011 Oct 28.","Washino S","Urol Int","2011","2011/11/02","","","10.1159/000327517"
"15361369","Urinary bladder cancer in Wegener's granulomatosis: is it more than cyclophosphamide?","Hellmich B, Kausch I, Doehn C, Jocham D, Holl-Ulrich K, Gross WL.","Ann Rheum Dis. 2004 Oct;63(10):1183-5. doi: 10.1136/ard.2004.023937.","Hellmich B","Ann Rheum Dis","2004","2004/09/14","PMC1754742","","10.1136/ard.2004.023937"
"9181928","[Role of MCP-1 chemokine in the response of monocytes of patients with superficial tumors of the bladder treated with BCG immunotherapy]","Iantorno R, Nicolai M, Cipollone G, Di Federico G, Tenaglia R.","Arch Ital Urol Androl. 1997 Feb;69 Suppl 1:71-2.","Iantorno R","Arch Ital Urol Androl","1997","1997/02/01","","",""
"9615199","Cell cycle regulators as prognostic factors for bladder cancer","Cordon-Cardo C.","Eur Urol. 1998;33 Suppl 4:11-2. doi: 10.1159/000052253.","Cordon-Cardo C","Eur Urol","1998","1998/06/06","","","10.1159/000052253"
"28004432","Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer","Alevizopoulos A, Tyritzis S, Leotsakos I, Anastasopoulou I, Pournaras C, Kotsis P, Katsarou O, Alamanis C, Stravodimos K, Constantinides C.","Int J Urol. 2017 Feb;24(2):130-136. doi: 10.1111/iju.13271. Epub 2016 Dec 22.","Alevizopoulos A","Int J Urol","2017","2016/12/23","","","10.1111/iju.13271"
"12016161","Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies","Airoldi L, Orsi F, Magagnotti C, Coda R, Randone D, Casetta G, Peluso M, Hautefeuille A, Malaveille C, Vineis P.","Carcinogenesis. 2002 May;23(5):861-6. doi: 10.1093/carcin/23.5.861.","Airoldi L","Carcinogenesis","2002","2002/05/23","","","10.1093/carcin/23.5.861"
"2176129","pSV3neo transfection and radiosensitivity of human cancer cell lines","Parris CN, Masters JR, Green MH.","Cancer Lett. 1990 Dec 3;55(2):171-5. doi: 10.1016/0304-3835(90)90029-w.","Parris CN","Cancer Lett","1990","1990/12/03","","","10.1016/0304-3835(90)90029-w"
"29454473","Re: Propensity Score Analysis of Radical Cystectomy Versus Bladder-sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic","El-Achkar A, Kassouf W.","Eur Urol. 2018 May;73(5):810-811. doi: 10.1016/j.eururo.2018.01.034. Epub 2018 Feb 14.","El-Achkar A","Eur Urol","2018","2018/02/19","","","10.1016/j.eururo.2018.01.034"
"30030660","Invasive non-urachal adenocarcinoma of the bladder: analysis of the National Cancer Database","Davaro F, Schaefer J, May A, Raza J, Siddiqui S, Hamilton Z.","World J Urol. 2019 Mar;37(3):497-505. doi: 10.1007/s00345-018-2411-7. Epub 2018 Jul 20.","Davaro F","World J Urol","2019","2018/07/22","","","10.1007/s00345-018-2411-7"
"28040422","Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients","Moschini M, Shariat SF, Lucianò R, D'Andrea D, Foerster B, Abufaraj M, Bandini M, Dell'Oglio P, Damiano R, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A.","Clin Genitourin Cancer. 2017 Aug;15(4):e603-e607. doi: 10.1016/j.clgc.2016.12.006. Epub 2016 Dec 14.","Moschini M","Clin Genitourin Cancer","2017","2017/01/02","","","10.1016/j.clgc.2016.12.006"
"26329815","The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy","Gershman B, Moreira DM, Tollefson MK, Frank I, Cheville JC, Thapa P, Tarrell RF, Thompson RH, Boorjian SA.","Urol Oncol. 2016 Jan;34(1):4.e1-9. doi: 10.1016/j.urolonc.2015.07.023. Epub 2015 Aug 29.","Gershman B","Urol Oncol","2016","2015/09/03","","","10.1016/j.urolonc.2015.07.023"
"10843452","Telomerase activity in urine after transurethral resection of superficial bladder cancer and early recurrence","Wu XX, Kakehi Y, Takahashi T, Habuchi T, Ogawa O.","Int J Urol. 2000 Jun;7(6):210-7. doi: 10.1046/j.1442-2042.2000.00178.x.","Wu XX","Int J Urol","2000","2000/06/08","","","10.1046/j.1442-2042.2000.00178.x"
"17315719","[Two cases of multifocal cancer--of the urinary bladder and prostatic gland]","Kaprin AD, Galil-Ogly GA, Anan'ev AP, Alipchenko LA, Bashmakov VA.","Urologiia. 2006 Nov-Dec;(6):74, 77-9.","Kaprin AD","Urologiia","2006","2007/02/24","","",""
"26242145","[LAPAROSCOPIC AND OPEN RADICAL CYSTECTOMY FOR BLADDER CANCER]","Nosov AK, Reva SA, Dzhalilov IB, Petrov SB.","Vopr Onkol. 2015;61(3):352-61.","Nosov AK","Vopr Onkol","2015","2015/08/06","","",""
"1942705","[A clinico-pathological study of 69 cases after total cystectomy]","Hayashi Y, Tawada T, Ando Y, Terao E, Yamasaki I, Tsujimura S, Shimaya M, Kondo T, Ikei K.","Nihon Hinyokika Gakkai Zasshi. 1991 Sep;82(9):1452-60. doi: 10.5980/jpnjurol1989.82.1452.","Hayashi Y","Nihon Hinyokika Gakkai Zasshi","1991","1991/09/01","","","10.5980/jpnjurol1989.82.1452"
"16325414","Continent urinary diversion","Burkhard FC, Kessler TM, Mills R, Studer UE.","Crit Rev Oncol Hematol. 2006 Mar;57(3):255-64. doi: 10.1016/j.critrevonc.2005.06.008. Epub 2005 Dec 1.","Burkhard FC","Crit Rev Oncol Hematol","2006","2005/12/06","","","10.1016/j.critrevonc.2005.06.008"
"28039452","Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor","Kang M, Jeong CW, Kwak C, Kim HH, Ku JH.","Oncotarget. 2017 Feb 21;8(8):12891-12901. doi: 10.18632/oncotarget.14179.","Kang M","Oncotarget","2017","2017/01/01","PMC5355064","","10.18632/oncotarget.14179"
"13687923","[Indication and results of partial bladder resections in bladder cancer]","BAUER KM, HESSE F.","Med Welt. 1961 Apr 1;13:628-30.","BAUER KM","Med Welt","1961","1961/04/01","","",""
"9733663","N-glucuronidation of benzidine and its metabolites. Role in bladder cancer","Zenser TV, Lakshmi VM, Davis BB.","Drug Metab Dispos. 1998 Sep;26(9):856-9.","Zenser TV","Drug Metab Dispos","1998","1998/09/12","","",""
